<?xml version="1.0" encoding="UTF-8"?>
<DataElementsList>
  <DataElement num="1">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>37</PUBLICID>
    <LONGNAME>Prior Growth Factor Received Ind-2</LONGNAME>
    <PREFERREDNAME>PRIO_GFAC_RECD_IND-2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator to specify if the patient received any growth factor agents just prior to study entry.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014048</PublicId>
      <PreferredName>PRIOR_GFAC_RECD</PreferredName>
      <PreferredDefinition>information relating to the administration of growth factors to the patient.</PreferredDefinition>
      <LongName>Prior Growth Factor Received</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206436</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C20424</PreferredName>
        <Version>1</Version>
        <LongName>Prior Growth Factor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20424</PREFERRED_NAME>
            <LONG_NAME>Growth Factor</LONG_NAME>
            <CON_ID>2202650</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2184327</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Received</PreferredName>
        <Version>1</Version>
        <LongName>Received</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Growth Factor Ind</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did patient receive growth fa</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did patient receive growth factors within 1 week of entry onto this study?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_TEXT_1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior hematopoietic growth factor agents received</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient receive growth factors that support platelet or white cell number or function within 7 days prior to study enrollment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient receive all colony forming growth factors for more than 1 week and all long acting growth factors for more than 2 weeks prior to registration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient received colony-stimulating factors &lt; 1 week prior to enrollment (GCSF, GM CSF, erythropoietin)? Two weeks must have elapsed if patients received PEG formulations.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text2, exclusion</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient received colony-stimulating factors &lt; 1 week prior to registration (GCSF, GM CSF, erythropoietin)?  Two weeks must have elapsed if patients received PEG formulations.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient receive growth factors?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has it been &lt;=7 days since the last dose of growth factors?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient is off all colony-stimulating growth factor(s) for at least 1 week prior to enrollment (i.e. filgrastim, sargramostim), and at least two weeks have elapsed if patients received PEG formulations?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient is off all colony-stimulating growth factor(s) for at least 7 days prior to enrollment (i.e. filgrastim, sargramostim), and at least 14 days have elapsed if patients received PEG formulations?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient is off all colony forming growth factor(s) for at least one week prior to enrollment (i.e. filgrastim, sargramostim and erythropoietin), and at least two weeks have elapsed if patient received  long acting growth factors?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has it been more than 7 days since the last dose of growth factor prior to study enrollment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient off all colony-stimulating growth factor(s) for at least 1 week prior to enrollment (i.e. filgrastim, sargramostim or erythropoietin), and at least 2 weeks have elapsed if patients received PEG formulations?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient is off all colony-stimulating growth factor(s) for at least 7 days prior to enrollment (i.e. filgrastim, sargramostim or erythropoietin), and at least 14 days have elapsed if patients received PEG formulations?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient is off all colony-stimulating growth factor(s) for at least 7 days prior to enrollment (e.g. filgrastim, sargramostim or erythropoietin), and at least 14 days have elapsed if patients received PEG formulations?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient off all colony-stimulating factor(s) (e.g. filgrastim, sargramostim or erythropoietin) for at least 1 week prior to enrollment, and at least 2 weeks have elapsed if patient received PEG formulations?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Have prior hematopoietic growth factor agents been received?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG-ACRIN - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If the patient completed the baseline (T0) FDG-PET/CT prior to registration, did the patient use colony stimulating growth factors within 14 days prior to completing the T0 scan?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient received prior hematopoietic growth factor agents?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase 1/Pilot Consortium</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3303197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4254096</PublicId>
          <ContextName>PBTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PBTC-042</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4254119</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4254096</PublicId>
          <ContextName>PBTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase I</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>10000103</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PRIO_GFAC_RECD_IND-2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRIO_GFAC_RECD_IND-2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="2">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2331</PUBLICID>
    <LONGNAME>Prior High-Dose Chemotherapy with Stem Cell Support Metastatic Recurrent Disease Administered End Date</LONGNAME>
    <PREFERREDNAME>PR_HD/A_ME_R_AD_E_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>an end date of previous cancer treatment for metastatic or recurrent disease using high dose chemotherapy with stem cell support or transplant.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189046</PublicId>
      <PreferredName>PRI_HDC/ASCT_MET_ADM</PreferredName>
      <PreferredDefinition>information related to previous high dose chemotherapy with stem cell support administered for metastatic disease.</PreferredDefinition>
      <LongName>Prior High-Dose Chemotherapy with Stem Cell Support Metastatic Recurrent Disease Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206629</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C38722</PreferredName>
        <Version>1</Version>
        <LongName>Prior High-Dose Chemotherapy with Stem Cell Support</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38722</PREFERRED_NAME>
            <LONG_NAME>High-Dose Chemotherapy with Stem Cell Support</LONG_NAME>
            <CON_ID>2202346</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2754945</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14174:C38155:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Metastatic Recurrent Disease Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14174</PREFERRED_NAME>
            <LONG_NAME>Metastatic</LONG_NAME>
            <CON_ID>2204914</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38155</PREFERRED_NAME>
            <LONG_NAME>Recurrent Disease</LONG_NAME>
            <CON_ID>2202887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188674</PublicId>
      <PreferredName>END_DT</PreferredName>
      <PreferredDefinition>The date on which an observation or an event ended.</PreferredDefinition>
      <LongName>End Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184285</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Date</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date Prior Metastatic/Recurre</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date Prior Metastatic/Recurrent HDC/ASCT Ended</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior Metastatic/Recurrent HDC/ASCT End Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Char.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0002900</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0002743</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0002422</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="3">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2988</PUBLICID>
    <LONGNAME>Other Site Involved Ind-3</LONGNAME>
    <PREFERREDNAME>OTHER_SITE_INVL_IND-3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator that asks whether another disease site was involved.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189769</PublicId>
      <PreferredName>OTHER_LCTN_INVL</PreferredName>
      <PreferredDefinition>information related to other location involved.</PreferredDefinition>
      <LongName>Other Location Involved</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206648</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:CL111053</PreferredName>
        <Version>1</Version>
        <LongName>Other Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL111053</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2203486</CON_ID>
            <DEFINITION_SOURCE>NCI; National Cancer Institute Thesaurus. September 2003</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2192548</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25548</PreferredName>
        <Version>1</Version>
        <LongName>Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other Site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this site involved</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other site</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Other site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other site</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other site(s)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other site(s)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Limited</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Non-local Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Stage I-III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Palliative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000614</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0062861</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0003241</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0058442</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0003013</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0003025</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_DADX_oth_site_involve_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OTHER_SITE_INVL_IND-3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_NMM_oth_site_involve_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_DALE_oth_site_involve_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NM_NMLM_oth_site_involve_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="4">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>61298</PUBLICID>
    <LONGNAME>Treatment First Cycle Begin Date</LONGNAME>
    <PREFERREDNAME>TX_FIRST_CYCLE_BEG_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>Date on which the first dose of the first cycle of treatment or therapy was given.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRDS</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2190029</PublicId>
      <PreferredName>TX_FIRST_CYCLE</PreferredName>
      <PreferredDefinition>information related to the first cycle of treatment.</PreferredDefinition>
      <LongName>Treatment First Cycle</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176930</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Treatment</PreferredName>
        <Version>1</Version>
        <LongName>Treatment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207208</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C25472</PreferredName>
        <Version>1</Version>
        <LongName>First Cycle</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25472</PREFERRED_NAME>
            <LONG_NAME>Cycle</LONG_NAME>
            <CON_ID>2202487</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188673</PublicId>
      <PreferredName>BEG_DT</PreferredName>
      <PreferredDefinition>The date on which an observation or an event began.</PreferredDefinition>
      <LongName>Begin Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yyyy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Begin Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Start Date of First Dose of F</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Start Date of First Dose of First Cycle</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>First Dose Start Date, First Cycle</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date First Dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Question Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of first visit</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Question Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of first visit (derived)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Question Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Start date of first course</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Question Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Start date of first course (derived)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Question Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Start date of first cycle</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Question Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Start date of first cycle (derived)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Start date of first reporting period (derived):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Curative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000369</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Palliative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000614</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858960</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Adopted</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caAERS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4861354</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858960</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Adopted</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RAVE Integrations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5858963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858960</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Adopted</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAE</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5858965</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TX_CRSE_BEG_DT</AlternateName>
        <AlternateNameType>NRDS Alternate Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRDS</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPAE_QVAL_FCYSTDAT</AlternateName>
        <AlternateNameType>OID, NRDS Standard</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="5">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>61435</PUBLICID>
    <LONGNAME>Malignant Neoplasm Progression Lymph Node Anatomic Site</LONGNAME>
    <PREFERREDNAME>MALN_PROG_LN_ANA_SIT</PREFERREDNAME>
    <PREFERREDDEFINITION>a text field to identify a rounded mass of lymphatic tissue in the body to which cancer (atypical neoplastic cells) has spread indicating advancement of disease.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2010323</PublicId>
      <PreferredName>MALNE_PROG_LN_ANATLC</PreferredName>
      <PreferredDefinition>related to spread of cancer (atypical neoplastic cells) to a rounded mass of lymphatic tissue in the body indicating advancement of disease.</PreferredDefinition>
      <LongName>Malignant Neoplasm Progression Lymph Node Anatomic Location</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2481122</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305:C25331</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm Progression</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25331</PREFERRED_NAME>
            <LONG_NAME>Progression</LONG_NAME>
            <CON_ID>2202788</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2480022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12745:C25421:C25341</PreferredName>
        <Version>1</Version>
        <LongName>Lymph Node Anatomic Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12745</PREFERRED_NAME>
            <LONG_NAME>Lymph Node</LONG_NAME>
            <CON_ID>2202290</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25421</PREFERRED_NAME>
            <LONG_NAME>Anatomic</LONG_NAME>
            <CON_ID>2202601</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180752</PublicId>
      <PreferredName>LN_PROG_SITE</PreferredName>
      <PreferredDefinition>the site of lymph node progression.</PreferredDefinition>
      <LongName>Lymph Node Progression Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2519596</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lymph Nodes Specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Lymph Nodes Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Progression Site Lymph Nodes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Cervical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Endometrial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Ovarian</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811819</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Recurrent Gyn</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811938</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="6">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>62339</PUBLICID>
    <LONGNAME>Gynecologic Malignant Neoplasm Progression Anatomic Site</LONGNAME>
    <PREFERREDNAME>GY_MALN_PROG_ANA_SIT</PREFERREDNAME>
    <PREFERREDDEFINITION>a structure or organ within the body to which cancer (atypical neoplastic cells) originating in the female reproductive organs has spread indicating advancement of disease.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2010313</PublicId>
      <PreferredName>GYN_MALN_PROG_ANATLC</PreferredName>
      <PreferredDefinition>related to the spread of cancer (atypical neoplastic cells) originating in the female reproductive organs to other structures or organs within the body indicating advancement of disease.</PreferredDefinition>
      <LongName>Gynecologic Malignant Neoplasm Progression Anatomic Location</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2481123</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28016:C9305:C25331</PreferredName>
        <Version>1</Version>
        <LongName>Gynecologic Malignant Neoplasm Progression</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28016</PREFERRED_NAME>
            <LONG_NAME>Gynecologic</LONG_NAME>
            <CON_ID>2202649</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25331</PREFERRED_NAME>
            <LONG_NAME>Progression</LONG_NAME>
            <CON_ID>2202788</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2442487</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25421:C25341</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25421</PREFERRED_NAME>
            <LONG_NAME>Anatomic</LONG_NAME>
            <CON_ID>2202601</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015353</PublicId>
      <PreferredName>GY_MALN_PROG_ANA_SIT</PreferredName>
      <PreferredDefinition>a structure or organ within the body to which cancer (atypical neoplastic cells) originating in the female reproductive organs has spread indicating advancement of disease.</PreferredDefinition>
      <LongName>Gynecologic Malignant Neoplasm Progression Anatomic Site</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTEP CDE Committee</Origin>
      <Representation>
        <PublicId>2519596</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ascites</VALIDVALUE>
          <VALUEMEANING>Ascites</VALUEMEANING>
          <MEANINGDESCRIPTION>The accumulation of fluid in the peritoneal cavity, which may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2885</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bladder</VALIDVALUE>
          <VALUEMEANING>Bladder</VALUEMEANING>
          <MEANINGDESCRIPTION>The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12414</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone</VALIDVALUE>
          <VALUEMEANING>Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Connective tissue that forms the skeletal components of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CNS/Brain</VALIDVALUE>
          <VALUEMEANING>CNS/BRAIN</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the nervous system that consists of the brain, spinal cord, and meninges.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12439, C37998, C12438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervix</VALIDVALUE>
          <VALUEMEANING>Cervix</VALUEMEANING>
          <MEANINGDESCRIPTION>(SER-viks) The lower, narrow end of the uterus that forms a canal between the uterus and vagina.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colon</VALIDVALUE>
          <VALUEMEANING>Colon</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrium</VALIDVALUE>
          <VALUEMEANING>Endometrium</VALUEMEANING>
          <MEANINGDESCRIPTION>The mucous membrane comprising the inner layer of the uterine wall; it consists of a simple columnar epithelium and a lamina propria that contains simple tubular uterine glands. The structure, thickness, and state of the endometrium undergo marked change with the menstrual cycle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver</VALIDVALUE>
          <VALUEMEANING>Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung</VALIDVALUE>
          <VALUEMEANING>Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Nodes</VALIDVALUE>
          <VALUEMEANING>Lymph Nodes</VALUEMEANING>
          <MEANINGDESCRIPTION>A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>OTHER SPECIFY</VALUEMEANING>
          <MEANINGDESCRIPTION>Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ovary</VALIDVALUE>
          <VALUEMEANING>Ovary</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the paired female reproductive glands containing the ova or germ cells; the ovary&#39;s stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova; surrounding this stroma is a more condensed layer of stroma called the tunica albuginea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574083</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parametrial Involvement</VALIDVALUE>
          <VALUEMEANING>PARAMETRIAL INVOLVEMENT</VALUEMEANING>
          <MEANINGDESCRIPTION>PARAMETRIAL INVOLVEMENT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritoneum</VALIDVALUE>
          <VALUEMEANING>Peritoneum</VALUEMEANING>
          <MEANINGDESCRIPTION>(PAIR-ih-toe-NEE-um) The tissue that lines the abdominal wall and covers most of the organs in the abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleura</VALIDVALUE>
          <VALUEMEANING>Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>(PLOOR-a) A thin layer of tissue covering the lungs and the wall of the chest cavity to protect and cushion the lungs. A small amount of fluid that acts as a lubricant allows the lungs to move smoothly in the chest cavity during breathing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleural Effusion</VALIDVALUE>
          <VALUEMEANING>Pleural effusion</VALUEMEANING>
          <MEANINGDESCRIPTION>Pleural effusion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3331</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin</VALIDVALUE>
          <VALUEMEANING>Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uterus</VALIDVALUE>
          <VALUEMEANING>Uterus</VALUEMEANING>
          <MEANINGDESCRIPTION>A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Site of Progression</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Site of Progression</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Progression Site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Cervical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Endometrial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Ovarian</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811819</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Recurrent Gyn</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811938</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="7">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>64299</PUBLICID>
    <LONGNAME>Associated Specimen Premalignant Histologic Change Pre-Malignant Histologic Change Name</LONGNAME>
    <PREFERREDNAME>A_SPE_PR_HIS_CHG_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the associated premalignant histologic, the microscopic physical features of cells and their surrounding extracellular environment prior to the tissues becoming cancerous.:a histologic change ia a specimen associated with the specified disease or disease process.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2640595</PublicId>
      <PreferredName>ASS_SPEC_HIS_PRE_CHG</PreferredName>
      <PreferredDefinition>Information related to the associated premalignant histologic, the microscopic physical features of cells and their surrounding extracellular environment prior to the tissues becoming cancerous.</PreferredDefinition>
      <LongName>Associated Specimen Premalignant Histologic Change</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206759</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25281:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Associated Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25281</PREFERRED_NAME>
            <LONG_NAME>Associated</LONG_NAME>
            <CON_ID>2202442</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2640593</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25624:C25526:C25446</PreferredName>
        <Version>1</Version>
        <LongName>Premalignant Histologic Change</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25624</PREFERRED_NAME>
            <LONG_NAME>Premalignant</LONG_NAME>
            <CON_ID>2202704</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25526</PREFERRED_NAME>
            <LONG_NAME>Histologic</LONG_NAME>
            <CON_ID>2206234</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019128</PublicId>
      <PreferredName>PREMAL_HIS_CHG_NM</PreferredName>
      <PreferredDefinition>a histologic change ia a specimen associated with the specified disease or disease process.</PreferredDefinition>
      <LongName>Pre-Malignant Histologic Change Name</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2238450</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25191</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25191</PREFERRED_NAME>
            <LONG_NAME>Person Name</LONG_NAME>
            <CON_ID>2203721</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atypical adenomatous hyperplasia</VALIDVALUE>
          <VALUEMEANING>Atypical adenomatous hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Atypical adenomatous hyperplasia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basal cell hyperplasia</VALIDVALUE>
          <VALUEMEANING>BASAL CELL HYPERPLASIA</VALUEMEANING>
          <MEANINGDESCRIPTION>BASAL CELL HYPERPLASIA</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35845</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basal cell hyperplasia with ASD changes</VALIDVALUE>
          <VALUEMEANING>BASAL CELL HYPERPLASIA WITH ANGIOGENIC SQUAMOUS DYSPLASIA CHANGES</VALUEMEANING>
          <MEANINGDESCRIPTION>BASAL CELL HYPERPLASIA WITH ANGIOGENIC SQUAMOUS DYSPLASIA CHANGES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma in situ</VALIDVALUE>
          <VALUEMEANING>Carcinoma in Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2917</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mild dysplasia</VALIDVALUE>
          <VALUEMEANING>Mild dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Mild dysplasia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mild dysplasia with ASD changes</VALIDVALUE>
          <VALUEMEANING>MILD DYPLASIA WITH ANGIOGENIC SQUAMOUS DYSPLASIA CHANGES</VALUEMEANING>
          <MEANINGDESCRIPTION>MILD DYPLASIA WITH ANGIOGENIC SQUAMOUS DYSPLASIA CHANGES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate dysplasia</VALIDVALUE>
          <VALUEMEANING>Moderate dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Moderate dysplasia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate dysplasia with ASD changes</VALIDVALUE>
          <VALUEMEANING>MODERATE DYSPLASIA WITH ANGIOGENIC SQUAMOUS DYSPLASIA CHANGES</VALUEMEANING>
          <MEANINGDESCRIPTION>MODERATE DYSPLASIA WITH ANGIOGENIC SQUAMOUS DYSPLASIA CHANGES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, specify</VALIDVALUE>
          <VALUEMEANING>Other specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Severe dysplasia</VALIDVALUE>
          <VALUEMEANING>Severe dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Severe dysplasia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8364</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous metaplasia with ASD changes</VALIDVALUE>
          <VALUEMEANING>SQUAMOUS METAPLASIA WITH ANGIOGENIC SQUAMOUS DYSPLASIA CHANGES</VALUEMEANING>
          <MEANINGDESCRIPTION>SQUAMOUS METAPLASIA WITH ANGIOGENIC SQUAMOUS DYSPLASIA CHANGES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Severe dysplasia with ASD changes</VALIDVALUE>
          <VALUEMEANING>SEVERE DYSPLASIA WITH ANGIOGENIC SQUAMOUS DYSPLASIA CHANGES</VALUEMEANING>
          <MEANINGDESCRIPTION>SEVERE DYSPLASIA WITH ANGIOGENIC SQUAMOUS DYSPLASIA CHANGES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Metaplasia</VALIDVALUE>
          <VALUEMEANING>Squamous metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous metaplasia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Associated Pre-Malignant Histologic Changes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COMMENT_408</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Add 2 instructions to form: If Pre-Malignant changes Observed, AND (check all that apply)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Associated Pre-Malignant Histologic Changes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Lung Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812017</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811936</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2931931</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Iloprost Trial</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Iloprost 12079</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2931952</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SPOREs</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="8">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>65027</PUBLICID>
    <LONGNAME>Vaccine Administered Specify</LONGNAME>
    <PREFERREDNAME>VAC_ADM_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the text field to describe an anatomic site where a vaccination is administered.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014275</PublicId>
      <PreferredName>VAC_ADM</PreferredName>
      <PreferredDefinition>the administration of a vaccine to the patient.</PreferredDefinition>
      <LongName>Vaccine Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176936</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Vaccine</PreferredName>
        <Version>1</Version>
        <LongName>Vaccine</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C923</PREFERRED_NAME>
            <LONG_NAME>Vaccine</LONG_NAME>
            <CON_ID>2202555</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177665</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Administered</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018810</PublicId>
      <PreferredName>TX_SPEC</PreferredName>
      <PreferredDefinition>the free text field related to therapy.</PreferredDefinition>
      <LongName>Therapies Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Vaccine Site Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If other, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811919</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Local-Reg Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811927</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="9">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2002134</PUBLICID>
    <LONGNAME>Patient Prior Protocol Therapy Refuse Specify</LONGNAME>
    <PREFERREDNAME>PT_PR_PRO_TX_REF_SPE</PREFERREDNAME>
    <PREFERREDDEFINITION>the free-text field to specify the reason the patient refused/withdrew from treatment prior to beginning protocol therapy.</PREFERREDDEFINITION>
    <VERSION>4.1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2437560</PublicId>
      <PreferredName>PT_PRI_PROT_TX_REF</PreferredName>
      <PreferredDefinition>information related to patient refusal of therapy prior to beginning protocol therapy.</PreferredDefinition>
      <LongName>Patient Prior Protocol Therapy Refuse</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008554</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_OTX_RSNS</PreferredName>
        <Version>1</Version>
        <LongName>Treatment/Off-treatment Reasons</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2437558</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C25320:C15368:C49161</PreferredName>
        <Version>1</Version>
        <LongName>Prior Protocol Therapy Refuse</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25320</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Protocol</LONG_NAME>
            <CON_ID>2202702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49161</PREFERRED_NAME>
            <LONG_NAME>Refuse</LONG_NAME>
            <CON_ID>2427336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019106</PublicId>
      <PreferredName>TX_OTX_RSN_SPEC</PreferredName>
      <PreferredDefinition>the free text field to specify a reason or event that caused a patient to be removed from a clinical protocol.</PreferredDefinition>
      <LongName>Treatment Off-Treatment Reason Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008554</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_OTX_RSNS</PreferredName>
        <Version>1</Version>
        <LongName>Treatment/Off-treatment Reasons</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Patient withdrawal/refusal pr</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Patient withdrawal/refusal prior to beginning protocol therapy specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>1-COMMENT</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>new version created which can be utilized with CDUS valid values for Off Treatment Reason</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>APL Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811786</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="10">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2002501</PUBLICID>
    <LONGNAME>Form Complete Date</LONGNAME>
    <PREFERREDNAME>FORM_COMP_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>The date this form was completed</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013942</PublicId>
      <PreferredName>FORM_COMP</PreferredName>
      <PreferredDefinition>the completion of data collection for the CRF.</PreferredDefinition>
      <LongName>Case Report Form Complete</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2542290</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C40988</PreferredName>
        <Version>1</Version>
        <LongName>Case Report Form</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40988</PREFERRED_NAME>
            <LONG_NAME>Case Report Form</LONG_NAME>
            <CON_ID>2202500</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2405014</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25250</PreferredName>
        <Version>1</Version>
        <LongName>Complete</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25250</PREFERRED_NAME>
            <LONG_NAME>Complete</LONG_NAME>
            <CON_ID>2203885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date Form Completed</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date Form Completed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Form completion date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of Assessment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date assessment form completed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date assessment completed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Diary completion date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Today&#39;s date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF_TEXT1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of ACE score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Current Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date questionnaire completed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Upper GI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Lung Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812017</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811951</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cytogenetics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811952</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Char.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol/Admin.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811961</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811810</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811821</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Extensive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811822</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Limited</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Stage I-III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hepatobiliary</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3298577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Advanced</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000001</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AML Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000362</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Muscle Invasive Blad</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000462</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnostic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812084</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Restorative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Endodontics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812087</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oral Surgery</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812093</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjunctive General Services</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812095</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DPBRN</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857184</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Potential CDEs for Reuse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PBRN</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812034</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0278</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4058120</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0920</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1010</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171061</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1005</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171062</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0534</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171063</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HEAR-QL-28</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900378</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preschool HEAR-QL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900381</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIDCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NIDCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>20039102002501</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>FORM_COMP_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FORM_COMP_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>iCaRe2</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>iCaRe2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TODAYDAT</AlternateName>
        <AlternateNameType>OID, Alliance</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_COMPDAT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="11">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2002961</PUBLICID>
    <LONGNAME>Ability Patient Work Assessment Quality of Life Scale</LONGNAME>
    <PREFERREDNAME>AB_PT_WO_ASS_QOL_SCA</PREFERREDNAME>
    <PREFERREDDEFINITION>the patient&#39;s assessment of the ability to work based on FACT questionnaire.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2200894</PublicId>
      <PreferredName>ABIL_PT_WORK_ASSESS</PreferredName>
      <PreferredDefinition>information related to the patient&#39;s assessment of ability to work.</PreferredDefinition>
      <LongName>Ability Patient Work Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2660511</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0085732:C16960</PreferredName>
        <Version>1</Version>
        <LongName>Ability Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0085732</PREFERRED_NAME>
            <LONG_NAME>Ability</LONG_NAME>
            <CON_ID>2203376</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660937</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0043227:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Work Physical Examination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0043227</PREFERRED_NAME>
            <LONG_NAME>Work</LONG_NAME>
            <CON_ID>2203329</CON_ID>
            <DEFINITION_SOURCE>MSH2004_2003_12_12</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016847</PublicId>
      <PreferredName>FACT_QOL_SCALE</PreferredName>
      <PreferredDefinition>the scale used on FACT Quality of Life questionnaires to assess patient responses.</PreferredDefinition>
      <LongName>FACT Quality of Life Scale</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Always</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all bothered</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little bit</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat bothered</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2927955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately</VALIDVALUE>
          <VALUEMEANING>Moderately</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely</VALIDVALUE>
          <VALUEMEANING>EXTREMELY</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slightly</VALIDVALUE>
          <VALUEMEANING>Slightly</VALUEMEANING>
          <MEANINGDESCRIPTION>Slightly</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not bothered at all</VALIDVALUE>
          <VALUEMEANING>Not bothered at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not bothered at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered somewhat</VALIDVALUE>
          <VALUEMEANING>Bothered somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered somewhat</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little</VALIDVALUE>
          <VALUEMEANING>Bothered a little</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered a little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little difficult</VALIDVALUE>
          <VALUEMEANING>A little difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>A little difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not difficult at all</VALIDVALUE>
          <VALUEMEANING>Not difficult at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not difficult at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted totally</VALIDVALUE>
          <VALUEMEANING>Disrupted totally</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was totally disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted quite a bit</VALIDVALUE>
          <VALUEMEANING>Disrupted quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted somewhat</VALIDVALUE>
          <VALUEMEANING>Disrupted somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted a little</VALIDVALUE>
          <VALUEMEANING>Disrupted a little</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was a little disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not disrupted at all</VALIDVALUE>
          <VALUEMEANING>Not disrupted at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not at all disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to do</VALIDVALUE>
          <VALUEMEANING>UNABLE To Do</VALUEMEANING>
          <MEANINGDESCRIPTION>UNABLE To Do (Health Activity Questionnaire)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very difficult</VALIDVALUE>
          <VALUEMEANING>Very difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Very difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat difficult</VALIDVALUE>
          <VALUEMEANING>Somewhat difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No pain</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had no pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I am able to work (include wo</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I am able to work (include work at home)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>I am able to work (include work at home)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0204</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104878</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0240</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104883</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0209</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104888</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0258</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104898</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0261</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104899</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000175</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AB_PT_WO_ASS_QOL_SCA</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="12">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2003798</PUBLICID>
    <LONGNAME>Quality-of-Life Assessment Patient Activity Type</LONGNAME>
    <PREFERREDNAME>QOL_PT_ACT_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the scale for the assessment of patient&#39;s actions taken in pursuit of an objective.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2012818</PublicId>
      <PreferredName>QOLASSESS_PT_ACT</PreferredName>
      <PreferredDefinition>information related to assessment of patient&#39;s actions taken in pursuit of an objective.</PreferredDefinition>
      <LongName>Quality-of-Life Assessment Patient Activity</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2424965</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15584</PreferredName>
        <Version>1</Version>
        <LongName>Quality-of-Life Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15584</PREFERRED_NAME>
            <LONG_NAME>Quality-of-Life Assessment</LONG_NAME>
            <CON_ID>2424964</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2494688</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C43431</PreferredName>
        <Version>1</Version>
        <LongName>Patient Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016885</PublicId>
      <PreferredName>QOL_EXP_TP</PreferredName>
      <PreferredDefinition>list of values that describe the extent to which a patient has experienced an illness or symptom.</PreferredDefinition>
      <LongName>QOL Experience Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>80</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A great deal</VALIDVALUE>
          <VALUEMEANING>A GREAT DEAL</VALUEMEANING>
          <MEANINGDESCRIPTION>A GREAT DEAL</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Big problem</VALIDVALUE>
          <VALUEMEANING>Big problem</VALUEMEANING>
          <MEANINGDESCRIPTION>Big problem</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate problem</VALIDVALUE>
          <VALUEMEANING>MODERATE PROBLEM</VALUEMEANING>
          <MEANINGDESCRIPTION>MODERATE PROBLEM</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561602</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small problem</VALIDVALUE>
          <VALUEMEANING>Small problem</VALUEMEANING>
          <MEANINGDESCRIPTION>Small problem</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very small problem</VALIDVALUE>
          <VALUEMEANING>Very small problem</VALUEMEANING>
          <MEANINGDESCRIPTION>Very small problem</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No problem</VALIDVALUE>
          <VALUEMEANING>No Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: A difficulty, disorder, or condition needing resolution. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28020, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A Medium Problem</VALIDVALUE>
          <VALUEMEANING>Medium Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>Mid-way between small and large in number, quantity, magnitude or extent.: A difficulty, disorder, or condition needing resolution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28020, C49507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5784016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I am able to do my usual acti</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I am able to do my usual activities</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>I am able to get around by myself</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000175</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QOL_PT_ACT_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="13">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2003958</PUBLICID>
    <LONGNAME>Transplant Donor Recipient Relationship Type</LONGNAME>
    <PREFERREDNAME>TSPL_DON_REC_RELA_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the familial relationship of the transplant donor to the recipient.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2197848</PublicId>
      <PreferredName>TSPL_DON_REC_RELAT</PreferredName>
      <PreferredDefinition>information related to the relationship of the transplant donor to recipient.</PreferredDefinition>
      <LongName>Transplant Donor Recipient Relationship</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206477</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12981:C25168</PreferredName>
        <Version>1</Version>
        <LongName>Transplant Donor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2195765</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Relationship</PreferredName>
        <Version>1</Version>
        <LongName>Relationship</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL110661</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2204509</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017256</PublicId>
      <PreferredName>TSPL_DON_REC_RELA_TP</PreferredName>
      <PreferredDefinition>the familial relationship of the transplant donor to the recipient.</PreferredDefinition>
      <LongName>Transplant Donor Recipient Relationship Type</LongName>
      <Version>4</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>sibling</VALIDVALUE>
          <VALUEMEANING>SIBLING</VALUEMEANING>
          <MEANINGDESCRIPTION>SIBLING</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>other family member</VALIDVALUE>
          <VALUEMEANING>OTHER FAMILY MEMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>OTHER FAMILY MEMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-08-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>unrelated</VALIDVALUE>
          <VALUEMEANING>UNRELATED</VALUEMEANING>
          <MEANINGDESCRIPTION>Not connected or associated e.g. by kinship.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Related</VALIDVALUE>
          <VALUEMEANING>RELATED BY BLOOD.</VALUEMEANING>
          <MEANINGDESCRIPTION>RELATED BY BLOOD.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Haploidentical</VALIDVALUE>
          <VALUEMEANING>Haploidentical</VALUEMEANING>
          <MEANINGDESCRIPTION>A first-degree relative who matches the recipient at only one HLA locus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-11-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3950194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Relationship to recipient</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Relationship to recipient</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Donor type:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TSPL_DON_REC_RELA_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="14">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2004541</PUBLICID>
    <LONGNAME>Patient Payment Specify</LONGNAME>
    <PREFERREDNAME>PT_PYMT_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify the other method of patient payment.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013923</PublicId>
      <PreferredName>PT_PYMT</PreferredName>
      <PreferredDefinition>the primary payer/insurance carrier at the time of treatment on a protocol.</PreferredDefinition>
      <LongName>Patient Payment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177443</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Payment</PreferredName>
        <Version>1</Version>
        <LongName>Payment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25371</PREFERRED_NAME>
            <LONG_NAME>Payment</LONG_NAME>
            <CON_ID>2202461</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2183516</PublicId>
      <PreferredName>PROT_ADM_SPEC</PreferredName>
      <PreferredDefinition>the free text field to related to protocol administration.</PreferredDefinition>
      <LongName>Protocol Administration Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of Payment other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0204</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104878</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_PYMT_SPEC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="15">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2005346</PUBLICID>
    <LONGNAME>Patient Diagnosis Pregnancy Ind-2</LONGNAME>
    <PREFERREDNAME>2013804v3.0:2018257v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>a yes/no indicator that asks whether the patient was pregnant at diagnosis.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013804</PublicId>
      <PreferredName>PT_DX_PREG</PreferredName>
      <PreferredDefinition>information related to patient being pregnant or having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth at diagnosis.</PreferredDefinition>
      <LongName>Patient Diagnosis Pregnancy</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2957986</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220:C25742</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis Pregnancy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25742</PREFERRED_NAME>
            <LONG_NAME>Pregnancy</LONG_NAME>
            <CON_ID>2202906</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was patient pregnant at diagn</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was patient pregnant at diagnosis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Pregnant At Diagnosis</AlternateName>
        <AlternateNameType>TCGA_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>pregnant_at_diagnosis</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="16">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2005454</PUBLICID>
    <LONGNAME>CTC Adverse Event Palpitation Grade</LONGNAME>
    <PREFERREDNAME>CTC_AE_PALPITAT_GD</PREFERREDNAME>
    <PREFERREDDEFINITION>in CTC category Cardiac Arrhythmia, assessment of the severity of a palpitations adverse event using a graded scale.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTCAE:Common Terminology Criteria for Adverse Events v3.0</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2192463</PublicId>
      <PreferredName>CTC_AE_PALPITATION</PreferredName>
      <PreferredDefinition>information related to a CTC adverse event of palpitation.</PreferredDefinition>
      <LongName>CTC Adverse Event Palpitation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2194907</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Palpitation</PreferredName>
        <Version>1</Version>
        <LongName>Palpitation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37999</PREFERRED_NAME>
            <LONG_NAME>Palpitation</LONG_NAME>
            <CON_ID>2203628</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017654</PublicId>
      <PreferredName>CTC_AE_PALPITAT_GD</PreferredName>
      <PreferredDefinition>in CTC category Cardiac Arrhythmia, assessment of the severity of a palpitations adverse event using a graded scale.</PreferredDefinition>
      <LongName>CTC Adverse Event Palpitation Grade</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTCAE:Common Terminology Criteria for Adverse Events v3.0</Origin>
      <Representation>
        <PublicId>2184299</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Grade</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Present with associated symptoms (e.g., lightheadedness, shortness of breath)</VALUEMEANING>
          <MEANINGDESCRIPTION>Present with associated symptoms (e.g., lightheadedness, shortness of breath)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-08-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTC Adverse Event Palpitation</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CTC Adverse Event Palpitations Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Palpitations Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)</DocumentText>
        <URL>http://ctep.cancer.gov/reporting/ctc.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000132</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="17">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2005474</PUBLICID>
    <LONGNAME>Common Toxicity Criteria Adverse Event PTT Grade</LONGNAME>
    <PREFERREDNAME>CTC_AE_PTT_GD</PREFERREDNAME>
    <PREFERREDDEFINITION>in CTC category Coagulation, assessment of the severity of a partial thromboplastin time adverse event using a graded scale.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTCAE:Common Terminology Criteria for Adverse Events v3.0</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2192525</PublicId>
      <PreferredName>CTC_AE_PTT</PreferredName>
      <PreferredDefinition>information related to the CTC adverse event of partial thromboplastin time.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Events Partial Thromboplastin Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2645365</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38462</PreferredName>
        <Version>1</Version>
        <LongName>Partial Thromboplastin Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38462</PREFERRED_NAME>
            <LONG_NAME>Activated Partial Thromboplastin Time</LONG_NAME>
            <CON_ID>2206355</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017674</PublicId>
      <PreferredName>CTC_AE_PTT_GD</PreferredName>
      <PreferredDefinition>in CTC category Coagulation, assessment of the severity of a partial thromboplastin time adverse event using a graded scale.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event PTT Grade</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTCAE:Common Terminology Criteria for Adverse Events v3.0</Origin>
      <Representation>
        <PublicId>2184299</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Grade</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>&gt;1 - 1.5 x ULN</VALUEMEANING>
          <MEANINGDESCRIPTION>&gt;1 - 1.5 x ULN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566340</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>&gt;1.5 - 2 x ULN</VALUEMEANING>
          <MEANINGDESCRIPTION>&gt;1.5 - 2 x ULN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>&gt;2 x ULN</VALUEMEANING>
          <MEANINGDESCRIPTION>&gt;2 x ULN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>WITHIN NORMAL LIMITS</VALUEMEANING>
          <MEANINGDESCRIPTION>a reported laboratory value that is within the institutional range of values for normal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTC Adverse Event PTT (Partia</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CTC Adverse Event PTT (Partial thromboplastin time) Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>PTT Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)</DocumentText>
        <URL>http://ctep.cancer.gov/reporting/ctc.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000132</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>2005474</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="18">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2005586</PUBLICID>
    <LONGNAME>Common Toxicity Criteria Adverse Event Renal Failure Grade</LONGNAME>
    <PREFERREDNAME>CTC_AE_RENALFLR_GD</PREFERREDNAME>
    <PREFERREDDEFINITION>in CTC category Renal/Genitourinary, assessment of the severity of a renal failure adverse event using a graded scale.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTCAE:Common Terminology Criteria for Adverse Events v3.0</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2193206</PublicId>
      <PreferredName>CTC_AE_RENALFLR</PreferredName>
      <PreferredDefinition>information related to the CTC adverse event of renal failure.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Renal Failure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2193204</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Renal Failure</PreferredName>
        <Version>1</Version>
        <LongName>Renal Failure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4376</PREFERRED_NAME>
            <LONG_NAME>Renal Failure</LONG_NAME>
            <CON_ID>2203678</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017786</PublicId>
      <PreferredName>CTC_AE_RENALFLR_GD</PreferredName>
      <PreferredDefinition>in CTC category Renal/Genitourinary, assessment of the severity of a renal failure adverse event using a graded scale.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Renal Failure Grade</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTCAE:Common Terminology Criteria for Adverse Events v3.0</Origin>
      <Representation>
        <PublicId>2184299</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Grade</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Death</VALUEMEANING>
          <MEANINGDESCRIPTION>The absence of life or state of being dead.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Chronic dialysis not indicated</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic dialysis not indicated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Chronic dialysis or renal transplant indicated</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic dialysis or renal transplant indicated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTC Adverse Event Renal Failu</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CTC Adverse Event Renal Failure Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Renal Failure Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)</DocumentText>
        <URL>http://ctep.cancer.gov/reporting/ctc.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000132</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="19">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2005702</PUBLICID>
    <LONGNAME>Common Toxicity Criteria Adverse Event Speech Impairment Grade</LONGNAME>
    <PREFERREDNAME>CTC_AE_SPEECHIMPA_GD</PREFERREDNAME>
    <PREFERREDDEFINITION>in CTC category Neurology, assessment of the severity of a speech impairment (e.g., dysphasia or aphasia) adverse event using a graded scale.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTCAE:Common Terminology Criteria for Adverse Events v3.0</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2194889</PublicId>
      <PreferredName>CTC_AE_SPEECHIMPAIR</PreferredName>
      <PreferredDefinition>information related to the CTC adverse event of speech impairment.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Speech Impairment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2194887</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Speech impairment NOS</PreferredName>
        <Version>1</Version>
        <LongName>Speech impairment NOS</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0233715</PREFERRED_NAME>
            <LONG_NAME>Speech impairment NOS</LONG_NAME>
            <CON_ID>2204358</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017902</PublicId>
      <PreferredName>CTC_AE_SPEECHIMPA_GD</PreferredName>
      <PreferredDefinition>in CTC category Neurology, assessment of the severity of a speech impairment (e.g., dysphasia or aphasia) adverse event using a graded scale.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Speech Impairment Grade</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTCAE:Common Terminology Criteria for Adverse Events v3.0</Origin>
      <Representation>
        <PublicId>2184299</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Grade</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>awareness of receptive or expressive dysphasia, not impairing ability to communicate</VALUEMEANING>
          <MEANINGDESCRIPTION>awareness of receptive or expressive dysphasia, not impairing ability to communicate</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>receptive or expressive dysphasia, impairing ability to communicate</VALUEMEANING>
          <MEANINGDESCRIPTION>receptive or expressive dysphasia, impairing ability to communicate</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>inability to communicate</VALUEMEANING>
          <MEANINGDESCRIPTION>inability to communicate</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTC Adverse Event Speech impa</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CTC Adverse Event Speech impairment (e.g., dysphasia or aphasia) Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Speech impairment Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)</DocumentText>
        <URL>http://ctep.cancer.gov/reporting/ctc.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000132</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="20">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2006517</PUBLICID>
    <LONGNAME>Quality-of-Life Assessment  Patient Small Fatigue Scale</LONGNAME>
    <PREFERREDNAME>QOL_PT_S_FTG_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>scale of the assessment of tiredness in the person who receives medical attention, care, or treatment.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014366</PublicId>
      <PreferredName>QOLASSESS_PT_SM_FT</PreferredName>
      <PreferredDefinition>information related to assessment of tiredness in the person who receives medical attention, care, or treatment.</PreferredDefinition>
      <LongName>Quality-of-Life Assessment  Patient Small Fatigue</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2424965</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15584</PreferredName>
        <Version>1</Version>
        <LongName>Quality-of-Life Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15584</PREFERRED_NAME>
            <LONG_NAME>Quality-of-Life Assessment</LONG_NAME>
            <CON_ID>2424964</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2494772</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C25376:C3036</PreferredName>
        <Version>1</Version>
        <LongName>Patient Small Fatigue</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25376</PREFERRED_NAME>
            <LONG_NAME>Small</LONG_NAME>
            <CON_ID>2206253</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3036</PREFERRED_NAME>
            <LONG_NAME>Fatigue</LONG_NAME>
            <CON_ID>2202444</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016847</PublicId>
      <PreferredName>FACT_QOL_SCALE</PreferredName>
      <PreferredDefinition>the scale used on FACT Quality of Life questionnaires to assess patient responses.</PreferredDefinition>
      <LongName>FACT Quality of Life Scale</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Always</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all bothered</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little bit</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat bothered</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2927955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately</VALIDVALUE>
          <VALUEMEANING>Moderately</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely</VALIDVALUE>
          <VALUEMEANING>EXTREMELY</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slightly</VALIDVALUE>
          <VALUEMEANING>Slightly</VALUEMEANING>
          <MEANINGDESCRIPTION>Slightly</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not bothered at all</VALIDVALUE>
          <VALUEMEANING>Not bothered at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not bothered at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered somewhat</VALIDVALUE>
          <VALUEMEANING>Bothered somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered somewhat</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little</VALIDVALUE>
          <VALUEMEANING>Bothered a little</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered a little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little difficult</VALIDVALUE>
          <VALUEMEANING>A little difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>A little difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not difficult at all</VALIDVALUE>
          <VALUEMEANING>Not difficult at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not difficult at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted totally</VALIDVALUE>
          <VALUEMEANING>Disrupted totally</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was totally disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted quite a bit</VALIDVALUE>
          <VALUEMEANING>Disrupted quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted somewhat</VALIDVALUE>
          <VALUEMEANING>Disrupted somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted a little</VALIDVALUE>
          <VALUEMEANING>Disrupted a little</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was a little disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not disrupted at all</VALIDVALUE>
          <VALUEMEANING>Not disrupted at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not at all disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to do</VALIDVALUE>
          <VALUEMEANING>UNABLE To Do</VALUEMEANING>
          <MEANINGDESCRIPTION>UNABLE To Do (Health Activity Questionnaire)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very difficult</VALIDVALUE>
          <VALUEMEANING>Very difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Very difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat difficult</VALIDVALUE>
          <VALUEMEANING>Somewhat difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No pain</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had no pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I feel tired</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I feel tired</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How often did you feel tired</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0815</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0924</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171065</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QOL_PT_S_FTG_SCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="21">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2006518</PUBLICID>
    <LONGNAME>Quality-of-Life Assessment Patient Begin Fatigue Scale</LONGNAME>
    <PREFERREDNAME>QOL_PT_BEG_FTG_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>the scale of the assessment of patient&#39;s tiredness in starting.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014367</PublicId>
      <PreferredName>QOLASSESS_PT_BG_FTG</PreferredName>
      <PreferredDefinition>information related to patient&#39;s tiredness in starting.</PreferredDefinition>
      <LongName>Quality-of-Life Assessment Patient Begin Fatigue</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2424965</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15584</PreferredName>
        <Version>1</Version>
        <LongName>Quality-of-Life Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15584</PREFERRED_NAME>
            <LONG_NAME>Quality-of-Life Assessment</LONG_NAME>
            <CON_ID>2424964</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2494794</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C25431:C3036</PreferredName>
        <Version>1</Version>
        <LongName>Patient Begin Fatigue</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3036</PREFERRED_NAME>
            <LONG_NAME>Fatigue</LONG_NAME>
            <CON_ID>2202444</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016847</PublicId>
      <PreferredName>FACT_QOL_SCALE</PreferredName>
      <PreferredDefinition>the scale used on FACT Quality of Life questionnaires to assess patient responses.</PreferredDefinition>
      <LongName>FACT Quality of Life Scale</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Always</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all bothered</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little bit</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat bothered</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2927955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately</VALIDVALUE>
          <VALUEMEANING>Moderately</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely</VALIDVALUE>
          <VALUEMEANING>EXTREMELY</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slightly</VALIDVALUE>
          <VALUEMEANING>Slightly</VALUEMEANING>
          <MEANINGDESCRIPTION>Slightly</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not bothered at all</VALIDVALUE>
          <VALUEMEANING>Not bothered at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not bothered at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered somewhat</VALIDVALUE>
          <VALUEMEANING>Bothered somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered somewhat</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little</VALIDVALUE>
          <VALUEMEANING>Bothered a little</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered a little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little difficult</VALIDVALUE>
          <VALUEMEANING>A little difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>A little difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not difficult at all</VALIDVALUE>
          <VALUEMEANING>Not difficult at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not difficult at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted totally</VALIDVALUE>
          <VALUEMEANING>Disrupted totally</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was totally disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted quite a bit</VALIDVALUE>
          <VALUEMEANING>Disrupted quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted somewhat</VALIDVALUE>
          <VALUEMEANING>Disrupted somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted a little</VALIDVALUE>
          <VALUEMEANING>Disrupted a little</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was a little disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not disrupted at all</VALIDVALUE>
          <VALUEMEANING>Not disrupted at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not at all disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to do</VALIDVALUE>
          <VALUEMEANING>UNABLE To Do</VALUEMEANING>
          <MEANINGDESCRIPTION>UNABLE To Do (Health Activity Questionnaire)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very difficult</VALIDVALUE>
          <VALUEMEANING>Very difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Very difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat difficult</VALIDVALUE>
          <VALUEMEANING>Somewhat difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No pain</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had no pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I have trouble starting thing</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I have trouble starting things because I am tired</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QOL_PT_BEG_FTG_SCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="22">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2007184</PUBLICID>
    <LONGNAME>Laboratory Procedure Creatinine Eligibility Determination ind-2</LONGNAME>
    <PREFERREDNAME>LAB_CREAT_ELIG_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether a medical procedure was performed that involves testing a sample of blood for creatinine, the breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function, as a method of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures. </PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2778339</PublicId>
      <PreferredName>LAB_CREAT_ELIG</PreferredName>
      <PreferredDefinition>information related to the medical procedure that involves testing a sample of blood for creatinine, the breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function, as a method of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.</PreferredDefinition>
      <LongName>Laboratory Procedure Creatinine Eligibility Determination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2778334</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C399:C25171</PreferredName>
        <Version>1</Version>
        <LongName>Creatinine Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C399</PREFERRED_NAME>
            <LONG_NAME>Creatinine</LONG_NAME>
            <CON_ID>2206188</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Serum creatinine less than 1.</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Serum creatinine less than 1.5 mg/dl or calculated creatinine clearance greater than or equal to 60 ml/min/1.73m^2 using Cockcroft-Gault equation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serum Creatinine &lt;=1.5 x ULN</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Creatinine &lt;= 1.5 mg/dL or a calculated creatinine clearance of &gt;= 50 ml/min (24-hour urine collection)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Creatinine &lt;=1.5 x ULN</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Creatinine &lt;=1.5 x ULN OR creatinine clearance &gt;=60 mL/min/1.73 m2 for patients with creatinine levels &gt;1.5 x ULN</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serum creatinine &lt;=1.5 x ULN; if &gt;1.25 x ULN calculated creatinine clearance must be &gt;=60 ml/min</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serum creatinine less than or equal to Institutional ULN OR creatinine clearance greater than or equal to 60 mL/min/1.73 m2 (calculated or measured)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the Serum creatinine less than or equal to 2.5 mg/dl?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serum creatinine &lt;= 1.5 x upper limit of normal (ULN)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this patient&#39;s creatinine &gt;1.5 x institutional ULN and/or creatinine clearance &lt;60 mL/min due to non-Hodgkin&#39;s lymphoma?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is pre-study creatinine &lt;= 2.0 upper limit or normal OR creatinine clearance (est. DFT (Cockcroft-Gault)) &gt;= 30 mL/min within 7 days prior to first dose of study drug?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Creatinine clearance &gt;=60 mL/min/1.73 m2 for patients with creatinine levels above institutional normal</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serum creatinine level within normal institutional limits OR a creatinine clearance of at least 60 mL/min within 14 days prior to registration</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Creatinine Clearance &gt;=70 mL/min/1.73 m2 or Serum Creatinine level within normal limits based on age/sex</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Creatinine Clearance &gt;=70 mL/min/1.73 m2 or Serum Creatinine level within normal limits based on age/sex, per protocol</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a serum creatinine &gt;3.0 mg/dL?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Estimated creatinine clearance greater than or equal to 50 ml/min/1.73m^2 using Cockcroft-Gault formula?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serum creatinine &lt;= 2.0 mg/dL</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF_Text12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serum creatinine less than or equal to 1.5 x institutional upper limit normal (ULN) or measured or calculated creatinine clearance greater than or equal to 50 mL/min (for subjects with creatinine levels 1.5 x greater than institutional  ULN).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text20</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Creatinine clearance &gt;50 mL/min estimated by Cockcroft-Gault formula?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text21</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Creatinine less than or equal to 1.5 Or Cal. Creatinine Clearance greater than or equal to 50</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text22</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Creatinine Met Criteria</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text13</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this patient&#39;s Creatinine greater than the age-sex-specific norms established per Protocol Section 3.2?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text14</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this patient&#39;s Creatinine greater than 1.0 x institutional ULN?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text23</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Calculated Creatinine Clearance greater than or equal to 30 mL/min by Cockcroft-Gault formula?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_eCRF_Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is creatinine clearance (CrCL) or estimated Glomerular filtration rate (eGFR) greater than 50 mL/min estimated using either the Cockcroft-Gault equation, the Modification of Diet in Renal Disease Study, or as reported in the comprehensive metabolic panel/basic metabolic panel (eGFR)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text24</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this patient&#39;s Creatinine &gt; 1.5 x institutional ULN?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does serum creatinine meet criteria outlined the protocol?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text25</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this patient’s Creatinine &gt; 2.0 x institutional ULN?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0231D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104894</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0257</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0257</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0257</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4254096</PublicId>
          <ContextName>PBTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PBTC-042</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4254119</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4254096</PublicId>
          <ContextName>PBTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase I</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>10000103</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15689233</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HHS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Completed</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15910169</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_CREAT_ELIG_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="23">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2179630</PUBLICID>
    <LONGNAME>Event Location Type Name</LONGNAME>
    <PREFERREDNAME>EVENT_LOC_TYPE_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>The name of the location where the serious adverse event occurred.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2179308</PublicId>
      <PreferredName>EVENT_LOC_TYPE_NM</PreferredName>
      <PreferredDefinition>Event Location Type Name</PreferredDefinition>
      <LongName>Event Location Type Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008583</PublicId>
        <ContextName>EDRN</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>RESPONSE</PreferredName>
        <Version>1</Version>
        <LongName>Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2179341</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Event</PreferredName>
        <Version>1</Version>
        <LongName>Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177288</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>location</PreferredName>
        <Version>1</Version>
        <LongName>location</LongName>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2179522</PublicId>
      <PreferredName>EVENT_LOC_TYPE_NM</PreferredName>
      <PreferredDefinition>The name of the location type.</PreferredDefinition>
      <LongName>Event Location Type Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008583</PublicId>
        <ContextName>EDRN</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>RESPONSE</PreferredName>
        <Version>1</Version>
        <LongName>Response</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Home</VALIDVALUE>
          <VALUEMEANING>Home2</VALUEMEANING>
          <MEANINGDESCRIPTION>A person&#39;s permanent place of residence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hospital</VALIDVALUE>
          <VALUEMEANING>Hospital</VALUEMEANING>
          <MEANINGDESCRIPTION>An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, Specify</VALIDVALUE>
          <VALUEMEANING>Other, Specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Be specific about something; define clearly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Event Occurred at Location</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Event Occurred at Location</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Event Location Type Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CSAERS Review Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811695</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SeriousAdverseEvents</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812325</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CSAERS Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812969</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2190530</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Demonstration Applications</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CIAF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812341</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EVENT_LOC_TYPE_NM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="24">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2179898</PUBLICID>
    <LONGNAME>Adverse Event Most Recent Assessment Date</LONGNAME>
    <PREFERREDNAME>AE_MOSTREC_ASSES_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date on which a patient was last evaluated to check for adverse events or reactions after treatment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195342</PublicId>
      <PreferredName>AE_MOSTREC_ASSESS</PreferredName>
      <PreferredDefinition>information related to the most recent assessment of an adverse event.</PreferredDefinition>
      <LongName>Adverse Event Most Recent Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2184272</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Adverse Event</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207486</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25577:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Most Recent Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25577</PREFERRED_NAME>
            <LONG_NAME>Most Recent</LONG_NAME>
            <CON_ID>2206311</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Most Recent Adverse E</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of Most Recent Adverse Event Assessment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of change</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811951</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0263</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229L</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229N</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229O</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104892</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0258</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104898</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0286B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104901</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104930</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104941</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0269</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104995</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0279</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104996</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000275</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000276</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000705</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_MOSTREC_ASSES_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="25">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2180811</PUBLICID>
    <LONGNAME>Transplant Donor Matching Type</LONGNAME>
    <PREFERREDNAME>TSPL_DON_MATCH_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of donor match that was determined from the cells which are transplanted into a patient.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195944</PublicId>
      <PreferredName>TSPL_DON_MATCH_DESC</PreferredName>
      <PreferredDefinition>information related to the description or type of matching of the donor transplant.</PreferredDefinition>
      <LongName>Transplant Donor Matching Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206477</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12981:C25168</PreferredName>
        <Version>1</Version>
        <LongName>Transplant Donor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660715</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0150103:C25365</PreferredName>
        <Version>1</Version>
        <LongName>MATCHING Description </LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0150103</PREFERRED_NAME>
            <LONG_NAME>MATCHING</LONG_NAME>
            <CON_ID>2615899</CON_ID>
            <DEFINITION_SOURCE>MCM92</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180810</PublicId>
      <PreferredName>TSPL_DONOR_MATCH_TP</PreferredName>
      <PreferredDefinition>information relating to the match type of a transplant donor.</PreferredDefinition>
      <LongName>Transplant Donor Matching Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>matched sibling or family member</VALIDVALUE>
          <VALUEMEANING>matched sibling or family member</VALUEMEANING>
          <MEANINGDESCRIPTION>matched sibling or family member</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>matched unrelated donor</VALIDVALUE>
          <VALUEMEANING>matched unrelated donor</VALUEMEANING>
          <MEANINGDESCRIPTION>matched unrelated donor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mismatched sibling or family member</VALIDVALUE>
          <VALUEMEANING>mismatched sibling or family member</VALUEMEANING>
          <MEANINGDESCRIPTION>mismatched sibling or family member</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mismatched unrelated donor</VALIDVALUE>
          <VALUEMEANING>mismatched unrelated donor</VALUEMEANING>
          <MEANINGDESCRIPTION>mismatched unrelated donor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Umbilical Cord Unit</VALIDVALUE>
          <VALUEMEANING>Umbilical Cord Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>Extraembryonic structure that connects the fetus to the placenta. It contains two arteries and one vein.: Any division of quantity accepted as a standard of measurement or exchange.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C44278, C34320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3756511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unrelated Adult Donor</VALIDVALUE>
          <VALUEMEANING>Unrelated Adult Donor</VALUEMEANING>
          <MEANINGDESCRIPTION>Unrelated; not connected or associated e.g. by kinship.: A human who has reached reproductive age.: Someone who gives blood or tissue or an organ to be used in another person.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25168, C17600, C25328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3756512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA Matched Relative</VALIDVALUE>
          <VALUEMEANING>HLA Matched Relative</VALUEMEANING>
          <MEANINGDESCRIPTION>A process in which blood or tissue samples are analyzed to determine their human leukocyte antigen (HLA) profiles so that transplant materials can be transfered into a patient with the same or similar profile.: Relative; a person related by blood or marriage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C21480, C68707</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3756514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 Antigen Mismatched Relative</VALIDVALUE>
          <VALUEMEANING>1 Antigen Mismatched Relative</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: Any substance that appears foreign or potentially adverse to the body and elicits immune response.: A failure to correspond or match; to match unsuitably or inaccurately.: Relative; a person related by blood or marriage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C21480, C67078, C268, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3756513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Related Umbilical Cord Unit</VALIDVALUE>
          <VALUEMEANING>Related Umbilical Cord Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>Related Umbilical Cord Unit</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4811951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unrelated Umbilical Cord Unit</VALIDVALUE>
          <VALUEMEANING>Unrelated Umbilical Cord Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>Unrelated Umbilical Cord Unit</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4811952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>-COMMENT</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Add instruction: If allogeneic</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Type of Donor Match</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Type of Donor Match</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Stem Cell Donor Type:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Transplant donor type:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="26">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2180826</PUBLICID>
    <LONGNAME>Assessment Gallium Scan Ind-3</LONGNAME>
    <PREFERREDNAME>ASSESS_GALL_SCA_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator to ask if a gallium imaging scan was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195553</PublicId>
      <PreferredName>ASSESS_GALLIUM_SCAN</PreferredName>
      <PreferredDefinition>information related to the gallium scan assessment.</PreferredDefinition>
      <LongName>Assessment Gallium Scan</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176954</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Assessment</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660830</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0016980:C17999</PreferredName>
        <Version>1</Version>
        <LongName>Gallium Scan</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0016980</PREFERRED_NAME>
            <LONG_NAME>Gallium</LONG_NAME>
            <CON_ID>2615860</CON_ID>
            <DEFINITION_SOURCE>NDFRT_2004_01</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17999</PREFERRED_NAME>
            <LONG_NAME>Scan</LONG_NAME>
            <CON_ID>2202631</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>-COMMENT</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Add instruction: this reporting period</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a gallium scan done</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was a gallium scan done</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Gallium Scan</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2670694</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Relapse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma Relapse</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812926</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2670694</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Relapse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Solid Tumor Relapse</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812928</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="27">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2181403</PUBLICID>
    <LONGNAME>Myeloma Symptom Type</LONGNAME>
    <PREFERREDNAME>MYE_SM_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the description of disease symptoms present in a patient for multiple myeloma or other hematopoietic disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2181310</PublicId>
      <PreferredName>MYE_SM</PreferredName>
      <PreferredDefinition>information related to myeloma symptom.</PreferredDefinition>
      <LongName>Myeloma Symptom</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177047</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Myeloma</PreferredName>
        <Version>1</Version>
        <LongName>Myeloma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3242</PREFERRED_NAME>
            <LONG_NAME>Multiple Myeloma</LONG_NAME>
            <CON_ID>2202758</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177304</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Symptom</PreferredName>
        <Version>1</Version>
        <LongName>Symptom</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181402</PublicId>
      <PreferredName>MYELOMA_SM_TP</PreferredName>
      <PreferredDefinition>information related to the type of symptom for myeloma.</PreferredDefinition>
      <LongName>Myeloma Symptom Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>33</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fatigue</VALIDVALUE>
          <VALUEMEANING>Fatigue</VALUEMEANING>
          <MEANINGDESCRIPTION>Overall tiredness and lack of energy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3036</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>syncope</VALIDVALUE>
          <VALUEMEANING>Syncope</VALUEMEANING>
          <MEANINGDESCRIPTION>Syncope</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35053</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>leg swelling</VALIDVALUE>
          <VALUEMEANING>leg swelling</VALUEMEANING>
          <MEANINGDESCRIPTION>leg swelling</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>painful/numb feet</VALIDVALUE>
          <VALUEMEANING>painful/numb feet</VALUEMEANING>
          <MEANINGDESCRIPTION>painful/numb feet</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>carpal tunnel</VALIDVALUE>
          <VALUEMEANING>carpal tunnel</VALUEMEANING>
          <MEANINGDESCRIPTION>carpal tunnel</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>purpura (skin)</VALIDVALUE>
          <VALUEMEANING>purpura (skin)</VALUEMEANING>
          <MEANINGDESCRIPTION>purpura (skin)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>diarrhea</VALIDVALUE>
          <VALUEMEANING>diarrhea</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition of frequent and watery bowel movements.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>light-headedness</VALIDVALUE>
          <VALUEMEANING>light-headedness</VALUEMEANING>
          <MEANINGDESCRIPTION>light-headedness</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>macroglossia</VALIDVALUE>
          <VALUEMEANING>macroglossia</VALUEMEANING>
          <MEANINGDESCRIPTION>macroglossia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>weight loss &gt;= 10% of body weight</VALIDVALUE>
          <VALUEMEANING>weight loss &gt;= 10% of body weight</VALUEMEANING>
          <MEANINGDESCRIPTION>weight loss &gt;= 10% of body weight</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dizziness</VALIDVALUE>
          <VALUEMEANING>dizziness</VALUEMEANING>
          <MEANINGDESCRIPTION>dizziness</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>visual disturbance</VALIDVALUE>
          <VALUEMEANING>visual disturbance</VALUEMEANING>
          <MEANINGDESCRIPTION>visual disturbance</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dyspnea</VALIDVALUE>
          <VALUEMEANING>DYSPNEA</VALUEMEANING>
          <MEANINGDESCRIPTION>ADVERSE EVENT DYSPNEA (SHORTNESS OF BREATH) AS DEFINED IN CTC VERSION 2.0</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>paresthesias or painful/numb feet</VALIDVALUE>
          <VALUEMEANING>paresthesias or painful/numb feet</VALUEMEANING>
          <MEANINGDESCRIPTION>paresthesias or painful/numb feet</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>retinal hemorrhage</VALIDVALUE>
          <VALUEMEANING>retinal hemorrhage</VALUEMEANING>
          <MEANINGDESCRIPTION>retinal hemorrhage</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>any other bleeding</VALIDVALUE>
          <VALUEMEANING>any other bleeding</VALUEMEANING>
          <MEANINGDESCRIPTION>any other bleeding</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>weakness</VALIDVALUE>
          <VALUEMEANING>weakness</VALUEMEANING>
          <MEANINGDESCRIPTION>weakness</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>headaches</VALIDVALUE>
          <VALUEMEANING>headaches</VALUEMEANING>
          <MEANINGDESCRIPTION>headaches</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>epistaxis</VALIDVALUE>
          <VALUEMEANING>Epistaxis</VALUEMEANING>
          <MEANINGDESCRIPTION>Bleeding from the nose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26766</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>livido reticularis</VALIDVALUE>
          <VALUEMEANING>livido reticularis</VALUEMEANING>
          <MEANINGDESCRIPTION>livido reticularis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>-COMMENT</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Add instruction: at Diagnosis, (current) (check all that apply)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Disease Symptoms Present</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="28">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2181481</PUBLICID>
    <LONGNAME>Prior RT Skeletal System Administered Ind-3</LONGNAME>
    <PREFERREDNAME>PRI_RT_SKEL_ADM_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator to ask if a skeletal targeted irradiation treatment was administered to a patient prior to enrolling on the current protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2196199</PublicId>
      <PreferredName>PRIOR_RT_SKELET_ADM</PreferredName>
      <PreferredDefinition>information related to prior radiation therapy to a part of the skeletal systm being administered.</PreferredDefinition>
      <LongName>Prior RT Skeletal System Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206566</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C15313</PreferredName>
        <Version>1</Version>
        <LongName>Prior Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660753</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12788:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Skeletal System Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12788</PREFERRED_NAME>
            <LONG_NAME>Skeletal System</LONG_NAME>
            <CON_ID>2233804</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Skeletal Targeted Irradiation</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Skeletal Targeted Irradiation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior radiotherapy to bone</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRI_RT_SKEL_ADM_IND3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="29">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2182242</PUBLICID>
    <LONGNAME>Image Scan Options Code</LONGNAME>
    <PREFERREDNAME>2639962v1.0:2542197v1.1</PREFERREDNAME>
    <PREFERREDDEFINITION>Parameters of image scanning sequence. [Standard-based]</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DICOM:Digital Imaging and Communications in Medicine</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2639962</PublicId>
      <PreferredName>2423453v1.0:2639960v1.0</PreferredName>
      <PreferredDefinition>Any record of an imaging event whether physical or electronic._The peak accelerating voltage applied in an X-ray tube between the cathode and anode._The data or image obtained by gathering information with a sensing device._Options; alternative choices or actions.</PreferredDefinition>
      <LongName>Image Scan Options</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2423453</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48179</PreferredName>
        <Version>1</Version>
        <LongName>Image</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2639960</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17999:C25374</PreferredName>
        <Version>1</Version>
        <LongName>Scan Options</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17999</PREFERRED_NAME>
            <LONG_NAME>Scan</LONG_NAME>
            <CON_ID>2202631</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25374</PREFERRED_NAME>
            <LONG_NAME>Options</LONG_NAME>
            <CON_ID>2203938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2542197</PublicId>
      <PreferredName>2542197v1.1</PreferredName>
      <PreferredDefinition>Pictures of structures inside the body. Scans often used in diagnosing, staging, and monitoring disease include liver scans, bone scans, and computed tomography (CT) or computerized axial tomography (CAT) scans and magnetic resonance imaging (MRI) scans. In liver scanning and bone scanning, radioactive substances that are injected into the bloodstream collect in these organs. A scanner that detects the radiation is used to create pictures. In CT scanning, an x-ray machine linked to a computer is used to produce detailed pictures of organs inside the body. MRI scans use a large magnet connected to a computer to create pictures of areas inside the body._Alternative choices or actions._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Scan Options Code</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>16</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
      <Representation>
        <PublicId>2542196</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17999:C25374:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Scan Options Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17999</PREFERRED_NAME>
            <LONG_NAME>Scan</LONG_NAME>
            <CON_ID>2202631</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25374</PREFERRED_NAME>
            <LONG_NAME>Options</LONG_NAME>
            <CON_ID>2203938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PER</VALIDVALUE>
          <VALUEMEANING>Phase Encode Reordering</VALUEMEANING>
          <MEANINGDESCRIPTION>Phase Encode Reordering</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RG</VALIDVALUE>
          <VALUEMEANING>Respitatory Gating</VALUEMEANING>
          <MEANINGDESCRIPTION>Respitatory Gating</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CG</VALIDVALUE>
          <VALUEMEANING>Cardiac Gating</VALUEMEANING>
          <MEANINGDESCRIPTION>Cardiac Gating</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PPG</VALIDVALUE>
          <VALUEMEANING>Peripheral Pulse Gating</VALUEMEANING>
          <MEANINGDESCRIPTION>Peripheral Pulse Gating</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FC</VALIDVALUE>
          <VALUEMEANING>Flow Compensation</VALUEMEANING>
          <MEANINGDESCRIPTION>Flow Compensation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PFF</VALIDVALUE>
          <VALUEMEANING>Partial Fourier-Frequency</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial Fourier-Frequency</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PFP</VALIDVALUE>
          <VALUEMEANING>Partial Fourier-Phase</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial Fourier-Phase</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581920</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SP</VALIDVALUE>
          <VALUEMEANING>Spatial Presaturation</VALUEMEANING>
          <MEANINGDESCRIPTION>Spatial Presaturation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FS</VALIDVALUE>
          <VALUEMEANING>Fat Saturation</VALUEMEANING>
          <MEANINGDESCRIPTION>Fat Saturation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EKG</VALIDVALUE>
          <VALUEMEANING>EKG Event Trigger</VALUEMEANING>
          <MEANINGDESCRIPTION>The Scan Option attribute identifies the EKG Event Trigger technique which was used during the acquisition of the image.  DICOM PS3.3: C.8.7.1.1.4</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PHY</VALIDVALUE>
          <VALUEMEANING>Physiological Event Trigger</VALUEMEANING>
          <MEANINGDESCRIPTION>Physiological Event Trigger</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CHASE</VALIDVALUE>
          <VALUEMEANING>Bolus Chasing</VALUEMEANING>
          <MEANINGDESCRIPTION>The Scan Option attribute identifies the Bolus Chasing technique which was used during the acquisition of the image.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STEP</VALIDVALUE>
          <VALUEMEANING>Stepping</VALUEMEANING>
          <MEANINGDESCRIPTION>The Scan Option attribute identifies the Stepping technique which was used during the acquisition of the image.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ROTA</VALIDVALUE>
          <VALUEMEANING>Rotational Acquisition</VALUEMEANING>
          <MEANINGDESCRIPTION>Acquisition where the x-ray source moves angularly in relation to the patient.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2797566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TOMO</VALIDVALUE>
          <VALUEMEANING>Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>Imaging by sections or sectioning.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38093</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>2006 DICOM Standard</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>2006 DICOM Standard - Sections 3, 5 &amp; 6</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scan Option</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Scan Option</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180933</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>LIDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rider Project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812022</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180933</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>LIDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Series</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812330</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DICOM Tag CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812790</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614828</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA Collection</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIDC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812770</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614828</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA Collection</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RIDER</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812771</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614828</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA Collection</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case-Study-Series</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812803</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614828</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA Collection</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Series</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812806</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2693115</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA_Model</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Silver Review Modified CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2838921</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2693115</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA_Model</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ncia.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000239</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2944977</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NBIA</PreferredName>
          <Version>5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ncia.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000240</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Scan Options</AlternateName>
        <AlternateNameType>DICOM Attribute Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>(0018,0022)</AlternateName>
        <AlternateNameType>DICOM_TAG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ncia.domain.Image.scanOptions</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Image:scanOptions</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="30">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2183439</PUBLICID>
    <LONGNAME>Beck Depression II Total Score</LONGNAME>
    <PREFERREDNAME>BECK_DEPRS_II_TTL_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Total numeric score for Beck Depression Inventory II, a psychometric questionnaire that consists of 21 groups of statements, yielding a total score of 21 to 63 points.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2183437</PublicId>
      <PreferredName>BECK_DEPRS_II_INVY</PreferredName>
      <PreferredDefinition>Results on the Beck Depression Inventory II (BDI-II), a psychometric questionnaire that consists of 21 groups of statements, yielding a total score of 1 to 7 points.</PreferredDefinition>
      <LongName>Beck Depression Inventory II Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2665184</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C40438</PreferredName>
        <Version>1</Version>
        <LongName>Beck Depression Inventory</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40438</PREFERRED_NAME>
            <LONG_NAME>Beck Depression Inventory</LONG_NAME>
            <CON_ID>2665182</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2322175</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2183451</PublicId>
      <PreferredName>PSYCM_QUEST_NUM_SC</PreferredName>
      <PreferredDefinition>Numeric score on a psychometric questionnaire or survey.</PreferredDefinition>
      <LongName>Psychometric Questionnaire Number Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>500</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2665189</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17034:C25337:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Psychometrics Number Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17034</PREFERRED_NAME>
            <LONG_NAME>Psychometrics</LONG_NAME>
            <CON_ID>2520620</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Beck Depression Inventory II</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Beck Depression Inventory II Total Score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BDI-II Profile</Name>
        <DocumentType>DESCRIPTION</DocumentType>
        <DocumentText/>
        <URL>http://www.musc.edu/dfm/RCMAR/Beck.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="31">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2183777</PUBLICID>
    <LONGNAME>Planned Surgery RT Treatment Type</LONGNAME>
    <PREFERREDNAME>P_SX_RT_TX_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of surgery and planned radiotherapy administered to a patient.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014069</PublicId>
      <PreferredName>SX_TX</PreferredName>
      <PreferredDefinition>the description of the surgical procedure performed on a patient.</PreferredDefinition>
      <LongName>Surgery Treatment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176917</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Surgery</PreferredName>
        <Version>1</Version>
        <LongName>Surgery</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177315</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Treatment</PreferredName>
        <Version>1</Version>
        <LongName>Treatment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2183776</PublicId>
      <PreferredName>SX_RT_TX_TP</PreferredName>
      <PreferredDefinition>the type of surgery and radiation therapy treatment.</PreferredDefinition>
      <LongName>Surgery RT Treatment Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lumpectomy and local RT without regional RT</VALIDVALUE>
          <VALUEMEANING>Lumpectomy and local RT without regional RT</VALUEMEANING>
          <MEANINGDESCRIPTION>Lumpectomy and local RT without regional RT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lumpectomy plus local RT with regional RT</VALIDVALUE>
          <VALUEMEANING>Lumpectomy plus local RT with regional RT</VALUEMEANING>
          <MEANINGDESCRIPTION>Lumpectomy plus local RT with regional RT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mastectomy without RT</VALIDVALUE>
          <VALUEMEANING>Mastectomy without RT</VALUEMEANING>
          <MEANINGDESCRIPTION>Mastectomy without RT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mastectomy with either local or regional RT</VALIDVALUE>
          <VALUEMEANING>Mastectomy with either local or regional RT</VALUEMEANING>
          <MEANINGDESCRIPTION>Mastectomy with either local or regional RT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Breast conserving surgery (WBRT)</VALIDVALUE>
          <VALUEMEANING>Breast conserving surgery plus whole breast radiation therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast conserving surgery plus whole breast radiation therapy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-05-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Breast conserving surgery (APBI pre/post chemo)</VALIDVALUE>
          <VALUEMEANING>Breast conserving surgery plus accelerated, partial breast irradiation before and/or after chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast conserving surgery plus accelerated, partial breast irradiation before and/or after chemotherapy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-05-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Type of surgery and planned r</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Type of surgery and planned radiotherapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="32">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2183832</PUBLICID>
    <LONGNAME>Tamoxifen Treatment Begin Date</LONGNAME>
    <PREFERREDNAME>TAM_TX_BEG_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date tamoxifen treatment began.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2183831</PublicId>
      <PreferredName>TAM_TX</PreferredName>
      <PreferredDefinition>information related to tamoxifen treatment._An antineoplastic nonsteroidal selective estrogen receptor modulator (SERM). Tamoxifen competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA. The result is a reduction in DNA synthesis and cellular response to estrogen. In addition, tamoxifen up-regulates the production of transforming growth factor B (TGFb), a factor that inhibits tumor cell growth, and down-regulates insulin-like growth factor 1 (IGF-1), a factor that stimulates breast cancer cell growth. (NCI04)</PreferredDefinition>
      <LongName>Tamoxifen Treatment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176919</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Tamoxifen</PreferredName>
        <Version>1</Version>
        <LongName>Tamoxifen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C855</PREFERRED_NAME>
            <LONG_NAME>Tamoxifen Citrate</LONG_NAME>
            <CON_ID>2202842</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177315</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Treatment</PreferredName>
        <Version>1</Version>
        <LongName>Treatment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tamoxifen Treatment Start Date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tamoxifen Treatment Start Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Beginning date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="33">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2187718</PUBLICID>
    <LONGNAME>Blood Sample Received Date</LONGNAME>
    <PREFERREDNAME>BLD_SMPL_RECD_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>Date of receipt of a blood sample.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2187714</PublicId>
      <PreferredName>BLD_SMPL_RECD</PreferredName>
      <PreferredDefinition>Receipt of a blood sample.</PreferredDefinition>
      <LongName>Blood Sample Received</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2187712</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17610</PreferredName>
        <Version>1</Version>
        <LongName>Blood Sample</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17610</PREFERRED_NAME>
            <LONG_NAME>Blood Sample</LONG_NAME>
            <CON_ID>2202864</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2184327</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Received</PreferredName>
        <Version>1</Version>
        <LongName>Received</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017121</PublicId>
      <PreferredName>CTMS_DT</PreferredName>
      <PreferredDefinition>Date as required for Clinical Trials Monitoring Service submissions.  Exchange format is YYYYMMDD.  Display format is DDMMMYYYY, with the month display the first three letters of each month (Jan, Feb, Mar, etc.).</PreferredDefinition>
      <LongName>CTMS Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>DD/MON/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date Sample Received</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date Sample Received</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UC Irvine</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811716</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DFMO/Sul Colon III UCI 02_06</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4631580</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Exceptional Responder CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exceptional Responder CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4631582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="34">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2187835</PUBLICID>
    <LONGNAME>Overall Treatment Response Type</LONGNAME>
    <PREFERREDNAME>OVERALL_TX_RESP_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Response based on the review of multiple types of evaluation (diagnostics, physical exams, lab tests) to formulate an overall assessment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2181964</PublicId>
      <PreferredName>PT_RESP</PreferredName>
      <PreferredDefinition>the reponse of the patient.</PreferredDefinition>
      <LongName>Patient Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177336</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Response</PreferredName>
        <Version>1</Version>
        <LongName>Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25755</PREFERRED_NAME>
            <LONG_NAME>Response</LONG_NAME>
            <CON_ID>2202805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2187830</PublicId>
      <PreferredName>TX_RESP_TP</PreferredName>
      <PreferredDefinition>Type of improvement/change in a patient due to a course of treatment.</PreferredDefinition>
      <LongName>Treatment Response Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2556191</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49656:C50995:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Treatment Study Response Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49656</PREFERRED_NAME>
            <LONG_NAME>Treatment Study</LONG_NAME>
            <CON_ID>2480684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50995</PREFERRED_NAME>
            <LONG_NAME>Disease Response</LONG_NAME>
            <CON_ID>2459436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complete Response</VALIDVALUE>
          <VALUEMEANING>Complete Response</VALUEMEANING>
          <MEANINGDESCRIPTION>The disappearance of all signs of cancer in response to treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Progressive Disease</VALIDVALUE>
          <VALUEMEANING>Progressive Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Cancer that is increasing in scope or severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial Response</VALIDVALUE>
          <VALUEMEANING>Partial Response</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stable/No Change</VALIDVALUE>
          <VALUEMEANING>Stable, No Change</VALUEMEANING>
          <MEANINGDESCRIPTION>Stable, No Change</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Evaluable</VALIDVALUE>
          <VALUEMEANING>Not Evaluable</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to be evaluated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to evaluate</VALIDVALUE>
          <VALUEMEANING>Unable to evaluate, specify reason</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to evaluate, specify reason</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recurrence</VALIDVALUE>
          <VALUEMEANING>Recurrent Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>the return of a sign, symptom, or disease after a remission.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3285249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>New Lesion</VALIDVALUE>
          <VALUEMEANING>New Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>Having no previous example or precedent or parallel; of a kind not seen before.: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25586, C3824</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3771274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Overall Tumor Response</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Overall Tumor Response</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify response to treatment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Response Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Response to Treatment Regimen</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Best Overall Response to Treatment:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886752</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>For Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3891931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0937</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171057</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4631580</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Exceptional Responder CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exceptional Responder CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4631582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OVERALL_TX_RESP_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="35">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2188247</PUBLICID>
    <LONGNAME>Dose Modification Dose Modification Status</LONGNAME>
    <PREFERREDNAME>DOSE_MOD_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>the dose modification status.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2184763</PublicId>
      <PreferredName>2411801v1.00:2239855v1.00</PreferredName>
      <PreferredDefinition>A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.:The act of alteration or modification; changed or altered in form or character.</PreferredDefinition>
      <LongName>Dose Change</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2411801</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488</PreferredName>
        <Version>1</Version>
        <LongName>Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446</PreferredName>
        <Version>1</Version>
        <LongName>Change</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188246</PublicId>
      <PreferredName>DOSE_MOD_STAT</PreferredName>
      <PreferredDefinition>the dose modification status.</PreferredDefinition>
      <LongName>Dose Modification Status</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No dose modification</VALIDVALUE>
          <VALUEMEANING>No dose modification</VALUEMEANING>
          <MEANINGDESCRIPTION>No dose modification</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-09-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose delayed</VALIDVALUE>
          <VALUEMEANING>Dose Delayed</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose of agent given later than scheduled.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-09-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose delayed and reduced</VALIDVALUE>
          <VALUEMEANING>Dose delayed and reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Made less in size or amount or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25640, C37912, C25476, C25488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-09-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drug discontinued</VALIDVALUE>
          <VALUEMEANING>Drug discontinued</VALUEMEANING>
          <MEANINGDESCRIPTION>Drug discontinued</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-09-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose escalated</VALIDVALUE>
          <VALUEMEANING>Dose escalated</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose escalated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dosing error</VALIDVALUE>
          <VALUEMEANING>DOSING ERROR</VALUEMEANING>
          <MEANINGDESCRIPTION>DOSING ERROR</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-10-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose held and reduced</VALIDVALUE>
          <VALUEMEANING>Dose Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose stopped</VALIDVALUE>
          <VALUEMEANING>Agent Stopped</VALUEMEANING>
          <MEANINGDESCRIPTION>Agent Stopped</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose or INR modfication</VALIDVALUE>
          <VALUEMEANING>Dose or INR modfication</VALUEMEANING>
          <MEANINGDESCRIPTION>A modification in the dose or international normalized ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2588573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose missed</VALIDVALUE>
          <VALUEMEANING>Dose missed</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose missed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2588574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drug changed</VALIDVALUE>
          <VALUEMEANING>Drug changed</VALUEMEANING>
          <MEANINGDESCRIPTION>Drug changed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2588575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IV rate decreased</VALIDVALUE>
          <VALUEMEANING>IV rate decreased</VALUEMEANING>
          <MEANINGDESCRIPTION>the rate of intravenous administration of an agent was reduced.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2698338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose delayed/omitted</VALIDVALUE>
          <VALUEMEANING>Dose delayed/omitted</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose delayed/omitted</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2698341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drug interrupted</VALIDVALUE>
          <VALUEMEANING>Drug Interrupted</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drug permanently discontinued prior to completion</VALIDVALUE>
          <VALUEMEANING>Drug permanently discontinued prior to completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Drug permanently discontinued prior to completion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose omitted</VALIDVALUE>
          <VALUEMEANING>Dose Omitted</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that a scheduled dose was not given.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202338</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2879744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Change of route</VALIDVALUE>
          <VALUEMEANING>Change of route</VALUEMEANING>
          <MEANINGDESCRIPTION>Change of route</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2879745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose increased (since last report)</VALIDVALUE>
          <VALUEMEANING>Dose increased (since last report)</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose increased (since last report)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3017658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose reduced (since last report)</VALIDVALUE>
          <VALUEMEANING>Dose reduced (since last report)</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose reduced (since last report)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3017659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Agent not scheduled for this cycle</VALIDVALUE>
          <VALUEMEANING>Agent not scheduled for this cycle</VALUEMEANING>
          <MEANINGDESCRIPTION>Agent not scheduled for this cycle</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3017605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dosing not indicated per protocol</VALIDVALUE>
          <VALUEMEANING>Dosing not indicated per protocol</VALUEMEANING>
          <MEANINGDESCRIPTION>Dosing not indicated per protocol</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Re-escalated</VALIDVALUE>
          <VALUEMEANING>Dose re-escalated</VALUEMEANING>
          <MEANINGDESCRIPTION>A re-escalation in the prescribed amount of an agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3161933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-Permanent Reduction</VALIDVALUE>
          <VALUEMEANING>Non-Permanent Reduction</VALUEMEANING>
          <MEANINGDESCRIPTION>A temporary reduction in the prescribed amount of an agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3161934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Permanent Reduction</VALIDVALUE>
          <VALUEMEANING>Permanent Reduction</VALUEMEANING>
          <MEANINGDESCRIPTION>A permanent reduction in the prescribed amount of an agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3161935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drug re-escalation</VALIDVALUE>
          <VALUEMEANING>Drug re-escalation</VALUEMEANING>
          <MEANINGDESCRIPTION>Drug re-escalation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3442950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drug given too early</VALIDVALUE>
          <VALUEMEANING>Drug given too early</VALUEMEANING>
          <MEANINGDESCRIPTION>Drug given too early</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3442951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drug increased (error)</VALIDVALUE>
          <VALUEMEANING>Drug increased (error)</VALUEMEANING>
          <MEANINGDESCRIPTION>Drug increased (error)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3442952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose delayed and escalated</VALIDVALUE>
          <VALUEMEANING>Dose Escalation Delay</VALUEMEANING>
          <MEANINGDESCRIPTION>A stepwise increase in the amount of a therapeutic or investigational agent given to an individual.: Delay; time during which some action is awaited; inactivity resulting in something being put off until a later time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25476, C107213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-11-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3946420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Treatment interrupted and reduced</VALIDVALUE>
          <VALUEMEANING>Treatment interrupted and reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment interrupted and reduced</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4187634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination that a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drug withdrawn</VALIDVALUE>
          <VALUEMEANING>Drug Withdrawn</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that a medication schedule was modified through termination of a prescribed regimen of medication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2659978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose delayed and drug discontinued</VALIDVALUE>
          <VALUEMEANING>Discontinued Delay</VALUEMEANING>
          <MEANINGDESCRIPTION>Discontinued; stopped permanently or temporarily.: Delay; time during which some action is awaited; inactivity resulting in something being put off until a later time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25476, C25484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-11-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3946421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose reduced and drug discontinued</VALIDVALUE>
          <VALUEMEANING>Discontinued Dose Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Discontinued; stopped permanently or temporarily.: An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49505, C25484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-11-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3946422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose modified</VALIDVALUE>
          <VALUEMEANING>Dose modified</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose modified</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676602</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose discontinued</VALIDVALUE>
          <VALUEMEANING>Dose Discontinued</VALUEMEANING>
          <MEANINGDESCRIPTION>The amount of medicine taken, or radiation given, at one time.: Discontinued; stopped permanently or temporarily.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25484, C25488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2871585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Treatment interrupted</VALIDVALUE>
          <VALUEMEANING>Treatment interrupted</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment interrupted</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4187635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose not changed</VALIDVALUE>
          <VALUEMEANING>Dose Not Changed</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that a medication schedule was continued without modification.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2660003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose not given</VALIDVALUE>
          <VALUEMEANING>Dose not given</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose not given</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4415411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose interruption</VALIDVALUE>
          <VALUEMEANING>Dose interruption</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose interruption</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4470066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose delayed, reduced, and then permanently withdrawn</VALIDVALUE>
          <VALUEMEANING>Dose delayed, reduced, and then permanently withdrawn</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose delayed, reduced, and then permanently withdrawn</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4470067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose delayed and then permanently withdrawn</VALIDVALUE>
          <VALUEMEANING>Dose delayed and then permanently withdrawn</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose delayed and then permanently withdrawn</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4470068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Permanently withdrawn</VALIDVALUE>
          <VALUEMEANING>Permanently withdrawn</VALUEMEANING>
          <MEANINGDESCRIPTION>Permanently withdrawn</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4470069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose reduced, and then permanently withdrawn</VALIDVALUE>
          <VALUEMEANING>Dose reduced, and then permanently withdrawn</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose reduced, and then permanently withdrawn</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4484491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose is stable</VALIDVALUE>
          <VALUEMEANING>Stable Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>Subject to little fluctuation; showing little if any change.: A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25488, C30103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4273135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RT given BID</VALIDVALUE>
          <VALUEMEANING>Twice Daily Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Two times per day, at unspecified times.: Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15313, C64496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7760026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose Held</VALIDVALUE>
          <VALUEMEANING>Dose Held</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose Held</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2021-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7765241</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose Reduced</VALIDVALUE>
          <VALUEMEANING>Dose Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>OHSU Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Action Taken with Study Drug</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Dose modification</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>RT Modification Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Dose modification</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Dose modification</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Agent dose modification</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Dose modification status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>OHSU Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Action Taken</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Modifications</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Modifications</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Dose modification type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Type of Modification</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Modification type:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Action taken with Letermovir:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Muscle Invasive Blad</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000462</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0263</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229L</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229N</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229O</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104892</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0250</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104897</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0277</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104900</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0286B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104901</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0252</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104930</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104941</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0275</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104991</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000175</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000275</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000276</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0252</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000589</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0252</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000590</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000705</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-Up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000342</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>5_FU_ECADJ</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPEC_QVAL_MODTYP</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="36">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2188265</PUBLICID>
    <LONGNAME>Metastasis Visceral Location Type</LONGNAME>
    <PREFERREDNAME>MET_VISC_LCTN_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the site of visceral metastatic disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188264</PublicId>
      <PreferredName>MET_VISC_LCTN</PreferredName>
      <PreferredDefinition>information related to the visceral location of a metastasis.</PreferredDefinition>
      <LongName>Metastasis Visceral Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177041</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Metastasis</PreferredName>
        <Version>1</Version>
        <LongName>Metastasis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19151</PREFERRED_NAME>
            <LONG_NAME>Metastasis</LONG_NAME>
            <CON_ID>2202751</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207141</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25315:C25341</PreferredName>
        <Version>1</Version>
        <LongName>Visceral Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25315</PREFERRED_NAME>
            <LONG_NAME>Visceral</LONG_NAME>
            <CON_ID>2202888</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188263</PublicId>
      <PreferredName>MET_VISC_LCTN_TP</PreferredName>
      <PreferredDefinition>the site of visceral metastatic disease.</PreferredDefinition>
      <LongName>Metastasis Visceral Location Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung</VALIDVALUE>
          <VALUEMEANING>Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver</VALIDVALUE>
          <VALUEMEANING>Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleura</VALIDVALUE>
          <VALUEMEANING>Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>Pleura</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CNS</VALIDVALUE>
          <VALUEMEANING>CNS</VALUEMEANING>
          <MEANINGDESCRIPTION>CNS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Visceral, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="37">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2188536</PUBLICID>
    <LONGNAME>Chemotherapy Infusion Begin Date</LONGNAME>
    <PREFERREDNAME>CT_INF_BEG_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date a chemotherapy infusion began.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188535</PublicId>
      <PreferredName>CT_INF</PreferredName>
      <PreferredDefinition>information related to chemotherapy infusion.</PreferredDefinition>
      <LongName>Chemotherapy Infusion</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177132</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Chemotherapy</PreferredName>
        <Version>1</Version>
        <LongName>Chemotherapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15632</PREFERRED_NAME>
            <LONG_NAME>Chemotherapy</LONG_NAME>
            <CON_ID>2202708</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177461</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Infusion</PreferredName>
        <Version>1</Version>
        <LongName>Infusion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15388</PREFERRED_NAME>
            <LONG_NAME>Infusion Procedure</LONG_NAME>
            <CON_ID>2203835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188673</PublicId>
      <PreferredName>BEG_DT</PreferredName>
      <PreferredDefinition>The date on which an observation or an event began.</PreferredDefinition>
      <LongName>Begin Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yyyy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Begin Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Infusion start date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Infusion start date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Start Date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of first Blinatumomab infusion:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Infusion start date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of Mitomycin-C infusion</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of 5-FU infusion</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Upper GI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Molecular Analysis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811958</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MITOMYCIN-C_ECSTDAT</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>5-FU_ECSTDAT</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="38">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2190282</PUBLICID>
    <LONGNAME>Primary Tumor Lymphoid Infiltration Type</LONGNAME>
    <PREFERREDNAME>PRM_TUM_LYM_INFIL_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of lyphoid infiltrate of the primary tumor.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2190280</PublicId>
      <PreferredName>PRM_TUM_LYMOID_INFIL</PreferredName>
      <PreferredDefinition>information related to lymphoid infiltration by the primary tumor</PreferredDefinition>
      <LongName>Primary Tumor Lymphoid Infiltration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206557</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25251:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Primary Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207668</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13810:C25754</PreferredName>
        <Version>1</Version>
        <LongName>Lymphoid Infiltration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13810</PREFERRED_NAME>
            <LONG_NAME>Lymphoid</LONG_NAME>
            <CON_ID>2206298</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25754</PREFERRED_NAME>
            <LONG_NAME>Infiltration</LONG_NAME>
            <CON_ID>2203836</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2190281</PublicId>
      <PreferredName>PRM_TUM_LYM_INFIL_TP</PreferredName>
      <PreferredDefinition>the type of lyphoid infiltrate of the primary tumor.</PreferredDefinition>
      <LongName>Primary Tumor Lymphoid Infiltration Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dense or prominent</VALIDVALUE>
          <VALUEMEANING>Dense or prominent</VALUEMEANING>
          <MEANINGDESCRIPTION>Dense or prominent</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-10-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sparse focal infiltrate</VALIDVALUE>
          <VALUEMEANING>sparse focal infiltrate</VALUEMEANING>
          <MEANINGDESCRIPTION>sparse focal infiltrate</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-10-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lymphoid infiltration of prim</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Lymphoid infiltration of primary tumor</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="39">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2191112</PUBLICID>
    <LONGNAME>Urine Collection Method Specify</LONGNAME>
    <PREFERREDNAME>URINE_COLL_METH_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the specified method of urine collection.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>GOG CRF:Gynecologic Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2191108</PublicId>
      <PreferredName>URINE_COLL_METH</PreferredName>
      <PreferredDefinition>information related to the urine collection method.</PreferredDefinition>
      <LongName>Urine Collection Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2191106</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Urine</PreferredName>
        <Version>1</Version>
        <LongName>Urine</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13283</PREFERRED_NAME>
            <LONG_NAME>Urine</LONG_NAME>
            <CON_ID>2202425</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207680</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25453:C16847</PreferredName>
        <Version>1</Version>
        <LongName>Collection Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16847</PREFERRED_NAME>
            <LONG_NAME>Technique</LONG_NAME>
            <CON_ID>2203854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180669</PublicId>
      <PreferredName>SPEC_CHAR_SPEC</PreferredName>
      <PreferredDefinition>information related to specified characteristics of a specimen.</PreferredDefinition>
      <LongName>Specimen Characteristics Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0219</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104879</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0263</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0250</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104897</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0258</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104898</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0261</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104899</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0277</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104900</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0212</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000079</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000080</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000175</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0212</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000593</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0212</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000594</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>URINE_COLL_METH_SPEC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="40">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2193076</PUBLICID>
    <LONGNAME>Protocol NABTC/NABTT Indicator</LONGNAME>
    <PREFERREDNAME>PROT_NABTC_NABTT_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no response to a question that asks whether this is a NABTC/NABTT trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013913</PublicId>
      <PreferredName>PROT_ID</PreferredName>
      <PreferredDefinition>a means of specifying a protocol for a clinical trial.</PreferredDefinition>
      <LongName>Protocol Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008529</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RSCH_PROT</PreferredName>
        <Version>1</Version>
        <LongName>Research Protocols</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176994</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Protocol</PreferredName>
        <Version>1</Version>
        <LongName>Protocol</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25320</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Protocol</LONG_NAME>
            <CON_ID>2202702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2184304</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Identifier</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015873</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>A choice of Yes and No answer.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008509</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPORES</PreferredName>
        <Version>2.31</Version>
        <LongName>SPOREs</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>YES</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NO</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NABTC/NABTT Trial?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>NABTC/NABTT Trial?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2190530</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Demonstration Applications</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rembrandt</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2812349</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="41">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2194581</PUBLICID>
    <LONGNAME>Cigarette Smoking Classification</LONGNAME>
    <PREFERREDNAME>CIGA_SMK_CLASS</PREFERREDNAME>
    <PREFERREDDEFINITION>The classification of how often a person currently smokes given they have smoked at least 100 cigarettes in their lifetime.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2010568</PublicId>
      <PreferredName>SMK_HX</PreferredName>
      <PreferredDefinition>the history of use of tobacco products by a person.</PreferredDefinition>
      <LongName>Smoking History</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177023</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Smoking</PreferredName>
        <Version>1</Version>
        <LongName>Smoking</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17934</PREFERRED_NAME>
            <LONG_NAME>Tobacco Smoking</LONG_NAME>
            <CON_ID>2202827</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>History</PreferredName>
        <Version>1</Version>
        <LongName>History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2194579</PublicId>
      <PreferredName>SMOK_CLAS</PreferredName>
      <PreferredDefinition>Inhaling smoke from tobacco . Classification; the grouping of things into classes or categories._Inhaling and exhaling the smoke of tobacco or something similar to tobacco._Classification; the grouping of things into classes or categories in regards to usage._Category; used informally to mean a class of things.</PreferredDefinition>
      <LongName>Smoking Classification Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2433877</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25372</PreferredName>
        <Version>1</Version>
        <LongName>Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No, not at all</VALIDVALUE>
          <VALUEMEANING>No, not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of non-agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Every Day</VALIDVALUE>
          <VALUEMEANING>About once a day</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring or done each day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some Days</VALIDVALUE>
          <VALUEMEANING>Some Days</VALUEMEANING>
          <MEANINGDESCRIPTION>Some Days</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Refused</VALIDVALUE>
          <VALUEMEANING>Refused/Don&#39;t Know</VALUEMEANING>
          <MEANINGDESCRIPTION>Participant does not answer question regarding cigarette type for, they have refused or do not know.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Don&#39;t Know</VALIDVALUE>
          <VALUEMEANING>Refused/Don&#39;t Know</VALUEMEANING>
          <MEANINGDESCRIPTION>Participant does not answer question regarding cigarette type for, they have refused or do not know.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Do you now smoke cigarettes,</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Do you now smoke cigarettes, every day, some days or not at all?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>AHB.030 (SMKNOW) Do you now smoke cigarettes, every day, some dats, or not at all?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="42">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2195611</PUBLICID>
    <LONGNAME>Common Toxicity Criteria Adverse Event Pulmonary Fistula Grade</LONGNAME>
    <PREFERREDNAME>CTC_AE_PULM_FISTU_GD</PREFERREDNAME>
    <PREFERREDDEFINITION>in CTC category Pulmonary/Upper Respiratory, assessment of the severity of an adverse event for the supraordinate term pulmonary fistula - select using a graded scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195609</PublicId>
      <PreferredName>CTC_AE_PULM_FISTULA</PreferredName>
      <PreferredDefinition>information related to the CTC adverse event of pulmonary fistula.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Pulmonary Fistula</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207547</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13304:C3045</PreferredName>
        <Version>1</Version>
        <LongName>Pulmonary Fistula</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13304</PREFERRED_NAME>
            <LONG_NAME>Pulmonary</LONG_NAME>
            <CON_ID>2204862</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3045</PREFERRED_NAME>
            <LONG_NAME>Fistula</LONG_NAME>
            <CON_ID>2203643</CON_ID>
            <DEFINITION_SOURCE>MSH2003_2003_05_12</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2195610</PublicId>
      <PreferredName>CTC_AE_PULM_FISTU_GD</PreferredName>
      <PreferredDefinition>in CTC category Pulmonary/Upper Respiratory, assessment of the severity of an adverse event for the supraordinate term pulmonary fistula - select using a graded scale.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Pulmonary Fistula Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184299</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Grade</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Asymptomatic, radiographic findings only </VALUEMEANING>
          <MEANINGDESCRIPTION>Asymptomatic, radiographic findings only </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Symptomatic, tube thoracostomy or medical management indicated; associated with altered respiratory function but not interfering with ADL</VALUEMEANING>
          <MEANINGDESCRIPTION>Symptomatic, tube thoracostomy or medical management indicated; associated with altered respiratory function but not interfering with ADL</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572820</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Symptomatic and associated with altered respiratory function interfering with ADL; or endoscopic (e.g., stent) or primary closure by operative intervention indicated</VALUEMEANING>
          <MEANINGDESCRIPTION>Symptomatic and associated with altered respiratory function interfering with ADL; or endoscopic (e.g., stent) or primary closure by operative intervention indicated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Life-threatening consequences; operative intervention with thoracoplasty, chronic open drainage or multiple thoracotomies indicated</VALUEMEANING>
          <MEANINGDESCRIPTION>Life-threatening consequences; operative intervention with thoracoplasty, chronic open drainage or multiple thoracotomies indicated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Death</VALUEMEANING>
          <MEANINGDESCRIPTION>The cessation of life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTC Adverse Event Fistula, pu</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CTC Adverse Event Fistula, pulmonary/upper respiratory - Select Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Fistula, pulmonary/upper respiratory - Select Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)</DocumentText>
        <URL>http://ctep.cancer.gov/reporting/ctc.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000132</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="43">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2201039</PUBLICID>
    <LONGNAME>Pathology Organ System Site Text Name</LONGNAME>
    <PREFERREDNAME>PATH_SYS_SITE_TXT_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>Text name of organ system or site as referenced on a pathology report.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>SPOREs</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2012994</PublicId>
      <PreferredName>ANAT_SITE_ASSESS</PreferredName>
      <PreferredDefinition>Evaluations of named anatomic site(s) in the body.</PreferredDefinition>
      <LongName>Anatomic Site Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2429762</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25367</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2201037</PublicId>
      <PreferredName>PATH_SYS_SITE_NM</PreferredName>
      <PreferredDefinition>Text names of organ systems or sites as referenced on a pathology report</PreferredDefinition>
      <LongName>Pathology Organ System Site Text Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>26</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood Vessel</VALIDVALUE>
          <VALUEMEANING>Blood Vessel</VALUEMEANING>
          <MEANINGDESCRIPTION>A tube through which the blood circulates in the body. Blood vessels include a network of arteries, arterioles, capillaries, venules, and veins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12679</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brain</VALIDVALUE>
          <VALUEMEANING>Brain</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ear</VALIDVALUE>
          <VALUEMEANING>Ear</VALUEMEANING>
          <MEANINGDESCRIPTION>The organ of hearing: composed of the external ear, which includes the auricle and the external acoustic, or auditory, meatus; the middle ear, or the tympanic cavity with its ossicles; and the internal ear or inner ear, or labyrinth, which includes the semicircular canals, vestibule, and cochlea. SEE ALSO auricle. SYN auris.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-07-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Gland</VALIDVALUE>
          <VALUEMEANING>Endocrine Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>Ductless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremities, Lower</VALIDVALUE>
          <VALUEMEANING>Extremities, Lower</VALUEMEANING>
          <MEANINGDESCRIPTION>Lower Extremities</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremities, Upper</VALIDVALUE>
          <VALUEMEANING>Extremities, Upper</VALUEMEANING>
          <MEANINGDESCRIPTION>Upper Extremities</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eye</VALIDVALUE>
          <VALUEMEANING>Eye</VALUEMEANING>
          <MEANINGDESCRIPTION>The organ of sight or vision. (On-line Medical Dictionary)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-06-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GI Tract</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Tract</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head</VALIDVALUE>
          <VALUEMEANING>Head</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior or superior part of an animal, containing the brain, or chief ganglia of the nervous system, the mouth, and in the higher animals, the chief sensory organs. (On-line Medical Dictionary)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heart</VALIDVALUE>
          <VALUEMEANING>Heart</VALUEMEANING>
          <MEANINGDESCRIPTION>A hollow muscular organ which receives the blood from the veins and propels it into the arteries. It is divided by a musculomembranous septum into two halves -- right or venous and left or arterial -- each of which consists of a receiving chamber (atrium) and an ejecting chamber (ventricle). SYN cor, coeur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Larynx</VALIDVALUE>
          <VALUEMEANING>Larynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The organ of voice production; the part of the respiratory tract between the pharynx and the trachea; it consists of a framework of cartilages and elastic membranes housing the vocal folds and the muscles which control the position and tension of these elements.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-06-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal Cavity</VALIDVALUE>
          <VALUEMEANING>Nasal cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>Nasal cavity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neck</VALIDVALUE>
          <VALUEMEANING>Neck</VALUEMEANING>
          <MEANINGDESCRIPTION>The region that connects the head to the rest of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oral Cavity</VALIDVALUE>
          <VALUEMEANING>Oral Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The cavity lying at the upper end of the alimentary canal, bounded on the outside by the lips and inside by the oropharynx and containing in humans the tongue, gums, and teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paranasal Sinus</VALIDVALUE>
          <VALUEMEANING>Paranasal Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>Air-filled extensions of the respiratory part of the nasal cavity into the frontal, ethmoid, sphenoid, and maxillary cranial bones. They vary in size and form in different individuals and are lined by the ciliated mucous membranes of the nasal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peripheral Nervous System</VALIDVALUE>
          <VALUEMEANING>Peripheral Nervous System</VALUEMEANING>
          <MEANINGDESCRIPTION>That part of the nervous system consisting of the nerves and neurons that reside or extend outside the central nervous system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pharynx</VALIDVALUE>
          <VALUEMEANING>Pharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>(FAIR-inks) The hollow tube about 5 inches long that starts behind the nose and ends at the top of the trachea (windpipe) and esophagus (the tube that goes to the stomach).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-06-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reproductive System</VALIDVALUE>
          <VALUEMEANING>Reproductive System</VALUEMEANING>
          <MEANINGDESCRIPTION>Reproductive System</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Salivary Gland</VALIDVALUE>
          <VALUEMEANING>Salivary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>An exocrine gland that secretes saliva.  Salivary glands are mostly located in and around the oral cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12426</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skeleton/Soft Tissue</VALIDVALUE>
          <VALUEMEANING>Skeleton/Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Skeleton/Soft Tissue</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573424</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skull</VALIDVALUE>
          <VALUEMEANING>Skull</VALUEMEANING>
          <MEANINGDESCRIPTION>The skeleton of the head including the bones of the face and the bones enclosing the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spine</VALIDVALUE>
          <VALUEMEANING>Spine, Whole</VALUEMEANING>
          <MEANINGDESCRIPTION>Whole; including all components without exception; being one unit or constituting the full amount or extent or duration; complete.: The elongated, approximately cylindrical part of the central nervous system of vertebrates that lies in the vertebral canal and from which the spinal nerves emerge.|On-line Medical Dictionary</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12464, C25326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thorax</VALIDVALUE>
          <VALUEMEANING>Thorax</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper part of the trunk between the neck and the abdomen. It contains the chief organs of the circulatory and respiratory systems. (From Stedman, 25th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12799</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-03-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Tract</VALIDVALUE>
          <VALUEMEANING>Urinary Tract</VALUEMEANING>
          <MEANINGDESCRIPTION>Urinary Tract</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573425</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Organ, NOS</VALIDVALUE>
          <VALUEMEANING>Organ, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>Organ, Not Otherwise Specified</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573426</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Organ</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Organ</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SPOREs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811689</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2201036</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Head and Neck SPOREs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Bank</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2201036</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Head and Neck SPOREs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812413</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PATH_SYS_SITE_TXT_NM</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="44">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2223756</PUBLICID>
    <LONGNAME>Vocabulary Object Terminology Entity java.lang.String</LONGNAME>
    <PREFERREDNAME>2223348v3.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The object describes the vocabulary._Terminology entities represent the elements that form and define an ontology._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2223348</PublicId>
      <PreferredName>2223311v1.0:2223239v1.0</PreferredName>
      <PreferredDefinition>The object describes the vocabulary._Terminology entities represent the elements that form and define an ontology.</PreferredDefinition>
      <LongName>Vocabulary Object Terminology Entity</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223311</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43528</PreferredName>
        <Version>1</Version>
        <LongName>Vocabulary Object</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43528</PREFERRED_NAME>
            <LONG_NAME>Enterprise Vocabulary</LONG_NAME>
            <CON_ID>2223176</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223239</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42698</PreferredName>
        <Version>1</Version>
        <LongName>Terminology Entity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42698</PREFERRED_NAME>
            <LONG_NAME>Terminology Entity</LONG_NAME>
            <CON_ID>2223177</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Vocabulary Object Terminology Entity java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Vocabulary Object Terminology Entity java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabio.domain.Vocabulary.coreTerm</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Vocabulary:coreTerm</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="45">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2228438</PUBLICID>
    <LONGNAME>Scientific Publication Source Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2228405v3.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A class of publication in which original scientific work is described.  The format usually includes an introduction in which relevant concepts are identified and the experimental system under study is presented, a section describing the experiments that were performed to test a specific hypothesis and the results and observations that were obtained, a section in which the results are discussed relative to findings by other investigators and the current state of knowledge in the field, and a section describing the experimental methods and procedures in sufficient detail to enable the reproduction of the work by independent investigators.:Where something is available or from where it originates._The words or language units by which a thing is known._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2228405</PublicId>
      <PreferredName>2228374v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>A class of publication in which original scientific work is described.  The format usually includes an introduction in which relevant concepts are identified and the experimental system under study is presented, a section describing the experiments that were performed to test a specific hypothesis and the results and observations that were obtained, a section in which the results are discussed relative to findings by other investigators and the current state of knowledge in the field, and a section describing the experimental methods and procedures in sufficient detail to enable the reproduction of the work by independent investigators.:Where something is available or from where it originates._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Scientific Publication Source Name</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2228374</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19026:C25683</PreferredName>
        <Version>1</Version>
        <LongName>Scientific Publication Source</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19026</PREFERRED_NAME>
            <LONG_NAME>Scientific Publication</LONG_NAME>
            <CON_ID>2223990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25683</PREFERRED_NAME>
            <LONG_NAME>Source</LONG_NAME>
            <CON_ID>2202479</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Scientific Publication Source Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Scientific Publication Source Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.common.provenance.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000617</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.common.provenance.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000618</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.common.provenance.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000620</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.common.provenance.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000621</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.common.provenance.domain.PublicationSource.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PublicationSource:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.common.provenance.domain.Source.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Source:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="46">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2230047</PUBLICID>
    <LONGNAME>Specimen Accession Number</LONGNAME>
    <PREFERREDNAME>SPEC_ACCNUM</PREFERREDNAME>
    <PREFERREDDEFINITION>The alphanumeric identifier assigned to the specimen to uniquely identify it.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2191580</PublicId>
      <PreferredName>SPEC_ACCNUM</PreferredName>
      <PreferredDefinition>information related to a specimen accession number.</PreferredDefinition>
      <LongName>Specimen Accession Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177026</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specimen</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177659</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Accession Number</PreferredName>
        <Version>1</Version>
        <LongName>Accession Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25402</PREFERRED_NAME>
            <LONG_NAME>Accession Number</LONG_NAME>
            <CON_ID>2203569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2230045</PublicId>
      <PreferredName>SPEC_ACCNUM</PreferredName>
      <PreferredDefinition>The alphanumeric identifier assigned to the specimen to uniquely identify it.</PreferredDefinition>
      <LongName>Specimen Accession Number</LongName>
      <Version>4</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specimen Accession #</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specimen Accession #</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Accession Number</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Accession Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NINDS CDE Project</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>NINDS CDE Project</DocumentText>
        <URL>http://www.commondataelements.ninds.nih.gov/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Yes, Accession #(s)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specimen ID number or Pathology accession number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specimen ID</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Blood Sample ID #</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Accession Number(s) and Number(s)/Letter(s) of FFPE Blocks</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Accession Number(s) and Number(s)/Letter(s) corresponding to slides</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>FFPE Block Accession Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>OPEN</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the Specimen # from the Children&#39;s Hospital of Los Angeles MRD report?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812205</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AZCC 0210</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812575</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Nebraska Med Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812726</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory Test/Results</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2864540</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E for Cervical Ca</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812399</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812415</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3194026</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>KAI Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812550</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3194026</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>KAI Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory Tracking and Results Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3212386</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4188651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-04</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280815</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889180</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory Test/Results</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000327</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory Tests and Biospecimens/ Biomarkers</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3151271</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory Tests and Tracking</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3152844</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Assessments and Examinations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000640</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SPEC_ACCNUM</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SPEC_ACCNUM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCTG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SPEC_ACCNUM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCIP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Accession Number</AlternateName>
        <AlternateNameType>NINDS Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CRDC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>biosample_accession</AlternateName>
        <AlternateNameType>GC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BE_BEREFID</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="47">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2232693</PUBLICID>
    <LONGNAME>Module Administered Item Change Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2232092v3.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A collection of data elements, or Common Data Elements, logically grouped on a case report form.:A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_An alteration or modification.:A statement or an account describing something. (Bartleby.com)_Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2232092</PublicId>
      <PreferredName>2231661v1.0:2231607v1.0</PreferredName>
      <PreferredDefinition>A collection of data elements, or Common Data Elements, logically grouped on a case report form.:A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_An alteration or modification.:A statement or an account describing something. (Bartleby.com)</PreferredDefinition>
      <LongName>Module Administered Item Change Description</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2231661</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42721:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Module Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42721</PREFERRED_NAME>
            <LONG_NAME>Module</LONG_NAME>
            <CON_ID>2231571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231607</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446:C25365</PreferredName>
        <Version>1</Version>
        <LongName>Change Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Module Administered Item Change Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Module Administered Item Change Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.Module.changeNote</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Module:changeNote</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.AdministeredComponent.changeNote</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AdministeredComponent:changeNote</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="48">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2238102</PUBLICID>
    <LONGNAME>Organizational Unit Toll-Free Telephone Number java.lang.String</LONGNAME>
    <PREFERREDNAME>2237957v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Organizational unit like a laboratory, institute or consortium. (caBIO)_A toll-free telephone number is a special telephone number in which the calling party is not charged for the cost of the call. Instead, the called party pays all of the charges for the call._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2237957</PublicId>
      <PreferredName>2224111v1.0:2236658v1.0</PreferredName>
      <PreferredDefinition>Organizational unit like a laboratory, institute or consortium. (caBIO)_A toll-free telephone number is a special telephone number in which the calling party is not charged for the cost of the call. Instead, the called party pays all of the charges for the call.</PreferredDefinition>
      <LongName>Organizational Unit Toll-Free Telephone Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2224111</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41167</PreferredName>
        <Version>1</Version>
        <LongName>Organizational Unit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41167</PREFERRED_NAME>
            <LONG_NAME>Organizational Unit</LONG_NAME>
            <CON_ID>2223214</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2236658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43413</PreferredName>
        <Version>1</Version>
        <LongName>Toll-Free Telephone Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43413</PREFERRED_NAME>
            <LONG_NAME>Toll-Free Telephone Number</LONG_NAME>
            <CON_ID>2236555</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Organizational Unit Toll-Free Telephone Number java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Organizational Unit Toll-Free Telephone Number java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.mageom.domain.AuditAndSecurity.Organization.tollFreePhone</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.mageom.domain.AuditAndSecurity.Contact.tollFreePhone</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Organization:tollFreePhone</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="49">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2262041</PUBLICID>
    <LONGNAME>Laboratory Procedure Corrected Serum Calcium Measurement Outcome Status</LONGNAME>
    <PREFERREDNAME>LAB_CSCM_OC_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>the qualitative result of the medical procedure that involves testing a sample of blood for an estimate of serum calcium, corrected for the amount of albumin-bound calcium, used when albumin levels are not within normal ranges using the following formula: Corrected calcium (mg/dL) = measured total Ca (mg/dL) + 0.8 (4.0 - serum albumin [g/dL]), where 4.0 represents the average albumin level.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2194573</PublicId>
      <PreferredName>LAB_CSCM_OC</PreferredName>
      <PreferredDefinition>information related to the medical procedure that involves testing a sample of blood for an estimate of serum calcium, corrected for the amount of albumin-bound calcium, used when albumin levels are not within normal ranges using the following formula: Corrected calcium (mg/dL) = measured total Ca (mg/dL) + 0.8 (4.0 - serum albumin [g/dL]), where 4.0 represents the average albumin level.</PreferredDefinition>
      <LongName>Laboratory Procedure Corrected Serum Calcium Measurement Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2770317</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C74950:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Corrected Serum Calcium Measurement Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C74950</PREFERRED_NAME>
            <LONG_NAME>Corrected Serum Calcium Measurement</LONG_NAME>
            <CON_ID>2767429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2225337</PublicId>
      <PreferredName>LAB_ASSESS_STAT</PreferredName>
      <PreferredDefinition>the status of a lab assessment.</PreferredDefinition>
      <LongName>Lab Assessment Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength>6</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>NOT DONE</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&gt; normal</VALIDVALUE>
          <VALUEMEANING>&gt; normal</VALUEMEANING>
          <MEANINGDESCRIPTION>&gt; normal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&lt; normal</VALIDVALUE>
          <VALUEMEANING>&lt; normal</VALUEMEANING>
          <MEANINGDESCRIPTION>&lt; normal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating from the norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Within normal limits</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal, eligibility not affected</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating from the norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal, not eligible</VALIDVALUE>
          <VALUEMEANING>ABNORMAL NOT ELIGIBLE</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal and no longer eligible</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal - Clinically significant</VALIDVALUE>
          <VALUEMEANING>Abnormal - Clinically significant</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal - Clinically significant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2645499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal - Not clinically significant</VALIDVALUE>
          <VALUEMEANING>Abnormal - Not clinically significant</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal - Not clinically significant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2645498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&gt;= ULN</VALIDVALUE>
          <VALUEMEANING>&gt;= Upper limit of institutional normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Value is greater or equal to upper limit of institutional normal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3392242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&lt; ULN</VALIDVALUE>
          <VALUEMEANING>Less than upper limit of institutional normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Value is less than upper limit of institutional normal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3392243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trace</VALIDVALUE>
          <VALUEMEANING>Trace</VALUEMEANING>
          <MEANINGDESCRIPTION>A barely detectable amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2912071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Undetectable</VALIDVALUE>
          <VALUEMEANING>Undetectable</VALUEMEANING>
          <MEANINGDESCRIPTION>Undetectable</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&gt;</VALIDVALUE>
          <VALUEMEANING>Greater than (&gt;)</VALUEMEANING>
          <MEANINGDESCRIPTION>Greater than (&gt;)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581799</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&lt;</VALIDVALUE>
          <VALUEMEANING>Less Than</VALUEMEANING>
          <MEANINGDESCRIPTION>Less Than</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2840098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5042698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Equivocal</VALIDVALUE>
          <VALUEMEANING>Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Open to question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5178198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&lt;= ULN</VALIDVALUE>
          <VALUEMEANING>Less Than or Equal To Upper Limit of Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.: The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25706, C61586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6013658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&gt;ULN</VALIDVALUE>
          <VALUEMEANING>Greater Than Upper Limit of Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25706, C61584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6013657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>=</VALIDVALUE>
          <VALUEMEANING>Equality</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being the same in quantity or measure or value or status.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61582</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3423503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Corrected Serum Calcium</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="50">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2329285</PUBLICID>
    <LONGNAME>Intra-arterial Catheter Patient Not Administered Reason</LONGNAME>
    <PREFERREDNAME>I_CTH_PT_N_ADMIN_RSN</PREFERREDNAME>
    <PREFERREDDEFINITION>the reason an intra-arterial catheter was not implanted.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2329282</PublicId>
      <PreferredName>IA_CATH_PT_NOT_ADMIN</PreferredName>
      <PreferredDefinition>Within an artery (blood vessel that carries blood from the heart to tissues and organs in the body)._A flexible tube designed to transfer fluids into or out of the body._A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.:An operation in which a term denies or inverts the meaning of another term or construction._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Intra-arterial Catheter Device Patient Negation Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008554</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_OTX_RSNS</PreferredName>
        <Version>1</Version>
        <LongName>Treatment/Off-treatment Reasons</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>16340196</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C94248:C50344:C16960</PreferredName>
        <Version>1</Version>
        <LongName>Intra-arterial Catheter Device Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94248</PREFERRED_NAME>
            <LONG_NAME>Intra-arterial</LONG_NAME>
            <CON_ID>3191083</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50344</PREFERRED_NAME>
            <LONG_NAME>Catheter Device</LONG_NAME>
            <CON_ID>3212279</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207837</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Not Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2329284</PublicId>
      <PreferredName>I_CTH_PT_N_ADMIN_RSN</PreferredName>
      <PreferredDefinition>the reason an intra-arterial catheter was not implanted.</PreferredDefinition>
      <LongName>Intra-arterial Catheter Patient Not Administered Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</Origin>
      <Representation>
        <PublicId>2184326</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Reason</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to cannulate artery</VALIDVALUE>
          <VALUEMEANING>Unable to cannulate artery</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to cannulate artery</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other technical difficulty</VALIDVALUE>
          <VALUEMEANING>Other technical difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>Other technical difficulty</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient refused</VALIDVALUE>
          <VALUEMEANING>PATIENT REFUSED</VALUEMEANING>
          <MEANINGDESCRIPTION>PATIENT REFUSED</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medical reasons</VALIDVALUE>
          <VALUEMEANING>Medical reasons</VALUEMEANING>
          <MEANINGDESCRIPTION>Medical reasons</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Primary Reason</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Primary Reason</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="51">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2342601</PUBLICID>
    <LONGNAME>Transit Peptide Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2342424v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The N-terminal sequence of a protein that is required to direct the localization of a cytoplasmic protein to a subcellular membrane-bound organelle._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Value Domain for java language Long datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2342424</PublicId>
      <PreferredName>2342255v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>The N-terminal sequence of a protein that is required to direct the localization of a cytoplasmic protein to a subcellular membrane-bound organelle._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Transit Peptide Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2342255</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47943</PreferredName>
        <Version>1</Version>
        <LongName>Transit Peptide</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47943</PREFERRED_NAME>
            <LONG_NAME>Transit Peptide</LONG_NAME>
            <CON_ID>2342195</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Transit Peptide Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Transit Peptide Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2496586</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PIR 1.1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.georgetown.pir.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812496</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716603</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PIR 1.2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.georgetown.pir.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000532</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.georgetown.pir.domain.TransitPeptide.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TransitPeptide:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.georgetown.pir.domain.ProteinFeature.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProteinFeature:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="52">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2411867</PUBLICID>
    <LONGNAME>Concomitant Procedure Name</LONGNAME>
    <PREFERREDNAME>CONCT_PROC_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>Text name of a measure that is not part of the protocol or treatment program regimen.  Concomitant procedures are performed in response to preexisting conditions/symptoms, or to treat adverse events.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2411812</PublicId>
      <PreferredName>CONCT_PROC</PreferredName>
      <PreferredDefinition>Measure that is not part of the protocol or treatment program regimen.  Concomitant procedures are performed in response to preexisting conditions/symptoms, or to treat adverse events.</PreferredDefinition>
      <LongName>Concomitant Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2411809</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25730</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25730</PREFERRED_NAME>
            <LONG_NAME>Concomitant</LONG_NAME>
            <CON_ID>2202429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2411810</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0184661</PreferredName>
        <Version>1</Version>
        <LongName>Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0184661</PREFERRED_NAME>
            <LONG_NAME>Procedure</LONG_NAME>
            <CON_ID>2203411</CON_ID>
            <DEFINITION_SOURCE>National Cancer Institute Thesaurus. Version 1.0b1. Bethesda (MD): National Cancer Institute; 1998.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2411813</PublicId>
      <PreferredName>CONCT_PROC_NM</PreferredName>
      <PreferredDefinition>Text names of procedures that are not part of the protocol regimen.  Concomitant procedures are used for treatment of preexisting conditions or symptoms, and for adverse events. [Manually-curated]</PreferredDefinition>
      <LongName>Concomitant Procedure Name</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>80</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2691090</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25218:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alternative Therapy</VALIDVALUE>
          <VALUEMEANING>Complementary and Alternative Medicine</VALUEMEANING>
          <MEANINGDESCRIPTION>Practices not generally recognized by the medical community as standard or conventional medical approaches and used to replace, enhance or complement standard treatments. Complementary medicine includes dietary supplements, megadose vitamins, herbal preparations, special teas, acupuncture, massage therapy, magnet therapy, spiritual healing, and meditation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15178</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apheresis</VALIDVALUE>
          <VALUEMEANING>Pheresis</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure that collects a component of the peripheral blood while returning the rest to the donor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15191</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Birth Control</VALIDVALUE>
          <VALUEMEANING>Contraception</VALUEMEANING>
          <MEANINGDESCRIPTION>The prevention of conception or impregnation by the use of devices or drugs or surgery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37932</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576540</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchoscopy/Bronch Lavage</VALIDVALUE>
          <VALUEMEANING>Bronchoalveolar Lavage</VALUEMEANING>
          <MEANINGDESCRIPTION>Washing out the bronchi and alveoli by flushing with a fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51913</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cauterization</VALIDVALUE>
          <VALUEMEANING>Cauterization</VALUEMEANING>
          <MEANINGDESCRIPTION>(KAW-ter-ih-ZAY-shun) The destruction of tissue with a hot instrument, an electrical current, or a caustic substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Venous Access/IV Removal</VALIDVALUE>
          <VALUEMEANING>Venous Access Device Removal</VALUEMEANING>
          <MEANINGDESCRIPTION>Venous Access Device Removal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dental Procedure</VALIDVALUE>
          <VALUEMEANING>Dental Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>A particular course of action intended to achieve a result.: Pertaining to a tooth or teeth, or to odontology.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41136, C25218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ear Tube(s) Insertion</VALIDVALUE>
          <VALUEMEANING>EAR TUBE PLACEMENT</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0743375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophageal Dilation</VALIDVALUE>
          <VALUEMEANING>Oesophageal dilation procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>CL051153</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576544</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperbaric Treatment(s)</VALIDVALUE>
          <VALUEMEANING>Whole body hyperbaric oxygen therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Oxygen that is at an atmospheric pressure higher than the pressure at sea level.  Breathing hyperbaric oxygen to enhance the effectiveness of radiation therapy is being studied.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IABP/Stent Placement</VALIDVALUE>
          <VALUEMEANING>Intraaortic Balloon Pump/Stent Placement</VALUEMEANING>
          <MEANINGDESCRIPTION>A device designed to support a tubular structure, especially the small stainless steel expandable mesh tube inserted within an artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576546</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Incision &amp; Drainage</VALIDVALUE>
          <VALUEMEANING>Incision and Drainage</VALUEMEANING>
          <MEANINGDESCRIPTION>A surgical procedure where a cut is made in a tissue or structure to allow the drainage of fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38067</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraventricular Shunt Access</VALIDVALUE>
          <VALUEMEANING>Intraventricular Shunt Access</VALUEMEANING>
          <MEANINGDESCRIPTION>An implantable device designed to drain fluid from a body cavity._The right to obtain or make use of or take advantage of something (as services or membership); the right to enter.  Also, an act or means of approaching._Located within a ventricle of the brain or heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13731, C25396, C50174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Irrigation</VALIDVALUE>
          <VALUEMEANING>Irrigation - action</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>CL291847</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphocyte Infusion</VALIDVALUE>
          <VALUEMEANING>Lymphocyte Infusion</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymphocyte Infusion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mechanical Ventilation</VALIDVALUE>
          <VALUEMEANING>Ventilation, Mechanical</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to mechanically assist or replace spontaneous breathing in patients by use of a powered device that forces oxygenated air into the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70909</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NG Decompression</VALIDVALUE>
          <VALUEMEANING>Tubes, Gastrointestinal Decompression</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0184130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxygen Administration</VALIDVALUE>
          <VALUEMEANING>Masks, Air-Oxygen, Aerosol Administration</VALUEMEANING>
          <MEANINGDESCRIPTION>Devices used to deliver air, oxygen, or a mixture of the two gases containing aerosol particles to the patient&#39;s airway. Air-oxygen masks used for aerosol administration are typically connected to the gas source with wide bore tubing and include head straps for stabilization. The devices are typically made of plastic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0181745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paracentesis</VALIDVALUE>
          <VALUEMEANING>Paracentesis</VALUEMEANING>
          <MEANINGDESCRIPTION>Insertion of a thin needle or tube into the abdomen to remove fluid from the peritoneal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleurodesis</VALIDVALUE>
          <VALUEMEANING>Pleurodesis</VALUEMEANING>
          <MEANINGDESCRIPTION>A therapeutic surgical procedure in which the pleural space is surgically eliminated by the adherence of the visceral and parietal pleurae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiation</VALIDVALUE>
          <VALUEMEANING>Radiation</VALUEMEANING>
          <MEANINGDESCRIPTION>The participant became menopausal through some form of radiation treatment</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stent/Catheter Removal</VALIDVALUE>
          <VALUEMEANING>Removal of stent</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>CL233428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576553</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stent/Catheter Change</VALIDVALUE>
          <VALUEMEANING>Stent/Catheter Change</VALUEMEANING>
          <MEANINGDESCRIPTION>Stent/Catheter Change</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576554</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surgical Procedure</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Used for operative procedures on organs, regions, or tissues in the treatment of diseases, including tissue section by lasers. It excludes transplantation, for which &quot;transplantation&quot; is used.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thoracentesis</VALIDVALUE>
          <VALUEMEANING>Thoracentesis</VALUEMEANING>
          <MEANINGDESCRIPTION>The removal of excess fluid via needle puncture from the thoracic cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Venous Access/IV Placement</VALIDVALUE>
          <VALUEMEANING>Venous Access Device Placement</VALUEMEANING>
          <MEANINGDESCRIPTION>Venous Access Device Placement</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stent/Catheter Placement</VALIDVALUE>
          <VALUEMEANING>Catheterization</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique in which a hollow, flexible tube is used to drain body fluids or to introduce fluids into the body, or to examine or widen a narrowed vein or artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Direct Current Cardioversion (DCCV)</VALIDVALUE>
          <VALUEMEANING>Direct Current Cardioversion</VALUEMEANING>
          <MEANINGDESCRIPTION>Direct Current Cardioversion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transfusion, RBC</VALIDVALUE>
          <VALUEMEANING>Packed red blood cell transfusion</VALUEMEANING>
          <MEANINGDESCRIPTION>Packed red blood cell transfusion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transfusion, Platelet</VALIDVALUE>
          <VALUEMEANING>Platelet transfusion</VALUEMEANING>
          <MEANINGDESCRIPTION>The infusion of platelets into the bloodstream.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemicolectomy</VALIDVALUE>
          <VALUEMEANING>PARTIAL COLECTOMY</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgical removal of approximately half of the colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86074</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemodialysis</VALIDVALUE>
          <VALUEMEANING>Hemodialysis</VALUEMEANING>
          <MEANINGDESCRIPTION>A therapeutic procedure used in patients with kidney failure.  It involves the extracorporeal removal of harmful wastes and fluids from the blood using a dialysis machine.  Following the dialysis, the blood is returned to the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15248</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive Partial Airway Pressure Treatment</VALIDVALUE>
          <VALUEMEANING>Partial Airway Pressure Treatment (includes BiPAP and CPAP)</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial Airway Pressure Treatment (includes BiPAP and CPAP)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arterial Access Port Removal</VALIDVALUE>
          <VALUEMEANING>Arterial Access Port Removed</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal of a medical device implanted in an artery for the delivery of medication, fluids, nutrition, or other ordered treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96175</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3212278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Continuous Veno-Venous Hemofiltration (CVVH)</VALIDVALUE>
          <VALUEMEANING>Continuous Veno-Venous Hemofiltration (CVVH)</VALUEMEANING>
          <MEANINGDESCRIPTION>Continuous Veno-Venous Hemofiltration (CVVH)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3297317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IV Hydration</VALIDVALUE>
          <VALUEMEANING>Intravenous Hydration</VALUEMEANING>
          <MEANINGDESCRIPTION>Into or within a vein. Intravenous usually refers to a way of giving a drug or other substance through a needle or tube inserted into a vein.: The process of combining with water. In medicine, the process of giving fluids needed by the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28009, C13346</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5207532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transfusion, Plasma</VALIDVALUE>
          <VALUEMEANING>Plasma Transfusion</VALUEMEANING>
          <MEANINGDESCRIPTION>The infusion of plasma into the bloodstream.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5984755</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Function Test/Forced Vital Capacity</VALIDVALUE>
          <VALUEMEANING>Pulmonary Function Test Forced Vital Capacity</VALUEMEANING>
          <MEANINGDESCRIPTION>A broad range of tests that are performed to assess how well lungs inhale and exhale air and how efficiently they transfer oxygen into the blood.: The maximum volume of air that can be exhaled after forced maximum inhalation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38081, C111361</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6944859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI, Endorectal</VALIDVALUE>
          <VALUEMEANING>Endorectal Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>Magnetic resonance imaging done from inside the rectum that usually utilizes a surface coil within a latex balloon to generate the magnetic field.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C137917</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6944861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Debridement</VALIDVALUE>
          <VALUEMEANING>Debridement of Wound of Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure to remove dead tissue or foreign material from a wound to expose underlying healthy tissue and to promote healing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pericardial Window</VALIDVALUE>
          <VALUEMEANING>Pericardial Window Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure in which an opening is made in the pericardium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51618</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6968122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Catheter</VALIDVALUE>
          <VALUEMEANING>Urinary Catheterization</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with urine or the organs of the body that produce and get rid of urine.: A technique in which a hollow, flexible tube is used to drain body fluids or to introduce fluids into the body, or to examine or widen a narrowed vein or artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38045, C25711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7245529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lumbar Puncture</VALIDVALUE>
          <VALUEMEANING>Lumbar Puncture</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive procedure in which a hollow needle is introduced through an intervertebral space in the lower back to access the subarachnoid space in order to sample cerebrospinal fluid or to administer medication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3829087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Self-Catheter</VALIDVALUE>
          <VALUEMEANING>Self Care Catheterization</VALUEMEANING>
          <MEANINGDESCRIPTION>Personal performance of activities or tasks traditionally performed by professional health care providers.: A technique in which a hollow, flexible tube is used to drain body fluids or to introduce fluids into the body, or to examine or widen a narrowed vein or artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38045, C15324</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7245530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Incentive Spirometry</VALIDVALUE>
          <VALUEMEANING>Incentive Spirometry</VALUEMEANING>
          <MEANINGDESCRIPTION>Use of an incentive spirometer to take slow, deep breaths, and maximize lung capacity. Visual feedback from the spirometer is designed to help the user execute sustained maximal inhalations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C171271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7245531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Celiac plexus block</VALIDVALUE>
          <VALUEMEANING>Celiac Plexus Neurolysis</VALUEMEANING>
          <MEANINGDESCRIPTION>A treatment that involves injection of local anesthetic and alcohol to the celiac plexus, causing temporary degeneration of the nerve fibers. The procedure is performed in an effort to alleviate intractable pain, generally caused by cancer or chronic pancreatitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-06-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7675509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Manual Disimpaction</VALIDVALUE>
          <VALUEMEANING>Manual Disimpaction</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of fingers to evacuate stool from the rectum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13928841</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>YAG Laser Posterior Capsulotomy</VALIDVALUE>
          <VALUEMEANING>YAG Laser Posterior Capsulotomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of a neodymium-doped yttrium-aluminum-garnet laser to treat posterior capsule opacification following cataract surgery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204076</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14764392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor Treating Fields Therapy</VALIDVALUE>
          <VALUEMEANING>Tumor Treating Fields Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of electromagnetic field therapy that uses low-intensity, intermediate-frequency alternating electrical fields to a target area to induce selective toxicity to proliferating cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C146882</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14831537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Electromyography</VALIDVALUE>
          <VALUEMEANING>Electromyography</VALUEMEANING>
          <MEANINGDESCRIPTION>An assessment of skeletal muscle function and nerve control, obtained by recording and studying the intrinsic electrical properties of the muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38056</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4821875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Craniotomy</VALIDVALUE>
          <VALUEMEANING>Craniotomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgical creation of an opening of the skull.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2799181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biopsy</VALIDVALUE>
          <VALUEMEANING>Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5476777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hearing Impairment</VALIDVALUE>
          <VALUEMEANING>Hearing Impairment</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial or complete loss of the ability to detect or understand sounds resulting from damage to the outer, middle, or inner ear structures. Causes include exposure to loud noise, ear infections, injuries to the ear, genetic, and congenital disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thoracoscopic Wedge Resection of the Lung</VALIDVALUE>
          <VALUEMEANING>Thorascopic Wedge Resection of the Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimally invasive surgical procedure in which video-assisted thoracoscopy is used to remove of a portion of the lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154873</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cryotherapy</VALIDVALUE>
          <VALUEMEANING>Cryotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The therapeutic use of cold or refrigeration in medicine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3253664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NG tube placement</VALIDVALUE>
          <VALUEMEANING>Nasogastric Tube Placement</VALUEMEANING>
          <MEANINGDESCRIPTION>A hollow tube that is directed into the stomach from the nose._The act of putting something into a position or location.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93310, C126366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15313145</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kyphoplasty</VALIDVALUE>
          <VALUEMEANING>Kyphoplasty</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure with the intent of expanding a collapsed vertebra. A surgical instrument is introduced into the spine with a balloon that is inflated to expand the bone. Once this instrument is withdrawn, the space created is then filled with bone cement mixture.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2832058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Embolization</VALIDVALUE>
          <VALUEMEANING>Embolization Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>(EM-bo-lih-ZAY-shun) The blocking of an artery by a clot or foreign material. Embolization can be done as treatment to block the flow of blood to a tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15230</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3630019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Holter Monitor</VALIDVALUE>
          <VALUEMEANING>Holter Monitoring</VALUEMEANING>
          <MEANINGDESCRIPTION>An ambulatory electrocardiography technique that records a continuous electrocardiographic rhythm pattern for 24 hours or more to detect heart arrhythmias.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>(Concomitant) Procedure</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>(Concomitant) Procedure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Concomitant Procedure Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Procedure/Measure</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Procedure/Measure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Agent/Procedure</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Agent/Procedure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCR-3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Procedure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMSv3.02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811686</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR 2011 Template</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248617</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Concomitant Meds/Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248622</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Infection Episode</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248631</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MediData Rave Use</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3308730</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol 10C0052D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3331757</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UC Irvine</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811716</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Albert Einstein Medical Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UPCC 07403</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812574</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DFMO/Sul Colon III UCI 02_06</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCI 0404</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812578</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>P1_CPT_BCNU_RD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Panvec</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812583</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 02452</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812584</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 03058</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812585</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 04251</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Northwestern University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812693</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NU 0943_011</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812695</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Nebraska Med Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812726</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U of Pa Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812727</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Washington</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812731</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FES Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812732</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FMISO Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812733</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AE_104_085</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oregon Health &amp; Sciences University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OHSU_288</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UNMC 284-04</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812981</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857175</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Adopter CDEs for Reuse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS 3.12B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812490</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2931931</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Iloprost Trial</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Iloprost 12079</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2931952</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SPOREs</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CONCT_PROC_NM</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CONCT_PROC_NM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="53">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2413314</PUBLICID>
    <LONGNAME>Patient Image Position Number</LONGNAME>
    <PREFERREDNAME>PT_IMAG_POS_MM_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>The x, y, and z coordinates of the upper left hand corner (center of the first voxel transmitted) of the image, expressed as a number of millimeters.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>CIP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>DICOM:Digital Imaging and Communications in Medicine</ORIGIN>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2413311</PublicId>
      <PreferredName>IMAGE_POS</PreferredName>
      <PreferredDefinition>Coordinates of a medical image.</PreferredDefinition>
      <LongName>Image Position</LongName>
      <Version>1</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2402958</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16831</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16831</PREFERRED_NAME>
            <LONG_NAME>Medical Imaging</LONG_NAME>
            <CON_ID>2224877</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2413309</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25339</PreferredName>
        <Version>1</Version>
        <LongName>Position</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25339</PREFERRED_NAME>
            <LONG_NAME>Position</LONG_NAME>
            <CON_ID>2203955</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2413312</PublicId>
      <PreferredName>IMAG_POS_MM_NUM</PreferredName>
      <PreferredDefinition>Value to specify the x, y, and z coordinates of the upper left hand corner of an image; it is the center of the first voxel transmitted, expressed in number of millimeters as specified by the Dicom tag.</PreferredDefinition>
      <LongName>Image Position Millimeter Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>6</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Image Position (Patient)</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Image Position (Patient)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180933</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>LIDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rider Project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812022</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614828</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA Collection</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RIDER</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812771</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>(0020,0032)</AlternateName>
        <AlternateNameType>DICOM_TAG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="54">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2414574</PUBLICID>
    <LONGNAME>Instance Composite Object Number</LONGNAME>
    <PREFERREDNAME>INSTC_COMP_OBJ_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value that identifies a composite object instance, as specified in a DICOM tag.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CIP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>DICOM:Digital Imaging and Communications in Medicine</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2413216</PublicId>
      <PreferredName>IMAG_STDY_INST</PreferredName>
      <PreferredDefinition>Occurrence of a medical imaging study</PreferredDefinition>
      <LongName>Imaging Study Instance</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2402958</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16831</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16831</PREFERRED_NAME>
            <LONG_NAME>Medical Imaging</LONG_NAME>
            <CON_ID>2224877</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2413214</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48364</PreferredName>
        <Version>1</Version>
        <LongName>Instance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48364</PREFERRED_NAME>
            <LONG_NAME>Instance</LONG_NAME>
            <CON_ID>2413213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2414572</PublicId>
      <PreferredName>COMP_OBJ_INST_NUM</PreferredName>
      <PreferredDefinition>Numeric value that identifies a composite object instance, as specified in a Dicom tag.</PreferredDefinition>
      <LongName>Composite Object Instance Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>64</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Instance Number</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Instance Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180933</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>LIDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rider Project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812022</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614828</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA Collection</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RIDER</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812771</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="55">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2423479</PUBLICID>
    <LONGNAME>Threshold Multiplier java.lang.Double</LONGNAME>
    <PREFERREDNAME>2423460v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The lowest limit at which something becomes detectable or relevant._A number by which another number is multiplied._Java Double Wrapper for primitive type double</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2423460</PublicId>
      <PreferredName>2423445v1.0:2423438v1.0</PreferredName>
      <PreferredDefinition>The lowest limit at which something becomes detectable or relevant._A number by which another number is multiplied.</PreferredDefinition>
      <LongName>Threshold Multiplier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2423445</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48228</PreferredName>
        <Version>1</Version>
        <LongName>Threshold</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48228</PREFERRED_NAME>
            <LONG_NAME>Threshold</LONG_NAME>
            <CON_ID>2423422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2423438</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48229</PreferredName>
        <Version>1</Version>
        <LongName>Multiplier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48229</PREFERRED_NAME>
            <LONG_NAME>Multiplier</LONG_NAME>
            <CON_ID>2423423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Threshold Multiplier java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Threshold Multiplier java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857185</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>RProteomics</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ServiceInterfaceModel</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812047</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857185</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>RProteomics</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.duke.cabig.rproteomics.model.serviceInterface</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.duke.cabig.rproteomics.model.serviceInterface.Threshold.multiplier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Threshold:multiplier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="56">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2438129</PUBLICID>
    <LONGNAME>Type Targeted Mutation Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2437925v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Something distinguishable as an identifiable class based on common qualities.:A mutation created in a gene at a specific location._The words or language units by which a thing is known._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2437925</PublicId>
      <PreferredName>2437798v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.:A mutation created in a gene at a specific location._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Type Targeted Mutation Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437798</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284:C48668</PreferredName>
        <Version>1</Version>
        <LongName>Type Targeted Mutation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48668</PREFERRED_NAME>
            <LONG_NAME>Targeted Mutation</LONG_NAME>
            <CON_ID>2437667</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Type Targeted Mutation Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Type Targeted Mutation Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.ModificationType.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ModificationType:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="57">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2444016</PUBLICID>
    <LONGNAME>Tooth 30 50 Years of Age Patient Mesial Surface Buccal Surface Pulp Horn Involvement Yes No Indicator</LONGNAME>
    <PREFERREDNAME>T3050Y_PT_MBPHI_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no question related to the involvement of the mesial (side of the tooth facing the midline), buccal (the surface of the tooth facing or in direct contact with the oral mucosa of the cheek), pulp horn (portion of the pulp chamber that extends towards a cusp) surface in 50 years of age patient&#39;s tooth 30 (the first, permanent six-year molar of the lower right arch as defined by the Universal tooth numbering system).</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2443558</PublicId>
      <PreferredName>T30_50Y_PT_M_B_PH_IN</PreferredName>
      <PreferredDefinition>information related to the involvement of the mesial (side of the tooth facing the midline), buccal (the surface of the tooth facing or in direct contact with the oral mucosa of the cheek), pulp horn (portion of the pulp chamber that extends towards a cusp) surface in 50 years of age patient&#39;s tooth 30 (the first, permanent six-year molar of the lower right arch as defined by the Universal tooth numbering system).</PreferredDefinition>
      <LongName>Tooth 30 50 Years of Age Patient Mesial Surface Buccal Surface Pulp Horn Involvement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443556</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52667:CL193193:C16960</PreferredName>
        <Version>1</Version>
        <LongName>Tooth 30 Adult 50 year screening Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52667</PREFERRED_NAME>
            <LONG_NAME>Tooth 30</LONG_NAME>
            <CON_ID>2443162</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL193193</PREFERRED_NAME>
            <LONG_NAME>Adult 50 year screening</LONG_NAME>
            <CON_ID>2443555</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2443361</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52590:C52589:C52670:C25548</PreferredName>
        <Version>1</Version>
        <LongName>Mesial Surface Buccal Surface Pulp Horn Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52590</PREFERRED_NAME>
            <LONG_NAME>Mesial Surface</LONG_NAME>
            <CON_ID>2443141</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52589</PREFERRED_NAME>
            <LONG_NAME>Buccal Surface</LONG_NAME>
            <CON_ID>2443116</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52670</PREFERRED_NAME>
            <LONG_NAME>Pulp Horn</LONG_NAME>
            <CON_ID>2443154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>In the EX1 question of the su</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>In the EX1 question of the survey would your response have been different if the age of the patient was 50</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>In the NE1 question of the survey would your response have been different if the age of the patient was 50</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Restorative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Endodontics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812087</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4442461</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDCR CDEs with Retired VDs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDEs for Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4442571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="58">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2448376</PUBLICID>
    <LONGNAME>Porcelain Veneer Dental Professional Practice Month Use Frequency</LONGNAME>
    <PREFERREDNAME>PORCV_D_PP_P_M_US_FR</PREFERREDNAME>
    <PREFERREDDEFINITION>the number of occurrences of something within a given time period of the monthly use of a restoration consisting of a layer of tooth-colored porcelain material cemented to the surface of a tooth in a health care professional business directed towards treatment and care of patients pertaining to a tooth or teeth, or to odontology.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2443704</PublicId>
      <PreferredName>PORC_DEN_PRO_MON_USE</PreferredName>
      <PreferredDefinition>information related to the monthly use of a restoration consisting of a layer of tooth-colored porcelain material cemented to the surface of a tooth in a health care professional business directed towards treatment and care of patients pertaining to a tooth or teeth, or to odontology.</PreferredDefinition>
      <LongName>Porcelain Veneer Dental Professional Practice Month Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443701</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52584</PreferredName>
        <Version>1</Version>
        <LongName>Porcelain Veneer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52584</PREFERRED_NAME>
            <LONG_NAME>Porcelain Veneer</LONG_NAME>
            <CON_ID>2443149</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2443702</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C52673:C29846:C25340</PreferredName>
        <Version>1</Version>
        <LongName>Dental Professional Practice Month Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52673</PREFERRED_NAME>
            <LONG_NAME>Professional Practice</LONG_NAME>
            <CON_ID>2443152</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2445986</PublicId>
      <PreferredName>PORCEVEN_USE_FREQ</PreferredName>
      <PreferredDefinition>the number of occurrences of something within a given time period of use of Porcelain Veneer (a layer of tooth-colored material consisting mainly of kaolin, feldspar and flux attached to the surface by direct fusion, cementation, or mechanical retention).</PreferredDefinition>
      <LongName>Porcelain Venner Use Frequency</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2443080</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25515</PreferredName>
        <Version>1</Version>
        <LongName>Temporal Frequency</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Less than once</VALIDVALUE>
          <VALUEMEANING>Less than once</VALUEMEANING>
          <MEANINGDESCRIPTION>Less than once</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>One or two times</VALIDVALUE>
          <VALUEMEANING>One or two times</VALUEMEANING>
          <MEANINGDESCRIPTION>One or two times</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Three or four times</VALIDVALUE>
          <VALUEMEANING>Three or four times</VALUEMEANING>
          <MEANINGDESCRIPTION>Three or four times</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>More than four times</VALIDVALUE>
          <VALUEMEANING>More than four times</VALUEMEANING>
          <MEANINGDESCRIPTION>More than four times</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Response</VALIDVALUE>
          <VALUEMEANING>No Response</VALUEMEANING>
          <MEANINGDESCRIPTION>No apparent change or worsening in lesion staging classification.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How often is porcelain repair</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How often is porcelain repair employed in your practice on a per month basis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Restorative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="59">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2449253</PUBLICID>
    <LONGNAME>State Dental License Smoking Cessation Program Requirement Indicator</LONGNAME>
    <PREFERREDNAME>ST_DNTLIC_SC_P_R_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>an indicator of a smoking cessation program designed to discontinue the habit of smoking a part of the requirement for the legal right to practice dentistry in a particular state.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2443775</PublicId>
      <PreferredName>ST_DEN_SMK_PRG_REQ</PreferredName>
      <PreferredDefinition>information related to a smoking cessation program designed to discontinue the habit of smoking a part of the requirement for the legal right to practice dentistry in a particular state.</PreferredDefinition>
      <LongName>State Dental License Smoking Cessation Program Requirement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443772</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C30010:C52649</PreferredName>
        <Version>1</Version>
        <LongName>State Dental License</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C30010</PREFERRED_NAME>
            <LONG_NAME>US State</LONG_NAME>
            <CON_ID>2204013</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52649</PREFERRED_NAME>
            <LONG_NAME>Dental License</LONG_NAME>
            <CON_ID>2443125</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2443773</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17427:C52647:C38015</PreferredName>
        <Version>1</Version>
        <LongName>Smoking Cessation Program Requirement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17427</PREFERRED_NAME>
            <LONG_NAME>Smoking Cessation</LONG_NAME>
            <CON_ID>2443753</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52647</PREFERRED_NAME>
            <LONG_NAME>Program</LONG_NAME>
            <CON_ID>2443153</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38015</PREFERRED_NAME>
            <LONG_NAME>Requirement</LONG_NAME>
            <CON_ID>2203776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2448430</PublicId>
      <PreferredName>DENTLIC_REQ_IND</PreferredName>
      <PreferredDefinition>an indicator of requirement for dental licence.</PreferredDefinition>
      <LongName>Dental License Requirement Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Response</VALIDVALUE>
          <VALUEMEANING>No Response</VALUEMEANING>
          <MEANINGDESCRIPTION>No apparent change or worsening in lesion staging classification.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is a course on smoking cessat</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is a course on smoking cessation required for a dental license in your state</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Restorative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="60">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2452246</PUBLICID>
    <LONGNAME>Protein Folding Begin Protein Sequence java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2452099v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The change in structure whereby a polypeptide assumes its functional shape or conformation. This is a process that occurs during either protein biosynthesis or protein reconstitution. Polypeptide chains assume their correct three-dimensional conformation through discrete intermediate (primary, secondary, and tertiary) structures prior to the development final quaternary structure._Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins.:The sequence of amino acids along a polypeptide chain._Value Domain for java language Integer datatype</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2452099</PublicId>
      <PreferredName>2451987v1.0:2451965v1.0</PreferredName>
      <PreferredDefinition>The change in structure whereby a polypeptide assumes its functional shape or conformation. This is a process that occurs during either protein biosynthesis or protein reconstitution. Polypeptide chains assume their correct three-dimensional conformation through discrete intermediate (primary, secondary, and tertiary) structures prior to the development final quaternary structure._Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins.:The sequence of amino acids along a polypeptide chain.</PreferredDefinition>
      <LongName>Protein Folding Begin Protein Sequence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2451987</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17568</PreferredName>
        <Version>1</Version>
        <LongName>Protein Folding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17568</PREFERRED_NAME>
            <LONG_NAME>Protein Folding</LONG_NAME>
            <CON_ID>2451936</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2451965</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C13187</PreferredName>
        <Version>1</Version>
        <LongName>Begin Protein Sequence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13187</PREFERRED_NAME>
            <LONG_NAME>Amino Acid Sequence</LONG_NAME>
            <CON_ID>2223225</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Protein Folding Begin Protein Sequence java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Protein Folding Begin Protein Sequence java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857164</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Cancer Molecular Pages</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Molecular Pages</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812107</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857164</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Cancer Molecular Pages</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CancerMoleculePages</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812108</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CancerMoleculePages.Fold.begin</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Fold:begin</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="61">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2452274</PUBLICID>
    <LONGNAME>COILS Program Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2452120v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A program that compares a sequence to a database of known parallel two-stranded coiled-coils and derives a similarity score. By comparing this score to the distribution of scores in globular and coiled-coil proteins, the program then calculates the probability that the sequence will adopt a coiled-coil conformation. (http://www.ch.embnet.org/software/coils/COILS_doc.html)_The words or language units by which a thing is known._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2452120</PublicId>
      <PreferredName>2451995v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>A program that compares a sequence to a database of known parallel two-stranded coiled-coils and derives a similarity score. By comparing this score to the distribution of scores in globular and coiled-coil proteins, the program then calculates the probability that the sequence will adopt a coiled-coil conformation. (http://www.ch.embnet.org/software/coils/COILS_doc.html)_The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>COILS Program Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2451995</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49044</PreferredName>
        <Version>1</Version>
        <LongName>COILS Program</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49044</PREFERRED_NAME>
            <LONG_NAME>COILS Program</LONG_NAME>
            <CON_ID>2451941</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element COILS Program Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element COILS Program Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857164</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Cancer Molecular Pages</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Molecular Pages</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812107</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857164</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Cancer Molecular Pages</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CancerMoleculePages</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812108</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CancerMoleculePages.Coils.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Coils:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="62">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2464328</PUBLICID>
    <LONGNAME>Bisphosphonate Support Administered Specify</LONGNAME>
    <PREFERREDNAME>BISPHO_SUPP_ADM_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify the bisphosphonate the patient received.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195983</PublicId>
      <PreferredName>BISPHOSPH_SUPP_ADM</PreferredName>
      <PreferredDefinition>information related to bisphosphonate support being administered.</PreferredDefinition>
      <LongName>Bisphosphonate Support Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2660538</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C443:C37902</PreferredName>
        <Version>1</Version>
        <LongName>Biphosphonate Support</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C443</PREFERRED_NAME>
            <LONG_NAME>Biphosphonate</LONG_NAME>
            <CON_ID>2202878</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37902</PREFERRED_NAME>
            <LONG_NAME>Support</LONG_NAME>
            <CON_ID>2202834</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177665</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Administered</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018810</PublicId>
      <PreferredName>TX_SPEC</PreferredName>
      <PreferredDefinition>the free text field related to therapy.</PreferredDefinition>
      <LongName>Therapies Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Bisphosphonates, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="63">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2465318</PUBLICID>
    <LONGNAME>Prior Systemic Therapy Thalidomide Administered Ind-2</LONGNAME>
    <PREFERREDNAME>P_SYSTX_THL_ADM_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether the prior systemic therapy was &lt;=8 weeks of thalidomide.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2465335</PublicId>
      <PreferredName>PRIOR_SYSTX_THAL_ADM</PreferredName>
      <PreferredDefinition>information relating to prior systemic thalidomide therapy administered.</PreferredDefinition>
      <LongName>Prior Systemic Therapy Thalidomide Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C15698</PreferredName>
        <Version>1</Version>
        <LongName>Prior Systemic Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15698</PREFERRED_NAME>
            <LONG_NAME>Systemic Therapy</LONG_NAME>
            <CON_ID>2202843</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2465317</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C870:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Thalidomide Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C870</PREFERRED_NAME>
            <LONG_NAME>Thalidomide</LONG_NAME>
            <CON_ID>2205408</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was prior systemic therapy &lt;=</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was prior systemic therapy &lt;=8 weeks of thalidomide</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="64">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2469150</PUBLICID>
    <LONGNAME>Unstable Angina Disease Present Ind-3</LONGNAME>
    <PREFERREDNAME>UST_ANG_DZ_PRES_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator related to unstable heart condition marked by paroxysms of chest pain due to reduced oxygen to the heart.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2469009</PublicId>
      <PreferredName>N_ST_ANG_DZ_PRES</PreferredName>
      <PreferredDefinition>information relating to unstable heart condition marked by paroxysms of chest pain due to reduced oxygen to the heart.</PreferredDefinition>
      <LongName>Unstable Angina Disease Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2675081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C30103:C51221:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Not Stable Angina Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C30103</PREFERRED_NAME>
            <LONG_NAME>Stable</LONG_NAME>
            <CON_ID>2204880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51221</PREFERRED_NAME>
            <LONG_NAME>Angina</LONG_NAME>
            <CON_ID>2469006</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Unstable angina</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Unstable angina</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Angina pectoris that requires the use of anti-anginal medication</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Unstable angina in last 6 months</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient had unstable angina within the past 180 days?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient experienced uncontrolled angina within 12 months of today?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>History of uncontrolled angina</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Unstable angina at step 2 registration</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Unstable angina within the last 6 months prior to registration</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Unstable angina in last 6 months prior to registration</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ABTC-1601</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have unstable angina pectoris?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient have myocardial infarction or unstable angina within 6 months prior to registration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF_Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have unstable angina requiring hospitalization in the last 6 months?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF_Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have history of unstable angina requiring hospitalization in the last 6 months?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0227G</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104881</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1216</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104934</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1221</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104935</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0920</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1010</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171061</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4280691</PublicId>
          <ContextName>ABTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Checklist</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4280724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>UST_ANG_DZ_PRES_IND3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>UST_ANG_DZ_PRES_IND3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ABTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ABTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="65">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2475552</PUBLICID>
    <LONGNAME>Diagnosis Universally Unique Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2475361v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The process of identifying a disease by the signs and symptoms._A 128 bit identifier. Depending on the mechanism used to generate it, it is either guaranteed to be different from all other UUIDs/GUIDs generated until 3400 AD or extremely likely to be different. Its relatively small size lends itself well to sorting, ordering, and hashing of all sorts, storing in databases, simple allocation, and ease of programming in general._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2475361</PublicId>
      <PreferredName>2442484v1.0:2475266v1.0</PreferredName>
      <PreferredDefinition>The process of identifying a disease by the signs and symptoms._A 128 bit identifier. Depending on the mechanism used to generate it, it is either guaranteed to be different from all other UUIDs/GUIDs generated until 3400 AD or extremely likely to be different. Its relatively small size lends itself well to sorting, ordering, and hashing of all sorts, storing in databases, simple allocation, and ease of programming in general.</PreferredDefinition>
      <LongName>Diagnosis Universally Unique Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2442484</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2475266</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54100</PreferredName>
        <Version>1</Version>
        <LongName>Universally Unique Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54100</PREFERRED_NAME>
            <LONG_NAME>Universally Unique Identifier</LONG_NAME>
            <CON_ID>2475252</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Diagnosis Universally Unique Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Diagnosis Universally Unique Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2475251</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTIES 2.0</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.upmc.opi.caBIG.caTIES.database.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812153</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2475251</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTIES 2.0</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caTIES</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812488</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Diagnosis:uuid</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.upmc.opi.caBIG.caTIES.database.domain.Diagnosis.uuid</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="66">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2479403</PUBLICID>
    <LONGNAME>Lesion Thickness Lesion Thickness Millimeter Number</LONGNAME>
    <PREFERREDNAME>LES_THKN_MM_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the slice thickness of a tumor or lesion, expressed in millimeters.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2479401</PublicId>
      <PreferredName>LES_THKN</PreferredName>
      <PreferredDefinition>Dimension between two surfaces of a tumor or site of disease, usually the smallest dimension as opposed to the width or the length.</PreferredDefinition>
      <LongName>Lesion Thickness</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2465192</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3824</PreferredName>
        <Version>1</Version>
        <LongName>Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2413317</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41145</PreferredName>
        <Version>1</Version>
        <LongName>Thickness</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41145</PREFERRED_NAME>
            <LONG_NAME>Thickness</LONG_NAME>
            <CON_ID>2413316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2479399</PublicId>
      <PreferredName>LSN_THKN_MM_NUM</PreferredName>
      <PreferredDefinition>Numeric value to represent the nominal slice thickness of a tumor or lesion, expressed in millimeters.</PreferredDefinition>
      <LongName>Lesion Thickness Millimeter Number</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>mm</UnitOfMeasure>
      <MaximumLength>6</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2413358</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28251:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Millimeter Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28251</PREFERRED_NAME>
            <LONG_NAME>Millimeter</LONG_NAME>
            <CON_ID>2204830</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Thickness (mm)</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Thickness (mm)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="67">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2500952</PUBLICID>
    <LONGNAME>Laboratory Procedure Chromogranin A Tumor Marker Result Ind-2</LONGNAME>
    <PREFERREDNAME>LA_CHRM_TMKR_RS_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether a laboratory test was performed for Chromogranin A (CHGA, Secretory Protein I, Parathyroid Secretory Protein, PSP), a protein that is stored and released with catecholamines in the adrenal medulla, as well as with PTH from the parathyroid gland, and is also secreted by many endocrine neoplasms: pheochromocytoma, parathyroid adenoma, medullary thyroid carcinoma, carcinoids, oat-cell lung cancer, pancreatic islet-cell tumors, and aortic-body tumor.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2500926</PublicId>
      <PreferredName>LAB_CGA_TMKR_RSLT</PreferredName>
      <PreferredDefinition>information related to the result of the medical procedure that involves testing a sample of blood or tissue for Chromogranin A (CHGA, Secretory Protein I, Parathyroid Secretory Protein, PSP),  a protein that is stored and released with catecholamines in the adrenal medulla, as well as with PTH from the parathyroid gland, and is also secreted by many endocrine neoplasms: pheochromocytoma, parathyroid adenoma, medullary thyroid carcinoma, carcinoids, oat-cell lung cancer, pancreatic islet-cell tumors, and aortic-body tumor.</PreferredDefinition>
      <LongName>Laboratory Procedure Chromogranin A Tumor Marker Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738951</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17284:C17220:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Chromogranin A Tumor Marker Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17284</PREFERRED_NAME>
            <LONG_NAME>Chromogranin-A</LONG_NAME>
            <CON_ID>2500923</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17220</PREFERRED_NAME>
            <LONG_NAME>Tumor Marker</LONG_NAME>
            <CON_ID>2202551</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was Chromogranin A assessed d</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was Chromogranin A assessed during this reporting period</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="68">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2513691</PUBLICID>
    <LONGNAME>Specimen Requirement Pathology Finding Status Histopathological Text Type</LONGNAME>
    <PREFERREDNAME>2513425v1.0:2547673v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:Something that is necessary; condition, something that is obligatory._The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes.:The result of an examination or inquiry.:A condition or state at a particular time._A branch of pathology concerned with the tissue changes characteristic of disease._Text; the words of something written._Type; a subdivision of a particular kind of thing.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2513425</PublicId>
      <PreferredName>2513349v1.0:2513294v1.0</PreferredName>
      <PreferredDefinition>A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:Something that is necessary; condition, something that is obligatory._The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes.:The result of an examination or inquiry.:A condition or state at a particular time.</PreferredDefinition>
      <LongName>Specimen Requirement Pathology Finding Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2513349</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157:C38015</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Requirement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38015</PREFERRED_NAME>
            <LONG_NAME>Requirement</LONG_NAME>
            <CON_ID>2203776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2513294</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18189:C3367:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Pathology Finding Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3367</PREFERRED_NAME>
            <LONG_NAME>Finding</LONG_NAME>
            <CON_ID>2202448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2547673</PublicId>
      <PreferredName>2547673v1.0</PreferredName>
      <PreferredDefinition>Specimen; a bit of tissue or blood or urine that is taken or used for research purposes._A branch of pathology concerned with the tissue changes characteristic of disease._Text; the words of something written._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Specimen Histopathological Text Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2207966</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Text Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-Malignant</VALIDVALUE>
          <VALUEMEANING>Non-Malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Not cancerous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malignant</VALIDVALUE>
          <VALUEMEANING>Malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metastatic</VALIDVALUE>
          <VALUEMEANING>Metastatic</VALUEMEANING>
          <MEANINGDESCRIPTION>Metastatic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Specified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malignant, Invasive</VALIDVALUE>
          <VALUEMEANING>Invasive Malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Marked by a tendency to spread especially into healthy tissue.: (ma-LIG-nant) Cancerous; a growth with a tendency to invade and destroy nearby tissue and spread to other parts of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14143, C14159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2623458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malignant, Pre-Invasive</VALIDVALUE>
          <VALUEMEANING>Prior Invasive Malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Earlier in time or order.: Marked by a tendency to spread especially into healthy tissue.: (ma-LIG-nant) Cancerous; a growth with a tendency to invade and destroy nearby tissue and spread to other parts of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14143, C14159, C25629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2623459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-Malignant, Diseased</VALIDVALUE>
          <VALUEMEANING>Abnormal Cells Present Non-Malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal Cells Present: Not cancerous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25588, C42076</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2623460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pre-Malignant</VALIDVALUE>
          <VALUEMEANING>Premalignant Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Cells which show sign/s, that they can become cancerous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12976</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2623461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Specimen Requirement Pathology Finding Status Histopathological Text Type does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Specimen Requirement Pathology Finding Status Histopathological Text Type does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2553133</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812526</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2661745</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_caArray</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000636</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2680967</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000633</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.SpecimenRequirement.pathologyStatus</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domainobject.SpecimenRequirement.pathologyStatus</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SpecimenRequirement:pathologyStatus</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="69">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2513791</PUBLICID>
    <LONGNAME>Molecular Specimen Requirement Microgram Quantity java.lang.Double</LONGNAME>
    <PREFERREDNAME>2513525v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Relating to or produced by or consisting of molecules.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:Something that is necessary; condition, something that is obligatory._A metric unit of mass equal to one millionth of a gram or one one thousandth of a milligram.:A measurable amount of a substance._Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2513525</PublicId>
      <PreferredName>2513386v1.0:2513289v1.0</PreferredName>
      <PreferredDefinition>Relating to or produced by or consisting of molecules.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:Something that is necessary; condition, something that is obligatory._A metric unit of mass equal to one millionth of a gram or one one thousandth of a milligram.:A measurable amount of a substance.</PreferredDefinition>
      <LongName>Molecular Specimen Requirement Microgram Quantity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2513386</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25574:C19157:C38015</PreferredName>
        <Version>1</Version>
        <LongName>Molecular Specimen Requirement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25574</PREFERRED_NAME>
            <LONG_NAME>Molecular</LONG_NAME>
            <CON_ID>2202608</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38015</PREFERRED_NAME>
            <LONG_NAME>Requirement</LONG_NAME>
            <CON_ID>2203776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2513289</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48152:C25256</PreferredName>
        <Version>1</Version>
        <LongName>Microgram Quantity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48152</PREFERRED_NAME>
            <LONG_NAME>Microgram</LONG_NAME>
            <CON_ID>2513257</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Molecular Specimen Requirement Microgram Quantity java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Molecular Specimen Requirement Microgram Quantity java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domainobject.MolecularSpecimenRequirement.quantityInMicrogram</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MolecularSpecimenRequirement:quantityInMicrogram</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="70">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2516943</PUBLICID>
    <LONGNAME>Cigarette Type</LONGNAME>
    <PREFERREDNAME>CIG_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>The type and class of cigarette a participant smokes.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2193965</PublicId>
      <PreferredName>Toba_Type</PreferredName>
      <PreferredDefinition>Indicates if an individual smokes or has ever smoked any other tobacco or tobacco related product and what type.</PreferredDefinition>
      <LongName>Tobacco Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2662193</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C891</PreferredName>
        <Version>1</Version>
        <LongName>Tobacco</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C891</PREFERRED_NAME>
            <LONG_NAME>Tobacco</LONG_NAME>
            <CON_ID>2202548</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2516931</PublicId>
      <PreferredName>CIG_TP</PreferredName>
      <PreferredDefinition>Finely cut tobacco encased in a wrapper of thin paper and rolled for smoking.(NCI)_Type; a subdivision of a cigarette being filtered or non-filtered. In addition, allowing for recording on Menthol and Nonmenthol.</PreferredDefinition>
      <LongName>Cigarette Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2186371</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0332307</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0332307</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2203010</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-filtered cigarettes</VALIDVALUE>
          <VALUEMEANING>Non-filtered cigarettes</VALUEMEANING>
          <MEANINGDESCRIPTION>Non-filtered cigarettes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Filtered cigarettes</VALIDVALUE>
          <VALUEMEANING>Filtered cigarettes</VALUEMEANING>
          <MEANINGDESCRIPTION>Filtered cigarettes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low tar cigarettes</VALIDVALUE>
          <VALUEMEANING>Low tar cigarettes</VALUEMEANING>
          <MEANINGDESCRIPTION>Low tar cigarettes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What type of cigarette have/d</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What type of cigarette have/do you smoke?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAMe - Hepatitis C cirrhosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812148</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="71">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2517448</PUBLICID>
    <LONGNAME>Dose Adverse Event Modification Specify</LONGNAME>
    <PREFERREDNAME>DOSE_AE_MOD_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free-text field to specify the adverse event that caused a treatment dose to be modified.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2517434</PublicId>
      <PreferredName>DOSE_AE_MOD</PreferredName>
      <PreferredDefinition>information related to dose modification due to any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s).</PreferredDefinition>
      <LongName>Dose Adverse Event Modification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2411801</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488</PreferredName>
        <Version>1</Version>
        <LongName>Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2517432</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331:C25572</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Modification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25572</PREFERRED_NAME>
            <LONG_NAME>Modification</LONG_NAME>
            <CON_ID>2203850</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018810</PublicId>
      <PreferredName>TX_SPEC</PreferredName>
      <PreferredDefinition>the free text field related to therapy.</PreferredDefinition>
      <LongName>Therapies Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="72">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2519098</PUBLICID>
    <LONGNAME>Coding Region Accession Number Primary UniProtKB Genomic Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2519083v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The sequences on a gene or messenger RNA that are translated into protein._A control number unique to an object, used to identify it among the other objects in a collection.:Occurring first in time or sequence; original; of greatest rank or importance or value.:The UniProt Knowledgebase (UniProtKB), a product of the UniProt consortium, provides a central database of protein sequences with accurate, consistent, rich sequence and functional annotation. The UniProt Knowledgebase consists of two sections: Swiss-Prot - a section containing manually-annotated records with information extracted from literature and curator-evaluated computational analysis, and TrEMBL - a section with computationally analyzed records that await full manual annotation.:One or more characters and/or numbers that are used to identify, name, or characterize the nature, properties, or contents of genomic sequences, mRNA transcripts, protein products, or other class of entities that occurs throughout the genome._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2519083</PublicId>
      <PreferredName>2519077v1.0:2519069v1.0</PreferredName>
      <PreferredDefinition>The sequences on a gene or messenger RNA that are translated into protein._A control number unique to an object, used to identify it among the other objects in a collection.:Occurring first in time or sequence; original; of greatest rank or importance or value.:The UniProt Knowledgebase (UniProtKB), a product of the UniProt consortium, provides a central database of protein sequences with accurate, consistent, rich sequence and functional annotation. The UniProt Knowledgebase consists of two sections: Swiss-Prot - a section containing manually-annotated records with information extracted from literature and curator-evaluated computational analysis, and TrEMBL - a section with computationally analyzed records that await full manual annotation.:One or more characters and/or numbers that are used to identify, name, or characterize the nature, properties, or contents of genomic sequences, mRNA transcripts, protein products, or other class of entities that occurs throughout the genome.</PreferredDefinition>
      <LongName>Coding Region Accession Number Primary UniProtKB Genomic Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2519077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48691</PreferredName>
        <Version>1</Version>
        <LongName>Coding Region</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48691</PREFERRED_NAME>
            <LONG_NAME>Coding Region</LONG_NAME>
            <CON_ID>2519061</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2519069</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25402:C25251:C47851:C45766</PreferredName>
        <Version>1</Version>
        <LongName>Accession Number Primary UniProtKB Genomic Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25402</PREFERRED_NAME>
            <LONG_NAME>Accession Number</LONG_NAME>
            <CON_ID>2203569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47851</PREFERRED_NAME>
            <LONG_NAME>UniProtKB</LONG_NAME>
            <CON_ID>2342206</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45766</PREFERRED_NAME>
            <LONG_NAME>Genomic Identifier</LONG_NAME>
            <CON_ID>2322216</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Coding Region Accession Number Primary UniProtKB Genomic Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Coding Region Accession Number Primary UniProtKB Genomic Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2519060</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Seed</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.uchicago.Seed.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812278</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.uchicago.Seed.domain.ProteinEncodingGeneFeature.uniprotkbPrimaryAccession</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProteinEncodingGeneFeature:uniprotkbPrimaryAccession</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="73">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2519440</PUBLICID>
    <LONGNAME>Specimen Registration Date and Time java.util.Date</LONGNAME>
    <PREFERREDNAME>2519351v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Specimen; a bit of tissue or blood or urine that is taken or used for research purposes._The act of enrolling; an entry in a register.:An expression of both date and time that an event has happened or will happened._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2519351</PublicId>
      <PreferredName>2241613v1.0:2519297v1.0</PreferredName>
      <PreferredDefinition>Specimen; a bit of tissue or blood or urine that is taken or used for research purposes._The act of enrolling; an entry in a register.:An expression of both date and time that an event has happened or will happened.</PreferredDefinition>
      <LongName>Specimen Registration Date and Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2241613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2519297</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25646:C37939</PreferredName>
        <Version>1</Version>
        <LongName>Registration Date and Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25646</PREFERRED_NAME>
            <LONG_NAME>Registration</LONG_NAME>
            <CON_ID>2202799</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Specimen Registration Date and Time java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Specimen Registration Date and Time java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ProteomicsLIMS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.fccc.lims.protlims.domain.class.sampledata</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Sample:inDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.fccc.lims.protlims.domain.class.sampledata.Sample.inDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="74">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2521954</PUBLICID>
    <LONGNAME>Cutaneous Melanoma Regression Status</LONGNAME>
    <PREFERREDNAME>CUT_MEL_REGR_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to signify if there is/has been a decrease in the size of a melanin-forming tumor or in the extent of cancer in the body,  in which cutaneous melanoma cells are replaced by lymphocytic inflammation with or without dermal melanophages and fibrosis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2431384</PublicId>
      <PreferredName>2431290v1.0:2431247v1.0</PreferredName>
      <PreferredDefinition>A malignant neoplasm derived from cells that are capable of forming melanin._A decrease in the size of a tumor or in the extent of cancer in the body.</PreferredDefinition>
      <LongName>Cutaneous Melanoma Regression</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2431290</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3510</PreferredName>
        <Version>1</Version>
        <LongName>Cutaneous Melanoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3510</PREFERRED_NAME>
            <LONG_NAME>Cutaneous Melanoma</LONG_NAME>
            <CON_ID>2431169</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2431247</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18243</PreferredName>
        <Version>1</Version>
        <LongName>Regression</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18243</PREFERRED_NAME>
            <LONG_NAME>Regression</LONG_NAME>
            <CON_ID>2431177</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2503735</PublicId>
      <PreferredName>ASSESS_RSL_STAT</PreferredName>
      <PreferredDefinition>A condition or state at a particular time to a question or occurrence.</PreferredDefinition>
      <LongName>Assessment Result Status</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2604856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20989:C20200:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Result Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No: C49487</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes: C49488</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No source documentation</VALIDVALUE>
          <VALUEMEANING>No/Not in source document</VALUEMEANING>
          <MEANINGDESCRIPTION>Data from an original source is not present, accessible or ready for use or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-03-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2604857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tumor Regression</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tumor Regression</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812205</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AZCC 0210</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812575</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="75">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2529092</PUBLICID>
    <LONGNAME>Clinical Study Participant Survival Status java.lang.Boolean</LONGNAME>
    <PREFERREDNAME>2528800v1.0:2178538v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, mechanism of human diseases, therapy, clinical trials, epidemiology, behavior and health services research.:Someone who takes part in an activity._Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.:A condition or state at a particular time._Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2528800</PublicId>
      <PreferredName>2528717v1.0:2528608v1.0</PreferredName>
      <PreferredDefinition>Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, mechanism of human diseases, therapy, clinical trials, epidemiology, behavior and health services research.:Someone who takes part in an activity._Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.:A condition or state at a particular time.</PreferredDefinition>
      <LongName>Clinical Study Participant Survival Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528717</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15206:C29867</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Study Participant</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29867</PREFERRED_NAME>
            <LONG_NAME>Participant</LONG_NAME>
            <CON_ID>2202627</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528608</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17177:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Survival Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17177</PREFERRED_NAME>
            <LONG_NAME>Survival</LONG_NAME>
            <CON_ID>2202477</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178538</PublicId>
      <PreferredName>java.lang.Boolean</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PreferredDefinition>
      <LongName>java.lang.Boolean</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Boolean</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Clinical Study Participant Survival Status java.lang.Boolean does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Clinical Study Participant Survival Status java.lang.Boolean does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2528519</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812313</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2707890</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator 2.1</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000247</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.study.StudyParticipant.survivalStatus</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudyParticipant:survivalStatus</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="76">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2529150</PUBLICID>
    <LONGNAME>Single Nucleotide Polymorphism Group Single Nucleotide Polymorphism Assay Count java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2528855v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:Any number of entities (members) considered as a unit._A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:The determination of the amount of a particular constituent of a mixture or of the biological or pharmacological potency of a drug.:To determine the number or amount of something; the result of this activity._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2528855</PublicId>
      <PreferredName>2528731v1.0:2528627v1.0</PreferredName>
      <PreferredDefinition>A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:Any number of entities (members) considered as a unit._A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:The determination of the amount of a particular constituent of a mixture or of the biological or pharmacological potency of a drug.:To determine the number or amount of something; the result of this activity.</PreferredDefinition>
      <LongName>Single Nucleotide Polymorphism Group Single Nucleotide Polymorphism Assay Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18279:C43359</PreferredName>
        <Version>1</Version>
        <LongName>Single Nucleotide Polymorphism Group</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18279</PREFERRED_NAME>
            <LONG_NAME>Single Nucleotide Polymorphism</LONG_NAME>
            <CON_ID>2433334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43359</PREFERRED_NAME>
            <LONG_NAME>Group</LONG_NAME>
            <CON_ID>2236516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528627</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18279:C60819:C25463</PreferredName>
        <Version>1</Version>
        <LongName>Single Nucleotide Polymorphism Assay Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18279</PREFERRED_NAME>
            <LONG_NAME>Single Nucleotide Polymorphism</LONG_NAME>
            <CON_ID>2433334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60819</PREFERRED_NAME>
            <LONG_NAME>Assay</LONG_NAME>
            <CON_ID>2528534</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Single Nucleotide Polymorphism Group Single Nucleotide Polymorphism Assay Count java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Single Nucleotide Polymorphism Group Single Nucleotide Polymorphism Assay Count java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2528519</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.annotation.snp</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812316</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2707890</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator 2.1</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.annotation.snp</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000401</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.annotation.snp.SNPPanel.assayCount</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SNPPanel:assayCount</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="77">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2529561</PUBLICID>
    <LONGNAME>Cancer Genome Anatomy Project Library UniGene Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2529508v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The Cancer Genome Anatomy Project (CGAP) is an interdisciplinary program to establish the information and technological tools needed to decipher the molecular anatomy of a cancer cell.  The Cancer Genome Anatomy Project (CGAP) will unite the newest techno:A collection of DNA molecules that have been cloned in vectors._UniGene is an experimental system for automatically partitioning GenBank sequences into a non-redundant set of gene-oriented clusters. Each UniGene cluster contains sequences that represent a unique gene, as well as related information such as the tissue types in which the gene has been expressed and map location.  It is provided as a web application from the National Center for Biotechnology Information (NCBI).:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2529508</PublicId>
      <PreferredName>2529487v1.0:2223267v1.0</PreferredName>
      <PreferredDefinition>The Cancer Genome Anatomy Project (CGAP) is an interdisciplinary program to establish the information and technological tools needed to decipher the molecular anatomy of a cancer cell.  The Cancer Genome Anatomy Project (CGAP) will unite the newest techno:A collection of DNA molecules that have been cloned in vectors._UniGene is an experimental system for automatically partitioning GenBank sequences into a non-redundant set of gene-oriented clusters. Each UniGene cluster contains sequences that represent a unique gene, as well as related information such as the tissue types in which the gene has been expressed and map location.  It is provided as a web application from the National Center for Biotechnology Information (NCBI).:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Cancer Genome Anatomy Project Library UniGene Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2529487</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15923:C16223</PreferredName>
        <Version>1</Version>
        <LongName>Cancer Genome Anatomy Project Library</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15923</PREFERRED_NAME>
            <LONG_NAME>Cancer Genome Anatomy Project</LONG_NAME>
            <CON_ID>2529469</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16223</PREFERRED_NAME>
            <LONG_NAME>DNA Library</LONG_NAME>
            <CON_ID>2223197</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223267</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43563:C25364</PreferredName>
        <Version>1</Version>
        <LongName>UniGene Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43563</PREFERRED_NAME>
            <LONG_NAME>UniGene</LONG_NAME>
            <CON_ID>2223200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Cancer Genome Anatomy Project Library UniGene Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Cancer Genome Anatomy Project Library UniGene Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000537</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000539</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000543</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000544</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Library:uniGeneId</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabio.domain.Library.uniGeneId</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>@uniGeneId</AlternateName>
        <AlternateNameType>GME_XMLLocReference</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="78">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2534512</PUBLICID>
    <LONGNAME>Colorectal Carcinoma Histopathologic Grade Missing Value Reason Histopathologic Grade ColorectalCancerHistologicGradeMVRVD</LONGNAME>
    <PREFERREDNAME>2534270v1.0:2534469v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Grossly, most colorectal carcinomas are either polypoid or of the ulcerative -infiltrating type.  Adenocarcinoma is the most common carcinoma in the colon and rectum.  Colorectal adenocarcinoma can be divided in three grades: Grade I (low grade or well-di:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior_A specific reason explaining why a meaningful value is not available.  A meaningful value answers the question posed by a Data Element Concept.  In contrast, a Missing Value Reason answers the implicit question &quot;Why is there no &#39;meaningful&#39; value?&quot;, when:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior_Permissible values for ColorectalCancerHistologicGradeMVRVD</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2534270</PublicId>
      <PreferredName>2534188v1.0:2534142v1.0</PreferredName>
      <PreferredDefinition>Grossly, most colorectal carcinomas are either polypoid or of the ulcerative -infiltrating type.  Adenocarcinoma is the most common carcinoma in the colon and rectum.  Colorectal adenocarcinoma can be divided in three grades: Grade I (low grade or well-di:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior_A specific reason explaining why a meaningful value is not available.  A meaningful value answers the question posed by a Data Element Concept.  In contrast, a Missing Value Reason answers the implicit question &quot;Why is there no &#39;meaningful&#39; value?&quot;, when:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior</PreferredDefinition>
      <LongName>Colorectal Carcinoma Histopathologic Grade Missing Value Reason Histopathologic Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2534188</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2955:C18000</PreferredName>
        <Version>1</Version>
        <LongName>Colorectal Carcinoma Histopathologic Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2955</PREFERRED_NAME>
            <LONG_NAME>Colorectal Carcinoma</LONG_NAME>
            <CON_ID>2534080</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2534142</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48655:C18000</PreferredName>
        <Version>1</Version>
        <LongName>Missing Value Reason Histopathologic Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48655</PREFERRED_NAME>
            <LONG_NAME>Missing Value Reason</LONG_NAME>
            <CON_ID>2431146</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2534469</PublicId>
      <PreferredName>2534469v1.0</PreferredName>
      <PreferredDefinition>Permissible values for ColorectalCancerHistologicGradeMVRVD</PreferredDefinition>
      <LongName>ColorectalCancerHistologicGradeMVRVD</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cannot be assessed</VALIDVALUE>
          <VALUEMEANING>Cannot be assessed</VALUEMEANING>
          <MEANINGDESCRIPTION>Aspects of the context prevent the evaluation needed to determine a value.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48657</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2566786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Colorectal Carcinoma Histopathologic Grade Missing Value Reason Histopathologic Grade ColorectalCancerHistologicGradeMVRVD does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Colorectal Carcinoma Histopathologic Grade Missing Value Reason Histopathologic Grade ColorectalCancerHistologicGradeMVRVD does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534075</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTISSUE CAE</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.pitt.cabig.cae.domain.colonrectum</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812218</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ColorectalHistologicGrade:gradeMVR</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.pitt.cabig.cae.domain.colonrectum.ColorectalHistologicGrade.gradeMVR</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="79">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2534551</PUBLICID>
    <LONGNAME>Invasive Lung Carcinoma Other Anatomic Site java.lang.String</LONGNAME>
    <PREFERREDNAME>2534307v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>User-supplied text indicating the tumor site</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2534307</PublicId>
      <PreferredName>2534221v1.0:2207113v1.0</PreferredName>
      <PreferredDefinition>Marked by a tendency to spread, especially into healthy surrounding tissue.:A carcinoma originating in the lung.  Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas.  Non-small cell lung carcinomas are usually ade_Not otherwise specified.:Named locations of, or within, the body.</PreferredDefinition>
      <LongName>Invasive Lung Carcinoma Other Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2534221</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14159:C4878</PreferredName>
        <Version>1</Version>
        <LongName>Invasive Lung Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14159</PREFERRED_NAME>
            <LONG_NAME>Invasive</LONG_NAME>
            <CON_ID>2203841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4878</PREFERRED_NAME>
            <LONG_NAME>Lung Carcinoma</LONG_NAME>
            <CON_ID>2202892</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207113</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C13717</PreferredName>
        <Version>1</Version>
        <LongName>Other Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If site is not listed above,</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If site is not listed above, please specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534075</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTISSUE CAE</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.pitt.cabig.cae.domain.lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812222</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.pitt.cabig.cae.domain.lung.InvasiveLungCarcinoma.otherLocation</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>InvasiveLungCarcinoma:otherLocation</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="80">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2535343</PUBLICID>
    <LONGNAME>Nucleic Acid Hybridization Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2535126v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The zipping reaction between complementary DNA or RNA single strands to form a duplex (double stranded) molecule is the basis of many techniques for assaying nucleic acid sequence complementarity._The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2535126</PublicId>
      <PreferredName>2236728v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>The zipping reaction between complementary DNA or RNA single strands to form a duplex (double stranded) molecule is the basis of many techniques for assaying nucleic acid sequence complementarity._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Nucleic Acid Hybridization Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236728</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16924</PreferredName>
        <Version>1</Version>
        <LongName>Nucleic Acid Hybridization</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16924</PREFERRED_NAME>
            <LONG_NAME>Nucleic Acid Hybridization</LONG_NAME>
            <CON_ID>2236551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Nucleic Acid Hybridization Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Nucleic Acid Hybridization Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.hybridization</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812746</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2804620</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GenePattern CN Analy Serv</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.hybridization</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000662</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2819751</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Copy Number Analysis Tool</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.hybridization</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000663</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2831137</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caCORRECT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caCORRECT Grid Services 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2832871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2831137</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caCORRECT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.hybridization</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000661</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.hybridization</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000660</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.hybridization</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000664</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2953481</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Service</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Service 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2953482</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2953481</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Service</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.external.v1_0.sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2953489</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Hybridization:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.mageom.domain.BioAssay.Hybridization.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.hybridization.Hybridization.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.external.v1_0.sample.Hybridization.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="81">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2539890</PUBLICID>
    <LONGNAME>Association Class Unified Modeling Language Metadata Target Lowest Cardinality java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2539692v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>In UML modeling, an association that is also a class.  It not only connects a set of classes, but also defines a set of features that belong to the relationship itself.:A non-proprietary, third generation modelling language. The Unified Modeling Language is an open method used to specify, visualise, construct and document the artifacts of an object-oriented software-intensive system under development. The UML represents:Data about data; information that describes another set of data._An object fixed as a goal or point of examination; something to point at; a destination.:In the lowest position, nearest the ground, at the bottom; minimal in magnitude, lowest in rank or importance; an extreme state of adversity.:The number of elements in a set._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2539692</PublicId>
      <PreferredName>2539538v1.0:2539517v1.0</PreferredName>
      <PreferredDefinition>In UML modeling, an association that is also a class.  It not only connects a set of classes, but also defines a set of features that belong to the relationship itself.:A non-proprietary, third generation modelling language. The Unified Modeling Language is an open method used to specify, visualise, construct and document the artifacts of an object-oriented software-intensive system under development. The UML represents:Data about data; information that describes another set of data._An object fixed as a goal or point of examination; something to point at; a destination.:In the lowest position, nearest the ground, at the bottom; minimal in magnitude, lowest in rank or importance; an extreme state of adversity.:The number of elements in a set.</PreferredDefinition>
      <LongName>Association Class Unified Modeling Language Metadata Target Lowest Cardinality</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2539538</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45672:C54193:C52095</PreferredName>
        <Version>1</Version>
        <LongName>Association Class Unified Modeling Language Metadata</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45672</PREFERRED_NAME>
            <LONG_NAME>Association Class</LONG_NAME>
            <CON_ID>2231583</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54193</PREFERRED_NAME>
            <LONG_NAME>Unified Modeling Language</LONG_NAME>
            <CON_ID>2539475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52095</PREFERRED_NAME>
            <LONG_NAME>Metadata</LONG_NAME>
            <CON_ID>2521487</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2539517</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25702:C43517:C54199</PreferredName>
        <Version>1</Version>
        <LongName>Target Lowest Cardinality</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25702</PREFERRED_NAME>
            <LONG_NAME>Target</LONG_NAME>
            <CON_ID>2206261</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43517</PREFERRED_NAME>
            <LONG_NAME>Lowest</LONG_NAME>
            <CON_ID>2202385</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54199</PREFERRED_NAME>
            <LONG_NAME>Cardinality</LONG_NAME>
            <CON_ID>2539477</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Association Class Unified Modeling Language Metadata Target Lowest Cardinality java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Association Class Unified Modeling Language Metadata Target Lowest Cardinality java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.umlproject.domain.UMLAssociationMetadata.targetLowCardinality</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>UMLAssociationMetadata:targetLowCardinality</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="82">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2541087</PUBLICID>
    <LONGNAME>Human Immunodeficiency Virus Viral Load Assay Performed Specify</LONGNAME>
    <PREFERREDNAME>HIV_VL_ASAY_PRF_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify the other type of  human immunodeficiency virus (HIV) viral load assay that was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2541079</PublicId>
      <PreferredName>HIV_VIRLD_ASSAY_PERF</PreferredName>
      <PreferredDefinition>information relating to a human immunodeficiency virus viral load (the number of HIV viral particles in a sample of blood plasma) assay performed.</PreferredDefinition>
      <LongName>Human Immunodeficiency Virus Viral Load Assay Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2541077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14219:C51952:C16341</PreferredName>
        <Version>1</Version>
        <LongName>Human Immunodeficiency Virus Viral Load Assay</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14219</PREFERRED_NAME>
            <LONG_NAME>Human Immunodeficiency Virus</LONG_NAME>
            <CON_ID>2202523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51952</PREFERRED_NAME>
            <LONG_NAME>Viral Load</LONG_NAME>
            <CON_ID>2541076</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16341</PREFERRED_NAME>
            <LONG_NAME>Bioassay</LONG_NAME>
            <CON_ID>2202922</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018806</PublicId>
      <PreferredName>ASSESS_SPEC</PreferredName>
      <PreferredDefinition>The free text field to specify the assessment performed.</PreferredDefinition>
      <LongName>Assessment Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lab</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7312661</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OTHSP_DDEVAL</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OTHSP_MBMETHOD</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="83">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2545509</PUBLICID>
    <LONGNAME>Chest Abdomen Cavity Computed Tomography Neoplasm Appearance Type</LONGNAME>
    <PREFERREDNAME>C_AC_CT_NEO_AP_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of appearance of tumor non-contrast enhanced images from chest/abdomen (soft tissue) CT scan.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2545463</PublicId>
      <PreferredName>C_CA_CT_NEO_APPEAR</PreferredName>
      <PreferredDefinition>information relating appearance of tumor as examined through body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis of the chest and abdomen.</PreferredDefinition>
      <LongName>Chest Abdominal Cavity Computed Tomography Neoplasm Appearance</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2545367</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25389:C12664:C17204:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Chest Abdominal Cavity Computed Tomography Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25389</PREFERRED_NAME>
            <LONG_NAME>Chest</LONG_NAME>
            <CON_ID>2202707</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12664</PREFERRED_NAME>
            <LONG_NAME>Abdomen</LONG_NAME>
            <CON_ID>2435963</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17204</PREFERRED_NAME>
            <LONG_NAME>Computed Tomography</LONG_NAME>
            <CON_ID>2202436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2545442</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25377</PreferredName>
        <Version>1</Version>
        <LongName>Appearance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25377</PREFERRED_NAME>
            <LONG_NAME>Appearance</LONG_NAME>
            <CON_ID>2203581</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2545489</PublicId>
      <PreferredName>CHEST_A_CT_APP_TP</PreferredName>
      <PreferredDefinition>the type of appearance of tumor non-contrast enhanced or contract enhanced images from chest/abdomen (soft tissue) CT scan.</PreferredDefinition>
      <LongName>Chest Abdomen Cavity Computed Tomography Neoplasm Appearance Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High-attenuation foci (e.g., calcification)</VALIDVALUE>
          <VALUEMEANING>High- attenuation foci (e.g., calcification)</VALUEMEANING>
          <MEANINGDESCRIPTION>High- attenuation foci (e.g., calcification)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Water-attenuation foci (e.g., necrosis)</VALIDVALUE>
          <VALUEMEANING>Water- attenuation foci (e.g., necrosis)</VALUEMEANING>
          <MEANINGDESCRIPTION>Water- attenuation foci (e.g., necrosis)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gas-attenuation foci</VALIDVALUE>
          <VALUEMEANING>Gas- attenuation foci</VALUEMEANING>
          <MEANINGDESCRIPTION>Gas- attenuation foci</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If the scan includes non-cont</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If the scan includes non-contrast enhanced images of the tumor, are any of the following present within the tumor</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="84">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2548304</PUBLICID>
    <LONGNAME>Other Prostate Biopsy Site Integer Count</LONGNAME>
    <PREFERREDNAME>O_PRS_BX_SITE_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of other biopsy sites sampled.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2548302</PublicId>
      <PreferredName>O_PRS_BX_SITE</PreferredName>
      <PreferredDefinition>Information pertaining to other prostate biopsy sites.</PreferredDefinition>
      <LongName>Other Prostate Biopsy Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2548300</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C12410:C15189</PreferredName>
        <Version>1</Version>
        <LongName>Other Prostate Biopsy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12410</PREFERRED_NAME>
            <LONG_NAME>Prostate Gland</LONG_NAME>
            <CON_ID>2202794</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15189</PREFERRED_NAME>
            <LONG_NAME>Biopsy Procedure</LONG_NAME>
            <CON_ID>2202502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2413203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37901</PreferredName>
        <Version>1</Version>
        <LongName>Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37901</PREFERRED_NAME>
            <LONG_NAME>Site</LONG_NAME>
            <CON_ID>2202394</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2548299</PublicId>
      <PreferredName>INTEGR_CT</PreferredName>
      <PreferredDefinition>A number with no fractional part.</PreferredDefinition>
      <LongName>Integer Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2183782</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>NCIP</PreferredName>
        <Version>1</Version>
        <LongName>NCIP</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2434150</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463:C45255</PreferredName>
        <Version>1</Version>
        <LongName>Count Integer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If other, number of biopsy si</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If other, number of biopsy sites</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Effect of Finasteride - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812182</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="85">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2548369</PUBLICID>
    <LONGNAME>Gross Tumor Residual Pathology Type</LONGNAME>
    <PREFERREDNAME>GROSS_RESID_PATH_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Text names to describe the pathologic content of a gross tumor specimen.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2200386</PublicId>
      <PreferredName>GROSS_TUM_RSDL_RMNG</PreferredName>
      <PreferredDefinition>Information relating to gross tumor residual remaining.</PreferredDefinition>
      <LongName>Gross Tumor Residual Remaining</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2660141</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43566:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Gross Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43566</PREFERRED_NAME>
            <LONG_NAME>Gross</LONG_NAME>
            <CON_ID>2223205</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207602</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37895:C25649</PreferredName>
        <Version>1</Version>
        <LongName>Residual Remaining</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37895</PREFERRED_NAME>
            <LONG_NAME>Residual</LONG_NAME>
            <CON_ID>2206361</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25649</PREFERRED_NAME>
            <LONG_NAME>Remaining</LONG_NAME>
            <CON_ID>2203780</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2548367</PublicId>
      <PreferredName>GROSS_PATH_TP</PreferredName>
      <PreferredDefinition>Text terms to describe pathologic types of gross residual tumor.</PreferredDefinition>
      <LongName>Gross Pathology Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>38</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548366</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43566:C18189:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Gross Pathology Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43566</PREFERRED_NAME>
            <LONG_NAME>Gross</LONG_NAME>
            <CON_ID>2223205</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None present</VALIDVALUE>
          <VALUEMEANING>None present</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.: Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626, C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-12-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Single discrete mass</VALIDVALUE>
          <VALUEMEANING>Single discrete mass</VALUEMEANING>
          <MEANINGDESCRIPTION>Not accompanied by another or others; exclusive of anyone or anything else.: Constituting a separate entity or part.: A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells, inflammatory cells, or cystic changes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34808, C75300, C48440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-12-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multifocal discrete masses</VALIDVALUE>
          <VALUEMEANING>Multifocal discrete masses</VALUEMEANING>
          <MEANINGDESCRIPTION>Arising from, pertaining to, or having many locations.: Constituting a separate entity or part.: A finding indicating the presence of more than two tumor masses in a single anatomic site or different anatomic sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39787, C75300, C25253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-12-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gross stromal alterations/fibrosis</VALIDVALUE>
          <VALUEMEANING>Gross stromal alterations/fibrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Visible to the naked eye.: Connective tissue cells found in the tissue stroma of any organ.: The act of alteration or modification; changed or altered in form or character.: The growth of fibrous tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3044, C25446, C12571, C43566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-12-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Gross pathology present</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Gross pathology present</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Gross pathology present? (Mark all that apply)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Gross pathology present? (Mark all that apply)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnosis Gross Tumor CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3914492</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2548333</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>I-SPY</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C911/C1000</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812254</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gross Pathology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5915896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="86">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2552316</PUBLICID>
    <LONGNAME>Patient Chest Wall Pain Assessment Score</LONGNAME>
    <PREFERREDNAME>PT_CW_PN_ASSESS_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to identify a person&#39;s level of pain, an unpleasant sensation displaying a number of signs and symptoms, in the chest wall.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2552314</PublicId>
      <PreferredName>PT_CW_PN_ASSESS</PreferredName>
      <PreferredDefinition>Reference to an assessment of a patient/participant&#39;s level of pain in the chest wall area.</PreferredDefinition>
      <LongName>Patient Chest Wall Pain Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2552312</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3303:C62484:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Pain Chest Wall Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3303</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>2202326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62484</PREFERRED_NAME>
            <LONG_NAME>Chest Wall</LONG_NAME>
            <CON_ID>2516459</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2552308</PublicId>
      <PreferredName>PN_SCL_SC</PreferredName>
      <PreferredDefinition>Numeric values to identify a person&#39;s level of pain, an unpleasant sensation displaying a number of signs and symptoms.</PreferredDefinition>
      <LongName>Pain Scale Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2552307</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3303:C25664:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Pain Scale Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3303</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>2202326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>Worst Possible Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Worst Possible Pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No pain</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had no pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Level 1 pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Level 1 pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Level 2 pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Level 2 pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Level 3 pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Level 3 pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Level 4 pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Level 4 pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Level 5 pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Level 5 pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Level 6 pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Level 6 pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Level 7 pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Level 7 pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Level 8 pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Level 8 pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Level 9 pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Level 9 pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Indicate your level of pain o</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Indicate your level of pain on or around your chest wall</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ThermoDox Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812723</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886752</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>For Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3891931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="87">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2552638</PUBLICID>
    <LONGNAME>Value Domain Administered Item Workflow Status Description  java.lang.String</LONGNAME>
    <PREFERREDNAME>2552473v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A set of permissible values for a data element.:A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_Workflow is the operational aspect of a work procedure: how tasks are structured, who performs them, what their relative order is, how they are synchronized, how information flows to support the tasks and how tasks are being tracked. (from Wikipedia):A condition or state at a particular time.:Description; a statement that represents something in words._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2552473</PublicId>
      <PreferredName>2231653v1.0:2442889v1.0</PreferredName>
      <PreferredDefinition>A set of permissible values for a data element.:A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_Workflow is the operational aspect of a work procedure: how tasks are structured, who performs them, what their relative order is, how they are synchronized, how information flows to support the tasks and how tasks are being tracked. (from Wikipedia):A condition or state at a particular time.:Description; a statement that represents something in words.</PreferredDefinition>
      <LongName>Value Domain Administered Item Workflow Status Description </LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2231653</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42748:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Value Domain Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42748</PREFERRED_NAME>
            <LONG_NAME>Value Domain</LONG_NAME>
            <CON_ID>2231559</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2442889</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42753:C25688:C25365</PreferredName>
        <Version>1</Version>
        <LongName>Workflow Status Description </LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42753</PREFERRED_NAME>
            <LONG_NAME>Workflow</LONG_NAME>
            <CON_ID>2231547</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Value Domain Administered Item Workflow Status Description  java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Value Domain Administered Item Workflow Status Description  java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.ValueDomain.workflowStatusDescription</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ValueDomain:workflowStatusDescription</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="88">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2552669</PUBLICID>
    <LONGNAME>Form Element Preferred Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2552497v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A printed or electronic document with spaces to be filled out.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system._Designated as more desirable.:The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2552497</PublicId>
      <PreferredName>2539527v1.0:2231599v1.0</PreferredName>
      <PreferredDefinition>A printed or electronic document with spaces to be filled out.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system._Designated as more desirable.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Form Element Preferred Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2539527</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19464:C48792</PreferredName>
        <Version>1</Version>
        <LongName>Form Element</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19464</PREFERRED_NAME>
            <LONG_NAME>Form</LONG_NAME>
            <CON_ID>2202476</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48792</PREFERRED_NAME>
            <LONG_NAME>Element</LONG_NAME>
            <CON_ID>2513271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231599</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42711:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Preferred Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42711</PREFERRED_NAME>
            <LONG_NAME>Preferred</LONG_NAME>
            <CON_ID>2231546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Form Element Preferred Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Form Element Preferred Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.FormElement.preferredName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FormElement:preferredName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="89">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2552740</PUBLICID>
    <LONGNAME>Clinical Trial Protocol Administered Item Registration Status Administered Component Registration Status</LONGNAME>
    <PREFERREDNAME>2552547v1.0:2463561v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will recei:A registry item for which administrative information is recorded in an Administration Record._The act of enrolling.:A condition or state at a particular time._A designation of the status in the registration life-cycle of an Administered Item.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2552547</PublicId>
      <PreferredName>2539530v1.0:2231613v1.0</PreferredName>
      <PreferredDefinition>An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will recei:A registry item for which administrative information is recorded in an Administration Record._The act of enrolling.:A condition or state at a particular time.</PreferredDefinition>
      <LongName>Clinical Trial Protocol Administered Item Registration Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2539530</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25320:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Protocol Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25320</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Protocol</LONG_NAME>
            <CON_ID>2202702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25646:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Registration Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25646</PREFERRED_NAME>
            <LONG_NAME>Registration</LONG_NAME>
            <CON_ID>2202799</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2463561</PublicId>
      <PreferredName>ADMIN_COMP_REG_STAT</PreferredName>
      <PreferredDefinition>A designation of the status in the registration life-cycle of an Administered Item.</PreferredDefinition>
      <LongName>Administered Component Registration Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2183782</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>NCIP</PreferredName>
        <Version>1</Version>
        <LongName>NCIP</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2463560</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25646:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Registration Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25646</PREFERRED_NAME>
            <LONG_NAME>Registration</LONG_NAME>
            <CON_ID>2202799</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Application</VALIDVALUE>
          <VALUEMEANING>Application</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the application unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Candidate</VALIDVALUE>
          <VALUEMEANING>Candidate</VALUEMEANING>
          <MEANINGDESCRIPTION>Candidate</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Proposed</VALIDVALUE>
          <VALUEMEANING>Proposed</VALUEMEANING>
          <MEANINGDESCRIPTION>Being reviewed for promotion to Candidate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Qualified</VALIDVALUE>
          <VALUEMEANING>Qualified</VALUEMEANING>
          <MEANINGDESCRIPTION>Met quality requirements, ready to be reviewed for Proposed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retired</VALIDVALUE>
          <VALUEMEANING>RETIRED</VALUEMEANING>
          <MEANINGDESCRIPTION>RETIRED</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Standard</VALIDVALUE>
          <VALUEMEANING>Standard</VALUEMEANING>
          <MEANINGDESCRIPTION>Recommended for usage by all contexts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Standardized Elsewhere</VALIDVALUE>
          <VALUEMEANING>Standardized Elsewhere</VALUEMEANING>
          <MEANINGDESCRIPTION>The Administered Component has been adopted for standard usage by a community outside of NCI.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Superceded</VALIDVALUE>
          <VALUEMEANING>Superceded</VALUEMEANING>
          <MEANINGDESCRIPTION>The Administered Component is no longer recommended for usage because it has been replaced by another Administered Component.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suspended</VALIDVALUE>
          <VALUEMEANING>Suspended status</VALUEMEANING>
          <MEANINGDESCRIPTION>The Administered Component has been considered for standard status in the past and was not selected for promotion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Clinical Trial Protocol Administered Item Registration Status Administered Component Registration Status does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Clinical Trial Protocol Administered Item Registration Status Administered Component Registration Status does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.Protocol.registrationStatus</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Protocol:registrationStatus</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="90">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2554518</PUBLICID>
    <LONGNAME>Patient First Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2554324v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A person who requires medical care._A word or group of words indicating a person&#39;s first (personal) name. (NCI)_Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2554324</PublicId>
      <PreferredName>2233604v1.0:2223450v1.0</PreferredName>
      <PreferredDefinition>A person who requires medical care._A word or group of words indicating a person&#39;s first (personal) name. (NCI)</PreferredDefinition>
      <LongName>Patient First Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223450</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C40974</PreferredName>
        <Version>1</Version>
        <LongName>First Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40974</PREFERRED_NAME>
            <LONG_NAME>First Name</LONG_NAME>
            <CON_ID>2203651</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FirstName</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>FirstName</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3185645</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BIGHealth ePRO Data Dictionary</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Care Monitor_PCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3185646</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.duke.cabig.tumorregistry.domain.Patient.firstName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caisis.domain.common.Patient.firstName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Patient:firstName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lungspore.domain.Patient.firstName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="91">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2557955</PUBLICID>
    <LONGNAME>Data Service Instance Service Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2557908v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.:Work, or a product of that work, done by one person or group that benefits another.:An occurrence of something._Work, or a product of that work, done by one person or group that benefits another.:The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2557908</PublicId>
      <PreferredName>2557896v1.0:2557873v1.0</PreferredName>
      <PreferredDefinition>A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.:Work, or a product of that work, done by one person or group that benefits another.:An occurrence of something._Work, or a product of that work, done by one person or group that benefits another.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Data Service Instance Service Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2557896</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25474:C47920:C48364</PreferredName>
        <Version>1</Version>
        <LongName>Data Service Instance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47920</PREFERRED_NAME>
            <LONG_NAME>Service</LONG_NAME>
            <CON_ID>2414569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48364</PREFERRED_NAME>
            <LONG_NAME>Instance</LONG_NAME>
            <CON_ID>2413213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2557873</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47920:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Service Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47920</PREFERRED_NAME>
            <LONG_NAME>Service</LONG_NAME>
            <CON_ID>2414569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Data Service Instance Service Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Data Service Instance Service Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2661628</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caFE Server</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.fe</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000308</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2661745</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_caArray</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000636</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.DataServiceInstance.serviceName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DataServiceInstance:serviceName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.fe.DataServiceInstance.serviceName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="92">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2620264</PUBLICID>
    <LONGNAME>Data Processing Data Set Parameter Set Column Threshold java.lang.Float</LONGNAME>
    <PREFERREDNAME>2620182v1.0:2178535v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A series of operations on data by a computer in order to retrieve or transform or classify information.:A collection of related data records.:Any factor that defines a system and determines (or limits) its performance.:A group of things of the same kind that belong together and are so used._An arrangement of objects one under another in a line.:The lowest limit at which something becomes detectable or relevant._Generic value domain for a primitive java datatype that is Single-precision floating point number (32-bit IEEE 754).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2620182</PublicId>
      <PreferredName>2620162v1.0:2620126v1.0</PreferredName>
      <PreferredDefinition>A series of operations on data by a computer in order to retrieve or transform or classify information.:A collection of related data records.:Any factor that defines a system and determines (or limits) its performance.:A group of things of the same kind that belong together and are so used._An arrangement of objects one under another in a line.:The lowest limit at which something becomes detectable or relevant.</PreferredDefinition>
      <LongName>Data Processing Data Set Parameter Set Column Threshold</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2620162</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47925:C47824:C44175:C47894</PreferredName>
        <Version>1</Version>
        <LongName>Data Processing Data Set Parameter Set</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47925</PREFERRED_NAME>
            <LONG_NAME>Data Processing</LONG_NAME>
            <CON_ID>2620096</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47824</PREFERRED_NAME>
            <LONG_NAME>Data Set</LONG_NAME>
            <CON_ID>2494294</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44175</PREFERRED_NAME>
            <LONG_NAME>Parameter</LONG_NAME>
            <CON_ID>2236569</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47894</PREFERRED_NAME>
            <LONG_NAME>Set</LONG_NAME>
            <CON_ID>2425537</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2620126</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43379:C48228</PreferredName>
        <Version>1</Version>
        <LongName>Column Threshold</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43379</PREFERRED_NAME>
            <LONG_NAME>Column</LONG_NAME>
            <CON_ID>2236513</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48228</PREFERRED_NAME>
            <LONG_NAME>Threshold</LONG_NAME>
            <CON_ID>2423422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178535</PublicId>
      <PreferredName>java.lang.Float</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is Single-precision floating point number (32-bit IEEE 754).</PreferredDefinition>
      <LongName>java.lang.Float</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Float</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Data Processing Data Set Parameter Set Column Threshold java.lang.Float does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Data Processing Data Set Parameter Set Column Threshold java.lang.Float does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2620091</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GenePattern</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gridExtensions</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812798</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2620091</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GenePattern</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.genepattern.caGrid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812799</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreprocessDatasetParameterSet:columnThreshold</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.genepattern.caGrid.PreprocessDatasetParameterSet.columnThreshold</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="93">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2624164</PUBLICID>
    <LONGNAME>Person Health Status Criteria</LONGNAME>
    <PREFERREDNAME>PRSN_HLTH_STAT_CRIT</PREFERREDNAME>
    <PREFERREDDEFINITION>A set of comparison criteria used together to evaluate the level of health of a person.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2624142</PublicId>
      <PreferredName>PRSN_HLTH_STAT_CRIT</PreferredName>
      <PreferredDefinition>A set of comparison criteria used to evaluate the level of health of a person.</PreferredDefinition>
      <LongName>Person Health Status Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2624139</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C16669</PreferredName>
        <Version>1</Version>
        <LongName>Person Health Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16669</PREFERRED_NAME>
            <LONG_NAME>Health Status</LONG_NAME>
            <CON_ID>2457012</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2624140</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25466</PreferredName>
        <Version>1</Version>
        <LongName>Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25466</PREFERRED_NAME>
            <LONG_NAME>Criterion</LONG_NAME>
            <CON_ID>2203889</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2624144</PublicId>
      <PreferredName>HLTH_STAT_CRIT</PreferredName>
      <PreferredDefinition>A set of standards used to evaluate the level of health of a person.</PreferredDefinition>
      <LongName>Health Status Criterion</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>38</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2624143</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16669:C25466</PreferredName>
        <Version>1</Version>
        <LongName>Health Status Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16669</PREFERRED_NAME>
            <LONG_NAME>Health Status</LONG_NAME>
            <CON_ID>2457012</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25466</PREFERRED_NAME>
            <LONG_NAME>Criterion</LONG_NAME>
            <CON_ID>2203889</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteoporosis</VALIDVALUE>
          <VALUEMEANING>Osteoporosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other (please specify)</VALIDVALUE>
          <VALUEMEANING>Other, Specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Be specific about something; define clearly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cancer (excluding non-melanoma skin)</VALIDVALUE>
          <VALUEMEANING>Cancer (excluding non-melanoma skin)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cancer (excluding non-melanoma skin)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624145</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cancer Recurrence</VALIDVALUE>
          <VALUEMEANING>Cancer Recurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>Cancer Recurrence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cirrhosis</VALIDVALUE>
          <VALUEMEANING>Cirrhosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholisms, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholecystectomy (removal of gallbladder)</VALIDVALUE>
          <VALUEMEANING>Cholecystectomy (removal of gallbladder)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cholecystectomy (removal of gallbladder)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gallbladder disease (gallstones)</VALIDVALUE>
          <VALUEMEANING>Gallbladder disease (gallstones)</VALUEMEANING>
          <MEANINGDESCRIPTION>Gallbladder disease (gallstones)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney or Bladder stones</VALIDVALUE>
          <VALUEMEANING>Kidney or Bladder stones</VALUEMEANING>
          <MEANINGDESCRIPTION>Kidney or Bladder stones</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624149</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arthritis</VALIDVALUE>
          <VALUEMEANING>Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of a joint or a state characterized by inflammation of joints.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2883</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malabsorption syndrome</VALIDVALUE>
          <VALUEMEANING>Malabsorption syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Malabsorption syndrome</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Irritable Bowel Syndrome</VALIDVALUE>
          <VALUEMEANING>Irritable Bowel Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Irritable Bowel Syndrome</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyps of colon, intestine, bowel</VALIDVALUE>
          <VALUEMEANING>Polyps of colon, intestine, bowel</VALUEMEANING>
          <MEANINGDESCRIPTION>Polyps of colon, intestine, bowel</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Part of intestines taken out</VALIDVALUE>
          <VALUEMEANING>Part of intestines taken out</VALUEMEANING>
          <MEANINGDESCRIPTION>Part of intestines taken out</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatitis (inflamed pancreas)</VALIDVALUE>
          <VALUEMEANING>Pancreatitis (inflamed pancreas)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pancreatitis (inflamed pancreas)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ulcerative colitis or Crohn&#39;s disease</VALIDVALUE>
          <VALUEMEANING>Ulcerative colitis or Crohn&#39;s disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Ulcerative colitis or Crohn&#39;s disease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diverticulitis</VALIDVALUE>
          <VALUEMEANING>Diverticulitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection that develops in the diverticula of the intestinal tract. Signs and symptoms include abdominal pain, fever, and leukocytosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach or duodenal ulcer</VALIDVALUE>
          <VALUEMEANING>Stomach or duodenal ulcer</VALUEMEANING>
          <MEANINGDESCRIPTION>Stomach or duodenal ulcer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peripheral Arterial Disease</VALIDVALUE>
          <VALUEMEANING>Peripheral Arterial Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Peripheral Arterial Disease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angina</VALIDVALUE>
          <VALUEMEANING>Angina</VALUEMEANING>
          <MEANINGDESCRIPTION>A heart condition marked by paroxysms of chest pain due to reduced oxygen to the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High Blood Pressure</VALIDVALUE>
          <VALUEMEANING>HIGH BLOOD PRESSURE</VALUEMEANING>
          <MEANINGDESCRIPTION>HIGH BLOOD PRESSURE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High Cholesterol (requiring medication)</VALIDVALUE>
          <VALUEMEANING>High Cholesterol (requiring medication)</VALUEMEANING>
          <MEANINGDESCRIPTION>High Cholesterol (requiring medication)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diabetes not requiring insulin</VALIDVALUE>
          <VALUEMEANING>Diabetes not requiring insulin</VALUEMEANING>
          <MEANINGDESCRIPTION>Diabetes not requiring insulin</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diabetes (requiring insulin)</VALIDVALUE>
          <VALUEMEANING>Diabetes (requiring insulin)</VALUEMEANING>
          <MEANINGDESCRIPTION>Diabetes (requiring insulin)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pre-diabetic (borderline blood sugar)</VALIDVALUE>
          <VALUEMEANING>Pre-diabetic (borderline blood sugar)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pre-diabetic (borderline blood sugar)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypoglycemia</VALIDVALUE>
          <VALUEMEANING>Hypoglycemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypoglycemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2624162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stroke</VALIDVALUE>
          <VALUEMEANING>Cerebrovascular Accident</VALUEMEANING>
          <MEANINGDESCRIPTION>A sudden, nonconvulsive loss of neurologic function due to an ischemic or hemorrhagic intracranial vascular event. In general, cerebrovascular accidents are classified by anatomic location in the brain, vascular distribution, etiology, age of the affected individual, and hemorrhagic vs. nonhemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney disease</VALIDVALUE>
          <VALUEMEANING>Kidney disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Kidney disease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2634542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver disease</VALIDVALUE>
          <VALUEMEANING>Liver disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Liver disease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2634543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammatory disease</VALIDVALUE>
          <VALUEMEANING>INFLAMMATORY DISEASE</VALUEMEANING>
          <MEANINGDESCRIPTION>INFLAMMATORY DISEASE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560997</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heart disease</VALIDVALUE>
          <VALUEMEANING>Heart disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Heart disease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2634544</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has your doctor told you that</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has your doctor told you that you currently have any of the following?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812205</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="94">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2634596</PUBLICID>
    <LONGNAME>Serological Hematology Hepatitis B Virus DNA Test Status</LONGNAME>
    <PREFERREDNAME>S_HE_HBV_DNA_TST_ST</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to serological Hepatitis B virus DNA test status.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Transplant CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2634595</PublicId>
      <PreferredName>SER_HEM_HBV_DNA_TST</PreferredName>
      <PreferredDefinition>information related to the serological hematology test, the in vitro reactions and properties of immune sera, particularly, the concept refers to the use of such reactions to measure serum titers of antibody against infectious and non-infectious agents (serologic tests), to the clinical correlations of the antibody titer, and to the use of serologic reactions to detect antigens, using DNA, molecules inside cells that carry genetic information, to determine hepatitis B virus infection, the prototype of the Hepadnavirus Family with a genome that is a partially double stranded circular DNA.</PreferredDefinition>
      <LongName>Serological Hematology Hepatitis B Virus DNA Test</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2634499</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41264:C16673</PreferredName>
        <Version>1</Version>
        <LongName>Serological Hematology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41264</PREFERRED_NAME>
            <LONG_NAME>Serological</LONG_NAME>
            <CON_ID>2634498</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16673</PREFERRED_NAME>
            <LONG_NAME>Hematology</LONG_NAME>
            <CON_ID>2202645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2634593</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14215:C449:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Hepatitis B Virus DNA Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14215</PREFERRED_NAME>
            <LONG_NAME>Hepatitis B Virus</LONG_NAME>
            <CON_ID>2205374</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C449</PREFERRED_NAME>
            <LONG_NAME>DNA</LONG_NAME>
            <CON_ID>2202485</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180457</PublicId>
      <PreferredName>SER_HEM_TST_STAT</PreferredName>
      <PreferredDefinition>information related to the status serological hematology test.</PreferredDefinition>
      <LongName>Serological Hematology Test Status</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested</VALIDVALUE>
          <VALUEMEANING>No testing done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a test was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inconclusive</VALIDVALUE>
          <VALUEMEANING>Inconclusive</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3079092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2617835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2931646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Test results of infectious disease marker for Hepatitis B - DNA:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Test results of infectious disease marker for Hepatitis B - DNA:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hepatitis B - DNA status</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Hepatitis B - DNA status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2634596</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedClinicalResult.value(ANY=&gt;CD) WHERE PerformedClinicalResult &gt; PerformedObservation &gt; DefinedObservation.nameCode = &quot;Assess Hepatitis B Virus DNA Status&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Hepatitis B DNA status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hepatitis B - DNA</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Hepatitis B - DNA</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hepatitis B - DNA</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Hepatitis B - DNA</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Hepatitis B Virus DNA (HBV DNA) result</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Char.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2000r1: Recipient Baseline Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964872</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>prep_hb_dna_tst</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedClinicalResult:value </AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>S_HE_HBV_DNA_TST_ST</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>S_HE_HBV_DNA_TST_ST</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MB_MBORRES_HBVDNA</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="95">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2651854</PUBLICID>
    <LONGNAME>Quality-of-Life Assessment Patient Difficulty Mobile Pain Scale</LONGNAME>
    <PREFERREDNAME>QOL_PT_DIF_MO_PN_SCA</PREFERREDNAME>
    <PREFERREDDEFINITION>the patient&#39;s assessment of the sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings causing difficulty in walking.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2651853</PublicId>
      <PreferredName>QOL_PT_DIF_MOB_PN</PreferredName>
      <PreferredDefinition>information related to the quality of life assessment of the sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings causing difficulty in walking.</PreferredDefinition>
      <LongName>Quality-of-Life Assessment Patient Difficulty Mobile Pain</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2424965</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15584</PreferredName>
        <Version>1</Version>
        <LongName>Quality-of-Life Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15584</PREFERRED_NAME>
            <LONG_NAME>Quality-of-Life Assessment</LONG_NAME>
            <CON_ID>2424964</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2651851</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C62189:C25295:C3303</PreferredName>
        <Version>1</Version>
        <LongName>Patient Difficulty Mobile Pain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62189</PREFERRED_NAME>
            <LONG_NAME>Difficulty</LONG_NAME>
            <CON_ID>2503546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25295</PREFERRED_NAME>
            <LONG_NAME>Mobile</LONG_NAME>
            <CON_ID>2205245</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3303</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>2202326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016847</PublicId>
      <PreferredName>FACT_QOL_SCALE</PreferredName>
      <PreferredDefinition>the scale used on FACT Quality of Life questionnaires to assess patient responses.</PreferredDefinition>
      <LongName>FACT Quality of Life Scale</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Always</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all bothered</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little bit</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat bothered</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2927955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately</VALIDVALUE>
          <VALUEMEANING>Moderately</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely</VALIDVALUE>
          <VALUEMEANING>EXTREMELY</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slightly</VALIDVALUE>
          <VALUEMEANING>Slightly</VALUEMEANING>
          <MEANINGDESCRIPTION>Slightly</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not bothered at all</VALIDVALUE>
          <VALUEMEANING>Not bothered at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not bothered at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered somewhat</VALIDVALUE>
          <VALUEMEANING>Bothered somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered somewhat</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little</VALIDVALUE>
          <VALUEMEANING>Bothered a little</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered a little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little difficult</VALIDVALUE>
          <VALUEMEANING>A little difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>A little difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not difficult at all</VALIDVALUE>
          <VALUEMEANING>Not difficult at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not difficult at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted totally</VALIDVALUE>
          <VALUEMEANING>Disrupted totally</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was totally disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted quite a bit</VALIDVALUE>
          <VALUEMEANING>Disrupted quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted somewhat</VALIDVALUE>
          <VALUEMEANING>Disrupted somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted a little</VALIDVALUE>
          <VALUEMEANING>Disrupted a little</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was a little disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not disrupted at all</VALIDVALUE>
          <VALUEMEANING>Not disrupted at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not at all disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to do</VALIDVALUE>
          <VALUEMEANING>UNABLE To Do</VALUEMEANING>
          <MEANINGDESCRIPTION>UNABLE To Do (Health Activity Questionnaire)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very difficult</VALIDVALUE>
          <VALUEMEANING>Very difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Very difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat difficult</VALIDVALUE>
          <VALUEMEANING>Somewhat difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No pain</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had no pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I have trouble walking becaus</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I have trouble walking because of pain</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="96">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2652733</PUBLICID>
    <LONGNAME>Progesterone Receptor Percentage Intensity Stain Range Description Text</LONGNAME>
    <PREFERREDNAME>PGR_R_PE_IN_S_R_D_TX</PREFERREDNAME>
    <PREFERREDDEFINITION>a free text field to specify information related to range of description or status of progesterone receptors, specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone, based on percentage and intensity of stained cells.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2653010</PublicId>
      <PreferredName>PGR_PER_INT_ST_R_DES</PreferredName>
      <PreferredDefinition>information related to range of description or status of progesterone receptors, specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone, based on percentage and intensity of stained cells.</PreferredDefinition>
      <LongName>Progesterone Receptor Percentage Intensity Stain Range Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2542381</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17075</PreferredName>
        <Version>1</Version>
        <LongName>Progesterone Receptor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17075</PREFERRED_NAME>
            <LONG_NAME>Progesterone Receptor</LONG_NAME>
            <CON_ID>2202348</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2653002</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25539:C0038128:C38013:</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Intensity Stain Range Description </LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25539</PREFERRED_NAME>
            <LONG_NAME>Intensity</LONG_NAME>
            <CON_ID>2202454</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0038128</PREFERRED_NAME>
            <LONG_NAME>Stain</LONG_NAME>
            <CON_ID>2203087</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38013</PREFERRED_NAME>
            <LONG_NAME>Range</LONG_NAME>
            <CON_ID>2204649</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018321</PublicId>
      <PreferredName>ASSESS_TXT</PreferredName>
      <PreferredDefinition>a free text field to specify information on the evaluations of the patient and the patient&#39;s disease</PreferredDefinition>
      <LongName>Assessment Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184342</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Text</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Range</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Range</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PGR_R_PE_IN_S_R_D_TX</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="97">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2656136</PUBLICID>
    <LONGNAME>Image Computed Tomography (CT) Pitch Factor 8 Byte Number</LONGNAME>
    <PREFERREDNAME>2639984v1.0:2556190v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Ratio of the Table Feed per Rotation (0018,9310) to the Total Collimation Width (0018,9307).  See C.8.15.3.4.1 for further explanation and some examples. Required if Frame Type (0008,9007) Value 1 of this frame is ORIGINAL and Acquisition Type (0018,9302) is SPIRAL.  May be present otherwise if Frame Type (0008,9007) Value 1 of this frame is DERIVED and Acquisition Type (0018,9302) is SPIRAL.   [Standard-based]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DICOM:Digital Imaging and Communications in Medicine</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2639984</PublicId>
      <PreferredName>2423453v1.0:2553690v1.0</PreferredName>
      <PreferredDefinition>Any record of an imaging event whether physical or electronic._A piece of furniture having a smooth flat top that is usually supported by one or more vertical legs or any object of a similar appearance._A scalar measure of the rate of movement of the object expressed either as the distance travelled divided by the time taken (average speed) or the rate of change of position with respect to time at a particular point (instantaneous speed)._A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis._The degree of deviation from a horizontal plane._Factor; anything that contributes causally to a result.</PreferredDefinition>
      <LongName>Image Computed Tomography (CT) Pitch Factor</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2423453</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48179</PreferredName>
        <Version>1</Version>
        <LongName>Image</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2553690</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17204:C48442:C25506</PreferredName>
        <Version>1</Version>
        <LongName>Computed Tomography Pitch Factor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17204</PREFERRED_NAME>
            <LONG_NAME>Computed Tomography</LONG_NAME>
            <CON_ID>2202436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48442</PREFERRED_NAME>
            <LONG_NAME>Pitch</LONG_NAME>
            <CON_ID>2414550</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25506</PREFERRED_NAME>
            <LONG_NAME>Factor</LONG_NAME>
            <CON_ID>2202640</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2556190</PublicId>
      <PreferredName>8_BYTE_NUM</PreferredName>
      <PreferredDefinition>FD:Double precision binary floating point number prepresented in IEEE 754:1985 64-bit Floating Point Number Format. [Standard-based]</PreferredDefinition>
      <LongName>8 Byte Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
      <Representation>
        <PublicId>2556189</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL124470:C48047:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Eight Byte Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL124470</PREFERRED_NAME>
            <LONG_NAME>Eight</LONG_NAME>
            <CON_ID>2208236</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48047</PREFERRED_NAME>
            <LONG_NAME>Byte</LONG_NAME>
            <CON_ID>2556188</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CT Pitch Factor</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CT Pitch Factor</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>2007 DICOM Standard</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>2007 DICOM Standard - Sections 3, 5 &amp; 6</DocumentText>
        <URL>http://medical.nema.org/dicom/2007/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-ImageAcq-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Pitch ([mm/rotation]/beam collimation)  --  I/NT</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Johns Hopkins</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2964473</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>JH FLT Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2983392</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DICOM Tag CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812790</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review - NCIA DICOM CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812828</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2693115</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA_Model</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Silver Review Modified CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2838921</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2693115</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA_Model</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ncia.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000239</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2944977</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NBIA</PreferredName>
          <Version>5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ncia.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000240</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506115</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Image Acquisition-Recon</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>(0018,9311)</AlternateName>
        <AlternateNameType>DICOM_TAG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CT Pitch Factor</AlternateName>
        <AlternateNameType>DICOM Attribute Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ncia.domain.Image.ctPitchFactor</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Image:ctPitchFactor</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>IMAG_CT_PTCH_NUM</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>MCL</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="98">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2669789</PUBLICID>
    <LONGNAME>Laboratory Procedure Bone Marrow Prolymphocyte Result Percentage Value</LONGNAME>
    <PREFERREDNAME>LAB_BM_PY_RS_PTG_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>the percentage value related to a bone marrow promyelocyte (a medium-sized round lymphocyte of B or T-cell lineage that is an intermediate cell between the lymphoblast and the small, mature lymphocyte) hematology laboratory procedure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2669276</PublicId>
      <PreferredName>LAB_PROLYMP_BM_RSLT</PreferredName>
      <PreferredDefinition>information relating to the result of the medical procedure that involves testing a sample of bone marrow for promyelocytes, a medium-sized round lymphocyte of B or T-cell lineage that is an intermediate cell between the lymphoblast and the small, mature lymphocyte.</PreferredDefinition>
      <LongName>Laboratory Procedure Bone Marrow Prolymphocyte Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738842</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12431:C13119:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Bone Marrow Prolymphocyte Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12431</PREFERRED_NAME>
            <LONG_NAME>Bone Marrow</LONG_NAME>
            <CON_ID>2202685</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13119</PREFERRED_NAME>
            <LONG_NAME>Prolymphocyte</LONG_NAME>
            <CON_ID>2206354</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019101</PublicId>
      <PreferredName>HMT_LAB_PTG_VAL</PreferredName>
      <PreferredDefinition>a percentage for a hematologic laboratory value.</PreferredDefinition>
      <LongName>Blood Specimen Lab Percentage Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Marrow prolymphocytes</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Marrow prolymphocytes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Lab Procedure Bone Marrow Prolymphocyte Result Percent Value</AlternateName>
        <AlternateNameType>TCGA_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lab_procedure_bone_marrow_prolymphocyte_result_percent_value</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="99">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2672030</PUBLICID>
    <LONGNAME>Protein Group Identifier java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2671737v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.:Any number of entities (members) considered as a unit._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2671737</PublicId>
      <PreferredName>2671638v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.:Any number of entities (members) considered as a unit._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Protein Group Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2671638</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17021:C43359</PreferredName>
        <Version>1</Version>
        <LongName>Protein Group</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17021</PREFERRED_NAME>
            <LONG_NAME>Protein</LONG_NAME>
            <CON_ID>2202792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43359</PREFERRED_NAME>
            <LONG_NAME>Group</LONG_NAME>
            <CON_ID>2236516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Protein Group Identifier java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Protein Group Identifier java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2640373</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LabKey CPAS Client API</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.labkey.cpas.client</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.labkey.cpas.client.ProteinGroups.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProteinGroups:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="100">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2672068</PUBLICID>
    <LONGNAME>Tandem Mass Spectrometry Run Spectrum Count java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2671777v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Mass spectrometers coupled in series.  The targeted compound is selectively ionized, and its characteristic ions are separated from others in the mixture in the first mass spectrometer. The selected primary ions are then decomposed by collision, and from the resulting products the final mass analyzer selects secondary ions characteristic of the targeted compound. Tandem mass spectrometry can achieve specificities and sensitivities equivalent of those of methods such as radioimmunoassay and gas chromatography/mass spectrometry, while performing analyses in much shorter times. (McLafferty, 1981.  Science 214:280-7):The act of testing or performing something._A charted band of wavelengths of electromagnetic vibrations.:To determine the number or amount of something; the result of this activity._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2671777</PublicId>
      <PreferredName>2671643v1.0:2671624v1.0</PreferredName>
      <PreferredDefinition>Mass spectrometers coupled in series.  The targeted compound is selectively ionized, and its characteristic ions are separated from others in the mixture in the first mass spectrometer. The selected primary ions are then decomposed by collision, and from the resulting products the final mass analyzer selects secondary ions characteristic of the targeted compound. Tandem mass spectrometry can achieve specificities and sensitivities equivalent of those of methods such as radioimmunoassay and gas chromatography/mass spectrometry, while performing analyses in much shorter times. (McLafferty, 1981.  Science 214:280-7):The act of testing or performing something._A charted band of wavelengths of electromagnetic vibrations.:To determine the number or amount of something; the result of this activity.</PreferredDefinition>
      <LongName>Tandem Mass Spectrometry Run Spectrum Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2671643</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18142:C47911</PreferredName>
        <Version>1</Version>
        <LongName>Tandem Mass Spectrometry Run</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18142</PREFERRED_NAME>
            <LONG_NAME>Tandem Mass Spectrometry</LONG_NAME>
            <CON_ID>2671518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47911</PREFERRED_NAME>
            <LONG_NAME>Run</LONG_NAME>
            <CON_ID>2422617</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2671624</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63808:C25463</PreferredName>
        <Version>1</Version>
        <LongName>Spectrum Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63808</PREFERRED_NAME>
            <LONG_NAME>Electromagnetic Spectrum</LONG_NAME>
            <CON_ID>2615668</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Tandem Mass Spectrometry Run Spectrum Count java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Tandem Mass Spectrometry Run Spectrum Count java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2640373</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LabKey CPAS Client API</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.labkey.cpas.client</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.labkey.cpas.client.MS2Runs.spectrumCount</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MS2Runs:spectrumCount</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="101">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2672261</PUBLICID>
    <LONGNAME>Sequest Scoring Engine Score Group Decimal Ratio java.lang.Float</LONGNAME>
    <PREFERREDNAME>2671902v1.0:2178535v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A proprietary scoring engine from Thermo Fisher Scientific that can match tandem mass spectra with peptide sequences.:A number or range of numeric values measuring performance, function, quality, or ability.:Any number of entities (members) considered as a unit._A ratio expressed in base 10 notation._Generic value domain for a primitive java datatype that is Single-precision floating point number (32-bit IEEE 754).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2671902</PublicId>
      <PreferredName>2671641v1.0:2671551v1.0</PreferredName>
      <PreferredDefinition>A proprietary scoring engine from Thermo Fisher Scientific that can match tandem mass spectra with peptide sequences.:A number or range of numeric values measuring performance, function, quality, or ability.:Any number of entities (members) considered as a unit._A ratio expressed in base 10 notation.</PreferredDefinition>
      <LongName>Sequest Scoring Engine Score Group Decimal Ratio</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2671641</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68825:C25338:C43359</PreferredName>
        <Version>1</Version>
        <LongName>Sequest Scoring Engine Score Group</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68825</PREFERRED_NAME>
            <LONG_NAME>Sequest Scoring Engine</LONG_NAME>
            <CON_ID>2671519</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43359</PREFERRED_NAME>
            <LONG_NAME>Group</LONG_NAME>
            <CON_ID>2236516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2671551</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C67272</PreferredName>
        <Version>1</Version>
        <LongName>Decimal Ratio</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67272</PREFERRED_NAME>
            <LONG_NAME>Decimal Ratio</LONG_NAME>
            <CON_ID>2671507</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178535</PublicId>
      <PreferredName>java.lang.Float</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is Single-precision floating point number (32-bit IEEE 754).</PreferredDefinition>
      <LongName>java.lang.Float</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Float</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Sequest Scoring Engine Score Group Decimal Ratio java.lang.Float does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Sequest Scoring Engine Score Group Decimal Ratio java.lang.Float does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2640373</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LabKey CPAS Client API</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.labkey.cpas.client</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.labkey.cpas.client.SequestScores.decimalRatio</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SequestScores:decimalRatio</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="102">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2672276</PUBLICID>
    <LONGNAME>Sequest Scoring Engine Score Group Light Last Scan Identifier java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2671917v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A proprietary scoring engine from Thermo Fisher Scientific that can match tandem mass spectra with peptide sequences.:A number or range of numeric values measuring performance, function, quality, or ability.:Any number of entities (members) considered as a unit._Of comparatively little physical weight or density.:Coming after all others in time or space or degree or being the only one remaining.:The data or image obtained by gathering information with a sensing device.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2671917</PublicId>
      <PreferredName>2671641v1.0:2671566v1.0</PreferredName>
      <PreferredDefinition>A proprietary scoring engine from Thermo Fisher Scientific that can match tandem mass spectra with peptide sequences.:A number or range of numeric values measuring performance, function, quality, or ability.:Any number of entities (members) considered as a unit._Of comparatively little physical weight or density.:Coming after all others in time or space or degree or being the only one remaining.:The data or image obtained by gathering information with a sensing device.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Sequest Scoring Engine Score Group Light Last Scan Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2671641</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68825:C25338:C43359</PreferredName>
        <Version>1</Version>
        <LongName>Sequest Scoring Engine Score Group</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68825</PREFERRED_NAME>
            <LONG_NAME>Sequest Scoring Engine</LONG_NAME>
            <CON_ID>2671519</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43359</PREFERRED_NAME>
            <LONG_NAME>Group</LONG_NAME>
            <CON_ID>2236516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2671566</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68808:C25551:C17999:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Light Last Scan Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68808</PREFERRED_NAME>
            <LONG_NAME>Light</LONG_NAME>
            <CON_ID>2671510</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25551</PREFERRED_NAME>
            <LONG_NAME>Last</LONG_NAME>
            <CON_ID>2206286</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17999</PREFERRED_NAME>
            <LONG_NAME>Scan</LONG_NAME>
            <CON_ID>2202631</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Sequest Scoring Engine Score Group Light Last Scan Identifier java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Sequest Scoring Engine Score Group Light Last Scan Identifier java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2640373</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LabKey CPAS Client API</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.labkey.cpas.client</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.labkey.cpas.client.SequestScores.lightLastScan</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SequestScores:lightLastScan</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="103">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2674076</PUBLICID>
    <LONGNAME>Person Education Level Type</LONGNAME>
    <PREFERREDNAME>PERSON_EDUC_LVL_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>A subdivision of the demographic parameter indicating the grade or highest level of education attained by a human being.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCISTD: NCI CRF Harmonization and Standards Initiative</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2651173</PublicId>
      <PreferredName>PERSON_EDUC_LVL</PreferredName>
      <PreferredDefinition>A demographic parameter indicating the number of years of schooling or the highest level of achievement at school by a human being.</PreferredDefinition>
      <LongName>Person Education Level</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2653845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17953</PreferredName>
        <Version>1</Version>
        <LongName>Education Level</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17953</PREFERRED_NAME>
            <LONG_NAME>Education Level</LONG_NAME>
            <CON_ID>2202380</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2674065</PublicId>
      <PreferredName>EDUC_LVL_TP</PreferredName>
      <PreferredDefinition>A subdivision of the demographic parameter indicating the highest level of education attained by a human being.  [Manually-curated]</PreferredDefinition>
      <LongName>Education Level Type</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2435358</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17953:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Education Level Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17953</PREFERRED_NAME>
            <LONG_NAME>Education Level</LONG_NAME>
            <CON_ID>2202380</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1st Grade</VALIDVALUE>
          <VALUEMEANING>1st Grade</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 1st grade is the highest level of educational achievement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67123</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Master&#39;s Degree</VALIDVALUE>
          <VALUEMEANING>Master&#39;s Degree Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has received a degree for completion of at least one year of prescribed study beyond the bachelor&#39;s degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70556</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2nd Grade</VALIDVALUE>
          <VALUEMEANING>2nd Grade</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 2nd grade is the highest level of educational achievement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67124</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3rd Grade</VALIDVALUE>
          <VALUEMEANING>3rd Grade</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 3rd grade is the highest level of educational achievement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67125</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4th Grade</VALIDVALUE>
          <VALUEMEANING>4th Grade</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 4th grade is the highest level of educational achievement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67126</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5th Grade</VALIDVALUE>
          <VALUEMEANING>5th Grade</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 5th grade is the highest level of educational achievement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67127</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6th Grade</VALIDVALUE>
          <VALUEMEANING>6th Grade</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 6th grade is the highest level of educational achievement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67128</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7th Grade</VALIDVALUE>
          <VALUEMEANING>7th Grade</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 7th grade is the highest level of educational achievement</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8th Grade</VALIDVALUE>
          <VALUEMEANING>8th Grade</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 8th grade is the highest level of educational achievement</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9th Grade</VALIDVALUE>
          <VALUEMEANING>9th Grade</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 9th grade is the highest level of educational achievement</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10th Grade</VALIDVALUE>
          <VALUEMEANING>10th Grade</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 10th grade is the highest level of educational achievement</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11th Grade</VALIDVALUE>
          <VALUEMEANING>11th Grade</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 11th grade is the highest level of educational achievement</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67133</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12th Grade No Diploma</VALIDVALUE>
          <VALUEMEANING>12th Grade</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person was in school through 12th grade but that they did not receive a high school diploma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67134</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High School Graduate</VALIDVALUE>
          <VALUEMEANING>High School Graduate</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has attended high school and has received a high school diploma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67136</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2681432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>General Equivalency Diploma</VALIDVALUE>
          <VALUEMEANING>General Equivalency Diploma</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has received a General Equivalency Diploma in lieu of a high school diploma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67135</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bachelor Degree</VALIDVALUE>
          <VALUEMEANING>Bachelor&#39;s Degree Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has received a degree for successful completion of a program of studies that normally requires at least 4-5 years of full-time equivalent college-level work.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Formal Schooling</VALIDVALUE>
          <VALUEMEANING>Never Attended</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person never attended school or only attended kindergarten.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654050</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Refused</VALIDVALUE>
          <VALUEMEANING>Refused</VALUEMEANING>
          <MEANINGDESCRIPTION>To decline to do, accept, give, or allow something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some College, No Degree</VALIDVALUE>
          <VALUEMEANING>Some College</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has attended college but that they did not receive any degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Don&#39;t Know</VALIDVALUE>
          <VALUEMEANING>Don&#39;t Know/Refused</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Associate Degree</VALIDVALUE>
          <VALUEMEANING>Associate Academic Degree Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has received a degree from a 2 year college program.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Academic Doctorate Degree</VALIDVALUE>
          <VALUEMEANING>Academic Doctorate Degree Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has received a degree the highest award earned for graduate study.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Professional Doctorate Degree</VALIDVALUE>
          <VALUEMEANING>Professional Doctorate Degree Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has received a degree allowing them to practice a profession, such as law, medicine, music, or ministry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VoTech Program</VALIDVALUE>
          <VALUEMEANING>Vocational Degree</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has received a degree from a occupational, technical, or vocational program.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kindergarten</VALIDVALUE>
          <VALUEMEANING>Kindergarten Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that kindergarten is the highest level of education achievement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Preschool</VALIDVALUE>
          <VALUEMEANING>Preschool Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that preschool is the highest level of education achievement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Education Level</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Education Level</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Highest Education Level</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Highest Education Level</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>U of Michigan Health Survey Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the last grade or level of school you have completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NIDA CTN PhenX Education for SAATier1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the highest grade or level of school you have completed or the highest degree you have received</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NIDA CTN Demographics</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the highest grade or level of school the participant has completed or the highest degree they have received</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Education (highest level of schooling you completed)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Education (highest level of schooling you completed)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If your child has another caregiver/parent (specify relationship: _____), what is the highest level of education he/she received?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the highest level of education you received?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812358</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Education Level</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Demography CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859967</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2552643</PublicId>
          <ContextName>Training</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Training Class Examples</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3637837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Demographics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3070841</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Core: Tier 1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3688551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Substance Abuse and Addiction Core Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3689959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mental Health Core Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4550917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Core: Tier 1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4550918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Health Survey </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259220</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Demographics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000061</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3952293</PublicId>
          <ContextName>NIDA</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDA CTN Usage</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Research</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3952294</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3952293</PublicId>
          <ContextName>NIDA</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDA CTN Usage</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Electronic Health Record</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3952296</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4826811</PublicId>
          <ContextName>iCaRe2</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Core</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Demographic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4826813</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Demography</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5635308</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675695</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDE by Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Education Level</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000258</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIDA</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NIDA</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>iCaRe2</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>iCaRe2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="104">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2678479</PUBLICID>
    <LONGNAME>Microsatellite Instability Experiment Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2678242v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Genomic instability associated with defective DNA mismatch repair in tumors._A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2678242</PublicId>
      <PreferredName>2678103v1.0:2677953v1.0</PreferredName>
      <PreferredDefinition>Genomic instability associated with defective DNA mismatch repair in tumors._A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Microsatellite Instability Experiment Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2678103</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C36318</PreferredName>
        <Version>1</Version>
        <LongName>Microsatellite Instability</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C36318</PREFERRED_NAME>
            <LONG_NAME>Microsatellite Instability</LONG_NAME>
            <CON_ID>2203608</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2677953</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42790:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Experiment Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42790</PREFERRED_NAME>
            <LONG_NAME>Experiment</LONG_NAME>
            <CON_ID>2223979</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Microsatellite Instability Experiment Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Microsatellite Instability Experiment Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2677906</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CoCaNUT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.princeton.cocanut.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.princeton.cocanut.domain.Msi.experimentDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Msi:experimentDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="105">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2678575</PUBLICID>
    <LONGNAME>Ribonucleic Acid Microarray Analysis Outcome Probe Set Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2678332v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A nucleic acid molecule similar to DNA but containing ribose rather than deoxyribose. RNA is formed upon a DNA template. There are several classes of RNA molecules. They play crucial roles in protein synthesis and other cell activities. (MedicineNet.com):Analysis using microarray technology (e.g., cDNA arrays to see gene expression or protein microarrays to profile the pattern of proteins).:A phenomenon that follows and is caused by some previous phenomenon._General term for a piece of DNA or RNA corresponding to a gene or sequence of interest, that has been labelled either radioactively or with some other detectable molecule, such as biotin, digoxygenin or fluorescein. As stretches of DNA or RNA with complementary sequences will (hybridize), a probe will label viral plaques, bacterial colonies or bands on a gel that contain the gene of interest.:A group of things of the same kind that belong together and are so used.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2678332</PublicId>
      <PreferredName>2678112v1.0:2678030v1.0</PreferredName>
      <PreferredDefinition>A nucleic acid molecule similar to DNA but containing ribose rather than deoxyribose. RNA is formed upon a DNA template. There are several classes of RNA molecules. They play crucial roles in protein synthesis and other cell activities. (MedicineNet.com):Analysis using microarray technology (e.g., cDNA arrays to see gene expression or protein microarrays to profile the pattern of proteins).:A phenomenon that follows and is caused by some previous phenomenon._General term for a piece of DNA or RNA corresponding to a gene or sequence of interest, that has been labelled either radioactively or with some other detectable molecule, such as biotin, digoxygenin or fluorescein. As stretches of DNA or RNA with complementary sequences will (hybridize), a probe will label viral plaques, bacterial colonies or bands on a gel that contain the gene of interest.:A group of things of the same kind that belong together and are so used.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Ribonucleic Acid Microarray Analysis Outcome Probe Set Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2678112</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C812:C18477:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Ribonucleic Acid Microarray Analysis Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C812</PREFERRED_NAME>
            <LONG_NAME>Ribonucleic Acid</LONG_NAME>
            <CON_ID>2222294</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18477</PREFERRED_NAME>
            <LONG_NAME>Microarray Analysis</LONG_NAME>
            <CON_ID>2557754</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2678030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43523:C47894:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Probe Set Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43523</PREFERRED_NAME>
            <LONG_NAME>Probe</LONG_NAME>
            <CON_ID>2433326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47894</PREFERRED_NAME>
            <LONG_NAME>Set</LONG_NAME>
            <CON_ID>2425537</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Ribonucleic Acid Microarray Analysis Outcome Probe Set Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Ribonucleic Acid Microarray Analysis Outcome Probe Set Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2677906</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CoCaNUT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.princeton.cocanut.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.princeton.cocanut.domain.RnaResult.probesetId</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RnaResult:probesetId</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="106">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2678596</PUBLICID>
    <LONGNAME>Primary Disease or Disorder Presentation N Stage java.lang.String</LONGNAME>
    <PREFERREDNAME>2678353v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Occurring first in time or sequence; original; of greatest rank or importance or value.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. Sometimes the term is used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:To show or display; the act of presenting something to sight or view: how something looks._One criteria of the TNM staging system.  N refers to the extent of lymph node involvement._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2678353</PublicId>
      <PreferredName>2678116v1.0:2678076v1.0</PreferredName>
      <PreferredDefinition>Occurring first in time or sequence; original; of greatest rank or importance or value.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. Sometimes the term is used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:To show or display; the act of presenting something to sight or view: how something looks._One criteria of the TNM staging system.  N refers to the extent of lymph node involvement.</PreferredDefinition>
      <LongName>Primary Disease or Disorder Presentation N Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2678116</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25251:C2991:C61388</PreferredName>
        <Version>1</Version>
        <LongName>Primary Disease or Disorder Presentation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61388</PREFERRED_NAME>
            <LONG_NAME>Presentation</LONG_NAME>
            <CON_ID>2584121</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2678076</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25580</PreferredName>
        <Version>1</Version>
        <LongName>N Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25580</PREFERRED_NAME>
            <LONG_NAME>N Category</LONG_NAME>
            <CON_ID>2204625</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Primary Disease or Disorder Presentation N Stage java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Primary Disease or Disorder Presentation N Stage java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2677906</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CoCaNUT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.princeton.cocanut.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.princeton.cocanut.domain.PrimaryDiseasePresentation.lymphNodeDiagnosis</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PrimaryDiseasePresentation:lymphNodeDiagnosis</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="107">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2681107</PUBLICID>
    <LONGNAME>Body Fluid or Substance Specimen Review Event Parameter Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2680998v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Liquid and semi liquid substances produced by living organisms to fulfill specific functions or excreted as waste; does not include hormones or enzymes.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodil:The act of appraisal, evaluation, or analysis.:Something that happens at a given place and time.:Any factor that defines a system and determines (or limits) its performance._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2680998</PublicId>
      <PreferredName>2680971v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Liquid and semi liquid substances produced by living organisms to fulfill specific functions or excreted as waste; does not include hormones or enzymes.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodil:The act of appraisal, evaluation, or analysis.:Something that happens at a given place and time.:Any factor that defines a system and determines (or limits) its performance._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Body Fluid or Substance Specimen Review Event Parameter Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2680971</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>2680971v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Body Fluid or Substance Specimen Review Event Parameter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13236</PREFERRED_NAME>
            <LONG_NAME>Body Fluid or Substance</LONG_NAME>
            <CON_ID>2673205</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42729</PREFERRED_NAME>
            <LONG_NAME>Review</LONG_NAME>
            <CON_ID>2202331</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44175</PREFERRED_NAME>
            <LONG_NAME>Parameter</LONG_NAME>
            <CON_ID>2236569</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Body Fluid or Substance Specimen Review Event Parameter Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Body Fluid or Substance Specimen Review Event Parameter Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2680967</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000633</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000638</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000639</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.FluidSpecimenReviewEventParameters.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FluidSpecimenReviewEventParameters:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="108">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2684905</PUBLICID>
    <LONGNAME>Person Intravenous Drug Abuse Personal Medical History Ind-2</LONGNAME>
    <PREFERREDNAME>PERS_IV_D_A_PMH_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether their is a history of intravenous drug abuse.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2684907</PublicId>
      <PreferredName>PERS_IV_D_U_PMH</PreferredName>
      <PreferredDefinition>information related to the personal medical history (the reporting of medical events) of intravenous (within a blood vessel) drug abuse (the use of a drug for a reason other than which it was intended or in a manner or in quantities other than directed) in a person.</PreferredDefinition>
      <LongName>Person Intravenous Drug Abuse Personal Medical History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2684904</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13346:C16522:C18772</PreferredName>
        <Version>1</Version>
        <LongName>Intravenous Drug Abuse Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13346</PREFERRED_NAME>
            <LONG_NAME>Intravenous</LONG_NAME>
            <CON_ID>2450528</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16522</PREFERRED_NAME>
            <LONG_NAME>Drug Abuse</LONG_NAME>
            <CON_ID>2684903</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>History of intravenous drug u</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>History of intravenous drug use</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="109">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2689806</PUBLICID>
    <LONGNAME>Stage Prognostic Factor Health Comorbidity Complication Three Factor Code</LONGNAME>
    <PREFERREDNAME>2689802v1.0:2647700v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Records the patient&#39;s pre-existing medical conditions, factors influencing health status, and/or complications during the patient&#39;s hospital stay for the treatment of this cancer using ICD-9-CM codes.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2689802</PublicId>
      <PreferredName>2688190v1.0:2689800v1.0</PreferredName>
      <PreferredDefinition>The patient&#39;s pre-existing medical conditions, factors influencing health status, and/or complications during the patient&#39;s hospital stay for the treatment of this cancer using ICD-9-CM codes.</PreferredDefinition>
      <LongName>Stage Prognostic Factor Health Comorbidity Complication Three Factor</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20047</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic or Prognostic Factor</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2688190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16899:C18959</PreferredName>
        <Version>1</Version>
        <LongName>Stage Prognostic Factor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18959</PREFERRED_NAME>
            <LONG_NAME>Prognostic Factor</LONG_NAME>
            <CON_ID>2512696</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2689800</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25178:C16457:C2959:C66834:C25</PreferredName>
        <Version>1</Version>
        <LongName>Health Comorbidity Complication Three Factor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25178</PREFERRED_NAME>
            <LONG_NAME>Health</LONG_NAME>
            <CON_ID>2202325</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16457</PREFERRED_NAME>
            <LONG_NAME>Comorbidity</LONG_NAME>
            <CON_ID>2589987</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2959</PREFERRED_NAME>
            <LONG_NAME>Complication</LONG_NAME>
            <CON_ID>2203884</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66834</PREFERRED_NAME>
            <LONG_NAME>Three</LONG_NAME>
            <CON_ID>2635616</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25506</PREFERRED_NAME>
            <LONG_NAME>Factor</LONG_NAME>
            <CON_ID>2202640</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2647700</PublicId>
      <PreferredName>2647700v1.0</PreferredName>
      <PreferredDefinition>ICD-9-CM codes used for recording the patient&#39;s pr-existing medical conditions, factors influencing health status, and/or complications during the hospital stay for the treatment of cancer.  All are considered secondary diagnoses. [Explanatory Comment: Refer to FORDS for additional instructions.  If no secondary diagnoses are documented, enter Comorbid/Complication 1 as 00000 meaning &#39;No secondary diagnosis documented.&#39;  Leave subsequent Comorbid/Complication 2 to 10 blank.]</PreferredDefinition>
      <LongName>Health Factor Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>5</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
      <Representation>
        <PublicId>2647699</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25178:C25506:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Health Factor Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25178</PREFERRED_NAME>
            <LONG_NAME>Health</LONG_NAME>
            <CON_ID>2202325</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25506</PREFERRED_NAME>
            <LONG_NAME>Factor</LONG_NAME>
            <CON_ID>2202640</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR, V 11.1 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.1 Data Standards and Data Dictionary (5/4/06)</DocumentText>
        <URL>http://www.naaccr.org/filesystem/pdf/Volume%20II%20Version%2011.1.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Comorbid/Complication 3</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Comorbid/Complication 3</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Comorbid/Complication 3 Description</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>All are considered secondary diagnoses.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FORDS Manual, Revised 2009</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>See FORDS Manual for specifications of codes and data entry rules.</DocumentText>
        <URL>http://www.facs.org/cancer/coc/fords/2009/fords2009.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ICD-9-CM Valid Values</Name>
        <DocumentType>VALID_VALUE_SOURCE</DocumentType>
        <DocumentText>The following ICD-9-CM Codes may be used: Codes 00100-13980, 24000-99990, E8700-E8799, E9300-E9499, V0720-V0739, V1000-V1590, V2220- V2310, V2540, V4400-V4589, and V5041-V5049. If no secondary diagnoses are documented, enter Comorbid/Complication 1 as 00000 meaning &#39;No secondary diagnosis documented.&#39; Leave subsequent Comorbid/Complication 2 to 10 blank. Refer to FORDS for additional instructions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>(ICD-9-CM) International Classification of Diseases,Ninth Revision, Clinical Modification</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) is based on the World Health Organization&#39;s Ninth Revision, International Classification of Diseases (ICD-9). ICD-9-CM is the official system of assigning codes to diagnoses and procedures associated with hospital utilization in the United States. The ICD-9 is use to code and classify mortality data from death certificates.</DocumentText>
        <URL>http://www.cdc.gov/nchs/icd/icd9cm.htm</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.2 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.2 Data Standards and Data Dictionary (5/30/2007)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=PQdlAnykU1U%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.3 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.3 Data Standards and Data Dictionary (4/2008)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=xSH32ZzIzGI%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 12.1, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&amp;tabid=133&amp;mid=473</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 16, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)</DocumentText>
        <URL>https://www.naaccr.org/data-standards-data-dictionary/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 12.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3134707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899833</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>StageProgFactors16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899845</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464305</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>StageProgFactors18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464319</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3130</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COMORBID/COMPLICATION 3</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Comorbidities and Complications #3</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Secondary Diagnosis</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Comorbid/Complication 3</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="110">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2689912</PUBLICID>
    <LONGNAME>Biochemical Pathway Curator java.lang.String</LONGNAME>
    <PREFERREDNAME>2689860v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An elaboration of the sequence of chemical reactions leading from one compound to another taking place in living tissue._The person in charge of the care and superintendence of something, especially a collection._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2689860</PublicId>
      <PreferredName>2223321v1.0:2689832v1.0</PreferredName>
      <PreferredDefinition>An elaboration of the sequence of chemical reactions leading from one compound to another taking place in living tissue._The person in charge of the care and superintendence of something, especially a collection.</PreferredDefinition>
      <LongName>Biochemical Pathway Curator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223321</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20633</PreferredName>
        <Version>1</Version>
        <LongName>Biochemical Pathway</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20633</PREFERRED_NAME>
            <LONG_NAME>Biochemical Pathway</LONG_NAME>
            <CON_ID>2211227</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2689832</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C69141</PreferredName>
        <Version>1</Version>
        <LongName>Curator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C69141</PREFERRED_NAME>
            <LONG_NAME>Curator</LONG_NAME>
            <CON_ID>2689829</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Biochemical Pathway Curator java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Biochemical Pathway Curator java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2689825</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PathwayInteractionDatabase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PID</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812660</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000543</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000544</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Pathway:curator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PID.Pathway.curator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabio.domain.Pathway.curator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>@curator</AlternateName>
        <AlternateNameType>GME_XMLLocReference</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="111">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2693488</PUBLICID>
    <LONGNAME>Hematopoietic Stem Cell Transplantation Recipient Identifier Assignment Organizational Unit Specify</LONGNAME>
    <PREFERREDNAME>HSCT_ID_ASGN_ORG_SP</PREFERREDNAME>
    <PREFERREDDEFINITION>The free-text field to describe the organization that assigned the hematopoietic cell transplantation recipient identifier.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2693471</PublicId>
      <PreferredName>HSCT_ID_ASGN_ORG</PreferredName>
      <PreferredDefinition>Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The grafting of tissues from one individual to another or place to place within a single individual._A person who gets something._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._An allotting or an appointment to a particular person or use, or for a particular time or object._Organizational unit like a laboratory, institute or consortium.</PreferredDefinition>
      <LongName>Hematopoietic Stem Cell Transplantation Recipient Identifier Assignment Organizational Unit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2693468</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12551:C15342:C53268:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Hematopoietic Stem Cell Transplantation Recipient Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53268</PREFERRED_NAME>
            <LONG_NAME>Recipient</LONG_NAME>
            <CON_ID>2512693</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2693469</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25426:C41167</PreferredName>
        <Version>1</Version>
        <LongName>Assignment Organizational Unit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25426</PREFERRED_NAME>
            <LONG_NAME>Assignment</LONG_NAME>
            <CON_ID>2204040</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41167</PREFERRED_NAME>
            <LONG_NAME>Organizational Unit</LONG_NAME>
            <CON_ID>2223214</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2693484</PublicId>
      <PreferredName>ID_ORG_SP</PreferredName>
      <PreferredDefinition>One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._An allotting or an appointment to a particular person or use, or for a particular time or object._Organizational unit like a laboratory, institute or consortium._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Identifier Assignment Organizational Unit Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2693483</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364:C25426:C41167:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Identifier Assignment Organizational Unit Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25426</PREFERRED_NAME>
            <LONG_NAME>Assignment</LONG_NAME>
            <CON_ID>2204040</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41167</PREFERRED_NAME>
            <LONG_NAME>Organizational Unit</LONG_NAME>
            <CON_ID>2223214</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the organization that</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify the organization that assigned the universal recipient ID:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping for CDE:2693488</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>Organization.name WHERE  Organization [id assigner] &gt; SubjectIdentifier &gt; Subject [recipient] &gt; PerformedProcedure [overall HCT process] AND SubjectIdentifier.typeCode = &quot;Unique Recipient ID&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>key_id_assign_spec</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Organization:name</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="112">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2693520</PUBLICID>
    <LONGNAME>HLA-DPB1 Gene Genotyping Allele Count</LONGNAME>
    <PREFERREDNAME>HLA_DPB1_GNTYP_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>The numeric value related to the HLA-DPB1 allele count.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2684974</PublicId>
      <PreferredName>HLA_DPB1_GNTYP</PreferredName>
      <PreferredDefinition>The HLA-DPB1 gene plays a critical regulatory role in antigen presentation and peptide binding specificity._The process of assessing genetic variation present in an individual.[manually curated]</PreferredDefinition>
      <LongName>HLA-DPB1 Gene Genotyping</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2684951</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29953</PreferredName>
        <Version>1</Version>
        <LongName>HLA-DPB1 Gene</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29953</PREFERRED_NAME>
            <LONG_NAME>HLA-DPB1 Gene</LONG_NAME>
            <CON_ID>2684950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2713362</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45447</PreferredName>
        <Version>1</Version>
        <LongName>Genotyping</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45447</PREFERRED_NAME>
            <LONG_NAME>Genotyping</LONG_NAME>
            <CON_ID>2502957</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2693326</PublicId>
      <PreferredName>ALLELE_CT</PreferredName>
      <PreferredDefinition>Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in DNA sequence and governing the same biochemical and developmental process._To determine the number or amount of something; the result of this activity.</PreferredDefinition>
      <LongName>Allele Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2713363</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16277:C25463</PreferredName>
        <Version>1</Version>
        <LongName>Allele Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16277</PREFERRED_NAME>
            <LONG_NAME>Allele</LONG_NAME>
            <CON_ID>2223183</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested</VALIDVALUE>
          <VALUEMEANING>Without Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>Used to indicate the absence or lack of something or someone. (from Merriam-Webster OnLine): Analysis; examination and interpretation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25391, C25718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2693327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Two</VALIDVALUE>
          <VALUEMEANING>integer::2</VALUEMEANING>
          <MEANINGDESCRIPTION>integer::2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2693328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>One</VALIDVALUE>
          <VALUEMEANING>integer::1</VALUEMEANING>
          <MEANINGDESCRIPTION>integer::1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2693329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of DPB1 alleles provid</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of DPB1 alleles provided:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>not tested</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>not tested</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2005r1: Confirmation of HLA Typing</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2007r1:Cord Blood Unit -SCTOD Data Requirements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3191905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Infectious Diseases and Immunity</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3009615</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2842777</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Labs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HLA Typing</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859958</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>hla_loc_dpb1_num_alls_prv</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="113">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2695284</PUBLICID>
    <LONGNAME>HLA-B Gene Second Antigen Name</LONGNAME>
    <PREFERREDNAME>HLA_B_2ND_ANTGN_NME</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the 2nd HLA-B antigen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2695277</PublicId>
      <PreferredName>HLA_B_2ND_ANTGN</PreferredName>
      <PreferredDefinition>The HLA-B gene plays a role in both immune responses and histocompatibility processes._Coming next after the first in position in space or time or degree or magnitude._Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.</PreferredDefinition>
      <LongName>HLA-B Gene Second Antigen</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2684934</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62778</PreferredName>
        <Version>1</Version>
        <LongName>HLA-B Gene</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62778</PREFERRED_NAME>
            <LONG_NAME>HLA-B Gene</LONG_NAME>
            <CON_ID>2647169</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2695258</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25666:C268</PreferredName>
        <Version>1</Version>
        <LongName>Second Antigen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25666</PREFERRED_NAME>
            <LONG_NAME>Second</LONG_NAME>
            <CON_ID>2202591</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C268</PREFERRED_NAME>
            <LONG_NAME>Antigen</LONG_NAME>
            <CON_ID>2202300</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2695156</PublicId>
      <PreferredName>HLA_B_ANTGN_NME</PreferredName>
      <PreferredDefinition>This gene plays a role in both immune responses and histocompatibility processes._Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>HLA-B Gene Antigen Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2695155</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62778:C268:C42614</PreferredName>
        <Version>1</Version>
        <LongName>HLA-B Gene Antigen Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62778</PREFERRED_NAME>
            <LONG_NAME>HLA-B Gene</LONG_NAME>
            <CON_ID>2647169</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C268</PREFERRED_NAME>
            <LONG_NAME>Antigen</LONG_NAME>
            <CON_ID>2202300</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B45(12)</VALIDVALUE>
          <VALUEMEANING>B45(12) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B45(12) Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B46</VALIDVALUE>
          <VALUEMEANING>B46 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B46 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B47</VALIDVALUE>
          <VALUEMEANING>B47 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B47 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B48</VALIDVALUE>
          <VALUEMEANING>B48 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B48 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B49(21)</VALIDVALUE>
          <VALUEMEANING>B49(21) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B49(21) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B5</VALIDVALUE>
          <VALUEMEANING>B5 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B5 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B50(21)</VALIDVALUE>
          <VALUEMEANING>B50(21) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B50(21) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B51(5)</VALIDVALUE>
          <VALUEMEANING>B51(5) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B51(5) Antigen  Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B5102</VALIDVALUE>
          <VALUEMEANING>B5102 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B5102  Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B5103</VALIDVALUE>
          <VALUEMEANING>B5103 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B5103 Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B52(5)</VALIDVALUE>
          <VALUEMEANING>B52(5) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B52(5) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B53</VALIDVALUE>
          <VALUEMEANING>B53 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B53 Antigen   Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B54(22)</VALIDVALUE>
          <VALUEMEANING>B54(22) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B54(22)  Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B55(22)</VALIDVALUE>
          <VALUEMEANING>B55(22) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B55(22) Antigen   Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B56(22)</VALIDVALUE>
          <VALUEMEANING>B56(22) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B56(22) Antigen   Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B57(17)</VALIDVALUE>
          <VALUEMEANING>B57(17) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B57(17) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B58(17)</VALIDVALUE>
          <VALUEMEANING>B58(17) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B58(17) Antigen  Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B59</VALIDVALUE>
          <VALUEMEANING>B59 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B59 Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B60(40)</VALIDVALUE>
          <VALUEMEANING>B60(40) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B60(40) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B61(40)</VALIDVALUE>
          <VALUEMEANING>B61(40) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B61(40) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B62(15)</VALIDVALUE>
          <VALUEMEANING>B62(15) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B62(15) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B63(15)</VALIDVALUE>
          <VALUEMEANING>B63(15) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B63(15) Antigen  Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B64(14)</VALIDVALUE>
          <VALUEMEANING>B64(14) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B64(14) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B65(14)</VALIDVALUE>
          <VALUEMEANING>B65(14) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B65(14) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B67</VALIDVALUE>
          <VALUEMEANING>B67 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B67 Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B7</VALIDVALUE>
          <VALUEMEANING>B7 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B7 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B70</VALIDVALUE>
          <VALUEMEANING>B70 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B70 Antigen  Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B703</VALIDVALUE>
          <VALUEMEANING>B703 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B703 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B71(70)</VALIDVALUE>
          <VALUEMEANING>B71(70) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B71(70) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B72(70)</VALIDVALUE>
          <VALUEMEANING>B72(70) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B72(70) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B73</VALIDVALUE>
          <VALUEMEANING>B73 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B73 Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B75(15)</VALIDVALUE>
          <VALUEMEANING>B75(15) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B75(15) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B76(15)</VALIDVALUE>
          <VALUEMEANING>B76(15) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B76(15) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B77(15)</VALIDVALUE>
          <VALUEMEANING>B77(15) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B77(15) Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B78</VALIDVALUE>
          <VALUEMEANING>B78 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B78 Antigen  Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B8</VALIDVALUE>
          <VALUEMEANING>B8 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B8 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B81</VALIDVALUE>
          <VALUEMEANING>B81 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B81 Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B82</VALIDVALUE>
          <VALUEMEANING>B82 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B82 Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B12</VALIDVALUE>
          <VALUEMEANING>B12 Antigen Specificity</VALUEMEANING>
          <MEANINGDESCRIPTION>B12 Antigen Specifity by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B13</VALIDVALUE>
          <VALUEMEANING>B13 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B13 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B14</VALIDVALUE>
          <VALUEMEANING>B14 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B14 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B15</VALIDVALUE>
          <VALUEMEANING>B15 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B15  Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B16</VALIDVALUE>
          <VALUEMEANING>B16 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B16 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B17</VALIDVALUE>
          <VALUEMEANING>B17 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B17  Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B18</VALIDVALUE>
          <VALUEMEANING>B18 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B18 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B21</VALIDVALUE>
          <VALUEMEANING>B21 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B21 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B22</VALIDVALUE>
          <VALUEMEANING>B22 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B22 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B27</VALIDVALUE>
          <VALUEMEANING>B27 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B27 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B2708</VALIDVALUE>
          <VALUEMEANING>B2708 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B2708 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B35</VALIDVALUE>
          <VALUEMEANING>B35 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B35 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B37</VALIDVALUE>
          <VALUEMEANING>B37 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B37 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B38(16)</VALIDVALUE>
          <VALUEMEANING>B38(16) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B38(16) Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B39(16)</VALIDVALUE>
          <VALUEMEANING>B39(16) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B39(16) Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B3901</VALIDVALUE>
          <VALUEMEANING>B3901 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B3901 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B3902</VALIDVALUE>
          <VALUEMEANING>B3902 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B3902 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B40</VALIDVALUE>
          <VALUEMEANING>B40 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B40 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B4005</VALIDVALUE>
          <VALUEMEANING>B4005 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B4005 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B41</VALIDVALUE>
          <VALUEMEANING>B41 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B41 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B42</VALIDVALUE>
          <VALUEMEANING>B42 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B42 Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B44(12)</VALIDVALUE>
          <VALUEMEANING>B44(12) Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>B44(12) Antigen by Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BX</VALIDVALUE>
          <VALUEMEANING>BX Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>BX Antigen Serologic Typing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2695217</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Second B antigen specificity:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Second B antigen specificity:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2695284</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedClinicalResult.value(ANY=&gt;CD) WHERE PerformedClinicalResult &gt; PerformedObservation &gt; DefinedObservation.nameCode = &quot;test for HLA-B Gene Antigen&quot; AND PerformedClinicalResult.targetBiomarkerCode = &quot;HLA-B Second Antigen&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specificity - 2nd antigen</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specificity - 2nd antigen</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specificity - 2nd antigen</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specificity - 2nd antigen</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2005r1: Confirmation of HLA Typing</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2842777</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Labs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HLA Typing</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859958</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>hla_srlgy_num_2_b_atgn_sp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedClinicalResult:value</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>hla_sero_B_2nd_antigen_name</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="114">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2704089</PUBLICID>
    <LONGNAME>Anatomic Site Positive Ultrasound Imaging Indicator</LONGNAME>
    <PREFERREDNAME>ANAT_STE_US_IMAG_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to signify whether or not a specified anatomic site was visualized during an ultrasound imaging procedure. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2704087</PublicId>
      <PreferredName>UTER_US_IMAG</PreferredName>
      <PreferredDefinition>Named locations of, or within, the body._Involving advantage or good._A technique in which high-frequency sound waves are bounced off internal organs and the echo pattern is converted into a 2 dimensional picture of the structures beneath the transducer.</PreferredDefinition>
      <LongName>Uterus Positive Ultrasound Imaging Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2429762</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2615151</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25246:C17230</PreferredName>
        <Version>1</Version>
        <LongName>Positive Ultrasound Imaging</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25246</PREFERRED_NAME>
            <LONG_NAME>Positive</LONG_NAME>
            <CON_ID>2202905</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17230</PREFERRED_NAME>
            <LONG_NAME>Ultrasound Imaging</LONG_NAME>
            <CON_ID>2202549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181608</PublicId>
      <PreferredName>Y_N_CHAR_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Character Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Anatomic site visualized?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Anatomic site visualized?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Northwestern University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812693</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Northwestern U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812694</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NU 0943_011</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812695</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Washington</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812731</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FES Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812732</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FMISO Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812733</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Washington New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812734</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="115">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2708028</PUBLICID>
    <LONGNAME>Somatic Mutation Finding Variation Classification java.lang.String</LONGNAME>
    <PREFERREDNAME>2707959v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A mutation that occurs in the somatic tissues of an organism and that will not, therefore, be heritable, since it is not present in the germ line. Somatic mutations may contribute to a disease state.:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom)._An alteration or difference from a norm or standard.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2707959</PublicId>
      <PreferredName>2528749v1.0:2707920v1.0</PreferredName>
      <PreferredDefinition>A mutation that occurs in the somatic tissues of an organism and that will not, therefore, be heritable, since it is not present in the germ line. Somatic mutations may contribute to a disease state.:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom)._An alteration or difference from a norm or standard.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.</PreferredDefinition>
      <LongName>Somatic Mutation Finding Variation Classification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528749</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18060:C3367</PreferredName>
        <Version>1</Version>
        <LongName>Somatic Mutation Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18060</PREFERRED_NAME>
            <LONG_NAME>Somatic Variation</LONG_NAME>
            <CON_ID>2528557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3367</PREFERRED_NAME>
            <LONG_NAME>Finding</LONG_NAME>
            <CON_ID>2202448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2707920</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25713:C25161</PreferredName>
        <Version>1</Version>
        <LongName>Variation Classification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25713</PREFERRED_NAME>
            <LONG_NAME>Variation</LONG_NAME>
            <CON_ID>2203982</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25161</PREFERRED_NAME>
            <LONG_NAME>Classification</LONG_NAME>
            <CON_ID>2203879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Somatic Mutation Finding Variation Classification java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Somatic Mutation Finding Variation Classification java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2707890</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator 2.1</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.finding.variation.somaticMutation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000566</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SomaticMutationFinding:variantClassification</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.finding.variation.somaticMutation.SomaticMutationFinding.variantClassification</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="116">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711641</PUBLICID>
    <LONGNAME>Analysis Record Seed Match java.lang.Double</LONGNAME>
    <PREFERREDNAME>2710884v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:Anything (e.g., a document) providing permanent evidence of or information about past events._An initial thing from which others are generated.:An exact duplicate; coinciding in characteristics; similar or consistent._Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2710884</PublicId>
      <PreferredName>2710717v1.0:2710346v1.0</PreferredName>
      <PreferredDefinition>Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:Anything (e.g., a document) providing permanent evidence of or information about past events._An initial thing from which others are generated.:An exact duplicate; coinciding in characteristics; similar or consistent.</PreferredDefinition>
      <LongName>Analysis Record Seed Match</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710717</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25391:C25198</PreferredName>
        <Version>1</Version>
        <LongName>Analysis Record</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25198</PREFERRED_NAME>
            <LONG_NAME>Record</LONG_NAME>
            <CON_ID>2203775</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710346</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70596:C54116</PreferredName>
        <Version>1</Version>
        <LongName>Seed Match</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70596</PREFERRED_NAME>
            <LONG_NAME>Seed</LONG_NAME>
            <CON_ID>2710234</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54116</PREFERRED_NAME>
            <LONG_NAME>Match</LONG_NAME>
            <CON_ID>2483562</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Analysis Record Seed Match java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Analysis Record Seed Match java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.AnalysisRecord.seedMatches</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AnalysisRecord:seedMatches</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="117">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711676</PUBLICID>
    <LONGNAME>Spot Set Match Statistical Confidence java.lang.String</LONGNAME>
    <PREFERREDNAME>2710919v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A mark on a substance or body made by foreign matter; a blot; a place discolored.:A group of things of the same kind that belong together and are so used._An exact duplicate; coinciding in characteristics; similar or consistent.:The statistical calculation of the percentage likelihood for a given set of data to have a given statistical value._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2710919</PublicId>
      <PreferredName>2710725v1.0:2710366v1.0</PreferredName>
      <PreferredDefinition>A mark on a substance or body made by foreign matter; a blot; a place discolored.:A group of things of the same kind that belong together and are so used._An exact duplicate; coinciding in characteristics; similar or consistent.:The statistical calculation of the percentage likelihood for a given set of data to have a given statistical value.</PreferredDefinition>
      <LongName>Spot Set Match Statistical Confidence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710725</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48039:C47894</PreferredName>
        <Version>1</Version>
        <LongName>Spot Set</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48039</PREFERRED_NAME>
            <LONG_NAME>Spot</LONG_NAME>
            <CON_ID>2422621</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47894</PREFERRED_NAME>
            <LONG_NAME>Set</LONG_NAME>
            <CON_ID>2425537</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710366</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54116:C49020</PreferredName>
        <Version>1</Version>
        <LongName>Match Statistical Confidence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54116</PREFERRED_NAME>
            <LONG_NAME>Match</LONG_NAME>
            <CON_ID>2483562</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49020</PREFERRED_NAME>
            <LONG_NAME>Statistical Confidence</LONG_NAME>
            <CON_ID>2451923</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Spot Set Match Statistical Confidence java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Spot Set Match Statistical Confidence java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.SpotSet.matchConfidence</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SpotSet:matchConfidence</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="118">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711834</PUBLICID>
    <LONGNAME>Liquid Chromatography Separation Column Batch Number java.lang.String</LONGNAME>
    <PREFERREDNAME>2711079v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A type of chromatography in which separation of a mixture is achieved by passing a sample in a stream of liquid solvent through some form of material that will provide resistance by virtue of chemical interactions between the components of the sample and the material.:A tube used in column chromatography._A quantity of people or things treated or regarded as a group, especially when subdivided from a larger group.:A numeral or string of numerals expressing value, quantity, or identification._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711079</PublicId>
      <PreferredName>2710745v1.0:2678040v1.0</PreferredName>
      <PreferredDefinition>A type of chromatography in which separation of a mixture is achieved by passing a sample in a stream of liquid solvent through some form of material that will provide resistance by virtue of chemical interactions between the components of the sample and the material.:A tube used in column chromatography._A quantity of people or things treated or regarded as a group, especially when subdivided from a larger group.:A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Liquid Chromatography Separation Column Batch Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710745</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16435:C47874</PreferredName>
        <Version>1</Version>
        <LongName>Liquid Chromatography Separation Column</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16435</PREFERRED_NAME>
            <LONG_NAME>Liquid Chromatography</LONG_NAME>
            <CON_ID>2710236</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47874</PREFERRED_NAME>
            <LONG_NAME>Separation Column</LONG_NAME>
            <CON_ID>2710245</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2678040</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C67073:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Batch Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67073</PREFERRED_NAME>
            <LONG_NAME>Batch</LONG_NAME>
            <CON_ID>2677936</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Liquid Chromatography Separation Column Batch Number java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Liquid Chromatography Separation Column Batch Number java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.LiquidChromatographyColumn.batchDecimal</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LiquidChromatographyColumn:batchDecimal</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="119">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711881</PUBLICID>
    <LONGNAME>Protein Spot Set Protein Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2711126v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.:A mark on a substance or body made by foreign matter; a blot; a place discolored.:A group of things of the same kind that belong together and are so used._A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711126</PublicId>
      <PreferredName>2710755v1.0:2710418v1.0</PreferredName>
      <PreferredDefinition>A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.:A mark on a substance or body made by foreign matter; a blot; a place discolored.:A group of things of the same kind that belong together and are so used._A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Protein Spot Set Protein Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710755</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17021:C48039:C47894</PreferredName>
        <Version>1</Version>
        <LongName>Protein Spot Set</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17021</PREFERRED_NAME>
            <LONG_NAME>Protein</LONG_NAME>
            <CON_ID>2202792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48039</PREFERRED_NAME>
            <LONG_NAME>Spot</LONG_NAME>
            <CON_ID>2422621</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47894</PREFERRED_NAME>
            <LONG_NAME>Set</LONG_NAME>
            <CON_ID>2425537</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710418</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17021:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Protein Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17021</PREFERRED_NAME>
            <LONG_NAME>Protein</LONG_NAME>
            <CON_ID>2202792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Protein Spot Set Protein Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Protein Spot Set Protein Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.ProteinSpotSet.proteinIdentifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProteinSpotSet:proteinIdentifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="120">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2712020</PUBLICID>
    <LONGNAME>Spot Calibration Background Level java.lang.Double</LONGNAME>
    <PREFERREDNAME>2711265v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A mark on a substance or body made by foreign matter; a blot; a place discolored._The act of checking or adjusting (by comparison with a standard) the accuracy of a measuring instrument.:Existing conditions, especially those that would be confused with the phenomenon to be observed or measured.:A position on a scale measuring intensity, quality, or amount._Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711265</PublicId>
      <PreferredName>2710776v1.0:2710554v1.0</PreferredName>
      <PreferredDefinition>A mark on a substance or body made by foreign matter; a blot; a place discolored._The act of checking or adjusting (by comparison with a standard) the accuracy of a measuring instrument.:Existing conditions, especially those that would be confused with the phenomenon to be observed or measured.:A position on a scale measuring intensity, quality, or amount.</PreferredDefinition>
      <LongName>Spot Calibration Background Level</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710776</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48039</PreferredName>
        <Version>1</Version>
        <LongName>Spot</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48039</PREFERRED_NAME>
            <LONG_NAME>Spot</LONG_NAME>
            <CON_ID>2422621</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710554</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C69187:C45782:C25554</PreferredName>
        <Version>1</Version>
        <LongName>Calibration Background Level</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C69187</PREFERRED_NAME>
            <LONG_NAME>Calibration</LONG_NAME>
            <CON_ID>2684069</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45782</PREFERRED_NAME>
            <LONG_NAME>Background</LONG_NAME>
            <CON_ID>2236603</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25554</PREFERRED_NAME>
            <LONG_NAME>Level</LONG_NAME>
            <CON_ID>2202440</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Spot Calibration Background Level java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Spot Calibration Background Level java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.Spot.backgroundLevelCalibrated</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Spot:backgroundLevelCalibrated</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="121">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2712031</PUBLICID>
    <LONGNAME>Spot Match Type java.lang.Double</LONGNAME>
    <PREFERREDNAME>2711276v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A mark on a substance or body made by foreign matter; a blot; a place discolored._An exact duplicate; coinciding in characteristics; similar or consistent.:Something distinguishable as an identifiable class based on common qualities._Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711276</PublicId>
      <PreferredName>2710776v1.0:2710561v1.0</PreferredName>
      <PreferredDefinition>A mark on a substance or body made by foreign matter; a blot; a place discolored._An exact duplicate; coinciding in characteristics; similar or consistent.:Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Spot Match Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710776</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48039</PreferredName>
        <Version>1</Version>
        <LongName>Spot</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48039</PREFERRED_NAME>
            <LONG_NAME>Spot</LONG_NAME>
            <CON_ID>2422621</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710561</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54116:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Match Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54116</PREFERRED_NAME>
            <LONG_NAME>Match</LONG_NAME>
            <CON_ID>2483562</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Spot Match Type java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Spot Match Type java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.Spot.matchType</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Spot:matchType</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="122">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2712112</PUBLICID>
    <LONGNAME>Differential In-Gel Electrophoresis Protein Secondary Analysis of Variance Second Condition java.lang.Double</LONGNAME>
    <PREFERREDNAME>2711357v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A form of gel electrophoresis where up to three different protein samples can be labeled with fluorescent dyes prior to two-dimensional electrophoresis in the same gel. After the gel electrophoresis, the gel is scanned with the excitation wavelength of each dye and the imges are superimposed, allowing detection of changes in protein abundance between samples.:A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence._Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.:A statistical technique which helps in making inference whether three or more samples might come from populations having the same mean; specifically, whether the differences among the samples might be caused by chance variation.:Coming next after the first in position in space or time or degree or magnitude.:A state of being, such as a state of health or physical being._Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711357</PublicId>
      <PreferredName>2710786v1.0:2710614v1.0</PreferredName>
      <PreferredDefinition>A form of gel electrophoresis where up to three different protein samples can be labeled with fluorescent dyes prior to two-dimensional electrophoresis in the same gel. After the gel electrophoresis, the gel is scanned with the excitation wavelength of each dye and the imges are superimposed, allowing detection of changes in protein abundance between samples.:A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence._Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.:A statistical technique which helps in making inference whether three or more samples might come from populations having the same mean; specifically, whether the differences among the samples might be caused by chance variation.:Coming next after the first in position in space or time or degree or magnitude.:A state of being, such as a state of health or physical being.</PreferredDefinition>
      <LongName>Differential In-Gel Electrophoresis Protein Secondary Analysis of Variance Second Condition</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710786</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70654:C17021</PreferredName>
        <Version>1</Version>
        <LongName>Differential In-Gel Electrophoresis Protein</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70654</PREFERRED_NAME>
            <LONG_NAME>Differential In-Gel Electrophoresis</LONG_NAME>
            <CON_ID>2710244</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17021</PREFERRED_NAME>
            <LONG_NAME>Protein</LONG_NAME>
            <CON_ID>2202792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710614</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25667:C53241:C25666:C25457</PreferredName>
        <Version>1</Version>
        <LongName>Secondary Analysis of Variance Second Condition</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25667</PREFERRED_NAME>
            <LONG_NAME>Secondary</LONG_NAME>
            <CON_ID>2206365</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53241</PREFERRED_NAME>
            <LONG_NAME>Analysis of Variance</LONG_NAME>
            <CON_ID>2710291</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25666</PREFERRED_NAME>
            <LONG_NAME>Second</LONG_NAME>
            <CON_ID>2202591</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25457</PREFERRED_NAME>
            <LONG_NAME>Condition</LONG_NAME>
            <CON_ID>2202899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Differential In-Gel Electrophoresis Protein Secondary Analysis of Variance Second Condition java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Differential In-Gel Electrophoresis Protein Secondary Analysis of Variance Second Condition java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.ProteinDige.anova2Condition2</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProteinDige:anova2Condition2</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="123">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2712122</PUBLICID>
    <LONGNAME>Differential In-Gel Electrophoresis Protein Isoelectric Point Status java.lang.String</LONGNAME>
    <PREFERREDNAME>2711367v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A form of gel electrophoresis where up to three different protein samples can be labeled with fluorescent dyes prior to two-dimensional electrophoresis in the same gel. After the gel electrophoresis, the gel is scanned with the excitation wavelength of each dye and the imges are superimposed, allowing detection of changes in protein abundance between samples.:A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence._The pH at which a molecule in solution has no net charge and does not migrate in an electric field.:A condition or state at a particular time._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711367</PublicId>
      <PreferredName>2710786v1.0:2710363v1.0</PreferredName>
      <PreferredDefinition>A form of gel electrophoresis where up to three different protein samples can be labeled with fluorescent dyes prior to two-dimensional electrophoresis in the same gel. After the gel electrophoresis, the gel is scanned with the excitation wavelength of each dye and the imges are superimposed, allowing detection of changes in protein abundance between samples.:A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence._The pH at which a molecule in solution has no net charge and does not migrate in an electric field.:A condition or state at a particular time.</PreferredDefinition>
      <LongName>Differential In-Gel Electrophoresis Protein Isoelectric Point Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710786</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70654:C17021</PreferredName>
        <Version>1</Version>
        <LongName>Differential In-Gel Electrophoresis Protein</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70654</PREFERRED_NAME>
            <LONG_NAME>Differential In-Gel Electrophoresis</LONG_NAME>
            <CON_ID>2710244</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17021</PREFERRED_NAME>
            <LONG_NAME>Protein</LONG_NAME>
            <CON_ID>2202792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710363</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54157:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Isoelectric Point Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54157</PREFERRED_NAME>
            <LONG_NAME>Isoelectric Point</LONG_NAME>
            <CON_ID>2710238</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Differential In-Gel Electrophoresis Protein Isoelectric Point Status java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Differential In-Gel Electrophoresis Protein Isoelectric Point Status java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.ProteinDige.isoelectricPointStatus</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProteinDige:isoelectricPointStatus</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="124">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2712328</PUBLICID>
    <LONGNAME>Fraction Analysis Specimen Step Liquid Chromatography Separation Column Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2711573v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A part, a fragment of a whole.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:A specific stage of progression through a sequential process._A type of chromatography in which separation of a mixture is achieved by passing a sample in a stream of liquid solvent through some form of material that will provide resistance by virtue of chemical interactions between the components of the sample and the material.:A tube used in column chromatography.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711573</PublicId>
      <PreferredName>2710825v1.0:2710405v1.0</PreferredName>
      <PreferredDefinition>A part, a fragment of a whole.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:A specific stage of progression through a sequential process._A type of chromatography in which separation of a mixture is achieved by passing a sample in a stream of liquid solvent through some form of material that will provide resistance by virtue of chemical interactions between the components of the sample and the material.:A tube used in column chromatography.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Fraction Analysis Specimen Step Liquid Chromatography Separation Column Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710825</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25514:C25391:C19157:C48176</PreferredName>
        <Version>1</Version>
        <LongName>Fraction Analysis Specimen Step</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25514</PREFERRED_NAME>
            <LONG_NAME>Fraction</LONG_NAME>
            <CON_ID>2203814</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48176</PREFERRED_NAME>
            <LONG_NAME>Step</LONG_NAME>
            <CON_ID>2427520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710405</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16435:C47874:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Liquid Chromatography Separation Column Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16435</PREFERRED_NAME>
            <LONG_NAME>Liquid Chromatography</LONG_NAME>
            <CON_ID>2710236</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47874</PREFERRED_NAME>
            <LONG_NAME>Separation Column</LONG_NAME>
            <CON_ID>2710245</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Fraction Analysis Specimen Step Liquid Chromatography Separation Column Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Fraction Analysis Specimen Step Liquid Chromatography Separation Column Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.FractionAnalyteSteps.liquidChromatographyColumnIdentifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FractionAnalyteSteps:liquidChromatographyColumnIdentifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="125">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2717478</PUBLICID>
    <LONGNAME>Post Procedure Pain Present Status</LONGNAME>
    <PREFERREDNAME>P_PROC_PAIN_PRS_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>the status in regards to the presence of pain after procedure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2705005</PublicId>
      <PreferredName>POST_PROC_PAIN_PRES</PreferredName>
      <PreferredDefinition>information regarding presence of pain after procedure.</PreferredDefinition>
      <LongName>Post Procedure Pain Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2705003</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38008:C25218:C3303</PreferredName>
        <Version>1</Version>
        <LongName>Post Procedure Pain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3303</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>2202326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2707789</PublicId>
      <PreferredName>PAIN_STAT</PreferredName>
      <PreferredDefinition>a condition or state at a particular time of pain.</PreferredDefinition>
      <LongName>Pain Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No pain</VALIDVALUE>
          <VALUEMEANING>No pain</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had no pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mild pain</VALIDVALUE>
          <VALUEMEANING>Mild pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Mild pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2651755</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate pain</VALIDVALUE>
          <VALUEMEANING>Moderate pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Moderate pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Severe pain</VALIDVALUE>
          <VALUEMEANING>Severe pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Severe pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very severe pain</VALIDVALUE>
          <VALUEMEANING>Very severe pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Very severe pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Which of the following best d</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Which of the following best describes your highest level of pain after your dental treatment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjunctive General Services</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812095</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="126">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2717721</PUBLICID>
    <LONGNAME>Scan Bed Position Count</LONGNAME>
    <PREFERREDNAME>SCAN_BED_POS_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>Number of bed positions scanned.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACRIN:American College of Radiology Imaging Network</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2717619</PublicId>
      <PreferredName>SCAN_BED_POS</PreferredName>
      <PreferredDefinition>The act of sending data or image gathered with a sensing device in a particular portion of space occupied by a physical object.</PreferredDefinition>
      <LongName>Scan Bed Position</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2436190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17999</PreferredName>
        <Version>1</Version>
        <LongName>Scan</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17999</PREFERRED_NAME>
            <LONG_NAME>Scan</LONG_NAME>
            <CON_ID>2202631</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2727628</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50367:C25339</PreferredName>
        <Version>1</Version>
        <LongName>Bed Position</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50367</PREFERRED_NAME>
            <LONG_NAME>Bed</LONG_NAME>
            <CON_ID>2472571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25339</PREFERRED_NAME>
            <LONG_NAME>Position</LONG_NAME>
            <CON_ID>2203955</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2717681</PublicId>
      <PreferredName>BED_POSITION_CT</PreferredName>
      <PreferredDefinition>The number of a particular portion of space occupied in each PET image.</PreferredDefinition>
      <LongName>Bed Position Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
      <Representation>
        <PublicId>2717680</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50367:C25339:C25463</PreferredName>
        <Version>1</Version>
        <LongName>Bed Position Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50367</PREFERRED_NAME>
            <LONG_NAME>Bed</LONG_NAME>
            <CON_ID>2472571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25339</PREFERRED_NAME>
            <LONG_NAME>Position</LONG_NAME>
            <CON_ID>2203955</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of bed positions scann</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of bed positions scanned</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the number of scanned bed positions?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of scanned bed positions</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PET Emissions Scan CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3163562</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314439</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging Modality</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Positron Emission Tomography (PET)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314449</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314514</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Under Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>E2410</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3428274</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PET Emissions Scan</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3163559</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC PET Scan</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7590133</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DU_DUORRES_NMBDPSSC</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="127">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2724780</PUBLICID>
    <LONGNAME>Test Result Laboratory Reference Range Code java.lang.String</LONGNAME>
    <PREFERREDNAME>2724661v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The outcome of a laboratory test._A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.:A note acknowledging a source of information or quoting a passage.:The difference between the lowest and highest numerical values.:A symbol or combination of symbols which are given certain arbitrary meanings within a systematized collection of concepts used for data representation._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2724661</PublicId>
      <PreferredName>2555440v1.0:2724648v1.0</PreferredName>
      <PreferredDefinition>The outcome of a laboratory test._A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.:A note acknowledging a source of information or quoting a passage.:The difference between the lowest and highest numerical values.:A symbol or combination of symbols which are given certain arbitrary meanings within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Test Result Laboratory Reference Range Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2555440</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C36292</PreferredName>
        <Version>1</Version>
        <LongName>Test Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C36292</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Result</LONG_NAME>
            <CON_ID>2451822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2724648</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37984:C25641:C38013:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Reference Range Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37984</PREFERRED_NAME>
            <LONG_NAME>Laboratory</LONG_NAME>
            <CON_ID>2202883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25641</PREFERRED_NAME>
            <LONG_NAME>Reference</LONG_NAME>
            <CON_ID>2206357</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38013</PREFERRED_NAME>
            <LONG_NAME>Range</LONG_NAME>
            <CON_ID>2204649</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Test Result Laboratory Reference Range Code java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Test Result Laboratory Reference Range Code java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2724612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTODS</PreferredName>
          <Version>0.53</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ctom.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.ClinicalResult.labReferenceRangeCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ClinicalResult:labReferenceRangeCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="128">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2727639</PUBLICID>
    <LONGNAME>Menses Longest Time Period Occurrence Day Count</LONGNAME>
    <PREFERREDNAME>MENS_LONG_TM_DAY_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to identify the longest period of time in days that has lapsed between a woman&#39;s menstrual cycles. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2727633</PublicId>
      <PreferredName>MENS_LONG_TMPD_OCCUR</PreferredName>
      <PreferredDefinition>Periodic discharge of blood and tissue from the uterus.  Until menopause, menstruation occurs approximately every 28 days when a woman is not pregnant._Having the greater length of two or the greatest length of several._the continuum of experience in which events pass from the future through the present to the past._An interval of time. (NCI)._Occurrence; an instance of something happening._</PreferredDefinition>
      <LongName>Menses Longest Time Period Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2598134</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3232</PreferredName>
        <Version>1</Version>
        <LongName>Menses</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3232</PREFERRED_NAME>
            <LONG_NAME>Menstruation</LONG_NAME>
            <CON_ID>2202741</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2727631</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25558:C25207:C25616:C25275</PreferredName>
        <Version>1</Version>
        <LongName>Longest Time Period Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25558</PREFERRED_NAME>
            <LONG_NAME>Longest</LONG_NAME>
            <CON_ID>2206293</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25616</PREFERRED_NAME>
            <LONG_NAME>Period</LONG_NAME>
            <CON_ID>2202575</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018594</PublicId>
      <PreferredName>D_CT</PreferredName>
      <PreferredDefinition>the quantity of days.</PreferredDefinition>
      <LongName>Day Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2207941</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25301:C25463</PreferredName>
        <Version>1</Version>
        <LongName>Day Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25301</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2202680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the longest period of</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the longest period of time that has lapsed between menstrual cycles? (first day of one to first day of the next)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the longest interval of time that has lapsed between menstrual cycles</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Northwestern University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812693</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Northwestern U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812694</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NU 0943_011</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812695</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U of Pa Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812727</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="129">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2732899</PUBLICID>
    <LONGNAME>Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Hand Activity Difficulty Psychometrics Assessment Score</LONGNAME>
    <PREFERREDNAME>CTCL_SKN_HD_DIFF_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Response on a psychometric measure documenting how often a human being has difficulty performing activities requiring the use of hands due to CTCL (Cutaneous T-Cell Lymphoma) in the skin. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2732867</PublicId>
      <PreferredName>PERS_CTCL_SKN_HD_DIF</PreferredName>
      <PreferredDefinition>A single human being._A T-cell non-Hodgkin lymphoma arising from the skin. Representative examples include mycosis fungoides and primary cutaneous anaplastic large cell lymphoma._An organ that constitutes the external surface of the body.  It consists of the epidermis, dermis, and skin appendages._The distal portion of the upper extremity.  It consists of the carpus, metacarpus, and digits._An action taken in pursuit of an objective; the state of being active._Something not easily done, accomplished, comprehended, or solved.</PreferredDefinition>
      <LongName>Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Hand Activity Difficulty</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2732708</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C3467:C12470</PreferredName>
        <Version>1</Version>
        <LongName>Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3467</PREFERRED_NAME>
            <LONG_NAME>Primary Cutaneous T-Cell Non-Hodgkin Lymphoma</LONG_NAME>
            <CON_ID>2732707</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12470</PREFERRED_NAME>
            <LONG_NAME>Skin</LONG_NAME>
            <CON_ID>2202821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2732865</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C32712:C43431:C62189</PreferredName>
        <Version>1</Version>
        <LongName>Hand Activity Difficulty</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C32712</PREFERRED_NAME>
            <LONG_NAME>Hand</LONG_NAME>
            <CON_ID>2202677</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62189</PREFERRED_NAME>
            <LONG_NAME>Difficulty</LONG_NAME>
            <CON_ID>2503546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2732886</PublicId>
      <PreferredName>PSYCH_ASSESS_SC</PreferredName>
      <PreferredDefinition>The science of measuring &quot;psychological&quot; aspects of a person such as knowledge, skills, abilities, or personality. Measurement of these unobservable phenomena is difficult and much of the research and accumulated art of this discipline is designed to reliably define and then quantify._The final result of a determination of the value, significance, or extent of._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Psychometrics Assessment Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>12</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2732885</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17034:C25217:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Psychometrics Assessed Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17034</PREFERRED_NAME>
            <LONG_NAME>Psychometrics</LONG_NAME>
            <CON_ID>2520620</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>All the time</VALIDVALUE>
          <VALUEMEANING>All the time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2732887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>I NEVER had an erection when I wanted one </VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I have difficulty doing thing</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I have difficulty doing things with my hands because of the condition of my skin.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="130">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2734659</PUBLICID>
    <LONGNAME>Past Integer::4 Week Adult Insurance Malignant Neoplasm Problem Psychometrics Assessment Score</LONGNAME>
    <PREFERREDNAME>PAST_4WK_INS_PRB_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the response to a QLAC question posed to an adult about problems with insurance over the past four weeks because of cancer. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2734533</PublicId>
      <PreferredName>PAST_4WK_ADT_INS_PRB</PreferredName>
      <PreferredDefinition>Past; before the present time._A number with no fractional part, including the negative and positive numbers as well as zero.::4_Any period of seven consecutive days._A human who has reached reproductive age._Coverage by contract whereby one part indemnifies or guarantees another against loss by a specified contingency._A term for diseases in which abnormal cells divide without control. Cancer cells can invade nearby tissues and can spread through the bloodstream and lymphatic system to other parts of the body._A difficulty, disorder, or condition needing resolution.</PreferredDefinition>
      <LongName>Past Integer::4 Week Adult Insurance Malignant Neoplasm Problem</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2732119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25609:C45255::4:C29844:C17600</PreferredName>
        <Version>1</Version>
        <LongName>Past Integer::4 Week Adult</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::4</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29844</PREFERRED_NAME>
            <LONG_NAME>Week</LONG_NAME>
            <CON_ID>2203710</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17600</PREFERRED_NAME>
            <LONG_NAME>Adult</LONG_NAME>
            <CON_ID>2204022</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2734531</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16745:C9305:C28020</PreferredName>
        <Version>1</Version>
        <LongName>Insurance Malignant Neoplasm Problem</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16745</PREFERRED_NAME>
            <LONG_NAME>Insurance</LONG_NAME>
            <CON_ID>2413105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28020</PREFERRED_NAME>
            <LONG_NAME>Problem</LONG_NAME>
            <CON_ID>2203953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>QLAC:Quality of Life in Adult Cancer Survivors Scale</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2734610</PublicId>
      <PreferredName>PSYCH_ASSESS_SC</PreferredName>
      <PreferredDefinition>The science of measuring &quot;psychological&quot; aspects of a person such as knowledge, skills, abilities, or personality. Measurement of these unobservable phenomena is difficult and much of the research and accumulated art of this discipline is designed to reliably define and then quantify._The final result of a determination of the value, significance, or extent of._A number or range of numeric values measuring performance, function, quality, or ability._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Psychometrics Assessment Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2732885</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17034:C25217:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Psychometrics Assessed Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17034</PREFERRED_NAME>
            <LONG_NAME>Psychometrics</LONG_NAME>
            <CON_ID>2520620</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>VERY OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>VERY OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Frequently</VALUEMEANING>
          <MEANINGDESCRIPTION>Frequently</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>About as often as not</VALUEMEANING>
          <MEANINGDESCRIPTION>About as often as not</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2734611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Seldom</VALUEMEANING>
          <MEANINGDESCRIPTION>Seldom</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2734612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>I NEVER had an erection when I wanted one </VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>You had problems with insuran</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>You had problems with insurance because of cancer.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="131">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2740628</PUBLICID>
    <LONGNAME>Sex Behavior Quality of Life Satisfaction Assessment Scale</LONGNAME>
    <PREFERREDNAME>SEX_QOL_SAT_ASS_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>the scale to evaluate a person&#39;s satisfaction with the act of physical intimacy that can be directed to reproduction (one possible goal of sexual intercourse) and/or to enjoying the body of someone else as part of the subjective measurement of an individual&#39;s sense of well-being and ability to enjoy life.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2740532</PublicId>
      <PreferredName>SEXB_QOL_SAT_ASS</PreferredName>
      <PreferredDefinition>information related the evaluation of a person&#39;s satisfaction with the act of physical intimacy that can be directed to reproduction (one possible goal of sexual intercourse) and/or to enjoying the body of someone else as part of the subjective measurement of an individual&#39;s sense of well-being and ability to enjoy life.</PreferredDefinition>
      <LongName>Sex Behavior Quality of Life Satisfaction Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2740425</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17127:C17047</PreferredName>
        <Version>1</Version>
        <LongName>Sex Behavior Quality of Life</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17127</PREFERRED_NAME>
            <LONG_NAME>Sex Behavior</LONG_NAME>
            <CON_ID>2442506</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17047</PREFERRED_NAME>
            <LONG_NAME>Quality of Life</LONG_NAME>
            <CON_ID>2202504</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2743660</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62185:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Satisfaction Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62185</PREFERRED_NAME>
            <LONG_NAME>Satisfaction</LONG_NAME>
            <CON_ID>2585226</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2740551</PublicId>
      <PreferredName>SEXBEH_QOL_SCALE</PreferredName>
      <PreferredDefinition>the ordered reference standard for quality of life related to sexual behavior.</PreferredDefinition>
      <LongName>Sex Behavior Quality of Life Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>75</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate</VALIDVALUE>
          <VALUEMEANING>Moderation</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Almost always or always</VALIDVALUE>
          <VALUEMEANING>Almost always or always</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happened always or almost always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740554</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Most times</VALIDVALUE>
          <VALUEMEANING>Most times</VALUEMEANING>
          <MEANINGDESCRIPTION>Most times</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A few times</VALIDVALUE>
          <VALUEMEANING>A few times</VALUEMEANING>
          <MEANINGDESCRIPTION>A few times</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Almost never or never</VALIDVALUE>
          <VALUEMEANING>Almost never or never</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happened never or almost never.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very high</VALIDVALUE>
          <VALUEMEANING>Very high</VALUEMEANING>
          <MEANINGDESCRIPTION>Very high</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High</VALIDVALUE>
          <VALUEMEANING>High</VALUEMEANING>
          <MEANINGDESCRIPTION>High; greater than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low</VALIDVALUE>
          <VALUEMEANING>Low</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimum level or position or degree; less than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very low or none at all</VALIDVALUE>
          <VALUEMEANING>Very low or none at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Very low or none at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No sexual activity</VALIDVALUE>
          <VALUEMEANING>No sexual activity</VALUEMEANING>
          <MEANINGDESCRIPTION>No sexual activity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2730413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very high confidence</VALIDVALUE>
          <VALUEMEANING>Very high confidence</VALUEMEANING>
          <MEANINGDESCRIPTION>Very high confidence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High confidence</VALIDVALUE>
          <VALUEMEANING>High confidence</VALUEMEANING>
          <MEANINGDESCRIPTION>High confidence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate confidence</VALIDVALUE>
          <VALUEMEANING>Moderate confidence</VALUEMEANING>
          <MEANINGDESCRIPTION>Moderate confidence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low confidence</VALIDVALUE>
          <VALUEMEANING>Low confidence</VALUEMEANING>
          <MEANINGDESCRIPTION>Low confidence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very low or no confidence</VALIDVALUE>
          <VALUEMEANING>Very low or no confidence</VALUEMEANING>
          <MEANINGDESCRIPTION>Very low or no confidence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely difficult or impossible</VALIDVALUE>
          <VALUEMEANING>Extremely difficult or impossible</VALUEMEANING>
          <MEANINGDESCRIPTION>Extremely difficult or impossible</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very difficult</VALIDVALUE>
          <VALUEMEANING>Very Difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Very Difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Difficult</VALIDVALUE>
          <VALUEMEANING>Difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slightly difficult</VALIDVALUE>
          <VALUEMEANING>Slightly difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Slightly difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not difficult</VALIDVALUE>
          <VALUEMEANING>Not difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Not difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very satisfied</VALIDVALUE>
          <VALUEMEANING>Very satisfied</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating a high level of satisfaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately satisfied</VALIDVALUE>
          <VALUEMEANING>Moderately satisfied</VALUEMEANING>
          <MEANINGDESCRIPTION>Moderately satisfied</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>About equally satisfied and dissatisfied</VALIDVALUE>
          <VALUEMEANING>About equally satisfied and dissatisfied</VALUEMEANING>
          <MEANINGDESCRIPTION>About equally satisfied and dissatisfied</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately dissatisfied</VALIDVALUE>
          <VALUEMEANING>Moderately dissatisfied</VALUEMEANING>
          <MEANINGDESCRIPTION>Moderately dissatisfied</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very dissatisfied</VALIDVALUE>
          <VALUEMEANING>Very dissatisfied</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating a high level of dissatisfaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Did not attempt intercourse</VALIDVALUE>
          <VALUEMEANING>Did not attempt intercourse</VALUEMEANING>
          <MEANINGDESCRIPTION>Did not attempt intercourse</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very low</VALIDVALUE>
          <VALUEMEANING>Very low</VALUEMEANING>
          <MEANINGDESCRIPTION>Very low</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely difficult</VALIDVALUE>
          <VALUEMEANING>Extremely difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Extremely difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No enjoyment</VALIDVALUE>
          <VALUEMEANING>No enjoyment</VALUEMEANING>
          <MEANINGDESCRIPTION>No enjoyment</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not very enjoyable</VALIDVALUE>
          <VALUEMEANING>Not very enjoyable</VALUEMEANING>
          <MEANINGDESCRIPTION>Not very enjoyable</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fairly enjoyable</VALIDVALUE>
          <VALUEMEANING>Fairly enjoyable</VALUEMEANING>
          <MEANINGDESCRIPTION>Fairly enjoyable</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Highly enjoyable</VALIDVALUE>
          <VALUEMEANING>Highly enjoyable</VALUEMEANING>
          <MEANINGDESCRIPTION>Highly enjoyable</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741230</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very highly enjoyable</VALIDVALUE>
          <VALUEMEANING>Very highly enjoyable</VALUEMEANING>
          <MEANINGDESCRIPTION>Very highly enjoyable</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No intercourse</VALIDVALUE>
          <VALUEMEANING>No intercourse</VALUEMEANING>
          <MEANINGDESCRIPTION>No intercourse</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No attempt</VALIDVALUE>
          <VALUEMEANING>No attempt</VALUEMEANING>
          <MEANINGDESCRIPTION>No attempt</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741241</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>One to two attempts</VALIDVALUE>
          <VALUEMEANING>One to two attempts</VALUEMEANING>
          <MEANINGDESCRIPTION>One to two attempts</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Three to four attempts</VALIDVALUE>
          <VALUEMEANING>Three to four attempts</VALUEMEANING>
          <MEANINGDESCRIPTION>Three to four attempts</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Five to six attempts</VALIDVALUE>
          <VALUEMEANING>Five to six attempts</VALUEMEANING>
          <MEANINGDESCRIPTION>Five to six attempts</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seven to ten attempts</VALIDVALUE>
          <VALUEMEANING>Seven to ten attempts</VALUEMEANING>
          <MEANINGDESCRIPTION>Seven to ten attempts</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>More than eleven attempts</VALIDVALUE>
          <VALUEMEANING>More than eleven attempts</VALUEMEANING>
          <MEANINGDESCRIPTION>More than eleven attempts</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>almost never/ never</VALIDVALUE>
          <VALUEMEANING>almost never/ never</VALUEMEANING>
          <MEANINGDESCRIPTION>almost never/ never</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2743303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>almost always/ always</VALIDVALUE>
          <VALUEMEANING>almost always/ always</VALUEMEANING>
          <MEANINGDESCRIPTION>almost always/ always</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2743304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very low/none at all</VALIDVALUE>
          <VALUEMEANING>Very low/none at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Very low/none at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-10-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2956262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very Good</VALIDVALUE>
          <VALUEMEANING>Very good</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that something has a high degree of quality, value or worth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103342</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570799</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Good</VALIDVALUE>
          <VALUEMEANING>Good</VALUEMEANING>
          <MEANINGDESCRIPTION>Good</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fair</VALIDVALUE>
          <VALUEMEANING>Fair</VALUEMEANING>
          <MEANINGDESCRIPTION>Having no exceptional quality or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571046</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poor</VALIDVALUE>
          <VALUEMEANING>Poor</VALUEMEANING>
          <MEANINGDESCRIPTION>Of low value or worth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3115746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very Poor to None</VALIDVALUE>
          <VALUEMEANING>Very Poor to None</VALUEMEANING>
          <MEANINGDESCRIPTION>Very Poor to None</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daily</VALIDVALUE>
          <VALUEMEANING>About once a day</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring or done each day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Several times a week</VALIDVALUE>
          <VALUEMEANING>Several times a week</VALUEMEANING>
          <MEANINGDESCRIPTION>Several times a week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>About once a week</VALIDVALUE>
          <VALUEMEANING>ABOUT ONCE A WEEK</VALUEMEANING>
          <MEANINGDESCRIPTION>About once a week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Less than once a week</VALIDVALUE>
          <VALUEMEANING>Less than once a week</VALUEMEANING>
          <MEANINGDESCRIPTION>Less than once a week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3120272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Over the past 4 weeks, how sa</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Over the past 4 weeks, how satisfied have you been with your sexual relationship with your partner</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="132">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2750407</PUBLICID>
    <LONGNAME>Calculation Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2750266v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The procedure or activity of determining something by mathematical or logical methods._A statement or an account describing something._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2750266</PublicId>
      <PreferredName>2750194v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>The procedure or activity of determining something by mathematical or logical methods._A statement or an account describing something.</PreferredDefinition>
      <LongName>Calculation Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2750194</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54125</PreferredName>
        <Version>1</Version>
        <LongName>Calculation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54125</PREFERRED_NAME>
            <LONG_NAME>Calculation</LONG_NAME>
            <CON_ID>2654477</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Calculation Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Calculation Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 3.0</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000056</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.Calculation.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Calculation:description</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="133">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752731</PUBLICID>
    <LONGNAME>Chemotherapy Data Comment java.lang.String</LONGNAME>
    <PREFERREDNAME>2752215v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term is used to describe any therapy involving the use of chemical-based agents, particularly, it refers to the variety of chemical-based agents employed to treat cancer. Antineoplastic chemotherapy works by arresting or killing the growth and spread of cancer cells. Chemotherapy may also include agents that enhance immune function or alter hormonal activity.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._A written explanation or criticism or illustration that is added to a book or other textual material._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752215</PublicId>
      <PreferredName>2751999v1.0:2223274v1.0</PreferredName>
      <PreferredDefinition>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term is used to describe any therapy involving the use of chemical-based agents, particularly, it refers to the variety of chemical-based agents employed to treat cancer. Antineoplastic chemotherapy works by arresting or killing the growth and spread of cancer cells. Chemotherapy may also include agents that enhance immune function or alter hormonal activity.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._A written explanation or criticism or illustration that is added to a book or other textual material.</PreferredDefinition>
      <LongName>Chemotherapy Data Comment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2751999</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15632:C25474</PreferredName>
        <Version>1</Version>
        <LongName>Chemotherapy Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15632</PREFERRED_NAME>
            <LONG_NAME>Chemotherapy</LONG_NAME>
            <CON_ID>2202708</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223274</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25393</PreferredName>
        <Version>1</Version>
        <LongName>Comment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25393</PREFERRED_NAME>
            <LONG_NAME>Comment</LONG_NAME>
            <CON_ID>2202716</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Chemotherapy Data Comment java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Chemotherapy Data Comment java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.ChemotherapyData.comments</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ChemotherapyData:comments</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="134">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752769</PUBLICID>
    <LONGNAME>Neoplasm Specimen Biopsy Tissue Collection Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2752253v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An abnormal tissue growth resulted from uncontrolled cell proliferation.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis._A repository of the tissue specimen, cells or cell lines, for experimental purpose. It can be from different diseases or different parts of the body.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752253</PublicId>
      <PreferredName>2752001v1.0:2751860v1.0</PreferredName>
      <PreferredDefinition>An abnormal tissue growth resulted from uncontrolled cell proliferation.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis._A repository of the tissue specimen, cells or cell lines, for experimental purpose. It can be from different diseases or different parts of the body.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Neoplasm Specimen Biopsy Tissue Collection Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2752001</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3262:C19157:C15189</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm Specimen Biopsy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15189</PREFERRED_NAME>
            <LONG_NAME>Biopsy Procedure</LONG_NAME>
            <CON_ID>2202502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2751860</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15339:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Collection Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15339</PREFERRED_NAME>
            <LONG_NAME>Tissue Collection</LONG_NAME>
            <CON_ID>2222487</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Neoplasm Specimen Biopsy Tissue Collection Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Neoplasm Specimen Biopsy Tissue Collection Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.TumorSpecimenBiopsy.tissueBankID</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TumorSpecimenBiopsy:tissueBankID</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="135">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752887</PUBLICID>
    <LONGNAME>Disease or Disorder Evaluation Clinical Study Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2752371v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria._Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, mechanism of human diseases, therapy, clinical trials, epidemiology, behavior and health services research.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752371</PublicId>
      <PreferredName>2752007v1.0:2555361v1.0</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria._Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, mechanism of human diseases, therapy, clinical trials, epidemiology, behavior and health services research.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Disease or Disorder Evaluation Clinical Study Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2752007</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C25214</PreferredName>
        <Version>1</Version>
        <LongName>Disease or Disorder Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2555361</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15206:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Study Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Disease or Disorder Evaluation Clinical Study Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Disease or Disorder Evaluation Clinical Study Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.DiseaseEvaluation.studyID</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DiseaseEvaluation:studyID</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="136">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752916</PUBLICID>
    <LONGNAME>Baseline Data Completed By Last Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2752400v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A starting point to which things may be compared.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._Indicates the person or authoritative body who made completed something.:A word or group of words indicating a person&#39;s last (family) name._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752400</PublicId>
      <PreferredName>2752010v1.0:2751744v1.0</PreferredName>
      <PreferredDefinition>A starting point to which things may be compared.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._Indicates the person or authoritative body who made completed something.:A word or group of words indicating a person&#39;s last (family) name.</PreferredDefinition>
      <LongName>Baseline Data Completed By Last Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2752010</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25213:C25474</PreferredName>
        <Version>1</Version>
        <LongName>Baseline Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25213</PREFERRED_NAME>
            <LONG_NAME>Baseline</LONG_NAME>
            <CON_ID>2202304</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2751744</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C73470:C40975</PreferredName>
        <Version>1</Version>
        <LongName>Completed By Last Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73470</PREFERRED_NAME>
            <LONG_NAME>Completed By</LONG_NAME>
            <CON_ID>2751675</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40975</PREFERRED_NAME>
            <LONG_NAME>Last Name</LONG_NAME>
            <CON_ID>2222026</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Baseline Data Completed By Last Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Baseline Data Completed By Last Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.BaselineData.lastNameComplete</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BaselineData:lastNameComplete</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="137">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2756211</PUBLICID>
    <LONGNAME>Other Function Entity Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2754101v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Different than the one(s) previously specified or mentioned.:The normal action performed by a structure or device.:An independently existing thing (living or nonliving)._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2754101</PublicId>
      <PreferredName>2753796v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned.:The normal action performed by a structure or device.:An independently existing thing (living or nonliving)._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Other Function Entity Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2753796</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25518:C51070</PreferredName>
        <Version>1</Version>
        <LongName>Other Function Entity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25518</PREFERRED_NAME>
            <LONG_NAME>Function</LONG_NAME>
            <CON_ID>2202643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Other Function Entity Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Other Function Entity Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2915522</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caNanoLab</PreferredName>
          <Version>1.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cananolab.domain.agentmaterial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2915882</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.particle.samplecomposition.functionalization.OtherFunctionalizingEntity.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OtherFunctionalizingEntity:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.agentmaterial.OtherFunctionalizingEntity.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="138">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2756542</PUBLICID>
    <LONGNAME>Expressed Sequence Tag Accession Number Version java.lang.String</LONGNAME>
    <PREFERREDNAME>2756456v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Refers to Sequence Tagged Sites (EST) that are represented in mRNA.  They are derived as 300-500 bp single-pass mRNA sequence reads from many of the genes expressed in a given tissue and/or at a given developmental stage. They represent a snapshot of gene expression in a given place or time._A control number unique to an object, used to identify it among the other objects in a collection.:A form or variant of a type or original._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2756456</PublicId>
      <PreferredName>2756423v1.0:2223256v1.0</PreferredName>
      <PreferredDefinition>Refers to Sequence Tagged Sites (EST) that are represented in mRNA.  They are derived as 300-500 bp single-pass mRNA sequence reads from many of the genes expressed in a given tissue and/or at a given developmental stage. They represent a snapshot of gene expression in a given place or time._A control number unique to an object, used to identify it among the other objects in a collection.:A form or variant of a type or original.</PreferredDefinition>
      <LongName>Expressed Sequence Tag Accession Number Version</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2756423</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18155</PreferredName>
        <Version>1</Version>
        <LongName>Expressed Sequence Tag</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18155</PREFERRED_NAME>
            <LONG_NAME>Expressed Sequence Tag</LONG_NAME>
            <CON_ID>2223201</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223256</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25402:C25714</PreferredName>
        <Version>1</Version>
        <LongName>Accession Number Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25402</PREFERRED_NAME>
            <LONG_NAME>Accession Number</LONG_NAME>
            <CON_ID>2203569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Expressed Sequence Tag Accession Number Version java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Expressed Sequence Tag Accession Number Version java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000539</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000543</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000544</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ExpressedSequenceTag:accessionNumberVersion</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabio.domain.ExpressedSequenceTag.accessionNumberVersion</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="139">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2764477</PUBLICID>
    <LONGNAME>Dental Professional Practice Dental School Use Status</LONGNAME>
    <PREFERREDNAME>DENT_PP_DS_U_STA</PREFERREDNAME>
    <PREFERREDDEFINITION>the state of use as related to use of dental school resources in the business directed towards treatment and care of patients pertaining to a tooth or teeth, or to odontology.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2764388</PublicId>
      <PreferredName>DEN_PRP_DEN_SCH_USE</PreferredName>
      <PreferredDefinition>information related to use of dental school resources in the business directed towards treatment and care of patients pertaining to a tooth or teeth, or to odontology.</PreferredDefinition>
      <LongName>Dental Professional Practice Dental School Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443314</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C52673</PreferredName>
        <Version>1</Version>
        <LongName>Dental Professional Practice</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52673</PREFERRED_NAME>
            <LONG_NAME>Professional Practice</LONG_NAME>
            <CON_ID>2443152</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2764386</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52652:C25340</PreferredName>
        <Version>1</Version>
        <LongName>Dental School Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52652</PREFERRED_NAME>
            <LONG_NAME>Dental School</LONG_NAME>
            <CON_ID>2443128</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2764389</PublicId>
      <PreferredName>DEN_PP_USE_TP</PreferredName>
      <PreferredDefinition>the state of use by dental professional practice.</PreferredDefinition>
      <LongName>Dental Professional Practice Use Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Most Influence</VALIDVALUE>
          <VALUEMEANING>Most Influence</VALUEMEANING>
          <MEANINGDESCRIPTION>Most Influence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2764390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some Influence</VALIDVALUE>
          <VALUEMEANING>Some Influence</VALUEMEANING>
          <MEANINGDESCRIPTION>Some Influence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2764391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Little Influence</VALIDVALUE>
          <VALUEMEANING>Little Influence</VALUEMEANING>
          <MEANINGDESCRIPTION>Little Influence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2764392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Symposiums or other offerings</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Symposiums or other offerings by a school of dentistry</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="140">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2768759</PUBLICID>
    <LONGNAME>Answer Metadata External Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2768710v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A statement (either spoken or written) that is made in reply to a question or request or criticism or accusation; a statement that solves a problem or explains how to solve the problem.:Data about data; information that describes another set of data._Happening or arising or located outside or beyond some limits, or especially, some surface.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2768710</PublicId>
      <PreferredName>2768691v1.0:2422660v1.0</PreferredName>
      <PreferredDefinition>A statement (either spoken or written) that is made in reply to a question or request or criticism or accusation; a statement that solves a problem or explains how to solve the problem.:Data about data; information that describes another set of data._Happening or arising or located outside or beyond some limits, or especially, some surface.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Answer Metadata External Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2768691</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49149:C52095</PreferredName>
        <Version>1</Version>
        <LongName>Answer Metadata</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49149</PREFERRED_NAME>
            <LONG_NAME>Answer</LONG_NAME>
            <CON_ID>2538654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52095</PREFERRED_NAME>
            <LONG_NAME>Metadata</LONG_NAME>
            <CON_ID>2521487</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2422660</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C44280:C25364</PreferredName>
        <Version>1</Version>
        <LongName>External Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44280</PREFERRED_NAME>
            <LONG_NAME>External</LONG_NAME>
            <CON_ID>2422632</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Answer Metadata External Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Answer Metadata External Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2768653</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIG Integration Hub</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG Integration Hub 2.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2967092</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2768653</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIG Integration Hub</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caxchange</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000646</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ResponseMetadata:externalIdentifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caxchange.ResponseMetadata.externalIdentifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="141">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2769934</PUBLICID>
    <LONGNAME>Hysterectomy Fluorescence in situ Hybridization Performed Ind-2</LONGNAME>
    <PREFERREDNAME>HYST_FISH_PERF_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicatory whether a surgical procedure to remove the uterus was performed along with a confirmatory Fluorescence in situ Hybridization test, a physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2769932</PublicId>
      <PreferredName>HYSTERECT_FISH_PERF</PreferredName>
      <PreferredDefinition>information related to the surgical procedure to remove the uterus and a confirmatory Fluorescence in situ Hybridization, a physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin, having been performed.</PreferredDefinition>
      <LongName>Hysterectomy Fluorescence in situ Hybridization Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2677655</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15256</PreferredName>
        <Version>1</Version>
        <LongName>Hysterectomy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15256</PREFERRED_NAME>
            <LONG_NAME>Hysterectomy</LONG_NAME>
            <CON_ID>2211763</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2769930</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17563:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Fluorescence in situ Hybridization Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17563</PREFERRED_NAME>
            <LONG_NAME>Fluorescence In Situ Hybridization</LONG_NAME>
            <CON_ID>2221360</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Age 54 or younger with a prio</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Age 54 or younger with a prior hysterectomy without oophorectomy (or in whom the status of the ovaries is unknown), with a documented FSH level demonstrating confirmatory elevation in the lab&#39;s postmenopausal range?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have at least one ovary and has had a hysterectomy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Char.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="142">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2771007</PUBLICID>
    <LONGNAME>Therapeutic Procedure Prior Malignant Neoplasm Administration Year Date</LONGNAME>
    <PREFERREDNAME>TX_P_MAIL_ADM_YR_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date, by year, that the prior action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process of cancer, term for diseases in which abnormal cells divide without control.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2771009</PublicId>
      <PreferredName>TX_P_MALIG_ADM</PreferredName>
      <PreferredDefinition>information related to the prior action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process of cancer, term for diseases in which abnormal cells divide without control.</PreferredDefinition>
      <LongName>Therapeutic Procedure Prior Malignant Neoplasm Administration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2771006</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C9305:C25409</PreferredName>
        <Version>1</Version>
        <LongName>Prior Malignant Neoplasm Administration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2195353</PublicId>
      <PreferredName>YR_DT</PreferredName>
      <PreferredDefinition>the numeric representation of the calendar year. </PreferredDefinition>
      <LongName>Year Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY</DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208026</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29848:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Year Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29848</PREFERRED_NAME>
            <LONG_NAME>Year</LONG_NAME>
            <CON_ID>2203986</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Year last given</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="143">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2771805</PUBLICID>
    <LONGNAME>Immunotherapy Erythropoietin Prior Administered Most Recent Date</LONGNAME>
    <PREFERREDNAME>IM_ERYT_P_ADM_MR_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date of the most recent prior administration of synthetic erythropoietin, a glycoprotein hormone, secreted chiefly by the kidney in the adult and the liver in the fetus, that acts on erythroid stem cells of the bone marrow to stimulate proliferation and differentiation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2771791</PublicId>
      <PreferredName>IT_ERYTH_P_ADM</PreferredName>
      <PreferredDefinition>information related to the prior administration of synthetic erythropoietin, a glycoprotein hormone, secreted chiefly by the kidney in the adult and the liver in the fetus, that acts on erythroid stem cells of the bone marrow to stimulate proliferation and differentiation.</PreferredDefinition>
      <LongName>Immunotherapy Erythropoietin Prior Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2554222</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15262</PreferredName>
        <Version>1</Version>
        <LongName>Immunotherapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15262</PREFERRED_NAME>
            <LONG_NAME>Immunotherapy</LONG_NAME>
            <CON_ID>2202664</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2771789</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20429:C25629:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Erythropoietin Prior Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20429</PREFERRED_NAME>
            <LONG_NAME>Erythropoietin</LONG_NAME>
            <CON_ID>2459801</CON_ID>
            <DEFINITION_SOURCE>MSH2002_06_01</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188928</PublicId>
      <PreferredName>MOSTRECENT_DT</PreferredName>
      <PreferredDefinition>the most recent date of an event, assessment, or treatment.</PreferredDefinition>
      <LongName>Most Recent Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yyyy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25577:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Most Recent Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25577</PREFERRED_NAME>
            <LONG_NAME>Most Recent</LONG_NAME>
            <CON_ID>2206311</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="144">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2772934</PUBLICID>
    <LONGNAME>Storage Space Change Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2772290v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The act of safekeeping goods in a depository.:An empty area; an area set apart or available for use._The act of alteration or modification; changed or altered in form or character.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2772290</PublicId>
      <PreferredName>2772231v1.0:2539482v1.0</PreferredName>
      <PreferredDefinition>The act of safekeeping goods in a depository.:An empty area; an area set apart or available for use._The act of alteration or modification; changed or altered in form or character.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Storage Space Change Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2772231</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C60824:C63629</PreferredName>
        <Version>1</Version>
        <LongName>Storage Space</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60824</PREFERRED_NAME>
            <LONG_NAME>Storage</LONG_NAME>
            <CON_ID>2547381</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63629</PREFERRED_NAME>
            <LONG_NAME>Space</LONG_NAME>
            <CON_ID>2666768</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2539482</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Change Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Storage Space Change Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Storage Space Change Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813050</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.administration.StorageSpace.dateModified</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StorageSpace:dateModified</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="145">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2773200</PUBLICID>
    <LONGNAME>Polymerase Chain Reaction Product Expected Size java.lang.Long</LONGNAME>
    <PREFERREDNAME>2772550v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.:The end result of a manufacturing process; anything that is produced._Considered likely or probable; anticipated.:The physical magnitude of something._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2772550</PublicId>
      <PreferredName>2772256v1.0:2772222v1.0</PreferredName>
      <PreferredDefinition>A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.:The end result of a manufacturing process; anything that is produced._Considered likely or probable; anticipated.:The physical magnitude of something.</PreferredDefinition>
      <LongName>Polymerase Chain Reaction Product Expected Size</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2772256</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17003:C51980</PreferredName>
        <Version>1</Version>
        <LongName>Polymerase Chain Reaction Product</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17003</PREFERRED_NAME>
            <LONG_NAME>Polymerase Chain Reaction</LONG_NAME>
            <CON_ID>2202449</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51980</PREFERRED_NAME>
            <LONG_NAME>Product</LONG_NAME>
            <CON_ID>2527882</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2772222</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25501:C25681</PreferredName>
        <Version>1</Version>
        <LongName>Expected Size</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25501</PREFERRED_NAME>
            <LONG_NAME>Expected</LONG_NAME>
            <CON_ID>2203925</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25681</PREFERRED_NAME>
            <LONG_NAME>Size</LONG_NAME>
            <CON_ID>2203799</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Polymerase Chain Reaction Product Expected Size java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Polymerase Chain Reaction Product Expected Size java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.PCRProduct.expectedSize</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCRProduct:expectedSize</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="146">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2773350</PUBLICID>
    <LONGNAME>Molecule Specimen Created By java.lang.String</LONGNAME>
    <PREFERREDNAME>2772696v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._Indicates the person or authoritative body who brought the item into existence._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2772696</PublicId>
      <PreferredName>2772243v1.0:2231611v1.0</PreferredName>
      <PreferredDefinition>An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._Indicates the person or authoritative body who brought the item into existence.</PreferredDefinition>
      <LongName>Molecule Specimen Created By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2772243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63816:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Molecule Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63816</PREFERRED_NAME>
            <LONG_NAME>Molecule</LONG_NAME>
            <CON_ID>2612116</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42628</PreferredName>
        <Version>1</Version>
        <LongName>Created By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42628</PREFERRED_NAME>
            <LONG_NAME>Created By</LONG_NAME>
            <CON_ID>2231551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Molecule Specimen Created By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Molecule Specimen Created By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MolecularSpecimen:createdBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.MolecularSpecimen.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="147">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2773358</PUBLICID>
    <LONGNAME>Molecule Specimen Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2772704v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2772704</PublicId>
      <PreferredName>2772243v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>An aggregate of two or more atoms in a defined arrangement held together by chemical bonds.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Molecule Specimen Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2772243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63816:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Molecule Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63816</PREFERRED_NAME>
            <LONG_NAME>Molecule</LONG_NAME>
            <CON_ID>2612116</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Molecule Specimen Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Molecule Specimen Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.MolecularSpecimen.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MolecularSpecimen:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="148">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2773465</PUBLICID>
    <LONGNAME>Polymerase Chain Reaction Product Created By java.lang.String</LONGNAME>
    <PREFERREDNAME>2772810v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.:The end result of a manufacturing process; anything that is produced._Indicates the person or authoritative body who brought the item into existence._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2772810</PublicId>
      <PreferredName>2772256v1.0:2231611v1.0</PreferredName>
      <PreferredDefinition>A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.:The end result of a manufacturing process; anything that is produced._Indicates the person or authoritative body who brought the item into existence.</PreferredDefinition>
      <LongName>Polymerase Chain Reaction Product Created By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2772256</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17003:C51980</PreferredName>
        <Version>1</Version>
        <LongName>Polymerase Chain Reaction Product</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17003</PREFERRED_NAME>
            <LONG_NAME>Polymerase Chain Reaction</LONG_NAME>
            <CON_ID>2202449</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51980</PREFERRED_NAME>
            <LONG_NAME>Product</LONG_NAME>
            <CON_ID>2527882</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42628</PreferredName>
        <Version>1</Version>
        <LongName>Created By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42628</PREFERRED_NAME>
            <LONG_NAME>Created By</LONG_NAME>
            <CON_ID>2231551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Polymerase Chain Reaction Product Created By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Polymerase Chain Reaction Product Created By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.PCRProduct.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCRProduct:createdBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="149">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2773520</PUBLICID>
    <LONGNAME>Fluid Specimen Status java.lang.String</LONGNAME>
    <PREFERREDNAME>2772859v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A continuous amorphous substance that tends to flow and to conform to the outline of its container (i.e., a liquid or a gas).  Also used as an adjective to describe something with properties like that of a fluid.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A condition or state at a particular time._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2772859</PublicId>
      <PreferredName>2513376v1.0:2320064v1.0</PreferredName>
      <PreferredDefinition>A continuous amorphous substance that tends to flow and to conform to the outline of its container (i.e., a liquid or a gas).  Also used as an adjective to describe something with properties like that of a fluid.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Fluid Specimen Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2513376</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25278:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Fluid Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25278</PREFERRED_NAME>
            <LONG_NAME>Fluid</LONG_NAME>
            <CON_ID>2202644</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2320064</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Fluid Specimen Status java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Fluid Specimen Status java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.FluidSpecimen.status</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FluidSpecimen:status</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="150">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2775920</PUBLICID>
    <LONGNAME>Laboratory Procedure Hematocrit Outcome Missing Value Reason Indicator</LONGNAME>
    <PREFERREDNAME>2195885v1.0:2756825v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>information related to the results of the medical procedure that involves testing a sample of blood for hematocrit, the percentage of a whole blood specimen that is composed of red blood cells (erythrocytes)._A specific reason explaining why a meaningful value is not available.  A meaningful value answers the question posed by a Data Element Concept.  In contrast, a Missing Value Reason answers the implicit question &quot;Why is there no &#39;meaningful&#39; value?&quot;, when there is none._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195885</PublicId>
      <PreferredName>LAB_HEMAT_OC</PreferredName>
      <PreferredDefinition>information related to the results of the medical procedure that involves testing a sample of blood for hematocrit, the percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).</PreferredDefinition>
      <LongName>Laboratory Procedure Hematocrit Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2739307</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C64796:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Hematocrit Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64796</PREFERRED_NAME>
            <LONG_NAME>Hematocrit Measurement</LONG_NAME>
            <CON_ID>2660103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2756825</PublicId>
      <PreferredName>MISS_IND</PreferredName>
      <PreferredDefinition>A specific reason explaining why a meaningful value is not available.  A meaningful value answers the question posed by a Data Element Concept.  In contrast, a Missing Value Reason answers the implicit question &quot;Why is there no &#39;meaningful&#39; value?&quot;, when there is none._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Missing Value Reason Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2756824</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48655:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Missing Value Reason Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48655</PREFERRED_NAME>
            <LONG_NAME>Missing Value Reason</LONG_NAME>
            <CON_ID>2431146</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-quantitative</VALIDVALUE>
          <VALUEMEANING>Negation Quantitative</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Capable of being estimated or expressed with numeric values.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70766, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2777712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested</VALIDVALUE>
          <VALUEMEANING>Negation Test</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47891, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2756826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown/not applicable</VALIDVALUE>
          <VALUEMEANING>Unknown Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.: Determination that a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660, C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2756827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested / unknown</VALIDVALUE>
          <VALUEMEANING>Negation Test Or Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.: Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998, C37998, C47891, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3262968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not measurable</VALIDVALUE>
          <VALUEMEANING>Non-Measurable</VALUEMEANING>
          <MEANINGDESCRIPTION>Non-Measurable; not possible to be measured.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2678954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the reason for the he</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the reason for the hematocrit missing value?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Not tested</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Not tested</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2775920</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedClinicalResult.valueNullFlavorReason WHERE PerformedClinicalResult &gt; PerformedObservation &gt; DefinedObservation.nameCode = &quot;Measure Hematocrit&quot; AND PerformedObservation.negationIndicator = &quot;true&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2000r1: Recipient Baseline Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964872</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2100r1: 100 Days Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964902</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2200r1: 6 Month to 2 Year Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964922</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>current_hct_nt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>prep_hct_nt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedClinicalResult:valueNullFlavorReason</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="151">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2783824</PUBLICID>
    <LONGNAME>Kidney Pathology Sarcomatoid Carcinoma Element Percentage java.lang.Double</LONGNAME>
    <PREFERREDNAME>2783059v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>One of the two organs that excrete the urine. The kidneys are bean-shaped organs (about 11 cm long, 5 cm wide, and 3 cm thick) lying on either side of the vertebral column, posterior to the peritoneum, about opposite the twelfth thoracic and first three lumbar vertebrae.:The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination._A malignant epithelial neoplasm characterized by the presence of spindle cells and anaplastic morphologic features.  Giant cells and a sarcomatous component may also be present.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.:A fraction or ratio with 100 understood as the denominator._Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2783059</PublicId>
      <PreferredName>2782811v1.0:2782710v1.0</PreferredName>
      <PreferredDefinition>One of the two organs that excrete the urine. The kidneys are bean-shaped organs (about 11 cm long, 5 cm wide, and 3 cm thick) lying on either side of the vertebral column, posterior to the peritoneum, about opposite the twelfth thoracic and first three lumbar vertebrae.:The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination._A malignant epithelial neoplasm characterized by the presence of spindle cells and anaplastic morphologic features.  Giant cells and a sarcomatous component may also be present.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.:A fraction or ratio with 100 understood as the denominator.</PreferredDefinition>
      <LongName>Kidney Pathology Sarcomatoid Carcinoma Element Percentage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2782811</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12415:C18189</PreferredName>
        <Version>1</Version>
        <LongName>Kidney Pathology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12415</PREFERRED_NAME>
            <LONG_NAME>Kidney</LONG_NAME>
            <CON_ID>2204911</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2782710</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C27004:C48792:C25613</PreferredName>
        <Version>1</Version>
        <LongName>Sarcomatoid Carcinoma Element Percentage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C27004</PREFERRED_NAME>
            <LONG_NAME>Sarcomatoid Carcinoma</LONG_NAME>
            <CON_ID>2204869</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48792</PREFERRED_NAME>
            <LONG_NAME>Element</LONG_NAME>
            <CON_ID>2513271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Kidney Pathology Sarcomatoid Carcinoma Element Percentage java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Kidney Pathology Sarcomatoid Carcinoma Element Percentage java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_SCG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000322</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_SCG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000323</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>KidneyPathologyAnnotation:percentOfSarcomatoidElement</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.PathAnnotation_SCG.KidneyPathologyAnnotation.percentOfSarcomatoidElement</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="152">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2784046</PUBLICID>
    <LONGNAME>Extensible Markup Language Content Data java.lang.String</LONGNAME>
    <PREFERREDNAME>2783278v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A general-purpose markup language for creating special-purpose markup languages. It is capable of describing many different kinds of data. Its primary purpose is to facilitate the sharing of data across different systems, particularly systems connected via the Internet.:Everything that is included in a collection, container, or communication._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2783278</PublicId>
      <PreferredName>2782835v1.0:2423441v1.0</PreferredName>
      <PreferredDefinition>A general-purpose markup language for creating special-purpose markup languages. It is capable of describing many different kinds of data. Its primary purpose is to facilitate the sharing of data across different systems, particularly systems connected via the Internet.:Everything that is included in a collection, container, or communication._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.</PreferredDefinition>
      <LongName>Extensible Markup Language Content Data</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2782835</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45967:C44476</PreferredName>
        <Version>1</Version>
        <LongName>Extensible Markup Language Content</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45967</PREFERRED_NAME>
            <LONG_NAME>Extensible Markup Language</LONG_NAME>
            <CON_ID>2388826</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44476</PREFERRED_NAME>
            <LONG_NAME>Content</LONG_NAME>
            <CON_ID>2236544</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2423441</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25474</PreferredName>
        <Version>1</Version>
        <LongName>Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Extensible Markup Language Content Data java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Extensible Markup Language Content Data java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.pathology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000671</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.pathology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000670</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XMLContent:data</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.pathology.XMLContent.data</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="153">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2816879</PUBLICID>
    <LONGNAME>Chronic Disease Infection Ind-3</LONGNAME>
    <PREFERREDNAME>CHR_DZ_INFEC_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator that asks whether the patient/participant has an infection.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195401</PublicId>
      <PreferredName>CHR_DZ_INFEC</PreferredName>
      <PreferredDefinition>information related to chronic infection.</PreferredDefinition>
      <LongName>Chronic Disease Infection</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206569</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14141:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Chronic Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14141</PREFERRED_NAME>
            <LONG_NAME>Chronic</LONG_NAME>
            <CON_ID>2206176</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177458</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Infection</PreferredName>
        <Version>1</Version>
        <LongName>Infection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26726</PREFERRED_NAME>
            <LONG_NAME>Infectious Disorder</LONG_NAME>
            <CON_ID>2203837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Infection</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Infection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have active infection or chronic infection requiring chronic suppressive antibiotics?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a known active infection of HCV?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have severe and/or symptomatic refractory concurrent infection other than EBV?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient have severe infections within 4 weeks of the anticipated Cycle 1, Day 1 (including, but not limited to, hospitalization for complications of infection, bacteremia, or severe pneumonia)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient had severe infections within 28 days prior to randomization, including but not limited to, hospitalization for complications of infection, bacteremia, or severe pneumonia?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>HCMI Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Infection history?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have an active uncontrolled infection?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>crf test 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have an Active uncontrolled infection?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have active or chronic infection requiring systemic therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRT Text_8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient currently have an active uncontrolled infection requiring IV antibiotics?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Within 4 weeks prior to randomization, does the patient have severe infection, including but not limited, to hospitalization for complications of infection, bacteremia, or severe pneumonia?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have severe infections within 4 weeks prior to registration including, but not limited to, hospitalization for complications of infection, bacteremia, or severe pneumonia?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Severe infection requiring IV antibiotics at the time of registration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_eCRF_Text_1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have an active infection, including tuberculosis, requiring antibiotic therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_eCRF_Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have an active infection, including tuberculosis, hepatitis B, or hepatitis C, requiring antibiotic therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Ongoing or active severe infection requiring IV antibiotics at time of registration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 13</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Infection requiring IV antibiotics at the time of study entry?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 14</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have an active infection, including tuberculosis (clinical evaluation that includes clinical history, physical examination and radiographic findings, and TB testing in line with local practice), hepatitis B (known positive HBV surface antigen (HBsAg) result), or hepatitis C?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 15</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have severe infections within 3 weeks prior to registration including, but not limited to, hospitalization for complications of infection, bacteremia, or severe pneumonia?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_eCRF_Text_2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Within 4 weeks prior to study entry, does the patient have severe infection, including but not limited to, hospitalization for complications of infection, bacteremia, or severe pneumonia?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF_Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have history of hepatitis C virus (HCV) infection?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a known, recent EBV infection or known history of chronic, active infection?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient meet the HIV, Hepatitis B, and Hepatitis C criteria in the protocol?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient infected with HIV?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have a known HIV infection?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1216</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104934</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1221</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104935</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0920</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pediatric Liver Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7589448</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CHR_DZ_INFEC_IND3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>chronic dieases infection ind-3</AlternateName>
        <AlternateNameType>HCMI Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="154">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2828463</PUBLICID>
    <LONGNAME>Biomarker Mean Chromosome Segment Biomarker Number java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2828412v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A variation in cellular or biochemical components or processes, structures, or functions that is objectively measurable in a biological system and that characterizes normal biologic processes, pathogenic processes, an organism&#39;s state of health or disease, likelihood of developing a disease, prognosis, or response to a particular therapeutic intervention. Biomarkers include but not limited to such phenotypic parameters as specific enzyme or hormone concentration, specific gene phenotype, presence or absence of biological substances.:The sum of a set of values divided by the number of values in the set.:One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.:One of the parts into which something naturally divides._A variation in cellular or biochemical components or processes, structures, or functions that is objectively measurable in a biological system and that characterizes normal biologic processes, pathogenic processes, an organism&#39;s state of health or disease, likelihood of developing a disease, prognosis, or response to a particular therapeutic intervention. Biomarkers include but not limited to such phenotypic parameters as specific enzyme or hormone concentration, specific gene phenotype, presence or absence of biological substances.:A numeral or string of numerals expressing value, quantity, or identification._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2828412</PublicId>
      <PreferredName>2828379v1.0:2828364v1.0</PreferredName>
      <PreferredDefinition>A variation in cellular or biochemical components or processes, structures, or functions that is objectively measurable in a biological system and that characterizes normal biologic processes, pathogenic processes, an organism&#39;s state of health or disease, likelihood of developing a disease, prognosis, or response to a particular therapeutic intervention. Biomarkers include but not limited to such phenotypic parameters as specific enzyme or hormone concentration, specific gene phenotype, presence or absence of biological substances.:The sum of a set of values divided by the number of values in the set.:One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.:One of the parts into which something naturally divides._A variation in cellular or biochemical components or processes, structures, or functions that is objectively measurable in a biological system and that characterizes normal biologic processes, pathogenic processes, an organism&#39;s state of health or disease, likelihood of developing a disease, prognosis, or response to a particular therapeutic intervention. Biomarkers include but not limited to such phenotypic parameters as specific enzyme or hormone concentration, specific gene phenotype, presence or absence of biological substances.:A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Biomarker Mean Chromosome Segment Biomarker Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2828379</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16342:C53319:C13202:C45312</PreferredName>
        <Version>1</Version>
        <LongName>Biomarker Mean Chromosome Segment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16342</PREFERRED_NAME>
            <LONG_NAME>Biomarker</LONG_NAME>
            <CON_ID>2202308</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53319</PREFERRED_NAME>
            <LONG_NAME>Arithmetic Mean</LONG_NAME>
            <CON_ID>2528578</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13202</PREFERRED_NAME>
            <LONG_NAME>Chromosome</LONG_NAME>
            <CON_ID>2203872</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45312</PREFERRED_NAME>
            <LONG_NAME>Segment</LONG_NAME>
            <CON_ID>2480800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2828364</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16342:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Biomarker Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16342</PREFERRED_NAME>
            <LONG_NAME>Biomarker</LONG_NAME>
            <CON_ID>2202308</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Biomarker Mean Chromosome Segment Biomarker Number java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Biomarker Mean Chromosome Segment Biomarker Number java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2620091</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GenePattern</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GISTIC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2828339</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2620091</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GenePattern</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.icr.asrv1.dnacopy</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2828340</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.icr.asrv1.dnacopy.ChromosomalSegmentWithMeanAndMarker.numberMarkers</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ChromosomalSegmentWithMeanAndMarker:numberMarkers</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="155">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2859704</PUBLICID>
    <LONGNAME>Microarray Design Element Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2859662v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.:An element of an array.  This is generally of type feature but can be specified as reporters or compositeSequence for arrays that are abstracted from a physical array. (caMAGE)_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2859662</PublicId>
      <PreferredName>2859631v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.:An element of an array.  This is generally of type feature but can be specified as reporters or compositeSequence for arrays that are abstracted from a physical array. (caMAGE)_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Microarray Design Element Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859631</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C44282:C43445</PreferredName>
        <Version>1</Version>
        <LongName>Microarray Design Element</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44282</PREFERRED_NAME>
            <LONG_NAME>Microarray</LONG_NAME>
            <CON_ID>2223237</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43445</PREFERRED_NAME>
            <LONG_NAME>Design Element</LONG_NAME>
            <CON_ID>2236522</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Microarray Design Element Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Microarray Design Element Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.array</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812742</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.array</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000649</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.array</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000652</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AbstractDesignElement:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.array.AbstractDesignElement.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="156">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2861291</PUBLICID>
    <LONGNAME>Cladribine Administered Indicator</LONGNAME>
    <PREFERREDNAME>2861289v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not cladribine was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2861289</PublicId>
      <PreferredName>2861287v1.0:2233610v1.0</PreferredName>
      <PreferredDefinition>A purine nucleoside antimetabolite analogue. Cladribine triphosphate, a phosphorylated metabolite of cladribine, incorporates into DNA, resulting in single-strand breaks in DNA, depletion of nicotinamide adenine dinucleotide (NAD) and adenosine triphosphate (ATP), and apoptosis.  Because this agent is resistant to adenosine deaminase, an enzyme that inactivates some antineoplastic agents, it is selectively toxic to lymphocytes and monocytes which exhibit little deoxynucleotide deaminase activity. (NCI04)_The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Cladribine Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2861287</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1336</PreferredName>
        <Version>1</Version>
        <LongName>Cladribine</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1336</PREFERRED_NAME>
            <LONG_NAME>Cladribine</LONG_NAME>
            <CON_ID>2521211</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was cladribine administered?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was cladribine administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cladribine</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cladribine</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cladribine (2-CdA, Leustatin)</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Cladribine (2-CdA, Leustatin)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2018r1: Lymphoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2013r1: CLL Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964930</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2842912</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Therapy</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Systemic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2842916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cll_base_tx_cladribne_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lym_base_tx_cladribne_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_LTHM_cladribine_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_therapy_multi_cladribine_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpost_therapy_multi_cladribine_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpre_therapy_multi_cladribine_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_DRPI_cladribine_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="157">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2861541</PUBLICID>
    <LONGNAME>Systemic Therapy Administered Type</LONGNAME>
    <PREFERREDNAME>2014193v1.0:2789942v2.1</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the systemic therapy administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014193</PublicId>
      <PreferredName>SYSTX_ADM</PreferredName>
      <PreferredDefinition>the administration of systemic therapy to an individual.</PreferredDefinition>
      <LongName>Systemic Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176918</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Systemic Therapy</PreferredName>
        <Version>1</Version>
        <LongName>Systemic Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15698</PREFERRED_NAME>
            <LONG_NAME>Systemic Therapy</LONG_NAME>
            <CON_ID>2202843</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177665</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Administered</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2789942</PublicId>
      <PreferredName>2789942v2.1</PreferredName>
      <PreferredDefinition>An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Therapeutic Procedure Type</LongName>
      <Version>2.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2749690</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Substrate deprivation / inhibitor</VALIDVALUE>
          <VALUEMEANING>Substrate Deprivation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A therapeutic procedure based on the inhibition or reduction of the biosynthesis of compounds that cannot break down in the cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gene transfer / gene therapy</VALIDVALUE>
          <VALUEMEANING>Gene Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Application of genetic material (usually DNA) into cells in order to permanently correct an inherited disease or an acquired disease such as cancer.  The genetic material as &#39;naked&#39; DNA can be delivered into the cells alone or can be delivered into cells by different types of vectors such as viruses which may contain DNA or RNA.  Gene therapy techniques attempt to replace a faulty/missing gene associated with a particular disease, mediate localized delivery of a protein producing specified therapeutic effects, or introduce new cellular functions.  Gene therapies are designed to deliver genetic material into somatic cells and not germ cells, so that only cells of patients and not those of their offspring contain and express the genetic material delivered. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3082843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enzyme replacement</VALIDVALUE>
          <VALUEMEANING>Protein Replacement Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Administration of a protein to compensate for the loss, as from disease or surgery, of a gland or tissue that would normally produce the protein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2980740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systemic therapy</VALIDVALUE>
          <VALUEMEANING>Systemic Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>(sis-TEM-ik THER-a-pee) Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3102869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pharmaceutical</VALIDVALUE>
          <VALUEMEANING>Pharmacologic Substance</VALUEMEANING>
          <MEANINGDESCRIPTION>Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1909</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3913791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Etanercept</VALIDVALUE>
          <VALUEMEANING>Etanercept</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant soluble dimeric fusion protein consisting of the extracellular ligand-binding region of recombinant human tumor necrosis factor (rhTNF) receptor attached to the constant (Fc) region of human immunoglobulin G (FcIgG). The receptor moiety of etanercept binds to circulating TNF (2 molecules of TNF per receptor) and inhibits its attachment to endogenous TNF cell surface receptors, thereby rendering TNF inactive and inhibiting TNF-mediated mechanisms of inflammation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5126589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infliximab</VALIDVALUE>
          <VALUEMEANING>Infliximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant chimeric, mouse-human monoclonal antibody directed against tumor necrosis factor alpha (TNF-alpha), a protein involved in inflammation, cell survival, and apoptosis.  Infliximab may be pro- apoptotic or anti-apoptotic, depending on cell type. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3235990</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclosporine</VALIDVALUE>
          <VALUEMEANING>Cyclosporine</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural cyclic polypeptide immunosuppressant isolated from the fungus Beauveria nivea. The exact mechanism of action of cyclosporine is not known but may involve binding to the cellular protein cytophilin, resulting in inhibition of the enzyme calcineurin. This agent appears to specifically and reversibly inhibit immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited with T-helper cells as the primary target. Cyclosporine also inhibits lymphokine production and release. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3253643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alemtuzumab</VALIDVALUE>
          <VALUEMEANING>Alemtuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant DNA-derived humanized monoclonal antibody directed against the cell surface glycoprotein, CD52. Alemtuzumab is an IgG1 kappa with human variable framework and constant regions, and complementarity-determining regions derived from a rat monoclonal antibody. This agent selectively binds to CD52, thereby triggering a host immune response that results in lysis of CD52 + cells. CD52 is a glycoprotein expressed on the surface of essentially all normal and malignant B and T cells, a majority of monocytes, macrophages and natural killer (NK) cells, a subpopulation of granulocytes, and tissues of the male reproductive system. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corticosteroids (systemic)</VALIDVALUE>
          <VALUEMEANING>Systemic Corticosteroid Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment with corticosteroids via a delivery method that will affect the entire body (oral, intramuscular, intravenous).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122080</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti CD 25</VALIDVALUE>
          <VALUEMEANING>Daclizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody that is being studied in the treatment of adult T-cell leukemia and in the treatment of cytopenia (low blood cell count).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ALG, ALS, ATG, ATS</VALIDVALUE>
          <VALUEMEANING>Anti-Thymocyte Globulin Antilymphocyte Serum</VALUEMEANING>
          <MEANINGDESCRIPTION>A purified gamma immunoglobulin (IgG) with immunosuppressive activity.  Obtained from animals that have been immunized with human thymocytes, antithymocyte globulin (ATG) specifically recognizes and destroys T lymphocytes.  Although not completely understood, the mechanism of action appears to involve T lymphocyte clearance from the circulation and modulation of T lymphocyte activity. Administering ATG with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host (GVH) disease.: Immunoglobulins raised xenogeneically against lymphocyte populations.  It is used both as a test for histocompatibility and in conjunction with other immunosuppressive agents to suppress rejection of grafts or organ transplants.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62577, C278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3125119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>In vivo immunotoxin</VALIDVALUE>
          <VALUEMEANING>in vivo Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>Located or occurring in the body.: Agents comprised of various toxic molecules (Radioactive Isotopes and Bacterial or Plant Toxins) conjugated with specific immune substances (Immunoglobulins, Monoclonal Antibodies, and Antigens) that targets affected cells allowing incorporation of the toxin into the cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C575, C15744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FK 506</VALIDVALUE>
          <VALUEMEANING>Tacrolimus</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug used to help reduce the risk of rejection by the body of organ and bone marrow transplants.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3305284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extra-corporeal photopheresis (ECP)</VALIDVALUE>
          <VALUEMEANING>Extracorporeal Photopheresis</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure which combines apheresis and photodynamic therapy, resulting in blood being treated with a photosensitizing agent and subsequently irradiated with specified wavelengths of light to achieve an effect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methotrexate (MTX)</VALIDVALUE>
          <VALUEMEANING>Methotrexate</VALUEMEANING>
          <MEANINGDESCRIPTION>An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bortezomib</VALIDVALUE>
          <VALUEMEANING>Bortezomib</VALUEMEANING>
          <MEANINGDESCRIPTION>A dipeptide boronic acid analogue with antineoplastic activity. Bortezomib reversibly inhibits the 26S proteasome, a large protease complex that degrades ubiquinated proteins. By blocking the targeted proteolysis normally performed by the proteasome, bortezomib disrupts various cell signaling pathways, leading to cell cycle arrest, apoptosis, and inhibition of angiogenesis. Specifically, the agent inhibits nuclear factor (NF)-kappaB, a protein that is constitutively activated in some cancers, thereby interfering with NF-kappaB-mediated cell survival, tumor growth, and angiogenesis. In vivo, bortezomib delays tumor growth and enhances the cytotoxic effects of radiation and chemotherapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sirolimus</VALIDVALUE>
          <VALUEMEANING>Sirolimus</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug used to keep the body from rejecting organ and bone marrow transplants. Rapamune blocks certain white blood cells that can reject foreign tissues and organs. It also blocks a protein that is involved in cell division. It is a type of antibiotic, a type of immunosuppressant, and a type of serine/threonine kinase inhibitor. Rapamune was previously called rapamycin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mycophenolate mofetil (MMF)</VALIDVALUE>
          <VALUEMEANING>Mycophenolate Mofetil</VALUEMEANING>
          <MEANINGDESCRIPTION>The mopholinoethyl ester of mycophenolic acid (MPA) with potent immunosuppressive properties.  Mycophenolate stops T-cell and B-cell proliferation through selective inhibition of the de novo pathway of purine biosynthesis.  In vivo, the active metabolite, MPA, reversibly inhibits inosine 5&#39;-monophosphate dehydrogenase, an enzyme involved in the de novo synthesis of guanine nucleotides.  MPA displays high lymphocyte specificity and cytotoxicity due to the higher dependence of activated lymphocytes on both salvage and de novo synthesis of guanine nucleotides relative to other cell types. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3253642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>In vivo monoclonal antibody</VALIDVALUE>
          <VALUEMEANING>in vivo Monoclonal Antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>Located or occurring in the body.: An antibody produced by a clone or genetically homogenous fast-growing cells i.e., hybridoma. Hybridoma cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis, and treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20401, C15744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pentostatin</VALIDVALUE>
          <VALUEMEANING>Pentostatin</VALUEMEANING>
          <MEANINGDESCRIPTION>The active ingredient in a drug that is used to treat hairy cell leukemia and is being studied in the treatment of other types of cancer. Pentostatin blocks a protein needed for cell growth and may kill cancer cells. It is made by a bacterium. It is a type of adenosine deaminase inhibitor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C732</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blinded randomized trial</VALIDVALUE>
          <VALUEMEANING>Blinded Randomized Clinical Trial</VALUEMEANING>
          <MEANINGDESCRIPTION>A characteristic of experiment design in which one or more groups involved (receiving, administering, or evaluating intervention) are unaware of which intervention any particular subject is receiving.: A study in which the participants are assigned by chance to separate groups that compare different treatments; neither the researchers nor the participants can choose which group. Using chance to assign people to groups means that the groups will be similar and that the treatments they receive can be compared objectively. At the time of the trial, it is not known which treatment is best. It is the patient&#39;s choice to be in a randomized trial.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15417, C49068</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JAK 2 inhibitors</VALIDVALUE>
          <VALUEMEANING>JAK2 Inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>Any substance that inhibits JAK2 tyrosine protein kinase, an enzyme that phosphorylates the hydroxyl group of tyrosine on various proteins in various signaling cascades.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tocilizumab</VALIDVALUE>
          <VALUEMEANING>Tocilizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, humanized IgG1 monoclonal antibody directed against the interleukin-6 receptor (IL-6R) with immunosuppressant activity. Tocilizumab targets and binds to both the soluble form of IL-6R (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of IL-6 to its receptor. This prevents IL-6-mediated signaling. Il-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders and certain types of cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4618052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PUVA</VALIDVALUE>
          <VALUEMEANING>PUVA Photochemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Phototherapy that combines the use of psoralen with UVA light as a treatment for various skin conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3865371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydroxychloroquine</VALIDVALUE>
          <VALUEMEANING>Hydroxychloroquine</VALUEMEANING>
          <MEANINGDESCRIPTION>A substance that decreases immune responses in the body.  It is used to treat some autoimmune diseases, and is being studied as a treatment for graft-versus-host disease. Hydroxychloroquine belongs to the family of drugs called antiprotozoals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin inhibitors</VALIDVALUE>
          <VALUEMEANING>Interleukin Inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>Any agent that inhibits the action of an interleukin. These agents inhibit various immune functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Azathioprine</VALIDVALUE>
          <VALUEMEANING>Azathioprine</VALUEMEANING>
          <MEANINGDESCRIPTION>A purine analogue with cytotoxic and immunosuppressive activity. Azathioprine is a prodrug that is converted by hepatic xanthine oxidase to its active metabolite 6-mercaptopurine (6-MP). 6-MP is further metabolized by hypoxanthine-guanine phosphoribosyltransferase (HGPRT) into 6-thioguanosine-5&#39;-phosphate (6-thio-GMP) and 6-thioinosine monophosphate (6-thio-IMP), both inhibit nucleotide conversions and de novo purine synthesis. This leads to inhibition of DNA, RNA, and protein synthesis. As a result, cell proliferation may be inhibited, particularly in lymphocytes and leukocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3128751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aldesleukin</VALIDVALUE>
          <VALUEMEANING>Aldesleukin</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant analog of the endogenous cytokine interleukin-2 (IL-2) with immunoregulatory and antineoplastic activities. Aldesleukin binds to and activates the IL-2 receptor, followed by heterodimerization of the cytoplasmic domains of the IL-2R beta and gamma(c) chains; activation of the tyrosine kinase Jak3; and phosphorylation of tyrosine residues on the IL-2R beta chain, resulting in an activated receptor complex. Various cytoplasmic signaling molecules are recruited to the activated receptor complex and become substrates for regulatory enzymes that are associated with the receptor complex. This agent enhances lymphocyte mitogenesis; stimulates long-term growth of human IL-2 dependent cell lines; enhances lymphocyte cytotoxicity; induces lymphokine-activated killer (LAK) cell and natural killer (NK) cell activities; and induces expression of interferon-gamma. Aldesleukin may induce T cell-mediated tumor regression in some tumor types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tyrosine kinase inhibitors (TKI)</VALIDVALUE>
          <VALUEMEANING>Tyrosine Kinase Inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>Any substance that inhibits tyrosine kinase, an enzyme involved in the transduction and processing of many extracellular and intracellular signals including cell proliferation. Inhibition of tyrosine kinase may result in inhibition of cell growth and cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rituximab</VALIDVALUE>
          <VALUEMEANING>Rituximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant chimeric murine/human antibody directed against the CD20 antigen, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes. Following binding, rituximab triggers a host cytotoxic immune response against CD20-positive cells. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UV therapy</VALIDVALUE>
          <VALUEMEANING>Ultraviolet Radiation</VALUEMEANING>
          <MEANINGDESCRIPTION>The invisible ultraviolet spectrum makes up one specific portion of sunlight. This unique portion accounts for three percent of all solar radiation reaching the earth. UV radiation causes many health problems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2620311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Defibrotide</VALIDVALUE>
          <VALUEMEANING>Defibrotide</VALUEMEANING>
          <MEANINGDESCRIPTION>A polydeoxyribonucleotide with antithrombotic, thrombolytic, and fibrinolytic properties.  Defibrotide induces the release of prostaglandin 12 and reduces the expression of adhesion molecules on endothelial cells, thereby interfering with platelet and leukocyte adhesion to the endothelium. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ursodiol</VALIDVALUE>
          <VALUEMEANING>Ursodiol</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetically-derived form of ursodiol, a bile acid produced by the liver and secreted and stored in the gallbladder.  Also produced by the Chinese black bear liver, ursodiol has been used in the treatment of liver disease for centuries.  This agent dissolves or prevents cholesterol gallstones by blocking hepatic cholesterol production and decreasing bile cholesterol.  Ursodiol also reduces the absorption of cholesterol from the intestinal tract.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1818</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tissue plasminogen activator (TPA)</VALIDVALUE>
          <VALUEMEANING>Tissue-Type Plasminogen Activator</VALUEMEANING>
          <MEANINGDESCRIPTION>Tissue-type plasminogen activator (562 aa, ~63 kDa) is encoded by the human PLAT gene. This protein plays a role in the cleavage of plasminogen between Arg-580 and Val-581 to form the fibrinolytic enzyme plasmin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16995</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other therapy</VALIDVALUE>
          <VALUEMEANING>Other Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Not otherwise specified.: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C49236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiation</VALIDVALUE>
          <VALUEMEANING>Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemotherapy</VALIDVALUE>
          <VALUEMEANING>Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-acetylcysteine</VALIDVALUE>
          <VALUEMEANING>Acetylcysteine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic N-acetyl derivative of the endogenous amino acid L-cysteine, a precursor of the antioxidant enzyme glutathione.  Acetylcysteine regenerates liver stores of glutathione. This agent also reduces disulfide bonds in mucoproteins, resulting in liquification of mucus.  Some evidence suggests that acetylcysteine may exert an anti-apoptotic effect due to its antioxidant activity, possibly preventing cancer cell development or growth.  In addition, acetylcysteine has inhibited viral stimulation by reactive oxygen intermediates, thereby producing antiviral activity in HIV patients. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3128727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Montelukast</VALIDVALUE>
          <VALUEMEANING>Montelukast</VALUEMEANING>
          <MEANINGDESCRIPTION>The active ingredient in a drug used to treat symptoms of asthma, such as trouble breathing, tight chest, wheezing, coughing, and runny nose. Montelukast blocks the action of a substance that causes airways in the lungs to narrow and causes other symptoms of asthma. It is a type of leukotriene receptor antagonist and a type of antiasthmatic agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-12-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5588941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrolide antibiotic</VALIDVALUE>
          <VALUEMEANING>Macrolide Antibiotic</VALUEMEANING>
          <MEANINGDESCRIPTION>An anti-microbial compound comprised of a macrocyclic lactone with a ring of twelve or more members linked to one or more monosaccharides, with bacteriostatic and potential antifungal activities. Macrolide antibiotics generally inhibit protein synthesis by binding to the 50S subunit of the bacterial ribosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-12-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5588943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ibrutinib</VALIDVALUE>
          <VALUEMEANING>Ibrutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, small-molecule inhibitor of Bruton&#39;s tyrosine kinase (BTK) with potential antineoplastic activity. Upon oral administration, ibrutinib binds to and irreversibly inhibits BTK activity, thereby preventing both B-cell activation and B-cell-mediated signaling. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is required for B cell receptor signaling, plays a key role in B-cell maturation, and is overexpressed in a number of B-cell malignancies. The expression of BTK in tumor cells is also associated with increased proliferation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-12-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5588944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Treosulfan</VALIDVALUE>
          <VALUEMEANING>Treosulfan</VALUEMEANING>
          <MEANINGDESCRIPTION>The prodrug of a bifunctional sulfonate alkylating agent with myeloablative, immunosuppressive, and antineoplastic activities. Under physiological conditions, treosulfan converts nonenzymatically to L-diepoxybutane via a monoepoxide intermediate. The monoepoxide intermediate and L-diepoxybutane alkylate DNA at guanine residues and produce DNA interstrand crosslinks, resulting in DNA fragmentation and apoptosis. In escalated doses, this agent also exhibits myeloablative and immunosuppressive activities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1257</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3922372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Teniposide</VALIDVALUE>
          <VALUEMEANING>Teniposide</VALUEMEANING>
          <MEANINGDESCRIPTION>An anticancer drug that is a podophyllotoxin derivative and belongs to the family of drugs called mitotic inhibitors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C857</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paclitaxel</VALIDVALUE>
          <VALUEMEANING>Paclitaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>A compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity.  Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division.  This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nitrosourea</VALIDVALUE>
          <VALUEMEANING>Nitrosourea Compound</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of anticancer drugs that can cross the blood-brain barrier. Carmustine (BCNU) and lomustine (CCNU) are nitrosoureas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C699</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2829938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoclonal antibody</VALIDVALUE>
          <VALUEMEANING>Monoclonal Antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody produced by a clone or genetically homogenous fast-growing cells i.e., hybridoma. Hybridoma cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis, and treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4232285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other systemic therapy</VALIDVALUE>
          <VALUEMEANING>Other Systemic Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15698, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5805894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thioguanine</VALIDVALUE>
          <VALUEMEANING>Thioguanine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic guanosine analogue antimetabolite. Phosphorylated by hypoxanthine-guanine phosphoribosyltransferase, thioguanine incorporates into DNA and RNA, resulting in inhibition of DNA and RNA syntheses and cell death. This agent also inhibits glutamine-5-phosphoribosylpyrophosphate amidotransferase, thereby inhibiting purine synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2744957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sorafenib</VALIDVALUE>
          <VALUEMEANING>Sorafenib</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Midostaurin</VALIDVALUE>
          <VALUEMEANING>Midostaurin</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic indolocarbazole multikinase inhibitor with potential antiangiogenic and antineoplastic activities. Midostaurin inhibits protein kinase C alpha (PKCalpha), vascular endothelial growth factor receptor 2 (VEGFR2), c-kit, platelet-derived growth factor receptor (PDGFR) and FMS-like tyrosine kinase 3 (FLT3) tyrosine kinases, which may result in disruption of the cell cycle, inhibition of proliferation, apoptosis, and inhibition of angiogenesis in susceptible tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1872</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5805895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intrathecal therapy</VALIDVALUE>
          <VALUEMEANING>Intrathecal Route of Administration Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C38267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5805896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decitabine</VALIDVALUE>
          <VALUEMEANING>Decitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytidine antimetabolite analogue with potential antineoplastic activity. Decitabine incorporates into DNA and inhibits DNA methyltransferase, resulting in hypomethylation of DNA and intra-S-phase arrest of DNA replication. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>All-trans retinoic acid</VALIDVALUE>
          <VALUEMEANING>Tretinoin</VALUEMEANING>
          <MEANINGDESCRIPTION>A naturally-occurring acid of retinol. Tretinoin binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of tumorigenesis.  This agent also inhibits telomerase, resulting in telomere shortening and eventual apoptosis of some tumor cell types.  The oral form of tretinoin has teratogenic and embryotoxic properties.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5342173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gemtuzumab</VALIDVALUE>
          <VALUEMEANING>Gemtuzumab Ozogamicin</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin.  In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clofarabine</VALIDVALUE>
          <VALUEMEANING>Clofarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A second generation purine nucleoside analog with antineoplastic activity. Clofarabine is phosphorylated intracellularly to the cytotoxic active 5&#39;-triphosphate metabolite, which inhibits the enzymatic activities of ribonucleotide reductase and DNA polymerase, resulting in inhibition of DNA repair and synthesis of DNA and RNA. This nucleoside analog also disrupts mitochondrial function and membrane integrity, resulting in the release of pre-apoptotic factors, including cytochrome C and apoptotic-inducing factors, which activate apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arsenic</VALIDVALUE>
          <VALUEMEANING>Arsenic</VALUEMEANING>
          <MEANINGDESCRIPTION>An element with atomic symbol As, atomic number 33, and atomic weight 74.92.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3971521</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cladribine</VALIDVALUE>
          <VALUEMEANING>Cladribine</VALUEMEANING>
          <MEANINGDESCRIPTION>A purine nucleoside antimetabolite analogue. Cladribine triphosphate, a phosphorylated metabolite of cladribine, incorporates into DNA, resulting in single-strand breaks in DNA, depletion of nicotinamide adenine dinucleotide (NAD) and adenosine triphosphate (ATP), and apoptosis.  Because this agent is resistant to adenosine deaminase, an enzyme that inactivates some antineoplastic agents, it is selectively toxic to lymphocytes and monocytes which exhibit little deoxynucleotide deaminase activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2829877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin</VALIDVALUE>
          <VALUEMEANING>Cisplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5544728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboplatin</VALIDVALUE>
          <VALUEMEANING>Carboplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378841</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Busulfan</VALIDVALUE>
          <VALUEMEANING>Busulfan</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of dimethane-sulfonate with antineoplastic and cytotoxic properties.  Although its mechanism of action is not fully understood, busulfan appears to act through the alkylation of DNA.  Following systemic absorption of busulfan, carbonium ions are formed, resulting in DNA alkylation and DNA breaks and inhibition of DNA replication and RNA transcription. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C321</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bleomycin</VALIDVALUE>
          <VALUEMEANING>Bleomycin</VALUEMEANING>
          <MEANINGDESCRIPTION>A mixture of glycopeptide antineoplastic antibiotics isolated from the fungus Streptomyces verticillus.  Bleomycin forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals which cause single- and double-stranded breaks in DNA; these reactive oxygen species also induce lipid peroxidation, carbohydrate oxidation, and alterations in prostaglandin synthesis and degradation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739540</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anthracycline</VALIDVALUE>
          <VALUEMEANING>Anthracycline Antibiotic</VALUEMEANING>
          <MEANINGDESCRIPTION>A member of a family of anticancer drugs that are also antibiotics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2750845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mitoxantrone</VALIDVALUE>
          <VALUEMEANING>Mitoxantrone</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication. This agent also binds to topoisomerase II, resulting in DNA strand breaks and inhibition of DNA repair. Mitoxantrone is less cardiotoxic compared to doxorubicin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62050</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3518877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melphalan</VALIDVALUE>
          <VALUEMEANING>Melphalan</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available phenylalanine derivative of nitrogen mustard with antineoplastic activity. Melphalan alkylates DNA at the N7 position of guanine and induces DNA inter-strand cross-linkages, resulting in the inhibition of DNA and RNA synthesis and cytotoxicity against both dividing and non-dividing tumor cells. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ifosfamide</VALIDVALUE>
          <VALUEMEANING>Ifosfamide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic analogue of the nitrogen mustard cyclophosphamide with antineoplastic activity. Ifosfamide alkylates and forms DNA crosslinks, thereby preventing DNA strand separation and DNA replication.  This agent is a prodrug that must be activated through hydroxylation by hepatic microsomal enzymes. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fludarabine</VALIDVALUE>
          <VALUEMEANING>Fludarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A fluorinated nucleotide antimetabolite analog of the antiviral agent vidarabine (ara-A) with antineoplastic activity. Administered parenterally as a phosphate salt, fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite may inhibit DNA polymerase alpha, ribonucleotide reductase and DNA primase, thereby interrupting DNA synthesis and inhibiting tumor cell growth.  </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1094</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Etoposide</VALIDVALUE>
          <VALUEMEANING>Etoposide</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytarabine</VALIDVALUE>
          <VALUEMEANING>Cytarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>An anticancer drug that belongs to the family of drugs called antimetabolites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Obinutuzumab</VALIDVALUE>
          <VALUEMEANING>Obinutuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A glycoengineered, humanized IgG1 monoclonal antibody with potential antineoplastic activity. Afutuzumab, a third generation type II anti-CD20 antibody, selectivity binds to the extracellular domain of the human CD20 antigen on malignant human B cells. The Fc region carbohydrates of the antibody, enriched in bisected non-fucosylated glycosylation variants, contribute to its higher binding affinity for human FcgammaRIII receptors compared to non-glycoengineered antibodies, resulting in enhanced antibody-dependent cellular cytotoxicity (ADCC) and caspase-independent apoptosis. In addition, modification of elbow hinge sequences within the antibody variable framework regions may account for the strong apoptosis-inducing activity of R7159 upon binding to CD20 on target cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ponatinib</VALIDVALUE>
          <VALUEMEANING>Ponatinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities. Ponatinib inhibits unmutated and all mutated forms of Bcr-Abl, including T315I, the highly drug therapy-resistant missense mutation of Bcr-Abl. This agent also inhibits other tyrosine kinases including those associated with vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs); in addition, it inhibits the tyrosine kinase receptor TIE2 and FMS-related tyrosine kinase receptor-3 (Flt3). RTK inhibition by ponatinib may result in the inhibition of cellular proliferation and angiogenesis and may induce cell death. Bcr-Abl is a fusion tyrosine kinase encoded by the Philadelphia chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3776076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nilotinib</VALIDVALUE>
          <VALUEMEANING>Nilotinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable aminopyrimidine-derivative Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. Designed to overcome imatinib resistance, nilotinib binds to and stabilizes the inactive conformation of the kinase domain of the Abl protein of the Bcr-Abl fusion protein, resulting in the inhibition of the Bcr-Abl-mediated proliferation of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) cells. This agent also inhibits the receptor tyrosine kinases platelet-derived growth factor receptor (PDGF-R) and c-kit, a receptor tyrosine kinase mutated and constitutively activated in most gastrointestinal stromal tumors (GISTs). With a binding mode that is energetically more favorable than that of imatinib, nilotinib has been shown to have an approximately 20-fold increased potency in kinase and proliferation assays compared to imatinib.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5805905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inotuzumab</VALIDVALUE>
          <VALUEMEANING>Inotuzumab Ozogamicin</VALUEMEANING>
          <MEANINGDESCRIPTION>A CD22-targeted cytotoxic immunoconjugate composed of a humanized IgG4 anti-CD22 antibody covalently linked to N-acetyl-gamma-calicheamicin dimethyl hydrazide (CalichDMH) with potential antineoplastic activity. Inotuzumab ozogamicin is rapidly internalized upon binding of the antibody moiety to B cell-specific CD22 receptors, delivering the conjugated CalichDMH intracellularly; the CalichDMH moiety binds to the minor groove of DNA in a sequence-specific manner, resulting in double-strand DNA breaks and apoptosis. CalichDMH is a derivative of gamma calicheamicin, a cytotoxic antibiotic produced by the bacterium Micromonospora echinospora.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5577157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Imatinib</VALIDVALUE>
          <VALUEMEANING>Imatinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain the Philadelphia chromosome.  Imatinib also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and stem cell factor (SCF)/c-kit; the SCF/c-kit receptor tyrosine kinase is activated in gastrointestinal stromal tumor (GIST).  This agent inhibits proliferation and induces apoptosis in cells that overexpress these oncoproteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62035</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dasatinib</VALIDVALUE>
          <VALUEMEANING>Dasatinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases.  Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blinatumomab</VALIDVALUE>
          <VALUEMEANING>Blinatumomab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, single-chain, anti-CD19/anti-CD3 bispecific monoclonal antibody with potential immunostimulating and antineoplastic activities. Blinatumomab possesses two antigen-recognition sites, one for the CD3 complex, a group of T cell surface glycoproteins that complex with the T cell receptor (TCR), and one for CD19, a tumor-associated antigen (TAA) overexpressed on the surface of B cells. This bispecific monoclonal antibody brings CD19-expressing tumor B-cells and cytotoxic T lymphocytes (CTLs) and helper T lymphocytes (HTLs) together, which may result in the CTL- and HTL-mediated cell death of CD19-expressing B-lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3690103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Azacytidine</VALIDVALUE>
          <VALUEMEANING>Azacitidine</VALUEMEANING>
          <MEANINGDESCRIPTION>A pyrimidine nucleoside analogue of cytidine with antineoplastic activity. Azacitidine is incorporated into DNA, where it reversibly inhibits DNA methyltransferase, thereby blocking DNA methylation.  Hypomethylation of DNA by azacitidine may activate tumor suppressor genes silenced by hypermethylation, resulting in an antitumor effect. This agent is also incorporated into RNA, thereby disrupting normal RNA function and impairing tRNA cytosine-5-methyltransferase activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3013054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytarabine (Ara - C) &gt; 10 g/m2/cycle</VALIDVALUE>
          <VALUEMEANING>Greater Than 10 Gram per Square Meter Per Cycle Cytarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A number with no fractional part, including the negative and positive numbers as well as zero.::10: A metric unit of areal density defined as a spread rate at which one gram of a substance is spread over the area of one square meter. It is equal to approximately 0.029 4935 ounce per square yard. Also used as a dose calculation unit to express quantity of an agent in grams per body surface area in square meters.: For each, generally denoting a ratio.: An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.: A drug used to treat certain types of leukemia and prevent the spread of leukemia to the meninges (three thin layers of tissue that cover and protect the brain and spinal cord). It is also being studied in the treatment of other types of cancer. Cytarabine blocks tumor growth by stopping DNA synthesis. It is a type of antimetabolite.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C408, C25472, C65039, C67282, C45255::10, C61584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5837559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thiotepa</VALIDVALUE>
          <VALUEMEANING>Thiotepa</VALUEMEANING>
          <MEANINGDESCRIPTION>A polyfunctional, organophosphorus alkylating agent and a stable derivative of N,N&#39;,N&#39;&#39;-triethylenephosphoramide (TEPA), with antineoplastic activity. Upon administration, thiotepa is converted into highly reactive ethylenimine groups, which covalently bind to nucleophilic groups in DNA and demonstrate a preference for the N7 position of guanine bases. This induces crosslinking of alkylated guanine bases in double-stranded DNA, interferes with both DNA replication and cell division, and results in both the induction of apoptosis and the inhibition of cell growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5810420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Siltuximab</VALIDVALUE>
          <VALUEMEANING>Siltuximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A chimeric, human-murine, monoclonal antibody targeting the pro-inflammatory cytokine interleukin 6 (IL-6), with antitumor and anti-inflammatory activities. Upon intravenous administration of siltuximab, this agent targets and binds to IL-6. This inhibits the binding of IL-6 to the IL-6 receptor (IL-6R), which results in the blockade of the IL-6/IL-6R-mediated signal transduction pathway. This inhibits cancer cell growth in tumors overexpressing IL-6.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61084</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytarabine (Ara - C) &lt;= 10 g/m2/cycle</VALIDVALUE>
          <VALUEMEANING>Less Than or Equal To 10 Gram per Square Meter Per Cycle Cytarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.: A number with no fractional part, including the negative and positive numbers as well as zero.::10: A metric unit of areal density defined as a spread rate at which one gram of a substance is spread over the area of one square meter. It is equal to approximately 0.029 4935 ounce per square yard. Also used as a dose calculation unit to express quantity of an agent in grams per body surface area in square meters.: For each, generally denoting a ratio.: An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.: A drug used to treat certain types of leukemia and prevent the spread of leukemia to the meninges (three thin layers of tissue that cover and protect the brain and spinal cord). It is also being studied in the treatment of other types of cancer. Cytarabine blocks tumor growth by stopping DNA synthesis. It is a type of antimetabolite.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C408, C25472, C65039, C67282, C45255::10, C61586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5837560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daunorubicin</VALIDVALUE>
          <VALUEMEANING>Daunorubicin</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin.  Daunorubicin exhibits cytotoxic activity through topoisomerase-mediated interaction with DNA, thereby inhibiting DNA replication and repair and RNA and protein synthesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62091</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2724326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Idarubicin</VALIDVALUE>
          <VALUEMEANING>Idarubicin</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic anthracycline antineoplastic antibiotic derived from daunorubicin.  Idarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  Due to its high lipophilicity, idarubicin penetrates cell membranes better than other anthracycline antibiotics.  Idarubicin hydrochloride is the therapeutic form of this drug. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2744955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other drug</VALIDVALUE>
          <VALUEMEANING>Other Pharmacologic Substance</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C1909</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2775670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High dose methotrexate</VALIDVALUE>
          <VALUEMEANING>High Dose Chemotherapy Methotrexate</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer treatment having a treatment dose that is higher than the standard dosage levels recommended on the product labeling for that chemotherapeutic agent. This dose is concurrently toxic and destroys the normal bone marrow stem cells.: An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C642, C15807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5982054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bexarotene</VALIDVALUE>
          <VALUEMEANING>Bexarotene</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic retinoic acid agent with potential antineoplastic, chemopreventive, teratogenic and embryotoxic properties.  Bexarotene selectively binds to and activates retinoid X receptors (RXRs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, apoptosis of some cancer cell types, and tumor regression. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ibritumomab tiuxetan</VALIDVALUE>
          <VALUEMEANING>Ibritumomab Tiuxetan</VALUEMEANING>
          <MEANINGDESCRIPTION>ZEVALIN (Ibritumomab Tiuxetan) is the immunoconjugate resulting from a stable thiourea covalent bond between the monoclonal antibody Ibritumomab and the linker-chelator tiuxetan.  This linker-chelator provides a high affinity, conformationally restricted chelation site for Indium-111 or Yttrium-90.  The ZEVALIN therapeutic regimen is administered in two steps: Step 1 includes one infusion of Rituximab preceding In-111 ZEVALIN. Step 2 follows Step 1 by seven to nine days and consists of a second infusion of Rituximab followed by Y-90 ZEVALIN.  ZEVALIN is supplied as two separate and distinctly labeled kits that contain all of the non-radioactive ingredients necessary to produce a single dose of In-111 ZEVALIN and a single dose of Y-90 ZEVALIN, both essential components of the ZEVALIN therapeutic regimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Everolimus</VALIDVALUE>
          <VALUEMEANING>Everolimus</VALUEMEANING>
          <MEANINGDESCRIPTION>A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxorubicin liposomal</VALIDVALUE>
          <VALUEMEANING>Doxorubicin Hydrochloride Liposome</VALUEMEANING>
          <MEANINGDESCRIPTION>A liposome-encapsulated form of the hydrochloride salt of the anthracycline antineoplastic antibiotic doxorubicin.  Liposomal delivery of doxorubicin HCL improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of therapeutic drug effects.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, consequently inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxorubicin</VALIDVALUE>
          <VALUEMEANING>Doxorubicin</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the hydroxylated congener of daunorubicin. Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids; the formation of oxygen free radicals also contributes to the toxicity of the anthracycline antibiotics, namely the cardiac and cutaneous vascular effects.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dacarbazine</VALIDVALUE>
          <VALUEMEANING>Dacarbazine</VALUEMEANING>
          <MEANINGDESCRIPTION>A triazene derivative with antineoplastic activity. Dacarbazine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carmustine</VALIDVALUE>
          <VALUEMEANING>Carmustine</VALUEMEANING>
          <MEANINGDESCRIPTION>An antineoplastic nitrosourea. Carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  This agent also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect.  Carmustine is highly lipophilic and crosses the blood-brain barrier readily. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brentuximab vedotin</VALIDVALUE>
          <VALUEMEANING>Brentuximab Vedotin</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody-drug conjugate (ADC) directed against the tumor necrosis factor (TNF) receptor CD30 with potential antineoplastic activity. Brentuximab vedotin is generated by conjugating the humanized anti-CD30 monoclonal antibody SGN-30 to the cytotoxic agent monomethyl auristatin E (MMAE) via a valine-citrulline peptide linker. Upon administration and internalization by CD30-positive tumor cells, brentuximab vedotin undergoes enzymatic cleavage, releasing MMAE into the cytosol; MMAE binds to tubulin and inhibits tubulin polymerization, which may result in G2/M phase arrest and tumor cell apoptosis. Transiently activated during lymphocyte activation, CD30 (tumor necrosis factor receptor superfamily, member 8;TNFRSF8) may be constitutively expressed in hematologic malignancies including Hodgkin lymphoma and some T-cell non-Hodgkin lymphomas. The linkage system in brentuximab vedotin is highly stable in plasma, resulting in cytotoxic specificity for CD30-positive cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bendamustine</VALIDVALUE>
          <VALUEMEANING>Bendamustine</VALUEMEANING>
          <MEANINGDESCRIPTION>A bifunctional mechlorethamine derivative with alkylating and antimetabolite activities. Although the exact mechanism of action of bendamustine is unknown, this agent appears to alkylate and crosslink macromolecules, resulting in DNA, RNA and protein synthesis inhibition, and eventually the induction of apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4862971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pembrolizumab</VALIDVALUE>
          <VALUEMEANING>Pembrolizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal immunoglobulin (Ig) G4 antibody directed against human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1) with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, pembrolizumab binds to PD-1, an inhibitory signaling receptor expressed on the surface of activated T cells, and blocks the binding to and activation of PD-1 by its ligands, which results in the activation of T-cell-mediated immune responses against tumor cells. The ligands for PD-1 include programmed cell death ligand 1 (PD-L1), overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on APCs. Activated PD-1 negatively regulates T-cell activation and plays a key role in in tumor evasion from host immunity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5076693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ofatumumab</VALIDVALUE>
          <VALUEMEANING>Ofatumumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human, high-affinity IgG1 monoclonal antibody directed against the B cell CD20 cell surface antigen with potential antineoplastic activity. Ofatumumab binds specifically to CD20 on the surfaces of B cells, triggering complement-dependent cell lysis (CDCL) and antibody-dependent cell-mediated cytotoxicity (ADCC) of B cells overexpressing CD20. The CD20 antigen, found on over 90% of B cells, B cell lymphomas, and other B cells of lymphoid tumors of B cell origin, is a non-glycosylated cell surface phosphoprotein that acts a calcium ion channel; it is exclusively expressed on B cells during most stages of B cell development.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66952</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nivolumab</VALIDVALUE>
          <VALUEMEANING>Nivolumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1,) with immune checkpoint inhibitory and antineoplastic activities. Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands programmed cell death ligand 1 (PD-L1), overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on APCs. This results in the activation of T-cells and cell-mediated immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and and plays a key role in in tumor evasion from host immunity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5076694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mogamulizumab</VALIDVALUE>
          <VALUEMEANING>Mogamulizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against C-C chemokine receptor 4 (CCR4) with potential anti-inflammatory and antineoplastic activities. Mogamulizumab selectively binds to and blocks the activity of CCR4, which may inhibit CCR4-mediated signal transduction pathways and, so, chemokine-mediated cellular migration and proliferation of T cells, and chemokine-mediated angiogenesis. In addition, this agent may induce antibody-dependent cell-mediated cytotoxicity (ADCC) against CCR4-positive T cells. CCR4, a G-coupled-protein receptor for C-C chemokines such MIP-1, RANTES, TARC and MCP-1, is expressed on the surfaces of some types of T cells, endothelial cells, and some types of neurons. CCR4, also known as CD194, may be overexpressed on adult T-cell lymphoma (ATL) and peripheral T-cell lymphoma (PTCL) cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5944042</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lenalidomide</VALIDVALUE>
          <VALUEMEANING>Lenalidomide</VALUEMEANING>
          <MEANINGDESCRIPTION>A thalidomide analog with potential antineoplastic activity.  Lenalidomide inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis.  This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PEG-asparaginase</VALIDVALUE>
          <VALUEMEANING>Pegaspargase</VALUEMEANING>
          <MEANINGDESCRIPTION>A complex of polyethylene glycol conjugated with L-asparaginase.  Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting these cells of asparagine and blocking protein synthesis and tumor cell proliferation, especially in the G1 phase of the cell cycle.  The agent also induces apoptosis in tumor cells. Pegylation decreases the enzyme&#39;s antigenicity. Asparagine is critical to protein synthesis in leukemic cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L-asparaginase</VALIDVALUE>
          <VALUEMEANING>Asparaginase</VALUEMEANING>
          <MEANINGDESCRIPTION>An enzyme isolated from the bacterium Escherichia coli or the bacterium Erwinia carotovora with antileukemic activity. Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia in leukemic cells, resulting in the depletion of asparagine, inhibition of protein synthesis, cell cycle arrest in the G1 phase, and apoptosis in susceptible leukemic cell populations. Asparagine is critical to protein synthesis in leukemic cells; some leukemic cells cannot synthesize this amino acid de novo due to the absent or deficient expression of the enzyme asparagine synthase. The E. carotovora-derived form of asparaginase is typically reserved for cases of asparaginase hypersensitivity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ixazomib</VALIDVALUE>
          <VALUEMEANING>Ixazomib</VALUEMEANING>
          <MEANINGDESCRIPTION>An active metabolite of MLN9708, a second generation, boron containing peptide proteasome inhibitor (PI) with potential antineoplastic activity. Ixazomib binds to and inhibits the 20S catalytic core of the proteasome, thereby blocking the targeted proteolysis normally performed by the proteasome, which results in an accumulation of unwanted or misfolded proteins; disruption of various cell signaling pathways may follow, resulting in the induction of apoptosis. Compared to first generation PIs, second generation PIs may have an improved pharmacokinetic profile with increased potency and less toxicity. Proteasomes are large protease complexes that degrade unneeded or damaged proteins that have been ubiquinated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97940</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5944043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ipilimumab</VALIDVALUE>
          <VALUEMEANING>Ipilimumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody directed against cytotoxic T-lymphocyte-associated antigen-4 (CTLA4), an antigen that is expressed on activated T-cells and exhibits affinity for B7 co-stimulatory molecules. By binding CTLA4, ipilimumab enhances T-cell activation and blocks B7-1 and B7-2 T-cell co-stimulatory pathways.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3185135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Idelalisib</VALIDVALUE>
          <VALUEMEANING>Idelalisib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, small molecule inhibitor of the delta isoform of the 110 kDa catalytic subunit of class I phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities.  Idelalisib inhibits the production of the second messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3), preventing the activation of the PI3K signaling pathway and inhibiting tumor cell proliferation, motility, and survival. Unlike other isoforms of PI3K, PI3K-delta is expressed primarily in hematopoietic lineages. The targeted inhibition of PI3K-delta is designed to preserve PI3K signaling in normal, non-neoplastic cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gemcitabine</VALIDVALUE>
          <VALUEMEANING>Gemcitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>The active ingredient in a drug that is used to treat pancreatic cancer that is advanced or has spread. It is also used with other drugs to treat breast cancer that has spread, advanced ovarian cancer, and non-small cell lung cancer that is advanced or has spread. It is also being studied in the treatment of other types of cancer. Gemcitabine blocks the cell from making DNA and may kill cancer cells. It is a type of antimetabolite.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5242658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vorinostat</VALIDVALUE>
          <VALUEMEANING>Vorinostat</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic hydroxamic acid derivative with antineoplastic activity. Vorinostat, a second generation polar-planar compound, binds to the catalytic domain of the histone deacetylases (HDACs). This allows the hydroxamic moiety to chelate zinc ion located in the catalytic pockets of HDAC, thereby inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors. Hyperacetylation of histone proteins results in the upregulation of the cyclin-dependant kinase p21, followed by G1 arrest. Hyperacetylation of non-histone proteins such as tumor suppressor p53, alpha tubulin, and heat-shock protein 90 produces additional anti-proliferative effects. This agent also induces apoptosis and sensitizes tumor cells to cell death processes. Vorinostat crosses the blood-brain barrier.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vinorelbine</VALIDVALUE>
          <VALUEMEANING>Vinorelbine</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic vinca alkaloid. Vinorelbine binds to tubulin and prevents formation of the mitotic spindle,resulting in the arrest of tumor cell growth in metaphase. This agent may also interfere with amino acid, cyclic AMP. and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vincristine</VALIDVALUE>
          <VALUEMEANING>Vincristine</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vinblastine</VALIDVALUE>
          <VALUEMEANING>Vinblastine</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural alkaloid isolated from the plant Vinca rosea Linn. Vinblastine binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and arrest of tumor cells in the M phase of the cell cycle. This agent may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C930</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Venetoclax</VALIDVALUE>
          <VALUEMEANING>Venetoclax</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, selective small molecule inhibitor of the anti-apoptotic protein Bcl-2, with potential antineoplastic activity. Venetoclax mimics BH3-only proteins, the native ligands of Bcl-2 and apoptosis activators, by binding to the hydrophobic groove of Bcl-2 proteins thereby repressing Bcl-2 activity and restoring apoptotic processes in tumor cells. Bcl-2 protein is overexpressed in some cancers and plays an important role in the regulation of apoptosis; its expression is associated with increased drug resistance and tumor cell survival. Compared to the Bcl-2 inhibitor navitoclax, this agent does not inhibit bcl-XL and does not cause bcl-XL-mediated thrombocytopenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103147</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5944045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tositumomab</VALIDVALUE>
          <VALUEMEANING>Tositumomab</VALUEMEANING>
          <MEANINGDESCRIPTION>A murine IgG2 monoclonal antibody directed against the CD20 antigen, found on the surface of B-cells.  Tositumomab binds to the CD20 surface membrane antigen, resulting in apoptosis, and may stimulate antitumoral cell-mediated and/or antibody-dependent cytotoxicity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Temsirolimus</VALIDVALUE>
          <VALUEMEANING>Temsirolimus</VALUEMEANING>
          <MEANINGDESCRIPTION>An ester analog of rapamycin. Temsirolimus binds to and inhibits the mammalian target of rapamycin (mTOR), resulting in decreased expression of mRNAs necessary for cell cycle progression and arresting cells in the G1 phase of the cell cycle. mTOR is a serine/threonine kinase which plays a role in the PI3K/AKT pathway that is upregulated in some tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Temozolomide</VALIDVALUE>
          <VALUEMEANING>Temozolomide</VALUEMEANING>
          <MEANINGDESCRIPTION>A triazene analog of dacarbazine with antineoplastic activity.  As a cytotoxic alkylating agent, temozolomide is converted at physiologic pH to the short-lived active compound, monomethyl triazeno imidazole carboxamide (MTIC). The cytotoxicity of MTIC is due primarily to methylation of DNA at the O6 and N7 positions of guanine, resulting in inhibition of  DNA replication.  Unlike dacarbazine, which is metabolized to MITC only in the liver, temozolomide is metabolized to MITC at all sites. Temozolomide is administered orally and penetrates well into the central nervous system. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Romidepsin</VALIDVALUE>
          <VALUEMEANING>Romidepsin</VALUEMEANING>
          <MEANINGDESCRIPTION>A bicyclic depsipeptide antibiotic isolated from the bacterium Chromobacterium violaceum with antineoplastic activity. After intracellular activation, romidepsin binds to and inhibits histone deacetylase (HDAC), resulting in alterations in gene expression and the induction of cell differentiation, cell cycle arrest, and apoptosis. This agent also inhibits hypoxia-induced angiogenesis and depletes several heat shock protein 90 (Hsp90)-dependent oncoproteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1544</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5342172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Procarbazine</VALIDVALUE>
          <VALUEMEANING>Procarbazine</VALUEMEANING>
          <MEANINGDESCRIPTION>A methylhydrazine derivative with antineoplastic and mutagenic activities. Although the exact mode of cytotoxicity has not been elucidated, procarbazine, after metabolic activation, appears to inhibit the trans-methylation of methionine into transfer RNA (t-RNA), thereby preventing protein synthesis and consequently DNA and RNA synthesis. This agent may also undergo auto-oxidation, resulting in the formation of cytotoxic free radicals which damage DNA through an alkylation reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62072</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pralatrexate</VALIDVALUE>
          <VALUEMEANING>10-Propargyl-10-Deazaaminopterin</VALUEMEANING>
          <MEANINGDESCRIPTION>A folate analogue inhibitor of dihydrofolate reductase (DHFR) exhibiting high affinity for reduced folate carrier-1 (RFC-1) with antineoplastic and immunosuppressive activities. Pralatrexate selectively enters cells expressing RFC-1; intracellularly, this agent is highly polyglutamylated and competes for the folate binding site of DHFR, blocking tetrahydrofolate synthesis, which may result in depletion of nucleotide precursors; inhibition of DNA, RNA and protein synthesis; and apoptotic tumor cell death. Efficient intracellular polyglutamylation of pralatrexate results in higher intracellular concentrations compared to non-polyglutamylated pralatrexate, which is more readily effuxed by the MRP (multidrug resistance protein) drug efflux pump. RFC-1, an oncofetal protein expressed at highest levels during embryonic development, may be over-expressed on the cell surfaces of various cancer cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High dose cytarabine</VALIDVALUE>
          <VALUEMEANING>High Dose Chemotherapy Cytarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer treatment having a treatment dose that is higher than the standard dosage levels recommended on the product labeling for that chemotherapeutic agent. This dose is concurrently toxic and destroys the normal bone marrow stem cells.: A drug used to treat certain types of leukemia and prevent the spread of leukemia to the meninges (three thin layers of tissue that cover and protect the brain and spinal cord). It is also being studied in the treatment of other types of cancer. Cytarabine blocks tumor growth by stopping DNA synthesis. It is a type of antimetabolite.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C408, C15807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-09-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5981834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acalabrutinib</VALIDVALUE>
          <VALUEMEANING>Acalabrutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available inhibitor of Bruton&#39;s tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, acalabrutinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6028593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Copanlisib</VALIDVALUE>
          <VALUEMEANING>Copanlisib</VALUEMEANING>
          <MEANINGDESCRIPTION>A phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-09-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5982159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-epileptics</VALIDVALUE>
          <VALUEMEANING>Anticonvulsant Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>(an-tee-kon-VUL-sants) Drugs that prevent, reduce, or stop convulsions or seizures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cellular therapy</VALIDVALUE>
          <VALUEMEANING>Cellular Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70601</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4666954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thalidomide</VALIDVALUE>
          <VALUEMEANING>Thalidomide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of glutamic acid (alpha-phthalimido-glutarimide) with teratogenic, immunomodulatory, anti-inflammatory and anti-angiogenic properties.  Thalidomide acts primarily by inhibiting both the production of tumor necrosis factor alpha (TNF-alpha) in stimulated peripheral monocytes and the activities of interleukins and interferons.  This agent also inhibits polymorphonuclear chemotaxis and monocyte phagocytosis.  In addition, thalidomide inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), thereby inhibiting angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pomalidomide</VALIDVALUE>
          <VALUEMEANING>Pomalidomide</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities. Although its exact mechanism of action has yet to be fully elucidated, pomalidomide appears to inhibit TNF-alpha production, enhance the activity of T cells and natural killer (NK) cells and enhance antibody-dependent cellular cytotoxicity (ADCC). In addition, pomalidomide may inhibit tumor angiogenesis, promote cell cycle arrest in susceptible tumor cell populations, and stimulate erythropoeisis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C72560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3944871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carfilzomib</VALIDVALUE>
          <VALUEMEANING>Carfilzomib</VALUEMEANING>
          <MEANINGDESCRIPTION>An epoxomicin derivate with potential antineoplastic activity. Carfilzomib irreversibly binds to and inhibits the chymotrypsin-like activity of the 20S catalytic core subunit of the proteasome, a protease complex responsible for degrading a large variety of cellular proteins. Inhibition of proteasome-mediated proteolysis results in an accumulation of polyubiquinated proteins, which may lead to cell cycle arrest, induction of apoptosis, and inhibition of tumor growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sunitinib</VALIDVALUE>
          <VALUEMEANING>Sunitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An indolinone derivative and tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation.  This agent also inhibits the phosphorylation of Fms-related tyrosine kinase 3 (FLT3), another receptor tyrosine kinase expressed by some leukemic cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3107588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quizartinib</VALIDVALUE>
          <VALUEMEANING>Quizartinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available small molecule with potential antineoplastic activity. Quizartinib selectively inhibits class III receptor tyrosine kinases, including FMS-related tyrosine kinase 3 (FLT3/STK1), colony-stimulating factor 1 receptor (CSF1R/FMS), stem cell factor receptor (SCFR/KIT), and platelet derived growth factor receptors (PDGFRs), resulting in inhibition of ligand-independent leukemic cell proliferation and apoptosis. Mutations in FLT3, resulting in constitutive activation, are the most frequent genetic alterations in acute myeloid leukemia (AML) and occur in approximately one-third of AML cases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68936</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lestaurtinib</VALIDVALUE>
          <VALUEMEANING>Lestaurtinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable indolocarbazole derivative with antineoplastic properties. Lestaurtinib inhibits autophosphorylation of FMS-like tyrosine kinase 3 (FLT3), resulting in inhibition of FLT3 activity and induction of apoptosis in tumor cells that overexpress FLT3. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gilteritinib</VALIDVALUE>
          <VALUEMEANING>Gilteritinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of the receptor tyrosine kinases (RTKs) FMS-related tyrosine kinase 3 (FLT3, STK1, or FLK2), AXL (UFO or JTK11) and anaplastic lymphoma kinase (ALK or CD246), with potential antineoplastic activity. Gilteritinib binds to and inhibits both the wild-type and mutated forms of FLT3, AXL and ALK. This may result in an inhibition of FLT3, AXL, and ALK-mediated signal transduction pathways and reduces tumor cell proliferation in cancer cell types that overexpress these RTKs. FLT3, AXL and ALK, overexpressed or mutated in a variety of cancer cell types, play a key role in tumor cell growth and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fecal matter transplant</VALIDVALUE>
          <VALUEMEANING>Fecal Microbiota Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>The transplantation of fecal bacteria, via enema, colonoscopy, or other method, from a healthy individual to a recipient.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IDH2 Inhibitor</VALIDVALUE>
          <VALUEMEANING>IDH2 inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>Any agent that inhibits isocitrate dehydrogenase (IDH) type 2 (IDH2, isocitrate dehydrogenase [NADP+], mitochondrial) found in the mitochondria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7159110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IDH1 Inhibitor</VALIDVALUE>
          <VALUEMEANING>IDH1 inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>Any agent that inhibits isocitrate dehydrogenase (IDH) type 1 (IDH1, IDH1 [NADP+] soluble) found in the cytoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168618</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7159111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bosutinib</VALIDVALUE>
          <VALUEMEANING>Bosutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity. Unlike imatinib, bosutinib inhibits the autophosphorylation of both Abl and Src kinases, resulting in inhibition of cell growth and apoptosis. Because of the dual mechanism of action, this agent may have activity in resistant CML disease, other myeloid malignancies and solid tumors. Abl kinase is upregulated in the presence of the abnormal Bcr-abl fusion protein which is commonly associated with chronic myeloid leukemia (CML). Overexpression of specific Src kinases is also associated with the imatinib-resistant CML phenotype.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Imatinib mesylate</VALIDVALUE>
          <VALUEMEANING>Imatinib Mesylate</VALUEMEANING>
          <MEANINGDESCRIPTION>The mesylate salt of an antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain the Philadelphia chromosome.  Imatinib also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and stem cell factor (SCF)/c-kit; the SCF/c-kit receptor tyrosine kinase is activated in gastrointestinal stromal tumor (GIST).  This agent inhibits proliferation and induces apoptosis in cells that overexpress these oncoproteins. It is also known as Gleevec.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Panobinostat</VALIDVALUE>
          <VALUEMEANING>Panobinostat</VALUEMEANING>
          <MEANINGDESCRIPTION>A cinnamic hydroxamic acid analogue with potential antineoplastic activity. Panobinostat selectively inhibits histone deacetylase (HDAC), inducing hyperacetylation of core histone proteins, which may result in modulation of cell cycle protein expression, cell cycle arrest in the G2/M phase and apoptosis. In addition, this agent appears to modulate the expression of angiogenesis-related genes, such as hypoxia-inducible factor-1alpha (HIF-1a) and vascular endothelial growth factor (VEGF), thus impairing endothelial cell chemotaxis and invasion. HDAC is an enzyme that deacetylates chromatin histone proteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Selinexor</VALIDVALUE>
          <VALUEMEANING>Selinexor</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available, small molecule inhibitor of CRM1 (chromosome region maintenance 1 protein, exportin 1 or XPO1), with potential antineoplastic activity. Selinexor modifies the essential CRM1-cargo binding residue cysteine-528, thereby irreversibly inactivates CRM1-mediated nuclear export of cargo proteins such as tumor suppressor proteins (TSPs), including p53, p21, BRCA1/2, pRB, FOXO, and other growth regulatory proteins. As a result, this agent, via the approach of selective inhibition of nuclear export (SINE), restores endogenous tumor suppressing processes to selectively eliminate tumor cells while sparing normal cells. CRM1, the major export factor for proteins from the nucleus to the cytoplasm, is overexpressed in a variety of cancer cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oprozomib</VALIDVALUE>
          <VALUEMEANING>Oprozomib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable proteasome inhibitor with potential antineoplastic activity. Proteasome inhibitor ONX 0912 inhibits the activity of the proteasome, thereby blocking the targeted proteolysis normally performed by the proteasome; this may result in an accumulation of unwanted or misfolded proteins. Disruption of various cell signaling pathways may follow, eventually leading to the induction of apoptosis and inhibition of tumor growth. Proteasomes are large protease complexes that degrade unneeded or damaged proteins that have been ubiquitinated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4740632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Isatuximab</VALIDVALUE>
          <VALUEMEANING>Isatuximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized IgG1 monoclonal antibody directed against the cell surface glycoprotein CD-38 with potential antineoplastic activity. Isatuximab specifically binds to CD38 on CD38-positive tumor cells. This may trigger antitumoral antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC) and apoptosis eventually leading to cell lysis in CD38-expressing tumor cells. CD38, a type II transmembrane glycoprotein, is present on various immune cells and hematologic malignancies, and its expression has been correlated with poor prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90578</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon-α</VALIDVALUE>
          <VALUEMEANING>Interferon Alpha</VALUEMEANING>
          <MEANINGDESCRIPTION>A class of interferon (leukocyte interferon) produced predominantly by B lymphocytes.  Located in a cluster on 9p22 there are at least 13 functional genes and 1 pseudogene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3185133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elotuzumab</VALIDVALUE>
          <VALUEMEANING>Elotuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against the human CS1 (CD2 subset 1, CRACC, SLAMF7) antigen with potential antineoplastic activity. Elotuzumab binds to the CS1 antigen, which may trigger antibody-dependent cellular cytotoxicity (ADCC) in cells expressing CS1. CS1 is a cell surface glycoprotein belonging to the CD2 subset of the immunoglobulin superfamily (IgSF) and is highly expressed by multiple myeloma cells, but minimally expressed by normal cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66982</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daratumumab</VALIDVALUE>
          <VALUEMEANING>Daratumumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human monoclonal antibody directed against the cell surface glycoprotein CD-38 with potential antineoplastic activity. The binding of anti-CD38 monoclonal antibody to natural killer (NK) cells mimics the normal CD38-CD31 interaction on the NK cell surface. CD38 is also present on multiple myeloma (MM) cells and plasma leukemia cells; this agent may preferentially bind these cells, triggering antitumoral antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). CD38, a cell surface glycoprotein, is present on various immune cells and has been shown to regulate the cytotoxic response of activated NK cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clarithromycin</VALIDVALUE>
          <VALUEMEANING>Clarithromycin</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic 14-membered ring macrolide antibiotic.  Clarithromycin binds to the 50S ribosomal subunit and inhibits RNA-dependent protein synthesis in susceptible organisms.  Clarithromycin has been shown to eradicate gastric MALT (mucosa-associated lymphoid tissue) lymphomas, presumably due to the eradication of tumorigenic Helicobacter pylori infection. This agent also acts as a biological response modulator, possibly inhibiting angiogenesis and tumor growth through alterations in growth factor expression. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1054</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Marizomib</VALIDVALUE>
          <VALUEMEANING>Marizomib</VALUEMEANING>
          <MEANINGDESCRIPTION>A naturally-occurring salinosporamide, isolated from the marine actinomycete Salinospora tropica, with potential antineoplastic activity. Marizomib irreversibly binds to and inhibits the 20S catalytic core subunit of the proteasome by covalently modifying its active site threonine residues; inhibition of ubiquitin-proteasome mediated proteolysis results in an accumulation of poly-ubiquitinated proteins, which may result in the disruption of cellular processes, cell cycle arrest, the induction of apoptosis, and the inhibition of tumor growth and angiogenesis. This agent more may more potent and selective than the proteasome inhibitor bortezomib.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Propylene glycol-free melphalan</VALIDVALUE>
          <VALUEMEANING>Melphalan Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>A bifunctional alkylating agent and phenylalanine derivative of nitrogen mustard. Melphalan hydrochloride is converted into highly reactive ethylenimmonium intermediates that induce covalent guanine N7-N7 intra- and inter-crosslinks and alkylation of adenine N3 of DNA. This agent also alkylates RNA and protein structures. As a result RNA transcription and protein synthesis are inhibited, ultimately leading to cell growth arrest and/or death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6592216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other JAK1 or JAK2 inhibitor</VALIDVALUE>
          <VALUEMEANING>Other JAK1 Inhibitor Or JAK2 Inhibitor Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Any substance that inhibits the biological action of tyrosine-protein kinase JAK1, an enzyme that plays a key role in certain types of cancer and cytokine signaling.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Any substance that inhibits JAK2 tyrosine protein kinase, an enzyme that phosphorylates the hydroxyl group of tyrosine on various proteins in various signaling cascades.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C129650, C37998, C125450, C49236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>4, 3, 2, 1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7134887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ruxolitinib</VALIDVALUE>
          <VALUEMEANING>Ruxolitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77888</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5125106</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydroxyurea</VALIDVALUE>
          <VALUEMEANING>Hydroxyurea</VALUEMEANING>
          <MEANINGDESCRIPTION>A monohydroxyl-substituted urea (hydroxycarbamate) antimetabolite. Hydroxyurea selectively inhibits ribonucleoside diphosphate reductase, an enzyme required to convert ribonucleoside diphosphates into deoxyribonucleoside diphosphates, thereby preventing cells from leaving the G1/S phase of the cell cycle.  This agent also exhibits radiosensitizing activity by maintaining cells in the radiation-sensitive G1 phase and interfering with DNA repair. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fedratinib</VALIDVALUE>
          <VALUEMEANING>Fedratinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, small-molecule, ATP-competitive inhibitor of Janus-associated kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2), with potential antineoplastic activity. Upon oral administration, fedratinib competes with wild-type JAK2 as well as mutated forms for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, inhibition of tumor cell proliferation and induction of tumor cell apoptosis. JAK2 is the most commonly mutated gene in bcr-abl-negative myeloproliferative disorders (MPDs). In addition, fedratinib targets, binds to and inhibits the activity of FLT3. This inhibits uncontrolled FLT3 signaling and results in the inhibition of proliferation in tumor cells overexpressing FLT3. FLT3, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias and plays a key role in tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7134889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Androgen</VALIDVALUE>
          <VALUEMEANING>Androgen</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of hormone that promotes the development and maintenance of male sex characteristics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3554908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liposomal daunorubicin/cytarabine</VALIDVALUE>
          <VALUEMEANING>Liposome-encapsulated Daunorubicin-Cytarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A liposomal formulation containing a fixed combination of the antineoplastic agents cytarabine and daunorubicin in a 5:1 molar ratio. Liposome-encapsulated daunorubicin-cytarabine has been designed to provide optimal delivery of a specific ratio of cytarabine to daunorubicin, one that has been shown to be synergistic in vitro. The antimetabolite cytarabine competes with cytidine for incorporation into DNA, inhibiting DNA synthesis. This agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair. Daunorubicin, an intercalator and a topoisomerase II inhibitor, prevents DNA replication and inhibits protein synthesis. This agent also generates oxygen free radicals, resulting in the cytotoxic lipid peroxidation of cell membrane lipids.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Checkpoint Inhibitors</VALIDVALUE>
          <VALUEMEANING>Immune Checkpoint Inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>An agent that inhibits any of the immune checkpoint inhibitory proteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C143250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7150349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immune therapy</VALIDVALUE>
          <VALUEMEANING>Immunotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Therapy designed to induce changes in a patient&#39;s immune status in order to treat disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5102332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antithymocyte globulin (ATG)</VALIDVALUE>
          <VALUEMEANING>Anti-Thymocyte Globulin</VALUEMEANING>
          <MEANINGDESCRIPTION>Purified gamma globulin, with immunosuppressive activity. Obtained from animals that have been immunized with human thymocytes, antithymocyte globulin (ATG) specifically recognizes and destroys T lymphocytes. Although not completely understood, the mechanism of action appears to involve T lymphocyte clearance from the circulation and modulation of T lymphocyte activity. Administering ATG with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host (GVH) disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3253646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Luspatercept</VALIDVALUE>
          <VALUEMEANING>Luspatercept</VALUEMEANING>
          <MEANINGDESCRIPTION>A soluble, recombinant fusion protein composed of a modified form of the extracellular domain of human activin receptor type IIb (ActRIIb) and linked to the human IgG1 Fc domain, with red blood cell stimulating activity. Upon subcutaneous administration, luspatercept inhibits several ligands in the transforming growth factor (TGF)-beta superfamily. This prevents activation of a variety of TGF-beta superfamily members involved in late stage erythropoiesis and results in an increased differentiation and proliferation of erythroid progenitors. luspatercept acts at a different, later stage than erythropoietin. This agent ultimately enhances red blood cell production and prevents anemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104012</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7150067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deferasirox</VALIDVALUE>
          <VALUEMEANING>Deferasirox</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, orally bioavailable, achiral, tridentate triazole derived from salicylic acid with iron-chelating activity. Deferasirox chelates iron at a 2:1 (ligand:iron) ratio. Because of its oral availability and long plasma half-life, this agent may be superior to desferrioxamine (desferal, DFO), which is orally inactive and has a short plasma half-life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deferoxamine</VALIDVALUE>
          <VALUEMEANING>Deferoxamine</VALUEMEANING>
          <MEANINGDESCRIPTION>An iron-chelating agent that binds free iron in a stable complex, preventing it from engaging in chemical reactions. Deferoxamine chelates iron from intra-lysosomal ferritin and siderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile.  This agent does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7135786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deferiprone</VALIDVALUE>
          <VALUEMEANING>Deferiprone</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable bidentate ligand with iron chelating activity. Deferiprone binds to iron in a 3:1 (ligand:iron) molar ratio. By binding to iron, deferiprone is able to remove excess iron from the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7135785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Voxelotor</VALIDVALUE>
          <VALUEMEANING>Voxelotor</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable modulator and stabilizer of sickle cell hemoglobin (HbS), with potential use in the treatment of sickle cell disease (SCD).  Upon administration, voxelotor targets and covalently binds to the N-terminal valine of the alpha chain of HbS. This stabilizes HbS, thereby improving oxygen binding affinity. The binding of voxelotor to HbS prevents HbS polymerization, reduces sickling, decreases red blood cell (RBC) damage and increases the half-life of RBCs. This improves blood flow and decreases hemolytic anemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C152089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7331717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L-Glutamine</VALIDVALUE>
          <VALUEMEANING>Glutamine</VALUEMEANING>
          <MEANINGDESCRIPTION>A nonessential amino acid. Glutamine can donate the ammonia on its side chain to the formation of urea (for eventual excretion by the kidneys) and to purines (necessary for the synthesis of nucleic acids). Glutamine may become a conditionally essential nutrient during certain catabolic states. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Crizanlizumab</VALIDVALUE>
          <VALUEMEANING>Crizanlizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal immunoglobulin G1 anti-P-selectin antibody with vaso-protective and anti-vaso-occlusive properties. Upon administration, crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand-1 (PSGL-1; SELPLG) on neutrophils and monocytes. P-selectin, a glycoprotein that functions as a cell adhesion molecule (CAM), translocates to the surface of activated endothelial cells and platelets, upon stimulation, where it binds to its ligand and mediates the rolling of platelets and neutrophils on activated endothelial cells. Therefore, blockade of p-selectin may inhibit platelet aggregation, maintain blood flow and minimize sickle cell-related pain crises (SCPC).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7331719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Promacta</VALIDVALUE>
          <VALUEMEANING>Eltrombopag Olamine</VALUEMEANING>
          <MEANINGDESCRIPTION>The orally active ethanolamine salt of eltrombopag, a small-molecule, nonpeptide thrombopoietin receptor agonist with megakaryopoiesis-stimulating activity. Eltrombopag binds to and stimulates the transmembrane domain of the platelet thrombopoietin receptor (TPO-R or CD110), a member of the hematopoietin receptor superfamily. Activation of TPO-R leads to the proliferation and differentiation of cells in the megakaryocytic lineage and an increase in platelet production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prednisone</VALIDVALUE>
          <VALUEMEANING>Prednisone</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nplate</VALIDVALUE>
          <VALUEMEANING>Romiplostim (Nplate)</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant protein with megakaryopoiesis stimulating activity. Romiplostim mimics endogenous thrombopoietin (TPO), directly binding to and activating the platelet thrombopoietin receptor (TpoR, Mpl, or CD110 antigen), a cytokine receptor belonging to the hematopoietin receptor superfamily. Activation of TpoR stimulates the proliferation and differentiation of megakaryocytes, resulting in an increase in the production of blood platelets.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anakinra</VALIDVALUE>
          <VALUEMEANING>Anakinra</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant human nonglycosylated interleukin-1 (IL-1) receptor antagonist with potential antineoplastic activity. Anakinra binds to the IL-1 receptor, thereby blocking the binding of the IL-1 to and activation of its receptor. Blockade of IL-1 activity may inhibit the cascade of downstream pro-angiogenic factors such as vascular endothelial cell growth factor, tumor necrosis factor-alpha, and IL-6, resulting in inhibition of tumor angiogenesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7092700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enoxaparin</VALIDVALUE>
          <VALUEMEANING>Enoxaparin</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug used to prevent blood clots.  It belongs to the family of drugs called anticoagulants.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heparin</VALIDVALUE>
          <VALUEMEANING>Heparin</VALUEMEANING>
          <MEANINGDESCRIPTION>A sulfur-rich glycosaminoglycan with anticoagulant property. Heparin binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors, such as factors IX, X, XI, and XII, thereby preventing the polymerization of fibrinogen to fibrin and the subsequent formation of clots.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C539</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corticosteroids (topical GI)</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Topical Corticosteroid</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines.: Any synthetic steroid derivative exhibiting the same function as the naturally occurring corticosteroid hormone, formulated for topical application. Topical corticosteroids are applied to the skin where it exerts its effect, however, corticosteroids can be absorbed systemically after being applied locally. Topical corticosteroids are mainly used for the localized treatment of inflammation of the skin and help relieve symptoms such as itching, swelling and redness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29505, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7652524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corticosteroids (topical skin)</VALIDVALUE>
          <VALUEMEANING>Skin Topical Corticosteroid</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.: Any synthetic steroid derivative exhibiting the same function as the naturally occurring corticosteroid hormone, formulated for topical application. Topical corticosteroids are applied to the skin where it exerts its effect, however, corticosteroids can be absorbed systemically after being applied locally. Topical corticosteroids are mainly used for the localized treatment of inflammation of the skin and help relieve symptoms such as itching, swelling and redness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29505, C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7652525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corticosteroids (topical inhaled)</VALIDVALUE>
          <VALUEMEANING>Inhalation Topical Corticosteroid</VALUEMEANING>
          <MEANINGDESCRIPTION>To draw in with the breath through the nose or mouth.: Any synthetic steroid derivative exhibiting the same function as the naturally occurring corticosteroid hormone, formulated for topical application. Topical corticosteroids are applied to the skin where it exerts its effect, however, corticosteroids can be absorbed systemically after being applied locally. Topical corticosteroids are mainly used for the localized treatment of inflammation of the skin and help relieve symptoms such as itching, swelling and redness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29505, C95464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7652526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasma exchange / plasmapheresis</VALIDVALUE>
          <VALUEMEANING>Therapeutic Exchange Plasma Or Plasmapheresis</VALUEMEANING>
          <MEANINGDESCRIPTION>Plasma obtained from a patient who undergoes plasma exchange (also called therapeutic plasmapheresis).: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The process of separating certain cells from the plasma in the blood by a machine; only the cells are returned to the person. Plasmapheresis can be used to remove excess antibodies from the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15304, C37998, C133348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7617080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eculizumab</VALIDVALUE>
          <VALUEMEANING>Eculizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against terminal complement protein C5. Eculizumab binds to terminal complement protein C5, thereby blocking C5 cleavage into pro-inflammatory components and blocking the complement-mediated destruction of paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7092697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corticosteroids (topical)</VALIDVALUE>
          <VALUEMEANING>Topical Corticosteroids</VALUEMEANING>
          <MEANINGDESCRIPTION>Any synthetic steroid derivatives exhibiting the same function as the naturally occurring corticosteroid hormones, formulated for topical application. Topical corticosteroids are applied to the skin where it exerts its effect, however, corticosteroids can be absorbed systemically after being applied locally. Topical corticosteroids are mainly used for the localized treatment of inflammation of the skin and help relieve symptoms such as itching, swelling and redness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3253644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other TKI</VALIDVALUE>
          <VALUEMEANING>Other Tyrosine Kinase Inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Any substance that inhibits tyrosine kinase, an enzyme involved in the transduction and processing of many extracellular and intracellular signals including cell proliferation. Inhibition of tyrosine kinase may result in inhibition of cell growth and cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C1967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5125101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other JAK 2 inhibitor</VALIDVALUE>
          <VALUEMEANING>Other JAK2 Inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Any substance that inhibits JAK2 tyrosine protein kinase, an enzyme that phosphorylates the hydroxyl group of tyrosine on various proteins in various signaling cascades.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C125450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5125105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other interleukin inhibitor</VALIDVALUE>
          <VALUEMEANING>Other Interleukin Inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Any agent that inhibits the action of an interleukin. These agents inhibit various immune functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C124064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5125055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UVB</VALIDVALUE>
          <VALUEMEANING>Ultraviolet B Radiation</VALUEMEANING>
          <MEANINGDESCRIPTION>Ultraviolet B Radiation is the 290 to 320 nanometers portion of the sun&#39;s radiant electromagnetic energy spectrum, partially absorbed by the Earth&#39;s protective stratospheric ozone layer. Recent ozone depletion has permitted more UVB to reach the Earth&#39;s surface with a wide range of potentially damaging health effects related to skin, eyes, and immune system. Evidence shows a dose-response relationship between nonmelanoma skin cancer and cumulative exposure to UVB radiation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Belumosudil (KD025)</VALIDVALUE>
          <VALUEMEANING>Belumosudil</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally administered inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2; ROCK-II), with potential immunomodulating activity. Upon administration, belumosudil binds to and inhibits the serine/threonine kinase activity of ROCK2. This inhibits ROCK2-mediated signal transduction pathways and modulates various pro- and anti-inflammatory immune cell responses. ROCK2 is upregulated in various diseases, including various fibrotic, neurodegenerative and autoimmune diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7614732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Azithromycin</VALIDVALUE>
          <VALUEMEANING>Azithromycin</VALUEMEANING>
          <MEANINGDESCRIPTION>An azalide, derived from erythromycin, and a member of a subclass of macrolide antibiotics with bacteriocidal and bacteriostatic activities. Azithromycin reversibly binds to the 50S ribosomal subunit of the 70S ribosome of sensitive microorganisms, thereby inhibiting the translocation step of protein synthesis, wherein a newly synthesized peptidyl tRNA molecule moves from the acceptor site on the ribosome to the peptidyl (donor) site, and consequently inhibiting RNA-dependent protein synthesis leading to cell growth inhibition and cell death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-IL6</VALIDVALUE>
          <VALUEMEANING>IL6 Receptor Antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>Any antibody that recognizes an interleukin 6 receptor protein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7614733</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other in vivo monoclonal antibody</VALIDVALUE>
          <VALUEMEANING>Other in vivo Monoclonal Antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Located or occurring in the body.: An antibody produced by a clone or genetically homogenous fast-growing cells i.e., hybridoma. Hybridoma cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis, and treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20401, C15744, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7613933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-IL2</VALIDVALUE>
          <VALUEMEANING>IL2 Receptor Antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>Any antibody that recognizes an interleukin 2 receptor protein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7614734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iron chelation</VALIDVALUE>
          <VALUEMEANING>Iron Chelation</VALUEMEANING>
          <MEANINGDESCRIPTION>Iron Chelation involves non-covalent coordination bonding between iron and an organic chemical, often as part of an enzyme or protein complex, as in the iron-binding porphyrin group of hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7619730</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phlebotomy</VALIDVALUE>
          <VALUEMEANING>Phlebotomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The puncture of a vein with a needle for the purpose of drawing blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abatacept</VALIDVALUE>
          <VALUEMEANING>Abatacept</VALUEMEANING>
          <MEANINGDESCRIPTION>A soluble fusion protein consisting of the extracellular domain of human cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) linked to a modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1) with immunosuppressive activity. Abatacept binds CD80 and CD86 on antigen presenting cells (APCs), blocking interaction with CD28 on T lymphocytes, which initiates a co-stimulatory signal required for full activation of T lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1 antitrypsin</VALIDVALUE>
          <VALUEMEANING>Alpha-1-Proteinase Inhibitor Human</VALUEMEANING>
          <MEANINGDESCRIPTION>Human serum-derived alpha-1 proteinase inhibitor (alpha-1-antitrypsin or AAT) with immunomodulating and anti-inflammatory activity. Upon administration, AAT reduces the production of proinflammatory cytokines, such as tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-32, IL-6, and proteinase 3, and induces the production of anti-inflammatory cytokines, such as IL-10 and the IL-1 receptor antagonist IL-1RN. This agent also downregulates heparan sulfate and reduces the expansion of cytotoxic effector T cells, interferes with the maturation of dendritic cells and increases T regulatory cells. Altogether, AAT may attenuate acute graft-versus-host disease (GvHD) and may facilitate graft acceptance and survival. In addition, AAT enhances levels of cAMP and activation of cAMP-dependent protein kinase A. AAT, a 52kD protein and serine protease inhibitor, belongs to the serpin superfamily.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82258</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7631837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Teclistamab</VALIDVALUE>
          <VALUEMEANING>Teclistamab</VALUEMEANING>
          <MEANINGDESCRIPTION>A bispecific humanized monoclonal antibody against human CD3, a T-cell surface antigen, and human B-cell maturation antigen (BCMA; TNFRSF17), a tumor-associated antigen (TAA) expressed on plasma cells, with potential antineoplastic activity. Upon administration, teclistamab binds to both CD3 on T-cells and BCMA expressed on malignant plasma cells. This results in the cross-linking of T-cells and tumor cells, and induces a potent cytotoxic T-lymphocyte (CTL) response against BCMA-expressing plasma cells. BCMA, a member of the tumor necrosis factor receptor superfamily that is specifically overexpressed on malignant plasma cells, plays a key role in promoting plasma cell survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136823</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7554850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Talquetamab</VALIDVALUE>
          <VALUEMEANING>Talquetamab</VALUEMEANING>
          <MEANINGDESCRIPTION>A bispecific humanized monoclonal antibody against human CD3, a T-cell surface antigen, and human G-protein coupled receptor family C group 5 member D (GPRC5D), a tumor-associated antigen (TAA), with potential antineoplastic activity. Upon administration, talquetamab binds to both CD3 on T-cells and GPRC5D expressed on certain tumor cells. This results in the cross-linking of T-cells and tumor cells, and induces a potent cytotoxic T-lymphocyte (CTL) response against GPRC5D-expressing tumor cells. GPRC5D is overexpressed on certain tumors, such as multiple myeloma, while minimally expressed on normal, healthy cells, and plays a key role in tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C171840</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7554852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iberdomide</VALIDVALUE>
          <VALUEMEANING>Iberdomide</VALUEMEANING>
          <MEANINGDESCRIPTION>A modulator of the E3 ubiquitin ligase complex containing cereblon (CRL4-CRBN E3 ubiquitin ligase), with immunomodulating and pro-apoptotic activities. Upon administration, iberdomide specifically binds to the cereblon (CRBN) part of the ligase complex, thereby affecting the ubiquitin E3 ligase activity, and targeting certain substrate proteins for ubiquitination. This induces the proteasome-mediated degradation of certain transcription factors, including Ikaros (IKZF1) and Aiolos (IKZF3) which are transcriptional repressors in T-cells. This leads to a reduction of their protein levels, and the modulation of the immune system, including activation of T-lymphocytes. In addition, this leads to a downregulation of other proteins, including interferon regulatory factor 4 (IRF4), which plays a key role in the proliferation of certain cancer cell types. CRBN, the substrate recognition component of the E3 ubiquitin ligase complex, plays a key role in the ubiquitination of certain proteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129048</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7554854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Belantamab mafodotin</VALIDVALUE>
          <VALUEMEANING>Belantamab Mafodotin</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody-drug conjugate (ADC) consisting of belantamab, an afucosylated, humanized monoclonal antibody, directed against the B-cell maturation antigen (BCMA), conjugated to mafodotin, an auristatin analogue and microtubule inhibitor monomethyl auristatin phenylalanine (MMAF), with potential antineoplastic activity. Upon administration of belantamab mafodotin, the anti-BCMA antibody moiety selectively binds to BCMA on tumor cell surfaces. Upon internalization, the MMAF moiety binds to tubulin and inhibits its polymerization, which results in G2/M phase arrest and induces tumor cell apoptosis. In addition, belantamab mafodotin induces antibody-dependent cellular cytotoxicity (ADCC). Altogether, this results in the inhibition of cellular proliferation in tumor cells that overexpress BCMA. BCMA, a receptor for a proliferation-inducing ligand and B-cell activating factor, is a member of the tumor necrosis factor (TNF) receptor superfamily and plays a key role in plasma cell survival; it is found on the surfaces of plasma cells and overexpressed on malignant plasma cells. Afucosylation of the antibody moiety increases ADCC.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114299</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7554856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesenchymal stem cells (MSCs)</VALIDVALUE>
          <VALUEMEANING>Mesenchymal Stem Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>An undifferentiated stromal cell with the ability to develop into the cells that form distinct mesenchymal tissues; such as bone, muscle, connective tissue, blood vessels, and lymphatic tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4197222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corticosteroids - Pulse dose</VALIDVALUE>
          <VALUEMEANING>Pulse Steroids</VALUEMEANING>
          <MEANINGDESCRIPTION>Intermittent therapeutic administration of high doses of steroids over short periods of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C182447</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797672</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GTE:GTO oil (Lorenzo&#39;s oil)</VALIDVALUE>
          <VALUEMEANING>Lorenzo&#39;s Oil</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally-administered oil composed of the monounsaturated fatty acids glyceryl trioleate (GTO), the triacylglycerol form of oleic acid derived from olive oil, and glyceryl trierucate (GTE), the triacylglycerol form of erucic acid derived from rapeseed oil, in a 4:1 ratio, that can be used in the treatment of adrenoleukodystrophy (ALD). Upon oral administration of Lorenzo&#39;s oil, the monounsaturated fatty acids compete with saturated fatty acids as substrates for enzymes in the elongation of very long-chain fatty acids (ELOVL) family. This results in the elongation and production of monounsaturated very long-chain fatty acids (VLCFAs) and reduces the elongation of saturated VLCFAs. This reduces the plasma levels of saturated VLCFAs and prevents their accumulation in the brain, thereby preventing demyelination of cerebral nerves and halting the progression of ALD.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121561</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7681465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Itacitinib</VALIDVALUE>
          <VALUEMEANING>Itacitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of Janus-associated kinase 1 (JAK1) with potential antineoplastic and immunomodulating activities. Upon oral administration, itacitinib selectively inhibits JAK-1, thereby inhibiting the phosphorylation of signal transducer and activator of transcription (STAT) proteins and the production of proinflammatory factors induced by other cytokines, including interleukin-23 (IL-23) and interleukin-6 (IL-6). The JAK-STAT pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8123275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KGF</VALIDVALUE>
          <VALUEMEANING>Fibroblast Growth Factor 7</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibroblast Growth Factor 7 (Keratinocyte Growth Factor) is a member of the fibroblast growth factor family that stimulates the growth of epithelial cells, but lacks mitogenic activity on fibroblasts or endothelial cells.  FGF7 is a single polypeptide chain of about 28 kD that has predominant activity in keratinocytes.  (from OMIM 148180 and NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2644088</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Evusheld</VALIDVALUE>
          <VALUEMEANING>Cilgavimab/Tixagevimab</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination of two neutralizing human monoclonal antibodies cilgavimab and tixagevimab, that are isolated from convalescent patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, and directed against the spike (S) protein, that can potentially be used for passive immunization against Coronavirus disease 2019 (COVID-19). Upon administration of cilgavimab/tixagevimab, both antibodies specifically target and bind to the SARS-CoV-2 S protein, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2. S protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C175229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12112943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Emapalumab</VALIDVALUE>
          <VALUEMEANING>Emapalumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A human monoclonal antibody against the cytokine interferon-gamma (IFN-gamma; IFNg), with potential immunomodulating activity. Upon administration, emapalumab binds to and neutralizes IFNg. This inhibits IFNg-mediated signaling pathways and suppresses the activation of the immune system. IFNg, a cell-signaling protein, plays a key role in the regulation and activation of the immune system; its upregulation is associated with certain auto-immune and auto-inflammatory diseases in which the immune system is abnormally activated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127123</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12151552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antiviral drugs</VALIDVALUE>
          <VALUEMEANING>Antiviral Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>Drugs used to treat infections caused by viruses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3235629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decorporation drugs</VALIDVALUE>
          <VALUEMEANING>Radionuclide Decorporation Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>Any agent that is able to prevent absorption or facilitate the removal of internal radionuclide contamination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14718278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Growth factors</VALIDVALUE>
          <VALUEMEANING>Growth Factor</VALUEMEANING>
          <MEANINGDESCRIPTION>Substances made by the body that function to regulate cell division and cell survival. Some growth factors are also produced in the laboratory and used in biological therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2918795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-absorbable oral antibiotics</VALIDVALUE>
          <VALUEMEANING>Negation Absorbable Oral Route of Administration Antibiotic</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._Capable of being taken up or taken in._The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins._Substances naturally produced by microorganisms or their derivatives that selectively target microorganisms not humans. Antibiotics kill or inhibit the growth of microorganisms by targeting components of the microbial cell absent from human cells, including bacterial cell walls, cell membrane, and 30S or 50S ribosomal subunits. These substances are used in the treatment of bacterial and other microbial infections.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C258, C38288, C75520, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2799757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet transfusion</VALIDVALUE>
          <VALUEMEANING>Platelet transfusion</VALUEMEANING>
          <MEANINGDESCRIPTION>The infusion of platelets into the bloodstream.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RBC transfusion</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Blood Transfusion</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood cell specialized for oxygen transport, having a high concentration of hemoglobin in the cytoplasm. They are biconcave, anucleate discs, with a 6-8um diameter in humans._The injection of whole blood or a blood component directly into the bloodstream.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15192, C12521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14718279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systemic antibacterial antibiotics</VALIDVALUE>
          <VALUEMEANING>Systemic Therapy Antibacterial Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body._A family of substances capable of destroying or inhibiting the growth of bacteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52588, C15698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14718280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systemic antifungal drugs</VALIDVALUE>
          <VALUEMEANING>Systemic Therapy Antifungal Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body._Substances that treat systemic or topical infections caused by fungi. Antifungal agents kill or inhibit the growth of fungi, by various mechanisms. These mechanisms include inhibition of fungal mitosis, impairing synthesis or binding to ergosterol, inhibition of RNA or DNA synthesis, and interfering with other fungal metabolic processes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C514, C15698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14718281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corticosteroids</VALIDVALUE>
          <VALUEMEANING>Corticosteroid</VALUEMEANING>
          <MEANINGDESCRIPTION>Hormones synthesized in the cortex of the adrenal gland and consist of two subclasses, glucocorticoids (carbohydrate regulation) and mineralocorticoids (electrolyte regulation).(NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2322</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3951357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythropoietin</VALIDVALUE>
          <VALUEMEANING>Erythropoietin</VALUEMEANING>
          <MEANINGDESCRIPTION>Glycoprotein hormone, secreted chiefly by the kidney in the adult and the liver in the fetus, that acts on erythroid stem cells of the bone marrow to stimulate proliferation and differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2644085</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HCT</VALIDVALUE>
          <VALUEMEANING>Hematopoietic Cell Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leriglitazone</VALIDVALUE>
          <VALUEMEANING>Leriglitazone</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, blood-brain-barrier (BBB) penetrable, selective peroxisome proliferator-activated receptor (PPAR) subtype gamma agonist, with potential neuroprotective activity that could be used for certain central nervous system (CNS) diseases, such as adrenomyeloneuropathy, cerebral adrenoleukodystrophy (cALD), Friedreich&#39;s ataxia, and certain other CNS diseases. Upon oral administration, leriglitazone selectively targets, binds to and activates PPARgamma, thereby regulating the expression of genes involved in mitochondrial biogenesis. This modulates pathways leading to the restoration of mitochondrial function in which dysfunction is caused by the accumulation of very long-chain fatty acids (VLCFAs), and increases energy production, decreases oxidative stress, decreases nuclear factor kappa B (NF-kB) levels, inhibits neuroinflammation, protects the BBB integrity, prevents demyelination and axonal degeneration, increases neuronal survival, increases myelination and oligodendrocyte survival and improves motor function. Mutations in the ABCD1 gene, which encodes the peroxisomal membrane adrenoleukodystrophy protein, cause a defective function of the ABCD1 transporter leading to an accumulation of VLCFA. VLCFA accumulation contributes to membrane destabilization of the myelin sheath, mitochondrial dysfunction, oxidative stress, neuroinflammation and compromised BBB integrity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170108</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14883069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zanubrutinib</VALIDVALUE>
          <VALUEMEANING>Zanubrutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An inhibitor of Bruton&#39;s tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, zanubrutinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways, which leads to the inhibition of the growth of malignant B-cells that overexpress BTK. BTK, a member of the Src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B-lymphocyte development, activation, signaling, proliferation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13744151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pirtobrutinib</VALIDVALUE>
          <VALUEMEANING>Pirtobrutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available, selective, non-covalent Bruton&#39;s tyrosine kinase (BTK) inhibitor with potential antineoplastic activity. Upon oral administration, pirtobrutinib selectively and reversibly binds to BTK. This prevents both the activation of the B-cell antigen receptor (BCR) signaling pathway and BTK-mediated activation of downstream survival pathways, thereby inhibiting the growth of malignant B-cells that overexpress BTK. Reversible binding of LOXO-305 may preserve antitumor activity in the presence of certain acquired resistance mutations, including C481 mutated BTK, and limit toxicity associated with inhibition of other non-BTK kinases. BTK, a member of the Src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed or mutated in B-cell malignancies; it plays an important role in the development, activation, signaling, proliferation and survival of B-lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158617</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13956445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxaliplatin</VALIDVALUE>
          <VALUEMEANING>Oxaliplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane (DACH) and with an oxalate ligand as a &#39;leaving group.&#39; A &#39;leaving group&#39; is an atom or a group of atoms that is displaced as a stable species taking with it the bonding electrons. After displacement of the labile oxalate ligand leaving group, active oxaliplatin derivatives, such as monoaquo and diaquo DACH platinum, alkylate macromolecules, forming both inter- and intra-strand platinum-DNA crosslinks, which result in inhibition of DNA replication and transcription and cell-cycle nonspecific cytotoxicity. The DACH side chain appears to inhibit alkylating-agent resistance. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1181</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Duvelisib</VALIDVALUE>
          <VALUEMEANING>Duvelisib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. Upon administration, duvelisib prevents the activation of the PI3K delta/gamma-mediated signaling pathways which may lead to a reduction in cellular proliferation in PI3K delta/gamma-expressing tumor cells. Unlike other isoforms of PI3K, the delta and gamma isoforms are overexpressed primarily in hematologic malignancies and inflammatory and autoimmune diseases. By selectively targeting these PI3K isoforms, PI3K signaling in normal, non-neoplastic cells is minimally or not affected which would result in a more favorable side effect profile.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7464061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chlorambucil</VALIDVALUE>
          <VALUEMEANING>Chlorambucil</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally-active antineoplastic aromatic nitrogen mustard. Chlorambucil alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oblimersen</VALIDVALUE>
          <VALUEMEANING>Oblimersen</VALUEMEANING>
          <MEANINGDESCRIPTION>A phosphorothioate antisense oligonucleotide. Targeted to the initiation codon region of the bcl-2 mRNA, oblimersen inhibits bcl-2 mRNA translation, resulting in decreased expression of the bcl-2 protein, an apoptotic inhibitor expressed in some types of cancer and linked to tumor drug resistance. This agent may enhance the efficacy of standard cytotoxic chemotherapy. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15039491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Topotecan</VALIDVALUE>
          <VALUEMEANING>Topotecan</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Topotecan inhibits topoisomerase I activity by stabilizing the topoisomerase I-DNA covalent complexes during S phase of cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Docetaxel</VALIDVALUE>
          <VALUEMEANING>Docetaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata.  Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death.  This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response.  Docetaxel has been studied for use as a radiation-sensitizing agent. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dactinomycin</VALIDVALUE>
          <VALUEMEANING>Dactinomycin</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromopeptide antineoplastic antibiotic isolated from the bacterium Streptomyces parvulus.  Dactinomycin intercalates between adjacent guanine-cytosine base pairs, blocking the transcription of DNA by RNA polymerase; it also causes single-strand DNA breaks, possibly via a free-radical intermediate or an interaction with topoisomerase II. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trabectedin</VALIDVALUE>
          <VALUEMEANING>Trabectedin</VALUEMEANING>
          <MEANINGDESCRIPTION>A tetrahydroisoquinoline alkaloid isolated from the marine tunicate Ecteinascidia turbinata with potential antineoplastic activity. Binding to the minor groove of DNA, trabectedin interferes with the transcription-coupled nucleotide excision repair machinery to induce lethal DNA strand breaks and blocks the cell cycle in the G2 phase.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pazopanib</VALIDVALUE>
          <VALUEMEANING>Pazopanib</VALUEMEANING>
          <MEANINGDESCRIPTION>A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3107591</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin E</VALIDVALUE>
          <VALUEMEANING>Vitamin E Compound</VALUEMEANING>
          <MEANINGDESCRIPTION>A fat-soluble vitamin which is primarily a chain-breaking antioxidant that prevents the propagation of lipid peroxidation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C942</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4804371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low molecular weight heparin</VALIDVALUE>
          <VALUEMEANING>Low-molecular weight heparin (LMWH)</VALUEMEANING>
          <MEANINGDESCRIPTION>Substances comprised of fragmented heparin molecules derived from unfractionated heparin that bind to antithrombin III with a molecular weight ranging from 1000 to 10,000 daltons, which causes changes in property from unfractionated heparin, including decreased protein binding, enhanced bioavailability, decreased platelet interaction, and decreased binding to thrombin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2578</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8067188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Isotretinoin</VALIDVALUE>
          <VALUEMEANING>Isotretinoin</VALUEMEANING>
          <MEANINGDESCRIPTION>A naturally-occurring retinoic acid with potential antineoplastic activity. Isotretinoin binds to and activates nuclear retinoic acid receptors (RARs); activated RARs serve as transcription factors that promote cell differentiation and apoptosis. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dinutuximab</VALIDVALUE>
          <VALUEMEANING>Monoclonal Antibody Ch14.18</VALUEMEANING>
          <MEANINGDESCRIPTION>A chimeric mouse/human monoclonal antibody with potential antineoplastic activity. Monoclonal antibody Ch14.18 binds to the ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells.  GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3597790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Combination chemotherapy</VALIDVALUE>
          <VALUEMEANING>Combination Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment using more than one anticancer drug.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None of the above</VALIDVALUE>
          <VALUEMEANING>None of the above</VALUEMEANING>
          <MEANINGDESCRIPTION>None of the choices above are suitable.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577583</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Local therapy</VALIDVALUE>
          <VALUEMEANING>Local Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Any therapeutic procedure that targets, or is restricted to, a specific anatomical location.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16280680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cabozantinib</VALIDVALUE>
          <VALUEMEANING>Cabozantinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (MET), RET (rearranged during transfection), vascular endothelial growth factor receptor types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6824783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Steroids</VALIDVALUE>
          <VALUEMEANING>Steroid</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of exogenous steroids for the treatment of any disease or disorder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-07-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5511067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intravenous immunoglobulin (IVIG)</VALIDVALUE>
          <VALUEMEANING>Intravenous Immunoglobulin Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The administration of a blood product derived from pooled IgG antibodies extracted from donor plasma delivered intravenously. It is used to treat multiple disorders, including immunodeficiencies, autoimmune disorders, and active infections.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121331</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6051439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intrathecal / intraventricular therapy</VALIDVALUE>
          <VALUEMEANING>Intrathecal Route of Administration And/Or Intraventricular Route of Administration Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Administration of drugs directly into spinal subarachnoid space in the cerebrospinal fluid, at any level of the cerebrospinal axis, including injection into the cerebral ventricles, in order to bypass the blood-brain barrier and achieve local, rapid effects on the meninges or cerebrospinal axis._Used to indicate that either or both of two items or options may be valid._Administration of a drug directly into a cerebral ventricle, commonly using a reservoir. This allows a more even distribution of drug through the cerebrospinal fluid (CSF) and is particularly useful in the treatment of certain types of cancers._Medical care intended to treat or cure a condition or lessen its symptoms. This includes the administration of drugs, surgical procedures, physical or psychotherapy, or the use of therapeutic devices.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C38277, C48928, C38267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16478059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the systemic therapy</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the systemic therapy administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify systemic therapy:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify systemic therapy:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify systemic therapy given</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify systemic therapy given</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify systemic therapy given</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify systemic therapy given</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify therapy</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify therapy given</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify therapy given</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify if the recipient received any of the following</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify if the recipient received any of the following</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Systemic drugs</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Systemic drugs</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify systemic therapy</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify systemic therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify systemic therapy given for maintenance</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify systemic therapy given for maintenance</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify systemic drugs given</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify systemic drugs given</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Drug</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Drug</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>10115208</PublicId>
          <ContextName>TEST</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>10115208v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>QA Test CSI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>10115209</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_IGM_sys_thr_all_typ</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_PT_sys_thr_all_alt_typ</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLP_LTHM_aml_alt_sys_thr_tp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLP_PTM_sys_thr_all_typ</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_IGM_aml_alt_sys_thr_tp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_PT_aml_sys_ther_tp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_OT_systemic_drug_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_THM_sys_thrpy_lym_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_thrpym_systemic_drug_ty</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_PHCT_sys_thrpy_admin_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_RP_sys_thrpy_admin_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_STD_systemic_th_adm_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_RP_sys_therapy_adm_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CBSE_STD_systemic_th_adm_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_PIID_sys_therapy_adm_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="158">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2862118</PUBLICID>
    <LONGNAME>Patient Food Assessment FACT-G Questionnaire Scale Score</LONGNAME>
    <PREFERREDNAME>FOOD_ASSESS_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric score from the 5-step scale used by FACT-G tool to assess an individual&#39;s ability to eat as much food as he/she wants.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2228466</PublicId>
      <PreferredName>PATIENT_FOOD_ASSESS</PreferredName>
      <PreferredDefinition>information relating to patient food assessment.</PreferredDefinition>
      <LongName>Patient Food Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2228464</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0016452:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Food Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0016452</PREFERRED_NAME>
            <LONG_NAME>Food</LONG_NAME>
            <CON_ID>2203349</CON_ID>
            <DEFINITION_SOURCE>Medical Subject Headings (MeSH). Bethesda (MD): National Library of Medicine.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2552203</PublicId>
      <PreferredName>FACT_SCL_SC</PreferredName>
      <PreferredDefinition>Numeric scores from the 5-step scale used by FACT-G Quality of Life questionnaires to assess a patient. [Manually-curated]</PreferredDefinition>
      <LongName>FACT-G Questionnaire Scale Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2552202</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45899:C25664:C25338</PreferredName>
        <Version>1</Version>
        <LongName>FACT-G Questionnaire Scale Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45899</PREFERRED_NAME>
            <LONG_NAME>FACT-G Questionnaire</LONG_NAME>
            <CON_ID>2552004</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Some-what</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a great amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I am able to eat as much food</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I am able to eat as much food as I want.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812605</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="159">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2866764</PUBLICID>
    <LONGNAME>Hematopoietic Stem Cell Transplantation Response Negation Complete Remission Date</LONGNAME>
    <PREFERREDNAME>HSCT_RES_NO_CR_AS_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The grafting of tissues from one individual to another or place to place within a single individual_Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._An operation in which a term denies or inverts the meaning of another term or construction._The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured._The particular day, month and year an event has happened or will happen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2769649</PublicId>
      <PreferredName>HSCT_RES_NO_CR</PreferredName>
      <PreferredDefinition>Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The grafting of tissues from one individual to another or place to place within a single individual_Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._An operation in which a term denies or inverts the meaning of another term or construction._The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.</PreferredDefinition>
      <LongName>Hematopoietic Cell Transplantation Response Negation Complete Remission</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2769708</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12551:C15342:C25755</PreferredName>
        <Version>1</Version>
        <LongName>Hematopoietic Stem Cell Transplantation Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25755</PREFERRED_NAME>
            <LONG_NAME>Response</LONG_NAME>
            <CON_ID>2202805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2769709</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C4870</PreferredName>
        <Version>1</Version>
        <LongName>Negation Complete Remission</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4870</PREFERRED_NAME>
            <LONG_NAME>Complete Remission</LONG_NAME>
            <CON_ID>2202721</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2532012</PublicId>
      <PreferredName>DATE</PreferredName>
      <PreferredDefinition>The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY-MM-DD</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What assessment date determin</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What assessment date determined that CR has not been achieved from the HSCT?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping for CDE:2866764</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedObservation.dateRange WHERE   PerformedObservation &gt; PerformedClinicalInterpretation.value(ANY=&gt;CD) = &quot;Complete Remission never achieved&quot; AND PerformedObservation &gt; DefinedObservation.nameCode = &quot;Review disease statuses&quot; AND PerformedObservation &gt; AssessedActivityRelationship &gt; PerformedSubstanceAdministration &gt; DefinedSubstanceAdministration.nameCode = &quot;Administer Hematopoietic Stem Cell Product {Transplantation}&quot; AND PerformedObservation &gt; AssessedResultRelationship &gt; PerformedDiagnosis.diseaseStatus [all statuses recorded]</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2450r1: Post-TED</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964925</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>post_ted_hsct_no_rspn_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedObservation:dateRange</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="160">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2869673</PUBLICID>
    <LONGNAME>Research Resource Provider Identifier ISO21090.II.v1.0</LONGNAME>
    <PREFERREDNAME>2868007v1.0:2803193v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A unique symbol that establishes identity of the resource provider.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868007</PublicId>
      <PreferredName>2867599v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>The funding, research facilities, and materials available for research:One that makes something available._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Research Resource Provider Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867599</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15321:C37900</PreferredName>
        <Version>1</Version>
        <LongName>Research Resource Provider</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15321</PREFERRED_NAME>
            <LONG_NAME>Research Resource</LONG_NAME>
            <CON_ID>2867549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37900</PREFERRED_NAME>
            <LONG_NAME>Provider</LONG_NAME>
            <CON_ID>2202411</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803193</PublicId>
      <PreferredName>2803193v1.0</PreferredName>
      <PreferredDefinition>Identifier that uniquely identifies a thing or object.</PreferredDefinition>
      <LongName>ISO21090.II.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090IIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Research Resource Provider Identifier ISO21090.II.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Research Resource Provider Identifier ISO21090.II.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.CommonSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757153</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ResourceProvider.identifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ResourceProvider:identifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.CommonSubDomain.ResourceProvider.identifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ResourceProvider.identifier</AlternateName>
        <AlternateNameType>Map:CTRv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudyParticipation RMIM</AlternateName>
        <AlternateNameType>Map:HL7SP</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ResourceProvider.identifier</AlternateName>
        <AlternateNameType>Map:CTRPv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Protocol.sponsorCode</AlternateName>
        <AlternateNameType>Map:CTOM</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Study.sponsorCode</AlternateName>
        <AlternateNameType>Map:C3PR</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="161">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2869836</PUBLICID>
    <LONGNAME>Study Protocol Document Healthy Subject Acceptable Flag ISO21090.BL.v1.0</LONGNAME>
    <PREFERREDNAME>2868163v1.0:2803169v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:A rule which guides how an activity should be performed.:An organized collection of records that describe a particular body of data._An individual who is or becomes a participant in a research study and has no significant health-related issues.:Satisfying an established set of qualifying measures.:An indicator that can be set or unset in order to signal whether a particular condition is true._Values of two-valued logic.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868163</PublicId>
      <PreferredName>2867648v1.0:2867842v1.0</PreferredName>
      <PreferredDefinition>A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:A rule which guides how an activity should be performed.:An organized collection of records that describe a particular body of data._An individual who is or becomes a participant in a research study and has no significant health-related issues.:Satisfying an established set of qualifying measures.:An indicator that can be set or unset in order to signal whether a particular condition is true.</PreferredDefinition>
      <LongName>Study Protocol Document Healthy Subject Acceptable Flag</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867648</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63536:C42651:C19498</PreferredName>
        <Version>1</Version>
        <LongName>Study Protocol Document</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42651</PREFERRED_NAME>
            <LONG_NAME>Protocol</LONG_NAME>
            <CON_ID>2211236</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19498</PREFERRED_NAME>
            <LONG_NAME>Document</LONG_NAME>
            <CON_ID>2223216</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867842</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49651:C63350:C43578</PreferredName>
        <Version>1</Version>
        <LongName>Healthy Subject Acceptable Flag</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49651</PREFERRED_NAME>
            <LONG_NAME>Healthy Subject</LONG_NAME>
            <CON_ID>2480672</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63350</PREFERRED_NAME>
            <LONG_NAME>Acceptable</LONG_NAME>
            <CON_ID>2538603</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43578</PREFERRED_NAME>
            <LONG_NAME>Flag</LONG_NAME>
            <CON_ID>2223213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803169</PublicId>
      <PreferredName>2803169v1.0</PreferredName>
      <PreferredDefinition>Values of two-valued logic.</PreferredDefinition>
      <LongName>ISO21090.BL.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090BLv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Study Protocol Document Healthy Subject Acceptable Flag ISO21090.BL.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Study Protocol Document Healthy Subject Acceptable Flag ISO21090.BL.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2958963</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COPPA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.COPPA.InformationModel</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2958964</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyProtocol.acceptsHealthyVolunteersIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudyProtocol:acceptsHealthyVolunteersIndicator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.COPPA.InformationModel.StudyProtocol.acceptsHealthyVolunteersIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="162">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2870265</PUBLICID>
    <LONGNAME>Performed Observation Outcome Uncertain Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>2868588v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded value specifying whether and to what degree this evaluation or observation has been asserted to be in doubt in any way. EXAMPLE(S): A patient might have had a cholecystectomy procedure in the past, but isn&#39;t sure what the outcome was.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868588</PublicId>
      <PreferredName>2867619v1.0:2607674v1.0</PreferredName>
      <PreferredDefinition>Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._Not established beyond doubt; still undecided or unknown.:A system, often of numbered categories, for representation of data.</PreferredDefinition>
      <LongName>Performed Observation Outcome Uncertain Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867619</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000:C25598:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Performed Observation Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607674</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47944:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Uncertain Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47944</PREFERRED_NAME>
            <LONG_NAME>Uncertain</LONG_NAME>
            <CON_ID>2342198</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Performed Observation Outcome Uncertain Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Performed Observation Outcome Uncertain Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedObservationResult.uncertaintyCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedObservationResult:uncertaintyCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain.PerformedObservationResult.uncertaintyCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CDE 2695060:Lab Results.If FDA licensed nucleic acid amplification test (NAT) for human immunodeficiency virus(HIV)-1 performed; specify results</AlternateName>
        <AlternateNameType>Map:HCTv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Death_Cause.death_cause_confidence</AlternateName>
        <AlternateNameType>Map:PCORNetv3.1</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Cause of Death.Confidence</AlternateName>
        <AlternateNameType>Map:Sentinelv6.0.2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Death_Cause.death_cause_confidence</AlternateName>
        <AlternateNameType>Map:PCORNetv4.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ClinicalResult.uncertaintyCode</AlternateName>
        <AlternateNameType>Map:CTOM</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Histopathology.uncertaintyCode</AlternateName>
        <AlternateNameType>Map:CTOM</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Observation.uncertaintyCode</AlternateName>
        <AlternateNameType>Map:CTOM</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedObservationResult.uncertaintyCode</AlternateName>
        <AlternateNameType>Map:CDMHv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Death.death_match_confidence</AlternateName>
        <AlternateNameType>Map:PCORNetv3.1</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedObservationResult.uncertaintyCode</AlternateName>
        <AlternateNameType>Map:CTRv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Death.Confidence</AlternateName>
        <AlternateNameType>Map:Sentinelv6.0.2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Death.death_match_confidence</AlternateName>
        <AlternateNameType>Map:PCORNetv4.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LesionDescription.uncertaintyCode</AlternateName>
        <AlternateNameType>Map:CTOM</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedObservationResult.uncertaintyCode</AlternateName>
        <AlternateNameType>Map:LSDAMv2.2.3Plus</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="163">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2870643</PUBLICID>
    <LONGNAME>Clinical Interpretation Performed Observation Outcome Confidentiality Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>2868968v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An assessment which involves determining the meaning of a clinical result. EXAMPLE(S): The results of a white blood cell count may be interpreted as constituting a grade 2 toxicity. A coded value specifying the degree of privacy applicable for the observation result.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868968</PublicId>
      <PreferredName>2867642v1.0:2867838v1.0</PreferredName>
      <PreferredDefinition>Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. Examples of interpretation include rendering by the psychotherapist the latent or hidden meaning of what the patient says, does, or experiences in understandable to him format; the conception of another&#39;s behavior; the establishment of significance of something; the result of EKG tracing reading.:Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._Treatment of information so that it is not divulged in ways that are inconsistent with the understanding of the original disclosure. Particularly, the ethical principle or legal right that a physician or other health professional will hold secret all information relating to a patient, unless the patient gives consent permitting disclosure.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Clinical Interpretation Performed Observation Outcome Confidentiality Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867642</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>2867642v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Interpretation Performed Observation Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41255</PREFERRED_NAME>
            <LONG_NAME>Interpretation</LONG_NAME>
            <CON_ID>2230185</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867838</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16466:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Confidentiality Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16466</PREFERRED_NAME>
            <LONG_NAME>Confidentiality</LONG_NAME>
            <CON_ID>2493174</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Clinical Interpretation Performed Observation Outcome Confidentiality Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Clinical Interpretation Performed Observation Outcome Confidentiality Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedClinicalInterpretation:confidentialityCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedClinicalInterpretation.confidentialityCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain.PerformedClinicalInterpretation.confidentialityCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="164">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2876906</PUBLICID>
    <LONGNAME>Surgical Resection Rectum Performed Ind-2</LONGNAME>
    <PREFERREDNAME>SURG_R_REC_PERF_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to the removal or excision by surgical measures of the last 6 inches of the large intestine.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2876872</PublicId>
      <PreferredName>SURG_RES_REC_PERF</PreferredName>
      <PreferredDefinition>information related to the removal or excision by surgical measures of the last 6 inches of the large intestine.</PreferredDefinition>
      <LongName>Surgical Resection Rectum Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206549</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25698:C15232</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Resection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25698</PREFERRED_NAME>
            <LONG_NAME>Surgical</LONG_NAME>
            <CON_ID>2202592</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15232</PREFERRED_NAME>
            <LONG_NAME>Excision</LONG_NAME>
            <CON_ID>2202806</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2876870</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12390:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Rectum Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12390</PREFERRED_NAME>
            <LONG_NAME>Rectum</LONG_NAME>
            <CON_ID>2202801</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Rectum</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Rectum</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>History of anterior resection of the rectum</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="165">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2897102</PUBLICID>
    <LONGNAME>Day Radiation Therapy Start Number</LONGNAME>
    <PREFERREDNAME>DAY_RT_ST_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the day of the start of radiation therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188786</PublicId>
      <PreferredName>RT_BEG_OCUR</PreferredName>
      <PreferredDefinition>information related to begin date or occurrence for radiation therapy.</PreferredDefinition>
      <LongName>RT Begin Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176998</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RT</PreferredName>
        <Version>1</Version>
        <LongName>RT</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207746</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25275</PreferredName>
        <Version>1</Version>
        <LongName>Begin Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896868</PublicId>
      <PreferredName>EVT_DAY_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._time for Earth to make a complete rotation on its axis._A numeral or string of numerals expressing value, quantity, or identification</PreferredDefinition>
      <LongName>Event Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C0439228:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Day Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0439228</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2204684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>22nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::22: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::22</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>21st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>20th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::20: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>19th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::19: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>18th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::18: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>17th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::17: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>16th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::16: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>15th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::15: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>14th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::14: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>13th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::13: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::10: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::4: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::5: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>31st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::31: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::31</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>30th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::30: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::30</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>29th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::29: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>28th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::28: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>27th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::27: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>26th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::26: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>25th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::25: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>24th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>23rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::23: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day of Radiation Therapy start</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Day of Radiation Therapy start</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day Radiation Therapy Started</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Day Radiation Therapy Started</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>TCGA Application Question</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Day Radiation Therapy Started for the Other Malignancy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLGSP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5655940</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>day_of_radiation_therapy_start</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="166">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2897108</PUBLICID>
    <LONGNAME>Day Radiation Therapy End Number</LONGNAME>
    <PREFERREDNAME>DAY_RT_END_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the day of the end of radiation therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188789</PublicId>
      <PreferredName>RT_END_OCUR</PreferredName>
      <PreferredDefinition>information related to the end date or occurrence of radiation therapy.</PreferredDefinition>
      <LongName>RT End Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176998</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RT</PreferredName>
        <Version>1</Version>
        <LongName>RT</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2598135</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25496:C25275</PreferredName>
        <Version>1</Version>
        <LongName>End Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896868</PublicId>
      <PreferredName>EVT_DAY_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._time for Earth to make a complete rotation on its axis._A numeral or string of numerals expressing value, quantity, or identification</PreferredDefinition>
      <LongName>Event Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C0439228:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Day Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0439228</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2204684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>22nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::22: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::22</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>21st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>20th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::20: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>19th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::19: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>18th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::18: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>17th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::17: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>16th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::16: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>15th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::15: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>14th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::14: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>13th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::13: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::10: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::4: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::5: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>31st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::31: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::31</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>30th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::30: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::30</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>29th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::29: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>28th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::28: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>27th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::27: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>26th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::26: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>25th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::25: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>24th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>23rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::23: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day of Radiation Therapy End</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Day of Radiation Therapy End</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day Radiation Therapy Ended</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Day Radiation Therapy Ended</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLGSP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5655940</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>day_of_radiation_therapy_end</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="167">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2898743</PUBLICID>
    <LONGNAME>Variable Value Life Sciences Identifier Namespace java.lang.String</LONGNAME>
    <PREFERREDNAME>2898577v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any characteristic or attribute that can be measured.:The information contained in a data field.  It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute._A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:In general, a namespace is an abstract container, which is or could be filled by names, or technical terms, or words, and these represent or stand for real-world things.  A description logic terminology namespace is a collection of Kind, Role, Property and Concept definitions. As in computer programming, context namespaces are intended to allow multiple knowledge bases to reside in the same physical database. (from Apelon)_Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2898577</PublicId>
      <PreferredName>2726722v1.0:2898545v1.0</PreferredName>
      <PreferredDefinition>Any characteristic or attribute that can be measured.:The information contained in a data field.  It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute._A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:In general, a namespace is an abstract container, which is or could be filled by names, or technical terms, or words, and these represent or stand for real-world things.  A description logic terminology namespace is a collection of Kind, Role, Property and Concept definitions. As in computer programming, context namespaces are intended to allow multiple knowledge bases to reside in the same physical database. (from Apelon)</PreferredDefinition>
      <LongName>Variable Value Life Sciences Identifier Namespace</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2726722</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43371:C49100</PreferredName>
        <Version>1</Version>
        <LongName>Variable Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43371</PREFERRED_NAME>
            <LONG_NAME>Variable Characteristic</LONG_NAME>
            <CON_ID>2236568</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49100</PREFERRED_NAME>
            <LONG_NAME>Data Value</LONG_NAME>
            <CON_ID>2463853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2898545</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47841:C42699</PreferredName>
        <Version>1</Version>
        <LongName>Life Sciences Identifier Namespace</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47841</PREFERRED_NAME>
            <LONG_NAME>Life Sciences Identifier</LONG_NAME>
            <CON_ID>2423426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42699</PREFERRED_NAME>
            <LONG_NAME>Namespace</LONG_NAME>
            <CON_ID>2222837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Variable Value Life Sciences Identifier Namespace java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Variable Value Life Sciences Identifier Namespace java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000576</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.project.AbstractFactorValue.lsidNamespace</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AbstractFactorValue:lsidNamespace</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="168">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2898807</PUBLICID>
    <LONGNAME>Microarray Life Sciences Identifier Namespace java.lang.String</LONGNAME>
    <PREFERREDNAME>2898641v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A microarray is a piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues._A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:In general, a namespace is an abstract container, which is or could be filled by names, or technical terms, or words, and these represent or stand for real-world things.  A description logic terminology namespace is a collection of Kind, Role, Property and Concept definitions. As in computer programming, context namespaces are intended to allow multiple knowledge bases to reside in the same physical database. (from Apelon)_Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2898641</PublicId>
      <PreferredName>2223346v1.0:2898545v1.0</PreferredName>
      <PreferredDefinition>A microarray is a piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues._A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:In general, a namespace is an abstract container, which is or could be filled by names, or technical terms, or words, and these represent or stand for real-world things.  A description logic terminology namespace is a collection of Kind, Role, Property and Concept definitions. As in computer programming, context namespaces are intended to allow multiple knowledge bases to reside in the same physical database. (from Apelon)</PreferredDefinition>
      <LongName>Microarray Life Sciences Identifier Namespace</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223346</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C44282</PreferredName>
        <Version>1</Version>
        <LongName>Microarray</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44282</PREFERRED_NAME>
            <LONG_NAME>Microarray</LONG_NAME>
            <CON_ID>2223237</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2898545</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47841:C42699</PreferredName>
        <Version>1</Version>
        <LongName>Life Sciences Identifier Namespace</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47841</PREFERRED_NAME>
            <LONG_NAME>Life Sciences Identifier</LONG_NAME>
            <CON_ID>2423426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42699</PREFERRED_NAME>
            <LONG_NAME>Namespace</LONG_NAME>
            <CON_ID>2222837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Microarray Life Sciences Identifier Namespace java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Microarray Life Sciences Identifier Namespace java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.array</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000649</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.array</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000652</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.array.Array.lsidNamespace</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Array:lsidNamespace</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="169">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2900058</PUBLICID>
    <LONGNAME>Medical Image Pixel Resolution java.lang.Float</LONGNAME>
    <PREFERREDNAME>2899800v1.0:2178535v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any record of a medical imaging event whether physical or electronic._The smallest resolvable rectangular area of an image, either on a screen or stored in memory.:The size of the smallest element that can be separated from neighboring elements._Generic value domain for a primitive java datatype that is Single-precision floating point number (32-bit IEEE 754).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2899800</PublicId>
      <PreferredName>2224117v1.0:2899705v1.0</PreferredName>
      <PreferredDefinition>Any record of a medical imaging event whether physical or electronic._The smallest resolvable rectangular area of an image, either on a screen or stored in memory.:The size of the smallest element that can be separated from neighboring elements.</PreferredDefinition>
      <LongName>Medical Image Pixel Resolution</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2224117</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19477</PreferredName>
        <Version>1</Version>
        <LongName>Medical Image</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19477</PREFERRED_NAME>
            <LONG_NAME>Medical Image</LONG_NAME>
            <CON_ID>2202344</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2899705</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48367:C47876</PreferredName>
        <Version>1</Version>
        <LongName>Pixel Resolution</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48367</PREFERRED_NAME>
            <LONG_NAME>Pixel</LONG_NAME>
            <CON_ID>2413294</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47876</PREFERRED_NAME>
            <LONG_NAME>Resolution</LONG_NAME>
            <CON_ID>2669351</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178535</PublicId>
      <PreferredName>java.lang.Float</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is Single-precision floating point number (32-bit IEEE 754).</PreferredDefinition>
      <LongName>java.lang.Float</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Float</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Medical Image Pixel Resolution java.lang.Float does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Medical Image Pixel Resolution java.lang.Float does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2899621</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ImageMiner</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ImageMinerCore</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2899622</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2899621</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ImageMiner</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.imageminer.domain.image</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2899632</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.imageminer.domain.image.Image.pixelResolution</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Image:pixelResolution</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="170">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2902011</PUBLICID>
    <LONGNAME>Physical Entity Family Collection Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2901996v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Having substance or material existence; concerned with material things; of or pertaining to the body as distinguished from the mind or spirit.:An independently existing thing (living or nonliving).:A collection of things sharing a common attribute._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2901996</PublicId>
      <PreferredName>2901995v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Having substance or material existence; concerned with material things; of or pertaining to the body as distinguished from the mind or spirit.:An independently existing thing (living or nonliving).:A collection of things sharing a common attribute._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Physical Entity Family Collection Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2901995</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25618:C51070:C79273</PreferredName>
        <Version>1</Version>
        <LongName>Physical Entity Family Collection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25618</PREFERRED_NAME>
            <LONG_NAME>Physical</LONG_NAME>
            <CON_ID>2203948</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79273</PREFERRED_NAME>
            <LONG_NAME>Family Collection</LONG_NAME>
            <CON_ID>2860264</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Physical Entity Family Collection Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Physical Entity Family Collection Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.pathways</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000687</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.pathways</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2860261</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabio.pathways.FamilyMember.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FamilyMember:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="171">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2902228</PUBLICID>
    <LONGNAME>Diagnostic Procedure Physical Examination Assessment Yes No Indicator</LONGNAME>
    <PREFERREDNAME>DISPR_PE_ASS_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator related to diagnostic assessment by a systemic evaluation of the body and its functions using visual inspection, palpation, percussion, and auscultation, aimed to determine the presence or absence of physical signs of disease or abnormality for individual&#39;s health assessment.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2902219</PublicId>
      <PreferredName>DIAPROC_PE_ASSESS</PreferredName>
      <PreferredDefinition>information related to diagnostic assessment by a systemic evaluation of the body and its functions using visual inspection, palpation, percussion, and auscultation, aimed to determine the presence or absence of physical signs of disease or abnormality for individual&#39;s health assessment.</PreferredDefinition>
      <LongName>Diagnostic Procedure Physical Examination Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2639063</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18020</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18020</PREFERRED_NAME>
            <LONG_NAME>Diagnostic Procedure</LONG_NAME>
            <CON_ID>2488312</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2902217</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20989:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Physical Examination Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>By physical examination</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>By physical examination</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnostic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812084</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Orthodontics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812094</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4442461</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDCR CDEs with Retired VDs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDEs for Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4442571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="172">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2902589</PUBLICID>
    <LONGNAME>Copy Number Analysis Programming Parameter Hidden Markov Model Normal State Minimum Observation java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2902561v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of molecules of a particular type on or in a cell or part of a cell. Usually applied to specific genes or to plasmids within a bacterium.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:A value that is passed to a routine._A statistical model in which the system being modeled has unknown parameters, but the hidden parameters can be determined from the observable parameters. While the state is not directly visible, the variables influenced by the state are visible. Each state has a probability distribution over the possible output tokens. Therefore the sequence of tokens generated by a Hidden Markov Model (HMM) gives some information about the sequence of states.:Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.:The way something is with respect to its main attributes.:The smallest possible quantity.:Watching something and taking note of what happens._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2902561</PublicId>
      <PreferredName>2819800v1.0:2902539v1.0</PreferredName>
      <PreferredDefinition>The number of molecules of a particular type on or in a cell or part of a cell. Usually applied to specific genes or to plasmids within a bacterium.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:A value that is passed to a routine._A statistical model in which the system being modeled has unknown parameters, but the hidden parameters can be determined from the observable parameters. While the state is not directly visible, the variables influenced by the state are visible. Each state has a probability distribution over the possible output tokens. Therefore the sequence of tokens generated by a Hidden Markov Model (HMM) gives some information about the sequence of states.:Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.:The way something is with respect to its main attributes.:The smallest possible quantity.:Watching something and taking note of what happens.</PreferredDefinition>
      <LongName>Copy Number Analysis Programming Parameter Hidden Markov Model Normal State Minimum Observation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2819800</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49142:C25391:C48913</PreferredName>
        <Version>1</Version>
        <LongName>Copy Number Analysis Programming Parameter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49142</PREFERRED_NAME>
            <LONG_NAME>Copy Number</LONG_NAME>
            <CON_ID>2528506</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48913</PREFERRED_NAME>
            <LONG_NAME>Programming Parameter</LONG_NAME>
            <CON_ID>2451932</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2902539</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>2902539v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Hidden Markov Model Normal State Minimum Observation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C75940</PREFERRED_NAME>
            <LONG_NAME>Hidden Markov Model</LONG_NAME>
            <CON_ID>2819754</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14165</PREFERRED_NAME>
            <LONG_NAME>Normal</LONG_NAME>
            <CON_ID>2204843</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25687</PREFERRED_NAME>
            <LONG_NAME>State</LONG_NAME>
            <CON_ID>2203805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25570</PREFERRED_NAME>
            <LONG_NAME>Minimum</LONG_NAME>
            <CON_ID>2206306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Copy Number Analysis Programming Parameter Hidden Markov Model Normal State Minimum Observation java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Copy Number Analysis Programming Parameter Hidden Markov Model Normal State Minimum Observation java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2819751</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Copy Number Analysis Tool</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.icr.asrv1.cnat</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2819753</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CnatParameters:normalStateMinObservation</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.icr.asrv1.cnat.CnatParameters.normalStateMinObservation</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="173">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2903388</PUBLICID>
    <LONGNAME>Image Revolution Time 8 Byte Seconds Number</LONGNAME>
    <PREFERREDNAME>2639976v1.0:2903386v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Period of time required for a single complete turn of the source around the gantry orbit, expressed as a number of seconds.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DICOM:Digital Imaging and Communications in Medicine</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2639976</PublicId>
      <PreferredName>2423453v1.0:2541717v1.0</PreferredName>
      <PreferredDefinition>Any record of an imaging event whether physical or electronic._A single complete turn (axial or orbital)._The continuum of experience in which events pass from the future through the present to the past.</PreferredDefinition>
      <LongName>Image Revolution Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2423453</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48179</PreferredName>
        <Version>1</Version>
        <LongName>Image</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2541717</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48439:C25207</PreferredName>
        <Version>1</Version>
        <LongName>Revolution Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48439</PREFERRED_NAME>
            <LONG_NAME>Revolution</LONG_NAME>
            <CON_ID>2413369</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2903386</PublicId>
      <PreferredName>8_BYTE_SEC_NUM</PreferredName>
      <PreferredDefinition>FD SEC:Double precision binary floating point number prepresented in IEEE 754:1985 64-bit Floating Point Number Format measured in seconds.</PreferredDefinition>
      <LongName>8 Byte Seconds Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>seconds</UnitOfMeasure>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
      <Representation>
        <PublicId>2903385</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL124470:C48047:C42535:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Eight Byte Second Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL124470</PREFERRED_NAME>
            <LONG_NAME>Eight</LONG_NAME>
            <CON_ID>2208236</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48047</PREFERRED_NAME>
            <LONG_NAME>Byte</LONG_NAME>
            <CON_ID>2556188</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42535</PREFERRED_NAME>
            <LONG_NAME>Second</LONG_NAME>
            <CON_ID>2534958</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Revolution Time</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Revolution Time</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-ImageAcq-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Gantry rotation time</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DICOM Tag CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812790</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2693115</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA_Model</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Silver Review Modified CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2838921</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2944977</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NBIA</PreferredName>
          <Version>5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ncia.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000240</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506115</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Image Acquisition-Recon</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Image:revolutionTime</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ncia.domain.Image.revolutionTime</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>(0018,9305) </AlternateName>
        <AlternateNameType>DICOM_TAG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Revolution Time</AlternateName>
        <AlternateNameType>DICOM Attribute Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>MCL</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="174">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2914027</PUBLICID>
    <LONGNAME>Peritoneal Carcinomatosis Exploratory Surgery Involvement Total Score</LONGNAME>
    <PREFERREDNAME>PER_CAR_E_INV_TL_SCO</PREFERREDNAME>
    <PREFERREDDEFINITION>a total score measuring the extent of peritoneal cancer or peritoneal cancer index (PCI) related to spread of cancer within the peritoneum (the tissue that lines the abdominal wall and covers most of the organs in the abdomen) by surgery to look inside the body to help make a diagnosis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2859418</PublicId>
      <PreferredName>PERI_CARC_EXUSR_INV</PreferredName>
      <PreferredDefinition>information related to spread of cancer within the peritoneum (the tissue that lines the abdominal wall and covers most of the organs in the abdomen) by surgery to look inside the body to help make a diagnosis.</PreferredDefinition>
      <LongName>Peritoneal Carcinomatosis Exploratory Surgery Involvement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2846902</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25313:C3693</PreferredName>
        <Version>1</Version>
        <LongName>Peritoneal Carcinomatosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25313</PREFERRED_NAME>
            <LONG_NAME>Peritoneal</LONG_NAME>
            <CON_ID>2204854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3693</PREFERRED_NAME>
            <LONG_NAME>Carcinomatosis</LONG_NAME>
            <CON_ID>2846901</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2859416</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66747:C25548</PreferredName>
        <Version>1</Version>
        <LongName>Exploratory Surgery Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66747</PREFERRED_NAME>
            <LONG_NAME>Exploratory Surgery</LONG_NAME>
            <CON_ID>2686010</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2876508</PublicId>
      <PreferredName>2876508v1.0</PreferredName>
      <PreferredDefinition>a total score measuring the extent of peritoneal cancer or peritoneal cancer index (PCI).</PreferredDefinition>
      <LongName>Peritoneal Cancer Total Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>GOG CRF:Gynecologic Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2495121</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25304:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Total Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25304</PREFERRED_NAME>
            <LONG_NAME>Total</LONG_NAME>
            <CON_ID>2204938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total PCI Score</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Total PCI Score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="175">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2916060</PUBLICID>
    <LONGNAME>Shape Assay Type java.lang.String</LONGNAME>
    <PREFERREDNAME>2915938v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The spatial arrangement of something as distinct from its substance._The determination of the amount of a particular constituent of a mixture or of the biological or pharmacological potency of a drug.:Something distinguishable as an identifiable class based on common qualities._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2915938</PublicId>
      <PreferredName>2612281v1.0:2528663v1.0</PreferredName>
      <PreferredDefinition>The spatial arrangement of something as distinct from its substance._The determination of the amount of a particular constituent of a mixture or of the biological or pharmacological potency of a drug.:Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Shape Assay Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2612281</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25677</PreferredName>
        <Version>1</Version>
        <LongName>Shape</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25677</PREFERRED_NAME>
            <LONG_NAME>Shape</LONG_NAME>
            <CON_ID>2203587</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528663</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C60819:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Assay Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60819</PREFERRED_NAME>
            <LONG_NAME>Assay</LONG_NAME>
            <CON_ID>2528534</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Shape Assay Type java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Shape Assay Type java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2915522</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caNanoLab</PreferredName>
          <Version>1.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cananolab.domain.characterization.physical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2915885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.characterization.physical.Shape.assayType</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Shape:assayType</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="176">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2916098</PUBLICID>
    <LONGNAME>Purity Analysis Conclusion java.lang.String</LONGNAME>
    <PREFERREDNAME>2915976v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A quantitative assessment of the homogeneity or uniformity of a mixture. Alternatively, purity refers to the degree of being free of contaminants or heterogeneous components._Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:A position or opinion or judgment reached after consideration._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2915976</PublicId>
      <PreferredName>2612277v1.0:2915588v1.0</PreferredName>
      <PreferredDefinition>A quantitative assessment of the homogeneity or uniformity of a mixture. Alternatively, purity refers to the degree of being free of contaminants or heterogeneous components._Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:A position or opinion or judgment reached after consideration.</PreferredDefinition>
      <LongName>Purity Analysis Conclusion</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2612277</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62352</PreferredName>
        <Version>1</Version>
        <LongName>Purity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62352</PREFERRED_NAME>
            <LONG_NAME>Purity Assessment</LONG_NAME>
            <CON_ID>2612114</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2915588</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25391:C54033</PreferredName>
        <Version>1</Version>
        <LongName>Analysis Conclusion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54033</PREFERRED_NAME>
            <LONG_NAME>Conclusion</LONG_NAME>
            <CON_ID>2787001</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Purity Analysis Conclusion java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Purity Analysis Conclusion java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2915522</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caNanoLab</PreferredName>
          <Version>1.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cananolab.domain.characterization.physical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2915885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.characterization.physical.Purity.analysisConclusion</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Purity:analysisConclusion</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="177">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2923527</PUBLICID>
    <LONGNAME>Esophageal Malignant Neoplasm Distal Extent Measurement</LONGNAME>
    <PREFERREDNAME>ESOPH_MN_D_EXT_MSRMT</PREFERREDNAME>
    <PREFERREDDEFINITION>the measurement of the distal distance or extent of an esophageal malignant neoplasm.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2923507</PublicId>
      <PreferredName>ESOPH_MN_DIST_EXT</PreferredName>
      <PreferredDefinition>information relating to the distal (situated farthest from a point of attachment or origin) extent (the range, magnitude, or distance over which a thing spans an interval of distance) of an esophageal (of or relating to the esophagus) malignant neoplasm (a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues).</PreferredDefinition>
      <LongName>Esophageal Malignant Neoplasm Distal Extent</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2923501</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37950:C9305</PreferredName>
        <Version>1</Version>
        <LongName>Esophageal Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37950</PREFERRED_NAME>
            <LONG_NAME>Esophageal</LONG_NAME>
            <CON_ID>2202496</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2923505</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25237:C25332</PreferredName>
        <Version>1</Version>
        <LongName>Distal Extent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25237</PREFERRED_NAME>
            <LONG_NAME>Distal</LONG_NAME>
            <CON_ID>2205252</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25332</PREFERRED_NAME>
            <LONG_NAME>Extent</LONG_NAME>
            <CON_ID>2203921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2923523</PublicId>
      <PreferredName>ESOPH_MN_EXT_MSRMT</PreferredName>
      <PreferredDefinition>the measurement of the extent of an esophageal malignant neoplasm.</PreferredDefinition>
      <LongName>Esophageal Malignant Neoplasm Extent Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008548</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TUMOR_MSRMTS</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Measurements</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2184312</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25209</PreferredName>
        <Version>1</Version>
        <LongName>Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Distal tumor extent</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Distal tumor extent</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Distal</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Esophageal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="178">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2931791</PUBLICID>
    <LONGNAME>Child-Pugh Classification Grade</LONGNAME>
    <PREFERREDNAME>CHPUG_CLAS_GR</PREFERREDNAME>
    <PREFERREDDEFINITION>the grade from an assessment method used in the prognosis of chronic liver disease, mainly cirrhosis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2931772</PublicId>
      <PreferredName>CHILDPUGH_CLASS_GR</PreferredName>
      <PreferredDefinition>A standardized rating scale used to assess the severity of liver cirrhosis and determine the prognosis, the required strength of treatment, and the necessity of liver transplantation. This instrument uses the following clinical and lab criteria: encephalopathy grade, ascites, bilirubin, albumin, and prothrombin index.:A position on a scale of intensity or amount or quality.</PreferredDefinition>
      <LongName>Child-Pugh Classification Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6092439</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121007</PreferredName>
        <Version>1</Version>
        <LongName>Child-Pugh Clinical Classification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121007</PREFERRED_NAME>
            <LONG_NAME>Child-Pugh Clinical Classification</LONG_NAME>
            <CON_ID>6092438</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2512773</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48309</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2931786</PublicId>
      <PreferredName>CHIL_PUGH_CL_GRD</PreferredName>
      <PreferredDefinition>a position on a scale of intensity or amount or quality for the Child-Pugh hepatic disease classification.</PreferredDefinition>
      <LongName>Child-Pugh Classification Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2453188</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48309</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C</VALIDVALUE>
          <VALUEMEANING>Child-Pugh Class C</VALUEMEANING>
          <MEANINGDESCRIPTION>Child-Pugh score indicating one-year survival of 45% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2931787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B</VALIDVALUE>
          <VALUEMEANING>Child-Pugh Class B</VALUEMEANING>
          <MEANINGDESCRIPTION>Child-Pugh score indicating one-year survival of 80% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2931788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A</VALIDVALUE>
          <VALUEMEANING>Child-Pugh Class A</VALUEMEANING>
          <MEANINGDESCRIPTION>Child-Pugh score indicating one-year survival of 100% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2931789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C12</VALIDVALUE>
          <VALUEMEANING>Grade C12</VALUEMEANING>
          <MEANINGDESCRIPTION>Child-Pugh score indicating one-year survival of 45% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.: A position on a scale of intensity or amount or quality.: A natural number greater than 11 and less than 13 and the quantity that it denotes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113426, C48309, C113694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3923459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C11</VALIDVALUE>
          <VALUEMEANING>Grade C11</VALUEMEANING>
          <MEANINGDESCRIPTION>Child-Pugh score indicating one-year survival of 45% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.: A position on a scale of intensity or amount or quality.: A natural number greater than 10 and less than 12 and the quantity that it denotes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113425, C48309, C113694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3923460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C10</VALIDVALUE>
          <VALUEMEANING>Grade C 10</VALUEMEANING>
          <MEANINGDESCRIPTION>Child-Pugh score indicating one-year survival of 45% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.: A position on a scale of intensity or amount or quality.: A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69122, C48309, C113694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3923461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B9</VALIDVALUE>
          <VALUEMEANING>Grade B9</VALUEMEANING>
          <MEANINGDESCRIPTION>Child-Pugh score indicating one-year survival of 80% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.: A position on a scale of intensity or amount or quality.: A natural number greater than 8 and less than 10 and the quantity that it denotes: the sum of nine and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66840, C48309, C113692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3923462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B8</VALIDVALUE>
          <VALUEMEANING>Grade B8</VALUEMEANING>
          <MEANINGDESCRIPTION>Child-Pugh score indicating one-year survival of 80% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.: A position on a scale of intensity or amount or quality.: A natural number greater than 7 and less than 9 and the quantity that it denotes: the sum of seven and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66839, C48309, C113692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3923463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B7</VALIDVALUE>
          <VALUEMEANING>Grade B7</VALUEMEANING>
          <MEANINGDESCRIPTION>Child-Pugh score indicating one-year survival of 80% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.: A position on a scale of intensity or amount or quality.: A natural number greater than 6 and less than 8 and the quantity that it denotes: the sum of six and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66838, C48309, C113692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A6</VALIDVALUE>
          <VALUEMEANING>Grade A6</VALUEMEANING>
          <MEANINGDESCRIPTION>Child-Pugh score indicating one-year survival of 100% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.: A position on a scale of intensity or amount or quality.: A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66837, C48309, C113691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3923464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A5</VALIDVALUE>
          <VALUEMEANING>Grade A5</VALUEMEANING>
          <MEANINGDESCRIPTION>Child-Pugh score indicating one-year survival of 100% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.: A position on a scale of intensity or amount or quality.: A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66836, C48309, C113691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3923465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Child Pugh Classification</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Child Pugh Classification</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Significant Functional Compromise</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Significant Functional Compromise</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Decompensated Disease</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Decompensated Disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Well Compensated Disease</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Well Compensated Disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>HCMI Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Child-Pugh classification</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1112</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104993</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HCC and Bile Duct Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6403794</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>child_pugh_classification_grade</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CHPUG_CLAS_GR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CHPUG_CLAS_GR</AlternateName>
        <AlternateNameType>HCMI Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="179">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2934873</PUBLICID>
    <LONGNAME>Incomplete Blood Cell Count Recovery Cellular Morphology Complete Remission Confirmed Date</LONGNAME>
    <PREFERREDNAME>I_BC_R_CM_CR_CONF_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date a morphologic complete remission with incomplete blood count recovery (CRi) was confirmed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2934850</PublicId>
      <PreferredName>I_BC_REC_CM_CR_CONF</PreferredName>
      <PreferredDefinition>information relating to incomplete (not whole) blood count (the number of red blood cells, white blood cells, and platelets in a sample of blood) recovery (getting back or regaining) and the morphologic (cellular morphology is the form and structure of cells, and its relation to cell function) complete remission (the disappearance of all signs of cancer in response to treatment) confirmed (having been established or verified).</PreferredDefinition>
      <LongName>Incomplete Blood Cell Count Recovery Cellular Morphology Complete Remission Confirmed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2935265</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49160:C28133:C70827:C17768:C4</PreferredName>
        <Version>1</Version>
        <LongName>Incomplete Blood Cell Count Recovery Cellular Morphology Complete Remission</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49160</PREFERRED_NAME>
            <LONG_NAME>Incomplete</LONG_NAME>
            <CON_ID>2427335</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28133</PREFERRED_NAME>
            <LONG_NAME>Blood Cell Count</LONG_NAME>
            <CON_ID>2479406</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70827</PREFERRED_NAME>
            <LONG_NAME>Recovery</LONG_NAME>
            <CON_ID>2710284</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17768</PREFERRED_NAME>
            <LONG_NAME>Cellular Morphology</LONG_NAME>
            <CON_ID>2841404</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4870</PREFERRED_NAME>
            <LONG_NAME>Complete Remission</LONG_NAME>
            <CON_ID>2202721</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2240805</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25458</PreferredName>
        <Version>1</Version>
        <LongName>Confirmed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25458</PREFERRED_NAME>
            <LONG_NAME>Confirmation</LONG_NAME>
            <CON_ID>2203883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Morphologic Complete Remissio</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Morphologic Complete Remission With Incomplete Blood Count Recovery (CRi) Confirmed Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="180">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2935344</PUBLICID>
    <LONGNAME>Urinary System American Urological Association Symptom Assessment Total Score</LONGNAME>
    <PREFERREDNAME>UR_SYS_AUA_SX_TTL_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value for the compiled score of self-reported urinary system performance, function, quality, or ability as measured by the American Urological Association (AUA).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AUA:American Urological Association</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2935303</PublicId>
      <PreferredName>UR_SYS_ASSESS</PreferredName>
      <PreferredDefinition>The organs of the body that produce and discharge urine. These include the kidneys, ureters, bladder, and urethra._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Urinary System Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2935301</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12413</PreferredName>
        <Version>1</Version>
        <LongName>Urinary System</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12413</PREFERRED_NAME>
            <LONG_NAME>Urinary System</LONG_NAME>
            <CON_ID>2206266</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25367</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2935305</PublicId>
      <PreferredName>AUA_SX_TTL_SC</PreferredName>
      <PreferredDefinition>a number or range of numeric values measuring performance, function, quality, or ability for the American Urological Association Symptom Score._Subjective evidence of disease perceived by the patient._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete._Having determined the value, significance, or extent of.</PreferredDefinition>
      <LongName>American Urological Association Symptom Assessment Total Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008575</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SM</PreferredName>
        <Version>1</Version>
        <LongName>Symptoms</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>40</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>AUA:American Urological Association</Origin>
      <Representation>
        <PublicId>2935304</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4876:C25217:C25304:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Symptom Assessment Total Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25304</PREFERRED_NAME>
            <LONG_NAME>Total</LONG_NAME>
            <CON_ID>2204938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AUA Total Score</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>AUA Total Score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="181">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2935920</PUBLICID>
    <LONGNAME>Dental Professional Practice Caries Dental Explorer Diagnosis Yes No Indicator</LONGNAME>
    <PREFERREDNAME>D_PP_DEREST_DIA_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator related to identification of the decay of a tooth, in which it becomes softened, discolored, and/or porous in the dental practice by used of a dental explorer.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2932803</PublicId>
      <PreferredName>D_PP_DR_DAIG</PreferredName>
      <PreferredDefinition>information related to identification of the decay of a tooth, in which it becomes softened, discolored, and/or porous.</PreferredDefinition>
      <LongName>Dental Professional Practice Caries Dental Explorer Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443314</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C52673</PreferredName>
        <Version>1</Version>
        <LongName>Dental Professional Practice</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52673</PREFERRED_NAME>
            <LONG_NAME>Professional Practice</LONG_NAME>
            <CON_ID>2443152</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2932796</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52593:C60716:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Caries Dental Explorer Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52593</PREFERRED_NAME>
            <LONG_NAME>Caries</LONG_NAME>
            <CON_ID>2443118</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60716</PREFERRED_NAME>
            <LONG_NAME>Dental Explorer</LONG_NAME>
            <CON_ID>2481611</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>An explorer</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>An explorer</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Periodontics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812088</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4442461</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDCR CDEs with Retired VDs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDEs for Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4442571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="182">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2939378</PUBLICID>
    <LONGNAME>Bioassay Preparation For Clinical Trial Indicator</LONGNAME>
    <PREFERREDNAME>ASSAY_PREP_C_TRL_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator that represents the evaluation about whether an assay is ready for clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2939376</PublicId>
      <PreferredName>ASSAY_PREP_CLN_TRL</PreferredName>
      <PreferredDefinition>Information pertaining to the act or process of making a method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions ready for a research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.</PreferredDefinition>
      <LongName>Bioassay Preparation For Clinical Trial</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435013</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17828 </PreferredName>
        <Version>1</Version>
        <LongName>Biological Process</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176953</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Assay</PreferredName>
        <Version>1</Version>
        <LongName>Assay</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16341</PREFERRED_NAME>
            <LONG_NAME>Bioassay</LONG_NAME>
            <CON_ID>2202922</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2939374</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25625:C64956:C71104</PreferredName>
        <Version>1</Version>
        <LongName>Preparation For Clinical Trial</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25625</PREFERRED_NAME>
            <LONG_NAME>Preparation</LONG_NAME>
            <CON_ID>2202599</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64956</PREFERRED_NAME>
            <LONG_NAME>For</LONG_NAME>
            <CON_ID>2689723</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71104</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial</LONG_NAME>
            <CON_ID>2735720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015873</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>A choice of Yes and No answer.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008509</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPORES</PreferredName>
        <Version>2.31</Version>
        <LongName>SPOREs</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>YES</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NO</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Assay Ready for Trial</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Assay Ready for Trial</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939361</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCTD</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Assay Development</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2939362</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="183">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2944515</PUBLICID>
    <LONGNAME>Adverse Event Severity Grade</LONGNAME>
    <PREFERREDNAME>AE_SEV_GD</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric representation of the intensity/severity of an unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CTCAE:Common TerminologyCriteria for Adverse Events</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2747735</PublicId>
      <PreferredName>2235992v1.0:2747512v1.0</PreferredName>
      <PreferredDefinition>Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used._A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event.:Used of the degree of something undesirable e.g. pain or weather; also, strictness.:A position on a scale of intensity or amount or quality.</PreferredDefinition>
      <LongName>Adverse Event Severity/Intensity Scale for Adverse Events Severity Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2235992</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2747512</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49705:C25676:C48309</PreferredName>
        <Version>1</Version>
        <LongName>Severity/Intensity Scale for Adverse Events Severity Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49705</PREFERRED_NAME>
            <LONG_NAME>Severity/Intensity Scale for Adverse Events</LONG_NAME>
            <CON_ID>2480698</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2943992</PublicId>
      <PreferredName>AE_SEV_GD</PreferredName>
      <PreferredDefinition>Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used._Severity; used of the degree of something undesirable e.g. pain or weather._A position on a scale of intensity or amount or quality.</PreferredDefinition>
      <LongName>Adverse Event Severity Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTCAE:Common TerminologyCriteria for Adverse Events</Origin>
      <Representation>
        <PublicId>2944509</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331:C25676:C41331:C48309</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Severity Adverse Event Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Absent Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>Grade 0 is universally defined as absence of Adverse Events or within normal limits or values.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Mild Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>An adverse event that is asymptomatic; or involves mild or minor symptoms; or is of marginal clinical relevance; or consists of clinical or diagnostic observations alone; or for which intervention is not indicated; or for which only non-prescription intervention is indicated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Moderate Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>An adverse event for which only minimal, local, or noninvasive intervention (e.g. packing, cautery) is indicated; or that limits instrumental activities of daily living (ADLs, e.g., shopping, laundry, transportation, or ability to conduct finances).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Severe Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>An adverse event that is medically significant but not life-threatening; or for which inpatient care or prolongation of hospitalization are indicated; or that is an important medical event that does not result in hospitalization, but may jeopardize the patient or may require intervention either to prevent hospitalization, to prevent the AE from becoming life-threatening or causing death; or that is disabling; or that results in persistent or significant disability, incapacity, or limitation of self care activities of daily living (ADLs, e.g., getting in and out of bed, dressing, eating, getting around inside, bathing, or using the toilet).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Death Related to Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>The termination of life associated with an adverse event.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2660006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Life Threatening Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>An adverse event that has life-threatening consequences; for which urgent intervention is indicated; that puts the patient at risk of death at the time of the event if immediate intervention is not undertaken.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84266</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>CTC AE Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Adverse Event Grade</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Adverse Event Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>CTC Adverse Event Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Severity of Adverse Event</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Severity of Adverse Event</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Mandatory NCI Standard CRF Question</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Must be included on CRF when this data is collected for reporting.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Grade</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ABTC Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Highest grade of toxicity responsible for dose holding/reduction</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>OHSU Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Grade if ongoing</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTCAE (4.0) Grade</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>CTCAE (4.0) Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>AE Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>CTCAE grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>CTC Adverse Event Grade:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Adverse Event Grade:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>OHSU Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Grade, if applicable</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Worst Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>AE Grade:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Adverse event grade:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF_Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>NCI CTC Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>AE grade:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Alternate Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Adverse event grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>CTCAE v5 Grade:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTCAE grade</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>CTCAE grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>AE grade:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the highest grade for this AE during this Maintenance cycle?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCIP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Grade of AE per CTCAE version 3</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCIP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Grade, per CTCAE Version 3</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the highest grade experienced?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811951</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR 2011 Template</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248617</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Base Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248619</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory All</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248632</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000677</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms Version 3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2957372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MediData Rave Use</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3308730</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol 10C0052D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3331757</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Candidate Reuse</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2992453</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859992</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>All Mandatory CRF CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3943912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>9cUAB30</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812998</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin Colorectal Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018781</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Resveratrol in Postmenopausal Women</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018782</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSC and L SeMet in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3110219</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cholecalciferol and Genistein</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3114163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Lung Pre-Surgical NSCLC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3152820</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vitamin D - Bioactivity in the Skin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182878</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin - Pre-Prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182879</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barrett&#39;s Esophagus Chemoprevention Metformin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3211792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAB30 in NMSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3293737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pomegranate - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3303133</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2552643</PublicId>
          <ContextName>Training</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Training Class Examples</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3637837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v4.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2958139</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase 1/Pilot Consortium</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3303197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2964591</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Eligibility Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Structured Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2965104</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2964591</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Eligibility Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>History</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3070847</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Caris Registry</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3060676</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3121334</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTCAE based CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTCAEv4.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3121335</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3194026</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>KAI Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812550</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3194026</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>KAI Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000679</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3335728</PublicId>
          <ContextName>ABTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocols</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ABTC 0904</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3335732</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3835419</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Pharmacovigilance</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Baseline</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3835421</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3835419</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Pharmacovigilance</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow Up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3902524</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2012-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3694151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896537</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896538</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4111771</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4188651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261112</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2013-01-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528054</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528056</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-04-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280811</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280813</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280814</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-04</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280815</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280816</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5416571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5441476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5592146</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5598962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5612586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-07-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889176</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2017-09-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889179</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889180</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-08-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889185</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889187</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6005698</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0278</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4058120</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229L</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229N</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229O</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104892</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0250</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104897</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0277</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104900</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0286B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104901</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104930</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104941</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0275</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104991</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1112</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104993</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0279</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104996</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1010</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171061</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1005</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171062</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0924</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171065</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000175</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000275</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000276</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000705</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635298</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>All Mandatory CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mandatory CRF CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5635299</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000681</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858960</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Adopted</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caAERS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4861354</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858960</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Adopted</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RAVE Integrations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5858963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858960</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Adopted</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAE</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5858965</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858962</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Under Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDUS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4861352</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858962</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Under Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RAVE Integrations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000092</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6147165</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>WFB Medical Center</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>WFB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6147167</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MATCHBox</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13484613</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ECOG-ACRIN DD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13484614</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Severity</AlternateName>
        <AlternateNameType>Screen Label</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>VALXX</AlternateName>
        <AlternateNameType>OID, Alliance</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>2005090</AlternateName>
        <AlternateNameType>COG GDE #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTC_AE_GD</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>AE_SEV_GD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SWOG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TOXDEG</AlternateName>
        <AlternateNameType>OID, SWOG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_SEV_GD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_SEV_GD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_SEV_GD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Ctcae4Gd</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ABTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ABTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_SEV_GD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_SEV_GD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_SEV_GD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRDS</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCTG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_SEV_GD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCIP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_grade</AlternateName>
        <AlternateNameType>CTDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>adverse_event_grade</AlternateName>
        <AlternateNameType>CTDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ae_grade</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_AETOXG</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_AETOXGR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="184">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2947089</PUBLICID>
    <LONGNAME>Local-Regional Therapy Last Administered Date</LONGNAME>
    <PREFERREDNAME>2947082v1.0:2018550v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the date of the last administration of therapy to the local-regional (affecting only a restricted part or area of the body).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2947082</PublicId>
      <PreferredName>LOCREG_TX_LAS_ADMIN</PreferredName>
      <PreferredDefinition>information regarding the last administration of therapy to the local-regional (affecting only a restricted part or area of the body).</PreferredDefinition>
      <LongName>Local-Regional Therapy Last Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2947080</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25388:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Local-Regional Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25388</PREFERRED_NAME>
            <LONG_NAME>Local-Regional</LONG_NAME>
            <CON_ID>2204916</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207840</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25551:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Last Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25551</PREFERRED_NAME>
            <LONG_NAME>Last</LONG_NAME>
            <CON_ID>2206286</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of last locoregional the</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of last locoregional therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>End date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Local Therapy End Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Upper GI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hepatobiliary</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3298577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LclTpyLastDt</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="185">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2949741</PUBLICID>
    <LONGNAME>Dental Professional Practice Dental Prophylaxis Rubber Cup Therapy Yes No Indicator</LONGNAME>
    <PREFERREDNAME>D_PP_PD_DP_RCTX_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator related to dental practice&#39;s use of treatment for the prevention of periodontal diseases or other dental diseases by the cleaning of the teeth in the dental office.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2935391</PublicId>
      <PreferredName>D_PP_DP_RC_TX</PreferredName>
      <PreferredDefinition>information related to dental practice&#39;s use of treatment for the prevention of periodontal diseases or other dental diseases by the cleaning of the teeth in the dental office.</PreferredDefinition>
      <LongName>Dental Professional Practice Dental Prophylaxis Rubber Cup Therapy</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443314</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C52673</PreferredName>
        <Version>1</Version>
        <LongName>Dental Professional Practice</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52673</PREFERRED_NAME>
            <LONG_NAME>Professional Practice</LONG_NAME>
            <CON_ID>2443152</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2935389</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62548:C82066:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Dental Prophylaxis Rubber Cup Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62548</PREFERRED_NAME>
            <LONG_NAME>Dental Prophylaxis</LONG_NAME>
            <CON_ID>2518911</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82066</PREFERRED_NAME>
            <LONG_NAME>Rubber Cup</LONG_NAME>
            <CON_ID>2904789</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Full mouth polish (rubber cup</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Full mouth polish (rubber cup prophylaxis)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Periodontics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812088</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4442461</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDCR CDEs with Retired VDs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDEs for Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4442571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="186">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2950100</PUBLICID>
    <LONGNAME>Finding Present Type</LONGNAME>
    <PREFERREDNAME>2943226v1.0:2939747v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of clinical, laboratory or molecular evidence of disease that was present.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2943226</PublicId>
      <PreferredName>2528734v1.0:2233878v1.0</PreferredName>
      <PreferredDefinition>Clinical, laboratory or molecular evidence, or absence of evidence of disease._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Finding Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528734</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3367</PreferredName>
        <Version>1</Version>
        <LongName>Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3367</PREFERRED_NAME>
            <LONG_NAME>Finding</LONG_NAME>
            <CON_ID>2202448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2939747</PublicId>
      <PreferredName>2939747v1.0</PreferredName>
      <PreferredDefinition>Clinical, laboratory or molecular evidence, or absence of evidence of disease._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Finding Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2230030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3367:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Finding Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3367</PREFERRED_NAME>
            <LONG_NAME>Finding</LONG_NAME>
            <CON_ID>2202448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatomegaly</VALIDVALUE>
          <VALUEMEANING>Hepatomegaly</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatomegaly; abnormal enlargement of the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3100</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Splenomegaly</VALIDVALUE>
          <VALUEMEANING>Splenomegaly</VALUEMEANING>
          <MEANINGDESCRIPTION>Splenomegaly; an abnormal enlargement of the spleen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systemic symptoms</VALIDVALUE>
          <VALUEMEANING>Systemic Symptom</VALUEMEANING>
          <MEANINGDESCRIPTION>(sis-TEM-ik) Affecting the entire body.: An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4876, C13310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Warts</VALIDVALUE>
          <VALUEMEANING>Verrucous Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>A raised growth on the surface of the skin or other organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5028</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3235572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Veno-occlusive disease</VALIDVALUE>
          <VALUEMEANING>Veno-Occlusive Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Disorder in which veins are partially or completely obstructed or the blood flow through the veins is suboptimal.--2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2768635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thrombotic thrombocytopenia purpura</VALIDVALUE>
          <VALUEMEANING>Thrombocytopenic Purpura</VALUEMEANING>
          <MEANINGDESCRIPTION>Purpura associated with a reduction in circulating blood platelets which can result from a variety of factors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2769001</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Growth retardation</VALIDVALUE>
          <VALUEMEANING>Growth Retardation</VALUEMEANING>
          <MEANINGDESCRIPTION>Stature that is smaller than normal as expected for age.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Growth hormone deficiency</VALIDVALUE>
          <VALUEMEANING>Growth Hormone Deficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>A peptide hormone secreted by the anterior lobe of the pituitary gland and regulates several physiologic processes, including growth and metabolism.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94372, C2288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3235574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chronic graft versus host disease</VALIDVALUE>
          <VALUEMEANING>Chronic Graft Versus Host Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2769010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acute graft versus host disease</VALIDVALUE>
          <VALUEMEANING>Acute Graft Versus Host Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4980</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2769014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Failure to thrive</VALIDVALUE>
          <VALUEMEANING>Failure to Thrive</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical finding indicating less than normal growth in infancy or early childhood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85038</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3235575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune hemolytic anemia</VALIDVALUE>
          <VALUEMEANING>Autoimmune Hemolytic Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An acquired anemia caused by destruction of the red blood cells by autoantibodies. Causes include autoimmune disorders, lymphoproliferative disorders, infections and drugs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other hematologic impairment</VALIDVALUE>
          <VALUEMEANING>Other Hematologic Impairment</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Pertaining to or related to the blood and blood-forming organs.: Loss or abnormality of psychological, physiological, or anatomic structure or function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C21055, C62780, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3286129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strabismus / nystagmus</VALIDVALUE>
          <VALUEMEANING>Strabismus And/Or Nystagmus</VALUEMEANING>
          <MEANINGDESCRIPTION>Misalignment of the visual axes of the eyes. In comitant strabismus the degree of ocular misalignment does not vary with the direction of gaze. In noncomitant strabismus the degree of misalignment varies depending on direction of gaze or which eye is fixating on the target. (Miller, Walsh &amp; Hoyt&#39;s Clinical Neuro-Ophthalmology, 4th ed, p641): Used to indicate that either or both of two items or options: Involuntary movements of the eyeballs. The presence or absence of nystagmus is often used in the diagnosis of a variety of neurological and visual disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3282, C48928, C35040</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3286130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skull circumference above 95th percentile</VALIDVALUE>
          <VALUEMEANING>Skull Circumference Greater Than Integer::5 Percentile</VALUEMEANING>
          <MEANINGDESCRIPTION>The skeleton of the head including the bones of the face and the bones enclosing the brain.: The length of the closed curve of a circle; the size of something as given by the distance around it.: A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A number with no fractional part.::5: Any of the 99 numbered points that divide an ordered set of scores into 100 parts each of which contains one-hundredth of the total.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48919, C45255::5, C61584, C64265, C12789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3287772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypertriglyceridemia</VALIDVALUE>
          <VALUEMEANING>Hypertriglyceridemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypertriglyceridemia; the condition of elevated triglyceride concentration in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypofibrinogenemia</VALIDVALUE>
          <VALUEMEANING>Hypofibrinogenemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually inherited blood coagulation disorder characterized by the partial or complete absence of fibrinogen in the blood, resulting in bleeding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3285367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aplastic Anemia</VALIDVALUE>
          <VALUEMEANING>Aplastic Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which the bone marrow is unable to produce blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Septicemia</VALIDVALUE>
          <VALUEMEANING>Septicemia</VALUEMEANING>
          <MEANINGDESCRIPTION>The presence of pathogenic microorganisms in the blood stream causing a rapidly progressing systemic reaction that may lead to shock. Symptoms include fever, chills, tachycardia, and increased respiratory rate. It is a medical emergency that requires urgent medical attention.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3364</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteomyelitis</VALIDVALUE>
          <VALUEMEANING>Osteomyelitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute or chronic inflammation of the bone and its structures due to infection with pyogenic bacteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27577</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2871912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal congestion</VALIDVALUE>
          <VALUEMEANING>Nasal Congestion</VALUEMEANING>
          <MEANINGDESCRIPTION>The blockage of the nasal passage due to mucosal edema. It is usually the result of a viral infection or an allergic reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gross motor delay</VALIDVALUE>
          <VALUEMEANING>Gross Motor Skill Delay</VALUEMEANING>
          <MEANINGDESCRIPTION>The ability to use large muscle groups for gross body movements.  This developmental skill begins in infancy and early childhood.: Delay; time during which some action is awaited; inactivity resulting in something being put off until a later time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25476, C88420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3286131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypertelorism</VALIDVALUE>
          <VALUEMEANING>Hypertelorism</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal increase in the interorbital distance due to overdevelopment of the lesser wings of the sphenoid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34715</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3286136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Height below 5th percentile</VALIDVALUE>
          <VALUEMEANING>Height Less Than Integer::5 Percentile</VALUEMEANING>
          <MEANINGDESCRIPTION>Height; the vertical dimension of extension; distance from the base of something to the top.: A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: A number with no fractional part.::5: Any of the 99 numbered points that divide an ordered set of scores into 100 parts each of which contains one-hundredth of the total.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48919, C45255::5, C61585, C25347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3287500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hearing impairment</VALIDVALUE>
          <VALUEMEANING>Hearing Impairment</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial or complete loss of the ability to detect or understand sounds resulting from damage to the outer, middle, or inner ear structures. Causes include exposure to loud noise, ear infections, injuries to the ear, genetic, and congenital disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frontal bossing / prominent forehead</VALIDVALUE>
          <VALUEMEANING>Frontal Bossing</VALUEMEANING>
          <MEANINGDESCRIPTION>A skeletal deformity characterized by an unusually prominent forehead. Causes include acromegaly, Hurler syndrome, Silver-Russell syndrome, and thalassemia major.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3287501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fractures</VALIDVALUE>
          <VALUEMEANING>Fracture</VALUEMEANING>
          <MEANINGDESCRIPTION>A traumatic injury to the bone in which the continuity of the bone is broken. - 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944828</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Exophthalmos</VALIDVALUE>
          <VALUEMEANING>Exophthalmos</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior displacement of the eye within the orbit, giving a bulging appearance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3286134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dentition problems</VALIDVALUE>
          <VALUEMEANING>Dentition Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>The teeth collectively in the dental arch. Dentition ordinarily refers to the natural teeth in position in their alveoli. Dentition referring to the deciduous teeth is DENTITION, PRIMARY; to the permanent teeth, DENTITION, PERMANENT. (From Jablonski, Dictionary of Dentistry, 1992): Problem; a state of difficulty that needs to be resolved.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28020, C13072</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3286132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Convulsions</VALIDVALUE>
          <VALUEMEANING>Seizure</VALUEMEANING>
          <MEANINGDESCRIPTION>Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.--2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blindness / visual impairment</VALIDVALUE>
          <VALUEMEANING>Blindness And/Or Visual Impairment</VALUEMEANING>
          <MEANINGDESCRIPTION>The lack of vision.  It is caused by neurological or physiological factors.: Used to indicate that either or both of two items or options: Visual; relating to or using sight; able to be seen.: Loss or abnormality of psychological, physiological, or anatomic structure or function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C21055, C38059, C48928, C97109</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3286133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary outlet obstruction</VALIDVALUE>
          <VALUEMEANING>Bladder Obstruction</VALUEMEANING>
          <MEANINGDESCRIPTION>Blockage of the opening between the bladder and the urethra resulting in the reduction or prevention of the urine flow from the bladder into the urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79541</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3309126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastric outlet obstruction</VALIDVALUE>
          <VALUEMEANING>Pyloric Stenosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Narrowing of the pyloric lumen caused either by hypertrophy of the surrounding muscles or tissue scarring due to a chronic peptic ulcer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3309127</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoproliferative disorder</VALIDVALUE>
          <VALUEMEANING>Lymphoproliferative Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis). --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3235573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thrombocytopenia</VALIDVALUE>
          <VALUEMEANING>Thrombocytopenia</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which there is an abnormally small number of platelets in the circulating blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammatory bowel disease</VALIDVALUE>
          <VALUEMEANING>Inflammatory Bowel Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn&#39;s disease, ulcerative colitis, and colitis of indeterminate type. --2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3138</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3305590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypogammaglobulinemia</VALIDVALUE>
          <VALUEMEANING>Hypogammaglobulinemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which the level of immunoglobulins (antibodies) in the blood is low and the risk of infection is high.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26931</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3303158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemophagocytic disorder</VALIDVALUE>
          <VALUEMEANING>Hemophagocytic Lymphohistiocytosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare but potentially life-threatening disorder characterized by the proliferation of histiocytes and macrophages and phagocytosis of red blood cells, white blood cells, and platelets. It may be inherited or secondary, due to infections, autoimmune disorders, or underlying malignancies. Signs and symptoms include fever, lymphadenopathy, hepatomegaly, splenomegaly, and pancytopenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34792</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mental development  delay</VALIDVALUE>
          <VALUEMEANING>Mental Process Development Delay</VALUEMEANING>
          <MEANINGDESCRIPTION>Conceptual functions or thinking in all its forms. (NCI): The act of improving by expanding or enlarging or refining.: Delay; time during which some action is awaited; inactivity resulting in something being put off until a later time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25476, C84377, C16840</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3303192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutropenia</VALIDVALUE>
          <VALUEMEANING>Neutrophil Count Decreased</VALUEMEANING>
          <MEANINGDESCRIPTION>A decrease in the number of neutrophils in the peripheral blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fever</VALIDVALUE>
          <VALUEMEANING>Fever</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by elevation of the body&#39;s temperature above the upper limit of normal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>E11102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>CTCAE</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anemia</VALIDVALUE>
          <VALUEMEANING>Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A reduction in the number of red blood cells per cu mm, the amount of hemoglobin in 100 ml of blood, and the volume of packed red blood cells per 100 ml of blood. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2869</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Graft versus host disease due to maternal engraftment</VALIDVALUE>
          <VALUEMEANING>Graft Versus Host Disease Reason Maternal Engraftment</VALUEMEANING>
          <MEANINGDESCRIPTION>An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.: An explanation of the cause of some phenomenon or action.: A designation that has some relationship to motherhood.: The establishment of viable, functional grafted tissue within the body of a host.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37947, C89336, C25638, C3063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3640457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatosplenomegaly</VALIDVALUE>
          <VALUEMEANING>Hepatosplenomegaly</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal enlargement of both the liver and spleen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3637923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal T-cell engraftment</VALIDVALUE>
          <VALUEMEANING>Maternal T-Lymphocyte Engraftment</VALUEMEANING>
          <MEANINGDESCRIPTION>A designation that has some relationship to motherhood.: One type of white blood cell that attacks virus-infected cells, foreign cells, and cancer cells.  T cells also produce a number of substances that regulate the immune response.: The establishment of viable, functional grafted tissue within the body of a host.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37947, C12476, C89336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3637924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Microcephaly</VALIDVALUE>
          <VALUEMEANING>Microcephaly</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital or acquired developmental disorder in which the circumference of the head is smaller than normal for the person&#39;s age and sex.  It is the result of brain developmental delay.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85874</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3004991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin rash</VALIDVALUE>
          <VALUEMEANING>Skin Rash</VALUEMEANING>
          <MEANINGDESCRIPTION>Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypoproteinemia</VALIDVALUE>
          <VALUEMEANING>Hypoproteinemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A laboratory test result indicating abnormally low levels of total protein in the serum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88511</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3637925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Graft versus host disease due to blood transfusion</VALIDVALUE>
          <VALUEMEANING>Graft Versus Host Disease Reason Blood Transfusion</VALUEMEANING>
          <MEANINGDESCRIPTION>An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.: An explanation of the cause of some phenomenon or action.: The administration of blood or blood products into a blood vessel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15192, C25638, C3063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3637927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophilia</VALIDVALUE>
          <VALUEMEANING>Eosinophilia</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which the number of eosinophils (a type of white blood cell) in the blood is greatly increased. Eosinophilia is often a response to infection or allergens (substances that cause an allergic response).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3015</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2793850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Edema</VALIDVALUE>
          <VALUEMEANING>Edema</VALUEMEANING>
          <MEANINGDESCRIPTION>Accumulation of an excessive amount of watery fluid in cells or intercellular tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3637928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone abnormalities</VALIDVALUE>
          <VALUEMEANING>Bone Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>Connective tissue that forms the skeletal components of the body.: A condition that differs from the usual physical or mental state.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9440, C12366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3637929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other disease</VALIDVALUE>
          <VALUEMEANING>Other Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C2991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3158622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thalassemia</VALIDVALUE>
          <VALUEMEANING>Thalassemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sickle cell anemia</VALIDVALUE>
          <VALUEMEANING>Sickle Cell Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3301976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Giant leukocyte granules</VALIDVALUE>
          <VALUEMEANING>Large Granulocyte</VALUEMEANING>
          <MEANINGDESCRIPTION>Of considerable or relatively great size, extent, or capacity.: A leucocyte with conspicuous cytoplasmic granules. In humans the granulocytes are also classified as polymorphonuclear leucocytes and are subdivided according to the staining properties of the granules into eosinophils, basophils and neutrophils.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12530, C49508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4293936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Facial dysmorphisms</VALIDVALUE>
          <VALUEMEANING>Abnormality Face</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition that differs from the usual physical or mental state.: The anterior portion of the head extending from the forehead to the chin and ear to ear. The facial structures contain the eyes, nose and mouth, cheeks and jaws.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13071, C9440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4293937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ocular albinism</VALIDVALUE>
          <VALUEMEANING>Ocular Albinism</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the eye.: A congenital disorder characterized by partial or complete absence of melanin pigment in the eyes, hair and skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84543, C87163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4293938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recurrent infections</VALIDVALUE>
          <VALUEMEANING>Recurrent Infectious Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>occurring again.: A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26726, C14173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4295701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin involvement</VALIDVALUE>
          <VALUEMEANING>Skin Involvement</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that constitutes the external surface of the body.  It consists of the epidermis, dermis, and skin appendages.: To have a connection by participation or association or use; sharing in an activity or process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25548, C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4240358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurofibromatosis</VALIDVALUE>
          <VALUEMEANING>Neurofibromatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. NEUROFIBROMATOSIS 1 (generalized neurofibromatosis) accounts for approximately 95% of cases, although multiple additional subtypes (e.g., NEUROFIBROMATOSIS 2, neurofibromatosis 3, etc.) have been described. (From Neurochirurgie 1998 Nov;44(4):267-72)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2967364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenopathy</VALIDVALUE>
          <VALUEMEANING>Lymphadenopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical finding indicating that a lymph node is enlarged. Causes include viral and bacterial infections and cancers that affect the lymph nodes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4240359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fair hair and/or abnormal accumulation of pigment at microscopic examination of hair</VALIDVALUE>
          <VALUEMEANING>Microscopic Examination Hair Abnormal Pigment Collection And/Or Fair Hair</VALUEMEANING>
          <MEANINGDESCRIPTION>An assessment by microscope.: The filamentous outgrowth of the epidermis.: Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.: A substance that gives color to tissue. Pigments are responsible for the color of skin, eyes, and hair.: The act of gathering things together; having been brought together in one place.: Used to indicate that either or both of two items or options may be valid.: A human hair color characterized by low levels of eumelanin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C115219, C48928, C25453, C747, C25401, C32705, C90424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4295557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin albinism / fair skin</VALIDVALUE>
          <VALUEMEANING>Skin Hypopigmentation Or Fair Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal lightening of skin due to decreased melanin production or deposition. Vitiligo, albinism, and leukoderma are among the disorders that are associated with skin hypopigmentation.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A human skin color characterized by low levels of eumelanin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C115220, C37998, C78610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4295558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bleeding diathesis</VALIDVALUE>
          <VALUEMEANING>Bleeding Diathesis</VALUEMEANING>
          <MEANINGDESCRIPTION>A coagulation disorder characterized by a tendency for excessive bleeding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C115221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4295559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobinopathy</VALIDVALUE>
          <VALUEMEANING>Hemoglobinopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G6PD</VALIDVALUE>
          <VALUEMEANING>Glucose-6-Phosphate Dehydrogenase Deficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>An X-linked recessive inherited disorder caused by mutations in the G6PD gene. It is characterized by the absence or presence of very low levels of glucose-6-phosphate dehydrogenase. Patients develop hemolytic anemia usually in response to infection or exposure to drugs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5944606</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other hemoglobinopathy</VALIDVALUE>
          <VALUEMEANING>Other Hemoglobinopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: An inherited disorder characterized by structural alterations of a globin chain within the hemoglobin molecule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3092, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2689130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What finding is present?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What finding is present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What kind of clinical features were presented?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What kind of clinical features were presented?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the presence of the following clinical indicators</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the presence of the following clinical indicators</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the recipient&#39;s clinical status:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the recipient&#39;s clinical status:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify if the recipient displayed evidence of the following disorders:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify if the recipient displayed evidence of the following disorders:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the recipient experience any of the following clinical features?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the recipient experience any of the following clinical features?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What features were present?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What features were present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the clinical finding?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the clinical finding?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was there evidence of the following clinical features?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was there evidence of the following clinical features?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2950100</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>&quot;PerformedDiagnosis [primary] &gt; PerformedObservation [diagnosis] &gt; AssessedResultRelationship &gt; PerformedMedicalConditionResult.value [sign] WHERE  PerformedDiagnosis.value = &quot;&quot;Myelodysplasia / Myeloproliferative Disorders&quot;&quot;&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify whether the recipient expressed the following clinical features:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify whether the recipient expressed the following clinical features:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify whether the recipient expressed the following clinical features at diagnosis</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify whether the recipient expressed the following clinical features at diagnosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the following clinical and laboratory features</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the following clinical and laboratory features</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2014r1: MDS Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2131r2: Immune Deficiencies Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3234637</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2034r1: X-Linked Lymphoproliferative Syndrome Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3279241</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2036r1: Osteopetrosis Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3279243</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2039r1: Hemophagocytic Lymphohistiocytosis Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3279244</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2134r1: X-Linked Lymphoproliferative Syndrome Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3279260</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2136r1: Osteopetrosis Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3279261</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2139r1: Hemophagocytic Lymphohistiocytosis Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3279262</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3279271</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2031r2: Immune Deficiencies Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3638517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedMedicalConditionResult:value </AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="187">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2950649</PUBLICID>
    <LONGNAME>Patient Eligibility Indicator</LONGNAME>
    <PREFERREDNAME>PT_ELIG_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no/not applicable indicator that asks the investigator to stipulate whether the patient is eligible for inclusion on this protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2010663</PublicId>
      <PreferredName>PT_ELIG</PreferredName>
      <PreferredDefinition>information that identifies whether eligibility criteria have been met for the patient to participate in the clinical study.</PreferredDefinition>
      <LongName>Patient Eligibility</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Eligibility</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017177</PublicId>
      <PreferredName>YES_NO_NA_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable.</PreferredDefinition>
      <LongName>Yes No Not Applicable Indicator</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2179965</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Indicator</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is Participant Eligible?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is Participant Eligible?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient listed on the coordinating center&#39;s master list of eligible patients at this COG site?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Myo-Inositol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812876</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="188">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2953625</PUBLICID>
    <LONGNAME>Variable Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2953548v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any characteristic or attribute that can be measured. (CDC)_A statement or an account describing something._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2953548</PublicId>
      <PreferredName>2236761v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>Any characteristic or attribute that can be measured. (CDC)_A statement or an account describing something.</PreferredDefinition>
      <LongName>Variable Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236761</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43371</PreferredName>
        <Version>1</Version>
        <LongName>Variable</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43371</PREFERRED_NAME>
            <LONG_NAME>Variable Characteristic</LONG_NAME>
            <CON_ID>2236568</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Variable Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Variable Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2953481</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Service</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Service 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2953482</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2953481</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Service</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.external.v1_0.factor</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2953487</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Factor:description</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.external.v1_0.factor.Factor.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="189">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2953630</PUBLICID>
    <LONGNAME>Biospecimen Search Criteria Biospecimen Type BiomaterialType</LONGNAME>
    <PREFERREDNAME>2953553v1.0:2953604v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:An object that exists for defining the search parameters for a domain._Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:Something distinguishable as an identifiable class based on common qualities._The specific type of biomaterial indicating if it is a sample or a dna extract etc.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2953553</PublicId>
      <PreferredName>2953504v1.0:2953529v1.0</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:An object that exists for defining the search parameters for a domain._Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Biospecimen Search Criteria Biospecimen Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2953504</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699:C42871</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Search Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42871</PREFERRED_NAME>
            <LONG_NAME>Search Criteria</LONG_NAME>
            <CON_ID>2953493</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2953529</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2953604</PublicId>
      <PreferredName>2953604v1.0</PreferredName>
      <PreferredDefinition>The specific type of biomaterial indicating if it is a sample or a dna extract etc.</PreferredDefinition>
      <LongName>BiomaterialType</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EXTRACT</VALIDVALUE>
          <VALUEMEANING>Extract</VALUEMEANING>
          <MEANINGDESCRIPTION>A solution of essential constituents of a complex material; a substance removed from another substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2953605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LABELED_EXTRACT</VALIDVALUE>
          <VALUEMEANING>Tracer Extract</VALUEMEANING>
          <MEANINGDESCRIPTION>A substance that is identifiable by virtue of its radioactive signature, color, or other distinguishing physical property, such as a dye, radioactive isotope, or inert chemical, that is introduced into a biological or mechanical system and can be followed through the course of a process, providing information on the pattern of events in the process or on the redistribution of the parts, elements, or events involved.:A solution of essential constituents of a complex material; a substance removed from another substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2480, C82948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2953606</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SAMPLE</VALIDVALUE>
          <VALUEMEANING>Specimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2581714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SOURCE</VALIDVALUE>
          <VALUEMEANING>Source</VALUEMEANING>
          <MEANINGDESCRIPTION>Where something is available or from where it originates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2953607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Biospecimen Search Criteria Biospecimen Type BiomaterialType does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Biospecimen Search Criteria Biospecimen Type BiomaterialType does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2953481</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Service</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Service 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2953482</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2953481</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Service</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.external.v1_0.query</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2953488</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BiomaterialSearchCriteria:types</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.external.v1_0.query.BiomaterialSearchCriteria.types</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="190">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2955154</PUBLICID>
    <LONGNAME>Genome Interaction Basis Relationship Label java.lang.String</LONGNAME>
    <PREFERREDNAME>2954897v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The complete genomic content of an organism, and possibly the full DNA sequence of that organism. It is contained in a set of chromosomes in eukaryotes, a single chromosome in bacteria, or a DNA or RNA molecule in viruses.:The quality, state, or process of (two or more things) acting on each other.:The fundamental assumptions underlying an explanation or a relation that provide the foundation for something.:A state of connectedness between people, objects, or events; to be associated or connected with something._A brief description given for purposes of identification; an identifying or descriptive marker that is attached to an object._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2954897</PublicId>
      <PreferredName>2954890v1.0:2422649v1.0</PreferredName>
      <PreferredDefinition>The complete genomic content of an organism, and possibly the full DNA sequence of that organism. It is contained in a set of chromosomes in eukaryotes, a single chromosome in bacteria, or a DNA or RNA molecule in viruses.:The quality, state, or process of (two or more things) acting on each other.:The fundamental assumptions underlying an explanation or a relation that provide the foundation for something.:A state of connectedness between people, objects, or events; to be associated or connected with something._A brief description given for purposes of identification; an identifying or descriptive marker that is attached to an object.</PreferredDefinition>
      <LongName>Genome Interaction Basis Relationship Label</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2954890</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16629:C54216:C25430:C25648</PreferredName>
        <Version>1</Version>
        <LongName>Genome Interaction Basis Relationship</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16629</PREFERRED_NAME>
            <LONG_NAME>Genome</LONG_NAME>
            <CON_ID>2399440</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54216</PREFERRED_NAME>
            <LONG_NAME>Interaction</LONG_NAME>
            <CON_ID>2689827</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25430</PREFERRED_NAME>
            <LONG_NAME>Basis</LONG_NAME>
            <CON_ID>2203857</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2422649</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45561</PreferredName>
        <Version>1</Version>
        <LongName>Label</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45561</PREFERRED_NAME>
            <LONG_NAME>Label</LONG_NAME>
            <CON_ID>2422619</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Genome Interaction Basis Relationship Label java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Genome Interaction Basis Relationship Label java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2954884</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GRANITE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.Granite</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2954885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GenomicRelation:label</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.Granite.GenomicRelation.label</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="191">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2959910</PUBLICID>
    <LONGNAME>Person Social Role Telecommunication Address ISO21090.DSET.TEL.v1.0</LONGNAME>
    <PREFERREDNAME>2959212v1.0:2803346v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A human being.:The action or activity assigned to or required or expected of a person or group._The value for a particular telecommunication address used as the contact telecommunication information for a person or organization._A collection containing unordered distinct/discrete values of the type TEL.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2959212</PublicId>
      <PreferredName>2959113v1.0:2715096v1.0</PreferredName>
      <PreferredDefinition>A human being.:The action or activity assigned to or required or expected of a person or group._The value for a particular telecommunication address used as the contact telecommunication information for a person or organization.</PreferredDefinition>
      <LongName>Person Social Role Telecommunication Address</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2959113</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C25199</PreferredName>
        <Version>1</Version>
        <LongName>Person Social Role</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25199</PREFERRED_NAME>
            <LONG_NAME>Social Role</LONG_NAME>
            <CON_ID>2203783</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2715096</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70806</PreferredName>
        <Version>1</Version>
        <LongName>Telecommunication Address</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70806</PREFERRED_NAME>
            <LONG_NAME>Telecommunication Address</LONG_NAME>
            <CON_ID>2714966</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803346</PublicId>
      <PreferredName>2803346v1.0</PreferredName>
      <PreferredDefinition>A collection containing unordered distinct/discrete values of the type TEL.</PreferredDefinition>
      <LongName>ISO21090.DSET.TEL.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090DSETv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Person Social Role Telecommunication Address ISO21090.DSET.TEL.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Person Social Role Telecommunication Address ISO21090.DSET.TEL.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2958963</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COPPA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.COPPA.InformationModel</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2958964</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2985612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CES</PreferredName>
          <Version>2.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.CES.InformationModel</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2985613</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.COPPA.InformationModel.PersonRole.telecomAddress</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PersonRole:telecomAddress</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.CES.InformationModel.PersonRole.telecomAddress</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="192">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2959972</PUBLICID>
    <LONGNAME>Procedure Type Code InterventionType</LONGNAME>
    <PREFERREDNAME>2959260v1.0:2959646v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A particular course of action intended to achieve a result._Something distinguishable as an identifiable class based on common qualities.:A system, often of numbered categories, for representation of data._The code that describes the kind of therpy or treatment administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2959260</PublicId>
      <PreferredName>2233215v1.0:2607570v1.0</PreferredName>
      <PreferredDefinition>A particular course of action intended to achieve a result._Something distinguishable as an identifiable class based on common qualities.:A system, often of numbered categories, for representation of data.</PreferredDefinition>
      <LongName>Procedure Type Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233215</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25218</PreferredName>
        <Version>1</Version>
        <LongName>Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607570</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Type Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2959646</PublicId>
      <PreferredName>2959646v1.0</PreferredName>
      <PreferredDefinition>The code that describes the kind of therpy or treatment administered.</PreferredDefinition>
      <LongName>InterventionType</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drug</VALIDVALUE>
          <VALUEMEANING>Pharmacologic Substance</VALUEMEANING>
          <MEANINGDESCRIPTION>An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1909</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2959401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic</VALIDVALUE>
          <VALUEMEANING>GENE THERAPY</VALUEMEANING>
          <MEANINGDESCRIPTION>GENE THERAPY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2561726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Procedure/Surgery</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Used for operative procedures on organs, regions, or tissues in the treatment of diseases, including tissue section by lasers. It excludes transplantation, for which &quot;transplantation&quot; is used.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2576555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Procedure Type Code InterventionType does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Procedure Type Code InterventionType does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2958963</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COPPA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.COPPA.InformationModel</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2958964</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Intervention:typeCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.COPPA.InformationModel.Intervention.typeCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="193">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2977753</PUBLICID>
    <LONGNAME>Neuroblastoma Histology Shimada Classification System Type</LONGNAME>
    <PREFERREDNAME>2961434v1.0:2977713v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the Shimada classification system used to determine the neuroblastoma histology.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2961434</PublicId>
      <PreferredName>NRBLSMA_HSTLGY</PreferredName>
      <PreferredDefinition>A neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.</PreferredDefinition>
      <LongName>Neuroblastoma Histology</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2961432</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3270</PreferredName>
        <Version>1</Version>
        <LongName>Neuroblastoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3270</PREFERRED_NAME>
            <LONG_NAME>Neuroblastoma</LONG_NAME>
            <CON_ID>2479017</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2186387</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16681</PreferredName>
        <Version>1</Version>
        <LongName>Histology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16681</PREFERRED_NAME>
            <LONG_NAME>Histology</LONG_NAME>
            <CON_ID>2202345</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2977713</PublicId>
      <PreferredName>2977713v1.0</PreferredName>
      <PreferredDefinition>A classification system defining a neuroblastoma as having a favorable or unfavorable prognosis, based on histopathologic criteria._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Shimada Classification System Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2977712</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C85413:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Shimada Classification System Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85413</PREFERRED_NAME>
            <LONG_NAME>Shimada Classification System</LONG_NAME>
            <CON_ID>2971956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stroma-rich</VALIDVALUE>
          <VALUEMEANING>High Stroma</VALUEMEANING>
          <MEANINGDESCRIPTION>High; greater than normal in degree or intensity or amount.: The non-neoplastic connective tissue of an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67387, C25227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2977714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stroma-poor</VALIDVALUE>
          <VALUEMEANING>Low Stroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimum level or position or degree; less than normal in degree or intensity or amount.: The non-neoplastic connective tissue of an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67387, C54722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2977715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the histologic findin</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify the histologic findings by Shimada classification:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2977753</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedClinicalResult.value(ANY=&gt;CD) WHERE  PerformedClinicalResult &gt;  PerformedObservation &gt; DefinedObservation.nameCode = &quot;Determine Neuroblastoma Histology&quot; AND PerformedObservation.methodCode = &quot;Shimada&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2026r1: Neuroblastoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964894</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_base_bx_smada_class</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedClinicalResult:value </AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="194">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2990483</PUBLICID>
    <LONGNAME>Tissue Specimen Acceptable Condition Receipt Indicator</LONGNAME>
    <PREFERREDNAME>SPEC_ACC_COND_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to signify whether a biospecimen sample was in acceptable condition upon receipt.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2990481</PublicId>
      <PreferredName>SPEC_ACC_COND_RECP</PreferredName>
      <PreferredDefinition>information about the condition of tissue specimens._Satisfying an established set of qualifying measures._A state of being, such as a state of health._Received; taken, gotten, or acquired.</PreferredDefinition>
      <LongName>Tissue Specimen Acceptable Condition Receipt</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206399</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12801:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12801</PREFERRED_NAME>
            <LONG_NAME>Tissue</LONG_NAME>
            <CON_ID>2202489</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2990479</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63350:C25457:C25639</PreferredName>
        <Version>1</Version>
        <LongName>Acceptable Condition Received</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63350</PREFERRED_NAME>
            <LONG_NAME>Acceptable</LONG_NAME>
            <CON_ID>2538603</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25457</PREFERRED_NAME>
            <LONG_NAME>Condition</LONG_NAME>
            <CON_ID>2202899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181608</PublicId>
      <PreferredName>Y_N_CHAR_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Character Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have the specimen(s) been rec</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have the specimen(s) been received in an acceptable condition?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Virginia Commonwealth University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2879403</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>VCU New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2879404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="195">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2997977</PUBLICID>
    <LONGNAME>Computer Configuration Property Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2992665v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Refers to 1) the way a computer&#39;s operating system is set up, 2) the total combination of hardware components that make up the computer system, or 3) the specific software settings that have been established for the system.:A basic or essential attribute shared by all members of a class._A statement or an account describing something._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2992665</PublicId>
      <PreferredName>2992539v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>Refers to 1) the way a computer&#39;s operating system is set up, 2) the total combination of hardware components that make up the computer system, or 3) the specific software settings that have been established for the system.:A basic or essential attribute shared by all members of a class._A statement or an account describing something.</PreferredDefinition>
      <LongName>Computer Configuration Property Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2992539</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C85235:C42605</PreferredName>
        <Version>1</Version>
        <LongName>Computer Configuration Property</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85235</PREFERRED_NAME>
            <LONG_NAME>Computer Configuration</LONG_NAME>
            <CON_ID>2992523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42605</PREFERRED_NAME>
            <LONG_NAME>Property</LONG_NAME>
            <CON_ID>2231569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Computer Configuration Property Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Computer Configuration Property Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain.report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000324</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ConfigProperty:description</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.report.ConfigProperty.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="196">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2997981</PUBLICID>
    <LONGNAME>Report Tracking Attempt Number java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2992669v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A short textual account; having provided a short account.:The act or process of following a person, animal, or object through space or time._An activity intended to do or accomplish something.  Routinely used as in &quot;number of tries to complete a procedure&quot;.:A numeral or string of numerals expressing value, quantity, or identification._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2992669</PublicId>
      <PreferredName>2992541v1.0:2992594v1.0</PreferredName>
      <PreferredDefinition>A short textual account; having provided a short account.:The act or process of following a person, animal, or object through space or time._An activity intended to do or accomplish something.  Routinely used as in &quot;number of tries to complete a procedure&quot;.:A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Report Tracking Attempt Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2992541</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25375:C45275</PreferredName>
        <Version>1</Version>
        <LongName>Report Tracking</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45275</PREFERRED_NAME>
            <LONG_NAME>Tracking</LONG_NAME>
            <CON_ID>2598128</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2992594</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C39769:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Attempt Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39769</PREFERRED_NAME>
            <LONG_NAME>Attempt</LONG_NAME>
            <CON_ID>2203722</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Report Tracking Attempt Number java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Report Tracking Attempt Number java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain.report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000324</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.report.ReportTracking.attemptNumber</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ReportTracking:attemptNumber</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="197">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2998236</PUBLICID>
    <LONGNAME>Local Research Personnel Staff Telephone Number java.lang.String</LONGNAME>
    <PREFERREDNAME>2992910v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Of or belonging to a restricted area or locality.:People engaged in research.:The employees of an organization; personnel who assist their superior in carrying out an assigned task._A telephone number is a sequence of decimal digits (0-9) that is used for identifying a destination telephone line or other device in a telephone network.  In the US this is a ten digit number resembling &quot;123-456-7890&quot;._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2992910</PublicId>
      <PreferredName>2992589v1.0:2223455v1.0</PreferredName>
      <PreferredDefinition>Of or belonging to a restricted area or locality.:People engaged in research.:The employees of an organization; personnel who assist their superior in carrying out an assigned task._A telephone number is a sequence of decimal digits (0-9) that is used for identifying a destination telephone line or other device in a telephone network.  In the US this is a ten digit number resembling &quot;123-456-7890&quot;.</PreferredDefinition>
      <LongName>Local Research Personnel Staff Telephone Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2992589</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C67263:C17089:C63612</PreferredName>
        <Version>1</Version>
        <LongName>Local Research Personnel Staff</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67263</PREFERRED_NAME>
            <LONG_NAME>Local</LONG_NAME>
            <CON_ID>2676068</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17089</PREFERRED_NAME>
            <LONG_NAME>Research Personnel</LONG_NAME>
            <CON_ID>2202675</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63612</PREFERRED_NAME>
            <LONG_NAME>Staff</LONG_NAME>
            <CON_ID>2667911</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223455</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C40978</PreferredName>
        <Version>1</Version>
        <LongName>Telephone Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40978</PREFERRED_NAME>
            <LONG_NAME>Telephone Number</LONG_NAME>
            <CON_ID>2223426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Local Research Personnel Staff Telephone Number java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Local Research Personnel Staff Telephone Number java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000413</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.LocalResearchStaff.phoneNumber</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LocalResearchStaff:phoneNumber</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="198">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2998279</PUBLICID>
    <LONGNAME>Distant Clinical Study Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2992953v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Far apart in space, time, or relevance from a point of origin.:Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research._A statement or an account describing something._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2992953</PublicId>
      <PreferredName>2992580v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>Far apart in space, time, or relevance from a point of origin.:Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research._A statement or an account describing something.</PreferredDefinition>
      <LongName>Distant Clinical Study Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2992580</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25321:C15206</PreferredName>
        <Version>1</Version>
        <LongName>Distant Clinical Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25321</PREFERRED_NAME>
            <LONG_NAME>Distant</LONG_NAME>
            <CON_ID>2204917</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Distant Clinical Study Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Distant Clinical Study Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000413</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RemoteStudy:descriptionText</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.RemoteStudy.descriptionText</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="199">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3005331</PUBLICID>
    <LONGNAME>Skin Graft Versus Host Disease Secondary Sign Name</LONGNAME>
    <PREFERREDNAME>SKN_GVHD_ANC_SGN_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>Objective ancillary data related to the signs and symptoms of skin Graft vs Host Disease (GVHD).  This is part of the Chronic GVHD Composite Assessment Scale evaluation tool, but does not contribute to that score.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3005322</PublicId>
      <PreferredName>SKN_GVHD_ANC_SGN</PreferredName>
      <PreferredDefinition>1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part._An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin._Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value._Objective evidence of disease perceptible to the examining physician.</PreferredDefinition>
      <LongName>Skin Graft Versus Host Disease Secondary Sign</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3005319</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12470:C3063</PreferredName>
        <Version>1</Version>
        <LongName>Skin Graft Versus Host Disease</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12470</PREFERRED_NAME>
            <LONG_NAME>Skin</LONG_NAME>
            <CON_ID>2202821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3063</PREFERRED_NAME>
            <LONG_NAME>Graft Versus Host Disease</LONG_NAME>
            <CON_ID>2206367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3005320</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25667:C53458</PreferredName>
        <Version>1</Version>
        <LongName>Secondary Sign</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25667</PREFERRED_NAME>
            <LONG_NAME>Secondary</LONG_NAME>
            <CON_ID>2206365</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53458</PREFERRED_NAME>
            <LONG_NAME>Sign</LONG_NAME>
            <CON_ID>2750639</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3005324</PublicId>
      <PreferredName>SKN_GVHD_SGN_NM</PreferredName>
      <PreferredDefinition>1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part._An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin._Objective evidence of disease perceptible to the examining physician._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Skin Graft Versus Host Disease Sign Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3005323</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12470:C3063:C53458:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Skin Graft Versus Host Disease Sign Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12470</PREFERRED_NAME>
            <LONG_NAME>Skin</LONG_NAME>
            <CON_ID>2202821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3063</PREFERRED_NAME>
            <LONG_NAME>Graft Versus Host Disease</LONG_NAME>
            <CON_ID>2206367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53458</PREFERRED_NAME>
            <LONG_NAME>Sign</LONG_NAME>
            <CON_ID>2750639</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Xerosis</VALIDVALUE>
          <VALUEMEANING>Xerosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Dry skin</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-02-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Edema</VALIDVALUE>
          <VALUEMEANING>Edema</VALUEMEANING>
          <MEANINGDESCRIPTION>Pathological transudate within one or more tissues.(FMA)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nail dystrophy</VALIDVALUE>
          <VALUEMEANING>Nail dystrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>Nail dystrophy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-02-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erosions/Ulcerations</VALIDVALUE>
          <VALUEMEANING>Erosions/Ulcerations</VALUEMEANING>
          <MEANINGDESCRIPTION>Erosions/Ulcerations</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-02-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pigmentation alteration</VALIDVALUE>
          <VALUEMEANING>Pigmentation Alteration</VALUEMEANING>
          <MEANINGDESCRIPTION>Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.: A change resulting in something that is different from the original.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28344, C38005</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alopecia</VALIDVALUE>
          <VALUEMEANING>Alopecia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hair loss usually from the scalp. It may result in bald spots or spread to the entire scalp or the entire epidermis. It may be androgenetic or caused by chemotherapeutic agents, compulsive hair pulling, autoimmune disorders or congenital conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50575</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Objective ancillary date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Objective ancillary date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="200">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3019436</PUBLICID>
    <LONGNAME>Person Pincer Grip Lateral Left Hand Measurement Pressure Pound Value</LONGNAME>
    <PREFERREDNAME>PIN_GRP_LAT_LF_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the Pincer grip strength generated when the pad of the thumb of the left hand opposes the lateral side of the index finger of the same hand, as measued in pounds.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3019271</PublicId>
      <PreferredName>PIN_GRP_LAT_LF_HD</PreferredName>
      <PreferredDefinition>Person; a human being._A tool consisting of a pair of handled jaws designed for holding and pulling._The ability to hold or grasp._Lateral; situated at or extending to the side._Being or located on or directed toward the side of the body to the west when facing north._The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits._Measurement is the determination of the size or magnitude of something.  It is also used ro refer to the result of this act.</PreferredDefinition>
      <LongName>Person Pincer Grip Lateral Left Hand Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3104689</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C87796:C78654</PreferredName>
        <Version>1</Version>
        <LongName>Person Pincers Grip</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C87796</PREFERRED_NAME>
            <LONG_NAME>Pincers</LONG_NAME>
            <CON_ID>3019434</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78654</PREFERRED_NAME>
            <LONG_NAME>Grip</LONG_NAME>
            <CON_ID>2808025</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3019269</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25230:C25229:C32712:C37990</PreferredName>
        <Version>1</Version>
        <LongName>Lateral Left Hand Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25230</PREFERRED_NAME>
            <LONG_NAME>Lateral</LONG_NAME>
            <CON_ID>2205046</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25229</PREFERRED_NAME>
            <LONG_NAME>Left</LONG_NAME>
            <CON_ID>2204810</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C32712</PREFERRED_NAME>
            <LONG_NAME>Hand</LONG_NAME>
            <CON_ID>2202677</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37990</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2534954</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3019297</PublicId>
      <PreferredName>PRESS_LB_VAL</PreferredName>
      <PreferredDefinition>The force applied to a unit area of surface._A numerical quantity measured or assigned or computed._A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Pressure Pound Value</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3019296</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25195:C48531:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Pressure Pound Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25195</PREFERRED_NAME>
            <LONG_NAME>Pressure</LONG_NAME>
            <CON_ID>2203954</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48531</PREFERRED_NAME>
            <LONG_NAME>Pound</LONG_NAME>
            <CON_ID>2480771</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PS_LateralLeft</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>PS_LateralLeft</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="201">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3078945</PUBLICID>
    <LONGNAME>Dental Implant Patient Mastication Discomfort Oral Health Impact Profile Physical Examination Oral Health Impact Profile Scale</LONGNAME>
    <PREFERREDNAME>3078943v1.0:2504090v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>a scaled index related to the Oral Health Impact Profile assessment, a measure of a person&#39;s perceptions of the social impact of oral disorders on their well-being, of a patient&#39;s sensation of discomfort in the process by which food is torn or crushed by the teeth from the materials placed into (endosseous) or onto (subperiosteal) the jawbone.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3078943</PublicId>
      <PreferredName>3078858v1.0:2516908v1.0</PreferredName>
      <PreferredDefinition>information related to the Oral Health Impact Profile assessment, a measure of a person&#39;s perceptions of the social impact of oral disorders on their well-being, of a patient&#39;s sensation of discomfort in the process by which food is torn or crushed by the teeth from the materials placed into (endosseous) or onto (subperiosteal) the jawbone.</PreferredDefinition>
      <LongName>Dental Implant Patient Mastication Discomfort Oral Health Impact Profile Physical Examination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3078858</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63718:C16960</PreferredName>
        <Version>1</Version>
        <LongName>Dental Implant Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63718</PREFERRED_NAME>
            <LONG_NAME>Dental Implant</LONG_NAME>
            <CON_ID>2547874</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2516908</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62062:C50535:C62359:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Mastication Discomfort Oral Health Impact Profile Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62062</PREFERRED_NAME>
            <LONG_NAME>Mastication</LONG_NAME>
            <CON_ID>2500111</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50535</PREFERRED_NAME>
            <LONG_NAME>Discomfort</LONG_NAME>
            <CON_ID>2500860</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62359</PREFERRED_NAME>
            <LONG_NAME>Oral Health Impact Profile</LONG_NAME>
            <CON_ID>2511485</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2504090</PublicId>
      <PreferredName>OHIP_SCALE</PreferredName>
      <PreferredDefinition>a scaled index of the social impact of oral disorders which draws on a theoretical heirarchy of  oral health outcomes (Oral Health Impact Profile).</PreferredDefinition>
      <LongName>Oral Health Impact Profile Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hardly ever</VALIDVALUE>
          <VALUEMEANING>Hardly ever</VALUEMEANING>
          <MEANINGDESCRIPTION>Hardly ever</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occasionally</VALIDVALUE>
          <VALUEMEANING>OCCASIONALLY</VALUEMEANING>
          <MEANINGDESCRIPTION>OCCASIONALLY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fairly often</VALIDVALUE>
          <VALUEMEANING>Fairly often</VALUEMEANING>
          <MEANINGDESCRIPTION>Fairly often</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very often</VALIDVALUE>
          <VALUEMEANING>VERY OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>VERY OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you found it uncomfortab</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you found it uncomfortable to eat any foods because of problems with your implant placement</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="202">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101096</PUBLICID>
    <LONGNAME>Laboratory Supplies Medical Product Expiration Date java.lang.String</LONGNAME>
    <PREFERREDNAME>3099862v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.:Goods for the support and maintenance of some endeavor._A date determined by appropriate stability testing of the medical product lot, batch, or item, after which the product may not meet the appropriate regulatory agencies requirements. The expiration date must be placed on the container or label(s) of a medical product designating the time during which a batch of the product is expected to remain within the approved shelf life specifications if stored under defined conditions, and after which it may not be used._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3099862</PublicId>
      <PreferredName>3099572v1.0:2715111v1.0</PreferredName>
      <PreferredDefinition>A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.:Goods for the support and maintenance of some endeavor._A date determined by appropriate stability testing of the medical product lot, batch, or item, after which the product may not meet the appropriate regulatory agencies requirements. The expiration date must be placed on the container or label(s) of a medical product designating the time during which a batch of the product is expected to remain within the approved shelf life specifications if stored under defined conditions, and after which it may not be used.</PreferredDefinition>
      <LongName>Laboratory Supplies Medical Product Expiration Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099572</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37984:C60759</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Supplies</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37984</PREFERRED_NAME>
            <LONG_NAME>Laboratory</LONG_NAME>
            <CON_ID>2202883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60759</PREFERRED_NAME>
            <LONG_NAME>Supplies</LONG_NAME>
            <CON_ID>2922995</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2715111</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70854</PreferredName>
        <Version>1</Version>
        <LongName>Medical Product Expiration Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70854</PREFERRED_NAME>
            <LONG_NAME>Medical Product Expiration Date</LONG_NAME>
            <CON_ID>2714980</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Laboratory Supplies Medical Product Expiration Date java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Laboratory Supplies Medical Product Expiration Date java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.LabSupply.expirationDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LabSupply:expirationDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="203">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101468</PUBLICID>
    <LONGNAME>Birth Weight Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>3100225v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>In humans, the weight of a neonate measured within one hour after birth. The factors influencing the birth weight include but not limited to infant sex, racial and ethnic group, maternal size and health status, concurrent diseases, parity, and nutrition, pregnancy environment and conditions, e.g. altitude of geographic area._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100225</PublicId>
      <PreferredName>3099555v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>In humans, the weight of a neonate measured within one hour after birth. The factors influencing the birth weight include but not limited to infant sex, racial and ethnic group, maternal size and health status, concurrent diseases, parity, and nutrition, pregnancy environment and conditions, e.g. altitude of geographic area._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Birth Weight Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099555</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C76325</PreferredName>
        <Version>1</Version>
        <LongName>Birth Weight</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C76325</PREFERRED_NAME>
            <LONG_NAME>Birth Weight</LONG_NAME>
            <CON_ID>2958280</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Birth Weight Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Birth Weight Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BirthWeight:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.BirthWeight.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="204">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101863</PUBLICID>
    <LONGNAME>Pathology Status Created By java.lang.Long</LONGNAME>
    <PREFERREDNAME>3100623v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.:A condition or state at a particular time._Indicates the person or authoritative body who brought the item into existence._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100623</PublicId>
      <PreferredName>3099581v1.0:2231611v1.0</PreferredName>
      <PreferredDefinition>The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.:A condition or state at a particular time._Indicates the person or authoritative body who brought the item into existence.</PreferredDefinition>
      <LongName>Pathology Status Created By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099581</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18189:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Pathology Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42628</PreferredName>
        <Version>1</Version>
        <LongName>Created By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42628</PREFERRED_NAME>
            <LONG_NAME>Created By</LONG_NAME>
            <CON_ID>2231551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Pathology Status Created By java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Pathology Status Created By java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.PathologyStatus.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PathologyStatus:createdBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="205">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101945</PUBLICID>
    <LONGNAME>Generation Status java.lang.String</LONGNAME>
    <PREFERREDNAME>3100705v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A single step in the line of descent from a common ancestor._A condition or state at a particular time._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100705</PublicId>
      <PreferredName>3099559v1.0:2320064v1.0</PreferredName>
      <PreferredDefinition>A single step in the line of descent from a common ancestor._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Generation Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099559</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C88214</PreferredName>
        <Version>1</Version>
        <LongName>Generation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C88214</PREFERRED_NAME>
            <LONG_NAME>Generation</LONG_NAME>
            <CON_ID>3099496</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2320064</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Generation Status java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Generation Status java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.Generation.status</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Generation:status</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="206">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3108974</PUBLICID>
    <LONGNAME>Diseases and Disorders Patient Self-Report Arthritis Diagnosis Yes No Indicator</LONGNAME>
    <PREFERREDNAME>2716015v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator related to information related to the self-reported diagnosis by a physician of arthritis, inflammation of a joint or a state characterized by inflammation of joints., as an abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2716015</PublicId>
      <PreferredName>DAD_PSR_ARTH_DX</PreferredName>
      <PreferredDefinition>information related to the self-reported diagnosis by a physician of arthritis, inflammation of a joint or a state characterized by inflammation of joints., as an abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person.</PreferredDefinition>
      <LongName>Diseases and Disorders Patient Self-Report Arthritis Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2716013</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21089:C2883:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Patient Self-Report Arthritis Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21089</PREFERRED_NAME>
            <LONG_NAME>Patient Self-Report</LONG_NAME>
            <CON_ID>2234887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2883</PREFERRED_NAME>
            <LONG_NAME>Arthritis</LONG_NAME>
            <CON_ID>2206374</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you ever been diagnosed</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you ever been diagnosed by your doctor with Arthritis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4442461</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDCR CDEs with Retired VDs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDEs for Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4442571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="207">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3110194</PUBLICID>
    <LONGNAME>Oral Cavity Lesion Patient Self-Report Personal Medical History Yes or No Response</LONGNAME>
    <PREFERREDNAME>3110192v1.0:3108967v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue. An area of abnormal tissue change. Subjective reports made by the patient. An account of all medical events and problems a person has experienced. A caDSR representation term that is used to indicate a question with permissible values of yes/no</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3110192</PublicId>
      <PreferredName>3110190v1.0:2793065v1.0</PreferredName>
      <PreferredDefinition>The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue. An area of abnormal tissue change. Subjective reports made by the patient. An account of all medical events and problems a person has experienced.</PreferredDefinition>
      <LongName>Oral Cavity Lesion Patient Self-Report Personal Medical History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3110190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12421:C3824</PreferredName>
        <Version>1</Version>
        <LongName>Oral Cavity Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12421</PREFERRED_NAME>
            <LONG_NAME>Oral Cavity</LONG_NAME>
            <CON_ID>2202746</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2793065</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21089:C18772</PreferredName>
        <Version>1</Version>
        <LongName>Patient Self-Report Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21089</PREFERRED_NAME>
            <LONG_NAME>Patient Self-Report</LONG_NAME>
            <CON_ID>2234887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3108967</PublicId>
      <PreferredName>C49487:C49488:3108967v1.0</PreferredName>
      <PreferredDefinition>A caDSR representation term that is used to indicate a question with permissible values of yes/no</PreferredDefinition>
      <LongName>Yes or No Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No [0]</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes [0]</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Sores or growths in mouth</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Sores or growths in mouth</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="208">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3111523</PUBLICID>
    <LONGNAME>School Or College Difficulty With Memory Quantity_5PointScale</LONGNAME>
    <PREFERREDNAME>SCH_DIF_MEMRY_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&quot;s stated perception of how much difficulty they have remembering things at school/college or work, using a 5-point likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MMQL: Minneapolis-Manchester QOL Survey of Health</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3111411</PublicId>
      <PreferredName>3111320v1.0:3111355v1.0</PreferredName>
      <PreferredDefinition>An educational institution.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:An institution of higher education created to educate and grant degrees; often a part of a university.:Something not easily done, accomplished, comprehended, or solved._Used to indicate the presence of something or someone.:Memory; the power of retaining and recalling past experience, something that is remembered.</PreferredDefinition>
      <LongName>School Or College Difficulty With Memory</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3111320</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17118:C37998:C61514:C62189</PreferredName>
        <Version>1</Version>
        <LongName>School Or College Difficulty</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17118</PREFERRED_NAME>
            <LONG_NAME>School</LONG_NAME>
            <CON_ID>2436198</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61514</PREFERRED_NAME>
            <LONG_NAME>College</LONG_NAME>
            <CON_ID>2936659</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62189</PREFERRED_NAME>
            <LONG_NAME>Difficulty</LONG_NAME>
            <CON_ID>2503546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3111355</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62355:C37992</PreferredName>
        <Version>1</Version>
        <LongName>With Memory</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62355</PREFERRED_NAME>
            <LONG_NAME>With</LONG_NAME>
            <CON_ID>2532083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37992</PREFERRED_NAME>
            <LONG_NAME>Memory</LONG_NAME>
            <CON_ID>2202428</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3111477</PublicId>
      <PreferredName>QUANT_5PT_SCL</PreferredName>
      <PreferredDefinition>Five-point Likert scale representing an estimate of how much.</PreferredDefinition>
      <LongName>Quantity_5PointScale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2193053</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL052713</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL052713</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2204709</CON_ID>
            <DEFINITION_SOURCE>NCI04</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>Little</VALUEMEANING>
          <MEANINGDESCRIPTION>A small amount or duration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C76350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>3025019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A whole lot</VALIDVALUE>
          <VALUEMEANING>A whole lot</VALUEMEANING>
          <MEANINGDESCRIPTION>A whole lot.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>3111478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a lot</VALIDVALUE>
          <VALUEMEANING>QUITE A LOT</VALUEMEANING>
          <MEANINGDESCRIPTION>QUITE A LOT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2561674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some</VALIDVALUE>
          <VALUEMEANING>Some</VALUEMEANING>
          <MEANINGDESCRIPTION>At least a small amount or number of, but not a large amount of, or often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>3025018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How much difficulty do you ha</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How much difficulty do you have remembering things at school/college or work?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MMQL Question Number</Name>
        <DocumentType>LABEL</DocumentType>
        <DocumentText>G5.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MMQL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3111285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.MinneapolisManchesterQOLSurveyOfHealth.MMQL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3111286</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SchoolOrCollegeDifficulty:memory</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.MinneapolisManchesterQOLSurveyOfHealth.MMQL.SchoolOrCollegeDifficulty.memory</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="209">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3131877</PUBLICID>
    <LONGNAME>Positive Finding Metastatic Breast Carcinoma Estrogen Receptor Other Measuremenet Scale Text</LONGNAME>
    <PREFERREDNAME>3131876v1.0:3086849v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text to describe a different scale used to measure metastatic breast carcinoma estrogen receptor (ER) positivity.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3131876</PublicId>
      <PreferredName>3131874v1.0:3086845v1.0</PreferredName>
      <PreferredDefinition>An observation confirming something, such as the presence of a disease, condition, or microorganism.__A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site._A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  -Different than the one(s) previously specified or mentioned._An ordered reference standard used to measure incremental changes._Measurement; the size or magnitude of something.</PreferredDefinition>
      <LongName>Positive Finding Metastatic Breast Carcinoma Estrogen Receptor Other Scale Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3131874</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38758:C14174:C4872:C17069</PreferredName>
        <Version>1</Version>
        <LongName>Positive Finding Metastatic Breast Carcinoma ER</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38758</PREFERRED_NAME>
            <LONG_NAME>Positive Finding</LONG_NAME>
            <CON_ID>2516404</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14174</PREFERRED_NAME>
            <LONG_NAME>Metastatic</LONG_NAME>
            <CON_ID>2204914</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4872</PREFERRED_NAME>
            <LONG_NAME>Breast Carcinoma</LONG_NAME>
            <CON_ID>2475940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17069</PREFERRED_NAME>
            <LONG_NAME>Estrogen Receptor Family</LONG_NAME>
            <CON_ID>2202618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3086845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25664:C25209</PreferredName>
        <Version>1</Version>
        <LongName>Other Scale Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3086849</PublicId>
      <PreferredName>3086849v1.0</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._A receptor is a protein located on the cell surface, or in the cytoplasm, that binds to a specific signaling factor, such as a hormone, antigen, or neurotransmitter, causing a conformational and functional change in the receptor molecule.  The ligand-bound receptor then alters its interaction with target molecules, which leads to changes in cellular physiology through modification of the activity of one or more signal transduction pathways._an ordered reference standard._Text; the words of something written.</PreferredDefinition>
      <LongName>Other Receptor Scale Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1000</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3086848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C18106:C25664:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Other Receptor Scale Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18106</PREFERRED_NAME>
            <LONG_NAME>Receptor</LONG_NAME>
            <CON_ID>2612148</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other Scale used to Measure E</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other Scale used to Measure ER Positivity (Metastatic)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="210">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3136597</PUBLICID>
    <LONGNAME>Disease or Disorder Chemosensitivity Type</LONGNAME>
    <PREFERREDNAME>3136596v1.0:2961482v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the sensitivity of the disease to chemotherapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3136596</PublicId>
      <PreferredName>2404658v1.0:2954712v1.0</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better.</PreferredDefinition>
      <LongName>Disease or Disorder Chemosensitivity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2954712</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71488</PreferredName>
        <Version>1</Version>
        <LongName>Chemosensitivity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71488</PREFERRED_NAME>
            <LONG_NAME>Chemosensitivity</LONG_NAME>
            <CON_ID>2719537</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2961482</PublicId>
      <PreferredName>S_TUMR_CHEMO_TP</PreferredName>
      <PreferredDefinition>A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors._Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Solid Tumor Chemosensitivity Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2961481</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9292:C71488:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Solid Neoplasm Chemosensitivity Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9292</PREFERRED_NAME>
            <LONG_NAME>Solid Neoplasm</LONG_NAME>
            <CON_ID>2593120</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71488</PREFERRED_NAME>
            <LONG_NAME>Chemosensitivity</LONG_NAME>
            <CON_ID>2719537</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sensitive</VALIDVALUE>
          <VALUEMEANING>Sensitive</VALUEMEANING>
          <MEANINGDESCRIPTION>Greater than or equal to 50 percent reduction in bidimensional diameter of all disease sites with no new sites of disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not assessed, or chemotherapy less than 2 cycles</VALIDVALUE>
          <VALUEMEANING>Not assessed, or chemotherapy less than 2 cycles</VALUEMEANING>
          <MEANINGDESCRIPTION>Not assessed, or chemotherapy less than 2 cycles</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resistant</VALIDVALUE>
          <VALUEMEANING>Resistant</VALUEMEANING>
          <MEANINGDESCRIPTION>Less than 50 percent reduction in diameter of all disease sites or development of new disease sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Untreated, or treated greater than 6 months prior to transplant</VALIDVALUE>
          <VALUEMEANING>Untreated, or treated greater than 6 months prior to transplant</VALUEMEANING>
          <MEANINGDESCRIPTION>Untreated, or treated greater than 6 months prior to transplant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Untreated</VALIDVALUE>
          <VALUEMEANING>Negation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._Medical care intended to treat or cure a condition or lessen its symptoms. This includes the administration of drugs, surgical procedures, physical or psychotherapy, or the use of therapeutic devices.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3061597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Refractory</VALIDVALUE>
          <VALUEMEANING>Refractory</VALUEMEANING>
          <MEANINGDESCRIPTION>Progression of disease within 4 weeks of last Cisplatin dose</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3117283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemotherapy was only given as adjuvant to the primary surgery or radiation therapy</VALIDVALUE>
          <VALUEMEANING>Chemotherapy was only given as adjuvant to the primary surgery or radiation therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Chemotherapy was only given as adjuvant to the primary surgery or radiation therapy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the sensitivity of t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the sensitivity of the disease to chemotherapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Indicate the sensitivity of the testicular carcinoma to any chemotherapeutic agent administered:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Indicate the sensitivity of the testicular carcinoma to any chemotherapeutic agent administered:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:3136597</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedClinicalInterpretation.value WHERE PerformedClinicalInterpretation &gt; PerformedObservation &gt; DefinedObservation.nameCode = &quot;assess sensitivity&quot; AND PerformedObservation &gt; AssessActivityRelationship &gt; PerformedSubstanceAdministration &gt; DefinedSubstanceAdministration.nameCode = &quot;Administer chemotherapy&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the sensitivity of the central nervous system tumor to chemotherapy?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the sensitivity of the central nervous system tumor to chemotherapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the sensitivity of myeloma to chemotherapy</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the sensitivity of myeloma to chemotherapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have recurrent platinum-resistant or refractory disease (defined as disease that has progressed while receiving platinum or had recurrence within 6 months of the last receipt of platinum based chemotherapy)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have recurrent platinum-resistant or refractory disease (defined as disease that has progressed by imaging while receiving platinum or had recurrence within 6 months of the last receipt of platinum based chemotherapy)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2018r1: Lymphoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2020r1: Breast Cancer Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2025r1: Central Nervous System Tumor Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964893</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2022r1: Testicular / Germ Cell Cancer Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964899</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>tc_base_sens_chemo_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>bc_base_sens_chemo_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lym_base_prep_chem_sentvy</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cns_base_sens_chemo_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedClinicalInterpretation:value </AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="211">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3143548</PUBLICID>
    <LONGNAME>Chest Wall Ulceration Mastectomy Present Longest Dimension Value</LONGNAME>
    <PREFERREDNAME>3143325v1.0:3143406v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the measured or computed greater length of two measurements, especially length or width or height of an ulceration, the formation of a break on the skin on the surface of one of two hemispheric projections of variable size situated on the skin on either side of the chest following surgery to remove the breast (or as much of the breast tissue as possible).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3143325</PublicId>
      <PreferredName>3143316v1.0:3143323v1.0</PreferredName>
      <PreferredDefinition>information related to the presence of the formation of a break on the skin on the surface of one of two hemispheric projections of variable size situated on the skin on either side of the chest following surgery to remove the breast (or as much of the breast tissue as possible).</PreferredDefinition>
      <LongName>Chest Wall Ulceration Mastectomy Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3143316</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62484</PreferredName>
        <Version>1</Version>
        <LongName>Chest Wall</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62484</PREFERRED_NAME>
            <LONG_NAME>Chest Wall</LONG_NAME>
            <CON_ID>2516459</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3143323</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25757:C15277:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Ulceration Mastectomy Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25757</PREFERRED_NAME>
            <LONG_NAME>Ulceration</LONG_NAME>
            <CON_ID>2203971</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15277</PREFERRED_NAME>
            <LONG_NAME>Mastectomy</LONG_NAME>
            <CON_ID>2204820</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3143406</PublicId>
      <PreferredName>3143406v1.0</PreferredName>
      <PreferredDefinition>the measured or computed greater length of two measurements, especially length or width or height.</PreferredDefinition>
      <LongName>Longest Dimension Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008548</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TUMOR_MSRMTS</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Measurements</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>cm</UnitOfMeasure>
      <DisplayFormat>99.9</DisplayFormat>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3143405</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25558:C25483:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Longest Dimension Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25558</PREFERRED_NAME>
            <LONG_NAME>Longest</LONG_NAME>
            <CON_ID>2206293</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25483</PREFERRED_NAME>
            <LONG_NAME>Dimension</LONG_NAME>
            <CON_ID>2203908</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Area of Ulceration</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Area of Ulceration</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="212">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3163023</PUBLICID>
    <LONGNAME>Person Abdominal Organ Computed Tomography Assessment Description Text</LONGNAME>
    <PREFERREDNAME>3163022v1.0:2954078v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis._Of, or related to, the abdomen._A part of the body that performs a specific function.  For example, the heart is an organ._A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis._Person; a human being._The final result of a determination of the value, significance, or extent of._A written or verbal account, representation, statement, or explanation of something._The words of something written.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3163022</PublicId>
      <PreferredName>2236731v1.0:3163020v1.0</PreferredName>
      <PreferredDefinition>A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis._Of, or related to, the abdomen._A part of the body that performs a specific function.  For example, the heart is an organ._A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis._Person; a human being.</PreferredDefinition>
      <LongName>Person Abdominal Organ Computed Tomography</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3163020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25342:C13018:C17204</PreferredName>
        <Version>1</Version>
        <LongName>Abdominal Organ Computed Tomography</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25342</PREFERRED_NAME>
            <LONG_NAME>Abdominal</LONG_NAME>
            <CON_ID>2204983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13018</PREFERRED_NAME>
            <LONG_NAME>Organ</LONG_NAME>
            <CON_ID>2202464</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17204</PREFERRED_NAME>
            <LONG_NAME>Computed Tomography</LONG_NAME>
            <CON_ID>2202436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2954078</PublicId>
      <PreferredName>ASSE_DESC_TEXT</PreferredName>
      <PreferredDefinition>The final result of a determination of the value, significance, or extent of._A written or verbal account, representation, statement, or explanation of something._The words of something written.</PreferredDefinition>
      <LongName>Assessment Description Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>16040817</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16040817v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Description Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>3-D medical imaging of the ab</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>3-D medical imaging of the abdominal region to determine anatomic features and correlates of digestive diseases and cancers.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gastrointestinal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3009614</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="213">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3163069</PUBLICID>
    <LONGNAME>Person Gastrointestinal Condition Personal Medical History Assessment Description Text</LONGNAME>
    <PREFERREDNAME>3163068v1.0:2954078v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Person; a human being._(GAS-tro-in-TES-tih-nul) GI.  Refers to the stomach and intestines._A state of being, such as a state of health._an account of all medical events and problems a person has experienced._The final result of a determination of the value, significance, or extent of._A written or verbal account, representation, statement, or explanation of something._The words of something written.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3163068</PublicId>
      <PreferredName>2236731v1.0:3163066v1.0</PreferredName>
      <PreferredDefinition>Person; a human being._(GAS-tro-in-TES-tih-nul) GI.  Refers to the stomach and intestines._A state of being, such as a state of health._an account of all medical events and problems a person has experienced.</PreferredDefinition>
      <LongName>Person Gastrointestinal Condition Personal Medical History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3163066</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13359:C25457:C18772</PreferredName>
        <Version>1</Version>
        <LongName>Gastrointestinal Condition Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13359</PREFERRED_NAME>
            <LONG_NAME>Gastrointestinal</LONG_NAME>
            <CON_ID>2202578</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25457</PREFERRED_NAME>
            <LONG_NAME>Condition</LONG_NAME>
            <CON_ID>2202899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2954078</PublicId>
      <PreferredName>ASSE_DESC_TEXT</PreferredName>
      <PreferredDefinition>The final result of a determination of the value, significance, or extent of._A written or verbal account, representation, statement, or explanation of something._The words of something written.</PreferredDefinition>
      <LongName>Assessment Description Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>16040817</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16040817v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Description Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Measure to assess personal hi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Measure to assess personal history of gastrointestinal conditions and procedures.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gastrointestinal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3009614</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="214">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3175996</PUBLICID>
    <LONGNAME>Notification Performed Study Activity Message Title ISO21090.ST.v1.0</LONGNAME>
    <PREFERREDNAME>3174879v1.0:2803207v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The subject of the notification.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3174879</PublicId>
      <PreferredName>3174226v1.0:3174553v1.0</PreferredName>
      <PreferredDefinition>Informing by words.:Executed and carried through to completion.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._A usually short communication transmitted by words, signals, or other means from one person, station, or group to another.:An official descriptive name of a document, e.g. the long name of a study protocol provided by the study sponsor.</PreferredDefinition>
      <LongName>Notification Performed Study Activity Message Title</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174226</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25297:C38000:C63536:C43431</PreferredName>
        <Version>1</Version>
        <LongName>Notification Performed Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25297</PREFERRED_NAME>
            <LONG_NAME>Notification</LONG_NAME>
            <CON_ID>2202895</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3174553</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62608:C42774</PreferredName>
        <Version>1</Version>
        <LongName>Message Title</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62608</PREFERRED_NAME>
            <LONG_NAME>Message</LONG_NAME>
            <CON_ID>2677363</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42774</PREFERRED_NAME>
            <LONG_NAME>Title</LONG_NAME>
            <CON_ID>2223215</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803207</PublicId>
      <PreferredName>2803207v1.0</PreferredName>
      <PreferredDefinition>Character string datatype stands for text data.</PreferredDefinition>
      <LongName>ISO21090.ST.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090STv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Notification Performed Study Activity Message Title ISO21090.ST.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Notification Performed Study Activity Message Title ISO21090.ST.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedNotification.messageTitle</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedNotification:messageTitle</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="215">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176075</PUBLICID>
    <LONGNAME>Research Resource Active Flag ISO21090.BL.v1.0</LONGNAME>
    <PREFERREDNAME>3174938v1.0:2803169v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Specifies whether the resource is active.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3174938</PublicId>
      <PreferredName>3174245v1.0:2737789v1.0</PreferredName>
      <PreferredDefinition>The funding, research facilities, and materials available for research_Exerting influence or producing an effect; taking part in an activity.:An indicator that can be set or unset in order to signal whether a particular condition is true.</PreferredDefinition>
      <LongName>Research Resource Active Flag</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174245</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15321</PreferredName>
        <Version>1</Version>
        <LongName>Research Resource</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15321</PREFERRED_NAME>
            <LONG_NAME>Research Resource</LONG_NAME>
            <CON_ID>2867549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2737789</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45329:C43578</PreferredName>
        <Version>1</Version>
        <LongName>Active Flag</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45329</PREFERRED_NAME>
            <LONG_NAME>Active</LONG_NAME>
            <CON_ID>2342187</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43578</PREFERRED_NAME>
            <LONG_NAME>Flag</LONG_NAME>
            <CON_ID>2223213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803169</PublicId>
      <PreferredName>2803169v1.0</PreferredName>
      <PreferredDefinition>Values of two-valued logic.</PreferredDefinition>
      <LongName>ISO21090.BL.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090BLv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Research Resource Active Flag ISO21090.BL.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Research Resource Active Flag ISO21090.BL.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.Resource.activeIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Resource:activeIndicator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain.Resource.activeIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudyResourcing.activeIndicator</AlternateName>
        <AlternateNameType>Map:CTRPv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Resource.activeIndicator</AlternateName>
        <AlternateNameType>Map:CTRv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="216">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176277</PUBLICID>
    <LONGNAME>Negation Study Subject Administration Reuse Template Study Activity Repeat Frequency Ratio ISO21090.RTO.INT,PQ.TIME.v1.0</LONGNAME>
    <PREFERREDNAME>3175119v1.0:3152481v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An administrative activity defined at a global library level that represents a study level administrative activity that is independent of a study subject. EXAMPLE(S): IRB Approval, site enrollment, FDA audit A ratio representing the number of occurrences of an activity within a given time period. EXAMPLE(S): Once per 12 hours; 2 times per day</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175119</PublicId>
      <PreferredName>3174170v1.0:3174538v1.0</PreferredName>
      <PreferredDefinition>An operation in which a term denies or inverts the meaning of another term or construction.:A matter or an individual that is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study.:Performing or possessing executive duties; acting as a supervisor or manager.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._Make or do or perform again.:The number of occurrences of something within a given time period.:Quotient of quantities of the same kind for different components within the same system.</PreferredDefinition>
      <LongName>Negation Study Subject Administration Reuse Template Study Activity Repeat Frequency Ratio</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174170</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174170v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Negation Study Subject Administration Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41189</PREFERRED_NAME>
            <LONG_NAME>Study Subject</LONG_NAME>
            <CON_ID>2202706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48905</PREFERRED_NAME>
            <LONG_NAME>Administration, Management</LONG_NAME>
            <CON_ID>2528523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3174538</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47886:C25515:C44256</PreferredName>
        <Version>1</Version>
        <LongName>Repeat Frequency Ratio</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47886</PREFERRED_NAME>
            <LONG_NAME>Repeat</LONG_NAME>
            <CON_ID>2415563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44256</PREFERRED_NAME>
            <LONG_NAME>Ratio</LONG_NAME>
            <CON_ID>2230969</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3152481</PublicId>
      <PreferredName>3152481v1.0</PreferredName>
      <PreferredDefinition>Quantity quotient of a numerator of type INT divided by a denominator of type PQ.TIME.</PreferredDefinition>
      <LongName>ISO21090.RTO.INT,PQ.TIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090RTOv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Negation Study Subject Administration Reuse Template Study Activity Repeat Frequency Ratio ISO21090.RTO.INT,PQ.TIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Negation Study Subject Administration Reuse Template Study Activity Repeat Frequency Ratio ISO21090.RTO.INT,PQ.TIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DefinedStudyAdministrativeActivity.repeatFrequencyRatio</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedStudyAdministrativeActivity:repeatFrequencyRatio</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="217">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176290</PUBLICID>
    <LONGNAME>Clinical Coordinator Study Site Research Personnel Role Effective Date and Time Range ISO21090.IVL.TS.DATETIME.v1.0</LONGNAME>
    <PREFERREDNAME>3175132v1.0:3152480v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A person who handles the administrative responsibilities of a study on behalf of a study site, acts as a liaison between the study site and the study investigator and/or study sponsor, and reviews all data and records before a monitor&#39;s visit. EXAMPLE(S): trial coordinator, study coordinator, research coordinator, clinical coordinator, research nurse, protocol nurse. OTHER NAME(S): At some sites (primarily in academic settings) StudySiteResearchCoordinators are called Clinical Research Coordinators or Clinical Research Associates (CRAs). The date and time span for when the study site personnel is active.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175132</PublicId>
      <PreferredName>3174224v1.0:2867942v1.0</PreferredName>
      <PreferredDefinition>A person to whom a clinical investigator delegates a few of the routine administrative requirements of a protocol. The duties and responsibilities of a clinical research coordinator may vary across different infrastructures. Generally, the coordinator manages the subject&#39;s clinical trial participation and provides a vital linkage between the subject, the investigator, and the sponsor.:A facility in which study/protocol activities are conducted.:People engaged in research.:The usual or expected function of something; the part something plays in an action or event._Existing in fact and ready for service.:An expression of both date and time that an event has happened or will happen.:The difference between the lowest and highest numerical values; the limits or scale of variation.</PreferredDefinition>
      <LongName>Clinical Coordinator Study Site Research Personnel Role Effective Date and Time Range</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174224</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C51811:C80403:C17089:C48835</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Coordinator Study Site Research Personnel Role</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51811</PREFERRED_NAME>
            <LONG_NAME>Clinical Coordinator</LONG_NAME>
            <CON_ID>2479762</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80403</PREFERRED_NAME>
            <LONG_NAME>Study Site</LONG_NAME>
            <CON_ID>2866824</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17089</PREFERRED_NAME>
            <LONG_NAME>Research Personnel</LONG_NAME>
            <CON_ID>2202675</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48835</PREFERRED_NAME>
            <LONG_NAME>Role</LONG_NAME>
            <CON_ID>2519065</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867942</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49287:C37939:C38013</PreferredName>
        <Version>1</Version>
        <LongName>Effective Date and Time Range</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49287</PREFERRED_NAME>
            <LONG_NAME>Effective</LONG_NAME>
            <CON_ID>2790040</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38013</PREFERRED_NAME>
            <LONG_NAME>Range</LONG_NAME>
            <CON_ID>2204649</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3152480</PublicId>
      <PreferredName>3152480v1.0</PreferredName>
      <PreferredDefinition>Set of consecutive values of an ordered base datatype of the type TS.DATETIME.</PreferredDefinition>
      <LongName>ISO21090.IVL.TS.DATETIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090IVLv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Clinical Coordinator Study Site Research Personnel Role Effective Date and Time Range ISO21090.IVL.TS.DATETIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Clinical Coordinator Study Site Research Personnel Role Effective Date and Time Range ISO21090.IVL.TS.DATETIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudySiteResearchCoordinator.effectiveDateRange</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudySiteResearchCoordinator:effectiveDateRange</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain.StudySiteResearchCoordinator.effectiveDateRange</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="218">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176417</PUBLICID>
    <LONGNAME>Notification Reuse Template Study Activity Identifier ISO21090.II.v1.0</LONGNAME>
    <PREFERREDNAME>3175245v1.0:2803193v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An administrative activity defined at the global library level that represents the communication of a message to a recipient. EXAMPLE(S): An alert sent to a study PI that the study has reached 75% of target subject accrual. A unique symbol that establishes identity of an activity. EXAMPLE(S): 12345 is the identifier for a substance administration</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175245</PublicId>
      <PreferredName>3174180v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Informing by words.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Notification Reuse Template Study Activity Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174180</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174180v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Notification Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25297</PREFERRED_NAME>
            <LONG_NAME>Notification</LONG_NAME>
            <CON_ID>2202895</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803193</PublicId>
      <PreferredName>2803193v1.0</PreferredName>
      <PreferredDefinition>Identifier that uniquely identifies a thing or object.</PreferredDefinition>
      <LongName>ISO21090.II.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090IIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Notification Reuse Template Study Activity Identifier ISO21090.II.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Notification Reuse Template Study Activity Identifier ISO21090.II.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DefinedNotification.identifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedNotification:identifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="219">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176763</PUBLICID>
    <LONGNAME>Protocol Deviation Performed Observation Outcome Identifier ISO21090.II.v1.0</LONGNAME>
    <PREFERREDNAME>3175277v1.0:2803193v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A variation from process or procedures defined in a study protocol. EXAMPLE(S): Study subject not withdrawn as per protocol, excluded concomitant medication, treatment deviation. NOTE(S): Deviations usually do not preclude the overall evaluability of subject data for either efficacy or safety. The unique symbol that establishes identity of the observation result.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175277</PublicId>
      <PreferredName>3174235v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>An unintended departure from the study plan which has not been prospectively reviewed and approved by the IRB and FDA.:Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Protocol Deviation Performed Observation Outcome Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174235</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50996:C38000:C25598:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Deviation Performed Observation Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50996</PREFERRED_NAME>
            <LONG_NAME>Protocol Deviation</LONG_NAME>
            <CON_ID>2434968</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803193</PublicId>
      <PreferredName>2803193v1.0</PreferredName>
      <PreferredDefinition>Identifier that uniquely identifies a thing or object.</PreferredDefinition>
      <LongName>ISO21090.II.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090IIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Protocol Deviation Performed Observation Outcome Identifier ISO21090.II.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Protocol Deviation Performed Observation Outcome Identifier ISO21090.II.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedProtocolDeviation.identifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedProtocolDeviation:identifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain.PerformedProtocolDeviation.identifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="220">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176837</PUBLICID>
    <LONGNAME>Study Subject Protocol Milestone Administration Reuse Template Study Activity Category Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>3175340v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An administrative activity defined at a global library level that represents a common administrative landmark for a study subject in the course of a study. EXAMPLE(S): obtain informed consent, verify eligibility criteria, enroll, registration to a study, randomize, assignment to a treatment arm, start of on-study period, complete study visits, end of on-study period, exit trial, break treatment blind, protocol violation, premature withdrawal A coded value specifying a classification of activities. EXAMPLE(S): In the case where categoryCode = &quot;anti-cancer treatment&quot;, the subcategoryCode may = &quot;radiotherapy&quot;, and the nameCode may = &quot;external beam radiotherapy&quot;. Foe a procedure, categoryCode may = &quot;abdominal surgery&quot;. For an administrative activity, the categoryCode may = &quot;Disposition&quot; (off study, epoch completion), &quot;Milestone&quot; (informed consent, enrollment, registry, randomization) or &quot;Other&quot; (unblinding) activities. For lab procedures, categoryCode may = &quot;hematology&quot;, &quot;urinalysis&quot;, or &quot;chemistry&quot;.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175340</PublicId>
      <PreferredName>3174203v1.0:2867794v1.0</PreferredName>
      <PreferredDefinition>A matter or an individual that is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study.:Occurrences within some epochs that are initiated by a protocol-specified event. The most common protocol milestone is &quot;Informed Consent Obtained&quot; which usually documents the start of the study.:Performing or possessing executive duties; acting as a supervisor or manager.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._This term is used informally to mean a class of things.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Study Subject Protocol Milestone Administration Reuse Template Study Activity Category Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174203v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Study Subject Protocol Milestone Administration Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41189</PREFERRED_NAME>
            <LONG_NAME>Study Subject</LONG_NAME>
            <CON_ID>2202706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C74588</PREFERRED_NAME>
            <LONG_NAME>Protocol Milestone</LONG_NAME>
            <CON_ID>3174121</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48905</PREFERRED_NAME>
            <LONG_NAME>Administration, Management</LONG_NAME>
            <CON_ID>2528523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867794</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25372:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Category Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Study Subject Protocol Milestone Administration Reuse Template Study Activity Category Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Study Subject Protocol Milestone Administration Reuse Template Study Activity Category Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DefinedStudySubjectMilestone.categoryCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedStudySubjectMilestone:categoryCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.DefinedStudySubjectMilestone.categoryCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="221">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176852</PUBLICID>
    <LONGNAME>Personal Medical History Performed Observation Outcome Code Change Text ISO21090.ST.v1.0</LONGNAME>
    <PREFERREDNAME>3175355v1.0:2803207v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The case history of a subject. NOTE(S): This case history may have been recalled by the subject or a caregiver or provided in their medical record. A character string that is a revision of the original text observation result to enable the coding of the text. EXAMPLE(S): If the originalText is &quot;hedache&quot;, the resultCodeModifiedText could be changed to &quot;headache&quot;, so that the text can be successfully coded.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175355</PublicId>
      <PreferredName>2867663v1.0:3174585v1.0</PreferredName>
      <PreferredDefinition>A record of a patient&#39;s background regarding health and the occurrence of disease events of the individual.  In addition, personal medical history may be a variable in epidemiologic studies.:Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.:The act of alteration or modification; changed or altered in form or character.:The words of something written.</PreferredDefinition>
      <LongName>Personal Medical History Performed Observation Outcome Code Change Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867663</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18772:C38000:C25598:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Personal Medical History Performed Observation Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3174585</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162:C25446:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Code Change Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803207</PublicId>
      <PreferredName>2803207v1.0</PreferredName>
      <PreferredDefinition>Character string datatype stands for text data.</PreferredDefinition>
      <LongName>ISO21090.ST.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090STv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Personal Medical History Performed Observation Outcome Code Change Text ISO21090.ST.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Personal Medical History Performed Observation Outcome Code Change Text ISO21090.ST.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedMedicalHistoryResult.resultCodeModifiedText</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedMedicalHistoryResult:resultCodeModifiedText</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="222">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176931</PUBLICID>
    <LONGNAME>Adverse Event Outcome Performed Observation Outcome Baseline Flag ISO21090.BL.v1.0</LONGNAME>
    <PREFERREDNAME>3175428v1.0:2803169v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An assessment result of the final state in a person who experienced an adverse event, which takes place after the adverse event occurs. EXAMPLE(S): Recovered/Resolved, Recovering/Resolving, Not Recovered/Not Resolved, Recovered/Resolved with Sequelae, Fatal, Unknown Specifies whether the result is a starting point to which other results may be compared.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175428</PublicId>
      <PreferredName>3174128v1.0:2867864v1.0</PreferredName>
      <PreferredDefinition>Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s).:The result of an action.:Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._A starting point to which things may be compared.:An indicator that can be set or unset in order to signal whether a particular condition is true.</PreferredDefinition>
      <LongName>Adverse Event Outcome Performed Observation Outcome Baseline Flag</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174128</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174128v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Outcome Performed Observation Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867864</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25213:C43578</PreferredName>
        <Version>1</Version>
        <LongName>Baseline Flag</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25213</PREFERRED_NAME>
            <LONG_NAME>Baseline</LONG_NAME>
            <CON_ID>2202304</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43578</PREFERRED_NAME>
            <LONG_NAME>Flag</LONG_NAME>
            <CON_ID>2223213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803169</PublicId>
      <PreferredName>2803169v1.0</PreferredName>
      <PreferredDefinition>Values of two-valued logic.</PreferredDefinition>
      <LongName>ISO21090.BL.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090BLv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Adverse Event Outcome Performed Observation Outcome Baseline Flag ISO21090.BL.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Adverse Event Outcome Performed Observation Outcome Baseline Flag ISO21090.BL.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.AdverseEventSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.AdverseEventOutcomeResult.baselineIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AdverseEventOutcomeResult:baselineIndicator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.AdverseEventSubDomain.AdverseEventOutcomeResult.baselineIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="223">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176992</PUBLICID>
    <LONGNAME>Exclusion Criteria Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity Target Anatomic Site Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>3175489v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity defined at a global library level that identifies a characteristic or requirement intended to be applied to a potential study subject to determine whether they may participate in a study. EXAMPLE(S): Must be over the age of 18. A coded value specifying the anatomic location that is the focus of the observation. EXAMPLE(S): lung, leg. NOTE(S): The target site of the observation result may be different than the target site of the observation that generated it. For instance, the target site of the observation may be broad (e.g. skin) while the target site of the observation result is specific (e.g. skin on chest).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175489</PublicId>
      <PreferredName>3174215v1.0:2867757v1.0</PreferredName>
      <PreferredDefinition>Medical and/or social characteristics that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.:Watching something and taking note of what happens.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._An object fixed as a goal or point of examination; something to point at; a destination.:Named locations of or within the body.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Exclusion Criteria Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity Target Anatomic Site Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174215</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174215v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Exclusion Criteria Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25370</PREFERRED_NAME>
            <LONG_NAME>Exclusion Criteria</LONG_NAME>
            <CON_ID>2203927</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867757</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25702:C13717:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Target Anatomic Site Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25702</PREFERRED_NAME>
            <LONG_NAME>Target</LONG_NAME>
            <CON_ID>2206261</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Exclusion Criteria Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity Target Anatomic Site Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Exclusion Criteria Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity Target Anatomic Site Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DefinedExclusionCriterion.targetAnatomicSiteCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedExclusionCriterion:targetAnatomicSiteCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.DefinedExclusionCriterion.targetAnatomicSiteCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="224">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3177191</PUBLICID>
    <LONGNAME>Biospecimen Collection Intervention or Procedure Reuse Template Study Activity Repeat Duration ISO21090.PQ.TIME.v1.0</LONGNAME>
    <PREFERREDNAME>3175686v1.0:2848092v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity defined at a global library level that is an action of gathering samples that may be used for subsequent analysis. EXAMPLE(S): blood draw The period of time over which the activity is repeated.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175686</PublicId>
      <PreferredName>3174208v1.0:3174540v1.0</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:The act of gathering things together; having been brought together in one place.:An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._Make or do or perform again.:The period of time during which something continues.</PreferredDefinition>
      <LongName>Biospecimen Collection Intervention or Procedure Reuse Template Study Activity Repeat Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174208</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174208v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Collection Intervention or Procedure Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3174540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47886:C25330</PreferredName>
        <Version>1</Version>
        <LongName>Repeat Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47886</PREFERRED_NAME>
            <LONG_NAME>Repeat</LONG_NAME>
            <CON_ID>2415563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2848092</PublicId>
      <PreferredName>2848092v1.0</PreferredName>
      <PreferredDefinition>Constrains PQ to have units that describe a period of time.</PreferredDefinition>
      <LongName>ISO21090.PQ.TIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090PQTIMEv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Biospecimen Collection Intervention or Procedure Reuse Template Study Activity Repeat Duration ISO21090.PQ.TIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Biospecimen Collection Intervention or Procedure Reuse Template Study Activity Repeat Duration ISO21090.PQ.TIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DefinedSpecimenCollection.repeatDuration</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedSpecimenCollection:repeatDuration</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.DefinedSpecimenCollection.repeatDuration</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="225">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3178353</PUBLICID>
    <LONGNAME>Radiation Therapy Administered Extent Type</LONGNAME>
    <PREFERREDNAME>2013998v1.0:3178351v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that represents the extent of the radiation therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013998</PublicId>
      <PreferredName>RT_ADM</PreferredName>
      <PreferredDefinition>information related to radiation therapy administered to a patient.</PreferredDefinition>
      <LongName>Radiation Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2403872</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15313</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3178351</PublicId>
      <PreferredName>3178351v1.0</PreferredName>
      <PreferredDefinition>An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The range, magnitude, or distance over which a thing spans an interval of distance, space, or time._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Therapy Extent Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>12</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>TCGA:The Cancer Genome Atlas</Origin>
      <Representation>
        <PublicId>3178361</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236:C25332:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure Extent Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25332</PREFERRED_NAME>
            <LONG_NAME>Extent</LONG_NAME>
            <CON_ID>2203921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Locoregional</VALIDVALUE>
          <VALUEMEANING>Local-Regional</VALUEMEANING>
          <MEANINGDESCRIPTION>Local-Regional; affecting only a restricted part or area of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systemic</VALIDVALUE>
          <VALUEMEANING>Systemic</VALUEMEANING>
          <MEANINGDESCRIPTION>(sis-TEM-ik) Affecting the entire body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3178352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Extent of Radiation Therapy</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Extent of Radiation Therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>TCGA Comment</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Exclusionary, stop here</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>TCGA Other Malignancy Question</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Extent of Radiation Therapy for the Other Malignancy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="226">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3179471</PUBLICID>
    <LONGNAME>Amphotericin B Deoxycholate Administered Indicator</LONGNAME>
    <PREFERREDNAME>3179455v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not amphotericin B deoxycholate was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3179455</PublicId>
      <PreferredName>3179453v1.0:2233610v1.0</PreferredName>
      <PreferredDefinition>The deoxycholate salt of amphotericin B, a polyene antifungal antibiotic produced by Streptomyces nodosus, with antifungal activity. Amphotericin B binds to ergosterol, an essential component of the fungal cell membrane. This results in depolarization of the cell membrane, alterations in cell membrane permeability, leakage of important intracellular components, and cell rupture. This agent may also induce oxidative damage in fungal cells and has been reported to stimulate host immune cells._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Amphotericin B Deoxycholate Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3179453</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62201</PreferredName>
        <Version>1</Version>
        <LongName>Amphotericin B Deoxycholate</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62201</PREFERRED_NAME>
            <LONG_NAME>Amphotericin B Deoxycholate</LONG_NAME>
            <CON_ID>2593838</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was amphotericin B deoxychola</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was amphotericin B deoxycholate administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>IV amphotericin</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>IV amphotericin</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Amphotericin</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Amphotericin</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Amphotericin (Fungizone)</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Amphotericin (Fungizone)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2046r1: Fungal Infection Supplemental Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964901</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>fng_inf_iv_ampho_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNbas_thr_m_ampho_nonlipd_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNfup_thrpy_ampho_nonlipd_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="227">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3182269</PUBLICID>
    <LONGNAME>Paternal Race Category</LONGNAME>
    <PREFERREDNAME>PATERNAL_RACE_CAT</PREFERREDNAME>
    <PREFERREDDEFINITION>Racial origination of the individual&#39;s father based on OMB approved categories.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NINDS:National Institute of Neurological Disorders and Stroke Common Data Element Project</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3182268</PublicId>
      <PreferredName>PATERNAL_RACE_CAT</PreferredName>
      <PreferredDefinition>The category describing the race of the individual&#39;s father.</PreferredDefinition>
      <LongName>Paternal Race Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2181708</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Race</PreferredName>
        <Version>1</Version>
        <LongName>Race</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17049</PREFERRED_NAME>
            <LONG_NAME>Race</LONG_NAME>
            <CON_ID>2202465</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3182263</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL162064:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Paternal Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL162064</PREFERRED_NAME>
            <LONG_NAME>Paternal</LONG_NAME>
            <CON_ID>2203453</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NINDS:National Institute of Neurological Disorders and Stroke Common Data Element Project</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015164</PublicId>
      <PreferredName>RACE_CAT</PreferredName>
      <PreferredDefinition>racial origination based on OMB approved categories.</PreferredDefinition>
      <LongName>Race Category</LongName>
      <Version>6</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008552</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PHYS_DESC_OF_INDS</PreferredName>
        <Version>1</Version>
        <LongName>Physical Description of Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>41</MaximumLength>
      <MinimumLength>5</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCI CRF Standards</Origin>
      <Representation>
        <PublicId>2433877</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25372</PreferredName>
        <Version>1</Version>
        <LongName>Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Reported</VALIDVALUE>
          <VALUEMEANING>Not Reported</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572578</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>American Indian or Alaska Native</VALIDVALUE>
          <VALUEMEANING>American Indian or Alaska Native </VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in any of the original peoples of North and South America (including Central America) and who maintains tribal affiliation or community attachment. (OMB)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41259</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Native Hawaiian or other Pacific Islander</VALIDVALUE>
          <VALUEMEANING>Native Hawaiian or Other Pacific Islander</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes a person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands. The term covers particularly people who identify themselves as part-Hawaiian, Native Hawaiian, Guamanian or Chamorro, Carolinian, Samoan, Chuukese (Trukese), Fijian, Kosraean, Melanesian, Micronesian, Northern Mariana Islander, Palauan, Papua New Guinean, Pohnpeian, Polynesian, Solomon Islander, Tahitian, Tokelauan, Tongan, Yapese, or Pacific Islander, not specified.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572235</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asian</VALIDVALUE>
          <VALUEMEANING>Asian</VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent, including for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. (OMB)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>White</VALIDVALUE>
          <VALUEMEANING>White</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes person with European, Middle Eastern, or North African ancestral origin who identifies, or is identified, as White.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Black or African American</VALIDVALUE>
          <VALUEMEANING>Black or African American </VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in any of the Black racial groups of Africa. Terms such as &quot;Haitian&quot; or &quot;Negro&quot; can be used in addition to &quot;Black or African American&quot;. (OMB)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not allowed to collect</VALIDVALUE>
          <VALUEMEANING>Not Allowed To Collect</VALUEMEANING>
          <MEANINGDESCRIPTION>An indicator that specifies that a collection event was not permitted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6662191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Paternal Race</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Paternal Race</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NINDS CDE Project</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>NINDS CDE Project</DocumentText>
        <URL>http://www.commondataelements.ninds.nih.gov/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Demographics-Pediatrics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3180984</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Demographics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000063</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Participant/Subject Characteristics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000397</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PATERNAL_RACE_CAT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="228">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3188362</PUBLICID>
    <LONGNAME>Patient Self-Report Canker Sore Assessment Type</LONGNAME>
    <PREFERREDNAME>3188327v1.0:2016885v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>list of values related to subjective reports made by the patient regarding a recurrent disease of the oral mucosa of unknown etiology.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3188327</PublicId>
      <PreferredName>3188309v1.0:3188325v1.0</PreferredName>
      <PreferredDefinition>information related to subjective reports made by the patient regarding a recurrent disease of the oral mucosa of unknown etiology.</PreferredDefinition>
      <LongName>Patient Self-Report Canker Sore Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3188309</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21089</PreferredName>
        <Version>1</Version>
        <LongName>Patient Self-Report</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21089</PREFERRED_NAME>
            <LONG_NAME>Patient Self-Report</LONG_NAME>
            <CON_ID>2234887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3188325</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62546:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Canker Sore Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62546</PREFERRED_NAME>
            <LONG_NAME>Canker Sore</LONG_NAME>
            <CON_ID>2518909</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016885</PublicId>
      <PreferredName>QOL_EXP_TP</PreferredName>
      <PreferredDefinition>list of values that describe the extent to which a patient has experienced an illness or symptom.</PreferredDefinition>
      <LongName>QOL Experience Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>80</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A great deal</VALIDVALUE>
          <VALUEMEANING>A GREAT DEAL</VALUEMEANING>
          <MEANINGDESCRIPTION>A GREAT DEAL</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Big problem</VALIDVALUE>
          <VALUEMEANING>Big problem</VALUEMEANING>
          <MEANINGDESCRIPTION>Big problem</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate problem</VALIDVALUE>
          <VALUEMEANING>MODERATE PROBLEM</VALUEMEANING>
          <MEANINGDESCRIPTION>MODERATE PROBLEM</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561602</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small problem</VALIDVALUE>
          <VALUEMEANING>Small problem</VALUEMEANING>
          <MEANINGDESCRIPTION>Small problem</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very small problem</VALIDVALUE>
          <VALUEMEANING>Very small problem</VALUEMEANING>
          <MEANINGDESCRIPTION>Very small problem</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No problem</VALIDVALUE>
          <VALUEMEANING>No Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: A difficulty, disorder, or condition needing resolution. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28020, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A Medium Problem</VALIDVALUE>
          <VALUEMEANING>Medium Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>Mid-way between small and large in number, quantity, magnitude or extent.: A difficulty, disorder, or condition needing resolution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28020, C49507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5784016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How much did MOUTH OR THROAT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How much did MOUTH OR THROAT SORES INTERFERE with your usual or daily activities</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>In the last 7 days, how much did your MOUTH OR THROAT SORES INTERFERE with your usual daily activities?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3188327v1.0:2016885v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="229">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3191904</PUBLICID>
    <LONGNAME>Umbilical Cord Blood Collection Between Begin Collection And Prior Cryopreservation Elapsed Time Minute Number</LONGNAME>
    <PREFERREDNAME>3191902v1.0:3201557v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The numeric value related to the number of minutes that elapsed between the start of the umbilical cord blood collection and the start of cryopreservation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3191902</PublicId>
      <PreferredName>3192022v1.0:3203257v1.0</PreferredName>
      <PreferredDefinition>Blood from the umbilical cord of a newborn baby. This blood contains high concentrations of stem cells (cells from which all blood cells develop)._The act of gathering things together; having been brought together in one place._The interval between two reference points in time._Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins._The act of gathering things together; having been brought together in one place._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Earlier in time or order._Preservation of cells, tissues, organs, or embryos by storage at low temperatures.._The space or interval separating two things.</PreferredDefinition>
      <LongName>Umbilical Cord Blood Collection Between Begin Collection And Prior Cryopreservation Elapsed Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3192022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13300:C25453</PreferredName>
        <Version>1</Version>
        <LongName>Umbilical Cord Blood Collection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13300</PREFERRED_NAME>
            <LONG_NAME>Umbilical Cord Blood</LONG_NAME>
            <CON_ID>2527864</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3203257</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3203257v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Between Begin Collection And Prior Cryopreservation Elapsed Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94545</PREFERRED_NAME>
            <LONG_NAME>Between</LONG_NAME>
            <CON_ID>3163100</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37912</PREFERRED_NAME>
            <LONG_NAME>And</LONG_NAME>
            <CON_ID>2528554</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16475</PREFERRED_NAME>
            <LONG_NAME>Cryopreservation</LONG_NAME>
            <CON_ID>2205413</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82572</PREFERRED_NAME>
            <LONG_NAME>Elapsed Time</LONG_NAME>
            <CON_ID>3005029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>RADLEX_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3201557</PublicId>
      <PreferredName>MIN_NUM</PreferredName>
      <PreferredDefinition>Length or duration of an event or activity measured in minutes.</PreferredDefinition>
      <LongName>Minute Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>6</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2552449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48154:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Minute Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48154</PREFERRED_NAME>
            <LONG_NAME>Minute</LONG_NAME>
            <CON_ID>2513263</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Minutes elapsed from start of</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Minutes elapsed from start of CBU collection to start of cryopreservation:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2007r1:Cord Blood Unit -SCTOD Data Requirements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3191905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cbu_collect_time_min</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="230">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3194598</PUBLICID>
    <LONGNAME>Filgrastim Administered Indicator</LONGNAME>
    <PREFERREDNAME>3194597v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not filgrastim was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3194597</PublicId>
      <PreferredName>3194595v1.0:2233610v1.0</PreferredName>
      <PreferredDefinition>A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine human granulocyte colony-stimulating factor (G-CSF). Produced endogenously by monocytes, fibroblasts, and endothelial cells, G-CSF binds to and activates specific cell surface receptors, stimulating neutrophil progenitor proliferation and differentiation and selected neutrophil functions. (NCI04)  NC _The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Filgrastim Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3194595</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1474</PreferredName>
        <Version>1</Version>
        <LongName>Filgrastim</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1474</PREFERRED_NAME>
            <LONG_NAME>Filgrastim</LONG_NAME>
            <CON_ID>2427132</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was filgrastim administered?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was filgrastim administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>G-CSF</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>G-CSF</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>TBO-filgrastim</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>TBO-filgrastim</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>TBO-filgrastim (Granix, Teva)</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>TBO-filgrastim (Granix, Teva)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2028r1: Aplastic Anemia Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964900</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNbase_thrpy_m_tbo_filgr_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNfup_thrpy_tbo_filgr_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="231">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3206050</PUBLICID>
    <LONGNAME>Stage Prognostic Factor Collaborative Staging Factor Fifteen Site Code</LONGNAME>
    <PREFERREDNAME>3177725v1.0:2647689v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage of survival.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3177725</PublicId>
      <PreferredName>2688190v1.0:3177723v1.0</PreferredName>
      <PreferredDefinition>Site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival.</PreferredDefinition>
      <LongName>Stage Prognostic Factor Collaborative Staging Factor Fifteen Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20047</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic or Prognostic Factor</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2688190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16899:C18959</PreferredName>
        <Version>1</Version>
        <LongName>Stage Prognostic Factor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18959</PREFERRED_NAME>
            <LONG_NAME>Prognostic Factor</LONG_NAME>
            <CON_ID>2512696</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3177723</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3177723v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Collaborative Staging Factor Integer::15 Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62575</PREFERRED_NAME>
            <LONG_NAME>Collaborative Staging</LONG_NAME>
            <CON_ID>2554140</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25506</PREFERRED_NAME>
            <LONG_NAME>Factor</LONG_NAME>
            <CON_ID>2202640</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::15</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37901</PREFERRED_NAME>
            <LONG_NAME>Site</LONG_NAME>
            <CON_ID>2202394</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2647689</PublicId>
      <PreferredName>2647689v1.0</PreferredName>
      <PreferredDefinition>A coding system for staging of cancer bringing together the principles of Summary Stage, the TNM categories and stage groupings, and the SEER Extent of Disease (EOD) coding structure, creating a carefully selected set of data items that describe how far a cancer has spread at the time of diagnosis. The Collaborative Staging System uses a modified EOD coding system, a five-field, 10 digit system: tumor size (3 digits), extension of the primary tumor (2 digits), regional lymph node involvement (highest specific lymph node chain involved by tumor) (1 digit), the number of pathologically reviewed regional lymph nodes that are positive (2 digits), and the number of pathologically examined regional lymph nodes (2 digits)._Position in relation to the surroundings._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Collaborative Staging Site Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>3</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
      <Representation>
        <PublicId>2647688</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62575:C37901:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Collaborative Staging Site Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62575</PREFERRED_NAME>
            <LONG_NAME>Collaborative Staging</LONG_NAME>
            <CON_ID>2554140</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37901</PREFERRED_NAME>
            <LONG_NAME>Site</LONG_NAME>
            <CON_ID>2202394</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Collaborative Staging Site-Sp</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Collaborative Staging Site-Specific Factor 15</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Rationale</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Site-specific factors are used to record additional staging information needed by Collaborative Staging to derive TNM and/or SEER Summary Stage codes for particular site-histology schema.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Collaborative Stage (CS) Coding</Name>
        <DocumentType>Coding Instructions</DocumentType>
        <DocumentText>The information recorded in CS Site-Specific Factor 15 differs for each anatomic site. See the most current verison of the Collaborative Staging Data Collection System for rules and site-specific codes and coding structures.</DocumentText>
        <URL>http://cancerstaging.org</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 12.1, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&amp;tabid=133&amp;mid=473</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 16, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)</DocumentText>
        <URL>https://www.naaccr.org/data-standards-data-dictionary/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 12.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3134707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899833</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>StageProgFactors16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899845</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464305</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>StageProgFactors18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464319</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>2869</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CS SITE-SPECIFIC FACTOR15</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CS Site-Specific Factor15</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="232">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3210307</PUBLICID>
    <LONGNAME>Patient Prior Registration Laboratory Procedure Malignant Neoplasm Eligibility Determination Date</LONGNAME>
    <PREFERREDNAME>3210301v1.0:2018550v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the date related to the medical procedure regarding tumor prior to the act of enrolling on a clinical trial as a determination of the suitable for enrollment in a study according specific protocol criteria and procedures.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3210301</PublicId>
      <PreferredName>2233604v1.0:3210299v1.0</PreferredName>
      <PreferredDefinition>information related to the medical procedure regarding tumor prior to the act of enrolling on a clinical trial as a determination of the suitable for enrollment in a study according specific protocol criteria and procedures.</PreferredDefinition>
      <LongName>Patient Prior Registration Laboratory Procedure Malignant Neoplasm Eligibility Determination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3210299</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3210299v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Prior Registration Laboratory Procedure Malignant Neoplasm Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25646</PREFERRED_NAME>
            <LONG_NAME>Registration</LONG_NAME>
            <CON_ID>2202799</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Exception test date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Exception test date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="233">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3225980</PUBLICID>
    <LONGNAME>Neuroglial Tumor Assessment Cell Density Category</LONGNAME>
    <PREFERREDNAME>3225976v1.0:3225978v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that describes the cell density of the neuroglial tumor.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3225976</PublicId>
      <PreferredName>3139372v1.0:2465182v1.0</PreferredName>
      <PreferredDefinition>A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells).  Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas.  Tumors that arise from oligodendrocytes are called oligodendroglial tumors.  Tumors that arise from ependymal cells are called ependymomas. -- 2004_Having determined the value, significance, or extent of.</PreferredDefinition>
      <LongName>Neuroglial Tumor Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3139372</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3059</PreferredName>
        <Version>1</Version>
        <LongName>Neuroglial Tumor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3059</PREFERRED_NAME>
            <LONG_NAME>Glioma</LONG_NAME>
            <CON_ID>2786103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2465182</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25217</PreferredName>
        <Version>1</Version>
        <LongName>Assessed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3225978</PublicId>
      <PreferredName>3225978v1.0</PreferredName>
      <PreferredDefinition>The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._The amount of something per unit size._Category; used informally to mean a class of things.</PreferredDefinition>
      <LongName>Cell Density Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3225977</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12508:C45781:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Cell Density Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12508</PREFERRED_NAME>
            <LONG_NAME>Cell</LONG_NAME>
            <CON_ID>2202900</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45781</PREFERRED_NAME>
            <LONG_NAME>Density</LONG_NAME>
            <CON_ID>2236512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High</VALIDVALUE>
          <VALUEMEANING>High</VALUEMEANING>
          <MEANINGDESCRIPTION>High; greater than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low</VALIDVALUE>
          <VALUEMEANING>Low</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimum level or position or degree; less than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Minimal</VALIDVALUE>
          <VALUEMEANING>Minimum</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest possible quantity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2753155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cell Density</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cell Density</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Inactive CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044924</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="234">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3227037</PUBLICID>
    <LONGNAME>Other Fanconi Anemia Complementation Group Protein Present Indicator</LONGNAME>
    <PREFERREDNAME>3193818v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not another Fanconi anemia complementation group protein was present.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3193818</PublicId>
      <PreferredName>3193816v1.0:2233878v1.0</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._A protein that is a member of a structurally diverse group that forms a protein complex which may regulate both DNA repair and the cell cycle. Mutation of any member of this group may inhibit the formation of the complex and is associated with Fanconi anemia._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Other Fanconi Anemia Complementation Group Protein Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3193816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C85881</PreferredName>
        <Version>1</Version>
        <LongName>Other Fanconi Anemia Complementation Group Protein</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85881</PREFERRED_NAME>
            <LONG_NAME>Fanconi Anemia Complementation Group Protein</LONG_NAME>
            <CON_ID>2992033</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was an other fanconi anemia c</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was an other fanconi anemia complementation group protein present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other group</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other group</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964895</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>fan_base_comptst_othr_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="235">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3241829</PUBLICID>
    <LONGNAME>Dental Implant Bone Loss Assessment Actual Measurement</LONGNAME>
    <PREFERREDNAME>3241824v1.0:3241815v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the real measurement related to the assessment of bone loss in a dental prosthesis placed permanently in tissue.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3241824</PublicId>
      <PreferredName>2597304v1.0:3241822v1.0</PreferredName>
      <PreferredDefinition>information related to the assessment of bone loss in a dental prosthesis placed permanently in tissue.</PreferredDefinition>
      <LongName>Dental Implant Bone Loss Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2597304</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63718</PreferredName>
        <Version>1</Version>
        <LongName>Dental Implant</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63718</PREFERRED_NAME>
            <LONG_NAME>Dental Implant</LONG_NAME>
            <CON_ID>2547874</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3241822</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12366:C25559:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Bone Loss Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12366</PREFERRED_NAME>
            <LONG_NAME>Bone</LONG_NAME>
            <CON_ID>2202686</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25559</PREFERRED_NAME>
            <LONG_NAME>Loss</LONG_NAME>
            <CON_ID>2203844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3241815</PublicId>
      <PreferredName>3241815v1.0</PreferredName>
      <PreferredDefinition>the real measurement of the dental implant length.</PreferredDefinition>
      <LongName>Dental Implant Length Actual Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>mm</UnitOfMeasure>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
      <Representation>
        <PublicId>3241814</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25274:C25209</PreferredName>
        <Version>1</Version>
        <LongName>Actual Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25274</PREFERRED_NAME>
            <LONG_NAME>Actual</LONG_NAME>
            <CON_ID>2206152</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Actual bone loss</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Actual bone loss</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="236">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3249257</PUBLICID>
    <LONGNAME>Alcohol Substance Abuse Problem Knowledge Base Therapy Type</LONGNAME>
    <PREFERREDNAME>3249206v1.0:2489013v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the text that describes the strength of agreement related to problems in knowledge of therapy for maladaptive pattern of alcohol use that may lead to social, occupational, psychological, or physical problems.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3249206</PublicId>
      <PreferredName>3249025v1.0:3249202v1.0</PreferredName>
      <PreferredDefinition>information related to problems in knowledge of therapy for maladaptive pattern of alcohol use that may lead to social, occupational, psychological, or physical problems.</PreferredDefinition>
      <LongName>Alcohol Substance Abuse Problem Knowledge Base Therapy</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3249025</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2190:C18272</PreferredName>
        <Version>1</Version>
        <LongName>Alcohol Substance Abuse</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2190</PREFERRED_NAME>
            <LONG_NAME>Alcohol</LONG_NAME>
            <CON_ID>2202315</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18272</PREFERRED_NAME>
            <LONG_NAME>Substance Abuse</LONG_NAME>
            <CON_ID>2585790</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3249202</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28020:C47846:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Problem Knowledge Base Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28020</PREFERRED_NAME>
            <LONG_NAME>Problem</LONG_NAME>
            <CON_ID>2203953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47846</PREFERRED_NAME>
            <LONG_NAME>Knowledge Base</LONG_NAME>
            <CON_ID>3249201</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2489013</PublicId>
      <PreferredName>2489013v1.0</PreferredName>
      <PreferredDefinition>The text that describes the strength of agreement.</PreferredDefinition>
      <LongName>Agreement Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strongly Agree</VALIDVALUE>
          <VALUEMEANING>STRONGLY AGREE</VALUEMEANING>
          <MEANINGDESCRIPTION>STRONGLY AGREE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat Agree</VALIDVALUE>
          <VALUEMEANING>Somewhat Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat Agree</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neither agree nor disagree</VALIDVALUE>
          <VALUEMEANING>NEITHER AGREE NOR DISAGREE</VALUEMEANING>
          <MEANINGDESCRIPTION>NEITHER AGREE NOR DISAGREE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat Disagree</VALIDVALUE>
          <VALUEMEANING>somewhat disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>somewhat disagree</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strongly Disagree</VALIDVALUE>
          <VALUEMEANING>STRONGLY DISAGREE</VALUEMEANING>
          <MEANINGDESCRIPTION>STRONGLY DISAGREE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutral</VALIDVALUE>
          <VALUEMEANING>Neutral</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that a person has a neutral opinion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2902512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uncertain</VALIDVALUE>
          <VALUEMEANING>Uncertain</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3291262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>My staff and I don&#39;t have eno</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>My staff and I don&#39;t have enough knowledge/training in providing interventions for alcohol</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="237">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3250007</PUBLICID>
    <LONGNAME>Vertical Crack Connect Dental Restoration Yes or No Response</LONGNAME>
    <PREFERREDNAME>3250006v1.0:3108967v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Upright in position or posture._A break or fissure in a structure._To become joined or linked._Replacement or reconstruction of a lost tooth structure._A caDSR representation term that is used to indicate a question with permissible values of yes/no</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3250006</PublicId>
      <PreferredName>3249922v1.0:3249892v1.0</PreferredName>
      <PreferredDefinition>Upright in position or posture._A break or fissure in a structure._To become joined or linked._Replacement or reconstruction of a lost tooth structure.</PreferredDefinition>
      <LongName>Vertical Crack Connect Dental Restoration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3249922</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25243:C52648</PreferredName>
        <Version>1</Version>
        <LongName>Vertical Crack</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25243</PREFERRED_NAME>
            <LONG_NAME>Vertical</LONG_NAME>
            <CON_ID>2206270</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52648</PREFERRED_NAME>
            <LONG_NAME>Crack</LONG_NAME>
            <CON_ID>2443124</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3249892</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C94560:C60718</PreferredName>
        <Version>1</Version>
        <LongName>Connect Dental Restoration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94560</PREFERRED_NAME>
            <LONG_NAME>Connect</LONG_NAME>
            <CON_ID>3163125</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60718</PREFERRED_NAME>
            <LONG_NAME>Dental Restoration</LONG_NAME>
            <CON_ID>2481613</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3108967</PublicId>
      <PreferredName>C49487:C49488:3108967v1.0</PreferredName>
      <PreferredDefinition>A caDSR representation term that is used to indicate a question with permissible values of yes/no</PreferredDefinition>
      <LongName>Yes or No Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No [0]</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes [0]</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does any vertical crack conne</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does any vertical crack connect with a restoration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="238">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3263412</PUBLICID>
    <LONGNAME>Isotretinoin Administered Indicator</LONGNAME>
    <PREFERREDNAME>3263407v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not isotretinoin was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3263407</PublicId>
      <PreferredName>3263405v1.0:2233610v1.0</PreferredName>
      <PreferredDefinition>A naturally-occurring retinoic acid with potential antineoplastic activity. Isotretinoin binds to and activates nuclear retinoic acid receptors (RARs); activated RARs serve as transcription factors that promote cell differentiation and apoptosis. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization._The act of having given something (e.g., a medication or test). [Manually curated]</PreferredDefinition>
      <LongName>Isotretinoin Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3263405</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C603</PreferredName>
        <Version>1</Version>
        <LongName>Isotretinoin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C603</PREFERRED_NAME>
            <LONG_NAME>Isotretinoin</LONG_NAME>
            <CON_ID>2202281</CON_ID>
            <DEFINITION_SOURCE>MSH2002_06_01</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was isotretinoin administered?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was isotretinoin administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Isotretinoin:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Isotretinoin:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>13-cis-retinoic acid</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>13-cis-retinoic acid</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>13-cis-retinoic acid (RA)</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>13-cis-retinoic acid (RA)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the recipient receive 13-cis-retinoic acid?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the recipient receive 13-cis-retinoic acid?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF COG Text 02</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient receive Isotretinoin during this follow-up period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient receive Isotretinoin during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2126r1: Neuroblastoma Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_post_retinoid_isot_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_post_prog_ret_isot_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpre_therapy_isotretinoin_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpost_therapy_isotretinoin_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ISOT_ADMR_IND</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="239">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3270435</PUBLICID>
    <LONGNAME>Person History Cancer Screening Count</LONGNAME>
    <PREFERREDNAME>2961248v1.0:3269679v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Value to describe the number of cancer screening examinations a person has experienced in their lifetime.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2961248</PublicId>
      <PreferredName>2236731v1.0:2961246v1.0</PreferredName>
      <PreferredDefinition>Person; a human being._A term for diseases in which abnormal cells divide without control. Cancer cells can invade nearby tissues and can spread through the bloodstream and lymphatic system to other parts of the body._The use of any device, marker, or other means for the purpose of detecting the presence of disease, usually in asymptomatic individuals._The aggregate of past events; the continuum of events occurring in succession leading from the past to the present; a record or narrative description of past events.</PreferredDefinition>
      <LongName>Person Cancer Screening History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2961246</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305:C15419:C54625</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm Disease Screening History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15419</PREFERRED_NAME>
            <LONG_NAME>Disease Screening</LONG_NAME>
            <CON_ID>2321289</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54625</PREFERRED_NAME>
            <LONG_NAME>History</LONG_NAME>
            <CON_ID>2519676</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3269679</PublicId>
      <PreferredName>3269679v1.0</PreferredName>
      <PreferredDefinition>Clinical testing designed to identify the presence of a specific cancer in an asymptomatic individual or population thought to be at risk of that specific cancer. The intent is to find cancers at the earliest possible stage in their development, in order to improve the chances for disease cure._To determine the number or amount of something; the result of this activity.</PreferredDefinition>
      <LongName>Cancer Screening Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3269678</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15406:C25463</PreferredName>
        <Version>1</Version>
        <LongName>Cancer Screening Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15406</PREFERRED_NAME>
            <LONG_NAME>Cancer Screening</LONG_NAME>
            <CON_ID>3269657</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>not sure</VALIDVALUE>
          <VALUEMEANING>Don&#39;t Know/Refused</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>Integer::20 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::20: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>Integer::19 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::19: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>Integer::18 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::18: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>Integer::17 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::17: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>Integer::16 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::16: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>Integer::15 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::15: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>Integer::14 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::14: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>Integer::13 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::13: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>Integer::12 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::12: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>Integer::11 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::11: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>Integer::10 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::10: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Integer::9 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::9: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Integer::8 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::8: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Integer::7 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::7: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Integer::6 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::6: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Integer::5 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::5: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Integer::4 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::4: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Integer::3 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::3: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Integer::2 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::2: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Integer::1 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::1: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269699</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>40</VALIDVALUE>
          <VALUEMEANING>Integer::40 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::40: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::40</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269949</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>39</VALIDVALUE>
          <VALUEMEANING>Integer::39 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::39: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::39</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>38</VALIDVALUE>
          <VALUEMEANING>Integer::38 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::38: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::38</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>37</VALIDVALUE>
          <VALUEMEANING>Integer::37 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::37: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::37</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>36</VALIDVALUE>
          <VALUEMEANING>Integer::36 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::36: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::36</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>35</VALIDVALUE>
          <VALUEMEANING>Integer::35 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::35: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::35</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>34</VALIDVALUE>
          <VALUEMEANING>Integer::34 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::34: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::34</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>33</VALIDVALUE>
          <VALUEMEANING>Integer::33 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::33: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::33</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269956</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32</VALIDVALUE>
          <VALUEMEANING>Integer::32 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::32: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::32</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>Integer::31 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::31: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::31</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>50</VALIDVALUE>
          <VALUEMEANING>Integer::50 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::50: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::50</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>49</VALIDVALUE>
          <VALUEMEANING>Integer::49 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::49: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::49</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>48</VALIDVALUE>
          <VALUEMEANING>Integer::48 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::48: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::48</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>47</VALIDVALUE>
          <VALUEMEANING>Integer::47 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::47: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::47</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>46</VALIDVALUE>
          <VALUEMEANING>Integer::46 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::46: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::46</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>45</VALIDVALUE>
          <VALUEMEANING>Integer::45 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::45: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::45</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>44</VALIDVALUE>
          <VALUEMEANING>Integer::44 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::44: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::44</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>43</VALIDVALUE>
          <VALUEMEANING>Integer::43 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::43: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::43</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>42</VALIDVALUE>
          <VALUEMEANING>Integer::42 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::42: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::42</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>41</VALIDVALUE>
          <VALUEMEANING>Integer::41 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::41: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::41</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>99</VALIDVALUE>
          <VALUEMEANING>Integer::99 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::99: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::99</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>98</VALIDVALUE>
          <VALUEMEANING>Integer::98 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::98: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::98</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>97</VALIDVALUE>
          <VALUEMEANING>Integer::97 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::97: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::97</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>96</VALIDVALUE>
          <VALUEMEANING>Integer::95 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::95: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::95</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>95</VALIDVALUE>
          <VALUEMEANING>Integer::95 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::95: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::95</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>94</VALIDVALUE>
          <VALUEMEANING>Integer::94 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::94: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::94</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>93</VALIDVALUE>
          <VALUEMEANING>Integer::93 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::93: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::93</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>92</VALIDVALUE>
          <VALUEMEANING>Integer::92 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::92: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::92</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>91</VALIDVALUE>
          <VALUEMEANING>Integer::91 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::91: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::91</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>90</VALIDVALUE>
          <VALUEMEANING>Integer::90 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::90: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::90</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>89</VALIDVALUE>
          <VALUEMEANING>Integer::89 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::89: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::89</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>88</VALIDVALUE>
          <VALUEMEANING>Integer::88 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::88: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::88</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>87</VALIDVALUE>
          <VALUEMEANING>Integer::85 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::85: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::85</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>86</VALIDVALUE>
          <VALUEMEANING>Integer::86 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::86: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::86</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>85</VALIDVALUE>
          <VALUEMEANING>Integer::85 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::85: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::85</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>84</VALIDVALUE>
          <VALUEMEANING>Integer::84 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::84: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::84</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>83</VALIDVALUE>
          <VALUEMEANING>Integer::83 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::83: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::83</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>82</VALIDVALUE>
          <VALUEMEANING>Integer::82 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::82: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::82</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>81</VALIDVALUE>
          <VALUEMEANING>Integer::81 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::81: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::81</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>80</VALIDVALUE>
          <VALUEMEANING>Integer::80 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::80: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::80</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>79</VALIDVALUE>
          <VALUEMEANING>Integer::79 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::79: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::79</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>78</VALIDVALUE>
          <VALUEMEANING>Integer::78 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::78: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::78</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>77</VALIDVALUE>
          <VALUEMEANING>Integer::77 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::77: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::77</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>76</VALIDVALUE>
          <VALUEMEANING>Integer::76 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::76: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::76</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>75</VALIDVALUE>
          <VALUEMEANING>Integer::75 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::75: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::75</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>74</VALIDVALUE>
          <VALUEMEANING>Integer::74 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::74: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::74</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>73</VALIDVALUE>
          <VALUEMEANING>Integer::73 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::73: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::73</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>72</VALIDVALUE>
          <VALUEMEANING>Integer::72 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::72: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::72</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270321</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>71</VALIDVALUE>
          <VALUEMEANING>Integer::71 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::71: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::71</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>70</VALIDVALUE>
          <VALUEMEANING>Integer::70 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::70: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::70</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>69</VALIDVALUE>
          <VALUEMEANING>Integer::69 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::69: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::69</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>68</VALIDVALUE>
          <VALUEMEANING>Integer::68 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::68: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::68</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>67</VALIDVALUE>
          <VALUEMEANING>Integer::67 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::67: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::67</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>66</VALIDVALUE>
          <VALUEMEANING>Integer::66 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::66: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::66</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>Integer::30 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::30: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45255::30, C25275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>Integer::29 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::29: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>Integer::28 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::28: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>Integer::27 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::27: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>Integer::26 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::26: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>Integer::25 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::25: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>Integer::23 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::23: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>Integer::23 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::23: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>Integer::22 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::22: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::22</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>Integer::21 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::21: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>65</VALIDVALUE>
          <VALUEMEANING>Integer::65 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::65: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::65</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>64</VALIDVALUE>
          <VALUEMEANING>Integer::64 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::64: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::64</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>63</VALIDVALUE>
          <VALUEMEANING>Integer::63 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::63: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::63</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>62</VALIDVALUE>
          <VALUEMEANING>Integer::62 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::62: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::62</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>61</VALIDVALUE>
          <VALUEMEANING>Integer::61 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::61: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::61</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>60</VALIDVALUE>
          <VALUEMEANING>Integer::60 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::60: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::60</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>59</VALIDVALUE>
          <VALUEMEANING>Integer::59 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::59: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::59</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>58</VALIDVALUE>
          <VALUEMEANING>Integer::58 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::58: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::58</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>57</VALIDVALUE>
          <VALUEMEANING>Integer::57 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::57: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::57</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>56</VALIDVALUE>
          <VALUEMEANING>Integer::56 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::56: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::56</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>55</VALIDVALUE>
          <VALUEMEANING>Integer::55 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::55: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::55</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>54</VALIDVALUE>
          <VALUEMEANING>Integer::54 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::54: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::54</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>53</VALIDVALUE>
          <VALUEMEANING>Integer::53 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::53: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::53</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270079</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>52</VALIDVALUE>
          <VALUEMEANING>Integer::52 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::52: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::52</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>51</VALIDVALUE>
          <VALUEMEANING>Integer::51 Occurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::51: Occurrence; an instance of something happening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25275, C45255::51</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How many cancer screening exa</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How many cancer screening exams have you had in your lifetime?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cancer Screening Question #81 Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How many skin exams have you had in your lifetime?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cancer Screening Question #88 Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How many FOBTs have you had in your lifetime?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cancer Screening Question #92 Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How many Sigmoidoscopy or Colonoscopy exams have you had in your lifetime?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cancer Screening Question #98 Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How many Pap Smear exams have you had in your lifetime?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cancer Screening Question #102 Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How many CBEs have you had in your lifetime?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cancer Screening Question #106 Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How many Mammograms have you had in your lifetime?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cancer Screening Question #110 Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How many DREs have you had in your lifetime?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cancer Screening Question #114 Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How many PSAs tests have you had in your lifetime?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Health Survey </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259220</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Screening</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259228</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="240">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3279222</PUBLICID>
    <LONGNAME>Smoking Cessation Medication Use Indicator</LONGNAME>
    <PREFERREDNAME>3276640v1.0:2181608v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text indicator to signify whether or not medication has been used to help stop smoking.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3276640</PublicId>
      <PreferredName>2435430v1.0:3276643v1.0</PreferredName>
      <PreferredDefinition>The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe._A stopping.__A drug or medicine that treats or prevents or alleviates the symptoms of disease._Use; put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.</PreferredDefinition>
      <LongName>Smoking Cessation Medication Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2435430</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17934</PreferredName>
        <Version>1</Version>
        <LongName>Smoking</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17934</PREFERRED_NAME>
            <LONG_NAME>Tobacco Smoking</LONG_NAME>
            <CON_ID>2202827</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3276643</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61497:C459:C25340</PreferredName>
        <Version>1</Version>
        <LongName>Cessation Medication Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61497</PREFERRED_NAME>
            <LONG_NAME>Cessation</LONG_NAME>
            <CON_ID>2593553</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181608</PublicId>
      <PreferredName>Y_N_CHAR_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Character Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you ever used any stop-s</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you ever used any stop-smoking medications to help you quit smoking?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Health Survey </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259220</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Related Risks </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259229</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="241">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3279224</PUBLICID>
    <LONGNAME>Smoking Cessation Method Type</LONGNAME>
    <PREFERREDNAME>3276646v1.0:3276685v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text to describe the method used to help stop smoking.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3276646</PublicId>
      <PreferredName>2435430v1.0:3276644v1.0</PreferredName>
      <PreferredDefinition>The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe._A stopping._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.</PreferredDefinition>
      <LongName>Smoking Cessation Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2435430</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17934</PreferredName>
        <Version>1</Version>
        <LongName>Smoking</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17934</PREFERRED_NAME>
            <LONG_NAME>Tobacco Smoking</LONG_NAME>
            <CON_ID>2202827</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3276644</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61497:C71460</PreferredName>
        <Version>1</Version>
        <LongName>Cessation Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61497</PREFERRED_NAME>
            <LONG_NAME>Cessation</LONG_NAME>
            <CON_ID>2593553</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3276685</PublicId>
      <PreferredName>3276685v1.0</PreferredName>
      <PreferredDefinition>The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe._A stopping._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Smoking Cessation Method Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3276684</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17934:C61497:C71460:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Smoking Cessation Method Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17934</PREFERRED_NAME>
            <LONG_NAME>Tobacco Smoking</LONG_NAME>
            <CON_ID>2202827</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61497</PREFERRED_NAME>
            <LONG_NAME>Cessation</LONG_NAME>
            <CON_ID>2593553</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, please specify:</VALIDVALUE>
          <VALUEMEANING>Other specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Be specific about something; define clearly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Take home work book/video</VALIDVALUE>
          <VALUEMEANING>Home Work Book And Or Video Recording</VALUEMEANING>
          <MEANINGDESCRIPTION>Home; a person&#39;s permanent place of residence.: Exertion or effort directed to produce or accomplish something.: A volume made up of pages fastened along one edge and enclosed between protective covers. (from American Heritage Dictionary): An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The storing or preserving of video images to be displayed later.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91063, C37998, C37912, C16360, C74299, C18002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Physician counseling</VALIDVALUE>
          <VALUEMEANING>Physician Counseling</VALUEMEANING>
          <MEANINGDESCRIPTION>Physician; a licensed medical practitioner.: The act of receiving professional guidance in resolving personal conflicts and emotional problems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61547, C25741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypnosis/Acupuncture</VALIDVALUE>
          <VALUEMEANING>Hypnotherapy And Or Acupuncture Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Therapeutic use of hypnotism.  It has been used to treat phobias and anxiety, to manage pain, and to extinguish habits and addictions. (Taber&#39;s): An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The practice of piercing specific points on the body with very thin sterile needles in order to relieve pain or induce regional anesthesia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15176, C37998, C37912, C15420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Private therapy</VALIDVALUE>
          <VALUEMEANING>Private Behavioral Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>Not public; kept secret or restricted.: The use of operant conditioning, including rewards and punishments, in helping a person create an atmosphere where he or she does not contribute to painful stimuli.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15184, C54104</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buddy system</VALIDVALUE>
          <VALUEMEANING>Friend System</VALUEMEANING>
          <MEANINGDESCRIPTION>A person whom an individual knows, likes, and trusts. : a group of independent but interrelated elements comprising a unified whole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25700, C72884</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pamphlet</VALIDVALUE>
          <VALUEMEANING>Booklet</VALUEMEANING>
          <MEANINGDESCRIPTION>A small book, often having a paper cover.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94823</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Go to a stop smoking web site</VALIDVALUE>
          <VALUEMEANING>Smoking Cessation Web Site</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe.: A stopping.: A collection of web pages within a domain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67518, C61497, C17934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Call a telephone help line</VALIDVALUE>
          <VALUEMEANING>Telephone Assistance</VALUEMEANING>
          <MEANINGDESCRIPTION>Electronic equipment that converts sound into electrical signals that can be transmitted over distances and then converts received signals back into sounds.: The act of contributing to the fulfillment of a need or furtherance of an effort.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89271, C50212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Go to a stop smoking clinic or program</VALIDVALUE>
          <VALUEMEANING>Smoking Cessation Clinic Or Program</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe.: A stopping.: A facility that is devoted to the diagnosis and care of outpatients.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A broad framework of goals to be achieved.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52647, C37998, C51282, C61497, C17934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Switched to low tar cigarettes</VALIDVALUE>
          <VALUEMEANING>Change To Low Toxic Residue Cigarette</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of alteration or modification; changed or altered in form or character.: Used as a function word to indicate direction, purpose, or movement.: A minimum level or position or degree; less than normal in degree or intensity or amount.: Having to do with poison or something harmful to the body. Toxic substances usually cause unwanted side effects. : A single unit within a polymer; a recognizable molecular fragment embedded in a larger molecule.: Finely cut tobacco encased in a wrapper of thin paper and rolled for smoking.(NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1802, C48795, C28004, C54722, C65107, C25446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decrease the number of cigarettes smoked a day</VALIDVALUE>
          <VALUEMEANING>Reduced Number Cigarette Per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>Reduced; made less in size or amount or degree.: A numeral or string of numerals expressing value, quantity, or identification. (NCI): Finely cut tobacco encased in a wrapper of thin paper and rolled for smoking.(NCI): A frequency rate of occurrences of something within a period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66968, C1802, C0449788, C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276699</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quit on own</VALIDVALUE>
          <VALUEMEANING>Self Cessation</VALUEMEANING>
          <MEANINGDESCRIPTION>The individual as the object of his own reflective consciousness.: A stopping.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61497, C25200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you used any of these me</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you used any of these methods to stop smoking?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Health Survey </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259220</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Related Risks </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259229</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="242">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3286929</PUBLICID>
    <LONGNAME>Stage Prognostic Factor Derived American Joint Committee on Cancer Integer::7 Edition Post-treatment Stage Group Code</LONGNAME>
    <PREFERREDNAME>2689125v1.0:3285404v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>This field contains the numeric representation for the post-treatment AJCC 7th edition Stage Group and is derived from CS coded fields using the CS algorithm.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2689125</PublicId>
      <PreferredName>2688190v1.0:2689123v1.0</PreferredName>
      <PreferredDefinition>The AJCC &quot;Stage Group&quot; component that is derived from the CS detailed site-specific codes, using the CS from the CS algorithm effective with 2004 diagnosis.</PreferredDefinition>
      <LongName>Stage Prognostic Factor Derived Stage Group</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20047</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic or Prognostic Factor</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2688190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16899:C18959</PreferredName>
        <Version>1</Version>
        <LongName>Stage Prognostic Factor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18959</PREFERRED_NAME>
            <LONG_NAME>Prognostic Factor</LONG_NAME>
            <CON_ID>2512696</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2689123</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42885:C16899:C43359</PreferredName>
        <Version>1</Version>
        <LongName>Derived Stage Group</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42885</PREFERRED_NAME>
            <LONG_NAME>Derivation</LONG_NAME>
            <CON_ID>2231196</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43359</PREFERRED_NAME>
            <LONG_NAME>Group</LONG_NAME>
            <CON_ID>2236516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3285404</PublicId>
      <PreferredName>3285404v1.0</PreferredName>
      <PreferredDefinition>To take, obtain, or receive from a source; having been determined by mathematical computation._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._A number with no fractional part.::7_The form in which a text (especially a printed book) is published._Happening at a time subsequent to a reference time; later in time or order._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._Stage Grouping; an assessment based on the combined evaluation of the patient&#39;s T stage, M stage, and N stage. (caDSR)_A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Derived American Joint Committee on Cancer Integer::7 Edition Post Therapeutic Procedure Stage Grouping Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>3</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
      <Representation>
        <PublicId>3285403</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3285403v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Derived American Joint Committee on Cancer Integer::7 Edition Post Therapeutic Procedure Stage Grouping Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42885</PREFERRED_NAME>
            <LONG_NAME>Derivation</LONG_NAME>
            <CON_ID>2231196</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>7</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39315</PREFERRED_NAME>
            <LONG_NAME>American Joint Committee on Cancer</LONG_NAME>
            <CON_ID>2554142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62613</PREFERRED_NAME>
            <LONG_NAME>Edition</LONG_NAME>
            <CON_ID>2554148</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38027</PREFERRED_NAME>
            <LONG_NAME>Stage Grouping</LONG_NAME>
            <CON_ID>2230142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AJCC Coding Information</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>See the most current version of the Collaborative Stage Data Collection System (http://cancerstaging.org/cstage/manuals.html), for rules and site-specific codes and coding structures.</DocumentText>
        <URL>http://cancerstaging.org</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Derived Post-treatment AJCC-7</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Derived Post-treatment AJCC-7 Stage Group</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 12.1, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&amp;tabid=133&amp;mid=473</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Derived Post-Treatment Stage Grp Description</Name>
        <DocumentType>DESCRIPTION</DocumentType>
        <DocumentText>This data item belongs to the Collaborative Stage (CS) Data Collection System which is based on the AJCC Cancer Staging Manual, 6th and 7th editions. AJCC T, N, M plus descriptors and AJCC staging components are composed of combinations of characters, numbers, and/or special characters and can be of varying lengths. To more easily handle these components a numeric code was assigned to each unique category for each T, N, M plus descriptors and AJCC stage for 6th and 7th editions. This field contains the numeric representation for the post-treatment AJCC 7th edition &#39;Stage Group&#39; and is derived from CS coded fields using the CS algorithm. This numeric representation is referred to as the &#39;storage&#39; code and its associated label is referred to as the &#39;display&#39; code. Explanations of the &#39;storage&#39; codes and their corresponding &#39;display&#39; codes can be found in the most current version of the Collaborative Stage Data Collection System (http://cancerstaging.org/cstage/manuals.html). The display code should be used for display on the screen and in reports. Effective for cases diagnosed 2012+.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 16, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)</DocumentText>
        <URL>https://www.naaccr.org/data-standards-data-dictionary/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 12.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3134707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899833</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>StageProgFactors16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899845</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464305</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>StageProgFactors18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464319</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3492</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Derived PostRX 7 Stge Grp Storage Code</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DERIVED POSTRX-7 STGE GRP</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Derived PostRx-7 Stge Grp</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="243">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3303131</PUBLICID>
    <LONGNAME>Patient Oral Medication Administration Fasting Ability Ind-2</LONGNAME>
    <PREFERREDNAME>3303130v1.0:2018320v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._As pertains to a medication: ingest, inhale, instill, or inject._A drug or medicine that treats or prevents or alleviates the symptoms of disease._A systemic evaluation of the body and it&#39;s functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual&#39;s health assessment._Abstaining from food._Oral; of, or relating to, or affecting, or for use in the mouth._A drug or medicine that treats or prevents or alleviates the symptoms of disease._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine._Abstaining from food._The quality of being able to perform; a quality that permits or facilitates achievement or accomplishment ._the yes/no indicator related to the evaluation of the patient and patient&#39;s disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3303130</PublicId>
      <PreferredName>2233604v1.0:3303132v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._As pertains to a medication: ingest, inhale, instill, or inject._A drug or medicine that treats or prevents or alleviates the symptoms of disease._A systemic evaluation of the body and it&#39;s functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual&#39;s health assessment._Abstaining from food._Oral; of, or relating to, or affecting, or for use in the mouth._A drug or medicine that treats or prevents or alleviates the symptoms of disease._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine._Abstaining from food._The quality of being able to perform; a quality that permits or facilitates achievement or accomplishment .</PreferredDefinition>
      <LongName>Patient Oral Medication Administration Fasting Ability</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3303132</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3303132v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Oral Medication Administration Fasting Ability</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25311</PREFERRED_NAME>
            <LONG_NAME>Oral</LONG_NAME>
            <CON_ID>2204975</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63663</PREFERRED_NAME>
            <LONG_NAME>Fasting</LONG_NAME>
            <CON_ID>2555334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78209</PREFERRED_NAME>
            <LONG_NAME>Ability</LONG_NAME>
            <CON_ID>2798027</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is the patient able to take o</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the patient able to take oral medication and maintain a fast for 2 hours before and 1 hour after MLN8237 administration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0231D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104894</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3303130v1.0:2018320v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="244">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3359920</PUBLICID>
    <LONGNAME>Second Curettage Procedure Performed Date</LONGNAME>
    <PREFERREDNAME>3359914v1.0:2018550v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Coming next after the first in position in space or time or degree or magnitude._(kyoo-reh-TAHZH) Removal of tissue with a curette, a spoon-shaped instrument with a sharp edge._Performed; carried out._the date on which an observation was made or an event occurred.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3359914</PublicId>
      <PreferredName>3359912v1.0:2177693v1.0</PreferredName>
      <PreferredDefinition>Coming next after the first in position in space or time or degree or magnitude._(kyoo-reh-TAHZH) Removal of tissue with a curette, a spoon-shaped instrument with a sharp edge._Performed; carried out.</PreferredDefinition>
      <LongName>Second Curettage Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3359912</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25666:C15216</PreferredName>
        <Version>1</Version>
        <LongName>Second Curettage Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25666</PREFERRED_NAME>
            <LONG_NAME>Second</LONG_NAME>
            <CON_ID>2202591</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15216</PREFERRED_NAME>
            <LONG_NAME>Curettage Procedure</LONG_NAME>
            <CON_ID>2831356</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177693</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Performed</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0275</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104991</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3359914v1.0:2018550v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="245">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3380083</PUBLICID>
    <LONGNAME>Investigational Study Descriptive Text</LONGNAME>
    <PREFERREDNAME>3380059v1.0:2181231v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A textual description of an investigation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ISA-TAB-Nano:Investigation Study Assay Excel Table Format for Nanotechnology</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3380059</PublicId>
      <PreferredName>3380057v1.0:2322316v1.0</PreferredName>
      <PreferredDefinition>In the process of being studied; experimental.  (NCI)_A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it; the activities undertaken during a study._Identified; having the identity known or established.</PreferredDefinition>
      <LongName>Investigational Study Identification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2513925</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43431</PreferredName>
        <Version>1</Version>
        <LongName>Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3380057</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28041:C63536</PreferredName>
        <Version>1</Version>
        <LongName>Investigational Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28041</PREFERRED_NAME>
            <LONG_NAME>Investigational</LONG_NAME>
            <CON_ID>2422346</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2322316</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25737</PreferredName>
        <Version>1</Version>
        <LongName>Identified</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25737</PREFERRED_NAME>
            <LONG_NAME>Identification</LONG_NAME>
            <CON_ID>2203822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181231</PublicId>
      <PreferredName>DESCR_TXT</PreferredName>
      <PreferredDefinition>The text that provides a description of a topic.</PreferredDefinition>
      <LongName>Descriptive Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Investigation Description</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Investigation Description</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3354861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>nano-TAB</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ISA-TAB-Nano Version 1.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4286084</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3354861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>nano-TAB</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Investigation V1.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4286088</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3354861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>nano-TAB</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ISA-TAB-Nano Version 1.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4286095</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3354861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>nano-TAB</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Investigation V1.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4286100</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Investigation Description</AlternateName>
        <AlternateNameType>ISA-TAB-Nano Col Nm</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="246">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3420834</PUBLICID>
    <LONGNAME>Dental Patient  Retainer Device Component   Worse Orthodontic Braces Assessment Agreement Type</LONGNAME>
    <PREFERREDNAME>3420827v1.0:2489013v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The strength of the agreement of the participant&#39;s opinion that using a removable retainer is worse than using braces</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PRECEDENT CRF:Practice-based Research Collaborative in Evidence-Based Dentistry Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3420827</PublicId>
      <PreferredName>2714778v1.0:3420825v1.0</PreferredName>
      <PreferredDefinition>The participant&#39;s opinion that using a removable retainer is worse than using braces</PreferredDefinition>
      <LongName>Dental Patient  Retainer Device Component   Worse Orthodontic Braces Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2714778</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C16960</PreferredName>
        <Version>1</Version>
        <LongName>Dental Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3420825</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50144:C71686:C94550:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Retainer Device Component Worse Orthodontic Braces Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50144</PREFERRED_NAME>
            <LONG_NAME>Retainer Device</LONG_NAME>
            <CON_ID>3420764</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71686</PREFERRED_NAME>
            <LONG_NAME>Worse</LONG_NAME>
            <CON_ID>2721469</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94550</PREFERRED_NAME>
            <LONG_NAME>Orthodontic Braces</LONG_NAME>
            <CON_ID>3163104</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PRECEDENT CRF:Practice-based Research Collaborative in Evidence-Based Dentistry Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2489013</PublicId>
      <PreferredName>2489013v1.0</PreferredName>
      <PreferredDefinition>The text that describes the strength of agreement.</PreferredDefinition>
      <LongName>Agreement Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strongly Agree</VALIDVALUE>
          <VALUEMEANING>STRONGLY AGREE</VALUEMEANING>
          <MEANINGDESCRIPTION>STRONGLY AGREE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat Agree</VALIDVALUE>
          <VALUEMEANING>Somewhat Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat Agree</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neither agree nor disagree</VALIDVALUE>
          <VALUEMEANING>NEITHER AGREE NOR DISAGREE</VALUEMEANING>
          <MEANINGDESCRIPTION>NEITHER AGREE NOR DISAGREE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat Disagree</VALIDVALUE>
          <VALUEMEANING>somewhat disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>somewhat disagree</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strongly Disagree</VALIDVALUE>
          <VALUEMEANING>STRONGLY DISAGREE</VALUEMEANING>
          <MEANINGDESCRIPTION>STRONGLY DISAGREE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutral</VALIDVALUE>
          <VALUEMEANING>Neutral</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that a person has a neutral opinion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2902512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uncertain</VALIDVALUE>
          <VALUEMEANING>Uncertain</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3291262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Wearing my retainer(s) is wor</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Wearing my retainer(s) is worse than wearing my braces</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="247">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3421494</PUBLICID>
    <LONGNAME>Dental  Removable  Retainer Device Component  Difficulty  Sleep Assessment  Indicator</LONGNAME>
    <PREFERREDNAME>3421369v1.0:3421457v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The response of Yes or No or N/A to the difficulty a participant has in falling asleep or staying asleep due to the use of the removable retainer</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PRECEDENT CRF:Practice-based Research Collaborative in Evidence-Based Dentistry Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3421369</PublicId>
      <PreferredName>3421317v1.0:3421367v1.0</PreferredName>
      <PreferredDefinition>The difficulty a participant has in falling asleep or staying asleep due to the use of the removable retainer</PreferredDefinition>
      <LongName>Dental  Removable  Retainer Device Component  Difficulty  Sleep Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3421317</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C64250:C50144</PreferredName>
        <Version>1</Version>
        <LongName>Dental Removable Retainer Device Component</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64250</PREFERRED_NAME>
            <LONG_NAME>Removable</LONG_NAME>
            <CON_ID>2558027</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50144</PREFERRED_NAME>
            <LONG_NAME>Retainer Device</LONG_NAME>
            <CON_ID>3420764</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3421367</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62189:C73425:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Difficulty Sleep Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62189</PREFERRED_NAME>
            <LONG_NAME>Difficulty</LONG_NAME>
            <CON_ID>2503546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73425</PREFERRED_NAME>
            <LONG_NAME>Sleep</LONG_NAME>
            <CON_ID>2736838</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PRECEDENT CRF:Practice-based Research Collaborative in Evidence-Based Dentistry Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3421457</PublicId>
      <PreferredName>3421457v1.0</PreferredName>
      <PreferredDefinition>an indicator to a question regarding the participant&#39;s retainer use.</PreferredDefinition>
      <LongName>Dental Retainer Device Component  Use  Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PRECEDENT CRF:Practice-based Research Collaborative in Evidence-Based Dentistry Case Report Form</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I do not wear my retainer while sleeping</VALIDVALUE>
          <VALUEMEANING>I do not wear my retainer while sleeping</VALUEMEANING>
          <MEANINGDESCRIPTION>I do not wear my retainer while sleeping</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3421458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3006497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2889147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does wearing your removable r</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does wearing your removable retainer(s) at night make it more difficult to sleep</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="248">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3429202</PUBLICID>
    <LONGNAME>Dentist  Ethnic Group Ethnic Group Category</LONGNAME>
    <PREFERREDNAME>3427577v1.0:3186993v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>whether the dentist considers himself or herself to be Hispanic or Latino, Non-Hispanic or Latino, or doesn&#39;t know.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PRECEDENT CRF:Practice-based Research Collaborative in Evidence-Based Dentistry Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3427577</PublicId>
      <PreferredName>2443308v1.0:2388843v1.0</PreferredName>
      <PreferredDefinition>the dentist&#39;s self-declared cultural or ethnic origination.</PreferredDefinition>
      <LongName>Dentist Ethnic Group</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443308</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52654</PreferredName>
        <Version>1</Version>
        <LongName>Dentist</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52654</PREFERRED_NAME>
            <LONG_NAME>Dentist</LONG_NAME>
            <CON_ID>2443130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2388843</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16564</PreferredName>
        <Version>1</Version>
        <LongName>Ethnicity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16564</PREFERRED_NAME>
            <LONG_NAME>Ethnic Group</LONG_NAME>
            <CON_ID>2221860</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PRECEDENT CRF:Practice-based Research Collaborative in Evidence-Based Dentistry Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3186993</PublicId>
      <PreferredName>3186993v1.0</PreferredName>
      <PreferredDefinition>A social group characterized by a distinctive social and cultural tradition that is maintained from generation to generation. Members share a common history and origin and a sense of identification with the group. They have similar and distinctive features in their lifestyle habits and shared experiences. They often have a common genetic heritage which may be reflected in their experience of health and disease._Category; used informally to mean a class of things.</PreferredDefinition>
      <LongName>Ethnic Group Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008552</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PHYS_DESC_OF_INDS</PreferredName>
        <Version>1</Version>
        <LongName>Physical Description of Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2956811</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16564:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Ethnic Group Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16564</PREFERRED_NAME>
            <LONG_NAME>Ethnic Group</LONG_NAME>
            <CON_ID>2221860</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination that a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hispanic or Latino</VALIDVALUE>
          <VALUEMEANING>Hispanic or Latino</VALUEMEANING>
          <MEANINGDESCRIPTION>A person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. The term, &quot;Spanish origin,&quot; can be used in addition to &quot;Hispanic or Latino.&quot; (OMB)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Hispanic or Latino</VALIDVALUE>
          <VALUEMEANING>Not Hispanic or Latino</VALUEMEANING>
          <MEANINGDESCRIPTION>A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not reported</VALIDVALUE>
          <VALUEMEANING>Not Reported</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572578</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Ethnicity</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Ethnicity</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="249">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3431182</PUBLICID>
    <LONGNAME>Corticosteroid Administered Ind-2</LONGNAME>
    <PREFERREDNAME>RECVDCS</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator related to the administration of corticosteroids to the patient.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3431181</PublicId>
      <PreferredName>CORTICO_ADM</PreferredName>
      <PreferredDefinition>The administration of corticosteroids to the patient.</PreferredDefinition>
      <LongName>Corticosteroid Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2452713</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2322</PreferredName>
        <Version>1</Version>
        <LongName>Corticosteroid</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2322</PREFERRED_NAME>
            <LONG_NAME>Corticosteroid</LONG_NAME>
            <CON_ID>2202884</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the patient received cort</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the patient received corticosteroids (since the patient&#39;s last clinical assessment)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient need daily corticosteroids (with the exception of prednisone &lt; 20 mg equivalent dose daily)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient received corticosteroids?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient receiving corticosteroids?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient off corticosteroids?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="250">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3435159</PUBLICID>
    <LONGNAME>Biopsy Post Chemoradiotherapy Performed Ind-2</LONGNAME>
    <PREFERREDNAME>Biop_Post_Chem_Perf_DX_IND-2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to information related to the removal and pathologic examination of specimens in the form of small pieces of tissue from the living body occuring after treatment that combines chemotherapy with radiation therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3435151</PublicId>
      <PreferredName>Biop_Post_Chem_Perf</PreferredName>
      <PreferredDefinition>information related to the removal and pathologic examination of specimens in the form of small pieces of tissue from the living body occuring after treatment that combines chemotherapy with radiation therapy</PreferredDefinition>
      <LongName>Biopsy Post Chemoradiotherapy Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2187705</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15189</PreferredName>
        <Version>1</Version>
        <LongName>Biopsy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15189</PREFERRED_NAME>
            <LONG_NAME>Biopsy Procedure</LONG_NAME>
            <CON_ID>2202502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3435149</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38008:C94626:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Post Chemoradiotherapy Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94626</PREFERRED_NAME>
            <LONG_NAME>Chemoradiotherapy</LONG_NAME>
            <CON_ID>3432773</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a biopsy performed after</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was a biopsy performed after the completion of chemoradiation?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0279</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104996</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Biop_Post_Chem_Perf_DX_IND-2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="251">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3436204</PUBLICID>
    <LONGNAME>Material Characteristic Value Identification Term Accession Number</LONGNAME>
    <PREFERREDNAME>3421643v1.0:3377626v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Identification number of a term selected from an ontology or a controlled vocabulary, if the term is entered as a value for Material Characteristic Value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ISA-TAB-Nano:Investigation Study Assay Excel Table Format for Nanotechnology</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3421643</PublicId>
      <PreferredName>2640427v1.0:3421641v1.0</PreferredName>
      <PreferredDefinition>The tangible substance that goes into the makeup of a physical object._Characteristics; distinguishing qualities of a person, object, or substance._A numerical quantity measured or assigned or computed._The procedure of having an identity established.</PreferredDefinition>
      <LongName>Material Characteristic Value Identification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2640427</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48187</PreferredName>
        <Version>1</Version>
        <LongName>Material</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48187</PREFERRED_NAME>
            <LONG_NAME>Material</LONG_NAME>
            <CON_ID>2514541</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3421641</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25447:C25712:C25737</PreferredName>
        <Version>1</Version>
        <LongName>Characteristic Value Identification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25447</PREFERRED_NAME>
            <LONG_NAME>Characteristic</LONG_NAME>
            <CON_ID>2203874</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25737</PREFERRED_NAME>
            <LONG_NAME>Identification</LONG_NAME>
            <CON_ID>2203822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3377626</PublicId>
      <PreferredName>3377626v1.0</PreferredName>
      <PreferredDefinition>A word or expression used for some particular thing._A control number unique to an object, used to identify it among the other objects in a collection._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.</PreferredDefinition>
      <LongName>Term Accession Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISA-TAB-Nano:Investigation Study Assay Excel Table Format for Nanotechnology</Origin>
      <Representation>
        <PublicId>3377625</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45559:C25402:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Term Accession Number Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45559</PREFERRED_NAME>
            <LONG_NAME>Term</LONG_NAME>
            <CON_ID>2417435</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25402</PREFERRED_NAME>
            <LONG_NAME>Accession Number</LONG_NAME>
            <CON_ID>2203569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Characteristics Value Term Ac</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Characteristics Value Term Accession Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3354861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>nano-TAB</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ISA-TAB-Nano Version 1.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4286084</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3354861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>nano-TAB</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ISA-TAB-Nano Version 1.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4286095</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3354861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>nano-TAB</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Material V1.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4286097</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3354861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>nano-TAB</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Material V1.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4286102</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Characteristics Value Term Accession Number</AlternateName>
        <AlternateNameType>ISA-TAB-Nano Col Nm</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="252">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3436825</PUBLICID>
    <LONGNAME>Laboratory Procedure Albumin Result Ind-3</LONGNAME>
    <PREFERREDNAME>LAB_ALB_RSLT_ASSESS_IND-3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator related to assessment of the information related to the medical procedure that involves testing a sample of blood for albumin, the main protein in blood plasma.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>GOG CRF:Gynecologic Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189859</PublicId>
      <PreferredName>LAB_ALB_RSLT</PreferredName>
      <PreferredDefinition>information related to the medical procedure that involves testing a sample of blood for albumin, the main protein in blood plasma.</PreferredDefinition>
      <LongName>Laboratory Procedure Albumin Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738811</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C214:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Albumin Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C214</PREFERRED_NAME>
            <LONG_NAME>Albumin</LONG_NAME>
            <CON_ID>2202544</CON_ID>
            <DEFINITION_SOURCE>CSP2002</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was serum albumin drawn at th</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was serum albumin drawn at the visit?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0244</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104884</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0244</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000340</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0244</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000341</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_ALB_RSLT_ASSESS_IND-3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="253">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3448116</PUBLICID>
    <LONGNAME>Patient Refractory Inappropriate Transarterial Chemoembolization Drug-eluting Embolic Bead Clinical Trial Eligibility Criteria  Ind-2</LONGNAME>
    <PREFERREDNAME>3448114v1.0:2018257v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The Yes/No indicator that asks whetherthe patient is unsuitable ;for refractory chemoembolization or  drug eluding beads</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3448114</PublicId>
      <PreferredName>2233604v1.0:3448112v1.0</PreferredName>
      <PreferredDefinition>Information related to prior treatment for eligibility purposes</PreferredDefinition>
      <LongName>Patient Refractory Inappropriate Transarterial Chemoembolization Drug-eluting Embolic Bead Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3448112</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3448112v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Refractory Inappropriate Transarterial Chemoembolization Drug-eluting Embolic Bead Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38014</PREFERRED_NAME>
            <LONG_NAME>Refractory</LONG_NAME>
            <CON_ID>2205322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C74958</PREFERRED_NAME>
            <LONG_NAME>Inappropriate</LONG_NAME>
            <CON_ID>2782641</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C101514</PREFERRED_NAME>
            <LONG_NAME>Transarterial</LONG_NAME>
            <CON_ID>3447874</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15752</PREFERRED_NAME>
            <LONG_NAME>Chemoembolization</LONG_NAME>
            <CON_ID>3138177</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C97232</PREFERRED_NAME>
            <LONG_NAME>Drug-eluting Embolic Bead</LONG_NAME>
            <CON_ID>3444455</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Unsuitable for or refractory</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Unsuitable for or refractory to TACE or drug eluding beads</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Unsuitable for or refractory to TACE or drug eluting beads</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1112</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104993</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3448114v1.0:2018257v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="254">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3474305</PUBLICID>
    <LONGNAME>Patient Iobenguane Positive Finding Malignant Neoplasm Personal Medical History Ind-2</LONGNAME>
    <PREFERREDNAME>PvUptakeMIBGPse</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator related to a patient&#39;s history of MIBG (Iobenguane) positive tumors.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3474304</PublicId>
      <PreferredName>2233604v1.0:3474302v1.0</PreferredName>
      <PreferredDefinition>information related to patient&#39;s history of MIBG (Iobenguane) positive tumors.</PreferredDefinition>
      <LongName>Patient Iobenguane Positive Finding Malignant Neoplasm Personal Medical History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3474302</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C87757:C38758:C9305:C18772</PreferredName>
        <Version>1</Version>
        <LongName>Iobenguane Positive Finding Malignant Neoplasm Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C87757</PREFERRED_NAME>
            <LONG_NAME>Iobenguane</LONG_NAME>
            <CON_ID>3264701</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38758</PREFERRED_NAME>
            <LONG_NAME>Positive Finding</LONG_NAME>
            <CON_ID>2516404</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Positive uptake by MIBG scan</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Positive uptake by MIBG scan in at least one site at study enrollment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was scan determined to be MIBG Avid</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have evidence of MIBG avid disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have evaluable disease on MIBG scan?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have MIBG-avid evaluable disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_TEXT_6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have MIBG positive evaluable disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was disease determined to be MIBG avid?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have MIBG-avid disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase 1/Pilot Consortium</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3303197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>MIBGAvidDtmn</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="255">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3475304</PUBLICID>
    <LONGNAME>Patient Telephone First Attempt Communication Contact Follow-up Date</LONGNAME>
    <PREFERREDNAME>3475303v1.0:2018550v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The date of the first attempt to contact a patient over the telephone.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>SWOG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3475303</PublicId>
      <PreferredName>2233604v1.0:3475301v1.0</PreferredName>
      <PreferredDefinition>The first attempt to contact a patient over the telephone.</PreferredDefinition>
      <LongName>Patient Telephone First Attempt Communication Contact Follow-up</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SWOG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008544</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TELECOMMUNICATIONS</PreferredName>
        <Version>1</Version>
        <LongName>Telecommunications</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3475301</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3475301v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Telephone First Attempt Communication Contact Follow-up</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50212</PREFERRED_NAME>
            <LONG_NAME>Telephone Device</LONG_NAME>
            <CON_ID>3187018</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39769</PREFERRED_NAME>
            <LONG_NAME>Attempt</LONG_NAME>
            <CON_ID>2203722</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47954</PREFERRED_NAME>
            <LONG_NAME>Communication Contact</LONG_NAME>
            <CON_ID>2427513</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16033</PREFERRED_NAME>
            <LONG_NAME>Follow-Up</LONG_NAME>
            <CON_ID>2202303</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Phone Contact #1</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Phone Contact #1</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Phone Call #1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Phone Call #1</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CALL1DT</AlternateName>
        <AlternateNameType>OID, SWOG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3475303v1.0:2018550v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="256">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3515477</PUBLICID>
    <LONGNAME>Alcohol History 3 Beverage Per Day Consumption Indicator</LONGNAME>
    <PREFERREDNAME>3515474v1.0:2181608v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Yes/No indicator to signify a history of alcohol use of at least 3 alcoholic drinks per day.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3515474</PublicId>
      <PreferredName>3515471v1.0:3515472v1.0</PreferredName>
      <PreferredDefinition>The aggregate of past events; the continuum of events occurring in succession leading from the past to the present; a record or narrative description of past events._The use of alcoholic beverages to excess, either on individual occasions (&quot;binge drinking&quot;) or as a regular practice._A number with no fractional part, including the negative and positive numbers as well as zero.::3_A drink, including beer, wine or liquor, that is made by fermentation of raw materials. An alcoholic beverage contains ethanol (alcohol) as the active ingredient._A frequency rate of occurrences of something within a period of time equal to twenty-four hours._The bodily process of taking in and using up something, especially the eating or drinking of something.</PreferredDefinition>
      <LongName>Alcohol Abuse History 3 Beverage Per Day Consumption</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3515471</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20701:C54625</PreferredName>
        <Version>1</Version>
        <LongName>Alcohol Abuse History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20701</PREFERRED_NAME>
            <LONG_NAME>Alcohol Abuse</LONG_NAME>
            <CON_ID>2820806</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54625</PREFERRED_NAME>
            <LONG_NAME>History</LONG_NAME>
            <CON_ID>2519676</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3515472</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45255::3:C45902:C66968:C66715</PreferredName>
        <Version>1</Version>
        <LongName>Integer::3 Alcoholic Beverage Per Day Consumption</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::3</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45902</PREFERRED_NAME>
            <LONG_NAME>Alcoholic Beverage</LONG_NAME>
            <CON_ID>2782639</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66968</PREFERRED_NAME>
            <LONG_NAME>Per Day</LONG_NAME>
            <CON_ID>3170133</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66715</PREFERRED_NAME>
            <LONG_NAME>Consumption</LONG_NAME>
            <CON_ID>2635725</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>caBIG:Cancer Biomedical Informatics Grid</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181608</PublicId>
      <PreferredName>Y_N_CHAR_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Character Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>History of excessive alcohol</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>History of excessive alcohol abuse, defined by a habitual intake of more than three drinks daily</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="257">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3534752</PUBLICID>
    <LONGNAME>Person Full Term Birth Pregnancy Outcome Yes No Indicator</LONGNAME>
    <PREFERREDNAME>Pers_Full_Preg_Outc_YES_NO_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator related to the full-term birth, gestation greater than 37 weeks, as an outcome of pregnancy, a condition of having a developing embryo or fetus in human female.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>GOG CRF:Gynecologic Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3534751</PublicId>
      <PreferredName>Pers_Full_Preg_Outc</PreferredName>
      <PreferredDefinition>information related to the full-term birth, gestation greater than 37 weeks, as an outcome of pregnancy, a condition of having a developing embryo or fetus in human female.</PreferredDefinition>
      <LongName>Person Full Term Birth Pregnancy Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3534749</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C89887:C25742:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Full Term Neonatal Stage Pregnancy Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C89887</PREFERRED_NAME>
            <LONG_NAME>Full Term Neonatal Stage</LONG_NAME>
            <CON_ID>3534748</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25742</PREFERRED_NAME>
            <LONG_NAME>Pregnancy</LONG_NAME>
            <CON_ID>2202906</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>GOG CRF:Gynecologic Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Full-term Delivery:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Full-term Delivery:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0278</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4058120</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Pers_Full_Preg_Outc_YES_NO_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="258">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3567334</PUBLICID>
    <LONGNAME>Hematopoietic Cell Graft Type Indicator</LONGNAME>
    <PREFERREDNAME>2542273v2.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not a particular hematopoietic cell product (graft) was infused.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2542273</PublicId>
      <PreferredName>2531884v1.0:2223243v1.0</PreferredName>
      <PreferredDefinition>Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Hematopoietic Cell Graft Type</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435011</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12219</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Structure, System, or Substance</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2531884</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12551:C12981</PreferredName>
        <Version>1</Version>
        <LongName>Hematopoietic Stem Cell Transplant</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a particular hematopoieti</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was a particular hematopoietic cell transplant type used?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a particular hematopoietic stem cell transplant type used?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was a particular hematopoietic stem cell transplant type used?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Bone marrow</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Bone marrow</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBSC</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>PBSC</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Single cord blood unit</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Single cord blood unit</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Multiple cord blood units</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Multiple cord blood units</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other product</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other product</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2110r1: Acute Myelogenous Leukemia Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964903</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2111r1: All Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2122r1: Testicular / Germ Cell Cancer Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2010r1: Acute Myelogenous Leukemia Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964927</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2011r1: ALL Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964928</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2039r1: Hemophagocytic Lymphohistiocytosis Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3279244</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_KEY_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_KEY_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_KEY_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_KEY_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_KEY_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_KEY_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_KEY_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_KEY_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>key_prod_type_crd</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>key_prod_type_crdmult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>key_prod_type_mar</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>key_prod_type_othr</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Hematopoietic Stem Cell Graft Type Indicator</AlternateName>
        <AlternateNameType>System-Generated</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>hla_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>hla_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>hla_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>hla_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>hla_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_key_prod_type_ucb</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_key_hct_type_allo_related</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpre_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpre_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpre_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpre_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpre_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpost_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpost_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpost_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpost_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpost_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpre_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpre_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpre_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpre_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpre_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>death_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>death_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>death_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>death_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>death_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_KEY_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_KEY_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_KEY_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_KEY_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_KEY_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GVHDsup_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GVHDsup_Key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GVHDsup_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GVHDsup_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GVHDsup_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpost_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpost_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpost_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpost_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpost_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpre_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpre_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpre_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpre_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpre_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpost_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpost_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpost_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpost_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpost_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpre_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpre_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpre_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpre_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpre_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpost_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpost_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpost_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpost_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpost_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpre_key_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpre_key_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpre_key_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpre_key_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpre_key_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_KEY_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_KEY_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_KEY_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_KEY_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_KEY_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_KEY_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_KEY_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_KEY_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_KEY_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_KEY_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_KEY_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_KEY_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_KEY_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_KEY_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_KEY_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_KEY_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_KEY_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMSMF_KEY_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMSMF_KEY_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMSMF_KEY_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMSMF_KEY_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMSMF_KEY_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMSMP_KEY_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMSMP_KEY_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMSMP_KEY_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMSMP_KEY_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMSMP_KEY_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_KEY_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_KEY_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_KEY_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_KEY_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_KEY_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_KEY_prod_type_bm</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_KEY_prod_type_cbu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_KEY_prod_type_cbumult</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_KEY_prod_type_oth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_KEY_prod_type_pbsc</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="259">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3577271</PUBLICID>
    <LONGNAME>Adverse Event Mild Adverse Event Grade Occurrence Yes No Indicator</LONGNAME>
    <PREFERREDNAME>Adve_Mild_Grad_Occu_YES_NO_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator regarding information related to an experience that is usually transient, and requires no special treatment or intervention. The event does not generally interfere with usual daily activities. Includes transient laboratory test alterations(Grade 1 CTCAEv4.0). See NCI Common Terminology Criteria for Adverse Events.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>GOG CRF:Gynecologic Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3577260</PublicId>
      <PreferredName>Adve_Mild_Grad_Occu</PreferredName>
      <PreferredDefinition>information related to an experience that is usually transient, and requires no special treatment or intervention. The event does not generally interfere with usual daily activities. Includes transient laboratory test alterations(Grade 1 CTCAEv4.0). See NCI Common Terminology Criteria for Adverse Events.</PreferredDefinition>
      <LongName>Adverse Event Mild Adverse Event Grade Occurrence</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2235992</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3589651</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41338:C48309:C25275</PreferredName>
        <Version>1</Version>
        <LongName>Mild Adverse Event Grade Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41338</PREFERRED_NAME>
            <LONG_NAME>Mild Adverse Event</LONG_NAME>
            <CON_ID>2389414</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>GOG CRF:Gynecologic Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Adverse Event Grade 1</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Adverse Event Grade 1</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0278</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4058120</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229L</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229N</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229O</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104892</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0286B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104901</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104930</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104941</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0279</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104996</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000275</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000276</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000705</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Adve_Mild_Grad_Occu_YES_NO_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="260">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3587220</PUBLICID>
    <LONGNAME>Cardiovascular Disease Medical History Indicator</LONGNAME>
    <PREFERREDNAME>2760237v1.0:3587217v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Yes/no/unknown indicator to signify a medical history of Cardiovascular Disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2760237</PublicId>
      <PreferredName>2760235v1.0:2239981v1.0</PreferredName>
      <PreferredDefinition>A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels).  Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension.  Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma. -- 2003_The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</PreferredDefinition>
      <LongName>Cardiovascular Disorder Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2760235</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2931</PreferredName>
        <Version>1</Version>
        <LongName>Cardiovascular Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2931</PREFERRED_NAME>
            <LONG_NAME>Cardiovascular Disorder</LONG_NAME>
            <CON_ID>2495378</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239981</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3587217</PublicId>
      <PreferredName>3587217v1.0</PreferredName>
      <PreferredDefinition>Yes/no/unknonw indicator of an account of all medical events and problems a person has experienced.</PreferredDefinition>
      <LongName>Personal Medical History Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3587216</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18772:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Personal Medical History Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cardiovascular Disease</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cardiovascular Disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_TEXT_1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have known cardiac disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ABTC-1601</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have significant cardiac disease or abnormality?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have a significant cardiovascular or cerebrovascular disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_TEXT_2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have a history of the indicated cardiac disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ABTC 1701</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient at risk of QTc induced arrhythmias or uncontrolled or significant cardiovascular disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have significant cardiovascular disease as defined in the protocol?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have a history of cardiovascular disease prior to enrollment on AHOD1331?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4280691</PublicId>
          <ContextName>ABTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Checklist</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4280724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ABTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ABTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HxIndCdcDsz</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="261">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3600140</PUBLICID>
    <LONGNAME>Annotation Collection Description ISO21090.ST.v1.0</LONGNAME>
    <PREFERREDNAME>3599663v1.0:2803207v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A set of annotations, or comments about an idea, subject or item._A statement or an account describing something._Character string datatype stands for text data.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3599663</PublicId>
      <PreferredName>3599524v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>A set of annotations, or comments about an idea, subject or item._A statement or an account describing something.</PreferredDefinition>
      <LongName>Annotation Collection Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3599524</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C101123</PreferredName>
        <Version>1</Version>
        <LongName>Annotation Collection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C101123</PREFERRED_NAME>
            <LONG_NAME>Annotation Collection</LONG_NAME>
            <CON_ID>3419458</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803207</PublicId>
      <PreferredName>2803207v1.0</PreferredName>
      <PreferredDefinition>Character string datatype stands for text data.</PreferredDefinition>
      <LongName>ISO21090.ST.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090STv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Annotation Collection Description ISO21090.ST.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Annotation Collection Description ISO21090.ST.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000057</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3599505</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM FM</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.AnnotationCollection.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AnnotationCollection:description</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="262">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3600265</PUBLICID>
    <LONGNAME>Image Plane Row Image Orientation Y-Coordinate ISO21090.REAL.v1.0</LONGNAME>
    <PREFERREDNAME>3599738v1.0:2803201v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The position and orientation of the image slice relative to the patient-based coordinate system._An arrangement of objects side by side in a line.:Any record of an imaging event whether physical or electronic.:Position or alignment relative to points of the compass or other specific directions.:A vertical coordinate that is used together with a horizontal coordinate to specify an exact point in space._Fractional numbers represented by decimals.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3599738</PublicId>
      <PreferredName>3499317v1.0:3599634v1.0</PreferredName>
      <PreferredDefinition>The position and orientation of the image slice relative to the patient-based coordinate system._An arrangement of objects side by side in a line.:Any record of an imaging event whether physical or electronic.:Position or alignment relative to points of the compass or other specific directions.:A vertical coordinate that is used together with a horizontal coordinate to specify an exact point in space.</PreferredDefinition>
      <LongName>Image Plane Row Image Orientation Y-Coordinate</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3499317</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102516</PreferredName>
        <Version>1</Version>
        <LongName>Image Plane</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102516</PREFERRED_NAME>
            <LONG_NAME>Image Plane</LONG_NAME>
            <CON_ID>3479213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3599634</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43378:C48179:C45788:C44478</PreferredName>
        <Version>1</Version>
        <LongName>Row Image Orientation Y-Coordinate</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43378</PREFERRED_NAME>
            <LONG_NAME>Row</LONG_NAME>
            <CON_ID>2236514</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45788</PREFERRED_NAME>
            <LONG_NAME>Spatial Orientation</LONG_NAME>
            <CON_ID>2236529</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44478</PREFERRED_NAME>
            <LONG_NAME>Y-Coordinate</LONG_NAME>
            <CON_ID>2236520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803201</PublicId>
      <PreferredName>2803201v1.0</PreferredName>
      <PreferredDefinition>Fractional numbers represented by decimals.</PreferredDefinition>
      <LongName>ISO21090.REAL.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090REALv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Image Plane Row Image Orientation Y-Coordinate ISO21090.REAL.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Image Plane Row Image Orientation Y-Coordinate ISO21090.REAL.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000057</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3599505</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM FM</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.ImagePlane.rowImageOrientationY</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ImagePlane:rowImageOrientationY</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="263">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3600268</PUBLICID>
    <LONGNAME>Image Plane Column Image Orientation Y-Coordinate ISO21090.REAL.v1.0</LONGNAME>
    <PREFERREDNAME>3599741v1.0:2803201v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The position and orientation of the image slice relative to the patient-based coordinate system._An arrangement of objects one under another in a line.:Any record of an imaging event whether physical or electronic.:Position or alignment relative to points of the compass or other specific directions.:A vertical coordinate that is used together with a horizontal coordinate to specify an exact point in space._Fractional numbers represented by decimals.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3599741</PublicId>
      <PreferredName>3499317v1.0:3599637v1.0</PreferredName>
      <PreferredDefinition>The position and orientation of the image slice relative to the patient-based coordinate system._An arrangement of objects one under another in a line.:Any record of an imaging event whether physical or electronic.:Position or alignment relative to points of the compass or other specific directions.:A vertical coordinate that is used together with a horizontal coordinate to specify an exact point in space.</PreferredDefinition>
      <LongName>Image Plane Column Image Orientation Y-Coordinate</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3499317</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102516</PreferredName>
        <Version>1</Version>
        <LongName>Image Plane</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102516</PREFERRED_NAME>
            <LONG_NAME>Image Plane</LONG_NAME>
            <CON_ID>3479213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3599637</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43379:C48179:C45788:C44478</PreferredName>
        <Version>1</Version>
        <LongName>Column Image Orientation Y-Coordinate</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43379</PREFERRED_NAME>
            <LONG_NAME>Column</LONG_NAME>
            <CON_ID>2236513</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45788</PREFERRED_NAME>
            <LONG_NAME>Spatial Orientation</LONG_NAME>
            <CON_ID>2236529</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44478</PREFERRED_NAME>
            <LONG_NAME>Y-Coordinate</LONG_NAME>
            <CON_ID>2236520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803201</PublicId>
      <PreferredName>2803201v1.0</PreferredName>
      <PreferredDefinition>Fractional numbers represented by decimals.</PreferredDefinition>
      <LongName>ISO21090.REAL.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090REALv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Image Plane Column Image Orientation Y-Coordinate ISO21090.REAL.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Image Plane Column Image Orientation Y-Coordinate ISO21090.REAL.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000057</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3599505</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM FM</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.ImagePlane.columnImageOrientationY</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ImagePlane:columnImageOrientationY</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="264">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3600307</PUBLICID>
    <LONGNAME>Inference Entity Person Observer Statistical Confidence ISO21090.REAL.v1.0</LONGNAME>
    <PREFERREDNAME>3599764v1.0:2803201v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The process by which conclusions are derived from stated facts by the application of logical rules.:An independently existing thing (living or nonliving)._Human observer created the observations.:The statistical calculation of the percentage likelihood for a given set of data to have a given statistical value._Fractional numbers represented by decimals.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3599764</PublicId>
      <PreferredName>3599589v1.0:2969217v1.0</PreferredName>
      <PreferredDefinition>The process by which conclusions are derived from stated facts by the application of logical rules.:An independently existing thing (living or nonliving)._Human observer created the observations.:The statistical calculation of the percentage likelihood for a given set of data to have a given statistical value.</PreferredDefinition>
      <LongName>Inference Entity Person Observer Statistical Confidence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3599589</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C75591:C51070</PreferredName>
        <Version>1</Version>
        <LongName>Inference Entity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C75591</PREFERRED_NAME>
            <LONG_NAME>Inference</LONG_NAME>
            <CON_ID>2790011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2969217</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C69245:C49020</PreferredName>
        <Version>1</Version>
        <LongName>Person Observer Statistical Confidence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C69245</PREFERRED_NAME>
            <LONG_NAME>Person Observer</LONG_NAME>
            <CON_ID>2684119</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49020</PREFERRED_NAME>
            <LONG_NAME>Statistical Confidence</LONG_NAME>
            <CON_ID>2451923</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803201</PublicId>
      <PreferredName>2803201v1.0</PreferredName>
      <PreferredDefinition>Fractional numbers represented by decimals.</PreferredDefinition>
      <LongName>ISO21090.REAL.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090REALv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Inference Entity Person Observer Statistical Confidence ISO21090.REAL.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Inference Entity Person Observer Statistical Confidence ISO21090.REAL.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000057</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3599505</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM FM</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>InferenceEntity:annotatorConfidence</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.InferenceEntity.annotatorConfidence</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="265">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3600367</PUBLICID>
    <LONGNAME>Annotation Annotation Statement Subject Unique Identifier ISO21090.II.v1.0</LONGNAME>
    <PREFERREDNAME>3599837v1.0:2803193v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An explanatory or critical comment, or other in-context information (e.g., pattern, motif, link), that has been associated with data or other types of information.:An explanatory or critical comment, or other in-context information (e.g., pattern, motif, link), that has been associated with data or other types of information.:A verbal and/or written message that asserts, affirms, or declares something._Some matter, situation, or event that is thought about, written about, or discussed.:A set of characters used as a code that is unique in the context or the system for which it is created. It serves as a means of identification and reference (often instead of a name) for an entity, person, thing, function, procedure, activity, variable, or body of data._Identifier that uniquely identifies a thing or object.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3599837</PublicId>
      <PreferredName>3599597v1.0:3599616v1.0</PreferredName>
      <PreferredDefinition>An explanatory or critical comment, or other in-context information (e.g., pattern, motif, link), that has been associated with data or other types of information.:An explanatory or critical comment, or other in-context information (e.g., pattern, motif, link), that has been associated with data or other types of information.:A verbal and/or written message that asserts, affirms, or declares something._Some matter, situation, or event that is thought about, written about, or discussed.:A set of characters used as a code that is unique in the context or the system for which it is created. It serves as a means of identification and reference (often instead of a name) for an entity, person, thing, function, procedure, activity, variable, or body of data.</PreferredDefinition>
      <LongName>Annotation Annotation Statement Subject Unique Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3599597</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C44272:C44272:C49154</PreferredName>
        <Version>1</Version>
        <LongName>Annotation Annotation Statement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44272</PREFERRED_NAME>
            <LONG_NAME>Annotation</LONG_NAME>
            <CON_ID>2519066</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44272</PREFERRED_NAME>
            <LONG_NAME>Annotation</LONG_NAME>
            <CON_ID>2519066</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49154</PREFERRED_NAME>
            <LONG_NAME>Statement</LONG_NAME>
            <CON_ID>2489008</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3599616</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48910:C70663</PreferredName>
        <Version>1</Version>
        <LongName>Subject Unique Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48910</PREFERRED_NAME>
            <LONG_NAME>Subject</LONG_NAME>
            <CON_ID>2553605</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70663</PREFERRED_NAME>
            <LONG_NAME>Unique Identifier</LONG_NAME>
            <CON_ID>2714899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803193</PublicId>
      <PreferredName>2803193v1.0</PreferredName>
      <PreferredDefinition>Identifier that uniquely identifies a thing or object.</PreferredDefinition>
      <LongName>ISO21090.II.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090IIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Annotation Annotation Statement Subject Unique Identifier ISO21090.II.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Annotation Annotation Statement Subject Unique Identifier ISO21090.II.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000057</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3599505</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM FM</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AnnotationOfAnnotationStatement:subjectUniqueIdentifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.AnnotationOfAnnotationStatement.subjectUniqueIdentifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="266">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3600654</PUBLICID>
    <LONGNAME>Dimension Polygon Ring Flag ISO21090.BL.v1.0</LONGNAME>
    <PREFERREDNAME>3600113v1.0:2803169v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The spatial outline of an object as described by the configuration of straight or curved lines.:A closed plane figure bounded by straight sides._Doughnut-shaped object or surface generated by rotating a circle around an axis that does not intersect the circle; any object that resembles a ring.:An indicator that can be set or unset in order to signal whether a particular condition is true._Values of two-valued logic.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3600113</PublicId>
      <PreferredName>3599555v1.0:2750165v1.0</PreferredName>
      <PreferredDefinition>The spatial outline of an object as described by the configuration of straight or curved lines.:A closed plane figure bounded by straight sides._Doughnut-shaped object or surface generated by rotating a circle around an axis that does not intersect the circle; any object that resembles a ring.:An indicator that can be set or unset in order to signal whether a particular condition is true.</PreferredDefinition>
      <LongName>Dimension Polygon Ring Flag</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3599555</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25483:C73492</PreferredName>
        <Version>1</Version>
        <LongName>Dimension Polygon</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25483</PREFERRED_NAME>
            <LONG_NAME>Dimension</LONG_NAME>
            <CON_ID>2203908</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73492</PREFERRED_NAME>
            <LONG_NAME>Polygon</LONG_NAME>
            <CON_ID>2747422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2750165</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61458:C43578</PreferredName>
        <Version>1</Version>
        <LongName>Ring Flag</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61458</PREFERRED_NAME>
            <LONG_NAME>Ring</LONG_NAME>
            <CON_ID>2750138</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43578</PREFERRED_NAME>
            <LONG_NAME>Flag</LONG_NAME>
            <CON_ID>2223213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803169</PublicId>
      <PreferredName>2803169v1.0</PreferredName>
      <PreferredDefinition>Values of two-valued logic.</PreferredDefinition>
      <LongName>ISO21090.BL.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090BLv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Dimension Polygon Ring Flag ISO21090.BL.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Dimension Polygon Ring Flag ISO21090.BL.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3599505</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM FM</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.ThreeDimensionPolygon.includeFlag</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ThreeDimensionPolygon:includeFlag</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="267">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3600656</PUBLICID>
    <LONGNAME>Dimension Polygon Line Opacity ISO21090.ST.v1.0</LONGNAME>
    <PREFERREDNAME>3600115v1.0:2803207v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The spatial outline of an object as described by the configuration of straight or curved lines.:A closed plane figure bounded by straight sides._A mark that is long relative to its width; a length (straight or curved) without breadth or thickness; the trace of a moving point.:The quality of being opaque to a degree; the degree to which something reduces the passage of light._Character string datatype stands for text data.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3600115</PublicId>
      <PreferredName>3599555v1.0:2750162v1.0</PreferredName>
      <PreferredDefinition>The spatial outline of an object as described by the configuration of straight or curved lines.:A closed plane figure bounded by straight sides._A mark that is long relative to its width; a length (straight or curved) without breadth or thickness; the trace of a moving point.:The quality of being opaque to a degree; the degree to which something reduces the passage of light.</PreferredDefinition>
      <LongName>Dimension Polygon Line Opacity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3599555</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25483:C73492</PreferredName>
        <Version>1</Version>
        <LongName>Dimension Polygon</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25483</PREFERRED_NAME>
            <LONG_NAME>Dimension</LONG_NAME>
            <CON_ID>2203908</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73492</PREFERRED_NAME>
            <LONG_NAME>Polygon</LONG_NAME>
            <CON_ID>2747422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2750162</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71604:C71596</PreferredName>
        <Version>1</Version>
        <LongName>Line Opacity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71604</PREFERRED_NAME>
            <LONG_NAME>Line</LONG_NAME>
            <CON_ID>2750137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71596</PREFERRED_NAME>
            <LONG_NAME>Opacity</LONG_NAME>
            <CON_ID>2750136</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803207</PublicId>
      <PreferredName>2803207v1.0</PreferredName>
      <PreferredDefinition>Character string datatype stands for text data.</PreferredDefinition>
      <LongName>ISO21090.ST.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090STv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Dimension Polygon Line Opacity ISO21090.ST.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Dimension Polygon Line Opacity ISO21090.ST.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000057</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3599505</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM FM</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.ThreeDimensionPolygon.lineOpacity</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ThreeDimensionPolygon:lineOpacity</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="268">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3600793</PUBLICID>
    <LONGNAME>Laboratory Procedure Prior Participation Glioblastoma Clinical Trial MGMT Methylation Assay Performed Yes No Indicator</LONGNAME>
    <PREFERREDNAME>PREV_MGMT_PART_YN</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to participation in a previous glioblastoma multiforme clinical trial and determination of MGMT methylation status.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3600292</PublicId>
      <PreferredName>2639063v1.0:3600290v1.0</PreferredName>
      <PreferredDefinition>information related to participation in a previous glioblastoma multiforme clinical trial and determination of MGMT methylation status.</PreferredDefinition>
      <LongName>Laboratory Procedure Prior Participation Glioblastoma Clinical Trial MGMT Methylation Assay Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3600798</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3600798v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Prior Participation Glioblastoma Clinical Trial MGMT Methylation Assay Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25608</PREFERRED_NAME>
            <LONG_NAME>Participation</LONG_NAME>
            <CON_ID>2206339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3058</PREFERRED_NAME>
            <LONG_NAME>Glioblastoma</LONG_NAME>
            <CON_ID>2479034</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71104</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial</LONG_NAME>
            <CON_ID>2735720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79101</PREFERRED_NAME>
            <LONG_NAME>MGMT Methylation Assay</LONG_NAME>
            <CON_ID>3600289</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the patient participate i</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the patient participate in a previous RTOG GBM trial that collected MGMT methylation status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1205</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171135</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PREV_MGMT_PART_YN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="269">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3623698</PUBLICID>
    <LONGNAME>Blood Specimen Frozen Date</LONGNAME>
    <PREFERREDNAME>3623658v1.0:2434927v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Date that the clinical specimens are placed in the freezer</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3623658</PublicId>
      <PreferredName>2413071v1.0:2547997v1.0</PreferredName>
      <PreferredDefinition>information relating to hematology specimens frozen</PreferredDefinition>
      <LongName>Blood Specimen Frozen</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2413071</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12434:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Blood Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12434</PREFERRED_NAME>
            <LONG_NAME>Blood</LONG_NAME>
            <CON_ID>2202587</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2547997</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL267638</PreferredName>
        <Version>1</Version>
        <LongName>Frozen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL267638</PREFERRED_NAME>
            <LONG_NAME>Frozen</LONG_NAME>
            <CON_ID>2204514</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2434927</PublicId>
      <PreferredName>DATE</PreferredName>
      <PreferredDefinition>a particular day specified as the time something has, or will, happen.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CAP PROTOCOLS:College of American Pathologists Cancer Protocols</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date clinical specimens place</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date clinical specimens places in freezer</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="270">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3645865</PUBLICID>
    <LONGNAME>One Or Many New Lesion Identification Since Study Begin Yes No Numeric Indicator Code</LONGNAME>
    <PREFERREDNAME>ONE_MANY_LES_ID_STBEG_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded numeric indicators for Yes (1) or No (0)  in answer to the question if the patient has one or more new lesions since study start.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3645864</PublicId>
      <PreferredName>3645861v1.0:3645862v1.0</PreferredName>
      <PreferredDefinition>The smallest natural number and quantity it denotes: a single entity, unit, or object._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._More than one._The identification of a lesion which has not been previously seen or characterized._Subsequent to; after._A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it; the activities undertaken during a study._Have a beginning, in a temporal, spatial, or evaluative sense.</PreferredDefinition>
      <LongName>One Or Many New Lesion Identification Since Study Begin</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3645861</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66832:C37998:C78728:C94522</PreferredName>
        <Version>1</Version>
        <LongName>One Or Many New Lesion Identification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66832</PREFERRED_NAME>
            <LONG_NAME>One</LONG_NAME>
            <CON_ID>2636736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78728</PREFERRED_NAME>
            <LONG_NAME>Many</LONG_NAME>
            <CON_ID>3111307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94522</PREFERRED_NAME>
            <LONG_NAME>New Lesion Identification</LONG_NAME>
            <CON_ID>3645860</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3645862</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45325:C63536:C25431</PreferredName>
        <Version>1</Version>
        <LongName>Since Study Begin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45325</PREFERRED_NAME>
            <LONG_NAME>Since</LONG_NAME>
            <CON_ID>2240692</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222697</PublicId>
      <PreferredName>Y_N_NUM_IND_CD</PreferredName>
      <PreferredDefinition>Coded numeric indicators for Yes (1) or No (0)  in answer to a question.</PreferredDefinition>
      <LongName>Yes No Numeric Indicator Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2604855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337:C25180:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Number Indicator Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-04-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-04-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Patient has one or more new l</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Patient has one or more new lesions since study start?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CITN</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this a new lesion?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CITN text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this a new lesion since study start?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient has one or more new KS lesions since study start?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876594</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Theradex</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Theradex - CTMS 3.14</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3876603</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Theradex</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Theradex</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ONE_MANY_LES_ID_STBEG_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="271">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3690871</PUBLICID>
    <LONGNAME>Hormone Replacement Therapy Begin Age Number</LONGNAME>
    <PREFERREDNAME>2436241v1.0:3690106v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Age when HRT was begun</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2436241</PublicId>
      <PreferredName>HORM_REPL_TX_HX</PreferredName>
      <PreferredDefinition>A person&#39;s history of treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.</PreferredDefinition>
      <LongName>Hormone Replacement Therapy History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2436239</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15599</PreferredName>
        <Version>1</Version>
        <LongName>Hormone Replacement Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15599</PREFERRED_NAME>
            <LONG_NAME>Hormone Replacement Therapy</LONG_NAME>
            <CON_ID>2205038</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239976</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18772</PreferredName>
        <Version>1</Version>
        <LongName>Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3690106</PublicId>
      <PreferredName>3690106v1.0</PreferredName>
      <PreferredDefinition>Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins._How long something has existed; elapsed time since birth._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.</PreferredDefinition>
      <LongName>Begin Age Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3690243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25150:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Begin Age Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25150</PREFERRED_NAME>
            <LONG_NAME>Age</LONG_NAME>
            <CON_ID>2202837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How old were you when you fir</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How old were you when you first used female hormones for menopause?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="272">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3704298</PUBLICID>
    <LONGNAME>Pain Therapeutic Procedure Effect Relationship Yes No Indicator</LONGNAME>
    <PREFERREDNAME>PN_TX_RLTN_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to signify whether a person feels that their pain is due to the effect(s) of treatment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3704136</PublicId>
      <PreferredName>3158259v1.0:3704134v1.0</PreferredName>
      <PreferredDefinition>A disorder characterized by the sensation of marked discomfort, distress or agony._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._A phenomenon that follows and is caused by some previous phenomenon._Related; connected or associated.</PreferredDefinition>
      <LongName>Pain Therapeutic Procedure Effect Relationship</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3158259</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>E11167</PreferredName>
        <Version>1</Version>
        <LongName>Pain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>E11167</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>3123759</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>CTCAE</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3704134</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236:C25492:C25648</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure Effect Relationship</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25492</PREFERRED_NAME>
            <LONG_NAME>Effect</LONG_NAME>
            <CON_ID>2736779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I believe my pain is due to t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I believe my pain is due to the effects of treatment.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="273">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3760881</PUBLICID>
    <LONGNAME>Plan Study Activity Study Day Range ISO21090.IVL.INT.v1.0</LONGNAME>
    <PREFERREDNAME>3760099v1.0:2803352v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The relative timing for a planned activity expressed as the number of days offset from the study-defined reference activity (e.g., date of registration, start of treatment) for a particular subject, study subject or experimental unit. EXAMPLE(S): Day 1, Days 10-20 OTHER NAME(S): Visit Day NOTE(S): The study-defined reference activity can be different from study to study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3760099</PublicId>
      <PreferredName>2867606v1.0:3759938v1.0</PreferredName>
      <PreferredDefinition>To devise, contrive, or formed in design.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective; the state of being active._The relative timing for a planned or performed activity expressed as the number of days offset from the study-defined reference activity (e.g., date of registration, start of treatment) for this particular experimental unit.  EXAMPLE(S): Day 1, Days 10-20  OTHER NAME(S): Study Day  NOTE(S): The study-defined reference activity can be different from study to study. The study day for a date after this reference activity is a positive integer calculated as the difference in the two dates + 1.  The study day for dates before the reference activity is a negative integer calculated as the difference between the two dates.  Note that this means there is no &quot;Day 0.&quot;</PreferredDefinition>
      <LongName>Plan Study Activity Study Day Range</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867606</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25619:C63536:C43431</PreferredName>
        <Version>1</Version>
        <LongName>Plan Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25619</PREFERRED_NAME>
            <LONG_NAME>Plan</LONG_NAME>
            <CON_ID>2203947</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3759938</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95349</PreferredName>
        <Version>1</Version>
        <LongName>Study Day Range</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95349</PREFERRED_NAME>
            <LONG_NAME>Study Day Range</LONG_NAME>
            <CON_ID>3684419</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803352</PublicId>
      <PreferredName>2803352v1.0</PreferredName>
      <PreferredDefinition>Set of consecutive values of an ordered base datatype of the type INT.</PreferredDefinition>
      <LongName>ISO21090.IVL.INT.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090IVLv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Plan Study Activity Study Day Range ISO21090.IVL.INT.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Plan Study Activity Study Day Range ISO21090.IVL.INT.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PlannedActivity:studyDayRange</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.PlannedActivity.studyDayRange</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PlannedActivity.studyDayRange</AlternateName>
        <AlternateNameType>Map:CTRv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="274">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3760893</PUBLICID>
    <LONGNAME>Study Research Resource Inactive Comment ISO21090.ST.v1.0</LONGNAME>
    <PREFERREDNAME>3760110v1.0:2803207v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Additional description why the resource is no longer active.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3760110</PublicId>
      <PreferredName>3174223v1.0:3759941v1.0</PreferredName>
      <PreferredDefinition>A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:The funding, research facilities, and materials available for research_Indicates an absence of a measurable amount of a specific function or role performed by a biological entity in a Biophysical Process, Biochemical Reaction, or Biochemical Process.:A written explanation, observation or criticism added to textual material.</PreferredDefinition>
      <LongName>Study Research Resource Inactive Comment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174223</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63536:C15321</PreferredName>
        <Version>1</Version>
        <LongName>Study Research Resource</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15321</PREFERRED_NAME>
            <LONG_NAME>Research Resource</LONG_NAME>
            <CON_ID>2867549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3759941</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45422:C25393</PreferredName>
        <Version>1</Version>
        <LongName>Inactive Comment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45422</PREFERRED_NAME>
            <LONG_NAME>Absence of Biochemical Activity</LONG_NAME>
            <CON_ID>2737768</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25393</PREFERRED_NAME>
            <LONG_NAME>Comment</LONG_NAME>
            <CON_ID>2202716</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803207</PublicId>
      <PreferredName>2803207v1.0</PreferredName>
      <PreferredDefinition>Character string datatype stands for text data.</PreferredDefinition>
      <LongName>ISO21090.ST.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090STv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Study Research Resource Inactive Comment ISO21090.ST.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Study Research Resource Inactive Comment ISO21090.ST.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudyResource:inactiveComment</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain.StudyResource.inactiveComment</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudyResourcing.inactiveCommentText</AlternateName>
        <AlternateNameType>Map:CTRPv3.8</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudyResourcing.inactiveCommentText</AlternateName>
        <AlternateNameType>Map:CTRPv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="275">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3760993</PUBLICID>
    <LONGNAME>Intervention or Procedure Reuse Template Study Activity Repeat Quantity Range ISO21090.URG.INT.NONNEG.v1.0</LONGNAME>
    <PREFERREDNAME>3760215v1.0:3152485v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity defined at a global library level that is an action whose immediate and primary intention is the alteration of the physical condition of the subject, study subject or experimental unit. EXAMPLE(S): (1) Procedures may involve the disruption of some body surface (e.g. an incision in a surgical procedure). (2) Conservative procedures such as reduction of a luxated joint, including physiotherapy such as chiropractic treatment, massage, balneotherapy, acupuncture, shiatsu. An integer falling within minimum and maximum bounds that specifies how many times the activity occurs. NOTE(S): If the frequency is more than once a day, this is still interpreted per time, e.g. BID for 5 days = 10 repeats.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3760215</PublicId>
      <PreferredName>3174171v1.0:3758613v1.0</PreferredName>
      <PreferredDefinition>An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._Make or do or perform again.:How much there is of something that you can measure; the total amount or number.:The difference between the lowest and highest numerical values; the limits or scale of variation.</PreferredDefinition>
      <LongName>Intervention or Procedure Reuse Template Study Activity Repeat Quantity Range</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174171</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174171v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Intervention or Procedure Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3758613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47886:C25256:C38013</PreferredName>
        <Version>1</Version>
        <LongName>Repeat Quantity Range</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47886</PREFERRED_NAME>
            <LONG_NAME>Repeat</LONG_NAME>
            <CON_ID>2415563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38013</PREFERRED_NAME>
            <LONG_NAME>Range</LONG_NAME>
            <CON_ID>2204649</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3152485</PublicId>
      <PreferredName>3152485v1.0</PreferredName>
      <PreferredDefinition>Constrains URG so that the values are non-negative integers.</PreferredDefinition>
      <LongName>ISO21090.URG.INT.NONNEG.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090URGv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2433737</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45255</PreferredName>
        <Version>1</Version>
        <LongName>Integer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Intervention or Procedure Reuse Template Study Activity Repeat Quantity Range ISO21090.URG.INT.NONNEG.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Intervention or Procedure Reuse Template Study Activity Repeat Quantity Range ISO21090.URG.INT.NONNEG.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedProcedure:repeatQuantityRange</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.DefinedProcedure.repeatQuantityRange</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="276">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3761059</PUBLICID>
    <LONGNAME>Notification Plan Study Activity Duration ISO21090.PQ.TIME.v1.0</LONGNAME>
    <PREFERREDNAME>3760276v1.0:2848092v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity that is intended to occur at some point in the context of a particular study that represents the communication of a message to a recipient. The intended period of time for the planned activity as defined by the study. EXAMPLE(S): 6 weeks may be the planned duration for a composite activity that represents the activities occurring during an epoch on arm A.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3760276</PublicId>
      <PreferredName>3174178v1.0:2234809v1.0</PreferredName>
      <PreferredDefinition>Informing by words.:To devise, contrive, or formed in design.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._The period of time during which something continues.</PreferredDefinition>
      <LongName>Notification Plan Study Activity Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174178</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25297:C25619:C63536:C43431</PreferredName>
        <Version>1</Version>
        <LongName>Notification Plan Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25297</PREFERRED_NAME>
            <LONG_NAME>Notification</LONG_NAME>
            <CON_ID>2202895</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25619</PREFERRED_NAME>
            <LONG_NAME>Plan</LONG_NAME>
            <CON_ID>2203947</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234809</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25330</PreferredName>
        <Version>1</Version>
        <LongName>Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2848092</PublicId>
      <PreferredName>2848092v1.0</PreferredName>
      <PreferredDefinition>Constrains PQ to have units that describe a period of time.</PreferredDefinition>
      <LongName>ISO21090.PQ.TIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090PQTIMEv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Notification Plan Study Activity Duration ISO21090.PQ.TIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Notification Plan Study Activity Duration ISO21090.PQ.TIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PlannedNotification:duration</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.PlannedNotification.duration</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="277">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3761294</PUBLICID>
    <LONGNAME>Imaging Technique Observation Reuse Template Study Activity Method Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>3175216v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity defined at the global library level whose intention is to obtain pictures of the interior or exterior of the body usually for diagnostic reasons. EXAMPLE(S): X-ray, MRI A coded value specifying the technique that is used for the observation. EXAMPLE(S): (1) Arterial puncture, sphygmomanometry (for blood pressure measurement), (2) Global introspection, algorithm, bayesian (for Adverse Event causality), (3) Estrogen Receptor Assay, Progesterone Receptor Assay, p53 Assay (for clinical result assay).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175216</PublicId>
      <PreferredName>3174173v1.0:2839671v1.0</PreferredName>
      <PreferredDefinition>Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.:Watching something and taking note of what happens.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.:A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Imaging Technique Observation Reuse Template Study Activity Method Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174173</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174173v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Imaging Technique Observation Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17369</PREFERRED_NAME>
            <LONG_NAME>Imaging Procedure</LONG_NAME>
            <CON_ID>2713347</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2839671</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71460:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Method Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Imaging Technique Observation Reuse Template Study Activity Method Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Imaging Technique Observation Reuse Template Study Activity Method Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.DefinedImaging.methodCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedImaging:methodCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="278">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3761521</PUBLICID>
    <LONGNAME>Inclusion Criteria Clinical Trial Eligibility Criteria Plan Study Activity Discontinued Ability Flag ISO21090.BL.v1.0</LONGNAME>
    <PREFERREDNAME>3760717v1.0:2803169v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity that is intended to occur at some point in the context of a particular study that represents a characteristic or requirement intended to be applied to a potential study subject to determine whether they may participate in a study. NOTE(S): This allows questions defined as agnostic criteria in defined eligibility criterion (that is, they could be used either as inclusion or exclusion criteria) to be referenced in specific study protocols and allows the inclusion/exclusion distinction to be determined for that study specifically. Specifies whether the planned activity is interruptable by asynchronous events. NOTE(S): This may only be useful for planned subject activity groups or administrative activities.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3760717</PublicId>
      <PreferredName>3757191v1.0:3759937v1.0</PreferredName>
      <PreferredDefinition>Medical and/or social characteristics which are necessary for a subject to be allowed to participate in a clinical study, as outlined in the study protocol. Meeting inclusion criteria is not a sufficient condition for entry or recruitment of a subject into the study. Characteristics limiting the eligibility of a subject for the clinical study must be considered.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.:To devise, contrive, or form in design.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An active process; excludes processes and mechanisms which fulfill biological functions._To stop or end, permanently or temporarily.:The quality of being able to perform; a quality that permits or facilitates achievement or accomplishment .:An indicator that can be set or unset in order to signal whether a particular condition is true.</PreferredDefinition>
      <LongName>Inclusion Criteria Clinical Trial Eligibility Criteria Plan Study Activity Discontinued Ability Flag</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3757191</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3757191v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Inclusion Criteria Clinical Trial Eligibility Criteria Plan Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25532</PREFERRED_NAME>
            <LONG_NAME>Inclusion Criteria</LONG_NAME>
            <CON_ID>2202445</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25619</PREFERRED_NAME>
            <LONG_NAME>Plan</LONG_NAME>
            <CON_ID>2203947</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3759937</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25484:C78209:C43578</PreferredName>
        <Version>1</Version>
        <LongName>Discontinued Ability Flag</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25484</PREFERRED_NAME>
            <LONG_NAME>Discontinue</LONG_NAME>
            <CON_ID>2203906</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78209</PREFERRED_NAME>
            <LONG_NAME>Ability</LONG_NAME>
            <CON_ID>2798027</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43578</PREFERRED_NAME>
            <LONG_NAME>Flag</LONG_NAME>
            <CON_ID>2223213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803169</PublicId>
      <PreferredName>2803169v1.0</PreferredName>
      <PreferredDefinition>Values of two-valued logic.</PreferredDefinition>
      <LongName>ISO21090.BL.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090BLv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Inclusion Criteria Clinical Trial Eligibility Criteria Plan Study Activity Discontinued Ability Flag ISO21090.BL.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Inclusion Criteria Clinical Trial Eligibility Criteria Plan Study Activity Discontinued Ability Flag ISO21090.BL.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PlannedInclusionCriterion:interruptibleIndicator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.PlannedInclusionCriterion.interruptibleIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="279">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3763218</PUBLICID>
    <LONGNAME>Laboratory Procedure Chimerism Study Blood Performed Yes No Indicator</LONGNAME>
    <PREFERREDNAME>LabPdrChmSdyBdIND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to the laboratory procedure that involves testing the blood for the occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3763216</PublicId>
      <PreferredName>LabPdrChmSdyBd</PreferredName>
      <PreferredDefinition>information related to the laboratory procedure that involves testing the blood (a liquid tissue that has the major function to transport oxygen throughout the body, supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection) for the occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals.</PreferredDefinition>
      <LongName>Laboratory Procedure Chimerism Study Blood Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3763214</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62582:C63536:C12434:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Chimerism Study Blood Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62582</PREFERRED_NAME>
            <LONG_NAME>Chimerism</LONG_NAME>
            <CON_ID>2521747</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12434</PREFERRED_NAME>
            <LONG_NAME>Blood</LONG_NAME>
            <CON_ID>2202587</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a chimerism study done on</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was a chimerism study done on the patient&#39;s unsorted blood?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="280">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3791183</PUBLICID>
    <LONGNAME>Sentinel Lymph Node Biopsy Blue Dye Type</LONGNAME>
    <PREFERREDNAME>BLUEDYETYPE</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of blue-colored chemical substances that are used to stain and color other materials during the removal and examination of the sentinel node(s), the first lymph node(s) to which cancer cells are likely to spread from a primary tumor.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2683328</PublicId>
      <PreferredName>SLN_BL_DYE_USE</PreferredName>
      <PreferredDefinition>information related to the removal and examination of the sentinel node(s) (the first lymph node(s) to which cancer cells are likely to spread from a primary tumor), using blue dye, a chemical substance that is used to stain and color other materials, injected into the tumor which is then traced,  via the lymphatic system into the sentinel node.</PreferredDefinition>
      <LongName>Sentinel Lymph Node Biopsy Blue Dye Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2683321</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15667</PreferredName>
        <Version>1</Version>
        <LongName>Sentinel Lymph Node Biopsy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15667</PREFERRED_NAME>
            <LONG_NAME>Sentinel Lymph Node Biopsy</LONG_NAME>
            <CON_ID>2204871</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2683326</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48333:C461:C25340</PreferredName>
        <Version>1</Version>
        <LongName>Blue Dye Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48333</PREFERRED_NAME>
            <LONG_NAME>Blue</LONG_NAME>
            <CON_ID>2668066</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C461</PREFERRED_NAME>
            <LONG_NAME>Dye</LONG_NAME>
            <CON_ID>2443846</CON_ID>
            <DEFINITION_SOURCE>MSH2002_06_01</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3790743</PublicId>
      <PreferredName>BLUEDYETYPE</PreferredName>
      <PreferredDefinition>the type of blue-colored chemical substances used to stain and color other materials as therapeutic agents and test reagents in medicine and scientific research.</PreferredDefinition>
      <LongName>Blue Dye Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other, specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methylene blue</VALIDVALUE>
          <VALUEMEANING>Methylene Blue</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic basic dye. Methylene blue stains to negatively charged cell components like nucleic acids; when administered in the lymphatic bed of a tumor during oncologic surgery, methylene blue may stain lymph nodes draining from the tumor, thereby aiding in the visual localization of tumor sentinel lymph nodes. When administered intravenously in low doses, this agent may convert methemoglobin to hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3790745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphazurin blue</VALIDVALUE>
          <VALUEMEANING>Isosulfan Blue</VALUEMEANING>
          <MEANINGDESCRIPTION>A dye made in the laboratory that helps identify the sentinel lymph node (the first lymph node that cancer spreads to from a primary tumor). Isosulfan blue is injected at the edge of a tumor and travels through the lymph fluid to lymph nodes near the tumor. The sentinel lymph node is identified by removing lymph nodes that are stained with the blue dye and looking for cancer cells under a microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3790747</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vital blue</VALIDVALUE>
          <VALUEMEANING>Vital blue</VALUEMEANING>
          <MEANINGDESCRIPTION>Vital blue</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4536154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Type of blue dye</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Type of blue dye</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="281">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3808796</PUBLICID>
    <LONGNAME>Intravenous Contrast Agent Injection Anatomic Site Code</LONGNAME>
    <PREFERREDNAME>INJ_SITE_LOC_CD</PREFERREDNAME>
    <PREFERREDDEFINITION>A system of numbered categories that captures the location where fluids or drugs are pushed into the body.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACRIN:American College of Radiology Imaging Network</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3808664</PublicId>
      <PreferredName>2727608v1.0:3808662v1.0</PreferredName>
      <PreferredDefinition>(in-tra-VEE-nus) IV. Within a blood vessel._Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue._The anatomic site at which a medication or a vaccine is injected.</PreferredDefinition>
      <LongName>Intravenous Contrast Agent Injection Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2727608</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13346:C390</PreferredName>
        <Version>1</Version>
        <LongName>Intravenous Contrast Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13346</PREFERRED_NAME>
            <LONG_NAME>Intravenous</LONG_NAME>
            <CON_ID>2450528</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C390</PREFERRED_NAME>
            <LONG_NAME>Contrast Agent</LONG_NAME>
            <CON_ID>2202441</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3808662</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C77680</PreferredName>
        <Version>1</Version>
        <LongName>Injection Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C77680</PREFERRED_NAME>
            <LONG_NAME>Injection Site</LONG_NAME>
            <CON_ID>3377282</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2685181</PublicId>
      <PreferredName>INJECT_ANAT_SITE_CD</PreferredName>
      <PreferredDefinition>A system of numbered categories for representating the location of the body where a syringe and needle pushed fluids or drugs into the body.</PreferredDefinition>
      <LongName>Injection Anatomic Site Code</LongName>
      <Version>2.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
      <Representation>
        <PublicId>2714758</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28160:C13717:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Injection Anatomic Site Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28160</PREFERRED_NAME>
            <LONG_NAME>Injection Route of Administration</LONG_NAME>
            <CON_ID>2202407</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Right wrist</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the east when facing north.: The area of the body located between the antebrachial and metacarpal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111033, C25228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3882832</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Left antecubital</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the west when facing north.: A triangular space on the anterior side of the elbow joint. Three main veins of the arm, the brachial artery, the medial nerve and the tendon of the biceps pass through this space.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103238, C25229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3882833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Right antecubital</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the east when facing north.: A triangular space on the anterior side of the elbow joint. Three main veins of the arm, the brachial artery, the medial nerve and the tendon of the biceps pass through this space.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103238, C25228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3882831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Left wrist</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the west when facing north.: The area of the body located between the antebrachial and metacarpal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111033, C25229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3882834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Right foot</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the east when facing north.: The terminal part of the lower extremity, especially the part below the ankle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32622, C25228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Left foot</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the west when facing north.: The terminal part of the lower extremity, especially the part below the ankle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32622, C25229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412519</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>99</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>88</VALIDVALUE>
          <VALUEMEANING>Other specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Location of injection site</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Location of injection site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Prior Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Location of Injection Site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CT Imaging Agent CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3793463</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CT Imaging Agent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5635307</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3808664v1.0:2685181v2.1</AlternateName>
        <AlternateNameType>System-Generated</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCI Standards</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="282">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3812863</PUBLICID>
    <LONGNAME>Medical Device Energy Pulse Output Measurement</LONGNAME>
    <PREFERREDNAME>3812862v1.0:3116463v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Measurement of the energy delivered per unit area by a medical device</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3812862</PublicId>
      <PreferredName>2541698v1.0:3812860v1.0</PreferredName>
      <PreferredDefinition>Any physical object that is useful for prevention, diagnosis, monitoring, or treatment of disease or other conditions._Any of a series of intermittent occurrences characterized by a brief, sudden change in a quantity.(NCI)_The period of time during which something continues._Anything coming out of a system.</PreferredDefinition>
      <LongName>Medical Device Energy Pulse Output</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19238</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic, Therapeutic, and Research Equipment</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2541698</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16830</PreferredName>
        <Version>1</Version>
        <LongName>Medical_Device</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16830</PREFERRED_NAME>
            <LONG_NAME>Medical Device</LONG_NAME>
            <CON_ID>2240760</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3812860</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C64713:C47906</PreferredName>
        <Version>1</Version>
        <LongName>Pulse Output</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64713</PREFERRED_NAME>
            <LONG_NAME>Pulse</LONG_NAME>
            <CON_ID>2593743</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47906</PREFERRED_NAME>
            <LONG_NAME>Output</LONG_NAME>
            <CON_ID>2425536</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3116463</PublicId>
      <PreferredName>C25337:3116463v1.0</PreferredName>
      <PreferredDefinition>Measurement; the size or magnitude of something.</PreferredDefinition>
      <LongName>Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184312</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25209</PreferredName>
        <Version>1</Version>
        <LongName>Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Medical Device Energy Fluence</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Medical Device Energy Fluence</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="283">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3813885</PUBLICID>
    <LONGNAME>Patient Prophylactic Antimicrobial Therapeutic Schedule Clinical Trial Eligibility Criteria Yes No Unknown Not Applicable Indicator</LONGNAME>
    <PREFERREDNAME>PtPrxAntimcTxSchEligIND</PREFERREDNAME>
    <PREFERREDDEFINITION>a yes/no/unknown/not applicable indicator related to a patient planned to take medicine capable of destroying or inhibiting the growth of microorganisms to allow an individual to participate in a specific clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3813832</PublicId>
      <PreferredName>PtPrxAntimcTxSchElig</PreferredName>
      <PreferredDefinition>information related to a patient planned to take medicine capable of destroying or inhibiting the growth of microorganisms to allow an individual to participate in a specific clinical trial.</PreferredDefinition>
      <LongName>Patient Prophylactic Antimicrobial Therapeutic Schedule Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3821158</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3821158v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Prophylactic Antimicrobial Solution Therapeutic Procedure Schedule Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95560</PREFERRED_NAME>
            <LONG_NAME>Prophylactic</LONG_NAME>
            <CON_ID>3290677</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52588</PREFERRED_NAME>
            <LONG_NAME>Antibacterial Agent</LONG_NAME>
            <CON_ID>2443115</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25211</PREFERRED_NAME>
            <LONG_NAME>Schedule</LONG_NAME>
            <CON_ID>2203792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is patient scheduled to recei</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is patient scheduled to receive broad-spectrum prophylactic antibacterial therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CITN</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Must not be receiving prophylactic therapy for an opportunistic infection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CITN-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient is not receiving prophylactic therapy for an opportunistic infection.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5999742</PublicId>
          <ContextName>CITN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5999747</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PtPrxAntimcTxSchEligIND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="284">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3837872</PUBLICID>
    <LONGNAME>in vivo Monoclonal Antibody Administered Specify Text</LONGNAME>
    <PREFERREDNAME>2787457v1.0:2799057v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The free-text field to describe the in vivo monoclonal antibody that was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2787457</PublicId>
      <PreferredName>INVIV_MON_ADMIN</PreferredName>
      <PreferredDefinition>Located or occurring in the body._An antibody produced by a clone or genetically homogenous fast-growing cells i.e., hybridoma. Hybridoma cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis, and treatment.__The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>in vivo Monoclonal Antibody Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2861828</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15744:C20401</PreferredName>
        <Version>1</Version>
        <LongName>in vivo Monoclonal Antibody</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15744</PREFERRED_NAME>
            <LONG_NAME>In Vivo</LONG_NAME>
            <CON_ID>2590820</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20401</PREFERRED_NAME>
            <LONG_NAME>Monoclonal Antibody</LONG_NAME>
            <CON_ID>2205426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2799057</PublicId>
      <PreferredName>SPC_TXT</PreferredName>
      <PreferredDefinition>Be specific about something; define clearly._Text; the words of something written.</PreferredDefinition>
      <LongName>Specify Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2799056</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25685:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Specify Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify in vivo monoclonal an</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify in vivo monoclonal antibody administered:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify antibody:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify antibody:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify antibody:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify antibody:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_gvhd_prophy_oth_in_vivo_mAb_spec</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_gvhd_prophy_daclizumab_specify</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="285">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3854782</PUBLICID>
    <LONGNAME>HMG-CoA Reductase Inhibitor Fulfill Low Density Lipoprotein Criterion Requirement Yes No Indicator</LONGNAME>
    <PREFERREDNAME>3854781v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no response regarding the requirement for administration of or increase in dosage of statins to meet low density lipoprotein (LDL) protocol goals.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>LCC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3854781</PublicId>
      <PreferredName>2480490v1.0:3854779v1.0</PreferredName>
      <PreferredDefinition>Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis._Satisfy the requirements or expectations of._Low-density lipoprotein (LDL) is a lipoprotein that carries cholesterol around the body, for use by various cells.  LDL transports cholesterol to the arteries and increased levels are associated with atherosclerosis, and thus myocardial infarctions and strokes. This is why cholesterol inside LDL lipoproteins is called bad cholesterol. (from Wikipedia)_Criteria; a basis for comparison; a reference point against which other things can be evaluated._Requirement; something that is necessary.</PreferredDefinition>
      <LongName>HMG-CoA Reductase Inhibitor Fulfill Low Density Lipoprotein Criterion Requirement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>LCC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480490</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1655</PreferredName>
        <Version>1</Version>
        <LongName>HMG-CoA Reductase Inhibitor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1655</PREFERRED_NAME>
            <LONG_NAME>HMG-CoA Reductase Inhibitor</LONG_NAME>
            <CON_ID>2480489</CON_ID>
            <DEFINITION_SOURCE>MSH2002_06_01</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3854779</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C87531:C25187:C25466:C38015</PreferredName>
        <Version>1</Version>
        <LongName>Fulfill Low Density Lipoprotein Criterion Requirement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C87531</PREFERRED_NAME>
            <LONG_NAME>Fulfill</LONG_NAME>
            <CON_ID>3017448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25187</PREFERRED_NAME>
            <LONG_NAME>Low Density Lipoprotein</LONG_NAME>
            <CON_ID>2206288</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25466</PREFERRED_NAME>
            <LONG_NAME>Criterion</LONG_NAME>
            <CON_ID>2203889</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38015</PREFERRED_NAME>
            <LONG_NAME>Requirement</LONG_NAME>
            <CON_ID>2203776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Start or increase dose of sta</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Start or increase dose of statin is needed to meet goal:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>STATIN_LDL_CRIT_REQU_IND</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>STAT_FFL_LDL_CRT_IND</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3854781v1.0:3506068v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="286">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3855885</PUBLICID>
    <LONGNAME>Radiation Therapy Reduced Movement During Administration Type</LONGNAME>
    <PREFERREDNAME>RT_RED_MVT_ADM_TYP</PREFERREDNAME>
    <PREFERREDDEFINITION>information relating whether the patient/participant was immobilized (restrained to reduce or prevent movement) during the planned administration of radiation therapy (treatment of a disease by means of exposure of the target or the whole body to radiation).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2807872</PublicId>
      <PreferredName>RT_RED_MOVE_D_ADMIN</PreferredName>
      <PreferredDefinition>information relating whether the patient/participant was immobilized (restrained to reduce or prevent movement) during the planned administration of radiation therapy (treatment of a disease by means of exposure of the target or the whole body to radiation).</PreferredDefinition>
      <LongName>Radiation Therapy Reduced Movement During Administration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2403872</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15313</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2807870</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25640:C37994:C25490:C25409</PreferredName>
        <Version>1</Version>
        <LongName>Reduced Movement During Administration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25640</PREFERRED_NAME>
            <LONG_NAME>Reduced</LONG_NAME>
            <CON_ID>2204920</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37994</PREFERRED_NAME>
            <LONG_NAME>Movement</LONG_NAME>
            <CON_ID>2203634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3244917</PublicId>
      <PreferredName>3244917v1.0</PreferredName>
      <PreferredDefinition>Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Describe method of patient im</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Describe method of patient immobilization</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1308</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104933</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RT_RED_MVT_ADM_TYP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="287">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3872070</PUBLICID>
    <LONGNAME>OARS Physical Health Comorbidity Scale Have Current Illness Gastrointestinal System Ulcer Indicator</LONGNAME>
    <PREFERREDNAME>OARS_PHC_GIULCER_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated perception of whether or not they currently have ulcers of the digestive system, using a yes or no indicator.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>OAMFQ:Older Americans Resource Scale (OARS) Multidimensional Functional Assessment Questionnaire, Fillenbaum, G.G. &amp; Smyer, M., 1981</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3871917</PublicId>
      <PreferredName>3871831v1.0:3871915v1.0</PreferredName>
      <PreferredDefinition>A section of the Older Americans Resources and Services (OARS) physical health questionnaire that rates the type of comorbidity and the impact of that comorbidity on an individual&#39;s daily function._A question about whether an individual currently has a disease._The system that includes the esophagus, stomach, small and large intestine, anus, liver, biliary tract, and pancreas._A circumscribed inflammatory and often suppurating lesion on the skin or an internal mucous surface resulting in necrosis of tissue.</PreferredDefinition>
      <LongName>OARS Physical Health Comorbidity Scale Have Current Illness Gastrointestinal System Ulcer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3871831</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C110967</PreferredName>
        <Version>1</Version>
        <LongName>Older Americans Resources and Services Comorbidity Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110967</PREFERRED_NAME>
            <LONG_NAME>Older Americans Resources and Services Comorbidity Scale</LONG_NAME>
            <CON_ID>3871073</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3871915</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C110955:C12378:C3426</PreferredName>
        <Version>1</Version>
        <LongName>Have Current Illness Gastrointestinal System Ulcer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110955</PREFERRED_NAME>
            <LONG_NAME>Have Current Illness Question</LONG_NAME>
            <CON_ID>3863084</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12378</PREFERRED_NAME>
            <LONG_NAME>Digestive System</LONG_NAME>
            <CON_ID>2593722</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3426</PREFERRED_NAME>
            <LONG_NAME>Ulcer</LONG_NAME>
            <CON_ID>2509376</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>OAMFQ:Older Americans Resource Scale (OARS) Multidimensional Functional Assessment Questionnaire, Fillenbaum, G.G. &amp; Smyer, M., 1981</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Ulcers (of the digestive syst</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Ulcers (of the digestive system)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3863413</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>OAMFQ</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Comorbidity Assessment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3867573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3863413</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>OAMFQ</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical Health</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000702</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="288">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3901760</PUBLICID>
    <LONGNAME>Testicular Cancer Bilateral Diagnosis Day Number</LONGNAME>
    <PREFERREDNAME>3901757v1.0:2896868v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the day of the bilateral malignant testicular germ cell tumor diagnosis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3901757</PublicId>
      <PreferredName>2986052v1.0:3901755v1.0</PreferredName>
      <PreferredDefinition>A malignant tumor predominantly affecting young men and often associated with cryptorchidism.  Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor. -- 2004_Affecting both sides of the body, or a matched pair of organs._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</PreferredDefinition>
      <LongName>Malignant Testicular Germ Cell Tumor Bilateral Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2986052</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9063</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Testicular Germ Cell Tumor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9063</PREFERRED_NAME>
            <LONG_NAME>Malignant Testicular Germ Cell Tumor</LONG_NAME>
            <CON_ID>2672903</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3901755</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13332:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Bilateral Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13332</PREFERRED_NAME>
            <LONG_NAME>Bilateral</LONG_NAME>
            <CON_ID>2204746</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896868</PublicId>
      <PreferredName>EVT_DAY_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._time for Earth to make a complete rotation on its axis._A numeral or string of numerals expressing value, quantity, or identification</PreferredDefinition>
      <LongName>Event Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C0439228:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Day Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0439228</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2204684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>22nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::22: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::22</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>21st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>20th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::20: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>19th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::19: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>18th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::18: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>17th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::17: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>16th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::16: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>15th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::15: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>14th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::14: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>13th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::13: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::10: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::4: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::5: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>31st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::31: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::31</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>30th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::30: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::30</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>29th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::29: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>28th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::28: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>27th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::27: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>26th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::26: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>25th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::25: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>24th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>23rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::23: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Bilateral Tumor: Day of Diagn</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Bilateral Tumor: Day of Diagnosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="289">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3902247</PUBLICID>
    <LONGNAME>Patient Infusion Catheter Maintenance Occurrence Yes No Unknown Not Applicable Indicator</LONGNAME>
    <PREFERREDNAME>PtInfnCthrMntOcrIND4</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no/unknown/not applicable indicator relating to the upkeep/maintenance of an infusion catheter, an invasive flexible tube placed within a tumor location to deliver fluids or therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2747010</PublicId>
      <PreferredName>PT_INFUS_CATH_MAIN</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord._A flexible tube designed to transfer fluids into or out of the body._The act of sustaining something in its current form or proper condition; upkeep.:An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Patient Infusion Catheter Maintenance Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>16340529</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C15388:C50344:C53297</PreferredName>
        <Version>1</Version>
        <LongName>Patient Infusion Procedure Catheter Device Maintenance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15388</PREFERRED_NAME>
            <LONG_NAME>Infusion Procedure</LONG_NAME>
            <CON_ID>2203835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50344</PREFERRED_NAME>
            <LONG_NAME>Catheter Device</LONG_NAME>
            <CON_ID>3212279</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53297</PREFERRED_NAME>
            <LONG_NAME>Maintenance</LONG_NAME>
            <CON_ID>2512708</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the patient have a centra</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the patient have a central line repair during the Study period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="290">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3935922</PUBLICID>
    <LONGNAME>Medical Outcomes Study Your Feelings Questionnaire Past Month How Much of the Time Have You Been Moody or Brooded About Things Score 6 Point Scale</LONGNAME>
    <PREFERREDNAME>MOS_MOODY_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated perception of how much of the time they have been moody or brooded about things during the past month, using a 6 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MOS:Medical Outcomes Study, Sherbourne, C. D., 1991 and Stewart, A. L. and J. E. Ware, Jr., Eds. 1992</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3934120</PublicId>
      <PreferredName>3933991v1.0:3934118v1.0</PreferredName>
      <PreferredDefinition>A survey of multiple dimensions of functioning and well being, representing the feelings scale._Past; before the present time._One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks._A question about how much of the time something is occurring or has occurred._A question about whether an individual is or has been moody or brooded about things._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Medical Outcomes Study Your Feelings Questionnaire Past Month How Much of the Time Have You Been Moody or Brooded About Things Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3933991</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C111697</PreferredName>
        <Version>1</Version>
        <LongName>Medical Outcomes Study Your Feelings Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C111697</PREFERRED_NAME>
            <LONG_NAME>Medical Outcomes Study Your Feelings Questionnaire</LONG_NAME>
            <CON_ID>3930411</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3934118</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3934118v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Past Month How Much of the Time Have You Been Moody or Brooded About Things Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C111702</PREFERRED_NAME>
            <LONG_NAME>How Much of the Time Question</LONG_NAME>
            <CON_ID>3930498</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C111726</PREFERRED_NAME>
            <LONG_NAME>Have You Been Moody or Brooded About Things Question</LONG_NAME>
            <CON_ID>3930483</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MOS:Medical Outcomes Study, Sherbourne, C. D., 1991 and Stewart, A. L. and J. E. Ware, Jr., Eds. 1992</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3918393</PublicId>
      <PreferredName>TIME_6PT_SCL</PreferredName>
      <PreferredDefinition>an ordered reference standard.</PreferredDefinition>
      <LongName>How Much of the Time 6 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>MOS:Medical Outcomes Study, Sherbourne, C. D., 1991 and Stewart, A. L. and J. E. Ware, Jr., Eds. 1992</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>A Good Bit of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a good bit of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3918394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Most of the time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Some of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened some of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>A Little of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a little of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>During the past month, how mu</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>During the past month, how much of the time have you been moody or brooded about things?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3863415</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MOS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Core Survey Instrument</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3863417</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3863415</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MOS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Your Feelings</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3918392</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="291">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3944966</PUBLICID>
    <LONGNAME>Patient Reported Outcome Religion and Spirituality Index Experience Assessment True Status</LONGNAME>
    <PREFERREDNAME>DIVEXPSTAT</PREFERREDNAME>
    <PREFERREDDEFINITION>The level of truth status related to the religion and spirituality index patient reported outcome of experiencing the presence of the Divine.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3944943</PublicId>
      <PreferredName>EXPDIVINE</PreferredName>
      <PreferredDefinition>Information related to the religion and spirituality index patient reported outcome of experiencing the presence of the Divine.</PreferredDefinition>
      <LongName>Patient Reported Outcome Religion and Spirituality Index Experience Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3944900</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95401</PreferredName>
        <Version>1</Version>
        <LongName>Patient Reported Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95401</PREFERRED_NAME>
            <LONG_NAME>Patient Reported Outcome</LONG_NAME>
            <CON_ID>3185129</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3944941</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15713:C25390:C54627:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Religion and Spirituality Index Experience Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15713</PREFERRED_NAME>
            <LONG_NAME>Religion and Spirituality</LONG_NAME>
            <CON_ID>3944933</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25390</PREFERRED_NAME>
            <LONG_NAME>Index</LONG_NAME>
            <CON_ID>2203825</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54627</PREFERRED_NAME>
            <LONG_NAME>Experience</LONG_NAME>
            <CON_ID>2731931</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3944958</PublicId>
      <PreferredName>TRUESTAT</PreferredName>
      <PreferredDefinition>A condition or state at a particular time.</PreferredDefinition>
      <LongName>Patient Reported Outcome Religion and Spirituality Index True Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</Origin>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Definitely true of me</VALUEMEANING>
          <MEANINGDESCRIPTION>Definitely true of me</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3944959</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Tends to be true</VALUEMEANING>
          <MEANINGDESCRIPTION>Tends to be true</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3944960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Unsure</VALUEMEANING>
          <MEANINGDESCRIPTION>Unsure</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3944961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Tends not to be true</VALUEMEANING>
          <MEANINGDESCRIPTION>Tends not to be true</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3944962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Definitely not true</VALUEMEANING>
          <MEANINGDESCRIPTION>Definitely not true</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3944963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>In my life, I experience the</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>In my life, I experience the presence of the Divine (i.e., God).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DIVEXPSTAT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="292">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3978800</PUBLICID>
    <LONGNAME>RT Beam Name 64 Character Text</LONGNAME>
    <PREFERREDNAME>3954334v1.0:2584117v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>User-defined name for Beam.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DICOM:Digital Imaging and Communications in Medicine</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3954334</PublicId>
      <PreferredName>3954211v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._A group of nearly parallel rays of electromagnetic radiation or a stream of particles._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Radiation Therapy Beam Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3954211</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15313:C70569</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Therapy Beam</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70569</PREFERRED_NAME>
            <LONG_NAME>Beam</LONG_NAME>
            <CON_ID>2684863</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2584117</PublicId>
      <PreferredName>2584117v1.0</PreferredName>
      <PreferredDefinition>LO: A 64-character string with leading or trailing spaces being non-significant; NO CONTROL characters. [Standard-based]</PreferredDefinition>
      <LongName>64 Character Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>64</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
      <Representation>
        <PublicId>2637360</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45253:C25704</PreferredName>
        <Version>1</Version>
        <LongName>String Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45253</PREFERRED_NAME>
            <LONG_NAME>String</LONG_NAME>
            <CON_ID>2539471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Beam Name</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Beam Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DICOM Reference</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>PS 3.3-2011: Digital Imaging and Communications in Medicine (DICOM), Part 3: Information Object Definitions</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DICOM Tag CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812790</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RT-Radiotherapy CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000493</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3938979</PublicId>
          <ContextName>NHC-NCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RT-Radiotherapy CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3934151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>(300A,00C2)</AlternateName>
        <AlternateNameType>DICOM_TAG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Beam Name</AlternateName>
        <AlternateNameType>DICOM Attribute Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3</AlternateName>
        <AlternateNameType>DICOM Type</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="293">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4000111</PUBLICID>
    <LONGNAME>RT DVH Mean Dose Float 16 Character Number</LONGNAME>
    <PREFERREDNAME>3983798v1.0:2585012v1.1</PREFERREDNAME>
    <PREFERREDDEFINITION>Mean calculated dose to ROI(s) described by DVH Referenced ROI Sequence (3004,0060).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DICOM:Digital Imaging and Communications in Medicine</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3983798</PublicId>
      <PreferredName>3983654v1.0:3983796v1.0</PreferredName>
      <PreferredDefinition>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._A plot of a cumulative dose-volume frequency distribution that graphically summarizes the simulated radiation distribution within a volume of interest of a patient which would result from a proposed radiation treatment plan._The sum of a set of values divided by the number of values in the set._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.</PreferredDefinition>
      <LongName>Radiation Therapy Dose Volume Histogram Mean Dose</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3983654</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15313:C112816</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Therapy Dose Volume Histogram</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C112816</PREFERRED_NAME>
            <LONG_NAME>Dose Volume Histogram</LONG_NAME>
            <CON_ID>3983336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3983796</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C53319:C25488</PreferredName>
        <Version>1</Version>
        <LongName>Mean Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53319</PREFERRED_NAME>
            <LONG_NAME>Arithmetic Mean</LONG_NAME>
            <CON_ID>2528578</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2585012</PublicId>
      <PreferredName>FLOAT_16_CHAR_NUM</PreferredName>
      <PreferredDefinition>DS: A string of characters representing either a fixed point number or a floating point number. A fixed point number shall contain only the characters 0-9 with an optional leading &quot;+&quot; or &quot;-&quot; and an optional &quot;.&quot; to mark the decimal point. A floating point number shall be conveyed as defined in ANSI X3.9, with an &quot;E&quot; or &quot;e&quot; to indicate the start of the exponent. Decimal Strings may be padded with leading or trailing spaces. Embedded spaces are not allowed.  (valid characters 0-9, +,-, E,e,&quot;.&quot;) [Standard-based]</PreferredDefinition>
      <LongName>Float 16 Character Number</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>16</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
      <Representation>
        <PublicId>2585011</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45253:C25337</PreferredName>
        <Version>1</Version>
        <LongName>String Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45253</PREFERRED_NAME>
            <LONG_NAME>String</LONG_NAME>
            <CON_ID>2539471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DVH Mean Dose</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>DVH Mean Dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DICOM Reference</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>PS 3.3-2011: Digital Imaging and Communications in Medicine (DICOM), Part 3: Information Object Definitions</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DICOM Tag CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812790</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RT-Radiotherapy CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000493</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3938979</PublicId>
          <ContextName>NHC-NCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RT-Radiotherapy CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3934151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>(3004,0074)</AlternateName>
        <AlternateNameType>DICOM Attribute Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3</AlternateName>
        <AlternateNameType>DICOM Type</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DVH Mean Dose</AlternateName>
        <AlternateNameType>DICOM Attribute Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="294">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4012048</PUBLICID>
    <LONGNAME>MD Anderson Symptom Inventory - Brain Tumor Past 24 Hours Severity Vision at its Worst Score 11 Point Likert Scale</LONGNAME>
    <PREFERREDNAME>MDASI_BT_VISION_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated perception of the severity of their vision at its worst in the last 24 hours, using an eleven-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MDASI:M.D. Anderson Symptom Inventory, Cleeland et al., 2000</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4012033</PublicId>
      <PreferredName>4012013v1.0:4012031v1.0</PreferredName>
      <PreferredDefinition>A self-administered questionnaire designed specifically for evaluating the severity of symptoms related to a brain tumor._Past; before the present time._A number with no fractional part, including the negative and positive numbers as well as zero.::24_In modern usage, an hour is defined as a unit of time 60 minutes, or 3600 seconds in length. It is approximately 1/24 of a median day._Severity; used of the degree of something undesirable e.g. pain or weather._A question about an individual&#39;s vision at its worst._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>MD Anderson Symptom Inventory - Brain Tumor Past 24 Hour Severity Vision at its Worst Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4012013</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C113089</PreferredName>
        <Version>1</Version>
        <LongName>MD Anderson Symptom Inventory - Brain Tumor </LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113089</PREFERRED_NAME>
            <LONG_NAME>MD Anderson Symptom Inventory - Brain Tumor</LONG_NAME>
            <CON_ID>4004132</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4012031</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4012031v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Past Integer::24 Hour Severity Vision at its Worst Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::24</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25529</PREFERRED_NAME>
            <LONG_NAME>Hour</LONG_NAME>
            <CON_ID>2203682</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113095</PREFERRED_NAME>
            <LONG_NAME>Vision at its Worst Question</LONG_NAME>
            <CON_ID>4004140</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MDASI:M.D. Anderson Symptom Inventory, Cleeland et al., 2000</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3698754</PublicId>
      <PreferredName>3698754v1.0</PreferredName>
      <PreferredDefinition>Subjective evidence of disease perceived by the patient._Used of the degree of something undesirable e.g. pain or weather; also, strictness._A number or range of numeric values measuring performance, function, quality, or ability._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The precise location of something; a spatially limited location._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Symptom Severity Score 11 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>10</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>MDASI:M.D. Anderson Symptom Inventory, Cleeland et al., 2000</Origin>
      <Representation>
        <PublicId>3704131</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3704131v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Symptom Severity Score Integer::11 Point Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70656</PREFERRED_NAME>
            <LONG_NAME>Point</LONG_NAME>
            <CON_ID>2710246</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 2</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 2 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91291, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 3</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 3 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91292, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 4</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 4 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91293, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 5</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 5 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91294, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 6</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 6 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103507, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 7</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 7 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103508, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 8</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 8 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103509, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704143</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 9</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 9 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103510, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not Present To As Bad as You Can Imagine 11 Range Likert Score 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 1 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103506, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>As Bad as You Can Imagine</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating the something is as bad as can be expected or imagined.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Your vision at its WORST?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Your vision at its WORST?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5024211</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MD Anderson Measures</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDASI-BT (M.D. Anderson Symptom Inventory - Brain Tumor)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5024213</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MD Anderson Symptom Inventory - Brain Tumor (MDASI-BT)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>MDASI_BT_VISION_SCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDASI_BT_VISION_SCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDASI_BT_VISION_SCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="295">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4101094</PUBLICID>
    <LONGNAME>Healthy Volunteer Medical History Questionnaire Have History of Opportunistic or Frequent Infection Indicator</LONGNAME>
    <PREFERREDNAME>HTH_VOL_OPP_INF_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of whether or not they have a history of opportunistic or frequent infections.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4101055</PublicId>
      <PreferredName>4101031v1.0:4101053v1.0</PreferredName>
      <PreferredDefinition>A predetermined set of questions designed to identify individuals without significant health related issues to participate in a research study._A question about whether an individual has a history of opportunistic or frequent infections.</PreferredDefinition>
      <LongName>Healthy Volunteer Medical History Questionnaire Have History of Opportunistic or Frequent Infection</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4101031</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C113401</PreferredName>
        <Version>1</Version>
        <LongName>Healthy Volunteer Medical History Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113401</PREFERRED_NAME>
            <LONG_NAME>Healthy Volunteer Medical History Questionnaire</LONG_NAME>
            <CON_ID>4101011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4101053</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C113408</PreferredName>
        <Version>1</Version>
        <LongName>Have History of Opportunistic or Frequent Infection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113408</PREFERRED_NAME>
            <LONG_NAME>Have History of Opportunistic or Frequent Infection Question</LONG_NAME>
            <CON_ID>4101019</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3270332</PublicId>
      <PreferredName>3270332v1.0</PreferredName>
      <PreferredDefinition>The affirmative response to a question or activity._The non-affirmative response to a question._The answer is not known by the person answering._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Yes No Does Not Know Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3270331</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C67142:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Does Not Know Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67142</PREFERRED_NAME>
            <LONG_NAME>Does Not Know</LONG_NAME>
            <CON_ID>2653836</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Don&#39;t know</VALIDVALUE>
          <VALUEMEANING>Don&#39;t Know/Refused</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Do you have a history of oppo</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Do you have a history of opportunistic or frequent infections?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4101003</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HVMHQ</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HVMHQ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4101004</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="296">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4132155</PUBLICID>
    <LONGNAME>Melphalan Dose Clinical Trial Protocol Modification Yes No Unable to Assess Indicator</LONGNAME>
    <PREFERREDNAME>MelpDsMod</PREFERREDNAME>
    <PREFERREDDEFINITION>information related to the change, addition, or omission, as part of the action plan for a clinical trial, in the administered amount of melphalan, an orally available phenylalanine derivative of nitrogen mustard with antineoplastic activity that alkylates DNA at the N7 position of guanine and induces DNA inter-strand cross-linkages, resulting in the inhibition of DNA and RNA synthesis and cytotoxicity against both dividing and non-dividing tumor cells.:The preferred value domain to indicate a question with permissible values of yes/no/unable to assess.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2705096</PublicId>
      <PreferredName>MEL_DOSE_PROT_MOD</PreferredName>
      <PreferredDefinition>information related to the change, addition, or omission, as part of the action plan for a clinical trial, in the administered amount of melphalan, an orally available phenylalanine derivative of nitrogen mustard with antineoplastic activity that alkylates DNA at the N7 position of guanine and induces DNA inter-strand cross-linkages, resulting in the inhibition of DNA and RNA synthesis and cytotoxicity against both dividing and non-dividing tumor cells.</PreferredDefinition>
      <LongName>Melphalan Dose Clinical Trial Protocol Modification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2705062</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C633:C25488</PreferredName>
        <Version>1</Version>
        <LongName>Melphalan Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C633</PREFERRED_NAME>
            <LONG_NAME>Melphalan</LONG_NAME>
            <CON_ID>2521240</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2666439</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25320:C25572</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Protocol Modification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25320</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Protocol</LONG_NAME>
            <CON_ID>2202702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25572</PREFERRED_NAME>
            <LONG_NAME>Modification</LONG_NAME>
            <CON_ID>2203850</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4132153</PublicId>
      <PreferredName>YNUAssessIND</PreferredName>
      <PreferredDefinition>The preferred value domain to indicate a question with permissible values of yes/no/unable to assess.</PreferredDefinition>
      <LongName>Yes No Unable to Assess Indicator</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to Assess</VALIDVALUE>
          <VALUEMEANING>Cannot Be Assessed</VALUEMEANING>
          <MEANINGDESCRIPTION>Aspects of the context prevent the evaluation needed to determine a value.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48657</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2897789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3945562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is there an anatomical abnormality involving the ophthalmic artery that will require increasing the dose of Melphalan for subsequent doses?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="297">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4147832</PUBLICID>
    <LONGNAME>Measurement First Dimension Millimeter Float</LONGNAME>
    <PREFERREDNAME>4321815v1.0:4282731v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A response for questions capturing the measurement or location in the &quot;X&quot; (first or length) dimension in millimeters; this is the longest measurement or largest value if only one measurement is captured.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACRIN:American College of Radiology Imaging Network</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4321815</PublicId>
      <PreferredName>2236773v1.0:2710558v1.0</PreferredName>
      <PreferredDefinition>Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard. Preceding all others in time or space or degree. The magnitude of something in a particular direction, especially length or width or height.</PreferredDefinition>
      <LongName>Measurement First Dimension</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236773</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25209</PreferredName>
        <Version>1</Version>
        <LongName>Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710558</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C25483</PreferredName>
        <Version>1</Version>
        <LongName>First Dimension</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25483</PREFERRED_NAME>
            <LONG_NAME>Dimension</LONG_NAME>
            <CON_ID>2203908</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4282731</PublicId>
      <PreferredName>4282731v1.0</PreferredName>
      <PreferredDefinition>A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch._A number that can have its decimal point in any position.</PreferredDefinition>
      <LongName>Millimeter Float</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>mm</UnitOfMeasure>
      <DisplayFormat>9999.999</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
      <Representation>
        <PublicId>3876477</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28251:C48150</PreferredName>
        <Version>1</Version>
        <LongName>Millimeter Float</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28251</PREFERRED_NAME>
            <LONG_NAME>Millimeter</LONG_NAME>
            <CON_ID>2204830</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48150</PREFERRED_NAME>
            <LONG_NAME>Float</LONG_NAME>
            <CON_ID>2433734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>ML Size</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Measurement X</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Measurement X</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>6702 MR Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>ML Size</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CITN - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>MEASUREMENT_X (Long Axis)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-Lung-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Size-Long (mm)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314439</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging Modality</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mammography</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812368</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314439</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging Modality</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Computed Tomography (CT)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314446</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314439</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging Modality</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Magnetic Resonance Imaging (MRI)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314448</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314439</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging Modality</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Positron Emission Tomography (PET)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314449</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314439</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging Modality</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tomosynthesis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314451</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314439</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging Modality</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ultrasound (US)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314454</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Abdominal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314463</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314464</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecological</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314465</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head/Neck/Neuro</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314470</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Neuroscience</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314471</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Thoracic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Image Finding</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3625159</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Site</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3852732</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506111</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Lung</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung-Vanderbilt</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5506169</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506111</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Lung</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5506173</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>MCL</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="298">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4155044</PUBLICID>
    <LONGNAME>Diagnostic Imaging Review Assessment Received Date</LONGNAME>
    <PREFERREDNAME>IMAGEREVRECD</PREFERREDNAME>
    <PREFERREDDEFINITION>The date information the imaging review was received.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4155043</PublicId>
      <PreferredName>IMAGEREVRECD</PreferredName>
      <PreferredDefinition>Information related to the assessment of an imaging review.</PreferredDefinition>
      <LongName>Diagnostic Imaging Review Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2321520</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16502</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic Imaging</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16502</PREFERRED_NAME>
            <LONG_NAME>Diagnostic Imaging Testing</LONG_NAME>
            <CON_ID>2321519</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4155045</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42729:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Review Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42729</PREFERRED_NAME>
            <LONG_NAME>Review</LONG_NAME>
            <CON_ID>2202331</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2190376</PublicId>
      <PreferredName>RECD_DT</PreferredName>
      <PreferredDefinition>the date an assessment, evaluation, or treatment was received.</PreferredDefinition>
      <LongName>Received Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208024</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25639:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Received Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date mandatory imaging review</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date mandatory imaging review received from Alliance Imaging Core Laboratory</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date local review submitted:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_02</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date report submitted:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_03</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date form submitted:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date Density Measurement Received</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>IMAGEREVRECD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPBE_QVAL_LSUBMTDT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPBE_QVAL_CSUBMTDT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="299">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4179254</PUBLICID>
    <LONGNAME>Polyp Location Description Number</LONGNAME>
    <PREFERREDNAME>POLYP_LOC_DESC_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>The number description of the location of a polyp that was only identified by measurement.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4179252</PublicId>
      <PreferredName>2480176v1.0:2240715v1.0</PreferredName>
      <PreferredDefinition>A usually exophytic mass attached to the underlying tissue by a broad base or a thin stalk.  Polyps can be neoplastic or non-neoplastic.  Neoplastic polyps usually represent proliferations of the epithelium, and are commonly seen in the gastrointestinal tract.  Polyps of the gastrointestinal tract are often called adenomas, are associated with dysplasia, and may eventually transform into carcinomas.  Non-neoplastic polyps may be inflammatory, degenerative, or the result of malformations._A position, site, or point in space where something can be found.</PreferredDefinition>
      <LongName>Polyp Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480176</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3340</PreferredName>
        <Version>1</Version>
        <LongName>Polyp</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3340</PREFERRED_NAME>
            <LONG_NAME>Polyp</LONG_NAME>
            <CON_ID>2202781</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2240715</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25341</PreferredName>
        <Version>1</Version>
        <LongName>Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4179253</PublicId>
      <PreferredName>LOC_DESC_NUM</PreferredName>
      <PreferredDefinition>A written or verbal account, representation, statement, or explanation of something._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.</PreferredDefinition>
      <LongName>Location Description Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>4276353</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Description Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If location only identified b</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If location only identified by cm:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="300">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4182706</PUBLICID>
    <LONGNAME>Injection Site Pruritus Occurrence Yes None Indicator</LONGNAME>
    <PREFERREDNAME>INJ_SIT_PRUR_OCC_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/none response regarding whether an intense itching sensation occurred at the site where a medication or vaccine was injected.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4182696</PublicId>
      <PreferredName>4182694v1.0:2234856v1.0</PreferredName>
      <PreferredDefinition>The anatomic site at which a medication or a vaccine is injected._An instance of something happening, such as an event or incident._An intense itching sensation.</PreferredDefinition>
      <LongName>Injection Site Pruritus Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4182694</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C77680:C3344</PreferredName>
        <Version>1</Version>
        <LongName>Injection Site Pruritus</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C77680</PREFERRED_NAME>
            <LONG_NAME>Injection Site</LONG_NAME>
            <CON_ID>3377282</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3344</PREFERRED_NAME>
            <LONG_NAME>Pruritus</LONG_NAME>
            <CON_ID>2203698</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4684012</PublicId>
      <PreferredName>4684012v1.0</PreferredName>
      <PreferredDefinition>The affirmative response to a question._No person or thing, nobody, not any._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Yes None Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DCP:Division of Cancer Prevention</Origin>
      <Representation>
        <PublicId>4684011</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C41132:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Yes None Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41132</PREFERRED_NAME>
            <LONG_NAME>None</LONG_NAME>
            <CON_ID>2433421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Itching at site</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Itching at site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="301">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4188243</PUBLICID>
    <LONGNAME>Investigational Product Overdose Start Date</LONGNAME>
    <PREFERREDNAME>4188242v1.0:2179512v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The start date for the overdose of the investigational product</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4188242</PublicId>
      <PreferredName>4188239v1.0:4188240v1.0</PreferredName>
      <PreferredDefinition>Information related to an overdose of the investigational product being studied.</PreferredDefinition>
      <LongName>Investigational Product Overdose</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4188239</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28041:C51980</PreferredName>
        <Version>1</Version>
        <LongName>Investigational Product</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28041</PREFERRED_NAME>
            <LONG_NAME>Investigational</LONG_NAME>
            <CON_ID>2422346</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51980</PREFERRED_NAME>
            <LONG_NAME>Product</LONG_NAME>
            <CON_ID>2527882</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4188240</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50873</PreferredName>
        <Version>1</Version>
        <LongName>Overdose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50873</PREFERRED_NAME>
            <LONG_NAME>Overdose</LONG_NAME>
            <CON_ID>4170179</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2179512</PublicId>
      <PreferredName>AGT_START_DT</PreferredName>
      <PreferredDefinition>The date an agent dosage begin.</PreferredDefinition>
      <LongName>Agent Start Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008565</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TEMPORAL_CONCEPTS</PreferredName>
        <Version>1</Version>
        <LongName>Temporal concepts</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength>10</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Overdose start date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Overdose start date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="302">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4233293</PUBLICID>
    <LONGNAME>Hypersensitivity Recombinant Granulocyte-Macrophage Colony-Stimulating Factor Test Performed Laboratory Finding Result</LONGNAME>
    <PREFERREDNAME>4233147v1.0:2676304v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The outcome of the laboratory procedure related to the assessment of hypersensitivity to recombinant granulocyte macrophage colony stimulating factor.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4233147</PublicId>
      <PreferredName>4233145v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>A local or general reaction of an organism following contact with a specific allergen to which it has been previously exposed and to which it has become sensitized._Granulocyte-macrophage colony-stimulating factor. A colony-stimulating factor that stimulates the production of white blood cells, especially granulocytes and macrophages, and cells (in the bone marrow) that are precursors of platelets. It is a cytokine that belongs to the family of drugs called hematopoietic (blood-forming) agents. Also called sargramostim._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Hypersensitivity Recombinant Granulocyte-Macrophage Colony-Stimulating Factor Test Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4233145</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3114:C1288:C47891</PreferredName>
        <Version>1</Version>
        <LongName>Hypersensitivity Recombinant Granulocyte-Macrophage Colony-Stimulating Factor Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3114</PREFERRED_NAME>
            <LONG_NAME>Hypersensitivity</LONG_NAME>
            <CON_ID>2203756</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1288</PREFERRED_NAME>
            <LONG_NAME>Recombinant Granulocyte-Macrophage Colony-Stimulating Factor</LONG_NAME>
            <CON_ID>2415074</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47891</PREFERRED_NAME>
            <LONG_NAME>Test</LONG_NAME>
            <CON_ID>2427511</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2676304</PublicId>
      <PreferredName>LAB_RSLT</PreferredName>
      <PreferredDefinition>The outcome of a laboratory test._Outcome; a phenomenon that follows and is caused by some previous phenomenon.</PreferredDefinition>
      <LongName>Laboratory Finding Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>41</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2876957</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C36292:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test Result Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C36292</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Result</LONG_NAME>
            <CON_ID>2451822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated</VALIDVALUE>
          <VALUEMEANING>Elevated</VALUEMEANING>
          <MEANINGDESCRIPTION>Elevated; raised or increased.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-05</PVBEGINDATE>
          <PVENDDATE>2013-09-04</PVENDDATE>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes: C49488</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never below</VALIDVALUE>
          <VALUEMEANING>Never Less Than</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).: A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61585, C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2682054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reactive</VALIDVALUE>
          <VALUEMEANING>Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported reactive, not tested</VALIDVALUE>
          <VALUEMEANING>Previous Report Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.: Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637, C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not reported</VALIDVALUE>
          <VALUEMEANING>Not Report</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not performed; HIV NAT testing performed</VALIDVALUE>
          <VALUEMEANING>Human Immunodeficiency Virus Nucleic Acid Amplification Test Performed</VALUEMEANING>
          <MEANINGDESCRIPTION>Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME.: Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.: Performed; carried out.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38000, C20055, C14219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2727600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-reactive</VALIDVALUE>
          <VALUEMEANING>Not Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2617835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known</VALIDVALUE>
          <VALUEMEANING>Laboratory Finding Received</VALUEMEANING>
          <MEANINGDESCRIPTION>The outcome of a laboratory test._To take, accept, or get something offered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25639, C36292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2729916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low</VALIDVALUE>
          <VALUEMEANING>Low</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimum level or position or degree; less than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inconclusive</VALIDVALUE>
          <VALUEMEANING>Uncertain</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2749725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate/equivocal</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-09</PVBEGINDATE>
          <PVENDDATE>2013-12-17</PVENDDATE>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline</VALIDVALUE>
          <VALUEMEANING>Borderline</VALUEMEANING>
          <MEANINGDESCRIPTION>Straddling the dividing line between two categories.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reduced; decreased</VALIDVALUE>
          <VALUEMEANING>Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Made less in size or amount or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-09</PVBEGINDATE>
          <PVENDDATE>2012-06-29</PVENDDATE>
          <VMPUBLICID>3135563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3079341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invalid neutralization</VALIDVALUE>
          <VALUEMEANING>Unacceptable Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>Failing to satisfy an established set of qualifying measures.: The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533, C63354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutralized</VALIDVALUE>
          <VALUEMEANING>Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not neutralizable</VALIDVALUE>
          <VALUEMEANING>Negation Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Increased</VALIDVALUE>
          <VALUEMEANING>Increase</VALUEMEANING>
          <MEANINGDESCRIPTION>Increase; a process of becoming larger or more numerous or more important.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decreased</VALIDVALUE>
          <VALUEMEANING>Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Made less in size or amount or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3135563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Severe</VALIDVALUE>
          <VALUEMEANING>Severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely or extremely bad or unpleasant in degree, quality, or extent; life threatening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2842706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mild</VALIDVALUE>
          <VALUEMEANING>Mild</VALUEMEANING>
          <MEANINGDESCRIPTION>Not severe or strong; far from extreme; not serious enough to endanger life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High</VALIDVALUE>
          <VALUEMEANING>High</VALUEMEANING>
          <MEANINGDESCRIPTION>High; greater than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not evaluable</VALIDVALUE>
          <VALUEMEANING>Not Assessable/Not Evaluable</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to be evaluated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carrier of the trait</VALIDVALUE>
          <VALUEMEANING>Genetic Carrier Trait</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who carries an inheritable genetic mutation without manifestation of the associated condition.: Any genetically determined characteristic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85496, C111031</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3872849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate/equivocal</VALIDVALUE>
          <VALUEMEANING>Indeterminate Or Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071, C37998, C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4012172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resolved</VALIDVALUE>
          <VALUEMEANING>Resolved</VALUEMEANING>
          <MEANINGDESCRIPTION>Return to the normal structure and/or function, e.g. the subsidence of a pathologic process, as the subsidence of an inflammatory lesion or new growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2936016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Improved</VALIDVALUE>
          <VALUEMEANING>Better</VALUEMEANING>
          <MEANINGDESCRIPTION>In an improved condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Worse</VALIDVALUE>
          <VALUEMEANING>Worse</VALUEMEANING>
          <MEANINGDESCRIPTION>In an declined condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unchanged</VALIDVALUE>
          <VALUEMEANING>About the same</VALUEMEANING>
          <MEANINGDESCRIPTION>In an unchanged or similar condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3178174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Involved</VALIDVALUE>
          <VALUEMEANING>Involvement</VALUEMEANING>
          <MEANINGDESCRIPTION>To have a connection by participation or association or use; sharing in an activity or process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4244451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not available</VALIDVALUE>
          <VALUEMEANING>Negation Availability</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Available; obtainable or accessible and ready for use or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25429, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested</VALIDVALUE>
          <VALUEMEANING>Not Tested</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a test was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3918247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-secretory</VALIDVALUE>
          <VALUEMEANING>Non-Secretory Myeloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare type of multiple myeloma in which the plasma cells synthesize but do not secrete immunoglobulins.  As a result, none of the immunoglobulins appear out of the normal range.  The symptoms are generally the same with those of immunoglobulin-secreting myeloma; however, the incidence of renal insufficiency is lower in non-secretory myeloma.  The diagnosis can be missed because of the absence of monoclonal immunoglobulin in the serum or urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4734</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive/Suggestive</VALIDVALUE>
          <VALUEMEANING>Positive Finding And/Or Characteristic</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.: Used to indicate that either or both of two items or options may be valid.: The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25447, C48928, C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5036957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inconclusive / equivocal</VALIDVALUE>
          <VALUEMEANING>Uncertain And/Or Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.: Used to indicate that either or both of two items or options may be valid.: Open to question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071, C48928, C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suggestive</VALIDVALUE>
          <VALUEMEANING>Suggestion</VALUEMEANING>
          <MEANINGDESCRIPTION>A proposal offered for acceptance or rejection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5070731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not assessed</VALIDVALUE>
          <VALUEMEANING>Negation Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The final result of a determination of the value, significance, or extent of.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25594, C25217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4982117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Confirmed positive</VALIDVALUE>
          <VALUEMEANING>Confirmation Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>Having been established or verified.: A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758, C25458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5677531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No growth</VALIDVALUE>
          <VALUEMEANING>Negation Growth</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: A process of becoming larger or longer or more numerous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64379, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5653622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pending</VALIDVALUE>
          <VALUEMEANING>Pending</VALUEMEANING>
          <MEANINGDESCRIPTION>Not yet decided or settled; awaiting conclusion or confirmation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2784518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unsatisfactory</VALIDVALUE>
          <VALUEMEANING>Unsatisfactory</VALUEMEANING>
          <MEANINGDESCRIPTION>Failing to meet the quantitative or qualitative measures for the needs of a situation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5255277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No result</VALIDVALUE>
          <VALUEMEANING>Negation Laboratory Test Result</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The outcome of a laboratory test.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36292, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7096109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Contraindicated</VALIDVALUE>
          <VALUEMEANING>Contraindicated</VALUEMEANING>
          <MEANINGDESCRIPTION>State of a particular method of treatment, regimen, procedure, medication, etc. of being unsuitable and inadvisable, often because of a likely adverse reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14665139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Equivocal</VALIDVALUE>
          <VALUEMEANING>Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What were the results for the</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What were the results for the hypersensitivity recombinant granulocyte macrophage colony stimulating factor assessment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify result</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify result</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify result</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify result</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpre_lab_diag_hypersen_gm_csf_result</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="303">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4233310</PUBLICID>
    <LONGNAME>Lung Pleural Effusion Yes No Not Applicable Indicator</LONGNAME>
    <PREFERREDNAME>LNG_PLR_EFF_YNNA_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The Yes/No/NA Indicator for information related to pleural effusion pertaining to the lung.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NRG CRF:NRG Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188745</PublicId>
      <PreferredName>LUNG_PLRL_EFF</PreferredName>
      <PreferredDefinition>information related to pleural effusion pertaining to the lung.</PreferredDefinition>
      <LongName>Lung Pleural Effusion</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177118</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Lung</PreferredName>
        <Version>1</Version>
        <LongName>Lung</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12468</PREFERRED_NAME>
            <LONG_NAME>Lung</LONG_NAME>
            <CON_ID>2202738</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207735</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25223:C3003</PreferredName>
        <Version>1</Version>
        <LongName>Pleural Effusion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25223</PREFERRED_NAME>
            <LONG_NAME>Pleural</LONG_NAME>
            <CON_ID>2206346</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3003</PREFERRED_NAME>
            <LONG_NAME>Effusion</LONG_NAME>
            <CON_ID>2203915</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506036</PublicId>
      <PreferredName>YES_NO_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.</PreferredDefinition>
      <LongName>Yes No Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694966</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49797</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3b</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49797</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Not Applicable Response</LONG_NAME>
            <CON_ID>2694965</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If a pleural effusion is pres</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If a pleural effusion is present, were all of the criteria met from section 3.1?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If a pleural effusion is present, were all of the criteria from Patient Eligibility met?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is pleural effusion less than or equal to grade 2?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LNG_PLR_EFF_YNNA_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="304">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4276832</PUBLICID>
    <LONGNAME>Laboratory Procedure Serum Immunologic IgM Result Integer::2 Decimal Place Value</LONGNAME>
    <PREFERREDNAME>2191524v1.0:2784513v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The 2 decimal place numeric laboratory value measured, assigned or computed related to the assessment of IgM in a specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2191524</PublicId>
      <PreferredName>LAB_SRM_IGM_RSLT</PreferredName>
      <PreferredDefinition>information related to the result of the medical procedure that involves testing a sample of blood for immunoglobulin type M (IgM), the major immunoglobulin secreted during a primary immune response, serum immunologic laboratory.</PreferredDefinition>
      <LongName>Laboratory Procedure Serum Immunologic IgM Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738926</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25675:C569:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Serum Immunologic IgM Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25675</PREFERRED_NAME>
            <LONG_NAME>Serum Immunologic</LONG_NAME>
            <CON_ID>2202817</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C569</PREFERRED_NAME>
            <LONG_NAME>IgM</LONG_NAME>
            <CON_ID>2206240</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784513</PublicId>
      <PreferredName>LAB_PROC_OUT_2DP_VAL</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Outcome; a phenomenon that follows and is caused by some previous phenomenon._A number with no fractional part, including the negative and positive numbers as well as zero.::2_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Laboratory Procedure Outcome Integer::2 Decimal Place Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784512</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294:C20200:C45255::2:C42646</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Outcome Integer::2 Decimal Place Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the value of serum Ig</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the value of serum IgM?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the value of IgM?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the value of IgM?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpost_best_resp_stat_IgM_value</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpost_lab_eval_IgM_value</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="305">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4281575</PUBLICID>
    <LONGNAME>SF-36v2 Health Survey  Past 4 Weeks How Much Physical Health Or Emotional Problems Interfere With Normal Social Activities Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>SF36_INF_SOCIAL_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated perception of the extent that their physical health or emotional problems has interferred with their normal social activities with family, friends, neighbors, or groups, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>SF-36v2:Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire, Sherbourne Cathy D; Ware John E., 1998</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4281342</PublicId>
      <PreferredName>4281291v1.0:4281340v1.0</PreferredName>
      <PreferredDefinition>A standardized, multipurpose, general health survey developed by John E. Ware and copyrighted by Quality Metric Inc. and the Medical Outcomes Trust in 1996 and 2000 which is used to assess the patient&#39;s functional health and overall well-being. This second version contains 36 questions that refer to the patient&#39;s symptoms or status within the past four weeks and can be completed by the patient. For each question the patient must choose from five different responses._A period of time consisting of the 28 days before the present._A question about how much of the time something is occurring or has occurred._The general condition of one&#39;s body._A difficulty, disorder, or condition needing resolution._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A perceived issue with a person&#39;s emotional wellbeing._The act of hindering or obstructing or impeding._Used to indicate the presence of something or someone._Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm._Interactions with one or more individuals, usually with a common purpose or with regards to a common topic of interest._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Short Form 36 Health Survey Standard US Version 2.0 Questionnaire Past 4 Weeks How Much of the Time Physical Well-being Problem Or Emotional Problem Interference With Normal Socializing Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4281291</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102122</PreferredName>
        <Version>1</Version>
        <LongName>Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102122</PREFERRED_NAME>
            <LONG_NAME>Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire</LONG_NAME>
            <CON_ID>4276451</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4281340</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4281340v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Past 4 Weeks How Much of the Time Physical Well-being Problem Or Emotional Problem Interference With Normal Socializing Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110986</PREFERRED_NAME>
            <LONG_NAME>Past 4 Weeks</LONG_NAME>
            <CON_ID>3871096</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>10</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C111702</PREFERRED_NAME>
            <LONG_NAME>How Much of the Time Question</LONG_NAME>
            <CON_ID>3930498</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>9</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91779</PREFERRED_NAME>
            <LONG_NAME>Physical Well-being</LONG_NAME>
            <CON_ID>3133348</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>8</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28020</PREFERRED_NAME>
            <LONG_NAME>Problem</LONG_NAME>
            <CON_ID>2203953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>7</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C114900</PREFERRED_NAME>
            <LONG_NAME>Emotional Problem</LONG_NAME>
            <CON_ID>4276791</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C72886</PREFERRED_NAME>
            <LONG_NAME>Interference</LONG_NAME>
            <CON_ID>2734007</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62355</PREFERRED_NAME>
            <LONG_NAME>With</LONG_NAME>
            <CON_ID>2532083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14165</PREFERRED_NAME>
            <LONG_NAME>Normal</LONG_NAME>
            <CON_ID>2204843</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C81007</PREFERRED_NAME>
            <LONG_NAME>Socializing</LONG_NAME>
            <CON_ID>2878370</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>SF-36v2:Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire, Sherbourne Cathy D; Ware John E., 1998</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4281251</PublicId>
      <PreferredName>EXT_INTERF_5PT_SCL</PreferredName>
      <PreferredDefinition>A Likert scale that captures the score of the extent of interference from 1 (not at all) to 5 (extremely).</PreferredDefinition>
      <LongName>Extent of Interference 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>SF-36v2:Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire, Sherbourne Cathy D; Ware John E., 1998</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Slight</VALUEMEANING>
          <MEANINGDESCRIPTION>Small or little in size, quantity, or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3906434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Extremely</VALUEMEANING>
          <MEANINGDESCRIPTION>The highest degree of severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4281252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>During the past 4 weeks, to w</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3863415</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MOS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SF-36v2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4281631</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4280881</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>SF-36v2</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SF-36v2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4281200</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Social Support Survey</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900387</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SF36_INF_SOCIAL_SCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="306">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4320675</PUBLICID>
    <LONGNAME>Nodule Density Maximum Measurement Value</LONGNAME>
    <PREFERREDNAME>NOD_DENS_MAX_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>Value for the maximum density of a nodule.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4320674</PublicId>
      <PreferredName>2453620v1.0:4320672v1.0</PreferredName>
      <PreferredDefinition>A small lump, swelling or collection of tissue._The amount of something per unit size._Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard._The largest possible quantity or degree.</PreferredDefinition>
      <LongName>Nodule Density Maximum Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2453620</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3280</PreferredName>
        <Version>1</Version>
        <LongName>Nodule</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3280</PREFERRED_NAME>
            <LONG_NAME>Nodule</LONG_NAME>
            <CON_ID>2202765</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4320676</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45781:C25564:C25209</PreferredName>
        <Version>1</Version>
        <LongName>Density Maximum Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45781</PREFERRED_NAME>
            <LONG_NAME>Density</LONG_NAME>
            <CON_ID>2236512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25564</PREFERRED_NAME>
            <LONG_NAME>Maximum</LONG_NAME>
            <CON_ID>2202550</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4339102</PublicId>
      <PreferredName>NOD_DSTY_VAL</PreferredName>
      <PreferredDefinition>Value to represent the counted number of nodules within an area of assessed tissue.</PreferredDefinition>
      <LongName>Nodule Density Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2183095</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Value</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Maximum Density</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Maximum Density</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="307">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4321821</PUBLICID>
    <LONGNAME>Patient Reported Outcome Oral Symptoms Burning Sensation Assessment Likert Scale Text</LONGNAME>
    <PREFERREDNAME>OSBURN</PREFERREDNAME>
    <PREFERREDDEFINITION>A psychometric scale (0-10, with 0 being No stinging or burning and 10 being Worst stinging or burning possible) for information regarding the Patient Completed Oral Symptoms assessment of a burning or stinging sensation, collected directly from a patient that typically includes subjective feelings regarding symptoms, functions in daily life, physical, mental, emotional, spiritual, and social well being, and satisfaction with his/her health care.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4321811</PublicId>
      <PreferredName>OSBURN</PreferredName>
      <PreferredDefinition>Information on the Patient Completed Oral Symptoms assessment of a burning or stinging sensation, collected directly from a patient that typically includes subjective feelings regarding symptoms, functions in daily life, physical, mental, emotional, spiritual, and social well being, and satisfaction with his/her health care.</PreferredDefinition>
      <LongName>Patient Reported Outcome Oral Symptoms Burning Sensation Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3944900</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95401</PreferredName>
        <Version>1</Version>
        <LongName>Patient Reported Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95401</PREFERRED_NAME>
            <LONG_NAME>Patient Reported Outcome</LONG_NAME>
            <CON_ID>3185129</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4321809</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25311:C4876:C50476:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Oral Symptom Burning Sensation Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25311</PREFERRED_NAME>
            <LONG_NAME>Oral</LONG_NAME>
            <CON_ID>2204975</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50476</PREFERRED_NAME>
            <LONG_NAME>Burning Sensation</LONG_NAME>
            <CON_ID>2871837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3626258</PublicId>
      <PreferredName>3626258v1.0</PreferredName>
      <PreferredDefinition>A psychometric scale commonly used in questionnaires where a respondent is asked to evaluate an opinion according to subjective or objective criteria, by rating their level of agreement or disagreement with a statement._Text; the words of something written.</PreferredDefinition>
      <LongName>Likert Scale Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3626257</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C85429:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Likert Scale Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85429</PREFERRED_NAME>
            <LONG_NAME>Likert Scale</LONG_NAME>
            <CON_ID>2971959</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>On a scale from 0 to 10, what</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>On a scale from 0 to 10, what number best describes any STINGING OR BURNING FROM THE ORAL RINSE now? (circle one number)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>On a scale from 0 to 10, what number best describes any STINGING OR BURNING FROM THE ORAL RINSE this day? (circle one number)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OSBURN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="308">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4321918</PUBLICID>
    <LONGNAME>Patient Reported Outcome Oral Symptoms Rinse Use Assessment Yes No Indicator</LONGNAME>
    <PREFERREDNAME>OSRINSEUSE</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator for information on the Patient Completed Oral Symptoms assessment regarding use of the oral rinse, collected directly from a patient that typically includes subjective feelings regarding symptoms, functions in daily life, physical, mental, emotional, spiritual, and social well being, and satisfaction with his/her health care.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4321914</PublicId>
      <PreferredName>OSRINSEUSE</PreferredName>
      <PreferredDefinition>Information on the Patient Completed Oral Symptoms assessment regarding use of the oral rinse, collected directly from a patient that typically includes subjective feelings regarding symptoms, functions in daily life, physical, mental, emotional, spiritual, and social well being, and satisfaction with his/her health care.</PreferredDefinition>
      <LongName>Patient Reported Outcome Oral Symptoms Rinse Use Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3944900</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95401</PreferredName>
        <Version>1</Version>
        <LongName>Patient Reported Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95401</PREFERRED_NAME>
            <LONG_NAME>Patient Reported Outcome</LONG_NAME>
            <CON_ID>3185129</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4321912</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4321912v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Oral Symptom Rinse Dosage Form Use Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25311</PREFERRED_NAME>
            <LONG_NAME>Oral</LONG_NAME>
            <CON_ID>2204975</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42979</PREFERRED_NAME>
            <LONG_NAME>Rinse Dosage Form</LONG_NAME>
            <CON_ID>2480453</CON_ID>
            <DEFINITION_SOURCE>FDA</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did you use the study rinse t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did you use the study rinse today? (circle &#39;Yes&#39; or &#39;No&#39;)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OSRINSEUSE</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="309">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4339043</PUBLICID>
    <LONGNAME>Patient Version Prognosis Treatment and Perceptions Questionnaire Feelings About the Amount of Information Known About Cancer Prognosis 3 Point Scale</LONGNAME>
    <PREFERREDNAME>PT_FEEL_INFO_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation, considering all things, of how they feel about the amount of information they know about the likely outcome of your cancer over time, using a 3 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PTPQ:Prognosis and Treatment Perceptions Questionnaire as referenced in Associations Among Prognostic Understanding, Quality of Life, El-Jawahri A, et.al., 2014</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4336997</PublicId>
      <PreferredName>4336902v1.0:4336995v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications._A 13-item questionnaire used to assess information preferences, perceptions of prognosis and goal of therapy, and communication about end-of-life care._A question about a person&#39;s feelings about the amount of information they know about the likely outcome of the patient&#39;s cancer.</PreferredDefinition>
      <LongName>Patient Version Prognosis Treatment and Perceptions Questionnaire Feelings About the Amount of Information Known About Cancer Prognosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4336902</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C25714:C115446</PreferredName>
        <Version>1</Version>
        <LongName>Patient Version Prognosis Treatment and Perceptions Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C115446</PREFERRED_NAME>
            <LONG_NAME>Prognosis Treatment and Perceptions Questionnaire</LONG_NAME>
            <CON_ID>4336889</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4336995</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C115453</PreferredName>
        <Version>1</Version>
        <LongName>Feelings About the Amount of Information Known About Cancer Prognosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C115453</PREFERRED_NAME>
            <LONG_NAME>Feelings About the Amount of Information Known About Cancer Prognosis Question</LONG_NAME>
            <CON_ID>4336896</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PTPQ:Prognosis and Treatment Perceptions Questionnaire as referenced in Associations Among Prognostic Understanding, Quality of Life, El-Jawahri A, et.al., 2014</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4337232</PublicId>
      <PreferredName>PROGINFO_AMT_3PT_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard with three text responses related to the amount of information an individual has or wants about their prognosis.</PreferredDefinition>
      <LongName>Prognosis Information Amount 3 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>57</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PTPQ:Prognosis and Treatment Perceptions Questionnaire as referenced in Associations Among Prognostic Understanding, Quality of Life, El-Jawahri A, et.al., 2014</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I wish I had less information about my prognosis</VALIDVALUE>
          <VALUEMEANING>Want Less Information About Prognosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that a person would have liked less information about the patient&#39;s prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C115913</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4337233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I now have about the right amount of information</VALIDVALUE>
          <VALUEMEANING>Have Right Amount of Information About Prognosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that a person has the right amount of information about the patient&#39;s prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C115911</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4337234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I wish I had more information about my prognosis</VALIDVALUE>
          <VALUEMEANING>Want More Information About Prognosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that a person would like more information about the patient&#39;s prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C115909</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4337235</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>All things considered, how do</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>All things considered, how do you feel about the amount of information you know about the likely outcome of your cancer over time (i.e. your prognosis)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4320453</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PTPQ</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Version PTPQ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4320455</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Version PTPQ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900390</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="310">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4356910</PUBLICID>
    <LONGNAME>Event Location United States Time Zone Code</LONGNAME>
    <PREFERREDNAME>EVENT_LOC_US_TM_ZN_CD</PREFERREDNAME>
    <PREFERREDDEFINITION>A code that represents the time zone in which an event occured.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4356838</PublicId>
      <PreferredName>EVENT_LOC</PreferredName>
      <PreferredDefinition>A position, site, or point in space where something happens.</PreferredDefinition>
      <LongName>Event Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2423306</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499</PreferredName>
        <Version>1</Version>
        <LongName>Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2240715</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25341</PreferredName>
        <Version>1</Version>
        <LongName>Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4356772</PublicId>
      <PreferredName>US_TIME_ZONE_CDS</PreferredName>
      <PreferredDefinition>Codes representing the United States geographic regions where the same standard time is used.</PreferredDefinition>
      <LongName>United States Time Zone Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008565</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TEMPORAL_CONCEPTS</PreferredName>
        <Version>1</Version>
        <LongName>Temporal concepts</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>3</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>4356771</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17234:C80453:C25162</PreferredName>
        <Version>1</Version>
        <LongName>United States Time Zone Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17234</PREFERRED_NAME>
            <LONG_NAME>United States</LONG_NAME>
            <CON_ID>2480138</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80453</PREFERRED_NAME>
            <LONG_NAME>Time Zone</LONG_NAME>
            <CON_ID>2928099</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AKST</VALIDVALUE>
          <VALUEMEANING>Alaska Standard Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Local standard time, based at the 135th meridian west of the Greenwich Observatory, established as nine hours behind Coordinated Universal Time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4356773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CST</VALIDVALUE>
          <VALUEMEANING>Central Standard Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Local standard time, based at the 90th meridian west of the Greenwich Observatory, established as six hours behind Coordinated Universal Time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4356774</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EST</VALIDVALUE>
          <VALUEMEANING>Eastern Standard Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Local standard time, based at the 75th meridian west of the Greenwich Observatory, established as five hours behind Coordinated Universal Time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4356775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HAST</VALIDVALUE>
          <VALUEMEANING>Hawaii-Aleutian Standard Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Local standard time, based at the 150th meridian west of the Greenwich Observatory, established as ten hours behind Coordinated Universal Time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4356776</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MST</VALIDVALUE>
          <VALUEMEANING>Mountain Standard Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Local standard time, based at the 105th meridian west of the Greenwich Observatory, established as seven hours behind Coordinated Universal Time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116266</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4356777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PST</VALIDVALUE>
          <VALUEMEANING>Pacific Standard Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Local standard time, based at the 120th meridian west of the Greenwich Observatory, established as eight hours behind Coordinated Universal Time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4356778</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AKDT</VALIDVALUE>
          <VALUEMEANING>Alaska Daylight Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Local daylight-savings time, based at the 135th meridian west of the Greenwich Observatory, established as eight hours behind Coordinated Universal Time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4356779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CDT</VALIDVALUE>
          <VALUEMEANING>Central Daylight Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Local daylight-savings time, based at the 90th meridian west of the Greenwich Observatory, established as five hours behind Coordinated Universal Time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116258</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4356780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EDT</VALIDVALUE>
          <VALUEMEANING>Eastern Daylight Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Local daylight-savings time, based at the 75th meridian west of the Greenwich Observatory, established as four hours behind Coordinated Universal Time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116257</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4356781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HADT</VALIDVALUE>
          <VALUEMEANING>Hawaii-Aleutian Daylight Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Local daylight-savings time, based at the 150th meridian west of the Greenwich Observatory, established as nine hours behind Coordinated Universal Time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4356782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MDT</VALIDVALUE>
          <VALUEMEANING>Mountain Daylight Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Local daylight-savings time, based at the 105th meridian west of the Greenwich Observatory, established as six hours behind Coordinated Universal Time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116259</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4356783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PDT</VALIDVALUE>
          <VALUEMEANING>Pacific Daylight Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Local daylight-savings time, based at the 120th meridian west of the Greenwich Observatory, established as seven hours behind Coordinated Universal Time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4356784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Time Zone</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Time Zone</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="311">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4379964</PUBLICID>
    <LONGNAME>Person Hyponatremia Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>HYPON_ELIG_COD_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded yes/no/not applicable indicator regarding whether a person has a lower than normal levels of sodium in the circulating blood as an element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3182767</PublicId>
      <PreferredName>2236731v1.0:3182765v1.0</PreferredName>
      <PreferredDefinition>information related to a person having lower than normal levels of sodium in the circulating blood as an element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.</PreferredDefinition>
      <LongName>Person Hyponatremia Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3182765</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37976:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Hyponatremia Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37976</PREFERRED_NAME>
            <LONG_NAME>Hyponatremia</LONG_NAME>
            <CON_ID>2203720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have hyponatremi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have hyponatremia (sodium less than 130 mmol/L)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is pre-study serum sodium greater than 130 mmol/L?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is baseline sodium less than or equal to 130 mEq/L?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is baseline sodium greater than or equal to 130 mEq/L?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876359</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Exclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory Data (including serologic/viral status)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876594</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Theradex</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Theradex - CTMS 3.14</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3876603</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Theradex</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HYPON_ELIG_COD_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="312">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4385754</PUBLICID>
    <LONGNAME>Equipment Reprocessor Manufacturer Geographic Location Address Postal Code Identifier</LONGNAME>
    <PREFERREDNAME>4385736v1.0:2179524v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Further or repeated use of equipment, instruments, devices, or materials. It includes additional use regardless of the original intent of the producer as to disposability or durability. It does not include the repeated use of fluids or solutions.A person, enterprise, or entity that produces finished goods._A position, site, or point in space where something can be found._Of or relating to the science of geography; determined by geography.__The string of characters used to identify the five-digit Zone Improvement Plan (ZIP) code and the four-digit extension code (if available) that represents the geographic segment that is a subunit of the ZIPcode, assigned by the U.S. Postal Service to a geographic location to facilitate mail delivery; or the postal zone specific to the country, other than the U.S., where the mail is delivered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ONC SDC Project</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4385736</PublicId>
      <PreferredName>2192995v1.0:4385734v1.0</PreferredName>
      <PreferredDefinition>Further or repeated use of equipment, instruments, devices, or materials. It includes additional use regardless of the original intent of the producer as to disposability or durability. It does not include the repeated use of fluids or solutions.A person, enterprise, or entity that produces finished goods._A position, site, or point in space where something can be found._Of or relating to the science of geography; determined by geography._</PreferredDefinition>
      <LongName>Equipment Reuse Manufacturer Geographic Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ONC SDC Project</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008543</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>GEO_LCTNS</PreferredName>
        <Version>1</Version>
        <LongName>Geographic Locations</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2192995</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Equipment Reuse</PreferredName>
        <Version>1</Version>
        <LongName>Equipment Reuse</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0206199</PREFERRED_NAME>
            <LONG_NAME>Equipment Reuse</LONG_NAME>
            <CON_ID>2203286</CON_ID>
            <DEFINITION_SOURCE>MSH2004_2003_12_12</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4385734</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25392:C37957:C25341</PreferredName>
        <Version>1</Version>
        <LongName>Manufacturer Geographic Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25392</PREFERRED_NAME>
            <LONG_NAME>Manufacturer</LONG_NAME>
            <CON_ID>2203842</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37957</PREFERRED_NAME>
            <LONG_NAME>Geographic</LONG_NAME>
            <CON_ID>2434959</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2179524</PublicId>
      <PreferredName>ADDR_POSTAL_CD_ID</PreferredName>
      <PreferredDefinition>The string of characters used to identify the five-digit Zone Improvement Plan (ZIP) code and the four-digit extension code (if available) that represents the geographic segment that is a subunit of the ZIPcode, assigned by the U.S. Postal Service to a geographic location to facilitate mail delivery; or the postal zone specific to the country, other than the U.S., where the mail is delivered.</PreferredDefinition>
      <LongName>Address Postal Code Identifier</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008573</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2598491</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25407:C25621:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Address Postal Code Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25407</PREFERRED_NAME>
            <LONG_NAME>Address</LONG_NAME>
            <CON_ID>2202289</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25621</PREFERRED_NAME>
            <LONG_NAME>Postal Code</LONG_NAME>
            <CON_ID>2202573</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Reprocessor Zip Code</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Reprocessor Zip Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4272090</PublicId>
          <ContextName>ONC SDC Project</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MedWatch Form FDA 3500A</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Suspect medical device</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4382695</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4382692</PublicId>
          <ContextName>ONC SDC Project</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MedWatch Form FDA 3500</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>All Sections</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4940571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="313">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4440829</PUBLICID>
    <LONGNAME>Bacterial Vaginosis Occurrence Count</LONGNAME>
    <PREFERREDNAME>4440828v1.0:2018392v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Count of the occurrences of Bacterial Vaginosis (BV)</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4440828</PublicId>
      <PreferredName>4440826v1.0:2234856v1.0</PreferredName>
      <PreferredDefinition>Occurence of a Bacterial Vaginosis (BV) infection caused by bacterial overgrowth in the vagina. Most affected women are asymptomatic. When symptoms occur, they include foul-smelling vaginal discharge, vaginal itching, and burning. Risk factors include sexual activity with multiple partners and the use of vaginal douches and intrauterine devices. Up to a third of cases resolve without treatment. Antibiotic treatment is recommended when symptoms are present and for women that are pregnant at the time of infection.</PreferredDefinition>
      <LongName>Bacterial Vaginosis Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4440826</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C116973</PreferredName>
        <Version>1</Version>
        <LongName>Bacterial Vaginosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C116973</PREFERRED_NAME>
            <LONG_NAME>Bacterial Vaginosis</LONG_NAME>
            <CON_ID>4420911</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018392</PublicId>
      <PreferredName>CT</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of times</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of times</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="314">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4472256</PUBLICID>
    <LONGNAME>Cigarette Smoking Lifetime Daily Use Indicator</LONGNAME>
    <PREFERREDNAME>CIG_SMK_LFTM_DAILY_USE_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no condition reported to record whether criteria are satisfied about inhaling smoke from tobacco in the form of a cigarette that is done each day from the perspective of quantified use causing risk over the individual&#39;s lifetime.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDA</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4472255</PublicId>
      <PreferredName>CIG_SMK_LFTM_DAILY_USE</PreferredName>
      <PreferredDefinition>Inhaling smoke from tobacco in the form of a cigarette that is done each day from the perspective of use over the individual&#39;s lifetime.</PreferredDefinition>
      <LongName>Cigarette Smoking Lifetime Daily Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDA</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2193181</PublicId>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Cigarette Smoking</PreferredName>
        <Version>1</Version>
        <LongName>Cigarette Smoking</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18270</PREFERRED_NAME>
            <LONG_NAME>Cigarette Smoking</LONG_NAME>
            <CON_ID>2202494</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4472253</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19662:C25473:C25340</PreferredName>
        <Version>1</Version>
        <LongName>Lifetime Risk Daily Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19662</PREFERRED_NAME>
            <LONG_NAME>Lifetime Risk</LONG_NAME>
            <CON_ID>2221386</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25473</PREFERRED_NAME>
            <LONG_NAME>Daily</LONG_NAME>
            <CON_ID>2204015</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4471807</PublicId>
      <PreferredName>SUBSTANCE_USE_IND</PreferredName>
      <PreferredDefinition>The reported condition describing whether criteria are satisfied about using a substance whose origin may be mineral or chemical.</PreferredDefinition>
      <LongName>Substance Use Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDA</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>4471806</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45306:C25340:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Substance Use Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45306</PREFERRED_NAME>
            <LONG_NAME>Substance</LONG_NAME>
            <CON_ID>2523396</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Don&#39;t know or Refused</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you ever smoked cigarett</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you ever smoked cigarettes every day for at least 6 months?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Adolescent smoked cigarettes at least 30 days</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has there ever been a period in your life when you smoked cigarettes every day for at least 30 days?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Core: Tier 1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3688551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Core: Tier 2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3688552</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Substance Abuse and Addiction Core Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3689959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3952293</PublicId>
          <ContextName>NIDA</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDA CTN Usage</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Research</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3952294</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3952293</PublicId>
          <ContextName>NIDA</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDA CTN Usage</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Electronic Health Record</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3952296</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="315">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4475081</PUBLICID>
    <LONGNAME>Treatment Cohort Study 9343 Code</LONGNAME>
    <PREFERREDNAME>TX_COH_SDY_9343_CD</PREFERREDNAME>
    <PREFERREDDEFINITION>The code that represents the information pertaining to protocol 9343 in which subsets of a defined population are identified.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2497526</PublicId>
      <PreferredName>TX_COHORT_STDY</PreferredName>
      <PreferredDefinition>Medical care intended to treat or cure a condition or lessen its symptoms. This includes the administration of drugs, surgical procedures, physical or psychotherapy, or the use of therapeutic devices.:A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).</PreferredDefinition>
      <LongName>Therapeutic Procedure Cohort Study</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2497524</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15208</PreferredName>
        <Version>1</Version>
        <LongName>Cohort Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15208</PREFERRED_NAME>
            <LONG_NAME>Cohort Study</LONG_NAME>
            <CON_ID>2497523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4474350</PublicId>
      <PreferredName>4474350v1.0</PreferredName>
      <PreferredDefinition>A group of individuals, identified by a common characteristic._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>9343 Cohort Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>250</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>4386398</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61512:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Cohort Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61512</PREFERRED_NAME>
            <LONG_NAME>Cohort</LONG_NAME>
            <CON_ID>2555083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H1 DL-1</VALIDVALUE>
          <VALUEMEANING>H1 DL-1 = Hepatic: Mild (Bilirubin less than or equal to ULN; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 125 mg PO Day 1 &amp; 125 mg PO BID days 2-28; Cycles 2+ Dabrafenib 125 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H1 DL-1 = Hepatic: Mild (Bilirubin less than or equal to ULN; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 125 mg PO Day 1 &amp; 125 mg PO BID days 2-28; Cycles 2+ Dabrafenib 125 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H1 DL-2</VALIDVALUE>
          <VALUEMEANING>H1 DL-2 = Hepatic: Mild (Bilirubin less than or equal to ULN; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 100 mg PO Day 1 &amp; 100 mg PO BID days 2-28; Cycles 2+ Dabrafenib 100 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H1 DL-2 = Hepatic: Mild (Bilirubin less than or equal to ULN; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 100 mg PO Day 1 &amp; 100 mg PO BID days 2-28; Cycles 2+ Dabrafenib 100 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H1 DL-3</VALIDVALUE>
          <VALUEMEANING>H1 DL-3 = Hepatic: Mild (Bilirubin less than or equal to  ULN; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 75 mg PO Day 1 &amp; 75 mg PO BID days 2-28; Cycles 2+ Dabrafenib 75 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H1 DL-3 = Hepatic: Mild (Bilirubin less than or equal to  ULN; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 75 mg PO Day 1 &amp; 75 mg PO BID days 2-28; Cycles 2+ Dabrafenib 75 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H1 DL-4</VALIDVALUE>
          <VALUEMEANING>H1 DL-4 = Hepatic: Mild (Bilirubin less than or equal to ULN; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib: 50 mg PO Day 1 &amp; 50 mg PO BID days 2-28; Cycles 2+ Dabrafenib 50 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H1 DL-4 = Hepatic: Mild (Bilirubin less than or equal to ULN; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib: 50 mg PO Day 1 &amp; 50 mg PO BID days 2-28; Cycles 2+ Dabrafenib 50 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H1 DL1</VALIDVALUE>
          <VALUEMEANING>H1 DL1 = Hepatic: Mild (Bilirubin less than or equal to ULN; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 150 mg PO Day 1 &amp; 150 mg PO BID days 2-28; Cycles 2+ Dabrafenib 150 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H1 DL1 = Hepatic: Mild (Bilirubin less than or equal to ULN; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 150 mg PO Day 1 &amp; 150 mg PO BID days 2-28; Cycles 2+ Dabrafenib 150 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H2 DL-1</VALIDVALUE>
          <VALUEMEANING>H2 DL-1=Hepatic: Moderate (Bili greater than ULN &amp; less than or equal to 3x ULN; AST greater than ULN); Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 125mg PO d1 &amp; 125mg PO BID days 2-28; Cycles 2+ Dabrafenib 125mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H2 DL-1 = Hepatic: Moderate (Bili greater than ULN &amp; less than or equal to 3x ULN; AST greater than ULN); Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 125mg PO d1 &amp; 125mg PO BID days 2-28; Cycles 2+ Dabrafenib 125mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H2 DL-2</VALIDVALUE>
          <VALUEMEANING>H2 DL-2=Hepatic: Moderate (Bili greater than ULN &amp; less than or equal to 3x ULN; AST greater than ULN); Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 100mg PO d1 &amp; 100mg PO BID days 2-28; Cycles 2+ Dabrafenib 100mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H2 DL-2 = Hepatic: Moderate (Bili greater than ULN &amp; less than or equal to 3x ULN; AST greater than ULN); Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 100mg PO d1 &amp; 100mg PO BID days 2-28; Cycles 2+ Dabrafenib 100mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H2 DL-3</VALIDVALUE>
          <VALUEMEANING>H2 DL-3 = Hepatic: Moderate (Bili greater than ULN &amp; less than or equal to 3x ULN; AST greater than ULN); Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 75mg PO d1 &amp; 75mg PO BID days 2-28; Cycles 2+ Dabrafenib 75mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H2 DL-3 = Hepatic: Moderate (Bili greater than ULN &amp; less than or equal to 3x ULN; AST greater than ULN); Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 75mg PO d1 &amp; 75mg PO BID days 2-28; Cycles 2+ Dabrafenib 75mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H2 DL-4</VALIDVALUE>
          <VALUEMEANING>H2 DL-4 = Hepatic: Moderate (Bili greater than ULN &amp; less than or equal to 3x ULN; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 50mg PO d1 &amp; 50mg PO BID days 2-28; Cycles 2+ Dabrafenib 50 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H2 DL-4 = Hepatic: Moderate (Bili greater than ULN &amp; less than or equal to 3x ULN; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 50mg PO d1 &amp; 50mg PO BID days 2-28; Cycles 2+ Dabrafenib 50 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H2 DL1</VALIDVALUE>
          <VALUEMEANING>H2 DL1=Hepatic: Moderate (Bili greater than ULN &amp; less than or equal to 3x ULN; AST greater than ULN); Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 150mg PO d1 &amp; 150mg PO BID days 2-28; Cycles 2+ Dabrafenib 150mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H2 DL1 = Hepatic: Moderate (Bili greater than ULN &amp; less than or equal to 3x ULN; AST greater than ULN); Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 150mg PO d1 &amp; 150mg PO BID days 2-28; Cycles 2+ Dabrafenib 150mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H3 DL-1</VALIDVALUE>
          <VALUEMEANING>H3 DL-1=Hepatic:Severe (Bili greater than 3x ULN + up to investigators discretion; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min; Cycle 1: Dabrafenib: 125mg PO D1 &amp; 125mg PO BID D 2-28; Cycles 2+ Dabrafenib: 125mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H3 DL-1 = Hepatic: Severe (Bili greater than 3x ULN + up to investigators discretion; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min; Cycle 1: Dabrafenib: 125mg PO D1 &amp; 125mg PO BID D 2-28; Cycles 2+ Dabrafenib: 125mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H3 DL-2</VALIDVALUE>
          <VALUEMEANING>H3 DL-2 = Hepatic: Severe (Bili greater than 3x ULN + up to investigators discretion; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min);Cycle 1 Dabrafenib 100mg PO D1 &amp; 100mg PO BID D 2-28; Cycles 2+ Dabrafenib 100mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H3 DL-2 = Hepatic: Severe (Bili greater than 3x ULN + up to investigators discretion; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min);Cycle 1 Dabrafenib 100mg PO D1 &amp; 100mg PO BID D 2-28; Cycles 2+ Dabrafenib 100mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H3 DL-3</VALIDVALUE>
          <VALUEMEANING>H3 DL-3 = Hepatic: Severe (Bili greater than 3x ULN + up to investigators discretion; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 75mg PO D1 &amp; 75mg PO BID D 2-28; Cycles 2+ Dabrafenib 75mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H3 DL-3 = Hepatic: Severe (Bili greater than 3x ULN + up to investigators discretion; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 75mg PO D1 &amp; 75mg PO BID D 2-28; Cycles 2+ Dabrafenib 75mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H3 DL-4</VALIDVALUE>
          <VALUEMEANING>H3 DL-4 = Hepatic: Severe (Bili greater than 3x ULN + up to investigators discretion; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib: 50mg PO D1 &amp; 50mg PO BID D 2-28; Cycles 2+ Dabrafenib 50mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H3 DL-4 = Hepatic: Severe (Bili greater than 3x ULN + up to investigators discretion; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib: 50mg PO D1 &amp; 50mg PO BID D 2-28; Cycles 2+ Dabrafenib 50mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H3 DL1</VALIDVALUE>
          <VALUEMEANING>H3 DL1 = Hepatic: Severe (Bili greater than 3x ULN + up to investigators discretion; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 150mg PO D1 &amp; 150mg PO BID D 2-28; Cycles 2+ Dabrafenib 150mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>H3 DL1 = Hepatic: Severe (Bili greater than 3x ULN + up to investigators discretion; AST greater than ULN) Renal: Acceptable (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 150mg PO D1 &amp; 150mg PO BID D 2-28; Cycles 2+ Dabrafenib 150mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N DL-1</VALIDVALUE>
          <VALUEMEANING>N DL-1 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Normal (CrCl greater than or equal to  60 mL/min); Cycle 1 Dabrafenib 125 mg PO d1 &amp; 125 mg PO BID days 2-28; Cycles 2+ Dabrafenib: 125 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>N DL-1 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Normal (CrCl greater than or equal to  60 mL/min); Cycle 1 Dabrafenib 125 mg PO d1 &amp; 125 mg PO BID days 2-28; Cycles 2+ Dabrafenib: 125 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N DL-2</VALIDVALUE>
          <VALUEMEANING>N DL-2 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Normal CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 100 mg PO d1 &amp; 100 mg PO BID days 2-28; Cycles 2+ Dabrafenib 100 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>N DL-2 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Normal CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 100 mg PO d1 &amp; 100 mg PO BID days 2-28; Cycles 2+ Dabrafenib 100 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N DL-3</VALIDVALUE>
          <VALUEMEANING>N DL-3 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Normal (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib: 75 mg PO d1 &amp; 75 mg PO BID  days 2-28; Cycles 2+ Dabrafenib 75 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>N DL-3 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Normal (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib: 75 mg PO d1 &amp; 75 mg PO BID  days 2-28; Cycles 2+ Dabrafenib 75 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N DL-4</VALIDVALUE>
          <VALUEMEANING>N DL-4 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Normal (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 50 mg PO d1 &amp; 50 mg PO BID days 2-28; Cycles 2+ Dabrafenib 50 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>N DL-4 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Normal (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 50 mg PO d1 &amp; 50 mg PO BID days 2-28; Cycles 2+ Dabrafenib 50 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N DL1</VALIDVALUE>
          <VALUEMEANING>N DL1 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Normal (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 150 mg PO d1 &amp; 150 mg PO BID days 2-28; Cycles 2+ Dabrafenib 150 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>N DL1 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Normal (CrCl greater than or equal to 60 mL/min); Cycle 1 Dabrafenib 150 mg PO d1 &amp; 150 mg PO BID days 2-28; Cycles 2+ Dabrafenib 150 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R3 DL-1</VALIDVALUE>
          <VALUEMEANING>R3 DL-1=Hepatic:Normal (Bilirubin less than or equal to ULN;AST less than or equal to ULN) Renal:Severe (CrCl greater than or equal to 15 &amp; less than 30 mL/min); Cycle 1 Dabrafenib 125 mg PO d1 &amp; 125 mg PO BID days 2-28; Cycles 2+ Dabrafenib 125 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>R3 DL-1 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Severe (CrCl greater than or equal to 15 &amp; less than 30 mL/min); Cycle 1 Dabrafenib 125 mg PO d1 &amp; 125 mg PO BID days 2-28; Cycles 2+ Dabrafenib 125 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R3 DL-2</VALIDVALUE>
          <VALUEMEANING>R3 DL-2=Hepatic:Normal (Bilirubin less than or equal to ULN;AST less than or equal to ULN) Renal:Severe (CrCl greater than or equal to 15 &amp; less than 30 mL/min); Cycle 1 Dabrafenib 100 mg PO d1 &amp; 100 mg PO BID days 2-28; Cycles 2+ Dabrafenib 100 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>R3 DL-2 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Severe (CrCl greater than or equal to 15 &amp; less than 30 mL/min); Cycle 1 Dabrafenib 100 mg PO d1 &amp; 100 mg PO BID days 2-28; Cycles 2+ Dabrafenib 100 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R3 DL-3</VALIDVALUE>
          <VALUEMEANING>R3 DL-3=Hepatic:Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal:Severe (CrCl greater than or equal to 15 &amp; less than 30 mL/min); Cycle 1 Dabrafenib 75 mg PO d1 &amp; 75 mg PO BID days 2-28; Cycles 2+ Dabrafenib 75 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>R3 DL-3 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Severe (CrCl greater than or equal to 15 &amp; less than 30 mL/min); Cycle 1 Dabrafenib 75 mg PO d1 &amp; 75 mg PO BID days 2-28; Cycles 2+ Dabrafenib 75 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R3 DL-4</VALIDVALUE>
          <VALUEMEANING>R3 DL-4=Hepatic:Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal:Severe (CrCl greater than or equal to 15 &amp; less than 30 mL/min); Cycle 1 Dabrafenib 50 mg PO d1 &amp; 50 mg PO BID days 2-28; Cycles 2+ Dabrafenib 50 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>R3 DL-4 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Severe (CrCl greater than or equal to 15 &amp; less than 30 mL/min); Cycle 1 Dabrafenib 50 mg PO d1 &amp; 50 mg PO BID days 2-28; Cycles 2+ Dabrafenib 50 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R3 DL1</VALIDVALUE>
          <VALUEMEANING>R3 DL1=Hepatic:Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal:Severe (CrCl greater than or equal to 15 &amp; less than 30 mL/min); Cycle 1 Dabrafenib 150 mg PO d1 &amp; 150 mg PO BID days 2-28; Cycles 2+ Dabrafenib 150 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>R3 DL1 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Severe (CrCl greater than or equal to 15 &amp; less than 30 mL/min); Cycle 1 Dabrafenib 150 mg PO d1 &amp; 150 mg PO BID days 2-28; Cycles 2+ Dabrafenib 150 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R4 DL-1</VALIDVALUE>
          <VALUEMEANING>R4 DL-1 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Renal failure (hemodialysis); Cycle 1 Dabrafenib: 125 mg PO d1 &amp; 125 mg PO BID days 2-28; Cycles 2+ Dabrafenib 125 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>R4 DL-1 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Renal failure (hemodialysis); Cycle 1 Dabrafenib: 125 mg PO d1 &amp; 125 mg PO BID days 2-28; Cycles 2+ Dabrafenib 125 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R4 DL-2</VALIDVALUE>
          <VALUEMEANING>R4 DL-2 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Renal failure (hemodialysis); Cycle 1 Dabrafenib 100 mg PO d1 &amp; 100 mg PO BID days 2-28; Cycles 2+ Dabrafenib 100 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>R4 DL-2 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Renal failure (hemodialysis); Cycle 1 Dabrafenib 100 mg PO d1 &amp; 100 mg PO BID days 2-28; Cycles 2+ Dabrafenib 100 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647519</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R4 DL-3</VALIDVALUE>
          <VALUEMEANING>R4 DL-3 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Renal failure (hemodialysis); Cycle 1 Dabrafenib 75 mg PO d1 &amp; 75 mg PO BID days 2-28; Cycles 2+ Dabrafenib 75 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>R4 DL-3 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Renal failure (hemodialysis); Cycle 1 Dabrafenib 75 mg PO d1 &amp; 75 mg PO BID days 2-28; Cycles 2+ Dabrafenib 75 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R4 DL-4</VALIDVALUE>
          <VALUEMEANING>R4 DL-4 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Renal failure (hemodialysis); Cycle 1 Dabrafenib: 50 mg PO  d1 &amp; 50 mg PO BID days 2-28; Cycles 2+ Dabrafenib 50 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>R4 DL-4 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Renal failure (hemodialysis); Cycle 1 Dabrafenib: 50 mg PO  d1 &amp; 50 mg PO BID days 2-28; Cycles 2+ Dabrafenib 50 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647521</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R4 DL1</VALIDVALUE>
          <VALUEMEANING>R4 DL1 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Renal failure (hemodialysis); Cycle 1 Dabrafenib 150 mg PO d1 &amp; 150 mg PO BID days 2-28; Cycles 2+ Dabrafenib 150 mg PO BID</VALUEMEANING>
          <MEANINGDESCRIPTION>R4 DL1 = Hepatic: Normal (Bilirubin less than or equal to ULN; AST less than or equal to ULN) Renal: Renal failure (hemodialysis); Cycle 1 Dabrafenib 150 mg PO d1 &amp; 150 mg PO BID days 2-28; Cycles 2+ Dabrafenib 150 mg PO BID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4647522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Please select the cohort</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Please select the cohort</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876594</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Theradex</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Theradex - CTMS 3.14</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3876603</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="316">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4476133</PUBLICID>
    <LONGNAME>Person Pleural Effusion Personal Medical History Yes No Indicator</LONGNAME>
    <PREFERREDNAME>PLEURALEFFUSION</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator for information related to a personal medical history of pleural effusion, increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumors, connective tissue disorders, and trauma.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4476130</PublicId>
      <PreferredName>PLEURALEFFUSION</PreferredName>
      <PreferredDefinition>Information related to a personal medical history of pleural effusion, increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumors, connective tissue disorders, and trauma.</PreferredDefinition>
      <LongName>Person Pleural Effusion Personal Medical History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4476128</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3331:C18772</PreferredName>
        <Version>1</Version>
        <LongName>Pleural Effusion Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3331</PREFERRED_NAME>
            <LONG_NAME>Pleural Effusion</LONG_NAME>
            <CON_ID>2203668</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>History of grade 2 or higher</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>History of grade 2 or higher pleural effusion</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2552643</PublicId>
          <ContextName>Training</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Training Class Examples</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3637837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="317">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4533403</PUBLICID>
    <LONGNAME>Patient Has Concomitant Genetic Syndrome Eligibility Criteria Yes No Unknown Not Applicable Indicator</LONGNAME>
    <PREFERREDNAME>CcmGntcSyd</PREFERREDNAME>
    <PREFERREDDEFINITION>a yes/no/unknown/not applicable indicator related to a patient occurs to have a set of symptoms that is passed from parents to offspring through genes in sperm and egg cells to allow a subject to participate in a clinical study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4533393</PublicId>
      <PreferredName>CcmGntcSydElig</PreferredName>
      <PreferredDefinition>information related to a patient occurs to have a set of symptoms that is passed from parents to offspring through genes in sperm and egg cells to allow a subject to participate in a clinical study.</PreferredDefinition>
      <LongName>Patient Has Concomitant Genetic Syndrome Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4533391</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4533391v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Have Concomitant Genetic Syndrome Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C101282</PREFERRED_NAME>
            <LONG_NAME>Have</LONG_NAME>
            <CON_ID>3437377</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25730</PREFERRED_NAME>
            <LONG_NAME>Concomitant</LONG_NAME>
            <CON_ID>2202429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17938</PREFERRED_NAME>
            <LONG_NAME>Genetic</LONG_NAME>
            <CON_ID>2206224</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28193</PREFERRED_NAME>
            <LONG_NAME>Syndrome</LONG_NAME>
            <CON_ID>2203692</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have  one of the</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have  one of the following concomitant genetic syndromes: Down syndrome, Bloom syndrome, ataxia-telangiectasia, Fanconi anemia, Kostmann syndrome, Shwachman syndrome or any other known bone marrow failure syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient known to have one of the concomitant genetic syndromes defined in the protocol?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_TEXT_2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have known symptomatic Fanconi Anemia , Ataxia-telangiectasia  Syndrome, Bloom syndrome or Nijmegen breakage syndrome</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have one of the following concomitant genetic syndromes: Bloom syndrome, ataxia-telangiectasia, Fanconi anemia, Kostmann syndrome, Shwachman syndrome or any other known bone marrow failure syndrome.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have one of the following concomitant genetic syndromes: Bloom syndrome, ataxia-telangiectasia, Fanconi anemia, Kostmann syndrome, Shwachman syndrome or any other known bone marrow failure syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have Fanconi anemia, Kostmann syndrome, Shwachman syndrome or any other known congenital bone marrow failure syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have known hereditary diseases characterized by genetic defects of DNA repair mechanisms, including ataxia telangiectasia, Nijmegen breakage syndrome, Werner syndrome, Bloom Syndrome, Fanconi anemia, xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient known to have a congenital bone marrow failure syndrome where increased risk of toxicity may be expected as judged by the Investigator?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="318">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4566267</PUBLICID>
    <LONGNAME>FACT-Br Questionnaire Version 4 Br10 How True Past Seven Days Bothered by Change in Personality Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>FACTBR_V4_BR10_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of how true in the past 7 days they are bothered by the change in their personality, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FACT-Br:Functional Assessment of Cancer Therapy - Brain, David Cella, Ph.D., Version 4, Nov. 2007</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3876348</PublicId>
      <PreferredName>2555185v1.0:3876346v1.0</PreferredName>
      <PreferredDefinition>A 50-item instrument that assesses general physical, social, emotional and functional well-being, as well as brain tumor-specific concerns._The most recent week, including today._A survey question about a person&#39;s agreement with a statement._A question about whether an individual is or was bothered by the change in their personality._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>FACT-Br Questionnaire Past Seven Days Bothered by Change in Personality How True Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2555185</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63928</PreferredName>
        <Version>1</Version>
        <LongName>FACT-BR Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63928</PREFERRED_NAME>
            <LONG_NAME>FACT-BR Questionnaire</LONG_NAME>
            <CON_ID>2549644</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3876346</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C91781:C111053:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week How True Bothered by Change in Personality Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91781</PREFERRED_NAME>
            <LONG_NAME>How True Question</LONG_NAME>
            <CON_ID>3133350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C111053</PREFERRED_NAME>
            <LONG_NAME>Bothered by Change in Personality Question</LONG_NAME>
            <CON_ID>3875910</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>FACT-Br:Functional Assessment of Cancer Therapy - Brain, David Cella, Ph.D., Version 4, Nov. 2007</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4552765</PublicId>
      <PreferredName>4552765v1.0</PreferredName>
      <PreferredDefinition>Numeric scores from 0 (Not at all) to 4 (Very Much) on a Likert scale used on FACT questionnaires.</PreferredDefinition>
      <LongName>FACT Score 5 Point Likert Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>FACT-G:Functional Assessment of Cancer Therapy - General, David Cella, Ph.D., Version 4, Nov. 2007</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Some-what</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a great amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I am bothered by a change in my personality</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACT-Br</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am bothered by the change in my personality (39)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Link to Scoring and Interpretation Materials</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Scoring and Interpretation materials are accessible after registration on the FACIT website.</DocumentText>
        <URL>http://www.facit.org/FACITOrg/Questionnaires</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the  measure.  The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCCN-FACT FBrSI</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am bothered by the change in my personality (13)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measure CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718286</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Br </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718290</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000349</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Br (Functional Assessment of Cancer Therapy - Brain) </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4551833</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NCCN-FACT FBrSI (National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy - Breast Symptom Index)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916703</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACIT/FACT</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5918014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Br (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918033</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCI Standards</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="319">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4566279</PUBLICID>
    <LONGNAME>FACT-An Questionnaire Version 4 An10 How True Past Seven Days Get Headaches Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>FACTAN_V4_AN10_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of how true in the past 7 days they get headaches, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FACT-An:Functional Assessment of Cancer Therapy - Anemia/Fatigue, David Cella, Ph.D., Version 4, Nov. 2007</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4496813</PublicId>
      <PreferredName>4046272v1.0:3876433v1.0</PreferredName>
      <PreferredDefinition>A subscale complement to the FACT-G developed specifically for evaluating the quality of life of cancer patients with anemia and fatigue._The most recent week, including today._A survey question about a person&#39;s agreement with a statement._A question about whether an individual gets headaches._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>FACT-An Questionnaire Past Week How True Get Headaches Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4046272</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C113187</PreferredName>
        <Version>1</Version>
        <LongName>FACT-An Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113187</PREFERRED_NAME>
            <LONG_NAME>FACT-An Questionnaire</LONG_NAME>
            <CON_ID>4035031</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3876433</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C91781:C111065:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week How True Get Headaches Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91781</PREFERRED_NAME>
            <LONG_NAME>How True Question</LONG_NAME>
            <CON_ID>3133350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C111065</PREFERRED_NAME>
            <LONG_NAME>Get Headaches Question</LONG_NAME>
            <CON_ID>3875923</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>FACT-An:Functional Assessment of Cancer Therapy - Anemia/Fatigue, David Cella, Ph.D., Version 4, Nov. 2007</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4552765</PublicId>
      <PreferredName>4552765v1.0</PreferredName>
      <PreferredDefinition>Numeric scores from 0 (Not at all) to 4 (Very Much) on a Likert scale used on FACT questionnaires.</PreferredDefinition>
      <LongName>FACT Score 5 Point Likert Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>FACT-G:Functional Assessment of Cancer Therapy - General, David Cella, Ph.D., Version 4, Nov. 2007</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Some-what</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a great amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACT-Br</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I get headaches (51)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I get headaches</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I get headaches</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACT-ES</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I get headaches (42)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Link to Scoring and Interpretation Materials</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Scoring and Interpretation materials are accessible after registration on the FACIT website.</DocumentText>
        <URL>http://www.facit.org/FACITOrg/Questionnaires</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the  measure.  The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACT-An</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I get headaches (40)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCCN-FACT FBrSI</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I get headaches (1)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FBrSI</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I get headaches (1)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measure CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718286</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Br </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718290</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Es </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718480</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FBrSI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4997415</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000349</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-ES (Functional Assessment of Cancer Therapy - Endocrine Symptoms)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4551757</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Br (Functional Assessment of Cancer Therapy - Brain) </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4551833</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FBrSI (Functional Assessment of Cancer Therapy - Brain Symptom Index)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916693</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NCCN-FACT FBrSI (National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy - Breast Symptom Index)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916703</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACIT/FACT</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5918014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Br (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918033</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-ES (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918037</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCI Standards</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="320">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4588765</PUBLICID>
    <LONGNAME>Adult Since Last Visit Suicidal Ideation Behavior Classification Questionnaire Score</LONGNAME>
    <PREFERREDNAME>Adul_Sinc_Last_Visi_Suic_Beha_</PREFERREDNAME>
    <PREFERREDDEFINITION>A juvenile between the onset of puberty and maturity; in the state of development between puberty and maturity._Subsequent to; after._Coming after all others in time or space or degree or being the only one remaining._The act of going to see some person or place or thing; it can cover a short or long period but refers to a non-permanent arrangement._Thinking about ending or making plans to end one&#39;s own life._human or animal activity studied in terms of motivation, direction, result, emotion, perception, or etiology._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument._A human who has reached reproductive age._The final result of a determination of the value, significance, or extent of._A number or range of numeric values measuring performance, function, quality, or ability.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4588764</PublicId>
      <PreferredName>Adul_Sinc_Last_Visi_Suic_Beha_</PreferredName>
      <PreferredDefinition>A juvenile between the onset of puberty and maturity; in the state of development between puberty and maturity._Subsequent to; after._Coming after all others in time or space or degree or being the only one remaining._The act of going to see some person or place or thing; it can cover a short or long period but refers to a non-permanent arrangement._Thinking about ending or making plans to end one&#39;s own life._human or animal activity studied in terms of motivation, direction, result, emotion, perception, or etiology._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument._A human who has reached reproductive age.</PreferredDefinition>
      <LongName>Adult Since Last Visit Suicidal Ideation Behavior Classification Questionnaire</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2944354</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17600</PreferredName>
        <Version>1</Version>
        <LongName>Adult</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17600</PREFERRED_NAME>
            <LONG_NAME>Adult</LONG_NAME>
            <CON_ID>2204022</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4588749</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4588749v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Since Last Visit Suicidal Ideation Behavior Classification Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45325</PREFERRED_NAME>
            <LONG_NAME>Since</LONG_NAME>
            <CON_ID>2240692</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25551</PREFERRED_NAME>
            <LONG_NAME>Last</LONG_NAME>
            <CON_ID>2206286</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25716</PREFERRED_NAME>
            <LONG_NAME>Visit</LONG_NAME>
            <CON_ID>2202626</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80102</PREFERRED_NAME>
            <LONG_NAME>Suicidal Ideation</LONG_NAME>
            <CON_ID>2944587</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16326</PREFERRED_NAME>
            <LONG_NAME>Behavior</LONG_NAME>
            <CON_ID>2203709</CON_ID>
            <DEFINITION_SOURCE>CSP2000</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25161</PREFERRED_NAME>
            <LONG_NAME>Classification</LONG_NAME>
            <CON_ID>2203879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17048</PREFERRED_NAME>
            <LONG_NAME>Questionnaire</LONG_NAME>
            <CON_ID>2202367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3076086</PublicId>
      <PreferredName>ASSES_SC</PreferredName>
      <PreferredDefinition>A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Assessment Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2193207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Adult Since Last Visit Suicidal Ideation Behavior Classification Questionnaire Score does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Adult Since Last Visit Suicidal Ideation Behavior Classification Questionnaire Score does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mental Health Specialty Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4550934</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Suicide</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4550935</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="321">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4619918</PUBLICID>
    <LONGNAME>Prior First Clinical Study Pharmacologic Substance Administration Active Gastrointestinal Disorder Less Than 3 Month Code Indicator</LONGNAME>
    <PREFERREDNAME>GAST_DIS_LT3MO_CD_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded indicator response regarding whether a patient has an active gastrointestinal disorder within 3 months before the start of protocol therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4619896</PublicId>
      <PreferredName>4363919v1.0:4619894v1.0</PreferredName>
      <PreferredDefinition>Earlier in time or order._Preceding all others in time or space or degree._Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research._Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine._Exerting influence or producing an effect; taking part in an activity._A non-neoplastic or neoplastic disorder that affects the gastrointestinal tract, anus, liver, biliary system, and pancreas._A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status._A number with no fractional part, including the negative and positive numbers as well as zero.::3_One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</PreferredDefinition>
      <LongName>Prior First Clinical Study Pharmacologic Substance Administration Active Gastrointestinal Disorder Less Than 3 Month</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4363919</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4363919v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Prior First Clinical Study Pharmacologic Substance Administration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1909</PREFERRED_NAME>
            <LONG_NAME>Pharmacologic Substance</LONG_NAME>
            <CON_ID>2437691</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4619894</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4619894v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Active Gastrointestinal Disorder Less Than Integer::3 Month</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45329</PREFERRED_NAME>
            <LONG_NAME>Active</LONG_NAME>
            <CON_ID>2342187</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2990</PREFERRED_NAME>
            <LONG_NAME>Digestive System Disorder</LONG_NAME>
            <CON_ID>2469346</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61585</PREFERRED_NAME>
            <LONG_NAME>Less Than</LONG_NAME>
            <CON_ID>2620099</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::3</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have a history w</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have a history within 3 months prior to treatment of Grade 3-4 GI bleeding/hemorrhage, treatment resistant peptic ulcer disease, erosive esophagitis or gastritis, infectious or inflammatory bowel disease, diverticulitis, pulmonary embolus, or other uncontrolled thromboembolic event?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876359</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Exclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical &amp; Concomitant Requirements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000083</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="322">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4681095</PUBLICID>
    <LONGNAME>MD Anderson Symptom Inventory - Core 18 Last 24 Hours Interference Walking Score 11 Point Likert Scale</LONGNAME>
    <PREFERREDNAME>MDASI_C18_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how much symptoms interfered with walking in the last 24 hours, using an eleven-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MDASI-Core:M.D. Anderson Symptom Inventory - Core, Cleeland CS, 1999</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3813540</PublicId>
      <PreferredName>3813443v1.0:3813599v1.0</PreferredName>
      <PreferredDefinition>A self-administered questionnaire designed to assess multiple symptoms experienced by cancer patients and the interference with daily living caused by these symptoms._Past; before the present time._A number with no fractional part, including the negative and positive numbers as well as zero.::24_In modern usage, an hour is defined as a unit of time 60 minutes, or 3600 seconds in length. It is approximately 1/24 of a median day._The act of hindering or obstructing or impeding._Used to indicate the presence of something or someone._The act of traveling by foot._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>MD Anderson Symptom Inventory - Core Past 24 Hours Interference With Walking Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3813443</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C107378</PreferredName>
        <Version>1</Version>
        <LongName>MD Anderson Symptom Inventory - Core </LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107378</PREFERRED_NAME>
            <LONG_NAME>MD Anderson Symptom Inventory - Core</LONG_NAME>
            <CON_ID>3812939</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3813599</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3813599v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Past Integer::24 Hour Interference With Walking Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::24</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25529</PREFERRED_NAME>
            <LONG_NAME>Hour</LONG_NAME>
            <CON_ID>2203682</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C72886</PREFERRED_NAME>
            <LONG_NAME>Interference</LONG_NAME>
            <CON_ID>2734007</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62355</PREFERRED_NAME>
            <LONG_NAME>With</LONG_NAME>
            <CON_ID>2532083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73554</PREFERRED_NAME>
            <LONG_NAME>Walking</LONG_NAME>
            <CON_ID>2743260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MDASI-Core:M.D. Anderson Symptom Inventory - Core, Cleeland CS, 1999</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4680965</PublicId>
      <PreferredName>4680965v1.0</PreferredName>
      <PreferredDefinition>An ordered reference standard for the subjective scoring of a symptom&#39;s interference with life that ranges from 0: Did Not Interfere to 10: Interfered Completely.</PreferredDefinition>
      <LongName>MDASI Symptom Interference with Life Score 11 Point Likert Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>10</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>MDASI-Core:M.D. Anderson Symptom Inventory - Core, Cleeland CS, 1999</Origin>
      <Representation>
        <PublicId>4680964</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C120085:C25664</PreferredName>
        <Version>1</Version>
        <LongName>Symptom Interference with Life Likert Scale Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120085</PREFERRED_NAME>
            <LONG_NAME>Symptom Interference with Life Likert Scale</LONG_NAME>
            <CON_ID>4674464</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Symptom Interference with Life Score 0</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 0 on a scale that ranges from 0: Did Not Interfere to 10: Interfered Completely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120086</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4680966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Symptom Interference with Life Score 1</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 1 on a scale that ranges from 0: Did Not Interfere to 10: Interfered Completely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4680967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>Symptom Interference with Life Score 10</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 10 on a scale that ranges from 0: Did Not Interfere to 10: Interfered Completely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4680968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Symptom Interference with Life Score 2</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 2 on a scale that ranges from 0: Did Not Interfere to 10: Interfered Completely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120088</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4680969</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Symptom Interference with Life Score 3</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 3 on a scale that ranges from 0: Did Not Interfere to 10: Interfered Completely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4680970</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Symptom Interference with Life Score 4</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 4 on a scale that ranges from 0: Did Not Interfere to 10: Interfered Completely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120090</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4680971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Symptom Interference with Life Score 5</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 5 on a scale that ranges from 0: Did Not Interfere to 10: Interfered Completely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120091</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4680972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Symptom Interference with Life Score 6</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 6 on a scale that ranges from 0: Did Not Interfere to 10: Interfered Completely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4680973</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Symptom Interference with Life Score 7</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 7 on a scale that ranges from 0: Did Not Interfere to 10: Interfered Completely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120093</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4680974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Symptom Interference with Life Score 8</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 8 on a scale that ranges from 0: Did Not Interfere to 10: Interfered Completely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120094</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4680975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Symptom Interference with Life Score 9</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 9 on a scale that ranges from 0: Did Not Interfere to 10: Interfered Completely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120095</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4680976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MDASI User Guide</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Documentation of the development and psychometric properties of the MDASI and its modules</DocumentText>
        <URL>http://www.mdanderson.org/education-and-research/departments-programs-and-labs/departments-and-divisions/symptom-research/symptom-assessment-tools/MDASI_userguide.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Walking?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Walking?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MDASI-Core</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Walking? (18)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MDASI-GI</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Walking? (25)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measure CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718286</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDASI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718487</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000349</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDASI-(MD Anderson Symptom Inventory)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4643053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5024211</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MD Anderson Measures</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDASI-Core (M.D. Anderson Symptom Inventory - Core)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5024214</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MD Anderson</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5918050</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MD Anderson Symptom Inventory - Brain Tumor (MDASI-BT)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MD Anderson Symptom Inventory - Core Symptoms (MDASI-Core)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MD Anderson Symptom Inventory-HN (MDASI-HN)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918054</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MD Anderson Symptom Inventory-LC (MDASI-LC)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MD Anderson Symptom Inventory-GI (MDASI-GI)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6429537</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MD Anderson Symptom Inventory (MDASI)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000433</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCI Standards</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="323">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4718874</PUBLICID>
    <LONGNAME>Prior Therapy Group Assignment Identifier</LONGNAME>
    <PREFERREDNAME>PR_TX_GP_ASSIGN_ID</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric identifier for treatment modalities and systemic agent regimens for the purpose of segregating prior therapy history into the specific treatment plans.  </PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4718873</PublicId>
      <PreferredName>4718871v1.00:2454524v1.00</PreferredName>
      <PreferredDefinition>Prior action or administration of therapeutic agents that produced an effect that is intended to alter or stop a pathologic process._The act of taking part in an activity._A group of individuals united by a common factor (e.g., geographic location, ethnicity, disease, age, sex).:An allotting or an appointment to a particular person or use, or for a particular time or object.</PreferredDefinition>
      <LongName>Prior Therapy Participation Group Assignment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4718871</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16124:C25608:C17005</PreferredName>
        <Version>1</Version>
        <LongName>Prior Therapy Participation Population Group</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16124</PREFERRED_NAME>
            <LONG_NAME>Prior Therapy</LONG_NAME>
            <CON_ID>2202433</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25608</PREFERRED_NAME>
            <LONG_NAME>Participation</LONG_NAME>
            <CON_ID>2206339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17005</PREFERRED_NAME>
            <LONG_NAME>Population Group</LONG_NAME>
            <CON_ID>2202651</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2454524</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25426</PreferredName>
        <Version>1</Version>
        <LongName>Assignment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25426</PREFERRED_NAME>
            <LONG_NAME>Assignment</LONG_NAME>
            <CON_ID>2204040</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2465540</PublicId>
      <PreferredName>ID</PreferredName>
      <PreferredDefinition>One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Identifier</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Prior therapy treatment</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Prior therapy treatment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15689233</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HHS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Completed</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15910169</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="324">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4724020</PUBLICID>
    <LONGNAME>Laboratory Procedure FISH Deletion Occurrence Specify</LONGNAME>
    <PREFERREDNAME>FISHDelOccSpc</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field related to an instance of any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA during  a physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4724019</PublicId>
      <PreferredName>FISHDelOcc</PreferredName>
      <PreferredDefinition>information related to an instance of any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA during  a physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.</PreferredDefinition>
      <LongName>Laboratory Procedure FISH Deletion Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4724017</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17563:C19296:C25275</PreferredName>
        <Version>1</Version>
        <LongName>Fluorescence in Situ Hybridization Deletion Mutation Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17563</PREFERRED_NAME>
            <LONG_NAME>Fluorescence In Situ Hybridization</LONG_NAME>
            <CON_ID>2221360</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19296</PREFERRED_NAME>
            <LONG_NAME>Deletion Mutation</LONG_NAME>
            <CON_ID>2528568</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2194376</PublicId>
      <PreferredName>ASSESS_OTHER_SPEC</PreferredName>
      <PreferredDefinition>the free text field related to other specified assessment.</PreferredDefinition>
      <LongName>Assessment Other Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If Fusion with cryptic deleti</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If Fusion with cryptic deletion, describe where deletion occurs:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="325">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4724997</PUBLICID>
    <LONGNAME>Laboratory Procedure B-Lymphocyte CD19 Antigen Outcome Integer::0 Decimal Place Value</LONGNAME>
    <PREFERREDNAME>2543452v1.0:2784511v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The 0 decimal place numeric laboratory value measured, assigned or computed related to the assessment of CD19 antigen in a specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2543452</PublicId>
      <PreferredName>LAB_BLYMPH_CD19_OC</PreferredName>
      <PreferredDefinition>information relating to the results of the medical procedure that involves testing a sample of blood for CD19+ (a type I cell surface protein with 2 extracellular IgC2 domains, a cytoplasmic tail with 9 conserved Tyr residues, and no significant homology with other known proteins) B-lymphocyte, a type of blood cell that helps stimulate immune system reactions.</PreferredDefinition>
      <LongName>Laboratory Procedure B-Lymphocyte CD19 Antigen Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2779799</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12474:C38894:C20200</PreferredName>
        <Version>1</Version>
        <LongName>B-Lymphocyte CD19 Antigen Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12474</PREFERRED_NAME>
            <LONG_NAME>B-Lymphocyte</LONG_NAME>
            <CON_ID>2529669</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38894</PREFERRED_NAME>
            <LONG_NAME>B-Lymphocyte Antigen CD19</LONG_NAME>
            <CON_ID>2667900</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784511</PublicId>
      <PreferredName>LP_OT_I0DP_VL</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The result of an action._A number with no fractional part, including the negative and positive numbers as well as zero.::0_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Laboratory Procedure Outcome 0 Decimal Place Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784510</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294:C20200:C45255::0:C42646</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Outcome Integer::0 Decimal Place Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the value of the CD19</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the value of the CD19 antigen test?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the value of CD19?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the value of CD19?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CD19:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>CD19:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CD19 (B lymphocyte cells):</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>CD19 (B lymphocyte cells):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_IR_cd19_value</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNfup_lym_anly_cd19_value</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNbase_lym_anly_mul_cd19_val</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="326">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4763948</PUBLICID>
    <LONGNAME>Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Perform all the Activities in Which I Participate in Daily Life Score Toronto Extremity Salvage Score Difficulty 5 Point Likert Scale</LONGNAME>
    <PREFERREDNAME>TESSLE_DAILYLIFE_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of the difficulty in the past week performing all the activities in which they participate in daily life, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Toronto Extremity Salvage Score (TESS); 1996</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4761509</PublicId>
      <PreferredName>4761151v1.0:4762967v1.0</PreferredName>
      <PreferredDefinition>A self-administered questionnaire designed to assess physical disability for patients undergoing lower limb salvage sugery for musculoskeletal tumors._The most recent week, including today._Something not easily done, accomplished, comprehended, or solved._A question about an individual&#39;s ability to perform all the activities in which they participate in daily life._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Toronto Extremity Salvage Score, Lower Extremity Past Week Difficulty Ability to Perform all the Activities in Which I Participate in Daily Life Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4761151</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121218</PreferredName>
        <Version>1</Version>
        <LongName>Toronto Extremity Salvage Score, Lower Extremity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121218</PREFERRED_NAME>
            <LONG_NAME>Toronto Extremity Salvage Score, Lower Extremity</LONG_NAME>
            <CON_ID>4747333</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4762967</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C62189:C121267:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Difficulty Ability to Perform all the Activities in Which I Participate in Daily Life Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62189</PREFERRED_NAME>
            <LONG_NAME>Difficulty</LONG_NAME>
            <CON_ID>2503546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121267</PREFERRED_NAME>
            <LONG_NAME>Ability to Perform all the Activities in Which I Participate in Daily Life Question</LONG_NAME>
            <CON_ID>4747471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Toronto Extremity Salvage Score (TESS); 1996</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4744189</PublicId>
      <PreferredName>TESS_DIFFICULTY_SCL</PreferredName>
      <PreferredDefinition>Numeric scores from 1 (Impossible to do) to 5 (Not at all difficult) on a Likert scale used on the Toronto Extremity Salvage Score questionnaires.</PreferredDefinition>
      <LongName>Toronto Extremity Salvage Score Difficulty 5 Point Likert Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue>888</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>Toronto Extremity Salvage Score (TESS); 1996</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>888</VALIDVALUE>
          <VALUEMEANING>This task is not applicable to me</VALUEMEANING>
          <MEANINGDESCRIPTION>An assigned piece of work, usually with a time allotment.: Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660, C101129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4761312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Not difficult at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of non-agreement.: Something not easily done, accomplished, comprehended, or solved.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62189, C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3811316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>A little bit Difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.: Something not easily done, accomplished, comprehended, or solved.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62189, C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4761313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Moderately Difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.: Something not easily done, accomplished, comprehended, or solved.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62189, C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4761314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Extremely Difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>The highest degree of severity.: Something not easily done, accomplished, comprehended, or solved.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62189, C102844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3811313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Impossible to do</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Capable of happening or occurring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82490, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4744212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Considering all the activitie</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Considering all the activities in which I participate in daily life, I would rate the ability to perform these activities during the past week as:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4748831</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Prospective Sarcoma PRO</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma PRO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4748832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="327">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4769369</PUBLICID>
    <LONGNAME>Laboratory Procedure CD2 Gene BM Evaluation Yes No Unknown Not Applicable Indicator</LONGNAME>
    <PREFERREDNAME>4769293v1.0:3506035v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to CD2 immunophenotyping performed by institution from a bone marrow sample with permissible values of yes/no/unknown/not applicable.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4769293</PublicId>
      <PreferredName>BM_CD2_EVAL_IND</PreferredName>
      <PreferredDefinition>Information related to evaluation CD2 immunophenotyping from a bone marrow sample.</PreferredDefinition>
      <LongName>Laboratory Procedure CD2 Gene Evaluation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4769291</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21361:C25214</PreferredName>
        <Version>1</Version>
        <LongName>CD2 Gene Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21361</PREFERRED_NAME>
            <LONG_NAME>CD2 Gene</LONG_NAME>
            <CON_ID>4297098</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was CD2 institutional immunop</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was CD2 institutional immunophenotyping done?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CD2InstIptDn</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="328">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4770275</PUBLICID>
    <LONGNAME>Patient Last Follow-up Timepoint Status</LONGNAME>
    <PREFERREDNAME>4770272v1.0:2719434v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the patient&#39;s survival status at the last follow-up.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4770272</PublicId>
      <PreferredName>2233604v1.0:2786108v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Coming after all others in time or space or degree or being the only one remaining._The process by which information about the health status of an individual is obtained after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done._A specific point in the time continuum, including those established relative to an event._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Patient Last Follow-up Timepoint Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2786108</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25551:C16033:C68568:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Last Follow-up Timepoint Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25551</PREFERRED_NAME>
            <LONG_NAME>Last</LONG_NAME>
            <CON_ID>2206286</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16033</PREFERRED_NAME>
            <LONG_NAME>Follow-Up</LONG_NAME>
            <CON_ID>2202303</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68568</PREFERRED_NAME>
            <LONG_NAME>Timepoint</LONG_NAME>
            <CON_ID>2656619</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2719434</PublicId>
      <PreferredName>FU_STAT</PreferredName>
      <PreferredDefinition>The process by which information about the health status of an individual is obtained after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Follow-up Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008570</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PERSONAL_ATTRIBUTES</PreferredName>
        <Version>1</Version>
        <LongName>Personal attributes</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>22</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2719433</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16033:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Follow-up Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16033</PREFERRED_NAME>
            <LONG_NAME>Follow-Up</LONG_NAME>
            <CON_ID>2202303</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alive</VALIDVALUE>
          <VALUEMEANING>Alive</VALUEMEANING>
          <MEANINGDESCRIPTION>Showing characteristics of life; displaying signs of life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580948</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dead</VALIDVALUE>
          <VALUEMEANING>Death</VALUEMEANING>
          <MEANINGDESCRIPTION>The cessation of life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lost to Follow-up(LTF)</VALIDVALUE>
          <VALUEMEANING>Negation Follow-up</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The process by which information about the health status of an individual is obtained after a study has officially closed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16033, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2775119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the patient&#39;s surviv</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the patient&#39;s survival status at latest follow-up?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the patient&#39;s survival status at the date of last contact</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the patient&#39;s survival status at the date of last contact</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the patient&#39;s survival status at the date of last contact</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify the patient&#39;s survival status at the date of last contact</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the recipient&#39;s survival status at the date of last contact</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the recipient&#39;s survival status at the date of last contact</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Moderately Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_VS_survival_stat</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_SRV_survival_stat</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNfup_vital_survival_stat</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_SRV_survival_stat</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedMedicalConditionResult:value</AlternateName>
        <AlternateNameType>HCT_BRIDG_5</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="329">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4770720</PUBLICID>
    <LONGNAME>Behavior Rating Inventory of Executive Function-Parent Form Metacognition Index T-Score Value</LONGNAME>
    <PREFERREDNAME>BRIEF_MI_TSCR</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric representation of the T-score for the Metacognition Index in the Behavior Rating Inventory of Executive Function-Parent Form.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BRIEF-Parent Version:Behavior Rating Inventory of Executive Function-Parent Version. Gerard A. Gioia, PhD, Peter K. Isquith, PhD, Steven C. Guy, PhD, and Lauren Kenworthy, PhD, Psychological Assessment Resources, Lutz, FL, 2000</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4770479</PublicId>
      <PreferredName>4770283v1.0:4770477v1.0</PreferredName>
      <PreferredDefinition>A standardized rating scale designed to assess the executive function behaviors in the school and home environments for children and adolescents as observed by a parent or teacher._A questionnaire included in the Behavior Rating Inventory of Executive Function. The parent form is completed by one or both parents who must have recent and extensive contact with the child over the past 6 months._An index of the Behavior Rating Inventory of Executive Function that reflects the individual&#39;s ability to initiate, plan, organize, self-monitor, and sustain working memory. It combines the Initiate, Working Memory, Plan/Organize, Organization of Materials, and Monitor scales._A method for converting an individual score into a standard form. While similar to a z-score, t-score is used when the conversion is made without knowledge of the population standard deviation and mean.</PreferredDefinition>
      <LongName>Behavior Rating Inventory of Executive Function BRIEF Parent Form Questionnaire Metacognition Index T-Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4770283</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121459</PreferredName>
        <Version>1</Version>
        <LongName>Behavior Rating Inventory of Executive Function</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121459</PREFERRED_NAME>
            <LONG_NAME>Behavior Rating Inventory of Executive Function</LONG_NAME>
            <CON_ID>4769210</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4770477</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121461:C121483:C120401</PreferredName>
        <Version>1</Version>
        <LongName>BRIEF Parent Form Questionnaire Metacognition Index T-Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121461</PREFERRED_NAME>
            <LONG_NAME>BRIEF Parent Form Questionnaire</LONG_NAME>
            <CON_ID>4769211</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121483</PREFERRED_NAME>
            <LONG_NAME>Metacognition Index</LONG_NAME>
            <CON_ID>4770470</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120401</PREFERRED_NAME>
            <LONG_NAME>T-Score</LONG_NAME>
            <CON_ID>4733378</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BRIEF-Parent Version:Behavior Rating Inventory of Executive Function-Parent Version. Gerard A. Gioia, PhD, Peter K. Isquith, PhD, Steven C. Guy, PhD, and Lauren Kenworthy, PhD, Psychological Assessment Resources, Lutz, FL, 2000</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4757289</PublicId>
      <PreferredName>BRIEF_TSCORE_VAL</PreferredName>
      <PreferredDefinition>A numerical quantity that represents the conversion of an individual score into a standard form made without knowledge of the population standard deviation and mean for the Behavior Rating Inventory of Executive Function.</PreferredDefinition>
      <LongName>BRIEF T Score Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>BRIEF-SR: Behavior Rating Inventory of Executive Function-Self-Report Version. Steven C. Guy, PhD, Peter K. Isquith, PhD, Gerard A. Gioia, PhD, Psychological Assessment Resources, 2004</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Behavior Rating Inventory of</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Behavior Rating Inventory of Executive Function (BRIEF) - Metacognition Index (MI) T-Score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Behavior Rating Inventory of Executive Function Second Edition (BRIEF-2) - Metacognition Index (MI) T-Score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PhenX</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PhenX</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="330">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4797993</PUBLICID>
    <LONGNAME>Ataxia Rating Assessment Scale</LONGNAME>
    <PREFERREDNAME>4797989v1.0:4797990v1.0_ASSESS</PREFERREDNAME>
    <PREFERREDDEFINITION>A disorder characterized by lack of coordination of muscle movements resulting in the impairment or inability to perform voluntary activities._The act of ascertaining or fixing the value or worth of something._the scale to determine the patient&#39;s assessment of general health.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4797992</PublicId>
      <PreferredName>4797989v1.0:4797990v1.0</PreferredName>
      <PreferredDefinition>A disorder characterized by lack of coordination of muscle movements resulting in the impairment or inability to perform voluntary activities._The act of ascertaining or fixing the value or worth of something.</PreferredDefinition>
      <LongName>Ataxia Rating</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4797989</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>E12597</PreferredName>
        <Version>1</Version>
        <LongName>Ataxia</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>E12597</PREFERRED_NAME>
            <LONG_NAME>Ataxia</LONG_NAME>
            <CON_ID>3123214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>CTCAE</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4797990</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C77538</PreferredName>
        <Version>1</Version>
        <LongName>Rating</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C77538</PREFERRED_NAME>
            <LONG_NAME>Rating</LONG_NAME>
            <CON_ID>2793832</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016428</PublicId>
      <PreferredName>ASSESS_SCALE</PreferredName>
      <PreferredDefinition>the scale to determine the patient&#39;s assessment of general health.</PreferredDefinition>
      <LongName>Assessment Scale</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>All of the time</VALIDVALUE>
          <VALUEMEANING>All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Most of the time</VALIDVALUE>
          <VALUEMEANING>Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A good bit of the time</VALIDVALUE>
          <VALUEMEANING>A Good Bit of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a good bit of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some of the time</VALIDVALUE>
          <VALUEMEANING>Some of the time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened some of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little of the time</VALIDVALUE>
          <VALUEMEANING>A Little of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a little of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None of the time</VALIDVALUE>
          <VALUEMEANING>None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat bothered</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little bit</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all bothered</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted totally</VALIDVALUE>
          <VALUEMEANING>Disrupted totally</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was totally disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted quite a bit</VALIDVALUE>
          <VALUEMEANING>Disrupted quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted somewhat</VALIDVALUE>
          <VALUEMEANING>Disrupted somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted a little</VALIDVALUE>
          <VALUEMEANING>Disrupted a little</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was a little disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not disrupted at all</VALIDVALUE>
          <VALUEMEANING>Not disrupted at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not at all disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable/have not received instructions about taking 6MP</VALIDVALUE>
          <VALUEMEANING>Not Applicable Have Negation Receive Instruction Approximate Take Six Mercaptopurine</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.: Used to describe the possession, relationships, or the state of something or someone.: An operation in which a term denies or inverts the meaning of another term or construction.: To take, accept, or get something offered.: A message describing how something is to be done.: Not quite exact or correct; almost exact or correct.: As pertains to a medication: ingest, inhale, instill, or inject.: A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.: A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities.  Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5&#39;-phosphate (6-thioGMP) and 6-thioinosine monophosphate (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis.  This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C195, C66837, C65105, C45828, C42688, C25639, C25594, C101282, C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6, 7, 8</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5782771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>About half of the time</VALIDVALUE>
          <VALUEMEANING>Approximate Half Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Not quite exact or correct; almost exact or correct.: One of two equal parts; a quantity corresponding to one half of the whole.: The continuum of experience in which events pass from the future through the present to the past.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25207, C81009, C45828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5782772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>All or almost all the time</VALIDVALUE>
          <VALUEMEANING>All of the Time Or Almost All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A response indicating that something happens or happened almost all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119986, C37998, C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6630428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None or almost none of the time</VALIDVALUE>
          <VALUEMEANING>None of the Time Or Nearly None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened none of the time.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Not quite or just short of.: A response indicating that something happens or happened none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110994, C107222, C37998, C110994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6630427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Ataxia Rating Assessment Scale does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Ataxia Rating Assessment Scale does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rare Genetic Conditions</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4809611</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="331">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4810635</PUBLICID>
    <LONGNAME>PROMIS 43 Adult Profile v2.0 Sleep72 Past 7 Days Try Hard to Get to Sleep Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PROMIS43_SLEEP72_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of how often in the past 7 days they tried hard to get to sleep, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4810248</PublicId>
      <PreferredName>4810131v1.0:4810246v1.0</PreferredName>
      <PreferredDefinition>A 43-item multidimensional and universal measure of health intended for use across a variety of conditions. It measures an adult patient&#39;s self-reported health status in seven domains: physical function, anxiety, depression, fatigue, sleep disturbance, pain interference, and participation in social roles._The most recent week, including today._A question about whether an individual tries or tried hard to get to sleep._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>PROMIS-43 Adult Profile v2.0 Past Week Try Hard to Get to Sleep Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4810131</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121683</PreferredName>
        <Version>1</Version>
        <LongName>PROMIS-43 Adult Profile v2.0</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121683</PREFERRED_NAME>
            <LONG_NAME>PROMIS-43 Adult Profile v2.0</LONG_NAME>
            <CON_ID>4806811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4810246</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C121710:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Try Hard to Get to Sleep Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121710</PREFERRED_NAME>
            <LONG_NAME>Try Hard to Get to Sleep Question</LONG_NAME>
            <CON_ID>4809513</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4810013</PublicId>
      <PreferredName>PROMIS_HOW_MUCH_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used with the PROMIS items that describes a range of subjective scores for representing how much of something an individual experiences from 1: Not at all, to 5: Very much.</PreferredDefinition>
      <LongName>PROMIS Quantity Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PROMIS 43 Profile v2.0</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Item #30 of 43</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring Manual Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText/>
        <URL>http://www.assessmentcenter.net/documents/PROMIS%20Profile%20Scoring%20Manual.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I tried hard to get to sleep</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I tried hard to get to sleep</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4857911</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PROMIS Item Banks</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult Profiles</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15974421</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult Profiles</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15974422</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="332">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4838225</PUBLICID>
    <LONGNAME>FACIT-Dyspnea 10 Item Short Form Past Seven Days Short of Breath Severity Did Not Sweep or Mop Reason</LONGNAME>
    <PREFERREDNAME>FACITDOE_NOSWEEP_RS</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated indication of the reason why in the past 7 days they did not sweep or mop, using one of two text responses.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FACIT-Dyspnea SF:FACIT-dyspnea (dyspnoea)-short form, Seung W. Choi, Ph.D., David Cella, Ph.D., R 01 October 2012</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4837979</PublicId>
      <PreferredName>4837931v1.0:4837977v1.0</PreferredName>
      <PreferredDefinition>A patient-reported outcome measure designed to evaluate an individual&#39;s shortness of breath across ten functional activities over the past 7 days._A question about an individual&#39;s agreement with a statement._The most recent week, including today._A question about how short of breath an individual gets or got when walking faster than their usual speed for one half mile without stopping._A number or range of numeric values measuring performance, function, quality, or ability._Difficult, painful breathing or shortness of breath._Used of the degree of something undesirable e.g. pain or weather; also, strictness._A question about the reason why an individual did not sweep or mop.</PreferredDefinition>
      <LongName>FACIT-Dyspnea 10 Item Short Form How True Past Week Dyspnea Severity Did Not Sweep or Mop</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4837931</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121853</PreferredName>
        <Version>1</Version>
        <LongName>FACIT-Dyspnea 10 Item Short Form</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121853</PREFERRED_NAME>
            <LONG_NAME>FACIT-Dyspnea 10 Item Short Form</LONG_NAME>
            <CON_ID>4826693</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4837977</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4837977v1.0</PreferredName>
        <Version>1</Version>
        <LongName>How True Past Week Dyspnea Severity Did Not Sweep or Mop</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91781</PREFERRED_NAME>
            <LONG_NAME>How True Question</LONG_NAME>
            <CON_ID>3133350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2998</PREFERRED_NAME>
            <LONG_NAME>Dyspnea</LONG_NAME>
            <CON_ID>2202612</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121876</PREFERRED_NAME>
            <LONG_NAME>Did Not Sweep or Mop Reason Question</LONG_NAME>
            <CON_ID>4826720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>FACIT-Dyspnea SF:FACIT-dyspnea (dyspnoea)-short form, Seung W. Choi, Ph.D., David Cella, Ph.D., R 01 October 2012</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4837844</PublicId>
      <PreferredName>FACIT_DYSPNEA_MVR</PreferredName>
      <PreferredDefinition>An explanation of the cause of an individual not being able to complete an activity included in the FACIT Dyspnea questionnaire.</PreferredDefinition>
      <LongName>FACIT Dyspnea MVR Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>115</MaximumLength>
      <MinimumLength>94</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>FACIT-Dyspnea SF:FACIT-dyspnea (dyspnoea)-short form, Seung W. Choi, Ph.D., David Cella, Ph.D., R 01 October 2012</Origin>
      <Representation>
        <PublicId>2240632</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I did not do this activity for some other reason (including not having a chance to do it, other health issues etc).</VALIDVALUE>
          <VALUEMEANING>I did not do this activity for some other reason (including not having a chance to do it, other health issues etc). </VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has not done an activity for some reason not listed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4837845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I have stopped trying, or knew I could not do this activity because of my shortness of breath.</VALIDVALUE>
          <VALUEMEANING>I have stopped trying, or knew I could not do this activity because of my shortness of breath.</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has stopped trying, or knew they could not do this activity because of their shortness of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4837846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents.  In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring Manual Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Scoring and Interpretation materials are accessible after registration on the FACIT website.</DocumentText>
        <URL>http://www.facit.org/FACITOrg/Questionnaires</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Please indicate why you did n</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Please indicate why you did not do this in the past 7 days:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACIT-Dyspnea 10 Item Short Form</Name>
        <DocumentType>LABEL</DocumentType>
        <DocumentText>Question #12 of 30</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4811884</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FACIT System Scales</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACIT-Dyspnea (Dyspnoea) - 10 Item Short Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4836812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="333">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4851499</PUBLICID>
    <LONGNAME>Acute Promyelocytic Leukemia Diagnosis Code Indicator</LONGNAME>
    <PREFERREDNAME>APL_DX_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded response that indicates a patient has a diagnosis of acute promyelocytic leukemia that meets the eligibility criteria for participation in a clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4851376</PublicId>
      <PreferredName>4718186v1.0:2239981v1.0</PreferredName>
      <PreferredDefinition>An acute myeloid leukemia (AML) in which abnormal promyelocytes predominate.  It is characterized by the t(15;17)(q22;q12) translocation.  There are two variants: the typical and microgranular variant.  This AML is particularly sensitive to treatment with all trans-retinoic acid and has a favorable prognosis.  (WHO, 2001)_The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</PreferredDefinition>
      <LongName>Acute Promyelocytic Leukemia with t(15;17)(q22;q12); PML-RARA Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4718186</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3182</PreferredName>
        <Version>1</Version>
        <LongName>Acute Promyelocytic Leukemia with t(15;17)(q22;q12); PML-RARA</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3182</PREFERRED_NAME>
            <LONG_NAME>Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA</LONG_NAME>
            <CON_ID>2202299</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239981</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have promyelocytic leukemia (FAB M3)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have acute promy</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have acute promyelocytic leukemia (APL, M3)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have acute promyelocytic leukemia with t(15;17)(q22;q12) and/or PML-RARA molecular rearrangement?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_TEXT_2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have acute promyelocytic leukemia?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have acute promyelocytic leukemia with t(15;17)(q22;q12) and/or PML-RARA molecular rearrangement, or other atypical RARA translocation partner?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have promyelocytic leukemia (FAB M3)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have acute promyelocytic leukemia (FAB M3)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have acute promyelocytic leukemia (APL) or AML with t(15;17)(q22;q12) - PML::RARA)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have Acute promyelocytic leukemia (APL) with PML-RARA genetic abnormality according to WHO classification or t(15;17)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have acute promyelocytic leukemia?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876359</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Exclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status &amp; Genetics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000703</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="334">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4866054</PUBLICID>
    <LONGNAME>PROMIS Adult Global Health Version 1.1 Global01 General Health Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PROMIS_GLOBAL01_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of their health in general, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4865773</PublicId>
      <PreferredName>4865771v1.0:3626326v1.0</PreferredName>
      <PreferredDefinition>A Patient Reported Outcomes Measurement Information System (PROMIS) domain that assesses overall health in general, including global ratings of the five primary PROMIS domains (physical function, fatigue, pain, emotional distress, social health) as well as perceptions of general health that cut across domains._A question about an individual&#39;s assessment of their general health._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>PROMIS Adult Global Health Domain In General Would You Say Your Health Is Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4865771</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C122355</PreferredName>
        <Version>1</Version>
        <LongName>PROMIS Adult Global Health Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122355</PREFERRED_NAME>
            <LONG_NAME>PROMIS Adult Global Health Domain</LONG_NAME>
            <CON_ID>4860865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3626326</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C103254:C25338</PreferredName>
        <Version>1</Version>
        <LongName>In General Would You Say Your Health Is Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C103254</PREFERRED_NAME>
            <LONG_NAME>In General Would You Say Your Health Is Question</LONG_NAME>
            <CON_ID>3625818</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4865405</PublicId>
      <PreferredName>PROMIS_GEN_HLTH_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used with the PROMIS Global Health items that describes a range of subjective scores for rating health in general from 1: Poor, to 5: Excellent.</PreferredDefinition>
      <LongName>PROMIS General Health Rating Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Poor</VALUEMEANING>
          <MEANINGDESCRIPTION>Of low value or worth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3115746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Good</VALUEMEANING>
          <MEANINGDESCRIPTION>Valuable or useful or agreeable or pleasing.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Fair</VALUEMEANING>
          <MEANINGDESCRIPTION>Having no exceptional quality or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very good</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that something has a high degree of quality, value or worth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103342</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3626566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Excellent</VALUEMEANING>
          <MEANINGDESCRIPTION>Conforming to the highest quality or standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring Manual Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Link to PROMIS Assessment Center for additional information and scoring.</DocumentText>
        <URL>https://www.assessmentcenter.net/documents/Scoring%20PROMIS%20Global%20short%20form.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>In general, would you say you</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>In general, would you say your health is:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PROMIS v.1.1 - Global</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #1 of 10</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PROMIS v1.1 Global Health</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>10000293</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000428</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4857911</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PROMIS Item Banks</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult Global Health</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4857923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711235</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult Global Health</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14947564</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="335">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4888116</PUBLICID>
    <LONGNAME>PROMIS Version 2.0 Adult Physical Health Domain Physical Function PFA16r1 Ability to Dress Yourself Including Tying Shoelaces and Buttoning Clothes Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PROMISV2_PFA16r1_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of the difficulty they have with their ability to dress themselves, including tying shoelaces and buttoning their clothes, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4888098</PublicId>
      <PreferredName>4888071v1.0:4888096v1.0</PreferredName>
      <PreferredDefinition>A Patient Reported Outcomes Measurement Information System (PROMIS) domain that assesses the status of an individual&#39;s physical health._The collection of PROMIS item scales that assess an individual&#39;s ability to carry out activities that require physical actions including more complex activities that require a combination of skills, often within a social context._A question about the ability of an individual to dress, including tying shoelaces and doing buttons._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>PROMIS Adult Physical Health Domain Physical Function Ability to Dress Yourself Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4888071</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C122346:C122356</PreferredName>
        <Version>1</Version>
        <LongName>PROMIS Adult Physical Health Domain Physical Function Subordinate Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122346</PREFERRED_NAME>
            <LONG_NAME>PROMIS Adult Physical Health Domain</LONG_NAME>
            <CON_ID>4860856</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122356</PREFERRED_NAME>
            <LONG_NAME>Physical Function Subordinate Domain</LONG_NAME>
            <CON_ID>4860871</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4888096</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C122361:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Ability to Dress Yourself Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122361</PREFERRED_NAME>
            <LONG_NAME>Ability to Dress Yourself Question</LONG_NAME>
            <CON_ID>4860896</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4809918</PublicId>
      <PreferredName>PROMIS_V2_DIFCLT_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used with the PROMIS items that describes a range of subjective scores from 1: Cannot do, to 5: Without any difficulty.</PreferredDefinition>
      <LongName>PROMIS 2.0 Ability Difficulty Score 5 Point Scale</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Without Any Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something without any difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>With a Little Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something with a little difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809920</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>With Some Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something with some difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121739</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>With Much Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something with much difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Cannot Do</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual cannot do something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Are you able to dress yoursel</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Are you able to dress yourself, including tying shoelaces and buttoning your clothes?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring and Interpretation Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Scoring and Interpretation materials are available from the PROMIS Assessment Center.</DocumentText>
        <URL>https://www.assessmentcenter.net/documents/PROMIS%20Physical%20Function%20Scoring%20Manual.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Physical Function - SF 10a</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #7 of 10</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551591</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measure CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718286</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PROMIS Item Bank v1.0 - Physical Function - Short Form 10a</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4887912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PROMIS Item Bank v1.0 - Physical Function - Short Form 10a</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>10000292</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000428</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4857911</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PROMIS Item Banks</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult Physical Health</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4857913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4857911</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PROMIS Item Banks</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical Function</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4857918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711235</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical Function</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14951259</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="336">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4890982</PUBLICID>
    <LONGNAME>Patient Non-Small Cell Small Cell Lung Carcinoma Clinical Trial Eligibility Criteria Status</LONGNAME>
    <PREFERREDNAME>4890981v1.0:4801291v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the status of whether a subject is suitable for enrollment in a study based on the presence of Non-Small Cell Lung Carcinoma and small cell lung cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4890981</PublicId>
      <PreferredName>2177068v1.0:4890979v1.0</PreferredName>
      <PreferredDefinition>information related to the presence of Non-Small Cell Lung Carcinoma and small cell lung cancer as an element of the personal medical history which is necessary to allow an individual to participate in a specific clinical trial.</PreferredDefinition>
      <LongName>Patient Non-Small Cell Small Cell Lung Carcinoma Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4890979</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2926:C4917:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Non-Small Cell Lung Carcinoma Small Cell Lung Carcinoma Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2926</PREFERRED_NAME>
            <LONG_NAME>Lung Non-Small Cell Carcinoma</LONG_NAME>
            <CON_ID>2202762</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4917</PREFERRED_NAME>
            <LONG_NAME>Lung Small Cell Carcinoma</LONG_NAME>
            <CON_ID>2202810</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4801291</PublicId>
      <PreferredName>4801291v1.0</PreferredName>
      <PreferredDefinition>Satisfying the appropriate conditions for inclusion._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Eligibility Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>5</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>5340941</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C126586:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Eligible Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126586</PREFERRED_NAME>
            <LONG_NAME>Eligible</LONG_NAME>
            <CON_ID>5227195</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Criterion not evaluated</VALIDVALUE>
          <VALUEMEANING>Criterion Negation Evaluation</VALUEMEANING>
          <MEANINGDESCRIPTION>That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.: An operation in which a term denies or inverts the meaning of another term or construction.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25214, C25594, C25466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5340942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient is eligible based on this criterion</VALIDVALUE>
          <VALUEMEANING>Patient Eligible Basis Upon Criterion</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.: Satisfying the appropriate conditions for inclusion.: The fundamental assumptions underlying an explanation or a relation that provide the foundation for something.: Used to indicate that an event is to immediately follow another event.: That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25466, C65137, C25430, C126586, C16960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5340943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient is NOT eligible based on this criterion</VALIDVALUE>
          <VALUEMEANING>Patient Negation Basis Upon Criterion</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.: An operation in which a term denies or inverts the meaning of another term or construction.: The fundamental assumptions underlying an explanation or a relation that provide the foundation for something.: Used to indicate that an event is to immediately follow another event.: That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25466, C65137, C25430, C25594, C16960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5340945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Patients with non-small cell</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Patients with non-small cell lung cancer and small cell lung cancer will be excluded.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="337">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5016432</PUBLICID>
    <LONGNAME>Search Outcome Total Page Number</LONGNAME>
    <PREFERREDNAME>3118461v1.0:5016411v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The numeric value related to the total number of pages of a search result.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3118461</PublicId>
      <PreferredName>3118459v1.0:2224045v1.0</PreferredName>
      <PreferredDefinition>The activity of looking thoroughly in order to find something or someone; an operation that determines whether one or more of a set of items has a specified property._The result of an action.</PreferredDefinition>
      <LongName>Search Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008555</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MED_RCD_AND_FORMS</PreferredName>
        <Version>1</Version>
        <LongName>Medical Records and Forms</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3118459</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54117</PreferredName>
        <Version>1</Version>
        <LongName>Search</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54117</PREFERRED_NAME>
            <LONG_NAME>Search</LONG_NAME>
            <CON_ID>2505702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2224045</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20200</PreferredName>
        <Version>1</Version>
        <LongName>Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5016411</PublicId>
      <PreferredName>5016411v1.0</PreferredName>
      <PreferredDefinition>Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._One side of one leaf (of a book or magazine or newspaper or letter etc.) or the written or pictorial matter it contains._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.</PreferredDefinition>
      <LongName>Total Page Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>5017771</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25304:C42783:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Total Page Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25304</PREFERRED_NAME>
            <LONG_NAME>Total</LONG_NAME>
            <CON_ID>2204938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42783</PREFERRED_NAME>
            <LONG_NAME>Page</LONG_NAME>
            <CON_ID>2223992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is ?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is ?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total pages:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Total pages:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total pages:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Total pages:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FrmDue_page_rslt_ttl_pg</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="338">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5016714</PUBLICID>
    <LONGNAME>First Hematopoietic Recovery Occurrence Indicator</LONGNAME>
    <PREFERREDNAME>5016713v1.0:5096872v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not an initial hematopoietic recovery occurred or if it was previously reported.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5016713</PublicId>
      <PreferredName>5096631v1.0:2234856v1.0</PreferredName>
      <PreferredDefinition>Preceding all others in time or space or degree._Pertaining to or related to the formation of blood cells._A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>First Hematopoietic Recovery Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5096631</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C13324:C25746</PreferredName>
        <Version>1</Version>
        <LongName>First Hematopoietic Recovery</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13324</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic</LONG_NAME>
            <CON_ID>2206232</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25746</PREFERRED_NAME>
            <LONG_NAME>Recovery</LONG_NAME>
            <CON_ID>2203774</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5096872</PublicId>
      <PreferredName>5096872v1.0</PreferredName>
      <PreferredDefinition>Indicator of Yes, No, Unknown, Not done, Not applicable or Previously reported to a question.[manually curated].</PreferredDefinition>
      <LongName>Yes No Unk ND NA Previous Report Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>5096871</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5096871v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Previous Report Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>7</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25627</PREFERRED_NAME>
            <LONG_NAME>Previous</LONG_NAME>
            <CON_ID>2206349</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did an initial hematopoietic</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did an initial hematopoietic recovery occur?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was there evidence of initial hematopoietic recovery?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Was there evidence of initial hematopoietic recovery?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was there evidence of initial hematopoietic recovery?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was there evidence of initial hematopoietic recovery?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_GNR_initial_hem_rec_ynnp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_IAR_initial_hem_rec_ynnp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="339">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5025008</PUBLICID>
    <LONGNAME>Patient Phosphorylated Epidermal Growth Factor Receptor Staining Not Evaluable Reason Category</LONGNAME>
    <PREFERREDNAME>PT_PHO_EGFR_STN_N_EVL_RSN_CAT</PREFERREDNAME>
    <PREFERREDDEFINITION>The choice of reasons why a patient was not evaluable for epidermal growth factor receptor protein (EGFR) bearing phosphorylated tyrosine residues within the 194 amino acids of the carboxyl-terminal intracellular domain of the protein staining.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5024965</PublicId>
      <PreferredName>2233604v1.0:5024963v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Epidermal growth factor receptor protein (EGFR) bearing phosphorylated tyrosine residues within the 194 amino acids of the carboxyl-terminal intracellular domain of the protein. Five ligand-dependent autophosphorylation sites have been identified; overexpression or mutation of EGFR can decouple ligand-binding from autophosphorylation and the subsequent activation of downstream signaling pathways. The presence of phosphorylated EGFR in a malignant tumor is generally correlated with poor prognosis and could be used as a predictive biomarker to identify individuals who may respond to EGFR-tyrosine kinase inhibitor treatment._Discoloration of patient tissue(s) produced by absorption of, or contact with, foreign matter, such as with medical dyes._Disease that cannot be measured directly by the size of the tumor but can be evaluated by other methods specific to a particular clinical trial._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Patient Phosphorylated Epidermal Growth Factor Receptor Staining Evaluable Disease Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5024963</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C123765:C50753:C8503:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Phosphorylated Epidermal Growth Factor Receptor Staining Evaluable Disease Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C123765</PREFERRED_NAME>
            <LONG_NAME>Phosphorylated Epidermal Growth Factor Receptor</LONG_NAME>
            <CON_ID>5023047</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50753</PREFERRED_NAME>
            <LONG_NAME>Staining</LONG_NAME>
            <CON_ID>2664657</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C8503</PREFERRED_NAME>
            <LONG_NAME>Evaluable Disease</LONG_NAME>
            <CON_ID>2206207</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCP:Division of Cancer Prevention</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5024989</PublicId>
      <PreferredName>5024989v1.0</PreferredName>
      <PreferredDefinition>An operation in which a term denies or inverts the meaning of another term or construction._Disease that cannot be measured directly by the size of the tumor but can be evaluated by other methods specific to a particular clinical trial._An explanation of the cause of some phenomenon or action._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Not Evaluable Reason Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DCP:Division of Cancer Prevention</Origin>
      <Representation>
        <PublicId>5024988</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C8503:C25638:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Negation Evaluable Disease Reason Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C8503</PREFERRED_NAME>
            <LONG_NAME>Evaluable Disease</LONG_NAME>
            <CON_ID>2206207</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, specify</VALIDVALUE>
          <VALUEMEANING>Other Specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Be specific about something; define clearly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-09-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4188777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Specimen lost</VALIDVALUE>
          <VALUEMEANING>Lost Specimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Parted with; no longer held or possessed; incapable of being recovered or regained.: A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19157, C25560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-09-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5024990</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Assay failed</VALIDVALUE>
          <VALUEMEANING>Failed Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>Having undergone failure; did not accomplish the intended purpose.: A qualitative or quantitative analysis performed to determine the amount of a particular constituent in a sample or the biological or pharmacological potency of a drug.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60819, C44281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-09-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5024991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insufficient tissue</VALIDVALUE>
          <VALUEMEANING>Inadequate Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Not meeting a quantitative or qualitative measure necessary for a requirement.: An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12801, C69177</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-09-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5024992</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No positive pixels</VALIDVALUE>
          <VALUEMEANING>No Positive Pixel</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: Involving advantage or good.: The smallest resolvable rectangular area of an image, either on a screen or stored in memory.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48367, C25246, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-09-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5024993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If no, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If no, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="340">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5027151</PUBLICID>
    <LONGNAME>Biopsy Performed Procedure Type</LONGNAME>
    <PREFERREDNAME>BX_PERF_PROC_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Name of a procedure used to remove tissue specimen(s) or fluid from the body for examination.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2015095</PublicId>
      <PreferredName>BX_PERF</PreferredName>
      <PreferredDefinition>information related to a biopsy (removal of tissue specimens or fluid from the living body for microscopic examination to establish a diagnosis) being performed (carried out).</PreferredDefinition>
      <LongName>Biopsy Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2187705</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15189</PreferredName>
        <Version>1</Version>
        <LongName>Biopsy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15189</PREFERRED_NAME>
            <LONG_NAME>Biopsy Procedure</LONG_NAME>
            <CON_ID>2202502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5027131</PublicId>
      <PreferredName>BX_TP</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Biopsy Procedure Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fine needle aspiration</VALIDVALUE>
          <VALUEMEANING>Fine-Needle Aspiration</VALUEMEANING>
          <MEANINGDESCRIPTION>The removal of tissue or fluid with a thin needle for examination under a microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15361</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3226038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Shave</VALIDVALUE>
          <VALUEMEANING>Shave Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal skin tissue, for microscopic examination, using a blade oriented in the horizontal plane of the skin surface.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5027133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Punch</VALIDVALUE>
          <VALUEMEANING>Punch Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal of a disk of skin tissue, for microscopic examination, using a punch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28743</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5027134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ultrasound guided</VALIDVALUE>
          <VALUEMEANING>Ultrasound-guided Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>A biopsy procedure that uses an ultrasound imaging device to find an abnormal area of tissue and guide its removal for examination under a microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93022</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5027135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI-Guided</VALIDVALUE>
          <VALUEMEANING>Magnetic Resonance Imaging Guided Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.: The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis, using imaging technology.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15652, C16809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5263794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CT-Guided</VALIDVALUE>
          <VALUEMEANING>Computed Tomography Guided Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.: The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis, using imaging technology.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15652, C17204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5263795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Biopsy Type</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Biopsy Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="341">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5092094</PUBLICID>
    <LONGNAME>Product Infusion Procedure Administered Begin Date</LONGNAME>
    <PREFERREDNAME>5092092v1.0:2557783v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The month, day, and year the product (e.g.,human drugs; therapeutic biologics; allergenics; cells, tissue and gene therapy products; blood components and blood derivative products)  infusion procedure began.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5092092</PublicId>
      <PreferredName>5092074v1.0:2233610v1.0</PreferredName>
      <PreferredDefinition>A thing produced by or resulting from a process. EXAMPLE(S): drug, device. The FDA list of regulated products: animal and human drugs; therapeutic biologics; allergenics; cell, tissue and gene therapy products; blood components; blood derivative products; devices; and animal (pets and livestock) and human food/feed (medicated and un-medicated); cosmetics; pet treats; and dietary supplements._A method of putting fluids, including drugs, into the bloodstream. Also called intravenous infusion._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Product Infusion Procedure Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5092074</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C51980:C15388</PreferredName>
        <Version>1</Version>
        <LongName>Product Infusion Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51980</PREFERRED_NAME>
            <LONG_NAME>Product</LONG_NAME>
            <CON_ID>2527882</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15388</PREFERRED_NAME>
            <LONG_NAME>Infusion Procedure</LONG_NAME>
            <CON_ID>2203835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2557783</PublicId>
      <PreferredName>BEG_DT</PreferredName>
      <PreferredDefinition>Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins._The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Begin Date</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY-MM-DD</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2208020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Begin Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the date the product</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the date the product infusion procedure began?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date infusion started:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date infusion started:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date infusion started:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Date infusion started:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="342">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5114686</PUBLICID>
    <LONGNAME>Memorial Symptom Assessment Scale D16 Past Week How Much Distress Feeling Sad Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>MSAS_D_FEELINGSAD_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated observation in the past week how much distress they had from symptoms of feeling sad, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5114598</PublicId>
      <PreferredName>5114473v1.0:5114596v1.0</PreferredName>
      <PreferredDefinition>A patient-rated instrument developed to provide multidimensional information about a diverse group of common symptoms. This 32-question, self-rated questionnaire evaluates the prevalence, characteristics, and distress associated with each of the symptoms._The most recent week, including today._A question about an individual&#39;s distress from their feeling of sadness._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale Past Week How Much Distress Feeling Sad Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5114473</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C125238</PreferredName>
        <Version>1</Version>
        <LongName>Memorial Symptom Assessment Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125238</PREFERRED_NAME>
            <LONG_NAME>Memorial Symptom Assessment Scale</LONG_NAME>
            <CON_ID>5109052</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5114596</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C125345:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week How Much Distress Feeling Sad Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125345</PREFERRED_NAME>
            <LONG_NAME>How Much Distress Feeling Sad Question</LONG_NAME>
            <CON_ID>5109183</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5114472</PublicId>
      <PreferredName>MSAS_DISTRESS_SCL</PreferredName>
      <PreferredDefinition>Numeric scores from 0 (Not at all) to 4 (Very Much) on a Likert scale used on the Memorial Symptom Assessment Scale questionnaire.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale Distress Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How much did your feeling sad</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How much did your feeling sad DISTRESS or BOTHER you?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure.  The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents.  Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Feeling sad</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Feeling sad</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS (Memorial Symptom Assessment Scale)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5115651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840828</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS (Memorial Symptom Assessment Scale)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCI Standards</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="343">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5126930</PUBLICID>
    <LONGNAME>Memorial Symptom Assessment Scale S22 Past Week Usual Severity Dizziness Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>MSAS_S_DIZZINESS_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated observation in the past week the severity of their dizziness, using a four-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MSAS:Memorial Symptom Assessment Scale. Portenoy, RK, et.al. Eur J Cancer. 1994;30A(9):1326-36.</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5114816</PublicId>
      <PreferredName>5114473v1.0:5114814v1.0</PreferredName>
      <PreferredDefinition>A patient-rated instrument developed to provide multidimensional information about a diverse group of common symptoms. This 32-question, self-rated questionnaire evaluates the prevalence, characteristics, and distress associated with each of the symptoms._The most recent week, including today._A question about the usual severity of an individual&#39;s dizziness._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale Past Week Usual Severity Dizziness Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5114473</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C125238</PreferredName>
        <Version>1</Version>
        <LongName>Memorial Symptom Assessment Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125238</PREFERRED_NAME>
            <LONG_NAME>Memorial Symptom Assessment Scale</LONG_NAME>
            <CON_ID>5109052</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5114814</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C125319:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Usual Severity Dizziness Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125319</PREFERRED_NAME>
            <LONG_NAME>Usual Severity Dizziness Question</LONG_NAME>
            <CON_ID>5109156</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5114471</PublicId>
      <PreferredName>MSAS_SEVERE_SCL</PreferredName>
      <PreferredDefinition>Numeric scores from 1 (Slight) to 4 (Very Severe) on a Likert scale used on the Memorial Symptom Assessment Scale questionnaire.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale Severity Score 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very Severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Exceedingly intense or unpleasant in degree, quality or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3906433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely bad or unpleasant in degree, quality or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4633034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Slight</VALUEMEANING>
          <MEANINGDESCRIPTION>Small or little in size, quantity, or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3906434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure.  The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents.  Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MSAS</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #70 of 126</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How SEVERE was your dizziness</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How SEVERE was your dizziness usually?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS (Memorial Symptom Assessment Scale)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5115651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840828</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS (Memorial Symptom Assessment Scale)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCI Standards</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="344">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5145133</PUBLICID>
    <LONGNAME>Patient Refuse Other Clinical Trial Participation Specify</LONGNAME>
    <PREFERREDNAME>REFUSEOTHSP</PREFERREDNAME>
    <PREFERREDDEFINITION>The free-text field for information related to a patient&#39;s participation in a clinical trial due to refusal over reason other than the one(s) previously specified or mentioned.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5145122</PublicId>
      <PreferredName>REFUSEOTH</PreferredName>
      <PreferredDefinition>Information related to a patient&#39;s participation in a clinical trial due to refusal over reason other than the one(s) previously specified or mentioned.</PreferredDefinition>
      <LongName>Patient Refuse Other Clinical Trial Participation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5145120</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49161:C17649:C71104:C25608</PreferredName>
        <Version>1</Version>
        <LongName>Refuse Other Clinical Trial Participation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49161</PREFERRED_NAME>
            <LONG_NAME>Refuse</LONG_NAME>
            <CON_ID>2427336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71104</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial</LONG_NAME>
            <CON_ID>2735720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25608</PREFERRED_NAME>
            <LONG_NAME>Participation</LONG_NAME>
            <CON_ID>2206339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018806</PublicId>
      <PreferredName>ASSESS_SPEC</PreferredName>
      <PreferredDefinition>The free text field to specify the assessment performed.</PreferredDefinition>
      <LongName>Assessment Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify reason not interested</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify reason not interested</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="345">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5216325</PUBLICID>
    <LONGNAME>Case Stop Other Specify</LONGNAME>
    <PREFERREDNAME>CASE_STOP_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>The response that indicates the reason the case was stopped that has not been previously listed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>BBRB</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BPV: Biospecimen Pre-analytical Variables (BPV) Program</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5216038</PublicId>
      <PreferredName>3310760v1.0:2728085v1.0</PreferredName>
      <PreferredDefinition>A problem requiring investigation._Put an end to a state or an activity.</PreferredDefinition>
      <LongName>Case Stop</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>BBRB</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2230266</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TISSUE BANKING</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Banking</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3310760</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49152</PreferredName>
        <Version>1</Version>
        <LongName>Case</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49152</PREFERRED_NAME>
            <LONG_NAME>Case</LONG_NAME>
            <CON_ID>2491895</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2728085</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C65125</PreferredName>
        <Version>1</Version>
        <LongName>Stop</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C65125</PREFERRED_NAME>
            <LONG_NAME>Stop</LONG_NAME>
            <CON_ID>2660108</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BPV: Biospecimen Pre-analytical Variables (BPV) Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666713</PublicId>
      <PreferredName>OTH_SPEC</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Other Specify</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCI CRF Standards</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If case was stopped select re</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If case was stopped select reason - other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BPV - Tumor Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Quality Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736418</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BBRB</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BBRB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="346">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5220151</PUBLICID>
    <LONGNAME>Biospecimen Primary Organ Site Text</LONGNAME>
    <PREFERREDNAME>BIOSP_PRI_ORGAN_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>The primary anatomic site/organ from which the biospecimen was obtained.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>BBRB</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BPV: Biospecimen Pre-analytical Variables (BPV) Program</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5202013</PublicId>
      <PreferredName>2859635v1.0:5202011v1.0</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._Occurring first in time or sequence; original; of greatest rank or importance or value._A unique macroscopic (gross) anatomic structure that performs specific functions.  It is composed of various tissues.  An organ is part of an anatomic system or a body region.  Representative examples include the heart, lung, liver, spleen, and uterus.</PreferredDefinition>
      <LongName>Biospecimen Primary Organ</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>BBRB</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5202011</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25251:C13018</PreferredName>
        <Version>1</Version>
        <LongName>Primary Organ</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13018</PREFERRED_NAME>
            <LONG_NAME>Organ</LONG_NAME>
            <CON_ID>2202464</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BPV: Biospecimen Pre-analytical Variables (BPV) Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178168</PublicId>
      <PreferredName>ORGAN_SITE_TEXT</PreferredName>
      <PreferredDefinition>text that describes the anatomical location from which a biopsy specimen was collected.</PreferredDefinition>
      <LongName>Organ Site Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>EDRN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178079</PublicId>
        <ContextName>EDRN</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength>0</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177855</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Text</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Primary Organ</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Primary Organ</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>GTEx - Organ</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Organ</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>GTEx - Organ Type</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Organ Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BPV - Tumor Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FFPE Section-Stain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736421</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Gross Evaluation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736427</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Processing Wksht</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736429</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Processing - Embedding</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736430</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Receipt - Dissection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736431</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GTEx - Postmortem Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Shipping Manifest</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736393</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Manifest: Frozen Tissue Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BBRB</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BBRB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="347">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5228071</PUBLICID>
    <LONGNAME>Biospecimen Tissue Collection Method Other Specify</LONGNAME>
    <PREFERREDNAME>TISS_SPEC_METH_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>The tissue collection procedure with which the tumor tissue was obtained that was not previously listed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>BBRB</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BPV: Biospecimen Pre-analytical Variables (BPV) Program</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5227313</PublicId>
      <PreferredName>2859635v1.0:5227311v1.0</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._A repository of the tissue specimen, cells or cell lines, for experimental purpose. It can be from different diseases or different parts of the body._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.</PreferredDefinition>
      <LongName>Biospecimen Tissue Collection Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>BBRB</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2230266</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TISSUE BANKING</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Banking</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5227311</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15339:C71460</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Collection Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15339</PREFERRED_NAME>
            <LONG_NAME>Tissue Collection</LONG_NAME>
            <CON_ID>2222487</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BPV: Biospecimen Pre-analytical Variables (BPV) Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666713</PublicId>
      <PreferredName>OTH_SPEC</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Other Specify</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCI CRF Standards</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify Other tissue collecti</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify Other tissue collection Procedure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BPV - Tumor Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Receipt - Dissection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736431</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BBRB</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BBRB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="348">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5235463</PUBLICID>
    <LONGNAME>Biospecimen Heart Tissue Donor Verification Indicator</LONGNAME>
    <PREFERREDNAME>HEART_TISS_DONOR_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The response to indicate supporting evidence that the patient will provide a heart tissue specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>BBRB</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5231629</PublicId>
      <PreferredName>2859635v1.0:5231627v1.0</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._A hollow organ located slightly to the left of the middle portion of the chest. It is composed of muscle and it is divided by a septum into two sides: the right side which receives de-oxygenated blood from the body and the left side which sends newly oxygenated blood to the body. Each side is composed of two chambers: the atrium (receiving blood) and ventricle (ejecting blood)._Someone who gives blood or tissue or an organ to be used in another person._Support or establish by evidence or proof.</PreferredDefinition>
      <LongName>Biospecimen Heart Tissue Donor Verification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>BBRB</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2230266</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TISSUE BANKING</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Banking</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5231627</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12727:C25168:C45513</PreferredName>
        <Version>1</Version>
        <LongName>Heart Tissue Donor Verification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12727</PREFERRED_NAME>
            <LONG_NAME>Heart</LONG_NAME>
            <CON_ID>2202646</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45513</PREFERRED_NAME>
            <LONG_NAME>Verification</LONG_NAME>
            <CON_ID>2673245</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Heart tissue</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Heart tissue</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GTEx - Postmortem Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NDRI Consent Verification - Postmortem</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736406</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BBRB</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BBRB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="349">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5300693</PUBLICID>
    <LONGNAME>Walking Practice Minute Duration Time</LONGNAME>
    <PREFERREDNAME>WALK_PRAC_MIN_DUR_TIME</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the time in minutes of walking practice.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5300692</PublicId>
      <PreferredName>WALK_PRAC</PreferredName>
      <PreferredDefinition>The act of traveling by foot._In medicine, treatment that experts agree is appropriate, accepted, and widely used. Health care providers are obligated to provide patients with the standard of care.</PreferredDefinition>
      <LongName>Walking Practice</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3198924</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C73554</PreferredName>
        <Version>1</Version>
        <LongName>Walking</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73554</PREFERRED_NAME>
            <LONG_NAME>Walking</LONG_NAME>
            <CON_ID>2743260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5300652</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C94396</PreferredName>
        <Version>1</Version>
        <LongName>Best Practice</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94396</PREFERRED_NAME>
            <LONG_NAME>Best Practice</LONG_NAME>
            <CON_ID>3681388</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3812462</PublicId>
      <PreferredName>3812462v1.0</PreferredName>
      <PreferredDefinition>The time in minutes (nnnn.nn) that it takes for an event or activity to take place from beginning to end.</PreferredDefinition>
      <LongName>Minute Duration Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>min</UnitOfMeasure>
      <MaximumLength>6</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2193249</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25207</PreferredName>
        <Version>1</Version>
        <LongName>Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Walking Practice in Minutes</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Walking Practice in Minutes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="350">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5508290</PUBLICID>
    <LONGNAME>First Patient Visit Intervention or Procedure Therapy Name</LONGNAME>
    <PREFERREDNAME>FST_VIS_INT_TX_NAME</PREFERREDNAME>
    <PREFERREDDEFINITION>The name of the protocol intervention or procedure that the participant will receive for the first visit.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5508273</PublicId>
      <PreferredName>5508271v1.0:2940267v1.0</PreferredName>
      <PreferredDefinition>Preceding all others in time or space or degree._A visit by a patient or study participant to a medical professional._An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.</PreferredDefinition>
      <LongName>First Patient Visit Intervention or Procedure Therapy</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008514</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>DCP</PreferredName>
        <Version>1</Version>
        <LongName>DCP Conceptual Domain</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5508271</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C39564</PreferredName>
        <Version>1</Version>
        <LongName>First Patient Visit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39564</PREFERRED_NAME>
            <LONG_NAME>Patient Visit</LONG_NAME>
            <CON_ID>2684743</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2940267</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25218:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Intervention or Procedure Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCP:Division of Cancer Prevention</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5508286</PublicId>
      <PreferredName>INTVN_PROC_NM</PreferredName>
      <PreferredDefinition>The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Intervention or Procedure Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008514</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>DCP</PreferredName>
        <Version>1</Version>
        <LongName>DCP Conceptual Domain</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DCP:Division of Cancer Prevention</Origin>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Treatment (Off study)</VALIDVALUE>
          <VALUEMEANING>None Therapeutic Procedure Off Study</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.: No longer participating in a study; not being followed and will not be retreated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29851, C49236, C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5508287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 6 Visit or Early Termination</VALIDVALUE>
          <VALUEMEANING>Month Six Patient Visit Or Early Off Study</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.: A visit by a patient or study participant to a medical professional.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: At or near the beginning of a period of time or course of events.: No longer participating in a study; not being followed and will not be retreated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29851, C61589, C37998, C39564, C66837, C29846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5508288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 3 Visit</VALIDVALUE>
          <VALUEMEANING>Month Three Patient Visit</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.: A visit by a patient or study participant to a medical professional.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39564, C66834, C29846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5508289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Week 0 (first vaccine)</VALIDVALUE>
          <VALUEMEANING>First Zero Week Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>Preceding all others in time or space or degree.: A mathematical element that when added to another number yields the same number; the cardinal number meaning one less than one.: Any period of seven consecutive days.: Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C923, C29844, C70430, C25509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6044970</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intervention Period 1</VALIDVALUE>
          <VALUEMEANING>Intervention or Procedure Period One</VALUEMEANING>
          <MEANINGDESCRIPTION>An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects._An interval of time._The smallest natural number and quantity it denotes: a single entity, unit, or object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25616, C66832, C25218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14478099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intervention Period 2</VALIDVALUE>
          <VALUEMEANING>Intervention or Procedure Period Two</VALUEMEANING>
          <MEANINGDESCRIPTION>An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects._An interval of time._A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66833, C25616, C25218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14478100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What protocol intervention wi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What protocol intervention will the participant receive for the first visit?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5592146</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6005698</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-08-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6025104</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="351">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5509518</PUBLICID>
    <LONGNAME>FSFI 1 Past 4 Weeks Frequency Sexual Desire Interest Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>FSFI_1_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how often in the past 4 weeks they felt sexual desire or interest, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5487992</PublicId>
      <PreferredName>5487989v1.0:5487990v1.0</PreferredName>
      <PreferredDefinition>A 19-item self-report questionnaire designed to measure sexual function in women. It was developed for assessing domains of sexual functioning (e.g. sexual arousal, orgasm, satisfaction, pain) in women participating in clinical trials for arousal disorders._A period of time consisting of the 28 days before the present._A question about how often an individual felt sexual desire or interest._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Female Sexual Function Index Past 4 Weeks Frequency of Sexual Desire or Interest Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5487989</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C129328</PreferredName>
        <Version>1</Version>
        <LongName>Female Sexual Function Index</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C129328</PREFERRED_NAME>
            <LONG_NAME>Female Sexual Function Index</LONG_NAME>
            <CON_ID>5482810</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5487990</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C110986:C129329:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past 4 Weeks Frequency of Sexual Desire or Interest Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110986</PREFERRED_NAME>
            <LONG_NAME>Past 4 Weeks</LONG_NAME>
            <CON_ID>3871096</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C129329</PREFERRED_NAME>
            <LONG_NAME>Frequency of Sexual Desire or Interest Question</LONG_NAME>
            <CON_ID>5482811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5509283</PublicId>
      <PreferredName>FSFI_DESIRE_5_PT_SCL</PreferredName>
      <PreferredDefinition>5 point scale.</PreferredDefinition>
      <LongName>Female Sexual Function Index Desire Frequency 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Never or Almost Never</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happened never or almost never.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5509281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A Few Times</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happened less than half the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5509282</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Almost All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened almost all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Over the past 4 weeks, how of</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Over the past 4 weeks, how often did you feel sexual desire or interest?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Female Sexual Function Index (FSFI)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #1 of 19.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring Manual Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure.</DocumentText>
        <URL>http://www.fsfiquestionnaire.org/Published%20Format.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions. Questions used in this manner do not represent the original measure and should not be referenced by the measure’s name.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5485865</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FSFI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FSFI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5485866</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Female Sexual Function Index (FSFI)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900304</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="352">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5511060</PUBLICID>
    <LONGNAME>Person Diabetes Mellitus Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>DM_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A response to determine eligibility for clinical trial participation for questions related to a metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5511058</PublicId>
      <PreferredName>5511056v1.0:2494487v1.0</PreferredName>
      <PreferredDefinition>A human being._A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Person Diabetes Mellitus Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5511056</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C2985</PreferredName>
        <Version>1</Version>
        <LongName>Person Diabetes Mellitus</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2985</PREFERRED_NAME>
            <LONG_NAME>Diabetes Mellitus</LONG_NAME>
            <CON_ID>2202847</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2494487</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16112</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If patient has diabetes, is i</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If patient has diabetes, is it controlled?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have known pre-existing diabetes mellitus?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have uncontrolled Type I or II diabetes mellitus?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have uncontrolled Type I or II diabetes mellitus (DM) within 14 days prior to trial entry?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient has history of known Type I or Type II diabetes, is the fasting glucose level less than 120 mg/dL on at least 2 separate occasions or HbA1c less than 8.5% at screening within 14 days prior to registration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient has controlled Type 1 diabetes mellitus is the patient on a stable insulin regimen?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have uncontrolled diabetes?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient has diabetes, have they been on a stable dose of oral diabetes medication greater than or equal to 4 weeks prior to initiation of study treatment and laboratory eligibility criteria for fasting blood glucose (less than or equal to 150 mg/dL (8.3 mmol/L) and hemoglobin A1c (less than or equal to 7.5% (58 mmol/mol) are met?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient has non-insulin dependent diabetes mellitus, is patient on a stable dose of oral diabetes medication greater than or equal to 4 weeks prior to initiation of study?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have diabetes and is being treated with insulin?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a history of uncontrolled diabetes mellitus within 3 months before the first dose of study treatment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876352</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Inclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status &amp; Genetics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3876422</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="353">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5527398</PUBLICID>
    <LONGNAME>PRO-CTCAE Version 1.0 6a. Past Seven Days Worst Severity Hoarse Voice 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PROCTCAE_6A_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of the worst severity they have experienced related to hoarse voice over the past seven days, using a text term rating of the degree of the severity.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PRO-CTCAE TM:Patient-Reported Outcomes version of the CTCAE, Item Library Version 1.0, 3/24/2016</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5525842</PublicId>
      <PreferredName>3645995v1.0:5525840v1.0</PreferredName>
      <PreferredDefinition>A library of items for patient self-reporting of symptoms and side effects associated with cancer treatment trials._A question about an individual&#39;s observation of the worst severity they have experienced related to hoarse voice over the past seven days.</PreferredDefinition>
      <LongName>Patient Reported Outcomes Version of CTCAE Worst Severity Past Seven Days Hoarse Voice</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3645995</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C103843</PreferredName>
        <Version>1</Version>
        <LongName>Patient Reported Outcomes Version of CTCAE</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C103843</PREFERRED_NAME>
            <LONG_NAME>Patient Reported Outcomes Version of CTCAE</LONG_NAME>
            <CON_ID>3640502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5525840</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C129275</PreferredName>
        <Version>1</Version>
        <LongName>Worst Severity Past Seven Days Hoarse Voice</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C129275</PREFERRED_NAME>
            <LONG_NAME>Worst Severity Past Seven Days Hoarse Voice Question</LONG_NAME>
            <CON_ID>5477024</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PRO-CTCAE TM:Patient-Reported Outcomes version of the CTCAE, Item Library Version 1.0, 3/24/2016</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3646000</PublicId>
      <PreferredName>SEVERITY_5PT_SCL</PreferredName>
      <PreferredDefinition>Used of the degree of something undesirable e.g. pain or weather; also, strictness._A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one._The precise location of something; a spatially limited location._an ordered reference standard.</PreferredDefinition>
      <LongName>Severity 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>11</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PRO-CTCAE TM:Patient-Reported Outcomes version of the CTCAE, Item Library Version 1.0, 3/24/2016</Origin>
      <Representation>
        <PublicId>3813616</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25676:C66836:C70656:C25664</PreferredName>
        <Version>1</Version>
        <LongName>Severity Five Point Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66836</PREFERRED_NAME>
            <LONG_NAME>Five</LONG_NAME>
            <CON_ID>2664639</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70656</PREFERRED_NAME>
            <LONG_NAME>Point</LONG_NAME>
            <CON_ID>2710246</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2577064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mild</VALIDVALUE>
          <VALUEMEANING>Mild</VALUEMEANING>
          <MEANINGDESCRIPTION>Not severe or strong; far from extreme; not serious enough to endanger life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2563414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>3225979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Severe</VALIDVALUE>
          <VALUEMEANING>Severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely or extremely bad or unpleasant in degree, quality, or extent; life threatening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2842706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very severe</VALIDVALUE>
          <VALUEMEANING>Very severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Exceedingly intense or unpleasant in degree, quality or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3626595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>In the last 7 days, what was</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>In the last 7 days, what was the SEVERITY of your HOARSE VOICE at its WORST?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PRO-CTCAE Spanish Translation</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>En los últimos 7 días, ¿cuál fue la INTENSIDAD de la RONQUERA (VOZ RONCA) en su PEOR momento?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Medidata ePRO CDE</Name>
        <DocumentType>ePRO Compliant</DocumentType>
        <DocumentText>This CDE has been validated for use with the Medidata Rave ePRO module.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3638608</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-CTCAE </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-CTCAE Version 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5675450</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574822</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-CTCAE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-CTCAE Item Library Version 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6051090</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-CTCAE Item Library Version 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000711</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6051063</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Electronic PROs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-CTCAE Library Version 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6051064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_PT01_05</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="354">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5542590</PUBLICID>
    <LONGNAME>Bone Marrow Biopsy Myeloid Precursor Involvement Specimen Percentage Value</LONGNAME>
    <PREFERREDNAME>BM_BX_MYL_PRC_PC_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the percentage of erythroid precursors in a bone marrow specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>C3D:Central Cancer Clinical Database</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5542586</PublicId>
      <PreferredName>BM_BX_MYL_PRECR_INVL</PreferredName>
      <PreferredDefinition>The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes._The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis._A type of white blood cell. Neutrophils, eosinophils, and basophils are granulocytes._A substance from which another substance is formed._To have a connection by participation or association or use; sharing in an activity or process.</PreferredDefinition>
      <LongName>Bone Marrow Biopsy Myeloid Precursor Involvement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206880</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12431:C15189</PreferredName>
        <Version>1</Version>
        <LongName>Bone Marrow Biopsy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12431</PREFERRED_NAME>
            <LONG_NAME>Bone Marrow</LONG_NAME>
            <CON_ID>2202685</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15189</PREFERRED_NAME>
            <LONG_NAME>Biopsy Procedure</LONG_NAME>
            <CON_ID>2202502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5542584</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13349:C48044:C25548</PreferredName>
        <Version>1</Version>
        <LongName>Myeloid Precursor Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13349</PREFERRED_NAME>
            <LONG_NAME>Myeloid</LONG_NAME>
            <CON_ID>2459024</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48044</PREFERRED_NAME>
            <LONG_NAME>Precursor</LONG_NAME>
            <CON_ID>2671512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019101</PublicId>
      <PreferredName>HMT_LAB_PTG_VAL</PreferredName>
      <PreferredDefinition>a percentage for a hematologic laboratory value.</PreferredDefinition>
      <LongName>Blood Specimen Lab Percentage Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Percent Myeloid Precursors</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Percent Myeloid Precursors</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="355">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5557262</PUBLICID>
    <LONGNAME>Bone Marrow CD10 Count Flow Cytometry Result Percentage Value</LONGNAME>
    <PREFERREDNAME>BM_CD10_FC_PC_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>Percentage result of the evaluation of a bone marrow specimen for CD10 cells using flow cytometry.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>C3D:Central Cancer Clinical Database</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5547126</PublicId>
      <PreferredName>5543716v1.0:5547124v1.0</PreferredName>
      <PreferredDefinition>A procedure for critical evaluation._The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes._The determination of the amount of CD10 expressing cells per unit present in a sample._A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid._The result of an action.</PreferredDefinition>
      <LongName>Testing Bone Marrow CD10 Count Flow Cytometry Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5543716</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15336:C12431</PreferredName>
        <Version>1</Version>
        <LongName>Testing Bone Marrow</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15336</PREFERRED_NAME>
            <LONG_NAME>Testing</LONG_NAME>
            <CON_ID>2204718</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12431</PREFERRED_NAME>
            <LONG_NAME>Bone Marrow</LONG_NAME>
            <CON_ID>2202685</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5547124</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C111146:C16585:C20200</PreferredName>
        <Version>1</Version>
        <LongName>CD10 Expressing Cell Count Flow Cytometry Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C111146</PREFERRED_NAME>
            <LONG_NAME>CD10 Expressing Cell Count</LONG_NAME>
            <CON_ID>5547123</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16585</PREFERRED_NAME>
            <LONG_NAME>Flow Cytometry</LONG_NAME>
            <CON_ID>2202602</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>C3D:Central Cancer Clinical Database</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180903</PublicId>
      <PreferredName>BM_PTG_VAL</PreferredName>
      <PreferredDefinition>the numeric value in percentage for a test on a bone marrow specimen.</PreferredDefinition>
      <LongName>Bone Marrow Percentage Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CD10, Percent count, Bone Mar</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CD10, Percent count, Bone Marrow</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="356">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5583113</PUBLICID>
    <LONGNAME>Progressive Disease Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>PRVDZ_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded response to determine patient eligibility for clinical trial participation for questions related to cancer that is increasing in scope or severity as outlined in the protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5583112</PublicId>
      <PreferredName>2234199v1.0:2494487v1.0</PreferredName>
      <PreferredDefinition>Cancer that is increasing in scope or severity._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Progressive Disease Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2234199</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C35571</PreferredName>
        <Version>1</Version>
        <LongName>PD</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C35571</PREFERRED_NAME>
            <LONG_NAME>Progressive Disease</LONG_NAME>
            <CON_ID>2202776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2494487</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16112</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have progression</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have progression as documented by: Two consecutively rising PSA values, above the baseline, at a minimum of 1-week intervals, appearance of one or more new lesions on bone scan and progressive measurable disease by RECIST 1.1?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has GIST demonstrated progression by RECIST v1.1 within the past 12 months?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient is in the expansion cohort and has urothelial cancer or renal cell carcinoma does patient have progressive disease defined as new or progressive lesions on cross-sectional imaging and at least one measurable site of disease (according to RECIST criteria)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient&#39;s disease progressed following standard therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient is in the expansion cohort and has urothelial cancer or renal cell carcinoma does patient have progressive disease defined as new or progressive lesions on cross-sectional imaging and at least one measurable site of disease (according to RECIST criteria) or bone disease by NaF PET/CT?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have evidence of disease progression per RECIST1.1 prior to enrollment or have evidence of cancer-related pain requiring symptom management with narcotic analgesics?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have progression as documented by: Two consecutively rising PSA values, above the baseline, at a minimum of 1-week intervals, appearance of one or more new lesions on bone scan or progressive measurable disease by RECIST 1.1?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient experienced disease progression after treatment with 1 or more prior chemotherapies?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If yes, did patient have progressive disease on Sorafenib?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have radiologic evidence of disease progression?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have progressive disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient has WHO grade II glioma, does patient have progression as defined by one of the following: Development of new lesions or increase of enhancement (radiological evidence of malignant transformation) OR a 25% increase of the T2 or FLAIR non-enhancing lesion on stable or increasing doses of corticosteroids compared with baseline scan or best response after initiation of therapy, not attributable to radiation effect or to comorbid events?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 13</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have progression as documented by: Two consecutively rising PSA values, above the baseline, at a minimum of 1-week intervals, appearance of one or more new lesions on bone scan or progressive disease by RECIST 1.1?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 14</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have progressive cancer at the time of study entry?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 15</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have progressive disease defined by any of the following: Castrate resistant disease as defined by PCWG-3 criteria; an increase in PSA on two successive determination at least one week apart and PSA levels greater than or equal to 2 ng/mL (only the screening PSA needs to be greater than or equal to 2 ng/mL) and serum testosterone less than 50 ng/dL; Soft tissue progression as defined by RECIST version 1.1; Bone disease progression as defined by PCWG-3 criteria including the development of two or more new lesions on bone scan?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 16</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a baseline PSA level of 1 ng/mL or higher with evidence of progressively increasing PSA values (two consecutive increases over the previous reference value)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 17</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have progressive disease based on RECIST Criteria, Version 1.1 evidenced with CT scans/MRI obtained within 24 months from enrollment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 18</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Randomized portion: If patient has unresectable, metastatic and measurable ASPS, does patient have clinical evidence of disease progression (including history and increasing physical symptoms)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 19</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have current disease progression according to PCWG3 criteria?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 20</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have documented disease progression per RECIST 1.1 within 12 months of initiation of the study protocol?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 21</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have documented disease progression (1 or more new bone lesion or enlargement of existing bone lesion, identified by Tc-99m bone scintigraphy or CT scan, MRI, FDG PET CT scan or PSMA PET CT scan)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 22</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a known history of progressive multifocal leukoencephalopathy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876352</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Inclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status &amp; Genetics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3876422</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="357">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5611339</PUBLICID>
    <LONGNAME>PRO-CTCAE Version 1.0 31a. Past Seven Days Loss of Any Fingernails or Toenails Indicator</LONGNAME>
    <PREFERREDNAME>PROCTCAE_31A_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of whether or not they had loss of any fingernails or toenails over the past seven days.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PRO-CTCAE TM:Patient-Reported Outcomes version of the CTCAE, Item Library Version 1.0, 3/24/2016</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5611326</PublicId>
      <PreferredName>3645995v1.0:5611324v1.0</PreferredName>
      <PreferredDefinition>A library of items for patient self-reporting of symptoms and side effects associated with cancer treatment trials._A question about whether or not an individual lost any fingernails or toenails over the past seven days.</PreferredDefinition>
      <LongName>Patient Reported Outcomes Version of CTCAE Past Seven Days Loss of Fingernails or Toenails</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3645995</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C103843</PreferredName>
        <Version>1</Version>
        <LongName>Patient Reported Outcomes Version of CTCAE</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C103843</PREFERRED_NAME>
            <LONG_NAME>Patient Reported Outcomes Version of CTCAE</LONG_NAME>
            <CON_ID>3640502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5611324</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C129279</PreferredName>
        <Version>1</Version>
        <LongName>Past Seven Days Loss of Fingernails or Toenails</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C129279</PREFERRED_NAME>
            <LONG_NAME>Past Seven Days Loss of Fingernails or Toenails Question</LONG_NAME>
            <CON_ID>5477027</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PRO-CTCAE TM:Patient-Reported Outcomes version of the CTCAE, Item Library Version 1.0, 3/24/2016</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>In the last 7 days, did you L</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>In the last 7 days, did you LOSE ANY FINGERNAILS OR TOENAILS?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PRO-CTCAE Spanish Translation</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>En los últimos 7 días, ¿PERDIÓ ALGUNA UÑA DE LAS MANOS O DE LOS PIES?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Medidata ePRO CDE</Name>
        <DocumentType>ePRO Compliant</DocumentType>
        <DocumentText>This CDE has been validated for use with the Medidata Rave ePRO module.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3638608</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-CTCAE </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-CTCAE Version 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5675450</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574822</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-CTCAE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-CTCAE Item Library Version 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6051090</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-CTCAE Item Library Version 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000711</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6051063</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Electronic PROs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-CTCAE Library Version 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6051064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="358">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5629944</PUBLICID>
    <LONGNAME>Neoadjuvant Chemotherapy Docetaxel Cyclophosphamide Carboplatin Administered Begin Date</LONGNAME>
    <PREFERREDNAME>3647283v1.0:2188673v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>information related to the administration of a neoadjuvant chemotherapy regimen consisting of taxotere (docetaxel), carboplatin, and cyclophosphamide._the date on which an observation or an event began.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3647283</PublicId>
      <PreferredName>2206713v1.0:3647281v1.0</PreferredName>
      <PreferredDefinition>information related to the administration of a neoadjuvant chemotherapy regimen consisting of taxotere (docetaxel), carboplatin, and cyclophosphamide.</PreferredDefinition>
      <LongName>Neoadjuvant Chemotherapy Docetaxel Cyclophosphamide Carboplatin Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206713</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15665:C15632</PreferredName>
        <Version>1</Version>
        <LongName>Neoadjuvant Therapy Chemotherapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15665</PREFERRED_NAME>
            <LONG_NAME>Neoadjuvant Therapy</LONG_NAME>
            <CON_ID>2206319</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15632</PREFERRED_NAME>
            <LONG_NAME>Chemotherapy</LONG_NAME>
            <CON_ID>2202708</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3647281</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1526:C405:C1282:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Docetaxel Cyclophosphamide Carboplatin Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1526</PREFERRED_NAME>
            <LONG_NAME>Docetaxel</LONG_NAME>
            <CON_ID>2421116</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C405</PREFERRED_NAME>
            <LONG_NAME>Cyclophosphamide</LONG_NAME>
            <CON_ID>2204906</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1282</PREFERRED_NAME>
            <LONG_NAME>Carboplatin</LONG_NAME>
            <CON_ID>2241604</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188673</PublicId>
      <PreferredName>BEG_DT</PreferredName>
      <PreferredDefinition>The date on which an observation or an event began.</PreferredDefinition>
      <LongName>Begin Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yyyy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Begin Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date First Dose</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date First Dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="359">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5684588</PUBLICID>
    <LONGNAME>Centers for Medicare and Medicaid Services Certification Laboratory Test Performed Indicator</LONGNAME>
    <PREFERREDNAME>5684587v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not tests were performed by a laboratory certified by Centers for Medicare and Medicaid Services.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5684587</PublicId>
      <PreferredName>5794942v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>An agency within the US Department of Health and Human Services responsible for administration of several key federal health care programs. In addition to Medicare and Medicaid, the Centers for Medicare and Medicaid Services oversee the Children&#39;s Health Insurance Program (CHIP), the Health Insurance Portability and Accountability Act (HIPAA), the Clinical Laboratory Improvement Amendments (CLIA), and other services._The process by which a person demonstrates specific knowledge, skills, or abilities in the view of a certifying body.  Similarly, the process by which a product or process can achieve certification indicating its suitability for a specific purpose._A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Centers for Medicare and Medicaid Services Certification Laboratory Test Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5794942</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95516:C43610:C37984:C47891</PreferredName>
        <Version>1</Version>
        <LongName>Centers for Medicare and Medicaid Services Certification Laboratory Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95516</PREFERRED_NAME>
            <LONG_NAME>Centers for Medicare and Medicaid Services</LONG_NAME>
            <CON_ID>3188403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43610</PREFERRED_NAME>
            <LONG_NAME>Certification</LONG_NAME>
            <CON_ID>2536953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37984</PREFERRED_NAME>
            <LONG_NAME>Laboratory</LONG_NAME>
            <CON_ID>2202883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47891</PREFERRED_NAME>
            <LONG_NAME>Test</LONG_NAME>
            <CON_ID>2427511</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were tests performed by a lab</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Were tests performed by a laboratory certified by Centers for Medicare and Medicaid Services?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were all required tests performed by a laboratory certified by Centers for Medicare and Medicaid Services (CMS)?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were all required tests performed by a laboratory certified by Centers for Medicare and Medicaid Services (CMS)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were all required tests performed by a laboratory certified by Centers for Medicare and Medicaid Services (CMS)?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Were all required tests performed by a laboratory certified by Centers for Medicare and Medicaid Services (CMS)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="360">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5690456</PUBLICID>
    <LONGNAME>Task Order Request for Proposals Number</LONGNAME>
    <PREFERREDNAME>TASK_ORD_RFP_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>A number that identifies the task order request for proposals.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5690435</PublicId>
      <PreferredName>5690431v1.0:5690433v1.0</PreferredName>
      <PreferredDefinition>An assigned piece of work, usually with a time allotment._A commercial document used to request someone to supply something in return for payment and providing specifications and quantities._In a Request for Proposals (RFPs) the Government states work to be undertaken or a problem to be solved.  Respondents compete for a common requirement open to all eligible offerors/bidders. Proposals are evaluated using technical and business evaluation criteria and generally involve negotiations. Bids are awarded to the bidder who is responsible and offers the lowest overall price. (from Acquisition Program)</PreferredDefinition>
      <LongName>Task Order Request for Proposals</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178071</PublicId>
        <ContextName>EDRN</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5690431</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C101129:C54092</PreferredName>
        <Version>1</Version>
        <LongName>Task Order</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C101129</PREFERRED_NAME>
            <LONG_NAME>Task</LONG_NAME>
            <CON_ID>3419461</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54092</PREFERRED_NAME>
            <LONG_NAME>Order</LONG_NAME>
            <CON_ID>2475258</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5690433</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17088</PreferredName>
        <Version>1</Version>
        <LongName>Request for Proposals</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17088</PREFERRED_NAME>
            <LONG_NAME>Request for Proposals</LONG_NAME>
            <CON_ID>5690432</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3247302</PublicId>
      <PreferredName>3247302v1.0</PreferredName>
      <PreferredDefinition>Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.</PreferredDefinition>
      <LongName>Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2991873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2.5 mm</VALIDVALUE>
          <VALUEMEANING>2.5 mm</VALUEMEANING>
          <MEANINGDESCRIPTION>2.5 mm</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3245434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2.0 mm</VALIDVALUE>
          <VALUEMEANING>2.0 mm</VALUEMEANING>
          <MEANINGDESCRIPTION>2.0 mm</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3115579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1.8 mm</VALIDVALUE>
          <VALUEMEANING>1.8 mm</VALUEMEANING>
          <MEANINGDESCRIPTION>1.8 mm</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3245435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1.6 mm</VALIDVALUE>
          <VALUEMEANING>1.6 mm</VALUEMEANING>
          <MEANINGDESCRIPTION>1.6 mm</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3245436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1.4 mm</VALIDVALUE>
          <VALUEMEANING>1.4 mm</VALUEMEANING>
          <MEANINGDESCRIPTION>1.4 mm</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3245437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Task Order RFP Number</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Task Order RFP Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-07-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889176</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2017-09-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="361">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5695556</PUBLICID>
    <LONGNAME>Problem</LONGNAME>
    <PREFERREDNAME>5676284v1.0:5695555v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The name of the problem, illness, disorder, or symptom.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ONC SDC Project</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>2015 Edition Common Clinical Data Set - 45 CFR 170.102</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5676284</PublicId>
      <PreferredName>4973954v1.0</PreferredName>
      <PreferredDefinition>No Value Exists</PreferredDefinition>
      <LongName>Illness</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ONC SDC Project</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4973954</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>39104002</PreferredName>
        <Version>1</Version>
        <LongName>Illness</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>39104002</PREFERRED_NAME>
            <LONG_NAME>Illness</LONG_NAME>
            <CON_ID>4973953</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN>SNOMED</ORIGIN>
            <EVS_SOURCE>SNOMED-CT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7318108</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38046:C42605</PreferredName>
        <Version>1</Version>
        <LongName>Unspecified Property</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38046</PREFERRED_NAME>
            <LONG_NAME>Unspecified</LONG_NAME>
            <CON_ID>2230154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42605</PREFERRED_NAME>
            <LONG_NAME>Property</LONG_NAME>
            <CON_ID>2231569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>2015 Edition Common Clinical Data Set - 45 CFR 170.102</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5695555</PublicId>
      <PreferredName>5695555v1.0</PreferredName>
      <PreferredDefinition>A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>2.16.840.1.113883.3.88.12.3221.7.4</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ONC SDC Project</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>HL7CDv3</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>2015 Edition Common Clinical Data Set - 45 CFR 170.102</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>2015 Edition Common Clinical Data Set</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>CFR_Part_45_170.315</DocumentText>
        <URL>http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;amp;SID=100cd9d5ee5778b04fdc629f70dc02a1&amp;amp;mc=true&amp;amp;r=SECTION&amp;amp;n=se45.1.170_1315</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Problems</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Problems</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Standard Referenced</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>§ 170.207(a)(4) International Health Terminology Standards Development Organization (IHTSDO) Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT®) U.S. Edition, September 2015 Release</DocumentText>
        <URL>https://www.nlm.nih.gov/healthit/snomedct/us_edition.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4970851</PublicId>
          <ContextName>ONC SDC Project</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MU Clinical Data Set</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Meaningful Use 2015 Edition Common Clinical Data Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5700858</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="362">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5718118</PUBLICID>
    <LONGNAME>NCCN Distress Thermometer and Problem List for Patients Version 2.2016 Past Week Distress over Emotional Problem with Fear Indicator</LONGNAME>
    <PREFERREDNAME>NCCN_DTPL_FEAR_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how distressed they have been during the past week over emotional problems with fear, using a yes or no indicator.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCCN Distress Management Guidelines, Version 2.2016, 07/25/16.</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5717497</PublicId>
      <PreferredName>5717471v1.0:3807917v1.0</PreferredName>
      <PreferredDefinition>A screening tool developed by the National Comprehensive Cancer Network (NCCN) Distress Management Panel used to identify patient distress coming from any source and patient problems in five categories._The most recent week, including today._A question about an individual&#39;s distress related to their emotional problems with fear.</PreferredDefinition>
      <LongName>NCCN Distress Thermometer and Problem List for Patients Version 2.2016 Past Week Distress over Emotional Problem with Fear</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5717471</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C132492</PreferredName>
        <Version>1</Version>
        <LongName>NCCN Distress Thermometer and Problem List for Patients Version 2.2016</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C132492</PREFERRED_NAME>
            <LONG_NAME>NCCN Distress Thermometer and Problem List for Patients Version 2.2016</LONG_NAME>
            <CON_ID>5709921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3807917</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C107180</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Distress over Emotional Problem with Fear</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107180</PREFERRED_NAME>
            <LONG_NAME>Distress over Emotional Problem with Fear Question</LONG_NAME>
            <CON_ID>3794734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCN Distress Management Guidelines, Version 2.2016, 07/25/16.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Fears</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Fears</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Emotional Problems - Fears</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3793272</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCCN Guidelines</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Distress Thermometer and Problem List for Patients Version 2.2016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5717470</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="363">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5776102</PUBLICID>
    <LONGNAME>Alcohol Past 30 Days Frequency Use</LONGNAME>
    <PREFERREDNAME>5776101v1.0:5775918v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The response that indicates, during the past 30 days, how many days per week or per month a person drank any alcoholic beverages, on the average.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5776101</PublicId>
      <PreferredName>2820661v1.0:5776099v1.0</PreferredName>
      <PreferredDefinition>A volatile liquid prepared by fermentation of certain carbohydrates. Alcohol acts as a central nervous system (CNS) depressant, a diuretic, and a disinfectant. Although the exact mechanism of CNS depression is unknown, alcohol may act by inhibiting the opening of calcium channels, mediated by the binding of the inhibitory neurotransmitter gamma-amino butyric acid (GABA) to GABA-A receptors, or through inhibitory actions at N-methyl-D-aspartate (NMDA)-type glutamate receptors. Alcohol inhibits the production of antidiuretic hormone, thereby producing diuresis that may lead to dehydration. This agent kills organisms by denaturing their proteins._A period of time consisting of the 30 days before the present._The number of occurrences of something within a given time period._A manner, or usual, or accepted practice of using something.</PreferredDefinition>
      <LongName>Alcohol Past 30 Days Frequency Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008514</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>DCP</PreferredName>
        <Version>1</Version>
        <LongName>DCP Conceptual Domain</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2820661</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2190</PreferredName>
        <Version>1</Version>
        <LongName>Alcohol</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2190</PREFERRED_NAME>
            <LONG_NAME>Alcohol</LONG_NAME>
            <CON_ID>2202315</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5776099</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C131330:C25515:C25340</PreferredName>
        <Version>1</Version>
        <LongName>Past 30 Days Temporal Frequency Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131330</PREFERRED_NAME>
            <LONG_NAME>Past 30 days</LONG_NAME>
            <CON_ID>5615928</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCP:Division of Cancer Prevention</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5775918</PublicId>
      <PreferredName>5775918v1.0</PreferredName>
      <PreferredDefinition>A list or register of events; a tabular array of the days._The number of occurrences of something within a given time period. (NCI)</PreferredDefinition>
      <LongName>Calendar Frequency</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008514</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>DCP</PreferredName>
        <Version>1</Version>
        <LongName>DCP Conceptual Domain</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DCP:Division of Cancer Prevention</Origin>
      <Representation>
        <PublicId>3277355</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19459:C25515</PreferredName>
        <Version>1</Version>
        <LongName>Calendar Frequency</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19459</PREFERRED_NAME>
            <LONG_NAME>Calendar</LONG_NAME>
            <CON_ID>2615818</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Don&#39;t know/Not sure</VALIDVALUE>
          <VALUEMEANING>Does Not Know</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Refused</VALIDVALUE>
          <VALUEMEANING>Refuse</VALUEMEANING>
          <MEANINGDESCRIPTION>To decline to do, accept, give, or allow something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4827135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month</VALIDVALUE>
          <VALUEMEANING>Month</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Week</VALIDVALUE>
          <VALUEMEANING>Week</VALUEMEANING>
          <MEANINGDESCRIPTION>Any period of seven consecutive days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Year</VALIDVALUE>
          <VALUEMEANING>Year</VALUEMEANING>
          <MEANINGDESCRIPTION>The period of time that it takes for Earth to make a complete revolution around the sun; a period of time containing 365 days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29848</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2670939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>During the past 30 days, how</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>During the past 30 days, how many days per week or per month did you drink any alcoholic beverages, on the average?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Timeframe:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280816</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-07-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889176</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2017-09-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889179</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889180</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-08-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889185</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889187</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2017-09-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5981652</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6005698</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-08-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6025104</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6046252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALCH_PAST_USE_FREQ</AlternateName>
        <AlternateNameType>DCP Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="364">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5778240</PUBLICID>
    <LONGNAME>Primary Neoplasm Image Definition Risk Factor Present Indicator</LONGNAME>
    <PREFERREDNAME>Pmy_Npm_IDRF_Ind</PREFERREDNAME>
    <PREFERREDDEFINITION>Information regarding presence of primary neoplasm image defined risk factors indicator</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5778237</PublicId>
      <PreferredName>5778235v1.0:2233878v1.0</PreferredName>
      <PreferredDefinition>Occurring first in time or sequence; original; of greatest rank or importance or value._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Any record of an imaging event whether physical or electronic._A concise explanation of the meaning of a word or phrase or symbol._Something that increases the chance of developing a disease. Some examples of risk factors for cancer are age, a family history of certain cancers, use of tobacco products, being exposed to radiation or certain chemicals, infection with certain viruses or bacteria, and certain genetic changes._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Primary Neoplasm Image Definition Risk Factor Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5778235</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5778235v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Primary Neoplasm Image Definition Risk Factor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42777</PREFERRED_NAME>
            <LONG_NAME>Definition</LONG_NAME>
            <CON_ID>2222839</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17103</PREFERRED_NAME>
            <LONG_NAME>Risk Factor</LONG_NAME>
            <CON_ID>2217585</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Are there image-defined risk</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Are there image-defined risk factors (IDRF) present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="365">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5849228</PUBLICID>
    <LONGNAME>Memorial Symptom Assessment Scale (MSAS) 10-18 Past Week Have Difficulty Concentrating Coded Indicator</LONGNAME>
    <PREFERREDNAME>MSAS10_18_CONC_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated observation of whether or not they had difficulty concentrating, within the past week, using a coded yes or no response.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MSAS 10-18:  Memorial Symptom Assessment Scale (10-18). J. Collins, et al. Journal of Pain and Symptom Management. 2000 May; 19(5): 363-377</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5840807</PublicId>
      <PreferredName>5840805v1.0:5116091v1.0</PreferredName>
      <PreferredDefinition>A patient-rated questionnaire designed to evaluate the prevalence, characteristics, and distress to children with cancer aged 10-18. This 30-question instrument was adapted from a previously-validated adult version._The most recent week, including today._A question about whether an individual has or had difficulty concentrating.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale (MSAS) 10-18 Past Week Have Difficulty Concentrating</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5840805</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C134965</PreferredName>
        <Version>1</Version>
        <LongName>Memorial Symptom Assessment Scale (MSAS) 10-18</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C134965</PREFERRED_NAME>
            <LONG_NAME>Memorial Symptom Assessment Scale (MSAS) 10-18</LONG_NAME>
            <CON_ID>5840197</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5116091</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C125405</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Have Difficulty Concentrating</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125405</PREFERRED_NAME>
            <LONG_NAME>Have Difficulty Concentrating Question</LONG_NAME>
            <CON_ID>5115631</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2183836</PublicId>
      <PreferredName>YES_NO_CD_IND</PreferredName>
      <PreferredDefinition>Yes or No response to a question coded as 1 (Yes) or 2 (No).</PreferredDefinition>
      <LongName>Yes No Coded Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2183782</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>NCIP</PreferredName>
        <Version>1</Version>
        <LongName>NCIP</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did you have any difficulty c</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did you have any difficulty concentrating or paying attention?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MSAS 10-18</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question # 1 of 112</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840828</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS 10-18 (Memorial Symptom Assessment Scale 10-18)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840838</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_DIFCPAYATTN</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="366">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5917263</PUBLICID>
    <LONGNAME>Generalized Competing Event Model for Cancer Risk Assessment Score</LONGNAME>
    <PREFERREDNAME>GCE_SCORE</PREFERREDNAME>
    <PREFERREDDEFINITION>The numeric score calculated using the generalized competing event (GCE) model for cancer risk assessment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5917259</PublicId>
      <PreferredName>5917257v1.0:2465182v1.0</PreferredName>
      <PreferredDefinition>A stratification method that can be used to identify groups of patients at highest risk for a poor outcome and therefore most likely to benefit from treatment intensification._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Generalized Competing Event Model for Cancer Risk Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5917257</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C137799</PreferredName>
        <Version>1</Version>
        <LongName>Generalized Competing Event Model for Cancer Risk</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C137799</PREFERRED_NAME>
            <LONG_NAME>Generalized Competing Event Model for Cancer Risk</LONG_NAME>
            <CON_ID>5916554</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2465182</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25217</PreferredName>
        <Version>1</Version>
        <LongName>Assessed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5917260</PublicId>
      <PreferredName>5917260v1.0</PreferredName>
      <PreferredDefinition>A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Generalized Competing Event Model for Cancer Risk Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2193207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>GCE model score</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>GCE model score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF_Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>ω score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="367">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5946750</PUBLICID>
    <LONGNAME>Period Hour Duration</LONGNAME>
    <PREFERREDNAME>5946193v1.0:2717593v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An interval of time._The period of time during which something continues._the period of time which something continues in unit measure of time equal to 3,600 seconds or 60 minutes.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5946193</PublicId>
      <PreferredName>2672784v1.0:2234809v1.0</PreferredName>
      <PreferredDefinition>An interval of time._The period of time during which something continues.</PreferredDefinition>
      <LongName>Period Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2672784</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25616</PreferredName>
        <Version>1</Version>
        <LongName>Period</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25616</PREFERRED_NAME>
            <LONG_NAME>Period</LONG_NAME>
            <CON_ID>2202575</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234809</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25330</PreferredName>
        <Version>1</Version>
        <LongName>Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2717593</PublicId>
      <PreferredName>HR_DUR</PreferredName>
      <PreferredDefinition>the period of time which something continues in unit measure of time equal to 3,600 seconds or 60 minutes.</PreferredDefinition>
      <LongName>Hour Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue>24</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
      <Representation>
        <PublicId>2207993</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25529:C25330</PreferredName>
        <Version>1</Version>
        <LongName>Hour Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25529</PREFERRED_NAME>
            <LONG_NAME>Hour</LONG_NAME>
            <CON_ID>2203682</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Period</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Period</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="368">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6021131</PUBLICID>
    <LONGNAME>BREAST-Q Mastectomy Breast Cancer Surgeon was Professional Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>BREASTQ_MASQA_MD_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated agreement about whether they felt their surgeon was professional, using a 4 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BREAST-Q Version 2.0:Pusic, Klassen, et.al., Memorial Sloan Kettering Cancer Center and the University of British Columbia, 2017.</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6021032</PublicId>
      <PreferredName>6012909v1.0:6021030v1.0</PreferredName>
      <PreferredDefinition>A patient-reported outcome measure designed to provide information about the impact and effectiveness of breast surgery. It consists of 5 modules: augmentation, reduction (or mastopexy), breast conserving therapy, mastectomy, and post-mastectomy reconstruction. Each module is divided into multiple scales that can be used independently._Surgical removal of the breast._A question about whether an individual&#39;s breast cancer surgeon was professional._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>BREAST-Q Mastectomy Breast Cancer Surgeon was Professional Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6012909</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C141134</PreferredName>
        <Version>1</Version>
        <LongName>BREAST-Q</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C141134</PREFERRED_NAME>
            <LONG_NAME>BREAST-Q</LONG_NAME>
            <CON_ID>6012031</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6021030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15277:C140810:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Mastectomy Breast Cancer Surgeon was Professional Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15277</PREFERRED_NAME>
            <LONG_NAME>Mastectomy</LONG_NAME>
            <CON_ID>2204820</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C140810</PREFERRED_NAME>
            <LONG_NAME>Breast Cancer Surgeon was Professional Question</LONG_NAME>
            <CON_ID>6009410</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BREAST-Q Version 2.0:Pusic, Klassen, et.al., Memorial Sloan Kettering Cancer Center and the University of British Columbia, 2017.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6019309</PublicId>
      <PreferredName>BREASTQ_AGR_4PT_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>BREAST-Q Agreement 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>BREAST-Q Version 2.0:Pusic, Klassen, et.al., Memorial Sloan Kettering Cancer Center and the University of British Columbia, 2017.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Definitely Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>An unequivocal feeling of opposition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103802</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6028387</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Definitely Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>An unequivocal feeling of concurrence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6028388</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Slightly Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in slight agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5119337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Slightly Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in slight disagreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5119338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was professional?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was professional?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BREAST-Q Version 2.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6011949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mastectomy Module</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6024499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="369">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6025337</PUBLICID>
    <LONGNAME>BREAST-Q Mastectomy How Often Feel Confident Sexually About How Your Breast Area Looks When Unclothed Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>BREASTQ_MASQE_SX_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation about how often they generally feel confident sexually about how their breast area looks when unclothed, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BREAST-Q Version 2.0:Pusic, Klassen, et.al., Memorial Sloan Kettering Cancer Center and the University of British Columbia, 2017.</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6025329</PublicId>
      <PreferredName>6012909v1.0:6025327v1.0</PreferredName>
      <PreferredDefinition>A patient-reported outcome measure designed to provide information about the impact and effectiveness of breast surgery. It consists of 5 modules: augmentation, reduction (or mastopexy), breast conserving therapy, mastectomy, and post-mastectomy reconstruction. Each module is divided into multiple scales that can be used independently._Surgical removal of the breast._A question about how often an individual feels confident sexually about how their breast area looks when unclothed._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>BREAST-Q Mastectomy How Often Feel Confident Sexually About How Your Breast Area Looks When Unclothed Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6012909</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C141134</PreferredName>
        <Version>1</Version>
        <LongName>BREAST-Q</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C141134</PREFERRED_NAME>
            <LONG_NAME>BREAST-Q</LONG_NAME>
            <CON_ID>6012031</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6025327</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15277:C140808:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Mastectomy How Often Feel Confident Sexually About How Your Breast Area Looks When Unclothed Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15277</PREFERRED_NAME>
            <LONG_NAME>Mastectomy</LONG_NAME>
            <CON_ID>2204820</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C140808</PREFERRED_NAME>
            <LONG_NAME>How Often Feel Confident Sexually About How Your Breast Area Looks When Unclothed Question</LONG_NAME>
            <CON_ID>6009408</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BREAST-Q Version 2.0:Pusic, Klassen, et.al., Memorial Sloan Kettering Cancer Center and the University of British Columbia, 2017.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6012907</PublicId>
      <PreferredName>BREASTQ_5_PT_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>BREAST-Q 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>BREAST-Q Version 2.0:Pusic, Klassen, et.al., Memorial Sloan Kettering Cancer Center and the University of British Columbia, 2017.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A Little of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a little of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Some of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened some of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Confident sexually about how</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Confident sexually about how your breast area looks when unclothed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BREAST-Q Version 2.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6011949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mastectomy Module</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6024499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="370">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6029550</PUBLICID>
    <LONGNAME>Intrathecal Route of Administration Therapeutic Procedure Administered Start Date Indicator</LONGNAME>
    <PREFERREDNAME>2763950v1.0:5957201v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the start date of the intrathecal therapy that was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2763950</PublicId>
      <PreferredName>INT_ADM_TP_ADM</PreferredName>
      <PreferredDefinition>Administration of drugs directly into spinal subarachnoid space in the cerebrospinal fluid, at any level of the cerebrospinal axis, including injection into the cerebral ventricles, in order to bypass the blood-brain barrier and achieve local, rapid effects on the meninges or cerebrospinal axis._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Intrathecal Route of Administration Therapeutic Procedure Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2763948</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38267:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Intrathecal Route of Administration Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38267</PREFERRED_NAME>
            <LONG_NAME>Intrathecal Route of Administration</LONG_NAME>
            <CON_ID>2453306</CON_ID>
            <DEFINITION_SOURCE>FDA</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5957201</PublicId>
      <PreferredName>5957201v1.0</PreferredName>
      <PreferredDefinition>The calendar date on which something is to start or did start._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Start Date Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>5957202</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68616:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Start Date Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68616</PREFERRED_NAME>
            <LONG_NAME>Start Date</LONG_NAME>
            <CON_ID>2712678</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known</VALIDVALUE>
          <VALUEMEANING>Known</VALUEMEANING>
          <MEANINGDESCRIPTION>Recognized, familiar, or within the scope of knowledge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2934435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the start date of the int</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the start date of the intrathecal therapy that was administered known?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date therapy started</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date therapy started</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date therapy started</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Date therapy started</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_thrpym_it_th_str_dt_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_OT_it_thpy_str_dt_kuna</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="371">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6029633</PUBLICID>
    <LONGNAME>Stage Prognostic Factor SEER Primary Tumor Indicator Number Code</LONGNAME>
    <PREFERREDNAME>6027995v1.0:6024182v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Variable used to collect information on the primary tumor so that a summary stage can be easily derived for these cases.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6027995</PublicId>
      <PreferredName>2688190v1.0:6027993v1.0</PreferredName>
      <PreferredDefinition>The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body._The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From a brochure of the National Cancer Institute, NIH Publication No. 91-3074, October 1990)_A tumor at the original site of origin._To have a connection by participation or association or use; sharing in an activity or process.</PreferredDefinition>
      <LongName>Stage Prognostic Factor Diagnosis Surveillance, Epidemiology, and End Results Program Primary Neoplasm Involvement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20047</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic or Prognostic Factor</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2688190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16899:C18959</PreferredName>
        <Version>1</Version>
        <LongName>Stage Prognostic Factor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18959</PREFERRED_NAME>
            <LONG_NAME>Prognostic Factor</LONG_NAME>
            <CON_ID>2512696</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6027993</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220:C15432:C8509:C25548</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis Surveillance, Epidemiology, and End Results Program Primary Neoplasm Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15432</PREFERRED_NAME>
            <LONG_NAME>Surveillance, Epidemiology, and End Results Program</LONG_NAME>
            <CON_ID>2554150</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C8509</PREFERRED_NAME>
            <LONG_NAME>Primary Neoplasm</LONG_NAME>
            <CON_ID>2240094</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6024182</PublicId>
      <PreferredName>6024182v1.0</PreferredName>
      <PreferredDefinition>A numeral or string of numerals expressing value, quantity, or identification._A symbol or combination of symbols which is assigned to the members of a collection.</PreferredDefinition>
      <LongName>Primary Neoplasm Involvement Number Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20047</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic or Prognostic Factor</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
      <Representation>
        <PublicId>2208104</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Number Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>999</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>800</VALIDVALUE>
          <VALUEMEANING>No Evidence Primary Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: Knowledge on which to base belief.: A tumor at the original site of origin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8509, C43583, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6024183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>700</VALIDVALUE>
          <VALUEMEANING>Distant</VALUEMEANING>
          <MEANINGDESCRIPTION>Far apart in space, time, or relevance from a point of reference.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25321</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>500</VALIDVALUE>
          <VALUEMEANING>Regional Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or belonging to a broader area or region of the body.: Not characterized in any other way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594, C25643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6024184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>200</VALIDVALUE>
          <VALUEMEANING>Regional Direct Extension</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or belonging to a broader area or region of the body.: The spread or migration of cancer cells through the wall of an organ into surrounding organs and/or adjacent tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120271, C25643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6024185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>100</VALIDVALUE>
          <VALUEMEANING>Localized</VALUEMEANING>
          <MEANINGDESCRIPTION>Restricted to the site of origin, without evidence of spread.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>000</VALIDVALUE>
          <VALUEMEANING>In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>In the natural or normal place, confined to the site of origin without invasion of neighboring tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4579513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 16, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)</DocumentText>
        <URL>https://www.naaccr.org/data-standards-data-dictionary/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SEER Primary Tumor Involvement</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>SEER Primary Tumor Involvement</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Valid Values</Name>
        <DocumentType>VALID_VALUE_SOURCE</DocumentType>
        <DocumentText>See NAACCR 16, Data Stds/Dictionary, Data Dictionary section for a list of code sources and coding instructions.</DocumentText>
        <URL>https://www.naaccr.org/data-standards-data-dictionary/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899833</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>StageProgFactors16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899845</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>772</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SEER Primary Tumor</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="372">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6035104</PUBLICID>
    <LONGNAME>Hemorrhage Present Indicator</LONGNAME>
    <PREFERREDNAME>HMRG_PRST_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether or not a hemorrhage is present.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6035018</PublicId>
      <PreferredName>2970205v1.0:2233878v1.0</PreferredName>
      <PreferredDefinition>The flow of blood from a ruptured blood vessel._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Hemorrhage Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2970205</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C26791</PreferredName>
        <Version>1</Version>
        <LongName>Hemorrhage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26791</PREFERRED_NAME>
            <LONG_NAME>Hemorrhage</LONG_NAME>
            <CON_ID>2203751</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506036</PublicId>
      <PreferredName>YES_NO_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.</PreferredDefinition>
      <LongName>Yes No Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694966</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49797</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3b</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49797</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Not Applicable Response</LONG_NAME>
            <CON_ID>2694965</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Presence of hemorrhage</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Presence of hemorrhage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the reason for visit Bleeding?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hemorrhage</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Hemorrhage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hemorrhage</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Hemorrhage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="373">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6036515</PUBLICID>
    <LONGNAME>Eligibility Change Additional Testing Indicator</LONGNAME>
    <PREFERREDNAME>ELIG_AD_TST_CHG_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether or not additional testing would change the determination of eligibility.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6036394</PublicId>
      <PreferredName>2597465v1.0:6036392v1.0</PreferredName>
      <PreferredDefinition>Criteria to determine eligibility of patients for medical care programs and services._Added; extra; further._A procedure for critical evaluation._The act of alteration or modification; changed or altered in form or character.</PreferredDefinition>
      <LongName>Eligibility Determination Additional Testing Change</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2597465</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25171</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6036392</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25406:C15336:C25446</PreferredName>
        <Version>1</Version>
        <LongName>Additional Testing Change</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25406</PREFERRED_NAME>
            <LONG_NAME>Additional</LONG_NAME>
            <CON_ID>2206153</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15336</PREFERRED_NAME>
            <LONG_NAME>Testing</LONG_NAME>
            <CON_ID>2204718</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506036</PublicId>
      <PreferredName>YES_NO_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.</PreferredDefinition>
      <LongName>Yes No Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694966</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49797</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3b</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49797</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Not Applicable Response</LONG_NAME>
            <CON_ID>2694965</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Would additional test change</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Would additional test change trial eligibility?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="374">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6058860</PUBLICID>
    <LONGNAME>Ipilimumab Administered Indicator</LONGNAME>
    <PREFERREDNAME>6058835v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not ipilimumab was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6058835</PublicId>
      <PreferredName>6058833v1.0:2233610v1.0</PreferredName>
      <PreferredDefinition>A recombinant human immunoglobulin (Ig) G1 monoclonal antibody directed against the human T-cell receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), with immune checkpoint inhibitory and antineoplastic activities. Ipilimumab binds to CTLA4 expressed on T-cells and inhibits the CTLA4-mediated downregulation of T-cell activation. This leads to a cytotoxic T-lymphocyte (CTL)-mediated immune response against cancer cells. CTLA4, an inhibitory receptor and member of the immunoglobulin superfamily, plays a key role in the downregulation of the immune system._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Ipilimumab Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6058833</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2654</PreferredName>
        <Version>1</Version>
        <LongName>Ipilimumab</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2654</PREFERRED_NAME>
            <LONG_NAME>Ipilimumab</LONG_NAME>
            <CON_ID>3185134</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was ipilimumab administered?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was ipilimumab administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Ipilimumab</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Ipilimumab</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Ipilimumab</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Ipilimumab</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="375">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6059584</PUBLICID>
    <LONGNAME>Castration-Resistant Prostate Carcinoma Development PSA Level Outcome Value</LONGNAME>
    <PREFERREDNAME>6059581v1.0:6059577v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A response used to indicate the numerical quantity result of the concentration of prostate specific antigen in a sample at the time of the formation of prostate carcinoma that grows and continues to spread despite the surgical removal of the testes or medical intervention to block androgen production.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6059581</PublicId>
      <PreferredName>5589077v1.0:6059591v1.0</PreferredName>
      <PreferredDefinition>Prostate carcinoma that grows and continues to spread despite the surgical removal of the testes or medical intervention to block androgen production._Processes that involve and promote formation of more mature organs, organ systems, or organisms; general development. (NCI)_The concentration of prostate specific antigen in a sample._The result of an action.</PreferredDefinition>
      <LongName>Castration-Resistant Prostate Carcinoma Development PSA Level Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5589077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C130234</PreferredName>
        <Version>1</Version>
        <LongName>Castration-Resistant Prostate Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C130234</PREFERRED_NAME>
            <LONG_NAME>Castration-Resistant Prostate Carcinoma</LONG_NAME>
            <CON_ID>5589000</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6059591</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18732:C124827:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Development PSA Level Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18732</PREFERRED_NAME>
            <LONG_NAME>Organism Development</LONG_NAME>
            <CON_ID>4798273</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C124827</PREFERRED_NAME>
            <LONG_NAME>PSA Level</LONG_NAME>
            <CON_ID>6059578</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6059577</PublicId>
      <PreferredName>6059577v1.0</PreferredName>
      <PreferredDefinition>A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>6 Digits 2 Decimals Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>9999.99</DisplayFormat>
      <MaximumLength>6</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PSA value at CRPC (Castrate-R</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>PSA value at CRPC (Castrate-Resistance Prostate Cancer)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314494</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="376">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6078874</PUBLICID>
    <LONGNAME>MET Gene Mutation Analysis Performed Indicator</LONGNAME>
    <PREFERREDNAME>MET_mutation_analysis</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether or not an analysis for mutation in the MET gene was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HCMI:Human Cancer Models Initiative</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6078848</PublicId>
      <PreferredName>3028537v1.0:6060065v1.0</PreferredName>
      <PreferredDefinition>This gene plays a regulatory role in the modulation of cell-surface receptors and hepatocyte growth factor interactions._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it._Executed and carried through to completion.</PreferredDefinition>
      <LongName>MET Gene Mutation Abnormality Analysis Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3028537</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18325</PreferredName>
        <Version>1</Version>
        <LongName>MET Gene</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18325</PREFERRED_NAME>
            <LONG_NAME>MET Gene</LONG_NAME>
            <CON_ID>3028520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>RADLEX_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6060065</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45576:C25391:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Mutation Abnormality Analysis Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45576</PREFERRED_NAME>
            <LONG_NAME>Mutation Abnormality</LONG_NAME>
            <CON_ID>2532673</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HCMI:Human Cancer Models Initiative</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was MET mutation analysis per</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was MET mutation analysis performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Renal Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6788377</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000003</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="377">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6101046</PUBLICID>
    <LONGNAME>Pathology Diagnosis Other Specify</LONGNAME>
    <PREFERREDNAME>PATH_DX_OTH_SPF</PREFERREDNAME>
    <PREFERREDDEFINITION>A free-text field to describe another pathology diagnosis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2008621</PublicId>
      <PreferredName>PATH_DX</PreferredName>
      <PreferredDefinition>the identification or classification of a patient&#39;s cancer using data reported by a pathologist.</PreferredDefinition>
      <LongName>Pathology Diagnosis</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177067</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Pathology</PreferredName>
        <Version>1</Version>
        <LongName>Pathology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Diagnosis</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666713</PublicId>
      <PreferredName>OTH_SPEC</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Other Specify</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCI CRF Standards</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If Other, specify:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If Other, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="378">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6143229</PUBLICID>
    <LONGNAME>Person Medical History Major Problem Type</LONGNAME>
    <PREFERREDNAME>MMP_PROB</PREFERREDNAME>
    <PREFERREDDEFINITION>A response for the patient&#39;s history regarding the types of major medical conditions, disorders, and disease events.  </PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCTG: Canadian Cancer Trials Group</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6143227</PublicId>
      <PreferredName>2236731v1.0:6143230v1.0</PreferredName>
      <PreferredDefinition>A human being._A record of a patient&#39;s background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies._Greater or bigger in amount, extent, or size._A difficulty, disorder, or condition needing resolution.</PreferredDefinition>
      <LongName>Person Personal Medical History Major Problem</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6143230</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18772:C45368:C28020</PreferredName>
        <Version>1</Version>
        <LongName>Personal Medical History Major Problem</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45368</PREFERRED_NAME>
            <LONG_NAME>Major</LONG_NAME>
            <CON_ID>2240979</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28020</PREFERRED_NAME>
            <LONG_NAME>Problem</LONG_NAME>
            <CON_ID>2203953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCTG: Canadian Cancer Trials Group</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6143040</PublicId>
      <PreferredName>6143040v1.0</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Medical History Problem Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCTG: Canadian Cancer Trials Group</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatitis</VALIDVALUE>
          <VALUEMEANING>Hepatobiliary System Pancreas Pancreatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>The liver, gallbladder, and associated ducts, considered collectively.: An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known.: Inflammation of the pancreas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3306, C12393, C43612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cirrhosis - without portal hypertension</VALIDVALUE>
          <VALUEMEANING>Hepatobiliary System Pancreas Cirrhosis Without Portal Hypertension</VALUEMEANING>
          <MEANINGDESCRIPTION>The liver, gallbladder, and associated ducts, considered collectively.: An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known.: A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.: Used to indicate the absence or lack of something or someone.: Increased blood pressure in the portal venous system. It is most commonly caused by cirrhosis. Other causes include portal vein thrombosis, Budd-Chiari syndrome, and right heart failure. Complications include ascites, esophageal varices, encephalopathy, and splenomegaly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3119, C25718, C2951, C12393, C43612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cirrhosis - with portal hypertension</VALIDVALUE>
          <VALUEMEANING>Hepatobiliary System Pancreas Cirrhosis With Portal Hypertension</VALUEMEANING>
          <MEANINGDESCRIPTION>The liver, gallbladder, and associated ducts, considered collectively.: An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known.: A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.: Used to indicate the presence of something or someone.: Increased blood pressure in the portal venous system. It is most commonly caused by cirrhosis. Other causes include portal vein thrombosis, Budd-Chiari syndrome, and right heart failure. Complications include ascites, esophageal varices, encephalopathy, and splenomegaly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3119, C62355, C2951, C12393, C43612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145042</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholecystitis</VALIDVALUE>
          <VALUEMEANING>Hepatobiliary System Pancreas Cholecystitis</VALUEMEANING>
          <MEANINGDESCRIPTION>The liver, gallbladder, and associated ducts, considered collectively.: An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known.: An acute or chronic inflammation involving the gallbladder wall. It may be associated with the presence of gallstones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34465, C12393, C43612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HIV only</VALIDVALUE>
          <VALUEMEANING>HIV Only</VALUEMEANING>
          <MEANINGDESCRIPTION>The virus isolated and recognized as the etiologic agent of AIDS. HIV-1 is classified as a lentivirus, a subtype of retroviruses.: Not accompanied by another or others; exclusive of anyone or anything else.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48440, C14219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Breast cancer</VALIDVALUE>
          <VALUEMEANING>Other Malignant Neoplasm Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.: A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4872, C9305, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allergy - penicillin</VALIDVALUE>
          <VALUEMEANING>Immunology Allergic Reaction Penicillin Antibiotic</VALUEMEANING>
          <MEANINGDESCRIPTION>The study of the body&#39;s immune system.: An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.: A drug that is used to treat infection. It belongs to the family of drugs called antibiotics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1500, C114476, C18011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allergy - iodine</VALIDVALUE>
          <VALUEMEANING>Immunology Allergic Reaction Iodine</VALUEMEANING>
          <MEANINGDESCRIPTION>The study of the body&#39;s immune system.: An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.: An element with atomic symbol I, atomic number 53, and atomic weight of 126.90.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C594, C114476, C18011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tamponade</VALIDVALUE>
          <VALUEMEANING>Cardiac Tamponade</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute compression of the heart caused by increased intrapericardial pressure due to the collection of blood or fluid in the pericardium from rupture of the heart, penetrating trauma, or progressive effusion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Depression</VALIDVALUE>
          <VALUEMEANING>Neurology Depression</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A melancholy feeling of sadness and despair.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2982, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dementia</VALIDVALUE>
          <VALUEMEANING>Neurology Dementia</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: Loss of intellectual abilities interfering with an individual&#39;s social and occupational functions. Causes include Alzheimer&#39;s disease, brain injuries, brain tumors, and vascular disorders. 
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4786, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebrovascular accident (stroke) - with continuing hemiplegia</VALIDVALUE>
          <VALUEMEANING>Neurology Cerebrovascular Accident With Continue Hemiplegia</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.: Used to indicate the presence of something or someone.: Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption.: Paralysis of one side of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64329, C53279, C62355, C3390, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebrovascular accident (stroke) - recovered</VALIDVALUE>
          <VALUEMEANING>Neurology Cerebrovascular Accident Recovered or Resolved</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.: One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49498, C3390, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bells palsy</VALIDVALUE>
          <VALUEMEANING>Neurology Facial Nerve Palsy</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: Partial or complete paralysis of the facial muscles of one side of a person&#39;s face. It is caused by damage to the seventh cranial nerve. It is usually temporary but it may recur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26769, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anxiety</VALIDVALUE>
          <VALUEMEANING>Neurology Anxiety</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: Apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26696, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Septal defect repair</VALIDVALUE>
          <VALUEMEANING>Cardiac Septal Defect Repair</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Any surgical repair of a septal defect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C148075, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6153681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peripheral vascular insufficiency</VALIDVALUE>
          <VALUEMEANING>Cardiac Peripheral Vascular Insufficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: A condition in which there is inadequate blood flow through the peripheral blood vessels due to intrinsic disease of the vasculature.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C148074, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6153682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate hypertrophy</VALIDVALUE>
          <VALUEMEANING>Renal Genitourinary Benign Prostatic Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the kidney.: Of or related to the genital and urinary organs or their functions.: A non-cancerous nodular enlargement of the prostate gland.  It is characterized by the presence of epithelial cell nodules, and stromal nodules containing fibrous and smooth muscle elements.  It is the most common urologic disorder in men, causing blockage of urine flow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2897, C25350, C25225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infection-urinary tract (UTI)</VALIDVALUE>
          <VALUEMEANING>Renal Genitourinary Urinary Tract Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the kidney.: Of or related to the genital and urinary organs or their functions.: A bacterial infectious process affecting any part of the urinary tract, most commonly the bladder and the urethra. Symptoms include urinary urgency and frequency, burning sensation during urination, lower abdominal discomfort, and cloudy urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50791, C25350, C25225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renal transplant</VALIDVALUE>
          <VALUEMEANING>Renal Genitourinary Kidney Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the kidney.: Of or related to the genital and urinary organs or their functions.: The transfer of a healthy kidney from a donor to a patient for the purpose of replacing one of the failing kidneys of the patient.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15265, C25350, C25225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Past renal failure or dialysis</VALIDVALUE>
          <VALUEMEANING>Renal Genitourinary Past Renal Failure Or Dialysis</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the kidney.: Of or related to the genital and urinary organs or their functions.: Before the present time.: An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A procedure to remove toxic substances from the blood that is used in patients with end-stage chronic kidney disease or acute kidney failure. This includes hemodialysis and peritoneal dialysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15221, C37998, C4376, C25609, C25350, C25225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Menorrhagia</VALIDVALUE>
          <VALUEMEANING>Renal Genitourinary Menorrhagia</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the kidney.: Of or related to the genital and urinary organs or their functions.: Heavy bleeding during regular menstruation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26829, C25350, C25225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Menopause</VALIDVALUE>
          <VALUEMEANING>Renal Genitourinary Menopause</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the kidney.: Of or related to the genital and urinary organs or their functions.: The permanent cessation of menses, usually defined by 6 to 12 months of amenorrhea in a woman over 45 years of age.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3231, C25350, C25225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney stones</VALIDVALUE>
          <VALUEMEANING>Renal Genitourinary Kidney Stone</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the kidney.: Of or related to the genital and urinary organs or their functions.: Crystals in the pelvis of the kidney. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26807, C25350, C25225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147251</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allergy - codeine</VALIDVALUE>
          <VALUEMEANING>Immunology Allergic Reaction Codeine</VALUEMEANING>
          <MEANINGDESCRIPTION>The study of the body&#39;s immune system.: An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.: An opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C383, C114476, C18011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systolic murmur</VALIDVALUE>
          <VALUEMEANING>Cardiac Systolic Murmur</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: The contraction of the chambers of the heart (especially the ventricles) to drive blood into the aorta and pulmonary artery.: A periodic humming or blowing sound heard on auscultation of the heart that can indicate the presence of cardiac disease; murmurs are the result of vibrations caused by the turbulent flow of blood in the heart or great vessels. Murmurs are characterized according to the area of generation (mitral, aortic, tricuspid, or pulmonary) and according to the period of the cycle (systolic or diastolic).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84480, C62110, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145009</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Restrictive cardiomyopathy</VALIDVALUE>
          <VALUEMEANING>Cardiac Restrictive Cardiomyopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: A type of heart disorder referring to the inability of the ventricles to fill with blood because the myocardium (heart muscle) stiffens and looses its flexibility. Causes include replacement of the myocardium with scar tissue, abnormal cellular infiltration of the myocardium, or deposition of a substance (e.g., amyloid) in the myocardium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62798, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palpitations</VALIDVALUE>
          <VALUEMEANING>Cardiac Palpitation</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: An unpleasant sensation of irregular and/or forceful beating of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37999, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myocarditis</VALIDVALUE>
          <VALUEMEANING>Cardiac Myocarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Inflammation of the muscle tissue of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34831, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myocardial infarction</VALIDVALUE>
          <VALUEMEANING>Cardiac Myocardial Infarction</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27996, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypovolemic shock</VALIDVALUE>
          <VALUEMEANING>Cardiac Hypovolemic Shock</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Shock resulting from insufficient blood volume for the maintenance of adequate cardiac output, blood pressure and tissue perfusion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50596, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypotension</VALIDVALUE>
          <VALUEMEANING>Cardiac Hypotension</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Blood pressure that is abnormally low.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3128, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oophorectomy</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Oophorectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: The surgical removal of one or both ovaries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15291, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Knee replacement</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Total Knee Replacement</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: Surgical replacement of all parts of a damaged knee joint with an artificial joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51565, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hysterectomy</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Hysterectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: A surgical procedure to remove the uterine body (partial hysterectomy) or the uterine body and cervix (total hysterectomy).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15256, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hip replacement</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Hip Joint Replacement</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: The lateral prominence of the pelvis from the waist to the thigh.: A surgical procedure to replace part, or all structures, of a joint with an orthopedic prosthesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131579, C64193, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hickman catheter</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Central Venous Access Catheter</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: A venous catheter positioned with the tip in the proximal third of the superior vena cava, the right atrium, or the inferior vena cava.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17612, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hernia repair</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Hernia Repair</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: The protrusion of part of an organ or fibroadipose tissue through an abnormal opening. : The act of returning something to working order.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53611, C34685, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemicolectomy</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Hemicolectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: Surgical removal of approximately half of the colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86074, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147259</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Coronary artery bypass graft (CABG)</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Coronary Artery Bypass Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: Surgery performed to bypass partially or completely occluded coronary arteries, thereby increasing the blood supply of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51998, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colostomy</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Colostomy</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: The surgical creation of an opening between the colon and the surface of the body. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15211, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cataract surgery</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Cataract Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: Partial or complete opacity of the crystalline lens of one or both eyes that decreases visual acuity and eventually results in blindness. Some cataracts appear in infancy or in childhood, but most develop in older individuals. (Sternberg Diagnostic Surgical Pathology, 3rd ed.): The branch of medical science that treats disease or injury by operative procedures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17173, C26713, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carotid endarterectomy</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Carotid Artery Endarterectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: One of two arteries that supply oxygenated blood to the head and neck; the left common carotid branches from the aorta and the right common carotid from the innominate (brachiocephalic artery).: Excision of an atheromatous plaque.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52002, C12687, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Back surgery</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Back Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: The dorsal area between the base of the neck and the sacrum.: The branch of medical science that treats disease or injury by operative procedures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17173, C13062, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Appendectomy</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Appendectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: Surgical removal of the vermiform appendix.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51687, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aneurysm repair</VALIDVALUE>
          <VALUEMEANING>Surgical Procedure Aneurysm Repair</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: Bulging or ballooning in an area of an artery secondary to arterial wall weakening.: The act of returning something to working order.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53611, C26693, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parkinson&#39;s disease</VALIDVALUE>
          <VALUEMEANING>Neurology Parkinson&#39;s Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26845, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144578</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate cancer</VALIDVALUE>
          <VALUEMEANING>Other Malignant Neoplasm Prostate Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.: One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4863, C9305, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma</VALIDVALUE>
          <VALUEMEANING>Other Malignant Neoplasm Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3208, C9305, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HIV + AIDS</VALIDVALUE>
          <VALUEMEANING>HIV And AIDS</VALUEMEANING>
          <MEANINGDESCRIPTION>The virus isolated and recognized as the etiologic agent of AIDS. HIV-1 is classified as a lentivirus, a subtype of retroviruses.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2851, C14219, C37912</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 2, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3187543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vision loss</VALIDVALUE>
          <VALUEMEANING>Ocular Visual Loss Of Vision</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the eye.: Relating to or using sight; able to be seen.: A condition in which the ability to see is impaired.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50638, C38059, C87163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macular degeneration</VALIDVALUE>
          <VALUEMEANING>Ocular Visual Macular Degeneration</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the eye.: Relating to or using sight; able to be seen.: Loss of vision in the central portion of the retina (macula), secondary to retinal degeneration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123330, C38059, C87163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Keratoconus</VALIDVALUE>
          <VALUEMEANING>Ocular Visual Keratoconus</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the eye.: Relating to or using sight; able to be seen.: A degenerative, structural disorder of the eye, characterized by a cone-shaped protrusion of the cornea. It may lead to visual disturbances.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26806, C38059, C87163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glaucoma</VALIDVALUE>
          <VALUEMEANING>Ocular Visual Glaucoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the eye.: Relating to or using sight; able to be seen.: Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26782, C38059, C87163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cataract(s)</VALIDVALUE>
          <VALUEMEANING>Ocular Visual Bilateral Cataracts</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the eye.: Relating to or using sight; able to be seen.: Partial or complete opacity of the crystalline lens of both eyes that decreases visual acuity and eventually results in blindness. Some cataracts appear in infancy or in childhood, but most develop in older individuals. (Sternberg Diagnostic Surgical Pathology, 3rd ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101193, C38059, C87163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vertigo</VALIDVALUE>
          <VALUEMEANING>Neurology Vertigo</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A feeling of movement, a sensation as if the external world were revolving around the patient (objective vertigo) or as if he himself were revolving in space (subjective vertigo). Vertigo is medically distinct from dizziness, lightheadedness, and unsteadiness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38057, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transient ischemic attack (TIA)</VALIDVALUE>
          <VALUEMEANING>Neurology Transient Ischemic Attack</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A brief attack (from a few minutes to an hour) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50781, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stroke at birth</VALIDVALUE>
          <VALUEMEANING>Neurology Cerebrovascular Accident At Birth</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.: Used to indicate position, location, or state.: The event of being born.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25155, C25427, C3390, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sleep apnea</VALIDVALUE>
          <VALUEMEANING>Neurology Sleep Apnea</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: Cessation of breathing for short periods during sleep. It is classified as obstructive, central, or mixed obstructive-central. It can occur at any age but it is more frequent in people over forty. Risk factors include male sex and obesity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26884, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Schizophrenia</VALIDVALUE>
          <VALUEMEANING>Neurology Schizophrenia</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A major psychotic disorder characterized by abnormalities in the perception or expression of reality. It affects the cognitive and psychomotor functions. Common clinical signs and symptoms include delusions, hallucinations, disorganized thinking, and retreat from reality.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3362, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multiple sclerosis</VALIDVALUE>
          <VALUEMEANING>Neurology Multiple Sclerosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers. 
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3243, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Migraines</VALIDVALUE>
          <VALUEMEANING>Neurology Migraine</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A common, severe type of vascular headache often associated with increased sympathetic activity, resulting in nausea, vomiting, and light sensitivity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89715, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insomnia</VALIDVALUE>
          <VALUEMEANING>Neurology Insomnia</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28286, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epilepsy</VALIDVALUE>
          <VALUEMEANING>Neurology Seizure Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A brain disorder characterized by episodes of abnormally increased neuronal discharge resulting in transient episodes of sensory or motor neurological dysfunction, or psychic dysfunction. These episodes may or may not be associated with loss of consciousness or convulsions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3020, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angina</VALIDVALUE>
          <VALUEMEANING>Cardiac Angina</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Paroxysms of chest pain due to reduced oxygen to the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51221, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144997</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary embolism</VALIDVALUE>
          <VALUEMEANING>Cardiac Pulmonary Embolism</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50713, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144998</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deep vein thrombosis (DVT)</VALIDVALUE>
          <VALUEMEANING>Cardiac Deep Vein Thrombosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: A blood clot in a deep vein, predominantly in the lower extremity, but may include the pelvis or upper extremity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49343, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144999</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aortic aneurysm</VALIDVALUE>
          <VALUEMEANING>Cardiac Aortic Aneurysm</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: A sac formation resulting from the localized dilatation of the wall of the aorta.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26697, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pernicious anemia</VALIDVALUE>
          <VALUEMEANING>Blood Bone Marrow Pernicious Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.: The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.: Megaloblastic anemia caused by vitamin B-12 deficiency due to impaired absorption. The impaired absorption of vitamin B-12 is secondary to atrophic gastritis and loss of gastric parietal cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2871, C12431, C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145001</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Idiopathic thrombocytopenic purpura (ITP)</VALIDVALUE>
          <VALUEMEANING>Blood Bone Marrow Idiopathic Thrombocytopenic Purpura</VALUEMEANING>
          <MEANINGDESCRIPTION>A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.: The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.: An autoimmune disorder in which the number of circulating platelets is reduced due to their antibody-mediated destruction. ITP is a diagnosis of exclusion and is heterogeneous in origin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3446, C12431, C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145002</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Herpes zoster</VALIDVALUE>
          <VALUEMEANING>Infection Herpes Zoster</VALUEMEANING>
          <MEANINGDESCRIPTION>The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.: A common dermal and neurologic disorder caused by reactivation of the varicella-zoster virus that has remained dormant within dorsal root ganglia, often for decades, after the patient&#39;s initial exposure to the virus in the form of varicella (chickenpox). It is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71079, C128320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatitis C</VALIDVALUE>
          <VALUEMEANING>Infection Hepatitis C Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.: A viral infection caused by the hepatitis C virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3098, C128320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145046</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tuberculosis</VALIDVALUE>
          <VALUEMEANING>Infection Tuberculosis</VALUEMEANING>
          <MEANINGDESCRIPTION>The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.: A chronic, recurrent infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis (TB) may affect almost any tissue or organ of the body with the lungs being the most common site of infection. The clinical stages of TB are primary or initial infection, latent or dormant infection, and recrudescent or adult-type TB. Ninety to 95% of primary TB infections may go unrecognized. Histopathologically, tissue lesions consist of granulomas which usually undergo central caseation necrosis. Local symptoms of TB vary according to the part affected; acute symptoms include hectic fever, sweats, and emaciation; serious complications include granulomatous erosion of pulmonary bronchi associated with hemoptysis. If untreated, progressive TB may be associated with a high degree of mortality. This infection is frequently observed in immunocompromised individuals with AIDS or a history of illicit IV drug use.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3423, C128320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatitis B</VALIDVALUE>
          <VALUEMEANING>Infection Hepatitis B Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.: A viral infection caused by the hepatitis B virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3097, C128320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145047</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatitis A</VALIDVALUE>
          <VALUEMEANING>Infection Hepatitis A Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.: Acute inflammation of the liver caused by the hepatitis A virus. It is highly contagious and usually contracted through close contact with an infected individual or their feces, contaminated food or water.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3096, C128320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145048</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heart block/pacemaker</VALIDVALUE>
          <VALUEMEANING>Cardiac Heart Block Pacemaker</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: An electrocardiographic finding of blocked cardiac electrical impulses along the fibers normally responsible for impulse conduction.: An electronic device that is implanted in the body to monitor heart rate and rhythm. It gives the heart electrical stimulation when it does not beat normally. It runs on batteries and has long, thin wires that connect it to the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34665, C13306, C94198</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 2, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Congestive heart failure</VALIDVALUE>
          <VALUEMEANING>Cardiac Congestive Heart Failure</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3080, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arterial thromboembolism</VALIDVALUE>
          <VALUEMEANING>Cardiac Arterial Thrombosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Formation of a blood clot in the lumen of an artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98826, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arrhythmia - ventricular</VALIDVALUE>
          <VALUEMEANING>Cardiac Arrhythmia Ventricular</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.: Of or relating to a ventricle (of the heart or brain).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38055, C2881, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arrhythmia - atrial</VALIDVALUE>
          <VALUEMEANING>Cardiac Arrhythmia Atrial</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.: Of or relating to a cavity or chamber in the body, especially one of the upper chambers of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37914, C2881, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypomagnesemia</VALIDVALUE>
          <VALUEMEANING>Metabolic Laboratory Test Result Hypomagnesemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with metabolism.: The outcome of a laboratory test.: Lower than normal levels of magnesium in the circulating blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37975, C36292, C28240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypokalemia</VALIDVALUE>
          <VALUEMEANING>Metabolic Laboratory Test Result Hypokalemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with metabolism.: The outcome of a laboratory test.: Lower than normal levels of potassium in the circulating blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37974, C36292, C28240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypertriglyceridemia</VALIDVALUE>
          <VALUEMEANING>Metabolic Laboratory Test Result Hypertriglyceridemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with metabolism.: The outcome of a laboratory test.: A laboratory test result indicating elevated triglyceride concentration in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37971, C36292, C28240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypercholesterolemia</VALIDVALUE>
          <VALUEMEANING>Metabolic Laboratory Test Result Hypercholesterolemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with metabolism.: The outcome of a laboratory test.: A laboratory test result indicating an increased amount of cholesterol in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37967, C36292, C28240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gout/hyperuricemia</VALIDVALUE>
          <VALUEMEANING>Metabolic Laboratory Test Result Gout Hyperuricemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with metabolism.: The outcome of a laboratory test.: A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals. : Elevated blood concentrations of uric acid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3961, C34650, C36292, C28240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ulcer(s)</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Ulcer</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines.: A circumscribed inflammatory and often suppurating lesion on the skin or an internal mucous surface resulting in necrosis of tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3426, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145023</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Perforated bowel</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Intestinal Perforation</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines.: A rupture in the wall of the small or large intestine due to traumatic or pathologic processes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39611, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Irritable bowel syndrome</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Irritable Bowel Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines.: Gastrointestinal symptoms characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82343, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145025</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hernia</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Hernia</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines.: The protrusion of part of an organ or fibroadipose tissue through an abnormal opening. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34685, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemorrhoids</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Hemorrhoid</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines.: Dilated veins in the anal canal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26792, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145027</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastroesophageal reflux (GERD)</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Gastroesophageal Reflux Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines.: A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26781, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145028</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastritis</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Gastritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines.: Inflammation of the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26780, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145029</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eating disorder</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Eating Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines.: A broad group of psychological disorders with abnormal eating behaviors leading to physiological effects from overeating or insufficient food intake.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89332, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diverticular disease</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Diverticulosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines.: A finding indicating the presence of multiple pouches, usually in the colonic or gastric wall. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4922, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Crohns/ulcerative colitis</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Crohn Disease Ulcerative Colitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines.: A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn disease most commonly involves the terminal ileum; the colon is the second most common site of involvement.: An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2952, C2965, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypothyroidism</VALIDVALUE>
          <VALUEMEANING>Endocrine Hypothyroidism</VALUEMEANING>
          <MEANINGDESCRIPTION>Collective designation for those tissues capable of secreting hormones.: Abnormally low levels of thyroid hormone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26800, C41064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145033</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperthyroidism/Graves</VALIDVALUE>
          <VALUEMEANING>Endocrine Hyperthyroidism Graves Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Collective designation for those tissues capable of secreting hormones.: Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves&#39; disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.: Hyperthyroidism associated with diffuse hyperplasia of the thyroid gland (goiter), resulting from production of antibodies that are directed against the thyrotropin receptor complex of the follicular epithelial cells. As a result, the thyroid gland enlarges and secrets increased amounts of thyroid hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3071, C3123, C41064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diabetes - non-insulin dependent</VALIDVALUE>
          <VALUEMEANING>Endocrine Type 2 Diabetes Mellitus</VALUEMEANING>
          <MEANINGDESCRIPTION>Collective designation for those tissues capable of secreting hormones.: A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26747, C41064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diabetes - insulin dependent</VALIDVALUE>
          <VALUEMEANING>Endocrine Type 1 Diabetes Mellitus</VALUEMEANING>
          <MEANINGDESCRIPTION>Collective designation for those tissues capable of secreting hormones.: A chronic condition characterized by minimal or absent production of insulin by the pancreas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2986, C41064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cushings disease</VALIDVALUE>
          <VALUEMEANING>Endocrine Cushing Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Collective designation for those tissues capable of secreting hormones.: Cushing&#39;s syndrome due to abnormally high secretion of adrenocorticotropic hormone (ACTH) from the pituitary gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113210, C41064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Addisons</VALIDVALUE>
          <VALUEMEANING>Endocrine Addison&#39;s Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Collective designation for those tissues capable of secreting hormones.: A long-standing and persistent diminished production of adrenocortical hormones due to a disorder originating within the adrenal glands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26689, C41064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allergy - environmental (dust, pollen, etc)</VALIDVALUE>
          <VALUEMEANING>Immunology Allergic Reaction Environmental Particulates</VALUEMEANING>
          <MEANINGDESCRIPTION>The study of the body&#39;s immune system.: An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.: Problem associated with fine solids or liquid particles such as dust, smoke, fume, and/or mist suspended in the immediate atmosphere in which the device is being used.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C72674, C114476, C18011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144836</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allergy - contrast dye</VALIDVALUE>
          <VALUEMEANING>Immunology Allergic Reaction Contrast Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>The study of the body&#39;s immune system.: An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.: Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C390, C114476, C18011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemolytic anemia</VALIDVALUE>
          <VALUEMEANING>Blood Bone Marrow Hemolytic Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.: The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.: Anemia resulting from the premature destruction of the peripheral blood red cells. It may be congenital or it may be caused by infections, medications, or malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34376, C12431, C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144842</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta thalassemia</VALIDVALUE>
          <VALUEMEANING>Blood Bone Marrow Beta Thalassemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.: The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.: An autosomal recessive disorder that affects the production of beta polypeptide chains which are necessary for the hemoglobin synthesis. Anemia and failure to thrive are characteristic features.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34375, C12431, C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anemia</VALIDVALUE>
          <VALUEMEANING>Blood Bone Marrow Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.: The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.: A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2869, C12431, C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144844</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hearing loss</VALIDVALUE>
          <VALUEMEANING>Auditory Ear Hearing Loss</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the process of hearing.: A sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contains the ossicles (malleus, incus and stapes). The inner ear is made up of the cochlea needed for hearing and the vestibular apparatus required for balance.: A partial or complete loss of hearing in one or both ears. It is classified as conductive, sensory, or central.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35731, C12394, C37915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin cancer - squamous cell</VALIDVALUE>
          <VALUEMEANING>Other Malignant Neoplasm Skin Carcinoma Squamous Cell </VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.: Skin cancer that arises in basal cells or squamous cells but not in melanocytes (pigment-producing cells of the skin).: A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2929, C4914, C9305, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin cancer - melanoma in situ</VALIDVALUE>
          <VALUEMEANING>Other Malignant Neoplasm Skin Carcinoma Cutaneous Melanoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.: Skin cancer that arises in basal cells or squamous cells but not in melanocytes (pigment-producing cells of the skin).: A primary melanoma arising from atypical melanocytes in the skin.  Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi.  Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.: In the natural or normal place, confined to the site of origin without invasion of neighboring tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14160, C3510, C4914, C9305, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6146313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chronic obstructive pulmonary</VALIDVALUE>
          <VALUEMEANING>Pulmonary Upper Respiratory System Chronic Obstructive Pulmonary Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the lungs.: The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea.: A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3199, C33839, C13304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144583</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin cancer - basal cell</VALIDVALUE>
          <VALUEMEANING>Other Malignant Neoplasm Skin Carcinoma Basal Cell </VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.: Skin cancer that arises in basal cells or squamous cells but not in melanocytes (pigment-producing cells of the skin).: The most frequently seen skin cancer. It arises from basal cells of the epidermis and pilosebaceous units. Clinically it is divided into the following types: nodular, ulcerative, superficial, multicentric, erythematous, and sclerosing or morphea-like. More than 95% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck and the remaining 15% on the trunk and extremities. Basal cell carcinoma usually grows in a slow and indolent fashion. However, if untreated, the tumor may invade the subcutaneous fat, skeletal muscle and bone. Distant metastases are rare. Excision, curettage and irradiation cure most basal cell carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2921, C4914, C9305, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Psoriasis</VALIDVALUE>
          <VALUEMEANING>Dermatology Psoriasis</VALUEMEANING>
          <MEANINGDESCRIPTION>The branch of medicine focused on the study of the skin, and responsible for the medical management of its associated diseases. : An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3346, C16500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Photosensitivity</VALIDVALUE>
          <VALUEMEANING>Dermatology Skin Photosensitivity</VALUEMEANING>
          <MEANINGDESCRIPTION>The branch of medicine focused on the study of the skin, and responsible for the medical management of its associated diseases. : Increased sensitivity of the skin to light exposure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38004, C16500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypercoagulable state</VALIDVALUE>
          <VALUEMEANING>Coagulation Disorder Thrombophilia</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.: A condition characterized by an abnormally high level of thrombi. Causes include thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, bone marrow disorders, and antiphospholipid antibody syndrome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84479, C2902</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Venous thromboembolism</VALIDVALUE>
          <VALUEMEANING>Cardiac Venous Thromboembolism</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Occlusion of the lumen of a vein by a thrombus that has migrated from a distal site via the blood stream.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99537, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Valvular heart disease</VALIDVALUE>
          <VALUEMEANING>Cardiac Valvular Heart Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Any heart disorder characterized by a defect in valve structure or function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45525, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tachycardia</VALIDVALUE>
          <VALUEMEANING>Cardiac Tachycardia</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart._An abnormally rapid heart rate. Thresholds for different age, sex, and patient populations exist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38029, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colon cancer</VALIDVALUE>
          <VALUEMEANING>Other Malignant Neoplasm Colon Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.: A malignant epithelial neoplasm that arises from the colon and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4910, C9305, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arthritis</VALIDVALUE>
          <VALUEMEANING>Musculoskeletal Soft Tissue Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the muscles and skeleton. : Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.: An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2883, C12471, C25348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paget&#39;s disease</VALIDVALUE>
          <VALUEMEANING>Musculoskeletal Soft Tissue Bone Paget Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the muscles and skeleton. : Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.: A disease of bone that initially results in the excessive resorption of bone (by osteoclasts) followed by the replacement of normal bone marrow with vascular and fibrous tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3292, C12471, C25348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteopenia</VALIDVALUE>
          <VALUEMEANING>Musculoskeletal Soft Tissue Osteopenia</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the muscles and skeleton. : Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.: Decreased calcification or density of bone tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50910, C12471, C25348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Degenerative disc disease</VALIDVALUE>
          <VALUEMEANING>Musculoskeletal Soft Tissue Intervertebral Disc Degenerative Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the muscles and skeleton. : Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.: Any disease of a degenerative nature that affects the intervertebral disc.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26983, C12471, C25348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145106</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Connective tissue disease</VALIDVALUE>
          <VALUEMEANING>Musculoskeletal Soft Tissue Connective Tissue Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the muscles and skeleton. : Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.: A non-neoplastic or neoplastic disorder that affects the connective tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26729, C12471, C25348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arthritis - rheumatoid</VALIDVALUE>
          <VALUEMEANING>Musculoskeletal Soft Tissue Rheumatoid Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the muscles and skeleton. : Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.: A chronic, systemic autoimmune disorder characterized by inflammation in the synovial membranes and articular surfaces. It manifests primarily as a symmetric, erosive polyarthritis that spares the axial skeleton and is typically associated with the presence in the serum of rheumatoid factor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2884, C12471, C25348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145108</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arthritis - psoriatic</VALIDVALUE>
          <VALUEMEANING>Musculoskeletal Soft Tissue Psoriatic Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the muscles and skeleton. : Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.: Joint inflammation associated with psoriasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61277, C12471, C25348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arthritis - osteo</VALIDVALUE>
          <VALUEMEANING>Musculoskeletal Soft Tissue Osteoarthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the muscles and skeleton. : Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.: A noninflammatory degenerative joint disease occurring chiefly in older persons, characterised by degeneration of the articular cartilage, hypertrophy of bone at the margins and changes in the synovial membrane. It is accompanied by pain and stiffness, particularly after prolonged activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3293, C12471, C25348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6145110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diabetes - gestational</VALIDVALUE>
          <VALUEMEANING>Endocrine Diabetes Mellitus Gestational</VALUEMEANING>
          <MEANINGDESCRIPTION>Collective designation for those tissues capable of secreting hormones.: A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.: The period of fetal development in the uterus from the start of conception until its birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92804, C2985, C41064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Coronary artery disease</VALIDVALUE>
          <VALUEMEANING>Cardiac Coronary Artery Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: An imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26732, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypertension</VALIDVALUE>
          <VALUEMEANING>Cardiac Hypertension</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart.: Blood pressure that is abnormally high.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3117, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144581</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Psychosis, psychiatric</VALIDVALUE>
          <VALUEMEANING>Neurology Psychosis Psychiatric Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of medicine concerned with the development, anatomy, function, and dysfunction of the nervous system.: A mental disorder characterized by personality change, impaired functioning, and loss of touch with reality.: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2893, C78576, C16908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144582</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Smoker</VALIDVALUE>
          <VALUEMEANING>Pulmonary Upper Respiratory System Smoker</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the lungs.: The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea.: A person who inhales or has inhaled combustible products of organic material during their lifetime.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68751, C33839, C13304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pneumothorax</VALIDVALUE>
          <VALUEMEANING>Pulmonary Upper Respiratory System Pneumothorax</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the lungs.: The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea.: Abnormal presence of air in the pleural cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38006, C33839, C13304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Emphysema</VALIDVALUE>
          <VALUEMEANING>Pulmonary Upper Respiratory System Emphysema</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the lungs.: The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea.: A subcategory of chronic obstructive pulmonary disease (COPD). It occurs in people who smoke and suffer from chronic bronchitis. It is characterized by inflation of the alveoli, alveolar wall damage, and reduction in the number of alveoli, resulting in difficulty breathing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3348, C33839, C13304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asthma</VALIDVALUE>
          <VALUEMEANING>Pulmonary Upper Respiratory System Asthma</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the lungs.: The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea.: A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28397, C33839, C13304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other </VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteoporosis</VALIDVALUE>
          <VALUEMEANING>Musculoskeletal Soft Tissue Osteoporosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the muscles and skeleton. : Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.: A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3298, C12471, C25348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6144584</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Major medical problem</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Major medical problem</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Medical History Term</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_02</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Medical Problem Term</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15689233</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HHS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Completed</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15910169</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MMP_PROB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MH_MHDECOD</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CE_CETERM</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="379">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6153918</PUBLICID>
    <LONGNAME>Person Biological Entity Ethnic Group Code OMOP CDM Ethnicity Concept Identifier</LONGNAME>
    <PREFERREDNAME>ethnicity_concept_id</PREFERREDNAME>
    <PREFERREDDEFINITION>A social group characterized by a distinctive social and cultural tradition that is maintained from generation to generation. Members share a common history and origin and a sense of identification with the group. They have similar and distinctive features in their lifestyle habits and shared experiences. They often have a common genetic heritage which may be reflected in their experience of health and disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>OMOP CDM:The Observational Medical Outcomes Partnership (OMOP) Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868137</PublicId>
      <PreferredName>2867644v1.0:2493200v1.0</PreferredName>
      <PreferredDefinition>A single human being.:Pertaining to biology or to life and living things.:An independently existing thing (living or nonliving)._A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of:A system, often of numbered categories, for representation of data.</PreferredDefinition>
      <LongName>Person Biological Entity Ethnic Group Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867644</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C28226:C51070</PreferredName>
        <Version>1</Version>
        <LongName>Person Biological Entity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28226</PREFERRED_NAME>
            <LONG_NAME>Biological</LONG_NAME>
            <CON_ID>2206378</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2493200</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16564:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Ethnic Group Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16564</PREFERRED_NAME>
            <LONG_NAME>Ethnic Group</LONG_NAME>
            <CON_ID>2221860</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BRIDG:Biomedical Research Integrated Domain Group</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6153916</PublicId>
      <PreferredName>6153916v1.0</PreferredName>
      <PreferredDefinition>A foreign key that refers to the standard concept identifier in the Standardized Vocabularies for the ethnicity of the person.</PreferredDefinition>
      <LongName>OMOP CDM Ethnicity Concept Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008552</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PHYS_DESC_OF_INDS</PreferredName>
        <Version>1</Version>
        <LongName>Physical Description of Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>OMOP CDM:The Observational Medical Outcomes Partnership (OMOP) Common Data Model</Origin>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>38003563</VALIDVALUE>
          <VALUEMEANING>Hispanic or Latino</VALUEMEANING>
          <MEANINGDESCRIPTION>A person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. The term, &quot;Spanish origin,&quot; can be used in addition to &quot;Hispanic or Latino.&quot; (OMB)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>38003564</VALIDVALUE>
          <VALUEMEANING>Not Hispanic or Latino</VALUEMEANING>
          <MEANINGDESCRIPTION>A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Ethnicity</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Ethnicity</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5279492</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>OMOP 5.31</PreferredName>
          <Version>5.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Person</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>8003202</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ethnicity_concept_id</AlternateName>
        <AlternateNameType>OMOP Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PERSON</AlternateName>
        <AlternateNameType>OMOP Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="380">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6161331</PUBLICID>
    <LONGNAME>Arm and Breast Symptom Questionnaire 11 Past 7 Days How Much Bothered by Tightness, Pulling, or Stretching in Affected Underarm, Arm, or Hand Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>ARM_BRST_11_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how much they have been bothered in the past 7 days by tightness, pulling, or stretching in their affected underarm, arm or hand, using a 5-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCTG: Canadian Cancer Trials Group</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6161240</PublicId>
      <PreferredName>6161207v1.0:6161318v1.0</PreferredName>
      <PreferredDefinition>The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest._Subjective evidence of disease perceived by the patient._Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument._The most recent week, including today._A question about how bothered an individual is by tenderness in their affected underarm, arm, or hand._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Arm and Breast Symptom Questionnaire Past Week How Much Bothered by Tightness, Pulling, or Stretching in Affected Underarm, Arm, or Hand Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6161207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>6161207v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Arm And Breast Symptom Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C32141</PREFERRED_NAME>
            <LONG_NAME>Arm</LONG_NAME>
            <CON_ID>2202427</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37912</PREFERRED_NAME>
            <LONG_NAME>And</LONG_NAME>
            <CON_ID>2528554</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12971</PREFERRED_NAME>
            <LONG_NAME>Breast</LONG_NAME>
            <CON_ID>2202571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17048</PREFERRED_NAME>
            <LONG_NAME>Questionnaire</LONG_NAME>
            <CON_ID>2202367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6161318</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C148208:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week How Much Bothered by Tightness, Pulling, or Stretching in Affected Underarm, Arm, or Hand Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C148208</PREFERRED_NAME>
            <LONG_NAME>How Much Bothered by Tightness, Pulling, or Stretching in Affected Underarm, Arm, or Hand Question</LONG_NAME>
            <CON_ID>6161126</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCTG: Canadian Cancer Trials Group</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6161291</PublicId>
      <PreferredName>ARM_BRST_BTHRD_SCL</PreferredName>
      <PreferredDefinition>Numeric scores from 1 (not at all difficult) to 5 (Unable to do) on a 5-point Likert scale.</PreferredDefinition>
      <LongName>Arm and Breast Symptom Questionnaire Bothered 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>CCTG: Canadian Cancer Trials Group</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tightness, pulling, or stretc</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tightness, pulling, or stretching in the underarm, arm or hand?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ARM_BRST_11_SCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="381">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6208254</PUBLICID>
    <LONGNAME>Common Toxicity Criteria for Adverse Events Hallucination Indicator</LONGNAME>
    <PREFERREDNAME>6242561v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not there was a common toxicity criteria adverse event of hallucinations.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6242561</PublicId>
      <PreferredName>2480706v1.0:6242559v1.0</PreferredName>
      <PreferredDefinition>A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event._A false sensory perception in the absence of an external stimulus, as distinct from an illusion which is a misperception of an external stimulus.</PreferredDefinition>
      <LongName>Common Toxicity Criteria for Adverse Events Hallucination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6242559</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37961</PreferredName>
        <Version>1</Version>
        <LongName>Hallucination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37961</PREFERRED_NAME>
            <LONG_NAME>Hallucination</LONG_NAME>
            <CON_ID>2922961</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was there was a common toxici</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was there was a common toxicity criteria adverse event of hallucinations?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hallucinations</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Hallucinations</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hallucinations</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Hallucinations</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_ctcae_halluc_ynu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="382">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6261213</PUBLICID>
    <LONGNAME>Patient Visit Site Type</LONGNAME>
    <PREFERREDNAME>6260951v1.0:6261030v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the site of visit by a patient to a medical professional.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6260951</PublicId>
      <PreferredName>2960652v1.0:2413203v1.0</PreferredName>
      <PreferredDefinition>A visit by a patient or study participant to a medical professional._A position in relation to its surroundings.</PreferredDefinition>
      <LongName>Patient Visit Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2960652</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C39564</PreferredName>
        <Version>1</Version>
        <LongName>Health Care Visit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39564</PREFERRED_NAME>
            <LONG_NAME>Patient Visit</LONG_NAME>
            <CON_ID>2684743</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2413203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37901</PreferredName>
        <Version>1</Version>
        <LongName>Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37901</PREFERRED_NAME>
            <LONG_NAME>Site</LONG_NAME>
            <CON_ID>2202394</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6261030</PublicId>
      <PreferredName>6261030v1.0</PreferredName>
      <PreferredDefinition>The type of site related to the patient visit.</PreferredDefinition>
      <LongName>Patient Visit Site Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>Alliance Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intensive Care Unit (ICU) Hospital Inpatient Department</VALIDVALUE>
          <VALUEMEANING>Intensive Care Unit Hospital Inpatient Department</VALUEMEANING>
          <MEANINGDESCRIPTION>A health care facility unit that provides intensive care to critically ill patients and patients with complex medical problems who require constant monitoring or special therapy.: An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured.: A patient who is residing in the hospital where he is being treated.: A specialized division of a large organization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42671, C25182, C16696, C53511</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6261031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hospital Inpatient Department</VALIDVALUE>
          <VALUEMEANING>Hospital Inpatient Department</VALUEMEANING>
          <MEANINGDESCRIPTION>An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured.: A patient who is residing in the hospital where he is being treated.: A specialized division of a large organization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42671, C25182, C16696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6261032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Telemedicine</VALIDVALUE>
          <VALUEMEANING>Telemedicine</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of telecommunications technology to provide, enhance, or expedite health care services, as by accessing off-site databases, linking clinics or physicians&#39; offices to central hospitals, or transmitting x-rays or other diagnostic images for examination at another site. (Bartleby.com)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6261035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Email to provider</VALIDVALUE>
          <VALUEMEANING>E-mail To Health Care Provider</VALUEMEANING>
          <MEANINGDESCRIPTION>E-mail is short for &quot;electronic mail&quot; and refers to composing, sending, and receiving messages over electronic communication systems. Most e-mail systems use the Internet.: Used as a function word to indicate direction, purpose, or movement.: Persons who provides health care as part of their job responsibilities: or a person or organization who is licensed to supply health care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16666, C65107, C25170</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6261036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phone call to provider</VALIDVALUE>
          <VALUEMEANING>Telephone Call To Health Care Provider</VALUEMEANING>
          <MEANINGDESCRIPTION>Electronic equipment that converts sound into electrical signals that can be transmitted over distances and then converts received signals back into sounds.: Send a message or attempt to reach someone by radio, phone, etc.: Used as a function word to indicate direction, purpose, or movement.: Persons who provides health care as part of their job responsibilities: or a person or organization who is licensed to supply health care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16666, C65107, C64924, C50212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6261037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Provider&#39;s Office</VALIDVALUE>
          <VALUEMEANING>Physician Office</VALUEMEANING>
          <MEANINGDESCRIPTION>The room or rooms in which the physician and staff provide patient care. The offices include all rooms in the physician&#39;s office suite.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16988</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5633383</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Emergency Department</VALIDVALUE>
          <VALUEMEANING>Emergency Room</VALUEMEANING>
          <MEANINGDESCRIPTION>The section of a hospital or clinic staffed and equipped to provide immediate medical treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4399667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hospital Outpatient Department</VALIDVALUE>
          <VALUEMEANING>Hospital Outpatient Department</VALUEMEANING>
          <MEANINGDESCRIPTION>An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured.: A patient who comes to a healthcare facility for diagnosis or treatment but is not admitted for an overnight stay.: A specialized division of a large organization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42671, C28293, C16696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6261038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Site of Care</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Site of Care</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="383">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6289555</PUBLICID>
    <LONGNAME>Patient Pregnancy Yes No Unk Previous Report Indicator</LONGNAME>
    <PREFERREDNAME>2014052v1.0:5096872v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the patient was / is pregnant or if it was previously reported.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014052</PublicId>
      <PreferredName>PT_PREG</PreferredName>
      <PreferredDefinition>information regarding a patient&#39;s pregnancy.</PreferredDefinition>
      <LongName>Patient Pregnancy</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177414</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Pregnancy</PreferredName>
        <Version>1</Version>
        <LongName>Pregnancy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25742</PREFERRED_NAME>
            <LONG_NAME>Pregnancy</LONG_NAME>
            <CON_ID>2202906</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5096872</PublicId>
      <PreferredName>5096872v1.0</PreferredName>
      <PreferredDefinition>Indicator of Yes, No, Unknown, Not done, Not applicable or Previously reported to a question.[manually curated].</PreferredDefinition>
      <LongName>Yes No Unk ND NA Previous Report Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>5096871</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5096871v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Previous Report Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>7</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25627</PREFERRED_NAME>
            <LONG_NAME>Previous</LONG_NAME>
            <CON_ID>2206349</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the recipient pregnant?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Was the recipient pregnant?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the patient pregnant?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the patient pregnant?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the recipient pregnant at any time in this reporting period?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the recipient pregnant at any time in this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the recipient become pregnant?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the patient pregnant?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_FS_preg_ynupr</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_PS_preg_ynupr</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_FS_preg_ynupr</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="384">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6343328</PUBLICID>
    <LONGNAME>Lab Test or Examination Name</LONGNAME>
    <PREFERREDNAME>LBTEST</PREFERREDNAME>
    <PREFERREDDEFINITION>Descriptive name of the lab test or examination used to obtain the measurement or finding. Any test normally performed by a clinical laboratory is considered a lab test. This content is being reviewed for compliance with Executive Order 14168 which mandates that gender should not be used as a replacement for sex.</PREFERREDDEFINITION>
    <VERSION>11</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6422504</PublicId>
      <PreferredName>6401816v1.0:6422502v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to laboratory data._A character or string that represents the full name of the laboratory assessment.</PreferredDefinition>
      <LongName>Laboratory Data Domain Laboratory Test</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6401816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49592</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Data Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49592</PREFERRED_NAME>
            <LONG_NAME>Laboratory Data Domain</LONG_NAME>
            <CON_ID>2469066</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6422502</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117142</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117142</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Name</LONG_NAME>
            <CON_ID>5581796</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6401058</PublicId>
      <PreferredName>LBTEST</PreferredName>
      <PreferredDefinition>Terminology used for laboratory test names of the CDISC Study Data Tabulation Model._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>CDISC SDTM Laboratory Test Name Terminology Name</LongName>
      <Version>2.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6343326</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C67154:C42614</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Laboratory Test Name Terminology Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67154</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Laboratory Test Name Terminology</LONG_NAME>
            <CON_ID>6343325</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kallikrein-2</VALIDVALUE>
          <VALUEMEANING>Kallikrein-2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of kallikrein-2 in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132374</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kallikrein-5</VALIDVALUE>
          <VALUEMEANING>Kallikrein-5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of kallikrein-5 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091625</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kallikrein-7</VALIDVALUE>
          <VALUEMEANING>Kallikrein-7 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of kallikrein-7 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kappa Light Chain</VALIDVALUE>
          <VALUEMEANING>Kappa Light Chain Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of kappa light chain present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kappa Light Chain, Free</VALIDVALUE>
          <VALUEMEANING>Free Kappa Light Chain Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free kappa light chain present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98730</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6142752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kappa Light Chain/Lambda Light Chain</VALIDVALUE>
          <VALUEMEANING>Kappa Light Chain to Lambda Light Chain Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of kappa light chain compared to lambda light chain present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kappa Lt Chain,Free/Lambda Lt Chain,Free</VALIDVALUE>
          <VALUEMEANING>Free Kappa Light Chain to Free Lambda Light Chain Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of free kappa light chain compared to free lambda light chain present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98731</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6183725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Keratocyte</VALIDVALUE>
          <VALUEMEANING>Keratocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of keratocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ketamine</VALIDVALUE>
          <VALUEMEANING>Ketamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the ketamine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ketobemidone</VALIDVALUE>
          <VALUEMEANING>Ketobemidone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the ketobemidone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ketoisoleucine</VALIDVALUE>
          <VALUEMEANING>Ketoisoleucine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ketoisoleucine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ketoleucine</VALIDVALUE>
          <VALUEMEANING>Ketoleucine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ketoleucine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ketone Bodies Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Ketone Bodies Excretion Rate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amount of ketone bodies being excreted in a biological specimen over a defined period of time (e.g. one hour).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ketone Bodies</VALIDVALUE>
          <VALUEMEANING>Ketone Body Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ketone bodies (acetone, acetoacetic acid, beta-hydroxybutyric acid, beta-ketopentanoate and beta-hydroxypentanoate) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ketones</VALIDVALUE>
          <VALUEMEANING>Ketone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of ketones present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64854</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ketovaline</VALIDVALUE>
          <VALUEMEANING>Ketovaline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ketovaline in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ki-67</VALIDVALUE>
          <VALUEMEANING>Ki67 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Ki-67 protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6422539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney Injury Molecule-1 Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Kidney Injury Molecule-1 Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of kidney injury molecule-1 being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163462</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney Injury Molecule-1</VALIDVALUE>
          <VALUEMEANING>Kidney Injury Molecule-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of kidney injury molecule-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney Injury Molecule-1/Creatinine</VALIDVALUE>
          <VALUEMEANING>Kidney Injury Molecule-1/Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of kidney injury molecule-1 compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177955</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Klotho</VALIDVALUE>
          <VALUEMEANING>Klotho Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of klotho protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127624</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Krebs von den Lungen-6</VALIDVALUE>
          <VALUEMEANING>Krebs von den Lungen-6 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Krebs von den Lungen-6 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154724</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kurloff Cells</VALIDVALUE>
          <VALUEMEANING>Kurloff Cells Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kynurenine</VALIDVALUE>
          <VALUEMEANING>Kynurenine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of kynurenine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lacosamide</VALIDVALUE>
          <VALUEMEANING>Lacosamide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the lacosamide in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lactate Dehydrogenase Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Lactate Dehydrogenase Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lactate dehydrogenase being excreted in a biological specimen over a defined amount of time (e.g. one hour).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lactate Dehydrogenase</VALIDVALUE>
          <VALUEMEANING>Lactate Dehydrogenase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of lactate dehydrogenase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lactate Dehydrogenase/Creatinine</VALIDVALUE>
          <VALUEMEANING>Lactate Dehydrogenase to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of lactate dehydrogenase compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lactic Acid</VALIDVALUE>
          <VALUEMEANING>Lactic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lactic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methanol</VALIDVALUE>
          <VALUEMEANING>Methanol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of methanol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403802</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methaqualone</VALIDVALUE>
          <VALUEMEANING>Methaqualone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of methaqualone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74882</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methasterone</VALIDVALUE>
          <VALUEMEANING>Methasterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the methasterone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methcathinone</VALIDVALUE>
          <VALUEMEANING>Methcathinone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the methcathinone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184552</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methemoglobin</VALIDVALUE>
          <VALUEMEANING>Methemoglobin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of methemoglobin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96689</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methemoglobin/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Methemoglobin to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of methemoglobin compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methionine</VALIDVALUE>
          <VALUEMEANING>Methionine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of methionine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methohexital</VALIDVALUE>
          <VALUEMEANING>Methohexital Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the methohexital in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methylmalonic Acid</VALIDVALUE>
          <VALUEMEANING>Methylmalonic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of methylmalonic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96690</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methylphenidate</VALIDVALUE>
          <VALUEMEANING>Methylphenidate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of methylphenidate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170581</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methylphenobarbital</VALIDVALUE>
          <VALUEMEANING>Mephobarbital Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mephobarbital present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methyltestosterone</VALIDVALUE>
          <VALUEMEANING>Methyltestosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the methyltestosterone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184590</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010426</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methyltransferase</VALIDVALUE>
          <VALUEMEANING>Methyltransferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the total methyltransferase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methyprylon</VALIDVALUE>
          <VALUEMEANING>Methyprylon Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the methyprylon in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184591</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010424</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MHC Class I Chain Related Protein A</VALIDVALUE>
          <VALUEMEANING>MHC Class I Chain Related Protein A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of MHC class I chain related protein A in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351802</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Microcytes</VALIDVALUE>
          <VALUEMEANING>Microcyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of microcytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64822</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mid Cell Fraction</VALIDVALUE>
          <VALUEMEANING>Mid Cell Fraction Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mid cell fraction (including eosinophils, basophils, monocytes and other precursor white blood cells) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mid-Reg Pro-Atrial Natriuretic Peptide</VALIDVALUE>
          <VALUEMEANING>Mid-Regional Pro-Atrial Natriuretic Peptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mid-Regional pro-atrial natriuretic peptide in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Midazolam</VALIDVALUE>
          <VALUEMEANING>Midazolam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of midazolam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139083</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bioavailable Testosterone</VALIDVALUE>
          <VALUEMEANING>Bioavailable Testosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of bioavailable testosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117860</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bite Cells</VALIDVALUE>
          <VALUEMEANING>Bite Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of bite cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74700</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bite Cells/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Bite Cell to Erythrocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of bite cells compared to erythrocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bizarre Platelets</VALIDVALUE>
          <VALUEMEANING>Bizarre Platelet Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of bizarre platelets present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154733</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blasts</VALIDVALUE>
          <VALUEMEANING>Blast Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of blast cells present in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74605</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blasts/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Blast to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of blasts compared to leukocytes in a blood sample. The result may be expressed as either a ratio or a percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blasts/Total Cells</VALIDVALUE>
          <VALUEMEANING>Blasts to Total Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of blasts compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150836</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bleeding Time</VALIDVALUE>
          <VALUEMEANING>Bleeding Time</VALUEMEANING>
          <MEANINGDESCRIPTION>The amount of time it take for a cessation of bleeding. It is a measurement of the ability of capillaries and platelets to interact to form a blood clot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89775</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407426</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blister Cell</VALIDVALUE>
          <VALUEMEANING>Blister Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of blister cells in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bolasterone</VALIDVALUE>
          <VALUEMEANING>Bolasterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the bolasterone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184579</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Boldenone</VALIDVALUE>
          <VALUEMEANING>Boldenone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of boldenone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Specific Alkaline Phosphatase</VALIDVALUE>
          <VALUEMEANING>Bone Specific Alkaline Phosphatase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of bone specific alkaline phosphatase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92287</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brain Natriuretic Peptide</VALIDVALUE>
          <VALUEMEANING>Brain Natriuretic Peptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of brain natriuretic peptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74735</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brain-Derived Neurotrophic Factor</VALIDVALUE>
          <VALUEMEANING>Brain-Derived Neurotrophic Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of brain-derived neurotrophic factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82004</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brexpiprazole</VALIDVALUE>
          <VALUEMEANING>Brexpiprazole Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of brexpiprazole in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brivaracetam</VALIDVALUE>
          <VALUEMEANING>Brivaracetam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the brivaracetam in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184639</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Broad Casts</VALIDVALUE>
          <VALUEMEANING>Broad Casts Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of urinary broad (waxy) casts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bromazepam</VALIDVALUE>
          <VALUEMEANING>Bromazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the bromazepam in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bruton&#39;s Tyrosine Kinase</VALIDVALUE>
          <VALUEMEANING>Bruton&#39;s Tyrosine Kinase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Bruton&#39;s tyrosine kinase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165772</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bruton&#39;s Tyrosine Kinase, Free</VALIDVALUE>
          <VALUEMEANING>Free Bruton&#39;s Tyrosine Kinase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free Bruton&#39;s tyrosine kinase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bufotenine</VALIDVALUE>
          <VALUEMEANING>Bufotenine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the bufotenine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184531</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buprenorphine</VALIDVALUE>
          <VALUEMEANING>Buprenorphine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of buprenorphine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Burr Cells</VALIDVALUE>
          <VALUEMEANING>Burr Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of Burr cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74701</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Butabarbital</VALIDVALUE>
          <VALUEMEANING>Butabarbital Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of butabarbital present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75364</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Butalbital</VALIDVALUE>
          <VALUEMEANING>Butalbital Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of butalbital present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75365</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Butorphanol</VALIDVALUE>
          <VALUEMEANING>Butorphanol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the butorphanol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Butylone</VALIDVALUE>
          <VALUEMEANING>Butylone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the butylone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184532</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Butyrylcholinesterase</VALIDVALUE>
          <VALUEMEANING>Butyrylcholinesterase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total butyrylcholinesterase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Butyrylfentanyl</VALIDVALUE>
          <VALUEMEANING>Butyrylfentanyl Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the butyrylfentanyl in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010321</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C Reactive Protein</VALIDVALUE>
          <VALUEMEANING>C-Reactive Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of C-reactive protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6142758</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C-C Chemokine Receptor Type 5</VALIDVALUE>
          <VALUEMEANING>C-C Chemokine Receptor Type 5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of C-C chemokine receptor type 5 in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C-Peptide Excretion Rate</VALIDVALUE>
          <VALUEMEANING>C-Peptide Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of C-peptide being excreted in a biological specimen over a defined amount of time (e.g. one hour).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C-peptide</VALIDVALUE>
          <VALUEMEANING>C-peptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of C-peptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C-peptide/Creatinine</VALIDVALUE>
          <VALUEMEANING>C-peptide to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of C-peptide compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cabot Rings</VALIDVALUE>
          <VALUEMEANING>Cabot Ring Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of Cabot rings present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cadherin 1</VALIDVALUE>
          <VALUEMEANING>Cadherin 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cadherin 1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Caffeine</VALIDVALUE>
          <VALUEMEANING>Caffeine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of caffeine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75346</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calbindin</VALIDVALUE>
          <VALUEMEANING>Calbindin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of calbindin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125942</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcitonin</VALIDVALUE>
          <VALUEMEANING>Calcitonin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of calcitonin hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74848</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcitriol</VALIDVALUE>
          <VALUEMEANING>Calcitriol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of calcitriol hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74849</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404339</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium - Phosphorus Product</VALIDVALUE>
          <VALUEMEANING>Calcium and Phosphorus Product Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the product of the calcium and phosphate measurements in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409143</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium Carbonate Crystals</VALIDVALUE>
          <VALUEMEANING>Calcium Carbonate Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of calcium carbonate crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium Clearance</VALIDVALUE>
          <VALUEMEANING>Calcium Clearance Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the calcium clearance in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium Corrected for Albumin</VALIDVALUE>
          <VALUEMEANING>Albumin Corrected Calcium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of calcium in a sample, which has been corrected for albumin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154753</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium Corrected for Total Protein</VALIDVALUE>
          <VALUEMEANING>Calcium Corrected for Total Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of calcium, which has been corrected for total protein, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium Corrected</VALIDVALUE>
          <VALUEMEANING>Calcium Corrected Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the calcium corrected in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Calcium Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the amount of calcium being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150815</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium Oxalate Crystals</VALIDVALUE>
          <VALUEMEANING>Calcium Oxalate Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of calcium oxalate crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Milnacipran</VALIDVALUE>
          <VALUEMEANING>Milnacipran Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the milnacipran in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187815</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed Casts</VALIDVALUE>
          <VALUEMEANING>Mixed Cast Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of mixed casts present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74771</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed Lymphocyte Reaction</VALIDVALUE>
          <VALUEMEANING>Mixed Lymphocyte Reaction Test</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay that measures the proliferative response of lymphocytes from one individual when they are exposed to inactivated lymphocytes from another individual. The reaction can be performed on lymphocytes from the same individual (auto-MLR), from different individuals of the same species (allo-MLR), or individuals from different species (xeno-MLR). It is used to evaluate the potential for graft-versus-host or host-versus-graft reactions during transplantation procedures involving mismatched tissue types or individuals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Modafinil</VALIDVALUE>
          <VALUEMEANING>Modafinil Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the modafinil in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184628</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010649</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Molindone</VALIDVALUE>
          <VALUEMEANING>Molindone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of molindone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoblasts</VALIDVALUE>
          <VALUEMEANING>Monoblast Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of monoblast cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74631</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoblasts/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Monoblast to Leukocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of monoblast cells compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoblasts/Total Cells</VALIDVALUE>
          <VALUEMEANING>Monoblast to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the monoblasts to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187677</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoclonal Prot Immunoglobulin Isotype</VALIDVALUE>
          <VALUEMEANING>Monoclonal Protein Immunoglobulin Isotype Determination</VALUEMEANING>
          <MEANINGDESCRIPTION>The identification of the monoclonal protein immunoglobulin isotype present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186081</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoclonal Protein Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Monoclonal Protein Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of monoclonal protein spike being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoclonal Protein Region</VALIDVALUE>
          <VALUEMEANING>Monoclonal Protein Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of a monoclonal protein spike region present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoclonal Protein</VALIDVALUE>
          <VALUEMEANING>Monoclonal Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of monoclonal protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoclonal Protein/Total Protein</VALIDVALUE>
          <VALUEMEANING>Monoclonal Protein to Total Protein Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of monoclonal protein compared to total protein present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monocyte Chemotactic Protein 1</VALIDVALUE>
          <VALUEMEANING>Monocyte Chemotactic Protein 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of monocyte chemotactic protein 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monocyte Distribution Width</VALIDVALUE>
          <VALUEMEANING>Monocyte Distribution Width Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of monocyte dispersion present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14537238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monocytes and Macrophages/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Monocytes and Macrophages to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of monocytes and macrophages compared to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147396</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403263</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monocytes</VALIDVALUE>
          <VALUEMEANING>Monocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of monocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64823</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Monocyte to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of monocytes compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64824</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monocytes/Macrocytes</VALIDVALUE>
          <VALUEMEANING>Monocytes to Macrocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of monocytes compared to macrocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106544</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monocytes/Non-Squam Epi Cells</VALIDVALUE>
          <VALUEMEANING>Monocytes to Non-Squamous Epithelial Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of monocytes compared to non-squamous epithelial cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407447</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monocytes/Total Cells</VALIDVALUE>
          <VALUEMEANING>Monocytes to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of monocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98872</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monocytoid Cells</VALIDVALUE>
          <VALUEMEANING>Monocytoid Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of monocytoid cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monocytoid Cells/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Monocytoid Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of monocytoid cells compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monocytoid Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Monocytoid Cell to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the monocytoid cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monomethylarginine</VALIDVALUE>
          <VALUEMEANING>Monomethylarginine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of monomethylarginine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mononuclear Cells Atypical</VALIDVALUE>
          <VALUEMEANING>Atypical Mononuclear Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the atypical mononuclear cells in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mononuclear Cells Atypical/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Atypical Mononuclear Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the atypical mononuclear cells to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C3a</VALIDVALUE>
          <VALUEMEANING>Complement C3a Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement C3a present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80175</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C3b</VALIDVALUE>
          <VALUEMEANING>Complement C3b Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement C3b present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80176</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407992</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C3c</VALIDVALUE>
          <VALUEMEANING>Complement C3c Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the complement C3c in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C4</VALIDVALUE>
          <VALUEMEANING>Complement C4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement C4 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80177</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C4a</VALIDVALUE>
          <VALUEMEANING>Complement C4a Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement C4a present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80178</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C4d</VALIDVALUE>
          <VALUEMEANING>Complement C4d Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement C4d present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C5</VALIDVALUE>
          <VALUEMEANING>Complement C5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the total complement C5 in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160935</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C5, Free</VALIDVALUE>
          <VALUEMEANING>Free Complement C5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free complement C5 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161357</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C5a</VALIDVALUE>
          <VALUEMEANING>Complement C5a Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement C5a present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80179</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C5b-9</VALIDVALUE>
          <VALUEMEANING>Complement C5b-9 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement C5b-9 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158235</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774760</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement CH100</VALIDVALUE>
          <VALUEMEANING>Complement CH100 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement required to lyse 100 percent of red blood cells in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147317</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement CH50</VALIDVALUE>
          <VALUEMEANING>CH50 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement Factor H</VALIDVALUE>
          <VALUEMEANING>Complement Factor H Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement factor H in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199918</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement Factor H-Related Protein 1</VALIDVALUE>
          <VALUEMEANING>Complement Factor H-Related Protein 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement factor H-related Protein 1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199919</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement Total</VALIDVALUE>
          <VALUEMEANING>Complement Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Connective Tissue Growth Factor</VALIDVALUE>
          <VALUEMEANING>Connective Tissue Growth Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of connective tissue growth factor in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Consistency</VALIDVALUE>
          <VALUEMEANING>Consistency</VALUEMEANING>
          <MEANINGDESCRIPTION>A description about the firmness, uniformity or make-up of an entity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95110</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Copeptin</VALIDVALUE>
          <VALUEMEANING>Copeptin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of copeptin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413429</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Copper</VALIDVALUE>
          <VALUEMEANING>Copper Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of copper present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corpuscular Hemoglobin Content</VALIDVALUE>
          <VALUEMEANING>Corpuscular Hemoglobin Content</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the mean red blood cell hemoglobin content within an individual red blood cell, calculated as the product of cell volume and cell hemoglobin concentration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139066</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium Oxalate Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Calcium Oxalate Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of calcium oxalate being excreted in a biological specimen over a defined amount of time (e.g. one hour).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187793</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium Phosphate Crystals</VALIDVALUE>
          <VALUEMEANING>Calcium Phosphate Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of calcium phosphate crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74671</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium Sulfate Crystals</VALIDVALUE>
          <VALUEMEANING>Calcium Sulfate Crystals Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of calcium sulphate crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124340</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406282</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium Sulphate</VALIDVALUE>
          <VALUEMEANING>Calcium Sulphate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of calcium sulphate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96590</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium</VALIDVALUE>
          <VALUEMEANING>Calcium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the calcium in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium, Ionized pH Adjusted</VALIDVALUE>
          <VALUEMEANING>Ionized pH Adjusted Calcium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ionized pH adjusted calcium present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125941</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium, Ionized</VALIDVALUE>
          <VALUEMEANING>Ionized Calcium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ionized calcium present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium/Creatinine</VALIDVALUE>
          <VALUEMEANING>Calcium to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of calcium compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium/Phosphorus</VALIDVALUE>
          <VALUEMEANING>Calcium to Phosphorus Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of calcium to phosphorus in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413739</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calprotectin</VALIDVALUE>
          <VALUEMEANING>Calprotectin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of calprotectin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82005</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3588761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cancer Antigen 1</VALIDVALUE>
          <VALUEMEANING>Cancer Antigen 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the cancer antigen 1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103361</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cancer Antigen 125</VALIDVALUE>
          <VALUEMEANING>CA-125 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cancer antigen 125 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cancer Antigen 15-3</VALIDVALUE>
          <VALUEMEANING>Cancer Antigen 15-3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the cancer antigen 15-3 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cancer Antigen 19-9</VALIDVALUE>
          <VALUEMEANING>Cancer Antigen 19-9 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cancer antigen 19-9 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81982</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cancer Antigen 242</VALIDVALUE>
          <VALUEMEANING>Cancer Antigen 242 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cancer antigen 242 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cancer Antigen 27-29</VALIDVALUE>
          <VALUEMEANING>Cancer Antigen 27-29 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cancer antigen 27-29 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cancer Antigen 50</VALIDVALUE>
          <VALUEMEANING>Cancer Antigen 50 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the cancer antigen 50 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187794</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cancer Antigen 72-4</VALIDVALUE>
          <VALUEMEANING>Cancer Antigen 72-4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the cancer antigen 72-4 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cannabinoid Metabolites</VALIDVALUE>
          <VALUEMEANING>Cannabinoid Metabolite Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of any cannabinoid drug class metabolite(s) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165946</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cannabinoids</VALIDVALUE>
          <VALUEMEANING>Cannabinoid Drug Class Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cannabinoid class agents present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74689</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407949</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cannabinoids, Synthetic</VALIDVALUE>
          <VALUEMEANING>Synthetic Cannabinoid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of synthetic cannabinoids present in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carb-Deficient Transferrin/Transferrin</VALIDVALUE>
          <VALUEMEANING>Carbohydrate-Deficient Transferrin to Transferrin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of carbohydrate-deficient transferrin to total transferrin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125943</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413447</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carbamazepine</VALIDVALUE>
          <VALUEMEANING>Carbamazepine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of carbamazepine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147322</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carbohydrate-Deficient Transferrin</VALIDVALUE>
          <VALUEMEANING>Carbohydrate-Deficient Transferrin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of transferrin with a reduced number of carbohydrate moieties present in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101016</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carbon Dioxide</VALIDVALUE>
          <VALUEMEANING>Carbon Dioxide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the carbon dioxide gas in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carbon Monoxide</VALIDVALUE>
          <VALUEMEANING>Carbon Monoxide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of carbon monoxide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139084</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carbonic Anhydrase 9</VALIDVALUE>
          <VALUEMEANING>Carbonic Anhydrase 9 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of carbonic anhydrase 9 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboxyhemoglobin</VALIDVALUE>
          <VALUEMEANING>Carboxyhemoglobin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of carboxyhemoglobin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96591</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboxyhemoglobin/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Carboxyhemoglobin to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of carboxyhemoglobin compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboxypeptidase B2</VALIDVALUE>
          <VALUEMEANING>Carboxypeptidase B2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of carboxypeptidase B2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165953</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoembryonic Antigen</VALIDVALUE>
          <VALUEMEANING>Carcinoembryonic Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of carcinoembryonic antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6142761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cariprazine</VALIDVALUE>
          <VALUEMEANING>Cariprazine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cariprazine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carisoprodol</VALIDVALUE>
          <VALUEMEANING>Carisoprodol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the carisoprodol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carnitine Acetyl Transferase</VALIDVALUE>
          <VALUEMEANING>Carnitine Acetyl Transferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of carnitine Acetyl transferase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carnitine Esters</VALIDVALUE>
          <VALUEMEANING>Carnitine Ester Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of carnitine ester present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147323</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carnitine Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Carnitine Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of carnitine being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carnitine</VALIDVALUE>
          <VALUEMEANING>Total Carnitine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total carnitine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carnitine, Free</VALIDVALUE>
          <VALUEMEANING>Free Carnitine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free carnitine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74677</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carotene</VALIDVALUE>
          <VALUEMEANING>Carotene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total carotenes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186034</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cartilage Oligomeric Matrix Protein</VALIDVALUE>
          <VALUEMEANING>Cartilage Oligomeric Matrix Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cartilage oligomeric matrix protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111145</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Casein</VALIDVALUE>
          <VALUEMEANING>Casein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of casein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Catecholamines</VALIDVALUE>
          <VALUEMEANING>Catecholamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total catecholamines present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186037</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cathepsin D</VALIDVALUE>
          <VALUEMEANING>Cathepsin D Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cathepsin D in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199917</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cathinone</VALIDVALUE>
          <VALUEMEANING>Cathinone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the cathinone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184534</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CEA Cell Adhesion Molecule 1</VALIDVALUE>
          <VALUEMEANING>CEA Cell Adhesion Molecule 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of CEA cell adhesion molecule 1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172511</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CEA Cell Adhesion Molecule 5</VALIDVALUE>
          <VALUEMEANING>CEA Cell Adhesion Molecule 5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of carcinoembryonic antigen (CEA) cell adhesion molecule 5 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cells</VALIDVALUE>
          <VALUEMEANING>Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure to determine the number of cells in a sample. Also used to mean the result of such a procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48938</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2915742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cellular Casts</VALIDVALUE>
          <VALUEMEANING>Cellular Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cellular casts present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cellularity</VALIDVALUE>
          <VALUEMEANING>Cellularity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of degree, quality or condition of cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111153</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ceruloplasmin</VALIDVALUE>
          <VALUEMEANING>Ceruloplasmin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ceruloplasmin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 1</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-C motif) ligand 1 (CCL1) in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091619</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 12</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 12 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-C Motif) ligand 12 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130156</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 13</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 13 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of CCL13, chemokine (C-C motif) ligand 13, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165947</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 15</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 15 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of CCL15, chemokine (C-C motif) ligand 15, in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199914</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 16</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 16 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of CCL16, chemokine (C-C motif) ligand 16, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 17</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 17 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-C Motif) ligand 17 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 18</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 18 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the CCL18, chemokine (C-C motif) ligand 18, in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 19</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 19 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-C Motif) ligand 19 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 2 Excr Rate</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 2 Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-C Motif) ligand 2 being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 20</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 20 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-C Motif) ligand 20 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 21</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 21 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-C motif) ligand 21 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 23</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 23 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the CCL23, chemokine (C-C motif) ligand 23, in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 25</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 25 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of CCL25, chemokine (C-C motif) ligand 25, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 7</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 7 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-C Motif) ligand 7 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130158</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402487</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-C Motif) Ligand 8</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-C Motif) Ligand 8 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of CCL8, chemokine (C-C motif) ligand 8, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Ligand 1</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-X-C Motif) Ligand 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-X-C motif) ligand 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128952</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Ligand 10</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-X-C Motif) Ligand 10 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-X-C Motif) ligand 10 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Ligand 11</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-X-C Motif) Ligand 11 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-X-C Motif) ligand 11 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Ligand 12</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-X-C Motif) Ligand 12 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of CXCL12, chemokine (C-X-C motif) ligand 12, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165954</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155521</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Ligand 13</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-X-C Motif) Ligand 13 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-X-C motif) ligand 13 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Ligand 2</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-X-C Motif) Ligand 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of CXCL2, chemokine (C-X-C motif) ligand 2, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186039</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Ligand 3</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-X-C Motif) Ligand 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-X-C motif) ligand 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Ligand 4</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-X-C Motif) Ligand 4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-X-C mofitf) ligand 4 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147330</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Ligand 6</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-X-C Motif) Ligand 6 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-X-C Motif) ligand 6 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Ligand 7</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-X-C Motif) Ligand 7 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pro-platelet basic protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165955</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155519</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Ligand 9</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-X-C Motif) Ligand 9 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of CXCL9, chemokine (C-X-C motif) ligand 9, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165956</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Receptor 3</VALIDVALUE>
          <VALUEMEANING>Chemokine Receptor CXCR3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine receptor CXCR3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X-C Motif) Receptor 4</VALIDVALUE>
          <VALUEMEANING>C-X-C Chemokine Receptor Type 4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the CXCR4, chemokine (C-X-C motif) receptor 4, in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159102</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemokine (C-X3-C Motif) Ligand 1</VALIDVALUE>
          <VALUEMEANING>Chemokine (C-X3-C Motif) Ligand 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chemokine (C-X3-C Motif) ligand 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161361</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chenodeoxycholate Compounds</VALIDVALUE>
          <VALUEMEANING>Chenodeoxycholate Compounds Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chenodeoxycholic acid, glycochenodeoxycholic acid, and taurochenodeoxycholic acid in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chenodeoxycholate</VALIDVALUE>
          <VALUEMEANING>Chenodeoxycholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chenodeoxycholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chitotriosidase</VALIDVALUE>
          <VALUEMEANING>Chitotriosidase-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the chitotriosidase-1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187795</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chloral Hydrate</VALIDVALUE>
          <VALUEMEANING>Chloral Hydrate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the chloral hydrate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chlordiazepoxide</VALIDVALUE>
          <VALUEMEANING>Chlordiazepoxide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chlordiazepoxide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75371</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chloride Clearance</VALIDVALUE>
          <VALUEMEANING>Chloride Clearance Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the chloride clearance in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chloride Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Chloride Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the amount of chloride being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA Class IA Antigen</VALIDVALUE>
          <VALUEMEANING>HLA Class IA Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA class IA histocompatibility antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154746</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA Class IB Antigen</VALIDVALUE>
          <VALUEMEANING>HLA Class IB Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA class IB histocompatibility antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA Class IC Antigen</VALIDVALUE>
          <VALUEMEANING>HLA Class IC Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA class IC histocompatibility antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619528</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VLDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>Very Low Density Lipoprotein Cholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of very low-density lipoprotein cholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VLDL Particle Size</VALIDVALUE>
          <VALUEMEANING>VLDL Particle Size Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the average particle size of very-low-density lipoprotein in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VLDL Trig + Chylomicron Trig</VALIDVALUE>
          <VALUEMEANING>VLDL Triglyceride and Chylomicron Triglyceride Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the VLDL triglyceride and chylomicron triglyceride in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VLDL Triglyceride</VALIDVALUE>
          <VALUEMEANING>VLDL Triglyceride Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the VLDL triglyceride in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174303</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Volume</VALIDVALUE>
          <VALUEMEANING>Volume Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the volume of a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>von Will Factor Act Actual/Control</VALIDVALUE>
          <VALUEMEANING>von Willebrand Factor Activity Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the biological activity of von Willebrand factor dependent coagulation in a subject&#39;s specimen when compared to the same activity in a control specimen. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147447</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>von Will Factor Actual/Control</VALIDVALUE>
          <VALUEMEANING>von Willebrand Factor Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the von Willebrand factor in a subject&#39;s specimen compared to a control sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170597</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>von Willebrand Factor Activity</VALIDVALUE>
          <VALUEMEANING>von Willebrand Factor Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the biological activity of von Willebrand factor in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122117</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>von Willebrand Factor Multimers</VALIDVALUE>
          <VALUEMEANING>von Willebrand Factor Multimers Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of von Willebrand factor multimers present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>von Willebrand Factor</VALIDVALUE>
          <VALUEMEANING>von Willebrand Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of von Willebrand factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98799</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vortioxetine</VALIDVALUE>
          <VALUEMEANING>Vortioxetine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the vortioxetine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Waxy Casts</VALIDVALUE>
          <VALUEMEANING>Waxy Cell Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of waxy cell casts present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WBC Casts</VALIDVALUE>
          <VALUEMEANING>White Blood Cell Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of white blood cell casts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74778</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WD Repeat-Containing Protein 26</VALIDVALUE>
          <VALUEMEANING>WD Repeat-Containing Protein 26 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of WD-repeat containing protein 26 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Whole Blood Equivalent Glucose</VALIDVALUE>
          <VALUEMEANING>Whole Blood Equivalent Glucose Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of whole blood equivalent glucose in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176296</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551755</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Xanthochromia</VALIDVALUE>
          <VALUEMEANING>Xanthochromia Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of xanthochromia present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Xylose</VALIDVALUE>
          <VALUEMEANING>Xylose Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of xylose present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Xylose/Xylose Dose</VALIDVALUE>
          <VALUEMEANING>Xylose to Xylose Dose Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (percentage) of the xylose in a biological specimen to an administered dose of xylose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186098</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yeast Budding</VALIDVALUE>
          <VALUEMEANING>Budding Yeast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>Examination of a biological specimen to detect the presence of any yeast cells that are in the budding phase of asexual reproduction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-Hydroxytriazolam</VALIDVALUE>
          <VALUEMEANING>Alpha-Hydroxytriazolam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-hydroxytriazolam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181418</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-Methylacyl Coenzyme A Racemase</VALIDVALUE>
          <VALUEMEANING>Alpha-Methylacyl Coenzyme A Racemase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-methylacyl coenzyme A racemase in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132364</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-Methylfentanyl</VALIDVALUE>
          <VALUEMEANING>Alpha-Methylfentanyl Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the alpha-methylfentanyl in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184537</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-Methylphenethylamine</VALIDVALUE>
          <VALUEMEANING>Amphetamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amphetamine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7255356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-N-acetylglucosaminidase</VALIDVALUE>
          <VALUEMEANING>Alpha-N-acetylglucosaminidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-N-acetylglucosaminidase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147299</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-Smooth Muscle Actin</VALIDVALUE>
          <VALUEMEANING>Alpha-Smooth Muscle Actin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-smooth muscle actin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alphaprodine</VALIDVALUE>
          <VALUEMEANING>Alphaprodine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the alphaprodine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184567</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alprazolam</VALIDVALUE>
          <VALUEMEANING>Alprazolam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alprazolam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ALT/AST</VALIDVALUE>
          <VALUEMEANING>Alanine Aminotransferase to Aspartate Aminotransferase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of alanine aminotransferase (ALT) compared to aspartate aminotransferase (AST) present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412446</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aluminum</VALIDVALUE>
          <VALUEMEANING>Aluminum Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of aluminum present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111127</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AM-2201</VALIDVALUE>
          <VALUEMEANING>AM-2201 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the AM-2201 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184539</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AM694 N-5-hydroxypentyl</VALIDVALUE>
          <VALUEMEANING>AM694 N-5-hydroxypentyl Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the synthetic cannabinoid metabolite AM694 N-5-hydroxypentyl in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184538</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AMACR mRNA</VALIDVALUE>
          <VALUEMEANING>Alpha-Methylacyl Coenzyme A Racemase mRNA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-methylacyl coenzyme A racemase mRNA in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132365</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amino Acids</VALIDVALUE>
          <VALUEMEANING>Amino Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The measurement of the amount of amino acids in a biologic specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amitriptyline</VALIDVALUE>
          <VALUEMEANING>Amitriptyline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amitriptyline present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186023</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8160969</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ammonia</VALIDVALUE>
          <VALUEMEANING>Ammonia Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ammonia present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74799</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ammonium Biurate Crystals</VALIDVALUE>
          <VALUEMEANING>Ammonium Biurate Crystals Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ammonium biurate crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105590</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ammonium</VALIDVALUE>
          <VALUEMEANING>Ammonium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ammonium ion (NH4+) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186024</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8160967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ammonium/Creatinine</VALIDVALUE>
          <VALUEMEANING>Ammonium to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio) of ammonium to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8160965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amobarbital</VALIDVALUE>
          <VALUEMEANING>Amobarbital Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amobarbital present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406116</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amorphous Crystals</VALIDVALUE>
          <VALUEMEANING>Amorphous Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amorphous crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amorphous Phosphate Crystals</VALIDVALUE>
          <VALUEMEANING>Amorphous Phosphate Crystals Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amorphous phosphate crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92243</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amorphous Sediment</VALIDVALUE>
          <VALUEMEANING>Amorphous Sediment Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amorphous sediment present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amorphous Urate Crystals</VALIDVALUE>
          <VALUEMEANING>Amorphous Urate Crystals Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amorphous urate crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amphetamine</VALIDVALUE>
          <VALUEMEANING>Amphetamine Drug Class Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amphetamine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amphiregulin</VALIDVALUE>
          <VALUEMEANING>Amphiregulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amphiregulin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199888</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amylase</VALIDVALUE>
          <VALUEMEANING>Amylase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of amylase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amylase, Pancreatic</VALIDVALUE>
          <VALUEMEANING>Pancreatic Amylase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pancreatic amylase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404345</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA Cw Antigen</VALIDVALUE>
          <VALUEMEANING>HLA Cw Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA Cw antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DP Alpha1 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DP Alpha1 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA DP Alpha 1 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DP Beta Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DP Beta Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA DP beta antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DP Beta1 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DP Beta1 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA DP beta1 histocompatibility antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DQ Alpha1 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DQ Alpha1 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA DQ Alpha 1 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798079</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DQ Beta1 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DQ Beta1 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA DQ beta1 histocompatibility antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DQ2 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DQ2 Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA DQ2 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186061</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DQ8 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DQ8 Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA DQ8 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186062</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DR Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DR Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA-DR protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DR Beta Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DR Beta Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the total HLA DR beta antigen in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DR Beta1 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DR Beta1 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA DR beta1 histocompatibility antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154749</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DR Beta2 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DR Beta 2 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA DR Beta 2 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DR Beta3 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DR Beta 3 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA DR Beta 3 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DR Beta4 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DR Beta 4 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA DR Beta 4 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798085</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA DR Beta5 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA DR Beta 5 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA DR Beta 5 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181414</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798083</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA Mismatch Count</VALIDVALUE>
          <VALUEMEANING>HLA Mismatch Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the total number of mismatches between the study subject and his or her donor for the human leukocyte antigens (HLA).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA-A Antigen Type</VALIDVALUE>
          <VALUEMEANING>HLA-A Antigen Type</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of human leukocyte antigen, class I, group A (HLA-A), present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128955</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA-A Mismatch Count</VALIDVALUE>
          <VALUEMEANING>HLA-A Mismatch Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of mismatch between the study subject and his or her donor for the human leukocyte antigen, class I, group A (HLA-A).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128956</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA-B Antigen Type</VALIDVALUE>
          <VALUEMEANING>HLA-B Antigen Type</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of human leukocyte antigen, class I, group B (HLA-B), present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128957</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA-B Mismatch Count</VALIDVALUE>
          <VALUEMEANING>HLA-B Mismatch Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of mismatch between the study subject and his or her donor for the human leukocyte antigen, class I, group B (HLA-B).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128958</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA-B27 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA-B27 Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA-B27 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100460</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA-DR Antigen Type</VALIDVALUE>
          <VALUEMEANING>HLA-DR Antigen Type</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of human leukocyte antigen, class II, antigen-D-related (HLA-DR), present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA-DR Mismatch Count</VALIDVALUE>
          <VALUEMEANING>HLA-DR Mismatch Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of mismatch between the study subject and his or her donor for the human leukocyte antigen, class II, antigen-D-related (HLA-DR).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128963</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA-DR51 Antigen Type</VALIDVALUE>
          <VALUEMEANING>HLA-DR51 Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The identification of the type of human leukocyte antigen, class II, antigen-D-related 51 (HLA-DR51), in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA-DR52 Antigen Type</VALIDVALUE>
          <VALUEMEANING>HLA-DR52 Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The identification of the type of human leukocyte antigen, class II, antigen-D-related 52 (HLA-DR52), in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189511</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA-DR53 Antigen Type</VALIDVALUE>
          <VALUEMEANING>HLA-DR53 Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The identification of the type of human leukocyte antigen, class II, antigen-D-related 53 (HLA-DR53), in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Homocitrulline</VALIDVALUE>
          <VALUEMEANING>Homocitrulline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of homocitrulline present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Homocysteine</VALIDVALUE>
          <VALUEMEANING>Homocysteine Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the homocysteine amino acid in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Homovanillic Acid</VALIDVALUE>
          <VALUEMEANING>Homovanillic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of homovanillic acid metabolite present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74863</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Howell-Jolly Bodies</VALIDVALUE>
          <VALUEMEANING>Howell-Jolly Body Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of Howell-Jolly bodies present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Human Epidermal Growth Factor Receptor 2</VALIDVALUE>
          <VALUEMEANING>Human Epidermal Growth Factor Receptor 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of human epidermal growth factor receptor 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112312</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4577520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Human Epididymis Protein 4</VALIDVALUE>
          <VALUEMEANING>Human Epididymis Protein 4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of human epididymis protein 4 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Huntingtin Protein</VALIDVALUE>
          <VALUEMEANING>Huntingtin Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of huntingtin protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Huntingtin Protein, Mutant</VALIDVALUE>
          <VALUEMEANING>Mutant Huntingtin Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mutant huntingtin protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Huntingtin Protein, Wild Type</VALIDVALUE>
          <VALUEMEANING>Wild Type Huntingtin Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of wild type huntingtin protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyaline Casts</VALIDVALUE>
          <VALUEMEANING>Hyaline Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hyaline casts present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyalogranular Casts</VALIDVALUE>
          <VALUEMEANING>Hyalogranular Casts</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the hyalogranular casts in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174305</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyaluronic Acid</VALIDVALUE>
          <VALUEMEANING>Hyaluronic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hyaluronic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112319</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amylase, Salivary</VALIDVALUE>
          <VALUEMEANING>Salivary Amylase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of salivary amylase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amyloid A</VALIDVALUE>
          <VALUEMEANING>Amyloid A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amyloid A present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125940</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amyloid Alpha Precursor Protein</VALIDVALUE>
          <VALUEMEANING>Amyloid Alpha Precursor Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the amyloid alpha precursor protein in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amyloid Beta 1-38</VALIDVALUE>
          <VALUEMEANING>Amyloid Beta 1-38 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amyloid beta protein which is composed of peptides 1 to 38 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amyloid Beta 1-40</VALIDVALUE>
          <VALUEMEANING>Amyloid Beta 1-40 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amyloid beta protein which is composed of peptides 1 to 40 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amyloid Beta 1-41</VALIDVALUE>
          <VALUEMEANING>Amyloid Beta 1-41 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amyloid beta protein which is composed of peptides 1 to 41 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184518</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amyloid Beta 1-42</VALIDVALUE>
          <VALUEMEANING>Beta Amyloid 42 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the 1-42 amino acid beta amyloid protein isoform present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amyloid Beta 1-42/Amyloid Beta 1-40</VALIDVALUE>
          <VALUEMEANING>Amyloid Beta 1-42 to Amyloid Beta 1-40 Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the amyloid beta 1-42 to amyloid beta 1-40 in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199923</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amyloid Beta Precursor Protein</VALIDVALUE>
          <VALUEMEANING>Amyloid Beta Precursor Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amyloid beta precursor protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amyloid P</VALIDVALUE>
          <VALUEMEANING>Amyloid P Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amyloid P present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amyloid, Beta</VALIDVALUE>
          <VALUEMEANING>Beta Amyloid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the total amyloid beta in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81999</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anabasine</VALIDVALUE>
          <VALUEMEANING>Anabasine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of anabasine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Androstenediol</VALIDVALUE>
          <VALUEMEANING>Androstenediol Metabolite Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of androstenediol metabolite present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74842</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Androstenedione</VALIDVALUE>
          <VALUEMEANING>Androstenedione Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of androstenedione hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74843</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Androsterone</VALIDVALUE>
          <VALUEMEANING>Androsterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of androsterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186026</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161417</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angiopoietin 1</VALIDVALUE>
          <VALUEMEANING>Angiopoietin 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of angiopoietin 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111128</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402910</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angiopoietin 2</VALIDVALUE>
          <VALUEMEANING>Angiopoietin 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of angiopoietin 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angiopoietin-Related Protein 4</VALIDVALUE>
          <VALUEMEANING>Angiopoietin-Related Protein 4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of angiopoietin-related protein 4 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199911</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angiotensin Converting Enzyme</VALIDVALUE>
          <VALUEMEANING>Angiotensin Converting Enzyme Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of angiotensin converting enzyme present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80169</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HDL Cholesterol/LDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>HDL Cholesterol to LDL Cholesterol Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of HDL cholesterol compared to LDL cholesterol present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HDL Cholesterol/Total Cholesterol</VALIDVALUE>
          <VALUEMEANING>HDL Cholesterol to Total Cholesterol Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of HDL cholesterol compared to total cholesterol present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HDL Particle Size</VALIDVALUE>
          <VALUEMEANING>HDL Particle Size Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the average particle size of high-density lipoprotein in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HDL Phospholipid</VALIDVALUE>
          <VALUEMEANING>HDL Phospholipid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of high-density lipoprotein phospholipid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619424</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HDL-Cholesterol Subclass 2</VALIDVALUE>
          <VALUEMEANING>HDL-Cholesterol Subclass 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HDL-cholesterol subclass 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HDL-Cholesterol Subclass 3</VALIDVALUE>
          <VALUEMEANING>HDL-Cholesterol Subclass 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heat Shock Protein 70</VALIDVALUE>
          <VALUEMEANING>Heat Shock Protein 70 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of heat shock protein 70 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147368</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heat Shock Protein 90 Alpha</VALIDVALUE>
          <VALUEMEANING>Heat Shock Protein 90 Alpha Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of heat shock protein 90 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413832</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hect Domain and RLD 5</VALIDVALUE>
          <VALUEMEANING>Hect Domain and RLD 5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Hect domain and RLD 5 protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154028</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heinz Bodies</VALIDVALUE>
          <VALUEMEANING>Heinz-Ehrlich Body Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Heinz bodies (denatured hemoglobin) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74709</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402830</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heinz Bodies/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Heinz Body to Erythrocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the erythrocytes that contain heinz bodies compared to total erythrocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Helicase MOV-10 Protein</VALIDVALUE>
          <VALUEMEANING>Helicase MOV-10 Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of helicase MOV-10 protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Helmet Cells</VALIDVALUE>
          <VALUEMEANING>Helmet Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of helmet cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematocrit Corrected Reticulocytes</VALIDVALUE>
          <VALUEMEANING>Hematocrit Corrected Reticulocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hematocrit corrected reticulocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematocrit</VALIDVALUE>
          <VALUEMEANING>Hematocrit</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of the volume of red blood cells expressed as a percentage of the total blood volume. Normal in males is 43-49%, in females 37-43%.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin A</VALIDVALUE>
          <VALUEMEANING>Hemoglobin A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin A present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92258</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402820</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin A/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin A to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of Hemoglobin A compared to total Hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin A1/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin A1 to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hemoglobin A1 compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin A1A</VALIDVALUE>
          <VALUEMEANING>Hemoglobin A1A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin A1A present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin A1B</VALIDVALUE>
          <VALUEMEANING>Hemoglobin A1B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin A1B present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163451</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin A1C</VALIDVALUE>
          <VALUEMEANING>Glycosylated Hemoglobin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of glycosylated hemoglobin present in a sample of blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64849</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3729988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin A1C/Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin A1C to Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the glycosylated hemoglobin compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin A2 Prime/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin A2 Prime to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hemoglobin A2 prime compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin A2</VALIDVALUE>
          <VALUEMEANING>Hemoglobin A2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin A2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92259</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402774</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin A2/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin A2 to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of Hemoglobin A2 compared to total Hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydrocodone</VALIDVALUE>
          <VALUEMEANING>Hydrocodone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hydrocodone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74879</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydrogen</VALIDVALUE>
          <VALUEMEANING>Hydrogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hydrogen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydrogen+Methane</VALIDVALUE>
          <VALUEMEANING>Hydrogen and Methane Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hydrogen and methane present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydromorphone</VALIDVALUE>
          <VALUEMEANING>Hydromorphone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hydromorphone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74880</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydroxyalprazolam</VALIDVALUE>
          <VALUEMEANING>Hydroxyalprazolam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hydroxyprazolam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydroxyethylflurazepam</VALIDVALUE>
          <VALUEMEANING>Hydroxyethylflurazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hydroxyethylflurazepam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydroxylysine</VALIDVALUE>
          <VALUEMEANING>Hydroxylysine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hydroxylysine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydroxyproline</VALIDVALUE>
          <VALUEMEANING>Hydroxyproline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hydroxyproline present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyocholate</VALIDVALUE>
          <VALUEMEANING>Hyocholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hyocholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551747</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperchromia</VALIDVALUE>
          <VALUEMEANING>Hyperchromia Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the prevalence of erthrocytes with an elevated hemoglobin concentration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperchromic Erythrocytes/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Hyperchromic Erythrocytes to Erythrocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hyperchromic erythrocytes compared to total erythrocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypersegmented Cells</VALIDVALUE>
          <VALUEMEANING>Hypersegmented Neutrophil Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of hypersegmented neutrophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypochromia</VALIDVALUE>
          <VALUEMEANING>Hypochromia</VALUEMEANING>
          <MEANINGDESCRIPTION>An anemic condition which results from a lack hemoglobin within erythrocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64802</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypochromic Erythrocytes/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Hypochromic Erythrocytes to Erythrocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hypochromic erythrocytes compared to total erythrocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypogranular Neutrophils</VALIDVALUE>
          <VALUEMEANING>Hypogranular Neutrophil Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hypogranular neutrophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116201</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypoxanthine-Guanine PRT</VALIDVALUE>
          <VALUEMEANING>Hypoxanthine-Guanine Phosphoribosyltransferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the hypoxanthine-guanine phosphoribosyltransferase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Icteric Index</VALIDVALUE>
          <VALUEMEANING>Icteric Index</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of yellow color of a biological specimen, due to the presence of bile pigments.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IDL Apolipoprotein B</VALIDVALUE>
          <VALUEMEANING>IDL Apolipoprotein B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the apolipoprotein B in the intermediate density lipoprotein fraction of a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>Intermediate Density Lipoprotein Cholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of intermediate density lipoprotein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112325</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IDL Cholesterol/LDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>IDL Cholesterol to LDL Cholesterol Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the amount of intermediate density lipoprotein cholesterol compared to low density lipoprotein cholesterol present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187810</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IDL Particles</VALIDVALUE>
          <VALUEMEANING>IDL Particles Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of intermediate density lipoprotein particles present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IDL Triglyceride</VALIDVALUE>
          <VALUEMEANING>IDL Triglyceride Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of intermediate density lipoprotein triglyceride in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IDL+VLDL Cholesterol Subtype 3</VALIDVALUE>
          <VALUEMEANING>IDL Cholesterol and VLDL Cholesterol Subtype 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of IDL cholesterol and VLDLD cholesterol subtype 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147371</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413828</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IgG Clearance</VALIDVALUE>
          <VALUEMEANING>IgG Clearance</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the clearance of endogenous IgG, used for evaluating the glomerular filtration rate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147373</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IgG Clearance/Albumin Clearance</VALIDVALUE>
          <VALUEMEANING>IgG Clearance to Albumin Clearance Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of IgG clearance compared to albumin clearance present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147374</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IgG IgM IgA Total</VALIDVALUE>
          <VALUEMEANING>IgG IgM IgA Total Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the total amount of IgG, IgM, and IgA present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IgG Synthesis Rate</VALIDVALUE>
          <VALUEMEANING>IgG Synthesis Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the IgG synthesis rate in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iloperidone</VALIDVALUE>
          <VALUEMEANING>Iloperidone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of iloperidone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177984</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Imipramine</VALIDVALUE>
          <VALUEMEANING>Imipramine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of imipramine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Basophils</VALIDVALUE>
          <VALUEMEANING>Immature Basophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immature basophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Basophils/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Immature Basophil to Leukocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immature basophils compared to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96671</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6410960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Cells</VALIDVALUE>
          <VALUEMEANING>Immature Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immature cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96672</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6410961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Immature Cell to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio or percentage) of the immature hematopoietic cells to total cells in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404417</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Eosinophils</VALIDVALUE>
          <VALUEMEANING>Immature Eosinophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immature eosinophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96673</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6410963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Eosinophils/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Immature Eosinophil to Leukocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immature eosinophils compared to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96674</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6410965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Granulocytes</VALIDVALUE>
          <VALUEMEANING>Immature Granulocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immature granulocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96675</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Granulocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Immature Granulocytes to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immature granulocytes compared to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Leukocytes</VALIDVALUE>
          <VALUEMEANING>Immature Leukocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of immature leukocytes in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphorylated STAT3/STAT3</VALIDVALUE>
          <VALUEMEANING>Phosphorylated STAT3 to STAT3 Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of phosphorylated STAT3 compared to STAT3 present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphorylated Tau Prot/Amyloid Beta1-42</VALIDVALUE>
          <VALUEMEANING>Phosphorylated Tau Protein to Amyloid Beta1-42 Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of phosphorylated Tau protein compared to amyloid beta 1-42 present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176312</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphorylated Tau Protein 181</VALIDVALUE>
          <VALUEMEANING>Phosphorylated Tau Protein 181 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the phosphorylated Tau protein 181 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphorylated Tau Protein 212</VALIDVALUE>
          <VALUEMEANING>Phosphorylated Tau Protein 212 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Tau protein where threonine 212 is phosphorylated in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphorylated Tau Protein 217</VALIDVALUE>
          <VALUEMEANING>Phosphorylated Tau Protein 217 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Tau protein where threonine 217 is phosphorylated in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphorylated Tau Protein 231</VALIDVALUE>
          <VALUEMEANING>Phosphorylated Tau Protein 231 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>he determination of the amount of Tau protein where threonine 231 is phosphorylated in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphorylated Tau Protein</VALIDVALUE>
          <VALUEMEANING>Phosphorylated Tau Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phosphorylated Tau protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84812</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pi-GST Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Pi-GST Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the amount of pi glutathione-s-transferase being excreted over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pigment Casts</VALIDVALUE>
          <VALUEMEANING>Pigment Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pigment casts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189518</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491803</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin B</VALIDVALUE>
          <VALUEMEANING>Hemoglobin B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin B present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin Barts/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin Barts to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hemoglobin Barts compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin C Crystals</VALIDVALUE>
          <VALUEMEANING>Hemoglobin C Crystals Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin c crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin C</VALIDVALUE>
          <VALUEMEANING>Hemoglobin C Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin C present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin C/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin C to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of Hemoglobin C compared to total Hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin Casts</VALIDVALUE>
          <VALUEMEANING>Hemoglobin Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin casts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156515</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin D/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin D to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hemoglobin D compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147364</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin Distribution Width</VALIDVALUE>
          <VALUEMEANING>Hemoglobin Distribution Width Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the distribution of the hemoglobin concentration in red blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin E/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin E to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hemoglobin E compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147365</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin F</VALIDVALUE>
          <VALUEMEANING>Hemoglobin F Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin F present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin F/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin F to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hemoglobin F compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin Fraction Pattern</VALIDVALUE>
          <VALUEMEANING>Hemoglobin Fraction Pattern</VALUEMEANING>
          <MEANINGDESCRIPTION>A description of the hemoglobin fraction pattern in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin G Coushatta/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin G Coushatta to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hemoglobin G compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin H Inclusion Bodies</VALIDVALUE>
          <VALUEMEANING>Hemoglobin H Inclusion Bodies Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin H inclusion bodies present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin Lepore/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin Lepore to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hemoglobin Lepore compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147357</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin O-Arab/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin O-Arab to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hemoglobin O-Arab compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147358</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin S</VALIDVALUE>
          <VALUEMEANING>Hemoglobin S Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin S present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122123</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin S/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin S to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of Hemoglobin S compared to total Hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin Tetramer</VALIDVALUE>
          <VALUEMEANING>Hemoglobin Tetramer Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin tetramer in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin Variants</VALIDVALUE>
          <VALUEMEANING>Hemoglobin Variant Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A test to measure the variants of hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103845</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159083</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of hemoglobin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64848</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yeast Hyphae</VALIDVALUE>
          <VALUEMEANING>Yeast Hyphae Screening</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the yeast hyphae present in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>YKL-40 Protein</VALIDVALUE>
          <VALUEMEANING>YKL-40 Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of YKL-40 protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zaleplon</VALIDVALUE>
          <VALUEMEANING>Zaleplon Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the zaleplon in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zinc Protoporphyrin</VALIDVALUE>
          <VALUEMEANING>Zinc Protoporphyrin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of zinc protoporphyrin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zinc</VALIDVALUE>
          <VALUEMEANING>Zinc Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of zinc present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3654489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ziprasidone</VALIDVALUE>
          <VALUEMEANING>Ziprasidone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ziprasidone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zolpidem</VALIDVALUE>
          <VALUEMEANING>Zolpidem Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the zolpidem in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zopiclone</VALIDVALUE>
          <VALUEMEANING>Zopiclone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the zopiclone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxytocin</VALIDVALUE>
          <VALUEMEANING>Oxytocin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oxytocin hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74869</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver Specific Alkaline Phosphatase</VALIDVALUE>
          <VALUEMEANING>Liver Specific Alkaline Phosphatase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the liver specific alkaline phosphatase in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yeast Cells</VALIDVALUE>
          <VALUEMEANING>Yeast Cell Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of yeast cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74664</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angiotensin I</VALIDVALUE>
          <VALUEMEANING>Angiotensin I Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of angiotensin I hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angiotensin II</VALIDVALUE>
          <VALUEMEANING>Angiotensin II Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of angiotensin II hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74845</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angiotensinogen</VALIDVALUE>
          <VALUEMEANING>Angiotensinogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of angiotensinogen hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anileridine</VALIDVALUE>
          <VALUEMEANING>Anileridine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the anileridine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184568</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anion Gap 3</VALIDVALUE>
          <VALUEMEANING>Anion Gap 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of unmeasured anions (computed as sodium minus the chloride and bicarbonate) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147303</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403949</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anion Gap 4</VALIDVALUE>
          <VALUEMEANING>Anion Gap 4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of unmeasured anions (computed as the difference between the sum of serum sodium and serum potassium, and the sum of the serum bicarbonate and chloride) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anion Gap</VALIDVALUE>
          <VALUEMEANING>Anion Gap Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the unmeasured anions (those other than the chloride and bicarbonate anions) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anisochromia</VALIDVALUE>
          <VALUEMEANING>Anisochromia Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the color variation of erythrocytes in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anisocytes</VALIDVALUE>
          <VALUEMEANING>Anisocyte Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of anisocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-Double Stranded DNA IgG</VALIDVALUE>
          <VALUEMEANING>Anti-Double Stranded DNA IgG Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of anti-double stranded DNA IgG antibodies present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154769</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-Factor Xa Activity</VALIDVALUE>
          <VALUEMEANING>Anti-Factor Xa Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of anti-activated Factor X present in a sample. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98706</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-Mullerian Hormone</VALIDVALUE>
          <VALUEMEANING>Anti-Mullerian Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the anti-Mullerian hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-Single Stranded DNA IgG</VALIDVALUE>
          <VALUEMEANING>Anti-Single Stranded DNA IgG Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of anti-single stranded DNA IgG present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411554</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pimozide</VALIDVALUE>
          <VALUEMEANING>Pimozide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pimozide in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pipradrol</VALIDVALUE>
          <VALUEMEANING>Pipradrol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the pipradrol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Placental Growth Factor</VALIDVALUE>
          <VALUEMEANING>Placental Growth Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of placental growth factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163482</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Placental Specific Alkaline Phosphatase</VALIDVALUE>
          <VALUEMEANING>Placental Specific Alkaline Phosphatase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the placental specific alkaline phosphatase isoform in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasma Equivalent Glucose Distribution</VALIDVALUE>
          <VALUEMEANING>Plasma Equivalent Glucose Distribution Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of plasma equivalent glucose distribution present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163447</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasma Equivalent Glucose</VALIDVALUE>
          <VALUEMEANING>Plasma Equivalent Glucose Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of plasma equivalent glucose present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153969</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasmacytoid Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Plasmacytoid Lymphocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of plasmacytoid lymphocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74618</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasmacytoid Lymphocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Plasmacytoid Lymphocytes to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of plasmacytoid lymphocytes compared to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasmacytoid Lymphocytes/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Plasmacytoid Lymphocyte to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of plasmacytoid lymphocytes compared to all lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasmin Alpha-2 Antiplasmin Complex</VALIDVALUE>
          <VALUEMEANING>Plasmin Alpha-2 Antiplasmin Complex Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of plasmin alpha-2 antiplasmin complex in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasminogen Activator Inhibitor-1 AG</VALIDVALUE>
          <VALUEMEANING>Plasminogen Activator Inhibitor-1 Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of plasminogen activator inhibitor-1 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81989</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasminogen Activator Inhibitor-1</VALIDVALUE>
          <VALUEMEANING>Plasminogen Activator Inhibitor-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of plasminogen activator inhibitor-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasminogen</VALIDVALUE>
          <VALUEMEANING>Plasminogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of plasminogen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Activating Factor</VALIDVALUE>
          <VALUEMEANING>Platelet Activating Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of platelet activating factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Aggregation Amplitude</VALIDVALUE>
          <VALUEMEANING>Platelet Aggregation Amplitude Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount or magnitude of the platelet aggregation present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Aggregation Curve Type</VALIDVALUE>
          <VALUEMEANING>Platelet Aggregometry Curve Type</VALUEMEANING>
          <MEANINGDESCRIPTION>The classification of the curve pattern that is formed as a result of platelet aggregation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Aggregation Mean Amplitude</VALIDVALUE>
          <VALUEMEANING>Platelet Aggregometry Mean Amplitude</VALUEMEANING>
          <MEANINGDESCRIPTION>An average of the measurements of the magnitude of the platelet aggregation in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412619</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Aggregation Mean Curve Type</VALIDVALUE>
          <VALUEMEANING>Platelet Aggregometry Mean Curve Type</VALUEMEANING>
          <MEANINGDESCRIPTION>The average curve type resulting from platelet aggregometry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Aggregation</VALIDVALUE>
          <VALUEMEANING>Platelet Aggregation Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the association of platelets to one another via adhesion molecules in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Clumps</VALIDVALUE>
          <VALUEMEANING>Platelet Clumps Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of platelet clumps present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96624</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Component Distribution Width</VALIDVALUE>
          <VALUEMEANING>Platelet Component Distribution Width Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of platelet shape changes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Derived Growth Factor IsoformAA</VALIDVALUE>
          <VALUEMEANING>Platelet Derived Growth Factor Isoform AA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of platelet derived growth factor isoform AA present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Derived Growth Factor IsoformAB</VALIDVALUE>
          <VALUEMEANING>Platelet Derived Growth Factor Isoform AB Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of platelet-derived growth factor isoform AB present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Derived Growth Factor IsoformBB</VALIDVALUE>
          <VALUEMEANING>Platelet Derived Growth Factor IsoformBB Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of platelet derived growth factor isoform BB in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199893</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Distribution Width</VALIDVALUE>
          <VALUEMEANING>Platelet Distribution Width</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the range of platelet sizes in a blood specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Endothelial Adhesion Molecule 1</VALIDVALUE>
          <VALUEMEANING>Platelet Endothelial Cell Adhesion Molecule 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of platelet endothelial cell adhesion molecule 1 in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6422574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Function Closure Time</VALIDVALUE>
          <VALUEMEANING>Platelet Function Closure Time Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the collagen closure time, as a surrogate of platelet function, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Hematocrit</VALIDVALUE>
          <VALUEMEANING>Platelet Hematocrit Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of platelet hematocrit present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Mass Distribution Width</VALIDVALUE>
          <VALUEMEANING>Platelet Mass Distribution Width</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the variation defined by two standard deviations of the platelet dry mass distribution in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Morphology</VALIDVALUE>
          <VALUEMEANING>Platelet Morphology Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>An examination or assessment of the form and structure of platelets.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111296</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet Satellitism</VALIDVALUE>
          <VALUEMEANING>Platelet Satellitism Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the presence of platelet satellitism in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelet-Granulocyte Agg</VALIDVALUE>
          <VALUEMEANING>Platelet-Granulocyte Aggregate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of aggregates composed of platelets and granulocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165978</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelets</VALIDVALUE>
          <VALUEMEANING>Platelet Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of platelets in a blood sample, usually expressed as platelets per cubic millimeter (cmm) of whole blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelets, Agranular</VALIDVALUE>
          <VALUEMEANING>Agranular Platelets Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of agranular platelets present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403253</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelets, Estimated</VALIDVALUE>
          <VALUEMEANING>Estimated Platelets Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The estimated amount of platelets in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poikilocytes</VALIDVALUE>
          <VALUEMEANING>Poikilocyte Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of poikilocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79602</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poikilocytes/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Poikilocyte to Erythrocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of poikilocytes compared to all erythrocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polychromasia</VALIDVALUE>
          <VALUEMEANING>Polychromasia</VALUEMEANING>
          <MEANINGDESCRIPTION>The reaction of red cells to stain as indicated by the appearance of bluish or grayish colored erythrocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64803</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polychromatophilic Erythroblast</VALIDVALUE>
          <VALUEMEANING>Polychromatophilic Erythroblast Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of polychromatophilic erythroblasts present in a sample from an experimental organism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147418</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polychromatophilic Normoblast</VALIDVALUE>
          <VALUEMEANING>Polychromatophilic Normoblast Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of polychromatophilic normoblasts present in a sample from an experimental organism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403259</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Porphobilinogen</VALIDVALUE>
          <VALUEMEANING>Porphobilinogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of porphobilinogen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156539</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619983</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Porphobilinogen/Creatinine</VALIDVALUE>
          <VALUEMEANING>Porphobilinogen to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of porphobilinogen compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156540</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Porphyrin</VALIDVALUE>
          <VALUEMEANING>Porphyrin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the porphyrin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Potassium Clearance</VALIDVALUE>
          <VALUEMEANING>Potassium Clearance Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the potassium clearance in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Potassium Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Potassium Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the amount of potassium being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150820</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Potassium</VALIDVALUE>
          <VALUEMEANING>Potassium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the potassium in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antidepressants</VALIDVALUE>
          <VALUEMEANING>Antidepressant Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of antidepressant class drug present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413669</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antidiuretic Hormone</VALIDVALUE>
          <VALUEMEANING>Antidiuretic Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of antidiuretic hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74847</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antiglobulin Test, Direct</VALIDVALUE>
          <VALUEMEANING>Direct Antiglobulin Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the antibody or complement-coated erythrocytes in a blood specimen in vivo.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antiglobulin Test, Indirect</VALIDVALUE>
          <VALUEMEANING>Indirect Antiglobulin Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A test that uses Coombs&#39; reagent to detect the presence of anti-erythrocyte antibodies in serum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402770</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antileukoproteinase</VALIDVALUE>
          <VALUEMEANING>Antileukoproteinase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of antileukoproteinase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199912</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antithrombin Activity Actual/Control</VALIDVALUE>
          <VALUEMEANING>Antithrombin Activity Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the biological activity of antithrombin in a subject&#39;s specimen when compared to the same activity in a control specimen. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antithrombin Activity</VALIDVALUE>
          <VALUEMEANING>Antithrombin Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of antithrombin activity in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81958</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antithrombin Actual/Control</VALIDVALUE>
          <VALUEMEANING>Antithrombin Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the antithrombin in a subject&#39;s specimen compared to a control sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170592</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7255354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antithrombin Antigen</VALIDVALUE>
          <VALUEMEANING>Antithrombin Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of antithrombin antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81977</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein A</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apolipoprotein A present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124337</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein A/Apolipoprotein B</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein A to Apolipoprotein B Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of apolipoprotein A compared to apolipoprotein B present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein A1</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein A1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apolipoprotein A1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74733</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein A1/Apolipoprotein B</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein A1 to Apolipoprotein B Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of apolipoprotein A1 compared to apolipoprotein B present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403230</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein A4</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein A4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the apolipoprotein A4 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein A5</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein A5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the apolipoprotein A5 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein AII</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein AII Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apolipoprotein AII present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6199728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein B</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apolipoprotein B present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74734</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein B/Apolipoprotein A1</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein B to Apolipoprotein A1 Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the Apolipoprotein B compared with Apolipoprotein A1 in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein B100</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein B100 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the apolipoprotein B100 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120628</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein B48</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein B48 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the apolipoprotein B48 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein C2</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein C2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apolipoprotein C2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein CI</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein CI Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the apolipoprotein CI present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120630</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein CIII</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein CIII Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apolipoprotein CIII present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82001</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein D</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein D Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apolipoprotein D present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433544</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein E</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein E Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apolipoprotein E present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein E4</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein E4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apolipoprotein E4 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein H</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein H Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apolipoprotein H present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82003</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein J</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein J Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apolipoprotein J present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolipoprotein J/Creatinine</VALIDVALUE>
          <VALUEMEANING>Apolipoprotein J to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the apolipoprotein J compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aprobarbital</VALIDVALUE>
          <VALUEMEANING>Aprobarbital Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the aprobarbital in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184578</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APTT-LA Actual/Control</VALIDVALUE>
          <VALUEMEANING>APTT-LA Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the Lupus anticoagulant sensitive APTT in a subject&#39;s specimen compared to a control sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin, Free</VALIDVALUE>
          <VALUEMEANING>Free Hemoglobin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free hemoglobin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127617</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemolytic Index</VALIDVALUE>
          <VALUEMEANING>Hemolytic Index</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of destruction of red blood cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemosiderin</VALIDVALUE>
          <VALUEMEANING>Hemosiderin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemosiderin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96659</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heparin Binding EGF Like Growth Factor</VALIDVALUE>
          <VALUEMEANING>Heparin Binding EGF Like Growth Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of heparin binding EGF like growth factor in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199892</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heparin</VALIDVALUE>
          <VALUEMEANING>Heparin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of heparin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatocyte Growth Factor Receptor</VALIDVALUE>
          <VALUEMEANING>Hepatocyte Growth Factor Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hepatocyte growth factor receptor in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatocyte Growth Factor Receptor, Free</VALIDVALUE>
          <VALUEMEANING>Free Hepatocyte Growth Factor Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free hepatocyte growth factor receptor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatocyte Growth Factor</VALIDVALUE>
          <VALUEMEANING>Hepatocyte Growth Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hepatocyte growth factor in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135426</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepcidin</VALIDVALUE>
          <VALUEMEANING>Hepcidin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the hepcidin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepsin</VALIDVALUE>
          <VALUEMEANING>Hepsin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hepsin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199897</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heterophils</VALIDVALUE>
          <VALUEMEANING>Heterophil Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of heterophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116186</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heterophils/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Heterophils to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of heterophils compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hexokinase</VALIDVALUE>
          <VALUEMEANING>Hexokinase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hexokinase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hexosaminidase A</VALIDVALUE>
          <VALUEMEANING>Hexosaminidase A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hexosaminidase A present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High Absorption Retic/Reticulocytes</VALIDVALUE>
          <VALUEMEANING>High Absorption Reticulocytes to Total Reticulocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of high absorption reticulocytes compared to total reticulocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High Absorption Reticulocytes</VALIDVALUE>
          <VALUEMEANING>High Absorption Reticulocyte Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of high absorption reticulocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Potassium/Creatinine</VALIDVALUE>
          <VALUEMEANING>Potassium to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of potassium compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79462</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412581</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PP Arterial O2/Fraction Inspired O2</VALIDVALUE>
          <VALUEMEANING>Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the pressure of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prazepam</VALIDVALUE>
          <VALUEMEANING>Prazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prazepam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139080</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prealbumin</VALIDVALUE>
          <VALUEMEANING>Prealbumin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prealbumin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100435</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Precursor Plasma Cells</VALIDVALUE>
          <VALUEMEANING>Precursor Plasma Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of precursor plasma cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402832</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Precursor Plasma Cells/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Precursor Plasma Cell to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of precursor plasma cells compared to all lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pregabalin</VALIDVALUE>
          <VALUEMEANING>Pregabalin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the pregabalin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pregnancy-Associated Plasma Protein-A</VALIDVALUE>
          <VALUEMEANING>Pregnancy-Associated Plasma Protein-A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pregnancy-associated plasma protein-A present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82031</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pregnanediol</VALIDVALUE>
          <VALUEMEANING>Pregnanediol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pregnanediol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pregnenolone</VALIDVALUE>
          <VALUEMEANING>Pregnenolone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pregnenolone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pro-C6</VALIDVALUE>
          <VALUEMEANING>Pro-C6 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pro-C6 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165979</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pro-gastrin Releasing Peptide</VALIDVALUE>
          <VALUEMEANING>Pro-gastrin Releasing Peptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pro-gastrin releasing peptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ProB-type Natriuretic Peptide</VALIDVALUE>
          <VALUEMEANING>ProB-Type Natriuretic Peptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of proB-type natriuretic peptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82032</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Procalcitonin</VALIDVALUE>
          <VALUEMEANING>Procalcitonin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the procalcitonin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prochlorperazine</VALIDVALUE>
          <VALUEMEANING>Prochlorperazine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prochlorperazine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Procollagen 1 N-Terminal Propeptide</VALIDVALUE>
          <VALUEMEANING>Procollagen 1 N-Terminal Propeptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of procollagen 1 N-terminal propeptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Procollagen 3 N-Terminal Propeptide</VALIDVALUE>
          <VALUEMEANING>Procollagen 3 N-Terminal Propeptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of procollagen 3 N-terminal propeptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Procollagen Type I Carboxy Term Peptide</VALIDVALUE>
          <VALUEMEANING>Procollagen Type I Carboxy Terminal Peptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of procollagen type I carboxy terminal peptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82033</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409028</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Progesterone Receptor</VALIDVALUE>
          <VALUEMEANING>Progesterone Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of progesterone receptor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401947</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Progesterone</VALIDVALUE>
          <VALUEMEANING>Progesterone, Serum/Plasma</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of progesterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3091441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Progranulin</VALIDVALUE>
          <VALUEMEANING>Progranulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of progranulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165964</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Proinsulin</VALIDVALUE>
          <VALUEMEANING>Proinsulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of proinsulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406149</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Proinsulin/Insulin Ratio</VALIDVALUE>
          <VALUEMEANING>Proinsulin to Insulin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the proinsulin compared to insulin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111299</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prolactin</VALIDVALUE>
          <VALUEMEANING>Prolactin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prolactin hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Proliferating Cell Nuclear Antigen</VALIDVALUE>
          <VALUEMEANING>Proliferating Cell Nuclear Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the proliferating cell nuclear antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Proliferating Erythroid/Total Cells</VALIDVALUE>
          <VALUEMEANING>Proliferating Erythroid Cell to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of proliferating erythroid cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Proliferating Myeloid Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Proliferating Myeloid Cell to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of proliferating myeloid cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Proline Aminopeptidase</VALIDVALUE>
          <VALUEMEANING>Proline Aminopeptidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of proline aminopeptidase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Proline</VALIDVALUE>
          <VALUEMEANING>Proline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of proline present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prolymphocytes</VALIDVALUE>
          <VALUEMEANING>Prolymphocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of prolymphocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74620</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407582</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prolymphocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Prolymphocyte to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of prolymphocytes compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64829</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prolymphocytes/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Prolymphocyte to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of prolymphocytes compared to all lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74651</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409049</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Promonocytes</VALIDVALUE>
          <VALUEMEANING>Promonocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the promonocytes in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74621</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Promonocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Promonocyte to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of promonocytes compared to all lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74652</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Promonocytes/Total Cells</VALIDVALUE>
          <VALUEMEANING>Promonocyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the promonocytes to total cells in a biological specimen (for example a bone marrow specimen).The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187678</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Promyeloblasts</VALIDVALUE>
          <VALUEMEANING>Promyeloblasts Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of promyeloblasts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117847</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Promyelocytes</VALIDVALUE>
          <VALUEMEANING>Promyelocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of promyelocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Promyelocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Promyelocyte to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of promyelocytes compared to all lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74653</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Promyelocytes/Total Cells</VALIDVALUE>
          <VALUEMEANING>Promyelocyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of promyelocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98773</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Propoxyphene</VALIDVALUE>
          <VALUEMEANING>Propoxyphene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of propoxyphene present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74885</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408230</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Proprotein Convertase Subtilisin/Kexin 9</VALIDVALUE>
          <VALUEMEANING>Proprotein Convertase Subtilisin/Kexin Type 9 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the proprotein convertase subtilisin/kexin type 9 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120647</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prorubricyte</VALIDVALUE>
          <VALUEMEANING>Prorubricyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prorubricytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128976</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prorubricyte/Total Cells</VALIDVALUE>
          <VALUEMEANING>Prorubricyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the prorubricytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128977</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostaglandin D2 Receptor 2</VALIDVALUE>
          <VALUEMEANING>Prostaglandin D2 Receptor 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prostaglandin D2 receptor 2 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189515</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostaglandin D2 Synthase</VALIDVALUE>
          <VALUEMEANING>Prostaglandin D2 Synthase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the prostaglandin D2 synthase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostaglandin D2</VALIDVALUE>
          <VALUEMEANING>Prostaglandin D2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the prostaglandin D2 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostaglandin E Synthase</VALIDVALUE>
          <VALUEMEANING>Prostaglandin E Synthase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the prostaglandin E synthase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hippuric Acid Crystals</VALIDVALUE>
          <VALUEMEANING>Hippuric Acid Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hippuric acid crystals present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Histamine</VALIDVALUE>
          <VALUEMEANING>Histamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of histamine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Histidine</VALIDVALUE>
          <VALUEMEANING>Histidine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of histidine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122124</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA A03 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA A03 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA A03 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA A2 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA A2 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA A2 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA A24 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA A24 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA A24 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLA A3 Antigen</VALIDVALUE>
          <VALUEMEANING>HLA A3 Histocompatibility Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HLA A3 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181443</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Leukocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Immature Leukocyte to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immature leukocytes compared to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Immature Lymphocytes Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immature lymphocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Lymphocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Immature Lymphocytes to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immature lymphocytes compared to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100443</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Monocytes</VALIDVALUE>
          <VALUEMEANING>Immature Monocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immature monocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96676</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6410951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Monocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Immature Monocyte to Leukocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immature monocytes compared to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96677</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Neutrophils</VALIDVALUE>
          <VALUEMEANING>Immature Neutrophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immature neutrophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96678</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6410953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Neutrophils/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Immature Neutrophils to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immature neutrophils compared to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Plasma Cells</VALIDVALUE>
          <VALUEMEANING>Immature Plasma Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immature plasma cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96679</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6410955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Plasma Cells/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Immature Plasma Cell to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immature plasma cells compared to total lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Plasma Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Immature Plasma Cells to Total Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immature plasma cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Platelets</VALIDVALUE>
          <VALUEMEANING>Immature Platelet Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immature platelets present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154723</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Platelets/Total Platelets</VALIDVALUE>
          <VALUEMEANING>Immature Platelets to Total Platelets Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immature platelets compared to total platelets present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170580</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature Reticulocyte Fraction</VALIDVALUE>
          <VALUEMEANING>Immature Reticulocyte Fraction Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immature reticulocytes to total reticulocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoblasts</VALIDVALUE>
          <VALUEMEANING>Immunoblast Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the immunoblasts in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoblasts/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Immunoblasts to Lymphocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immunoblasts compared to all lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin A</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin A present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6142756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin A/Complement C3</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin A to Complement C3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio) of the immunoglobulin A to complement C3 in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184515</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin D</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin D Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin D present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin E</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin E Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin E present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405733</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin E, Free</VALIDVALUE>
          <VALUEMEANING>Free Immunoglobulin E Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free Immunoglobulin E in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin G Subclass 1</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin G Subclass 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin G subclass 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122127</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin G Subclass 2</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin G Subclass 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin G subclass 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122128</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipoarabinomannan</VALIDVALUE>
          <VALUEMEANING>Lipoarabinomannan Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lipoarabinomannan present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125947</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipocalin-2</VALIDVALUE>
          <VALUEMEANING>Lipocalin-2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lipocalin-2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106539</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipocalin-2/Creatinine</VALIDVALUE>
          <VALUEMEANING>Lipocalin-2 to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of lipocalin-2 compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106540</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipoprotein Associated Phospholipase A2</VALIDVALUE>
          <VALUEMEANING>Lipoprotein Associated Phospholipase A2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the lipoprotein associated phospholipase A2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipoprotein Lipase</VALIDVALUE>
          <VALUEMEANING>Lipoprotein Lipase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lipoprotein lipase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463321</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipoprotein-a</VALIDVALUE>
          <VALUEMEANING>Lipoprotein a Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lipoprotein a present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82022</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liquefaction Time</VALIDVALUE>
          <VALUEMEANING>Liquefaction Time Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the time it takes for a gelatinous or semi-solid substance to change to a liquid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142284</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lithium</VALIDVALUE>
          <VALUEMEANING>Lithium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lithium in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lithocholate Compounds</VALIDVALUE>
          <VALUEMEANING>Lithocholate Compounds Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lithocholic acid, glycolithocholic acid, and taurolithocholic acid in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lithocholate</VALIDVALUE>
          <VALUEMEANING>Lithocholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lithocholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176307</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551733</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver Fibrosis Score</VALIDVALUE>
          <VALUEMEANING>Liver Fibrosis Score</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the liver pathology through the assessment of multiple blood test parameters, taking into account the age and gender of the patient.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Loprazolam</VALIDVALUE>
          <VALUEMEANING>Loprazolam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the loprazolam in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184621</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010663</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lorazepam</VALIDVALUE>
          <VALUEMEANING>Lorazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lorazepam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75374</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lormetazepam</VALIDVALUE>
          <VALUEMEANING>Lormetazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the lormetazepam in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low Absorption Retic/Reticulocytes</VALIDVALUE>
          <VALUEMEANING>Low Absorption Reticulocytes to Total Reticulocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of low absorption reticulocytes compared to total reticulocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116191</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404425</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low Absorption Reticulocytes</VALIDVALUE>
          <VALUEMEANING>Low Absorption Reticulocyte Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of low absorption reticulocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostaglandin E1</VALIDVALUE>
          <VALUEMEANING>Prostaglandin E1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the prostaglandin E1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostaglandin E2</VALIDVALUE>
          <VALUEMEANING>Prostaglandin E2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the prostaglandin E2 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103435</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostaglandin F1 Alpha</VALIDVALUE>
          <VALUEMEANING>Prostaglandin F1 Alpha Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the prostaglandin F1 alpha in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostaglandin F2 Alpha</VALIDVALUE>
          <VALUEMEANING>Prostaglandin F2 Alpha Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the prostaglandin F2 alpha in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103437</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostaglandin</VALIDVALUE>
          <VALUEMEANING>Prostaglandin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the total prostaglandin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostanozol</VALIDVALUE>
          <VALUEMEANING>Prostanozol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the prostanozol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184598</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate Cancer Antigen 3 mRNA</VALIDVALUE>
          <VALUEMEANING>Prostate Cancer Antigen 3 mRNA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prostate cancer antigen 3 mRNA in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6035478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate Circulating Tumor Cells</VALIDVALUE>
          <VALUEMEANING>Circulating Prostate Tumor Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of circulating prostate tumor cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate Specific Antigen mRNA</VALIDVALUE>
          <VALUEMEANING>Prostate Specific Antigen mRNA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prostate specific antigen mRNA in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate Specific Antigen</VALIDVALUE>
          <VALUEMEANING>Prostate Specific Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the prostate specific antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate Specific Antigen, Free</VALIDVALUE>
          <VALUEMEANING>Free Prostate Specific Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free prostate specific antigen in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostatic Acid Phosphatase</VALIDVALUE>
          <VALUEMEANING>Prostatic Acid Phosphatase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prostatic acid phosphatase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Protein Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the amount of total protein being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150822</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein Induced by Vitamin K Absence-II</VALIDVALUE>
          <VALUEMEANING>Protein Induced by Vitamin K Absence-II Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the protein induced by vitamin K absence-II in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein Pattern</VALIDVALUE>
          <VALUEMEANING>Protein Pattern Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>An assessment of the protein band pattern present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein S Activity Actual/Control</VALIDVALUE>
          <VALUEMEANING>Protein S Activity Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the biological activity of protein S in a subject&#39;s specimen when compared to the same activity in a control specimen. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407722</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein S Actual/Control</VALIDVALUE>
          <VALUEMEANING>Protein S Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the protein S in a subject&#39;s specimen compared to a control sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170593</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein S Free Activity Actual/Control</VALIDVALUE>
          <VALUEMEANING>Free Protein S Activity Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the biological activity of free protein S in a subject&#39;s specimen when compared to the same activity in a control specimen. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein S</VALIDVALUE>
          <VALUEMEANING>Protein S Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of protein S present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein S, Free Actual/Control</VALIDVALUE>
          <VALUEMEANING>Free Protein S Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the free protein S in a subject&#39;s specimen compared to a control sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170596</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein S, Free</VALIDVALUE>
          <VALUEMEANING>Free Protein S Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of unbound protein S in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein</VALIDVALUE>
          <VALUEMEANING>Total Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the total protein in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64858</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4897692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein/Creatinine</VALIDVALUE>
          <VALUEMEANING>Protein to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of total protein compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79463</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412582</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein/Osmolality</VALIDVALUE>
          <VALUEMEANING>Protein to Osmolality Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of total protein compared to the osmolality a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prothrombin Activity</VALIDVALUE>
          <VALUEMEANING>Prothrombin Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the biological activity of prothrombin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98774</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prothrombin Fragment 1</VALIDVALUE>
          <VALUEMEANING>Prothrombin Fragment 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prothrombin fragment 1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491799</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prothrombin Fragment 2</VALIDVALUE>
          <VALUEMEANING>Prothrombin Fragment 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prothrombin fragment 2 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prothrombin Fragments 1 + 2</VALIDVALUE>
          <VALUEMEANING>Prothrombin Fragments 1 and 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prothrombin fragments 1 and 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82034</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prothrombin Intl. Normalized Ratio</VALIDVALUE>
          <VALUEMEANING>International Normalized Ratio of Prothrombin Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64805</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prothrombin Time Actual/Control</VALIDVALUE>
          <VALUEMEANING>Prothrombin Time Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the prothrombin time in a subject&#39;s specimen compared to a control sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170591</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prothrombin Time</VALIDVALUE>
          <VALUEMEANING>Prothrombin Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62656</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833108</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protoporphyrin, Free</VALIDVALUE>
          <VALUEMEANING>Free Protoporphyrin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free protoporphyrin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147341</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protriptyline</VALIDVALUE>
          <VALUEMEANING>Protriptyline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of protriptyline present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191287</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prprot Cnvrtase Subtilisin-Kexin 9, Free</VALIDVALUE>
          <VALUEMEANING>Free Proprotein Convertase Subtilisin/Kexin Type 9 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free proprotein convertase subtilisin/kexin type 9 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186091</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PSA, Free/PSA</VALIDVALUE>
          <VALUEMEANING>Free PSA to Total PSA Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of free prostate specific antigen as compared to the total prostate specific antigen present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pseudo Pelger-Huet Neutrophils</VALIDVALUE>
          <VALUEMEANING>Pseudo Pelger-Huet Neutrophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the neutrophils with a Pelger-Huet-like nucleus (hyposegmented) in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187823</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159127</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pseudo-Eosinophils</VALIDVALUE>
          <VALUEMEANING>Pseudo-Eosinophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pseudo-eosinophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165958</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tissue Inhibitor of Metalloproteinase 3</VALIDVALUE>
          <VALUEMEANING>Tissue Inhibitor of Metalloproteinase 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tissue inhibitor of metalloproteinase 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165988</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tissue Plasminogen Activator Antigen</VALIDVALUE>
          <VALUEMEANING>Tissue Plasminogen Activator Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tissue plasminogen activator antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407998</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tissue Polypeptide Antigen</VALIDVALUE>
          <VALUEMEANING>Tissue Polypeptide Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tissue polypeptide antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TNF Receptor 1B</VALIDVALUE>
          <VALUEMEANING>TNF Receptor 1B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tumor necrosis factor receptor superfamily member 1B present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TNF Receptor Superfamily Member 10c</VALIDVALUE>
          <VALUEMEANING>Tumor Necrosis Factor Receptor Superfamily Member 10c Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of TNF receptor superfamily member 10c present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433554</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TNF Superfamily Member 10</VALIDVALUE>
          <VALUEMEANING>TNF Superfamily Member 10 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total tumor necrosis factor superfamily member 10 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165989</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TNF Superfamily Member 12 Excretion Rate</VALIDVALUE>
          <VALUEMEANING>TNF Superfamily Member 12 Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of TNF superfamily member 12 being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TNF Superfamily Member 12</VALIDVALUE>
          <VALUEMEANING>TNF Superfamily Member 12 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total tumor necrosis factor superfamily member 12 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Loxapine</VALIDVALUE>
          <VALUEMEANING>Loxapine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of loxapine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177977</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637376</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lupus Anticoagulant Sensitive APTT</VALIDVALUE>
          <VALUEMEANING>Lupus Anticoagulant Sensitive APTT Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of time that it takes for clotting to occur when a lupus sensitive reagent is added to a plasma specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lurasidone</VALIDVALUE>
          <VALUEMEANING>Lurasidone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lurasidone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177963</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Luteinizing Hormone</VALIDVALUE>
          <VALUEMEANING>Luteinizing Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of luteinizing hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3293685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoblasts</VALIDVALUE>
          <VALUEMEANING>Lymphoblast Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lymphoblasts (immature cells that differentiate to form lymphocytes) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoblasts/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Lymphoblast to Leukocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of lymphoblasts compared to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoblasts/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Lymphoblast to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the lymphoblasts to lymphocytes in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphocyte Antigen 6E</VALIDVALUE>
          <VALUEMEANING>Lymphocyte Antigen 6E Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lymphocyte antigen 6E present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163463</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphocytes Activated</VALIDVALUE>
          <VALUEMEANING>Activated Lymphocytes Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of activated lymphocytes in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphocytes Atypical</VALIDVALUE>
          <VALUEMEANING>Atypical Lymphocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of atypical lymphocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64818</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukocytes/Total Cells</VALIDVALUE>
          <VALUEMEANING>Leukocytes to Total Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of leukocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135451</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukotriene B4</VALIDVALUE>
          <VALUEMEANING>Leukotriene B4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the leukotriene B4 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukotriene C4 Synthase</VALIDVALUE>
          <VALUEMEANING>Leukotriene C4 Synthase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of leukotriene C4 synthase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491801</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukotriene D4</VALIDVALUE>
          <VALUEMEANING>Leukotriene D4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the leukotriene D4 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103414</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukotriene E4</VALIDVALUE>
          <VALUEMEANING>Leukotriene E4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the leukotriene E4 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leuks Corrected for Nucl Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Leukocytes Corrected for Nucleated Erythrocytes Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of leukocytes, which has been corrected for nucleated erythrocytes, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413824</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Levetiracetam</VALIDVALUE>
          <VALUEMEANING>Levetiracetam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of levetiracetam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Levorphanol</VALIDVALUE>
          <VALUEMEANING>Levorphanol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the levorphanol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184572</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipase</VALIDVALUE>
          <VALUEMEANING>Lipase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lipase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6384461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipase, Gastric</VALIDVALUE>
          <VALUEMEANING>Gastric Lipase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of gastric lipase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117840</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipase, Hepatic</VALIDVALUE>
          <VALUEMEANING>Hepatic Triacylglycerol Lipase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the hepatic triacylglycerol lipase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187808</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipase, Lysosomal Acid</VALIDVALUE>
          <VALUEMEANING>Lysosomal Acid Lipase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lysosomal acid lipase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117842</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipase, Pancreatic</VALIDVALUE>
          <VALUEMEANING>Pancreatic Lipase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pancreatic lipase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117841</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipemic Index</VALIDVALUE>
          <VALUEMEANING>Lipemic Index</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of abnormally high concentration of lipid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipid</VALIDVALUE>
          <VALUEMEANING>Lipid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of lipids (cholesterol, lipoproteins, and triglycerides) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3729572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphocytes Atypical/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Atypical Lymphocyte to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of atypical lymphocytes to leukocytes in a blood sample. The measurement may be expressed as either a ratio or a percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64819</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Lymphocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of lymphocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphocytes, Clefted</VALIDVALUE>
          <VALUEMEANING>Clefted Lymphocytes Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cryofibrinogen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphocytes, Clefted/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Clefted Lymphocytes to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of clefted lymphocytes compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Lymphocyte to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of lymphocytes compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64820</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406268</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphocytes/Neutrophils</VALIDVALUE>
          <VALUEMEANING>Lymphocyte to Neutrophil Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio) of lymphocytes to neutrophils present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186079</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphocytes/Non-Squam Epi Cells</VALIDVALUE>
          <VALUEMEANING>Lymphocytes to Non-Squamous Epithelial Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of lymphocytes compared to non-squamous epithelial cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arachidonate 5-Lipoxygenase</VALIDVALUE>
          <VALUEMEANING>Arachidonate 5-Lipoxygenase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the arachidonate 5-lipoxygenase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arachidonic Acid</VALIDVALUE>
          <VALUEMEANING>Arachidonic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of arachidonic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102259</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arginine</VALIDVALUE>
          <VALUEMEANING>Arginine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of arginine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122095</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Argininosuccinic Acid</VALIDVALUE>
          <VALUEMEANING>Argininosuccinic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of argininosuccinic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aripiprazole</VALIDVALUE>
          <VALUEMEANING>Aripiprazole Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of aripiprazole in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arsenic</VALIDVALUE>
          <VALUEMEANING>Arsenic Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of arsenic present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147305</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407810</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asenapine</VALIDVALUE>
          <VALUEMEANING>Asenapine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of asenapine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asparagine</VALIDVALUE>
          <VALUEMEANING>Asparagine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of asparagine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aspartate Aminotransferase Antigen</VALIDVALUE>
          <VALUEMEANING>Aspartate Aminotransferase Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of aspartate aminotransferase antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81978</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aspartate Aminotransferase Isoenzyme C</VALIDVALUE>
          <VALUEMEANING>Aspartate Aminotransferase Isoenzyme C Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of aspartate aminotransferase isoenzyme C present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14537236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aspartate Aminotransferase Isoenzyme M</VALIDVALUE>
          <VALUEMEANING>Aspartate Aminotransferase Isoenzyme M Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of aspartate aminotransferase isoenzyme M present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14537237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aspartate Aminotransferase</VALIDVALUE>
          <VALUEMEANING>Aspartate Aminotransferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of aspartate aminotransferase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aspartate Aminotransferase/Creatinine</VALIDVALUE>
          <VALUEMEANING>Aspartate Aminotransferase to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of aspartate aminotransferase compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117830</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aspartic Acid</VALIDVALUE>
          <VALUEMEANING>Aspartic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of aspartic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AST to Platelet Ratio Index</VALIDVALUE>
          <VALUEMEANING>Aspartate Aminotransferase to Platelet Ratio Index</VALUEMEANING>
          <MEANINGDESCRIPTION>A calculation that indicates the likely presence of liver cirrhosis and fibrosis, measured as the relative measurement of aspartate aminotransferase (AST) to AST upper limit of normal, divided by the platelet count, and multiplied by 100.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AST/ALT</VALIDVALUE>
          <VALUEMEANING>Aspartate Aminotransferase to Alanine Aminotransferase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of aspartate aminotransferase (AST) compared to alanine aminotransferase (ALT) present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176297</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TNF-a Production Inhibition</VALIDVALUE>
          <VALUEMEANING>TNF-a Production Inhibitory Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of TNF-alpha production inhibitory activity present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tomoregulin-2</VALIDVALUE>
          <VALUEMEANING>Tomoregulin-2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the tomoregulin-2 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187827</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Total Amyloid Precursor Protein</VALIDVALUE>
          <VALUEMEANING>Total Amyloid Precursor Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the total amyloid precursor protein in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Total Iron Binding Capacity</VALIDVALUE>
          <VALUEMEANING>Total Iron Binding Capacity</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the saturation of iron binding sites on serum transferrin proteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3654514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Total Plasma Cells</VALIDVALUE>
          <VALUEMEANING>Plasma Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of plasma cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Total Plasma Cells/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Plasma Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the plasma cells compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Total Plasma Cells/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Plasma Cell to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the total plasma cells to lymphocytes in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Total Plasma Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Plasma Cell to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the total plasma cells to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Total Radical-Trap Antioxidant Potential</VALIDVALUE>
          <VALUEMEANING>Total Radical-Trap Antioxidant Potential Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the potential for the antioxidants contained in a biological specimen to buffer free radicals in a solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Toxic Granulation</VALIDVALUE>
          <VALUEMEANING>Toxic Granulation Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the toxic granulation in neutrophilic blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Toxic Vacuolation</VALIDVALUE>
          <VALUEMEANING>Toxic Vacuolation Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>An evaluation of the presence or degree of toxic vacuolation present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TPR-Ankyrin Repeat-Containing Protein 1</VALIDVALUE>
          <VALUEMEANING>TPR-Ankyrin Repeat-containing Protein 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of TPR-ankyrin repeat-containing protein 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154841</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tramadol</VALIDVALUE>
          <VALUEMEANING>Tramadol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tramadol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transferrin Receptor Protein 1</VALIDVALUE>
          <VALUEMEANING>Transferrin Receptor Protein 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of transferrin receptor protein 1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199909</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transferrin Saturation</VALIDVALUE>
          <VALUEMEANING>Transferrin Saturation Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the iron bound to transferrin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98792</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transferrin</VALIDVALUE>
          <VALUEMEANING>Transferrin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of transferrin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82037</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transforming Growth Factor Alpha</VALIDVALUE>
          <VALUEMEANING>Transforming Growth Factor Alpha Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of transforming growth factor alpha present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transforming Growth Factor Beta 1</VALIDVALUE>
          <VALUEMEANING>Transforming Growth Factor Beta 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of transforming growth factor Beta 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117861</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transforming Growth Factor Beta 2</VALIDVALUE>
          <VALUEMEANING>Transforming Growth Factor Beta 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of transforming growth factor beta 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transforming Growth Factor Beta 3</VALIDVALUE>
          <VALUEMEANING>Transforming Growth Factor Beta 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of transforming growth factor beta 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transforming Growth Factor Beta</VALIDVALUE>
          <VALUEMEANING>Transforming Growth Factor Beta Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total transforming growth factor beta in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413387</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transitional Epithelial Cells</VALIDVALUE>
          <VALUEMEANING>Transitional Epithelial Cells Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of transitional epithelial cells present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Translocase Inner Mitochondrial Membr 10</VALIDVALUE>
          <VALUEMEANING>Translocase Inner Mitochondrial Membrane 10 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of translocase inner mitochondrial membrane 10 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trazodone</VALIDVALUE>
          <VALUEMEANING>Trazodone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the trazodone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trefoil Factor 3</VALIDVALUE>
          <VALUEMEANING>Trefoil Factor 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of trefoil factor 3 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199896</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trenbolone</VALIDVALUE>
          <VALUEMEANING>Trenbolone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the trenbolone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184605</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Triazolam</VALIDVALUE>
          <VALUEMEANING>Triazolam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of triazolam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181451</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trichomonas</VALIDVALUE>
          <VALUEMEANING>Trichomonas Screening</VALUEMEANING>
          <MEANINGDESCRIPTION>Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tricyclic Antidepressants</VALIDVALUE>
          <VALUEMEANING>Tricyclic Antidepressant Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tricyclic antidepressants present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trifluoperazine</VALIDVALUE>
          <VALUEMEANING>Trifluoperazine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of trifluoperazine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177982</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637388</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AST/Creatine Kinase</VALIDVALUE>
          <VALUEMEANING>Aspartate Aminotransferase to Creatine Kinase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of aspartate aminotransferase compared to creatine kinase present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774778</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asymmetric Dimethylarginine</VALIDVALUE>
          <VALUEMEANING>Asymmetric Dimethylarginine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of asymmetric dimethylarginine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774764</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atherogenic Index of Plasma</VALIDVALUE>
          <VALUEMEANING>Atherogenic Index of Plasma</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the base 10 logarithm of the ratio of molar concentration of plasma triglyceride to high density lipoprotein cholesterol present in a sample</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atrial Natriuretic Peptide</VALIDVALUE>
          <VALUEMEANING>Atrial Natriuretic Peptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of atrial-natriuretic peptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74886</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atypical Lymphocytes/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Reactive Lymphocyte to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of reactive lymphocytes compared to all lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409033</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Auer Rods</VALIDVALUE>
          <VALUEMEANING>Auer Rod Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of Auer rods present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74657</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AXL Receptor Tyrosine Kinase</VALIDVALUE>
          <VALUEMEANING>AXL Receptor Tyrosine Kinase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of AXL receptor tyrosine kinase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165943</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Azurophilic Granules</VALIDVALUE>
          <VALUEMEANING>Azurophilic Granule Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of azurophilic granules present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B-Cell Activating Factor</VALIDVALUE>
          <VALUEMEANING>B-Cell Activating Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of B-cell activating factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111135</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B-lymphocyte Crossmatch</VALIDVALUE>
          <VALUEMEANING>B-lymphocyte Crossmatch Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the HLA histocompatibility between the donor and the study subject by examining the presence or absence of the subject&#39;s anti-HLA antibody reactivity towards HLA antigens expressed on the donor B-lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B-Lymphocytes</VALIDVALUE>
          <VALUEMEANING>B-Lymphocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the B-lymphocyte count in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B-Lymphocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>B-Lymphocyte to Leukocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the B-lymphocyte to leukocyte ratio in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B-Lymphocytes/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>B-Lymphocyte to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the B-lymphocyte to lymphocyte ratio in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B-Lymphocytes/Total Cells</VALIDVALUE>
          <VALUEMEANING>B-Lymphocyte to Total Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the B-lymphocyte to total cells ratio in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174317</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bacteria</VALIDVALUE>
          <VALUEMEANING>Bacterial Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The quantitative determination of bacterial populations. The two most widely used methods for determining bacterial numbers are: 1) the standard, or viable, plate count method and 2) spectrophotometric (turbidimetric) analysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bacterial Casts</VALIDVALUE>
          <VALUEMEANING>Bacterial Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of bacterial casts present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74762</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Barbital</VALIDVALUE>
          <VALUEMEANING>Barbital Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the barbital in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Barbiturates</VALIDVALUE>
          <VALUEMEANING>Barbiturate Drug Class Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of barbiturate class agents present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407996</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Base Deficit</VALIDVALUE>
          <VALUEMEANING>Base Deficit</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alkali required to return a biological specimen to a normal pH under standard conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Base Excess</VALIDVALUE>
          <VALUEMEANING>Base Excess Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the base excess in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basophilic Erythroblast</VALIDVALUE>
          <VALUEMEANING>Basophilic Erythroblast Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of basophilic erythroblasts present in a sample from an experimental organism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basophilic Metamyelocytes</VALIDVALUE>
          <VALUEMEANING>Basophilic Metamyelocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of basophilic metamyelocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APTT-LA Screen to Confirm Pct Difference</VALIDVALUE>
          <VALUEMEANING>APTT-LA Screen to Confirm Percent Difference</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement to confirm the presence of Lupus anticoagulants, calculated as [(Screen aPTT - Confirm aPTT)/Screen aPTT]x100.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basophilic Myelocytes</VALIDVALUE>
          <VALUEMEANING>Basophilic Myelocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of basophilic myelocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404429</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basophilic Myelocytes/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Basophilic Myelocytes to Lymphocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of basophilic myelocytes compared to lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181448</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basophilic Normoblast</VALIDVALUE>
          <VALUEMEANING>Basophilic Normoblast Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of basophilic normoblasts present in a sample from an experimental organism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basophilic Stippling</VALIDVALUE>
          <VALUEMEANING>Basophilic Stippling Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of basophilic stippling present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96567</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basophils Band Form</VALIDVALUE>
          <VALUEMEANING>Basophil Band Form Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of band basophils in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130154</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basophils Band Form/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Basophil Band Form to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of band basophils compared to leukocytes in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407521</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basophils</VALIDVALUE>
          <VALUEMEANING>Total Basophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the absolute number of basophils in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basophils, Segmented</VALIDVALUE>
          <VALUEMEANING>Segmented Basophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of segmented basophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin G Subclass 3</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin G Subclass 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin G subclass 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin G Subclass 4</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin G Subclass 4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin G subclass 4 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405956</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin G</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin G Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin G present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6142754</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin G/Albumin</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin G to Albumin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of IgG compared to albumin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin G/Creatinine</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin G to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of immunoglobulin G to creatinine in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119285</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin Heavy Constant Gamma 2</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin Heavy Constant Gamma 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin heavy constant gamma 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin Heavy Constant Gamma 4</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin Heavy Constant Gamma 4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin heavy constant gamma 4 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154738</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin Light Chains</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin Light Chain Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin light chain present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin Light Chains, Free</VALIDVALUE>
          <VALUEMEANING>Free Immunoglobulin Light Chain Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free immunoglobulin light chains present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin M</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin M Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin M present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6142750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immunoglobulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81869</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inclusion Bodies</VALIDVALUE>
          <VALUEMEANING>Inclusion Body Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the protein, lipid or small molecule aggregates located within the cytoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116184</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404048</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indican</VALIDVALUE>
          <VALUEMEANING>Indican Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of indican present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82044</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indirect Bilirubin</VALIDVALUE>
          <VALUEMEANING>Indirect Bilirubin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4264571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indocyanine Green Clearance</VALIDVALUE>
          <VALUEMEANING>Indocyanine Green Clearance Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the volume of serum or plasma that would be cleared of indocyanine green by excretion for a specified unit of time (e.g. one minute).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indocyanine Green</VALIDVALUE>
          <VALUEMEANING>Indocyanine Green Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the indocyanine green in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inhibin A</VALIDVALUE>
          <VALUEMEANING>Inhibin A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of inhibin A present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82020</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inhibin B</VALIDVALUE>
          <VALUEMEANING>Inhibin B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of inhibin B present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inorganic Pyrophosphate</VALIDVALUE>
          <VALUEMEANING>Inorganic Pyrophosphate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of inorganic pyrophosphate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161358</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insulin Resistance</VALIDVALUE>
          <VALUEMEANING>Insulin Resistance Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the insulin resistance (cells inability to respond to insulin) in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413419</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insulin Sensitivity</VALIDVALUE>
          <VALUEMEANING>Insulin Sensitivity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the insulin sensitivity (cells are stimulated by lower than normal insulin levels) in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insulin</VALIDVALUE>
          <VALUEMEANING>Insulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of insulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74788</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insulin, Free</VALIDVALUE>
          <VALUEMEANING>Free Insulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free insulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insulin, Intact</VALIDVALUE>
          <VALUEMEANING>Intact Insulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of intact insulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186072</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insulin-Like Growth Factor Binding Prot1</VALIDVALUE>
          <VALUEMEANING>Insulin-Like Growth Factor Binding Protein 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of insulin-like growth factor binding protein 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128968</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insulin-Like Growth Factor Binding Prot2</VALIDVALUE>
          <VALUEMEANING>Insulin-Like Growth Factor Binding Protein 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of insulin-like growth factor binding protein 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insulin-Like Growth Factor Binding Prot3</VALIDVALUE>
          <VALUEMEANING>Insulin-Like Growth Factor Binding Protein 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of insulin-like growth factor binding protein 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112322</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insulin-Like Growth Factor Binding Prot7</VALIDVALUE>
          <VALUEMEANING>Insulin-Like Growth Factor Binding Protein 7 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of insulin-like growth factor binding protein 7 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insulin-like Growth Factor-1</VALIDVALUE>
          <VALUEMEANING>Insulin Like Growth Factor-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of insulin-like growth factor-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74864</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insulin-like Growth Factor-2</VALIDVALUE>
          <VALUEMEANING>Insulin Like Growth Factor-2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of insulin-like growth factor-2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74865</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intelectin-1</VALIDVALUE>
          <VALUEMEANING>Intelectin-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of intelectin-1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intercellular Adhesion Molecule 1</VALIDVALUE>
          <VALUEMEANING>Intercellular Adhesion Molecule 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of intercellular adhesion molecule 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intercellular Adhesion Molecule 3</VALIDVALUE>
          <VALUEMEANING>Intercellular Adhesion Molecule 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of intercellular adhesion molecule 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165968</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intercellular Adhesion Molecule</VALIDVALUE>
          <VALUEMEANING>Intercellular Adhesion Molecule Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of intercellular adhesion molecule present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409042</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon Alpha Type 2</VALIDVALUE>
          <VALUEMEANING>Interferon Alpha Type 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the interferon alpha type 2 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon Alpha</VALIDVALUE>
          <VALUEMEANING>Interferon Alpha Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the interferon alpha in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon Alpha-Inducible Protein 27</VALIDVALUE>
          <VALUEMEANING>Interferon Alpha-Inducible Protein 27 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interferon alpha-inducible protein 27 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163455</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon Alpha-Inducible Protein 6</VALIDVALUE>
          <VALUEMEANING>Interferon Alpha-Inducible Protein 6 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interferon alpha-inducible protein 6 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon Beta</VALIDVALUE>
          <VALUEMEANING>Interferon Beta Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interferon beta present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81995</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon Gamma</VALIDVALUE>
          <VALUEMEANING>Interferon Gamma Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interferon gamma present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81996</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon-Induced 56 kDa Protein</VALIDVALUE>
          <VALUEMEANING>Interferon-Induced 56 kDa Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interferon-induced 56 kDa protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon-Induced 60 kDa Protein</VALIDVALUE>
          <VALUEMEANING>Interferon-Induced 60 kDa Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interferon-induced 60 kDa protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163460</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon-Induced Protein 44</VALIDVALUE>
          <VALUEMEANING>Interferon-Induced Protein 44 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interferon-induced protein 44 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon-Induced Protein 44-Like</VALIDVALUE>
          <VALUEMEANING>Interferon-Induced Protein 44-Like Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interferon-induced protein 44-Like present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon-Induced Protein p78</VALIDVALUE>
          <VALUEMEANING>Interferon-Induced Protein p78 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interferon-induced protein p78 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 1 Alpha</VALIDVALUE>
          <VALUEMEANING>Interleukin 1 Alpha Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin-1 alpha present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphocytes/Total Cells</VALIDVALUE>
          <VALUEMEANING>Lymphocyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of lymphocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoid Cells</VALIDVALUE>
          <VALUEMEANING>Lymphoid Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lymphoid cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Cells</VALIDVALUE>
          <VALUEMEANING>Lymphoma Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of lymphoma cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74613</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Cells/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Lymphoma Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of lymphoma cells compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Cells/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Lymphoma Cell to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of lymphoma cells compared to lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74910</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Lymphoma Cell to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of lymphoma cells to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphotactin</VALIDVALUE>
          <VALUEMEANING>Lymphotactin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lymphotactin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81955</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphotoxin Alpha</VALIDVALUE>
          <VALUEMEANING>Lymphotoxin Alpha Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lymphotoxin alpha in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lysergic Acid Diethylamide</VALIDVALUE>
          <VALUEMEANING>Lysergide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lysergide (LSD) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lysine</VALIDVALUE>
          <VALUEMEANING>Lysine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lysine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122134</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lysosomal Associated Membrane Protein 2</VALIDVALUE>
          <VALUEMEANING>Lysosome-Associated Membrane Protein 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lysosomal associated membrane protein 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lysozyme</VALIDVALUE>
          <VALUEMEANING>Lysozyme Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the lysozyme present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAB-CHMINACA</VALIDVALUE>
          <VALUEMEANING>MAB-CHMINACA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the MAB-CHMINACA in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184550</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macroamylase</VALIDVALUE>
          <VALUEMEANING>Macroamylase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of macroamylase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111243</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrocytes</VALIDVALUE>
          <VALUEMEANING>Macrocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of macrocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrophage Colony Stimulating Factor</VALIDVALUE>
          <VALUEMEANING>Macrophage Colony Stimulating Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of macrophage colony stimulating factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80191</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrophage Inflammatory Protein 1 Alpha</VALIDVALUE>
          <VALUEMEANING>Macrophage Inflammatory Protein 1 Alpha Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of macrophage inflammatory protein 1 alpha present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82023</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrophage Inflammatory Protein 1 Beta</VALIDVALUE>
          <VALUEMEANING>Macrophage Inflammatory Protein 1 Beta Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of macrophage inflammatory protein 1 beta present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82024</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrophage Inflammatory Protein 1 Gamma</VALIDVALUE>
          <VALUEMEANING>Macrophage Inflammatory Protein 1 Gamma Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of macrophage inflammatory protein 1 gamma present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130164</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrophage Inflammatory Protein 1</VALIDVALUE>
          <VALUEMEANING>Macrophage Inflammatory Protein 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of macrophage inflammatory protein 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrophage Migration Inhibitory Factor</VALIDVALUE>
          <VALUEMEANING>Macrophage Migration Inhibitory Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of macrophage migration inhibitory factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154002</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrophage-Derived Chemokine</VALIDVALUE>
          <VALUEMEANING>Macrophage-Derived Chemokine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of macrophage-derived chemokine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81956</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrophages</VALIDVALUE>
          <VALUEMEANING>Macrophage Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of macrophages present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrophages/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Macrophage to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of macrophages compared to leukocytes in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123460</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrophages/Non-Squam Epi Cells</VALIDVALUE>
          <VALUEMEANING>Macrophages to Non-Squamous Epithelial Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of macrophages compared to non-squamous epithelial cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macrophages/Total Cells</VALIDVALUE>
          <VALUEMEANING>Macrophage to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the macrophages compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404235</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macroscopic Blood</VALIDVALUE>
          <VALUEMEANING>Macroscopic Blood Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount or presence of macroscopic blood present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Magnesium</VALIDVALUE>
          <VALUEMEANING>Magnesium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of magnesium present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64840</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Magnesium, Ionized</VALIDVALUE>
          <VALUEMEANING>Ionized Magnesium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the ionized magnesium in a biological specimen.

</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C175951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7507143</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Magnesium/Creatinine</VALIDVALUE>
          <VALUEMEANING>Magnesium to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of magnesium compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malignant Cells, NOS</VALIDVALUE>
          <VALUEMEANING>Malignant Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of malignant cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malignant Cells, NOS/Blood Cells</VALIDVALUE>
          <VALUEMEANING>Malignant Cell to Blood Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of malignant cells compared to blood cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malondialdehyde</VALIDVALUE>
          <VALUEMEANING>Malondialdehyde Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the malondialdehyde in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187811</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159116</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mannitol</VALIDVALUE>
          <VALUEMEANING>Mannitol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mannitol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620001</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mast Cells</VALIDVALUE>
          <VALUEMEANING>Mast Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mast cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mast Cells/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Mast Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of mast cells to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187812</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mast Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Mast Cell to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the mast cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412528</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mast/Stem Cell Growth Factor Rec Kit</VALIDVALUE>
          <VALUEMEANING>Mast/Stem Cell Growth Factor Receptor Kit Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amount of mast/stem cell growth factor receptor kit in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Matrix Metalloproteinase 1</VALIDVALUE>
          <VALUEMEANING>Matrix Metalloproteinase 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of matrix metalloproteinase 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Matrix Metalloproteinase 2</VALIDVALUE>
          <VALUEMEANING>Matrix Metalloproteinase 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of matrix metalloproteinase 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Matrix Metalloproteinase 3</VALIDVALUE>
          <VALUEMEANING>Matrix Metalloproteinase 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of matrix metalloproteinase 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402970</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Matrix Metalloproteinase 7</VALIDVALUE>
          <VALUEMEANING>Matrix Metalloproteinase 7 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of matrix metalloproteinase 7 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Matrix Metalloproteinase 8</VALIDVALUE>
          <VALUEMEANING>Matrix Metalloproteinase 8 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of matrix metalloproteinase 8 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Matrix Metalloproteinase 9</VALIDVALUE>
          <VALUEMEANING>Matrix Metalloproteinase 9 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of matrix metalloproteinase 9 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mature Plasma Cells</VALIDVALUE>
          <VALUEMEANING>Mature Plasma Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of mature plasma cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74661</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mature Plasma Cells/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Mature Plasma Cell to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74911</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basophils/Total Cells</VALIDVALUE>
          <VALUEMEANING>Basophil to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of basophils compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98865</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bence-Jones Protein</VALIDVALUE>
          <VALUEMEANING>Bence-Jones Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Bence-Jones protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111136</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Benzodiazepine</VALIDVALUE>
          <VALUEMEANING>Benzodiazepine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of benzodiazepine class drug present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Benzoylecgonine</VALIDVALUE>
          <VALUEMEANING>Benzoylecgonine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of benzoylecgonine, the primary metabolite of cocaine, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Benzylpiperazine</VALIDVALUE>
          <VALUEMEANING>Benzylpiperazine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the benzylpiperazine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta Alanine</VALIDVALUE>
          <VALUEMEANING>Beta Alanine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of beta alanine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta Carotene</VALIDVALUE>
          <VALUEMEANING>Beta Carotene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of beta-carotene present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta Catenin</VALIDVALUE>
          <VALUEMEANING>Beta Catenin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the beta catenin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103357</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta Globulin</VALIDVALUE>
          <VALUEMEANING>Beta Globulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of beta globulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta Globulin/Total Protein</VALIDVALUE>
          <VALUEMEANING>Beta Globulin to Total Protein Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of beta globulin compared to total protein present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta+Gamma Tocopherol</VALIDVALUE>
          <VALUEMEANING>Beta and Gamma Tocopherol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of beta and gamma tocopherol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351764</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-1 Globulin</VALIDVALUE>
          <VALUEMEANING>Beta-1 Globulin</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the beta-1 globulin activity in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119274</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5879777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-1 Globulin/Beta Protein</VALIDVALUE>
          <VALUEMEANING>Beta-1 Globulin to Total Beta Protein Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of beta-1 globulin compared to beta protein present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-1 Globulin/Total Protein</VALIDVALUE>
          <VALUEMEANING>Beta-1 Globulin to Total Protein Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the beta-1 globulin to albumin in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-1B Glycoprotein</VALIDVALUE>
          <VALUEMEANING>Beta-1B Glycoprotein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of beta-1B glycoprotein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127607</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-2 Globulin</VALIDVALUE>
          <VALUEMEANING>Beta-2 Globulin</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the beta-2 globulin activity in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5879764</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-2 Globulin/Total Protein</VALIDVALUE>
          <VALUEMEANING>Beta-2 Globulin to Total Protein Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the beta-2 globulin to total protein in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-2 Microglobulin</VALIDVALUE>
          <VALUEMEANING>Beta-2 Microglobulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of beta-2 microglobulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81980</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6142762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-2 Microglobulin/Creatinine</VALIDVALUE>
          <VALUEMEANING>Beta-2 Microglobulin to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of beta-2 microglobulin compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-Actin</VALIDVALUE>
          <VALUEMEANING>Beta-Actin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the beta-actin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010079</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-Aminobutyric Acid</VALIDVALUE>
          <VALUEMEANING>Beta-Aminobutyric Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of beta-aminobutyric acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-cell Function</VALIDVALUE>
          <VALUEMEANING>Beta-Cell Function Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the beta cell function (insulin production and secretion) in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123455</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-defensin 2</VALIDVALUE>
          <VALUEMEANING>Beta-defensin 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of beta-defensin 2 in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chloride</VALIDVALUE>
          <VALUEMEANING>Chloride Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the chloride in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833102</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chloride/Creatinine</VALIDVALUE>
          <VALUEMEANING>Chloride to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of chloride compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chlorphentermine</VALIDVALUE>
          <VALUEMEANING>Chlorphentermine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the chlorphentermine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184580</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010446</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chlorpromazine</VALIDVALUE>
          <VALUEMEANING>Chlorpromazine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chlorpromazine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177968</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholate Compounds</VALIDVALUE>
          <VALUEMEANING>Cholate Compounds Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cholic acid, glycocholic acid, hyocholic acid, and taurocholic acid in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholate</VALIDVALUE>
          <VALUEMEANING>Cholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholecystokinin</VALIDVALUE>
          <VALUEMEANING>Cholecystokinin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cholecystokinin hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74850</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholestanol</VALIDVALUE>
          <VALUEMEANING>Cholestanol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cholestanol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181435</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholesterol Crystals</VALIDVALUE>
          <VALUEMEANING>Cholesterol Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cholesterol crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74672</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholesterol Sulfate</VALIDVALUE>
          <VALUEMEANING>Cholesterol Sulfate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cholesterol sulfate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798116</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholesterol</VALIDVALUE>
          <VALUEMEANING>Cholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total cholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholesterol/HDL-Cholesterol</VALIDVALUE>
          <VALUEMEANING>Cholesterol to HDL-Cholesterol Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of total cholesterol compared to high-density lipoprotein type cholesterol present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholesteryl Ester Transfer Protein Act</VALIDVALUE>
          <VALUEMEANING>Cholesteryl Ester Transfer Protein Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the biological activity of cholesteryl ester transfer protein in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholesteryl Ester Transfer Protein</VALIDVALUE>
          <VALUEMEANING>Cholesteryl Ester Transfer Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the cholesteryl ester transfer protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basophils/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Basophil to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of basophils to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholinesterase</VALIDVALUE>
          <VALUEMEANING>Cholinesterase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cholinesterase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Choriogonadotropin Adj for Maternal Wt</VALIDVALUE>
          <VALUEMEANING>Choriogonadotropin Adjusted for Maternal Weight Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of choriogonadotropin, adjusted for maternal weight, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161374</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Choriogonadotropin Beta</VALIDVALUE>
          <VALUEMEANING>Choriogonadotropin Beta Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the presence of Choriogonadotropin Beta protein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6384486</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Choriogonadotropin Beta, Free</VALIDVALUE>
          <VALUEMEANING>Free Choriogonadotropin Beta Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free choriogonadotropin beta present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Choriogonadotropin</VALIDVALUE>
          <VALUEMEANING>Choriogonadotropin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of choriogonadotropin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147128</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6384475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Choriogonadotropin, Intact</VALIDVALUE>
          <VALUEMEANING>Intact Choriogonadotropin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of intact choriogonadotropin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147361</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chromogranin A</VALIDVALUE>
          <VALUEMEANING>Chromogranin A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chromogranin A present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122108</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chylomicron Triglyceride</VALIDVALUE>
          <VALUEMEANING>Chylomicron Triglyceride Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the chylomicron triglyceride in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174302</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 1 Beta</VALIDVALUE>
          <VALUEMEANING>Interleukin 1 Beta Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 1 beta present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112323</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 1 Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Interleukin 1 Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 1 being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156518</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 1 Receptor Antagonist</VALIDVALUE>
          <VALUEMEANING>Interleukin 1 Receptor Antagonist Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 1 receptor antagonist present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112324</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 1 Receptor Type 2</VALIDVALUE>
          <VALUEMEANING>Interleukin 1 Receptor Type 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 1 receptor type 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 1 Receptor-Like 1</VALIDVALUE>
          <VALUEMEANING>Interleukin 1 Receptor-Like 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 1 receptor-like 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 1</VALIDVALUE>
          <VALUEMEANING>Interleukin 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74805</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 10</VALIDVALUE>
          <VALUEMEANING>Interleukin 10 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 10 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 11</VALIDVALUE>
          <VALUEMEANING>Interleukin 11 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 11 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 12 Beta</VALIDVALUE>
          <VALUEMEANING>Interleukin 12 Beta Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 12 beta present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 12</VALIDVALUE>
          <VALUEMEANING>Interleukin 12 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 12 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74808</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 12+23 p40</VALIDVALUE>
          <VALUEMEANING>Interleukin 12+23 p40 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 12+23 p40 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 13</VALIDVALUE>
          <VALUEMEANING>Interleukin 13 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 13 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 14</VALIDVALUE>
          <VALUEMEANING>Interleukin 14 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 14 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74810</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 15</VALIDVALUE>
          <VALUEMEANING>Interleukin 15 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 15 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74811</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 16</VALIDVALUE>
          <VALUEMEANING>Interleukin 16 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 16 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74812</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 17</VALIDVALUE>
          <VALUEMEANING>Interleukin 17 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 17 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corpuscular HGB Conc Distribution Width</VALIDVALUE>
          <VALUEMEANING>Corpuscular Hemoglobin Concentration Distribution Width</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the standard deviation of hemoglobin concentrations in individual red blood cells, calculated as the standard deviation of hemoglobin content divided by the mean hemoglobin content.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139068</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corpuscular HGB Concentration Mean</VALIDVALUE>
          <VALUEMEANING>Corpuscular Hemoglobin Concentration Mean</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the average concentration of hemoglobin per erythrocyte in a biological specimen, derived from flow cytometric light scatter analysis of intact cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139067</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corticosterone</VALIDVALUE>
          <VALUEMEANING>Corticosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of corticosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corticosterone/Creatinine</VALIDVALUE>
          <VALUEMEANING>Corticosterone to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of corticosterone compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106511</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corticotropin Releasing Hormone</VALIDVALUE>
          <VALUEMEANING>Corticotropin Releasing Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of corticotropin releasing hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cortisol</VALIDVALUE>
          <VALUEMEANING>Cortisol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cortisol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74781</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cortisol, Free Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Free Cortisol Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free cortisol being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cortisol, Free</VALIDVALUE>
          <VALUEMEANING>Free Cortisol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free, unbound cortisol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88113</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cortisol/Creatinine</VALIDVALUE>
          <VALUEMEANING>Cortisol to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of cortisol compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412438</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cotinine</VALIDVALUE>
          <VALUEMEANING>Cotinine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cotinine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92249</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Creatine Kinase BB</VALIDVALUE>
          <VALUEMEANING>Creatine Kinase BB Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of homozygous B-type creatine kinase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407253</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Creatine Kinase BB/Total Creatine Kinase</VALIDVALUE>
          <VALUEMEANING>Creatine Kinase BB to Total Creatine Kinase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of creatine kinase BB compared to total creatine kinase present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Creatine Kinase MB</VALIDVALUE>
          <VALUEMEANING>Creatine Kinase MB Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of heterozygous MB-type creatine kinase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6380337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Creatine Kinase MB/Total Creatine Kinase</VALIDVALUE>
          <VALUEMEANING>Creatine Kinase MB to Total Creatine Kinase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of creatine kinase MB compared to total creatine kinase present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6380335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Creatine Kinase MM</VALIDVALUE>
          <VALUEMEANING>Creatine Kinase MM Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of homozygous M-type creatine kinase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Creatine Kinase MM/Total Creatine Kinase</VALIDVALUE>
          <VALUEMEANING>Creatine Kinase MM to Total Creatine Kinase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of creatine kinase MM compared to total creatine kinase present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Creatine Kinase</VALIDVALUE>
          <VALUEMEANING>Creatine Kinase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of creatine kinase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6380338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Creatinine Clearance Adjusted for BSA</VALIDVALUE>
          <VALUEMEANING>Creatinine Clearance Adjusted for BSA</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the clearance of creatinine and whose result is adjusted for body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147324</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Creatinine Clearance</VALIDVALUE>
          <VALUEMEANING>Creatinine Clearance</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the clearance of endogenous creatinine, used for evaluating the glomerular filtration rate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Creatinine Clearance, Estimated</VALIDVALUE>
          <VALUEMEANING>Estimated Creatinine Clearance</VALUEMEANING>
          <MEANINGDESCRIPTION>An estimate of the clearance of endogenous creatinine, used for evaluating the glomerular filtration rate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150847</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Creatinine Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Creatinine Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the amount of creatinine being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150817</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Creatinine</VALIDVALUE>
          <VALUEMEANING>Creatinine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of creatinine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6142759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Crenated Cells</VALIDVALUE>
          <VALUEMEANING>Crenated Cell Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of crenated red blood cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74703</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cryofibrinogen</VALIDVALUE>
          <VALUEMEANING>Cryofibrinogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cryofibrinogen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cryoglobulin Volume/Serum Volume</VALIDVALUE>
          <VALUEMEANING>Cryoglobulin Volume to Serum Volume Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of cryoglobulin volume compared to serum volume present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147325</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cryoglobulin</VALIDVALUE>
          <VALUEMEANING>Cryoglobulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cryoglobulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111164</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lactoferrin</VALIDVALUE>
          <VALUEMEANING>Lactoferrin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lactoferrin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82021</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lactose</VALIDVALUE>
          <VALUEMEANING>Lactose Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lactose present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186077</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lactulose</VALIDVALUE>
          <VALUEMEANING>Lactulose Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lactulose present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lambda Light Chain</VALIDVALUE>
          <VALUEMEANING>Lambda Light Chain Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lambda light chain present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lambda Light Chain, Free</VALIDVALUE>
          <VALUEMEANING>Free Lambda Light Chain Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free lambda light chain present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98732</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6142751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LAMP2/GAPDH</VALIDVALUE>
          <VALUEMEANING>Lysosomal Associated Membrane Protein 2 to Glyceraldehyde-3-Phosphate Dehydrogenase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of lysosomal associated membrane protein 2 to glyceraldehyde-3-phosphate dehydrogenase present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Large Lymphocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of large lymphocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774758</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large Platelets</VALIDVALUE>
          <VALUEMEANING>Large Platelet Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of large platelets present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large Platelets/Total Platelets</VALIDVALUE>
          <VALUEMEANING>Large Platelets to Total Platelets Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of large platelets compared to total platelets present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large Unstained Cells</VALIDVALUE>
          <VALUEMEANING>Large Unstained Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of large unstained cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74659</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 18 Binding Protein</VALIDVALUE>
          <VALUEMEANING>Interleukin 18 Binding Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 18 binding protein in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 18 Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Interleukin 18 Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 18 being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 18</VALIDVALUE>
          <VALUEMEANING>Interleukin 18 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 18 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 19</VALIDVALUE>
          <VALUEMEANING>Interleukin 19 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 19 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74815</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 2 Receptor Subunit Alpha</VALIDVALUE>
          <VALUEMEANING>Interleukin 2 Receptor Subunit Alpha Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 2 receptor subunit alpha present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 2 Receptor Subunit Beta</VALIDVALUE>
          <VALUEMEANING>Interleukin 2 Receptor Subunit Beta Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 2 receptor subunit beta present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142283</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 2 Receptor</VALIDVALUE>
          <VALUEMEANING>Interleukin 2 Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 2 receptor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158147</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 2</VALIDVALUE>
          <VALUEMEANING>Interleukin 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 20</VALIDVALUE>
          <VALUEMEANING>Interleukin 20 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 20 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74817</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 21</VALIDVALUE>
          <VALUEMEANING>Interleukin 21 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 21 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74818</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 22</VALIDVALUE>
          <VALUEMEANING>Interleukin 22 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 22 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74819</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 23</VALIDVALUE>
          <VALUEMEANING>Interleukin 23 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 23 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74820</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 24</VALIDVALUE>
          <VALUEMEANING>Interleukin 24 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 24 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 25</VALIDVALUE>
          <VALUEMEANING>Interleukin 25 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 25 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74822</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404042</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 26</VALIDVALUE>
          <VALUEMEANING>Interleukin 26 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 26 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74823</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 27</VALIDVALUE>
          <VALUEMEANING>Interleukin 27 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 27 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74824</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 28</VALIDVALUE>
          <VALUEMEANING>Interleukin 28 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 28 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 29</VALIDVALUE>
          <VALUEMEANING>Interleukin 29 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 29 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74826</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 3</VALIDVALUE>
          <VALUEMEANING>Interleukin 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74827</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 30</VALIDVALUE>
          <VALUEMEANING>Interleukin 30 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 30 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 31</VALIDVALUE>
          <VALUEMEANING>Interleukin 31 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 31 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74829</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 32</VALIDVALUE>
          <VALUEMEANING>Interleukin 32 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 32 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74830</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 33</VALIDVALUE>
          <VALUEMEANING>Interleukin 33 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 33 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74831</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 4</VALIDVALUE>
          <VALUEMEANING>Interleukin 4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 4 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 5</VALIDVALUE>
          <VALUEMEANING>Interleukin 5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 5 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 6</VALIDVALUE>
          <VALUEMEANING>Interleukin 6 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 6 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 7</VALIDVALUE>
          <VALUEMEANING>Interleukin 7 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 7 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 8</VALIDVALUE>
          <VALUEMEANING>Interleukin 8 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 8 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74836</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 9</VALIDVALUE>
          <VALUEMEANING>Interleukin 9 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of interleukin 9 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404388</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intestinal Specific Alkaline Phosphatase</VALIDVALUE>
          <VALUEMEANING>Intestinal Specific Alkaline Phosphatase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the intestinal specific alkaline phosphatase in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119266</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inulin Clearance</VALIDVALUE>
          <VALUEMEANING>Inulin Clearance</VALUEMEANING>
          <MEANINGDESCRIPTION>The rate at which inulin is removed or cleared from the whole or part of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inulin</VALIDVALUE>
          <VALUEMEANING>Inulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of inulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125945</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mature Plasma Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Plasma Cell to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of plasma cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98869</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409716</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maturing Erythroid Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Maturing Erythroid Cell to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of maturing erythroid cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127628</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maturing Myeloid Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Maturing Myeloid Cell to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of maturing myeloid cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>May-Hegglin Anomaly</VALIDVALUE>
          <VALUEMEANING>May-Hegglin Anomaly Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of May-Hegglin anomaly present in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74614</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mazindol</VALIDVALUE>
          <VALUEMEANING>Mazindol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the mazindol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MCV Reticulocytes</VALIDVALUE>
          <VALUEMEANING>Reticulocyte Mean Corpuscular Volume</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the average reticulocyte volume in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mean Platelet Component</VALIDVALUE>
          <VALUEMEANING>Mean Platelet Component Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mean platelet component present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mean Platelet Dry Mass</VALIDVALUE>
          <VALUEMEANING>Mean Platelet Dry Mass</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mean platelet dry mass present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mean Platelet Volume</VALIDVALUE>
          <VALUEMEANING>Mean Platelet Volume Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the average size of the platelets present in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74730</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meconium</VALIDVALUE>
          <VALUEMEANING>Meconium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of meconium present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medazepam</VALIDVALUE>
          <VALUEMEANING>Medazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of medazepam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139079</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medium Absorption Retic/Reticulocytes</VALIDVALUE>
          <VALUEMEANING>Medium Absorption Reticulocytes to Total Reticulocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of medium absorption reticulocytes compared to total reticulocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medium Absorption Reticulocytes</VALIDVALUE>
          <VALUEMEANING>Medium Absorption Reticulocyte Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of medium absorption reticulocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mefenorex</VALIDVALUE>
          <VALUEMEANING>Mefenorex Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the mefenorex in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184624</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Megakaryoblasts</VALIDVALUE>
          <VALUEMEANING>Megakaryoblast Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of megakaryoblasts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Megakaryoblasts/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Megakaryoblasts to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of megakaryoblasts to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large Unstained Cells/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Large Unstained Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of large unstained cells compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412554</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDH Isoenzyme 1</VALIDVALUE>
          <VALUEMEANING>Lactate Dehydrogenase Isoenzyme 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the lactate dehydrogenase isoenzyme 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDH Isoenzyme 1/LDH</VALIDVALUE>
          <VALUEMEANING>LDH Isoenzyme 1 to LDH Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of LDH isoenzyme 1 compared to total LDH present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79451</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDH Isoenzyme 2</VALIDVALUE>
          <VALUEMEANING>Lactate Dehydrogenase Isoenzyme 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the lactate dehydrogenase isoenzyme 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74888</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDH Isoenzyme 2/LDH</VALIDVALUE>
          <VALUEMEANING>LDH Isoenzyme 2 to LDH Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of LDH isoenzyme 2 compared to total LDH present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDH Isoenzyme 3</VALIDVALUE>
          <VALUEMEANING>Lactate Dehydrogenase Isoenzyme 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the lactate dehydrogenase isoenzyme 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74889</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDH Isoenzyme 3/LDH</VALIDVALUE>
          <VALUEMEANING>LDH Isoenzyme 3 to LDH Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of LDH isoenzyme 3 compared to total LDH present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDH Isoenzyme 4</VALIDVALUE>
          <VALUEMEANING>Lactate Dehydrogenase Isoenzyme 4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the lactate dehydrogenase isoenzyme 4 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74890</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDH Isoenzyme 4/LDH</VALIDVALUE>
          <VALUEMEANING>LDH Isoenzyme 4 to LDH Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of LDH isoenzyme 4 compared to total LDH present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDH Isoenzyme 5</VALIDVALUE>
          <VALUEMEANING>Lactate Dehydrogenase Isoenzyme 5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the lactate dehydrogenase isoenzyme 5 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74891</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDH Isoenzyme 5/LDH</VALIDVALUE>
          <VALUEMEANING>LDH Isoenzyme 5 to LDH Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of LDH isoenzyme 5 compared to total LDH present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79455</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDL Apolipoprotein B</VALIDVALUE>
          <VALUEMEANING>LDL Fraction Apoliprotein B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apolipoprotein B in the low density lipoprotein fraction of a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>Low Density Lipoprotein Cholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of low-density lipoprotein cholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6380333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDL Cholesterol/HDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>LDL Cholesterol to HDL Cholesterol Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of LDL cholesterol compared to HDL cholesterol present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDL Particle Size</VALIDVALUE>
          <VALUEMEANING>LDL Particle Size Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the average particle size of low-density lipoprotein in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDL Particles</VALIDVALUE>
          <VALUEMEANING>LDL Particles Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the LDL particles present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDL Subtype Pattern</VALIDVALUE>
          <VALUEMEANING>LDL Subtype Pattern</VALUEMEANING>
          <MEANINGDESCRIPTION>A description of the low density lipoprotein particle pattern (an interpretation of the amounts of LDL particles based on size and density) in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LDL Triglyceride</VALIDVALUE>
          <VALUEMEANING>LDL Triglyceride Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of low density lipoprotein triglyceride in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lead</VALIDVALUE>
          <VALUEMEANING>Lead Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lead present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lecithin/Sphingomyelin</VALIDVALUE>
          <VALUEMEANING>Lecithin to Sphingomyelin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of lecithin compared to sphingomyelin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404241</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lectin-Like Oxidized LDL Receptor-1</VALIDVALUE>
          <VALUEMEANING>Lectin-Like Oxidized LDL Receptor-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of lectin-like oxidized LDL Receptor-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198285</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left Shift Neutrophils</VALIDVALUE>
          <VALUEMEANING>Left Shift Neutrophil Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the presence of left shift neutrophils in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116202</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405997</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leptin Receptor</VALIDVALUE>
          <VALUEMEANING>Leptin Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of leptin receptor in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leptin</VALIDVALUE>
          <VALUEMEANING>Leptin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of leptin hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74866</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leptocytes</VALIDVALUE>
          <VALUEMEANING>Leptocyte Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the leptocytes in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leucine Aminopeptidase</VALIDVALUE>
          <VALUEMEANING>Leucine Aminopeptidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of leucine aminopeptidase related peptide present in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407755</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leucine Crystals</VALIDVALUE>
          <VALUEMEANING>Leucine Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of leucine crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leucine Rich Alpha-2-Glycoprotein 1</VALIDVALUE>
          <VALUEMEANING>Leucine Rich Alpha-2-Glycoprotein 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of leucine rich alpha-2-glycoprotein 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leucine</VALIDVALUE>
          <VALUEMEANING>Leucine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of leucine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122133</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia Inhibitory Factor</VALIDVALUE>
          <VALUEMEANING>Leukemia Inhibitory Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of leukemia inhibitory factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemic Blasts</VALIDVALUE>
          <VALUEMEANING>Leukemic Blast Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of leukemic blasts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74630</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemic Blasts/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Leukemic Blast to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of leukemic blasts compared to lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemic Cells</VALIDVALUE>
          <VALUEMEANING>Leukemic Cells Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of leukemic cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukocyte Cell Clumps</VALIDVALUE>
          <VALUEMEANING>Leukocyte Cell Clumps Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of leukocyte cell clumps present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukocyte Cell Differential</VALIDVALUE>
          <VALUEMEANING>Differential Leukocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>A hematologic procedure for the evaluation of the qualitative and quantitative characteristics of the white cells in peripheral blood smears and bone marrow aspirates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukocyte Cell Morphology</VALIDVALUE>
          <VALUEMEANING>Leukocyte Cell Morphology</VALUEMEANING>
          <MEANINGDESCRIPTION>An examination or assessment of the form and structure of white blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92297</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404259</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukocyte Esterase</VALIDVALUE>
          <VALUEMEANING>Leukocyte Esterase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of leukocyte esterase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64856</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukocytes</VALIDVALUE>
          <VALUEMEANING>Leukocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>A test to determine the number of leukocytes in a sample of blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mononuclear Cells</VALIDVALUE>
          <VALUEMEANING>Mononuclear Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mononuclear cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619997</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monosodium Urate Crystals</VALIDVALUE>
          <VALUEMEANING>Monosodium Urate Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of monosodium urate crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Morphine</VALIDVALUE>
          <VALUEMEANING>Morphine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of morphine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74883</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Motile Sperm/Total Sperm</VALIDVALUE>
          <VALUEMEANING>Motile Sperm to Total Sperm Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of motile sperm compared to total sperm present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mu Glutathione-S-Transferase</VALIDVALUE>
          <VALUEMEANING>Mu Glutathione-S-Transferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mu glutathione-s-transferase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412591</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mu Glutathione-S-Transferase/Creatinine</VALIDVALUE>
          <VALUEMEANING>Mu Glutathione-S-Transferase to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of mu glutathione-s-transferase compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucous Threads</VALIDVALUE>
          <VALUEMEANING>Mucous Thread Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of mucous threads present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74721</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407578</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Murinoglobulin</VALIDVALUE>
          <VALUEMEANING>Murinoglobulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of murinoglobulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127630</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myelin Basic Protein</VALIDVALUE>
          <VALUEMEANING>Myelin Basic Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of myelin basic protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122135</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Megakaryoblasts/Total Cells</VALIDVALUE>
          <VALUEMEANING>Megakaryoblast to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of megakaryoblasts compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98753</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Megakaryocyte and Megakaryoblast Morph</VALIDVALUE>
          <VALUEMEANING>Megakaryocyte and Megakaryoblast Morphology Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>An examination or assessment of the form and structure of megakaryocytes and megakaryoblasts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Megakaryocytes</VALIDVALUE>
          <VALUEMEANING>Megakaryocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of megakaryocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405910</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Megakaryocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Megakaryocytes to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of megakaryocytes compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619999</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Megakaryocytes/Total Cells</VALIDVALUE>
          <VALUEMEANING>Megakaryocyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of megakaryocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98867</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melatonin</VALIDVALUE>
          <VALUEMEANING>Melatonin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of melatonin hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74867</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404046</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meningeal Cells</VALIDVALUE>
          <VALUEMEANING>Meningeal Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of meningeal cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meningeal Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Meningeal Cell to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the meningeal cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meperidine</VALIDVALUE>
          <VALUEMEANING>Meperidine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of meperidine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mephedrone</VALIDVALUE>
          <VALUEMEANING>Mephedrone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the mephedrone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meprobamate</VALIDVALUE>
          <VALUEMEANING>Meprobamate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the meprobamate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010655</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mercury</VALIDVALUE>
          <VALUEMEANING>Mercury Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mercury present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413820</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mescaline</VALIDVALUE>
          <VALUEMEANING>Mescaline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cocaine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesoridazine</VALIDVALUE>
          <VALUEMEANING>Mesoridazine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mesoridazine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177979</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesothelial Cells</VALIDVALUE>
          <VALUEMEANING>Mesothelial Cells Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mesothelial cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesothelial Cells/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Mesothelial Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of mesothelial cells compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesterolone</VALIDVALUE>
          <VALUEMEANING>Mesterolone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the mesterolone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metamyelocytes</VALIDVALUE>
          <VALUEMEANING>Metamyelocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of metamyelocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74615</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metamyelocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Metamyelocyte to Leukocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of metamyelocytes compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metamyelocytes/Total Cells</VALIDVALUE>
          <VALUEMEANING>Metamyelocyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of metamyelocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metanephrine Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Metanephrine Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of metanephrine being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153998</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metanephrine</VALIDVALUE>
          <VALUEMEANING>Metanephrine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of metanephrine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116198</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metanephrine+Normetanephrine Excr Rate</VALIDVALUE>
          <VALUEMEANING>Metanephrine and Normetanephrine Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of metanephrine and normetanephrine being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metanephrine+Normetanephrine</VALIDVALUE>
          <VALUEMEANING>Metanephrine and Normetanephrine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of metanephrine and normetanephrine   in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metanephrine, Free</VALIDVALUE>
          <VALUEMEANING>Free Metanephrine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free metanephrine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metarubricyte</VALIDVALUE>
          <VALUEMEANING>Metarubricyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of metarubricytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metarubricyte/Total Cells</VALIDVALUE>
          <VALUEMEANING>Metarubricyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the metarubricytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metarubricytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Metarubricyte to Leukocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio or percentage) of the metarubricytes to leukocytes in a biological sample. The measurement may be expressed as either a ratio or a percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methadone</VALIDVALUE>
          <VALUEMEANING>Methadone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of methadone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74881</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413487</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methamphetamine</VALIDVALUE>
          <VALUEMEANING>Methamphetamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of methamphetamine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methane</VALIDVALUE>
          <VALUEMEANING>Methane Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of methane present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186080</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chylomicrons</VALIDVALUE>
          <VALUEMEANING>Chylomicrons Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the chylomicrons present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chymotrypsin</VALIDVALUE>
          <VALUEMEANING>Chymotrypsin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of chymotrypsin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ciliary Neurotrophic Factor</VALIDVALUE>
          <VALUEMEANING>Ciliary Neurotrophic Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ciliary neurotrophic factor in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199890</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Circulating Endothelial Cells</VALIDVALUE>
          <VALUEMEANING>Circulating Endothelial Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of circulating endothelial cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96592</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3298964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Circulating Immune Complexes</VALIDVALUE>
          <VALUEMEANING>Circulating Immune Complex Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of circulating immune complexes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5834225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Circulating Tumor Cells</VALIDVALUE>
          <VALUEMEANING>Circulating Tumor Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of circulating tumor cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96593</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Circulating Tumor Cells, Apoptotic</VALIDVALUE>
          <VALUEMEANING>Apoptotic Circulating Tumor Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of apoptotic circulating tumor cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186036</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Circulating Tumor Cells, Traditional</VALIDVALUE>
          <VALUEMEANING>Traditional Circulating Tumor Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of traditional circulating tumor cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186038</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Citalopram</VALIDVALUE>
          <VALUEMEANING>Citalopram Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of citalopram present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Citrate Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Citrate Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of citrate being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Citrate</VALIDVALUE>
          <VALUEMEANING>Citrate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of citrate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92248</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405716</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Citrate/Creatinine</VALIDVALUE>
          <VALUEMEANING>Citrate to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of citrate to creatinine present in a sample. The measurement by be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122110</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Citrulline</VALIDVALUE>
          <VALUEMEANING>Citrulline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of citrulline present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122109</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Citrulline/Creatinine</VALIDVALUE>
          <VALUEMEANING>Citrulline to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the citrulline to creatinine in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CK, Macromolecular Type 1/Total CK</VALIDVALUE>
          <VALUEMEANING>Macromolecular Type 1 Creatine Kinase to Total Creatine Kinase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of macromolecular type 1 creatine kinase compared to total creatine kinase present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147319</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CK, Macromolecular Type 2/Total CK</VALIDVALUE>
          <VALUEMEANING>Macromolecular Type 2 Creatine Kinase to Total Creatine Kinase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of macromolecular type 2 creatine kinase compared to total creatine kinase present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clarity</VALIDVALUE>
          <VALUEMEANING>Clarity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the transparency of a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloblasts</VALIDVALUE>
          <VALUEMEANING>Myeloblast Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of myeloblast cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloblasts/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Myeloblast to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of myeloblasts compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloblasts/Total Cells</VALIDVALUE>
          <VALUEMEANING>Myeloblast to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of myeloblasts compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409755</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myelocytes</VALIDVALUE>
          <VALUEMEANING>Myelocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of myelocyte cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74662</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myelocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Myelocyte to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of myelocytes compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64826</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myelocytes/Total Cells</VALIDVALUE>
          <VALUEMEANING>Myelocyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of myelocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98868</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloid Maturation Index</VALIDVALUE>
          <VALUEMEANING>Myeloid Maturation Index</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the sum of myeloid maturation phase cells (pool) to the sum of myeloid proliferative phase cells (pool) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413747</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloid Maturation Pool</VALIDVALUE>
          <VALUEMEANING>Myeloid Maturation Pool Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of myeloid maturation phase cells (metamyelocytes, band neutrophils, and segmented neutrophils) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135435</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloid Progenitor Cells</VALIDVALUE>
          <VALUEMEANING>Myeloid Progenitor Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of myeloid progenitor cells in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloid Progenitor Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Myeloid Progenitor Cell to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of myeloid progenitor cells to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186084</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloid Proliferation Index</VALIDVALUE>
          <VALUEMEANING>Myeloid Proliferation Index</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the sum of myeloid proliferative phase cells (pool) to the sum of myeloid maturation phase cells (pool) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloid Proliferation Pool</VALIDVALUE>
          <VALUEMEANING>Myeloid Proliferation Pool Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of myeloid proliferative phase cells (myeloblasts, promyelocytes, and myelocytes) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135437</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloid/Erythroid Ratio</VALIDVALUE>
          <VALUEMEANING>Myeloid to Erythroid Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of myeloid cells compared to erythroid cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloperoxidase Index</VALIDVALUE>
          <VALUEMEANING>Neutrophil Myeloperoxidase Index</VALUEMEANING>
          <MEANINGDESCRIPTION>The mean myeloperoxidase staining intensity of the neutrophil population relative to the archetype.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloperoxidase</VALIDVALUE>
          <VALUEMEANING>Myeloperoxidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of myeloperoxidase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80198</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myoglobin</VALIDVALUE>
          <VALUEMEANING>Myoglobin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of myoglobin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myoglobin/Creatinine</VALIDVALUE>
          <VALUEMEANING>Myoglobin to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of myoglobin compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myosin Light Chain 3</VALIDVALUE>
          <VALUEMEANING>Myosin Light Chain 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of myosin light chain 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N,N-Dimethyltryptamine</VALIDVALUE>
          <VALUEMEANING>N,N-Dimethyltryptamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the N,N-dimethyltryptamine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184536</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-Acetyl Glucosamide</VALIDVALUE>
          <VALUEMEANING>N-Acetyl Glucosamide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of N-acetyl glucosamide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-Acetyl Glucosamide/Creatinine</VALIDVALUE>
          <VALUEMEANING>N-Acetyl Glucosamide to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of N-acetyl glucosamide compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79460</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-acetyl-B-D-glucosaminidase/Creatinine</VALIDVALUE>
          <VALUEMEANING>N-acetyl-Beta-D-glucosaminidase to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the N-acetyl-B-D-glucosaminidase to creatinine in a biological sample. The measurement may be expressed as either a ratio or a percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154056</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-acetyl-beta-D-glucosaminidase</VALIDVALUE>
          <VALUEMEANING>N-acetyl-beta-D-glucosaminidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the N-acetyl-beta-D-glucosaminidase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-Demethylase</VALIDVALUE>
          <VALUEMEANING>N-Demethylase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of N-demethylase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-Desmethylolanzapine</VALIDVALUE>
          <VALUEMEANING>N-Desmethylolanzapine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of N-desmethylolanzapine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-Desmethyltramadol</VALIDVALUE>
          <VALUEMEANING>N-Desmethyltramadol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of N-desmethyltramadol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798388</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-methylhistamine</VALIDVALUE>
          <VALUEMEANING>N-methylhistamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of N-methylhistamine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-telopeptide</VALIDVALUE>
          <VALUEMEANING>N-Telopeptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of N-telopeptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74743</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-telopeptide/Creatinine</VALIDVALUE>
          <VALUEMEANING>N-telopeptide to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of N-telopeptide compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-Terminal ProA-type Natriuretic Peptide</VALIDVALUE>
          <VALUEMEANING>N-Terminal ProA-type Natriuretic Peptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of N-terminal proA-type natriuretic peptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139088</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-Terminal ProB-type Natriuretic Peptide</VALIDVALUE>
          <VALUEMEANING>N-Terminal ProB-type Natriuretic Peptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of N-terminal proB-type natriuretic peptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NAGASE Excretion Rate</VALIDVALUE>
          <VALUEMEANING>N-acetyl-beta-D-glucosaminidase Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of N-acetyl-beta-D-glucosaminidase being excreted in a biological specimen over a defined amount of time (e.g. one hour).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nalorphine</VALIDVALUE>
          <VALUEMEANING>Nalorphine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the nalorphine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184592</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nandrolone</VALIDVALUE>
          <VALUEMEANING>Nandrolone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nandrolone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Naphyrone</VALIDVALUE>
          <VALUEMEANING>Naphyrone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the naphyrone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Killer Cell Function</VALIDVALUE>
          <VALUEMEANING>Natural Killer Cell Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of natural killer cell activity in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Killer Cells</VALIDVALUE>
          <VALUEMEANING>Natural Killer Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of natural killer cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98762</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-Hydroxybutyrate Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Beta-Hydroxybutyrate Excretion Rate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amount of beta-Hydroxybutyrate being excreted in a biological specimen over a defined period of time (e.g. one hour).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491805</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-Hydroxybutyrate</VALIDVALUE>
          <VALUEMEANING>Beta-Hydroxybutyrate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of beta-hydroxybutyrate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96568</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-Hydroxybutyrate/Acetoacetate</VALIDVALUE>
          <VALUEMEANING>Beta-Hydroxybutyrate to Acetoacetate Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of beta-hydroxybutyrate to acetoacetate present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186028</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-Hydroxythiofentanyl</VALIDVALUE>
          <VALUEMEANING>Beta-Hydroxythiofentanyl Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the beta-hydroxythiofentanyl in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184530</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Betacellulin</VALIDVALUE>
          <VALUEMEANING>Betacellulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of betacellulin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199889</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Betaines</VALIDVALUE>
          <VALUEMEANING>Betaines Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of betaines in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bicarbonate</VALIDVALUE>
          <VALUEMEANING>Bicarbonate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of bicarbonate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bile Acid</VALIDVALUE>
          <VALUEMEANING>Bile Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of bile acids present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bilirubin Crystals</VALIDVALUE>
          <VALUEMEANING>Bilirubin Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of bilirubin crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405735</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bilirubin</VALIDVALUE>
          <VALUEMEANING>Total Bilirubin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>Bilirubin is a breakdown product of hemoglobin. Total and direct bilirubin are usually measured to screen for or to monitor liver or gall bladder dysfunction. (from MedlinePlus Medical Encyclopedia)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38037</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clobazam</VALIDVALUE>
          <VALUEMEANING>Clobazam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the clobazam in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184613</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clonazepam and/or Metabolites</VALIDVALUE>
          <VALUEMEANING>Clonazepam and/or Metabolites Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of clonazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both clonazepam and its metabolites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186031</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clonazepam</VALIDVALUE>
          <VALUEMEANING>Clonazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of clonazepam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clorazepate</VALIDVALUE>
          <VALUEMEANING>Clorazepate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of clorazepate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139077</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clostebol</VALIDVALUE>
          <VALUEMEANING>Clostebol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the clostebol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184581</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clot Lysis Time</VALIDVALUE>
          <VALUEMEANING>Euglobulin Clot Lysis Time</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of time it takes for dissolution of a fibrin clot in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187805</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clot Retraction Time</VALIDVALUE>
          <VALUEMEANING>Clot Retraction Time Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the amount of time it takes for a clot to retract, or pull away from, the wall of a glass collection container.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181437</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clot Retraction</VALIDVALUE>
          <VALUEMEANING>Qualitative Clot Retraction Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A qualitative assessment of clot retraction in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clue Cells</VALIDVALUE>
          <VALUEMEANING>Clue Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of clue cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Coagulation Index</VALIDVALUE>
          <VALUEMEANING>Coagulation Index Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the efficiency of coagulation of a biological specimen. This is calculated by a mathematical formula that takes into account the R value, K value, angle and maximum amplitude of clot formation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cocaethylene</VALIDVALUE>
          <VALUEMEANING>Cocaethylene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cocaethylene present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cocaine Amphetamine-Reg Transcript Prot</VALIDVALUE>
          <VALUEMEANING>Cocaine Amphetamine-Regulated Transcript Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cocaine amphetamine-regulated transcript protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cocaine and/or Metabolites</VALIDVALUE>
          <VALUEMEANING>Cocaine And/Or Metabolites Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the cocaine and/or its metabolite(s) present in a biological specimen, for an assay that can measure both cocaine and its metabolites but may not distinguish either in the result.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cocaine Benzoylecgonine Ecgonine</VALIDVALUE>
          <VALUEMEANING>Cocaine, Benzoylecgonine, and/or Ecgonine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cocaine, benzoylecgonine, and/or ecgonine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142274</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cocaine Metabolites</VALIDVALUE>
          <VALUEMEANING>Cocaine Metabolites Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cocaine metabolites in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cocaine</VALIDVALUE>
          <VALUEMEANING>Cocaine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cocaine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74690</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Codeine</VALIDVALUE>
          <VALUEMEANING>Codeine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of codeine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74877</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Coefficient of Fat Absorption</VALIDVALUE>
          <VALUEMEANING>Coefficient of Fat Absorption Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the coefficient of fat absorption in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Coefficient of Nitrogen Absorption</VALIDVALUE>
          <VALUEMEANING>Coefficient of Nitrogen Absorption Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the coefficient of nitrogen absorption in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Collagen III Neo-Peptide C3M</VALIDVALUE>
          <VALUEMEANING>Collagen III Neo-Peptide C3M Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of collagen III neo-peptide C3M present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165945</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Collagen Type IV</VALIDVALUE>
          <VALUEMEANING>Collagen Type IV Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the collagen type IV in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Color</VALIDVALUE>
          <VALUEMEANING>Color Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>A qualitative assessment of the color of a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Columnar Epi Cells/Non-Squam Epi Cells</VALIDVALUE>
          <VALUEMEANING>Columnar Epithelial Cells to Non-Squamous Epithelial Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of columnar epithelial cells compared to non-squamous epithelial cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement Ba</VALIDVALUE>
          <VALUEMEANING>Complement Ba Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Ba fragment of complement factor B in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402484</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement Bb</VALIDVALUE>
          <VALUEMEANING>Complement Bb Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement Bb present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80172</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C1 Esterase Inhibitor</VALIDVALUE>
          <VALUEMEANING>Complement C1 Esterase Inhibitor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement C1 esterase inhibitor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C1q</VALIDVALUE>
          <VALUEMEANING>Complement C1q Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement C1q present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186029</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C2</VALIDVALUE>
          <VALUEMEANING>Complement C2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement C2 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C3</VALIDVALUE>
          <VALUEMEANING>Complement C3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement C3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C3a DesArg</VALIDVALUE>
          <VALUEMEANING>Complement C3a DesArg Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of complement C3a DesArg present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iodine</VALIDVALUE>
          <VALUEMEANING>Iodine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the total iodine in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iodine, Free</VALIDVALUE>
          <VALUEMEANING>Free Iodine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free iodine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iohexol Clearance</VALIDVALUE>
          <VALUEMEANING>Iohexol Clearance</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the volume of serum or plasma that would be cleared of Iohexol through excretion for a specified unit of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iohexol</VALIDVALUE>
          <VALUEMEANING>Iohexol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of iohexol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125946</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iothalamate Clearance Adjusted for BSA</VALIDVALUE>
          <VALUEMEANING>Iothalamate Clearance Adjusted for BSA</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the clearance of iothalamate and whose result is adjusted for body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iothalamate Clearance</VALIDVALUE>
          <VALUEMEANING>Iothalamate Clearance</VALUEMEANING>
          <MEANINGDESCRIPTION>The rate at which iothalamate is removed or cleared from the whole or part of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98749</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iron Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Iron Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the amount of iron being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150819</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iron</VALIDVALUE>
          <VALUEMEANING>Iron Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the iron in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74679</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3654516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Islet Amyloid Polypeptide</VALIDVALUE>
          <VALUEMEANING>Islet Amyloid Polypeptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of islet amyloid polypeptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Islet Cell 512 Antigen</VALIDVALUE>
          <VALUEMEANING>Islet Cell 512 Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of islet cell 512 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Isoleucine</VALIDVALUE>
          <VALUEMEANING>Isoleucine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the isoleucine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412417</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JWH-018</VALIDVALUE>
          <VALUEMEANING>JWH-018 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the JWH-018 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010362</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JWH-073</VALIDVALUE>
          <VALUEMEANING>JWH-073 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the JWH-073 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JWH-081</VALIDVALUE>
          <VALUEMEANING>JWH-081 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the JWH-081 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JWH-122</VALIDVALUE>
          <VALUEMEANING>JWH-122 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the JWH-122 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JWH-200</VALIDVALUE>
          <VALUEMEANING>JWH-200 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the JWH-200 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184544</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JWH-250</VALIDVALUE>
          <VALUEMEANING>JWH-250 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the JWH-250 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JWH-398</VALIDVALUE>
          <VALUEMEANING>JWH-398 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the JWH-398 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sodium Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Sodium Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the amount of sodium being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150823</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sodium</VALIDVALUE>
          <VALUEMEANING>Sodium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of sodium present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5290837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sodium/Creatinine</VALIDVALUE>
          <VALUEMEANING>Sodium to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of sodium compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sodium/Potassium</VALIDVALUE>
          <VALUEMEANING>Sodium to Potassium Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of sodium to potassium present in a sample. The measurement by be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble B Cell Maturation Antigen</VALIDVALUE>
          <VALUEMEANING>Soluble B Cell Maturation Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble B cell maturation antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170577</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble CEA Cell Adhesion Molecule 5</VALIDVALUE>
          <VALUEMEANING>Soluble CEA Cell Adhesion Molecule 5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble carcinoembryonic antigen (CEA) cell adhesion molecule 5 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Complement C5b-9</VALIDVALUE>
          <VALUEMEANING>Soluble Complement C5b-9 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble complement C5b-9 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170579</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble E-Selectin</VALIDVALUE>
          <VALUEMEANING>Soluble E-Selectin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the soluble E-selectin activity in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble HER2</VALIDVALUE>
          <VALUEMEANING>HER2 Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of HER2 antigen, including peptides, epitopes, and receptor, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Immunoglobulin</VALIDVALUE>
          <VALUEMEANING>Soluble Immunoglobulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble immunoglobulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Intercell Adhesion Molecule 1</VALIDVALUE>
          <VALUEMEANING>Soluble Intercellular Adhesion Molecule 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble intercellular adhesion molecule 1 in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Intercell Adhesion Molecule 4</VALIDVALUE>
          <VALUEMEANING>Soluble Intercellular Adhesion Molecule 4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble intercellular adhesion molecule 4 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Interleukin 2 Receptor</VALIDVALUE>
          <VALUEMEANING>Soluble Interleukin 2 Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble interleukin 2 receptor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Interleukin 6 Receptor</VALIDVALUE>
          <VALUEMEANING>Soluble Interleukin 6 Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble interleukin 6 Receptor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Interleukin-1 Receptor Type I</VALIDVALUE>
          <VALUEMEANING>Soluble Interleukin-1 Receptor Type I Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble interleukin-1 receptor type I present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117836</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Kidney Injury Molecule-1</VALIDVALUE>
          <VALUEMEANING>Soluble Kidney Injury Molecule-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble kidney injury molecule-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble L-Selectin</VALIDVALUE>
          <VALUEMEANING>Soluble L-Selectin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble L-selectin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sonic Hedgehog</VALIDVALUE>
          <VALUEMEANING>Sonic Hedgehog Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sonic hedgehog in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177989</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sorbitol Dehydrogenase</VALIDVALUE>
          <VALUEMEANING>Sorbitol Dehydrogenase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sorbitol dehydrogenase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Specific Gravity</VALIDVALUE>
          <VALUEMEANING>Specific Gravity</VALUEMEANING>
          <MEANINGDESCRIPTION>The density (mass per unit volume) of any material divided by that of water at a standard temperature.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Specimen Appearance</VALIDVALUE>
          <VALUEMEANING>Specimen Appearance Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>An evalation of the outward or visible aspect of a biospecimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C179695</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7742878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Specimen Weight</VALIDVALUE>
          <VALUEMEANING>Specimen Weight Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the weight of a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sperm Agglutination</VALIDVALUE>
          <VALUEMEANING>Sperm Agglutination Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the motile spermatozoa agglutination present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sperm Aggregation</VALIDVALUE>
          <VALUEMEANING>Sperm Aggregation Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of immotile spermatozoa aggregation present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sperm Motility</VALIDVALUE>
          <VALUEMEANING>Sperm Motility Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sperm capable of forward, progressive movement present in a semen sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spermatozoa</VALIDVALUE>
          <VALUEMEANING>Spermatozoa Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of spermatozoa cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74663</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spermatozoa, Progressive</VALIDVALUE>
          <VALUEMEANING>Progressive Spermatozoa Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of progressive spermatozoa present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spermatozoa, Progressive/Spermatozoa</VALIDVALUE>
          <VALUEMEANING>Progressive Spermatozoa to Total Spermatozoa Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of progressive spermatozoa compared to total spermatozoa present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161365</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spherocytes</VALIDVALUE>
          <VALUEMEANING>Spherocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of spherocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74707</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Galactose-Deficient IgA1</VALIDVALUE>
          <VALUEMEANING>Galactose-Deficient IgA1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of galactose-deficient IgA1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165961</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Galanin</VALIDVALUE>
          <VALUEMEANING>Galanin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of galanin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Galectin-3 Binding Protein</VALIDVALUE>
          <VALUEMEANING>Galectin-3 Binding Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of galectin-3 binding protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186053</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Galectin-3</VALIDVALUE>
          <VALUEMEANING>Galectin-3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of galectin-3 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351730</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gamma Globulin</VALIDVALUE>
          <VALUEMEANING>Gamma Globulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of gamma globulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92257</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gamma Globulin/Total Protein</VALIDVALUE>
          <VALUEMEANING>Gamma Globulin to Total Protein Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of gamma globulin compared to total protein present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gamma Glutamyl Transferase</VALIDVALUE>
          <VALUEMEANING>Gamma Glutamyl Transpeptidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64847</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gamma Glutamyl Transferase/Creatinine</VALIDVALUE>
          <VALUEMEANING>Gamma Glutamyl Transferase to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of gamma glutamyl transferase compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gamma Tocopherol</VALIDVALUE>
          <VALUEMEANING>Gamma Tocopherol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of gamma tocopherol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gamma-Aminobutyric Acid</VALIDVALUE>
          <VALUEMEANING>Gamma-Aminobutyric Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of gamma-aminobutyric acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154766</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gamma-Hydroxybutyrate</VALIDVALUE>
          <VALUEMEANING>Gamma-Hydroxybutyrate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of gamma-hydroxybutyrate (GHB) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75357</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GammaGlutamyl Transferase Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Gamma Glutamyl Transferase Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of gamma glutamyl transferase being excreted in a biological specimen over a defined amount of time (e.g. one hour).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganglioside GM3</VALIDVALUE>
          <VALUEMEANING>Ganglioside GM3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the ganglioside GM3 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrin</VALIDVALUE>
          <VALUEMEANING>Gastrin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of gastrin hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74858</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1,25-Dihydroxyvitamin D2</VALIDVALUE>
          <VALUEMEANING>1,25-Dihydroxyvitamin D2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 1,25-dihydroxyvitamin D2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C179752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7742931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1,25-Dihydroxyvitamin D3</VALIDVALUE>
          <VALUEMEANING>1,25-Dihydroxyvitamin D3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 1,25-dihydroxyvitamin D3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C179754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7742927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1,25-DihydroxyvitD2+1,25-DihydroxyvitD3</VALIDVALUE>
          <VALUEMEANING>1,25-Dihydroxyvitamin D2 and 1,25-Dihydroxyvitamin D3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C179753</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7742929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1,3-Beta-D-Glucan</VALIDVALUE>
          <VALUEMEANING>1,3-Beta-D-Glucan Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 1,3-beta-D-glucan in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1,5-Anhydroglucitol</VALIDVALUE>
          <VALUEMEANING>1,5-Anhydroglucitol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 1,5-anhydroglucitol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1-Hydroxymidazolam</VALIDVALUE>
          <VALUEMEANING>1-Hydroxymidazolam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 1-hydroxymidazolam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154732</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11-Dehydro-Thromboxane B2 Excretion Rate</VALIDVALUE>
          <VALUEMEANING>11-Dehydro-Thromboxane B2 Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 11-dehydro-thromboxane B2 being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11-Dehydro-Thromboxane B2</VALIDVALUE>
          <VALUEMEANING>11-Dehydro-Thromboxane B2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the 11-dehydro-thromboxane B2 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3783686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11-Deoxycorticosteroids</VALIDVALUE>
          <VALUEMEANING>11-Deoxycorticosteroid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total 11-deoxycorticosteroids present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11-Deoxycorticosterone</VALIDVALUE>
          <VALUEMEANING>11-Deoxycorticosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 11-deoxycorticosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11-Deoxycortisol</VALIDVALUE>
          <VALUEMEANING>11-Deoxycortisol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 11-deoxycortisol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186043</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11-Hydroxyandrostenedione</VALIDVALUE>
          <VALUEMEANING>11-Hydroxyandrostenedione Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 11-hydroxyandrostenedione present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11-Hydroxyandrosterone</VALIDVALUE>
          <VALUEMEANING>11-Hydroxyandrosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 11-hydroxyandrosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11-Hydroxyetiocholanolone</VALIDVALUE>
          <VALUEMEANING>11-Hydroxyetiocholanolone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 11-hydroxyetiocholanolone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from B-2 Microglobulin Adj for BSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from B-2 Microglobulin Adjusted for BSA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from Beta-Trace Protein Adj for BSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from Beta-Trace Protein Adjusted for BSA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411347</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from Creat and UreaN Adj BSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from Creatinine and Urea Nitrogen Adjusted for Body Surface Area Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the glomerular filtration rate by measurement of creatinine and urea nitrogen clearance and whose result is adjusted for body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from Creat,UreaN,Alb Adj BSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from Creatinine, Urea Nitrogen, and Albumin Adjusted for Body Surface Area Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the glomerular filtration rate by measurement of creatinine, urea nitrogen, and albumin clearance and whose result is adjusted for body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163443</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from Creatinine Adjusted for BSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from Creatinine Adjusted for BSA</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the glomerular filtration rate by measurement of creatinine clearance and whose result is adjusted for body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98735</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from Cystatin C Adjusted for BSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from Cystatin C Adjusted for BSA</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the glomerular filtration rate by measurement of cystatin c clearance and whose result is adjusted for body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from Cystatin C and Creat Adj BSA</VALIDVALUE>
          <VALUEMEANING>Glomeluar Filtration Rate from Cystatin C and Creatinine Adjusted for BSA</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the glomerular filtration rate by measurement of creatinine and cystatin C clearance and whose result is adjusted for body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127614</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ghrelin</VALIDVALUE>
          <VALUEMEANING>Ghrelin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ghrelin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Giant Neutrophils</VALIDVALUE>
          <VALUEMEANING>Giant Neutrophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of giant neutrophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96651</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Giant Platelets</VALIDVALUE>
          <VALUEMEANING>Giant Platelet Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of giant platelets present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74728</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glial Fibrillary Acidic Protein</VALIDVALUE>
          <VALUEMEANING>Glial Fibrillary Acidic Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glial fibrillary acidic protein in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glitter Cells</VALIDVALUE>
          <VALUEMEANING>Glitter Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glitter cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Globulin</VALIDVALUE>
          <VALUEMEANING>Globulin Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of globulin protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74738</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Globulin/Creatinine</VALIDVALUE>
          <VALUEMEANING>Globulin to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of globulin compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glomerular Filtration Rate Adj for BSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate Adjusted for BSA</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the glomerular filtration rate whose result is adjusted for body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98734</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glomerular Filtration Rate</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman&#39;s capsule per unit of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glomerular Filtration Rate, Estimated</VALIDVALUE>
          <VALUEMEANING>Estimated Glomerular Filtration Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A laboratory test that estimates kidney function. It is calculated using an individual&#39;s serum creatinine measurement, age, sex, and race. Actual results are reported when the estimated glomerular filtration rate is less than 60 ml/min.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110935</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404085</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11-Ketoandrosterone</VALIDVALUE>
          <VALUEMEANING>11-Ketoandrosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 11-ketoandrosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11-Ketoetiocholanolone</VALIDVALUE>
          <VALUEMEANING>11-Ketoetiocholanolone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 11-ketoetiocholanolone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186074</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11-Nor-Delta9-THC-9-Carboxylic Acid</VALIDVALUE>
          <VALUEMEANING>11-Nor-Delta9-THC-9-Carboxylic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 11-nor-delta-9-THC-9-carboxylic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17-Hydroxycorticosteroids</VALIDVALUE>
          <VALUEMEANING>17-Hydroxycorticosteroid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 17-hydroxycorticosteroids present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186065</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17-Hydroxypregnenolone</VALIDVALUE>
          <VALUEMEANING>17-Hydroxypregnenolone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 17-hydroxypregnenolone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186070</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17-Hydroxyprogesterone</VALIDVALUE>
          <VALUEMEANING>17-Hydroxyprogesterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 17-hydroxyprogesterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413830</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17-Ketogenic steroids</VALIDVALUE>
          <VALUEMEANING>17-Ketogenic Steroid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total 17-ketogenic steroids present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186075</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17-Ketosteroids</VALIDVALUE>
          <VALUEMEANING>17-Ketosteroid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total 17-ketosteroids present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186076</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18-Hydroxycorticosterone</VALIDVALUE>
          <VALUEMEANING>18-Hydroxycorticosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 18-hydroxycorticosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186067</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18-Hydroxycortisol</VALIDVALUE>
          <VALUEMEANING>18-Hydroxycortisol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 18-hydroxycortisol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186066</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161492</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18-Hydroxydeoxycorticosterone</VALIDVALUE>
          <VALUEMEANING>18-Hydroxydeoxycorticosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 18-hydroxydeoxycorticosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186068</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-5-Oligoadenylate Synthase 1</VALIDVALUE>
          <VALUEMEANING>2-5-Oligoadenylate Synthase 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 2-5-oligoadenylate synthase 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-5-Oligoadenylate Synthase 2</VALIDVALUE>
          <VALUEMEANING>2-5-Oligoadenylate Synthase 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 2-5-oligoadenylate synthase 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154042</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-5-Oligoadenylate Synthase 3</VALIDVALUE>
          <VALUEMEANING>2-5-Oligoadenylate Synthase 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 2-5-oligoadenylate synthase 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-Hydroxyglutarate</VALIDVALUE>
          <VALUEMEANING>2-Hydroxyglutarate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 2-hydroxyglutarate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-Methylcitrate</VALIDVALUE>
          <VALUEMEANING>2-Methylcitrate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 2-methylcitrate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177957</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20(S)-Hydroxycholesterol</VALIDVALUE>
          <VALUEMEANING>20(S)-Hydroxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 20(S)-hydroxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21-Deoxycorticosterone</VALIDVALUE>
          <VALUEMEANING>21-Deoxycorticosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 21-deoxycorticosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21-Deoxycortisol</VALIDVALUE>
          <VALUEMEANING>21-Deoxycortisol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 21-deoxycortisol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186044</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22(R)-Hydroxycholesterol</VALIDVALUE>
          <VALUEMEANING>22(R)-Hydroxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 22(R)-hydroxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22(S)-Hydroxycholesterol</VALIDVALUE>
          <VALUEMEANING>22(S)-Hydroxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 22(S)-hydroxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24(R)-Hydroxycholesterol</VALIDVALUE>
          <VALUEMEANING>24(R)-Hydroxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 24(R)-hydroxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24(S),25-Epoxycholesterol</VALIDVALUE>
          <VALUEMEANING>24(S),25-Epoxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 24(S),25-epoxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24(S)-Hydroxycholesterol</VALIDVALUE>
          <VALUEMEANING>24(S)-Hydroxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 24(S)-hydroxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24,25-Dihydroxyvitamin D3</VALIDVALUE>
          <VALUEMEANING>24,25-Dihydroxyvitamin D Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 24,25-dihydroxyvitamin D present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156511</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25-Hydroxycholesterol</VALIDVALUE>
          <VALUEMEANING>25-Hydroxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 25-hydroxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181426</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798089</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25-Hydroxyvit D2 + 25-Hydroxyvit D3</VALIDVALUE>
          <VALUEMEANING>25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25-Hydroxyvitamin D2</VALIDVALUE>
          <VALUEMEANING>25-Hydroxyvitamin D2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 25-hydroxyvitamin D2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25-Hydroxyvitamin D3</VALIDVALUE>
          <VALUEMEANING>25-Hydroxyvitamin D3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 25-hydroxyvitamin D3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156529</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27-Hydroxycholesterol</VALIDVALUE>
          <VALUEMEANING>27-Hydroxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 27-hydroxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3,4-Dihydroxyphenylacetic Acid</VALIDVALUE>
          <VALUEMEANING>3,4-Dihydroxyphenylacetic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the 3,4-dihydroxyphenylacetic acid in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3,4-Dihydroxyphenylglycol</VALIDVALUE>
          <VALUEMEANING>3,4-Dihydroxyphenylglycol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 3,4-Dihydroxyphenylglycol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101017</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3,4-methylenedioxy-N-ethylamphetamine</VALIDVALUE>
          <VALUEMEANING>3,4-methylenedioxy-N-ethylamphetamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the 3,4-methylenedioxy-n-ethylamphetamine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3,4-methylenedioxyamphetamine</VALIDVALUE>
          <VALUEMEANING>3,4-methylenedioxyamphetamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the 3,4-methylenedioxyamphetamine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3,4-methylenedioxymethamphetamine</VALIDVALUE>
          <VALUEMEANING>3,4-Methylenedioxymethamphetamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 3,4-methylenedioxymethamphetamine (MDMA) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3-Alpha-Androstanediol Glucuronide</VALIDVALUE>
          <VALUEMEANING>3-Alpha-Androstanediol Glucuronide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 3-alpha-androstanediol glucuronide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3-Methoxytyramine</VALIDVALUE>
          <VALUEMEANING>Total 3-Methoxytyramine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total 3-methoxytyramine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166841</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3-Methoxytyramine, Free</VALIDVALUE>
          <VALUEMEANING>Free 3-Methoxytyramine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free 3-methoxytyramine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186083</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3-Methylfentanyl</VALIDVALUE>
          <VALUEMEANING>3-Methylfentanyl Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the 3-methylfentanyl in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3-Nitrotyrosine</VALIDVALUE>
          <VALUEMEANING>3-Nitrotyrosine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total 3-nitrotyrosine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3beta-Hydroxy-5-Cholestenoic Acid</VALIDVALUE>
          <VALUEMEANING>3beta-Hydroxy-5-Cholestenoic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 3beta-hydroxy-5-cholestenoic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4-Beta-Hydroxycholesterol</VALIDVALUE>
          <VALUEMEANING>4-Beta-Hydroxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 4-beta-hydroxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4-Hydroxymidazolam</VALIDVALUE>
          <VALUEMEANING>4-Hydroxymidazolam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 4-hydroxymidazolam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154731</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4-Hydroxynonenal</VALIDVALUE>
          <VALUEMEANING>4-Hydroxynonenal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the 4-hydroxynonenal in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187788</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4-Hydroxytestosterone</VALIDVALUE>
          <VALUEMEANING>4-Hydroxytestosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 4-hydroxytestosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5 Prime Nucleotidase</VALIDVALUE>
          <VALUEMEANING>5 Prime Nucleotidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the 5&#39;-nucleotidase in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79437</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraldehyde</VALIDVALUE>
          <VALUEMEANING>Paraldehyde Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the paraldehyde in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184630</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epidermal Growth Factor Receptor</VALIDVALUE>
          <VALUEMEANING>Epidermal Growth Factor Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of epidermal growth factor receptor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraoxonase 1</VALIDVALUE>
          <VALUEMEANING>Paraoxonase 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of paraoxonase 1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199905</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parathyroid Hormone, C-Terminal</VALIDVALUE>
          <VALUEMEANING>C-Terminal Parathyroid Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of C-terminal parathyroid hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81964</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parathyroid Hormone, Fragmented</VALIDVALUE>
          <VALUEMEANING>Fragmented Parathyroid Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fragmented parathyroid hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74784</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parathyroid Hormone, Intact</VALIDVALUE>
          <VALUEMEANING>Intact Parathyroid Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of intact parathyroid hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parathyroid Hormone, Mid-Molecule</VALIDVALUE>
          <VALUEMEANING>Mid-Molecule Parathyroid Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of mid-molecule parathyroid hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parathyroid Hormone, N-Terminal</VALIDVALUE>
          <VALUEMEANING>N-Terminal Parathyroid Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of N-terminal parathyroid hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parathyroid Hormone, Whole</VALIDVALUE>
          <VALUEMEANING>Whole Parathyroid Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the whole parathyroid hormone (consisting of amino acids 1-84) in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103451</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parathyroid Hormone-related Protein</VALIDVALUE>
          <VALUEMEANING>Parathyroid Hormone-related Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of parathyroid hormone-related protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402841</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parkinson Disease Protein 7</VALIDVALUE>
          <VALUEMEANING>Parkinson Disease Protein 7 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Parkinson disease protein 7 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199907</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paroxetine</VALIDVALUE>
          <VALUEMEANING>Paroxetine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of paroxetine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial Pressure Carbon Dioxide Adj Temp</VALIDVALUE>
          <VALUEMEANING>Partial Pressure of Carbon Dioxide Adjusted for Body Temperature Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the partial pressure of carbon dioxide, adjusted for body temperature, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophils Band Form/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Eosinophil Band Form to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of band eosinophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophils</VALIDVALUE>
          <VALUEMEANING>Eosinophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of eosinophils in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64550</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophils, Segmented</VALIDVALUE>
          <VALUEMEANING>Segmented Eosinophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of segmented eosinophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413765</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophils/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Eosinophil to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of eosinophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64604</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophils/Non-Squam Epi Cells</VALIDVALUE>
          <VALUEMEANING>Eosinophils to Non-Squamous Epithelial Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of eosinophils compared to non-squamous epithelial cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophils/Total Cells</VALIDVALUE>
          <VALUEMEANING>Eosinophils to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of eosinophils compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eotaxin-1</VALIDVALUE>
          <VALUEMEANING>Eotaxin-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of eotaxin-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81952</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eotaxin-2</VALIDVALUE>
          <VALUEMEANING>Eotaxin-2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of eotaxin-2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81953</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eotaxin-3</VALIDVALUE>
          <VALUEMEANING>Eotaxin-3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of eotaxin-3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81954</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ephedrine</VALIDVALUE>
          <VALUEMEANING>Ephedrine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the ephedrine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174296</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epi Cells/Non-Squam Epi Cells</VALIDVALUE>
          <VALUEMEANING>Epithelial Cells to Non-Squamous Epithelial Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of epithelial cells compared to non-squamous epithelial cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135414</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Taurochenodeoxycholate</VALIDVALUE>
          <VALUEMEANING>Taurochenodeoxycholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of taurochenodeoxycholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551735</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Taurocholate</VALIDVALUE>
          <VALUEMEANING>Taurocholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of taurocholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Taurolithocholate</VALIDVALUE>
          <VALUEMEANING>Taurolithocholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of taurolithocholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tauroursodeoxycholate</VALIDVALUE>
          <VALUEMEANING>Tauroursodeoxycholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tauroursodeoxycholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176303</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Temazepam</VALIDVALUE>
          <VALUEMEANING>Temazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of temazepam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405739</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tenascin C</VALIDVALUE>
          <VALUEMEANING>Tenascin C Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tenacin C in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Terminal Deoxynucleotidyl Transferase Ag</VALIDVALUE>
          <VALUEMEANING>Terminal Deoxynucleotidyl Transferase Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of terminal deoxynucleotidyl transferase antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117859</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testolactone</VALIDVALUE>
          <VALUEMEANING>Testolactone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the testolactone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184601</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testosterone Free+Weakly Bound/Testost</VALIDVALUE>
          <VALUEMEANING>Free Testosterone and Weakly Bound to Total Testosterone Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of free and weakly bound testosterone compared to total testosterone present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6421205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testosterone</VALIDVALUE>
          <VALUEMEANING>Total Testosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free and bound testosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74793</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404149</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testosterone, Free</VALIDVALUE>
          <VALUEMEANING>Free Testosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free testosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409002</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testosterone, Free/Testosterone</VALIDVALUE>
          <VALUEMEANING>Free Testosterone to Testosterone Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of free testosterone compared to total testosterone present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testosterone, Free/Total Protein</VALIDVALUE>
          <VALUEMEANING>Free Testosterone to Total Protein Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio or percentage) of free testosterone to total proteins in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128980</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testosterone, Weakly Bound</VALIDVALUE>
          <VALUEMEANING>Weakly Bound Testosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of weakly bound testosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tetrahydrocannabinol</VALIDVALUE>
          <VALUEMEANING>Tetrahydrocannabinol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tetrahydrocannabinol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403810</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tetrahydrogestrinone</VALIDVALUE>
          <VALUEMEANING>Tetrahydrogestrinone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the tetrahydrogestrinone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184602</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thebaine</VALIDVALUE>
          <VALUEMEANING>Thebaine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the thebaine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184577</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Theophylline</VALIDVALUE>
          <VALUEMEANING>Theophylline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of theophylline present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thiamine</VALIDVALUE>
          <VALUEMEANING>Vitamin B1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin B1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74896</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407251</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thiamylal</VALIDVALUE>
          <VALUEMEANING>Thiamylal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the thiamylal in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thiocyanate</VALIDVALUE>
          <VALUEMEANING>Thiocyanate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of thiocyanate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thiopental</VALIDVALUE>
          <VALUEMEANING>Thiopental Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the thiopental in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184604</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thioridazine</VALIDVALUE>
          <VALUEMEANING>Thioridazine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of thioridazine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177978</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637374</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thiothixene</VALIDVALUE>
          <VALUEMEANING>Thiothixene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of thiothixene in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177976</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Threonine</VALIDVALUE>
          <VALUEMEANING>Threonine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of threonine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122156</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Threonine/Creatinine</VALIDVALUE>
          <VALUEMEANING>Threonine to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of threonine compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thrombin Activity Actual/Control</VALIDVALUE>
          <VALUEMEANING>Thrombin Activity Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the biological activity of thrombin dependent coagulation in a subject&#39;s specimen when compared to the same activity in a control specimen. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147437</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thrombin Antithrombin Complex</VALIDVALUE>
          <VALUEMEANING>Thrombin Antithrombin Complex Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of thrombin antithrombin complex present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161371</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thrombin Time Actual/Control</VALIDVALUE>
          <VALUEMEANING>Thrombin Time Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the thrombin time in a subject&#39;s specimen compared to a control sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thrombin Time</VALIDVALUE>
          <VALUEMEANING>Thrombin Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80365</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thrombin/Antithrombin</VALIDVALUE>
          <VALUEMEANING>Thrombin to Antithrombin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of thrombin compared to antithrombin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thrombocytes</VALIDVALUE>
          <VALUEMEANING>Nucleated Thrombocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nucleated thrombocytes present in a sample. This is typically measured in birds and other non-mammalian vertebrates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111283</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thrombomodulin</VALIDVALUE>
          <VALUEMEANING>Thrombomodulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of thrombomodulin in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Triglycerides</VALIDVALUE>
          <VALUEMEANING>Triglyceride Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of triglyceride present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64812</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6384458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Triglycerides/HDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>Triglycerides to HDL Cholesterol Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of triglycerides compared to HDL cholesterol present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Triiodothyronine Uptake</VALIDVALUE>
          <VALUEMEANING>Triiodothyronine Uptake Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the binding of triiodothyonine to thyroxine binding globulin protein in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Triiodothyronine</VALIDVALUE>
          <VALUEMEANING>Triiodothyronine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free and bound triiodothyronine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Triiodothyronine, Free</VALIDVALUE>
          <VALUEMEANING>Free Triiodothyronine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free triiodothyronine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74787</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Triiodothyronine, Reverse</VALIDVALUE>
          <VALUEMEANING>Reverse Triiodothyronine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the reverse triiodothyronine in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81968</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trimeperidine</VALIDVALUE>
          <VALUEMEANING>Trimeperidine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the trimeperidine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tripartite Motif Containing Protein 21</VALIDVALUE>
          <VALUEMEANING>Tripartite Motif Containing Protein 21 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tripartite motif containing protein 21 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tripartite Motif Containing Protein 38</VALIDVALUE>
          <VALUEMEANING>Tripartite Motif Containing Protein 38 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tripartite motif containing protein 38 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Triple Phosphate Crystals</VALIDVALUE>
          <VALUEMEANING>Triple Phosphate Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of triple phosphate crystals present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Troponin I Type 1</VALIDVALUE>
          <VALUEMEANING>Troponin I Type 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of troponin I type 1 (slow twitch skeletal muscle) in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135447</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Troponin I Type 2</VALIDVALUE>
          <VALUEMEANING>Troponin I Type 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of toponin I type 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Troponin I Type 3</VALIDVALUE>
          <VALUEMEANING>Troponin I Type 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of troponin I type 3 (cardiac muscle) in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135448</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Troponin I</VALIDVALUE>
          <VALUEMEANING>Troponin I Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of troponin I present in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74749</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5655117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acute Kidney Injury Risk Score</VALIDVALUE>
          <VALUEMEANING>Acute Kidney Injury Risk Score</VALUEMEANING>
          <MEANINGDESCRIPTION>A scoring system that evaluates acute kidney injury risk through the assessment of urine test parameter(s), and which may take into account additional factors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5-Alpha Tetrahydrocortisol</VALIDVALUE>
          <VALUEMEANING>5-Alpha Tetrahydrocortisol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 5-alpha tetrahydrocortisol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5-fluoro PB-22 3-carboxyindole</VALIDVALUE>
          <VALUEMEANING>5-fluoro PB-22 3-carboxyindole Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the synthetic cannabinoid metabolite 5-fluoro PB-22 3-carboxyindole in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5-Hydroxyindoleacetic Acid</VALIDVALUE>
          <VALUEMEANING>5-Hydroxyindoleacetic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 5-hydroxyindoleacetic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5-Hydroxyindoleacetic Acid/Creatinine</VALIDVALUE>
          <VALUEMEANING>5-Hydroxyindoleacetic Acid to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of 5-hydroxyindoleacetic acid compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170578</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5-HydroxyindoleaceticAcid Excretion Rate</VALIDVALUE>
          <VALUEMEANING>5-Hydroxyindoleacetic Acid Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 5-hydroxyindoleacetic acid being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6 Beta-Hydroxycortisol</VALIDVALUE>
          <VALUEMEANING>6 Beta-Hydroxycortisol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 6 beta-hydroxycortisol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6-Monoacetylmorphine</VALIDVALUE>
          <VALUEMEANING>6-Monoacetylmorphine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 6-monoacetylmorphine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6a OH-tetrahydro-11-DeH-Corticosterone</VALIDVALUE>
          <VALUEMEANING>6a OH-tetrahydro-11-DeH-Corticosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 6-alpha hydroxytetrahydro-11-dehydrocorticosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neoplastic Plasma Cells</VALIDVALUE>
          <VALUEMEANING>Neoplastic Plasma Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of neoplastic plasma cells in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351770</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neopterin</VALIDVALUE>
          <VALUEMEANING>Neopterin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of neopterin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nephrin</VALIDVALUE>
          <VALUEMEANING>Nephrin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the nephrin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nerve Growth Factor Alpha</VALIDVALUE>
          <VALUEMEANING>Nerve Growth Factor Alpha Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nerve growth factor alpha present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198287</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nerve Growth Factor Beta</VALIDVALUE>
          <VALUEMEANING>Nerve Growth Factor Beta Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nerve growth factor beta present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nerve Growth Factor Gamma</VALIDVALUE>
          <VALUEMEANING>Nerve Growth Factor Gamma Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nerve growth factor gamma present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nerve Growth Factor</VALIDVALUE>
          <VALUEMEANING>Nerve Growth Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nerve growth factor in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurofilament Heavy Polypeptide</VALIDVALUE>
          <VALUEMEANING>Neurofilament Heavy Polypeptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of neurofilament heavy polypeptide in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199902</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurofilament Light Chain Protein</VALIDVALUE>
          <VALUEMEANING>Neurofilament Light Chain Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of neurofilament light chain protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142285</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurokinin A</VALIDVALUE>
          <VALUEMEANING>Neurokinin A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of neurokinin A present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154050</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuron Specific Enolase</VALIDVALUE>
          <VALUEMEANING>Neuron Specific Enolase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of neuron specific enolase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuropeptide Y</VALIDVALUE>
          <VALUEMEANING>Neuropeptide Y Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of neuropeptide Y present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74892</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuropilin-1</VALIDVALUE>
          <VALUEMEANING>Neuropilin-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of neuropilin-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165977</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurotensin</VALIDVALUE>
          <VALUEMEANING>Neurotensin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of neurotensin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154046</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutral Fats</VALIDVALUE>
          <VALUEMEANING>Neutral Fats Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of neutral fats present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophil Elastase</VALIDVALUE>
          <VALUEMEANING>Neutrophil Elastase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of neutrophil elastase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82026</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophil Elastase, Polymorphonuclear</VALIDVALUE>
          <VALUEMEANING>Polymorphonuclear Neutrophil Elastase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of polymorphonuclear neutrophil elastase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophilic Metamyelocytes</VALIDVALUE>
          <VALUEMEANING>Neutrophilic Metamyelocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of neutrophilic metamyelocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84822</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophilic Metamyelocytes/Total Cells</VALIDVALUE>
          <VALUEMEANING>Neutrophilic Metamyelocyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the neutrophilic metamyelocytes to total cells in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophilic Myelocytes</VALIDVALUE>
          <VALUEMEANING>Neutrophilic Myelocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of neutrophilic myelocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84823</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophilic Myelocytes/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Neutrophilic Myelocytes to Lymphocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of neutrophilic myelocytes compared to lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophilic Toxic Change</VALIDVALUE>
          <VALUEMEANING>Neutrophilic Toxic Change Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of any type of toxic change in the neutrophilic cells within a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils Band Form</VALIDVALUE>
          <VALUEMEANING>Neutrophil Band Form Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of band neutrophils in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64830</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils Band Form/ Neutrophils</VALIDVALUE>
          <VALUEMEANING>Neutrophils Band Form to Neutrophils Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of neutrophil band form compared to neutrophils present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils Band Form/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Neutrophil Band Form to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of band neutrophils compared to leukocytes in a blood sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64831</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils Band Form/Total Cells</VALIDVALUE>
          <VALUEMEANING>Neutrophil Band Form to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187701</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils</VALIDVALUE>
          <VALUEMEANING>Absolute Neutrophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The real number of white blood cells (WBC) that are neutrophils. It is derived by multiplying the WBC count by the percent of neutrophils in the differential WBC count. The normal range for ANC is 1.5 to 8.0 (1,500 to 8,000/mm3).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63321</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils, Seg + Band Form + Precursor</VALIDVALUE>
          <VALUEMEANING>Segmented, Band Form and Precursor Neutrophils Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of segmented, band form, and precursor neutrophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619995</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils, Segmented + Band Form</VALIDVALUE>
          <VALUEMEANING>Segmented and Band Form Neutrophils Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of segmented and band form neutrophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils, Segmented</VALIDVALUE>
          <VALUEMEANING>Segmented Neutrophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of segmented neutrophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81997</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405722</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils, Segmented/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Segmented Neutrophil to Leukocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of segmented neutrophils compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405824</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils, Segmented/Neutrophils</VALIDVALUE>
          <VALUEMEANING>Segmented Neutrophils to Neutrophils Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of segmented neutrophils compared to neutrophils present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils, Segmented/Total Cells</VALIDVALUE>
          <VALUEMEANING>Segmented Neutrophil to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of segmented neutrophils to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187679</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Neutrophil to Leukocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of neutrophils compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64827</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Neutrophil to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of neutrophils compared to lymphocytes present in a biological sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8160972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epidermal Growth Factor Receptor, Free</VALIDVALUE>
          <VALUEMEANING>Free Epidermal Growth Factor Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free epidermal growth factor receptor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epidermal Growth Factor</VALIDVALUE>
          <VALUEMEANING>Epidermal Growth Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of epidermal growth factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82009</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epimerized Ursodeoxycholate</VALIDVALUE>
          <VALUEMEANING>Epimerized Ursodeoxycholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of epimerized ursodeoxycholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551739</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epinephrine Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Epinephrine Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of epinephrine being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epinephrine</VALIDVALUE>
          <VALUEMEANING>Epinephrine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of epinephrine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epiregulin</VALIDVALUE>
          <VALUEMEANING>Epiregulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of epiregulin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199891</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epith Neutrophil-Activating Peptide 78</VALIDVALUE>
          <VALUEMEANING>Epithelial Neutrophil-Activating Peptide 78 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of epithelial neutrophil-activating peptide 78 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82010</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epithelial Casts</VALIDVALUE>
          <VALUEMEANING>Epithelial-Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of epithelial casts present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epithelial Cell Clumps</VALIDVALUE>
          <VALUEMEANING>Epithelial Cell Clumps Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the epithelial cell clumps in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159106</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epithelial Cells</VALIDVALUE>
          <VALUEMEANING>Epithelial Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of epithelial cells in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64605</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epithelial Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Epithelial Cells to Total Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of epithelial cells compared to total cells in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epithelial Stromal Interaction Protein 1</VALIDVALUE>
          <VALUEMEANING>Epithelial Stromal Interaction 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of epithelial stromal interaction 1 protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ery. Mean Corpuscular Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Mean Corpuscular Hemoglobin</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen, calculated as the product of hemoglobin times ten, divided by the number of erythrocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ery. Mean Corpuscular HGB Concentration</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Mean Corpuscular Hemoglobin Concentration</VALUEMEANING>
          <MEANINGDESCRIPTION>The mean cell hemoglobin concentration (MCHC), which is the average concentration of hemoglobin in a given volume of blood. The MCHC is a calculated value derived from the measurement of hemoglobin and the hematocrit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ery. Mean Corpuscular Volume</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Mean Corpuscular Volume</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the mean cellular volume per erythrocyte in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64799</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythrocyte Agglutination</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Agglutination Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of erythrocyte agglutination present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythrocyte Cell Clumps</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Cell Clumps Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of erythrocyte cell clumps present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92245</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythrocyte Cell Morphology</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Cell Morphology</VALUEMEANING>
          <MEANINGDESCRIPTION>An examination or assessment of the form and structure of red blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92296</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythrocyte Fragment</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Fragment Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of red blood cell fragments present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythrocyte Ghosts</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Ghost Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96605</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythrocyte Inclusion Bodies</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Inclusion Bodies Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of erythrocyte inclusion bodies present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythrocyte Protoporphyrin, Free</VALIDVALUE>
          <VALUEMEANING>Free Erythrocyte Protoporphyrin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free erythrocyte protoporphyrin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147339</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythrocyte Sedimentation Rate</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Sedimentation Rate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the distance that red blood cells travel in one hour in a sample of unclotted blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4661103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythrocytes Distribution Width</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Distribution Width Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>An index of the variation in the size of the red cells and can be used to detect subtle degress of anisocytosis. It is computed directly from the RBC histogram and is calculated as a standard statictical value, the coefficient of variation of the red cell volume ditribution (ratio of standard deviation and mean copuscular volume).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of erythrocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51946</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6058410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythroferrone</VALIDVALUE>
          <VALUEMEANING>Erythroferrone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of erythroferrone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186047</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythroid Cells/Nucleated Cells</VALIDVALUE>
          <VALUEMEANING>Erythroid Cells to Nucleated Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of erythroid cells compared to nucleated cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythroid Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Erythroid Cells to Total Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of erythroid cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythroid Maturation Index</VALIDVALUE>
          <VALUEMEANING>Erythroid Maturation Index</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the sum of erythroid maturation phase cells (pool) to the sum of erythroid proliferative phase cells (pool) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythroid Maturation Pool</VALIDVALUE>
          <VALUEMEANING>Erythroid Maturation Pool Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of erythroid maturation phase cells (polychromatic rubricytes, normochromic rubricytes, and metarubricytes) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythroid Precursor Cells</VALIDVALUE>
          <VALUEMEANING>Erythroid Precursor Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the erythroid precursors in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187802</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythroid Precursor Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Erythroid Precursor Cells to Total Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the erythroid precursors to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187803</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159108</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythroid Proliferation Index</VALIDVALUE>
          <VALUEMEANING>Erythroid Proliferation Index</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the sum of erythroid proliferative phase cells (pool) to the sum of erythroid maturation phase cells (pool) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial Pressure Carbon Dioxide</VALIDVALUE>
          <VALUEMEANING>Partial Pressure of Carbon Dioxide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the partial pressure of carbon dioxide in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5914713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial Pressure Oxygen Adj for Temp</VALIDVALUE>
          <VALUEMEANING>Partial Pressure of Oxygen Adjusted for Body Temperature Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the partial pressure of oxygen, adjusted for body temperature, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial Pressure Oxygen</VALIDVALUE>
          <VALUEMEANING>Partial Pressure of Oxygen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>Measures the pressure of oxygen dissolved in the blood and how well oxygen is able to move from the airspace of the lungs into the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2926819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial Thromboplastin Time</VALIDVALUE>
          <VALUEMEANING>Partial Thromboplastin Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the length of time that it takes for clotting to occur when no activating reagents are added to a biological specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637830</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pathologic Casts</VALIDVALUE>
          <VALUEMEANING>Pathologic Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pathologic (non-hyaline) casts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186035</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PB-22 3-carboxyindole</VALIDVALUE>
          <VALUEMEANING>PB-22 3-carboxyindole Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the PB-22 3-carboxyindole in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184559</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PCA3 mRNA/PSA mRNA</VALIDVALUE>
          <VALUEMEANING>PCA3 mRNA to PSA mRNA Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of prostate cancer antigen 3 mRNA as compared to the total prostate specific antigen mRNA present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelger Huet Anomaly</VALIDVALUE>
          <VALUEMEANING>Pelger Huet Anomaly Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Pelger Huet anomaly present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74617</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pemoline</VALIDVALUE>
          <VALUEMEANING>Pemoline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the pemoline in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184631</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pentazocine</VALIDVALUE>
          <VALUEMEANING>Pentazocine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the pentazocine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pentedrone</VALIDVALUE>
          <VALUEMEANING>Pentedrone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the pentedrone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184561</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pentobarbital</VALIDVALUE>
          <VALUEMEANING>Pentobarbital Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pentobarbital present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pentylone</VALIDVALUE>
          <VALUEMEANING>Pentylone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the pentylone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor Necrosis Factor</VALIDVALUE>
          <VALUEMEANING>Dectin-1-induced TNF-α production by monocytes</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7519045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Turbidity</VALIDVALUE>
          <VALUEMEANING>Turbidity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the opacity of a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74723</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Type I Collagen C-Telopeptides Beta</VALIDVALUE>
          <VALUEMEANING>Beta Isomer of C-Terminal Telopeptide of Type I Collagen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the beta isomer of type I collagen cross-linked C-telopeptides in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187792</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Type I Collagen C-Telopeptides</VALIDVALUE>
          <VALUEMEANING>C-Telopeptide, Serum</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the type I collagen C-telopeptides in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82038</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3090339</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Type I Collagen C-Telopeptides/Creat</VALIDVALUE>
          <VALUEMEANING>Type I Collagen C-Telopeptide to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of type I collagen c-telopeptides compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127613</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Type I Collagen N-Telopeptides</VALIDVALUE>
          <VALUEMEANING>Type I Collagen N-Telopeptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the type I collagen N-telopeptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82039</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Type I Myeloblasts</VALIDVALUE>
          <VALUEMEANING>Type I Myeloblasts Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of type I myeloblasts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92283</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Type II Collagen C-Telopeptides</VALIDVALUE>
          <VALUEMEANING>Type II Collagen C-Telopeptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the type II collagen C-telopeptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82040</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Type II Collagen C-Telopeptides/Creat</VALIDVALUE>
          <VALUEMEANING>Type II Collagen C-Telopeptides to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of type II collagen C-telopeptides to creatinine present in a sample. The measurement by be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122113</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Type II Collagen N-Telopeptides</VALIDVALUE>
          <VALUEMEANING>Type II Collagen N-Telopeptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the type II collagen N-telopeptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82041</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Type II Myeloblasts</VALIDVALUE>
          <VALUEMEANING>Type II Myeloblasts Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of type II myeloblasts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92284</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Type II Secretory Phospholipase A2</VALIDVALUE>
          <VALUEMEANING>Type II Secretory Phospholipase A2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the type II secretory phospholipase A2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120663</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Type III Myeloblasts</VALIDVALUE>
          <VALUEMEANING>Type III Myeloblasts Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of type III myeloblasts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92285</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tyrosine Crystals</VALIDVALUE>
          <VALUEMEANING>Tyrosine Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tyrosine crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tyrosine</VALIDVALUE>
          <VALUEMEANING>Tyrosine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tyrosine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413381</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urea/Creatinine</VALIDVALUE>
          <VALUEMEANING>Urea to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of urea to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404344</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uric Acid Crystals</VALIDVALUE>
          <VALUEMEANING>Uric Acid Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the uric acid crystals present in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urine Conductivity</VALIDVALUE>
          <VALUEMEANING>Urine Conductivity</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ability of urine to conduct an electrical current. This test is a non-linear function of the electrolyte concentration in the urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urobilinogen</VALIDVALUE>
          <VALUEMEANING>Urobilinogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of urobilinogen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urokinase Plasminogen Activator</VALIDVALUE>
          <VALUEMEANING>Urokinase Plasminogen Activator Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of urokinase plasminogen activator present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181447</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uromodulin</VALIDVALUE>
          <VALUEMEANING>Uromodulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of uromodulin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199895</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urothelial Cells</VALIDVALUE>
          <VALUEMEANING>Urothelial Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of urothelial cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ursodeoxycholate Compounds</VALIDVALUE>
          <VALUEMEANING>Ursodeoxycholate Compounds Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ursodeoxycholic acid, glycoursodeoxycholic acid, tauroursodeoxycholic acid, and epimerized ursodeoxycholic acid in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ursodeoxycholate</VALIDVALUE>
          <VALUEMEANING>Ursodeoxycholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ursodeoxycholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vacuolated Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Vacuolated Lymphocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vacuolated lymphocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vacuolated Lymphocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Vacuolated Lymphocyte to Leukocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of vacuolated lymphocytes compared to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vacuolated Neutrophils</VALIDVALUE>
          <VALUEMEANING>Vacuolated Neutrophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of neutrophils containing small vacuoles present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74628</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Valerylfentanyl</VALIDVALUE>
          <VALUEMEANING>Valerylfentanyl Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the valerylfentanyl in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184607</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Valine</VALIDVALUE>
          <VALUEMEANING>Valine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of valine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Valproate</VALIDVALUE>
          <VALUEMEANING>Valproate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of valproate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vanillyl Mandelic Acid Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Vanillyl Mandelic Acid Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vanillyl mandelic acid being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vanillyl Mandelic Acid</VALIDVALUE>
          <VALUEMEANING>Vanillyl Mandelic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vanillyl mandelic acid metabolite present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vasc Endothelial Growth Factor Rec 2</VALIDVALUE>
          <VALUEMEANING>Vascular Endothelial Growth Factor Receptor 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vascular endothelial growth factor receptor 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vascular Cell Adhesion Molecule 1</VALIDVALUE>
          <VALUEMEANING>Vascular Cell Adhesion Molecule 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vascular cell adhesion molecule 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407608</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vascular Endothelial Growth Factor A</VALIDVALUE>
          <VALUEMEANING>Vascular Endothelial Growth Factor A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vascular endothelial growth factor A in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vascular Endothelial Growth Factor C</VALIDVALUE>
          <VALUEMEANING>Vascular Endothelial Growth Factor C Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vascular endothelial growth factor C present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vascular Endothelial Growth Factor D</VALIDVALUE>
          <VALUEMEANING>Vascular Endothelial Growth Factor D Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vascular endothelial growth factor D in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351766</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Fetoprotein L2</VALIDVALUE>
          <VALUEMEANING>Alpha Fetoprotein L2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha fetoprotein L2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Fetoprotein L3</VALIDVALUE>
          <VALUEMEANING>Alpha Fetoprotein L3 Isoform</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the alpha fetoprotein L3 in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3462850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Fetoprotein</VALIDVALUE>
          <VALUEMEANING>Alpha-fetoprotein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-fetoprotein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74732</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6142744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Globulin</VALIDVALUE>
          <VALUEMEANING>Alpha Globulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha globulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Glutathione-S-Transferase</VALIDVALUE>
          <VALUEMEANING>Alpha Glutathione-S-Transferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha glutathione-s-transferase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Hydroxybutyrate Dehydrogenase</VALIDVALUE>
          <VALUEMEANING>Alpha Hydroxybutyrate Dehydrogenase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-hydroxybutyrate dehydrogenase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111126</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Melanocyte Stimulating Hormone</VALIDVALUE>
          <VALUEMEANING>Alpha Melanocyte Stimulating Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the alpha melanocyte stimulating hormone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Synuclein Protein</VALIDVALUE>
          <VALUEMEANING>Alpha Synuclein Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha synuclein protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Tocopherol</VALIDVALUE>
          <VALUEMEANING>Alpha Tocopherol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the alpha tocopherol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pepsinogen A</VALIDVALUE>
          <VALUEMEANING>Pepsinogen A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pepsinogen A present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407969</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pepsinogen C</VALIDVALUE>
          <VALUEMEANING>Pepsinogen C Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pepsinogen C present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pepsinogen I</VALIDVALUE>
          <VALUEMEANING>Pepsinogen I Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pepsinogen I present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pepsinogen II</VALIDVALUE>
          <VALUEMEANING>Pepsinogen II Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pepsinogen II present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pepsinogen</VALIDVALUE>
          <VALUEMEANING>Pepsinogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pepsinogen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peptide Transporter TAP1</VALIDVALUE>
          <VALUEMEANING>Peptide Transporter TAP1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of peptide transporter TAP1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peptide YY</VALIDVALUE>
          <VALUEMEANING>Peptide YY Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of peptide YY present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80202</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peptidylprolyl Isomerase A</VALIDVALUE>
          <VALUEMEANING>Peptidylprolyl Isomerase A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the peptidylprolyl isomerase A in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187819</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Perampanel</VALIDVALUE>
          <VALUEMEANING>Perampanel Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the perampanel in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184596</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Periostin</VALIDVALUE>
          <VALUEMEANING>Periostin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of periostin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Perphenazine</VALIDVALUE>
          <VALUEMEANING>Perphenazine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of perphenazine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177988</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pH Adjusted for Body Temp</VALIDVALUE>
          <VALUEMEANING>pH Adjusted for Body Temperature Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the pH, adjusted for body temperature, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pH</VALIDVALUE>
          <VALUEMEANING>pH</VALUEMEANING>
          <MEANINGDESCRIPTION>Quantity of dimension one used to express on a scale from 0 to 14 the amount-of-substance concentration of hydrogen ion of dilute aqueous solution, calculated as the logarithm of the reciprocal of hydrogen-ion concentration in gram atoms per liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45997</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenazocine</VALIDVALUE>
          <VALUEMEANING>Phenazocine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the phenazocine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phencyclidine</VALIDVALUE>
          <VALUEMEANING>Phencyclidine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phencyclidine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phendimetrazine</VALIDVALUE>
          <VALUEMEANING>Phendimetrazine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the phendimetrazine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184597</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenmetrazine</VALIDVALUE>
          <VALUEMEANING>Phenmetrazine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the phenmetrazine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenobarbital</VALIDVALUE>
          <VALUEMEANING>Phenobarbital Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phenobarbital present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75368</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenothiazine</VALIDVALUE>
          <VALUEMEANING>Phenothiazine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phenothiazine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74695</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phentermine</VALIDVALUE>
          <VALUEMEANING>Phentermine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the phentermine in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174299</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenylalanine</VALIDVALUE>
          <VALUEMEANING>Phenylalanine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The measurement of the amount of phenylalanine in a biologic specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenylalanine/Tyrosine</VALIDVALUE>
          <VALUEMEANING>Phenylalanine to Tyrosine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of phenylalanine compared to tyrosine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166803</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenylketones</VALIDVALUE>
          <VALUEMEANING>Phenylketone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phenylketone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147414</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenylpropanolamine</VALIDVALUE>
          <VALUEMEANING>Phenylpropanolamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the phenylpropanolamine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174297</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenylpyruvate</VALIDVALUE>
          <VALUEMEANING>Phenylpyruvate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phenylpyruvate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14537239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenytoin</VALIDVALUE>
          <VALUEMEANING>Phenytoin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phenytoin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phos-S6 Ribosomal Protein</VALIDVALUE>
          <VALUEMEANING>Phosphorylated 40S Ribosomal Protein S6 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phosphorylated S6 protein of the 40S ribosomal subunit present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphate Clearance</VALIDVALUE>
          <VALUEMEANING>Phosphate Clearance Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the phosphate clearance in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphate Crystals</VALIDVALUE>
          <VALUEMEANING>Phosphate Crystals Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the phosphate crystals in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphate</VALIDVALUE>
          <VALUEMEANING>Phosphate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of phosphate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64857</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4971503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphate/Creatinine</VALIDVALUE>
          <VALUEMEANING>Phosphate to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of phosphate compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphatidylcholine/Albumin</VALIDVALUE>
          <VALUEMEANING>Phosphatidylcholine to Albumin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of phosphatidylcholine compared to albumin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphatidylethanol</VALIDVALUE>
          <VALUEMEANING>Phosphatidylethanol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the total phosphatidylethanol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187820</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphatidylglycerol/Lung Surfactant</VALIDVALUE>
          <VALUEMEANING>Phosphatidylglycerol to Lung Surfactant Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of phosphatidylglycerol compared to lung surfactant present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phospholipase A2</VALIDVALUE>
          <VALUEMEANING>Phospholipase A2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phospholipase A2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythropoietin</VALIDVALUE>
          <VALUEMEANING>Erythropoietin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of erythropoietin hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Escitalopram</VALIDVALUE>
          <VALUEMEANING>Escitalopram Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the escitalopram in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187804</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estazolam</VALIDVALUE>
          <VALUEMEANING>Estazolam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the estazolam in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184615</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estradiol</VALIDVALUE>
          <VALUEMEANING>Estradiol, Serum</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of estradiol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74782</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3090370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estradiol, Free</VALIDVALUE>
          <VALUEMEANING>Free Estradiol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free estradiol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150842</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estradiol, Free/Estradiol</VALIDVALUE>
          <VALUEMEANING>Free Estradiol to Estradiol Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of free estradiol compared to total estradiol present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150843</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estriol</VALIDVALUE>
          <VALUEMEANING>Estriol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the estriol hormone in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74856</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estriol, Free</VALIDVALUE>
          <VALUEMEANING>Free Estriol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free estriol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81963</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estrogen Receptor</VALIDVALUE>
          <VALUEMEANING>Estrogen Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of estrogen receptor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112274</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estrogen</VALIDVALUE>
          <VALUEMEANING>Estrogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of estrogen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147335</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413842</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estrone Sulfate</VALIDVALUE>
          <VALUEMEANING>Estrone Sulfate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of estrone sulfate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estrone</VALIDVALUE>
          <VALUEMEANING>Estrone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of estrone hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74857</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethanol</VALIDVALUE>
          <VALUEMEANING>Ethanol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ethanol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74693</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethchlorvynol</VALIDVALUE>
          <VALUEMEANING>Ethchlorvynol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the ethchlorvynol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184616</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucagon</VALIDVALUE>
          <VALUEMEANING>Glucagon Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glucagon hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74859</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucagon-Like Peptide-1</VALIDVALUE>
          <VALUEMEANING>Glucagon-like Peptide-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glucagon-like peptide-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucagon-Like Peptide-1, Active Form</VALIDVALUE>
          <VALUEMEANING>Active Glucagon-like Peptide-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of active glucagon-like peptide-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80164</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucagon-Like Peptide-1, Inactive Form</VALIDVALUE>
          <VALUEMEANING>Inactive Glucagon-Like Peptide-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of inactive glucagon-like peptide-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619426</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucopsychosine</VALIDVALUE>
          <VALUEMEANING>Glucopsychosine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the glucopsychosine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucose Clearance</VALIDVALUE>
          <VALUEMEANING>Glucose Clearance Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the glucose clearance in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96652</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucose Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Glucose Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the amount of glucose being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150818</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucose Management Indicator</VALIDVALUE>
          <VALUEMEANING>Glucose Management Indicator</VALUEMEANING>
          <MEANINGDESCRIPTION>An approximate measure (expressed as a % or mmol/mol) of an individual&#39;s expected hemoglobin A1c/hemoglobin level, based on the mean glucose measured over a period of at least 10 days by continuous glucose monitoring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucose</VALIDVALUE>
          <VALUEMEANING>Glucose Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glucose present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5290836</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucose, Estimated Average</VALIDVALUE>
          <VALUEMEANING>Estimated Average Glucose</VALUEMEANING>
          <MEANINGDESCRIPTION>A computed estimate of the blood glucose based on the value of the glycated hemoglobin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucose, Radiolabeled/Glucose</VALIDVALUE>
          <VALUEMEANING>Radiolabeled Glucose to Glucose Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of radiolabeled glucose to total glucose present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186054</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucose-6-Phosphate Dehydrogenase Act</VALIDVALUE>
          <VALUEMEANING>Glucose-6-Phosphate Dehydrogenase Activity</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glucose-6-phosphate dehydrogenase activity present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139065</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucose-6-Phosphate Dehydrogenase</VALIDVALUE>
          <VALUEMEANING>Glucose-6-Phosphate Dehydrogenase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glucose-6-phosphate dehydrogenase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80184</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucose-dep Insulinotropic Pep, Intact</VALIDVALUE>
          <VALUEMEANING>Intact Glucose-dependent Insulinotropic Peptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the intact (containing amino acids 1-42) glucose-dependent insulinotropic peptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106537</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402810</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucose/Creatinine</VALIDVALUE>
          <VALUEMEANING>Glucose to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of glucose compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79447</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Cell Carcinoma Antigen</VALIDVALUE>
          <VALUEMEANING>Squamous Cell Carcinoma Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the squamous cell carcinoma antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Epithelial Cells</VALIDVALUE>
          <VALUEMEANING>Squamous Epithelial Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of squamous epithelial cells present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74773</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Epithelial Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Squamous Epithelial Cells to Total Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the squamous epithelial cells compared to the total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Transitional Epithelial Cells</VALIDVALUE>
          <VALUEMEANING>Squamous Transitional Epithelial Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of squamous transitional epithelial cells present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74774</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Standard Base Excess</VALIDVALUE>
          <VALUEMEANING>Standard Base Excess Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A calculated measurement of the amount of acid required to return blood with hemoglobin at 5g/dL, which is used as a surrogate for extracellular fluid, to a normal pH under standard conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154721</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stanozolol</VALIDVALUE>
          <VALUEMEANING>Stanozolol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the stanozolol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Starch Crystals</VALIDVALUE>
          <VALUEMEANING>Starch Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of starch crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STAT3</VALIDVALUE>
          <VALUEMEANING>STAT3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of STAT3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stem Cell Factor</VALIDVALUE>
          <VALUEMEANING>Stem Cell Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of stem cell factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82035</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stenbolone</VALIDVALUE>
          <VALUEMEANING>Stenbolone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the stenbolone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Steroid Sulfatase</VALIDVALUE>
          <VALUEMEANING>Steroid Sulfatase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of steroid sulfatase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomatocytes</VALIDVALUE>
          <VALUEMEANING>Stomatocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of stomatocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74708</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Succinylacetone</VALIDVALUE>
          <VALUEMEANING>Succinylacetone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of succinylacetone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186095</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sufentanil</VALIDVALUE>
          <VALUEMEANING>Sufentanil Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the sufentanil in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184575</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sulfa Crystals</VALIDVALUE>
          <VALUEMEANING>Sulfa Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sulfa crystals present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sulfate</VALIDVALUE>
          <VALUEMEANING>Sulfate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sulfate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122153</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sulfur Dioxide</VALIDVALUE>
          <VALUEMEANING>Sulfur Dioxide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sulfur dioxide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surfactant Protein D</VALIDVALUE>
          <VALUEMEANING>Surfactant Protein D Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of surfactant protein D present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111322</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Symmetric Dimethylarginine</VALIDVALUE>
          <VALUEMEANING>Symmetric Dimethylarginine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of symmetric dimethylarginine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774766</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Synoviocytes</VALIDVALUE>
          <VALUEMEANING>Synoviocytes Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total synoviocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Synoviocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Synoviocytes to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of synoviocytes to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191297</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T-Kininogen</VALIDVALUE>
          <VALUEMEANING>T-Kininogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of T-kininogen in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T-lymphocyte Crossmatch</VALIDVALUE>
          <VALUEMEANING>T-lymphocyte Crossmatch Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the HLA histocompatibility between the donor and the study subject by examining the presence or absence of the subject&#39;s anti-HLA antibody reactivity towards HLA antigens expressed on the donor T-lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128979</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T-Lymphocytes</VALIDVALUE>
          <VALUEMEANING>T-Lymphocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of T-lymphocytes in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413383</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T1 Collagen X-link N-Telopeptides/Creat</VALIDVALUE>
          <VALUEMEANING>Type 1 Collagen X-link N-Telopeptides to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the type 1 collagen X-link N-telopeptides compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tapentadol</VALIDVALUE>
          <VALUEMEANING>Tapentadol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the tapentadol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Target Cells</VALIDVALUE>
          <VALUEMEANING>Target Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of target cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tartrate-Resistant Acid Phosphatase 5b</VALIDVALUE>
          <VALUEMEANING>Tartrate-Resistant Acid Phosphatase 5b Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tartrate-resistant acid phosphatase 5b present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117865</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TATA Box Binding Protein</VALIDVALUE>
          <VALUEMEANING>TATA Box Binding Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of TATA-box binding protein in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tau Protein</VALIDVALUE>
          <VALUEMEANING>Tau Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Tau protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84810</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tau Protein, Free</VALIDVALUE>
          <VALUEMEANING>Free Tau Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free tau protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Taurine</VALIDVALUE>
          <VALUEMEANING>Taurine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of taurine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122154</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethinamate</VALIDVALUE>
          <VALUEMEANING>Ethinamate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the ethinamate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184617</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethyl Glucuronide Ethyl Sulfate</VALIDVALUE>
          <VALUEMEANING>Ethyl Glucuronide And Ethyl Sulfate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ethyl glucuronide and/or ethyl sulfate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7255350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethyl Glucuronide</VALIDVALUE>
          <VALUEMEANING>Ethyl Glucuronide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ethyl glucuronide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7255352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethyl Sulfate</VALIDVALUE>
          <VALUEMEANING>Ethyl Sulfate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ethyl sulfate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7255348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethylamphetamine</VALIDVALUE>
          <VALUEMEANING>Ethylamphetamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the ethylamphetamine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010376</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethylestrenol</VALIDVALUE>
          <VALUEMEANING>Ethylestrenol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the ethylestrenol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010438</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethylmorphine</VALIDVALUE>
          <VALUEMEANING>Ethylmorphine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the ethylmorphine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ETP Area Under Curve</VALIDVALUE>
          <VALUEMEANING>Endogenous Thrombin Potential Area Under Curve Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The measurement of the area under the thrombin generation curve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ETP Lag Time Relative</VALIDVALUE>
          <VALUEMEANING>Endogenous Thrombin Potential Lag Time Relative Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio or percentage) of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ETP Lag Time</VALIDVALUE>
          <VALUEMEANING>Endogenous Thrombin Potential Lag Time Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ETP Peak Height Relative</VALIDVALUE>
          <VALUEMEANING>Endogenous Thrombin Potential Peak Height Relative Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative (ratio or percentage) of the maximum concentration of thrombin generated during a thrombin generation test.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ETP Peak Height</VALIDVALUE>
          <VALUEMEANING>Endogenous Thrombin Potential Peak Height Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of maximum concentration of thrombin generated during a thrombin generation test.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ETP Time to Peak Relative</VALIDVALUE>
          <VALUEMEANING>Endogenous Thrombin Potential Time to Peak Relative Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative (ratio or percentage) measurement of the time it takes to generate the maximum concentration of thrombin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ETP Time to Peak</VALIDVALUE>
          <VALUEMEANING>Endogenous Thrombin Potential Time to Peak Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of time it takes to generate the maximum concentration of thrombin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extracell Newly Ident RAGE Bind Protein</VALIDVALUE>
          <VALUEMEANING>Extracell Newly Ident RAGE Bind Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of extracellular newly identified RAGE (receptor for advanced glycation end products) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ezogabine</VALIDVALUE>
          <VALUEMEANING>Ezogabine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the ezogabine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010625</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>F2-Isoprostane</VALIDVALUE>
          <VALUEMEANING>F2 Isoprostane Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of F2 isoprostane present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80180</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3852213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor II</VALIDVALUE>
          <VALUEMEANING>Prothrombin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of prothrombin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor III</VALIDVALUE>
          <VALUEMEANING>Factor III Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of factor III present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor IX Activity Actual/Control</VALIDVALUE>
          <VALUEMEANING>Factor IX Activity Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the biological activity of factor IX dependent coagulation in a subject&#39;s specimen when compared to the same activity in a control specimen. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor IX Activity</VALIDVALUE>
          <VALUEMEANING>Factor IX Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the biological activity of factor IX in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor IX</VALIDVALUE>
          <VALUEMEANING>Factor IX Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of factor IX present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98725</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor V Activity Actual/Control</VALIDVALUE>
          <VALUEMEANING>Factor V Activity Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the biological activity of factor V dependent coagulation in a subject&#39;s specimen when compared to the same activity in a control specimen. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythroid Proliferation Pool</VALIDVALUE>
          <VALUEMEANING>Erythroid Proliferation Pool Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of erythroid proliferative phase cells (rubriblasts, prorubricytes, and basophilic rubricytes) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135418</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor V Activity</VALIDVALUE>
          <VALUEMEANING>Factor V Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the biological activity of factor V in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103396</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor V Leiden</VALIDVALUE>
          <VALUEMEANING>Factor V Leiden Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Factor V Leiden present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor V</VALIDVALUE>
          <VALUEMEANING>Factor V Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of factor V present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor VII Activity Actual/Control</VALIDVALUE>
          <VALUEMEANING>Factor VII Activity Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the biological activity of factor VII dependent coagulation in a subject&#39;s specimen when compared to the same activity in a control specimen. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor VII Activity</VALIDVALUE>
          <VALUEMEANING>Factor VII Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the biological activity of factor VII in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor VII</VALIDVALUE>
          <VALUEMEANING>Factor VII Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of factor VII present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor VIIa Activity</VALIDVALUE>
          <VALUEMEANING>Factor VIIa Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the biological activity of factor VIIa in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412425</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor VIII Activity Actual/Control</VALIDVALUE>
          <VALUEMEANING>Factor VIII Activity Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the biological activity of factor VIII dependent coagulation in a subject&#39;s specimen when compared to the same activity in a control specimen. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor VIII Activity</VALIDVALUE>
          <VALUEMEANING>Factor VIII Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the biological activity of factor VIII in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phospholipid Scramblase 1</VALIDVALUE>
          <VALUEMEANING>Phospholipid Scramblase 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phospholipid scramblase 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phospholipid</VALIDVALUE>
          <VALUEMEANING>Phospholipid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phospholipid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphorus Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Phosphorus Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the amount of phosphorus being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphorylated Neurofilament Heavy Chain</VALIDVALUE>
          <VALUEMEANING>Phosphorylated Neurofilament Heavy Chain Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phosphorylated neurofilament heavy chain in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phosphorylated STAT3</VALIDVALUE>
          <VALUEMEANING>Phosphorylated STAT3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of phosphorylated STAT3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619987</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pseudo-Eosinophils/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Pseudo-Eosinophils to Leukocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio or percentage) of the pseudo-eosinophils to the leukocytes in a biological sample. The measurement may be expressed as either a ratio or a percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pseudoephedrine</VALIDVALUE>
          <VALUEMEANING>Pseudoephedrine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pseudoephedrine present in a sample</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Psilocybin</VALIDVALUE>
          <VALUEMEANING>Psilocybine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of psilocybine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PTT/Standard</VALIDVALUE>
          <VALUEMEANING>Partial Thromboplastin Time to Standard Thromboplastin Time Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the subject&#39;s partial thromboplastin time to a standard or control partial thromboplastin time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187818</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pus</VALIDVALUE>
          <VALUEMEANING>Pus Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pus present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857127</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pyknotic Cells</VALIDVALUE>
          <VALUEMEANING>Pyknotic Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pyknotic cells in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189346</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491778</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pyocytes</VALIDVALUE>
          <VALUEMEANING>Pyocytes Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pyocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pyridinoline</VALIDVALUE>
          <VALUEMEANING>Pyridinoline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pyridinoline present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pyridinoline/Creatinine</VALIDVALUE>
          <VALUEMEANING>Pyridinoline to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of pyridinoline compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147426</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acyl Coenzyme A Oxidase</VALIDVALUE>
          <VALUEMEANING>Acyl Coenzyme A Oxidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acyl coenzyme A oxidase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acylcarnitine</VALIDVALUE>
          <VALUEMEANING>Acylcarnitine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acylcarnitine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acylcarnitine/Carnitine, Free</VALIDVALUE>
          <VALUEMEANING>Acylcarnitine to Free Carnitine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of acylcarnitine compared to free carnitine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acylglycine</VALIDVALUE>
          <VALUEMEANING>Acylglycine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acylglycine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156534</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ADAM Metallopeptidase Domain 8</VALIDVALUE>
          <VALUEMEANING>ADAM Metallopeptidase Domain 8 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ADAM metallopeptidase domain 8 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ADAMTS13 Activity</VALIDVALUE>
          <VALUEMEANING>von Willebrand Coagulation Factor Cleaving Protease Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the biological activity of von Willebrand coagulation factor cleaving protease, ADAMTS13, in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187830</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ADAMTS13</VALIDVALUE>
          <VALUEMEANING>von Willebrand Coagulation Factor Cleaving Protease Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of von Willebrand coagulation factor cleaving protease in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ADB-PINACA</VALIDVALUE>
          <VALUEMEANING>ADB-PINACA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the ADB-PINACA in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184529</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenosine Diphosphate</VALIDVALUE>
          <VALUEMEANING>Adenosine Diphosphate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of adenosine diphosphate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102257</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404447</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenosine Triphosphate</VALIDVALUE>
          <VALUEMEANING>Adenosine Triphosphate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of adenosine triphosphate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147307</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adiponectin</VALIDVALUE>
          <VALUEMEANING>Adiponectin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of adiponectin hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74839</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adiponectin, High Molecular Weight</VALIDVALUE>
          <VALUEMEANING>High Molecular Weight Adiponectin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of high molecular weight adiponectin in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenocorticotropic Hormone</VALIDVALUE>
          <VALUEMEANING>Adrenocorticotropic Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the adrenocorticotropic hormone in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404217</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenomedullin</VALIDVALUE>
          <VALUEMEANING>Adrenomedullin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of adrenomedullin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199910</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aggrecan Chondroitin Sulfate Epitope 846</VALIDVALUE>
          <VALUEMEANING>Aggrecan Chondroitin Sulfate Epitope 846 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of aggrecan chondroitin sulfate epitope 846 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Agranular Neutrophils</VALIDVALUE>
          <VALUEMEANING>Agranular Neutrophils Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of agranular neutrophils present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alanine Aminopeptidase</VALIDVALUE>
          <VALUEMEANING>Alanine Aminopeptidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alanine aminopeptidase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alanine Aminotransferase</VALIDVALUE>
          <VALUEMEANING>Alanine Aminotransferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of alanine aminotransferase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alanine</VALIDVALUE>
          <VALUEMEANING>Alanine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alanine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122091</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Albumin Clearance</VALIDVALUE>
          <VALUEMEANING>Albumin Clearance</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the clearance of endogenous albumin, used for evaluating the glomerular filtration rate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Albumin Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Albumin Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the amount of albumin being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Albumin Index</VALIDVALUE>
          <VALUEMEANING>Albumin Index</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio) of the albumin in cerebrospinal fluid to albumin in serum in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154734</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Albumin</VALIDVALUE>
          <VALUEMEANING>Albumin, Serum</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of albumin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Albumin/Creatinine</VALIDVALUE>
          <VALUEMEANING>Albumin To Creatinine Protein Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of albumin compared to creatinine protein present in a urine sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Albumin/Globulin</VALIDVALUE>
          <VALUEMEANING>Albumin to Globulin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of albumin compared to globulin in a blood sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Albumin/Total Protein</VALIDVALUE>
          <VALUEMEANING>Albumin to Total Protein Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the albumin compared with total protein in a biological sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aldolase</VALIDVALUE>
          <VALUEMEANING>Aldolase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of aldolase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74731</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aldosterone Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Aldosterone Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the amount of aldosterone being excreted in a biological specimen over a defined amount of time (e.g. one hour).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aldosterone</VALIDVALUE>
          <VALUEMEANING>Aldosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of aldosterone hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74841</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aldosterone/Renin Activity</VALIDVALUE>
          <VALUEMEANING>Aldosterone to Renin Activity Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the aldosterone compared to renin activity present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124338</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413417</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aldrin Epoxidase</VALIDVALUE>
          <VALUEMEANING>Aldrin Epoxidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of aldrin epoxidase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154743</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alfentanil</VALIDVALUE>
          <VALUEMEANING>Alfentanil Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the alfentanil in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010388</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alk Phos, Bone/Total Alk Phos</VALIDVALUE>
          <VALUEMEANING>Bone Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of bone-specific alkaline phosphatase compared to total alkaline phosphatase present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alk Phos, Intestinal/Total Alk Phos</VALIDVALUE>
          <VALUEMEANING>Intestinal Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of intestinal-specific alkaline phosphatase compared to total alkaline phosphatase present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alk Phos, Liver + Bone/Total Alk Phos</VALIDVALUE>
          <VALUEMEANING>Liver and Bone Specific Alkaline Phosphatase Isoform to Alkaline Phosphatase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the liver and bone specific alkaline phosphatase isoforms to total alkaline phosphatase in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alk Phos, Liver/Total Alk Phos</VALIDVALUE>
          <VALUEMEANING>Liver Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of liver-specific alkaline phosphatase compared to total alkaline phosphatase present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147296</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alk Phos, Placental/Total Alk Phos</VALIDVALUE>
          <VALUEMEANING>Placental Alkaline Phosphatase to Total Alkaline Phosphatase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of placental specific alkaline phosphatase isoform compared to total alkaline phosphatase present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010083</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alkaline Phosphatase Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Alkaline Phosphatase Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alkaline phosphatase being excreted in a biological specimen over a defined amount of time (e.g. one hour).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165942</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alkaline Phosphatase Isoenzyme</VALIDVALUE>
          <VALUEMEANING>Alkaline Phosphatase Isoenzyme Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alkaline phosphatase isoenzyme present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139091</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405755</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alkaline Phosphatase</VALIDVALUE>
          <VALUEMEANING>Alkaline Phosphatase, Serum</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of alkaline phosphatase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alkaline Phosphatase/Creatinine</VALIDVALUE>
          <VALUEMEANING>Alkaline Phosphatase to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of alkaline phosphatase compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alloisoleucine</VALIDVALUE>
          <VALUEMEANING>Alloisoleucine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alloisoleucine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154762</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Cortol</VALIDVALUE>
          <VALUEMEANING>Alpha Cortol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha cortol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186032</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161447</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Cortolone</VALIDVALUE>
          <VALUEMEANING>Alpha Cortolone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha cortolone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186033</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Fetoprotein Adj for Body Weight</VALIDVALUE>
          <VALUEMEANING>Alpha Fetoprotein Adjusted for Body Weight Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha fetoprotein, adjusted for body weight, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403102</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Fetoprotein L1</VALIDVALUE>
          <VALUEMEANING>Alpha Fetoprotein L1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha fetoprotein L1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Growth Differentiation Factor 15</VALIDVALUE>
          <VALUEMEANING>Growth Differentiation Factor 15 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of growth differentiation factor 15 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytokeratin 18 Fragment</VALIDVALUE>
          <VALUEMEANING>Cytokeratin 18 Fragment Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cytokeratin 18 fragment present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytokeratin 19 Fragment 21-1</VALIDVALUE>
          <VALUEMEANING>Cytokeratin 19 Fragment 21-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the cytokeratin 19 fragment 21-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407553</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytomegalovirus-Induced Gene 5 Protein</VALIDVALUE>
          <VALUEMEANING>Cytomegalovirus-Induced Gene 5 Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cytomegalovirus-induced gene 5 protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytoplasmic Basophilia Neutrophil</VALIDVALUE>
          <VALUEMEANING>Cytoplasmic Basophilia Neutrophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of neutrophils in a biological specimen showing a dark staining pattern in the cytoplasm due to increased acidic content.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111166</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D-Dimer</VALIDVALUE>
          <VALUEMEANING>D-Dimer</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of d-dimers present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82621</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3351588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D-Norpseudoephedrine</VALIDVALUE>
          <VALUEMEANING>D-Norpseudoephedrine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the D-norpseudoephedrine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dacryocytes</VALIDVALUE>
          <VALUEMEANING>Dacryocyte Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the presence or absence of dacryocytes, abnormal erythrocytes shaped like a teardrop, seen in myelofibrosis and certain other myeloproliferative diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402765</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DEAD Box Protein 58</VALIDVALUE>
          <VALUEMEANING>DEAD Box Protein 58 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of DEAD box protein 58 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decanoylcarnitine</VALIDVALUE>
          <VALUEMEANING>Decanoylcarnitine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of decanoylcarnitine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156536</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decorin</VALIDVALUE>
          <VALUEMEANING>Decorin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of decorin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Degenerated Leukocytes</VALIDVALUE>
          <VALUEMEANING>Degenerated Leukocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of degenerated leukocytes (leukocytes that show deterioration in form or function) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dehydroepiandrosterone Sulfate</VALIDVALUE>
          <VALUEMEANING>Dehydroepiandrosterone sulfate (DHEA-S)</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sulfated dehydroepiandrosterone (DHEA) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dehydroepiandrosterone</VALIDVALUE>
          <VALUEMEANING>Dehydroepiandrosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of dehydroepiandrosterone hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Delta Aminolevulinate</VALIDVALUE>
          <VALUEMEANING>Delta Aminolevulinate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of delta aminolevulinate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156537</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Delta Aminolevulinate/Creatinine</VALIDVALUE>
          <VALUEMEANING>Delta Aminolevulinate to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of delta aminolevulinate compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156538</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619446</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils/Non-Squam Epi Cells</VALIDVALUE>
          <VALUEMEANING>Neutrophils to Non-Squamous Epithelial Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of neutrophils compared to non-squamous epithelial cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophils/Total Cells</VALIDVALUE>
          <VALUEMEANING>Neutrophil to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of neutrophils compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405810</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Niacin</VALIDVALUE>
          <VALUEMEANING>Vitamin B3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin B3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nicomorphine</VALIDVALUE>
          <VALUEMEANING>Nicomorphine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the nicomorphine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184556</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010374</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nicotinamide Phosphoribosyltransferase</VALIDVALUE>
          <VALUEMEANING>Nicotinamide Phosphoribosyltransferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nicotinamide phosphoribosyltransferase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nicotine</VALIDVALUE>
          <VALUEMEANING>Nicotine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nicotine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nitrate</VALIDVALUE>
          <VALUEMEANING>Nitrate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nitrate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nitrazepam and/or Metabolites</VALIDVALUE>
          <VALUEMEANING>Nitrazepam and/or Metabolites Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nitrazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both nitrazepam and its metabolites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CSF IgG Index</VALIDVALUE>
          <VALUEMEANING>IgG Index</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio) of the IgG in cerebrospinal fluid to IgG in serum in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154735</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclic Adenosine 3,5-Monophosphate</VALIDVALUE>
          <VALUEMEANING>Cyclic Adenosine 3,5-Monophosphate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cyclic adenosine 3,5-monophosphate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124339</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclic Adenosine Monophosphate/Creat</VALIDVALUE>
          <VALUEMEANING>Cyclic Adenosine 3,5 Monophosphate to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of cyclic adenosine 3,5-monophosphate to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclic ADP Ribose Hydrolase 1</VALIDVALUE>
          <VALUEMEANING>Cyclic ADP Ribose Hydrolase 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the cyclic ADP ribose hydrolase 1 protein in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187826</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclic Guanosine Monophosphate</VALIDVALUE>
          <VALUEMEANING>Cyclic Guanosine Monophosphate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cyclic guanosine 3,5-monophosphate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cylindroid Casts</VALIDVALUE>
          <VALUEMEANING>Cylindroid Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cylindroid casts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150838</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystathionine Beta-Synthase</VALIDVALUE>
          <VALUEMEANING>Cystathionine Beta-Synthase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cystathionine beta-synthase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystathionine</VALIDVALUE>
          <VALUEMEANING>Cystathionine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cystathionine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147331</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystatin B</VALIDVALUE>
          <VALUEMEANING>Cystatin B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cystatin B in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199920</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystatin C</VALIDVALUE>
          <VALUEMEANING>Cystatin C Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cystatin C present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystatin C/Creatinine</VALIDVALUE>
          <VALUEMEANING>Cystatin C to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of cystatin C compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cysteine</VALIDVALUE>
          <VALUEMEANING>Cysteine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cysteine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172518</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cysteinyl Leukotriene Receptor 1</VALIDVALUE>
          <VALUEMEANING>Cysteinyl Leukotriene Receptor 1</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cysteinyl leukotriene receptor 1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491802</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystine Crystals</VALIDVALUE>
          <VALUEMEANING>Cystine Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cystine crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74674</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405802</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystine</VALIDVALUE>
          <VALUEMEANING>Cystine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cystine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytidine-Uridine Monophosphate Kinase 2</VALIDVALUE>
          <VALUEMEANING>Cytidine-Uridine Monophosphate Kinase 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cytidine-uridine monophosphate kinase 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163426</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytochrome P450 2C9</VALIDVALUE>
          <VALUEMEANING>Cytochrome P450 2C9 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cytochrome P450 2C9 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pyridoxal Phosphate</VALIDVALUE>
          <VALUEMEANING>Pyridoxal Phosphate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pyridoxal phosphate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pyrovalerone</VALIDVALUE>
          <VALUEMEANING>Pyrovalerone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the pyrovalerone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pyruvate Kinase Isozyme M1</VALIDVALUE>
          <VALUEMEANING>Pyruvate Kinase Isozyme M1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pyruvate kinase isozyme M1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156532</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pyruvate Kinase Isozyme M2</VALIDVALUE>
          <VALUEMEANING>Pyruvate Kinase Isozyme M2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pyruvate kinase isozyme M2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156531</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pyruvate Kinase Muscle Isozyme</VALIDVALUE>
          <VALUEMEANING>Pyruvate Kinase Muscle Isozyme Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pyruvate kinase muscle isozyme present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156530</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620127</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pyruvate Kinase</VALIDVALUE>
          <VALUEMEANING>Pyruvate Kinase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pyruvate kinase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pyruvate</VALIDVALUE>
          <VALUEMEANING>Pyruvate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pyruvate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quazepam</VALIDVALUE>
          <VALUEMEANING>Quazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the quazepam in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quetiapine</VALIDVALUE>
          <VALUEMEANING>Quetiapine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of quetiapine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RBC Casts</VALIDVALUE>
          <VALUEMEANING>Red Blood Cell Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of red blood cell casts present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74772</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404102</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RDW Standard Deviation</VALIDVALUE>
          <VALUEMEANING>Red Cell Volume Distribution Width Standard Deviation</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the volume dispersion within a red blood cell population, calculated as the width of the distribution curve at the 20% frequency level.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reactive Oxygen Metabolite</VALIDVALUE>
          <VALUEMEANING>Reactive Oxygen Metabolite Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of reactive oxygen metabolite present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Receptor Activator Nuclear KappaB Ligand</VALIDVALUE>
          <VALUEMEANING>Receptor Activator Nuclear KappaB Ligand Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of receptor activator nuclear kappaB ligand present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Receptor Advanced Glycation Endproducts</VALIDVALUE>
          <VALUEMEANING>Receptor Advanced Glycation Endproducts Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of receptor advanced glycation endproducts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165980</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reducing Substances</VALIDVALUE>
          <VALUEMEANING>Reducing Substance Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of reducing substances present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reducing Sugars</VALIDVALUE>
          <VALUEMEANING>Reducing Sugar Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of reducing sugars present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reg upon Act Normal T-cell Exprd Secrtd</VALIDVALUE>
          <VALUEMEANING>Reg upon Act Normal T-cell Exprd Secrtd Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81957</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Remnant Lipoprotein</VALIDVALUE>
          <VALUEMEANING>Remnant Lipoprotein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the remnant lipoprotein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120656</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renal Epithelial Casts</VALIDVALUE>
          <VALUEMEANING>Renal Epithelial Casts Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the renal epithelial cell casts in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renal Epithelial Cells</VALIDVALUE>
          <VALUEMEANING>Renal Epithelial Cells Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of renal epithelial cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renal Papillary Antigen 1</VALIDVALUE>
          <VALUEMEANING>Renal Papillary Antigen 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of renal papillary antigen 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403088</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renal Tubular Epithelial Casts</VALIDVALUE>
          <VALUEMEANING>Renal Tubular Epithelial Casts Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the renal tubular epithelial casts in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renin Activity</VALIDVALUE>
          <VALUEMEANING>Renin Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of renin activity present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111305</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renin</VALIDVALUE>
          <VALUEMEANING>Renin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of renin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74893</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reptilase Activity Actual/Control</VALIDVALUE>
          <VALUEMEANING>Reptilase Activity Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the biological activity of reptilase dependent coagulation in a subject&#39;s specimen when compared to the same activity in a control specimen. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reptilase Time</VALIDVALUE>
          <VALUEMEANING>Reptilase Time Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the time it takes a plasma sample to clot after adding the snake venom enzyme batroxobin (reptilase). This procedure can be used to detect deficiencies or abnormalities in fibrinogen and this enzyme is resistant to both endogenous thrombin inhibitors and heparin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96628</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resistin</VALIDVALUE>
          <VALUEMEANING>Resistin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of resistin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ret Corpuscular HGB Conc Distr Width</VALIDVALUE>
          <VALUEMEANING>Reticulocyte Corpuscular Hemoglobin Distribution Width</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the standard deviation of hemoglobin concentrations in reticulocytes, calculated as the standard deviation of hemoglobin content divided by the mean hemoglobin content.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ret Hemoglobin Distribution Width</VALIDVALUE>
          <VALUEMEANING>Reticulocyte Hemoglobin Distribution Width</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the distribution of the hemoglobin concentration in reticulocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139070</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407584</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ret RDW Coefficient of Variation</VALIDVALUE>
          <VALUEMEANING>Reticulocyte Volume Distribution Width Coefficient of Variation</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the volume dispersion within a reticulocyte population, calculated as the standard deviation of the mean reticulocyte volume divided by the mean reticulocyte volume, multiplied by 100 for conversion to a percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139072</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ret RDW Standard Deviation</VALIDVALUE>
          <VALUEMEANING>Reticulocyte Volume Distribution Width Standard Deviation</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the volume dispersion within a reticulocyte population, calculated as the width of the distribution curve at the 20% frequency level.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402755</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ret Volume Distribution Width</VALIDVALUE>
          <VALUEMEANING>Reticulocyte Volume Distribution Width</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the volume dispersion within a reticulocyte population in a biological specimen, derived from flow cytometric pulse-height analysis and expressed as either coefficient of variation or standard deviation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139074</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ret. Corpuscular Hemoglobin Content</VALIDVALUE>
          <VALUEMEANING>Reticulocyte Corpuscular Hemoglobin Content</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of hemoglobin in reticulocytes within a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98776</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor VIII</VALIDVALUE>
          <VALUEMEANING>Factor VIII Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of factor VIII present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81961</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402828</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor X Activity Actual/Control</VALIDVALUE>
          <VALUEMEANING>Factor X Activity Actual/Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the biological activity of factor X dependent coagulation in a subject&#39;s specimen when compared to the same activity in a control specimen. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256028</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor X Activity</VALIDVALUE>
          <VALUEMEANING>Factor X Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the biological activity of factor X in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122118</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor X Actual/Control</VALIDVALUE>
          <VALUEMEANING>Factor X Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the factor X in a subject&#39;s specimen compared to a control sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170590</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor X</VALIDVALUE>
          <VALUEMEANING>Factor X Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of factor X present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor XI Activity</VALIDVALUE>
          <VALUEMEANING>Factor XI Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of factor XI activity present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153948</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor XI</VALIDVALUE>
          <VALUEMEANING>Factor XI Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of factor XI present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163435</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor XII Activity</VALIDVALUE>
          <VALUEMEANING>Factor XII Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of factor XII activity present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor XII</VALIDVALUE>
          <VALUEMEANING>Factor XII Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of factor XII present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163437</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor XIII Activity</VALIDVALUE>
          <VALUEMEANING>Factor XIII Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the factor XIII activity in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor XIII</VALIDVALUE>
          <VALUEMEANING>Factor XIII Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of factor XIII present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor XIV Activity Actual/Control</VALIDVALUE>
          <VALUEMEANING>Factor XIV Activity Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the biological activity of factor XIV dependent coagulation in a subject&#39;s specimen when compared to the same activity in a control specimen. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147346</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor XIV Activity</VALIDVALUE>
          <VALUEMEANING>Factor XIV Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Factor XIV activity present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urate</VALIDVALUE>
          <VALUEMEANING>Urate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of urate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Vasc Cell Adhesion Molecule 1</VALIDVALUE>
          <VALUEMEANING>Soluble Vascular Cell Adhesion Molecule 1</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroxine</VALIDVALUE>
          <VALUEMEANING>Total Thyroxine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free and bound thyroxine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74794</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urate/Creatinine</VALIDVALUE>
          <VALUEMEANING>Urate to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of urate compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117866</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Vasc Endoth Growth Factor Rec1</VALIDVALUE>
          <VALUEMEANING>Soluble Vascular Endothelial Growth Factor Receptor Type 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble vascular endothelial growth factor receptor 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroxine, Free Index</VALIDVALUE>
          <VALUEMEANING>Free Thyroxine Index</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the thyroid status (function, disease diagnosis, or therapy effectiveness) in a biological specimen. This is calculated by a mathematical formula that takes into account the total thyroxine and unbound thyroxine binding globulins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170598</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urea Distribution Volume Ratio</VALIDVALUE>
          <VALUEMEANING>Urea Distribution Volume Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>A calculated measurement of the urea distribution volume (ratio) in a biological specimen used to quantify adequacy of dialysis treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Vasc Endoth Growth Factor Rec2</VALIDVALUE>
          <VALUEMEANING>Soluble Vascular Endothelial Growth Factor Receptor Type 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble vascular endothelial growth factor receptor 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroxine, Free</VALIDVALUE>
          <VALUEMEANING>Free Thyroxine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free thyroxine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3308481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urea Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Urea Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the amount of urea excreted in a biological specimen over a defined period of time (e.g. one hour).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717217</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Vasc Endoth Growth Factor Rec3</VALIDVALUE>
          <VALUEMEANING>Soluble Vascular Endothelial Growth Factor Receptor Type 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble vascular endothelial growth factor receptor 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urea Nitrogen Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Urea Nitrogen Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of urea nitrogen being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroxine, Free, Indirect</VALIDVALUE>
          <VALUEMEANING>Indirect Free Thyroxine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the free thyroxine present in a sample by indirect measure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120664</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somatostatin Receptor Type 2</VALIDVALUE>
          <VALUEMEANING>Somatostatin Receptor Type 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of somatostatin receptor type 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165984</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urea Nitrogen</VALIDVALUE>
          <VALUEMEANING>Urea Nitrogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of urea nitrogen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha Tocopherol/Vitamin E</VALIDVALUE>
          <VALUEMEANING>Alpha Tocopherol to Vitamin E Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of alpha-tocopherol compared with the total vitamin E in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407321</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1 Acid Glycoprotein</VALIDVALUE>
          <VALUEMEANING>Alpha-1 Acid Glycoprotein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-1 acid glycoprotein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1 Antitrypsin Z-Polymer</VALIDVALUE>
          <VALUEMEANING>Alpha-1 Antitrypsin Z-Polymer Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of polymers of Z-variant alpha-1 antitrypsin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1 Antitrypsin</VALIDVALUE>
          <VALUEMEANING>Alpha-1 Antitrypsin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-1 antitrypsin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1 Antitrypsin, Functional</VALIDVALUE>
          <VALUEMEANING>Functional Alpha-1 Antitrypsin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-1 antitrypsin, Functional present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1 Globulin</VALIDVALUE>
          <VALUEMEANING>Alpha-1 Globulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-1 globulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92252</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1 Globulin/Total Protein</VALIDVALUE>
          <VALUEMEANING>Alpha-1 Globulin to Total Protein Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of alpha-1 globulin compared to total protein present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1 Microglobulin Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Alpha-1 Microglobulin Excretion Rate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amount of alpha-1 microglobulin being excreted in a biological specimen over a defined amount of time (e.g. one hour).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186022</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8160971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1 Microglobulin</VALIDVALUE>
          <VALUEMEANING>Alpha-1 Microglobulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-1 microglobulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1 Microglobulin/Creatinine</VALIDVALUE>
          <VALUEMEANING>Alpha-1 Microglobulin to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of alpha-1 microglobulin compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100462</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-2 Antiplasmin Activity</VALIDVALUE>
          <VALUEMEANING>Alpha-2 Antiplasmin Activity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the biological activity of alpha-2 antiplasmin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122094</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406033</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-2 Antiplasmin</VALIDVALUE>
          <VALUEMEANING>Alpha-2 Antiplasmin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the alpha-2 antiplasmin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-2 Globulin</VALIDVALUE>
          <VALUEMEANING>Alpha-2 Globulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-2 globulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92254</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-2 Globulin/Total Protein</VALIDVALUE>
          <VALUEMEANING>Alpha-2 Globulin to Total Protein Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of alpha-2 globulin compared to total protein present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92255</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-2 Macroglobulin</VALIDVALUE>
          <VALUEMEANING>Alpha-2 Macroglobulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-2 macroglobulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-Aminoadipic Acid</VALIDVALUE>
          <VALUEMEANING>Alpha-Aminoadipic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-aminoadipic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-Aminobutyric Acid</VALIDVALUE>
          <VALUEMEANING>Alpha-Aminobutyric Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-aminobutyric acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154759</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-GST Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Alpha-GST Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A determination of the amount of alpha glutathione-s-transferase being excreted over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-Hydroxyalprazolam</VALIDVALUE>
          <VALUEMEANING>Alpha-Hydroxyalprazolam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha-hydroxyalprazolam in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177954</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unspecified Cells/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Unspecified Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of unspecified cells compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161364</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble TNF Superfamily Member 12</VALIDVALUE>
          <VALUEMEANING>Soluble TNF Superfamily Member 12 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble TNF superfamily member 12 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyrotropin Releasing Hormone</VALIDVALUE>
          <VALUEMEANING>Thyrotropin Releasing Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of thyrotropin releasing hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74874</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unspecified Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Unspecified Cells to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the cells not otherwise identified or specified compared to total cells in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble TNF Superfamily Member 5</VALIDVALUE>
          <VALUEMEANING>Soluble TNF Superfamily Member 5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the soluble TNF superfamily member 5 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyrotropin</VALIDVALUE>
          <VALUEMEANING>Thyrotropin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of thyrotropin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6384457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UR-144</VALIDVALUE>
          <VALUEMEANING>UR-144 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the UR-144 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184565</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Transferrin Receptor</VALIDVALUE>
          <VALUEMEANING>Soluble Transferrin Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble transferrin receptor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyrotropin/Thyroxine, Free</VALIDVALUE>
          <VALUEMEANING>Thyrotropin to Free Thyroxine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of thyrotropin compared to free thyroxine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urate Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Urate Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of urate being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Tumor Necrosis Factor Receptor</VALIDVALUE>
          <VALUEMEANING>Soluble Tumor Necrosis Factor Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble tumor necrosis factor receptor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117749</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroxine Binding Globulin</VALIDVALUE>
          <VALUEMEANING>Thyroxine Binding Globulin Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of thyroxine binding globulin protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74746</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Density</VALIDVALUE>
          <VALUEMEANING>Density</VALUEMEANING>
          <MEANINGDESCRIPTION>The amount of something per unit size.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45781</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deoxycholate</VALIDVALUE>
          <VALUEMEANING>Deoxycholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of deoxycholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deoxyhemoglobin</VALIDVALUE>
          <VALUEMEANING>Deoxyhemoglobin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of deoxyhemoglobin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deoxypyridinoline</VALIDVALUE>
          <VALUEMEANING>Deoxypyridinoline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of deoxypyridinoline present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79443</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deoxypyridinoline/Creatinine</VALIDVALUE>
          <VALUEMEANING>Deoxypyridinoline to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of deoxypyridinoline compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deoxyribonucleic Acid</VALIDVALUE>
          <VALUEMEANING>Deoxyribonucleic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of a targeted deoxyribonucleic acid (DNA) in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desipramine</VALIDVALUE>
          <VALUEMEANING>Desipramine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of desipramine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186040</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desmethylcitalopram</VALIDVALUE>
          <VALUEMEANING>Desmethylcitalopram Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of desmethylcitalopram in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desomorphine</VALIDVALUE>
          <VALUEMEANING>Desomorphine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the desomorphine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desoxymethyltestosterone</VALIDVALUE>
          <VALUEMEANING>Desoxymethyltestosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the desoxymethyltestosterone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184582</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desvenlafaxine</VALIDVALUE>
          <VALUEMEANING>Desvenlafaxine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of desvenlafaxine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147333</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413844</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dextroamphetamine</VALIDVALUE>
          <VALUEMEANING>Dextroamphetamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of dextroamphetamine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Di-Desmethylcitalopram</VALIDVALUE>
          <VALUEMEANING>Di-Desmethylcitalopram Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of di-desmethylcitalopram in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491816</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diazepam</VALIDVALUE>
          <VALUEMEANING>Diazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of diazepam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405820</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dicalcium Phosphate Crystals</VALIDVALUE>
          <VALUEMEANING>Dicalcium Phosphate Crystals Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of dicalcium phosphate crystals in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nitrazepam</VALIDVALUE>
          <VALUEMEANING>Nitrazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the nitrazepam in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nitric Oxide</VALIDVALUE>
          <VALUEMEANING>Nitric Oxide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nitric oxide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nitrite</VALIDVALUE>
          <VALUEMEANING>Nitrite Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of nitrite present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64810</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NK Cells/Lym</VALIDVALUE>
          <VALUEMEANING>Natural Killer Cells to Lymphocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the natural killer cells to lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181258</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8003096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nociceptin</VALIDVALUE>
          <VALUEMEANING>Nociceptin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nociceptin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-HDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>Non-High Density Lipoprotein Cholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of non-high density lipoprotein cholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406230</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-HDL Cholesterol/HDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>Non-HDL Cholesterol to HDL Cholesterol Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of non-HDL cholesterol compared to HDL cholesterol present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-HDL Cholesterol/LDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>Non-HDL Cholesterol to LDL Cholesterol Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of non-HDL cholesterol to LDL cholesterol present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186085</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-Phosphorylated Tau Protein</VALIDVALUE>
          <VALUEMEANING>Nonphosphorylated Tau Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nonphosphorylated Tau protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84811</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411591</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-Prostatic Acid Phosphatase</VALIDVALUE>
          <VALUEMEANING>Non-Prostatic Acid Phosphatase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of non-prostatic acid phosphatase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-Squamous Epithelial Cells</VALIDVALUE>
          <VALUEMEANING>Non-Squamous Epithelial Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of non-squamous epithelial cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nonhematic Cells</VALIDVALUE>
          <VALUEMEANING>Nonhematic Cells Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nonhematic cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403836</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nonhematic Cells/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Nonhematic Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of nonhematic cells compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Norclostebol</VALIDVALUE>
          <VALUEMEANING>Norclostebol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the norclostebol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184593</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nordazepam</VALIDVALUE>
          <VALUEMEANING>Nordazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nordazepam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139076</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nordoxepin</VALIDVALUE>
          <VALUEMEANING>Nordoxepin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nordoxepin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Norepinephrine Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Norepinephrine Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of norepinephrine being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Norepinephrine</VALIDVALUE>
          <VALUEMEANING>Noradrenaline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of noradrenaline hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74868</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Norethandrolone</VALIDVALUE>
          <VALUEMEANING>Norethandrolone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the norethandrolone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Norfluoxetine</VALIDVALUE>
          <VALUEMEANING>Norfluoxetine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the norfluoxetine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Norhydrocodone</VALIDVALUE>
          <VALUEMEANING>Norhydrocodone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of norhydrocodone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177952</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal Sperm/Total Sperm</VALIDVALUE>
          <VALUEMEANING>Normal Sperm to Total Sperm Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of normal sperm compared to total sperm present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normalized Protein Catabolism Rate</VALIDVALUE>
          <VALUEMEANING>Normalized Protein Catabolism Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>A calculated measurement of the normalized protein catabolism rate in a biological specimen used to assess dietary protein intake in dialysis patients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normetanephrine Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Normetanephrine Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of normetanephrine being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154048</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normetanephrine</VALIDVALUE>
          <VALUEMEANING>Normetanephrine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of normetanephrine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122138</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normetanephrine, Free</VALIDVALUE>
          <VALUEMEANING>Free Normetanephrine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free normetanephrine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186086</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normoblasts</VALIDVALUE>
          <VALUEMEANING>Normoblast Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of normoblasts in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normoblasts/Total Cells</VALIDVALUE>
          <VALUEMEANING>Normoblast to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of normoblasts compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normorphine</VALIDVALUE>
          <VALUEMEANING>Normorphine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the normorphine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nornicotine</VALIDVALUE>
          <VALUEMEANING>Nornicotine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nornicotine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Noroxycodone</VALIDVALUE>
          <VALUEMEANING>Noroxycodone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of noroxycodone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177953</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Norpropoxyphene</VALIDVALUE>
          <VALUEMEANING>Norpropoxyphene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of norpropoxyphene present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186088</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Norsertraline</VALIDVALUE>
          <VALUEMEANING>Norsertraline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the norsertraline in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187817</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor XIV Actual/Control</VALIDVALUE>
          <VALUEMEANING>Factor XIV Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the factor XIV in a subject&#39;s specimen compared to a control sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Factor XIV</VALIDVALUE>
          <VALUEMEANING>Factor XIV Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of factor XIV present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fas Cell Surface Death Receptor</VALIDVALUE>
          <VALUEMEANING>Fas Cell Surface Death Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Fas cell surface death receptor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fas Ligand</VALIDVALUE>
          <VALUEMEANING>Fas Ligand Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Fas ligand in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199921</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fat Bodies, Oval</VALIDVALUE>
          <VALUEMEANING>Oval Fat Body Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oval-shaped fat bodies present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81947</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fat Droplet</VALIDVALUE>
          <VALUEMEANING>Fat Droplet Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of triglyceride aggregates present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98728</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fat</VALIDVALUE>
          <VALUEMEANING>Fat Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fat present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fat/Total Solids</VALIDVALUE>
          <VALUEMEANING>Fats to Total Solids Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the fat to total solid material in a biological specimen (for example a stool specimen). The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fatty Acid Binding Protein 1</VALIDVALUE>
          <VALUEMEANING>Fatty Acid Binding Protein 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fatty acid binding protein-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82012</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408127</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fatty Acid Binding Protein 3</VALIDVALUE>
          <VALUEMEANING>Fatty Acid Binding Protein 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the fatty acid binding protein 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fatty Acid Binding Protein 4</VALIDVALUE>
          <VALUEMEANING>Fatty Acid Binding Protein 4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fatty acid binding protein 4 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199922</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fatty Acids, Very Long Chain</VALIDVALUE>
          <VALUEMEANING>Very Long Chain Fatty Acids Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of very long chain fatty acids present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147337</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413838</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fatty Casts</VALIDVALUE>
          <VALUEMEANING>Fatty Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fatty casts present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74766</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fatty Liver Index</VALIDVALUE>
          <VALUEMEANING>Fatty Liver Index</VALUEMEANING>
          <MEANINGDESCRIPTION>A calculation that indicates the likely presence of fatty liver disease, taking into account waist circumference, body mass index, triglyceride concentrations, and gamma-glutamyltransferase activity. (Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006 Nov 2;6:33.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fencamfamin</VALIDVALUE>
          <VALUEMEANING>Fencamfamin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the fencamfamin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184618</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010669</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fenfluramine</VALIDVALUE>
          <VALUEMEANING>Fenfluramine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the fenfluramine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fenproporex</VALIDVALUE>
          <VALUEMEANING>Fenproporex Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the fenproporex in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184620</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010665</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fentanyl</VALIDVALUE>
          <VALUEMEANING>Fentanyl Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fentanyl present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147338</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403108</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ferritin Heavy Chain</VALIDVALUE>
          <VALUEMEANING>Ferritin Heavy Chain Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ferritin heavy chain in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ferritin Light Chain</VALIDVALUE>
          <VALUEMEANING>Ferritin Light Chain Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ferritin light chain in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ferritin</VALIDVALUE>
          <VALUEMEANING>Ferritin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ferritin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrin Degradation Products</VALIDVALUE>
          <VALUEMEANING>Fibrin Degradation Products Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fibrin degradation products present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82013</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrin Monomer</VALIDVALUE>
          <VALUEMEANING>Fibrin Monomer Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fibrin monomer in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrinogen</VALIDVALUE>
          <VALUEMEANING>Fibrinogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the fibrinogen in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64606</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrinogen, Functional</VALIDVALUE>
          <VALUEMEANING>Functional Fibrinogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of functional fibrinogen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139075</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroblast Growth Factor 19</VALIDVALUE>
          <VALUEMEANING>Fibroblast Growth Factor 19 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fibroblast growth factor 19 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroblast Growth Factor 21</VALIDVALUE>
          <VALUEMEANING>Fibroblast Growth Factor 21 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the fibroblast growth factor 21 in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroblast Growth Factor 23</VALIDVALUE>
          <VALUEMEANING>Fibroblast Growth Factor 23 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fibroblast growth factor 23 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407724</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroblast Growth Factor 23, C-Terminal</VALIDVALUE>
          <VALUEMEANING>C-Terminal Fibroblast Growth Factor 23 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the C-terminal fibroblast growth factor 23 in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroblast Growth Factor 23, Intact</VALIDVALUE>
          <VALUEMEANING>Intact Fibroblast Growth Factor 23 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the intact fibroblast growth factor 23 in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroblast Growth Factor 9</VALIDVALUE>
          <VALUEMEANING>Fibroblast Growth Factor 9 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fibroblast growth factor 9 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130162</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroblast Growth Factor Basic Form</VALIDVALUE>
          <VALUEMEANING>Fibroblast Growth Factor Basic Form Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fibroblast growth factor basic form present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82014</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibronectin, Cellular</VALIDVALUE>
          <VALUEMEANING>Cellular Fibronectin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cellular fibronectin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351828</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibronectin, Fetal</VALIDVALUE>
          <VALUEMEANING>Fetal Fibronectin Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A test for the presence of fetal fibronectin in the cervico-vaginal area that is used to predict preterm birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ret. Corpuscular HGB Concentration Mean</VALIDVALUE>
          <VALUEMEANING>Reticulocyte Corpuscular Hemoglobin Concentration Mean</VALUEMEANING>
          <MEANINGDESCRIPTION>An indirect measurement of the average concentration of hemoglobin per reticulocyte in a biological specimen, calculated as the ratio of hemoglobin to hematocrit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C138970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reticulocytes</VALIDVALUE>
          <VALUEMEANING>Reticulocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of reticulocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51947</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reticulocytes/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Reticulocyte to Erythrocyte Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of reticulocytes compared to erythrocytes in a blood sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reticulocytes/Total Cells</VALIDVALUE>
          <VALUEMEANING>Reticulocyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of reticulocytes to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009268</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinoic Acid</VALIDVALUE>
          <VALUEMEANING>Retinoic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the retinoic acid in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187824</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinol Binding Protein 1</VALIDVALUE>
          <VALUEMEANING>Retinol Binding Protein 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of retinol binding protein 1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinol Binding Protein 2</VALIDVALUE>
          <VALUEMEANING>Retinol Binding Protein 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of retinol binding protein 2 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491810</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinol Binding Protein 3</VALIDVALUE>
          <VALUEMEANING>Retinol Binding Protein 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of retinol binding protein 3 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinol Binding Protein 4</VALIDVALUE>
          <VALUEMEANING>Retinol Binding Protein 4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of retinol binding protein 4 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinol Binding Protein</VALIDVALUE>
          <VALUEMEANING>Retinol Binding Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of retinol binding protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100437</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinol Binding Protein/Creatinine</VALIDVALUE>
          <VALUEMEANING>Retinol Binding Protein to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of retinol binding protein compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinyl Palmitate</VALIDVALUE>
          <VALUEMEANING>Retinyl Palmitate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of endogenous retinyl palmitate in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rh Factor</VALIDVALUE>
          <VALUEMEANING>Rh Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunology test to measure for the presence of the Rh factor antigen in blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucosylceramidase Beta</VALIDVALUE>
          <VALUEMEANING>Glucosylceramidase Beta Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the glucosylceramidase beta in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucosylceramide</VALIDVALUE>
          <VALUEMEANING>Glucosylceramide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the glucosylceramide in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucuronidase, Alpha</VALIDVALUE>
          <VALUEMEANING>Alpha Glucuronidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of alpha glucuronidase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucuronidase, Beta</VALIDVALUE>
          <VALUEMEANING>Beta Glucuronidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of beta glucuronidase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80170</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutamate Dehydrogenase</VALIDVALUE>
          <VALUEMEANING>Glutamate Dehydrogenase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glutamate dehydrogenase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79448</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutamate</VALIDVALUE>
          <VALUEMEANING>Glutamate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glutamate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74739</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3264713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutamic Acid Decarboxylase 1</VALIDVALUE>
          <VALUEMEANING>Glutamic Acid Decarboxylase 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glutamic acid decarboxylase 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82015</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutamic Acid Decarboxylase 2</VALIDVALUE>
          <VALUEMEANING>Glutamic Acid Decarboxylase 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glutamic acid decarboxylase 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82016</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402948</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutamine</VALIDVALUE>
          <VALUEMEANING>Glutamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glutamine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122121</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutathione S-Transferase, Alpha/Creat</VALIDVALUE>
          <VALUEMEANING>Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of alpha glutathione-s-transferase compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80166</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutathione S-Transferase, Pi</VALIDVALUE>
          <VALUEMEANING>Pi Glutathione S-Transferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Pi glutathione-s-transferase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutathione S-Transferase, Theta</VALIDVALUE>
          <VALUEMEANING>Theta Glutathione S-Transferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Theta glutathione-s-transferase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutathione S-Transferase, Total</VALIDVALUE>
          <VALUEMEANING>Glutathione-S-Transferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glutathione-s-transferase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutathione S-Transferase, Y1</VALIDVALUE>
          <VALUEMEANING>Glutathione S-Transferase Y1 Subunit Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glutathione S-transferase Y1 subunit present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutathione-S-Transferase/Creatinine</VALIDVALUE>
          <VALUEMEANING>Glutathione-S-Transferase to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of glutathione-s-transferase compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79435</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutethimide</VALIDVALUE>
          <VALUEMEANING>Glutethimide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the glutethimide in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycated Albumin</VALIDVALUE>
          <VALUEMEANING>Glycated Albumin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glycated albumin related peptide present in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycated Albumin/Albumin</VALIDVALUE>
          <VALUEMEANING>Glycated Albumin to Albumin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of glycated albumin compared to total albumin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774774</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycated Ferritin</VALIDVALUE>
          <VALUEMEANING>Glycated Ferritin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glycated ferritin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186049</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycated Ferritin/Ferritin</VALIDVALUE>
          <VALUEMEANING>Glycated Ferritin to Ferritin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of glycated ferritin to total ferritin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186050</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glyceraldehyde-3-Phosphate Dehydrogenase</VALIDVALUE>
          <VALUEMEANING>Glyceraldehyde-3-Phosphate Dehydrogenase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the glyceraldehyde-3-phosphate dehydrogenase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycerol</VALIDVALUE>
          <VALUEMEANING>Glycerol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glycerol in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132371</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycine</VALIDVALUE>
          <VALUEMEANING>Glycine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glycine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycine/Creatinine</VALIDVALUE>
          <VALUEMEANING>Glycine to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of glycine compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycochenodeoxycholate</VALIDVALUE>
          <VALUEMEANING>Glycochenodeoxycholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glycochenodeoxycholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176305</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycocholate</VALIDVALUE>
          <VALUEMEANING>Glycocholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glycocholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176299</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycogen Phosphorylase Isoenzyme BB</VALIDVALUE>
          <VALUEMEANING>Glycogen Phosphorylase Isoenzyme BB Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glycogen phosphorylase isoenzyme BB present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198284</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycolithocholate</VALIDVALUE>
          <VALUEMEANING>Glycolithocholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glycolithocholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycoursodeoxycholate</VALIDVALUE>
          <VALUEMEANING>Glycoursodeoxycholate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of glycoursodeoxycholate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176302</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7551743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycylproline Dipeptidyl Aminopeptidase</VALIDVALUE>
          <VALUEMEANING>Glycylproline Dipeptidyl Aminopeptidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the glycylproline dipeptidyl aminopeptidase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gold</VALIDVALUE>
          <VALUEMEANING>Gold Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of gold present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80186</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gonadotropin Releasing Hormone</VALIDVALUE>
          <VALUEMEANING>Gonadotropin Releasing Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of gonadotropin releasing hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74860</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granular Casts</VALIDVALUE>
          <VALUEMEANING>Granular Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of granular casts present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407424</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granular Coarse Casts</VALIDVALUE>
          <VALUEMEANING>Coarse Granular Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of coarse granular casts present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granular Fine Casts</VALIDVALUE>
          <VALUEMEANING>Granular Fine Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fine granular casts present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74769</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulin</VALIDVALUE>
          <VALUEMEANING>Granulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of granulin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165963</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulocyte Colony Stimulating Factor</VALIDVALUE>
          <VALUEMEANING>Granulocyte Colony Stimulating Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of granulocyte colony stimulating factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulocyte Macrophage Colony Stm Factor</VALIDVALUE>
          <VALUEMEANING>Granulocyte Macrophage Colony Stm Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of granulocyte macrophage colony stimulating factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82019</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulocytes Band Form</VALIDVALUE>
          <VALUEMEANING>Granulocytes Band Form Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of banded granulocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186055</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulocytes Band Form/Total Cells</VALIDVALUE>
          <VALUEMEANING>Band Form Granulocyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of band form granulocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127615</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413425</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulocytes Segmented</VALIDVALUE>
          <VALUEMEANING>Segmented Granulocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of segmented granulocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186056</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulocytes Segmented/Total Cells</VALIDVALUE>
          <VALUEMEANING>Segmented Granulocyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of segmented granulocytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127616</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulocytes</VALIDVALUE>
          <VALUEMEANING>Granulocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the granulocytes in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Granulocytes to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of granulocytes compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413836</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulocytes/Total Cells</VALIDVALUE>
          <VALUEMEANING>Granulocyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98866</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407339</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Growth Differentiation Factor 11</VALIDVALUE>
          <VALUEMEANING>Growth Differentiation Factor 11 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of growth differentiation factor 11 in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Taurine/Creatinine</VALIDVALUE>
          <VALUEMEANING>Taurine to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of taurine compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nortriptyline</VALIDVALUE>
          <VALUEMEANING>Nortriptyline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nortriptyline present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nuclear Matrix Protein 22</VALIDVALUE>
          <VALUEMEANING>Nuclear Matrix Protein 22 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nuclear matrix protein 22 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nuclear Swelling</VALIDVALUE>
          <VALUEMEANING>Nuclear Swelling Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the expansion of the nucleus of the cells in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nucleated Cells</VALIDVALUE>
          <VALUEMEANING>Nucleated Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nucleated cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150841</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nucleated Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Nucleated Red Blood Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of nucleated red blood cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nucleated Erythrocytes/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Nucleated Red Blood Cell to Erythrocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of nucleated red blood cells compared to erythrocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74647</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5914884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nucleated Erythrocytes/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Nucleated Erythrocyte to Leukocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of nucleated erythrocytes compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>O-Demethylase</VALIDVALUE>
          <VALUEMEANING>O-Demethylase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of O-demethylase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163479</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>O-Desmethyltramadol</VALIDVALUE>
          <VALUEMEANING>O-Desmethyltramadol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of O-desmethyltramadol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occult Blood</VALIDVALUE>
          <VALUEMEANING>Occult Blood Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the blood in body products such as a urine or stool sample, not detectable on gross examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409009</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Olanzapine</VALIDVALUE>
          <VALUEMEANING>Olanzapine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of olanzapine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oligoclonal Bands</VALIDVALUE>
          <VALUEMEANING>Oligoclonal Bands Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oligoclonal bands in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122139</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oncostatin M</VALIDVALUE>
          <VALUEMEANING>Oncostatin M Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oncostatin M in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Opiate</VALIDVALUE>
          <VALUEMEANING>Opiate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of any opiate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ornithine</VALIDVALUE>
          <VALUEMEANING>Ornithine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ornithine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dickkopf WNT Signaling Path Inhibitor 1</VALIDVALUE>
          <VALUEMEANING>Dickkopf WNT Signaling Path Inhibitor 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of dickkopf WNT signaling pathway inhibitor 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165957</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diethylpropion</VALIDVALUE>
          <VALUEMEANING>Diethylpropion Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the diethylpropion in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184614</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dihydrocodeine</VALIDVALUE>
          <VALUEMEANING>Dihydrocodeine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of dihydrocodeine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74878</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dihydrotestosterone</VALIDVALUE>
          <VALUEMEANING>Dihydrotestosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of dihydrotestosterone hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dilute Russell&#39;s Viper Venom Time Ratio</VALIDVALUE>
          <VALUEMEANING>Dilute Russell&#39;s Viper Venom Time to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the dilute Russell&#39;s viper venom time in a subject sample to a control sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dilute Russell&#39;s Viper Venom Time</VALIDVALUE>
          <VALUEMEANING>Dilute Russell&#39;s Viper Venom Time Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the time it takes a plasma sample to clot after adding dilute Russell&#39;s viper venom.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dimethylglycine</VALIDVALUE>
          <VALUEMEANING>Dimethylglycine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of dimethylglycine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dimorphic Erythrocyte Population</VALIDVALUE>
          <VALUEMEANING>Dimorphic Erythrocyte Population</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of dimorphic erythrocyes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dipeptidyl Peptidase-4</VALIDVALUE>
          <VALUEMEANING>Dipeptidyl Peptidase-4 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of dipeptidyl peptidase-4 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diphenoxylate</VALIDVALUE>
          <VALUEMEANING>Diphenoxylate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the diphenoxylate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dipipanone</VALIDVALUE>
          <VALUEMEANING>Dipipanone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the dipipanone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184540</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Direct Bilirubin</VALIDVALUE>
          <VALUEMEANING>Direct Bilirubin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The bilirubin is bound to glucuronide to form conjugated bilirubin (direct bilirubin). Direct Bilirubin measurement is accomplished by a colorimetric method. Direct Bilirubin in biological fluids reacts with sulfanilic acid at acidic pH to produce a red colored complex. The optical density of produced color has a direct relationship with Direct Bilirubin concentration in the solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Direct Bilirubin/Bilirubin</VALIDVALUE>
          <VALUEMEANING>Direct Bilirubin to Bilirubin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of direct bilirubin compared to total bilirubin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158226</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774776</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DNA Fragmentation Index</VALIDVALUE>
          <VALUEMEANING>DNA Fragmentation Index</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the deoxyribonucleic acid fragmentation within the nucleated cells in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dohle Bodies</VALIDVALUE>
          <VALUEMEANING>Dohle Body Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of Dohle bodies present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dopamine Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Dopamine Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of dopamine being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153920</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dopamine</VALIDVALUE>
          <VALUEMEANING>Dopamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of dopamine hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74854</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxepin and/or Metabolites</VALIDVALUE>
          <VALUEMEANING>Doxepin And/Or Metabolites Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of doxepin and/or its metabolite(s) present in a biological specimen, for an assay that can measure both doxepin and its metabolites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186041</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxepin</VALIDVALUE>
          <VALUEMEANING>Doxepin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of doxepin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191285</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drostanolone</VALIDVALUE>
          <VALUEMEANING>Drostanolone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the drostanolone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drug Crystals</VALIDVALUE>
          <VALUEMEANING>Drug Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of drug crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drug Screen</VALIDVALUE>
          <VALUEMEANING>Drug Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A laboratory test of biological material such as blood, urine, hair, saliva or sweat, used to detect the presence of a drug or its metabolites with in the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78139</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2926788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dRVVT Screen to Confirm Pct Difference</VALIDVALUE>
          <VALUEMEANING>dRVVT Screen to Confirm Percent Difference</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement to confirm the presence of Lupus anticoagulants, calculated as [(Screen dRVVT - Confirm dRVVT)/Screen dRVVT]x100.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161373</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DRVVT Screen to Confirm Ratio</VALIDVALUE>
          <VALUEMEANING>Dilute Russell&#39;s Viper Venom Time to Confirm Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio) of the dilute Russell&#39;s viper venom time without the presence of excess phospholipid to the dRVVT in the presence of excess phospholipid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DTPA Clearance</VALIDVALUE>
          <VALUEMEANING>Diethylene Triamine Pentaacetic Acid Clearance</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) through its excretion for a specified unit of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DU-PAN-2</VALIDVALUE>
          <VALUEMEANING>Duke Pancreatic Monoclonal Antigen Type 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Duke pancreatic monoclonal antigen type 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14537240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Duloxetine</VALIDVALUE>
          <VALUEMEANING>Duloxetine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the duloxetine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dysmorphic Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Dysmorphic Erythrocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of dysmorphic erythrocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dysmorphic Erythrocytes/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Dysmorphic Erythrocytes to Erythrocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of dysmorphic erythrocytes compared to total erythrocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150839</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>E-Selectin</VALIDVALUE>
          <VALUEMEANING>E-selectin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of E-selectin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619438</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>E3 Ubiquitin-Protein Ligase TRIM33</VALIDVALUE>
          <VALUEMEANING>E3 Ubiquitin-Protein Ligase TRIM33 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the E3 ubiquitin-protein ligase TRIM33 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187799</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ecarin Clotting Time</VALIDVALUE>
          <VALUEMEANING>Ecarin Clotting Time Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eccentrocytes</VALIDVALUE>
          <VALUEMEANING>Eccentrocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of eccentrocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96598</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RhD Factor</VALIDVALUE>
          <VALUEMEANING>RhD Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Rhesus factor type D present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Riboflavin</VALIDVALUE>
          <VALUEMEANING>Vitamin B2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin B2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ribonucleic Acid</VALIDVALUE>
          <VALUEMEANING>Ribonucleic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ribonucleic acids in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ringed Sideroblasts</VALIDVALUE>
          <VALUEMEANING>Ring Sideroblast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ringed sideroblasts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409268</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Risperidone</VALIDVALUE>
          <VALUEMEANING>Risperidone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of risperidone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637344</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Risperidone+9-Hydroxyrisperidone</VALIDVALUE>
          <VALUEMEANING>Risperidone and 9-Hydroxyrisperidone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of risperidone and 9-hydroxyrisperidone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637340</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ritalinic Acid</VALIDVALUE>
          <VALUEMEANING>Ritalinic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ritalinic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170582</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7256014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RLP Cholesterol</VALIDVALUE>
          <VALUEMEANING>Remnant-like Particle Cholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the RLP cholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rouleaux Formation</VALIDVALUE>
          <VALUEMEANING>Rouleaux Formation Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of stacking red blood cells present in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74624</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405583</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Round Cells</VALIDVALUE>
          <VALUEMEANING>Round Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of round shaped cells, mainly comprised of white blood cells and immature spermatogenic cells, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Round Epithelial Cells</VALIDVALUE>
          <VALUEMEANING>Round Epithelial Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of round epithelial cells present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rubriblast</VALIDVALUE>
          <VALUEMEANING>Proerythroblast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of proerythroblasts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rubriblast/Total Cells</VALIDVALUE>
          <VALUEMEANING>Pronormoblast to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of pronormoblasts compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rubricyte</VALIDVALUE>
          <VALUEMEANING>Rubricyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of rubricytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128978</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rubricyte/Total Cells</VALIDVALUE>
          <VALUEMEANING>Rubricyte to Total Cell Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the rubricytes compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129006</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>S-Adenosylhomocysteine</VALIDVALUE>
          <VALUEMEANING>S-Adenosylhomocysteine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of S-adenosylhomocysteine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>S-Adenosylmethionine</VALIDVALUE>
          <VALUEMEANING>S-Adenosylmethionine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of S-adenosylmethionine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172515</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>S-Pancreas-1 Antigen</VALIDVALUE>
          <VALUEMEANING>S-Pancreas-1 Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of S-pancreas-1 antigen in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>S100 Calcium Binding Protein A8</VALIDVALUE>
          <VALUEMEANING>S100 Calcium Binding Protein A8 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of S100 calcium binding protein A8 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154730</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>S100 Calcium-Binding Protein B</VALIDVALUE>
          <VALUEMEANING>S100 Calcium-Binding Protein B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of S100 calcium-binding protein B present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Salicylates</VALIDVALUE>
          <VALUEMEANING>Salicylates Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of salicylates present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcosine</VALIDVALUE>
          <VALUEMEANING>Sarcosine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sarcosine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154760</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scavenger Rcpt Cys-Rich Type1 Prot M130</VALIDVALUE>
          <VALUEMEANING>Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of scavenger receptor cysteine-rich type 1 protein M130 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154728</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Schistocytes</VALIDVALUE>
          <VALUEMEANING>Schistocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the schistocytes (fragmented red blood cells) in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74706</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Schistocytes/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Schistocyte to Erythrocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of schistocytes to erythrocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186094</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sclerostin</VALIDVALUE>
          <VALUEMEANING>Sclerostin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sclerostin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117857</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Secobarbital</VALIDVALUE>
          <VALUEMEANING>Secobarbital Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of secobarbital present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Secretin</VALIDVALUE>
          <VALUEMEANING>Secretin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of secretin hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74871</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sediment Examination</VALIDVALUE>
          <VALUEMEANING>Sediment Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>An observation, assessment or examination of the sediment in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Selenium</VALIDVALUE>
          <VALUEMEANING>Selenium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the selenium in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serine Peptidase Inhibitor Kazal Type 1</VALIDVALUE>
          <VALUEMEANING>Serine Peptidase Inhibitor Kazal Type 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of serine peptidase inhibitor Kazal type 1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serine</VALIDVALUE>
          <VALUEMEANING>Serine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of serine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122149</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413389</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serotonin</VALIDVALUE>
          <VALUEMEANING>Serotonin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of serotonin hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74872</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serpin A12</VALIDVALUE>
          <VALUEMEANING>Serpin A12 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of serpin A12 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433553</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serpin Family B Member 5</VALIDVALUE>
          <VALUEMEANING>Serpin Family B Member 5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of serpin family B member 5 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6a OH-tetrahydro-11-Deoxycortisol</VALIDVALUE>
          <VALUEMEANING>6a OH-tetrahydro-11-Deoxycortisol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 6-alpha hydroxytetrahydro-11-deoxycortisol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186059</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7-alpha-Hydroxy-4-cholesten-3-one</VALIDVALUE>
          <VALUEMEANING>7-alpha-Hydroxy-4-cholesten-3-one Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 7-alpha-hydroxy-4-cholesten-3-one in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7-Ketocholesterol</VALIDVALUE>
          <VALUEMEANING>7-Ketocholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 7-ketocholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7alpha,25-Dihydroxycholesterol</VALIDVALUE>
          <VALUEMEANING>7alpha,25-Dihydroxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 7alpha,25-Dihydroxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7alpha,27-Dihydroxycholesterol</VALIDVALUE>
          <VALUEMEANING>7alpha,27-Dihydroxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 7alpha,27-dihydroxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7alpha-Hydroxycholesterol</VALIDVALUE>
          <VALUEMEANING>7alpha-Hydroxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 7alpha-hydroxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7beta-Hydroxycholesterol</VALIDVALUE>
          <VALUEMEANING>7beta-Hydroxycholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 7beta-Hydroxycholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8-Hydroxy-2&#39;-Deoxyguanosine</VALIDVALUE>
          <VALUEMEANING>8-Hydroxy-2&#39;-Deoxyguanosine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the 8-hydroxy-2&#39;-deoxyguanosine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8-Hydroxydeoxyguanosine</VALIDVALUE>
          <VALUEMEANING>8-Hydroxydeoxyguanosine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 8-hydroxydeoxyguanosine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8-Iso-PGF2alpha/Creatinine</VALIDVALUE>
          <VALUEMEANING>8-Iso-Prostaglandin F2 Alpha to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the 8-iso-prostaglandin F2 alpha to creatinine in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412844</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8-Iso-Prostaglandin F2 Alpha</VALIDVALUE>
          <VALUEMEANING>8-Iso-Prostaglandin F2 Alpha Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 8-iso-prostaglandin F2 alpha in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412842</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9-Hydroxyrisperidone</VALIDVALUE>
          <VALUEMEANING>9-Hydroxyrisperidone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 9-hydroxyrisperidone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A Fetoprotein L3/A Fetoprotein</VALIDVALUE>
          <VALUEMEANING>Alpha Fetoprotein L3 to Total Alpha Fetoprotein Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of alpha fetoprotein L3 compared to total alpha fetoprotein present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96565</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Growth Differentiation Factor 2</VALIDVALUE>
          <VALUEMEANING>Growth Differentiation Factor 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of growth differentiation factor 2 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199913</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Growth Differentiation Factor 8</VALIDVALUE>
          <VALUEMEANING>Growth Differentiation Factor 8 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of growth differentiation factor 8 in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Growth Hormone Binding Protein</VALIDVALUE>
          <VALUEMEANING>Growth Hormone Binding Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of growth hormone binding protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Growth Hormone Inhibiting Hormone</VALIDVALUE>
          <VALUEMEANING>Growth Hormone Inhibiting Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of growth hormone inhibiting hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74861</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Growth Hormone Releasing Hormone</VALIDVALUE>
          <VALUEMEANING>Growth Hormone Releasing Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of growth hormone releasing hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Growth Regulated Oncogene</VALIDVALUE>
          <VALUEMEANING>Growth Regulated Oncogene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total growth regulated oncogene proteins present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186057</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guanine Deaminase</VALIDVALUE>
          <VALUEMEANING>Guanine Deaminase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of guanine deaminase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150845</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407994</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guanylate Binding Protein 1</VALIDVALUE>
          <VALUEMEANING>Guanylate Binding Protein 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of guanylate binding protein 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Lymphocyte Activation Gene-3</VALIDVALUE>
          <VALUEMEANING>Soluble Lymphocyte Activation Gene-3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble lymphocyte activation gene-3 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thrombopoietin</VALIDVALUE>
          <VALUEMEANING>Thrombopoietin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of thrombopoietin hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74873</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U-47700</VALIDVALUE>
          <VALUEMEANING>U-47700 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the U-47700 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Mesothelin Related Peptides</VALIDVALUE>
          <VALUEMEANING>Soluble Mesothelin Related Peptides Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble mesothelin related peptides in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thrombospondin 1</VALIDVALUE>
          <VALUEMEANING>Thrombospondin 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of thrombospondin 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ubiquinone 10</VALIDVALUE>
          <VALUEMEANING>Ubiquinone 10 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ubiquinone 10 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147321</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble P-Selectin</VALIDVALUE>
          <VALUEMEANING>Soluble P-Selectin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the soluble P-selectin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thromboxane B2</VALIDVALUE>
          <VALUEMEANING>Thromboxane B2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the thromboxane B2 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ubiquitin C-Terminal Hydrolase L1</VALIDVALUE>
          <VALUEMEANING>Ubiquitin C-Terminal Hydrolase L1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ubiquitin C-terminal hydrolase L1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189529</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Programmed Death Ligand 1</VALIDVALUE>
          <VALUEMEANING>Soluble Programmed Death Ligand 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble programmed death ligand 1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymic Stromal Lymphopoietin</VALIDVALUE>
          <VALUEMEANING>Thymic Stromal Lymphopoietin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the thymic stromal lymphopoietin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184511</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ubiquitin Protein</VALIDVALUE>
          <VALUEMEANING>Ubiquitin Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ubiquitin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147443</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble Programmed Death-1</VALIDVALUE>
          <VALUEMEANING>Soluble Programmed Death-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble programmed death-1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351832</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymidine Kinase 1</VALIDVALUE>
          <VALUEMEANING>Thymidine Kinase 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of thymidine kinase 1 in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ubiquitin-Like Protein ISG15</VALIDVALUE>
          <VALUEMEANING>Ubiquitin-Like Protein ISG15 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ubiquitin-like protein ISG15 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble TNF Receptor Superfamily Mem 5</VALIDVALUE>
          <VALUEMEANING>Soluble TNF Receptor Superfamily Member 5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the soluble TNF receptor superfamily member 5 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174312</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymidine Kinase 2</VALIDVALUE>
          <VALUEMEANING>Thymidine Kinase 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of thymidine kinase 2 in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unclassified Casts</VALIDVALUE>
          <VALUEMEANING>Unclassified Cast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of unclassified casts present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74776</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble TNF Receptor Superfamily Mem 7</VALIDVALUE>
          <VALUEMEANING>Soluble TNF Receptor Superfamily Mem 7 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble tumor necrosis factor receptor superfamily member 7 (CD27) in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199916</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymidine Kinase</VALIDVALUE>
          <VALUEMEANING>Thymidine Kinase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the thymidine kinase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unclassified Crystals</VALIDVALUE>
          <VALUEMEANING>Unclassified Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of unclassified crystals present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble TNF Receptor Superfamily Mem 9</VALIDVALUE>
          <VALUEMEANING>Soluble Tumor Necrosis Factor Receptor Superfamily Member 9 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble tumor necrosis factor receptor superfamily member 9 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroglobulin Recovery Rate</VALIDVALUE>
          <VALUEMEANING>Thyroglobulin Recovery Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the thyroglobulin recovery rate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147435</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unsaturated Iron Binding Capacity</VALIDVALUE>
          <VALUEMEANING>Unsaturated Iron Binding Capacity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the binding capacity of unsaturated iron in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble TNF Receptor Type I</VALIDVALUE>
          <VALUEMEANING>Soluble Tumor Necrosis Factor Receptor Type I Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble TNF receptor type I present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117863</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroglobulin</VALIDVALUE>
          <VALUEMEANING>Thyroglobulin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the thyroglobulin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6416616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unspecified Cells</VALIDVALUE>
          <VALUEMEANING>Count of Unspecified Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of unspecified cells, those not otherwise identified, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112241</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soluble TNF Receptor Type II</VALIDVALUE>
          <VALUEMEANING>Soluble Tumor Necrosis Factor Receptor Type II Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of soluble TNF receptor type II present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117864</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroperoxidase</VALIDVALUE>
          <VALUEMEANING>Thyroperoxidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of thyroperoxidase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96639</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Troponin T</VALIDVALUE>
          <VALUEMEANING>Troponin T Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of troponin T present in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6384471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Troponin</VALIDVALUE>
          <VALUEMEANING>Troponin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total troponin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trypsin 1 and Trypsinogen 1</VALIDVALUE>
          <VALUEMEANING>Trypsin 1 and Trypsinogen 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the trypsin 1 and trypsinogen 1 in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trypsin and Trypsinogen</VALIDVALUE>
          <VALUEMEANING>Trypsin and Trypsinogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the total trypsin and total trypsinogen in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trypsin</VALIDVALUE>
          <VALUEMEANING>Trypsin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of trypsin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tryptase</VALIDVALUE>
          <VALUEMEANING>Tryptase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tryptase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tryptophan</VALIDVALUE>
          <VALUEMEANING>Tryptophan Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tryptophan present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154739</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6620107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tryptophan/Creatinine</VALIDVALUE>
          <VALUEMEANING>Tryptophan to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the tryptophan to creatinine in a biological sample. The measurement may be expressed as either a ratio or a percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tubular Epithelial Cells</VALIDVALUE>
          <VALUEMEANING>Tubular Epithelial Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of tubular epithelial cells present in a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74775</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor Necrosis Factor Receptor 1</VALIDVALUE>
          <VALUEMEANING>Tumor Necrosis Factor Receptor 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the tumor necrosis factor receptor 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EDDP</VALIDVALUE>
          <VALUEMEANING>EDDP Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of EDDP, the primary metabolite of methadone, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12539159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EDTA Clearance</VALIDVALUE>
          <VALUEMEANING>EDTA Clearance</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) through its excretion for a specified unit of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elliptocytes</VALIDVALUE>
          <VALUEMEANING>Elliptocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of elliptocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endogenous Thrombin Potential</VALIDVALUE>
          <VALUEMEANING>Endogenous Thrombin Potential Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the total concentration of thrombin generated in the presence of a substrate in a plasma or blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102266</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endostatin</VALIDVALUE>
          <VALUEMEANING>Endostatin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of endostatin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endothelin-1</VALIDVALUE>
          <VALUEMEANING>Endothelin-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of endothelin-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82008</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endothelin-3</VALIDVALUE>
          <VALUEMEANING>Endothelin-3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the endothelin-3 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophil-Derived Neurotoxin</VALIDVALUE>
          <VALUEMEANING>Eosinophil-Derived Neurotoxin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the eosinophil-derived neurotoxin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophilic Metamyelocytes</VALIDVALUE>
          <VALUEMEANING>Eosinophilic Metamyelocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of eosinophilic metamyelocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84819</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophilic Myelocytes</VALIDVALUE>
          <VALUEMEANING>Eosinophilic Myelocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of eosinophilic myelocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophilic Myelocytes/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Eosinophilic Myelocytes to Lymphocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of eosinophilic myelocytes compared to lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophils Band Form</VALIDVALUE>
          <VALUEMEANING>Eosinophil Band Form Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of band eosinophils in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osmolality</VALIDVALUE>
          <VALUEMEANING>Osmolality Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the osmoles of solute per kilogram of solvent present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osmolarity</VALIDVALUE>
          <VALUEMEANING>Osmolarity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the osmoles of solute per liter of solution present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74802</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteocalcin</VALIDVALUE>
          <VALUEMEANING>Osteocalcin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of osteocalcin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteopontin</VALIDVALUE>
          <VALUEMEANING>Osteopontin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of osteopontin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteopontin/Creatinine</VALIDVALUE>
          <VALUEMEANING>Osteopontin to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of osteopontin compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteoprotegerin</VALIDVALUE>
          <VALUEMEANING>Osteoprotegerin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of osteoprotegerin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401949</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ovalocytes</VALIDVALUE>
          <VALUEMEANING>Ovalocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ovalocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142287</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxalate Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Oxalate Excretion Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oxalate being excreted in a biological specimen over a defined period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxalate</VALIDVALUE>
          <VALUEMEANING>Oxalate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oxalate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxalate/Creatinine</VALIDVALUE>
          <VALUEMEANING>Oxalate to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of oxalate compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxandrolone</VALIDVALUE>
          <VALUEMEANING>Oxandrolone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oxandrolone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxazepam</VALIDVALUE>
          <VALUEMEANING>Oxazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oxazepam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxidized LDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>Oxidized LDL Cholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the oxidized LDL cholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxycodone</VALIDVALUE>
          <VALUEMEANING>Oxycodone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oxycodone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74884</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408992</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxygen Capacity</VALIDVALUE>
          <VALUEMEANING>Oxygen Capacity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96614</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxygen Content</VALIDVALUE>
          <VALUEMEANING>Oxygen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oxygen content present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111284</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxygen Saturation</VALIDVALUE>
          <VALUEMEANING>Oxygen Saturation</VALUEMEANING>
          <MEANINGDESCRIPTION>The measurement of the ratio of oxygenated hemoglobin to total hemoglobin in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3800015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxygen Saturation/Fraction Inspired O2</VALIDVALUE>
          <VALUEMEANING>Oxygen Saturation/Fraction Inspired O2</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxyhemoglobin</VALIDVALUE>
          <VALUEMEANING>Oxyhemoglobin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oxyhemoglobin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96616</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxyhemoglobin/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Oxyhemoglobin to Total Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of oxyhemoglobin compared to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxymesterone</VALIDVALUE>
          <VALUEMEANING>Oxymesterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the oxymesterone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxymetholone</VALIDVALUE>
          <VALUEMEANING>Oxymetholone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oxymetholone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxymorphone</VALIDVALUE>
          <VALUEMEANING>Oxymorphone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of oxymorphone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>P-Selectin</VALIDVALUE>
          <VALUEMEANING>P-Selectin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of P-selectin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117850</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>P50 Oxygen</VALIDVALUE>
          <VALUEMEANING>P50 Oxygen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of partial pressure of oxygen when hemoglobin is half saturated that is present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatic Elastase 1</VALIDVALUE>
          <VALUEMEANING>Pancreatic Elastase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pancreatic elastase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82028</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatic Elastase 1, Polymorphonuclear</VALIDVALUE>
          <VALUEMEANING>Polymorphonuclear Pancreatic Elastase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of polymorphonuclear pancreatic elastase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82029</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatic Polypeptide</VALIDVALUE>
          <VALUEMEANING>Pancreatic Polypeptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of pancreatic polypeptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80201</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pappenheimer Bodies</VALIDVALUE>
          <VALUEMEANING>Pappenheimer Body Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of Pappenheimer bodies in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74616</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Para Aminohippurate Clearance</VALIDVALUE>
          <VALUEMEANING>Para Aminohippurate Clearance Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of volume of serum or plasma that would be cleared of para aminohippurate by excretion of urine for a specified unit of time (e.g. one minute).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189530</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Para Aminohippurate</VALIDVALUE>
          <VALUEMEANING>Para Aminohippurate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of para aminohippurate in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Para-Aminobenzoate</VALIDVALUE>
          <VALUEMEANING>Para-Aminobenzoate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of para-aminobenzoate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186090</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Para-Fluorofentanyl</VALIDVALUE>
          <VALUEMEANING>Para-Fluorofentanyl Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the para-fluorofentanyl in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A Proliferation-Inducing Ligand</VALIDVALUE>
          <VALUEMEANING>A Proliferation-Inducing Ligand Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of a proliferation-inducing ligand present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111123</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AB-FUBINACA</VALIDVALUE>
          <VALUEMEANING>AB-FUBINACA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the synthetic cannabinoid AB-FUBINACA in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AB-PINACA</VALIDVALUE>
          <VALUEMEANING>AB-PINACA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the synthetic cannabinoid AB-PINACA in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal Cells</VALIDVALUE>
          <VALUEMEANING>Abnormal Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of abnormal cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111124</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal Cells/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Abnormal Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of abnormal cells compared to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403841</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Abnormal Cells to Total Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of abnormal cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ABO A1 Subtype</VALIDVALUE>
          <VALUEMEANING>ABO A1 Subtype Determination</VALUEMEANING>
          <MEANINGDESCRIPTION>The characterization of the ABO blood group A1 subtype in an individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ABO Blood Group</VALIDVALUE>
          <VALUEMEANING>ABO Blood Group Determination</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the blood type of an individual by testing for the presence or absence of A antigen and/or B antigen on the surface of red blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125939</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acanthocytes</VALIDVALUE>
          <VALUEMEANING>Acanthocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of acanthocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74699</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404321</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acanthocytes/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Acanthocyte to Erythrocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of acanthocytes compared to erythrocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetaminophen</VALIDVALUE>
          <VALUEMEANING>Acetaminophen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acetaminophen in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetaminophen-Cysteine Adduct</VALIDVALUE>
          <VALUEMEANING>Acetaminophen-Cysteine Adduct Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acetaminophen-cysteine adduct in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetoacetic Acid Excretion Rate</VALIDVALUE>
          <VALUEMEANING>Acetoacetic Acid Excretion Rate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of amount of acetoacetic acid being excreted in a biological specimen over a defined period of time (e.g. one hour).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetoacetic Acid</VALIDVALUE>
          <VALUEMEANING>Acetoacetic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acetoacetic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetone</VALIDVALUE>
          <VALUEMEANING>Acetone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acetone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetylcholine</VALIDVALUE>
          <VALUEMEANING>Acetylcholine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acetylcholine hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74838</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413553</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetylcholinesterase</VALIDVALUE>
          <VALUEMEANING>Acetylcholinesterase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acetylcholinesterase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetylfentanyl</VALIDVALUE>
          <VALUEMEANING>Acetylfentanyl Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the acetylfentanyl in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acid Alpha-Glucosidase</VALIDVALUE>
          <VALUEMEANING>Acid Alpha-Glucosidase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acid alpha-glucosidase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acid Labile Subunit</VALIDVALUE>
          <VALUEMEANING>Acid Labile Subunit Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acid labile subunit present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acid Phosphatase</VALIDVALUE>
          <VALUEMEANING>Acid Phosphatase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acid phosphatase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acid Sphingomyelinase</VALIDVALUE>
          <VALUEMEANING>Sphingomyelin Phosphodiesterase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acid sphingomyelinase in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11491807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Activated Coagulation Time</VALIDVALUE>
          <VALUEMEANING>Activated Coagulation Time</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the inhibition of blood coagulation in response to anticoagulant therapies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Activated Partial Thromboplastin Time</VALIDVALUE>
          <VALUEMEANING>Activated Partial Thromboplastin Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the length of time that it takes for clotting to occur when activating reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38462</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Activated Protein C Resistance</VALIDVALUE>
          <VALUEMEANING>Activated Protein C Resistance Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Activated PTT/Standard</VALIDVALUE>
          <VALUEMEANING>Activated PTT/Standard Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of a subject&#39;s partial thromboplastin time to a standard or control partial thromboplastin time. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402816</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Active Ghrelin</VALIDVALUE>
          <VALUEMEANING>Active Ghrelin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of active ghrelin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Activin A</VALIDVALUE>
          <VALUEMEANING>Activin A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of activin A (a homodimer consisting of inhibin subunit beta A) in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Activin AB</VALIDVALUE>
          <VALUEMEANING>Activin AB Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of activin AB (a heterodimer consisting of inhibin subunit beta A and Inhibin Subunit Beta B) in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Activin B</VALIDVALUE>
          <VALUEMEANING>Activin B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of activin B (a homodimer consisting of inhibin subunit beta B) in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibronectin, Maternal + Fetal</VALIDVALUE>
          <VALUEMEANING>Maternal and Fetal Fibronectin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of maternal and fetal fibronectin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibronectin, Plasma</VALIDVALUE>
          <VALUEMEANING>Plasma Fibronectin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of plasma fibronectin in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FibroTest Score</VALIDVALUE>
          <VALUEMEANING>FibroTest Score Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A patented biomarker test (APHP, 2001) that measures liver pathology through the assessment of a six-parameter blood test (for alpha-2-macroglobulin, haptoglobin, apolipoprotein A1, gamma-glutamyl transpeptidase, total bilirubin, and alanine aminotransferase), taking into account the age and gender of the patient.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105443</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ficolin-3</VALIDVALUE>
          <VALUEMEANING>Ficolin-3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of ficolin-3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198283</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433546</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluid Output</VALIDVALUE>
          <VALUEMEANING>Fluid Output</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the total volume of fluid discharged over a set period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C171455</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7290150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluid Output, Estimated</VALIDVALUE>
          <VALUEMEANING>Estimated Fluid Output</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the total volume of fluid discharged over a set period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C171508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7290148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flunitrazepam and/or Metabolites</VALIDVALUE>
          <VALUEMEANING>Flunitrazepam and/or Metabolites Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of flunitrazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both flunitrazepam and its metabolites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186048</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161528</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flunitrazepam</VALIDVALUE>
          <VALUEMEANING>Flunitrazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of flunitrazepam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139081</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluoride</VALIDVALUE>
          <VALUEMEANING>Fluoride Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fluoride present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122120</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405995</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluoxetine</VALIDVALUE>
          <VALUEMEANING>Fluoxetine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fluoxetine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluoxymesterone</VALIDVALUE>
          <VALUEMEANING>Fluoxymesterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the fluoxymesterone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluphenazine</VALIDVALUE>
          <VALUEMEANING>Fluphenazine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fluphenazine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177980</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flurazepam and/or Metabolites</VALIDVALUE>
          <VALUEMEANING>Flurazepam and/or Metabolites Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of flurazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both flurazepam and its metabolites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186051</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flurazepam</VALIDVALUE>
          <VALUEMEANING>Flurazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of flurazepam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75373</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluvoxamine</VALIDVALUE>
          <VALUEMEANING>Fluvoxamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fluvoxamine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147340</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403970</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FMS-like Receptor Tyrosine Kinase 3</VALIDVALUE>
          <VALUEMEANING>FMS-like Receptor Tyrosine Kinase 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the FMS-like receptor tyrosine kinase 3 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174307</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FMS-like Tyrosine Kinase 3 Ligand</VALIDVALUE>
          <VALUEMEANING>FMS-like Tyrosine Kinase 3 Ligand Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the FMS-like tyrosine kinase 3 ligand in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Folate Hydrolase mRNA</VALIDVALUE>
          <VALUEMEANING>Folate Hydrolase mRNA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of folate hydrolase mRNA in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TIMP1/Creatinine</VALIDVALUE>
          <VALUEMEANING>Tissue Inhibitor of Metalloproteinase 1 to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of tissue inhibitor of metalloproteinase 1 compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106575</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somatotrophin</VALIDVALUE>
          <VALUEMEANING>Somatotrophin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of somatotrophin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402776</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urea Nitrogen/Creatinine</VALIDVALUE>
          <VALUEMEANING>Urea Nitrogen to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of urea-nitrogen to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tissue Factor Pathway Inhibitor, Free</VALIDVALUE>
          <VALUEMEANING>Free Tissue Factor Pathway Inhibitor Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free tissue factor pathway inhibitor in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urea Reduction Ratio</VALIDVALUE>
          <VALUEMEANING>Urea Reduction Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>A calculated measurement (ratio or percentage) of the proportionate reduction in urea nitrogen over the course of dialysis present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191296</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12919303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tissue Inhibitor of Metalloproteinase 1</VALIDVALUE>
          <VALUEMEANING>Tissue Inhibitor of Metalloproteinase 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82036</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urea</VALIDVALUE>
          <VALUEMEANING>Urea Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative measurement of the amount of urea present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64815</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tissue Inhibitor of Metalloproteinase 2</VALIDVALUE>
          <VALUEMEANING>Tissue Inhibitor of Metalloproteinase 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of tissue inhibitor of metalloproteinase 2 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guanylate Binding Protein 2</VALIDVALUE>
          <VALUEMEANING>Guanylate Binding Protein 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of guanylate binding protein 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hairy Cells</VALIDVALUE>
          <VALUEMEANING>Hairy Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of hairy cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74604</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hairy Cells/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Hairy Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hairy cells (B-cell lymphocytes with hairy projections from the cytoplasm) compared to all leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hairy Cells/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Hairy Cell to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hairy cells compared to lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hairy Cells/Total Cells</VALIDVALUE>
          <VALUEMEANING>Hairy Cells to Total Cells Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of hairy cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Halazepam</VALIDVALUE>
          <VALUEMEANING>Halazepam Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of halazepam present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hallucinogen</VALIDVALUE>
          <VALUEMEANING>Hallucinogen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of any hallucinogen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7544366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Haloperidol</VALIDVALUE>
          <VALUEMEANING>Haloperidol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of haloperidol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177964</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Haptoglobin</VALIDVALUE>
          <VALUEMEANING>Haptoglobin Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of haptoglobin protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HCT Corrected Reticulocytes/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Hematocrit Corrected Reticulocytes to Erythrocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio or percentage) of the hematocrit corrected reticulocytes to erythrocytes present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102274</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404023</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>High Density Lipoprotein Cholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of high-density lipoprotein cholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6384470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vascular Endothelial Growth Factor</VALIDVALUE>
          <VALUEMEANING>Vascular Endothelial Growth Factor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vascular epithelial growth factor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vasoactive Intestinal Polypeptide</VALIDVALUE>
          <VALUEMEANING>Vasoactive Intestinal Polypeptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vasoactive intestinal polypeptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Venlafaxine</VALIDVALUE>
          <VALUEMEANING>Venlafaxine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of venlafaxine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Viable Cells</VALIDVALUE>
          <VALUEMEANING>Viable Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of viable cells in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130166</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5627577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vilazodone</VALIDVALUE>
          <VALUEMEANING>Vilazodone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the vilazodone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187829</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11159133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vinbarbital</VALIDVALUE>
          <VALUEMEANING>Vinbarbital Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the vinbarbital in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184606</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Viscosity</VALIDVALUE>
          <VALUEMEANING>Viscosity</VALUEMEANING>
          <MEANINGDESCRIPTION>The resistance of a liquid to sheer forces and flow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75912</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin A</VALIDVALUE>
          <VALUEMEANING>Vitamin A Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin A present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74895</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin B12</VALIDVALUE>
          <VALUEMEANING>Vitamin B12 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the Vitamin B12 in a serum specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64817</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3654512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin B17</VALIDVALUE>
          <VALUEMEANING>Vitamin B17 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin B17 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74897</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407973</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin B5</VALIDVALUE>
          <VALUEMEANING>Vitamin B5 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin B5 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin B6</VALIDVALUE>
          <VALUEMEANING>Vitamin B6 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin B6 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin B7</VALIDVALUE>
          <VALUEMEANING>Vitamin B7 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin B7 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74902</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin B9</VALIDVALUE>
          <VALUEMEANING>Folic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of folic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74676</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin C</VALIDVALUE>
          <VALUEMEANING>Vitamin C Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin C present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin D Binding Protein</VALIDVALUE>
          <VALUEMEANING>Vitamin D Binding Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vitamin D binding protein in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351830</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin D2 + Vitamin D3</VALIDVALUE>
          <VALUEMEANING>Vitamin D2 and Vitamin D3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vitamin D2 and vitamin D3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C179751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7742876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin D2 D3 25-OH</VALIDVALUE>
          <VALUEMEANING>Vitamin D2 and Vitamin D3 and 25-Hydroxyvitamin D Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vitamin D2, vitamin D3, and 25-hydroxyvitamin D present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6416611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin D2</VALIDVALUE>
          <VALUEMEANING>Vitamin D2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin D2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin D3</VALIDVALUE>
          <VALUEMEANING>Vitamin D3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin D3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74905</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin E</VALIDVALUE>
          <VALUEMEANING>Vitamin E Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin E present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3535375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin E/Cholesterol</VALIDVALUE>
          <VALUEMEANING>Vitamin E to Cholesterol Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of vitamin E compared with the total cholesterol in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103448</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin K</VALIDVALUE>
          <VALUEMEANING>Vitamin K Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of Vitamin K present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74907</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin K1</VALIDVALUE>
          <VALUEMEANING>Vitamin K1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the Vitamin K1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitronectin</VALIDVALUE>
          <VALUEMEANING>Vitronectin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of vitronectin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165995</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VLDL Apolipoprotein B</VALIDVALUE>
          <VALUEMEANING>VLDL Apolipoprotein B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the apolipoprotein B in the very low density lipoprotein fraction of a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VLDL Cholesterol Subtype 1</VALIDVALUE>
          <VALUEMEANING>VLDL Cholesterol Subtype 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the very low density lipoprotein cholesterol subtype 1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VLDL Cholesterol Subtype 2</VALIDVALUE>
          <VALUEMEANING>VLDL Cholesterol Subtype 2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the very low density lipoprotein cholesterol subtype 2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VLDL Cholesterol Subtype 3</VALIDVALUE>
          <VALUEMEANING>VLDL Cholesterol Subtype 3 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the very low density lipoprotein cholesterol subtype 3 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Follicle Stimulating Hormone</VALIDVALUE>
          <VALUEMEANING>Follicle Stimulating Hormone</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of follicle stimulating hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3293687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fraction of Inspired Oxygen</VALIDVALUE>
          <VALUEMEANING>Inspired Oxygen Fraction Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A test to evaluate amount of oxygen taken up by arterial blood and expressed as a fraction of total oxygen of inspired air. This test may include other test such as pulse oximetry for the measurement of arterial blood oxygen levels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6619430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fractional Calcium Excretion</VALIDVALUE>
          <VALUEMEANING>Fractional Excretion of Calcium</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the fractional excretion of calcium that is computed based upon the concentrations of calcium and creatinine in both blood and urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fractional Chloride Excretion</VALIDVALUE>
          <VALUEMEANING>Fractional Excretion of Chloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the fractional excretion of chloride that is computed based upon the concentrations of chloride and creatinine in both blood and urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fractional Iron Absorption</VALIDVALUE>
          <VALUEMEANING>Fractional Iron Absorption</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (ratio or percentage) of the iron absorbed into tissue or cells to the total available iron.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fractional Magnesium Excretion</VALIDVALUE>
          <VALUEMEANING>Fractional Excretion of Magnesium</VALUEMEANING>
          <MEANINGDESCRIPTION>The percentage of the total magnesium filtered by the kidney that is excreted in the urine. The fractional excretion is calculated by multiplying urinary magnesium concentration by the plasma creatinine concentration, then dividing by the urinary creatinine concentration multiplied by the plasma magnesium concentration. The resulting ratio is multiplied by 100.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122119</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fractional Phosphorus Excretion</VALIDVALUE>
          <VALUEMEANING>Fractional Excretion of Phosphate</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the fractional excretion of hosphate that is computed based upon the concentrations of hosphate and creatinine in both blood and urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fractional Potassium Excretion</VALIDVALUE>
          <VALUEMEANING>Fractional Excretion of Potassium</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the fractional excretion of potassium that is computed based upon the concentrations of potassium and creatinine in both blood and urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fractional Sodium Excretion</VALIDVALUE>
          <VALUEMEANING>Fractional Excretion of Sodium</VALUEMEANING>
          <MEANINGDESCRIPTION>The percentage of the total sodium filtered by the kidney that is excreted in the urine. The fractional excretion is calculated by multiplying urinary sodium concentration by the plasma creatinine concentration, then dividing by the urinary creatinine concentration multiplied by the plasma sodium concentration. The resulting ratio is multiplied by 100.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107435</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3852205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Free Androgen Index</VALIDVALUE>
          <VALUEMEANING>Free Androgen Index</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of androgen status in a biological specimen, which is calculated by dividing total testosterone by sex hormone binding globulin and multiplying by a constant (usually 100).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124341</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Free Fatty Acid</VALIDVALUE>
          <VALUEMEANING>Non-esterified Fatty Acids Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free non-esterified fatty acids present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3553472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Free Fatty Acid, Saturated</VALIDVALUE>
          <VALUEMEANING>Saturated Non-esterified Fatty Acids Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of saturated non-esterified fatty acids present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Free Fatty Acid, Unsaturated</VALIDVALUE>
          <VALUEMEANING>Unsaturated Non-esterified Fatty Acids Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of unsaturated non-esterified fatty acids present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Free Glycerol</VALIDVALUE>
          <VALUEMEANING>Free Glycerol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free glycerol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100448</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fructosamine Corrected for Total Protein</VALIDVALUE>
          <VALUEMEANING>Fructosamine Corrected for Total Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fructosamine, corrected for total protein, present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6857142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fructosamine</VALIDVALUE>
          <VALUEMEANING>Fructosamine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fructosamine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74678</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3553470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fructose</VALIDVALUE>
          <VALUEMEANING>Fructose Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of fructose present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147342</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fungi</VALIDVALUE>
          <VALUEMEANING>Fungi Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the fungi present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6652015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fungi, Filamentous</VALIDVALUE>
          <VALUEMEANING>Filamentous Fungi Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of filamentous fungus present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fungi, Yeast-Like</VALIDVALUE>
          <VALUEMEANING>Yeast-Like Fungi Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of yeast-like fungus present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Furanylfentanyl</VALIDVALUE>
          <VALUEMEANING>Furanylfentanyl Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the furanylfentanyl in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184541</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Furazabol</VALIDVALUE>
          <VALUEMEANING>Furazabol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the furazabol in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G6PD-Deficient Erythrocytes</VALIDVALUE>
          <VALUEMEANING>G6PD-Deficient Erythrocytes Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of G6PD-deficient erythrocytes in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132368</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G6PD-Deficient Erythrocytes/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>G6PD-Deficient Erythrocytes to Erythrocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the G6PD-deficient erythrocytes as compared to the total erythrocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Galactose Elimination Capacity</VALIDVALUE>
          <VALUEMEANING>Galactose Elimination Capacity</VALUEMEANING>
          <MEANINGDESCRIPTION>A liver function test that measures galactose elimination capacity in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124342</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Galactose Mutarotase</VALIDVALUE>
          <VALUEMEANING>Galactose Mutarotase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of galactose mutarotase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7153984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Galactose</VALIDVALUE>
          <VALUEMEANING>Galactose Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The measurement of the amount of galactose in a biologic specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166801</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Galactose-1-Phos Uridylyltransferase</VALIDVALUE>
          <VALUEMEANING>Galactose-1-Phosphate Uridyltransferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The measurement of the galactose-1-phosphate uridyltransferase in a biologic specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166805</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Galactose-1-Phosphate</VALIDVALUE>
          <VALUEMEANING>Galactose-1-Phosphate Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of galactose-1-phosphate present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186052</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8161520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serpin Family F Member 1</VALIDVALUE>
          <VALUEMEANING>Serpin Family F Member 1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of serpin family F member 1 in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sertraline</VALIDVALUE>
          <VALUEMEANING>Sertraline Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sertraline present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serum Amyloid A1</VALIDVALUE>
          <VALUEMEANING>Serum Amyloid A1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of serum amyloid A1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165982</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serum-Ascites Albumin Gradient</VALIDVALUE>
          <VALUEMEANING>Serum-Ascites Albumin Gradient Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of serum-ascites albumin gradient, calculated by subtracting the amount of albumin in ascites fluid from the albumin in serum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186093</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8166819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sex Hormone Binding Globulin</VALIDVALUE>
          <VALUEMEANING>Sex Hormone Binding Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sex hormone binding protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3564199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sezary Cells</VALIDVALUE>
          <VALUEMEANING>Sezary Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of Sezary cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sezary Cells/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Sezary Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of Sezary cells compared to total leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sezary Cells/Lymphocytes</VALIDVALUE>
          <VALUEMEANING>Sezary Cell to Lymphocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of Sezary cells compared to all lymphocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SH2 Domain Containing 1A Protein</VALIDVALUE>
          <VALUEMEANING>SH2 Domain Containing 1A Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of SH2 domain containing 1A protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7158656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sialyl SSEA-1 Antigen</VALIDVALUE>
          <VALUEMEANING>Sialyl SSEA-1 Antigen Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sialyl SSEA-1 antigen present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sibutramine</VALIDVALUE>
          <VALUEMEANING>Sibutramine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the sibutramine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8010635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sickle Cells</VALIDVALUE>
          <VALUEMEANING>Sickle Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of sickle cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409056</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sickle Cells/Erythrocytes</VALIDVALUE>
          <VALUEMEANING>Sickle Cell to Erythrocyte Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of sickle cells compared to all erythrocytes present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74656</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sideroblast</VALIDVALUE>
          <VALUEMEANING>Sideroblast Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of sideroblasts present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100418</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6409272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skeletal Troponin I</VALIDVALUE>
          <VALUEMEANING>Skeletal Troponin I Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of total skeletal troponin I in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135443</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Smudge Cells</VALIDVALUE>
          <VALUEMEANING>Smudge Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the number of smudge cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Smudge Cells/Leukocytes</VALIDVALUE>
          <VALUEMEANING>Smudge Cells to Leukocytes Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of smudge cells to leukocytes in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sodium Clearance</VALIDVALUE>
          <VALUEMEANING>Sodium Clearance Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of the sodium clearance in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106568</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cell Morphology</VALIDVALUE>
          <VALUEMEANING>Cell Morphology Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>A laboratory procedure that involves the examination of cell morphology.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184342</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C2, Free/Complement C2</VALIDVALUE>
          <VALUEMEANING>Free Complement C2 to Complement C2 Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of free complement C2 to total complement C2 present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complement C2, Free</VALIDVALUE>
          <VALUEMEANING>Free Complement C2 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the free complement C2 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Smear Examination</VALIDVALUE>
          <VALUEMEANING>Smear Examination</VALUEMEANING>
          <MEANINGDESCRIPTION>An observation, assessment or examination of a smear of a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920969</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heparin-Binding Protein</VALIDVALUE>
          <VALUEMEANING>Heparin-Binding Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the heparin-binding protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920970</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythroid Cells</VALIDVALUE>
          <VALUEMEANING>Erythroid Cell Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the erythroid cells present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1,3-Butadiene</VALIDVALUE>
          <VALUEMEANING>1,3-Butadiene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 1,3-butadiene in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1-Aminonaphthalene</VALIDVALUE>
          <VALUEMEANING>1-Aminonaphthalene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 1-aminonaphthalene in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204639</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920973</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-Aminonaphthalene</VALIDVALUE>
          <VALUEMEANING>2-Aminonaphthalene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 2-aminonaphthalene in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4-Aminobiphenyl</VALIDVALUE>
          <VALUEMEANING>4-Aminobiphenyl Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of 4-aminobiphenyl in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetaldehyde</VALIDVALUE>
          <VALUEMEANING>Acetaldehyde Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acetaldehyde in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acrolein</VALIDVALUE>
          <VALUEMEANING>Acrolein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acrolein in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acrylonitrile</VALIDVALUE>
          <VALUEMEANING>Acrylonitrile Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of acrylonitrile in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Benzene</VALIDVALUE>
          <VALUEMEANING>Benzene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of benzene in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Benzo[a]pyrene</VALIDVALUE>
          <VALUEMEANING>Benzo[a]pyrene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of benzo[a]pyrene in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cadmium</VALIDVALUE>
          <VALUEMEANING>Cadmium Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of cadmium in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204647</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Crotonaldehyde</VALIDVALUE>
          <VALUEMEANING>Crotonaldehyde Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of crotonaldehyde in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Formaldehyde</VALIDVALUE>
          <VALUEMEANING>Formaldehyde Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of formaldehyde in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920983</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Isoprene</VALIDVALUE>
          <VALUEMEANING>Isoprene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of isoprene in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nicotine-Derived Nitrosamine Ketone</VALIDVALUE>
          <VALUEMEANING>Nicotine-Derived Nitrosamine Ketone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of nicotine-derived nitrosamine ketone in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204651</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-Nitrosonornicotine</VALIDVALUE>
          <VALUEMEANING>N-Nitrosonornicotine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of N-nitrosonornicotine in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204652</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Toluene</VALIDVALUE>
          <VALUEMEANING>Toluene Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of toluene in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204653</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920987</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dystrophin Actual/Control</VALIDVALUE>
          <VALUEMEANING>Dystrophin Actual to Control Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the dystrophin in a subject&#39;s specimen when compared to a control specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eosinophil Cationic Protein</VALIDVALUE>
          <VALUEMEANING>Eosinophil Cationic Protein Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the eosinophil cationic protein present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vegetable Fiber</VALIDVALUE>
          <VALUEMEANING>Vegetable Fiber Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the vegetable fiber present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209590</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycosylated Ferritin</VALIDVALUE>
          <VALUEMEANING>Glycosylated Ferritin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the glycosylated ferritin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209591</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycosylated Ferritin/Ferritin</VALIDVALUE>
          <VALUEMEANING>Glycosylated Ferritin to Ferritin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the glycosylated ferritin to total ferritin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209592</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Globotriaosylceramide</VALIDVALUE>
          <VALUEMEANING>Globotriaosylceramide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the globotriaosylceramide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209593</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HDL+LDL Cholesterol</VALIDVALUE>
          <VALUEMEANING>High Density Lipoprotein Cholesterol and Low Density Lipoprotein Cholesterol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the high density lipoprotein cholesterol and the low density lipoprotein cholesterol present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemoglobin H/Total Hemoglobin</VALIDVALUE>
          <VALUEMEANING>Hemoglobin H to Hemoglobin Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the hemoglobin H to total hemoglobin present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3-Hydroxypropyl Mercapturic Acid</VALIDVALUE>
          <VALUEMEANING>3-Hydroxypropyl Mercapturic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the 3-hydroxypropyl mercapturic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209597</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3-Hydroxy-1-Methyl-PropylmercapturicAcid</VALIDVALUE>
          <VALUEMEANING>3-Hydroxy-1-Methyl-Propylmercapturic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the 3-hydroxy-1-methyl-propylmercapturic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209596</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydroxybupropion</VALIDVALUE>
          <VALUEMEANING>Hydroxybupropion Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the hydroxybupropion present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209598</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-Hydroxyethyl Mercapturic Acid</VALIDVALUE>
          <VALUEMEANING>2-Hydroxyethyl Mercapturic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the 2-hydroxyethyl mercapturic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 28B</VALIDVALUE>
          <VALUEMEANING>Interleukin 28B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the interleukin 28B present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monocyte Chemotactic Protein1/Creatinine</VALIDVALUE>
          <VALUEMEANING>Monocyte Chemotactic Protein 1 to Creatinine Ratio Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the ratio of the monocyte chemotactic protein 1 to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209602</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Globotriaosylsphingosine</VALIDVALUE>
          <VALUEMEANING>Globotriaosylsphingosine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the globotriaosylsphingosine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209601</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monohydroxybutenyl Mercapturic Acid</VALIDVALUE>
          <VALUEMEANING>Monohydroxybutenyl Mercapturic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the monohydroxybutenyl mercapturic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Matrix Metalloproteinase 10</VALIDVALUE>
          <VALUEMEANING>Matrix Metalloproteinase 10 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the matrix metalloproteinase 10 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209604</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Matrix Metalloproteinase 12</VALIDVALUE>
          <VALUEMEANING>Matrix Metalloproteinase 12 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the matrix metalloproteinase 12 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209605</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Matrix Metalloproteinase 13</VALIDVALUE>
          <VALUEMEANING>Matrix Metalloproteinase 13 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the matrix metalloproteinase 13 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209606</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nicotine Glucuronide</VALIDVALUE>
          <VALUEMEANING>Nicotine Glucuronide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the nicotine glucuronide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209607</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253699</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nicotine, Free</VALIDVALUE>
          <VALUEMEANING>Free Nicotine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the free (unbound) cotinine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polycystin-1</VALIDVALUE>
          <VALUEMEANING>Polycystin-1 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the polycystin-1 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253704</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>o-Toluidine</VALIDVALUE>
          <VALUEMEANING>o-Toluidine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the o-toluidine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasminogen Activator Urokinase Receptor</VALIDVALUE>
          <VALUEMEANING>Plasminogen Activator Urokinase Receptor Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the plasminogen activator urokinase receptor present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Presepsin</VALIDVALUE>
          <VALUEMEANING>Presepsin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the presepsin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209613</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraxanthine</VALIDVALUE>
          <VALUEMEANING>Paraxanthine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the paraxanthine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209614</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NNAL</VALIDVALUE>
          <VALUEMEANING>4-(Methylnitrosamino)-4-(3-pyridyl)-1-Butanol Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the total 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol (NNAL) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythrocyte Deformability</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Deformability Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>An assessment of a red blood cell&#39;s ability to adapt its shape to dynamically changing flow conditions, thus minimizing resistance to flow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209615</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2,3-dihydroxypropyl Mercapturic Acid</VALIDVALUE>
          <VALUEMEANING>2,3-dihydroxypropyl Mercapturic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the 2,3-dihydroxypropyl mercapturic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15157329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythrocyte Membrane Rigidity</VALIDVALUE>
          <VALUEMEANING>Erythrocyte Membrane Rigidity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>An assessment of the rigidity of the membrane of erythrocytes in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209616</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253739</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>S-Benzyl Mercapturic Acid</VALIDVALUE>
          <VALUEMEANING>S-Benzyl Mercapturic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the S-benzyl mercapturic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209617</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serpin A6</VALIDVALUE>
          <VALUEMEANING>Serpin A6 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the serpin A6 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209618</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trans-3&#39;- Hydroxycotinine, Free</VALIDVALUE>
          <VALUEMEANING>Free Trans-3&#39;-Hydroxycotinine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the free (unbound) trans-3&#39;-hydroxycotinine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trans-3&#39;- Hydroxycotinineglucuronide</VALIDVALUE>
          <VALUEMEANING>Trans-3&#39;-Hydroxycotinineglucuronide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the trans-3&#39;-hydroxycotinineglucuronide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209620</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Total Antioxidant Capacity</VALIDVALUE>
          <VALUEMEANING>Total Antioxidant Capacity Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount and/or activity of antioxidants present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209621</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tetraspanin-29</VALIDVALUE>
          <VALUEMEANING>Tetraspanin-29 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the tetraspanin-29 present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11-Ketotestosterone</VALIDVALUE>
          <VALUEMEANING>11-Ketotestosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the 11-ketotestosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15157328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinalysis Panel Interpretation</VALIDVALUE>
          <VALUEMEANING>Urinalysis Panel Interpretation</VALUEMEANING>
          <MEANINGDESCRIPTION>An interpretation of the results of a panel of urinalysis tests.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209624</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dystrophin</VALIDVALUE>
          <VALUEMEANING>Dystrophin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the total dystrophin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nicotine and/or Metabolites</VALIDVALUE>
          <VALUEMEANING>Nicotine And/Or Metabolites Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the nicotine and/or its metabolite(s) present in a specimen, for an assay that can measure both nicotine and its metabolites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209443</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trans-3 Hydroxycotinine</VALIDVALUE>
          <VALUEMEANING>Trans-3 Hydroxycotinine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the total trans-3&#39;- hydroxycotinine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amyloid Probability Score</VALIDVALUE>
          <VALUEMEANING>Amyloid Probability Score</VALUEMEANING>
          <MEANINGDESCRIPTION>A probability score representing the estimated likelihood that the patient has or will have pathologic amyloid accumulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209578</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bupropion</VALIDVALUE>
          <VALUEMEANING>Bupropion Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the bupropion present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209579</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cotinine, Free</VALIDVALUE>
          <VALUEMEANING>Free Cotinine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the free (unbound) cotinine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209580</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Charcot-Leyden Crystals</VALIDVALUE>
          <VALUEMEANING>Charcot-Leyden Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the Charcot-Leyden crystals present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209582</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cotinine Glucuronide</VALIDVALUE>
          <VALUEMEANING>Cotinine Glucuronide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the cotinine glucuronide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209581</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-Cyanoethyl Mercapturic Acid</VALIDVALUE>
          <VALUEMEANING>2-Cyanoethyl Mercapturic Acid Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the 2-cyanoethyl mercapturic acid present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253665</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-Cyanoethyl Mercapturic Acid Cysteine</VALIDVALUE>
          <VALUEMEANING>2-Cyanoethyl Mercapturic Acid Cysteine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the 2-cyanoethyl mercapturic acid cysteine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytochrome P450 2A6</VALIDVALUE>
          <VALUEMEANING>Cytochrome P450 2A6 Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the cytochrome P450 2A6 enzyme present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desmosine</VALIDVALUE>
          <VALUEMEANING>Desmosine Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the desmosine present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253672</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granzyme B</VALIDVALUE>
          <VALUEMEANING>Granzyme B Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of granzyme B present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7165787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Casts</VALIDVALUE>
          <VALUEMEANING>Cast Absent Indicator</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that casts were looked for and not found in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C213922</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Crystals</VALIDVALUE>
          <VALUEMEANING>Crystal Absent Indicator</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that crystals were looked for and not found in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C213923</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ammonium Oxalate Crystals</VALIDVALUE>
          <VALUEMEANING>Ammonium Oxalate Crystal Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of the ammonium oxalate crystals in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C213924</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin 17C</VALIDVALUE>
          <VALUEMEANING>Interleukin 17C Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the interleukin 17C present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214675</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucuronidated Bilirubin</VALIDVALUE>
          <VALUEMEANING>Glucuronidated Bilirubin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the glucuronidated bilirubin (water soluble) present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214676</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Delta Bilirubin</VALIDVALUE>
          <VALUEMEANING>Delta Bilirubin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the albumin-bound bilirubin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214677</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gluten Immunogenic Peptide</VALIDVALUE>
          <VALUEMEANING>Gluten Immunogenic Peptide Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of gluten immunogenic peptide present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214678</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR, Estimated Non-Indexed</VALIDVALUE>
          <VALUEMEANING>Non-Indexed Estimated Glomerular Filtration Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>An estimated GFR (eGFR) that takes into account the individual&#39;s actual body surface area (BSA) value.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214679</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR, Estimated Indexed</VALIDVALUE>
          <VALUEMEANING>Indexed Estimated Glomerular Filtration Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>An estimated GFR (eGFR) that takes into account a standardized body surface area (BSA) value of 1.73m2.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from B-2 Microglobulin Adj for aBSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from B-2 Microglobulin Adjusted for Actual BSA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A direct measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the individual&#39;s actual body surface area value.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from Beta-Trace Protein Adj for aBSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from Beta-Trace Protein Adjusted for Actual BSA Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A direct measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the individual&#39;s actual body surface area value.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from Cystatin C and Creat Adj aBSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from Cystatin C and Creatinine Adjusted for Actual BSA</VALUEMEANING>
          <MEANINGDESCRIPTION>An estimation of the glomerular filtration rate based on the clearance of cystatin C and creatinine after adjusting it for an individual&#39;s actual body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from Creat and UreaN Adj aBSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from Creatinine and Urea Nitrogen Adjusted for Actual Body Surface Area Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>An estimation of the glomerular filtration rate based on the clearance of creatinine and urea nitrogen after adjusting it for an individual&#39;s actual body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from Creat,UreaN,Alb Adj aBSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from Creatinine, Urea Nitrogen, and Albumin Adjusted for Actual Body Surface Area Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>An estimation of the glomerular filtration rate based on the clearance of creatinine, urea nitrogen and albumin after adjusting it for an individual&#39;s actual body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from Creatinine Adjusted for aBSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from Creatinine Adjusted for Actual BSA</VALUEMEANING>
          <MEANINGDESCRIPTION>An estimation of the glomerular filtration rate based on the clearance of creatinine after adjusting it for an individual&#39;s actual body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GFR from Cystatin C Adjusted for aBSA</VALIDVALUE>
          <VALUEMEANING>Glomerular Filtration Rate from Cystatin C Adjusted for Actual BSA</VALUEMEANING>
          <MEANINGDESCRIPTION>An estimation of the glomerular filtration rate based on the clearance of cystatin C after adjusting it for an individual&#39;s actual body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clot Firmness</VALIDVALUE>
          <VALUEMEANING>Clot Firmness Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the firmness of a clot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clot Formation Time</VALIDVALUE>
          <VALUEMEANING>Clot Formation Time Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the elapsed time from the start of clot formation to the point at which the clot reaches a firmness of 20mm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214689</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clot Initiation Time</VALIDVALUE>
          <VALUEMEANING>Clot Initiation Time Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the elapsed time from the addition of the clot activating agent to the start of clot formation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214690</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maximum Clot Firmness</VALIDVALUE>
          <VALUEMEANING>Maximum Clot Firmness Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the maximum firmness of a clot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clot Lysis Index</VALIDVALUE>
          <VALUEMEANING>Clot Lysis Index</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (percentage) of remaining clot stability in relation to the maximum clot firmness value at some time point after clot initiation time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maximum Clot Lysis</VALIDVALUE>
          <VALUEMEANING>Maximum Clot Lysis Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative measurement (percentage) of the decrease in amplitude of the waveform at rotational thromboelastometry test completion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214693</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clot Formation Alpha Angle</VALIDVALUE>
          <VALUEMEANING>Clot Formation Alpha Angle Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the angle of incline (tangent at 20mm and the midline) during the rising phase of the thromboelastogram curve, during the clot formation process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the lab test name?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Prompt</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lab Test Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form Completion Instructions</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the name of the Lab measurement or finding, if not pre-printed on the CRF. If collected on the CRF, the sponsor may provide additional instructions to ensure the data is entered as intended.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>LBTEST; LBTESTCD</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable. The SDTMIG variable LBTESTCD may be determined from the value collected in LBTEST. The SDTMIG variables LBTESTCD and LBTEST are required in the SDTM submission datasets. Use appropriate CDISC Controlled Terminology for the test and test code.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>Required to identify which test the result is for. It is recommended that the test names be pre-printed on the CRF rather than collected in a field that requires the site to enter text. If the form is laid out as a grid, then words such as Test can be included as the column header.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Laboratory Test Results</Name>
        <DocumentType>CDASH Alternate Question Text</DocumentType>
        <DocumentText>What is the lab test name?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Alternate Question Text - Laboratory Test Results</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the lab test name?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC SDTM Laboratory Test Name Terminology</Name>
        <DocumentType>VALID_VALUE_SOURCE</DocumentType>
        <DocumentText>A terminology set that includes concepts contained in the CDISC laboratory test codelist.</DocumentText>
        <URL>https://ncit.nci.nih.gov/ncitbrowser/ajax?action=create_src_vs_tree&amp;amp;vsd_uri=http%3A//evs.nci.nih.gov/valueset/CDISC/C67154</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Biomarker</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Publication Package</Name>
        <DocumentType>CDISC EVS Controlled Terminology Update</DocumentType>
        <DocumentText>CDISC value sets have been updated to the P41 publication version (2020-03-27).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Package Publication</Name>
        <DocumentType>CDISC EVS Controlled Terminology Update</DocumentType>
        <DocumentText>CDISC value sets have been updated to P41a publication version (2020-05-08).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lab Test</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the lab test name?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the lab test name?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lab test name</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lab test name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Yes above, Name of pathogenic somatic mutation test performed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lab Test Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Investigation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Highly Recommended Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329800</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory (LB) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329802</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Semantically Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685479</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Lab Test Results</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7554864</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Laboratory (LB) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943389</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15689233</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HHS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>External Standards</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15910167</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_INR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_FIBRINODDIMER</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>LB_LBTEST</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_ALB</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_MG</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_PHOS</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB.LBTEST</AlternateName>
        <AlternateNameType>Map:CDASHv1.1</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_PSM</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_PT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_PTT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_TNT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_CPK</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_CRP</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_TSH</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_T3</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_T4</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_AMYLASE</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_LIPASE</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_HGB</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_WBC</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_MCV</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_RDW</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_BLAST</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_NEUT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_PLAT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_ALP</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_CK</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_FERRITIN</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_TFRRNSAT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_BILI</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_ALT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_CREAT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_CREATCLR</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_EPO</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_HEM</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_BIO</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="385">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6382993</PUBLICID>
    <LONGNAME>The Health Care Climate Questionnaire 6 Physician Made Sure I Understood about My Condition and what I Need to Do Agreement Score 7 Point Scale</LONGNAME>
    <PREFERREDNAME>HCCQ_6_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated agreement about whether their physician has made sure they really understand about their condition and what they need to do, using a 7 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HCCQ:The Health Care Climate Questionnaire</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6382847</PublicId>
      <PreferredName>6382829v1.0:6402869v1.0</PreferredName>
      <PreferredDefinition>A questionnaire designed to assess a patient&#39;s perceptions of the degree to which their specific doctor supports the patient&#39;s autonomy._A question about whether an individual&#39;s physician has made sure they really understand about their condition and what they need to do._The act of agreeing to a plan, protocol, or arrangement. Also used to describe a harmony of opinion._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>The Health Care Climate Questionnaire Physician Made Sure I Understood about My Condition and what I Need to Do Agreement Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6382829</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C153434</PreferredName>
        <Version>1</Version>
        <LongName>The Health Care Climate Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C153434</PREFERRED_NAME>
            <LONG_NAME>The Health Care Climate Questionnaire</LONG_NAME>
            <CON_ID>6381677</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6402869</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C153440:C25369:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Physician Made Sure I Understood about My Condition and what I Need to Do Agreement Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C153440</PREFERRED_NAME>
            <LONG_NAME>Physician Made Sure I Understood about My Condition and what I Need to Do Question</LONG_NAME>
            <CON_ID>6381695</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25369</PREFERRED_NAME>
            <LONG_NAME>Agreement</LONG_NAME>
            <CON_ID>2204037</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HCCQ:The Health Care Climate Questionnaire</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6382888</PublicId>
      <PreferredName>AGREEMENT_7PT_SCL</PreferredName>
      <PreferredDefinition>Numeric scores from 1 (Strongly Disagree) to 7 (Strongly Agree), with 4: Neutral on a 7-point Likert scale._The act of agreeing to a plan, protocol, or arrangement. Also used to describe a harmony of opinion._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Agreement 7 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>7</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>6242381</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25369:C25664</PreferredName>
        <Version>1</Version>
        <LongName>Agreement Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25369</PREFERRED_NAME>
            <LONG_NAME>Agreement</LONG_NAME>
            <CON_ID>2204037</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Agreement Rating 6</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 6 on a scale that ranges from 1: Strongly Disagree to 7: Strongly Agree, with 4: Neutral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6382891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Agreement Rating 5</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 5 on a scale that ranges from 1: Strongly Disagree to 7: Strongly Agree, with 4: Neutral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153455</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6382892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Agreement Rating 7</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 7 on a scale that ranges from 1: Strongly Disagree to 7: Strongly Agree, with 4: Neutral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6382890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Agreement Rating 4</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 4 (neutral) on a scale that ranges from 1: Strongly Disagree to 7: Strongly Agree, with 4: Neutral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6382893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Agreement Rating 3</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 3 on a scale that ranges from 1: Strongly Disagree to 7: Strongly Agree, with 4: Neutral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6382894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Agreement Rating 1</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 1 on a scale that ranges from 1: Strongly Disagree to 7: Strongly Agree, with 4: Neutral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153451</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6382895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Agreement Rating 2</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 2 on a scale that ranges from 1: Strongly Disagree to 7: Strongly Agree, with 4: Neutral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6382896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>My physician has made sure I</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>My physician has made sure I really understand about my condition and what I need to do.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>My surgeon has made sure I really understand about my condition and what I need to do.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>The Health Care Climate Questionnaire (HCCQ)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900310</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6382879</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCCQ</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HCCQ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6382880</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="386">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6408926</PUBLICID>
    <LONGNAME>Findings About Method</LONGNAME>
    <PREFERREDNAME>FAMETHOD</PREFERREDNAME>
    <PREFERREDDEFINITION>Method of the test or examination.</PREFERREDDEFINITION>
    <VERSION>5</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6408920</PublicId>
      <PreferredName>6407857v1.0:6408918v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to findings about events or interventions._The technique used to administer a particular examination or assessment.</PreferredDefinition>
      <LongName>Findings About Events or Interventions Domain Test Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407857</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C85442</PreferredName>
        <Version>1</Version>
        <LongName>Findings About Events or Interventions Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85442</PREFERRED_NAME>
            <LONG_NAME>Findings About Events or Interventions Domain</LONG_NAME>
            <CON_ID>6407856</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6408918</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C82535</PreferredName>
        <Version>1</Version>
        <LongName>Test Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82535</PREFERRED_NAME>
            <LONG_NAME>Test Method</LONG_NAME>
            <CON_ID>4291134</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6401601</PublicId>
      <PreferredName>METHOD</PreferredName>
      <PreferredDefinition>Terminology associated with the method codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM)._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>CDISC SDTM Method Terminology Type</LongName>
      <Version>1.8</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6401600</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C85492:C25284</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Method Terminology Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85492</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Method Terminology</LONG_NAME>
            <CON_ID>6401599</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPLC-UV</VALIDVALUE>
          <VALUEMEANING>High-performance Liquid Chromatography-UV</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique where high performance liquid chromatography with an ultraviolet light detector is used to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120693</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402336</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPLC-FL</VALIDVALUE>
          <VALUEMEANING>High-performance Liquid Chromatography-Fluorescence</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique where high performance liquid chromatography with a fluorescence detector is used to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPLC/MS/MS</VALIDVALUE>
          <VALUEMEANING>High-performance Liquid Chromatography/Tandem Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique wherein high performance liquid chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402340</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPLC/MS</VALIDVALUE>
          <VALUEMEANING>High Performance Liquid Chromatography Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique wherein high performance liquid chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPLC/IEX</VALIDVALUE>
          <VALUEMEANING>High-performance Liquid Chromatography/Ion-Exchange Chromatography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of high performance liquid chromatography that separates proteins based on net charge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120690</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402344</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPLC</VALIDVALUE>
          <VALUEMEANING>High Performance Liquid Chromatography</VALUEMEANING>
          <MEANINGDESCRIPTION>Frequently referred to simply as HPLC, this form of column chromatography is used frequently in biochemistry. The analyte is forced through a column by liquid at high pressure, which decreases the time the separated components remain on the stationary phase. Less time on the column then translates to narrower peaks in the resulting chromatogram and thence to better selectivity and sensitivity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2915756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HILLMEN COLOR CHART</VALIDVALUE>
          <VALUEMEANING>Hillmen Color Chart</VALUEMEANING>
          <MEANINGDESCRIPTION>A visual color scale created by Hillman et al in 2004 to enable standardization of urine color in the assessment of hemoglobinuria. (Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, Cullen MJ, Richards SJ, Rollins SA, Mojcik CF, Rother RP. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2004 Feb 5;350(6):552-9.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HIGH RESOLUTION MELT ANALYSIS</VALIDVALUE>
          <VALUEMEANING>High Resolution Melt Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>A reverse, real-time, polymerase chain reaction technique in which fluroescently labeled double-stranded DNA is slowly melted apart by increasing temperature. Genetic mutations and polymorphisms can be detected by analyzing the melt curves, which correspond to the rate at which double-stranded DNA become single-stranded.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HIGH LEVEL AMINOGLYCOSIDE SCREEN</VALIDVALUE>
          <VALUEMEANING>Aminoglycoside Screening Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to determine microbial susceptibility to high concentrations of aminoglycoside antibiotics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85556</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY</VALIDVALUE>
          <VALUEMEANING>Hepatitis C Virus Recombinant Immunoblot Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay used to verify the presence of anti-HCV antibodies in a blood sample. Serum is incubated with a membrane strip on which four recombinant viral proteins are attached. The immunoblot is considered positive if two or more proteins react and indeterminate if only one positive band is detected.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402351</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HEMOCYTOMETRY</VALIDVALUE>
          <VALUEMEANING>Hemocytometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method that uses a thick glass slide containing a chamber with a defined volume, which is etched with a precisely ruled grid and is used to quantify cells or cell-sized particles in suspension.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120689</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TEST STRIP</VALIDVALUE>
          <VALUEMEANING>Test Strip Device</VALUEMEANING>
          <MEANINGDESCRIPTION>A piece of chemically treated medium designed to react in the presence of specific amounts of a trigger substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50322</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TEMPLATE INCISION METHOD</VALIDVALUE>
          <VALUEMEANING>Template Incision Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for assessing bleeding time in which two controlled incisions are made on the forearm, using a template to guide placement of the scalpel or blade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OSCILLOMETRY</VALIDVALUE>
          <VALUEMEANING>Oscillometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique to measure a motion that repeats itself in a regular cycle around an equilibrium point or mean value.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154788</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618739</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MANUAL COUNT</VALIDVALUE>
          <VALUEMEANING>Manual Count</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique to determine the number of entities, which is performed by visual inspection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154795</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Magnetic Resonance Cholangiopancreatography</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive procedure in which magnetic resonance imaging is used to visualize the intrahepatic and extrahepatic bile ducts, the pancreatic duct, and the surrounding parenchyma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113775</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5529041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAGNETIC RESONANCE ANGIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>MRI-Based Angiogram</VALUEMEANING>
          <MEANINGDESCRIPTION>An image of blood vessels constructed using magnetic resonance imaging.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114867</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4723855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KNEMOMETRY</VALIDVALUE>
          <VALUEMEANING>Knemometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique which measures lower limb length using a knemometer, for the assessment of short-term growth and development in childhood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154787</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMPEDANCE CONDUCTIVITY</VALIDVALUE>
          <VALUEMEANING>Impedance Conductivity</VALUEMEANING>
          <MEANINGDESCRIPTION>A method that measures impedance of conductivity which corrects for the concentrations of conducting ions in the sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNOCHROMATOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Immunochromatography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of chromatography assay in which an antibody-conjugate is passed over an immobilized antigen, giving a visual indication of positive or negative result.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154792</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618747</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HEMATOXYLIN AND EOSIN STAIN</VALIDVALUE>
          <VALUEMEANING>Hematoxylin and Eosin Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>Hematoxylin-and-eosin, or H&amp;E, is a routine staining procedure of tissue sections. This staining method uses two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C23011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4588572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HEMAGGLUTINATION INHIBITION ASSAY</VALIDVALUE>
          <VALUEMEANING>Hemagglutination Inhibition Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An in vitro assay that is used to determine whether antibodies present in serum samples will prevent hemagglutination in a cell culture plate containing red blood cells and influenza virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HEMAGGLUTINATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Hemagglutination Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An in vitro assay used to measure the relative concentration of viruses, bacteria, or antibodies in which serial dilutions of solution containing virus, bacteria, or antibody are applied to red blood cells in culture to look for the presence of hemagglutination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HANSEL STAIN</VALIDVALUE>
          <VALUEMEANING>Hansel Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes Hansel reagent to differentiate eosinophils and neutrophils in a specimen. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GRAM STAIN</VALIDVALUE>
          <VALUEMEANING>Gram Stain</VALUEMEANING>
          <MEANINGDESCRIPTION>This is a method (named after the Danish bacteriologist, Hans Christian Gram) for staining and identifying bacteria. It is based on the differential retention of a crystal violet-iodine complex within the cell membrane. Gram-positive organisms will appear blue-black or purple while Gram-negative organisms will appear red.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C23014</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2960786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GRADIENT DIFFUSION</VALIDVALUE>
          <VALUEMEANING>Gradient Diffusion Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to determine microbial susceptibility to antibiotics in which an agar plate, which has a concentration gradient of the drug within the agar, is streaked with the microorganism of interest. Microbial susceptibility as well as minimum inhibitory concentration of antibiotic is assessed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GIEMSA STAIN</VALIDVALUE>
          <VALUEMEANING>Giemsa Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes Giemsa, a mixture of ethylene blue and eosin, which forms purplish-black crystals when dried. This stain preferentially binds to the phosphate groups of DNA and aggregates at areas with an increase in adenine-thymine binding, thus leading to chromosomal staining patterns that lend themselves to g-banding analysis. Additionally Giemsa can be used as a differential stain to determine microbial cell adherence to human cells as well as in the diagnosis of malaria, spirochete, and protozoal infections.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85598</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402362</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GEL ELECTROPHORESIS</VALIDVALUE>
          <VALUEMEANING>Gel Electrophoresis</VALUEMEANING>
          <MEANINGDESCRIPTION>Gel electrophoresis is a method of separating large molecules (such as DNA fragments or proteins) from a mixture of similar molecules by electrophoretic filtration through a gelatinous matrix.  Subject to an electric field, each molecule in the sample mixture migrates through the matrix at a different rate, depending mainly on electrical charge and size, resulting in spatial separation within the matrix of each molecular species in the sample mixture.  Agarose and acrylamide in a cylindrical tube or slab gel are commonly used media for electrophoresis of proteins and nucleic acids.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18091</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3340005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GC/MS-EI</VALIDVALUE>
          <VALUEMEANING>Gas Chromatography/Electron Ionization Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique where gas chromatography is coupled with electron ionization mass spectrometry in order to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GC/MS-CI</VALIDVALUE>
          <VALUEMEANING>Gas Chromatography/Chemical Ionization Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique where gas chromatography is coupled with chemical ionization mass spectrometry in order to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GC/MS/MS</VALIDVALUE>
          <VALUEMEANING>Gas Chromatography/Tandem Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique wherein gas chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICROBIAL CULTURE, LIQUID</VALIDVALUE>
          <VALUEMEANING>Microbial Liquid Culture</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for growing microorganisms in liquid culture media.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICROBIAL CULTURE</VALIDVALUE>
          <VALUEMEANING>Microbial Culture Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Any laboratory procedure for growing microorganisms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5695525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICROBIAL CONCENTRATION</VALIDVALUE>
          <VALUEMEANING>Microbial Concentration Method</VALUEMEANING>
          <MEANINGDESCRIPTION>Any technique in which a sample is condensed in order to afford greater sensitivity for the detection of microorganisms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICROBIAL BIOCHEMICAL IDENTIFICATION</VALIDVALUE>
          <VALUEMEANING>Bacterial Typing Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure for identifying types and strains of bacteria. The most frequently used typing systems are bacteriophage typing, serotyping, bacteriocin typing, and biotyping.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51955</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Micro-Latex Particle-Mediated Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay technique used to test a individual&#39;s antigen-antibody immune response, which involves coating microbeads of latex with pathogen-specific antigens or antibodies, mixing them with the subject&#39;s fluid of interest, and then observing for any agglutination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142341</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICROARRAY</VALIDVALUE>
          <VALUEMEANING>Microarray</VALUEMEANING>
          <MEANINGDESCRIPTION>A microarray is a piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C44282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICRO BROTH DILUTION</VALIDVALUE>
          <VALUEMEANING>Micro Broth Dilution Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to determine the minimum inhibitory concentration (MIC) of antibiotics in which growth media is pipetted into a multi-well plate. Each well contains a known concentration of drug which is inoculated with a known quantity of bacteria. The plate is incubated for a specified period of time and each well is assessed for bacterial cell growth. The drug concentration in the first well showing no growth is known as the MIC for that antibiotic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85701</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MEDIASTINOSCOPY</VALIDVALUE>
          <VALUEMEANING>Mediastinoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>(MEE-dee-a-stin-AHS-ko-pee) A procedure in which a tube is inserted into the chest to view the organs in the area between the lungs and nearby lymph nodes. The tube is inserted through an incision above the breastbone. This procedure is usually performed to get a tissue sample from the lymph nodes on the right side of the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16829</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3009156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICRONEUTRALIZATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Microneutralization Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An in vitro assay that is used to determine whether antibodies that can block viral infection are present in a biological specimen. Virus is mixed with serum taken from the subject and is incubated in culture with laboratory cells, which are monitored over time for cytotoxicity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120695</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICRODENSITOMETRY</VALIDVALUE>
          <VALUEMEANING>Microdensitometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for measuring microscopic optical density on exposed film or photographic images through the detection of faint spectral lines.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150872</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MECHANICAL CLOT DETECTION</VALIDVALUE>
          <VALUEMEANING>Mechanical Clot Detection</VALUEMEANING>
          <MEANINGDESCRIPTION>A clot detection method that uses a mechanical means (electromagnetic mechanical or electromechanical) to detect the presence and/or quantify the formation of a thrombus in a specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111249</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GC/MS</VALIDVALUE>
          <VALUEMEANING>Gas Chromatography Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique wherein gas chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GC/FID</VALIDVALUE>
          <VALUEMEANING>Gas Chromatography and Flame Ionization Detection</VALUEMEANING>
          <MEANINGDESCRIPTION>A method that combines a flame ionization detector with a gas chromatograph to identify and quantify organic species within a gas stream.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FUNDUS PHOTOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Eye Fundus Photography</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of capturing images of the vitreous, retina, choroid, and optic nerve using a specialized low power microscope with an attached camera.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FUNCTIONAL MRI</VALIDVALUE>
          <VALUEMEANING>Functional Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A noninvasive tool used to observe functioning in the brain or other organs by detecting changes in chemical composition, blood flow, or both.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17958</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5153236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FREEZING POINT DEPRESSION</VALIDVALUE>
          <VALUEMEANING>Freezing Point Depression</VALUEMEANING>
          <MEANINGDESCRIPTION>The addition of a solute to a solvent that results in a decrease in the temperature at which the solute-solvent mixture freezes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FORCED OSCILLATION TECHNIQUE</VALIDVALUE>
          <VALUEMEANING>Forced Oscillation Technique</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive method to evaluate respiratory mechanical properties of the lung and airways using small-amplitude pressure oscillations superimposed on the normal, tidal breathing of a subject.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLUORIMETRY</VALIDVALUE>
          <VALUEMEANING>Fluorimetry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical method that utilizes ultraviolet light to excite the sample and detects the fluorescence emitted during the return of the sample to its ground state.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62322</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLUORESCENT SPOT TEST</VALIDVALUE>
          <VALUEMEANING>Fluorescent Spot Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to assess enzymatic activity in which a substrate reagent is incubated with a biological specimen and spotted on filter paper. The spots are then examined for fluorescence, which correlates with enzyme activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLUORESCENT MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Fluorescence Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique in which samples that either contain fluorescent compounds or are stained with fluorescent dyes are exposed to a wavelength of light that excites the fluorophore, allowing for an image to be captured by a microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16856</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLUORESCENT IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Fluorescent Antibody Technique</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunological technique in which the antibodies are coupled with molecules which fluoresce under ultra violet (UV) light. This makes them particularly suitable for detection of specific antigens in tissues or on cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2978232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLUORESCENT ENZYME IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Fluorescent Enzyme Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay technique that uses enzymes, which when bound to the substrate transform into a fluorescent product, to detect the presence of a substance, usually an antigen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLUORESCENCE ANGIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Fluorescence Angiography</VALUEMEANING>
          <MEANINGDESCRIPTION>An examination technique that uses fluorescent dye and a specialized camera to inspect blood flow in the retina and choroid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLOW MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Flow Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of measuring the number of cells in a sample by placing the cells in a fluid and passing them, in a stream, through a special light microscope that can record and analyze images of the cells (presence of foreign particles, cell counts, protein aggregates, morphology information).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112284</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLOW CYTOMETRY</VALIDVALUE>
          <VALUEMEANING>Flow Cytometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2974014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLUOROSCOPY</VALIDVALUE>
          <VALUEMEANING>Fluoroscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Examination of the tissues and deep structures of the body by x-ray, using the fluoroscope, a device that produces an image when x-rays strike a fluorescent screen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3794687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLUORESCENT LIFETIME IMAGING MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Fluorescence Lifetime Imaging Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging technique that produces spatially resolved images based on the differences in the excited state decay rates of fluorescent compounds in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLOCCULATION</VALIDVALUE>
          <VALUEMEANING>Flocculation Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A process in which microscopic particles in suspension aggregate to form loosely clumped masses that are often macroscopically observable.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ENZYMATIC SPECTROPHOTOMETRY</VALIDVALUE>
          <VALUEMEANING>Enzymatic Spectrophotometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A spectrophotometry technique that measures the changes in the intensity of the light absorbed or scattered in response to an enzymatic reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELECTRONEUROGRAPHY</VALIDVALUE>
          <VALUEMEANING>Electroneurography</VALUEMEANING>
          <MEANINGDESCRIPTION>A nerve conduction study technique where a brief electrical stimulation is delivered under the skin, and the resulting electrical activity is recorded to assess the conductivity of peripheral nerve impulses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154784</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618755</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DOPPLER ULTRASOUND</VALIDVALUE>
          <VALUEMEANING>Doppler Ultrasound</VALUEMEANING>
          <MEANINGDESCRIPTION>Diagnostic imaging that uses sound waves (ultrasound) applying the Doppler effect, with frequency-shifted ultrasound reflections produced by moving targets (usually red blood cells) in the bloodstream along the ultrasound axis in direct proportion to the velocity of movement of the targets, to determine both direction and velocity of blood flow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62781</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3594790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTRAST ENHANCED X-RAY</VALIDVALUE>
          <VALUEMEANING>Contrast Enhanced X-ray</VALUEMEANING>
          <MEANINGDESCRIPTION>An x-ray technique that incorporates the administration of an iodinated contrast agent to enhance lesions that are not visible on standard x-rays.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONGO RED STAIN</VALIDVALUE>
          <VALUEMEANING>Congo Red Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes the Congo Red stain, a benzidine derivative dye that has applications in staining biological structures, such as amyloid, as well as a pH indicator.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154782</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COMPLEMENT FIXATION</VALIDVALUE>
          <VALUEMEANING>Complement Fixation Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An in vitro immunoassay that measures the binding of complement to antigen-antibody complexes in serum, leading to the depletion of free complement and the reduction of hemolytic activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154799</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AUTOMATED COUNT</VALIDVALUE>
          <VALUEMEANING>Automated Count</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique to determine the number of entities, that employs a machine or device to automatically detect cells as they pass through the instrument&#39;s light path.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154794</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KLEIHAUER-BETKE</VALIDVALUE>
          <VALUEMEANING>Kleihauer-Betke Staining Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>A biospecimen collection and staining procedure in which maternal blood smear is prepared and stained using Shepard&#39;s staining method, followed by microscopic examination to identify fetal-maternal hemorrhage (fetal hemoglobin transference to the mother&#39;s bloodstream).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MIGET</VALIDVALUE>
          <VALUEMEANING>Multiple Inert Gas Elimination Technique</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique that measures the pulmonary exchange of a set of six different inert gases dissolved together in saline (or dextrose) and infused intravenously. The measurements are then used to compute the distribution of ventilation/perfusion ratios that best describes the exchange of the six gases simultaneously. (Wagner PD. The multiple inert gas elimination technique (MIGET). Intensive Care Med. 2008 Jun;34(6):994-1001.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DYNAMOMETRY</VALIDVALUE>
          <VALUEMEANING>Dynamometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique that measures the torque, or force, of muscle action.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SINGLE-MOLECULE ARRAY</VALIDVALUE>
          <VALUEMEANING>Single-Molecule Array</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of enzyme-linked immunoassay in which single molecules can be detected through the use of femtomolar-sized reaction chambers and an excess of fluorescently labeled antibody-bound beads.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>QUANTITATIVE COMPUTED TOMOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Quantitative Computed Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of computed tomography in which a calibration standard correlates radiodensity values to quantitative tissue density values.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SURFACE PLASMON RESONANCE</VALIDVALUE>
          <VALUEMEANING>Surface Plasmon Resonance</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantum optical-electrical phenomena consisting of an alteration in light reflectance as a result of binding of molecules to a surface from which total internal reflection is occurring. Used to detect macromolecular interactions, SPR can be used as the basis for a sensor which is capable of sensitive and quantitative measurement of a broad spectrum of chemical and biological entities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18117</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONFOCAL MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Confocal Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A system of (usually) epifluorescence light microscopy in which a fine laser beam of light is scanned over the object through the objective lens. The technique is particularly good at rejecting light from outside the plane of focus and so produces higher effective resolution than is normally achieved.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17753</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2915745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ICC</VALIDVALUE>
          <VALUEMEANING>Immunocytochemistry</VALUEMEANING>
          <MEANINGDESCRIPTION>A laboratory tissue staining procedure involving monoclonal or polyclonal antibodies that react with specific tissue antigens.  Initially used as a research tool, immunocytochemistry has become routine in diagnostic work-up of diseases in pathology. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17731</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2926775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TARGETED GENOME SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Targeted Genome Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A DNA sequencing technique in which selected regions of an individual&#39;s genome are sequenced.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TARGETED TRANSCRIPTOME SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Targeted Transcriptome Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of whole transcriptome shotgun sequencing technique in which select portions of the transcriptome are selected for sequencing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158252</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IN VITRO GENE EXPRESSION ASSAY</VALIDVALUE>
          <VALUEMEANING>In vitro Gene Expression Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A method that detects gene transcription associated with an in vitro cellular stimulus, through detection of the resulting transcribed mRNA or translated protein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY</VALIDVALUE>
          <VALUEMEANING>Multiplex Real-time Polymerase Chain Reaction Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay technique that utilizes the polymerase chain reaction (PCR) method to amplify multiple DNA sequences in a single cycle, with the accumulation of amplification product being measured as the reaction progresses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNE REPERTOIRE DEEP SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Immune Repertoire Deep Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>DNA sequencing of the full complement of genes associated with T and B cell antigen-specific receptors in an individual, performed with a high number of replications.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158249</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CELL OF ORIGIN ASSAY</VALIDVALUE>
          <VALUEMEANING>Cell-of-Origin Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay that utilizes gene expression profiling of RNA extracted from formalin-fixed, paraffin-embedded tissue biopsies, in order to determine the cell of origin of the tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158248</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Fluorescent Antibody Virus Neutralization Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunofluorescence assay method that measures the level of virus-specific neutralizing antibodies in a serum or a plasma sample by the detection of fluorescence in susceptible cells incubated with serial dilutions of the serum/plasma and fluorophore-conjugated virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SLOAN LETTER EYE CHART 100%</VALIDVALUE>
          <VALUEMEANING>Sloan Letter Eye Chart 100 Percent</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagrammatic method of vision testing that utilizes black letters on a white background to assess high contrast visual acuity that uses the Sloan optotypes and a 100% contrast level.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MYELOPEROXIDASE STAIN</VALIDVALUE>
          <VALUEMEANING>Myeloperoxidase Stain</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunohistochemical or enzyme cytochemical staining method to detect myeloperoxidase, a lysosomal protein that has peroxidase enzyme activity and is present in granulocytic and monocytic cells, but absent in lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158245</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>THERMAL IONIZATION MASS SPECTROMETRY</VALIDVALUE>
          <VALUEMEANING>Thermal Ionization Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A mass spectrometry method in which chemically-purified samples are heated to create positively ionized atoms that are then accelerated by an electric field and mass separated by an electromagnet.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SLIT LAMP PHOTOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Slit Lamp Photography</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of capturing images of the structures of the eye using a horizontally mounted microscope with an attached slit lamp.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158243</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLUORESCEIN STAIN</VALIDVALUE>
          <VALUEMEANING>Fluorescein Stain</VALUEMEANING>
          <MEANINGDESCRIPTION>A vital staining method that utilizes an orange phthalic indicator dye, which emits green fluorescence in the presence of alkaline solutions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LISSAMINE GREEN STAIN</VALIDVALUE>
          <VALUEMEANING>Lissamine Green Stain</VALUEMEANING>
          <MEANINGDESCRIPTION>A vital staining method that utilizes a green, synthetically-produced phenyl methane dye that preferentially stains degenerate and dead epithelial cells and stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158241</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ROMANOWSKY STAIN</VALIDVALUE>
          <VALUEMEANING>Romanowsky Stain</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes both cationic and anionic dyes (typically methylene blue and eosin Y, respectively) for the morphological assessment of cells in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNODIFFUSION</VALIDVALUE>
          <VALUEMEANING>Immunodiffusion</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative technique used to detect and estimate the concentration of an antigen by measuring the precipitation which is formed as a result of the interaction of the antigen and an antibody at optimal concentration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WHOLE TRANSCRIPTOME SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Whole Transcriptome Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure that can determine the nucleotide sequence for all of the RNA transcripts in an individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5076611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WHOLE EXOME SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Exome Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure that can determine the DNA sequence for all of the exons in an individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3589477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WHOLE GENOME SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Whole Genome Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure that can determine the DNA sequence for nearly the entire genome of an individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3463244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ACCELERATOR MASS SPECTROMETRY</VALIDVALUE>
          <VALUEMEANING>Accelerator Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of mass spectrometry in which ions in the sample are accelerated to very high kinetic energies, thus allowing for the separation of rare isotopes from more abundant isotopes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ENDOSCOPY</VALIDVALUE>
          <VALUEMEANING>Endoscopic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or therapeutic procedure in which an endoscope is inserted in a tubular organ to examine the structural architecture and/or remove abnormal tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5566277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELLA</VALIDVALUE>
          <VALUEMEANING>Enzyme-Linked Lectin Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An enzyme immunoassay that utilizes enzyme-lectin conjugates to detect specific carbohydrate end groups on immobilized glycoproteins on microtiter plates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELISPOT</VALIDVALUE>
          <VALUEMEANING>Enzyme-linked Immunosorbent Spot Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A highly sensitive immunoassay capable of detecting secreted materials from individual cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3645813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELISA</VALIDVALUE>
          <VALUEMEANING>ELISA</VALUEMEANING>
          <MEANINGDESCRIPTION>A highly sensitive technique for detecting and measuring antigens or antibodies in a solution; the solution is run over a surface to which immobilized antibodies specific to the substance have been attatched, and if the substance is present, it will bind to the antibody layer, and its presence is verified and visualized with an application of antibodies that have been tagged in some way. (BioTech Life Science Dictionary)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3173905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELECTROPHORESIS</VALIDVALUE>
          <VALUEMEANING>Electrophoresis</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrochemical process in which macromolecules or colloidal particles with a net electric charge migrate in a solution under the influence of an electric current.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16536</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELECTROMYOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Electromyography</VALUEMEANING>
          <MEANINGDESCRIPTION>An assessment of skeletal muscle function and nerve control, obtained by recording and studying the intrinsic electrical properties of the muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38056</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4821875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELECTROGASTROGRAPHY</VALIDVALUE>
          <VALUEMEANING>Electrogastrography</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive technique that utilizes abdominal skin electrodes and computerized spectral analysis to assess gastric myoelectrical activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150871</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401739</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELECTROCHEMILUMINESCENCE IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Electrochemiluminescence Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>A method in which electromagnetic radiation, in the form of light emission, is generated from an electrochemical reaction in a solution due to the formation of antigen-antibody complexes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELECTROCHEMILUMINESCENCE</VALIDVALUE>
          <VALUEMEANING>Electrochemiluminescence</VALUEMEANING>
          <MEANINGDESCRIPTION>A method in which electromagnetic radiation, in the form of light emission, is generated from an electrochemical reaction in a solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLAME PHOTOMETRY</VALIDVALUE>
          <VALUEMEANING>Flame Photometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of atomic spectroscopy capable of qualitatively or quantitatively determining certain cations (particularly Na, K, Rb, Cs, Ca, Ba, Cu) by utilizing a low temperature flame capable of exciting a valence electron to an upper energy state which emits light at a wavelength unique to each cation as the electron returns to its ground state.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FISH</VALIDVALUE>
          <VALUEMEANING>Fluorescence in Situ Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5622317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FARNSWORTH-MUNSELL 100 HUE TEST</VALIDVALUE>
          <VALUEMEANING>Farnsworth-Munsell 100 Hue Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagrammatic method to test color blindness or deficiencies, which uses 100 colors from the Munsell color system arranged in rows of four color families, containing 25 hues for each color. The subject must put the hues in order based on the anchor colors at the ends of each row.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130172</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ETDRS EYE CHART</VALIDVALUE>
          <VALUEMEANING>Early Treatment of Diabetic Retinopathy Study Eye Chart</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagrammatic method to test visual acuity which incorporates the Bailey-Lovie layout in conjunction with Sloan optotypes, which was first used in the Early Treatment of Diabetic Retinopathy Study.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117877</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EPSILOMETER</VALIDVALUE>
          <VALUEMEANING>Epsilometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to determine microbial susceptibility to antibiotics in which a plastic strip impregnated with the antibiotic of interest is placed on an agar plate that has been inoculated with bacteria. The antibiotic diffuses from the strip producing a concentration gradient of drug on the agar. The point at which the elliptical shaped area of growth inhibition meets the strip is the minimum inhibitory concentration of the drug of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85596</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402230</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE</VALIDVALUE>
          <VALUEMEANING>Enzyme Multiplied Immunoassay Technique</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of homogenous immunoassay in which sample is applied to a reagent mixture of enzyme-labeled ligand, antibody, and substrate. Substrate binding to enzyme leads to inactivation and unlabeled-ligand in the sample can be quantified by colorimetric analysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ENZYMATIC ULTRACENTRIFUGATION</VALIDVALUE>
          <VALUEMEANING>Enzymatic Ultracentrifugation</VALUEMEANING>
          <MEANINGDESCRIPTION>An ultracentrifugation based method that uses enzymatic catalytic reaction to quantify a substance, which has been separated in solution by an ultracentrifugation process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122164</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ENZYMATIC COLORIMETRY</VALIDVALUE>
          <VALUEMEANING>Enzymatic Colorimetry</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of colorimetry that makes use of an enzymatic reaction to induce a color change.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ENDPOINT DILUTION ASSAY</VALIDVALUE>
          <VALUEMEANING>Endpoint Dilution Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An in vitro cell based assay in which plated host cells are inoculated with serial dilutions of an infective agent and observed for cytotoxic effects in order to calculate the titer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY</VALIDVALUE>
          <VALUEMEANING>Multiplexed Opsonophagocytic Killing Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay technique that measures the opsonophagocytic killing activity of antibodies against multiple serotypes in a single serum assay.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413910</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MULTIPLEXED BEAD BASED IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Multiplexed Bead Based Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of solid-phase immunoassay that uses distinctly colored microbeads coated with one or more reagents, which may be antigens, antibodies, oligonucleotides, enzyme substrates, or receptors, for the simultaneous detection and measurement of one or many analytes within a single sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135455</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION</VALIDVALUE>
          <VALUEMEANING>Multiplex Ligation-dependent Probe Amplification</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of high-throughput, multiplex PCR method used to determine abnormal DNA copy number changes of up to 50 genomic DNA or RNA sequences with a single pair of PCR primers. It is frequently used in the detection of genetic aberrations in tumors, and can distinguish sequences differing in only a single nucleotide.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING</VALIDVALUE>
          <VALUEMEANING>Multiple Complete Digest Restriction Fragment Mapping</VALUEMEANING>
          <MEANINGDESCRIPTION>A DNA mapping technique based on complete restriction enzyme digestion of a set of overlapping clones that provides highly redundant coverage of the mapping target.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6287907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MULTIPLE BREATH WASHOUT</VALIDVALUE>
          <VALUEMEANING>Multiple Breath Washout</VALUEMEANING>
          <MEANINGDESCRIPTION>A test of lung function in which changes in exhaled tracer gas concentration is analyzed for a specified number of tidal expirations, a defined period of time, or a defined index of expired gas volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130176</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MULTI-SLICE SPIRAL CT</VALIDVALUE>
          <VALUEMEANING>Multi-slice Spiral Computed Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of spiral computed tomography that employs multiple rows of detectors, each capable of producing a simultaneous image (slice).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MUGA</VALIDVALUE>
          <VALUEMEANING>Radionuclide Ventriculogram Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A multi-gated acquisition (MUGA) scan and a form of radionuclide imaging that provides a comprehensive look at blood flow and the function of the lower chambers of the heart ventricles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581619</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRS</VALIDVALUE>
          <VALUEMEANING>Magnetic Resonance Spectroscopic Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>Magnetic resonance spectroscopy is a noninvasive imaging technique that acts as a complement to conventional imaging of brain tumors in order to improve the sensitivity and specificity of the diagnostic process. This technique operates by exciting and recording signals from a range of magnetic resonance frequencies, allowing the identification and quantification of several biologically significant molecules containing proton groups that resonate in the appropriate frequency range. The technique facilitates observation of the spatial distribution of metabolic patterns over a region of interest and surrounding tissue at a high spatial resolution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI WITHOUT CONTRAST</VALIDVALUE>
          <VALUEMEANING>MRI Without Contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique that uses radiofrequency waves and a magnet to image the body, in which the images are not enhanced by the addition of contrast agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114184</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4443475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI</VALIDVALUE>
          <VALUEMEANING>Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MODIFIED ACID FAST STAIN</VALIDVALUE>
          <VALUEMEANING>Modified Acid Fast Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method, that does not utilize heat in the slide preparation, used to examine a specimen for the presence of acid-fast microorganisms, specifically nocardia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICROPARTICLE ENZYME IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Microparticle Enzyme Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of enzyme immunoassay that uses antigen-coated microparticles as a substrate for antibody binding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111252</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY</VALIDVALUE>
          <VALUEMEANING>Complement-dependent Lymphocytotoxicity Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A method that detects the presence and reaction of alloantibodies to donor lymphocytes in pre-transplant patients via the addition of complement proteins and lysis of the lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COLORIMETRY</VALIDVALUE>
          <VALUEMEANING>Colorimetry</VALUEMEANING>
          <MEANINGDESCRIPTION>An assessment used to quantify and describe the colors within the visible spectrum of light.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LC/MS</VALIDVALUE>
          <VALUEMEANING>Liquid Chromatography Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>LC/MS is a hyphenated technique, combining the separation power of liquid chromatography (LC), an analytical chromatographic technique for separating ions or molecules dissolved in a solvent, with the detection power of mass spectrometry(MS), a technique to separate gas phase ions according their m/z (mass to charge ratio) value. Used for drug screening, pharmacology studies, environmental analyses and forensics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELASTOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Elastography</VALUEMEANING>
          <MEANINGDESCRIPTION>An ultrasound-based imaging technique used to examine the stiffness or elasticity of a tissue by applying mechanical compression or vibration to the tissue being imaged. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EIA</VALIDVALUE>
          <VALUEMEANING>Enzyme Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of several immunoassay methods that use an enzyme covalently linked to an antigen or antibody as a label; the most common types are enzyme-linked immunosorbent assay (ELISA) and enzyme-multiplied immunoassay technique (EMIT).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17455</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6384483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EEG</VALIDVALUE>
          <VALUEMEANING>Electroencephalography</VALUEMEANING>
          <MEANINGDESCRIPTION>The neurophysiologic exploration of the electrical activity of the brain by the application of electrodes to the scalp. The resulting traces are known as an electroencephalogram (EEG). This test is used to assess brain damage, epilepsy and other problems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38054</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ECHOCARDIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>ECHOCARDIOGRAPHY</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure that uses ultrasonic waves directed over the chest wall to obtain a graphic record of the heart&#39;s position, motion of the walls, or internal parts such as the valves.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DYNAMIC SUSCEPTIBILITY-CONTRAST MRI</VALIDVALUE>
          <VALUEMEANING>Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of magnetic resonance imaging that uses the transient signal reduction induced by the first pass of gadolinium chelate through the brain vessels to calculate cerebral blood flow maps, and to determine the ratio between the cerebral blood volume in the lesion and the cerebral blood volume in normal tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401747</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DYNAMIC LIGHT SCATTERING</VALIDVALUE>
          <VALUEMEANING>Photon Correlation Spectroscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of spectroscopy that utilizes a laser beam to irradiate a sample containing particles in suspension, resulting in light scattering. Rapid fluctuations in scattering intensity, around a mean value at a certain angle, occur because of particle diffusion and are dependent upon on particle size. The calculated correlation function yields a diffusion coefficient, for a given temperature and viscosity, which can be used to calculate particle size.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2915746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DYNAMIC CONTRAST ENHANCED MRI</VALIDVALUE>
          <VALUEMEANING>Dynamic Contrast-enhanced Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A modification of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DXA SCAN</VALIDVALUE>
          <VALUEMEANING>Dual X-ray Absorptiometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for scanning bone and measuring bone mineral density (BMD). A DXA scanner produces 2 X-ray beams, each with different energy levels. One beam is high energy while the other is low energy. The amount of x-rays that pass through the bone is measured for each beam. This will vary depending on the thickness of the bone. Based on the difference between the 2 beams, the bone density can be measured.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DUKE INCISION METHOD</VALIDVALUE>
          <VALUEMEANING>Duke Incision Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for assessing bleeding time in which a controlled incision is made on the ear or fingertip.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DUCTOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Ductography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of mammography that uses contrast medium to visualize the ducts of the breast.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DNA MICROARRAY</VALIDVALUE>
          <VALUEMEANING>DNA Microarray Chip</VALUEMEANING>
          <MEANINGDESCRIPTION>An orderly array of DNA samples affixed to a support.  Using robots thousands of samples can be arrayed on a single chip. The chip is used in various types of hybridization experiments.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18158</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DISK DIFFUSION</VALIDVALUE>
          <VALUEMEANING>Disk Diffusion Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to determine microbial susceptibility to antibiotics in which filter paper disks containing known concentrations of antibiotics are placed on the agar surface that has been previously inoculated with the bacteria of interest. Microbial susceptibility is assessed by measuring the area around the disk that is free of microbial growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401755</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIRECT SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Direct Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique used to identify the sequence of individual nucleobases in a single strand of DNA fragment template, which can be a plasmid insert, genomic DNA or a PCR product. In addition, direct sequencing of genomic DNA or PCR products does not require sub-cloning of the gene of interest into a vector.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116154</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIGITAL PCR ARRAY</VALIDVALUE>
          <VALUEMEANING>Digital Array</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique used to deliver high-throughput digital PCR. The digital array partitions a sample premixed with PCR reagents into hundreds of individual PCR reactions, which allows the absolute quantification of target sequences and rare allele detection, as compared to conventional real-time quantitative PCR.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116158</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401760</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIFFUSION WEIGHTED MRI</VALIDVALUE>
          <VALUEMEANING>Diffusion Weighted Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DARK FIELD MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Dark Field Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A light microscopic technique in which the light that does not come into contact with the structures or details of interest is subtracted from the ocular image. This yields an image in which the structures or details are alight while the areas where the structures or details are absent are dark.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CYSTOSCOPY</VALIDVALUE>
          <VALUEMEANING>Cystoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Endoscopic examination of the urinary bladder or urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16482</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CT SCAN WITHOUT CONTRAST</VALIDVALUE>
          <VALUEMEANING>Computed Tomography without Contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>Computed tomography that does not use a contrast agent to visualize anatomic structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C137806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401765</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CT SCAN</VALIDVALUE>
          <VALUEMEANING>Computed Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CRYOSCOPY</VALIDVALUE>
          <VALUEMEANING>Cryoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for measuring the molar concentration of a substance in solution by determining the freezing point of the solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122162</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CORONARY ANGIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Coronary Angiography</VALUEMEANING>
          <MEANINGDESCRIPTION>The passage of a catheter into the aortic root or other great vessel for the purpose of angiography of the native coronary arteries or bypass grafts supplying native coronary arteries. (ACC)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100085</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Transthoracic Echocardiography With Contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive cardiac ultrasound performed by placing the transducer on the chest, with intravenous application of a contrast agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Transesophageal Echocardiography With Contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>A cardiac ultrasound performed by passing a specialized probe containing a transducer into the patient&#39;s esophagus, with intravenous application of a contrast agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401774</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTRAST ENHANCED PET/CT SCAN</VALIDVALUE>
          <VALUEMEANING>Contrast Enhanced PET-CT Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of PET/CT imaging in which radiopharmaceuticals is either ingested or injected intravenously in an attempt to enhance the collected images for diagnostic purposes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142335</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401776</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTRAST ENHANCED MRI</VALIDVALUE>
          <VALUEMEANING>Magnetic Resonance Imaging with Contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique that uses radiofrequency waves and a magnet to image the body.  The images are enhanced by the addition of contrast agents which selectively intensify anatomical regions to intensify the clarity of the image for diagnostic purposes. 2005</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C46087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4443476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTRAST ENHANCED CT SCAN</VALIDVALUE>
          <VALUEMEANING>Computed Tomography with Contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>Computed tomography that uses a contrast agent to visualize anatomic structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C137805</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTACT SPECULAR MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Contact Specular Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of specular microscopy in which the specular microscope makes contact with the cornea of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MACRO BROTH DILUTION</VALIDVALUE>
          <VALUEMEANING>Macro Broth Dilution Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to determine the minimum inhibitory concentration (MIC) of antibiotics in which growth media is pipetted into a test tube. Each tube contains a known concentration of drug and is inoculated with a known quantity of bacteria. The tubes are incubated for a specified period of time and each is assessed for bacterial cell growth. The drug concentration in the first tube showing no growth is known as the MIC for that antibiotic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85697</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LUXOL FAST BLUE AND CRESYL VIOLET STAIN</VALIDVALUE>
          <VALUEMEANING>Luxol Fast Blue and Cresyl Violet Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes luxol fast blue, an alcohol soluble copper phthalocyanine dye, and cresyl violet, an organic compound that is commonly used as a counter stain, to determine the presence of myelin as well as helicobacter and campylobacter bacterial species.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402268</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LOOP-MEDIATED ISOTHERMAL AMPLIFICATION</VALIDVALUE>
          <VALUEMEANING>Loop-mediated Isothermal Amplification</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of nucleic acid amplification test in which sample DNA is exposed to a single temperature in the presence of multiple sets of primers and a polymerase with replication and high strand displacement activity. This test negates the need for thermal cyclers and may be a low cost alternative to PCR.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102661</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LIQUID SCINTILLATION COUNTING</VALIDVALUE>
          <VALUEMEANING>Liquid Scintillation Counting</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for measuring the amount of ionizing radiation in a liquid substance. Samples are mixed with a mixture of solvent, surfactant and scintillators that can convert beta particles into light energy, which can be measured.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122170</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LINE PROBE ASSAY</VALIDVALUE>
          <VALUEMEANING>Line Probe Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique in which polymerase chain reaction is used to amplify specific nucleic acid sequences in a biospecimen. The product of this reaction is then applied to a nitrocellulose test strip containing complementary DNA probes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102656</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LIGHT SCATTERING SPECTROSCOPY</VALIDVALUE>
          <VALUEMEANING>Light-Scattering Spectroscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>The nuclei of precancerous lesions are distinct in that they become enlarged, crowded and hyperchromatic.  Light-scattering spectroscopy can diagnose early epithelial cancers based on the scattering of light through their enlarged nuclei. (from Medscape)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20059</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LIGHT MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Light Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Light Microscopy is a technique for producing visible images of structures or details which are too small to be otherwise seen by the human eye. It involves passing light transmitted through or reflected from the subject through a series of lenses to be detected directly by the eye, imaged on a photographic plate, or captured digitally.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17995</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LEAD CITRATE STAIN</VALIDVALUE>
          <VALUEMEANING>Lead Citrate Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes lead citrate, a mixture of lead nitrate and sodium citrate, and has applications for electron microscopy staining.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LC-FL</VALIDVALUE>
          <VALUEMEANING>Liquid Chromatography-Fluorescence</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique where liquid chromatography with a fluorescence detector is used to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122169</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LC/MS/MS</VALIDVALUE>
          <VALUEMEANING>Liquid Chromatography/Tandem Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique wherein liquid chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NESTED POLYMERASE CHAIN REACTION</VALIDVALUE>
          <VALUEMEANING>Nested PCR</VALUEMEANING>
          <MEANINGDESCRIPTION>Polymerase chain reaction that uses two sets of primers, in two sequential runs of amplification, with the second set intended to amplify a target within the first run product.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127880</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SUSCEPTIBILITY WEIGHTED MRI</VALIDVALUE>
          <VALUEMEANING>Susceptibility Weighted Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging technique that uses phase differences between tissues due to differences in magnetic susceptibilities to produce an enhanced contrast magnitude image. These phase differences can provide excellent contrast between gray matter and white matter, iron-laden tissues, venous blood vessels, and other tissues with susceptibilities that are different from the background tissue. The technique is commonly used for imaging in cases of traumatic brain injuries and for high resolution brain venographies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NUCLEIC ACID SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Nucleic Acid Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>The process of determining the sequence of purines and pyrimidines in nucleic acids and polynucleotides.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18881</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3339147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CLOT DETECTION</VALIDVALUE>
          <VALUEMEANING>Clot Detection</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of several methods used to detect the presence of or quantify the formation of a thrombus in a specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111095</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CLIP SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Cross-linking Immunoprecipitation High-throughput Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A molecular biology method combining crosslinking-immunoprecipitation and high-throughput sequencing techniques to detect and map RNA-protein interactions. In CLIP, whole tissues, organisms or individual cell types are treated with UV irradiation, which introduces covalent bonds between RNA-protein complexes. This is followed by immunoprecipitation and removal of the protein component of the crosslinked complex. The purified RNAs are then fragmented, reduced in size and subjected to high-throughput sequencing for the identification of RNA binding sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116152</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CLIP</VALIDVALUE>
          <VALUEMEANING>Cross-Linking and Immunoprecipitation</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of immunoprecipitation protocol that employs UV-light induced covalent cross-linking of molecules (for instance protein and RNA) prior to the immunoprecipitation and purification steps.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CLAUSS METHOD</VALIDVALUE>
          <VALUEMEANING>Clauss Method</VALUEMEANING>
          <MEANINGDESCRIPTION>An in vitro method to determine the rate of fibrin clot formation, in which diluted plasma (with thrombin-dependency removed) is mixed with high concentrations of thrombin. This reaction is run in tandem with a control sample and compared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CISH</VALIDVALUE>
          <VALUEMEANING>Chromogenic in situ Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>Chromogenic in situ hybridization is a technique that combines the sequence-specific detection aspects of FISH with the simple detection methods of immunohistochemistry. Briefly, sequence-specific probes are hybridized to cells fixed on slides and the sequestered probe is visualized by a peroxidase reaction. It has the advantage of being a less costly assay that does not require fluorescence microscopy with results that are stable over time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CINEANGIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Cineangiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of angiography in which motion picture camera technology is used to record the passage of dye (usually fluorescent) through blood vessels and the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127679</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CHROMATOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Chromatography</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for the separation of complex mixtures that relys on the differential affinities of substances for a gas or liquid mobile medium and for a stationary adsorbing medium through which they pass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TELLER ACUITY CARDS</VALIDVALUE>
          <VALUEMEANING>Teller Acuity Cards</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagrammatic method to test visual acuity that uses a set of cards with parallel lines, used for those individuals who are unable to provide a verbal response to questions, including infants, toddlers, and other non verbal individuals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SXA SCAN</VALIDVALUE>
          <VALUEMEANING>Single Energy X-Ray Absorptiometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for measuring anatomical densities in which a single X-ray beam, whose low and high energy is separated, is aimed at the bone or tissue of interest and x-ray absorption is assessed. This technique has multiple applications including the measurement of bone mineral density and bone mineral content and more novel applications such as breast density.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150874</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STRESS ECHOCARDIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Stress Echocardiography</VALUEMEANING>
          <MEANINGDESCRIPTION>An image of the heart produced by ultrasonography under conditions intended to elicit signs and symptoms of myocardial ischemia. Conditions often include exercise, pharmacologic agents or pacing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SPIROMETRY</VALIDVALUE>
          <VALUEMEANING>Spirometry</VALUEMEANING>
          <MEANINGDESCRIPTION>Measurement of the breathing capacity of the lung by means of a spirometer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OPTICAL COHERENCE TOMOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Optical Coherence Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>Optical Coherence Tomography (OCT) combines the principles of ultrasound with the imaging performance of a microscope.  OCT uses infrared light waves that reflect off the internal microstructure within the biological tissues. The frequencies and bandwidths of infrared light are orders of magnitude higher than medical ultrasound signals, resulting in greatly increased image resolution, 8-25 times greater than any existing modality. In addition to providing high-level resolutions for the evaluation of microanatomic structures OCT is also able to provide information regarding tissue composition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OPTICAL MAPPING</VALIDVALUE>
          <VALUEMEANING>Optical Mapping</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique used for constructing the ordered and high-resolution genome or chromosome sized restriction enzyme map of an organism from a single, stained DNA molecule, digested by the restriction enzyme and imaged by an optical microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116162</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OPTICAL DENSITY MEASUREMENT</VALIDVALUE>
          <VALUEMEANING>Optical Density Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantification of the amount of light that is absorbed by or transmitted through a substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85776</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OPHTHALMOSCOPY</VALIDVALUE>
          <VALUEMEANING>Ophthalmoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique used to examine of the back (fundus) and other anatomical structures of the eye with a magnifying instrument.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OLIGO ACGH</VALIDVALUE>
          <VALUEMEANING>Oligonucleotide Array-based Comparative Genomic Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>A molecular cytogenetic method combining chromosomal comparative genomic hybridization technique and microarray to detect chromosomal aberrations and changes in DNA copy numbers in the genome, using oligonucleotides immobilized on a solid support as targets for hybridization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116156</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413983</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OBSERVATION</VALIDVALUE>
          <VALUEMEANING>Observation</VALUEMEANING>
          <MEANINGDESCRIPTION>Observation; watching something and taking note of what happens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25598</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLUID ATTENUATED INVERSION RECOVERY MRI</VALIDVALUE>
          <VALUEMEANING>Fluid Attenuated Inversion Recovery</VALUEMEANING>
          <MEANINGDESCRIPTION>A magnetic resonance imaging (MRI) pulse sequence that uses an inversion recovery technique to null fluids present in the imaging area, improving clarity of the object of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BLOOD OXYGEN LEVEL-DEPENDENT FUNCTIONAL MRI</VALIDVALUE>
          <VALUEMEANING>Blood Oxygen Level-Dependent Functional MRI</VALUEMEANING>
          <MEANINGDESCRIPTION>A magnetic resonance imaging technique that uses the difference between the magnetic signals of hemoglobin when it is carrying oxygen (oxyhemoglobin) and when it is not carrying oxygen (deoxyhemoglobin) to detect metabolic activity, and hence neurologic activity, in the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RETROGRADE PYELOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Retrograde Pyelogram</VALUEMEANING>
          <MEANINGDESCRIPTION>X-ray images of the ureters and kidneys obtained by injection of a radioopaque substance into the ureter, usually done via a cystoscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5529030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INTRAVENOUS PYELOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Intravenous Pyelography</VALUEMEANING>
          <MEANINGDESCRIPTION>The creation of an image of the kidneys and urinary system using an intravenously administered contrast medium. By taking several X-rays over a short period of time, it is possible to check for the proper functioning of both kidneys and the urinary system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20177</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5529029</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COLD PRECIPITATION</VALIDVALUE>
          <VALUEMEANING>Cold Precipitation</VALUEMEANING>
          <MEANINGDESCRIPTION>The process of precipitating proteins from solution by exposing the sample to cold temperatures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TITRIMETRY</VALIDVALUE>
          <VALUEMEANING>Titrimetry</VALUEMEANING>
          <MEANINGDESCRIPTION>Adjust a condition by a dropwise addition of a solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181463</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SESI-HRMS</VALIDVALUE>
          <VALUEMEANING>Secondary Electrospray Ionization High-resolution Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of mass spectrometry in which a nano-electrospray produces charging agents that collide with analyte molecules in gas-phase, creating an ionized vapor that is then analyzed via high resolution mass spectrometry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181462</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DISK DIFFUSION ZONE EDGE TEST</VALIDVALUE>
          <VALUEMEANING>Penicillin Zone Edge</VALUEMEANING>
          <MEANINGDESCRIPTION>A method that is used to detect beta-lactamase production by assessing the zone edge of penicillin-susceptible bacteria isolates after disk diffusion. A fuzzy zone edge indicates a beta-lactamase negative result and a sharp zone edge indicates a beta-lactamase positive result.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LASER CAPTURE MICRODISSECTION</VALIDVALUE>
          <VALUEMEANING>Laser Capture Microdissection</VALUEMEANING>
          <MEANINGDESCRIPTION>Laser capture microdissection is a new technology developed in the Intramural Program to allow sampling of specific cells under direct microscopic visualization by a pathologist. A film is placed against the heterogeneous tissue and activated by a laser beam to capture only the cells of interest. Those cells are transferred to the film to provide a visual microscopic record of what was transferred, which can be analyzed for DNA, RNA, or protein.  The film upon which the cells are transferred is incorporated into the cap of a vial so that, when the transfer is done under a routine microscopic visualization, the microdissected material can immediately be put into a vial for processing. The system is integrated into a pathologist&#39;s microscope so that the cells are microdissected, transferred to the cap, and then rotated into a vial by a rotating arm in a hands-off operation. (from Cancer Genome Anatomy Project (CGAP) Update)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LAPAROSCOPY</VALIDVALUE>
          <VALUEMEANING>Laparoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Laparoscopic examination of the abdominal cavity and its contents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3859297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LANDOLT RING</VALIDVALUE>
          <VALUEMEANING>Landolt Ring</VALUEMEANING>
          <MEANINGDESCRIPTION>A standard test of visual acuity, a symbol, in the shape of the letter C, is presented to the patient who must identify on which side of the symbol the gap is present. Both the size of the gap and the size of the symbol are reduced until the subject makes a predetermined rate of errors, thus ending the test.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142340</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KINYOUN STAIN</VALIDVALUE>
          <VALUEMEANING>Kinyoun Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy acid fast staining method that utilizes kinyoun carbol fuchsin, a dye containing basic fuchsin in solution with ethyl alcohol and aqueous phenol. This acid fast staining technique does not require heating during the primary staining step involving the carbol fuchsin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85651</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KINETIC MICROPARTICLE IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Kinetic Microparticle Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of immunoassay in which the antigen of interest found in a biological specimen competes with a lattice of antigen-antibody complexes. Competing antigen inhibits lattice formation and decreases absorbance in proportion to the amount of antigen present in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KINETIC CHROMOGENIC ASSAY</VALIDVALUE>
          <VALUEMEANING>Kinetic Chromogenic Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A bioassay in which a biological specimen is incubated with a kinetic substrate, followed by optical analysis of color change.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142339</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KARYOTYPING</VALIDVALUE>
          <VALUEMEANING>Karyotyping</VALUEMEANING>
          <MEANINGDESCRIPTION>The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5095203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JAFFE REACTION</VALIDVALUE>
          <VALUEMEANING>Jaffe Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A colorimetric method used to measure creatinine, in which color change is directly related to the amount of creatinine in an alkaline solution containing picric acid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JAEGER EYE CHART</VALIDVALUE>
          <VALUEMEANING>Jaeger Eye Chart</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagrammatic method to test visual acuity that uses paragraphs of text in differing font sizes to assess near vision.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130175</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IVY INCISION METHOD</VALIDVALUE>
          <VALUEMEANING>Ivy Incision Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for assessing bleeding time in which a controlled incision is made on the underside of the arm and blood is drawn off of the incision site with blotting paper every 30 seconds until bleeding stops.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ISHIHARA COLOR PLATES</VALIDVALUE>
          <VALUEMEANING>Ishihara Color Plates</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagrammatic method to test color blindness of deficiencies, which utilizes a circular form composed of multiple size circles in varying colors. A number or symbol is present in the middle of the circle and is composed of little circles which are a different color from the circles composing the outer circular form.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IRON HEMATOXYLIN STAIN</VALIDVALUE>
          <VALUEMEANING>Iron Hematoxylin Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes a mixture of iron and hematoxylin to visualize intracellular structures in a microscopic sample. In this dye system, iron acts as a mordant to hematoxylin rendering it insoluble, thereby allowing irreversible blue-black colored dyeing to the cell nucleus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IODINE STAIN</VALIDVALUE>
          <VALUEMEANING>Iodine Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes Iodine, an element belonging to the halogen group, which specifically stains polysaccharides such as cellulose, chitin, glycogen, and starch a blue color.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INTERRUPTER TECHNIQUE</VALIDVALUE>
          <VALUEMEANING>Interrupter Technique</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive method of measuring airway resistance during which the subject breathes normally while airflow is interrupted at a predetermined rate and volume during the early exhalation phase. Airway resistance is calculated as the ratio of alveolar pressure, which is estimated from mouth pressure during occlusion, to airflow before interruption. This method is used most often in children and other subjects unable to comply with instructions for conventional lung function tests.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INFRARED SPECTROMETRY</VALIDVALUE>
          <VALUEMEANING>Infrared Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A spectrometric method that determines the type and concentration of elements or chemicals in a sample, based upon the principle that the atoms in a sample will vibrate or rotate at a specific frequency when exposed to infrared light.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INDIA INK STAIN</VALIDVALUE>
          <VALUEMEANING>India Ink Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes India Ink, a water soluble carbon-based black ink, to determine the presence of microorganisms that are surrounded by a gelatinous capsule. This is a negative staining method in which background is stained in black and the microbes and microscopic structures of interest remain white.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INCISION-INDUCED BLEEDING METHOD</VALIDVALUE>
          <VALUEMEANING>Incision-induced Bleeding Method</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of multiple methods used to assess bleeding time, in which a controlled incision is made in the dermis and clotting time is measured.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122039</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IN SITU HYBRIDIZATION</VALIDVALUE>
          <VALUEMEANING>in situ Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMPULSE OSCILLOMETRY</VALIDVALUE>
          <VALUEMEANING>Impulse Oscillometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive method to measure pulmonary resistance and reactance, and the impedance of the respiratory system, using small pressure oscillation of a regular square wave of pressure 5 times per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122166</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNOTURBIDIMETRY</VALIDVALUE>
          <VALUEMEANING>Immunoturbidimetry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method that measures the absorbance of light from a sample which is used for quantifying an amount of analyte based on the level of turbidity produced by the formation and precipitation of an immune complex containing the analyte.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106536</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNORADIOMETRIC ASSAY</VALIDVALUE>
          <VALUEMEANING>Immunoradiometric Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of antibody-excess, non-competition radioimmunometric assay in which ligand is sandwiched between an immobilized antibody on a solid phase and a radiolabeled antibody raised against a different epitope of the ligand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402321</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNOPRECIPITATION</VALIDVALUE>
          <VALUEMEANING>Immunoprecipitation</VALUEMEANING>
          <MEANINGDESCRIPTION>Antigen aggregation with antibody, in the right ratios, to cause precipitation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16724</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3173902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Immunomagnetic Fluorescence Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging technique in which fluorescently labeled cells are immunomagnetically selected and imaged by a semi-automated fluorescence microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142338</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNOFLUORESCENT STAIN</VALIDVALUE>
          <VALUEMEANING>Immunofluorescent Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes immunofluorescent markers for use with histological applications of preserved cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142337</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNOFIXATION ELECTROPHORESIS</VALIDVALUE>
          <VALUEMEANING>Immunofixation</VALUEMEANING>
          <MEANINGDESCRIPTION>An enhancement of immunoelectrophoresis in which a series of post-electrophoretic gel slabs are layered with cellulose-acetate gels saturated with specific antibodies. The resulting antigen-antibody complexes fixed on the second gel may then be stained, allowing sensitive and specific qualitative visual identification of paraproteins by electrophoretic position. It can be used to identify specific proteins in the blood or urine. It has greatest application in the identification and monitoring of monoclonal proteins that are produced in conditions like Waldenstom&#39;s macroglobulinaemia and multiple myeloma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54536</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNOCHEMILUMINOMETRIC ASSAY</VALIDVALUE>
          <VALUEMEANING>Immunochemiluminometric Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of immunoassay in which the antigen-antibody complex is quantified using light emission, which is generated from a chemical reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111235</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNOBLOT</VALIDVALUE>
          <VALUEMEANING>Immunoblot Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for analyzing or identifying proteins immobilized on a filter by complementary reaction with specific antibodies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Immunoenzyme Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunological procedure used for the microscopic examination of tissues.  It involves the usage of enzyme-antibody or enzyme-antigen conjugates, antienzyme antibodies, or enzyme-antienzyme complexes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16714</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IHC</VALIDVALUE>
          <VALUEMEANING>Immunohistochemistry Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C23020</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ICP-MS</VALIDVALUE>
          <VALUEMEANING>Inductively-Coupled Plasma Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A mass spectrometry technique that uses inductively-coupled plasma generated from argon gas to atomize and ionize a sample. The resulting ions are separated and analyzed using a mass spectrometer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>REAL-TIME POLYMERASE CHAIN REACTION ASSAY</VALIDVALUE>
          <VALUEMEANING>Real Time PCR</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified polymerase chain reaction (PCR) technique in which DNA amplification is detected and quantified as the PCR reaction progresses, through the use of fluorescent DNA probes in the reaction mixture.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3727155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RAJI CELL RIA</VALIDVALUE>
          <VALUEMEANING>Raji Cell Radioimmunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of complement receptor-dependent immune complex assay that uses radiolabeled anti-IgA, anti-IgG, or anti-IgM Raji cells to detect the presence of soluble immune complexes in biologic fluids.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RAJI CELL EIA</VALIDVALUE>
          <VALUEMEANING>Raji Cell Enzyme Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of complement receptor-dependent immune complex assay that uses Raji cells washed with anti-IgA, anti-IgG, anti-IgM, and anti-Ig (A+G+M) conjugated with an enzyme to detect the presence of circulating immune complexes in biologic fluids.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RADIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Radiographic Examination</VALUEMEANING>
          <MEANINGDESCRIPTION>A radiographic procedure using the emission of penetrating energy waves to form an image of the structure penetrated by the radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128940</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RADIAL IMMUNODIFFUSION</VALIDVALUE>
          <VALUEMEANING>Radial Immunodiffusion</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative technique used to detect and estimate the concentration of an antigen by measuring the diameter of the ring of precipitation (precipitin ring), which is formed as a result of the interaction of the antigen and an antibody at optimal concentration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119296</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SPECULAR MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Specular Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A noninvasive photographic technique used to visualize and examine the corneal endothelium, in which a source of light is projected onto the cornea and the subsequent image reflected from the optical interface between the corneal endothelium and the aqueous humor is captured.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414149</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SPECTROPHOTOMETRY</VALIDVALUE>
          <VALUEMEANING>Spectrophotometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A laboratory test that produces a quantitative measurement of the reflection or transmission properties of a material as a function of wavelength.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116701</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SPECT SCAN</VALIDVALUE>
          <VALUEMEANING>Single Photon Emission Computed Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of tomography in which gamma photon-emitting radionuclides are administered to the patient and then detected by one or more gamma cameras rotated around the patient. From the series of two-dimensional images produced, a three-dimensional image can be created by computer reconstruction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2754163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SNP ARRAY</VALIDVALUE>
          <VALUEMEANING>Single Nucleotide Polymorphism Array</VALUEMEANING>
          <MEANINGDESCRIPTION>A genomic microarray-based method able to detect single nucleotide polymorphisms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116151</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6333960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SNELLEN EYE CHART</VALIDVALUE>
          <VALUEMEANING>Snellen Eye Chart</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagrammatic method to test visual acuity, which utilizes a chart containing 11 lines of Sloan optotypes in varying sizes, the largest located at the top of the chart and decreasing in size toward the bottom of the chart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SMEAR</VALIDVALUE>
          <VALUEMEANING>Smear</VALUEMEANING>
          <MEANINGDESCRIPTION>The action of spreading a thin layer of material across a surface.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65126</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4297175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SLOAN LETTER EYE CHART 2.5%</VALIDVALUE>
          <VALUEMEANING>Sloan Letter Eye Chart 2.5 Percent</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagrammatic method to test visual acuity that utilizes the Sloan optotypes and a 2.5% contrast level.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117881</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SLOAN LETTER EYE CHART 1.25%</VALIDVALUE>
          <VALUEMEANING>Sloan Letter Eye Chart 1.25 Percent</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagrammatic method to test visual acuity that utilizes the Sloan optotypes and a 1.25% contrast level.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117880</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SLIT LAMP</VALIDVALUE>
          <VALUEMEANING>Slit-lamp Examination</VALUEMEANING>
          <MEANINGDESCRIPTION>Examination of the anterior segment of the eye using a medical instrument called a slit lamp.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SIZE EXCLUSION CHROMATOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Gel Filtration Chromatography</VALUEMEANING>
          <MEANINGDESCRIPTION>Gel permeation or sieve chromatography that is performed on porous gels that separate solutes on the basis of size. Smaller solutes are included within the particles of the gel matrix more frequently than larger solutes, thus affecting elution rates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2915755</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SISH</VALIDVALUE>
          <VALUEMEANING>Silver-Enhanced in Situ Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of in situ hybridization that uses a hybridization probe linked to an enzyme that elicits neutralization and deposition of silver onto the probe target site.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NON-CONTACT SPECULAR MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Non-Contact Specular Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of specular microscopy in which the specular microscope does not make contact with the cornea of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120697</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NEXT GENERATION TARGETED SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Next Generation Targeted Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique that determines the nucleotide sequence of a pre-specified region of DNA or RNA by using primers that are specific for that region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130177</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6003647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NEXT GENERATION SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Next Generation Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>Technologies that facilitate the rapid determination of the DNA sequence of large numbers of strands or segments of DNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4448577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NEURAMINIDASE INHIBITION ASSAY</VALIDVALUE>
          <VALUEMEANING>Neuraminidase Inhibition Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of enzyme-based assay that assesses neuraminidase activity in the presence of an enzyme inhibitor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413990</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NEPHELOMETRY</VALIDVALUE>
          <VALUEMEANING>Nephelometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to quantify the concentration of particulate matter suspended in a liquid or gas using a nephelometer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413992</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>POTENTIOMETRY</VALIDVALUE>
          <VALUEMEANING>Potentiometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An electroanalytical technique in which the electrical potential of a solution is measured to determine the composition of the sample, by comparing the constant potential of the reference electrode with the actual potential of the indicator electrode.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>POPULATION SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Population Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A process by which the individual genomes of most or all of an entire population of a species undergoes a large-scale comparison of the DNA sequences within that population, using probabilistic matching tools. Such comparison allows for the study of microevolution within a population.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414028</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>POLYSOMNOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Polysomnography</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of tests taken during sleep to capture and record brain wave changes, eye movements, breathing rate, blood pressure, heart rate, and the electrical activity of the heart and other muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>POLYMERASE CHAIN REACTION</VALIDVALUE>
          <VALUEMEANING>Polymerase Chain Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17003</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3234683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PLETHYSMOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Plethysmography</VALUEMEANING>
          <MEANINGDESCRIPTION>A method used to measure changes in volume, pressure and resistance within an organ or whole body by means of a plethysmograph.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MASS SPECTROMETRY</VALIDVALUE>
          <VALUEMEANING>Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique wherein ions are separate according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17156</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3339145</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAPH</VALIDVALUE>
          <VALUEMEANING>Multiplex Amplifiable Probe Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>A screening method used to determine abnormal DNA copy number changes in complex genomes. This method uses unique short probes which can be quantitatively recovered and amplified after hybridization to genomic DNA. In addition, the probes can be specifically designed for any genomic region of interest (such as locus, telomere, chromosomal segment, whole chromosome or total genome) with high hybridization specificity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MANUAL CLOT DETECTION</VALIDVALUE>
          <VALUEMEANING>Manual Clot Detection</VALUEMEANING>
          <MEANINGDESCRIPTION>A clot detection method that uses a manual means (visual discernment) to detect the presence and/or quantify the formation of a thrombus in a specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111245</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAMMOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Mammography</VALUEMEANING>
          <MEANINGDESCRIPTION>Imaging examination of the breast by means of x-rays.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16818</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MALDI-TOF</VALIDVALUE>
          <VALUEMEANING>Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>In MALDI-TOF, a laser pulse is fired into a protein or peptide sample contained in a light-absorbing matrix. A small explosion vaporizes and ionizes the sample. In the presence of a high electric field, peptide ions are accelerated down an evacuated flight tube. Because large particles travel more slowly than small ones, the masses of the ionized particles are determined by measuring their arrival time at the end of the tube</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19935</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2915761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MALDI</VALIDVALUE>
          <VALUEMEANING>Matrix-Assisted Laser Desorption Ionization Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample- matrix mixture into free (gas phase) matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis. (CHI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48040</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAGNETIC RESONANCE ELASTOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Magnetic Resonance Elastography</VALUEMEANING>
          <MEANINGDESCRIPTION>This imaging technique returns information about the mechanical properties (feel) of tissues by combining MRI with ultrasound.  A properly equipped MRI machine captures a cross sectional image of the sound waves, produced by ultrasound techniques, which are then processed by computer to produce an image showing the hardness or elasticity of tissues within the cross section.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19338</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5508033</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WESTERGREN</VALIDVALUE>
          <VALUEMEANING>Westergren Tube Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method that measures the sedimentation rate of an entity in an aqueous solution using a Westergren tube.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618730</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRANSVAGINAL ULTRASOUND</VALIDVALUE>
          <VALUEMEANING>Transvaginal Ultrasound</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique in which sound waves are sent out by an ultrasound probe that has been inserted in the vagina and a computer uses the ultrasound echoes to create an image of the female genital tract. The test can be performed to evaluate women with infertility problems, abnormal bleeding, sources of unexplained pain, congenital malformations of the uterus and ovaries, and possible tumors and infection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2644703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SPECT/CT SCAN</VALIDVALUE>
          <VALUEMEANING>Single Photon Tomography and Computed Tomography Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A dual-modality imaging technique that merges data from single-photon emission computed tomography (SPECT) and computed tomography (CT) to provide structural and functional information.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PULMONARY ANGIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Pulmonary Angiography</VALUEMEANING>
          <MEANINGDESCRIPTION>An x-ray imaging technique that involves visualization of the pulmonary vasculature after fluoroscopy-guided catheter placement and injection of an iodinated contrast medium into the pulmonary circulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PALM METHOD</VALIDVALUE>
          <VALUEMEANING>Palm Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for estimating body surface area, in which the individual&#39;s palm, excluding fingers and wrist, accounts for about 0.5% of the total body surface area of that individual. The entire palmar surface (including fingers) accounts for about 1% of the individuals total body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154793</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HIGH RESOLUTION CT</VALIDVALUE>
          <VALUEMEANING>High Resolution Computed Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>Defined as thin section (1-2 mm collimation) CT optimized by using a high-spatial-frequency (bone) algorithm. (from Radiol Clin North Am 1991;29:1043-9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MS/MS</VALIDVALUE>
          <VALUEMEANING>Tandem Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>Mass spectrometers coupled in series.  The targeted compound is selectively ionized, and its characteristic ions are separated from others in the mixture in the first mass spectrometer. The selected primary ions are then decomposed by collision, and from the resulting products the final mass analyzer selects secondary ions characteristic of the targeted compound. Tandem mass spectrometry can achieve specificities and sensitivities equivalent of those of methods such as radioimmunoassay and gas chromatography/mass spectrometry, while performing analyses in much shorter times.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SICKLE CELL SOLUBILITY TEST</VALIDVALUE>
          <VALUEMEANING>Sickle Cell Solubility Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of screening for sickle cell disease or trait in which sodium dithionite or a similar chemical is used to lyse red blood cells in a blood sample. This allows any hemoglobin S, which does not dissolve easily in plasma, to form crystals that visibly cloud the plasma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166070</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>POLYGRAPHY</VALIDVALUE>
          <VALUEMEANING>Polygraphy</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of simultaneously recording variations in multiple physiological pulsations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NON-INVASIVE DIELECTRIC SENSING</VALIDVALUE>
          <VALUEMEANING>Non-Invasive Dielectric Sensing</VALUEMEANING>
          <MEANINGDESCRIPTION>A method in which the dielectric tissue properties are measured based on the emission and reflection of low-power electromagnetic signals in between two sensors attached to the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166068</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS</VALIDVALUE>
          <VALUEMEANING>Multiplexed Digital Gene Expression Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of digital gene expression analysis to detect or quantify targeted RNA transcripts using bar code indexing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166067</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MOUSE PROTECTION ASSAY</VALIDVALUE>
          <VALUEMEANING>Mouse Protection Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay method that is used for the detection of neutralizing antibodies in serum by determining the ability of the serum to prevent the death of mice that are exposed to a lethal dose of toxin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166066</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELECTRICAL IMPEDANCE MYOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Electrical Impedance Myography</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of applying and measuring high-frequency, low-intensity electrical currents at the surface of localized areas of muscle to assess neuromuscular disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166065</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DROPLET DIGITAL PCR</VALIDVALUE>
          <VALUEMEANING>Droplet Digital PCR</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of digital polymerase chain reaction technique in which the sample is fractionated into thousands of tiny droplets using a water-oil emulsion droplet technology, within which individual PCR reactions occur in each droplet.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIGITAL PCR</VALIDVALUE>
          <VALUEMEANING>Digital Polymerase Chain Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of polymerase chain reaction technique in which the sample is fractionated, within which individual PCR reactions occur in each fraction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CYSTOMETRY</VALIDVALUE>
          <VALUEMEANING>Cystometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of bladder function testing in which pressure and volume measurements are taken during the filling and voiding phases of micturition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166062</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CHROMOGENIC ASSAY</VALIDVALUE>
          <VALUEMEANING>Chromogenic Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay in which the reaction product produces a visible color change.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166061</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT</VALIDVALUE>
          <VALUEMEANING>Automated Capillary Electrophoresis Western Blot</VALUEMEANING>
          <MEANINGDESCRIPTION>An automated Western Blot system that uses capillary electrophoresis to characterize and separate proteins of interest by size or charge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LYMPHANGIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Lymphangiography</VALUEMEANING>
          <MEANINGDESCRIPTION>The examination of the lymph nodes and lymphatic vessels following the injection of a radiopaque substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7240396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRYPAN BLUE STAIN</VALIDVALUE>
          <VALUEMEANING>Trypan Blue Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes trypan blue, an acid azo dye that can traverse the cell membrane of dead cells and is used to differentiate between living and dead cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163743</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7166387</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ORCHIDOMETERY</VALIDVALUE>
          <VALUEMEANING>Orchidometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method used to measure testicular volume by comparing the size of one&#39;s testicles to the beads in a orchidometer, which consists of a string of 12 numbered beads of increasing sizes of 1 to 6, 8, 10, 12, 15, 20, and 25mL.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7166389</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMMUNO-PET SCAN</VALIDVALUE>
          <VALUEMEANING>Immuno-Positron Emission Tomography Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of positron emission tomography in which labeled monoclonal antibodies are tracked and quantitated after administration to the subject.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7166391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DOUBLE IMMUNODIFFUSION</VALIDVALUE>
          <VALUEMEANING>Double Immunodiffusion</VALUEMEANING>
          <MEANINGDESCRIPTION>A qualitative technique used to identify specific antibodies bound to an antigen by the appearance of a precipitation band (precipitin band) formed between wells in an agar gel plate as a result of the interaction of the antigen and antibodies at optimal concentration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7166393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BRDU CELLULAR PROLIFERATION ASSAY</VALIDVALUE>
          <VALUEMEANING>BrdU Cellular Proliferation Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of cellular proliferation assay in which bromodeoxyuridine (BrdU) is used as a substitute for thymidine in the DNA of replicating cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7166395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CELLULAR PROLIFERATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Cell Proliferation Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>Any method to measure the number of dividing cells in a culture, or to measure the change in the proportion of cells that are dividing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7166397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CELL CYTOTOXICITY NEUTRALIZATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Cell Cytotoxicity Neutralization Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay that is used to detect the presence of a toxin in a biological sample by inoculating two sets of tissue cell cultures, one prepared with anti-toxin and one prepared without anti-toxin, with filtrates of the sample and assessing for a cytopathic effect after an incubation period.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172559</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351665</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTRAST ENHANCED SPIRAL CT SCAN</VALIDVALUE>
          <VALUEMEANING>Contrast Enhanced Spiral CT Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of spiral CT scan in which images are enhanced by the addition of contrast agents into the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351663</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AGAR PROPORTION</VALIDVALUE>
          <VALUEMEANING>Agar Proportion</VALUEMEANING>
          <MEANINGDESCRIPTION>A method that is used to determine microbial susceptibility to antibiotics by evaluating the extent of growth of several dilutions of a standardized inoculum of microorganism in drug-free and drug-containing agar mediums. The number of colony-forming units grown are compared and expressed as a percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Chemiluminescent Microparticle Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of chemiluminescent immunoassay that uses paramagnetic microparticles bound to antigen or primary antibodies as a substrate for analyte binding prior to labeling with a luminescent compound.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351669</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BIOIMPEDANCE SPECTROSCOPY</VALIDVALUE>
          <VALUEMEANING>Bioimpedance Spectroscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique of measuring resistance to electrical current to assess tissue composition and fluid levels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172556</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TOTAL BODY IRRADIATION</VALIDVALUE>
          <VALUEMEANING>Total-Body Irradiation</VALUEMEANING>
          <MEANINGDESCRIPTION>Radiation therapy to the entire body. Usually followed by bone marrow or peripheral stem cell transplantation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228419</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TONOMETRY</VALIDVALUE>
          <VALUEMEANING>Tonometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method in which pressure is applied to the surface of the cornea in order to flatten a prespecified area of the membrane, which is used to calculate intraocular pressure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TOLUIDINE BLUE STAIN</VALIDVALUE>
          <VALUEMEANING>Toluidine Blue Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes toluidine blue, a solution composed of tolonium chloride, to determine the presence of mast cells, lignin, proteoglycans and glycosaminoglycans.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92302</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>THICK SMEAR</VALIDVALUE>
          <VALUEMEANING>Thick Smear Technique</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood smear technique used to make a thick blood smear on a microscope slide which is generally used to look for blood parasites such as those causing malaria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85819</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SELF-REPORT</VALIDVALUE>
          <VALUEMEANING>Self-Report</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual&#39;s perspective or subjective interpretation of an event or information.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIPSTICK MEASUREMENT METHOD</VALIDVALUE>
          <VALUEMEANING>Dipstick Measurement Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement methodology in which a dipstick device is used to detect the presence of an analyte in a liquid by producing a color change.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INTERNATIONAL READING SPEED TEXT TEST</VALIDVALUE>
          <VALUEMEANING>International Reading Speed Text Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A standardized set of ten equivalent paragraphs of text, based on everyday life reading demands with equivalent levels of difficulty, that is used to provide repeat assessments of reading performance for a wide range of subjects. It is available in multiple languages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178032</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RAPID IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Rapid Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunoassay where results can be generated immediately or within minutes from antibody/antigen interactions with an analyte of interest in a biological specimen with little or no sample processing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178031</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LIGAND BINDING ASSAY</VALIDVALUE>
          <VALUEMEANING>Ligand Binding Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunoassay that utilizes the interactions between two molecules, or the binding of molecules to antibodies, to detect and quantify analytes of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SELF ASSESSMENT</VALIDVALUE>
          <VALUEMEANING>Self Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>The evaluation of oneself or one&#39;s actions or performance without external input.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178029</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COMPETITIVE ELISA</VALIDVALUE>
          <VALUEMEANING>Competitive Enzyme-linked Immunosorbent Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of ELISA assay that uses a reference antigen to competitively bind labeled antibody against an antigen of interest. The strength of the signal interference caused by antibody bound to the reference antigen is used to determine the concentration of the antigen of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178028</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INDIRECT BINDING ELECTROCHEMILUMINESCENCE IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Indirect Binding Electrochemiluminescence Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of electrochemiluminescence assay that utilizes primary and secondary antibodies in a two-step binding process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INTRACELLULAR CYTOKINE STAIN FLOW CYTOMETRIC ASSAY</VALIDVALUE>
          <VALUEMEANING>Intracellular Cytokine Stain Flow Cytometric Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique that is used with flow cytometry to measure cytokine production in isolated cells. Cells are stimulated with an antigen or mitogen, and cytokine secretion is blocked using protein transport inhibitors. The cells are then stained with fluorochrome labeled monoclonal antibodies that target surface markers, fixed and permeabilized, and stained with fluorochrome labeled anti-cytokine monoclonal antibodies prior to analysis by flow cytometry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178026</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VAN DE KAMER TITRATION METHOD</VALIDVALUE>
          <VALUEMEANING>Van de Kamer Titration Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemical titration method described by van de Kamer, et al. in 1949 in which fecal fat is quantitatively measured by conversion of fecal lipids into fatty acids through saponification with ethanolic potassium hydroxide, release of the free fatty acids by the addition of hydrochloric acid and extraction into ether, and titration of the fatty acids against sodium hydroxide.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RESTING FUNCTIONAL MRI</VALIDVALUE>
          <VALUEMEANING>Resting Functional Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of functional magnetic resonance imaging that is performed on an organ or brain tissue in the absence of a stimulus or task.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178024</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TASK FUNCTIONAL MRI</VALIDVALUE>
          <VALUEMEANING>Task Functional Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of functional MRI that images dynamic changes in brain tissue while the subject performs a task or experiences a sensory stimulus designed to target specific cognitive processes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178023</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COMPUTED TOMOGRAPHY PERFUSION</VALIDVALUE>
          <VALUEMEANING>Computed Tomography Perfusion Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>An application of CT imaging used to assess the quality of blood flow to an organ or tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NUCLEIC ACID HYBRIDIZATION</VALIDVALUE>
          <VALUEMEANING>Nucleic Acid Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>Technique in which single stranded nucleic acids are allowed to interact so that complexes, or hybrids, are formed by molecules with sufficiently similar, complementary sequences. By this means the degree of sequence identity can be assessed and specific sequences detected. (From Biology-online)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16924</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2673666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NUCLEIC ACID AMPLIFICATION TEST</VALIDVALUE>
          <VALUEMEANING>Nucleic Acid Amplification Test</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20055</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NUCLEAR RADIOLOGY</VALIDVALUE>
          <VALUEMEANING>Nuclear Radiology Imaging Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Any type of imaging method that uses radioactive materials.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY</VALIDVALUE>
          <VALUEMEANING>Magnetic Resonance Spectroscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Detection and measurement of the resonant spectra of molecular species in a tissue or sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16810</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SPIRAL CT</VALIDVALUE>
          <VALUEMEANING>Spiral CT</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of computed tomography (CT) that uses continuous rotation of the X-ray tube and continuous transport of the patient through the scanning aperture that allows the rapid acquisition of a volume of CT data.  Advantages over conventional CT include: rapid acquisition of a large volume of data within a single breath-hold, thus minimizing respiration artifact and misregistration between slices; the ability to reconstruct images retrospectively at any level within the scanned volume; optimization of intravenous contrast enhancement due to the short scan times; improved multi-planar and 3-D reconstruction; and the potential for radiation dose reduction.  Same as helical computed tomography. (British Journal of Radiology 1994 May;67(797):436-44)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970362</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CENTRIFUGATION</VALIDVALUE>
          <VALUEMEANING>Centrifugation</VALUEMEANING>
          <MEANINGDESCRIPTION>Process of using a rotating machine to generate centrifugal force to separate substances of different densities, remove moisture, or simulate gravitational effects. It employs a large motor-driven apparatus with a long arm, at the end of which human and animal subjects, biological specimens, or equipment can be revolved and rotated at various speeds to study gravitational effects. (From Websters, 10th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2915651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CELL BASED BIOASSAY</VALIDVALUE>
          <VALUEMEANING>Cell Based Bioassay</VALUEMEANING>
          <MEANINGDESCRIPTION>An in vitro assay that utilizes live cells to test the biological activity or potency of a drug substance or product.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CARDIAC THERMODILUTION</VALIDVALUE>
          <VALUEMEANING>Cardiac Output Thermodilution Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for calculating cardiac output using a Swan-Ganz catheter that is inserted into the pulmonary artery through a peripheral vein to measure the change in right ventricular outflow blood temperature after a cold saline solution is injected into the right atrium from a proximal catheter port.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAPILLARY ELECTROPHORESIS</VALIDVALUE>
          <VALUEMEANING>Capillary Electrophoresis</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrophoresis procedure, in which a sample is introduced into a capillary tube and the components are separated by the application of high voltage. Due to the large surface to volume ratio, cooling is more efficient, allowing use of higher voltages.  As a result, separation occurs more quickly and sensitivity is increased. The technique allows for separation of proteins, nucleic acids, and carbohydrates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2915741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CALCULATION</VALIDVALUE>
          <VALUEMEANING>Calculated</VALUEMEANING>
          <MEANINGDESCRIPTION>The procedure or activity of determining something by mathematical or logical methods.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54125</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5355833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CALCOFLUOR WHITE STAIN</VALIDVALUE>
          <VALUEMEANING>Calcofluor White Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes calcofluor, a fluorescent dye that preferentially stains chitin and cellulose on the cell walls of fungi, parasites, and some cysts of the Pneumocystis genus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85577</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BIOPSY</VALIDVALUE>
          <VALUEMEANING>Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PLAQUE REDUCTION NEUTRALIZATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Plaque Reduction Neutralization Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A serological test that measures the ability of antibodies in specific concentrations of serum to prevent the formation of plaques in a cell monolayer when combined with a viral suspension.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COMPUTERIZED CORNEAL TOPOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Computerized Corneal Topography</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive, computer-assisted method of measuring the shape of the cornea of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLOCCULATION, CHARCOAL ENHANCED</VALIDVALUE>
          <VALUEMEANING>Charcoal Enhanced Flocculation</VALUEMEANING>
          <MEANINGDESCRIPTION>A flocculation process in which microscopic charcoal particles are used to enhance the visibility of aggregated masses in suspension.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351655</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PSEUDOVIRION-BASED NEUTRALIZATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Pseudovirion-Based Neutralization Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunoassay that is used to determine whether antibodies that can block pseudovirus replication are present in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172552</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FARR ASSAY</VALIDVALUE>
          <VALUEMEANING>Farr Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of radioimmunoprecipitation assay that uses ammonium sulfate to precipitate immune complexes formed with radiolabeled antigen. This is most commonly used to detect levels of DNA antibody complexes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RADIOIMMUNOPRECIPITATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Radioimmunoprecipitation Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunoassay method that involves the binding of antibodies to radiolabeled antigen, precipitation of the antibody/antigen complex using a special reagent, and analysis of the precipitate, usually by gel electrophoresis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NO INFORMATION</VALIDVALUE>
          <VALUEMEANING>No Information Available</VALUEMEANING>
          <MEANINGDESCRIPTION>Information regarding the subject is unknown or inaccessible at this time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578438</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ERGOSPIROMETRY</VALIDVALUE>
          <VALUEMEANING>Ergospirometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An exercise testing method that continuously measures respiratory volume and frequency, oxygen intake, carbon-dioxide output, and heart rate during ergometer exercise to assess integrative cardiopulmonary, musculoskeletal, and metabolic response to physical stress.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ULTRASONOGRAPHIC ELASTOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Ultrasonographic Elastography</VALUEMEANING>
          <MEANINGDESCRIPTION>A noninvasive technique that is used to measure organ or tissue stiffness. An ultrasound wave is passed into the organ or tissue from a small transducer on the end of an ultrasound probe which measures the velocity of the shear wave (in meters per second) as this wave passes through the organ or tissue. The shear wave velocity can then be converted into organ or tissue stiffness. This technique may be used as an alternative to organ or tissue biopsy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTRAST ENHANCED PET SCAN</VALIDVALUE>
          <VALUEMEANING>Contrast Enhanced PET Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of positron emission tomography scan in which the images are not enhanced by the addition of contrast agents into the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SPIRAL CT SCAN WITHOUT CONTRAST</VALIDVALUE>
          <VALUEMEANING>Spiral CT Scan Without Contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of spiral CT scan in which the images are not enhanced by the addition of contrast agents into the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172561</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VIRUS PLAQUE ASSAY</VALIDVALUE>
          <VALUEMEANING>Virus Plaque Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay that is used to determine viral quantity by infecting monolayers of host cells with serially diluted virus, covering the monolayers with an immobilizing overlay after a period of incubation to restrict the spread of the virus to neighboring cells, and counting the resulting visible plaques of infected cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463351</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COULOMETRIC TITRATION</VALIDVALUE>
          <VALUEMEANING>Coulometric Titration</VALUEMEANING>
          <MEANINGDESCRIPTION>A titration method in which the titrating agent is generated electrochemically in solution, and the amount of electricity used is measured.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174335</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STATIC PERIMETRY</VALIDVALUE>
          <VALUEMEANING>Static Perimetry</VALUEMEANING>
          <MEANINGDESCRIPTION>An eye examination technique that utilizes test objects with gradually increasing luminance that are positioned at fixed locations across the visual field to determine the threshold of visibility.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7463355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION</VALIDVALUE>
          <VALUEMEANING>Single-strand Conformation Polymerase Chain Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified polymerase chain reaction (PCR) technique that uses differences in molecular weights and three-dimensional structures to identify mutations in DNA configurations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SINGLE-SLICE SPIRAL CT</VALIDVALUE>
          <VALUEMEANING>Single-slice Spiral Computed Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of spiral computed tomography that employs only one detector that produces one image (slice).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106567</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY</VALIDVALUE>
          <VALUEMEANING>Single Antigen Bead-based Multiplex Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of solid-phase multiplex assay that uses microbeads coated with recombinant or infinity purified antigens from a single allele for the detection and identification of an antibody that would bind and react to this antigen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Biopolymer Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A process to identify and determine the primary structure of, and the order of constituents in a biopolymer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION</VALIDVALUE>
          <VALUEMEANING>Sequence-specific Oligonucleotide Probe Polymerase Chain Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified polymerase chain reaction (PCR) technique that uses distinct probes, specifically synthesized according to the polymorphic region sequence of the gene of interest, to detect nucleotide differences during genotype testing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130181</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION</VALIDVALUE>
          <VALUEMEANING>Sequence-based Typing</VALUEMEANING>
          <MEANINGDESCRIPTION>A method that provides the entirety of the nucleotide sequence of a specific DNA strand, allowing for reliable and thorough genotyping of the allele in question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130180</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION</VALIDVALUE>
          <VALUEMEANING>Allele Specific Primer Polymerase Chain Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified polymerase chain reaction (PCR) technique in which a specific primer can amplify its corresponding allele only; this allows for the determination of the presence or absence of a single, specific allele during genotype testing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130179</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SCINTIGRAPHY</VALIDVALUE>
          <VALUEMEANING>Radionuclide Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging technique that uses a small dose of a radioactive chemical (isotope) called a tracer that can detect sites of cancer growth, trauma, infection or degenerative disorders. The tracer, which is either injected into a vein or swallowed, travels through the bloodstream to the target organ, and emits gamma rays, which are detected by a gamma camera and analyzed by a computer to form an image of the target organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2979516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SCANNING ELECTRON MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Scanning Electron Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Technique of electron microscopy in which the specimen is coated with heavy metal and then scanned by an electron beam. The resolution is not as great as with transmission electron microscopy, but preparation is easier (often by fixation followed by critical point drying), the depth of focus is relatively enormous, the surface of a specimen can be seen (though not the interior unless the specimen is cracked open) and the image is aesthetically pleasing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2915768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TURBIDIMETRY</VALIDVALUE>
          <VALUEMEANING>Turbidimetry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to quantify the opaqueness of a liquid using a turbidimeter, by measuring the decrease in light intensity due to the scattering effect of suspended particles in the liquid sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRIPLE-PHASE SPIRAL CT SCAN</VALIDVALUE>
          <VALUEMEANING>Triple-Phase Spiral CT</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of computed tomography (CT) in which images are taken during three distinct timing points (phases) following the injection of contrast material: arterial, venous, and delayed. This form of CT imaging is most commonly used to image hepatic lesions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19907</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRIPLE-PHASE MRI SCAN</VALIDVALUE>
          <VALUEMEANING>Triple Phase MRI</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of magnetic resonance imaging (MRI) in which images are taken during three distinct timing points (phases) following the injection of contrast material: arterial, venous, and delayed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130184</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WRIGHT-GIEMSA STAIN</VALIDVALUE>
          <VALUEMEANING>Wright-Giemsa Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>Geimsa is a polychromatic stain that permits the differentiation of cells present in hematopoietic tissues and for the demonstration of certain microorganisms. It is used for the detection of helicobacter pylori. The H. pylori and nuclei stain dark blue and cytoplasm stain pink with this stain (From BioGenex).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C23041</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4908692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WRIGHT STAIN</VALIDVALUE>
          <VALUEMEANING>Wright Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes the Romanowsky stains, eosin and methylene blue, solubilized in methanol. In this staining protocol, methanol is also utilized as a fixative agent prior to staining.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85829</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WESTERN BLOT</VALIDVALUE>
          <VALUEMEANING>Blotting, Western</VALUEMEANING>
          <MEANINGDESCRIPTION>Identification of proteins or peptides that have been separated by gel electrophoresis and transferred (blotted) to strips of nitrocellulose paper. The blots are then detected by enzymatically labelled or radiolabeled antibody probes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16357</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3173903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WEBER GREEN STAIN</VALIDVALUE>
          <VALUEMEANING>Weber Green Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes a modified trichrome stain to determine the presence of microspordial, sporulating species. The staining method utilizes chromotrope 2R, a red acidic dye, the counterstain fast green, and phosphotungstic acid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VENTILATION PERFUSION LUNG SCAN</VALIDVALUE>
          <VALUEMEANING>Ventilation Perfusion Scanning</VALUEMEANING>
          <MEANINGDESCRIPTION>A nuclear imaging test that uses radiopharmaceuticals to produce an image of the blood flow to the lungs, that measures the ability of the lungs to inhale gas, and that assesses the gas distribution within the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38100</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>URANYL ACETATE STAIN</VALIDVALUE>
          <VALUEMEANING>Uranyl Acetate Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes uranyl acetate, a water insoluble yellow crystalline solid, which is used as a negative stain in electron microscopy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92303</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ULTRASOUND</VALIDVALUE>
          <VALUEMEANING>Ultrasonography</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique in which high-frequency sound waves are bounced off internal organs and the echo pattern is converted into a 2 dimensional picture of the structures beneath the transducer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17230</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U-HPLC/MS/MS</VALIDVALUE>
          <VALUEMEANING>Ultra High-performance Liquid Chromatography/Tandem Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique wherein ultra-high performance liquid chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122176</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TWO-COLOR MICROARRAY</VALIDVALUE>
          <VALUEMEANING>Two Color Microarray</VALUEMEANING>
          <MEANINGDESCRIPTION>A genomic microarray-based method using cDNA from two samples, labeled with two separate fluorophores/dyes at different emission wavelengths, and hybridized to a single microarray for laser excitation in a microarray scanner. Relative fluorescence intensity of each dye can be measured and used in log- or intensity- ratio based comparative analysis for gene expression between the two experimental conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116153</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BETA LACTAMASE</VALIDVALUE>
          <VALUEMEANING>Beta Lactamase Screening Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A test that detects beta lactamase produced by Staphylococcus species, Haemophilus species, Moraxella catarrhalis, and Neisseria gonorrhoeae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>QUANTITATIVE ULTRASOUND</VALIDVALUE>
          <VALUEMEANING>Quantitative Ultrasound</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of empirically measuring the velocity and attenuation of ultrasonic sound waves as they pass through tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150873</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION</VALIDVALUE>
          <VALUEMEANING>Quantitative Reverse Transcriptase PCR</VALUEMEANING>
          <MEANINGDESCRIPTION>Quantitative PCR: a method to measure very small amounts of RNA transcripts as cDNA targets. There are two strategies currently used, one is called Competitive RTPCR and the other is called Real-Time PCR.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4118586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>QUANTITATIVE PERIPHERAL ANGIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Quantitative Peripheral Angiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of angiographic procedure that allows for direct quantitative assessment of the vessels of the hands, arms, feet and legs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>QUANTITATIVE CORONARY ANGIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Quantitative Coronary Angiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of angiographic procedure that allows for direct quantitative assessment of the native coronary arteries or bypass grafts supplying native coronary arteries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120701</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PYROSEQUENCING</VALIDVALUE>
          <VALUEMEANING>Pyrosequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A DNA sequencing method that uses a &quot;sequencing by synthesis&quot; strategy. The strand complementary to a template is synthesized a single base at a time through the sequential addition of individual solutions of each base. Incorporation of a base into the growing strand generates free pyrophosphate that is detected as light, as generated by a luciferase-catalyzed reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3364586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PUPILLOMETRY</VALIDVALUE>
          <VALUEMEANING>Monocular Pupillometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique used to measure the diameter of a single pupil in response to stimuli.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120700</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414023</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PULSE OXIMETRY</VALIDVALUE>
          <VALUEMEANING>Pulse Oximetry</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive method that provides estimates of arterial oxyhemoglobin saturation by utilizing selected wavelengths of light to determine the saturation of oxyhemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38085</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APPLANATION TONOMETRY</VALIDVALUE>
          <VALUEMEANING>Applanation Tonometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method in which a constant pressure is applied to the surface of the cornea in order to flatten a prespecified area of the membrane, which is used to calculate intraocular pressure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ANTIMICROBIAL COMBINATION TESTING</VALIDVALUE>
          <VALUEMEANING>Antimicrobial Combination Testing Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to determine the microbial susceptibility to two or more antibiotics. Numerical result translated into indifference, antagonism, synergism, or additive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ANTIBIOTIC AGAR SCREEN</VALIDVALUE>
          <VALUEMEANING>Antibiotic Agar Screening Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method used to detect organisms that have resistance to a single concentration of antibiotics in an agar matrix.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ANGIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Angiography</VALUEMEANING>
          <MEANINGDESCRIPTION>The X-ray examination of the blood vessels or chambers of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20080</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4567822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ANALYTICAL ULTRACENTRIFUGATION</VALIDVALUE>
          <VALUEMEANING>Analytical Ultracentrifugation</VALUEMEANING>
          <MEANINGDESCRIPTION>An ultracentrifugation based method that uses an optical detection system to monitor and record data during the centrifugation process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AMSLER GRID</VALIDVALUE>
          <VALUEMEANING>Amsler Grid</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagrammatic method to test visual acuity and presence of macular degeneration, which utilizes a uniform square grid of lines with a dot in the center.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ALCIAN BLUE STAIN</VALIDVALUE>
          <VALUEMEANING>Alcian Blue Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes alcian blue, a cationic, water soluble copper-containing phthalocyanine dye to determine the presence of acid mucopolysaccharides and glycosaminoglycans.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92299</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN</VALIDVALUE>
          <VALUEMEANING>Alcian Blue and Periodic Acid Schiff Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes periodic acid, an oxoacid of iodine, Schiff reagent, the reaction product of fuchsine and sodium bisulfite, and Alcian blue, a water soluble copper phthalocyanine dye. This staining method is used to differentially stain glycoproteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY</VALIDVALUE>
          <VALUEMEANING>AHG-enhanced Complement-dependent Lymphocytotoxicity Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of complement-dependent lymphocytotoxicity assay with the addition of anti-human globulin (AHG), which is a complement fixing antibody to human immunoglobulin. The AHG binds to both complement proteins and alloantibodies bound to donor lymphocytes, thereby increasing the antibody density and the likelihood of activating complement, resulting in increased sensitivity of the assy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130170</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AGAR DILUTION</VALIDVALUE>
          <VALUEMEANING>Agar Dilution Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to determine microbial susceptibility to antibiotics in which test bacteria is inoculated onto agar plates with serial dilutions of know quantities of antibiotics. The minimum inhibitory concentration of antibiotic is assessed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ACRIDINE ORANGE STAIN</VALIDVALUE>
          <VALUEMEANING>Acridine Orange Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes acridine orange, a fluorescent cationic dye that is selective for nucleic acids, to determine the presence of viable cells or microorganisms in a sample. Acridine orange interacts with RNA and DNA and the lysosomal compartment of cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ACID FAST STAIN</VALIDVALUE>
          <VALUEMEANING>Acid Fast Bacillae Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of acid-fast stain to examine a specimen for the presence of acid-fast microorganisms, specifically mycobacteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C23015</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BALLPOINT PEN TECHNIQUE</VALIDVALUE>
          <VALUEMEANING>Ballpoint Pen Technique</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique used to measure the skin induration diameter of intradermal tuberculin tests based on resistance to the movement of a ballpoint pen across the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BAC ACGH</VALIDVALUE>
          <VALUEMEANING>Bacterial Artificial Chromosome Array-based Comparative Genomic Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>A molecular cytogenetic method combining chromosomal comparative genomic hybridization technique and microarray to detect chromosomal aberrations and changes in DNA copy numbers, using bacterial artificial chromosome clones containing target DNA fragments for hybridization. This method is especially sensitive in detecting single copy changes in the genome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICROBIAL CULTURE, SOLID</VALIDVALUE>
          <VALUEMEANING>Microbial Solid Culture</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for growing microorganisms in solid culture media.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SANGER SEQUENCING</VALIDVALUE>
          <VALUEMEANING>Dideoxy Chain Termination DNA Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>DNA sequencing in which chain termination is caused by incorporation of a dideoxynucleotide into a growing DNA strand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3339130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RYAN BLUE STAIN</VALIDVALUE>
          <VALUEMEANING>Ryan Blue Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes a modified trichrome stain to determine the presence of microsporidial species. This staining technique substitutes aniline blue for the fast green counterstain of the original trichrome staining method and decreased levels of phosphotungstic acid in the reagent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413998</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RIA</VALIDVALUE>
          <VALUEMEANING>Radioimmunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>Radioimmunoassay (RIA) is an immunological technique, which quantitatively determines antigen and antibody concentrations, using a radioactively labeled substance (radioligand), either directly or indirectly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17057</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>REVERSE TRANSCRIPTASE PCR</VALIDVALUE>
          <VALUEMEANING>RT-PCR</VALUEMEANING>
          <MEANINGDESCRIPTION>RT-PCR is short for reverse transcriptase-polymerase chain reaction. It is a technique in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase. (from Wikipedia)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18136</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3121570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS</VALIDVALUE>
          <VALUEMEANING>Representational Oligonucleotide Microarray Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>A genomic microarray-based method able to identify regions in the cancer genome that have undergone copy number fluctuation. This method is reported to be highly sensitive and quantitative, able to detect loss of a single allele. See: Genome Res. 2003 Oct;13(10):2291-305. Epub 2003 Sep 15.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414002</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>REFRACTOMETRY</VALIDVALUE>
          <VALUEMEANING>Refractometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to measure the refractive index (propensity for light to bend) of a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AUSCULTATION</VALIDVALUE>
          <VALUEMEANING>Auscultation</VALUEMEANING>
          <MEANINGDESCRIPTION>Listening with a device, such as a stethoscope, to anatomical locations that produce audible sounds like the heart, lungs and abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AURAMINE STAIN</VALIDVALUE>
          <VALUEMEANING>Auramine Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy acid fast staining method that utilizes auramine O, a bright yellow ketonimine dye, which binds to the mycolic acid in the cell walls of acid fast microorganisms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AUDIOMETRY</VALIDVALUE>
          <VALUEMEANING>Audiometric Test</VALUEMEANING>
          <MEANINGDESCRIPTION>Testing conducted utilizing a manual or microprocessor audiometer to test for hearing loss.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38036</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5806321</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ATOMIC ABSORPTION SPECTROMETRY</VALIDVALUE>
          <VALUEMEANING>Atomic Absorption Spectroscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A spectrometric method that determines the type and concentration of metal elements in a sample, based upon the principle that each elemental metal absorbs a particular wavelength of ultraviolet light when exposed to heat.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ARTERIAL SPIN LABELING FUNCTIONAL MRI</VALIDVALUE>
          <VALUEMEANING>Arterial Spin Labeling Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>An application of functional MRI used to measure cerebral blood flow. ASL uses magnetically labeled water as the tracer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>REFLECTANCE SPECTROSCOPY</VALIDVALUE>
          <VALUEMEANING>Reflectance or Transmission Spectroscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>The spectroscopic analysis of light reflected from a polished sample.  The peaks of reflectance/transmittance occur in the same spectral region where the sample absorbs light.  In near infrared (IR) reflectance/transmission spectroscopy (NIRS), the reflectance signals result from bending and stretching vibrations in molecular bonds between carbon, nitrogen, hydrogen, and oxygen. (from FRTR Field Sampling and Analysis Technologies Reference Guide (online))</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19340</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>REBOUND TONOMETRY</VALIDVALUE>
          <VALUEMEANING>Rebound Tonometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method in which a probe is bounced off of the surface of the cornea, creating an induction current that is used to calculate intraocular pressure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120703</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PHYSICAL EXAMINATION</VALIDVALUE>
          <VALUEMEANING>Physical Examination</VALUEMEANING>
          <MEANINGDESCRIPTION>A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual&#39;s health assessment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20989</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PHOTOMETRY</VALIDVALUE>
          <VALUEMEANING>Photometry</VALUEMEANING>
          <MEANINGDESCRIPTION>Measurement of the properties of light, especially luminous intensity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65109</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PHOTOMETRIC CLOT DETECTION</VALIDVALUE>
          <VALUEMEANING>Photometric Clot Detection</VALUEMEANING>
          <MEANINGDESCRIPTION>A clot detection method that uses a photometric means (measuring the absorbancy of monochromatic light) to detect the presence and/or quantify the formation of a thrombus in a specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PHOTOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Photography</VALUEMEANING>
          <MEANINGDESCRIPTION>The process by which an image is acquired by recording light emissions on radiation-sensitive paper.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413947</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PHOROPTER</VALIDVALUE>
          <VALUEMEANING>Phoropter</VALUEMEANING>
          <MEANINGDESCRIPTION>An instrument composed of multiple lenses that refract the light going into the subject&#39;s eye, allowing the examiner to determine the refractive error of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120699</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413949</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY</VALIDVALUE>
          <VALUEMEANING>Phenotypic Multiple Antigen Bead-based Multiplex Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of solid-phase multiplex assay that uses microbeads coated with recombinant or infinity purified antigens from multiple alleles for the detection and identification of antibodies that would bind and react to these antigens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130178</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CLINICAL EVALUATION</VALIDVALUE>
          <VALUEMEANING>Clinical Evaluation</VALUEMEANING>
          <MEANINGDESCRIPTION>An assessment of an individual&#39;s physical, mental, or emotional condition; information can be gathered from multiple sources, including physical exam, personal interview and observation, medical history, laboratory and imaging tests.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6427461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PHASE-CONTRAST MRI</VALIDVALUE>
          <VALUEMEANING>Phase-Contrast Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of MRI in which a phase shift between flowing tissue and static tissue is generated in order to determine the quantity and velocity of blood flow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PHASE CONTRAST MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Phase-Contrast Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A simple non-quantitative form of interference microscopy of great utility in visualising live cells. Small differences in optical path length due to differences in refractive index and thickness of structures are visualised as differences in light intensity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16857</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET/SPECT SCAN</VALIDVALUE>
          <VALUEMEANING>Positron Emission Tomography and Single Photon Emission Computed Tomography Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging technique that utilizes positron emission tomography and single-photon emission computed tomography in a single machine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111297</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4136310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET/MRI SCAN</VALIDVALUE>
          <VALUEMEANING>Positron Emission Tomography and Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging technique that utilizes positron emission tomography and magnetic resonance imaging in a single machine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4136341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET/CT SCAN WITHOUT CONTRAST</VALIDVALUE>
          <VALUEMEANING>PET-CT Scan Without Contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of PET/CT imaging in which radiopharmaceuticals is not used.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142342</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413959</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET/CT SCAN</VALIDVALUE>
          <VALUEMEANING>Positron Emission Tomography and Computed Tomography Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5627465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X-RAY</VALIDVALUE>
          <VALUEMEANING>Radiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ZIEHL NEELSEN ACID FAST STAIN</VALIDVALUE>
          <VALUEMEANING>Ziehl Neelsen Acid Fast Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy acid fast staining method that utilizes Ziehl-Neelsen carbol fuchsin, acid alcohol and methylene blue, to determine the presence of acid fast microorganisms. This acid fast staining technique requires heating during the primary staining step involving the carbol fuchsin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85831</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X-RAY FLUORESCENCE SPECTROMETRY</VALIDVALUE>
          <VALUEMEANING>X-Ray Fluorescence Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A spectrometric method that determines the type and concentration of elements or chemicals in a sample, based upon the principle that each element emits fluorescent light of a particular wavelength when exposed to an X-ray.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85830</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET SCAN</VALIDVALUE>
          <VALUEMEANING>Positron Emission Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2919109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PERIPHERAL ANGIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Peripheral Angiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure in which the catheter is passed into a peripheral vessel (usually in the groin) for the purpose of angiography of the abdomen, hands, arms, feet and legs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117879</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PERIODIC ACID SCHIFF STAIN</VALIDVALUE>
          <VALUEMEANING>Periodic Acid Schiff Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>This is an all-round useful stain for many things, including glycogen, mucin, mucoprotein, glycoprotein, as well as fungi. The reaction is based on the oxidation of glycol group to aldehydes by periodate. The schiff&#39;s reagent selectively stains the aldehydes to a rose pink color. PAS is useful for outlining tissue structures--basement membranes, capsules, blood vessels, etc.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C23019</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PERCUSSION</VALIDVALUE>
          <VALUEMEANING>Percussion</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic test performed on a tooth by tapping on the crown with a dental instrument.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3119880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PELLI-ROBSON EYE CHART</VALIDVALUE>
          <VALUEMEANING>Pelli-Robson Contrast Sensitivity Eye Chart</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagrammatic method to test visual acuity and contrast sensitivity, which utilizes large letters (at a 20/60 acuity) that decrease in contrast from right to left and top to bottom.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117878</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PEAK FLOWMETRY</VALIDVALUE>
          <VALUEMEANING>Peak Flowmetry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for measuring the flow of air through the bronchi upon expiration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PATHOLOGICAL EVALUATION</VALIDVALUE>
          <VALUEMEANING>Pathologic Examination</VALUEMEANING>
          <MEANINGDESCRIPTION>An assessment of disease process to include cause, development, and/or structural and functional changes associated with the disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125006</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413969</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Particle-Enhanced Turbidimetric Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to quantify the opaqueness of a liquid using a turbidimeter, by measuring the decrease in light intensity due to the scattering effect of suspended immunoaggregates in a liquid sample. The immunoaggregates are target antigens agglutinated to antigen-specific antibody-coated polystyrene latex-enhanced particles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125953</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Particle-Enhanced Nephelometric Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to quantify the concentration of immunoaggregates suspended in a liquid or gas using a nephelometer. The immunoaggregates are target antigens agglutinated to antigen-specific antibody-coated polystyrene latex-enhanced particles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125952</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413973</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PAP STAIN</VALIDVALUE>
          <VALUEMEANING>Papanicolaou Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopy staining method that utilizes a mixture of dyes including hematoxylin, orange G (OG), and eosin azure, which contains variable portions of Eosin Y, light green SF yellowish, and Bismarck brown Y. This multichromatic staining method is used to differentially stain samples containing mixed cell populations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128984</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SECONDARY ION MASS SPECTROMETRY</VALIDVALUE>
          <VALUEMEANING>Secondary Ion Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique in which a mass spectrometer is used to detect sputtered ionized atoms (secondary ions) that are ejected from a solid surface after application of a beam of high energy primary ions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>THIN SMEAR</VALIDVALUE>
          <VALUEMEANING>Thin Smear Technique</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood smear technique used to make a thin blood smear on a microscope slide which is generally used to look for blood parasites such as those causing malaria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85820</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PERFUSION MRI</VALIDVALUE>
          <VALUEMEANING>Perfusion Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A special type of magnetic resonance imaging (MRI) that uses an injected dye in order to see blood flow through tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93243</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5094405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NUCLEIC ACID BASED METHOD</VALIDVALUE>
          <VALUEMEANING>Molecular Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2861224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PH METER MEASUREMENT METHOD</VALIDVALUE>
          <VALUEMEANING>pH Meter Measurement Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement methodology in which a pH meter device is used for measuring the alkalinity or acidity of a liquid or semi-solid substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7552076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CALIPER MEASUREMENT METHOD</VALIDVALUE>
          <VALUEMEANING>Vernier Caliper Measurement Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement methodology in which a caliper device is used for measuring the length of dimension, consisting of two hinged legs (that may be inturned or outturned) usually, but not always, attached to a ruled scale, dial, or digital display.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7552078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RULER MEASUREMENT METHOD</VALIDVALUE>
          <VALUEMEANING>Ruler Measurement Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement methodology in which a ruler device is used for measuring distance, consisting of an elongated piece of material marked with units of length.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7552080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INDIRECT IMMUNOFLUORESCENCE</VALIDVALUE>
          <VALUEMEANING>Indirect Immunofluorescence</VALUEMEANING>
          <MEANINGDESCRIPTION>A fluorescent antibody technique in which a secondary fluorophore-conjugated antibody is used to detect a primary, unconjugated antibody directed against a target antigen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176332</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7552082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAGNETIC RESONANCE ENTEROGRAPHY</VALIDVALUE>
          <VALUEMEANING>Magnetic Resonance Enterography</VALUEMEANING>
          <MEANINGDESCRIPTION>A magnetic resonance imaging technique that allows for the visualization of the entire small bowel by imaging the abdomen and pelvis during the enteric phase of digestion following oral administration of large volumes of enteric contrast material for bowel distention and intravenous contrast administration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176331</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7552084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AUTOREFRACTION</VALIDVALUE>
          <VALUEMEANING>Autorefraction</VALUEMEANING>
          <MEANINGDESCRIPTION>An eye examination method in which a computer-controlled electronic optometer is used to automatically measure refractive error.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176330</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7552086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY</VALIDVALUE>
          <VALUEMEANING>Sodium Lauryl Sulphate Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A hemoglobin estimation technique that utilizes sodium lauryl sulphate, a surfactant that lyses erythrocytes, converts the released hemoglobin into methemoglobin, and forms a sodium lauryl sulphate-methemoglobin complex with a characteristic light absorbance spectrum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7552088</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DC SHEATH FLOW</VALIDVALUE>
          <VALUEMEANING>Sheath Flow Direct Current Detection</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytometry technique that utilizes hydrodynamic focusing to create a sheath flow and that measures direct current impedance signals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7552090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RADIATION DOSIMETRY</VALIDVALUE>
          <VALUEMEANING>Radiation Dosimetry</VALUEMEANING>
          <MEANINGDESCRIPTION>The measurement of radiation by photography, as in x-ray film and film badge, by Geiger-Mueller tube, and by scintillation counting.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15312</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7552091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PALPATION</VALIDVALUE>
          <VALUEMEANING>Palpation</VALUEMEANING>
          <MEANINGDESCRIPTION>Examination by pressing on the surface of the body to feel the organs or tissues underneath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2832987</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PANENDOSCOPY</VALIDVALUE>
          <VALUEMEANING>Panendoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>An endoscopic examination of the pharynx, larynx, trachea and esophagus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3564169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INTRAVASCULAR ULTRASOUND</VALIDVALUE>
          <VALUEMEANING>Intravascular Ultrasound</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive procedure in which sound waves (called ultrasound) are bounced off of vascular tissues from within the vessel and the echoes produce a picture (sonogram).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6427010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIFFUSION TENSOR MRI</VALIDVALUE>
          <VALUEMEANING>Diffusion Tensor Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of diffusion-weighted magnetic resonance imaging (DW-MRI) that maps the diffusion of water in three dimensions, the principal purpose of which is to image the white matter of the brain, specifically measuring the anisotropy, location, and orientation of the neural tracts, which can demonstrate microstructural changes or differences with neuropathology and treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6427012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRICHROME STAIN</VALIDVALUE>
          <VALUEMEANING>Trichrome Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A histological staining method that uses acid dyes and washes to selectively dye the structural elements in tissue samples in three or more contrasting colors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C23012</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRANSTHORACIC ECHOCARDIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Transthoracic Echocardiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive cardiac ultrasound performed by placing the transducer on the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRANSMISSION ELECTRON MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Transmission Electron Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>An electron microscopy imaging technique that is utilized to examine structural components of a sample by passing electrons through the specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2915773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRANSESOPHAGEAL ECHOCARDIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Transesophageal Echocardiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A cardiac ultrasound performed by passing a specialized probe containing a transducer into the patient&#39;s esophagus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRANSCRIPTION-MEDIATED AMPLIFICATION</VALIDVALUE>
          <VALUEMEANING>Transcription-mediated Amplification</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique used to selectively replicate nucleic acid sequences from RNA templates using reverse transcriptase and RNA polymerase. Reverse transcriptase generates cDNA from the region of interest using primers and then RNA polymerase generates copies of the original RNA template.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122175</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414127</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TOTAL BODY RADIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Total Body Radiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic radiologic test that involves the examination of the entire body in a single procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6414129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRANSABDOMINAL ULTRASOUND</VALIDVALUE>
          <VALUEMEANING>Transabdominal Ultrasound</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of ultrasound imaging in which the ultrasound probe is pressed against the skin of the abdomen in order to create an image of the abdominal organs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7742932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ENDOSCOPIC ULTRASOUND</VALIDVALUE>
          <VALUEMEANING>Endoscopic Ultrasound</VALUEMEANING>
          <MEANINGDESCRIPTION>An ultrasound administered by using a tube containing flexible fibre optic wires that allows for the analysis of tissues inside the body.  Ultrasound technology utilizes high frequency waves and their echoes to produce an image. 2005</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C46078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6214227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ROTH 28 HUE TEST</VALIDVALUE>
          <VALUEMEANING>Roth-28 Hue Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A standardized method of color vision testing that is a shortened version of the Farnsworth-Munsell 100-Hue test (FM100), using every third of the FM100&#39;s 85 color caps that are arranged in rows of four color families. The subject must put the hues in order based on the anchor colors at the ends of each row.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C179765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7742934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PULSED-FIELD GEL ELECTROPHORESIS</VALIDVALUE>
          <VALUEMEANING>Pulsed-Field Gel Electrophoresis</VALUEMEANING>
          <MEANINGDESCRIPTION>Pulsed-field gel electrophoresis (PFGE) is a method used to separate proteins or high molecular weight linear DNA fragments that are greater than 50 kilobases (kb) in size. Fragments are separated by pulsing an electrical field across an agarose gel rather than applying the constant field used in conventional electrophoresis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17426</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7742936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Endoscopic Retrograde Cholangiopancreatography</VALUEMEANING>
          <MEANINGDESCRIPTION>Endoscopic retrograde cholangiopancreatography (en-do-SKAH-pik RET-ro-grade ko-LAN-jee-o-PAN-kree-a-TAW-gra-fee). A procedure to x-ray the pancreatic duct, hepatic duct, common bile duct, duodenal papilla, and gallbladder. In this procedure, a thin, lighted tube (endoscope) is passed through the mouth and down into the first part of the small intestine (duodenum). A smaller tube (catheter) is then inserted through the endoscope into the bile and pancreatic ducts. A dye is injected through the catheter into the ducts, and an x-ray is taken.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2926786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COMPETITIVE DNA HYBRIDIZATION</VALIDVALUE>
          <VALUEMEANING>Competitive DNA Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>A hybridization method in which complementary single-stranded DNA from different sources compete to form complexes with target DNA sequences.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ISOTHERMAL AMPLIFICATION</VALIDVALUE>
          <VALUEMEANING>Isothermal Amplification</VALUEMEANING>
          <MEANINGDESCRIPTION>Nucleic acid amplification at a constant temperature.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>METHYLATION-SENSITIVE QUANTITATIVE LOCKED NUCLEIC ACID PCR</VALIDVALUE>
          <VALUEMEANING>Methylation-Sensitive Quantitative Locked Nucleic Acid Polymerase Chain Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified polymerase chain reaction (PCR) technique in which bisulphite-converted methylated CpG target sequences are amplified in the presence of locked nucleic acid (LNA) modified primers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>QUANTITATIVE METHYLATION-SPECIFIC PCR</VALIDVALUE>
          <VALUEMEANING>Quantitative Methylation-Specific Polymerase Chain Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified polymerase chain reaction (PCR) technique in which bisulphite-converted methylated DNA target sequences are amplified in the presence of an excess of unmethylated counterpart sequences.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PINHOLE OCCLUSION</VALIDVALUE>
          <VALUEMEANING>Pinhole Occlusion Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A visual acuity method using a pinhole occluder device, an opaque disk-shaped eye shield with one or more holes, that is used to differentiate between reduced visual acuity caused by refractive error and ocular pathology.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002754</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICROFLOCCULATION</VALIDVALUE>
          <VALUEMEANING>Microflocculation Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of flocculation method in which particles in suspension aggregate in loosely clumped microscopic masses, which are then detected via microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184679</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MACROFLOCCULATION</VALIDVALUE>
          <VALUEMEANING>Macroflocculation Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of flocculation method in which particles in suspension aggregate in loosely clumped macroscopic masses, which are then detected with the naked eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184678</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002758</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICROFLUIDIC IMMUNOASSAY</VALIDVALUE>
          <VALUEMEANING>Microfluidic Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of a number of immunoassay-based techniques that use very small amounts (e.g., on a nanoliter scale) of biological fluids.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8159492</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HAND-HELD DYNAMOMETRY</VALIDVALUE>
          <VALUEMEANING>Hand-held Dynamometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique to assess isometric muscle strength using a hand-held dynamometer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8159494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAGNETOENCEPHALOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Magnetoencephalography</VALUEMEANING>
          <MEANINGDESCRIPTION>The measurement of the magnetic fields produced by electrical activity in the brain, usually conducted externally, using extremely sensitive devices. The measurement of electric fields in the brain provides information about the localization of brain activity which is complementary to that provided by electroencephalography.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16811</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8159496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VISUAL ANALOG SCALE</VALIDVALUE>
          <VALUEMEANING>Visual Analog Scale</VALUEMEANING>
          <MEANINGDESCRIPTION>A psychometric response scale to assess subjective characteristics or symptoms, which relies upon a continuum of possible result values in between two fixed end-points.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8159497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIGITAL RADIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Digital Radiography</VALUEMEANING>
          <MEANINGDESCRIPTION>Acquisition or display of radiographic images using digital techniques.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18001</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>REVERSE PHASE PROTEIN ARRAY</VALIDVALUE>
          <VALUEMEANING>Reverse Phase Protein Array</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody-based functional proteomic microarray that can characterize basal protein expression and levels of protein modifications in a series of samples of body fluids or those derived from tissue or cellular lysates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LATERAL FLOW ASSAY</VALIDVALUE>
          <VALUEMEANING>Lateral Flow Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for the detection of a target analyte from a sample placed onto a slot found on one end of a testing device or strip. Capillary action, driven by a buffering liquid either intrinsic to or added with the sample, draws the sample across zones within the device containing molecules that specifically interact with the analyte. This method is designed to visually confirm the presence or absence of the analyte, or indicate a quantitative or semi-quantitative measurement of analyte levels within minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189805</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INTRA-ARTERIAL DIFFERENTIAL PRESSURE TRANDUCTION</VALIDVALUE>
          <VALUEMEANING>Intra-Arterial Differential Pressure Transduction</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for blood pressure measurement in which the motion of flow within a cannulated peripheral artery is transmitted to a transducer that converts the information into electrical signals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202396</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INDIRECT IMMUNOFLUORESCENT MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Indirect Immunofluorescent Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Microscopy of specimens stained with a secondary fluorophore-conjugated binding agent to detect a primary, unconjugated antibody directed against a target antigen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>THROMBOELASTOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Thromboelastography</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of testing the efficiency of blood coagulation in which the amplitude of movement of a pin suspended in the center of an oscillating blood sample, or the vertical movement of the meniscus of a vibrating blood sample, is measured over time and analyzed to assess the dynamics and physical properties of blood clot formation in a low shear environment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FOCUS FORMING ASSAY</VALIDVALUE>
          <VALUEMEANING>Focus Forming Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay used to determine viral quantity, where host cells are infected with serially diluted virus and incubated. Conjugated antibodies that bind to the infected cells are then added, leading to the formation of precipitates that can be visualized.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AGGLUTINATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Immunoagglutination Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An in vitro assay that is used to detect the presence of antibodies or antigens of interest by evaluating whether particles (cells, beads, etc.) clump together in response to the introduction of a specific antibody or complement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CELL BASED NEUTRALIZING ANTIBODY ASSAY</VALIDVALUE>
          <VALUEMEANING>Cell Based Neutralizing Antibody Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunoassay in which an antigen of interest and neutralizing antibodies that are specific to the antigen are added to cells in culture that express proteins that are targets of the antigen. Antigen function is then measured to determine the neutralizing effects of the antibodies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SEMI-QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION</VALIDVALUE>
          <VALUEMEANING>Semi-Quantitative Reverse Transcriptase Polymerase Chain Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of reverse transcriptase-polymerase chain reaction combined with electrophoresis. After real-time PCR reaction, amplified gene products undergo electrophoretic separation and the level of expression of the target gene is determined by measuring the intensity of the gel bands corresponding to the target gene amplicon normalized to a housekeeping, internal control gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPLC/AMS</VALIDVALUE>
          <VALUEMEANING>High Performance Liquid Chromatography/Accelerator Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique wherein high performance liquid chromatography is coupled to accelerator mass spectrometry in order to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLUORESCENCE RESONANCE ENERGY TRANSFER</VALIDVALUE>
          <VALUEMEANING>Fluorescence Resonance Energy Transfer</VALUEMEANING>
          <MEANINGDESCRIPTION>A process to measure the proximity of two fluorochromes whereby the excitation energy of one fluorochrome is released and absorbed by the second fluorochrome. It is used to study interactions and structure of macromolecules. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DYE DILUTION METHOD</VALIDVALUE>
          <VALUEMEANING>Dye Dilution Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of measuring cardiac output by rapidly injecting a known quantity of dye through a central venous catheter and then monitoring arterial blood at fixed time intervals to determine the change in concentration of dye over time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VOLUME CONDUCTIVITY SCATTER METHOD</VALIDVALUE>
          <VALUEMEANING>Volume Conductivity Scatter Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of blood cell analysis that uses impedance, conductivity, and laser scatter to measure cell volume, cell size, chemical composition, nuclear volume, cellular granularity, nuclear structure, and cell surface characteristics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CT ANGIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Computed Tomography Angiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of computed tomography that is used to construct images of blood vessels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SCHIRMER METHOD</VALIDVALUE>
          <VALUEMEANING>Schirmer Test Wetting</VALUEMEANING>
          <MEANINGDESCRIPTION>A test used to determine the amount of tears collected on a filter paper strip in 5 minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14685894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WALLACE RULE OF NINES</VALIDVALUE>
          <VALUEMEANING>Wallace Rule of Nines</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for estimating body surface area of second and third degree burns, based on assigned percentages for different regions of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8159488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TOURNIQUET TEST</VALIDVALUE>
          <VALUEMEANING>Tourniquet Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of assessing capillary fragility that is used in the diagnosis of hemorrhagic fevers. After taking a blood pressure measurement, the cuff is inflated to a point midway between the assessed systolic and diastolic pressures and maintained for five minutes; the cuff is then released and, after two minutes, the number of petechiae below the antecubital fossa are counted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8159490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RESTRICTION FRAGMENT LENGTH POLYMORPHISM ANALYSIS</VALIDVALUE>
          <VALUEMEANING>Restriction Fragment Length Polymorphism Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>Use of restriction fragment polymorphism for detection of point mutations or other chromosomal changes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009251</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ACTIVITY TRACKING</VALIDVALUE>
          <VALUEMEANING>Activity Tracking</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to track an individual&#39;s physical activity using an activity monitor or other tracking device.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187892</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY ASSAY</VALIDVALUE>
          <VALUEMEANING>Antibody Dependent Cellular Cytotoxicity Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An in vitro assay that is used to determine the presence of antibodies that are capable of eliciting effector cell-mediated lysis of target cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187893</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009253</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIRECT ELISA</VALIDVALUE>
          <VALUEMEANING>Direct Enzyme-linked Immunosorbent Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of enzyme-linked immunosorbent assay that uses a one-step process, where a labeled antibody binds the antigen of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INDIRECT ELISA</VALIDVALUE>
          <VALUEMEANING>Indirect Enzyme-linked Immunosorbent Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of enzyme-linked immunosorbent assay that uses a two-step process, where a primary antibody binds the antigen of interest and then a labeled secondary antibody binds to the primary antibody.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187895</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LAG AVIDITY EIA</VALIDVALUE>
          <VALUEMEANING>Limiting Antigen-Avidity Enzyme Immunoassay</VALUEMEANING>
          <MEANINGDESCRIPTION>An enzyme immunoassay technique that limits the amount of antigen available for binding in order to measure antibody avidity, with or without the use of a dissociation buffer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187896</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LIPS</VALIDVALUE>
          <VALUEMEANING>Luciferase Immunoprecipitation System Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunoassay method that involves the binding of antibodies to luciferase-labeled antigen, precipitation of the antibody/antigen complex, and analysis of the precipitate through the light-producing interaction of luciferase and luciferin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187897</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MASS CYTOMETRY</VALIDVALUE>
          <VALUEMEANING>Mass Cytometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A flow cytometry technique that utilizes mass spectrometry to detect antibodies labeled with heavy metal ion tags that are bound to antigens of interest on single cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SANDWICH ELISA</VALIDVALUE>
          <VALUEMEANING>Sandwich Enzyme-linked Immunosorbent Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of enzyme-linked immunosorbent assay that uses separate capture and detection antibodies that are bound to non-overlapping epitopes on the same antigen of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009259</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TOXIN NEUTRALIZATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Toxin Neutralization Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An in vitro assay that is used to determine whether antibodies that can protect cells in culture from toxin activity are present in a biological specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11009260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CO-OXIMETRY</VALIDVALUE>
          <VALUEMEANING>CO-oximetry</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive method that provides a direct measurement of fractional oxygen saturation in arterial blood by utilizing spectrophotometry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICROFLUIDIC ELISA</VALIDVALUE>
          <VALUEMEANING>Microfluidic ELISA</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of enzyme-linked immunosorbent assay that utilizes microfluidic channels to simultaneously measure analytes of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189604</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ACTIGRAPHY</VALIDVALUE>
          <VALUEMEANING>Actigraphy</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for continuous recording of body movement that uses an actimetry sensor worn by an individual to measure rest/activity (sleep/wake) cycles. Monitoring can last several days to several weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C180883</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12539268</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TYMPANOMETRY</VALIDVALUE>
          <VALUEMEANING>Tympanometry</VALUEMEANING>
          <MEANINGDESCRIPTION>The study of the mobility of the tympanic membrane and conduction bones through air pressure changes. It is used to detect middle ear abnormalities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7994085</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Intravascular Optical Coherence Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>Optical coherence tomography used for imaging within blood vessels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C190550</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12057569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AUTOMATED MICROSCOPY</VALIDVALUE>
          <VALUEMEANING>Automated Microscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Any type of computer-assisted microscopy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CELL-BASED TRANSDUCTION INHIBITION ASSAY</VALIDVALUE>
          <VALUEMEANING>Cell-based Transduction Inhibition Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of cell-based assay that measures the ability of a biological specimen to inhibit transduction of the target cell line (for example, antibody-dependent inhibition of recombinant adeno-associated virus vector transfection).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONDITIONED PLAY AUDIOMETRY</VALIDVALUE>
          <VALUEMEANING>Conditioned Play Audiometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of conditioned audiometry to detect sound, where the child performs a motor activity in response to a specific auditory stimulus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONDITIONED-ORIENTATION REFLEX AUDIOMETRY</VALIDVALUE>
          <VALUEMEANING>Conditioned Orientation Reflex Audiometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of conditioned audiometry to detect and localize sound, where a delayed visual presentation is used to support a child&#39;s reflexive orientation response to an audio signal from one of multiple spatially separated sources.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPLC-EC</VALIDVALUE>
          <VALUEMEANING>High-Performance Liquid Chromatography with Electrochemical Detection</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique where high performance liquid chromatography with an electrochemical detector is used to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BIURET REACTION METHOD</VALIDVALUE>
          <VALUEMEANING>Biuret Reaction Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemical technique where an alkaline solution is treated with Biuret reagent containing copper (II) ions that form complexes with peptide bonds in the solution and create a color change that is proportional in intensity to the number of peptide bonds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198346</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LUCIFERASE PROTEIN COMPLEMENTATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Luciferase Protein Complementation Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A cell-based assay that utilizes a luciferase complementation reporter mechanism to detect regulated protein-protein interactions in situ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VISUAL REINFORCEMENT AUDIOMETRY</VALIDVALUE>
          <VALUEMEANING>Visual Reinforcement Audiometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of conditioned audiometry to detect sound, where a delayed visual presentation is used to support a child&#39;s reflexive orientation response to a audio signal from a single source.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MULTIPLEX IMMUNOHISTOCHEMISTRY</VALIDVALUE>
          <VALUEMEANING>Multiplexed Immunohistochemistry</VALUEMEANING>
          <MEANINGDESCRIPTION>A method that enables simultaneous detection of multiple biomarkers on a single tissue section using immunohistochemistry techniques.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181927</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7789191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MULTIPLEX IMMUNOFLUORESCENCE</VALIDVALUE>
          <VALUEMEANING>Multiplexed Immunofluorescence</VALUEMEANING>
          <MEANINGDESCRIPTION>A method that enables simultaneous detection of multiple biomarkers on a single tissue section using immunofluorescence techniques.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181928</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7789190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DOPPLER ECHOCARDIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Doppler Echocardiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure that uses sound waves to measure characteristics of disturbed bood flow, such as direction, velocity and turbulence. This enables the examiner to differentiate between normal and abnormal flow patterns and, in some cases, to quantitate those characteristics that are helpful in determining the severity of abnormal flow states.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4129639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HEMOLYTIC COMPLEMENT ACTIVITY ASSAY</VALIDVALUE>
          <VALUEMEANING>Complement CH50</VALUEMEANING>
          <MEANINGDESCRIPTION>A screening assay for circulating complement proteins in which diluted serum samples are added to antibody-coated erythrocytes and the percentage of cell lysis is measured. The values are expressed in hemolytic complement units per milliliter (CH50), the dilution of serum required to lyse 50 percent of the erythrocytes in the assay.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3310775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COLLOIDAL GOLD IMMUNOFILTRATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Colloidal Gold Immunofiltration Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of immunoassay in which a solution containing a target antigen is run through a membrane filter to which antibodies specific to the target antigen have been immobilized, and where antibodies labeled with colloidal gold nanoparticles are used for detection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X-RAY WITHOUT CONTRAST</VALIDVALUE>
          <VALUEMEANING>X-Ray Without Contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of X-ray in which the images are not enhanced by the addition of contrast agents into the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET SCAN WITHOUT CONTRAST</VALIDVALUE>
          <VALUEMEANING>PET SCAN Without Contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of PET scan in which the images are not enhanced by the addition of contrast agents into the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191330</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SWEEP VISUAL EVOKED POTENTIAL</VALIDVALUE>
          <VALUEMEANING>Sweep Visual Evoked Potential</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique that measures an evoked potential caused by a visual stimulus and recorded by an electroencephalogram, used for those individuals who are unable to provide a verbal response to questions, including infants, toddlers, and other non verbal individuals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191332</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WEBER TEST METHOD</VALIDVALUE>
          <VALUEMEANING>Weber Test Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique that assesses auditory function and/or type of hearing loss, in which a vibrating tuning fork (typically at 256Hz or 512Hz) is placed on top of the head or over the upper lip with the subject reporting whether sound is hear equally in both ears or whether the sound is louder in one ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191333</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RINNE TEST METHOD</VALIDVALUE>
          <VALUEMEANING>Rinne Test Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique that assesses auditory function by comparing sound conduction through air versus the mastoid bone, in which a vibrating tuning fork (at 512Hz) is placed on the mastoid bone and the subject indicates when they can no longer hear the vibration, at which point the still vibrating tuning fork is moved 1-2cm from the auditory canal and the subject again indicates when they can no longer hear the fork.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FOCUS REDUCTION NEUTRALIZATION ASSAY</VALIDVALUE>
          <VALUEMEANING>Focus Reduction Neutralization Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay that is used to determine whether neutralizing antibodies that are present in a biological specimen can block viral infection/proliferation ex vivo, by counting the number of viral foci. This assay typically uses live virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191335</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920217</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CARDIFF ACUITY CARDS</VALIDVALUE>
          <VALUEMEANING>Cardiff Acuity Cards</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagrammatic method to test visual acuity that uses a set of cards with familiar pictures placed in either the top or bottom half of the card, used for those individuals who are unable to provide a verbal response to questions, including infants, toddlers, and other non verbal individuals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191331</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BREATH TEST</VALIDVALUE>
          <VALUEMEANING>Breath Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique to assess the presence and/or amount of analyte(s) in breath exhaled into a device.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116515</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIRECT DIGITAL RADIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Direct Digital Radiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of digital radiography in which X-rays are directly registered by flat panel detector (FPDs), without the need for an intermediate cassette.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INDIRECT DIGITAL RADIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Indirect Digital Radiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of digital radiography in which X-rays are converted to visible light by a scintillator and then registered by a detector, without the need for an intermediate cassette.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OPSONOPHAGOCYTIC KILLING ASSAY</VALIDVALUE>
          <VALUEMEANING>Opsonophagocytic Killing Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay to assess the opsonophagocytic killing activity of antibodies that measures the functionality of phagocytic immune cells by incubating different dilutions of co-cultured bacteria, sera, and complement, and then quantifying the percent bacterial survival of a single serotype relative to serum-negative controls.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SINGLE-NUCLEOTIDE PRIMER EXTENSION ASSAY</VALIDVALUE>
          <VALUEMEANING>Single-Nucleotide Primer Extension</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay technique where a primer is hybridized adjacent to the interrogated variant site and is extended by deoxyribonucleic acid (DNA) polymerase to incorporate a complementary base that can be labeled for detection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209651</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SMOKING TOPOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Smoking Topography</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique to assess puffing behavior in smokers, using a smoking topography (ST) device.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209652</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RAPID ANTIGEN TEST</VALIDVALUE>
          <VALUEMEANING>Rapid Antigen Test</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunoassay that can quickly detect the presence of specific antigens in a sample and return results during a patient visit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U-HPLC/AMS</VALIDVALUE>
          <VALUEMEANING>Ultra High Performance Liquid Chromatography/Accelerator Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique where ultra-high performance liquid chromatography is coupled to accelerated mass spectrometry in order to separate, identify, and quantify substances in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209653</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ESOPHAGOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Barium Swallow</VALUEMEANING>
          <MEANINGDESCRIPTION>The process of obtaining contrast esophagrams.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38112</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573948</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COMPUTED RADIOGRAPHY</VALIDVALUE>
          <VALUEMEANING>Computed Radiography</VALUEMEANING>
          <MEANINGDESCRIPTION>X-ray imaging that replaces film with a phosphor imaging plate to create a digital image.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C190521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INTERFERON GAMMA RELEASE ASSAY</VALIDVALUE>
          <VALUEMEANING>Interferon Gamma Release Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood test that exposes a person&#39;s T-lymphocytes ex vivo to specific microbial antigen(s) to stimulate the production and release of interferon gamma, which provides an indication that the person has been exposed to a specific microbe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VISUAL INSPECTION</VALIDVALUE>
          <VALUEMEANING>Visual Inspection</VALUEMEANING>
          <MEANINGDESCRIPTION>Human evaluation of an attribute of a subject or material using visual discernment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214703</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ROTATIONAL THROMBOELASTOMETRY</VALIDVALUE>
          <VALUEMEANING>Rotational Thromboelastography</VALUEMEANING>
          <MEANINGDESCRIPTION>A method to evaluate clotting dynamics and physical properties in which the amplitude of movement of an oscillating pin within a static blood sample is measured over time and analyzed using an optical detection system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ISOTOPE-RELEASE CYTOTOXICITY ASSAY</VALIDVALUE>
          <VALUEMEANING>Isotope-release Cytotoxicity Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>An assay that is used to quantify cytotoxic effector cell activity (e.g., cytotoxic T cell (CTL) or natural killer (NK) cell) by measuring target cell lysis. The process involves bathing and labeling the target cells with a radioactive isotope (e.g. Chromium 51 or Indium-111) or fluorescent molecule. The target cells are then mixed with the effector cells (CTL or NK). The killing of the labeled target cells leads to the release of the radioactive isotope into the supernatant after cell lysis. Accumulation of the radioactive isotope is quantified and measured in the supernatant which indicates effector cell-mediated cytolysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16076318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the method (used for the [measurement/test/examination])?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC SDTM Method Terminology</Name>
        <DocumentType>VALID_VALUE_SOURCE</DocumentType>
        <DocumentText>Terminology associated with the method codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).</DocumentText>
        <URL>https://ncit.nci.nih.gov/ncitbrowser/ajax?action=create_src_vs_tree&amp;amp;vsd_uri=http%3A//evs.nci.nih.gov/valueset/CDISC/C85492</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form  Completion Instructions</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the method used to measure Findings About test.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FAMETHOD</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTM variable listed in the column with the heading &quot;SDTMIG Target&quot;.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Package Publication</Name>
        <DocumentType>CDISC EVS Controlled Terminology Update</DocumentType>
        <DocumentText>CDISC value sets have been updated to P41a publication version (2020-05-08).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of evaluation:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the method (used for the [measurement/test/examination])?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Findings About (FA) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329798</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Semantically Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685479</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Findings About (FA) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943384</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>FA_FAMETHOD</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="387">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6410983</PUBLICID>
    <LONGNAME>Wheal Mean Diameter Unit</LONGNAME>
    <PREFERREDNAME>WHLMDIM_SRORRESU</PREFERREDNAME>
    <PREFERREDDEFINITION>The unit of measure for the mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.</PREFERREDDEFINITION>
    <VERSION>5</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6409800</PublicId>
      <PreferredName>6407705v1.0:6409798v1.0</PreferredName>
      <PreferredDefinition>A findings domain for assessments that determine whether a therapy induced an immune response._The mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin._The unit of measure for the result of the skin response test or finding as originally received or collected.</PreferredDefinition>
      <LongName>Skin Response Domain Wheal Mean Diameter Skin Response Original Result Unit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407705</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C112420</PreferredName>
        <Version>1</Version>
        <LongName>Skin Response Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C112420</PREFERRED_NAME>
            <LONG_NAME>Skin Response Domain</LONG_NAME>
            <CON_ID>6407704</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6409798</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C112428:C117680</PreferredName>
        <Version>1</Version>
        <LongName>Wheal Mean Diameter Skin Response Original Result Unit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C112428</PREFERRED_NAME>
            <LONG_NAME>Wheal Mean Diameter</LONG_NAME>
            <CON_ID>6409797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117680</PREFERRED_NAME>
            <LONG_NAME>Skin Response Original Result Unit</LONG_NAME>
            <CON_ID>6409759</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6401717</PublicId>
      <PreferredName>UNIT</PreferredName>
      <PreferredDefinition>Terminology codelist used with Units of Measure within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</PreferredDefinition>
      <LongName>CDISC SDTM Unit of Measure Terminology Unit of Measure</LongName>
      <Version>1.5</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6401716</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71620:C25709</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Unit of Measure Terminology Unit of Measure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71620</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Unit of Measure Terminology</LONG_NAME>
            <CON_ID>6401715</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25709</PREFERRED_NAME>
            <LONG_NAME>Unit of Measure</LONG_NAME>
            <CON_ID>2203864</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/10 HPFs</VALIDVALUE>
          <VALUEMEANING>Per 10 High Powered Fields</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of the number of entities per unit of area equal to ten high powered fields.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158699</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ARMOUR UNIT</VALIDVALUE>
          <VALUEMEANING>Armour Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of proteolytic activity for trypsin and/or chymotrypsin that, upon incubation with the hemoglobin substrate, will release a quantity of phenolic substances that react with Folin-Ciocalteu phenol reagent to produce a colorimetric change of equal intensity to that produced from the reaction of one microgram of tyrosine with Folin-Ciocalteau phenol reagent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/L/h</VALIDVALUE>
          <VALUEMEANING>Millimole per Liter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of dose concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution per unit of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/L/s</VALIDVALUE>
          <VALUEMEANING>Nanomole per Liter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of dose concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute per one liter of solution per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/2 mm2</VALIDVALUE>
          <VALUEMEANING>Per Two Square Millimeters</VALUEMEANING>
          <MEANINGDESCRIPTION>The denominator of a derived area unit ratio expressed as two squared millimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Binding Ab Unit/mL</VALIDVALUE>
          <VALUEMEANING>Binding Antibody Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration expressed as binding antibody units per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189647</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mkat/L</VALIDVALUE>
          <VALUEMEANING>Millikatal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity measurement equal to one thousandth of one katal (1E-3 katal) per liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/L/day</VALIDVALUE>
          <VALUEMEANING>Millimole per Liter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement expressed in millimoles of solute per liter of solution per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm2/us</VALIDVALUE>
          <VALUEMEANING>Square Millimeter per Microsecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived metric unit of kinematic viscosity expressed as millimeters squared per microsecond.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FFU/mL</VALIDVALUE>
          <VALUEMEANING>Focus Forming Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived concentration unit expressed as focus forming units per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ukat/g Hb</VALIDVALUE>
          <VALUEMEANING>Microkatal per Gram Hemoglobin</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of catalytic activity concentration expressed as microkatals per gram of hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189651</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/h</VALIDVALUE>
          <VALUEMEANING>Unit per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/h</VALIDVALUE>
          <VALUEMEANING>Millimole per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>Millimoles per hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6640558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAE Unit</VALIDVALUE>
          <VALUEMEANING>Complement Activity Enzyme Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measurement of enzymatic activity of plasma and membrane-bound proteins that comprise a complement system and their split products in functional assays indicative of the activity of the classical and alternative pathways designed to ward off invading pathogens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/CAPSULE</VALIDVALUE>
          <VALUEMEANING>Milligram per Capsule</VALUEMEANING>
          <MEANINGDESCRIPTION>A capsule dosing unit expressed in milligram(s) per capsule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73739</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12539278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 IU/mL</VALIDVALUE>
          <VALUEMEANING>Million International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to one million international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 DNA copies/mL</VALIDVALUE>
          <VALUEMEANING>Million DNA Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one million deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/cm H2O</VALIDVALUE>
          <VALUEMEANING>Milliliter per Centimeter of Water</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure expressed in milliliter(s) per centimeter of water.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5/hpf</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand per High Powered Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one hundred thousand entities per unit of area equal to one high powered field.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98743</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DNA copies/mL</VALIDVALUE>
          <VALUEMEANING>DNA Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of the concentration of deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406754</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MESF</VALIDVALUE>
          <VALUEMEANING>Molecule of Equivalent Soluble Fluorochrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of the fluorescence intensity of a fluorochrome-labeled sample, which is equivalent to the fluorescence intensity of a solution containing an equivalent number of molecules of free fluorochrome in solution, under identical experimental conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FEU</VALIDVALUE>
          <VALUEMEANING>Fibrinogen Equivalent Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of fibrinogen contained within that sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6384481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/LPF</VALIDVALUE>
          <VALUEMEANING>Per Low Powered Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the instances of an entity per visual field of a microscope set to its minimum magnification power.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96620</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/HPF</VALIDVALUE>
          <VALUEMEANING>Per High Powered Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the instances of an entity per visual field of a microscope set to its maximum magnification power.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EU</VALIDVALUE>
          <VALUEMEANING>Ehrlich Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to one milligram of urobilinogen per deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hounsfield Unit</VALIDVALUE>
          <VALUEMEANING>Hounsfield Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>Term given to the dimensions of the quantifier of x-ray attenuation, CT number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406765</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AMPULE</VALIDVALUE>
          <VALUEMEANING>Ampule Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in an ampule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci</VALIDVALUE>
          <VALUEMEANING>Curie</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity in the CGS system, defined as 3.7 E10 atomic disintegrations or other nuclear transformations per second. One curie is equal to 37 gigabecquerels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569376</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ft2</VALIDVALUE>
          <VALUEMEANING>Square Foot</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of area equal to 144 square inches, 929.0304 square centimeters, or 9.290304E-2 square meters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm2</VALIDVALUE>
          <VALUEMEANING>Square Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A CGS unit of area measurement equal to a square measuring one centimeter on each side. One square centimeter is equal to 10E-4 square meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48460</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PIXEL</VALIDVALUE>
          <VALUEMEANING>Pixel</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest resolvable rectangular area of an image, either on a screen or stored in memory. (Free On-Line Dictionary of Computing)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>min</VALIDVALUE>
          <VALUEMEANING>Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DRUM</VALIDVALUE>
          <VALUEMEANING>Drum Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a drum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>gtt</VALIDVALUE>
          <VALUEMEANING>Metric Drop</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume used in pharmacy and equal to 0.05 milliliter (20 drops/ml).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DISK</VALIDVALUE>
          <VALUEMEANING>Disk Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a disk.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CYLINDER</VALIDVALUE>
          <VALUEMEANING>Cylinder Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a cylinder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTAINER</VALIDVALUE>
          <VALUEMEANING>Container Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) in a container.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COAT</VALIDVALUE>
          <VALUEMEANING>Coat Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the coat unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406388</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CARTRIDGE</VALIDVALUE>
          <VALUEMEANING>Cartridge</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a cartridge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAPSULE</VALIDVALUE>
          <VALUEMEANING>Capsule Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a capsule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAN</VALIDVALUE>
          <VALUEMEANING>Can Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a can.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48479</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406389</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BOX</VALIDVALUE>
          <VALUEMEANING>Box Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a box.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BOTTLE</VALIDVALUE>
          <VALUEMEANING>Bottle Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit that contains medicinal substance(s) in the form of a receptacle with a narrow neck designed to accept a specific closure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BOLUS</VALIDVALUE>
          <VALUEMEANING>Bolus Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a bolus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BAR</VALIDVALUE>
          <VALUEMEANING>Bar Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a bar.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 TCID 50/mL</VALIDVALUE>
          <VALUEMEANING>Log10 50 Percent Tissue Culture Infective Dose per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one milliliter of infectious material contains one 50 percent tissue culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BP</VALIDVALUE>
          <VALUEMEANING>Base Pair Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of measure for the number of paired nucleotides in a DNA or RNA sequence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/500 WBC</VALIDVALUE>
          <VALUEMEANING>Per 500 White Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 500 white blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/40 HPFs</VALIDVALUE>
          <VALUEMEANING>Per 40 High Powered Fields</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of the number of entities per unit of area equal to 40 high powered fields.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/2500 WBC</VALIDVALUE>
          <VALUEMEANING>Per 2500 White Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 2500 white blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/2000 RBC</VALIDVALUE>
          <VALUEMEANING>Per 2000 Red Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell (excluding red blood cell subtypes) per 2000 red blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/200 HPFs</VALIDVALUE>
          <VALUEMEANING>Per 200 High Powered Fields</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of the number of entities per unit of area equal to 200 high powered fields.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m</VALIDVALUE>
          <VALUEMEANING>Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of linear measure in the metric system, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). Meter is defined as the length of the path traveled by light in a vacuum during a time interval of 1/299 792 458 of a second and is equal to 1.093 61 yards.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41139</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>YEARS</VALIDVALUE>
          <VALUEMEANING>Year</VALUEMEANING>
          <MEANINGDESCRIPTION>The period of time that it takes for Earth to make a complete revolution around the sun; a period of time containing 365 days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29848</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2670939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MONTHS</VALIDVALUE>
          <VALUEMEANING>Month</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WEEKS</VALIDVALUE>
          <VALUEMEANING>Week</VALUEMEANING>
          <MEANINGDESCRIPTION>Any period of seven consecutive days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kg</VALIDVALUE>
          <VALUEMEANING>Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A basic SI unit of mass. It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28252</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm</VALIDVALUE>
          <VALUEMEANING>Millimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3915857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%</VALIDVALUE>
          <VALUEMEANING>Percentage</VALUEMEANING>
          <MEANINGDESCRIPTION>Percentage; a fraction or ratio with 100 understood as the denominator.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25613</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APPLICATION</VALIDVALUE>
          <VALUEMEANING>Application</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the application unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DAYS</VALIDVALUE>
          <VALUEMEANING>Day</VALUEMEANING>
          <MEANINGDESCRIPTION>The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3481386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm/h</VALIDVALUE>
          <VALUEMEANING>Millimeter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travelled per unit time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol</VALIDVALUE>
          <VALUEMEANING>Millimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to 0.001 mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/day</VALIDVALUE>
          <VALUEMEANING>Millimole per 24 Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance flow rate equivalent to the rate at which one thousandth of a mole of substance crosses a given surface or is delivered to a given object or space over a period of time equal to 24 hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2721403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/L</VALIDVALUE>
          <VALUEMEANING>Millimole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of concentration (molarity unit) equal to one one-thousandth of a mole of solute in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2685301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/min/kPa/L</VALIDVALUE>
          <VALUEMEANING>Millimole per Minute per Thousand Pascal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI-coherent unit for measuring a pulmonary diffusing capacity adjusted for lung volume and expressed in units of a substance flow rate (in millimoles per minute) per unit of pressure (in kilopascals) per unit of alveolar volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2721401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg</VALIDVALUE>
          <VALUEMEANING>Millimeter of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth&#39;s surface. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mOsm/kg</VALIDVALUE>
          <VALUEMEANING>Milliosmole per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of osmotic strength of solution as a measure of concentration of osmotically active particles expressed in a number of milliosmoles of solute per kilogram of solvent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2721399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/dL</VALIDVALUE>
          <VALUEMEANING>Nanogram per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one nanogram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one nanogram occupies the volume of one deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2721393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nm</VALIDVALUE>
          <VALUEMEANING>Nanometer</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of length equal to to one billionth of a meter (10E-9 meter). Nanometer is used as a unit for light wavelength measurement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3648817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRANSDUCING UNIT/mL</VALIDVALUE>
          <VALUEMEANING>Transducing Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of measure of potency expressed as a number of transducing units per one milliliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/dose</VALIDVALUE>
          <VALUEMEANING>Microgram per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in microgram(s) per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124462</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uIU/dL</VALIDVALUE>
          <VALUEMEANING>Micro-International Unit per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (biologic activity) equal to one micro-international unit of substance per deciliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124463</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uIU/L</VALIDVALUE>
          <VALUEMEANING>Micro-International Unit per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (biologic activity) equal to one micro-international unit of substance per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/breath</VALIDVALUE>
          <VALUEMEANING>Milliliter per Breath</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per inspiration or expiration of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73749</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/animal/wk</VALIDVALUE>
          <VALUEMEANING>Milliliter per Animal per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per animal per period of time equal to seven days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/animal/day</VALIDVALUE>
          <VALUEMEANING>Milliliter per Animal per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per animal per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/animal</VALIDVALUE>
          <VALUEMEANING>Milliliter per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per animal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73746</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/m2/min</VALIDVALUE>
          <VALUEMEANING>Milligram per Square Meter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/m2/h</VALIDVALUE>
          <VALUEMEANING>Milligram per Square Meter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73743</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/min</VALIDVALUE>
          <VALUEMEANING>Milligram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation expressed in milligram(s) period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/g/min</VALIDVALUE>
          <VALUEMEANING>Milligram per Gram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/g/h</VALIDVALUE>
          <VALUEMEANING>Milligram per Gram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/animal</VALIDVALUE>
          <VALUEMEANING>Milligram per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per animal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73738</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/mL</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed in milliequivalent(s) of solute per milliliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/mg/min</VALIDVALUE>
          <VALUEMEANING>Micromole per Milligram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one millionth of a mole (10E-6 mole) per milligram of a substance per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73735</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/m2/min</VALIDVALUE>
          <VALUEMEANING>Microgram per Square Meter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73733</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/kg/h</VALIDVALUE>
          <VALUEMEANING>Microgram per Kilogram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73730</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/kg/day</VALIDVALUE>
          <VALUEMEANING>Microgram per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3059690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/animal</VALIDVALUE>
          <VALUEMEANING>Microgram per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per animal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73728</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/m2/h</VALIDVALUE>
          <VALUEMEANING>Microgram per Square Meter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uEq</VALIDVALUE>
          <VALUEMEANING>Microequivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance equal to one millionth of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/m2/day</VALIDVALUE>
          <VALUEMEANING>Gram per Square Meter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose of drug administered per day expressed as grams per square meter of body surface area (BSA).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/mol</VALIDVALUE>
          <VALUEMEANING>Gram per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass commonly used to express the molar mass of a substance in gram(s) per mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73721</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/g/day</VALIDVALUE>
          <VALUEMEANING>Gram per Gram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per gram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/cage/wk</VALIDVALUE>
          <VALUEMEANING>Gram per Cage per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per cage per period of time equal to seven days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/cage/day</VALIDVALUE>
          <VALUEMEANING>Gram per Cage per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per cage per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/cage</VALIDVALUE>
          <VALUEMEANING>Gram per Cage</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per cage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73716</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 organisms/mL</VALIDVALUE>
          <VALUEMEANING>Thousand Organisms per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism concentration expressed in thousands of organisms per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 organisms/mg</VALIDVALUE>
          <VALUEMEANING>Billion Organisms per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism content expressed in billions of organisms per unit of mass equal to one milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 organisms/mg</VALIDVALUE>
          <VALUEMEANING>Million Organisms per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism content expressed in millions of organisms per unit of mass equal to one milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 organisms/g</VALIDVALUE>
          <VALUEMEANING>Billion Organisms per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism content expressed in billions of organisms per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 organisms/g</VALIDVALUE>
          <VALUEMEANING>Million Organisms per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism content expressed in millions of organisms per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71191</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 organisms/g</VALIDVALUE>
          <VALUEMEANING>Thousand Organisms per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism content expressed in thousands of organisms per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rad</VALIDVALUE>
          <VALUEMEANING>Rads</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radiation absorbed dose equal to the amount of energy from any type of ionizing radiation (e.g., alpha, beta, gamma, neutrons, etc.) deposited in any medium (e.g., water, tissue, air). A dose of one rad means the absorption of 100 ergs per gram of absorbing tissue (100 rad = 1 gray). (The U.S. Nuclear Regulatory Commission, NRC).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4115051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gy</VALIDVALUE>
          <VALUEMEANING>Gray</VALUEMEANING>
          <MEANINGDESCRIPTION>The SI derived unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter; one gray equals 100 rads. The unit is named for the British physician L. Harold Gray, an authority on the use of radiation in the treatment of cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EVENTS</VALIDVALUE>
          <VALUEMEANING>Event Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the number of happenings at a given place or time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg*min/L</VALIDVALUE>
          <VALUEMEANING>Hybrid Resistance Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to the number of millimeters of mercury times minutes, per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>s/h</VALIDVALUE>
          <VALUEMEANING>Seconds Per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit expressed in seconds per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmAL</VALIDVALUE>
          <VALUEMEANING>Millimeters of Aluminum Equivalents</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit defined as the thickness, in millimeters, of aluminum that has the equivalent degree of attenuation, under specified conditions, as the actual material in use within the procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/mmol</VALIDVALUE>
          <VALUEMEANING>Unit per Millimole</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration equal to the concentration at which one millimole of a mixture contains one unit of a substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92618</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/mmol</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Milliimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of one thousandth of an equivalent weight per millimole of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92616</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kN/cm2</VALIDVALUE>
          <VALUEMEANING>Kilonewton per Centimeter Squared</VALUEMEANING>
          <MEANINGDESCRIPTION>The kilonewton per centimeter squared is an SI derived unit of pressure; one newton is computed as the force necessary to accelerate a mass of one gram at the rate of one centimeter per second squared. One kilonewton per centimeter squared is descriptive of the amount of force exerted in a particular area. This measurement is frequently used when describing conditions of cellular movement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92615</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/mL/min</VALIDVALUE>
          <VALUEMEANING>Nanomole per Minute per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute per minute per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92613</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GLOBULE</VALIDVALUE>
          <VALUEMEANING>Globule Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An unit of small globular masses of various sizes. Medications are compounded with globular shaped sucrose, lactose, or other polysaccharides and dried before administered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91803</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm H2O</VALIDVALUE>
          <VALUEMEANING>Centimeters of water</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure defined by a column of water with a height of one centimeter, frequently used to measure central venous pressure, intracranial pressure, and for pressures during mechanical ventilation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5477037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/g</VALIDVALUE>
          <VALUEMEANING>Nanomole per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanomoles per gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/day</VALIDVALUE>
          <VALUEMEANING>Nanomole per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanomoles per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol/day</VALIDVALUE>
          <VALUEMEANING>Mole per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>Moles per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WAFER</VALIDVALUE>
          <VALUEMEANING>Wafer Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a wafer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48552</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406446</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VIAL</VALIDVALUE>
          <VALUEMEANING>Vial Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a single vial.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TUBE</VALIDVALUE>
          <VALUEMEANING>Tube Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a tube.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TROCHE</VALIDVALUE>
          <VALUEMEANING>Troche Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in a single item of a discoid-shaped solid oral dosage form containing the medicinal agent in a suitably flavored base.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRACE</VALIDVALUE>
          <VALUEMEANING>Trace Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An extremely small amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tsp</VALIDVALUE>
          <VALUEMEANING>Teaspoon Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume used in pharmacy and equal to 5 milliliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48544</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TAMPON</VALIDVALUE>
          <VALUEMEANING>Tampon Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a tampon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TABLET</VALIDVALUE>
          <VALUEMEANING>Tablet Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in a single item of a tablet dosage form comprising of compressed medicinal substance(s) with or without suitable diluents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tbsp</VALIDVALUE>
          <VALUEMEANING>Tablespoon Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume informally used in pharmacy. Under the metric system the tablespoon has been standardized at 15 milliliters in the US, Britain, Canada, and New Zealand, and at 20 milliliters in Australia and some European countries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48541</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SYRINGE</VALIDVALUE>
          <VALUEMEANING>Syringe Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a single syringe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48540</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SUPPOSITORY</VALIDVALUE>
          <VALUEMEANING>Suppository Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in a single item of a suppository dosage form that is designed for introduction into the orifice of the human body and usually melts, softens, or dissolves at body temperature.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48539</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STRIP</VALIDVALUE>
          <VALUEMEANING>Strip Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a strip.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48538</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SPRAY</VALIDVALUE>
          <VALUEMEANING>Spray Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in the volume of liquid delivered by the single operation of a spray dosage form container.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48537</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SCOOPFUL</VALIDVALUE>
          <VALUEMEANING>Scoopful Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained typically in a spoon-shaped object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48536</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PRESSOR UNITS</VALIDVALUE>
          <VALUEMEANING>Pressor Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The activity of a pressor agent expressed as one pressor unit being equal to the activity of 0.5 milligram of the USP Standard Powdered Pituitary U.S.P., a USP posterior pituitary reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48532</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LB</VALIDVALUE>
          <VALUEMEANING>Pound</VALUEMEANING>
          <MEANINGDESCRIPTION>The traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48531</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>POUCH</VALIDVALUE>
          <VALUEMEANING>Pouch Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a pouch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48530</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pt_us</VALIDVALUE>
          <VALUEMEANING>Pint</VALUEMEANING>
          <MEANINGDESCRIPTION>A United States liquid unit equal to 16 fluid ounces; two pints equal one quart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48529</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mCi/kg</VALIDVALUE>
          <VALUEMEANING>Millicurie per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one millicurie of the sample with total mass of one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pptr</VALIDVALUE>
          <VALUEMEANING>Part Per Trillion</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of proportion equal to 10E-12.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406606</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ppb</VALIDVALUE>
          <VALUEMEANING>Part Per Billion</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of proportion equal to 10E-9.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70565</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406608</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ukat</VALIDVALUE>
          <VALUEMEANING>Microkatal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity measurement equal to one millionth of katal (10E-6 katal).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TCID 50/dose</VALIDVALUE>
          <VALUEMEANING>50 Percent Tissue Culture Infective Dose per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit equal to the potency at which one dose of preparation contains one 50 percent tissue culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70537</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CCID 50/dose</VALIDVALUE>
          <VALUEMEANING>50 Percent Cell Culture Infective Dose per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit equal to the potency at which one dose of preparation contains one 50 percent cell culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EID 50/dose</VALIDVALUE>
          <VALUEMEANING>50 Percent Embryo Infective Dose per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit for measuring infectious activity of a biologic product or an infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/mg</VALIDVALUE>
          <VALUEMEANING>Curie per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70531</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/ug</VALIDVALUE>
          <VALUEMEANING>Curie per Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one microgram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70530</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/kg</VALIDVALUE>
          <VALUEMEANING>Curie per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70529</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/g</VALIDVALUE>
          <VALUEMEANING>Curie per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GBq/mg</VALIDVALUE>
          <VALUEMEANING>Gigabecquerel per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 organisms</VALIDVALUE>
          <VALUEMEANING>Billion Organisms</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of quantity of organisms expressed in billions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 organisms</VALIDVALUE>
          <VALUEMEANING>Million Organisms</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of quantity of organisms expressed in millions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 organisms</VALIDVALUE>
          <VALUEMEANING>Thousand Organisms</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of quantity of organisms expressed in thousands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406699</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>100 IU/mL</VALIDVALUE>
          <VALUEMEANING>100 International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one hundred international units per one milliliter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mile</VALIDVALUE>
          <VALUEMEANING>Mile</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of distance equal to 5280 international feet, 1760 international yards, or 1609.344 meters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6272184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>km</VALIDVALUE>
          <VALUEMEANING>Kilometer</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of distance equal to 1000 meters, 0.621 miles, 1094 yards, or 3281 feet.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71177</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127033</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cycle/min</VALIDVALUE>
          <VALUEMEANING>Cycle per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of frequency equal to the frequency at which one complete execution of a periodically repeated phenomenon, alternation, event, or sequence of events occurs per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71176</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uV</VALIDVALUE>
          <VALUEMEANING>Microvolt</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI unit of an electric potential and electromotive force equal to one millionth of a volt.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71175</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mCi/L</VALIDVALUE>
          <VALUEMEANING>Millicurie per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousandth of a curie per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uCi/L</VALIDVALUE>
          <VALUEMEANING>Microcurie per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one millionth of a curie per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/mL</VALIDVALUE>
          <VALUEMEANING>Curie per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one curie per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71172</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/uL</VALIDVALUE>
          <VALUEMEANING>Curie per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one curie per unit volume equal to one millionth of a liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/L</VALIDVALUE>
          <VALUEMEANING>Curie per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one liter.(NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71170</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MBq/uL</VALIDVALUE>
          <VALUEMEANING>Megabecquerel per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one million becquerels per unit volume equal to one millionth of a liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71169</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kBq/uL</VALIDVALUE>
          <VALUEMEANING>Kilobecquerel per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousand becquerels per unit volume equal to one millionth of a liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 TCID 50/dose</VALIDVALUE>
          <VALUEMEANING>Log10 50 Percent Tissue Culture Infective Dose per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent tissue culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406553</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 CCID 50/dose</VALIDVALUE>
          <VALUEMEANING>Log10 50 Percent Cell Culture Infective Dose per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent cell culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70485</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 EID 50/dose</VALIDVALUE>
          <VALUEMEANING>Log10 50 Percent Embryo Infective Dose per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dyn</VALIDVALUE>
          <VALUEMEANING>Dyne</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of force in the CGS system defined as the force that accelerates a mass of one gram at the rate of one centimeter per second squared. One dyne is equal to 10E-5 newton and 2.248E-6 pound of force.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Therapeutic Cells</VALIDVALUE>
          <VALUEMEANING>Therapeutic Cells Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit for the number of therapeutic cells administered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dpm/g</VALIDVALUE>
          <VALUEMEANING>Disintegration per Minute per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5 Therapeutic Cells</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand Therapeutic Cells Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit for the number of therapeutic cells administered, expressed as 10 to the fifth power.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg*beats/min</VALIDVALUE>
          <VALUEMEANING>Millimeters of Mercury times Beats per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure equal to millimeters of mercury times the number of heartbeats measured per minute unit of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 Therapeutic Cells</VALIDVALUE>
          <VALUEMEANING>Million Therapeutic Cells Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit for the number of therapeutic cells administered, expressed as 10 to the sixth power.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%*min/h</VALIDVALUE>
          <VALUEMEANING>Percentage times Minute per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement expressed as the percentage times minutes divided by hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167716</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/m2*h</VALIDVALUE>
          <VALUEMEANING>Gram per Hour times Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement expressed as grams per square meter times a unit of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187982</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/s/kg</VALIDVALUE>
          <VALUEMEANING>Milliliter per Kilogram per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliliters per kilogram per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85715</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 Therapeutic Cells</VALIDVALUE>
          <VALUEMEANING>Billion Therapeutic Cells Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit for the number of therapeutic cells administered, expressed as 10 to the ninth power.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 Therapeutic Cells</VALIDVALUE>
          <VALUEMEANING>Thousand Therapeutic Cells Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit for the number of therapeutic cells administered, expressed as 10 to the third power.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GBq/ug</VALIDVALUE>
          <VALUEMEANING>Gigabecquerel per Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one microgram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GBq/g</VALIDVALUE>
          <VALUEMEANING>Gigabecquerel per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/mg</VALIDVALUE>
          <VALUEMEANING>Becquerel per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one becquerel of the sample with total mass of one milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/ug</VALIDVALUE>
          <VALUEMEANING>Becquerel per Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one becquerel of the sample with total mass of one microgram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/g</VALIDVALUE>
          <VALUEMEANING>Becquerel per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one becquerel of the sample with total mass of one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/kg</VALIDVALUE>
          <VALUEMEANING>Becquerel per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one becquerel of the sample with total mass of one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%(w/w)</VALIDVALUE>
          <VALUEMEANING>Percent Mass by Mass</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of percentage concentration expressed as a fraction of a solute by mass in the entire mass of a resulting solution. The concept also refers to the weight-weight percentage concentration given that standard values for specific gravity of the solute and the solution are used.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2689780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enzyme U/L</VALIDVALUE>
          <VALUEMEANING>Enzyme Unit per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of catalytic activity concentration defined as activity equal to one enzyme unit per one liter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmHg</VALIDVALUE>
          <VALUEMEANING>Centimeters of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one centimeter rise of mercury in a barometer at the Earth&#39;s surface.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6352132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kcal/day</VALIDVALUE>
          <VALUEMEANING>Kilocalorie per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy equal to one kilocalorie per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139135</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6352129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Linear ft*LB</VALIDVALUE>
          <VALUEMEANING>Linear Foot Pound</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy that equals the work required to move one pound a distance of one foot in the direction of the applied force.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139134</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug</VALIDVALUE>
          <VALUEMEANING>Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass equal to one millionth of a gram or one thousandth of a milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48152</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5656837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>Any division of quantity accepted as a standard of measurement or exchange.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C44278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>F</VALIDVALUE>
          <VALUEMEANING>Fahrenheit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of temperature of the temperature scale designed so that the freezing point of water is 32 degrees and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. One degree Fahrenheit is 5/9ths of a kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C44277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5387072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RATIO</VALIDVALUE>
          <VALUEMEANING>Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>Quotient of quantities of the same kind for different components within the same system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C44256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m/s2</VALIDVALUE>
          <VALUEMEANING>Meter per Second Squared</VALUEMEANING>
          <MEANINGDESCRIPTION>Meter per second squared is a SI unit of acceleration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42572</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m/s</VALIDVALUE>
          <VALUEMEANING>Meter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of both speed (scalar) and velocity (vector), defined as the distance of one meter travelled per unit time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m3</VALIDVALUE>
          <VALUEMEANING>Cubic Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI unit of volume or capacity equal to the volume of a cube with edges one meter in length. It is equal to 1,000 liters; 1,000 cubic decimeters; 10(e+6) cubic centimeters; 25.3 cubic feet; 6.29 barrels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m2</VALIDVALUE>
          <VALUEMEANING>Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>Square meter is the SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kat</VALIDVALUE>
          <VALUEMEANING>Katal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring catalytic (e.g. enzymatic) activity, the ability of the compound to accelerate the chemical reaction by providing a lower energy pathway between the reactants and the products. One katal is that catalytic activity which will raise the rate of reaction by one mole per second in a specified assay system. When the katal is used, the measurand should be specified by reference to the measurement procedure; the measurement procedure must identify the indicator reaction. The katal is not used to express a rate of reaction itself, which should be expressed in moles per second. Katal is coherent with the SI.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq</VALIDVALUE>
          <VALUEMEANING>Becquerel</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of activity of a radionuclide, equal to one nuclear disintegration or other nuclear transition from a particular energy state occurring in an amount of a radionuclide during one second-long time interval.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>lx</VALIDVALUE>
          <VALUEMEANING>Lux</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of illuminance equal to the direct illumination on a surface that is everywhere one meter from a uniform point source of one candela; a unit of illuminance that is equal to one lumen per square meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42561</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>lm</VALIDVALUE>
          <VALUEMEANING>Lumen</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of luminous flux. It is the amount of light that falls on a unit area at unit distance from a source of one candela.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C</VALIDVALUE>
          <VALUEMEANING>Degree Celsius</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42559</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Henry</VALIDVALUE>
          <VALUEMEANING>Henry</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of electric inductance. A coil with an inductance of one henry requires a flux of one weber for each ampere of induced current. If it is the current which changes, then the induced field will generate a potential difference within the coil: if the inductance is one henry a current change of one ampere per second generates a potential difference of one volt. The henry is a large unit; inductances in practical circuits are measured in millihenrys or microhenrys.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tesla</VALIDVALUE>
          <VALUEMEANING>Tesla</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI unit of magnetic flux density equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Weber</VALIDVALUE>
          <VALUEMEANING>Weber</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one volt, when the flux is uniformly reduced to zero within one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42556</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Siemens</VALIDVALUE>
          <VALUEMEANING>Siemens</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electrical conductance, admittance, and susceptance. A conductor has a conductance of one siemens if an electrical potential difference of one volt produces a one ampere current in it. The conductance in siemens is the reciprocal of its resistance in ohms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5/L</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed as a number or quantity of objects in hundred thousands per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kDa</VALIDVALUE>
          <VALUEMEANING>Kilodalton</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of atomic mass equal to one thousand daltons.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404669</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kPa/L/s</VALIDVALUE>
          <VALUEMEANING>Kilopascal Per Liter Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to the number of kilopascals per unit of volume equal to one liter per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ks</VALIDVALUE>
          <VALUEMEANING>Kilosecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time equal to one thousand seconds (10E3 seconds).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/L</VALIDVALUE>
          <VALUEMEANING>Liter Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of volume concentration expressed as the number of liters of a dissolved substance per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/min/m2</VALIDVALUE>
          <VALUEMEANING>Liter Per Minute Per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit expressed as one liter of volume per unit of time equal to one minute per square meter of area. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ugEq</VALIDVALUE>
          <VALUEMEANING>Microgram Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance concentration equal to one millionth of a gram of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/L/s</VALIDVALUE>
          <VALUEMEANING>Micromole Per Liter Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/kg</VALIDVALUE>
          <VALUEMEANING>Microgram per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67396</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/h</VALIDVALUE>
          <VALUEMEANING>Microgram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725050</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/mg</VALIDVALUE>
          <VALUEMEANING>International Unit per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milligram of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/kg</VALIDVALUE>
          <VALUEMEANING>International Unit per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in international units of biological activity per one kilogram of mass of the system. It is also used as a dose calculation unit expressed in international units of biological activity per one kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nCi</VALIDVALUE>
          <VALUEMEANING>Nanocurie</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to one billionth of a curie or 37 becquerels, and corresponding to radioactivity of 37 atomic disintegrations per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 IU</VALIDVALUE>
          <VALUEMEANING>Million International Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of biological activity equal to one million international units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67335</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>psi</VALIDVALUE>
          <VALUEMEANING>Pound per Square Inch</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of pressure equivalent to 6.894757 kilopascals, or 703.0696 kilograms per square meter, or 51.71507 millimeters of mercury.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/L</VALIDVALUE>
          <VALUEMEANING>Nanogram per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one nanogram of a substance per one liter of the mixture, or one picogram of a substance per unit volume of the mixture equal to one milliliter, or one microgram of a substance per one cubic meter of the mixture. The concept also refers to the metric unit of mass density (volumic mass) defined as the density of a substance which mass equal to one nanogram occupies the volume of one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2724560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mV</VALIDVALUE>
          <VALUEMEANING>Millivolt</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of an electric potential and electromotive force equal to one thousandth of a volt.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67324</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569419</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mOsm</VALIDVALUE>
          <VALUEMEANING>Milliosmole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of osmotic pressure equal to one thousandth of osmole or osmotic pressure of 0.001 molar solution of a substance that does not dissociate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MHz</VALIDVALUE>
          <VALUEMEANING>Megahertz</VALUEMEANING>
          <MEANINGDESCRIPTION>The SI derived unit of frequency; equal to one million oscillations per second or to 10E6 hertz.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/m2</VALIDVALUE>
          <VALUEMEANING>Microgram per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of areal density equal to approximately 2.94935E-8 ounce per square yard. Also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67312</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/cm2</VALIDVALUE>
          <VALUEMEANING>Microgram per meter squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of areal density equal to approximately 2.94935E-4 ounce per square yard. Also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 U</VALIDVALUE>
          <VALUEMEANING>Million Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantity equivalent to one million units (10E6 units).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Therapeutic Cells/m2</VALIDVALUE>
          <VALUEMEANING>Therapeutic Cells per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit for the number of therapeutic cells given per meter squared of body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MPS U/mL</VALIDVALUE>
          <VALUEMEANING>Phosphatidylserine IgM Antibody Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of measure of potency of allergenic product expressed as a number of immunoglobin M phosphatidylserine units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GUMMY</VALIDVALUE>
          <VALUEMEANING>Chewable Gel Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the gummy unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GPS U/mL</VALIDVALUE>
          <VALUEMEANING>Phosphatidylserine IgG Antibody Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of measure of potency of allergenic product expressed as a number of immunoglobin G phosphatidylserine units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ENVELOPE</VALIDVALUE>
          <VALUEMEANING>Envelope Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the envelope unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APS U/mL</VALIDVALUE>
          <VALUEMEANING>Phosphatidylserine IgA Antibody Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of measure of potency of allergenic product expressed as a number of immunoglobin A phosphatidylserine units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ngEq</VALIDVALUE>
          <VALUEMEANING>Nanogram Equivalents</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance equal to one billionth of a gram of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ngEq/g</VALIDVALUE>
          <VALUEMEANING>Nanogram Equivalents Per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of nanogram equivalents per gram of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PILL</VALIDVALUE>
          <VALUEMEANING>Pill Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a pill.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PUMP</VALIDVALUE>
          <VALUEMEANING>Pump Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in one actuation of a pumping device.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111984</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kPa</VALIDVALUE>
          <VALUEMEANING>Kilopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of pressure equivalent to 1000 newtons per square meter or 10000 bars or to 0.145 pound per square inch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67284</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/m2</VALIDVALUE>
          <VALUEMEANING>Gram per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of areal density defined as a spread rate at which one gram of a substance is spread over the area of one square meter. It is equal to approximately 0.029 4935 ounce per square yard. Also used as a dose calculation unit to express quantity of an agent in grams per body surface area in square meters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725116</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kHz</VALIDVALUE>
          <VALUEMEANING>Kilohertz</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure denoting the frequency equal to 1000 cycles per second meaning e.g. that the cylical waveform changes from one state to the other (from one polarity to the other) 1000 times per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569389</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>eq</VALIDVALUE>
          <VALUEMEANING>Equivalent Weight</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance that combines with or displaces 8.0 grams of oxygen or 1.008 gram of hydrogen. The unit is usually expressed in grams and is equal to the amount of substance that gains or loses one mole of electrons in a redox reaction, or to the amount of substances that releases or accepts one mole of hydrogen ions in a neutralization reaction; or to the amount of electrolyte that carries one mole of positive or negative charge. This is a large unit and measurements are more often done in its derivatives, e.g. in milliequivalents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%(w/v)</VALIDVALUE>
          <VALUEMEANING>Percent Mass per Volume</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of percentage concentration expressed as a fraction of a component by mass in the entire volume of a resulting mixture. The standard conditions for temperature and pressure apply. The mass-volume percentage is used for liquid solute/solution systems and systems containing solid phase components. The concept also refers to the weight-volume percentage concentration given that standard values for specific gravity of the solute are used.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2689781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PELLET</VALIDVALUE>
          <VALUEMEANING>Pellet Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a pellet.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PATCH</VALIDVALUE>
          <VALUEMEANING>Patch Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in a single item of a patch drug delivery system which often has an adhesive backing that is applied to an external site on the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ppm</VALIDVALUE>
          <VALUEMEANING>Part Per Million</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of proportion equal to 10E-6.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PACKET</VALIDVALUE>
          <VALUEMEANING>Packet Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in a single item of a packet dosage form.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/min</VALIDVALUE>
          <VALUEMEANING>Micromole per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>Micromoles per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85708</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/day</VALIDVALUE>
          <VALUEMEANING>International Unit per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>International units per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg/L</VALIDVALUE>
          <VALUEMEANING>Femtogram per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Femtograms per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85597</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/mL</VALIDVALUE>
          <VALUEMEANING>Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in unit(s) per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77607</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/g</VALIDVALUE>
          <VALUEMEANING>Unit per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in unit(s) per gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77606</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AFU</VALIDVALUE>
          <VALUEMEANING>Arbitrary Fluorescence Units</VALUEMEANING>
          <MEANINGDESCRIPTION>Arbitrary unit(s) of fluorescent luminescence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77534</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/mL/h</VALIDVALUE>
          <VALUEMEANING>Microgram per Milliliter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per milliliter of solution per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75905</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arbitrary U</VALIDVALUE>
          <VALUEMEANING>Arbitrary Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A single undivided thing (unit) based on or subject to individual judgment or preference, and not by necessity, reason, or principle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406802</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PA</VALIDVALUE>
          <VALUEMEANING>Per Year</VALUEMEANING>
          <MEANINGDESCRIPTION>A frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74924</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/g/min</VALIDVALUE>
          <VALUEMEANING>Microgram per Gram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74923</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/g/h</VALIDVALUE>
          <VALUEMEANING>Microgram per Gram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74922</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/g/day</VALIDVALUE>
          <VALUEMEANING>Microgram per Gram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per gram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74921</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pack Year</VALIDVALUE>
          <VALUEMEANING>Pack Year</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantification of lifetime tobacco exposure defined as (number of cigarettes smoked per day x number of years smoked)/20. One pack-year is smoking 20 cigarettes a day for one year.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/m2/day</VALIDVALUE>
          <VALUEMEANING>Microgram per Square Meter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per square meter per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73787</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/m2/min</VALIDVALUE>
          <VALUEMEANING>Unit per Square Meter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/m2/h</VALIDVALUE>
          <VALUEMEANING>Unit per Square Meter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73784</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/m2/day</VALIDVALUE>
          <VALUEMEANING>Unit per Square Meter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/mg</VALIDVALUE>
          <VALUEMEANING>Unit per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in unit(s) per milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/kg/min</VALIDVALUE>
          <VALUEMEANING>Unit per Kilogram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/kg/h</VALIDVALUE>
          <VALUEMEANING>Unit per Kilogram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73778</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/kg/day</VALIDVALUE>
          <VALUEMEANING>Unit per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/g/min</VALIDVALUE>
          <VALUEMEANING>Unit per Gram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73776</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/g/h</VALIDVALUE>
          <VALUEMEANING>Unit per Gram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73775</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/g/day</VALIDVALUE>
          <VALUEMEANING>Unit per Gram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73774</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/animal</VALIDVALUE>
          <VALUEMEANING>Unit per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary dosing unit expressed in unit(s) per animal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73773</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gravitational Unit</VALIDVALUE>
          <VALUEMEANING>Unit of Gravity</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of gravity expressed as a multiple of the force of gravity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73772</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^4/L</VALIDVALUE>
          <VALUEMEANING>Thousand per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration measurement expressed in thousand(s) per deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73771</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>um2</VALIDVALUE>
          <VALUEMEANING>Square Micrometer</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI unit of area measurement equal to a square whose sides are one micrometer long.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ps</VALIDVALUE>
          <VALUEMEANING>Picosecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time equal to one trillionth of a second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ns</VALIDVALUE>
          <VALUEMEANING>Nanosecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time equal to one billionth of a second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406841</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mPa</VALIDVALUE>
          <VALUEMEANING>Millipascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of pressure equivalent to one thousandth of one pascal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg/s</VALIDVALUE>
          <VALUEMEANING>Millimeter of Mercury per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate of inflation or deflation of a manometric device based on the unit of pressure equal to 133,332 Pa or 1.316E10-3 standard atmosphere during period of time equal to one sixtieth of a minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/m2/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per Square Meter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/m2/h</VALIDVALUE>
          <VALUEMEANING>Milliliter per Square Meter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73762</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/m2</VALIDVALUE>
          <VALUEMEANING>Milliliter per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per square meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/kg/h</VALIDVALUE>
          <VALUEMEANING>Milliliter per Kilogram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per kilogram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73759</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/kg/day</VALIDVALUE>
          <VALUEMEANING>Milliliter per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliliters per kilogram per day or milliliters per day (flow rate), divided by kilograms (weight).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/s</VALIDVALUE>
          <VALUEMEANING>Millimole per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>Millimoles per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85723</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8/L</VALIDVALUE>
          <VALUEMEANING>Hundred Million Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed as a number or quantity of objects in hundred millions per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^11/L</VALIDVALUE>
          <VALUEMEANING>Hundred Billion Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed as a number or quantity of objects in hundred billions per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hPa</VALIDVALUE>
          <VALUEMEANING>Hectopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of pressure equivalent to one hundred pascals, 1 millibar or 0.0145 pounds per square inch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GBq</VALIDVALUE>
          <VALUEMEANING>Gigabecquerel</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to 10E9 nuclear disintegrations or other nuclear transformations per second, or to 10E9 becquerels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fraction of 1</VALIDVALUE>
          <VALUEMEANING>Fraction of 1</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for expressing a percentage as a decimal whereby the total value is measured as a fraction of the numeric 1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PFU</VALIDVALUE>
          <VALUEMEANING>Plaque Forming Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of viable infectious entities (e.g. viral particles or group of particles) in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope and/or to the naked eye as a plaque. A number of plaque forming units (PFU) per unit volume is a conventional way to refer the titer of an infective entity in a specimen or preparation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kcal</VALIDVALUE>
          <VALUEMEANING>Calorie</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI unit of energy defined as the amount of heat required to raise the temperature of one kilogram of pure water by one degree Centigrade under standard conditions (the specific heat of the water at 15 degrees Celsius and the constant pressure of 101.325 kPa or one atm being defined as unity), equal to approximately 4.1855 kJ. It is also is used by nutritionists in measuring the energy-producing potential of food as a unit of potential energy contained by a substance, which can be liberated when the material is oxidized, usually by combustion in the presence of oxygen. According to the current national standard in the United States (IEEE/ASTM SI 10 TM-2002. American National Standard for Use of the International System of Units (SI): The Modern Metric System, New York: IEEE, 2002) the calorie in any form is not to be used. Joules should be used instead.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cal</VALIDVALUE>
          <VALUEMEANING>calorie</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI unit of energy defined as the amount of heat required to raise the temperature of one gram of pure water by one degree Centigrade under standard conditions (the specific heat of the water at 3.98, 14.5, or 19.5 degrees Celcius and the constant pressure of 101.325 kPa or one atm being defined as unity), equal to approximately 4.184 J. According to the current national standard in the United States (IEEE/ASTM SI 10 TM-2002. American National Standard for Use of the International System of Units (SI): The Modern Metric System, New York: IEEE, 2002) the calorie in any form is not to be used. Joules should be used instead.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406492</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/wk</VALIDVALUE>
          <VALUEMEANING>Weekly</VALUEMEANING>
          <MEANINGDESCRIPTION>Every week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3277357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/m2/day</VALIDVALUE>
          <VALUEMEANING>Milliliter per Square Meter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66977</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg/day</VALIDVALUE>
          <VALUEMEANING>Milligram per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per kilogram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66976</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108591</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/kg/day</VALIDVALUE>
          <VALUEMEANING>Gram per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose administration rate unit equal to the rate at which one gram of a product per kilogram of body mass is delivered or administered over the period of one day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/m2/day</VALIDVALUE>
          <VALUEMEANING>Milligram per Square Meter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per square meter per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3059688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uL/kg/day</VALIDVALUE>
          <VALUEMEANING>Microliter per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume expressed as a number of microliters of the constituent per kilogram of weight per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mMU/mL</VALIDVALUE>
          <VALUEMEANING>MilliMerck Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration based on the vaccine specific number of titers that are the geometric mean titer at which an individual is considered to convert from a seronegative to a seropositive response due to the vaccine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 TCID 50/uL</VALIDVALUE>
          <VALUEMEANING>Log10 50 Percent Tissue Culture Infective Dose per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one microliter of infectious material contains one 50 percent tissue culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132479</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uV*s</VALIDVALUE>
          <VALUEMEANING>Microvolt Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one microvolt, when the flux is uniformly reduced to zero within one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mph</VALIDVALUE>
          <VALUEMEANING>Mile Per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one mile traveled per unit time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/cm</VALIDVALUE>
          <VALUEMEANING>Milliliter per Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the number of milliliters per unit of length equal to one centimeter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kg/cm</VALIDVALUE>
          <VALUEMEANING>Kilogram per Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to kilograms per length unit equal to one centimeter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120849</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ka_u/dL</VALIDVALUE>
          <VALUEMEANING>King-Armstrong Unit per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of phosphatase concentration that can free one milligram of phenol from disodium phenylphosphate at standard conditions, per unit volume of the mixture equal to one deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 copies/mL</VALIDVALUE>
          <VALUEMEANING>Log10 Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 IU/mL</VALIDVALUE>
          <VALUEMEANING>Log10 International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring international units per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5778792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uEq/L</VALIDVALUE>
          <VALUEMEANING>Microequivalent per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance concentration equal to one billionth of a gram of an equivalent weight per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/L/min</VALIDVALUE>
          <VALUEMEANING>Micromole per Liter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/mol</VALIDVALUE>
          <VALUEMEANING>Milligram per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass commonly used to express the molar mass of a substance in milligram(s) per mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120843</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mJoule/cm2</VALIDVALUE>
          <VALUEMEANING>Millijoules per Square Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radiant exposure defined as a unit of energy equal to one millijoule applied to a unit of area equal to one square centimeter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116241</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/mol</VALIDVALUE>
          <VALUEMEANING>Millimole per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of fraction expressed as the ratio of the amount of substance of solute in millimoles to the amount of substance of the mixture in moles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/min/kPa</VALIDVALUE>
          <VALUEMEANING>Millimoles per Minute per Kilopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of gas diffusion capacity equal to one millimole per minute per kilopascal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mV2/Hz</VALIDVALUE>
          <VALUEMEANING>Millivolt Squared per Hertz</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one thousandth of a volt squared per unit of frequency equal to one Hertz.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114241</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol BCE/L</VALIDVALUE>
          <VALUEMEANING>Nanomole Bone Collagen Equivalent per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JDF Unit</VALIDVALUE>
          <VALUEMEANING>Juvenile Diabetes Foundation Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure, defined by the Juvenile Diabetes Foundation, used to express the amount of islet cell antibodies in a biological sample; it is calculated by multiplying the titer by five.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172606</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>oz eq</VALIDVALUE>
          <VALUEMEANING>Ounce Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance equal to one ounce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172605</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cup eq</VALIDVALUE>
          <VALUEMEANING>Cup Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance equal to one cup.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172604</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tsp eq</VALIDVALUE>
          <VALUEMEANING>Teaspoon Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance equal to one teaspoon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MBP</VALIDVALUE>
          <VALUEMEANING>Megabase Pair</VALUEMEANING>
          <MEANINGDESCRIPTION>A number representing one million paired nucleotides in a DNA or RNA sequence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/MBP</VALIDVALUE>
          <VALUEMEANING>Per Megabase Pair</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one million base pairs used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/mol</VALIDVALUE>
          <VALUEMEANING>Nanogram per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass commonly used to express the molar mass of a substance in nanogram(s) per mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/mol</VALIDVALUE>
          <VALUEMEANING>Microgram per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass commonly used to express the molar mass of a substance in microgram(s) per mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EP U</VALIDVALUE>
          <VALUEMEANING>European Pharmacopoeia Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of measurement established by the European Pharmacopoeia that corresponds to 1800 Kallidinogenase Inactivator units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nkat/g Hb</VALIDVALUE>
          <VALUEMEANING>Nanokatal per Gram Hemoglobin</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity concentration defined as the catalytic activity equal to one billionth of katal (10E-9 katal) per gram hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>breaths/30 s</VALIDVALUE>
          <VALUEMEANING>Breaths per Thirty Seconds</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of breaths (inhalation and exhalation) taken within a period of time equal to thirty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>min/day</VALIDVALUE>
          <VALUEMEANING>Minute per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to the number of minutes within a period of time equal to one day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hr/day</VALIDVALUE>
          <VALUEMEANING>Hour per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to the number of hours within a period of time equal to one day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/kg/day</VALIDVALUE>
          <VALUEMEANING>Nanomole per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in nanomoles per kilogram per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/mL/day</VALIDVALUE>
          <VALUEMEANING>Gram per Liter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligrams per milliliter per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg/cell</VALIDVALUE>
          <VALUEMEANING>Picogram Per Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration for the number of picograms of substance per cell.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osm</VALIDVALUE>
          <VALUEMEANING>Osmole</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI unit of osmotic pressure equal to that of an ideal solution of a nondissociating substance that has a concentration of one mole of solute per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67330</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uOsm</VALIDVALUE>
          <VALUEMEANING>Microosmole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of osmotic pressure equal to one millionth of an osmole or the osmotic pressure of a 10E-6 molar solution of a substance that does not dissociate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>min*mg/mL</VALIDVALUE>
          <VALUEMEANING>Minute Times Milligram per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Minutes times milligrams per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6639631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7 TCID 50/dose</VALIDVALUE>
          <VALUEMEANING>Ten Million Tissue Culture Infectious Dose 50%</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency equal to ten million tissue culture infectious dose 50% units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6273369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipase Units/kg</VALIDVALUE>
          <VALUEMEANING>Lipase Units per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit based on lipase activity per kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipase Units</VALIDVALUE>
          <VALUEMEANING>Lipase Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit based on lipase activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178059</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/h</VALIDVALUE>
          <VALUEMEANING>International Unit per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>International units per hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6639392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand Colony Forming Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the fifth power colony forming units in one milliliter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RADIOACTIVE SEED IMPLANT</VALIDVALUE>
          <VALUEMEANING>Radioactive Seed Implant Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit in a form of an incapsulated radioactive material that constitutes an implantable pellet designed for brachytherapy administration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RAE</VALIDVALUE>
          <VALUEMEANING>Retinol Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit for measurement of a vitamin A activity of provitamin A carotenoids (such as carotenes, xanthophylls, and compounds that arise from rearrangement of carotene I skeleton) in a mixed diet introduced by FAO/WHO Expert Group in 1967. The concept of the retinol equivalent (RE) is established on the following relationships among food sources of the vitamin A: one microgram of all-trans retinol is equal to one RE, one microgram of beta-carotene is equal to 0.167 RE, and one microgram of other pro-vitamin A carotenoids is equal to 0.084 RE.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/kg</VALIDVALUE>
          <VALUEMEANING>Nanogram per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass fraction expressed as a number of nanograms of a substance per kilogram of the mixture. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mIU/m2</VALIDVALUE>
          <VALUEMEANING>Milliinternational Unit per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one-thousandth (10E-3) of an arbitrary unit of biological activity (International Unit) of substance per square meter of body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/wk</VALIDVALUE>
          <VALUEMEANING>Milligram per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose administration rate unit equal to the rate at which one thousandth of a gram of a product is delivered or administered over the time period of one week. This is also a unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to one week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>J/cm2</VALIDVALUE>
          <VALUEMEANING>Joule per Square Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radiant exposure equal to radiant energy of one joule arriving upon a surface area of one square centimeter. The unit is also used for measurement of output of the energy-emitting source.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67357</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mrad</VALIDVALUE>
          <VALUEMEANING>Megarad</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of absorbed radiation dose equal to one million rad (10E6 rad), or 10000 Gy (10E4 Gy).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 PFU</VALIDVALUE>
          <VALUEMEANING>Million Plaque Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of viable infectious entities expressed in millions in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope or/and to the naked eye as a plaque.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 PFU</VALIDVALUE>
          <VALUEMEANING>Billion Plaque Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of viable infectious entities expressed in billions in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope or/and to the naked eye as a plaque.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/breath</VALIDVALUE>
          <VALUEMEANING>Milligram Per Breath</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in milligram(s) per inspiration or expiration of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184723</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RLU</VALIDVALUE>
          <VALUEMEANING>Relative Luminescence Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit used to measure the intensity of the emitted light from a sample; it is dependent on instrument and measurement parameters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tuberculin unit/0.1mL</VALIDVALUE>
          <VALUEMEANING>Tuberculin Unit per 100 Microliters</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of biologic activity of tuberculin expressed as a number of arbitrary units of tuberculin in one milliliter of preparation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184721</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SERVING</VALIDVALUE>
          <VALUEMEANING>Serving Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the serving unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/10^6</VALIDVALUE>
          <VALUEMEANING>Per Million</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one million entities used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7/kg</VALIDVALUE>
          <VALUEMEANING>Ten Million Per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the seventh power of the number of entities per unit of mass equal to one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5/kg</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand Per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the fifth power of the number of entities per unit of mass equal to one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184715</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>rad/s</VALIDVALUE>
          <VALUEMEANING>Radians Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>An SI unit of angular velocity defined as the change in angular velocity equal to one radian per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184714</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m*%</VALIDVALUE>
          <VALUEMEANING>Meters Times Percent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the distance saturation product (DSP) defined as meters times percent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8 IU</VALIDVALUE>
          <VALUEMEANING>Hundred Million International Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of biological activity equal to one hundred million international units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156119</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6535804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MeV</VALIDVALUE>
          <VALUEMEANING>Megaelectronvolt</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy that is equal to one million electron volts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C152057</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6338208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8 TCID 50/dose</VALIDVALUE>
          <VALUEMEANING>Hundred Million Tissue Culture Infectious Dose 50%</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency equal to one hundred million tissue culture infectious dose 50% units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6273368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 TCID 50/dose</VALIDVALUE>
          <VALUEMEANING>Million Tissue Culture Infectious Dose 50%</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency equal to one million tissue culture infectious dose 50% units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6273370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CGE</VALIDVALUE>
          <VALUEMEANING>Cobalt Gray Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative biological effectiveness of protons equivalent to 60 cobalt gamma rays.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5343411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/kg/wk</VALIDVALUE>
          <VALUEMEANING>Microgram per Kilogram per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose administration rate unit where the amount of product to be delivered or administered is calculated in micrograms as a function of the subject&#39;s weight in kilograms and is delivered or administered over the time period of one week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89830</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3113232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/wk</VALIDVALUE>
          <VALUEMEANING>Gram per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose administration rate unit equal to the rate at which a gram of a product is delivered or administered over the time period of one week. This is also a unit of mass flow rate equivalent to the rate at which a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to one week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89829</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3113233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/m2/wk</VALIDVALUE>
          <VALUEMEANING>Milligram per Square Meter per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s)per square meter per period of time equal to seven days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88148</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3059686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>meq/h</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance crosses a given surface or is delivered to a given object or space over a period of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/dL</VALIDVALUE>
          <VALUEMEANING>Milliliter per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of volume concentration expressed as the number of milliters of a dissolved substance per deciliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/s/1.73 m2</VALIDVALUE>
          <VALUEMEANING>Milliliter Per Second Per 1.73 Meter Squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one second per 1.73 meters squared of body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg/L/min</VALIDVALUE>
          <VALUEMEANING>Millimeter Mercury Per Liter Per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to the number of millimeters of mercury per unit of volume equal to one liter per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm/min</VALIDVALUE>
          <VALUEMEANING>Millimeter Per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter traveled per unit time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm/s</VALIDVALUE>
          <VALUEMEANING>Millimeter Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter traveled per unit time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm/2h</VALIDVALUE>
          <VALUEMEANING>Millimeter per Two Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter traveled per unit time equal to two hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mV*min</VALIDVALUE>
          <VALUEMEANING>Millivolt Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one millivolt, when the flux is uniformly reduced to zero within one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nU/cL</VALIDVALUE>
          <VALUEMEANING>Nanounit Per Centiliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in nanounit(s) per centiliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/VF</VALIDVALUE>
          <VALUEMEANING>Per Visual Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the instances of an entity per visual field of a microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^10/L</VALIDVALUE>
          <VALUEMEANING>Ten Billion Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed as a number or quantity of objects in ten billions per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^12 IU/L</VALIDVALUE>
          <VALUEMEANING>Tera International Unit Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of 10^12 international unit per one liter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105518</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3/L</VALIDVALUE>
          <VALUEMEANING>Thousand Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed as a number or quantity of objects in thousands per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/cL</VALIDVALUE>
          <VALUEMEANING>Unit Per Centiliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration expressed in unit(s) per centiliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/dL</VALIDVALUE>
          <VALUEMEANING>Unit Per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration expressed in unit(s) per deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/g Hb</VALIDVALUE>
          <VALUEMEANING>Unit Per Gram Hemoglobin</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one unit per gram of hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>V/s</VALIDVALUE>
          <VALUEMEANING>Volt Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived rate unit equal to one volt per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frames/s</VALIDVALUE>
          <VALUEMEANING>Frames Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the number of visual frames per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/mmHg</VALIDVALUE>
          <VALUEMEANING>Milliliters Per Millimeter of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to the volume in milliliters per one millimeter rise of mercury in a barometer at the Earth&#39;s surface.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404733</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antibody Unit</VALIDVALUE>
          <VALUEMEANING>Antibody Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of antibody concentration measured by comparison against a known concentration of antibodies in a standard reference specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404735</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BAG</VALIDVALUE>
          <VALUEMEANING>Bag Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a bag.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol</VALIDVALUE>
          <VALUEMEANING>Nanomole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to 10E-9 mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/L</VALIDVALUE>
          <VALUEMEANING>Nanomole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg</VALIDVALUE>
          <VALUEMEANING>Picogram</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass equal to one trillionth of a gram (10E-12 gram).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg/dL</VALIDVALUE>
          <VALUEMEANING>Picogram per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one picogram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of a substance which mass equal to one picogram occupies the volume of one deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67331</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2724562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/L</VALIDVALUE>
          <VALUEMEANING>Picomole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one trillionth of a mole (10E-12 mole) in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>s</VALIDVALUE>
          <VALUEMEANING>Second</VALUEMEANING>
          <MEANINGDESCRIPTION>The second is the unit of time, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). The second is the duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the ground state of the caesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour. Abbreviation Sec. is acceptable in non-scientific usage only.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/L</VALIDVALUE>
          <VALUEMEANING>Unit per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration equal to the concentration at which one liter of mixture contains one unit of a substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2724566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/m2</VALIDVALUE>
          <VALUEMEANING>Unit per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed as a number of arbitrary units of substance per one square meter of a body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ejaculate U</VALIDVALUE>
          <VALUEMEANING>Ejaculate Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume equal to the amount of seminal fluid produced by a single ejaculation event.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/LSQN</VALIDVALUE>
          <VALUEMEANING>Per Large Square Neubauer Chamber</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the instances of an entity per large square (with a 1mm x 1mm area) in a Neubauer chamber.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405983</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/mm</VALIDVALUE>
          <VALUEMEANING>Per Millimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of length equal to one millimeter that is used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6/Ejaculate U</VALIDVALUE>
          <VALUEMEANING>Million Per Ejaculate Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the sixth power of entities per unit equal to one ejaculation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405987</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/animal/wk</VALIDVALUE>
          <VALUEMEANING>Gram per Animal per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per animal per period of time equal to seven days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73715</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/animal/day</VALIDVALUE>
          <VALUEMEANING>Gram per Animal per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per animal per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73714</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/animal</VALIDVALUE>
          <VALUEMEANING>Gram per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per animal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fmol/g</VALIDVALUE>
          <VALUEMEANING>Femtomole per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A molality unit that describes the amount of substance, expressed in femtomole(s) per gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DPM</VALIDVALUE>
          <VALUEMEANING>Disintegration per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73710</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cpm</VALIDVALUE>
          <VALUEMEANING>Count per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of frequency expressed as the detection rate of ionization events per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>s^-1(%O2)^-1</VALIDVALUE>
          <VALUEMEANING>Reciprocal of Seconds Times Percent O2 Concentration</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of oxygen transfer function expressed as the reciprocal of time in seconds divided by the oxygen concentration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uSiemens</VALIDVALUE>
          <VALUEMEANING>Microsiemens</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electrical conductance, admittance, and susceptance equal to one millionth of a Siemens (10E-6 Siemens).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154859</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>um/s</VALIDVALUE>
          <VALUEMEANING>Micrometer per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one micrometer travelled per unit time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154858</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RFU</VALIDVALUE>
          <VALUEMEANING>Relative Fluorescence Intensity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement that estimates the size or amount of material in a sample by normalizing its luminescence to that of a reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>P</VALIDVALUE>
          <VALUEMEANING>Poise</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of dynamic viscosity equal to one pascal-second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154857</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OD Unit</VALIDVALUE>
          <VALUEMEANING>Unit of Optical Density</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication of the type of unit of measure being used to express an optical density of a substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/day</VALIDVALUE>
          <VALUEMEANING>Nanogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanograms per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/100g/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per 100 Grams per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of flow rate expressed as the number of milliliters per 100g of material per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mgEq</VALIDVALUE>
          <VALUEMEANING>Milligram Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance concentration equal to one thousandth of a gram of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hz/s</VALIDVALUE>
          <VALUEMEANING>Hertz Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of frequency rate change defined as the number of Hertz per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154854</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enzyme U/m2</VALIDVALUE>
          <VALUEMEANING>Enzyme Unit per Meter Squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (catalytic activity) equal to one enzyme unit of substance per one square meter of surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enzyme U/g Hb</VALIDVALUE>
          <VALUEMEANING>Enzyme Unit per Gram Hemoglobin</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (biologic activity) equal to one enzyme unit of substance per gram of hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154856</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HOURS</VALIDVALUE>
          <VALUEMEANING>Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25529</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5228317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/L</VALIDVALUE>
          <VALUEMEANING>Kilogram per Cubic Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>The SI derived unit of mass concentration defined as the concentration of one kilogram of a substance in unit volume of the mixture equal to one cubic meter, or the concentration of one milligram of a substance in unit volume of the mixture equal to one milliliter, or one gram of a substance per one liter of the mixture. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2685297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/L</VALIDVALUE>
          <VALUEMEANING>International Unit per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one liter of the system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/kg</VALIDVALUE>
          <VALUEMEANING>Liter per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in liter(s) per kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73725</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/g</VALIDVALUE>
          <VALUEMEANING>Nanomole per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanomoles per kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/day</VALIDVALUE>
          <VALUEMEANING>Daily</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring or done each day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/month</VALIDVALUE>
          <VALUEMEANING>Monthly</VALUEMEANING>
          <MEANINGDESCRIPTION>Every month.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mIU/L</VALIDVALUE>
          <VALUEMEANING>Microinternational Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one millionth of international unit per one milliliter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CCID 50/mL</VALIDVALUE>
          <VALUEMEANING>50 Percent Cell Culture Infective Dose per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit equal to the potency at which one milliliter of preparation contains one 50 percent cell culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120845</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EID 50/mL</VALIDVALUE>
          <VALUEMEANING>50 Percent Embryo Infective Dose per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit for measuring infectious activity of a biologic product or an infectious agent preparation equal to the potency at which one milliliter of infectious material contains one 50 percent embryo infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120847</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PNU/mL</VALIDVALUE>
          <VALUEMEANING>Allergenic Protein Nitrogen Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of allergenic product potency expressed as the number of protein nitrogen units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anson U</VALIDVALUE>
          <VALUEMEANING>Anson Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of enzyme concentration which is defined as the amount of enzyme that can digest urea-denatured hemoglobin at the same initial rate as one milliequivalent of tyrosine at standard conditions (25C and pH 7.50).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122201</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BU</VALIDVALUE>
          <VALUEMEANING>Bethesda Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement for blood coagulation inhibitor activity, expressed in the amount of an inhibitor neutralizing 50% of a coagulant during the incubation period per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BU/mL</VALIDVALUE>
          <VALUEMEANING>Bethesda Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement for blood coagulation inhibitor activity, expressed as a Bethesda Unit per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9/g</VALIDVALUE>
          <VALUEMEANING>Billion per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the ninth power of the number of entities per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BAU/mL</VALIDVALUE>
          <VALUEMEANING>Bioequivalent Allergy Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of allergenic product potency expressed as the number of bioequivalent allergy units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116235</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BE/mL</VALIDVALUE>
          <VALUEMEANING>Biological Allergy Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of allergenic product potency expressed as a number of biological units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BISCUIT</VALIDVALUE>
          <VALUEMEANING>Biscuit Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of ingredient(s) in a biscuit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111139</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BLOCKS</VALIDVALUE>
          <VALUEMEANING>Block Unit of Distance</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure to quantify the number of rectangular areas in a city surrounded by streets.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405591</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cd/m2</VALIDVALUE>
          <VALUEMEANING>Candela per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of luminous intensity expressed as one candela per square meter of area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cd*s/m2</VALIDVALUE>
          <VALUEMEANING>Candela Second per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of luminous intensity expressed as one candela in one second of light emittance per square meter of area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U.CARR</VALIDVALUE>
          <VALUEMEANING>Carratelli Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration expressed in milligrams per a volume of hydrogen peroxide. One Carratelli unit is equal to 0.8mg substance per liter of hydrogen peroxide.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CIGAR</VALIDVALUE>
          <VALUEMEANING>Cigar Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of ingredient(s) in a cigar.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CIGARETTE</VALIDVALUE>
          <VALUEMEANING>Cigarette Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of ingredient(s) in a cigarette.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116245</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>copies/uL</VALIDVALUE>
          <VALUEMEANING>Copies per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration expressed as a number of copies per unit volume equal to one microliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405625</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dpm/100 mg</VALIDVALUE>
          <VALUEMEANING>Disintegration per Minute per 100 milligrams</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one centigram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117968</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dpm/mg</VALIDVALUE>
          <VALUEMEANING>Disintegration per Minute per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>rpm</VALIDVALUE>
          <VALUEMEANING>Revolution per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of frequency equal to one revolution per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol/mol</VALIDVALUE>
          <VALUEMEANING>Mole per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of fraction expressed as the ratio of the amount of substance of solute in moles to the amount of substance of the mixture in moles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70455</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/g</VALIDVALUE>
          <VALUEMEANING>Gram per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a mass fraction expressed as a number of grams of substance per gram of mixture. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DROP</VALIDVALUE>
          <VALUEMEANING>Drop</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of volume defined as the amount of liquid dispensed as one drop from a dropper dispenser. The volume of a drop depends on the physical properties of the liquid dispensed, the dispenser device, and the technique used to produce the drop.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pL</VALIDVALUE>
          <VALUEMEANING>Picoliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume equal to one trillionth of a liter (10E-12 liter).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nL</VALIDVALUE>
          <VALUEMEANING>Nanoliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume equal to one billionth of a liter (10E-9 liter).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uL/mL</VALIDVALUE>
          <VALUEMEANING>Microliter per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume fraction expressed as a number of microliters of the constituent per the volume of the system represented in milliliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69175</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2689613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/h</VALIDVALUE>
          <VALUEMEANING>Liter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI unit of volumetric flow rate defined as the rate at which one liter of matter crosses a given surface during the period of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>us</VALIDVALUE>
          <VALUEMEANING>Microsecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time equal to one millionth of a second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69149</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pm</VALIDVALUE>
          <VALUEMEANING>Picometer</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of length equal to one trillionth of a
meter (10E-12 meter).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69148</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pt_br</VALIDVALUE>
          <VALUEMEANING>Pint British</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of volume equal to 20 British fluid ounces, 34.678 cubic inches or approximately 568.261 milliliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69114</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ppth</VALIDVALUE>
          <VALUEMEANING>Part per Thousand</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of proportion equal to 10E-3.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69112</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/day</VALIDVALUE>
          <VALUEMEANING>Liter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one liter of matter crosses a given surface during the period of time equal to one day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69110</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/kg</VALIDVALUE>
          <VALUEMEANING>Gram per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a mass fraction expressed as a number of grams of substance per kilogram of mixture. Gram per kilogram is also used as a dose calculation unit to express a quantity of substance in grams per one kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69104</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406578</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kg/cm2</VALIDVALUE>
          <VALUEMEANING>Kilogram per Square Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of spread rate of a substance by mass expressed in kilograms per area unit equal to one square centimeter, used also as a measure of area density and as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69094</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cL</VALIDVALUE>
          <VALUEMEANING>Centiliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of volume equal to one hundredth of a liter or 10 milliliters. One centiliter is equivalent to 0.6102 cubic inch, or 0.338 U.S. fluid ounce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gauss</VALIDVALUE>
          <VALUEMEANING>Gauss</VALUEMEANING>
          <MEANINGDESCRIPTION>A CGS unit of magnetic flux density. A field of one gauss exerts a force on a conductor, placed in the field of 0.1 dyne per ampere of current per centimetre of conductor. One gauss represents a magnetic flux of one maxwell per square centimetre of cross-section perpendicular to the field. In SI units, one gauss equals 10-4 tesla.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406582</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Billion Colony Forming Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of billion colony forming units (10E9 CFU) in one milliliter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68905</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406584</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Million Colony Forming Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of million colony forming units (10E6 CFU) in one milliliter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Thousand Colony Forming Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of thousand colony forming units (10E3 CFU) in one milliliter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CFU/mL</VALIDVALUE>
          <VALUEMEANING>Colony Forming Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of colony forming units in one milliliter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68902</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>POINT</VALIDVALUE>
          <VALUEMEANING>Point</VALUEMEANING>
          <MEANINGDESCRIPTION>A numeric unit used to quantify a score.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6428092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ohm</VALIDVALUE>
          <VALUEMEANING>Ohm</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in siemens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sv</VALIDVALUE>
          <VALUEMEANING>Sievert</VALUEMEANING>
          <MEANINGDESCRIPTION>The international system (SI) unit for radiation dose equivalent equal to 1 Joule/kilogram. 1 sievert = 100 rem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4723805</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Farad</VALIDVALUE>
          <VALUEMEANING>Farad</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI unit of capacitance equal to the capacitance of a capacitor having an equal and opposite charge of one coulomb on each plate and a potential difference of one volt between the plates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42552</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>V</VALIDVALUE>
          <VALUEMEANING>Volt</VALUEMEANING>
          <MEANINGDESCRIPTION>The SI derived unit of electric potential and electromotive force, equal to the difference of electric potential between two points on a conducting wire carrying a constant current of one ampere when the power dissipated between the points is one watt, equivalent to the potential difference across a resistance of one ohm when one ampere of current flows through it.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Coulomb</VALIDVALUE>
          <VALUEMEANING>Coulomb</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of quantity of electricity, equal to the quantity of charge transferred in one second across a conductor in which there is a constant current of one ampere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42550</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol BCE/mmol</VALIDVALUE>
          <VALUEMEANING>Nanomole Bone Collagen Equivalent per Millimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of substance concentration equal to one millimole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/4.0 mL</VALIDVALUE>
          <VALUEMEANING>per 4.0 Milliliters</VALUEMEANING>
          <MEANINGDESCRIPTION>A volume unit equal to 4.0 milliliters used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/7.5 mL</VALIDVALUE>
          <VALUEMEANING>per 7.5 Milliliters</VALUEMEANING>
          <MEANINGDESCRIPTION>A volume unit equal to 7.5 milliliters used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122198</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/kg</VALIDVALUE>
          <VALUEMEANING>Per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A mass unit equal to one kilogram used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/mm2</VALIDVALUE>
          <VALUEMEANING>per Square Millimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>An area unit equal to one millimeter squared used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>% INHIBITION</VALIDVALUE>
          <VALUEMEANING>Percent Inhibition</VALUEMEANING>
          <MEANINGDESCRIPTION>The rate of measured normal activity minus inhibited activity, divided by the rate of normal activity of a given object. It is expressed as a percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117963</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%/min</VALIDVALUE>
          <VALUEMEANING>Percent per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of frequency expressed as the percentage of entities or events per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PIPE</VALIDVALUE>
          <VALUEMEANING>Pipe Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of ingredient(s) in a pipe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PIXELS/cm</VALIDVALUE>
          <VALUEMEANING>Pixels per Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of image resolution expressed in the numbers of pixels per centimeter in the horizontal or vertical direction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PIXELS/in</VALIDVALUE>
          <VALUEMEANING>Pixels per Inch</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of image resolution expressed in the numbers of pixels per inch in the horizontal or vertical direction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Shock Wave</VALIDVALUE>
          <VALUEMEANING>Shockwave Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the shock wave unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MBq</VALIDVALUE>
          <VALUEMEANING>Megabecquerel</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to 10E6 nuclear disintegrations or other nuclear transformations per second, or to 10E6 becquerels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kBq</VALIDVALUE>
          <VALUEMEANING>Kilobecquerel</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to 10E3 nuclear disintegrations or other nuclear transformations per second, or to 10E3 becquerels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70511</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cP</VALIDVALUE>
          <VALUEMEANING>Centipoise</VALUEMEANING>
          <MEANINGDESCRIPTION>A CGS unit of dynamic viscosity equal to 10E-3 pascal second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Watt</VALIDVALUE>
          <VALUEMEANING>Watt</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI unit of power equal to the power which in one second produces or transfers the energy of one joule. The unit is used in measurements of power emitted, transferred or received as radiation, sound waves, heat flow rate, and rate of energy transfer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Joule</VALIDVALUE>
          <VALUEMEANING>Joule</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electrical, mechanical, and thermal energy (as well as work and quantity of heat) in the SI system, equal to the work done when the point of application of a force of one newton is displaced through a distance of one meter in the direction of the force or the work done when a current of one ampere passes through a resistance of one ohm for one second. Joule is equal to 0.23889 gram-calorie (mean).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pa</VALIDVALUE>
          <VALUEMEANING>Pascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of pressure equivalent to one newton per square meter or 10 bars or to 1.45x10E-4 pounds per square inch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Newton</VALIDVALUE>
          <VALUEMEANING>Newton</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of force. The force which, when applied in a vacuum to a body having a mass of one kilogram, causes an acceleration of one meter per second squared. It is equal to 10E5 dynes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hz</VALIDVALUE>
          <VALUEMEANING>Hertz</VALUEMEANING>
          <MEANINGDESCRIPTION>The SI derived unit of frequency; equal to one oscillation per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569383</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol</VALIDVALUE>
          <VALUEMEANING>Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>The the basic unit of substance, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). It is the amount of substance that contains as many elementary units as there are atoms in 0.012 kg of carbon-12. When the mole is used, the elementary entities must be specified and may be atoms, molecules, ions, electrons, other particles, or specified groups of such particles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42539</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cd</VALIDVALUE>
          <VALUEMEANING>Candela</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of luminous intensity, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). It is the luminous intensity in a given direction of a small monochromatic light source at 540 terahertz emitting 1/683 watt per steradian in that direction. This is dependent upon the definitions of the meter, kilogram, and second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42538</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>K</VALIDVALUE>
          <VALUEMEANING>Kelvin</VALUEMEANING>
          <MEANINGDESCRIPTION>A basic unit of thermodynamic temperature, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). It is 1/273.16th of the thermodynamic temperature of the triple point of water, This sets the size of the kelvin unit for temperature differences and defines the thermodynamic temperature of an equilibrium mixture of waters ice-liquid-vapor as 273.16 K, where 0 K is the lowest possible temperature (&quot;absolute zero&quot;).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42537</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>amp</VALIDVALUE>
          <VALUEMEANING>Ampere</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electric current, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). It is that constant current which, if maintained in two straight parallel conductors of infinite length and zero diameter separated by one meter in a vacuum, would produce between these conductors a force equal to 2x10E7 newton per meter of length. This is dependent upon the definitions of the meter, kilogram, and second. One ampere represents 6.24 x 10E18 unit electric charge carriers, such as electrons, passing a specified fixed point in one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42536</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ms</VALIDVALUE>
          <VALUEMEANING>Millisecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time equal to one thousandth of a second (10E-3 second).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406336</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PACKAGE</VALIDVALUE>
          <VALUEMEANING>Package Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a package.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>oz</VALIDVALUE>
          <VALUEMEANING>Ounce</VALUEMEANING>
          <MEANINGDESCRIPTION>The traditional unit of mass. The avoirdupois ounce is equal to 1/16 pound, or 28.3495 grams, or 0.911 457 troy ounce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569429</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng</VALIDVALUE>
          <VALUEMEANING>Nanogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass equal to 10E-9 gram, or one millionth of a milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mCi</VALIDVALUE>
          <VALUEMEANING>Millicurie</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to one thousandth of a curie or 37 megabecquerels, and corresponding to a radioactivity of 37 millions of atomic disintegrations per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48511</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>um</VALIDVALUE>
          <VALUEMEANING>Micron</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of length in metric system equal to 10E-6 meter, or micrometer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uCi</VALIDVALUE>
          <VALUEMEANING>Microcurie</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to one millionth of a curie or 37 kilobecquerels, and corresponding to a radioactivity of 37 000 atomic disintegrations per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LOZENGE</VALIDVALUE>
          <VALUEMEANING>Lozenge Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a lozenge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L</VALIDVALUE>
          <VALUEMEANING>Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-SI unit of volume accepted for use with the SI. One liter is equal to cubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or approximately 61.023 744 cubic inches.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5656836</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KIT</VALIDVALUE>
          <VALUEMEANING>Kit Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a kit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KALLIKREIN INHIBITOR UNIT</VALIDVALUE>
          <VALUEMEANING>Kallikrein Inhibitor Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the Kallikrein inhibitor unit.(NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JAR</VALIDVALUE>
          <VALUEMEANING>Jar Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a jar.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/min/1.73 m2</VALIDVALUE>
          <VALUEMEANING>Milliliter per Minute per 1.73 m2 of Body Surface Area</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one milliliter of preparation per 1.73 square meters of body surface area delivered during a period of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nkat/L</VALIDVALUE>
          <VALUEMEANING>Nanokatal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity concentration defined as the catalytic activity of the component equal to one billionth of katal (10E-9 katal) in the unit volume of the system equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pkat</VALIDVALUE>
          <VALUEMEANING>Picokatal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity measurement equal to trillionth of katal (10E-12 katal).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nkat</VALIDVALUE>
          <VALUEMEANING>Nanokatal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity measurement equal to one billionth of katal (10E-9 katal).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mkat</VALIDVALUE>
          <VALUEMEANING>Millikatal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity measurement equal to one thousandth of katal (10E-3 katal).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tuberculin unit/mL</VALIDVALUE>
          <VALUEMEANING>Tuberculin Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of biologic activity of tuberculin expressed as a number of arbitrary units of tuberculin in one milliliter of preparation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BAU</VALIDVALUE>
          <VALUEMEANING>Bioequivalent Allergy Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit used for standardization of an allergenic product based on evaluation of product potency against reference standard in combined in vivo (skin test) and in vitro (IgE-based ELISA) testing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AU/mL</VALIDVALUE>
          <VALUEMEANING>Allergy Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of measure of potency of allergenic product expressed as a number of allergy units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DAgU/mL</VALIDVALUE>
          <VALUEMEANING>D Antigen Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency of poliovirus vaccine expressed as a number of D antigen units per one milliliter of vaccine formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VOXEL</VALIDVALUE>
          <VALUEMEANING>Voxel</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest distinguishable &#39;rectangular-parallel-piped-shaped&#39; part of a three-dimensional space or image.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>keV</VALIDVALUE>
          <VALUEMEANING>Kiloelectronvolt</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy equal to 1000 electronvolts, or (approximately) 1,602 177 x 10-16 joule. The unit is accepted for use with SI units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gy/min</VALIDVALUE>
          <VALUEMEANING>Gray per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of absorbed radiation dose rate defined as the number of Grays per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158296</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gy/h</VALIDVALUE>
          <VALUEMEANING>Gray per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of absorbed radiation dose rate defined as the number of Grays per hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7 CFU</VALIDVALUE>
          <VALUEMEANING>Ten Million Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of viable bacterial numbers equal to 10 to the seventh power colony forming units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775801</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^4 CFU</VALIDVALUE>
          <VALUEMEANING>Ten Thousand Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of viable bacterial numbers equal to 10 to the fourth power colony forming units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775803</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/L FEU</VALIDVALUE>
          <VALUEMEANING>Microgram per Liter Fibrinogen Equivalent Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of equivalent concentration equal to the number of micrograms of fibrinogen per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775805</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/L FEU</VALIDVALUE>
          <VALUEMEANING>Milligram per Liter Fibrinogen Equivalent Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of equivalent concentration equal to the number of milligrams of fibrinogen per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APS U</VALIDVALUE>
          <VALUEMEANING>Phosphatidylserine IgA Antibody Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with phosphatidylserine evaluated against an established reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GPS U</VALIDVALUE>
          <VALUEMEANING>Phosphatidylserine IgG Antibody Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with phosphatidylserine evaluated against an established reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MPS U</VALIDVALUE>
          <VALUEMEANING>Phosphatidylserine IgM Antibody Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with phosphatidylserine evaluated against an established reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/L DDU</VALIDVALUE>
          <VALUEMEANING>Micrograms DDU Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of equivalent concentration equal to the number of micrograms of D-dimer per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DDU</VALIDVALUE>
          <VALUEMEANING>D-Dimer Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of D-dimers contained within that sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>genEq</VALIDVALUE>
          <VALUEMEANING>Genomic Equivalents</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit defined as the number of whole organism genomes in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>genEq/mL</VALIDVALUE>
          <VALUEMEANING>Genomic Equivalents per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration defined as the number of genomic equivalents per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859339</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ECL unit</VALIDVALUE>
          <VALUEMEANING>Electrochemiluminescence Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring concentration or/and reactivity of a test substance as defined in the literature reference standard for the particular quantitative electrochemiluminescent method.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/ms</VALIDVALUE>
          <VALUEMEANING>Per Millisecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time, which is equal to the reciprocal of one thousandth of a second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859343</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ms2</VALIDVALUE>
          <VALUEMEANING>Square Millisecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time which is equal to one thousandth of a second squared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859345</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>deg/mm</VALIDVALUE>
          <VALUEMEANING>Degree Per Millimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of rotation expressed as the number of degrees per unit of length equal to one millimeter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859347</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DRINK</VALIDVALUE>
          <VALUEMEANING>Drink Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the drink unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg/week</VALIDVALUE>
          <VALUEMEANING>Milligram Per Kilogram Per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per kilogram per period of time equal to seven days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859351</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mAmp</VALIDVALUE>
          <VALUEMEANING>Milliampere</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electric current equal to one thousandth of an ampere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIP</VALIDVALUE>
          <VALUEMEANING>Dip Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the dip unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>USP U</VALIDVALUE>
          <VALUEMEANING>United States Pharmacopeia Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit for the measurement of the biologic activity of antibiotics, endocrine preparations, sera, toxins, vaccines, and related products established by the United States Pharmacopeia (USP), the official public standards-setting authority for all prescription and over-the-counter medicines, dietary supplements, and other healthcare products manufactured and sold in the US. For each substance to which this unit applies, USP determines a Reference Standard and a specified assay. If the standard is the same as the WHO-approved International Biological Reference Preparation, and the same assay procedure was used for the biological effect evaluation, the USP unit is considered equal to International Unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>vg/kg</VALIDVALUE>
          <VALUEMEANING>Vector Genomes per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for the vector amount expressed as the number of vector genomes per kilogram of body weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ms/mmHg</VALIDVALUE>
          <VALUEMEANING>Millisecond per Millimeter Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to one millisecond per one millimeter of mercury (mmHg).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163565</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MnFI</VALIDVALUE>
          <VALUEMEANING>Mean Fluorescence Intensity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the mean fluorescence intensity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/cm3/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per Cubic Centimeter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of flow rate equal to one milliliter per cm3 per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>gMFI</VALIDVALUE>
          <VALUEMEANING>Geometric Mean Fluorescence Intensity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the geometric mean fluorescence intensity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FIU</VALIDVALUE>
          <VALUEMEANING>Fluorescence Intensity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the fluorescence intensity when the mathematic calculation is unspecified or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FFU</VALIDVALUE>
          <VALUEMEANING>Focus Forming Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative unit of measure of cell clusters of a specific interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75303</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>aMFI</VALIDVALUE>
          <VALUEMEANING>Arithmetic Mean Fluorescence Intensity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the arithmetic mean fluorescence intensity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9/dose</VALIDVALUE>
          <VALUEMEANING>Billion per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to 10 to the ninth power of the number of entities per single dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163561</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%/s</VALIDVALUE>
          <VALUEMEANING>Percent per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of frequency expressed as the percentage of entities or events per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mU</VALIDVALUE>
          <VALUEMEANING>Milliunit</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantity equivalent to the one thousandth unit (10E-3 unit).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uV2</VALIDVALUE>
          <VALUEMEANING>Microvolts Squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electromotive force equal to a microvolt squared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>steps/min</VALIDVALUE>
          <VALUEMEANING>Steps Per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of steps occurring within a minute unit of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/s/m2</VALIDVALUE>
          <VALUEMEANING>Milliliter Per Second Per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one second per meter squared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166100</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/U</VALIDVALUE>
          <VALUEMEANING>Gram Per Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration or mass density equal to one gram of substance per unit(s) of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>damol/L</VALIDVALUE>
          <VALUEMEANING>Decamole Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one decamole of solute in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cs</VALIDVALUE>
          <VALUEMEANING>Centisecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time equal to one hundredth of a second (10E-2 seconds).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105482</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm/min</VALIDVALUE>
          <VALUEMEANING>Centimeter Per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter traveled per unit time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100 HPFs</VALIDVALUE>
          <VALUEMEANING>Per 100 High Powered Fields</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of the number of entities per unit of area equal to one hundred high powered fields.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102695</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Log10 Colony Forming Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring colony forming units per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102659</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ukat/10^12 RBC</VALIDVALUE>
          <VALUEMEANING>Microkatal per Trillion Erythrocytes</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of catalytic activity concentration defined as activity equal to one millionth of a katal per 10^12 erythrocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uL/dose</VALIDVALUE>
          <VALUEMEANING>Microliter per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in microliter(s) per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kg/mol</VALIDVALUE>
          <VALUEMEANING>Kilogram per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass commonly used to express the molar mass of a substance in kilogram(s) per mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mAnson U/mL</VALIDVALUE>
          <VALUEMEANING>Milli-Anson Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of enzymatic activity defined a one milli-Anson unit per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg2/dL2</VALIDVALUE>
          <VALUEMEANING>Square Milligram per Square Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as one square milligram of a substance in unit volume of the mixture equal to one square deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol2/L2</VALIDVALUE>
          <VALUEMEANING>Square Millimole per Square Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one square millimole of solute per square liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405765</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mOsm/L</VALIDVALUE>
          <VALUEMEANING>Milliosmole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of osmotic pressure equal to one thousandth of an osmole per unit of volume equal to one Liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mU/g</VALIDVALUE>
          <VALUEMEANING>Milliunit per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in milliunit(s) per gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mV/s</VALIDVALUE>
          <VALUEMEANING>Millivolt per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived rate unit equal to one millivolt per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/s/kPa</VALIDVALUE>
          <VALUEMEANING>Liter per Second per Kilopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of conductance equal to the number of liters per unit of time equal to one second per unit of pressure equal to one kilopascal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139133</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>s*kPa</VALIDVALUE>
          <VALUEMEANING>Second Times Kilopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to one second times one kilopascal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>h*%</VALIDVALUE>
          <VALUEMEANING>Hour Times Percent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the area under an effect curve (AUEC), defined as hours times percent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAC50</VALIDVALUE>
          <VALUEMEANING>Minimum Alveolar Concentration 50 Percent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency for inhalational gases, defined as the concentration of gas in the lung required to immobilize 50% of individuals in response to a stimulus, such as pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL*cmH2O</VALIDVALUE>
          <VALUEMEANING>Milliliter Times Centimeter of Water</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for volume change calculation expressed by multiplying the volume of air flow in mL by the air pressure in cmH2O.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmH2O/mL</VALIDVALUE>
          <VALUEMEANING>Centimeter of Water per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for pressure change that is expressed in cmH2O per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmH2O*s2/mL</VALIDVALUE>
          <VALUEMEANING>Centimeter of Water Times Second Squared per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for pressure change that is expressed by multiplying cmH2O by seconds, multiplying that product by seconds, then dividing that subsequent product by the volume of air flow in milliliters</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmH2O*s/mL</VALIDVALUE>
          <VALUEMEANING>Centimeter of Water Times Second per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for pressure change that is expressed by multiplying cmH2O by seconds, and then dividing that product by the volume of air flow in milliliters</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135518</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/cmH2O</VALIDVALUE>
          <VALUEMEANING>Per Centimeter of Water</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure equal to one centimeter of water used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/10^5</VALIDVALUE>
          <VALUEMEANING>Per Hundred Thousand</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit, equal to one hundred thousand entities, is used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/10^4</VALIDVALUE>
          <VALUEMEANING>Per Ten Thousand</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit, equal to ten thousand entities, is used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135515</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 CFU/g</VALIDVALUE>
          <VALUEMEANING>Log10 Colony Forming Units per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring colony forming units per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dB</VALIDVALUE>
          <VALUEMEANING>Decibel</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure representing the intensity of an electrical signal or sound which is equal to ten times the logarithm of the ratio of two signals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm/s</VALIDVALUE>
          <VALUEMEANING>Centimeter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAPFUL</VALIDVALUE>
          <VALUEMEANING>Capful Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the capful unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INHALATION</VALIDVALUE>
          <VALUEMEANING>Inhalation Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of the medicinal substance(s) delivered via the respiratory tract by one oral or nasal inhalation in the form of a gas, aerosol, mist, liquid, or fine powder using a nebulizer or an aerosol device, or the force of natural breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>in</VALIDVALUE>
          <VALUEMEANING>Inch</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of length equal to 1/12 of a foot or 2.54 centimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3915556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMPLANT</VALIDVALUE>
          <VALUEMEANING>Implant Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in an implant.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HOMEOPATHIC DILUTION</VALIDVALUE>
          <VALUEMEANING>Homeopathic Dilution Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit that is based on homeopathic dilution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>grain</VALIDVALUE>
          <VALUEMEANING>Grain</VALUEMEANING>
          <MEANINGDESCRIPTION>The traditional unit of mass derived from the weight of a grain and equal to one seven-thousandth of a pound, or 1/480 troy ounce, or 64.79891 milligrams. The original English grain unit based on the mass of a ripe grain barleycorn was larger the corresponding grain units of France and other European nations which were based on the weight of the smaller wheat grain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>foz_us</VALIDVALUE>
          <VALUEMEANING>Fluid Ounce US</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of liquid volume equal in the US customary system to 1/16 pint, or 1.804 687 cubic inches or 29.573 531 milliliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol BCE/nmol</VALIDVALUE>
          <VALUEMEANING>Nanomole Bone Collagen Equivalents per Nanomole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of substance concentration equal to one nanomole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/L/h</VALIDVALUE>
          <VALUEMEANING>Nanomole per Liter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit expressed in nanomole(s) per liter of solution per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405841</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/L/min</VALIDVALUE>
          <VALUEMEANING>Nanomole per Liter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit equal to the number of nanomoles per unit of volume equal to one liter per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/mol</VALIDVALUE>
          <VALUEMEANING>Nanomole per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of fraction expressed as the ratio of the amount of a substance in solution, in nanomoles, to the amount of a different substance in the mixture, in moles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/dL</VALIDVALUE>
          <VALUEMEANING>Microgram per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of  one microgram of a substance in unit volume of the mixture equal to one  deciliter. The concept also refers to the unit of mass density (volumic  mass) defined as the density of substance which mass equal to one  microgram occupies the volume one deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67305</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/L</VALIDVALUE>
          <VALUEMEANING>Microgram per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumic mass) defined as the density of a substance which mass equal to one microgram occupies the volume of one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ukat/L</VALIDVALUE>
          <VALUEMEANING>Microkatal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of catalytic activity concentration defined as activity equal to one millionth of katal per one liter of the system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DAgU</VALIDVALUE>
          <VALUEMEANING>D Antigen Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency of poliovirus vaccine used for poliomyelitis prevention. The unit is poliovirus type-specific.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AgU/mL</VALIDVALUE>
          <VALUEMEANING>Antigen Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of an antigen potency defined as a number of antigen units per one milliliter of product.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>anti-Xa IU/mL</VALIDVALUE>
          <VALUEMEANING>Anti-Xa Activity International Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A specific anticoagulation activity of unfractionated or low molecular weight heparin on factor Xa, expressed as a number of international anti-Xa heparin units per one milliliter of plasma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>anti-Xa IU</VALIDVALUE>
          <VALUEMEANING>Anti-Xa Activity International Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of unfractionated or low molecular weight heparin anticoagulation potency determined as the amount that neutralizes one unit of coagulation factor Xa preparation defined as an international biological standard by WHO First International Low Molecular Weight Heparin Reference Standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/g</VALIDVALUE>
          <VALUEMEANING>International Unit per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of a quantity of substance per unit mass, expressed as the quantity of substance in International Units, divided by the mass of the substance in grams. It is also used as a dose calculation unit expressed in International Units of biological activity per one gram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kIU</VALIDVALUE>
          <VALUEMEANING>Kilointernational Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one thousand international units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OI50</VALIDVALUE>
          <VALUEMEANING>Opsonization Index 50%</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit equal to the dilution of serum that causes opsonization and phagocytosis of 50% of the bacteria in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ngEq/L</VALIDVALUE>
          <VALUEMEANING>Nanogram Equivalents Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of nanogram equivalent of solute per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/(min*100mL)</VALIDVALUE>
          <VALUEMEANING>Milliliter Per Minute Times One Hundred Milliliters</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of flow rate expressed as the number of milliliters per number of minutes times a unit of volume equal to 100 milliliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130191</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>gpELISA unit/mL</VALIDVALUE>
          <VALUEMEANING>Glycoprotein-ELISA Unit Per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring potency of immunologically active substance in a product determined as reactivity in a glycoprotein enzyme-linked immunosorbent assay for particular antigen or antibody and expressed per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 CFU/g</VALIDVALUE>
          <VALUEMEANING>Billion Colony Forming Units per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of billion colony forming units (10E9 CFU) in one gram of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 CFU/g</VALIDVALUE>
          <VALUEMEANING>Million Colony Forming Units per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of million colony forming units (10E6 CFU) in one gram of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 CFU/g</VALIDVALUE>
          <VALUEMEANING>Thousand Colony Forming Units per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of thousand colony forming units (10E3 CFU) in one gram of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CFU/g</VALIDVALUE>
          <VALUEMEANING>Colony Forming Unit per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of colony forming units in one gram of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 CFU</VALIDVALUE>
          <VALUEMEANING>Billion Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of viable cell quantity equal to 10E9 colony forming units (10E9 CFU).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68897</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 CFU</VALIDVALUE>
          <VALUEMEANING>Million Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of viable cell quantity equal to 10E6 colony forming units (10E6 CFU).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68896</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 CFU</VALIDVALUE>
          <VALUEMEANING>Thousand Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of viable cell quantity equal to 10E3 colony forming units (10E3 CFU).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68895</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol/mg</VALIDVALUE>
          <VALUEMEANING>Mole per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance content (molality unit) defined as one mole of solute per one milligram of solvent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406519</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol/g</VALIDVALUE>
          <VALUEMEANING>Mole per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance content (molality unit) defined as one mole of solute per one gram of solvent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68893</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406521</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/kg</VALIDVALUE>
          <VALUEMEANING>Millimole per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance content (molality unit) defined as one thousandth of mole (10E-3 mole) of solute per one kilogram of solvent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68892</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol/mL</VALIDVALUE>
          <VALUEMEANING>Mole per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one mole of solute in one milliliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68891</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol</VALIDVALUE>
          <VALUEMEANING>Picomole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to a trillionth (10E-12) of a mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fL</VALIDVALUE>
          <VALUEMEANING>Femtoliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-SI unit of volume accepted for use with the SI equal to one quadrillionth of a liter (10E-15 liter).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enzyme U</VALIDVALUE>
          <VALUEMEANING>Enzyme Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity measurement defined as the quantity of a particular enzyme that catalyzes the transformation of one micromole of the substrate per minute under standard conditions for specified assay system. The usage of this unit is discouraged in favor of the katal by International Federation of Clinical Chemistry and Laboratory Medicine due to lack of its coherence with the SI system. One enzyme unit is equal to 16.667 nanokatals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64778</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dL</VALIDVALUE>
          <VALUEMEANING>Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of volume equal to one tenth of a liter. Accepted for use with the SI.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64697</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAPLET</VALIDVALUE>
          <VALUEMEANING>Caplet Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a caplet.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cGy</VALIDVALUE>
          <VALUEMEANING>Centigray</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of absorbed radiation dose equal to the absorption of one hundredth of joule of radiation energy per kilogram of matter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64693</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dram</VALIDVALUE>
          <VALUEMEANING>Dram Mass Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-SI unit of mass equal to 1/16 Avoirdupois ounce or 1/256 Avoirdupois pound. One dram equals approximately 1.7718451953125 grams.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>amu</VALIDVALUE>
          <VALUEMEANING>Atomic Mass Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A small unit of mass used to express atomic and molecular masses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64559</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cg</VALIDVALUE>
          <VALUEMEANING>Centigram</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass equal to one hundredth of a gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ag</VALIDVALUE>
          <VALUEMEANING>Attogram</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass equal to one a quintillionth of a gram (10E-18 gram).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fg</VALIDVALUE>
          <VALUEMEANING>Femtogram</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass equal to one quadrillionth of a gram (10E-15 gram).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64552</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PACK</VALIDVALUE>
          <VALUEMEANING>Pack Dosage Form</VALUEMEANING>
          <MEANINGDESCRIPTION>A number of individual items packaged as a unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62653</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RING</VALIDVALUE>
          <VALUEMEANING>Ring Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a ring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>atm</VALIDVALUE>
          <VALUEMEANING>Atmosphere</VALUEMEANING>
          <MEANINGDESCRIPTION>Non-SI unit of pressure equal to 101 325 Pa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CUP</VALIDVALUE>
          <VALUEMEANING>Cup Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a cup.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54703</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>breaths/min</VALIDVALUE>
          <VALUEMEANING>Breaths per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of breaths (inhalation and exhalation) taken per minute time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49674</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>beats/min</VALIDVALUE>
          <VALUEMEANING>Beats per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of heartbeats measured per minute time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49673</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2659976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kg/m2</VALIDVALUE>
          <VALUEMEANING>Kilogram Per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>The SI derived unit of spread rate of a substance by mass, used also as a measure of area density.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49671</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm</VALIDVALUE>
          <VALUEMEANING>Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3915555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>QUANTITY SUFFICIENT</VALIDVALUE>
          <VALUEMEANING>Quantity Sufficient</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantity of an ingredient or product needed to bring up a volume or weight of the preparation to a final amount as it is indicated in the prescription; also refers to a determination of an adequate supply of medicine to fulfill either a prescribed amount or a sufficient quantity to provide treatment over a specified time frame.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48590</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2929840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>foz_br</VALIDVALUE>
          <VALUEMEANING>Fluid Ounce British</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of liquid volume equal in the British Imperial system to 1/20 pint, or 1.733 871 cubic inches or 28.413 063 milliliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48577</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406484</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%(v/v)</VALIDVALUE>
          <VALUEMEANING>Percent Volume per Volume</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of percentage concentration expressed as a fraction of a component by volume s in the entire volume of a resulting mixture. The unit denotes a number of milliliters of a solute per 100 milliliters of solution. The standard conditions for temperature and pressure apply.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406486</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol/L</VALIDVALUE>
          <VALUEMEANING>Molar</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one mole of solute per one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>yd</VALIDVALUE>
          <VALUEMEANING>Yard</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of length equal to 3 feet, or 36 inches, or 0.9144 meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fmol/L</VALIDVALUE>
          <VALUEMEANING>Femtomole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one quadrillionth of a mole (10E-15 mole) of solute in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2685296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmol/L</VALIDVALUE>
          <VALUEMEANING>Centimole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one hundredth of a mole (10E-2 mole) of solute in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68886</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Log10 ELISA unit/dose</VALIDVALUE>
          <VALUEMEANING>Log10 Enzyme-Linked Immunosorbent Assay Unit per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68879</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Log10 ELISA unit</VALIDVALUE>
          <VALUEMEANING>Log10 Enzyme-Linked Immunosorbent Assay Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring concentration and/or reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference for the particular quantitative enzyme-linked immunosorbent assay method.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68878</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>copies/mL</VALIDVALUE>
          <VALUEMEANING>Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration expressed as a number of copies per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIOPTER</VALIDVALUE>
          <VALUEMEANING>Diopter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of the optical power of a curved mirror or lens represented by the inverse of the focal length in meters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 copies/mL</VALIDVALUE>
          <VALUEMEANING>Million Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the sixth power copies in unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 copies/mL</VALIDVALUE>
          <VALUEMEANING>Thousand Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the third power copies in unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100897</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absorbance U/min</VALIDVALUE>
          <VALUEMEANING>Absorbance Unit per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a speed of optical density change expressed as a logarithm of absorbance of light transmitted through a partially absorbing substance per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absorbance U</VALIDVALUE>
          <VALUEMEANING>Absorbance Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of optical density expressed as the absorbance of light transmitted through the medium on the logarithmic scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg/h</VALIDVALUE>
          <VALUEMEANING>Milligram per Kilogram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SACHET</VALIDVALUE>
          <VALUEMEANING>Sachet Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit that contains a solid pharmaceutical preparation in the form of a small packet or bag made from a flexible, often porous material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71324</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2735738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FINGERTIP UNIT</VALIDVALUE>
          <VALUEMEANING>Fingertip Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary dosing unit used predominantly for semisolid topical formulations such as cream, ointment, paste, etc. One fingertip unit is the amount of a product that is squeezed out from a standard tube with 5-millimeter diameter nozzle along an adult&#39;s fingertip. A fingertip length is defined from the tip of the index finger to the first finger crease. A fingertip dosing unit varies with age and size of the body. The average fingertip unit is equal to approximately 0.5 gram for an adult male and 0.4 gram for an adult female.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71321</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>deg2</VALIDVALUE>
          <VALUEMEANING>Degrees Squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI unit of solid angle equal to approximately 3.0462x10^-4 steradians.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166098</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>deg/s</VALIDVALUE>
          <VALUEMEANING>Degrees Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of angular velocity defined as the number of degrees per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236047</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Ten Million Colony Forming Units Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the seventh power colony forming units in one liter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236049</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^4 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Ten Thousand Colony Forming Units Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the fourth power colony forming units in one liter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166095</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 PFU</VALIDVALUE>
          <VALUEMEANING>Log10 Plaque Forming Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) potency unit for measuring the quantity of individual infectious particles (usually viral particles) based on the number of plaques formed in a cell culture infected with the virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73568</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PFU/animal</VALIDVALUE>
          <VALUEMEANING>Plaque Forming Units per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in plaque forming unit(s) per animal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pkat/L</VALIDVALUE>
          <VALUEMEANING>Picokatal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity concentration defined as activity equal to a picokatal per one liter of the system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/10^10 cells</VALIDVALUE>
          <VALUEMEANING>Picomole per Ten Billion Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one picomole of substance per ten to the tenth power cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/10^9 cells</VALIDVALUE>
          <VALUEMEANING>Picomole per Billion Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one picomole of substance per ten to the ninth power cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/day</VALIDVALUE>
          <VALUEMEANING>Picomole per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance flow rate equivalent to the rate at which one picomole of substance travels to a given object or space over a period of time equal to 24 hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/dL</VALIDVALUE>
          <VALUEMEANING>Picomole per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one picomole of solute per deciliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122226</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/L/h</VALIDVALUE>
          <VALUEMEANING>Picomole per Liter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit expressed in picomole(s) per liter of solution per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/10^12 RBC</VALIDVALUE>
          <VALUEMEANING>Unit per Trillion Red Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in units of biological activity per ten to the twelfth power red blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/L/h</VALIDVALUE>
          <VALUEMEANING>Microgram per Liter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit equal to the number of micrograms per unit of volume equal to one liter per unit of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ugEq/L</VALIDVALUE>
          <VALUEMEANING>Microgram Equivalent per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of microgram equivalent of solute per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122230</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/mol</VALIDVALUE>
          <VALUEMEANING>Micromole per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of fraction expressed as the ratio of the amount of a substance in solution, in micromoles, to the amount of a different substance in the mixture, in moles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/10^3</VALIDVALUE>
          <VALUEMEANING>Per Thousand</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one thousand entities used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/cm2</VALIDVALUE>
          <VALUEMEANING>Milligram per Squared Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of area density defined as a spread rate at which one milligram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/dose</VALIDVALUE>
          <VALUEMEANING>Milligram per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in milligram(s) per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg/dose</VALIDVALUE>
          <VALUEMEANING>Milligram per Kilogram per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per kilogram per single dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/dose</VALIDVALUE>
          <VALUEMEANING>Milliliter per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in milliliter(s) per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRANSDUCING UNIT</VALIDVALUE>
          <VALUEMEANING>Transducing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of biological activity described as the number of viral particles in solution that are capable of infecting a cell and stimulating expression of a transgene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124460</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9/L</VALIDVALUE>
          <VALUEMEANING>Billion per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit expressed as a number or quantity of objects in billions per unit of volume equal to one liter, or the equivalent in milliliters or microliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67255</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^12/L</VALIDVALUE>
          <VALUEMEANING>Million per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit expressed as a number of entities or quantity in millions per unit of volume equal to one microliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fmol</VALIDVALUE>
          <VALUEMEANING>Femtomole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to one quadrillionth of a mole (10E-15 mole).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68854</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g</VALIDVALUE>
          <VALUEMEANING>Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass equal to one one thousandth of a kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567649</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/day</VALIDVALUE>
          <VALUEMEANING>Gram per 24 Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric mass flow rate unit equal to the rate at which mass of matter of one gram crosses a given surface or/and is transferred over a period of twenty four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/dL</VALIDVALUE>
          <VALUEMEANING>Gram per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one gram of a substance in unit volume of the mixture equal to one deciliter (100 milliliters). The concept also refers to the metric unit of mass density (volumic mass) defined as the density of substance which mass equal to one gram occupies the volume one deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2685299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/min</VALIDVALUE>
          <VALUEMEANING>Liter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one liter of matter crosses a given surface during the period of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/s</VALIDVALUE>
          <VALUEMEANING>Liter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one liter of matter crosses a given surface during the period of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq</VALIDVALUE>
          <VALUEMEANING>Milliequivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance equal to one thousandth of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/day</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per 24 Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance crosses a given surface or is delivered to a given object or space over a period of time equal to twenty four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/dL</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of milliequivalents of solute per deciliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/kg</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance content equivalent to the content at which one kilogram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/L</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of milliequivalents of solute per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719056</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg</VALIDVALUE>
          <VALUEMEANING>Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of weight.  A milligram is approximately 450,000 times smaller than a pound and 28,000 times smaller than an ounce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/day</VALIDVALUE>
          <VALUEMEANING>Milligram per 24 Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to twenty four hours. Milligram per twenty four hours is also a dose administration rate unit equal to the rate at which one thousandth of a gram of a product is administered per unit of time equal to twenty four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/dL</VALIDVALUE>
          <VALUEMEANING>Milligram per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67015</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg</VALIDVALUE>
          <VALUEMEANING>Milligram per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a mass fraction expressed as a number of milligrams of substance per kilogram of mixture. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719050</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/L</VALIDVALUE>
          <VALUEMEANING>Microgram per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass concentration defined as the  concentration of one gram of a substance in unit volume of the mixture  equal to one cubic meter. The concept also refers to the metric unit of  mass density (volumic mass) defined as the density of substance which  mass equal to one gram occupies the volume one cubic meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64572</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719048</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/mL/min</VALIDVALUE>
          <VALUEMEANING>Milligram per Milliliter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to mass concentration of a substance expressed in kilograms per unit volume of the mixture equal to one cubic meter per time period of one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL</VALIDVALUE>
          <VALUEMEANING>Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of volume for a liquid.  A milliliter is approximately 950 times smaller than a quart and 30 times smaller than a fluid ounce.  A milliliter of liquid and a cubic centimeter (cc) of liquid are the same.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28254</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter crosses a given surface during the period of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dpm/mL</VALIDVALUE>
          <VALUEMEANING>Disintegration per Minute per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a volume unit equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8 PFU</VALIDVALUE>
          <VALUEMEANING>Hundred Million Plaque Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of viable infectious entities expressed in hundreds of millions in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope or/and to the naked eye as a plaque.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67266</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7 PFU</VALIDVALUE>
          <VALUEMEANING>Ten Million Plaque Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of viable infectious entities expressed in tens of millions in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope or/and to the naked eye as a plaque.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LENS</VALIDVALUE>
          <VALUEMEANING>Lens Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the lens unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MASK</VALIDVALUE>
          <VALUEMEANING>Mask Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the mask unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/5x10^4 WBC</VALIDVALUE>
          <VALUEMEANING>Per 50,000 White Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 50,000 white blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>h/wk</VALIDVALUE>
          <VALUEMEANING>Hours Per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to the number of hours within a period of time equal to one week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>days/month</VALIDVALUE>
          <VALUEMEANING>Days Per Month</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to the number of days within a period of time equal to one month.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>days/wk</VALIDVALUE>
          <VALUEMEANING>Days Per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to the number of days within a period of time equal to one week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DNA copies/ug</VALIDVALUE>
          <VALUEMEANING>DNA Copies Per Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to the number of deoxyribonucleic acid (DNA) copies per unit of mass equal to one microgram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 PFU/mL</VALIDVALUE>
          <VALUEMEANING>log10 Plaque Forming Units Per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring plaque forming units per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170631</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241649</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kV</VALIDVALUE>
          <VALUEMEANING>Kilovolt</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electric potential and electromotive force, equal to one thousand volts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170630</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BOWL</VALIDVALUE>
          <VALUEMEANING>Bowl Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of smokable material in a pipe bowl.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C151970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PLUG</VALIDVALUE>
          <VALUEMEANING>Plug Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of presentation used to represent the quantity of product that is found in a single discrete entity where the pharmaceutical dose form is a type of plug.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C149763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NFIU</VALIDVALUE>
          <VALUEMEANING>Normalized Fluorescence Intensity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative fluorescence intensity unit that is adjusted to a reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7244767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MdFI</VALIDVALUE>
          <VALUEMEANING>Median Fluorescence Intensity</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the geometric mean fluorescence intensity of a log-normal distribution of fluorescence signals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ft</VALIDVALUE>
          <VALUEMEANING>International Foot</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of length defined by the U.S. National Bureau of Standards as 30.48 centimeters. It is equal to 0.3048 meter, 12 inches, or to approximately 0.999998 survey foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/min</VALIDVALUE>
          <VALUEMEANING>Microgram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to one minute. Microgram per minute is also a dose administration rate unit equal to the rate at which one millionth of a gram of a product is administered per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6400548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/kg/min</VALIDVALUE>
          <VALUEMEANING>Microgram per Kilogram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one millionth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/kg/h</VALIDVALUE>
          <VALUEMEANING>International Unit per Kilogram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one international unit (an arbitrary unit of biological activity) of a product per one kilogram of body mass administered per unit of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406663</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg/min</VALIDVALUE>
          <VALUEMEANING>Milligram per Kilogram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406665</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/day</VALIDVALUE>
          <VALUEMEANING>Microgram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to twenty four hours. Microgram per 24 hours is also a dose administration rate unit equal to the rate at which one millionth of a gram of a product is administered per unit of time equal to twenty four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6132701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NEBULE</VALIDVALUE>
          <VALUEMEANING>Nebule Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a nebule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>km/h</VALIDVALUE>
          <VALUEMEANING>Kilometer per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one thousand meters travelled per unit time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795699</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kUSP</VALIDVALUE>
          <VALUEMEANING>Kilo United States Pharmacopeia Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency equal to one thousand US Pharmacopoeia Units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71202</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406669</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/cm2</VALIDVALUE>
          <VALUEMEANING>Gram per Square Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of areal density defined as a spread rate at which one gram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71201</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>bel</VALIDVALUE>
          <VALUEMEANING>Bel</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic ratio unit (base-10 logarithms) used to express relative magnitude of a physical quantity (usually power or intensity) in comparison with a specified or implied reference level. Particularly, Bel is used as a unit of relative sound intensity. In the latter context it is equal to ten decibels or to approximately 1.151293 nepers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PFU/mL</VALIDVALUE>
          <VALUEMEANING>Plaque Forming Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency of a biological product expressed as a quantity of viable infectious entities capable to produce a cytopathic effect in the appropriate cell culture per one milliliter of the preparation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PFU/dose</VALIDVALUE>
          <VALUEMEANING>Plaque Forming Unit per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency of a biological product expressed as a quantity of viable infectious entities capable to produce a cytopathic effect in the appropriate cell culture per a single dose of the preparation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71198</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 organisms/mL</VALIDVALUE>
          <VALUEMEANING>Billion Organisms per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism concentration expressed in billions of organisms per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 organisms/mL</VALIDVALUE>
          <VALUEMEANING>Million Organisms per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism concentration expressed in millions of organisms per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/g/day</VALIDVALUE>
          <VALUEMEANING>Milliliter per Gram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per gram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/cage/wk</VALIDVALUE>
          <VALUEMEANING>Milliliter per Cage per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per cage expressed per period of time equal to seven days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/cage/day</VALIDVALUE>
          <VALUEMEANING>Milliliter per Cage per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per cage per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/cage</VALIDVALUE>
          <VALUEMEANING>Milliliter per Cage</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per cage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELISA unit/mL</VALIDVALUE>
          <VALUEMEANING>Enzyme-Linked Immunosorbent Assay Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68877</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELISA unit/dose</VALIDVALUE>
          <VALUEMEANING>Enzyme-Linked Immunosorbent Assay Unit per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELISA unit</VALIDVALUE>
          <VALUEMEANING>Enzyme-Linked Immunosorbent Assay Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring concentration or/and reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference standard for the particular quantitative enzyme-linked immunosorbent assay method. The enzyme-linked immunosorbent assay unit is used to express potency of immunologically active substances and products, e.g. vaccines.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>in2</VALIDVALUE>
          <VALUEMEANING>Square Inch</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of area equal to the area of a square with sides of one inch. It is equal to 6.4516 square centimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68871</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ft3</VALIDVALUE>
          <VALUEMEANING>Standard Cubic Foot</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic foot at 60 degrees Fahrenheit and pressure of one atmosphere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68859</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>scm</VALIDVALUE>
          <VALUEMEANING>Standard Cubic Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic meter at standard (according to DIN 1343 standard) conditions: temperature 273.15 K and pressure of one atmosphere (101.325 kPa).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68858</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>amol</VALIDVALUE>
          <VALUEMEANING>Attomole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount substance equal to one quintillionth of a mole (10E-18 mole).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/g</VALIDVALUE>
          <VALUEMEANING>Mole per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit amount of substance content (molality unit) defined as one mole of solute per one kilogram of solvent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmol</VALIDVALUE>
          <VALUEMEANING>Centimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to one hundredth of a mole (10E-2 mole).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dmol</VALIDVALUE>
          <VALUEMEANING>Decimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to one tenth of a mole (10E-1 mole).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>deg</VALIDVALUE>
          <VALUEMEANING>Degree Unit of Plane Angle</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of plane angle measurement equal to the length of the arc cut out by the angle, divided by the circumference of the circle, and multiplied by 360. The symbol for degrees is a small superscript circle. One radian is about 57 degrees and one degree is pi/180 radians.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/kg</VALIDVALUE>
          <VALUEMEANING>Unit per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in units of biological activity per unit of mass equal to one kilogram. Unit per kilogram is also used as a dose calculation unit expressed in arbitrary units per one kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>titer</VALIDVALUE>
          <VALUEMEANING>Titer</VALUEMEANING>
          <MEANINGDESCRIPTION>Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6/L</VALIDVALUE>
          <VALUEMEANING>Thousand per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed as a number or quantity of objects in thousands per unit of volume equal to one milliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/kg</VALIDVALUE>
          <VALUEMEANING>Milliliter per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one milliliter of preparation per one kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/day</VALIDVALUE>
          <VALUEMEANING>Milliliter per 24 Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter crosses a given surface during the period of time equal to 24 hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/m2</VALIDVALUE>
          <VALUEMEANING>Milligram per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of areal density equal to approximately 2.94935E-5 ounce per square yard. Also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/h/m2</VALIDVALUE>
          <VALUEMEANING>Liter Per Hour Per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit expressed as one liter of volume per unit of time equal to one hour per square meter of area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/g/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per Gram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per gram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/g/h</VALIDVALUE>
          <VALUEMEANING>Milliliter per Gram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per gram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100 WBC</VALIDVALUE>
          <VALUEMEANING>Per 100 White Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit for measurement of portion of a particular type of blood cells (such as any type of white blood cells or nucleated red blood cells) in the total white blood cell count expressed per count of 100.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kg/L</VALIDVALUE>
          <VALUEMEANING>Kilogram per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one kilogram of a substance in unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one kilogram occupies the volume one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SFC/10^6 PBMC</VALIDVALUE>
          <VALUEMEANING>Spot Forming Units Per Million Peripheral Blood Mononuclear Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the spot forming units per million cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120850</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/h</VALIDVALUE>
          <VALUEMEANING>Milligram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725048</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/min</VALIDVALUE>
          <VALUEMEANING>Per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of occurrences of something within a minute of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/h</VALIDVALUE>
          <VALUEMEANING>Per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A frequency rate of occurrences of something within a period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/s</VALIDVALUE>
          <VALUEMEANING>Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of occurrences of something within a second of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/h</VALIDVALUE>
          <VALUEMEANING>Milliliter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter crosses a given surface during the period of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tuberculin unit</VALIDVALUE>
          <VALUEMEANING>Tuberculin Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of tuberculin dosage defined by comparison of clinical response to a preparation of the purified protein derivative standardized for use in humans for tuberculin skin test reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm2</VALIDVALUE>
          <VALUEMEANING>Square Millimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of area measurement equal to a square measuring one millimeter on each side. One square millimeter is equal to 10(E-2) square centimeter and 10(E-6) square meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65104</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PUFF</VALIDVALUE>
          <VALUEMEANING>Puff Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to a metered dose of medicinal substance(s) that is delivered in uniform quantity upon each activation of a medical device (e.g. an inhaler), in which the dosage form is contained.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/mL</VALIDVALUE>
          <VALUEMEANING>Becquerel per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one becquerel per unit volume equal to one milliliter or one kilobecquerel per liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406592</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/uL</VALIDVALUE>
          <VALUEMEANING>Becquerel per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one becquerel per unit volume equal to one millionth of a liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71166</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/L</VALIDVALUE>
          <VALUEMEANING>Becquerel per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one becquerel per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/ug</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance content equivalent to the content at which one millionth of a gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70581</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/g</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance content equivalent to the content at which one gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70580</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/uL</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of milliequivalents of solute per microliter of solution.(NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70578</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406602</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Roentgen</VALIDVALUE>
          <VALUEMEANING>Roentgen</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of exposure to ionizing radiation in CGS system. One roentgen is the amount of gamma or x-rays required to produce ions resulting in a charge of 2.58E-4 coulombs/kilogram of air under standard conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70575</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uCi/kg</VALIDVALUE>
          <VALUEMEANING>Microcurie per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one microcurie of the sample with total mass of one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uL</VALIDVALUE>
          <VALUEMEANING>Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volume equal to one millionth of a liter or one one thousandth of a milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48153</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol</VALIDVALUE>
          <VALUEMEANING>Micromole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to a millionth of a mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/day</VALIDVALUE>
          <VALUEMEANING>Micromole per 24 Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance flow rate equivalent to the rate at which one millionth of a mole of substance crosses a given surface or is delivered to a given object or space over a period of time equal to 24 hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/dL</VALIDVALUE>
          <VALUEMEANING>Micromole per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of concentration (molarity unit) equal to one millionth of mole of a solute in one deciliter of the solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/L</VALIDVALUE>
          <VALUEMEANING>Micromole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one one-millionth of a mole (10E-6 mole) of solute per one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4094774</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mU/L</VALIDVALUE>
          <VALUEMEANING>Microunit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration equal to the concentration at which one milliliter of mixture contains one millionth of a unit of a substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GPL U</VALIDVALUE>
          <VALUEMEANING>IgG Phospholipid Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with negatively charged phospholipids evaluated in ELISA serum anticardiolipin or anionic phospholipid assay against an established reference standard. One IgG phospholipid unit is equivalent to one mg/mL of an affinity-purified standard IgG sample obtained from specified individuals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU</VALIDVALUE>
          <VALUEMEANING>International Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The unitage assigned by the WHO to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization (e.g. hormones, enzymes, and vaccines), to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48579</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/mL</VALIDVALUE>
          <VALUEMEANING>International Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MPL U</VALIDVALUE>
          <VALUEMEANING>IgM Phospholipid Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with negatively charged phospholipids evaluated in ELISA serum anticardiolipin or anionic phospholipid assay against an established reference standard. One IgM phospholipid unit is equivalent to one mg/mL of an affinity-purified standard IgM sample obtained from the specified individuals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2721397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RNA copies/mL</VALIDVALUE>
          <VALUEMEANING>Copy per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration of RNA copies expressed as a number of copies per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 RNA copies/mL</VALIDVALUE>
          <VALUEMEANING>Thousand RNA Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one thousand ribonucleic acid (RNA) copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406730</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3/hpf</VALIDVALUE>
          <VALUEMEANING>Thousand per High Powered Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one thousand entities per unit of area equal to one high powered field.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 DNA copies/mL</VALIDVALUE>
          <VALUEMEANING>Thousand DNA Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one thousand deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98788</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^4/hpf</VALIDVALUE>
          <VALUEMEANING>Ten Thousand per High Powered Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to ten thousand entities per unit of area equal to one high powered field.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98787</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7/L</VALIDVALUE>
          <VALUEMEANING>Ten Million per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to ten million entities per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 RNA copies/mL</VALIDVALUE>
          <VALUEMEANING>Million RNA Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one million ribonucleic acid (RNA) copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98760</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6/hpf</VALIDVALUE>
          <VALUEMEANING>Million per High Powered Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one million entities per unit of area equal to one high powered field.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98759</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6/g</VALIDVALUE>
          <VALUEMEANING>Million per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one million entities per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SBE/mL</VALIDVALUE>
          <VALUEMEANING>Standardized Allergy Biological Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of allergenic product potency expressed as the number of standardized biological units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SQU/mL</VALIDVALUE>
          <VALUEMEANING>Standardized Allergy Quality Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of allergenic product potency expressed as the number of standardized quality units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405619</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STEPS</VALIDVALUE>
          <VALUEMEANING>Step Unit of Distance</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure to quantify the number of strides taken during a normal walking gait.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Torr</VALIDVALUE>
          <VALUEMEANING>Torr</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI unit of pressure equal to 1/760 of a standard atmosphere (a standard atmosphere being defined as equal to 101 325 pascals). One Torr is equal to 133.3223684 pascals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VIRTUAL PIXEL</VALIDVALUE>
          <VALUEMEANING>Virtual Pixel</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of pixel created from overlying two adjacent real pixels to create an additional virtual image of a pixel that is visible to the human eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/h/mmol</VALIDVALUE>
          <VALUEMEANING>Micromole per Hour per Millimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of fraction expressed as the ratio of the number of micromoles of substance per unit of time equal to one hour, to the amount of a different substance, in millimoles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/L/h</VALIDVALUE>
          <VALUEMEANING>Micromole per Liter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uU/dL</VALIDVALUE>
          <VALUEMEANING>Micro-Unit per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in microunit(s) per deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uU/L</VALIDVALUE>
          <VALUEMEANING>Micro-Unit per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in microunit(s) per liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>vg/dose</VALIDVALUE>
          <VALUEMEANING>Vector Genomes per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for cloning vector amounts expressed as the number of vector genomes per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>vg/mL</VALIDVALUE>
          <VALUEMEANING>Vector Genomes per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for cloning vector amounts expressed as the number of vector genomes per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>vp/dose</VALIDVALUE>
          <VALUEMEANING>Viral Particles per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for virus amount expressed as the number of viral particles per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>vp/mL</VALIDVALUE>
          <VALUEMEANING>Viral Particles per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for virus amount expressed as the number of viral particles per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absorbance U/mL</VALIDVALUE>
          <VALUEMEANING>Absorbance Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of optical density expressed as the absorbance of light transmitted through the medium on the logarithmic scale per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>copies/ug</VALIDVALUE>
          <VALUEMEANING>Copies per Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration expressed as a number of copies per unit mass equal to one microgram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126079</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm3/mm2/year</VALIDVALUE>
          <VALUEMEANING>Cubic Millimeter per Square Millimeter per Year</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit defined as the number of cubic millimeters of substance per area equal to one square millimeter per unit of time equal to one year.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126080</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>um/day</VALIDVALUE>
          <VALUEMEANING>Micrometer per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volumetric flow rate defined as the rate at which one micrometer of matter crosses a given surface during the period of time equal to one day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126081</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/kg/min</VALIDVALUE>
          <VALUEMEANING>Micromole per Kilogram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one millionth of a mole (10E-6 mole) per kilogram of a substance per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1/(s*kPa)</VALIDVALUE>
          <VALUEMEANING>One per Second Times Kilopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to the inverse of one kilopascal multiplied by a unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127804</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MET</VALIDVALUE>
          <VALUEMEANING>Metabolic Equivalent of Task Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy expenditure equal to the ratio of the metabolic rate during physical activity in comparison to a reference metabolic rate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127805</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6352134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MET*h</VALIDVALUE>
          <VALUEMEANING>Metabolic Equivalent of Task Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy expenditure equal to the number of metabolic equivalent of task units multiplied by the number of hours of performed activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MET*min</VALIDVALUE>
          <VALUEMEANING>Metabolic Equivalent of Task Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy expenditure equal to the number of metabolic equivalent units multiplied by the number of minutes of performed activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405970</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/beat</VALIDVALUE>
          <VALUEMEANING>Milliliter per Heartbeat</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed as the number of milliliter(s) per heart beat.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127808</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405973</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mN</VALIDVALUE>
          <VALUEMEANING>Millinewton</VALUEMEANING>
          <MEANINGDESCRIPTION>An SI derived unit of force equal to one thousandth of a Newton.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PHERESIS UNIT</VALIDVALUE>
          <VALUEMEANING>Pheresis Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration equal to the yield from a blood pheresis procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127810</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BEAM BREAKS</VALIDVALUE>
          <VALUEMEANING>Beam Break Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of measure for the number of times in which light paths are interrupted by movement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dpm/0.5 mL</VALIDVALUE>
          <VALUEMEANING>Disintegrations per Minute per 0.5 Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a volume unit equal to a half milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EIA unit</VALIDVALUE>
          <VALUEMEANING>Enzyme Immunoassay Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring concentration or/and reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference standard for the particular quantitative enzyme immunoassay method.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fmol/L/s</VALIDVALUE>
          <VALUEMEANING>Femtomole per Liter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit equal to one femtomole of solute in one liter of solution per unit of time equal to one second. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cy/cm</VALIDVALUE>
          <VALUEMEANING>Grating Cycles per Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the number of repeating vertical or horizontal bars per unit of length equal to one centimeter on a visual acuity testing card.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HEP</VALIDVALUE>
          <VALUEMEANING>Histamine Equivalent Prick Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of allergenic product potency expressed as the number of histamine equivalent prick units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APL U</VALIDVALUE>
          <VALUEMEANING>IgA Phospholipid Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122202</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APL U/mL</VALIDVALUE>
          <VALUEMEANING>Immunoglobin A Phospholipid Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with negatively charged phospholipids evaluated in ELISA serum anticardiolipin or anionic phospholipid assay against an established reference standard, per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GPL U/mL</VALIDVALUE>
          <VALUEMEANING>Immunoglobin G Phospholipid Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with negatively charged phospholipids evaluated in ELISA serum anticardiolipin or anionic phospholipid assay against an established reference standard, per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MPL U/mL</VALIDVALUE>
          <VALUEMEANING>Immunoglobin M Phospholipid Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with negatively charged phospholipids evaluated in ELISA serum anticardiolipin or anionic phospholipid assay against an established reference standard, per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/dL</VALIDVALUE>
          <VALUEMEANING>International Unit per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one deciliter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120848</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405672</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/g Hb</VALIDVALUE>
          <VALUEMEANING>International Unit per Gram Hemoglobin</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (biologic activity) equal to one international unit of substance per gram of hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/mmol</VALIDVALUE>
          <VALUEMEANING>International Unit per Millimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (biologic activity) equal to one international unit of substance per millimole of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405704</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/kg/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per Kilogram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per kilogram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73760</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3652834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/min/mmHg</VALIDVALUE>
          <VALUEMEANING>Milliliter per Minute per Millimeters of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring a pulmonary diffusing capacity expressed in units of gas flow rate (in milliliters per minute) per a unit of pressure (in torrs).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/mmHg/min/L</VALIDVALUE>
          <VALUEMEANING>Milliliter per Minute per Millimeters of Mercury per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring a pulmonary diffusing capacity adjusted for lung volume expressed in units of gas flow rate (in milliliters per minute) per a unit of pressure (in torrs) per one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67418</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/s</VALIDVALUE>
          <VALUEMEANING>Milliliter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter crosses a given surface during the period of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>day*ng/mL/(mg/kg)</VALIDVALUE>
          <VALUEMEANING>Day Times Nanogram Per Milliliter Per Milligram Per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>Days times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/animal</VALIDVALUE>
          <VALUEMEANING>Per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one animal used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198368</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^10 copies/mL</VALIDVALUE>
          <VALUEMEANING>Ten Billion Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the tenth power copies in unit volume equal to one milliliter. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^10 IU/mL</VALIDVALUE>
          <VALUEMEANING>Ten Billion International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the tenth power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198371</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^10 vp/dose</VALIDVALUE>
          <VALUEMEANING>Ten Billion Viral Particles per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for virus amount equal to 10 to the tenth power of the number of viral particles per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433716</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^10 vp/mL</VALIDVALUE>
          <VALUEMEANING>Ten Billion Viral Particles per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for virus concentration equal to 10 to the tenth power of the number of viral particles per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198373</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 IU/mL</VALIDVALUE>
          <VALUEMEANING>Thousand International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the third power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198374</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/g</VALIDVALUE>
          <VALUEMEANING>Per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one gram used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^4 copies/mL</VALIDVALUE>
          <VALUEMEANING>Ten Thousand Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the fourth power copies in unit volume equal to one milliliter. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^4 IU/mL</VALIDVALUE>
          <VALUEMEANING>Ten Thousand International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the fourth power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5 CFU</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of colony forming cells or microorganisms equal to 10 to the fifth power colony forming units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5 copies/mL</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the fifth power copies in unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433722</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6/kg</VALIDVALUE>
          <VALUEMEANING>Million per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the sixth power of the number of entities per unit of mass equal to one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433724</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7 copies/mL</VALIDVALUE>
          <VALUEMEANING>Ten Million Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the seventh power copies in unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7 IU/mL</VALIDVALUE>
          <VALUEMEANING>Ten Million International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the seventh power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8 CFU</VALIDVALUE>
          <VALUEMEANING>Hundred Million Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of colony forming cells or microorganisms equal to 10 to the eighth power colony forming units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8 copies/mL</VALIDVALUE>
          <VALUEMEANING>One Hundred Million Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the eight power copies in unit volume equal to one milliliter. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5 IU/mL</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand International Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the fifth power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8 IU/mL</VALIDVALUE>
          <VALUEMEANING>One Hundred Million International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the eight power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 copies/mL</VALIDVALUE>
          <VALUEMEANING>Billion Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the ninth power copies in unit volume equal to one milliliter. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433730</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 IU/mL</VALIDVALUE>
          <VALUEMEANING>Billion International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the ninth power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9/uL</VALIDVALUE>
          <VALUEMEANING>Billion per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the ninth power of entities per unit of volume equal to one microliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/ston_av</VALIDVALUE>
          <VALUEMEANING>Gram per Short Ton</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in gram(s) per short ton (US).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GLASS</VALIDVALUE>
          <VALUEMEANING>Glass Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the glass unit. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433735</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 minutes of arc</VALIDVALUE>
          <VALUEMEANING>Log10 Arcminutes</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring angular equal to 1/60 degree or to 60 arcseconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 U/mL</VALIDVALUE>
          <VALUEMEANING>Log10 Arbitrary Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring arbitrary units per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>lton_av</VALIDVALUE>
          <VALUEMEANING>Long Ton</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of mass in the United Kingdom equal to 2,240 pounds or 1.017 metric tons.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>copies/cell</VALIDVALUE>
          <VALUEMEANING>Copies per Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration expressed as a number of copies per cell.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433733</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/dL</VALIDVALUE>
          <VALUEMEANING>Nanomole per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one nanomole of solute in one deciliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433739</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/mg/h</VALIDVALUE>
          <VALUEMEANING>Nanomole per Milligram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in nanomole(s) per milligram per period of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198396</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Organisms/g</VALIDVALUE>
          <VALUEMEANING>Organism Per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism content expressed in organisms per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Organisms/mL</VALIDVALUE>
          <VALUEMEANING>Organism Per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism concentration expressed in organisms per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ston_av</VALIDVALUE>
          <VALUEMEANING>Short Ton</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of mass in the United States equal to 2,000 pounds or 0.907 metric tons.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/mg/min</VALIDVALUE>
          <VALUEMEANING>Nanomole per Milligram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in nanomole(s) per milligram per period of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/400 Cells</VALIDVALUE>
          <VALUEMEANING>Per 400 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of entities per 400 total cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SFC/10^5 PBMC</VALIDVALUE>
          <VALUEMEANING>Spot Forming Units Per Ten Thousand Peripheral Blood Mononuclear Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per one hundred thousand peripheral blood mononuclear cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SFC/2x10^5 PBMC</VALIDVALUE>
          <VALUEMEANING>Spot Forming Units Per Twenty Thousand Peripheral Blood Mononuclear Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per two hundred thousand peripheral blood mononuclear cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191357</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/10^3 RBC</VALIDVALUE>
          <VALUEMEANING>Per Thousand Red Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell (excluding red blood cell subtypes) per one thousand red blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>daPa</VALIDVALUE>
          <VALUEMEANING>Decapascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure equivalent to ten Pascals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arbitrary U/mL</VALIDVALUE>
          <VALUEMEANING>Arbitrary Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit based on or subject to individual judgment, preference, or predetermined reference per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191361</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nm/min</VALIDVALUE>
          <VALUEMEANING>Nanometer Per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one nanometer travelled per unit time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100 RBC</VALIDVALUE>
          <VALUEMEANING>Per 100 Red Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell (excluding red blood cell subtypes) per one hundred red blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191358</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Binding Ab Unit</VALIDVALUE>
          <VALUEMEANING>Binding Antibody Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of measure that is used to compare binding antibody assays that detect the same class of immunoglobulins with the same specificity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189120</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13361745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tonne</VALIDVALUE>
          <VALUEMEANING>Ton</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass equal to 1000 kilograms, or 2204.623 pounds avoirdupois.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Organisms</VALIDVALUE>
          <VALUEMEANING>Organism-Based Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71186</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13361746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10 copies/mL</VALIDVALUE>
          <VALUEMEANING>Ten Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to ten copies of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10 IU/mL</VALIDVALUE>
          <VALUEMEANING>Ten International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to ten international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>100 copies/mL</VALIDVALUE>
          <VALUEMEANING>Hundred Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one hundred copies of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100x FIELD</VALIDVALUE>
          <VALUEMEANING>Per 100x Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of the number of entities per microscopic field at 100x magnification.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199995</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ACTUATION</VALIDVALUE>
          <VALUEMEANING>Actuation Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in an actuation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14549121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/punch/h</VALIDVALUE>
          <VALUEMEANING>Picomole per Punch Observational Unit per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit expressed as the number of picomoles per punch observational unit per hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201485</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14549122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>(mmHg*min/L)*m2</VALIDVALUE>
          <VALUEMEANING>Millimeter Mercury times Minute per Liter times Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to the number of millimeters of mercury times minutes, per unit of volume equal to one liter times meters squared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14549123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmH2O/mL/s</VALIDVALUE>
          <VALUEMEANING>Centimeter of Water per Milliliter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure defined as centimeters of water per unit of volume equal to one milliliter per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14549124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m2/s</VALIDVALUE>
          <VALUEMEANING>Meter Squared per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of diffusion coefficient in SI system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14549125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uL/L</VALIDVALUE>
          <VALUEMEANING>Microliter per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume concentration equal to one microliter per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202451</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14688612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/50 Cells</VALIDVALUE>
          <VALUEMEANING>Per 50 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of entities per 50 total cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14688613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100 Cells</VALIDVALUE>
          <VALUEMEANING>Per 100 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of entities per 100 total cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14688614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/Cell</VALIDVALUE>
          <VALUEMEANING>Per Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of entities per one cell.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14688615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/PLATE</VALIDVALUE>
          <VALUEMEANING>Per Plate</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the instances of an entity per culture plate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204701</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CUTS/in</VALIDVALUE>
          <VALUEMEANING>Cuts per Inch</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the number of physical cuts made per one inch of a tobacco leaf.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cu</VALIDVALUE>
          <VALUEMEANING>Coresta Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for air permeability defined as the volumetric flow rate of air (cm3 min-1) passing through a 1 cm2 sample of substrate at an applied pressure difference of 1 kPa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204703</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm2/s</VALIDVALUE>
          <VALUEMEANING>Square Centimeter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived metric unit of kinematic viscosity expressed as centimeters squared per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/9000m</VALIDVALUE>
          <VALUEMEANING>Gram per 9000 Meters</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the linear mass density of fibers in grams per 9000 meters of the fiber.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/cm3</VALIDVALUE>
          <VALUEMEANING>Gram per Cubic Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one cubed centimeter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204706</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mAh</VALIDVALUE>
          <VALUEMEANING>Milliampere Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy or power equal to one thousandth of an ampere hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204707</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mPa/s</VALIDVALUE>
          <VALUEMEANING>Millipascal per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of pressure equivalent to one thousandth of one pascal per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204708</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/cm3</VALIDVALUE>
          <VALUEMEANING>Per Cubic Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A volume unit equal to one centimeter squared used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204709</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/m2/s</VALIDVALUE>
          <VALUEMEANING>Liter per Square Meter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in liter(s) per square meter per period of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204710</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm H2O</VALIDVALUE>
          <VALUEMEANING>Millimeter of Water Column</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI manometric unit of pressure defined by a column of water at 4 degrees Celsius with a height of one millimeter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69107</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14902097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100 Enterocytes</VALIDVALUE>
          <VALUEMEANING>per 100 Enterocytes</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell per one hundred enterocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209700</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmolEq</VALIDVALUE>
          <VALUEMEANING>Nanomole Equivalents</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance equal to one billionth of a mole of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/mmol</VALIDVALUE>
          <VALUEMEANING>Curie per Millimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie in one millimole of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209703</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253619</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/EXOME</VALIDVALUE>
          <VALUEMEANING>Per Exome</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to an exome used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209701</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AGGREGATION UNIT</VALIDVALUE>
          <VALUEMEANING>Aggregation Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of measure for particle aggregation which is derived from an increase in sample impedance as aggregation occurs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FINGERTIP LENGTH UNIT</VALIDVALUE>
          <VALUEMEANING>Fingertip Unit of Length</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of length defined as the length from the tip of the index finger to the first finger crease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GBq/umol</VALIDVALUE>
          <VALUEMEANING>Gigabecquerel per Micromole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to the activity of one gigabecquerel in one micromole of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253625</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 copies</VALIDVALUE>
          <VALUEMEANING>log10 Copy</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring the number of copies of an entity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209706</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RELATIVE U</VALIDVALUE>
          <VALUEMEANING>Relative Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of measure that is expressed in relation to a test-specific internal standard; it is dependent on instrument and measurement parameters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209707</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RELATIVE U/mL</VALIDVALUE>
          <VALUEMEANING>Relative Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of measure that is expressed in relation to a test-specific internal standard per unit of volume equal to one milliliter; it is dependent on instrument and measurement parameters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209708</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/CIGARETTE</VALIDVALUE>
          <VALUEMEANING>Milligram per Cigarette</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass equal to one milligram per cigarette dosing unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/PUFF</VALIDVALUE>
          <VALUEMEANING>Milligram per Puff</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass equal to one milligram per puff dosing unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/CIGARETTE</VALIDVALUE>
          <VALUEMEANING>Nanogram per Cigarette</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass equal to one nanogram per cigarette dosing unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210340</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/PUFF</VALIDVALUE>
          <VALUEMEANING>Nanogram per Puff</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass equal to one nanogram per puff dosing unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210341</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PUFF/min</VALIDVALUE>
          <VALUEMEANING>Puffs per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of inhalational puffs taken per minute unit of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/CIGARETTE</VALIDVALUE>
          <VALUEMEANING>Microgram per Cigarette</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass equal to one microgram per cigarette dosing unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FILM</VALIDVALUE>
          <VALUEMEANING>Film Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a film.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 TCID 50</VALIDVALUE>
          <VALUEMEANING>Log10 50 Percent Tissue Culture Infective Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to a base-10 logarithm of amount of product or agent preparation that causes infection in the 50% of the tissue culture-containing flasks inoculated with that dilution of infectious material in the product potency assay or pathogen activity assay.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HAND UNIT</VALIDVALUE>
          <VALUEMEANING>Hand Unit of Length</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of length equal to 4 inches or 10.16 centimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/PUFF</VALIDVALUE>
          <VALUEMEANING>Microgram per Puff</VALUEMEANING>
          <MEANINGDESCRIPTION>Micrograms per puff.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ugEq/mL</VALIDVALUE>
          <VALUEMEANING>Microgram Equivalents Per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of microgram equivalent of solute per milliliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INJECTION</VALIDVALUE>
          <VALUEMEANING>Injection Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in an injection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg*m2/L/min</VALIDVALUE>
          <VALUEMEANING>Millimeter Mercury times Square Meter per Liter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to the number of millimeters of mercury times meters squared, per unit of volume equal to one liter per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SFC/WELL</VALIDVALUE>
          <VALUEMEANING>Spot Forming Cells per Well</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per one culture plate well.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/WELL</VALIDVALUE>
          <VALUEMEANING>Per Culture Plate Well</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the instances of an entity per culture plate well.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/um2</VALIDVALUE>
          <VALUEMEANING>per Square Micrometer</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one square micrometer used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214759</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/kg/s</VALIDVALUE>
          <VALUEMEANING>Millimole per Kilogram per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in millimole(s) per kilogram per period of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214760</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ABC</VALIDVALUE>
          <VALUEMEANING>Antibody Binding Capacity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the number of target molecules per cell as determined by actual binding of a labeled antibody to a target.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the unit of the wheal mean diameter measurement?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC SDTM Unit of Measure Terminology</Name>
        <DocumentType>VALID_VALUE_SOURCE</DocumentType>
        <DocumentText>Terminology codelist used with Units of Measure within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model.</DocumentText>
        <URL>https://ncit.nci.nih.gov/ncitbrowser/ajax?action=create_src_vs_tree&amp;amp;vsd_uri=http%3A//evs.nci.nih.gov/valueset/CDISC/C71620</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record or select the original units in which these data were collected, if not pre-printed on CRF.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SRORRESU</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>Should be pre-printed on the CRF with the associated test when possible, rather than collected in a field that requires the site to enter text.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Wheal Mean Diameter Unit</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Publication Package</Name>
        <DocumentType>CDISC EVS Controlled Terminology Update</DocumentType>
        <DocumentText>CDISC value sets have been updated to the P41 publication version (2020-03-27).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the unit of the wheal mean diameter measurement?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Recommended/Conditional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329810</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Skin Response (SR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Skin Response (SR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943407</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SR_SRORRESU_WHLMDIM</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="388">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6413066</PUBLICID>
    <LONGNAME>Subcategory for Vital Signs</LONGNAME>
    <PREFERREDNAME>VSSCAT</PREFERREDNAME>
    <PREFERREDDEFINITION>A sub-division of the VSCAT values based on user defined characteristics.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6412938</PublicId>
      <PreferredName>6354444v1.0:6412936v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to vital sign._A subdivision of vital signs data.</PreferredDefinition>
      <LongName>Vital Signs Domain Vital Signs Subcategory</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6354444</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49622</PreferredName>
        <Version>1</Version>
        <LongName>Vital Signs Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49622</PREFERRED_NAME>
            <LONG_NAME>Vital Signs Domain</LONG_NAME>
            <CON_ID>2469086</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6412936</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83461</PreferredName>
        <Version>1</Version>
        <LongName>Vital Signs Subcategory</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83461</PREFERRED_NAME>
            <LONG_NAME>Vital Signs Subcategory</LONG_NAME>
            <CON_ID>6412935</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the subcategory of t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the subcategory of the vital signs?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the vital signs subcategory, if not pre-printed on the CRF.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>VSSCAT</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>Sponsor-defined Controlled Terminology. This would most commonly be either a heading, or a pre-printed category value on the CRF and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as &quot;Subcategory&quot; can be included as the column header. VSSCAT can only be used if there is a VSCAT and it must be a subcategorization of VSCAT.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[Vital Signs Subcategory]; NULL</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[Vital Signs Subcategory]; NULL</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vital Signs (VS) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329814</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Semantically Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685479</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Vital Signs (VS) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943413</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>VS_VSSCAT</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="389">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6421593</PUBLICID>
    <LONGNAME>Primary Cause of Death</LONGNAME>
    <PREFERREDNAME>PRCDTH_DDORRES</PREFERREDNAME>
    <PREFERREDDEFINITION>Result of the death detail assessment, as originally received or collected.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6421575</PublicId>
      <PreferredName>6408103v1.0:6421573v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to death diagnosis._The first significant event which ultimately led to death._The outcome of the death diagnosis assessment as originally received or collected.</PreferredDefinition>
      <LongName>Death Diagnosis Domain Primary Cause of Death Death Diagnosis Original Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6408103</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95087</PreferredName>
        <Version>1</Version>
        <LongName>Death Diagnosis Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95087</PREFERRED_NAME>
            <LONG_NAME>Death Diagnosis Domain</LONG_NAME>
            <CON_ID>6408102</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6421573</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C99531:C117546</PreferredName>
        <Version>1</Version>
        <LongName>Primary Cause of Death Death Diagnosis Original Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C99531</PREFERRED_NAME>
            <LONG_NAME>Primary Cause of Death</LONG_NAME>
            <CON_ID>6421571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117546</PREFERRED_NAME>
            <LONG_NAME>Death Diagnosis Original Result</LONG_NAME>
            <CON_ID>6421572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Result</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the primary cause of</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the primary cause of death?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form  Completion Instructions</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the primary cause of death.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DDORRES; DDTEST; DDTESTCD;</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If other cause of death, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Primary cause, other</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Primary cause, other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 4783275 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Due to other cause, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the primary cause of death?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the primary cause of death?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Primary cause of death</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Primary cause of death</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Death (DD) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Death (DD) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000714</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Survival and Follow-Up - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318690</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Follow Up/Survival</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7475678</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Moonshot Biobank</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13484615</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTDC CDISC CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14645981</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Death (DD) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943376</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DDDTHRNX</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DD_DDORRES_PRIM_OTHS</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DD_DDORRES_PRCDTH</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DD_DDORES_PRIM_OTHS</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>primary_cause_of_death</AlternateName>
        <AlternateNameType>CMB Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>primary_cause_of_death</AlternateName>
        <AlternateNameType>CTDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DD</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRCDTH_DDORRES</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="390">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6422452</PUBLICID>
    <LONGNAME>Medical Condition Performed Observation Outcome Condition Status Change Reason OMOP CDM Condition Stop Reason</LONGNAME>
    <PREFERREDNAME>stop_reason</PREFERREDNAME>
    <PREFERREDDEFINITION>Relating to the study or practice of medicine._A state of being, such as a state of health._Executed and carried through to completion._Watching something and taking note of what happens._The result of an action._A state of being, such as a state of health._A condition or state at a particular time._The act of alteration or modification; changed or altered in form or character._An explanation of the cause of some phenomenon or action._The reason that the condition was no longer present, as indicated in the source data.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>OMOP CDM:The Observational Medical Outcomes Partnership (OMOP) Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6422412</PublicId>
      <PreferredName>3757329v1.0:6422410v1.0</PreferredName>
      <PreferredDefinition>Relating to the study or practice of medicine._A state of being, such as a state of health._Executed and carried through to completion._Watching something and taking note of what happens._The result of an action._A state of being, such as a state of health._A condition or state at a particular time._The act of alteration or modification; changed or altered in form or character._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Medical Condition Performed Observation Outcome Condition Status Change Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3757329</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3757329v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Medical Condition Performed Observation Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25261</PREFERRED_NAME>
            <LONG_NAME>Medical</LONG_NAME>
            <CON_ID>2202452</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25457</PREFERRED_NAME>
            <LONG_NAME>Condition</LONG_NAME>
            <CON_ID>2202899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6422410</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25457:C25688:C25446:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Condition Status Change Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25457</PREFERRED_NAME>
            <LONG_NAME>Condition</LONG_NAME>
            <CON_ID>2202899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BRIDG:Biomedical Research Integrated Domain Group</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6382930</PublicId>
      <PreferredName>6382930v1.0</PreferredName>
      <PreferredDefinition>The reason that the condition was no longer present, as indicated in the source data.</PreferredDefinition>
      <LongName>OMOP CDM Condition Stop Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>varchar</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>OMOP CDM:The Observational Medical Outcomes Partnership (OMOP) Common Data Model</Origin>
      <Representation>
        <PublicId>2240632</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Condition no longer present</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Condition no longer present</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5279492</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>OMOP 5.31</PreferredName>
          <Version>5.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Condition Occurrence</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>8003195</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>stop_reason</AlternateName>
        <AlternateNameType>OMOP Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CONDITION_OCCURRENCE</AlternateName>
        <AlternateNameType>OMOP Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="391">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6423242</PUBLICID>
    <LONGNAME>Consultation Medical Student Present Yes No Indicator</LONGNAME>
    <PREFERREDNAME>6423241v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator related to a medical student being present at the consultation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6423241</PublicId>
      <PreferredName>6423220v1.0:6423239v1.0</PreferredName>
      <PreferredDefinition>A conference between two or more people to consider a particular question; the act of deliberating together; confering with another researcher, physician, or expert about an issue or a case._Relating to the study or practice of medicine._A person who is enrolled in an educational institution._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Consultation Medical Student Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6423220</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41188</PreferredName>
        <Version>1</Version>
        <LongName>Consultation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41188</PREFERRED_NAME>
            <LONG_NAME>Consultation</LONG_NAME>
            <CON_ID>2747447</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6423239</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25261:C75561:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Medical Student Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25261</PREFERRED_NAME>
            <LONG_NAME>Medical</LONG_NAME>
            <CON_ID>2202452</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C75561</PREFERRED_NAME>
            <LONG_NAME>Student</LONG_NAME>
            <CON_ID>2787652</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Medical student</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Medical student</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="392">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6438195</PUBLICID>
    <LONGNAME>Esophagus and Esophagogastric Junction Adenocarcinoma AJCC Edition 8 Pathologic Regional Lymph Node N Category</LONGNAME>
    <PREFERREDNAME>ESAD_AJC8_PTH_N_CAT</PREFERREDNAME>
    <PREFERREDDEFINITION>Extent of the regional lymph node involvement for esophageal and esophagogastric junction adenocarcinoma based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6438165</PublicId>
      <PreferredName>6438155v1.0:2428379v1.0</PreferredName>
      <PreferredDefinition>A malignant tumor with glandular differentiation arising predominantly from Barrett mucosa in the lower third of the esophagus.  Rare examples of esophageal adenocarcinoma deriving from ectopic gastric mucosa in the upper esophagus have also been reported.  Grossly, esophageal adenocarcinomas are similar to esophageal squamous cell carcinomas.  Microscopically, adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular.  The prognosis is poor._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.</PreferredDefinition>
      <LongName>Esophageal Adenocarcinoma Pathologic N Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6438155</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4025</PreferredName>
        <Version>1</Version>
        <LongName>Esophageal Adenocarcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4025</PREFERRED_NAME>
            <LONG_NAME>Esophageal Adenocarcinoma</LONG_NAME>
            <CON_ID>4722732</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2428379</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25610:C25580</PreferredName>
        <Version>1</Version>
        <LongName>Pathologic N Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25610</PREFERRED_NAME>
            <LONG_NAME>Pathologic</LONG_NAME>
            <CON_ID>2204850</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25580</PREFERRED_NAME>
            <LONG_NAME>N Category</LONG_NAME>
            <CON_ID>2204625</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6437882</PublicId>
      <PreferredName>6437882v1.0</PreferredName>
      <PreferredDefinition>A finding about one or more characteristics of esophagus and esophagogastric junction cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to carcinomas including squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, undifferentiated carcinoma, neuroendocrine cancers, and adenocarcinoma with neuroendocrine features. Sarcomas, nonepithelial cancers, and gastrointestinal stromal tumors are not staged using this staging system. (from AJCC 8th Ed.)_One criteria of the TNM staging system. N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Esophagus and Esophagogastric Junction Carcinoma American Joint Committee on Cancer Edition 8 N Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
      <Representation>
        <PublicId>6437881</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C133365:C25580:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Esophagus and Esophagogastric Junction Cancer TNM Finding v8 N Category Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C133365</PREFERRED_NAME>
            <LONG_NAME>Esophagus and Esophagogastric Junction Cancer TNM Finding v8</LONG_NAME>
            <CON_ID>6437841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25580</PREFERRED_NAME>
            <LONG_NAME>N Category</LONG_NAME>
            <CON_ID>2204625</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N3</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pN3 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with metastasis in seven or more regional lymph nodes. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N2</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pN2 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with metastasis in three to six regional lymph nodes. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N1</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pN1 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with metastasis in one or two regional lymph nodes. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N0</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pN0 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with no metastasis to regional lymph nodes. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NX</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pNX TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer in which the regional lymph nodes cannot be assessed.  (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pathologic N category</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pathologic N category</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AJCC Edition 8</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6005920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Esophagus and Esophagogastric Junction</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6437866</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="393">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6438303</PUBLICID>
    <LONGNAME>Treatment Quantity Dose</LONGNAME>
    <PREFERREDNAME>Daily_Dose_7</PREFERREDNAME>
    <PREFERREDDEFINITION>the measured quantity of an administered therapy._the dose in milligrams.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014023</PublicId>
      <PreferredName>TX_QTY</PreferredName>
      <PreferredDefinition>the measured quantity of an administered therapy.</PreferredDefinition>
      <LongName>Treatment Quantity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176930</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Treatment</PreferredName>
        <Version>1</Version>
        <LongName>Treatment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177391</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Quantity</PreferredName>
        <Version>1</Version>
        <LongName>Quantity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2432128</PublicId>
      <PreferredName>DOSE</PreferredName>
      <PreferredDefinition>the dose in milligrams.</PreferredDefinition>
      <LongName>Dose</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2432127</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488</PreferredName>
        <Version>1</Version>
        <LongName>Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day 7 Daily Dose</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Day 7 Daily Dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Daily_Dose_7</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="394">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6543135</PUBLICID>
    <LONGNAME>Prior Solid Organ Transplantation Performed Year Date</LONGNAME>
    <PREFERREDNAME>6543088v1.0:2195353v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The year the prior solid organ transplant was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6543088</PublicId>
      <PreferredName>6543086v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>Earlier in time or order._An internal organ with firm consistency without a liquid or hollow structural component._Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Prior Solid Organ Transplantation Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6543086</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C124068:C15342</PreferredName>
        <Version>1</Version>
        <LongName>Prior Solid Organ Transplantation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C124068</PREFERRED_NAME>
            <LONG_NAME>Solid Organ</LONG_NAME>
            <CON_ID>5041927</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2195353</PublicId>
      <PreferredName>YR_DT</PreferredName>
      <PreferredDefinition>the numeric representation of the calendar year. </PreferredDefinition>
      <LongName>Year Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY</DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208026</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29848:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Year Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29848</PREFERRED_NAME>
            <LONG_NAME>Year</LONG_NAME>
            <CON_ID>2203986</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the year the prior s</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the year the prior solid organ transplant was performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Year of prior solid organ transplant:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Year of prior solid organ transplant:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Year of prior solid organ transplant:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Year of prior solid organ transplant:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_PSOT_solid_organ_tx_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="395">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6547158</PUBLICID>
    <LONGNAME>Bone Mineral Density Test Assessment Indicator</LONGNAME>
    <PREFERREDNAME>BMD_SC_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>information related to bone mineral density (BMD) test measuring the mineral density (such as calcium) in your bones using a special X-ray, computed tomography (CT) scan, or ultrasound. with permissible values of yes/no/unknown/not applicable.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2495117</PublicId>
      <PreferredName>2497213v1.00:2465182v1.00</PreferredName>
      <PreferredDefinition>A scanning procedure used to measure calcium and other minerals present in bone.:The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Bone Mineral Density Test Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2497213</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61545</PreferredName>
        <Version>1</Version>
        <LongName>Bone Mineral Density Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61545</PREFERRED_NAME>
            <LONG_NAME>Bone Mineral Density Test</LONG_NAME>
            <CON_ID>2495488</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2465182</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25217</PreferredName>
        <Version>1</Version>
        <LongName>Assessed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is bone mineral density score</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is bone mineral density score available?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the femoral neck bone mineral density score available?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the whole body bone mineral density score available?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the spine bone mineral density score available?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the total hip bone mineral density score available?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the whole body bone mineral density Z score available?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the whole body less head bone mineral density Z score available?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the spine bone mineral density Z score available?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the total hip bone mineral density Z score available?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the femoral neck bone mineral density Z score available?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="396">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6577043</PUBLICID>
    <LONGNAME>Loes Score Assessment Performed Composite Score Value</LONGNAME>
    <PREFERREDNAME>6577040v1.0:6577042v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The numeric composite value measured, assigned or computed related to the assessment of the loes score.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6577040</PublicId>
      <PreferredName>6577038v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>A rating of the severity of abnormalities in the brain found on MRI. It ranges from 0 to 34, based on a point system derived from the location and extent of disease and the presence of atrophy in the brain, either localized to specific points or globally throughout the brain._The final result of a determination of the value, significance, or extent of._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Loes Score Assessment Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6577038</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C156449:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Loes Score Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C156449</PREFERRED_NAME>
            <LONG_NAME>Loes Score</LONG_NAME>
            <CON_ID>6562001</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6577042</PublicId>
      <PreferredName>6577042v1.0</PreferredName>
      <PreferredDefinition>A single value that is calculated from multiple scores. This composite score can then be used as a single variable in further analysis and comparison._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Composite Score Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>6577041</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121197:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Composite Score Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121197</PREFERRED_NAME>
            <LONG_NAME>Composite Score</LONG_NAME>
            <CON_ID>4747500</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the value of the loes</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the value of the loes composite score?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Loes composite score</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Loes composite score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Loes composite score</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Loes composite score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Loes composite score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_IDM_loes_comp_sc_val</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="397">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6594596</PUBLICID>
    <LONGNAME>Primary Malignant Neoplasm Cancer Model Sequence Number Identifier</LONGNAME>
    <PREFERREDNAME>PRI_MODEL_SEQ_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Numerical value to represent the sequence count of primary cancer models.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HCMI:Human Cancer Models Initiative</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6594580</PublicId>
      <PreferredName>6594578v1.0:2422672v1.0</PreferredName>
      <PreferredDefinition>A malignant tumor at the original site of growth._Any model that can be used to study issues important in cancer such as cancer development or prediction._A serial arrangement in which things follow in logical order or a recurrent pattern._A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Primary Malignant Neoplasm Cancer Model Sequence Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2230266</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TISSUE BANKING</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Banking</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6594578</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C84509:C19691</PreferredName>
        <Version>1</Version>
        <LongName>Primary Malignant Neoplasm Cancer Model</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C84509</PREFERRED_NAME>
            <LONG_NAME>Primary Malignant Neoplasm</LONG_NAME>
            <CON_ID>3205843</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19691</PREFERRED_NAME>
            <LONG_NAME>Cancer Model</LONG_NAME>
            <CON_ID>2224027</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2422672</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25673:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Sequence Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25673</PREFERRED_NAME>
            <LONG_NAME>Sequence</LONG_NAME>
            <CON_ID>2203798</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HCMI:Human Cancer Models Initiative</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2465540</PublicId>
      <PreferredName>ID</PreferredName>
      <PreferredDefinition>One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Identifier</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Primary model numerical seque</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Primary model numerical sequence count</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rare Cancers</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7589449</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="398">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6608432</PUBLICID>
    <LONGNAME>Nicotine Product Past Use Smoking Product Type</LONGNAME>
    <PREFERREDNAME>6607610v1.0:6597568v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Kind of specific product previously used that contains nicotine, an addictive substance found in tobacco plants and tobacco products.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6607610</PublicId>
      <PreferredName>6608050v1.0:6608051v1.0</PreferredName>
      <PreferredDefinition>A plant alkaloid, found in the tobacco plant, and addictive central nervous system (CNS) stimulant that causes either ganglionic stimulation in low doses or ganglionic blockage in high doses. Nicotine acts as an agonist at the nicotinic cholinergic receptors in the autonomic ganglia, at neuromuscular junctions, and in the adrenal medulla and the brain. Nicotine&#39;s CNS-stimulating activities may be mediated through the release of several neurotransmitters, including acetylcholine, beta-endorphin, dopamine, norepinephrine, serotonin, and ACTH. As a result, peripheral vasoconstriction, tachycardia, and elevated blood pressure may be observed with nicotine intake. This agent may also stimulate the chemoreceptor trigger zone, thereby inducing nausea and vomiting._The end result of a manufacturing process; anything that is produced._Before the present time._To put into action or service.</PreferredDefinition>
      <LongName>Nicotine Product Past Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6608050</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C691:C51980</PreferredName>
        <Version>1</Version>
        <LongName>Nicotine Product</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C691</PREFERRED_NAME>
            <LONG_NAME>Nicotine</LONG_NAME>
            <CON_ID>2435400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51980</PREFERRED_NAME>
            <LONG_NAME>Product</LONG_NAME>
            <CON_ID>2527882</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6608051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25609:C95018</PreferredName>
        <Version>1</Version>
        <LongName>Past Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95018</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>3248409</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6597568</PublicId>
      <PreferredName>6597568v1.0</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Smoking Product Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cigars</VALIDVALUE>
          <VALUEMEANING>Cigar</VALUEMEANING>
          <MEANINGDESCRIPTION>A compact roll of tobacco leaves prepared for smoking. (WEBS84)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>E-cig/Vapor w/o nicotine</VALIDVALUE>
          <VALUEMEANING>Nicotine Negation Electronic Nicotine Delivery Device</VALUEMEANING>
          <MEANINGDESCRIPTION>A plant alkaloid, found in the tobacco plant, and addictive central nervous system (CNS) stimulant that causes either ganglionic stimulation in low doses or ganglionic blockage in high doses. Nicotine acts as an agonist at the nicotinic cholinergic receptors in the autonomic ganglia, at neuromuscular junctions, and in the adrenal medulla and the brain. Nicotine&#39;s CNS-stimulating activities may be mediated through the release of several neurotransmitters, including acetylcholine, beta-endorphin, dopamine, norepinephrine, serotonin, and ACTH. As a result, peripheral vasoconstriction, tachycardia, and elevated blood pressure may be observed with nicotine intake. This agent may also stimulate the chemoreceptor trigger zone, thereby inducing nausea and vomiting.: An operation in which a term denies or inverts the meaning of another term or construction.: A battery-powered electronic device designed to atomize a nicotine-containing liquid solution for inhalation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128795, C25594, C691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6597569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>E-cig/Vapor w/nicotine</VALIDVALUE>
          <VALUEMEANING>Electronic Cigarette Personal Vaporizer Electronic Nicotine Delivery Device</VALUEMEANING>
          <MEANINGDESCRIPTION>A battery-powered electronic device designed to atomize a nicotine-containing liquid solution for inhalation in a manner that simulates smoking a tobacco cigarette.: A battery-powered atomizer designed to aerosolize a liquid solution for inhalation.: A battery-powered electronic device designed to atomize a nicotine-containing liquid solution for inhalation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128795, C120481, C120482</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6597570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cigarettes</VALIDVALUE>
          <VALUEMEANING>Cigarette</VALUEMEANING>
          <MEANINGDESCRIPTION>Finely cut tobacco encased in a wrapper of thin paper and rolled for smoking.(NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1802</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2889177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, Please specify:</VALIDVALUE>
          <VALUEMEANING>Specify Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4888051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pipes</VALIDVALUE>
          <VALUEMEANING>Pipe</VALUEMEANING>
          <MEANINGDESCRIPTION>A tube with a small bowl at one end, especially one used for smoking tobacco.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86044</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What type of tobacco or nicot</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What type of tobacco or nicotine products did you use?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="399">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6631097</PUBLICID>
    <LONGNAME>Tissue Processing Embedding Medium Other Specify</LONGNAME>
    <PREFERREDNAME>EMBD_MTRIAL_OTH_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>Records a text description of an embedding material used, if not on the list provided.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>MCL</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MCL:Molecular and Cellular Characterization of Screened Lesions</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6631082</PublicId>
      <PreferredName>5406520v1.0:2513335v1.0</PreferredName>
      <PreferredDefinition>Cleaning and preparation of tissues for further use in biological products._To surround an object with a firm chemical substance such as wax or resin, in order to perform cutting of thin sections for microscopic examination._A substance holding another substance in solution or suspension.</PreferredDefinition>
      <LongName>Tissue Processing Embedding Medium</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>MCL</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2230266</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TISSUE BANKING</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Banking</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5406520</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C113056</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Processing</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113056</PREFERRED_NAME>
            <LONG_NAME>Tissue Processing</LONG_NAME>
            <CON_ID>5219571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2513335</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48163:C48164</PreferredName>
        <Version>1</Version>
        <LongName>Embed Medium</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48163</PREFERRED_NAME>
            <LONG_NAME>Embedding</LONG_NAME>
            <CON_ID>2513276</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48164</PREFERRED_NAME>
            <LONG_NAME>Medium</LONG_NAME>
            <CON_ID>2513277</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MCL:Molecular and Cellular Characterization of Screened Lesions</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666713</PublicId>
      <PreferredName>OTH_SPEC</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Other Specify</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCI CRF Standards</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Embedding material used (Othe</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Embedding material used (Other, specify)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="400">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6631201</PUBLICID>
    <LONGNAME>Patient Occupation Requiring To Continue With Pace Assessment Scale</LONGNAME>
    <PREFERREDNAME>6631158v1.0:2016428v3.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The assessment scale related to the patient&#39;s occupation requiring to keep up with the pace of others.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6631158</PublicId>
      <PreferredName>6630441v1.00:14117850v1.00</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._The principal activity that a person does to earn money.:Something that is a necessary condition; something that is obligatory._Used as a function word to indicate direction, purpose, or movement._Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption._Used to indicate the presence of something or someone._A traditional unit of length equal to 152.4 centimeters, or 1.52 meter._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Patient Occupation Requirement To Continue With Pace Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6630441</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C25193</PreferredName>
        <Version>1</Version>
        <LongName>Patient Occupation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25193</PREFERRED_NAME>
            <LONG_NAME>Occupation</LONG_NAME>
            <CON_ID>2202912</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14117850</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>14117850v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Requirement To Continue With Pace Unit of Measure Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25652</PREFERRED_NAME>
            <LONG_NAME>Requirement</LONG_NAME>
            <CON_ID>2204014</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C65107</PREFERRED_NAME>
            <LONG_NAME>To</LONG_NAME>
            <CON_ID>2672667</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53279</PREFERRED_NAME>
            <LONG_NAME>Continue</LONG_NAME>
            <CON_ID>2443956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62355</PREFERRED_NAME>
            <LONG_NAME>With</LONG_NAME>
            <CON_ID>2532083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71254</PREFERRED_NAME>
            <LONG_NAME>Pace Unit of Measure</LONG_NAME>
            <CON_ID>10092062</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016428</PublicId>
      <PreferredName>ASSESS_SCALE</PreferredName>
      <PreferredDefinition>the scale to determine the patient&#39;s assessment of general health.</PreferredDefinition>
      <LongName>Assessment Scale</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>All of the time</VALIDVALUE>
          <VALUEMEANING>All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Most of the time</VALIDVALUE>
          <VALUEMEANING>Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A good bit of the time</VALIDVALUE>
          <VALUEMEANING>A Good Bit of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a good bit of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some of the time</VALIDVALUE>
          <VALUEMEANING>Some of the time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened some of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little of the time</VALIDVALUE>
          <VALUEMEANING>A Little of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a little of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None of the time</VALIDVALUE>
          <VALUEMEANING>None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat bothered</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little bit</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all bothered</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted totally</VALIDVALUE>
          <VALUEMEANING>Disrupted totally</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was totally disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted quite a bit</VALIDVALUE>
          <VALUEMEANING>Disrupted quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted somewhat</VALIDVALUE>
          <VALUEMEANING>Disrupted somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted a little</VALIDVALUE>
          <VALUEMEANING>Disrupted a little</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was a little disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not disrupted at all</VALIDVALUE>
          <VALUEMEANING>Not disrupted at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not at all disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable/have not received instructions about taking 6MP</VALIDVALUE>
          <VALUEMEANING>Not Applicable Have Negation Receive Instruction Approximate Take Six Mercaptopurine</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.: Used to describe the possession, relationships, or the state of something or someone.: An operation in which a term denies or inverts the meaning of another term or construction.: To take, accept, or get something offered.: A message describing how something is to be done.: Not quite exact or correct; almost exact or correct.: As pertains to a medication: ingest, inhale, instill, or inject.: A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.: A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities.  Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5&#39;-phosphate (6-thioGMP) and 6-thioinosine monophosphate (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis.  This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C195, C66837, C65105, C45828, C42688, C25639, C25594, C101282, C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6, 7, 8</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5782771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>About half of the time</VALIDVALUE>
          <VALUEMEANING>Approximate Half Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Not quite exact or correct; almost exact or correct.: One of two equal parts; a quantity corresponding to one half of the whole.: The continuum of experience in which events pass from the future through the present to the past.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25207, C81009, C45828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5782772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>All or almost all the time</VALIDVALUE>
          <VALUEMEANING>All of the Time Or Almost All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A response indicating that something happens or happened almost all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119986, C37998, C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6630428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None or almost none of the time</VALIDVALUE>
          <VALUEMEANING>None of the Time Or Nearly None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened none of the time.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Not quite or just short of.: A response indicating that something happens or happened none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110994, C107222, C37998, C110994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6630427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>My job requires me to keep up</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>My job requires me to keep up with the pace set by others:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="401">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6643726</PUBLICID>
    <LONGNAME>Modified Reported Name</LONGNAME>
    <PREFERREDNAME>CMMODIFY</PREFERREDNAME>
    <PREFERREDDEFINITION>An indication or description of a change in concomitant medication.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6640621</PublicId>
      <PreferredName>4550855v1.0:6640619v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration._An indication or description of a change in concomitant medication.</PreferredDefinition>
      <LongName>Concomitant Medication Domain Concomitant Medication Modified Reported Term</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4550855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49568</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Medication Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49568</PREFERRED_NAME>
            <LONG_NAME>Concomitant Medication Domain</LONG_NAME>
            <CON_ID>2469052</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6640619</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83229</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Medication Modified Reported Term</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83229</PREFERRED_NAME>
            <LONG_NAME>Concomitant Medication Modified Reported Term</LONG_NAME>
            <CON_ID>6640618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6353425</PublicId>
      <PreferredName>CDISCNAM</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396646</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C42614</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Modified Reported Name</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Modified Reported Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Permissible</Name>
        <DocumentType>SDTM Core</DocumentType>
        <DocumentText>Permissible</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDTM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7218795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Concomitant Medications (CM) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7331372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CM.CMMODIFY</AlternateName>
        <AlternateNameType>Map:SDTM IGv3.1.2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CM.CMMODIFY</AlternateName>
        <AlternateNameType>Map:SDTM IGv3.1.3</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CM.CMMODIFY</AlternateName>
        <AlternateNameType>Map:SDTM IGv3.1.1</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CM.CMMODIFY</AlternateName>
        <AlternateNameType>Map:SDTM IGv3.2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMMODIFY</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CM</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="402">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6663274</PUBLICID>
    <LONGNAME>Procedure Collected Duration Unit</LONGNAME>
    <PREFERREDNAME>PRCDURU</PREFERREDNAME>
    <PREFERREDDEFINITION>The unit for the duration of the procedure as collected.</PREFERREDDEFINITION>
    <VERSION>6</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRDS</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6663256</PublicId>
      <PreferredName>6407261v1.0:6662811v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._The act of gathering things together; having been brought together in one place._The unit of measure for the duration of substance usage.</PreferredDefinition>
      <LongName>Procedure Domain Collection Use Duration Unit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102700</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102700</PREFERRED_NAME>
            <LONG_NAME>Procedure Domain</LONG_NAME>
            <CON_ID>6407260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6662811</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25453:C82584</PreferredName>
        <Version>1</Version>
        <LongName>Collection Use Duration Unit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82584</PREFERRED_NAME>
            <LONG_NAME>Use Duration Unit</LONG_NAME>
            <CON_ID>6409737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6401717</PublicId>
      <PreferredName>UNIT</PreferredName>
      <PreferredDefinition>Terminology codelist used with Units of Measure within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</PreferredDefinition>
      <LongName>CDISC SDTM Unit of Measure Terminology Unit of Measure</LongName>
      <Version>1.5</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6401716</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71620:C25709</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Unit of Measure Terminology Unit of Measure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71620</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Unit of Measure Terminology</LONG_NAME>
            <CON_ID>6401715</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25709</PREFERRED_NAME>
            <LONG_NAME>Unit of Measure</LONG_NAME>
            <CON_ID>2203864</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/10 HPFs</VALIDVALUE>
          <VALUEMEANING>Per 10 High Powered Fields</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of the number of entities per unit of area equal to ten high powered fields.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158699</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ARMOUR UNIT</VALIDVALUE>
          <VALUEMEANING>Armour Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of proteolytic activity for trypsin and/or chymotrypsin that, upon incubation with the hemoglobin substrate, will release a quantity of phenolic substances that react with Folin-Ciocalteu phenol reagent to produce a colorimetric change of equal intensity to that produced from the reaction of one microgram of tyrosine with Folin-Ciocalteau phenol reagent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/L/h</VALIDVALUE>
          <VALUEMEANING>Millimole per Liter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of dose concentration (molarity unit) equal to one thousandth of a mole (10E-3 mole) of solute per one liter of solution per unit of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/L/s</VALIDVALUE>
          <VALUEMEANING>Nanomole per Liter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of dose concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute per one liter of solution per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/2 mm2</VALIDVALUE>
          <VALUEMEANING>Per Two Square Millimeters</VALUEMEANING>
          <MEANINGDESCRIPTION>The denominator of a derived area unit ratio expressed as two squared millimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Binding Ab Unit/mL</VALIDVALUE>
          <VALUEMEANING>Binding Antibody Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration expressed as binding antibody units per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189647</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mkat/L</VALIDVALUE>
          <VALUEMEANING>Millikatal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity measurement equal to one thousandth of one katal (1E-3 katal) per liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/L/day</VALIDVALUE>
          <VALUEMEANING>Millimole per Liter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement expressed in millimoles of solute per liter of solution per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm2/us</VALIDVALUE>
          <VALUEMEANING>Square Millimeter per Microsecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived metric unit of kinematic viscosity expressed as millimeters squared per microsecond.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FFU/mL</VALIDVALUE>
          <VALUEMEANING>Focus Forming Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived concentration unit expressed as focus forming units per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ukat/g Hb</VALIDVALUE>
          <VALUEMEANING>Microkatal per Gram Hemoglobin</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of catalytic activity concentration expressed as microkatals per gram of hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189651</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/h</VALIDVALUE>
          <VALUEMEANING>Unit per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11483311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/h</VALIDVALUE>
          <VALUEMEANING>Millimole per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>Millimoles per hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6640558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAE Unit</VALIDVALUE>
          <VALUEMEANING>Complement Activity Enzyme Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measurement of enzymatic activity of plasma and membrane-bound proteins that comprise a complement system and their split products in functional assays indicative of the activity of the classical and alternative pathways designed to ward off invading pathogens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/CAPSULE</VALIDVALUE>
          <VALUEMEANING>Milligram per Capsule</VALUEMEANING>
          <MEANINGDESCRIPTION>A capsule dosing unit expressed in milligram(s) per capsule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73739</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12539278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 IU/mL</VALIDVALUE>
          <VALUEMEANING>Million International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to one million international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 DNA copies/mL</VALIDVALUE>
          <VALUEMEANING>Million DNA Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one million deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/cm H2O</VALIDVALUE>
          <VALUEMEANING>Milliliter per Centimeter of Water</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure expressed in milliliter(s) per centimeter of water.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5/hpf</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand per High Powered Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one hundred thousand entities per unit of area equal to one high powered field.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98743</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DNA copies/mL</VALIDVALUE>
          <VALUEMEANING>DNA Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of the concentration of deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406754</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MESF</VALIDVALUE>
          <VALUEMEANING>Molecule of Equivalent Soluble Fluorochrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of the fluorescence intensity of a fluorochrome-labeled sample, which is equivalent to the fluorescence intensity of a solution containing an equivalent number of molecules of free fluorochrome in solution, under identical experimental conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FEU</VALIDVALUE>
          <VALUEMEANING>Fibrinogen Equivalent Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of fibrinogen contained within that sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6384481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/LPF</VALIDVALUE>
          <VALUEMEANING>Per Low Powered Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the instances of an entity per visual field of a microscope set to its minimum magnification power.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96620</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/HPF</VALIDVALUE>
          <VALUEMEANING>Per High Powered Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the instances of an entity per visual field of a microscope set to its maximum magnification power.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EU</VALIDVALUE>
          <VALUEMEANING>Ehrlich Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to one milligram of urobilinogen per deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hounsfield Unit</VALIDVALUE>
          <VALUEMEANING>Hounsfield Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>Term given to the dimensions of the quantifier of x-ray attenuation, CT number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406765</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AMPULE</VALIDVALUE>
          <VALUEMEANING>Ampule Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in an ampule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci</VALIDVALUE>
          <VALUEMEANING>Curie</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity in the CGS system, defined as 3.7 E10 atomic disintegrations or other nuclear transformations per second. One curie is equal to 37 gigabecquerels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569376</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ft2</VALIDVALUE>
          <VALUEMEANING>Square Foot</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of area equal to 144 square inches, 929.0304 square centimeters, or 9.290304E-2 square meters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm2</VALIDVALUE>
          <VALUEMEANING>Square Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A CGS unit of area measurement equal to a square measuring one centimeter on each side. One square centimeter is equal to 10E-4 square meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48460</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PIXEL</VALIDVALUE>
          <VALUEMEANING>Pixel</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest resolvable rectangular area of an image, either on a screen or stored in memory. (Free On-Line Dictionary of Computing)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>min</VALIDVALUE>
          <VALUEMEANING>Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DRUM</VALIDVALUE>
          <VALUEMEANING>Drum Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a drum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>gtt</VALIDVALUE>
          <VALUEMEANING>Metric Drop</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume used in pharmacy and equal to 0.05 milliliter (20 drops/ml).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DISK</VALIDVALUE>
          <VALUEMEANING>Disk Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a disk.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CYLINDER</VALIDVALUE>
          <VALUEMEANING>Cylinder Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a cylinder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTAINER</VALIDVALUE>
          <VALUEMEANING>Container Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) in a container.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COAT</VALIDVALUE>
          <VALUEMEANING>Coat Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the coat unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406388</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CARTRIDGE</VALIDVALUE>
          <VALUEMEANING>Cartridge</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a cartridge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAPSULE</VALIDVALUE>
          <VALUEMEANING>Capsule Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a capsule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAN</VALIDVALUE>
          <VALUEMEANING>Can Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a can.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48479</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406389</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BOX</VALIDVALUE>
          <VALUEMEANING>Box Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a box.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BOTTLE</VALIDVALUE>
          <VALUEMEANING>Bottle Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit that contains medicinal substance(s) in the form of a receptacle with a narrow neck designed to accept a specific closure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BOLUS</VALIDVALUE>
          <VALUEMEANING>Bolus Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a bolus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BAR</VALIDVALUE>
          <VALUEMEANING>Bar Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a bar.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 TCID 50/mL</VALIDVALUE>
          <VALUEMEANING>Log10 50 Percent Tissue Culture Infective Dose per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one milliliter of infectious material contains one 50 percent tissue culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BP</VALIDVALUE>
          <VALUEMEANING>Base Pair Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of measure for the number of paired nucleotides in a DNA or RNA sequence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/500 WBC</VALIDVALUE>
          <VALUEMEANING>Per 500 White Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 500 white blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/40 HPFs</VALIDVALUE>
          <VALUEMEANING>Per 40 High Powered Fields</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of the number of entities per unit of area equal to 40 high powered fields.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/2500 WBC</VALIDVALUE>
          <VALUEMEANING>Per 2500 White Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 2500 white blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/2000 RBC</VALIDVALUE>
          <VALUEMEANING>Per 2000 Red Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell (excluding red blood cell subtypes) per 2000 red blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/200 HPFs</VALIDVALUE>
          <VALUEMEANING>Per 200 High Powered Fields</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of the number of entities per unit of area equal to 200 high powered fields.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m</VALIDVALUE>
          <VALUEMEANING>Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of linear measure in the metric system, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). Meter is defined as the length of the path traveled by light in a vacuum during a time interval of 1/299 792 458 of a second and is equal to 1.093 61 yards.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41139</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>YEARS</VALIDVALUE>
          <VALUEMEANING>Year</VALUEMEANING>
          <MEANINGDESCRIPTION>The period of time that it takes for Earth to make a complete revolution around the sun; a period of time containing 365 days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29848</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2670939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MONTHS</VALIDVALUE>
          <VALUEMEANING>Month</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WEEKS</VALIDVALUE>
          <VALUEMEANING>Week</VALUEMEANING>
          <MEANINGDESCRIPTION>Any period of seven consecutive days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kg</VALIDVALUE>
          <VALUEMEANING>Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A basic SI unit of mass. It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28252</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm</VALIDVALUE>
          <VALUEMEANING>Millimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3915857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%</VALIDVALUE>
          <VALUEMEANING>Percentage</VALUEMEANING>
          <MEANINGDESCRIPTION>Percentage; a fraction or ratio with 100 understood as the denominator.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25613</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APPLICATION</VALIDVALUE>
          <VALUEMEANING>Application</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the application unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DAYS</VALIDVALUE>
          <VALUEMEANING>Day</VALUEMEANING>
          <MEANINGDESCRIPTION>The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3481386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm/h</VALIDVALUE>
          <VALUEMEANING>Millimeter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travelled per unit time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol</VALIDVALUE>
          <VALUEMEANING>Millimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to 0.001 mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/day</VALIDVALUE>
          <VALUEMEANING>Millimole per 24 Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance flow rate equivalent to the rate at which one thousandth of a mole of substance crosses a given surface or is delivered to a given object or space over a period of time equal to 24 hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2721403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/L</VALIDVALUE>
          <VALUEMEANING>Millimole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of concentration (molarity unit) equal to one one-thousandth of a mole of solute in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2685301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/min/kPa/L</VALIDVALUE>
          <VALUEMEANING>Millimole per Minute per Thousand Pascal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI-coherent unit for measuring a pulmonary diffusing capacity adjusted for lung volume and expressed in units of a substance flow rate (in millimoles per minute) per unit of pressure (in kilopascals) per unit of alveolar volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2721401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg</VALIDVALUE>
          <VALUEMEANING>Millimeter of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth&#39;s surface. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mOsm/kg</VALIDVALUE>
          <VALUEMEANING>Milliosmole per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of osmotic strength of solution as a measure of concentration of osmotically active particles expressed in a number of milliosmoles of solute per kilogram of solvent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2721399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/dL</VALIDVALUE>
          <VALUEMEANING>Nanogram per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one nanogram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one nanogram occupies the volume of one deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2721393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nm</VALIDVALUE>
          <VALUEMEANING>Nanometer</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of length equal to to one billionth of a meter (10E-9 meter). Nanometer is used as a unit for light wavelength measurement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3648817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRANSDUCING UNIT/mL</VALIDVALUE>
          <VALUEMEANING>Transducing Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of measure of potency expressed as a number of transducing units per one milliliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/dose</VALIDVALUE>
          <VALUEMEANING>Microgram per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in microgram(s) per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124462</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uIU/dL</VALIDVALUE>
          <VALUEMEANING>Micro-International Unit per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (biologic activity) equal to one micro-international unit of substance per deciliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124463</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uIU/L</VALIDVALUE>
          <VALUEMEANING>Micro-International Unit per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (biologic activity) equal to one micro-international unit of substance per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/breath</VALIDVALUE>
          <VALUEMEANING>Milliliter per Breath</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per inspiration or expiration of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73749</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/animal/wk</VALIDVALUE>
          <VALUEMEANING>Milliliter per Animal per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per animal per period of time equal to seven days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/animal/day</VALIDVALUE>
          <VALUEMEANING>Milliliter per Animal per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per animal per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/animal</VALIDVALUE>
          <VALUEMEANING>Milliliter per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per animal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73746</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/m2/min</VALIDVALUE>
          <VALUEMEANING>Milligram per Square Meter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/m2/h</VALIDVALUE>
          <VALUEMEANING>Milligram per Square Meter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73743</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/min</VALIDVALUE>
          <VALUEMEANING>Milligram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation expressed in milligram(s) period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/g/min</VALIDVALUE>
          <VALUEMEANING>Milligram per Gram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/g/h</VALIDVALUE>
          <VALUEMEANING>Milligram per Gram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/animal</VALIDVALUE>
          <VALUEMEANING>Milligram per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per animal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73738</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/mL</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed in milliequivalent(s) of solute per milliliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/mg/min</VALIDVALUE>
          <VALUEMEANING>Micromole per Milligram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one millionth of a mole (10E-6 mole) per milligram of a substance per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73735</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/m2/min</VALIDVALUE>
          <VALUEMEANING>Microgram per Square Meter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73733</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/kg/h</VALIDVALUE>
          <VALUEMEANING>Microgram per Kilogram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73730</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/kg/day</VALIDVALUE>
          <VALUEMEANING>Microgram per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3059690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/animal</VALIDVALUE>
          <VALUEMEANING>Microgram per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per animal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73728</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/m2/h</VALIDVALUE>
          <VALUEMEANING>Microgram per Square Meter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uEq</VALIDVALUE>
          <VALUEMEANING>Microequivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance equal to one millionth of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/m2/day</VALIDVALUE>
          <VALUEMEANING>Gram per Square Meter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>Dose of drug administered per day expressed as grams per square meter of body surface area (BSA).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/mol</VALIDVALUE>
          <VALUEMEANING>Gram per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass commonly used to express the molar mass of a substance in gram(s) per mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73721</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/g/day</VALIDVALUE>
          <VALUEMEANING>Gram per Gram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per gram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/cage/wk</VALIDVALUE>
          <VALUEMEANING>Gram per Cage per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per cage per period of time equal to seven days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/cage/day</VALIDVALUE>
          <VALUEMEANING>Gram per Cage per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per cage per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/cage</VALIDVALUE>
          <VALUEMEANING>Gram per Cage</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per cage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73716</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 organisms/mL</VALIDVALUE>
          <VALUEMEANING>Thousand Organisms per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism concentration expressed in thousands of organisms per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 organisms/mg</VALIDVALUE>
          <VALUEMEANING>Billion Organisms per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism content expressed in billions of organisms per unit of mass equal to one milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 organisms/mg</VALIDVALUE>
          <VALUEMEANING>Million Organisms per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism content expressed in millions of organisms per unit of mass equal to one milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 organisms/g</VALIDVALUE>
          <VALUEMEANING>Billion Organisms per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism content expressed in billions of organisms per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 organisms/g</VALIDVALUE>
          <VALUEMEANING>Million Organisms per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism content expressed in millions of organisms per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71191</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 organisms/g</VALIDVALUE>
          <VALUEMEANING>Thousand Organisms per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism content expressed in thousands of organisms per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rad</VALIDVALUE>
          <VALUEMEANING>Rads</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radiation absorbed dose equal to the amount of energy from any type of ionizing radiation (e.g., alpha, beta, gamma, neutrons, etc.) deposited in any medium (e.g., water, tissue, air). A dose of one rad means the absorption of 100 ergs per gram of absorbing tissue (100 rad = 1 gray). (The U.S. Nuclear Regulatory Commission, NRC).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4115051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gy</VALIDVALUE>
          <VALUEMEANING>Gray</VALUEMEANING>
          <MEANINGDESCRIPTION>The SI derived unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter; one gray equals 100 rads. The unit is named for the British physician L. Harold Gray, an authority on the use of radiation in the treatment of cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EVENTS</VALIDVALUE>
          <VALUEMEANING>Event Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the number of happenings at a given place or time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg*min/L</VALIDVALUE>
          <VALUEMEANING>Hybrid Resistance Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to the number of millimeters of mercury times minutes, per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>s/h</VALIDVALUE>
          <VALUEMEANING>Seconds Per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit expressed in seconds per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmAL</VALIDVALUE>
          <VALUEMEANING>Millimeters of Aluminum Equivalents</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit defined as the thickness, in millimeters, of aluminum that has the equivalent degree of attenuation, under specified conditions, as the actual material in use within the procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/mmol</VALIDVALUE>
          <VALUEMEANING>Unit per Millimole</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration equal to the concentration at which one millimole of a mixture contains one unit of a substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92618</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/mmol</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Milliimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of one thousandth of an equivalent weight per millimole of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92616</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kN/cm2</VALIDVALUE>
          <VALUEMEANING>Kilonewton per Centimeter Squared</VALUEMEANING>
          <MEANINGDESCRIPTION>The kilonewton per centimeter squared is an SI derived unit of pressure; one newton is computed as the force necessary to accelerate a mass of one gram at the rate of one centimeter per second squared. One kilonewton per centimeter squared is descriptive of the amount of force exerted in a particular area. This measurement is frequently used when describing conditions of cellular movement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92615</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/mL/min</VALIDVALUE>
          <VALUEMEANING>Nanomole per Minute per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute per minute per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92613</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GLOBULE</VALIDVALUE>
          <VALUEMEANING>Globule Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An unit of small globular masses of various sizes. Medications are compounded with globular shaped sucrose, lactose, or other polysaccharides and dried before administered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91803</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm H2O</VALIDVALUE>
          <VALUEMEANING>Centimeters of water</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure defined by a column of water with a height of one centimeter, frequently used to measure central venous pressure, intracranial pressure, and for pressures during mechanical ventilation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5477037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/g</VALIDVALUE>
          <VALUEMEANING>Nanomole per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanomoles per gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/day</VALIDVALUE>
          <VALUEMEANING>Nanomole per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanomoles per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol/day</VALIDVALUE>
          <VALUEMEANING>Mole per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>Moles per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WAFER</VALIDVALUE>
          <VALUEMEANING>Wafer Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a wafer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48552</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406446</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VIAL</VALIDVALUE>
          <VALUEMEANING>Vial Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a single vial.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TUBE</VALIDVALUE>
          <VALUEMEANING>Tube Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a tube.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TROCHE</VALIDVALUE>
          <VALUEMEANING>Troche Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in a single item of a discoid-shaped solid oral dosage form containing the medicinal agent in a suitably flavored base.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRACE</VALIDVALUE>
          <VALUEMEANING>Trace Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An extremely small amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tsp</VALIDVALUE>
          <VALUEMEANING>Teaspoon Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume used in pharmacy and equal to 5 milliliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48544</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TAMPON</VALIDVALUE>
          <VALUEMEANING>Tampon Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a tampon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TABLET</VALIDVALUE>
          <VALUEMEANING>Tablet Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in a single item of a tablet dosage form comprising of compressed medicinal substance(s) with or without suitable diluents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tbsp</VALIDVALUE>
          <VALUEMEANING>Tablespoon Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume informally used in pharmacy. Under the metric system the tablespoon has been standardized at 15 milliliters in the US, Britain, Canada, and New Zealand, and at 20 milliliters in Australia and some European countries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48541</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SYRINGE</VALIDVALUE>
          <VALUEMEANING>Syringe Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a single syringe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48540</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SUPPOSITORY</VALIDVALUE>
          <VALUEMEANING>Suppository Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in a single item of a suppository dosage form that is designed for introduction into the orifice of the human body and usually melts, softens, or dissolves at body temperature.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48539</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STRIP</VALIDVALUE>
          <VALUEMEANING>Strip Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a strip.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48538</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SPRAY</VALIDVALUE>
          <VALUEMEANING>Spray Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in the volume of liquid delivered by the single operation of a spray dosage form container.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48537</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SCOOPFUL</VALIDVALUE>
          <VALUEMEANING>Scoopful Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained typically in a spoon-shaped object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48536</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PRESSOR UNITS</VALIDVALUE>
          <VALUEMEANING>Pressor Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The activity of a pressor agent expressed as one pressor unit being equal to the activity of 0.5 milligram of the USP Standard Powdered Pituitary U.S.P., a USP posterior pituitary reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48532</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LB</VALIDVALUE>
          <VALUEMEANING>Pound</VALUEMEANING>
          <MEANINGDESCRIPTION>The traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48531</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>POUCH</VALIDVALUE>
          <VALUEMEANING>Pouch Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a pouch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48530</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pt_us</VALIDVALUE>
          <VALUEMEANING>Pint</VALUEMEANING>
          <MEANINGDESCRIPTION>A United States liquid unit equal to 16 fluid ounces; two pints equal one quart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48529</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mCi/kg</VALIDVALUE>
          <VALUEMEANING>Millicurie per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one millicurie of the sample with total mass of one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pptr</VALIDVALUE>
          <VALUEMEANING>Part Per Trillion</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of proportion equal to 10E-12.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406606</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ppb</VALIDVALUE>
          <VALUEMEANING>Part Per Billion</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of proportion equal to 10E-9.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70565</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406608</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ukat</VALIDVALUE>
          <VALUEMEANING>Microkatal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity measurement equal to one millionth of katal (10E-6 katal).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TCID 50/dose</VALIDVALUE>
          <VALUEMEANING>50 Percent Tissue Culture Infective Dose per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit equal to the potency at which one dose of preparation contains one 50 percent tissue culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70537</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CCID 50/dose</VALIDVALUE>
          <VALUEMEANING>50 Percent Cell Culture Infective Dose per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit equal to the potency at which one dose of preparation contains one 50 percent cell culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EID 50/dose</VALIDVALUE>
          <VALUEMEANING>50 Percent Embryo Infective Dose per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit for measuring infectious activity of a biologic product or an infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/mg</VALIDVALUE>
          <VALUEMEANING>Curie per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70531</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/ug</VALIDVALUE>
          <VALUEMEANING>Curie per Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one microgram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70530</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/kg</VALIDVALUE>
          <VALUEMEANING>Curie per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70529</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/g</VALIDVALUE>
          <VALUEMEANING>Curie per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GBq/mg</VALIDVALUE>
          <VALUEMEANING>Gigabecquerel per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 organisms</VALIDVALUE>
          <VALUEMEANING>Billion Organisms</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of quantity of organisms expressed in billions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 organisms</VALIDVALUE>
          <VALUEMEANING>Million Organisms</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of quantity of organisms expressed in millions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 organisms</VALIDVALUE>
          <VALUEMEANING>Thousand Organisms</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of quantity of organisms expressed in thousands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406699</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>100 IU/mL</VALIDVALUE>
          <VALUEMEANING>100 International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one hundred international units per one milliliter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mile</VALIDVALUE>
          <VALUEMEANING>Mile</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of distance equal to 5280 international feet, 1760 international yards, or 1609.344 meters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6272184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>km</VALIDVALUE>
          <VALUEMEANING>Kilometer</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of distance equal to 1000 meters, 0.621 miles, 1094 yards, or 3281 feet.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71177</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127033</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cycle/min</VALIDVALUE>
          <VALUEMEANING>Cycle per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of frequency equal to the frequency at which one complete execution of a periodically repeated phenomenon, alternation, event, or sequence of events occurs per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71176</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uV</VALIDVALUE>
          <VALUEMEANING>Microvolt</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI unit of an electric potential and electromotive force equal to one millionth of a volt.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71175</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mCi/L</VALIDVALUE>
          <VALUEMEANING>Millicurie per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousandth of a curie per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uCi/L</VALIDVALUE>
          <VALUEMEANING>Microcurie per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one millionth of a curie per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/mL</VALIDVALUE>
          <VALUEMEANING>Curie per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one curie per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71172</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/uL</VALIDVALUE>
          <VALUEMEANING>Curie per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one curie per unit volume equal to one millionth of a liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/L</VALIDVALUE>
          <VALUEMEANING>Curie per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one liter.(NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71170</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MBq/uL</VALIDVALUE>
          <VALUEMEANING>Megabecquerel per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one million becquerels per unit volume equal to one millionth of a liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71169</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kBq/uL</VALIDVALUE>
          <VALUEMEANING>Kilobecquerel per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousand becquerels per unit volume equal to one millionth of a liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 TCID 50/dose</VALIDVALUE>
          <VALUEMEANING>Log10 50 Percent Tissue Culture Infective Dose per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent tissue culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406553</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 CCID 50/dose</VALIDVALUE>
          <VALUEMEANING>Log10 50 Percent Cell Culture Infective Dose per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent cell culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70485</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 EID 50/dose</VALIDVALUE>
          <VALUEMEANING>Log10 50 Percent Embryo Infective Dose per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dyn</VALIDVALUE>
          <VALUEMEANING>Dyne</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of force in the CGS system defined as the force that accelerates a mass of one gram at the rate of one centimeter per second squared. One dyne is equal to 10E-5 newton and 2.248E-6 pound of force.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Therapeutic Cells</VALIDVALUE>
          <VALUEMEANING>Therapeutic Cells Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit for the number of therapeutic cells administered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dpm/g</VALIDVALUE>
          <VALUEMEANING>Disintegration per Minute per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5 Therapeutic Cells</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand Therapeutic Cells Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit for the number of therapeutic cells administered, expressed as 10 to the fifth power.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg*beats/min</VALIDVALUE>
          <VALUEMEANING>Millimeters of Mercury times Beats per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure equal to millimeters of mercury times the number of heartbeats measured per minute unit of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 Therapeutic Cells</VALIDVALUE>
          <VALUEMEANING>Million Therapeutic Cells Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit for the number of therapeutic cells administered, expressed as 10 to the sixth power.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%*min/h</VALIDVALUE>
          <VALUEMEANING>Percentage times Minute per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement expressed as the percentage times minutes divided by hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167716</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/m2*h</VALIDVALUE>
          <VALUEMEANING>Gram per Hour times Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement expressed as grams per square meter times a unit of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187982</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/s/kg</VALIDVALUE>
          <VALUEMEANING>Milliliter per Kilogram per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliliters per kilogram per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85715</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 Therapeutic Cells</VALIDVALUE>
          <VALUEMEANING>Billion Therapeutic Cells Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit for the number of therapeutic cells administered, expressed as 10 to the ninth power.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 Therapeutic Cells</VALIDVALUE>
          <VALUEMEANING>Thousand Therapeutic Cells Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit for the number of therapeutic cells administered, expressed as 10 to the third power.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11167715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GBq/ug</VALIDVALUE>
          <VALUEMEANING>Gigabecquerel per Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one microgram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GBq/g</VALIDVALUE>
          <VALUEMEANING>Gigabecquerel per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/mg</VALIDVALUE>
          <VALUEMEANING>Becquerel per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one becquerel of the sample with total mass of one milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/ug</VALIDVALUE>
          <VALUEMEANING>Becquerel per Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one becquerel of the sample with total mass of one microgram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/g</VALIDVALUE>
          <VALUEMEANING>Becquerel per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one becquerel of the sample with total mass of one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/kg</VALIDVALUE>
          <VALUEMEANING>Becquerel per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one becquerel of the sample with total mass of one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%(w/w)</VALIDVALUE>
          <VALUEMEANING>Percent Mass by Mass</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of percentage concentration expressed as a fraction of a solute by mass in the entire mass of a resulting solution. The concept also refers to the weight-weight percentage concentration given that standard values for specific gravity of the solute and the solution are used.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2689780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enzyme U/L</VALIDVALUE>
          <VALUEMEANING>Enzyme Unit per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of catalytic activity concentration defined as activity equal to one enzyme unit per one liter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmHg</VALIDVALUE>
          <VALUEMEANING>Centimeters of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one centimeter rise of mercury in a barometer at the Earth&#39;s surface.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6352132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kcal/day</VALIDVALUE>
          <VALUEMEANING>Kilocalorie per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy equal to one kilocalorie per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139135</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6352129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Linear ft*LB</VALIDVALUE>
          <VALUEMEANING>Linear Foot Pound</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy that equals the work required to move one pound a distance of one foot in the direction of the applied force.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139134</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug</VALIDVALUE>
          <VALUEMEANING>Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass equal to one millionth of a gram or one thousandth of a milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48152</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5656837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>Any division of quantity accepted as a standard of measurement or exchange.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C44278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>F</VALIDVALUE>
          <VALUEMEANING>Fahrenheit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of temperature of the temperature scale designed so that the freezing point of water is 32 degrees and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. One degree Fahrenheit is 5/9ths of a kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C44277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5387072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RATIO</VALIDVALUE>
          <VALUEMEANING>Ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>Quotient of quantities of the same kind for different components within the same system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C44256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m/s2</VALIDVALUE>
          <VALUEMEANING>Meter per Second Squared</VALUEMEANING>
          <MEANINGDESCRIPTION>Meter per second squared is a SI unit of acceleration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42572</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m/s</VALIDVALUE>
          <VALUEMEANING>Meter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of both speed (scalar) and velocity (vector), defined as the distance of one meter travelled per unit time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m3</VALIDVALUE>
          <VALUEMEANING>Cubic Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI unit of volume or capacity equal to the volume of a cube with edges one meter in length. It is equal to 1,000 liters; 1,000 cubic decimeters; 10(e+6) cubic centimeters; 25.3 cubic feet; 6.29 barrels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m2</VALIDVALUE>
          <VALUEMEANING>Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>Square meter is the SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kat</VALIDVALUE>
          <VALUEMEANING>Katal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring catalytic (e.g. enzymatic) activity, the ability of the compound to accelerate the chemical reaction by providing a lower energy pathway between the reactants and the products. One katal is that catalytic activity which will raise the rate of reaction by one mole per second in a specified assay system. When the katal is used, the measurand should be specified by reference to the measurement procedure; the measurement procedure must identify the indicator reaction. The katal is not used to express a rate of reaction itself, which should be expressed in moles per second. Katal is coherent with the SI.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq</VALIDVALUE>
          <VALUEMEANING>Becquerel</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of activity of a radionuclide, equal to one nuclear disintegration or other nuclear transition from a particular energy state occurring in an amount of a radionuclide during one second-long time interval.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>lx</VALIDVALUE>
          <VALUEMEANING>Lux</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of illuminance equal to the direct illumination on a surface that is everywhere one meter from a uniform point source of one candela; a unit of illuminance that is equal to one lumen per square meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42561</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>lm</VALIDVALUE>
          <VALUEMEANING>Lumen</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of luminous flux. It is the amount of light that falls on a unit area at unit distance from a source of one candela.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C</VALIDVALUE>
          <VALUEMEANING>Degree Celsius</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42559</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Henry</VALIDVALUE>
          <VALUEMEANING>Henry</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of electric inductance. A coil with an inductance of one henry requires a flux of one weber for each ampere of induced current. If it is the current which changes, then the induced field will generate a potential difference within the coil: if the inductance is one henry a current change of one ampere per second generates a potential difference of one volt. The henry is a large unit; inductances in practical circuits are measured in millihenrys or microhenrys.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tesla</VALIDVALUE>
          <VALUEMEANING>Tesla</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI unit of magnetic flux density equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Weber</VALIDVALUE>
          <VALUEMEANING>Weber</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one volt, when the flux is uniformly reduced to zero within one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42556</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Siemens</VALIDVALUE>
          <VALUEMEANING>Siemens</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electrical conductance, admittance, and susceptance. A conductor has a conductance of one siemens if an electrical potential difference of one volt produces a one ampere current in it. The conductance in siemens is the reciprocal of its resistance in ohms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5/L</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed as a number or quantity of objects in hundred thousands per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kDa</VALIDVALUE>
          <VALUEMEANING>Kilodalton</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of atomic mass equal to one thousand daltons.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404669</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kPa/L/s</VALIDVALUE>
          <VALUEMEANING>Kilopascal Per Liter Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to the number of kilopascals per unit of volume equal to one liter per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ks</VALIDVALUE>
          <VALUEMEANING>Kilosecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time equal to one thousand seconds (10E3 seconds).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/L</VALIDVALUE>
          <VALUEMEANING>Liter Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of volume concentration expressed as the number of liters of a dissolved substance per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/min/m2</VALIDVALUE>
          <VALUEMEANING>Liter Per Minute Per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit expressed as one liter of volume per unit of time equal to one minute per square meter of area. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ugEq</VALIDVALUE>
          <VALUEMEANING>Microgram Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance concentration equal to one millionth of a gram of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/L/s</VALIDVALUE>
          <VALUEMEANING>Micromole Per Liter Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/kg</VALIDVALUE>
          <VALUEMEANING>Microgram per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67396</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/h</VALIDVALUE>
          <VALUEMEANING>Microgram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725050</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/mg</VALIDVALUE>
          <VALUEMEANING>International Unit per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milligram of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/kg</VALIDVALUE>
          <VALUEMEANING>International Unit per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in international units of biological activity per one kilogram of mass of the system. It is also used as a dose calculation unit expressed in international units of biological activity per one kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nCi</VALIDVALUE>
          <VALUEMEANING>Nanocurie</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to one billionth of a curie or 37 becquerels, and corresponding to radioactivity of 37 atomic disintegrations per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 IU</VALIDVALUE>
          <VALUEMEANING>Million International Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of biological activity equal to one million international units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67335</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>psi</VALIDVALUE>
          <VALUEMEANING>Pound per Square Inch</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of pressure equivalent to 6.894757 kilopascals, or 703.0696 kilograms per square meter, or 51.71507 millimeters of mercury.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/L</VALIDVALUE>
          <VALUEMEANING>Nanogram per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one nanogram of a substance per one liter of the mixture, or one picogram of a substance per unit volume of the mixture equal to one milliliter, or one microgram of a substance per one cubic meter of the mixture. The concept also refers to the metric unit of mass density (volumic mass) defined as the density of a substance which mass equal to one nanogram occupies the volume of one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2724560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mV</VALIDVALUE>
          <VALUEMEANING>Millivolt</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of an electric potential and electromotive force equal to one thousandth of a volt.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67324</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569419</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mOsm</VALIDVALUE>
          <VALUEMEANING>Milliosmole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of osmotic pressure equal to one thousandth of osmole or osmotic pressure of 0.001 molar solution of a substance that does not dissociate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MHz</VALIDVALUE>
          <VALUEMEANING>Megahertz</VALUEMEANING>
          <MEANINGDESCRIPTION>The SI derived unit of frequency; equal to one million oscillations per second or to 10E6 hertz.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/m2</VALIDVALUE>
          <VALUEMEANING>Microgram per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of areal density equal to approximately 2.94935E-8 ounce per square yard. Also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67312</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/cm2</VALIDVALUE>
          <VALUEMEANING>Microgram per meter squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of areal density equal to approximately 2.94935E-4 ounce per square yard. Also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 U</VALIDVALUE>
          <VALUEMEANING>Million Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantity equivalent to one million units (10E6 units).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Therapeutic Cells/m2</VALIDVALUE>
          <VALUEMEANING>Therapeutic Cells per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit for the number of therapeutic cells given per meter squared of body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MPS U/mL</VALIDVALUE>
          <VALUEMEANING>Phosphatidylserine IgM Antibody Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of measure of potency of allergenic product expressed as a number of immunoglobin M phosphatidylserine units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GUMMY</VALIDVALUE>
          <VALUEMEANING>Chewable Gel Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the gummy unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GPS U/mL</VALIDVALUE>
          <VALUEMEANING>Phosphatidylserine IgG Antibody Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of measure of potency of allergenic product expressed as a number of immunoglobin G phosphatidylserine units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ENVELOPE</VALIDVALUE>
          <VALUEMEANING>Envelope Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the envelope unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APS U/mL</VALIDVALUE>
          <VALUEMEANING>Phosphatidylserine IgA Antibody Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of measure of potency of allergenic product expressed as a number of immunoglobin A phosphatidylserine units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ngEq</VALIDVALUE>
          <VALUEMEANING>Nanogram Equivalents</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance equal to one billionth of a gram of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ngEq/g</VALIDVALUE>
          <VALUEMEANING>Nanogram Equivalents Per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of nanogram equivalents per gram of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PILL</VALIDVALUE>
          <VALUEMEANING>Pill Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a pill.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PUMP</VALIDVALUE>
          <VALUEMEANING>Pump Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in one actuation of a pumping device.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111984</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kPa</VALIDVALUE>
          <VALUEMEANING>Kilopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of pressure equivalent to 1000 newtons per square meter or 10000 bars or to 0.145 pound per square inch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67284</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/m2</VALIDVALUE>
          <VALUEMEANING>Gram per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of areal density defined as a spread rate at which one gram of a substance is spread over the area of one square meter. It is equal to approximately 0.029 4935 ounce per square yard. Also used as a dose calculation unit to express quantity of an agent in grams per body surface area in square meters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725116</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kHz</VALIDVALUE>
          <VALUEMEANING>Kilohertz</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure denoting the frequency equal to 1000 cycles per second meaning e.g. that the cylical waveform changes from one state to the other (from one polarity to the other) 1000 times per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569389</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>eq</VALIDVALUE>
          <VALUEMEANING>Equivalent Weight</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance that combines with or displaces 8.0 grams of oxygen or 1.008 gram of hydrogen. The unit is usually expressed in grams and is equal to the amount of substance that gains or loses one mole of electrons in a redox reaction, or to the amount of substances that releases or accepts one mole of hydrogen ions in a neutralization reaction; or to the amount of electrolyte that carries one mole of positive or negative charge. This is a large unit and measurements are more often done in its derivatives, e.g. in milliequivalents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%(w/v)</VALIDVALUE>
          <VALUEMEANING>Percent Mass per Volume</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of percentage concentration expressed as a fraction of a component by mass in the entire volume of a resulting mixture. The standard conditions for temperature and pressure apply. The mass-volume percentage is used for liquid solute/solution systems and systems containing solid phase components. The concept also refers to the weight-volume percentage concentration given that standard values for specific gravity of the solute are used.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2689781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PELLET</VALIDVALUE>
          <VALUEMEANING>Pellet Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a pellet.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PATCH</VALIDVALUE>
          <VALUEMEANING>Patch Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in a single item of a patch drug delivery system which often has an adhesive backing that is applied to an external site on the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ppm</VALIDVALUE>
          <VALUEMEANING>Part Per Million</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of proportion equal to 10E-6.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PACKET</VALIDVALUE>
          <VALUEMEANING>Packet Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in a single item of a packet dosage form.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/min</VALIDVALUE>
          <VALUEMEANING>Micromole per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>Micromoles per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85708</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/day</VALIDVALUE>
          <VALUEMEANING>International Unit per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>International units per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg/L</VALIDVALUE>
          <VALUEMEANING>Femtogram per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Femtograms per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85597</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/mL</VALIDVALUE>
          <VALUEMEANING>Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in unit(s) per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77607</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/g</VALIDVALUE>
          <VALUEMEANING>Unit per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in unit(s) per gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77606</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AFU</VALIDVALUE>
          <VALUEMEANING>Arbitrary Fluorescence Units</VALUEMEANING>
          <MEANINGDESCRIPTION>Arbitrary unit(s) of fluorescent luminescence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77534</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/mL/h</VALIDVALUE>
          <VALUEMEANING>Microgram per Milliliter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per milliliter of solution per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75905</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arbitrary U</VALIDVALUE>
          <VALUEMEANING>Arbitrary Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A single undivided thing (unit) based on or subject to individual judgment or preference, and not by necessity, reason, or principle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406802</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PA</VALIDVALUE>
          <VALUEMEANING>Per Year</VALUEMEANING>
          <MEANINGDESCRIPTION>A frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74924</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/g/min</VALIDVALUE>
          <VALUEMEANING>Microgram per Gram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74923</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/g/h</VALIDVALUE>
          <VALUEMEANING>Microgram per Gram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74922</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/g/day</VALIDVALUE>
          <VALUEMEANING>Microgram per Gram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per gram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74921</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pack Year</VALIDVALUE>
          <VALUEMEANING>Pack Year</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantification of lifetime tobacco exposure defined as (number of cigarettes smoked per day x number of years smoked)/20. One pack-year is smoking 20 cigarettes a day for one year.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/m2/day</VALIDVALUE>
          <VALUEMEANING>Microgram per Square Meter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in microgram(s) per square meter per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73787</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/m2/min</VALIDVALUE>
          <VALUEMEANING>Unit per Square Meter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/m2/h</VALIDVALUE>
          <VALUEMEANING>Unit per Square Meter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73784</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/m2/day</VALIDVALUE>
          <VALUEMEANING>Unit per Square Meter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/mg</VALIDVALUE>
          <VALUEMEANING>Unit per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in unit(s) per milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/kg/min</VALIDVALUE>
          <VALUEMEANING>Unit per Kilogram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/kg/h</VALIDVALUE>
          <VALUEMEANING>Unit per Kilogram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73778</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/kg/day</VALIDVALUE>
          <VALUEMEANING>Unit per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/g/min</VALIDVALUE>
          <VALUEMEANING>Unit per Gram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73776</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/g/h</VALIDVALUE>
          <VALUEMEANING>Unit per Gram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73775</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/g/day</VALIDVALUE>
          <VALUEMEANING>Unit per Gram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73774</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/animal</VALIDVALUE>
          <VALUEMEANING>Unit per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary dosing unit expressed in unit(s) per animal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73773</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gravitational Unit</VALIDVALUE>
          <VALUEMEANING>Unit of Gravity</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of gravity expressed as a multiple of the force of gravity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73772</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^4/L</VALIDVALUE>
          <VALUEMEANING>Thousand per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration measurement expressed in thousand(s) per deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73771</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>um2</VALIDVALUE>
          <VALUEMEANING>Square Micrometer</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI unit of area measurement equal to a square whose sides are one micrometer long.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ps</VALIDVALUE>
          <VALUEMEANING>Picosecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time equal to one trillionth of a second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ns</VALIDVALUE>
          <VALUEMEANING>Nanosecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time equal to one billionth of a second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406841</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mPa</VALIDVALUE>
          <VALUEMEANING>Millipascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of pressure equivalent to one thousandth of one pascal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg/s</VALIDVALUE>
          <VALUEMEANING>Millimeter of Mercury per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate of inflation or deflation of a manometric device based on the unit of pressure equal to 133,332 Pa or 1.316E10-3 standard atmosphere during period of time equal to one sixtieth of a minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/m2/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per Square Meter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/m2/h</VALIDVALUE>
          <VALUEMEANING>Milliliter per Square Meter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73762</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/m2</VALIDVALUE>
          <VALUEMEANING>Milliliter per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per square meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/kg/h</VALIDVALUE>
          <VALUEMEANING>Milliliter per Kilogram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per kilogram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73759</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/kg/day</VALIDVALUE>
          <VALUEMEANING>Milliliter per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliliters per kilogram per day or milliliters per day (flow rate), divided by kilograms (weight).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/s</VALIDVALUE>
          <VALUEMEANING>Millimole per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>Millimoles per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85723</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8/L</VALIDVALUE>
          <VALUEMEANING>Hundred Million Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed as a number or quantity of objects in hundred millions per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^11/L</VALIDVALUE>
          <VALUEMEANING>Hundred Billion Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed as a number or quantity of objects in hundred billions per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hPa</VALIDVALUE>
          <VALUEMEANING>Hectopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of pressure equivalent to one hundred pascals, 1 millibar or 0.0145 pounds per square inch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GBq</VALIDVALUE>
          <VALUEMEANING>Gigabecquerel</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to 10E9 nuclear disintegrations or other nuclear transformations per second, or to 10E9 becquerels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fraction of 1</VALIDVALUE>
          <VALUEMEANING>Fraction of 1</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for expressing a percentage as a decimal whereby the total value is measured as a fraction of the numeric 1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PFU</VALIDVALUE>
          <VALUEMEANING>Plaque Forming Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of viable infectious entities (e.g. viral particles or group of particles) in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope and/or to the naked eye as a plaque. A number of plaque forming units (PFU) per unit volume is a conventional way to refer the titer of an infective entity in a specimen or preparation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kcal</VALIDVALUE>
          <VALUEMEANING>Calorie</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI unit of energy defined as the amount of heat required to raise the temperature of one kilogram of pure water by one degree Centigrade under standard conditions (the specific heat of the water at 15 degrees Celsius and the constant pressure of 101.325 kPa or one atm being defined as unity), equal to approximately 4.1855 kJ. It is also is used by nutritionists in measuring the energy-producing potential of food as a unit of potential energy contained by a substance, which can be liberated when the material is oxidized, usually by combustion in the presence of oxygen. According to the current national standard in the United States (IEEE/ASTM SI 10 TM-2002. American National Standard for Use of the International System of Units (SI): The Modern Metric System, New York: IEEE, 2002) the calorie in any form is not to be used. Joules should be used instead.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cal</VALIDVALUE>
          <VALUEMEANING>calorie</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI unit of energy defined as the amount of heat required to raise the temperature of one gram of pure water by one degree Centigrade under standard conditions (the specific heat of the water at 3.98, 14.5, or 19.5 degrees Celcius and the constant pressure of 101.325 kPa or one atm being defined as unity), equal to approximately 4.184 J. According to the current national standard in the United States (IEEE/ASTM SI 10 TM-2002. American National Standard for Use of the International System of Units (SI): The Modern Metric System, New York: IEEE, 2002) the calorie in any form is not to be used. Joules should be used instead.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406492</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/wk</VALIDVALUE>
          <VALUEMEANING>Weekly</VALUEMEANING>
          <MEANINGDESCRIPTION>Every week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3277357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/m2/day</VALIDVALUE>
          <VALUEMEANING>Milliliter per Square Meter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66977</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg/day</VALIDVALUE>
          <VALUEMEANING>Milligram per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per kilogram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66976</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108591</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/kg/day</VALIDVALUE>
          <VALUEMEANING>Gram per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose administration rate unit equal to the rate at which one gram of a product per kilogram of body mass is delivered or administered over the period of one day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/m2/day</VALIDVALUE>
          <VALUEMEANING>Milligram per Square Meter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per square meter per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3059688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uL/kg/day</VALIDVALUE>
          <VALUEMEANING>Microliter per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume expressed as a number of microliters of the constituent per kilogram of weight per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mMU/mL</VALIDVALUE>
          <VALUEMEANING>MilliMerck Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration based on the vaccine specific number of titers that are the geometric mean titer at which an individual is considered to convert from a seronegative to a seropositive response due to the vaccine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 TCID 50/uL</VALIDVALUE>
          <VALUEMEANING>Log10 50 Percent Tissue Culture Infective Dose per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one microliter of infectious material contains one 50 percent tissue culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132479</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uV*s</VALIDVALUE>
          <VALUEMEANING>Microvolt Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one microvolt, when the flux is uniformly reduced to zero within one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mph</VALIDVALUE>
          <VALUEMEANING>Mile Per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one mile traveled per unit time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/cm</VALIDVALUE>
          <VALUEMEANING>Milliliter per Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the number of milliliters per unit of length equal to one centimeter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kg/cm</VALIDVALUE>
          <VALUEMEANING>Kilogram per Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to kilograms per length unit equal to one centimeter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120849</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ka_u/dL</VALIDVALUE>
          <VALUEMEANING>King-Armstrong Unit per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of phosphatase concentration that can free one milligram of phenol from disodium phenylphosphate at standard conditions, per unit volume of the mixture equal to one deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 copies/mL</VALIDVALUE>
          <VALUEMEANING>Log10 Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 IU/mL</VALIDVALUE>
          <VALUEMEANING>Log10 International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring international units per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5778792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uEq/L</VALIDVALUE>
          <VALUEMEANING>Microequivalent per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance concentration equal to one billionth of a gram of an equivalent weight per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/L/min</VALIDVALUE>
          <VALUEMEANING>Micromole per Liter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/mol</VALIDVALUE>
          <VALUEMEANING>Milligram per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass commonly used to express the molar mass of a substance in milligram(s) per mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120843</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mJoule/cm2</VALIDVALUE>
          <VALUEMEANING>Millijoules per Square Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radiant exposure defined as a unit of energy equal to one millijoule applied to a unit of area equal to one square centimeter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116241</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/mol</VALIDVALUE>
          <VALUEMEANING>Millimole per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of fraction expressed as the ratio of the amount of substance of solute in millimoles to the amount of substance of the mixture in moles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/min/kPa</VALIDVALUE>
          <VALUEMEANING>Millimoles per Minute per Kilopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of gas diffusion capacity equal to one millimole per minute per kilopascal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mV2/Hz</VALIDVALUE>
          <VALUEMEANING>Millivolt Squared per Hertz</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one thousandth of a volt squared per unit of frequency equal to one Hertz.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114241</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol BCE/L</VALIDVALUE>
          <VALUEMEANING>Nanomole Bone Collagen Equivalent per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JDF Unit</VALIDVALUE>
          <VALUEMEANING>Juvenile Diabetes Foundation Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure, defined by the Juvenile Diabetes Foundation, used to express the amount of islet cell antibodies in a biological sample; it is calculated by multiplying the titer by five.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172606</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>oz eq</VALIDVALUE>
          <VALUEMEANING>Ounce Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance equal to one ounce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172605</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cup eq</VALIDVALUE>
          <VALUEMEANING>Cup Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance equal to one cup.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172604</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tsp eq</VALIDVALUE>
          <VALUEMEANING>Teaspoon Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance equal to one teaspoon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MBP</VALIDVALUE>
          <VALUEMEANING>Megabase Pair</VALUEMEANING>
          <MEANINGDESCRIPTION>A number representing one million paired nucleotides in a DNA or RNA sequence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/MBP</VALIDVALUE>
          <VALUEMEANING>Per Megabase Pair</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one million base pairs used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/mol</VALIDVALUE>
          <VALUEMEANING>Nanogram per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass commonly used to express the molar mass of a substance in nanogram(s) per mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/mol</VALIDVALUE>
          <VALUEMEANING>Microgram per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass commonly used to express the molar mass of a substance in microgram(s) per mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EP U</VALIDVALUE>
          <VALUEMEANING>European Pharmacopoeia Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of measurement established by the European Pharmacopoeia that corresponds to 1800 Kallidinogenase Inactivator units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nkat/g Hb</VALIDVALUE>
          <VALUEMEANING>Nanokatal per Gram Hemoglobin</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity concentration defined as the catalytic activity equal to one billionth of katal (10E-9 katal) per gram hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>breaths/30 s</VALIDVALUE>
          <VALUEMEANING>Breaths per Thirty Seconds</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of breaths (inhalation and exhalation) taken within a period of time equal to thirty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>min/day</VALIDVALUE>
          <VALUEMEANING>Minute per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to the number of minutes within a period of time equal to one day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hr/day</VALIDVALUE>
          <VALUEMEANING>Hour per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to the number of hours within a period of time equal to one day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/kg/day</VALIDVALUE>
          <VALUEMEANING>Nanomole per Kilogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in nanomoles per kilogram per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/mL/day</VALIDVALUE>
          <VALUEMEANING>Gram per Liter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligrams per milliliter per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg/cell</VALIDVALUE>
          <VALUEMEANING>Picogram Per Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration for the number of picograms of substance per cell.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osm</VALIDVALUE>
          <VALUEMEANING>Osmole</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI unit of osmotic pressure equal to that of an ideal solution of a nondissociating substance that has a concentration of one mole of solute per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67330</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uOsm</VALIDVALUE>
          <VALUEMEANING>Microosmole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of osmotic pressure equal to one millionth of an osmole or the osmotic pressure of a 10E-6 molar solution of a substance that does not dissociate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>min*mg/mL</VALIDVALUE>
          <VALUEMEANING>Minute Times Milligram per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Minutes times milligrams per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6639631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7 TCID 50/dose</VALIDVALUE>
          <VALUEMEANING>Ten Million Tissue Culture Infectious Dose 50%</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency equal to ten million tissue culture infectious dose 50% units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6273369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipase Units/kg</VALIDVALUE>
          <VALUEMEANING>Lipase Units per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit based on lipase activity per kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipase Units</VALIDVALUE>
          <VALUEMEANING>Lipase Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit based on lipase activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178059</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7637283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/h</VALIDVALUE>
          <VALUEMEANING>International Unit per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>International units per hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6639392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand Colony Forming Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the fifth power colony forming units in one milliliter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RADIOACTIVE SEED IMPLANT</VALIDVALUE>
          <VALUEMEANING>Radioactive Seed Implant Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit in a form of an incapsulated radioactive material that constitutes an implantable pellet designed for brachytherapy administration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RAE</VALIDVALUE>
          <VALUEMEANING>Retinol Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit for measurement of a vitamin A activity of provitamin A carotenoids (such as carotenes, xanthophylls, and compounds that arise from rearrangement of carotene I skeleton) in a mixed diet introduced by FAO/WHO Expert Group in 1967. The concept of the retinol equivalent (RE) is established on the following relationships among food sources of the vitamin A: one microgram of all-trans retinol is equal to one RE, one microgram of beta-carotene is equal to 0.167 RE, and one microgram of other pro-vitamin A carotenoids is equal to 0.084 RE.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/kg</VALIDVALUE>
          <VALUEMEANING>Nanogram per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass fraction expressed as a number of nanograms of a substance per kilogram of the mixture. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mIU/m2</VALIDVALUE>
          <VALUEMEANING>Milliinternational Unit per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one-thousandth (10E-3) of an arbitrary unit of biological activity (International Unit) of substance per square meter of body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/wk</VALIDVALUE>
          <VALUEMEANING>Milligram per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose administration rate unit equal to the rate at which one thousandth of a gram of a product is delivered or administered over the time period of one week. This is also a unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to one week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>J/cm2</VALIDVALUE>
          <VALUEMEANING>Joule per Square Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radiant exposure equal to radiant energy of one joule arriving upon a surface area of one square centimeter. The unit is also used for measurement of output of the energy-emitting source.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67357</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mrad</VALIDVALUE>
          <VALUEMEANING>Megarad</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of absorbed radiation dose equal to one million rad (10E6 rad), or 10000 Gy (10E4 Gy).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 PFU</VALIDVALUE>
          <VALUEMEANING>Million Plaque Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of viable infectious entities expressed in millions in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope or/and to the naked eye as a plaque.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 PFU</VALIDVALUE>
          <VALUEMEANING>Billion Plaque Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of viable infectious entities expressed in billions in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope or/and to the naked eye as a plaque.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/breath</VALIDVALUE>
          <VALUEMEANING>Milligram Per Breath</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in milligram(s) per inspiration or expiration of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184723</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RLU</VALIDVALUE>
          <VALUEMEANING>Relative Luminescence Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit used to measure the intensity of the emitted light from a sample; it is dependent on instrument and measurement parameters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tuberculin unit/0.1mL</VALIDVALUE>
          <VALUEMEANING>Tuberculin Unit per 100 Microliters</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of biologic activity of tuberculin expressed as a number of arbitrary units of tuberculin in one milliliter of preparation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184721</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SERVING</VALIDVALUE>
          <VALUEMEANING>Serving Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the serving unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/10^6</VALIDVALUE>
          <VALUEMEANING>Per Million</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one million entities used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7/kg</VALIDVALUE>
          <VALUEMEANING>Ten Million Per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the seventh power of the number of entities per unit of mass equal to one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5/kg</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand Per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the fifth power of the number of entities per unit of mass equal to one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184715</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>rad/s</VALIDVALUE>
          <VALUEMEANING>Radians Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>An SI unit of angular velocity defined as the change in angular velocity equal to one radian per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184714</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m*%</VALIDVALUE>
          <VALUEMEANING>Meters Times Percent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the distance saturation product (DSP) defined as meters times percent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C184713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8 IU</VALIDVALUE>
          <VALUEMEANING>Hundred Million International Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of biological activity equal to one hundred million international units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156119</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6535804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MeV</VALIDVALUE>
          <VALUEMEANING>Megaelectronvolt</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy that is equal to one million electron volts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C152057</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6338208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8 TCID 50/dose</VALIDVALUE>
          <VALUEMEANING>Hundred Million Tissue Culture Infectious Dose 50%</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency equal to one hundred million tissue culture infectious dose 50% units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6273368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 TCID 50/dose</VALIDVALUE>
          <VALUEMEANING>Million Tissue Culture Infectious Dose 50%</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency equal to one million tissue culture infectious dose 50% units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6273370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CGE</VALIDVALUE>
          <VALUEMEANING>Cobalt Gray Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative biological effectiveness of protons equivalent to 60 cobalt gamma rays.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5343411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/kg/wk</VALIDVALUE>
          <VALUEMEANING>Microgram per Kilogram per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose administration rate unit where the amount of product to be delivered or administered is calculated in micrograms as a function of the subject&#39;s weight in kilograms and is delivered or administered over the time period of one week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89830</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3113232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/wk</VALIDVALUE>
          <VALUEMEANING>Gram per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose administration rate unit equal to the rate at which a gram of a product is delivered or administered over the time period of one week. This is also a unit of mass flow rate equivalent to the rate at which a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to one week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89829</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3113233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/m2/wk</VALIDVALUE>
          <VALUEMEANING>Milligram per Square Meter per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s)per square meter per period of time equal to seven days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88148</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3059686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>meq/h</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance crosses a given surface or is delivered to a given object or space over a period of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/dL</VALIDVALUE>
          <VALUEMEANING>Milliliter per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of volume concentration expressed as the number of milliters of a dissolved substance per deciliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/s/1.73 m2</VALIDVALUE>
          <VALUEMEANING>Milliliter Per Second Per 1.73 Meter Squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one second per 1.73 meters squared of body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg/L/min</VALIDVALUE>
          <VALUEMEANING>Millimeter Mercury Per Liter Per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to the number of millimeters of mercury per unit of volume equal to one liter per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm/min</VALIDVALUE>
          <VALUEMEANING>Millimeter Per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter traveled per unit time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm/s</VALIDVALUE>
          <VALUEMEANING>Millimeter Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter traveled per unit time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm/2h</VALIDVALUE>
          <VALUEMEANING>Millimeter per Two Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter traveled per unit time equal to two hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mV*min</VALIDVALUE>
          <VALUEMEANING>Millivolt Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one millivolt, when the flux is uniformly reduced to zero within one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nU/cL</VALIDVALUE>
          <VALUEMEANING>Nanounit Per Centiliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in nanounit(s) per centiliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/VF</VALIDVALUE>
          <VALUEMEANING>Per Visual Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the instances of an entity per visual field of a microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^10/L</VALIDVALUE>
          <VALUEMEANING>Ten Billion Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed as a number or quantity of objects in ten billions per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^12 IU/L</VALIDVALUE>
          <VALUEMEANING>Tera International Unit Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of 10^12 international unit per one liter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105518</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3/L</VALIDVALUE>
          <VALUEMEANING>Thousand Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed as a number or quantity of objects in thousands per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/cL</VALIDVALUE>
          <VALUEMEANING>Unit Per Centiliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration expressed in unit(s) per centiliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/dL</VALIDVALUE>
          <VALUEMEANING>Unit Per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration expressed in unit(s) per deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/g Hb</VALIDVALUE>
          <VALUEMEANING>Unit Per Gram Hemoglobin</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one unit per gram of hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>V/s</VALIDVALUE>
          <VALUEMEANING>Volt Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived rate unit equal to one volt per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frames/s</VALIDVALUE>
          <VALUEMEANING>Frames Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the number of visual frames per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/mmHg</VALIDVALUE>
          <VALUEMEANING>Milliliters Per Millimeter of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to the volume in milliliters per one millimeter rise of mercury in a barometer at the Earth&#39;s surface.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404733</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antibody Unit</VALIDVALUE>
          <VALUEMEANING>Antibody Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of antibody concentration measured by comparison against a known concentration of antibodies in a standard reference specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404735</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BAG</VALIDVALUE>
          <VALUEMEANING>Bag Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a bag.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol</VALIDVALUE>
          <VALUEMEANING>Nanomole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to 10E-9 mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/L</VALIDVALUE>
          <VALUEMEANING>Nanomole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg</VALIDVALUE>
          <VALUEMEANING>Picogram</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass equal to one trillionth of a gram (10E-12 gram).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg/dL</VALIDVALUE>
          <VALUEMEANING>Picogram per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one picogram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of a substance which mass equal to one picogram occupies the volume of one deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67331</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2724562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/L</VALIDVALUE>
          <VALUEMEANING>Picomole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one trillionth of a mole (10E-12 mole) in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>s</VALIDVALUE>
          <VALUEMEANING>Second</VALUEMEANING>
          <MEANINGDESCRIPTION>The second is the unit of time, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). The second is the duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the ground state of the caesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour. Abbreviation Sec. is acceptable in non-scientific usage only.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/L</VALIDVALUE>
          <VALUEMEANING>Unit per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration equal to the concentration at which one liter of mixture contains one unit of a substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2724566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/m2</VALIDVALUE>
          <VALUEMEANING>Unit per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed as a number of arbitrary units of substance per one square meter of a body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ejaculate U</VALIDVALUE>
          <VALUEMEANING>Ejaculate Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume equal to the amount of seminal fluid produced by a single ejaculation event.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/LSQN</VALIDVALUE>
          <VALUEMEANING>Per Large Square Neubauer Chamber</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the instances of an entity per large square (with a 1mm x 1mm area) in a Neubauer chamber.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405983</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/mm</VALIDVALUE>
          <VALUEMEANING>Per Millimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of length equal to one millimeter that is used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6/Ejaculate U</VALIDVALUE>
          <VALUEMEANING>Million Per Ejaculate Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the sixth power of entities per unit equal to one ejaculation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405987</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/animal/wk</VALIDVALUE>
          <VALUEMEANING>Gram per Animal per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per animal per period of time equal to seven days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73715</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/animal/day</VALIDVALUE>
          <VALUEMEANING>Gram per Animal per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per animal per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73714</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/animal</VALIDVALUE>
          <VALUEMEANING>Gram per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in gram(s) per animal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fmol/g</VALIDVALUE>
          <VALUEMEANING>Femtomole per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A molality unit that describes the amount of substance, expressed in femtomole(s) per gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DPM</VALIDVALUE>
          <VALUEMEANING>Disintegration per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73710</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cpm</VALIDVALUE>
          <VALUEMEANING>Count per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of frequency expressed as the detection rate of ionization events per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>s^-1(%O2)^-1</VALIDVALUE>
          <VALUEMEANING>Reciprocal of Seconds Times Percent O2 Concentration</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of oxygen transfer function expressed as the reciprocal of time in seconds divided by the oxygen concentration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uSiemens</VALIDVALUE>
          <VALUEMEANING>Microsiemens</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electrical conductance, admittance, and susceptance equal to one millionth of a Siemens (10E-6 Siemens).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154859</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>um/s</VALIDVALUE>
          <VALUEMEANING>Micrometer per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one micrometer travelled per unit time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154858</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RFU</VALIDVALUE>
          <VALUEMEANING>Relative Fluorescence Intensity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement that estimates the size or amount of material in a sample by normalizing its luminescence to that of a reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>P</VALIDVALUE>
          <VALUEMEANING>Poise</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of dynamic viscosity equal to one pascal-second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154857</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OD Unit</VALIDVALUE>
          <VALUEMEANING>Unit of Optical Density</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication of the type of unit of measure being used to express an optical density of a substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/day</VALIDVALUE>
          <VALUEMEANING>Nanogram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanograms per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/100g/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per 100 Grams per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of flow rate expressed as the number of milliliters per 100g of material per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mgEq</VALIDVALUE>
          <VALUEMEANING>Milligram Equivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance concentration equal to one thousandth of a gram of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hz/s</VALIDVALUE>
          <VALUEMEANING>Hertz Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of frequency rate change defined as the number of Hertz per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154854</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enzyme U/m2</VALIDVALUE>
          <VALUEMEANING>Enzyme Unit per Meter Squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (catalytic activity) equal to one enzyme unit of substance per one square meter of surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enzyme U/g Hb</VALIDVALUE>
          <VALUEMEANING>Enzyme Unit per Gram Hemoglobin</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (biologic activity) equal to one enzyme unit of substance per gram of hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154856</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HOURS</VALIDVALUE>
          <VALUEMEANING>Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25529</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5228317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/L</VALIDVALUE>
          <VALUEMEANING>Kilogram per Cubic Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>The SI derived unit of mass concentration defined as the concentration of one kilogram of a substance in unit volume of the mixture equal to one cubic meter, or the concentration of one milligram of a substance in unit volume of the mixture equal to one milliliter, or one gram of a substance per one liter of the mixture. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2685297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/L</VALIDVALUE>
          <VALUEMEANING>International Unit per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one liter of the system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/kg</VALIDVALUE>
          <VALUEMEANING>Liter per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in liter(s) per kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73725</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/g</VALIDVALUE>
          <VALUEMEANING>Nanomole per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanomoles per kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/day</VALIDVALUE>
          <VALUEMEANING>Daily</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring or done each day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/month</VALIDVALUE>
          <VALUEMEANING>Monthly</VALUEMEANING>
          <MEANINGDESCRIPTION>Every month.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mIU/L</VALIDVALUE>
          <VALUEMEANING>Microinternational Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one millionth of international unit per one milliliter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CCID 50/mL</VALIDVALUE>
          <VALUEMEANING>50 Percent Cell Culture Infective Dose per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit equal to the potency at which one milliliter of preparation contains one 50 percent cell culture infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120845</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EID 50/mL</VALIDVALUE>
          <VALUEMEANING>50 Percent Embryo Infective Dose per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit for measuring infectious activity of a biologic product or an infectious agent preparation equal to the potency at which one milliliter of infectious material contains one 50 percent embryo infective dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120847</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PNU/mL</VALIDVALUE>
          <VALUEMEANING>Allergenic Protein Nitrogen Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of allergenic product potency expressed as the number of protein nitrogen units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anson U</VALIDVALUE>
          <VALUEMEANING>Anson Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of enzyme concentration which is defined as the amount of enzyme that can digest urea-denatured hemoglobin at the same initial rate as one milliequivalent of tyrosine at standard conditions (25C and pH 7.50).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122201</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BU</VALIDVALUE>
          <VALUEMEANING>Bethesda Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement for blood coagulation inhibitor activity, expressed in the amount of an inhibitor neutralizing 50% of a coagulant during the incubation period per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BU/mL</VALIDVALUE>
          <VALUEMEANING>Bethesda Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement for blood coagulation inhibitor activity, expressed as a Bethesda Unit per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9/g</VALIDVALUE>
          <VALUEMEANING>Billion per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the ninth power of the number of entities per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BAU/mL</VALIDVALUE>
          <VALUEMEANING>Bioequivalent Allergy Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of allergenic product potency expressed as the number of bioequivalent allergy units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116235</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BE/mL</VALIDVALUE>
          <VALUEMEANING>Biological Allergy Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of allergenic product potency expressed as a number of biological units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BISCUIT</VALIDVALUE>
          <VALUEMEANING>Biscuit Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of ingredient(s) in a biscuit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111139</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BLOCKS</VALIDVALUE>
          <VALUEMEANING>Block Unit of Distance</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure to quantify the number of rectangular areas in a city surrounded by streets.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405591</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cd/m2</VALIDVALUE>
          <VALUEMEANING>Candela per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of luminous intensity expressed as one candela per square meter of area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cd*s/m2</VALIDVALUE>
          <VALUEMEANING>Candela Second per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of luminous intensity expressed as one candela in one second of light emittance per square meter of area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U.CARR</VALIDVALUE>
          <VALUEMEANING>Carratelli Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration expressed in milligrams per a volume of hydrogen peroxide. One Carratelli unit is equal to 0.8mg substance per liter of hydrogen peroxide.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CIGAR</VALIDVALUE>
          <VALUEMEANING>Cigar Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of ingredient(s) in a cigar.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CIGARETTE</VALIDVALUE>
          <VALUEMEANING>Cigarette Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of ingredient(s) in a cigarette.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116245</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>copies/uL</VALIDVALUE>
          <VALUEMEANING>Copies per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration expressed as a number of copies per unit volume equal to one microliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405625</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dpm/100 mg</VALIDVALUE>
          <VALUEMEANING>Disintegration per Minute per 100 milligrams</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one centigram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117968</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dpm/mg</VALIDVALUE>
          <VALUEMEANING>Disintegration per Minute per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>rpm</VALIDVALUE>
          <VALUEMEANING>Revolution per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of frequency equal to one revolution per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol/mol</VALIDVALUE>
          <VALUEMEANING>Mole per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of fraction expressed as the ratio of the amount of substance of solute in moles to the amount of substance of the mixture in moles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70455</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/g</VALIDVALUE>
          <VALUEMEANING>Gram per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a mass fraction expressed as a number of grams of substance per gram of mixture. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DROP</VALIDVALUE>
          <VALUEMEANING>Drop</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of volume defined as the amount of liquid dispensed as one drop from a dropper dispenser. The volume of a drop depends on the physical properties of the liquid dispensed, the dispenser device, and the technique used to produce the drop.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pL</VALIDVALUE>
          <VALUEMEANING>Picoliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume equal to one trillionth of a liter (10E-12 liter).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nL</VALIDVALUE>
          <VALUEMEANING>Nanoliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume equal to one billionth of a liter (10E-9 liter).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uL/mL</VALIDVALUE>
          <VALUEMEANING>Microliter per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume fraction expressed as a number of microliters of the constituent per the volume of the system represented in milliliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69175</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2689613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/h</VALIDVALUE>
          <VALUEMEANING>Liter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI unit of volumetric flow rate defined as the rate at which one liter of matter crosses a given surface during the period of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>us</VALIDVALUE>
          <VALUEMEANING>Microsecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time equal to one millionth of a second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69149</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pm</VALIDVALUE>
          <VALUEMEANING>Picometer</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of length equal to one trillionth of a
meter (10E-12 meter).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69148</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pt_br</VALIDVALUE>
          <VALUEMEANING>Pint British</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of volume equal to 20 British fluid ounces, 34.678 cubic inches or approximately 568.261 milliliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69114</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ppth</VALIDVALUE>
          <VALUEMEANING>Part per Thousand</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of proportion equal to 10E-3.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69112</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/day</VALIDVALUE>
          <VALUEMEANING>Liter per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one liter of matter crosses a given surface during the period of time equal to one day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69110</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/kg</VALIDVALUE>
          <VALUEMEANING>Gram per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a mass fraction expressed as a number of grams of substance per kilogram of mixture. Gram per kilogram is also used as a dose calculation unit to express a quantity of substance in grams per one kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69104</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406578</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kg/cm2</VALIDVALUE>
          <VALUEMEANING>Kilogram per Square Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of spread rate of a substance by mass expressed in kilograms per area unit equal to one square centimeter, used also as a measure of area density and as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69094</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cL</VALIDVALUE>
          <VALUEMEANING>Centiliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of volume equal to one hundredth of a liter or 10 milliliters. One centiliter is equivalent to 0.6102 cubic inch, or 0.338 U.S. fluid ounce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gauss</VALIDVALUE>
          <VALUEMEANING>Gauss</VALUEMEANING>
          <MEANINGDESCRIPTION>A CGS unit of magnetic flux density. A field of one gauss exerts a force on a conductor, placed in the field of 0.1 dyne per ampere of current per centimetre of conductor. One gauss represents a magnetic flux of one maxwell per square centimetre of cross-section perpendicular to the field. In SI units, one gauss equals 10-4 tesla.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406582</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Billion Colony Forming Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of billion colony forming units (10E9 CFU) in one milliliter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68905</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406584</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Million Colony Forming Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of million colony forming units (10E6 CFU) in one milliliter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Thousand Colony Forming Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of thousand colony forming units (10E3 CFU) in one milliliter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CFU/mL</VALIDVALUE>
          <VALUEMEANING>Colony Forming Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of colony forming units in one milliliter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68902</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>POINT</VALIDVALUE>
          <VALUEMEANING>Point</VALUEMEANING>
          <MEANINGDESCRIPTION>A numeric unit used to quantify a score.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6428092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ohm</VALIDVALUE>
          <VALUEMEANING>Ohm</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in siemens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sv</VALIDVALUE>
          <VALUEMEANING>Sievert</VALUEMEANING>
          <MEANINGDESCRIPTION>The international system (SI) unit for radiation dose equivalent equal to 1 Joule/kilogram. 1 sievert = 100 rem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4723805</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Farad</VALIDVALUE>
          <VALUEMEANING>Farad</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI unit of capacitance equal to the capacitance of a capacitor having an equal and opposite charge of one coulomb on each plate and a potential difference of one volt between the plates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42552</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>V</VALIDVALUE>
          <VALUEMEANING>Volt</VALUEMEANING>
          <MEANINGDESCRIPTION>The SI derived unit of electric potential and electromotive force, equal to the difference of electric potential between two points on a conducting wire carrying a constant current of one ampere when the power dissipated between the points is one watt, equivalent to the potential difference across a resistance of one ohm when one ampere of current flows through it.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Coulomb</VALIDVALUE>
          <VALUEMEANING>Coulomb</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of quantity of electricity, equal to the quantity of charge transferred in one second across a conductor in which there is a constant current of one ampere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42550</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol BCE/mmol</VALIDVALUE>
          <VALUEMEANING>Nanomole Bone Collagen Equivalent per Millimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of substance concentration equal to one millimole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/4.0 mL</VALIDVALUE>
          <VALUEMEANING>per 4.0 Milliliters</VALUEMEANING>
          <MEANINGDESCRIPTION>A volume unit equal to 4.0 milliliters used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/7.5 mL</VALIDVALUE>
          <VALUEMEANING>per 7.5 Milliliters</VALUEMEANING>
          <MEANINGDESCRIPTION>A volume unit equal to 7.5 milliliters used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122198</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/kg</VALIDVALUE>
          <VALUEMEANING>Per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A mass unit equal to one kilogram used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/mm2</VALIDVALUE>
          <VALUEMEANING>per Square Millimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>An area unit equal to one millimeter squared used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>% INHIBITION</VALIDVALUE>
          <VALUEMEANING>Percent Inhibition</VALUEMEANING>
          <MEANINGDESCRIPTION>The rate of measured normal activity minus inhibited activity, divided by the rate of normal activity of a given object. It is expressed as a percentage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117963</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%/min</VALIDVALUE>
          <VALUEMEANING>Percent per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of frequency expressed as the percentage of entities or events per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PIPE</VALIDVALUE>
          <VALUEMEANING>Pipe Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of ingredient(s) in a pipe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PIXELS/cm</VALIDVALUE>
          <VALUEMEANING>Pixels per Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of image resolution expressed in the numbers of pixels per centimeter in the horizontal or vertical direction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PIXELS/in</VALIDVALUE>
          <VALUEMEANING>Pixels per Inch</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of image resolution expressed in the numbers of pixels per inch in the horizontal or vertical direction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Shock Wave</VALIDVALUE>
          <VALUEMEANING>Shockwave Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the shock wave unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MBq</VALIDVALUE>
          <VALUEMEANING>Megabecquerel</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to 10E6 nuclear disintegrations or other nuclear transformations per second, or to 10E6 becquerels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kBq</VALIDVALUE>
          <VALUEMEANING>Kilobecquerel</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to 10E3 nuclear disintegrations or other nuclear transformations per second, or to 10E3 becquerels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70511</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cP</VALIDVALUE>
          <VALUEMEANING>Centipoise</VALUEMEANING>
          <MEANINGDESCRIPTION>A CGS unit of dynamic viscosity equal to 10E-3 pascal second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Watt</VALIDVALUE>
          <VALUEMEANING>Watt</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI unit of power equal to the power which in one second produces or transfers the energy of one joule. The unit is used in measurements of power emitted, transferred or received as radiation, sound waves, heat flow rate, and rate of energy transfer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Joule</VALIDVALUE>
          <VALUEMEANING>Joule</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electrical, mechanical, and thermal energy (as well as work and quantity of heat) in the SI system, equal to the work done when the point of application of a force of one newton is displaced through a distance of one meter in the direction of the force or the work done when a current of one ampere passes through a resistance of one ohm for one second. Joule is equal to 0.23889 gram-calorie (mean).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pa</VALIDVALUE>
          <VALUEMEANING>Pascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of pressure equivalent to one newton per square meter or 10 bars or to 1.45x10E-4 pounds per square inch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Newton</VALIDVALUE>
          <VALUEMEANING>Newton</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of force. The force which, when applied in a vacuum to a body having a mass of one kilogram, causes an acceleration of one meter per second squared. It is equal to 10E5 dynes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hz</VALIDVALUE>
          <VALUEMEANING>Hertz</VALUEMEANING>
          <MEANINGDESCRIPTION>The SI derived unit of frequency; equal to one oscillation per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569383</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol</VALIDVALUE>
          <VALUEMEANING>Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>The the basic unit of substance, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). It is the amount of substance that contains as many elementary units as there are atoms in 0.012 kg of carbon-12. When the mole is used, the elementary entities must be specified and may be atoms, molecules, ions, electrons, other particles, or specified groups of such particles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42539</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cd</VALIDVALUE>
          <VALUEMEANING>Candela</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of luminous intensity, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). It is the luminous intensity in a given direction of a small monochromatic light source at 540 terahertz emitting 1/683 watt per steradian in that direction. This is dependent upon the definitions of the meter, kilogram, and second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42538</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>K</VALIDVALUE>
          <VALUEMEANING>Kelvin</VALUEMEANING>
          <MEANINGDESCRIPTION>A basic unit of thermodynamic temperature, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). It is 1/273.16th of the thermodynamic temperature of the triple point of water, This sets the size of the kelvin unit for temperature differences and defines the thermodynamic temperature of an equilibrium mixture of waters ice-liquid-vapor as 273.16 K, where 0 K is the lowest possible temperature (&quot;absolute zero&quot;).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42537</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>amp</VALIDVALUE>
          <VALUEMEANING>Ampere</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electric current, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). It is that constant current which, if maintained in two straight parallel conductors of infinite length and zero diameter separated by one meter in a vacuum, would produce between these conductors a force equal to 2x10E7 newton per meter of length. This is dependent upon the definitions of the meter, kilogram, and second. One ampere represents 6.24 x 10E18 unit electric charge carriers, such as electrons, passing a specified fixed point in one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42536</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ms</VALIDVALUE>
          <VALUEMEANING>Millisecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time equal to one thousandth of a second (10E-3 second).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406336</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PACKAGE</VALIDVALUE>
          <VALUEMEANING>Package Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a package.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>oz</VALIDVALUE>
          <VALUEMEANING>Ounce</VALUEMEANING>
          <MEANINGDESCRIPTION>The traditional unit of mass. The avoirdupois ounce is equal to 1/16 pound, or 28.3495 grams, or 0.911 457 troy ounce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569429</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng</VALIDVALUE>
          <VALUEMEANING>Nanogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass equal to 10E-9 gram, or one millionth of a milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mCi</VALIDVALUE>
          <VALUEMEANING>Millicurie</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to one thousandth of a curie or 37 megabecquerels, and corresponding to a radioactivity of 37 millions of atomic disintegrations per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48511</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>um</VALIDVALUE>
          <VALUEMEANING>Micron</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of length in metric system equal to 10E-6 meter, or micrometer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uCi</VALIDVALUE>
          <VALUEMEANING>Microcurie</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to one millionth of a curie or 37 kilobecquerels, and corresponding to a radioactivity of 37 000 atomic disintegrations per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LOZENGE</VALIDVALUE>
          <VALUEMEANING>Lozenge Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a lozenge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L</VALIDVALUE>
          <VALUEMEANING>Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-SI unit of volume accepted for use with the SI. One liter is equal to cubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or approximately 61.023 744 cubic inches.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5656836</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KIT</VALIDVALUE>
          <VALUEMEANING>Kit Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a kit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KALLIKREIN INHIBITOR UNIT</VALIDVALUE>
          <VALUEMEANING>Kallikrein Inhibitor Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the Kallikrein inhibitor unit.(NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JAR</VALIDVALUE>
          <VALUEMEANING>Jar Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a jar.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/min/1.73 m2</VALIDVALUE>
          <VALUEMEANING>Milliliter per Minute per 1.73 m2 of Body Surface Area</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one milliliter of preparation per 1.73 square meters of body surface area delivered during a period of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nkat/L</VALIDVALUE>
          <VALUEMEANING>Nanokatal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity concentration defined as the catalytic activity of the component equal to one billionth of katal (10E-9 katal) in the unit volume of the system equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pkat</VALIDVALUE>
          <VALUEMEANING>Picokatal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity measurement equal to trillionth of katal (10E-12 katal).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nkat</VALIDVALUE>
          <VALUEMEANING>Nanokatal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity measurement equal to one billionth of katal (10E-9 katal).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mkat</VALIDVALUE>
          <VALUEMEANING>Millikatal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity measurement equal to one thousandth of katal (10E-3 katal).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tuberculin unit/mL</VALIDVALUE>
          <VALUEMEANING>Tuberculin Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of biologic activity of tuberculin expressed as a number of arbitrary units of tuberculin in one milliliter of preparation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BAU</VALIDVALUE>
          <VALUEMEANING>Bioequivalent Allergy Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit used for standardization of an allergenic product based on evaluation of product potency against reference standard in combined in vivo (skin test) and in vitro (IgE-based ELISA) testing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AU/mL</VALIDVALUE>
          <VALUEMEANING>Allergy Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of measure of potency of allergenic product expressed as a number of allergy units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DAgU/mL</VALIDVALUE>
          <VALUEMEANING>D Antigen Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency of poliovirus vaccine expressed as a number of D antigen units per one milliliter of vaccine formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VOXEL</VALIDVALUE>
          <VALUEMEANING>Voxel</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest distinguishable &#39;rectangular-parallel-piped-shaped&#39; part of a three-dimensional space or image.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>keV</VALIDVALUE>
          <VALUEMEANING>Kiloelectronvolt</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy equal to 1000 electronvolts, or (approximately) 1,602 177 x 10-16 joule. The unit is accepted for use with SI units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gy/min</VALIDVALUE>
          <VALUEMEANING>Gray per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of absorbed radiation dose rate defined as the number of Grays per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158296</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gy/h</VALIDVALUE>
          <VALUEMEANING>Gray per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of absorbed radiation dose rate defined as the number of Grays per hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7 CFU</VALIDVALUE>
          <VALUEMEANING>Ten Million Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of viable bacterial numbers equal to 10 to the seventh power colony forming units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775801</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^4 CFU</VALIDVALUE>
          <VALUEMEANING>Ten Thousand Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of viable bacterial numbers equal to 10 to the fourth power colony forming units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775803</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/L FEU</VALIDVALUE>
          <VALUEMEANING>Microgram per Liter Fibrinogen Equivalent Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of equivalent concentration equal to the number of micrograms of fibrinogen per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775805</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/L FEU</VALIDVALUE>
          <VALUEMEANING>Milligram per Liter Fibrinogen Equivalent Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of equivalent concentration equal to the number of milligrams of fibrinogen per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APS U</VALIDVALUE>
          <VALUEMEANING>Phosphatidylserine IgA Antibody Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with phosphatidylserine evaluated against an established reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GPS U</VALIDVALUE>
          <VALUEMEANING>Phosphatidylserine IgG Antibody Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with phosphatidylserine evaluated against an established reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MPS U</VALIDVALUE>
          <VALUEMEANING>Phosphatidylserine IgM Antibody Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with phosphatidylserine evaluated against an established reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/L DDU</VALIDVALUE>
          <VALUEMEANING>Micrograms DDU Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of equivalent concentration equal to the number of micrograms of D-dimer per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DDU</VALIDVALUE>
          <VALUEMEANING>D-Dimer Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of D-dimers contained within that sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>genEq</VALIDVALUE>
          <VALUEMEANING>Genomic Equivalents</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit defined as the number of whole organism genomes in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>genEq/mL</VALIDVALUE>
          <VALUEMEANING>Genomic Equivalents per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration defined as the number of genomic equivalents per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859339</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ECL unit</VALIDVALUE>
          <VALUEMEANING>Electrochemiluminescence Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring concentration or/and reactivity of a test substance as defined in the literature reference standard for the particular quantitative electrochemiluminescent method.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/ms</VALIDVALUE>
          <VALUEMEANING>Per Millisecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time, which is equal to the reciprocal of one thousandth of a second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859343</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ms2</VALIDVALUE>
          <VALUEMEANING>Square Millisecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time which is equal to one thousandth of a second squared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859345</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>deg/mm</VALIDVALUE>
          <VALUEMEANING>Degree Per Millimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of rotation expressed as the number of degrees per unit of length equal to one millimeter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859347</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DRINK</VALIDVALUE>
          <VALUEMEANING>Drink Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the drink unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg/week</VALIDVALUE>
          <VALUEMEANING>Milligram Per Kilogram Per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per kilogram per period of time equal to seven days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859351</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mAmp</VALIDVALUE>
          <VALUEMEANING>Milliampere</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electric current equal to one thousandth of an ampere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIP</VALIDVALUE>
          <VALUEMEANING>Dip Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the dip unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>USP U</VALIDVALUE>
          <VALUEMEANING>United States Pharmacopeia Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit for the measurement of the biologic activity of antibiotics, endocrine preparations, sera, toxins, vaccines, and related products established by the United States Pharmacopeia (USP), the official public standards-setting authority for all prescription and over-the-counter medicines, dietary supplements, and other healthcare products manufactured and sold in the US. For each substance to which this unit applies, USP determines a Reference Standard and a specified assay. If the standard is the same as the WHO-approved International Biological Reference Preparation, and the same assay procedure was used for the biological effect evaluation, the USP unit is considered equal to International Unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>vg/kg</VALIDVALUE>
          <VALUEMEANING>Vector Genomes per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for the vector amount expressed as the number of vector genomes per kilogram of body weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ms/mmHg</VALIDVALUE>
          <VALUEMEANING>Millisecond per Millimeter Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to one millisecond per one millimeter of mercury (mmHg).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163565</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MnFI</VALIDVALUE>
          <VALUEMEANING>Mean Fluorescence Intensity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the mean fluorescence intensity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/cm3/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per Cubic Centimeter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of flow rate equal to one milliliter per cm3 per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>gMFI</VALIDVALUE>
          <VALUEMEANING>Geometric Mean Fluorescence Intensity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the geometric mean fluorescence intensity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FIU</VALIDVALUE>
          <VALUEMEANING>Fluorescence Intensity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the fluorescence intensity when the mathematic calculation is unspecified or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FFU</VALIDVALUE>
          <VALUEMEANING>Focus Forming Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantitative unit of measure of cell clusters of a specific interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75303</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>aMFI</VALIDVALUE>
          <VALUEMEANING>Arithmetic Mean Fluorescence Intensity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the arithmetic mean fluorescence intensity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9/dose</VALIDVALUE>
          <VALUEMEANING>Billion per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to 10 to the ninth power of the number of entities per single dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163561</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%/s</VALIDVALUE>
          <VALUEMEANING>Percent per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of frequency expressed as the percentage of entities or events per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mU</VALIDVALUE>
          <VALUEMEANING>Milliunit</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantity equivalent to the one thousandth unit (10E-3 unit).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uV2</VALIDVALUE>
          <VALUEMEANING>Microvolts Squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electromotive force equal to a microvolt squared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>steps/min</VALIDVALUE>
          <VALUEMEANING>Steps Per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of steps occurring within a minute unit of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/s/m2</VALIDVALUE>
          <VALUEMEANING>Milliliter Per Second Per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one second per meter squared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166100</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/U</VALIDVALUE>
          <VALUEMEANING>Gram Per Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration or mass density equal to one gram of substance per unit(s) of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>damol/L</VALIDVALUE>
          <VALUEMEANING>Decamole Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one decamole of solute in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cs</VALIDVALUE>
          <VALUEMEANING>Centisecond</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of time equal to one hundredth of a second (10E-2 seconds).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105482</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm/min</VALIDVALUE>
          <VALUEMEANING>Centimeter Per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter traveled per unit time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100 HPFs</VALIDVALUE>
          <VALUEMEANING>Per 100 High Powered Fields</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of the number of entities per unit of area equal to one hundred high powered fields.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102695</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Log10 Colony Forming Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring colony forming units per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102659</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ukat/10^12 RBC</VALIDVALUE>
          <VALUEMEANING>Microkatal per Trillion Erythrocytes</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of catalytic activity concentration defined as activity equal to one millionth of a katal per 10^12 erythrocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uL/dose</VALIDVALUE>
          <VALUEMEANING>Microliter per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in microliter(s) per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kg/mol</VALIDVALUE>
          <VALUEMEANING>Kilogram per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass commonly used to express the molar mass of a substance in kilogram(s) per mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mAnson U/mL</VALIDVALUE>
          <VALUEMEANING>Milli-Anson Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of enzymatic activity defined a one milli-Anson unit per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg2/dL2</VALIDVALUE>
          <VALUEMEANING>Square Milligram per Square Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as one square milligram of a substance in unit volume of the mixture equal to one square deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol2/L2</VALIDVALUE>
          <VALUEMEANING>Square Millimole per Square Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one square millimole of solute per square liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405765</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mOsm/L</VALIDVALUE>
          <VALUEMEANING>Milliosmole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of osmotic pressure equal to one thousandth of an osmole per unit of volume equal to one Liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mU/g</VALIDVALUE>
          <VALUEMEANING>Milliunit per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in milliunit(s) per gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mV/s</VALIDVALUE>
          <VALUEMEANING>Millivolt per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived rate unit equal to one millivolt per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/s/kPa</VALIDVALUE>
          <VALUEMEANING>Liter per Second per Kilopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of conductance equal to the number of liters per unit of time equal to one second per unit of pressure equal to one kilopascal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139133</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>s*kPa</VALIDVALUE>
          <VALUEMEANING>Second Times Kilopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to one second times one kilopascal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>h*%</VALIDVALUE>
          <VALUEMEANING>Hour Times Percent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the area under an effect curve (AUEC), defined as hours times percent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAC50</VALIDVALUE>
          <VALUEMEANING>Minimum Alveolar Concentration 50 Percent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency for inhalational gases, defined as the concentration of gas in the lung required to immobilize 50% of individuals in response to a stimulus, such as pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL*cmH2O</VALIDVALUE>
          <VALUEMEANING>Milliliter Times Centimeter of Water</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for volume change calculation expressed by multiplying the volume of air flow in mL by the air pressure in cmH2O.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmH2O/mL</VALIDVALUE>
          <VALUEMEANING>Centimeter of Water per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for pressure change that is expressed in cmH2O per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmH2O*s2/mL</VALIDVALUE>
          <VALUEMEANING>Centimeter of Water Times Second Squared per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for pressure change that is expressed by multiplying cmH2O by seconds, multiplying that product by seconds, then dividing that subsequent product by the volume of air flow in milliliters</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmH2O*s/mL</VALIDVALUE>
          <VALUEMEANING>Centimeter of Water Times Second per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for pressure change that is expressed by multiplying cmH2O by seconds, and then dividing that product by the volume of air flow in milliliters</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135518</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/cmH2O</VALIDVALUE>
          <VALUEMEANING>Per Centimeter of Water</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure equal to one centimeter of water used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/10^5</VALIDVALUE>
          <VALUEMEANING>Per Hundred Thousand</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit, equal to one hundred thousand entities, is used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/10^4</VALIDVALUE>
          <VALUEMEANING>Per Ten Thousand</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit, equal to ten thousand entities, is used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135515</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 CFU/g</VALIDVALUE>
          <VALUEMEANING>Log10 Colony Forming Units per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring colony forming units per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dB</VALIDVALUE>
          <VALUEMEANING>Decibel</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure representing the intensity of an electrical signal or sound which is equal to ten times the logarithm of the ratio of two signals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm/s</VALIDVALUE>
          <VALUEMEANING>Centimeter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAPFUL</VALIDVALUE>
          <VALUEMEANING>Capful Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the capful unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INHALATION</VALIDVALUE>
          <VALUEMEANING>Inhalation Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of the medicinal substance(s) delivered via the respiratory tract by one oral or nasal inhalation in the form of a gas, aerosol, mist, liquid, or fine powder using a nebulizer or an aerosol device, or the force of natural breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>in</VALIDVALUE>
          <VALUEMEANING>Inch</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of length equal to 1/12 of a foot or 2.54 centimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3915556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMPLANT</VALIDVALUE>
          <VALUEMEANING>Implant Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in an implant.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HOMEOPATHIC DILUTION</VALIDVALUE>
          <VALUEMEANING>Homeopathic Dilution Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit that is based on homeopathic dilution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>grain</VALIDVALUE>
          <VALUEMEANING>Grain</VALUEMEANING>
          <MEANINGDESCRIPTION>The traditional unit of mass derived from the weight of a grain and equal to one seven-thousandth of a pound, or 1/480 troy ounce, or 64.79891 milligrams. The original English grain unit based on the mass of a ripe grain barleycorn was larger the corresponding grain units of France and other European nations which were based on the weight of the smaller wheat grain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>foz_us</VALIDVALUE>
          <VALUEMEANING>Fluid Ounce US</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of liquid volume equal in the US customary system to 1/16 pint, or 1.804 687 cubic inches or 29.573 531 milliliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol BCE/nmol</VALIDVALUE>
          <VALUEMEANING>Nanomole Bone Collagen Equivalents per Nanomole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of substance concentration equal to one nanomole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/L/h</VALIDVALUE>
          <VALUEMEANING>Nanomole per Liter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit expressed in nanomole(s) per liter of solution per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405841</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/L/min</VALIDVALUE>
          <VALUEMEANING>Nanomole per Liter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit equal to the number of nanomoles per unit of volume equal to one liter per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/mol</VALIDVALUE>
          <VALUEMEANING>Nanomole per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of fraction expressed as the ratio of the amount of a substance in solution, in nanomoles, to the amount of a different substance in the mixture, in moles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/dL</VALIDVALUE>
          <VALUEMEANING>Microgram per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of  one microgram of a substance in unit volume of the mixture equal to one  deciliter. The concept also refers to the unit of mass density (volumic  mass) defined as the density of substance which mass equal to one  microgram occupies the volume one deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67305</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/L</VALIDVALUE>
          <VALUEMEANING>Microgram per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumic mass) defined as the density of a substance which mass equal to one microgram occupies the volume of one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ukat/L</VALIDVALUE>
          <VALUEMEANING>Microkatal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of catalytic activity concentration defined as activity equal to one millionth of katal per one liter of the system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DAgU</VALIDVALUE>
          <VALUEMEANING>D Antigen Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency of poliovirus vaccine used for poliomyelitis prevention. The unit is poliovirus type-specific.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AgU/mL</VALIDVALUE>
          <VALUEMEANING>Antigen Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of an antigen potency defined as a number of antigen units per one milliliter of product.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>anti-Xa IU/mL</VALIDVALUE>
          <VALUEMEANING>Anti-Xa Activity International Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A specific anticoagulation activity of unfractionated or low molecular weight heparin on factor Xa, expressed as a number of international anti-Xa heparin units per one milliliter of plasma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>anti-Xa IU</VALIDVALUE>
          <VALUEMEANING>Anti-Xa Activity International Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of unfractionated or low molecular weight heparin anticoagulation potency determined as the amount that neutralizes one unit of coagulation factor Xa preparation defined as an international biological standard by WHO First International Low Molecular Weight Heparin Reference Standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/g</VALIDVALUE>
          <VALUEMEANING>International Unit per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of a quantity of substance per unit mass, expressed as the quantity of substance in International Units, divided by the mass of the substance in grams. It is also used as a dose calculation unit expressed in International Units of biological activity per one gram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kIU</VALIDVALUE>
          <VALUEMEANING>Kilointernational Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one thousand international units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OI50</VALIDVALUE>
          <VALUEMEANING>Opsonization Index 50%</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit equal to the dilution of serum that causes opsonization and phagocytosis of 50% of the bacteria in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ngEq/L</VALIDVALUE>
          <VALUEMEANING>Nanogram Equivalents Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of nanogram equivalent of solute per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/(min*100mL)</VALIDVALUE>
          <VALUEMEANING>Milliliter Per Minute Times One Hundred Milliliters</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of flow rate expressed as the number of milliliters per number of minutes times a unit of volume equal to 100 milliliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130191</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>gpELISA unit/mL</VALIDVALUE>
          <VALUEMEANING>Glycoprotein-ELISA Unit Per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring potency of immunologically active substance in a product determined as reactivity in a glycoprotein enzyme-linked immunosorbent assay for particular antigen or antibody and expressed per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 CFU/g</VALIDVALUE>
          <VALUEMEANING>Billion Colony Forming Units per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of billion colony forming units (10E9 CFU) in one gram of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 CFU/g</VALIDVALUE>
          <VALUEMEANING>Million Colony Forming Units per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of million colony forming units (10E6 CFU) in one gram of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 CFU/g</VALIDVALUE>
          <VALUEMEANING>Thousand Colony Forming Units per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of thousand colony forming units (10E3 CFU) in one gram of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CFU/g</VALIDVALUE>
          <VALUEMEANING>Colony Forming Unit per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit of viable cell concentration defined as the number of colony forming units in one gram of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 CFU</VALIDVALUE>
          <VALUEMEANING>Billion Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of viable cell quantity equal to 10E9 colony forming units (10E9 CFU).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68897</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 CFU</VALIDVALUE>
          <VALUEMEANING>Million Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of viable cell quantity equal to 10E6 colony forming units (10E6 CFU).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68896</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 CFU</VALIDVALUE>
          <VALUEMEANING>Thousand Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of viable cell quantity equal to 10E3 colony forming units (10E3 CFU).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68895</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol/mg</VALIDVALUE>
          <VALUEMEANING>Mole per Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance content (molality unit) defined as one mole of solute per one milligram of solvent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406519</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol/g</VALIDVALUE>
          <VALUEMEANING>Mole per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance content (molality unit) defined as one mole of solute per one gram of solvent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68893</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406521</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/kg</VALIDVALUE>
          <VALUEMEANING>Millimole per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance content (molality unit) defined as one thousandth of mole (10E-3 mole) of solute per one kilogram of solvent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68892</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol/mL</VALIDVALUE>
          <VALUEMEANING>Mole per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one mole of solute in one milliliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68891</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol</VALIDVALUE>
          <VALUEMEANING>Picomole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to a trillionth (10E-12) of a mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fL</VALIDVALUE>
          <VALUEMEANING>Femtoliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-SI unit of volume accepted for use with the SI equal to one quadrillionth of a liter (10E-15 liter).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enzyme U</VALIDVALUE>
          <VALUEMEANING>Enzyme Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity measurement defined as the quantity of a particular enzyme that catalyzes the transformation of one micromole of the substrate per minute under standard conditions for specified assay system. The usage of this unit is discouraged in favor of the katal by International Federation of Clinical Chemistry and Laboratory Medicine due to lack of its coherence with the SI system. One enzyme unit is equal to 16.667 nanokatals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64778</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dL</VALIDVALUE>
          <VALUEMEANING>Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of volume equal to one tenth of a liter. Accepted for use with the SI.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64697</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAPLET</VALIDVALUE>
          <VALUEMEANING>Caplet Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a caplet.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cGy</VALIDVALUE>
          <VALUEMEANING>Centigray</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of absorbed radiation dose equal to the absorption of one hundredth of joule of radiation energy per kilogram of matter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64693</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dram</VALIDVALUE>
          <VALUEMEANING>Dram Mass Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-SI unit of mass equal to 1/16 Avoirdupois ounce or 1/256 Avoirdupois pound. One dram equals approximately 1.7718451953125 grams.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>amu</VALIDVALUE>
          <VALUEMEANING>Atomic Mass Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A small unit of mass used to express atomic and molecular masses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64559</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cg</VALIDVALUE>
          <VALUEMEANING>Centigram</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass equal to one hundredth of a gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ag</VALIDVALUE>
          <VALUEMEANING>Attogram</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass equal to one a quintillionth of a gram (10E-18 gram).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fg</VALIDVALUE>
          <VALUEMEANING>Femtogram</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass equal to one quadrillionth of a gram (10E-15 gram).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64552</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PACK</VALIDVALUE>
          <VALUEMEANING>Pack Dosage Form</VALUEMEANING>
          <MEANINGDESCRIPTION>A number of individual items packaged as a unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62653</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RING</VALIDVALUE>
          <VALUEMEANING>Ring Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a ring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>atm</VALIDVALUE>
          <VALUEMEANING>Atmosphere</VALUEMEANING>
          <MEANINGDESCRIPTION>Non-SI unit of pressure equal to 101 325 Pa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CUP</VALIDVALUE>
          <VALUEMEANING>Cup Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a cup.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54703</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>breaths/min</VALIDVALUE>
          <VALUEMEANING>Breaths per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of breaths (inhalation and exhalation) taken per minute time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49674</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>beats/min</VALIDVALUE>
          <VALUEMEANING>Beats per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of heartbeats measured per minute time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49673</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2659976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kg/m2</VALIDVALUE>
          <VALUEMEANING>Kilogram Per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>The SI derived unit of spread rate of a substance by mass, used also as a measure of area density.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49671</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm</VALIDVALUE>
          <VALUEMEANING>Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3915555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>QUANTITY SUFFICIENT</VALIDVALUE>
          <VALUEMEANING>Quantity Sufficient</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantity of an ingredient or product needed to bring up a volume or weight of the preparation to a final amount as it is indicated in the prescription; also refers to a determination of an adequate supply of medicine to fulfill either a prescribed amount or a sufficient quantity to provide treatment over a specified time frame.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48590</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2929840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>foz_br</VALIDVALUE>
          <VALUEMEANING>Fluid Ounce British</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of liquid volume equal in the British Imperial system to 1/20 pint, or 1.733 871 cubic inches or 28.413 063 milliliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48577</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406484</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%(v/v)</VALIDVALUE>
          <VALUEMEANING>Percent Volume per Volume</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of percentage concentration expressed as a fraction of a component by volume s in the entire volume of a resulting mixture. The unit denotes a number of milliliters of a solute per 100 milliliters of solution. The standard conditions for temperature and pressure apply.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406486</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mol/L</VALIDVALUE>
          <VALUEMEANING>Molar</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one mole of solute per one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>yd</VALIDVALUE>
          <VALUEMEANING>Yard</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of length equal to 3 feet, or 36 inches, or 0.9144 meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fmol/L</VALIDVALUE>
          <VALUEMEANING>Femtomole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one quadrillionth of a mole (10E-15 mole) of solute in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2685296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmol/L</VALIDVALUE>
          <VALUEMEANING>Centimole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one hundredth of a mole (10E-2 mole) of solute in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68886</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Log10 ELISA unit/dose</VALIDVALUE>
          <VALUEMEANING>Log10 Enzyme-Linked Immunosorbent Assay Unit per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68879</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Log10 ELISA unit</VALIDVALUE>
          <VALUEMEANING>Log10 Enzyme-Linked Immunosorbent Assay Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring concentration and/or reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference for the particular quantitative enzyme-linked immunosorbent assay method.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68878</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>copies/mL</VALIDVALUE>
          <VALUEMEANING>Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration expressed as a number of copies per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DIOPTER</VALIDVALUE>
          <VALUEMEANING>Diopter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of the optical power of a curved mirror or lens represented by the inverse of the focal length in meters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 copies/mL</VALIDVALUE>
          <VALUEMEANING>Million Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the sixth power copies in unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 copies/mL</VALIDVALUE>
          <VALUEMEANING>Thousand Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the third power copies in unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100897</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absorbance U/min</VALIDVALUE>
          <VALUEMEANING>Absorbance Unit per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a speed of optical density change expressed as a logarithm of absorbance of light transmitted through a partially absorbing substance per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absorbance U</VALIDVALUE>
          <VALUEMEANING>Absorbance Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of optical density expressed as the absorbance of light transmitted through the medium on the logarithmic scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg/h</VALIDVALUE>
          <VALUEMEANING>Milligram per Kilogram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SACHET</VALIDVALUE>
          <VALUEMEANING>Sachet Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit that contains a solid pharmaceutical preparation in the form of a small packet or bag made from a flexible, often porous material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71324</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2735738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FINGERTIP UNIT</VALIDVALUE>
          <VALUEMEANING>Fingertip Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary dosing unit used predominantly for semisolid topical formulations such as cream, ointment, paste, etc. One fingertip unit is the amount of a product that is squeezed out from a standard tube with 5-millimeter diameter nozzle along an adult&#39;s fingertip. A fingertip length is defined from the tip of the index finger to the first finger crease. A fingertip dosing unit varies with age and size of the body. The average fingertip unit is equal to approximately 0.5 gram for an adult male and 0.4 gram for an adult female.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71321</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>deg2</VALIDVALUE>
          <VALUEMEANING>Degrees Squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI unit of solid angle equal to approximately 3.0462x10^-4 steradians.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166098</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>deg/s</VALIDVALUE>
          <VALUEMEANING>Degrees Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of angular velocity defined as the number of degrees per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236047</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Ten Million Colony Forming Units Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the seventh power colony forming units in one liter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236049</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^4 CFU/mL</VALIDVALUE>
          <VALUEMEANING>Ten Thousand Colony Forming Units Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the fourth power colony forming units in one liter of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166095</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7236051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 PFU</VALIDVALUE>
          <VALUEMEANING>Log10 Plaque Forming Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) potency unit for measuring the quantity of individual infectious particles (usually viral particles) based on the number of plaques formed in a cell culture infected with the virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73568</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PFU/animal</VALIDVALUE>
          <VALUEMEANING>Plaque Forming Units per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in plaque forming unit(s) per animal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pkat/L</VALIDVALUE>
          <VALUEMEANING>Picokatal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of catalytic activity concentration defined as activity equal to a picokatal per one liter of the system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/10^10 cells</VALIDVALUE>
          <VALUEMEANING>Picomole per Ten Billion Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one picomole of substance per ten to the tenth power cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/10^9 cells</VALIDVALUE>
          <VALUEMEANING>Picomole per Billion Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one picomole of substance per ten to the ninth power cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/day</VALIDVALUE>
          <VALUEMEANING>Picomole per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance flow rate equivalent to the rate at which one picomole of substance travels to a given object or space over a period of time equal to 24 hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/dL</VALIDVALUE>
          <VALUEMEANING>Picomole per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one picomole of solute per deciliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122226</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/L/h</VALIDVALUE>
          <VALUEMEANING>Picomole per Liter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit expressed in picomole(s) per liter of solution per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/10^12 RBC</VALIDVALUE>
          <VALUEMEANING>Unit per Trillion Red Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in units of biological activity per ten to the twelfth power red blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/L/h</VALIDVALUE>
          <VALUEMEANING>Microgram per Liter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit equal to the number of micrograms per unit of volume equal to one liter per unit of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ugEq/L</VALIDVALUE>
          <VALUEMEANING>Microgram Equivalent per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of microgram equivalent of solute per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122230</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/mol</VALIDVALUE>
          <VALUEMEANING>Micromole per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of fraction expressed as the ratio of the amount of a substance in solution, in micromoles, to the amount of a different substance in the mixture, in moles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/10^3</VALIDVALUE>
          <VALUEMEANING>Per Thousand</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one thousand entities used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/cm2</VALIDVALUE>
          <VALUEMEANING>Milligram per Squared Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of area density defined as a spread rate at which one milligram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/dose</VALIDVALUE>
          <VALUEMEANING>Milligram per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in milligram(s) per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg/dose</VALIDVALUE>
          <VALUEMEANING>Milligram per Kilogram per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milligram(s) per kilogram per single dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/dose</VALIDVALUE>
          <VALUEMEANING>Milliliter per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in milliliter(s) per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRANSDUCING UNIT</VALIDVALUE>
          <VALUEMEANING>Transducing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of biological activity described as the number of viral particles in solution that are capable of infecting a cell and stimulating expression of a transgene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124460</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9/L</VALIDVALUE>
          <VALUEMEANING>Billion per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit expressed as a number or quantity of objects in billions per unit of volume equal to one liter, or the equivalent in milliliters or microliters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67255</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^12/L</VALIDVALUE>
          <VALUEMEANING>Million per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A derived unit expressed as a number of entities or quantity in millions per unit of volume equal to one microliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fmol</VALIDVALUE>
          <VALUEMEANING>Femtomole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to one quadrillionth of a mole (10E-15 mole).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68854</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g</VALIDVALUE>
          <VALUEMEANING>Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass equal to one one thousandth of a kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567649</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/day</VALIDVALUE>
          <VALUEMEANING>Gram per 24 Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric mass flow rate unit equal to the rate at which mass of matter of one gram crosses a given surface or/and is transferred over a period of twenty four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/dL</VALIDVALUE>
          <VALUEMEANING>Gram per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one gram of a substance in unit volume of the mixture equal to one deciliter (100 milliliters). The concept also refers to the metric unit of mass density (volumic mass) defined as the density of substance which mass equal to one gram occupies the volume one deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2685299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/min</VALIDVALUE>
          <VALUEMEANING>Liter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one liter of matter crosses a given surface during the period of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/s</VALIDVALUE>
          <VALUEMEANING>Liter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one liter of matter crosses a given surface during the period of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq</VALIDVALUE>
          <VALUEMEANING>Milliequivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance equal to one thousandth of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/day</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per 24 Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance crosses a given surface or is delivered to a given object or space over a period of time equal to twenty four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/dL</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of milliequivalents of solute per deciliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/kg</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance content equivalent to the content at which one kilogram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/L</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of milliequivalents of solute per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719056</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg</VALIDVALUE>
          <VALUEMEANING>Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of weight.  A milligram is approximately 450,000 times smaller than a pound and 28,000 times smaller than an ounce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/day</VALIDVALUE>
          <VALUEMEANING>Milligram per 24 Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to twenty four hours. Milligram per twenty four hours is also a dose administration rate unit equal to the rate at which one thousandth of a gram of a product is administered per unit of time equal to twenty four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/dL</VALIDVALUE>
          <VALUEMEANING>Milligram per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67015</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg</VALIDVALUE>
          <VALUEMEANING>Milligram per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a mass fraction expressed as a number of milligrams of substance per kilogram of mixture. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719050</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/L</VALIDVALUE>
          <VALUEMEANING>Microgram per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass concentration defined as the  concentration of one gram of a substance in unit volume of the mixture  equal to one cubic meter. The concept also refers to the metric unit of  mass density (volumic mass) defined as the density of substance which  mass equal to one gram occupies the volume one cubic meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64572</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719048</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/mL/min</VALIDVALUE>
          <VALUEMEANING>Milligram per Milliliter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to mass concentration of a substance expressed in kilograms per unit volume of the mixture equal to one cubic meter per time period of one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL</VALIDVALUE>
          <VALUEMEANING>Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of volume for a liquid.  A milliliter is approximately 950 times smaller than a quart and 30 times smaller than a fluid ounce.  A milliliter of liquid and a cubic centimeter (cc) of liquid are the same.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28254</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter crosses a given surface during the period of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dpm/mL</VALIDVALUE>
          <VALUEMEANING>Disintegration per Minute per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a volume unit equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8 PFU</VALIDVALUE>
          <VALUEMEANING>Hundred Million Plaque Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of viable infectious entities expressed in hundreds of millions in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope or/and to the naked eye as a plaque.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67266</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7 PFU</VALIDVALUE>
          <VALUEMEANING>Ten Million Plaque Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of viable infectious entities expressed in tens of millions in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope or/and to the naked eye as a plaque.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LENS</VALIDVALUE>
          <VALUEMEANING>Lens Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the lens unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MASK</VALIDVALUE>
          <VALUEMEANING>Mask Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the mask unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/5x10^4 WBC</VALIDVALUE>
          <VALUEMEANING>Per 50,000 White Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 50,000 white blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>h/wk</VALIDVALUE>
          <VALUEMEANING>Hours Per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to the number of hours within a period of time equal to one week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>days/month</VALIDVALUE>
          <VALUEMEANING>Days Per Month</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to the number of days within a period of time equal to one month.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>days/wk</VALIDVALUE>
          <VALUEMEANING>Days Per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to the number of days within a period of time equal to one week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DNA copies/ug</VALIDVALUE>
          <VALUEMEANING>DNA Copies Per Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to the number of deoxyribonucleic acid (DNA) copies per unit of mass equal to one microgram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 PFU/mL</VALIDVALUE>
          <VALUEMEANING>log10 Plaque Forming Units Per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring plaque forming units per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170631</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241649</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kV</VALIDVALUE>
          <VALUEMEANING>Kilovolt</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of electric potential and electromotive force, equal to one thousand volts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170630</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BOWL</VALIDVALUE>
          <VALUEMEANING>Bowl Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of smokable material in a pipe bowl.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C151970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PLUG</VALIDVALUE>
          <VALUEMEANING>Plug Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of presentation used to represent the quantity of product that is found in a single discrete entity where the pharmaceutical dose form is a type of plug.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C149763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7241654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NFIU</VALIDVALUE>
          <VALUEMEANING>Normalized Fluorescence Intensity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative fluorescence intensity unit that is adjusted to a reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7244767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MdFI</VALIDVALUE>
          <VALUEMEANING>Median Fluorescence Intensity</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the geometric mean fluorescence intensity of a log-normal distribution of fluorescence signals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ft</VALIDVALUE>
          <VALUEMEANING>International Foot</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of length defined by the U.S. National Bureau of Standards as 30.48 centimeters. It is equal to 0.3048 meter, 12 inches, or to approximately 0.999998 survey foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/min</VALIDVALUE>
          <VALUEMEANING>Microgram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to one minute. Microgram per minute is also a dose administration rate unit equal to the rate at which one millionth of a gram of a product is administered per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6400548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/kg/min</VALIDVALUE>
          <VALUEMEANING>Microgram per Kilogram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one millionth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/kg/h</VALIDVALUE>
          <VALUEMEANING>International Unit per Kilogram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one international unit (an arbitrary unit of biological activity) of a product per one kilogram of body mass administered per unit of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406663</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg/min</VALIDVALUE>
          <VALUEMEANING>Milligram per Kilogram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406665</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/day</VALIDVALUE>
          <VALUEMEANING>Microgram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to twenty four hours. Microgram per 24 hours is also a dose administration rate unit equal to the rate at which one millionth of a gram of a product is administered per unit of time equal to twenty four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6132701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NEBULE</VALIDVALUE>
          <VALUEMEANING>Nebule Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a nebule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>km/h</VALIDVALUE>
          <VALUEMEANING>Kilometer per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one thousand meters travelled per unit time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795699</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kUSP</VALIDVALUE>
          <VALUEMEANING>Kilo United States Pharmacopeia Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency equal to one thousand US Pharmacopoeia Units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71202</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406669</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/cm2</VALIDVALUE>
          <VALUEMEANING>Gram per Square Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of areal density defined as a spread rate at which one gram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71201</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>bel</VALIDVALUE>
          <VALUEMEANING>Bel</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic ratio unit (base-10 logarithms) used to express relative magnitude of a physical quantity (usually power or intensity) in comparison with a specified or implied reference level. Particularly, Bel is used as a unit of relative sound intensity. In the latter context it is equal to ten decibels or to approximately 1.151293 nepers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PFU/mL</VALIDVALUE>
          <VALUEMEANING>Plaque Forming Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency of a biological product expressed as a quantity of viable infectious entities capable to produce a cytopathic effect in the appropriate cell culture per one milliliter of the preparation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PFU/dose</VALIDVALUE>
          <VALUEMEANING>Plaque Forming Unit per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of potency of a biological product expressed as a quantity of viable infectious entities capable to produce a cytopathic effect in the appropriate cell culture per a single dose of the preparation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71198</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 organisms/mL</VALIDVALUE>
          <VALUEMEANING>Billion Organisms per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism concentration expressed in billions of organisms per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 organisms/mL</VALIDVALUE>
          <VALUEMEANING>Million Organisms per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism concentration expressed in millions of organisms per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/g/day</VALIDVALUE>
          <VALUEMEANING>Milliliter per Gram per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per gram per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/cage/wk</VALIDVALUE>
          <VALUEMEANING>Milliliter per Cage per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per cage expressed per period of time equal to seven days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/cage/day</VALIDVALUE>
          <VALUEMEANING>Milliliter per Cage per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per cage per period of time equal to twenty-four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/cage</VALIDVALUE>
          <VALUEMEANING>Milliliter per Cage</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per cage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELISA unit/mL</VALIDVALUE>
          <VALUEMEANING>Enzyme-Linked Immunosorbent Assay Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68877</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELISA unit/dose</VALIDVALUE>
          <VALUEMEANING>Enzyme-Linked Immunosorbent Assay Unit per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELISA unit</VALIDVALUE>
          <VALUEMEANING>Enzyme-Linked Immunosorbent Assay Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring concentration or/and reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference standard for the particular quantitative enzyme-linked immunosorbent assay method. The enzyme-linked immunosorbent assay unit is used to express potency of immunologically active substances and products, e.g. vaccines.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>in2</VALIDVALUE>
          <VALUEMEANING>Square Inch</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of area equal to the area of a square with sides of one inch. It is equal to 6.4516 square centimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68871</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ft3</VALIDVALUE>
          <VALUEMEANING>Standard Cubic Foot</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic foot at 60 degrees Fahrenheit and pressure of one atmosphere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68859</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>scm</VALIDVALUE>
          <VALUEMEANING>Standard Cubic Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic meter at standard (according to DIN 1343 standard) conditions: temperature 273.15 K and pressure of one atmosphere (101.325 kPa).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68858</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>amol</VALIDVALUE>
          <VALUEMEANING>Attomole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount substance equal to one quintillionth of a mole (10E-18 mole).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/g</VALIDVALUE>
          <VALUEMEANING>Mole per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit amount of substance content (molality unit) defined as one mole of solute per one kilogram of solvent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmol</VALIDVALUE>
          <VALUEMEANING>Centimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to one hundredth of a mole (10E-2 mole).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dmol</VALIDVALUE>
          <VALUEMEANING>Decimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to one tenth of a mole (10E-1 mole).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>deg</VALIDVALUE>
          <VALUEMEANING>Degree Unit of Plane Angle</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of plane angle measurement equal to the length of the arc cut out by the angle, divided by the circumference of the circle, and multiplied by 360. The symbol for degrees is a small superscript circle. One radian is about 57 degrees and one degree is pi/180 radians.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U/kg</VALIDVALUE>
          <VALUEMEANING>Unit per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in units of biological activity per unit of mass equal to one kilogram. Unit per kilogram is also used as a dose calculation unit expressed in arbitrary units per one kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>titer</VALIDVALUE>
          <VALUEMEANING>Titer</VALUEMEANING>
          <MEANINGDESCRIPTION>Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6/L</VALIDVALUE>
          <VALUEMEANING>Thousand per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit expressed as a number or quantity of objects in thousands per unit of volume equal to one milliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/kg</VALIDVALUE>
          <VALUEMEANING>Milliliter per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one milliliter of preparation per one kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/day</VALIDVALUE>
          <VALUEMEANING>Milliliter per 24 Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter crosses a given surface during the period of time equal to 24 hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/m2</VALIDVALUE>
          <VALUEMEANING>Milligram per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of areal density equal to approximately 2.94935E-5 ounce per square yard. Also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/h/m2</VALIDVALUE>
          <VALUEMEANING>Liter Per Hour Per Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit expressed as one liter of volume per unit of time equal to one hour per square meter of area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/g/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per Gram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per gram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/g/h</VALIDVALUE>
          <VALUEMEANING>Milliliter per Gram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per gram per period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100 WBC</VALIDVALUE>
          <VALUEMEANING>Per 100 White Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit for measurement of portion of a particular type of blood cells (such as any type of white blood cells or nucleated red blood cells) in the total white blood cell count expressed per count of 100.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kg/L</VALIDVALUE>
          <VALUEMEANING>Kilogram per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one kilogram of a substance in unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one kilogram occupies the volume one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SFC/10^6 PBMC</VALIDVALUE>
          <VALUEMEANING>Spot Forming Units Per Million Peripheral Blood Mononuclear Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the spot forming units per million cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120850</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/h</VALIDVALUE>
          <VALUEMEANING>Milligram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725048</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/min</VALIDVALUE>
          <VALUEMEANING>Per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of occurrences of something within a minute of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/h</VALIDVALUE>
          <VALUEMEANING>Per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A frequency rate of occurrences of something within a period of time equal to sixty minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/s</VALIDVALUE>
          <VALUEMEANING>Per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of occurrences of something within a second of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/h</VALIDVALUE>
          <VALUEMEANING>Milliliter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter crosses a given surface during the period of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tuberculin unit</VALIDVALUE>
          <VALUEMEANING>Tuberculin Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of tuberculin dosage defined by comparison of clinical response to a preparation of the purified protein derivative standardized for use in humans for tuberculin skin test reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm2</VALIDVALUE>
          <VALUEMEANING>Square Millimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of area measurement equal to a square measuring one millimeter on each side. One square millimeter is equal to 10(E-2) square centimeter and 10(E-6) square meter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65104</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PUFF</VALIDVALUE>
          <VALUEMEANING>Puff Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to a metered dose of medicinal substance(s) that is delivered in uniform quantity upon each activation of a medical device (e.g. an inhaler), in which the dosage form is contained.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/mL</VALIDVALUE>
          <VALUEMEANING>Becquerel per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one becquerel per unit volume equal to one milliliter or one kilobecquerel per liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406592</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/uL</VALIDVALUE>
          <VALUEMEANING>Becquerel per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one becquerel per unit volume equal to one millionth of a liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71166</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bq/L</VALIDVALUE>
          <VALUEMEANING>Becquerel per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one becquerel per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/ug</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance content equivalent to the content at which one millionth of a gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70581</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/g</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance content equivalent to the content at which one gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70580</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/uL</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of milliequivalents of solute per microliter of solution.(NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70578</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406602</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Roentgen</VALIDVALUE>
          <VALUEMEANING>Roentgen</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of exposure to ionizing radiation in CGS system. One roentgen is the amount of gamma or x-rays required to produce ions resulting in a charge of 2.58E-4 coulombs/kilogram of air under standard conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70575</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uCi/kg</VALIDVALUE>
          <VALUEMEANING>Microcurie per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of specific radioactivity (massic activity) equal to activity of one microcurie of the sample with total mass of one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uL</VALIDVALUE>
          <VALUEMEANING>Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volume equal to one millionth of a liter or one one thousandth of a milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48153</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol</VALIDVALUE>
          <VALUEMEANING>Micromole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance equal to a millionth of a mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/day</VALIDVALUE>
          <VALUEMEANING>Micromole per 24 Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of amount of substance flow rate equivalent to the rate at which one millionth of a mole of substance crosses a given surface or is delivered to a given object or space over a period of time equal to 24 hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/dL</VALIDVALUE>
          <VALUEMEANING>Micromole per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of concentration (molarity unit) equal to one millionth of mole of a solute in one deciliter of the solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/L</VALIDVALUE>
          <VALUEMEANING>Micromole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one one-millionth of a mole (10E-6 mole) of solute per one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4094774</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mU/L</VALIDVALUE>
          <VALUEMEANING>Microunit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration equal to the concentration at which one milliliter of mixture contains one millionth of a unit of a substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GPL U</VALIDVALUE>
          <VALUEMEANING>IgG Phospholipid Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with negatively charged phospholipids evaluated in ELISA serum anticardiolipin or anionic phospholipid assay against an established reference standard. One IgG phospholipid unit is equivalent to one mg/mL of an affinity-purified standard IgG sample obtained from specified individuals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU</VALIDVALUE>
          <VALUEMEANING>International Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The unitage assigned by the WHO to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization (e.g. hormones, enzymes, and vaccines), to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48579</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/mL</VALIDVALUE>
          <VALUEMEANING>International Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MPL U</VALIDVALUE>
          <VALUEMEANING>IgM Phospholipid Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with negatively charged phospholipids evaluated in ELISA serum anticardiolipin or anionic phospholipid assay against an established reference standard. One IgM phospholipid unit is equivalent to one mg/mL of an affinity-purified standard IgM sample obtained from the specified individuals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2721397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RNA copies/mL</VALIDVALUE>
          <VALUEMEANING>Copy per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration of RNA copies expressed as a number of copies per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 RNA copies/mL</VALIDVALUE>
          <VALUEMEANING>Thousand RNA Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one thousand ribonucleic acid (RNA) copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406730</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3/hpf</VALIDVALUE>
          <VALUEMEANING>Thousand per High Powered Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one thousand entities per unit of area equal to one high powered field.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 DNA copies/mL</VALIDVALUE>
          <VALUEMEANING>Thousand DNA Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one thousand deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98788</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^4/hpf</VALIDVALUE>
          <VALUEMEANING>Ten Thousand per High Powered Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to ten thousand entities per unit of area equal to one high powered field.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98787</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7/L</VALIDVALUE>
          <VALUEMEANING>Ten Million per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to ten million entities per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6 RNA copies/mL</VALIDVALUE>
          <VALUEMEANING>Million RNA Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one million ribonucleic acid (RNA) copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98760</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6/hpf</VALIDVALUE>
          <VALUEMEANING>Million per High Powered Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one million entities per unit of area equal to one high powered field.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98759</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6/g</VALIDVALUE>
          <VALUEMEANING>Million per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one million entities per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SBE/mL</VALIDVALUE>
          <VALUEMEANING>Standardized Allergy Biological Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of allergenic product potency expressed as the number of standardized biological units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SQU/mL</VALIDVALUE>
          <VALUEMEANING>Standardized Allergy Quality Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of allergenic product potency expressed as the number of standardized quality units per one milliliter of formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405619</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STEPS</VALIDVALUE>
          <VALUEMEANING>Step Unit of Distance</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure to quantify the number of strides taken during a normal walking gait.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Torr</VALIDVALUE>
          <VALUEMEANING>Torr</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI unit of pressure equal to 1/760 of a standard atmosphere (a standard atmosphere being defined as equal to 101 325 pascals). One Torr is equal to 133.3223684 pascals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VIRTUAL PIXEL</VALIDVALUE>
          <VALUEMEANING>Virtual Pixel</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of pixel created from overlying two adjacent real pixels to create an additional virtual image of a pixel that is visible to the human eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/h/mmol</VALIDVALUE>
          <VALUEMEANING>Micromole per Hour per Millimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of fraction expressed as the ratio of the number of micromoles of substance per unit of time equal to one hour, to the amount of a different substance, in millimoles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/L/h</VALIDVALUE>
          <VALUEMEANING>Micromole per Liter per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uU/dL</VALIDVALUE>
          <VALUEMEANING>Micro-Unit per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in microunit(s) per deciliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uU/L</VALIDVALUE>
          <VALUEMEANING>Micro-Unit per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in microunit(s) per liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>vg/dose</VALIDVALUE>
          <VALUEMEANING>Vector Genomes per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for cloning vector amounts expressed as the number of vector genomes per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>vg/mL</VALIDVALUE>
          <VALUEMEANING>Vector Genomes per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for cloning vector amounts expressed as the number of vector genomes per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>vp/dose</VALIDVALUE>
          <VALUEMEANING>Viral Particles per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for virus amount expressed as the number of viral particles per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>vp/mL</VALIDVALUE>
          <VALUEMEANING>Viral Particles per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for virus amount expressed as the number of viral particles per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absorbance U/mL</VALIDVALUE>
          <VALUEMEANING>Absorbance Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of optical density expressed as the absorbance of light transmitted through the medium on the logarithmic scale per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>copies/ug</VALIDVALUE>
          <VALUEMEANING>Copies per Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration expressed as a number of copies per unit mass equal to one microgram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126079</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm3/mm2/year</VALIDVALUE>
          <VALUEMEANING>Cubic Millimeter per Square Millimeter per Year</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit defined as the number of cubic millimeters of substance per area equal to one square millimeter per unit of time equal to one year.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126080</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>um/day</VALIDVALUE>
          <VALUEMEANING>Micrometer per Day</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volumetric flow rate defined as the rate at which one micrometer of matter crosses a given surface during the period of time equal to one day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126081</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>umol/kg/min</VALIDVALUE>
          <VALUEMEANING>Micromole per Kilogram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one millionth of a mole (10E-6 mole) per kilogram of a substance per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1/(s*kPa)</VALIDVALUE>
          <VALUEMEANING>One per Second Times Kilopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to the inverse of one kilopascal multiplied by a unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127804</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MET</VALIDVALUE>
          <VALUEMEANING>Metabolic Equivalent of Task Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy expenditure equal to the ratio of the metabolic rate during physical activity in comparison to a reference metabolic rate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127805</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6352134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MET*h</VALIDVALUE>
          <VALUEMEANING>Metabolic Equivalent of Task Hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy expenditure equal to the number of metabolic equivalent of task units multiplied by the number of hours of performed activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MET*min</VALIDVALUE>
          <VALUEMEANING>Metabolic Equivalent of Task Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy expenditure equal to the number of metabolic equivalent units multiplied by the number of minutes of performed activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405970</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/beat</VALIDVALUE>
          <VALUEMEANING>Milliliter per Heartbeat</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed as the number of milliliter(s) per heart beat.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127808</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405973</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mN</VALIDVALUE>
          <VALUEMEANING>Millinewton</VALUEMEANING>
          <MEANINGDESCRIPTION>An SI derived unit of force equal to one thousandth of a Newton.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PHERESIS UNIT</VALIDVALUE>
          <VALUEMEANING>Pheresis Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance concentration equal to the yield from a blood pheresis procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127810</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BEAM BREAKS</VALIDVALUE>
          <VALUEMEANING>Beam Break Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of measure for the number of times in which light paths are interrupted by movement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dpm/0.5 mL</VALIDVALUE>
          <VALUEMEANING>Disintegrations per Minute per 0.5 Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a volume unit equal to a half milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EIA unit</VALIDVALUE>
          <VALUEMEANING>Enzyme Immunoassay Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring concentration or/and reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference standard for the particular quantitative enzyme immunoassay method.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fmol/L/s</VALIDVALUE>
          <VALUEMEANING>Femtomole per Liter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit equal to one femtomole of solute in one liter of solution per unit of time equal to one second. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cy/cm</VALIDVALUE>
          <VALUEMEANING>Grating Cycles per Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the number of repeating vertical or horizontal bars per unit of length equal to one centimeter on a visual acuity testing card.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HEP</VALIDVALUE>
          <VALUEMEANING>Histamine Equivalent Prick Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of allergenic product potency expressed as the number of histamine equivalent prick units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APL U</VALIDVALUE>
          <VALUEMEANING>IgA Phospholipid Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122202</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APL U/mL</VALIDVALUE>
          <VALUEMEANING>Immunoglobin A Phospholipid Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with negatively charged phospholipids evaluated in ELISA serum anticardiolipin or anionic phospholipid assay against an established reference standard, per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GPL U/mL</VALIDVALUE>
          <VALUEMEANING>Immunoglobin G Phospholipid Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with negatively charged phospholipids evaluated in ELISA serum anticardiolipin or anionic phospholipid assay against an established reference standard, per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MPL U/mL</VALIDVALUE>
          <VALUEMEANING>Immunoglobin M Phospholipid Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with negatively charged phospholipids evaluated in ELISA serum anticardiolipin or anionic phospholipid assay against an established reference standard, per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/dL</VALIDVALUE>
          <VALUEMEANING>International Unit per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one deciliter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120848</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405672</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/g Hb</VALIDVALUE>
          <VALUEMEANING>International Unit per Gram Hemoglobin</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (biologic activity) equal to one international unit of substance per gram of hemoglobin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU/mmol</VALIDVALUE>
          <VALUEMEANING>International Unit per Millimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (biologic activity) equal to one international unit of substance per millimole of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405704</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/kg/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per Kilogram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per kilogram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73760</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3652834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/min/mmHg</VALIDVALUE>
          <VALUEMEANING>Milliliter per Minute per Millimeters of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring a pulmonary diffusing capacity expressed in units of gas flow rate (in milliliters per minute) per a unit of pressure (in torrs).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/mmHg/min/L</VALIDVALUE>
          <VALUEMEANING>Milliliter per Minute per Millimeters of Mercury per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for measuring a pulmonary diffusing capacity adjusted for lung volume expressed in units of gas flow rate (in milliliters per minute) per a unit of pressure (in torrs) per one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67418</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/s</VALIDVALUE>
          <VALUEMEANING>Milliliter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter crosses a given surface during the period of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>day*ng/mL/(mg/kg)</VALIDVALUE>
          <VALUEMEANING>Day Times Nanogram Per Milliliter Per Milligram Per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>Days times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/animal</VALIDVALUE>
          <VALUEMEANING>Per Animal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one animal used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198368</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^10 copies/mL</VALIDVALUE>
          <VALUEMEANING>Ten Billion Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the tenth power copies in unit volume equal to one milliliter. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^10 IU/mL</VALIDVALUE>
          <VALUEMEANING>Ten Billion International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the tenth power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198371</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^10 vp/dose</VALIDVALUE>
          <VALUEMEANING>Ten Billion Viral Particles per Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for virus amount equal to 10 to the tenth power of the number of viral particles per dose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433716</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^10 vp/mL</VALIDVALUE>
          <VALUEMEANING>Ten Billion Viral Particles per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for virus concentration equal to 10 to the tenth power of the number of viral particles per milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198373</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^3 IU/mL</VALIDVALUE>
          <VALUEMEANING>Thousand International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the third power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198374</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/g</VALIDVALUE>
          <VALUEMEANING>Per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one gram used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^4 copies/mL</VALIDVALUE>
          <VALUEMEANING>Ten Thousand Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the fourth power copies in unit volume equal to one milliliter. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^4 IU/mL</VALIDVALUE>
          <VALUEMEANING>Ten Thousand International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the fourth power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5 CFU</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of colony forming cells or microorganisms equal to 10 to the fifth power colony forming units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5 copies/mL</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the fifth power copies in unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433722</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^6/kg</VALIDVALUE>
          <VALUEMEANING>Million per Kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the sixth power of the number of entities per unit of mass equal to one kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433724</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7 copies/mL</VALIDVALUE>
          <VALUEMEANING>Ten Million Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the seventh power copies in unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^7 IU/mL</VALIDVALUE>
          <VALUEMEANING>Ten Million International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the seventh power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8 CFU</VALIDVALUE>
          <VALUEMEANING>Hundred Million Colony Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of colony forming cells or microorganisms equal to 10 to the eighth power colony forming units.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8 copies/mL</VALIDVALUE>
          <VALUEMEANING>One Hundred Million Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the eight power copies in unit volume equal to one milliliter. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^5 IU/mL</VALIDVALUE>
          <VALUEMEANING>Hundred Thousand International Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the fifth power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^8 IU/mL</VALIDVALUE>
          <VALUEMEANING>One Hundred Million International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the eight power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 copies/mL</VALIDVALUE>
          <VALUEMEANING>Billion Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of concentration expressed as the number of 10 to the ninth power copies in unit volume equal to one milliliter. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433730</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9 IU/mL</VALIDVALUE>
          <VALUEMEANING>Billion International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the ninth power of the number of international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10^9/uL</VALIDVALUE>
          <VALUEMEANING>Billion per Microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to 10 to the ninth power of entities per unit of volume equal to one microliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/ston_av</VALIDVALUE>
          <VALUEMEANING>Gram per Short Ton</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure expressed in gram(s) per short ton (US).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GLASS</VALIDVALUE>
          <VALUEMEANING>Glass Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the glass unit. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433735</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 minutes of arc</VALIDVALUE>
          <VALUEMEANING>Log10 Arcminutes</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring angular equal to 1/60 degree or to 60 arcseconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 U/mL</VALIDVALUE>
          <VALUEMEANING>Log10 Arbitrary Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring arbitrary units per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>lton_av</VALIDVALUE>
          <VALUEMEANING>Long Ton</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of mass in the United Kingdom equal to 2,240 pounds or 1.017 metric tons.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>copies/cell</VALIDVALUE>
          <VALUEMEANING>Copies per Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration expressed as a number of copies per cell.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433733</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/dL</VALIDVALUE>
          <VALUEMEANING>Nanomole per Deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one nanomole of solute in one deciliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433739</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/mg/h</VALIDVALUE>
          <VALUEMEANING>Nanomole per Milligram per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in nanomole(s) per milligram per period of time equal to one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198396</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Organisms/g</VALIDVALUE>
          <VALUEMEANING>Organism Per Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism content expressed in organisms per unit of mass equal to one gram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Organisms/mL</VALIDVALUE>
          <VALUEMEANING>Organism Per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure of organism concentration expressed in organisms per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ston_av</VALIDVALUE>
          <VALUEMEANING>Short Ton</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of mass in the United States equal to 2,000 pounds or 0.907 metric tons.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/mg/min</VALIDVALUE>
          <VALUEMEANING>Nanomole per Milligram per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in nanomole(s) per milligram per period of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13433741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/400 Cells</VALIDVALUE>
          <VALUEMEANING>Per 400 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of entities per 400 total cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SFC/10^5 PBMC</VALIDVALUE>
          <VALUEMEANING>Spot Forming Units Per Ten Thousand Peripheral Blood Mononuclear Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per one hundred thousand peripheral blood mononuclear cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SFC/2x10^5 PBMC</VALIDVALUE>
          <VALUEMEANING>Spot Forming Units Per Twenty Thousand Peripheral Blood Mononuclear Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per two hundred thousand peripheral blood mononuclear cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191357</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/10^3 RBC</VALIDVALUE>
          <VALUEMEANING>Per Thousand Red Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell (excluding red blood cell subtypes) per one thousand red blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>daPa</VALIDVALUE>
          <VALUEMEANING>Decapascal</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure equivalent to ten Pascals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arbitrary U/mL</VALIDVALUE>
          <VALUEMEANING>Arbitrary Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit based on or subject to individual judgment, preference, or predetermined reference per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191361</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nm/min</VALIDVALUE>
          <VALUEMEANING>Nanometer Per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of both speed (scalar) and velocity (vector), defined as the distance of one nanometer travelled per unit time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100 RBC</VALIDVALUE>
          <VALUEMEANING>Per 100 Red Blood Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell (excluding red blood cell subtypes) per one hundred red blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191358</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12920299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Binding Ab Unit</VALIDVALUE>
          <VALUEMEANING>Binding Antibody Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of measure that is used to compare binding antibody assays that detect the same class of immunoglobulins with the same specificity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189120</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13361745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tonne</VALIDVALUE>
          <VALUEMEANING>Ton</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass equal to 1000 kilograms, or 2204.623 pounds avoirdupois.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Organisms</VALIDVALUE>
          <VALUEMEANING>Organism-Based Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71186</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13361746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10 copies/mL</VALIDVALUE>
          <VALUEMEANING>Ten Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to ten copies of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10 IU/mL</VALIDVALUE>
          <VALUEMEANING>Ten International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to ten international units of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>100 copies/mL</VALIDVALUE>
          <VALUEMEANING>Hundred Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement equal to one hundred copies of an entity per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100x FIELD</VALIDVALUE>
          <VALUEMEANING>Per 100x Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measurement of the number of entities per microscopic field at 100x magnification.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199995</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14091746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ACTUATION</VALIDVALUE>
          <VALUEMEANING>Actuation Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in an actuation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14549121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/punch/h</VALIDVALUE>
          <VALUEMEANING>Picomole per Punch Observational Unit per Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A rate unit expressed as the number of picomoles per punch observational unit per hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201485</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14549122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>(mmHg*min/L)*m2</VALIDVALUE>
          <VALUEMEANING>Millimeter Mercury times Minute per Liter times Square Meter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to the number of millimeters of mercury times minutes, per unit of volume equal to one liter times meters squared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14549123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cmH2O/mL/s</VALIDVALUE>
          <VALUEMEANING>Centimeter of Water per Milliliter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure defined as centimeters of water per unit of volume equal to one milliliter per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14549124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>m2/s</VALIDVALUE>
          <VALUEMEANING>Meter Squared per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of diffusion coefficient in SI system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14549125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>uL/L</VALIDVALUE>
          <VALUEMEANING>Microliter per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume concentration equal to one microliter per unit of volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202451</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14688612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/50 Cells</VALIDVALUE>
          <VALUEMEANING>Per 50 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of entities per 50 total cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14688613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100 Cells</VALIDVALUE>
          <VALUEMEANING>Per 100 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of entities per 100 total cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14688614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/Cell</VALIDVALUE>
          <VALUEMEANING>Per Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of entities per one cell.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14688615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/PLATE</VALIDVALUE>
          <VALUEMEANING>Per Plate</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the instances of an entity per culture plate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204701</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CUTS/in</VALIDVALUE>
          <VALUEMEANING>Cuts per Inch</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the number of physical cuts made per one inch of a tobacco leaf.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cu</VALIDVALUE>
          <VALUEMEANING>Coresta Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for air permeability defined as the volumetric flow rate of air (cm3 min-1) passing through a 1 cm2 sample of substrate at an applied pressure difference of 1 kPa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204703</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm2/s</VALIDVALUE>
          <VALUEMEANING>Square Centimeter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived metric unit of kinematic viscosity expressed as centimeters squared per second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/9000m</VALIDVALUE>
          <VALUEMEANING>Gram per 9000 Meters</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the linear mass density of fibers in grams per 9000 meters of the fiber.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/cm3</VALIDVALUE>
          <VALUEMEANING>Gram per Cubic Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one cubed centimeter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204706</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mAh</VALIDVALUE>
          <VALUEMEANING>Milliampere Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of energy or power equal to one thousandth of an ampere hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204707</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mPa/s</VALIDVALUE>
          <VALUEMEANING>Millipascal per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of pressure equivalent to one thousandth of one pascal per unit of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204708</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/cm3</VALIDVALUE>
          <VALUEMEANING>Per Cubic Centimeter</VALUEMEANING>
          <MEANINGDESCRIPTION>A volume unit equal to one centimeter squared used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204709</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/m2/s</VALIDVALUE>
          <VALUEMEANING>Liter per Square Meter per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in liter(s) per square meter per period of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204710</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm H2O</VALIDVALUE>
          <VALUEMEANING>Millimeter of Water Column</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-SI manometric unit of pressure defined by a column of water at 4 degrees Celsius with a height of one millimeter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69107</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14902097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100 Enterocytes</VALIDVALUE>
          <VALUEMEANING>per 100 Enterocytes</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit of measurement for a portion of a particular type of cell per one hundred enterocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209700</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmolEq</VALIDVALUE>
          <VALUEMEANING>Nanomole Equivalents</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance equal to one billionth of a mole of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ci/mmol</VALIDVALUE>
          <VALUEMEANING>Curie per Millimole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie in one millimole of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209703</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253619</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/EXOME</VALIDVALUE>
          <VALUEMEANING>Per Exome</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to an exome used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209701</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AGGREGATION UNIT</VALIDVALUE>
          <VALUEMEANING>Aggregation Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of measure for particle aggregation which is derived from an increase in sample impedance as aggregation occurs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FINGERTIP LENGTH UNIT</VALIDVALUE>
          <VALUEMEANING>Fingertip Unit of Length</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of length defined as the length from the tip of the index finger to the first finger crease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GBq/umol</VALIDVALUE>
          <VALUEMEANING>Gigabecquerel per Micromole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of radioactivity equal to the activity of one gigabecquerel in one micromole of substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253625</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 copies</VALIDVALUE>
          <VALUEMEANING>log10 Copy</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring the number of copies of an entity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209706</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RELATIVE U</VALIDVALUE>
          <VALUEMEANING>Relative Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of measure that is expressed in relation to a test-specific internal standard; it is dependent on instrument and measurement parameters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209707</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RELATIVE U/mL</VALIDVALUE>
          <VALUEMEANING>Relative Unit per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of measure that is expressed in relation to a test-specific internal standard per unit of volume equal to one milliliter; it is dependent on instrument and measurement parameters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209708</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/CIGARETTE</VALIDVALUE>
          <VALUEMEANING>Milligram per Cigarette</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass equal to one milligram per cigarette dosing unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/PUFF</VALIDVALUE>
          <VALUEMEANING>Milligram per Puff</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass equal to one milligram per puff dosing unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/CIGARETTE</VALIDVALUE>
          <VALUEMEANING>Nanogram per Cigarette</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass equal to one nanogram per cigarette dosing unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210340</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/PUFF</VALIDVALUE>
          <VALUEMEANING>Nanogram per Puff</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass equal to one nanogram per puff dosing unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210341</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PUFF/min</VALIDVALUE>
          <VALUEMEANING>Puffs per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of inhalational puffs taken per minute unit of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/CIGARETTE</VALIDVALUE>
          <VALUEMEANING>Microgram per Cigarette</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass equal to one microgram per cigarette dosing unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FILM</VALIDVALUE>
          <VALUEMEANING>Film Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a film.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>log10 TCID 50</VALIDVALUE>
          <VALUEMEANING>Log10 50 Percent Tissue Culture Infective Dose</VALUEMEANING>
          <MEANINGDESCRIPTION>A potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to a base-10 logarithm of amount of product or agent preparation that causes infection in the 50% of the tissue culture-containing flasks inoculated with that dilution of infectious material in the product potency assay or pathogen activity assay.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HAND UNIT</VALIDVALUE>
          <VALUEMEANING>Hand Unit of Length</VALUEMEANING>
          <MEANINGDESCRIPTION>A traditional unit of length equal to 4 inches or 10.16 centimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/PUFF</VALIDVALUE>
          <VALUEMEANING>Microgram per Puff</VALUEMEANING>
          <MEANINGDESCRIPTION>Micrograms per puff.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15253651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ugEq/mL</VALIDVALUE>
          <VALUEMEANING>Microgram Equivalents Per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of microgram equivalent of solute per milliliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INJECTION</VALIDVALUE>
          <VALUEMEANING>Injection Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in an injection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg*m2/L/min</VALIDVALUE>
          <VALUEMEANING>Millimeter Mercury times Square Meter per Liter per Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of resistance equal to the number of millimeters of mercury times meters squared, per unit of volume equal to one liter per unit of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SFC/WELL</VALIDVALUE>
          <VALUEMEANING>Spot Forming Cells per Well</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per one culture plate well.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/WELL</VALIDVALUE>
          <VALUEMEANING>Per Culture Plate Well</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure equal to the instances of an entity per culture plate well.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/um2</VALIDVALUE>
          <VALUEMEANING>per Square Micrometer</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one square micrometer used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214759</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/kg/s</VALIDVALUE>
          <VALUEMEANING>Millimole per Kilogram per Second</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in millimole(s) per kilogram per period of time equal to one second.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214760</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ABC</VALIDVALUE>
          <VALUEMEANING>Antibody Binding Capacity Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of measure for the number of target molecules per cell as determined by actual binding of a labeled antibody to a target.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16074193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Publication Package</Name>
        <DocumentType>CDISC EVS Controlled Terminology Update</DocumentType>
        <DocumentText>CDISC value sets have been updated to the P41 publication version (2020-03-27).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What [is/was] the duration unit of the [procedure]?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC SDTM Unit of Measure Terminology</Name>
        <DocumentType>VALID_VALUE_SOURCE</DocumentType>
        <DocumentText>Terminology codelist used with Units of Measure within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model.</DocumentText>
        <URL>https://ncit.nci.nih.gov/ncitbrowser/ajax?action=create_src_vs_tree&amp;amp;vsd_uri=http%3A//evs.nci.nih.gov/valueset/CDISC/C71620</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Duration Unit</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Alternate Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What [is/was] the duration unit of the [intervention]?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858962</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Under Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDISC (NRDS Implementation)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7066596</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Procedures (PR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943401</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR_PRCDURU</AlternateName>
        <AlternateNameType>OID, NRDS Standard</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="403">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6703580</PUBLICID>
    <LONGNAME>EGFR Gene Mutation Abnormality Identified Type</LONGNAME>
    <PREFERREDNAME>EGFR_MUT_ABN_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that represents the kind of EGFR gene mutation abnormality identified.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6063521</PublicId>
      <PreferredName>2240797v1.0:6060068v1.0</PreferredName>
      <PreferredDefinition>This gene is involved in the epidermal growth factor signal transduction pathway._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._The procedure of having an identity established.</PreferredDefinition>
      <LongName>EGFR Gene Mutation Abnormality Identification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2240797</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17757</PreferredName>
        <Version>1</Version>
        <LongName>EGFR Gene</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17757</PREFERRED_NAME>
            <LONG_NAME>EGFR Gene</LONG_NAME>
            <CON_ID>2240633</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6060068</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45576:C25737</PreferredName>
        <Version>1</Version>
        <LongName>Mutation Abnormality Identification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45576</PREFERRED_NAME>
            <LONG_NAME>Mutation Abnormality</LONG_NAME>
            <CON_ID>2532673</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25737</PREFERRED_NAME>
            <LONG_NAME>Identification</LONG_NAME>
            <CON_ID>2203822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HCMI:Human Cancer Models Initiative</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6703552</PublicId>
      <PreferredName>6703552v1.0</PreferredName>
      <PreferredDefinition>Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Mutation Abnormality Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength>100</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>6703551</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45576:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Mutation Abnormality Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45576</PREFERRED_NAME>
            <LONG_NAME>Mutation Abnormality</LONG_NAME>
            <CON_ID>2532673</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Exon 19 Deletion</VALIDVALUE>
          <VALUEMEANING>EGFR Exon 19 Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>In-frame deletions occurring within the exon 19-encoded part of the epidermal growth factor receptor (EGFR) kinase domain. These mutations are commonly seen in non-small cell lung cancer and are associated with increased sensitivity to EGFR tyrosine kinase inhibitors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126892</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6703554</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L858R/other</VALIDVALUE>
          <VALUEMEANING>EGFR NP_005219.2:p.L858R Other</VALUEMEANING>
          <MEANINGDESCRIPTION>A change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.: Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C98515</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6703555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>EGFR mutation status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If EGFR Mutation Identified,</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If EGFR Mutation Identified, which one?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="404">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6707196</PUBLICID>
    <LONGNAME>Household Member Reside Count</LONGNAME>
    <PREFERREDNAME>6707145v1.0:2018392v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of persons living in the household.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6707145</PublicId>
      <PreferredName>6707143v1.0:6662983v1.0</PreferredName>
      <PreferredDefinition>An individual who is considered part of the social unit comprising one or more individuals living together (all of whom need not be related) in the same dwelling, who aggregate and share their incomes._To live in a certain place.</PreferredDefinition>
      <LongName>Household Member Reside</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6707143</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C132449</PreferredName>
        <Version>1</Version>
        <LongName>Household Member</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C132449</PREFERRED_NAME>
            <LONG_NAME>Household Member</LONG_NAME>
            <CON_ID>6662981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6662983</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C89279</PreferredName>
        <Version>1</Version>
        <LongName>Reside</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C89279</PREFERRED_NAME>
            <LONG_NAME>Reside</LONG_NAME>
            <CON_ID>3111449</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018392</PublicId>
      <PreferredName>CT</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How many people live in the h</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How many people live in the household?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of people living in the household:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of people living in the household:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of people living in the household:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Number of people living in the household:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Total:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Including yourself, how many people live in your household, at least 50% of the time?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Including yourself, how many people live in your household, at least 50% of the time?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_soc_household_res_count</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_socioec_household_res_count</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CBSE_soc_household_res_count</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="405">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6712203</PUBLICID>
    <LONGNAME>Individual Pharmacokinetic Study Coagulation Factor VIII Extended Half Life Chromogenic Substrate Clotting Factor Assay</LONGNAME>
    <PREFERREDNAME>Indi_Phar_FVIII_Ext_Half_Ass</PREFERREDNAME>
    <PREFERREDDEFINITION>Individual; a single human being._A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body._Coagulation factor VIII (2351 aa, ~267 kDa) is encoded by the human F8 gene. This protein plays a role in the modulation of coagulation factor IX activity and blood coagulation._The amount of time needed for a material to lose half of its physical, chemical, or biological activity._To increase in length or duration._A reagent containing purified coagulation factors (FIXa, FX and thrombin) in optimal concentrations is added to test plasma in the first stage, which does not rely on the extrinsic or intrinsic initiation pathways as the thrombin activates FVIII. The amount of FXa generated in the first stage is measured by its action on a specific chromogenic substrate, which releases a chromophore upon cleavage. The color intensity produced is directly proportional to the amount of FXa, which in turn is directly proportional to the FVIII activity in the sample.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6712194</PublicId>
      <PreferredName>Indi_Phar_FactorVIII_Ext_Half</PreferredName>
      <PreferredDefinition>Individual; a single human being._A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body._Coagulation factor VIII (2351 aa, ~267 kDa) is encoded by the human F8 gene. This protein plays a role in the modulation of coagulation factor IX activity and blood coagulation._The amount of time needed for a material to lose half of its physical, chemical, or biological activity._To increase in length or duration.</PreferredDefinition>
      <LongName>Individual Pharmacokinetic Study Coagulation Factor VIII Extended Half Life</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6706625</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0237401:C49663</PreferredName>
        <Version>1</Version>
        <LongName>Individual Pharmacokinetic Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0237401</PREFERRED_NAME>
            <LONG_NAME>Individual</LONG_NAME>
            <CON_ID>2204169</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49663</PREFERRED_NAME>
            <LONG_NAME>Pharmacokinetic Study</LONG_NAME>
            <CON_ID>2480753</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6706647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16571:C25270:C70916</PreferredName>
        <Version>1</Version>
        <LongName>Coagulation Factor VIII Extend Half Life</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16571</PREFERRED_NAME>
            <LONG_NAME>Coagulation Factor VIII</LONG_NAME>
            <CON_ID>3416105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25270</PREFERRED_NAME>
            <LONG_NAME>Extend</LONG_NAME>
            <CON_ID>2203922</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70916</PREFERRED_NAME>
            <LONG_NAME>Half Life</LONG_NAME>
            <CON_ID>2939190</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6732893</PublicId>
      <PreferredName>6732893v1.0</PreferredName>
      <PreferredDefinition>A reagent containing purified coagulation factors (FIXa, FX and thrombin) in optimal concentrations is added to test plasma in the first stage, which does not rely on the extrinsic or intrinsic initiation pathways as the thrombin activates FVIII. The amount of FXa generated in the first stage is measured by its action on a specific chromogenic substrate, which releases a chromophore upon cleavage. The color intensity produced is directly proportional to the amount of FXa, which in turn is directly proportional to the FVIII activity in the sample.</PreferredDefinition>
      <LongName>Chromogenic Substrate Clotting Factor Assay</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>6732892</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C159552</PreferredName>
        <Version>1</Version>
        <LongName>Chromogenic Substrate Clotting Factor Assay</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159552</PREFERRED_NAME>
            <LONG_NAME>Chromogenic Substrate Clotting Factor Assay</LONG_NAME>
            <CON_ID>6718375</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Individual Pharmacokinetic Study Coagulation Factor VIII Extended Half Life Chromogenic Substrate Clotting Factor Assay does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Individual Pharmacokinetic Study Coagulation Factor VIII Extended Half Life Chromogenic Substrate Clotting Factor Assay does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hemophilia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6641385</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="406">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6731696</PUBLICID>
    <LONGNAME>Protein Expression Immunohistochemistry Staining Method Identifier Other Specify Text</LONGNAME>
    <PREFERREDNAME>PROT_IHC_ID_SPEC_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>The text response that indicates the antigen in which immunohistochemistry staining method was used to identify not previously listed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6731460</PublicId>
      <PreferredName>6731457v1.0:6731458v1.0</PreferredName>
      <PreferredDefinition>The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus._Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Protein Expression Immunohistochemistry Staining Method Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435028</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C26548</PreferredName>
        <Version>1</Version>
        <LongName>Gene Product</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6731457</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18966</PreferredName>
        <Version>1</Version>
        <LongName>Protein Expression</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18966</PREFERRED_NAME>
            <LONG_NAME>Protein Expression</LONG_NAME>
            <CON_ID>3463240</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6731458</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C23020:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Immunohistochemistry Staining Method Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C23020</PREFERRED_NAME>
            <LONG_NAME>Immunohistochemistry Staining Method</LONG_NAME>
            <CON_ID>2528548</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2857322</PublicId>
      <PreferredName>OTHR_SPEC_TXT</PreferredName>
      <PreferredDefinition>The free text field that describes another response when other is chosen from a list of values.</PreferredDefinition>
      <LongName>Other Specify Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2857047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other IHC performed on slide</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other IHC performed on slide</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6705584</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCG_PTCL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PTCL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6705585</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="407">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6733189</PUBLICID>
    <LONGNAME>Country Person Receive Therapeutic Procedure Country Name</LONGNAME>
    <PREFERREDNAME>CNTRY_RCV_TRPY</PREFERREDNAME>
    <PREFERREDDEFINITION>Pertains to which country the person received or receives therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6733179</PublicId>
      <PreferredName>6733176v1.0:6733177v1.0</PreferredName>
      <PreferredDefinition>A collective generic term that refers here to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states._A human being._To take, accept, or get something offered._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</PreferredDefinition>
      <LongName>Country Person Receive Therapeutic Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2861581</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ADDRESS</PreferredName>
        <Version>1</Version>
        <LongName>Address</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6733176</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25464:C25190</PreferredName>
        <Version>1</Version>
        <LongName>Country Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25464</PREFERRED_NAME>
            <LONG_NAME>Country</LONG_NAME>
            <CON_ID>2202437</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6733177</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25639:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Receive Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3151957</PublicId>
      <PreferredName>3151957v1.0</PreferredName>
      <PreferredDefinition>collective generic term &quot;Country&quot; refers to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states. (from CIA World Factbook 2002: http://www.cia.gov/cia/publications/factbook/docs/notesanddefs.html)_The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Country Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008543</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>GEO_LCTNS</PreferredName>
        <Version>1</Version>
        <LongName>Geographic Locations</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CIA:The World Factbook Cross-Reference List of Country Data Codes</Origin>
      <Representation>
        <PublicId>2486461</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25464:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Country Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25464</PREFERRED_NAME>
            <LONG_NAME>Country</LONG_NAME>
            <CON_ID>2202437</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Falkland Islands</VALIDVALUE>
          <VALUEMEANING>Falkland Isl.</VALUEMEANING>
          <MEANINGDESCRIPTION>Falkland Islands (Malvinas)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Faroe Islands</VALIDVALUE>
          <VALUEMEANING>Faroe Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Faroe Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>France</VALIDVALUE>
          <VALUEMEANING>France</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Western Europe, bordering the Bay of Biscay and English Channel, between Belgium and Spain, southeast of the UK; bordering the Mediterranean Sea, between Italy and Spain. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16592</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>France, Metropolitan</VALIDVALUE>
          <VALUEMEANING>France (European Territory)</VALUEMEANING>
          <MEANINGDESCRIPTION>France (European Territory)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151973</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gabon</VALIDVALUE>
          <VALUEMEANING>Gabon</VALUEMEANING>
          <MEANINGDESCRIPTION>Gabon</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16596</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>United Kingdom</VALIDVALUE>
          <VALUEMEANING>Great Britain</VALUEMEANING>
          <MEANINGDESCRIPTION>(UK)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0018223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grenada</VALIDVALUE>
          <VALUEMEANING>Grenada</VALUEMEANING>
          <MEANINGDESCRIPTION>Grenada</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16647</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Georgia</VALIDVALUE>
          <VALUEMEANING>Georgia</VALUEMEANING>
          <MEANINGDESCRIPTION>A state in the southeastern United States. Its capital is Atlanta.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563969</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>French Guiana</VALIDVALUE>
          <VALUEMEANING>Guiana (French)</VALUEMEANING>
          <MEANINGDESCRIPTION>French Guyana</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guernsey</VALIDVALUE>
          <VALUEMEANING>Guernsey</VALUEMEANING>
          <MEANINGDESCRIPTION>A British Crown dependency in the English Channel, between England and France.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ghana</VALIDVALUE>
          <VALUEMEANING>Ghana</VALUEMEANING>
          <MEANINGDESCRIPTION>Ghana</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26330</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gibraltar</VALIDVALUE>
          <VALUEMEANING>Gibraltar</VALUEMEANING>
          <MEANINGDESCRIPTION>Gibraltar</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563973</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Greenland</VALIDVALUE>
          <VALUEMEANING>Greenland</VALUEMEANING>
          <MEANINGDESCRIPTION>Greenland</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gambia, The</VALIDVALUE>
          <VALUEMEANING>Gambia</VALUEMEANING>
          <MEANINGDESCRIPTION>Gambia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16598</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guinea</VALIDVALUE>
          <VALUEMEANING>Guinea</VALUEMEANING>
          <MEANINGDESCRIPTION>Guinea</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guadeloupe</VALIDVALUE>
          <VALUEMEANING>Guadeloupe</VALUEMEANING>
          <MEANINGDESCRIPTION>Islands in the eastern Caribbean Sea, southeast of Puerto Rico. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16651</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Equatorial Guinea</VALIDVALUE>
          <VALUEMEANING>Equatorial Guinea</VALUEMEANING>
          <MEANINGDESCRIPTION>Equatorial Guinea</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Greece</VALIDVALUE>
          <VALUEMEANING>Greece</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>South Georgia and the Islands</VALIDVALUE>
          <VALUEMEANING>South Georgia and South Sandwich Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>South Georgia and South Sandwich Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guatemala</VALIDVALUE>
          <VALUEMEANING>Guatemala</VALUEMEANING>
          <MEANINGDESCRIPTION>Guatemala</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guam</VALIDVALUE>
          <VALUEMEANING>Guam (US)</VALUEMEANING>
          <MEANINGDESCRIPTION>Guam (US)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guinea-Bissau</VALIDVALUE>
          <VALUEMEANING>Guinea Bissau</VALUEMEANING>
          <MEANINGDESCRIPTION>Guinea Bissau</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563983</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guyana</VALIDVALUE>
          <VALUEMEANING>Guyana</VALUEMEANING>
          <MEANINGDESCRIPTION>Guyana</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16657</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hong Kong</VALIDVALUE>
          <VALUEMEANING>Hong Kong</VALUEMEANING>
          <MEANINGDESCRIPTION>A special administrative region of China, bordering the South China Sea and China. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16695</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heard Island and McDonald Islands</VALIDVALUE>
          <VALUEMEANING>Heard &amp; McDonald Isl.</VALUEMEANING>
          <MEANINGDESCRIPTION>Heard and McDonald Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Honduras</VALIDVALUE>
          <VALUEMEANING>Honduras</VALUEMEANING>
          <MEANINGDESCRIPTION>Honduras</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574033</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Croatia</VALIDVALUE>
          <VALUEMEANING>Croatia</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southeastern Europe, bordering the Adriatic Sea, between Bosnia and Herzegovina and Slovenia. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563987</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Haiti</VALIDVALUE>
          <VALUEMEANING>Haiti</VALUEMEANING>
          <MEANINGDESCRIPTION>Haiti</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hungary</VALIDVALUE>
          <VALUEMEANING>Hungary</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Central Europe, northwest of Romania. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16699</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indonesia</VALIDVALUE>
          <VALUEMEANING>Indonesia</VALUEMEANING>
          <MEANINGDESCRIPTION>Indonesia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16728</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ireland</VALIDVALUE>
          <VALUEMEANING>Ireland</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Israel</VALIDVALUE>
          <VALUEMEANING>Israel</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16760</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563990</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Isle of Man</VALIDVALUE>
          <VALUEMEANING>Isle of Man</VALUEMEANING>
          <MEANINGDESCRIPTION>An island in the Irish Sea, between Great Britain and Ireland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C44480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>India</VALIDVALUE>
          <VALUEMEANING>India</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan.  (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>British Indian Ocean Territory</VALIDVALUE>
          <VALUEMEANING>British Indian Ocean Territory</VALUEMEANING>
          <MEANINGDESCRIPTION>British Indian Ocean Territory</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iraq</VALIDVALUE>
          <VALUEMEANING>Iraq</VALUEMEANING>
          <MEANINGDESCRIPTION>Iraq</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iran</VALIDVALUE>
          <VALUEMEANING>Iran</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan.  (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iceland</VALIDVALUE>
          <VALUEMEANING>Iceland</VALUEMEANING>
          <MEANINGDESCRIPTION>Iceland</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563994</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Italy</VALIDVALUE>
          <VALUEMEANING>Italy</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in southern Europe, occupying a peninsula extending into the central Mediterranean Sea, northeast of Tunisia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Jersey</VALIDVALUE>
          <VALUEMEANING>Jersey</VALUEMEANING>
          <MEANINGDESCRIPTION>(Channel Islands)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563995</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Jamaica</VALIDVALUE>
          <VALUEMEANING>Jamaica</VALUEMEANING>
          <MEANINGDESCRIPTION>Jamaica</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563996</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Jordan</VALIDVALUE>
          <VALUEMEANING>Jordan</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in the Middle East, northwest of Saudi Arabia. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Japan</VALIDVALUE>
          <VALUEMEANING>Japan</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Eastern Asia, occupying an island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563997</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kenya</VALIDVALUE>
          <VALUEMEANING>Kenya</VALUEMEANING>
          <MEANINGDESCRIPTION>Kenya</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16769</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kyrgyzstan</VALIDVALUE>
          <VALUEMEANING>Kyrgyzstan</VALUEMEANING>
          <MEANINGDESCRIPTION>Kyrgyzstan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cambodia</VALIDVALUE>
          <VALUEMEANING>Cambodia</VALUEMEANING>
          <MEANINGDESCRIPTION>Cambodia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563999</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kiribati</VALIDVALUE>
          <VALUEMEANING>Kiribati</VALUEMEANING>
          <MEANINGDESCRIPTION>Kiribati</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16639</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Comoros</VALIDVALUE>
          <VALUEMEANING>Comoros</VALUEMEANING>
          <MEANINGDESCRIPTION>Comoros</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Saint Kitts and Nevis</VALIDVALUE>
          <VALUEMEANING>St. Kitts and Nevis</VALUEMEANING>
          <MEANINGDESCRIPTION>St. Kitts and Nevis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Korea, North</VALIDVALUE>
          <VALUEMEANING>Korea, North</VALUEMEANING>
          <MEANINGDESCRIPTION>Korea, North</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Korea, South</VALIDVALUE>
          <VALUEMEANING>Korea, South</VALUEMEANING>
          <MEANINGDESCRIPTION>Korea, South</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kuwait</VALIDVALUE>
          <VALUEMEANING>Kuwait</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in the Middle East, bordering the Persian Gulf, between Iraq and Saudi Arabia. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16775</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574042</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cayman Islands</VALIDVALUE>
          <VALUEMEANING>Cayman Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Cayman Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kazakhstan</VALIDVALUE>
          <VALUEMEANING>Kazakhstan</VALUEMEANING>
          <MEANINGDESCRIPTION>Kazakhstan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Laos</VALIDVALUE>
          <VALUEMEANING>Laos</VALUEMEANING>
          <MEANINGDESCRIPTION>Laos</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lebanon</VALIDVALUE>
          <VALUEMEANING>Lebanon</VALUEMEANING>
          <MEANINGDESCRIPTION>Lebanon</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16784</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Saint Lucia</VALIDVALUE>
          <VALUEMEANING>Saint Lucia</VALUEMEANING>
          <MEANINGDESCRIPTION>Saint Lucia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17113</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liechtenstein</VALIDVALUE>
          <VALUEMEANING>Liechtenstein</VALUEMEANING>
          <MEANINGDESCRIPTION>Liechtenstein</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16794</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sri Lanka</VALIDVALUE>
          <VALUEMEANING>Sri Lanka</VALUEMEANING>
          <MEANINGDESCRIPTION>Sri Lanka</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liberia</VALIDVALUE>
          <VALUEMEANING>Liberia</VALUEMEANING>
          <MEANINGDESCRIPTION>Liberia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564009</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lesotho</VALIDVALUE>
          <VALUEMEANING>Lesotho</VALUEMEANING>
          <MEANINGDESCRIPTION>Lesotho</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16787</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lithuania</VALIDVALUE>
          <VALUEMEANING>Lithuania</VALUEMEANING>
          <MEANINGDESCRIPTION>Lithuania</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16799</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Luxembourg</VALIDVALUE>
          <VALUEMEANING>Luxembourg</VALUEMEANING>
          <MEANINGDESCRIPTION>Luxembourg</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16803</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574046</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Latvia</VALIDVALUE>
          <VALUEMEANING>Latvia</VALUEMEANING>
          <MEANINGDESCRIPTION>Latvia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Libya</VALIDVALUE>
          <VALUEMEANING>Libya</VALUEMEANING>
          <MEANINGDESCRIPTION>Libya</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Morocco</VALIDVALUE>
          <VALUEMEANING>Morocco</VALUEMEANING>
          <MEANINGDESCRIPTION>Morocco</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16878</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574047</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monaco</VALIDVALUE>
          <VALUEMEANING>Monaco</VALUEMEANING>
          <MEANINGDESCRIPTION>Monaco</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16874</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moldova</VALIDVALUE>
          <VALUEMEANING>Moldova</VALUEMEANING>
          <MEANINGDESCRIPTION>Moldova</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16871</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574048</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Madagascar</VALIDVALUE>
          <VALUEMEANING>Madagascar</VALUEMEANING>
          <MEANINGDESCRIPTION>Madagascar</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16808</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Marshall Islands</VALIDVALUE>
          <VALUEMEANING>Marshall Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Marshall Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16822</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Micronesia, Federated States of</VALIDVALUE>
          <VALUEMEANING>Micronesia</VALUEMEANING>
          <MEANINGDESCRIPTION>Micronesia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0026001</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macedonia</VALIDVALUE>
          <VALUEMEANING>Macedonia</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in southeastern Europe, north of Greece, between Albania and Bulgaria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mali</VALIDVALUE>
          <VALUEMEANING>Mali</VALUEMEANING>
          <MEANINGDESCRIPTION>Mali</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574049</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myanmar</VALIDVALUE>
          <VALUEMEANING>Myanmar</VALUEMEANING>
          <MEANINGDESCRIPTION>Myanmar</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mongolia</VALIDVALUE>
          <VALUEMEANING>Mongolia</VALUEMEANING>
          <MEANINGDESCRIPTION>Mongolia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574050</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macau</VALIDVALUE>
          <VALUEMEANING>Macau</VALUEMEANING>
          <MEANINGDESCRIPTION>Macau</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Northern Mariana Islands</VALIDVALUE>
          <VALUEMEANING>Northern Mariana Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Northern Mariana Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Martinique</VALIDVALUE>
          <VALUEMEANING>Martinique</VALUEMEANING>
          <MEANINGDESCRIPTION>Martinique</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mauritania</VALIDVALUE>
          <VALUEMEANING>Mauritania</VALUEMEANING>
          <MEANINGDESCRIPTION>Mauritania</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16826</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Montserrat</VALIDVALUE>
          <VALUEMEANING>Montserrat</VALUEMEANING>
          <MEANINGDESCRIPTION>Montserrat</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malta</VALIDVALUE>
          <VALUEMEANING>Malta</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southern Europe, occupying islands in the Mediterranean Sea, south of Sicily (Italy). (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16817</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mauritius</VALIDVALUE>
          <VALUEMEANING>Mauritius</VALUEMEANING>
          <MEANINGDESCRIPTION>Mauritius</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16827</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maldives</VALIDVALUE>
          <VALUEMEANING>Maldives</VALUEMEANING>
          <MEANINGDESCRIPTION>Maldives</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16815</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malawi</VALIDVALUE>
          <VALUEMEANING>Malawi</VALUEMEANING>
          <MEANINGDESCRIPTION>Malawi</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mexico</VALIDVALUE>
          <VALUEMEANING>Mexico</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in southern North America, bordering the North Pacific Ocean and the Gulf of Mexico, south of the US.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16850</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malaysia</VALIDVALUE>
          <VALUEMEANING>Malaysia</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southeastern Asia, occupying a peninsula and the northern one-third of the island of Borneo, bordering Indonesia and the South China Sea, south of Vietnam. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564023</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mozambique</VALIDVALUE>
          <VALUEMEANING>Mozambique</VALUEMEANING>
          <MEANINGDESCRIPTION>Mozambique</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16882</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Namibia</VALIDVALUE>
          <VALUEMEANING>Namibia</VALUEMEANING>
          <MEANINGDESCRIPTION>Namibia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16891</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>New Caledonia</VALIDVALUE>
          <VALUEMEANING>New Caledonia</VALUEMEANING>
          <MEANINGDESCRIPTION>New Caledonia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151983</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Niger</VALIDVALUE>
          <VALUEMEANING>Niger</VALUEMEANING>
          <MEANINGDESCRIPTION>Niger</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16916</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Norfolk Island</VALIDVALUE>
          <VALUEMEANING>Norfolk Island</VALUEMEANING>
          <MEANINGDESCRIPTION>Norfolk Island</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16919</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574056</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nigeria</VALIDVALUE>
          <VALUEMEANING>Nigeria</VALUEMEANING>
          <MEANINGDESCRIPTION>Nigeria</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16917</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564027</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nicaragua</VALIDVALUE>
          <VALUEMEANING>Nicaragua</VALUEMEANING>
          <MEANINGDESCRIPTION>Nicaragua</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Netherlands</VALIDVALUE>
          <VALUEMEANING>Netherlands</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Western Europe, bordering the North Sea, between Belgium and Germany. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564028</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Norway</VALIDVALUE>
          <VALUEMEANING>Norway</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16920</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nepal</VALIDVALUE>
          <VALUEMEANING>Nepal</VALUEMEANING>
          <MEANINGDESCRIPTION>Nepal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564029</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nauru</VALIDVALUE>
          <VALUEMEANING>Nauru</VALUEMEANING>
          <MEANINGDESCRIPTION>Nauru</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16896</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Niue</VALIDVALUE>
          <VALUEMEANING>Niue</VALUEMEANING>
          <MEANINGDESCRIPTION>Niue</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16918</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>New Zealand</VALIDVALUE>
          <VALUEMEANING>New Zealand</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in the Pacific, comprised of islands in the South Pacific Ocean, southeast of Australia. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16914</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oman</VALIDVALUE>
          <VALUEMEANING>Oman</VALUEMEANING>
          <MEANINGDESCRIPTION>Oman</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Panama</VALIDVALUE>
          <VALUEMEANING>Panama</VALUEMEANING>
          <MEANINGDESCRIPTION>Panama</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peru</VALIDVALUE>
          <VALUEMEANING>Peru</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Western South America, bordering the South Pacific Ocean, between Chile and Ecuador. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>French Polynesia</VALIDVALUE>
          <VALUEMEANING>French Polynesia</VALUEMEANING>
          <MEANINGDESCRIPTION>French Polynesia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papua New Guinea</VALIDVALUE>
          <VALUEMEANING>Papua New Guinea</VALUEMEANING>
          <MEANINGDESCRIPTION>Papua New Guinea</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16952</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Philippines</VALIDVALUE>
          <VALUEMEANING>Philippines</VALUEMEANING>
          <MEANINGDESCRIPTION>Philippines</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16978</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pakistan</VALIDVALUE>
          <VALUEMEANING>Pakistan</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poland</VALIDVALUE>
          <VALUEMEANING>Poland</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Central Europe, east of Germany. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Saint Pierre and Miquelon</VALIDVALUE>
          <VALUEMEANING>Saint Pierre and Miquelon</VALUEMEANING>
          <MEANINGDESCRIPTION>Saint Pierre and Miquelon</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pitcairn Islands</VALIDVALUE>
          <VALUEMEANING>Pitcairn</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in the Pacific, comprised of islands in the South Pacific Ocean, about midway between Peru and New Zealand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Puerto Rico</VALIDVALUE>
          <VALUEMEANING>Puerto Rico</VALUEMEANING>
          <MEANINGDESCRIPTION>Puerto Rico</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17043</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Portugal</VALIDVALUE>
          <VALUEMEANING>Portugal</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southwestern Europe, bordering the North Atlantic Ocean, west of Spain. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17006</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palau</VALIDVALUE>
          <VALUEMEANING>Palau</VALUEMEANING>
          <MEANINGDESCRIPTION>Palau</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17733</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraguay</VALIDVALUE>
          <VALUEMEANING>Paraguay</VALUEMEANING>
          <MEANINGDESCRIPTION>Paraguay</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16953</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Qatar</VALIDVALUE>
          <VALUEMEANING>Qatar</VALUEMEANING>
          <MEANINGDESCRIPTION>Qatar</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Romania</VALIDVALUE>
          <VALUEMEANING>Romania</VALUEMEANING>
          <MEANINGDESCRIPTION>Romania</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17108</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564042</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Russia</VALIDVALUE>
          <VALUEMEANING>Russia</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Northern Asia (that part west of the Urals is sometimes included with Europe), bordering the Arctic Ocean, between Europe and the North Pacific Ocean. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17111</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578992</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reunion</VALIDVALUE>
          <VALUEMEANING>Reunion</VALUEMEANING>
          <MEANINGDESCRIPTION>Reunion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rwanda</VALIDVALUE>
          <VALUEMEANING>Rwanda</VALUEMEANING>
          <MEANINGDESCRIPTION>Rwanda</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17112</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Saudi Arabia</VALIDVALUE>
          <VALUEMEANING>Saudi Arabia</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17117</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Solomon Islands</VALIDVALUE>
          <VALUEMEANING>Solomon Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Solomon Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17148</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seychelles</VALIDVALUE>
          <VALUEMEANING>Seychelles</VALUEMEANING>
          <MEANINGDESCRIPTION>Seychelles</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sudan</VALIDVALUE>
          <VALUEMEANING>Sudan</VALUEMEANING>
          <MEANINGDESCRIPTION>Sudan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17170</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sweden</VALIDVALUE>
          <VALUEMEANING>Sweden</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17180</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564046</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Singapore</VALIDVALUE>
          <VALUEMEANING>Singapore</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southeastern Asia, comprised of islands between Malaysia and Indonesia. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17134</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Saint Helena</VALIDVALUE>
          <VALUEMEANING>Saint Helena</VALUEMEANING>
          <MEANINGDESCRIPTION>Saint Helena</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151994</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slovenia</VALIDVALUE>
          <VALUEMEANING>Slovenia</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Central Europe, bordering the Adriatic Sea, between Austria and Croatia. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17138</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564049</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Svalbard</VALIDVALUE>
          <VALUEMEANING>Svalbard</VALUEMEANING>
          <MEANINGDESCRIPTION>Svalbard</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151995</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slovakia</VALIDVALUE>
          <VALUEMEANING>Slovakia</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Central Europe, south of Poland. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564050</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sierra Leone</VALIDVALUE>
          <VALUEMEANING>Sierra Leone</VALUEMEANING>
          <MEANINGDESCRIPTION>Sierra Leone</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>San Marino</VALIDVALUE>
          <VALUEMEANING>San Marino</VALUEMEANING>
          <MEANINGDESCRIPTION>San Marino</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17115</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Senegal</VALIDVALUE>
          <VALUEMEANING>Senegal</VALUEMEANING>
          <MEANINGDESCRIPTION>Senegal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17121</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Timor-Leste</VALIDVALUE>
          <VALUEMEANING>Timor-Leste</VALUEMEANING>
          <MEANINGDESCRIPTION>Timor-Leste</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152002</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somalia</VALIDVALUE>
          <VALUEMEANING>Somalia</VALUEMEANING>
          <MEANINGDESCRIPTION>Somalia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17149</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suriname</VALIDVALUE>
          <VALUEMEANING>Suriname</VALUEMEANING>
          <MEANINGDESCRIPTION>Suriname</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17175</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sao Tome and Principe</VALIDVALUE>
          <VALUEMEANING>Sao Tome and Principe</VALUEMEANING>
          <MEANINGDESCRIPTION>Saine Tome (Sao Tome) and Principe</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>El Salvador</VALIDVALUE>
          <VALUEMEANING>El Salvador</VALUEMEANING>
          <MEANINGDESCRIPTION>El Salvador</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16532</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Syria</VALIDVALUE>
          <VALUEMEANING>Syria</VALUEMEANING>
          <MEANINGDESCRIPTION>Syria</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Swaziland</VALIDVALUE>
          <VALUEMEANING>Swaziland</VALUEMEANING>
          <MEANINGDESCRIPTION>Swaziland</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17179</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chad</VALIDVALUE>
          <VALUEMEANING>Chad</VALUEMEANING>
          <MEANINGDESCRIPTION>Chad</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>French Southern and Antarctic Lands</VALIDVALUE>
          <VALUEMEANING>French Southern and Antarctic Lands</VALUEMEANING>
          <MEANINGDESCRIPTION>French Southern and Antarctic Lands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Togo</VALIDVALUE>
          <VALUEMEANING>Togo</VALUEMEANING>
          <MEANINGDESCRIPTION>Togo</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17202</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thailand</VALIDVALUE>
          <VALUEMEANING>Thailand</VALUEMEANING>
          <MEANINGDESCRIPTION>Thailand</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tajikistan</VALIDVALUE>
          <VALUEMEANING>Tajikistan</VALUEMEANING>
          <MEANINGDESCRIPTION>Tajikistan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tokelau</VALIDVALUE>
          <VALUEMEANING>Tokelau</VALUEMEANING>
          <MEANINGDESCRIPTION>Tokelau</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Turkmenistan</VALIDVALUE>
          <VALUEMEANING>Turkmenistan</VALUEMEANING>
          <MEANINGDESCRIPTION>Turkmenistan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tunisia</VALIDVALUE>
          <VALUEMEANING>Tunisia</VALUEMEANING>
          <MEANINGDESCRIPTION>Tunisia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tonga</VALIDVALUE>
          <VALUEMEANING>Tonga</VALUEMEANING>
          <MEANINGDESCRIPTION>Tonga</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Turkey</VALIDVALUE>
          <VALUEMEANING>Turkey</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trinidad and Tobago</VALIDVALUE>
          <VALUEMEANING>Trinidad and Tobago</VALUEMEANING>
          <MEANINGDESCRIPTION>Trinidad and Tobago</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tuvalu</VALIDVALUE>
          <VALUEMEANING>Tuvalu</VALUEMEANING>
          <MEANINGDESCRIPTION>Tuvalu</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Taiwan</VALIDVALUE>
          <VALUEMEANING>Taiwan</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17184</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tanzania</VALIDVALUE>
          <VALUEMEANING>Tanzania</VALUEMEANING>
          <MEANINGDESCRIPTION>Tanzania</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ukraine</VALIDVALUE>
          <VALUEMEANING>Ukraine</VALUEMEANING>
          <MEANINGDESCRIPTION>Ukraine</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uganda</VALIDVALUE>
          <VALUEMEANING>Uganda</VALUEMEANING>
          <MEANINGDESCRIPTION>Uganda</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>United States Minor Outlying Islands</VALIDVALUE>
          <VALUEMEANING>United States Minor Outlying Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>United States Minor Outlying Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>United States</VALIDVALUE>
          <VALUEMEANING>United States</VALUEMEANING>
          <MEANINGDESCRIPTION>United States</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uruguay</VALIDVALUE>
          <VALUEMEANING>Uruguay</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southern South America, bordering the South Atlantic Ocean, between Argentina and Brazil. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uzbekistan</VALIDVALUE>
          <VALUEMEANING>Uzbekistan</VALUEMEANING>
          <MEANINGDESCRIPTION>Uzbekistan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Holy See (Vatican City)</VALIDVALUE>
          <VALUEMEANING>Holy See (Vatican City)</VALUEMEANING>
          <MEANINGDESCRIPTION>Holy See (Vatican City)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152009</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Saint Vincent and the Grenadines</VALIDVALUE>
          <VALUEMEANING>Saint Vincent and the Grenadines</VALUEMEANING>
          <MEANINGDESCRIPTION>Saint Vincent and the Grenadines</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Virgin Islands (UK)</VALIDVALUE>
          <VALUEMEANING>Virgin Islands (UK)</VALUEMEANING>
          <MEANINGDESCRIPTION>Virgin Islands (UK)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Virgin Islands (US)</VALIDVALUE>
          <VALUEMEANING>Virgin Islands (US)</VALUEMEANING>
          <MEANINGDESCRIPTION>Virgin Islands (US)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vietnam</VALIDVALUE>
          <VALUEMEANING>Vietnam</VALUEMEANING>
          <MEANINGDESCRIPTION>Vietnam</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17252</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564088</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vanuatu</VALIDVALUE>
          <VALUEMEANING>Vanuatu</VALUEMEANING>
          <MEANINGDESCRIPTION>Vanuatu</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wallis and Futuna</VALIDVALUE>
          <VALUEMEANING>Wallis and Futuna</VALUEMEANING>
          <MEANINGDESCRIPTION>Wallis and Futuna</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Western Samoa</VALIDVALUE>
          <VALUEMEANING>Western Samoa</VALUEMEANING>
          <MEANINGDESCRIPTION>Western Samoa</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yemen</VALIDVALUE>
          <VALUEMEANING>Yemen</VALUEMEANING>
          <MEANINGDESCRIPTION>Yemen</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mayotte</VALIDVALUE>
          <VALUEMEANING>Mayotte</VALUEMEANING>
          <MEANINGDESCRIPTION>Mayotte</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>South Africa</VALIDVALUE>
          <VALUEMEANING>South Africa</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southern Africa, at the southern tip of the continent of Africa. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17151</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zambia</VALIDVALUE>
          <VALUEMEANING>Zambia</VALUEMEANING>
          <MEANINGDESCRIPTION>Zambia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Congo, Democratic Republic of the</VALIDVALUE>
          <VALUEMEANING>Democratic Republic of the Congo</VALUEMEANING>
          <MEANINGDESCRIPTION>Democratic Republic of the Congo</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zimbabwe</VALIDVALUE>
          <VALUEMEANING>Zimbabwe</VALUEMEANING>
          <MEANINGDESCRIPTION>Zimbabwe</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>United Arab Emirates</VALIDVALUE>
          <VALUEMEANING>United Arab Emirates</VALUEMEANING>
          <MEANINGDESCRIPTION>United Arab Emirates</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Afghanistan</VALIDVALUE>
          <VALUEMEANING>Afghanistan</VALUEMEANING>
          <MEANINGDESCRIPTION>(Islamic St.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antigua and Barbuda</VALIDVALUE>
          <VALUEMEANING>Antigua and Barbuda</VALUEMEANING>
          <MEANINGDESCRIPTION>Antigua and Barbuda</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16303</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anguilla</VALIDVALUE>
          <VALUEMEANING>Anguilla</VALUEMEANING>
          <MEANINGDESCRIPTION>Anguilla</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20133</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Albania</VALIDVALUE>
          <VALUEMEANING>Albania</VALUEMEANING>
          <MEANINGDESCRIPTION>Albania</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Armenia</VALIDVALUE>
          <VALUEMEANING>Armenia</VALUEMEANING>
          <MEANINGDESCRIPTION>Armenia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563920</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Netherland Antilles</VALIDVALUE>
          <VALUEMEANING>Netherland Antilles</VALUEMEANING>
          <MEANINGDESCRIPTION>Netherland Antilles</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angola</VALIDVALUE>
          <VALUEMEANING>Angola</VALUEMEANING>
          <MEANINGDESCRIPTION>Angola</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antarctica</VALIDVALUE>
          <VALUEMEANING>Antarctica</VALUEMEANING>
          <MEANINGDESCRIPTION>Antarctica</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Argentina</VALIDVALUE>
          <VALUEMEANING>Argentina</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16305</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>American Samoa</VALIDVALUE>
          <VALUEMEANING>American Samoa</VALUEMEANING>
          <MEANINGDESCRIPTION>American Samoa</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17739</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Austria</VALIDVALUE>
          <VALUEMEANING>Austria</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Central Europe, north of Italy and Slovenia. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16312</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Australia</VALIDVALUE>
          <VALUEMEANING>Australia</VALUEMEANING>
          <MEANINGDESCRIPTION>The continent between the Indian Ocean and the South Pacific Ocean. The US State Department considers Ashmore and Cartier Islands and the Coral Sea Islands as a separate entities, each with its own code (AT and CR, respectively). (from CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aruba</VALIDVALUE>
          <VALUEMEANING>Aruba</VALUEMEANING>
          <MEANINGDESCRIPTION>Aruba</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17884</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Barbados</VALIDVALUE>
          <VALUEMEANING>Barbados</VALUEMEANING>
          <MEANINGDESCRIPTION>Barbados</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16324</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bangladesh</VALIDVALUE>
          <VALUEMEANING>Bangladesh</VALUEMEANING>
          <MEANINGDESCRIPTION>Bangladesh</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16323</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Belgium</VALIDVALUE>
          <VALUEMEANING>Belgium</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Western Europe, bordering the North Sea, between France and the Netherlands. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Burkina Faso</VALIDVALUE>
          <VALUEMEANING>Burkina Faso</VALUEMEANING>
          <MEANINGDESCRIPTION>Burkina Faso</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bulgaria</VALIDVALUE>
          <VALUEMEANING>Bulgaria</VALUEMEANING>
          <MEANINGDESCRIPTION>Bulgaria</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16368</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bahrain</VALIDVALUE>
          <VALUEMEANING>Bahrain</VALUEMEANING>
          <MEANINGDESCRIPTION>Bahrain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16322</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Burundi</VALIDVALUE>
          <VALUEMEANING>Burundi</VALUEMEANING>
          <MEANINGDESCRIPTION>Burundi</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16371</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Benin</VALIDVALUE>
          <VALUEMEANING>Benin</VALUEMEANING>
          <MEANINGDESCRIPTION>Benin</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palmyra Atoll</VALIDVALUE>
          <VALUEMEANING>Palmyra Atoll</VALUEMEANING>
          <MEANINGDESCRIPTION>Palmyra Atoll</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Navassa Island</VALIDVALUE>
          <VALUEMEANING>Navassa Island</VALUEMEANING>
          <MEANINGDESCRIPTION>Navassa Island</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Midway Islands</VALIDVALUE>
          <VALUEMEANING>Midway Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Midway Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kosovo</VALIDVALUE>
          <VALUEMEANING>Kosovo</VALUEMEANING>
          <MEANINGDESCRIPTION>Kosovo</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152143</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kingman Reef</VALIDVALUE>
          <VALUEMEANING>Kingman Reef</VALUEMEANING>
          <MEANINGDESCRIPTION>Kingman Reef</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Juan de Nova Island</VALIDVALUE>
          <VALUEMEANING>Juan de Nova Island</VALUEMEANING>
          <MEANINGDESCRIPTION>Juan de Nova Island</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152145</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Jarvis Island</VALIDVALUE>
          <VALUEMEANING>Jarvis Island</VALUEMEANING>
          <MEANINGDESCRIPTION>Jarvis Island</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Jan Mayen</VALIDVALUE>
          <VALUEMEANING>Jan Mayen</VALUEMEANING>
          <MEANINGDESCRIPTION>Jan Mayen</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Howland Island</VALIDVALUE>
          <VALUEMEANING>Howland Island</VALUEMEANING>
          <MEANINGDESCRIPTION>Howland Island</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glorioso Islands</VALIDVALUE>
          <VALUEMEANING>Glorioso Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Glorioso Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152149</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gaza Strip</VALIDVALUE>
          <VALUEMEANING>Gaza Strip</VALUEMEANING>
          <MEANINGDESCRIPTION>Gaza Strip</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Europa Island</VALIDVALUE>
          <VALUEMEANING>Europa Island</VALUEMEANING>
          <MEANINGDESCRIPTION>Europa Island</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Coral Sea Islands</VALIDVALUE>
          <VALUEMEANING>Coral Sea Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Coral Sea Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clipperton Island</VALIDVALUE>
          <VALUEMEANING>Clipperton Island</VALUEMEANING>
          <MEANINGDESCRIPTION>Clipperton Island</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Burma</VALIDVALUE>
          <VALUEMEANING>Burma</VALUEMEANING>
          <MEANINGDESCRIPTION>Burma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brunei</VALIDVALUE>
          <VALUEMEANING>Brunei</VALUEMEANING>
          <MEANINGDESCRIPTION>Brunei</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bassas da India</VALIDVALUE>
          <VALUEMEANING>Bassas da India</VALUEMEANING>
          <MEANINGDESCRIPTION>Bassas da India</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Baker Island</VALIDVALUE>
          <VALUEMEANING>Baker Island</VALUEMEANING>
          <MEANINGDESCRIPTION>Baker Island</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ashmore and Cartier Islands</VALIDVALUE>
          <VALUEMEANING>Ashmore and Cartier Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Ashmore and Cartier Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Congo, Republic of the</VALIDVALUE>
          <VALUEMEANING>Congo</VALUEMEANING>
          <MEANINGDESCRIPTION>Congo</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574025</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cote d&#39;Ivoire</VALIDVALUE>
          <VALUEMEANING>Cote d&#39;Ivoire</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Western Africa, bordering the North Atlantic Ocean, between Ghana and Liberia. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16762</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578969</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zaire</VALIDVALUE>
          <VALUEMEANING>Zaire</VALUEMEANING>
          <MEANINGDESCRIPTION>Zaire</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>West Bank</VALIDVALUE>
          <VALUEMEANING>West Bank</VALUEMEANING>
          <MEANINGDESCRIPTION>West Bank</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wake Island</VALIDVALUE>
          <VALUEMEANING>Wake Island</VALUEMEANING>
          <MEANINGDESCRIPTION>Wake Island</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Virgin Islands</VALIDVALUE>
          <VALUEMEANING>Virgin Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Virgin Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spratly Islands</VALIDVALUE>
          <VALUEMEANING>Spratly Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Spratly Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serbia</VALIDVALUE>
          <VALUEMEANING>Serbia</VALUEMEANING>
          <MEANINGDESCRIPTION>A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3119206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Samoa</VALIDVALUE>
          <VALUEMEANING>Samoa</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578997</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Saint Martin</VALIDVALUE>
          <VALUEMEANING>Saint Martin</VALUEMEANING>
          <MEANINGDESCRIPTION>Saint Martin</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Saint Barthelemy</VALIDVALUE>
          <VALUEMEANING>Saint Barthelemy</VALUEMEANING>
          <MEANINGDESCRIPTION>An island in the Caribbean sea, between Saint Martin and Saint Kitts and Nevis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C83609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3118626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paracel Islands</VALIDVALUE>
          <VALUEMEANING>Paracel Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Paracel Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3152164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Turks and Caicos Islands</VALIDVALUE>
          <VALUEMEANING>Turks &amp; Caicos Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Turks and Caicos Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Venezuela</VALIDVALUE>
          <VALUEMEANING>Venezuela</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ascension Island</VALIDVALUE>
          <VALUEMEANING>Ascension Island</VALUEMEANING>
          <MEANINGDESCRIPTION>Ascension Island</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Andorra</VALIDVALUE>
          <VALUEMEANING>Andorra</VALUEMEANING>
          <MEANINGDESCRIPTION>Andorra</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bermuda</VALIDVALUE>
          <VALUEMEANING>Bermuda</VALUEMEANING>
          <MEANINGDESCRIPTION>Bermuda</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bolivia</VALIDVALUE>
          <VALUEMEANING>Bolivia</VALUEMEANING>
          <MEANINGDESCRIPTION>Bolivia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brazil</VALIDVALUE>
          <VALUEMEANING>Brazil</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Eastern South America, bordering the Atlantic Ocean. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16364</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bahamas, The</VALIDVALUE>
          <VALUEMEANING>Bahamas</VALUEMEANING>
          <MEANINGDESCRIPTION>Bahamas</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16321</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bhutan</VALIDVALUE>
          <VALUEMEANING>Bhutan</VALUEMEANING>
          <MEANINGDESCRIPTION>Bhutan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bouvet Island</VALIDVALUE>
          <VALUEMEANING>Bouvet Island</VALUEMEANING>
          <MEANINGDESCRIPTION>Bouvet Island</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20104</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Botswana</VALIDVALUE>
          <VALUEMEANING>Botswana</VALUEMEANING>
          <MEANINGDESCRIPTION>Botswana</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574023</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Belarus</VALIDVALUE>
          <VALUEMEANING>Belarus</VALUEMEANING>
          <MEANINGDESCRIPTION>Belarus</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Belize</VALIDVALUE>
          <VALUEMEANING>Belize</VALUEMEANING>
          <MEANINGDESCRIPTION>Belize</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16331</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Canada</VALIDVALUE>
          <VALUEMEANING>Canada</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bosnia and Herzegovina</VALIDVALUE>
          <VALUEMEANING>Bosnia-Herzegovina</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southeastern Europe, bordering the Adriatic Sea and Croatia. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16361</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Azerbaijan</VALIDVALUE>
          <VALUEMEANING>Azerbaijan</VALUEMEANING>
          <MEANINGDESCRIPTION>Azerbaidjan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central African Republic</VALIDVALUE>
          <VALUEMEANING>Central African Republic</VALUEMEANING>
          <MEANINGDESCRIPTION>Central African Republic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Switzerland</VALIDVALUE>
          <VALUEMEANING>Switzerland</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Central Europe, east of France, north of Italy. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17181</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cook Islands</VALIDVALUE>
          <VALUEMEANING>Cook Islands</VALUEMEANING>
          <MEANINGDESCRIPTION>Cook Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chile</VALIDVALUE>
          <VALUEMEANING>Chile</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southern South America, bordering the South Atlantic Ocean and South Pacific Ocean, between Argentina and Peru. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cameroon</VALIDVALUE>
          <VALUEMEANING>Cameroon</VALUEMEANING>
          <MEANINGDESCRIPTION>Cameroon</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>China</VALIDVALUE>
          <VALUEMEANING>China</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in eastern Asia, bordering the East China Sea, Korea Bay, Yellow Sea, and South China Sea, south of Kazakhstan, Mongolia and Russia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574027</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colombia</VALIDVALUE>
          <VALUEMEANING>Colombia</VALUEMEANING>
          <MEANINGDESCRIPTION>Colombia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cocos (Keeling) Islands</VALIDVALUE>
          <VALUEMEANING>Cocos Isl.</VALUEMEANING>
          <MEANINGDESCRIPTION>Cocos (Keeling) Islands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Costa Rica</VALIDVALUE>
          <VALUEMEANING>Costa Rica</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Nicaragua and Panama. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574028</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cuba</VALIDVALUE>
          <VALUEMEANING>Cuba</VALUEMEANING>
          <MEANINGDESCRIPTION>An island between the Caribbean Sea and the North Atlantic Ocean, 150 km south of Key West, Florida. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563947</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cape Verde</VALIDVALUE>
          <VALUEMEANING>Cape Verde</VALUEMEANING>
          <MEANINGDESCRIPTION>Cape Verde</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574029</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Christmas Island</VALIDVALUE>
          <VALUEMEANING>Christmas Island</VALUEMEANING>
          <MEANINGDESCRIPTION>An Australian-administered island in the eastern Indian Ocean south of Java, Indonesia. (American Heritage Dictionary)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C44482</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyprus</VALIDVALUE>
          <VALUEMEANING>Cyprus</VALUEMEANING>
          <MEANINGDESCRIPTION>An island in the Mediterranean Sea, south of Turkey. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563948</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Czech Republic</VALIDVALUE>
          <VALUEMEANING>Czech Republic</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Central Europe, southeast of Germany. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Germany</VALIDVALUE>
          <VALUEMEANING>Germany</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563949</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Djibouti</VALIDVALUE>
          <VALUEMEANING>Djibouti</VALUEMEANING>
          <MEANINGDESCRIPTION>Djibouti</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Denmark</VALIDVALUE>
          <VALUEMEANING>Denmark</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn). (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dominica</VALIDVALUE>
          <VALUEMEANING>Dominica</VALUEMEANING>
          <MEANINGDESCRIPTION>Dominica</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dominican Republic</VALIDVALUE>
          <VALUEMEANING>Dominican Republic</VALUEMEANING>
          <MEANINGDESCRIPTION>Dominican Republic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Algeria</VALIDVALUE>
          <VALUEMEANING>Algeria</VALUEMEANING>
          <MEANINGDESCRIPTION>Algeria</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16274</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ecuador</VALIDVALUE>
          <VALUEMEANING>Ecuador</VALUEMEANING>
          <MEANINGDESCRIPTION>Ecuador</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estonia</VALIDVALUE>
          <VALUEMEANING>Estonia</VALUEMEANING>
          <MEANINGDESCRIPTION>Estonia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Egypt</VALIDVALUE>
          <VALUEMEANING>Egypt</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16530</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Western Sahara</VALIDVALUE>
          <VALUEMEANING>Western Sahara</VALUEMEANING>
          <MEANINGDESCRIPTION>Western Sahara</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20113</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563956</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eritrea</VALIDVALUE>
          <VALUEMEANING>Eritrea</VALUEMEANING>
          <MEANINGDESCRIPTION>Eritrea</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spain</VALIDVALUE>
          <VALUEMEANING>Spain</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17152</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethiopia</VALIDVALUE>
          <VALUEMEANING>Ethiopia</VALUEMEANING>
          <MEANINGDESCRIPTION>Ethiopia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563959</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Finland</VALIDVALUE>
          <VALUEMEANING>Finland</VALUEMEANING>
          <MEANINGDESCRIPTION>A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. (CIA World Factbook 2002)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fiji</VALIDVALUE>
          <VALUEMEANING>Fiji</VALUEMEANING>
          <MEANINGDESCRIPTION>Fiji</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16582</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Europe</VALIDVALUE>
          <VALUEMEANING>Europe</VALUEMEANING>
          <MEANINGDESCRIPTION>The continent whose boundaries are the Atlantic Ocean in the west, the Arctic Ocean to the north, the Ural Mountains and Ural River in the east, the Caspian Sea, Caucasus mountains and Black Sea in the southeast and the Mediterranean Sea in the south.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26274</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4512828</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asia</VALIDVALUE>
          <VALUEMEANING>Asia</VALUEMEANING>
          <MEANINGDESCRIPTION>The world&#39;s largest continent; it occupies the eastern part of the Eurasian landmass and its adjacent islands and is separated from Europe by the Ural Mountains.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5356418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Africa</VALIDVALUE>
          <VALUEMEANING>Africa</VALUEMEANING>
          <MEANINGDESCRIPTION>The continent located south of Europe and bordered to the west by the South Atlantic and to the east by the India Ocean.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oceania</VALIDVALUE>
          <VALUEMEANING>Oceania</VALUEMEANING>
          <MEANINGDESCRIPTION>A term used to refer to Polynesia (including New Zealand), Melanesia (including New Guinea), Micronesia as a whole, and Australia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12387692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prefer Not To Answer</VALIDVALUE>
          <VALUEMEANING>Prefer Not to Answer</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual prefers or preferred not to answer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5684650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>South or Central America</VALIDVALUE>
          <VALUEMEANING>South America Or Central America</VALUEMEANING>
          <MEANINGDESCRIPTION>South America is a continent of the western hemisphere with most of its area in the southern hemisphere.  It is situated between the Pacific Ocean and the Atlantic Ocean and is attached at the north to North America by the Isthmus of Panama._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._The isthmus joining North America and South America, extending from the southern border of Mexico to the northern border of Colombia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90602, C37998, C26277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12390791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Country in which patient is r</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Country in which patient is receiving therapy:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="408">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6764291</PUBLICID>
    <LONGNAME>Patient Mixed Phenotype Acute Leukemia Eligibility Determination Yes No Unknown Indicator</LONGNAME>
    <PREFERREDNAME>MPAL_ELIG_YES_NO_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The response to a question asking whether a patient is eligible to be considered MPAL.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6764290</PublicId>
      <PreferredName>2233604v1.0:6764288v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._An acute leukemia of ambiguous lineage.  It is characterized by the presence of either separate populations of blasts of more than one lineage, or one population of blasts co-expressing markers of more than one lineage._The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.</PreferredDefinition>
      <LongName>Patient Mixed Phenotype Acute Leukemia Eligibility Determination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6764288</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C82179:C25171</PreferredName>
        <Version>1</Version>
        <LongName>Mixed Phenotype Acute Leukemia Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82179</PREFERRED_NAME>
            <LONG_NAME>Mixed Phenotype Acute Leukemia</LONG_NAME>
            <CON_ID>6764287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is the patient eligible based</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the patient eligible based on the WHO 2016 criteria for MPAL?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient been diagnosed with mixed phenotype acute leukemia (MPAL)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="409">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6788012</PUBLICID>
    <LONGNAME>Human Papillomavirus Transforming Protein E6 E7 mRNA Reverse Transcriptase-Polymerase Chain Reaction Performed Indicator</LONGNAME>
    <PREFERREDNAME>HPVE6E7_MRNA_PCR_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The text response indicating whether Human Papillomavirus E6/E7 mRNA status was assessed using a polymerase chain reaction assay.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HCMI:Human Cancer Models Initiative</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6776683</PublicId>
      <PreferredName>6776671v1.0:6776681v1.0</PreferredName>
      <PreferredDefinition>Binds to and promotes degradation of p53 protein resulting in disruption of cell cycle regulation._Protein E7 (98 aa, ~11 kDa) is encoded by the human papillomavirus type 16 E7 gene. This protein is involved in the modulation of the activity of both retinoblastoma protein and histone deacetylases in the infected host cell, which is associated with viral genome replication and host cell transformation._Any RNA molecule that is the product of transcription of a human papillomavirus gene and contains coding information that can be translated into the amino acid sequence of a protein._A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Papillomavirus Transforming Protein E6 Protein E7, Human Papillomavirus Type 16 Human Papillomavirus mRNA Reverse Transcriptase-Polymerase Chain Reaction Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6776671</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19170:C1179:C156861</PreferredName>
        <Version>1</Version>
        <LongName>Papillomavirus Transforming Protein E6 Protein E7, Human Papillomavirus Type 16 Human Papillomavirus mRNA</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19170</PREFERRED_NAME>
            <LONG_NAME>Papillomavirus Transforming Protein E6</LONG_NAME>
            <CON_ID>3865431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1179</PREFERRED_NAME>
            <LONG_NAME>Protein E7, Human Papillomavirus Type 16</LONG_NAME>
            <CON_ID>3589770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C156861</PREFERRED_NAME>
            <LONG_NAME>Human Papillomavirus mRNA</LONG_NAME>
            <CON_ID>6601414</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6776681</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18136:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Reverse Transcriptase-Polymerase Chain Reaction Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18136</PREFERRED_NAME>
            <LONG_NAME>Reverse Transcriptase-Polymerase Chain Reaction</LONG_NAME>
            <CON_ID>2202804</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HCMI:Human Cancer Models Initiative</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was HPV-E6/E7 mRNA RT-PCR per</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was HPV-E6/E7 mRNA RT-PCR performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000454</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="410">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6788033</PUBLICID>
    <LONGNAME>PAX3 Gene Chromosomal Translocation Analysis Performed Indicator</LONGNAME>
    <PREFERREDNAME>PAX3_TNLOC_PRFM_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether or not an analysis for translocation in the PAX3 gene was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HCMI:Human Cancer Models Initiative</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6787418</PublicId>
      <PreferredName>6787416v1.0:6776714v1.0</PreferredName>
      <PreferredDefinition>This gene plays a role in the transcriptional activation of target genes. It is involved in melanogenesis, neurogenesis and skeletal muscle development._A genetic exchange where a piece of one chromosome is transfered to another chromosome._Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it._Executed and carried through to completion.</PreferredDefinition>
      <LongName>PAX3 Gene Chromosomal Translocation Analysis Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6787416</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C24658</PreferredName>
        <Version>1</Version>
        <LongName>PAX3 Gene</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C24658</PREFERRED_NAME>
            <LONG_NAME>PAX3 Gene</LONG_NAME>
            <CON_ID>3729298</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6776714</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3420:C25391:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Chromosomal Translocation Analysis Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3420</PREFERRED_NAME>
            <LONG_NAME>Chromosomal Translocation</LONG_NAME>
            <CON_ID>2206260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HCMI:Human Cancer Models Initiative</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was PAX3 translocation analys</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was PAX3 translocation analysis performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000454</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="411">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6790015</PUBLICID>
    <LONGNAME>Time of Reference Time Point</LONGNAME>
    <PREFERREDNAME>OERFTTIM</PREFERREDNAME>
    <PREFERREDDEFINITION>The time for a fixed reference time point related to ophthalmic examinations.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6789717</PublicId>
      <PreferredName>6789652v1.0:6783946v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to ophthalmic examinations._The time for a fixed reference time point.</PreferredDefinition>
      <LongName>Ophthalmic Examinations Domain Time of Reference Time Point</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6789652</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C147180</PreferredName>
        <Version>1</Version>
        <LongName>Ophthalmic Examinations Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C147180</PREFERRED_NAME>
            <LONG_NAME>Ophthalmic Examinations Domain</LONG_NAME>
            <CON_ID>6789651</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6783946</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C158112</PreferredName>
        <Version>1</Version>
        <LongName>Time of Reference Time Point</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C158112</PREFERRED_NAME>
            <LONG_NAME>Time of Reference Time Point</LONG_NAME>
            <CON_ID>6663758</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6341396</PublicId>
      <PreferredName>CDISCTIM</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The continuum of experience in which events pass from the future through the present to the past.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396937</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25207</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Time of Reference Time Point</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Time of Reference Time Point</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the time of the [Reference Time point]?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDTM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7218795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ophthalmic Examinations (OE) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7330204</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Ophthalmic Examinations (OE) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943397</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OE</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OERFTTIM</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>OE_OERFTTIM</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="412">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6790160</PUBLICID>
    <LONGNAME>PBRM1 Gene Mutation Abnormality Identified Indicator</LONGNAME>
    <PREFERREDNAME>PBRM1_GEN_MUT_ID_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The text response indicating whether a mutation was identified while performing the PBRM1 gene mutation analysis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HCMI:Human Cancer Models Initiative</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6789188</PublicId>
      <PreferredName>6789169v1.0:6060068v1.0</PreferredName>
      <PreferredDefinition>Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._The procedure of having an identity established._This gene plays a role in chromatin remodeling.</PreferredDefinition>
      <LongName>PBRM1 Gene Mutation Abnormality Identified</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6789169</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95438</PreferredName>
        <Version>1</Version>
        <LongName>PBRM1 Gene</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95438</PREFERRED_NAME>
            <LONG_NAME>PBRM1 Gene</LONG_NAME>
            <CON_ID>4792072</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6060068</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45576:C25737</PreferredName>
        <Version>1</Version>
        <LongName>Mutation Abnormality Identification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45576</PREFERRED_NAME>
            <LONG_NAME>Mutation Abnormality</LONG_NAME>
            <CON_ID>2532673</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25737</PREFERRED_NAME>
            <LONG_NAME>Identification</LONG_NAME>
            <CON_ID>2203822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HCMI:Human Cancer Models Initiative</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a mutation in PBRM1 ident</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was a mutation in PBRM1 identified?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Renal Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6788377</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="413">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6790451</PUBLICID>
    <LONGNAME>Link ID</LONGNAME>
    <PREFERREDNAME>RPLNKID</PREFERREDNAME>
    <PREFERREDDEFINITION>A sequence of characters used as a linkage between related reproductive system findings identifier records.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6790422</PublicId>
      <PreferredName>6408578v1.0:6790420v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to reproductive system findings._A sequence of characters used as a linkage between related reproductive system findings identifier records.</PreferredDefinition>
      <LongName>Reproductive System Findings Domain Reproductive System Findings Link Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6408578</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102707</PreferredName>
        <Version>1</Version>
        <LongName>Reproductive System Findings Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102707</PREFERRED_NAME>
            <LONG_NAME>Reproductive System Findings Domain</LONG_NAME>
            <CON_ID>6408577</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6790420</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C162024</PreferredName>
        <Version>1</Version>
        <LongName>Reproductive System Findings Link Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C162024</PREFERRED_NAME>
            <LONG_NAME>Reproductive System Findings Link Identifier</LONG_NAME>
            <CON_ID>6788228</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6353492</PublicId>
      <PreferredName>CDISCID</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396665</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25364</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Link ID</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Link ID</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[Domain/Observation] Link Identifier</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDTM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7218795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Reproductive System Findings (RP) domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7331370</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Reproductive System Findings (RP) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RP</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RPLNKID</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>RP_RPLNKID</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="414">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6790597</PUBLICID>
    <LONGNAME>Result or Finding in Original Units</LONGNAME>
    <PREFERREDNAME>URORRES</PREFERREDNAME>
    <PREFERREDDEFINITION>The outcome of the urinary system finding as originally received or collected.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6790581</PublicId>
      <PreferredName>6790567v1.0:6789426v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to urinary system findings._The outcome of the test or finding as originally received or collected.</PreferredDefinition>
      <LongName>Urinary System Findings Domain Original Result or Finding</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6790567</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102726</PreferredName>
        <Version>1</Version>
        <LongName>Urinary System Findings Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102726</PREFERRED_NAME>
            <LONG_NAME>Urinary System Findings Domain</LONG_NAME>
            <CON_ID>6790566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6789426</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117221</PreferredName>
        <Version>1</Version>
        <LongName>Original Result or Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117221</PREFERRED_NAME>
            <LONG_NAME>Original Result or Finding</LONG_NAME>
            <CON_ID>6789425</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6400810</PublicId>
      <PreferredName>CDISCRES</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The result of an action.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6400811</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C20200</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Result or Finding in Original</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Result or Finding in Original Units</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What [is/was] the [result/amount/(subject&#39;s) characteristic] (of the [measurement/test/examination/question/assessment])?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDTM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7218795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Urinary System Findings (UR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7331365</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Urinary System Findings (UR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>UR</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>URORRES</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>UR_URORRES</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="415">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6944832</PUBLICID>
    <LONGNAME>Assessment Discontinuation Reason Text</LONGNAME>
    <PREFERREDNAME>RSDRSTXT</PREFERREDNAME>
    <PREFERREDDEFINITION>Text specification of the reason the tumor assessment using Immune Response Evaluation Criteria in Solid Tumors (iRECIST) was stopped.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCI CRF Standards</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6944829</PublicId>
      <PreferredName>6608777v1.0:6944830v1.0</PreferredName>
      <PreferredDefinition>A domain for disease response evaluations._The final result of a determination of the value, significance, or extent of._To stop or end, permanently or temporarily._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Disease Response Domain Assessment Discontinue Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6608777</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C107097</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107097</PREFERRED_NAME>
            <LONG_NAME>Disease Response Domain</LONG_NAME>
            <CON_ID>6608776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6944830</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25217:C25484:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Discontinue Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25484</PREFERRED_NAME>
            <LONG_NAME>Discontinue</LONG_NAME>
            <CON_ID>2203906</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCI CRF Standards</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify reason</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify reason</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If yes, reason:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RECIST - CDISC Aligned </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6921972</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>iRECIST - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6921974</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="416">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7028297</PUBLICID>
    <LONGNAME>Para-aortic Sentinel Lymph Node Examined Count</LONGNAME>
    <PREFERREDNAME>PRATC_SNTLN_EX_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>The numeric response that indicates the number of paraaortic sentinel lymph nodes examined.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HCMI:Human Cancer Models Initiative</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7027518</PublicId>
      <PreferredName>7027516v1.0:2330418v1.0</PreferredName>
      <PreferredDefinition>A lymph node located adjacent to the lumbar region of the spine._The first lymph node to which cancer is likely to spread from the primary tumor. Cancer cells may appear first in the sentinel node before spreading to other lymph nodes._Having been subjected to inspection or evaluation.</PreferredDefinition>
      <LongName>Paraaortic Lymph Node Sentinel Lymph Node Examined</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7027516</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C77643:C12947</PreferredName>
        <Version>1</Version>
        <LongName>Paraaortic Lymph Node Sentinel Lymph Node</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C77643</PREFERRED_NAME>
            <LONG_NAME>Paraaortic Lymph Node</LONG_NAME>
            <CON_ID>3137526</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12947</PREFERRED_NAME>
            <LONG_NAME>Sentinel Lymph Node</LONG_NAME>
            <CON_ID>2202807</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2330418</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25500</PreferredName>
        <Version>1</Version>
        <LongName>Examined</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25500</PREFERRED_NAME>
            <LONG_NAME>Examined</LONG_NAME>
            <CON_ID>2203928</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HCMI:Human Cancer Models Initiative</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018392</PublicId>
      <PreferredName>CT</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of para-aortic sentine</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of para-aortic sentinel nodes examined</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Endometrial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7026248</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="417">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7050283</PUBLICID>
    <LONGNAME>Sex Gender Type</LONGNAME>
    <PREFERREDNAME>DMSXGEN</PREFERREDNAME>
    <PREFERREDDEFINITION>Sex of the subject as determined by the investigator.  </PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCI CRF Standards</ORIGIN>
    <REGISTRATIONSTATUS>Superseded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6412386</PublicId>
      <PreferredName>6409089v1.0:2403945v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to demographics._The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female.</PreferredDefinition>
      <LongName>Demographics Domain Sex</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6409089</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49572</PreferredName>
        <Version>1</Version>
        <LongName>Demographics Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49572</PREFERRED_NAME>
            <LONG_NAME>Demographics Domain</LONG_NAME>
            <CON_ID>2469053</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2403945</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28421</PreferredName>
        <Version>1</Version>
        <LongName>Sex</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28421</PREFERRED_NAME>
            <LONG_NAME>Sex</LONG_NAME>
            <CON_ID>2403944</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222445</PublicId>
      <PreferredName>PRSN_GENDER_TXT_TP</PreferredName>
      <PreferredDefinition>Text designations that identify gender.   Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles.</PreferredDefinition>
      <LongName>Person Gender Text Type</LongName>
      <Version>2</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008552</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PHYS_DESC_OF_INDS</PreferredName>
        <Version>1</Version>
        <LongName>Physical Description of Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>13</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCISTD: NCI CRF Harmonization and Standards Initiative</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Male</VALIDVALUE>
          <VALUEMEANING>Male</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who belongs to the sex that normally produces sperm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-07-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unspecified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-07-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Female</VALIDVALUE>
          <VALUEMEANING>Female</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who belongs to the sex that normally produces ova.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-07-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Reported</VALIDVALUE>
          <VALUEMEANING>Not Reported</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intersex</VALIDVALUE>
          <VALUEMEANING>Intersex</VALUEMEANING>
          <MEANINGDESCRIPTION>A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Gender</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Gender</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 2200604 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCIP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Sex</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Demography - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318327</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15689233</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HHS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Completed</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15910169</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>sex</AlternateName>
        <AlternateNameType>VM Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="418">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7063884</PUBLICID>
    <LONGNAME>Clinical Trial Ineligibility Reason Text</LONGNAME>
    <PREFERREDNAME>DSIERSNX</PREFERREDNAME>
    <PREFERREDDEFINITION>The reason a patient was not able to participate in a clinical trial not previously listed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCI CRF Standards</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7063446</PublicId>
      <PreferredName>2859364v1.0:7063444v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition._A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes._The state or quality of being disqualified by law, rule, or provision._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Disposition Domain Clinical Trial Ineligibility Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859364</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49576</PreferredName>
        <Version>1</Version>
        <LongName>Disposition Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49576</PREFERRED_NAME>
            <LONG_NAME>Disposition Domain</LONG_NAME>
            <CON_ID>2469056</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7063444</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71104:C40412:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Ineligibility Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71104</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial</LONG_NAME>
            <CON_ID>2735720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40412</PREFERRED_NAME>
            <LONG_NAME>Ineligibility</LONG_NAME>
            <CON_ID>2204007</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCI CRF Standards</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 2960892 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify reason patient not ab</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify reason patient not able to participate in trial</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If None of the above, specify the reason:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 001</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the reason why the patient was not able to participate in the trial:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify reason patient not able to participate in trial</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify reason patient not able to participate in trial</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318331</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Eligibility</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7473984</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SUPPIE_QVAL_IETEST</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="419">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7072113</PUBLICID>
    <LONGNAME>DICOM Image Pixel Measurement Sequence Text</LONGNAME>
    <PREFERREDNAME>PXLMSSEQ</PREFERREDNAME>
    <PREFERREDDEFINITION>The description of the physical characteristics of the pixels in the frame.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCI CRF Standards</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7071775</PublicId>
      <PreferredName>7071772v1.0:7071773v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to device-in-use._A comprehensive set of standards for communications between medical imaging devices, including handling, storing and transmitting information in medical imaging. It includes a file format definition and a network communication protocol._Any record of an imaging event whether physical or electronic._The smallest resolvable rectangular area of an image, either on a screen or stored in memory._Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard._A serial arrangement in which things follow in logical order or a recurrent pattern.</PreferredDefinition>
      <LongName>Device-In-Use Domain DICOM Image Pixel Measurement Sequence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7071772</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102622</PreferredName>
        <Version>1</Version>
        <LongName>Device-In-Use Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102622</PREFERRED_NAME>
            <LONG_NAME>Device-In-Use Domain</LONG_NAME>
            <CON_ID>7071771</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7071773</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>7071773v1.0</PreferredName>
        <Version>1</Version>
        <LongName>DICOM Image Pixel Measurement Sequence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49059</PREFERRED_NAME>
            <LONG_NAME>DICOM</LONG_NAME>
            <CON_ID>2553610</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48367</PREFERRED_NAME>
            <LONG_NAME>Pixel</LONG_NAME>
            <CON_ID>2413294</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25673</PREFERRED_NAME>
            <LONG_NAME>Sequence</LONG_NAME>
            <CON_ID>2203798</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCI CRF Standards</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pixel Measures Sequence</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pixel Measures Sequence</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 2717692 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the pixel measures sequence?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Pixel measures sequence</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PET - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318349</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PET Emissions Scan - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318350</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC PET Scan</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7590133</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DU_DUORRES_PXLMSSEQ</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="420">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7123035</PUBLICID>
    <LONGNAME>Antineoplastic Agent Therapeutic Procedure During Clinical Trial Period Begin Yes No Unknown Not Applicable Indicator</LONGNAME>
    <PREFERREDNAME>ANTI_TX_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not anti-cancer therapy was started during the clinical trial period.</PREFERREDDEFINITION>
    <VERSION>1.1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7123034</PublicId>
      <PreferredName>7123031v1.0:7123032v1.0</PreferredName>
      <PreferredDefinition>A substance that inhibits the maturation, growth or spread of tumor cells._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._At some point in a given period of time._A possibly-repeating collection of consecutive days that define the length of a Study Segment_Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins.</PreferredDefinition>
      <LongName>Antineoplastic Agent Therapeutic Procedure During Clinical Trial Period Begin</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7123031</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C274:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Antineoplastic Agent Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C274</PREFERRED_NAME>
            <LONG_NAME>Antineoplastic Agent</LONG_NAME>
            <CON_ID>2751673</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7123032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25490:C71737:C25431</PreferredName>
        <Version>1</Version>
        <LongName>During Clinical Trial Period Begin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71737</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Period</LONG_NAME>
            <CON_ID>2732740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the patient start any ant</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the patient start any anti-cancer therapy during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient receive any anti-cancer therapy during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="421">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7171842</PUBLICID>
    <LONGNAME>ECOG Performance Status Outcome Clinical Trial Eligibility Criteria Confirmation Status</LONGNAME>
    <PREFERREDNAME>ELIG_ECOGPS_CONF</PREFERREDNAME>
    <PREFERREDDEFINITION>Verification that the patient meets the ECOG Performance Status eligibility criteria outlined in the study protocol.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5893180</PublicId>
      <PreferredName>5893177v1.0:5893178v1.0</PreferredName>
      <PreferredDefinition>A performance status scale designed to assess disease progression and its affect on the daily living abilities of the patient._The result of an action._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>ECOG Performance Status Outcome Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5893177</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C105721</PreferredName>
        <Version>1</Version>
        <LongName>ECOG Performance Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C105721</PREFERRED_NAME>
            <LONG_NAME>ECOG Performance Status</LONG_NAME>
            <CON_ID>5893176</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5893178</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20200:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Outcome Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5676955</PublicId>
      <PreferredName>CONFSTAT</PreferredName>
      <PreferredDefinition>Having been established or verified._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Confirmation Status</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>11</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
      <Representation>
        <PublicId>7329879</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25458:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Confirmation Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25458</PREFERRED_NAME>
            <LONG_NAME>Confirmation</LONG_NAME>
            <CON_ID>2203883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unconfirmed</VALIDVALUE>
          <VALUEMEANING>Negation Confirmation</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Having been established or verified.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25594, C25458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5676956</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Confirmed</VALIDVALUE>
          <VALUEMEANING>Confirmation</VALUEMEANING>
          <MEANINGDESCRIPTION>Having been established or verified.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3953314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>EA1183 - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient has an ECOG Performance (PS) &lt;/=2.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Patient has an ECOG Performan</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Patient has an ECOG Performance (PS) less than/equal to 2.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>EAQ191 - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient must have an ECOG performance status 0-2</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>EAQ202</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient must have an ECOG performance status 0-3.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="422">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7215585</PUBLICID>
    <LONGNAME>Gemtuzumab Ozogamicin Dose Administered 0 Decimal Place Milligram per Square Meter Value</LONGNAME>
    <PREFERREDNAME>7206463v1.0:7283690v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The 0 decimal place milligram per square meter numeric value for the dose of gemtuzumab ozogamicin that was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7206463</PublicId>
      <PreferredName>7267616v1.0:2233610v1.0</PreferredName>
      <PreferredDefinition>A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin.  In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis. (NCI04)_The act of having given something (e.g., a medication or test)._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.</PreferredDefinition>
      <LongName>Gemtuzumab Ozogamicin Dose Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7267616</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1806:C25488</PreferredName>
        <Version>1</Version>
        <LongName>Gemtuzumab Ozogamicin Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1806</PREFERRED_NAME>
            <LONG_NAME>Gemtuzumab Ozogamicin</LONG_NAME>
            <CON_ID>2466311</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7283690</PublicId>
      <PreferredName>7283690v1.0</PreferredName>
      <PreferredDefinition>A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._A number with no fractional part, including the negative and positive numbers as well as zero.::0_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A metric unit of areal density equal to approximately 2.94935E-5 ounce per square yard. Also used as a dose calculation unit._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Medication Dose 0 Decimal Place Milligram per Square Meter Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>mg/m2</UnitOfMeasure>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>7283689</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>7283689v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Medication Dose Integer::0 Decimal Place Milligram per Square Meter Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67402</PREFERRED_NAME>
            <LONG_NAME>Milligram per Square Meter</LONG_NAME>
            <CON_ID>2725140</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the dose of gemtuzuma</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify the dose of gemtuzumab ozogamicin that was administered:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify dose administered:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify dose administered:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify dose administered:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify dose administered:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="423">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7222869</PUBLICID>
    <LONGNAME>Patient Demyelinating Disorder Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>PT_DEMYTN_DIS_CD_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded response to questions which are necessary to allow a person to participate in a clinical study that are related to a broad group of disorders that affect the myelin sheaths that cover the neurons as outlined in the study protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7222868</PublicId>
      <PreferredName>2233604v1.0:7222866v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._A broad group of disorders that affect the myelin sheaths that cover the neurons. Myelin sheathes cover neuronal axons in the central and peripheral nervous system and function to increase travelling impulse speeds. Disruption of this sheath impairs neuronal transmission and can result in disorders such as multiple sclerosis and Guillain-Barre syndrome, among others._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Patient Demyelinating Disorder Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7222866</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C34527:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Demyelinating Disorder Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C34527</PREFERRED_NAME>
            <LONG_NAME>Demyelinating Disorder</LONG_NAME>
            <CON_ID>7222865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have any form of</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have any form of demyelinating disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have a known history of demyelinating disease, such as multiple sclerosis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876359</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Exclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical &amp; Concomitant Requirements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000083</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="424">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7239077</PUBLICID>
    <LONGNAME>FACT-ICM Toxicity Questionnaire 23 How True Past 7 Days Bothered by Short-term Treatment Reactions Experienced Immediately After or Within 24 Hours of an Infusion Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>FACTICM_23_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated observation of how true in the past 7 days they were bothered by short-term treatment reactions that they experience immediately after, or within 24 hours of, an infusion, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FACT-ICM Based:Based on Functional Assessment Cancer Therapy - Immune Checkpoint Modulator</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7222830</PublicId>
      <PreferredName>7222797v1.0:7239048v1.0</PreferredName>
      <PreferredDefinition>A health related quality of life questionnaire designed to record patient reported outcomes in patients receiving immune checkpoint modulator (ICM) therapy._A question about an individual&#39;s agreement with a statement._The most recent week. May include the present day._A question about whether an individual is or was bothered by short-term treatment reactions that they experienced immediately after, or within 24 hours of, an infusion.</PreferredDefinition>
      <LongName>FACT-ICM Toxicity Questionnaire How True Past Week Bothered by Short-term Treatment Reactions Experienced Immediately After or Within 24 Hours of an Infusion</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7222797</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C170845</PreferredName>
        <Version>1</Version>
        <LongName>FACT-ICM Toxicity Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C170845</PREFERRED_NAME>
            <LONG_NAME>FACT-ICM Toxicity Questionnaire</LONG_NAME>
            <CON_ID>7211812</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7239048</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C91781:C95402:C170852</PreferredName>
        <Version>1</Version>
        <LongName>How True Past Week Bothered by Short-term Treatment Reactions Experienced Immediately After or Within 24 Hours of an Infusion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91781</PREFERRED_NAME>
            <LONG_NAME>How True Question</LONG_NAME>
            <CON_ID>3133350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C170852</PREFERRED_NAME>
            <LONG_NAME>Bothered by Short-term Treatment Reactions Experienced Immediately After or Within 24 Hours of an Infusion Question</LONG_NAME>
            <CON_ID>7211920</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4552765</PublicId>
      <PreferredName>4552765v1.0</PreferredName>
      <PreferredDefinition>Numeric scores from 0 (Not at all) to 4 (Very Much) on a Likert scale used on FACT questionnaires.</PreferredDefinition>
      <LongName>FACT Score 5 Point Likert Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>FACT-G:Functional Assessment of Cancer Therapy - General, David Cella, Ph.D., Version 4, Nov. 2007</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Some-what</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a great amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I am bothered by short-term t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I am bothered by short-term treatment reactions that I experience immediately after, or within 24 hours of, an infusion (such as chills, dizziness, hives, rashes lasting no more than 24 hours)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACIT/FACT</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5918014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-ICM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7235622</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="425">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7315365</PUBLICID>
    <LONGNAME>Regular Physical Activity Past 2 Weeks Participation Count</LONGNAME>
    <PREFERREDNAME>7318629v1.0:2018392v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The average number times of participation in regular physical activity in the past 2 weeks.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7318629</PublicId>
      <PreferredName>4960938v1.0:7435701v1.0</PreferredName>
      <PreferredDefinition>Customary, usual, or at fixed intervals; conforming to a standard or pattern._Any form of exercise or movement. Physical activity may include planned activity such as walking, running, basketball, or other sports. Physical activity may also include other daily activities such as household chores, yard work, walking the dog, etc._A period of time consisting of the 14 days before the present._The act of taking part in an activity.</PreferredDefinition>
      <LongName>Regular Physical Activity Past 2 Weeks Participation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2513925</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43431</PreferredName>
        <Version>1</Version>
        <LongName>Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4960938</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25647:C17708</PreferredName>
        <Version>1</Version>
        <LongName>Regular Physical Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25647</PREFERRED_NAME>
            <LONG_NAME>Regular</LONG_NAME>
            <CON_ID>2203771</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17708</PREFERRED_NAME>
            <LONG_NAME>Physical Activity</LONG_NAME>
            <CON_ID>2202366</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7435701</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C126890:C25608</PreferredName>
        <Version>1</Version>
        <LongName>Past 2 Weeks Participation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126890</PREFERRED_NAME>
            <LONG_NAME>Past 2 Weeks</LONG_NAME>
            <CON_ID>5271604</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25608</PREFERRED_NAME>
            <LONG_NAME>Participation</LONG_NAME>
            <CON_ID>2206339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018392</PublicId>
      <PreferredName>CT</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the average number t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the average number times of regular participation in physical activity in the past 2 weeks?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of times you have been participating in any regular exercise program  in the past two weeks:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of times you have been participating in any regular exercise program  in the past two weeks:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How many times in the past two weeks have you been participating in any regular exercise program?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How many times in the past two weeks have you been participating in any regular exercise program?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How many times in the past two weeks have you been participating in any regular exercise program?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>How many times in the past two weeks have you been participating in any regular exercise program?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="426">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7334303</PUBLICID>
    <LONGNAME>Kaposi Sarcoma Related Edema Limb Anatomic Site</LONGNAME>
    <PREFERREDNAME>KS_R/T_ED_LIM_ANAT_SITE</PREFERREDNAME>
    <PREFERREDDEFINITION>information relating to the anatomic location of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related edema (pathological transudate within one or more tissues)._A body region referring to an upper or lower extremity._Named locations of or within the body.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2640458</PublicId>
      <PreferredName>KS_R/T_EDEMA_ANATLOC</PreferredName>
      <PreferredDefinition>information relating to the anatomic location of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related edema (pathological transudate within one or more tissues).</PreferredDefinition>
      <LongName>Kaposi Sarcoma Related Edema Anatomic Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2640430</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9087:C25648:C3002</PreferredName>
        <Version>1</Version>
        <LongName>Kaposi Sarcoma Related Edema</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9087</PREFERRED_NAME>
            <LONG_NAME>Kaposi Sarcoma</LONG_NAME>
            <CON_ID>2637488</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3002</PREFERRED_NAME>
            <LONG_NAME>Edema</LONG_NAME>
            <CON_ID>2202735</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2442487</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25421:C25341</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25421</PREFERRED_NAME>
            <LONG_NAME>Anatomic</LONG_NAME>
            <CON_ID>2202601</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7334298</PublicId>
      <PreferredName>7334298v1.0</PreferredName>
      <PreferredDefinition>A body region referring to an upper or lower extremity._Named locations of or within the body.</PreferredDefinition>
      <LongName>Limb Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>AMC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>7334297</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12429:C13717</PreferredName>
        <Version>1</Version>
        <LongName>Limb Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12429</PREFERRED_NAME>
            <LONG_NAME>Limb</LONG_NAME>
            <CON_ID>2443801</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left Hand</VALIDVALUE>
          <VALUEMEANING>Left Hand</VALUEMEANING>
          <MEANINGDESCRIPTION>Left; being or located on or directed toward the side of the body to the west when facing north.: The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32712, C25229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2860932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right Hand</VALIDVALUE>
          <VALUEMEANING>Right Hand</VALUEMEANING>
          <MEANINGDESCRIPTION>Right; being or located on or directed toward the side of the body to the east when facing north.: The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32712, C25228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2860933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left Arm</VALIDVALUE>
          <VALUEMEANING>Left Arm</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the west when facing north.: The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32141, C25229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right Arm</VALIDVALUE>
          <VALUEMEANING>Right Arm</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the east when facing north.: The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32141, C25228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4320224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left Foot</VALIDVALUE>
          <VALUEMEANING>Left foot</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the west when facing north.: The terminal part of the lower extremity, especially the part below the ankle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32622, C25229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412519</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right Foot</VALIDVALUE>
          <VALUEMEANING>Right foot</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the east when facing north.: The terminal part of the lower extremity, especially the part below the ankle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32622, C25228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left Calf</VALIDVALUE>
          <VALUEMEANING>Left Calf</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the west when facing north.: The posterior aspect of the lower extremity that extends from the knee to the foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93027, C25229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7334299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right Calf</VALIDVALUE>
          <VALUEMEANING>Right Calf Right Calf</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the east when facing north.: The posterior aspect of the lower extremity that extends from the knee to the foot.: Being or located on or directed toward the side of the body to the east when facing north.: The posterior aspect of the lower extremity that extends from the knee to the foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93027, C25228, C93027, C25228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7334300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left Ankle</VALIDVALUE>
          <VALUEMEANING>Left Ankle Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the west when facing north.: A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32078, C25229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7334301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right Ankle</VALIDVALUE>
          <VALUEMEANING>Right Ankle Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the east when facing north.: A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32078, C25228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7334302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Edema Site</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Edema Site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7312662</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QSLOC2</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="427">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7338128</PUBLICID>
    <LONGNAME>Patient Receive Local Palliative Radiation Therapy Anatomic Site Within Timepoint Eligibility Determination Indicator</LONGNAME>
    <PREFERREDNAME>PT_LOC_RAD_PERIOD_SITE_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator that indicates if the patient meets the eligibility requirements for participation in a clinical trial with regards to receiving local palliative radiation therapy to an anatomical site within the timepoint.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7338121</PublicId>
      <PreferredName>7498771v1.0:7498772v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._To take, accept, or get something offered._Of or belonging to a restricted area or locality._Any radiation treatment done with the intent to relieve symptoms and reduce the suffering caused by the cancer, and not with the intent of curing the cancer._Named locations of or within the body._On the inside; contained in._A specific point in the time continuum, including those established relative to an event._The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.</PreferredDefinition>
      <LongName>Patient Receive Local Palliative Radiation Therapy Anatomic Site Within Timepoint Eligibility Determination</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7498771</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C25639:C116433</PreferredName>
        <Version>1</Version>
        <LongName>Patient Receive Palliative Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C116433</PREFERRED_NAME>
            <LONG_NAME>Palliative Radiation Therapy</LONG_NAME>
            <CON_ID>4743020</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7498772</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717:C25282:C68568:C25171</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site Within Timepoint Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25282</PREFERRED_NAME>
            <LONG_NAME>Within</LONG_NAME>
            <CON_ID>2206273</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68568</PREFERRED_NAME>
            <LONG_NAME>Timepoint</LONG_NAME>
            <CON_ID>2656619</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the patient had palliativ</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the patient had palliative local XRT to any anatomical site within the body in last 4 weeks?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient had palliative local XRT to areas other than the chest or whole brain radiotherapy within 13 days from study enrollment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="428">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7339606</PUBLICID>
    <LONGNAME>Very Low Density Lipoprotein Cholesterol Measurement Laboratory Procedure Performed Result Value in mg/dL</LONGNAME>
    <PREFERREDNAME>7339605v1.0:2655757v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The 1 decimal place numeric laboratory value measured, assigned or computed related to the amount  of very low density lipoprotein cholesterol in the blood measured in milligrams per deciliter (mg/dL).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7339605</PublicId>
      <PreferredName>7343852v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>The determination of the amount of very low-density lipoprotein cholesterol present in a sample._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Very Low Density Lipoprotein Cholesterol Measurement Laboratory Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7343852</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C105589:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Very Low Density Lipoprotein Cholesterol Measurement Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C105589</PREFERRED_NAME>
            <LONG_NAME>Very Low Density Lipoprotein Cholesterol Measurement</LONG_NAME>
            <CON_ID>6407302</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2655757</PublicId>
      <PreferredName>2655757v1.0</PreferredName>
      <PreferredDefinition>A laboratory result using the metric measure of milligrams per deciliter (mg/dL).</PreferredDefinition>
      <LongName>Laboratory Result Value in mg/dL</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>mg/dL</UnitOfMeasure>
      <MaximumLength>6</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NHLBI FBPP:Family Blood Pressure Program</Origin>
      <Representation>
        <PublicId>2655756</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37984:C20200:C28253:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Result Milligram Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37984</PREFERRED_NAME>
            <LONG_NAME>Laboratory</LONG_NAME>
            <CON_ID>2202883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28253</PREFERRED_NAME>
            <LONG_NAME>Milligram</LONG_NAME>
            <CON_ID>2204828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the value of very low</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the value of very low density lipoprotein cholesterol in the blood measured in milligrams per deciliter (mg/dL)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>VLDL level:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>VLDL level:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>VLDL level:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>VLDL level:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="429">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7351035</PUBLICID>
    <LONGNAME>Telomere Length Laboratory Procedure Performed Known Unknown Indicator</LONGNAME>
    <PREFERREDNAME>7351034v1.0:2935542v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes if the telomere length was known or unknown.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7351034</PublicId>
      <PreferredName>7351032v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>The number of nucleotide base pairs located in the telomere of a chromosome. Telomere length decreases during each cell division and can be a marker for aging. Additionally, aberrant length can be an indicator of cell transformation._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Telomere Length Laboratory Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7351032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C129765:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Telomere Length Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C129765</PREFERRED_NAME>
            <LONG_NAME>Telomere Length</LONG_NAME>
            <CON_ID>5906682</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2935542</PublicId>
      <PreferredName>2935542v1.0</PreferredName>
      <PreferredDefinition>Recognized, familiar, or within the scope of knowledge._Not known, not observed, not recorded, or refused._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Known Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2935541</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C80137:C17998:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Known Unknown Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80137</PREFERRED_NAME>
            <LONG_NAME>Known</LONG_NAME>
            <CON_ID>2858228</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known</VALIDVALUE>
          <VALUEMEANING>Known</VALUEMEANING>
          <MEANINGDESCRIPTION>Recognized, familiar, or within the scope of knowledge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2934435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not known</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-25</PVBEGINDATE>
          <PVENDDATE>2013-09-04</PVENDDATE>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the telomere length known</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the telomere length known or unknown?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Telomere length (TL)</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Telomere length (TL)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Telomere length (TL)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Telomere length (TL)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="430">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7365662</PUBLICID>
    <LONGNAME>Exposed to COVID-19 Occurrence Last Date</LONGNAME>
    <PREFERREDNAME>EXPSUR_COVID19_LST_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>The last date of exposure to COVID-19.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7365592</PublicId>
      <PreferredName>7365590v1.0:2234856v1.0</PreferredName>
      <PreferredDefinition>A finding indicating that an individual has been exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Exposed to COVID-19 Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7365590</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C171571</PreferredName>
        <Version>1</Version>
        <LongName>Exposed to COVID-19</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C171571</PREFERRED_NAME>
            <LONG_NAME>Exposed to COVID-19</LONG_NAME>
            <CON_ID>7341040</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2192181</PublicId>
      <PreferredName>LAST_DT</PreferredName>
      <PreferredDefinition>the last date of an evaluation, assessment, or treatment.</PreferredDefinition>
      <LongName>Last Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yyyy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208025</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25551:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Last Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25551</PREFERRED_NAME>
            <LONG_NAME>Last</LONG_NAME>
            <CON_ID>2206286</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the last date of exp</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the last date of exposure to COVID-19.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Last Date of Contact</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Last Date of Contact</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7244861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COVID-19</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>WHO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7247342</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="431">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7372237</PUBLICID>
    <LONGNAME>Sign or Symptom Physiologic Resolution Date</LONGNAME>
    <PREFERREDNAME>SGN_SYMP_RSLT_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>The month, day and year of the sign or symptom resolution.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7372220</PublicId>
      <PreferredName>5255344v1.0:2503262v1.0</PreferredName>
      <PreferredDefinition>Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom)._Return to the normal structure and/or function, e.g. the subsidence of a pathologic process, as the subsidence of an inflammatory lesion or new growth.</PreferredDefinition>
      <LongName>Sign or Symptom Physiologic Resolution</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5255344</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C100104</PreferredName>
        <Version>1</Version>
        <LongName>Sign or Symptom</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C100104</PREFERRED_NAME>
            <LONG_NAME>Sign or Symptom</LONG_NAME>
            <CON_ID>3645797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2503262</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25655</PreferredName>
        <Version>1</Version>
        <LongName>Resolution</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25655</PREFERRED_NAME>
            <LONG_NAME>Physiologic Resolution</LONG_NAME>
            <CON_ID>2202897</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the date of the sign</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the date of the sign or symptom resolution?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If symptomatic, date of symptom resolution:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If symptomatic, date of symptom resolution:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7244861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COVID-19</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7247341</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="432">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7402804</PUBLICID>
    <LONGNAME>MFSI-SF 11 How True Past Seven Days Confused Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>MFSISF_11_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how true, in the past seven days, they were confused, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MFSI-SF: Multidimensional Fatigue Symptom Inventory-Short Form, Kevin D. Stein, PhD, et al, Journal of Pain and Symptom Mgmt, Jan 2004</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7402737</PublicId>
      <PreferredName>7402704v1.0:7402735v1.0</PreferredName>
      <PreferredDefinition>A 30-item short form of the Multidimensional Fatigue Symptom Inventory that yields scores only for the empirically derived subscales._A question about an individual&#39;s agreement with a statement._The most recent week. May include the present day._A question about whether an individual feels confused._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Multidimensional Fatigue Symptom Inventory-Short Form How True Past Week Am Confused Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7402704</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C173905</PreferredName>
        <Version>1</Version>
        <LongName>Multidimensional Fatigue Symptom Inventory-Short Form</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C173905</PREFERRED_NAME>
            <LONG_NAME>Multidimensional Fatigue Symptom Inventory-Short Form</LONG_NAME>
            <CON_ID>7380449</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7402735</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C91781:C95402:C173912:C25338</PreferredName>
        <Version>1</Version>
        <LongName>How True Past Week Am Confused Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91781</PREFERRED_NAME>
            <LONG_NAME>How True Question</LONG_NAME>
            <CON_ID>3133350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C173912</PREFERRED_NAME>
            <LONG_NAME>Am Confused Question</LONG_NAME>
            <CON_ID>7380456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7402702</PublicId>
      <PreferredName>7402702v1.0</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes with ranges from 0 (Not At All), 1 (A little), 2 (Moderately), 3 (Quite a bit) and 4 (Extremely) on a 5-point Likert scale.</PreferredDefinition>
      <LongName>MFSI-SF 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Moderately Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating moderate agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6396817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Extremely Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7402703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I am confused</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I am confused</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Multidimensional Fatigue Symptom Inventory  Short Form (MFSI-SF)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #11 of 30</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring Manual Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure.</DocumentText>
        <URL>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2547485</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900325</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7408846</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MFSI-SF</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MFSI-SF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7408847</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="433">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7409443</PUBLICID>
    <LONGNAME>Laboratory Procedure Absolute Neutrophil Count Result 1 Decimal Place Billion per Liter Value</LONGNAME>
    <PREFERREDNAME>2597227v1.0:3181146v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The 1 decimal place billion per liter numeric laboratory value measured, assigned or computed related to the assessment of absolute neutrophil count.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2597227</PublicId>
      <PreferredName>LAB_ANC_RSLT</PreferredName>
      <PreferredDefinition>information related to the medical procedure that involves testing a sample of blood for the absolute neutrophil count, the real number of white blood cells (WBCs) that are neutrophils and is derived by multiplying the WBC count times the percent of neutrophils in the differential WBC count; the percent of neutrophils consists of the segmented (fully mature neutrophils) + the bands (almost mature neutrophils).</PreferredDefinition>
      <LongName>Laboratory Procedure Absolute Neutrophil Count Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738810</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63321:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Absolute Neutrophil Count Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63321</PREFERRED_NAME>
            <LONG_NAME>Absolute Neutrophil Count</LONG_NAME>
            <CON_ID>2531941</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3181146</PublicId>
      <PreferredName>3181146v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A number with no fractional part, including the negative and positive numbers as well as zero.::1_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A derived unit expressed as a number or quantity of objects in billions per unit of volume equal to one liter,or the equivalent in mililiters or microliters._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Laboratory Procedure 1 Decimal Place Billion per Liter Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>10E9/L</UnitOfMeasure>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3181145</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3181145v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Integer::1 Decimal Place Billion per Liter Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67255</PREFERRED_NAME>
            <LONG_NAME>Billion per Liter</LONG_NAME>
            <CON_ID>2725037</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the absolute neutroph</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify the absolute neutrophil count one decimal place billion per liter value:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Absolute neutrophil count (ANC):</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Absolute neutrophil count (ANC):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Absolute neutrophil count (ANC):</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Absolute neutrophil count (ANC):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="434">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7412894</PUBLICID>
    <LONGNAME>Human Epidermal Growth Factor Receptor 2 Measurement Assessment Lab Percentage Value</LONGNAME>
    <PREFERREDNAME>HER2_EXP_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>The percent of HER2 expression obtained from laboratory testing results.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7412893</PublicId>
      <PreferredName>4982238v1.0:2465182v1.0</PreferredName>
      <PreferredDefinition>The determination of the amount of human epidermal growth factor receptor 2 present in a sample._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Human Epidermal Growth Factor Receptor 2 Measurement Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4982238</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C112312</PreferredName>
        <Version>1</Version>
        <LongName>Human Epidermal Growth Factor Receptor 2 Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C112312</PREFERRED_NAME>
            <LONG_NAME>Human Epidermal Growth Factor Receptor 2 Measurement</LONG_NAME>
            <CON_ID>4577519</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2465182</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25217</PreferredName>
        <Version>1</Version>
        <LongName>Assessed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180234</PublicId>
      <PreferredName>LAB_PTG_VAL</PreferredName>
      <PreferredDefinition>the value as a percentage of 100.</PreferredDefinition>
      <LongName>Lab Percentage Value</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the percentage of HER</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the percentage of HER2 expression?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="435">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7446037</PUBLICID>
    <LONGNAME>Time Interval From Freezing To Blood Product Storage Occurrence Time</LONGNAME>
    <PREFERREDNAME>7437707v1.0:7332471v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The period of time from freezing to blood product storage measured in hours and minutes.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCCPR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CPTAC: Clinical Proteomic Tumor Analysis Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7437707</PublicId>
      <PreferredName>2726230v1.0:7437705v1.0</PreferredName>
      <PreferredDefinition>The period of time between two dates or events or between the beginning and end of something._Used to indicate a specified place or time as a starting point; used to indicate a source, cause, agent, or instrument._The act or event which causes the transition from a liquid to solid matter phase._Used as a function word to indicate direction, purpose, or movement._Keeping a stock of blood products under conditions that ensure those products are suitable for future use._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Time Interval From Freezing To Blood Product Storage Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2726230</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68594</PreferredName>
        <Version>1</Version>
        <LongName>Timespan</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68594</PREFERRED_NAME>
            <LONG_NAME>Timespan</LONG_NAME>
            <CON_ID>2673257</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7437705</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>7437705v1.0</PreferredName>
        <Version>1</Version>
        <LongName>From Freezing To Blood Product Storage Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25516</PREFERRED_NAME>
            <LONG_NAME>From</LONG_NAME>
            <CON_ID>2206220</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48160</PREFERRED_NAME>
            <LONG_NAME>Freezing</LONG_NAME>
            <CON_ID>2513273</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C65107</PREFERRED_NAME>
            <LONG_NAME>To</LONG_NAME>
            <CON_ID>2672667</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113072</PREFERRED_NAME>
            <LONG_NAME>Blood Product Storage</LONG_NAME>
            <CON_ID>7437694</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7332471</PublicId>
      <PreferredName>7332471v1.0</PreferredName>
      <PreferredDefinition>A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day._A unit measure of time equal to 60 seconds._The continuum of experience in which events pass from the future through the present to the past.</PreferredDefinition>
      <LongName>Hour Minute Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>TIME (HR(24):MN)</DisplayFormat>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
      <Representation>
        <PublicId>2635753</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25529:C48154:C25207</PreferredName>
        <Version>1</Version>
        <LongName>Hour Minute Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25529</PREFERRED_NAME>
            <LONG_NAME>Hour</LONG_NAME>
            <CON_ID>2203682</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48154</PREFERRED_NAME>
            <LONG_NAME>Minute</LONG_NAME>
            <CON_ID>2513263</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Interval from Time of Freezin</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Interval from Time of Freezing at -20°C to Time of Transfer to -80°C (&gt;24H, &lt; 72H)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>All Procurement CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7409064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Solid Tumor Specimen</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7409065</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="436">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7475134</PUBLICID>
    <LONGNAME>Previous Breast Imaging Study Outcome</LONGNAME>
    <PREFERREDNAME>PREV_BRST_IMG_PRFM_OUT</PREFERREDNAME>
    <PREFERREDDEFINITION>The results from the performance of a breast imaging study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7475131</PublicId>
      <PreferredName>7475129v1.00:2241241v1.00</PreferredName>
      <PreferredDefinition>Occurring prior to something else._Procedures for obtaining internal images of the breast.:Executed and carried through to completion.</PreferredDefinition>
      <LongName>Previous Breast Imaging Study Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7475129</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25627:C62683</PreferredName>
        <Version>1</Version>
        <LongName>Previous Breast Imaging Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25627</PREFERRED_NAME>
            <LONG_NAME>Previous</LONG_NAME>
            <CON_ID>2206349</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62683</PREFERRED_NAME>
            <LONG_NAME>Breast Imaging Study</LONG_NAME>
            <CON_ID>7475128</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCP:Division of Cancer Prevention</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3194155</PublicId>
      <PreferredName>3194155v1.0</PreferredName>
      <PreferredDefinition>information related to results from mammogram.</PreferredDefinition>
      <LongName>Mammogram Performed Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2476191</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20200</PreferredName>
        <Version>1</Version>
        <LongName>Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mass and microcalcifications</VALIDVALUE>
          <VALUEMEANING>Mass and microcalcifications</VALUEMEANING>
          <MEANINGDESCRIPTION>Mass and microcalcifications</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3194156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3194157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3126125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable/No mammogram</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination that a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3194158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Microcalcifications only</VALIDVALUE>
          <VALUEMEANING>Microcalcification</VALUEMEANING>
          <MEANINGDESCRIPTION>(MY-krow-kal-si-fi-KAY-shunz) Tiny deposits of calcium in the breast that cannot be felt but can be detected on a mammogram. A cluster of these very small specks of calcium may indicate that cancer is present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3194159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mass density only</VALIDVALUE>
          <VALUEMEANING>Mass</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells, inflammatory cells, or cystic changes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34808</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3194160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lump</VALIDVALUE>
          <VALUEMEANING>Breast Lump</VALUEMEANING>
          <MEANINGDESCRIPTION>A mass in the mammary gland, either mobile or immobile. Once the mass has reached the size of a small garden pea, it can be detected by palpation. With mammography a larger number of early breast cancers are being detected since this techniques allows detection prior to the point at which the mass can be felt. Breast masses are not always malignant. Benign fibrocystic breast disease is not uncommon. A fine needle biopsy aspiration can distinguish a cystic mass from a solid one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asymmetry</VALIDVALUE>
          <VALUEMEANING>Asymmetry</VALUEMEANING>
          <MEANINGDESCRIPTION>Lack or absence of balanced proportions between parts of a thing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243765</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Benign cyst</VALIDVALUE>
          <VALUEMEANING>Benign Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>(beh-NINE) Not cancerous; does not invade nearby tissue or spread to other parts of the body.: (sist) A sac or capsule filled with fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2978, C14172</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243766</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcification</VALIDVALUE>
          <VALUEMEANING>Calcification</VALUEMEANING>
          <MEANINGDESCRIPTION>Deposition of calcium in the tissues.  It may be the result of a metabolic disorder or long-standing infection, or it may be associated with the presence of cancer. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3672</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroadenoma</VALIDVALUE>
          <VALUEMEANING>Fibroadenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign tumor of the breast characterized by the presence of stromal and epithelial elements. It presents as a painless, solitary, slow growing, firm, and mobile mass. It is the most common benign breast lesion. It usually occurs in women of childbearing age. The majority of fibroadenomas do not recur after complete excision. A slightly increased risk of developing cancer within fibroadenomas or in the breast tissue of patients previously treated for fibroadenomas has been reported.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thickening</VALIDVALUE>
          <VALUEMEANING>Skin thickening</VALUEMEANING>
          <MEANINGDESCRIPTION>Definition not available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0241165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BI-RADS2 (Benign)</VALIDVALUE>
          <VALUEMEANING>Benign Breast Imaging Reporting and Data System</VALUEMEANING>
          <MEANINGDESCRIPTION>Not cancerous. Benign tumors may grow larger but do not spread to other parts of the body.: The Breast Imaging Reporting and Data System (BI-RADS) Atlas is a quality assurance guide to standardize breast-imaging reporting and to facilitate outcome monitoring. The atlas contains a guide to standardized mammographic reporting, including a breast-imaging lexicon of terminology, a report organization and assessment structure and coding system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38071, C14172</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6070479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BI-RADS1 (Negative)</VALIDVALUE>
          <VALUEMEANING>Negative Breast Imaging Reporting and Data System</VALUEMEANING>
          <MEANINGDESCRIPTION>Involving disadvantage or harm.: The Breast Imaging Reporting and Data System (BI-RADS) Atlas is a quality assurance guide to standardize breast-imaging reporting and to facilitate outcome monitoring. The atlas contains a guide to standardized mammographic reporting, including a breast-imaging lexicon of terminology, a report organization and assessment structure and coding system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38071, C25247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6070480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BI-RADS 0 (Incomplete-Needs Additional Imaging Evaluation)</VALIDVALUE>
          <VALUEMEANING>Incomplete Breast Imaging Reporting and Data System</VALUEMEANING>
          <MEANINGDESCRIPTION>Not whole; lacking some necessary part or detail; unfinished.: The Breast Imaging Reporting and Data System (BI-RADS) Atlas is a quality assurance guide to standardize breast-imaging reporting and to facilitate outcome monitoring. The atlas contains a guide to standardized mammographic reporting, including a breast-imaging lexicon of terminology, a report organization and assessment structure and coding system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38071, C49160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6430452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Breast Imaging Results</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Breast Imaging Results</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="437">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7496425</PUBLICID>
    <LONGNAME>Normal Tissue Segment Devascularization Collection Date and Time</LONGNAME>
    <PREFERREDNAME>7496396v1.0:7414605v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The date or date and time the normal adjacent tissue was obtained by a procedure that interrupts blood supply to an organ or tissue.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCCPR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CPTAC: Clinical Proteomic Tumor Analysis Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7496396</PublicId>
      <PreferredName>7120745v1.0:7496394v1.0</PreferredName>
      <PreferredDefinition>Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into one to three aliquots of non-neoplastic (&quot;normal&quot;) adjacent tissue (as feasible) suitable for processing for proteomic and genomic analysis._A procedure that interrupts blood supply to an organ or tissue._The date or date and time of the specimen or data collection.</PreferredDefinition>
      <LongName>Normal Tissue Segment Devascularization Collection Date Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7120745</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C162623</PreferredName>
        <Version>1</Version>
        <LongName>Normal Tissue Segment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C162623</PREFERRED_NAME>
            <LONG_NAME>Normal Tissue Sample</LONG_NAME>
            <CON_ID>6825350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7496394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C175666:C82515</PreferredName>
        <Version>1</Version>
        <LongName>Devascularization Collection Date Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C175666</PREFERRED_NAME>
            <LONG_NAME>Devascularization</LONG_NAME>
            <CON_ID>7490679</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82515</PREFERRED_NAME>
            <LONG_NAME>Collection Date Time</LONG_NAME>
            <CON_ID>7434420</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7414605</PublicId>
      <PreferredName>7414605v1.0</PreferredName>
      <PreferredDefinition>The date or date and time that an event has happened or will happen.</PreferredDefinition>
      <LongName>Date and Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>255</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date/Time of Devascularization</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date/Time of Devascularization</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="438">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7507233</PUBLICID>
    <LONGNAME>Disease Response Domain Overall Response Sufficient Information Y/N/NA Indicator</LONGNAME>
    <PREFERREDNAME>SUPPRS_QVAL_RSOVLRESPINFO</PREFERREDNAME>
    <PREFERREDDEFINITION>An indication as to whether or not there is sufficient information to assess the patient&#39;s overall response to treatment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7507222</PublicId>
      <PreferredName>6608777v1.0:7507220v1.0</PreferredName>
      <PreferredDefinition>A domain for disease response evaluations._Including everything._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._Meeting a quantitative or qualitative measure necessary for a requirement; enough to meet the needs of a situation._Knowledge derived from study, experience, or instruction that has been gathered or received by communication.</PreferredDefinition>
      <LongName>Disease Response Domain Overall Response Sufficient Information</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6608777</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C107097</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107097</PREFERRED_NAME>
            <LONG_NAME>Disease Response Domain</LONG_NAME>
            <CON_ID>6608776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7507220</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25605:C25755:C63351:C48191</PreferredName>
        <Version>1</Version>
        <LongName>Overall Response Sufficient Information</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25605</PREFERRED_NAME>
            <LONG_NAME>Overall</LONG_NAME>
            <CON_ID>2203597</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25755</PREFERRED_NAME>
            <LONG_NAME>Response</LONG_NAME>
            <CON_ID>2202805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63351</PREFERRED_NAME>
            <LONG_NAME>Sufficient</LONG_NAME>
            <CON_ID>2538604</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48191</PREFERRED_NAME>
            <LONG_NAME>Information</LONG_NAME>
            <CON_ID>2422630</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6343337</PublicId>
      <PreferredName>NY</PreferredName>
      <PreferredDefinition>Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6343336</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66742:C25180</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66742</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</LONG_NAME>
            <CON_ID>4852475</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5676138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is there sufficient informati</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is there sufficient information to assess the patient&#39;s overall response?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is there sufficient information at this time to assess this patient&#39;s overall response?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="439">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7545526</PUBLICID>
    <LONGNAME>Myelodysplastic Syndrome Assessment  Blast Cell Status</LONGNAME>
    <PREFERREDNAME>MDS_ASMT_BLAST_STS</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that represents the blast cell status related to myelodysplastic syndrome (MDS).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2466257</PublicId>
      <PreferredName>MDS_ASSESS</PreferredName>
      <PreferredDefinition>information related to assessment of myelodysplastic syndrome (MDS; a clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines).</PreferredDefinition>
      <LongName>Myelodysplastic Syndrome Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008536</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2459218</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3247</PreferredName>
        <Version>1</Version>
        <LongName>MDS</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3247</PREFERRED_NAME>
            <LONG_NAME>Myelodysplastic Syndrome</LONG_NAME>
            <CON_ID>2202745</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25367</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7545522</PublicId>
      <PreferredName>MDS_BLAST_STATUS</PreferredName>
      <PreferredDefinition>A condition or state at a particular time.</PreferredDefinition>
      <LongName>MDS Blast Cell Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BM Blasts&lt;10%PB&lt;5-19% + Auer rods</VALIDVALUE>
          <VALUEMEANING>Blasts Under 10 Percent of Bone Marrow Nucleated Cells and Blasts Under 5-19 Percent of Peripheral Blood White Cells plus Auer Rods Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Blasts Under 10 Percent of Bone Marrow Nucleated Cells and Blasts Under 5-19 Percent of Peripheral Blood White Cells plus Auer Rods Present</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2021-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7545523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BM Blasts&lt;5-9%PB&lt;2-4%</VALIDVALUE>
          <VALUEMEANING>Blasts 5-9 Percent of Bone Marrow Nucleated Cells and Blasts Under 2-4 Percent of Peripheral Blood White Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Blasts 5-9 Percent of Bone Marrow Nucleated Cells and Blasts Under 2-4 Percent of Peripheral Blood White Cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2021-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7545524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BM Blasts&lt;5%PB&lt;1%</VALIDVALUE>
          <VALUEMEANING>Blasts Under 5 Percent of Bone Marrow Nucleated Cells and Blasts Under 1 Percent of Peripheral Blood White Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Blasts Under 5 Percent of Bone Marrow Nucleated Cells and Blasts Under 1 Percent of Peripheral Blood White Cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2021-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7545525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MDS Status</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>MDS Status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="440">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7550029</PUBLICID>
    <LONGNAME>Pharmacologic Substance Administration Assessment Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>PHRM_SUB_ADMN_ASSES_CD_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded response to questions which are necessary to allow a person to participate in a clinical study that are related to an assessment of administration pharmacologic substance as outlined in the study protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7550028</PublicId>
      <PreferredName>2437803v1.0:7550026v1.0</PreferredName>
      <PreferredDefinition>Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine._A measurement, evaluation, or judgment for a study variable pertaining to the status of a subject. NOTE: Assessments are usually measured at a certain time, and usually are not compounded significantly by combining several simultaneous measurements to form a derived assessment (e.g., BMI) or a result of statistical analysis. The term assessment is intended to invoke some degree of evaluation or judgment concerning subject status. Refer to COA glossary of terms. See also variable, outcome, endpoint. [After Clinical Outcome Assessment (COA) Glossary of Terms FDA FDA eCOA Glossary]_Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Pharmacologic Substance Administration Assessment Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437803</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1909</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacologic Substance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1909</PREFERRED_NAME>
            <LONG_NAME>Pharmacologic Substance</LONG_NAME>
            <CON_ID>2437691</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7550026</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25409:C25217:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Administration Assessment Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is patient able to begin abem</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is patient able to begin abemaciclib administration no later than 14 days after the date of radiographic diagnosis (by T2 or FLAIR imaging)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Will patient be able to start ASTX727 and filgrastim (rh-GCSF) between day 30 and day 60 following completion of allo-HCT?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Will patient be able to start ASTX727 and filgrastim (rh-GCSF) between day 42 and day 100 following completion of allo-HCT?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876352</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Inclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prior Treatments</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000494</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="441">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7559664</PUBLICID>
    <LONGNAME>Planned Time Point Name</LONGNAME>
    <PREFERREDNAME>QSTPT_SPD</PREFERREDNAME>
    <PREFERREDDEFINITION>One or more sponsor defined characters used to identify a point in time that questionnaire data is obtained.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6631710</PublicId>
      <PreferredName>6607890v1.0:6631708v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire._A point in time that questionnaire data is obtained.</PreferredDefinition>
      <LongName>Questionnaire Domain Questionnaire Time Point</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6607890</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49609</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49609</PREFERRED_NAME>
            <LONG_NAME>Questionnaire Domain</LONG_NAME>
            <CON_ID>2469074</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6631708</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83387</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Time Point</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83387</PREFERRED_NAME>
            <LONG_NAME>Questionnaire Time Point</LONG_NAME>
            <CON_ID>6631707</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7559663</PublicId>
      <PreferredName>QSTPT_SPD</PreferredName>
      <PreferredDefinition>A point in time that questionnaire data is obtained._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Questionnaire Time Point Clinical Study Sponsor Defined Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>7185522</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83387:C70793:C165683:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Time Point Clinical Study Sponsor Defined Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83387</PREFERRED_NAME>
            <LONG_NAME>Questionnaire Time Point</LONG_NAME>
            <CON_ID>6631707</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70793</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Sponsor</LONG_NAME>
            <CON_ID>2715021</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C165683</PREFERRED_NAME>
            <LONG_NAME>Defined</LONG_NAME>
            <CON_ID>7050024</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 MONTHS</VALIDVALUE>
          <VALUEMEANING>12 months</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4769207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6 MONTHS</VALIDVALUE>
          <VALUEMEANING>6 months</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4769208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3 MONTHS</VALIDVALUE>
          <VALUEMEANING>3 months</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4769209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BASELINE</VALIDVALUE>
          <VALUEMEANING>Baseline</VALUEMEANING>
          <MEANINGDESCRIPTION>A starting point to which things may be compared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Assessment Timepoint</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Assessment Timepoint</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="442">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7580667</PUBLICID>
    <LONGNAME>Procedure Domain Reported Name of Procedure Target Specify</LONGNAME>
    <PREFERREDNAME>PR_CART_TGT_OTH</PREFERREDNAME>
    <PREFERREDDEFINITION>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._The literal identifier of the procedure._Be specific about something; define clearly.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6411454</PublicId>
      <PreferredName>6407261v1.0:6411452v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._The literal identifier of the procedure.</PreferredDefinition>
      <LongName>Procedure Domain Reported Name of Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102700</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102700</PREFERRED_NAME>
            <LONG_NAME>Procedure Domain</LONG_NAME>
            <CON_ID>6407260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6411452</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117511</PreferredName>
        <Version>1</Version>
        <LongName>Reported Name of Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117511</PREFERRED_NAME>
            <LONG_NAME>Reported Name of Procedure</LONG_NAME>
            <CON_ID>6411451</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7580664</PublicId>
      <PreferredName>7580664v1.0</PreferredName>
      <PreferredDefinition>Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Target Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If Other, specify:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If Other, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="443">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7588906</PUBLICID>
    <LONGNAME>Cytogenetic Analysis of Hematologic Neoplasm Chromosome Band Resolution Value</LONGNAME>
    <PREFERREDNAME>CHRM_BAND_RESL_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric representation of the chromosome band pattern resolution obtained in the hematologic neoplasm chromosome analysis testing.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7588759</PublicId>
      <PreferredName>7588747v1.0:7588757v1.0</PreferredName>
      <PreferredDefinition>A cytogenetic test to define and interpret chromosomal aberrations that occur in neoplastic cells associated with hematologic malignancies._The treatment of chromosomes to reveal characteristic patterns of horizontal bands.  The banding patterns lend each chromosome a distinctive appearance so the 22 pairs of human non-sex chromosomes and the X and Y chromosomes can be identified and distinguished without ambiguity. Banding also permits the recognition of chromosome deletions (lost segments), chromosome duplications (surplus segments) and other types of structural rearrangements of chromosomes._The size of the smallest element that can be separated from neighboring elements.</PreferredDefinition>
      <LongName>Cytogenetic Analysis of Hematologic Neoplasm Chromosome Banding Resolution</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7588747</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C177773</PreferredName>
        <Version>1</Version>
        <LongName>Cytogenetic Analysis of Hematologic Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C177773</PREFERRED_NAME>
            <LONG_NAME>Cytogenetic Analysis of Hematologic Neoplasm</LONG_NAME>
            <CON_ID>7587166</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7588757</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16437:C47876</PreferredName>
        <Version>1</Version>
        <LongName>Chromosome Banding Resolution</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16437</PREFERRED_NAME>
            <LONG_NAME>Chromosome Banding</LONG_NAME>
            <CON_ID>2777686</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47876</PREFERRED_NAME>
            <LONG_NAME>Resolution</LONG_NAME>
            <CON_ID>2669351</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7588895</PublicId>
      <PreferredName>CHRM_BND_RSOLV_VAL</PreferredName>
      <PreferredDefinition>A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Chromosome Banding Resolution Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Band resolution</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Band resolution</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="444">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7591785</PUBLICID>
    <LONGNAME>Myeloblast Count Laboratory Procedure Performed Laboratory Procedure Outcome Percentage 0 Decimal Place Value</LONGNAME>
    <PREFERREDNAME>7591784v1.0:3061015v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The 0 decimal place numeric laboratory percentage value measured, assigned or computed related to myeloblasts in blood.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7591784</PublicId>
      <PreferredName>7290683v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>The determination of the number of myeloblast cells present in a sample._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Myeloblast Count Laboratory Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7290683</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C74632:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Myeloblast Count Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C74632</PREFERRED_NAME>
            <LONG_NAME>Myeloblast Count</LONG_NAME>
            <CON_ID>6402889</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3061015</PublicId>
      <PreferredName>3061015v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The result of an action._A fraction or ratio with 100 understood as the denominator._A number with no fractional part, including the negative and positive numbers as well as zero.::0_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Laboratory Procedure Outcome Percentage Integer::0 Decimal Place Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <DisplayFormat>%</DisplayFormat>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3061014</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294:C20200:C25613:C45255::0</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Outcome Percentage Integer::0 Decimal Place Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the percentage value</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the percentage value of myeloblasts in blood?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="445">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7640265</PUBLICID>
    <LONGNAME>Sepsis Adverse Event Neoplasm Therapeutic Procedure Yes/No/Unk/NA Ind</LONGNAME>
    <PREFERREDNAME>AE_SEPSIS_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator that asks whether spesis adverse events occurred during this report period.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7640264</PublicId>
      <PreferredName>7640262v1.0:3693397v1.0</PreferredName>
      <PreferredDefinition>A disorder characterized by the presence of pathogenic microorganisms in the blood stream that cause a rapidly progressing systemic reaction that may lead to shock._Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</PreferredDefinition>
      <LongName>Sepsis Adverse Event Neoplasm Therapeutic Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7640262</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C143827:C41331</PreferredName>
        <Version>1</Version>
        <LongName>Sepsis Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C143827</PREFERRED_NAME>
            <LONG_NAME>Sepsis, CTCAE</LONG_NAME>
            <CON_ID>6071722</CON_ID>
            <DEFINITION_SOURCE>CTCAE</DEFINITION_SOURCE>
            <ORIGIN>CTCAE</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3693397</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3262:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the patient experience gr</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the patient experience grade 3 or higher Sepsis according to the current CTCAE during this cycle?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="446">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7715614</PUBLICID>
    <LONGNAME>Cerebrospinal Fluid Diagnostic Procedure Opening Pressure Performed Centimeters of water 1 Decimal Place Value</LONGNAME>
    <PREFERREDNAME>2871809v1.0:7715604v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The 1 decimal place numeric cm H2O value measured, assigned or computed related to the assessment of cerebrospinal fluid opening pressure in a specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2871809</PublicId>
      <PreferredName>3124157v1.0:7715613v1.0</PreferredName>
      <PreferredDefinition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord._Any procedure or test to diagnose a disease or disorder._The initial pressure of cerebrospinal fluid when sampled via lumbar puncture. It is a surrogate measurement of intracranial pressure._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Cerebrospinal Fluid Diagnostic Procedure Opening Pressure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3124157</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12692:C18020</PreferredName>
        <Version>1</Version>
        <LongName>Cerebrospinal Fluid Diagnostic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12692</PREFERRED_NAME>
            <LONG_NAME>Cerebrospinal Fluid</LONG_NAME>
            <CON_ID>2202710</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18020</PREFERRED_NAME>
            <LONG_NAME>Diagnostic Procedure</LONG_NAME>
            <CON_ID>2488312</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7715613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C180559:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Opening Pressure at Lumbar Puncture Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C180559</PREFERRED_NAME>
            <LONG_NAME>Opening Pressure at Lumbar Puncture</LONG_NAME>
            <CON_ID>7709338</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7715604</PublicId>
      <PreferredName>7715604v1.0</PreferredName>
      <PreferredDefinition>A unit of pressure defined by a column of water with a height of one centimeter, frequently used to measure central venous pressure, intracranial pressure, and for pressures during mechanical ventilation._A number with no fractional part, including the negative and positive numbers as well as zero.::1_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Centimeters of water 1 Decimal Place Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>cm H2O</UnitOfMeasure>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>7715603</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C91060:C45255::1:C42646:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Centimeters of water Integer::1 Decimal Place Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91060</PREFERRED_NAME>
            <LONG_NAME>Centimeters of Water</LONG_NAME>
            <CON_ID>3124180</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the cm H2O value of t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the cm H2O value of the cerebrospinal fluid opening pressure?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Opening pressure:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Opening pressure:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Opening pressure:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Opening pressure:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="447">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7784538</PUBLICID>
    <LONGNAME>Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Been Bowling Indicator Average Minute Time</LONGNAME>
    <PREFERREDNAME>JHFAC_BWLNG_IND_MIN</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated response, during the past two weeks, of the average amount of minutes they have been bowling.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7784534</PublicId>
      <PreferredName>7784396v1.0:7784532v1.0</PreferredName>
      <PreferredDefinition>A standardized assessment tool that assesses frailty by measuring five phenotypic criteria: unintentional weight loss, exhaustion, low energy expenditure, low grip strength, and/or slowed walking speed. A single score is automatically generated and interpreted as either frail (score 3-5), pre-frail (score 1 or 2), or non-frail or robust (score 0)._At some point in a given period of time._A period of time consisting of the 14 days before the present._A question about whether an individual has been bowling._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Have Been Bowling Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7784396</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C181867</PreferredName>
        <Version>1</Version>
        <LongName>Johns Hopkins Frailty Assessment Calculator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C181867</PREFERRED_NAME>
            <LONG_NAME>Johns Hopkins Frailty Assessment Calculator</LONG_NAME>
            <CON_ID>7784330</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7784532</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25490:C126890:C181887:C25180</PreferredName>
        <Version>1</Version>
        <LongName>During Past 2 Weeks Have Been Bowling Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126890</PREFERRED_NAME>
            <LONG_NAME>Past 2 Weeks</LONG_NAME>
            <CON_ID>5271604</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C181887</PREFERRED_NAME>
            <LONG_NAME>Have Been Bowling Question</LONG_NAME>
            <CON_ID>7784361</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7782011</PublicId>
      <PreferredName>AVG_AMT_MN_TM</PreferredName>
      <PreferredDefinition>The time in minutes that it takes for an event or activity to take place from beginning to end.</PreferredDefinition>
      <LongName>Average Amount Minute Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>min</UnitOfMeasure>
      <MaximumLength>6</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2193249</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25207</PreferredName>
        <Version>1</Version>
        <LongName>Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Average amount of time (minut</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Average amount of time (minutes)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="448">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7786773</PUBLICID>
    <LONGNAME>Short Physical Performance Battery 10 Did Not Attempt or Failed Tandem Stand Reason</LONGNAME>
    <PREFERREDNAME>SPPB_10_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>The reason that a participant did not attempt or failed the tandem stand test.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>SPPB:Short Physical Performance Battery, Guralnik JM, Simonsick EM, Ferrucci L, et al.J Gerontol. 1994;49(2):M85-94.</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7784968</PublicId>
      <PreferredName>7784669v1.0:7784966v1.0</PreferredName>
      <PreferredDefinition>Short Physical Performance Battery V1.2 (SPPB V1.2) (Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, Studenski S, Berkman LF, Wallace RB. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000 April;55(4):M221-M231)._A question about whether an individual did not attempt or failed the Tandem Stand as part of the Short Physical Performance Battery._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Short Physical Performance Battery Version 1.2 Functional Test Did Not Attempt or Failed Tandem Stand Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7784669</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C170646</PreferredName>
        <Version>1</Version>
        <LongName>Short Physical Performance Battery Version 1.2 Functional Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C170646</PREFERRED_NAME>
            <LONG_NAME>Short Physical Performance Battery Version 1.2 Functional Test</LONG_NAME>
            <CON_ID>7245937</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7784966</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C181913:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Did Not Attempt or Failed Tandem Stand Specify  Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C181913</PREFERRED_NAME>
            <LONG_NAME>Did Not Attempt or Failed Tandem Stand Question</LONG_NAME>
            <CON_ID>7784616</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7785502</PublicId>
      <PreferredName>SPPB_NOT_STND_RSN</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>SPPB Negation Stand Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2240632</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7 - Participant refused</VALIDVALUE>
          <VALUEMEANING>Participant refused</VALUEMEANING>
          <MEANINGDESCRIPTION>Participant refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2021-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7785503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5 - Participant unable to understand instructions</VALIDVALUE>
          <VALUEMEANING>Participant unable to understand instructions</VALUEMEANING>
          <MEANINGDESCRIPTION>Participant unable to understand instructions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2021-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7785505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 - Tried but unable</VALIDVALUE>
          <VALUEMEANING>Tried but unable</VALUEMEANING>
          <MEANINGDESCRIPTION>Participant tried but unable.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2021-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7785509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4 - Not attempted, participant felt unsafe</VALIDVALUE>
          <VALUEMEANING>Not attempted, participant felt unsafe</VALUEMEANING>
          <MEANINGDESCRIPTION>Not attempted, participant felt unsafe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2021-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7785506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3 - Not attempted, you felt unsafe</VALIDVALUE>
          <VALUEMEANING>Not attempted, examiner felt unsafe</VALUEMEANING>
          <MEANINGDESCRIPTION>Not attempted, examiner felt unsafe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2021-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7785507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6 - Other (specify)</VALIDVALUE>
          <VALUEMEANING>Other (specify)</VALUEMEANING>
          <MEANINGDESCRIPTION>Other (specify)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2021-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7785504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2 - Participant could not hold position unassisted</VALIDVALUE>
          <VALUEMEANING>Participant could not hold position unassisted - 2</VALUEMEANING>
          <MEANINGDESCRIPTION>Participant could not hold position unassisted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2021-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7785508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tandem Stand</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tandem Stand</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="449">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7787678</PUBLICID>
    <LONGNAME>Channel Analysis Metadata Electronic File Name Text</LONGNAME>
    <PREFERREDNAME>7781970v1.0:6847557v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The full path name of the uploaded file containing channel-level metadata describing the processes used to analyze the experimental data in a study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>HTAN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HTAN:Human Tumor Atlas Network</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7781970</PublicId>
      <PreferredName>7781968v1.0:7781950v1.0</PreferredName>
      <PreferredDefinition>An independent acquisition scheme, i.e., a route or conduit through which flows data consisting of one particular measurement using one particular parameter._Supporting information that describes the processes used to analyze the experimental data in a study._The literal identifier for an electronic file.</PreferredDefinition>
      <LongName>Channel Analysis Metadata Electronic File Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>HTAN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7781968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C44170:C165211</PreferredName>
        <Version>1</Version>
        <LongName>Channel Analysis Metadata</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44170</PREFERRED_NAME>
            <LONG_NAME>Channel</LONG_NAME>
            <CON_ID>2236547</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C165211</PREFERRED_NAME>
            <LONG_NAME>Analysis Metadata</LONG_NAME>
            <CON_ID>7781967</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7781950</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C171191</PreferredName>
        <Version>1</Version>
        <LongName>Electronic File Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C171191</PREFERRED_NAME>
            <LONG_NAME>Electronic File Name</LONG_NAME>
            <CON_ID>7781949</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HTAN:Human Tumor Atlas Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6847557</PublicId>
      <PreferredName>6847557v1.0</PreferredName>
      <PreferredDefinition>The words of something written.</PreferredDefinition>
      <LongName>4000 Character Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>4000</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Channel Metadata Filename</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Channel Metadata Filename</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>HTAN-Instruction</Name>
        <DocumentType>Coding Instructions</DocumentType>
        <DocumentText>May be a delimited LIST of protocol ids or links.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7639423</PublicId>
          <ContextName>HTAN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>SRRS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SRRS Imaging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7639428</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7788578</PublicId>
          <ContextName>HTAN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging Data Tier 2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7788582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>8064110</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GC (General Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14470388</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>HTAN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ChannelMetadataFilename</AlternateName>
        <AlternateNameType>HTAN Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>channel_metadata_filename</AlternateName>
        <AlternateNameType>GC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="450">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7788560</PUBLICID>
    <LONGNAME>Parent Eligibility Determination Source Information Resource Type</LONGNAME>
    <PREFERREDNAME>PRT_ELIG_DTMN_INFO_RSC_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that represents the information source type used to determine a parent&#39;s eligibility status.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7788559</PublicId>
      <PreferredName>3111322v1.0:7411270v1.0</PreferredName>
      <PreferredDefinition>A mother or a father; an immediate progenitor._The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures._Where something is available or from where it originates.</PreferredDefinition>
      <LongName>Parent Eligibility Determination Source</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3111322</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42709</PreferredName>
        <Version>1</Version>
        <LongName>Parent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42709</PREFERRED_NAME>
            <LONG_NAME>Parent</LONG_NAME>
            <CON_ID>2222173</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7411270</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25171:C25683</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility Determination Source</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25683</PREFERRED_NAME>
            <LONG_NAME>Source</LONG_NAME>
            <CON_ID>2202479</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3370585</PublicId>
      <PreferredName>Info_Type</PreferredName>
      <PreferredDefinition>An identifiable class of sources of information such as libraries, databases, and websites.</PreferredDefinition>
      <LongName>Information Resource Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008576</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DATA_SOURCE</PreferredName>
        <Version>1</Version>
        <LongName>Data Source</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>255</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>3392200</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16048:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Information Resource Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16048</PREFERRED_NAME>
            <LONG_NAME>Information Resource</LONG_NAME>
            <CON_ID>2786998</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2991873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Institutional report</VALIDVALUE>
          <VALUEMEANING>Institutional report</VALUEMEANING>
          <MEANINGDESCRIPTION>Institutional report</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rapid central review</VALIDVALUE>
          <VALUEMEANING>Rapid central review</VALUEMEANING>
          <MEANINGDESCRIPTION>Rapid central review</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Audit</VALIDVALUE>
          <VALUEMEANING>Audit</VALUEMEANING>
          <MEANINGDESCRIPTION>A methodical examination or review of a condition or situation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3370587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central review</VALIDVALUE>
          <VALUEMEANING>Central review (surgery, pathology, etc.)</VALUEMEANING>
          <MEANINGDESCRIPTION>Central review (surgery, pathology, etc.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4207498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rapid Central Imaging Review</VALIDVALUE>
          <VALUEMEANING>Rapid Central Imaging Review</VALUEMEANING>
          <MEANINGDESCRIPTION>Rapid Central Imaging Review</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5254487</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rapid Central Molecular Review</VALIDVALUE>
          <VALUEMEANING>Rapid Central Molecular Review</VALUEMEANING>
          <MEANINGDESCRIPTION>Rapid Central Molecular Review</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5254488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rapid Central Pathology Review</VALIDVALUE>
          <VALUEMEANING>Rapid Central Pathology Review</VALUEMEANING>
          <MEANINGDESCRIPTION>Rapid Central Pathology Review</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5254489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pathology report</VALIDVALUE>
          <VALUEMEANING>Pathology report</VALUEMEANING>
          <MEANINGDESCRIPTION>Pathology report</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Member Institution Self-Report</VALIDVALUE>
          <VALUEMEANING>Member Institution Self-Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Member Institution Self-Report</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rapid Central Pathology-Molecular Review</VALIDVALUE>
          <VALUEMEANING>Rapidly Performed Pathology Molecular Review</VALUEMEANING>
          <MEANINGDESCRIPTION>Acting or occurring in a brief period of time.: Executed and carried through to completion.: The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.: Relating to or produced by or consisting of molecules.: The act of appraisal, evaluation, or analysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42729, C25574, C18189, C38000, C65069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7992779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rapid Central Audiology Review</VALIDVALUE>
          <VALUEMEANING>Rapidly Performed Audiology Review</VALUEMEANING>
          <MEANINGDESCRIPTION>Acting or occurring in a brief period of time.: Executed and carried through to completion.: The study of hearing, including the diagnosis and treatment of hearing defects.: The act of appraisal, evaluation, or analysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42729, C61153, C38000, C65069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7992780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Molecular Characterization Report</VALIDVALUE>
          <VALUEMEANING>Molecular Characterization Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to or produced by or consisting of molecules.: The act of describing distinctive characteristics or essential features.: A short textual account; having provided a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C62606, C25574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-01-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8009958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source of information used to</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Source of information used to determine the parent&#39;s eligibility status:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="451">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7847453</PUBLICID>
    <LONGNAME>Assessment Questionnaire Complete Comprehensive Indicators</LONGNAME>
    <PREFERREDNAME>ASMT_QTNR_CPLT_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indication as to whether or not an assessment/questionnaire has been completed or to otherwise indicate the status of completion of the questionnaire.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7847452</PublicId>
      <PreferredName>2494682v1.0:2660772v1.0</PreferredName>
      <PreferredDefinition>The final result of a determination of the value, significance, or extent of._A predetermined set of questions._To possess every necessary or normal part or component or step; having come or been brought to a conclusion.</PreferredDefinition>
      <LongName>Assessment Questionnaire Complete</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2494682</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25217</PreferredName>
        <Version>1</Version>
        <LongName>Assessed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660772</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17048:C25250</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Complete</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17048</PREFERRED_NAME>
            <LONG_NAME>Questionnaire</LONG_NAME>
            <CON_ID>2202367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25250</PREFERRED_NAME>
            <LONG_NAME>Complete</LONG_NAME>
            <CON_ID>2203885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7410395</PublicId>
      <PreferredName>7410395v2.0</PreferredName>
      <PreferredDefinition>Broad in scope; including all or everything._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Comprehensive List of Indicators</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>7490448</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61528:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Comprehensive Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61528</PREFERRED_NAME>
            <LONG_NAME>Comprehensive</LONG_NAME>
            <CON_ID>3332482</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Evaluated</VALIDVALUE>
          <VALUEMEANING>Not Evaluated</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25214, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5607983</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Available</VALIDVALUE>
          <VALUEMEANING>Unavailable</VALUEMEANING>
          <MEANINGDESCRIPTION>The desired information is not available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5828000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3382682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2960664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Assessed</VALIDVALUE>
          <VALUEMEANING>NOT ASSESSED</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that an assessment was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Specified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5697867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unsure</VALIDVALUE>
          <VALUEMEANING>Uncertain</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3291262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not due</VALIDVALUE>
          <VALUEMEANING>Negation due</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._Expected or scheduled.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45263, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12106778</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Eligible</VALIDVALUE>
          <VALUEMEANING>Ineligible</VALUEMEANING>
          <MEANINGDESCRIPTION>The state or quality of being disqualified by law, rule, or provision.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Evaluable</VALIDVALUE>
          <VALUEMEANING>unevaluable</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to be evaluated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prefer Not to Answer</VALIDVALUE>
          <VALUEMEANING>Prefer Not to Answer</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual prefers or preferred not to answer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5684650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were the questionnaires/assessments completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the questionnaire/assessment completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was a parent or guardian able to complete the parent-report assessments?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was a psychologist able to complete the assessments?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the COG Language Preference Questionnaire completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the Household Material Hardship Questionnaire completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the Household Survey completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the Household Material Hardship Survey completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the assessment completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were the assessments completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was/Were the assessment(s) co</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was/Were the assessment(s) completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient complete the assessment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did caregiver complete the assessment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did parent/guardian complete the assessment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPQS_QVAL_PATIENTCOMP</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPQS_QVAL_PRNTGRDNCOMP</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPQS_QVAL_CRGVPTCOMP</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="452">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7992789</PUBLICID>
    <LONGNAME>MYC Gene Amplification Status</LONGNAME>
    <PREFERREDNAME>MYC_GENE_AMP_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>The results of laboratory testing to determine MYC gene amplification status.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7992784</PublicId>
      <PreferredName>7992781v1.0:7992782v1.0</PreferredName>
      <PreferredDefinition>This gene plays a role in cell cycle progression and apoptosis. Cytogenetic aberrations in the gene are involved in cellular transformation and are associated with a variety of hematopoietic tumors, leukemias and lymphomas._Addition of extra material._A condition or state at a particular time.</PreferredDefinition>
      <LongName>MYC Gene Amplification Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7992781</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16887</PreferredName>
        <Version>1</Version>
        <LongName>MYC Gene</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16887</PREFERRED_NAME>
            <LONG_NAME>MYC Gene</LONG_NAME>
            <CON_ID>3236015</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7992782</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25418:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Amplification Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25418</PREFERRED_NAME>
            <LONG_NAME>Amplification</LONG_NAME>
            <CON_ID>2528524</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7992785</PublicId>
      <PreferredName>7992785v1.0</PreferredName>
      <PreferredDefinition>Any DNA sequence rearrangement that results in the gain of one or more copies of a DNA segment that contains at least one gene._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Gene Amplification Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>250</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>3124941</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16605:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Gene Amplification Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16605</PREFERRED_NAME>
            <LONG_NAME>Gene Amplification</LONG_NAME>
            <CON_ID>2991393</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unsatisfactory</VALIDVALUE>
          <VALUEMEANING>Unsatisfactory</VALUEMEANING>
          <MEANINGDESCRIPTION>Failing to meet the quantitative or qualitative measures for the needs of a situation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5255277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Amplified</VALIDVALUE>
          <VALUEMEANING>No Amplification</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: Addition of extra material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25418, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7992786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amplified</VALIDVALUE>
          <VALUEMEANING>Gene Amplification Positive</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that amplification of one or more genes of interest was detected in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7992788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MYC Status:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>MYC Status:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>MYC FISH testing:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 100</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>MYC test results:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>MYC FISH testing</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>MYC Status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GF_GFORRES_GENEAMP_MYC_BPC</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GF_GFORRES_GENEAMP_MYC_MCI</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="453">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>8024390</PUBLICID>
    <LONGNAME>Patient COVID-19 Vaccine Treatment Plan Clinical Trial Eligibility Criteria Yes No Indicator</LONGNAME>
    <PREFERREDNAME>PT_COV_VAX_PLN_ELIG_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indication as to whether the patient meets the eligibility requirements for participation in a clinical trial with regards to planning to receive a COVID-19 Vaccine.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>8024389</PublicId>
      <PreferredName>2236731v1.0:8024387v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Any vaccine that may prevent coronavirus disease-2019 (COVID-19) that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)._A document outlining the essential treatment issues which will be addressed. This may include the problem to be addressed, the proposed treatment, the treatment goal, the time frame to meet goals, and an estimate of the costs._In clinical trials, requirements that must be met for a person to be included in a trial. These requirements help make sure that participants in a trial are like each other in terms of specific factors such as age, type and stage of cancer, general health, and previous treatment. When all participants meet the same eligibility criteria, it is more likely that results of the study are caused by the intervention being tested and not by other factors or by chance.</PreferredDefinition>
      <LongName>Patient COVID-19 Vaccine Treatment Plan Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>8026573</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C173023:C60735:C16112</PreferredName>
        <Version>1</Version>
        <LongName>COVID-19 Vaccine Treatment Plan Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C173023</PREFERRED_NAME>
            <LONG_NAME>COVID-19 Vaccine</LONG_NAME>
            <CON_ID>7554829</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60735</PREFERRED_NAME>
            <LONG_NAME>Treatment Plan</LONG_NAME>
            <CON_ID>2919103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is patient planning to receiv</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is patient planning to receive one of the FDA approved/FDA-EUA approved COVID-19 vaccines?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient planning to receive their first vaccine dose OR has already received their first vaccine dose less than or equal to 24 months prior to enrollment using one of the FDA approved/FDA-EUA approved COVID-19 vaccines?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_COV_VAX_ELIG_IND</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="454">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>8083031</PUBLICID>
    <LONGNAME>Organism Infection Description Specify Text</LONGNAME>
    <PREFERREDNAME>4459415v1.0:6921623v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A textual description of the infection organism.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4459415</PublicId>
      <PreferredName>IfcOgzNm</PreferredName>
      <PreferredDefinition>information related to the known general term of a living thing for invasion and growth of microorganisms in bodily tissues.</PreferredDefinition>
      <LongName>Organism Infection Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008573</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223316</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14250</PreferredName>
        <Version>1</Version>
        <LongName>Organism</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14250</PREFERRED_NAME>
            <LONG_NAME>Organism</LONG_NAME>
            <CON_ID>2208240</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4461999</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0021311:C25365</PreferredName>
        <Version>1</Version>
        <LongName>Infection Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0021311</PREFERRED_NAME>
            <LONG_NAME>Infection</LONG_NAME>
            <CON_ID>2203024</CON_ID>
            <DEFINITION_SOURCE>CSP2003</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6921623</PublicId>
      <PreferredName>6921623v1.0</PreferredName>
      <PreferredDefinition>Be specific about something; define clearly._The words of something written.</PreferredDefinition>
      <LongName>Specify Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008552</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PHYS_DESC_OF_INDS</PreferredName>
        <Version>1</Version>
        <LongName>Physical Description of Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5000</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2799056</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25685:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Specify Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Name of organism or infection:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Name of organism or infection:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="455">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>8131255</PUBLICID>
    <LONGNAME>Auditory Test Method Type</LONGNAME>
    <PREFERREDNAME>AUMETHOD</PREFERREDNAME>
    <PREFERREDDEFINITION>The technique used to administer the audiologic assessment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>8131142</PublicId>
      <PreferredName>8131133v1.0:7092813v1.0</PreferredName>
      <PreferredDefinition>Of or relating to the process of hearing._An area of knowledge considered as a discrete unit for some purpose._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.</PreferredDefinition>
      <LongName>Auditory Domain Test Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>8131133</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37915:C62289</PreferredName>
        <Version>1</Version>
        <LongName>Auditory Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37915</PREFERRED_NAME>
            <LONG_NAME>Auditory</LONG_NAME>
            <CON_ID>2203757</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62289</PREFERRED_NAME>
            <LONG_NAME>Domain</LONG_NAME>
            <CON_ID>2553135</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7092813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47891:C71460</PreferredName>
        <Version>1</Version>
        <LongName>Test Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47891</PREFERRED_NAME>
            <LONG_NAME>Test</LONG_NAME>
            <CON_ID>2427511</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>8131203</PublicId>
      <PreferredName>AUTYP</PreferredName>
      <PreferredDefinition>Of or relating to the process of hearing._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Auditory Test Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>8131260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37915:C47891:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Auditory Test Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37915</PREFERRED_NAME>
            <LONG_NAME>Auditory</LONG_NAME>
            <CON_ID>2203757</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47891</PREFERRED_NAME>
            <LONG_NAME>Test</LONG_NAME>
            <CON_ID>2427511</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BONE CONDUCTION</VALIDVALUE>
          <VALUEMEANING>Bone Conduction Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>A test of the transmission of sound to the inner ear through the bones of the skull. This testing can measure functionality of the inner ear independent of the functionality of the outer and middle ears.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60916</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8131204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AIR CONDUCTION</VALIDVALUE>
          <VALUEMEANING>Air Conduction Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>An audiometric test of the transmission of sound through the air in the ear canal to the inner ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186675</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8140958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Method</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Method</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Test mode</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7668442</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Content</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH Compliant</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7668399</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="456">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10539566</PUBLICID>
    <LONGNAME>NHSPAQII Past Year Weekly Average Time Tennis, Squash, or Racquetball Duration</LONGNAME>
    <PREFERREDNAME>NHSPAQII_TNNS_DUR</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated response about the average time per week they spent at tennis, squash or racquetball, during the past year.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>10534419</PublicId>
      <PreferredName>10534406v1.00:10534418v1.00</PreferredName>
      <PreferredDefinition>_A prospective cohort study started in 1989 for single and married female nurses, ages 25 to 42. It looks at the impact on women&#39;s health of oral contraceptives initiated during adolescence, diet and physical activity in adolescence, lifestyle risk factors, as well as the diseases examined in the original nurses&#39; health study. The NHSII cohort is a younger population than the NHS Original Cohort:A period of time consisting of the 12 months before the present._Every week._A question about the average time that an individual spent playing tennis, squash, or racquetball.</PreferredDefinition>
      <LongName>Nurses&#39; Health Study II Past Year Weekly Average Time Tennis, Squash, or Racquetball</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>10534406</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C188144</PreferredName>
        <Version>1</Version>
        <LongName>Nurses&#39; Health Study II</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C188144</PREFERRED_NAME>
            <LONG_NAME>Nurses&#39; Health Study II</LONG_NAME>
            <CON_ID>10497249</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>10534418</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C125217:C67069:C188154</PreferredName>
        <Version>1</Version>
        <LongName>Past Year Weekly Average Time Tennis, Squash, or Racquetball</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125217</PREFERRED_NAME>
            <LONG_NAME>Past Year</LONG_NAME>
            <CON_ID>5108191</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67069</PREFERRED_NAME>
            <LONG_NAME>Weekly</LONG_NAME>
            <CON_ID>2730407</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C188154</PREFERRED_NAME>
            <LONG_NAME>Average Time Tennis, Squash, or Racquetball Question</LONG_NAME>
            <CON_ID>10497255</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2970429</PublicId>
      <PreferredName>2970429v1.0</PreferredName>
      <PreferredDefinition>The period of time during which something occurs per week within a given month.</PreferredDefinition>
      <LongName>Week Month Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2970696</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29844:C29846:C25330</PreferredName>
        <Version>1</Version>
        <LongName>Week Month Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29844</PREFERRED_NAME>
            <LONG_NAME>Week</LONG_NAME>
            <CON_ID>2203710</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11 or more hours</VALIDVALUE>
          <VALUEMEANING>11 or more hours</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 11 or more hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7 to 10 hours</VALIDVALUE>
          <VALUEMEANING>7 to 10 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 7 to 10 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4 to 6 hours</VALIDVALUE>
          <VALUEMEANING>4 to 6 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 4 to 6 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2 to 3 hours</VALIDVALUE>
          <VALUEMEANING>2 to 3 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 2 to 3 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 to 1.5 hours</VALIDVALUE>
          <VALUEMEANING>1 to 1.5 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 1 to 1.5 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 hour</VALIDVALUE>
          <VALUEMEANING>1 hour</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 1 hour</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20 to 59 min.</VALIDVALUE>
          <VALUEMEANING>20 to 59 minutes</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 20 to 59 minutes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5 to 19 min.</VALIDVALUE>
          <VALUEMEANING>5 to 19 minutes</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 5 to 19 minutes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 to 4 min.</VALIDVALUE>
          <VALUEMEANING>1 to 4 minutes</VALUEMEANING>
          <MEANINGDESCRIPTION>1 to 4 minutes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970438</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zero</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>A mathematical element that when added to another number yields the same number; the cardinal number meaning one less than one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2683226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tennis, squash, racquetball</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tennis, squash, racquetball</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="457">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10563133</PUBLICID>
    <LONGNAME>Lost Productivity Occurrence Day Number</LONGNAME>
    <PREFERREDNAME>LT_PRD_OCC_D_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>A number that identifies how many days of lost productivity occurred.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>10563131</PublicId>
      <PreferredName>6160815v1.00:2234856v1.00</PreferredName>
      <PreferredDefinition>Parted with; no longer held or possessed; incapable of being recovered or regained._The ratio of the quantity and quality of units produced to the labor per unit of time.:An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Lost Productivity Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6160815</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25560:C86582</PreferredName>
        <Version>1</Version>
        <LongName>Lost Productivity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25560</PREFERRED_NAME>
            <LONG_NAME>Lost</LONG_NAME>
            <CON_ID>2204933</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C86582</PREFERRED_NAME>
            <LONG_NAME>Productivity</LONG_NAME>
            <CON_ID>3128137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCTG: Canadian Cancer Trials Group</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2184729</PublicId>
      <PreferredName>DAY_NUM</PreferredName>
      <PreferredDefinition>information related to the day number.</PreferredDefinition>
      <LongName>Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184315</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Number</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How many days of lost productivity occurred?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify number of days:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_DAYS_LPA_05</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_DAYS_LPA_06A</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_DAYS_LPA_06B</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_DAYS_LPA_08</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_DAYS_LPA_09</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_DAYS_LPUPC_02</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_DAYS_LPUPC_03</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="458">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10908249</PUBLICID>
    <LONGNAME>EORTC QLQ-CR29 Version 2.1 50 Past Week Leakage of Stools Back Passage Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>EORTC_QLQCR29_50_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated response during the past week of having leakage of stools from their back passage, using a 4-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>10882782</PublicId>
      <PreferredName>10882720v1.00:10882781v1.00</PreferredName>
      <PreferredDefinition>_A question associated with the EORTC QLQ-CR29 Version 2.1 questionnaire:The most recent week. May include the present day._European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Module Version 2.1 (EORTC QLQ-CR29 Version 2.1) During the past week: Have you had leakage of stools from your back passage?_A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>EORTC QLQ-CR29 Version 2.1 Questionnaire Question Past Week EORTC QLQ-CR29 Version 2.1 - Leakage of Stools Back Passage Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>10882720</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C170531</PreferredName>
        <Version>1</Version>
        <LongName>EORTC QLQ-CR29 Version 2.1 Questionnaire Question</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C170531</PREFERRED_NAME>
            <LONG_NAME>EORTC QLQ-CR29 Version 2.1 Questionnaire Question</LONG_NAME>
            <CON_ID>10043266</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>10882781</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C170683:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week EORTC QLQ-CR29 Version 2.1 - Leakage of Stools Back Passage Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C170683</PREFERRED_NAME>
            <LONG_NAME>EORTC QLQ-CR29 Version 2.1 - Leakage of Stools Back Passage</LONG_NAME>
            <CON_ID>10041464</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4728552</PublicId>
      <PreferredName>EORTC_4PT_SCL</PreferredName>
      <PreferredDefinition>Numeric scores from 1 (Not at All) to 4 (Very Much) on a Likert scale used on EORTC questionnaires.</PreferredDefinition>
      <LongName>EORTC Score 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>EORTC QLQ-C30:European Organization for Research and Treatment of Cancer Quality of Life Group, Questionnaire C30, Version 3. 1995</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A Little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4733151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a great amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you had leakage of stools from your back passage?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Rectal Cancer Female Sexuality Score</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question 27 of 35</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>2</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions. Questions used in this manner do not represent the original measure and should not be referenced by the measure’s name.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>3</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EORTC QLQ-CR29</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15869800</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_QLQCR29_50</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="459">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10984702</PUBLICID>
    <LONGNAME>Prior Therapy Name Text</LONGNAME>
    <PREFERREDNAME>PRTHRPNM</PREFERREDNAME>
    <PREFERREDDEFINITION>The prior therapy/ drug name, found as the EVS display name.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PMI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PMI CDISC Harmonization</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>10983889</PublicId>
      <PreferredName>2747595v1.00:2430155v1.00</PreferredName>
      <PreferredDefinition>Prior action or administration of therapeutic agents that produced an effect that is intended to alter or stop a pathologic process.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Prior Therapy Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PMI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2747595</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16124</PreferredName>
        <Version>1</Version>
        <LongName>Prior Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16124</PREFERRED_NAME>
            <LONG_NAME>Prior Therapy</LONG_NAME>
            <CON_ID>2202433</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PMI CDISC Harmonization</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2815301</PublicId>
      <PreferredName>2815301v1.0</PreferredName>
      <PreferredDefinition>The words or language units by which a thing is known._Text; the words of something written.</PreferredDefinition>
      <LongName>Name Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2436186</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Name Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Prior therapy name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7765162</PublicId>
          <ContextName>PMI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Precision Medicine Initiative</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PMI CDISC EC Template v1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10882766</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_1</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_2</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_3</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_4</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_5</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_6</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_7</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_8</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_9</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_10</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_11</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_12</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_13</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_14</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_15</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_16</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_17</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_18</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_19</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_20</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_21</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_22</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_23</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_24</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_25</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_26</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_27</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_28</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_29</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTHRPNM_30</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="460">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>11060758</PUBLICID>
    <LONGNAME>Disease Response Domain Non-Target Lesion Identification Overall Response Status</LONGNAME>
    <PREFERREDNAME>DR_NTLOR_ST</PREFERREDNAME>
    <PREFERREDDEFINITION>The text term that represents the status of Non-Target Lesion Identification Overall Response.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6941733</PublicId>
      <PreferredName>6608777v1.0:6941731v1.0</PreferredName>
      <PreferredDefinition>A domain for disease response evaluations._The identification of a lesion that is not considered a target lesion but may be affected by the therapeutic intervention._An assessment of the overall response of the disease to the therapy.</PreferredDefinition>
      <LongName>Disease Response Domain Non-Target Lesion Identification Overall Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6608777</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C107097</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107097</PREFERRED_NAME>
            <LONG_NAME>Disease Response Domain</LONG_NAME>
            <CON_ID>6608776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6941731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C94521:C96613</PreferredName>
        <Version>1</Version>
        <LongName>Non-Target Lesion Identification Overall Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94521</PREFERRED_NAME>
            <LONG_NAME>Non-Target Lesion Identification</LONG_NAME>
            <CON_ID>3859321</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C96613</PREFERRED_NAME>
            <LONG_NAME>Overall Response</LONG_NAME>
            <CON_ID>4273163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCI CRF Standards</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6345652</PublicId>
      <PreferredName>6345652v2.0</PreferredName>
      <PreferredDefinition>The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Disease Response Status</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>250</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>6612626</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50995:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50995</PREFERRED_NAME>
            <LONG_NAME>Disease Response</LONG_NAME>
            <CON_ID>2459436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to Assess (UA)</VALIDVALUE>
          <VALUEMEANING>Cannot Be Assessed</VALUEMEANING>
          <MEANINGDESCRIPTION>Aspects of the context prevent the evaluation needed to determine a value.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48657</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2897789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Incomplete Response/Stable Disease (IR/SD)</VALIDVALUE>
          <VALUEMEANING>Incomplete Response/Stable Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Persistence of one or more non-target lesions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6345656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complete Response (CR)</VALIDVALUE>
          <VALUEMEANING>Complete Response</VALUEMEANING>
          <MEANINGDESCRIPTION>The disappearance of all signs of cancer in response to treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Progressive Disease (PD)</VALIDVALUE>
          <VALUEMEANING>Progressive Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Cancer that is increasing in scope or severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial Response (PR)</VALIDVALUE>
          <VALUEMEANING>Partial Response</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stable Disease (SD)</VALIDVALUE>
          <VALUEMEANING>Stable Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Cancer that is neither decreasing nor increasing in extent or severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-CR/Non-PD</VALIDVALUE>
          <VALUEMEANING>Non Complete Response/Non Progressive Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96700</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5946383</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not present</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Continued Complete Response (CCR)</VALIDVALUE>
          <VALUEMEANING>Continued Complete Response</VALUEMEANING>
          <MEANINGDESCRIPTION>The patient had achieved a complete response; received more therapy and continued in complete response.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Non-Target Lesions overall response</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RS_RSORRES_NTRGRESP</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RS_RSORRES_NTRGRESP_CNS</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="461">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>11167724</PUBLICID>
    <LONGNAME>Person Medical History Change From Last Visit Seen Yes No Indicator</LONGNAME>
    <PREFERREDNAME>PRSN_MH_CHNGE_Y/N_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>An Yes/No indicator to indicate any changes in Person Medical History since last visit.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>11167722</PublicId>
      <PreferredName>11167720v1.00:11167721v1.00</PreferredName>
      <PreferredDefinition>A record of a patient&#39;s background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies._The act of alteration or modification; changed or altered in form or character._Used to indicate a specified place or time as a starting point; used to indicate a source, cause, agent, or instrument.:An indication of the most recent visit during which a particular event or status was noted.</PreferredDefinition>
      <LongName>Personal Medical History Change From Last Visit Seen</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>11167720</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18772:C25446:C25516</PreferredName>
        <Version>1</Version>
        <LongName>Personal Medical History Change From</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25516</PREFERRED_NAME>
            <LONG_NAME>From</LONG_NAME>
            <CON_ID>2206220</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>11167721</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C159694</PreferredName>
        <Version>1</Version>
        <LongName>Last Visit Seen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159694</PREFERRED_NAME>
            <LONG_NAME>Last Visit Seen</LONG_NAME>
            <CON_ID>10037612</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have there been any changes in the participant&#39;s medical history since the last visit?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Have there been any changes in the participant&#39;s medical/surgical history since the last visit?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Have there been any changes in the participant&#39;s medical/surgical history since the last visit when medical history was assessed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRSN_MH_CHNGE_Y_N_IND</AlternateName>
        <AlternateNameType>DCP Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="462">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>11190087</PUBLICID>
    <LONGNAME>Cancer Prevention Vaccinated Due To Lynch Syndrome Assessment Scale</LONGNAME>
    <PREFERREDNAME>CNCR_PRVNT_VACCN_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated response to have vaccinated for Cancer Prevention due to Lynch syndrome, using Assessment Scale</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>11190086</PublicId>
      <PreferredName>11190084v1.00:11190085v1.00</PreferredName>
      <PreferredDefinition>All methods of preventing cancer including limit of exposure to carcinogens and infectious agents, diet, education, etc_A status indicating that an individual has received a vaccination.:Caused by or resulting from._An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma. Patients often develop colorectal carcinomas at an early age (mean, 45 years). In the majority of the cases the lesions arise from the proximal colon. At the molecular level, high-frequency microsatellite instability is present.</PreferredDefinition>
      <LongName>Cancer Prevention Vaccinated Due To Lynch Syndrome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>11190084</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15669:C28385</PreferredName>
        <Version>1</Version>
        <LongName>Cancer Prevention Vaccinated</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15669</PREFERRED_NAME>
            <LONG_NAME>Cancer Prevention</LONG_NAME>
            <CON_ID>2959066</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28385</PREFERRED_NAME>
            <LONG_NAME>Vaccinated</LONG_NAME>
            <CON_ID>10060909</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>11190085</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C89272:C8494</PreferredName>
        <Version>1</Version>
        <LongName>Due To Lynch Syndrome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C89272</PREFERRED_NAME>
            <LONG_NAME>Due To</LONG_NAME>
            <CON_ID>3111313</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C8494</PREFERRED_NAME>
            <LONG_NAME>Lynch Syndrome</LONG_NAME>
            <CON_ID>2716423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>11190079</PublicId>
      <PreferredName>11190079v1.00</PreferredName>
      <PreferredDefinition>The final result of a determination of the value, significance, or extent of._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Assessment Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>6586855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25217:C25664</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely</VALIDVALUE>
          <VALUEMEANING>Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a great amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7590024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very</VALIDVALUE>
          <VALUEMEANING>Very</VALUEMEANING>
          <MEANINGDESCRIPTION>Existing to a great degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116076</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11256809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>My doctors would want me to have a vaccine to protect against cancer due to Lynch syndrome.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="463">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>11192546</PUBLICID>
    <LONGNAME>How Often Worry about Developing Cancer Post Cancer Prevention Vaccination Assessment Scale</LONGNAME>
    <PREFERREDNAME>WRY_DEV_CNCR_PST_VACCN_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated response of worried about getting  cancer even after cancer prevention vaccination, using Assessment Scale</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>11192544</PublicId>
      <PreferredName>11190081v1.00:11192543v1.00</PreferredName>
      <PreferredDefinition>A question about how often an individual worries or has worried about developing cancer.:Happening at a time subsequent to a reference time; later in time or order._A vaccination design to provide protection from a type of cancer.</PreferredDefinition>
      <LongName>How Often Worry about Developing Cancer Post Cancer Prevention Vaccination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>11190081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C176447</PreferredName>
        <Version>1</Version>
        <LongName>How Often Worry about Developing Cancer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C176447</PREFERRED_NAME>
            <LONG_NAME>How Often Worry about Developing Cancer Question</LONG_NAME>
            <CON_ID>7527858</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>11192543</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38008:C63337</PreferredName>
        <Version>1</Version>
        <LongName>Post Cancer Prevention Vaccination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63337</PREFERRED_NAME>
            <LONG_NAME>Cancer Prevention Vaccination</LONG_NAME>
            <CON_ID>10080853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>11190079</PublicId>
      <PreferredName>11190079v1.00</PreferredName>
      <PreferredDefinition>The final result of a determination of the value, significance, or extent of._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Assessment Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>6586855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25217:C25664</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely</VALIDVALUE>
          <VALUEMEANING>Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a great amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7590024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very</VALIDVALUE>
          <VALUEMEANING>Very</VALUEMEANING>
          <MEANINGDESCRIPTION>Existing to a great degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116076</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11256809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I might get cancer even if I take the vaccine.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="464">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>11449440</PUBLICID>
    <LONGNAME>Neuro-QOL Item Bank v2.0 Adult Mental Health Cognitive Function NQCOG68r1 Past 7 Days How Often Had Trouble Remembering New Information Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>NQCOG68R1_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how often during the past 7 days they had trouble remembering new information, like phone numbers or simple instructions, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Neuro-QoL Item Bank v2.0  - Cognitive Function, David Cella and PROMIS Health Organization on behalf of NINDS. Sept. 8, 2014.</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>11449412</PublicId>
      <PreferredName>11449388v1.00:11449411v1.00</PreferredName>
      <PreferredDefinition>A domain of the Quality of Life in Neurological Disorders that assesses the status of an adult individual&#39;s mental health._The collection of Neuro-QoL item scales that assess perceived difficulties in cognitive abilities related to both executive function and general concerns.:_The most recent week. May include the present day._A question about how often an individual has or had trouble remembering new information like phone numbers or simple instructions._A number or range of numeric values measuring performance, function, quality, or ability</PreferredDefinition>
      <LongName>Neuro-QoL Adult Self-Reported Mental Health Domain Neuro QoL Cognitive Function Subdomain Past Week How Often Had Trouble Remembering New Information Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5920628</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C137841:C137842</PreferredName>
        <Version>1</Version>
        <LongName>Neuro-QoL Adult Self-Reported Mental Health Domain Neuro QoL Cognitive Function Subdomain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C137841</PREFERRED_NAME>
            <LONG_NAME>Neuro-QoL Adult Self-Reported Mental Health Domain</LONG_NAME>
            <CON_ID>5919203</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C137842</PREFERRED_NAME>
            <LONG_NAME>Neuro QoL Cognitive Function Subdomain</LONG_NAME>
            <CON_ID>5919204</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>11449411</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C190229:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week How Often Had Trouble Remembering New Information Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C190229</PREFERRED_NAME>
            <LONG_NAME>How Often Had Trouble Remembering New Information Question</LONG_NAME>
            <CON_ID>11421508</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5920652</PublicId>
      <PreferredName>NEUROQOL_RVFREQ_SCL</PreferredName>
      <PreferredDefinition>A set of self-reported and proxy-reported measures of physical, mental, and social health for adults and children living with a neurological condition._An ordered reference standard used with the Neuro-QoL item bank that describes a reverse range of subjective scores for representing how often an individual experiences something from 5: Never, to 1: Very often.</PreferredDefinition>
      <LongName>Neuro-QoL Reverse Frequency 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>Neuro-QoL Item Bank v2.0  - Cognitive Function, David Cella and PROMIS Health Organization on behalf of NINDS. Sept. 8, 2014.</Origin>
      <Representation>
        <PublicId>5920651</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C137840:C25664</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life in Neurological Disorders Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C137840</PREFERRED_NAME>
            <LONG_NAME>Quality of Life in Neurological Disorders</LONG_NAME>
            <CON_ID>5919202</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Rarely (Once)</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4869035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Sometimes (Two or three times)</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4869034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Often (About once a day)</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something occurs frequently.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4869033</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Very Often (Several times a day)</VALUEMEANING>
          <MEANINGDESCRIPTION>On most occasions, or in most situations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91245</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4869032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I had trouble remembering new information, like phone numbers or simple instructions</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Neuro-QOL Item Bank v2.0 - Cognitive Function</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #17 of 28</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="465">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>12922548</PUBLICID>
    <LONGNAME>Exposure as Collected Domain Dose Interruption Reason</LONGNAME>
    <PREFERREDNAME>EC_ECITRPRS</PREFERREDNAME>
    <PREFERREDDEFINITION>The reason that specifies why the dose was interrupted.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>12922547</PublicId>
      <PreferredName>6407207v1.00:12922546v1.00</PreferredName>
      <PreferredDefinition>This interventions domain model reflects protocol-specified study treatment administrations, as collected.:A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._A time interval during which there is a temporary cessation of something._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Exposure as Collected Domain Dose Interruption Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117466</PreferredName>
        <Version>1</Version>
        <LongName>Exposure as Collected Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117466</PREFERRED_NAME>
            <LONG_NAME>Exposure as Collected Domain</LONG_NAME>
            <CON_ID>6407206</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>12922546</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488:C25542:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Dose Interruption Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25542</PREFERRED_NAME>
            <LONG_NAME>Interruption</LONG_NAME>
            <CON_ID>2203831</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7426104</PublicId>
      <PreferredName>7426104v1.0</PreferredName>
      <PreferredDefinition>Specified quantity of a medicine, to be taken at one time or at stated intervals. [ISO 11615:2012 Health Informatics]_Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Dose Delay Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>7434008</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488:C25476:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Dose Delay Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25476</PREFERRED_NAME>
            <LONG_NAME>Delay</LONG_NAME>
            <CON_ID>2203898</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucositis (Grade 3 or greater)</VALIDVALUE>
          <VALUEMEANING>Mucositis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the mucous membranes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C115965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7492308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated creatinine (Grade 2 or greater)</VALIDVALUE>
          <VALUEMEANING>Elevated Creatinine</VALUEMEANING>
          <MEANINGDESCRIPTION>Raised or increased above normal levels or limits.: The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C399, C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7492335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low platelets (Grade 1 or greater)</VALIDVALUE>
          <VALUEMEANING>Low Platelet Count</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimum level or position or degree; less than normal in degree, intensity or amount.: The determination of the number of platelets in a blood sample, usually expressed as platelets per cubic millimeter (cmm) of whole blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51951, C54722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7492332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated ALT/AST (Grade 4)</VALIDVALUE>
          <VALUEMEANING>Laboratory Test Result Elevated</VALUEMEANING>
          <MEANINGDESCRIPTION>The outcome of a laboratory test.: Raised or increased above normal levels or limits.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25493, C36292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7549569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated liver enzymes</VALIDVALUE>
          <VALUEMEANING>Elevated Liver Enzyme</VALUEMEANING>
          <MEANINGDESCRIPTION>Elevated; raised or increased.: A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.: A protein that speeds up chemical reactions in the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16554, C12392, C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2801062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3126125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infection</VALIDVALUE>
          <VALUEMEANING>Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6610519</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renal dysfunction</VALIDVALUE>
          <VALUEMEANING>Renal Dysfunction</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the kidney.: Disturbance, impairment or abnormality of function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53526, C25225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7415464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated triglycerides</VALIDVALUE>
          <VALUEMEANING>Elevated Triglycerides</VALUEMEANING>
          <MEANINGDESCRIPTION>Raised or increased above normal levels or limits.: Fats composed of three fatty acid chains linked to a glycerol molecule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C906, C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7426106</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated direct bilirubin (greater than 2mg/dL)</VALIDVALUE>
          <VALUEMEANING>Elevated Direct Bilirubin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>Raised or increased above normal levels or limits.: The bilirubin is bound to glucuronide to form conjugated bilirubin (direct bilirubin). Direct Bilirubin measurement is accomplished by a colorimetric method. Direct Bilirubin in biological fluids reacts with sulfanilic acid at acidic pH to produce a red colored complex. The optical density of produced color has a direct relationship with Direct Bilirubin concentration in the solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64481, C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7492334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated ALT (Grade 3 or greater)</VALIDVALUE>
          <VALUEMEANING>Elevated Alanine Aminotransferase Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>Raised or increased above normal levels or limits.: A quantitative measurement of alanine aminotransferase present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64433, C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7492333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low ANC (Grade 3 or greater)</VALIDVALUE>
          <VALUEMEANING>Low Absolute Neutrophil Count</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimum level or position or degree; less than normal in degree, intensity or amount.: The real number of white blood cells (WBC) that are neutrophils. It is derived by multiplying the WBC count by the percent of neutrophils in the differential WBC count. The normal range for ANC is 1.5 to 8.0 (1,500 to 8,000/mm3).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63321, C54722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7492330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low platelets (Grade 3 or greater)</VALIDVALUE>
          <VALUEMEANING>Low Platelet Count</VALUEMEANING>
          <MEANINGDESCRIPTION>A lower than average level of platelets in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C162108</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12922540</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological toxicity</VALIDVALUE>
          <VALUEMEANING>Hematologic Toxicity</VALUEMEANING>
          <MEANINGDESCRIPTION>A toxicity that impairs or damages the hematologic system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C185640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14900856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-hematological toxicity</VALIDVALUE>
          <VALUEMEANING>Non-Hematologic Toxicity</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._A toxicity that impairs or damages the hematologic system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C185640, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor lysis syndrome (TLS)</VALIDVALUE>
          <VALUEMEANING>Tumor Lysis Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and T cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944002</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate or strong CYP3A4/5 inhibitor</VALIDVALUE>
          <VALUEMEANING>Moderate Or Strong CYP3A4 Inhibitor And/Or CYP3A5 Inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Having strength, power, or intensity greater than average or expected._Any substance capable of decreasing the activity of cytochrome P450 3A4._Used to indicate that either or both of two items or options may be valid._Any substance capable of decreasing the activity of cytochrome P450 3A5.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C155914, C48928, C111373, C62223, C37998, C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14900859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolism and nutrition adverse event</VALIDVALUE>
          <VALUEMEANING>Pharmacokinetics: Metabolism And Nutrition Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._That which is consumed to fuel necessary life processes of an organism._Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41331, C28294, C37912, C79371</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14900872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disseminated intravascular coagulation, hemolysis, hemolytic uremic syndrome, thrombotic thrombocytopenic purpura</VALIDVALUE>
          <VALUEMEANING>Disseminated Intravascular Coagulation Hemolysis Hemolytic Uremic Syndrome Thrombotic Thrombocytopenic Purpura</VALUEMEANING>
          <MEANINGDESCRIPTION>A pathological process where the blood starts to coagulate throughout the whole body. This depletes the body of its platelets and coagulation factors, and there is an increased risk of hemorrhage._Disruption of the integrity of the erythrocyte membrane causing release of hemoglobin._Acute kidney injury associated with microangiopathic hemolytic anemia and thrombocytopenia._A coagulation disorder characterized by extensive formation of thrombi in small blood vessels throughout the body due to low levels of ADAMTS13 protein, and resulting in consumption of circulating platelets, which is characterized by thrombocytopenia, anemia, neurologic changes, and sometimes fever and renal dysfunction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78797, C75545, C37965, C2992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14900871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thromboembolic event</VALIDVALUE>
          <VALUEMEANING>Thromboembolism</VALUEMEANING>
          <MEANINGDESCRIPTION>Occlusion of the lumen of a vessel by a thrombus that has migrated from a distal site via the blood stream.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3024906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytokine release syndrome</VALIDVALUE>
          <VALUEMEANING>Cytokine Release Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seizure</VALIDVALUE>
          <VALUEMEANING>Seizure</VALUEMEANING>
          <MEANINGDESCRIPTION>Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5026016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Psychiatric finding and/or nervous system disorder</VALIDVALUE>
          <VALUEMEANING>Psychiatric Finding And/Or Nervous System Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Symptoms, physical examination results, and/or laboratory test results related to mental health._Used to indicate that either or both of two items or options may be valid._A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26835, C48928, C168404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14900870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Technical problem</VALIDVALUE>
          <VALUEMEANING>Technical Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>A problem with some technical aspect of a clinical study, usually related to an instrucment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nephritis/renal failure</VALIDVALUE>
          <VALUEMEANING>Nephritis Or Renal Failure</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of renal tissue._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4376, C37998, C26833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15380603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pneumonitis</VALIDVALUE>
          <VALUEMEANING>Pneumonitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process affecting the lung parenchyma. It is a milder form of lung inflammation compared to pneumonia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7318722</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatitis</VALIDVALUE>
          <VALUEMEANING>Pancreatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the pancreas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurologic</VALIDVALUE>
          <VALUEMEANING>Neurologic</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to nerves or the nervous system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5235831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiac toxicity (including CHF, LV systolic dysfunction, myocarditis)</VALIDVALUE>
          <VALUEMEANING>Cardiotoxicity Inclusive Congestive Heart Failure Left Ventricular Systolic Dysfunction Myocarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>Toxicity that impairs or damages the heart. This condition is often caused by the administration of a pharmaceutical agent that initiates a poisonous or toxic response in cardiac tissue._Including the stated limits._Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales._The degree of impairment of the left cardiac ventricle to contract efficiently. (ACC)_Inflammation of the muscle tissue of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64251, C34831, C3080, C166400, C27994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15380602</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infusion reaction</VALIDVALUE>
          <VALUEMEANING>Infusion-Related Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A reaction to the infusion of pharmacological or biological substances. Symptoms may appear within minutes to hours following the infusion and may include pruritus, flushing, swelling, dyspnea, bronchospasm, and hypotension.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78361</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine abnormality (including hypophysitis)</VALIDVALUE>
          <VALUEMEANING>Endocrine Abnormality Inclusive Hypophysitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Collective designation for those tissues capable of secreting hormones._A condition that differs from the usual physical or mental state._Including the stated limits._An inflammatory process in the pituitary gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121147, C166400, C9440, C41064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15380601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Type 1 diabetes mellitus (new onset)</VALIDVALUE>
          <VALUEMEANING>Type 1 Diabetes Mellitus New Onset</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic condition characterized by minimal or absent production of insulin by the pancreas._Having no previous example or precedent or parallel; of a kind not seen before._The start, beginning, or early stages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25279, C25586, C2986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15380600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated LFTs/bilirubin</VALIDVALUE>
          <VALUEMEANING>Elevated Liver Function Test Or Bilirubin</VALUEMEANING>
          <MEANINGDESCRIPTION>Raised or increased above normal levels or limits._The quantitative measurement of liver enzymes in the blood, which is useful in assessing the functional state of a patient&#39;s liver. Liver function tests include the measurement of albumin, alanine transaminase, aspartate transaminase, alkaline phosphatase, bilirubin, and gamma glutamyl transferase._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A dark orange, yellow pigment that is the product of the breakdown of iron in the blood; it is conjugated in the liver and excreted in the bile.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C305, C37998, C74954, C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15380599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diarrhea/Colitis</VALIDVALUE>
          <VALUEMEANING>Diarrhea Or Colitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Watery bowel movements._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Inflammation of the colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26723, C37998, C2987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15380598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rash</VALIDVALUE>
          <VALUEMEANING>Skin Rash</VALUEMEANING>
          <MEANINGDESCRIPTION>Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If yes, reason for dose interruption:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the reason for any dose reduction/interruption to blinatumomab administration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the reason for any dose reduction/interruption to venetoclax administration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the reason for any dose modifications or additions/omissions to Nivolumab administration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the reason for any dose modification/interruption to blinatumomab administration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECITRPRS_6MP</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECDOSADJ_INT_VNTCLX_R</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECDOSADJ_INT_VNTCLX_AR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECDOSADJ_INT_BLINA_R</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECDOSADJ_INT_BLINA_G</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECADJ_VNTCLX</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECADJ_BLINA_KMT2AR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECADJ_BLINA_KMT2AG</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECADJ_VNTCLX_TULYSSYDM</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECADJ_VNTCLX_INHB_CYP3A45</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECADJ_BLINA_KMT2AR_ISS</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECADJ_BLINA_KMT2AR_PAE</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECADJ_BLINA_KMT2AR_SZR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECADJ_BLINA_KMT2AR_CAE</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECADJ_BLINA_KMT2AR_MAE</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EC_ECADJ_BLINA</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="466">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>12952392</PUBLICID>
    <LONGNAME>Increase Digestive System Therapy-Related Toxicity Adverse Event Severity Grade</LONGNAME>
    <PREFERREDNAME>INC_GI_TX_TOX_AE_GR</PREFERREDNAME>
    <PREFERREDDEFINITION>The increased therapy related toxicity severity grade to the digestive system.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>12952367</PublicId>
      <PreferredName>5262052v1.00:12952362v1.00</PreferredName>
      <PreferredDefinition>A process of becoming larger, more numerous, more important, or more likely.:The system that includes the esophagus, stomach, small and large intestine, anus, liver, biliary tract, and pancreas._The finding of bodily harm due to the poisonous effects associated with the action or administration of therapeutic agents.</PreferredDefinition>
      <LongName>Increase Digestive System Therapy-Related Toxicity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5262052</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25533</PreferredName>
        <Version>1</Version>
        <LongName>Increase</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25533</PREFERRED_NAME>
            <LONG_NAME>Increase</LONG_NAME>
            <CON_ID>2203826</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>12952362</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12378:C42607</PreferredName>
        <Version>1</Version>
        <LongName>Digestive System Therapy-Related Toxicity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12378</PREFERRED_NAME>
            <LONG_NAME>Digestive System</LONG_NAME>
            <CON_ID>2593722</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42607</PREFERRED_NAME>
            <LONG_NAME>Therapy-Related Toxicity</LONG_NAME>
            <CON_ID>2637268</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2943992</PublicId>
      <PreferredName>AE_SEV_GD</PreferredName>
      <PreferredDefinition>Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used._Severity; used of the degree of something undesirable e.g. pain or weather._A position on a scale of intensity or amount or quality.</PreferredDefinition>
      <LongName>Adverse Event Severity Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTCAE:Common TerminologyCriteria for Adverse Events</Origin>
      <Representation>
        <PublicId>2944509</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331:C25676:C41331:C48309</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Severity Adverse Event Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Absent Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>Grade 0 is universally defined as absence of Adverse Events or within normal limits or values.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Mild Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>An adverse event that is asymptomatic; or involves mild or minor symptoms; or is of marginal clinical relevance; or consists of clinical or diagnostic observations alone; or for which intervention is not indicated; or for which only non-prescription intervention is indicated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Moderate Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>An adverse event for which only minimal, local, or noninvasive intervention (e.g. packing, cautery) is indicated; or that limits instrumental activities of daily living (ADLs, e.g., shopping, laundry, transportation, or ability to conduct finances).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Severe Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>An adverse event that is medically significant but not life-threatening; or for which inpatient care or prolongation of hospitalization are indicated; or that is an important medical event that does not result in hospitalization, but may jeopardize the patient or may require intervention either to prevent hospitalization, to prevent the AE from becoming life-threatening or causing death; or that is disabling; or that results in persistent or significant disability, incapacity, or limitation of self care activities of daily living (ADLs, e.g., getting in and out of bed, dressing, eating, getting around inside, bathing, or using the toilet).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Death Related to Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>The termination of life associated with an adverse event.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2660006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Life Threatening Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>An adverse event that has life-threatening consequences; for which urgent intervention is indicated; that puts the patient at risk of death at the time of the event if immediate intervention is not undertaken.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84266</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the increased therapy related toxicity severity grade to the digestive system?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCR Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>GI - Increase in Treatment-Related Toxicity from Baseline</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="467">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>13443888</PUBLICID>
    <LONGNAME>Disease or Disorder Immunotherapy-Related Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>DZ_ITX_RELT_CD_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded indicator to determine clinical trial participation for questions that addresses disease or disorder related to immunotherapy as outlined to the study protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>13443884</PublicId>
      <PreferredName>2404658v1.00:13443883v1.00</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:An observation that a situation is related to immunotherapy received._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Disease or Disorder Immunotherapy-Related Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>13443883</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C168874:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Immunotherapy-Related Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C168874</PREFERRED_NAME>
            <LONG_NAME>Immunotherapy-Related</LONG_NAME>
            <CON_ID>10043352</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have an ongoing greater than or equal to Grade 3 immunotherapy-related hypothyroidism or panhypopituitarism?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="468">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>13474626</PUBLICID>
    <LONGNAME>Pulmonary Nodule Density Type</LONGNAME>
    <PREFERREDNAME>LDCTDensity</PREFERREDNAME>
    <PREFERREDDEFINITION>The response describing the type of lung nodule density as determined using a computed tomography scan.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCG:Center for Cancer Genomics</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>13472803</PublicId>
      <PreferredName>8177601v1.00:2261962v1.00</PreferredName>
      <PreferredDefinition>A benign or malignant small, oval or round growth in the lung. It can be due to infectious, inflammatory or neoplastic processes.:The amount of something per unit size.</PreferredDefinition>
      <LongName>Pulmonary Nodule Density</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>8177601</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C122407</PreferredName>
        <Version>1</Version>
        <LongName>Pulmonary Nodule</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122407</PREFERRED_NAME>
            <LONG_NAME>Pulmonary Nodule</LONG_NAME>
            <CON_ID>5612343</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2261962</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45781</PreferredName>
        <Version>1</Version>
        <LongName>Density</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45781</PREFERRED_NAME>
            <LONG_NAME>Density</LONG_NAME>
            <CON_ID>2236512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>13474500</PublicId>
      <PreferredName>13474500v1.00</PreferredName>
      <PreferredDefinition>A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors._The amount of something per unit size._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Lung Carcinoma Density Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>13474594</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>13474594v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Lung Carcinoma Density Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4878</PREFERRED_NAME>
            <LONG_NAME>Lung Carcinoma</LONG_NAME>
            <CON_ID>2202892</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45781</PREFERRED_NAME>
            <LONG_NAME>Density</LONG_NAME>
            <CON_ID>2236512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Solid nodule</VALIDVALUE>
          <VALUEMEANING>Solid Pulmonary Nodule</VALUEMEANING>
          <MEANINGDESCRIPTION>A pulmonary nodule with well-defined margins and homogenous soft-tissue attenuation on CT scan examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C138143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13474559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Part solid nodule</VALIDVALUE>
          <VALUEMEANING>Part-Solid Ground-Glass Pulmonary Nodule</VALUEMEANING>
          <MEANINGDESCRIPTION>A term that refers to a pulmonary nodule in which part of the ground-glass opacity completely obscures the parenchyma on CT scan examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13474560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Subsolid or nonsolid nodule</VALIDVALUE>
          <VALUEMEANING>Subsolid Pulmonary Nodule</VALUEMEANING>
          <MEANINGDESCRIPTION>A term that refers to a pure ground-glass pulmonary nodule or a part-solid pulmonary nodule on CT scan examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C138144</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13474561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>LC nodule density</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>LC nodule density</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3533741</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCORP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Screening and Accrual Log</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3533742</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6705584</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCG_PTCL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MILD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13461199</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="469">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14057937</PUBLICID>
    <LONGNAME>Immune Checkpoint Inhibitor Disease or Disorder Assessment Stratification Status</LONGNAME>
    <PREFERREDNAME>ICI_DX_ASSES_SRT_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>The condition or state at particular time related to the use of Immune Checkpoint Inhibitor to assess the disease or disorder stratification.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14056376</PublicId>
      <PreferredName>6059279v1.00:2861218v1.00</PreferredName>
      <PreferredDefinition>An agent that inhibits any of the immune checkpoint inhibitory proteins.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Immune Checkpoint Inhibitor Disease or Disorder Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6059279</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C143250</PreferredName>
        <Version>1</Version>
        <LongName>Immune Checkpoint Inhibitor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C143250</PREFERRED_NAME>
            <LONG_NAME>Immune Checkpoint Inhibitor</LONG_NAME>
            <CON_ID>6059263</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2861218</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Disease or Disorder Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14056377</PublicId>
      <PreferredName>14056377v1.00</PreferredName>
      <PreferredDefinition>The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</PreferredDefinition>
      <LongName>Stratification Disease or Disorder Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>14068473</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>14068473v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Stratification Disease or Disorder Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25689</PREFERRED_NAME>
            <LONG_NAME>Stratification</LONG_NAME>
            <CON_ID>2203803</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PICI</VALIDVALUE>
          <VALUEMEANING>Primary ICI-refractory disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring first in time or sequence; original; of greatest rank or importance or value._An agent that inhibits any of the immune checkpoint inhibitory proteins._A disease that resists treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39752, C143250, C25251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14056378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AICI</VALIDVALUE>
          <VALUEMEANING>Acquired ICI-refractory disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to a medical condition or characteristic that is not present at birth but develops subsequently._An agent that inhibits any of the immune checkpoint inhibitory proteins._A disease that resists treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39752, C143250, C85869</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14056379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>ICI status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876352</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Inclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical &amp; Concomitant Requirements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3876426</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="470">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14411423</PUBLICID>
    <LONGNAME>First Degree Relative Twelve Person Name</LONGNAME>
    <PREFERREDNAME>14411318v1.00:2746719v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The first and last name of the number 12 first direct relative.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14411318</PublicId>
      <PreferredName>2400272v1.00:14411317v1.00</PreferredName>
      <PreferredDefinition>Any relative who is one meiosis away from a particular individual in a family; a relative with whom one half of an individual&#39;s genes is shared (i.e., parent, sibling, offspring) (from Genetics Home Reference glossary):A natural number greater than 11 and less than 13 and the quantity that it denotes._A word or group of words indicating the identity of a person usually consisting of a first (personal) name and a last (family) name with an optional middle name. In some cultural traditions the family name comes first.</PreferredDefinition>
      <LongName>First Degree Relative Twelve Person Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2400272</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21481</PreferredName>
        <Version>1</Version>
        <LongName>First Degree Relative</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21481</PREFERRED_NAME>
            <LONG_NAME>First Degree Relative</LONG_NAME>
            <CON_ID>2400271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14411317</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C113426:C25191</PreferredName>
        <Version>1</Version>
        <LongName>Twelve Person Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113426</PREFERRED_NAME>
            <LONG_NAME>Twelve</LONG_NAME>
            <CON_ID>4205459</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25191</PREFERRED_NAME>
            <LONG_NAME>Person Name</LONG_NAME>
            <CON_ID>2203721</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2746719</PublicId>
      <PreferredName>PERS_NM</PreferredName>
      <PreferredDefinition>The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Person Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FDR 12 Name</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>FDR 12 Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="471">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14616759</PUBLICID>
    <LONGNAME>Research Activity PDX Tumor Neither Mouse Nor EBV Origin Indicator</LONGNAME>
    <PREFERREDNAME>14616476v1.00:6059598v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>A response that indicates tumor confirmed not to be of mouse or EBV origin.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>Pediatric Cancer</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCDI:Childhood Cancer Data Initiative</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14616476</PublicId>
      <PreferredName>3693395v1.00:16092794v1.00</PreferredName>
      <PreferredDefinition>Systematic investigation into a subject in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered.:A mouse model for human cancer studies in which a human-derived tumor sample is transplanted into an immunodeficient mouse._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Not either one; not the one or the other._Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae._A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt&#39;s lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations._The place where something begins or comes from in either the sense of a physical location or a metaphysical source.</PreferredDefinition>
      <LongName>Research Activity PDX Tumor Neither Mouse Nor EBV Origin</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>Pediatric Cancer</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3693395</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15429</PreferredName>
        <Version>1</Version>
        <LongName>Research Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15429</PREFERRED_NAME>
            <LONG_NAME>Research Activity</LONG_NAME>
            <CON_ID>2528433</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16092794</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16092794v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Patient Derived Xenograft Neoplasm Neither Mouse Epstein-Barr Virus Origin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122936</PREFERRED_NAME>
            <LONG_NAME>Patient Derived Xenograft</LONG_NAME>
            <CON_ID>10015829</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126390</PREFERRED_NAME>
            <LONG_NAME>Neither</LONG_NAME>
            <CON_ID>5209220</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14238</PREFERRED_NAME>
            <LONG_NAME>Mouse</LONG_NAME>
            <CON_ID>2437670</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14204</PREFERRED_NAME>
            <LONG_NAME>Epstein-Barr Virus</LONG_NAME>
            <CON_ID>2205370</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42703</PREFERRED_NAME>
            <LONG_NAME>Origin</LONG_NAME>
            <CON_ID>2204026</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCDI:Childhood Cancer Data Initiative</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6059598</PublicId>
      <PreferredName>Y_N_UNK_NRPT_IND</PreferredName>
      <PreferredDefinition>An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Yes No Unknown Not Reported Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>GDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>GDC:NCI Genomic Data Commons</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Reported</VALIDVALUE>
          <VALUEMEANING>Not Reported</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5697865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5697866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>PDX Tumor Origin</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594093</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PDX</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13596046</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>tumor_not_mus_or_ebv_origin</AlternateName>
        <AlternateNameType>CCDI Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>pdx</AlternateName>
        <AlternateNameType>CCDI Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="472">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14651959</PUBLICID>
    <LONGNAME>Healthcare Encounter Primary Healthcare Payer PCORnet Common Data Model Code</LONGNAME>
    <PREFERREDNAME>14635892v1.00:14641787v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Interactions between patients and providers within the context of healthcare delivery.:A health plan or payer obligated to pay a healthcare service claim first.:An entity, organization, government, corporation, health plan sponsor, or any other financial agent who pays a healthcare provider for the healthcare service rendered to a patient or reimburses the cost of the healthcare service._A symbol or combination of symbols which is assigned to the members of a collection.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14635892</PublicId>
      <PreferredName>14596371v1.00:3588409v1.00</PreferredName>
      <PreferredDefinition>Interactions between patients and providers within the context of healthcare delivery.:A health plan or payer obligated to pay a healthcare service claim first.</PreferredDefinition>
      <LongName>Healthcare Encounter Primary Healthcare Payer</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14596371</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C154624</PreferredName>
        <Version>1</Version>
        <LongName>Healthcare Encounter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C154624</PREFERRED_NAME>
            <LONG_NAME>Healthcare Encounter</LONG_NAME>
            <CON_ID>6424582</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3588409</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70688</PreferredName>
        <Version>1</Version>
        <LongName>Primary Healthcare Payer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70688</PREFERRED_NAME>
            <LONG_NAME>Primary Healthcare Payer</LONG_NAME>
            <CON_ID>3588385</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14641787</PublicId>
      <PreferredName>14641787v1.00</PreferredName>
      <PreferredDefinition>A health plan or payer obligated to pay a healthcare service claim first._A data model designed to standardize PCORnet data._A symbol or combination of symbols which is assigned to the members of a collection.</PreferredDefinition>
      <LongName>Primary Healthcare Payer PCORnet Common Data Model Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>SAS Char</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>15018661</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15018661v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Primary Healthcare Payer PCORnet Common Data Model Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70688</PREFERRED_NAME>
            <LONG_NAME>Primary Healthcare Payer</LONG_NAME>
            <CON_ID>3588385</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C203939</PREFERRED_NAME>
            <LONG_NAME>PCORnet Common Data Model</LONG_NAME>
            <CON_ID>14741507</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Medicare</VALUEMEANING>
          <MEANINGDESCRIPTION>A program under the U.S. Social Security Administration that reimburses hospitals and physicians for medical care provided to qualifying people over 65 years old.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2932789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>Medicare Managed Care</VALUEMEANING>
          <MEANINGDESCRIPTION>Private medical care coverage that provides all of Part A (Hospital Insurance) and Part B (Medical Insurance) coverage. Medicare pays a fixed amount every month to the companies offering Medicare Advantage Plans.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>111</VALIDVALUE>
          <VALUEMEANING>Medicare Health Maintenance Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>The US federal health insurance program run by the Health Care Financing Administration for people 65 years of age or older, certain people with disabilities who have not reached this age, and individuals with permanent kidney failure with dialysis or a transplant.  People over 65 years old, younger disabled people, and dialysis patients are eligible for the program regardless of their income. Participating beneficiaries pay part of healthcare costs through deductible amounts. Limited monthly premiums are required from beneficiaries for non-hospital coverage._A type of managed health care that requires enrollees to see health care providers that are part in the plan&#39;s network; exceptions are made for emergency care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15242, C16665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1111</VALIDVALUE>
          <VALUEMEANING>Chronic Condition Special Needs Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of Medicare managed health plan designed to meet the unique needs of people with one or more chronic conditions, including diabetes, end-stage renal disease, lung conditions, or heart disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1112</VALIDVALUE>
          <VALUEMEANING>Institutional Special Needs Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of Medicare managed health plan for eligible individuals who, for 90 days or longer, have had or are expected to need the level of services provided in a long-term care (LTC) skilled nursing facility (SNF), a LTC nursing facility (NF), a SNF/NF, an intermediate care facility for individuals with intellectual disabilities (ICF/IDD), or an inpatient psychiatric facility.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>112</VALIDVALUE>
          <VALUEMEANING>Medicare Preferred Provider Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>The US federal health insurance program run by the Health Care Financing Administration for people 65 years of age or older, certain people with disabilities who have not reached this age, and individuals with permanent kidney failure with dialysis or a transplant.  People over 65 years old, younger disabled people, and dialysis patients are eligible for the program regardless of their income. Participating beneficiaries pay part of healthcare costs through deductible amounts. Limited monthly premiums are required from beneficiaries for non-hospital coverage._A type of managed health care that encourages enrollees to use providers from within their network, but allows them to see providers outside of the network for higher out-of-pocket charges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203278, C16665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>113</VALIDVALUE>
          <VALUEMEANING>Medicare Health Maintenance Organization Point of Service</VALUEMEANING>
          <MEANINGDESCRIPTION>The US federal health insurance program run by the Health Care Financing Administration for people 65 years of age or older, certain people with disabilities who have not reached this age, and individuals with permanent kidney failure with dialysis or a transplant.  People over 65 years old, younger disabled people, and dialysis patients are eligible for the program regardless of their income. Participating beneficiaries pay part of healthcare costs through deductible amounts. Limited monthly premiums are required from beneficiaries for non-hospital coverage._A type of health maintenance organization (HMO) plan that allows enrollees to get certain services from out-of-network providers, usually at a higher cost for these services than from an in-network provider.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203279, C16665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717362</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>119</VALIDVALUE>
          <VALUEMEANING>Other Medicare Managed Care</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of Medicare Advantage plan not elsewhere listed or described.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>Medicare Non-Managed Care</VALUEMEANING>
          <MEANINGDESCRIPTION>Participation in Medicare without enrollment in a managed care plan.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>121</VALIDVALUE>
          <VALUEMEANING>Medicare Fee for Service Healthcare Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>The US federal health insurance program run by the Health Care Financing Administration for people 65 years of age or older, certain people with disabilities who have not reached this age, and individuals with permanent kidney failure with dialysis or a transplant.  People over 65 years old, younger disabled people, and dialysis patients are eligible for the program regardless of their income. Participating beneficiaries pay part of healthcare costs through deductible amounts. Limited monthly premiums are required from beneficiaries for non-hospital coverage._A health care plan that allows the enrollee to see any healthcare provider, without requiring a primary care doctor or referrals, and provides compensation for a set portion of the costs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203495, C16665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>122</VALIDVALUE>
          <VALUEMEANING>Medicare Drug Coverage</VALUEMEANING>
          <MEANINGDESCRIPTION>A voluntary outpatient prescription drug benefit for people with Medicare. Medicare drug plans are provided through private plans that contract with the federal government.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203287</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>123</VALIDVALUE>
          <VALUEMEANING>Medicare Medical Savings Account Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of Medicare Advantage plan that combines a high-deductible health plan with a medical savings account. Enrollees are able to put pre-tax earnings into a savings account and use these funds to pay out-of-pocket medical costs until they meet their deductible.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>129</VALIDVALUE>
          <VALUEMEANING>Other Medicare Non-managed Care Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of Medicare non-managed plan not elsewhere listed or described.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>Medicare Hospice Care Coverage</VALUEMEANING>
          <MEANINGDESCRIPTION>Medical coverage through Medicare Part A or Medicare Advantage that pays for hospice services.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>Dual Eligible Health Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>Medical coverage for individuals who are eligible for both Medicare and Medicaid. Medicare is their primary source of health insurance coverage, and Medicaid, jointly funded by federal and state governments, provides supplemental coverage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>141</VALIDVALUE>
          <VALUEMEANING>Dual Eligible Special Needs Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed care plan for individuals who qualify for both Medicare and Medicaid and who qualify for a special needs program.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>142</VALIDVALUE>
          <VALUEMEANING>Fully Integrated Dual Eligible Special Needs Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed care plan that fully integrates care under a single managed care organization for individuals who qualify for both Medicare and Medicaid and who qualify for a special needs program.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>Other Medicare Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A Medicare coverage plan not elsewhere listed or described.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>191</VALIDVALUE>
          <VALUEMEANING>Medicare Pharmacy Benefit Manager</VALUEMEANING>
          <MEANINGDESCRIPTION>The US federal health insurance program run by the Health Care Financing Administration for people 65 years of age or older, certain people with disabilities who have not reached this age, and individuals with permanent kidney failure with dialysis or a transplant.  People over 65 years old, younger disabled people, and dialysis patients are eligible for the program regardless of their income. Participating beneficiaries pay part of healthcare costs through deductible amounts. Limited monthly premiums are required from beneficiaries for non-hospital coverage._Third party companies that function as intermediaries between insurance providers and pharmaceutical manufacturers. They create formularies, negotiate rebates with manufacturers, process claims, create pharmacy networks, review drug utilization, and sometimes manage mail-order specialty pharmacies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203295, C16665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717374</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Medicaid</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint federal and state program that provides assistance with healthcare costs to people with low income and limited resources. Medicaid is run by state and local governments within federal guidelines. Healthcare bills are paid from federal, state and local tax funds. The eligibility for the program does not depend on a person&#39;s age. Participating beneficiaries usually pay no part of costs for covered healthcare expenses except a small co-payment required in some cases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2865123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>Medicaid Managed Care</VALUEMEANING>
          <MEANINGDESCRIPTION>Managed care plans that provide Medicaid health benefits and additional services through contracted arrangements between state Medicaid agencies and managed care organizations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203296</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>211</VALIDVALUE>
          <VALUEMEANING>Medicaid Health Maintenance Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint federal and state program that provides assistance with healthcare costs to people with low income and limited resources. Medicaid is run by state and local governments within federal guidelines. Healthcare bills are paid from federal, state and local tax funds. The eligibility for the program does not depend on a person&#39;s age. Participating beneficiaries usually pay no part of costs for covered healthcare expenses except a small co-payment required in some cases._A type of managed health care that requires enrollees to see health care providers that are part in the plan&#39;s network; exceptions are made for emergency care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15242, C68633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717376</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>212</VALIDVALUE>
          <VALUEMEANING>Medicaid Preferred Provider Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint federal and state program that provides assistance with healthcare costs to people with low income and limited resources. Medicaid is run by state and local governments within federal guidelines. Healthcare bills are paid from federal, state and local tax funds. The eligibility for the program does not depend on a person&#39;s age. Participating beneficiaries usually pay no part of costs for covered healthcare expenses except a small co-payment required in some cases._A type of managed health care that encourages enrollees to use providers from within their network, but allows them to see providers outside of the network for higher out-of-pocket charges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203278, C68633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>213</VALIDVALUE>
          <VALUEMEANING>Primary Care Case Management</VALUEMEANING>
          <MEANINGDESCRIPTION>A system of managed care used by state Medicaid agencies where a primary care provider is responsible for approving and monitoring the care of enrolled Medicaid beneficiaries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203297</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>219</VALIDVALUE>
          <VALUEMEANING>Other Medicaid Managed Care</VALUEMEANING>
          <MEANINGDESCRIPTION>A Medicaid managed care plan not elsewhere listed or described.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203299</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>Medicaid Non-managed Care Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>Medicaid medical coverage that is not acquired through a managed care system or plan.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>Medicaid State-sponsored Children&#39;s Health Insurance Program</VALUEMEANING>
          <MEANINGDESCRIPTION>A health insurance program that provides health coverage to eligible children, through both Medicaid and separate Children&#39;s Health Insurance programs (CHIP). CHIP is administered by states, according to federal requirements. The program is funded jointly by states and the federal government.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717381</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>Medicaid Applicant</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint federal and state program that provides assistance with healthcare costs to people with low income and limited resources. Medicaid is run by state and local governments within federal guidelines. Healthcare bills are paid from federal, state and local tax funds. The eligibility for the program does not depend on a person&#39;s age. Participating beneficiaries usually pay no part of costs for covered healthcare expenses except a small co-payment required in some cases._A person who requests or seeks something such as assistance or employment or admission.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61186, C68633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>Medicaid Out-of-State Exception</VALUEMEANING>
          <MEANINGDESCRIPTION>An exception to Medicaid&#39;s rules that do not cover the cost of services for care outside of a beneficiary&#39;s home state except for life-threatening emergencies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203303</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717383</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>Medicaid Long Term Services and Supports</VALUEMEANING>
          <MEANINGDESCRIPTION>Medicaid services for individuals over 65, individuals with physical disabilities, individuals with intellectual disabilities, and chronically ill children. It is available to these participants based on medical necessity and technical and financial eligibility, and covers care in home, community-based settings, and in institutions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>Other Medicaid Plan or Service</VALUEMEANING>
          <MEANINGDESCRIPTION>Medicaid plans or services not elsewhere listed or described.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>291</VALIDVALUE>
          <VALUEMEANING>Medicaid Pharmacy Benefit Manager</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint federal and state program that provides assistance with healthcare costs to people with low income and limited resources. Medicaid is run by state and local governments within federal guidelines. Healthcare bills are paid from federal, state and local tax funds. The eligibility for the program does not depend on a person&#39;s age. Participating beneficiaries usually pay no part of costs for covered healthcare expenses except a small co-payment required in some cases._Third party companies that function as intermediaries between insurance providers and pharmaceutical manufacturers. They create formularies, negotiate rebates with manufacturers, process claims, create pharmacy networks, review drug utilization, and sometimes manage mail-order specialty pharmacies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203295, C68633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>299</VALIDVALUE>
          <VALUEMEANING>Medicaid Dental Coverage</VALUEMEANING>
          <MEANINGDESCRIPTION>Dental service coverage paid through Medicaid. It is made available to all enrolled children through the Children&#39;s Health Insurance Program (CHIP), but states choose whether to provide dental benefits for adults.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203305</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717387</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Other Government Health Care Funding</VALUEMEANING>
          <MEANINGDESCRIPTION>Government programs for health care coverage not elsewhere listed or described.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717388</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>Department of Defense</VALUEMEANING>
          <MEANINGDESCRIPTION>Department of Defense (DOD). According to the FY2004 Defense Appropriations Act, DOD is responsible for funding of several cancer research programs such as studies on breast, ovarian, and prostate cancer, leukemia, and myeloproliferative disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717389</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>311</VALIDVALUE>
          <VALUEMEANING>Tricare</VALUEMEANING>
          <MEANINGDESCRIPTION>A federal health care program for uniformed service members, retirees, and their families around the world. The government administers Tricare by contracting with private entities</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157361</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3111</VALIDVALUE>
          <VALUEMEANING>TRICARE Prime Health Maintenance Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed care option for TRICARE enrollees._A type of managed health care that requires enrollees to see health care providers that are part in the plan&#39;s network; exceptions are made for emergency care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15242, C203471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3112</VALIDVALUE>
          <VALUEMEANING>TRICARE Extra</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed healthcare plan that requires the enrollee to choose a doctor from a limited number of in-network providers. It was replaced by TRICARE Select on January 1, 2018.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3113</VALIDVALUE>
          <VALUEMEANING>TRICARE Standard</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-managed care plan that allows individuals to manage their own health care, with the ability to seek care from any TRICARE-authorized provider they choose. It was replaced by TRICARE Select on January 1, 2018.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3114</VALIDVALUE>
          <VALUEMEANING>TRICARE For Life</VALUEMEANING>
          <MEANINGDESCRIPTION>A dual-coverage healthcare plan for individuals who are TRICARE-eligible and have Medicare Part A and B. Medicare pays its portion first and sends the claim to the TRICARE For Life claims processor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3115</VALIDVALUE>
          <VALUEMEANING>TRICARE Reserve Select</VALUEMEANING>
          <MEANINGDESCRIPTION>A premium-based plan, available worldwide, for members and their families. Members may see in-network providers, out-of-network providers, or receive care at a military hospital.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3116</VALIDVALUE>
          <VALUEMEANING>Uniformed Services Family Health Plan Health Maintenance Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>A contracted TRICARE program under which the TRICARE Prime benefit is offered to eligible military beneficiaries. The Uniformed Services Family Health Plan requires beneficiaries to enroll and is offered through six participating non-profit plans, each serving different regions of the country._A type of managed health care that requires enrollees to see health care providers that are part in the plan&#39;s network; exceptions are made for emergency care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15242, C203478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3119</VALIDVALUE>
          <VALUEMEANING>Other Department of Defense</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._Department of Defense (DOD). According to the FY2004 Defense Appropriations Act, DOD is responsible for funding of several cancer research programs such as studies on breast, ovarian, and prostate cancer, leukemia, and myeloproliferative disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19225, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>312</VALIDVALUE>
          <VALUEMEANING>Military Healthcare Facility</VALUEMEANING>
          <MEANINGDESCRIPTION>A healthcare facility that provides routine therapeutic or preventive services on a military installation or one that is off base but is operated under the authority or direction of the Department of Defense or the Department of Homeland Security.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114865</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3121</VALIDVALUE>
          <VALUEMEANING>TRICARE Prime Enrolled Health Maintenance Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed care option for TRICARE enrollees._Having been registered into a group, activity, course, or similar._A type of managed health care that requires enrollees to see health care providers that are part in the plan&#39;s network; exceptions are made for emergency care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15242, C203479, C203471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3122</VALIDVALUE>
          <VALUEMEANING>Space-Available Care</VALUEMEANING>
          <MEANINGDESCRIPTION>Veterans who need health care, but who have not enrolled into a care plan, will be seen for care as space allows.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>313</VALIDVALUE>
          <VALUEMEANING>Stand-Alone Dental Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of dental plan that&#39;s not included as part of a health plan. They can be obtained through the Affordable Care Act Marketplace or other marketplaces.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32</VALIDVALUE>
          <VALUEMEANING>Veterans Administration</VALUEMEANING>
          <MEANINGDESCRIPTION>A government-run comprehensive benefit system for veterans and for their families, caregivers, and survivors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>321</VALIDVALUE>
          <VALUEMEANING>Veterans Health Administration</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest integrated health care system in the United States, providing health care services to over 9 million veterans enrolled in the VA health care program. The VHA manages 1,250 health care facilities, including 172 VA Medical Centers and 1,069 outpatient sites and clinics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3211</VALIDVALUE>
          <VALUEMEANING>VA Healthcare Facility</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the medical centers or outpatient clinics and sites administered by the Department of Veterans Affairs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3212</VALIDVALUE>
          <VALUEMEANING>VA Healthcare Facility Outside Facility</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the medical centers or outpatient clinics and sites administered by the Department of Veterans Affairs._Services or locations not controlled by a specified group.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203482, C203481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32121</VALIDVALUE>
          <VALUEMEANING>VA Fee Basis Medical Program</VALUEMEANING>
          <MEANINGDESCRIPTION>A medical coverage program that provides payment authorization for eligible veterans to obtain routine medical treatment services through non-VA health care providers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32122</VALIDVALUE>
          <VALUEMEANING>VA Foreign Medical Program</VALUEMEANING>
          <MEANINGDESCRIPTION>A medical program for veterans living or traveling abroad. It will pay for health care services, medications, and durable medical equipment for service-connected conditions and conditions associated with and held to be aggravating a service-connected condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32123</VALIDVALUE>
          <VALUEMEANING>VA Community Nursing Home</VALUEMEANING>
          <MEANINGDESCRIPTION>A nursing home with VA contracts where veterans can live full time and receive skilled nursing care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32124</VALIDVALUE>
          <VALUEMEANING>State Veterans Home</VALUEMEANING>
          <MEANINGDESCRIPTION>State-owned facilities that provide eligible veterans with nursing home, domiciliary, or adult day care. Each state establishes eligibility and admission criteria for its homes, and some State Veterans Homes may admit non-veteran spouses and gold star parents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32125</VALIDVALUE>
          <VALUEMEANING>Sharing Agreements</VALUEMEANING>
          <MEANINGDESCRIPTION>Agreements that provide a written structure to exchange clinical and non-clinical resources between VA and DoD medical facilities. They are established to support increased patient access to medical services, promote improved efficiency by reducing duplication of services, and encourage the sharing of medical facility space.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32126</VALIDVALUE>
          <VALUEMEANING>Other Federal Agency</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._Any department, independent establishment, Government corporation, or other agency of the executive branch of the Federal Government, including the United States Postal Service, but not including the American National Red Cross.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C203489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32127</VALIDVALUE>
          <VALUEMEANING>Dental Care</VALUEMEANING>
          <MEANINGDESCRIPTION>The maintenance of healthy teeth and gums through oral hygiene and dental care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32128</VALIDVALUE>
          <VALUEMEANING>Vision Care</VALUEMEANING>
          <MEANINGDESCRIPTION>The maintenance of eye health and visual acuity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>322</VALIDVALUE>
          <VALUEMEANING>Non-Veterans Health Administration Health Care</VALUEMEANING>
          <MEANINGDESCRIPTION>Medical care that is provided by some entity other than the Veterans Health Administration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3221</VALIDVALUE>
          <VALUEMEANING>Civilian Health and Medical Program of the Department of Veterans Affairs</VALUEMEANING>
          <MEANINGDESCRIPTION>A comprehensive health care program, administered by the Department of Veterans Affairs, designed to provide health care services for military veterans.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3222</VALIDVALUE>
          <VALUEMEANING>Spina Bifida Health Care Benefits Program</VALUEMEANING>
          <MEANINGDESCRIPTION>Benefits provided by the Department of Veterans Affairs (VA) to certain Korea and Vietnam Veterans&#39; birth children who have been diagnosed with spina bifida. It provides monetary allowances, vocational training and rehabilitation, and VA-financed health care benefits.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3223</VALIDVALUE>
          <VALUEMEANING>Children of Women Vietnam Veterans Health Care Benefits Program</VALUEMEANING>
          <MEANINGDESCRIPTION>VA-financed health care benefits to women Vietnam Veterans&#39; birth children who the Veterans Benefits Administration (VBA) has determined to have a covered birth defect. This program is not a comprehensive health care plan and only covers those services necessary for the treatment of a covered birth defect and associated medical conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717417</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3229</VALIDVALUE>
          <VALUEMEANING>Other Non-Veterans Health Administration Health Care</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._Medical care that is provided by some entity other than the Veterans Health Administration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203490, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>33</VALIDVALUE>
          <VALUEMEANING>Indian Health Service</VALUEMEANING>
          <MEANINGDESCRIPTION>An agency within the Department of Health and Human Services. It is responsible for providing comprehensive health services to American Indians and Alaska Natives through IHS and tribally contracted hospitals, health centers, school health centers, and health stations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68716</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6662773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>331</VALIDVALUE>
          <VALUEMEANING>Indian Health Care Program Services</VALUEMEANING>
          <MEANINGDESCRIPTION>Health care services provided to American Indians and Alaska Natives (AI/ANs) at healthcare facilities run and funded directly by the Indian Health Service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717419</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>332</VALIDVALUE>
          <VALUEMEANING>Indian Health Care Contracted Services</VALUEMEANING>
          <MEANINGDESCRIPTION>Health care services provided to American Indians and Alaska Natives (AI/ANs) at healthcare facilities that are funded through contracts paid by the Indian Health Service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>333</VALIDVALUE>
          <VALUEMEANING>Indian Managed Care Entity</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed care organization (MCO), pre-paid inpatient health plan (PIHP), pre-paid ambulatory health plan (PAHP), primary care case management (PCCM) plan, or PCCM entity that is controlled by the Indian Health Service, a Tribe, Tribal Organization, or Urban Indian Organization, or consortium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203590</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>334</VALIDVALUE>
          <VALUEMEANING>Tribally-Sponsored Health Insurance Program</VALUEMEANING>
          <MEANINGDESCRIPTION>Private health insurance coverage purchased by tribal consortia to provide health care coverage in addition to those provided for Indian Health Service beneficiaries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203591</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>34</VALIDVALUE>
          <VALUEMEANING>Health Resources and Services Administration</VALUEMEANING>
          <MEANINGDESCRIPTION>The Health Resources and Services Administration (HRSA) is an Access Agency of the U.S. Department of Health and Human Services, charged with improving and expanding access to quality health care for low income, uninsured, isolated, vulnerable and special needs populations and meeting their unique health care needs. Provides funds for scientific projects and public health programs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>341</VALIDVALUE>
          <VALUEMEANING>Title V Mother and Child Health Block Grant</VALUEMEANING>
          <MEANINGDESCRIPTION>A program authorized under Title V of the Social Security Act to ensure the health and well-being of women, mothers, infants, children (including children with special health care needs), adolescents and their families. It is provided by funds given to states by the federal government.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203592</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717424</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>342</VALIDVALUE>
          <VALUEMEANING>Migrant Health Program</VALUEMEANING>
          <MEANINGDESCRIPTION>A federal government program that provides funds to health centers located around the country to provide health care to farmworkers and their families.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203593</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717425</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>343</VALIDVALUE>
          <VALUEMEANING>Ryan White HIV/AIDS Program</VALUEMEANING>
          <MEANINGDESCRIPTION>A discretionary, grant program enacted in 1990 to provide outpatient HIV care, treatment, and support services to those without health insurance and fill gaps in coverage and cost for those with insurance limitations. Funding is distributed to states/territories, cities, and HIV organizations in the form of grants.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717426</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>344</VALIDVALUE>
          <VALUEMEANING>Disaster Assistance</VALUEMEANING>
          <MEANINGDESCRIPTION>Federal, state, or local funds or programs designed to provide financial assistance and direct services to eligible individuals and households affected by a disaster, who have uninsured or underinsured necessary expenses and serious needs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>349</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6431768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>35</VALIDVALUE>
          <VALUEMEANING>Black Lung Benefits Act</VALUEMEANING>
          <MEANINGDESCRIPTION>A federal funding act that provides compensation to coal miners who are totally disabled by pneumoconiosis arising out of coal mine employment, and to survivors of coal miners whose deaths are attributable to the disease. The Act also provides eligible miners with medical coverage for the treatment of lung diseases related to pneumoconiosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203596</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>36</VALIDVALUE>
          <VALUEMEANING>State Government</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of government that makes and enforces laws for a state.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717429</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>361</VALIDVALUE>
          <VALUEMEANING>Medicaid State-sponsored Children&#39;s Health Insurance Program</VALUEMEANING>
          <MEANINGDESCRIPTION>A health insurance program that provides health coverage to eligible children, through both Medicaid and separate Children&#39;s Health Insurance programs (CHIP). CHIP is administered by states, according to federal requirements. The program is funded jointly by states and the federal government.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717381</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>362</VALIDVALUE>
          <VALUEMEANING>Specified State Government</VALUEMEANING>
          <MEANINGDESCRIPTION>Clearly and explicitly stated._The unit of government that makes and enforces laws for a state.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203492, C38024</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>369</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified State Government</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way._The unit of government that makes and enforces laws for a state.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203492, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>37</VALIDVALUE>
          <VALUEMEANING>Local Government</VALUEMEANING>
          <MEANINGDESCRIPTION>The unit of government that determines and executes laws and measures within an area inside and smaller than a whole state.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>371</VALIDVALUE>
          <VALUEMEANING>Local Managed Health Care</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed health care plan that is overseen by an entity smaller than a state.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3711</VALIDVALUE>
          <VALUEMEANING>Health Maintenance Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed care organization that provides health services to enrolled individuals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576383</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3712</VALIDVALUE>
          <VALUEMEANING>Preferred Provider Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of managed health care that encourages enrollees to use providers from within their network, but allows them to see providers outside of the network for higher out-of-pocket charges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3713</VALIDVALUE>
          <VALUEMEANING>Health Maintenance Organization Point of Service</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of health maintenance organization (HMO) plan that allows enrollees to get certain services from out-of-network providers, usually at a higher cost for these services than from an in-network provider.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>372</VALIDVALUE>
          <VALUEMEANING>Fee for Service Healthcare Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A health care plan that allows the enrollee to see any healthcare provider, without requiring a primary care doctor or referrals, and provides compensation for a set portion of the costs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>379</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Local Government</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way._The unit of government that determines and executes laws and measures within an area inside and smaller than a whole state.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203493, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>38</VALIDVALUE>
          <VALUEMEANING>Other Government</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._The political organization by which a state or nation is ruled.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78315, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717438</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>381</VALIDVALUE>
          <VALUEMEANING>Unspecified Government Managed Care</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail._The political organization by which a state or nation is ruled._An arrangement whereby a third-party payer (e.g., insurance company, federal government, or corporation) mediates between physicians and patients, negotiating fees for service and overseeing the types of treatment given.  Managed care has virtually replaced unmanaged indemnity plans, where payment is automatic and oversight procedures are minimal.  Whereas 96% of American workers had unmanaged indemnity in 1984, only 28% did in 1988.  Typically, in managed care, the third-party payer requires second opinions and pre-certification review for patients requiring hospital admission.  They obtain wholesale prices from doctors, and carry out cost-containment measures, including auditing hospitals and reviewing claims.  Managed care has figured heavily in the national debate over health care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15364, C78315, C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3811</VALIDVALUE>
          <VALUEMEANING>Unspecified Government Health Maintenance Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail._The political organization by which a state or nation is ruled._A type of managed health care that requires enrollees to see health care providers that are part in the plan&#39;s network; exceptions are made for emergency care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15242, C78315, C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3812</VALIDVALUE>
          <VALUEMEANING>Unspecified Preferred Provider Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail._A type of managed health care that encourages enrollees to use providers from within their network, but allows them to see providers outside of the network for higher out-of-pocket charges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203278, C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3813</VALIDVALUE>
          <VALUEMEANING>Unspecified Government Health Maintenance Organization Point of Service</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail._The political organization by which a state or nation is ruled._A type of health maintenance organization (HMO) plan that allows enrollees to get certain services from out-of-network providers, usually at a higher cost for these services than from an in-network provider.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203279, C78315, C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3819</VALIDVALUE>
          <VALUEMEANING>Unspecified Government Managed Healthcare Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail._The political organization by which a state or nation is ruled._An organization that integrates financing and management of healthcare with the delivery of healthcare services to an enrolled population. It employs or contracts with an organized system of providers that delivers services, manages the costs of healthcare services, as well as accessibility and quality of care for its enrolled members, and frequently shares financial risk. Managed healthcare plan can do this through a variety of means but usually this involves offering limited choices of providers to its enrollees and negotiating with providers for reimbursement costs. Typically in managed care the third party payer requires second opinions and pre-certification review for patients requiring hospital admission.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70694, C78315, C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>382</VALIDVALUE>
          <VALUEMEANING>Unspecified Government Fee for Service Healthcare Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail._The political organization by which a state or nation is ruled._A health care plan that allows the enrollee to see any healthcare provider, without requiring a primary care doctor or referrals, and provides compensation for a set portion of the costs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203495, C78315, C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>389</VALIDVALUE>
          <VALUEMEANING>Other Unspecified Government</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._Not stated explicitly or in detail._The political organization by which a state or nation is ruled.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78315, C38046, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>39</VALIDVALUE>
          <VALUEMEANING>Other Federal Employees Health Benefits Program</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._Health care coverage for civilian employees of the United States federal government, retirees, and their families. Plan options include Fee-For-Service, Health Maintenance Organization, High Deductible, and Consumer-Driven Health Plans (HMO, PPO, etc.).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203496, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717446</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>391</VALIDVALUE>
          <VALUEMEANING>Federal Employees Health Benefits Program</VALUEMEANING>
          <MEANINGDESCRIPTION>Health care coverage for civilian employees of the United States federal government, retirees, and their families. Plan options include Fee-For-Service, Health Maintenance Organization, High Deductible, and Consumer-Driven Health Plans (HMO, PPO, etc.).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717447</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Department of Corrections</VALUEMEANING>
          <MEANINGDESCRIPTION>Agencies at the federal, state, or local level established for the housing and care of prisoners.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203597</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>41</VALIDVALUE>
          <VALUEMEANING>Federal Bureau of Prisons</VALUEMEANING>
          <MEANINGDESCRIPTION>The federal agency established to protect society by confining federal offenders in the controlled environments of prisons and community-based facilities that are safe, humane, cost-efficient, and appropriately secure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203598</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3123</VALIDVALUE>
          <VALUEMEANING>TRICARE For Life</VALUEMEANING>
          <MEANINGDESCRIPTION>A dual-coverage healthcare plan for individuals who are TRICARE-eligible and have Medicare Part A and B. Medicare pays its portion first and sends the claim to the TRICARE For Life claims processor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>42</VALIDVALUE>
          <VALUEMEANING>State Department of Corrections</VALUEMEANING>
          <MEANINGDESCRIPTION>A state agency established for the housing and care of prisoners.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>43</VALIDVALUE>
          <VALUEMEANING>Local Department of Corrections</VALUEMEANING>
          <MEANINGDESCRIPTION>Agencies for regions smaller than a state that detain offenders prior to trial or release on bond or for short-term criminal conviction sentences.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>44</VALIDVALUE>
          <VALUEMEANING>Unknown Department of Corrections</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor._Agencies at the federal, state, or local level established for the housing and care of prisoners.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203597, C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Private Health Insurance</VALUEMEANING>
          <MEANINGDESCRIPTION>Financial coverage provided through third party reimbursement, that is designed to minimize monetary loss associated with health care costs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3587173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>51</VALIDVALUE>
          <VALUEMEANING>Private Health Insurance Managed Care</VALUEMEANING>
          <MEANINGDESCRIPTION>Financial coverage provided through third party reimbursement, that is designed to minimize monetary loss associated with health care costs._An arrangement whereby a third-party payer (e.g., insurance company, federal government, or corporation) mediates between physicians and patients, negotiating fees for service and overseeing the types of treatment given.  Managed care has virtually replaced unmanaged indemnity plans, where payment is automatic and oversight procedures are minimal.  Whereas 96% of American workers had unmanaged indemnity in 1984, only 28% did in 1988.  Typically, in managed care, the third-party payer requires second opinions and pre-certification review for patients requiring hospital admission.  They obtain wholesale prices from doctors, and carry out cost-containment measures, including auditing hospitals and reviewing claims.  Managed care has figured heavily in the national debate over health care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15364, C70696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>511</VALIDVALUE>
          <VALUEMEANING>Commercial Managed Healthcare Plan Health Maintenance Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed health care plan provided by a private organization._A type of managed health care that requires enrollees to see health care providers that are part in the plan&#39;s network; exceptions are made for emergency care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15242, C203634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>512</VALIDVALUE>
          <VALUEMEANING>Commercial Managed Healthcare Plan Preferred Provider Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed health care plan provided by a private organization._A type of managed health care that encourages enrollees to use providers from within their network, but allows them to see providers outside of the network for higher out-of-pocket charges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203278, C203634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>513</VALIDVALUE>
          <VALUEMEANING>Commercial Managed Healthcare Plan Health Maintenance Organization Point of Service</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed health care plan provided by a private organization._A type of health maintenance organization (HMO) plan that allows enrollees to get certain services from out-of-network providers, usually at a higher cost for these services than from an in-network provider.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203279, C203634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>514</VALIDVALUE>
          <VALUEMEANING>Exclusive Provider Organization Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed health care plan that requires enrollees to use doctors and facilities in the plan&#39;s network, except in cases of emergency.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>515</VALIDVALUE>
          <VALUEMEANING>Gatekeeper Preferred Provider Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of preferred provider plan that requires an enrollee to go through their primary care physician for all referrals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>516</VALIDVALUE>
          <VALUEMEANING>Commercial Managed Healthcare Plan Pharmacy Benefit Manager</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed health care plan provided by a private organization._Third party companies that function as intermediaries between insurance providers and pharmaceutical manufacturers. They create formularies, negotiate rebates with manufacturers, process claims, create pharmacy networks, review drug utilization, and sometimes manage mail-order specialty pharmacies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203295, C203634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>517</VALIDVALUE>
          <VALUEMEANING>Commercial Managed Healthcare Plan Dental Insurance</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed health care plan provided by a private organization._Health insurance that covers routine dental care as well as dental procedures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203640, C203634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>519</VALIDVALUE>
          <VALUEMEANING>Other Managed Healthcare Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._An organization that integrates financing and management of healthcare with the delivery of healthcare services to an enrolled population. It employs or contracts with an organized system of providers that delivers services, manages the costs of healthcare services, as well as accessibility and quality of care for its enrolled members, and frequently shares financial risk. Managed healthcare plan can do this through a variety of means but usually this involves offering limited choices of providers to its enrollees and negotiating with providers for reimbursement costs. Typically in managed care the third party payer requires second opinions and pre-certification review for patients requiring hospital admission.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70694, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>52</VALIDVALUE>
          <VALUEMEANING>Private Health Insurance Fee for Service Healthcare Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>Financial coverage provided through third party reimbursement, that is designed to minimize monetary loss associated with health care costs._A health care plan that allows the enrollee to see any healthcare provider, without requiring a primary care doctor or referrals, and provides compensation for a set portion of the costs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203495, C70696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>521</VALIDVALUE>
          <VALUEMEANING>Commercial Managed Healthcare Plan Fee for Service Healthcare Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed health care plan provided by a private organization._A health care plan that allows the enrollee to see any healthcare provider, without requiring a primary care doctor or referrals, and provides compensation for a set portion of the costs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203495, C203634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>522</VALIDVALUE>
          <VALUEMEANING>Self-funded Insurance Plan Administrative Services Only Health Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of health insurance where an organization funds all of the costs. These plans are subject to the rules established by the Employee Retirement Income and Security Act of 1974 (ERISA)._A health care plan where a company funds their employee benefit plan but hire an outside vendor to administer it.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203605, C203604</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>523</VALIDVALUE>
          <VALUEMEANING>Medigap</VALUEMEANING>
          <MEANINGDESCRIPTION>Various private health insurance plans designed to supplement the coverage of Medicare.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157358</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6662775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>524</VALIDVALUE>
          <VALUEMEANING>Fee for Service Healthcare Plan Dental Insurance</VALUEMEANING>
          <MEANINGDESCRIPTION>A health care plan that allows the enrollee to see any healthcare provider, without requiring a primary care doctor or referrals, and provides compensation for a set portion of the costs._Health insurance that covers routine dental care as well as dental procedures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203640, C203495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>529</VALIDVALUE>
          <VALUEMEANING>Private Health Insurance Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Financial coverage provided through third party reimbursement, that is designed to minimize monetary loss associated with health care costs._Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C70696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>53</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Managed Healthcare Plan Or Private Health Insurance</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way._An organization that integrates financing and management of healthcare with the delivery of healthcare services to an enrolled population. It employs or contracts with an organized system of providers that delivers services, manages the costs of healthcare services, as well as accessibility and quality of care for its enrolled members, and frequently shares financial risk. Managed healthcare plan can do this through a variety of means but usually this involves offering limited choices of providers to its enrollees and negotiating with providers for reimbursement costs. Typically in managed care the third party payer requires second opinions and pre-certification review for patients requiring hospital admission._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Financial coverage provided through third party reimbursement, that is designed to minimize monetary loss associated with health care costs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70696, C37998, C70694, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>54</VALIDVALUE>
          <VALUEMEANING>Organized Delivery System</VALUEMEANING>
          <MEANINGDESCRIPTION>A network of health care organizations that provides a coordinated continuum of services to a defined population and is willing to be held clinically and fiscally accountable for the outcomes and the health status of the population served.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>55</VALIDVALUE>
          <VALUEMEANING>Small Employer Purchasing Group</VALUEMEANING>
          <MEANINGDESCRIPTION>An arrangement that allows small employers to pool together to collectively purchase health insurance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>56</VALIDVALUE>
          <VALUEMEANING>Specialized Stand-Alone Insurance Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>An insurance policy that covers a specialized risk or cost that may not otherwise be covered by other existing policies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203639</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>561</VALIDVALUE>
          <VALUEMEANING>Dental Insurance</VALUEMEANING>
          <MEANINGDESCRIPTION>Health insurance that covers routine dental care as well as dental procedures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>562</VALIDVALUE>
          <VALUEMEANING>Vision Insurance</VALUEMEANING>
          <MEANINGDESCRIPTION>Health insurance that covers the maintenance of eye health and visual acuity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>59</VALIDVALUE>
          <VALUEMEANING>Other Private Insurance</VALUEMEANING>
          <MEANINGDESCRIPTION>Private health insurance from a provider other than those listed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C192326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Blue Cross Blue Shield</VALUEMEANING>
          <MEANINGDESCRIPTION>An American federation of independent and locally operated Blue Cross Blue Shield Association (BCBSA) companies that provide health insurance in the United States.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>611</VALIDVALUE>
          <VALUEMEANING>Blue Cross Blue Shield Managed Care Health Maintenance Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>An American federation of independent and locally operated Blue Cross Blue Shield Association (BCBSA) companies that provide health insurance in the United States._An arrangement whereby a third-party payer (e.g., insurance company, federal government, or corporation) mediates between physicians and patients, negotiating fees for service and overseeing the types of treatment given.  Managed care has virtually replaced unmanaged indemnity plans, where payment is automatic and oversight procedures are minimal.  Whereas 96% of American workers had unmanaged indemnity in 1984, only 28% did in 1988.  Typically, in managed care, the third-party payer requires second opinions and pre-certification review for patients requiring hospital admission.  They obtain wholesale prices from doctors, and carry out cost-containment measures, including auditing hospitals and reviewing claims.  Managed care has figured heavily in the national debate over health care._A type of managed health care that requires enrollees to see health care providers that are part in the plan&#39;s network; exceptions are made for emergency care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15242, C15364, C203603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>612</VALIDVALUE>
          <VALUEMEANING>Blue Cross Blue Shield Managed Care Preferred Provider Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>An American federation of independent and locally operated Blue Cross Blue Shield Association (BCBSA) companies that provide health insurance in the United States._An arrangement whereby a third-party payer (e.g., insurance company, federal government, or corporation) mediates between physicians and patients, negotiating fees for service and overseeing the types of treatment given.  Managed care has virtually replaced unmanaged indemnity plans, where payment is automatic and oversight procedures are minimal.  Whereas 96% of American workers had unmanaged indemnity in 1984, only 28% did in 1988.  Typically, in managed care, the third-party payer requires second opinions and pre-certification review for patients requiring hospital admission.  They obtain wholesale prices from doctors, and carry out cost-containment measures, including auditing hospitals and reviewing claims.  Managed care has figured heavily in the national debate over health care._A type of managed health care that encourages enrollees to use providers from within their network, but allows them to see providers outside of the network for higher out-of-pocket charges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203278, C15364, C203603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>613</VALIDVALUE>
          <VALUEMEANING>Blue Cross Blue Shield Managed Care Health Maintenance Organization Point of Service</VALUEMEANING>
          <MEANINGDESCRIPTION>An American federation of independent and locally operated Blue Cross Blue Shield Association (BCBSA) companies that provide health insurance in the United States._An arrangement whereby a third-party payer (e.g., insurance company, federal government, or corporation) mediates between physicians and patients, negotiating fees for service and overseeing the types of treatment given.  Managed care has virtually replaced unmanaged indemnity plans, where payment is automatic and oversight procedures are minimal.  Whereas 96% of American workers had unmanaged indemnity in 1984, only 28% did in 1988.  Typically, in managed care, the third-party payer requires second opinions and pre-certification review for patients requiring hospital admission.  They obtain wholesale prices from doctors, and carry out cost-containment measures, including auditing hospitals and reviewing claims.  Managed care has figured heavily in the national debate over health care._A type of health maintenance organization (HMO) plan that allows enrollees to get certain services from out-of-network providers, usually at a higher cost for these services than from an in-network provider.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203279, C15364, C203603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>614</VALIDVALUE>
          <VALUEMEANING>Blue Cross Blue Shield Managed Care Dental Care</VALUEMEANING>
          <MEANINGDESCRIPTION>An American federation of independent and locally operated Blue Cross Blue Shield Association (BCBSA) companies that provide health insurance in the United States._An arrangement whereby a third-party payer (e.g., insurance company, federal government, or corporation) mediates between physicians and patients, negotiating fees for service and overseeing the types of treatment given.  Managed care has virtually replaced unmanaged indemnity plans, where payment is automatic and oversight procedures are minimal.  Whereas 96% of American workers had unmanaged indemnity in 1984, only 28% did in 1988.  Typically, in managed care, the third-party payer requires second opinions and pre-certification review for patients requiring hospital admission.  They obtain wholesale prices from doctors, and carry out cost-containment measures, including auditing hospitals and reviewing claims.  Managed care has figured heavily in the national debate over health care._The maintenance of healthy teeth and gums through oral hygiene and dental care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203584, C15364, C203603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>619</VALIDVALUE>
          <VALUEMEANING>Other Blue Cross Blue Shield Managed Care</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._An American federation of independent and locally operated Blue Cross Blue Shield Association (BCBSA) companies that provide health insurance in the United States._An arrangement whereby a third-party payer (e.g., insurance company, federal government, or corporation) mediates between physicians and patients, negotiating fees for service and overseeing the types of treatment given.  Managed care has virtually replaced unmanaged indemnity plans, where payment is automatic and oversight procedures are minimal.  Whereas 96% of American workers had unmanaged indemnity in 1984, only 28% did in 1988.  Typically, in managed care, the third-party payer requires second opinions and pre-certification review for patients requiring hospital admission.  They obtain wholesale prices from doctors, and carry out cost-containment measures, including auditing hospitals and reviewing claims.  Managed care has figured heavily in the national debate over health care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15364, C203603, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>62</VALIDVALUE>
          <VALUEMEANING>Blue Cross Blue Shield Fee for Service Healthcare Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>An American federation of independent and locally operated Blue Cross Blue Shield Association (BCBSA) companies that provide health insurance in the United States._A health care plan that allows the enrollee to see any healthcare provider, without requiring a primary care doctor or referrals, and provides compensation for a set portion of the costs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203495, C203603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>621</VALIDVALUE>
          <VALUEMEANING>Blue Cross Blue Shield Fee for Service Healthcare Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>An American federation of independent and locally operated Blue Cross Blue Shield Association (BCBSA) companies that provide health insurance in the United States._A health care plan that allows the enrollee to see any healthcare provider, without requiring a primary care doctor or referrals, and provides compensation for a set portion of the costs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203495, C203603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>622</VALIDVALUE>
          <VALUEMEANING>Self-funded Insurance Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of health insurance where an organization funds all of the costs. These plans are subject to the rules established by the Employee Retirement Income and Security Act of 1974 (ERISA).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203604</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>623</VALIDVALUE>
          <VALUEMEANING>Blue Cross Blue Shield Medigap</VALUEMEANING>
          <MEANINGDESCRIPTION>An American federation of independent and locally operated Blue Cross Blue Shield Association (BCBSA) companies that provide health insurance in the United States._Various private health insurance plans designed to supplement the coverage of Medicare to help pay out-of-pocket costs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157358, C203603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>629</VALIDVALUE>
          <VALUEMEANING>Blue Cross Blue Shield Fee for Service Healthcare Plan Dental Care</VALUEMEANING>
          <MEANINGDESCRIPTION>An American federation of independent and locally operated Blue Cross Blue Shield Association (BCBSA) companies that provide health insurance in the United States._A health care plan that allows the enrollee to see any healthcare provider, without requiring a primary care doctor or referrals, and provides compensation for a set portion of the costs._The maintenance of healthy teeth and gums through oral hygiene and dental care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203584, C203495, C203603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717484</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Unspecified Managed Healthcare Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail._An organization that integrates financing and management of healthcare with the delivery of healthcare services to an enrolled population. It employs or contracts with an organized system of providers that delivers services, manages the costs of healthcare services, as well as accessibility and quality of care for its enrolled members, and frequently shares financial risk. Managed healthcare plan can do this through a variety of means but usually this involves offering limited choices of providers to its enrollees and negotiating with providers for reimbursement costs. Typically in managed care the third party payer requires second opinions and pre-certification review for patients requiring hospital admission.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70694, C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>71</VALIDVALUE>
          <VALUEMEANING>Health Maintenance Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>A managed care organization that provides health services to enrolled individuals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576383</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>72</VALIDVALUE>
          <VALUEMEANING>Preferred Provider Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of managed health care that encourages enrollees to use providers from within their network, but allows them to see providers outside of the network for higher out-of-pocket charges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>73</VALIDVALUE>
          <VALUEMEANING>Health Maintenance Organization Point of Service</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of health maintenance organization (HMO) plan that allows enrollees to get certain services from out-of-network providers, usually at a higher cost for these services than from an in-network provider.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>79</VALIDVALUE>
          <VALUEMEANING>Other Managed Care</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._An arrangement whereby a third-party payer (e.g., insurance company, federal government, or corporation) mediates between physicians and patients, negotiating fees for service and overseeing the types of treatment given.  Managed care has virtually replaced unmanaged indemnity plans, where payment is automatic and oversight procedures are minimal.  Whereas 96% of American workers had unmanaged indemnity in 1984, only 28% did in 1988.  Typically, in managed care, the third-party payer requires second opinions and pre-certification review for patients requiring hospital admission.  They obtain wholesale prices from doctors, and carry out cost-containment measures, including auditing hospitals and reviewing claims.  Managed care has figured heavily in the national debate over health care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15364, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717486</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Healthcare Payer Not Listed</VALUEMEANING>
          <MEANINGDESCRIPTION>An entity, organization, government, corporation, health plan sponsor, or any other financial agent who pays a healthcare provider for the healthcare service rendered to a patient or reimburses the cost of the healthcare service._Not included on a list of items.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203644, C70686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717487</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>81</VALIDVALUE>
          <VALUEMEANING>Out of Pocket Payment</VALUEMEANING>
          <MEANINGDESCRIPTION>A payment made from personal funds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C148250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6183479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>61</VALIDVALUE>
          <VALUEMEANING>Blue Cross Blue Shield Managed Care</VALUEMEANING>
          <MEANINGDESCRIPTION>An American federation of independent and locally operated Blue Cross Blue Shield Association (BCBSA) companies that provide health insurance in the United States._An arrangement whereby a third-party payer (e.g., insurance company, federal government, or corporation) mediates between physicians and patients, negotiating fees for service and overseeing the types of treatment given.  Managed care has virtually replaced unmanaged indemnity plans, where payment is automatic and oversight procedures are minimal.  Whereas 96% of American workers had unmanaged indemnity in 1984, only 28% did in 1988.  Typically, in managed care, the third-party payer requires second opinions and pre-certification review for patients requiring hospital admission.  They obtain wholesale prices from doctors, and carry out cost-containment measures, including auditing hospitals and reviewing claims.  Managed care has figured heavily in the national debate over health care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15364, C203603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>82</VALIDVALUE>
          <VALUEMEANING>No Charge</VALUEMEANING>
          <MEANINGDESCRIPTION>Goods or services received at no cost to the consumer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>821</VALIDVALUE>
          <VALUEMEANING>Charity</VALUEMEANING>
          <MEANINGDESCRIPTION>An organization which exists to help those in need or provide educational, scientific, religious and/or artistic assistance to members of the public.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203647</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>822</VALIDVALUE>
          <VALUEMEANING>Professional Courtesy</VALUEMEANING>
          <MEANINGDESCRIPTION>Providing advice or treatment to colleagues without charge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>823</VALIDVALUE>
          <VALUEMEANING>Research Activity And/Or Clinical Trial</VALUEMEANING>
          <MEANINGDESCRIPTION>Systematic investigation into a subject in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered._Used to indicate that either or both of two items or options may be valid._A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71104, C48928, C15429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717492</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>83</VALIDVALUE>
          <VALUEMEANING>Refusal to Pay And/Or Bad Debt</VALUEMEANING>
          <MEANINGDESCRIPTION>Describes the situation when an individual has made no effort to make any payment for an extended period of time._Used to indicate that either or both of two items or options may be valid._Loans or outstanding balances owed that are no longer deemed recoverable and must be written off.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203650, C48928, C203649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>84</VALIDVALUE>
          <VALUEMEANING>Hill-Burton Act</VALUEMEANING>
          <MEANINGDESCRIPTION>A federal government program that requires health care facilities, including hospitals and other locations that have been granted federal funds for facility construction, modernization, or reconstruction, to provide patients with free or low cost health care services.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203651</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>85</VALIDVALUE>
          <VALUEMEANING>Research Support Or Donation</VALUEMEANING>
          <MEANINGDESCRIPTION>This includes all types of grants, cooperative agreements, and research contracts that support research directly and for which individuals and/or projects have been peer-reviewed._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._The act of giving money or materials or other items of worth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156020, C37998, C17090</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>89</VALIDVALUE>
          <VALUEMEANING>Other Negation Payment</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._An operation in which a term denies or inverts the meaning of another term or construction._A sum of money paid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25371, C25594, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Other Miscellaneous</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._Diverse, mixed, consisting of an assortment of different kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69023, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>91</VALIDVALUE>
          <VALUEMEANING>Foreign National</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who is neither a citizen of their host country nor admitted for permanent residency.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203652</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>92</VALIDVALUE>
          <VALUEMEANING>Negation Other Government Health Care Funding</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._Government programs for health care coverage not elsewhere listed or described.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203306, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>93</VALIDVALUE>
          <VALUEMEANING>Disability Insurance</VALUEMEANING>
          <MEANINGDESCRIPTION>Insurance that provides income in the event that a policyholder is prevented from working and earning an income due to a disability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203606</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>94</VALIDVALUE>
          <VALUEMEANING>Long-term Care Insurance</VALUEMEANING>
          <MEANINGDESCRIPTION>Insurance that covers the care needed for chronic medical conditions and disabilities. Long-term care insurance covers the costs of home care, nursing home, assisted living, or adult day care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203607</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>95</VALIDVALUE>
          <VALUEMEANING>Workers Compensation Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>An insurance program designed to financially compensate an employee in the event of an injury sustained while working.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3588463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>951</VALIDVALUE>
          <VALUEMEANING>Workers Compensation Plan Health Maintenance Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>An insurance program designed to financially compensate an employee in the event of an injury sustained while working._A type of managed health care that requires enrollees to see health care providers that are part in the plan&#39;s network; exceptions are made for emergency care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15242, C70692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>953</VALIDVALUE>
          <VALUEMEANING>Workers Compensation Plan Fee for Service Healthcare Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>An insurance program designed to financially compensate an employee in the event of an injury sustained while working._A health care plan that allows the enrollee to see any healthcare provider, without requiring a primary care doctor or referrals, and provides compensation for a set portion of the costs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203495, C70692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>954</VALIDVALUE>
          <VALUEMEANING>Workers Compensation Plan Other Managed Care</VALUEMEANING>
          <MEANINGDESCRIPTION>An insurance program designed to financially compensate an employee in the event of an injury sustained while working._Different than the one(s) previously specified or mentioned._An arrangement whereby a third-party payer (e.g., insurance company, federal government, or corporation) mediates between physicians and patients, negotiating fees for service and overseeing the types of treatment given.  Managed care has virtually replaced unmanaged indemnity plans, where payment is automatic and oversight procedures are minimal.  Whereas 96% of American workers had unmanaged indemnity in 1984, only 28% did in 1988.  Typically, in managed care, the third-party payer requires second opinions and pre-certification review for patients requiring hospital admission.  They obtain wholesale prices from doctors, and carry out cost-containment measures, including auditing hospitals and reviewing claims.  Managed care has figured heavily in the national debate over health care.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15364, C17649, C70692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>959</VALIDVALUE>
          <VALUEMEANING>Workers Compensation Plan Other Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>An insurance program designed to financially compensate an employee in the event of an injury sustained while working._Different than the one(s) previously specified or mentioned._Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046, C17649, C70692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>96</VALIDVALUE>
          <VALUEMEANING>Automobile Insurance</VALUEMEANING>
          <MEANINGDESCRIPTION>Insurance that helps pay for the repair of vehicle damage that results from accidents or vandalism, loss due to theft, and for liability against the result of accidents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>97</VALIDVALUE>
          <VALUEMEANING>Liability Insurance</VALUEMEANING>
          <MEANINGDESCRIPTION>Insurance designed to protect the holder from claims related to others&#39; bodily injury, property damage, and more.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>98</VALIDVALUE>
          <VALUEMEANING>Specify Other Not Elsewhere Classified</VALUEMEANING>
          <MEANINGDESCRIPTION>A directive to indicate a response not listed._An entity that does not belong to any other separately identified category.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C193405, C157106</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>99</VALIDVALUE>
          <VALUEMEANING>Not Available Payment Method Code</VALUEMEANING>
          <MEANINGDESCRIPTION>The desired information is not available._A coded value specifying the method by which payment is delivered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93619, C126101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14717509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9999</VALIDVALUE>
          <VALUEMEANING>Unavailable</VALUEMEANING>
          <MEANINGDESCRIPTION>The desired information is not available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5828000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NI</VALIDVALUE>
          <VALUEMEANING>No Information Available</VALUEMEANING>
          <MEANINGDESCRIPTION>Information regarding the subject is unknown or inaccessible at this time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OT</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6431768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UN</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Payer Type Primary</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Payer Type Primary</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14522553</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PCORnet CDM 6.1</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Encounter</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>14522558</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PAYER_TYPE_PRIMARY</AlternateName>
        <AlternateNameType>PCORNet Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENCOUNTER</AlternateName>
        <AlternateNameType>PCORnet Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="473">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14882622</PUBLICID>
    <LONGNAME>Progression or Relapse Evaluation Method Extended Codelist Element</LONGNAME>
    <PREFERREDNAME>RS_RSMETHOD_EXT</PREFERREDNAME>
    <PREFERREDDEFINITION>The method used to determine disease response, per the type of response being collected (e.g., target response, pathologic response, best response, overall response), using an extended codelist.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDISC Harmonization</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7592177</PublicId>
      <PreferredName>6608777v1.0:2958344v1.0</PreferredName>
      <PreferredDefinition>A domain for disease response evaluations._A description of the technique for the appraisal of a subject or object.</PreferredDefinition>
      <LongName>Disease Response Domain Evaluation Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6608777</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C107097</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107097</PREFERRED_NAME>
            <LONG_NAME>Disease Response Domain</LONG_NAME>
            <CON_ID>6608776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2958344</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C81265</PreferredName>
        <Version>1</Version>
        <LongName>Evaluation Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C81265</PREFERRED_NAME>
            <LONG_NAME>Evaluation Method</LONG_NAME>
            <CON_ID>2958270</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CTEP CDISC Harmonization</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14882620</PublicId>
      <PreferredName>RS_RSMETHOD_EXT</PreferredName>
      <PreferredDefinition>An indication as to whether a subject has a progressive disease or a recurrent disease._A description of the technique for the appraisal of a subject or object._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._To increase in length or duration._A list of standard terms and meanings that represent the allowable values for a data item._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Progression or Relapse Evaluation Method Sponsor Identified Extensible Codelist</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTEP CDISC Harmonization</Origin>
      <Representation>
        <PublicId>14882619</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>14882619v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Progressive or Recurrent Disease Indicator Evaluation Method Clinical Study Sponsor Defined Extend Codelist Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C177601</PREFERRED_NAME>
            <LONG_NAME>Progressive or Recurrent Disease Indicator</LONG_NAME>
            <CON_ID>10048401</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C81265</PREFERRED_NAME>
            <LONG_NAME>Evaluation Method</LONG_NAME>
            <CON_ID>2958270</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70793</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Sponsor</LONG_NAME>
            <CON_ID>2715021</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C165683</PREFERRED_NAME>
            <LONG_NAME>Defined</LONG_NAME>
            <CON_ID>7050024</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25270</PREFERRED_NAME>
            <LONG_NAME>Extend</LONG_NAME>
            <CON_ID>2203922</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C142454</PREFERRED_NAME>
            <LONG_NAME>Codelist</LONG_NAME>
            <CON_ID>10025266</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OTHER</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6431768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Method used for evaluation of progression or relapse</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP-Text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the method used for the evaluation of progression or relapse?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP-Text-2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the method used to determine progression or relapse?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>RS_RSMETHOD_TRGRESP_EXT</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>RS_RSMETHOD_PATHRESP_EXT</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>RS_RSMETHOD_BESTRESP_EXT</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>RS_RSMETHOD_OVRLRESP_EXT</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="474">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14922599</PUBLICID>
    <LONGNAME>Wechsler Adult Intelligence Scale - Fourth Edition Letter Numbering Sequence Scaled Score Value</LONGNAME>
    <PREFERREDNAME>WAISIV_LET_NUM_SQ_SSCR</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric representation of the scaled score for the Letter Numbering Sequence subtest in the Wechsler Adult Intelligence Scale, Fourth Edition.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>WAIS-IV:Wechsler Adult Intelligence Scale-Fourth Edition. Pearson, San Antonio, TX, 2008</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14922592</PublicId>
      <PreferredName>4725395v1.00:14922591v1.00</PreferredName>
      <PreferredDefinition>The fourth version of the Wechsler Adult Intelligence Scale that was published in 2008. It is a test designed to measure intelligence in individuals ranging in age from 16 to 90 years.:A subtest of the Wechsler Adult Intelligence Scale that is designed to measure visual-spatial working memory by assessing an individual&#39;s ability to manipulate and remember sequences of letters and numbers._A subtest of the Wechsler Memory Scale, 4th Edition that assesses narrative memory under a free recall condition. A short story is presented orally. Immediately after presentation of the story the subject is asked to recall the story from memory.</PreferredDefinition>
      <LongName>Wechsler Adult Intelligence Scale - Fourth Edition Letter Numbering Sequence Subtest (WAIS-IV) Logical Memory I Subtest (WMS-IV)</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4725395</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C120254</PreferredName>
        <Version>1</Version>
        <LongName>Wechsler Adult Intelligence Scale - Fourth Edition </LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120254</PREFERRED_NAME>
            <LONG_NAME>Wechsler Adult Intelligence Scale - Fourth Edition</LONG_NAME>
            <CON_ID>4711078</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14922591</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C205804:C120342</PreferredName>
        <Version>1</Version>
        <LongName>Letter Numbering Sequence Subtest (WAIS-IV) Logical Memory I Subtest (WMS-IV)</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C205804</PREFERRED_NAME>
            <LONG_NAME>Letter Numbering Sequence Subtest (WAIS-IV)</LONG_NAME>
            <CON_ID>14922566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120342</PREFERRED_NAME>
            <LONG_NAME>Logical Memory I Subtest (WMS-IV)</LONG_NAME>
            <CON_ID>4723991</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>WAIS-IV:Wechsler Adult Intelligence Scale-Fourth Edition. Pearson, San Antonio, TX, 2008</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4725335</PublicId>
      <PreferredName>WAISIV_SSCR_VAL</PreferredName>
      <PreferredDefinition>A numerical quantity that represents the conversion of a raw score on a test to a common scale in the Wechsler Adult Intelligence Scale - Fourth Edition.</PreferredDefinition>
      <LongName>WAIS-IV Scaled Score Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>WAIS-IV:Wechsler Adult Intelligence Scale-Fourth Edition. Pearson, San Antonio, TX, 2008</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV) - Letter Numbering Sequence scaled score:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV) - Letter Numbering Sequence scaled score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Letter-numbering sequencing scaled score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="475">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14959046</PUBLICID>
    <LONGNAME>Health Status Assessment Proxy Respondent Impaired Vision Or Unable to See Well Enough even with Correction Disability Difficulty Indicator</LONGNAME>
    <PREFERREDNAME>14959036v1.00:14936180v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated level of difficulty seeing, using a 4 point Likert scale, as reported by proxy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14959036</PublicId>
      <PreferredName>14936166v1.00:14959035v1.00</PreferredName>
      <PreferredDefinition>Assessments of health-related matters of interest, importance, or worry to a patient, patient’s family, or patient’s healthcare provider that could identify a need, problem, or condition.:A person in a clinical trial other than the subject who provides responses about the subject on their behalf, but not as an observer._Sight that is impaired._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A response indicating that an individual is or was unable to see well enough even with glasses or contact lenses._Any physical or mental impairment that interferes with an individual&#39;s ability to perform desired activities.</PreferredDefinition>
      <LongName>Health Status Assessment Proxy Respondent Impaired Vision Or Unable to See Well Enough even with Correction Disability</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14936166</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C205784</PreferredName>
        <Version>1</Version>
        <LongName>Health Status Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C205784</PREFERRED_NAME>
            <LONG_NAME>Health Status Assessment</LONG_NAME>
            <CON_ID>14920961</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14959035</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>14959035v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Proxy Respondent Impaired Vision Or Unable to See Well Enough even with Correction Disability</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C142652</PREFERRED_NAME>
            <LONG_NAME>Proxy Respondent</LONG_NAME>
            <CON_ID>10027965</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50602</PREFERRED_NAME>
            <LONG_NAME>Impaired Vision</LONG_NAME>
            <CON_ID>4394287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C156146</PREFERRED_NAME>
            <LONG_NAME>Unable to See Well Enough even with Correction</LONG_NAME>
            <CON_ID>6544776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21007</PREFERRED_NAME>
            <LONG_NAME>Disability</LONG_NAME>
            <CON_ID>2204977</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDC:Center for Disease Control</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14936180</PublicId>
      <PreferredName>14936180v1.00</PreferredName>
      <PreferredDefinition>Something not easily done, accomplished, comprehended, or solved._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Difficulty Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>14936179</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>14936179v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Difficulty Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62189</PREFERRED_NAME>
            <LONG_NAME>Difficulty</LONG_NAME>
            <CON_ID>2503546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cannot do at all</VALIDVALUE>
          <VALUEMEANING>Cannot Do</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual cannot do something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes - a lot of difficulty</VALIDVALUE>
          <VALUEMEANING>Severe Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had severe difficulty doing something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C167316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7128548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes - some difficulty</VALIDVALUE>
          <VALUEMEANING>Some difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something with some difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121739</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4837749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No - no difficulty</VALIDVALUE>
          <VALUEMEANING>No Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had no difficulty doing something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C167313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7128551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is SP blind or does he/she have serious difficulty seeing, even when wearing glasses?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14916558</PublicId>
          <ContextName>NIH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>14916558v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDoH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14916559</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="476">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14984506</PUBLICID>
    <LONGNAME>Diagnosis Original Metastasis Receptor Type</LONGNAME>
    <PREFERREDNAME>14959572v1.00:14984504v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that represents the original metastasis receptor type in the investigation or research study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CIP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>TCIA:TheCancerImagingArchive</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14959572</PublicId>
      <PreferredName>2442484v1.00:14959571v1.00</PreferredName>
      <PreferredDefinition>The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:Preceding all others in time or being as first made or performed._The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor._A protein located on the cell surface, or in the cytoplasm, that binds to a specific signaling factor, such as a hormone, antigen, or neurotransmitter, causing a conformational and functional change in the receptor molecule.  The ligand-bound receptor then alters its interaction with target molecules, which leads to changes in cellular physiology through modification of the activity of one or more signal transduction pathways.</PreferredDefinition>
      <LongName>Diagnosis Original Metastasis Receptor</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2442484</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14959571</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25604:C19151:C18106</PreferredName>
        <Version>1</Version>
        <LongName>Original Metastasis Receptor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25604</PREFERRED_NAME>
            <LONG_NAME>Original</LONG_NAME>
            <CON_ID>2206332</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19151</PREFERRED_NAME>
            <LONG_NAME>Metastasis</LONG_NAME>
            <CON_ID>2202751</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18106</PREFERRED_NAME>
            <LONG_NAME>Receptor</LONG_NAME>
            <CON_ID>2612148</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>TCIA:TheCancerImagingArchive</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14984504</PublicId>
      <PreferredName>14984504v1.00</PreferredName>
      <PreferredDefinition>A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla._A protein located on the cell surface, or in the cytoplasm, that binds to a specific signaling factor, such as a hormone, antigen, or neurotransmitter, causing a conformational and functional change in the receptor molecule.  The ligand-bound receptor then alters its interaction with target molecules, which leads to changes in cellular physiology through modification of the activity of one or more signal transduction pathways._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Breast Cancer Receptor Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>TCIA:TheCancerImagingArchive</Origin>
      <Representation>
        <PublicId>14984503</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>14984503v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Breast Carcinoma Receptor Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4872</PREFERRED_NAME>
            <LONG_NAME>Breast Carcinoma</LONG_NAME>
            <CON_ID>2475940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18106</PREFERRED_NAME>
            <LONG_NAME>Receptor</LONG_NAME>
            <CON_ID>2612148</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7590024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TNBC</VALIDVALUE>
          <VALUEMEANING>Triple-Negative Breast Cancer Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>Triple-negative breast cancer is defined by a lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4413621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HR+/HER2-</VALIDVALUE>
          <VALUEMEANING>Hormone Receptor Positive HER2/Neu Negative</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding indicating that the neoplastic cells in a tissue sample test positive for hormone receptors._The absence of detectable HER2/Neu in a tissue sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68749, C101267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14988819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HER2+</VALIDVALUE>
          <VALUEMEANING>HER2/Neu Positive</VALUEMEANING>
          <MEANINGDESCRIPTION>A laboratory test result indicating the presence of HER2/Neu in a tissue sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5497864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Original Metastasis Receptor</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6305258</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TCIA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AURORA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943540</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>Metastasis original receptors</AlternateName>
        <AlternateNameType>TCIA Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="477">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15004644</PUBLICID>
    <LONGNAME>Laboratory Procedure Time</LONGNAME>
    <PREFERREDNAME>15003573v1.00:15004632v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:The continuum of experience in which events pass from the future through the present to the past.:The continuum of experience in which events pass from the future through the present to the past.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>OMOP CDM:The Observational Medical Outcomes Partnership (OMOP) Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15003573</PublicId>
      <PreferredName>2543047v1.00:2193270v1.00</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:The continuum of experience in which events pass from the future through the present to the past.</PreferredDefinition>
      <LongName>Laboratory Procedure Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2193270</PublicId>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Time</PreferredName>
        <Version>1</Version>
        <LongName>Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15004632</PublicId>
      <PreferredName>15004632v1.00</PreferredName>
      <PreferredDefinition>The continuum of experience in which events pass from the future through the present to the past.</PreferredDefinition>
      <LongName>Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>varchar</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2193249</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25207</PreferredName>
        <Version>1</Version>
        <LongName>Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Measurement Time</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Measurement Time</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>etlConventions</Name>
        <DocumentType>OMOP CDM ETL Conventions</DocumentType>
        <DocumentText>This is present for backwards compatibility and will be deprecated in an upcoming version.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14522466</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>OMOP 5.4</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Measurement</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>14522478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MEASUREMENT</AlternateName>
        <AlternateNameType>OMOP Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>measurement_time</AlternateName>
        <AlternateNameType>OMOP Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="478">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15004746</PUBLICID>
    <LONGNAME>Laboratory Procedure History Applicable Start Date</LONGNAME>
    <PREFERREDNAME>15000212v1.00:14597071v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:The aggregate of past events; the continuum of events occurring in succession leading from the past to the present; a record or narrative description of past events._Having relevance; capable of being applied._The calendar date on which something is to start or did start.:The particular day, month and year an event has happened or will happen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15000212</PublicId>
      <PreferredName>2543047v1.00:15024654v1.00</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:A set of values of particular type of measurement that is used to interpret corresponding observation results._The calendar date on which something is to start or did start.</PreferredDefinition>
      <LongName>Laboratory Procedure Reference Range Start Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15024654</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71474:C68616</PreferredName>
        <Version>1</Version>
        <LongName>Reference Range Start Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71474</PREFERRED_NAME>
            <LONG_NAME>Reference Range</LONG_NAME>
            <CON_ID>2859323</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68616</PREFERRED_NAME>
            <LONG_NAME>Start Date</LONG_NAME>
            <CON_ID>2712678</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14597071</PublicId>
      <PreferredName>14597071v1.00</PreferredName>
      <PreferredDefinition>The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>SAS Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Period Start</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Period Start</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14522553</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PCORnet CDM 6.1</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lab History</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>14522578</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PERIOD_START</AlternateName>
        <AlternateNameType>PCORNet Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_HISTORY</AlternateName>
        <AlternateNameType>PCORnet Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="479">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15081264</PUBLICID>
    <LONGNAME>Health Status Assessment FAQLQ-PF 20 Food Allergy Impact Child Feels Concerned Accidentally Eat Allergic Ingredient Score 7 Point Scale</LONGNAME>
    <PREFERREDNAME>FAQLQ_PF_20_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation, because of  the impact of their child&#39;s food allergy, whether their child feels concerned about accidentally eating an ingredient to which he/she is allergic, using a 7-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15080911</PublicId>
      <PreferredName>14936166v1.00:15081234v1.00</PreferredName>
      <PreferredDefinition>Assessments of health-related matters of interest, importance, or worry to a patient, patient&#39;s family, or patient&#39;s healthcare provider that could identify a need, problem, or condition.:A questionnaire designed to be completed by a parent to assess how much of an impact food allergies have on their child&#39;s quality of life. It is designed for children ages 0-12._An allergic reaction triggered by exposure to allergens found in food; exposure can occur through the skin, respiratory tract or digestive tract._The effect or consequence of an event or condition._A question about whether an individual&#39;s child feels concerned about accidentally eating an ingredient to which they are allergic._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Health Status Assessment Food Allergy Quality of Life Questionnaire - Parent Form Food Allergy Impact Child Feels Concerned Accidentally Eat Allergic Ingredient Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14936166</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C205784</PreferredName>
        <Version>1</Version>
        <LongName>Health Status Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C205784</PREFERRED_NAME>
            <LONG_NAME>Health Status Assessment</LONG_NAME>
            <CON_ID>14920961</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15081234</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15081234v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Food Allergy Quality of Life Questionnaire - Parent Form Food Allergy Impact Child Feels Concerned Accidentally Eat Allergic Ingredient Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C209941</PREFERRED_NAME>
            <LONG_NAME>Food Allergy Quality of Life Questionnaire - Parent Form</LONG_NAME>
            <CON_ID>15063847</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C172304</PREFERRED_NAME>
            <LONG_NAME>Food Allergy</LONG_NAME>
            <CON_ID>7465895</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122929</PREFERRED_NAME>
            <LONG_NAME>Impact</LONG_NAME>
            <CON_ID>4930073</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C209961</PREFERRED_NAME>
            <LONG_NAME>Child Feels Concerned Accidentally Eat Allergic Ingredient Question</LONG_NAME>
            <CON_ID>15063867</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15081014</PublicId>
      <PreferredName>FAQLQPF_QUANT_7PT_SCL</PreferredName>
      <PreferredDefinition>A questionnaire designed to be completed by a parent to assess how much of an impact food allergies have on their child&#39;s quality of life. It is designed for children ages 0-12._An ordered reference standard used to measure incremental changes with responses from 0=not at all, 1=a little bit, 2=slightly, 3=moderately, 4=quite a bit, 5=very much, 6=extremely.</PreferredDefinition>
      <LongName>FAQLQ Parent Form Quantity 7 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>15081013</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15081013v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Food Allergy Quality of Life Questionnaire - Parent Form Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C209941</PREFERRED_NAME>
            <LONG_NAME>Food Allergy Quality of Life Questionnaire - Parent Form</LONG_NAME>
            <CON_ID>15063847</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Extremely Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7402703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>A lot</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3679493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Quite a lot</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Moderate Response</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of a degree of agreement that is approximately halfway between the highest and lowest degrees of agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5576773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Slightly Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in slight agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5119337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A Little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4733151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of non-agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6730940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Because of food allergy, my child feels concerned about accidentally eating an ingredient to which he/she is allergic</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Because of food allergy, my child feels concerned about accidentally eating an ingredient to which he/she is allergic</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Concerned about accidentally eating an ingredient to which he/she is allergic</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FAQLQ-Parent Form</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question 20 of 63</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions. Questions used in this manner do not represent the original measure and should not be referenced by the measure’s name.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>2</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>3</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Parent Forms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15175023</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15099037</PublicId>
          <ContextName>NIAID</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>15099037v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Parent Forms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15100801</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="480">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15083514</PUBLICID>
    <LONGNAME>Health Status Assessment PAR-Q+ Currently Have a Bone, Joint, or Soft Tissue Problem that Could be Worsened by More Physical Activity Yes No Indicator</LONGNAME>
    <PREFERREDNAME>PARQ+_7_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A person’s yes/no response of whether or not they currently have (or have had within the past 12 months) a bone, joint, or soft tissue problem that could be made worse by becoming more physically active.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PAR-Q+: Physical Activity Readiness Questionnaire for Everyone</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15082609</PublicId>
      <PreferredName>14936166v1.00:15082608v1.00</PreferredName>
      <PreferredDefinition>Assessments of health-related matters of interest, importance, or worry to a patient, patient&#39;s family, or patient&#39;s healthcare provider that could identify a need, problem, or condition.:A self-administered health screening tool designed to identify individuals who may need medical clearance before starting a group exercise class._A question about whether an individual currently has a bone, joint, or soft tissue problem that could be made worse by becoming more physically active.</PreferredDefinition>
      <LongName>Health Status Assessment The Physical Activity Readiness Questionnaire for Everyone Currently Have a Bone, Joint, or Soft Tissue Problem that Could be Worsened by More Physical Activity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14936166</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C205784</PreferredName>
        <Version>1</Version>
        <LongName>Health Status Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C205784</PREFERRED_NAME>
            <LONG_NAME>Health Status Assessment</LONG_NAME>
            <CON_ID>14920961</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15082608</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C209997:C209998</PreferredName>
        <Version>1</Version>
        <LongName>The Physical Activity Readiness Questionnaire for Everyone Currently Have a Bone, Joint, or Soft Tissue Problem that Could be Worsened by More Physical Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C209997</PREFERRED_NAME>
            <LONG_NAME>The Physical Activity Readiness Questionnaire for Everyone</LONG_NAME>
            <CON_ID>15081002</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C209998</PREFERRED_NAME>
            <LONG_NAME>Currently Have a Bone, Joint, or Soft Tissue Problem that Could be Worsened by More Physical Activity Question</LONG_NAME>
            <CON_ID>15081003</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PAR-Q+: Physical Activity Readiness Questionnaire for Everyone</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Do you currently have (or have had within the past 12 months) a bone, joint, or soft tissue (muscle, ligament, or tendon) problem that could be made worse by becoming more physically active?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Do you currently have (or have had within the past 12 months) a bone, joint, or soft tissue (muscle, ligament, or tendon) problem that could be made worse by becoming more physically active?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PARQ_7_IND</AlternateName>
        <AlternateNameType>DCP Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="481">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15112420</PUBLICID>
    <LONGNAME>Specimen Analyte Type Identifier</LONGNAME>
    <PREFERREDNAME>15112170v1.00:7344497v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>A sequence of characters used to identify the type of a biological material sample.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>CRDC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>GDC:NCI Genomic Data Commons</ORIGIN>
    <REGISTRATIONSTATUS>Superseded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15112170</PublicId>
      <PreferredName>2859635v1.00:15112169v1.00</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:The sample or material being subjected to analysis._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Specimen Analyte Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CRDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15112169</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C128639:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Analyte Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C128639</PREFERRED_NAME>
            <LONG_NAME>Analyte</LONG_NAME>
            <CON_ID>5431051</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>GDC:NCI Genomic Data Commons</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7344497</PublicId>
      <PreferredName>7344497v1.0</PreferredName>
      <PreferredDefinition>One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008576</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DATA_SOURCE</PreferredName>
        <Version>1</Version>
        <LongName>Data Source</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>255</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specimen Type ID</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="482">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15114134</PUBLICID>
    <LONGNAME>Health Status Assessment FAQLQ-PF10 4 Food Allergy Impact Child Has Limitations in Variety of Foods They Can Try or Taste Score 7 Point Scale</LONGNAME>
    <PREFERREDNAME>FAQLQ_PF10_4_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation, due to the impact of their child&#39;s food allergy, whether their child has limitations in the variety of foods he/she can try or taste, using a 7-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FAQLQ-PF10: Food Allergy Quality of Life Questionnaire, Parent Form 10, Moynihan D., Morrissey E., et al.,  Clinical and Translational Allergy, 2015</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15114110</PublicId>
      <PreferredName>14936166v1.00:15114147v1.00</PreferredName>
      <PreferredDefinition>Assessments of health-related matters of interest, importance, or worry to a patient, patient&#39;s family, or patient&#39;s healthcare provider that could identify a need, problem, or condition.:A 10-item, shortened version of the Food Allergy Quality of Life Questionnaire - Parent Form, which is designed to be completed by a parent to assess how much of an impact food allergies have on their child&#39;s quality of life._An allergic reaction triggered by exposure to allergens found in food; exposure can occur through the skin, respiratory tract or digestive tract._The effect or consequence of an event or condition._A question about whether an individual&#39;s child has or had limitations in the variety of foods they can try or taste._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Health Status Assessment Food Allergy Quality of Life Questionnaire - Parent Form 10 Food Allergy Impact Child Has Limitations in Variety of Foods They Can Try or Taste Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14936166</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C205784</PreferredName>
        <Version>1</Version>
        <LongName>Health Status Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C205784</PREFERRED_NAME>
            <LONG_NAME>Health Status Assessment</LONG_NAME>
            <CON_ID>14920961</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15114147</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15114147v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Food Allergy Quality of Life Questionnaire - Parent Form 10 Food Allergy Impact Child Has Limitations in Variety of Foods They Can Try or Taste Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C210473</PREFERRED_NAME>
            <LONG_NAME>Food Allergy Quality of Life Questionnaire - Parent Form 10</LONG_NAME>
            <CON_ID>15114002</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C172304</PREFERRED_NAME>
            <LONG_NAME>Food Allergy</LONG_NAME>
            <CON_ID>7465895</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122929</PREFERRED_NAME>
            <LONG_NAME>Impact</LONG_NAME>
            <CON_ID>4930073</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C210477</PREFERRED_NAME>
            <LONG_NAME>Child Has Limitations in Variety of Foods They Can Try or Taste Question</LONG_NAME>
            <CON_ID>15114006</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>FAQLQ-PF10: Food Allergy Quality of Life Questionnaire, Parent Form 10, Moynihan D., Morrissey E., et al.,  Clinical and Translational Allergy, 2015</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15114068</PublicId>
      <PreferredName>15114068v1.00</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes with values 0=Not at all, 1=Hardly at all, 2=A little bit, 3=Moderate Response, 4=Quite a bit, 5=Very much, 6=Extremely.</PreferredDefinition>
      <LongName>Patient Reported Outcome Measures 7 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>15382018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15382018v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Patient Reported Outcome Measures Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C177377</PREFERRED_NAME>
            <LONG_NAME>Patient Reported Outcome Measures</LONG_NAME>
            <CON_ID>10049650</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>EXTREMELY</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Moderate Response</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of a degree of agreement that is approximately halfway between the highest and lowest degrees of agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5576773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Hardly at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something occurs rarely or with very little intensity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4267061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Because of food allergy, my child has limitations in the variety of foods he/she can try or taste</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Because of food allergy, my child has limitations in the variety of foods he/she can try or taste</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has limitations in the variety of foods he/she can try or taste</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FAQLQ-Parent Form 10</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question 4 of 10</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions. Questions used in this manner do not represent the original measure and should not be referenced by the measure’s name.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>2</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>3</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Parent Forms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15175023</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15099037</PublicId>
          <ContextName>NIAID</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>15099037v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Parent Forms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15100801</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="483">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15157371</PUBLICID>
    <LONGNAME>Person Gender Identity HL7 FHIR Terminology Code</LONGNAME>
    <PREFERREDNAME>14522614v1.00:15092056v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>An individual&#39;s personal sense of being a man, woman, boy, girl, nonbinary, or something else, ascertained by asking them what that identity is. This element holds the &quot;code&quot; part of the value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14522614</PublicId>
      <PreferredName>2236731v1.00:14522613v1.00</PreferredName>
      <PreferredDefinition>A human being.:A person&#39;s internally held sense of their gender, which may or may not correspond to the individual&#39;s genotypic or phenotypic sex.</PreferredDefinition>
      <LongName>Person Gender Identity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14522613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C158277</PreferredName>
        <Version>1</Version>
        <LongName>Gender Identity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C158277</PREFERRED_NAME>
            <LONG_NAME>Gender Identity</LONG_NAME>
            <CON_ID>6774019</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15092056</PublicId>
      <PreferredName>15092056v1.00</PreferredName>
      <PreferredDefinition>A person&#39;s internally held sense of their gender, which may or may not correspond to the individual&#39;s genotypic or phenotypic sex. IMPORTANT NOTICE: The NCI Thesaurus contains biomedical terminologies that NCI does not own or control. This concept contains gender-related content that does not comply with Executive Order 14168._A set of healthcare-associated terms, codes, and related resources that comprise the Health Level Seven (HL7) Fast Healthcare Interoperability Resources standard for data exchange._A symbol or combination of symbols which is assigned to the members of a collection.</PreferredDefinition>
      <LongName>Gender Identity HL7 FHIR Terminology Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1048576</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>16084488</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16084488v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Gender Identity HL7 FHIR Terminology Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C158277</PREFERRED_NAME>
            <LONG_NAME>Gender Identity</LONG_NAME>
            <CON_ID>6774019</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C213710</PREFERRED_NAME>
            <LONG_NAME>HL7 FHIR Terminology</LONG_NAME>
            <CON_ID>15750010</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>asked-declined</VALIDVALUE>
          <VALUEMEANING>Declined to answer</VALUEMEANING>
          <MEANINGDESCRIPTION>Used to indicate when a respondent makes a decision to not answer a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51024</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5936254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UNK</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OTH</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>33791000087105</VALIDVALUE>
          <VALUEMEANING>Gender Variant</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who does not conform to a male/female gender identity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160941</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6845832</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>407376001</VALIDVALUE>
          <VALUEMEANING>Male-to-Female Transsexual</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who was assigned to the male gender at birth based on physical characteristics but who self-identifies psychologically and emotionally as female.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C46120</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>407377005</VALIDVALUE>
          <VALUEMEANING>Female-to-Male Transsexual</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who was assigned to the female gender at birth based on physical characteristics but who self-identifies psychologically and emotionally as male.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C46121</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>446131000124102</VALIDVALUE>
          <VALUEMEANING>Genderqueer</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who does not subscribe to conventional gender distinctions but identifies with neither, both, or a combination of male and female genders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7483540</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>446141000124107</VALIDVALUE>
          <VALUEMEANING>Female Gender Identity</VALUEMEANING>
          <MEANINGDESCRIPTION>A person&#39;s innate sense of their self as female. This identity may be at odds with their sex assigned at birth. Gender identity is different from gender expression, how they display their self outwardly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C205466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14918685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>446151000124109</VALIDVALUE>
          <VALUEMEANING>Male Gender Identity</VALUEMEANING>
          <MEANINGDESCRIPTION>A person&#39;s innate sense of their self as male. This identity may be at odds with their sex assigned at birth. Gender identity is different from gender expression, how they display their self outwardly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C205467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14918684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Gender Identity</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Patient Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15063897</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15689233</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HHS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>External Standards</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15910167</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Patient</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>extension[]@url[http://hl7.org/fhir/us/core/StructureDefinition/us-core-genderIdentity].valueCodeableConcept.coding[].code@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="484">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15316544</PUBLICID>
    <LONGNAME>Lesion Type</LONGNAME>
    <PREFERREDNAME>LESN_TYP</PREFERREDNAME>
    <PREFERREDDEFINITION>The type of lesion assessed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15316509</PublicId>
      <PreferredName>2465192v1.00:2223243v1.00</PreferredName>
      <PreferredDefinition>A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Lesion Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2465192</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3824</PreferredName>
        <Version>1</Version>
        <LongName>Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15316510</PublicId>
      <PreferredName>15316510v1.00</PreferredName>
      <PreferredDefinition>A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Lesion Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>3271385</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3824:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Lesion Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unilocular</VALIDVALUE>
          <VALUEMEANING>Unilocular Ovarian Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>An ovarian cyst that has a single compartment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15316543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multiseptated</VALIDVALUE>
          <VALUEMEANING>Multiple Septate</VALUEMEANING>
          <MEANINGDESCRIPTION>Having, relating to, or consisting of more than one individual, element, part, or other component; manifold._Of or relating to a septum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28380, C17648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15316542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cannot be determined</VALIDVALUE>
          <VALUEMEANING>Cannot Be Determined</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that a reason or result cannot be established.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C179711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7758876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Lesion type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this lesion multiseptated or unilocular?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cyst Type:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CYST_TYP</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="485">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15726834</PUBLICID>
    <LONGNAME>Intervention or Procedure Start Date and Time</LONGNAME>
    <PREFERREDNAME>14758345v1.00:15102796v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Estimated or actual date, date-time, period, or age when the procedure was performed. Allows a period to support complex procedures that span more than one date, and also allows for the length of the procedure to be captured. This element holds the &quot;start&quot; part of the period.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14758345</PublicId>
      <PreferredName>2233215v1.00:14737635v1.00</PreferredName>
      <PreferredDefinition>An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.:The calendar date on which something is to start or did start._The time at which something is to start or did start.</PreferredDefinition>
      <LongName>Intervention or Procedure Start Date Start Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233215</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25218</PreferredName>
        <Version>1</Version>
        <LongName>Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14737635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68616:C78441</PreferredName>
        <Version>1</Version>
        <LongName>Start Date Start Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68616</PREFERRED_NAME>
            <LONG_NAME>Start Date</LONG_NAME>
            <CON_ID>2712678</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78441</PREFERRED_NAME>
            <LONG_NAME>Start Time</LONG_NAME>
            <CON_ID>2975813</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>RADLEX_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15102796</PublicId>
      <PreferredName>15102796v1.00</PreferredName>
      <PreferredDefinition>An expression of both date and time that an event has happened or will happen.</PreferredDefinition>
      <LongName>Date and Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE/TIME</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Performed Period Start</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Procedure Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15744772</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Procedure</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>performedPeriod.start@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="486">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15811858</PUBLICID>
    <LONGNAME>EORTC QLQ-C30 Version 3.0 8 Past Week Have Been Short of Breath Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>QS_QSORRES_EOR0108</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated perception of how often in the past week they were short of breath, using a four point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDISC Harmonization</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15811857</PublicId>
      <PreferredName>6607890v1.00:15811856v1.00</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire.:A 30-item questionnaire about patient ability to function, symptoms related to the cancer and its treatment, overall health and quality of life, and perceived financial impact of cancer and its treatment._The most recent week. May include the present day._A question about whether an individual has or had shortness of breath._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Questionnaire Domain European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Past Week Have Shortness of Breath Question Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6607890</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49609</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49609</PREFERRED_NAME>
            <LONG_NAME>Questionnaire Domain</LONG_NAME>
            <CON_ID>2469074</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15811856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C104355:C95402:C99773:C25338</PreferredName>
        <Version>1</Version>
        <LongName>European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Past Week Have Shortness of Breath Question Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104355</PREFERRED_NAME>
            <LONG_NAME>European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30</LONG_NAME>
            <CON_ID>3673437</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C99773</PREFERRED_NAME>
            <LONG_NAME>Have Shortness of Breath Question</LONG_NAME>
            <CON_ID>3377309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CTEP CDISC Harmonization</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15792214</PublicId>
      <PreferredName>EORTC_QLQ_4PT_SCL</PreferredName>
      <PreferredDefinition>The first outcome of a study questionnaire assessment._A 30-item questionnaire about patient ability to function, symptoms related to the cancer and its treatment, overall health and quality of life, and perceived financial impact of cancer and its treatment._A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one._The precise location of something; a spatially limited location._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>EORTC QLQ Score 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTEP CDISC Harmonization</Origin>
      <Representation>
        <PublicId>15792213</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15792213v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Original Result European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Four Point Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83375</PREFERRED_NAME>
            <LONG_NAME>Questionnaire Original Result</LONG_NAME>
            <CON_ID>6641690</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104355</PREFERRED_NAME>
            <LONG_NAME>European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30</LONG_NAME>
            <CON_ID>3673437</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66835</PREFERRED_NAME>
            <LONG_NAME>Four</LONG_NAME>
            <CON_ID>2673235</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70656</PREFERRED_NAME>
            <LONG_NAME>Point</LONG_NAME>
            <CON_ID>2710246</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Were you short of breath?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC EORTC QLQ-H&amp;N35 (Version 1)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>15383911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC EORTC QLQ-C30 (Version 3)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>15383912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="487">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16018075</PUBLICID>
    <LONGNAME>Laboratory Procedure Test Result Missing Data Reason HL7 FHIR Terminology Code</LONGNAME>
    <PREFERREDNAME>16017003v1.00:16018054v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Provides a reason why the expected value in the element Observation.value[x] is missing. This element holds the &quot;code&quot; part of the value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16017003</PublicId>
      <PreferredName>2543047v1.00:16017002v1.00</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:A qualifier used to describe the workflow progression of a laboratory observation outcome in terms of being finished, concluded, interpreted as preliminary, needed to be repeated, etc._Required or expected data that is not present, which may be due to non-completion or corruption._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Laboratory Procedure Test Result Missing Data Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16017002</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70768:C142610:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test Result Status Missing Data Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70768</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Result Status</LONG_NAME>
            <CON_ID>2714950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C142610</PREFERRED_NAME>
            <LONG_NAME>Missing Data</LONG_NAME>
            <CON_ID>10028156</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>16018054</PublicId>
      <PreferredName>16018054v1.00</PreferredName>
      <PreferredDefinition>Required or expected data that is not present, which may be due to non-completion or corruption._An explanation of the cause of some phenomenon or action._A data feed that allows the transmission of medical and administrative events in a healthcare setting to different systems._A symbol or combination of symbols which is assigned to the members of a collection.</PreferredDefinition>
      <LongName>Missing Data Reason HL7 FHIR Terminology Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1048576</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>16018053</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16018053v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Missing Data Reason HL7 Feed Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C142610</PREFERRED_NAME>
            <LONG_NAME>Missing Data</LONG_NAME>
            <CON_ID>10028156</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C203663</PREFERRED_NAME>
            <LONG_NAME>HL7 Feed</LONG_NAME>
            <CON_ID>14717536</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>asked-declined</VALIDVALUE>
          <VALUEMEANING>Response Declined</VALUEMEANING>
          <MEANINGDESCRIPTION>Used to indicate when a respondent makes a decision to not answer a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51024</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>masked</VALIDVALUE>
          <VALUEMEANING>Masked Data</VALUEMEANING>
          <MEANINGDESCRIPTION>Information exists but is not provided due to security or privacy concerns.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16075804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>not-applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>unsupported</VALIDVALUE>
          <VALUEMEANING>Not Offered</VALUEMEANING>
          <MEANINGDESCRIPTION>Is not an option.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16075805</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>negative-infinity</VALIDVALUE>
          <VALUEMEANING>Negative Infinity</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with a value that is less than any other negative number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2929835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>positive-infinity</VALIDVALUE>
          <VALUEMEANING>Positive Infinity</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with a value that is larger than any other positive number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2929836</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>not-performed</VALIDVALUE>
          <VALUEMEANING>Not Performed</VALUEMEANING>
          <MEANINGDESCRIPTION>An indicator that specifies that an activity did not occur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10570813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>not-permitted</VALIDVALUE>
          <VALUEMEANING>Not Allowed To Collect</VALUEMEANING>
          <MEANINGDESCRIPTION>An indicator that specifies that a collection event was not permitted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6662191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>asked-unknown</VALIDVALUE>
          <VALUEMEANING>Asked but Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that a question was asked and the response is unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6153913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>not-asked</VALIDVALUE>
          <VALUEMEANING>Not asked</VALUEMEANING>
          <MEANINGDESCRIPTION>This information has not been sought (e.g., patient was not asked)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2839358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>temp-unknown</VALIDVALUE>
          <VALUEMEANING>Temporarily Unavailable</VALUEMEANING>
          <MEANINGDESCRIPTION>Information is not available currently but expected to be made available in the near future.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16089628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>as-text</VALIDVALUE>
          <VALUEMEANING>Value Represented As Text</VALUEMEANING>
          <MEANINGDESCRIPTION>A value expected as a number is represented as text in its source.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C216154</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16089629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>error</VALIDVALUE>
          <VALUEMEANING>System Error</VALUEMEANING>
          <MEANINGDESCRIPTION>The value is missing due to a processing error.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C216155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16089630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>not-a-number</VALIDVALUE>
          <VALUEMEANING>Floating Point Processing Error</VALUEMEANING>
          <MEANINGDESCRIPTION>The numeric value is undefined or unrepresentable due to a floating point processing error.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C216156</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16089631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Absent Reason Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Laboratory Result Observation Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16021024</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>dataAbsentReason.coding[].code@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LaboratoryResultObservation</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="488">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16018083</PUBLICID>
    <LONGNAME>Laboratory Procedure Test Result Observation Category Health Level Seven System Version Text</LONGNAME>
    <PREFERREDNAME>16017005v1.00:15918461v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>A code that classifies the general type of observation being made. This element holds the &quot;version&quot; part of the value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16017005</PublicId>
      <PreferredName>2543047v1.00:16084814v1.00</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:The outcome of a laboratory test._The act, by a healthcare worker, of monitoring an identified subject and recording signs, symptoms, or behavior._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Laboratory Procedure Test Result Observation Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16084814</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C36292:C116555:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test Result Clinical Observation Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C36292</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Result</LONG_NAME>
            <CON_ID>2451822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C116555</PREFERRED_NAME>
            <LONG_NAME>Clinical Observation</LONG_NAME>
            <CON_ID>6058376</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15918461</PublicId>
      <PreferredName>15918461v1.00</PreferredName>
      <PreferredDefinition>A Standards Developing Organization (SDO) operating in the healthcare arena with an emphasis on the domain of clinical and administrative data._A group of independent but interrelated elements comprising a unified whole._A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications._The words of something written.</PreferredDefinition>
      <LongName>Health Level Seven System Version Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1048576</MaximumLength>
      <MinimumLength>0</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</Origin>
      <Representation>
        <PublicId>15918460</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15918460v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Health Level Seven System Version Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80485</PREFERRED_NAME>
            <LONG_NAME>Health Level Seven</LONG_NAME>
            <CON_ID>2928160</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25700</PREFERRED_NAME>
            <LONG_NAME>System</LONG_NAME>
            <CON_ID>2202584</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Category System Version</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Laboratory Result Observation Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16021024</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>category[].coding[].version@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LaboratoryResultObservation</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="489">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16092807</PUBLICID>
    <LONGNAME>Disease Non WHO CNS 2021 Glioblastoma Diagnosis Type</LONGNAME>
    <PREFERREDNAME>16092798v1.00:16084648v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The description of the type of disease present in a glioblastoma diagnosis prior to the WHO Classification of Tumors of the Central Nervous System 2021.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CIP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>TCIA:TheCancerImagingArchive</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16092798</PublicId>
      <PreferredName>2404658v1.00:16092797v1.00</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:An operation in which a term denies or inverts the meaning of another term or construction._A classification for the grading and staging of brain and spinal cord tumors published by the World Health Organization (WHO) in 2021.</PreferredDefinition>
      <LongName>Disease Non WHO CNS 2021</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16092797</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C216233</PreferredName>
        <Version>1</Version>
        <LongName>Negation WHO Classification of Tumors of the Central Nervous System 2021</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C216233</PREFERRED_NAME>
            <LONG_NAME>WHO Classification of Tumors of the Central Nervous System 2021</LONG_NAME>
            <CON_ID>16089860</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>TCIA:TheCancerImagingArchive</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>16084648</PublicId>
      <PreferredName>16084648v1.00</PreferredName>
      <PreferredDefinition>The most malignant astrocytic tumor (WHO grade 4).  It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO)_Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Glioblastoma Diagnosis Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>TCIA:TheCancerImagingArchive</Origin>
      <Representation>
        <PublicId>16084647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16084647v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Glioblastoma Disease or Disorder Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3058</PREFERRED_NAME>
            <LONG_NAME>Glioblastoma</LONG_NAME>
            <CON_ID>2479034</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oligoastrocytoma</VALIDVALUE>
          <VALUEMEANING>Oligoastrocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade II tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4050</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glioblastoma</VALIDVALUE>
          <VALUEMEANING>Glioblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma). Two histologic variants are recognized: giant cell glioblastoma and gliosarcoma. (WHO) </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Astrocytoma, IDH-Mutant</VALIDVALUE>
          <VALUEMEANING>Astrocytoma, IDH-Mutant</VALUEMEANING>
          <MEANINGDESCRIPTION>An astrocytoma associated with IDH1 or IDH2 gene mutations and absence of 1p/19q codeletion. It is classified as grade 2, 3, or 4.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C185167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14235586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anaplastic Astrocytoma</VALIDVALUE>
          <VALUEMEANING>Anaplastic astrocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A diffusely infiltrating, WHO grade III astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Astrocytoma</VALIDVALUE>
          <VALUEMEANING>Astrocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60781</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5097352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Non WHO 2021 Diagnosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6305258</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TCIA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCSD-PTGBM-Clinical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15741979</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>Non WHO 2021 Diagnosis</AlternateName>
        <AlternateNameType>TCIA Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="490">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16250099</PUBLICID>
    <LONGNAME>Subject Brain Neoplasm Primary Diagnosis Type</LONGNAME>
    <PREFERREDNAME>16250045v1.00:16250048v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The type of neoplasm that arises from or metastasizes to the brain.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CIP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>TCIA:TheCancerImagingArchive</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16250045</PublicId>
      <PreferredName>2523466v1.00:16250044v1.00</PreferredName>
      <PreferredDefinition>A matter or an individual that is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study.:A benign or malignant neoplasm that arises from or metastasizes to the brain._The patient&#39;s condition which is the main reason for evaluation and treatment.</PreferredDefinition>
      <LongName>Subject Brain Neoplasm Primary Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2523466</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41189</PreferredName>
        <Version>1</Version>
        <LongName>Study Subject</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41189</PREFERRED_NAME>
            <LONG_NAME>Study Subject</LONG_NAME>
            <CON_ID>2202706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16250044</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2907:C202033</PreferredName>
        <Version>1</Version>
        <LongName>Brain Neoplasm Primary Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2907</PREFERRED_NAME>
            <LONG_NAME>Brain Neoplasm</LONG_NAME>
            <CON_ID>2740429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C202033</PREFERRED_NAME>
            <LONG_NAME>Primary Diagnosis</LONG_NAME>
            <CON_ID>14598302</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>TCIA:TheCancerImagingArchive</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>16250048</PublicId>
      <PreferredName>16250048v1.00</PreferredName>
      <PreferredDefinition>A benign or malignant neoplasm that arises from or metastasizes to the brain._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Brain Neoplasm Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>TCIA:TheCancerImagingArchive</Origin>
      <Representation>
        <PublicId>16250047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16250047v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Brain Neoplasm Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2907</PREFERRED_NAME>
            <LONG_NAME>Brain Neoplasm</LONG_NAME>
            <CON_ID>2740429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glioma w/ GBM features</VALIDVALUE>
          <VALUEMEANING>Glioma With Glioblastoma Feature</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas._Used to indicate the presence of something or someone._The most malignant astrocytic tumor (WHO grade 4).  It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO)_A prominent or identifiable aspect, region, or site of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73619, C3058, C62355, C3059</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16250049</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diffuse glioma</VALIDVALUE>
          <VALUEMEANING>Diffuse Glioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A glioma that has diffusely infiltrated the surrounding central nervous system tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129325</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14670055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oligodendro-glioma</VALIDVALUE>
          <VALUEMEANING>Oligodendroglioma, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>An oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129319</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5698554</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Astrocytoma</VALIDVALUE>
          <VALUEMEANING>Astrocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60781</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5097352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pilocytic astrocytoma</VALIDVALUE>
          <VALUEMEANING>Pilocytic astrocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Pilocytic Astrocytoma, the most common glioma in children, is a WHO grade I astrocytic tumor. It is a generally well circumscribed, slowly growing, often cystic, astrocytoma. It is histologically characterized by a biphasic pattern with varying proportion of compacted bipolar cells which may have Rosenthal fibers (tapered corkscrew-shaped, brightly eosinophilic, intracytoplasmic hyaline masses) and loose textured multipolar cells with microcysts and granular bodies. (WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4047</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glioneural</VALIDVALUE>
          <VALUEMEANING>Glioneural</VALUEMEANING>
          <MEANINGDESCRIPTION>Glioneural</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16250052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurocytoma</VALIDVALUE>
          <VALUEMEANING>Neurocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Neurocytoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16250051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glioblastoma</VALIDVALUE>
          <VALUEMEANING>Glioblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma). Two histologic variants are recognized: giant cell glioblastoma and gliosarcoma. (WHO) </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anaplastic Astrocytoma</VALIDVALUE>
          <VALUEMEANING>Anaplastic astrocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A diffusely infiltrating, WHO grade III astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Astrocytoma, IDH-Mutant</VALIDVALUE>
          <VALUEMEANING>Astrocytoma, IDH-Mutant</VALUEMEANING>
          <MEANINGDESCRIPTION>An astrocytoma associated with IDH1 or IDH2 gene mutations and absence of 1p/19q codeletion. It is classified as grade 2, 3, or 4.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C185167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14235586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oligoastrocytoma</VALIDVALUE>
          <VALUEMEANING>Oligoastrocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade II tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4050</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Primary Diagnosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6305258</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TCIA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MU-Glioma-Post-Clinical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15741978</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6305258</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TCIA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCSD-PTGBM-Clinical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15741979</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>Primary Diagnosis</AlternateName>
        <AlternateNameType>TCIA Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="491">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16303418</PUBLICID>
    <LONGNAME>Health Status Assessment Sexual Orientation Type Health Level Seven Display Name Text</LONGNAME>
    <PREFERREDNAME>16075773v1.00:15918457v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Describes what was observed. Sometimes this is called the observation &quot;name&quot;. This element holds the &quot;display&quot; part of the value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16075773</PublicId>
      <PreferredName>14936166v1.00:16456926v1.00</PreferredName>
      <PreferredDefinition>Assessments of health-related matters of interest, importance, or worry to a patient, patient&#39;s family, or patient&#39;s healthcare provider that could identify a need, problem, or condition.:The pattern of a person&#39;s emotional, romantic, and/or sexual attractions._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Health Status Assessment Sexual Orientation Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14936166</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C205784</PreferredName>
        <Version>1</Version>
        <LongName>Health Status Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C205784</PREFERRED_NAME>
            <LONG_NAME>Health Status Assessment</LONG_NAME>
            <CON_ID>14920961</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16456926</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C84361:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Sexual Orientation Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C84361</PREFERRED_NAME>
            <LONG_NAME>Sexual Orientation</LONG_NAME>
            <CON_ID>6361528</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15918457</PublicId>
      <PreferredName>15918457v1.00</PreferredName>
      <PreferredDefinition>A Standards Developing Organization (SDO) operating in the healthcare arena with an emphasis on the domain of clinical and administrative data._The standardized text associated with a code in a particular code system._The words of something written.</PreferredDefinition>
      <LongName>Health Level Seven Display Name Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1048576</MaximumLength>
      <MinimumLength>0</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</Origin>
      <Representation>
        <PublicId>15918456</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15918456v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Health Level Seven Display Name Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80485</PREFERRED_NAME>
            <LONG_NAME>Health Level Seven</LONG_NAME>
            <CON_ID>2928160</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70896</PREFERRED_NAME>
            <LONG_NAME>Display Name</LONG_NAME>
            <CON_ID>2715009</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Code Display</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Observation Sexual Orientation Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16075303</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ObservationSexualOrientation</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>code.coding[].display@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="492">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16304918</PUBLICID>
    <LONGNAME>Therapeutic Procedure Not Planned Reason Other Specify Text</LONGNAME>
    <PREFERREDNAME>16304917v1.00:4975733v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Text describing the other reason(s) that no therapy is planned than previously listed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16304917</PublicId>
      <PreferredName>2512834v1.00:16340808v1.00</PreferredName>
      <PreferredDefinition>Medical care intended to treat or cure a condition or lessen its symptoms. This includes the administration of drugs, surgical procedures, physical or psychotherapy, or the use of therapeutic devices.:An operation in which a term denies or inverts the meaning of another term or construction._An instance of an event or incident that is intended to take place._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Therapeutic Procedure Negation Planned Occurrence Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>AMC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16340808</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C102557:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Negation Planned Occurrence Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102557</PREFERRED_NAME>
            <LONG_NAME>Planned Occurrence</LONG_NAME>
            <CON_ID>3915747</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4975733</PublicId>
      <PreferredName>OTH_SPEC_TXT</PreferredName>
      <PreferredDefinition>The free text field that describes another response when other is chosen from a list of values.</PreferredDefinition>
      <LongName>Other Specify Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>500</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTEP:Cancer Therapy Evaluation Program</Origin>
      <Representation>
        <PublicId>2857047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify “Other” reason no therapy is planned:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCTNTRTNSP</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="493">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16310512</PUBLICID>
    <LONGNAME>Vital Signs Blood Pressure Missing Data Reason Health Level Seven Display Name Text</LONGNAME>
    <PREFERREDNAME>16076236v1.00:15918457v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Provides a reason why the expected value in the element Observation.value[x] is missing. This element holds the &quot;display&quot; part of the value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16076236</PublicId>
      <PreferredName>7547055v1.00:16076235v1.00</PreferredName>
      <PreferredDefinition>Vital signs (such as height, weight, and blood pressure) directly measure an individual&#39;s current state of attributes.:The pressure of the circulating blood against the walls of the blood vessels._Required or expected data that is not present, which may be due to non-completion or corruption._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Vital Signs Blood Pressure Missing Data Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7547055</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C154628</PreferredName>
        <Version>1</Version>
        <LongName>Vital Signs</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C154628</PREFERRED_NAME>
            <LONG_NAME>Vital Signs</LONG_NAME>
            <CON_ID>6424595</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16076235</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54706:C142610:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Blood Pressure Missing Data Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54706</PREFERRED_NAME>
            <LONG_NAME>Blood Pressure</LONG_NAME>
            <CON_ID>2552352</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C142610</PREFERRED_NAME>
            <LONG_NAME>Missing Data</LONG_NAME>
            <CON_ID>10028156</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15918457</PublicId>
      <PreferredName>15918457v1.00</PreferredName>
      <PreferredDefinition>A Standards Developing Organization (SDO) operating in the healthcare arena with an emphasis on the domain of clinical and administrative data._The standardized text associated with a code in a particular code system._The words of something written.</PreferredDefinition>
      <LongName>Health Level Seven Display Name Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1048576</MaximumLength>
      <MinimumLength>0</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</Origin>
      <Representation>
        <PublicId>15918456</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15918456v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Health Level Seven Display Name Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80485</PREFERRED_NAME>
            <LONG_NAME>Health Level Seven</LONG_NAME>
            <CON_ID>2928160</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70896</PREFERRED_NAME>
            <LONG_NAME>Display Name</LONG_NAME>
            <CON_ID>2715009</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Absent Reason Display</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Blood Pressure Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16075302</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BloodPressure</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>dataAbsentReason.coding[].display@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="494">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16310911</PUBLICID>
    <LONGNAME>Medication Prescription Identifier</LONGNAME>
    <PREFERREDNAME>16310895v1.00:15102793v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Identifiers associated with this medication request that are defined by business processes and/or used to refer to it when a direct URL reference to the resource itself is not appropriate. They are business identifiers assigned to this resource by the performer or other systems and remain constant as the resource is updated and propagates from server to server.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16310895</PublicId>
      <PreferredName>2411879v1.00:16310894v1.00</PreferredName>
      <PreferredDefinition>A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.:A verbal or written order given by an authorized person instructing a patient to obtain and use a medical device, prescription or undergo a procedure._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Medication Prescription Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2411879</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C459</PreferredName>
        <Version>1</Version>
        <LongName>Medication</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16310894</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28180:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Prescription Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28180</PREFERRED_NAME>
            <LONG_NAME>Prescription</LONG_NAME>
            <CON_ID>2230250</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15102793</PublicId>
      <PreferredName>15102793v1.00</PreferredName>
      <PreferredDefinition>One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1048576</MaximumLength>
      <MinimumLength>0</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Identifier</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Medication Request Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16075306</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Medication Request</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>identifier[].value@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="495">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16310930</PUBLICID>
    <LONGNAME>Medication Prescription Dose Schedule Frequency Health Level Seven System Text</LONGNAME>
    <PREFERREDNAME>16110818v1.00:15918459v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>When medication should be administered. This element holds the &quot;system&quot; part of the value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16110818</PublicId>
      <PreferredName>2411879v1.00:16310878v1.00</PreferredName>
      <PreferredDefinition>A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.:A verbal or written order given by an authorized person instructing a patient to obtain and use a medical device, prescription or undergo a procedure._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._A regimen for an intervention which consists of a specified number of instances within a specific time period.</PreferredDefinition>
      <LongName>Medication Prescription Dose Schedule Frequency</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2411879</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C459</PreferredName>
        <Version>1</Version>
        <LongName>Medication</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16310878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28180:C25488:C64493</PreferredName>
        <Version>1</Version>
        <LongName>Prescription Dose Schedule Frequency</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28180</PREFERRED_NAME>
            <LONG_NAME>Prescription</LONG_NAME>
            <CON_ID>2230250</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64493</PREFERRED_NAME>
            <LONG_NAME>Schedule Frequency</LONG_NAME>
            <CON_ID>2714999</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15918459</PublicId>
      <PreferredName>15918459v1.00</PreferredName>
      <PreferredDefinition>A Standards Developing Organization (SDO) operating in the healthcare arena with an emphasis on the domain of clinical and administrative data._A group of independent but interrelated elements comprising a unified whole._The words of something written.</PreferredDefinition>
      <LongName>Health Level Seven System Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1048576</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</Origin>
      <Representation>
        <PublicId>15918458</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15918458v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Health Level Seven System Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80485</PREFERRED_NAME>
            <LONG_NAME>Health Level Seven</LONG_NAME>
            <CON_ID>2928160</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25700</PREFERRED_NAME>
            <LONG_NAME>System</LONG_NAME>
            <CON_ID>2202584</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Dosage Instruction Timing System</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Medication Request Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16075306</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Medication Request</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>dosageInstruction[].timing.code.coding[].system@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="496">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16310934</PUBLICID>
    <LONGNAME>Medication Prescription Dose Repeat Duration</LONGNAME>
    <PREFERREDNAME>16310903v1.00:16310910v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicates the duration of time over which repetitions are to occur; e.g. to express &quot;3 times per day&quot;, 3 would be the frequency and &quot;1 day&quot; would be the period.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16310903</PublicId>
      <PreferredName>2411879v1.00:16310902v1.00</PreferredName>
      <PreferredDefinition>A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.:A verbal or written order given by an authorized person instructing a patient to obtain and use a medical device, prescription or undergo a procedure._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._The period of time over which the event or activity is repeated.</PreferredDefinition>
      <LongName>Medication Prescription Dose Repeat Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2411879</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C459</PreferredName>
        <Version>1</Version>
        <LongName>Medication</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16310902</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28180:C25488:C93647</PreferredName>
        <Version>1</Version>
        <LongName>Prescription Dose Repeat Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28180</PREFERRED_NAME>
            <LONG_NAME>Prescription</LONG_NAME>
            <CON_ID>2230250</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C93647</PREFERRED_NAME>
            <LONG_NAME>Repeat Duration</LONG_NAME>
            <CON_ID>10105036</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>16310910</PublicId>
      <PreferredName>16310910v1.00</PreferredName>
      <PreferredDefinition>The period of time during which something continues.</PreferredDefinition>
      <LongName>Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>decimal</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2404653</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25330</PreferredName>
        <Version>1</Version>
        <LongName>Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Dosage Instruction Timing Repeat Period</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Medication Request Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16075306</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Medication Request</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>dosageInstruction[].timing.repeat.period@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="497">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16333700</PUBLICID>
    <LONGNAME>Research Activity Origin Qualifier CDISC Variable Terminology Text</LONGNAME>
    <PREFERREDNAME>16333697v1.00:6338238v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Because QVAL can represent a mixture of collected (on a CRF), derived, or assigned items, QORIG is used to indicate the origin of this data. Examples: &quot;CRF&quot;, &quot;Assigned&quot;, &quot;Derived&quot;. See Section 4.1.8, Origin Metadata.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16333697</PublicId>
      <PreferredName>3693395v1.00:16333696v1.00</PreferredName>
      <PreferredDefinition>Systematic investigation into a subject in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered.:The source of a data modifier.</PreferredDefinition>
      <LongName>Research Activity Qualifier Origin</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3693395</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15429</PreferredName>
        <Version>1</Version>
        <LongName>Research Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15429</PREFERRED_NAME>
            <LONG_NAME>Research Activity</LONG_NAME>
            <CON_ID>2528433</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16333696</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83366</PreferredName>
        <Version>1</Version>
        <LongName>Qualifier Origin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83366</PREFERRED_NAME>
            <LONG_NAME>Qualifier Origin</LONG_NAME>
            <CON_ID>10109875</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Origin</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Supplemental Qualifiers for DM (SUPPDM)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15063895</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Supplemental Qualifiers for HO (SUPPHO)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15177697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Supplemental Qualifiers for SC (SUPPSC)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15177698</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Supplemental Qualifiers for PR (SUPPPR)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15744769</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Supplemental Qualifiers for CM (SUPPCM)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16333692</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Supplemental Qualifiers for FAMH (SUPPFAMH)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16333693</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Supplemental Qualifiers for MH (SUPPMH)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16333694</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPSC</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPPR</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPMH</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPHO</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPFAMH</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPDM</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPCM</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QORIG</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="498">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16390467</PUBLICID>
    <LONGNAME>Laboratory Procedure Test Toxicity CDISC Variable Terminology Text</LONGNAME>
    <PREFERREDNAME>16390427v1.00:6338238v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Description of toxicity quantified by LBTOXGR. The sponsor is expected to provide the name of the scale and version used to map the terms, utilizing the external codelist element in the Define-XML document.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16390427</PublicId>
      <PreferredName>2543047v1.00:6404110v1.00</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:A laboratory test designed to quantify or qualify the poisonous nature of a sample.</PreferredDefinition>
      <LongName>Laboratory Procedure Test Toxicity</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6404110</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83323</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test Toxicity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83323</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Toxicity</LONG_NAME>
            <CON_ID>6404109</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Toxicity</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory Test Results (LB)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15969143</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LBTOX</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="499">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16396305</PUBLICID>
    <LONGNAME>Disease or Disorder Diabetes Mellitus And/Or Hyperglycemia Present Disorder Indicator</LONGNAME>
    <PREFERREDNAME>16396276v1.00:16392819v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes the diabetes and/or hyperglycemia that was present.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16396276</PublicId>
      <PreferredName>2404658v1.00:16396275v1.00</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization._Used to indicate that either or both of two items or options may be valid._Abnormally high level of glucose in the blood._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Disease or Disorder Diabetes Mellitus And/Or Hyperglycemia Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008544</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TELECOMMUNICATIONS</PreferredName>
        <Version>1</Version>
        <LongName>Telecommunications</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16396275</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2985:C48928:C26797:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Diabetes Mellitus And/Or Hyperglycemia Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2985</PREFERRED_NAME>
            <LONG_NAME>Diabetes Mellitus</LONG_NAME>
            <CON_ID>2202847</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48928</PREFERRED_NAME>
            <LONG_NAME>And/Or</LONG_NAME>
            <CON_ID>2431163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26797</PREFERRED_NAME>
            <LONG_NAME>Hyperglycemia</LONG_NAME>
            <CON_ID>2203768</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>16392819</PublicId>
      <PreferredName>16392819v1.00</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Disease or Disorder Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>120</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2684204</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not present</VALIDVALUE>
          <VALUEMEANING>Negation Present</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-08-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16392821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Persisted</VALIDVALUE>
          <VALUEMEANING>Persistent</VALUEMEANING>
          <MEANINGDESCRIPTION>Retained; never-ceasing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-08-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Developed</VALIDVALUE>
          <VALUEMEANING>Develop</VALUEMEANING>
          <MEANINGDESCRIPTION>To occur, create, or be acquired over time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220631</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-08-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16392820</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was diabetes and/or hyperglycemia requiring chronic treatment present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Was diabetes / hyperglycemia requiring chronic treatment present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="500">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16457138</PUBLICID>
    <LONGNAME>Laboratory Procedure Maximum Prothrombin Time Outcome 2 Decimal Place Second Value</LONGNAME>
    <PREFERREDNAME>16456842v1.00:16456219v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The 2 decimal place numeric laboratory maximum seconds value measured, assigned or computed related to the assessment of prothrombin time in a specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16456842</PublicId>
      <PreferredName>2543047v1.00:16456841v1.00</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:The largest possible quantity or degree._A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.</PreferredDefinition>
      <LongName>Laboratory Procedure Maximum Prothrombin Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16456841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25564:C62656</PreferredName>
        <Version>1</Version>
        <LongName>Maximum Prothrombin Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25564</PREFERRED_NAME>
            <LONG_NAME>Maximum</LONG_NAME>
            <CON_ID>2202550</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62656</PREFERRED_NAME>
            <LONG_NAME>Prothrombin Time</LONG_NAME>
            <CON_ID>2525591</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>16456219</PublicId>
      <PreferredName>16456219v1.00</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The result of an action._A number with no fractional part, including the negative and positive numbers as well as zero.::2_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A unit of time, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). The second is the duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the caesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Laboratory Procedure Outcome 2 Decimal Place Second Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>16456218</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16456218v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Outcome Integer::2 Decimal Place Second Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42535</PREFERRED_NAME>
            <LONG_NAME>Second</LONG_NAME>
            <CON_ID>2534958</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the maximum value of prothrombin time?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Maximum prothrombin time (PT):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="501">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15</PUBLICID>
    <LONGNAME>Agent Initial Dose</LONGNAME>
    <PREFERREDNAME>AGT_INIT_DOSE</PREFERREDNAME>
    <PREFERREDDEFINITION>the amount of the first dose of an agent or drug administered to the patient.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188675</PublicId>
      <PreferredName>AGT_INIT_QTY</PreferredName>
      <PreferredDefinition>information related to the amount of the first dose of an agent or drug administered to the patient.</PreferredDefinition>
      <LongName>Agent First Quantity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223333</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1708</PreferredName>
        <Version>1</Version>
        <LongName>Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207361</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C25256</PreferredName>
        <Version>1</Version>
        <LongName>First Quantity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018364</PublicId>
      <PreferredName>AGT_DOSE</PreferredName>
      <PreferredDefinition>the quantity of an agent or drug.</PreferredDefinition>
      <LongName>Agent Dose</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>3</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2207920</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1708:C25488</PreferredName>
        <Version>1</Version>
        <LongName>Agent Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Initial Dose</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Initial Dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COMMENT_215</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Instruction on template form: (use protocol specified units)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>3</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>2-COMMENT</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Instruction on template form: Complete only if cycle 1 included in this reporting period</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>4-COMMENT</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Instruction on template form: of Cycle 1</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>2</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Agent Initial Dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Initial dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Upper GI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Cervical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Endometrial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Ovarian</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811819</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Recurrent Gyn</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811938</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Met/Urothelial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000311</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Superficial Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000312</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Muscle Invasive Blad</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000462</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0065121</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0001827</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0064800</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0002619</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0058474</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0061251</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0002642</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0062761</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="502">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2808</PUBLICID>
    <LONGNAME>Lung Tumor Stage Grouping Assessment Type</LONGNAME>
    <PREFERREDNAME>LUN_TUM_STG_ASSE_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the method to obtain information used to classify tumors.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189188</PublicId>
      <PreferredName>LUNG_TUMOR_STG_ASSES</PreferredName>
      <PreferredDefinition>information related to stage grouping assessment of a lung tumor.</PreferredDefinition>
      <LongName>Lung Tumor Stage Grouping Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206550</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12468:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Lung Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12468</PREFERRED_NAME>
            <LONG_NAME>Lung</LONG_NAME>
            <CON_ID>2202738</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660943</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38027:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Stage Grouping Physical Examination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38027</PREFERRED_NAME>
            <LONG_NAME>Stage Grouping</LONG_NAME>
            <CON_ID>2230142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018502</PublicId>
      <PreferredName>LUN_TUM_STG_ASSE_TP</PreferredName>
      <PreferredDefinition>the stage gouping assessment type of a lung tumor.</PreferredDefinition>
      <LongName>Lung Tumor Stage Grouping Assessment Type</LongName>
      <Version>4</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pathologic</VALIDVALUE>
          <VALUEMEANING>Pathologic</VALUEMEANING>
          <MEANINGDESCRIPTION>Caused by or altered by or manifesting disease or pathology.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559724</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clinical</VALIDVALUE>
          <VALUEMEANING>Clinical</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the examination and treatment of patients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Stage Grouping Assessment Met</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Stage Grouping Assessment Method</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Stage Grouping Assessment Method</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What type of staging was used</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="503">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>58232</PUBLICID>
    <LONGNAME>Vomiting Present Ind-3</LONGNAME>
    <PREFERREDNAME>VOMITING_PRES_IND-3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator for whether a patient is experiencng vomiting as a disease sign/symptom.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014603</PublicId>
      <PreferredName>VOMITING_PRES</PreferredName>
      <PreferredDefinition>the presence of vomiting.</PreferredDefinition>
      <LongName>Vomiting Pres</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2187674</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Vomiting</PreferredName>
        <Version>1</Version>
        <LongName>Vomiting</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3442</PREFERRED_NAME>
            <LONG_NAME>Vomiting</LONG_NAME>
            <CON_ID>2202859</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177376</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Present</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Vomiting?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Vomiting?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Vomiting Ind</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Vomiting</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Vomiting</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Vomiting</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Vomiting</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOMITING_PRES_IND-3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOMITING_PRES_IND-3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNbase_trma_vomit_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="504">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>58270</PUBLICID>
    <LONGNAME>Laboratory Procedure Bone Marrow Lymphocyte Outcome Percentage Value</LONGNAME>
    <PREFERREDNAME>LAB_BM_LY_OC_PTG_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>the percentage value of the medical procedure that involves testing a sample of bone marrow, the soft, sponge-like tissue in the center of bones that produces white blood cells, red blood cells, and platelets, for lymphocytes, a type of white blood cell that has a number of roles in the immune system, including the production of antibodies and other substances that fight infection and diseases.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189856</PublicId>
      <PreferredName>LAB_BM_LYMPH_OC</PreferredName>
      <PreferredDefinition>information related to the result of the medical procedure that involves testing a sample of bone marrow, the soft, sponge-like tissue in the center of bones that produces white blood cells, red blood cells, and platelets, for lymphocytes, a type of white blood cell that has a number of roles in the immune system, including the production of antibodies and other substances that fight infection and diseases.</PreferredDefinition>
      <LongName>Laboratory Procedure Bone Marrow Lymphocyte Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2779792</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12431:C12535:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Bone Marrow Lymphocyte Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12431</PREFERRED_NAME>
            <LONG_NAME>Bone Marrow</LONG_NAME>
            <CON_ID>2202685</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12535</PREFERRED_NAME>
            <LONG_NAME>Lymphocyte</LONG_NAME>
            <CON_ID>2211956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019101</PublicId>
      <PreferredName>HMT_LAB_PTG_VAL</PreferredName>
      <PreferredDefinition>a percentage for a hematologic laboratory value.</PreferredDefinition>
      <LongName>Blood Specimen Lab Percentage Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Marrow Lymphocytes (%)</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Marrow Lymphocytes (%)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Bone Marrow, Lymphocytes, Cell Percentage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lymphocytes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>what % of the lymphocytes are CLL cells?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CLL Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HCL Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811802</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CLL Relapse/Refract</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811924</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AML Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000362</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Nebraska Med Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812726</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Lab Procedure Bone Marrow Lymphocyte Outcome Percent Value</AlternateName>
        <AlternateNameType>TCGA_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lab_procedure_bone_marrow_lymphocyte_outcome_percent_value</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="505">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>58288</PUBLICID>
    <LONGNAME>Laboratory Procedure Erythroblast Outcome Count</LONGNAME>
    <PREFERREDNAME>LAB_ERYTB_OC_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>the absolute count of erythroblasts, immature, nucleated erythrocytes occupying the stage of erythropoiesis that follows formation of erythroid progenitor cells and precedes formation of reticulocytes, in a sample of blood.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189876</PublicId>
      <PreferredName>LAB_ERYT_OC</PreferredName>
      <PreferredDefinition>information related to the results of a medical procedure that involves testing a sample of blood for erythroblasts, immature, nucleated erythrocytes occupying the stage of erythropoiesis that follows formation of erythroid progenitor cells and precedes formation of reticulocytes.</PreferredDefinition>
      <LongName>Laboratory Procedure Erythroblast Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2739057</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12527:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Erythroblast Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12527</PREFERRED_NAME>
            <LONG_NAME>Erythroblast</LONG_NAME>
            <CON_ID>2206206</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019080</PublicId>
      <PreferredName>CELL_SP_CT</PreferredName>
      <PreferredDefinition>the count or number of cells in a specimen.</PreferredDefinition>
      <LongName>Cell Specimen Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Peripheral Erythroblast Count</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Peripheral Erythroblast Count</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>-COMMENT</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Units on Template form: (1000/ul)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lab, Hematology, Erythroblast Count</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Lung Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812017</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="506">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>64355</PUBLICID>
    <LONGNAME>Tumor Lung Position Type</LONGNAME>
    <PREFERREDNAME>TUMOR_LUNG_POS_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the location or position by zone or centrality for a tumor within an organ (paired or unpaired) or the relative position of a tissue or tumor specimen sampled for analysis within an affected organ.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2191278</PublicId>
      <PreferredName>LUNG_TUMOR_POS</PreferredName>
      <PreferredDefinition>information related to lung tumor position.</PreferredDefinition>
      <LongName>Lung Tumor Position</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206550</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12468:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Lung Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12468</PREFERRED_NAME>
            <LONG_NAME>Lung</LONG_NAME>
            <CON_ID>2202738</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177452</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Position</PreferredName>
        <Version>1</Version>
        <LongName>Position</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25339</PREFERRED_NAME>
            <LONG_NAME>Position</LONG_NAME>
            <CON_ID>2203955</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015471</PublicId>
      <PreferredName>TUMOR_LUNG_POS_TP</PreferredName>
      <PreferredDefinition>the location or position by zone or centrality for a lung tumor within the organ or the relative position of a tissue or tumor specimen sampled from the lung for analysis.</PreferredDefinition>
      <LongName>Tumor Lung Position Zone</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength>7</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Predominantly central</VALIDVALUE>
          <VALUEMEANING>PREDOMINANTLY CENTRAL</VALUEMEANING>
          <MEANINGDESCRIPTION>PREDOMINANTLY CENTRAL</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Predominantly peripheral</VALIDVALUE>
          <VALUEMEANING>PREDOMINANTLY PERIPHERAL</VALUEMEANING>
          <MEANINGDESCRIPTION>PREDOMINANTLY PERIPHERAL</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mid zone</VALIDVALUE>
          <VALUEMEANING>Mid zone</VALUEMEANING>
          <MEANINGDESCRIPTION>Mid zone</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2734338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Zone</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Zone</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Tumor Location, Zone</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COMMENT_423</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Add instruction to form: (check all that apply)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Tumor location zone</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Lung Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812017</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811936</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TUMOR_LUNG_POS_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="507">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>64741</PUBLICID>
    <LONGNAME>Breast Malignant Neoplasm Necrosis Type</LONGNAME>
    <PREFERREDNAME>BRST_MALNEO_NECR_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>a description of a type or pattern for localized death of living cells in the breast associated with presence of tumor composed of atypical neoplastic cells.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2009709</PublicId>
      <PreferredName>BRST_MAL_NEOPL_NECR</PreferredName>
      <PreferredDefinition>information related to localized death of living cells in the breast (projection on the chest containing mammary glands) associated with presence of tumor composed of atypical neoplastic cells.</PreferredDefinition>
      <LongName>Breast Malignant Neoplasm Necrosis</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443376</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12971:C9305</PreferredName>
        <Version>1</Version>
        <LongName>Breast Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12971</PREFERRED_NAME>
            <LONG_NAME>Breast</LONG_NAME>
            <CON_ID>2202571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2448417</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16897</PreferredName>
        <Version>1</Version>
        <LongName>Necrosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16897</PREFERRED_NAME>
            <LONG_NAME>Necrotic Process</LONG_NAME>
            <CON_ID>2202853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015528</PublicId>
      <PreferredName>BRST_MALNEO_NECR_TP</PreferredName>
      <PreferredDefinition>a description of a type or pattern for localized death of living cells in the breast associated with presence of tumor composed of atypical neoplastic cells.</PreferredDefinition>
      <LongName>Breast Malignant Neoplasm Necrosis Type</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Comedonecrosis</VALIDVALUE>
          <VALUEMEANING>COMEDONECROSIS</VALUEMEANING>
          <MEANINGDESCRIPTION>COMEDONECROSIS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-comedonecrosis</VALIDVALUE>
          <VALUEMEANING>NON-COMEDONECROSIS</VALUEMEANING>
          <MEANINGDESCRIPTION>NON-COMEDONECROSIS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>OTHER SPECIFY</VALUEMEANING>
          <MEANINGDESCRIPTION>Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Type of Necrosis</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Type of Necrosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Necrosis Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Char.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811932</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="508">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>64875</PUBLICID>
    <LONGNAME>Malignant Neoplasm Non-visceral Metastatic Involvement Specify</LONGNAME>
    <PREFERREDNAME>MALN_NV_MET_INV_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>an anatomic location where evidence is detected for spread of cancer from a tumor composed of atypical neoplastic cells to another part of the body not related to the internal organs.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2009667</PublicId>
      <PreferredName>MALNEO_NVIS_MET_INVL</PreferredName>
      <PreferredDefinition>information related to evidence of the spread of cancer from a malignant tumor composed of atypical neoplastic cells to another part of the body not related to the internal organs.</PreferredDefinition>
      <LongName>Malignant Neoplasm Non-Visceral Metastatic Involvement</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2186369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2443386</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25593:C14174:C25548</PreferredName>
        <Version>1</Version>
        <LongName>Non-Visceral Metastatic Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25593</PREFERRED_NAME>
            <LONG_NAME>Non-Visceral</LONG_NAME>
            <CON_ID>2206328</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14174</PREFERRED_NAME>
            <LONG_NAME>Metastatic</LONG_NAME>
            <CON_ID>2204914</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2226669</PublicId>
      <PreferredName>ANATSITE_SPEC</PreferredName>
      <PreferredDefinition>the free text field to specify an anatomic site.</PreferredDefinition>
      <LongName>Anatomic Site Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other non-visceral specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other non-visceral specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Metastatic Site Other Non-visceral</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>(specify)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Other non-visceral, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811919</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SWOG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NVISCINVSP</AlternateName>
        <AlternateNameType>OID, SWOG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="509">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>65175</PUBLICID>
    <LONGNAME>Upper GI Tumor Clinical N Stage</LONGNAME>
    <PREFERREDNAME>UPPERGI_TUMOR_C_N_ST</PREFERREDNAME>
    <PREFERREDDEFINITION>the exent of nodal involvement of upper GI cancer as determined prior to treatment based on evidence obtained from clinical assessment parameters (physcial examination, imaging, endoscopy, biopsy, surgical exploration, etc.).</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2192277</PublicId>
      <PreferredName>UPPERGI_TUMOR_C_N</PreferredName>
      <PreferredDefinition>information related to clinical N stage for an upper GI tumor.</PreferredDefinition>
      <LongName>Upper GI Tumor Clinical N Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206811</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17639:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Upper GI Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17639</PREFERRED_NAME>
            <LONG_NAME>Upper Gastrointestinal Series</LONG_NAME>
            <CON_ID>2202557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2428496</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25398:C25580</PreferredName>
        <Version>1</Version>
        <LongName>Clinical N Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25580</PREFERRED_NAME>
            <LONG_NAME>N Category</LONG_NAME>
            <CON_ID>2204625</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018469</PublicId>
      <PreferredName>UPPERGI_TUMOR_C_N_ST</PreferredName>
      <PreferredDefinition>the clinical N (nodal) stage of an upper GI (gastroinestinal) tumor, including pancreas and esophagus.</PreferredDefinition>
      <LongName>Upper GI Tumor Clinical N Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184339</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Stage</PreferredName>
        <Version>1</Version>
        <LongName>Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N0</VALIDVALUE>
          <VALUEMEANING>NO LYMPH NODE INVOLVEMENT ACCORDING TO AJCC GUIDELINES</VALUEMEANING>
          <MEANINGDESCRIPTION>NO LYMPH NODE INVOLVEMENT ACCORDING TO AJCC GUIDELINES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N1</VALIDVALUE>
          <VALUEMEANING>N1, ACCORDING TO AJCC CRITERIA</VALUEMEANING>
          <MEANINGDESCRIPTION>N1, ACCORDING TO AJCC CRITERIA</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N2</VALIDVALUE>
          <VALUEMEANING>N2, ACCORDING TO AJCC CRITERIA</VALUEMEANING>
          <MEANINGDESCRIPTION>N2, ACCORDING TO AJCC CRITERIA</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N3</VALIDVALUE>
          <VALUEMEANING>N3, ACCORDING TO AJCC CRITERIA</VALUEMEANING>
          <MEANINGDESCRIPTION>N3, ACCORDING TO AJCC CRITERIA</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NX</VALIDVALUE>
          <VALUEMEANING>LYMPH NODE INVOLVEMENT CANNOT BE ASSESSED ACCORDING TO AJCC GUIDELINES (USE FOR ESOPHAGEAL, GASTRIC, AND PANCREATIC)</VALUEMEANING>
          <MEANINGDESCRIPTION>LYMPH NODE INVOLVEMENT CANNOT BE ASSESSED ACCORDING TO AJCC GUIDELINES (USE FOR ESOPHAGEAL, GASTRIC, AND PANCREATIC)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>N Stage, Clinical</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Clinical N Stage</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Clinical N Stage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Upper GI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="510">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2001011</PUBLICID>
    <LONGNAME>Patient Name</LONGNAME>
    <PREFERREDNAME>PT_NAME</PREFERREDNAME>
    <PREFERREDDEFINITION>the current legal name of the person registered on the clinical trial.</PREFERREDDEFINITION>
    <VERSION>5</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013914</PublicId>
      <PreferredName>PT_ID</PreferredName>
      <PreferredDefinition>a means of specifying a patient on a clinical trial.</PreferredDefinition>
      <LongName>Patient Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2184304</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Identifier</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018284</PublicId>
      <PreferredName>INDS_NAME</PreferredName>
      <PreferredDefinition>The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Individuals Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Patient&#39;s Name</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Patient&#39;s Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>CDE and values comply with Clinical Data Update System v. 3.0 May 2002</DocumentText>
        <URL>www.cancer.gov</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>2015 Edition Common Clinical Data Set</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>CFR_Part_45_170.315</DocumentText>
        <URL>http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;amp;SID=100cd9d5ee5778b04fdc629f70dc02a1&amp;amp;mc=true&amp;amp;r=SECTION&amp;amp;n=se45.1.170_1315</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Lung Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812017</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Demographics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811960</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol/Admin.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811961</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>APL Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811786</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811810</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811821</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Extensive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811822</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Limited</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811884</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811886</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811889</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Stage I-III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812013</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain Recurr</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metastatic Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812015</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Advanced</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000001</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000027</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma Recur</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Curative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000369</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Palliative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000614</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812205</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AZCC 0210</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812575</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716207</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ASCO</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colon Adjuvant Treatment Summary</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812709</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716207</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ASCO</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer Adjuvant Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812713</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716207</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ASCO</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2898482</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3241399</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>IARC Cancer Registry</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Data Elements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000136</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0204</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104878</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0924</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171065</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4970851</PublicId>
          <ContextName>ONC SDC Project</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MU Clinical Data Set</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Meaningful Use 2015 Edition Common Clinical Data Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5700858</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>2001611</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>2002095</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PT_NAME</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CIP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>Patient:patientName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PT_NAME</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.Patient.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Patient:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Name</AlternateName>
        <AlternateNameType>IARC Cancer Dataset</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_NAME</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ONC SDC Project</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Patient Name</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ONC SDC Project</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>54125-0</AlternateName>
        <AlternateNameType>LOINC_CODE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ONC SDC Project</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Name:Pn:Pt:^Patient:Nom</AlternateName>
        <AlternateNameType>LOINC_NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ONC SDC Project</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ONC SDC Project</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="511">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2003069</PUBLICID>
    <LONGNAME>Highest Education Level Complete Status</LONGNAME>
    <PREFERREDNAME>HIGH_EDLVL_COMP_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>the highest education level completed.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2199694</PublicId>
      <PreferredName>HIGHEST_EDLVL_COMP</PreferredName>
      <PreferredDefinition>information related to the highest educated level completed.</PreferredDefinition>
      <LongName>Highest Education Level Complete</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206980</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25525:C0013622</PreferredName>
        <Version>1</Version>
        <LongName>Highest Education Level</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25525</PREFERRED_NAME>
            <LONG_NAME>Highest</LONG_NAME>
            <CON_ID>2202386</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0013622</PREFERRED_NAME>
            <LONG_NAME>Education Level</LONG_NAME>
            <CON_ID>2202944</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177594</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Complete</PreferredName>
        <Version>1</Version>
        <LongName>Complete</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25250</PREFERRED_NAME>
            <LONG_NAME>Complete</LONG_NAME>
            <CON_ID>2203885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016892</PublicId>
      <PreferredName>HIGH_EDLVL_COMP_STAT</PreferredName>
      <PreferredDefinition>the highest education level completed.</PreferredDefinition>
      <LongName>Highest Education Level Complete Status</LongName>
      <Version>4</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184340</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Status</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Advanced degree</VALIDVALUE>
          <VALUEMEANING>ADVANCED DEGREE</VALUEMEANING>
          <MEANINGDESCRIPTION>ADVANCED DEGREE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1-8 grades</VALIDVALUE>
          <VALUEMEANING>1-8 GRADES</VALUEMEANING>
          <MEANINGDESCRIPTION>1-8 GRADES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9-11 grades</VALIDVALUE>
          <VALUEMEANING>9-11 GRADES</VALUEMEANING>
          <MEANINGDESCRIPTION>9-11 GRADES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High School graduate</VALIDVALUE>
          <VALUEMEANING>HIGH SCHOOL GRADUATE</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has attended high school and has received a high school diploma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67136</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some college</VALIDVALUE>
          <VALUEMEANING>SOME COLLEGE</VALUEMEANING>
          <MEANINGDESCRIPTION>SOME COLLEGE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Junior college degree</VALIDVALUE>
          <VALUEMEANING>JUNIOR COLLEGE DEGREE</VALUEMEANING>
          <MEANINGDESCRIPTION>JUNIOR COLLEGE DEGREE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>College degree (B.A./B.S.)</VALIDVALUE>
          <VALUEMEANING>COLLEGE DEGREE (B.A./B.S.)</VALUEMEANING>
          <MEANINGDESCRIPTION>COLLEGE DEGREE (B.A./B.S.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some post-college work</VALIDVALUE>
          <VALUEMEANING>SOME POST-COLLEGE WORK</VALUEMEANING>
          <MEANINGDESCRIPTION>SOME POST-COLLEGE WORK</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Associate Degree</VALIDVALUE>
          <VALUEMEANING>Associates Degree</VALUEMEANING>
          <MEANINGDESCRIPTION>A degree granted by a two-year college on successful completion of the undergraduates course of studies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71340</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2713414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vocational Program Completion</VALIDVALUE>
          <VALUEMEANING>Vocational Program Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has attended or received a degree from an occupational, technical, or vocational program as their highest level of educational achievement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never attended school</VALIDVALUE>
          <VALUEMEANING>No Formal Schooling Or Kindergarten Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has never attended an educational program or formal schooling.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Indicates that kindergarten is the highest level of education achievement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70432, C37998, C67122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7579101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Refused</VALIDVALUE>
          <VALUEMEANING>Refuse</VALUEMEANING>
          <MEANINGDESCRIPTION>To decline to do, accept, give, or allow something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4827135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the highest grade you</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the highest grade you finished in school?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the highest grade or level of education you have achieved?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the highest grade or level of education you have achieved?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the highest grade you finished in school?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>What is the highest grade you finished in school?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the highest grade or year of school completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Char.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Muscle Invasive Blad</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000462</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NRG-CC002</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4471913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NRG-CC002</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE2</ClassificationSchemeItemType>
        <CsiPublicId>4514847</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NRG-CC002</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HIGH_EDLVL_COMP_STAT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BASEDU</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="512">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2004073</PUBLICID>
    <LONGNAME>Patient Signature Consent Ind-2</LONGNAME>
    <PREFERREDNAME>PT_SIG_CONSENT_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks if written informed consent has been obtained from a patient.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2732128</PublicId>
      <PreferredName>PT_SIGN_CONSENT</PreferredName>
      <PreferredDefinition>the patient&#39;s signature to consent to participate in various research activities.</PreferredDefinition>
      <LongName>Patient Signature Consent</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008530</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PT_CONSENT</PreferredName>
        <Version>1</Version>
        <LongName>Patient Consent</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2732126</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25678:C25460</PreferredName>
        <Version>1</Version>
        <LongName>Signature Consent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25678</PREFERRED_NAME>
            <LONG_NAME>Signature</LONG_NAME>
            <CON_ID>2202359</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25460</PREFERRED_NAME>
            <LONG_NAME>Consent</LONG_NAME>
            <CON_ID>2203590</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has written informed consent</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has written informed consent been obtained?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient Consent Signed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient willing and able to understand and sign the informed consent form and for individuals under the age of 18, the parental/guardian assent form?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the subject willing and able to understand and sign the informed consent form and for individuals under the age of 18, the parental/guardian assent form?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ACRIN Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient willing and able to provide written informed consent?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>9117 Inclusion Criteria</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has a signed infomed consent/assen/durable power of attorney (DPA) been obtained by the patient or parent/legal guardian</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Ability to understand and the willingness to sign a written informed consent document</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ACRIN 6685</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the participant willing to provide a written informed consent?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ACRIN 6702</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the informed consent obtained from the patient?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alternate Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient able to understand and is willing to sign a written informed consent document?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ACRIN 6690</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the participant provided a written informed consent?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ACRIN Standard</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the participant been provided written and oral consent information and consented to participate in the study?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CITN-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient has the ability to understand, and the willingness to sign, a written informed consent document.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient and/or his/her parent(s) or legal guardian(s) signed an informed consent form for the APEC14B1 CCDI Molecular Characterization Initiative?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG-ACRIN-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has written informed consent been obtained?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG-ACRIN - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient sign the main study consent form?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Upper GI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2552643</PublicId>
          <ContextName>Training</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Training Class Examples</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3637837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Restorative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oral Surgery</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812093</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjunctive General Services</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812095</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol Administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314495</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5999742</PublicId>
          <ContextName>CITN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5999747</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIDCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NIDCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PT_CONSENT_SIG_IND2</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_SIG_CONSENT_IND2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_SIG_CONSENT_IND2</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MCI_CNSNT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DS_DSYN_MCI</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="513">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2004087</PUBLICID>
    <LONGNAME>Patient Medical Condition Text</LONGNAME>
    <PREFERREDNAME>PT_MED_COND_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify ongoing medical problem.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2197460</PublicId>
      <PreferredName>PT_MED_COND</PreferredName>
      <PreferredDefinition>information related to the medical condition of the patient.</PreferredDefinition>
      <LongName>Patient Medical Condition</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207472</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25261:C25457</PreferredName>
        <Version>1</Version>
        <LongName>Medical Condition</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25261</PREFERRED_NAME>
            <LONG_NAME>Medical</LONG_NAME>
            <CON_ID>2202452</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25457</PREFERRED_NAME>
            <LONG_NAME>Condition</LONG_NAME>
            <CON_ID>2202899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018321</PublicId>
      <PreferredName>ASSESS_TXT</PreferredName>
      <PreferredDefinition>a free text field to specify information on the evaluations of the patient and the patient&#39;s disease</PreferredDefinition>
      <LongName>Assessment Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184342</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Text</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Condition</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Condition</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Medical condition</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="514">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2004257</PUBLICID>
    <LONGNAME>Specimen Submitted Reason</LONGNAME>
    <PREFERREDNAME>SPEC_SUBM_RSN</PREFERREDNAME>
    <PREFERREDDEFINITION>the reason a specimen was submitted.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014625</PublicId>
      <PreferredName>SPEC_SUBM</PreferredName>
      <PreferredDefinition>information related to a specimen being submitted.</PreferredDefinition>
      <LongName>Specimen Submitted</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177026</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specimen</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177298</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Submitted</PreferredName>
        <Version>1</Version>
        <LongName>Submitted</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25695</PREFERRED_NAME>
            <LONG_NAME>Submission</LONG_NAME>
            <CON_ID>2203811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017400</PublicId>
      <PreferredName>SPEC_SUBM_RSN</PreferredName>
      <PreferredDefinition>the reason a specimen was submitted.</PreferredDefinition>
      <LongName>Specimen Submission Reason</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>75</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2240632</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prestudy submission</VALIDVALUE>
          <VALUEMEANING>PRESTUDY SUBMISSION</VALUEMEANING>
          <MEANINGDESCRIPTION>PRESTUDY SUBMISSION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-08-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562340</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complete remission/response specimen</VALIDVALUE>
          <VALUEMEANING>COMPLETE REMISSION/RESPONSE SPECIMEN</VALUEMEANING>
          <MEANINGDESCRIPTION>COMPLETE REMISSION/RESPONSE SPECIMEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-08-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Relapse/recurrence specimen</VALIDVALUE>
          <VALUEMEANING>RELAPSE/RECURRENCE SPECIMEN</VALUEMEANING>
          <MEANINGDESCRIPTION>RELAPSE/RECURRENCE SPECIMEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-08-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other specimen, specify</VALIDVALUE>
          <VALUEMEANING>OTHER SPECIMEN, SPECIFY</VALUEMEANING>
          <MEANINGDESCRIPTION>OTHER SPECIMEN, SPECIFY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-08-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central Pathology Review</VALIDVALUE>
          <VALUEMEANING>Central Pathology Review</VALUEMEANING>
          <MEANINGDESCRIPTION>The process by which specimens are sent to a central lab for confirmatory analysis using standardized methods and result criteria in order to minimize inter-reviewer differences thereby improving the accuracy of pathology data.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4115880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Banking</VALIDVALUE>
          <VALUEMEANING>Banking</VALUEMEANING>
          <MEANINGDESCRIPTION>Banking</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4419551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRD</VALIDVALUE>
          <VALUEMEANING>Minimal Residual Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3896</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3664073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLT3</VALIDVALUE>
          <VALUEMEANING>FLT3</VALUEMEANING>
          <MEANINGDESCRIPTION>FLT3</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4723233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GD2 expression</VALIDVALUE>
          <VALUEMEANING>GD2 expression</VALUEMEANING>
          <MEANINGDESCRIPTION>GD2 expression</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5012651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ctDNA</VALIDVALUE>
          <VALUEMEANING>ctDNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A metastatic cancer cell found in the peripheral blood.: A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C449, C63797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5308508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Persistence of LMP-specific T cells; Immunity to EBV</VALIDVALUE>
          <VALUEMEANING>Persistence of LMP-specific T cells; Immunity to EBV</VALUEMEANING>
          <MEANINGDESCRIPTION>Persistence of LMP-specific T cells; Immunity to EBV</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5515272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>General Immune Reconstitution</VALIDVALUE>
          <VALUEMEANING>General Immune Reconstitution</VALUEMEANING>
          <MEANINGDESCRIPTION>General Immune Reconstitution</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5515273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peripheral blood markers of effects of MIBG</VALIDVALUE>
          <VALUEMEANING>Peripheral blood markers of effects of MIBG</VALUEMEANING>
          <MEANINGDESCRIPTION>Peripheral blood markers of effects of MIBG</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5778246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immune function profiling</VALIDVALUE>
          <VALUEMEANING>Immune function profiling</VALUEMEANING>
          <MEANINGDESCRIPTION>Immune function profiling</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5778247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Changes in tumor markers during therapy</VALIDVALUE>
          <VALUEMEANING>Changes in tumor markers during therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Changes in tumor markers during therapy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5778248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Germline predictors of outcome</VALIDVALUE>
          <VALUEMEANING>Germline predictors of outcome</VALUEMEANING>
          <MEANINGDESCRIPTION>Germline predictors of outcome</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5778249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somatic predictors of outcome</VALIDVALUE>
          <VALUEMEANING>Somatic predictors of outcome</VALUEMEANING>
          <MEANINGDESCRIPTION>Somatic predictors of outcome</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5794964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein markers of benefit from MIBG</VALIDVALUE>
          <VALUEMEANING>Protein markers of benefit from MIBG</VALUEMEANING>
          <MEANINGDESCRIPTION>Protein markers of benefit from MIBG</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5794965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein predictors of outcome</VALIDVALUE>
          <VALUEMEANING>Protein predictors of outcome</VALUEMEANING>
          <MEANINGDESCRIPTION>Protein predictors of outcome</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5794966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Persistence of LMP-specific T cells</VALIDVALUE>
          <VALUEMEANING>Persistence of LMP-specific T cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Persistence of LMP-specific T cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5935562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>General Immune Reconstitution, in case of CRS</VALIDVALUE>
          <VALUEMEANING>General Immune Reconstitution, in case of CRS</VALUEMEANING>
          <MEANINGDESCRIPTION>General Immune Reconstitution, in case of CRS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5935376</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Delayed surgery of responding tumor</VALIDVALUE>
          <VALUEMEANING>Delayed surgery of responding tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Delayed surgery of responding tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6379839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Relapse</VALIDVALUE>
          <VALUEMEANING>Recurrent Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>The return of a disease after a period of remission.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3828963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diagnosis</VALIDVALUE>
          <VALUEMEANING>Diagnosis</VALUEMEANING>
          <MEANINGDESCRIPTION>The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4434771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5697874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RNA Sequencing</VALIDVALUE>
          <VALUEMEANING>RNA Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>RNA Sequencing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6562585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gene expression</VALIDVALUE>
          <VALUEMEANING>Gene Expression</VALUEMEANING>
          <MEANINGDESCRIPTION>Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2727072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GD2 Biomarkers</VALIDVALUE>
          <VALUEMEANING>GD2 Biomarkers</VALUEMEANING>
          <MEANINGDESCRIPTION>GD2 Biomarkers</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6562586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immune Function Studies: Cytokine analysis</VALIDVALUE>
          <VALUEMEANING>Immune Function Studies: Cytokine analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>Immune Function Studies: Cytokine analysis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6562587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NK cell receptor NKp30 isoform</VALIDVALUE>
          <VALUEMEANING>NK cell receptor NKp30 isoform</VALUEMEANING>
          <MEANINGDESCRIPTION>NK cell receptor NKp30 isoform</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6562588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Naturally occurring anti-glycan antibodies</VALIDVALUE>
          <VALUEMEANING>Naturally occurring anti-glycan antibodies</VALUEMEANING>
          <MEANINGDESCRIPTION>Naturally occurring anti-glycan antibodies</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6562589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allograft rejection or failure</VALIDVALUE>
          <VALUEMEANING>Allograft Rejection Or Failure</VALUEMEANING>
          <MEANINGDESCRIPTION>A graft transferred from a donor of one species to a recipient of the same species but different genetic makeup.: Dismiss from consideration.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A lack of occurrence or performance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25745, C37998, C82650, C60701</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6617845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MMD or MRD testing</VALIDVALUE>
          <VALUEMEANING>MMD/MRD testing</VALUEMEANING>
          <MEANINGDESCRIPTION>MMD/MRD testing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6833039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Whole blood for potential future studies, such as gene expression/sequencing studies</VALIDVALUE>
          <VALUEMEANING>Whole blood for potential future studies, such as gene expression/sequencing studies</VALUEMEANING>
          <MEANINGDESCRIPTION>Whole blood for potential future studies, such as gene expression/sequencing studies</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7425601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Whole blood for future studies, such as circulating tumor (ct) DNA studies</VALIDVALUE>
          <VALUEMEANING>Whole blood for future studies, such as circulating tumor (ct) DNA studies</VALUEMEANING>
          <MEANINGDESCRIPTION>Whole blood for future studies, such as circulating tumor (ct) DNA studies</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7425602</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasma for potential future studies, such as HACA</VALIDVALUE>
          <VALUEMEANING>Plasma for potential future studies, such as HACA</VALUEMEANING>
          <MEANINGDESCRIPTION>Plasma for potential future studies, such as HACA</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7425603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immune Profiling: Cytokine Analysis</VALIDVALUE>
          <VALUEMEANING>Immune Profiling: Cytokine Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>Immune Profiling: Cytokine Analysis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7421772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immune Profiling: Immune Phenotyping</VALIDVALUE>
          <VALUEMEANING>Immune Profiling: Immune Phenotyping</VALUEMEANING>
          <MEANINGDESCRIPTION>Immune Profiling: Immune Phenotyping</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7421773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reasons for specimen submission</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Reasons for specimen submissi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Reasons for specimen submission</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specimen Purpose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specimen purpose:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Purpose of this shipment&#39;s specimens?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="515">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2005402</PUBLICID>
    <LONGNAME>Patient Absent Visit Reason</LONGNAME>
    <PREFERREDNAME>PT_ABSENT_VISIT_RSN</PREFERREDNAME>
    <PREFERREDDEFINITION>the reason a patient missed a protocol-related visit.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2201054</PublicId>
      <PreferredName>PT_ABSENT_VISIT</PreferredName>
      <PreferredDefinition>information relating to a patient absent visit.</PreferredDefinition>
      <LongName>Patient Absent Visit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660673</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48190:C25716</PreferredName>
        <Version>1</Version>
        <LongName>Absent Visit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48190</PREFERRED_NAME>
            <LONG_NAME>Absent</LONG_NAME>
            <CON_ID>2425465</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25716</PREFERRED_NAME>
            <LONG_NAME>Visit</LONG_NAME>
            <CON_ID>2202626</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018204</PublicId>
      <PreferredName>PT_ABSENT_VISIT_RSN</PreferredName>
      <PreferredDefinition>the reason a patient missed a protocol-related visit.</PreferredDefinition>
      <LongName>Patient Absent Visit Reason</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>225</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>Alliance Case Report Form</Origin>
      <Representation>
        <PublicId>2184326</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Reason</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Health reasons</VALIDVALUE>
          <VALUEMEANING>HEALTH REASONS</VALUEMEANING>
          <MEANINGDESCRIPTION>HEALTH REASONS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Distance from home to clinical site</VALIDVALUE>
          <VALUEMEANING>DISTANCE FROM HOME TO CLINICAL SITE</VALUEMEANING>
          <MEANINGDESCRIPTION>DISTANCE FROM HOME TO CLINICAL SITE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scheduling difficulties</VALIDVALUE>
          <VALUEMEANING>SCHEDULING DIFFICULTIES</VALUEMEANING>
          <MEANINGDESCRIPTION>SCHEDULING DIFFICULTIES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563764</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient forgot</VALIDVALUE>
          <VALUEMEANING>Patient forgot</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient forgot</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient could not get off work</VALIDVALUE>
          <VALUEMEANING>Patient could not get off work</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient could not get off work</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient unable to obtain dependent care</VALIDVALUE>
          <VALUEMEANING>Patient unable to obtain dependent care</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient unable to obtain dependent care</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient unhappy with frequency of visits</VALIDVALUE>
          <VALUEMEANING>Patient unhappy with frequency of visits</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient unhappy with frequency of visits</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient decided to discontinue study</VALIDVALUE>
          <VALUEMEANING>Patient decided to discontinue study</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient decided to discontinue study</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient experienced an Adverse Event</VALIDVALUE>
          <VALUEMEANING>Patient experienced an Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient experienced an Adverse Event</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient had transportation problems</VALIDVALUE>
          <VALUEMEANING>Patient had transportation problems</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient had transportation problems</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Visit is optional per protocol</VALIDVALUE>
          <VALUEMEANING>Visit is optional per protocol</VALUEMEANING>
          <MEANINGDESCRIPTION>Visit is optional per protocol</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5035531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient was a no show</VALIDVALUE>
          <VALUEMEANING>Patient was a no show</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient was a no show</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5302897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient rescheduled</VALIDVALUE>
          <VALUEMEANING>Patient Scheduled</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.: To order a planned list of activities or events.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125937, C16960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5302899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient cancelled</VALIDVALUE>
          <VALUEMEANING>Patient Cancel</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.: Postpone indefinitely or annul something that was scheduled.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63471, C16960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5302900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Reason patient missed visit</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Reason patient missed visit</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>please provide a reason:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_ABSENT_VISIT_RSN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="516">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2005597</PUBLICID>
    <LONGNAME>Common Toxicity Criteria Adverse Event Tumor Lysis Syndrome Grade</LONGNAME>
    <PREFERREDNAME>CTC_AE_TLS_GD</PREFERREDNAME>
    <PREFERREDDEFINITION>in CTC category Syndromes, assessment of the severity of a tumor lysis syndrome adverse event using a graded scale.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTCAE:Common Terminology Criteria for Adverse Events v3.0</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2193247</PublicId>
      <PreferredName>CTC_AE_TLS</PreferredName>
      <PreferredDefinition>information related to the CTC adverse event of tumor lysis syndrome.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Tumor Lysis Syndrome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2193245</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Tumor Lysis Syndrome</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Lysis Syndrome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3425</PREFERRED_NAME>
            <LONG_NAME>Tumor Lysis Syndrome</LONG_NAME>
            <CON_ID>2202533</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017797</PublicId>
      <PreferredName>CTC_AE_TLS_GD</PreferredName>
      <PreferredDefinition>in CTC category Syndromes, assessment of the severity of a tumor lysis syndrome adverse event using a graded scale.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Tumor Lysis Syndrome Grade</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTCAE:Common Terminology Criteria for Adverse Events v3.0</Origin>
      <Representation>
        <PublicId>2184299</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Grade</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Death</VALUEMEANING>
          <MEANINGDESCRIPTION>The absence of life or state of being dead.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>ABSENT</VALUEMEANING>
          <MEANINGDESCRIPTION>ABSENT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Tumor lysis syndrome Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)</DocumentText>
        <URL>http://ctep.cancer.gov/reporting/ctc.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTC Adverse Event Tumor lysis</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CTC Adverse Event Tumor lysis syndrome Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000132</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="517">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2005622</PUBLICID>
    <LONGNAME>Common Toxicity Criteria Adverse Event Other Syndrome Grade</LONGNAME>
    <PREFERREDNAME>CTC_AE_OTH_SYNDRO_GD</PREFERREDNAME>
    <PREFERREDDEFINITION>in CTC category Syndromes, assessment of the severity of an unlisted adverse event type using a graded scale.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2193340</PublicId>
      <PreferredName>CTC_AE_O_SYNDROME</PreferredName>
      <PreferredDefinition>information related to the CTC adverse event of other syndrome.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Other Syndrome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207568</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C28193</PreferredName>
        <Version>1</Version>
        <LongName>Other Syndrome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28193</PREFERRED_NAME>
            <LONG_NAME>Syndrome</LONG_NAME>
            <CON_ID>2203692</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017821</PublicId>
      <PreferredName>CTC_AE_OTH_SYNDRO_GD</PreferredName>
      <PreferredDefinition>in CTC category Syndromes, assessment of the severity of an unlisted adverse event type using a graded scale.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Other Syndrome Grade</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184299</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Grade</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Severe</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Life-threatening or disabling</VALUEMEANING>
          <MEANINGDESCRIPTION>Life-threatening or disabling</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563417</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Death</VALUEMEANING>
          <MEANINGDESCRIPTION>The absence of life or state of being dead.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Mild</VALUEMEANING>
          <MEANINGDESCRIPTION>Not severe or strong; far from extreme; not serious enough to endanger life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTC Adverse Event Syndromes-O</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CTC Adverse Event Syndromes-Other (Specify) Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Syndromes-Other Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)</DocumentText>
        <URL>http://ctep.cancer.gov/reporting/ctc.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000132</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="518">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2178504</PUBLICID>
    <LONGNAME>Vaginal Dryness Assessment Response</LONGNAME>
    <PREFERREDNAME>VAGI_DRY_ASSESS_RESP</PREFERREDNAME>
    <PREFERREDDEFINITION>an assessment response to whether an individual is experiences vaginal dryness.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2178503</PublicId>
      <PreferredName>DRY_ASSESS</PreferredName>
      <PreferredDefinition>an assessment of dryness.</PreferredDefinition>
      <LongName>Dryness Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7318107</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38046:C41106</PreferredName>
        <Version>1</Version>
        <LongName>Unspecified Object Class</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38046</PREFERRED_NAME>
            <LONG_NAME>Unspecified</LONG_NAME>
            <CON_ID>2230154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41106</PREFERRED_NAME>
            <LONG_NAME>Object Class</LONG_NAME>
            <CON_ID>2223438</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7318108</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38046:C42605</PreferredName>
        <Version>1</Version>
        <LongName>Unspecified Property</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38046</PREFERRED_NAME>
            <LONG_NAME>Unspecified</LONG_NAME>
            <CON_ID>2230154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42605</PREFERRED_NAME>
            <LONG_NAME>Property</LONG_NAME>
            <CON_ID>2231569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178127</PublicId>
      <PreferredName>ASSESS_RESP_TP</PreferredName>
      <PreferredDefinition>the response type or report regarding an assessment.</PreferredDefinition>
      <LongName>Assessment Response Type</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>2</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat</VALIDVALUE>
          <VALUEMEANING>3</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>4</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>5</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66836</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>1</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest natural number and quantity it denotes: a single entity, unit, or object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately</VALIDVALUE>
          <VALUEMEANING>Moderately</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely</VALIDVALUE>
          <VALUEMEANING>EXTREMELY</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat bothered</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little bit</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all bothered</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2927955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No, not limited at all</VALIDVALUE>
          <VALUEMEANING>No, not limited at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No, not limited at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3442202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, limited a little</VALIDVALUE>
          <VALUEMEANING>Yes, Limited a Little</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, Limited a Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3115762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, limited a lot</VALIDVALUE>
          <VALUEMEANING>Yes, Limited a Lot</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, Limited a Lot</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3115763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slightly</VALIDVALUE>
          <VALUEMEANING>Slightly</VALUEMEANING>
          <MEANINGDESCRIPTION>Slightly</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-09-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not bothered at all</VALIDVALUE>
          <VALUEMEANING>Not bothered at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not bothered at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered somewhat</VALIDVALUE>
          <VALUEMEANING>Bothered somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered somewhat</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little</VALIDVALUE>
          <VALUEMEANING>Bothered a little</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered a little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat difficult</VALIDVALUE>
          <VALUEMEANING>Somewhat difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to do</VALIDVALUE>
          <VALUEMEANING>UNABLE To Do</VALUEMEANING>
          <MEANINGDESCRIPTION>UNABLE To Do (Health Activity Questionnaire)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very difficult</VALIDVALUE>
          <VALUEMEANING>Very difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Very difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little difficult</VALIDVALUE>
          <VALUEMEANING>A little difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>A little difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not difficult at all</VALIDVALUE>
          <VALUEMEANING>Not difficult at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not difficult at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>More than twice</VALIDVALUE>
          <VALUEMEANING>Greater Than Twice</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status._Two times.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65134, C61584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3983131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Twice</VALIDVALUE>
          <VALUEMEANING>Twice</VALUEMEANING>
          <MEANINGDESCRIPTION>Twice</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Once</VALIDVALUE>
          <VALUEMEANING>Once</VALUEMEANING>
          <MEANINGDESCRIPTION>One time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2965297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Always</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A great deal</VALIDVALUE>
          <VALUEMEANING>A great deal of the time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened much of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114706</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4270273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Most of the Time</VALIDVALUE>
          <VALUEMEANING>Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5731765</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>To a large extent</VALIDVALUE>
          <VALUEMEANING>To Large Extent</VALUEMEANING>
          <MEANINGDESCRIPTION>Used as a function word to indicate direction, purpose, or movement.: Of considerable or relatively great size, extent, or capacity.: The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25332, C49508, C65107</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5731758</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>To some extent</VALIDVALUE>
          <VALUEMEANING>To Some Extent</VALUEMEANING>
          <MEANINGDESCRIPTION>Used as a function word to indicate direction, purpose, or movement.: At least a small amount or number of, but not a large amount of, or often.: The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25332, C65099, C65107</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5731759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>To a slight extent</VALIDVALUE>
          <VALUEMEANING>To Slight Extent</VALUEMEANING>
          <MEANINGDESCRIPTION>Used as a function word to indicate direction, purpose, or movement.: Small or little in size, quantity, or degree.: The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25332, C103807, C65107</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5731760</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Halfway between Jesse and Alex</VALIDVALUE>
          <VALUEMEANING>Halfway between Jesse and Alex</VALUEMEANING>
          <MEANINGDESCRIPTION>Halfway between Jesse and Alex</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat like Alex</VALIDVALUE>
          <VALUEMEANING>Somewhat like Alex</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat like Alex</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat like Jesse</VALIDVALUE>
          <VALUEMEANING>Somewhat like Jesse</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat like Jesse</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Exactly or a lot like Alex</VALIDVALUE>
          <VALUEMEANING>Exactly or a lot like Alex</VALUEMEANING>
          <MEANINGDESCRIPTION>Exactly or a lot like Alex</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Exactly or a lot like Jesse</VALIDVALUE>
          <VALUEMEANING>Exactly or a lot like Jesse</VALUEMEANING>
          <MEANINGDESCRIPTION>Exactly or a lot like Jesse</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely sure</VALIDVALUE>
          <VALUEMEANING>Extreme Certain</VALUEMEANING>
          <MEANINGDESCRIPTION>The highest degree of severity.: Having no doubts; definitely true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107561, C102844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5801949</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately sure</VALIDVALUE>
          <VALUEMEANING>Moderate Certain</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.: Having no doubts; definitely true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107561, C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5801950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slightly sure</VALIDVALUE>
          <VALUEMEANING>Slight Certain</VALUEMEANING>
          <MEANINGDESCRIPTION>Small or little in size, quantity, or degree.: Having no doubts; definitely true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107561, C103807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5801951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all sure</VALIDVALUE>
          <VALUEMEANING>Not at All Certain</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of non-agreement.: Having no doubts; definitely true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107561, C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3852903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely concerned</VALIDVALUE>
          <VALUEMEANING>Extreme Concern</VALUEMEANING>
          <MEANINGDESCRIPTION>The highest degree of severity.: A matter of interest or importance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79892, C102844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5734744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat concerned</VALIDVALUE>
          <VALUEMEANING>Somewhat Concern</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.: A matter of interest or importance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79892, C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5734745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slightly concerned</VALIDVALUE>
          <VALUEMEANING>Slight Concern</VALUEMEANING>
          <MEANINGDESCRIPTION>Small or little in size, quantity, or degree.: A matter of interest or importance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79892, C103807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5734746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not concerned</VALIDVALUE>
          <VALUEMEANING>Negation Concern</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: A matter of interest or importance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79892, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5734747</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>Often</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something occurs frequently.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4271632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occasionally</VALIDVALUE>
          <VALUEMEANING>Occasionally</VALUEMEANING>
          <MEANINGDESCRIPTION>Not frequently or regularly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C151974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6341147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>vaginal dryness</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="519">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2179986</PUBLICID>
    <LONGNAME>Concomitant Medication Use Ind-3</LONGNAME>
    <PREFERREDNAME>CONCOM_MEDS_USE_IND-3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator to ask if a patient is taking any medication that is not part of protocol treatment (including medication prescribed for other medical conditions).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195376</PublicId>
      <PreferredName>CONCOM_MEDS_USE</PreferredName>
      <PreferredDefinition>information related to the use of concomitant medication.</PreferredDefinition>
      <LongName>Concomitant Medication Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206481</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25730:C459</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Medication</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25730</PREFERRED_NAME>
            <LONG_NAME>Concomitant</LONG_NAME>
            <CON_ID>2202429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177321</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Use</PreferredName>
        <Version>1</Version>
        <LongName>Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is the patient taking any con</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the patient taking any concomitant medications</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Medications</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient receive concomitant medications while on protocol therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Do you take medications for it regularly</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the participant report taking any concomitant medication</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient taken any other medications during this reporting period</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Concomitant medications</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Current pharmacologic treatment for insomnia or mood</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Concomitant chemotherapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient require the use of a concomitant medication that can prolong the QT interval?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were any medications or supplements used in the last 30 days?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were any medications or supplements used in the last 30 days?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is the participant taking any concomitant medications?</Name>
        <DocumentType>Activity Diagram</DocumentType>
        <DocumentText>Is the participant taking any concomitant medications?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Concurrent zidovudine or stavudine</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient receiving any of the following medications: pyrimethamine, cimetidine, rifampin, cephalexin, tamoxifen, or raloxifene?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_TEXT_1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were concomitant medications used during this reporting period</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient received any of the concomitant medications?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>eligibility question</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient receiving any medication that may markedly affect renal function (e.g., vancomycin, amphotericin, pentamidine)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COF CRF Text 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient receiving medications for treatment of left ventricular systolic dysfunction?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient receiving medications for treatment of left ventricular systolic dysfunction?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were there any concomitant medications given (this reporting period)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF_Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Are there any concomitant medications to report for this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 13</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient meet any of the protocol defined concomitant medication restrictions?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 16</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient taking any concomitant medications?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 14</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient taken any concomitant medications prior to start of protocol therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 15</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient taken any concomitant medications during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ConMed</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were there any concomitant medications taken?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Have any concomitant medications been started or stopped this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 17</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were concomitant medications used during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the patient taking any concomitant medications?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 18</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient receive any type of concomitant therapy that is prohibited as listed in protocol section 4.1.7 during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient currently receiving medications for treatment of persistent left ventricular systolic dysfunction?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did you take any medications?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Concomitant Medication CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2867242</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase 1/Pilot Consortium</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3303197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Biospecimen Repository</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3060675</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000006</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2012-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3694151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2013-01-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528054</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5592146</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6005698</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0286B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104901</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104930</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1308</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104933</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1306</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104937</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104941</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000275</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000276</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000705</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Concomitant Medication</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5635301</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CONCOM_MEDS_USE_IND-3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CONC_MEDS_RECD_IND2</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CONCOM_MEDS_USE_IND-3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CONCOM_MEDS_USE_IND-3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CONCOM_MEDS_USE_IND-3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCTG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="520">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2180297</PUBLICID>
    <LONGNAME>Heart LVEF Test Date</LONGNAME>
    <PREFERREDNAME>HRT_LVEF_TST_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date on which a test evaluating the ejection fraction of the left ventricle of the heart was performed on a patient to assess cardiovascular health.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195563</PublicId>
      <PreferredName>HRT_LVEF_TST</PreferredName>
      <PreferredDefinition>information related to the left ventricle ejection fraction heart test.</PreferredDefinition>
      <LongName>Heart LVEF Test</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177089</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Heart</PreferredName>
        <Version>1</Version>
        <LongName>Heart</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12727</PREFERRED_NAME>
            <LONG_NAME>Heart</LONG_NAME>
            <CON_ID>2202646</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207091</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37946:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Ejection Fraction Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37946</PREFERRED_NAME>
            <LONG_NAME>Measurement of Left Ventricular Ejection Fraction</LONG_NAME>
            <CON_ID>2202616</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of LVEF</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of LVEF</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date LVEF performed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Collection Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ABTC Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>When was the LVEF taken?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Left ventricular ejection fraction date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Left ventricular ejection fraction date, by gated radionuclide study</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of Left Ventricle Ejection Fraction (LVEF) assessment:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811951</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oregon Health &amp; Sciences University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OHSU_2683</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812946</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3335728</PublicId>
          <ContextName>ABTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocols</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ABTC 1302</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4264871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1010</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171061</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ABTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ABTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HRT_LVEF_TST_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CV_CVDAT_LVEF</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="521">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2180339</PUBLICID>
    <LONGNAME>Transplant Delayed Failure Ind-3</LONGNAME>
    <PREFERREDNAME>TSPL_DELAYE_FLR_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator to ask if transplanted tissue from a donor was rejected after transplant by the patient as indicated by laboratory results described in protocol specified criteria.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195557</PublicId>
      <PreferredName>TSPL_DELAYED_FLR</PreferredName>
      <PreferredDefinition>information related to the delayed failure of a transplant.</PreferredDefinition>
      <LongName>Transplant Delayed Failure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176929</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Transplant</PreferredName>
        <Version>1</Version>
        <LongName>Transplant</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207643</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25477:C25745</PreferredName>
        <Version>1</Version>
        <LongName>Delayed Failure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25477</PREFERRED_NAME>
            <LONG_NAME>Delayed</LONG_NAME>
            <CON_ID>2203897</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25745</PREFERRED_NAME>
            <LONG_NAME>Failure</LONG_NAME>
            <CON_ID>2203812</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the patient experience la</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the patient experience late graft failure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>-COMMENT</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Add instruction: (follow definition per protocol)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient meet the definition of Secondary Graft Failure per protocol?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="522">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2180640</PUBLICID>
    <LONGNAME>Recurrent Disease Diagnosis Count</LONGNAME>
    <PREFERREDNAME>RECURDZ_DX_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>the numeric count for each time a patient receives a cancer treatment regimen with an initial successful response but followed by a return to disease advancement.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2728560</PublicId>
      <PreferredName>RECURDZ_DX</PreferredName>
      <PreferredDefinition>information related to the diagnosis or recognition of the presence and nature of the return of signs and symptoms of cancer after a period of improvement.</PreferredDefinition>
      <LongName>Recurrent Disease Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2678101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38155</PreferredName>
        <Version>1</Version>
        <LongName>Recurrent Disease</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38155</PREFERRED_NAME>
            <LONG_NAME>Recurrent Disease</LONG_NAME>
            <CON_ID>2202887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239981</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180639</PublicId>
      <PreferredName>DZ_REL_CT</PreferredName>
      <PreferredDefinition>information related to the disease relapse count.</PreferredDefinition>
      <LongName>Disease Relapse Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184284</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Count</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of Relapses or Recurre</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of Relapses or Recurrences</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of recurrences prior to enrollment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How many prior relapses has the patient had?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPPR_QVAL_PRIORRLP</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="523">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2181370</PUBLICID>
    <LONGNAME>Myeloma Gastrointestinal Response Type</LONGNAME>
    <PREFERREDNAME>MYE_GI_RESP_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the description of objective response following treatment for gastrointestinal symptoms as observed during a follow-up assessment of multiple myeloma disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2196047</PublicId>
      <PreferredName>MYE_GI_RESP</PreferredName>
      <PreferredDefinition>information related to the gastrointestinal response for myeloma.</PreferredDefinition>
      <LongName>Myeloma Gastrointestinal Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177047</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Myeloma</PreferredName>
        <Version>1</Version>
        <LongName>Myeloma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3242</PREFERRED_NAME>
            <LONG_NAME>Multiple Myeloma</LONG_NAME>
            <CON_ID>2202758</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207373</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13359:C25755</PreferredName>
        <Version>1</Version>
        <LongName>Gastrointestinal Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13359</PREFERRED_NAME>
            <LONG_NAME>Gastrointestinal</LONG_NAME>
            <CON_ID>2202578</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25755</PREFERRED_NAME>
            <LONG_NAME>Response</LONG_NAME>
            <CON_ID>2202805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181369</PublicId>
      <PreferredName>GI_RESP_TP</PreferredName>
      <PreferredDefinition>information related to the response type for gastrointestinal disease.</PreferredDefinition>
      <LongName>Gastrointestinal Response Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>response</VALIDVALUE>
          <VALUEMEANING>Response</VALUEMEANING>
          <MEANINGDESCRIPTION>Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568419</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>stable</VALIDVALUE>
          <VALUEMEANING>Stable</VALUEMEANING>
          <MEANINGDESCRIPTION>Stable; subject to little fluctuation; showing little if any change.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C30103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>progressed</VALIDVALUE>
          <VALUEMEANING>progressed</VALUEMEANING>
          <MEANINGDESCRIPTION>progressed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>not assessed</VALIDVALUE>
          <VALUEMEANING>NOT ASSESSED</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that an assessment was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Gastrointestinal Tract Response</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="524">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2181913</PUBLICID>
    <LONGNAME>Neurological Evaluation Sensory Deficit Specify</LONGNAME>
    <PREFERREDNAME>NEUR_EVA_SE_DEF_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify the sensory deficit.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>Brain CDE Disease Committee</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188953</PublicId>
      <PreferredName>NEURO_EVAL_SEN_DEF</PreferredName>
      <PreferredDefinition>information related to sensory neurological evaluation deficit.</PreferredDefinition>
      <LongName>Neurological Evaluation Sensory Deficit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206617</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25262:C25214</PreferredName>
        <Version>1</Version>
        <LongName>Neurologic Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25262</PREFERRED_NAME>
            <LONG_NAME>Neurologic</LONG_NAME>
            <CON_ID>2202770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207715</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28259:C37940</PreferredName>
        <Version>1</Version>
        <LongName>Sensory Deficit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28259</PREFERRED_NAME>
            <LONG_NAME>Sensory</LONG_NAME>
            <CON_ID>2206369</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37940</PREFERRED_NAME>
            <LONG_NAME>Deficit</LONG_NAME>
            <CON_ID>2203899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2228479</PublicId>
      <PreferredName>SM_SPEC</PreferredName>
      <PreferredDefinition>the free-text field related to a symptom.</PreferredDefinition>
      <LongName>Symptom Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008575</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SM</PreferredName>
        <Version>1</Version>
        <LongName>Symptoms</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Severe, specify areas</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Severe, specify areas</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812013</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain Recurr</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metastatic Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812015</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="525">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2182155</PUBLICID>
    <LONGNAME>Treatment Modified Not Restart Dose Ind-2</LONGNAME>
    <PREFERREDNAME>TX_MDNTRST_DOSE_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether a patient has not returned to a protocol-specified dose of treatment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2453136</PublicId>
      <PreferredName>TX_MODNOTRESTRT_QUAN</PreferredName>
      <PreferredDefinition>information relating to a modified and then not restarted treatment quantity.</PreferredDefinition>
      <LongName>Treatment Modified Not Restart Quantity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2416951</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15368</PreferredName>
        <Version>1</Version>
        <LongName>Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2453134</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25573:C25594:C25658:C25256</PreferredName>
        <Version>1</Version>
        <LongName>Modified Not Restart Quantity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25573</PREFERRED_NAME>
            <LONG_NAME>Modified</LONG_NAME>
            <CON_ID>2203849</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25658</PREFERRED_NAME>
            <LONG_NAME>Restart</LONG_NAME>
            <CON_ID>2203786</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Treatment not yet restarted</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Treatment not yet restarted</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="526">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2182510</PUBLICID>
    <LONGNAME>Evaluation Method Specify</LONGNAME>
    <PREFERREDNAME>EVAL_METH_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the text field to a describe another method of assessment by which a lesion is examined and/or measured.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2182509</PublicId>
      <PreferredName>EVAL_METH</PreferredName>
      <PreferredDefinition>information related to an evaluation method.</PreferredDefinition>
      <LongName>Evaluation Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177161</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Evaluation</PreferredName>
        <Version>1</Version>
        <LongName>Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177492</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Method</PreferredName>
        <Version>1</Version>
        <LongName>Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16847</PREFERRED_NAME>
            <LONG_NAME>Technique</LONG_NAME>
            <CON_ID>2203854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018806</PublicId>
      <PreferredName>ASSESS_SPEC</PreferredName>
      <PreferredDefinition>The free text field to specify the assessment performed.</PreferredDefinition>
      <LongName>Assessment Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If Other Specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If Other Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of Evaluation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify other method of evaluation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0240</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104883</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229L</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229N</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0250</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104897</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0258</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104898</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0261</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104899</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0213</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000079</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000080</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0213</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000287</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0213</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000288</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EVAL_METH_SPEC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EVAL_METH_SPEC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EVAL_METH_SPEC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EVAL_METH_SPEC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OTHSP_DXMTHD</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HHSOTSP</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD_SUSO</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD_DEFO</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="527">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2183299</PUBLICID>
    <LONGNAME>Pregnancy Live Birth Count</LONGNAME>
    <PREFERREDNAME>PREG_LIVEBIRTH_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>Count of the number of successful pregnancies that resulted in the birth of at least one child.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013800</PublicId>
      <PreferredName>2555192v1.0:6488201v1.0</PreferredName>
      <PreferredDefinition>The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth._A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways._The smallest natural number and quantity it denotes: a single entity, unit, or object._The complete expulsion or extraction from the mother of a fetus, irrespective of the duration of pregnancy, which, after such expulsion or extraction, breathes or shows any other evidence of life, such as beating of the heart, pulsation of the umbilical cord, or definite movement of voluntary muscles.</PreferredDefinition>
      <LongName>Pregnancy Greater Than or Equal To One Live Birth</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435013</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17828 </PreferredName>
        <Version>1</Version>
        <LongName>Biological Process</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2555192</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25742</PreferredName>
        <Version>1</Version>
        <LongName>Pregnancy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25742</PREFERRED_NAME>
            <LONG_NAME>Pregnancy</LONG_NAME>
            <CON_ID>2202906</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6488201</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61583:C66832:C114091</PreferredName>
        <Version>1</Version>
        <LongName>Greater Than or Equal To One Live Birth</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61583</PREFERRED_NAME>
            <LONG_NAME>Greater Than or Equal To</LONG_NAME>
            <CON_ID>2673224</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66832</PREFERRED_NAME>
            <LONG_NAME>One</LONG_NAME>
            <CON_ID>2636736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C114091</PREFERRED_NAME>
            <LONG_NAME>Live Birth</LONG_NAME>
            <CON_ID>5097377</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180636</PublicId>
      <PreferredName>PREG_CT</PreferredName>
      <PreferredDefinition>information related to a patient&#39;s pregnancy count.</PreferredDefinition>
      <LongName>Pregnancy Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184284</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Count</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How many of your pregnancies</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How many of your pregnancies resulted in a live birth?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Document Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Parity (number of live births)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Document Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Total number of pregnancies resulting in live births</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of live births</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How many of the pregnancies ended with a live birth?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How many of the pregnancies ended with a live birth?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>(If yes), total number of pregnancies resulting in live births</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Para - total number of pregnancies resulting in live births (including current)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PS&amp;CC Document Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How many of your pregnancies resulted in a live birth?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-5</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Para-Total number of pregnancies resulting in live births</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of prior live births</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Para (live births)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Para</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms Version 3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2957372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Washington</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812731</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FES Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812732</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193113</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCEG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CGEMS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812078</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Acolbifene - High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812190</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E for Cervical Ca</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812399</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>9cUAB30</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Transdermal 4-OHT vs oral TAM DCIS of the Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812736</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyethylene Glycol - Colon Carcinogenesis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812843</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Myo-Inositol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812876</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exp. PK Formulations of SR13668</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812998</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ursodeoxycholic Acid - Barrett&#39;s Patients</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2813043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Erlotinib - Lesions of Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2813064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Sulindac DFMO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2859628</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E in Women w/ Modulation of Arachidonic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2936518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2979172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin Colorectal Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018781</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Resveratrol in Postmenopausal Women</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018782</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSC and L SeMet in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3110219</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Lung Pre-Surgical NSCLC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3152820</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vitamin D - Bioactivity in the Skin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182878</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barrett&#39;s Esophagus Chemoprevention Metformin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3211792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2012-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3694151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896537</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896538</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4188651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261112</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2013-01-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528054</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528056</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-04-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280811</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280813</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280814</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-04</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280815</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280816</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5416571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5441476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5592146</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-07-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889176</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2017-09-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889179</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889180</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889187</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2017-09-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5981652</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6005698</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-08-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6025104</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6046252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0278</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4058120</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PS&amp;CC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LIVEBIRTH_NUM</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PREG_LIVEBIRTH_CT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>number_of_successful_pregnancies_which_resulted_in_at_least_1_live_birth</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="528">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2185960</PUBLICID>
    <LONGNAME>Patient Age Year Count</LONGNAME>
    <PREFERREDNAME>PT_AGE_YR_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>the patient&#39;s age in number of years.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2185959</PublicId>
      <PreferredName>PT_AGE</PreferredName>
      <PreferredDefinition>information related to patient age.</PreferredDefinition>
      <LongName>Patient Age</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239916</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25150</PreferredName>
        <Version>1</Version>
        <LongName>Age</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25150</PREFERRED_NAME>
            <LONG_NAME>Age</LONG_NAME>
            <CON_ID>2202837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2185961</PublicId>
      <PreferredName>AGE_YR_CT</PreferredName>
      <PreferredDefinition>the age in years.</PreferredDefinition>
      <LongName>Age Year Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2524762</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29848:C25463</PreferredName>
        <Version>1</Version>
        <LongName>Year Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29848</PREFERRED_NAME>
            <LONG_NAME>Year</LONG_NAME>
            <CON_ID>2203986</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is your age in years?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Age</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Age</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient age</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NIDA CTN PhenX Current Age for SAATier1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>About how old are you</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Age (years):</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Age (years):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer DataMart</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer Data Mart</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812624</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3952293</PublicId>
          <ContextName>NIDA</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDA CTN Usage</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Research</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3952294</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3952293</PublicId>
          <ContextName>NIDA</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDA CTN Usage</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Electronic Health Record</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3952296</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1216</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104934</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0920</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0534</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171063</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7244861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COVID-19</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>WHO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7247342</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PT_AGE_YR_CT</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIDA</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NIDA</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_AGE_YR_CT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCIP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="529">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2187966</PUBLICID>
    <LONGNAME>Common Toxicity Criteria Adverse Event Skin Stria Grade</LONGNAME>
    <PREFERREDNAME>CTC_AE_SKIN_STRI_GD</PREFERREDNAME>
    <PREFERREDDEFINITION>in CTC category Dermatology/Skin, assessment of the severity of a striae adverse event using a graded scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2198305</PublicId>
      <PreferredName>CTC_AE_SKIN_STRIA</PreferredName>
      <PreferredDefinition>information related to the CTC adverse event of skin stria.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Skin Stria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207882</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12470:C1253938</PreferredName>
        <Version>1</Version>
        <LongName>Skin Stria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12470</PREFERRED_NAME>
            <LONG_NAME>Skin</LONG_NAME>
            <CON_ID>2202821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1253938</PREFERRED_NAME>
            <LONG_NAME>Stria</LONG_NAME>
            <CON_ID>2204421</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2187965</PublicId>
      <PreferredName>CTC_AE_SKIN_STRI_GD</PreferredName>
      <PreferredDefinition>in CTC category Dermatology/Skin, assessment of the severity of a striae adverse event using a graded scale.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Skin Stria Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184299</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Grade</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Mild</VALUEMEANING>
          <MEANINGDESCRIPTION>Not severe or strong; far from extreme; not serious enough to endanger life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Cosmetically significant</VALUEMEANING>
          <MEANINGDESCRIPTION>Cosmetically significant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-08-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTC Adverse Event Striae Grade</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CTC Adverse Event Striae Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Striae Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)</DocumentText>
        <URL>http://ctep.cancer.gov/reporting/ctc.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000132</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="530">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2200523</PUBLICID>
    <LONGNAME>Patient Questionnaire Administered Method Specify</LONGNAME>
    <PREFERREDNAME>PT_QUE_ADM_METH_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the specified method the patient questionnaire was  administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2200522</PublicId>
      <PreferredName>PT_QUEST_ADM_METH</PreferredName>
      <PreferredDefinition>information related to the method that a patient questionnaire was administered.</PreferredDefinition>
      <LongName>Patient Questionnaire Administered Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2516212</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C17048</PreferredName>
        <Version>1</Version>
        <LongName>Patient Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17048</PREFERRED_NAME>
            <LONG_NAME>Questionnaire</LONG_NAME>
            <CON_ID>2202367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207686</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382:C16847</PreferredName>
        <Version>1</Version>
        <LongName>Administered Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16847</PREFERRED_NAME>
            <LONG_NAME>Technique</LONG_NAME>
            <CON_ID>2203854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018806</PublicId>
      <PreferredName>ASSESS_SPEC</PreferredName>
      <PreferredDefinition>The free text field to specify the assessment performed.</PreferredDefinition>
      <LongName>Assessment Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="531">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2201963</PUBLICID>
    <LONGNAME>Dressing Breath Shortness Assessment Scale</LONGNAME>
    <PREFERREDNAME>DRES_BRSHRT_ASES_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>the assessment of the patient&#39;s shortness of breath while dressing.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2201962</PublicId>
      <PreferredName>DRES_BRTHSHRT_ASSESS</PreferredName>
      <PreferredDefinition>information relating to dressing breath shortness assessment.</PreferredDefinition>
      <LongName>Dressing Breath Shortness Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2660608</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL313791:C0392680</PreferredName>
        <Version>1</Version>
        <LongName>Dressing Breath shortness</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL313791</PREFERRED_NAME>
            <LONG_NAME>Dressing</LONG_NAME>
            <CON_ID>2472592</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0392680</PREFERRED_NAME>
            <LONG_NAME>Breath shortness</LONG_NAME>
            <CON_ID>2203361</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177637</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Assessment</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2201889</PublicId>
      <PreferredName>BREATHSHORTNES_SCALE</PreferredName>
      <PreferredDefinition>the scale to determine the patient&#39;s shortness of breath.</PreferredDefinition>
      <LongName>Breath Shortness Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184332</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Scale</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest natural number and quantity it denotes: a single entity, unit, or object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Maximum</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest possible quantity or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573764</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Dressing</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Dressing</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1308</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104933</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DRES_BRSHRT_ASES_SCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="532">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2202008</PUBLICID>
    <LONGNAME>Washing Breath Shortness Assessment Scale</LONGNAME>
    <PREFERREDNAME>WASH_BRSHRT_ASES_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>the assessment of the patient&#39;s shortness of breath while washing the car.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2202005</PublicId>
      <PreferredName>WASH_BRTHSHRT_ASSESS</PreferredName>
      <PreferredDefinition>information relating to washing breath shortness assessment.</PreferredDefinition>
      <LongName>Washing Breath Shortness Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2660601</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0563947:C0392680</PreferredName>
        <Version>1</Version>
        <LongName>Does washing-up Breath shortness</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0563947</PREFERRED_NAME>
            <LONG_NAME>Does washing-up</LONG_NAME>
            <CON_ID>2615843</CON_ID>
            <DEFINITION_SOURCE>SNOMEDCT_2004_01_31</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0392680</PREFERRED_NAME>
            <LONG_NAME>Breath shortness</LONG_NAME>
            <CON_ID>2203361</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177637</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Assessment</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2201889</PublicId>
      <PreferredName>BREATHSHORTNES_SCALE</PreferredName>
      <PreferredDefinition>the scale to determine the patient&#39;s shortness of breath.</PreferredDefinition>
      <LongName>Breath Shortness Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184332</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Scale</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest natural number and quantity it denotes: a single entity, unit, or object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Maximum</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest possible quantity or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573764</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Washing car</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Washing car</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1308</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104933</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>WASH_BRSHRT_ASES_SCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="533">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2220369</PUBLICID>
    <LONGNAME>Collected Blood Infusion Reaction Biomarker Ind-2</LONGNAME>
    <PREFERREDNAME>C_BLD_INFRX_BIO_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether blood was drawn for infusion reaction biomarkers.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2220368</PublicId>
      <PreferredName>COL_BLD_INFRX_BIOMKR</PreferredName>
      <PreferredDefinition>The act of gathering things together; having been brought together in one place._A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.:A reaction to the infusion of pharmacological or biological substances. Symptoms may appear within minutes to hours following the infusion and may include pruritus, flushing, swelling, dyspnea, bronchospasm, and hypotension._A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.</PreferredDefinition>
      <LongName>Collected Blood Infusion Reaction Biomarker</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206752</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25453:C12434</PreferredName>
        <Version>1</Version>
        <LongName>Collection Blood</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12434</PREFERRED_NAME>
            <LONG_NAME>Blood</LONG_NAME>
            <CON_ID>2202587</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16340767</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C78361:C16342</PreferredName>
        <Version>1</Version>
        <LongName>Infusion-Related Reaction Biomarker</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78361</PREFERRED_NAME>
            <LONG_NAME>Infusion-Related Reaction</LONG_NAME>
            <CON_ID>2945112</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16342</PREFERRED_NAME>
            <LONG_NAME>Biomarker</LONG_NAME>
            <CON_ID>2202308</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was blood drawn for infusion</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was blood drawn for infusion reaction biomarkers</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="534">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2224307</PUBLICID>
    <LONGNAME>Sex Distribution Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2224159v3.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of males and females in a given population. The distribution may refer to how many men or women or what proportion of either in the group.  The population is often a group of defined patients with a specific disease but the concept is not restricted to humans nor medical conditions. (from On-line Medical Dictionary)_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Value Domain for java language Long datatype.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2224159</PublicId>
      <PreferredName>2224098v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>The number of males and females in a given population. The distribution may refer to how many men or women or what proportion of either in the group.  The population is often a group of defined patients with a specific disease but the concept is not restricted to humans nor medical conditions. (from On-line Medical Dictionary)_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Sex Distribution Identifier</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2224098</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C40994</PreferredName>
        <Version>1</Version>
        <LongName>Sex Distribution</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40994</PREFERRED_NAME>
            <LONG_NAME>Sex Distribution</LONG_NAME>
            <CON_ID>2223983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Sex Distribution Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Sex Distribution Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SexDistribution:sexDistributionId</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.SexDistribution.sexDistributionId</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.SexDistribution.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SexDistribution:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="535">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2232295</PUBLICID>
    <LONGNAME>Administered Item Workflow Status Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2231694v3.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_Workflow is the operational aspect of a work procedure: how tasks are structured, who performs them, what their relative order is, how they are synchronized, how information flows to support the tasks and how tasks are being tracked. (from Wikipedia):._A condition or state at a particular time._Description; a statement that represents something in words._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2231694</PublicId>
      <PreferredName>2231648v1:2442889v1</PreferredName>
      <PreferredDefinition>A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_Workflow is the operational aspect of a work procedure: how tasks are structured, who performs them, what their relative order is, how they are synchronized, how information flows to support the tasks and how tasks are being tracked. (from Wikipedia):._A condition or state at a particular time._Description; a statement that represents something in words.</PreferredDefinition>
      <LongName>Administered Item Workflow Status Description</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2231648</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42613</PreferredName>
        <Version>1</Version>
        <LongName>Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2442889</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42753:C25688:C25365</PreferredName>
        <Version>1</Version>
        <LongName>Workflow Status Description </LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42753</PREFERRED_NAME>
            <LONG_NAME>Workflow</LONG_NAME>
            <CON_ID>2231547</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Administered Item Workflow Status Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Administered Item Workflow Status Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.AdministeredComponent.workflowStatusDescription</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AdministeredComponent:workflowStatusDescription</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>@workflowStatusDescription</AlternateName>
        <AlternateNameType>GME_XMLLocReference</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="536">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2342448</PUBLICID>
    <LONGNAME>Protein Sequence Variation Original Protein Sequence java.lang.String</LONGNAME>
    <PREFERREDNAME>2342274v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The sequence of amino acids along a polypeptide chain.:An alteration or difference from a norm or standard._Preceding all others in time or being as first made or performed.:The sequence of amino acids along a polypeptide chain._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2342274</PublicId>
      <PreferredName>2342250v1.0:2342212v1.0</PreferredName>
      <PreferredDefinition>The sequence of amino acids along a polypeptide chain.:An alteration or difference from a norm or standard._Preceding all others in time or being as first made or performed.:The sequence of amino acids along a polypeptide chain.</PreferredDefinition>
      <LongName>Protein Sequence Variation Original Protein Sequence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2342250</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13187:C25713</PreferredName>
        <Version>1</Version>
        <LongName>Protein Sequence Variation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13187</PREFERRED_NAME>
            <LONG_NAME>Amino Acid Sequence</LONG_NAME>
            <CON_ID>2223225</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25713</PREFERRED_NAME>
            <LONG_NAME>Variation</LONG_NAME>
            <CON_ID>2203982</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2342212</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25604:C13187</PreferredName>
        <Version>1</Version>
        <LongName>Original Protein Sequence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25604</PREFERRED_NAME>
            <LONG_NAME>Original</LONG_NAME>
            <CON_ID>2206332</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13187</PREFERRED_NAME>
            <LONG_NAME>Amino Acid Sequence</LONG_NAME>
            <CON_ID>2223225</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Protein Sequence Variation Original Protein Sequence java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Protein Sequence Variation Original Protein Sequence java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2496586</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PIR 1.1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.georgetown.pir.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812496</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716603</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PIR 1.2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.georgetown.pir.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000532</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.georgetown.pir.domain.SequenceVariant.originalSequence</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SequenceVariant:originalSequence</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="537">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2388940</PUBLICID>
    <LONGNAME>Concept Reference Object Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2388884v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A unit of knowledge created by a unique combination of characteristics. (ISO 1087):Something referred to; the object of a reference._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2388884</PublicId>
      <PreferredName>2388857v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A unit of knowledge created by a unique combination of characteristics. (ISO 1087):Something referred to; the object of a reference._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Concept Reference Object Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2388857</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45728:C48294</PreferredName>
        <Version>1</Version>
        <LongName>Concept Reference Object</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45728</PREFERRED_NAME>
            <LONG_NAME>Concept</LONG_NAME>
            <CON_ID>2388821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48294</PREFERRED_NAME>
            <LONG_NAME>Reference Object</LONG_NAME>
            <CON_ID>2388820</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Concept Reference Object Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Concept Reference Object Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.upmc.opi.cabig.caties.document.domain.ConceptReferent.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ConceptReferent:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="538">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2404652</PUBLICID>
    <LONGNAME>Small Cell Lung Carcinoma Invasion Status</LONGNAME>
    <PREFERREDNAME>SCLC_INVA_STATUS</PREFERREDNAME>
    <PREFERREDDEFINITION>the status of the extent of invasion or involvement of Small Cell Lung Cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2404649</PublicId>
      <PreferredName>SCLC_INVASION</PreferredName>
      <PreferredDefinition>information related to the spread, by infiltration or destruction of adjacent tissue, of a highly aggressive subtype of lung carcinoma characterized by the presence of malignant small cells and necrosis.</PreferredDefinition>
      <LongName>Small Cell Lung Carcinoma Invasion</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404646</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4917</PreferredName>
        <Version>1</Version>
        <LongName>SCLC</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4917</PREFERRED_NAME>
            <LONG_NAME>Lung Small Cell Carcinoma</LONG_NAME>
            <CON_ID>2202810</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2404647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20625</PreferredName>
        <Version>1</Version>
        <LongName>Invasion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20625</PREFERRED_NAME>
            <LONG_NAME>Tumor Cell Invasion</LONG_NAME>
            <CON_ID>2203828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2404651</PublicId>
      <PreferredName>LU_CA_INVAS_STAT</PreferredName>
      <PreferredDefinition>a description of the severity of the spread of cancer originating in the pairs organs of respiration in the thoracic cavity.</PreferredDefinition>
      <LongName>Lung Carcinoma Invasion Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>9</MaximumLength>
      <MinimumLength>7</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Limited</VALIDVALUE>
          <VALUEMEANING>Limited</VALUEMEANING>
          <MEANINGDESCRIPTION>Restricted or in amount, size, or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142988</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recurrent</VALIDVALUE>
          <VALUEMEANING>RECURRENT</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring again.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extensive</VALIDVALUE>
          <VALUEMEANING>Extensive</VALUEMEANING>
          <MEANINGDESCRIPTION>Large in quantity, range, or spatial extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47863</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558760</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Extent of disease</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Extent of disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the extent of the disease?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the extent of the disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Lung Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812017</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811821</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Extensive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811822</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Limited</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3279271</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="539">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2405161</PUBLICID>
    <LONGNAME>Address Door Text Identifier</LONGNAME>
    <PREFERREDNAME>ADDR_DOOR_TXT_ID</PREFERREDNAME>
    <PREFERREDDEFINITION>A component of an address that specifies a location by identification of an entrance way into a building.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2405156</PublicId>
      <PreferredName>ADDR_DOOR</PreferredName>
      <PreferredDefinition>The identification of a door; a structure where people live or work (usually ordered along a street or road); the entrance through which you enter or leave a room or building, as it relates to address.</PreferredDefinition>
      <LongName>Address Door</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008543</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>GEO_LCTNS</PreferredName>
        <Version>1</Version>
        <LongName>Geographic Locations</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2341906</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25407</PreferredName>
        <Version>1</Version>
        <LongName>Address</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25407</PREFERRED_NAME>
            <LONG_NAME>Address</LONG_NAME>
            <CON_ID>2202289</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2422596</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48950</PreferredName>
        <Version>1</Version>
        <LongName>Door</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48950</PREFERRED_NAME>
            <LONG_NAME>Door</LONG_NAME>
            <CON_ID>2422328</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2405142</PublicId>
      <PreferredName>ENT_TXT_ID</PreferredName>
      <PreferredDefinition>The text representing the name of an entity.  An entity is defined as one or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Entity Text Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008581</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PropertiesOrAttributes</PreferredName>
        <Version>1</Version>
        <LongName>Properties or Attributes</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>355</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2230101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Text Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Address Door</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Address Door</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Address</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812358</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675695</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDE by Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Address</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000554</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="540">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2415625</PUBLICID>
    <LONGNAME>Laboratory Procedure Peripheral Blood Result Ind-3</LONGNAME>
    <PREFERREDNAME>LAB_PER_BLO_RSL_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator related to the laboratory assessment or analysis of a patient&#39;s/participant&#39;s peripheral blood.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2415624</PublicId>
      <PreferredName>LAB_PER_BL_RSLT</PreferredName>
      <PreferredDefinition>information related to the result of the medical procedure that involves testing a sample of peripheral blood.</PreferredDefinition>
      <LongName>Laboratory Procedure Peripheral Blood Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738906</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25233:C12434:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Peripheral Blood Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25233</PREFERRED_NAME>
            <LONG_NAME>Peripheral</LONG_NAME>
            <CON_ID>2206343</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12434</PREFERRED_NAME>
            <LONG_NAME>Blood</LONG_NAME>
            <CON_ID>2202587</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the patient have a periph</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the patient have a peripheral blood examination during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were blood products utilized since the last visit</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was lab analysis performed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was peripheral blood assessed by flow cytometry this evaluation?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient have a peripheral blood evaluation prior to study entry?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient have a peripheral blood evaluation prior to study enrollment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="541">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2418341</PUBLICID>
    <LONGNAME>Patient Frozen Specimen Consent Status</LONGNAME>
    <PREFERREDNAME>PT_FR_SPEC_CONS_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>the status of the informed consent given by an individual regarding a frozen sample of tissue or blood or urine collected for research purposes.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2416520</PublicId>
      <PreferredName>PT_FROZ_SPEC_CONSENT</PreferredName>
      <PreferredDefinition>information related to the informed consent of an individual regarding a frozen sample of tissue or blood or urine collected for research purposes.</PreferredDefinition>
      <LongName>Patient Frozen Specimen Consent</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008530</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PT_CONSENT</PreferredName>
        <Version>1</Version>
        <LongName>Patient Consent</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2416518</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL267638:C19157:C25460</PreferredName>
        <Version>1</Version>
        <LongName>Frozen Specimen Consent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL267638</PREFERRED_NAME>
            <LONG_NAME>Frozen</LONG_NAME>
            <CON_ID>2204514</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25460</PREFERRED_NAME>
            <LONG_NAME>Consent</LONG_NAME>
            <CON_ID>2203590</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2418340</PublicId>
      <PreferredName>PT_SPEC_CONSENT_STAT</PreferredName>
      <PreferredDefinition>the status of the informed consent given by an individual regarding a sample of tissue or blood or urine collected for research purposes.</PreferredDefinition>
      <LongName>Patient Specimen Consent Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008530</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PT_CONSENT</PreferredName>
        <Version>1</Version>
        <LongName>Patient Consent</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>SWOG CRF:Southwest Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2184340</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Status</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granted</VALIDVALUE>
          <VALUEMEANING>Consent given to participate</VALUEMEANING>
          <MEANINGDESCRIPTION>Consent given to participate</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Declined</VALIDVALUE>
          <VALUEMEANING>Declined to participate</VALUEMEANING>
          <MEANINGDESCRIPTION>Declining to take part in activities or procedures that are available to, or requested or expected of, an individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124784</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Consent for fresh frozen tiss</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Consent for fresh frozen tissue submission</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Upper GI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="542">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2423064</PUBLICID>
    <LONGNAME>Genotype Diagnosis Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2422863v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The genetic constitution of an organism or cell, as distinct from its expressed features or phenotype.:The investigation, analysis and recognizing of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise description of characterization of a species where the c_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Value Domain for java language Long datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2422863</PublicId>
      <PreferredName>2422762v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>The genetic constitution of an organism or cell, as distinct from its expressed features or phenotype.:The investigation, analysis and recognizing of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise description of characterization of a species where the c_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Genotype Diagnosis Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2422762</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16631:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Genotype Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16631</PREFERRED_NAME>
            <LONG_NAME>Genotype</LONG_NAME>
            <CON_ID>2221799</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Genotype Diagnosis Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Genotype Diagnosis Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ProteomicsLIMS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.fccc.lims.protlims.domain.class.sampledata</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.fccc.lims.protlims.domain.class.sampledata.GenotypeDiagnosis.genotypeDiagnosisId</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GenotypeDiagnosis:genotypeDiagnosisId</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="543">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2423104</PUBLICID>
    <LONGNAME>Protocol Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2422904v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A protocol is a rule which guides how an activity should be performed; a set of formal rules used to specify the format of an exchange of data._The words or language units by which a thing is known._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2422904</PublicId>
      <PreferredName>2236759v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>A protocol is a rule which guides how an activity should be performed; a set of formal rules used to specify the format of an exchange of data._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Protocol Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236759</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42651</PreferredName>
        <Version>1</Version>
        <LongName>Protocol</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42651</PREFERRED_NAME>
            <LONG_NAME>Protocol</LONG_NAME>
            <CON_ID>2211236</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Protocol Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Protocol Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2523764</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCI-60 SKY</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKY</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812298</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2523764</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCI-60 SKY</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.lmp.nci60</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812299</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.protocol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812748</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.workflow</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099477</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ProteomicsLIMS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.fccc.lims.protlims.domain.class.labproject</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812036</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.protocol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000256</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.protocol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000257</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.tgen.BCR.Protocol.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calab.domain.Protocol.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.mageom.domain.Protocol.Protocol.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.lmp.nci60.Protocol.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.fccc.lims.protlims.domain.class.labproject.Protocol.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Protocol:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.protocol.Protocol.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ncicb.tcga.dcc.grid.Protocol.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.workflow.Protocol.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="544">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2426251</PUBLICID>
    <LONGNAME>Hormone Refractory Prostate Carcinoma Therapy Administration First Date</LONGNAME>
    <PREFERREDNAME>HO_RE_PR_TX_ADM_F_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date of the first therapy for hormone refractory prostate cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2426250</PublicId>
      <PreferredName>HOR_REFR_PRST_TX_ADM</PreferredName>
      <PreferredDefinition>information related to the action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process for hormone refractory, not responding to treatment, prostate cancer.</PreferredDefinition>
      <LongName>Hormone Refractory Prostate Carcinoma Therapy Administration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2425590</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2315:C38014:C4863</PreferredName>
        <Version>1</Version>
        <LongName>Hormone Refractory Prostate Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2315</PREFERRED_NAME>
            <LONG_NAME>Hormone</LONG_NAME>
            <CON_ID>2231216</CON_ID>
            <DEFINITION_SOURCE>MSH2002_06_01</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38014</PREFERRED_NAME>
            <LONG_NAME>Refractory</LONG_NAME>
            <CON_ID>2205322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4863</PREFERRED_NAME>
            <LONG_NAME>Prostate Carcinoma</LONG_NAME>
            <CON_ID>2237042</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2426248</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15368:C25409</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Administration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016734</PublicId>
      <PreferredName>FIRST_DT</PreferredName>
      <PreferredDefinition>the first date of an assessment, test, or treatment.</PreferredDefinition>
      <LongName>First Date</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yyyy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C25164</PreferredName>
        <Version>1</Version>
        <LongName>First Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of first therapy for Hormone Refractory Prostate Cancer</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="545">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2428126</PUBLICID>
    <LONGNAME>Patient Clinical Pelvis Fracture Status</LONGNAME>
    <PREFERREDNAME>PT_CLIN_PELV_FX_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>the status or cause of a clinical fracture of the pelvis experienced by a patient/participant.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2428120</PublicId>
      <PreferredName>PT_CLIN_PELV_FX</PreferredName>
      <PreferredDefinition>information related to a traumatic injury to the bone supporting the lower limbs in humans,  in which the continuity of the bone is broken in a patient/participant.</PreferredDefinition>
      <LongName>Patient Clinical Pelvis Fracture</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2428118</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25398:C12767:C3046</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Pelvis Fracture</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12767</PREFERRED_NAME>
            <LONG_NAME>Pelvis</LONG_NAME>
            <CON_ID>2202775</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3046</PREFERRED_NAME>
            <LONG_NAME>Fracture</LONG_NAME>
            <CON_ID>2203813</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2427815</PublicId>
      <PreferredName>SKELE_FX_STAT</PreferredName>
      <PreferredDefinition>the status of a skeletal fracture.</PreferredDefinition>
      <LongName>Skeletal Fracture Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>55</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184340</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Status</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pathological</VALIDVALUE>
          <VALUEMEANING>Pathological</VALUEMEANING>
          <MEANINGDESCRIPTION>Pathological</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-11-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Traumatic</VALIDVALUE>
          <VALUEMEANING>Traumatic</VALUEMEANING>
          <MEANINGDESCRIPTION>Traumatic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-11-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Hip fractures</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="546">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2431879</PUBLICID>
    <LONGNAME>Radical Prostatectomy Prostate Surgical Pathology Specimen Missing Value Reason Surgical Procedure java.lang.String</LONGNAME>
    <PREFERREDNAME>2431489v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Surgery to remove the entire prostate. The two types of radical prostatectomy are retropubic prostatectomy and perineal prostatectomy.:The walnut shaped accessory sex gland of the male reproductive system.  It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra.  The prostate gland secretes a fluid which is part of the semen.:A field of anatomical pathology in which living tissue is surgically removed for the purpose of diagnosis and treatment.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A specific reason explaining why a meaningful value is not available.  A meaningful value answers the question posed by a Data Element Concept.  In contrast, a Missing Value Reason answers the implicit question &quot;Why is there no &#39;meaningful&#39; value?&quot;, when there is none.:Surgical Procedure is a diagnostic or treatment medical procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CAP PROTOCOLS:College of American Pathologists Cancer Protocols</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2431489</PublicId>
      <PreferredName>2431304v1.0:2431207v1.0</PreferredName>
      <PreferredDefinition>Surgery to remove the entire prostate. The two types of radical prostatectomy are retropubic prostatectomy and perineal prostatectomy.:The walnut shaped accessory sex gland of the male reproductive system.  It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra.  The prostate gland secretes a fluid which is part of the semen.:A field of anatomical pathology in which living tissue is surgically removed for the purpose of diagnosis and treatment.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A specific reason explaining why a meaningful value is not available.  A meaningful value answers the question posed by a Data Element Concept.  In contrast, a Missing Value Reason answers the implicit question &quot;Why is there no &#39;meaningful&#39; value?&quot;, when there is none.:Surgical Procedure is a diagnostic or treatment medical procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue.</PreferredDefinition>
      <LongName>Radical Prostatectomy Prostate Gland Surgical Pathology Specimen Missing Value Reason Surgical Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2431304</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15399:C12410:C16958:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Radical Prostatectomy Prostate Gland Surgical Pathology Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15399</PREFERRED_NAME>
            <LONG_NAME>Radical Prostatectomy</LONG_NAME>
            <CON_ID>2431187</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12410</PREFERRED_NAME>
            <LONG_NAME>Prostate Gland</LONG_NAME>
            <CON_ID>2202794</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16958</PREFERRED_NAME>
            <LONG_NAME>Surgical Pathology</LONG_NAME>
            <CON_ID>2431154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2431207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48655:C15329</PreferredName>
        <Version>1</Version>
        <LongName>Missing Value Reason Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48655</PREFERRED_NAME>
            <LONG_NAME>Missing Value Reason</LONG_NAME>
            <CON_ID>2431146</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CAP PROTOCOLS:College of American Pathologists Cancer Protocols</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Radical Prostatectomy Prostate Surgical Pathology Specimen Missing Value Reason Surgical Procedure java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Radical Prostatectomy Prostate Surgical Pathology Specimen Missing Value Reason Surgical Procedure java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857187</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CAP Cancer Checklists</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.upmc.opi.cabig.caties.cap.domain.prostate.radical_prostatectomy</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812068</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.upmc.opi.cabig.caties.cap.domain.prostate.radical_prostatectomy.RadicalProstatectomyProstateSurgicalPathologySpecimen.surgicalProcedureMVR</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RadicalProstatectomyProstateSurgicalPathologySpecimen:surgicalProcedureMVR</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="547">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2438096</PUBLICID>
    <LONGNAME>Transgene Conditionality Transgene Conditionality Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2437893v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicates if a transgene or targeted modification is done conditionally (time or tissue specific). (caBIO)_Indicates if a transgene or targeted modification is done conditionally (time or tissue specific).:A statement or an account describing something._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2437893</PublicId>
      <PreferredName>2224126v1.0:2437744v1.0</PreferredName>
      <PreferredDefinition>Indicates if a transgene or targeted modification is done conditionally (time or tissue specific). (caBIO)_Indicates if a transgene or targeted modification is done conditionally (time or tissue specific).:A statement or an account describing something.</PreferredDefinition>
      <LongName>Transgene Conditionality Transgene Conditionality Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2224126</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41084</PreferredName>
        <Version>1</Version>
        <LongName>Transgene Conditionality</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41084</PREFERRED_NAME>
            <LONG_NAME>Transgene Conditionality</LONG_NAME>
            <CON_ID>2224021</CON_ID>
            <DEFINITION_SOURCE>CABIO</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2437744</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41084:C25365</PreferredName>
        <Version>1</Version>
        <LongName>Transgene Conditionality Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41084</PREFERRED_NAME>
            <LONG_NAME>Transgene Conditionality</LONG_NAME>
            <CON_ID>2224021</CON_ID>
            <DEFINITION_SOURCE>CABIO</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Transgene Conditionality Transgene Conditionality Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Transgene Conditionality Transgene Conditionality Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.Conditionality.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Conditionality:description</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="548">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2442458</PUBLICID>
    <LONGNAME>Neurotoxicity Patient Temperature Sense Assessment Quality of Life Scale</LONGNAME>
    <PREFERREDNAME>NT_PT_TE_S_ASS_QO_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>a description of symptoms of painful sensation of cold or temperature change in the hands or feet using a quality of life scale to evaluate possible damage to the nervous system.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2442282</PublicId>
      <PreferredName>NTX_PT_TEMP_S_ASSESS</PreferredName>
      <PreferredDefinition>related to examination of an individual to evaluate damage to the nervous system with regard to symptoms of painful sensation of cold or temperature change in the hands or feet.</PreferredDefinition>
      <LongName>Neurotoxicity Patient Temperature Sense Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2442148</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C27961:C16960</PreferredName>
        <Version>1</Version>
        <LongName>Neurotoxicity Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C27961</PREFERRED_NAME>
            <LONG_NAME>Neurotoxicity Syndrome</LONG_NAME>
            <CON_ID>2442147</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2442280</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0039478:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Temperature Sense Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0039478</PREFERRED_NAME>
            <LONG_NAME>Temperature Sense</LONG_NAME>
            <CON_ID>2442279</CON_ID>
            <DEFINITION_SOURCE>MSH2005_2004_10_12</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016847</PublicId>
      <PreferredName>FACT_QOL_SCALE</PreferredName>
      <PreferredDefinition>the scale used on FACT Quality of Life questionnaires to assess patient responses.</PreferredDefinition>
      <LongName>FACT Quality of Life Scale</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Always</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all bothered</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little bit</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat bothered</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2927955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately</VALIDVALUE>
          <VALUEMEANING>Moderately</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely</VALIDVALUE>
          <VALUEMEANING>EXTREMELY</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slightly</VALIDVALUE>
          <VALUEMEANING>Slightly</VALUEMEANING>
          <MEANINGDESCRIPTION>Slightly</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not bothered at all</VALIDVALUE>
          <VALUEMEANING>Not bothered at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not bothered at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered somewhat</VALIDVALUE>
          <VALUEMEANING>Bothered somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered somewhat</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little</VALIDVALUE>
          <VALUEMEANING>Bothered a little</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered a little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little difficult</VALIDVALUE>
          <VALUEMEANING>A little difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>A little difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not difficult at all</VALIDVALUE>
          <VALUEMEANING>Not difficult at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not difficult at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted totally</VALIDVALUE>
          <VALUEMEANING>Disrupted totally</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was totally disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted quite a bit</VALIDVALUE>
          <VALUEMEANING>Disrupted quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted somewhat</VALIDVALUE>
          <VALUEMEANING>Disrupted somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted a little</VALIDVALUE>
          <VALUEMEANING>Disrupted a little</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was a little disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not disrupted at all</VALIDVALUE>
          <VALUEMEANING>Not disrupted at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not at all disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to do</VALIDVALUE>
          <VALUEMEANING>UNABLE To Do</VALUEMEANING>
          <MEANINGDESCRIPTION>UNABLE To Do (Health Activity Questionnaire)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very difficult</VALIDVALUE>
          <VALUEMEANING>Very difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Very difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat difficult</VALIDVALUE>
          <VALUEMEANING>Somewhat difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No pain</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had no pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I have pain in my hands or fe</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I have pain in my hands or feet when I am exposed to cold temperatures</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>I am bothered by the chills</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FACT_NTX10_PN_CLD_SC</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="549">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2458742</PUBLICID>
    <LONGNAME>Pills Lost Count</LONGNAME>
    <PREFERREDNAME>PILL_LOST_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>the quantity of the pills lost (no longer held or possessed).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2458739</PublicId>
      <PreferredName>PILLS_LOST</PreferredName>
      <PreferredDefinition>information regarding the pills lost (no longer held or possessed).</PreferredDefinition>
      <LongName>Pills Lost</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2458719</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25394</PreferredName>
        <Version>1</Version>
        <LongName>Pills</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25394</PREFERRED_NAME>
            <LONG_NAME>Pill Dosage Form</LONG_NAME>
            <CON_ID>2202784</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2458737</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25560</PreferredName>
        <Version>1</Version>
        <LongName>Lost</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25560</PREFERRED_NAME>
            <LONG_NAME>Lost</LONG_NAME>
            <CON_ID>2204933</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018392</PublicId>
      <PreferredName>CT</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of pills lost but not</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of pills lost but not taken</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText># Tabs lost or not returned</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="550">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2459826</PUBLICID>
    <LONGNAME>Erythropoietin Agent Response Type</LONGNAME>
    <PREFERREDNAME>ERYTH_AGT_RESP_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of response from erythropoietic agent.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2459804</PublicId>
      <PreferredName>ERYTP_AGT_RESP</PreferredName>
      <PreferredDefinition>information related to the response from erythropoietin agent administered.</PreferredDefinition>
      <LongName>Erythropoietin Agent Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2459802</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20429:C1708</PreferredName>
        <Version>1</Version>
        <LongName>Erythropoietin Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20429</PREFERRED_NAME>
            <LONG_NAME>Erythropoietin</LONG_NAME>
            <CON_ID>2459801</CON_ID>
            <DEFINITION_SOURCE>MSH2002_06_01</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2193203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25755</PreferredName>
        <Version>1</Version>
        <LongName>Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25755</PREFERRED_NAME>
            <LONG_NAME>Response</LONG_NAME>
            <CON_ID>2202805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2459824</PublicId>
      <PreferredName>ERYTHRO_AGT_RES_TP</PreferredName>
      <PreferredDefinition>the type of response from Erythropoietic agent.</PreferredDefinition>
      <LongName>Erythropoietic Agent Response Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EPO/DA failure</VALIDVALUE>
          <VALUEMEANING>EPO/DA failure</VALUEMEANING>
          <MEANINGDESCRIPTION>EPO/DA failure</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578347</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EPO/DA benefit</VALIDVALUE>
          <VALUEMEANING>EPO/DA benefit</VALUEMEANING>
          <MEANINGDESCRIPTION>EPO/DA benefit</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>EPO/DA response</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>EPO/DA response</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="551">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2466340</PUBLICID>
    <LONGNAME>Increased Anemia Adverse Event Observed Ind-2</LONGNAME>
    <PREFERREDNAME>INANEMIA_AE_OBS_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether the patient experienced increasing anemia.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2466339</PublicId>
      <PreferredName>INCRESDANEMIA_AE_OBS</PreferredName>
      <PreferredDefinition>information relating to an observed adverse event of increasing anemia.</PreferredDefinition>
      <LongName>Increased Anemia Adverse Event Observed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2466337</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL124321:C2869:C41331</PreferredName>
        <Version>1</Version>
        <LongName>Increased Anemia Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL124321</PREFERRED_NAME>
            <LONG_NAME>Increased</LONG_NAME>
            <CON_ID>2240803</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2869</PREFERRED_NAME>
            <LONG_NAME>Anemia</LONG_NAME>
            <CON_ID>2419896</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2419892</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25599</PreferredName>
        <Version>1</Version>
        <LongName>Observed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25599</PREFERRED_NAME>
            <LONG_NAME>Observed</LONG_NAME>
            <CON_ID>2203942</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Increasing anemia</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Increasing anemia</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="552">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2469002</PUBLICID>
    <LONGNAME>Non-protocol Therapy 5 Alpha-Reductase Inhibitor Administered Ind-2</LONGNAME>
    <PREFERREDNAME>NP_TX_5AR_IN_ADM_IN2</PREFERREDNAME>
    <PREFERREDDEFINITION>a yes/no indicator to ask if a substance to inhibit 5-alpha-reductase, an enzyme metabolizing testosterone to dihydrotestosterone, was used for therapeutic purposes not specified for a clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCIC CRF:National Cancer Institute of Canada Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2468985</PublicId>
      <PreferredName>NPR_TX_5ARED_INH_ADM</PreferredName>
      <PreferredDefinition>related to the use of substances that inhibit 5-alpha-reductase, an enzyme that metabolizes testosterone to dihydrotestosterone, for therapeutic purposes not specified for a clinical trial.</PreferredDefinition>
      <LongName>Non-protocol Therapy 5 Alpha-Reductase Inhibitor Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206588</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25590:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Non-Protocol Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25590</PREFERRED_NAME>
            <LONG_NAME>Non-Protocol</LONG_NAME>
            <CON_ID>2206325</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2468983</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2319:C25382</PreferredName>
        <Version>1</Version>
        <LongName>5 Alpha-Reductase Inhibitor Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2319</PREFERRED_NAME>
            <LONG_NAME>5 Alpha-Reductase Inhibitor</LONG_NAME>
            <CON_ID>2451705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Non-protocol 5 alpha reductas</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Non-protocol 5 alpha reductase inhibitors</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient receiving a 5-alpha reductase inhibitor?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF_2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior use of 5-alpha-reductase inhibitors</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="553">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2472901</PUBLICID>
    <LONGNAME>Radiation Surgery Isocenter Method Count</LONGNAME>
    <PREFERREDNAME>RS_ISO_METH_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>the number of isocenters (either a point at which there is a maximum or minimum of a radiation dose or the center point of a radiation field where the origin of the coordinate system is (x, y, z) = (0, 0 ,0)) for radiation therapy technique that delivers radiation directly to the tumor while sparing the healthy tissue.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2472833</PublicId>
      <PreferredName>RADSURG_ISOCENT_METH</PreferredName>
      <PreferredDefinition>information related to isocenters (either a point at which there is a maximum or minimum of a radiation dose or the center point of a radiation field where the origin of the coordinate system is (x, y, z) = (0, 0 ,0)) for radiation therapy technique that delivers radiation directly to the tumor while sparing the healthy tissue.</PreferredDefinition>
      <LongName>Radiation Surgery Isocenter Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2472810</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15696</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Surgery</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15696</PREFERRED_NAME>
            <LONG_NAME>Radiosurgery</LONG_NAME>
            <CON_ID>2202849</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2479683</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54651:C16847</PreferredName>
        <Version>1</Version>
        <LongName>Isocenter Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54651</PREFERRED_NAME>
            <LONG_NAME>Isocenter</LONG_NAME>
            <CON_ID>2479359</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16847</PREFERRED_NAME>
            <LONG_NAME>Technique</LONG_NAME>
            <CON_ID>2203854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018392</PublicId>
      <PreferredName>CT</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of isocenters or beam-</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of isocenters or beam-center positions</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RS_ISO_METH_CT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="554">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2480048</PUBLICID>
    <LONGNAME>Protocol Screen Failure Reason Type</LONGNAME>
    <PREFERREDNAME>PROT_SCRN_FLR_RSN_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>The reason for the screen failure.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2184689</PublicId>
      <PreferredName>PROT_SCRN</PreferredName>
      <PreferredDefinition>A human being._A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.:A systematic examination or assessment.</PreferredDefinition>
      <LongName>Person Protocol Screen</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5633268</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C71104</PreferredName>
        <Version>1</Version>
        <LongName>Person Clinical Trial</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71104</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial</LONG_NAME>
            <CON_ID>2735720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2680362</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48261</PreferredName>
        <Version>1</Version>
        <LongName>Screening</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48261</PREFERRED_NAME>
            <LONG_NAME>Screening</LONG_NAME>
            <CON_ID>2437683</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2480046</PublicId>
      <PreferredName>PROT_SCRN_FLR_RSN_TP</PreferredName>
      <PreferredDefinition>The type that describes the reason the participant was a screen failure.</PreferredDefinition>
      <LongName>Protocol Screen Failure Reason Type</LongName>
      <Version>2</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>45</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2480045</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Reason Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Investigator decision</VALIDVALUE>
          <VALUEMEANING>Investigator decision</VALUEMEANING>
          <MEANINGDESCRIPTION>The decision of the investigator</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Participant Decision</VALIDVALUE>
          <VALUEMEANING>Participant decision</VALUEMEANING>
          <MEANINGDESCRIPTION>Participant decision</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, specify</VALIDVALUE>
          <VALUEMEANING>Other specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Did not meet eligibility criteria, specify</VALIDVALUE>
          <VALUEMEANING>Did not meet eligibility criteria, specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Did not meet eligibility criteria, specify</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-01-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2587634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Primary reason for screen fai</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Primary reason for screen failure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus - ASA-Esomeprazole</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Sulindac</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sporadic Colorectal Neoplasia - Atrovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812155</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="555">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2503808</PUBLICID>
    <LONGNAME>Treatment Clinical Trial Indicator</LONGNAME>
    <PREFERREDNAME>TX_CLIN_TRIAL_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to signify determination that an action or administration of therapeutic agents to produce an effect is part of a research study performed in human subjects and intended to discover, and/or evaluate, and/or verify safety, effectiveness, clinical and pharmacological effects, and adverse reactions.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2503806</PublicId>
      <PreferredName>TX_CLIN_TRIAL_IND</PreferredName>
      <PreferredDefinition>Determination that an action or administration of therapeutic agents to produce an effect is part of a research study performed in human subjects and intended to discover, and/or evaluate, and/or verify safety, effectiveness, clinical and pharmacological effects, and adverse reactions.</PreferredDefinition>
      <LongName>Treatment Clinical Trial Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2416951</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15368</PreferredName>
        <Version>1</Version>
        <LongName>Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2503804</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15207:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15207</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial</LONG_NAME>
            <CON_ID>2202567</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181608</PublicId>
      <PreferredName>Y_N_CHAR_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Character Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Treatment on Clinical Trial</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Treatment on Clinical Trial</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812205</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AZCC 0210</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812575</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716207</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ASCO</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colon Adjuvant Treatment Summary</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812709</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716207</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ASCO</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer Adjuvant Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812713</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716207</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ASCO</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Chemotherapy Administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2861473</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Tx On Clinical Trial</AlternateName>
        <AlternateNameType>TCGA_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>tx_on_clinical_trial</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="556">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2513737</PUBLICID>
    <LONGNAME>Storage Unit Type Second Dimension Label java.lang.String</LONGNAME>
    <PREFERREDNAME>2513471v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A physical structure or device capable of holding objects or samples.:A subdivision of a particular kind of thing._Coming next after the first in position in space or time or degree or magnitude.:The magnitude of something in a particular direction, especially length or width or height.:A brief description given for purposes of identification; an identifying or descriptive marker that is attached to an object._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2513471</PublicId>
      <PreferredName>2513365v1.0:2513314v1.0</PreferredName>
      <PreferredDefinition>A physical structure or device capable of holding objects or samples.:A subdivision of a particular kind of thing._Coming next after the first in position in space or time or degree or magnitude.:The magnitude of something in a particular direction, especially length or width or height.:A brief description given for purposes of identification; an identifying or descriptive marker that is attached to an object.</PreferredDefinition>
      <LongName>Storage Unit Type Second Dimension Label</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2513365</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45322:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Storage Unit Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45322</PREFERRED_NAME>
            <LONG_NAME>Storage Unit</LONG_NAME>
            <CON_ID>2240763</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2513314</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25666:C25483:C45561</PreferredName>
        <Version>1</Version>
        <LongName>Second Dimension Label</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25666</PREFERRED_NAME>
            <LONG_NAME>Second</LONG_NAME>
            <CON_ID>2202591</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25483</PREFERRED_NAME>
            <LONG_NAME>Dimension</LONG_NAME>
            <CON_ID>2203908</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45561</PREFERRED_NAME>
            <LONG_NAME>Label</LONG_NAME>
            <CON_ID>2422619</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Storage Unit Type Second Dimension Label java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Storage Unit Type Second Dimension Label java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2553133</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812526</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2661745</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_caArray</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000636</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2680967</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000633</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000638</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000639</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.StorageType.twoDimensionLabel</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StorageType:twoDimensionLabel</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domainobject.StorageType.twoDimensionLabel</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="557">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2514555</PUBLICID>
    <LONGNAME>Dental Restoration Material Brand Name Specify</LONGNAME>
    <PREFERREDNAME>2514544v1.0:2514553v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An free text related to the name of the manufacturer of the material used for the dental restoration.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2514544</PublicId>
      <PreferredName>2514540v1.0:2514542v1.0</PreferredName>
      <PreferredDefinition>The material used in the replacement for a lost tooth structure of a patient&#39;s tooth.</PreferredDefinition>
      <LongName>Dental Restoration Material</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2514540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C60718</PreferredName>
        <Version>1</Version>
        <LongName>Dental Restoration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60718</PREFERRED_NAME>
            <LONG_NAME>Dental Restoration</LONG_NAME>
            <CON_ID>2481613</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2514542</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48187</PreferredName>
        <Version>1</Version>
        <LongName>Material</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48187</PREFERRED_NAME>
            <LONG_NAME>Material</LONG_NAME>
            <CON_ID>2514541</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2514553</PublicId>
      <PreferredName>2514553v1.0</PreferredName>
      <PreferredDefinition>An free text related to the name by which a thing is known.</PreferredDefinition>
      <LongName>Brand Name Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2514552</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0592503:C25685</PreferredName>
        <Version>1</Version>
        <LongName>brand name Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0592503</PREFERRED_NAME>
            <LONG_NAME>brand name</LONG_NAME>
            <CON_ID>2204271</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify Brand Name</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify Brand Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oral Surgery</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812093</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="558">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2515896</PUBLICID>
    <LONGNAME>DNA Polymerase Chain Reaction Molecular Marker Specify</LONGNAME>
    <PREFERREDNAME>DNA_PCR_MOL_MARK_SPE</PREFERREDNAME>
    <PREFERREDDEFINITION>a text field to describe a molecular marker tested by Southern Blot analysis or DNA-PCR (polymerase chain reaction).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014991</PublicId>
      <PreferredName>DNA_PCR_MOL_MARK</PreferredName>
      <PreferredDefinition>information related to the molecular marker using DNA-PCR (polymerase chain reaction).</PreferredDefinition>
      <LongName>DNA PCR Molecular Marker</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2660439</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C449:C17003</PreferredName>
        <Version>1</Version>
        <LongName>DNA Polymerase Chain Reaction</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C449</PREFERRED_NAME>
            <LONG_NAME>DNA</LONG_NAME>
            <CON_ID>2202485</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17003</PREFERRED_NAME>
            <LONG_NAME>Polymerase Chain Reaction</LONG_NAME>
            <CON_ID>2202449</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207080</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25574:C16342</PreferredName>
        <Version>1</Version>
        <LongName>Molecular Biomarker</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25574</PREFERRED_NAME>
            <LONG_NAME>Molecular</LONG_NAME>
            <CON_ID>2202608</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16342</PREFERRED_NAME>
            <LONG_NAME>Biomarker</LONG_NAME>
            <CON_ID>2202308</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018806</PublicId>
      <PreferredName>ASSESS_SPEC</PreferredName>
      <PreferredDefinition>The free text field to specify the assessment performed.</PreferredDefinition>
      <LongName>Assessment Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If other, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Molecular Analysis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811958</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811935</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="559">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2518568</PUBLICID>
    <LONGNAME>Patient Smoking Cessation Health Care Provider Instruction Indicator</LONGNAME>
    <PREFERREDNAME>SMOK_CESS_INST_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Text indicator to signify information related to a smoking cessation was passed by a health care professional to a patient.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2518566</PublicId>
      <PreferredName>SMOK_CESS_HCP_INST</PreferredName>
      <PreferredDefinition>Information related to a smoking cessation passed by a health care professional business directed toward a patient.</PreferredDefinition>
      <LongName>Patient Smoking Cessation Health Care Provider Instruction</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2518562</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C17427</PreferredName>
        <Version>1</Version>
        <LongName>Patient Smoking Cessation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17427</PREFERRED_NAME>
            <LONG_NAME>Smoking Cessation</LONG_NAME>
            <CON_ID>2443753</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2518563</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16666:C42688</PreferredName>
        <Version>1</Version>
        <LongName>Health Care Provider Instruction</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16666</PREFERRED_NAME>
            <LONG_NAME>Health Care Provider</LONG_NAME>
            <CON_ID>2479788</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42688</PREFERRED_NAME>
            <LONG_NAME>Instruction</LONG_NAME>
            <CON_ID>2231589</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017177</PublicId>
      <PreferredName>YES_NO_NA_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable.</PreferredDefinition>
      <LongName>Yes No Not Applicable Indicator</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2179965</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Indicator</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Smoking cessation</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Smoking cessation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812205</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AZCC 0210</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812575</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="560">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2519099</PUBLICID>
    <LONGNAME>Organism Taxonomy National Center for Biotechnology Information Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2519084v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A living thing, such as an animal, a plant, a bacterium, or a fungus._The theories and techniques of naming, describing, and classifying organisms, and the study of the relationships of taxa. (from On-line Medical Dictionary):Established in 1988 as a national resource for molecular biology information, NCBI creates public databases, conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information - all for the better understanding of molecular processes affecting human health and disease. (http://www.ncbi.nlm.nih.gov/):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2519084</PublicId>
      <PreferredName>2223316v1.0:2519070v1.0</PreferredName>
      <PreferredDefinition>A living thing, such as an animal, a plant, a bacterium, or a fungus._The theories and techniques of naming, describing, and classifying organisms, and the study of the relationships of taxa. (from On-line Medical Dictionary):Established in 1988 as a national resource for molecular biology information, NCBI creates public databases, conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information - all for the better understanding of molecular processes affecting human health and disease. (http://www.ncbi.nlm.nih.gov/):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Organism Taxonomy National Center for Biotechnology Information Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223316</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14250</PreferredName>
        <Version>1</Version>
        <LongName>Organism</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14250</PREFERRED_NAME>
            <LONG_NAME>Organism</LONG_NAME>
            <CON_ID>2208240</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2519070</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17469:C45799:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Taxonomy National Center for Biotechnology Information Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17469</PREFERRED_NAME>
            <LONG_NAME>Taxonomy</LONG_NAME>
            <CON_ID>2342204</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45799</PREFERRED_NAME>
            <LONG_NAME>National Center for Biotechnology Information</LONG_NAME>
            <CON_ID>2342205</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Organism Taxonomy National Center for Biotechnology Information Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Organism Taxonomy National Center for Biotechnology Information Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2519060</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Seed</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.uchicago.Seed.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812278</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.uchicago.Seed.domain.Organism.ncbiTaxonomyId</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Organism:ncbiTaxonomyId</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="561">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2519629</PUBLICID>
    <LONGNAME>Adverse Event Resolution Date</LONGNAME>
    <PREFERREDNAME>AE_RSLN_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date related to adverse event being settled or resolved.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2519293</PublicId>
      <PreferredName>AE_RSLN</PreferredName>
      <PreferredDefinition>information related to adverse event settled or resolved.</PreferredDefinition>
      <LongName>Adverse Event Resolution</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008573</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2235992</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2503262</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25655</PreferredName>
        <Version>1</Version>
        <LongName>Resolution</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25655</PREFERRED_NAME>
            <LONG_NAME>Physiologic Resolution</LONG_NAME>
            <CON_ID>2202897</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of resolution</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of resolution</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>AE Stop Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>TMD resolution date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Restorative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oral Surgery</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812093</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjunctive General Services</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812095</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_RSLN_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="562">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2526994</PUBLICID>
    <LONGNAME>Wide Range Achievement Test 3 Percentile Value</LONGNAME>
    <PREFERREDNAME>WRAT3_PCT_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric designation of an individual&#39;s position relative to the standardization sample when tested with the Wide Range Achievement Test Revision 3 (WRAT3).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2527280</PublicId>
      <PreferredName>PRSN_WRAT3_TEST_RSL</PreferredName>
      <PreferredDefinition>Outcomes from testing a person/subject using the Wide Range Achievement Test Revision 3 (WRAT3), measuring basic skills in reading, arithmetic, and spelling.</PreferredDefinition>
      <LongName>Person Wide Range Achievement Test 3 Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2527303</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C62716</PreferredName>
        <Version>1</Version>
        <LongName>Person Wide Range Achievement Test, 3rd Edition</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62716</PREFERRED_NAME>
            <LONG_NAME>Wide Range Achievement Test, 3rd Edition</LONG_NAME>
            <CON_ID>2527142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2527278</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15336:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Testing Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15336</PREFERRED_NAME>
            <LONG_NAME>Testing</LONG_NAME>
            <CON_ID>2204718</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2526992</PublicId>
      <PreferredName>WRAT3_PCT_VAL</PreferredName>
      <PreferredDefinition>An individual&#39;s position relative to the standardization sample when tested with the Wide Range Achievement Test Revision 3 (WRAT3).</PreferredDefinition>
      <LongName>Wide Range Achievement Test 3 Percentile Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>3</MinimumLength>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue>99.98</MaximumValue>
      <MinimumValue>0.02</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2527283</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62716:C48919:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Wide Range Achievement Test, 3rd Edition Percentile Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62716</PREFERRED_NAME>
            <LONG_NAME>Wide Range Achievement Test, 3rd Edition</LONG_NAME>
            <CON_ID>2527142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48919</PREFERRED_NAME>
            <LONG_NAME>Percentile</LONG_NAME>
            <CON_ID>2423425</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>%ile</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>%ile</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857168</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR CRF Collection</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Neuropsych Testing</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812287</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="563">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2528476</PUBLICID>
    <LONGNAME>Research Activity Institution Source Address java.lang.String</LONGNAME>
    <PREFERREDNAME>2528455v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Systematic investigation into a subject in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered.:An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research; also used to refer to a building or buildings occupied or used by such organization.:Where something is available or from where it originates._A standardized representation of the geographical location of a person, business, building, or organization.  In the US this usually consists of a street name and number, a city, a state, and a zipcode._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2528455</PublicId>
      <PreferredName>2528442v1.0:2228367v1.0</PreferredName>
      <PreferredDefinition>Systematic investigation into a subject in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered.:An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research; also used to refer to a building or buildings occupied or used by such organization.:Where something is available or from where it originates._A standardized representation of the geographical location of a person, business, building, or organization.  In the US this usually consists of a street name and number, a city, a state, and a zipcode.</PreferredDefinition>
      <LongName>Research Activity Institution Source Address</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528442</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15429:C41206:C25683</PreferredName>
        <Version>1</Version>
        <LongName>Research Activity Institution Source</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15429</PREFERRED_NAME>
            <LONG_NAME>Research Activity</LONG_NAME>
            <CON_ID>2528433</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41206</PREFERRED_NAME>
            <LONG_NAME>Institution</LONG_NAME>
            <CON_ID>2228359</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25683</PREFERRED_NAME>
            <LONG_NAME>Source</LONG_NAME>
            <CON_ID>2202479</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2228367</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25407</PreferredName>
        <Version>1</Version>
        <LongName>Address</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25407</PREFERRED_NAME>
            <LONG_NAME>Address</LONG_NAME>
            <CON_ID>2202289</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Research Activity Institution Source Address java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Research Activity Institution Source Address java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.common.provenance.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000617</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.common.provenance.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000618</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.common.provenance.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000620</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.common.provenance.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000621</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ResearchInstitutionSource:institutionAddress</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.common.provenance.domain.ResearchInstitutionSource.institutionAddress</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>@institutionAddress</AlternateName>
        <AlternateNameType>GME_XMLLocReference</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="564">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2529059</PUBLICID>
    <LONGNAME>Specimen Secondary Identifier Professional Organization or Group Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2528768v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._A formal group of people with one or more shared goals.:The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2528768</PublicId>
      <PreferredName>2528713v1.0:2528592v1.0</PreferredName>
      <PreferredDefinition>A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._A formal group of people with one or more shared goals.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Specimen Secondary Identifier Professional Organization or Group Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528713</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157:C25667:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Secondary Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25667</PREFERRED_NAME>
            <LONG_NAME>Secondary</LONG_NAME>
            <CON_ID>2206365</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528592</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19711:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Professional Organization or Group Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19711</PREFERRED_NAME>
            <LONG_NAME>Professional Organization or Group</LONG_NAME>
            <CON_ID>2202773</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Specimen Secondary Identifier Professional Organization or Group Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Specimen Secondary Identifier Professional Organization or Group Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2528519</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812313</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SecondarySpecimenIdentier:organizationName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.study.SecondarySpecimenIdentier.organizationName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="565">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2529109</PUBLICID>
    <LONGNAME>Histology Neoplasm Type InvasivePresentation</LONGNAME>
    <PREFERREDNAME>2528817v1.0:2529042v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004:Something distinguishable as an identifiable class based on common qualities._indication of tumor type</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2528817</PublicId>
      <PreferredName>2404668v1.0:2528614v1.0</PreferredName>
      <PreferredDefinition>The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004:Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Histology Neoplasm Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404668</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16681</PreferredName>
        <Version>1</Version>
        <LongName>Histology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16681</PREFERRED_NAME>
            <LONG_NAME>Histology</LONG_NAME>
            <CON_ID>2202345</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528614</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3262:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2529042</PublicId>
      <PreferredName>2529042v1.0</PreferredName>
      <PreferredDefinition>A subdivision of a particular kind of tumor.</PreferredDefinition>
      <LongName>Invasive Presentation Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>benign</VALIDVALUE>
          <VALUEMEANING>Benign</VALUEMEANING>
          <MEANINGDESCRIPTION>(beh-NINE) Not cancerous; does not invade nearby tissue or spread to other parts of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14172</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2558281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dcis</VALIDVALUE>
          <VALUEMEANING>Ductal Breast Carcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>Ductal carcinoma in situ (DCIS) is a carcinoma entirely confined to the mammary ducts. There is no evidence of invasion of the basement membrane. Currently, DCIS is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS. --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2924</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2581232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>invasive</VALIDVALUE>
          <VALUEMEANING>Invasive</VALUEMEANING>
          <MEANINGDESCRIPTION>Marked by a tendency to spread especially into healthy tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Icis</VALIDVALUE>
          <VALUEMEANING>Lobular Breast Carcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>Lobular carcinoma in situ is characterized by a proliferation of monomorphic cells completely filling the lumina. The overall lobular architecture is preserved. LCIS is frequently multifocal (90% in some series) and bilateral. LCIS seldom becomes invasive, however there is an increased risk of infiltrating ductal adenocarcinoma.  --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nme</VALIDVALUE>
          <VALUEMEANING>Non-Malignant Breast Epithelial Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Not cancerous.: One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.: Cells that cover the surface of the body and line its cavities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12578, C12971, C25588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nms</VALIDVALUE>
          <VALUEMEANING>Non-Malignant Stromal Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Not cancerous.: Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12571, C25588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Histology Neoplasm Type InvasivePresentation does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Histology Neoplasm Type InvasivePresentation does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2528519</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812313</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2707890</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator 2.1</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000247</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.study.Histology.invasivePresentation</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Histology:invasivePresentation</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="566">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2529209</PUBLICID>
    <LONGNAME>Protein Domain Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2452041v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A structurally and functionally defined protein region. (from http://www.ddmag.com)_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2452041</PublicId>
      <PreferredName>2451992v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A structurally and functionally defined protein region. (from http://www.ddmag.com)_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Protein Domain Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2451992</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13379</PreferredName>
        <Version>1</Version>
        <LongName>Protein Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13379</PREFERRED_NAME>
            <LONG_NAME>Protein Domain</LONG_NAME>
            <CON_ID>2342210</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Protein Domain Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Protein Domain Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2528519</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.finding.variation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812206</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FunctionalProteinDomain:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.finding.variation.FunctionalProteinDomain.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="567">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2529283</PUBLICID>
    <LONGNAME>Single Nucleotide Polymorphism Relationship Analysis Techniques java.lang.String</LONGNAME>
    <PREFERREDNAME>2528987v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:A state of connectedness between people, objects, or events; to be associated or connected with something.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it._Scientific or clinical procedures and methods._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2528987</PublicId>
      <PreferredName>2528764v1.0:2231639v1.0</PreferredName>
      <PreferredDefinition>A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:A state of connectedness between people, objects, or events; to be associated or connected with something.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it._Scientific or clinical procedures and methods.</PreferredDefinition>
      <LongName>Single Nucleotide Polymorphism Relationship Analysis Techniques</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528764</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18279:C25648:C25391</PreferredName>
        <Version>1</Version>
        <LongName>Single Nucleotide Polymorphism Relationship Analysis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18279</PREFERRED_NAME>
            <LONG_NAME>Single Nucleotide Polymorphism</LONG_NAME>
            <CON_ID>2433334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231639</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16847</PreferredName>
        <Version>1</Version>
        <LongName>Techniques</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16847</PREFERRED_NAME>
            <LONG_NAME>Technique</LONG_NAME>
            <CON_ID>2203854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Single Nucleotide Polymorphism Relationship Analysis Techniques java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Single Nucleotide Polymorphism Relationship Analysis Techniques java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2528519</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.analysis.snp</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812214</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2707890</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator 2.1</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.analysis.snp</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000644</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SNPAssociationAnalysis:methods</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.analysis.snp.SNPAssociationAnalysis.methods</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="568">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2532838</PUBLICID>
    <LONGNAME>Patient Not Schedule Visit Date</LONGNAME>
    <PREFERREDNAME>PT_N_SCHED_VISIT_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date of unscheduled or unplanned visit of a person who requires medical care.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2532837</PublicId>
      <PreferredName>PT_N_SCHED_VISIT</PreferredName>
      <PreferredDefinition>information related to the unscheduled or unplanned visit of a person who requires medical care.</PreferredDefinition>
      <LongName>Patient Not Schedule Visit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2532835</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C25211:C25716</PreferredName>
        <Version>1</Version>
        <LongName>Not Schedule Visit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25211</PREFERRED_NAME>
            <LONG_NAME>Schedule</LONG_NAME>
            <CON_ID>2203792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25716</PREFERRED_NAME>
            <LONG_NAME>Visit</LONG_NAME>
            <CON_ID>2202626</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="569">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2537021</PUBLICID>
    <LONGNAME>Malignant Neoplasm Change Lesser Previous Longest Diameter Percentage Value</LONGNAME>
    <PREFERREDNAME>MA_C_L_P_LG_DI_P_VA</PREFERREDNAME>
    <PREFERREDDEFINITION>the difference, as a percentage, between the current and previous smallest sum measurements (nadir) of the longest baseline diameters of tumors composed of atypical neoplastic, often pleomorphic cells that invade other tissues.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2537020</PublicId>
      <PreferredName>MAL_CH_L_PR_LGS_DIAM</PreferredName>
      <PreferredDefinition>information related to the change or alteration in the previous smallest longest diameter of a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.</PreferredDefinition>
      <LongName>Malignant Neoplasm Change Lesser Previous Longest Diameter</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008548</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TUMOR_MSRMTS</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Measurements</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2186369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2537018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>2537018v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Change Lesser Previous Longest Diameter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61422</PREFERRED_NAME>
            <LONG_NAME>Lesser</LONG_NAME>
            <CON_ID>2537013</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25627</PREFERRED_NAME>
            <LONG_NAME>Previous</LONG_NAME>
            <CON_ID>2206349</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25558</PREFERRED_NAME>
            <LONG_NAME>Longest</LONG_NAME>
            <CON_ID>2206293</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25285</PREFERRED_NAME>
            <LONG_NAME>Diameter</LONG_NAME>
            <CON_ID>2203909</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2536993</PublicId>
      <PreferredName>TUM_DIAM_PCTG_VAL</PreferredName>
      <PreferredDefinition>the numeric fraction, or ratio with 100 understood as the denominator, of the change in the diameter of tumor.</PreferredDefinition>
      <LongName>Tumor Diameter Percentage Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008548</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TUMOR_MSRMTS</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Measurements</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>%</DisplayFormat>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Percent change</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Percent change</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Percent change from smallest sum</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Percent change (calculated from nadir)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CITN</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Percent (%) Change from Nadir</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hepatobiliary</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3298577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RECIST</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2831187</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MA_C_L_P_LG_DI_P_VA</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MA_C_L_P_LG_DI_P_VA</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="570">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2538770</PUBLICID>
    <LONGNAME>Cutaneous Melanoma Neoplasm by Morphology Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2534395v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A malignant neoplasm derived from cells that are capable of forming melanin.:definition pending_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2534395</PublicId>
      <PreferredName>2431285v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A malignant neoplasm derived from cells that are capable of forming melanin.:definition pending_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Cutaneous Melanoma Neoplasm by Morphology Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2431285</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3510:C4741</PreferredName>
        <Version>1</Version>
        <LongName>Cutaneous Melanoma Neoplasm by Morphology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3510</PREFERRED_NAME>
            <LONG_NAME>Cutaneous Melanoma</LONG_NAME>
            <CON_ID>2431169</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4741</PREFERRED_NAME>
            <LONG_NAME>Neoplasm by Morphology</LONG_NAME>
            <CON_ID>2431145</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Cutaneous Melanoma Neoplasm by Morphology Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Cutaneous Melanoma Neoplasm by Morphology Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534075</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTISSUE CAE</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.pitt.cabig.cae.domain.cutaneousmelanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812219</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.pitt.cabig.cae.domain.cutaneousmelanoma.CutaneousMelanomaNeoplasmHistologicType.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CutaneousMelanomaNeoplasmHistologicType:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="571">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2539738</PUBLICID>
    <LONGNAME>Organization Created By java.lang.String</LONGNAME>
    <PREFERREDNAME>2539546v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A formal group of people with one or more shared goals._Indicates the person or authoritative body who brought the item into existence._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2539546</PublicId>
      <PreferredName>2407006v1.0:2231611v1.0</PreferredName>
      <PreferredDefinition>A formal group of people with one or more shared goals._Indicates the person or authoritative body who brought the item into existence.</PreferredDefinition>
      <LongName>Organization Created By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2407006</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19711</PreferredName>
        <Version>1</Version>
        <LongName>Organization</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19711</PREFERRED_NAME>
            <LONG_NAME>Professional Organization or Group</LONG_NAME>
            <CON_ID>2202773</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42628</PreferredName>
        <Version>1</Version>
        <LongName>Created By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42628</PREFERRED_NAME>
            <LONG_NAME>Created By</LONG_NAME>
            <CON_ID>2231551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Organization Created By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Organization Created By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813050</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.Organization.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Organization:createdBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.administration.Organization.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>@createdBy</AlternateName>
        <AlternateNameType>GME_XMLLocReference</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="572">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2542217</PUBLICID>
    <LONGNAME>Patient Human Immunodeficiency Virus Risk Category Specify</LONGNAME>
    <PREFERREDNAME>PT_HIV_RISK_CAT_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify the other category of risk group for the Human Immunodeficiency Virus (HIV).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2542213</PublicId>
      <PreferredName>PT_HIV_RISK_CLASS</PreferredName>
      <PreferredDefinition>information related to a patient&#39;s/participant&#39;s Human Immunodeficiency Virus (HIV) risk classification.</PreferredDefinition>
      <LongName>Patient Human Immunodeficiency Virus Risk Classification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2542211</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17102:C14219:C25161</PreferredName>
        <Version>1</Version>
        <LongName>Risk Human Immunodeficiency Virus Classification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17102</PREFERRED_NAME>
            <LONG_NAME>Risk</LONG_NAME>
            <CON_ID>2412275</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14219</PREFERRED_NAME>
            <LONG_NAME>Human Immunodeficiency Virus</LONG_NAME>
            <CON_ID>2202523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25161</PREFERRED_NAME>
            <LONG_NAME>Classification</LONG_NAME>
            <CON_ID>2203879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018806</PublicId>
      <PreferredName>ASSESS_SPEC</PreferredName>
      <PreferredDefinition>The free text field to specify the assessment performed.</PreferredDefinition>
      <LongName>Assessment Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2201036</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Head and Neck SPOREs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck/HIV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2943034</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655968</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HTMCP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HTMCP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000067</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SPOREs</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HHSRISKSP</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="573">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2546335</PUBLICID>
    <LONGNAME>Preoperative Needle Biopsy Performed Date</LONGNAME>
    <PREFERREDNAME>PO_NEDBPS_PERF_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date of the preoperative course of action intended to remove tissue or fluid with a needle for examination under a microscope.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2546305</PublicId>
      <PreferredName>PO_NEDLEBX_PERF</PreferredName>
      <PreferredDefinition>information related to preoperative course of action intended to remove tissue or fluid with a needle for examination under a microscope.</PreferredDefinition>
      <LongName>Preoperative Needle Biopsy Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2546303</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54732:C15190</PreferredName>
        <Version>1</Version>
        <LongName>Preoperative Needle Biopsy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54732</PREFERRED_NAME>
            <LONG_NAME>Preoperative</LONG_NAME>
            <CON_ID>2512567</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15190</PREFERRED_NAME>
            <LONG_NAME>Needle Biopsy</LONG_NAME>
            <CON_ID>2204839</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of biopsy</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of biopsy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="574">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2547753</PUBLICID>
    <LONGNAME>Quality Assurance Person Identifier Name</LONGNAME>
    <PREFERREDNAME>QA_PERS_ID_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>the name of the quality assurance person.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2547752</PublicId>
      <PreferredName>QA_PERS_ID</PreferredName>
      <PreferredDefinition>information related to the identifier of the quality assurance person.</PreferredDefinition>
      <LongName>Quality Assurance Person Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2547750</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15381:C25190</PreferredName>
        <Version>1</Version>
        <LongName>Quality Assurance Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15381</PREFERRED_NAME>
            <LONG_NAME>Quality Assurance</LONG_NAME>
            <CON_ID>2547749</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018284</PublicId>
      <PreferredName>INDS_NAME</PreferredName>
      <PreferredDefinition>The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Individuals Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>QA name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol/Admin.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811961</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="575">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2547906</PUBLICID>
    <LONGNAME>Laboratory Procedure Circulating Tumor Cell Result Count</LONGNAME>
    <PREFERREDNAME>LAB_CTC_RSLT_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>the numeric count of circulating tumor cells per 7.5 milliliter of blood specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2547852</PublicId>
      <PreferredName>LAB_CTC_RSLT</PreferredName>
      <PreferredDefinition>information related to the result of the medical procedure that involves testing a sample of blood for circulating tumor cells, metastatic cancer cells found in a specimen of peripheral blood.</PreferredDefinition>
      <LongName>Laboratory Procedure Circulating Tumor Cell Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63797:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Circulating Tumor Cell Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63797</PREFERRED_NAME>
            <LONG_NAME>Circulating Tumor Cell</LONG_NAME>
            <CON_ID>2547860</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2547918</PublicId>
      <PreferredName>BL_SPEC_CTC_LABP_CT</PreferredName>
      <PreferredDefinition>the numerical count of circluating tumor cell per 7.5 millileters of blood.</PreferredDefinition>
      <LongName>Blood Specimen Circulating Tumor Cell Laboratory Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTC Result #</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CTC Result #</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UC Irvine</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811716</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="576">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2548397</PUBLICID>
    <LONGNAME>Specimen Therapeutic Effect Type</LONGNAME>
    <PREFERREDNAME>SPEC_THER_EFFECT_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Terms to identify evidence of therapeutic effects on a specimen&#39;s histologic findings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014223</PublicId>
      <PreferredName>SPEC_TE</PreferredName>
      <PreferredDefinition>evidence of cancer treatment in the tissue specimen.</PreferredDefinition>
      <LongName>Specimen Therapeutic Effect</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177026</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specimen</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2184343</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Therapeutic Effect</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Effect</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38032</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Effect</LONG_NAME>
            <CON_ID>2203965</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2548395</PublicId>
      <PreferredName>THER_EFFECT_TP</PreferredName>
      <PreferredDefinition>Text terms to represent types of evidence of therapeutic effects.</PreferredDefinition>
      <LongName>Therapeutic Effect Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>24</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38032:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Effect Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38032</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Effect</LONG_NAME>
            <CON_ID>2203965</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No therapeutic effect</VALUEMEANING>
          <MEANINGDESCRIPTION>No therapeutic effect</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apocrine/eosinophilic</VALIDVALUE>
          <VALUEMEANING>Apocrine/eosinophilic effect(s)</VALUEMEANING>
          <MEANINGDESCRIPTION>Apocrine/eosinophilic effect(s)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hystiocytoid</VALIDVALUE>
          <VALUEMEANING>Hystiocytoid effect(s)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hystiocytoid effect(s)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytoplasmic vacuolation</VALIDVALUE>
          <VALUEMEANING>Cytoplasmic vacuolation effect(s)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cytoplasmic vacuolation effect(s)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lobular appearance</VALIDVALUE>
          <VALUEMEANING>Lobular appearance</VALUEMEANING>
          <MEANINGDESCRIPTION>Lobular appearance</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2611612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Evidence of therapeutic effec</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Evidence of therapeutic effects?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What type of therapeutic effects?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If yes, what type of therapeutic effects?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2548333</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>I-SPY</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C911/C1000</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812254</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3461586</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BOLD </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preoperative Elements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3461587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886755</PublicId>
          <ContextName>BOLD</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Preoperative Elements</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preoperative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3902140</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BOLD</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BOLD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="577">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2548495</PUBLICID>
    <LONGNAME>Breast Tumor Pathologic N Stage</LONGNAME>
    <PREFERREDNAME>BRSTCA_PATH_N_STAGE</PREFERREDNAME>
    <PREFERREDDEFINITION>Value to represent the pathologic N (nodal) stage of a breast tumor, as defined by the AJCC Cancer Staging Manual, 6th Ed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189064</PublicId>
      <PreferredName>BRST_TUMOR_P_N</PreferredName>
      <PreferredDefinition>Information related to pathologic N stage of a breast tumor.</PreferredDefinition>
      <LongName>Breast Tumor Pathologic N Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206465</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12971:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Breast Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12971</PREFERRED_NAME>
            <LONG_NAME>Breast</LONG_NAME>
            <CON_ID>2202571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2428379</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25610:C25580</PreferredName>
        <Version>1</Version>
        <LongName>Pathologic N Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25610</PREFERRED_NAME>
            <LONG_NAME>Pathologic</LONG_NAME>
            <CON_ID>2204850</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25580</PREFERRED_NAME>
            <LONG_NAME>N Category</LONG_NAME>
            <CON_ID>2204625</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018464</PublicId>
      <PreferredName>BRST_TUMOR_C_N_ST</PreferredName>
      <PreferredDefinition>the clinical N (nodal) stage of a breast tumor, as defined by the AJCC Cancer Staging Manual, 6th Ed.</PreferredDefinition>
      <LongName>Breast Tumor Clinical N Stage</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184339</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Stage</PreferredName>
        <Version>1</Version>
        <LongName>Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N0</VALIDVALUE>
          <VALUEMEANING>NO REGIONAL LYMPH NODE METASTASIS</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N1</VALIDVALUE>
          <VALUEMEANING>METASTASIS TO MOVABLE IPSILATERAL AXILLARY LYMPH NODE(S)</VALUEMEANING>
          <MEANINGDESCRIPTION>METASTASIS TO MOVABLE IPSILATERAL AXILLARY LYMPH NODE(S)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N2</VALIDVALUE>
          <VALUEMEANING>Metastasis to ipsilateral axillary lymph node(s) fixed or matted, or in clinically apparent* ipsilateral internal mammary nodes in the absence of clinically evident lymph node metastasis</VALUEMEANING>
          <MEANINGDESCRIPTION>Metastasis to ipsilateral axillary lymph node(s) fixed or matted, or in clinically apparent* ipsilateral internal mammary nodes in the absence of clinically evident lymph node metastasis * [Note: Clinically apparent is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination or grossly visible pathologically.]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N3</VALIDVALUE>
          <VALUEMEANING>Metastasis in ipsilateral infraclavicular lymph node(s) with or without axillary lymph node involvement, or in clinically apparent* ipsilateral internal mammary lymph node(s) and in the presence of clinically evident axillary lymph node metastasis; or, me</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer with metastasis in ipsilateral infraclavicular lymph node(s). (from AJCC 6th and 7th Eds.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NX</VALIDVALUE>
          <VALUEMEANING>REGIONAL LYMPH NODES CANNOT BE ASSESSED (E.G., PREVIOUSLY REMOVED)</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73346</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N2a</VALIDVALUE>
          <VALUEMEANING>Metastasis in ipsilateral axillary lymph nodes fixed to one another (matted) or to other structures</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer with metastases in ipsilateral level I, II axillary lymph nodes fixed to one another (matted) or to other structures. (from AJCC 6th and 7th Eds.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N2b</VALIDVALUE>
          <VALUEMEANING>Metastasis only in clinically apparent* ipsilateral internal mammary nodes and in the absence of clinically evident axillary lymph node metastasis</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer with metastases only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident level I, II axillary lymph node metastases.  &quot;Clinically detected&quot; is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination. (from AJCC 7th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N3a</VALIDVALUE>
          <VALUEMEANING>Metastasis in ipsilateral infraclavicular lymph node(s) with or without axillary lymph node involvement, or in clinically apparent* ipsilateral internal mammary lymph node(s) and in the presence of clinically evident axillary lymph node metastasis; or, me</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer with metastasis in ipsilateral infraclavicular lymph node(s). (from AJCC 6th and 7th Eds.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N3b</VALIDVALUE>
          <VALUEMEANING>Metastasis in ipsilateral internal mammary lymph node(s) and axillary lymph node(s)</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer with metastasis in ipsilateral internal mammary lymph node(s) and axillary lymph node(s). (from AJCC 6th and 7th Eds.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N3c</VALIDVALUE>
          <VALUEMEANING>Metastasis in ipsilateral supraclavicular lymph node(s)</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer with metastasis in ipsilateral supraclavicular lymph nodes. (from AJCC 6th and 7th Eds.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N1a</VALIDVALUE>
          <VALUEMEANING>N1a Stage Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastasis in 1 to 3 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm); for cutaneous melanoma it refers to micrometastasis in one regional lymph node; for colorectal cancer it refers to metastasis in one regional lymph node.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48707</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5654386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N1mi</VALIDVALUE>
          <VALUEMEANING>N1mi Stage Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer with micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm) (from AJCC 7th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3202517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N0 (i-)</VALIDVALUE>
          <VALUEMEANING>N0 (i-) Stage Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis histologically, and immunohistochemistry is negative.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95921</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3202525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N0 (i+)</VALIDVALUE>
          <VALUEMEANING>N0 (i+) Stage Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A regional lymph node TNM finding indicating that there are malignant cells in regional lymph node(s) no greater than 0.2 mm and are detected by hematoxylin and eosin stain or immunohistochemistry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95922</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3202524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>yN</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>yN</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2548333</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>I-SPY</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C911/C1000</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812254</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="578">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2552665</PUBLICID>
    <LONGNAME>Form Element Long Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2552493v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A printed or electronic document with spaces to be filled out.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system._Of relatively great or greater than average spatial extension or temporal duration.:The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2552493</PublicId>
      <PreferredName>2539527v1.0:2231601v1.0</PreferredName>
      <PreferredDefinition>A printed or electronic document with spaces to be filled out.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system._Of relatively great or greater than average spatial extension or temporal duration.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Form Element Long Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2539527</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19464:C48792</PreferredName>
        <Version>1</Version>
        <LongName>Form Element</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19464</PREFERRED_NAME>
            <LONG_NAME>Form</LONG_NAME>
            <CON_ID>2202476</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48792</PREFERRED_NAME>
            <LONG_NAME>Element</LONG_NAME>
            <CON_ID>2513271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231601</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25248:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Long Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25248</PREFERRED_NAME>
            <LONG_NAME>Long</LONG_NAME>
            <CON_ID>2206292</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Form Element Long Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Form Element Long Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.FormElement.longName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FormElement:longName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="579">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2552666</PUBLICID>
    <LONGNAME>Form Element Modified By java.lang.String</LONGNAME>
    <PREFERREDNAME>2552494v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A printed or electronic document with spaces to be filled out.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system._Indicates the person or authoritative body who changed an item._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2552494</PublicId>
      <PreferredName>2539527v1.0:2231612v1.0</PreferredName>
      <PreferredDefinition>A printed or electronic document with spaces to be filled out.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system._Indicates the person or authoritative body who changed an item.</PreferredDefinition>
      <LongName>Form Element Modified By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2539527</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19464:C48792</PreferredName>
        <Version>1</Version>
        <LongName>Form Element</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19464</PREFERRED_NAME>
            <LONG_NAME>Form</LONG_NAME>
            <CON_ID>2202476</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48792</PREFERRED_NAME>
            <LONG_NAME>Element</LONG_NAME>
            <CON_ID>2513271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231612</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42629</PreferredName>
        <Version>1</Version>
        <LongName>Modified By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42629</PREFERRED_NAME>
            <LONG_NAME>Modified By</LONG_NAME>
            <CON_ID>2231552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Form Element Modified By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Form Element Modified By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.FormElement.modifiedBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FormElement:modifiedBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="580">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2553361</PUBLICID>
    <LONGNAME>Type Container Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2553219v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A subdivision of a particular kind of thing.:An object that can be used to hold things._The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2553219</PublicId>
      <PreferredName>2553167v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>A subdivision of a particular kind of thing.:An object that can be used to hold things._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Type Container Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2553167</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284:C43186</PreferredName>
        <Version>1</Version>
        <LongName>Type Container</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43186</PREFERRED_NAME>
            <LONG_NAME>Container</LONG_NAME>
            <CON_ID>2513272</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Type Container Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Type Container Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2553133</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812526</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2661745</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_caArray</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000636</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2680967</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000633</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000638</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000639</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.ContainerType.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ContainerType:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="581">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2555586</PUBLICID>
    <LONGNAME>Principal Investigator Birth Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2555510v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An investigator who is responsible for all aspects of the conduct of a study._The event of being born.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2555510</PublicId>
      <PreferredName>2436717v1.0:2475284v1.0</PreferredName>
      <PreferredDefinition>An investigator who is responsible for all aspects of the conduct of a study._The event of being born.:The particular day, month and year an event has happened or will happen._An investigator who is responsible for all aspects of the conduct of a study.</PreferredDefinition>
      <LongName>Principal Investigator Birth Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2436717</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19924</PreferredName>
        <Version>1</Version>
        <LongName>Principal Investigator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19924</PREFERRED_NAME>
            <LONG_NAME>Principal Investigator</LONG_NAME>
            <CON_ID>2202387</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2475284</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25155:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Birth Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25155</PREFERRED_NAME>
            <LONG_NAME>Birth</LONG_NAME>
            <CON_ID>2202896</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Principal Investigator Birth Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Principal Investigator Birth Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Investigator:dateOfBirth</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.labhub.domain.Investigator.dateOfBirth</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="582">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2608119</PUBLICID>
    <LONGNAME>Qualitative Evaluation Numeric Pain Scale Score java.lang.Long</LONGNAME>
    <PREFERREDNAME>2607744v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A type of evaluation that is primarily descriptive and interpretative, and may or may not lend itself to quantification. Mainly concerned with the properties, the state, and the character (i.e., the nature) of phenomena. It implies an emphasis on processes and meanings that are rigorously examined, but not measured in terms of quantity, amount, or frequency. (www.unfpa.org/monitoring/toolkit/glossary.pdf and Nonprofit Good Practice Guide Glossary)_A pain rating scale that attempts objectivity by reliance on a person&#39;s ability to rate pain on a scale of 0 to 5, 10, or 100, where the lowest number in the scale represents no pain and the highest number represents the worst imaginable pain.:A number or range of numeric values measuring performance, function, quality, or ability._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2607744</PublicId>
      <PreferredName>2607684v1.0:2607538v1.0</PreferredName>
      <PreferredDefinition>A type of evaluation that is primarily descriptive and interpretative, and may or may not lend itself to quantification. Mainly concerned with the properties, the state, and the character (i.e., the nature) of phenomena. It implies an emphasis on processes and meanings that are rigorously examined, but not measured in terms of quantity, amount, or frequency. (www.unfpa.org/monitoring/toolkit/glossary.pdf and Nonprofit Good Practice Guide Glossary)_A pain rating scale that attempts objectivity by reliance on a person&#39;s ability to rate pain on a scale of 0 to 5, 10, or 100, where the lowest number in the scale represents no pain and the highest number represents the worst imaginable pain.:A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Qualitative Evaluation Numeric Pain Scale Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2607684</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49143</PreferredName>
        <Version>1</Version>
        <LongName>Qualitative Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49143</PREFERRED_NAME>
            <LONG_NAME>Qualitative Evaluation</LONG_NAME>
            <CON_ID>2607495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607538</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21082:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Numeric Pain Scale Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21082</PREFERRED_NAME>
            <LONG_NAME>Numeric Pain Scale</LONG_NAME>
            <CON_ID>2607498</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Qualitative Evaluation Numeric Pain Scale Score java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Qualitative Evaluation Numeric Pain Scale Score java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2724612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTODS</PreferredName>
          <Version>0.53</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ctom.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QualitativeEvaluation:painIndexCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.QualitativeEvaluation.painIndexCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="583">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2608395</PUBLICID>
    <LONGNAME>Healthcare Facility Site Postal Code java.lang.String</LONGNAME>
    <PREFERREDNAME>2608012v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The buildings and organizations where healthcare services are provided.:A position in relation to its surroundings._Any system designed to expedite the sorting and delivery of mail by assigning a series of alphanumeric codes to each delivery area.  Also used to refer to any individual delivery area code._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2608012</PublicId>
      <PreferredName>2607685v1.0:2523439v1.0</PreferredName>
      <PreferredDefinition>The buildings and organizations where healthcare services are provided.:A position in relation to its surroundings._Any system designed to expedite the sorting and delivery of mail by assigning a series of alphanumeric codes to each delivery area.  Also used to refer to any individual delivery area code.</PreferredDefinition>
      <LongName>Healthcare Facility Site Postal Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2607685</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21541:C37901</PreferredName>
        <Version>1</Version>
        <LongName>Healthcare Facility Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21541</PREFERRED_NAME>
            <LONG_NAME>Healthcare Facility</LONG_NAME>
            <CON_ID>2202668</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37901</PREFERRED_NAME>
            <LONG_NAME>Site</LONG_NAME>
            <CON_ID>2202394</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2523439</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25621</PreferredName>
        <Version>1</Version>
        <LongName>Postal Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25621</PREFERRED_NAME>
            <LONG_NAME>Postal Code</LONG_NAME>
            <CON_ID>2202573</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Healthcare Facility Site Postal Code java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Healthcare Facility Site Postal Code java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2724612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTODS</PreferredName>
          <Version>0.53</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ctom.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.HealthcareSite.postalCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HealthcareSite:postalCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="584">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2613553</PUBLICID>
    <LONGNAME>Report Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2521556v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Report; a short account._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2521556</PublicId>
      <PreferredName>2430912v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Report; a short account._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Report Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2430912</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25375</PreferredName>
        <Version>1</Version>
        <LongName>Report</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Report Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Report Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Report:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calab.domain.Report.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.report.Report.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="585">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2627508</PUBLICID>
    <LONGNAME>New Lesion Cancer Progression Diagnosis Date</LONGNAME>
    <PREFERREDNAME>N_LES_CPROG_DIA_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date on which an observation was made or an event occurred related to the diagnosis of a new lesion as the worsening of a cancer over time.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2626389</PublicId>
      <PreferredName>NEW_LES_CPRO_DX</PreferredName>
      <PreferredDefinition>information relating to the diagnosis of a new lesion as the worsening of a cancer over time.</PreferredDefinition>
      <LongName>New Lesion Cancer Progression Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206397</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25586:C3824</PreferredName>
        <Version>1</Version>
        <LongName>New Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25586</PREFERRED_NAME>
            <LONG_NAME>New</LONG_NAME>
            <CON_ID>2204982</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2626387</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19987:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Cancer Progression Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19987</PREFERRED_NAME>
            <LONG_NAME>Cancer Progression</LONG_NAME>
            <CON_ID>2552423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Record the date of appearance</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Record the date of appearance</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2670694</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Relapse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma Relapse</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812926</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2670694</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Relapse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Solid Tumor Relapse</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812928</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="586">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2641868</PUBLICID>
    <LONGNAME>Material Source Life Sciences Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2640494v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The tangible substance that goes into the makeup of a physical object.:Where something is available or from where it originates._The Life Sciences Identifier (LSID) is an I3C and OMG Life Sciences Research (LSR) Uniform Resource Name (URN) specification. The LSID concept introduces a straightforward approach to naming and identifying data resources stored in multiple, distributed data stores in a manner that overcomes the limitations of naming schemes in use today. By defining a simple, common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources, LSID provides a naming standard underpinning for wide-area science and interoperability. (from W3C)_Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2640494</PublicId>
      <PreferredName>2640425v1.0:2425540v1.0</PreferredName>
      <PreferredDefinition>The tangible substance that goes into the makeup of a physical object.:Where something is available or from where it originates._The Life Sciences Identifier (LSID) is an I3C and OMG Life Sciences Research (LSR) Uniform Resource Name (URN) specification. The LSID concept introduces a straightforward approach to naming and identifying data resources stored in multiple, distributed data stores in a manner that overcomes the limitations of naming schemes in use today. By defining a simple, common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources, LSID provides a naming standard underpinning for wide-area science and interoperability. (from W3C)</PreferredDefinition>
      <LongName>Material Source Life Sciences Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2640425</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48187:C25683</PreferredName>
        <Version>1</Version>
        <LongName>Material Source</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48187</PREFERRED_NAME>
            <LONG_NAME>Material</LONG_NAME>
            <CON_ID>2514541</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25683</PREFERRED_NAME>
            <LONG_NAME>Source</LONG_NAME>
            <CON_ID>2202479</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2425540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47841</PreferredName>
        <Version>1</Version>
        <LongName>Life Sciences Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47841</PREFERRED_NAME>
            <LONG_NAME>Life Sciences Identifier</LONG_NAME>
            <CON_ID>2423426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Material Source Life Sciences Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Material Source Life Sciences Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2640373</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LabKey CPAS Client API</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.labkey.cpas.client</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.labkey.cpas.client.MaterialSource.lsid</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MaterialSource:lsid</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="587">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2644401</PUBLICID>
    <LONGNAME>Person Vital Signs Temperature Physical Examination Value</LONGNAME>
    <PREFERREDNAME>P_VS_BT_PHYSEXM_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>The numeric value of a person&#39;s body temperature.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2639347</PublicId>
      <PreferredName>P_VITLSIN_BT_PHYEXM</PreferredName>
      <PreferredDefinition>information relating to physical examination (a systemic evaluation of the body and its functions using visual inspection, palpation, percussion, and auscultation, aimed to determine the presence or absence of physical signs of disease or abnormality for individual&#39;s health assessment) of a person&#39;s body temperature.</PreferredDefinition>
      <LongName>Person Vital Signs Temperature Physical Examination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2956871</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49672:C25206:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Vital Signs Test Name Temperature Physical Examination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49672</PREFERRED_NAME>
            <LONG_NAME>Vital Signs Measurement</LONG_NAME>
            <CON_ID>2451562</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25206</PREFERRED_NAME>
            <LONG_NAME>Temperature</LONG_NAME>
            <CON_ID>2202772</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2644404</PublicId>
      <PreferredName>BT_VAL</PreferredName>
      <PreferredDefinition>the value for the body temperature of a person.</PreferredDefinition>
      <LongName>Body Temperature Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>999.9</DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AMC CRF:AIDS Malignancy Consortium Case Report Form</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Body Temperature</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Body Temperature</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NINDS CDE Project</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>NINDS CDE Project</DocumentText>
        <URL>http://www.commondataelements.ninds.nih.gov/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NICHD Newborn Exam Question</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Newborn Vital Sign Temperature Value</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Body temperature</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Temperature</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>GTEx - Core Body Temperature (if can be obtained)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Core Body Temperature (if can be obtained)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Temperature in Celsius</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Temperature</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Temp</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Temperature in celsuis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP CRF TEXT 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Evening Temperature</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Temperature:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Temperature (Fahrenheit)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Candidate Reuse</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2992453</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vital Signs CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2956217</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sickle Cell Disease Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4809631</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3194026</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>KAI Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812550</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3194026</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>KAI Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vital Signs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000073</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3335728</PublicId>
          <ContextName>ABTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocols</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ABTC 0904</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3335732</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3685569</PublicId>
          <ContextName>NICHD</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Newborn Examination</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical Examination</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000329</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2012-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3694151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896537</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896538</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4111771</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4188651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261112</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2013-01-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528054</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528056</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-04-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280811</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280813</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280814</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-04</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280815</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280816</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5416571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5441476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5592146</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5598962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5612586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-07-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889176</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2017-09-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889179</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889180</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889187</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2017-09-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5981652</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6005698</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6046252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229O</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104892</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0286B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104901</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104930</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104941</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000275</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000276</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000705</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GTEx - Postmortem Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Recovery Case Report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736405</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vital Signs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000272</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Assessments and Examinations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3139477</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vital Signs and Other Body Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3139479</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vital Signs, Weight and Height</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3139481</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vital Signs-Pediatrics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3151142</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vital Signs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000074</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Assessments and Examinations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000640</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vital Signs and Other Body Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000701</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NICHD</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NICHD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NICHD</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Newborn Vital Sign Temperature Value</AlternateName>
        <AlternateNameType>NICHD Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>P_VS_BT_PHYSEXM_NUM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>P_VS_BT_PHYSEXM_NUM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ABTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ABTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SWOG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TEMP</AlternateName>
        <AlternateNameType>OID, SWOG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>P_VS_BT_PHYSEXM_NUM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BBRB</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BBRB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCI Standards</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCIP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Temperature</AlternateName>
        <AlternateNameType>NINDS Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="588">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2645563</PUBLICID>
    <LONGNAME>Laboratory Procedure Result Status</LONGNAME>
    <PREFERREDNAME>LAB_RSLT_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>the status of a blood lab assessment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013600</PublicId>
      <PreferredName>BL_SPEC_LABPROC</PreferredName>
      <PreferredDefinition>the result of the medical procedure that involves testing a sample of blood to determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time.</PreferredDefinition>
      <LongName>Laboratory Procedure Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2224045</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20200</PreferredName>
        <Version>1</Version>
        <LongName>Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2225337</PublicId>
      <PreferredName>LAB_ASSESS_STAT</PreferredName>
      <PreferredDefinition>the status of a lab assessment.</PreferredDefinition>
      <LongName>Lab Assessment Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength>6</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>NOT DONE</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&gt; normal</VALIDVALUE>
          <VALUEMEANING>&gt; normal</VALUEMEANING>
          <MEANINGDESCRIPTION>&gt; normal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&lt; normal</VALIDVALUE>
          <VALUEMEANING>&lt; normal</VALUEMEANING>
          <MEANINGDESCRIPTION>&lt; normal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating from the norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Within normal limits</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal, eligibility not affected</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating from the norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal, not eligible</VALIDVALUE>
          <VALUEMEANING>ABNORMAL NOT ELIGIBLE</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal and no longer eligible</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal - Clinically significant</VALIDVALUE>
          <VALUEMEANING>Abnormal - Clinically significant</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal - Clinically significant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2645499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal - Not clinically significant</VALIDVALUE>
          <VALUEMEANING>Abnormal - Not clinically significant</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal - Not clinically significant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2645498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&gt;= ULN</VALIDVALUE>
          <VALUEMEANING>&gt;= Upper limit of institutional normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Value is greater or equal to upper limit of institutional normal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3392242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&lt; ULN</VALIDVALUE>
          <VALUEMEANING>Less than upper limit of institutional normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Value is less than upper limit of institutional normal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3392243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trace</VALIDVALUE>
          <VALUEMEANING>Trace</VALUEMEANING>
          <MEANINGDESCRIPTION>A barely detectable amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2912071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Undetectable</VALIDVALUE>
          <VALUEMEANING>Undetectable</VALUEMEANING>
          <MEANINGDESCRIPTION>Undetectable</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&gt;</VALIDVALUE>
          <VALUEMEANING>Greater than (&gt;)</VALUEMEANING>
          <MEANINGDESCRIPTION>Greater than (&gt;)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581799</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&lt;</VALIDVALUE>
          <VALUEMEANING>Less Than</VALUEMEANING>
          <MEANINGDESCRIPTION>Less Than</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2840098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5042698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Equivocal</VALIDVALUE>
          <VALUEMEANING>Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Open to question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5178198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&lt;= ULN</VALIDVALUE>
          <VALUEMEANING>Less Than or Equal To Upper Limit of Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.: The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25706, C61586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6013658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&gt;ULN</VALIDVALUE>
          <VALUEMEANING>Greater Than Upper Limit of Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25706, C61584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6013657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>=</VALIDVALUE>
          <VALUEMEANING>Equality</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being the same in quantity or measure or value or status.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61582</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3423503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Result</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Result</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lab Values</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Result Status</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Result Status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Report Value</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG - MA39</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Interpretation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Value qualifier</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0534</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171063</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0815</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_RSLT_STAT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCTG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBVALQUAL_TUMK</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="589">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2646513</PUBLICID>
    <LONGNAME>Kaposi Sarcoma Related Edema Present Ind-2</LONGNAME>
    <PREFERREDNAME>KS_R/T_ED_PRES_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether Kaposi Sarcoma related edema is present.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2640464</PublicId>
      <PreferredName>KS_R/T_EDEMA_PRES</PreferredName>
      <PreferredDefinition>information relating to the presence of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) related edema (pathological transudate within one or more tissues).</PreferredDefinition>
      <LongName>Kaposi Sarcoma Related Edema Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2640430</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9087:C25648:C3002</PreferredName>
        <Version>1</Version>
        <LongName>Kaposi Sarcoma Related Edema</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9087</PREFERRED_NAME>
            <LONG_NAME>Kaposi Sarcoma</LONG_NAME>
            <CON_ID>2637488</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3002</PREFERRED_NAME>
            <LONG_NAME>Edema</LONG_NAME>
            <CON_ID>2202735</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Edema Present</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Edema Present</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have edema beyond trace edema?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>KS_REL_ED_PRES_IND2</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QSYN_QSLOC2</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QSYN_QSLOC1</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="590">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2656739</PUBLICID>
    <LONGNAME>Single Malignant Neoplasm Size Indicator</LONGNAME>
    <PREFERREDNAME>SNGL_MALNEO_SZ_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the indicator relating to whether the participant has a single focus of disease that measures &lt;10 cm.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2656728</PublicId>
      <PreferredName>SINGLE_MALIGNEO_SZ</PreferredName>
      <PreferredDefinition>information relating to the size of a single malignant neoplasm.</PreferredDefinition>
      <LongName>Single Malignant Neoplasm Size</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008548</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TUMOR_MSRMTS</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Measurements</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2656721</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48440:C9305</PreferredName>
        <Version>1</Version>
        <LongName>Single Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48440</PREFERRED_NAME>
            <LONG_NAME>Single</LONG_NAME>
            <CON_ID>2413378</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2224066</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25681</PreferredName>
        <Version>1</Version>
        <LongName>Size</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25681</PREFERRED_NAME>
            <LONG_NAME>Size</LONG_NAME>
            <CON_ID>2203799</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2390702</PublicId>
      <PreferredName>TUM_PRES_IND</PreferredName>
      <PreferredDefinition>the indicator whether a neoplasm was present.</PreferredDefinition>
      <LongName>Tumor Present Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>12</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not operated</VALIDVALUE>
          <VALUEMEANING>Not operated</VALUEMEANING>
          <MEANINGDESCRIPTION>Not operated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574766</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does the participant have a s</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does the participant have a single focus of disease that measures &lt;10 cm</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="591">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2660034</PUBLICID>
    <LONGNAME>Clinical Trial Subject Identifier 64 Character Text</LONGNAME>
    <PREFERREDNAME>CT_SUBJ_ID_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>The assigned identifier for the patient as a clinical trial subject.  [Standard-based]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DICOM:Digital Imaging and Communications in Medicine</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2648246</PublicId>
      <PreferredName>CLIN_TRIAL_SUBJ_ID</PreferredName>
      <PreferredDefinition>One or more characters used to identify, name, or characterize a person that is analyzed, examined, investigated, experimented upon, treated in the course of a research study, also called a clinical study.  [Manually-curated]</PreferredDefinition>
      <LongName>Clinical Trial Subject Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2814109</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71104:C41189</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Study Subject</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71104</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial</LONG_NAME>
            <CON_ID>2735720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41189</PREFERRED_NAME>
            <LONG_NAME>Study Subject</LONG_NAME>
            <CON_ID>2202706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2584117</PublicId>
      <PreferredName>2584117v1.0</PreferredName>
      <PreferredDefinition>LO: A 64-character string with leading or trailing spaces being non-significant; NO CONTROL characters. [Standard-based]</PreferredDefinition>
      <LongName>64 Character Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>64</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
      <Representation>
        <PublicId>2637360</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45253:C25704</PreferredName>
        <Version>1</Version>
        <LongName>String Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45253</PREFERRED_NAME>
            <LONG_NAME>String</LONG_NAME>
            <CON_ID>2539471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Clinical Trial Subject ID</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Clinical Trial Subject ID</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>2007 DICOM Standard</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>2007 DICOM Standard - Sections 3, 5 &amp; 6</DocumentText>
        <URL>http://medical.nema.org/dicom/2007/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DICOM Tag CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812790</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review - NCIA DICOM CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812828</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2693115</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA_Model</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ncia.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000239</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2944977</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NBIA</PreferredName>
          <Version>5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ncia.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000240</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Clinical Trial Subject ID</AlternateName>
        <AlternateNameType>DICOM Attribute Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>(0012,0040)</AlternateName>
        <AlternateNameType>DICOM_TAG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ncia.domain.ClinicalTrialSubject.subjectId</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ClinicalTrialSubject:subjectId</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ncia.domain.ClinicalTrialSubject.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ClinicalTrialSubject:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="592">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2669204</PUBLICID>
    <LONGNAME>Adverse Event Complicating Viral Infection Specify</LONGNAME>
    <PREFERREDNAME>AE_CM_VIR_INFEC_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify the other complicating viral infection.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2669017</PublicId>
      <PreferredName>AE_CM_VIRAL_INFEC</PreferredName>
      <PreferredDefinition>information relating to a complicating (making more complex or intricate) viral (having to do with a virus) infection as an adverse event.</PreferredDefinition>
      <LongName>Adverse Event Complicating Viral Infection</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2235992</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2669015</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25455:C27985:C26726</PreferredName>
        <Version>1</Version>
        <LongName>Complicating Viral Infection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25455</PREFERRED_NAME>
            <LONG_NAME>Complicating</LONG_NAME>
            <CON_ID>2206180</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C27985</PREFERRED_NAME>
            <LONG_NAME>Viral</LONG_NAME>
            <CON_ID>2205414</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26726</PREFERRED_NAME>
            <LONG_NAME>Infectious Disorder</LONG_NAME>
            <CON_ID>2203837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018370</PublicId>
      <PreferredName>AE_SPEC</PreferredName>
      <PreferredDefinition>the free text field to specify an adverse event.</PreferredDefinition>
      <LongName>Adverse Event Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="593">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2669669</PUBLICID>
    <LONGNAME>Data Unit Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2669514v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.:A single undivided thing occurring in the composition of something else._The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2669514</PublicId>
      <PreferredName>2669389v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.:A single undivided thing occurring in the composition of something else._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Data Unit Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2669389</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25474:C44278</PreferredName>
        <Version>1</Version>
        <LongName>Data Unit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44278</PREFERRED_NAME>
            <LONG_NAME>Unit</LONG_NAME>
            <CON_ID>2236581</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Data Unit Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Data Unit Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614836</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Generic Image</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ivi.genericimage</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Chunk:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ivi.genericimage.Chunk.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="594">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2669702</PUBLICID>
    <LONGNAME>Region Minimum Z-Dimension java.lang.Double</LONGNAME>
    <PREFERREDNAME>2669547v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An area or portion of something with more or less definite boundaries designed or specified according to some established biological, administrative, economic, demographic, etc. criteria._The smallest possible quantity.:The magnitude of something in a third direction, generally representing depth._Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2669547</PublicId>
      <PreferredName>2669394v1.0:2669379v1.0</PreferredName>
      <PreferredDefinition>An area or portion of something with more or less definite boundaries designed or specified according to some established biological, administrative, economic, demographic, etc. criteria._The smallest possible quantity.:The magnitude of something in a third direction, generally representing depth.</PreferredDefinition>
      <LongName>Region Minimum Z-Dimension</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2669394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41129</PreferredName>
        <Version>1</Version>
        <LongName>Region</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41129</PREFERRED_NAME>
            <LONG_NAME>Region</LONG_NAME>
            <CON_ID>2422333</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2669379</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25570:C49150</PreferredName>
        <Version>1</Version>
        <LongName>Minimum Z-Dimension</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25570</PREFERRED_NAME>
            <LONG_NAME>Minimum</LONG_NAME>
            <CON_ID>2206306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49150</PREFERRED_NAME>
            <LONG_NAME>Z-Dimension</LONG_NAME>
            <CON_ID>2607509</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Region Minimum Z-Dimension java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Region Minimum Z-Dimension java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614836</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Generic Image</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ivi.genericimage</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Tile:minimumZ</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ivi.genericimage.Tile.minimumZ</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="595">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2670595</PUBLICID>
    <LONGNAME>Stem Cell Mobilization Therapy Administered Projected Begin Date</LONGNAME>
    <PREFERREDNAME>STMT_ADM_PR_BEG_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>The month, day and year of the stem cell mobilization therapy administration projected start date.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Transplant CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2670594</PublicId>
      <PreferredName>SCMT_ADM</PreferredName>
      <PreferredDefinition>information related to the administration of therapy to cause release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of collection. Hematopoietic growth factors or chemotherapeutic agents often are used to stimulate the mobilization.</PreferredDefinition>
      <LongName>Stem Cell Mobilization Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2670592</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62604</PreferredName>
        <Version>1</Version>
        <LongName>Stem Cell Mobilization Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62604</PREFERRED_NAME>
            <LONG_NAME>Stem Cell Mobilization Therapy</LONG_NAME>
            <CON_ID>2521765</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016226</PublicId>
      <PreferredName>PROJ_BEG_DT</PreferredName>
      <PreferredDefinition>The estimated or predicted start date of an event.</PreferredDefinition>
      <LongName>Projected Begin Date</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2670036</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25631:C25431:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Projected Begin Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25631</PREFERRED_NAME>
            <LONG_NAME>Projected</LONG_NAME>
            <CON_ID>2206353</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Projected Start Date of Mobil</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Projected Start Date of Mobilization Therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Start date of mobilization therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="596">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2672079</PUBLICID>
    <LONGNAME>Protein Group Entity Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2671788v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.:Any number of entities (members) considered as a unit.:An independently existing thing (living or nonliving)._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2671788</PublicId>
      <PreferredName>2671646v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.:Any number of entities (members) considered as a unit.:An independently existing thing (living or nonliving)._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Protein Group Entity Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2671646</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17021:C43359:C51070</PreferredName>
        <Version>1</Version>
        <LongName>Protein Group Entity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17021</PREFERRED_NAME>
            <LONG_NAME>Protein</LONG_NAME>
            <CON_ID>2202792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43359</PREFERRED_NAME>
            <LONG_NAME>Group</LONG_NAME>
            <CON_ID>2236516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Protein Group Entity Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Protein Group Entity Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2640373</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LabKey CPAS Client API</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.labkey.cpas.client</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.labkey.cpas.client.ProteinGroupMembers.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProteinGroupMembers:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="597">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2672245</PUBLICID>
    <LONGNAME>Comet Scoring Engine Score Group Peptide Protein Sequence java.lang.String</LONGNAME>
    <PREFERREDNAME>2671886v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A private scoring engine developed by the Fred Hutchinson Cancer Research Institute that can match tandem mass spectra with peptide sequences.:A number or range of numeric values measuring performance, function, quality, or ability.:Any number of entities (members) considered as a unit._A compound of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another. Peptides are smaller than proteins and the dividing line is around 50 amino acids.:The sequence of amino acids along a polypeptide chain._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2671886</PublicId>
      <PreferredName>2671633v1.0:2671571v1.0</PreferredName>
      <PreferredDefinition>A private scoring engine developed by the Fred Hutchinson Cancer Research Institute that can match tandem mass spectra with peptide sequences.:A number or range of numeric values measuring performance, function, quality, or ability.:Any number of entities (members) considered as a unit._A compound of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another. Peptides are smaller than proteins and the dividing line is around 50 amino acids.:The sequence of amino acids along a polypeptide chain.</PreferredDefinition>
      <LongName>Comet Scoring Engine Score Group Peptide Protein Sequence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2671633</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68827:C25338:C43359</PreferredName>
        <Version>1</Version>
        <LongName>Comet Scoring Engine Score Group</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68827</PREFERRED_NAME>
            <LONG_NAME>Comet Scoring Engine</LONG_NAME>
            <CON_ID>2671500</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43359</PREFERRED_NAME>
            <LONG_NAME>Group</LONG_NAME>
            <CON_ID>2236516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2671571</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C735:C13187</PreferredName>
        <Version>1</Version>
        <LongName>Peptide Protein Sequence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C735</PREFERRED_NAME>
            <LONG_NAME>Peptide</LONG_NAME>
            <CON_ID>2342173</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13187</PREFERRED_NAME>
            <LONG_NAME>Amino Acid Sequence</LONG_NAME>
            <CON_ID>2223225</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Comet Scoring Engine Score Group Peptide Protein Sequence java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Comet Scoring Engine Score Group Peptide Protein Sequence java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2640373</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LabKey CPAS Client API</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.labkey.cpas.client</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.labkey.cpas.client.CometScores.peptide</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CometScores:peptide</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="598">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2677770</PUBLICID>
    <LONGNAME>Enumerated Value Domain Administered Item Data Type Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2677507v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Individually specified; expressed as a list.:A set of permissible values for a data element.:A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_An indication of the form that a value will have.  Examples include string, integer, and character.:A written or verbal account, representation, statement, or explanation of something._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2677507</PublicId>
      <PreferredName>2231687v1.0:2677371v1.0</PreferredName>
      <PreferredDefinition>Individually specified; expressed as a list.:A set of permissible values for a data element.:A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_An indication of the form that a value will have.  Examples include string, integer, and character.:A written or verbal account, representation, statement, or explanation of something.</PreferredDefinition>
      <LongName>Enumerated Value Domain Administered Item Data Type Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2231687</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45674:C42748:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Enumerated Value Domain Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45674</PREFERRED_NAME>
            <LONG_NAME>Enumeration</LONG_NAME>
            <CON_ID>2231597</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42748</PREFERRED_NAME>
            <LONG_NAME>Value Domain</LONG_NAME>
            <CON_ID>2231559</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2677371</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42645:C25365</PreferredName>
        <Version>1</Version>
        <LongName>Data Type Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42645</PREFERRED_NAME>
            <LONG_NAME>Data Type</LONG_NAME>
            <CON_ID>2231560</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Enumerated Value Domain Administered Item Data Type Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Enumerated Value Domain Administered Item Data Type Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EnumeratedValueDomain:datatypeDescription</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.EnumeratedValueDomain.datatypeDescription</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="599">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2678484</PUBLICID>
    <LONGNAME>Scientific Control Gene 5&#39; Region Signal java.lang.Double</LONGNAME>
    <PREFERREDNAME>2678247v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Methodology that testts integrity in experiments by isolating variables as dictated by the scientific method in order to make a conclusion about such variables. In a controlled experiment, two virtually identical experiments are conducted, but the factor being tested is varied in only one of them. This serves to isolate any causal phenomena.:A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product._Sequences immediately preceding a point of interest.:A detectable physical quantity or impulse (e.g., voltage, current, or magnetic field strength)._Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2678247</PublicId>
      <PreferredName>2678104v1.0:2678022v1.0</PreferredName>
      <PreferredDefinition>Methodology that testts integrity in experiments by isolating variables as dictated by the scientific method in order to make a conclusion about such variables. In a controlled experiment, two virtually identical experiments are conducted, but the factor being tested is varied in only one of them. This serves to isolate any causal phenomena.:A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product._Sequences immediately preceding a point of interest.:A detectable physical quantity or impulse (e.g., voltage, current, or magnetic field strength).</PreferredDefinition>
      <LongName>Scientific Control Gene 5&#39; Region Signal</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2678104</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C64355:C16612</PreferredName>
        <Version>1</Version>
        <LongName>Scientific Control Gene</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64355</PREFERRED_NAME>
            <LONG_NAME>Scientific Control</LONG_NAME>
            <CON_ID>2677935</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16612</PREFERRED_NAME>
            <LONG_NAME>Gene</LONG_NAME>
            <CON_ID>2202483</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2678022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63581:C43382</PreferredName>
        <Version>1</Version>
        <LongName>5&#39; Region Signal</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63581</PREFERRED_NAME>
            <LONG_NAME>5&#39; Region</LONG_NAME>
            <CON_ID>2611733</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43382</PREFERRED_NAME>
            <LONG_NAME>Signal</LONG_NAME>
            <CON_ID>2236605</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Scientific Control Gene 5&#39; Region Signal java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Scientific Control Gene 5&#39; Region Signal java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2677906</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CoCaNUT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.princeton.cocanut.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.princeton.cocanut.domain.ControlGenes.signal5PrimeEnd</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ControlGenes:signal5PrimeEnd</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="600">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2685355</PUBLICID>
    <LONGNAME>Hospital Specific Patient Identifier</LONGNAME>
    <PREFERREDNAME>2685353v1.0:2645021v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Provides a unique identifier for the patient consisting of the year in which the patient was first seen at the reporting facility and the consecutive order in which the patient was abstracted.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2685353</PublicId>
      <PreferredName>2685312v1.0:2685351v1.0</PreferredName>
      <PreferredDefinition>Unique identifier for the patient consisting of the year in which the patient was first seen at the reporting facility and the consecutive order in which the patient was abstracted.</PreferredDefinition>
      <LongName>Hospital Specific Patient</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008555</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MED_RCD_AND_FORMS</PreferredName>
        <Version>1</Version>
        <LongName>Medical Records and Forms</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2685312</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16696:C38024</PreferredName>
        <Version>1</Version>
        <LongName>Hospital Specified</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16696</PREFERRED_NAME>
            <LONG_NAME>Hospital</LONG_NAME>
            <CON_ID>2202656</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38024</PREFERRED_NAME>
            <LONG_NAME>Specified</LONG_NAME>
            <CON_ID>2211671</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2685351</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2645021</PublicId>
      <PreferredName>2645021v1.0</PreferredName>
      <PreferredDefinition>A person who requires medical care._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Patient Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>9</MaximumLength>
      <MinimumLength>9</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
      <Representation>
        <PublicId>2645020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Patient Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Accession Number Hospital</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Accession Number Hospital</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR, V 11.1 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.1 Data Standards and Data Dictionary (5/4/06)</DocumentText>
        <URL>http://www.naaccr.org/filesystem/pdf/Volume%20II%20Version%2011.1.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Accession Number--Hosp Description</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>The first four numbers specify the year and the last five numbers are the numeric order in which the patient was  entered into the registry database. Within a registry, all primaries for an individual must have the same accession number. The first four digits must be greater than or equal to 1944.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Exceptions</Name>
        <DocumentType>NOTE</DocumentType>
        <DocumentText>There may be some variations in this formatting depending on the business rules of a particular repository.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.2 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.2 Data Standards and Data Dictionary (5/30/2007)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=PQdlAnykU1U%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.3 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.3 Data Standards and Data Dictionary (4/2008)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=xSH32ZzIzGI%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 12.1, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&amp;tabid=133&amp;mid=473</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 16, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)</DocumentText>
        <URL>https://www.naaccr.org/data-standards-data-dictionary/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 12.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3134707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899833</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HospitalSpecific16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899839</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464305</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HospitalSpecific18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464313</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>550</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ACCESSION NUMBER--HOSP</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HOSP_SPEC_PT_ID</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Accession Number (CoC)</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Accession Number--Hosp</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="601">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2698024</PUBLICID>
    <LONGNAME>Edit Over-ride Surveillance, Epidemiology, and End Results Program Coding System Current Number Code</LONGNAME>
    <PREFERREDNAME>2698022v1.0:2656693v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>This shows the SEER coding system best describing the majority of SEER items as they are in the record (after conversion).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2698022</PublicId>
      <PreferredName>2695315v1.0:2698020v1.0</PreferredName>
      <PreferredDefinition>The SEER coding system best describing the majority of SEER items.</PreferredDefinition>
      <LongName>Edit Overr-ide Surveillance, Epidemiology, and End Results Program Coding System Current</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008576</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DATA_SOURCE</PreferredName>
        <Version>1</Version>
        <LongName>Data Source</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2695315</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42682:C67529</PreferredName>
        <Version>1</Version>
        <LongName>Edit Action Override</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42682</PREFERRED_NAME>
            <LONG_NAME>Edit Action</LONG_NAME>
            <CON_ID>2222833</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67529</PREFERRED_NAME>
            <LONG_NAME>Override</LONG_NAME>
            <CON_ID>2653013</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2698020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15432:C45971:C25700:C25471</PreferredName>
        <Version>1</Version>
        <LongName>Surveillance, Epidemiology, and End Results Program Coding System Current</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15432</PREFERRED_NAME>
            <LONG_NAME>Surveillance, Epidemiology, and End Results Program</LONG_NAME>
            <CON_ID>2554150</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45971</PREFERRED_NAME>
            <LONG_NAME>Coding</LONG_NAME>
            <CON_ID>2492757</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25700</PREFERRED_NAME>
            <LONG_NAME>System</LONG_NAME>
            <CON_ID>2202584</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2656693</PublicId>
      <PreferredName>2656693v1.0</PreferredName>
      <PreferredDefinition>A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From a brochure of the National Cancer Institute, NIH Publication No. 91-3074, October 1990)_The activity of implementing rules that are used to map the elements of one set onto the elements of another set, usually on a one-to-one basis. (from Wikipedia)_a group of independent but interrelated elements comprising a unified whole._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Surveillance, Epidemiology, and End Results Program Coding System Number Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
      <Representation>
        <PublicId>2662953</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15432:C45971:C25700:C25337:C2</PreferredName>
        <Version>1</Version>
        <LongName>Surveillance, Epidemiology, and End Results Program Coding System Number Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15432</PREFERRED_NAME>
            <LONG_NAME>Surveillance, Epidemiology, and End Results Program</LONG_NAME>
            <CON_ID>2554150</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45971</PREFERRED_NAME>
            <LONG_NAME>Coding</LONG_NAME>
            <CON_ID>2492757</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25700</PREFERRED_NAME>
            <LONG_NAME>System</LONG_NAME>
            <CON_ID>2202584</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>January 2004 SEER Coding Manual</VALUEMEANING>
          <MEANINGDESCRIPTION>January 2004 SEER Coding Manual</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2656694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>January 2003 SEER Coding Manual</VALUEMEANING>
          <MEANINGDESCRIPTION>January 2003 SEER Coding Manual</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2656695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>January 1998 SEER Coding Manual</VALUEMEANING>
          <MEANINGDESCRIPTION>January 1998 SEER Coding Manual</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2656696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>January 1992 SEER Coding Manual</VALUEMEANING>
          <MEANINGDESCRIPTION>January 1992 SEER Coding Manual</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2656697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>January 1989 SEER Coding Manual</VALUEMEANING>
          <MEANINGDESCRIPTION>January 1989 SEER Coding Manual</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2656698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>May 1988 SEER Coding Manual</VALUEMEANING>
          <MEANINGDESCRIPTION>May 1988 SEER Coding Manual</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2656699</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Pre-1988 SEER Coding Manuals</VALUEMEANING>
          <MEANINGDESCRIPTION>Pre-1988 SEER Coding Manuals</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2656700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No SEER coding</VALUEMEANING>
          <MEANINGDESCRIPTION>No SEER coding</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2656701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SEER Coding System Current</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>SEER Coding System Current</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR, V 11.1 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.1 Data Standards and Data Dictionary (5/4/06)</DocumentText>
        <URL>http://www.naaccr.org/filesystem/pdf/Volume%20II%20Version%2011.1.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SEER Coding and Staging Manuals</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Coding and Staging Manuals for the Surveillance Epidemiology and End Results (SEER) Program</DocumentText>
        <URL>http://seer.cancer.gov/tools/codingmanuals/index.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.2 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.2 Data Standards and Data Dictionary (5/30/2007)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=PQdlAnykU1U%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EditOverrides11.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103523</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EditOverrides11.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3242105</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>2120</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SEER CODING SYS--CURRENT</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="602">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2708044</PUBLICID>
    <LONGNAME>Pharmacologic Substance Synonym Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2528776v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)).:A word having the same or nearly the same meaning as another word or other words in a language; a word or an expression that serves as a figurative or symbolic substitute for another._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2528776</PublicId>
      <PreferredName>2528715v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)).:A word having the same or nearly the same meaning as another word or other words in a language; a word or an expression that serves as a figurative or symbolic substitute for another._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Pharmacologic Substance Synonym Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528715</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1909:C52469</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacologic Substance Synonym</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1909</PREFERRED_NAME>
            <LONG_NAME>Pharmacologic Substance</LONG_NAME>
            <CON_ID>2437691</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52469</PREFERRED_NAME>
            <LONG_NAME>Synonym</LONG_NAME>
            <CON_ID>2528522</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Pharmacologic Substance Synonym Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Pharmacologic Substance Synonym Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2707890</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator 2.1</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000247</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.study.AgentSynonym.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AgentSynonym:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="603">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2712150</PUBLICID>
    <LONGNAME>Protein Post-Translational Modification java.lang.String</LONGNAME>
    <PREFERREDNAME>2711395v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Proteins are a group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence._The enzymatic processing of a polypeptide chain after translation from messenger RNA and after peptide bond formation has occurred. Examples include glycosylation, acylation, limited proteolysis, phosphorylation, isoprenylation._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711395</PublicId>
      <PreferredName>2223335v1.0:2689830v1.0</PreferredName>
      <PreferredDefinition>Proteins are a group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence._The enzymatic processing of a polypeptide chain after translation from messenger RNA and after peptide bond formation has occurred. Examples include glycosylation, acylation, limited proteolysis, phosphorylation, isoprenylation.</PreferredDefinition>
      <LongName>Protein Post-Translational Modification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223335</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17021</PreferredName>
        <Version>1</Version>
        <LongName>Protein</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17021</PREFERRED_NAME>
            <LONG_NAME>Protein</LONG_NAME>
            <CON_ID>2202792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2689830</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17019</PreferredName>
        <Version>1</Version>
        <LongName>Post-Translational Modification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17019</PREFERRED_NAME>
            <LONG_NAME>Post-Translational Modification</LONG_NAME>
            <CON_ID>2689826</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Protein Post-Translational Modification java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Protein Post-Translational Modification java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.Protein.modifications</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Protein:modifications</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="604">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2715761</PUBLICID>
    <LONGNAME>Agent Administration Start Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2715419v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of applying, dispensing or tendering a medical product or other agent to a clinical study subject._The calendar date on which something is to start or did start._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2715419</PublicId>
      <PreferredName>2715181v1.0:2712679v1.0</PreferredName>
      <PreferredDefinition>A description of applying, dispensing or tendering a medical product or other agent to a clinical study subject._The calendar date on which something is to start or did start.</PreferredDefinition>
      <LongName>Agent Administration Start Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2715181</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70962</PreferredName>
        <Version>1</Version>
        <LongName>Agent Administration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70962</PREFERRED_NAME>
            <LONG_NAME>Agent Administration</LONG_NAME>
            <CON_ID>2714997</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2712679</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68616</PreferredName>
        <Version>1</Version>
        <LongName>Start Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68616</PREFERRED_NAME>
            <LONG_NAME>Start Date</LONG_NAME>
            <CON_ID>2712678</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Agent Administration Start Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Agent Administration Start Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2724612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTODS</PreferredName>
          <Version>0.53</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ctom.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.BRIDG_Model.SubstanceAdministration.startDateTime</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SubstanceAdministration:startDateTime</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.SubstanceAdministration.startDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SubstanceAdministration:startDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="605">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2717713</PUBLICID>
    <LONGNAME>PET Facility Completed Questionnaire Indicator</LONGNAME>
    <PREFERREDNAME>PET_FAC_COMP_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded numeric response of No (1) or Yes (2) to idicate if a PET facility questionnaire been completed for this exam.  [Manually_curated]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACRIN:American College of Radiology Imaging Network</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2717445</PublicId>
      <PreferredName>PET_FAC_COMP_QUESTN</PreferredName>
      <PreferredDefinition>A quality, ability, or accomplishment that makes a digital Positron Emission Tomography (PET) device suitable for an imaging task._Services and space and equipment provided for a particular purpose; a building or place that provides a particular service or is used for a particular industry._To possess every necessary or normal part or component or step; having come or been brought to a conclusion._A predetermined set of questions.</PreferredDefinition>
      <LongName>PET Facility Completed Questionnaire</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2717442</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17007:C62574</PreferredName>
        <Version>1</Version>
        <LongName>Positron Emission Tomography Facility</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17007</PREFERRED_NAME>
            <LONG_NAME>Positron Emission Tomography</LONG_NAME>
            <CON_ID>2224887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62574</PREFERRED_NAME>
            <LONG_NAME>Facility</LONG_NAME>
            <CON_ID>2542035</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2717443</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25250:C17048</PreferredName>
        <Version>1</Version>
        <LongName>Complete Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25250</PREFERRED_NAME>
            <LONG_NAME>Complete</LONG_NAME>
            <CON_ID>2203885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17048</PREFERRED_NAME>
            <LONG_NAME>Questionnaire</LONG_NAME>
            <CON_ID>2202367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2598021</PublicId>
      <PreferredName>N_Y_CD_IND</PreferredName>
      <PreferredDefinition>Coded numeric response for No (1) or Yes (2) in answer to a question.</PreferredDefinition>
      <LongName>No Yes Coded Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>IVI:caBIG In Vivo Imaging Workspace</Origin>
      <Representation>
        <PublicId>2208003</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-04-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-04-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has a PET facility questionna</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has a PET facility questionnaire been completed for this exam?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314439</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging Modality</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Positron Emission Tomography (PET)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314449</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="606">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2724416</PUBLICID>
    <LONGNAME>Hydroxyurea Agent Administered Day Count</LONGNAME>
    <PREFERREDNAME>HYDRO_AGT_ADMIN_D_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>the quantity of days given an anticancer drug that belongs to the family of drugs called antimetabolites.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2724414</PublicId>
      <PreferredName>HYDROXYUR_AGT_ADMIN</PreferredName>
      <PreferredDefinition>information related to being given an anticancer drug that belongs to the family of drugs called antimetabolites.</PreferredDefinition>
      <LongName>Hydroxyurea Agent Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2724412</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C560:C1708</PreferredName>
        <Version>1</Version>
        <LongName>Hydroxyurea Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C560</PREFERRED_NAME>
            <LONG_NAME>Hydroxyurea</LONG_NAME>
            <CON_ID>2453786</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018594</PublicId>
      <PreferredName>D_CT</PreferredName>
      <PreferredDefinition>the quantity of days.</PreferredDefinition>
      <LongName>Day Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2207941</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25301:C25463</PreferredName>
        <Version>1</Version>
        <LongName>Day Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25301</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2202680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of days hydroxyurea re</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of days hydroxyurea received</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Hydroxyurea Agent Administered Day Count</AlternateName>
        <AlternateNameType>TCGA_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>hydroxyurea_agent_administered_day_count</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="607">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2724790</PUBLICID>
    <LONGNAME>Concept Descriptor Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2555478v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Represents any kind of concept usually by giving a code defined in a code system._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2555478</PublicId>
      <PreferredName>2555441v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Represents any kind of concept usually by giving a code defined in a code system._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Concept Descriptor Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2555441</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C64208</PreferredName>
        <Version>1</Version>
        <LongName>Concept Descriptor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64208</PREFERRED_NAME>
            <LONG_NAME>Concept Descriptor</LONG_NAME>
            <CON_ID>2555338</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Concept Descriptor Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Concept Descriptor Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2724612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTODS</PreferredName>
          <Version>0.53</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ctom.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ConceptDescriptor:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.ConceptDescriptor.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="608">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2727141</PUBLICID>
    <LONGNAME>Experiment Experiment Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2726797v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena._A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2726797</PublicId>
      <PreferredName>2619601v1.0:2677953v1.0</PreferredName>
      <PreferredDefinition>A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena._A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Experiment Experiment Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2619601</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42790</PreferredName>
        <Version>1</Version>
        <LongName>Experiment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42790</PREFERRED_NAME>
            <LONG_NAME>Experiment</LONG_NAME>
            <CON_ID>2223979</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2677953</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42790:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Experiment Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42790</PREFERRED_NAME>
            <LONG_NAME>Experiment</LONG_NAME>
            <CON_ID>2223979</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Experiment Experiment Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Experiment Experiment Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812747</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2831137</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caCORRECT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caCORRECT Grid Services 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2832871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2831137</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caCORRECT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000575</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2839153</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>omniBiomarker</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>omniBiomarker Grid Services 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2839155</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2839153</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>omniBiomarker</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000574</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000576</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.project.Experiment.dateOfExperiment</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Experiment:dateOfExperiment</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.project.Experiment.date</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Experiment:date</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="609">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2731366</PUBLICID>
    <LONGNAME>Biospecimen Collection Plan Indicator java.lang.Boolean</LONGNAME>
    <PREFERREDNAME>2724742v1.0:2178538v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The act or process of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes._To devise, contrive, or formed in design.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether or not certain stated circumstances exist or criteria are satisfied._Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2724742</PublicId>
      <PreferredName>2715159v1.0:2555435v1.0</PreferredName>
      <PreferredDefinition>The act or process of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes._To devise, contrive, or formed in design.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether or not certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Biospecimen Collection Plan Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2715159</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70945</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Collection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70945</PREFERRED_NAME>
            <LONG_NAME>Biospecimen Collection</LONG_NAME>
            <CON_ID>2714902</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2555435</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25619:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Plan Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25619</PREFERRED_NAME>
            <LONG_NAME>Plan</LONG_NAME>
            <CON_ID>2203947</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178538</PublicId>
      <PreferredName>java.lang.Boolean</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PreferredDefinition>
      <LongName>java.lang.Boolean</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Boolean</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Biospecimen Collection Plan Indicator java.lang.Boolean does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Biospecimen Collection Plan Indicator java.lang.Boolean does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2555333</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trials Lab Model</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.labhub.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000317</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2964508</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LabViewer</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.labhub.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000318</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.labhub.domain.SpecimenCollection.plannedIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SpecimenCollection:plannedIndicator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="610">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2732794</PUBLICID>
    <LONGNAME>Schedule Clinical Study Segment Begin Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2732759v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An ordered list of times at which things are planned to occur.:Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.:One of the parts into which something naturally divides._Have a beginning, in a temporal, spatial, or evaluative sense.:a particular day specified as the time something has, or will, happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2732759</PublicId>
      <PreferredName>2732747v1.0:2207412v1.0</PreferredName>
      <PreferredDefinition>An ordered list of times at which things are planned to occur.:Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.:One of the parts into which something naturally divides._Have a beginning, in a temporal, spatial, or evaluative sense.:a particular day specified as the time something has, or will, happen.</PreferredDefinition>
      <LongName>Schedule Clinical Study Segment Begin Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2732747</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25211:C15206:C45312</PreferredName>
        <Version>1</Version>
        <LongName>Schedule Clinical Study Segment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25211</PREFERRED_NAME>
            <LONG_NAME>Schedule</LONG_NAME>
            <CON_ID>2203792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45312</PREFERRED_NAME>
            <LONG_NAME>Segment</LONG_NAME>
            <CON_ID>2480800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207412</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Begin Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Schedule Clinical Study Segment Begin Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Schedule Clinical Study Segment Begin Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2672769</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PSC</PreferredName>
          <Version>2.6</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.bioinformatics.studycalendar.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000049</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ScheduledStudySegment:startDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.bioinformatics.studycalendar.domain.ScheduledStudySegment.startDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="611">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2732831</PUBLICID>
    <LONGNAME>Blackout Specified Date Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2732790v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A suspension of service (especially of radio or tv broadcasting).:Clearly and explicitly stated.:The particular day, month and year an event has happened or will happen._A statement or an account describing something._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2732790</PublicId>
      <PreferredName>2732756v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>A suspension of service (especially of radio or tv broadcasting).:Clearly and explicitly stated.:The particular day, month and year an event has happened or will happen._A statement or an account describing something.</PreferredDefinition>
      <LongName>Blackout Specified Date Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2732756</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71739:C38024:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Blackout Specified Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71739</PREFERRED_NAME>
            <LONG_NAME>Blackout</LONG_NAME>
            <CON_ID>2732737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38024</PREFERRED_NAME>
            <LONG_NAME>Specified</LONG_NAME>
            <CON_ID>2211671</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Blackout Specified Date Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Blackout Specified Date Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2672769</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PSC</PreferredName>
          <Version>2.6</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.bioinformatics.studycalendar.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000049</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.bioinformatics.studycalendar.domain.SpecificDateBlackout.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SpecificDateBlackout:description</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="612">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2732901</PUBLICID>
    <LONGNAME>Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Dryness Psychometrics Assessment Score</LONGNAME>
    <PREFERREDNAME>CTCL_SKN_DRY_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Response on a psychometric measure documenting how often a human being experiences dry or flaky skin due to CTCL (Cutaneous T-Cell Lymphoma) involvement. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2732850</PublicId>
      <PreferredName>PERS_CTCL_SKN_DRY</PreferredName>
      <PreferredDefinition>A single human being._A T-cell non-Hodgkin lymphoma arising from the skin. Representative examples include mycosis fungoides and primary cutaneous anaplastic large cell lymphoma._An organ that constitutes the external surface of the body.  It consists of the epidermis, dermis, and skin appendages._The lack of natural or normal moisture.</PreferredDefinition>
      <LongName>Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin Dryness</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2732708</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C3467:C12470</PreferredName>
        <Version>1</Version>
        <LongName>Person Cutaneous T-Cell Non-Hodgkin Lymphoma Skin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3467</PREFERRED_NAME>
            <LONG_NAME>Primary Cutaneous T-Cell Non-Hodgkin Lymphoma</LONG_NAME>
            <CON_ID>2732707</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12470</PREFERRED_NAME>
            <LONG_NAME>Skin</LONG_NAME>
            <CON_ID>2202821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2732837</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25489</PreferredName>
        <Version>1</Version>
        <LongName>Dryness</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25489</PREFERRED_NAME>
            <LONG_NAME>Dryness</LONG_NAME>
            <CON_ID>2203911</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2732886</PublicId>
      <PreferredName>PSYCH_ASSESS_SC</PreferredName>
      <PreferredDefinition>The science of measuring &quot;psychological&quot; aspects of a person such as knowledge, skills, abilities, or personality. Measurement of these unobservable phenomena is difficult and much of the research and accumulated art of this discipline is designed to reliably define and then quantify._The final result of a determination of the value, significance, or extent of._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Psychometrics Assessment Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>12</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2732885</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17034:C25217:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Psychometrics Assessed Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17034</PREFERRED_NAME>
            <LONG_NAME>Psychometrics</LONG_NAME>
            <CON_ID>2520620</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>All the time</VALIDVALUE>
          <VALUEMEANING>All the time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2732887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>I NEVER had an erection when I wanted one </VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>My skin is dry or &#39;flaky&#39;.</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>My skin is dry or &#39;flaky&#39;.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="613">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2734594</PUBLICID>
    <LONGNAME>Pathology Tissue Specimen Cytoplasm Stain Malignant Cell Percentage Value</LONGNAME>
    <PREFERREDNAME>P_T_S_C_S_M_C_PT_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>a percentage expressing the quantity of cancer cells identified by dye applied to the cytoplasm of a cell during microscopic assessment of a tissue sample by a specialist in cellular function.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2734593</PublicId>
      <PreferredName>P_TI_SP_CY_ST_MA_CEL</PreferredName>
      <PreferredDefinition>information relating to cancerous cells identified by dye (a coloring material that is used in microscopy to make structures visible) applied to the cytoplasm (the portion of the cell contained within the plasma membrane but excluding the nucleus) surface during microscopic assessment of a sample of tissue by a specialist in cellular function and changes.</PreferredDefinition>
      <LongName>Pathology Tissue Specimen Cytoplasm Stain Malignant Cell</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2488643</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18189:C12801:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Pathology Tissue Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12801</PREFERRED_NAME>
            <LONG_NAME>Tissue</LONG_NAME>
            <CON_ID>2202489</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2734591</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13226:C841:C14143:C12508</PreferredName>
        <Version>1</Version>
        <LongName>Cytoplasm Stain Malignant Cell</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13226</PREFERRED_NAME>
            <LONG_NAME>Cytoplasm</LONG_NAME>
            <CON_ID>2205293</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C841</PREFERRED_NAME>
            <LONG_NAME>Stain</LONG_NAME>
            <CON_ID>2202830</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14143</PREFERRED_NAME>
            <LONG_NAME>Malignant</LONG_NAME>
            <CON_ID>2203843</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12508</PREFERRED_NAME>
            <LONG_NAME>Cell</LONG_NAME>
            <CON_ID>2202900</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018830</PublicId>
      <PreferredName>PA_SPE_ST_CEL_PT_VAL</PreferredName>
      <PreferredDefinition>a fraction with the denominator 100 representing a quantity of cells from a sample of tissue or body fluid dyed for microscopic assessment of disease by a specialist in cellular function and changes.</PreferredDefinition>
      <LongName>Pathology Specimen Stain Cell Percentage Value</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>999.9</DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTEP CDE Committee</Origin>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Percentage of Invasive Tumor Cells with Cytoplasmic Staining</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="614">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2734600</PUBLICID>
    <LONGNAME>Laboratory Procedure Immunohistochemistry Result Ind-2</LONGNAME>
    <PREFERREDNAME>LAB_IHC_RSLT_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether the patient is evaluable for immunohistochemistry (IHC).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2734599</PublicId>
      <PreferredName>LAB_IHC_RSLT</PreferredName>
      <PreferredDefinition>information relating to the result of a medical procedure that involves testing a tissue sample by immunohistochemistry, histochemical localization of immunoreactive substances using labeled antibodies as reagents.</PreferredDefinition>
      <LongName>Laboratory Procedure Immunohistochemistry Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738945</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16722:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Immunohistochemistry Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16722</PREFERRED_NAME>
            <LONG_NAME>Immunohistochemistry</LONG_NAME>
            <CON_ID>2202666</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is this patient evaluable for</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is this patient evaluable for immunostaining (IHC)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR 2011 Template</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248617</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248635</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>St. Joseph Hospital</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813054</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="615">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2735235</PUBLICID>
    <LONGNAME>Investigator Identifier java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2724671v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>a researcher in a clinical trial or clinical study._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2724671</PublicId>
      <PreferredName>2528490v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>a researcher in a clinical trial or clinical study._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Investigator Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528490</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25936</PreferredName>
        <Version>1</Version>
        <LongName>Investigator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25936</PREFERRED_NAME>
            <LONG_NAME>Investigator</LONG_NAME>
            <CON_ID>2202869</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Investigator Identifier java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Investigator Identifier java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000413</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.duke.cabig.c3pr.domain.StudyInvestigator.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudyInvestigator:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.Investigator.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Investigator:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="616">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2735292</PUBLICID>
    <LONGNAME>Clinical Study Site Investigator Group Affiliation End Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2735155v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A healthcare organization, a facility, a healthcare provider, or a part or a constituent of any of the above entities directly involved in conducting a particular clinical study.:An individual who conducts scientific research. In a clinical setting this individual actually conducts and/or supervises the clinical investigation and study-related procedures.  The investigator monitors the safety of the trial subjects and investigational staff (under whose immediate direction an agent is administered or dispensed to a subject).  The investigator collects and analyses data and study documents, and provides reports in compliance with applicable requirements.:Any number of entities (members) considered as a unit.:A formal association between entities._The point or place at which something terminates in time, space, or extent.:The particular day, month and year an event will happen or has happened._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2735155</PublicId>
      <PreferredName>2734864v1.0:2231605v1.0</PreferredName>
      <PreferredDefinition>A healthcare organization, a facility, a healthcare provider, or a part or a constituent of any of the above entities directly involved in conducting a particular clinical study.:An individual who conducts scientific research. In a clinical setting this individual actually conducts and/or supervises the clinical investigation and study-related procedures.  The investigator monitors the safety of the trial subjects and investigational staff (under whose immediate direction an agent is administered or dispensed to a subject).  The investigator collects and analyses data and study documents, and provides reports in compliance with applicable requirements.:Any number of entities (members) considered as a unit.:A formal association between entities._The point or place at which something terminates in time, space, or extent.:The particular day, month and year an event will happen or has happened.</PreferredDefinition>
      <LongName>Clinical Study Site Investigator Group Affiliation End Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2734864</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70777:C25936:C43359:C25412</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Study Site Investigator Group Affiliation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70777</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Site</LONG_NAME>
            <CON_ID>2714955</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25936</PREFERRED_NAME>
            <LONG_NAME>Investigator</LONG_NAME>
            <CON_ID>2202869</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43359</PREFERRED_NAME>
            <LONG_NAME>Group</LONG_NAME>
            <CON_ID>2236516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25412</PREFERRED_NAME>
            <LONG_NAME>Affiliation</LONG_NAME>
            <CON_ID>2202923</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231605</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25496:C25164</PreferredName>
        <Version>1</Version>
        <LongName>End Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Clinical Study Site Investigator Group Affiliation End Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Clinical Study Site Investigator Group Affiliation End Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.duke.cabig.c3pr.domain.SiteInvestigatorGroupAffiliation.endDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SiteInvestigatorGroupAffiliation:endDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="617">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2738727</PUBLICID>
    <LONGNAME>Patient Mouth Pain Assessment Scale</LONGNAME>
    <PREFERREDNAME>PT_MT_PA_ASS_SCALE</PREFERREDNAME>
    <PREFERREDDEFINITION>the pain scale related to patient/participant&#39;s unpleasant sensation induced by noxious stimuli and generally received by specialized nerve endings in the mouth.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2585129</PublicId>
      <PreferredName>PT_MOUTH_PA_ASSESS</PreferredName>
      <PreferredDefinition>information relating to patient/participant&#39;s unpleasant sensation induced by noxious stimuli and generally received by specialized nerve endings in the mouth.</PreferredDefinition>
      <LongName>Patient Mouth Pain Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2500857</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12421:C3303:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Mouth Pain Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12421</PREFERRED_NAME>
            <LONG_NAME>Oral Cavity</LONG_NAME>
            <CON_ID>2202746</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3303</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>2202326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017156</PublicId>
      <PreferredName>PT_PN_SCALE</PreferredName>
      <PreferredDefinition>the patient&#39;s pain scale.</PreferredDefinition>
      <LongName>Patient Pain Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue>10</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2184332</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Scale</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pain intensity rating scale</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pain intensity rating scale</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Which number represents the worst severity of your mouth pain over the past 24 hours that you think was caused by your cancer medication?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Restorative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="618">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2743157</PUBLICID>
    <LONGNAME>Recurrent Disease Assessment Fluorescence in situ Hybridization Disease or Disorder Finding Yes No Character Indicator</LONGNAME>
    <PREFERREDNAME>RD_AS_FSH_DS_FD_YN</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the fluorescence in situ hybridization assessment used to assess the disease relapse showed evidence of disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2743142</PublicId>
      <PreferredName>RD_AS_FSH_DS_FD</PreferredName>
      <PreferredDefinition>The return of a disease after a period of remission._The act of judging the value, significance, or extent of something._A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Clinical, laboratory or molecular evidence, or absence of evidence of disease.</PreferredDefinition>
      <LongName>Recurrent Disease Assessment Fluorescence in situ Hybridization Disease or Disorder Finding</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2743140</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38155:C25217:C17563</PreferredName>
        <Version>1</Version>
        <LongName>Recurrent Disease Assessed Fluorescence in situ Hybridization</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38155</PREFERRED_NAME>
            <LONG_NAME>Recurrent Disease</LONG_NAME>
            <CON_ID>2202887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17563</PREFERRED_NAME>
            <LONG_NAME>Fluorescence In Situ Hybridization</LONG_NAME>
            <CON_ID>2221360</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2739620</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C3367</PreferredName>
        <Version>1</Version>
        <LongName>Disease or Disorder Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3367</PREFERRED_NAME>
            <LONG_NAME>Finding</LONG_NAME>
            <CON_ID>2202448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181608</PublicId>
      <PreferredName>Y_N_CHAR_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Character Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the FISH assessment used</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the FISH assessment used to assess disease relapse show evidence of disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was there evidence of disease?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was there evidence of disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="619">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2746489</PUBLICID>
    <LONGNAME>During Hematopoietic Cell Graft Manipulation Other Antibody Administered Therapies Specify</LONGNAME>
    <PREFERREDNAME>MANI_ANTI_OTH_SPE</PREFERREDNAME>
    <PREFERREDDEFINITION>The free-text field that describes another antibody used during the hematopoietic cell graft manipulation.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2746483</PublicId>
      <PreferredName>MANI_ANTI_OTH_ADM</PreferredName>
      <PreferredDefinition>At some point in a given period of time._Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body._Move, treat, or operate with the hands or by mechanical means, especially in a skillful manner._Different than the one(s) previously specified or mentioned._A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>During Hematopoietic Cell Graft Manipulation Other Antibody Administered</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435033</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16847</PreferredName>
        <Version>1</Version>
        <LongName>Techniques</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2744969</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25490:C12551:C12981:C48310</PreferredName>
        <Version>1</Version>
        <LongName>During Hematopoietic Stem Cell Transplant Manipulation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48310</PREFERRED_NAME>
            <LONG_NAME>Manipulation</LONG_NAME>
            <CON_ID>2437660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2746481</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C16295:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Other Antibody Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16295</PREFERRED_NAME>
            <LONG_NAME>Antibody</LONG_NAME>
            <CON_ID>2202301</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018810</PublicId>
      <PreferredName>TX_SPEC</PreferredName>
      <PreferredDefinition>the free text field related to therapy.</PreferredDefinition>
      <LongName>Therapies Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other antibody:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify other antibody:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other antibody.</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify other antibody.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the other antibody used during graft manipulation:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the other antibody used during graft manipulation:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other antibody:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify other antibody:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping for CDE:2746489</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>MaterialName.name WHERE MaterialName &gt; Product.typeCode = &quot;antibody&quot; AND Product [antibody, used Material] &gt; PerformedMaterialProcessStep AND Biologic [pre-processed HCT product] &gt; Subject &gt; PerformedMaterialProcessStep &gt; Biologic [processed HCT product]</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2100r1: 100 Days Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964902</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2006r1: HSCT Infusion</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2200r1: 6 Month to 2 Year Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964922</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2300r1: Greater Than 2 Years Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>During Hematopoietic Stem Cell Graft Manipulation Other Antibody Administered Therapies Specify</AlternateName>
        <AlternateNameType>System-Generated</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_proc_man_ab_othr_spec</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MaterialName:name</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="620">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2750387</PUBLICID>
    <LONGNAME>Text Annotation Font java.lang.String</LONGNAME>
    <PREFERREDNAME>2750247v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The words of something written.:An explanatory or critical comment that has been added to a text._A specific size and style of type within a type family._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2750247</PublicId>
      <PreferredName>2750191v1.0:2750154v1.0</PreferredName>
      <PreferredDefinition>The words of something written.:An explanatory or critical comment that has been added to a text._A specific size and style of type within a type family.</PreferredDefinition>
      <LongName>Text Annotation Font</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2750191</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704:C44272</PreferredName>
        <Version>1</Version>
        <LongName>Text Annotation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44272</PREFERRED_NAME>
            <LONG_NAME>Annotation</LONG_NAME>
            <CON_ID>2519066</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2750154</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71594</PreferredName>
        <Version>1</Version>
        <LongName>Font</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71594</PREFERRED_NAME>
            <LONG_NAME>Font</LONG_NAME>
            <CON_ID>2750133</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Text Annotation Font java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Text Annotation Font java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 3.0</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000056</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.TextAnnotation.font</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TextAnnotation:font</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="621">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2750400</PUBLICID>
    <LONGNAME>Shape Ring Flag java.lang.Boolean</LONGNAME>
    <PREFERREDNAME>2750259v1.0:2178538v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The spatial arrangement of something as distinct from its substance._Doughnut-shaped object or surface generated by rotating a circle around an axis that does not intersect the circle; any object that resembles a ring.:An indicator that can be set or unset in order to signal whether a particular condition is true._Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2750259</PublicId>
      <PreferredName>2612281v1.0:2750165v1.0</PreferredName>
      <PreferredDefinition>The spatial arrangement of something as distinct from its substance._Doughnut-shaped object or surface generated by rotating a circle around an axis that does not intersect the circle; any object that resembles a ring.:An indicator that can be set or unset in order to signal whether a particular condition is true.</PreferredDefinition>
      <LongName>Shape Ring Flag</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2612281</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25677</PreferredName>
        <Version>1</Version>
        <LongName>Shape</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25677</PREFERRED_NAME>
            <LONG_NAME>Shape</LONG_NAME>
            <CON_ID>2203587</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2750165</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61458:C43578</PreferredName>
        <Version>1</Version>
        <LongName>Ring Flag</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61458</PREFERRED_NAME>
            <LONG_NAME>Ring</LONG_NAME>
            <CON_ID>2750138</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43578</PREFERRED_NAME>
            <LONG_NAME>Flag</LONG_NAME>
            <CON_ID>2223213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178538</PublicId>
      <PreferredName>java.lang.Boolean</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PreferredDefinition>
      <LongName>java.lang.Boolean</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Boolean</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Shape Ring Flag java.lang.Boolean does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Shape Ring Flag java.lang.Boolean does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 3.0</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000056</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GeometricShape:includeFlag</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.GeometricShape.includeFlag</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="622">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752582</PUBLICID>
    <LONGNAME>Longterm Follow-up Death Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2752066v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The follow-up activities that take place following the end of the active intervention period._The absence of life or state of being dead.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752066</PublicId>
      <PreferredName>2751996v1.0:2493198v1.0</PreferredName>
      <PreferredDefinition>The follow-up activities that take place following the end of the active intervention period._The absence of life or state of being dead.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Longterm Follow-up Death Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2751996</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16032</PreferredName>
        <Version>1</Version>
        <LongName>Longterm Follow-up</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16032</PREFERRED_NAME>
            <LONG_NAME>Long-term Follow-up</LONG_NAME>
            <CON_ID>2751672</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2493198</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28554:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Death Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28554</PREFERRED_NAME>
            <LONG_NAME>Dead</LONG_NAME>
            <CON_ID>2202731</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Longterm Follow-up Death Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Longterm Follow-up Death Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.LongTermFU.dateDeath</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LongTermFU:dateDeath</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="623">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752629</PUBLICID>
    <LONGNAME>Chemotherapy Doxorubicin Hydrochloride java.lang.Boolean</LONGNAME>
    <PREFERREDNAME>2752113v1.0:2178538v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)_The hydrochloride salt of doxorubicin, an anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from Streptomyces peucetius, is the hydroxylated congener of daunorubicin. Doxorubicin intercalates between DNA base pairs, thereby hinders the movement of replication machinery along DNA strands, as well as blocks the activity of topoisomerase II during replication. As a result, this agent causes DNA adducts formation, renders single- and double-stranded DNA breakages that induce DNA repair and or apoptotic processes. Doxorubicin also generates reactive oxygen species that leads to cytotoxicity secondary to lipid peroxidation of cell membrane lipids._Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752113</PublicId>
      <PreferredName>2404910v1.0:2751778v1.0</PreferredName>
      <PreferredDefinition>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)_The hydrochloride salt of doxorubicin, an anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from Streptomyces peucetius, is the hydroxylated congener of daunorubicin. Doxorubicin intercalates between DNA base pairs, thereby hinders the movement of replication machinery along DNA strands, as well as blocks the activity of topoisomerase II during replication. As a result, this agent causes DNA adducts formation, renders single- and double-stranded DNA breakages that induce DNA repair and or apoptotic processes. Doxorubicin also generates reactive oxygen species that leads to cytotoxicity secondary to lipid peroxidation of cell membrane lipids.</PreferredDefinition>
      <LongName>Chemotherapy Doxorubicin Hydrochloride</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404910</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15632</PreferredName>
        <Version>1</Version>
        <LongName>Chemotherapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15632</PREFERRED_NAME>
            <LONG_NAME>Chemotherapy</LONG_NAME>
            <CON_ID>2202708</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2751778</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1326</PreferredName>
        <Version>1</Version>
        <LongName>Doxorubicin Hydrochloride</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1326</PREFERRED_NAME>
            <LONG_NAME>Doxorubicin Hydrochloride</LONG_NAME>
            <CON_ID>2751680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178538</PublicId>
      <PreferredName>java.lang.Boolean</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PreferredDefinition>
      <LongName>java.lang.Boolean</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Boolean</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Chemotherapy Doxorubicin Hydrochloride java.lang.Boolean does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Chemotherapy Doxorubicin Hydrochloride java.lang.Boolean does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.Chemotherapy.adriamycin</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Chemotherapy:adriamycin</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="624">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752649</PUBLICID>
    <LONGNAME>Chemotherapy Vinblastine java.lang.Boolean</LONGNAME>
    <PREFERREDNAME>2752133v1.0:2178538v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)_A natural alkaloid isolated from the plant Vinca rosea Linn. Vinblastine binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and arrest of tumor cells in the M phase of the cell cycle. This agent may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)_Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752133</PublicId>
      <PreferredName>2404910v1.0:2751794v1.0</PreferredName>
      <PreferredDefinition>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)_A natural alkaloid isolated from the plant Vinca rosea Linn. Vinblastine binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and arrest of tumor cells in the M phase of the cell cycle. This agent may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)</PreferredDefinition>
      <LongName>Chemotherapy Vinblastine</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404910</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15632</PreferredName>
        <Version>1</Version>
        <LongName>Chemotherapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15632</PREFERRED_NAME>
            <LONG_NAME>Chemotherapy</LONG_NAME>
            <CON_ID>2202708</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2751794</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C930</PreferredName>
        <Version>1</Version>
        <LongName>Vinblastine</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C930</PREFERRED_NAME>
            <LONG_NAME>Vinblastine</LONG_NAME>
            <CON_ID>2751684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178538</PublicId>
      <PreferredName>java.lang.Boolean</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PreferredDefinition>
      <LongName>java.lang.Boolean</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Boolean</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Chemotherapy Vinblastine java.lang.Boolean does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Chemotherapy Vinblastine java.lang.Boolean does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.Chemotherapy.vinblastine</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Chemotherapy:vinblastine</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="625">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752787</PUBLICID>
    <LONGNAME>Disease or Disorder Evaluation Details Lesion Anatomic Site Evaluation Method java.lang.String</LONGNAME>
    <PREFERREDNAME>2752271v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.:Particulars considered individually and in relation to a whole._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:Named locations of or within the body.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752271</PublicId>
      <PreferredName>2752003v1.0:2751867v1.0</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.:Particulars considered individually and in relation to a whole._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:Named locations of or within the body.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.</PreferredDefinition>
      <LongName>Disease or Disorder Evaluation Details Lesion Anatomic Site Evaluation Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2752003</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C25214:C25480</PreferredName>
        <Version>1</Version>
        <LongName>Disease or Disorder Evaluation Details</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25480</PREFERRED_NAME>
            <LONG_NAME>Details</LONG_NAME>
            <CON_ID>2203578</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2751867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3824:C13717:C25214:C71460</PreferredName>
        <Version>1</Version>
        <LongName>Lesion Anatomic Site Evaluation Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Disease or Disorder Evaluation Details Lesion Anatomic Site Evaluation Method java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Disease or Disorder Evaluation Details Lesion Anatomic Site Evaluation Method java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.DiseaseEvaluationDetail.lesionSiteMethod</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DiseaseEvaluationDetail:lesionSiteMethod</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="626">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752910</PUBLICID>
    <LONGNAME>Baseline Data Amendment Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2752394v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A starting point to which things may be compared.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._A change in a document made by correction, adding, substituting or omitting a certain part. Amendments are the mechanism of changes introduction, further development and improvement of previously submitted or approved clinical study protocols and proposals.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752394</PublicId>
      <PreferredName>2752010v1.0:2607553v1.0</PreferredName>
      <PreferredDefinition>A starting point to which things may be compared.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._A change in a document made by correction, adding, substituting or omitting a certain part. Amendments are the mechanism of changes introduction, further development and improvement of previously submitted or approved clinical study protocols and proposals.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Baseline Data Amendment Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2752010</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25213:C25474</PreferredName>
        <Version>1</Version>
        <LongName>Baseline Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25213</PREFERRED_NAME>
            <LONG_NAME>Baseline</LONG_NAME>
            <CON_ID>2202304</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607553</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41200:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Amendment Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41200</PREFERRED_NAME>
            <LONG_NAME>Amendment</LONG_NAME>
            <CON_ID>2551428</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Baseline Data Amendment Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Baseline Data Amendment Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.BaselineData.dateAmended</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BaselineData:dateAmended</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="627">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2753341</PUBLICID>
    <LONGNAME>Cervical Carcinoma Clinical Stage</LONGNAME>
    <PREFERREDNAME>CERV_CA_CLIN_STG</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term for the extent of cervical carcinoma within the body, using noninvasive and/or imaging means. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FIGO:International Federal of Gynecology and Obstetrics</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2753332</PublicId>
      <PreferredName>CERV_CA_CLIN_STG</PreferredName>
      <PreferredDefinition>Cervical carcinoma may arise from either the exocervical squamous epithelium or the endocervical glandular epithelium.  The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.</PreferredDefinition>
      <LongName>Cervical Carcinoma Clinical Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2753329</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9039</PreferredName>
        <Version>1</Version>
        <LongName>Cervical Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9039</PREFERRED_NAME>
            <LONG_NAME>Cervical Carcinoma</LONG_NAME>
            <CON_ID>2753328</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2753330</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25398:C16899</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2753334</PublicId>
      <PreferredName>CERV_CA_STG</PreferredName>
      <PreferredDefinition>Cervical carcinoma may arise from either the exocervical squamous epithelium or the endocervical glandular epithelium.  The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.</PreferredDefinition>
      <LongName>Cervical Carcinoma Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>12</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>FIGO:International Federal of Gynecology and Obstetrics</Origin>
      <Representation>
        <PublicId>2753333</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9039:C16899</PreferredName>
        <Version>1</Version>
        <LongName>Cervical Carcinoma Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9039</PREFERRED_NAME>
            <LONG_NAME>Cervical Carcinoma</LONG_NAME>
            <CON_ID>2753328</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage IV</VALIDVALUE>
          <VALUEMEANING>Invasive cancer with tumor spreading to other parts of the body</VALUEMEANING>
          <MEANINGDESCRIPTION>Invasive cancer with tumor spreading to other parts of the body</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-05-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2753335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage III</VALIDVALUE>
          <VALUEMEANING>Invasive cancer with tumor spreading to the lower third of the vagina or onto the pelvic wall; tumor may be blocking the flow of urine from the kidneys to the bladder</VALUEMEANING>
          <MEANINGDESCRIPTION>Invasive cancer with tumor spreading to the lower third of the vagina or onto the pelvic wall; tumor may be blocking the flow of urine from the kidneys to the bladder</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-05-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2753336</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage II</VALIDVALUE>
          <VALUEMEANING>Invasive cancer with tumor extending beyond the cervix and/or the upper two-thirds of the vagina, but not onto the pelvic wall</VALUEMEANING>
          <MEANINGDESCRIPTION>Invasive cancer with tumor extending beyond the cervix and/or the upper two-thirds of the vagina, but not onto the pelvic wall</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-05-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2753337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage I</VALIDVALUE>
          <VALUEMEANING>Invasive cancer with tumor strictly confined to the cervix</VALUEMEANING>
          <MEANINGDESCRIPTION>Invasive cancer with tumor strictly confined to the cervix</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-05-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2753338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage 0</VALIDVALUE>
          <VALUEMEANING>Cervical Carcinoma in situ</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoma in situ; Tumor is present only in the epithelium (cells lining the cervix) and has not invaded deeper tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-05-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2753339</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage IVB</VALIDVALUE>
          <VALUEMEANING>Stage IVB</VALUEMEANING>
          <MEANINGDESCRIPTION>Distant metastases, including intra-abdominal metastases and/or inguinal lymph nodes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage IVA</VALIDVALUE>
          <VALUEMEANING>Stage IVA</VALUEMEANING>
          <MEANINGDESCRIPTION>Tumor invasion of bladder and/or bowel mucosa</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage IIIC2</VALIDVALUE>
          <VALUEMEANING>Stage IIIC2</VALUEMEANING>
          <MEANINGDESCRIPTION>Local and/or regional spread of the tumor; positive para-aortic lymph nodes with or without positive pelvic lymph nodes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage IIIC1</VALIDVALUE>
          <VALUEMEANING>Stage IIIC1</VALUEMEANING>
          <MEANINGDESCRIPTION>Local and/or regional spread of the tumor; positive pelvic lymph nodes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage IIIC</VALIDVALUE>
          <VALUEMEANING>Stage IIIC</VALUEMEANING>
          <MEANINGDESCRIPTION>Local and/or regional spread of the tumor; metastases to pelvic and/or para-aortic lymph nodes (Positive cytology has to be reported separately without changing the stage)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage IIIB</VALIDVALUE>
          <VALUEMEANING>Stage IIIB</VALUEMEANING>
          <MEANINGDESCRIPTION>Local and/or regional spread of the tumor; vaginal and/or parametrial involvement (Positive cytology has to be reported separately without changing the stage)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage IIIA</VALIDVALUE>
          <VALUEMEANING>Stage IIIA</VALUEMEANING>
          <MEANINGDESCRIPTION>Local and/or regional spread of the tumor; tumorinvades the serosa of the corpus uteri and/or adnexae (Positive cytology has to be reported separately without changing the stage)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage IB</VALIDVALUE>
          <VALUEMEANING>Stage IB</VALUEMEANING>
          <MEANINGDESCRIPTION>Tumor confined to the corpus uteri; invasion equal to or more than half of the myometrial</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage IA</VALIDVALUE>
          <VALUEMEANING>Stage IA</VALUEMEANING>
          <MEANINGDESCRIPTION>Tumor confined to the corpus uteri; no or less then half myometrial invasion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FIGO Clinical Stage</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>FIGO Clinical Stage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FIGO Stage</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>FIGO Stage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Washington</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812731</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FES Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812732</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FMISO Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812733</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Washington New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812734</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="628">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2756200</PUBLICID>
    <LONGNAME>Other Target Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2754090v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Different than the one(s) previously specified or mentioned.:An object fixed as a goal or point of examination; something to point at; a destination._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2754090</PublicId>
      <PreferredName>2753800v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned.:An object fixed as a goal or point of examination; something to point at; a destination._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Other Target Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2753800</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25702</PreferredName>
        <Version>1</Version>
        <LongName>Other Target</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25702</PREFERRED_NAME>
            <LONG_NAME>Target</LONG_NAME>
            <CON_ID>2206261</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Other Target Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Other Target Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2915522</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caNanoLab</PreferredName>
          <Version>1.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cananolab.domain.function</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2915887</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.particle.samplecomposition.OtherTarget.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OtherTarget:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.function.OtherTarget.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="629">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2758932</PUBLICID>
    <LONGNAME>Neoadjuvant Immunotherapy Begin Date</LONGNAME>
    <PREFERREDNAME>NEOADJ_IMMU_STT_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>Date that neoadjuvant immunotherapy began. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2758930</PublicId>
      <PreferredName>NEOADJ_IMMU_OCC</PreferredName>
      <PreferredDefinition>information related to the begin date or occurrence of neoadjuvant hormone therapy._An indicator that a person has been previously treated for the same condition or with the same therapy._(IM-yoo-no-THER-a-pee) Treatment to stimulate or restore the ability of the immune system to fight infections and other diseases. Also used to lessen side effects that may be caused by some cancer treatments.</PreferredDefinition>
      <LongName>Neoadjuvant Therapy  Immunotherapy Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2759138</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15665:C15262</PreferredName>
        <Version>1</Version>
        <LongName>Neoadjuvant Therapy Immunotherapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15665</PREFERRED_NAME>
            <LONG_NAME>Neoadjuvant Therapy</LONG_NAME>
            <CON_ID>2206319</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15262</PREFERRED_NAME>
            <LONG_NAME>Immunotherapy</LONG_NAME>
            <CON_ID>2202664</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016970</PublicId>
      <PreferredName>START_DT</PreferredName>
      <PreferredDefinition>A particular calendar day specified as when an event or activity began or was initiated.  Exchange format is YYYYMMDD.</PreferredDefinition>
      <LongName>Start Date</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>DD/MON/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Start Date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Start Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Inactive CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044924</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="630">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2768639</PUBLICID>
    <LONGNAME>Hematopoietic Cell Transplantation Relationship Death Main Reason Indicator</LONGNAME>
    <PREFERREDNAME>2768630v2.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the main cause of death was HCT related.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2768630</PublicId>
      <PreferredName>2768628v1.0:2768363v1.0</PreferredName>
      <PreferredDefinition>Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The grafting of tissues from one individual to another or place to place within a single individual._A state of connectedness between people, objects, or events; to be associated or connected with something._The absence of life or state of being dead._Most important; principal._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Hematopoietic Cell Transplantation Relationship Death Main Reason</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2768628</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12551:C15342:C25648:C28554</PreferredName>
        <Version>1</Version>
        <LongName>Hematopoietic Stem Cell Transplantation Relationship Death</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28554</PREFERRED_NAME>
            <LONG_NAME>Dead</LONG_NAME>
            <CON_ID>2202731</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2768363</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25562:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Main Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25562</PREFERRED_NAME>
            <LONG_NAME>Main</LONG_NAME>
            <CON_ID>2206300</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the main cause of death H</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the main cause of death HCT related?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the main cause of HSCT related death?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the main cause of HSCT related death?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did a particular HSCT-related main cause of death occur?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did a particular HSCT-related main cause of death occur?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping for CDE:2768639</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedMedicalConditionResult [death] &gt; AssessedResultRelationship &gt; PerformedObservation [primary etiology] &gt; PerformedClinicalInterpretation.value(ANY=&gt;DSET&lt;CD&gt;).item(CD).code WHERE  PerformedMedicalConditionResult.value = &quot;death&quot; AND AssessedResultRelationship.typeCode = &quot;primary etiology&quot; AND PerformedSubstanceAdministration.dateRange [transplant] IS LESS THAN PerformedObservation.dateRange [post-HSCT condition identifcation] AND PerformedObservation.dateRange [post-HSCT condition identifcation] IS LESS THAN PerformedMedicalConditionResult.occurrenceDateRange [death] AND PerformedObservation.dateRange [post-HSCT condition identifcation] &gt; PerformedObservationResult [post-HSCT condition] AND PerformedSubstanceAdministration &gt; DefinedSubstanceAdministration.nameCode = &quot;Administer Hematopoietic Stem Cell Product{transplantation}&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the physician consider the cause of death HCT related?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Did the physician consider the cause of death HCT related?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2450r1: Post-TED</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964925</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2455: Selective Post-Transplant Essential Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3160397</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>post_ted_hsct_cod_vod_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="631">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2771346</PUBLICID>
    <LONGNAME>Protocol Application Part Life Sciences Identifier Namespace java.lang.String</LONGNAME>
    <PREFERREDNAME>2771166v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The use of a protocol with the requisite Parameters and ParameterValues._One of the portions into which something is regarded as divided and which together constitute a whole.:A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:In general, a namespace is an abstract container, which is or could be filled by names, or technical terms, or words, and these represent or stand for real-world things.  A description logic terminology namespace is a collection of Kind, Role, Property and Concept definitions. As in computer programming, context namespaces are intended to allow multiple knowledge bases to reside in the same physical database. (from Apelon)_Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2771166</PublicId>
      <PreferredName>2236762v1.0:2771056v1.0</PreferredName>
      <PreferredDefinition>The use of a protocol with the requisite Parameters and ParameterValues._One of the portions into which something is regarded as divided and which together constitute a whole.:A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:In general, a namespace is an abstract container, which is or could be filled by names, or technical terms, or words, and these represent or stand for real-world things.  A description logic terminology namespace is a collection of Kind, Role, Property and Concept definitions. As in computer programming, context namespaces are intended to allow multiple knowledge bases to reside in the same physical database. (from Apelon)</PreferredDefinition>
      <LongName>Protocol Application Part Life Sciences Identifier Namespace</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236762</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C44184</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Application</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44184</PREFERRED_NAME>
            <LONG_NAME>Protocol Application Object</LONG_NAME>
            <CON_ID>2236570</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2771056</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45313:C47841:C42699</PreferredName>
        <Version>1</Version>
        <LongName>Part Life Sciences Identifier Namespace</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45313</PREFERRED_NAME>
            <LONG_NAME>Part</LONG_NAME>
            <CON_ID>2405237</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47841</PREFERRED_NAME>
            <LONG_NAME>Life Sciences Identifier</LONG_NAME>
            <CON_ID>2423426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42699</PREFERRED_NAME>
            <LONG_NAME>Namespace</LONG_NAME>
            <CON_ID>2222837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Protocol Application Part Life Sciences Identifier Namespace java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Protocol Application Part Life Sciences Identifier Namespace java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.protocol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812748</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.protocol.ProtocolApplication.lsidNamespace</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProtocolApplication:lsidNamespace</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="632">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2771351</PUBLICID>
    <LONGNAME>Nucleic Acids Biospecimen Part Life Sciences Identifier Organizational Unit java.lang.String</LONGNAME>
    <PREFERREDNAME>2771171v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A family of macromolecules, composed of various moiety: purines, pyrimidines, phosphoric acid, and a pentose, either d-ribose or d-deoxyribose. Nucleic acids in the form either DNA or RNA was found in the chromosomes, nucleoli, mitochondria, and cytoplasm of all cells, and in viruses.  Nucleic acids are the major players in controlling cellular function and heredity. (NCI):Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._One of the portions into which something is regarded as divided and which together constitute a whole.:A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:Organizational unit like a laboratory, institute or consortium._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2771171</PublicId>
      <PreferredName>2726731v1.0:2771055v1.0</PreferredName>
      <PreferredDefinition>A family of macromolecules, composed of various moiety: purines, pyrimidines, phosphoric acid, and a pentose, either d-ribose or d-deoxyribose. Nucleic acids in the form either DNA or RNA was found in the chromosomes, nucleoli, mitochondria, and cytoplasm of all cells, and in viruses.  Nucleic acids are the major players in controlling cellular function and heredity. (NCI):Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._One of the portions into which something is regarded as divided and which together constitute a whole.:A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:Organizational unit like a laboratory, institute or consortium.</PreferredDefinition>
      <LongName>Nucleic Acids Biospecimen Part Life Sciences Identifier Organizational Unit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2726731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C706:C70699</PreferredName>
        <Version>1</Version>
        <LongName>Nucleic Acids Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C706</PREFERRED_NAME>
            <LONG_NAME>Nucleic Acids</LONG_NAME>
            <CON_ID>2673214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2771055</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45313:C47841:C41167</PreferredName>
        <Version>1</Version>
        <LongName>Part Life Sciences Identifier Organizational Unit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45313</PREFERRED_NAME>
            <LONG_NAME>Part</LONG_NAME>
            <CON_ID>2405237</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47841</PREFERRED_NAME>
            <LONG_NAME>Life Sciences Identifier</LONG_NAME>
            <CON_ID>2423426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41167</PREFERRED_NAME>
            <LONG_NAME>Organizational Unit</LONG_NAME>
            <CON_ID>2223214</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Nucleic Acids Biospecimen Part Life Sciences Identifier Organizational Unit java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Nucleic Acids Biospecimen Part Life Sciences Identifier Organizational Unit java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812750</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.sample.Extract.lsidAuthority</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Extract:lsidAuthority</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="633">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2771962</PUBLICID>
    <LONGNAME>Natural Killer Cell Laboratory Procedure Cell Total Integer::2 Decimal Place Count</LONGNAME>
    <PREFERREDNAME>NKC_LP_CL_TL_I2_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>Natural killer cells are cells that resemble large granular lymphocytes.  They do not express markers of either T or B cell lineage. They are positive for CD16, CD56, and CD 94.  These cells do possess Fc receptors for IgG and can kill target cells using antibody-dependent cell-mediated cytotoxicity. They can also use perforin to kill cells in the absence of antibody and killing may occur without previous sensitization._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._A number with no fractional part, including the negative and positive numbers as well as zero.::2_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._To determine the number or amount of something; the result of this activity.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2771956</PublicId>
      <PreferredName>NK_CELL_LAB_PROC</PreferredName>
      <PreferredDefinition>Natural killer cells are cells that resemble large granular lymphocytes.  They do not express markers of either T or B cell lineage. They are positive for CD16, CD56, and CD 94.  These cells do possess Fc receptors for IgG and can kill target cells using antibody-dependent cell-mediated cytotoxicity. They can also use perforin to kill cells in the absence of antibody and killing may occur without previous sensitization._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.</PreferredDefinition>
      <LongName>Natural Killer Cell Laboratory Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2771954</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12536</PreferredName>
        <Version>1</Version>
        <LongName>Natural Killer Cell</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12536</PREFERRED_NAME>
            <LONG_NAME>Natural Killer Cell</LONG_NAME>
            <CON_ID>2614190</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2486250</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2794421</PublicId>
      <PreferredName>CELL_TTL_2D_CT</PreferredName>
      <PreferredDefinition>The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._A number with no fractional part, including the negative and positive numbers as well as zero.::2_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._To determine the number or amount of something; the result of this activity.</PreferredDefinition>
      <LongName>Cell Total Integer::2 Decimal Place Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>9999.99</DisplayFormat>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2794420</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12508:C25304:C45255::2:C42646</PreferredName>
        <Version>1</Version>
        <LongName>Cell Total Integer::2 Decimal Place Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12508</PREFERRED_NAME>
            <LONG_NAME>Cell</LONG_NAME>
            <CON_ID>2202900</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25304</PREFERRED_NAME>
            <LONG_NAME>Total</LONG_NAME>
            <CON_ID>2204938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total value of NK cells:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Total value of NK cells:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NK cells</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>NK cells:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2100r1: 100 Days Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964902</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2200r1: 6 Month to 2 Year Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964922</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2300r1: Greater Than 2 Years Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>dci_cells_nkcells</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="634">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2773029</PUBLICID>
    <LONGNAME>Name Convention Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2772381v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The words or language units by which a thing is known.:Something regarded as a normative example._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2772381</PublicId>
      <PreferredName>2772237v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>The words or language units by which a thing is known.:Something regarded as a normative example._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Name Convention Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2772237</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614:C61300</PreferredName>
        <Version>1</Version>
        <LongName>Name Convention</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61300</PREFERRED_NAME>
            <LONG_NAME>Convention</LONG_NAME>
            <CON_ID>2626356</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Name Convention Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Name Convention Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813050</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NamingConvention:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.administration.NamingConvention.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="635">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2773056</PUBLICID>
    <LONGNAME>Electronic Document Format Specification Created By java.lang.String</LONGNAME>
    <PREFERREDNAME>2772407v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Material recorded in a format that requires an electronic device to view or modify the content.:The organization of information according to preset specifications.:A detailed description of criteria for a piece of work._Indicates the person or authoritative body who brought the item into existence._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2772407</PublicId>
      <PreferredName>2772239v1.0:2231611v1.0</PreferredName>
      <PreferredDefinition>Material recorded in a format that requires an electronic device to view or modify the content.:The organization of information according to preset specifications.:A detailed description of criteria for a piece of work._Indicates the person or authoritative body who brought the item into existence.</PreferredDefinition>
      <LongName>Electronic Document Format Specification Created By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2772239</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C73620:C42761:C73537</PreferredName>
        <Version>1</Version>
        <LongName>Electronic Document Format Specification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73620</PREFERRED_NAME>
            <LONG_NAME>Electronic Document</LONG_NAME>
            <CON_ID>2772172</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42761</PREFERRED_NAME>
            <LONG_NAME>Format</LONG_NAME>
            <CON_ID>2231562</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73537</PREFERRED_NAME>
            <LONG_NAME>Specification</LONG_NAME>
            <CON_ID>2772177</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42628</PreferredName>
        <Version>1</Version>
        <LongName>Created By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42628</PREFERRED_NAME>
            <LONG_NAME>Created By</LONG_NAME>
            <CON_ID>2231551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Electronic Document Format Specification Created By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Electronic Document Format Specification Created By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813050</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.administration.FileFormatSpecification.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FileFormatSpecification:createdBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="636">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2773230</PUBLICID>
    <LONGNAME>Summary Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2772580v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A shortened version of a speech or written text, containing only the main points._The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2772580</PublicId>
      <PreferredName>2772258v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>A shortened version of a speech or written text, containing only the main points._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Summary Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2772258</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42581</PreferredName>
        <Version>1</Version>
        <LongName>Summary</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42581</PREFERRED_NAME>
            <LONG_NAME>Summary</LONG_NAME>
            <CON_ID>2203701</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Summary Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Summary Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.report.Summary.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Summary:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="637">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2773379</PUBLICID>
    <LONGNAME>Biological Characteristic Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2772725v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Pertaining to biology or to life and living things.:The distinguishing qualities or prominent aspect of a person, object, action, process, or substance._The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2772725</PublicId>
      <PreferredName>2772255v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>Pertaining to biology or to life and living things.:The distinguishing qualities or prominent aspect of a person, object, action, process, or substance._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Biological Characteristic Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2772255</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28226:C25447</PreferredName>
        <Version>1</Version>
        <LongName>Biological Characteristic</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28226</PREFERRED_NAME>
            <LONG_NAME>Biological</LONG_NAME>
            <CON_ID>2206378</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25447</PREFERRED_NAME>
            <LONG_NAME>Characteristic</LONG_NAME>
            <CON_ID>2203874</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Biological Characteristic Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Biological Characteristic Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BioCharacteristics:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.BioCharacteristics.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="638">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2773439</PUBLICID>
    <LONGNAME>Cell Specimen Activity Status java.lang.String</LONGNAME>
    <PREFERREDNAME>2513565v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid. Cells are highly variable and specialized in both structure and function, though all must at some stage replicate proteins and nucleic acids, utilize energy, and reproduce themselves.:Specimen; a bit of tissue or blood or urine that is taken or used for research purposes._The state of being active; any specific activity.:A condition or state at a particular time._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2513565</PublicId>
      <PreferredName>2206545v1.0:2513283v1.0</PreferredName>
      <PreferredDefinition>The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid. Cells are highly variable and specialized in both structure and function, though all must at some stage replicate proteins and nucleic acids, utilize energy, and reproduce themselves.:Specimen; a bit of tissue or blood or urine that is taken or used for research purposes._The state of being active; any specific activity.:A condition or state at a particular time.</PreferredDefinition>
      <LongName>Cell Specimen Activity Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206545</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12508:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Cell Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12508</PREFERRED_NAME>
            <LONG_NAME>Cell</LONG_NAME>
            <CON_ID>2202900</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2513283</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43431:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Activity Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Cell Specimen Activity Status java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Cell Specimen Activity Status java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CellSpecimen:activityStatus</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.CellSpecimen.activityStatus</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="639">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2774431</PUBLICID>
    <LONGNAME>Neurological Evaluation Reflex Function Deep Tendon Reflex Criterion Type</LONGNAME>
    <PREFERREDNAME>NEURO_DTR_CRIT_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Text to capture criteria used for an examination of the deep tendon reflex (DTR) component on a neurological evaluation. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188956</PublicId>
      <PreferredName>NEURO_EVAL_REF_FUNC</PreferredName>
      <PreferredDefinition>information related to reflex neurological evaluation function.</PreferredDefinition>
      <LongName>Neurological Evaluation Reflex Function</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206617</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25262:C25214</PreferredName>
        <Version>1</Version>
        <LongName>Neurologic Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25262</PREFERRED_NAME>
            <LONG_NAME>Neurologic</LONG_NAME>
            <CON_ID>2202770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660698</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0034929:C25518</PreferredName>
        <Version>1</Version>
        <LongName>Reflex Function</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0034929</PREFERRED_NAME>
            <LONG_NAME>Reflex</LONG_NAME>
            <CON_ID>2615943</CON_ID>
            <DEFINITION_SOURCE>MSH2005_2004_10_12</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25518</PREFERRED_NAME>
            <LONG_NAME>Function</LONG_NAME>
            <CON_ID>2202643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2774421</PublicId>
      <PreferredName>DTR_EVAL_CRIT_TP</PreferredName>
      <PreferredDefinition>An appraisal or evaluation of a patient&#39;s condition by a physician or registered nurse, based on clinical and laboratory data, medical history, and the patient&#39;s account of symptoms.  2. The process by which a patient&#39;s condition is appraised or evaluated. (Taber&#39;s)_That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison._Type; a subdivision of a particular kind of thing._Pertaining to or used in or practicing neurology.._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria._That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison._Muscle; one of the contractile organs of the body._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria._That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.</PreferredDefinition>
      <LongName>Deep Tendon Reflex Evaluation Criterion Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2774420</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13056:C25214:C25466:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Muscle Evaluation Criterion Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13056</PREFERRED_NAME>
            <LONG_NAME>Muscle</LONG_NAME>
            <CON_ID>2453608</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25466</PREFERRED_NAME>
            <LONG_NAME>Criterion</LONG_NAME>
            <CON_ID>2203889</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ankle Jerk</VALIDVALUE>
          <VALUEMEANING>Ankle Jerk Reflex</VALUEMEANING>
          <MEANINGDESCRIPTION>Ankle Jerk Reflex</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2774422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Knee Jerk</VALIDVALUE>
          <VALUEMEANING>Knee Jerk Reflex</VALUEMEANING>
          <MEANINGDESCRIPTION>Knee Jerk Reflex</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2774423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Triceps</VALIDVALUE>
          <VALUEMEANING>Triceps</VALUEMEANING>
          <MEANINGDESCRIPTION>A skeletal muscle of the limb comprised of three muscular bundles called the heads that originate seperately and join together.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33812</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2774425</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biceps</VALIDVALUE>
          <VALUEMEANING>Biceps</VALUEMEANING>
          <MEANINGDESCRIPTION>A muscle in the upper arm. Its action involves the rotation of the arm and the flexing of the elbow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2774427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Deep Tendon Reflexes</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Deep Tendon Reflexes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Catheter Protocol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886752</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>For Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3891931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="640">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2774522</PUBLICID>
    <LONGNAME>Erythrocyte Count Reduced Method Sedimentation Performed Indicator</LONGNAME>
    <PREFERREDNAME>ER_RD_ME_SED_PRF_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the method used to reduce the erythrocyte count was sedimentation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2774518</PublicId>
      <PreferredName>ERYT_RDC_MTH_SED_PRF</PreferredName>
      <PreferredDefinition>The determination of the number of erythrocytes in a blood sample._Made less in size or amount or degree._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._The act or process of settling particles by mechanical means from a state of suspension in air or water._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Erythrocyte Count Reduced Method Sedimentation Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435033</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16847</PreferredName>
        <Version>1</Version>
        <LongName>Techniques</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2774157</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C51946:C25640:C71460</PreferredName>
        <Version>1</Version>
        <LongName>Erythrocyte Count Reduced Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51946</PREFERRED_NAME>
            <LONG_NAME>Erythrocyte Count</LONG_NAME>
            <CON_ID>2743985</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25640</PREFERRED_NAME>
            <LONG_NAME>Reduced</LONG_NAME>
            <CON_ID>2204920</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2774516</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54178:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Sedimentation Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54178</PREFERRED_NAME>
            <LONG_NAME>Sedimentation</LONG_NAME>
            <CON_ID>2614285</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was sedimentation used to man</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was sedimentation used to manipulate the product?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Sedimentation (i.e., hetastarch)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Sedimentation (i.e., hetastarch)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Sedimentation</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Sedimentation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2100r1: 100 Days Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964902</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2006r1: HSCT Infusion</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2200r1: 6 Month to 2 Year Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964922</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2300r1: Greater Than 2 Years Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_proc_abo_sedimntn_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>dci_manip_abo_sediment_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="641">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2778154</PUBLICID>
    <LONGNAME>Recurrent Or Progressive Disease or Disorder Detected Finding Molecular Analysis Indicator</LONGNAME>
    <PREFERREDNAME>RP_DIS_DE_MO_AN_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the disease relapse or progression was detected by molecular analysis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2778146</PublicId>
      <PreferredName>RE_PR_DI_DE_MO_AN</PreferredName>
      <PreferredDefinition>The return of a disease after a period of remission._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Perceived, discerned, or discovered._A laboratory procedure that involves the study of tissues, cells, and fluids using techniques to analyze biologically active molecules, including nucleic acids, proteins, lipids and carbohydrates, for the identification of processes, characteristics and abnormalities at the molecular level.</PreferredDefinition>
      <LongName>Recurrent Disease Or Progressive Disease Disease or Disorder Detected Finding Molecular Analysis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2778143</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38155:C37998:C35571:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Recurrent Disease Or PD Disease or Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38155</PREFERRED_NAME>
            <LONG_NAME>Recurrent Disease</LONG_NAME>
            <CON_ID>2202887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C35571</PREFERRED_NAME>
            <LONG_NAME>Progressive Disease</LONG_NAME>
            <CON_ID>2202776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16181622</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C191719:C19770</PreferredName>
        <Version>1</Version>
        <LongName>Detected Finding Molecular Analysis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C191719</PREFERRED_NAME>
            <LONG_NAME>Detected Finding</LONG_NAME>
            <CON_ID>12573666</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19770</PREFERRED_NAME>
            <LONG_NAME>Molecular Analysis</LONG_NAME>
            <CON_ID>2528322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the disease relapse or pr</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the disease relapse or progression detected by a molecular method?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Relapse / progression detected by molecular method:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Relapse / progression detected by molecular method:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If yes, was the status considered a disease relapse or progression?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If yes, was the status considered a disease relapse or progression?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a disease relapse or progression detected by molecular testing (e.g. PCR)?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Was a disease relapse or progression detected by molecular testing (e.g. PCR)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a disease relapse or progression detected by molecular testing?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was a disease relapse or progression detected by molecular testing?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_dis_rel_progress_detect_mole_test_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_DRPI_rel_pr_det_ml_tst_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_DRPI_rel_pr_dt_mo_tst_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="642">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2778510</PUBLICID>
    <LONGNAME>Gene Delivery Alternative Entry Viral Vector java.lang.String</LONGNAME>
    <PREFERREDNAME>2778417v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Gene is delivered to specific organs or specific receptors within the animal model. using viral vectors (caBIO)_Available in place of something else.:An item inserted in a written or electronic record.:A viral gene transduction agent used to transfer genes or genetic materials, such as retroviruses and adenoviruses._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2778417</PublicId>
      <PreferredName>2224122v1.0:2778322v1.0</PreferredName>
      <PreferredDefinition>Gene is delivered to specific organs or specific receptors within the animal model. using viral vectors (caBIO)_Available in place of something else.:An item inserted in a written or electronic record.:A viral gene transduction agent used to transfer genes or genetic materials, such as retroviruses and adenoviruses.</PreferredDefinition>
      <LongName>Gene Delivery Alternative Entry Viral Vector</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2224122</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41096</PreferredName>
        <Version>1</Version>
        <LongName>Gene Delivery</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41096</PREFERRED_NAME>
            <LONG_NAME>Gene Delivery</LONG_NAME>
            <CON_ID>2224014</CON_ID>
            <DEFINITION_SOURCE>CABIO</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2778322</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25415:C43381:C2173</PreferredName>
        <Version>1</Version>
        <LongName>Alternative Entry Viral Vector</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25415</PREFERRED_NAME>
            <LONG_NAME>Alternative</LONG_NAME>
            <CON_ID>2206155</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43381</PREFERRED_NAME>
            <LONG_NAME>Entry</LONG_NAME>
            <CON_ID>2236576</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2173</PREFERRED_NAME>
            <LONG_NAME>Viral Vector</LONG_NAME>
            <CON_ID>2224015</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Gene Delivery Alternative Entry Viral Vector java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Gene Delivery Alternative Entry Viral Vector java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.GeneDelivery.viralVectorAlternEntry</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GeneDelivery:viralVectorAlternEntry</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="643">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2783707</PUBLICID>
    <LONGNAME>Satellite Nodule Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2782943v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Additional, separate neoplastic nodules surrounding a central neoplastic lesion._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2782943</PublicId>
      <PreferredName>2782766v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Additional, separate neoplastic nodules surrounding a central neoplastic lesion._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Satellite Nodule Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2782766</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48598</PreferredName>
        <Version>1</Version>
        <LongName>Satellite Nodule</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48598</PREFERRED_NAME>
            <LONG_NAME>Satellite Nodule</LONG_NAME>
            <CON_ID>2431173</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Satellite Nodule Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Satellite Nodule Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_SCG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000322</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_SCG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000323</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SatelliteNodule:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.PathAnnotation_SCG.SatelliteNodule.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="644">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2783896</PUBLICID>
    <LONGNAME>Report Section Document Fragment java.lang.String</LONGNAME>
    <PREFERREDNAME>2783131v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A short textual account.:One of several parts or pieces that fit with others to constitute a whole object; a self-contained part of a larger composition (written or musical)._An organized collection of records that describe a particular body of data.:A part of a larger entity._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2783131</PublicId>
      <PreferredName>2475319v1.0:2782725v1.0</PreferredName>
      <PreferredDefinition>A short textual account.:One of several parts or pieces that fit with others to constitute a whole object; a self-contained part of a larger composition (written or musical)._An organized collection of records that describe a particular body of data.:A part of a larger entity.</PreferredDefinition>
      <LongName>Report Section Document Fragment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2475319</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25375:C54091</PreferredName>
        <Version>1</Version>
        <LongName>Report Section</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54091</PREFERRED_NAME>
            <LONG_NAME>Section</LONG_NAME>
            <CON_ID>2475257</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2782725</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70899:C48295</PreferredName>
        <Version>1</Version>
        <LongName>Document Fragment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70899</PREFERRED_NAME>
            <LONG_NAME>Document</LONG_NAME>
            <CON_ID>2707704</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48295</PREFERRED_NAME>
            <LONG_NAME>Fragment</LONG_NAME>
            <CON_ID>2388822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Report Section Document Fragment java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Report Section Document Fragment java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.pathology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000671</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.pathology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000670</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ReportSection:documentFragment</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.pathology.ReportSection.documentFragment</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="645">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2783918</PUBLICID>
    <LONGNAME>Consent Response Response ConsentTierResponseResponse</LONGNAME>
    <PREFERREDNAME>2783151v1.0:2783561v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Permission to do something.:Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._Response is any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._participant agreement or disagreement to one or more consent tiers when registered to a collection protocol</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2783151</PublicId>
      <PreferredName>2782847v1.0:2193203v1.0</PreferredName>
      <PreferredDefinition>Permission to do something.:Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._Response is any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.</PreferredDefinition>
      <LongName>Consent Response Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2782847</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25460:C25755</PreferredName>
        <Version>1</Version>
        <LongName>Consent Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25460</PREFERRED_NAME>
            <LONG_NAME>Consent</LONG_NAME>
            <CON_ID>2203590</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25755</PREFERRED_NAME>
            <LONG_NAME>Response</LONG_NAME>
            <CON_ID>2202805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2193203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25755</PreferredName>
        <Version>1</Version>
        <LongName>Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25755</PREFERRED_NAME>
            <LONG_NAME>Response</LONG_NAME>
            <CON_ID>2202805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2783561</PublicId>
      <PreferredName>2783561v1.0</PreferredName>
      <PreferredDefinition>participant agreement or disagreement to one or more consent tiers when registered to a collection protocol</PreferredDefinition>
      <LongName>ConsentTierResponseResponse</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>notSpecified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2573360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>withdrawn</VALIDVALUE>
          <VALUEMEANING>Withdrawn</VALUEMEANING>
          <MEANINGDESCRIPTION>Withdrawn; having ceased active participation in.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38061</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2573942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>no</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Consent Response Response ConsentTierResponseResponse does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Consent Response Response ConsentTierResponseResponse does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000638</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000639</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ConsentTierResponse:response</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.ConsentTierResponse.response</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="646">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2784447</PUBLICID>
    <LONGNAME>Tissue Donor Recipient RelationshipType</LONGNAME>
    <PREFERREDNAME>DNR_RCP_RLTV_TYPE</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the relationship of the donor to the recipient.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2784445</PublicId>
      <PreferredName>DNR_RECP_RLTV</PreferredName>
      <PreferredDefinition>Someone who gives blood or tissue or an organ to be used in another person._A person who gets something._A state of connectedness between people, objects, or events; to be associated or connected with something.</PreferredDefinition>
      <LongName>Tissue Donor  Recipient Relationship</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25168</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Donor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2784443</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C53268:C25648</PreferredName>
        <Version>1</Version>
        <LongName>Recipient Relationship</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53268</PREFERRED_NAME>
            <LONG_NAME>Recipient</LONG_NAME>
            <CON_ID>2512693</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2633530</PublicId>
      <PreferredName>DNR_RCP_RLTN_TYP</PreferredName>
      <PreferredDefinition>Someone who gives blood or tissue or an organ to be used in another person._In medicine, a person who receives blood, cells, tissue, or an organ from another person, such as in a blood transfusion or an organ transplant._A state of connectedness between people, objects, or events; to be associated or connected with something._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Tissue Donor Recipient Relationship Type</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008570</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PERSONAL_ATTRIBUTES</PreferredName>
        <Version>1</Version>
        <LongName>Personal attributes</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2728878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25168:C53268:C25648:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Donor Recipient Related Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53268</PREFERRED_NAME>
            <LONG_NAME>Recipient</LONG_NAME>
            <CON_ID>2512693</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cousin</VALIDVALUE>
          <VALUEMEANING>Cousin</VALUEMEANING>
          <MEANINGDESCRIPTION>A child of your aunt or uncle or their descendents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uncle</VALIDVALUE>
          <VALUEMEANING>Uncle</VALUEMEANING>
          <MEANINGDESCRIPTION>The brother of your father or mother; the husband of your aunt.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2716527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aunt</VALIDVALUE>
          <VALUEMEANING>Aunt</VALUEMEANING>
          <MEANINGDESCRIPTION>The sister of your father or mother; the wife of your uncle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parent</VALIDVALUE>
          <VALUEMEANING>Parent</VALUEMEANING>
          <MEANINGDESCRIPTION>A mother or a father; the immediate progenitor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42709</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2716524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other relative</VALIDVALUE>
          <VALUEMEANING>Other Relative</VALUEMEANING>
          <MEANINGDESCRIPTION>Not otherwise specified.: Relative; a person related by blood or marriage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C21480, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recipient&#39;s child</VALIDVALUE>
          <VALUEMEANING>Recipient Child</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who gets something.: A human offspring (son or daughter) of any age; an immediate progeny.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42708, C53268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2728845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sibling</VALIDVALUE>
          <VALUEMEANING>SIBLING</VALUEMEANING>
          <MEANINGDESCRIPTION>SIBLING</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unrelated</VALIDVALUE>
          <VALUEMEANING>Unrelated</VALUEMEANING>
          <MEANINGDESCRIPTION>A characteristic used to qualify the adverse event as clearly not related to the medical intervention.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other biological relative</VALIDVALUE>
          <VALUEMEANING>Other Biological Relative</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A person related by descent rather than by marriage or law.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71384, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3004998</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Syngeneic (identical) twin</VALIDVALUE>
          <VALUEMEANING>Identical Twin</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two offspring resulting from a shared ovum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3870108</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fraternal twin</VALIDVALUE>
          <VALUEMEANING>Fraternal Twin</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two offspring from separately fertilized ova during the same pregnancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3870107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Half-sibling</VALIDVALUE>
          <VALUEMEANING>Half Sibling</VALUEMEANING>
          <MEANINGDESCRIPTION>A sibling with whom you share a single parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal cousin</VALIDVALUE>
          <VALUEMEANING>Biological Paternal Cousin</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative who is the offspring of a sibling of the biological father and thus sharing a common ancestor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96582</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3870403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal uncle</VALIDVALUE>
          <VALUEMEANING>Biological Paternal Uncle</VALUEMEANING>
          <MEANINGDESCRIPTION>A male relative who is a sibling of the biological father, and who both share a common ancestor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3870404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal aunt</VALIDVALUE>
          <VALUEMEANING>Biological Paternal Aunt</VALUEMEANING>
          <MEANINGDESCRIPTION>A female relative who is a sibling of the biological father, and who both share a common ancestor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96581</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3870405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal cousin</VALIDVALUE>
          <VALUEMEANING>Biological Maternal Cousin</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative who is the offspring of a sibling of the biological mother and thus sharing a common ancestor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3870406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal uncle</VALIDVALUE>
          <VALUEMEANING>Biological Maternal Uncle</VALUEMEANING>
          <MEANINGDESCRIPTION>A male relative who is a sibling of the biological mother, and who both share a common ancestor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96579</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3870407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal aunt</VALIDVALUE>
          <VALUEMEANING>Biological Maternal Aunt</VALUEMEANING>
          <MEANINGDESCRIPTION>A female relative who is a sibling of the biological mother, and who both share a common ancestor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96575</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3870408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mother</VALIDVALUE>
          <VALUEMEANING>Biological Mother</VALUEMEANING>
          <MEANINGDESCRIPTION>A female who contributes to the genetic makeup of her offspring from the fertilization of her ovum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96580</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3870413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Father</VALIDVALUE>
          <VALUEMEANING>Biological Father</VALUEMEANING>
          <MEANINGDESCRIPTION>A male who contributes to the genetic makeup of his offspring through the fertilization of an ovum by his sperm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96572</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3870409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grandchild</VALIDVALUE>
          <VALUEMEANING>Grandchild</VALUEMEANING>
          <MEANINGDESCRIPTION>A child of your son or daughter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grandparent</VALIDVALUE>
          <VALUEMEANING>Grandparent</VALUEMEANING>
          <MEANINGDESCRIPTION>A parent of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2716523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unspecified cousin</VALIDVALUE>
          <VALUEMEANING>Unspecified Biological Cousin</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.: A relative who is the offspring of a sibling of either of the biological parents, and who share a common ancestor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96571, C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7144097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unspecified uncle</VALIDVALUE>
          <VALUEMEANING>Unspecified Biological Uncle</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.: A male relative who is a sibling of either of the biological parents, and who share a common ancestor. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96587, C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7144098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unspecified aunt</VALIDVALUE>
          <VALUEMEANING>Unspecified Biological Aunt</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.: A female relative who is a sibling of either of the biological parents, and who share a common ancestor. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96569, C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7144099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Full sibling</VALIDVALUE>
          <VALUEMEANING>Full Sibling</VALUEMEANING>
          <MEANINGDESCRIPTION>A sibling with whom you share both parents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7144100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the relationship of t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the relationship of the donor to the recipient?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping for CDE:2784447</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>Subject [donor] &gt; BiologicEntitiy &gt; AssociatedBiologicEntity.typeCode WHERE AssociatedBiologicEntity &gt; Subject [recipient]</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2006r1: HSCT Infusion</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_demo_dnr_relation_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AssociatedBiologicEntity:typeCode</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="647">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2794168</PUBLICID>
    <LONGNAME>Dental Professional Practice National Meeting Use Frequency</LONGNAME>
    <PREFERREDNAME>DENT_PP_N_M_U_FREQ</PREFERREDNAME>
    <PREFERREDDEFINITION>the frequency of use as related to National meeting being used in business directed towards treatment and care of patients pertaining to a tooth or teeth, or to odontology.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2764384</PublicId>
      <PreferredName>DEN_PRP_N_MTG_USE</PreferredName>
      <PreferredDefinition>information related to National meeting being used in business directed towards treatment and care of patients pertaining to a tooth or teeth, or to odontology.</PreferredDefinition>
      <LongName>Dental Professional Practice National Meeting Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443314</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C52673</PreferredName>
        <Version>1</Version>
        <LongName>Dental Professional Practice</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52673</PREFERRED_NAME>
            <LONG_NAME>Professional Practice</LONG_NAME>
            <CON_ID>2443152</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2764382</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61423:C52661:C25340</PreferredName>
        <Version>1</Version>
        <LongName>National Meeting Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61423</PREFERRED_NAME>
            <LONG_NAME>National</LONG_NAME>
            <CON_ID>2516882</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52661</PREFERRED_NAME>
            <LONG_NAME>Meeting</LONG_NAME>
            <CON_ID>2443140</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2794143</PublicId>
      <PreferredName>DENT_PP_USE_FREQ</PreferredName>
      <PreferredDefinition>the occurrence of use in the dental professional practice.</PreferredDefinition>
      <LongName>Dental Professional Practice Use Frequency</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
      <Representation>
        <PublicId>2443080</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25515</PreferredName>
        <Version>1</Version>
        <LongName>Temporal Frequency</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-10-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite frequently or every time available</VALIDVALUE>
          <VALUEMEANING>Quite frequently or every time available</VALUEMEANING>
          <MEANINGDESCRIPTION>Quite frequently or every time available</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-10-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2794146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>National dental meetings</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>National dental meetings</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="648">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2802281</PUBLICID>
    <LONGNAME>Patient Difficulty Comprehension Symptom Scale</LONGNAME>
    <PREFERREDNAME>PT_DIF_COMP_SYM_SCAL</PREFERREDNAME>
    <PREFERREDDEFINITION>the person&#39;s symptom scale as related to trouble with understanding as an indication of a condition or disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2802200</PublicId>
      <PreferredName>PT_DIFF_COMP_SYMPT</PreferredName>
      <PreferredDefinition>information related to trouble with understanding as an indication that a person has a condition or disease.</PreferredDefinition>
      <LongName>Patient Difficulty Comprehension Symptom</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008575</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SM</PreferredName>
        <Version>1</Version>
        <LongName>Symptoms</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2802198</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62189:C0162340:C4876</PreferredName>
        <Version>1</Version>
        <LongName>Difficulty Comprehension Symptom</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62189</PREFERRED_NAME>
            <LONG_NAME>Difficulty</LONG_NAME>
            <CON_ID>2503546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0162340</PREFERRED_NAME>
            <LONG_NAME>Comprehension</LONG_NAME>
            <CON_ID>2204368</CON_ID>
            <DEFINITION_SOURCE>CSP2003</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2801776</PublicId>
      <PreferredName>PERSON_SM_SCALE</PreferredName>
      <PreferredDefinition>the person&#39;s symptom scale.</PreferredDefinition>
      <LongName>Person Symptom Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008575</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SM</PreferredName>
        <Version>1</Version>
        <LongName>Symptoms</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>WHOLE NUMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>WHOLE NUMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Your difficulty understanding</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Your difficulty understanding at its worst</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="649">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2848561</PUBLICID>
    <LONGNAME>Tissue Sample Child-Pugh Classification java.lang.String</LONGNAME>
    <PREFERREDNAME>2848409v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A piece of tissue removed from an organism for examination, analysis, or propagation.:A standardized rating scale used to assess the severity of liver cirrhosis and determine the prognosis, the required strength of treatment, and the necessity of liver transplantation. This instrument uses the following clinical and lab criteria: encephalopathy grade, ascites, bilirubin, albumin, and prothrombin index._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2848409</PublicId>
      <PreferredName>2480187v1.00:7115533v1.00</PreferredName>
      <PreferredDefinition>A piece of tissue removed from an organism for examination, analysis, or propagation.:A standardized rating scale used to assess the severity of liver cirrhosis and determine the prognosis, the required strength of treatment, and the necessity of liver transplantation. This instrument uses the following clinical and lab criteria: encephalopathy grade, ascites, bilirubin, albumin, and prothrombin index.</PreferredDefinition>
      <LongName>Tissue Sample Child-Pugh Classification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480187</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19697</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Sample</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19697</PREFERRED_NAME>
            <LONG_NAME>Tissue Sample</LONG_NAME>
            <CON_ID>2222017</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7115533</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121007</PreferredName>
        <Version>1</Version>
        <LongName>Child-Pugh Clinical Classification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121007</PREFERRED_NAME>
            <LONG_NAME>Child-Pugh Clinical Classification</LONG_NAME>
            <CON_ID>6092438</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Tissue Sample Child-Pugh Classification java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Tissue Sample Child-Pugh Classification java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2611721</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CGWB</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cgwb.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000139</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cgwb.domain.Sample.childPughClass</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Sample:childPughClass</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="650">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2848676</PUBLICID>
    <LONGNAME>Dermatology Life Quality Index Complete Indicator</LONGNAME>
    <PREFERREDNAME>DERM_LIFQUALIDX_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to signify that the Dermatology Life Quality Index tool, with 10 items, was completed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2848674</PublicId>
      <PreferredName>DERM_LIFQUALIDX_COMP</PreferredName>
      <PreferredDefinition>A medical specialty concerned with the skin, its structure, functions, diseases, and treatment. (MeSH)_Life; the organic phenomenon that distinguishes living organisms from nonliving ones._An essential and distinguishing attribute of something or someone; a degree or grade of excellence or worth._Index; a numerical scale used to compare variables with one another or with some reference number._Complete; having every necessary or normal part or component or step; or having come or been brought to a conclusion.</PreferredDefinition>
      <LongName>Dermatology Life Quality Index Complete</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2848672</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16500:C37987:C25283:C25390</PreferredName>
        <Version>1</Version>
        <LongName>Dermatology Life Quality Index</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16500</PREFERRED_NAME>
            <LONG_NAME>Dermatology</LONG_NAME>
            <CON_ID>2202424</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37987</PREFERRED_NAME>
            <LONG_NAME>Alive</LONG_NAME>
            <CON_ID>2210813</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25283</PREFERRED_NAME>
            <LONG_NAME>Quality</LONG_NAME>
            <CON_ID>2203963</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25390</PREFERRED_NAME>
            <LONG_NAME>Index</LONG_NAME>
            <CON_ID>2203825</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2405014</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25250</PreferredName>
        <Version>1</Version>
        <LongName>Complete</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25250</PREFERRED_NAME>
            <LONG_NAME>Complete</LONG_NAME>
            <CON_ID>2203885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181608</PublicId>
      <PreferredName>Y_N_CHAR_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Character Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DLQI completed?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>DLQI completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="651">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2854093</PUBLICID>
    <LONGNAME>HER2/neu Therapy Prior Post Surgical Procedure Administered Ind-2</LONGNAME>
    <PREFERREDNAME>HER2_T_P_P_S_AD_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether HER2-targeted therapy was administered preoperatively or postoperatively.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2854083</PublicId>
      <PreferredName>HER2_TX_P_P_SP_ADMIN</PreferredName>
      <PreferredDefinition>information relating to HER2 (the ERBB2 Gene at 17q21.1 that encodes ERRB2 Receptor Protein Tyrosine Kinase) therapy (an action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process) administered (given) either prior to or after a surgical procedure (operative procedures on organs, regions, or tissues in the treatment of diseases).</PreferredDefinition>
      <LongName>HER2/neu Therapy Prior Post Surgical Procedure Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2854080</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17756:C15368</PreferredName>
        <Version>1</Version>
        <LongName>HER2/neu Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17756</PREFERRED_NAME>
            <LONG_NAME>ERBB2 Gene</LONG_NAME>
            <CON_ID>2202658</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2854081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C38008:C0038895:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Prior Post Surgical Procedure Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0038895</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2238392</CON_ID>
            <DEFINITION_SOURCE>MSH2004_2003_12_12</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was HER2-targeted therapy adm</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was HER2-targeted therapy administered pre-operatively or post-operatively prior to study entry</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was anti-HER2 therapy not previously noted administered before surgery?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="652">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2856608</PUBLICID>
    <LONGNAME>Specimen Other Submission Specify</LONGNAME>
    <PREFERREDNAME>SPEC_OTH_SUBM_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free-text field to specify the type of other specimen being submitted.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2856604</PublicId>
      <PreferredName>SPEC_OTH_SUBM</PreferredName>
      <PreferredDefinition>information related to other specimen being submitted.</PreferredDefinition>
      <LongName>Specimen Other Submission</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2241613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2856602</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25695</PreferredName>
        <Version>1</Version>
        <LongName>Other Submission</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25695</PREFERRED_NAME>
            <LONG_NAME>Submission</LONG_NAME>
            <CON_ID>2203811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180669</PublicId>
      <PreferredName>SPEC_CHAR_SPEC</PreferredName>
      <PreferredDefinition>information related to specified characteristics of a specimen.</PreferredDefinition>
      <LongName>Specimen Characteristics Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Other, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Muscle Invasive Blad</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000462</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="653">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2857291</PUBLICID>
    <LONGNAME>Current Treatment Study Best Response Type</LONGNAME>
    <PREFERREDNAME>CR_TR_STD_BST_RSP_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>The subdivision that describes most positive improvement related to treatment on the study protocol evaluating intervention at the present point in time.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2857283</PublicId>
      <PreferredName>CUR_TRMT_STD_BS_RSP</PreferredName>
      <PreferredDefinition>The most positive improvement related to treatment on the study protocol evaluating intervention at the present point in time.</PreferredDefinition>
      <LongName>Current Treatment Study Best Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2857281</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25471:C49656</PreferredName>
        <Version>1</Version>
        <LongName>Current Treatment Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49656</PREFERRED_NAME>
            <LONG_NAME>Treatment Study</LONG_NAME>
            <CON_ID>2480684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2751982</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25432:C50995</PreferredName>
        <Version>1</Version>
        <LongName>Best Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25432</PREFERRED_NAME>
            <LONG_NAME>Best</LONG_NAME>
            <CON_ID>2206164</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50995</PREFERRED_NAME>
            <LONG_NAME>Disease Response</LONG_NAME>
            <CON_ID>2459436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2857285</PublicId>
      <PreferredName>TRMT_STDY_BST_RSP_TP</PreferredName>
      <PreferredDefinition>The subdivision that describes most positive improvement related to treatment on the study protocol evaluating intervention.</PreferredDefinition>
      <LongName>Treatment Study Best Response Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2857284</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49656:C25432:C50995:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Treatment Study Best Response Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49656</PREFERRED_NAME>
            <LONG_NAME>Treatment Study</LONG_NAME>
            <CON_ID>2480684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25432</PREFERRED_NAME>
            <LONG_NAME>Best</LONG_NAME>
            <CON_ID>2206164</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50995</PREFERRED_NAME>
            <LONG_NAME>Disease Response</LONG_NAME>
            <CON_ID>2459436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Too Early to Assess per Protocol</VALIDVALUE>
          <VALUEMEANING>Too Early to Assess per Protocol</VALUEMEANING>
          <MEANINGDESCRIPTION>At or near the beginning of a period of time or course of events.: Aspects of the context prevent the evaluation needed to determine a value.: For each, generally denoting a ratio.: An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25320, C65039, C48657, C61589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surgical Progressive Disease</VALIDVALUE>
          <VALUEMEANING>Surgical PD</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35571, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2857286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stable Disease</VALIDVALUE>
          <VALUEMEANING>Stable Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Cancer that is neither decreasing nor increasing in extent or severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2771435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiographic Progressive Disease</VALIDVALUE>
          <VALUEMEANING>Radiograph PD</VALUEMEANING>
          <MEANINGDESCRIPTION>An image produced on a radiosensitive surface by x-ray radiation that has penetrated and passed through a structure.: Cancer that is increasing in scope or severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35571, C60727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2857287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial Response</VALIDVALUE>
          <VALUEMEANING>Partial Response</VALUEMEANING>
          <MEANINGDESCRIPTION>A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2857275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Evaluable</VALIDVALUE>
          <VALUEMEANING>Not evaluated</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25214, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2769814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Assessed</VALIDVALUE>
          <VALUEMEANING>Not Assessed</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Having determined the value, significance, or extent of.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25594, C25217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688820</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable per Protocol</VALIDVALUE>
          <VALUEMEANING>Not Applicable Per Clinical Study Protocol</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination that a value is not relevant in the current context.: For each, generally denoting a ratio.: An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25320, C65039, C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2857288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complete Response</VALIDVALUE>
          <VALUEMEANING>Complete Response</VALUEMEANING>
          <MEANINGDESCRIPTION>Complete; having every necessary or normal part or component or step; or having come or been brought to a conclusion.: In medicine, an improvement related to treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50995, C25250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2857276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clinical Progressive Disease</VALIDVALUE>
          <VALUEMEANING>Clinical Progressive Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the examination and treatment of patients.: Cancer that is increasing in scope or severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35571, C25398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2857289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Minimal/Marginal Response</VALIDVALUE>
          <VALUEMEANING>Marginal Response</VALUEMEANING>
          <MEANINGDESCRIPTION>Of questionable or minimal quality; just barely adequate or within a lower limit.: The pathologic and/or clinical changes that result from treatment. The changes may refer to eradication of detectable disease, stabilization of disease, or disease progression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50995, C67037</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3756751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complete Response Unconfirmed</VALIDVALUE>
          <VALUEMEANING>Not Confirmed CR</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Confirmed; having been established or verified.: The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4870, C25458, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2677064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Progressive Disease</VALIDVALUE>
          <VALUEMEANING>PD</VALUEMEANING>
          <MEANINGDESCRIPTION>A disease process that is increasing in scope or severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3090977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial Response Unconfirmed</VALIDVALUE>
          <VALUEMEANING>Not Confirmed Partial Remission</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Having been established or verified.: A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18058, C25458, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3855414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable - Therapy Ongoing</VALIDVALUE>
          <VALUEMEANING>Not Applicable Ongoing Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.: Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C53279, C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5438159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed Response</VALIDVALUE>
          <VALUEMEANING>Mixed response</VALUEMEANING>
          <MEANINGDESCRIPTION>Involving or composed of different kinds.: The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50995, C25259</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the Best Response for</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the Best Response for this Study so far?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Measure of Subject&#39;s Best Response to Current Course of Treatment</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Measure of Subject&#39;s Best Response to Current Course of Treatment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Response to Treatment</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Response to Treatment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Candidate Reuse</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2992453</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3234177</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Patient Outcomes Data System</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PODS Elements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3234178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886752</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>For Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3891931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229L</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>measure_of_response</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CR_TR_STD_BST_RSP_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="654">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2859437</PUBLICID>
    <LONGNAME>Peritoneal Carcinomatosis Laparoscopy Involvement Score</LONGNAME>
    <PREFERREDNAME>PER_CAR_L_INV_SCOR</PREFERREDNAME>
    <PREFERREDDEFINITION>a number measuring the extent of spread of cancer within the peritoneum (the tissue that lines the abdominal wall and covers most of the organs in the abdomen) by laparoscopic examination of the abdominal cavity and its contents.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2859415</PublicId>
      <PreferredName>PERI_CARC_LAP_INV</PreferredName>
      <PreferredDefinition>information related to spread of cancer within the peritoneum (the tissue that lines the abdominal wall and covers most of the organs in the abdomen) by laparoscopic examination of the abdominal cavity and its contents.</PreferredDefinition>
      <LongName>Peritoneal Carcinomatosis Laparoscopy Involvement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2846902</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25313:C3693</PreferredName>
        <Version>1</Version>
        <LongName>Peritoneal Carcinomatosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25313</PREFERRED_NAME>
            <LONG_NAME>Peritoneal</LONG_NAME>
            <CON_ID>2204854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3693</PREFERRED_NAME>
            <LONG_NAME>Carcinomatosis</LONG_NAME>
            <CON_ID>2846901</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2859413</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16969:C25548</PreferredName>
        <Version>1</Version>
        <LongName>Laparoscopy Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16969</PREFERRED_NAME>
            <LONG_NAME>Laparoscopy</LONG_NAME>
            <CON_ID>2204807</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2845288</PublicId>
      <PreferredName>PCI</PreferredName>
      <PreferredDefinition>a number measuring the extent of peritoneal cancer or peritoneal cancer index (PCI).</PreferredDefinition>
      <LongName>Peritoneal Cancer Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue>39</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>GOG CRF:Gynecologic Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2193207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CT/Laparoscopic PCI</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CT/Laparoscopic PCI</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="655">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2870016</PUBLICID>
    <LONGNAME>Document Identifier Primary Flag ISO21090.BL.v1.0</LONGNAME>
    <PREFERREDNAME>2868339v1.0:2803169v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Specifies whether this is the main or principal document identifier.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868339</PublicId>
      <PreferredName>2867713v1.0:2231647v1.0</PreferredName>
      <PreferredDefinition>An organized collection of records that describe a particular body of data.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Occurring first in time or sequence; original; of greatest rank or importance or value.:An indicator that can be set or unset in order to signal whether a particular condition is true. The indicator usually takes the form of a single binary digit, or bit (either 0 or 1). (from Dictionary of Computers)</PreferredDefinition>
      <LongName>Document Identifier Primary Flag</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867713</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19498:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Document Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19498</PREFERRED_NAME>
            <LONG_NAME>Document</LONG_NAME>
            <CON_ID>2223216</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25251:C43578</PreferredName>
        <Version>1</Version>
        <LongName>Primary Flag</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43578</PREFERRED_NAME>
            <LONG_NAME>Flag</LONG_NAME>
            <CON_ID>2223213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803169</PublicId>
      <PreferredName>2803169v1.0</PreferredName>
      <PreferredDefinition>Values of two-valued logic.</PreferredDefinition>
      <LongName>ISO21090.BL.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090BLv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Document Identifier Primary Flag ISO21090.BL.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Document Identifier Primary Flag ISO21090.BL.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.CommonSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757153</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DocumentIdentification.primaryIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DocumentIdentification:primaryIndicator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DocumentIdentifier.primaryIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DocumentIdentifier:primaryIndicator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.CommonSubDomain.DocumentIdentifier.primaryIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="656">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2870248</PUBLICID>
    <LONGNAME>Clinical Trial Eligibility Criteria Observation Performed Study Activity Negation Occurrence Reason ISO21090.DSET.SC.v1.0</LONGNAME>
    <PREFERREDNAME>2868571v1.0:2803350v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>One of a set of conditions that a study subject must meet in order to participate in a study. The text and/or code that describes the rationale behind why an activity is not done.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868571</PublicId>
      <PreferredName>2867671v1.0:2867945v1.0</PreferredName>
      <PreferredDefinition>Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.:Watching something and taking note of what happens.:Executed and carried through to completion.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective; the state of being active._An operation in which a term denies or inverts the meaning of another term or construction.:An instance of something happening, such as an event or incident.:An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Clinical Trial Eligibility Criteria Observation Performed Study Activity Negation Occurrence Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867671</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>2867671v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Eligibility Criteria Observation Performed Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867945</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C25275:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Negation Occurrence Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803350</PublicId>
      <PreferredName>2803350v1.0</PreferredName>
      <PreferredDefinition>A collection containing unordered distinct/discrete values of the type SC.</PreferredDefinition>
      <LongName>ISO21090.DSET.SC.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090DSETv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Clinical Trial Eligibility Criteria Observation Performed Study Activity Negation Occurrence Reason ISO21090.DSET.SC.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Clinical Trial Eligibility Criteria Observation Performed Study Activity Negation Occurrence Reason ISO21090.DSET.SC.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedEligibilityCriterion.missedReason</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedEligibilityCriterion:missedReason</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="657">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2876919</PUBLICID>
    <LONGNAME>Surgical Resection Bladder Performed Ind-2</LONGNAME>
    <PREFERREDNAME>SURG_R_BLAD_PE_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>ithe yes/no indicator related to the removal or excision by surgical measures of the distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2876896</PublicId>
      <PreferredName>SURG_RES_BLADD_PERF</PreferredName>
      <PreferredDefinition>information related to the removal or excision by surgical measures of the distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.</PreferredDefinition>
      <LongName>Surgical Resection Bladder Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206549</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25698:C15232</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Resection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25698</PREFERRED_NAME>
            <LONG_NAME>Surgical</LONG_NAME>
            <CON_ID>2202592</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15232</PREFERRED_NAME>
            <LONG_NAME>Excision</LONG_NAME>
            <CON_ID>2202806</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207776</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12414:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Bladder Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12414</PREFERRED_NAME>
            <LONG_NAME>Bladder</LONG_NAME>
            <CON_ID>2202678</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Bladder</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Bladder</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="658">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2889202</PUBLICID>
    <LONGNAME>Human Immunodeficiency Virus Viral Load Assay Performed Indicator</LONGNAME>
    <PREFERREDNAME>HIV_VL_ASAY_PERF_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the indicator for the involvement or extent of the disease relating to a human immunodeficiency virus viral load (the number of HIV viral particles in a sample of blood plasma).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2541079</PublicId>
      <PreferredName>HIV_VIRLD_ASSAY_PERF</PreferredName>
      <PreferredDefinition>information relating to a human immunodeficiency virus viral load (the number of HIV viral particles in a sample of blood plasma) assay performed.</PreferredDefinition>
      <LongName>Human Immunodeficiency Virus Viral Load Assay Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2541077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14219:C51952:C16341</PreferredName>
        <Version>1</Version>
        <LongName>Human Immunodeficiency Virus Viral Load Assay</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14219</PREFERRED_NAME>
            <LONG_NAME>Human Immunodeficiency Virus</LONG_NAME>
            <CON_ID>2202523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51952</PREFERRED_NAME>
            <LONG_NAME>Viral Load</LONG_NAME>
            <CON_ID>2541076</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16341</PREFERRED_NAME>
            <LONG_NAME>Bioassay</LONG_NAME>
            <CON_ID>2202922</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018823</PublicId>
      <PreferredName>INV_EXT_DZ_IND</PreferredName>
      <PreferredDefinition>the indicator for the involvement or extent of the disease.</PreferredDefinition>
      <LongName>Involvement Extent Disease Ind</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>23</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>YES</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NO</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UNKNOWN</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INDETERMINATE</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No source documentation</VALIDVALUE>
          <VALUEMEANING>No source documentation</VALUEMEANING>
          <MEANINGDESCRIPTION>Data from an original source is not present, accessible or ready for use or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2590731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A</VALIDVALUE>
          <VALUEMEANING>Not Available</VALUEMEANING>
          <MEANINGDESCRIPTION>Information regarding the subject is unknown or inaccessible at this time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ND</VALIDVALUE>
          <VALUEMEANING>Not Determined</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2876209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not sampled/dissected</VALIDVALUE>
          <VALUEMEANING>Not sampled/dissected</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: The process of cutting apart or separating tissue as, for example, in the study of anatomy or in the course of a surgical procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15227, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3192095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present - extensive</VALIDVALUE>
          <VALUEMEANING>Present - extensive</VALUEMEANING>
          <MEANINGDESCRIPTION>Large in quantity, range, or spatial extent.: Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626, C47863</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4730371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present - minimal</VALIDVALUE>
          <VALUEMEANING>Present - Minimal</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status._The smallest natural number and quantity it denotes: a single entity, unit, or object._A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch._To increase in length or duration._The dense connective tissue that surrounds a lymph node._The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19151, C33028, C25270, C28251, C66832, C61585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3729231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unspecified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is the viral load &lt;= 50 copie</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the viral load &lt;= 50 copies/ml</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>HIV viral load</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Upper GI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HIV_VL_ASAY_PERF_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="659">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2898716</PUBLICID>
    <LONGNAME>Free Text Format Variable Value Value java.lang.String</LONGNAME>
    <PREFERREDNAME>2898550v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A format that does not specify any text properties and does not require pre-established arrangement or organization of data.:Any characteristic or attribute that can be measured.:The information contained in a data field.  It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute._A numerical quantity measured or assigned or computed._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2898550</PublicId>
      <PreferredName>2898535v1.0:2186636v1.0</PreferredName>
      <PreferredDefinition>A format that does not specify any text properties and does not require pre-established arrangement or organization of data.:Any characteristic or attribute that can be measured.:The information contained in a data field.  It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Free Text Format Variable Value Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2898535</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70764:C43371:C49100</PreferredName>
        <Version>1</Version>
        <LongName>Free Text Format Variable Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70764</PREFERRED_NAME>
            <LONG_NAME>Free Text Format</LONG_NAME>
            <CON_ID>2898534</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43371</PREFERRED_NAME>
            <LONG_NAME>Variable Characteristic</LONG_NAME>
            <CON_ID>2236568</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49100</PREFERRED_NAME>
            <LONG_NAME>Data Value</LONG_NAME>
            <CON_ID>2463853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2186636</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Free Text Format Variable Value Value java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Free Text Format Variable Value Value java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000576</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.project.UserDefinedFactorValue.value</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>UserDefinedFactorValue:value</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="660">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2898852</PUBLICID>
    <LONGNAME>Free Text Format Parameter Value Life Sciences Identifier Entity Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2898686v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A format that does not specify any text properties and does not require pre-established arrangement or organization of data.:Any factor that defines a system and determines (or limits) its performance.:The information contained in a data field.  It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute._A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:An independently existing thing (living or nonliving).:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2898686</PublicId>
      <PreferredName>2898539v1.0:2898546v1.0</PreferredName>
      <PreferredDefinition>A format that does not specify any text properties and does not require pre-established arrangement or organization of data.:Any factor that defines a system and determines (or limits) its performance.:The information contained in a data field.  It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute._A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:An independently existing thing (living or nonliving).:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Free Text Format Parameter Value Life Sciences Identifier Entity Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2898539</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70764:C44175:C49100</PreferredName>
        <Version>1</Version>
        <LongName>Free Text Format Parameter Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70764</PREFERRED_NAME>
            <LONG_NAME>Free Text Format</LONG_NAME>
            <CON_ID>2898534</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44175</PREFERRED_NAME>
            <LONG_NAME>Parameter</LONG_NAME>
            <CON_ID>2236569</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49100</PREFERRED_NAME>
            <LONG_NAME>Data Value</LONG_NAME>
            <CON_ID>2463853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2898546</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47841:C51070:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Life Sciences Identifier Entity Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47841</PREFERRED_NAME>
            <LONG_NAME>Life Sciences Identifier</LONG_NAME>
            <CON_ID>2423426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Free Text Format Parameter Value Life Sciences Identifier Entity Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Free Text Format Parameter Value Life Sciences Identifier Entity Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.protocol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000256</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.protocol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000257</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.protocol.UserDefinedParameterValue.lsidObjectId</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>UserDefinedParameterValue:lsidObjectId</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="661">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2900123</PUBLICID>
    <LONGNAME>Malignant Neoplasm Clinical Information Group N Stage java.lang.String</LONGNAME>
    <PREFERREDNAME>2899865v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.:Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:Knowledge derived from study, experience, or instruction that has been gathered or received by communication.:Any number of entities (members) considered as a unit._One criteria of the TNM staging system.  N refers to the extent of lymph node involvement._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2899865</PublicId>
      <PreferredName>2899675v1.0:2678076v1.0</PreferredName>
      <PreferredDefinition>A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.:Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:Knowledge derived from study, experience, or instruction that has been gathered or received by communication.:Any number of entities (members) considered as a unit._One criteria of the TNM staging system.  N refers to the extent of lymph node involvement.</PreferredDefinition>
      <LongName>Malignant Neoplasm Clinical Information Group N Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2899675</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305:C25398:C48191:C43359</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm Clinical Information Group</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48191</PREFERRED_NAME>
            <LONG_NAME>Information</LONG_NAME>
            <CON_ID>2422630</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43359</PREFERRED_NAME>
            <LONG_NAME>Group</LONG_NAME>
            <CON_ID>2236516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2678076</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25580</PreferredName>
        <Version>1</Version>
        <LongName>N Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25580</PREFERRED_NAME>
            <LONG_NAME>N Category</LONG_NAME>
            <CON_ID>2204625</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Malignant Neoplasm Clinical Information Group N Stage java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Malignant Neoplasm Clinical Information Group N Stage java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2899621</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ImageMiner</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>TMAMiner</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2899634</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2899621</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ImageMiner</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.imageminer.domain.tma.dynamic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2899635</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.imageminer.domain.tma.dynamic.CancerClinicalPanel.nStage</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CancerClinicalPanel:nStage</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="662">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2900254</PUBLICID>
    <LONGNAME>Image Registration Source java.lang.String</LONGNAME>
    <PREFERREDNAME>2899996v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The process of transforming sets of image data from different times or perspectives into one coordinate system._Where something is available._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2899996</PublicId>
      <PreferredName>2899653v1.0:2223297v1.0</PreferredName>
      <PreferredDefinition>The process of transforming sets of image data from different times or perspectives into one coordinate system._Where something is available.</PreferredDefinition>
      <LongName>Image Registration Source</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2899653</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C80145</PreferredName>
        <Version>1</Version>
        <LongName>Image Registration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80145</PREFERRED_NAME>
            <LONG_NAME>Image Registration</LONG_NAME>
            <CON_ID>2899638</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223297</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25683</PreferredName>
        <Version>1</Version>
        <LongName>Source</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25683</PREFERRED_NAME>
            <LONG_NAME>Source</LONG_NAME>
            <CON_ID>2202479</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Image Registration Source java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Image Registration Source java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2899621</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ImageMiner</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ImageMinerCore</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2899622</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2899621</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ImageMiner</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.imageminer.domain.analysis.registration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2899626</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Registration:source</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.imageminer.domain.analysis.registration.Registration.source</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="663">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2902340</PUBLICID>
    <LONGNAME>Image Study Patient DICOM Age Measurement</LONGNAME>
    <PREFERREDNAME>2648223v2.0:2645996v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The size or magnitude representing the period of life since birth based on the DICOM standard format as a string of characters with one of the following formats -- nnnD, nnnW, nnnM, nnnY; where nnn shall contain the number of days for D, weeks for W, months for M, or years for Y.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DICOM:Digital Imaging and Communications in Medicine</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2648223</PublicId>
      <PreferredName>2548004v1.0:2553627v1.0</PreferredName>
      <PreferredDefinition>The years since birth of a person undergoing a radiographic technique.</PreferredDefinition>
      <LongName>Image Study Patient Age</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2548004</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63859</PreferredName>
        <Version>1</Version>
        <LongName>Image Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63859</PREFERRED_NAME>
            <LONG_NAME>Image Study</LONG_NAME>
            <CON_ID>2547913</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2553627</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C25150</PreferredName>
        <Version>1</Version>
        <LongName>Patient Age</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25150</PREFERRED_NAME>
            <LONG_NAME>Age</LONG_NAME>
            <CON_ID>2202837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2645996</PublicId>
      <PreferredName>2645996v1.0</PreferredName>
      <PreferredDefinition>AS: The size or magnitude representing the period of life since birth based on the DICOM standard format as a string of characters with one of the following formats -- nnnD, nnnW, nnnM, nnnY; where nnn shall contain the number of days for D, weeks for W, months for M, or years for Y.  [Manually-curated]</PreferredDefinition>
      <LongName>DICOM Age Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
      <Representation>
        <PublicId>2645995</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49059:C25150:C25209</PreferredName>
        <Version>1</Version>
        <LongName>DICOM Age Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49059</PREFERRED_NAME>
            <LONG_NAME>DICOM</LONG_NAME>
            <CON_ID>2553610</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25150</PREFERRED_NAME>
            <LONG_NAME>Age</LONG_NAME>
            <CON_ID>2202837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Patient&#39;s Age</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Patient&#39;s Age</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DICOM Tag CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812790</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2693115</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA_Model</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Silver Review Modified CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2838921</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2944977</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NBIA</PreferredName>
          <Version>5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ncia.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000240</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>(0010,1010)</AlternateName>
        <AlternateNameType>DICOM_TAG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Patient&#39;s Age</AlternateName>
        <AlternateNameType>DICOM Attribute Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ncia.domain.ImageStudy.patientAge</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ImageStudy:patientAge</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="664">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2903884</PUBLICID>
    <LONGNAME>Temporomandibular Joint Disorder Pain Treatment No Tooth Pressure Tongue Administered Frequency</LONGNAME>
    <PREFERREDNAME>TMJD_P_T_N_TPT_A_FR</PREFERREDNAME>
    <PREFERREDDEFINITION>the number of occurrences of not pushing tongue against teeth as treatment for pain from any condition affecting the anatomic and functional characteristics of the temporomandibular joint.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2903480</PublicId>
      <PreferredName>TMJD_PAI_TX_NTPT_AD</PreferredName>
      <PreferredDefinition>information related to not pushing tongue against teeth as treatment for pain from any condition affecting the anatomic and functional characteristics of the temporomandibular joint.</PreferredDefinition>
      <LongName>Temporomandibular Joint Disorder Pain Treatment No Tooth Pressure Tongue Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2862211</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63709:C3303:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Temporomandibular Joint Disorder Pain Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63709</PREFERRED_NAME>
            <LONG_NAME>Temporomandibular Joint Disorder</LONG_NAME>
            <CON_ID>2547865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3303</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>2202326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2903478</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49487:C12506:C25195:C12422:C2</PreferredName>
        <Version>1</Version>
        <LongName>No Tooth Pressure Tongue Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12506</PREFERRED_NAME>
            <LONG_NAME>Tooth</LONG_NAME>
            <CON_ID>2202581</CON_ID>
            <DEFINITION_SOURCE>UWDA142</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25195</PREFERRED_NAME>
            <LONG_NAME>Pressure</LONG_NAME>
            <CON_ID>2203954</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12422</PREFERRED_NAME>
            <LONG_NAME>Tongue</LONG_NAME>
            <CON_ID>2451477</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2902259</PublicId>
      <PreferredName>DNTL_QUEST_FREQ</PreferredName>
      <PreferredDefinition>the number of occurrences of something used in dental questionnaire.</PreferredDefinition>
      <LongName>Dental Questionnaire Frequency</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
      <Representation>
        <PublicId>2443080</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25515</PreferredName>
        <Version>1</Version>
        <LongName>Temporal Frequency</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Usually</VALIDVALUE>
          <VALUEMEANING>Usually</VALUEMEANING>
          <MEANINGDESCRIPTION>That which is considered customary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102843</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Half of time</VALIDVALUE>
          <VALUEMEANING>Half of the time</VALUEMEANING>
          <MEANINGDESCRIPTION>Half of the time</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-06-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2902260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2889147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Always</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2889148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Avoid pushing your tongue aga</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Avoid pushing your tongue against your teeth</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnostic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812084</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Orthodontics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812094</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="665">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2915818</PUBLICID>
    <LONGNAME>Experiment Arrangement Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2915629v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena.:The spatial property of the way in which something is placed._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2915629</PublicId>
      <PreferredName>2915582v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena.:The spatial property of the way in which something is placed._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Experiment Arrangement Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2915582</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42790:C61532</PreferredName>
        <Version>1</Version>
        <LongName>Experiment Arrangement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42790</PREFERRED_NAME>
            <LONG_NAME>Experiment</LONG_NAME>
            <CON_ID>2223979</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61532</PREFERRED_NAME>
            <LONG_NAME>Arrangement</LONG_NAME>
            <CON_ID>2534082</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Experiment Arrangement Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Experiment Arrangement Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2915522</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caNanoLab</PreferredName>
          <Version>1.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cananolab.domain.common</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000157</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.common.ExperimentConfig.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ExperimentConfig:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="666">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2915820</PUBLICID>
    <LONGNAME>File Type java.lang.String</LONGNAME>
    <PREFERREDNAME>2915631v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A set of related records (either written or electronic) kept together._A subdivision of a particular kind of thing._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2915631</PublicId>
      <PreferredName>2726237v1.0:2223243v1.0</PreferredName>
      <PreferredDefinition>A set of related records (either written or electronic) kept together._A subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>File Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2726237</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42883</PreferredName>
        <Version>1</Version>
        <LongName>File</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42883</PREFERRED_NAME>
            <LONG_NAME>File</LONG_NAME>
            <CON_ID>2422612</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element File Type java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element File Type java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2915522</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caNanoLab</PreferredName>
          <Version>1.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cananolab.domain.common</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000157</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.common.File.type</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>File:type</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="667">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2919554</PUBLICID>
    <LONGNAME>Abstract Position Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2919406v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A concept or idea not associated with any specific instance.:The particular portion of space occupied by a physical object._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2919406</PublicId>
      <PreferredName>2919354v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A concept or idea not associated with any specific instance.:The particular portion of space occupied by a physical object._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Abstract Position Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2919354</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42874:C25339</PreferredName>
        <Version>1</Version>
        <LongName>Abstract Position</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42874</PREFERRED_NAME>
            <LONG_NAME>Abstract</LONG_NAME>
            <CON_ID>2224028</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25339</PREFERRED_NAME>
            <LONG_NAME>Position</LONG_NAME>
            <CON_ID>2203955</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Abstract Position Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Abstract Position Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000638</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000639</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.AbstractPosition.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AbstractPosition:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="668">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2926874</PUBLICID>
    <LONGNAME>Tobacco Smoking Report Period Use Ind-2</LONGNAME>
    <PREFERREDNAME>2926872v1.0:2179984v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether the act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe occurred during the current reporting period.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2926872</PublicId>
      <PreferredName>2435430v1.0:2926870v1.0</PreferredName>
      <PreferredDefinition>information related to the act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe during the current reporting period.</PreferredDefinition>
      <LongName>Tobacco Smoking Report Period Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2435430</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17934</PreferredName>
        <Version>1</Version>
        <LongName>Smoking</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17934</PREFERRED_NAME>
            <LONG_NAME>Tobacco Smoking</LONG_NAME>
            <CON_ID>2202827</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2926870</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25375:C25616:C25340</PreferredName>
        <Version>1</Version>
        <LongName>Report Period Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25616</PREFERRED_NAME>
            <LONG_NAME>Period</LONG_NAME>
            <CON_ID>2202575</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the patient smoked at any</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the patient smoked at any time during this report period</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>2926872v1.0:2179984v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="669">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2936683</PUBLICID>
    <LONGNAME>Dental Professional Practice Bleeding on Probing Multiple Periodontium Diagnosis Yes No Indicator</LONGNAME>
    <PREFERREDNAME>D_PP_BOP_M_PR_D_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator related to dental practice diagnosis of multiple site of bleeding that is induced by gentle manipulation of the gingival tissue at the depth of the gingival sulcus from examination of the fibrous connective tissue surrounding the root of a tooth that separates it from and attaches it to the alveolar bone.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2935314</PublicId>
      <PreferredName>D_PP_BOP_M_PER_DIAG</PreferredName>
      <PreferredDefinition>information related to dental practice diagnosis of multiple site of bleeding that is induced by gentle manipulation of the gingival tissue at the depth of the gingival sulcus from examination of the fibrous connective tissue surrounding the root of a tooth that separates it from and attaches it to the alveolar bone.</PreferredDefinition>
      <LongName>Dental Professional Practice Bleeding on Probing Multiple Periodontium Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443314</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C52673</PreferredName>
        <Version>1</Version>
        <LongName>Dental Professional Practice</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52673</PREFERRED_NAME>
            <LONG_NAME>Professional Practice</LONG_NAME>
            <CON_ID>2443152</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2935312</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C74951:C17648:C33304:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Bleeding on Probing Multiple Periodontium Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C74951</PREFERRED_NAME>
            <LONG_NAME>Bleeding on Probing</LONG_NAME>
            <CON_ID>2935269</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17648</PREFERRED_NAME>
            <LONG_NAME>Multiple</LONG_NAME>
            <CON_ID>2202577</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C33304</PREFERRED_NAME>
            <LONG_NAME>Periodontium</LONG_NAME>
            <CON_ID>2203988</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Only if multiple sites</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Only if multiple sites</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Periodontics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812088</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4442461</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDCR CDEs with Retired VDs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDEs for Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4442571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="670">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2949355</PUBLICID>
    <LONGNAME>Person Disease or Disorder Therapeutic Procedure Etiology Clinical Trial Eligibility Criteria Ind-2</LONGNAME>
    <PREFERREDNAME>2949354v1.0:2018257v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether an action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process is the cause any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person as an element of a personal medical history which is necessary to allow an individual to participate in a specific clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2949354</PublicId>
      <PreferredName>2236731v1.0:2949352v1.0</PreferredName>
      <PreferredDefinition>information related to an action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process as the cause any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person as an element of a personal medical history which is necessary to allow an individual to participate in a specific clinical trial.</PreferredDefinition>
      <LongName>Person Disease or Disorder Therapeutic Procedure Etiology Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2949352</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C49236:C16390:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Disease or Disorder Therapeutic Procedure Etiology Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16390</PREFERRED_NAME>
            <LONG_NAME>Etiology</LONG_NAME>
            <CON_ID>2497372</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is the disease treatment-indu</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the disease treatment-induced</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="671">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2952465</PUBLICID>
    <LONGNAME>Extranodal Involvement Anatomic Site Specify Text</LONGNAME>
    <PREFERREDNAME>EXNDAL_INVOL_ST_SPE</PREFERREDNAME>
    <PREFERREDDEFINITION>A free-text field to describe the anatomical site of the extranodal involvement.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2952457</PublicId>
      <PreferredName>EXNDAL_INVOLV_ST</PreferredName>
      <PreferredDefinition>Situated outside of a node._To have a connection by participation or association or use; sharing in an activity or process._Named locations of or within the body.</PreferredDefinition>
      <LongName>Extranodal Involvement Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2952455</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25504:C25548</PreferredName>
        <Version>1</Version>
        <LongName>Extranodal Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25504</PREFERRED_NAME>
            <LONG_NAME>Extranodal</LONG_NAME>
            <CON_ID>2206211</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2186622</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2799057</PublicId>
      <PreferredName>SPC_TXT</PreferredName>
      <PreferredDefinition>Be specific about something; define clearly._Text; the words of something written.</PreferredDefinition>
      <LongName>Specify Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2799056</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25685:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Specify Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Extranodal involvement anatom</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Extranodal involvement anatomic site specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2952465</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedDiagnosis &gt; TargetAnatomicSite.code(CD).originalText WHERE PerfornedDiagnosis.value = {main Disease}</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify other site:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 2</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify other extranodal site:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Semantically Similar</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685477</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TargetAnatomicSite:code </AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="672">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2954746</PUBLICID>
    <LONGNAME>Disease or Disorder Course Timepoint Performed Hematopoietic Cell Transplantation Performed Type</LONGNAME>
    <PREFERREDNAME>DIS_CRS_TP_HCT_PF_T</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the timepoint in the disease course when the hematopoietic cell transplantation was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2954720</PublicId>
      <PreferredName>DIS_CRS_TP_HCT_PFMD</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Passage through time; duration; a systematic or/and orderly succession; a sequence, e.g. course of treatment; a mode of action or behavior; natural development, typical manner of proceeding._A specific point in the time continuum, including those established relative to an event._A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Disease or Disorder Course Timepoint Performed Hematopoietic Cell Transplantation Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7533608</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C25379:C68568:C15431</PreferredName>
        <Version>1</Version>
        <LongName>Disease or Disorder Course Timepoint Hematopoietic Cell Transplantation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25379</PREFERRED_NAME>
            <LONG_NAME>Course</LONG_NAME>
            <CON_ID>2202898</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68568</PREFERRED_NAME>
            <LONG_NAME>Timepoint</LONG_NAME>
            <CON_ID>2656619</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15431</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Cell Transplantation</LONG_NAME>
            <CON_ID>2512694</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2954735</PublicId>
      <PreferredName>DIS_CRSE_TP_TYP</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Passage through time; duration; a systematic or/and orderly succession; a sequence, e.g. course of treatment; a mode of action or behavior; natural development, typical manner of proceeding._A specific point in the time continuum, including those established relative to an event._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Disease or Disorder Course Timepoint Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>96</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2954734</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C25379:C68568:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Disease or Disorder Course Timepoint Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25379</PREFERRED_NAME>
            <LONG_NAME>Course</LONG_NAME>
            <CON_ID>2202898</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68568</PREFERRED_NAME>
            <LONG_NAME>Timepoint</LONG_NAME>
            <CON_ID>2656619</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Later</VALIDVALUE>
          <VALUEMEANING>Later</VALUEMEANING>
          <MEANINGDESCRIPTION>Later in the disease course for a recipient with disease progression at any time prior to HSCT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Initial therapy</VALIDVALUE>
          <VALUEMEANING>Initial therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>As part of initial therapy for a recipient with no disease progression at any time prior to HSCT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>At what point in the disease</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>At what point in the disease course was the hematopoietic cell transplantation  performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>At what point in the disease course was the HSCT performed?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>At what point in the disease course was the HSCT performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2954746</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedObservation &gt; PerformedObservationResult.value WHERE PerformedObservation &gt; DefinedObservation.nameCode = &quot;Assess Disease Course&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2016r1: Myeloma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964888</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mye_base_dx_hcst_perf_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedObservationResult:value </AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="673">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2957359</PUBLICID>
    <LONGNAME>Breast Carcinoma Estrogen Receptor Status</LONGNAME>
    <PREFERREDNAME>2534235v1.0:2957355v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to represent the overall result of Estrogen Receptor (ER) testing.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2534235</PublicId>
      <PreferredName>2534174v1.0:2534137v1.0</PreferredName>
      <PreferredDefinition>(brest KAN-ser) Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare.:A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis_The estrogen receptor level measured in a primary tumor or in metastases.  There are essentially two distinct forms of breast cancer, one that tends to have an early onset and is characterized by an ER- status, and one that tends to have a late onset and</PreferredDefinition>
      <LongName>Breast Carcinoma Tumor Marker Estrogen Receptor Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2534174</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4872:C17220</PreferredName>
        <Version>1</Version>
        <LongName>Breast Carcinoma Tumor Marker</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4872</PREFERRED_NAME>
            <LONG_NAME>Breast Carcinoma</LONG_NAME>
            <CON_ID>2475940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17220</PREFERRED_NAME>
            <LONG_NAME>Tumor Marker</LONG_NAME>
            <CON_ID>2202551</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2534137</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16150</PreferredName>
        <Version>1</Version>
        <LongName>Estrogen Receptor Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16150</PREFERRED_NAME>
            <LONG_NAME>Estrogen Receptor Status</LONG_NAME>
            <CON_ID>2534076</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2957355</PublicId>
      <PreferredName>RCPT_STAT</PreferredName>
      <PreferredDefinition>A receptor is a protein located on the cell surface, or in the cytoplasm, that binds to a specific signaling factor, such as a hormone, antigen, or neurotransmitter, causing a conformational and functional change in the receptor molecule.  The ligand-bound receptor then alters its interaction with target molecules, which leads to changes in cellular physiology through modification of the activity of one or more signal transduction pathways._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Receptor Status</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2957354</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18106:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Receptor Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18106</PREFERRED_NAME>
            <LONG_NAME>Receptor</LONG_NAME>
            <CON_ID>2612148</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2931646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2617835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline</VALIDVALUE>
          <VALUEMEANING>Borderline Receptor Result</VALUEMEANING>
          <MEANINGDESCRIPTION>Straddling the dividing line between two categories.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3010632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Performed</VALIDVALUE>
          <VALUEMEANING>Not Performed</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3027962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Performed but Not Available</VALIDVALUE>
          <VALUEMEANING>Performed but Not Available</VALUEMEANING>
          <MEANINGDESCRIPTION>Performed; carried out.: An operation in which a term denies or inverts the meaning of another term or construction.: Available; obtainable or accessible and ready for use or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25429, C25594, C38000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Equivocal</VALIDVALUE>
          <VALUEMEANING>Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-08-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3128156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Estrogen Receptor status</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Estrogen Receptor status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Estrogen Receptor Status by IHC</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Estrogen Receptor Status by IHC</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text- 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Estrogen Receptor Status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>ER status (historical context)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text- 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Progesterone Receptor Status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>ER status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Baseline estrogen receptor (ER) status:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180933</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>LIDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>QIN Breast Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6788757</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2956164</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Transcend</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Transcend CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2956165</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280816</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-08-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889185</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>breast_carcinoma_estrogen_receptor_status</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>2534235v1.0:2957355v2.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>2534235v1.0:2957355v2.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>ER status</AlternateName>
        <AlternateNameType>QIN Breast Study</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="674">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2957563</PUBLICID>
    <LONGNAME>Laboratory Procedure HER2/neu Immunohistochemistry Receptor Status</LONGNAME>
    <PREFERREDNAME>2221357v1.0:2957355v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to signify the result of the medical procedure that involves testing a sample of blood or tissue for HER2 by histochemical localization of immunoreactive substances using labeled antibodies as reagents.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2221357</PublicId>
      <PreferredName>LAB_HER2_IHC_RSLT</PreferredName>
      <PreferredDefinition>information related to the result of the medical procedure that involves testing a sample of blood or tissue for HER2/NEU by histochemical localization of immunoreactive substances using labeled antibodies as reagents.</PreferredDefinition>
      <LongName>Laboratory Procedure HER2/neu Immunohistochemistry Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738954</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17756:C16722:C20200</PreferredName>
        <Version>1</Version>
        <LongName>HER2/neu Immunohistochemistry Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17756</PREFERRED_NAME>
            <LONG_NAME>ERBB2 Gene</LONG_NAME>
            <CON_ID>2202658</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16722</PREFERRED_NAME>
            <LONG_NAME>Immunohistochemistry</LONG_NAME>
            <CON_ID>2202666</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2957355</PublicId>
      <PreferredName>RCPT_STAT</PreferredName>
      <PreferredDefinition>A receptor is a protein located on the cell surface, or in the cytoplasm, that binds to a specific signaling factor, such as a hormone, antigen, or neurotransmitter, causing a conformational and functional change in the receptor molecule.  The ligand-bound receptor then alters its interaction with target molecules, which leads to changes in cellular physiology through modification of the activity of one or more signal transduction pathways._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Receptor Status</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2957354</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18106:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Receptor Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18106</PREFERRED_NAME>
            <LONG_NAME>Receptor</LONG_NAME>
            <CON_ID>2612148</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2931646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2617835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline</VALIDVALUE>
          <VALUEMEANING>Borderline Receptor Result</VALUEMEANING>
          <MEANINGDESCRIPTION>Straddling the dividing line between two categories.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3010632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Performed</VALIDVALUE>
          <VALUEMEANING>Not Performed</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3027962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Performed but Not Available</VALIDVALUE>
          <VALUEMEANING>Performed but Not Available</VALUEMEANING>
          <MEANINGDESCRIPTION>Performed; carried out.: An operation in which a term denies or inverts the meaning of another term or construction.: Available; obtainable or accessible and ready for use or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25429, C25594, C38000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Equivocal</VALIDVALUE>
          <VALUEMEANING>Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-08-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3128156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>HER2 IHC Status</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>HER2 IHC Status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the level of HER2/NEU protein expression:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the level of HER2/NEU protein expression:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>HER2/ERBB2 IHC  Status</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>HER2/ERBB2 IHC  Status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>HCMI Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>HER2 expression by IHC</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180933</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>LIDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>QIN Breast Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6788757</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2020r1: Breast Cancer Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2956164</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Transcend</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Transcend CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2956165</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Endometrial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7026248</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000003</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Stomach</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000437</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000454</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>bc_base_diag_her2_neu_lvl</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lab_proc_her2_neu_immunohistochemistry_receptor_status</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HER2_IHC_assessment</AlternateName>
        <AlternateNameType>HCMI Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>HER2-Neu status by IHC</AlternateName>
        <AlternateNameType>QIN Breast Study</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CIP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="675">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2957793</PUBLICID>
    <LONGNAME>Patient Cardiovascular Abnormality Personal Medical History Ind-3</LONGNAME>
    <PREFERREDNAME>PT_CV_ABNRM_PMH_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator that asks whether there was a history of cardiac comorbidities.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2853732</PublicId>
      <PreferredName>PT_CV_ABNORM_PMH</PreferredName>
      <PreferredDefinition>information relating to the patient having a personal medical history of cardiovascular (pertaining to the heart or blood vessels) abnormality (a condition that differs from the usual physical or mental state).</PreferredDefinition>
      <LongName>Patient Cardiovascular Abnormality Personal Medical History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2853730</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0374861:C9440:C18772</PreferredName>
        <Version>1</Version>
        <LongName>Cardiovascular Abnormality Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0374861</PREFERRED_NAME>
            <LONG_NAME>Cardiovascular</LONG_NAME>
            <CON_ID>2203004</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9440</PREFERRED_NAME>
            <LONG_NAME>Abnormality</LONG_NAME>
            <CON_ID>2203567</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cardiac</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cardiac</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have any of the following cardiac diseases?  Congestive heart failure (New York Heart Association ≥ Grade 2)  Clinically significant cardiac arrhythmia  Any factors that increased the risk of QTc prolongation such as chronic hypokalemia not correctable with supplements, congenital or familial long QT syndrome, or family history of unexplained sudden death under 40 years of age.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have any factors that increased the risk of QTc prolongation such as chronic hypokalemia not correctable with supplements, congenital or familial long QT syndrome, or family history of unexplained sudden death under 40 years of age?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have any factors that may increase the risk of QTc prolongation such as chronic hypokalemia not correctable with supplements, congenital or familial long QT syndrome, or family history of unexplained sudden death under 40 years of age in first-degree relatives or any concomitant medication known to prolong the QT interval and cause Torsade de Pointes?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have any of the following cardiac conditions: Known genetic disorder that increases risk for coronary artery disease, symptomatic heart failure, NYHA Class II-IV prior or current cardiomyopathy, severe valvular heart disease, or history of atrial fibrillation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 001</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have any of the following cardiac conditions: Known genetic disorder that increases risk for coronary artery disease, symptomatic heart failure, prior or current NYHA Class II-IV cardiomyopathy, severe valvular heart disease, or a history of atrial fibrillation.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_eCRF_Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have any of the risk factors defined in the protocol section 3.2.12 that would require baseline cardiac assessment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="676">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2968180</PUBLICID>
    <LONGNAME>Valid Value Form Element Administered Item End Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2967691v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The allowable values for a given data element (question) on a Case Report Form.:A printed or electronic document with spaces to be filled out.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.:A registry item for which administrative information is recorded in an Administration Record._The point or place at which something terminates in time, space, or extent.:The particular day, month and year an event will happen or has happened._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2967691</PublicId>
      <PreferredName>2967421v1.0:2231605v1.0</PreferredName>
      <PreferredDefinition>The allowable values for a given data element (question) on a Case Report Form.:A printed or electronic document with spaces to be filled out.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.:A registry item for which administrative information is recorded in an Administration Record._The point or place at which something terminates in time, space, or extent.:The particular day, month and year an event will happen or has happened.</PreferredDefinition>
      <LongName>Valid Value Form Element Administered Item End Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2967421</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41124:C19464:C48792:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Valid Value Form Element Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41124</PREFERRED_NAME>
            <LONG_NAME>Valid Value</LONG_NAME>
            <CON_ID>2231578</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19464</PREFERRED_NAME>
            <LONG_NAME>Form</LONG_NAME>
            <CON_ID>2202476</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48792</PREFERRED_NAME>
            <LONG_NAME>Element</LONG_NAME>
            <CON_ID>2513271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231605</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25496:C25164</PreferredName>
        <Version>1</Version>
        <LongName>End Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Valid Value Form Element Administered Item End Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Valid Value Form Element Administered Item End Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ValidValue:endDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.ValidValue.endDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="677">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2968209</PUBLICID>
    <LONGNAME>Form Form Element Administered Item Registration Status Administered Component Registration Status Name</LONGNAME>
    <PREFERREDNAME>2967720v1.0:2463561v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A printed or electronic document with spaces to be filled out.:A printed or electronic document with spaces to be filled out.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.:A registry item for which administrative information is recorded in an Administration Record._The act of enrolling.:A condition or state at a particular time._A designation of the status in the registration life-cycle of an Administered Item.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2967720</PublicId>
      <PreferredName>2967432v1.0:2231613v1.0</PreferredName>
      <PreferredDefinition>A printed or electronic document with spaces to be filled out.:A printed or electronic document with spaces to be filled out.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.:A registry item for which administrative information is recorded in an Administration Record._The act of enrolling.:A condition or state at a particular time.</PreferredDefinition>
      <LongName>Form Form Element Administered Item Registration Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2967432</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19464:C19464:C48792:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Form Form Element Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19464</PREFERRED_NAME>
            <LONG_NAME>Form</LONG_NAME>
            <CON_ID>2202476</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19464</PREFERRED_NAME>
            <LONG_NAME>Form</LONG_NAME>
            <CON_ID>2202476</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48792</PREFERRED_NAME>
            <LONG_NAME>Element</LONG_NAME>
            <CON_ID>2513271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25646:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Registration Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25646</PREFERRED_NAME>
            <LONG_NAME>Registration</LONG_NAME>
            <CON_ID>2202799</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2463561</PublicId>
      <PreferredName>AC_REG_STAT_NAME</PreferredName>
      <PreferredDefinition>A designation of the status in the registration life-cycle of an Administered Item.</PreferredDefinition>
      <LongName>Administered Component Registration Status Name</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2183782</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>NCIP</PreferredName>
        <Version>1</Version>
        <LongName>NCIP</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2638254</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Status Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Application</VALIDVALUE>
          <VALUEMEANING>Application</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing measurement based on the application unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Candidate</VALIDVALUE>
          <VALUEMEANING>Candidate</VALUEMEANING>
          <MEANINGDESCRIPTION>Candidate</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Proposed</VALIDVALUE>
          <VALUEMEANING>Proposed</VALUEMEANING>
          <MEANINGDESCRIPTION>Being reviewed for promotion to Candidate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Qualified</VALIDVALUE>
          <VALUEMEANING>Qualified</VALUEMEANING>
          <MEANINGDESCRIPTION>Met quality requirements, ready to be reviewed for Proposed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Standard</VALIDVALUE>
          <VALUEMEANING>Standard</VALUEMEANING>
          <MEANINGDESCRIPTION>Recommended for usage by all contexts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Standardized Elsewhere</VALIDVALUE>
          <VALUEMEANING>Standardized Elsewhere</VALUEMEANING>
          <MEANINGDESCRIPTION>The Administered Component has been adopted for standard usage by a community outside of NCI.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Superceded</VALIDVALUE>
          <VALUEMEANING>Superceded</VALUEMEANING>
          <MEANINGDESCRIPTION>The Administered Component is no longer recommended for usage because it has been replaced by another Administered Component.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suspended</VALIDVALUE>
          <VALUEMEANING>Suspended status</VALUEMEANING>
          <MEANINGDESCRIPTION>The Administered Component has been considered for standard status in the past and was not selected for promotion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retired</VALIDVALUE>
          <VALUEMEANING>RETIRED</VALUEMEANING>
          <MEANINGDESCRIPTION>RETIRED</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Form Form Element Administered Item Registration Status Administered Component Registration Status Name does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Form Form Element Administered Item Registration Status Administered Component Registration Status Name does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Form:registrationStatus</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.Form.registrationStatus</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="678">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2970715</PUBLICID>
    <LONGNAME>Person Comorbidity Condition Name</LONGNAME>
    <PREFERREDNAME>PER_COMORB_COND_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to identify a coexistent disease or condition in a person.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2839780</PublicId>
      <PreferredName>PERS_COMBD_OCC</PreferredName>
      <PreferredDefinition>Person; a human being._The coexistence of two or more disease processes._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Person Comorbidity Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2839778</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C16457</PreferredName>
        <Version>1</Version>
        <LongName>Person Comorbidity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16457</PREFERRED_NAME>
            <LONG_NAME>Comorbidity</LONG_NAME>
            <CON_ID>2589987</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2970663</PublicId>
      <PreferredName>COMORB_NM</PreferredName>
      <PreferredDefinition>The coexistence of two or more disease processes._A state of being, such as a state of health._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Comorbidity Condition Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2970662</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16457:C25457:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Comorbidity Condition Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16457</PREFERRED_NAME>
            <LONG_NAME>Comorbidity</LONG_NAME>
            <CON_ID>2589987</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25457</PREFERRED_NAME>
            <LONG_NAME>Condition</LONG_NAME>
            <CON_ID>2202899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Coronary Artery Disease</VALIDVALUE>
          <VALUEMEANING>Coronary Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>An imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26732</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2760269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypercholesterolemia</VALIDVALUE>
          <VALUEMEANING>Hypercholesterolemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypercholesterolemia; the presence of an abnormal amount of cholesterol in the cells and plasma of the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2751387</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypertension</VALIDVALUE>
          <VALUEMEANING>Hypertension</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormally high blood pressure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3117</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peripheral Vascular Disease</VALIDVALUE>
          <VALUEMEANING>Peripheral Vascular Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Any disorder affecting blood flow through the veins or arteries outside of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35136</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GERD</VALIDVALUE>
          <VALUEMEANING>Gastroesophageal Reflux Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26781</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAI</VALIDVALUE>
          <VALUEMEANING>Mycobacterium Avium Intracellulare</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymph node infection by Mycobacterium avium or Mycobacterium intracellulare. It most often affects children and usually presents with cervical lymph node enlargement. It generally follows a benign clinical course.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2975593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asthma</VALIDVALUE>
          <VALUEMEANING>Asthma</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2975594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Fibrosis</VALIDVALUE>
          <VALUEMEANING>Pulmonary Fibrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic progressive interstitial lung disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure, or right heart failure. Causes include chronic inflammatory processes, exposure to environmental irritants, radiation therapy, autoimmune disorders, certain drugs, or it may be idiopathic (no identifiable cause).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26869</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney Disease</VALIDVALUE>
          <VALUEMEANING>Renal Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3149</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2975595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatitis C Infection</VALIDVALUE>
          <VALUEMEANING>Hepatitis C</VALUEMEANING>
          <MEANINGDESCRIPTION>An RNA virus, causes non-A and non-B Hepatitis and liver cancer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3098</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2975596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatitis B Infection</VALIDVALUE>
          <VALUEMEANING>Hepatitis B</VALUEMEANING>
          <MEANINGDESCRIPTION>A viral hepatitis caused by the Hepatitis B virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood Clots</VALIDVALUE>
          <VALUEMEANING>Blood Clot</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggregation of blood factors, primarily platelets and fibrin with entrapment of cellular elements, frequently causing vascular obstruction at the point of its formation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27083</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoidosis</VALIDVALUE>
          <VALUEMEANING>Sarcoidosis</VALUEMEANING>
          <MEANINGDESCRIPTION>inflammatory disease characterized by small lumps or granulomas in lymph nodes and other organs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34995</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2975598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myocardial Infarction</VALIDVALUE>
          <VALUEMEANING>Myocardial Infarction</VALUEMEANING>
          <MEANINGDESCRIPTION>Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27996</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allergies</VALIDVALUE>
          <VALUEMEANING>Allergies</VALUEMEANING>
          <MEANINGDESCRIPTION>An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3114</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcium Channel Blockers</VALIDVALUE>
          <VALUEMEANING>Calcium Channel Blocker</VALUEMEANING>
          <MEANINGDESCRIPTION>A class of drugs that act by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools. Since they are inducers of vascular and other smooth muscle relaxation, they are used in the drug therapy of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C333</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renal Insufficiency</VALIDVALUE>
          <VALUEMEANING>Renal Insufficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE. The most severe form is KIDNEY FAILURE. Renal function may deteriorate slowly (RENAL INSUFFICIENCY, CHRONIC) or precipitously (RENAL INSUFFICIENCY, ACUTE).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1565489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diabetes</VALIDVALUE>
          <VALUEMEANING>Diabetes Mellitus</VALUEMEANING>
          <MEANINGDESCRIPTION>(dye-a-BEE-teez) A disease in which the body does not properly control the amount of sugar in the blood. As a result, the level of sugar in the blood is too high. This disease occurs when the body does not produce enough insulin or does not use it properly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebrovascular Disease</VALIDVALUE>
          <VALUEMEANING>Cerebrovascular Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A broad category of disorders characterized by impairment of blood flow in the arteries and veins which supply the brain. These include CEREBRAL INFARCTION; BRAIN ISCHEMIA; HYPOXIA, BRAIN; INTRACRANIAL EMBOLISM AND THROMBOSIS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; and VASCULITIS, CENTRAL NERVOUS SYSTEM. In common usage, the term cerebrovascular disorders is not limited to conditions that affect the cerebrum, but refers to vascular disorders of the entire brain including the DIENCEPHALON; BRAIN STEM; and CEREBELLUM.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2938</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tuberculosis</VALIDVALUE>
          <VALUEMEANING>Tuberculosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic, recurrent infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis (TB) may affect almost any tissue or organ of the body with the lungs being the most common site of infection. The clinical stages of TB are primary or initial</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2971315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epilepsy</VALIDVALUE>
          <VALUEMEANING>Epilepsy</VALUEMEANING>
          <MEANINGDESCRIPTION>brain disorder characterized by recurring excessive neuronal discharge, exhibited by transient episodes of motor, sensory, or psychic dysfunction, with or without unconsciousness or convulsive movements.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3020</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2971317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatitis</VALIDVALUE>
          <VALUEMEANING>Hepatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the liver and liver disease involving degenerative or necrotic alterations of hepatocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3095</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver Cirrhosis (Liver Disease)</VALIDVALUE>
          <VALUEMEANING>Cirrhosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2971318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anemia</VALIDVALUE>
          <VALUEMEANING>Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A reduction in the number of red blood cells per cu mm, the amount of hemoglobin in 100 ml of blood, and the volume of packed red blood cells per 100 ml of blood. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2869</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchitis</VALIDVALUE>
          <VALUEMEANING>Bronchitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute or chronic inflammatory process affecting the bronchi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2911</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arrhythmia</VALIDVALUE>
          <VALUEMEANING>Arrhythmia</VALUEMEANING>
          <MEANINGDESCRIPTION>Arrhythmia; an abnormal rate of muscle contractions in the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2881</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peptic Ulcer (Ulcer)</VALIDVALUE>
          <VALUEMEANING>Peptic Ulcer</VALUEMEANING>
          <MEANINGDESCRIPTION>Ulcer that occurs in those portions of the alimentary tract which come into contact with gastric juice containing pepsin and acid. It occurs when the amount of acid and pepsin is sufficient to overcome the gastric mucosal barrier.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rheumatologic Disease</VALIDVALUE>
          <VALUEMEANING>Rheumatologic Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammatory and degenerative diseases of connective tissue structures, such as arthritis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2971319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Obesity</VALIDVALUE>
          <VALUEMEANING>Obesity</VALUEMEANING>
          <MEANINGDESCRIPTION>Having a high amount of body fat (body mass index [BMI] of 30 or more).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3283</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Smoking</VALIDVALUE>
          <VALUEMEANING>Smoking</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3187551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heart disease</VALIDVALUE>
          <VALUEMEANING>Heart Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic or neoplastic disorder that affects the heart and/or the pericardium. Representative examples include endocarditis, pericarditis, atrial myxoma, cardiac myeloid sarcoma, and pericardial malignant mesothelioma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3079</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3181118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammatory Bowel Disease</VALIDVALUE>
          <VALUEMEANING>Inflammatory Bowel Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn&#39;s disease, ulcerative colitis, and colitis of indeterminate type. --2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3138</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3305590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperlipidemia</VALIDVALUE>
          <VALUEMEANING>Hyperlipidemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An excess of lipids in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34707</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2751390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COPD</VALIDVALUE>
          <VALUEMEANING>Chronic Obstructive Pulmonary Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3385484</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basal Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Basal Cell Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplastic proliferation of basal cells in the epidermis (part of the skin) or other anatomic sites (most frequently the salivary glands).  The basal cell neoplastic proliferation in the epidermis results in basal cell carcinomas.  The basal cell neoplastic proliferation in the salivary glands can be benign, resulting in basal cell adenomas or malignant, resulting in basal cell adenocarcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3784</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3626733</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cancer</VALIDVALUE>
          <VALUEMEANING>Carcinoma - Type Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2916</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atrial Fibrillation</VALIDVALUE>
          <VALUEMEANING>Atrial Fibrillation</VALUEMEANING>
          <MEANINGDESCRIPTION>A supraventricular arrhythmia characterized by uncoordinated atrial myocardium activation due to multiple reentry circuits with consequent deterioration of atrial mechanical function. Instead of intermittently contracting, the atria quiver continuously in a chaotic pattern, causing a totally irregular, often tachycardia ventricular rate. On the ECG it is described by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape, and timing, associated with an irregular, frequently rapid ventricular response when atrioventricular conduction is intact.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2760267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Connective Tissue Disorder</VALIDVALUE>
          <VALUEMEANING>Connective Tissue Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic or neoplastic disorder that affects the connective tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lupus</VALIDVALUE>
          <VALUEMEANING>Lupus Erythematosus</VALUEMEANING>
          <MEANINGDESCRIPTION>An autoimmune, connective tissue chronic inflammatory disorder affecting the skin, joints, kidneys, lungs, heart, and the peripheral blood cells. It is more commonly seen in women than men. Variants include discoid and systemic lupus erythematosus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27153</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210816</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ulcerative Colitis</VALIDVALUE>
          <VALUEMEANING>Ulcerative Colitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammatory disease of unknown cause which involves the mucosa of the colon. Onset may be acute and fulminant, and its course often continues chronically in an intermittent or continuous form. Diarrhea is a common symptom and bleeding an almost constant concomitant symptom.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2952</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Psoriasis</VALIDVALUE>
          <VALUEMEANING>Psoriasis</VALUEMEANING>
          <MEANINGDESCRIPTION>A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3346</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arthritis</VALIDVALUE>
          <VALUEMEANING>Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2883</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3292693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Congestive Heart Failure (CHF)</VALIDVALUE>
          <VALUEMEANING>Congestive heart failure</VALUEMEANING>
          <MEANINGDESCRIPTION>Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3080</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insulin controlled Diabetes</VALIDVALUE>
          <VALUEMEANING>Insulin-controlled Diabetes</VALUEMEANING>
          <MEANINGDESCRIPTION>(IN-su-lin) A hormone made by the islet cells of the pancreas. Insulin controls the amount of sugar in the blood by moving it into the cells, where it can be used by the body for energy.: The act of directing or determining; regulation or maintenance of a function or action; a relation of constraint of one entity (thing or person or group) by another.: A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2985, C61299, C2271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3718031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diet controlled Diabetes</VALIDVALUE>
          <VALUEMEANING>Diet-controlled Diabetes</VALUEMEANING>
          <MEANINGDESCRIPTION>Regular course of eating and drinking adopted by a person or animal. This does not include DIET THERAPY, a specific diet prescribed in the treatment of a disease.: The act of directing or determining; regulation or maintenance of a function or action; a relation of constraint of one entity (thing or person or group) by another.: A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2985, C61299, C15222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3718032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diabetic Neuropathy</VALIDVALUE>
          <VALUEMEANING>Diabetic Neuropathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5040588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other cancer within 5 years</VALIDVALUE>
          <VALUEMEANING>Past 5 Year Malignant Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Before the present time.: A number with no fractional part, including the negative and positive numbers as well as zero.::5: A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9305, C29848, C45255::5, C25609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5040590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other nonmalignant systemic disease</VALIDVALUE>
          <VALUEMEANING>Other Nonmalignant Systemic Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: For neoplasms, a neoplastic process that, at the time of the pathologic diagnosis, does not show evidence of tissue infiltration and may or may not show evidence of atypical morphologic features (e.g., cellular atypia, formation of complex structures, cellular pseudostratification, and increased mitotic activity).  This term encompasses benign neoplastic processes, neoplastic processes with dysplastic features, and borderline processes.  The former do not metastasize and the latter two are associated with a future risk of stromal invasion and metastasis. For other conditions, a process that is not seriously resistant to treatment or dangerous to health.: Affecting the entire body.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C13310, C25588, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5040589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cataracts</VALIDVALUE>
          <VALUEMEANING>Cataract</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by partial or complete opacity of the crystalline lens of one or both eyes. This results in a decrease in visual acuity and eventual blindness if untreated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>E10350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>CTCAE</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stroke</VALIDVALUE>
          <VALUEMEANING>Cerebrovascular Accident</VALUEMEANING>
          <MEANINGDESCRIPTION>A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Diminished or absent blood supply to the brain caused by obstruction (thrombosis or embolism) of an artery resulting in neurologic damage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78394, C37998, C3390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4733294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renal failure (requiring dialysis)</VALIDVALUE>
          <VALUEMEANING>Renal Failure with dialysis</VALUEMEANING>
          <MEANINGDESCRIPTION>The process of cleansing the blood when the kidneys are not able to filter the blood.: An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4376, C15221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other pulmonary complications</VALIDVALUE>
          <VALUEMEANING>Other Pulmonary Complication</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Having to do with the lungs.: Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2959, C13304, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HUS/TTP</VALIDVALUE>
          <VALUEMEANING>Hemolytic Uremic Syndrome or Thrombotic Thrombocytopenic Purpura</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute kidney injury associated with microangiopathic hemolytic anemia and thrombocytopenia.: A coagulation disorder characterized by extensive formation of thrombi in small blood vessels throughout the body due to low levels of ADAMTS13 protein, and resulting in consumption of circulating platelets, which is characterized by thrombocytopenia, anemia, neurologic changes, and sometimes fever and renal dysfunction.: The coexistence of two or more disease processes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16457, C78797, C75545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pregnancy in patient or partner</VALIDVALUE>
          <VALUEMEANING>Pregnancy</VALUEMEANING>
          <MEANINGDESCRIPTION>The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteoporosis or Osteopenia</VALIDVALUE>
          <VALUEMEANING>Osteoporosis or Osteopenia</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).: Decreased calcification or density of bone tissue.: The coexistence of two or more disease processes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16457, C50910, C3298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Organ transplant (site)</VALIDVALUE>
          <VALUEMEANING>Organ Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>The transfer of an organ, organ part, or tissue from one body to another, for the purpose of replacing the recipient&#39;s damaged or failing organ with a working one from the donor. Donors can be living, or cadaveric (dead).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver toxicity (non-infectious)</VALIDVALUE>
          <VALUEMEANING>Liver Toxicity</VALUEMEANING>
          <MEANINGDESCRIPTION>A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.: The finding of bodily harm due to the poisonous effects of something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27990, C12392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Joint replacement</VALIDVALUE>
          <VALUEMEANING>Joint replacement</VALUEMEANING>
          <MEANINGDESCRIPTION>A surgical procedure to replace part, or all structures, of a joint with an orthopedic prosthesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131579</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ITP</VALIDVALUE>
          <VALUEMEANING>Idiopathic Thrombocytopenic Purpura</VALUEMEANING>
          <MEANINGDESCRIPTION>Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gonadal dysfunction</VALIDVALUE>
          <VALUEMEANING>Gonadal Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Disease of the ovaries and testes of any etiology.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621716</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenocortical Insufficiency</VALIDVALUE>
          <VALUEMEANING>Adrenocortical Insufficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>An endocrine or hormonal disorder that occurs when the adrenal cortex does not produce enough of the hormone cortisol and in some cases, the hormone aldosterone. It may be due to a disorder of the adrenal cortex (Addison&#39;s disease or primary adrenal insufficiency) or to inadequate secretion of ACTH by the pituitary gland (secondary adrenal insufficiency).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Avascular Necrosis</VALIDVALUE>
          <VALUEMEANING>Avascular Necrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Tissue death resulting from an interruption to the blood supply.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4733331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Fracture(s)</VALIDVALUE>
          <VALUEMEANING>Fracture</VALUEMEANING>
          <MEANINGDESCRIPTION>A traumatic injury to the bone in which the continuity of the bone is broken.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cryptogenic Organizing Pneumonia</VALIDVALUE>
          <VALUEMEANING>Cryptogenic Organizing Pneumonia</VALUEMEANING>
          <MEANINGDESCRIPTION>A disease formerly considered a form of interstitial pneumonia. Its etiology is obscure but it may be associated with toxic fumes, infection, and connective tissue disease. Clinical symptoms include cough, dyspnea and influenza-like symptoms with the development of the usual interstitial pneumonia in many cases. Obstructive symptoms are limited to smokers. There are patchy polypoid masses of intra-alveolar granulation tissue in small airway lumina and alveolar ducts. &quot;Organizing&quot; refers to unresolved pneumonia (in which the alveolar exudate persists and eventually undergoes fibrosis) in which fibrous tissue forms in the alveoli.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2804712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DVT/PE</VALIDVALUE>
          <VALUEMEANING>Deep Vein Thrombosis or Pulmonary Embolism</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood clot in a deep vein, predominantly in the lower extremity, but may include the pelvis or upper extremity.: The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.: The coexistence of two or more disease processes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16457, C50713, C49343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemorrhagic Cystitis</VALIDVALUE>
          <VALUEMEANING>Hemorrhagic Cystitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the bladder resulting in bloody urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypothyroidism</VALIDVALUE>
          <VALUEMEANING>Hypothyroidism</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which the production of thyroid hormone by the thyroid gland is diminished. Signs and symptoms of hypothyroidism include low metabolic rate, tendency to weight gain, somnolence and sometimes myxedema. In the United States, the most common cause of hypothyroidism is Hashimoto&#39;s thyroiditis, an autoimmune disorder. SYN athyrea. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562672</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interstitial Pneumontis or ARDS</VALIDVALUE>
          <VALUEMEANING>Interstitial pneumonitis or Acute Respiratory Distress Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery. Cases of neonatal respiratory distress syndrome are not included in this definition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iron Overload</VALIDVALUE>
          <VALUEMEANING>Iron Overload</VALUEMEANING>
          <MEANINGDESCRIPTION>Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatitis</VALIDVALUE>
          <VALUEMEANING>Pancreatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the pancreas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Hemorrhage</VALIDVALUE>
          <VALUEMEANING>Pulmonary Hemorrhage</VALUEMEANING>
          <MEANINGDESCRIPTION>Bleeding from the lung parenchyma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78578</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seizure</VALIDVALUE>
          <VALUEMEANING>Seizure</VALUEMEANING>
          <MEANINGDESCRIPTION>Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5026016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beckwith-Wiedemann</VALIDVALUE>
          <VALUEMEANING>Beckwith-Wiedemann Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A genetic syndrome caused by abnormalities in chromosome 11.  It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia.  Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, Rhabdomyosarcoma) and adrenal cortex carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2967368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cirrhosis unknown etiology</VALIDVALUE>
          <VALUEMEANING>Unknown Etiology Cirrhosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.: The cause of a disease or abnormal condition.: A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2951, C16390, C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6148977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tyrosinemia</VALIDVALUE>
          <VALUEMEANING>Tyrosinemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal recessive inherited metabolic disorder caused by mutations in the FAH, HPD, and TAT genes. It is characterized by deficiency of one of the enzymes that are involved in the metabolism of tyrosine. It results in elevated blood tyrosine levels and accumulation of tyrosine and its byproducts in the liver, kidney, nervous system and other organs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6013366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biliary disorder</VALIDVALUE>
          <VALUEMEANING>Biliary Tract Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic or neoplastic disorder affecting the intrahepatic or extrahepatic biliary tract. Examples of non-neoplastic disorders include infection and atresia. Examples of neoplastic disorders include adenoma and carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycogen storage disease</VALIDVALUE>
          <VALUEMEANING>Glycogen Storage Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited metabolic disorder characterized either by defects in glycogen synthesis or defects in the breaking down of glycogen. It results either in the creation of abnormal forms of glycogen or accumulation of glycogen in the tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1 antitrypsin</VALIDVALUE>
          <VALUEMEANING>Alpha-1 Antitrypsin Deficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>A genetic disorder characterized by decreased alpha-1 antitrypsin activity in the lungs and blood and deposition of alpha-1 antitrypsin protein in the hepatocytes. These abnormalities result from defective production of alpha-1 antitrypsin and lead to the development of emphysema, cirrhosis, and liver failure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3171840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2831117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuroendocrine tumor</VALIDVALUE>
          <VALUEMEANING>Neuroendocrine Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant neoplasm composed of cells of neuroendocrine origin.  Representative examples include paraganglioma, carcinoid tumor, and neuroendocrine carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraductal papillary mucinous neoplasm</VALIDVALUE>
          <VALUEMEANING>Pancreatic Intraductal Papillary-Mucinous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant glandular neoplasm arising from the exocrine pancreas. Microscopically it is characterized by the presence of mucoid stroma formation, papillary patterns, and cystic changes. It has been associated with KRAS and Tp53 gene mutations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5725</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H. pylori infection</VALIDVALUE>
          <VALUEMEANING>Helicobacter Pylori Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>A bacterial infection of the stomach, caused by Helicobacter pylori.  It is associated with the development of peptic ulcer and mucosa-associated lymphoid tissue lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6148978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Barrett&#39;s Esophagus</VALIDVALUE>
          <VALUEMEANING>Barrett Esophagus</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophageal segment lined with columnar metaplastic epithelium which is flat or villiform.  Barrett&#39;s epithelium is characterized by two different types of cells: goblet cells and columnar cells.  The symptomatology of Barrett&#39;s esophagus is that of gastro-esophageal reflux.  It is the precursor of most esophageal adenocarcinomas.  (WHO, 2000) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2891</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colon polyps</VALIDVALUE>
          <VALUEMEANING>Colon Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A polypoid lesion that arises from the colon and protrudes into the lumen.  This group includes adenomatous polyps, serrated polyps, and hamartomatous polyps.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2954</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4827926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diabetes, NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Diabetes Mellitus</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2985, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6148979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fanconi anemia</VALIDVALUE>
          <VALUEMEANING>Fanconi Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare inherited disorder in which the bone marrow does not make blood cells. It is usually diagnosed in children between 2 and 15 years old. Symptoms include frequent infections, easy bleeding, and extreme tiredness. People with Fanconi anemia may have a small skeleton and brown spots on the skin. They also have an increased risk of developing certain types of cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5651022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rubinstein-Taybi syndrome</VALIDVALUE>
          <VALUEMEANING>Rubinstein-Taybi Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare genetic syndrome mapped to chromosome 16p13.3 and associated with mutations in the CREBBP gene.  It is characterized by mental and growth retardation, distinctive facial features (prominent nose, low-set ears, microcephaly, and small mouth), and broad thumbs and great toes.  Patients are at an increased risk of developing benign and malignant neoplasms, including nervous system neoplasms and malignant lymphoproliferative disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Li-Fraumeni syndrome</VALIDVALUE>
          <VALUEMEANING>Li-Fraumeni Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant hereditary neoplastic syndrome caused by an alteration in the p53 tumor suppressor gene.  It is characterized by the development of malignant neoplasms at various anatomic sites.  The malignant neoplasms associated with Li-Fraumeni syndrome include adrenal cortex carcinoma, astrocytic tumors, colorectal carcinoma, gastric carcinoma, malignant breast neoplasms, medulloblastoma, osteosarcoma, and soft tissue sarcomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gorlin syndrome</VALIDVALUE>
          <VALUEMEANING>Nevoid Basal Cell Carcinoma Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant genetic syndrome caused by abnormalities in the PTCH gene.  It is characterized by multiple basal cell carcinomas at a young age, odontogenic keratocysts, and skeletal defects (bifurcated and splayed ribs, fusion of vertebrae, spinal bifida).  Patients with this syndrome may also develop medulloblastomas and ovarian fibromas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2892</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Turcot syndrome</VALIDVALUE>
          <VALUEMEANING>Turcot Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant hereditary neoplastic syndrome caused by mutations in the PMS2, MLH1, MSH2, or APC genes. There are two types described, type 1, characterized by the presence of glioblastoma and often associated with hereditary nonpolyposis colorectal carcinoma, and type 2, characterized by the presence of medulloblastoma and familiar adenomatous polyposis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3938</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6002212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Familial Adenomatous Polyposis</VALIDVALUE>
          <VALUEMEANING>Adenomatous Polyposis Coli</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant disorder, characterized by the presence of multiple adenomas in the colon and rectum. It is caused by a germline mutation in the adenomatous polyposis coli (APC) gene which is located on the long arm of chromosome 5. The adenomas are most often tubular, and they have the tendency to progress to adenocarcinoma. They can occur throughout the colon, but they tend to concentrate in the rectum and sigmoid colon. The colorectal adenomas are detected during endoscopic examination between the age of 10 and 20 years. The adenomas increase in size and numbers with age, and there is usually progression of one or more adenomas to adenocarcinoma. The mean age of development of adenocarcinoma is about 40 years. Signs include rectal bleeding and mucousy diarrhea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3339</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lynch Syndrome</VALIDVALUE>
          <VALUEMEANING>Hereditary Non-Polyposis Colon Cancer</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma.  Patients often develop colorectal carcinomas at an early age (mean, 45 years).  In the majority of the cases the lesions arise from the proximal colon.  At the molecular level, high-frequency microsatellite instability is present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2716424</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diabetes, type II</VALIDVALUE>
          <VALUEMEANING>Type 2 Diabetes Mellitus</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2976115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peutz-Jeghers Syndrome</VALIDVALUE>
          <VALUEMEANING>Peutz-Jeghers Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited condition characterized by generalized hamartomatous multiple polyposis of the intestinal tract. Transmitted in an autosomal dominant fashion, Peutz-Jeghers syndrome consistently involves the jejunum and is associated with melanin spots of the lips, buccal mucosa, and fingers. This syndrome is associated with abnormalities of chromosome 19. Also known as Jeghers-Peutz syndrome and Peutz&#39;s syndrome. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3324</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Crohn Disease</VALIDVALUE>
          <VALUEMEANING>Crohn Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic, transmural inflammation that can affect any location along the gastrointestinal tract.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4618015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Celiac Disease</VALIDVALUE>
          <VALUEMEANING>Celiac Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A digestive disease that is caused by an immune response to a protein called gluten, which is found in wheat, rye, barley, and oats. Celiac disease damages the lining of the small intestine and interferes with the absorption of nutrients from food. A person with celiac disease may become malnourished no matter how much food is consumed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26714</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clonal hematopoiesis</VALIDVALUE>
          <VALUEMEANING>Age-Related Clonal Hematopoiesis</VALUEMEANING>
          <MEANINGDESCRIPTION>The gradual, clonal expansion of hematopoietic stem and progenitor cells carrying specific, disruptive, and recurrent genetic variants, in individuals without clear diagnosis of hematological malignancies. It is associated with an increased risk of developing hematologic cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C155821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6731055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HIV</VALIDVALUE>
          <VALUEMEANING>Human Immunodeficiency Virus</VALUEMEANING>
          <MEANINGDESCRIPTION>Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibromyalgia</VALIDVALUE>
          <VALUEMEANING>Fibromyalgia</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic disorder of unknown etiology charaterized by pain, stiffness, and tenderness in the muscles of the neck, shoulders, back, hips, arms, and legs  Other signs and symptoms include headaches, fatigue, sleep disturbances, and painful menstruation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C87497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chronic fatigue syndrome</VALIDVALUE>
          <VALUEMEANING>Chronic Fatigue Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A syndrome of unknown etiology. Chronic fatigue syndrome (CFS) is a clinical diagnosis characterized by an unexplained persistent or relapsing chronic fatigue that is of at least six months&#39; duration, is not the result of ongoing exertion, is not substantially alleviated by rest, and results in substantial reduction of previous levels of occupational, educational, social, or personal activities. Common concurrent symptoms of at least six months duration include impairment of memory or concentration, diffuse pain, sore throat, tender lymph nodes, headaches of a new type, pattern, or severity, and nonrestorative sleep. The etiology of CFS may be viral or immunologic. Neurasthenia and fibromyalgia may represent related disorders. Also known as myalgic encephalomyelitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3037</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6731057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AIDS</VALIDVALUE>
          <VALUEMEANING>Acquired Immunodeficiency Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin&#39;s lymphoma and Kaposi&#39;s sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3105388</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemiplegia</VALIDVALUE>
          <VALUEMEANING>Hemiplegia</VALUEMEANING>
          <MEANINGDESCRIPTION>Paralysis of one side of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8172574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dementia</VALIDVALUE>
          <VALUEMEANING>Dementia</VALUEMEANING>
          <MEANINGDESCRIPTION>An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3165569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TIA</VALIDVALUE>
          <VALUEMEANING>Transient Ischemic Attack</VALUEMEANING>
          <MEANINGDESCRIPTION>A brief attack (from a few minutes to an hour) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50781</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CVA or TIA</VALIDVALUE>
          <VALUEMEANING>Has a Cerebrovascular Accident or Transient Ischemic Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A question about whether an individual has or had a cerebrovascular accident or transient ischemic disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14506029</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Comorbidity</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Comorbidity</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2976812</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>GO Trial</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GO Trial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2976834</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3533741</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCORP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Trial Screening Tool</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5023691</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5428034</PublicId>
          <ContextName>GDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Followup</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6059563</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5589063</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDDP/CTSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDDP/CTSP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5589068</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655968</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HTMCP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HTMCP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000067</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6705584</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCG_PTCL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PTCL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6705585</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SPOREs</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PER_COMORB_COND_NM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>GDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GDC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>GDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>comorbidity</AlternateName>
        <AlternateNameType>GDC_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="679">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2970731</PUBLICID>
    <LONGNAME>Oncogene TRK Laboratory Procedure Performed Finding Status Indicator</LONGNAME>
    <PREFERREDNAME>2970729v1.0:3436461v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the status of the laboratory results for the oncogene TRK.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2970729</PublicId>
      <PreferredName>3192543v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>Human Oncogene TRK is a mutated variant of NTRK1 Gene (INSR family), which encodes two alternative type I membrane protein Neurotrophic Tyrosine Kinase Receptor Type 1 with similar biological properties. TRKA-II is primarily expressed in neurons; TRKA-I is non-neuronal. NTRK1 exists as low affinity monomeric and high affinity dimeric structures, with TRKA, TRKB, or TRKC, that bind neurotrophins. TRKA, TRKB, and TRKC partners are preferred by NGF, NTF5 and BDNF, and NTF3, respectively. Ligands stimulate autophosphorylation of TRK. NTRK1 defects cause CIPA. Oncogene TRK disrupts normal cell function._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Oncogene TRK Laboratory Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3192543</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18457:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Oncogene TRK Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18457</PREFERRED_NAME>
            <LONG_NAME>Oncogene TRK</LONG_NAME>
            <CON_ID>2970726</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>RADLEX_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3436461</PublicId>
      <PreferredName>3436461v1.0</PreferredName>
      <PreferredDefinition>The result of an examination or inquiry._A condition or state at a particular time._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Finding Status Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3436460</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61036:C25688:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Finding Status Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61036</PREFERRED_NAME>
            <LONG_NAME>Investigation Finding</LONG_NAME>
            <CON_ID>2528540</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not known</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-11</PVBEGINDATE>
          <PVENDDATE>2013-03-12</PVENDDATE>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known</VALIDVALUE>
          <VALUEMEANING>Known</VALUEMEANING>
          <MEANINGDESCRIPTION>Recognized, familiar, or within the scope of knowledge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2934435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3371379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-03-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the status of the onc</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the status of the oncogene TRK finding?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Trk A expression:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Trk A expression:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2026r1: Neuroblastoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964894</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2842777</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Labs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_base_dna_ponc_trka_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="680">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2974219</PUBLICID>
    <LONGNAME>Disease Myelodysplastic Syndrome Hematology Response First Date</LONGNAME>
    <PREFERREDNAME>2772156v1.0:2016734v3.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the first date related to the hematologic improvement related to treatment of myelodysplastic syndrome, abnormal bone marrow cells that may lead to myelogenous leukemia, as an abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2772156</PublicId>
      <PreferredName>DZ_MDS_HEM_RESP</PreferredName>
      <PreferredDefinition>information related to the hematologic improvement related to treatment of myelodysplastic syndrome, abnormal bone marrow cells that may lead to myelogenous leukemia, as an abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person.</PreferredDefinition>
      <LongName>Disease Myelodysplastic Syndrome Hematology Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2772154</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3247:C16673:C50995</PreferredName>
        <Version>1</Version>
        <LongName>MDS Hematology Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3247</PREFERRED_NAME>
            <LONG_NAME>Myelodysplastic Syndrome</LONG_NAME>
            <CON_ID>2202745</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16673</PREFERRED_NAME>
            <LONG_NAME>Hematology</LONG_NAME>
            <CON_ID>2202645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50995</PREFERRED_NAME>
            <LONG_NAME>Disease Response</LONG_NAME>
            <CON_ID>2459436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016734</PublicId>
      <PreferredName>FIRST_DT</PreferredName>
      <PreferredDefinition>the first date of an assessment, test, or treatment.</PreferredDefinition>
      <LongName>First Date</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yyyy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C25164</PreferredName>
        <Version>1</Version>
        <LongName>First Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>First observed date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>First observed date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="681">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2975690</PUBLICID>
    <LONGNAME>Oncotype DX Breast Cancer Assay Biopsy Acquisition Occurrence Date</LONGNAME>
    <PREFERREDNAME>ONCO_BRCA_BX_ACQ_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>Calendar date for a breast carcinoma biopsy for oncotype score testing.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2975688</PublicId>
      <PreferredName>ONCO_BX_ACQ_OCC</PreferredName>
      <PreferredDefinition>A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX is validated for use in breast cancer patients whose disease is newly diagnosed, stage I or II, node-negative, estrogen receptor-positive and who will be treated with tamoxifen._Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body._The process by which something is acquired or obtained._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Oncotype DX Breast Cancer Assay Biopsy Acquisition Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2975685</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52159:C15189</PreferredName>
        <Version>1</Version>
        <LongName>Oncotype DX Breast Cancer Assay Biopsy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52159</PREFERRED_NAME>
            <LONG_NAME>Oncotype DX Breast Cancer Assay</LONG_NAME>
            <CON_ID>2442615</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15189</PREFERRED_NAME>
            <LONG_NAME>Biopsy Procedure</LONG_NAME>
            <CON_ID>2202502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2975686</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43384:C25275</PreferredName>
        <Version>1</Version>
        <LongName>Acquisition Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43384</PREFERRED_NAME>
            <LONG_NAME>Acquisition</LONG_NAME>
            <CON_ID>2413349</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017121</PublicId>
      <PreferredName>CTMS_DT</PreferredName>
      <PreferredDefinition>Date as required for Clinical Trials Monitoring Service submissions.  Exchange format is YYYYMMDD.  Display format is DDMMMYYYY, with the month display the first three letters of each month (Jan, Feb, Mar, etc.).</PreferredDefinition>
      <LongName>CTMS Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>DD/MON/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Biopsy for oncotype s</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of Biopsy for oncotype score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886752</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>For Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3891931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="682">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2978136</PUBLICID>
    <LONGNAME>Chemotherapy Administered Date Missing Value Reason Indicator</LONGNAME>
    <PREFERREDNAME>2014199v1.0:3294098v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes the reason why the date chemotherapy was administered is missing.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014199</PublicId>
      <PreferredName>CT_ADM</PreferredName>
      <PreferredDefinition>information related to the administration of chemotherapy to an individual.</PreferredDefinition>
      <LongName>Chemotherapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404910</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15632</PreferredName>
        <Version>1</Version>
        <LongName>Chemotherapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15632</PREFERRED_NAME>
            <LONG_NAME>Chemotherapy</LONG_NAME>
            <CON_ID>2202708</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3294098</PublicId>
      <PreferredName>3294098v1.0</PreferredName>
      <PreferredDefinition>The particular day, month and year an event has happened or will happen._A specific reason explaining why a meaningful value is not available.  A meaningful value answers the question posed by a Data Element Concept.  In contrast, a Missing Value Reason answers the implicit question &quot;Why is there no &#39;meaningful&#39; value?&quot;, when there is none._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Date Missing Value Reason Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3294097</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164:C48655:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Date Missing Value Reason Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48655</PREFERRED_NAME>
            <LONG_NAME>Missing Value Reason</LONG_NAME>
            <CON_ID>2431146</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination that a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-12-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Date previously reported</VALIDVALUE>
          <VALUEMEANING>Date Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>a particular day specified as the time something has, or will, happen.: Occurring prior to something else.: A short textual account; having provided a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627, C25164</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3324276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested</VALIDVALUE>
          <VALUEMEANING>Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the reason for the da</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the reason for the date of chemotherapy administered missing value?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2978136</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedSubstanceAdministration.dateRangeValidationCode WHERE PerformedSubstanceAdministration &gt; DefinedSubstanceAdministration.categoryCode = &quot;Administer Chemotherapy&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="683">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2983707</PUBLICID>
    <LONGNAME>Measure Author First Name</LONGNAME>
    <PREFERREDNAME>2983683v1.0:3029697v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The given name by which the developer or owner of the measure is known.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2983683</PublicId>
      <PreferredName>2236773v1.0:2983663v1.0</PreferredName>
      <PreferredDefinition>Measurement is the determination of the size or magnitude of something.  It is also used ro refer to the result of this act._The writer of a book, article, or other text.:A word or group of words indicating a person&#39;s first (personal or given) name; the name that precedes the surname.</PreferredDefinition>
      <LongName>Measurement Author First Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236773</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25209</PreferredName>
        <Version>1</Version>
        <LongName>Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2983663</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42781:C40974</PreferredName>
        <Version>1</Version>
        <LongName>Author First Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42781</PREFERRED_NAME>
            <LONG_NAME>Author</LONG_NAME>
            <CON_ID>2223995</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40974</PREFERRED_NAME>
            <LONG_NAME>First Name</LONG_NAME>
            <CON_ID>2203651</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3029697</PublicId>
      <PreferredName>3029697v1.0</PreferredName>
      <PreferredDefinition>The writer of a book, article, or other text._A word or group of words indicating a person&#39;s first (personal) name. (NCI)_The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Author First Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3029696</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42781:C40974:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Author First Name Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42781</PREFERRED_NAME>
            <LONG_NAME>Author</LONG_NAME>
            <CON_ID>2223995</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40974</PREFERRED_NAME>
            <LONG_NAME>First Name</LONG_NAME>
            <CON_ID>2203651</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lead Author First Name</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Lead Author First Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2983752</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GEM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>com.westat.cagrid.gem.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000270</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PS&amp;CC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>com.westat.cagrid.gem.domain.Measure.authorFirstName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Measure:authorFirstName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="684">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2985989</PUBLICID>
    <LONGNAME>Pathology Image File Change Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2985946v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.:Any record of an imaging event whether physical or electronic.:A set of related records (either written or electronic) kept together_The act of alteration or modification; changed or altered in form or character.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2985946</PublicId>
      <PreferredName>2985912v1.0:2539482v1.0</PreferredName>
      <PreferredDefinition>The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.:Any record of an imaging event whether physical or electronic.:A set of related records (either written or electronic) kept together_The act of alteration or modification; changed or altered in form or character.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Pathology Image File Change Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2985912</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18189:C48179:C42883</PreferredName>
        <Version>1</Version>
        <LongName>Pathology Image File</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42883</PREFERRED_NAME>
            <LONG_NAME>File</LONG_NAME>
            <CON_ID>2422612</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2539482</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Change Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Pathology Image File Change Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Pathology Image File Change Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2619399</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caElmir</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.ucdavis.caelmir.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2830086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Image:dateModified</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.ucdavis.caelmir.domain.Image.dateModified</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="685">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2989393</PUBLICID>
    <LONGNAME>Cytogenetic Abnormality Greater Than or Equal To Integer::3 Present Indicator</LONGNAME>
    <PREFERREDNAME>2989340v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not an irregularity in the number or structure of chromosomes in the form of three or more distinct chromosomes were present.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2989340</PublicId>
      <PreferredName>2459195v1.0:3236286v1.0</PreferredName>
      <PreferredDefinition>An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material._A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.</PreferredDefinition>
      <LongName>Cytogenetic Abnormality Greater Than or Equal To 3 Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2459195</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2950</PreferredName>
        <Version>1</Version>
        <LongName>Cytogenetic Abnormality</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2950</PREFERRED_NAME>
            <LONG_NAME>Cytogenetic Abnormality</LONG_NAME>
            <CON_ID>2459194</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3236286</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61583:C45255::3:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Greater Than or Equal To Integer::3 Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61583</PREFERRED_NAME>
            <LONG_NAME>Greater Than or Equal To</LONG_NAME>
            <CON_ID>2673224</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::3</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were three or more distinct c</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Were three or more distinct chromosomal abnormalities present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Complex (&gt;=3 distinct abnormalities)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Complex (&gt;=3 distinct abnormalities)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>complex (&gt;=3 distinct abnormalities)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>complex (&gt;=3 distinct abnormalities)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964895</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>fan_base_kry_diag_comp_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="686">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2990816</PUBLICID>
    <LONGNAME>Clinical Study Site Status History Begin Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2990604v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A healthcare organization, a facility, a healthcare provider, or a part or a constituent of any of the above entities directly involved in conducting a particular clinical study.:A condition or state at a particular time.:The aggregate of past events; the continuum of events occurring in succession leading from the past to the present; a record or narrative description of past events._Have a beginning, in a temporal, spatial, or evaluative sense.:a particular day specified as the time something has, or will, happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2990604</PublicId>
      <PreferredName>2990509v1.0:2207412v1.0</PreferredName>
      <PreferredDefinition>A healthcare organization, a facility, a healthcare provider, or a part or a constituent of any of the above entities directly involved in conducting a particular clinical study.:A condition or state at a particular time.:The aggregate of past events; the continuum of events occurring in succession leading from the past to the present; a record or narrative description of past events._Have a beginning, in a temporal, spatial, or evaluative sense.:a particular day specified as the time something has, or will, happen.</PreferredDefinition>
      <LongName>Clinical Study Site Status History Begin Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2990509</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70777:C25688:C54625</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Study Site Status History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70777</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Site</LONG_NAME>
            <CON_ID>2714955</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54625</PREFERRED_NAME>
            <LONG_NAME>History</LONG_NAME>
            <CON_ID>2519676</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207412</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Begin Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Clinical Study Site Status History Begin Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Clinical Study Site Status History Begin Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.duke.cabig.c3pr.domain.SiteStatusHistory.startDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SiteStatusHistory:startDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="687">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2998134</PUBLICID>
    <LONGNAME>Address Code java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2992809v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The location at which an organization or person can be reached. (from American Heritage Dictionary)_A system of numbered categories for representation of data._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2992809</PublicId>
      <PreferredName>2341906v1.0:2222855v1.0</PreferredName>
      <PreferredDefinition>The location at which an organization or person can be reached. (from American Heritage Dictionary)_A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Address Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2341906</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25407</PreferredName>
        <Version>1</Version>
        <LongName>Address</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25407</PREFERRED_NAME>
            <LONG_NAME>Address</LONG_NAME>
            <CON_ID>2202289</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Address Code java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Address Code java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000413</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Address:code</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.Address.code</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="688">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3005035</PUBLICID>
    <LONGNAME>Specimen Fixative Duration</LONGNAME>
    <PREFERREDNAME>SPEC_FIXATIVE_DUR</PREFERREDNAME>
    <PREFERREDDEFINITION>the duration of fixation relating to tissues or cells prepared for microscopic study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014683</PublicId>
      <PreferredName>SPEC_FIX</PreferredName>
      <PreferredDefinition>A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A compound that preserves tissues and cells for microscopic study.</PreferredDefinition>
      <LongName>Specimen Fixative</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177026</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specimen</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177510</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Fixative</PreferredName>
        <Version>1</Version>
        <LongName>Fixative</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C498</PREFERRED_NAME>
            <LONG_NAME>Fixative</LONG_NAME>
            <CON_ID>2203930</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3005033</PublicId>
      <PreferredName>SPEC_FIXATIVE_DUR</PreferredName>
      <PreferredDefinition>the duration relating to the fixation of tissues or cells.</PreferredDefinition>
      <LongName>Specimen Fixative Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>SWOG CRF:Southwest Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2404653</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25330</PreferredName>
        <Version>1</Version>
        <LongName>Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Duration of fixation</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Duration of fixation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="689">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3009833</PUBLICID>
    <LONGNAME>HDL Cholesterol Estimated Baseline Standard Error Measurement Result Number</LONGNAME>
    <PREFERREDNAME>3009417v1.0:2509368v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A number used to capture the approximated standard deviation of the smallest and densest lipoproteins (HDL).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>eMERGE:Electronic Medical Records and Genomics Network</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3009417</PublicId>
      <PreferredName>3008552v1.0:3009415v1.0</PreferredName>
      <PreferredDefinition>The approximated standard deviation of the smallest and densest lipoproteins (HDL) in a frequency distribution.</PreferredDefinition>
      <LongName>HDL Cholesterol Estimate Baseline Standard Error</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3008552</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25186:C369</PreferredName>
        <Version>1</Version>
        <LongName>High Density Lipoprotein Cholesterol</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25186</PREFERRED_NAME>
            <LONG_NAME>High Density Lipoprotein</LONG_NAME>
            <CON_ID>2206231</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C369</PREFERRED_NAME>
            <LONG_NAME>Cholesterol</LONG_NAME>
            <CON_ID>2203873</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3009415</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25498:C25213:C53323</PreferredName>
        <Version>1</Version>
        <LongName>Estimate Baseline Standard Error</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25498</PREFERRED_NAME>
            <LONG_NAME>Estimate</LONG_NAME>
            <CON_ID>2203929</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25213</PREFERRED_NAME>
            <LONG_NAME>Baseline</LONG_NAME>
            <CON_ID>2202304</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53323</PREFERRED_NAME>
            <LONG_NAME>Standard Error</LONG_NAME>
            <CON_ID>2707894</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>eMERGE:Electronic Medical Records and Genomics Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2509368</PublicId>
      <PreferredName>MSRMT_RSLT_NUM</PreferredName>
      <PreferredDefinition>The number used to describe the result of the test.</PreferredDefinition>
      <LongName>Measurement Result Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Estimated standard error for</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Estimated standard error for baseline HDL</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3006612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>eMERGE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>eMERGE Data Variables</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3006613</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HDL_Cholesterol_Measurement_Standard_Error</AlternateName>
        <AlternateNameType>eMERGE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="690">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3012737</PUBLICID>
    <LONGNAME>Age First Dementia ICD Event Value</LONGNAME>
    <PREFERREDNAME>3010161v1.0:3065706v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The first time the loss of intellectual abilities interfering with an individual&#39;s social and occupational functions documented by ICD.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>eMERGE:Electronic Medical Records and Genomics Network</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3010161</PublicId>
      <PreferredName>2261926v1.0:3010159v1.0</PreferredName>
      <PreferredDefinition>The first time the loss of intellectual abilities interfering with an individual&#39;s social and occupational functions documented by ICD.</PreferredDefinition>
      <LongName>Age First Dementia ICD Event</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2261926</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25150</PreferredName>
        <Version>1</Version>
        <LongName>Age</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25150</PREFERRED_NAME>
            <LONG_NAME>Age</LONG_NAME>
            <CON_ID>2202837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3010159</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C4786:C49474:C25499</PreferredName>
        <Version>1</Version>
        <LongName>First Dementia International Classification of Diseases Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4786</PREFERRED_NAME>
            <LONG_NAME>Dementia</LONG_NAME>
            <CON_ID>2584032</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49474</PREFERRED_NAME>
            <LONG_NAME>International Classification of Diseases</LONG_NAME>
            <CON_ID>2469037</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>eMERGE:Electronic Medical Records and Genomics Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3065706</PublicId>
      <PreferredName>3065706v1.0</PreferredName>
      <PreferredDefinition>A numerical quantity measured, assigned or computed to describe an individual&#39;s age.</PreferredDefinition>
      <LongName>Age Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>year</UnitOfMeasure>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue>90</MaximumValue>
      <MinimumValue>14</MinimumValue>
      <Origin>eMERGE:Electronic Medical Records and Genomics Network</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Age at 1st qualifying ICD9 de</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Age at 1st qualifying ICD9 dementia code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>eMERGE</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Age 90+ listed as age 90</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3006612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>eMERGE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>eMERGE Data Variables</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3006613</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Age_First_EMR_Dementia_ICD9_Code</AlternateName>
        <AlternateNameType>eMERGE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="691">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3060211</PUBLICID>
    <LONGNAME>Morphologic Finding Disease-Free Survival Leukemia Diagnosis Date</LONGNAME>
    <PREFERREDNAME>3060207v1.0:2018550v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the date related to a period after successful treatment in which there is no appearance of the malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood through morphologic assessment (achieving leukemia-free state).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3060207</PublicId>
      <PreferredName>3060205v1.0:2239981v1.0</PreferredName>
      <PreferredDefinition>information related to a period after successful treatment in which there is no appearance of the malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood through morphologic assessment (achieving leukemia-free state).</PreferredDefinition>
      <LongName>Morphologic Finding Disease-Free Survival Leukemia Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3060205</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C35867:C17751:C3161</PreferredName>
        <Version>1</Version>
        <LongName>Morphologic Finding Disease-Free Survival Leukemia</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C35867</PREFERRED_NAME>
            <LONG_NAME>Morphologic Finding</LONG_NAME>
            <CON_ID>3060204</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17751</PREFERRED_NAME>
            <LONG_NAME>Disease-Free Survival</LONG_NAME>
            <CON_ID>2494288</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3161</PREFERRED_NAME>
            <LONG_NAME>Leukemia</LONG_NAME>
            <CON_ID>2202669</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239981</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date patient achieved morphol</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date patient achieved morphologic leukemia-free state</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="692">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3099363</PUBLICID>
    <LONGNAME>Bile Duct Obstruction No Finding Ind-2</LONGNAME>
    <PREFERREDNAME>3099361v1.0:2018257v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to not finding blockage in the tubes that carry bile from the liver to the gallbladder and small intestine.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3099361</PublicId>
      <PreferredName>3099358v1.0:3099359v1.0</PreferredName>
      <PreferredDefinition>information related to not finding blockage in the tubes that carry bile from the liver to the gallbladder and small intestine.</PreferredDefinition>
      <LongName>Bile Duct Obstruction No Finding</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099358</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12376:C3284</PreferredName>
        <Version>1</Version>
        <LongName>Bile Duct Obstruction</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12376</PREFERRED_NAME>
            <LONG_NAME>Bile Duct</LONG_NAME>
            <CON_ID>2205913</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3284</PREFERRED_NAME>
            <LONG_NAME>Obstruction</LONG_NAME>
            <CON_ID>2203941</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3099359</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49487:C3367</PreferredName>
        <Version>1</Version>
        <LongName>No Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3367</PREFERRED_NAME>
            <LONG_NAME>Finding</LONG_NAME>
            <CON_ID>2202448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>No evidence of clinical (jaun</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>No evidence of clinical (jaundice), biochemical (abnormally elevated serum bilirubin and/or alkaline phosphatase) or radiological (ultrasound, CT, or MR) biliary obstruction</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="693">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101029</PUBLICID>
    <LONGNAME>Organization Legal Category Type java.lang.String</LONGNAME>
    <PREFERREDNAME>3099803v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A formal group of people with one or more shared goals._To meet the requirements under law; not in violation of law or anything related to the law.:This term is used informally to mean a class of things.:Something distinguishable as an identifiable class based on common qualities._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3099803</PublicId>
      <PreferredName>2407006v1.0:3099624v1.0</PreferredName>
      <PreferredDefinition>A formal group of people with one or more shared goals._To meet the requirements under law; not in violation of law or anything related to the law.:This term is used informally to mean a class of things.:Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Organization Legal Category Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2407006</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19711</PreferredName>
        <Version>1</Version>
        <LongName>Organization</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19711</PREFERRED_NAME>
            <LONG_NAME>Professional Organization or Group</LONG_NAME>
            <CON_ID>2202773</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3099624</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54074:C25372:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Legal Category Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54074</PREFERRED_NAME>
            <LONG_NAME>Legal</LONG_NAME>
            <CON_ID>2493182</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Organization Legal Category Type java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Organization Legal Category Type java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813050</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Organization:legalCategoryType</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.administration.Organization.legalCategoryType</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="694">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101139</PUBLICID>
    <LONGNAME>Approval Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>3099903v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Acceptance as satisfactory by an authoritative body; established by authority; given authoritative approval._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3099903</PublicId>
      <PreferredName>3099589v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Acceptance as satisfactory by an authoritative body; established by authority; given authoritative approval._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Approval Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099589</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25425</PreferredName>
        <Version>1</Version>
        <LongName>Approval</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25425</PREFERRED_NAME>
            <LONG_NAME>Approval</LONG_NAME>
            <CON_ID>2203580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Approval Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Approval Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.workflow</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099477</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Approval:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.workflow.Approval.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="695">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101600</PUBLICID>
    <LONGNAME>Feeding Event Modified By java.lang.String</LONGNAME>
    <PREFERREDNAME>3100357v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>To supply with nourishment; give food to.:Something that happens at a given place and time._Indicates the person or authoritative body who changed an item._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100357</PublicId>
      <PreferredName>3099546v1.0:2231612v1.0</PreferredName>
      <PreferredDefinition>To supply with nourishment; give food to.:Something that happens at a given place and time._Indicates the person or authoritative body who changed an item.</PreferredDefinition>
      <LongName>Feeding Event Modified By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099546</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C88198:C25499</PreferredName>
        <Version>1</Version>
        <LongName>Feeding Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C88198</PREFERRED_NAME>
            <LONG_NAME>Feeding</LONG_NAME>
            <CON_ID>3099493</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231612</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42629</PreferredName>
        <Version>1</Version>
        <LongName>Modified By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42629</PREFERRED_NAME>
            <LONG_NAME>Modified By</LONG_NAME>
            <CON_ID>2231552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Feeding Event Modified By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Feeding Event Modified By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory.event</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FeedingEvent:modifiedBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.event.FeedingEvent.modifiedBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="696">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101645</PUBLICID>
    <LONGNAME>Primary Data Name java.lang.String</LONGNAME>
    <PREFERREDNAME>3100405v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The fundamental representation of collected data (what is considered fundamental is defined by community consensus and may be ambiguous or mutable)._The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100405</PublicId>
      <PreferredName>3099587v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>The fundamental representation of collected data (what is considered fundamental is defined by community consensus and may be ambiguous or mutable)._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Primary Data Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099587</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C84339</PreferredName>
        <Version>1</Version>
        <LongName>Primary Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C84339</PREFERRED_NAME>
            <LONG_NAME>Primary Data</LONG_NAME>
            <CON_ID>3099508</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Primary Data Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Primary Data Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.workflow</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099477</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PrimaryData:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.workflow.PrimaryData.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="697">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101781</PUBLICID>
    <LONGNAME>Tissue Anatomic Site Created By java.lang.Long</LONGNAME>
    <PREFERREDNAME>3100541v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>is an organ part that consists of similarly specialized cells and intercellular matrix, aggregated according to specific spatial relationships; together with other tissues, it constitutes an organ component. Example(s): epithelium, muscle(tissue), connective tissue, neural tissue, lymphoid tissue.:Named locations of, or within, the body._Indicates the person or authoritative body who brought the item into existence._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100541</PublicId>
      <PreferredName>2231125v1.0:2231611v1.0</PreferredName>
      <PreferredDefinition>is an organ part that consists of similarly specialized cells and intercellular matrix, aggregated according to specific spatial relationships; together with other tissues, it constitutes an organ component. Example(s): epithelium, muscle(tissue), connective tissue, neural tissue, lymphoid tissue.:Named locations of, or within, the body._Indicates the person or authoritative body who brought the item into existence.</PreferredDefinition>
      <LongName>Tissue Anatomic Site Created By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2231125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12801:C13717</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12801</PREFERRED_NAME>
            <LONG_NAME>Tissue</LONG_NAME>
            <CON_ID>2202489</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42628</PreferredName>
        <Version>1</Version>
        <LongName>Created By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42628</PREFERRED_NAME>
            <LONG_NAME>Created By</LONG_NAME>
            <CON_ID>2231551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Tissue Anatomic Site Created By java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Tissue Anatomic Site Created By java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TissueSite:createdBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.TissueSite.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="698">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101797</PUBLICID>
    <LONGNAME>Withdraw Event Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>3100557v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>To cease active participation in; remove from active use.:Something that happens at a given place and time._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100557</PublicId>
      <PreferredName>3099547v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>To cease active participation in; remove from active use.:Something that happens at a given place and time._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Withdraw Event Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099547</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38061:C25499</PreferredName>
        <Version>1</Version>
        <LongName>Withdraw Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38061</PREFERRED_NAME>
            <LONG_NAME>Withdraw</LONG_NAME>
            <CON_ID>2434706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Withdraw Event Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Withdraw Event Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory.event</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RetireEvent:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.event.RetireEvent.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="699">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101864</PUBLICID>
    <LONGNAME>Pathology Status Created Date java.util.Date</LONGNAME>
    <PREFERREDNAME>3100624v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.:A condition or state at a particular time._Brought into existence.:The particular day, month and year an event will happen or has happened._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100624</PublicId>
      <PreferredName>3099581v1.0:2222853v1.0</PreferredName>
      <PreferredDefinition>The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.:A condition or state at a particular time._Brought into existence.:The particular day, month and year an event will happen or has happened.</PreferredDefinition>
      <LongName>Pathology Status Created Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099581</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18189:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Pathology Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222853</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42620:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Created Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42620</PREFERRED_NAME>
            <LONG_NAME>Creation</LONG_NAME>
            <CON_ID>2222835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Pathology Status Created Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Pathology Status Created Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.PathologyStatus.dateCreated</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PathologyStatus:dateCreated</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="700">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3102113</PUBLICID>
    <LONGNAME>Coat Color Modified By java.lang.Long</LONGNAME>
    <PREFERREDNAME>3100871v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The covering of hair, wool, or fur on the body of an animal.:The appearance of objects (or light sources) described in terms of a person&#39;s perception of their hue and lightness (or brightness) and saturation._Indicates the person or authoritative body who changed an item._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100871</PublicId>
      <PreferredName>3099577v1.0:2231612v1.0</PreferredName>
      <PreferredDefinition>The covering of hair, wool, or fur on the body of an animal.:The appearance of objects (or light sources) described in terms of a person&#39;s perception of their hue and lightness (or brightness) and saturation._Indicates the person or authoritative body who changed an item.</PreferredDefinition>
      <LongName>Coat Color Modified By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099577</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C88212:C37927</PreferredName>
        <Version>1</Version>
        <LongName>Coat Color</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C88212</PREFERRED_NAME>
            <LONG_NAME>Coat</LONG_NAME>
            <CON_ID>3099501</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37927</PREFERRED_NAME>
            <LONG_NAME>Color</LONG_NAME>
            <CON_ID>2710268</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231612</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42629</PreferredName>
        <Version>1</Version>
        <LongName>Modified By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42629</PREFERRED_NAME>
            <LONG_NAME>Modified By</LONG_NAME>
            <CON_ID>2231552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Coat Color Modified By java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Coat Color Modified By java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CoatColor:modifiedBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.CoatColor.modifiedBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="701">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3103078</PUBLICID>
    <LONGNAME>Pharmacologic Substance End Occurrence Day Number</LONGNAME>
    <PREFERREDNAME>3103076v1.0:2896868v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the day that the pharmaceutical therapy ended.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3103076</PublicId>
      <PreferredName>2437803v1.0:2598135v1.0</PreferredName>
      <PreferredDefinition>An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b))._information related to the end date or occurrence of chemotherapy.</PreferredDefinition>
      <LongName>Pharmacologic Substance End Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437803</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1909</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacologic Substance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1909</PREFERRED_NAME>
            <LONG_NAME>Pharmacologic Substance</LONG_NAME>
            <CON_ID>2437691</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2598135</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25496:C25275</PreferredName>
        <Version>1</Version>
        <LongName>End Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896868</PublicId>
      <PreferredName>EVT_DAY_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._time for Earth to make a complete rotation on its axis._A numeral or string of numerals expressing value, quantity, or identification</PreferredDefinition>
      <LongName>Event Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C0439228:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Day Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0439228</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2204684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>22nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::22: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::22</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>21st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>20th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::20: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>19th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::19: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>18th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::18: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>17th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::17: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>16th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::16: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>15th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::15: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>14th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::14: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>13th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::13: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::10: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::4: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::5: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>31st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::31: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::31</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>30th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::30: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::30</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>29th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::29: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>28th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::28: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>27th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::27: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>26th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::26: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>25th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::25: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>24th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>23rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::23: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day of Therapy End</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Day of Therapy End</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLGSP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5655940</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Initial Treatment and Followup Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000268</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>day_of_drug_therapy_end</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="702">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3111302</PUBLICID>
    <LONGNAME>Specimen Type Collection Biospecimen Type</LONGNAME>
    <PREFERREDNAME>SPEC_COLL_BIOSP_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to describe the source of a biospecimen used for a laboratory test.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2513409</PublicId>
      <PreferredName>2241613v1.0:2223243v1.0</PreferredName>
      <PreferredDefinition>Specimen; a bit of tissue or blood or urine that is taken or used for research purposes._A subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Specimen Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2241613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3111295</PublicId>
      <PreferredName>COLL_BIOSP_TP</PreferredName>
      <PreferredDefinition>The act of gathering something together._Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Collection Biospecimen Type</LongName>
      <Version>1.2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3111294</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25453:C70699:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Collection Biospecimen Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Marrow</VALIDVALUE>
          <VALUEMEANING>Bone Marrow (biopsy/aspirate)</VALUEMEANING>
          <MEANINGDESCRIPTION>The soft, sponge-like tissue in the center of bones that produces white blood cells, red blood cells, and platelets.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2873881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Saliva</VALIDVALUE>
          <VALUEMEANING>Saliva</VALUEMEANING>
          <MEANINGDESCRIPTION>(suh-LIE-vuh) The watery fluid made by mucous glands in the mouth. It moistens food to aid in digestion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3192162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tissue</VALIDVALUE>
          <VALUEMEANING>Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unspecified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cryopreserved Cells</VALIDVALUE>
          <VALUEMEANING>Cryopreserved Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Cells which are indefinitely maintained in a viable state at extremely low temperatures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urine Pellet</VALIDVALUE>
          <VALUEMEANING>Urine Pellet</VALUEMEANING>
          <MEANINGDESCRIPTION>The cells, crystals, casts, bacteria, yeast, or other particles collected by centrifugation of a urine sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5153233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor</VALIDVALUE>
          <VALUEMEANING>Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3071117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin</VALIDVALUE>
          <VALUEMEANING>Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Primary Tumor</VALIDVALUE>
          <VALUEMEANING>Primary Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A tumor at the original site of origin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2938142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleural Fluid</VALIDVALUE>
          <VALUEMEANING>Pleural Fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>The fluid that is ordinarily present in the pleural space. It allows for normal movement of the lungs during respiration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77613</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3111297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm. (NCI): An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12801, C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3227906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mononuclear Cells from Bone Marrow</VALIDVALUE>
          <VALUEMEANING>Bone Marrow Derivation Mononucleated Blood Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.: The source from which something comes or issues; to take, obtain, or receive from a source.: A mixture of cells possessing a single nucleus, including monocytes and lymphocytes; blood leukocytes from which granulocytes have been separated and removed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73123, C42885, C12431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5446316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metastatic Tumor</VALIDVALUE>
          <VALUEMEANING>Metastatic Malignant Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211553</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulocytes</VALIDVALUE>
          <VALUEMEANING>Granulocyte</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of leukocyte with a multilobed nucleus and cytoplasmic granules. The unique morphology of the nucleus has led to their also being known as polymorphonuclear leukocytes (PMLs or PMNs). Granulocytes are subdivided according to the staining properties of their granules into eosinophils (red with acidic dye), basophils (blue with basic dye), and neutrophils (not amenable to staining with either acidic or basic dyes).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12530</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3733455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FFPE Scrolls</VALIDVALUE>
          <VALUEMEANING>Formalin Fixed Paraffin Embedded Tissue Scroll</VALUEMEANING>
          <MEANINGDESCRIPTION>A colorless poisonous gas synthesized by the oxidation of methanol and used as an antiseptic, disinfectant, histologic fixative, and general-purpose chemical reagent for laboratory applications. Formaldehyde is readily soluble in water and is commonly distributed as a 37% solution in water; formalin, a 10% solution of formaldehyde in water, is used as a disinfectant and to preserve biological specimens. Environmentally, formaldehyde may be found in the atmosphere, smoke from fires, automobile exhaust and cigarette smoke. Small amounts are produced during normal metabolic processes in most organisms, including humans.: Tissue which is preserved in a fixative solution, usually formalin.: Tissue that is preserved and embedded in paraffin.: A piece of tissue cut on a microtome so that it rolls up on itself, giving it an appearance similar to a paper scroll.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99276, C19597, C84514, C29744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4399753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cell</VALIDVALUE>
          <VALUEMEANING>Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3111299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buffy Coat</VALIDVALUE>
          <VALUEMEANING>Buffy Coat</VALUEMEANING>
          <MEANINGDESCRIPTION>The middle layer of an anticoagulated blood specimen following separation by centrifugation. It contains most of the white blood cells and platelets.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5152974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood Derived</VALIDVALUE>
          <VALUEMEANING>Blood Derivation</VALUEMEANING>
          <MEANINGDESCRIPTION>A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.: The source from which something comes or issues; to take, obtain, or receive from a source.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42885, C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5446317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ascites</VALIDVALUE>
          <VALUEMEANING>Ascites</VALUEMEANING>
          <MEANINGDESCRIPTION>The accumulation of fluid in the peritoneal cavity, which may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2885</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5446318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urine</VALIDVALUE>
          <VALUEMEANING>Urine</VALUEMEANING>
          <MEANINGDESCRIPTION>The fluid that is excreted by the kidneys.  It is stored in the bladder and discharged through the urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13283</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3111296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serum</VALIDVALUE>
          <VALUEMEANING>Serum</VALUEMEANING>
          <MEANINGDESCRIPTION>The clear liquid part of the blood that remains after blood cells and clotting proteins have been removed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13325</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3004972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasma</VALIDVALUE>
          <VALUEMEANING>Plasma</VALUEMEANING>
          <MEANINGDESCRIPTION>Plasma is the fluid (noncellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Feces</VALIDVALUE>
          <VALUEMEANING>Feces</VALUEMEANING>
          <MEANINGDESCRIPTION>The material discharged from the bowel during defecation.  It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CSF</VALIDVALUE>
          <VALUEMEANING>Cerebrospinal Fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>The fluid that flows in and around the hollow spaces of the brain and spinal cord, and between two of the meninges (the thin layers of tissue that cover and protect the brain and spinal cord). CSF is made by tissue called the choroid plexus in the ventricles (hollow spaces) in the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buccal Mucosa</VALIDVALUE>
          <VALUEMEANING>Buccal Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>The mucosal membranes located on the inside of the cheek, in the buccal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood</VALIDVALUE>
          <VALUEMEANING>Blood</VALUEMEANING>
          <MEANINGDESCRIPTION>Blood circulating throughout the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3111300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PBMCs</VALIDVALUE>
          <VALUEMEANING>Peripheral Blood Mononuclear Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12954</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritoneal fluid</VALIDVALUE>
          <VALUEMEANING>Peritoneal Fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>The small amount of fluid that is generated in the abdominal cavity to lubricate the peritoneum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3902632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-neoplastic</VALIDVALUE>
          <VALUEMEANING>Non-Neoplastic</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Exhibiting characteristics of independently proliferating cells, notably altered morphology, growth characteristics, and/or biochemical and molecular properties.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45315, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5828001</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Overnight urine</VALIDVALUE>
          <VALUEMEANING>24 Hour Urine</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24_A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day._The fluid that is excreted by the kidneys.  It is stored in the bladder and discharged through the urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13283, C25529, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10207285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal cell collection</VALIDVALUE>
          <VALUEMEANING>Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid. Cells are highly variable and specialized in both structure and function, though all must at some stage replicate proteins and nucleic acids, utilize energy, and reproduce themselves.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2615470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eyebrow hair</VALIDVALUE>
          <VALUEMEANING>Eyebrow Hair</VALUEMEANING>
          <MEANINGDESCRIPTION>The arched strip of hair on the bony ridge above each eye socket.: The filamentous outgrowth of the epidermis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32705, C32575</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5720350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oral rinse</VALIDVALUE>
          <VALUEMEANING>Oral Rinse</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or relating to, or affecting, or for use in the mouth._Wash lightly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65120, C25311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11418036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vaginal swab</VALIDVALUE>
          <VALUEMEANING>Vaginal Swab</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the vagina._A tuft of material on the end of a stick for applying solutions and suspensions</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17627, C13309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11418037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Sample Type</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Sample Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source of Specimen</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Source of Specimen</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specimen</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Tissue type used for ALK FISH:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Tissue type used for ALK tumor sequencing:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specimen type:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specimen source/type:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939361</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCTD</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Biomarker Abstraction</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3263369</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5428053</PublicId>
          <ContextName>GDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Biospecimen</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5428054</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>GDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>sample_type</AlternateName>
        <AlternateNameType>GDC_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>GDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GDC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>tissue_type</AlternateName>
        <AlternateNameType>HCMI Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="703">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3121715</PUBLICID>
    <LONGNAME>Prior Treatment Blood Pressure Assessment Ind-3b</LONGNAME>
    <PREFERREDNAME>3121713v1.0:2958018v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>an indicator that can have a value of yes, no, or not applicable related to pretreatment assessment of the pressure of the circulating blood against the walls of the blood vessels.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>GOG CRF:Gynecologic Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3121713</PublicId>
      <PreferredName>3121711v1.0:2233077v1.0</PreferredName>
      <PreferredDefinition>information related to pretreatment assessment of the pressure of the circulating blood against the walls of the blood vessels.</PreferredDefinition>
      <LongName>Prior Treatment Blood Pressure Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3121711</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C15368:C54706</PreferredName>
        <Version>1</Version>
        <LongName>Prior Therapy Blood Pressure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54706</PREFERRED_NAME>
            <LONG_NAME>Blood Pressure</LONG_NAME>
            <CON_ID>2552352</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25367</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>GOG CRF:Gynecologic Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506036</PublicId>
      <PreferredName>YES_NO_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.</PreferredDefinition>
      <LongName>Yes No Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694966</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49797</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3b</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49797</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Not Applicable Response</LONG_NAME>
            <CON_ID>2694965</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the pre-treatment blood p</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the pre-treatment blood pressure been recorded</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have adequately controlled blood pressure, with a BP no greater than 140mmHg (systolic) and 90mmHg (diastolic)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229L</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229N</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229O</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104892</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000175</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3121713v1.0:2958018v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="704">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3132452</PUBLICID>
    <LONGNAME>Metastatic Breast Carcinoma HER2 ERBB Method Calculation Method Text</LONGNAME>
    <PREFERREDNAME>3132451v1.0:3087484v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text to describe the method used to calculate HER2/ERBB2 positivity in a specimen or sample of metastatic breast carcinoma tissue.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3132451</PublicId>
      <PreferredName>3132449v1.0:3087480v1.0</PreferredName>
      <PreferredDefinition>A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site._A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  _The ERBB2 Gene at 17q21.1 encodes ERRB2 Receptor Protein Tyrosine Kinase, a 185 kD type I membrane glycoprotein that controls cell growth with features similar to EGFR._An observation confirming something, such as the presence of a disease, condition, or microorganism._Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc_The ERBB2 Gene at 17q21.1 encodes ERRB2 Receptor Protein Tyrosine Kinase, a 185 kD type I membrane glycoprotein that controls cell growth with features similar to EGFR. Ligand binding increases phosphorylation of tyrosine residues. A potential heterodimer with ERBB3 and ERBB4 receptors, p185ERBB2 is an essential component of the heregulin/neuregulin receptor complex. ERBB2 homodimers do not bind heregulin but ERBB2/ERBB3 heterodimers do. Neuregulins do not interact with ERBB2 alone. The IL6 cytokine induces tyrosine phosphorylation of ERBB2 and ERBB3, but not EGFR. ERBB2 forms an IL6-dependent complex with the IL6R gp130 subunit resulting in MAPK activation. An observation confirming something, such as the presence of a disease, condition, or microorganism._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._The procedure or activity of determining something by mathematical or logical methods.</PreferredDefinition>
      <LongName>Metastatic Breast Carcinoma HER2 ERBB Positive Method Calculation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3132449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14174:C4872:C17756:C38758</PreferredName>
        <Version>1</Version>
        <LongName>Metastatic Breast Carcinoma HER2/neu Positive Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14174</PREFERRED_NAME>
            <LONG_NAME>Metastatic</LONG_NAME>
            <CON_ID>2204914</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4872</PREFERRED_NAME>
            <LONG_NAME>Breast Carcinoma</LONG_NAME>
            <CON_ID>2475940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17756</PREFERRED_NAME>
            <LONG_NAME>ERBB2 Gene</LONG_NAME>
            <CON_ID>2202658</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38758</PREFERRED_NAME>
            <LONG_NAME>Positive Finding</LONG_NAME>
            <CON_ID>2516404</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3087480</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71460:C54125</PreferredName>
        <Version>1</Version>
        <LongName>Method Calculation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54125</PREFERRED_NAME>
            <LONG_NAME>Calculation</LONG_NAME>
            <CON_ID>2654477</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3087484</PublicId>
      <PreferredName>3087484v1.0</PreferredName>
      <PreferredDefinition>A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Tests can help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time._The result of an action._The procedure or activity of determining something by mathematical or logical methods._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Text; the words of something written.</PreferredDefinition>
      <LongName>Laboratory Procedure Result Calculation Method Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1000</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3087483</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294:C20200:C54125:C71460:C2</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Outcome Calculation Method Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54125</PREFERRED_NAME>
            <LONG_NAME>Calculation</LONG_NAME>
            <CON_ID>2654477</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Define Method of Calculation</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Define Method of Calculation for HER2/ERBB2 Positivity (Metastatic)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="705">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3132910</PUBLICID>
    <LONGNAME>Metastatic Breast Carcinoma HER2 ERBB Positive Finding Fluorescence in situ Hybridization Calculation Method Text</LONGNAME>
    <PREFERREDNAME>3132909v1.0:3087484v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text to describe the method used to calculate HER2/ERBB2 Fluorescence in situ Hybridization (FISH) positivity in a specimen or sample of metastatic breast carcinoma.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3132909</PublicId>
      <PreferredName>3132449v1.0:3087925v1.0</PreferredName>
      <PreferredDefinition>A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site._A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit._The ERBB2 Gene at 17q21.1 encodes ERRB2 Receptor Protein Tyrosine Kinase, a 185 kD type I membrane glycoprotein that controls cell growth with features similar to EGFR. _An observation confirming something, such as the presence of a disease, condition, or microorganism._The ERBB2 Gene at 17q21.1 encodes ERRB2 Receptor Protein Tyrosine Kinase, a 185 kD type I membrane glycoprotein that controls cell growth with features similar to EGFR. Ligand binding increases phosphorylation of tyrosine residues. A potential heterodimer with ERBB3 and ERBB4 receptors, p185ERBB2 is an essential component of the heregulin/neuregulin receptor complex. ERBB2 homodimers do not bind heregulin but ERBB2/ERBB3 heterodimers do. Neuregulins do not interact with ERBB2 alone. The IL6 cytokine induces tyrosine phosphorylation of ERBB2 and ERBB3, but not EGFR. A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._</PreferredDefinition>
      <LongName>Metastatic Breast Carcinoma HER2 ERBB Positive Finding Fluorescence in situ Hybridization Method Calculation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3132449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14174:C4872:C17756:C38758</PreferredName>
        <Version>1</Version>
        <LongName>Metastatic Breast Carcinoma HER2/neu Positive Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14174</PREFERRED_NAME>
            <LONG_NAME>Metastatic</LONG_NAME>
            <CON_ID>2204914</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4872</PREFERRED_NAME>
            <LONG_NAME>Breast Carcinoma</LONG_NAME>
            <CON_ID>2475940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17756</PREFERRED_NAME>
            <LONG_NAME>ERBB2 Gene</LONG_NAME>
            <CON_ID>2202658</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38758</PREFERRED_NAME>
            <LONG_NAME>Positive Finding</LONG_NAME>
            <CON_ID>2516404</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3087925</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17563:C71460:C54125</PreferredName>
        <Version>1</Version>
        <LongName>Fluorescence in situ Hybridization Method Calculation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17563</PREFERRED_NAME>
            <LONG_NAME>Fluorescence In Situ Hybridization</LONG_NAME>
            <CON_ID>2221360</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54125</PREFERRED_NAME>
            <LONG_NAME>Calculation</LONG_NAME>
            <CON_ID>2654477</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3087484</PublicId>
      <PreferredName>3087484v1.0</PreferredName>
      <PreferredDefinition>A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Tests can help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time._The result of an action._The procedure or activity of determining something by mathematical or logical methods._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Text; the words of something written.</PreferredDefinition>
      <LongName>Laboratory Procedure Result Calculation Method Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1000</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3087483</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294:C20200:C54125:C71460:C2</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Outcome Calculation Method Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54125</PREFERRED_NAME>
            <LONG_NAME>Calculation</LONG_NAME>
            <CON_ID>2654477</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Define Method of Calculation</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Define Method of Calculation for HER2/ERBB2 FISH Positivity (Metastatic)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="706">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3135107</PUBLICID>
    <LONGNAME>Tooth Gingival Margin Apical To Cementoenamel Junction Present Data Unknown Text</LONGNAME>
    <PREFERREDNAME>3135106v1.0:2200608v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>is an organ, the organ parts of which primarily consist of dentine and dental enamel; together with other teeth it constitutes a subdivision of the facial skeleton. Example(s): incisor, molar._The crest of the gingiva surrounding a tooth_Relating to or located at the tip (an apex). (On-line Medical Dictionary)_Used as a function word to indicate direction, purpose, or movement._The area of a tooth where the enamel of the crown and the cementum of the root(s) are joined._Being or existing in a specified place or at the specified time._a single character text field to record data.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3135106</PublicId>
      <PreferredName>2514269v1.0:3135104v1.0</PreferredName>
      <PreferredDefinition>is an organ, the organ parts of which primarily consist of dentine and dental enamel; together with other teeth it constitutes a subdivision of the facial skeleton. Example(s): incisor, molar._The crest of the gingiva surrounding a tooth_Relating to or located at the tip (an apex). (On-line Medical Dictionary)_Used as a function word to indicate direction, purpose, or movement._The area of a tooth where the enamel of the crown and the cementum of the root(s) are joined._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Tooth Gingival Margin Apical To Cementoenamel Junction Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2514269</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12506</PreferredName>
        <Version>1</Version>
        <LongName>Tooth</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12506</PREFERRED_NAME>
            <LONG_NAME>Tooth</LONG_NAME>
            <CON_ID>2202581</CON_ID>
            <DEFINITION_SOURCE>UWDA142</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3135104</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3135104v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Gingival Margin Apical To Cementoenamel Junction Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60722</PREFERRED_NAME>
            <LONG_NAME>Gingival Margin</LONG_NAME>
            <CON_ID>2481618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25423</PREFERRED_NAME>
            <LONG_NAME>Apical</LONG_NAME>
            <CON_ID>2206158</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C65107</PREFERRED_NAME>
            <LONG_NAME>To</LONG_NAME>
            <CON_ID>2672667</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C74593</PREFERRED_NAME>
            <LONG_NAME>Normal Skin</LONG_NAME>
            <CON_ID>2767431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200608</PublicId>
      <PreferredName>DATA_UNKNOWN_TEXT</PreferredName>
      <PreferredDefinition>a single character text field to record data.</PreferredDefinition>
      <LongName>Data Unknown Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Free gingival margin is apica</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Free gingival margin is apical to the cemento-enamel junction.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="707">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3151499</PUBLICID>
    <LONGNAME>FDG Or CT PET Performed Day Number</LONGNAME>
    <PREFERREDNAME>3151496v1.0:2896868v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value that represents the day that a fludeoxyglucose F 18 or computed tomography positron emission tomography scan was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3151496</PublicId>
      <PreferredName>3151494v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>The radioactive form of glucose used in positron emission tomography (PET), a diagnostic imaging procedure._Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis._A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered._Performed; carried out.</PreferredDefinition>
      <LongName>FDG Or CT PET Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3151494</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C964:C37998:C17204:C17007</PreferredName>
        <Version>1</Version>
        <LongName>Fludeoxyglucose F 18 Or Computed Tomography Positron Emission Tomography</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C964</PREFERRED_NAME>
            <LONG_NAME>Fludeoxyglucose F-18</LONG_NAME>
            <CON_ID>2321503</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17204</PREFERRED_NAME>
            <LONG_NAME>Computed Tomography</LONG_NAME>
            <CON_ID>2202436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17007</PREFERRED_NAME>
            <LONG_NAME>Positron Emission Tomography</LONG_NAME>
            <CON_ID>2224887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>TCGA:The Cancer Genome Atlas</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896868</PublicId>
      <PreferredName>EVT_DAY_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._time for Earth to make a complete rotation on its axis._A numeral or string of numerals expressing value, quantity, or identification</PreferredDefinition>
      <LongName>Event Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C0439228:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Day Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0439228</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2204684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>22nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::22: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::22</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>21st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>20th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::20: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>19th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::19: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>18th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::18: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>17th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::17: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>16th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::16: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>15th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::15: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>14th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::14: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>13th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::13: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::10: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::4: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::5: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>31st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::31: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::31</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>30th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::30: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::30</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>29th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::29: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>28th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::28: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>27th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::27: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>26th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::26: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>25th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::25: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>24th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>23rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::23: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day of FDG-PET or PET/CT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Day of FDG-PET or PET/CT</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655968</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HTMCP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HTMCP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000067</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>day_of_fdg_or_ct_pet_performed</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="708">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3158165</PUBLICID>
    <LONGNAME>Bladder Carcinoma T Stage Present Ind-2</LONGNAME>
    <PREFERREDNAME>BLADCA_TST_PRES_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to Clinical T stage and bladder carcinoma.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3158117</PublicId>
      <PreferredName>BLADDERCA_TST_PRES</PreferredName>
      <PreferredDefinition>information relating to T Stage (one criteria of the TMN staging system, where T refers to the extent of tumor involvement at the primary site) and a bladder carcinoma (a carcinoma arising from the bladder epithelium) present (being or existing in a specified place or at the specified time).</PreferredDefinition>
      <LongName>Bladder Carcinoma T Stage Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3135356</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4912</PreferredName>
        <Version>1</Version>
        <LongName>Bladder Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4912</PREFERRED_NAME>
            <LONG_NAME>Bladder Carcinoma</LONG_NAME>
            <CON_ID>3130371</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3158115</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25728:C25626</PreferredName>
        <Version>1</Version>
        <LongName>T Stage Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25728</PREFERRED_NAME>
            <LONG_NAME>T Category</LONG_NAME>
            <CON_ID>2202382</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Clinical T4b</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Clinical T4b</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="709">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3160585</PUBLICID>
    <LONGNAME>Pre-study Evaluation Type</LONGNAME>
    <PREFERREDNAME>3160565v1.0:3160574v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of pre-study evaluation performed before enrollment/treatment on-study</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3160565</PublicId>
      <PreferredName>3160563v1.0:2239847v1.0</PreferredName>
      <PreferredDefinition>information related to a pre-study evaluation, an assessment occurring before enrollment/treatment on-study.</PreferredDefinition>
      <LongName>Pre-study Evaluation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3160563</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38010</PreferredName>
        <Version>1</Version>
        <LongName>Pre-study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38010</PREFERRED_NAME>
            <LONG_NAME>Pre-study</LONG_NAME>
            <CON_ID>2322178</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239847</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25214</PreferredName>
        <Version>1</Version>
        <LongName>Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3160574</PublicId>
      <PreferredName>3160574v1.0</PreferredName>
      <PreferredDefinition>the type of pre-study evaluation performed.</PreferredDefinition>
      <LongName>Pre-study Evaluation Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Performance status  (prior to starting study drug)</VALIDVALUE>
          <VALUEMEANING>Performance status  (prior to starting study drug)</VALUEMEANING>
          <MEANINGDESCRIPTION>Performance status  (prior to starting study drug)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3160575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EKG  (prior to starting study drug)</VALIDVALUE>
          <VALUEMEANING>EKG  (prior to starting study drug)</VALUEMEANING>
          <MEANINGDESCRIPTION>EKG  (prior to starting study drug)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3160576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Height, Weight, vital signs (prior to starting study drug)</VALIDVALUE>
          <VALUEMEANING>Height, Weight, vital signs (prior to starting study drug)</VALUEMEANING>
          <MEANINGDESCRIPTION>Height, Weight, vital signs (prior to starting study drug)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3160577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>History and Physical Exam  (prior to starting study drug)</VALIDVALUE>
          <VALUEMEANING>History and Physical Exam  (prior to starting study drug)</VALUEMEANING>
          <MEANINGDESCRIPTION>History and Physical Exam  (prior to starting study drug)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3160578</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pre Study Evaluations</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pre Study Evaluations</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="710">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3162438</PUBLICID>
    <LONGNAME>Product Related Mutation Identification Abnormality Type</LONGNAME>
    <PREFERREDNAME>PROD_REL_MUT_ABN_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Term to identify a specific type of product-related genetic mutation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3162431</PublicId>
      <PreferredName>PROD_REL_MUT_ID</PreferredName>
      <PreferredDefinition>The end result of a manufacturing process; anything that is produced._Related; connected or associated._Genetic alterations found in the neoplastic lesions of the animal model. These alterations are not made intentionally._The procedure of having an identity established.</PreferredDefinition>
      <LongName>Product Related Mutation Identification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435027</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16612</PreferredName>
        <Version>1</Version>
        <LongName>Gene</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3162429</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C51980:C25648:C16885</PreferredName>
        <Version>1</Version>
        <LongName>Product Relationship Mutation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51980</PREFERRED_NAME>
            <LONG_NAME>Product</LONG_NAME>
            <CON_ID>2527882</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16885</PREFERRED_NAME>
            <LONG_NAME>Mutation</LONG_NAME>
            <CON_ID>2224010</CON_ID>
            <DEFINITION_SOURCE>CABIO</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2322316</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25737</PreferredName>
        <Version>1</Version>
        <LongName>Identified</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25737</PREFERRED_NAME>
            <LONG_NAME>Identification</LONG_NAME>
            <CON_ID>2203822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3162433</PublicId>
      <PreferredName>MUT_ABN_TP</PreferredName>
      <PreferredDefinition>change occurring in one gene._Type; a subdivision of a particular kind of thing._</PreferredDefinition>
      <LongName>Mutation Abnormality Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435027</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16612</PreferredName>
        <Version>1</Version>
        <LongName>Gene</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>TCGA:The Cancer Genome Atlas</Origin>
      <Representation>
        <PublicId>3162440</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18093:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Gene Mutation Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18093</PREFERRED_NAME>
            <LONG_NAME>Gene Mutation</LONG_NAME>
            <CON_ID>3086322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Q61H</VALIDVALUE>
          <VALUEMEANING>Q61H</VALUEMEANING>
          <MEANINGDESCRIPTION>Q61H Genetic Mutation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3162434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Q61R</VALIDVALUE>
          <VALUEMEANING>Q61R</VALUEMEANING>
          <MEANINGDESCRIPTION>Q61R Genetic Mutation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3162435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Q61L</VALIDVALUE>
          <VALUEMEANING>Q61L</VALUEMEANING>
          <MEANINGDESCRIPTION>Q61L Genetic Mutation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3162436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G12C</VALIDVALUE>
          <VALUEMEANING>KRAS NP_004976.2:p.G12C </VALUEMEANING>
          <MEANINGDESCRIPTION>A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by cysteine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98365</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-10-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3147612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G12D</VALIDVALUE>
          <VALUEMEANING>KRAS NP_004976.2:p.G12D </VALUEMEANING>
          <MEANINGDESCRIPTION>A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by aspartic acid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-10-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3147611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G12R</VALIDVALUE>
          <VALUEMEANING>KRAS NP_004976.2:p.G12R </VALUEMEANING>
          <MEANINGDESCRIPTION>A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by arginine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-10-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3147610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G12V</VALIDVALUE>
          <VALUEMEANING>KRAS NP_004976.2:p.G12V </VALUEMEANING>
          <MEANINGDESCRIPTION>A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by valine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-10-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3147608</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>(If Yes) Select a mutation fr</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>(If Yes) Select a mutation from the following (Choose one):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812605</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="711">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3171101</PUBLICID>
    <LONGNAME>Patient Incomplete No Schedule Visit Questionnaire Other Specify</LONGNAME>
    <PREFERREDNAME>3171060v1.0:2194376v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field related to other specified related to the incomplete questionnaire due to no scheduled visits.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3171060</PublicId>
      <PreferredName>2177068v1.0:3171058v1.0</PreferredName>
      <PreferredDefinition>information related to the incomplete questionnaire due to no scheduled visits.</PreferredDefinition>
      <LongName>Patient Incomplete No Schedule Visit Questionnaire</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3171058</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3171058v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Incomplete No Schedule Visit Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49160</PREFERRED_NAME>
            <LONG_NAME>Incomplete</LONG_NAME>
            <CON_ID>2427335</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25211</PREFERRED_NAME>
            <LONG_NAME>Schedule</LONG_NAME>
            <CON_ID>2203792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25716</PREFERRED_NAME>
            <LONG_NAME>Visit</LONG_NAME>
            <CON_ID>2202626</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0034394</PREFERRED_NAME>
            <LONG_NAME>Questionnaire</LONG_NAME>
            <CON_ID>2203295</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2194376</PublicId>
      <PreferredName>ASSESS_OTHER_SPEC</PreferredName>
      <PreferredDefinition>the free text field related to other specified assessment.</PreferredDefinition>
      <LongName>Assessment Other Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="712">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3173724</PUBLICID>
    <LONGNAME>Salvage Therapy Identifier Type</LONGNAME>
    <PREFERREDNAME>2014118v1.0:3173723v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>a subdivision to identify a specific salvage therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014118</PublicId>
      <PreferredName>SALVAGETX_ID</PreferredName>
      <PreferredDefinition>the means to uniquely identify a specific salvage therapy.</PreferredDefinition>
      <LongName>Salvage Therapy Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177011</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Salvage Therapy</PreferredName>
        <Version>1</Version>
        <LongName>Salvage Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15359</PREFERRED_NAME>
            <LONG_NAME>Salvage Therapy</LONG_NAME>
            <CON_ID>2202812</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3173723</PublicId>
      <PreferredName>3173723v1.0</PreferredName>
      <PreferredDefinition>a subdivision of salvage therapy.</PreferredDefinition>
      <LongName>Salvage Therapy Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surgery</VALIDVALUE>
          <VALUEMEANING>Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiation Therapy</VALIDVALUE>
          <VALUEMEANING>Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunotherapy</VALIDVALUE>
          <VALUEMEANING>Immunotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>(IM-yoo-no-THER-a-pee) Treatment to stimulate or restore the ability of the immune system to fight infections and other diseases. Also used to lessen side effects that may be caused by some cancer treatments.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemotherapy</VALIDVALUE>
          <VALUEMEANING>Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiofrequency Ablation</VALIDVALUE>
          <VALUEMEANING>Radiofrequency Ablation</VALUEMEANING>
          <MEANINGDESCRIPTION>A therapeutic procedure to eradicate or reduce small tumors using radiowaves to generate heat. The procedure is performed by the insertion of a thin needle through the skin and into a tumor, which is guided by computed tomography (CT) or ultrasound. Electrical energy delivered through this needle (electrode) heats and destroys the tumor. This therapeutic option is widely utilized by patients that have inoperable cancers, or are unsuitable chemotherapy candidates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3029158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SBRT</VALIDVALUE>
          <VALUEMEANING>Stereotactic Body Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Stereotactic radiation therapy in which one or several maximum dose radiation treatments are delivered targeting cancers of the body, excluding the brain or spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3193538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-PDL1 antibody</VALIDVALUE>
          <VALUEMEANING>Anti-PD-L1 antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against human PD-L1 (programmed cell death 1; PDCD1), with immunomodulating and antitumor activities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3304775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-PD1 antibody</VALIDVALUE>
          <VALUEMEANING>Anti-PD1 antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against human PD-1 (programmed cell death 1; PDCD1), with immunomodulating and antitumor activities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3304776</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunotherapy - Other</VALIDVALUE>
          <VALUEMEANING>Immunotherapy - Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunotherapy - Other</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4780580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunotherapy - Other anti-PD1</VALIDVALUE>
          <VALUEMEANING>Immunotherapy - Other anti-PD1</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunotherapy - Other anti-PD1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4780581</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunotherapy - Repeat Ipilimumab</VALIDVALUE>
          <VALUEMEANING>Immunotherapy - Repeat Ipilimumab</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunotherapy - Repeat Ipilimumab</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4780582</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Molecularly targeted therapy - Other</VALIDVALUE>
          <VALUEMEANING>Molecularly targeted therapy - Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Molecularly targeted therapy - Other</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4780583</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Molecularly targeted therapy - BRAFi +/- MEK</VALIDVALUE>
          <VALUEMEANING>Molecularly targeted therapy - BRAFi +/- MEK</VALUEMEANING>
          <MEANINGDESCRIPTION>Molecularly targeted therapy - BRAFi +/- MEK</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4780584</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytotoxic Chemotherapy</VALIDVALUE>
          <VALUEMEANING>Cytotoxic Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Anticancer drugs that kill cells, especially cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4780585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Type of Salvage Therapy</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Type of Salvage Therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Type of local salvage therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="713">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3175725</PUBLICID>
    <LONGNAME>Experimental Entity Status Date and Time ISO21090.TS.DATETIME.v1.0</LONGNAME>
    <PREFERREDNAME>3174626v1.0:3148148v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The date (and time) on which the status is assigned to the experimental unit.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3174626</PublicId>
      <PreferredName>3174138v1.0:2867759v1.0</PreferredName>
      <PreferredDefinition>Being studied; investigational; derived by experimentation.:An independently existing thing (living or nonliving)._A condition or state at a particular time.:An expression of both date and time that an event has happened or will happen.</PreferredDefinition>
      <LongName>Experimental Entity Status Date and Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174138</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28296:C51070</PreferredName>
        <Version>1</Version>
        <LongName>Experimental Entity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28296</PREFERRED_NAME>
            <LONG_NAME>Experimental</LONG_NAME>
            <CON_ID>2427519</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867759</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688:C37939</PreferredName>
        <Version>1</Version>
        <LongName>Status Date and Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3148148</PublicId>
      <PreferredName>3148148v1.0</PreferredName>
      <PreferredDefinition>Constrains TS so that it&#39;s precision can not be more precise than seconds.</PreferredDefinition>
      <LongName>ISO21090.TS.DATETIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090TSDTTIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Experimental Entity Status Date and Time ISO21090.TS.DATETIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Experimental Entity Status Date and Time ISO21090.TS.DATETIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.CommonSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757153</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ExperimentalUnit.statusDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ExperimentalUnit:statusDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.CommonSubDomain.ExperimentalUnit.statusDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ExperimentalUnit.statusDate</AlternateName>
        <AlternateNameType>Map:CTRv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ExperimentalUnit.effectiveTime</AlternateName>
        <AlternateNameType>Map:HL7SP</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="714">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3175963</PUBLICID>
    <LONGNAME>Plan Study Activity Purpose ISO21090.ST.v1.0</LONGNAME>
    <PREFERREDNAME>3174848v1.0:2803207v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The reason for the planned activity. EXAMPLE(S): treating a disease (treatment), determining eligibility for a study (screening).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3174848</PublicId>
      <PreferredName>2867606v1.0:2186370v1.0</PreferredName>
      <PreferredDefinition>To devise, contrive, or formed in design.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective; the state of being active._Reason or intention.</PreferredDefinition>
      <LongName>Plan Study Activity Purpose</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867606</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25619:C63536:C43431</PreferredName>
        <Version>1</Version>
        <LongName>Plan Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25619</PREFERRED_NAME>
            <LONG_NAME>Plan</LONG_NAME>
            <CON_ID>2203947</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2186370</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25634</PreferredName>
        <Version>1</Version>
        <LongName>Purpose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25634</PREFERRED_NAME>
            <LONG_NAME>Purpose</LONG_NAME>
            <CON_ID>2202870</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803207</PublicId>
      <PreferredName>2803207v1.0</PreferredName>
      <PreferredDefinition>Character string datatype stands for text data.</PreferredDefinition>
      <LongName>ISO21090.ST.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090STv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Plan Study Activity Purpose ISO21090.ST.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Plan Study Activity Purpose ISO21090.ST.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PlannedActivity.purpose</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PlannedActivity:purpose</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="715">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176164</PUBLICID>
    <LONGNAME>Biospecimen Collection Intervention or Procedure Performed Study Activity Actual Duration ISO21090.PQ.TIME.v1.0</LONGNAME>
    <PREFERREDNAME>2868448v1.0:2848092v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The completed action of gathering samples that may be used for subsequent analysis. EXAMPLE(S): blood draw The period of time over which the activity is performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868448</PublicId>
      <PreferredName>2867584v1.0:2867941v1.0</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:The act of gathering things together; having been brought together in one place.:An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.:Executed and carried through to completion.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective; the state of being active._Existing in fact; real.:The period of time during which something continues.</PreferredDefinition>
      <LongName>Biospecimen Collection Intervention or Procedure Performed Study Activity Actual Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867584</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>2867584v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Collection Intervention or Procedure Performed Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867941</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25274:C25330</PreferredName>
        <Version>1</Version>
        <LongName>Actual Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25274</PREFERRED_NAME>
            <LONG_NAME>Actual</LONG_NAME>
            <CON_ID>2206152</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2848092</PublicId>
      <PreferredName>2848092v1.0</PreferredName>
      <PreferredDefinition>Constrains PQ to have units that describe a period of time.</PreferredDefinition>
      <LongName>ISO21090.PQ.TIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090PQTIMEv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Biospecimen Collection Intervention or Procedure Performed Study Activity Actual Duration ISO21090.PQ.TIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Biospecimen Collection Intervention or Procedure Performed Study Activity Actual Duration ISO21090.PQ.TIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedSpecimenCollection.actualDuration</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedSpecimenCollection:actualDuration</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="716">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176232</PUBLICID>
    <LONGNAME>Intervention or Procedure Reuse Template Study Activity Subcategory Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>3175075v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity defined at a global library level that is an action whose immediate and primary intention is the alteration of the physical condition of the study subject or experimental unit. EXAMPLE(S): Procedures may involve the disruption of some body surface (e.g. an incision in a surgical procedure). Conservative procedures such as reduction of a luxated joint, including physiotherapy such as chiropractic treatment, massage, balneotherapy, acupuncture, shiatsu. A coded value specifying a subdivision within a larger category of activities. EXAMPLE(S): chemotherapy, radiotherapy, hormonal therapy, alternative therapy. In the case where categoryCode = &quot;anti-cancer treatment&quot;, subcategoryCode may = &quot;radiotherapy&quot;, and nameCode may = &quot;external beam radiotherapy&quot;. If categoryCode = &quot;Intervention&quot;, subcategoryCode may = &quot;Drug&quot; (including placebo), &quot;Device&quot; (including sham), &quot;Biological/Vaccine&quot;, &quot;Procedure/Surgery&quot;, &quot;Radiation&quot;, &quot;Behavioral&quot; (e.g., Psychotherapy, Lifestyle Counseling), &quot;Genetic&quot; (including gene transfer, stem cell and recombinant DNA), Dietary Supplement.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175075</PublicId>
      <PreferredName>3174171v1.0:2867795v1.0</PreferredName>
      <PreferredDefinition>An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._A subdivision that has common differentiating characteristics within a larger category.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Intervention or Procedure Reuse Template Study Activity Subcategory Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174171</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174171v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Intervention or Procedure Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867795</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25692:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Subcategory Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25692</PREFERRED_NAME>
            <LONG_NAME>Subcategory</LONG_NAME>
            <CON_ID>2203589</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Intervention or Procedure Reuse Template Study Activity Subcategory Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Intervention or Procedure Reuse Template Study Activity Subcategory Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DefinedProcedure.subcategoryCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedProcedure:subcategoryCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.DefinedProcedure.subcategoryCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="717">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176294</PUBLICID>
    <LONGNAME>Amendment Change Summary Document Version Keyword Text ISO21090.DSET.ST.v1.0</LONGNAME>
    <PREFERREDNAME>3175136v1.0:2803347v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A document, memo or brief that enumerates the differences between two versions of a study protocol document. OTHER NAME(S): Amendment A character string of a word or phrase that describes the document and/or its context. Keywords help users find documents of interest. EXAMPLE(S): species, indication, biocompatibility, drug substance, drug product.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175136</PublicId>
      <PreferredName>3174200v1.0:2867936v1.0</PreferredName>
      <PreferredDefinition>A change in a document made by correction, adding, substituting or omitting a certain part. Amendments are the mechanism of changes introduction, further development and improvement of previously submitted or approved clinical study protocols and proposals.:The act of alteration or modification; changed or altered in form or character.:A shortened version of a speech or written text, containing only the main points.:An organized collection of records that describe a particular body of work.:A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications._A small set of words designed to convey the subject of a technical article.:The words of something written.</PreferredDefinition>
      <LongName>Amendment Change Summary Document Version Keyword Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174200</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174200v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Amendment Change Summary Document Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41200</PREFERRED_NAME>
            <LONG_NAME>Amendment</LONG_NAME>
            <CON_ID>2551428</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42581</PREFERRED_NAME>
            <LONG_NAME>Summary</LONG_NAME>
            <CON_ID>2203701</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19498</PREFERRED_NAME>
            <LONG_NAME>Document</LONG_NAME>
            <CON_ID>2223216</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867936</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43513:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Keyword Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43513</PREFERRED_NAME>
            <LONG_NAME>Keyword</LONG_NAME>
            <CON_ID>2223202</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803347</PublicId>
      <PreferredName>2803347v1.0</PreferredName>
      <PreferredDefinition>A collection containing unordered distinct/discrete values of the type ST.</PreferredDefinition>
      <LongName>ISO21090.DSET.ST.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090DSETv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Amendment Change Summary Document Version Keyword Text ISO21090.DSET.ST.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Amendment Change Summary Document Version Keyword Text ISO21090.DSET.ST.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.AmendmentChangeSummaryVersion.keywordText</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AmendmentChangeSummaryVersion:keywordText</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.AmendmentChangeSummaryVersion.keywordText</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="718">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176393</PUBLICID>
    <LONGNAME>Imaging Technique Observation Reuse Template Study Activity Foci Date and Time Range ISO21090.QTY.IVL.TS.DATETIME.v1.0</LONGNAME>
    <PREFERREDNAME>3175221v1.0:3152478v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity defined at the global library level whose intention is to obtain pictures of the interior or exterior of the body usually for diagnostic reasons. EXAMPLE(S): X-ray, MRI The time period in which the observation result is held to be true, expressed either as a simple date range or as an evaluable expression that references a study-defined date or milestone. EXAMPLE(S): For a survey question, &quot;Have you traveled to Europe between 1990 and 1999?&quot;, the focalDateRange would be &quot;January 1, 1990 to December 31, 1999&quot;. For the question, &quot;Have you smoked in the last 2 months&quot;, the focalDateRange would be an expression referencing a variable that represents the PerformedObservation.actualDateRange (a value yet to be defined) and a formula for the date range between when the question is asked (PerformedObservation.actualDateRange.low) and 2 months prior (PerformedObservation.actualDateRange.low - 2 months).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175221</PublicId>
      <PreferredName>3174173v1.0:3174559v1.0</PreferredName>
      <PreferredDefinition>Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.:Watching something and taking note of what happens.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._Area of greatest concentration, attention, or activity; a central point or locus, especially of an infection.:An expression of both date and time that an event has happened or will happen.:The difference between the lowest and highest numerical values; the limits or scale of variation.</PreferredDefinition>
      <LongName>Imaging Technique Observation Reuse Template Study Activity Foci Date and Time Range</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174173</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174173v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Imaging Technique Observation Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17369</PREFERRED_NAME>
            <LONG_NAME>Imaging Procedure</LONG_NAME>
            <CON_ID>2713347</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3174559</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25511:C37939:C38013</PreferredName>
        <Version>1</Version>
        <LongName>Foci Date and Time Range</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25511</PREFERRED_NAME>
            <LONG_NAME>Focus</LONG_NAME>
            <CON_ID>2203817</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38013</PREFERRED_NAME>
            <LONG_NAME>Range</LONG_NAME>
            <CON_ID>2204649</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3152478</PublicId>
      <PreferredName>3152478v1.0</PreferredName>
      <PreferredDefinition>Abstract generalization quantity of the type IVL.TS.DATETIME.</PreferredDefinition>
      <LongName>ISO21090.QTY.IVL.TS.DATETIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090QTYv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Imaging Technique Observation Reuse Template Study Activity Foci Date and Time Range ISO21090.QTY.IVL.TS.DATETIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Imaging Technique Observation Reuse Template Study Activity Foci Date and Time Range ISO21090.QTY.IVL.TS.DATETIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedImaging:focalDateRange </AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DefinedImaging.focalDateRange </AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="719">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3177014</PUBLICID>
    <LONGNAME>Inclusion Criteria Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity Foci Duration ISO21090.PQ.TIME.v1.0</LONGNAME>
    <PREFERREDNAME>3175511v1.0:2848092v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity defined at a global library level that identifies a characteristic or requirement intended to be applied to a potential study subject to determine whether they may not participate in a study. EXAMPLE(S): pregnancy A quantity of time in which the observation result is held to be true. EXAMPLE(S): 2 months is the focalDuration for the question, &quot;Have you smoked in the last 2 months?&quot;</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175511</PublicId>
      <PreferredName>3174195v1.0:3174558v1.0</PreferredName>
      <PreferredDefinition>Medical and/or social characteristics which are necessary for a subject to be allowed to participate in a clinical study, as outlined in the study protocol. Meeting inclusion criteria is not a sufficient condition for entry or recruitment of a subject into the study. Characteristics limiting the eligibility of a subject for the clinical study must be considered.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.:Watching something and taking note of what happens.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._Area of greatest concentration, attention, or activity; a central point or locus, especially of an infection.:The period of time during which something continues.</PreferredDefinition>
      <LongName>Inclusion Criteria Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity Foci Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174195</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174195v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Inclusion Criteria Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25532</PREFERRED_NAME>
            <LONG_NAME>Inclusion Criteria</LONG_NAME>
            <CON_ID>2202445</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3174558</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25511:C25330</PreferredName>
        <Version>1</Version>
        <LongName>Foci Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25511</PREFERRED_NAME>
            <LONG_NAME>Focus</LONG_NAME>
            <CON_ID>2203817</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2848092</PublicId>
      <PreferredName>2848092v1.0</PreferredName>
      <PreferredDefinition>Constrains PQ to have units that describe a period of time.</PreferredDefinition>
      <LongName>ISO21090.PQ.TIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090PQTIMEv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Inclusion Criteria Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity Foci Duration ISO21090.PQ.TIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Inclusion Criteria Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity Foci Duration ISO21090.PQ.TIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DefinedInclusionCriterion.focalDuration</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedInclusionCriterion:focalDuration</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.DefinedInclusionCriterion.focalDuration</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="720">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3177063</PUBLICID>
    <LONGNAME>Investigator Study Site Research Personnel Role Postal Address ISO21090.AD.v1.0</LONGNAME>
    <PREFERREDNAME>3175560v1.0:2803162v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A researcher at a study site who oversees multiple aspects of the study at a site, including protocol submission for IRB approval, participant recruitment, informed consent, data collection, and analysis. A contact point used to send physical forms of communication to the study site personnel.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175560</PublicId>
      <PreferredName>3174241v1.0:2715040v1.0</PreferredName>
      <PreferredDefinition>An individual who conducts scientific research. In a clinical setting this individual actually conducts and/or supervises the clinical investigation and study-related procedures.  The investigator monitors the safety of the trial subjects and investigational staff (under whose immediate direction an agent is administered or dispensed to a subject).  The investigator collects and analyses data and study documents, and provides reports in compliance with applicable requirements.:A facility in which study/protocol activities are conducted.:People engaged in research.:The usual or expected function of something; the part something plays in an action or event._A physical location used by a person or organization for the purpose of receiving postal mail deliveries.</PreferredDefinition>
      <LongName>Investigator Study Site Research Personnel Role Postal Address</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25936:C80403:C17089:C48835</PreferredName>
        <Version>1</Version>
        <LongName>Investigator Study Site Research Personnel Role</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25936</PREFERRED_NAME>
            <LONG_NAME>Investigator</LONG_NAME>
            <CON_ID>2202869</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80403</PREFERRED_NAME>
            <LONG_NAME>Study Site</LONG_NAME>
            <CON_ID>2866824</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17089</PREFERRED_NAME>
            <LONG_NAME>Research Personnel</LONG_NAME>
            <CON_ID>2202675</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48835</PREFERRED_NAME>
            <LONG_NAME>Role</LONG_NAME>
            <CON_ID>2519065</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2715040</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70946</PreferredName>
        <Version>1</Version>
        <LongName>Postal Address</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70946</PREFERRED_NAME>
            <LONG_NAME>Postal Address</LONG_NAME>
            <CON_ID>2714916</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803162</PublicId>
      <PreferredName>2803162v1.0</PreferredName>
      <PreferredDefinition>Parts for mailing and home or office addresses.</PreferredDefinition>
      <LongName>ISO21090.AD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090ADv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Investigator Study Site Research Personnel Role Postal Address ISO21090.AD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Investigator Study Site Research Personnel Role Postal Address ISO21090.AD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudySiteInvestigator.postalAddress</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudySiteInvestigator:postalAddress</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain.StudySiteInvestigator.postalAddress</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="721">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3177152</PUBLICID>
    <LONGNAME>Substance Administration Intervention or Procedure Performed Study Activity Negation Occurrence Reason ISO21090.DSET.SC.v1.0</LONGNAME>
    <PREFERREDNAME>3175648v1.0:2803350v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The completed action of applying, dispensing or otherwise giving medications or other substances to experimental units. EXAMPLE(S): An experimental unit who receives methotrexate as part of chemotherapy, radiation therapy. For a SubstanceAdministration, targetAnatomicSiteCode = &quot;coronary artery&quot;, approachAnatomicSiteCode = &quot;groin&quot;, routeOfAdministrationCode = &quot;intra-arterial&quot;. The text and/or code that describes the rationale behind why an activity is not done.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175648</PublicId>
      <PreferredName>3174249v1.0:2867945v1.0</PreferredName>
      <PreferredDefinition>A material with particular features.:The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.:An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.:Executed and carried through to completion.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._An operation in which a term denies or inverts the meaning of another term or construction.:An instance of something happening, such as an event or incident.:An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Substance Administration Intervention or Procedure Performed Study Activity Negation Occurrence Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174249</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174249v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Substance Administration Intervention or Procedure Performed Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45306</PREFERRED_NAME>
            <LONG_NAME>Substance</LONG_NAME>
            <CON_ID>2523396</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867945</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C25275:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Negation Occurrence Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803350</PublicId>
      <PreferredName>2803350v1.0</PreferredName>
      <PreferredDefinition>A collection containing unordered distinct/discrete values of the type SC.</PreferredDefinition>
      <LongName>ISO21090.DSET.SC.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090DSETv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Substance Administration Intervention or Procedure Performed Study Activity Negation Occurrence Reason ISO21090.DSET.SC.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Substance Administration Intervention or Procedure Performed Study Activity Negation Occurrence Reason ISO21090.DSET.SC.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedSubstanceAdministration.missedReason</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedSubstanceAdministration:missedReason</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="722">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3180086</PUBLICID>
    <LONGNAME>Person QTcB Prolongation Greater Than 500 msec Baseline Clinical Trial Eligibility Criteria Ind-2</LONGNAME>
    <PREFERREDNAME>3179386v1.0:2018257v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether a person has a QTc prolongation, a time interval between the start of the Q wave and the end of the T wave in the cardiac cycle longer than 500 msec, at baseline as an element of a personal medical history which is necessary to allow an individual to participate in a specific clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3179386</PublicId>
      <PreferredName>2236731v1.0:3179384v1.0</PreferredName>
      <PreferredDefinition>information related to a person having a QTc prolongation, a time interval between the start of the Q wave and the end of the T wave in the cardiac cycle longer than 500 msec, at baseline as an element of a personal medical history which is necessary to allow an individual to participate in a specific clinical trial.</PreferredDefinition>
      <LongName>Person QTcB Prolongation Greater Than 500 msec Baseline Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3179384</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71096:C25213:C16112</PreferredName>
        <Version>1</Version>
        <LongName>QTcB Prolongation Greater Than 500 msec Baseline Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71096</PREFERRED_NAME>
            <LONG_NAME>QTcB Prolongation Greater Than 500 msec</LONG_NAME>
            <CON_ID>3179208</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25213</PREFERRED_NAME>
            <LONG_NAME>Baseline</LONG_NAME>
            <CON_ID>2202304</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does she have a baseline QTc</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does she have a baseline QTc greater than or equal to 480 milliseconds?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the QTc interval greater than or equal to 450 sec?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have congenital long QT syndrome or baseline QTc greater than 480 ms</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the QTc interval greater than or equal to 470 msec?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have a history of congenital long QT syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have a QTc prolongation (&gt;500msec)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a baseline QT/QTc interval greater than or equal to 501 msec?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have a screening QTc interval &gt; 480 milliseconds?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have baseline QTc greater than 500 ms, either induced by medication or congenital long QT syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0230D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104893</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0186I</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0186J</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0186K</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0254</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104938</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0186J</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000081</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0186J</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000082</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0186K</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000345</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0186K</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000346</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0186I</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000429</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0186I</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000430</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3179386v1.0:2018257v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QTcGte501</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="723">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3182628</PUBLICID>
    <LONGNAME>Tooth Electricity Stimulation Sensitivity Assessment Yes No Indicator</LONGNAME>
    <PREFERREDNAME>3182627v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator related to assessment of electrical stimulation sensitivity in tooth.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3182627</PublicId>
      <PreferredName>2514269v1.0:3182625v1.0</PreferredName>
      <PreferredDefinition>information related to assessment of electrical stimulation sensitivity in tooth.</PreferredDefinition>
      <LongName>Tooth Electricity Stimulation Sensitivity Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2514269</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12506</PreferredName>
        <Version>1</Version>
        <LongName>Tooth</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12506</PREFERRED_NAME>
            <LONG_NAME>Tooth</LONG_NAME>
            <CON_ID>2202581</CON_ID>
            <DEFINITION_SOURCE>UWDA142</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3182625</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61332:C61406:C68816:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Electricity Stimulation Sensitivity Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61332</PREFERRED_NAME>
            <LONG_NAME>Electricity</LONG_NAME>
            <CON_ID>2698121</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61406</PREFERRED_NAME>
            <LONG_NAME>Stimulation</LONG_NAME>
            <CON_ID>2731657</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68816</PREFERRED_NAME>
            <LONG_NAME>Device Sensitivity</LONG_NAME>
            <CON_ID>2671523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is sensitivity present during</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is sensitivity present during EPT/electrical stimulation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4442461</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDCR CDEs with Retired VDs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDEs for Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4442571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="724">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3186510</PUBLICID>
    <LONGNAME>Abdominal Location Other Involved Specify</LONGNAME>
    <PREFERREDNAME>2189201v1.0:2182211v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field related to other involved locations or sites within the abdomen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189201</PublicId>
      <PreferredName>ABD_LCTN_OTHER_INVL</PreferredName>
      <PreferredDefinition>information related to other involved locations or sites within the abdomen. </PreferredDefinition>
      <LongName>Abdominal Location Other Involved</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206646</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25342:CL111053</PreferredName>
        <Version>1</Version>
        <LongName>Abdominal Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25342</PREFERRED_NAME>
            <LONG_NAME>Abdominal</LONG_NAME>
            <CON_ID>2204983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL111053</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2203486</CON_ID>
            <DEFINITION_SOURCE>NCI; National Cancer Institute Thesaurus. September 2003</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207673</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25547</PreferredName>
        <Version>1</Version>
        <LongName>Other Involved</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25547</PREFERRED_NAME>
            <LONG_NAME>Involved</LONG_NAME>
            <CON_ID>2203840</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2182211</PublicId>
      <PreferredName>INV_EXT_DZ_SPEC</PreferredName>
      <PreferredDefinition>the free text field to specify the involvement or extent of disease.</PreferredDefinition>
      <LongName>Involvement Extent Disease Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Non-Liver abdominal organ inv</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Non-Liver abdominal organ involvement, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="725">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3186684</PUBLICID>
    <LONGNAME>Post Surgical Procedure Assessment Thyroid Gland Carcinoma Status</LONGNAME>
    <PREFERREDNAME>3186651v1.0:3186657v1.1</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to describe a person&#39;s condition within three months after surgery and adjuvant therapy to treat a thyroid gland carcinoma.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3186651</PublicId>
      <PreferredName>3185657v1.0:3186649v1.0</PreferredName>
      <PreferredDefinition>A highly vascular endocrine gland consisting of two lobes, one on either side of the trachea, joined by a narrow isthmus; it produces the thyroid hormones which are concerned in regulating the metabolic rate of the body._A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004_Post; occuring after._A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Having determined the value, significance, or extent of.</PreferredDefinition>
      <LongName>Thyroid Gland Carcinoma Post Surgical Procedure Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3185657</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12400:C2916</PreferredName>
        <Version>1</Version>
        <LongName>Thyroid Gland Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12400</PREFERRED_NAME>
            <LONG_NAME>Thyroid Gland</LONG_NAME>
            <CON_ID>2202526</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2916</PREFERRED_NAME>
            <LONG_NAME>Carcinoma</LONG_NAME>
            <CON_ID>2202711</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3186649</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38008:C15329:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Post Surgical Procedure Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3186657</PublicId>
      <PreferredName>3186657v1.0</PreferredName>
      <PreferredDefinition>A highly vascular endocrine gland consisting of two lobes, one on either side of the trachea, joined by a narrow isthmus; it produces the thyroid hormones which are concerned in regulating the metabolic rate of the body._A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004_A condition or state at a particular time.</PreferredDefinition>
      <LongName>Thyroid Gland Carcinoma Status</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3186656</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12400:C2916:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Thyroid Gland Carcinoma Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12400</PREFERRED_NAME>
            <LONG_NAME>Thyroid Gland</LONG_NAME>
            <CON_ID>2202526</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2916</PREFERRED_NAME>
            <LONG_NAME>Carcinoma</LONG_NAME>
            <CON_ID>2202711</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Persistent distant metastases</VALIDVALUE>
          <VALUEMEANING>Distant Metastasis Persistent Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to cancer that has spread from the original (primary) tumor to distant organs or distant lymph nodes.: A disease that does not go to remission despite treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90169, C18206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Persistent locoregional disease</VALIDVALUE>
          <VALUEMEANING>Local-Regional Persistent Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Local-Regional; affecting only a restricted part or area of the body.: A disease that does not go to remission despite treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90169, C25388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No imaging evidence of disease</VALIDVALUE>
          <VALUEMEANING>No Evidence of Disease Radiologic Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>Diagnostic tests fail to detect presence of disease.: Results that have been obtained through x-ray imaging.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35869, C40413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Available</VALIDVALUE>
          <VALUEMEANING>Negation Availability</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Available; obtainable or accessible and ready for use or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25429, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biochemical Evidence of Disease</VALIDVALUE>
          <VALUEMEANING>Biochemical Evidence of Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to biochemistry; involving chemical processes in living organisms.: Knowledge on which to base belief.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C43583, C25434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3166454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>TCGA Comment</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Check all that apply</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Clinical Status Within Three</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Clinical Status Within Three (3) Months of Surgery (surgery and adjuvant therapies)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>post_surgical_procedure_assessment_thyroid_gland_carcinoma_status</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="726">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3192081</PUBLICID>
    <LONGNAME>Delivery of Placenta Route Type</LONGNAME>
    <PREFERREDNAME>3192080v1.0:3201485v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the route of delivery of the placenta.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3192080</PublicId>
      <PreferredName>3201483v1.0:2452898v1.0</PreferredName>
      <PreferredDefinition>The natural process whereby the placenta detaches from the uterus. It occurs during the third stage of childbirth and shortly after delivery of the fetus._A way of getting from one place to another; an established line of travel or access; the way a chemical or pollutant enters an organism after contact, particularly, the way of drug administration.</PreferredDefinition>
      <LongName>Delivery of Placenta Route</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3201483</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C92766</PreferredName>
        <Version>1</Version>
        <LongName>Delivery of Placenta</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C92766</PREFERRED_NAME>
            <LONG_NAME>Delivery of Placenta</LONG_NAME>
            <CON_ID>3201482</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2452898</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25169</PreferredName>
        <Version>1</Version>
        <LongName>Route</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25169</PREFERRED_NAME>
            <LONG_NAME>Route</LONG_NAME>
            <CON_ID>2203782</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3201485</PublicId>
      <PreferredName>3201485v1.0</PreferredName>
      <PreferredDefinition>The natural process whereby the placenta detaches from the uterus. It occurs during the third stage of childbirth and shortly after delivery of the fetus._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Delivery of Placenta Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3201484</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C92766:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Delivery of Placenta Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C92766</PREFERRED_NAME>
            <LONG_NAME>Delivery of Placenta</LONG_NAME>
            <CON_ID>3201482</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vaginal</VALIDVALUE>
          <VALUEMEANING>Vaginal</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to the vagina or to any sheath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cesarean Section</VALIDVALUE>
          <VALUEMEANING>Caesarian Section</VALUEMEANING>
          <MEANINGDESCRIPTION>The delivery of an infant through a surgical abdominal incision.  Surgery is performed when there may be complications associated with a vaginal birth and increased risk to the mother or fetus. 2005</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C46088</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Route of placenta delivery ty</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Route of placenta delivery type:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Route of placenta delivery:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Route of placenta delivery:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2007r1:Cord Blood Unit -SCTOD Data Requirements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3191905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cord_placenta_rt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="727">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3192299</PUBLICID>
    <LONGNAME>Umbilical Cord Blood Process Device Name</LONGNAME>
    <PREFERREDNAME>3202510v1.0:3189147v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the device that was used to process the umbilical cord blood.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3202510</PublicId>
      <PreferredName>2785788v1.0:3202508v1.0</PreferredName>
      <PreferredDefinition>Blood from the umbilical cord of a newborn baby. This blood contains high concentrations of stem cells (cells from which all blood cells develop)._A sequence of events which produces some outcome._An object contrived for a specific purpose. [Manually curated]</PreferredDefinition>
      <LongName>Umbilical Cord Blood Process Device</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2785788</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13300</PreferredName>
        <Version>1</Version>
        <LongName>Umbilical Cord Blood</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13300</PREFERRED_NAME>
            <LONG_NAME>Umbilical Cord Blood</LONG_NAME>
            <CON_ID>2527864</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3202508</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29862:C62103</PreferredName>
        <Version>1</Version>
        <LongName>Process Device</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29862</PREFERRED_NAME>
            <LONG_NAME>Process</LONG_NAME>
            <CON_ID>2202628</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62103</PREFERRED_NAME>
            <LONG_NAME>Device</LONG_NAME>
            <CON_ID>2529461</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3189147</PublicId>
      <PreferredName>3189147v1.0</PreferredName>
      <PreferredDefinition>A sequence of events which produces some outcome._An object contrived for a specific purpose._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Process Device Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3202511</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29862:C62103:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Process Device Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29862</PREFERRED_NAME>
            <LONG_NAME>Process</LONG_NAME>
            <CON_ID>2202628</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62103</PREFERRED_NAME>
            <LONG_NAME>Device</LONG_NAME>
            <CON_ID>2529461</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sepax</VALIDVALUE>
          <VALUEMEANING>Sepax Cell Separation Device</VALUEMEANING>
          <MEANINGDESCRIPTION>A proprietary system for the automated processing of whole blood into plasma, buffy coat, and erythrocyte fractions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3189180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AutoXpres Platform</VALIDVALUE>
          <VALUEMEANING>AXP AutoXpress Platform</VALUEMEANING>
          <MEANINGDESCRIPTION>A proprietary system for recovery of stem-cell rich fractions from human umbilical cord blood and volume reduction of blood components.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3189181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What device was used to proce</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What device was used to process the cord blood unit?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the system used for CBU processing:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the system used for CBU processing:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2007r1:Cord Blood Unit -SCTOD Data Requirements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3191905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cbu_proc_syst</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="728">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3192879</PUBLICID>
    <LONGNAME>Patient Reported Outcome Problem Worry Past Week Severity Score_11 Point Scale</LONGNAME>
    <PREFERREDNAME>3192868v1.0:3186243v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated perception of how bad, if at all, worry has been a problem during the past week, including today, using an 11-point Likert scale where 0 is not a problem and 10 is as bad as possible.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCM:Patient Care Monitor</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3192868</PublicId>
      <PreferredName>3191919v1.0:3192837v1.0</PreferredName>
      <PreferredDefinition>Information collected directly from a patient that typically includes subjective feelings regarding symptons, functions in daily life, physical, mental, emotional, spiritual, and social well being, and satisfaction with his/her health care.:A difficulty, disorder, or condition needing resolution._Mental distress resulting from concern for something impending or anticipated.:The most recent week, including today.:Severity; used of the degree of something undesirable e.g. pain or weather.:A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Patient Reported Outcome Problem Worry Past Week Severity Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3191919</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95401:C28020</PreferredName>
        <Version>1</Version>
        <LongName>Patient Reported Outcome Problem</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95401</PREFERRED_NAME>
            <LONG_NAME>Patient Reported Outcome</LONG_NAME>
            <CON_ID>3185129</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28020</PREFERRED_NAME>
            <LONG_NAME>Problem</LONG_NAME>
            <CON_ID>2203953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3192837</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C86941:C95402:C25676:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Worry Past Week Severity Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C86941</PREFERRED_NAME>
            <LONG_NAME>Worry</LONG_NAME>
            <CON_ID>3111315</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PCM:Patient Care Monitor</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3186243</PublicId>
      <PreferredName>3186243v1.0</PreferredName>
      <PreferredDefinition>The most recent week, including today._Severity; used of the degree of something undesirable e.g. pain or weather._A number or range of numeric values measuring performance, function, quality, or ability._A number with no fractional part.::11_The precise location of something; a spatially limited location._an ordered reference standard.</PreferredDefinition>
      <LongName>Past Week Severity Score_11 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ePRO:ePRO Data Dictionary</Origin>
      <Representation>
        <PublicId>3186242</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3186242v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Severity Score Integer::11 Point Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70656</PREFERRED_NAME>
            <LONG_NAME>Point</LONG_NAME>
            <CON_ID>2710246</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>A score of 10 on an 11 point scale meaning As Bad as Possible.</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 10 on an 11 point scale meaning As Bad as Possible.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>A score of 9 on an 11 point scale meaning Severe Problem.</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 9 on an 11 point scale meaning Severe Problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>A score of 8 on an 11 point scale meaning Severe Problem.</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 8 on an 11 point scale meaning Severe Problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>A score of 7 on an 11 point scale meaning Severe Problem.</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 7 on an 11 point scale meaning Severe Problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>A score of 6 on an 11 point scale meaning Moderate Problem.</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 6 on an 11 point scale meaning Moderate Problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>A score of 5 on an 11 point scale meaning Moderate Problem.</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 5 on an 11 point scale meaning Moderate Problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>A score of 4 on an 11 point scale meaning Moderate Problem.</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 4 on an 11 point scale meaning Moderate Problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>A score of 3 on an 11 point scale meaning Mild Problem.</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 3 on an 11 point scale meaning Mild Problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A score of 2 on an 11 point scale meaning Mild Problem.</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 2 on an 11 point scale meaning Mild Problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186321</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A score of 1 on an 11 point scale meaning Mild Problem.</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 1 on an 11 point scale meaning Mild Problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>A score of 0 on an 11 point scale meaning Not a Problem.</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 0 on an 11 point scale meaning Not a Problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Instrument Creator</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>ACORN</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Worry</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Worry</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Touch the red dot below that best describes how bad, if at all, worry has been a problem for you during the past week, including today.</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Touch the red dot below that best describes how bad, if at all, worry has been a problem for you during the past week, including today.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3185645</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BIGHealth ePRO Data Dictionary</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Care Monitor_PCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3185646</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCM78</AlternateName>
        <AlternateNameType>ePRO Field Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="729">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3212368</PUBLICID>
    <LONGNAME>Pain Medication Dentist Visit Identifier Number</LONGNAME>
    <PREFERREDNAME>3212365v1.0:3190378v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the numeric unique identifier for the act of going to an individual licensed for the prevention, diagnosis, and treatment of diseases in the oral cavity, adjacent tissues, and related structures identifier of a person who receives medical attention, care, or treatment for pain medication.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3212365</PublicId>
      <PreferredName>2207030v1.0:3199139v1.0</PreferredName>
      <PreferredDefinition>information related to the identifier for the act of going to an individual licensed for the prevention, diagnosis, and treatment of diseases in the oral cavity, adjacent tissues, and related structures identifier of a person who receives medical attention, care, or treatment for pain medication.</PreferredDefinition>
      <LongName>Pain Medication Dentist Visit Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2207030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3303:C459</PreferredName>
        <Version>1</Version>
        <LongName>Pain Medication</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3303</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>2202326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3199139</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52654:C25716:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Dentist Visit Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52654</PREFERRED_NAME>
            <LONG_NAME>Dentist</LONG_NAME>
            <CON_ID>2443130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25716</PREFERRED_NAME>
            <LONG_NAME>Visit</LONG_NAME>
            <CON_ID>2202626</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3190378</PublicId>
      <PreferredName>3190378v1.0</PreferredName>
      <PreferredDefinition>the alphanumeric unique identifier used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Identifier Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3190377</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Identifier Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pain medication visit number</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pain medication visit number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="730">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3219368</PUBLICID>
    <LONGNAME>Tooth Sensitivity First Tooth Dentition Code</LONGNAME>
    <PREFERREDNAME>3219359v1.0:2404907v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The values and value meanings for tooth designation related to the tooth sensitivity for a tooth.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3219359</PublicId>
      <PreferredName>3201262v1.0:3219349v1.0</PreferredName>
      <PreferredDefinition>information related to the tooth sensitivity for a tooth in the teeth collection in the dental arch.</PreferredDefinition>
      <LongName>Tooth Sensitivity First Tooth Dentition</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3201262</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12506:C25201</PreferredName>
        <Version>1</Version>
        <LongName>Tooth Sensitivity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12506</PREFERRED_NAME>
            <LONG_NAME>Tooth</LONG_NAME>
            <CON_ID>2202581</CON_ID>
            <DEFINITION_SOURCE>UWDA142</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25201</PREFERRED_NAME>
            <LONG_NAME>Sensitivity</LONG_NAME>
            <CON_ID>2203788</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3219349</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C12506:C13072</PreferredName>
        <Version>1</Version>
        <LongName>First Tooth Dentition</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12506</PREFERRED_NAME>
            <LONG_NAME>Tooth</LONG_NAME>
            <CON_ID>2202581</CON_ID>
            <DEFINITION_SOURCE>UWDA142</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13072</PREFERRED_NAME>
            <LONG_NAME>Dentition</LONG_NAME>
            <CON_ID>2404901</CON_ID>
            <DEFINITION_SOURCE>MeSH</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2404907</PublicId>
      <PreferredName>NLT_DNTN_CD</PreferredName>
      <PreferredDefinition>The values and value meanings for tooth designation.</PreferredDefinition>
      <LongName>National Dentition Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2407197</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13072:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Dentition Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13072</PREFERRED_NAME>
            <LONG_NAME>Dentition</LONG_NAME>
            <CON_ID>2404901</CON_ID>
            <DEFINITION_SOURCE>MeSH</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>3rd molar (wisdom tooth) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>3rd molar (wisdom tooth) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>1st molar (6-yr. molar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>1st molar (6-yr. molar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd molar (12-yr. molar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd molar (12-yr. molar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>1st molar (6-yr. molar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>1st molar (6-yr. molar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>2nd bicuspid (2nd premolar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd bicuspid (2nd premolar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>1st bicuspid (1st premolar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>1st bicuspid (1st premolar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>cuspid (canine/eye tooth) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>cuspid (canine/eye tooth) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>lateral incisor permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>central incisor permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>central incisor permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>lateral incisor permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>cuspid (canine/eye tooth) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>cuspid (canine/eye tooth) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>1st bicuspid (1st premolar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>1st bicuspid (1st premolar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>2nd bicuspid (2nd premolar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd bicuspid (2nd premolar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>2nd molar (12-yr. molar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd molar (12-yr. molar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>3rd molar (wisdom tooth) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>3rd molar (wisdom tooth) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>3rd molar (wisdom tooth) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>3rd molar (wisdom tooth) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>2nd molar (12-yr. molar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd molar (12-yr. molar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>1st molar (6-yr. molar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>1st molar (6-yr. molar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>2nd bicuspid (2nd premolar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd bicuspid (2nd premolar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>1st bicuspid (1st premolar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>1st bicuspid (1st premolar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>cuspid (canine/eye tooth) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>cuspid (canine/eye tooth) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>lateral incisor permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>central incisor permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>central incisor permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>lateral incisor permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>cuspid (canine/eye tooth) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>cuspid (canine/eye tooth) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>1st bicuspid (1st premolar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>1st bicuspid (1st premolar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>2nd bicuspid (2nd premolar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd bicuspid (2nd premolar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>1st molar (6-yr. molar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>1st molar (6-yr. molar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>2nd molar (12-yr. molar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd molar (12-yr. molar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32</VALIDVALUE>
          <VALUEMEANING>3rd molar (wisdom tooth) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>3rd molar (wisdom tooth) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>51</VALIDVALUE>
          <VALUEMEANING>supernumerary 3rd molar (wisdom tooth) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 3rd molar (wisdom tooth) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>52</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd molar (12-yr. molar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd molar (12-yr. molar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>53</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st molar (6-yr. molar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st molar (6-yr. molar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>54</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd bicuspid (2nd premolar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd bicuspid (2nd premolar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>55</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st bicuspid (1st premolar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st bicuspid (1st premolar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>56</VALIDVALUE>
          <VALUEMEANING>supernumerary cuspid (canine/eye tooth) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary cuspid (canine/eye tooth) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>57</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>58</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>59</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>60</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>61</VALIDVALUE>
          <VALUEMEANING>supernumerary cuspid (canine/eye tooth) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary cuspid (canine/eye tooth) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>62</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st bicuspid (1st premolar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st bicuspid (1st premolar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>63</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd bicuspid (2nd premolar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd bicuspid (2nd premolar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>64</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st molar (6-yr. molar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st molar (6-yr. molar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>65</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd molar (12-yr. molar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd molar (12-yr. molar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>66</VALIDVALUE>
          <VALUEMEANING>supernumerary 3rd molar (wisdom tooth) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 3rd molar (wisdom tooth) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>67</VALIDVALUE>
          <VALUEMEANING>supernumerary 3rd molar (wisdom tooth) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 3rd molar (wisdom tooth) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>68</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd molar (12-yr. molar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd molar (12-yr. molar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>69</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st molar (6-yr. molar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st molar (6-yr. molar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>70</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd bicuspid (2nd premolar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd bicuspid (2nd premolar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>71</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st bicuspid (1st premolar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st bicuspid (1st premolar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>72</VALIDVALUE>
          <VALUEMEANING>supernumerary cuspid (canine/eye tooth) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary cuspid (canine/eye tooth) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>73</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576217</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>74</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>75</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor permanent arch  lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor permanent arch  lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>76</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>77</VALIDVALUE>
          <VALUEMEANING>supernumerary cuspid (canine/eye tooth) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary cuspid (canine/eye tooth) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>78</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st bicuspid (1st premolar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st bicuspid (1st premolar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>79</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd bicuspid (2nd premolar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd bicuspid (2nd premolar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>80</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st molar (6-yr. molar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st molar (6-yr. molar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>81</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd molar (12-yr. molar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd molar (12-yr. molar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>82</VALIDVALUE>
          <VALUEMEANING>supernumerary 3rd molar (wisdom tooth) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 3rd molar (wisdom tooth) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A</VALIDVALUE>
          <VALUEMEANING>second molar primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>second molar primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B</VALIDVALUE>
          <VALUEMEANING>first molar primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>first molar primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C</VALIDVALUE>
          <VALUEMEANING>canine(cuspid) primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>canine(cuspid) primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D</VALIDVALUE>
          <VALUEMEANING>lateral incisor primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576230</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>E</VALIDVALUE>
          <VALUEMEANING>central incisor primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>F</VALIDVALUE>
          <VALUEMEANING>central incisor primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G</VALIDVALUE>
          <VALUEMEANING>lateral incisor primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H</VALIDVALUE>
          <VALUEMEANING>canine (cuspid) primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>canine (cuspid) primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I</VALIDVALUE>
          <VALUEMEANING>first molar primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>first molar primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576235</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>J</VALIDVALUE>
          <VALUEMEANING>second molar primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>second molar primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>K</VALIDVALUE>
          <VALUEMEANING>second molar primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>second molar primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L</VALIDVALUE>
          <VALUEMEANING>first molar primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>first molar primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>M</VALIDVALUE>
          <VALUEMEANING>canine (cuspid) primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>canine (cuspid) primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>lateral incisor primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>O</VALIDVALUE>
          <VALUEMEANING>central incisor primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576241</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>P</VALIDVALUE>
          <VALUEMEANING>central incisor primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Q</VALIDVALUE>
          <VALUEMEANING>lateral incisor primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R</VALIDVALUE>
          <VALUEMEANING>canine (cuspid) primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>canine (cuspid) primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>S</VALIDVALUE>
          <VALUEMEANING>first molar primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>first molar primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T</VALIDVALUE>
          <VALUEMEANING>second molar primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>second molar primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AS</VALIDVALUE>
          <VALUEMEANING>supernumerary second molar primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary second molar primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BS</VALIDVALUE>
          <VALUEMEANING>supernumerary first molar primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary first molar primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CS</VALIDVALUE>
          <VALUEMEANING>supernumerary canine(cuspid) primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary canine(cuspid) primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DS</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ES</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576251</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FS</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GS</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576253</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HS</VALIDVALUE>
          <VALUEMEANING>supernumerary canine (cuspid) primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary canine (cuspid) primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IS</VALIDVALUE>
          <VALUEMEANING>supernumerary first molar primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary first molar primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JS</VALIDVALUE>
          <VALUEMEANING>supernumerary second molar primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary second molar primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KS</VALIDVALUE>
          <VALUEMEANING>supernumerary second molar primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary second molar primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LS</VALIDVALUE>
          <VALUEMEANING>supernumerary first molar primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary first molar primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MS</VALIDVALUE>
          <VALUEMEANING>supernumerary canine (cuspid) primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary canine (cuspid) primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576259</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NS</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OS</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PS</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>QS</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576263</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RS</VALIDVALUE>
          <VALUEMEANING>supernumerary canine (cuspid) primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary canine (cuspid) primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SS</VALIDVALUE>
          <VALUEMEANING>supernumerary first molar primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary first molar primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TS</VALIDVALUE>
          <VALUEMEANING>supernumerary second molar primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary second molar primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tooth Number A</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tooth Number A</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3232580</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRL0602</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3232568</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3232580</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRL0602</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.nidcr.prl0602</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3232569</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIDCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.nidcr.prl0602.ToothSensitivity.tooth_Number_A</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIDCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ToothSensitivity:tooth_Number_A</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="731">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3225688</PUBLICID>
    <LONGNAME>Chloroma Disease At Diagnosis Present Indicator</LONGNAME>
    <PREFERREDNAME>3225687v1.0:2182115v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of Yes or No to a question related to the presence of myeloid sarcoma disease at diagnosis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3225687</PublicId>
      <PreferredName>3226320v1.0:2936200v1.0</PreferredName>
      <PreferredDefinition>A tumor mass composed of myeloblasts or immature myeloid cells.  It occurs in extramedullary sites or the bone.  (WHO, 2001)_Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Used to indicate position, location, or state (American Heritage Dictionary)_The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Chloroma Disease At Diagnosis Present Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3226320</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3520:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Myeloid Sarcoma Disease or Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3520</PREFERRED_NAME>
            <LONG_NAME>Myeloid Sarcoma</LONG_NAME>
            <CON_ID>2204838</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2936200</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25427:C15220:C25626</PreferredName>
        <Version>1</Version>
        <LongName>At Diagnosis Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25427</PREFERRED_NAME>
            <LONG_NAME>At</LONG_NAME>
            <CON_ID>2261927</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2182115</PublicId>
      <PreferredName>Y_N_U_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes, No, or Unknown to represent a condition.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Chloroma</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Chloroma</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have myeloid sarcoma?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have isolated myeloid sarcoma?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5650570</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TARGET</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5650572</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PTDXMLDSA_IND</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCTG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>IE_IEORRES_SARCOMA</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="732">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3227014</PUBLICID>
    <LONGNAME>Fanconi Anemia Complementation Group Protein Laboratory Procedure Performed Indicator</LONGNAME>
    <PREFERREDNAME>3226994v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not Fanconi anemia complementation group protein testing was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3226994</PublicId>
      <PreferredName>3219075v1.0:2177693v1.0</PreferredName>
      <PreferredDefinition>A protein that is a member of a structurally diverse group that forms a protein complex which may regulate both DNA repair and the cell cycle. Mutation of any member of this group may inhibit the formation of the complex and is associated with Fanconi anemia._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion. (NCI)</PreferredDefinition>
      <LongName>Fanconi Anemia Complementation Group Protein Laboratory Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3219075</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C85881:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Fanconi Anemia Complementation Group Protein Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85881</PREFERRED_NAME>
            <LONG_NAME>Fanconi Anemia Complementation Group Protein</LONG_NAME>
            <CON_ID>2992033</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177693</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Performed</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was complementation group tes</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was complementation group testing performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was complementation group testing performed at any time prior to the preparative regimen?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was complementation group testing performed at any time prior to the preparative regimen?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964895</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>fan_base_comp_tst_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="733">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3227031</PUBLICID>
    <LONGNAME>Cytogenetic Abnormality Chromosomal Translocation Chromosome 1 Chromosome 7 Present Indicator</LONGNAME>
    <PREFERREDNAME>3194078v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not there was an cytogenetic abnormality in the form of a translocation between chromosomes 1 and 7.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3194078</PublicId>
      <PreferredName>2459195v1.0:3236037v1.0</PreferredName>
      <PreferredDefinition>An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material._A genetic exchange where a piece of one chromosome is transfered to another chromosome._The designation for each member of the largest human autosomal chromosome pair. Chromosome 1 spans about 247 million nucleotide base pairs and represents about 8% of the total DNA in normal diploid cells._The designation for each member of the seventh largest human autosomal chromosome pair. Chromosome 7 spans more than 158 million base pairs and represents between 5 and 5.5% of the total DNA in normal diploid cells._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Cytogenetic Abnormality Chromosomal Translocation Chromosome 1 Chromosome 7 Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2459195</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2950</PreferredName>
        <Version>1</Version>
        <LongName>Cytogenetic Abnormality</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2950</PREFERRED_NAME>
            <LONG_NAME>Cytogenetic Abnormality</LONG_NAME>
            <CON_ID>2459194</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3236037</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3420:C13204:C13223:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Chromosomal Translocation Chromosome 1 Chromosome 7 Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3420</PREFERRED_NAME>
            <LONG_NAME>Chromosomal Translocation</LONG_NAME>
            <CON_ID>2206260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13204</PREFERRED_NAME>
            <LONG_NAME>Human Chromosome 1</LONG_NAME>
            <CON_ID>2958672</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13223</PREFERRED_NAME>
            <LONG_NAME>Human Chromosome 7</LONG_NAME>
            <CON_ID>2958690</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was there a translocation wit</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was there a translocation with chromosomes 1 and 7 present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>t(1;7)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>t(1;7)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964895</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>fan_base_kry_diag_t1_7_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>fan_base_kry_prep_t1_7_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="734">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3243849</PUBLICID>
    <LONGNAME>Orthodontist Discussion Group Yes or No Response</LONGNAME>
    <PREFERREDNAME>3243848v1.0:3108967v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A dentist specializing in the prevention, diagnosis, and treatment of malocclusions of the teeth and their surrounding structures._An extended communication (often interactive) dealing with some particular topic._Any number of entities (members) considered as a unit._A caDSR representation term that is used to indicate a question with permissible values of yes/no</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3243848</PublicId>
      <PreferredName>3243774v1.0:3243846v1.0</PreferredName>
      <PreferredDefinition>A dentist specializing in the prevention, diagnosis, and treatment of malocclusions of the teeth and their surrounding structures._An extended communication (often interactive) dealing with some particular topic._Any number of entities (members) considered as a unit.</PreferredDefinition>
      <LongName>Orthodontist Discussion Group</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3243774</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63737</PreferredName>
        <Version>1</Version>
        <LongName>Orthodontist</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63737</PREFERRED_NAME>
            <LONG_NAME>Orthodontist</LONG_NAME>
            <CON_ID>2547885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3243846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71323:C43359</PreferredName>
        <Version>1</Version>
        <LongName>Discussion Group</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71323</PREFERRED_NAME>
            <LONG_NAME>Discussion</LONG_NAME>
            <CON_ID>2704416</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43359</PREFERRED_NAME>
            <LONG_NAME>Group</LONG_NAME>
            <CON_ID>2236516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3108967</PublicId>
      <PreferredName>C49487:C49488:3108967v1.0</PreferredName>
      <PreferredDefinition>A caDSR representation term that is used to indicate a question with permissible values of yes/no</PreferredDefinition>
      <LongName>Yes or No Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No [0]</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes [0]</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Do you belong to an orthodont</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Do you belong to an orthodontic study club?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="735">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3248479</PUBLICID>
    <LONGNAME>Tissue Tooth Complication Event Type</LONGNAME>
    <PREFERREDNAME>3248474v1.0:3248475v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function._is an organ, the organ parts of which primarily consist of dentine and dental enamel; together with other teeth it constitutes a subdivision of the facial skeleton. Example(s): incisor, molar._Complication; any disease or disorder that occurs during the course of (or because of) another disease._Event; something that happens at a given place and time._Type; a subdivision of a particular kind of thing.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3248474</PublicId>
      <PreferredName>3248472v1.0:3248456v1.0</PreferredName>
      <PreferredDefinition>An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function._is an organ, the organ parts of which primarily consist of dentine and dental enamel; together with other teeth it constitutes a subdivision of the facial skeleton. Example(s): incisor, molar._Complication; any disease or disorder that occurs during the course of (or because of) another disease._Event; something that happens at a given place and time.</PreferredDefinition>
      <LongName>Tissue Tooth Complication Event</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3248472</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12801:C12506</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Tooth</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12801</PREFERRED_NAME>
            <LONG_NAME>Tissue</LONG_NAME>
            <CON_ID>2202489</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12506</PREFERRED_NAME>
            <LONG_NAME>Tooth</LONG_NAME>
            <CON_ID>2202581</CON_ID>
            <DEFINITION_SOURCE>UWDA142</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3248456</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2959:C25499</PreferredName>
        <Version>1</Version>
        <LongName>Complication Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2959</PREFERRED_NAME>
            <LONG_NAME>Complication</LONG_NAME>
            <CON_ID>2203884</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3248475</PublicId>
      <PreferredName>3248475v1.0</PreferredName>
      <PreferredDefinition>Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Tissue Tooth Complication Event Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2991873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sinus perforation</VALIDVALUE>
          <VALUEMEANING>Sinus perforation</VALUEMEANING>
          <MEANINGDESCRIPTION>Sinus perforation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3245518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Air subcutaneous emphysema</VALIDVALUE>
          <VALUEMEANING>Air subcutaneous emphysema</VALUEMEANING>
          <MEANINGDESCRIPTION>Air subcutaneous emphysema</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3245526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ankylosis</VALIDVALUE>
          <VALUEMEANING>Ankylosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Ankylosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Root damage</VALIDVALUE>
          <VALUEMEANING>Root damage</VALUEMEANING>
          <MEANINGDESCRIPTION>Root damage</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3245527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tooth sensitivity</VALIDVALUE>
          <VALUEMEANING>Tooth sensitivity</VALUEMEANING>
          <MEANINGDESCRIPTION>Tooth sensitivity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3245524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apthous ulcer</VALIDVALUE>
          <VALUEMEANING>Apthous ulcer</VALUEMEANING>
          <MEANINGDESCRIPTION>Apthous ulcer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3245520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infection</VALIDVALUE>
          <VALUEMEANING>Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>general term for invasion and growth of microorganisms in bodily tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0021311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soft-tissue overgrowth/irritation</VALIDVALUE>
          <VALUEMEANING>Soft-tissue overgrowth/irritation</VALUEMEANING>
          <MEANINGDESCRIPTION>Soft-tissue overgrowth/irritation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammation/Pain</VALIDVALUE>
          <VALUEMEANING>Inflammation/Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation/Pain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Teeth/Tissue Complicating Eve</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Teeth/Tissue Complicating Events: (Check all that apply)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="736">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3251818</PUBLICID>
    <LONGNAME>Biospecimen Diagnosis Modifier Name</LONGNAME>
    <PREFERREDNAME>3253831v1.0:3247836v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The results of the scientific determination of the presence and nature of disease used to classify a tumor sample taken from a human from a site other than the original which confirms extension from the original site.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CHTN:Cooperative Human Tissue Network</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3253831</PublicId>
      <PreferredName>3253801v1.0:2928438v1.0</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A term that helps define and render a concept unique.</PreferredDefinition>
      <LongName>Biospecimen Diagnosis Modifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3253801</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2928438</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41009</PreferredName>
        <Version>1</Version>
        <LongName>Qualifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41009</PREFERRED_NAME>
            <LONG_NAME>Qualifier</LONG_NAME>
            <CON_ID>2231576</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CHTN:Cooperative Human Tissue Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3247836</PublicId>
      <PreferredName>3247836v1.0</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Biospecimen Diagnosis Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CHTN:Cooperative Human Tissue Network</Origin>
      <Representation>
        <PublicId>3247835</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699:C15220:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Diagnosis Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemorrhoids</VALIDVALUE>
          <VALUEMEANING>Hemorrhoids</VALUEMEANING>
          <MEANINGDESCRIPTION>Dilated veins in the rectum and anal area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemorrhoid</VALIDVALUE>
          <VALUEMEANING>Hemorrhoid</VALUEMEANING>
          <MEANINGDESCRIPTION>Dilated veins in the rectum and anal area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26792</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945730</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Post-Transplant Lymphoproliferative Disorder, Polymorphic</VALIDVALUE>
          <VALUEMEANING>Polymorphic Post-Transplant Lymphoproliferative Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A clonal B-cell lymphoproliferative disorder, characterized by destructive infiltration of lymph nodes and extranodal sites by a polymorphic B-cell infiltrate composed of small and medium sized lymphocytes, immunoblasts, and plasma cells, arising as a result of post-transplant immunosuppression therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Polycythemia Vera</VALIDVALUE>
          <VALUEMEANING>Polycythemia Vera</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic myeloproliferative disorder characterized by an increased red blood cell production.  Excessive proliferation of the myeloid lineage is observed as well.  The major symptoms are related to hypertension or to vascular abnormalities caused by the increased red cell mass.  The cause is unknown.  With currently available treatment, the median survival exceeds 10 years.  (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Myeloproliferative Disease, Unclassifiable</VALIDVALUE>
          <VALUEMEANING>Chronic Myeloproliferative Disease, Unclassifiable</VALUEMEANING>
          <MEANINGDESCRIPTION>This subgroup of chronic myeloproliferative disorders includes cases which do not meet the morphologic criteria of any of the defined chronic myeloproliferative disorders, or which have characteristics that overlap at least two of the chronic myeloproliferative disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Idiopathic Thrombocytopenic Purpura (ITP)</VALIDVALUE>
          <VALUEMEANING>Idiopathic Thrombocytopenic Purpura</VALUEMEANING>
          <MEANINGDESCRIPTION>Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Hemosiderosis</VALIDVALUE>
          <VALUEMEANING>Hemosiderosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Accumulation of iron in internal organs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82892</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Hemorrhage</VALIDVALUE>
          <VALUEMEANING>Hemorrhage</VALUEMEANING>
          <MEANINGDESCRIPTION>Bleeding or escape of blood from a vessel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2684341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Hemolytic Anemia</VALIDVALUE>
          <VALUEMEANING>Hemolytic Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Anemia resulting from the premature destruction of the peripheral blood red cells. It may be congenital or it may be caused by infections, medications, or malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Hemoglobinopathy</VALIDVALUE>
          <VALUEMEANING>Hemoglobinopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Hemoglobin Disorders</VALIDVALUE>
          <VALUEMEANING>Hemoglobin Disorders</VALUEMEANING>
          <MEANINGDESCRIPTION>The red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the oxygen is readily released and HbO2 becomes Hb.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C16676</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Clotting Disorders</VALIDVALUE>
          <VALUEMEANING>Coagulation Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2902</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Bleeding &amp; Thrombosis</VALIDVALUE>
          <VALUEMEANING>Hemorrhage And Thrombosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Bleeding or escape of blood from a vessel.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: (throm-BOW-sis) The formation or presence of a blood clot inside a blood vessel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26891, C37912, C26791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Anemia</VALIDVALUE>
          <VALUEMEANING>Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A reduction in the number of red blood cells per cu mm, the amount of hemoglobin in 100 ml of blood, and the volume of packed red blood cells per 100 ml of blood. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2869</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemangiopericytoma</VALIDVALUE>
          <VALUEMEANING>Hemangiopericytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A mesenchymal tumor composed of dilated vascular spaces (some with a staghorn or bifed shape) throughout.  The individual tumor cells are surrounded by reticulin everywhere, are negative for muscle, nerve sheath, and epithelial markers, and are positive for CD34 and CD99.  The biologic behavior of hemangiopericytoma cannot always be predicted from the morphologic features.  The 5- and 10-year survival rates of malignant hemangiopericytomas have been reported to be 40% and 29% respectively (partially adapted from S. Sternberg&#39;s Diagnostic Surgical Pathology, 4th ed., 2004).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemangioblastoma</VALIDVALUE>
          <VALUEMEANING>Capillary Hemangioblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade I tumor of uncertain histogenesis which is composed of stromal cells and abundant capillaries. Approximately 25% of hemangioblastomas are associated with Von Hippel-Lindau disease, a disease inherited through an autosomal dominant trait and characterized by the development of capillary hemangioblastomas of the central nervous system and retina, clear cell renal carcinoma, pheochromocytoma, and pancreatic and inner ear tumors. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838583</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heavy Chain Disease</VALIDVALUE>
          <VALUEMEANING>Heavy Chain Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a group of rare disorders of immunoglobulin synthesis associated with B-cell proliferative disorders and diagnosed by the finding of heavy chains in the serum, urine, or both. Heavy chains are immunologically related to the Fc fragment of the immunoglobulin chain. Three types of heavy chain disease (HCD) have been recognized: gamma heavy chain disease (associated with Waldenstrom&#39;s macroglobulinemia), alpha heavy chain disease (also known as immunoproliferative small intestinal disease or Mediterranean lymphoma), and mu heavy chain disease (associated with chronic lymphocytic leukemia). Complications of HCD vary depending upon type.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hamartoma \ Infantile Myofibromatosis</VALIDVALUE>
          <VALUEMEANING>Hamartoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign and excessive tumor-like growth of mature cells and normal tissues which grow in a disorganized pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3075</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249799</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hair Follicle Tumors (Trico- )</VALIDVALUE>
          <VALUEMEANING>Hair Follicle Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant neoplasm arising from the hair follicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infarction</VALIDVALUE>
          <VALUEMEANING>Infarction</VALUEMEANING>
          <MEANINGDESCRIPTION>Infarction; localized necrosis resulting from obstruction of the blood supply.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25738</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypertrophy</VALIDVALUE>
          <VALUEMEANING>Hypertrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypertrophy; the abnormal enlargement of a body part or organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3124</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypersensitivity Pneumonitis</VALIDVALUE>
          <VALUEMEANING>Extrinsic Allergic Alveolitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Conditions in which inhalation of organic dusts results in hypersensitivity reactions at the alveolar level, associated with the production of precipitins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia, Atypical \ Atypical Simple</VALIDVALUE>
          <VALUEMEANING>Simple Endometrial Hyperplasia with Atypia</VALUEMEANING>
          <MEANINGDESCRIPTION>A proliferation of endometrial cells resulting in glandular enlargement and budding without changes in the basic structure of the endometrium. Epithelial atypia is present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia, Atypical \ Atypical Lobular</VALIDVALUE>
          <VALUEMEANING>Atypical Lobular Breast Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign (not cancer) condition in which there are more cells than normal in the breast lobules and the cells look abnormal under a microscope. Having ALH increases the risk of breast cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4730</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia, Atypical \ Atypical Glandular With HPV</VALIDVALUE>
          <VALUEMEANING>Atypical Glandular Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Proliferation of glandular epithelial cells associated with the presence of cytologic atypia and architectural growth pattern changes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia, Atypical \ Atypical Ductal</VALIDVALUE>
          <VALUEMEANING>Atypical Ductal Breast Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign (not cancer) condition in which there are more cells than normal in the breast lobules and the cells look abnormal under a microscope. Having atypical lobular hyperplasia increases the risk of breast cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia, Atypical \ Atypical Complex</VALIDVALUE>
          <VALUEMEANING>Complex Endometrial Hyperplasia with Atypia</VALUEMEANING>
          <MEANINGDESCRIPTION>A hyperplasia characterized by excessive proliferation of endometrial cells, resulting in the formation of complex epithelial structures.  It is associated with cytologic atypia and an increased risk of endometrial adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia, Atypical \ Atypical Adenomatous</VALIDVALUE>
          <VALUEMEANING>Atypical Adenomatous Lung Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A multifocal neoplastic process in the lung parenchyma characterized by the proliferation of atypical alveolar epithelial cells without the presence of significant chronic inflammation.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Simple</VALIDVALUE>
          <VALUEMEANING>Simple Endometrial Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign form of endometrial hyperplasia with increased number of endometrial glands and thickened endometrium. Simple hyperplasia has little risk of progression to endometrial carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35463</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Nodular</VALIDVALUE>
          <VALUEMEANING>Nodular Lymphoid Hyperplasia of Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, reactive lesion in the lung parenchyma. It is characterized by the formation of a single or several nodules that are composed of lymphocytic infiltrates with reactive germinal centers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Microglandular</VALIDVALUE>
          <VALUEMEANING>Cervical Microglandular Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign endocervical polypoid epithelial hyperplasia characterized by the presence of tightly packed glandular structures. It is usually seen in women on oral contraceptive therapy and during pregnancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6856</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Lymphoid</VALIDVALUE>
          <VALUEMEANING>Benign Lymphoid Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A polyclonal proliferation of lymphocytes without evidence of cytologic atypia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Follicular Hyperplasia</VALIDVALUE>
          <VALUEMEANING>Follicular Lymph Node Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hyperplasia of the germinal centers resulting in the enlargement of the lymph node.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97084</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Focal Nodular Hyperplasia</VALIDVALUE>
          <VALUEMEANING>Focal Nodular Hyperplasia of the Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic, regenerating hepatocellular hyperplasia, secondary to the presence of focal vascular abnormalities in the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4916</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Focal Epithelial Hyperplasia</VALIDVALUE>
          <VALUEMEANING>Focal Epithelial Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hyperplasia characterized by the presence of a focal proliferation of epithelial cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97083</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Ductal</VALIDVALUE>
          <VALUEMEANING>Ductal Hyperplasia (Usual)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hyperplasia of the epithelial cells in the breast ducts. It includes the atypical ductal hyperplasia, papillary intraductal hyperplasia, intraductal myoepitheliosis, and ductal hyperplasia of the usual type.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Drug Induced (Dilantin)</VALIDVALUE>
          <VALUEMEANING>Drug Induced Gingival Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Overgrowth of the gingival tissue caused by phenytoin, cyclosporine A, and calcium channel blockers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Diffuse</VALIDVALUE>
          <VALUEMEANING>Diffuse Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hyperplasia characterized by the presence of a diffuse cellular infiltrate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97081</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Denture-Induced</VALIDVALUE>
          <VALUEMEANING>Denture-Induced Fibrous Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign fibrous hyperplasia in the oral mucosa caused by the prolonged wear of ill-fitting denture.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97080</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Bronchial Epithelial Hyperplasia</VALIDVALUE>
          <VALUEMEANING>Bronchial Epithelial Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hyperplasia of the bronchial epithelial cells.  It is often associated with squamous metaplasia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97079</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Benign Prostatic Hyperplasia</VALIDVALUE>
          <VALUEMEANING>Benign Prostatic Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-cancerous nodular enlargement of the prostate gland.  It is characterized by the presence of epithelial cell nodules, and stromal nodules containing fibrous and smooth muscle elements.  It is the most common urologic disorder in men, causing blockage of urine flow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2897</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ T - Lymphoblastic</VALIDVALUE>
          <VALUEMEANING>Precursor T-Lymphoblastic Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>This type of acute lymphoblastic leukemia comprises about 15% of childhood cases and 25% of adult cases.  It is more common in males than females.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2590758</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ Plasma Cell</VALIDVALUE>
          <VALUEMEANING>Plasma Cell Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive plasma cell neoplasm with usually short survival. It is characterized by the presence of neoplastic plasma cells in the peripheral blood. The peripheral blood plasma cells comprise more than 20% of the peripheral blood white cells. It may be the initial presentation of a plasma cell neoplasm or manifest as a terminal complication of plasma cell myeloma. Lymphadenopathy and organomegaly are frequent clinical signs, whereas bone pain and osteolytic lesions are less frequently present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3180</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ Of Ambiguous Lineage</VALIDVALUE>
          <VALUEMEANING>Acute Leukemia of Ambiguous Lineage</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells.  The prognosis is usually unfavorable.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2835647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ Myeloid Sarcoma (Chloroma)</VALIDVALUE>
          <VALUEMEANING>Myeloid Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A tumor mass composed of myeloblasts or immature myeloid cells.  It occurs in extramedullary sites or the bone.  (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ Hairy Cell</VALIDVALUE>
          <VALUEMEANING>Hairy Cell Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare neoplasm of small B-lymphocytes with &quot;hairy&quot; projections in bone marrow, spleen and peripheral blood.  Most patients are middle-aged to elderly adults and present with splenomegaly and pancytopenia. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ Erythroleukemia</VALIDVALUE>
          <VALUEMEANING>Acute Erythroid Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute myeloid leukemia characterized by a predominant immature erythroid population.  There are two subtypes recognized: erythroleukemia and pure erythroid leukemia. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8923</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2836778</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ Basophilic</VALIDVALUE>
          <VALUEMEANING>Acute Basophilic Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare acute myeloid leukemia in which the immature cells differentiate towards basophils.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3164</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2836779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ B - Lymphoblastic</VALIDVALUE>
          <VALUEMEANING>Precursor B-Lymphoblastic Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>The most frequent type of acute lymphoblastic leukemia.  Approximately 75% of cases occur in children under six years of age.  This is a good prognosis leukemia.  In the pediatric age group the complete remission rate is approximately 95% and the disease free survival rate is 70%.  Approximately 80% of children appear to be cured.  In the adult age group the complete remission rate is 60-85%.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2590756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ AMML - Acute Myelomonocytic</VALIDVALUE>
          <VALUEMEANING>Acute Myelomonocytic Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute leukemia characterized by the proliferation of both neutrophil and monocyte precursors.  (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7463</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2836785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ AML - Therapy Related</VALIDVALUE>
          <VALUEMEANING>Therapy-Related Acute Myeloid Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute myeloid leukemia arising as a result of the mutagenic effect of alkylating agents and/or ionizing radiation.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8252</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Myelodysplastic Syndrome</VALIDVALUE>
          <VALUEMEANING>Myelodysplastic Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Myelodysplastic syndrome (MDS) is a clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines.  The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia.  MDS may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ Aml - Acute Myeloblastic With Myelodysplasia Changes</VALIDVALUE>
          <VALUEMEANING>Acute Myeloid Leukemia with Multilineage Dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute myeloid leukemia (AML) with at least 20% blasts in the marrow or blood, and dysplasia in 2 or more myeloid cell lines.  Dysplasia must be present in at least 50% of the cells of at least 2 cell lines.  Patients with this type of AML often present with severe cytopenia.  The presence of multilineage dysplasia has an adverse effect on the probability of achieving complete remission.  (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ AML - Acute Myeloblastic</VALIDVALUE>
          <VALUEMEANING>Acute Myeloid Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues.  The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities 2) AML with multilineage dysplasia 3) Therapy-related AML 4) AML not otherwise categorized.  The required bone marrow or peripheral blood blast percentage for the diagnosis of AML has been recently reduced from 30% (French-American-British [FAB] classification) to 20% (WHO classification).  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ ALL - Acute Lymphocytic</VALIDVALUE>
          <VALUEMEANING>ALL</VALUEMEANING>
          <MEANINGDESCRIPTION>A leukemia with an acute onset, characterized by the presence of lymphoblasts or Burkitt cells in the bone marrow and the peripheral blood.  It includes the precursor B lymphoblastic leukemia, precursor T lymphoblastic leukemia, and Burkitt&#39;s leukemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Myelodysplastic Syndrome \ Refractory Cytopenia With Unilineage Dysplasia</VALIDVALUE>
          <VALUEMEANING>Refractory Cytopenia with Unilineage Dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A myelodysplastic syndrome characterized by dysplastic changes involving only one myeloid cell lineage in the bone marrow. It primarily affects older adults and includes refractory anemia, refractory neutropenia, and refractory thrombocytopenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82591</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Myelodysplastic Syndrome \ Refractory Anemia With Ring Sideroblasts</VALIDVALUE>
          <VALUEMEANING>Refractory Anemia with Ringed Sideroblasts</VALUEMEANING>
          <MEANINGDESCRIPTION>A myelodysplastic syndrome characterized by an anemia in which 15% or more of the erythroid precursors are ringed sideroblasts.  The ring sideroblast is an erythroid precursor in which one third or more of the nucleus is encircled by granules which are positive for iron stain.  It occurs primarily in older individuals.  The median survival exceeds 5 years.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4036</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2771857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Myelodysplastic Syndrome \ Refractory Anemia With Excess Blasts</VALIDVALUE>
          <VALUEMEANING>Myelodysplastic Syndrome with Excess Blasts</VALUEMEANING>
          <MEANINGDESCRIPTION>Myelodysplastic syndrome characterized by the presence of 5-9% blasts in bone marrow and 2-9% blasts in peripheral blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia Chronic - Myeloproliferative Neoplasms (MPN) \ Primary Myelofibrosis</VALIDVALUE>
          <VALUEMEANING>Chronic Idiopathic Myelofibrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic myeloproliferative disorder characterized by bone marrow fibrosis, proliferation of atypical megakaryocytes (micromegakaryocytes) and granulocytes in the bone marrow, anemia, splenomegaly, and extramedullary hematopoiesis.  The cause is unknown.  The median survival time is 3-5 years from diagnosis. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2837867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia Chronic - Myeloproliferative Neoplasms (MPN) \ Polycythemia Vera</VALIDVALUE>
          <VALUEMEANING>Polycythemia Vera</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic myeloproliferative disorder characterized by an increased red blood cell production.  Excessive proliferation of the myeloid lineage is observed as well.  The major symptoms are related to hypertension or to vascular abnormalities caused by the increased red cell mass.  The cause is unknown.  With currently available treatment, the median survival exceeds 10 years.  (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia Chronic - Myeloproliferative Neoplasms (MPN) \ Mastocytosis</VALIDVALUE>
          <VALUEMEANING>Mastocytosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A clonal myeloproliferative neoplasm characterized by the proliferation and accumulation of neoplastic mast cells in one or multiple organs or organ systems.  It is a heterogeneous group of neoplasms, ranging from cutaneous proliferations which may regress spontaneously, to aggressive neoplasms associated with organ failure and short survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia Chronic - Myeloproliferative Neoplasms (MPN) \ Essential Thrombocythemia</VALIDVALUE>
          <VALUEMEANING>Essential Thrombocythemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic myeloproliferative disorder that involves primarily the megakaryocytic lineage and it is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or hemorrhage.  The cause is unknown.  Median survival times of 10-15 years are commonly reported.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia Chronic - Myeloproliferative Neoplasms (MPN) \ CMML - Chronic Myelomonocytic</VALIDVALUE>
          <VALUEMEANING>Chronic Myelomonocytic Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A myelodysplastic/myeloproliferative disease which is characterized by persistent monocytosis, absence of a Philadelphia chromosome and BCR/ABL fusion gene, fewer than 20% blasts in the bone marrow or blood, and myelodysplasia.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3178</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2771865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia Chronic - Myeloproliferative Neoplasms (MPN) \ CML/Chronic Myelocytic</VALIDVALUE>
          <VALUEMEANING>Chronic Myelogenous Leukemia, BCR-ABL1 Positive</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic myeloproliferative neoplasm characterized by the expression of the BCR-ABL1 fusion gene. It presents with neutrophilic leukocytosis. It can appear at any age, but it mostly affects middle aged and older individuals. Patients usually present with fatigue, weight loss, anemia, night sweats, and splenomegaly. If untreated, it follows a biphasic or triphasic natural course; an initial indolent chronic phase which is followed by an accelerated phase, a blast phase, or both. Allogeneic stem cell transplantation and imatinib therapy delay disease progression and prolong overall survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia Chronic - Myeloproliferative Neoplasms (MPN) \ CLL/Chronic Lymphocytic</VALIDVALUE>
          <VALUEMEANING>CLL</VALUEMEANING>
          <MEANINGDESCRIPTION>The most common type of chronic lymphoid leukemia, and comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  The clinical course is indolent, but this type of leukemia is not considered to be curable with available therapy. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2590865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia Chronic - Myeloproliferative Neoplasms (MPN) \ Chronic Eosinophilic</VALIDVALUE>
          <VALUEMEANING>Chronic Eosinophilic Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare chronic myeloproliferative disorder characterized by a clonal proliferation of eosinophilic precursors resulting in persistently increased numbers of eosinophils in the blood, marrow and peripheral tissues.  Since acute eosinophilic leukemia is at best exceedingly rare, the term eosinophilic leukemia is normally used as a synonym for chronic eosinophilic leukemia.  In cases in which it is impossible to prove clonality and there is no increase in blast cells, the diagnosis of &quot;idiopathic hypereosinophilic syndrome&quot; is preferred.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia Chronic - Myeloproliferative Neoplasms (MPN)</VALIDVALUE>
          <VALUEMEANING>Chronic Myeloproliferative Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic myeloproliferative disorders (CMPDs) are clonal hematopoietic stem cell disorders, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, and megakaryocytic) lineages.  The proliferation is associated with relatively normal, effective maturation, resulting in increased numbers of granulocytes, red blood cells, and/or platelets in the peripheral blood.  CMPDs are primarily diseases of adults.  -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2590870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuroma \ Acoustic</VALIDVALUE>
          <VALUEMEANING>Acoustic Schwannoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of benign brain tumor that begins in the Schwann cells, which produce the myelin that protects the acoustic nerve - the nerve of hearing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210830</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurofibromatosis \ Neurofibromatosis Type 2 (NF2)</VALIDVALUE>
          <VALUEMEANING>Neurofibromatosis Type 2</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant disorder caused by mutations in the NF2 tumor suppressor gene.  It is characterized by the development of peripheral and central nervous system tumors including acoustic schwannomas, neurofibromas, gliomas, and meningiomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3274</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2962078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurofibromatosis \ Neurofibromatosis (NF1) - Von Recklinghausen&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Neurofibromatosis Type 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Type 1 (peripheral) neurofibromatosis (von Recklinghausen&#39;s disease), is the most common type of neurofibromatosis.  It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface.  They can vary markedly in size and color.  The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath neoplasms, called neurofibromas.  They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures.  Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2962080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurofibroma \ Plexiform</VALIDVALUE>
          <VALUEMEANING>Plexiform Neurofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>An elongated and multinodular neurofibroma, formed when the tumor involves either multiple trunks of a plexus or multiple fascicles of a large nerve, such as the sciatic. Some plexiform neurofibromas resemble a bag of worms, others produce a massive ropy enlargement of the nerve. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurofibroma \ Hyperplastic/Metaplastic Subtype</VALIDVALUE>
          <VALUEMEANING>Hyperplasia Metaplastic Subtype Neurofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.: Pertaining to or characterized by metaplasia.: Subtype; a group forming a type within a larger type.: An intraneural or extraneural neoplasm arising from nerve tissues and neural sheaths. It is composed of perineurial-like fibroblasts and Schwann cells. It usually presents as a localized cutaneous lesion and less often as a circumscribed peripheral nerve mass. Patients with neurofibromatosis type 1 present with multiple masses. Neurofibromas which arise from major nerves and plexiform neurofibromas are precursor lesions to malignant peripheral nerve sheath tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3272, C25696, C25566, C3113</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuroendocrine Tumor (Includes Carcinoid) \ Multiple Endocrine Neoplasm (MEN) Type 1</VALIDVALUE>
          <VALUEMEANING>Multiple Endocrine Neoplasia Type 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple endocrine neoplasia caused by inactivation of the tumor suppressor gene MEN-1. Patients may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuroblastoma</VALIDVALUE>
          <VALUEMEANING>Neuroblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Neuroblastoma is a specific type of neuroblastic tumor which is characterized by the presense of neuroblastic cells forming groups or nests separated by delicate stromal septa without prominent Schwannian stroma. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurilemmoma/Schwannoma \ Plexiform</VALIDVALUE>
          <VALUEMEANING>Plexiform Schwannoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Plexiform Schwannoma (also called Plexiform Neurilemmoma and Plexiform Neurinoma) is a Schwannoma which grows in a plexiform or multinodular manner, presumably involving a nerve plexus. The majority arise in skin or subcutaneous tissue of an extremity, head and neck or trunk. The tumor is associated with Neurofibromatosis Type 1. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurilemmoma/Schwannoma \ Melanotic</VALIDVALUE>
          <VALUEMEANING>Melanocytic Schwannoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Melanotic Schwannoma (also called Melanotic Neurilemmoma or Melanotic Neurinoma) is a rare type of Schwannoma which is circumscribed, pigmented and composed of cells with the ultrastructure and immunophenotype of Schwann cells, but which contain melanosomes that are reactive for melanoma markers. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurilemmoma/Schwannoma \ Hyperplastic/Metaplastic Subtype</VALIDVALUE>
          <VALUEMEANING>Hyperplasia Metaplastic Subtype Schwannoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.: Pertaining to or characterized by metaplasia.: Subtype; a group forming a type within a larger type.: A tumor of the peripheral nervous system that arises in the nerve sheath (protective covering).  It is almost always benign, but rare malignant schwannomas have been reported.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3269, C25696, C25566, C3113</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neurilemmoma/Schwannoma \ Cellular</VALIDVALUE>
          <VALUEMEANING>Cellular Schwannoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Cellular Schwannoma (also called Cellular Neurilemmoma or Cellular Neurinoma) is a hypercellular Schwannoma composed exclusively or predominantly of Antoni A tissue, and devoid of Verocay bodies. Cellular Schwannomas are benign, although recurrences can occur, especially when located in the spine. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4724</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Tourette Syndrome</VALIDVALUE>
          <VALUEMEANING>Tourette Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A neurologic disorder caused by defective metabolism of the neurotransmitters in the brain. It is characterized by repeated involuntary movements (motor tics) and uncontrollable vocal sounds (vocal tics). The symptoms are usually manifested before the age of eighteen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3189981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Spinal Cord Disease</VALIDVALUE>
          <VALUEMEANING>Spinal Cord Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A non neoplastic or neoplastic disorder that affects the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97110</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Retinitis Pigmentosa</VALIDVALUE>
          <VALUEMEANING>Retinitis Pigmentosa</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare inherited retinal dystrophy disorder characterized by spots of black bone-spicule pigmentation of the retinal pigment epithelium. It is manifested with decreased vision in low light or in the night, followed by decreased peripheral vision, and, eventual decreased central vision. It may lead to blindness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Polymyositis</VALIDVALUE>
          <VALUEMEANING>Polymyositis</VALUEMEANING>
          <MEANINGDESCRIPTION>Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY, NERVOUS SYSTEM); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26925</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2585215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Pick&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Pick&#39;s Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare neurodegenerative disorder leading to dementia. It is characterized by frontotemporal lobar degeneration with accumulation of tau proteins which form Pick bodies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85008</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Parkinsonism</VALIDVALUE>
          <VALUEMEANING>Parkinson&#39;s Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>progressive, degenerative disorder of the nervous system characterized by tremors, rigidity, bradykinesia, postural instability, and gait abnormalities; caused by a loss of neurons and a decrease of dopamine in the basal ganglia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26845</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2751450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Muscular Dystrophy</VALIDVALUE>
          <VALUEMEANING>Muscular Dystrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of inherited progressive muscle disorders characterized by muscle weakness and eventual death of the muscle tissues. Examples include Duchenne muscular dystrophy, Becker&#39;s muscular dystrophy, Emery-Dreifuss muscular dystrophy, facioscapulohumeral muscular dystrophy, and limb-girdle muscular dystrophy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84910</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Multiple Sclerosis</VALIDVALUE>
          <VALUEMEANING>Multiple Sclerosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder of the central nervous system marked by weakness, numbness, a loss of muscle coordination, and problems with vision, speech, and bladder control. Multiple sclerosis is thought to be an autoimmune disease in which the body&#39;s immune system destroys myelin. Myelin is a substance that contains both protein and fat (lipid), serving as a nerve insulator and helping in the transmission of nerve signals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3243</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2760060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Lewey Body Disease</VALIDVALUE>
          <VALUEMEANING>Lewy Body Dementia</VALUEMEANING>
          <MEANINGDESCRIPTION>A progressive form of dementia characterized by the presence of protein deposits called Lewy bodies in the midbrain and cerebral cortex, and loss of cholinergic and dopaminergic neurons. The signs and symptoms overlap with Alzheimer and Parkinson disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84826</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Gliosis</VALIDVALUE>
          <VALUEMEANING>Gliosis</VALUEMEANING>
          <MEANINGDESCRIPTION>The production of a dense fibrous network of neuroglia; includes astrocytosis, which is a proliferation of astrocytes in the area of a degenerative lesion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Epilepsy</VALIDVALUE>
          <VALUEMEANING>Epilepsy</VALUEMEANING>
          <MEANINGDESCRIPTION>brain disorder characterized by recurring excessive neuronal discharge, exhibited by transient episodes of motor, sensory, or psychic dysfunction, with or without unconsciousness or convulsive movements.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3020</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2971317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Dementia, Senile</VALIDVALUE>
          <VALUEMEANING>Senile Dementia</VALUEMEANING>
          <MEANINGDESCRIPTION>Loss of intellectual abilities in an elderly person, interfering with this person&#39;s activities. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Dementia</VALIDVALUE>
          <VALUEMEANING>Dementia</VALUEMEANING>
          <MEANINGDESCRIPTION>An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3165569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Blindness</VALIDVALUE>
          <VALUEMEANING>Blindness</VALUEMEANING>
          <MEANINGDESCRIPTION>The lack of vision.  It is caused by neurological or physiological factors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97109</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Atelencephalia</VALIDVALUE>
          <VALUEMEANING>Brain Developmental Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of congenital or acquired disorders that affect the normal development of the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Astrocytosis/Gliosis</VALIDVALUE>
          <VALUEMEANING>Gliomatosis Cerebri Gliosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Gliomatosis cerebri (WHO grade II) is a diffuse glial tumor which infiltrates the brain, extensively, involving more than two lobes. It is frequently bilateral and often extends to the infratentorial structures, even to the spinal cord. It is probably of astrocytic origin, although GFAP expression may be scant or absent. (Adapted form WHO.): The production of a dense fibrous network of neuroglia; includes astrocytosis, which is a proliferation of astrocytes in the area of a degenerative lesion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26783, C4318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Alzheimer&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Alzheimer&#39;s Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2866</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3165575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nephrolith (Kidney Stone)</VALIDVALUE>
          <VALUEMEANING>Renal Stone</VALUEMEANING>
          <MEANINGDESCRIPTION>Calculi occurring in the kidney. Calculi too large to pass spontaneously range in size from 1 cm to the staghorn stones that occupy the renal pelvis and calyces.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Native Organ \ Any Disease</VALIDVALUE>
          <VALUEMEANING>Native Organ \ Any Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>The diseased, failing organ that is removed. The organ may have failed due to any disease process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloma</VALIDVALUE>
          <VALUEMEANING>Plasma Cell Myeloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myelolipoma</VALIDVALUE>
          <VALUEMEANING>Adrenal Gland Myelolipoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign soft tissue lesion arising from the adrenal gland.  It is composed of mature adipose and hematopoietic/lymphoid tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myeloid Metaplasia</VALIDVALUE>
          <VALUEMEANING>Chronic Idiopathic Myelofibrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic myeloproliferative disorder characterized by bone marrow fibrosis, proliferation of atypical megakaryocytes (micromegakaryocytes) and granulocytes in the bone marrow, anemia, splenomegaly, and extramedullary hematopoiesis.  The cause is unknown.  The median survival time is 3-5 years from diagnosis. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2837867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myelodysplasia</VALIDVALUE>
          <VALUEMEANING>Myelodysplastic Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Myelodysplastic syndrome (MDS) is a clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines.  The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia.  MDS may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Muscular Hypertrophy</VALIDVALUE>
          <VALUEMEANING>Muscle Cell Hypertrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the presence of enlarged muscle cells in a muscle tissue sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97100</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multinodular Goiter</VALIDVALUE>
          <VALUEMEANING>Goiter</VALUEMEANING>
          <MEANINGDESCRIPTION>Enlargement of the thyroid gland usually caused by lack of iodine in the diet, hyperthyroidism, or thyroid nodules. Symptoms include difficulty in breathing and swallowing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucosal Dysplasia \ VIN (Vulvar Intraepithelial Neoplasia)</VALIDVALUE>
          <VALUEMEANING>Vulvar Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A precancerous neoplastic process characterized by dysplasia and maturation abnormalities of the vulvar squamous epithelium. There is no evidence of invasion. It is associated with human papillomavirus infection and is classified as low or high grade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucosal Dysplasia \ Squamous</VALIDVALUE>
          <VALUEMEANING>Squamous Cell Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A general term for the abnormal growth of squamous cells on the surface of the cervix. The changes in the cells are described as low grade or high grade, depending on how much of the cervix is affected and how abnormal the cells appear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucosal Dysplasia \ Low  Grade</VALIDVALUE>
          <VALUEMEANING>Low Grade Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A precancerous neoplastic process that affects the squamous, glandular, or transitional cell epithelium without evidence of invasion. It is characterized by the presence of mild epithelial dysplasia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249002</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucosal Dysplasia \ High Grade</VALIDVALUE>
          <VALUEMEANING>High Grade Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A precancerous neoplastic process that affects the squamous, glandular, or transitional cell epithelium without evidence of invasion. According to the degree of nuclear atypia, number of mitotic figures, and presence of architectural distortion, it is classified as grade II (moderate dysplasia) or grade III (severe dysplasia).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucosal Dysplasia</VALIDVALUE>
          <VALUEMEANING>Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A precancerous neoplastic process that affects the squamous, glandular, or transitional cell epithelium without evidence of invasion. According to the degree of nuclear atypia, number of mitotic figures, and presence of architectural distortion, it is classified as low grade (mild dysplasia) or high grade (moderate or severe dysplasia).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucinous Cystic</VALIDVALUE>
          <VALUEMEANING>Pancreatic Mucinous-Cystic Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive or invasive cystic epithelial neoplasm that affects almost exclusively females.  It is characterized by the presence of columnar mucin-producing epithelial cells and ovarian-type stroma formation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoclonal Gammopathy Of Undetermined Significance (MGUS)</VALIDVALUE>
          <VALUEMEANING>Monoclonal Gammopathy of Undetermined Significance</VALUEMEANING>
          <MEANINGDESCRIPTION>A plasma cell disorder in which an abnormal amount of a single immunoglobulin is present in the serum. Up to 25% of cases of monoclonal gammopathy of undetermined significance (MGUS) progress to a B-cell malignancy or myeloma. MGUS may occur in conjunction with various carcinomas, chronic inflammatory and infectious conditions, and other diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3996</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed Mullerian Tumor \ Adenosarcoma</VALIDVALUE>
          <VALUEMEANING>Adenosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nodular Fasciitis</VALIDVALUE>
          <VALUEMEANING>Nodular Fasciitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rapid growing, non-encapsulated benign neoplasm that arises from the soft tissues. It is characterized by the presence of non-hyperchromatic spindle-shaped fibroblasts, multinucleated osteoclast-like giant cells, chronic inflammatory infiltrate, red blood cell extravasation, and high mitotic activity, in a storiform growth pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3827</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nevus \ Simple</VALIDVALUE>
          <VALUEMEANING>Benign Melanocytic Skin Nevus</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, circumscribed proliferation of melanocytes in the skin. Variants include the Spitz nevus, halo nevus, blue nevus, and balloon cell nevus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nevus \ Compound</VALIDVALUE>
          <VALUEMEANING>Compound Nevus</VALUEMEANING>
          <MEANINGDESCRIPTION>A nevus composed of neoplastic melanocytes that infiltrate both the epidermis and the dermis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuroma \ Traumatic</VALIDVALUE>
          <VALUEMEANING>Traumatic Neuroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic proliferation of a nerve caused by injury to the nerve due to trauma or surgery. It presents as a firm nodule that may be associated with pain or tenderness. It most often occurs in the lower extremity following amputation, or in the head and neck region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oncocytoma</VALIDVALUE>
          <VALUEMEANING>Oncocytic Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually benign neoplasm composed of large cells with abundant eosinophilic granular cytoplasm.  Representative examples include oncocytic neoplasms of the thyroid gland, and kidney. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7072</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oligodendroglioma, Anaplastic</VALIDVALUE>
          <VALUEMEANING>Anaplastic oligodendroglioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade III oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oligoastrocytoma \ Anaplastic</VALIDVALUE>
          <VALUEMEANING>Anaplastic Oligoastrocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An oligoastrocytoma characterized by the presence of increased cellularity, nuclear atypia, pleomorphism, and high mitotic activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oligioastrocytoma</VALIDVALUE>
          <VALUEMEANING>Oligoastrocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade II tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4050</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Odontoma</VALIDVALUE>
          <VALUEMEANING>Odontoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, slow growing, and painless hamartomatous tumor occurring in tooth-bearing areas of the jaws. According to the presence or absence of tooth-like structures, it is classified as complex type or compound type. Odontoma of complex type is characterized by the presence of enamel and dentin and the absence of tooth-like structures. It is treated with local excision. If it is incompletely removed, it may recur. Odontoma of compound type is characterized by the presence of tooth-like structures. It is treated by local excision. Recurrences have not been reported.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3287</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Notochord Tumor \ Ecchordosis Physaliphora</VALIDVALUE>
          <VALUEMEANING>Ecchordosis Physaliphora</VALUEMEANING>
          <MEANINGDESCRIPTION>A very rare, slow growing, usually asymptomatic hamartomatous lesion that arises from ectopic notochordal tissue.  Morphologically it is characterized by the presence of typical physaliphorous cells in a myxoid background.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97111</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251528</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Notochord \ Chordoma</VALIDVALUE>
          <VALUEMEANING>Chordoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant bone tumor arising from the remnants of the fetal notochord. Although it can occur at all ages, it is more frequently seen in middle-aged adults. Most frequent sites of involvement are: sacrococcygeal area, spheno-occipital area, and the cervico-thoraco-lumbar spine. Microscopically, chordomas are composed of cells that form cords and lobules, separated by mucoid intercellular tissue. Some of the cells are large (physaliphorous) and have vacuolated cytoplasm and prominent vesicular nuclei. Other tumor cells are small with small nuclei without visible nucleoli. Chordomas tend to recur and may metastasize. The most common sites of metastasis are skin and bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2947</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Notochord</VALIDVALUE>
          <VALUEMEANING>Notochord</VALUEMEANING>
          <MEANINGDESCRIPTION>The rod-shaped body, composed of cells derived from the mesoblast and defining the primitive axis of the embryo. In higher vertebrates it is replaced by the vertebral column. (MeSH)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12463</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Noninvasive Papillary Carcinoma</VALIDVALUE>
          <VALUEMEANING>Papillary Carcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>An epithelial neoplasm with a papillary growth pattern in which the malignant cells are confined to the epithelium, without evidence of invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papilloma</VALIDVALUE>
          <VALUEMEANING>Papilloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign epithelial neoplasm that projects above the surrounding epithelial surface and consists of villous or arborescent outgrowths of fibrovascular stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyp \ Hyperplastic</VALIDVALUE>
          <VALUEMEANING>Hyperplastic Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A polyp found mainly in the stomach and colon.  Microscopically, it is characterized by elongated, serrated crypts lined by proliferative epithelium.  Hyperplastic polyps are traditionally considered non-neoplastic, but ras mutation is common, clonality has been demonstrated and biochemical abnormalities and epidemiological associations that occur in colorectal adenomas and carcinomas have been found (WHO Tumors of the Digestive System, 2000).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4083</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyp \ Hamartomatous</VALIDVALUE>
          <VALUEMEANING>Hamartomatous Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A polyp characterized by an overgrowth of mature cells and tissues that normally occur in the affected area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2783546</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyp \ Fundic Gland</VALIDVALUE>
          <VALUEMEANING>Fundic Gland Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>The most common gastric polyp in the Western hemisphere.  The lesion consists of a localized hyperplasia of the deep epithelial compartment of the oxyntic mucosa, with variable degrees of cystic dilatation.  Malignant transformation is the exception.  (WHO, 2000)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8961</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251828</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyp</VALIDVALUE>
          <VALUEMEANING>Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually exophytic mass attached to the underlying tissue by a broad base or a thin stalk.  Polyps can be neoplastic or non-neoplastic.  Neoplastic polyps usually represent proliferations of the epithelium, and are commonly seen in the gastrointestinal tract.  Polyps of the gastrointestinal tract are often called adenomas, are associated with dysplasia, and may eventually transform into carcinomas.  Non-neoplastic polyps may be inflammatory, degenerative, or the result of malformations. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3340</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2684804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyembryoma</VALIDVALUE>
          <VALUEMEANING>Gonadal Polyembryoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare malignant germ cell tumor arising from the testis and less often from the ovary. It is characterized by the presence of embryoid bodies which resemble early embryos.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66776</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251830</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polycystic</VALIDVALUE>
          <VALUEMEANING>Polycystic</VALUEMEANING>
          <MEANINGDESCRIPTION>The presence of multiple cysts in one or several organs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleuritis</VALIDVALUE>
          <VALUEMEANING>Pleuritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the pleura. It is usually caused by infections. Chest pain while breathing or coughing is the presenting symptom.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26860</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Placental Site Trophoblastic Tumor</VALIDVALUE>
          <VALUEMEANING>Placental-Site Gestational Trophoblastic Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare gestational trophoblastic tumor characterized by the presence of a diffuse cellular infiltrate composed of intermediate trophoblasts and cytotrophoblasts and by the absense of a significant population of syncytiotrophoblasts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pineoblastoma</VALIDVALUE>
          <VALUEMEANING>Pineoblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Pineoblastoma (WHO grade IV) is a highly malignant, primitive embryonal neoplasm, which occurs more commonly in children. It is composed of patternless sheets of densely packed small cells with round-to-irregular nuclei and scant cytoplasm, similar to medulloblastoma and related primitive neuroectodermal tumors. A frequent complication is metastasis via cerebrospinal fluid pathways, which is often associated with a fatal outcome. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251836</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pinealoma</VALIDVALUE>
          <VALUEMEANING>Pineal Region Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Neoplasms that are located in the pineal gland.  These neoplasms arise either from pineal parenchymal cells (pineocytes), as do pineocytomas and the more aggressive pineoblastomas, or from other cell types, as do pineal astrocytic tumors (notably pilocytic astrocytomas) and germ cell tumors.  Clinical symptoms include neuro-ophthalmologic dysfunction, changes in mental status, dysfunction of the brain stem, and hypothalamic-based endocrine abnormalities. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pineal Blastoma</VALIDVALUE>
          <VALUEMEANING>Pineoblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Pineoblastoma (WHO grade IV) is a highly malignant, primitive embryonal neoplasm, which occurs more commonly in children. It is composed of patternless sheets of densely packed small cells with round-to-irregular nuclei and scant cytoplasm, similar to medulloblastoma and related primitive neuroectodermal tumors. A frequent complication is metastasis via cerebrospinal fluid pathways, which is often associated with a fatal outcome. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PIN (Prostatic Intraepithelial Neoplasia), Any Grade</VALIDVALUE>
          <VALUEMEANING>Prostatic Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplastic proliferation of the epithelial cells that line the acini and the ducts of the prostate gland.  The neoplastic epithelial cells are confined within the acini and the ducts and they do not invade the surrounding prostatic stroma.  Morphologically, it is classified as low or high grade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PIA (Proliferative Inflammatory Atrophy)</VALIDVALUE>
          <VALUEMEANING>Proliferative Inflammatory Atrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>A lesion in the prostate gland characterized by glandular atrophy, chronic inflammation, and epithelial hyperplasia.  It has been suggested that it is a precancerous lesion and it may lead to the development of prostatic intraepithelial neoplasia and prostatic carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97114</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Undifferentiated Mesenchymal</VALIDVALUE>
          <VALUEMEANING>Undifferentiated (Embryonal) Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare malignant tumor of the liver, the incidence of which is highest in children between 6 and 10 years of age.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Synovial Sarcoma</VALIDVALUE>
          <VALUEMEANING>Synovial Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Stromal</VALIDVALUE>
          <VALUEMEANING>Stromal Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm characterized by the presence of atypical mesenchymal-stromal cells. Representative examples include endometrial stromal sarcoma and prostate stromal sarcoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6926</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Schwannoma (Malignant)</VALIDVALUE>
          <VALUEMEANING>Malignant Schwannoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Also known as malignant peripheral nerve sheath tumor, an uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their 30s to 60s. It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region. It may be associated with NF1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251910</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Rhabdomyosarcoma</VALIDVALUE>
          <VALUEMEANING>Stratum 4: Rhabdomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults.  Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Rhabdoid</VALIDVALUE>
          <VALUEMEANING>Rhabdoid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive malignant embryonal neoplasm usually occurring during childhood.  It is characterized by the presence of large cells with abundant cytoplasm, large eccentric nucleus, and a prominent nucleolus and it is associated with abnormalities of chromosome 22.  It can arise from the central nervous system, kidney, and the soft tissues.  The prognosis is poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3808</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2962178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Pseudosarcoma</VALIDVALUE>
          <VALUEMEANING>Papillary Endothelial Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A reactive, well-circumscribed vascular lesion. It is characterized by the formation of thin papillae projecting within the lumen of blood vessels. The papillae are lined by plump endothelial cells. Blood clots are also present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Pleomorphic</VALIDVALUE>
          <VALUEMEANING>Pleomorphic Rhabdomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive malignant mesenchymal neoplasm with skeletal muscle differentiation, occurring in adults and rarely in children.  The tumor is characterized by the presence of bizarre round, spindle, and polygonal cells.  Clinical presentation includes a rapidly enlarging painful mass usually of the lower extremities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4258</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Osteosarcoma</VALIDVALUE>
          <VALUEMEANING>Osteosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive malignant bone-forming mesenchymal tumor, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9145</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Neurogenic/Schwannosarcoma</VALIDVALUE>
          <VALUEMEANING>Malignant Peripheral Nerve Sheath Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their 30s to 60s. It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region. It may be associated with NF1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Neurofibrosarcoma</VALIDVALUE>
          <VALUEMEANING>Malignant Peripheral Nerve Sheath Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Mesenchymoma</VALIDVALUE>
          <VALUEMEANING>Mesenchymoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A term describing a soft tissue tumor which consists of two or more mesenchymal lines of differentiation, excluding a fibroblastic line of differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Malignant Peripheral Nerve Sheath Tumor</VALIDVALUE>
          <VALUEMEANING>Malignant Peripheral Nerve Sheath Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Malignant Fibrous Histiocytoma</VALIDVALUE>
          <VALUEMEANING>Malignant Fibrous Histiocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A pleomorphic sarcoma characterized by the presence of fibrohistiocytic cells and spindle cells arranged in a storiform pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Lymphangiosarcoma</VALIDVALUE>
          <VALUEMEANING>Lymphangiosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm arising from the endothelial cells of the lymphatic vessels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Liposarcoma</VALIDVALUE>
          <VALUEMEANING>Liposarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually painless malignant tumor that arises from adipose tissue.  Microscopically, it may contain a spectrum of neoplastic adipocytes ranging from lipoblasts to pleomorphic malignant adipocytes.  Representative morphologic variants include: well differentiated, dedifferentiated, pleomorphic, and myxoid/round cell liposarcoma.  The metastatic potential is higher in less differentiated tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Leiomyosarcoma</VALIDVALUE>
          <VALUEMEANING>Leiomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women. It is characterized by a proliferation of neoplastic spindle cells. Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3158</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Kaposi Sarcoma</VALIDVALUE>
          <VALUEMEANING>Kaposi Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin however, it may also occur internally.  It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Hemangiosarcoma</VALIDVALUE>
          <VALUEMEANING>Angiosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor arising from the endothelial cells of the blood vessels.  Microscopically, it is characterized by frequently open vascular anastomosing and branching channels.  The malignant cells that line the vascular channels are spindle or epithelioid and often display hyperchromatic nuclei.  Angiosarcomas most frequently occur in the skin and breast.  Patients with long-standing lymphedema are at increased risk of developing angiosarcoma. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3088</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Hemangiopericytoma</VALIDVALUE>
          <VALUEMEANING>Hemangiopericytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A mesenchymal tumor composed of dilated vascular spaces (some with a staghorn or bifed shape) throughout.  The individual tumor cells are surrounded by reticulin everywhere, are negative for muscle, nerve sheath, and epithelial markers, and are positive for CD34 and CD99.  The biologic behavior of hemangiopericytoma cannot always be predicted from the morphologic features.  The 5- and 10-year survival rates of malignant hemangiopericytomas have been reported to be 40% and 29% respectively (partially adapted from S. Sternberg&#39;s Diagnostic Surgical Pathology, 4th ed., 2004).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Hemangioendothelioma</VALIDVALUE>
          <VALUEMEANING>Hemangioendothelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A vascular proliferation characterized by the presence of prominent endothelial cells and the formation of vascular channels. Hemangioendotheliomas may display borderline or low grade characteristics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3084</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Fibrosarcoma</VALIDVALUE>
          <VALUEMEANING>Fibrosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant mesenchymal tumor affecting soft tissues and bone. It is classified as adult or infantile.  Infantile fibrosarcomas generally have a much more favorable prognosis than adult fibrosarcomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3043</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Ewing&#39;s</VALIDVALUE>
          <VALUEMEANING>Ewing Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A small round cell tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor. It affects mostly males under age 20, and it can occur in soft tissue or bone. Pain and the presence of a mass are the most common clinical symptoms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4817</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Epithelioid</VALIDVALUE>
          <VALUEMEANING>Epithelioid Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive malignant neoplasm of uncertain lineage, characterized by the presence of epithelioid cells forming nodular patterns.  The nodules often undergo central necrosis, resulting in a pseudogranulomatous growth pattern.  It usually occurs in young adults.  The most common sites of involvement are the extremities (distal-type epithelioid sarcoma), and less frequently the pelvis, perineum, and genital organs (proximal-type epithelioid sarcoma).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3714</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179347</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Dysplasia Up To &amp; Including CIS (VAIN)</VALIDVALUE>
          <VALUEMEANING>Vaginal Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A superficial neoplastic process involving exclusively the vaginal squamous epithelium without extension to underlying tissue.  It is classified as low- or high-grade intraepithelial neoplasia.  --2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Solitary Fibrous Tumor</VALIDVALUE>
          <VALUEMEANING>Solitary Fibrous Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A localized neoplasm of probable fibroblastic derivation. It is characterized by the presence of round to spindle-shaped cells, hylanized stroma formation, thin-walled branching blood vessels, and thin bands of collagen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Solid &amp; Cystic Neoplasm \ Solid Pseudopapillary</VALIDVALUE>
          <VALUEMEANING>Solid Pseudopapillary Neoplasm of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>A low-grade malignant neoplasm that arises from the exocrine pancreas. It is characterized by the presence of uniform cells that form solid and pseudopapillary patterns, cystic changes, and hemorrhage. Perineural invasion, vascular invasion, and invasion into surrounding tissues may be present. It usually presents as an encapsulated, solitary, and lobulated pancreatic mass. It is usually found incidentally during physical examination or it may present with abdominal discomfort and pain. It occurs predominantly in young women. Complete removal of the tumor is curative in the majority of cases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Xeroderma Pigmentosum</VALIDVALUE>
          <VALUEMEANING>Xeroderma Pigmentosum</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited skin disorder characterized by photosensitivity with severe sunburn in infancy, the development of numerous pigmented spots resembling freckles, larger atrophic lesions associated with telangiectasis, and multiple solar keratoses. Transmitted in an autosomal recessive manner, xeroderma pigmentosa involves a defect in nucleotide excision repair (NER), leading to deficient repair of DNA damaged by UV radiation and chromosome breakage. Individuals with this disease develop multiple malignant cutaneous neoplasms at an early age and may suffer from severe ophthalmic and neurologic abnormalities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Vitiligo</VALIDVALUE>
          <VALUEMEANING>Vitiligo</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Stevens-Johnson Syndrome</VALIDVALUE>
          <VALUEMEANING>Stevens-Johnson Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A systemic, serious, and life-threatening disorder characterized by lesions in the skin and mucous membranes that may lead to necrosis. The lesions may appear anywhere in the body but they occur more commonly in the palms, soles, dorsum of the hands, and extensor surfaces. The lesions are vesicular or necrotic in the center, surrounded by an erythematous zone and occupy less than 10% of the body surfaces. The appearance of the mucocutaneous lesions is preceded by an upper respiratory tract infection. It is an immune complex hypersensitivity reaction usually caused by drugs (e.g., sulfa, phenytoin, penicillin), viruses (e.g., herpes simplex, influenza, hepatitis), and malignancies (e.g., carcinoma and lymphoma).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Scleroderma</VALIDVALUE>
          <VALUEMEANING>Scleroderma</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic disorder marked by hardening and thickening of the skin.  Scleroderma can be localized or it can affect the entire body (systemic).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26746</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Rosacea</VALIDVALUE>
          <VALUEMEANING>Rosacea</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic erythematous skin disorder that affects the face.  It is characterized by the development of redness in the cheeks, nose, and/or forehead and telangiectasia.  Sometimes, the erythematous changes may involve the eyelids.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97136</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Psoriasis</VALIDVALUE>
          <VALUEMEANING>Psoriasis</VALUEMEANING>
          <MEANINGDESCRIPTION>A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3346</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Pruritus</VALIDVALUE>
          <VALUEMEANING>Pruritus</VALUEMEANING>
          <MEANINGDESCRIPTION>An intense itching sensation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Pemphigus Vulgaris</VALIDVALUE>
          <VALUEMEANING>Pemphigus Vulgaris</VALUEMEANING>
          <MEANINGDESCRIPTION>An autoimmune blistering disorder. It is characterized by the presence of painful blisters and erosions in the skin and mucous membranes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34910</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Lichen Planus</VALIDVALUE>
          <VALUEMEANING>Lichen Planus</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a &quot;saw-tooth&quot; pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Keratosis</VALIDVALUE>
          <VALUEMEANING>Keratosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Any horny growth such as a wart or callus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Keloid</VALIDVALUE>
          <VALUEMEANING>Keloid</VALUEMEANING>
          <MEANINGDESCRIPTION>A thick, irregular scar caused by excessive tissue growth at the site of an incision or wound.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3145</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Hives/Urticaria</VALIDVALUE>
          <VALUEMEANING>Urticaria</VALUEMEANING>
          <MEANINGDESCRIPTION>An itchy skin eruption characterized by weals with pale interiors and well-defined red margins; usually the result of an allergic response to insect bites or food or drugs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2943926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Eczema</VALIDVALUE>
          <VALUEMEANING>Eczema</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of dermatitis characterized by red, itchy, scaly, or crusty patches that can be chronic or intermittent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3001</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Dermatomyositis</VALIDVALUE>
          <VALUEMEANING>Dermatomyositis</VALUEMEANING>
          <MEANINGDESCRIPTION>A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Dermatitis</VALIDVALUE>
          <VALUEMEANING>Dermatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process affecting the skin. Signs include red rash, itching, and blister formation. Representative examples are contact dermatitis, atopic dermatitis, and seborrheic dermatitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210810</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Bullous Pemphigoid</VALIDVALUE>
          <VALUEMEANING>Bullous Pemphigoid</VALUEMEANING>
          <MEANINGDESCRIPTION>An autoimmune chronic skin disorder characterized by the presence of large blisters. It usually affects elderly people and tends to subside spontaneously.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin Disorders \ Atopic (Allergic) Dermatitis</VALIDVALUE>
          <VALUEMEANING>Allergic Contact Dermatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sinusitis \ Chronic</VALIDVALUE>
          <VALUEMEANING>Chronic Sinusitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the paranasal sinuses that typically lasts beyond eight weeks. It is caused by infections, allergies, and the presence of sinus polyps or deviated septum. Signs and symptoms include headache, nasal discharge, swelling in the face, dizziness, and breathing difficulties.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35151</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sialadenitis \ Chronic</VALIDVALUE>
          <VALUEMEANING>Chronic Sclerosing Sialadenitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic fibrotic inflammatory process affecting the salivary gland. Signs and symptoms include firm and painful swelling of the salivary gland, often associated with the presence of salivary gland stones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sex Cord-Stromal Tumor \ Sertoli-Leydig Cell Tumor</VALIDVALUE>
          <VALUEMEANING>Ovarian Sertoli-Leydig Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant sex cord-stromal tumor arising from the ovary. It is characterized by the presence of neoplastic Leydig cells. Signs and symptoms include hirsutism, menorrhagia and metrorrhagia. It may be associated with trisomy 8.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2880</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sex Cord-Stromal Tumor \ Pick&#39;s Cell Adenoma</VALIDVALUE>
          <VALUEMEANING>Benign Testicular Sertoli Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-metastasizing sex cord-stromal tumor that arises from the testis. Morphologically, it is characterized by the presence of Sertoli cells forming tubules. Leydig cells are rare or absent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sex Cord-Stromal Tumor \ Lipoid Cell Tumor (Hilus)</VALIDVALUE>
          <VALUEMEANING>Ovarian Hilus Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign Leydig cell tumor which arises in the hilar area of the ovary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature T-Cell Type</VALIDVALUE>
          <VALUEMEANING>Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad spectrum of lymphocyte morphology, but in all instances express T-cell markers admixed with epithelioid histiocytes, plasma cells, and eosinophils. Although markedly similar to large-cell immunoblastic lymphoma (LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC), this group&#39;s unique features warrant separate treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ SLL/ Small Lymphocytic Leukemia</VALIDVALUE>
          <VALUEMEANING>Small Lymphocytic Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An indolent non-Hodgkin&#39;s lymphoma composed of monomorphic small, round B-lymphocytes in the lymph nodes.  When the lymphoid process involves predominantly the bone marrow and the peripheral blood it is called chronic lymphocytic leukemia. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7540</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ Primary Effusion Lymphoma</VALIDVALUE>
          <VALUEMEANING>Primary Effusion Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive non-Hodgkin B-cell lymphoma composed of large cells, presenting as a serous effusion without detectable tumor masses. It is universally associated with human herpes virus 8 (HHV-8)/Kaposi sarcoma herpes virus (KSHV) [HHV-8/KSHV]. It mostly occurs in the setting of immunodeficiency; most cases have been reported in HIV positive patients. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. The prognosis is extremely unfavorable.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ Plasma Cell (Myeloma)</VALIDVALUE>
          <VALUEMEANING>Plasma Cell Myeloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ Mediastinal Large B-Cell</VALIDVALUE>
          <VALUEMEANING>Mediastinal (Thymic) Large B-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A large B-cell non-Hodgkin lymphoma arising in the mediastinum.  Morphologically it is characterized by a massive diffuse lymphocytic proliferation associated with compartmentalizing fibrosis.  Response to intensive chemotherapy, with or without radiotherapy, is usually good. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ Marginal Zone</VALIDVALUE>
          <VALUEMEANING>Marginal Zone Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually indolent mature B-cell lymphoma, arising from the marginal zone of lymphoid tissues.  It is characterized by the presence of small to medium sized atypical lymphocytes.  It comprises three entities, according to the anatomic sites involved: extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue, which affects extranodal sites (most often stomach, lung, skin, and ocular adnexa); nodal marginal zone B-cell lymphoma, which affects lymph nodes without evidence of extranodal disease; and splenic marginal zone B-cell lymphoma, which affects the spleen and splenic hilar lymph nodes, bone marrow, and often the peripheral blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4341</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ Mantle Cell</VALIDVALUE>
          <VALUEMEANING>Mantle Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive, usually diffuse non-Hodgkin lymphoma composed of small to medium sized B-lymphocytes (centrocytes).  Most patients present with advanced stage disease with lymphadenopathy, hepatosplenomegaly, and bone marrow involvement.  The gastrointestinal tract is the most commonly affected extranodal site by this type of non-Hodgkin lymphoma.  The vast majority of cases express the t(11;14)(q13;q32) resulting in the rearrangement of the BCL-1 gene and the overexpression of cyclin D1 mRNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4337</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ Intravascular Large B-Cell</VALIDVALUE>
          <VALUEMEANING>Intravascular Large B-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare extranodal B-cell non-Hodgkin lymphoma, characterized by the presence of lymphoma cells exclusively in the lumina of small vessels, particularly capillaries.  This is an extremely aggressive lymphoma which responds poorly to chemotherapy.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4342</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2947252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute</VALIDVALUE>
          <VALUEMEANING>Acute Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>leukemia in which the involved cell shows little or no differentiation, usually consisting of blast cells; two types are distinguished, acute lymphocytic and acute myelogenous leukemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2590858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leiomyoma \ Hyalinized</VALIDVALUE>
          <VALUEMEANING>Hyalinized Stroma Formation</VALUEMEANING>
          <MEANINGDESCRIPTION>Replacement of tissue stromal elements by hyaline material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leiomyoma</VALIDVALUE>
          <VALUEMEANING>Leiomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A well-circumscribed benign smooth muscle neoplasm characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Langerhans Cell Histiocytosis/ Histiocytosis X</VALIDVALUE>
          <VALUEMEANING>Langerhans Cell Histiocytosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplastic proliferation of Langerhans cells which contain Birbeck granules by ultrastructural examination.  Three major overlapping syndromes are recognized: eosinophilic granuloma, Letterer-Siwe disease, and Hand-Schuller-Christian disease.  The clinical course is generally related to the number of organs affected at presentation.  (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3107</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ MALT - Mucosa Associated Lymphatic Tissue</VALIDVALUE>
          <VALUEMEANING>Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>MALT lymphoma.  A type of cancer that arises in cells in mucosal tissue that are involved in antibody production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ Lymphoplasmacytic (Waldenstrom&#39;s)</VALIDVALUE>
          <VALUEMEANING>Lymphoplasmacytic Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A clonal neoplasm of small B-lymphocytes, lymphoplasmacytoid cells, and plasma cells involving the bone marrow, lymph nodes, and the spleen. The majority of patients have a serum IgM paraprotein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2629954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ Follicular</VALIDVALUE>
          <VALUEMEANING>Follicular Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm of follicle centre B cells which has at least a partial follicular pattern.  Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide.  Most patients have widespread disease at diagnosis.  Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present.  The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)].  Histological grade correlates with prognosis.  Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088584</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ Diffuse Large B-Cell</VALIDVALUE>
          <VALUEMEANING>Diffuse Large B-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ CLL/SLL Chronic/Small Lymphocytic Leukemia</VALIDVALUE>
          <VALUEMEANING>Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An indolent, mature B-cell neoplasm composed of small, round B-lymphocytes. When the bone marrow and peripheral blood are involved, the term chronic lymphocytic leukemia is used. The term small lymphocytic lymphoma is restricted to cases which do not show leukemic involvement of the bone marrow and peripheral blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27911</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2837954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type \ Burkitt</VALIDVALUE>
          <VALUEMEANING>Burkitt Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures.  It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients.  Three morphologic variants are recognized: classical Burkitt&#39;s lymphoma, Burkitt&#39;s lymphoma with plasmacytoid differentiation, and atypical Burkitt&#39;s/Burkitt&#39;s-like lymphoma.  All cases express the MYC translocation [t(8;14)]. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2912</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature B-Cell Type</VALIDVALUE>
          <VALUEMEANING>Mature B-Cell Non-Hodgkin Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-Hodgkin lymphoma that originates from mature B lymphocytes. Representative examples include diffuse large B-cell lymphoma, follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, and small lymphocytic lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7056</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma \ Non Hodgkins</VALIDVALUE>
          <VALUEMEANING>Non-Hodgkin Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Distinct from Hodgkin&#39;s lymphoma both morphologically and biologically, NHL lymphoma is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss.  The clinical course varies according to the morphologic type.  NHL is clinically classified as indolent, aggressive, or having a variable clinical course.  NHL can be of B-or T-/NK-cell lineage. --2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2965201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma \ Precursor T-Cell</VALIDVALUE>
          <VALUEMEANING>T Lymphoblastic Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The most frequent type of lymphoblastic lymphoma.  It comprises approximately 85-90% of cases.  It is more frequently seen in adolescent males.  It frequently presents with a mass lesion in the mediastinum.  Pleural effusions are common.  (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6919</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma \ Hodgkin&#39;s</VALIDVALUE>
          <VALUEMEANING>Hodgkin&#39;s Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymphoma, previously known as Hodgkin&#39;s disease, characterized by the presence of Reed-Sternberg cells.  There are two distinct subtypes: nodular lymphocyte predominant Hodgkin&#39;s lymphoma and classical Hodgkin&#39;s lymphoma.  Hodgkin&#39;s lymphoma has a bimodal age distribution, and involves primarily lymph nodes.  Current therapy for Hodgkin&#39;s lymphoma has resulted in an excellent outcome and cure for the majority of patients. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9357</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma</VALIDVALUE>
          <VALUEMEANING>Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphangiectasia</VALIDVALUE>
          <VALUEMEANING>Lymphangiectasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Dilatation of the lymphatic vessels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251336</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Luteoma</VALIDVALUE>
          <VALUEMEANING>Ovarian Stromal Luteoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign ovarian stromal tumor in which more than 90% of the tumor cells resemble steroid hormone-secreting cells. Crystals of Reinke are not present. It occurs in post-menopausal women and it is usually associated with estrogenic effects.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3202</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low Grade Mucinous Cystic Tumor</VALIDVALUE>
          <VALUEMEANING>Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive mucinous cystic neoplasm that arises from the pancreas and is characterized by the presence of mild dysplasia and absence of mitotic figures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251340</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lobular Carcinoma In Situ</VALIDVALUE>
          <VALUEMEANING>Lobular Carcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lithiasis</VALIDVALUE>
          <VALUEMEANING>Lithiasis</VALUEMEANING>
          <MEANINGDESCRIPTION>The formation of stones (calculi) in the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97086</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipoma</VALIDVALUE>
          <VALUEMEANING>Lipoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, usually painless, well-circumscribed lipomatous tumor composed of adipose tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2974460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lipid Cell Tumors</VALIDVALUE>
          <VALUEMEANING>Ovarian Steroid Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An ovarian tumor in which the vast majority of the cells (more than 90% of the tumor cells) resemble steroid hormone-secreting cells. It usually presents with androgenic manifestations. Approximately one-third of the cases follow a malignant clinical course.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251344</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leydig Cell Tumor</VALIDVALUE>
          <VALUEMEANING>Leydig Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A sex cord-stromal tumor occurring in the testis and rarely in the ovary. It is predominantly or completely composed of Leydig cells which may contain crystals of Reinke. In males it usually presents as a painless testicular enlargement and it may be associated with gynecomastia and decreased libido. The majority of the cases have a benign clinical course. Approximately 10% of the cases have a malignant clinical course and metastasize. In females it may be associated with androgenic manifestations and it follows a benign clinical course.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia Cutis</VALIDVALUE>
          <VALUEMEANING>Leukemia Cutis</VALUEMEANING>
          <MEANINGDESCRIPTION>Cutaneous involvement by an acute or chronic leukemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88156</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meningioma \ Clear Cell</VALIDVALUE>
          <VALUEMEANING>Clear Cell Meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade II morphologic variant of meningioma characterized by the presence of clear glycogen-rich polygonal cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angiomatous Meningioma \ Atypical</VALIDVALUE>
          <VALUEMEANING>Atypical Meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade II meningioma with increased mitotic activity or three or more of the following features: increased cellularity, small cells with high nuclear to cytoplasm ratio, prominent nucleoli, uninterrupted patternless or sheet-like growth, and foci of spontaneous or geographic necrosis. (Adapted from WHO 2000.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4723</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meningioma \ Angiomatous (Vascular)</VALIDVALUE>
          <VALUEMEANING>Angiomatous Meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade I meningioma characterized by the presence of small and medium sized vessels that predominate over the meningioma cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4332</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melanoma \ Uveal</VALIDVALUE>
          <VALUEMEANING>Uveal Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melanoma \ Amelanotic</VALIDVALUE>
          <VALUEMEANING>Amelanotic Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A melanoma characterized by the complete absence of melanin pigment in the melanoma cells. It occurs more frequently on the face and it is often associated with desmoplastic reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3802</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melanoma</VALIDVALUE>
          <VALUEMEANING>Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medulloepithelioma</VALIDVALUE>
          <VALUEMEANING>Medulloepithelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, usually aggressive malignant embryonal neoplasm of the central nervous system occurring in children.  It is characterized by the presence of neuroepithelial cells which form papillary, trabecular, or tubular structures. Symptoms include headache, nausea, and vomiting.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medulloblastoma \ Large Cell</VALIDVALUE>
          <VALUEMEANING>Large Cell Medulloblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Large Cell Medulloblastoma is a variant of Medulloblastoma (about 4% of cases). Some features of the tumor cells are large, round and/or pleomorphic nuclei with prominent nucleoli and a more abundant cytoplasm than that found in the classic medulloblastoma. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medulloblastoma \ Anaplastic</VALIDVALUE>
          <VALUEMEANING>Anaplastic Medulloblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A medulloblastoma characterized by marked nuclear pleomorphism, and high mitotic activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medulloblastoma</VALIDVALUE>
          <VALUEMEANING>Medulloblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578699</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mastocytosis</VALIDVALUE>
          <VALUEMEANING>Mastocytosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A clonal myeloproliferative neoplasm characterized by the proliferation and accumulation of neoplastic mast cells in one or multiple organs or organ systems.  It is a heterogeneous group of neoplasms, ranging from cutaneous proliferations which may regress spontaneously, to aggressive neoplasms associated with organ failure and short survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoproliferative</VALIDVALUE>
          <VALUEMEANING>Lymphoproliferative Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis). --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3235573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphomatoid Granulomatosis</VALIDVALUE>
          <VALUEMEANING>Lymphomatoid Granulomatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>An angiocentric and angiodestructive lymphoproliferative disease involving extranodal sites, comprised of Epstein-Barr virus (EBV)-positive B-cells admixed with reactive T-cells.  Incidence is higher among adult males; patients with a history of immunodeficiency are at increased risk.  The most common site of involvement is the lung; other common sites include brain, kidney, liver, and skin.  Morphologically, three grades are recognized: grade I, II, and III.  Grade III lymphomatoid granulomatosis should be approached clinically as a subtype of diffuse large B-cell lymphoma. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7930</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature T-Cell Type \ T-Cell Prolymphocytic</VALIDVALUE>
          <VALUEMEANING>T-Cell Prolymphocytic Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive T-cell leukemia, characterized by the proliferation of small to medium sized prolymphocytes with a mature T-cell phenotype, involving the blood, bone marrow, lymph nodes, liver, spleen, and skin.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature T-Cell Type \ T-Cell Large Granular Lymphocytic</VALIDVALUE>
          <VALUEMEANING>T-Cell Large Granular Lymphocyte Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A T-cell peripheral neoplasm characterized by a persistent (&gt;6 months) increase in the number of peripheral blood large granular lymphocytes, without a clearly identified cause. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4664</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2590775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature T-Cell Type \ Peripheral T-Cell</VALIDVALUE>
          <VALUEMEANING>Unspecified Peripheral T-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Aggressive nodal or extranodal mature (peripheral) T-cell lymphomas that do not belong to the better defined entities of the remainder of mature T-cell lymphomas.  This category includes the lymphoepithelioid cell variant of mature T-cell lymphoma (Lennert&#39;s lymphoma) and the T-zone variant of mature T-cell lymphoma.--2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4340</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature T-Cell Type \ NK (Natural Killer) Cell, Nasal-Type</VALIDVALUE>
          <VALUEMEANING>Nasal Type Extranodal NK/T-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive, predominantly extranodal, mature T-cell non-Hodgkin lymphoma.  It is characterized by an often angiocentric and angiodestructive cellular infiltrate composed of EBV positive NK/T cells.  The nasal cavity is the commonest site of involvement.  Patients often present with midfacial destructive lesions (lethal midline granuloma).  The disease may disseminate rapidly to various anatomic sites including gastrointestinal tract, skin, testis, and cervical lymph nodes.  It is also known as angiocentric T-cell lymphoma.  The term &quot;polymorphic reticulosis&quot; has been widely used to describe the morphologic changes seen in this type of lymphoma.  However, the latter term may also apply to lymphomatoid granulomatosis which is an angiocentric and angiodestructive EBV positive B-cell lymphoproliferative disorder.  -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593089</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature T-Cell Type \ NK (Natural Killer) Cell Type</VALIDVALUE>
          <VALUEMEANING>Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad spectrum of lymphocyte morphology, but in all instances express T-cell markers admixed with epithelioid histiocytes, plasma cells, and eosinophils. Although markedly similar to large-cell immunoblastic lymphoma (LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC), this group&#39;s unique features warrant separate treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature T-Cell Type \ Mycosis Fungoides</VALIDVALUE>
          <VALUEMEANING>Mycosis Fungoides</VALUEMEANING>
          <MEANINGDESCRIPTION>A peripheral (mature) T-cell lymphoma presenting in the skin with patches/plaques. It is characterized by epidermal and dermal infiltration of small to medium-sized T-cells with cerebriform nuclei. Patients with limited disease generally have an excellent prognosis. In the more advanced stages, the prognosis is poor. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature T-Cell Type \ Hepatosplenic</VALIDVALUE>
          <VALUEMEANING>Hepatosplenic T-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An extranodal, mature T-cell non-Hodgkin lymphoma that originates from cytotoxic T-cells, usually of gamma/delta T-cell type.  It is characterized by the presence of medium-size neoplastic lymphocytes infiltrating the hepatic sinusoids.  A similar infiltrating pattern is also present in the spleen and bone marrow that are usually involved at the time of the diagnosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838581</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature T-Cell Type \ Enteropathy Type</VALIDVALUE>
          <VALUEMEANING>Enteropathy-type T-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon mature T-cell lymphoma of intraepithelial lymphocytes.  It usually arises from the small intestine, most commonly the jejunum or ileum.  Other less frequent primary anatomic sites include the duodenum, stomach, colon, or outside the gastrointestinal tract.  It is seen with increased frequency in regions with a high prevalence of celiac disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature T-Cell Type \ Angioimmunoblastic T-Cell</VALIDVALUE>
          <VALUEMEANING>Angioimmunoblastic T-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A mature T-cell non-Hodgkin lymphoma, characterized by systemic disease and a polymorphous infiltrate involving lymph nodes and extranodal sites.  The clinical course is typically aggressive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088583</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma Mature T-Cell Type \ Anaplastic Large Cell</VALIDVALUE>
          <VALUEMEANING>Anaplastic Large Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A peripheral (mature) T-cell lymphoma, consisting of usually large anaplastic, CD30 positive cells.  Majority of cases are positive for the anaplastic large cell lymphoma (ALK) protein.  The most frequently seen genetic alteration is a t(2;5) translocation.  Majority of patients present with advanced disease.  The most important prognostic indicator is ALK positivity, which has been associated with a favorable prognosis. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metaplasia \ Intestinal</VALIDVALUE>
          <VALUEMEANING>Intestinal Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the replacement of epithelial tissue outside the intestines by intestinal-type epithelium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metaplasia \ Glandular</VALIDVALUE>
          <VALUEMEANING>Glandular Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the alteration of the squamous or transitional epithelial cells to glandular cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8358</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metaplasia</VALIDVALUE>
          <VALUEMEANING>Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Transformation of a mature, normal cell or groups of mature cells to other forms of mature cells.  The capacity for malignant transformation of metaplastic cells is a subject of controversy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Uric Acid Disorder</VALIDVALUE>
          <VALUEMEANING>Hyperuricemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Elevated blood concentrations of uric acid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3961</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2938161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Porphyria</VALIDVALUE>
          <VALUEMEANING>Porphyria</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of genetic or acquired metabolic disorders characterized by defects in the enzymes that are involved in the heme synthesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Phosphorus Metabolic Disorder</VALIDVALUE>
          <VALUEMEANING>Phosphorus Metabolic Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A metabolic disorder that affects the phosphate homeostasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97095</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251362</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Oxalate Metabolic Disorder</VALIDVALUE>
          <VALUEMEANING>Calcium Oxalate Crystal Deposition</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding indicating the formation of calcium oxalate crystal deposits in an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97094</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Marfan&#39;s Syndrome</VALIDVALUE>
          <VALUEMEANING>Marfan Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A genetic syndrome inherited as an autosomal dominant trait.  It is caused by mutations in the FBN1 gene.  It is characterized by tall stature, elongated extremities, mitral valve prolapse, aortic dilatation, aortic dissection, and sublaxation of the lens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Lysosomal Storage Disease</VALIDVALUE>
          <VALUEMEANING>Lysosomal Storage Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of autosomal recessive or X-linked inherited metabolic disorders caused by defects in the function of the lysosomes.  Signs and symtoms include hepatomegaly, splenomegaly, nervous sytem manifestations, skeletal abnormalities, and mental deterioration.  Representative examples, include Gaucher disease, Neimann-Pick disease, Wolman disease, and Fabry disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Lipodystrophies</VALIDVALUE>
          <VALUEMEANING>Lipodystrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital or acquired disorder characterized by abnormal loss or redistribution of the adipose tissue in the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97093</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Lipid Metabolism Disorder</VALIDVALUE>
          <VALUEMEANING>Lipid Metabolism Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited metabolic disorder that affects the metabolism of the lipids.  Representative examples include Gaucher disease, Tay-Sachs disease, and Niemann-Pick disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Intermediary Metabolism Disorders</VALIDVALUE>
          <VALUEMEANING>Intermediary Metabolism Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>An inborn metabolic disorder affecting the intermediary metabolism process.  It results in accumulation of substances in the body that can cause acute or chronic intoxication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97091</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Inherited Disorder Of Amino Acid Metabolism &amp; Storage</VALIDVALUE>
          <VALUEMEANING>Amino Acid Metabolism Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited disorder that affects the metabolism of the amino acids.  Representative examples include alkaptonuria, homocystinuria, tyrosinemia, and phenylketonuria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97090</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Gout</VALIDVALUE>
          <VALUEMEANING>Gout</VALUEMEANING>
          <MEANINGDESCRIPTION>Hereditary metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of uric acid calculi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Carbohydrates Metabolism Disorder</VALIDVALUE>
          <VALUEMEANING>Carbohydrate Metabolism Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited or acquired disorder that affects the metabolism of the carbohydrates.  Representative examples include diabetes mellitus, glycogen storage disease, mucopolysaccharidoses, and lactose intolerance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metabolic Disease \ Amyloidosis</VALIDVALUE>
          <VALUEMEANING>Amyloidosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2868</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesothelioma</VALIDVALUE>
          <VALUEMEANING>Mesothelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm characterized by the proliferation of neoplastic mesothelial cells. It usually arises from the pleura or peritoneum. This category includes malignant mesothelioma, adenomatoid tumor (benign mesothelioma), well differentiated papillary mesothelial tumor, and multicystic mesothelioma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesoblastic Nephroma</VALIDVALUE>
          <VALUEMEANING>Congenital Mesoblastic Nephroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade childhood congenital malignant neoplasm arising from the kidney. It is characterized by the presence of fibroblastic cells. The majority of cases occur in the first year of life. Complete excision is usually associated with an excellent prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meningioma, Anaplastic</VALIDVALUE>
          <VALUEMEANING>Anaplastic (Malignant) Meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade III meningioma exhibiting histological features of frank malignancy that exceed the abnormalities present in atypical meningioma. Anaplastic meningiomas are usually fatal, with median survival of less than 2 years. (Adapted from WHO 2000.) - 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4051</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meningioma \ Transitional</VALIDVALUE>
          <VALUEMEANING>Transitional Meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade I meningioma characterized by the coexistence of meningothelial cells and fibrous architectural patterns.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4333</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma With Low Grade Dysplasia</VALIDVALUE>
          <VALUEMEANING>Colorectal Adenoma with Mild Dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenoma that arises from the colon or rectum.  It is characterized by the presence of mild epithelial dysplasia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247838</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma With High Grade Dysplasia</VALIDVALUE>
          <VALUEMEANING>Colorectal Adenoma with Severe Dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenoma that arises from the colon or rectum.  It is characterized by the presence of severe epithelial dysplasia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma - Villous</VALIDVALUE>
          <VALUEMEANING>Villous Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An epithelial neoplasm morphologically characterized by the presence of a villous architectural pattern. Most often it occurs in the large intestine, small intestine, and the stomach in which the neoplastic epithelial cells show dysplastic features. It may also arise in the urinary bladder, urethra, and vagina.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247842</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma - Tubulovillous</VALIDVALUE>
          <VALUEMEANING>Tubulovillous Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An epithelial neoplasm morphologically characterized by the presence of a villous and a tubular architectural pattern. Most often it occurs in the large intestine, small intestine, and the stomach in which the neoplastic epithelial cells show dysplastic features.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma - Tubular</VALIDVALUE>
          <VALUEMEANING>Tubular Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually polypoid neoplasm arising from the glandular epithelium. It is characterized by a tubular architectural pattern. The neoplastic glandular cells have dysplastic features. Representative examples include the tubular adenomas of the colon and rectum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4133</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma - Traditional Serrated</VALIDVALUE>
          <VALUEMEANING>Traditional Serrated Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenoma that arises from the large intestine and the appendix.  It is characterized by prominent serration of the glands and the presence of generalized low-grade dysplasia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma - Sessile Serrated</VALIDVALUE>
          <VALUEMEANING>Sessile Serrated Adenoma/Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A polyp that arises from the large intestine and the appendix.  It is characterized by the presence of serrated glands and the absence of generalized dysplasia.  Some authors have suggested that it is a precursor lesion for some colorectal adenocarcinomas with microsatellite instability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96414</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Virilization</VALIDVALUE>
          <VALUEMEANING>Virilization</VALUEMEANING>
          <MEANINGDESCRIPTION>The development of male secondary sex characteristics in a female or a prepubertal male.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79859</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2943853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ State Specific Hormone</VALIDVALUE>
          <VALUEMEANING>Functioning Pituitary Gland Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A hormone producing pituitary gland adenoma, associated with a hormonal syndrome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Sebaceous Lymphadenoma</VALIDVALUE>
          <VALUEMEANING>Salivary Gland Sebaceous Lymphadenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare benign epithelial tumor composed of irregular, proliferating nests and islands of epithelium, including solid and gland-like sebaceous elements, surrounded by lymphoid stroma. Most occur in the parotid gland. Symptoms include a progressively enlarging, painless mass.  Sebaceous lymphadenocarcinoma is the malignant counterpart. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Sebaceous</VALIDVALUE>
          <VALUEMEANING>Sebaceous Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, well circumscribed neoplasm arising from the sebaceous glands. It usually presents as a small yellowish tumor in the sun exposed skin of head and neck. It is characterized by the presence of sebaceous cells aggregates with a peripheral rim of basaloid cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Salivary Gland Subtype</VALIDVALUE>
          <VALUEMEANING>Salivary Gland Pleomorphic Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, slow-growing tumor composed of cells that demonstrate both epithelial and mesenchymal differentiation. It is the most common neoplasm of salivary gland origin, and mostly occurs in the parotid gland. The average age of patients has been reported to be 43 years; women are more often affected than men. The malignant change rate has been estimated to be 6%. The malignant counterpart is carcinoma ex pleomorphic adenoma. --2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Pleomorphic / Benign Mixed Tumor</VALIDVALUE>
          <VALUEMEANING>Mixed Tumor of the Skin (Chondroid Syringoma)</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, benign, slow-growing and painless neoplasm of sweat glands. It usually arises in the head and neck. It is characterized by the presence of a mesenchymal chondroid stroma, fibrosis, and epithelial structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Pleomorphic</VALIDVALUE>
          <VALUEMEANING>Pleomorphic Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm characterized by the presence of benign epithelial and myoepithelial cells and a mesenchymal component that may contain mucoid, myxoid, cartilaginous, or osseous areas. It may be completely or partially encapsulated. It occurs in the parotid gland, submandibular gland, minor salivary glands in the oral cavity, upper respiratory tract, and nasal cavity and paranasal sinuses. It usually presents as a slow growing painless mass. Infrequently, patients may present with pain and facial palsy. It may recur after excision or transform to a malignant neoplasm (carcinoma ex pleomorphic adenoma).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8602</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Papillary Adenoma</VALIDVALUE>
          <VALUEMEANING>Papillary Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenoma characterized by the presence of papillary epithelial patterns.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Non-Functional</VALIDVALUE>
          <VALUEMEANING>Non-Functioning Adrenal Cortex Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenoma of the adrenal cortex characterized by the absence of a hormonal syndrome or symptoms suggestive of adrenal disease. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Multiple Endocrine Neoplasm (Men) Type 1</VALIDVALUE>
          <VALUEMEANING>Multiple Endocrine Neoplasia Type 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple endocrine neoplasia caused by inactivation of the tumor suppressor gene MEN-1. Patients may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Mucus Gland</VALIDVALUE>
          <VALUEMEANING>Lung Mucus Gland Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign adenomatous neoplasm that arises from the mucous glands in the bronchus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5664</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Metanephric Adenoma</VALIDVALUE>
          <VALUEMEANING>Metanephric Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, well-circumscribed renal cortical neoplasm affecting females more often than males.  Polycythemia has been reported in twelve-percent of patients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Lipoadenoma</VALIDVALUE>
          <VALUEMEANING>Lipoadenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenoma in which the neoplastic epithelial cells are admixed with adipose tissue cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Hurthle Cell</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland Oncocytic Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A thyroid gland adenoma composed of large cells with abundant granular eosinophilic cytoplasm and large nuclei with prominent nucleoli. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Follicular</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland Follicular Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, encapsulated tumor, arising from the follicular cells of the thyroid gland. It may be associated with thyroid hormone secretion but it does not have malignant characteristics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Cushing&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Cushing Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A syndrome caused by high levels of cortisol in the blood either due to excessive production and secretion of corticosteroids secondary to pituitary or adrenocortical neoplasms, or intake of glucocorticoid drugs. Signs and symptoms include a round face, upper body obesity, fragile and thin skin, purple stretch marks in the skin, fatigue, muscle weakness, hypertension, diabetes mellitus, hypertrichosis and amenorrhea in women, impotence in men, and osteoporosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Conns Syndrome</VALIDVALUE>
          <VALUEMEANING>Conn Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An endocrine disorder characterized by excessive production of aldosterone by the adrenal glands. Causes include adrenal gland adenoma and adrenal gland hyperplasia. The overproduction of aldosterone results in sodium and water retention and hypokalemia. Patients present with high blood pressure, muscle weakness, and headache.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Canalicular</VALIDVALUE>
          <VALUEMEANING>Salivary Gland Canalicular Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign epithelial neoplasm primarily composed of branching and interconnecting cords of single and double-cell thick rows of columnar epithelium in a very loose stroma. It often occurs in the upper lip, where only pleomorphic adenoma is more frequent. Asymptomatic swelling of the upper lip is the most common clinical finding. It may present clinically and histologically as a multifocal lesion, a feature not generally seen with other intraoral salivary gland tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5979</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Basal Cell</VALIDVALUE>
          <VALUEMEANING>Salivary Gland Basal Cell Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign epithelial neoplasm with a uniform, monomorphic appearance that is dominated by basal cells forming trabecular structures. It is rare, and occurs mostly on the parotid gland. The average age of patients has been reported to be 58 years. Swelling is the most constant clinical finding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Alveolar</VALIDVALUE>
          <VALUEMEANING>Alveolar Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, well circumscribed lung neoplasm morphologically characterized by the presence of cystic spaces resembling alveoli, lined by a simple cuboidal epithelium. The cystic spaces are surrounded by a spindle cell stroma which may show myxoid changes. It is a solitary, usually peripheral lung lesion. Patients are usually asymptomatic and its discovery is an incidental finding during chest X-ray examination. Surgical excision is curative.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma</VALIDVALUE>
          <VALUEMEANING>Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm arising from the glandular epithelium.  It may be encapsulated or non-encapsulated.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenofibroma \ Metanephric Adenofibroma</VALIDVALUE>
          <VALUEMEANING>Metanephric Adenofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, solitary, and partially cystic neoplasm arising from the kidney. It occurs in children and adults. Presenting symptoms include hematuria and polycythemia. It is characterized by the presence of epithelial nodules embedded in a stroma containing spindle cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39812</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenofibroma</VALIDVALUE>
          <VALUEMEANING>Adenofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign neoplasm characterized by the presence of connective tissue stroma and epithelial structures. It occurs in the ovary, fallopian tube, uterine corpus, and cervix. Cases of adenofibroma of the ovary with low grade malignant potential have also been reported.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8984</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adamatinoma</VALIDVALUE>
          <VALUEMEANING>Adamantinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade malignant tumor arising from the bones.  The tibia is the most commonly affected site.  Swelling with or without pain is the most frequently reported clinical symptom.  The vast majority of cases recur if they are not treated with radical surgery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Actinic Keratosis</VALIDVALUE>
          <VALUEMEANING>Actinic (Solar) Keratosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A precancerous lesion of the skin composed of atypical keratinocytes. It is characterized by the presence of thick, scaly patches of skin. Several histologic variants have been described, including atrophic, acantholytic, and hyperkeratotic variants.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3148</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581230</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acanthoma \ Pilar Sheath</VALIDVALUE>
          <VALUEMEANING>Pilar Sheath Acanthoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, small, papular or nodular skin neoplasm that usually arises above the upper lip. It is characterized by an epithelial proliferation with a central cavity. The cavity wall is lined with keratinocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acanthoma \ Pale (Clear) Closed Cell</VALIDVALUE>
          <VALUEMEANING>Clear Cell Acanthoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An acanthoma characterized by the presence of psoriasiform epidermal acanthosis and basal cells with pale cytoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97041</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acanthoma \ Epidermonic</VALIDVALUE>
          <VALUEMEANING>Epidermolytic Acanthoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign epithelial verrucous lesion of the skin. Morphologically, it is characterized by the presence of epidermolytic hyperkeratosis and papillomatosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acanthoma \ Acantholytaic</VALIDVALUE>
          <VALUEMEANING>Acantholytic Acanthoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign epithelial neoplasm of the skin. It presents as a papular or nodular lesion. Morphologically, it is characterized by the presence of hyperkeratosis, acanthosis, papillomatosis, and prominent acantholysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abscess</VALIDVALUE>
          <VALUEMEANING>Abscess</VALUEMEANING>
          <MEANINGDESCRIPTION>Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dysplasia \ Urothelial</VALIDVALUE>
          <VALUEMEANING>Urothelial Dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the presence of dysplastic changes in the transitional cell epithelium of the urinary tract.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39856</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dysplasia \ Low Grade</VALIDVALUE>
          <VALUEMEANING>Low Grade Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A precancerous neoplastic process that affects the squamous, glandular, or transitional cell epithelium without evidence of invasion. It is characterized by the presence of mild epithelial dysplasia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249002</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dysplasia \ Intrahepatic Bile Duct</VALIDVALUE>
          <VALUEMEANING>Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplastic, non-invasive lesion that affects the intrahepatic bile duct epithelium.  It is characterized by the presence of atypical epithelial cells with an increased nuclear/cytoplasmic ratio, nuclear hyperchromasia, and loss of nuclear polarity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96943</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dysplasia \ High Grade</VALIDVALUE>
          <VALUEMEANING>High Grade Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A precancerous neoplastic process that affects the squamous, glandular, or transitional cell epithelium without evidence of invasion. According to the degree of nuclear atypia, number of mitotic figures, and presence of architectural distortion, it is classified as grade II (moderate dysplasia) or grade III (severe dysplasia).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dysplasia</VALIDVALUE>
          <VALUEMEANING>Dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns.  The cellular changes include nuclear and cytoplasmic abnormalities.  Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4086</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dysgerminoma</VALIDVALUE>
          <VALUEMEANING>Dysgerminoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant germ cell tumor arising from the ovary.  Morphologically, it is identical to seminoma and consists of a monotonous population of germ cells with abundant pale cytoplasm and uniform nuclei.  The stroma invariably contains chronic inflammatory cells, mostly T-lymphocytes. It responds to chemotherapy or radiotherapy and the prognosis relates to the tumor stage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8106</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ductal Carcinoma In Situ \ Solid</VALIDVALUE>
          <VALUEMEANING>Ductal Breast Carcinoma In Situ, Solid Type</VALUEMEANING>
          <MEANINGDESCRIPTION>A ductal carcinoma in situ of the breast in which the tumor cells fill the ductal spaces as solid sheets.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ductal Carcinoma In Situ \ Mixed</VALIDVALUE>
          <VALUEMEANING>Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>The co-existence of ductal and lobular carcinoma in situ in the breast, without evidence of stromal invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ductal Carcinoma In Situ \ Micropapillary</VALIDVALUE>
          <VALUEMEANING>Intraductal Micropapillary Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An intraductal papillary carcinoma in which the neoplastic epithelial cells are arranged in micropapillary patterns.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5139</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ductal Carcinoma In Situ \ Low Grade</VALIDVALUE>
          <VALUEMEANING>Low Grade Ductal Breast Carcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>Ductal breast carcinoma in situ characterized by the presence of small, monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. The nuclei are uniform and mitotic figures are rare.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ductal Carcinoma In Situ \ Intermediate Grade</VALIDVALUE>
          <VALUEMEANING>Intermediate Grade Ductal Breast Carcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>Ductal breast carcinoma in situ characterized by the presence of monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. Intraluminal necrosis is present in some ducts. Ducts that contain neoplastic cells with occasional nucleoli and coarse chromatin may also be present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ductal Carcinoma In Situ \ High Grade</VALIDVALUE>
          <VALUEMEANING>High Grade Ductal Breast Carcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>A ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ductal Carcinoma In Situ \ Cribriform</VALIDVALUE>
          <VALUEMEANING>Intraductal Cribriform Breast Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A ductal carcinoma in situ of the breast characterized by the presence of a cribriform architectural pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5138</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meningioma \ Psammomatous (Mineralized)</VALIDVALUE>
          <VALUEMEANING>Psammomatous Meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade I meningioma characterized by the presence of psammoma bodies that predominate over the meningeal cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4331</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meningioma \ Papillary</VALIDVALUE>
          <VALUEMEANING>Papillary Meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare WHO grade III meningioma defined by the presence of a perivascular pseudopapillary pattern in at least part of the tumor. They are clinically aggressive. (Adapted from WHO 2000.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meningioma \ Fibroblastic</VALIDVALUE>
          <VALUEMEANING>Fibrous Meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade I meningioma characterized by the presence of spindle cells that form bundles in a collagen matrix.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4330</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meningioma \ Epithelioid</VALIDVALUE>
          <VALUEMEANING>Secretory Meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade I meningioma characterized by the presence of epithelial differentiation and numerous intracellular PAS positive bodies that are rich in glycogen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed Mullerian Tumor</VALIDVALUE>
          <VALUEMEANING>Mixed Mesodermal (Mullerian) Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of tumors affecting the female reproductive system, characterized by the presence of epithelial and stromal elements. It includes the following clinicopathological entities: adenofibroma, adenomyoma, Mullerian adenosarcoma, and malignant mixed mesodermal (Mullerian) tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3730</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed Epithelial Stromal Tumor (Cystic Nephroma)</VALIDVALUE>
          <VALUEMEANING>Mixed Epithelial Stromal Tumor of the Kidney Cystic Nephroma</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists: A benign encapsulated neoplasm of the kidney, characterized by the presence of cysts separated by septa. There are no solid areas present. The septa are lined by one layer of epithelial cells that have eosinophilic or clear cytoplasm. The cystic spaces contain serous or hemorrhagic fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7504, C37263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed Epithelial \ Borderline</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Mixed Epithelial Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade ovarian epithelial tumor composed of an admixture of two or more of the five major cell types: serous, mucinous, endometrioid, clear cell, and Brenner/transitional.  The second or second and third cell types must comprise alone or together at least 10% of the tumor epithelium. The majority of patients present with stage I tumor and a minority present with bilateral disease. Morphologically, it shows papillae with detached cell clusters.  Microinvasion may be seen rarely. (WHO 2003)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed Epithelial</VALIDVALUE>
          <VALUEMEANING>Ovarian Mixed Epithelial Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, malignant, or borderline epithelial neoplasm that arises from the ovary. It is composed of an admixture of two or more of the following cell types: mucinous, serous, clear, transitional, and endometrioid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed Carcinoid-Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Appendix Goblet Cell Carcinoid</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive mixed adenoneuroendocrine carcinoma of the appendix characterized by a submucosal growth and the presence of neoplastic signet-ring cells resembling goblet cells of the intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3689</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mineral Metabolism Disorders \ Zinc Storage Disease</VALIDVALUE>
          <VALUEMEANING>Zinc Deficiency Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A genetic or acquired metabolic disorder that is associated with zinc deficiency in the tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mineral Metabolism Disorders \ Wilson&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Wilson Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive inherited disorder caused by mutations in the ATP7B gene. It is characterized by copper accumulation in the tissues, particularly brain and liver. It results in liver failure, neurologic, and psychotic manifestations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mineral Metabolism Disorders \ Nickel Storage Disease</VALIDVALUE>
          <VALUEMEANING>Nickel Metabolic Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A storage disorder that results from impaired metabolism of nickel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mineral Metabolism Disorders \ Magnesium Storage Disease</VALIDVALUE>
          <VALUEMEANING>Hypermagnesemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypermagnesemia; higher than normal levels of magnesium in the circulating blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mineral Metabolism Disorders \ Iron Storage Disease</VALIDVALUE>
          <VALUEMEANING>Iron Storage Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mineral Metabolism Disorders \ Hemosiderosis</VALIDVALUE>
          <VALUEMEANING>Hemosiderosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Accumulation of iron in internal organs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82892</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mineral Metabolism Disorders \ Hemochromatosis</VALIDVALUE>
          <VALUEMEANING>Hemochromatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited metabolic disorder characterized by iron accumulation in the tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3171844</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mineral Metabolism Disorders \ Copper Storage Disease</VALIDVALUE>
          <VALUEMEANING>Hepatolenticular Degeneration</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive inherited disorder caused by mutations in the ATP7B gene. It is characterized by copper accumulation in the tissues, particularly brain and liver. It results in liver failure, neurologic, and psychotic manifestations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mineral Metabolism Disorders \ Calcium Storage Disease</VALIDVALUE>
          <VALUEMEANING>Calcification</VALUEMEANING>
          <MEANINGDESCRIPTION>Deposition of calcium in the tissues.  It may be the result of a metabolic disorder or long-standing infection, or it may be associated with the presence of cancer. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3672</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mineral Metabolism Disorders \ Cadmium Storage Disease</VALIDVALUE>
          <VALUEMEANING>Cadmium Deposition</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding indicating the presence of cadmium mineral deposits in an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97098</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metaplasia \ Squamous</VALIDVALUE>
          <VALUEMEANING>Squamous Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the transformation of glandular or transitional epithelial cells to, usually, mature squamous epithelial cells. Representative examples include squamous metaplasia of bronchial epithelium, cervix, urinary bladder, and prostate gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metaplasia \ Spindle Cell</VALIDVALUE>
          <VALUEMEANING>Spindle Cell Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the transformation of non-spindle cells to spindle-shaped cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54709</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metaplasia \ Other</VALIDVALUE>
          <VALUEMEANING>Other Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Transformation of a mature, normal cell or groups of mature cells to other forms of mature cells.  The capacity for malignant transformation of metaplastic cells is a subject of controversy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3236, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metaplasia \ Nephrogenic</VALIDVALUE>
          <VALUEMEANING>Nephrogenic Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A reactive metaplastic change in the urinary tract epithelium.  The metaplastic changes in the epithelium resemble renal tubular structures.  It can occur following surgical procedures, inflammation, stone formation, or trauma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metaplasia \ Morular</VALIDVALUE>
          <VALUEMEANING>Morular Metaplasia of the Endometrium</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the replacement of part of the glandular endometrial epithelium by nodular structures that contain non-keratinizing squamous cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pheochromocytoma \ Multiple Endocrine Neoplasm (MEN) Type 2A</VALIDVALUE>
          <VALUEMEANING>Multiple Endocrine Neoplasia Type 2A</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple endocrine neoplasia caused by mutation of the RET gene. Patients develop medullary thyroid carcinomas, and may also develop pheochromocytomas and parathyroid gland hyperplasia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3226</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pheochromocytoma \ Multiple Endocrine Neoplasm (MEN) Type 2B</VALIDVALUE>
          <VALUEMEANING>Multiple Endocrine Neoplasia Type 2B</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple endocrine neoplasia caused by mutation of the RET gene. Patients develop medullary thyroid carcinomas and numerous neural defects including neuromas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ductal Carcinoma In Situ \ Apocrine</VALIDVALUE>
          <VALUEMEANING>Apocrine Breast Carcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>A ductal breast carcinoma in situ, characterized by the presence of neoplastic epithelial cells with apocrine differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epulides</VALIDVALUE>
          <VALUEMEANING>Congenital Epulis</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital gingival tumor that occurs along the alveolar ridge of the maxilla. It usually affects female infants. The histogenesis is unknown. Morphologically, it is characterized by the presence of large cells with eosinophilic granular cytoplasm. Complete surgical resection is curative.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4675</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ependymoma, Anaplastic</VALIDVALUE>
          <VALUEMEANING>Anaplastic Ependymoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Anaplastic Ependymoma (WHO grade III) is a malignant glioma of ependymal origin with accelerated growth and an unfavorable clinical outcome, particularly in children. Anaplastic Ependymomas show high mitotic activity, often accompanied by microvascular proliferation and pseudo-palisading necrosis. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4049</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ependymoma \ Tanycytic</VALIDVALUE>
          <VALUEMEANING>Tanycytic Ependymoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A variant of Ependymoma, often found in the spinal cord, with tumor cells arranged in fascicles of variable width and cell density. Ependymal rosettes are generally absent, so this lesion must be distinguished from astrocytic neoplasms, but its EM characteristics are ependymal. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ependymoma \ Papillary</VALIDVALUE>
          <VALUEMEANING>Papillary Ependymoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare variant of ependymoma characterized by well formed papillae. Tumor cell processes abutting capillaries are usually GFAP-positive. Differential diagnoses include choroid plexus papilloma, papillary meningioma and metastatic papillary carcinomas. (Adapted from WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4319</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ependymoma \ Myxopapillary</VALIDVALUE>
          <VALUEMEANING>Myxopapillary Ependymoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Myxopapillary Ependymomas (WHO grade I) are slow growing gliomas which generally occur in young adults and arise almost exclusively in the conus-cauda-filum terminale region. It generally has a favorable prognosis and is characterized histologically by tumor cells arranged in a papillary manner around vascularized mucoid stromal cores. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3697</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ependymoma \ Hyperplastic/Metaplastic Subtype</VALIDVALUE>
          <VALUEMEANING>Hyperplasia Metaplastic Subtype Ependymoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.: Pertaining to or characterized by metaplasia.: Subtype; a group forming a type within a larger type.: Ependymoma (WHO grade II) is the most common ependymal neoplasm. It is a slow growing tumor of children and young adults and is usually located intraventricularly.  It often causes clinical symptoms by blocking CSF pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes.(Adapted from WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3017, C25696, C25566, C3113</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249047</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometriosis</VALIDVALUE>
          <VALUEMEANING>Endometriosis</VALUEMEANING>
          <MEANINGDESCRIPTION>The growth of functional endometrial tissue in anatomic sites outside the uterine body. It most often occurs in the pelvic organs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3014</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrial Stromal Tumors</VALIDVALUE>
          <VALUEMEANING>Endometrial Stromal Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A mesenchymal gynecologic neoplasm. It is classified as endometrial stromal nodule or endometrial stromal sarcoma. Endometrial stromal nodule has been described in the uterine corpus and it is characterized by the lack of infiltration of the surrounding tissues. Endometrial stromal sarcoma affects the uterine corpus, ovaries, cervix, and vagina. It is characterized by an infiltrative growth pattern and is subdivided into low grade and undifferentiated (high grade) endometrial stromal sarcoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249049</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Tumor, Functional \ Somatostatinoma</VALIDVALUE>
          <VALUEMEANING>Pancreatic Somatostatinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neuroendocrine tumor arising from the delta cells of the pancreas.  It is characterized by inappropriate secretion of somatostatin and associated with diabetes mellitus, hypochlorhydria, gallbladder disease, diarrhea, steatorrhea, anemia, and weight loss.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Tumor, Functional \ Pancreatic Polypeptide Producing</VALIDVALUE>
          <VALUEMEANING>Pancreatic Polypeptide Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant neuroendocrine tumor that arises from the pancreas and secretes pancreatic polypeptide.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Tumor, Functional \ Other Hormone</VALIDVALUE>
          <VALUEMEANING>Other Hormone Endocrine Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.: A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ. --2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3010, C2315, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Tumor, Functional \ Multiple Endocrine Neoplasm (MEN) Type 1 &amp; 2</VALIDVALUE>
          <VALUEMEANING>Multiple Endocrine Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant inherited neoplastic syndrome characterized by the development of various endocrine neoplasms and abnormalities in various anatomic sites. There are three types recognized: type 1 (MEN 1), caused by inactivation of the tumor suppressor gene MEN-1, type 2A (MEN 2A), caused by mutation of the RET gene, and type 2B (MEN 2B) also caused by mutation of the RET gene. Patients with MEN 1 may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors. Patients with MEN 2A develop medullary thyroid carcinomas, and may also develop pheochromocytomas and parathyroid gland hyperplasia. Patients with MEN 2B develop medullary thyroid carcinomas and numerous neural defects including neuromas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Tumor, Functional \ Insulinoma</VALIDVALUE>
          <VALUEMEANING>Pancreatic Insulinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An insulin-producing neuroendocrine tumor arising from the beta cells of the pancreas.  Patients exhibit symptoms related to hypoglycemia due to inappropriate secretion of insulin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95598</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Tumor, Functional \ Glucagonoma</VALIDVALUE>
          <VALUEMEANING>Pancreatic Glucagonoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually malignant, glucagon-producing neuroendocrine tumor arising from the pancreatic alpha cells. It may be associated with necrolytic erythema migrans, diarrhea, diabetes, glossitis, weight loss, malabsorption, and anemia. Almost 25% of patients experience thromboembolic complications, and 50% have liver metastases at the time of diagnosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95597</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Tumor, Functional \ Gastrinoma</VALIDVALUE>
          <VALUEMEANING>Gastrin-Producing Neuroendocrine Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A gastrin-producing neuroendocrine tumor. It is usually located in the pancreas but it is also found at other anatomic sites, including the stomach and small intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3050</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Disorders \ Thyroiditis</VALIDVALUE>
          <VALUEMEANING>Thyroiditis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the thyroid gland. Thyroiditis may be an autoimmune disease that affects the thyroid gland over time, causing hypothyroidism (too little thyroid hormone). A temporary form of thyroiditis may also occur after the birth of a baby, or when viral or bacterial infections spread to the thyroid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Disorders \ Reidel&#39;s Thyroiditis</VALIDVALUE>
          <VALUEMEANING>Riedel Fibrosing Thyroiditis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory disorder of unknown etiology that affects the thyroid gland. It is characterized by extensive fibrosis of the thyroid parenchyma. The fibrosis extends beyond the thyroid gland capsule to the adjacent structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35827</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Disorders \ Multiple Endocrine Neoplasia</VALIDVALUE>
          <VALUEMEANING>Multiple Endocrine Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant inherited neoplastic syndrome characterized by the development of various endocrine neoplasms and abnormalities in various anatomic sites. There are three types recognized: type 1 (MEN 1), caused by inactivation of the tumor suppressor gene MEN-1, type 2A (MEN 2A), caused by mutation of the RET gene, and type 2B (MEN 2B) also caused by mutation of the RET gene. Patients with MEN 1 may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors. Patients with MEN 2A develop medullary thyroid carcinomas, and may also develop pheochromocytomas and parathyroid gland hyperplasia. Patients with MEN 2B develop medullary thyroid carcinomas and numerous neural defects including neuromas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Disorders \ Granulomatous Thyroiditis (Dequervain)</VALIDVALUE>
          <VALUEMEANING>Subacute Granulomatous Thyroiditis</VALUEMEANING>
          <MEANINGDESCRIPTION>Self-limited inflammation of the thyroid gland characterized by the presence of multinucleated giant cells. Patients present with neck pain, often associated with fever and dysphagia. The clinical course includes an initial phase of hyperthyroidism, followed by a phase of hypothyroidism, and eventually a return to normal thyroid function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Disorders \ Diabetes Mellitus</VALIDVALUE>
          <VALUEMEANING>Diabetes Mellitus</VALUEMEANING>
          <MEANINGDESCRIPTION>(dye-a-BEE-teez) A disease in which the body does not properly control the amount of sugar in the blood. As a result, the level of sugar in the blood is too high. This disease occurs when the body does not produce enough insulin or does not use it properly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ectopic</VALIDVALUE>
          <VALUEMEANING>Ectopia</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal position of a part or organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2966752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eccrine Tumor \ Any Benign/Hyperplastic/Metaplastic Subtype</VALIDVALUE>
          <VALUEMEANING>Benign Eccrine Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-metastasizing eccrine appendage sweat gland neoplasm. Representative examples include hidrocystoma, syringoma, and syringofibroadenoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eaton Lambert Syndrome</VALIDVALUE>
          <VALUEMEANING>Lambert Eaton Myasthenic Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autoimmune presynaptic disorder characterized by impairment of the impulse transmission at the neuromuscular junction. It affects predominantly the proximal muscles of the lower extremities, resulting in muscle weakness and fatigability. It has been associated with small cell lung carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dysplasia In Nodule</VALIDVALUE>
          <VALUEMEANING>Liver Dysplastic Nodule</VALUEMEANING>
          <MEANINGDESCRIPTION>A premalignant neoplastic nodular lesion of the liver that usually measures less than 15 mm.  It is found during microscopic examination of liver tissues, usually in cirrhotic livers.  Based on the degree of atypia, it is classified as low or high grade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7656</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine Tumor</VALIDVALUE>
          <VALUEMEANING>Endocrine Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ. --2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3010</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibromatosis \ Peyronie&#39;s</VALIDVALUE>
          <VALUEMEANING>Peyronie&#39;s Penile Fibromatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibromatosis arising from the soft tissues of the penis. It is characterized by the presence of spindle-shaped fibroblasts, and an infiltrative growth pattern.  It causes the penis to bend when it becomes erect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibromatosis \ Penile</VALIDVALUE>
          <VALUEMEANING>Penile Fibromatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibromatosis arising from the soft tissues of the penis. It is characterized by the presence of spindle-shaped fibroblasts, and an infiltrative growth pattern.  It causes the penis to bend when it becomes erect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibromatosis \ Inflammatory Myloblastic</VALIDVALUE>
          <VALUEMEANING>Inflammatory Myofibroblastic Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A multinodular intermediate fibrocytic neoplasm that arises from soft tissue or viscera, in children and young adults.  It is characterized by the presence of spindle-shaped myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibromatosis \ Desmoid</VALIDVALUE>
          <VALUEMEANING>Deep Fibromatosis/Desmoid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An insidious, locally aggressive, poorly circumscribed neoplasm arising from the deep soft tissues. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It lacks metastatic potential.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroma \ Hyperplastic/Metaplastic Subtype</VALIDVALUE>
          <VALUEMEANING>Hyperplasia Metaplastic Subtype Fibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.: Pertaining to or characterized by metaplasia.: Subtype; a group forming a type within a larger type.: A benign tumor of fibrous or fully developed connective tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3041, C25696, C25566, C3113</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroma \ Chondromyxoid</VALIDVALUE>
          <VALUEMEANING>Chondromyxoid Fibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon benign neoplasm arising from the bone. It is characterized by the presence of spindle-shaped or stellate chondrocytes, a lobulated growth pattern, myxoid stroma formation, and sometimes multinucleated giant cells. It has been associated with chromosomal rearrangement of 6q13 and 6q25 bands. The most common clinical symptom is mild, localized pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3830</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroma</VALIDVALUE>
          <VALUEMEANING>Fibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign tumor of fibrous or fully developed connective tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3041</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2974458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrocystic Changes \ Sclerosing Adenosis</VALIDVALUE>
          <VALUEMEANING>Breast Sclerosing Adenosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign condition in which scar-like tissue is found in a gland, such as the breast lobules or the prostate. A biopsy may be needed to tell the difference between the abnormal tissue and cancer. Women with sclerosing adenosis of the breast may have a slightly increased risk of breast cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrocystic Changes \ Papillary Apocrine Change</VALIDVALUE>
          <VALUEMEANING>Apocrine Metaplasia of Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the transformation of the epithelial cells in a breast tissue sample to cells with abundant eosinophilic cytoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7759</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrocystic Changes \ Cyst Formation</VALIDVALUE>
          <VALUEMEANING>Cyst Formation</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the presence of cystic structures in a tissue sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrocystic Changes \ Adenosis</VALIDVALUE>
          <VALUEMEANING>Breast Adenosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic disorder characterized by epithelial and/or myoepithelial tissue growth in the breast lobules.  It may be associated with apocrine changes or sclerosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroblastoma \ Giant Cell</VALIDVALUE>
          <VALUEMEANING>Giant Cell Fibroblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An intermediate cutaneous fibrohistiocytic neoplasm typically affecting young patients (predominantly boys), characterized by painless nodules in the dermis or subcutaneous tissues. Morphologically, it contains giant cells and wide vessel-like spaces.  This tumor can recur, but metastases have not been reported.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4700</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroadenoma</VALIDVALUE>
          <VALUEMEANING>Fibroadenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>This is the most common benign breast lesion.  It usually occurs in premenopausal women.  Diagnostic exams and procedures include: clinical exam, imaging (mammography and ultra sound), and tissue biopsy (fine-needle aspiration or core biopsy). -2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Female Adnexal Tumor Of Wolffian Origin</VALIDVALUE>
          <VALUEMEANING>Wolffian Adnexal Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant epithelial neoplasm of probable Wolffian origin. It predominantly arises from the broad ligament and presents as a unilateral adnexal mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extramedullary Hematopoiesis \ Adult</VALIDVALUE>
          <VALUEMEANING>Adult Extramedullary Hematopoiesis</VALUEMEANING>
          <MEANINGDESCRIPTION>Extramedullary hematopoiesis occurring during adulthood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97068</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extramedullary Hematopoiesis</VALIDVALUE>
          <VALUEMEANING>Extramedullary Hematopoiesis</VALUEMEANING>
          <MEANINGDESCRIPTION>Hematopoiesis that occurs outside of the bone marrow. It occurs during fetal development or it may result from pathologic processes that affect the bone marrow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41235</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Explant (Not Native Organ) \ Any Disease</VALIDVALUE>
          <VALUEMEANING>Explant Due To Any Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Donor tissue that is removed due to rejection.: Caused by or resulting from.: One, some, every, or all without specification.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C81168, C89272, C97326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Essential Thrombocythemia</VALIDVALUE>
          <VALUEMEANING>Essential Thrombocythemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic myeloproliferative disorder that involves primarily the megakaryocytic lineage and it is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or hemorrhage.  The cause is unknown.  Median survival times of 10-15 years are commonly reported.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagitis \ Viral</VALIDVALUE>
          <VALUEMEANING>Viral Esophagitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Viral infection of the esophagus. It often occurs in immunocompromised patients and it is caused by cytomegalovirus or herpes simplex virus. Symptoms include pain on swallowing, fever, and retrosternal burning.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27108</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagitis \ Fungal</VALIDVALUE>
          <VALUEMEANING>Fungal Esophagitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Infection of the esophagus caused by fungi, most often candida albicans and candida tropicalis. It usually affects patients with immunodeficiency disorders or diabetes mellitus. Symptoms include dysphagia and pain on swallowing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27107</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagitis \ Eosinophilic Esophagitis</VALIDVALUE>
          <VALUEMEANING>Eosinophilic Esophagitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Allergic inflammation of the esophagus. Morphologically, it is characterized by the presence of eosinophils infiltrating the esophageal epithelium. Patients present with swallowing difficulty and heartburn.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27105</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagitis \ Chronic</VALIDVALUE>
          <VALUEMEANING>Chronic Esophagitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic inflammatory process affecting the esophageal wall.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97067</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagitis \ Bacterial</VALIDVALUE>
          <VALUEMEANING>Bacterial Esophagitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute bacterial infection that affects the esophagus. Symptoms include severe pain on swallowing and retrosternal pain. Endoscopic examination reveals esophageal mucosal ulcerations and pseudomembranous formations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27106</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249241</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagitis \ Acute</VALIDVALUE>
          <VALUEMEANING>Acute Esophagitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute inflammatory process affecting the esophageal wall.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97066</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Metaplasia \ Without Atypia</VALIDVALUE>
          <VALUEMEANING>Squamous Metaplasia Without Atypia</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the transformation of glandular or transitional epithelial cells to squamous epithelial cells that lack atypical features.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Metaplasia</VALIDVALUE>
          <VALUEMEANING>Squamous Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the transformation of glandular or transitional epithelial cells to, usually, mature squamous epithelial cells. Representative examples include squamous metaplasia of bronchial epithelium, cervix, urinary bladder, and prostate gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Teratoma \ Mature</VALIDVALUE>
          <VALUEMEANING>Mature Teratoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A teratoma which may be cystic; it is composed entirely of well differentiated, adult-type tissues, without evidence of fetal-type tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9015</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Teratoma</VALIDVALUE>
          <VALUEMEANING>Teratoma</VALUEMEANING>
          <MEANINGDESCRIPTION>(ter-a-TOW-ma) A type of germ cell tumor that may contain several different types of tissue, such as hair, muscle, and bone.  Teratomas occur most often in the ovaries in women, the testicles in men, and the tailbone in children.  Not all teratomas are malignant.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3116442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tendonitis</VALIDVALUE>
          <VALUEMEANING>Tendonitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of a tendon, usually resulting from an overuse injury. It is characterized by swelling of the tendon, tenderness around the inflamed tendon, and pain while moving the affected area of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TCC (Transitional Cell Carcinoma) \ TCC (Transitional Cell Carcinoma)</VALIDVALUE>
          <VALUEMEANING>Transitional Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TCC (Transitional Cell Carcinoma)</VALIDVALUE>
          <VALUEMEANING>Transitional Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2930</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3182041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yolk Sac Tumor</VALIDVALUE>
          <VALUEMEANING>Yolk Sac Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-seminomatous malignant germ cell tumor composed of primitive germ cells. It is the most common malignant germ cell tumor in the pediatric population. It occurs in the infant testis, ovary, sacrococcygeal region, vagina, uterus, prostate, abdomen, liver, retroperitoneum, thorax, and pineal/third ventricle. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). Treatment includes: surgical resection, radiation, and chemotherapy. This tumor is very responsive to chemotherapy regimens that include cisplatinum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>With HPV Related Changes</VALIDVALUE>
          <VALUEMEANING>Endocervical Mucosa Ectocervical Mucosa Human Papillomavirus Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>The mucous lining of the canal of the cervix uteri. It is composed of epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae.: The mucous covering of the vaginal portion of the cervix. It is composed of epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae.: No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27851, C33990, C33989</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wilms&#39; Tumor</VALIDVALUE>
          <VALUEMEANING>Wilms Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms tumor of the kidney have been reported arising from the ovary and the cervix.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Warthin&#39;s (Papillary Cystic Lymphomatous) \ Parotid</VALIDVALUE>
          <VALUEMEANING>Parotid Gland Warthin Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenoma that arises from the parotid gland. It is characterized by an oncocytic, often papillary, epithelial component, dense lymphoid stroma, and cystic spaces. A strong association with smoking has been reported. About 10% develop simultaneous or metachronous contralateral tumors. It typically presents as a painless swelling in the lower portion of the parotid gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66865</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Verruca (Wart) \ Vulgaris</VALIDVALUE>
          <VALUEMEANING>Verruca Vulgaris</VALUEMEANING>
          <MEANINGDESCRIPTION>A wart caused by human papillomavirus. It can appear anywhere on the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Verruca (Wart) \ Plantaris</VALIDVALUE>
          <VALUEMEANING>Verruca Plantaris</VALUEMEANING>
          <MEANINGDESCRIPTION>A wart in the plantar surface of the foot. It is caused by human papillomavirus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26913</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Verruca</VALIDVALUE>
          <VALUEMEANING>Verrucous Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>A raised growth on the surface of the skin or other organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5028</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3235572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vascular Malformation \ Lymphangioma</VALIDVALUE>
          <VALUEMEANING>Lymphangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign neoplasm arising from the lymphatics. The tumor is composed of dilated lymphatic channels. Painless swelling is the usual clinical manifestation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vascular Malformation \ Hemangiopericytoma</VALIDVALUE>
          <VALUEMEANING>Hemangiopericytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A mesenchymal tumor composed of dilated vascular spaces (some with a staghorn or bifed shape) throughout.  The individual tumor cells are surrounded by reticulin everywhere, are negative for muscle, nerve sheath, and epithelial markers, and are positive for CD34 and CD99.  The biologic behavior of hemangiopericytoma cannot always be predicted from the morphologic features.  The 5- and 10-year survival rates of malignant hemangiopericytomas have been reported to be 40% and 29% respectively (partially adapted from S. Sternberg&#39;s Diagnostic Surgical Pathology, 4th ed., 2004).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vascular Malformation \ Hemangioma</VALIDVALUE>
          <VALUEMEANING>Hemangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign localized vascular neoplasm usually occurring in infancy and childhood. It is characterized by the formation of capillary-sized or cavernous vascular channels. The majority of cases are congenital.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3085</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vascular Malformation \ Arteriovenous</VALIDVALUE>
          <VALUEMEANING>Arteriovenous Malformation</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal, tangled collections of dilated blood vessels that result from congenitally malformed vascular structures in which arterial afferents flow directly into venous efferents without the usual resistance of an intervening capillary bed. A common type is the congenital arteriovenous fistula (ARTERIOVENOUS FISTULA /congenital). For arteriovenous malformations in the brain, INTRACRANIAL ARTERIOVENOUS MALFORMATIONS is available. (From Merck Manual, 15th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2882</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uveitis</VALIDVALUE>
          <VALUEMEANING>Uveitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process affecting a part of or the entire uvea. Causes include inflammatory agents (e.g., herpes simplex, herpes zoster, leptospirosis) and systemic diseases (e.g., inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus, ankylosing spondylitis). Patients present with pain and redness in the eye, light sensitivity, and blurred and decreased vision.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26909</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2943903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urticaria Pigmentosa</VALIDVALUE>
          <VALUEMEANING>Urticaria Pigmentosa/Maculopapular Cutaneous Mastocytosis</VALUEMEANING>
          <MEANINGDESCRIPTION>The most frequent form of cutaneous mastocytosis.  In children, the lesions tend to be papular, and are characterized by aggregates of elongated or spindle-shaped mast cells which fill the papillary dermis and extend into the reticular dermis.  In adults, the lesions tend to have fewer mast cells compared to those in children.  The lesions are located most commonly on the trunk, but they can be seen on the extremities, head and neck. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Tract Disorders \ Ureteritis Cystica</VALIDVALUE>
          <VALUEMEANING>Ureteritis Cystica</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic lesion of the ureter characterized by the presence of multiple submucosal small cysts in the ureteral wall.  It is caused by inflammation due to urinary tract stones or infection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Tract Disorders \ Tubulointerstitial Nephritis</VALIDVALUE>
          <VALUEMEANING>Interstitial Nephritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Diffuse or local inflammation and edema of the interstitial tissue of the kidney, including the tubules.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Tract Disorders \ Renal Failure, End Stage</VALIDVALUE>
          <VALUEMEANING>Chronic Kidney Disease, Stage 5</VALUEMEANING>
          <MEANINGDESCRIPTION>Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Tract Disorders \ Pyelonephritis</VALIDVALUE>
          <VALUEMEANING>Pyelonephritis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute or chronic inflammatory process affecting the kidney. It is caused by bacteria and in most cases it is the result of a urinary tract infection. Signs and symptoms include fever, chills, flank pain, painful and frequent urination, cloudy or bloody urine, and confusion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Tract Disorders \ Prostatitis</VALIDVALUE>
          <VALUEMEANING>Prostatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the prostate gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26866</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3236769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Tract Disorders \ Polycystic Kidney Disease</VALIDVALUE>
          <VALUEMEANING>Polycystic Kidney Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually autosomal dominant and less frequently autosomal recessive genetic disorder characterized by the presence of numerous cysts in the kidneys leading to end-stage renal failure.  The autosomal dominant trait is associated with abnormalities on the short arm of chromosome 16. Symptoms in patients with the autosomal dominant trait usually appear at middle age and include abdominal pain, hematuria, and high blood pressure.  Patients may develop brain aneurysms and liver cysts.  Patients with the autosomal recessive trait present with progressive renal failure early in life and symptoms resulting from hepatic fibrosis.  The autosomal recessive trait is associated with abnormalities of chromosome 6.  Polycystic kidney disease may also result as a side effect in patients on renal dialysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Tract Disorders \ Orchitis</VALIDVALUE>
          <VALUEMEANING>Orchitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of one or both testes due to viral or bacterial infections.  Signs and symptoms include enlargement or tenderness of the affected testis, inguinal lymphadenopathy, blood in the semen, and pain during urination, intercourse, or ejaculation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97145</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Tract Disorders \ Granulomatous Orchitis</VALIDVALUE>
          <VALUEMEANING>Non-Specific Granulomatous Orchitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Granulomatous inflammation of the testis. It is characterized by the formation of granulomas around the seminiferous tubules. History of trauma may be present. It is assumed to be a reactive process due to autoimmune phenomena.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27162</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Tract Disorders \ Glomerulonephritis</VALIDVALUE>
          <VALUEMEANING>Glomerulonephritis</VALUEMEANING>
          <MEANINGDESCRIPTION>A renal disorder characterized by damage in the glomeruli. It may be acute or chronic, focal or diffuse, and it may lead to renal failure. Causes include autoimmune disorders, infections, diabetes, and malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26784</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Tract Disorders \ Balanitis</VALIDVALUE>
          <VALUEMEANING>Balanitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the glans penis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary Tract Disorders \ Arterionephrosclerosis</VALIDVALUE>
          <VALUEMEANING>Arterionephrosclerosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Scarring and atrophy of the renal cortex that occurs in hypertensive patients and in old age.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97144</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ureteritis Cystica</VALIDVALUE>
          <VALUEMEANING>Ureteritis Cystica</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic lesion of the ureter characterized by the presence of multiple submucosal small cysts in the ureteral wall. It is caused by inflammation due to urinary tract stones or infection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ulcer</VALIDVALUE>
          <VALUEMEANING>Ulcer</VALUEMEANING>
          <MEANINGDESCRIPTION>A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3426</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tonsillitis \ Acute</VALIDVALUE>
          <VALUEMEANING>Acute Tonsillitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute inflammation of the tonsils caused by viruses or bacteria. Signs and symptoms include fever, enlargement of the tonsils, difficulty swallowing, and enlargement of the regional lymph nodes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymoma \ Invasive</VALIDVALUE>
          <VALUEMEANING>Invasive Thymoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A thymoma of any morphologic type that extends beyond the capsule and infiltrates the surrounding tissues.  --2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thecoma</VALIDVALUE>
          <VALUEMEANING>Thecoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An ovarian or testicular stromal tumor characterized by the presence of lipid-rich neoplastic spindle cells. In females, uterine bleeding is the most common symptom. A minority of post-menopausal women with thecoma have an associated endometrial adenocarcinoma or rarely a malignant mixed mullerian tumor or endometrial stromal sarcoma. Rare cases with nuclear atypia and mitotic activity may metastasize. In males, thecomas are rare and they usually present as slow growing, sometimes painful masses. Metastases have not been reported.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nervous System Disorders \ Convulsive Disorders</VALIDVALUE>
          <VALUEMEANING>Seizure</VALUEMEANING>
          <MEANINGDESCRIPTION>Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.--2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Lobular</VALIDVALUE>
          <VALUEMEANING>Atypical Lobular Breast Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign (not cancer) condition in which there are more cells than normal in the breast lobules and the cells look abnormal under a microscope. Having ALH increases the risk of breast cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4730</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematological Disorders \ Thrombotic Thrombocytopenic Purpura (TTP)</VALIDVALUE>
          <VALUEMEANING>Thrombotic Thrombocytopenic Purpura</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute or subacute syndrome characterized by the presence of microangiopathic hemolytic anemia, thrombocytopenic purpura, fever, renal abnormalities and neurologic abnormalities such as seizures, hemiplegia, and visual disturbances. Drugs and bacteria have been implicated as etiologic factors.  The introduction of plasma exchange has significantly lowered the mortality rate. If untreated, the mortality rate is high.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944528</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Biliary Atresia, Intrahepatic</VALIDVALUE>
          <VALUEMEANING>Intrahepatic Biliary Atresia</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital disorder characterized by blockage or absence of the intrahepatic bile ducts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97070</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Giant Cell Myocarditis</VALIDVALUE>
          <VALUEMEANING>Giant Cell Myocarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>An often fatal inflammatory disorder that affects the myocardium.  Morphologically, it is characterized by the presence of an inflammatory infiltrate in the myocardial tissue that includes multinucleated giant cells.  It is often associated with the presence of an autoimmune disorder.  Patients present with arrhythmias and/or heart failure.  Heart transplantation is the only treatment option available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97055</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248583</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Giant Cell Arteritis</VALIDVALUE>
          <VALUEMEANING>Temporal Arteritis</VALUEMEANING>
          <MEANINGDESCRIPTION>A systemic autoimmune vasculitis occurring primarily in people over the age of 50. Pathologic features include a necrotizing panarteritis including granulomas and giant cells. There is a predilection for involvement of central nervous system blood vessels and the most frequent neurologic complication is an OPTIC NEUROPATHY, ISCHEMIC. Large blood vessels may become involved, including the aorta. Clinical manifestations may include myalgias, weight loss, headache, visual loss, necrosis of the skin or tongue, and chest discomfort. Superficial scalp arteries may become tender and enlarged. A related condition, juvenile temporal arteritis, tends to occur in the first or second decade of life. (From Adams et al., Principles of Neurology, 6th ed, p856)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35065</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Endocarditis</VALIDVALUE>
          <VALUEMEANING>Endocarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the endocardium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34582</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Eisenmenger&#39;s</VALIDVALUE>
          <VALUEMEANING>Eisenmenger Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A syndrome characterized by the reversal of a septal defect-associated left-to-right shunt due to the resulting secondary pulmonary hypertension. The presence of the pulmonary hypertension causes increased pressure in the right heart chambers resulting in the reversal of the shunt into a right-to-left shunt. Signs and symptoms include cyanosis, pulmonary hypertension, heart failure, and high red blood cell count.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Congestive Heart Failure</VALIDVALUE>
          <VALUEMEANING>Congestive heart failure</VALUEMEANING>
          <MEANINGDESCRIPTION>Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3080</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Congenital Heart Disease</VALIDVALUE>
          <VALUEMEANING>Congenital Heart Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A heart abnormality that is present at birth. Representative examples include atrial septal defect, ventricular septal defect, tetralogy of Fallot, and patent foramen ovale</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248584</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Cardiomyopathy - Ischemic</VALIDVALUE>
          <VALUEMEANING>Ischemic Heart Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries, to obstruction by a thrombus, or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (myocardial infarction).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Cardiomyopathy - Idiopathic</VALIDVALUE>
          <VALUEMEANING>Idiopathic Cardiomyopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>A disease of the heart muscle or myocardium proper whose cause is unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Cardiomyopathy</VALIDVALUE>
          <VALUEMEANING>Cardiomyopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34830</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2585212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Cardiac Hypertrophy</VALIDVALUE>
          <VALUEMEANING>Cardiomegaly</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal enlargement of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Bacterial Endocarditis</VALIDVALUE>
          <VALUEMEANING>Subacute Bacterial Endocarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>Subacute inflammation of the endocardium. Streptococcus viridans is the usual etiologic agent of SBE. The distinction between &quot;acute&quot; and &quot;subacute&quot; endocarditis has traditionally been made based on the pathogenic organism and clinical presentation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Atherosclerosis</VALIDVALUE>
          <VALUEMEANING>Atherosclerosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Build-up of fatty material and calcium deposition in the arterial wall resulting in partial or complete occlusion of the arterial lumen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210735</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Arteritis</VALIDVALUE>
          <VALUEMEANING>Arteritis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infectious process affecting an artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Aneurysm</VALIDVALUE>
          <VALUEMEANING>Aneurysm</VALUEMEANING>
          <MEANINGDESCRIPTION>Bulging or ballooning in an area of an artery secondary to arterial wall weakening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26693</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210733</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C-Cell Hyperplasia \ Multiple Endocrine Neoplasm (MEN) Type 2A</VALIDVALUE>
          <VALUEMEANING>Multiple Endocrine Neoplasm Type 2A C-Cell Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple endocrine neoplasia caused by mutation of the RET gene. Patients develop medullary thyroid carcinomas, and may also develop pheochromocytomas and parathyroid gland hyperplasia.: Neoplastic or reactive proliferation of the C-cells in the thyroid gland. The neoplastic C-cell hyperplasia is associated with familial medullary thyroid gland carcinoma and multiple endocrine neoplasia type II and IIB. Morphologically, it is characterized by the presence of clusters of intrafollicular C-cells with atypical cytologic features. The reactive C-cell hyperplasia is also known as physiological or secondary C-cell hyperplasia and it is associated with conditions that cause hypercalcemia (e.g., hyperparathyroidism). </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C46100, C3226</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248592</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CIS (Carcinoma In Situ) \ Squamous</VALIDVALUE>
          <VALUEMEANING>Skin Squamous Cell Carcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraepidermal squamous cell carcinoma, confined to the epidermis. There is no evidence of invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Zollinger-Ellison Disease (Peptic Ulcer)</VALIDVALUE>
          <VALUEMEANING>Zollinger Ellison Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A syndrome characterized by the presence of a gastrin-secreting tumor, usually in the pancreas or duodenum, resulting in increased gastric acidity and formation of gastric ulcers. Signs and symptoms include abdominal pain and diarrhea. It may be sporadic or a manifestation of multiple endocrine neoplasia type 1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Whipple&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Whipple Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A systemic infection caused by the Gram-positive bacterium Tropheryma whipplei. It affects the small intestine resulting in malabsorption. Other sites or systems affected by the infection are the joints, central nervous system, and the cardiovascular system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Ulcerative Colitis</VALIDVALUE>
          <VALUEMEANING>Ulcerative Colitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammatory disease of unknown cause which involves the mucosa of the colon. Onset may be acute and fulminant, and its course often continues chronically in an intermittent or continuous form. Diarrhea is a common symptom and bleeding an almost constant concomitant symptom.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2952</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Steatosis (Fatty Liver)</VALIDVALUE>
          <VALUEMEANING>Steatosis (Fatty Liver)</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating intracytoplasmic fat accumulation in the liver parenchyma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Steatohepatitis</VALIDVALUE>
          <VALUEMEANING>Steatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating intracytoplasmic fat accumulation in the liver parenchyma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Seborrheic Dermatitis</VALIDVALUE>
          <VALUEMEANING>Seborrheic Keratosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A common benign skin neoplasm usually affecting older individuals. The lesions usually are multiple and arise in the face, chest, and shoulders. They appear as black or brown, slightly elevated skin lesions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9006</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Primary Sclerosing Cholangitis</VALIDVALUE>
          <VALUEMEANING>Primary Sclerosing Cholangitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Polycystic Liver Disease</VALIDVALUE>
          <VALUEMEANING>Polycystic Liver Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually asymptomatic hereditary disorder which is often associated with polycystic kidney disease. It is characterized by the presence of fluid-filled biliary cysts throughout the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Pancreatitis - Chronic</VALIDVALUE>
          <VALUEMEANING>Chronic Pancreatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic inflammatory process causing damage and fibrosis of the pancreatic parenchyma. Signs and symptoms include abdominal pain, malabsorption and diabetes mellitus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Pancreatitis - Acute</VALIDVALUE>
          <VALUEMEANING>Acute Pancreatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute inflammatory process that leads to necrosis of the pancreatic parenchyma.  Signs and symptoms include severe abdominal pain, nausea, vomiting, diarrhea, fever, and shock.  Causes include alcohol consumption, presence of gallstones, trauma, and drugs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95437</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Pancreatitis</VALIDVALUE>
          <VALUEMEANING>Pancreatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the pancreas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Necrotizing Enterocolitis</VALIDVALUE>
          <VALUEMEANING>Necrotizing Enterocolitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A serious, life-threatening disorder characterized by necrotic changes affecting portions of the small and large intestine. It is usually seen in neonates, particularly premature infants. Signs and symptoms include abdominal distention and tenderness, intestinal bleeding and ileus. It may lead to cardiovascular collapse and shock.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Lymphocytic Colitis</VALIDVALUE>
          <VALUEMEANING>Lymphocytic Colitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Microscopic colitis characterized by the accumulation of lymphocytes in the colonic epithelium and lamina propria. Patients present with chronic watery diarrhea. Colonoscopy reveals normal colonic mucosa. The diagnosis is made with the microscopic examination of the colonic biopsy samples.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27147</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Inflammatory Bowel Disease</VALIDVALUE>
          <VALUEMEANING>Inflammatory Bowel Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic, non-specific disorders of unknown etiology. Includes Crohn disease and ulcerative colitis. Extracolonic manifestations are often associated with Inflammatory Bowel Disease (IBD) and involve the liver, joints and skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3138</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Hypertrophic Gastritis (Ménétrier Disease)</VALIDVALUE>
          <VALUEMEANING>Giant Hypertrophic Gastritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Gastritis characterized by hypertrophy of the gastric mucosa with creation of giant gastric folds. It is associated with hypoalbuminemia due to albumin loss from the stomach. Signs and symptoms include nausea, vomiting, abdominal pain, edema, and weight loss.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Hepatitis - Viral</VALIDVALUE>
          <VALUEMEANING>Viral Hepatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute or chronic inflammation of the liver parenchyma caused by viruses. Representative examples include hepatitis A, B, and C, cytomegalovirus hepatitis, and herpes simplex hepatitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35124</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Hepatitis - Autoimmune</VALIDVALUE>
          <VALUEMEANING>Autoimmune Hepatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatitis caused by autoantibodies. Drugs, infections, and toxins may trigger the production of the autoantibodies against the liver parenchyma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27029</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Gastritis With Dysplasia</VALIDVALUE>
          <VALUEMEANING>Gastric Dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the presence of dysplastic changes within the gastric mucosal epithelial cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Gastritis - Atrophic</VALIDVALUE>
          <VALUEMEANING>Chronic Atrophic Gastritis</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which the stomach muscles shrink and become weak. The digestive (peptic) glands may also shrink, resulting in a lack of digestive juices.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249583</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Gastritis</VALIDVALUE>
          <VALUEMEANING>Gastritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the lining of the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gynecomastia</VALIDVALUE>
          <VALUEMEANING>Gynecomastia</VALUEMEANING>
          <MEANINGDESCRIPTION>Gynecomastia; excessive development of the breasts in males; usually the result of hormonal imbalance or treatment with certain drugs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gynecological Tract Disease \ Salpingitis</VALIDVALUE>
          <VALUEMEANING>Salpingitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the uterine salpinx, the trumpet-shaped FALLOPIAN TUBES, usually caused by ascending infections of organisms from the lower reproductive tract. Salpingitis can lead to tubal scarring, hydrosalpinx, tubal occlusion, INFERTILITY, and ectopic pregnancy (PREGNANCY, ECTOPIC)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26880</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gynecological Tract Disease \ Placental Abruption</VALIDVALUE>
          <VALUEMEANING>Premature Separation of Placenta</VALUEMEANING>
          <MEANINGDESCRIPTION>The separation of the placenta from the maternal uterine attachment when it occurs after the twentieth week of the pregnancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gynecological Tract Disease \ Funisitis</VALIDVALUE>
          <VALUEMEANING>Funisitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute inflammation of the umbilical cord.  It is characterized by the presence of polymorphonuclear cells migrating from the fetal umbilical cord vessels through the umbilical cord towards the bacteria containing amniotic fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97077</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249724</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gynecological Tract Disease \ Endometritis</VALIDVALUE>
          <VALUEMEANING>Endometritis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute or chronic, usually bacterial infectious process affecting the endometrium. It may extend to the myometrium and parametrial tissues. Symptoms include lower abdominal pain, vaginal discharge, and vaginal bleeding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2943934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gynecological Tract Disease \ Endometriosis</VALIDVALUE>
          <VALUEMEANING>Endometriosis</VALUEMEANING>
          <MEANINGDESCRIPTION>The growth of functional endometrial tissue in anatomic sites outside the uterine body. It most often occurs in the pelvic organs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3014</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gynecological Tract Disease \ Ectopic Pregnancy</VALIDVALUE>
          <VALUEMEANING>Ectopic Pregnancy</VALUEMEANING>
          <MEANINGDESCRIPTION>A potentially life-threatening condition in which the embryo implants outside the uterine endometrial cavity. Most ectopic pregnancies (&gt;96%) occur in the fallopian tube (PREGNANCY, TUBAL), but they can be in the uterine cornua, cervix, ovary, and abdominal cavity (PREGNANCY, ABDOMINAL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34945</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2724971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gynecological Tract Disease \ Chorioamnionitis</VALIDVALUE>
          <VALUEMEANING>Chorioamnionitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the fetal sac membranes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gynecological Tract Disease \ Cervicitis</VALIDVALUE>
          <VALUEMEANING>Cervicitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the cervix uteri. (Dorland 27th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26716</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gynecological Tract Disease</VALIDVALUE>
          <VALUEMEANING>Female Reproductive System Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic or neoplastic disorder that affects the female genital system. Representative examples of non-neoplastic disorders include infection, endometriosis, and adenomyosis. Representative examples of neoplastic disorders include germ cell tumors, carcinoma, lymphoma, and sarcoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27020</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gynandroblastoma</VALIDVALUE>
          <VALUEMEANING>Ovarian Gynandroblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare neoplasm arising from the ovary. Although it may occur at any age, it is more often seen in young females. Morphologically, it is characterized by a mixture of two cellular populations: well differentiated Sertoli cells and granulosa cells, with the latter constituting at least ten percent of the neoplasm. The vast majority of cases are stage I lesions at presentation and produce either estrogenic or androgenic manifestations. Although it may present as a massive ovarian tumor, it usually follows a benign clinical course. Very rare case reports of testicular lesions morphologically resembling gynandroblastomas are in fact variants of juvenile granulose cell tumor, or Sertoli cell tumor, or a combination of both.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3072</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granular Cell Tumor</VALIDVALUE>
          <VALUEMEANING>Granular Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Unusual tumor affecting any site of the body, but most often encountered in the head and neck. Considerable debate has surrounded the histogenesis of this neoplasm; it usually has a benign nature. It affects women more often than men. When it develops beneath the epidermis or mucous membrane, it can lead to proliferation of the squamous cells and mimic squamous cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gonadoblastoma</VALIDVALUE>
          <VALUEMEANING>Gonadoblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A mixed germ cell/sex cord-stromal tumor characterized by the presence of large germ cells which resemble seminoma cells and small cells which resemble Sertoli or granulosa cells. It occurs in the testis and the ovary and is identified in children and adults. It is often associated with gonadal dysgenesis and abnormal karyotype.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Goiter</VALIDVALUE>
          <VALUEMEANING>Goiter</VALUEMEANING>
          <MEANINGDESCRIPTION>Enlargement of the thyroid gland usually caused by lack of iodine in the diet, hyperthyroidism, or thyroid nodules. Symptoms include difficulty in breathing and swallowing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gliosarcoma</VALIDVALUE>
          <VALUEMEANING>Gliosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare histological variant of glioblastoma (WHO grade IV) characterized by a biphasic tissue pattern with alternating areas displaying glial and mesenchymal differentiation (WHO).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glioma</VALIDVALUE>
          <VALUEMEANING>Neuroglial Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells).  Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas.  Tumors that arise from oligodendrocytes are called oligodendroglial tumors.  Tumors that arise from ependymal cells are called ependymomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3059</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glioblastoma Multiforme</VALIDVALUE>
          <VALUEMEANING>Glioblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Giant Cell Tumor \ Pigmented Nodular Tenosynovitis</VALIDVALUE>
          <VALUEMEANING>Localized Giant Cell Tumor of Tendon Sheath</VALUEMEANING>
          <MEANINGDESCRIPTION>A well-circumscribed, lobulated tumor, completely or partially covered by a fibrous capsule. It usually arises in the fingers.  It is characterized by the presence of mononuclear cells, multinucleated osteoclast-like giant cells, hemosiderin-laden macrophages, foam cells, and an inflammatory infiltrate. The tumor is slow-growing, usually developing over several years. Clinical presentation includes painless edema of the affected site.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6532</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Giant Cell Tumor</VALIDVALUE>
          <VALUEMEANING>Giant Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant connective and soft tissue tumor, characterized by the presence of multinucleated osteoclast-like giant cells.  Representative examples include the giant cell tumor of bone and the giant cell tumor of tendon sheath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3055</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Giant Cell Angioblastoma</VALIDVALUE>
          <VALUEMEANING>Giant Cell Angioblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, slow-growing, locally aggressive soft tissue tumor characterized by the presence of oval to spindle cells forming concentric aggregates around small vessels.  Giant multinucleated cells are also present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97076</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249739</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Germ Cell-Sex Cord, Mixed, -Stromal Tumor</VALIDVALUE>
          <VALUEMEANING>Mixed Germ Cell-Sex Cord-Stromal Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A biphasic neoplasm that arises from the ovary or the testis. It is characterized by the presence of neoplastic germ cells and neoplastic sex cord-stromal cells. It includes the gonadoblastoma and mixed germ cell-sex cord stromal tumor, unclassifiable.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5241</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Germ Cell Tumor, Mixed</VALIDVALUE>
          <VALUEMEANING>Mixed Germ Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant germ cell tumor characterized by the presence of at least two different germ cell components. The different germ cell components include choriocarcinoma, embryonal carcinoma, yolk sac tumor, teratoma, and seminoma. It occurs in the ovary, testis, and extragonadal sites including central nervous system and mediastinum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Germ Cell Tumor</VALIDVALUE>
          <VALUEMEANING>Germ Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>This is a type of germ cell tumor that consists of large round cells with vesicular nuclei.  This tumor can be found in the ovary, undescended testis, anterior mediastinum or pineal gland. - 2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3708</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Storage Disease</VALIDVALUE>
          <VALUEMEANING>Glycogen Storage Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited metabolic disorder characterized either by defects in glycogen synthesis or defects in the breaking down of glycogen. It results either in the creation of abnormal forms of glycogen or accumulation of glycogen in the tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Sickle Cell</VALIDVALUE>
          <VALUEMEANING>Sickle Cell Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Hirschsprung&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Aganglionic Megacolon</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital disorder characterized by the absence of myenteric ganglion cells in the distal colon. It results in a functional stenosis of the distal colon and a massive distention of the proximal colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34700</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Heritable Disorders Of Connective Tissue</VALIDVALUE>
          <VALUEMEANING>Hereditary Connective Tissue Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited genetic disorder that affects the connective tissues.  Representative examples include Ehlers-Danlos syndrome and Marfan syndrome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97075</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Hereditary Spherocytosis</VALIDVALUE>
          <VALUEMEANING>Hereditary Spherocytosis</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant inherited disorder characterized by the presence of smaller than normal, sphere-shaped erythrocytes. It results in hemolytic anemia and splenomegaly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97074</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Hereditary Neuropathies</VALIDVALUE>
          <VALUEMEANING>Inherited Neuropathy</VALUEMEANING>
          <MEANINGDESCRIPTION>A hereditary disorder that affects the sensory and/or motor nerves or the autonomic nerves.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249747</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Hereditary Myopathies (Muscular Dystrophy)</VALIDVALUE>
          <VALUEMEANING>Muscular Dystrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of inherited progressive muscle disorders characterized by muscle weakness and eventual death of the muscle tissues. Examples include Duchenne muscular dystrophy, Becker&#39;s muscular dystrophy, Emery-Dreifuss muscular dystrophy, facioscapulohumeral muscular dystrophy, and limb-girdle muscular dystrophy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84910</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Hereditary Disorder Of Bilirubin Metabolism</VALIDVALUE>
          <VALUEMEANING>Hereditary Hyperbilirubinemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited disorder affecting the metabolism of bilirubin. It results in increased levels of bilirubin in the blood. Representative examples of this condition include Gilbert syndrome and Crigler-Najjar syndrome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211143</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Hereditary Degenerative Diseases</VALIDVALUE>
          <VALUEMEANING>Hereditary Neurodegenerative Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited disorder characterized by progressive degeneration and atrophy of the nervous system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Glycogen Storage Disease</VALIDVALUE>
          <VALUEMEANING>Glycogen Storage Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited metabolic disorder characterized either by defects in glycogen synthesis or defects in the breaking down of glycogen. It results either in the creation of abnormal forms of glycogen or accumulation of glycogen in the tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Gaucher&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Gaucher Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited lysosomal storage disease caused by deficiency of the enzyme glucocerebrosidase. It results in the accumulation of a fatty substance called glucocerebroside in mononuclear cells in the bone marrow, liver, spleen, brain, and kidneys. Signs and symptoms include hepatomegaly, splenomegaly, neurologic disorders, lymphadenopathy, skeletal disorders, anemia and thrombocytopenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Cystic Fibrosis</VALIDVALUE>
          <VALUEMEANING>Cystic Fibrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital metabolic disorder affecting the exocrine glands, inherited as an autosomal trait. The secretions of exocrine glands are abnormal, resulting in excessively viscid mucus production which causes obstruction of passageways (including pancreatic and bile ducts, intestines, and bronchi). The sweat sodium and chloride content are increased. Symptoms usually appear in childhood and include meconium ileus, poor growth despite good appetite, malabsorption and foul bulky stools, chronic bronchitis with cough, recurrent pneumonia, bronchiectasis, emphysema, clubbing of the fingers, and salt depletion in hot weather.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genetic Disorders \ Alpha-1 Antitrypsin Deficiency</VALIDVALUE>
          <VALUEMEANING>Alpha-1 Antitrypsin Deficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>A genetic disorder characterized by decreased alpha-1 antitrypsin activity in the lungs and blood and deposition of alpha-1 antitrypsin protein in the hepatocytes. These abnormalities result from defective production of alpha-1 antitrypsin and lead to the development of emphysema, cirrhosis, and liver failure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3171840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papillary Cystic Neoplasm</VALIDVALUE>
          <VALUEMEANING>Papillary Cystic Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, malignant, or borderline neoplasm characterized by the presence of papillary mucinous, serous, or clear cell structures and cystic structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4179</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papillary Cystadenoma \ Lymphomatosum</VALIDVALUE>
          <VALUEMEANING>Warthin Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenoma characterized by an oncocytic, often papillary, epithelial component, dense lymphoid stroma, and cystic spaces. It occurs primarily in the parotid gland, and is the second most common benign parotid salivary gland tumor. A strong association with smoking has been reported. About 10% develop simultaneous or metachronous contralateral tumors.  It typically presents as a painless swelling in the lower portion of the parotid gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2854</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papillary \ Papillary Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Papillary Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of adenocarcinoma. It is characterized by the presence of a papillary growth pattern. Representative examples include thyroid gland papillary carcinoma, invasive papillary breast carcinoma, and ovarian serous surface papillary adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papillary</VALIDVALUE>
          <VALUEMEANING>Papillary Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2927</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatoblastoma</VALIDVALUE>
          <VALUEMEANING>Pancreatoblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare malignant epithelial neoplasm arising from the pancreas. The vast majority of cases occur during childhood. It is characterized by acinar differentiation, the formation of squamoid corpuscles, and the formation of stromal bands. Patients may present with an abdominal mass. Symptoms include pain, weight loss, and diarrhea. It may metastasize to lymph nodes, liver, and distant anatomic sites. Children who do not have metastatic disease at the time of diagnosis usually have a favorable clinical outcome when treated with a combination of surgery and chemotherapy. However, children with metastatic disease at presentation or adult patients usually have a poor prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251704</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paget&#39;s Disease, W/O Invasive Carcinoma</VALIDVALUE>
          <VALUEMEANING>Paget Disease of the Breast without Invasive Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Paget disease involving the skin overlying the mammary gland, without accompanying invasive ductal or lobular breast carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47858</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pagets Disease, With Invasive Carcinoma</VALIDVALUE>
          <VALUEMEANING>Paget Disease of the Breast with Invasive Ductal Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Paget&#39;s disease involving the skin overlying the mammary gland, accompanied by invasive ductal breast carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paget&#39;s Disease, Without Invasive Carcinoma</VALIDVALUE>
          <VALUEMEANING>Paget Disease of the Breast without Invasive Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Paget disease involving the skin overlying the mammary gland, without accompanying invasive ductal or lobular breast carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47858</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paget&#39;s Disease With Invasive Carcinoma</VALIDVALUE>
          <VALUEMEANING>Paget&#39;s Disease of the Breast with Invasive Ductal Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Paget&#39;s disease involving the skin overlying the mammary gland, accompanied by invasive ductal breast carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paget&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Paget&#39;s Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells).  Paget&#39;s cell neoplasms include Paget&#39;s disease of the nipple and extramammary Paget&#39;s disease which may affect the vulva, penis, anus, skin and scrotum. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteoma \ Osteoid</VALIDVALUE>
          <VALUEMEANING>Osteoid Osteoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A small benign bone-forming neoplasm characterized by the presence of differentiated osteoblasts. The tumor is usually surrounded by hypervascular sclerotic bone and has limited growth potential. Clinical signs and symptoms include pain and localized tenderness, at the site of the lesion. The pain may be intense, but in the majority of cases it is completely alleviated by aspirin. Prognosis is excellent and recurrences are rare.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3297</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteochondroma</VALIDVALUE>
          <VALUEMEANING>Osteochondroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A common, benign cartiliginous neoplasm arising from the metaphysis of bone. The tumor grows on the surface of the bone; it may be pedunculated or sessile. It is characterized by the presence of chondrocytes, a cartilage cap, and a fibrous perichondrium that extends to the periosteum of the bone. In some cases, there is deletion of 8q24.1 chromosome locus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteoblastoma</VALIDVALUE>
          <VALUEMEANING>Osteoblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare benign bone-forming neoplasm usually arising from the spine. It is a well-circumscribed lytic tumor that varies in size. The tumor is composed of woven bone trabeculae and shares similar histologic characteristics with the osteoid osteoma. Surgical curettage is the treatment of choice. The prognosis is excellent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oncocytoma \ Parotid</VALIDVALUE>
          <VALUEMEANING>Salivary Gland Oncocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare benign epithelial neoplasm composed of oncocytes, which are large cells with a large amount of granular eosinophilic cytoplasm containing numerous tightly-packed mitochondria.  Approximately 85% to 90% occur in the parotid gland; most of the remainder occur in the submandibular gland. The peak incidence is in the seventh through ninth decades of life. In almost all cases, swelling is the only complaint of the patient.  -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5932</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251716</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phyllodes Tumor, Malignant</VALIDVALUE>
          <VALUEMEANING>Malignant Phyllodes Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A phylodes tumor with sarcomatous stroma. The sarcomatous component is usually of the fibrosarcomatous type. Liposarcomatous, chondrosarcomatous, osteosarcomatous, or rhabdomyosarcomatous differentiation may also occur in the stroma. It may recur and metastasize following surgical resection. The lung and skeleton are the anatomic sites most frequently involved by metastases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phyllodes Tumor \ Borderline</VALIDVALUE>
          <VALUEMEANING>Borderline Phyllodes Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A phylodes tumor with morphologic characteristics which are intermediate between a benign and a malignant phylodes tumor. The stromal sarcomatous changes are of low grade and are often reminiscent of low grade fibrosarcomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pheochromocytoma \ Associated Genetic Disorder</VALIDVALUE>
          <VALUEMEANING>Hereditary Paraganglioma-Pheochromocytoma Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant hereditary syndrome caused by mutations in the SDHD, SDHC, SDHB, and SDHAF2 genes. It is characterized by the development of paragangliomas and pheochromocytomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritonitis</VALIDVALUE>
          <VALUEMEANING>Peritonitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the peritoneum (tissue that lines the abdominal wall and covers most of the organs in the abdomen). Peritonitis can result from infection, injury, or certain diseases. Symptoms may include swelling of the abdomen, severe pain, and weight loss.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26849</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Passive Congestion</VALIDVALUE>
          <VALUEMEANING>Passive Congestion</VALUEMEANING>
          <MEANINGDESCRIPTION>Tissue congestion due to the obstruction of venous blood flow return.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97113</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraganglioma \ Uncertain Malignant Potential</VALIDVALUE>
          <VALUEMEANING>Paraganglioma-Like Dermal Melanocytic Tumor Neoplasm of Uncertain Malignant Potential</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists: A neoplasm displaying morphologic, phenotypic, or genotypic characteristics that are clearly not benign but do not permit the establishment of a definitive diagnosis of malignancy.  Such neoplasms may or may not eventually have a more aggressive clinical course.  Representative examples include lymphoproliferations of uncertain malignant potential (e.g., lymphomatoid granulomatosis and lymphomatoid papulosis), borderline ovarian epithelial neoplasms (e.g., borderline ovarian endometrioid tumor and borderline ovarian mucinous tumor), borderline exocrine pancreatic neoplasm (e.g., pancreatic borderline intraductal papillary-mucinous neoplasm), and primary borderline peritoneal epithelial neoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3646, C37258</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papilloma \ Squamous</VALIDVALUE>
          <VALUEMEANING>Squamous Papilloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign epithelial neoplasm characterized by a papillary growth pattern and a proliferation of neoplastic squamous cells without morphologic evidence of malignancy. Most frequently it arises in the oral cavity, nasopharynx, larynx, esophagus, vagina, and vulva.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papilloma \ Sialadenoma Papilliferium</VALIDVALUE>
          <VALUEMEANING>Salivary Gland Sialadenoma Papilliferum</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon exophytic papillary proliferation that involves mucosal surface epithelium and salivary duct epithelium. It is exceptional among salivary gland neoplasms because it manifests as an exophytic papillary excrescence of the mucosa, rather than as a submucosal or intraglandular mass. It most often affects the hard or soft palate.  It is generally asymptomatic. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35836</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papilloma \ Inverted Papilloma</VALIDVALUE>
          <VALUEMEANING>Inverted Papilloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of tumor in which surface epithelial cells grow downward into the underlying supportive tissue. It may occur in the nose and/or sinuses or in the urinary tract (bladder, renal pelvis, ureter, urethra). When it occurs in the nose or sinuses, it may cause symptoms similar to those caused by sinusitis, such as nasal congestion. When it occurs in the urinary tract, it may cause blood in the urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3793</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251799</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papilloma \ Inverted Ductal</VALIDVALUE>
          <VALUEMEANING>Salivary Gland Inverted Ductal Papilloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A very rare benign tumor of the minor salivary glands, characterized by a luminal papillary proliferation that arises at the junction of the salivary gland duct and the oral mucosal surface epithelium and expands as a nodular mass into the lamina propria.  It presents as an asymptomatic mucosal swelling. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251801</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papilloma \ Inverted</VALIDVALUE>
          <VALUEMEANING>Inverted Papilloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of tumor in which surface epithelial cells grow downward into the underlying supportive tissue. It may occur in the nose and/or sinuses or in the urinary tract (bladder, renal pelvis, ureter, urethra). When it occurs in the nose or sinuses, it may cause symptoms similar to those caused by sinusitis, such as nasal congestion. When it occurs in the urinary tract, it may cause blood in the urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3793</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251803</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papilloma \ Intraductal</VALIDVALUE>
          <VALUEMEANING>Intraductal Papilloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A small, often impalpable benign papilloma arising in a lactiferous duct and frequently causing bleeding from the nipple. (Stedman, 25th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemangioendothelioma \ Kaposiform</VALIDVALUE>
          <VALUEMEANING>Kaposiform Hemangioendothelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>An intermediate, locally aggressive blood vessel neoplasm characterized by the presence of spindle endothelial cells, and formation of capillary-sized and slit-like vascular channels.  It is often associated with hemorrhage and hemosiderin deposition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Addison&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Addison&#39;s Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A hormonal disorder that occurs when the adrenal glands fail to release adequate amounts of glucocorticoids (cortisol), mineralocorticoids (aldosterone, 11-deoxycorticosterone), and androgens (dehydroepiandrosterone) to meet physiologic needs, despite release of ACTH from the pituitary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26689</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atypical Adenomatous Hyperplasia</VALIDVALUE>
          <VALUEMEANING>Atypical Glandular Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Proliferation of glandular epithelial cells associated with the presence of cytologic atypia and architectural growth pattern changes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atrophy \ Age-Related</VALIDVALUE>
          <VALUEMEANING>Age-Related Atrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>Atrophy of the nervous system tissues and/or muscle tissues that is related to aging.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97044</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atrial Myxoma</VALIDVALUE>
          <VALUEMEANING>Atrial Myxoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A cardiac myxoma arising from the atrium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Astrocytoma \ Diffuse</VALIDVALUE>
          <VALUEMEANING>Diffuse astrocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A low-grade (WHO grade II) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578704</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Astrocytoma \ Anaplastic</VALIDVALUE>
          <VALUEMEANING>Anaplastic astrocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A diffusely infiltrating, WHO grade III astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apocrine Tumor</VALIDVALUE>
          <VALUEMEANING>Apocrine Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant sweat gland neoplasm with apocrine differentiation. Representative examples include apocrine adenoma, ceruminous adenocarcinoma, and apocrine breast carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APAH</VALIDVALUE>
          <VALUEMEANING>Associated Pulmonary Arterial Hypertension</VALUEMEANING>
          <MEANINGDESCRIPTION>Pulmonary hypertension that results from another disorder (e.g., connective tissue disorder).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97147</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angiosarcoma</VALIDVALUE>
          <VALUEMEANING>Angiosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor arising from the endothelial cells of the blood vessels.  Microscopically, it is characterized by frequently open vascular anastomosing and branching channels.  The malignant cells that line the vascular channels are spindle or epithelioid and often display hyperchromatic nuclei.  Angiosarcomas most frequently occur in the skin and breast.  Patients with long-standing lymphedema are at increased risk of developing angiosarcoma. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3088</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angiomyolipoma</VALIDVALUE>
          <VALUEMEANING>Angiomyolipoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm with perivascular epithelioid cell differentiation often associated with tuberous sclerosis.  It is characterized by a mixture of epithelioid cells, smooth muscle, vessels, and mature adipose tissue.  The kidney is the most common site of involvement.  Other sites of involvement include the liver, lung, lymph nodes, and retroperitoneum.  The vast majority of cases follow a benign clinical course.  However, cases of metastatic angiomyolipomas with sarcomatoid features have been described.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3734</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angiofibroma</VALIDVALUE>
          <VALUEMEANING>Angiofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of fibroma characterized by the presence of numerous dilated vascular channels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3799</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247910</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angioendothelioma</VALIDVALUE>
          <VALUEMEANING>Hemangioendothelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A vascular proliferation characterized by the presence of prominent endothelial cells and the formation of vascular channels. Hemangioendotheliomas may display borderline or low grade characteristics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3084</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ameloblastoma</VALIDVALUE>
          <VALUEMEANING>Ameloblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The most common odontogenic tumor, arising from the epithelial component of the embryonic tooth and usually affecting the molar-ramus region of the mandible or maxilla.  Although most ameloblastomas are morphologically and clinically benign, they may cause extensive local destruction, recur, or metastasize.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allergic Inflammation</VALIDVALUE>
          <VALUEMEANING>Allergies</VALUEMEANING>
          <MEANINGDESCRIPTION>An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3114</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alcoholic Atrophy</VALIDVALUE>
          <VALUEMEANING>Alcoholic Brain Atrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>Atrophy of the cerebral cortex and/or cerebellum due to chronic ethanol consumption.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97043</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adhesions</VALIDVALUE>
          <VALUEMEANING>Adhesion</VALUEMEANING>
          <MEANINGDESCRIPTION>The property of remaining in close proximity, as that resulting from the physical attraction of molecules to a substance or the molecular attraction existing between the surfaces of contacting bodies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17597</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenosquamous Carcinoma</VALIDVALUE>
          <VALUEMEANING>Adenosquamous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2836818</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenosarcoma</VALIDVALUE>
          <VALUEMEANING>Adenosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenomyosis</VALIDVALUE>
          <VALUEMEANING>Uterine Adenomyosis</VALUEMEANING>
          <MEANINGDESCRIPTION>The growth of endometrial tissue inside the muscular wall of the uterus. Clinical manifestations include pain, dysmenorrhea, and menorrhagia. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6996</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenomyoepithelioma</VALIDVALUE>
          <VALUEMEANING>Breast Adenomyoepithelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually benign neoplasm arising from the breast. It is characterized by the proliferation of cells with myoepithelial differentiation around spaces which are lined by epithelial cells. Rarely, the epithelial and/or myoepithelial cells may undergo malignant transformation. Cases with malignant transformation may follow an aggressive clinical course, including recurrences and local and distant metastases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247920</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Tubular</VALIDVALUE>
          <VALUEMEANING>Tubular Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>shaped like a tube; of or pertaining to a tubule. (On-line Medical Dictionary): A neoplasm arising from the glandular epithelium.  It may be encapsulated or non-encapsulated.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2855, C14169</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Papillary</VALIDVALUE>
          <VALUEMEANING>Papillary Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>of or relating to or resembling papilla.: A neoplasm arising from the glandular epithelium.  It may be encapsulated or non-encapsulated.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2855, C14166</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoma \ Lymphadenoma</VALIDVALUE>
          <VALUEMEANING>Adenoma Salivary Gland Sebaceous Lymphadenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm arising from the glandular epithelium.  It may be encapsulated or non-encapsulated.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract. -- 2004: A rare benign epithelial tumor composed of irregular, proliferating nests and islands of epithelium, including solid and gland-like sebaceous elements, surrounded by lymphoid stroma. Most occur in the parotid gland. Symptoms include a progressively enlarging, painless mass.  Sebaceous lymphadenocarcinoma is the malignant counterpart. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35555, C2855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Benign Mixed Tumor</VALIDVALUE>
          <VALUEMEANING>Mixed Tumor of the Skin (Chondroid Syringoma)</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, benign, slow-growing and painless neoplasm of sweat glands. It usually arises in the head and neck. It is characterized by the presence of a mesenchymal chondroid stroma, fibrosis, and epithelial structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Behcet&#39;s Syndrome</VALIDVALUE>
          <VALUEMEANING>Behcet Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS, THROMBOPHLEBITIS, gastrointestinal ulcerations, RETINAL VASCULITIS, and OPTIC ATROPHY may occur as well.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autolysis</VALIDVALUE>
          <VALUEMEANING>Autolized Specimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A specimen that has undergone autolysis, or self-digestion by the specimen&#39;s own digestive enzymes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78725</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ductal Carcinoma In Situ \ Comedo</VALIDVALUE>
          <VALUEMEANING>High Grade Ductal Breast Carcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>A ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystadenoma</VALIDVALUE>
          <VALUEMEANING>Cystadenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or borderline cystic epithelial neoplasm arising from the glandular epithelium.  The epithelial cells line the cystic spaces which contain serous or mucinous fluid.  Representative examples include ovarian and pancreatic cystadenomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyst \ Peritubal</VALIDVALUE>
          <VALUEMEANING>Hydatid Cyst of Morgagni</VALUEMEANING>
          <MEANINGDESCRIPTION>A cyst that is attached to the fallopian tube and originates from the remnants of the Mullerian duct.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Hepatoid</VALIDVALUE>
          <VALUEMEANING>Hepatoid Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma with morphologic characteristics similar to hepatocellular carcinoma, arising from an anatomic site other than the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Adenosquamous</VALIDVALUE>
          <VALUEMEANING>Adenosquamous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2836818</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenomatoid Tumor</VALIDVALUE>
          <VALUEMEANING>Adenomatoid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign neoplasm arising from mesothelial cells. It is characterized by the formation of glandular and tubular patterns. It can occur in several anatomic sites including the pleura, peritoneum, and epididymis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3762</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical Intraepithelial Neoplasia (CIN) Or Squamous Intraepithelial Lesion (SIL) \ Mild (CIN I) Or Low Grade (LGSIL)</VALIDVALUE>
          <VALUEMEANING>Low Grade Cervical Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A precancerous neoplastic process that affects the cervical epithelium without evidence of invasion. It is usually associated with human papillomavirus infection. It is characterized by the presence of mild atypia in the superficial epithelial layer that may be associated with koilocytosis. Maturation is present in the upper two thirds of the epithelium. Mitotic figures are not numerous and are present in the basal third of the epithelium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4630</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248578</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal Stromal Tumor (GIST) \ Unknown Malignant Potential</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Stromal Tumor of Uncertain Malignant Potential</VALUEMEANING>
          <MEANINGDESCRIPTION>A gastrointestinal stromal tumor that is characterized by a maximum diameter greater than 5 cm and equal or less than 10 cm (gastric localization), or greater than 2 cm and equal or less than 5 cm (intestinal localization) and no more than 5 mitotic figures per 50 high power fields.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Multiple Endocrine Neoplasm (MEN) Type 1</VALIDVALUE>
          <VALUEMEANING>Multiple Endocrine Neoplasia Type 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple endocrine neoplasia caused by inactivation of the tumor suppressor gene MEN-1. Patients may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Arterial Hypertension (PAH) \ Idiopathic Pulmonary Arterial Hypertension (IPAH)</VALIDVALUE>
          <VALUEMEANING>Idiopathic Pulmonary Hypertension</VALUEMEANING>
          <MEANINGDESCRIPTION>Increased blood pressure in the arteries of the lungs; the etiology is unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97119</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251844</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Wegener&#39;s Granulomatosis</VALIDVALUE>
          <VALUEMEANING>Wegener&#39;s Granulomatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A multisystem disease chiefly affecting males, characterized by necrotizing granulomatous vasculitis involving the upper and lower respiratory tracts, glomerulonephritis, and variable degrees of systemic, small vessel vasculitis, which is generally considered to represent an aberrant hypersensitivity reaction to an unknown antigen. (Dorland, 27th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Systemic Lupus Erythematous</VALIDVALUE>
          <VALUEMEANING>Systemic Lupus Erythematosus</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic inflammatory connective tissue disease marked by skin rashes, joint pain and swelling, inflammation of the kidneys, inflammation of the fibrous tissue surrounding the heart (i.e., the pericardium), as well as other problems.  Not all affected individuals display all of these problems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3201</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Sjögren&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Sjogren&#39;s Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26883</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Rheumatoid</VALIDVALUE>
          <VALUEMEANING>Rheumatoid Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2884</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Myasthenia Gravis</VALIDVALUE>
          <VALUEMEANING>Myasthenia Gravis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic autoimmune neuromuscular disorder characterized by skeletal muscle weakness.  It is caused by the blockage of the acetylcholine receptors at the neuromuscular junction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60989</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3143924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Mixed Connective Tissue</VALIDVALUE>
          <VALUEMEANING>Mixed Connective Tissue Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>An autoimmune overlap syndrome characterized by the presence of symptoms of systemic lupus erythematosus, systemic scleroderma, and polymyositis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84892</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Lupus - Discoid</VALIDVALUE>
          <VALUEMEANING>Discoid Lupus Erythematosus</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic form of cutaneous lupus erythematosus (LUPUS ERYTHEMATOSUS, CUTANEOUS) in which the skin lesions mimic those of the systemic form but in which systemic signs are rare. It is characterized by the presence of discoid skin plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and skin atrophy. Lesions are surrounded by an elevated erythematous border. The condition typically involves the face and scalp, but widespread dissemination may occur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26820</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Hypoparathyroidism</VALIDVALUE>
          <VALUEMEANING>Hypoparathyroidism</VALUEMEANING>
          <MEANINGDESCRIPTION>An endocrine disorder characterized by decreased production of parathyroid hormone by the parathyroid glands. It is usually caused by damage of the parathyroid glands during head and neck surgery. Signs and symptoms include muscle cramps, abdominal pain, dry skin, brittle nails, cataracts, tetany, and convulsions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Hashimoto&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Hashimoto Thyroiditis</VALUEMEANING>
          <MEANINGDESCRIPTION>An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27191</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Graves&#39; Disease</VALIDVALUE>
          <VALUEMEANING>Graves&#39; Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Hyperthyroidism associated with diffuse hyperplasia of the thyroid gland (goiter), resulting from production of antibodies that are directed against the thyrotropin receptor complex of the follicular epithelial cells.  As a result, the thyroid gland enlarges and secrets increased amounts of thyroid hormones. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Goodpasture&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Goodpasture Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An autoimmune disorder characterized by pulmonary hemorrhage and glomerulonephritis. It is a hypersensitivity reaction resulting in the formation of antibodies against the pulmonary alveoli and the basement membrane of the glomeruli.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors \ Transitional (Proliferating Brenner Tumor)</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Brenner Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A Brenner tumor of the ovary characterized by papillary structures, nuclear cytologic atypia, and absense of stromal invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors \ Serous</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Serous Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade serous epithelial neoplasm arising from the ovary.  It is characterized by an atypical proliferation of serous-type epithelial cells without evidence of stromal invasion.  It is often asymptomatic but rarely it may present with abdominal pain or abdominal enlargement due to rupture or torsion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5226</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors \ Mucinous</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Mucinous Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade mucinous epithelial neoplasm arising from the ovary.  It is characterized by an atypical proliferation of mucinous-type epithelial cells without evidence of stromal invasion.  The mucinous epithelial cells may be of intestinal or endocervical type.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40036</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors \ Mixed Epithelial</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Mixed Epithelial Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade ovarian epithelial tumor composed of an admixture of two or more of the five major cell types: serous, mucinous, endometrioid, clear cell, and Brenner/transitional.  The second or second and third cell types must comprise alone or together at least 10% of the tumor epithelium. The majority of patients present with stage I tumor and a minority present with bilateral disease. Morphologically, it shows papillae with detached cell clusters.  Microinvasion may be seen rarely. (WHO 2003)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors With Microinvasion \ Serous</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Serous Tumor with Microinvasion</VALUEMEANING>
          <MEANINGDESCRIPTION>An ovarian epithelial tumor characterized by the presence of neoplastic serous epithelial cells, atypia, and microinvasion of the ovarian stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors With Microinvasion \ Mucinous</VALIDVALUE>
          <VALUEMEANING>Borderline Tumors With Microinvasion Mucinous</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade mucinous epithelial neoplasm arising from the ovary.  It is characterized by an atypical proliferation of mucinous-type epithelial cells without evidence of stromal invasion.  The mucinous epithelial cells may be of intestinal or endocervical type.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40036</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors With Microinvasion \ Mixed Epithelial</VALIDVALUE>
          <VALUEMEANING>Borderline Tumors With Microinvasion Mixed Epithelial</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade ovarian epithelial tumor composed of an admixture of two or more of the five major cell types: serous, mucinous, endometrioid, clear cell, and Brenner/transitional.  The second or second and third cell types must comprise alone or together at least 10% of the tumor epithelium. The majority of patients present with stage I tumor and a minority present with bilateral disease. Morphologically, it shows papillae with detached cell clusters.  Microinvasion may be seen rarely. (WHO 2003)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors With Microinvasion \ Endometrioid</VALIDVALUE>
          <VALUEMEANING>Borderline Tumors With Microinvasion Endometrioid</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm of low malignant potential arising from the ovary. It is characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. The surrounding ovarian stroma is often fibrotic. There is no evidence of stromal invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors With Microinvasion \ Clear Cell</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Clear Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An epithelial neoplasm with low malignant potential affecting the ovary.  It is characterized by the presence of clear or hobnail cells.  In some cases, the cells may display nuclear atypia and prominent nucleoli.  When such cells are present, they remain confined to the glands.  There is no evidence of stromal invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40080</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors With Microinvasion</VALIDVALUE>
          <VALUEMEANING>Borderline Tumors With Microinvasion</VALUEMEANING>
          <MEANINGDESCRIPTION>An ovarian epithelial tumor characterized by the presence of neoplastic serous epithelial cells, atypia, and microinvasion of the ovarian stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors \ Endometrioid</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Endometrioid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm of low malignant potential arising from the ovary. It is characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. The surrounding ovarian stroma is often fibrotic. There is no evidence of stromal invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors \ Clear Cell</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Clear Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An epithelial neoplasm with low malignant potential affecting the ovary.  It is characterized by the presence of clear or hobnail cells.  In some cases, the cells may display nuclear atypia and prominent nucleoli.  When such cells are present, they remain confined to the glands.  There is no evidence of stromal invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40080</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247947</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline Tumors \ Any Dysplastic/Indeterminate Subtype</VALIDVALUE>
          <VALUEMEANING>Neoplasm of Uncertain Malignant Potential</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm displaying morphologic, phenotypic, or genotypic characteristics that are clearly not benign but do not permit the establishment of a definitive diagnosis of malignancy.  Such neoplasms may or may not eventually have a more aggressive clinical course.  Representative examples include lymphoproliferations of uncertain malignant potential (e.g., lymphomatoid granulomatosis and lymphomatoid papulosis), borderline ovarian epithelial neoplasms (e.g., borderline ovarian endometrioid tumor and borderline ovarian mucinous tumor), borderline exocrine pancreatic neoplasm (e.g., pancreatic borderline intraductal papillary-mucinous neoplasm), and primary borderline peritoneal epithelial neoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247949</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Disorders \ Osteoporosis</VALIDVALUE>
          <VALUEMEANING>Osteoporosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Disorders \ Osteomalacia</VALIDVALUE>
          <VALUEMEANING>Osteomalacia</VALUEMEANING>
          <MEANINGDESCRIPTION>A metabolic bone disease that results from either a deficiency in vitamin D, or an abnormality in the metabolism of vitamin D, or a deficiency of calcium in the diet.  The most common symptoms are bone pain and muscle weakness.  When it occurs in children it is commonly referred to as rickets. (Diagnostic Surgical Pathology, 3rd ed.) --2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26838</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Disorders \ Osteoarthritis</VALIDVALUE>
          <VALUEMEANING>Osteoarthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>A noninflammatory degenerative joint disease occurring chiefly in older persons, characterised by degeneration of the articular cartilage, hypertrophy of bone at the margins and changes in the synovial membrane. It is accompanied by pain and stiffness, particularly after prolonged activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3158617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Disorders \ Metabolic Bone Disease</VALIDVALUE>
          <VALUEMEANING>Metabolic Bone Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of disorders that affect the bones secondary to increased levels of minerals or deficient levels of minerals such as calcium, magnesium, phosphorus, and vitamin D.  Representative examples are osteomalacia, osteoporosis, and Paget disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Disorders \ Infarction (Osteonecrosis)</VALIDVALUE>
          <VALUEMEANING>Bone Infarction</VALUEMEANING>
          <MEANINGDESCRIPTION>Ischemic necrosis of the bone tissue and the marrow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Disorders \ Fracture</VALIDVALUE>
          <VALUEMEANING>Fracture</VALUEMEANING>
          <MEANINGDESCRIPTION>A traumatic injury to the bone in which the continuity of the bone is broken. - 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944828</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Craniopharygioma \ Hyperplastic/Metaplastic Subtype</VALIDVALUE>
          <VALUEMEANING>Subtype Craniopharyngioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Subtype; a group forming a type within a larger type.: Craniopharyngiomas (WHO grade I) are benign, partly cystic, epithelial tumors of the sellar region, presumably derived from Rathke pouch epithelium. They affect mainly children and young adults. There are two clinicopathological forms: Adamantinomatous Craniopharyngioma and Papillary Craniopharyngioma. Recent studies indicate that the age distribution and, to some extent, prognosis are different between these two variants. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2964, C25696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Craniopharygioma</VALIDVALUE>
          <VALUEMEANING>Craniopharyngioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Craniopharyngiomas (WHO grade I) are benign, partly cystic, epithelial tumors of the sellar region, presumably derived from Rathke pouch epithelium. They affect mainly children and young adults. There are two clinicopathological forms: Adamantinomatous Craniopharyngioma and Papillary Craniopharyngioma. Recent studies indicate that the age distribution and, to some extent, prognosis are different between these two variants. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2964</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578730</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cranial Fasciitis</VALIDVALUE>
          <VALUEMEANING>Cranial Nodular Fasciitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, rapid growing, non-encapsulated benign neoplasm that arises from the cranium. This is an osteolytic lesion. It is characterized by the presence of non-hyperchromatic spindle-shaped fibroblasts, multinucleated osteoclast-like giant cells, chronic inflammatory infiltrate, red blood cell extravasation, and high mitotic activity, in a storiform growth pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27248</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cortical Tumor \ Uncertain Malignant Potential</VALIDVALUE>
          <VALUEMEANING>Adrenal Cortex Neoplasm With Uncertain Malignant Potential</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant (primary or metastatic) neoplasm affecting the adrenal cortex. (NCI05): Used to indicate the presence of something or someone.: A neoplasm displaying morphologic, phenotypic, or genotypic characteristics that are clearly not benign but do not permit the establishment of a definitive diagnosis of malignancy.  Such neoplasms may or may not eventually have a more aggressive clinical course.  Representative examples include lymphoproliferations of uncertain malignant potential (e.g., lymphomatoid granulomatosis and lymphomatoid papulosis), borderline ovarian epithelial neoplasms (e.g., borderline ovarian endometrioid tumor and borderline ovarian mucinous tumor), borderline exocrine pancreatic neoplasm (e.g., pancreatic borderline intraductal papillary-mucinous neoplasm), and primary borderline peritoneal epithelial neoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3646, C62355, C2858</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cortical Tumor</VALIDVALUE>
          <VALUEMEANING>Adrenal Cortex Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant (primary or metastatic) neoplasm affecting the adrenal cortex. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2858</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Congenital Mesoblastic Nephroma \ Mixed Cellularity</VALIDVALUE>
          <VALUEMEANING>Mixed Congenital Mesoblastic Nephroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital mesoblastic nephroma characterized by the presence of classic and cellular areas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DJD/Osteoarthritis</VALIDVALUE>
          <VALUEMEANING>Osteoarthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>A noninflammatory degenerative joint disease occurring chiefly in older persons, characterised by degeneration of the articular cartilage, hypertrophy of bone at the margins and changes in the synovial membrane. It is accompanied by pain and stiffness, particularly after prolonged activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3158617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diverticulum</VALIDVALUE>
          <VALUEMEANING>Diverticulum</VALUEMEANING>
          <MEANINGDESCRIPTION>A pathological condition manifested as a pouch or sac opening from a tubular or saccular organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26753</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2684801</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desmoplastic Small Round Cell Tumor</VALIDVALUE>
          <VALUEMEANING>Desmoplastic Small Round Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive malignant neoplasm of uncertain lineage.  It is characterized by the presence of small round cells in a desmoplastic stroma.  It usually affects children and young adults.  The most common site of involvement is the abdomen.  Patients usually present with abdominal distention, pain, ascites, and a palpable abdominal mass.  The prognosis is usually poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desmoid Tumor \ Periosteal</VALIDVALUE>
          <VALUEMEANING>Periosteal Desmoid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A reactive, benign fibrous lesion that develops in the periosteum of the femur.  It usually affects boys and there is a history of trauma.  It is characterized by the formation of dense collagen tissue and reactive bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97065</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dermoid Cyst</VALIDVALUE>
          <VALUEMEANING>Dermoid Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>A mature teratoma characterized by the presence of a cyst which is lined by mature tissue resembling the epidermis and the epidermal appendages. It occurs in the ovary, testis, and extragonadal sites including central nervous system and skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dermatofibrosarcoma Protuberans</VALIDVALUE>
          <VALUEMEANING>Dermatofibrosarcoma Protuberans</VALUEMEANING>
          <MEANINGDESCRIPTION>An intermediate cutaneous fibrohistiocytic neoplasm, presenting as a nodular cutaneous mass, most often on the trunk and the proximal extremities.  The tumor diffusely infiltrates the dermis and the subcutaneous tissues.  It is considered a locally aggressive neoplasm, which often recurs but rarely metastasizes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dermatofibroma (Fibrous Histiocytoma)</VALIDVALUE>
          <VALUEMEANING>Cutaneous Fibrous Histiocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A solitary, slowly growing nodular mass, most often affecting the extremities.  It is composed of fibrous and histiocytic cells which infiltrate the dermis and occasionally the underlying subcutaneous tissue.  Usually local excision is curative.  Recurrences are reported only in a small minority of cases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dendritic Cell Neoplasms</VALIDVALUE>
          <VALUEMEANING>Histiocytic and Dendritic Cell Neoplasms</VALUEMEANING>
          <MEANINGDESCRIPTION>These are rare tumors that affect the hematopoietic and lymphoid tissues.  The cells of origin are the histiocytes and accessory cells. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystitis \ Glandularis</VALIDVALUE>
          <VALUEMEANING>Cystitis Glandularis</VALUEMEANING>
          <MEANINGDESCRIPTION>A reactive inflammatory disorder affecting the bladder.  It is characterized by the development of small cysts in the bladder wall.  The cysts are lined by metaplastic glandular cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39860</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystitis \ Cystica</VALIDVALUE>
          <VALUEMEANING>Cystitis Cystica</VALUEMEANING>
          <MEANINGDESCRIPTION>A reactive inflammatory disorder affecting the bladder.  It is characterized by the development of small cysts in the bladder wall.  The cysts are lined by urothelial cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96230</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystitis \ Acute</VALIDVALUE>
          <VALUEMEANING>Acute Cystitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute infection of the bladder. It is usually caused by bacteria. Signs and symptoms include increased frequency of urination, pain or burning during urination, fever, cloudy or bloody urine, and suprapubic pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystic Neoplasm \ Mucinous</VALIDVALUE>
          <VALUEMEANING>Bile Duct Cystadenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An epithelial, usually multiloculated neoplasm arising from the bile duct epithelium. It occurs predominantly in females. Signs and symptoms include abdominal mass, abdominal pain, and jaundice. Morphologically, the cystic spaces are lined by columnar epithelium and contain mucinous or serous fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystic Neoplasm \ Intraductal Papillary Mucinous</VALIDVALUE>
          <VALUEMEANING>Intrahepatic Bile Duct Mucinous Cystic Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A mucinous cystic neoplasm that arises from the intrahepatic bile ducts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248910</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystic Medial Necrosis</VALIDVALUE>
          <VALUEMEANING>Cystic Medial Necrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>An idiopathic disorder characterized by the degeneration of the aortic media tissue and formation of cyst-like spaces.  It may lead to aortic dissection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystadenoma \ Serous</VALIDVALUE>
          <VALUEMEANING>Serous Cystadenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A serous neoplasm in which the cysts and papillae are lined by a single layer of cells without atypia, architectural complexity or invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystadenoma \ Mucinous</VALIDVALUE>
          <VALUEMEANING>Mucinous Cystadenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or low malignant potential cystic epithelial neoplasm composed of cells which contain intracytoplasmic mucin. It may arise from the ovary, pancreas, appendix, and lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystadenoma \ Any Benign/Hyperplastic/Metaplastic Subtype</VALIDVALUE>
          <VALUEMEANING>Any Benign Hyperplasia Metaplastic Subtype Cystadenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One, some, every, or all without specification.: (beh-NINE) Not cancerous; does not invade nearby tissue or spread to other parts of the body.: An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.: Pertaining to or characterized by metaplasia.: Subtype; a group forming a type within a larger type.: A benign or borderline cystic epithelial neoplasm arising from the glandular epithelium.  The epithelial cells line the cystic spaces which contain serous or mucinous fluid.  Representative examples include ovarian and pancreatic cystadenomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2972, C25696, C25566, C3113, C14172, C81168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystadenofibroma</VALIDVALUE>
          <VALUEMEANING>Cystadenofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or borderline neoplasm that arises from the ovaries and the fallopian tubes. It is characterized by the presence of cystic glandular structures and fibrous tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystadenocarcinoma \ Mucinous</VALIDVALUE>
          <VALUEMEANING>Mucinous Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma characterized by cystic changes and the presence of malignant glandular cells which contain intracytoplasmic mucin. It may arise from the ovary, pancreas, appendix, and lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3776</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3027126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystadenocarcinoma \ Bile Duct Cystadenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Bile Duct Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A mucinous cystic neoplasm that arises from the intrahepatic or extrahepatic bile ducts and it is associated with an invasive carcinomatous component.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystadenocarcinoma \ Any Malignant Subtype</VALIDVALUE>
          <VALUEMEANING>Malignant Subtype Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>(ma-LIG-nant) Cancerous; a growth with a tendency to invade and destroy nearby tissue and spread to other parts of the body.: Subtype; a group forming a type within a larger type.: A malignant cystic epithelial neoplasm arising from the glandular epithelium.  The malignant epithelial cells invade the stroma.  The cystic spaces contain serous or mucinous fluid.  Representative examples include ovarian and pancreatic cystadenocarcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2971, C25696, C14143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystadenocarcinoma \ Acinar Cell</VALIDVALUE>
          <VALUEMEANING>Pancreatic Acinar Cell Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A cystic adenocarcinoma characterized by the presence of relatively uniform neoplastic cells which produce pancreatic enzymes and are arranged in acinar patterns. Signs and symptoms include abdominal pain, weight loss, nausea, and diarrhea. It usually has an aggressive clinical course.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystadenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant cystic epithelial neoplasm arising from the glandular epithelium.  The malignant epithelial cells invade the stroma.  The cystic spaces contain serous or mucinous fluid.  Representative examples include ovarian and pancreatic cystadenocarcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2831119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyst \ Simple Solitary</VALIDVALUE>
          <VALUEMEANING>Solitary Breast Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>A single, fluid-filled cyst in the breast parenchyma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyst \ Laryngocele</VALIDVALUE>
          <VALUEMEANING>Laryngocele</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare congenital malformation in the larynx.  It is characterized by the presence of an air-filled sac within the laryngeal wall which may bulge on the neck.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97062</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyst \ Hyperplastic/Metaplastic Subtype</VALIDVALUE>
          <VALUEMEANING>Metaplastic Synovial Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>A cyst lined by tissue that resembles synovial villi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97061</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyst \ Complex Cyst</VALIDVALUE>
          <VALUEMEANING>Complex Ovarian Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>A cystic lesion that arises from the ovary. It is characterized by the presence of cystic spaces that contain fluid and a solid tissue component.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyst \ Biliary</VALIDVALUE>
          <VALUEMEANING>Biliary Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>A cystic dilatation that occurs in any part of the biliary tree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyst \ Aneurysmal</VALIDVALUE>
          <VALUEMEANING>Aneurysmal Bone Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>Solitary lesions of bone that typically cause a bulging of the overlying cortex bearing some resemblance to the saccular protrusion of the aortic wall in aortic aneurysm, hence the name. (Dorland, 27th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3516</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyst</VALIDVALUE>
          <VALUEMEANING>Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>(sist) A sac or capsule filled with fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2978</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Craniopharygioma \ Papillary</VALIDVALUE>
          <VALUEMEANING>Papillary Craniopharyngioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A craniopharyngioma composed of sheets of squamous epithelium which separate to form pseudopapillae. This variant typically lacks nuclear palisading, wet keratin, calcification, and cholesterol deposits. Clinically, endocrine deficiencies are more often associated with papillary craniopharyngioma than with the adamantinomatous type. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4725</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fungal Infection \ Aspergillus</VALIDVALUE>
          <VALUEMEANING>Aspergillosis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infectious fungal disease that occurs most often in the skin, ears, nasal sinuses, and lungs of people with suppressed immune systems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2886</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Follicular Neoplasms</VALIDVALUE>
          <VALUEMEANING>Hair Follicle Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant neoplasm arising from the hair follicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibroxanthoma \ Atypical</VALIDVALUE>
          <VALUEMEANING>Atypical Fibroxanthoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An intermediate cutaneous fibrohistiocytic neoplasm, characterized by pleomorphic spindle cells, usually affecting the actinic-damaged skin of the elderly.  The tumor presents as a single cutaneous nodule which is often ulcerated.  Microscopically, it is indistinguishable from pleomorphic forms of malignant fibrous histiocytoma, and it is regarded by many experts as a superficial form of the latter.  The vast majority of patients have an excellent prognosis following conservative therapy.  Recurrences are infrequent, and metastasis is rare. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249521</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrous Tumors \ Tendon Sheath</VALIDVALUE>
          <VALUEMEANING>Tendon Sheath Fibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A small, slow growing, benign neoplasm arising from the tendon sheaths. The tumor is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6485</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrous Tumors \ Solitary</VALIDVALUE>
          <VALUEMEANING>Solitary Fibrous Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A localized neoplasm of probable fibroblastic derivation. It is characterized by the presence of round to spindle-shaped cells, hylanized stroma formation, thin-walled branching blood vessels, and thin bands of collagen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrous Tumors \ Reactive Myofibroblastic Proliferation At Visceral Locations</VALIDVALUE>
          <VALUEMEANING>Inflammatory Myofibroblastic Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A multinodular intermediate fibrocytic neoplasm that arises from soft tissue or viscera, in children and young adults.  It is characterized by the presence of spindle-shaped myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrous Tumors \ Proliferative</VALIDVALUE>
          <VALUEMEANING>Proliferative Fasciitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rapid growing, poorly circumscribed, non-encapsulated, benign neoplasm that arises from the subcutaneous tissues. It is characterized by the presence of spindle-shaped fibroblasts, round ganglion-like cells, myxoid to collagenous stroma formation, and high mitotic activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4728</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrous Tumors \ Nodular Fasciitis</VALIDVALUE>
          <VALUEMEANING>Nodular Fasciitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rapid growing, non-encapsulated benign neoplasm that arises from the soft tissues. It is characterized by the presence of non-hyperchromatic spindle-shaped fibroblasts, multinucleated osteoclast-like giant cells, chronic inflammatory infiltrate, red blood cell extravasation, and high mitotic activity, in a storiform growth pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3827</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrous Tumors \ Myositis Ossificans</VALIDVALUE>
          <VALUEMEANING>Myositis Ossificans</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by non-neoplastic bone formation in soft tissues. It usually follows blunt trauma and bleeding in the deep soft tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrous Tumors \ Myofibromatosis</VALIDVALUE>
          <VALUEMEANING>Myofibromatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign neoplasm arising from the soft tissues. It is characterized by the presence of myofibroblastic hyperchromatic spindle cells, hylanized stroma formation, calcification, necrosis, and a multinodular growth pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrous Tumors \ Myofibroma</VALIDVALUE>
          <VALUEMEANING>Myofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign localized neoplasm arising from the subcutaneous tissues and skeletal muscle. It is characterized by the presence of myofibroblastic hyperchromatic spindle cells, hylanized stroma formation, calcification, necrosis, and a multinodular growth pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7052</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrous Tumors \ Ischemic</VALIDVALUE>
          <VALUEMEANING>Fibrous Tumors \ Ischemic</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibrous Tumors \ Ischemic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrous Tumors \ Fibro-Osseous</VALIDVALUE>
          <VALUEMEANING>Fibro-Osseous Lesions</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibro-Osseous Lesions</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrous Tumors \ Elastofibroma</VALIDVALUE>
          <VALUEMEANING>Elastofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, slow-growing tumor arising from the soft tissues usually in the mid-thoracic region of the elderly. It is characterized by the presence of paucicellular collagenous tissue, adipocytes and a predominance of large coarse elastic fibers arranged in globules.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4245</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrous Tumors \ Dermatofibroma</VALIDVALUE>
          <VALUEMEANING>Cutaneous Fibrous Histiocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A solitary, slowly growing nodular mass, most often affecting the extremities.  It is composed of fibrous and histiocytic cells which infiltrate the dermis and occasionally the underlying subcutaneous tissue.  Usually local excision is curative.  Recurrences are reported only in a small minority of cases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrothecoma \ Luteinized</VALIDVALUE>
          <VALUEMEANING>Ovarian Luteinized Thecoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A variant of ovarian thecoma characterized by the presence of lutein cells. It is associated with a lower frequency of estrogenic manifestations compared to typical thymomas. In a minority of cases androgenic manifestations are present. It may also be associated with sclerosing peritonitis which presents with ascites and symptoms of bowel obstruction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrothecoma</VALIDVALUE>
          <VALUEMEANING>Tumor of the Thecoma/Fibroma Group</VALUEMEANING>
          <MEANINGDESCRIPTION>A sex cord-stromal tumor that arises from the ovary or the testis. Representative examples include fibroma, fibrosarcoma, and thecoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrosis (Peyronie&#39;s Disease)</VALIDVALUE>
          <VALUEMEANING>Peyronie&#39;s Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibromatosis arising from the soft tissues of the penis. It is characterized by the presence of spindle-shaped fibroblasts, and an infiltrative growth pattern.  It causes the penis to bend when it becomes erect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibromyalgia (Chronic Fatigue Syndrome)</VALIDVALUE>
          <VALUEMEANING>Fibromyalgia</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic disorder of unknown etiology charaterized by pain, stiffness, and tenderness in the muscles of the neck, shoulders, back, hips, arms, and legs  Other signs and symptoms include headaches, fatigue, sleep disturbances, and painful menstruation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C87497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibromatosis, Plantar</VALIDVALUE>
          <VALUEMEANING>Plantar Fibromatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A superficial fibromatosis arising from soft tissue of the plantar regions. It is characterized by the presence of spindle-shaped fibroblasts, hypercellularity, and an infiltrative growth pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibromatosis, Palmar (Dupuytrne&#39;s)</VALIDVALUE>
          <VALUEMEANING>Palmar Fibromatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A superficial fibromatosis arising from the soft tissue of the palm. It is characterized by the presence of spindle-shaped fibroblasts, and an infiltrative growth pattern. It predominantly affects adult males.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune Disease \ Rheumatoid Arthritis</VALIDVALUE>
          <VALUEMEANING>Rheumatoid Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2884</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ NASH (Non Alcoholic Steatohepatitis)</VALIDVALUE>
          <VALUEMEANING>Nonalcoholic Steatohepatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Fatty replacement and damage to the hepatocytes not related to alcohol use. It may lead to cirrhosis and liver failure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meningioma \ Atypical</VALIDVALUE>
          <VALUEMEANING>Atypical Meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade II meningioma with increased mitotic activity or three or more of the following features: increased cellularity, small cells with high nuclear to cytoplasm ratio, prominent nucleoli, uninterrupted patternless or sheet-like growth, and foci of spontaneous or geographic necrosis. (Adapted from WHO 2000.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4723</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuroendocrine Tumor (Includes Carcinoid) \ Multiple Endocrine Neoplasm (MEN) Type 2A</VALIDVALUE>
          <VALUEMEANING>Multiple Endocrine Neoplasia Type 2A</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple endocrine neoplasia caused by mutation of the RET gene. Patients develop medullary thyroid carcinomas, and may also develop pheochromocytomas and parathyroid gland hyperplasia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3226</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuroendocrine Tumor (Includes Carcinoid) \ Multiple Endocrine Neoplasm (MEN) Type 2B</VALIDVALUE>
          <VALUEMEANING>Multiple Endocrine Neoplasia Type 2B</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple endocrine neoplasia caused by mutation of the RET gene. Patients develop medullary thyroid carcinomas and numerous neural defects including neuromas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Congenital Mesoblastic Nephroma \ Classical</VALIDVALUE>
          <VALUEMEANING>Classic Congenital Mesoblastic Nephroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital mesoblastic nephroma characterized by the presence of interlacing fascicles of fibroblastic cells, low mitotic activity, and collagen formation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Congenital Mesoblastic Nephroma \ Cellular</VALIDVALUE>
          <VALUEMEANING>Cellular Congenital Mesoblastic Nephroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital mesoblastic nephroma characterized by increased cellularity, sheet-like proliferation of fibroblastic cells, and increased mitotic activity.  Necrotic changes are commonly present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39815</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Congenital Disease \ Malformation</VALIDVALUE>
          <VALUEMEANING>Congenital Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>Any abnormality, anatomical or biochemical, evident at birth or during the neonatal period.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2849</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2993000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Condyloma With Dysplasia</VALIDVALUE>
          <VALUEMEANING>Condyloma Acuminatum with Dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Condyloma acuminatum that is associated with the presence of dysplastic epithelial changes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97057</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Condyloma \ Acuminatum</VALIDVALUE>
          <VALUEMEANING>Condyloma Acuminatum</VALUEMEANING>
          <MEANINGDESCRIPTION>A sexually transmitted papillary growth caused by the human papilloma virus. It usually arises in the skin and mucous membranes of the perianal region and external genitalia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complex Sclerosing Lesion/Radial Scar</VALIDVALUE>
          <VALUEMEANING>Radial Scar/Complex Sclerosing Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign breast lesion characterized by the presence of fibrosis with stellate appearance in the parenchyma. The lesions are often multiple and bilateral. Grossly, the lesions are irregular and firm and resemble carcinoma. Microscopically, the stellate lesions are composed of dense, hyalinized collagen. Entrapped in the collagen are tubules. There is no evidence of cytologic atypia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Combined Hepatocellular &amp; Cholangiocarcinoma</VALIDVALUE>
          <VALUEMEANING>Combined Hepatocellular Carcinoma and Cholangiocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare tumor containing unequivocal elements of both hepatocellular and cholangiocarcinoma that are intimately admixed.  This tumor should be distinguished from separate hepatocellular carcinoma and cholangiocarcinoma arising in the same liver.  The prognosis of this tumor is poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colloid Nodule</VALIDVALUE>
          <VALUEMEANING>Colloid Nodule</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-cancerous thyroid gland nodule that contains colloid material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97056</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clear Cell Adenofibroma</VALIDVALUE>
          <VALUEMEANING>Clear Cell Adenofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign neoplasm characterized by the presence of glandular structures which contain clear cells and a fibrotic stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibromatosis (Desmoid Tumor)</VALIDVALUE>
          <VALUEMEANING>Fibromatosis Desmoid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An insidious poorly circumscribed neoplasm arising from the deep soft tissues. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249546</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Ductal Plate Formation</VALIDVALUE>
          <VALUEMEANING>Ductal Plate Malformation</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital disorder of the intrahepatic bile ducts characterized by abnormal embryonal development of the ductal plates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97072</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Diverticulum</VALIDVALUE>
          <VALUEMEANING>Diverticulum</VALUEMEANING>
          <MEANINGDESCRIPTION>A pathological condition manifested as a pouch or sac opening from a tubular or saccular organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26753</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2684801</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Diverticulosis</VALIDVALUE>
          <VALUEMEANING>Diverticulosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition marked by small sacs or pouches (diverticula) in the walls of an organ such as the stomach or colon. These sacs can become inflamed and cause a condition called diverticulitis, which may be a risk factor for certain types of cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4922</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Diverticulitis</VALIDVALUE>
          <VALUEMEANING>Diverticulitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection that develops in the diverticula of the intestinal tract. Signs and symptoms include abdominal pain, fever, and leukocytosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Crohn&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Crohn Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn&#39;s disease most commonly involves the terminal ileum; the colon is the second most common site of involvement. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Congenital Hepatic Fibrosis Not Associated With Polycystic Kidney Disease</VALIDVALUE>
          <VALUEMEANING>Congenital Hepatic Fibrosis Not Associated With Polycystic Kidney Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Congenital Hepatic Fibrosis Not Associated With Polycystic Kidney Disease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Congenital Hepatic Fibrosis Associated With Polycystic Kidney Disease</VALIDVALUE>
          <VALUEMEANING>Congenital Hepatic Fibrosis Associated With Polycystic Kidney Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Congenital Hepatic Fibrosis Associated With Polycystic Kidney Disease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Collagenous Colitis</VALIDVALUE>
          <VALUEMEANING>Collagenous Colitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of microscopic colitis of unknown etiology. It is characterized by the presence of collagen deposits in the lamina propria of the colonic mucosa. Patients present with chronic watery diarrhea. Colonoscopy reveals normal-appearing mucosa. The diagnosis is made with the microscopic examination of the colonic biopsy samples.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27021</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Cirrhosis, Primary Biliary</VALIDVALUE>
          <VALUEMEANING>Primary Biliary Cirrhosis</VALUEMEANING>
          <MEANINGDESCRIPTION>An autoimmune inflammatory disorder characterized by destruction of the small intrahepatic bile ducts. It affects predominantly females and it may lead to cirrhosis and liver failure. Patients have antimitochondrial and antinuclear antibodies in the peripheral blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210799</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Cirrhosis, Alcoholic</VALIDVALUE>
          <VALUEMEANING>Alcoholic Cirrhosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Liver cirrhosis in alcoholics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34782</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Cirrhosis</VALIDVALUE>
          <VALUEMEANING>Cirrhosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholisms, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Cholesterosis</VALIDVALUE>
          <VALUEMEANING>Cholesterol Deposit</VALUEMEANING>
          <MEANINGDESCRIPTION>Deposition of cholesterol in the skin. It appears as a slightly elevated and yellow bump usually in the skin around the eyes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Cholelithiasis/Gallstones</VALIDVALUE>
          <VALUEMEANING>Cholecystitis with Cholelithiasis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute or chronic inflammation of the gallbladder associated with the presence of gallstones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35332</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Cholecystitis</VALIDVALUE>
          <VALUEMEANING>Cholecystitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute or chronic inflammation involving the gallbladder wall. It may be associated with the presence of gallstones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Celiac Disease</VALIDVALUE>
          <VALUEMEANING>Celiac Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A digestive disease that is caused by an immune response to a protein called gluten, which is found in wheat, rye, barley, and oats. Celiac disease damages the lining of the small intestine and interferes with the absorption of nutrients from food. A person with celiac disease may become malnourished no matter how much food is consumed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26714</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Biliary Ductal Ectasia (Caroli&#39;s Disease)</VALIDVALUE>
          <VALUEMEANING>Caroli Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare congenital disorder characterized by cystic dilatation of the intrahepatic bile ducts. It is associated with cholangitis and the formation of stones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Biliary Atresia, Extrahepatic</VALIDVALUE>
          <VALUEMEANING>Extrahepatic Biliary Atresia</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital disorder characterized by blockage or absence of the extrahepatic bile ducts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249581</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Atrophic Gastritis</VALIDVALUE>
          <VALUEMEANING>Chronic Atrophic Gastritis</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which the stomach muscles shrink and become weak. The digestive (peptic) glands may also shrink, resulting in a lack of digestive juices.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249583</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Appendicitis</VALIDVALUE>
          <VALUEMEANING>Acute Appendicitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute inflammation of the vermiform appendix.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35145</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal/Liver Disorders \ Achalasia</VALIDVALUE>
          <VALUEMEANING>Achalasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Failure of the smooth muscle fibers of the gastrointestinal tract to relax at any one point of junction of one part with another.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50451</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganglioneuroma</VALIDVALUE>
          <VALUEMEANING>Ganglioneuroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign neuroblastic tumor of the sympathetic nervous system that occurs in childhood. Ganglioneuroma typically arises from the sympathetic trunk in the mediastinum. Histologic features include spindle cell proliferation (resembling a neurofibroma) and the presence of large ganglion cells. Common presenting features include a palpable abdominal mass, hepatomegaly, and a thoracic mass detected on routine chest X-ray.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3049</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2964423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganglioneuroblastoma</VALIDVALUE>
          <VALUEMEANING>Ganglioneuroblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A moderately malignant neoplasm composed of primitive neuroectodermal cells dispersed in myxomatous or fibrous stroma intermixed with mature ganglion cells. It may undergo transformation into a neuroblastoma. It arises from the sympathetic trunk or less frequently from the adrenal medulla, cerebral cortex, and other locations. Cervical ganglioneuroblastomas may be associated with HORNER SYNDROME and the tumor may occasionally secrete vasoactive intestinal peptide, resulting in chronic diarrhea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganglioma</VALIDVALUE>
          <VALUEMEANING>Paraganglioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant neoplasm arising from paraganglia located along the sympathetic or parasympathetic nerves.  Infrequently, it may arise outside the usual distribution of the sympathetic and parasympathetic paraganglia.  Tumors arising from the adrenal gland medulla are called pheochromocytomas.  Morphologically, paragangliomas usually display a nesting (Zellballen) growth pattern.  There are no reliable morphologic criteria to distinguish between benign and malignant paragangliomas.  The only definitive indicator of malignancy is the presence of regional or distant metastases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganglioglioma, Anaplastic</VALIDVALUE>
          <VALUEMEANING>Anaplastic Ganglioglioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Anaplastic Ganglioglioma (WHO grade III) is a neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and anaplastic glial cells. These anaplastic changes in the glial component and high MIB-1 and TP53 labelling indices may indicate aggressive behavior.  However, the correlation of histological anaplasia with clinical outcome is inconsistent. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganglioglioma</VALIDVALUE>
          <VALUEMEANING>Ganglioglioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Ganglioglioma (WHO grade I or II) and Gangliocytoma (WHO grade I) are well differentiated, slow growing neuroepithelial neoplasms composed of neoplastic, mature ganglion cells either alone (gangliocytoma), or in combination with neoplastic glial cells (ganglioglioma). Some Gangliogliomas show anaplastic features in their glial component and are considered to be WHO grade III (see &#39;Anaplastic Ganglioglioma). There are rare cases of newly diagnosed Gangliogliomas with grade IV (Glioblastoma) changes in the glial component. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3788</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gangliocytoma, Dysplastic</VALIDVALUE>
          <VALUEMEANING>Dysplastic Cerebellar Gangliocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Dysplastic Gangliocytoma of the Cerebellum (WHO grade I), also called Lhermitte-Duclos disease, is a benign cerebellar mass, which occurs in young adults and is composed of dysplastic ganglion cells.  It is the major CNS manifestation of Cowden Disease, an autosomal dominant condition that causes a variety of hamartomas and neoplasms.(Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gangliocytoma</VALIDVALUE>
          <VALUEMEANING>Gangliocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Gangliocytoma (WHO grade I) and Ganglioglioma (WHO grade I or II) are well differentiated, slow growing neuroepithelial neoplasms composed of neoplastic, mature ganglion cells either alone (gangliocytoma), or in combination with neoplastic glial cells (ganglioglioma). (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Endometrioid Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Endometrioid Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian carcinoma and endometrial carcinoma. There is a high frequency of cooccurence of this form of adenocarcinoma in both tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3769</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3183464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Embryonal</VALIDVALUE>
          <VALUEMEANING>Embryonal Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed &amp; Holland et al., Cancer Medicine, 3d ed, p1595)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Eccrine</VALIDVALUE>
          <VALUEMEANING>Eccrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma with eccrine differentiation arising from the sweat glands. It includes the following subtypes: ductal eccrine adenocarcinoma, papillary eccrine carcinoma, and eccrine porocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27255</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Ductal Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Ductal Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma arising from the ducts.  While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast.  Ductal carcinomas account for about two thirds of all breast cancers.  Two types of ductal carcinomas have been described: Ductal carcinoma in situ (DCIS) and invasive ductal carcinoma, not otherwise specified.  The latter often spreads to the axillary lymph nodes and other anatomic sites.  The two forms of ductal carcinoma often coexist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4017</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Cortical</VALIDVALUE>
          <VALUEMEANING>Adrenal Cortex Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing&#39;s syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9325</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Combined Small Cell &amp; Non-Small Cell</VALIDVALUE>
          <VALUEMEANING>Combined Small Cell Lung Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of small cell lung carcinoma in combination with a non-small cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Collecting Duct</VALIDVALUE>
          <VALUEMEANING>Carcinoma of the Collecting Ducts of Bellini</VALUEMEANING>
          <MEANINGDESCRIPTION>Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Clear Cell (Mesonephric)</VALIDVALUE>
          <VALUEMEANING>Bladder Clear Cell Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare morphologic variant of bladder adenocarcinoma characterized by the presence of malignant glandular epithelial cells and clear cells distributed in a tubulo-cystic, papillary, or diffuse pattern.  There is a female predilection.  Clinical presentation includes hematuria and dysuria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6179</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Clear Cell (Conventional)</VALIDVALUE>
          <VALUEMEANING>Conventional (Clear Cell) Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network.  The tumor may metastasize to unusual sites and late metastasis is common.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4033</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581625</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Clear Cell</VALIDVALUE>
          <VALUEMEANING>Clear Cell Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>(kar-sin-O-ma) A rare type of tumor of the female genital tract in which the inside of the cells looks clear when viewed under a microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3766</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3081856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Chromophobe</VALIDVALUE>
          <VALUEMEANING>Chromophobe Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical) or eosinophilic.  It has a much better prognosis than other renal cell carcinomas.  -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581665</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Cholangiocarcinoma</VALIDVALUE>
          <VALUEMEANING>Cholangiocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An malignant tumor composed of cells resembling those of bile ducts. Cholangiocarcinoma is a relatively rare tumor in most populations. It can arise from any portion of the intrahepatic bile duct epithelium or the hepatic ducts. Grossly, the lesions are nodular, grayish-white firm and solid. Microscopically, the vast majority of cholangiocarcinomas are adenocarcinomas showing tubular and/or papillary structures. Early detection of cholangiocarcinomas is difficult, and the overall prognosis after resection is poor (adapted from WHO, 2000).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3165468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Bronchoalveolar</VALIDVALUE>
          <VALUEMEANING>Bronchioalveolar Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A solitary adenocarcinoma arising from the lung measuring 3 cm or less. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2923</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3106712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Basaloid</VALIDVALUE>
          <VALUEMEANING>Basaloid Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant epithelial neoplasm characterized by the presence of neoplastic cells with hyperchromatic nuclei, small amount of cytoplasm, and peripheral nuclear palisading.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4121</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2861316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Basal Cell</VALIDVALUE>
          <VALUEMEANING>Skin Basal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The most frequently seen skin cancer. It arises from basal cells of the epidermis and pilosebaceous units. Clinically it is divided into the following types: nodular, ulcerative, superficial, multicentric, erythematous, and sclerosing or morphea-like.. More than 95% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck and the remaining 15% on the trunk and extremities. Basal cell carcinoma usually grows in a slow and indolent fashion. However, if untreated, the tumor may invade the subcutaneous fat, skeletal muscle and bone. Distant metastases are rare. Excision, curettage and irradiation cure most basal cell carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2921</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2961462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Apocrine Carcinoma</VALIDVALUE>
          <VALUEMEANING>Apocrine Gland Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma with apocrine differentiation arising from the sweat glands. It presents as single or multiple nodular lesions which may be ulcerated or hemorrhagic and is usually in the axilla and less often in the anogenital region. It grows in the dermis and infiltrates subcutaneous tissues. It is characterized by the presence of large cells with abundant eosinophilic cytoplasm and large often vesicular nuclei. Most cases are slow growing tumors and have a prolonged course.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4169</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Adnexal</VALIDVALUE>
          <VALUEMEANING>Adnexal Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma arising from the sebaceous glands, sweat glands, or the hair follicles. Representative examples include sebaceous carcinoma, apocrine carcinoma, eccrine carcinoma, and pilomatrical carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3775</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Adenosquamous With HPV</VALIDVALUE>
          <VALUEMEANING>Human Papillomavirus-Related Adenosquamous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenosquamous carcinoma associated with the presence of human papillomavirus infection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Adenoid Cystic</VALIDVALUE>
          <VALUEMEANING>Adenoid Cystic Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor arising from the epithelial cells, also known as cylindroma.  Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma).  Adenoid cystic carcinomas mostly occur in the salivary glands.  Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs.  Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur.  Lymph node metastases are unusual; hematogenous tumor spread is characteristic. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2836817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Adenocarcinoma With Signet Ring Cells</VALIDVALUE>
          <VALUEMEANING>Signet Ring Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A highly malignant type of cancer typically found in glandular cells that line the digestive organs. The cells resemble signet rings when examined under a microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3774</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Adenocarcinoma Arising In Polyp</VALIDVALUE>
          <VALUEMEANING>Adenocarcinoma in Adenomatous Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive or invasive adenocarcinoma arising from the neoplastic glandular cells in an adenomatous polyp.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7676</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Acinic Cell</VALIDVALUE>
          <VALUEMEANING>Acinar Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Benign Lymphoid Hyperplasia</VALIDVALUE>
          <VALUEMEANING>Benign Lymphoid Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A polyclonal proliferation of lymphocytes without evidence of cytologic atypia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia \ Adenomyomatous</VALIDVALUE>
          <VALUEMEANING>Adenomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign neoplasm characterized by the presence of a glandular and a mesenchymal (fibromyomatous) component. It occurs in the uterine corpus and the cervix. A variant of adenomyoma associated with glandular architectural complexity is called atypical polypoid adenomyoma. Simple polypectomy is usually curative. Atypical polypoid adenomyoma may recur following polypectomy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperplasia</VALIDVALUE>
          <VALUEMEANING>Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3113</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydatidiform Mole</VALIDVALUE>
          <VALUEMEANING>Hydatidiform Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A gestational disorder characterized by an abnormal placenta with marked enlargement of the chorionic villi and hyperplasia of the villous trophoblastic cells.  According to the amount of villous involvement, a hydatidiform mole is defined as complete or partial.  Most molar pregnancies are complete and are characterized by generalized hydropic villous changes.  Partial moles are characterized by a mixture of large hydropic villi and normal placenta tissue.  Complete moles are usually diploid and typically present between the eleventh and twenty-fifth week of pregnancy, whereas partial moles are usually triploid and usually present around the nineteenth week of pregnancy.  The incidence of choriocarcinoma is higher in patients with complete hydatidiform mole.  When a hydatidiform mole invades the myometrium and broad ligament, or it is found in distant sites as vagina, vulva, and lung, it is referred as invasive mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3110</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Histiocytic Neoplasm</VALIDVALUE>
          <VALUEMEANING>Fibrohistiocytic Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant neoplasm composed of fibrohistiocytic cells, spindle fibrocytic cells, and histiocytes, in a storiform pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Histiocytic Macrophage Neoplasms \ Letterer-Siwe Disease</VALIDVALUE>
          <VALUEMEANING>Letterer-Siwe Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A multifocal, multisystem form of Langerhans-cell histiocytosis. There is involvement of multiple organ systems including the bones, skin, liver, spleen, and lymph nodes. Patients are usually infants presenting with fever, hepatosplenomegaly, lymphadenopathy, bone and skin lesions, and pancytopenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249983</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Histiocytic Macrophage Neoplasms \ Interdigitating Dendritic Cell Sarcoma</VALIDVALUE>
          <VALUEMEANING>Interdigitating Dendritic Cell Sarcoma/Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplastic proliferation of spindle to ovoid cells which show phenotypic features similar to those of interdigitating dendritic cells.  The clinical course is variable ranging from benign localized disease to widespread lethal disease. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Histiocytic Macrophage Neoplasms \ Histiocytosis</VALIDVALUE>
          <VALUEMEANING>Histiocytic Infiltrate</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating tissue infiltration by non-neoplastic or neoplastic histiocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3106</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3226253</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Histiocytic Macrophage Neoplasms \ Follicular Dendritic Cell Sarcoma</VALIDVALUE>
          <VALUEMEANING>Follicular Dendritic Cell Sarcoma/Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm composed of spindle to ovoid cells which have morphologic and immunophenotypic characteristics of follicular dendritic cells. It affects lymph nodes and other sites including the tonsils, gastrointestinal tract, spleen, liver, soft tissues, skin, and oral cavity. It usually behaves as a low grade sarcoma. Treatment options include complete surgical removal of the tumor with or without adjuvant chemotherapy or radiotherapy. Recurrences have been reported in up to half of the cases. Cases which present with abdominal involvement and a high morphologic grade usually have a poorer prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2839726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Histiocytic Macrophage Neoplasms</VALIDVALUE>
          <VALUEMEANING>Histiocytic Macrophage Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Histiocytic Macrophage Neoplasm</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High Grade Dysplasia, Squamous</VALIDVALUE>
          <VALUEMEANING>High Grade Squamous Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A precancerous neoplastic process characterized by the presence of moderate or severe dysplastic cytological changes which extend to the upper part of the squamous epithelium.  Maturation at the surface of the squamous epithelium may or may not be present.  Representative examples include the high grade esophageal squamous intraepithelial neoplasia, high grade cervical squamous intraepithelial neoplasia, high grade vaginal intraepithelial neoplasia, and high grade vulvar intraepithelial neoplasia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatoma</VALIDVALUE>
          <VALUEMEANING>Hepatocellular Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatoblastoma</VALIDVALUE>
          <VALUEMEANING>Stratum 5: Hepatoblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant liver neoplasm that occurs almost exclusively in infants, although isolated cases in older children and adults have been reported. Grossly, hepatoblastoma is solid, well circumscribed, and more often solitary than multiple. Microscopically, most of the tumors are composed exclusively of immature hepatocytic elements. About a fourth of hepatoblastomas contain a stromal component that may be undifferentiated or develop into bone or cartilage. The treatment of choice for hepatoblastoma is surgical excision with adjuvant therapy. Liver transplantation is being increasingly used as well.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3728</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Keratoacanthoma</VALIDVALUE>
          <VALUEMEANING>Keratoacanthoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A dome-shaped, rapidly growing skin lesion composed of well differentiated squamous cells.  It represents a proliferation of the infundibular epithelium of the hair follicle and its morphologic distinction from a well differentiated carcinoma may be difficult or impossible.  Keratoacanthomas affect males more frequently than females and the majority tend to regress spontaneously.  It has been suggested that keratoacanthoma represents a distinct subtype of squamous cell carcinoma of the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Keloid/ Hyperplastic Scar</VALIDVALUE>
          <VALUEMEANING>Keloid</VALUEMEANING>
          <MEANINGDESCRIPTION>A thick, irregular scar caused by excessive tissue growth at the site of an incision or wound.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3145</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Islet Cell Tumor \ Gastrinoma</VALIDVALUE>
          <VALUEMEANING>Pancreatic Gastrinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neuroendocrine tumor arising from the pancreas.  It is characterized by inappropriate secretion of gastrin and associated with Zollinger Ellison syndrome. The latter is characterized by the presence of peptic ulcer, gastroesophageal reflux disease, abdominal pain, diarrhea, and malabsorption.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95596</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Islet Cell Tumor</VALIDVALUE>
          <VALUEMEANING>Pancreatic Neuroendocrine Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas.  According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Islet Cell Hyperplasia/ Nesidioblastosis</VALIDVALUE>
          <VALUEMEANING>Nesidioblastosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A sporadic or inherited disorder characterized by the focal or diffuse proliferation of Langerhans cells in the pancreas. It results in hyperinsulinemia and hypoglycemia.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3192960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraepithelial Neoplasia</VALIDVALUE>
          <VALUEMEANING>Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A precancerous neoplastic process that affects the squamous, glandular, or transitional cell epithelium without evidence of invasion. According to the degree of nuclear atypia, number of mitotic figures, and presence of architectural distortion, it is classified as low grade (mild dysplasia) or high grade (moderate or severe dysplasia).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraepithelial Dysplasia Of Prostatic Ducts</VALIDVALUE>
          <VALUEMEANING>Prostatic Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplastic proliferation of the epithelial cells that line the acini and the ducts of the prostate gland.  The neoplastic epithelial cells are confined within the acini and the ducts and they do not invade the surrounding prostatic stroma.  Morphologically, it is classified as low or high grade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraductal Papillary Mucinous Neoplasm</VALIDVALUE>
          <VALUEMEANING>Pancreatic Intraductal Papillary-Mucinous Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A glandular neoplasm arising from the exocrine pancreas.  Microscopically it is characterized by the presence of mucoid stroma formation, papillary patterns, and cystic changes.  It has been associated with KRAS and Tp53 gene mutations.  Histologic variants include adenoma, borderline tumors, and carcinomas.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38342</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intestinal Metaplasia (Barrett&#39;s Esophagus)  With Dysplasia</VALIDVALUE>
          <VALUEMEANING>Dysplasia in Barrett Esophagus</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelial dysplasia that develops in Barrett esophagus. It is classified as low or high grade. When technical reasons make the interpretation of atypia difficult, atypia is present but it is not quite to the level of dysplasia, or atypia is present at the bases of the crypts but does not reach the surface of the crypts, then the diagnosis of Barrett esophagus-indefinite for dysplasia is made.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intestinal Metaplasia (Barrett&#39;s Esophagus)</VALIDVALUE>
          <VALUEMEANING>Barrett Esophagus</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophageal segment lined with columnar metaplastic epithelium which is flat or villiform.  Barrett&#39;s epithelium is characterized by two different types of cells: goblet cells and columnar cells.  The symptomatology of Barrett&#39;s esophagus is that of gastro-esophageal reflux.  It is the precursor of most esophageal adenocarcinomas.  (WHO, 2000) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2891</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intestinal Metaplasia</VALIDVALUE>
          <VALUEMEANING>Intestinal Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the replacement of epithelial tissue outside the intestines by intestinal-type epithelium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammatory Myofibroblastic Tumor</VALIDVALUE>
          <VALUEMEANING>Inflammatory Myofibroblastic Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A multinodular intermediate fibrocytic neoplasm that arises from soft tissue or viscera, in children and young adults.  It is characterized by the presence of spindle-shaped myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammation Polymyositis</VALIDVALUE>
          <VALUEMEANING>Polymyositis</VALUEMEANING>
          <MEANINGDESCRIPTION>Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY, NERVOUS SYSTEM); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26925</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2585215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammation \ Granulomatous</VALIDVALUE>
          <VALUEMEANING>Granuloma</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory reaction usually caused by infectious organisms, foreign bodies, or cholesterol deposits. It is characterized by the presence of epithelioid histiocytes and chronic inflammation. Often times giant cells are present. Necrosis is sometimes observed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammation \ Eosinophilic</VALIDVALUE>
          <VALUEMEANING>Eosinophilic Infiltrate</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory infiltrate composed exclusively or predominantly of eosinophils.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammation \ Chronic</VALIDVALUE>
          <VALUEMEANING>Chronic Inflammatory Infiltrate</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the presence of reactive lymphocytes, lymphoplasmacytic cells, and/or reactive plasma cells in a tissue sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35980</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammation \ Aortitis</VALIDVALUE>
          <VALUEMEANING>Aortitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the aorta. Causes include trauma, infectious disorders, and connective tissue disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammation \ Acute</VALIDVALUE>
          <VALUEMEANING>Acute Inflammatory Infiltrate</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the presence of neutrophils and/or eosinophils in a tissue sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35979</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma</VALIDVALUE>
          <VALUEMEANING>Carcinoma - Type Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2916</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoid Tumor \ Atypical</VALIDVALUE>
          <VALUEMEANING>Atypical Carcinoid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoid tumor characterized by a high mitotic rate, often associated with the presence of necrosis and nuclear pleomorphism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C72074</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoid Tumor</VALIDVALUE>
          <VALUEMEANING>Carcinoid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A well-differentiated neuroendocrine neoplasm of low, intermediate, or high grade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C188218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2956072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchioloalveolar Carcinoma, Non-Invasive</VALIDVALUE>
          <VALUEMEANING>Bronchioalveolar Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A solitary adenocarcinoma arising from the lung measuring 3 cm or less. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2923</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3106712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brenner Tumor</VALIDVALUE>
          <VALUEMEANING>Brenner Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually benign tumor composed of solid and cystic nests of epithelial cells resembling transitional epithelium; it is surrounded by an abundant stromal component that is dense and fibroblastic in nature.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39954</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bowen&#39;s Disease</VALIDVALUE>
          <VALUEMEANING>Bowen Disease of the Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of squamous cell carcinoma in situ.  It is a distinct clinicopathological entity and arises from the skin or the mucocutaneous junction.  It affects predominantly white males in their 6-8th decades of life.  Exposed and non-exposed skin sites are equally affected.  UV damage and ingestion of inorganic arsenic may play a role in the development of the disease.  On the skin surface, it presents as a single or multiple erythematous, scaly, keratotic patches or plaques.  The clinical entity of erythroplasia of Queyrat is regarded as Bowen disease of the penis and it presents as an asymptomatic, red, circumscribed plaque.  Morphologically, Bowen disease is characterized by the presence of hyperkeratosis, parakeratosis, dyskeratosis, and acanthosis.  The keratotic squamous cells are atypical and display hyperchromatism and abnormal mitotic figures.  The dermoepidermal basement membrane is intact.  Complete surgical removal of the lesion may be curative.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Hepatocellular</VALIDVALUE>
          <VALUEMEANING>Hepatocellular Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Giant Cell</VALIDVALUE>
          <VALUEMEANING>Giant Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An epithelial neoplasm characterized by unusually large anaplastic cells. It is highly malignant with fulminant clinical course, bizarre histologic appearance and poor prognosis. It is most common in the lung and thyroid. (From Stedman, 25th ed &amp; Segen, Dictionary of Modern Medicine, 1992)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Follicular</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland Follicular Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  The nuclear features which characterise the thyroid gland papillary carcinoma are absent.  It is linked to radiation and comprises approximately 10% to 15% of thyroid cancers.  Clinically, it usually presents as a solitary mass in the thyroid gland.  It is generally unifocal and thickly encapsulated and shows invasion of the capsule or the vessels.  Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound and fine needle biopsy. Treatment options include: partial or complete thyroidectomy.  Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8054</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Ex Pleomorphic Adenoma (Malignant Mixed Tumor)</VALIDVALUE>
          <VALUEMEANING>Carcinoma ex Pleomorphic Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma arising in a pre-existing pleomorphic adenoma. It most often occurs in the parotid gland and less often in the submandibular gland and minor salivary gland. Patients usually present with a history of a long-standing mass which recently had undergone rapid growth. The prognosis depends on the invasiveness of the malignant component. Patients with non-invasive or minimally invasive tumors usually have a good prognosis following surgical resection. Invasive tumors are usually aggressive and are associated with recurrences and metastases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Epithelial-Myoepithelial</VALIDVALUE>
          <VALUEMEANING>Epithelial-Myoepithelial Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm which occurs mostly in the major salivary glands (most frequently in the parotid gland), but also in the minor salivary glands of the oral mucosa and the tracheobronchial tree. It is characterized by the presence of ductal structures which are lined by an inner layer of cuboidal epithelial-type cells and an outer layer of myoepithelial cells with clear or eosinophilic cytoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Invasive</VALIDVALUE>
          <VALUEMEANING>Invasive Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that is not confined to the epithelium, and has spread to the surrounding stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2947204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Inflammatory</VALIDVALUE>
          <VALUEMEANING>Inflammatory Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of breast cancer in which the breast looks red and swollen and feels warm. The skin of the breast may also show the pitted appearance called peau d&#39;orange (like the skin of an orange). The redness and warmth occur because the cancer cells block the lymph vessels in the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4001</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Hurthle Cell</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland Oncocytic Follicular Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A follicular carcinoma of the thyroid gland, characterized by the presence of large cells with eosinophilic granular cytoplasm and pleomorphic nuclei with prominent, eosinophilic nucleoli.  The nuclear features that characterize the papillary carcinomas of the thyroid gland are absent. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4946</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Mucoepidermoid</VALIDVALUE>
          <VALUEMEANING>Mucoepidermoid Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles &amp; Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3772</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Mucinous Noncystic</VALIDVALUE>
          <VALUEMEANING>Pancreatic Mucinous Noncystic Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A pancreatic adenocarcinoma, clinicopathologically distinct from conventional pancreatic ductal adenocarcinomas, with a relatively indolent behavior (5-year survival of 55%).  It often arises in association with intraductal pancreatic mucinous neoplasms. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Mucinous Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Mucinous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infection \ Viral</VALIDVALUE>
          <VALUEMEANING>Viral Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>A general term for diseases produced by viruses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2768976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infection \ Parasitic</VALIDVALUE>
          <VALUEMEANING>Parasitic Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>A successful invasion of a host by an organism that uses the host for food and shelter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27864</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infection \ Mycobacterial</VALIDVALUE>
          <VALUEMEANING>Mycobacterial Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>Infections with bacteria of the genus MYCOBACTERIUM.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26831</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3250516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infection \ Fungal</VALIDVALUE>
          <VALUEMEANING>Fungal Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection caused by eukaryotic heterotrophic organisms that live as saprobes or parasites, including mushrooms, yeasts, smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi refer to those that grow as multicellular colonies (mushrooms and molds).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3245</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2769007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infection \ Bacterial</VALIDVALUE>
          <VALUEMEANING>Bacterial Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>infections and associated diseases by bacteria, general or unspecified.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2890</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2769012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infarction \ Prostatectomy</VALIDVALUE>
          <VALUEMEANING>Prostatectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>(pros-ta-TEK-toe-mee) An operation to remove part or all of the prostate. Radical (or total) prostatectomy is the removal of the entire prostate and some of the tissue around it.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15307</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infarction \ Multi Infarct Dementia</VALIDVALUE>
          <VALUEMEANING>Multi-Infarct Dementia</VALUEMEANING>
          <MEANINGDESCRIPTION>A common form of dementia caused by multiple cortical or subcortical cerebral infarctions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Disorders \ Bronchitis</VALIDVALUE>
          <VALUEMEANING>Bronchitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute or chronic inflammatory process affecting the bronchi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2911</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Mixed Ductal-Endocrine</VALIDVALUE>
          <VALUEMEANING>Mixed Ductal-Endocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma of the pancreas containing both malignant ductal epithelial cells and endocrine cells.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6879</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248484</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Miixed Acinar-Endocrine</VALIDVALUE>
          <VALUEMEANING>Mixed Acinar-Endocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A pancreatic carcinoma characterized by the presence of a mixture of acinar and islet cell elements.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6878</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Metaplastic</VALIDVALUE>
          <VALUEMEANING>Metaplastic Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A general term used to describe carcinomas arising from epithelial cells that have been transformed into another cells type (metaplastic epithelial cells). A representative example is the adenocarcinoma arising in Barrett esophagus. This term is also used to describe carcinomas in which the malignant epithelial cells show differentiation towards another cell type. A representative example of the latter is the metaplastic breast carcinoma in which the malignant glandular cells show squamous, spindle cell, or chondroid/osseous differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248487</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Medullary Carcinoma</VALIDVALUE>
          <VALUEMEANING>Medullary Carcinoma, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>A term referring to medullary carcinomas which can develop in various anatomic sites such as the thyroid gland, breast, colon, rectum, and small intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Large Cell Undifferentiated</VALIDVALUE>
          <VALUEMEANING>Large Cell Lung Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An undifferentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular, squamous, or neuroendocrine differentiation. 
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Large Cell Neuroendocrine</VALIDVALUE>
          <VALUEMEANING>Large Cell Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838592</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Lacrimal Gland Carcinoma</VALIDVALUE>
          <VALUEMEANING>Lacrimal Gland Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that arises from the lacrimal glands. Representative examples include adenocarcinoma, carcinoma ex pleomorphic adenoma, squamous cell carcinoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Invasive Papillary-Mucinous</VALIDVALUE>
          <VALUEMEANING>Papillary Mucinous Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma characterized by cystic changes, papillary growth pattern, and the presence of malignant glandular cells which contain intracytoplasmic mucin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Invasive Micropapillary</VALIDVALUE>
          <VALUEMEANING>Invasive Micropapillary Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive breast carcinoma characterized by the presence of clusters of malignant cells located within artifactual clear stromal spaces that resemble vascular spaces.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36084</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Invasive Lobular - Tubulolobular</VALIDVALUE>
          <VALUEMEANING>Invasive Lobular Breast Carcinoma, Tubulolobular Variant</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells forming small tubular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97053</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Invasive Lobular - Solid</VALIDVALUE>
          <VALUEMEANING>Invasive Lobular Breast Carcinoma, Solid Variant</VALUEMEANING>
          <MEANINGDESCRIPTION>A grade I invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells that form trabeculae and groups infiltrating collagen bundles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97052</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Invasive Lobular - Pleomorphic</VALIDVALUE>
          <VALUEMEANING>Invasive Lobular Breast Carcinoma, Pleomorphic Variant</VALUEMEANING>
          <MEANINGDESCRIPTION>A grade II invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells with large and atypical nuclei.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97051</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Invasive Lobular - Alveolar Type</VALIDVALUE>
          <VALUEMEANING>Invasive Lobular Breast Carcinoma, Alveolar Variant</VALUEMEANING>
          <MEANINGDESCRIPTION>A grade I invasive lobular carcinoma of the breast, characterized by the presence of round groups of neoplastic cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97049</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Invasive Lobular</VALIDVALUE>
          <VALUEMEANING>Invasive Lobular Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An infiltrating lobular adenocarcinoma.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures. --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Invasive Ductal</VALIDVALUE>
          <VALUEMEANING>Invasive Ductal Carcinoma, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>Invasive ductal carcinoma is the most common type of invasive breast carcinoma (accounting for approximately 70% of breast carcinomas). The gross appearance is usually typical with an irregular stellate outline. Microscopically, randomly arranged epithelial elements are seen. When large sheets of malignant cells are present, necrosis may be seen. With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma. The in situ component is nearly always ductal but occasionally may be lobular or both. --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Invasive Cribriform</VALIDVALUE>
          <VALUEMEANING>Invasive Cribriform Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Invasive Alveolar</VALIDVALUE>
          <VALUEMEANING>Lung Adenocarcinoma with Mixed Bronchioloalveolar and Invasive Components</VALUEMEANING>
          <MEANINGDESCRIPTION>A lung adenocarcinoma consisting of a bronchioloalveolar component and an invasive adenocarcinomatous component.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Small Cell</VALIDVALUE>
          <VALUEMEANING>Pancreatic Small Cell Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas.  It is characterized by the presence of malignant small cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Signet-Ring Cell</VALIDVALUE>
          <VALUEMEANING>Signet Ring Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3774</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Serous</VALIDVALUE>
          <VALUEMEANING>Ovarian Serous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Ovarian serous adenocarcinoma is a serous neoplasm characterized by nuclear atypia, high mitotic activity, stratification, glandular complexity, branching papillary fronds and stromal invasion. --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7550</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Sebaceous</VALIDVALUE>
          <VALUEMEANING>Sebaceous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma with sebaceous differentiation. It presents as a painless mass and it may be multifocal. It grows in the ocular adnexae and in the skin of head and neck, trunk, genitals, and extremities. It is characterized by the presence of malignant cells with multivesicular and clear cytoplasm. It may recur and metastasize.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Sarcomatoid</VALIDVALUE>
          <VALUEMEANING>Sarcomatoid Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Cancer that arises in cells that appear spindle-shaped when viewed under a microscope. These cancers can occur in various places in the body, including the skin, lungs, kidney, breast, gastrointestinal tract, bone, and muscle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27004</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838764</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Salivary Gland Subtype</VALIDVALUE>
          <VALUEMEANING>Subtype Salivary Gland Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Subtype; a group forming a type within a larger type.: Malignant neoplasm of the salivary glands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9272, C25696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Salivary Duct</VALIDVALUE>
          <VALUEMEANING>Salivary Duct Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive, high grade adenocarcinoma that arises from the salivary glands. It usually affects elderly males and presents as a rapidly enlarging mass. It metastasizes to regional lymph nodes and distant anatomic sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Renal Cell - Papillary</VALIDVALUE>
          <VALUEMEANING>Hereditary Papillary Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A familiar carcinoma inherited in an autosomal dominant trait.  It is characterized by the development of multiple, bilateral papillary renal cell carcinomas.  The carcinomas range from microscopic lesions to clinically symptomatic tumors.  It is associated with activating mutations of the MET oncogene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Renal Cell - Clear Cell -Conventional</VALIDVALUE>
          <VALUEMEANING>Clear Cell Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network.  The tumor may metastasize to unusual sites and late metastasis is common.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4033</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Renal Cell - Chromophobe</VALIDVALUE>
          <VALUEMEANING>Chromophobe Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical) or eosinophilic.  It has a much better prognosis than other renal cell carcinomas.  -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Renal Cell</VALIDVALUE>
          <VALUEMEANING>Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Prostatic Duct</VALIDVALUE>
          <VALUEMEANING>Prostate Ductal Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive invasive adenocarcinoma of the prostate gland composed of large glands containing tall columnar cells.  The columnar cells have abundant cytoplasm and are reminiscent of endometrial carcinoma.  This type of adenocarcinoma has a tendency to metastasize to the lung and penis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Primary Peritoneal</VALIDVALUE>
          <VALUEMEANING>Primary Peritoneal Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, serous epithelial malignant tumor that arises from the lining of the peritoneum. It affects females. The clinical behavior and pathologic characteristics are similar to the papillary serous carcinoma that arises from the ovary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40022</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Polymorphous Low-Grade</VALIDVALUE>
          <VALUEMEANING>Salivary Gland Polymorphous Low Grade Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade malignant epithelial neoplasm arising from the salivary gland. It usually arises from the oral cavity, with approximately 60% of the cases involving the palate. The most common presenting sign is a painless mass in the palate. It is characterized by the presence of uniform, small to medium size malignant epithelial cells and an infiltrating pattern. There is a variety of morphologic patterns which may be present within an individual tumor, including lobular, papillary, papillary-cystic, cribriform, and trabecular pattern. It usually has a favorable clinical outcome and a low metastatic potential.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Papillary Serous</VALIDVALUE>
          <VALUEMEANING>Papillary Serous Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant cystic serous epithelial neoplasm characterized by the presence of malignant glandular epithelial cells forming papillary structures. Stromal invasion is present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Papillary</VALIDVALUE>
          <VALUEMEANING>Papillary Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2927</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Oncocytic</VALIDVALUE>
          <VALUEMEANING>Oxyphilic Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma characterized by the presence of large malignant epithelial cells with abundant granular eosinophilic cytoplasm (oncocytes). Representative examples include thyroid gland oncocytic follicular carcinoma, oncocytic breast carcinoma, and salivary gland oncocytic carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3679</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248544</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Non Small Cell - Non Endocrine</VALIDVALUE>
          <VALUEMEANING>Non Small Cell Non Endocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant epithelial neoplasm characterized by the absence of neoplastic small epithelial cells. A representative example is the lung non-small cell carcinoma.: An operation in which a term denies or inverts the meaning of another term or construction.: Collective designation for those tissues capable of secreting hormones.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2916, C41064, C25594, C65151</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Non Small Cell</VALIDVALUE>
          <VALUEMEANING>Non-Small Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant epithelial neoplasm characterized by the absence of neoplastic small epithelial cells. A representative example is the lung non-small cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65151</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2837836</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Neuroendocrine - Merkel Cell</VALIDVALUE>
          <VALUEMEANING>Merkel Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare malignant cutaneous tumor seen in elderly patients.  Its usual location is on the head, neck and extremities.  The tumor is composed of small round cells with scanty cytoplasm arranged in a trabecular pattern, or in ill-defined nodules or in a diffuse pattern.  The tumor cells contain cytoplasmic membrane-bound dense core granules resembling neurosecretory granules.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210716</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Disorders \ Bronchiectasis - Kartagener&#39;s Syndrome</VALIDVALUE>
          <VALUEMEANING>Kartagener Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive inherited syndrome characterized by situs inversus, bronchiectasis, and chronic sinusitis. There is a defect in the function of the cilia that line the respiratory tract.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Disorders \ Bronchiectasis</VALIDVALUE>
          <VALUEMEANING>Bronchiectasis</VALUEMEANING>
          <MEANINGDESCRIPTION>Segmental, irreversible dilation of the bronchial tree resulting in the accumulation of secretions which leads to obstruction. The most common cause is bacterial infection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Disorders \ Asthma</VALIDVALUE>
          <VALUEMEANING>Asthma</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2975594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Disorders \ Asbestosis</VALIDVALUE>
          <VALUEMEANING>Asbestosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A lung disorder caused by inhalation of asbestos fibers. It results in fibrosis of the lung parenchyma. Signs and symptoms include coughing, shortness of breath and chest pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Disorders \ Alveolar Proteinosis</VALIDVALUE>
          <VALUEMEANING>Pulmonary Alveolar Proteinosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare lung disorder characterized by the filling of the pulmonary alveoli with proteinaceous material which stains positive with periodic acid-Schiff stain. It may be idiopathic or secondary due to hematologic malignancies or the inhalation of mineral dusts. Signs and symptoms include dyspnea, cough and low grade fever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85037</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Blastoma</VALIDVALUE>
          <VALUEMEANING>Pulmonary Blastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm of the lung composed of tubular structures and immature mesenchymal elements, which may differentiate towards skeletal and smooth muscle, cartilage or a combination of muscle and cartilage.  This is a nodular tumor found in the periphery of the lung.  It can occur at any age.  The prognosis is related to the stage of the disease at the time of resection.  Pulmonary blastoma is divided into two subtypes: epithelial predominant and biphasic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3732</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pseudo-Tumor \ Inflammatory</VALIDVALUE>
          <VALUEMEANING>Inflammatory Myofibroblastic Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A multinodular intermediate fibrocytic neoplasm that arises from soft tissue or viscera, in children and young adults.  It is characterized by the presence of spindle-shaped myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pseudo-Tumor</VALIDVALUE>
          <VALUEMEANING>Pseudotumor Cerebri</VALUEMEANING>
          <MEANINGDESCRIPTION>An idiopathic disorder characterized by chronic increase in the intracranial pressure. It occurs predominantly in obese females of childbearing age. It is associated with papilledema.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85035</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pseudomonas Related Vasculitis</VALIDVALUE>
          <VALUEMEANING>Pseudomonas Related Vasculitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A necrotizing vasculitis caused by Pseudomonas aeruginosa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97118</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pseudocyst</VALIDVALUE>
          <VALUEMEANING>Pseudocyst</VALUEMEANING>
          <MEANINGDESCRIPTION>A cyst-like structure that lacks an epithelial lining.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97117</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pseudocarcinomatous/ Pseudoepitheliomatous</VALIDVALUE>
          <VALUEMEANING>Pseudoepitheliomatous Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign lesion characterized by epidermal and adnexal epithelial hyperplasia.  It is caused by chronic inflammation and infection.  It may be associated with cutaneous neoplasms as well.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97115</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Post-Transplant Lymphoproliferative Disorder</VALIDVALUE>
          <VALUEMEANING>Post-Transplant Lymphoproliferative Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Post-transplant lymphoproliferative disorder (PTLD) is a polyclonal (benign) or clonal (malignant) proliferation of lymphoid cells that develops as a consequence of immunosuppression in a recipient of a solid organ or bone marrow allograft.  PTLDs comprise a spectrum ranging from early, Epstein-Barr virus (EBV)-driven polyclonal lymphoid proliferations to EBV-positive or EBV- negative lymphomas of predominantly B-cell or less often T-cell type. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Porphryias</VALIDVALUE>
          <VALUEMEANING>Porphyria</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of genetic or acquired metabolic disorders characterized by defects in the enzymes that are involved in the heme synthesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poroma</VALIDVALUE>
          <VALUEMEANING>Poroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, well circumscribed sweat gland neoplasm with eccrine or apocrine differentiation. It usually presents as a solitary, dome-shaped papule, nodule, or plaque on acral sites. It is characterized by a proliferation of uniform basaloid cells in the dermis and it is associated with the presence of focal ductal and cystic structures. Complete excision is curative.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyp/Adenoma \ Singers Nodule</VALIDVALUE>
          <VALUEMEANING>Vocal Cord Nodule</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic growth in the vocal cord. It is characterized by tissue swelling in both vocal cords in a symmetrical manner. It is caused by vocal abuse behavior. Hoarseness is the presenting symptom.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyp/Adenoma \ Juvenile</VALIDVALUE>
          <VALUEMEANING>Juvenile Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic hamartomatous polyp that arises from the stomach and intestinal tract.  It is characterized by the presence of tortuous and cystically dilated glands, edematous changes, and inflammation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3826</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyp/Adenoma</VALIDVALUE>
          <VALUEMEANING>Adenomatous Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A polypoid neoplasm arising from the glandular epithelium. There is proliferation of glandular cells which may display dysplastic cytologic features. Representative examples include the adenomatous polyps of the colon and rectum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyp, Allergic</VALIDVALUE>
          <VALUEMEANING>Paranasal Sinus Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A polyp that arises from the paranasal sinus mucosa. Causes include allergic rhinitis, chronic sinusitis, and cystic fibrosis. It is characterized by the presence of edematous tissue infiltrated by inflammatory cells, including eosinophils.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyp Without Dysplasia</VALIDVALUE>
          <VALUEMEANING>Hyperplastic Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A polyp found mainly in the stomach and colon.  Microscopically, it is characterized by elongated, serrated crypts lined by proliferative epithelium.  Hyperplastic polyps are traditionally considered non-neoplastic, but ras mutation is common, clonality has been demonstrated and biochemical abnormalities and epidemiological associations that occur in colorectal adenomas and carcinomas have been found (WHO Tumors of the Digestive System, 2000).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4083</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyp \ Peutz-Jeghers Syndrome</VALIDVALUE>
          <VALUEMEANING>Peutz-Jeghers Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited condition characterized by generalized hamartomatous multiple polyposis of the intestinal tract. Transmitted in an autosomal dominant fashion, Peutz-Jeghers syndrome consistently involves the jejunum and is associated with melanin spots of the lips, buccal mucosa, and fingers. This syndrome is associated with abnormalities of chromosome 19. Also known as Jeghers-Peutz syndrome and Peutz&#39;s syndrome. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3324</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyp \ Juvenile</VALIDVALUE>
          <VALUEMEANING>Juvenile Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic hamartomatous polyp that arises from the stomach and intestinal tract.  It is characterized by the presence of tortuous and cystically dilated glands, edematous changes, and inflammation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3826</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyp \ Inflammatory</VALIDVALUE>
          <VALUEMEANING>Colorectal Inflammatory Polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic polypoid lesion in the colon and rectum.  It may arise in a background of inflammatory bowel disease or colitis.  It is characterized by the presence of a distorted epithelium, inflammation, and fibrosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Embryonal</VALIDVALUE>
          <VALUEMEANING>Undifferentiated (Embryonal) Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare malignant tumor of the liver, the incidence of which is highest in children between 6 and 10 years of age.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Ectomesenchymoma</VALIDVALUE>
          <VALUEMEANING>Sarcoma with Ganglionic or Neuroectodermal Differentiation</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive malignant mesenchymal neoplasm of the nervous system or soft tissues. It is characterized by the presence of a sarcomatous component (most often rhabdomyosarcoma) and a ganglionic or a neuroectodermal component.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4716</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Desmoplastic (Sclerosing) Small Round Cell Tumor</VALIDVALUE>
          <VALUEMEANING>Desmoplastic Small Round Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive malignant neoplasm of uncertain lineage.  It is characterized by the presence of small round cells in a desmoplastic stroma.  It usually affects children and young adults.  The most common site of involvement is the abdomen.  Patients usually present with abdominal distention, pain, ascites, and a palpable abdominal mass.  The prognosis is usually poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Dermatofibrosarcoma</VALIDVALUE>
          <VALUEMEANING>Dermatofibrosarcoma Protuberans</VALUEMEANING>
          <MEANINGDESCRIPTION>An intermediate cutaneous fibrohistiocytic neoplasm, presenting as a nodular cutaneous mass, most often on the trunk and the proximal extremities.  The tumor diffusely infiltrates the dermis and the subcutaneous tissues.  It is considered a locally aggressive neoplasm, which often recurs but rarely metastasizes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Clear Cell (Of Tendons &amp; Aponeuroses)</VALIDVALUE>
          <VALUEMEANING>Clear Cell Sarcoma of Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare malignant neoplasm with melanocytic differentiation characterized by the presence of polygonal or spindle shaped clear cells. This sarcoma usually affects the tendons and aponeuroses and is associated with a poor prognosis due to recurrences and metastases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Clear Cell</VALIDVALUE>
          <VALUEMEANING>Clear Cell Sarcoma of the Kidney</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare pediatric sarcoma affecting the kidney. It is characterized by the presence of epithelioid or spindle cells forming cords or nests, separated by fibrovascular septa. This type of sarcoma frequently metastasizes to the bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Chondrosarcoma</VALIDVALUE>
          <VALUEMEANING>Chondrosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant mesenchymal tumor arising from cartilage-forming tissues involving the bones.  It affects middle-aged to elderly adults, and the pelvic bones, ribs, shoulder girdle, and long bones are the most common sites of involvement.  Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2946</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Angiosarcoma</VALIDVALUE>
          <VALUEMEANING>Angiosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor arising from the endothelial cells of the blood vessels.  Microscopically, it is characterized by frequently open vascular anastomosing and branching channels.  The malignant cells that line the vascular channels are spindle or epithelioid and often display hyperchromatic nuclei.  Angiosarcomas most frequently occur in the skin and breast.  Patients with long-standing lymphedema are at increased risk of developing angiosarcoma. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3088</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Alveolar Soft Part Sarcoma</VALIDVALUE>
          <VALUEMEANING>Alveolar Soft Part Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare malignant neoplasm characterized by the presence of large epithelioid cells with abundant cytoplasm forming nests and pseudoalveolar structures. The groups of the epithelioid cells are separated by thin-walled sinusoidal spaces. It occurs most often in adolescents and young adults. In adults the most common sites of involvement are the extremities, and in infants and children, the head and neck. It usually presents as a slowly growing mass and it frequently metastasizes to other anatomic sites. The most common sites of metastasis are the lungs, bone, and brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma \ Adenosarcoma</VALIDVALUE>
          <VALUEMEANING>Adenosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma</VALIDVALUE>
          <VALUEMEANING>Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9118</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoidosis</VALIDVALUE>
          <VALUEMEANING>Sarcoidosis</VALUEMEANING>
          <MEANINGDESCRIPTION>inflammatory disease characterized by small lumps or granulomas in lymph nodes and other organs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34995</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2975598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rheumatic Fever</VALIDVALUE>
          <VALUEMEANING>Rheumatic Fever</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory disorder that follows infection with group A streptococcus. It affects the heart, joints, and subcutaneous tissues. It is manifested with pericarditis, heart murmur, congestive heart failure, polyarthritis, subcutaneous nodules, and erythema marginatum. It is characterized by the formation of granulomatous lesions called Aschoff bodies usually in the heart tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34984</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rhabdomyoma</VALIDVALUE>
          <VALUEMEANING>Rhabdomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign neoplasm arising from striated muscle. It is characterized by the presence of rhabdomyoblasts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3358</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rhabdoid Tumor</VALIDVALUE>
          <VALUEMEANING>Rhabdoid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive malignant embryonal neoplasm usually occurring during childhood.  It is characterized by the presence of large cells with abundant cytoplasm, large eccentric nucleus, and a prominent nucleolus and it is associated with abnormalities of chromosome 22.  It can arise from the central nervous system, kidney, and the soft tissues.  The prognosis is poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3808</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2962178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinoblastoma</VALIDVALUE>
          <VALUEMEANING>Retinoblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7541</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rejection \ Acute</VALIDVALUE>
          <VALUEMEANING>Acute Rejection</VALUEMEANING>
          <MEANINGDESCRIPTION>Rejection of a transplanted organ that usually occurs after the first week of the transplantation.  The risk of acute rejection is highest in the first three months following transplantation.  Morphologically, there is an inflammatory infiltrate composed of lymphocytes and neutrophils and vascular damage in the rejected tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97128</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Neuroendocrine</VALIDVALUE>
          <VALUEMEANING>Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neuroendocrine tumor composed of cells containing secretory granules that stain positive for NSE and chromogranin.  Tumor cells are often round and form clusters or trabecular sheets.  Representative examples are carcinoid tumor, small cell carcinoma, and Merkel cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3773</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Myoepithelial (Myoepithelioma)</VALIDVALUE>
          <VALUEMEANING>Malignant Myoepithelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>An infiltrating malignant epithelial neoplasm characterized by the presence of atypical cells with myoepithelial differentiation. Representative examples include malignant breast myoepithelioma and salivary gland myoepithelial carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7596</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Mucoepidermoid Carcinoma</VALIDVALUE>
          <VALUEMEANING>Carcinoma Mucoepidermoid Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004: A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles &amp; Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3772, C2916</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Non-Salivary Gland</VALIDVALUE>
          <VALUEMEANING>Non-Salivary Gland Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Malignant neoplasm of the salivary glands</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9272, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinosarcoma</VALIDVALUE>
          <VALUEMEANING>Carcinosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor composed of a mixture of carcinomatous and sarcomatous elements.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34448</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Thymus</VALIDVALUE>
          <VALUEMEANING>Thymic Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A diverse group of carcinomas of the thymus gland, previously known as thymoma type C (WHO-1999).  It includes morphologic variants derived from purely epithelial cells, as well as from cells with neuroendocrine differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Sweat Gland</VALIDVALUE>
          <VALUEMEANING>Sweat Gland Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma arising from the sweat glands. Representative examples include tubular carcinoma, spiradenocarcinoma, eccrine carcinoma, hidradenocarcinoma, and apocrine carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6938</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248553</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Squamous Metaplasia</VALIDVALUE>
          <VALUEMEANING>Adenocarcinoma with Squamous Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma characterized by the presence of focal or extensive transformation of malignant glandular cells to squamous epithelial cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2837862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Squamous Cell - Non-Keratinizing/Basaloid</VALIDVALUE>
          <VALUEMEANING>Basaloid Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A squamous cell carcinoma characterized by the presence of cells with hyperchromatic nuclei, scant amount of cytoplasm, and peripheral nuclear palisading.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Squamous Cell - Keratinizing</VALIDVALUE>
          <VALUEMEANING>Keratinizing Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinomas with morphologically prominent production of keratin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4105</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Squamous Cell</VALIDVALUE>
          <VALUEMEANING>Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma derived from stratified squamous epithelium. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2929</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Spindle Cell Metaplasia</VALIDVALUE>
          <VALUEMEANING>Adenocarcinoma with Spindle Cell Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma characterized by focal or extensive transformation of the malignant glandular cells to spindle-shaped cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4201</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2837864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Tubular</VALIDVALUE>
          <VALUEMEANING>Tubular Adenocarcinoma Or Tubular Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive adenocarcinoma that arises from the sweat glands. It usually presents as a firm, erythematous nodular lesion in the axilla. Morphologically, it is characterized by the presence of tubular structures and apocrine differentiation.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: An invasive adenocarcinoma of the breast with a favorable prognosis. It is composed of tubular structures lined by a single layer of epithelium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9135, C37998, C3682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinosarcoma \ True Malignant Mixed Tumor</VALIDVALUE>
          <VALUEMEANING>Carcinosarcoma of the Salivary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive, high grade malignant tumor that arises from the salivary gland. It is characterized by the presence of a malignant epithelial and a sarcomatous component.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35831</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ With Signet-Ring Cells</VALIDVALUE>
          <VALUEMEANING>Signet Ring Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3774</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ W/PIN (Prostatic Intraepithelial Neoplasia)</VALIDVALUE>
          <VALUEMEANING>Prostate Adenocarcinoma </VALUEMEANING>
          <MEANINGDESCRIPTION>Prostate adenocarcinoma is one of the most common malignant tumors afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease. --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2919</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Urothelial (Transitional Cell)</VALIDVALUE>
          <VALUEMEANING>Urothelial Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).  It is frequently papillary. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Undifferentiated With Osteoclast-Like Giant Cells</VALIDVALUE>
          <VALUEMEANING>Undifferentiated Carcinoma with Osteoclast-Like Giant Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular or squamous differentiation and giant cells resembling osteoclasts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Undifferentiated</VALIDVALUE>
          <VALUEMEANING>Undifferentiated Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma \ Tubular / Intestinal Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Gastric Tubular Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A variant of gastric adenocarcinoma characterized by prominent dilated or slit-like tubules.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CIS (Carcinoma In Situ)</VALIDVALUE>
          <VALUEMEANING>Carcinoma in Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2917</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Choroid Plexus Papilloma</VALIDVALUE>
          <VALUEMEANING>Choroid Plexus Papilloma</VALUEMEANING>
          <MEANINGDESCRIPTION>Choroid Plexus Papilloma (WHO grade I) is a benign, slow growing tumor which may cause symptoms by blocking CSF pathways. Surgical resection is usually curative. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Choriocarcinoma</VALIDVALUE>
          <VALUEMEANING>Choriocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive malignant tumor arising from trophoblastic cells.  The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells.  Approximately half of the cases develop from a complete hydatidiform mole.  A minority of cases arise in the testis or the ovaries.  There is often marked elevation of human chorionic gonadotropin (hCG) in the blood.  Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2837860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholangiocarcinoma \ Intrahepatic</VALIDVALUE>
          <VALUEMEANING>Intrahepatic Cholangiocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that arises from the intrahepatic bile duct epithelium in any site of the intrahepatic biliary tree.  Grossly, the malignant lesions are solid, nodular, and grayish.  Morphologically, the vast majority of cases are adenocarcinomas.  Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats.  Early detection is difficult and the prognosis is generally poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholangiocarcinoma</VALIDVALUE>
          <VALUEMEANING>Cholangiocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An malignant tumor composed of cells resembling those of bile ducts. Cholangiocarcinoma is a relatively rare tumor in most populations. It can arise from any portion of the intrahepatic bile duct epithelium or the hepatic ducts. Grossly, the lesions are nodular, grayish-white firm and solid. Microscopically, the vast majority of cholangiocarcinomas are adenocarcinomas showing tubular and/or papillary structures. Early detection of cholangiocarcinomas is difficult, and the overall prognosis after resection is poor (adapted from WHO, 2000).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3165468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemodectoma</VALIDVALUE>
          <VALUEMEANING>Carotid Body Paraganglioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant extra-adrenal parasympathetic paraganglioma arising from paraganglia adjacent to or in the bifurcation of the common carotid artery.  Most patients present with a slow growing, painless mass in the neck.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2932</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical Intraepithelial Neoplasia (CIN) Or Squamous Intraepithelial Lesion (SIL) \ Severe (CIN III) Or High Grade (HGSIL)</VALIDVALUE>
          <VALUEMEANING>High Grade Cervical Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A precancerous neoplastic process that affects the cervical epithelium. It is usually associated with human papillomavirus infection. It is classified as cervical intraepithelial neoplasia 2 when there is nuclear atypia in both the upper and lower epithelial layers, mitotic figures are confined to the basal two-thirds of the epithelium, and maturation is present in the upper half of the epithelium. It is classified as cervical intraepithelial neoplasia 3 when there is nuclear atypia and mitotic figures throughout the entire thickness of the epithelium, and maturation is absent or confined to the upper third of the epithelium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical Intraepithelial Neoplasia (CIN) Or Squamous Intraepithelial Lesion (SIL) \ Moderate (CIN II) Or High Grade (HGSIL)</VALIDVALUE>
          <VALUEMEANING>Cervical Intraepithelial Neoplasia Grade 2/3</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplastic process in the cervix characterized by morphologic features of both moderate and severe intraepithelial neoplasia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94676</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical Intraepithelial Neoplasia (CIN) Or Squamous Intraepithelial Lesion (SIL) \ Any Grade With HPV</VALIDVALUE>
          <VALUEMEANING>Cervical Intraepithelial Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous or glandular intraepithelial neoplasia that affects the cervical mucosal epithelium. There is no evidence of stromal invasion. According to the degree of cellular atypia and the associated architectural changes, it is classified as low or high grade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3782</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central Neurocytoma</VALIDVALUE>
          <VALUEMEANING>Central neurocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Central Neurocytoma is an intraventricular neuronal neoplasm composed of uniform round cells with neuronal differentiation. It is typically located in the lateral ventricles in the region of the foramen of Monro.  It generally affects young adults and has a favorable prognosis. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C-Cell Hyperplasia \ Multiple Endocrine Neoplasm (Men) Type 2B</VALIDVALUE>
          <VALUEMEANING>Multiple Endocrine Neoplasia Type 2B C-Cell Hyperplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple endocrine neoplasia caused by mutation of the RET gene. Patients develop medullary thyroid carcinomas and numerous neural defects including neuromas.: Neoplastic or reactive proliferation of the C-cells in the thyroid gland. The neoplastic C-cell hyperplasia is associated with familial medullary thyroid gland carcinoma and multiple endocrine neoplasia type II and IIB. Morphologically, it is characterized by the presence of clusters of intrafollicular C-cells with atypical cytologic features. The reactive C-cell hyperplasia is also known as physiological or secondary C-cell hyperplasia and it is associated with conditions that cause hypercalcemia (e.g., hyperparathyroidism). </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C46100, C3227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248582</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Vasculitis</VALIDVALUE>
          <VALUEMEANING>Vasculitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process involving the wall of the vessels (large, medium, or small-sized vessels). The inflammatory process may cause necrosis or formation of granulomas in the vascular wall. It may be the result of an autoimmune disorder, infection, or malignancy. Representative examples include polyarteritis nodosa, temporal arteritis, Wegener&#39;s granulomatosis, Kawasaki disease, Takayasu arteritis, and Henoch-Schonlein purpura.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26912</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2943908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Varix</VALIDVALUE>
          <VALUEMEANING>Varicose Vein</VALUEMEANING>
          <MEANINGDESCRIPTION>A vascular abnormality characterized by the presence of enlarged and tortuous veins, particularly in the legs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35114</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210766</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Thrombosis/Emboli</VALIDVALUE>
          <VALUEMEANING>Thromboembolism</VALUEMEANING>
          <MEANINGDESCRIPTION>Occlusion of the lumen of a vessel by a thrombus that has migrated from a distal site via the blood stream.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3024906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Thrombosis</VALIDVALUE>
          <VALUEMEANING>Thrombosis</VALUEMEANING>
          <MEANINGDESCRIPTION>(throm-BOW-sis) The formation or presence of a blood clot inside a blood vessel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26891</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2684342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Septic Thrombophlebitis</VALIDVALUE>
          <VALUEMEANING>Infective Phlebitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Infection at the site of needle puncture or intravenous catheter placement due to poor aseptic techniques. It is characterized by erythema, pain, swelling, and induration at the catheter insertion site.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Pericarditis</VALIDVALUE>
          <VALUEMEANING>Pericarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process affecting the pericardium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiovascular Disease \ Myocarditis</VALIDVALUE>
          <VALUEMEANING>Myocarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the muscle tissue of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34831</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rathke&#39;s Pouch Cyst</VALIDVALUE>
          <VALUEMEANING>Rathke Pouch Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>Rathke&#39;s pouch cysts are rarely symptomatic in the first two decades of life though they may produce symptoms in the third and fourth decades of life.  When the cysts do present in the first decades of life, the symptoms are generally associated with diabetes insipidus or other conditions related to hypopituitarism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4977</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiation Changes</VALIDVALUE>
          <VALUEMEANING>Radiation-Induced Change</VALUEMEANING>
          <MEANINGDESCRIPTION>Techniques used for altering the genetic material of an organism by exposure to ionizing radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C22493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Disorders \ Tracheitis</VALIDVALUE>
          <VALUEMEANING>Tracheitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Bacterial infectious process with formation of mucopurulent membranes affecting the trachea. Causative agents include Staphylococcus, Streptococcus, Haemophilus influenzae, Pseudomonas, and Klebsiella.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78647</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Disorders \ Pneumonia</VALIDVALUE>
          <VALUEMEANING>Pneumonia</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3333</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Disorders \ Idiopathic Pulmonary Fibrosis</VALIDVALUE>
          <VALUEMEANING>Idiopathic Pulmonary Fibrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic and progressive fibrosis of the lung parenchyma of unknown cause.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35716</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Disorders \ Emphysema</VALIDVALUE>
          <VALUEMEANING>Pulmonary Emphysema</VALUEMEANING>
          <MEANINGDESCRIPTION>A subcategory of chronic obstructive pulmonary disease (COPD). It occurs in people who smoke and suffer from chronic bronchitis. It is characterized by inflation of the alveoli, alveolar wall damage, and reduction in the number of alveoli, resulting in difficulty breathing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Disorders \ Chronic Obstructive Pulmonary Disease</VALIDVALUE>
          <VALUEMEANING>Chronic Obstructive Airways Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary Disorders \ Bronchopulmonary Sequestration</VALIDVALUE>
          <VALUEMEANING>Bronchopulmonary Sequestration</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare congenital abnormality of the lungs.  It consists of a mass of lung parenchyma that does not communicate with the bronchial tree and receives its blood supply from the systemic circulation instead of the pulmonary circulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97124</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sex Cord-Stromal Tumor \ Granulosa Cell Tumor, Juvenile</VALIDVALUE>
          <VALUEMEANING>Juvenile Type Granulosa Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A granulosa cell tumor occurring in the ovary and testis. In females it occurs predominantly in the first three decades of life and presents unilaterally as stage I disease in the vast majority of cases. It is characterized by the presence of granulosa cells forming macrofollicular structures. The majority of cases have a good prognosis. In males it represents the most frequent congenital testicular neoplasm and the vast majority of cases occur in the perinatal period. It presents as a scrotal or abdominal mass and it more often affects the left testis. Approximately 20% of the patients have ambiguous external genitalia. It is characterized by the presence of cystic spaces lined by granulosa cells and cells resembling theca cells. Metastases have not been reported.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sex Cord Stromal Tumor \ Granulosa Cell Tumor, Adult</VALIDVALUE>
          <VALUEMEANING>Adult Type Granulosa Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A granulosa cell tumor occurring in the ovary and rarely in the testis. It is composed of granulosa cells in an often fibrothecomatous stroma. The neoplastic cells may form various patterns including the microfollicular, which is characterized by the presence of Call-Exner bodies, macrofollicular, insular, trabecular, and diffuse pattern. In females, it affects middle aged to post-menopausal women. Signs and symptoms include abdominal mass, hemoperitoneum, and ascites. Estrogenic and rarely androgenic manifestations may be present. The vast majority of cases present as stage I tumors; however, all tumors have a potential for aggressive clinical course. In males, it is reported in the age range of 16-76 years and the average age at presentation is 44 years. A minority of patients have gynecomastia. Metastases have been reported in a minority of patients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sertoli Leydig Cell Tumor</VALIDVALUE>
          <VALUEMEANING>Leydig Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A sex cord-stromal tumor occurring in the testis and rarely in the ovary. It is predominantly or completely composed of Leydig cells which may contain crystals of Reinke. In males it usually presents as a painless testicular enlargement and it may be associated with gynecomastia and decreased libido. The majority of the cases have a benign clinical course. Approximately 10% of the cases have a malignant clinical course and metastasize. In females it may be associated with androgenic manifestations and it follows a benign clinical course.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sertoli Cell Tumor</VALIDVALUE>
          <VALUEMEANING>Sertoli Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A sex cord-stromal tumor of the testis or the ovary. It is characterized by the presence of Sertoli cells forming tubules. Leydig cells are rare or absent. It may be associated with Peutz-Jeghers syndrome. In males, the presenting symptom is a slow growing testicular mass. Most cases follow a benign clinical course. In females it may present with estrogenic or androgenic manifestations. The vast majority of cases have a benign clinical course.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39976</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serous Cystic Neoplasm</VALIDVALUE>
          <VALUEMEANING>Pancreatic Serous Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant epithelial neoplasm that is usually cystic and arises from the exocrine pancreas.  It is characterized by the presence of neoplastic epithelial cells that produce fluid similar to serum.  Representative examples include serous cystadenoma and serous cystadenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41248</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Separation</VALIDVALUE>
          <VALUEMEANING>Separate</VALUEMEANING>
          <MEANINGDESCRIPTION>Independent; not united or joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63803</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seminoma</VALIDVALUE>
          <VALUEMEANING>Seminoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A radiosensitive malignant germ cell tumor found in the testis (especially undescended), and extragonadal sites (anterior mediastinum and pineal gland).  It is characterized by the presence of uniform cells with clear or dense cytoplasm which contains glycogen, and by a large nucleus which contains one or more nucleoli.  The neoplastic germ cells form aggregates separated by fibrous septa.  The fibrous septa contain chronic inflammatory cells, mainly lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2986277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Secretory (Juvenile)</VALIDVALUE>
          <VALUEMEANING>Secretory Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, low grade invasive adenocarcinoma of the breast characterized by the presence of cells that secrete milk-like material. Morphologically, it usually appears as a circumscribed lesion, composed of cystic spaces, tubular structures, and solid areas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seborrheic Keratosis \ Melanoacanthoma</VALIDVALUE>
          <VALUEMEANING>Melanoacanthoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, darkly pigmented skin lesion characterized by proliferation of keratinocytes and melanocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seborrheic Keratosis \ Inverted</VALIDVALUE>
          <VALUEMEANING>Inverted Follicular Keratosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign usually solitary epithelial tumor originating in a hair follicle and occurring as a flesh-colored nodule or papule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sebaceous Gland Tumors</VALIDVALUE>
          <VALUEMEANING>Sebaceous Gland Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant neoplasm that arises from the sebaceous glands. Representative examples include sebaceous adenoma and sebaceous carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sclerosing Polycystic Adenosis (Kushner Disease)</VALIDVALUE>
          <VALUEMEANING>Sclerosing Polycystic Adenosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, benign, well-circumscribed salivary gland neoplasm that predominantly affects females.  It is characterized by the presence of microcysts, ducts, and acini in a sclerotic stroma.  Focal lymphocytic infiltrates may also be present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97135</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252079</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Schizophrenia</VALIDVALUE>
          <VALUEMEANING>Schizophrenia</VALUEMEANING>
          <MEANINGDESCRIPTION>A major psychotic disorder characterized by abnormalities in the perception or expression of reality. It affects the cognitive and psychomotor functions. Common clinical signs and symptoms include delusions, hallucinations, disorganized thinking, and retreat from reality.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3165564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scarring</VALIDVALUE>
          <VALUEMEANING>Scar</VALUEMEANING>
          <MEANINGDESCRIPTION>A mark left (usually on the skin) by the healing of injured tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scar</VALIDVALUE>
          <VALUEMEANING>Scar</VALUEMEANING>
          <MEANINGDESCRIPTION>The formation of new tissue in the process of wound healing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serous Cystic</VALIDVALUE>
          <VALUEMEANING>Cystic Change Pancreatic Serous Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists: A benign or malignant epithelial neoplasm that is usually cystic and arises from the exocrine pancreas.  It is characterized by the presence of neoplastic epithelial cells that produce fluid similar to serum.  Representative examples include serous cystadenoma and serous cystadenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41248, C41454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Synovitis \ Acute</VALIDVALUE>
          <VALUEMEANING>Acute Synovitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute inflammation of a synovial membrane. It is associated with swelling and pain in the affected area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sweat Gland Tumors</VALIDVALUE>
          <VALUEMEANING>Sweat Gland Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant neoplasm arising from the sweat glands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Subependymoma</VALIDVALUE>
          <VALUEMEANING>Subependymoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Subependymoma (WHO grade I) is a benign, slow growing neoplasm which is typically attached to a ventricular wall. It is composed of glial tumor cell clusters embedded in an abundant fibrillary matrix with frequent microcystic change. Some lesions have the histological features of both subependymoma and ependymoma. It is often detected incidentally and has a very favorable prognosis. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3795</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Struma Ovarii</VALIDVALUE>
          <VALUEMEANING>Struma Ovarii</VALUEMEANING>
          <MEANINGDESCRIPTION>An ovarian mature teratoma characterized by the presence of aberrant thyroid tissue. The aberrant thyroid tissue shows morphologic changes identical to thyroid adenoma or carcinoma. Patients may present with abdominal mass and unusual symptoms due to thyrotoxicosis, or Meigs syndrome (ascites and pleural effusion).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stromal Tumor \ Sclerosing</VALIDVALUE>
          <VALUEMEANING>Ovarian Sclerosing Stromal Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign ovarian stromal tumor characterized by the presence of cellular areas which contain fibroblasts and round cells. The cellular areas are separated by sclerotic or edematous hypocellular tissue. Symptoms include abdominal discomfort and menstrual abnormalities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stromal Sclerosis &amp; Fibrosis</VALIDVALUE>
          <VALUEMEANING>Collagenous Stroma Formation</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the presence of dense stromal fibrosis in a tissue sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stone</VALIDVALUE>
          <VALUEMEANING>Stone</VALUEMEANING>
          <MEANINGDESCRIPTION>Accumulated material from the secretions of an organ. It is solid and representative examples include gallbladder stones, kidney stones, and salivary gland stones. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35708</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Papilloma</VALIDVALUE>
          <VALUEMEANING>Squamous Papilloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign epithelial neoplasm characterized by a papillary growth pattern and a proliferation of neoplastic squamous cells without morphologic evidence of malignancy. Most frequently it arises in the oral cavity, nasopharynx, larynx, esophagus, vagina, and vulva.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia Chronic - Myeloproliferative Neoplasms (MPN) \ CML/Chronic Myelocytic Blast Phase (Crisis)</VALIDVALUE>
          <VALUEMEANING>Blast Phase Chronic Myelogenous Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An advanced phase of chronic myelogenous leukemia.  It is characterized a. by the presence of blasts in the peripheral blood or bone marrow that are at least 20% of the peripheral blood white cells or of the nucleated cells in the bone marrow respectively, or b. an extramedullary proliferation of blasts, and/or c. when there are large aggregates and clusters of blasts in the bone marrow biopsy specimen (adapted from WHO, 2001).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9110</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2675142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leukemia - Acute \ Promyelocytic</VALIDVALUE>
          <VALUEMEANING>Typical Acute Promyelocytic Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3507078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, specify</VALIDVALUE>
          <VALUEMEANING>Other specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Be specific about something; define clearly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not specified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Biospecimen Metastatic Diagno</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Biospecimen Metastatic Diagnosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3228240</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CHTN</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Biospecimen Pathology Vocabulary</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3257636</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3228240</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CHTN</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.nationwidechildrens.chtn.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3257637</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.nationwidechildrens.chtn.domain.BiospecimenDiagnosis.modifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BiospecimenDiagnosis:modifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="737">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3252622</PUBLICID>
    <LONGNAME>Surgical Procedure Malignant Neoplasm Histology Confirmed Diagnosis Date</LONGNAME>
    <PREFERREDNAME>3252618v1.0:2018550v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the date the surgical procedure was performed to histologically confirm, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues by employing various cytochemical and immunocytochemical stains, the presence of a malignant neoplasm, a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3252618</PublicId>
      <PreferredName>2322305v1.0:3252616v1.0</PreferredName>
      <PreferredDefinition>information related to the surgical procedure used to histologically confirm, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues by employing various cytochemical and immunocytochemical stains, the presence of a malignant neoplasm, a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.</PreferredDefinition>
      <LongName>Surgical Procedure Malignant Neoplasm Histology Confirmed Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2322305</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3252616</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305:C16681:C25458:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm Histology Confirmed Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16681</PREFERRED_NAME>
            <LONG_NAME>Histology</LONG_NAME>
            <CON_ID>2202345</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25458</PREFERRED_NAME>
            <LONG_NAME>Confirmation</LONG_NAME>
            <CON_ID>2203883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the date of patient d</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the date of patient disease diagnosis by surgery, biopsy, FNA or paracentesis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0273</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104919</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0273</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000164</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0273</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000165</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3252618v1.0:2018550v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="738">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3252791</PUBLICID>
    <LONGNAME>Dentist Pain Therapy Other Recommendation Scale</LONGNAME>
    <PREFERREDNAME>3252782v1.0:3251299v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>an ordered reference standard related to the dentist&#39;s advice to seek care by other types of pain relief.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3252782</PublicId>
      <PreferredName>2443308v1.0:3252780v1.0</PreferredName>
      <PreferredDefinition>information related to the dentist&#39;s advice to seek care by other types of pain relief.</PreferredDefinition>
      <LongName>Dentist Pain Therapy Other Recommendation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443308</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52654</PreferredName>
        <Version>1</Version>
        <LongName>Dentist</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52654</PREFERRED_NAME>
            <LONG_NAME>Dentist</LONG_NAME>
            <CON_ID>2443130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3252780</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15180:C17649:C25197</PreferredName>
        <Version>1</Version>
        <LongName>Pain Therapy Other Recommendation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15180</PREFERRED_NAME>
            <LONG_NAME>Pain Therapy</LONG_NAME>
            <CON_ID>3251294</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25197</PREFERRED_NAME>
            <LONG_NAME>Recommendation</LONG_NAME>
            <CON_ID>2203959</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3251299</PublicId>
      <PreferredName>3251299v1.0</PreferredName>
      <PreferredDefinition>an ordered reference standard for recommendation of dentist.</PreferredDefinition>
      <LongName>Dentist Recommendation Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 6 and less than 8 and the quantity that it denotes: the sum of six and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66838</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66836</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest natural number and quantity it denotes: a single entity, unit, or object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="739">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3279230</PUBLICID>
    <LONGNAME>Alcoholic Beverage Consumption MoreThan Six At One Occasion Frequency</LONGNAME>
    <PREFERREDNAME>3277352v1.0:3277356v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text to describe the frequency of drinking six or more beverages containing alcohol during one occasion.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3277352</PublicId>
      <PreferredName>3277349v1.0:3277350v1.0</PreferredName>
      <PreferredDefinition>A drink, including beer, wine or liquor, that is made by fermentation of raw materials. An alcoholic beverage contains ethanol (alcohol) as the active ingredient. Alcoholic beverage is a known human carcinogen._The bodily process of taking in and using up something, especially the eating or drinking of something._A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status._A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one._Used to indicate position, location, or state (American Heritage Dictionary)_The smallest natural number and quantity it denotes: a single entity, unit, or object._An occurrence of something.</PreferredDefinition>
      <LongName>Alcoholic Beverage Consumption MoreThan Six At One Occasion</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3277349</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45902</PreferredName>
        <Version>1</Version>
        <LongName>Alcoholic Beverage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45902</PREFERRED_NAME>
            <LONG_NAME>Alcoholic Beverage</LONG_NAME>
            <CON_ID>2782639</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3277350</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3277350v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Consumption Greater Than Six At One Instance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66715</PREFERRED_NAME>
            <LONG_NAME>Consumption</LONG_NAME>
            <CON_ID>2635725</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61584</PREFERRED_NAME>
            <LONG_NAME>Greater Than</LONG_NAME>
            <CON_ID>2620098</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66837</PREFERRED_NAME>
            <LONG_NAME>Six</LONG_NAME>
            <CON_ID>2647606</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25427</PREFERRED_NAME>
            <LONG_NAME>At</LONG_NAME>
            <CON_ID>2261927</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66832</PREFERRED_NAME>
            <LONG_NAME>One</LONG_NAME>
            <CON_ID>2636736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48364</PREFERRED_NAME>
            <LONG_NAME>Instance</LONG_NAME>
            <CON_ID>2413213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3277356</PublicId>
      <PreferredName>3277356v1.0</PreferredName>
      <PreferredDefinition>A list or register of events; a tabular array of the days._The number of occurrences of something within a given time period. (NCI)</PreferredDefinition>
      <LongName>Calendar Frequency</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3277355</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19459:C25515</PreferredName>
        <Version>1</Version>
        <LongName>Calendar Frequency</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19459</PREFERRED_NAME>
            <LONG_NAME>Calendar</LONG_NAME>
            <CON_ID>2615818</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daily or almost daily</VALIDVALUE>
          <VALUEMEANING>Daily</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring or done each day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3269963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Weekly</VALIDVALUE>
          <VALUEMEANING>Weekly</VALUEMEANING>
          <MEANINGDESCRIPTION>Every week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3277357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4 or more times a week</VALIDVALUE>
          <VALUEMEANING>Four Or Greater Than Integer::4 Instance Per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A number with no fractional part.::4: An occurrence of something.: For each, generally denoting a ratio.: Any period of seven consecutive days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29844, C65039, C48364, C45255::4, C61584, C37998, C66835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3277358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2 to 3 times a week</VALIDVALUE>
          <VALUEMEANING>Two To Three Instance Per Week</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.: Used as a function word to indicate direction, purpose, or movement.: A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.: An occurrence of something.: For each, generally denoting a ratio.: Any period of seven consecutive days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29844, C65039, C48364, C66834, C65107, C66833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3277359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monthly</VALIDVALUE>
          <VALUEMEANING>Monthly</VALUEMEANING>
          <MEANINGDESCRIPTION>Every month.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2991205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2 to 4 times a month</VALIDVALUE>
          <VALUEMEANING>Two To Four Instance Per Month</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.: Used as a function word to indicate direction, purpose, or movement.: A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.: An occurrence of something.: For each, generally denoting a ratio.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C65039, C48364, C66835, C65107, C66833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3277360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Less than monthly</VALIDVALUE>
          <VALUEMEANING>Less Than Monthly</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: Every month.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64498, C61585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3171658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How often do you have six or</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How often do you have six or more drinks on one occasion?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Health Survey </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259220</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Related Risks </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259229</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4826811</PublicId>
          <ContextName>iCaRe2</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Core</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Alcohol History</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4826818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIDA</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NIDA</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>iCaRe2</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>iCaRe2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="740">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3289496</PUBLICID>
    <LONGNAME>Southwest Oncology Group Patient Registration Eligibility Determination S0812 Mammogram Type</LONGNAME>
    <PREFERREDNAME>2697301v1.0:3289487v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>a subdivision for registration into S0812 for Southwest Oncology Group and a low voltage X-ray photograph of the breast generally done to detect breast cancer related to the act of determining if a Southwest Oncology Group, an NCI-sponsored cooperative group, an adult cancer clinical trials organization, subject is suitable for enrollment in a study according specific protocol criteria  and procedures.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2697301</PublicId>
      <PreferredName>SWOG_PT_REG_ELIG</PreferredName>
      <PreferredDefinition>information related to the act of determining if a Southwest Oncology Group, an NCI-sponsored cooperative group, an adult cancer clinical trials organization, subject is suitable for enrollment in a study according specific protocol criteria  and procedures.</PreferredDefinition>
      <LongName>Southwest Oncology Group Patient Registration Eligibility Determination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2436359</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25699:C16960</PreferredName>
        <Version>1</Version>
        <LongName>Southwest Oncology Group Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25699</PREFERRED_NAME>
            <LONG_NAME>Southwest Oncology Group</LONG_NAME>
            <CON_ID>2202383</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2697299</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25646:C25171</PreferredName>
        <Version>1</Version>
        <LongName>Registration Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25646</PREFERRED_NAME>
            <LONG_NAME>Registration</LONG_NAME>
            <CON_ID>2202799</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3289487</PublicId>
      <PreferredName>v1.0</PreferredName>
      <PreferredDefinition>a subdivision for registration into S0812 for Southwest Oncology Group and a low voltage X-ray photograph of the breast generally done to detect breast cancer.</PreferredDefinition>
      <LongName>Southwest Oncology Group Patient Registration Eligibility Determination S0812 Mammogram Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>SWOG CRF:Southwest Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>3289486</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20178:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Mammogram Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20178</PREFERRED_NAME>
            <LONG_NAME>Mammogram</LONG_NAME>
            <CON_ID>2202867</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>11-50%</VALUEMEANING>
          <MEANINGDESCRIPTION>11-50%</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-09-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3289488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>&gt; 50%</VALUEMEANING>
          <MEANINGDESCRIPTION>&gt; 50%</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-09-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3253672</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scattered fibro glandular density</VALIDVALUE>
          <VALUEMEANING>Scattered fibro glandular density</VALUEMEANING>
          <MEANINGDESCRIPTION>Scattered fibro glandular density</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3693771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&gt;=25%</VALIDVALUE>
          <VALUEMEANING>&gt;=25%</VALUEMEANING>
          <MEANINGDESCRIPTION>Greater than or equal to 25%</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3693772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Baseline mammographic density</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Baseline mammographic density</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="741">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3298921</PUBLICID>
    <LONGNAME>Graft Versus Host Disease Preventive Intervention Therapy Type</LONGNAME>
    <PREFERREDNAME>GVHD_PREV_INT_TX_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Text name of  the agent administered to an individual as part of Graft vs Host Disease (GVHD) prophylaxis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2681983</PublicId>
      <PreferredName>GVHD_PRV_ADMN</PreferredName>
      <PreferredDefinition>An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin._Therapeutic, nutritional, environmental, social and or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.</PreferredDefinition>
      <LongName>Graft Versus Host Disease Preventive Intervention Administration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2681981</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3063:C15843</PreferredName>
        <Version>1</Version>
        <LongName>Graft Versus Host Disease Preventive Intervention</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3063</PREFERRED_NAME>
            <LONG_NAME>Graft Versus Host Disease</LONG_NAME>
            <CON_ID>2206367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15843</PREFERRED_NAME>
            <LONG_NAME>Preventive Intervention</LONG_NAME>
            <CON_ID>2488996</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2320521</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25409</PreferredName>
        <Version>1</Version>
        <LongName>Administration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298920</PublicId>
      <PreferredName>GVHD_PRV_INT_TX_TP</PreferredName>
      <PreferredDefinition>An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin._Therapeutic, nutritional, environmental, social and or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Graft Versus Host Disease Preventive Intervention Therapy Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3298919</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3063:C15843:C49236:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Graft Versus Host Disease Preventive Intervention Therapeutic Procedure Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3063</PREFERRED_NAME>
            <LONG_NAME>Graft Versus Host Disease</LONG_NAME>
            <CON_ID>2206367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15843</PREFERRED_NAME>
            <LONG_NAME>Preventive Intervention</LONG_NAME>
            <CON_ID>2488996</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antithymocyte Globulin (ATG)</VALIDVALUE>
          <VALUEMEANING>Anti-Thymocyte Globulin</VALUEMEANING>
          <MEANINGDESCRIPTION>Purified gamma globulin, with immunosuppressive activity. Obtained from animals that have been immunized with human thymocytes, antithymocyte globulin (ATG) specifically recognizes and destroys T lymphocytes. Although not completely understood, the mechanism of action appears to involve T lymphocyte clearance from the circulation and modulation of T lymphocyte activity. Administering ATG with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host (GVH) disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3253646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclosporine</VALIDVALUE>
          <VALUEMEANING>Cyclosporine</VALUEMEANING>
          <MEANINGDESCRIPTION>11-residue cyclic peptide produced by certain fungi which has antifungal and T cell specific immunosuppressive properties.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tacrolimus</VALIDVALUE>
          <VALUEMEANING>Tacrolimus (Prograf, Protopic Ointment, Advagraf)</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug used to help reduce the risk of rejection by the body of organ and bone marrow transplants.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2775673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methotrexate (MTX)</VALIDVALUE>
          <VALUEMEANING>Methotrexate Administration</VALUEMEANING>
          <MEANINGDESCRIPTION>An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear.: The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25409, C642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2775672</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mycophenolate Mofetil (CellCept)</VALIDVALUE>
          <VALUEMEANING>Mycophenolate Mofetil</VALUEMEANING>
          <MEANINGDESCRIPTION>The mopholinoethyl ester of mycophenolic acid (MPA) with potent immunosuppressive properties.  Mycophenolate stops T-cell and B-cell proliferation through selective inhibition of the de novo pathway of purine biosynthesis.  In vivo, the active metabolite, MPA, reversibly inhibits inosine 5&#39;-monophosphate dehydrogenase, an enzyme involved in the de novo synthesis of guanine nucleotides.  MPA displays high lymphocyte specificity and cytotoxicity due to the higher dependence of activated lymphocytes on both salvage and de novo synthesis of guanine nucleotides relative to other cell types. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3253642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T-Cell Depletion</VALIDVALUE>
          <VALUEMEANING>T-cell depletion</VALUEMEANING>
          <MEANINGDESCRIPTION>T-cell depletion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15699</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alemtuzumab (Campath)</VALIDVALUE>
          <VALUEMEANING>Alemtuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant DNA-derived humanized monoclonal antibody directed against the cell surface glycoprotein, CD52. Alemtuzumab is an IgG1 kappa with human variable framework and constant regions, and complementarity-determining regions derived from a rat monoclonal antibody. This agent selectively binds to CD52, thereby triggering a host immune response that results in lysis of CD52 + cells. CD52 is a glycoprotein expressed on the surface of essentially all normal and malignant B and T cells, a majority of monocytes, macrophages and natural killer (NK) cells, a subpopulation of granulocytes, and tissues of the male reproductive system. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other (specify)</VALIDVALUE>
          <VALUEMEANING>Other Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C1708</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3202962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prednisone</VALIDVALUE>
          <VALUEMEANING>Prednisone</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sirolimus</VALIDVALUE>
          <VALUEMEANING>Sirolimus</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug used to help prevent rejection of organ and bone marrow transplants by the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2760061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-TNF Agent</VALIDVALUE>
          <VALUEMEANING>Anti-Tumor Necrosis Factor Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Drug treatment to reduce the activity of tumor necrosis factor, particulary to control inflammation in disease modalities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15577</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3233636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-T Cell Antibody</VALIDVALUE>
          <VALUEMEANING>T-Lymphocyte Antibody Inhibition</VALUEMEANING>
          <MEANINGDESCRIPTION>One type of white blood cell that attacks virus-infected cells, foreign cells, and cancer cells.  T cells also produce a number of substances that regulate the immune response.: (AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.: The interference with or prevention of an action or response even though the stimulus for that action or response is present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42791, C16295, C12476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3861599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corticosteroids</VALIDVALUE>
          <VALUEMEANING>Corticosteroid</VALUEMEANING>
          <MEANINGDESCRIPTION>Hormones synthesized in the cortex of the adrenal gland and consist of two subclasses, glucocorticoids (carbohydrate regulation) and mineralocorticoids (electrolyte regulation).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2322</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcineurin Inhibitors</VALIDVALUE>
          <VALUEMEANING>Calcineurin Inhibition</VALUEMEANING>
          <MEANINGDESCRIPTION>Ubiquitous heterodimeric human Calcineurin is Ca(2+)/calmodulin-regulated protein phosphatase involved in many biologic activities as a modifier of phosphorylation status. Composed of widely expressed or tissue-restricted 55-60-kDa calmodulin-binding catalytic subunit (PPP Phosphatase/PP-2B Family) and conserved 19-kD Ca(2+)-sensitive regulatory subunit, Calcineurin appears to regulate glycolytic metabolism, nuclear translocation of NFATC1 transcription factor, sperm motility, and dopaminergic signal transduction and NMDA receptor-dependent synaptic plasticity. (NCI): The interference with or prevention of an action or response even though the stimulus for that action or response is present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42791, C17275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3861602</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extra-Corporeal Photophoresis (ECP)</VALIDVALUE>
          <VALUEMEANING>Extracorporeal Photopheresis</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure in which blood is removed from the body and treated with ultraviolet light and drugs that become active when exposed to light. The blood is then returned to the body. It is being studied in the treatment of some blood and bone marrow diseases and graft-vs-host disease (GVHD).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2777671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydroxychloroquine</VALIDVALUE>
          <VALUEMEANING>Hydroxychloroquine</VALUEMEANING>
          <MEANINGDESCRIPTION>A substance that decreases immune responses in the body.  It is used to treat some autoimmune diseases, and is being studied as a treatment for graft-versus-host disease. Hydroxychloroquine belongs to the family of drugs called antiprotozoals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rituximab</VALIDVALUE>
          <VALUEMEANING>Rituximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of monoclonal antibody used in cancer detection or therapy. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mycophenolate</VALIDVALUE>
          <VALUEMEANING>Mycophenolate</VALUEMEANING>
          <MEANINGDESCRIPTION>The morpholinoethyl ester of mycophenolic acid (MPA).  As an immunosuppressive agent in vivo, the active metabolite mycophenolate reversibly inhibits inosine 5&#39;-monophosphate dehydrogenase (IMPDH), an enzyme involved in the de novo synthesis of guanine nucleotides, thereby retarding T-cell and B-cell proliferation.  MPA displays high lymphocyte specificity and cytotoxicity because lymphocyte metabolism is highly dependent on both salvage and de novo synthesis of guanine nucleotides. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methylprednisolone</VALIDVALUE>
          <VALUEMEANING>Methylprednisolone</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic corticosteroid with anti-inflammatory and immunomodulating properties.  Methylprednisolone binds to and activates specific nuclear receptors, resulting in altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C647</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoclonal antibodies</VALIDVALUE>
          <VALUEMEANING>Monoclonal Antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody produced by a clone or genetically homogenous fast-growing cells i.e., hybridoma. Hybridoma cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis, and treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4232285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abatacept</VALIDVALUE>
          <VALUEMEANING>Abatacept</VALUEMEANING>
          <MEANINGDESCRIPTION>A soluble fusion protein consisting of the extracellular domain of human cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) linked to a modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1) with immunosuppressive activity. Abatacept binds CD80 and CD86 on antigen presenting cells (APCs), blocking interaction with CD28 on T lymphocytes, which initiates a co-stimulatory signal required for full activation of T lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brutinib (Imbruvica)</VALIDVALUE>
          <VALUEMEANING>Ibrutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, small-molecule inhibitor of Bruton&#39;s tyrosine kinase (BTK) with potential antineoplastic activity. Upon oral administration, ibrutinib binds to and irreversibly inhibits BTK activity, thereby preventing both B-cell activation and B-cell-mediated signaling. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is required for B cell receptor signaling, plays a key role in B-cell maturation, and is overexpressed in a number of B-cell malignancies. The expression of BTK in tumor cells is also associated with increased proliferation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5588944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UVA1</VALIDVALUE>
          <VALUEMEANING>UVA1 Phototherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Phototherapy that uses UV light in the 340-400nm range.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186479</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8119694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daclizumab</VALIDVALUE>
          <VALUEMEANING>Daclizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody that is being studied in the treatment of adult T-cell leukemia and in the treatment of cytopenia (low blood cell count).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vedolizumab (Entyvio)</VALIDVALUE>
          <VALUEMEANING>Vedolizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against the human lymphocyte Peyer&#39;s patch adhesion molecule 1 (LPAM-1; alpha4beta7; a4b7), with immunomodulating, anti-inflammatory, and potential antineoplastic activities. Upon administration, vedolizumab selectively binds to integrin a4b7 and prevents the binding of a4b7, expressed on the surface of a subset of T-lymphocytes, to its natural ligand, mucosal addressin cell adhesion molecule-1 (MAdCAM-1), which is mainly expressed on the surface of gut endothelial cells. This prevents a4b7-mediated signaling, adhesion of lymphocytes to the endothelium and the migration of T-lymphocytes across the endothelium into inflamed gastrointestinal (GI) tissue. By preventing this infiltration to the affected area, inflammation is reduced. The human lymphocyte a4b7 integrin, plays a key role in gastrointestinal (GI) inflammation; it is overexpressed in certain types of cancer cells. The alpha4beta7/MAdCAM-1 signaling pathway plays a critical role in the homing of T-lymphocytes to intestinal tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8115529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tocilizumab</VALIDVALUE>
          <VALUEMEANING>Tocilizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, humanized IgG1 monoclonal antibody directed against the interleukin-6 receptor (IL-6R) with immunosuppressant activity. Tocilizumab targets and binds to both the soluble form of IL-6R (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of IL-6 to its receptor. This prevents IL-6-mediated signaling. Il-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders and certain types of cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4618052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ruxolitinib (Jakafi)</VALIDVALUE>
          <VALUEMEANING>Ruxolitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77888</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5125106</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natalizumab (PUVA)</VALIDVALUE>
          <VALUEMEANING>Natalizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized recombinant IgG4 monoclonal antibody directed against the alpha4 subunit of the integrins alpha4beta1and alpha4beta7 with immunomodulating, anti-inflammatory, and potential antineoplastic activities.  Natalizumab binds to the alpha4-subunit of alpha4beta1 and alpha4beta7 integrins expressed on the surface of all leukocytes except neutrophils, inhibiting the alpha4-mediated adhesion of leukocytes to counter-receptor(s) such as vascular cell adhesion molecule-1 (VCAM-1); natalizumab-mediated disruption of VCAM-1 binding by these integrins may prevent the transmigration of leukocytes across the endothelium into inflamed parenchymal tissue.  Integrins are cellular adhesion molecules (CAMs) that are upregulated in various types of cancer and some autoimmune diseases; alpha4beta1 integrin (VLA4) has been implicated in the survival of myeloma cells, possibly by mediating their adhesion to stromal cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8115531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesenchymal Stem Cells</VALIDVALUE>
          <VALUEMEANING>Mesenchymal Stem Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>An undifferentiated stromal cell with the ability to develop into the cells that form distinct mesenchymal tissues; such as bone, muscle, connective tissue, blood vessels, and lymphatic tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4197222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fecal Microbial Transplant</VALIDVALUE>
          <VALUEMEANING>Feces Microorganism Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>The material discharged from the bowel during defecation.  It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.: A microscopic organism. The term microorganism may refer to a prokaryote or eukaryote, and may be a unicellular or multicellular organism. All taxonomic kingdoms contain microorganisms.: Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15342, C14329, C13234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8115532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Etanercept (Adcetris)</VALIDVALUE>
          <VALUEMEANING>Etanercept</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant soluble dimeric fusion protein consisting of the extracellular ligand-binding region of recombinant human tumor necrosis factor (rhTNF) receptor attached to the constant (Fc) region of human immunoglobulin G (FcIgG). The receptor moiety of etanercept binds to circulating TNF (2 molecules of TNF per receptor) and inhibits its attachment to endogenous TNF cell surface receptors, thereby rendering TNF inactive and inhibiting TNF-mediated mechanisms of inflammation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5126589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pentostatin</VALIDVALUE>
          <VALUEMEANING>Pentostatin</VALUEMEANING>
          <MEANINGDESCRIPTION>The active ingredient in a drug that is used to treat hairy cell leukemia and is being studied in the treatment of other types of cancer. Pentostatin blocks a protein needed for cell growth and may kill cancer cells. It is made by a bacterium. It is a type of adenosine deaminase inhibitor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C732</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5127413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infliximab</VALIDVALUE>
          <VALUEMEANING>Infliximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant chimeric, mouse-human monoclonal antibody directed against tumor necrosis factor alpha (TNF-alpha), a protein involved in inflammation, cell survival, and apoptosis.  Infliximab may be pro- apoptotic or anti-apoptotic, depending on cell type. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3235990</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antilymphocyte Globulin (ALG)</VALIDVALUE>
          <VALUEMEANING>Antilymphocyte Serum</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunoglobulins raised xenogeneically against lymphocyte populations.  It is used both as a test for histocompatibility and in conjunction with other immunosuppressive agents to suppress rejection of grafts or organ transplants.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62577</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8115533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>GVHD Prophylaxis</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>GVHD Prophylaxis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Type of GVHD prophylaxis:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were any of these medications used for GVHD treatment/ prophylaxis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the recipient&#39;s GVHD prophylaxis</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the recipient&#39;s GVHD prophylaxis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the recipient&#39;s GVHD prophylaxis</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify the recipient&#39;s GVHD prophylaxis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient receive GVHD prophylaxis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="742">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3323194</PUBLICID>
    <LONGNAME>Surgical Procedure Exenteration Performed Ind-3b</LONGNAME>
    <PREFERREDNAME>3323193v1.0:2958018v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Removal of internal organs and tissues, usually radical removal of the contents of a body cavity._Performed; carried out._an assessment response or indicator that can have a value of yes, no, or not applicable.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3323193</PublicId>
      <PreferredName>2322305v1.0:3323191v1.0</PreferredName>
      <PreferredDefinition>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Removal of internal organs and tissues, usually radical removal of the contents of a body cavity._Performed; carried out.</PreferredDefinition>
      <LongName>Surgical Procedure Exenteration Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2322305</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3323191</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68790:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Exenteration Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68790</PREFERRED_NAME>
            <LONG_NAME>Exenteration</LONG_NAME>
            <CON_ID>2673232</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506036</PublicId>
      <PreferredName>YES_NO_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.</PreferredDefinition>
      <LongName>Yes No Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694966</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49797</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3b</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49797</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Not Applicable Response</LONG_NAME>
            <CON_ID>2694965</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was exenterative surgery perf</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was exenterative surgery performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Extensive pelvic exenteration surgery, surgeries which include partial or total vaginectomy with or without reconstruction; radical vulvectomy with or without remove of clitoris</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0238</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104895</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3323193v1.0:2958018v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SURG_EXENT_PERF</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="743">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3350656</PUBLICID>
    <LONGNAME>Lymphoma Disease Anatomic Site</LONGNAME>
    <PREFERREDNAME>3350654v1.0:3350655v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>a description of the anatomic site or location within the body of lymphoma-related disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3350654</PublicId>
      <PreferredName>3350652v1.0:2442487v1.0</PreferredName>
      <PreferredDefinition>information relating to the anatomic site or location within the body of lymphoma-related disease.</PreferredDefinition>
      <LongName>Lymphoma Disease Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3350652</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3208:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Lymphoma Disease or Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3208</PREFERRED_NAME>
            <LONG_NAME>Lymphoma</LONG_NAME>
            <CON_ID>2202736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2240715</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25341</PreferredName>
        <Version>1</Version>
        <LongName>Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3350655</PublicId>
      <PreferredName>3350655v1.0</PreferredName>
      <PreferredDefinition>a description of the anatomic site or location within the body of lymphoma-related disease.</PreferredDefinition>
      <LongName>Lymphoma Disease Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>80</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2519596</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>axillary/brachial</VALIDVALUE>
          <VALUEMEANING>axillary/brachial</VALUEMEANING>
          <MEANINGDESCRIPTION>One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: An axillary lymph node along the brachial vein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92221, C37998, C12904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>celiac axis/retrocrural</VALIDVALUE>
          <VALUEMEANING>celiac axis/retrocrural</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node at the base of the celiac artery.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A lymph node located within the most inferior portion of the posterior mediastinum. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103439, C37998, C65166</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cervical</VALIDVALUE>
          <VALUEMEANING>Cervical</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to a neck, or cervix, in any sense.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565996</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>common pelvic</VALIDVALUE>
          <VALUEMEANING>common pelvic</VALUEMEANING>
          <MEANINGDESCRIPTION>Any lymph node within the abdominal pelvic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568230</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>epitrochlear</VALIDVALUE>
          <VALUEMEANING>epitrochlear</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located above and adjacent to the elbow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>external/internal iliac</VALIDVALUE>
          <VALUEMEANING>external/internal iliac</VALUEMEANING>
          <MEANINGDESCRIPTION>An artery arising from the bifurcation of the common iliac artery in the lower torso. The external iliac artery becomes the femoral artery and is the main blood supply for the leg.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A short thick blood vessel arising from the bifurcation of the common iliac artery with numerous branches that supply the organs, walls and viscera of the pelvis as well as the inner thigh.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32845, C37998, C32558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hilar</VALIDVALUE>
          <VALUEMEANING>Hilar</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to the area where nerves and blood vessels attach to an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25724</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>infraclavicular</VALIDVALUE>
          <VALUEMEANING>infraclavicular</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the area below the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>inguinal/femoral</VALIDVALUE>
          <VALUEMEANING>inguinal/femoral</VALUEMEANING>
          <MEANINGDESCRIPTION>A superficial or deep lymph node located in the inguinal area.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A lymph node located in the upper inner portion of the thigh.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98183, C37998, C32801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mediastinal</VALIDVALUE>
          <VALUEMEANING>mediastinal</VALUEMEANING>
          <MEANINGDESCRIPTION>mediastinal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mesenteric</VALIDVALUE>
          <VALUEMEANING>mesenteric</VALUEMEANING>
          <MEANINGDESCRIPTION>mesenteric</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25226</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>para-aortic</VALIDVALUE>
          <VALUEMEANING>PARA-AORTIC</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located adjacent to the lumbar region of the spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559699</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>paratracheal</VALIDVALUE>
          <VALUEMEANING>paratracheal</VALUEMEANING>
          <MEANINGDESCRIPTION>Regions near to the trachea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25317</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568217</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pectoral</VALIDVALUE>
          <VALUEMEANING>pectoral</VALUEMEANING>
          <MEANINGDESCRIPTION>pectoral</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>porta caval</VALIDVALUE>
          <VALUEMEANING>porta caval</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the portal vein and inferior vena cava.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103847</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>porta hepatis</VALIDVALUE>
          <VALUEMEANING>porta hepatis</VALUEMEANING>
          <MEANINGDESCRIPTION>porta hepatis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0227498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pre-auricular</VALIDVALUE>
          <VALUEMEANING>pre-auricular</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located anterior to the auricle of the ear. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>retroperitoneal</VALIDVALUE>
          <VALUEMEANING>retroperitoneal</VALUEMEANING>
          <MEANINGDESCRIPTION>retroperitoneal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>splenic hilar</VALIDVALUE>
          <VALUEMEANING>splenic hilar</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the hilar region of the spleen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>supraclavicular</VALIDVALUE>
          <VALUEMEANING>SUPRACLAVICULAR</VALUEMEANING>
          <MEANINGDESCRIPTION>SUPRACLAVICULAR</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>waldeyer&#39;s ring</VALIDVALUE>
          <VALUEMEANING>waldeyer&#39;s ring</VALUEMEANING>
          <MEANINGDESCRIPTION>The ring of lymphoid tissue located in the pharynx, consisting of the pharyngeal, tubal, palatine, and lingual tonsils.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CNS - Leptomeninges</VALIDVALUE>
          <VALUEMEANING>CNS - leptomeninges</VALUEMEANING>
          <MEANINGDESCRIPTION>CNS - leptomeninges</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CNS - Brain</VALIDVALUE>
          <VALUEMEANING>CNS/BRAIN</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the nervous system that consists of the brain, spinal cord, and meninges.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12439, C37998, C12438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epidural</VALIDVALUE>
          <VALUEMEANING>Epidural</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the space between the wall of the spinal canal and the covering of the spinal cord. An epidural injection is given into this space.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282268</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testicle</VALIDVALUE>
          <VALUEMEANING>Testicle</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the paired male reproductive glands that produce the male germ cells and the male hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Submandibular gland</VALIDVALUE>
          <VALUEMEANING>Submandibular gland</VALUEMEANING>
          <MEANINGDESCRIPTION>Submandibular gland</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parotid gland</VALIDVALUE>
          <VALUEMEANING>Parotid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest of the three paired salivary glands, located in front of the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Conjunctiva</VALIDVALUE>
          <VALUEMEANING>Conjunctiva</VALUEMEANING>
          <MEANINGDESCRIPTION>A thin, transparent mucous membrane that covers the posterior surface of lids (palpebral conjunctiva) and the outer surface of the sclera (bulbar conjunctiva).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12341</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Orbit</VALIDVALUE>
          <VALUEMEANING>Orbit</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa.  Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin</VALIDVALUE>
          <VALUEMEANING>Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large intestine</VALIDVALUE>
          <VALUEMEANING>Large Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>A muscular tube that extends from the end of the small intestine to the anus. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2873884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small intestine</VALIDVALUE>
          <VALUEMEANING>Small Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the digestive tube between the stomach and the cecum or beginning of the large intestine; it consists of three portions: duodenum, jejunum, and ileum. SYN intestinum tenue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach</VALIDVALUE>
          <VALUEMEANING>Stomach</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney</VALIDVALUE>
          <VALUEMEANING>Kidney</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secret the metabolic products and minerals from the blood, thus maintaining the homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver</VALIDVALUE>
          <VALUEMEANING>Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone</VALIDVALUE>
          <VALUEMEANING>Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Connective tissue that forms the skeletal components of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone marrow</VALIDVALUE>
          <VALUEMEANING>Bone Marrow</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lungs</VALIDVALUE>
          <VALUEMEANING>Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2873883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleura</VALIDVALUE>
          <VALUEMEANING>Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>(PLOOR-a) A thin layer of tissue covering the lungs and the wall of the chest cavity to protect and cushion the lungs. A small amount of fluid that acts as a lubricant allows the lungs to move smoothly in the chest cavity during breathing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>popliteal</VALIDVALUE>
          <VALUEMEANING>popliteal</VALUEMEANING>
          <MEANINGDESCRIPTION>popliteal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0442037</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>iliac</VALIDVALUE>
          <VALUEMEANING>Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the three lymph nodes of the pelvis: the superior gluteal, interior gluteal or sacral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Site of Lesion</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Site of Lesion</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="744">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3351889</PUBLICID>
    <LONGNAME>Bone Scan Day Number</LONGNAME>
    <PREFERREDNAME>2008800v2.31:2896868v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the day that a bone scan was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2008800</PublicId>
      <PreferredName>BONE_MEDIMG_ASSESS</PreferredName>
      <PreferredDefinition>information relating to the medical imaging assessment (the determination of the value, significance, or extent of) to create images of bones on a computer screen or on film.</PreferredDefinition>
      <LongName>Bone Scan Medical Imaging Assessment</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2414920</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17646:C16831</PreferredName>
        <Version>1</Version>
        <LongName>Bone Scan Medical Imaging</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17646</PREFERRED_NAME>
            <LONG_NAME>Bone Scan</LONG_NAME>
            <CON_ID>2204749</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16831</PREFERRED_NAME>
            <LONG_NAME>Medical Imaging</LONG_NAME>
            <CON_ID>2224877</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25367</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896868</PublicId>
      <PreferredName>EVT_DAY_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._time for Earth to make a complete rotation on its axis._A numeral or string of numerals expressing value, quantity, or identification</PreferredDefinition>
      <LongName>Event Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C0439228:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Day Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0439228</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2204684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>22nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::22: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::22</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>21st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>20th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::20: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>19th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::19: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>18th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::18: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>17th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::17: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>16th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::16: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>15th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::15: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>14th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::14: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>13th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::13: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::10: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::4: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::5: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>31st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::31: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::31</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>30th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::30: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::30</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>29th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::29: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>28th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::28: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>27th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::27: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>26th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::26: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>25th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::25: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>24th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>23rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::23: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day Bone Scan Performed</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Day Bone Scan Performed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>day_of_bone_scan_performed</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="745">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3351891</PUBLICID>
    <LONGNAME>Prostate Cancer Patient Magnetic Resonance Imaging Result Clinical TNM Finding Stage</LONGNAME>
    <PREFERREDNAME>3350707v1.0:3351747v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text statement to describe the results of an MRI performed on a patient with prostate cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3350707</PublicId>
      <PreferredName>3350696v1.0:3350705v1.0</PreferredName>
      <PreferredDefinition>Prostate carcinoma is one of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002_A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders._The result of an action.</PreferredDefinition>
      <LongName>Prostate Carcinoma Patient Magnetic Resonance Imaging Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3350696</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4863:C16960</PreferredName>
        <Version>1</Version>
        <LongName>Prostate Carcinoma Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4863</PREFERRED_NAME>
            <LONG_NAME>Prostate Carcinoma</LONG_NAME>
            <CON_ID>2237042</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3350705</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16809:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Magnetic Resonance Imaging Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16809</PREFERRED_NAME>
            <LONG_NAME>Magnetic Resonance Imaging</LONG_NAME>
            <CON_ID>2202506</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3351747</PublicId>
      <PreferredName>3351747v1.0</PreferredName>
      <PreferredDefinition>Prostate carcinoma is one of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002_TNM staging performed with access to clinical information only._The data or image obtained by gathering information with a sensing device._The result of an action._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.</PreferredDefinition>
      <LongName>Prostate Cancer Clinical TNM Finding Scan Result Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3351871</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3351871v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Prostate Carcinoma Clinical TNM Finding Scan Outcome Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4863</PREFERRED_NAME>
            <LONG_NAME>Prostate Carcinoma</LONG_NAME>
            <CON_ID>2237042</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48881</PREFERRED_NAME>
            <LONG_NAME>Clinical TNM Finding</LONG_NAME>
            <CON_ID>2434282</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17999</PREFERRED_NAME>
            <LONG_NAME>Scan</LONG_NAME>
            <CON_ID>2202631</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extraprostatic Extension, Regional Lymphadenopathy [e.g., cN1]</VALIDVALUE>
          <VALUEMEANING>Prostate Cancer cN1 TNM Finding v7</VALUEMEANING>
          <MEANINGDESCRIPTION>Prostate cancer with metastasis in regional lymph node(s). (from AJCC 7th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3351759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Equivocal</VALIDVALUE>
          <VALUEMEANING>Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Distant Metastasis [e.g., cM1]</VALIDVALUE>
          <VALUEMEANING>Prostate Cancer cM1 TNM Finding v7</VALUEMEANING>
          <MEANINGDESCRIPTION>Prostate cancer with distant metastasis. (from AJCC 7th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3351757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extraprostatic Extension, Localized (e.g., seminal vesicles)</VALIDVALUE>
          <VALUEMEANING>Prostate Cancer pT3b TNM Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>Prostate cancer extending beyond the capsule of the prostate gland, with involvement of the seminal vesicles. (from AJCC 6th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833389</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Evidence of Extraprostatic Extension</VALIDVALUE>
          <VALUEMEANING>No Evidence of Extraprostatic Extension</VALUEMEANING>
          <MEANINGDESCRIPTION>Diagnostic tests fail to detect presence of metastatic lesions._Situated outside of the prostate._The spread or migration of cancer cells through the wall of an organ into surrounding organs and/or adjacent tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120271, C25505, C48558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3351760</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MRI Results</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>MRI Results</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>diagnostic_mri_result</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="746">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3370224</PUBLICID>
    <LONGNAME>Tubulovillous Adenoma Finding Lesion Shape Type</LONGNAME>
    <PREFERREDNAME>TUB_ADENO_LES_SH_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator that describe the shape of the tubulovillous adenoma.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3368846</PublicId>
      <PreferredName>3368844v1.0:2177509v1.0</PreferredName>
      <PreferredDefinition>An epithelial neoplasm morphologically characterized by the presence of a villous and a tubular architectural pattern. Most often it occurs in the large intestine, small intestine, and the stomach in which the neoplastic epithelial cells show dysplastic features._Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.</PreferredDefinition>
      <LongName>Tubulovillous Adenoma Finding</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3368844</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4143</PreferredName>
        <Version>1</Version>
        <LongName>Tubulovillous Adenoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4143</PREFERRED_NAME>
            <LONG_NAME>Gastrointestinal Tract Tubulovillous Adenoma</LONG_NAME>
            <CON_ID>2782648</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177509</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Finding</PreferredName>
        <Version>1</Version>
        <LongName>Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3367</PREFERRED_NAME>
            <LONG_NAME>Finding</LONG_NAME>
            <CON_ID>2202448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3368817</PublicId>
      <PreferredName>3368817v1.0</PreferredName>
      <PreferredDefinition>A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._The spatial arrangement of something as distinct from its substance._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Lesion Shape Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>12</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3368816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3824:C25677:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Lesion Shape Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25677</PREFERRED_NAME>
            <LONG_NAME>Shape</LONG_NAME>
            <CON_ID>2203587</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pedunculated</VALIDVALUE>
          <VALUEMEANING>Pedunculated Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>Having a narrow part by which some larger part is attached.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35936</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3368818</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sessile</VALIDVALUE>
          <VALUEMEANING>Sessile Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>Attached directly by the base; not having an intervening stalk.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35935</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3368819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Shape of tubulovillous adenom</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Shape of tubulovillous adenoma(s)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Biospecimen Repository</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3060675</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000190</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="747">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3370383</PUBLICID>
    <LONGNAME>Person Malignant Neoplasm Research Diagnostic Imaging Consent Ind-2</LONGNAME>
    <PREFERREDNAME>3370380v1.0:2018303v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether there was consent or permission from a person to use a portion of blood, tissue, or other substance from the body in cancer research, the systematic investigation of the nature of diseases in which abnormal cells divide without control using any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>SWOG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3370380</PublicId>
      <PreferredName>2236731v1.0:3431174v1.0</PreferredName>
      <PreferredDefinition>information related to the consent or permission from a person to use a portion of blood, tissue, or other substance from the body in cancer research, the systematic investigation of the nature of diseases in which abnormal cells divide without control using any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation..</PreferredDefinition>
      <LongName>Person Malignant Neoplasm Research Diagnostic Imaging Consent</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SWOG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3431174</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305:C15319:C16502:C25460</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm Research Diagnostic Imaging Consent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15319</PREFERRED_NAME>
            <LONG_NAME>Research</LONG_NAME>
            <CON_ID>2202802</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16502</PREFERRED_NAME>
            <LONG_NAME>Diagnostic Imaging Testing</LONG_NAME>
            <CON_ID>2321519</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25460</PREFERRED_NAME>
            <LONG_NAME>Consent</LONG_NAME>
            <CON_ID>2203590</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>My DXA scan may be kept for u</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>My DXA scan may be kept for use in research to learn about, prevent, treat or cure cancer.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="748">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3371909</PUBLICID>
    <LONGNAME>Patient Protocol Follow-up End Date</LONGNAME>
    <PREFERREDNAME>PT_FU_END_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the event end date related to the protocol-defined patient/participant follow-up, the process by which information about the health status of an individual is obtained after a study treatment has been discontinued.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2469623</PublicId>
      <PreferredName>PT_PROT_FU</PreferredName>
      <PreferredDefinition>information related to the protocol-defined patient/participant follow-up, the process by which information about the health status of an individual is obtained after a study treatment has been discontinued.</PreferredDefinition>
      <LongName>Patient Protocol Follow-up</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2469621</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25320:C16033</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Follow-up</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25320</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Protocol</LONG_NAME>
            <CON_ID>2202702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16033</PREFERRED_NAME>
            <LONG_NAME>Follow-Up</LONG_NAME>
            <CON_ID>2202303</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188674</PublicId>
      <PreferredName>END_DT</PreferredName>
      <PreferredDefinition>The date on which an observation or an event ended.</PreferredDefinition>
      <LongName>End Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184285</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Date</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Follow-up End Date:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Follow-up End Date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Follow-up end date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Follow-Up End Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reporting period end date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Follow-up end date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AOST2031 Reporting Period End Date</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>AOST2031 Reporting Period End Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="749">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3430826</PUBLICID>
    <LONGNAME>Dental  Patient Fix Maxilla   Retainer Device Component  Use Percentage Value</LONGNAME>
    <PREFERREDNAME>3427504v1.0:2903088v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The percentage of patients the orthodontist see who have received a fixed maxillary retainer</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PRECEDENT CRF:Practice-based Research Collaborative in Evidence-Based Dentistry Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3427504</PublicId>
      <PreferredName>2714778v1.0:3427502v1.0</PreferredName>
      <PreferredDefinition>The percentage of patients the orthodontist see who have received a fixed maxillary retainer</PreferredDefinition>
      <LongName>Dental  Patient Fix Maxilla   Retainer Device Component  Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2714778</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C16960</PreferredName>
        <Version>1</Version>
        <LongName>Dental Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3427502</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52253:C26470:C50144:C95018</PreferredName>
        <Version>1</Version>
        <LongName>Fix Maxilla Retainer Device Component Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52253</PREFERRED_NAME>
            <LONG_NAME>Fix</LONG_NAME>
            <CON_ID>2443940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26470</PREFERRED_NAME>
            <LONG_NAME>Maxilla</LONG_NAME>
            <CON_ID>2202586</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50144</PREFERRED_NAME>
            <LONG_NAME>Retainer Device</LONG_NAME>
            <CON_ID>3420764</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95018</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>3248409</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PRECEDENT CRF:Practice-based Research Collaborative in Evidence-Based Dentistry Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2903088</PublicId>
      <PreferredName>PER_VAL</PreferredName>
      <PreferredDefinition>A numerical quantity measured or assigned or computed that is a fraction or ratio with 100 understood as the denominator.</PreferredDefinition>
      <LongName>Percentage Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What percentage of your patie</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What percentage of your patients in retention receive a FIXED MAXILLARY retainer</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="750">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3430941</PUBLICID>
    <LONGNAME>New Primary Melanoma Anatomic Site</LONGNAME>
    <PREFERREDNAME>3430940v1.0:3426799v2.1</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that describes the anatomic site of the new primary cutaneous melanoma.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3430940</PublicId>
      <PreferredName>3430938v1.0:2186622v1.0</PreferredName>
      <PreferredDefinition>Having no previous example or precedent or parallel; of a kind not seen before._Occurring first in time or sequence; original; of greatest rank or importance or value._A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain._Named locations of, or within, the body.</PreferredDefinition>
      <LongName>New Primary Melanoma Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3430938</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25586:C25251:C3224</PreferredName>
        <Version>1</Version>
        <LongName>New Primary Melanoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25586</PREFERRED_NAME>
            <LONG_NAME>New</LONG_NAME>
            <CON_ID>2204982</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3224</PREFERRED_NAME>
            <LONG_NAME>Melanoma</LONG_NAME>
            <CON_ID>2202743</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2186622</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3426799</PublicId>
      <PreferredName>3426799v1.0</PreferredName>
      <PreferredDefinition>A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The place where something begins or comes from in either the sense of a physical location or a metaphysical source._Named locations of, or within, the body.</PreferredDefinition>
      <LongName>Neoplasm Origin Anatomic Site</LongName>
      <Version>2.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3426798</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3262:C42703:C13717</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm Origin Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42703</PREFERRED_NAME>
            <LONG_NAME>Origin</LONG_NAME>
            <CON_ID>2204026</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systemic</VALIDVALUE>
          <VALUEMEANING>Systemic</VALUEMEANING>
          <MEANINGDESCRIPTION>(sis-TEM-ik) Affecting the entire body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3178352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Synovium</VALIDVALUE>
          <VALUEMEANING>Synovial Membrane</VALUEMEANING>
          <MEANINGDESCRIPTION>The inner layer of the connective tissue that seals the joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Subcutaneous tissue</VALIDVALUE>
          <VALUEMEANING>Subcutaneous Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Beneath the skin.: An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12801, C13353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3187285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach, Mucosa only</VALIDVALUE>
          <VALUEMEANING>Stomach Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>The organ located between the esophagus and the small intestine where digestion of food occurs before passing to the small intestine.: The moist tissue that lines some organs and body cavities (such as the nose, mouth, lungs) and makes mucus (a thick, slippery fluid).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13166, C12391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sternum</VALIDVALUE>
          <VALUEMEANING>Sternum</VALUEMEANING>
          <MEANINGDESCRIPTION>The long, flat bone connecting with the cartilages of the first seven ribs and the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12793</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spine/Femur/Radius</VALIDVALUE>
          <VALUEMEANING>Vertebral Column and Femur Radius</VALUEMEANING>
          <MEANINGDESCRIPTION>The spinal or vertebral column.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The longest and largest bone of the skeleton, it is situated between the hip and the knee.: A straight line from the center to the perimeter of a circle or from the center to the surface of a sphere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63921, C12717, C37912, C12998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spine/Femur</VALIDVALUE>
          <VALUEMEANING>Vertebral Column and Femur</VALUEMEANING>
          <MEANINGDESCRIPTION>The spinal or vertebral column.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The longest and largest bone of the skeleton, it is situated between the hip and the knee.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12717, C37912, C12998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spine</VALIDVALUE>
          <VALUEMEANING>Vertebral Column</VALUEMEANING>
          <MEANINGDESCRIPTION>The spinal or vertebral column.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spinal Cord</VALIDVALUE>
          <VALUEMEANING>Spinal Cord</VALUEMEANING>
          <MEANINGDESCRIPTION>The elongated, approximately cylindrical part of the central nervous system of vertebrates that lies in the vertebral canal and from which the spinal nerves emerge.|On-line Medical Dictionary</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sphenoid bone</VALIDVALUE>
          <VALUEMEANING>Sphenoid Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The butterfly-shaped bone located at the base of the skull that helps to form the orbit of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small Bowel, Mucosa only</VALIDVALUE>
          <VALUEMEANING>Small Bowel Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the digestive tube between the stomach and the cecum or beginning of the large intestine; it consists of three portions: duodenum, jejunum, and ileum. SYN intestinum tenue.: The moist tissue that lines some organs and body cavities (such as the nose, mouth, lungs) and makes mucus (a thick, slippery fluid).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13166, C12386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skull</VALIDVALUE>
          <VALUEMEANING>Skull</VALUEMEANING>
          <MEANINGDESCRIPTION>The skeleton of the head including the bones of the face and the bones enclosing the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibula</VALIDVALUE>
          <VALUEMEANING>Fibula</VALUEMEANING>
          <MEANINGDESCRIPTION>The bone of the lower leg lateral to and smaller than the tibia. In proportion to its length, it is the most slender of the long bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Finger</VALIDVALUE>
          <VALUEMEANING>Fingers (Phalanges)</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the digits of the hand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibula head</VALIDVALUE>
          <VALUEMEANING>Head of the Fibula</VALUEMEANING>
          <MEANINGDESCRIPTION>The highest portion of the fibula that articulates with the patella.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4199812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Femur</VALIDVALUE>
          <VALUEMEANING>Femur</VALUEMEANING>
          <MEANINGDESCRIPTION>The longest and largest bone of the skeleton, it is situated between the hip and the knee.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fallopian tube</VALIDVALUE>
          <VALUEMEANING>Fallopian tube</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of tubes that extend from the uterus to each of the ovaries. Following ovulation the egg travels down the fallopian tube to the uterus where fertilization may or may not occur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eye</VALIDVALUE>
          <VALUEMEANING>Eye</VALUEMEANING>
          <MEANINGDESCRIPTION>The organ of sight or vision.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethmoid bone</VALIDVALUE>
          <VALUEMEANING>Ethmoid Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A light and spongy bone that is cubical in shape. This bone is positioned at the anterior part of the cranium, sitting between the two orbits, at the roof of the nose. It consists of four parts: a horizontal or cribriform plate; a perpendicular plate; and two lateral masses or labyrinths.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus, Mucosa only</VALIDVALUE>
          <VALUEMEANING>Esophageal Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the esophagus.: The moist tissue that lines some organs and body cavities (such as the nose, mouth, lungs) and makes mucus (a thick, slippery fluid).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13166, C37950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine gland</VALIDVALUE>
          <VALUEMEANING>Endocrine Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>Ductless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elbow</VALIDVALUE>
          <VALUEMEANING>Elbow Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of hinge joint located between the forearm and upper arm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Effusion</VALIDVALUE>
          <VALUEMEANING>Effusion</VALUEMEANING>
          <MEANINGDESCRIPTION>A collection of fluid in a body cavity.  It may be the result of a non-neoplastic disorder (e.g. heart failure) or a tumor (e.g. carcinoma of the lung). -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3003</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ear, Pinna (External)</VALIDVALUE>
          <VALUEMEANING>External Ear</VALUEMEANING>
          <MEANINGDESCRIPTION>The external part of the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ear canal</VALIDVALUE>
          <VALUEMEANING>Ear Canal</VALUEMEANING>
          <MEANINGDESCRIPTION>The organ of hearing: composed of the external ear, which includes the auricle and the external acoustic, or auditory, meatus; the middle ear, or the tympanic cavity with its ossicles; and the internal ear or inner ear, or labyrinth, which includes the semicircular canals, vestibule, and cochlea. SEE ALSO auricle. SYN auris.: A bodily passage or tube lined with epithelial cells and conveying a secretion or other substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61487, C12394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ear</VALIDVALUE>
          <VALUEMEANING>Ear</VALUEMEANING>
          <MEANINGDESCRIPTION>A sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contains the ossicles (malleus, incus and stapes). The inner ear is made up of the cochlea needed for hearing and the vestibular apparatus required for balance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Duodenum</VALIDVALUE>
          <VALUEMEANING>Duodenum</VALUEMEANING>
          <MEANINGDESCRIPTION>A jointed tube 25-30 cm long that connects the stomach to the jejunum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diaphragm</VALIDVALUE>
          <VALUEMEANING>Diaphragm</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibromuscular tissue that separates the thoracic from the abdominal cavity. It increases the volume of the thoracic cavity through contractions, thus facilitating respiration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bowel</VALIDVALUE>
          <VALUEMEANING>Bowel</VALUEMEANING>
          <MEANINGDESCRIPTION>The long, tube-shaped organ in the abdomen that completes the process of digestion. The intestine has two parts, the small intestine and the large intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4887671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest wall</VALIDVALUE>
          <VALUEMEANING>Chest Wall</VALUEMEANING>
          <MEANINGDESCRIPTION>The total system of structures outside the lungs that move as a part of breathing; it includes all structures from the skin to the parietal pleura.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest</VALIDVALUE>
          <VALUEMEANING>Chest</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervix</VALIDVALUE>
          <VALUEMEANING>Cervix Uteri</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical/Thoracic/Lumbar spine</VALIDVALUE>
          <VALUEMEANING>Cervical Thoracic Lumbar Spine Vertebral Column</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to a neck, or cervix, in any sense.: Having to do with the chest.: Those vertebrae between the ribs and the pelvis, L1-L5 in man.: A series of bones, muscles, tendons, and other tissues reaching from the base of the skull to the tailbone. The vertebral column forms the axis of the skeleton and encloses as well as protects the spinal cord and the fluid surrounding the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12998, C69314, C13360, C12844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4887891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical vertebra</VALIDVALUE>
          <VALUEMEANING>Cervical Vertebra</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the seven vertebrae that start with C1, connecting the skull to the spine, and ends with C7, which joins the cervical with the thoracic spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12693</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4199814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical spine</VALIDVALUE>
          <VALUEMEANING>Cervical spine</VALUEMEANING>
          <MEANINGDESCRIPTION>Those vertebrae immediately behind (caudal to) the skull, C1-C7 in man.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cranial Nerve</VALIDVALUE>
          <VALUEMEANING>Cranial Nerve</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the 12 paired nerves that originate in the brain stem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12700</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2798874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Connective tissue</VALIDVALUE>
          <VALUEMEANING>Connective Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>The supporting or framework tissue of the animal body, formed of fibrous and ground substance with more or less numerous cells of various kinds; it is derived from the mesenchyme, and this in turn from the mesoderm; the varieties of connective tissue are: areolar or loose; adipose; dense, regular or irregular, white fibrous; elastic; mucous; and lymphoid tissue; cartilage; and bone; the blood and lymph may be regarded as connective tissues the ground substance of which is a liquid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12374</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Common duct</VALIDVALUE>
          <VALUEMEANING>Common Bile Duct</VALUEMEANING>
          <MEANINGDESCRIPTION>Bile ducts are passageways that carry bile. Two major bile ducts come together into a &quot;trunk&quot;-the common bile duct which empties into the upper part of the small intestine (the part next to the stomach).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colon, mucosa only</VALIDVALUE>
          <VALUEMEANING>Colon Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.: The moist tissue that lines some organs and body cavities (such as the nose, mouth, lungs) and makes mucus (a thick, slippery fluid).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13166, C12382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colon and rectum</VALIDVALUE>
          <VALUEMEANING>Colon And Rectum Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12390, C37912, C12382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4887934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Coccyx</VALIDVALUE>
          <VALUEMEANING>Coccyx</VALUEMEANING>
          <MEANINGDESCRIPTION>The last portion of the vertebral column just below the sacrum consisting of 3-5 rudimentary vertebrae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clitoris</VALIDVALUE>
          <VALUEMEANING>Clitoris</VALUEMEANING>
          <MEANINGDESCRIPTION>The erectile tissue in the vulva. It is composed of the corpora cavernosa and the glans clitoris.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clavicle</VALIDVALUE>
          <VALUEMEANING>Clavicle</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone of the upper extremity that articulates with the acromion process of the scapula on one end and the sternum on the other.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12695</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chin</VALIDVALUE>
          <VALUEMEANING>Mentum</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the face below the lower lip and including the protruding part of the lower jaw.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81169</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest/Pelvis</VALIDVALUE>
          <VALUEMEANING>Chest And Pelvis Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12767, C37912, C25389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4887935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest/Abdomen/Pelvis</VALIDVALUE>
          <VALUEMEANING>Chest Abdomen Pelvis Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction.: The portion of the body that lies between the thorax and the pelvis.: The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12767, C12664, C25389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4887936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood vessel</VALIDVALUE>
          <VALUEMEANING>Blood Vessel</VALUEMEANING>
          <MEANINGDESCRIPTION>A tube through which the blood circulates in the body. Blood vessels include a network of arteries, arterioles, capillaries, venules, and veins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12679</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood</VALIDVALUE>
          <VALUEMEANING>Blood</VALUEMEANING>
          <MEANINGDESCRIPTION>A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bile duct</VALIDVALUE>
          <VALUEMEANING>Bile Duct</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the ducts conveying bile between the liver and the intestine, including hepatic, cystic, and common bile duct.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Back</VALIDVALUE>
          <VALUEMEANING>Back</VALUEMEANING>
          <MEANINGDESCRIPTION>The dorsal area between the base of the neck and the sacrum. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13062</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axilla</VALIDVALUE>
          <VALUEMEANING>Axilla</VALUEMEANING>
          <MEANINGDESCRIPTION>Axilla; the hollow under the arm where it is joined to the shoulder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12674</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autonomic nervous system</VALIDVALUE>
          <VALUEMEANING>Autonomic Nervous System</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the nervous system of vertebrates that controls involuntary actions of the smooth muscles and heart and glands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12673</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Auditory canal</VALIDVALUE>
          <VALUEMEANING>Auditory Canal</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the process of hearing.: A bodily passage or tube lined with epithelial cells and conveying a secretion or other substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61487, C37915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ascending Colon Hepatic Flexure</VALIDVALUE>
          <VALUEMEANING>Ascending Colon Hepatic Flexure</VALUEMEANING>
          <MEANINGDESCRIPTION>The first part of the colon (large intestine) that starts in the right lower quadrant of the abdomen and ends at the transverse colon in the right upper quadrant of the abdomen.: The bend of the colon at the juncture of its ascending and transverse portions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12266, C12265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Artery</VALIDVALUE>
          <VALUEMEANING>Artery</VALUEMEANING>
          <MEANINGDESCRIPTION>The vessels carrying blood away from the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569764</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arm</VALIDVALUE>
          <VALUEMEANING>Arm</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aqueous Fluid</VALIDVALUE>
          <VALUEMEANING>Aqueous Fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>The clear, watery fluid which fills the anterior and posterior chambers of the eye. It has a refractive index lower than the crystalline lens, which it surrounds, and is involved in the metabolism of the cornea and the crystalline lens. (Cline et al., Dictionary of Visual Science, 4th ed, p319)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aortic Body</VALIDVALUE>
          <VALUEMEANING>Aortic Body</VALUEMEANING>
          <MEANINGDESCRIPTION>A small mass that is located in the inferior surface of the aortic arch.  It functions as a peripheral chemoreceptor and is composed of glomus cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97112</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3259520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aorta</VALIDVALUE>
          <VALUEMEANING>Aorta</VALUEMEANING>
          <MEANINGDESCRIPTION>The major arterial trunk that carries oxygenated blood from the left ventricle into the ascending aorta behind the heart, the aortic arch, through the thorax as the descending aorta and through the abdomen as the abdominal aorta; it bifurcates into the left and right common iliac arteries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anus</VALIDVALUE>
          <VALUEMEANING>Anus</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3625363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antecubital fossa</VALIDVALUE>
          <VALUEMEANING>Antecubital Fossa</VALUEMEANING>
          <MEANINGDESCRIPTION>The hinge joint between the forearm and upper arm or the corresponding joint in the forelimb of a quadruped.: A concavity in a surface, especially an anatomical depression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34007, C32497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3393979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anorectum</VALIDVALUE>
          <VALUEMEANING>Anorectum</VALUEMEANING>
          <MEANINGDESCRIPTION>(AY-nus) The opening of the rectum to the outside of the body.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12390, C37912, C43362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3393978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ankle</VALIDVALUE>
          <VALUEMEANING>Ankle</VALUEMEANING>
          <MEANINGDESCRIPTION>A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anal sphincter</VALIDVALUE>
          <VALUEMEANING>Anal Sphincter</VALUEMEANING>
          <MEANINGDESCRIPTION>The area that includes the anus and the perianal skin.: A ring-shaped muscle that relaxes or tightens to open or close a passage or opening in the body. Examples are the anal sphincter (around the opening of the anus) and the pyloric sphincter (at the lower opening of the stomach).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28381, C32069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569665</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leg</VALIDVALUE>
          <VALUEMEANING>Leg</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the two lower extremities in humans used for locomotion and support.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Laryngopharynx</VALIDVALUE>
          <VALUEMEANING>Hypopharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the pharynx that connects to the esophagus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3595986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large bowel</VALIDVALUE>
          <VALUEMEANING>Large Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>A muscular tube that extends from the end of the small intestine to the anus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lacrimal Gland</VALIDVALUE>
          <VALUEMEANING>Lacrimal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>Paired, almond-shaped exocrine glands situated superior and posterior to each orbit of the eye that produce and secrete the watery serous component of tears.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12346</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lacrimal bone</VALIDVALUE>
          <VALUEMEANING>Lacrimal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A small rectangular thin plate forming part of the medial orbit wall. It is located posterior to the frontal process of the maxilla and articulates with the inferior nasal concha, ethmoid, frontal, and maxillary bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Knee</VALIDVALUE>
          <VALUEMEANING>Knee Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint connecting the lower part of the femur with the upper part of the tibia. The lower part of the femur and the upper part of the tibia are attached to each other by ligaments. Other structures of the knee joint include the upper part of the fibula, located below and parallel to the tibia, and the patella which moves as the knee bends.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Joints</VALIDVALUE>
          <VALUEMEANING>Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>The connection point between two bones or skeletal elements. The joint may be fixed or movable.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13044</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3305580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Jejunum</VALIDVALUE>
          <VALUEMEANING>Jejunum</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the small intestine that extends from the duodenum to the ileum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Jaw</VALIDVALUE>
          <VALUEMEANING>Jaw</VALUEMEANING>
          <MEANINGDESCRIPTION>The bones of the skull that frame the mouth and serve to open it; the bones that hold the teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ischium</VALIDVALUE>
          <VALUEMEANING>Ischium</VALUEMEANING>
          <MEANINGDESCRIPTION>The most posterior and ventral bone making up the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32884</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intestine</VALIDVALUE>
          <VALUEMEANING>Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the gastrointestinal tract between the stomach and the anus. It includes the small intestine and large intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ilium</VALIDVALUE>
          <VALUEMEANING>Ilium</VALUEMEANING>
          <MEANINGDESCRIPTION>The broad, dorsal, upper, and widest of the three principal bones composing either half of the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ileum</VALIDVALUE>
          <VALUEMEANING>Ileum</VALUEMEANING>
          <MEANINGDESCRIPTION>The final section of the small intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242838</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Humerus</VALIDVALUE>
          <VALUEMEANING>Humerus</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper arm bone between the shoulder and elbow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12731</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hip</VALIDVALUE>
          <VALUEMEANING>Hip</VALUEMEANING>
          <MEANINGDESCRIPTION>The lateral prominence of the pelvis from the waist to the thigh.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hilum</VALIDVALUE>
          <VALUEMEANING>Hilum</VALUEMEANING>
          <MEANINGDESCRIPTION>A depression or fissure where vessels or nerves or ducts enter a bodily organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatic duct</VALIDVALUE>
          <VALUEMEANING>Hepatic Duct</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the three ducts associated with the liver including the right hepatic duct, left hepatic duct and common hepatic duct.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32730</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head/Neck/Chest/Abd/Pelvis</VALIDVALUE>
          <VALUEMEANING>Head Neck Chest Abdomen Pelvis Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior and superior part of a human bearing the mouth, the brain and sensory organs.: The region that connects the head to the rest of the body.: The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction.: The portion of the body that lies between the thorax and the pelvis.: The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12767, C12664, C25389, C13063, C12419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4888120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head - face or neck, NOS</VALIDVALUE>
          <VALUEMEANING>Head Face Or Neck Not Otherwise Specified Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior and superior part of a human bearing the mouth, the brain and sensory organs.: The anterior portion of the head extending from the forehead to the chin and ear to ear. The facial structures contain the eyes, nose and mouth, cheeks and jaws.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The region that connects the head to the rest of the body.: Not characterized in any other way.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C19594, C13063, C37998, C13071, C12419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4888121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hand</VALIDVALUE>
          <VALUEMEANING>Hand</VALUEMEANING>
          <MEANINGDESCRIPTION>The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gum</VALIDVALUE>
          <VALUEMEANING>Gingiva</VALUEMEANING>
          <MEANINGDESCRIPTION>The soft tissue surrounding the neck of individual teeth as well as covering the alveolar bone. The tissue is fibrous and continuous with the periodontal ligament and mucosal covering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32677</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3491749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Groin</VALIDVALUE>
          <VALUEMEANING>Inguinal Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower region of the anterior abdominal wall located laterally to the pubic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genitourinary</VALIDVALUE>
          <VALUEMEANING>Genitourinary</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or related to the genital and urinary organs or their functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganglia</VALIDVALUE>
          <VALUEMEANING>Ganglion</VALUEMEANING>
          <MEANINGDESCRIPTION>A cluster of nervous tissue principally composed of neuronal cell bodies external to the central nervous system (CNS).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frontal lobe</VALIDVALUE>
          <VALUEMEANING>Frontal Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the brain located anterior to the parietal lobes at the front of each cerebral hemisphere. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frontal bone</VALIDVALUE>
          <VALUEMEANING>Frontal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone of the skull forming the forehead, root of the nose and the roof of both orbits.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foreskin</VALIDVALUE>
          <VALUEMEANING>Male Prepuce</VALUEMEANING>
          <MEANINGDESCRIPTION>A fold of skin covering the tip of the penis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33049</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Forehead</VALIDVALUE>
          <VALUEMEANING>Forehead</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the face between the eyebrows and the normal hairline.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89803</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Forearm</VALIDVALUE>
          <VALUEMEANING>Forearm</VALUEMEANING>
          <MEANINGDESCRIPTION>The structure on the upper limb, between the elbow and the wrist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32628</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foot</VALIDVALUE>
          <VALUEMEANING>Foot</VALUEMEANING>
          <MEANINGDESCRIPTION>The structure found below the ankle joint required for locomotion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluid</VALIDVALUE>
          <VALUEMEANING>Body Fluid or Substance</VALUEMEANING>
          <MEANINGDESCRIPTION>Liquid and semi liquid substances produced by living organisms to fulfill specific functions or excreted as waste; does not include hormones or enzymes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3212369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brow</VALIDVALUE>
          <VALUEMEANING>Eyebrow</VALUEMEANING>
          <MEANINGDESCRIPTION>The arched strip of hair on the bony ridge above each eye socket.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32575</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4889212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Submandibular</VALIDVALUE>
          <VALUEMEANING>Submandibular Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two salivary glands in the neck, located in the space bound by the two bellies of the digastric muscle and the angle of the mandible. It discharges through the submandibular duct. The secretory units are predominantly serous although a few mucous alveoli, some with serous demilunes, occur. (Stedman, 25th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach</VALIDVALUE>
          <VALUEMEANING>Stomach</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Splenic lymph nodes</VALIDVALUE>
          <VALUEMEANING>Splenic Hilar Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the hilar region of the spleen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>splenic hilar</VALIDVALUE>
          <VALUEMEANING>Splenic Hilum</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the spleen through which the vessels and nerves enter or exit the organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33601</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Splenic</VALIDVALUE>
          <VALUEMEANING>Splenic Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest mass of lymphatic tissue in the body. It consists of cells and vessels contained within a capsule lined by mesothelium, from which trabecula enter the splenic parenchyma. The parenchyma is supported by a framework of reticular fibers. The spleen consists of two types of parenchymal tissue, the white and red pulp. The white pulp is composed of elongated cords of compact lymphatic tissue containing nodules. The red pulp is composed of pulp cords and splenic sinusoids.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34086</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spleen</VALIDVALUE>
          <VALUEMEANING>Spleen</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that is part of the lymphatic system. The spleen produces lymphocytes, filters the blood, stores blood cells, and destroys old blood cells. It is located on the left side of the abdomen near the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soft Tissue (muscle, ligaments, subcutaneous)</VALIDVALUE>
          <VALUEMEANING>Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2990372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small Intestine</VALIDVALUE>
          <VALUEMEANING>Small Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>The section of the intestines between the pylorus and cecum. The small intestine is approximately 20 feet long and consists of the duodenum, the jejunum, and the ileum. Its main function is to absorb nutrients from food as the food is transported to the large intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin</VALIDVALUE>
          <VALUEMEANING>Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sinus</VALIDVALUE>
          <VALUEMEANING>Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>A recess, cavity, or channel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33556</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3071180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Salivary Gland</VALIDVALUE>
          <VALUEMEANING>Salivary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>An exocrine gland that secretes saliva.  Salivary glands are mostly located in and around the oral cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12426</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retroperitoneal lymph nodes</VALIDVALUE>
          <VALUEMEANING>Retroperitoneal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the retroperitoneal space.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>retroperitoneal</VALIDVALUE>
          <VALUEMEANING>Retroperitoneal</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring in, or located in the retroperitoneum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3387892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate</VALIDVALUE>
          <VALUEMEANING>Prostate Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pre-auricular</VALIDVALUE>
          <VALUEMEANING>Preauricular</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the area in front of the auricle of the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103848</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>porta hepatis</VALIDVALUE>
          <VALUEMEANING>Transverse Fissure</VALUEMEANING>
          <MEANINGDESCRIPTION>A cleft or groove on the visceral surface of the liver located where the portal vein and hepatic artery enter and the hepatic ducts leave the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639606</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>porta caval</VALIDVALUE>
          <VALUEMEANING>Porta caval</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the portal vein and inferior vena cava.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103847</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Popliteal lymph nodes</VALIDVALUE>
          <VALUEMEANING>Popliteal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymph node located within the fat layer of the knee joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>popliteal</VALIDVALUE>
          <VALUEMEANING>Popliteal Fossa</VALUEMEANING>
          <MEANINGDESCRIPTION>A diamond-shaped depression located in the back of the knee joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613838</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleura/Pleural Effusion</VALIDVALUE>
          <VALUEMEANING>Pleura And/Or Pleural Effusion</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissue that lines the wall of the thoracic cavity and the surface of the lungs.: Used to indicate that either or both of two items or options may be valid.: Increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumors, connective tissue disorders, and trauma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3331, C48928, C12469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639608</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleura</VALIDVALUE>
          <VALUEMEANING>Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peripheral Blood</VALIDVALUE>
          <VALUEMEANING>Peripheral Blood</VALUEMEANING>
          <MEANINGDESCRIPTION>On or near an edge or constituting an outer boundary; the outer area.: A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25233, C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peri-orbital Soft Tissue</VALIDVALUE>
          <VALUEMEANING>Periorbital Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring in, or located in the area around the orbit of the eye.: Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471, C98190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pericardium</VALIDVALUE>
          <VALUEMEANING>Pericardium</VALUEMEANING>
          <MEANINGDESCRIPTION>A conical membranous sac filled with serous fluid in which the heart as well as the roots of the aorta and other large blood vessels are contained.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13005</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pectoral</VALIDVALUE>
          <VALUEMEANING>Pectoral</VALUEMEANING>
          <MEANINGDESCRIPTION>Pectoral; of or pertaining to the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parotid Gland</VALIDVALUE>
          <VALUEMEANING>Parotid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest of the three paired salivary glands, located in front of the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parotid</VALIDVALUE>
          <VALUEMEANING>Parotid Gland Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located close to, on, or within the parotid gland. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occipital lymph nodes</VALIDVALUE>
          <VALUEMEANING>Occipital Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the back of the head adjacent to the trapezius muscle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>occipital</VALIDVALUE>
          <VALUEMEANING>Occipital Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the four regions of cortex in each cerebral hemisphere. It is located posterior to the temporal lobe and inferior to the parietal lobe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Known Nodal Involvement</VALIDVALUE>
          <VALUEMEANING>No Known Nodal Involvement</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Recognized, familiar, or within the scope of knowledge.: Nodal; of or pertaining to a node, any bulge or swelling of an anatomical structure or part.: To have a connection by participation or association or use; sharing in an activity or process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25548, CL110875, C80137, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3636157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Known Extranodal Involvement</VALIDVALUE>
          <VALUEMEANING>No Known Extranodal Involvement</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Recognized, familiar, or within the scope of knowledge.: Situated outside of a node.: To have a connection by participation or association or use; sharing in an activity or process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25548, C25504, C80137, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3636173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasopharynx</VALIDVALUE>
          <VALUEMEANING>Nasopharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the pharynx in the back of the throat, at and above the soft palate. The nasopharynx is continuous with the nasal passages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal Soft Tissue</VALIDVALUE>
          <VALUEMEANING>Nasal Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>By or having to do with the nose.: Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471, C27958</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesenteric lymph nodes</VALIDVALUE>
          <VALUEMEANING>Mesenteric Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the mesentery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mesenteric</VALIDVALUE>
          <VALUEMEANING>Mesenteric</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesenteric; of, or relating to, or located in a mesentery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25226</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinal Soft Tissue</VALIDVALUE>
          <VALUEMEANING>Mediastinal Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Mediastinal; related to the mediastinum.: Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471, C25310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinal lymph nodes</VALIDVALUE>
          <VALUEMEANING>Mediastinal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinal / Intra-thoracic</VALIDVALUE>
          <VALUEMEANING>Mediastinal Lymph Node And/Or Intrathoracic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent.: Used to indicate that either or both of two items or options may be valid.: Any lymph node within the thoracic cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12359, C48928, C33073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mediastinal</VALIDVALUE>
          <VALUEMEANING>Mediastinal</VALUEMEANING>
          <MEANINGDESCRIPTION>Mediastinal; related to the mediastinum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maxilla</VALIDVALUE>
          <VALUEMEANING>Maxilla</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper jawbone in vertebrates: it is fused to the cranium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mandible</VALIDVALUE>
          <VALUEMEANING>Mandible</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower jaw bone holding the lower teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>lower para-aortic</VALIDVALUE>
          <VALUEMEANING>Lower Paraaortic Region</VALUEMEANING>
          <MEANINGDESCRIPTION>Lower; the bottom one of two.: Regions near to the aorta.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25316, C25309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leptomeninges</VALIDVALUE>
          <VALUEMEANING>Leptomeninges</VALUEMEANING>
          <MEANINGDESCRIPTION>The two innermost layers of tissue that cover the brain and spinal cord, the arachnoid mater and the pia mater.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32979</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large Intestine</VALIDVALUE>
          <VALUEMEANING>Large Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>A muscular tube that extends from the end of the small intestine to the anus. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2873884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney</VALIDVALUE>
          <VALUEMEANING>Kidney</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secret the metabolic products and minerals from the blood, thus maintaining the homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraocular</VALIDVALUE>
          <VALUEMEANING>Intraocular</VALUEMEANING>
          <MEANINGDESCRIPTION>Within the eyeball.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282263</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>inguinal/femoral/iliac</VALIDVALUE>
          <VALUEMEANING>Inguinal Region And/Or Femur And/Or Ilium</VALUEMEANING>
          <MEANINGDESCRIPTION>The external junctural region between the lower part of the abdomen and the thigh.: Used to indicate that either or both of two items or options may be valid.: The longest and largest bone of the skeleton, it is situated between the hip and the knee.: Used to indicate that either or both of two items or options may be valid.: The broad, dorsal, upper, and widest of the three principal bones composing either half of the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32765, C48928, C12717, C48928, C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>inguinal/femoral</VALIDVALUE>
          <VALUEMEANING>Inguinal Region And/Or Femur</VALUEMEANING>
          <MEANINGDESCRIPTION>The external junctural region between the lower part of the abdomen and the thigh.: Used to indicate that either or both of two items or options may be valid.: The longest and largest bone of the skeleton, it is situated between the hip and the knee.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12717, C48928, C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inguinal</VALIDVALUE>
          <VALUEMEANING>Inguinal Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower region of the anterior abdominal wall located laterally to the pubic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>infraclavicular/axillary/pectoral</VALIDVALUE>
          <VALUEMEANING>Infraclavicular Region And/Or Axillary And/Or Pectoral</VALUEMEANING>
          <MEANINGDESCRIPTION>The region below the clavicle.: Used to indicate that either or both of two items or options may be valid.: (AK-sil-air-ee) Pertaining to the armpit area, including the lymph nodes that are located there.: Used to indicate that either or both of two items or options may be valid.: Pectoral; of or pertaining to the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25611, C48928, C13351, C48928, C25268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thorax</VALIDVALUE>
          <VALUEMEANING>Thorax</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper part of the trunk between the neck and the abdomen. It contains the chief organs of the circulatory and respiratory systems. (From Stedman, 25th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12799</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thoracic/Lumbar spine</VALIDVALUE>
          <VALUEMEANING>Thoracic And Lumbar Spine</VALUEMEANING>
          <MEANINGDESCRIPTION>(thor-ASS-ik) Having to do with the chest.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Those vertebrae between the ribs and the pelvis, L1-L5 in man.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69314, C37912, C13360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thoracic vertebra</VALIDVALUE>
          <VALUEMEANING>Thoracic Vertebra</VALUEMEANING>
          <MEANINGDESCRIPTION>One of 12 vertebrae in the human vertebral column. The thoracic vertebrae are situated between the seventh cervical vertebra down to the first lumbar vertebra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thoracic spine</VALIDVALUE>
          <VALUEMEANING>Thoracic spine</VALUEMEANING>
          <MEANINGDESCRIPTION>Those vertebrae of the thoracic region, T1-T12 in man.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thigh</VALIDVALUE>
          <VALUEMEANING>Thigh</VALUEMEANING>
          <MEANINGDESCRIPTION>A part of the lower limb, located between hip and knee.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testicle</VALIDVALUE>
          <VALUEMEANING>Testicle</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the paired male reproductive glands that produce the male germ cells and the male hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tendon</VALIDVALUE>
          <VALUEMEANING>Tendon</VALUEMEANING>
          <MEANINGDESCRIPTION>A band of fibrous connective tissue that joins bone to muscle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Temporal bone</VALIDVALUE>
          <VALUEMEANING>Temporal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A large irregular bone situated at the base and side of the skull, connected with the mandible via the temporomandibular joint. The temporal bone consists of the squamous, tympanic and petrous parts. The petrous portion of the temporal bone contains the vestibulocochlear organ of the inner ear. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tarsus</VALIDVALUE>
          <VALUEMEANING>Tarsal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the seven bones forming the instep of the foot. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zygomatic bone</VALIDVALUE>
          <VALUEMEANING>Zygomatic Buttress</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the maxillary jaw bone and other facial bones that form the most lateral mid face skeletal structure known as the cheekbone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94592</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wrist</VALIDVALUE>
          <VALUEMEANING>Wrist</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint between the distal end of the radius and the proximal row of carpal bones. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Whole body</VALIDVALUE>
          <VALUEMEANING>Body</VALUEMEANING>
          <MEANINGDESCRIPTION>The entire physical structure of an organism.  It is composed of anatomic systems, regions, cavities, and spaces.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13041</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566770</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vulva</VALIDVALUE>
          <VALUEMEANING>Vulva</VALUEMEANING>
          <MEANINGDESCRIPTION>The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vertebral column</VALIDVALUE>
          <VALUEMEANING>Vertebral Column</VALUEMEANING>
          <MEANINGDESCRIPTION>A series of bones, muscles, tendons, and other tissues reaching from the base of the skull to the tailbone. The vertebral column forms the axis of the skeleton and encloses as well as protects the spinal cord and the fluid surrounding the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vertebra</VALIDVALUE>
          <VALUEMEANING>Vertebra</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the ring-shaped bony structures that constitute the spinal column and surround the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vena Cava, Inferior/Superior</VALIDVALUE>
          <VALUEMEANING>Vena Cava</VALUEMEANING>
          <MEANINGDESCRIPTION>A large vein which returns blood from the head, neck and extremities to the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12817</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>infraclavicular</VALIDVALUE>
          <VALUEMEANING>Infraclavicular Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The region below the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iliac-external</VALIDVALUE>
          <VALUEMEANING>External Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located along the external iliac artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iliac-common</VALIDVALUE>
          <VALUEMEANING>Internal Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located along the internal iliac artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iliac</VALIDVALUE>
          <VALUEMEANING>Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the three lymph nodes of the pelvis: the superior gluteal, interior gluteal or sacral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hilar lymph nodes</VALIDVALUE>
          <VALUEMEANING>Hilar Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the hilum of the lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hilar</VALIDVALUE>
          <VALUEMEANING>Hilar</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to the area where nerves and blood vessels attach to an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25724</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heart</VALIDVALUE>
          <VALUEMEANING>Heart</VALUEMEANING>
          <MEANINGDESCRIPTION>A hollow muscular organ which receives the blood from the veins and propels it into the arteries. It is divided by a musculomembranous septum into two halves -- right or venous and left or arterial -- each of which consists of a receiving chamber (atrium) and an ejecting chamber (ventricle). SYN cor, coeur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal / Abdominal</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal And/Or Abdominal</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines. : Used to indicate that either or both of two items or options may be valid.: Of, or related to, the abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25342, C48928, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Femoral lymph nodes</VALIDVALUE>
          <VALUEMEANING>Femoral Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the upper inner portion of the thigh.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Femoral</VALIDVALUE>
          <VALUEMEANING>Femur</VALUEMEANING>
          <MEANINGDESCRIPTION>The longest and largest bone of the skeleton, it is situated between the hip and the knee.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremities</VALIDVALUE>
          <VALUEMEANING>Limb</VALUEMEANING>
          <MEANINGDESCRIPTION>A body region referring to an upper or lower extremity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2677356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>external/internal iliac</VALIDVALUE>
          <VALUEMEANING>External Iliac Lymph Node And/Or Internal Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located along the external iliac artery.: Used to indicate that either or both of two items or options may be valid.: A lymph node located along the internal iliac artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88142, C48928, C88143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus</VALIDVALUE>
          <VALUEMEANING>Esophagus</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>epitrochlear/brachial</VALIDVALUE>
          <VALUEMEANING>Epitrochlear Lymph Node And/Or Brachial Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located above and adjacent to the elbow.: Used to indicate that either or both of two items or options may be valid.: An axillary lymph node along the brachial vein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92221, C48928, C98182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epitrochlear lymph nodes</VALIDVALUE>
          <VALUEMEANING>Epitrochlear Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located above and adjacent to the elbow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epidural</VALIDVALUE>
          <VALUEMEANING>Epidural Spinal Canal Space</VALUEMEANING>
          <MEANINGDESCRIPTION>Space between the dura mater and the walls of the vertebral canal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epididymis</VALIDVALUE>
          <VALUEMEANING>Epididymis</VALUEMEANING>
          <MEANINGDESCRIPTION>A crescent-like structure located in the upper and posterior surfaces of the testis. It consists of the efferent ductules and the duct of the epididymis. It facilitates the maturation of sperm that is produced in the testis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gallbladder</VALIDVALUE>
          <VALUEMEANING>Gallbladder</VALUEMEANING>
          <MEANINGDESCRIPTION>A pear-shaped organ just below the liver that stores the bile secreted by the liver, delivering the bile through the bile ducts into the intestines to help with digestion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trachea</VALIDVALUE>
          <VALUEMEANING>Trachea</VALUEMEANING>
          <MEANINGDESCRIPTION>The fibrocartilaginous, mucous-lined tube passing from the larynx to the bronchi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Distant Metastasis</VALIDVALUE>
          <VALUEMEANING>Distant Metastasis</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to cancer that has spread from the original (primary) tumor to distant organs or distant lymph nodes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568046</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regional Cutaneous or Subcutaneous Tissue (includes satellite &amp; in-transit metastasis)</VALIDVALUE>
          <VALUEMEANING>Regional Cutaneous Or Subcutaneous Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Regional; limited to a particular location or area.: Having to do with the skin.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Beneath the skin.: An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12801, C13353, C37998, C13316, C25643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3426803</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regional Lymph Node</VALIDVALUE>
          <VALUEMEANING>Regional Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node that drains lymph from a region of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3422988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Primary Tumor</VALIDVALUE>
          <VALUEMEANING>Primary Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>The original tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2971662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trunk</VALIDVALUE>
          <VALUEMEANING>Trunk</VALUEMEANING>
          <MEANINGDESCRIPTION>The body excluding the head and neck and limbs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, Specify</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3423348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brain</VALIDVALUE>
          <VALUEMEANING>Brain</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver</VALIDVALUE>
          <VALUEMEANING>Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone</VALIDVALUE>
          <VALUEMEANING>Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Connective tissue that forms the skeletal components of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung</VALIDVALUE>
          <VALUEMEANING>Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head &amp; Neck</VALIDVALUE>
          <VALUEMEANING>Head and Neck</VALUEMEANING>
          <MEANINGDESCRIPTION>For oncology, area of the body generally construed to comprise base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12418</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2912041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremities</VALIDVALUE>
          <VALUEMEANING>Extremities</VALUEMEANING>
          <MEANINGDESCRIPTION>A body region referring to an upper or lower extremity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectosigmoid Junction</VALIDVALUE>
          <VALUEMEANING>Rectosigmoid Junction</VALUEMEANING>
          <MEANINGDESCRIPTION>An area of the body consisting of the rectum and the sigmoid colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3522962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transverse Colon</VALIDVALUE>
          <VALUEMEANING>Transverse Colon</VALUEMEANING>
          <MEANINGDESCRIPTION>The third division of the colon (large intestine). It communicates with the ascending colon in the upper right-hand quadrant of the abdomen and the descending colon in the upper left-hand quadrant.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tail of Pancreas</VALIDVALUE>
          <VALUEMEANING>Tail of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>The left extremity of the pancreas within the lienorenal ligament.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sigmoid Colon</VALIDVALUE>
          <VALUEMEANING>Sigmoid Colon</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the colon that connects to the descending colon above and the rectum below.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Splenic Flexure</VALIDVALUE>
          <VALUEMEANING>Splenic Flexure</VALUEMEANING>
          <MEANINGDESCRIPTION>The bend at the junction of the transverse and descending colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectum</VALIDVALUE>
          <VALUEMEANING>Rectum</VALUEMEANING>
          <MEANINGDESCRIPTION>The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oropharynx</VALIDVALUE>
          <VALUEMEANING>Oropharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>(or-o-FAIR-inks) The middle part of the throat that includes the soft palate, the base of the tongue, and the tonsils.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12762</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oral Tongue</VALIDVALUE>
          <VALUEMEANING>Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oral Cavity</VALIDVALUE>
          <VALUEMEANING>Oral Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The cavity lying at the upper end of the alimentary canal, bounded on the outside by the lips and inside by the oropharynx and containing in humans the tongue, gums, and teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lip</VALIDVALUE>
          <VALUEMEANING>Lip</VALUEMEANING>
          <MEANINGDESCRIPTION>Fleshy fold which surrounds the opening of the mouth. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3522963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Larynx</VALIDVALUE>
          <VALUEMEANING>Larynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The cartilaginous structure of the respiratory tract between the pharynx and the trachea. It contains elastic vocal cords required for sound production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypopharynx</VALIDVALUE>
          <VALUEMEANING>Hypopharynx (Laryngopharynx)</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the pharynx between the inferior portion of the oropharynx and the larynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatic Flexure</VALIDVALUE>
          <VALUEMEANING>Hepatic Flexure</VALUEMEANING>
          <MEANINGDESCRIPTION>The bend of the colon at the juncture of its ascending and transverse portions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12266</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head of Pancreas</VALIDVALUE>
          <VALUEMEANING>Head of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>That portion of the pancreas lying in the concavity of the duodenum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hard Palate</VALIDVALUE>
          <VALUEMEANING>Hard Palate</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony anterior part of the roof of the mouth separating the nose from the mouth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12230</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3522964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastroesophageal Junction</VALIDVALUE>
          <VALUEMEANING>Gastroesophageal Junction</VALUEMEANING>
          <MEANINGDESCRIPTION>The anatomical location where the esophagus joins to the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131339</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fundus/Body</VALIDVALUE>
          <VALUEMEANING>Fundus, Body</VALUEMEANING>
          <MEANINGDESCRIPTION>The entire physical structure of an organism.  It is composed of anatomic systems, regions, cavities, and spaces.: The bottom portion or the portion that is furthest from the opening of a hollow organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13378, C13041</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3522965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Floor of Mouth</VALIDVALUE>
          <VALUEMEANING>Floor of Mouth</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the mouth under the ventral surface of the tongue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sacrum</VALIDVALUE>
          <VALUEMEANING>Sacrum</VALUEMEANING>
          <MEANINGDESCRIPTION>The wedge-shaped bone consisting of five fused vertebrae, S1-S5 in man, forming the posterior part of the pelvis; its base connects with the lowest lumbar vertebra and its tip with the coccyx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Round ligament</VALIDVALUE>
          <VALUEMEANING>Round Ligament</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the round ligaments including the round ligament of the liver and the round ligament of the uterus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12319</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ribs</VALIDVALUE>
          <VALUEMEANING>Ribs</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the paired bones, 12 on either side, extending from the thoracic vertebrae toward the median line on the ventral aspect of the trunk. The long curved bones which form the rib cage. Generally, ribs 1 to 7 are connected to the sternum&#39; by their costal cartilages and are called true ribs, whereas ribs 8 to 12 are termed false ribs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12782</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retro-orbital Area</VALIDVALUE>
          <VALUEMEANING>Retro-Orbital Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the body behind the orbit of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3268518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retina</VALIDVALUE>
          <VALUEMEANING>Retina</VALUEMEANING>
          <MEANINGDESCRIPTION>A light-sensitive membrane that lines the back wall of the eyeball. The retina is continuous with the optic nerve and this way transmits optical images to the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radius</VALIDVALUE>
          <VALUEMEANING>Radius Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The long bone of the forearm that extends from the lateral aspect of the elbow to the thumb-side of the wrist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary system</VALIDVALUE>
          <VALUEMEANING>Respiratory System</VALUEMEANING>
          <MEANINGDESCRIPTION>(RES-pih-ra-tor-ee) The organs that are involved in breathing. These include the nose, throat, larynx, trachea, bronchi, and lungs.Also known as the respiratory tract.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3192589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pubis</VALIDVALUE>
          <VALUEMEANING>Pubic Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two bones (left and right) that form the front of the pelvis.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Popliteal fossa</VALIDVALUE>
          <VALUEMEANING>Popliteal Fossa</VALUEMEANING>
          <MEANINGDESCRIPTION>A diamond-shaped depression located in the back of the knee joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613838</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Placenta</VALIDVALUE>
          <VALUEMEANING>Placenta</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother&#39;s immune system by excretion of neurokinin B.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3192159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pituitary gland</VALIDVALUE>
          <VALUEMEANING>Pituitary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A small, unpaired gland situated in the sella turcica tissue. It is connected to the hypothalamus by a short stalk.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pineal Gland</VALIDVALUE>
          <VALUEMEANING>Pineal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A small endocrine gland in the brain, situated beneath the back part of the corpus callosum, that secretes melatonin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pharynx</VALIDVALUE>
          <VALUEMEANING>Pharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>(FAIR-inks) The hollow tube about 5 inches long that starts behind the nose and ends at the top of the trachea (windpipe) and esophagus (the tube that goes to the stomach).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritoneum</VALIDVALUE>
          <VALUEMEANING>Peritoneum</VALUEMEANING>
          <MEANINGDESCRIPTION>(PAIR-ih-toe-NEE-um) The tissue that lines the abdominal wall and covers most of the organs in the abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritoneal cavity</VALIDVALUE>
          <VALUEMEANING>Peritoneal Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the abdomen that contains the intestines (the last part of the digestive tract), the stomach, and the liver. It is bound by thin membranes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12769</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Perianus</VALIDVALUE>
          <VALUEMEANING>Anal Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The area that includes the anus and the perianal skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Penis</VALIDVALUE>
          <VALUEMEANING>Penis</VALUEMEANING>
          <MEANINGDESCRIPTION>The male organ of urination and copulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patella</VALIDVALUE>
          <VALUEMEANING>Patella</VALUEMEANING>
          <MEANINGDESCRIPTION>A small flat triangular bone in front of the knee that articulates with the femur and protects the knee joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571145</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parietal bone</VALIDVALUE>
          <VALUEMEANING>Parietal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two cranial bones that by their union form the sides and roof of the skull.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12766</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parathyroid</VALIDVALUE>
          <VALUEMEANING>Parathyroid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two small paired endocrine glands, superior and inferior, usually found embedded in the connective tissue capsule on the posterior surface of the thyroid gland; these glands secrete parathyroid hormone that regulates the metabolism of calcium and phosphorus. The parenchyma is composed of chief and oxyphilic cells arranged in anastomosing cords.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraspinal Ganglion</VALIDVALUE>
          <VALUEMEANING>Spinal Ganglion</VALUEMEANING>
          <MEANINGDESCRIPTION>Spinal; of or relating to the spine or spinal cord.: A cluster of nervous tissue principally composed of neuronal cell bodies external to the central nervous system (CNS).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12719, C38026</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palate</VALIDVALUE>
          <VALUEMEANING>Palate</VALUEMEANING>
          <MEANINGDESCRIPTION>(PAL-et) The roof of the mouth. The front portion is bony (hard palate), and the back portion is muscular (soft palate).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PA/Lat</VALIDVALUE>
          <VALUEMEANING>Posterior Anterior Lateral Chest</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting the back surface of the body; at or near the hind end in quadrupeds or toward the spine in primates.: Denoting the front surface of the body; often used to indicate the position of one structure relative to another.: Lateral; situated at or extending to the side.: The part of the human body between the neck and the diaphragm or the corresponding part in other vertebrates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25389, C25230, C25231, C25622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3395964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Descending Colon</VALIDVALUE>
          <VALUEMEANING>Descending Colon</VALUEMEANING>
          <MEANINGDESCRIPTION>The fourth portion of the large intestine (colon) that communicates with the transverse colon in the left-upper quadrant of the abdomen and the rectum below.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cecum</VALIDVALUE>
          <VALUEMEANING>Cecum</VALUEMEANING>
          <MEANINGDESCRIPTION>A blind pouch-like commencement of the colon in the right lower quadrant of the abdomen at the end of the small intestine and the start of the large intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardia/Proximal</VALIDVALUE>
          <VALUEMEANING>Gastric Cardia, Proximal </VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal; situated nearest to a point of attachment or origin.: The area around the esophagogastric mucosal junction where the esophageal mucosa transitions into the gastric mucosa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12256, C25236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3212020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buccal Mucosa</VALIDVALUE>
          <VALUEMEANING>Buccal Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>The mucosal membranes located on the inside of the cheek, in the buccal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3522966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchus</VALIDVALUE>
          <VALUEMEANING>Bronchus</VALUEMEANING>
          <MEANINGDESCRIPTION>Tubular structure in continuation with the trachea, serving as air passage. It terminates in the lung (terminal bronchiole).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558344</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchial</VALIDVALUE>
          <VALUEMEANING>Bronchial</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or pertaining to, the bronchus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2966741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Body of Pancreas</VALIDVALUE>
          <VALUEMEANING>Body of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the pancreas from the point where it crosses the portal vein to the point where it enters the lienorenal ligament.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Base of tongue</VALIDVALUE>
          <VALUEMEANING>Base of the Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>The posterior one third of the tongue behind the terminal sulcus that forms the anterior aspect of the oro-pharynx responsible for swallowing and modification of the voice in speech.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ascending Colon</VALIDVALUE>
          <VALUEMEANING>Ascending Colon</VALUEMEANING>
          <MEANINGDESCRIPTION>The first part of the colon (large intestine) that starts in the right lower quadrant of the abdomen and ends at the transverse colon in the right upper quadrant of the abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antrum/Distal</VALIDVALUE>
          <VALUEMEANING>Antrum, Distal</VALUEMEANING>
          <MEANINGDESCRIPTION>Situated farthest from a point of attachment or origin, as of a limb or bone; or directed away from the midline of the body. : A chamber formation in an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97102, C25237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3522967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alveolar Ridge</VALIDVALUE>
          <VALUEMEANING>Alveolar Ridge</VALUEMEANING>
          <MEANINGDESCRIPTION>The thickened bony structures in the mandible and maxilla that contain the sockets of the teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89749</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3491658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Conjunctiva</VALIDVALUE>
          <VALUEMEANING>Conjunctiva</VALUEMEANING>
          <MEANINGDESCRIPTION>A thin, transparent mucous membrane that covers the posterior surface of lids (palpebral conjunctiva) and the outer surface of the sclera (bulbar conjunctiva).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12341</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>common pelvic</VALIDVALUE>
          <VALUEMEANING>Common Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>Widely known or encountered; standard; of no special distinction or quality.: The structure of the vertebrate skeleton supporting the lower limbs in humans and the hind limbs or corresponding parts in other vertebrates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12767, C43461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colon</VALIDVALUE>
          <VALUEMEANING>Colon</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical lymph nodes</VALIDVALUE>
          <VALUEMEANING>Cervical Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the lymph nodes located in the neck.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cervical</VALIDVALUE>
          <VALUEMEANING>Cervical</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to a neck, or cervix, in any sense.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2966750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>celiac axis/retrocrural/upper para-aortic</VALIDVALUE>
          <VALUEMEANING>celiac axis/retrocrural/upper para-aortic</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node at the base of the celiac artery.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A lymph node located within the most inferior portion of the posterior mediastinum. (NCI): An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Higher in place or position; the topmost one of two.: A lymph node located adjacent to the lumbar region of the spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77643, C25355, C37998, C103439, C37998, C65166</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>celiac axis/retrocrural</VALIDVALUE>
          <VALUEMEANING>celiac axis/retrocrural space</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the most inferior portion of the posterior mediastinum.: A major abdominal artery that arises from the abdominal aorta below the diaphragm.  It supplies blood to the digestive organs. It has three major branches, left gastric artery, common hepatic artery, and splenic artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52846, C103846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Breast</VALIDVALUE>
          <VALUEMEANING>Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Marrow</VALIDVALUE>
          <VALUEMEANING>Bone Marrow</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>axillary/brachial</VALIDVALUE>
          <VALUEMEANING>Axillary And/Or Brachial Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>(AK-sil-air-ee) Pertaining to the armpit area, including the lymph nodes that are located there.: Used to indicate that either or both of two items or options may be valid.: An axillary lymph node along the brachial vein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92221, C48928, C13351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axillary lymph nodes</VALIDVALUE>
          <VALUEMEANING>Axillary Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axillary</VALIDVALUE>
          <VALUEMEANING>Axillary</VALUEMEANING>
          <MEANINGDESCRIPTION>(AK-sil-air-ee) Pertaining to the armpit area, including the lymph nodes that are located there.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ascites/Peritoneum</VALIDVALUE>
          <VALUEMEANING>Ascites And/Or Peritoneum</VALUEMEANING>
          <MEANINGDESCRIPTION>Accumulation of fluid in the peritoneal cavity.  The fluid may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum. -- 2004: Used to indicate that either or both of two items or options may be valid.: The tissue that lines the wall of the abdominal cavity, intestine, and mesentery. It consists of the parietal peritoneum that covers the inside of the abdominal wall and the visceral peritoneum that covers the surface of the intestine and mesentery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12770, C48928, C2885</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenal</VALIDVALUE>
          <VALUEMEANING>Adrenal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Appendix</VALIDVALUE>
          <VALUEMEANING>Appendix</VALUEMEANING>
          <MEANINGDESCRIPTION>A small, fingerlike pouch that sticks out from the cecum (the first part of the large intestine near the end of the small intestine).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Distant Lymph Node</VALIDVALUE>
          <VALUEMEANING>Distant Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located distant to the anatomic site of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4206839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central Nervous System</VALIDVALUE>
          <VALUEMEANING>Central Nervous System</VALUEMEANING>
          <MEANINGDESCRIPTION>The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thoracic</VALIDVALUE>
          <VALUEMEANING>Thoracic</VALUEMEANING>
          <MEANINGDESCRIPTION>(thor-ASS-ik) Having to do with the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2966753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvis</VALIDVALUE>
          <VALUEMEANING>Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination that a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3091616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdomen</VALIDVALUE>
          <VALUEMEANING>Abdominal Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the body that lies between the thorax and the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12664</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689447</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymus</VALIDVALUE>
          <VALUEMEANING>Thymus Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that is part of the lymphatic system, in which T lymphocytes grow and multiply. The thymus is in the chest behind the breastbone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bladder</VALIDVALUE>
          <VALUEMEANING>Bladder</VALUEMEANING>
          <MEANINGDESCRIPTION>The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12414</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior Mediastinum</VALIDVALUE>
          <VALUEMEANING>Anterior Mediastinum</VALUEMEANING>
          <MEANINGDESCRIPTION>The area between the lungs; it contains the thymus, some lymph nodes, and vessels and branches of the internal thoracic artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32098</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4575892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdomen/Pelvis</VALIDVALUE>
          <VALUEMEANING>Abdomen and Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the body that lies between the thorax and the pelvis.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The structure of the vertebrate skeleton supporting the lower limbs in humans and the hind limbs or corresponding parts in other vertebrates.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12767, C37912, C12664</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3393975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anal canal</VALIDVALUE>
          <VALUEMEANING>Anal Canal</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ampulla of Vater</VALIDVALUE>
          <VALUEMEANING>Ampulla of Vater</VALUEMEANING>
          <MEANINGDESCRIPTION>The junction of the common bile and main pancreatic ducts, which protrudes into the medial aspect of the descending duodenum at the major duodenal papilla. The flow of bile and pancreatic juices into the duodenum through the Ampulla of Vater is controlled by the sphincter of Oddi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amniotic Fluid</VALIDVALUE>
          <VALUEMEANING>Amniotic Fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>The fluid within the amniotic cavity which surrounds and protects the developing embryo.  It is initially produced by the amnion and then later by the lungs and kidneys.  The amount at term normally varies from 500 to 2000 ml.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adipose</VALIDVALUE>
          <VALUEMEANING>Adipose Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Connective tissue composed of fat cells lodged in the meshes of areolar tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574799</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoid</VALIDVALUE>
          <VALUEMEANING>Tonsillar Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>A fold of lymphatic tissue covered by ciliated epithelium at the very back of the nose, in the roof of the nasopharynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2761349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetabulum</VALIDVALUE>
          <VALUEMEANING>Acetabulum</VALUEMEANING>
          <MEANINGDESCRIPTION>Two cup shaped areas, one each on the lateral side of the lower pelvis that house the head of the femur to form the ball and socket joint of the hip.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdominal wall</VALIDVALUE>
          <VALUEMEANING>Abdominal wall</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissues that surround the organs that are present within the abdominal cavity. The abdominal wall tissue is composed of layers of fat, parietal peritoneum, fascia, and muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Femoral</VALIDVALUE>
          <VALUEMEANING>Femoral Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the upper inner portion of the thigh.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Hilar</VALIDVALUE>
          <VALUEMEANING>Pulmonary Hilar Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the hilum of the lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4618073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Epitrochlear</VALIDVALUE>
          <VALUEMEANING>Epitrochlear Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located above and adjacent to the elbow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Omentum</VALIDVALUE>
          <VALUEMEANING>Omentum</VALUEMEANING>
          <MEANINGDESCRIPTION>A fold of peritoneum originating at the stomach and supporting the viscera. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oral Cavity, Mucosa only</VALIDVALUE>
          <VALUEMEANING>Oral Cavity Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>The cavity lying at the upper end of the alimentary canal, bounded on the outside by the lips and inside by the oropharynx and containing in humans the tongue, gums, and teeth.: The moist tissue that lines some organs and body cavities (such as the nose, mouth, lungs) and makes mucus (a thick, slippery fluid).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13166, C12421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ocular Orbits</VALIDVALUE>
          <VALUEMEANING>Orbit</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa.  Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occipital bone</VALIDVALUE>
          <VALUEMEANING>Occipital Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The trapezoidal-shaped bone that forms the back and part of the base of the skull.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nerve(s) Cranial</VALIDVALUE>
          <VALUEMEANING>Cranial Nerve</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the 12 paired nerves that originate in the brain stem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12700</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2798874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nerve</VALIDVALUE>
          <VALUEMEANING>nerve</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the bundles of nerve fibers running to various organs and tissues of the body using chemical and electrical signals to transmit sensory and motor information from one body part to another.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neck/Chest/Abdomen/Pelvis</VALIDVALUE>
          <VALUEMEANING>Neck and Chest and Abdomen and Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>The region that connects the head to the rest of the body.: The part of the human body between the neck and the diaphragm or the corresponding part in other vertebrates.: The portion of the body that lies between the thorax and the pelvis.: The structure of the vertebrate skeleton supporting the lower limbs in humans and the hind limbs or corresponding parts in other vertebrates.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12767, C12664, C25389, C13063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3395963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neck/Chest</VALIDVALUE>
          <VALUEMEANING>Neck and Chest</VALUEMEANING>
          <MEANINGDESCRIPTION>The region that connects the head to the rest of the body.: The part of the human body between the neck and the diaphragm or the corresponding part in other vertebrates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25389, C13063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neck</VALIDVALUE>
          <VALUEMEANING>Neck</VALUEMEANING>
          <MEANINGDESCRIPTION>The region that connects the head to the rest of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal Cavity</VALIDVALUE>
          <VALUEMEANING>Nasal Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The proximal portion of the respiratory passages on either side of the nasal septum lying between the floor of the cranium and the roof of the mouth and extending from the face to the pharynx. The nasal cavity is lined with ciliated mucosa, extending from the nares to the pharynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal bone</VALIDVALUE>
          <VALUEMEANING>Nasal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two small oblong bones placed side by side at the middle and upper part of the face.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nails</VALIDVALUE>
          <VALUEMEANING>Nail</VALUEMEANING>
          <MEANINGDESCRIPTION>The cutaneous plate on the dorsal surface of the distal end of a finger or toe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33156</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211554</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Muscle</VALIDVALUE>
          <VALUEMEANING>Muscle</VALUEMEANING>
          <MEANINGDESCRIPTION>Muscle; one of the contractile organs of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13056</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mouth</VALIDVALUE>
          <VALUEMEANING>Oral Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The cavity lying at the upper end of the alimentary canal, bounded on the outside by the lips and inside by the oropharynx and containing in humans the tongue, gums, and teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mini Mantle</VALIDVALUE>
          <VALUEMEANING>Minimantle Radiation Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A radiation field that includes the bilateral cervical, supraclavicular, and axillary lymph nodes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metatarsus</VALIDVALUE>
          <VALUEMEANING>Metatarsal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone belonging to the middle part of the foot located between toes and ankle. There are 5 metatarsal bones and they are numbered from the medial side.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metacarpus</VALIDVALUE>
          <VALUEMEANING>Metacarpal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the five bones between the wrist and the fingers that form the skeleton of the palm.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesothelium</VALIDVALUE>
          <VALUEMEANING>Mesothelium</VALUEMEANING>
          <MEANINGDESCRIPTION>A simple layer of cells, derived from the mesoderm that lines the coelom or body cavity of the embryo. In the adult, it covers all true serous membranes (peritoneum, pericardium, pleura).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33105</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesentery</VALIDVALUE>
          <VALUEMEANING>Mesentery</VALUEMEANING>
          <MEANINGDESCRIPTION>A double layer of peritoneum that attaches to the back wall of the abdominal cavity and supports the small intestines.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinum</VALIDVALUE>
          <VALUEMEANING>Mediastinum</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of organs surrounded by loose connective tissue, separating the two pleural sacs, between the sternum anteriorly and the vertebral column posteriorly as well as from the thoracic inlet superiorly to the diaphragm inferiorly. The mediastinum contains the heart and pericardium, the bases of the great vessels, the trachea and bronchi, esophagus, thymus, lymph nodes, thoracic duct, phrenic and vagus nerves, and other structures and tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mammary Gland</VALIDVALUE>
          <VALUEMEANING>Mammary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the breast.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma</VALIDVALUE>
          <VALUEMEANING>Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Supraclav</VALIDVALUE>
          <VALUEMEANING>Supraclavicular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node which is located above the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Submandibular</VALIDVALUE>
          <VALUEMEANING>Submandibular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located beneath the floor of the oral cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Subclavicular</VALIDVALUE>
          <VALUEMEANING>Infraclavicular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the area below the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2969629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Splenic</VALIDVALUE>
          <VALUEMEANING>Splenic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the hilar region of the spleen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s) Scalene</VALIDVALUE>
          <VALUEMEANING>Scalene Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in proximity to any of the scalene muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3395734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Retroperitoneal</VALIDVALUE>
          <VALUEMEANING>Retroperitoneal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the retroperitoneal space.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s) Distant</VALIDVALUE>
          <VALUEMEANING>Distant Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Far apart in space from a point of origin on the body.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25321, C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2963867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Cervical</VALIDVALUE>
          <VALUEMEANING>Cervical Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the lymph nodes located in the neck.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Axilla</VALIDVALUE>
          <VALUEMEANING>Axillary Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s)</VALIDVALUE>
          <VALUEMEANING>Lymph node</VALUEMEANING>
          <MEANINGDESCRIPTION>A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lumbar vertebra</VALIDVALUE>
          <VALUEMEANING>Lumbar Vertebra</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the five bones situated between the thoracic vertebrae and the sacrum in the lower part of the spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lumbar spine</VALIDVALUE>
          <VALUEMEANING>Lumbar spine</VALUEMEANING>
          <MEANINGDESCRIPTION>Those vertebrae between the ribs and the pelvis, L1-L5 in man.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver/Spleen</VALIDVALUE>
          <VALUEMEANING>Liver And Spleen Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>A triangular-shaped organ located under the diaphragm in the right hypochondrium.  It is the largest internal organ of the body, weighting up to 2 kg.  Metabolism and bile secretion are its main functions.  It is composed of cells which have the ability to regenerate.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: An organ that is part of the lymphatic system. The spleen produces lymphocytes, filters the blood, stores blood cells, and destroys old blood cells. It is located on the left side of the abdomen near the stomach.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37912, C12392, C13717, C12432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>2, 3, 0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4888353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver and intrahepatic duct</VALIDVALUE>
          <VALUEMEANING>Liver Hepatic Duct Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>A triangular-shaped organ located under the diaphragm in the right hypochondrium.  It is the largest internal organ of the body, weighting up to 2 kg.  Metabolism and bile secretion are its main functions.  It is composed of cells which have the ability to regenerate.: Refers to the liver.: A tube that carries various secretions from one part of the body to another.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12948, C13308, C12392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4888354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ligament</VALIDVALUE>
          <VALUEMEANING>Ligament</VALUEMEANING>
          <MEANINGDESCRIPTION>Band of fibrous tissue connecting bone to bone or cartilage to bone thereby supporting or strengthening a joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skeletal Muscle</VALIDVALUE>
          <VALUEMEANING>Skeletal Muscle Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Striated muscles that are under voluntary control of the organism. They are connected at either or both ends to a bone and are utilized for locomotion and other movements. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13050</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sinus(es), Maxillary</VALIDVALUE>
          <VALUEMEANING>Maxillary Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>A pyramidal-shaped, thin-walled, air-filled cavity located in the maxilla. It is lined by mucus membrane and periosteum (mucoperiosteum) which contains cilia. It is adjacent to the nasal cavity and communicates with the middle meatus of the nose. It is the largest paranasal sinus and is composed of three recesses: alveolar, zygomatic, and infraorbital.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Shoulder</VALIDVALUE>
          <VALUEMEANING>Shoulder Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>The region of the body between the neck and the upper arm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seminal Vesicle</VALIDVALUE>
          <VALUEMEANING>Seminal Vesicle</VALUEMEANING>
          <MEANINGDESCRIPTION>(SEM-in-al VES-ih-kulz) Glands that help produce semen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12787</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2932862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scrotum</VALIDVALUE>
          <VALUEMEANING>Scrotum</VALUEMEANING>
          <MEANINGDESCRIPTION>The musculocutaneous pouch that encloses the testicles. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scapula</VALIDVALUE>
          <VALUEMEANING>Scapula</VALUEMEANING>
          <MEANINGDESCRIPTION>The flat triangle-shaped bone that connects the humerus with the clavicle in the back of the shoulder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scalp</VALIDVALUE>
          <VALUEMEANING>Scalp</VALUEMEANING>
          <MEANINGDESCRIPTION>The skin which covers the top of the head and which is usually covered by hair.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569920</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s) Regional</VALIDVALUE>
          <VALUEMEANING>Regional Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or belonging to a broader area or region of the body.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25643, C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2963866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Popliteal</VALIDVALUE>
          <VALUEMEANING>Popliteal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymph node located within the fat layer of the knee joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Periportal</VALIDVALUE>
          <VALUEMEANING>Periportal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Extending on all sides of simultaneously; encircling.: Of or pertaining to a porta, especially the porta of the liver; as, the portal vein, which enters the liver at the porta, and divides into capillaries after the manner of an artery. Portal is applied to other veins which break up into capillaries; as, the renal portal veins in the frog. (On-line Medical Dictionary): A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C38007, C52247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3526806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Pelvic</VALIDVALUE>
          <VALUEMEANING>Pelvic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Any lymph node within the pelvic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Parotid</VALIDVALUE>
          <VALUEMEANING>Parotid Gland Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located close to, on, or within the parotid gland. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Paracaval</VALIDVALUE>
          <VALUEMEANING>Paracaval Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Extending on all sides of simultaneously; encircling.: A large vein which returns blood from the head, neck and extremeties to the heart.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C12817, C52247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3526807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s) Para aortic</VALIDVALUE>
          <VALUEMEANING>Paraaortic Region Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Regions near to the aorta.: A rounded mass of lymphatic tissue that is surrounded by a capsule of connective tissue. Lymph glands filter lymph (lymphatic fluid), and they store lymphocytes (white blood cells). They are located along lymphatic vessels. Also called a lymph node.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25316, C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2965209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Occipital</VALIDVALUE>
          <VALUEMEANING>Occipital Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the back of the head adjacent to the trapezius muscle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Mesenteric</VALIDVALUE>
          <VALUEMEANING>Mesenteric Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the mesentery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3778534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Mediastinal</VALIDVALUE>
          <VALUEMEANING>Mediastinal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Mammary</VALIDVALUE>
          <VALUEMEANING>Mammary Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the breast.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C43595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3395732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Int Mammary</VALIDVALUE>
          <VALUEMEANING>Internal Mammary Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the lymph nodes of the breast located under the ribcage, near the sternum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3395731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Inguinal</VALIDVALUE>
          <VALUEMEANING>Inguinal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A superficial or deep lymph node located in the inguinal area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Iliac-external</VALIDVALUE>
          <VALUEMEANING>External Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located along the external iliac artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Iliac-common</VALIDVALUE>
          <VALUEMEANING>Common Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Widely known or encountered.: One of the three lymph nodes of the pelvis: the superior gluteal, interior gluteal or sacral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32761, C43461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3354957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Iliac</VALIDVALUE>
          <VALUEMEANING>Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the three lymph nodes of the pelvis: the superior gluteal, interior gluteal or sacral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Capillary</VALIDVALUE>
          <VALUEMEANING>Capillary</VALUEMEANING>
          <MEANINGDESCRIPTION>Tiny blood vessels that connect the arterioles with the venules.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calf</VALIDVALUE>
          <VALUEMEANING>Calf</VALUEMEANING>
          <MEANINGDESCRIPTION>The posterior aspect of the lower extremity that extends from the knee to the foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcaneus</VALIDVALUE>
          <VALUEMEANING>Calcaneum</VALUEMEANING>
          <MEANINGDESCRIPTION>The irregular and largest tarsal bone that forms the heel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4199816</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buttock</VALIDVALUE>
          <VALUEMEANING>Buttock</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the fleshy mounds in the rear pelvic area of the human body formed by the gluteal muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buccal cavity</VALIDVALUE>
          <VALUEMEANING>Buccal Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchus and Lung</VALIDVALUE>
          <VALUEMEANING>Bronchus And Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>Tubular structure in continuation with the trachea, serving as air passage. It terminates in the lung (terminal bronchiole).: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12468, C37912, C12683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchiole</VALIDVALUE>
          <VALUEMEANING>Bronchiole</VALUEMEANING>
          <MEANINGDESCRIPTION>(BRON-kee-olz) The tiny branches of air tubes in the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571106</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Broad ligament</VALIDVALUE>
          <VALUEMEANING>Broad Ligament</VALUEMEANING>
          <MEANINGDESCRIPTION>A broad fold of peritoneum that extends from the side of the uterus to the wall of the pelvis. (MeSH)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brain stem</VALIDVALUE>
          <VALUEMEANING>Brain Stem</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the brain that is connected to the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Throat</VALIDVALUE>
          <VALUEMEANING>Throat</VALUEMEANING>
          <MEANINGDESCRIPTION>The narrow passage from the mouth to the cavity at the back of the mouth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pylorus</VALIDVALUE>
          <VALUEMEANING>Pylorus</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the stomach that connects to the duodenum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebrum</VALIDVALUE>
          <VALUEMEANING>Cerebral Hemisphere</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the brain that controls muscle functions and also controls speech, thought, emotions, reading, writing, and learning. The right hemisphere controls the muscles on the left side of the body, and the left hemisphere controls the muscles on the right side of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebrospinal fluid</VALIDVALUE>
          <VALUEMEANING>Cerebrospinal fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567374</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebral cortex</VALIDVALUE>
          <VALUEMEANING>Cerebral Cortex</VALUEMEANING>
          <MEANINGDESCRIPTION>The outer layer of the cerebrum composed of neurons and unmyelinated nerve fibers.  It is responsible for memory, attention, consciousness and other high mental functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12443</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3134756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebellum</VALIDVALUE>
          <VALUEMEANING>Cerebellum</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the brain located at the base of the skull that is responsible for balance, equilibrium and movement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566001</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central Line Catheter</VALIDVALUE>
          <VALUEMEANING>Central Venous Access Catheter</VALUEMEANING>
          <MEANINGDESCRIPTION>A venous catheter positioned with the tip in the proximal third of the superior vena cava, the right atrium, or the inferior vena cava.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cartilage</VALIDVALUE>
          <VALUEMEANING>Cartilage</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of connective tissue composed of chondrocytes and an extracellular matrix, composed of collagen, elastin, and ground substance. There are three types of cartilage; namely elastic, hyaline, and fibrocartilage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12373</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carpus</VALIDVALUE>
          <VALUEMEANING>Carpal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The eight bones of the wrist: capitate bone, hamate bone, lunate bone (SEMILUNAR BONE), pisiform bone, SCAPHOID BONE, trapezium bone, trapezoid bone and triquetral bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4199815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carotid body</VALIDVALUE>
          <VALUEMEANING>Carotid Body</VALUEMEANING>
          <MEANINGDESCRIPTION>A cluster of cells that function as chemo-receptors, located at the bifurcation of the carotid artery. Its main purpose is to detect changes in the composition of arterial blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carotid artery</VALIDVALUE>
          <VALUEMEANING>Carotid Artery</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carina</VALIDVALUE>
          <VALUEMEANING>Carina</VALUEMEANING>
          <MEANINGDESCRIPTION>A ridge or ridge-like structure.  In humans it usually refers to the trachea.  The carina of trachea is part of the lowest tracheal cartilage which is placed between the orifices of the two bronchi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>paratracheal</VALIDVALUE>
          <VALUEMEANING>Paratracheal</VALUEMEANING>
          <MEANINGDESCRIPTION>Regions near to the trachea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25317</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extra-adrenal Site</VALIDVALUE>
          <VALUEMEANING>Extra-Adrenal</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to tissues outside the adrenal gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4132071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraaortic lymph nodes</VALIDVALUE>
          <VALUEMEANING>Paraaortic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located adjacent to the lumbar region of the spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>para-aortic</VALIDVALUE>
          <VALUEMEANING>Paraaortic</VALUEMEANING>
          <MEANINGDESCRIPTION>Regions near to the aorta.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreas</VALIDVALUE>
          <VALUEMEANING>Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-encapsulated elongated and lobulated organ, extending from the concavity of the duodenum to the spleen; it consists of a head, an elongated body, and a tail. It contains two functional components: an exocrine component that secretes juices into the intestine and an endocrine component that secretes hormones (insulin and glucagon).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ovary</VALIDVALUE>
          <VALUEMEANING>Ovary</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the paired female reproductive glands containing the ova or germ cells; the ovary&#39;s stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova; surrounding this stroma is a more condensed layer of stroma called the tunica albuginea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574083</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other Nodal</VALIDVALUE>
          <VALUEMEANING>Other Nodal</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Nodal; of or pertaining to a node, any bulge or swelling of an anatomical structure or part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25323, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other Extranodal Site</VALIDVALUE>
          <VALUEMEANING>Other Extranodal Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Situated outside of a node.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25504, C13717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>2, 1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>orbital</VALIDVALUE>
          <VALUEMEANING>Orbital Ridge</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony elevation located beneath the eyebrow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82953</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Orbit</VALIDVALUE>
          <VALUEMEANING>Orbit</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa.  Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>waldeyer&#39;s ring</VALIDVALUE>
          <VALUEMEANING>Waldeyer&#39;s Tonsillar Ring</VALUEMEANING>
          <MEANINGDESCRIPTION>The ring of lymphoid tissue located in the pharynx, consisting of the pharyngeal, tubal, palatine, and lingual tonsils.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uterus</VALIDVALUE>
          <VALUEMEANING>Uterus</VALUEMEANING>
          <MEANINGDESCRIPTION>A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>upper para-aortic</VALIDVALUE>
          <VALUEMEANING>Upper Paraaortic Region</VALUEMEANING>
          <MEANINGDESCRIPTION>Higher in place or position; the topmost one of two.: Regions near to the aorta.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25316, C25355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroid</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testes</VALIDVALUE>
          <VALUEMEANING>Testis</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the paired male reproductive glands that produce the male germ cells and the male hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567251</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Supraclavicular lymph nodes</VALIDVALUE>
          <VALUEMEANING>Supraclavicular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node which is located above the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>supraclavicular</VALIDVALUE>
          <VALUEMEANING>Supraclavicular</VALUEMEANING>
          <MEANINGDESCRIPTION>Supraclavicular; positioned above the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Submandibular lymph nodes</VALIDVALUE>
          <VALUEMEANING>Submandibular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located beneath the floor of the oral cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vein</VALIDVALUE>
          <VALUEMEANING>Vein</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood vessel that carries blood toward the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vas Deferens</VALIDVALUE>
          <VALUEMEANING>Vas Deferens</VALUEMEANING>
          <MEANINGDESCRIPTION>Duct carrying spermatozoa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vagina</VALIDVALUE>
          <VALUEMEANING>Vagina</VALUEMEANING>
          <MEANINGDESCRIPTION>The female genital canal, extending from the uterus to the vulva.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uvula</VALIDVALUE>
          <VALUEMEANING>Uvula</VALUEMEANING>
          <MEANINGDESCRIPTION>The fleshy lobe that hangs at the back of the soft palate.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary tract</VALIDVALUE>
          <VALUEMEANING>Urinary System</VALUEMEANING>
          <MEANINGDESCRIPTION>The organs of the body that produce and discharge urine. These include the kidneys, ureters, bladder, and urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urethra</VALIDVALUE>
          <VALUEMEANING>Urethra</VALUEMEANING>
          <MEANINGDESCRIPTION>(yoo-REE-thra) The tube through which urine leaves the body. It empties urine from the bladder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3181637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ureter</VALIDVALUE>
          <VALUEMEANING>Ureter</VALUEMEANING>
          <MEANINGDESCRIPTION>The thick-walled tube that carries urine from each kidney to the bladder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Upper extremity</VALIDVALUE>
          <VALUEMEANING>Upper Extremity</VALUEMEANING>
          <MEANINGDESCRIPTION>The region of the body that includes the arm, the forearm, and hand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12671</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Umbilical Cord</VALIDVALUE>
          <VALUEMEANING>Umbilical Cord</VALUEMEANING>
          <MEANINGDESCRIPTION>Extraembryonic structure that connects the fetus to the placenta. It contains two arteries and one vein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ulna</VALIDVALUE>
          <VALUEMEANING>Ulna</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the bones that comprise the forearm. The largest aspect articulates with the humerus at the elbow joint and the smallest portion of the ulna articulates with the carpal bones in the wrist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trunk, Superficial</VALIDVALUE>
          <VALUEMEANING>Superficial Trunk</VALUEMEANING>
          <MEANINGDESCRIPTION>Of little substance or significance; involving only a surface.: The body excluding the head and neck and limbs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33816, C25239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trachea/Major Bronchi</VALIDVALUE>
          <VALUEMEANING>Trachea and Main Bronchus</VALUEMEANING>
          <MEANINGDESCRIPTION>The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi.: The left and right main bronchi considered as a group.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12284, C12428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tonsil, Pharyngeal</VALIDVALUE>
          <VALUEMEANING>Tonsillar Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>A fold of lymphatic tissue covered by ciliated epithelium at the very back of the nose, in the roof of the nasopharynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2761349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tonsil</VALIDVALUE>
          <VALUEMEANING>Tonsil</VALUEMEANING>
          <MEANINGDESCRIPTION>The two organs situated in the throat on either side of the narrow passage from the mouth to the pharynx. They are composed of lymphoid tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12802</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tongue, Base of tongue</VALIDVALUE>
          <VALUEMEANING>Base of the Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>The posterior one third of the tongue behind the terminal sulcus that forms the anterior aspect of the oro-pharynx responsible for swallowing and modification of the voice in speech.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tongue</VALIDVALUE>
          <VALUEMEANING>Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Toe</VALIDVALUE>
          <VALUEMEANING>Toes (Phalanges)</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the terminal digits of the foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33788</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4207651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tibia</VALIDVALUE>
          <VALUEMEANING>Tibia</VALUEMEANING>
          <MEANINGDESCRIPTION>The second longest bone of the skeleton. It is located on the medial side of the lower leg, articulating with the FIBULA laterally, the TALUS distally, and the FEMUR proximally.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroid gland</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>(THIGH-royd) A gland located beneath the voice box (larynx) that produces thyroid hormone. The thyroid helps regulate growth and metabolism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenal gland</VALIDVALUE>
          <VALUEMEANING>Adrenal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oropharyngeal Soft Tissue</VALIDVALUE>
          <VALUEMEANING>Oropharyngeal Tissue Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Tissue that occupies the area between the soft palate and upper portion of the epiglottis.: Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471, C92600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5727044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s) non-regional</VALIDVALUE>
          <VALUEMEANING>Lymph node(s), non-regional</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Of or belonging to a broader area or region of the body.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C25643, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6065880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node (not mediastinum)</VALIDVALUE>
          <VALUEMEANING>Not Mediastinum Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: A group of organs surrounded by loose connective tissue, separating the two pleural sacs, between the sternum anteriorly and the vertebral column posteriorly as well as from the thoracic inlet superiorly to the diaphragm inferiorly. The mediastinum contains the heart and pericardium, the bases of the great vessels, the trachea and bronchi, esophagus, thymus, lymph nodes, thoracic duct, phrenic and vagus nerves, and other structures and tissues.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C12748, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5981833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renal pelvis</VALIDVALUE>
          <VALUEMEANING>Renal Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>The area at the center of the kidney. Urine collects here and is funneled into the ureter, the tube that connects the kidney to the bladder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3138163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peripheral nerves and autonomic nervous system of trunk</VALIDVALUE>
          <VALUEMEANING>Peripheral Nerve And Autonomic Nervous System Trunk</VALUEMEANING>
          <MEANINGDESCRIPTION>Any nerve outside the brain or spinal cord that connects with peripheral receptors or effectors. (NCI): An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The part of the nervous system of vertebrates that controls involuntary actions of the smooth muscles and heart and glands.: The body excluding the head and neck and limbs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33816, C12673, C37912, C12768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6127499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other ill-defined sites</VALIDVALUE>
          <VALUEMEANING>Other Ill-defined Site</VALUEMEANING>
          <MEANINGDESCRIPTION>An anatomic site that is not specified or defined well enough to associate with a specific site.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147919</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6127500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meninges</VALIDVALUE>
          <VALUEMEANING>Meninges</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of three membranes that surround the brain and spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Male genital organs</VALIDVALUE>
          <VALUEMEANING>Male Genitalia</VALUEMEANING>
          <MEANINGDESCRIPTION>The external male sexual organs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6127501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Accessory sinus</VALIDVALUE>
          <VALUEMEANING>Paranasal Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the air-filled spaces within the ethmoid, frontal, maxillary, or sphenoid bones, which communicate with the nasal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ascites</VALIDVALUE>
          <VALUEMEANING>Ascites</VALUEMEANING>
          <MEANINGDESCRIPTION>The accumulation of fluid in the peritoneal cavity, which may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2885</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5446318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extrahepatic Bile Duct</VALIDVALUE>
          <VALUEMEANING>Extrahepatic Bile Duct</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the biliary tract outside the liver; the common hepatic duct joins the cystic duct to form the common bile duct.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleural nodules</VALIDVALUE>
          <VALUEMEANING>Pleural Nodule</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the pleura.: A small lump, swelling or collection of tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3280, C25223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6161750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleural effusion</VALIDVALUE>
          <VALUEMEANING>Pleural Effusion</VALUEMEANING>
          <MEANINGDESCRIPTION>Increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumors, connective tissue disorders, and trauma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3331</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4264940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritoneal nodes</VALIDVALUE>
          <VALUEMEANING>Peritoneal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the peritoneum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6659691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intrahepatic Bile Duct</VALIDVALUE>
          <VALUEMEANING>Intrahepatic Bile Duct</VALUEMEANING>
          <MEANINGDESCRIPTION>The bile ducts that pass through and drain bile from the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12677</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3691244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left tubo-ovarian</VALIDVALUE>
          <VALUEMEANING>Left Tubo-Ovarian</VALUEMEANING>
          <MEANINGDESCRIPTION>A term that implies the left fallopian tube and left ovary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right tubo-ovarian</VALIDVALUE>
          <VALUEMEANING>Right Tubo-Ovarian</VALUEMEANING>
          <MEANINGDESCRIPTION>A term that implies the right fallopian tube and right ovary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left fallopian tube</VALIDVALUE>
          <VALUEMEANING>Left Fallopian Tube</VALUEMEANING>
          <MEANINGDESCRIPTION>The fallopian tube that extends from the uterus to the ovary in the left side of the pelvic cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right fallopian tube</VALIDVALUE>
          <VALUEMEANING>Right Fallopian Tube</VALUEMEANING>
          <MEANINGDESCRIPTION>The fallopian tube that extends from the uterus to the ovary in the right side of the pelvic cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left ovary</VALIDVALUE>
          <VALUEMEANING>Left Ovary</VALUEMEANING>
          <MEANINGDESCRIPTION>The ovary that is located in the left side of the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right ovary</VALIDVALUE>
          <VALUEMEANING>Right Ovary</VALUEMEANING>
          <MEANINGDESCRIPTION>The ovary that is located in the right side of the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin/subcutaneous</VALIDVALUE>
          <VALUEMEANING>Subcutaneous Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>Beneath the skin.: An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13353, C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head and neck (non-PM)</VALIDVALUE>
          <VALUEMEANING>Negation Parameningeal Head and Neck</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Of, or related to, the structures proximal to meninges.: For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12418, C93030, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5983505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left lower lobe lung</VALIDVALUE>
          <VALUEMEANING>Lower Lobe of the Left Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>The larger lobe of the left lung, situated below and behind the oblique fissure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33020</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left upper lobe lung</VALIDVALUE>
          <VALUEMEANING>Upper Lobe of the Left Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>The smaller lobe of the left lung, situated above and in front the oblique fissure, which includes the apex.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33021</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right lower lobe lung</VALIDVALUE>
          <VALUEMEANING>Lower Lobe of the Right Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>The lobe of the right lung situated below the oblique fissure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33022</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right middle lobe lung</VALIDVALUE>
          <VALUEMEANING>Middle Lobe of the Right Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest lobe of the right lung, situated above the oblique fissure and below the horizontal fissure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right upper lobe lung</VALIDVALUE>
          <VALUEMEANING>Upper Lobe of the Right Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>The lobe of the right lung, situated above the horizontal fissure, which includes the apex.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33023</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left breast</VALIDVALUE>
          <VALUEMEANING>Left Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>The hemispheric projection, including the mammary gland, located on the anterior portion of the chest, lateral to the midline, on the side of the body to the west when facing north.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2969601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right breast</VALIDVALUE>
          <VALUEMEANING>Right Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>The hemispheric projection, including the mammary gland, located on the anterior portion of the chest, lateral to the midline, on the side of the body to the east when facing north.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47856</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ileocecal valve</VALIDVALUE>
          <VALUEMEANING>Ileocecal Valve</VALUEMEANING>
          <MEANINGDESCRIPTION>The valve between the ileum of the small intestine and the cecum of the large intestine.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13066</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soft tissue</VALIDVALUE>
          <VALUEMEANING>Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2990372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CNS</VALIDVALUE>
          <VALUEMEANING>Central Nervous System</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the nervous system that consists of the brain, spinal cord, and meninges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5343369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testis</VALIDVALUE>
          <VALUEMEANING>Testis</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the paired male reproductive glands that produce the male germ cells and the male hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2873868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retroperitoneum</VALIDVALUE>
          <VALUEMEANING>Retroperitoneum</VALUEMEANING>
          <MEANINGDESCRIPTION>The back of the abdomen where the kidneys lie and the great blood vessels run.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parameningeal</VALIDVALUE>
          <VALUEMEANING>Parameningeal</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or related to, the structures proximal to the meninges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Limb</VALIDVALUE>
          <VALUEMEANING>Limb</VALUEMEANING>
          <MEANINGDESCRIPTION>A body region referring to an upper or lower extremity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2677356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biliary tract/liver</VALIDVALUE>
          <VALUEMEANING>Biliary Tract Or Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>The system that transports bile from the hepatocytes in the liver to the small intestine. It is comprised of the intrahepatic bile ducts, hepatic ducts, common bile duct, cystic duct, and the gallbladder.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392, C37998, C12678</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5983504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatic tail</VALIDVALUE>
          <VALUEMEANING>Tail of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>The left extremity of the pancreas within the lienorenal ligament.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4742916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatic body</VALIDVALUE>
          <VALUEMEANING>Body of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the pancreas from the point where it crosses the portal vein to the point where it enters the lienorenal ligament.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4742914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatic head</VALIDVALUE>
          <VALUEMEANING>Head of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>That portion of the pancreas lying in the concavity of the duodenum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4742915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus - distal third</VALIDVALUE>
          <VALUEMEANING>Lower Third of the Esophagus</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower one third of the esophagus in which the muscle layer is composed of muscle cells predominantly of the smooth type.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12255</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4419327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus - middle third</VALIDVALUE>
          <VALUEMEANING>Middle Third of the Esophagus</VALUEMEANING>
          <MEANINGDESCRIPTION>The middle one third of the esophagus in which the muscle layer is composed of muscle cells of the striated and smooth types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12254</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus - proximal third</VALIDVALUE>
          <VALUEMEANING>Upper Third of the Esophagus</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper one third of esophagus in which the muscle layer is composed of muscle cells of the striated type.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritoneal surfaces</VALIDVALUE>
          <VALUEMEANING>Peritoneal surface</VALUEMEANING>
          <MEANINGDESCRIPTION>The outer layer of the serous membrane that lines the abdominal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-regional/distant lymph nodes</VALIDVALUE>
          <VALUEMEANING>Negation Regional Or Distant Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Of or belonging to a broader area or region of the body.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A lymph node located distant to the anatomic site of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106042, C37998, C25643, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6816254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach (NOS)</VALIDVALUE>
          <VALUEMEANING>Stomach, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: An organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12391, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3684610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fundus</VALIDVALUE>
          <VALUEMEANING>Fundus</VALUEMEANING>
          <MEANINGDESCRIPTION>The bottom portion or the portion that is furthest from the opening of a hollow organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Body</VALIDVALUE>
          <VALUEMEANING>Body</VALUEMEANING>
          <MEANINGDESCRIPTION>The entire physical structure of an organism.  It is composed of anatomic systems, regions, cavities, and spaces.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13041</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566770</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antrum</VALIDVALUE>
          <VALUEMEANING>Antrum</VALUEMEANING>
          <MEANINGDESCRIPTION>A chamber formation in an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parotid gland, superficial lobe</VALIDVALUE>
          <VALUEMEANING>Parotid Gland Superficial Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the parotid gland that is superficial to the facial vein and facial nerve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal vestibule</VALIDVALUE>
          <VALUEMEANING>Nasal Vestibule</VALUEMEANING>
          <MEANINGDESCRIPTION>The most anterior part of the nasal cavity, lined by squamous epithelium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160989</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal lateral wall</VALIDVALUE>
          <VALUEMEANING>Lateral Wall of the Nose</VALUEMEANING>
          <MEANINGDESCRIPTION>The outside wall of the nasal passages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160988</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glottis, with subglottic extension</VALIDVALUE>
          <VALUEMEANING>Glottic Laryngeal Tumor with Subgolttic Extension</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of glottic involvement from a laryngeal tumor with extension of the tumor into the subglottis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161004</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arytenoid(s)</VALIDVALUE>
          <VALUEMEANING>Arytenoid Cartilage</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of a pair of small pyramidal laryngeal cartilages that articulate with the lamina of the cricoid cartilage and give attachment to the posterior part of the corresponding vocal ligament and to several muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32148</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aryepiglottic folds</VALIDVALUE>
          <VALUEMEANING>Aryepiglottic Fold</VALUEMEANING>
          <MEANINGDESCRIPTION>A membranous fold extending between the arytenoid cartilage and the epiglottis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32147</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epiglottis, laryngeal aspect</VALIDVALUE>
          <VALUEMEANING>Laryngeal Surface of the Epiglottis</VALUEMEANING>
          <MEANINGDESCRIPTION>The surface of the epiglottis that is oriented toward the larynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160979</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alveolar process, mandibular</VALIDVALUE>
          <VALUEMEANING>Mandibular Alveolar Process</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the mandible that contains the sockets of the teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alveolar process, maxillary</VALIDVALUE>
          <VALUEMEANING>Maxillary Alveolar Process</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the maxilla that contains the sockets of the teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vestibule of mouth, mandibular</VALIDVALUE>
          <VALUEMEANING>Mandibular Vestibule of the Mouth</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the mouth between the cheeks and the teeth of the mandible.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vestibule of mouth, maxillary</VALIDVALUE>
          <VALUEMEANING>Maxillary Vestibule of the Mouth</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the mouth between the cheeks and the teeth of the maxilla.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lateral border of tongue</VALIDVALUE>
          <VALUEMEANING>Lateral Surface of the Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>The side of the tongue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenal gland, ipsilateral</VALIDVALUE>
          <VALUEMEANING>Ipsilateral Adrenal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the same side of the body.: A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12666, C25308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6789069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenal gland, contralateral</VALIDVALUE>
          <VALUEMEANING>Contralateral Adrenal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>On or relating to the opposite side of the body.: A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12666, C25307</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6789070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Minor gland(s)</VALIDVALUE>
          <VALUEMEANING>Minor Salivary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A small salivary gland located in the oral cavity.  It produces saliva.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sublingual gland</VALIDVALUE>
          <VALUEMEANING>Sublingual Salivary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A salivary gland located under the tongue in the floor of the oral cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Submandibular gland</VALIDVALUE>
          <VALUEMEANING>Submandibular Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two salivary glands in the neck, located in the space bound by the two bellies of the digastric muscle and the angle of the mandible. It discharges through the submandibular duct. The secretory units are predominantly serous although a few mucous alveoli, some with serous demilunes, occur. (Stedman, 25th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parotid gland, total</VALIDVALUE>
          <VALUEMEANING>Parotid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest of the three paired salivary glands, located in front of the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parotid gland, deep lobe</VALIDVALUE>
          <VALUEMEANING>Parotid Gland Deep Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the parotid gland parenchyma lying deep to the facial nerve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96176</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paranasal sinus(es), sphenoid</VALIDVALUE>
          <VALUEMEANING>Sphenoid Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the paired paranasal sinuses, located in the anterior part of the body of the sphenoid bone and communicating with the superior meatus of the nasal cavity on the same side.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3698219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paranasal sinus(es), maxillary</VALIDVALUE>
          <VALUEMEANING>Maxillary Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>A pyramidal-shaped, thin-walled, air-filled cavity located in the maxilla. It is lined by mucus membrane and periosteum (mucoperiosteum) which contains cilia. It is adjacent to the nasal cavity and communicates with the middle meatus of the nose. It is the largest paranasal sinus and is composed of three recesses: alveolar, zygomatic, and infraorbital.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paranasal sinus(es), frontal</VALIDVALUE>
          <VALUEMEANING>Frontal Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>The paired, mucosal lined air spaces located above the orbit and communicating with the nasal passages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paranasal sinus(es), ethmoid</VALIDVALUE>
          <VALUEMEANING>Ethmoid Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>A sinus of the meatuses of the nasal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal cavity, NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Nasal Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: The proximal portion of the respiratory passages on either side of the nasal septum lying between the floor of the cranium and the roof of the mouth and extending from the face to the pharynx. The nasal cavity is lined with ciliated mucosa, extending from the nares to the pharynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12424, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal floor</VALIDVALUE>
          <VALUEMEANING>Nasal Cavity Floor</VALUEMEANING>
          <MEANINGDESCRIPTION>The proximal portion of the respiratory passages on either side of the nasal septum lying between the floor of the cranium and the roof of the mouth and extending from the face to the pharynx. The nasal cavity is lined with ciliated mucosa, extending from the nares to the pharynx.: The lower inner surface of an open space or hollow organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66795, C12424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal septum</VALIDVALUE>
          <VALUEMEANING>Nasal Septum</VALUEMEANING>
          <MEANINGDESCRIPTION>The thin wall between the two nasal cavities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other (specify)</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Subglottis</VALIDVALUE>
          <VALUEMEANING>Subglottis</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the larynx below the vocal cords down to the trachea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3698216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Posterior commissure</VALIDVALUE>
          <VALUEMEANING>Posterior Commissure</VALUEMEANING>
          <MEANINGDESCRIPTION>A small fasciculus that decussates in the inferior pineal lamina in the midbrain, and is the junctional landmark between the diencephalon and the mesencephalon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior commissure</VALIDVALUE>
          <VALUEMEANING>Anterior Commissure</VALUEMEANING>
          <MEANINGDESCRIPTION>A rounded band or bundle of nerve fibers that connects the two hemispheres of the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32086</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>True vocal cord</VALIDVALUE>
          <VALUEMEANING>True Vocal Cord</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower pair of vocal folds located below the glottis, which are the primary source of phonation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33815</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Larynx ventricle</VALIDVALUE>
          <VALUEMEANING>Laryngeal Ventricle</VALUEMEANING>
          <MEANINGDESCRIPTION>A fusiform fossa on the lateral sides of the larynx between the inferior and superior vocal cords.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32935</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>False vocal cord</VALIDVALUE>
          <VALUEMEANING>False Vocal Cord</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two folds of a mucous membrane spanning the larynx. The two folds aid in breathing and preventing regurgitation to a greater extent than producing sounds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5566348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epiglottis, lingual aspect</VALIDVALUE>
          <VALUEMEANING>Anterior Surface of the Epiglottis</VALUEMEANING>
          <MEANINGDESCRIPTION>The lingual or upper surface of the epiglottis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pharyngeal wall (posterior and/or lateral)</VALIDVALUE>
          <VALUEMEANING>Posterior Wall of the Pharynx And/Or Lateral Wall of the Pharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The dorsal portion of the fibromuscular tube that extends from the skull base to the lower border of the cricoid cartilage, and acts as a conduit for both the digestive and respiratory systems.: Used to indicate that either or both of two items or options may be valid.: The walls on either side of the swallowing passage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129817, C48928, C54222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Postcricoid</VALIDVALUE>
          <VALUEMEANING>Postcricoid region</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the hypopharynx that is located posteriorly to the larynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3698171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Piriform sinus</VALIDVALUE>
          <VALUEMEANING>Pyriform Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>A pear-shaped fossa in the wall of the laryngeal pharynx lateral to the arytenoid cartilage and medial to the lamina of the thyroid cartilage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasopharyngeal tonsils (adenoids)</VALIDVALUE>
          <VALUEMEANING>Tonsillar Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>A fold of lymphatic tissue covered by ciliated epithelium at the very back of the nose, in the roof of the nasopharynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2761349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pharyngeal wall (posterior)</VALIDVALUE>
          <VALUEMEANING>Posterior Wall of the Pharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The dorsal portion of the fibromuscular tube that extends from the skull base to the lower border of the cricoid cartilage, and acts as a conduit for both the digestive and respiratory systems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soft palate</VALIDVALUE>
          <VALUEMEANING>Soft Palate</VALUEMEANING>
          <MEANINGDESCRIPTION>A movable fold suspended from the posterior border of the hard palate. (MeSH)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3400913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Base of tongue, including lingual tonsil</VALIDVALUE>
          <VALUEMEANING>Base of the Tongue Include Lingual Tonsil</VALUEMEANING>
          <MEANINGDESCRIPTION>The posterior one third of the tongue behind the terminal sulcus that forms the anterior aspect of the oro-pharynx responsible for swallowing and modification of the voice in speech.: Add as part of something else; put in as part of a set, group, or category.: The lymphoid follicles on the dorsal surface in the posterior region of the tongue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32988, C74521, C12228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palatine tonsil</VALIDVALUE>
          <VALUEMEANING>Palatine Tonsil</VALUEMEANING>
          <MEANINGDESCRIPTION>Two masses of lymphatic tissue located one on either side of the oropharynx in the oropharyngeal isthmus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s), regional</VALIDVALUE>
          <VALUEMEANING>Regional Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node that drains lymph from a region of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3422988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s), non-regional</VALIDVALUE>
          <VALUEMEANING>Negation Local-Regional Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Of or belonging to both a local and regional area of the body.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C25388, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776235</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retromolar area</VALIDVALUE>
          <VALUEMEANING>Retromolar Trigone</VALUEMEANING>
          <MEANINGDESCRIPTION>The small area behind the wisdom teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3698194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior floor of mouth</VALIDVALUE>
          <VALUEMEANING>Anterior Floor of Mouth</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting the front surface of the body; often used to indicate the position of one structure relative to another.: The area of the mouth under the ventral surface of the tongue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54187, C25231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>External upper lip</VALIDVALUE>
          <VALUEMEANING>External Upper Lip</VALUEMEANING>
          <MEANINGDESCRIPTION>The external surface of the upper lip.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lower gingiva</VALIDVALUE>
          <VALUEMEANING>Lower Gingiva</VALUEMEANING>
          <MEANINGDESCRIPTION>The gingiva covering the mandibular alveolar bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Upper gingiva</VALIDVALUE>
          <VALUEMEANING>Upper Gingiva</VALUEMEANING>
          <MEANINGDESCRIPTION>The gingiva covering the maxillary alveolar bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior two-thirds of tongue</VALIDVALUE>
          <VALUEMEANING>Anterior 67 Percent Unit Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting the front surface of the body; often used to indicate the position of one structure relative to another.: A number with no fractional part, including the negative and positive numbers as well as zero.::67: A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).: The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12422, C48570, C45255::67, C25231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dorsal surface of tongue</VALIDVALUE>
          <VALUEMEANING>Dorsal Tongue Surface</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the back or upper surface of the body; opposite of ventral.: The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech.: The extended two-dimensional outer boundary of a three-dimensional object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25245, C12422, C45874</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ventral surface of tongue</VALIDVALUE>
          <VALUEMEANING>Ventral Tongue Surface</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the underside or lower surface of the body; opposite of dorsal.: The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech.: The extended two-dimensional outer boundary of a three-dimensional object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25245, C12422, C45875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Commissure of lip</VALIDVALUE>
          <VALUEMEANING>Commissure of the Lip</VALUEMEANING>
          <MEANINGDESCRIPTION>The junction of the upper and lower lips at the corner of the mouth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucosa of lower lip</VALIDVALUE>
          <VALUEMEANING>Mucosa of the Lower Lip</VALUEMEANING>
          <MEANINGDESCRIPTION>The lining of the inferior fleshy fold bordering the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucosa of upper lip</VALIDVALUE>
          <VALUEMEANING>Mucosa of the Upper Lip</VALUEMEANING>
          <MEANINGDESCRIPTION>The lining of the superior fleshy fold bordering the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>External lower lip</VALIDVALUE>
          <VALUEMEANING>External Lower Lip</VALUEMEANING>
          <MEANINGDESCRIPTION>The external surface of the lower lip.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lower uterine segment</VALIDVALUE>
          <VALUEMEANING>Endometrium Isthmus Uteri</VALUEMEANING>
          <MEANINGDESCRIPTION>The mucous membrane comprising the inner layer of the uterine wall; it consists of a simple columnar epithelium and a lamina propria that contains simple tubular uterine glands. The structure, thickness, and state of the endometrium undergo marked change with the menstrual cycle.: An elongated constriction of the lower part of the uterus, located at the junction of the body of the uterus and the cervix, that is composed principally of smooth muscle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12312, C12313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Para-aortic lymph node(s)</VALIDVALUE>
          <VALUEMEANING>Paraaortic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located adjacent to the lumbar region of the spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvic lymph node(s)</VALIDVALUE>
          <VALUEMEANING>Pelvic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Any lymph node within the abdominal pelvic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5216171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extra-abdominal lymph node(s)</VALIDVALUE>
          <VALUEMEANING>Extra-abdominal lymph node(s)</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node outside the abdominal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvic recurrence</VALIDVALUE>
          <VALUEMEANING>Pelvis Recurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.: To come back or to return.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3352, C12767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrium</VALIDVALUE>
          <VALUEMEANING>Endometrium</VALUEMEANING>
          <MEANINGDESCRIPTION>The mucous membrane comprising the inner layer of the uterine wall; it consists of a simple columnar epithelium and a lamina propria that contains simple tubular uterine glands. The structure, thickness, and state of the endometrium undergo marked change with the menstrual cycle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Posterior commissure of glottis</VALIDVALUE>
          <VALUEMEANING>Posterior commissure of glottis</VALUEMEANING>
          <MEANINGDESCRIPTION>The posterior surface of the glottic opening at the level of the vocal cords.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C164282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6943245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior commissure of glottis</VALIDVALUE>
          <VALUEMEANING>Anterior commissure of glottis</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior-most portion of the vocal cord, located within the larynx, that constitutes the junction of the conus elasticus and the thyroepiglottic, vestibular, and vocal ligaments.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128630</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6943246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not specified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5697867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Contralateral pleura</VALIDVALUE>
          <VALUEMEANING>Contralateral Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>On or relating to the opposite side (of the body): The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469, C25307</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3813651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Visceral pleura</VALIDVALUE>
          <VALUEMEANING>Visceral Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>Visceral; of, or relating to, or affecting the internal organs.: (PLOOR-a) A thin layer of tissue covering the lungs and the wall of the chest cavity to protect and cushion the lungs. A small amount of fluid that acts as a lubricant allows the lungs to move smoothly in the chest cavity during breathing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469, C25315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parietal pleura</VALIDVALUE>
          <VALUEMEANING>Parietal Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>The outermost of the two pleural membranes. It consists of a thin basal layer of fibrous tissue upon which sits a continuous layer of mesothelial cells. The cells function to secrete the lubricant lining the pleural cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7590003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bilateral pleura</VALIDVALUE>
          <VALUEMEANING>Bilateral Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>Affecting both sides of the body or a matched pair of organs.: The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469, C13332</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7590004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left pleura</VALIDVALUE>
          <VALUEMEANING>Left Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the west when facing north.: The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469, C25229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7590005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right pleura</VALIDVALUE>
          <VALUEMEANING>Right Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the east when facing north.: The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469, C25228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7590006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdominal/non-adrenal</VALIDVALUE>
          <VALUEMEANING>Abdominal/non-adrenal</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex)._Of, or related to, the abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25342, C12666, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10360279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Posterior mediastinum</VALIDVALUE>
          <VALUEMEANING>Posterior Mediastinum</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the lower portion of the mediastinum that is located behind the pericardium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33368</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5983746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Site of New Primary Melanoma</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Site of New Primary Melanoma</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>new_primary_melanoma_anatomic_site</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="751">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3447307</PUBLICID>
    <LONGNAME>Uterine Adenosarcoma American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Regional Lymph Node N Stage</LONGNAME>
    <PREFERREDNAME>3444923v1.0:3447078v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Extent of the regional lymph node involvement for the uterine adenosarcoma based on evidence obtained from pathologic examination through completion of definitive surgery.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</ORIGIN>
    <REGISTRATIONSTATUS>Preferred Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3444923</PublicId>
      <PreferredName>3444913v1.0:2428379v1.0</PreferredName>
      <PreferredDefinition>The Corpus uteri, or body of uterus, is the part of the uterus above the isthmus, comprising about two thirds of the non-pregnant organ._A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.</PreferredDefinition>
      <LongName>Uterine Adenosarcoma Pathologic N Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3444913</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12316:C9474</PreferredName>
        <Version>1</Version>
        <LongName>Corpus Uteri Adenosarcoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12316</PREFERRED_NAME>
            <LONG_NAME>Corpus Uteri</LONG_NAME>
            <CON_ID>2958984</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9474</PREFERRED_NAME>
            <LONG_NAME>Adenosarcoma</LONG_NAME>
            <CON_ID>2204731</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2428379</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25610:C25580</PreferredName>
        <Version>1</Version>
        <LongName>Pathologic N Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25610</PREFERRED_NAME>
            <LONG_NAME>Pathologic</LONG_NAME>
            <CON_ID>2204850</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25580</PREFERRED_NAME>
            <LONG_NAME>N Category</LONG_NAME>
            <CON_ID>2204625</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3447078</PublicId>
      <PreferredName>3447078v1.0</PreferredName>
      <PreferredDefinition>A finding about one or more characteristics of adenosarcoma, following the rules of the TNM AJCC v7 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.</PreferredDefinition>
      <LongName>Uterine Adenosarcoma American Joint Committee on Cancer (AJCC) Edition 7 N Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
      <Representation>
        <PublicId>3447077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C89606:C39315:C25580:C16899</PreferredName>
        <Version>1</Version>
        <LongName>Adenosarcoma TNM Finding v7 American Joint Committee on Cancer N Stage Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C89606</PREFERRED_NAME>
            <LONG_NAME>Adenosarcoma TNM Finding v7</LONG_NAME>
            <CON_ID>3447048</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39315</PREFERRED_NAME>
            <LONG_NAME>American Joint Committee on Cancer</LONG_NAME>
            <CON_ID>2554142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25580</PREFERRED_NAME>
            <LONG_NAME>N Category</LONG_NAME>
            <CON_ID>2204625</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N0</VALIDVALUE>
          <VALUEMEANING>Adenosarcoma pN0 TNM Finding v7</VALUEMEANING>
          <MEANINGDESCRIPTION>No regional lymph node metastasis. (from AJCC 7th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89624</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3447080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N1</VALIDVALUE>
          <VALUEMEANING>Adenosarcoma pN1 TNM Finding v7</VALUEMEANING>
          <MEANINGDESCRIPTION>Regional lymph node metastasis. (from AJCC 7th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3447082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NX</VALIDVALUE>
          <VALUEMEANING>Adenosarcoma pNX TNM Finding v7</VALUEMEANING>
          <MEANINGDESCRIPTION>Regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3447084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pathologic N Stage</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pathologic N Stage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Staging/Extent of Disease (by Disease)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3434437</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Corpus Uteri Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3444895</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3461150</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AJCC Edition 7</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3461151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Uterine Adenosarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5777531</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AJCC Edition 7</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000596</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="752">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3533944</PUBLICID>
    <LONGNAME>National Cancer Institute Cancer Centers Program Patient Rural Address Indicator</LONGNAME>
    <PREFERREDNAME>3533931v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to signify whether a patient address is rural according to NCI Cancer Centers Program (NCCCP) criteria.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3533931</PublicId>
      <PreferredName>3533928v1.0:3533929v1.0</PreferredName>
      <PreferredDefinition>The NCI Cancer Centers Program comprises more than 50 NCI-designated cancer centers engaged in multidisciplinary research to reduce cancer incidence, morbidity and mortality. Through Cancer Center Support grants, this program supports three types of centers: Comprehensive Cancer Centers, Clinical Cancer Centers, and Cancer Centers. It was the National Cancer Act of 1971 that strengthened the program by authorizing the establishment of 15 new cancer centers and the continued support for existing ones._A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Of or pertaining to the country as opposed to the city. (American Heritage Dictionary)_The location at which an organization or person can be reached. (from American Heritage Dictionary)</PreferredDefinition>
      <LongName>National Cancer Institute Cancer Centers Program Patient Rural Address</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3533928</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C39466:C16960</PreferredName>
        <Version>1</Version>
        <LongName>National Cancer Institute Cancer Centers Program Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39466</PREFERRED_NAME>
            <LONG_NAME>National Cancer Institute Cancer Centers Program</LONG_NAME>
            <CON_ID>3533746</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3533929</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17724:C25407</PreferredName>
        <Version>1</Version>
        <LongName>Rural Address</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17724</PREFERRED_NAME>
            <LONG_NAME>Rural</LONG_NAME>
            <CON_ID>2800185</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25407</PREFERRED_NAME>
            <LONG_NAME>Address</LONG_NAME>
            <CON_ID>2202289</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is the patient rural per NCCC</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the patient rural per NCCCP/site criteria?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does participant live in a nonmetro/rural county?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance - A211901</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does participant live in a nonmetro/rural county and/or a Rural-Urban Commuting Area Code of 4-10?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3533741</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCORP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Screening and Accrual Log</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3533742</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="753">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3535764</PUBLICID>
    <LONGNAME>Primary Cytotoxic Chemotherapy or Maintenance Bevacizumab Progressive Disease Occurrence Indicator</LONGNAME>
    <PREFERREDNAME>PRIM_MNT_BEV_PD_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to signify whether progressive disease occurred while on either frontline or maintenance Bevacizumab.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3535763</PublicId>
      <PreferredName>PRIM_MNT_BEVA_PD_OCC</PreferredName>
      <PreferredDefinition>Occurring first in time or sequence; original; of greatest rank or importance or value._A monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor._Anticancer drugs that kill cells, especially cancer cells._Cancer that is growing, spreading, or getting worse._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Primary Cytotoxic Chemotherapy Or Maintenance Therapy Bevacizumab Progressive Disease Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3535765</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3535765v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Primary Cytotoxic Chemotherapy Or Maintenance Therapy Bevacizumab</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15681</PREFERRED_NAME>
            <LONG_NAME>Cytotoxic Chemotherapy</LONG_NAME>
            <CON_ID>2464253</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15688</PREFERRED_NAME>
            <LONG_NAME>Maintenance Therapy</LONG_NAME>
            <CON_ID>2737352</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2039</PREFERRED_NAME>
            <LONG_NAME>Bevacizumab</LONG_NAME>
            <CON_ID>2202398</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3535761</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C8510:C25275</PreferredName>
        <Version>1</Version>
        <LongName>Progressive Neoplastic Disease Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C8510</PREFERRED_NAME>
            <LONG_NAME>Progressive Neoplastic Disease</LONG_NAME>
            <CON_ID>3535760</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Progressive disease on frontl</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Progressive disease on frontline or maintenance Bevacizumab</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886752</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>For Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3891931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="754">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3563210</PUBLICID>
    <LONGNAME>Treatment Study Group Best Overall Response Date</LONGNAME>
    <PREFERREDNAME>TX_GP_BEST_RESP_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>Calendar date for the best overall disease response for a treatment group.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3563209</PublicId>
      <PreferredName>TX_GP_BEST_RESP_DT</PreferredName>
      <PreferredDefinition>Calendar date for the best summary disease response for a treatment group.</PreferredDefinition>
      <LongName>Treatment Study Group Best Overall Response Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3563202</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49656:C43359</PreferredName>
        <Version>1</Version>
        <LongName>Treatment Study Group</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49656</PREFERRED_NAME>
            <LONG_NAME>Treatment Study</LONG_NAME>
            <CON_ID>2480684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43359</PREFERRED_NAME>
            <LONG_NAME>Group</LONG_NAME>
            <CON_ID>2236516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3563207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25432:C25605:C50995:C25275</PreferredName>
        <Version>1</Version>
        <LongName>Best Overall Response Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25432</PREFERRED_NAME>
            <LONG_NAME>Best</LONG_NAME>
            <CON_ID>2206164</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25605</PREFERRED_NAME>
            <LONG_NAME>Overall</LONG_NAME>
            <CON_ID>2203597</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50995</PREFERRED_NAME>
            <LONG_NAME>Disease Response</LONG_NAME>
            <CON_ID>2459436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017121</PublicId>
      <PreferredName>CTMS_DT</PreferredName>
      <PreferredDefinition>Date as required for Clinical Trials Monitoring Service submissions.  Exchange format is YYYYMMDD.  Display format is DDMMMYYYY, with the month display the first three letters of each month (Jan, Feb, Mar, etc.).</PreferredDefinition>
      <LongName>CTMS Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>DD/MON/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of best overall response</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of best overall response per Treatment Group</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886752</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>For Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3891931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="755">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3600133</PUBLICID>
    <LONGNAME>Audit History Status Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>3599656v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A methodical examination or review of a condition or situation.:The aggregate of past events; the continuum of events occurring in succession leading from the past to the present; a record or narrative description of past events._A condition or state at a particular time.:A system, often of numbered categories, for representation of data._Reference concept defined by a referenced code system.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3599656</PublicId>
      <PreferredName>3599521v1.0:2607549v1.0</PreferredName>
      <PreferredDefinition>A methodical examination or review of a condition or situation.:The aggregate of past events; the continuum of events occurring in succession leading from the past to the present; a record or narrative description of past events._A condition or state at a particular time.:A system, often of numbered categories, for representation of data.</PreferredDefinition>
      <LongName>Audit History Status Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3599521</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45269:C54625</PreferredName>
        <Version>1</Version>
        <LongName>Audit History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45269</PREFERRED_NAME>
            <LONG_NAME>Audit</LONG_NAME>
            <CON_ID>2513261</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54625</PREFERRED_NAME>
            <LONG_NAME>History</LONG_NAME>
            <CON_ID>2519676</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607549</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Status Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Audit History Status Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Audit History Status Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000057</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3599505</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM FM</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AuditTrail:statusCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.AuditTrail.statusCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="756">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3600405</PUBLICID>
    <LONGNAME>Uniform Resource Identifier Image Reference Object Entity Have Image Physical Entity Statement Object Unique Identifier ISO21090.II.v1.0</LONGNAME>
    <PREFERREDNAME>3599867v1.0:2803193v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A character string that can identify any kind of resource on the Internet, including images, text, video, audio and programs.  The most commom type of a URI is a URL.:Any record of an imaging event whether physical or electronic.:Something referred to; the object of a reference.:An independently existing thing (living or nonliving).:Used to describe the possession, relationships, or the state of something or someone.:Any record of an imaging event whether physical or electronic.:Having substance or material existence; concerned with material things; of or pertaining to the body as distinguished from the mind or spirit.:A declaration of a relationship between entities, consisting of a subject, predicate and object._Something perceptible by one or more of the senses, especially by vision or touch; a material thing.:A set of characters used as a code that is unique in the context or the system for which it is created. It serves as a means of identification and reference (often instead of a name) for an entity, person, thing, function, procedure, activity, variable, or body of data._Identifier that uniquely identifies a thing or object.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3599867</PublicId>
      <PreferredName>3599529v1.0:3599617v1.0</PreferredName>
      <PreferredDefinition>A character string that can identify any kind of resource on the Internet, including images, text, video, audio and programs.  The most commom type of a URI is a URL.:Any record of an imaging event whether physical or electronic.:Something referred to; the object of a reference.:An independently existing thing (living or nonliving).:Used to describe the possession, relationships, or the state of something or someone.:Any record of an imaging event whether physical or electronic.:Having substance or material existence; concerned with material things; of or pertaining to the body as distinguished from the mind or spirit.:A declaration of a relationship between entities, consisting of a subject, predicate and object._Something perceptible by one or more of the senses, especially by vision or touch; a material thing.:A set of characters used as a code that is unique in the context or the system for which it is created. It serves as a means of identification and reference (often instead of a name) for an entity, person, thing, function, procedure, activity, variable, or body of data.</PreferredDefinition>
      <LongName>Uniform Resource Identifier Image Reference Object Entity Have Image Physical Entity Statement Object Unique Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3599529</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3599529v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Uniform Resource Identifier Image Reference Object Entity Have Image Physical Entity Statement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42778</PREFERRED_NAME>
            <LONG_NAME>Uniform Resource Identifier</LONG_NAME>
            <CON_ID>2236546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>7</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48294</PREFERRED_NAME>
            <LONG_NAME>Reference Object</LONG_NAME>
            <CON_ID>2388820</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C101282</PREFERRED_NAME>
            <LONG_NAME>Have</LONG_NAME>
            <CON_ID>3437377</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25618</PREFERRED_NAME>
            <LONG_NAME>Physical</LONG_NAME>
            <CON_ID>2203948</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C101134</PREFERRED_NAME>
            <LONG_NAME>Entity Statement</LONG_NAME>
            <CON_ID>3419462</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3599617</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45281:C70663</PreferredName>
        <Version>1</Version>
        <LongName>Object Unique Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45281</PREFERRED_NAME>
            <LONG_NAME>Object</LONG_NAME>
            <CON_ID>2233226</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70663</PREFERRED_NAME>
            <LONG_NAME>Unique Identifier</LONG_NAME>
            <CON_ID>2714899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803193</PublicId>
      <PreferredName>2803193v1.0</PreferredName>
      <PreferredDefinition>Identifier that uniquely identifies a thing or object.</PreferredDefinition>
      <LongName>ISO21090.II.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090IIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Uniform Resource Identifier Image Reference Object Entity Have Image Physical Entity Statement Object Unique Identifier ISO21090.II.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Uniform Resource Identifier Image Reference Object Entity Have Image Physical Entity Statement Object Unique Identifier ISO21090.II.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000057</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3599505</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM FM</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>UriImageReferenceEntityHasImagingPhysicalEntityStatement:objectUniqueIdentifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.UriImageReferenceEntityHasImagingPhysicalEntityStatement.objectUniqueIdentifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="757">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3600638</PUBLICID>
    <LONGNAME>DICOM Image Reference Entity Have Image Observation Entity Statement Object Unique Identifier ISO21090.II.v1.0</LONGNAME>
    <PREFERREDNAME>3600097v1.0:2803193v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A comprehensive set of standards for communications between medical imaging devices, including handling, storing and transmitting information in medical imaging. It includes a file format definition and a network communication protocol.:Any record of an imaging event whether physical or electronic.:A note acknowledging a source of information or quoting a passage.:An independently existing thing (living or nonliving).:Used to describe the possession, relationships, or the state of something or someone.:Any record of an imaging event whether physical or electronic.:Watching something and taking note of what happens.:A declaration of a relationship between entities, consisting of a subject, predicate and object._Something perceptible by one or more of the senses, especially by vision or touch; a material thing.:A set of characters used as a code that is unique in the context or the system for which it is created. It serves as a means of identification and reference (often instead of a name) for an entity, person, thing, function, procedure, activity, variable, or body of data._Identifier that uniquely identifies a thing or object.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3600097</PublicId>
      <PreferredName>3599530v1.0:3599617v1.0</PreferredName>
      <PreferredDefinition>A comprehensive set of standards for communications between medical imaging devices, including handling, storing and transmitting information in medical imaging. It includes a file format definition and a network communication protocol.:Any record of an imaging event whether physical or electronic.:A note acknowledging a source of information or quoting a passage.:An independently existing thing (living or nonliving).:Used to describe the possession, relationships, or the state of something or someone.:Any record of an imaging event whether physical or electronic.:Watching something and taking note of what happens.:A declaration of a relationship between entities, consisting of a subject, predicate and object._Something perceptible by one or more of the senses, especially by vision or touch; a material thing.:A set of characters used as a code that is unique in the context or the system for which it is created. It serves as a means of identification and reference (often instead of a name) for an entity, person, thing, function, procedure, activity, variable, or body of data.</PreferredDefinition>
      <LongName>DICOM Image Reference Entity Have Image Observation Entity Statement Object Unique Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3599530</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3599530v1.0</PreferredName>
        <Version>1</Version>
        <LongName>DICOM Image Reference Entity Have Image Observation Entity Statement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49059</PREFERRED_NAME>
            <LONG_NAME>DICOM</LONG_NAME>
            <CON_ID>2553610</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>7</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25641</PREFERRED_NAME>
            <LONG_NAME>Reference</LONG_NAME>
            <CON_ID>2206357</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C101282</PREFERRED_NAME>
            <LONG_NAME>Have</LONG_NAME>
            <CON_ID>3437377</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C101134</PREFERRED_NAME>
            <LONG_NAME>Entity Statement</LONG_NAME>
            <CON_ID>3419462</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3599617</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45281:C70663</PreferredName>
        <Version>1</Version>
        <LongName>Object Unique Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45281</PREFERRED_NAME>
            <LONG_NAME>Object</LONG_NAME>
            <CON_ID>2233226</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70663</PREFERRED_NAME>
            <LONG_NAME>Unique Identifier</LONG_NAME>
            <CON_ID>2714899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803193</PublicId>
      <PreferredName>2803193v1.0</PreferredName>
      <PreferredDefinition>Identifier that uniquely identifies a thing or object.</PreferredDefinition>
      <LongName>ISO21090.II.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090IIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element DICOM Image Reference Entity Have Image Observation Entity Statement Object Unique Identifier ISO21090.II.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element DICOM Image Reference Entity Have Image Observation Entity Statement Object Unique Identifier ISO21090.II.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000057</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3599505</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM FM</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DicomImageReferenceEntityHasImagingObservationEntityStatement:objectUniqueIdentifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.DicomImageReferenceEntityHasImagingObservationEntityStatement.objectUniqueIdentifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="758">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3622099</PUBLICID>
    <LONGNAME>Infection Anatomic Site Indicator</LONGNAME>
    <PREFERREDNAME>3621798v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not infection was present in the anatomic sites.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3621798</PublicId>
      <PreferredName>2526456v1.0:2186622v1.0</PreferredName>
      <PreferredDefinition>A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact._Named locations of, or within, the body.</PreferredDefinition>
      <LongName>Infection Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435011</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12219</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Structure, System, or Substance</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2526456</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C26726</PreferredName>
        <Version>1</Version>
        <LongName>Infection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26726</PREFERRED_NAME>
            <LONG_NAME>Infectious Disorder</LONG_NAME>
            <CON_ID>2203837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2186622</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify infection site(s):</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify infection site(s):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was an infection present at t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was an infection present at this site?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2039r1: Hemophagocytic Lymphohistiocytosis Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3279244</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>felh_base_diag_inf_bld_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>felh_base_diag_inf_csf_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>felh_base_diag_inf_oth_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>felh_base_diag_inf_tss_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>felh_base_diag_inf_urn_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="759">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3626549</PUBLICID>
    <LONGNAME>Assessment of Survivor Concerns Worry About Dying Score Likert Scale Text</LONGNAME>
    <PREFERREDNAME>3626159v1.0:3626258v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how much they worry about dying, using a Likert scale value captured as a non-enumerated text field.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ASC Based: Based on Assessment of Survivor Concerns</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3626159</PublicId>
      <PreferredName>3626140v1.0:3626157v1.0</PreferredName>
      <PreferredDefinition>A brief questionnaire designed to measure fears about recurrence and health in cancer survivors._A survey question about whether a person worries about dying._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Assessment of Survivor Concerns Worry About Dying Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3626140</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C103247</PreferredName>
        <Version>1</Version>
        <LongName>Assessment of Survivor Concerns</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C103247</PREFERRED_NAME>
            <LONG_NAME>Assessment of Survivor Concerns</LONG_NAME>
            <CON_ID>3625812</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3626157</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C91212:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Worry Dying Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91212</PREFERRED_NAME>
            <LONG_NAME>Worry About Dying Question</LONG_NAME>
            <CON_ID>3124832</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ASC:Assessment of Survivor Concerns Gotay CC &amp; Pagano IS. Health Qual Life Outcomes. 2007 Mar 13;5:15</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3626258</PublicId>
      <PreferredName>3626258v1.0</PreferredName>
      <PreferredDefinition>A psychometric scale commonly used in questionnaires where a respondent is asked to evaluate an opinion according to subjective or objective criteria, by rating their level of agreement or disagreement with a statement._Text; the words of something written.</PreferredDefinition>
      <LongName>Likert Scale Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3626257</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C85429:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Likert Scale Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85429</PREFERRED_NAME>
            <LONG_NAME>Likert Scale</LONG_NAME>
            <CON_ID>2971959</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Nonenumerated Value Domain Use</Name>
        <DocumentType>NOTE</DocumentType>
        <DocumentText>Based on need of NCI Alliance LPO and approved by Dr. Jeff Sloan.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I worry about dying</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I worry about dying</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3626149</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ASC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ASC Text Format</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3626269</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="760">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3645522</PUBLICID>
    <LONGNAME>Agent Pertuzumab Administered Yes No Indicator</LONGNAME>
    <PREFERREDNAME>3645339v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether Pertuzumab was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3645339</PublicId>
      <PreferredName>2223333v1.0:3645337v1.0</PreferredName>
      <PreferredDefinition>information related to the administration of the agent Pertuzumab (a humanized recombinant monoclonal antibody directed against the extracellular dimerization domain of the HER-2 tyrosine kinase receptor) to a patient.</PreferredDefinition>
      <LongName>Agent Pertuzumab Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223333</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1708</PreferredName>
        <Version>1</Version>
        <LongName>Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3645337</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38692:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Pertuzumab Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38692</PREFERRED_NAME>
            <LONG_NAME>Pertuzumab</LONG_NAME>
            <CON_ID>3378886</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pertuzumab</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pertuzumab</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient ever take pertuzumab</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was pertuzumab administered during this cycle</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3645339v1.0:3506068v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="761">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3646360</PUBLICID>
    <LONGNAME>Beck Depression Inventory Seven Past Day Confidence True Score Scale</LONGNAME>
    <PREFERREDNAME>BECK_CONFDCE_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric response to a questionnaire item asking an individual about statements describing confidence.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3630770</PublicId>
      <PreferredName>BECK_7D_CONF_SC</PreferredName>
      <PreferredDefinition>A twenty-one question survey completed by a patient, with each answer scored on a scale of 0 to 3, designed to measure presence of depression._A natural number greater than 6 and less than 8 and the quantity that it denotes: the sum of six and one.:Before the present time.:The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day._A feeling of trust (in someone or something)..:A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Beck Depression Inventory Seven Past Day Confidence True Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2665184</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C40438</PreferredName>
        <Version>1</Version>
        <LongName>Beck Depression Inventory</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40438</PREFERRED_NAME>
            <LONG_NAME>Beck Depression Inventory</LONG_NAME>
            <CON_ID>2665182</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3630768</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3630768v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Seven Past Day Confidence Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66838</PREFERRED_NAME>
            <LONG_NAME>Seven</LONG_NAME>
            <CON_ID>2689988</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25301</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2202680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43367</PREFERRED_NAME>
            <LONG_NAME>Confidence</LONG_NAME>
            <CON_ID>2236609</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3631117</PublicId>
      <PreferredName>BECK_CONF_SCL</PreferredName>
      <PreferredDefinition>an ordered reference standard.</PreferredDefinition>
      <LongName>Beck Depression Inventory Confidence Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>I dislike myself.</VALUEMEANING>
          <MEANINGDESCRIPTION>I dislike myself.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-11-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3631118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>I feel the same about myself as ever.</VALUEMEANING>
          <MEANINGDESCRIPTION>I feel the same about myself as ever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-11-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3631121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>I am disappointed in myself.</VALUEMEANING>
          <MEANINGDESCRIPTION>I am disappointed in myself.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-11-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3631119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>I have lost confidence in myself.</VALUEMEANING>
          <MEANINGDESCRIPTION>I have lost confidence in myself.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-11-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3684456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>7.</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>7.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="762">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3647707</PUBLICID>
    <LONGNAME>Patient Cervical Carcinoma Diagnosis Clinical Trial Eligibility Criteria Yes No Indicator</LONGNAME>
    <PREFERREDNAME>Pati_Cerv_Diag_Clin_YES_NO_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial regarding if a person receiving medical care, or treatment has the investigation, analysis and recognition of the presence of cervical carcinoma.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3647706</PublicId>
      <PreferredName>Pati_Cerv_Diag_Clin</PreferredName>
      <PreferredDefinition>information related to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial regarding if a person receiving medical care, or treatment has the investigation, analysis and recognition of the presence of cervical carcinoma.</PreferredDefinition>
      <LongName>Patient Cervical Carcinoma Diagnosis Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3647704</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9039:C15220:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Cervical Carcinoma Diagnosis Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9039</PREFERRED_NAME>
            <LONG_NAME>Cervical Carcinoma</LONG_NAME>
            <CON_ID>2753328</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does the patient have primary</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does the patient have primary, previously untreated, histologically confirmed, locoregionally advanced invasive cervical carcinoma?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have histologically confirmed advanced cervical cancer</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_eCRF_Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have histologically confirmed newly diagnosed advanced cervical cancer (squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have pathologically confirmed newly diagnosed cervical cancer?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0221</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104880</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Pati_Cerv_Diag_Clin_YES_NO_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="763">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3652136</PUBLICID>
    <LONGNAME>Hot Flash Related Daily Interference Past Week Enjoyment of Life Score 11 Point Scale</LONGNAME>
    <PREFERREDNAME>3651244v1.0:3650056v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how much in the past week hot flashes have interfered with their enjoyment of life, using an eleven point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HFRDIS:Hot Flash Related Daily Interference Scale</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3651244</PublicId>
      <PreferredName>3651220v1.0:3651274v1.0</PreferredName>
      <PreferredDefinition>A tool designed to measure the impact of hot flashes on overall quality of life as well as nine specific activities using a 10 point Likert scale._The most recent week, including today._The level of happiness or contentment that an individual professes, or is observed to display with regards to their life situation._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Hot Flash Related Daily Interference Past Week Enjoyment of Life Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3651220</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C104044</PreferredName>
        <Version>1</Version>
        <LongName>Hot Flash Related Daily Interference Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104044</PREFERRED_NAME>
            <LONG_NAME>Hot Flash Related Daily Inference Scale</LONG_NAME>
            <CON_ID>3651219</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3651274</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C104080:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Enjoyment of Life Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104080</PREFERRED_NAME>
            <LONG_NAME>Enjoyment of Life</LONG_NAME>
            <CON_ID>3649922</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HFRDIS:Hot Flash Related Daily Interference Scale</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3650056</PublicId>
      <PreferredName>3650056v1.0</PreferredName>
      <PreferredDefinition>The act of hindering or obstructing or impeding._A number or range of numeric values measuring performance, function, quality, or ability._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The precise location of something; a spatially limited location._an ordered reference standard.</PreferredDefinition>
      <LongName>Interference Score 11 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>10</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>HFRDIS:Hot Flash Related Daily Interference Scale</Origin>
      <Representation>
        <PublicId>3650055</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3650055v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Interference Score Integer::11 Point Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C72886</PREFERRED_NAME>
            <LONG_NAME>Interference</LONG_NAME>
            <CON_ID>2734007</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70656</PREFERRED_NAME>
            <LONG_NAME>Point</LONG_NAME>
            <CON_ID>2710246</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Does Not Interfere To Completely Interferes Likert Score 4</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of hindering or obstructing or impeding.: Used as a function word to indicate direction, purpose, or movement.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: The act of hindering or obstructing or impeding.: A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: A subjective score of 4 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91293, C38013, C45255::11, C72886, C25250, C65107, C72886, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6, 7</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3651259</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Does Not Interfere To Completely Interferes Likert Score 5</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of hindering or obstructing or impeding.: Used as a function word to indicate direction, purpose, or movement.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: The act of hindering or obstructing or impeding.: A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: A subjective score of 5 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91294, C38013, C45255::11, C72886, C25250, C65107, C72886, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6, 7</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3651261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Does Not Interfere To Completely Interferes Likert Score 7</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of hindering or obstructing or impeding.: Used as a function word to indicate direction, purpose, or movement.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: The act of hindering or obstructing or impeding.: A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: A subjective score of 7 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103508, C38013, C45255::11, C72886, C25250, C65107, C72886, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6, 7</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3651262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Does Not Interfere To Completely Interferes Likert Score 8</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of hindering or obstructing or impeding.: Used as a function word to indicate direction, purpose, or movement.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: The act of hindering or obstructing or impeding.: A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: A subjective score of 8 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103509, C38013, C45255::11, C72886, C25250, C65107, C72886, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6, 7</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3651263</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Does Not Interfere To Completely Interferes Likert Score 9</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of hindering or obstructing or impeding.: Used as a function word to indicate direction, purpose, or movement.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: The act of hindering or obstructing or impeding.: A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: A subjective score of 9 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103510, C38013, C45255::11, C72886, C25250, C65107, C72886, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6, 7</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3651264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Does Not Interfere</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of hindering or obstructing or impeding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C72886, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3650057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Does Not Interfere To Completely Interferes Likert Score 1</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of hindering or obstructing or impeding.: Used as a function word to indicate direction, purpose, or movement.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: The act of hindering or obstructing or impeding.: The difference between the lowest and highest numerical values; the limits or scale of variation.: A subjective score of 1 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103506, C38013, C72886, C25250, C65107, C72886, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3650058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>Completely Interferes</VALUEMEANING>
          <MEANINGDESCRIPTION>To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: The act of hindering or obstructing or impeding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C72886, C25250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3650059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Does Not Interfere To Completely Interferes Likert Score 2</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of hindering or obstructing or impeding.: Used as a function word to indicate direction, purpose, or movement.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: The act of hindering or obstructing or impeding.: A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: A subjective score of 2 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91291, C38013, C45255::11, C72886, C25250, C65107, C72886, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6, 7</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3650060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Does Not Interfere To Completely Interferes Likert Score 3</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of hindering or obstructing or impeding.: Used as a function word to indicate direction, purpose, or movement.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: The act of hindering or obstructing or impeding.: A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: A subjective score of 3 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91292, C38013, C45255::11, C72886, C25250, C65107, C72886, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6, 7</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3650061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Does Not Interfere To Completely Interferes Likert Score 6</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of hindering or obstructing or impeding.: Used as a function word to indicate direction, purpose, or movement.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: The act of hindering or obstructing or impeding.: A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: A subjective score of 6 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103507, C38013, C45255::11, C72886, C25250, C65107, C72886, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6, 7</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3650063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Enjoyment of life</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Enjoyment of life</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3638606</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HFRDIS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HFRDIS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3638607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="764">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3673382</PUBLICID>
    <LONGNAME>Radiation Therapy Breast Carcinoma Medical Device Tissue-Equivalent Biomedical Material Thickness Administered Measurement</LONGNAME>
    <PREFERREDNAME>BOLUS_THICKNESS</PREFERREDNAME>
    <PREFERREDDEFINITION>the thickness of the bolus (a biomedical material applied to the surface of the skin to increase the radiation dose at the skin surface) used during radiation therapy for breast carcinoma.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3673380</PublicId>
      <PreferredName>2403872v1.0:3673378v1.0</PreferredName>
      <PreferredDefinition>information related to the administration of breast carcinoma (a carcinoma arising from the breast) radiation therapy and the thickness (the dimension between two surfaces of an object) of a tissue-equivalent (a substance equal to in effect or significance to an anatomical structure consisting of similarly specialized cells and intercellular matrix) biomedical material (any substance other than pharmacologic substance used in biomedical research or in constructing devices or prostheses) applied to the surface of the skin to increase the radiation dose at the skin surface of a patient.</PreferredDefinition>
      <LongName>Radiation Therapy Breast Carcinoma Medical Device Tissue-Equivalent Biomedical Material Thickness Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2403872</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15313</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3673378</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3673378v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Breast Carcinoma Medical Device Tissue Equivalent Biomaterials Thickness Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4872</PREFERRED_NAME>
            <LONG_NAME>Breast Carcinoma</LONG_NAME>
            <CON_ID>2475940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16830</PREFERRED_NAME>
            <LONG_NAME>Medical Device</LONG_NAME>
            <CON_ID>2240760</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12801</PREFERRED_NAME>
            <LONG_NAME>Tissue</LONG_NAME>
            <CON_ID>2202489</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48793</PREFERRED_NAME>
            <LONG_NAME>Equivalent</LONG_NAME>
            <CON_ID>2552426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16338</PREFERRED_NAME>
            <LONG_NAME>Biomedical Material</LONG_NAME>
            <CON_ID>2202681</CON_ID>
            <DEFINITION_SOURCE>CSP2000</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41145</PREFERRED_NAME>
            <LONG_NAME>Thickness</LONG_NAME>
            <CON_ID>2413316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3673381</PublicId>
      <PreferredName>3673381v1.0</PreferredName>
      <PreferredDefinition>the thickness of the bolus (a biomedical material applied to the surface of the skin to increase the radiation dose at the skin surface) used during radiation therapy for breast carcinoma.</PreferredDefinition>
      <LongName>Radiation Therapy Breast Carcinoma Biomedical Material Thickness Administered Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>mm</UnitOfMeasure>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</Origin>
      <Representation>
        <PublicId>2184312</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25209</PreferredName>
        <Version>1</Version>
        <LongName>Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Bolus thickness</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Bolus thickness</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="765">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3684458</PUBLICID>
    <LONGNAME>EORTC QLQ-G.I.NET21 Past Week Have Hot Flushes Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>3682597v1.0:3654523v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated perception of how often they had hot flushes during the past week, using a four point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>EORTC QLQ-GI.NET21:European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Gastrointestinal Net21</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3682597</PublicId>
      <PreferredName>3682594v1.0:3682595v1.0</PreferredName>
      <PreferredDefinition>The aims of the European Organisation for Research and Treatment of Cancer (EORTC) are to conduct, develop, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients&#39; quality of life. There are more than 60 institutions and departments that have been recognized by EORTC as affiliated. These groups conduct, on a voluntary basis, laboratory research and/or clinical trials on all types of cancers using a multidisciplinary approach. EORTC maintains close working relationship with NCI and the British Cancer Research United Kingdom in London._A questionnaire intended for use among patients with gastrointestinal-related neuroendocrine tumors, who vary in disease stage and treatments._The most recent week, including today._A question about whether an individual has or had hot flushes._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>EORTC QLQ-G.I.NET21 Past Week Have Hot Flushes Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3682594</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19741:C104319</PreferredName>
        <Version>1</Version>
        <LongName>European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Gastrointestinal Neuroendocrine Tumors 21</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19741</PREFERRED_NAME>
            <LONG_NAME>European Organization for Research and Treatment of Cancer</LONG_NAME>
            <CON_ID>2205056</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104319</PREFERRED_NAME>
            <LONG_NAME>Quality of Life Questionnaire - Gastrointestinal Neuroendocrine Tumors 21</LONG_NAME>
            <CON_ID>3680537</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3682595</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C104318:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Have Hot Flushes Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104318</PREFERRED_NAME>
            <LONG_NAME>Have Hot Flashes Question</LONG_NAME>
            <CON_ID>3680523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>EORTC QLQ-GI.NET21:European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Gastrointestinal Net21</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3654523</PublicId>
      <PreferredName>3654523v1.0</PreferredName>
      <PreferredDefinition>A psychometric scale commonly used in questionnaires where a respondent is asked to evaluate an opinion according to subjective or objective criteria, by rating their level of agreement or disagreement with a statement._How much there is of something that you can measure; the total amount or number._A number or range of numeric values measuring performance, function, quality, or ability._A number with no fractional part, including the negative and positive numbers as well as zero.::4_The precise location of something; a spatially limited location._an ordered reference standard.</PreferredDefinition>
      <LongName>How Much Score 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>3654522</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3654522v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Likert Scale Quantity Score Integer::4 Point Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85429</PREFERRED_NAME>
            <LONG_NAME>Likert Scale</LONG_NAME>
            <CON_ID>2971959</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70656</PREFERRED_NAME>
            <LONG_NAME>Point</LONG_NAME>
            <CON_ID>2710246</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>3144289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a great amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>3144292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did you have hot flushes?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did you have hot flushes?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3654497</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>EORTC QLQ</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EORTC QLQ-GI.NET21</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5138854</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Q31_EORTC_QLQ_GINET</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="766">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3687447</PUBLICID>
    <LONGNAME>Breast Cancer Family History Incidence Comparison Scale</LONGNAME>
    <PREFERREDNAME>3079289v1.0:3687446v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Comparison scale of breast cancer incidence in the family</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3079289</PublicId>
      <PreferredName>2475941v1.0:3079287v1.0</PreferredName>
      <PreferredDefinition>Family; a domestic group, or a number of domestic groups linked through descent (demonstrated or stipulated) from a common ancestor, marriage, or adoption._The aggregate of past events; the continuum of events occurring in succession leading from the past to the present; a record or narrative description of past events._A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter&#39;s syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002</PreferredDefinition>
      <LongName>Breast Cancer Family History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2475941</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4872</PreferredName>
        <Version>1</Version>
        <LongName>Breast Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4872</PREFERRED_NAME>
            <LONG_NAME>Breast Carcinoma</LONG_NAME>
            <CON_ID>2475940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3079287</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25173:C54625</PreferredName>
        <Version>1</Version>
        <LongName>Family History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25173</PREFERRED_NAME>
            <LONG_NAME>Family</LONG_NAME>
            <CON_ID>2202639</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54625</PREFERRED_NAME>
            <LONG_NAME>History</LONG_NAME>
            <CON_ID>2519676</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3687446</PublicId>
      <PreferredName>3687446v1.0</PreferredName>
      <PreferredDefinition>The number of new cases of a disease diagnosed each year._The examination of two or more people or things in order to detect similarities and differences._an ordered reference standard.</PreferredDefinition>
      <LongName>Incidence Comparison Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3687445</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16726:C49156:C25664</PreferredName>
        <Version>1</Version>
        <LongName>Incidence Comparison Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16726</PREFERRED_NAME>
            <LONG_NAME>Incidence</LONG_NAME>
            <CON_ID>2223206</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49156</PREFERRED_NAME>
            <LONG_NAME>Comparison</LONG_NAME>
            <CON_ID>2528577</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Same</VALIDVALUE>
          <VALUEMEANING>Same</VALUEMEANING>
          <MEANINGDESCRIPTION>Equal, or closely similar or comparable, in kind or quality or quantity or degree. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3408913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Don&#39;t Know</VALIDVALUE>
          <VALUEMEANING>Don&#39;t Know/Refused</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Less</VALIDVALUE>
          <VALUEMEANING>&lt;45</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status._The natural number greater than forty-four and less than forty-six and the quantity that it denotes._The length of a person&#39;s life, stated in years since birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C175677, C61585, C37908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 2, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2960757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>More</VALIDVALUE>
          <VALUEMEANING>Greater Than</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3134509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How do you think the amount o</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How do you think the amount of breast cancer in your family compares with other families; do you have more than average, about the same, or less than average?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="767">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3689375</PUBLICID>
    <LONGNAME>Infertility Treatment  Indicator</LONGNAME>
    <PREFERREDNAME>2436694v1.0:3270332v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An action or administration of therapeutic agents to produce an effect that is intended to alter a woman&#39;s inability to produce children._The affirmative response to a question or activity._The non-affirmative response to a question._The answer is not known by the person answering._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2436694</PublicId>
      <PreferredName>INFTL_TX</PreferredName>
      <PreferredDefinition>An action or administration of therapeutic agents to produce an effect that is intended to alter a woman&#39;s inability to produce children.</PreferredDefinition>
      <LongName>Infertility Treatment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2436692</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3836</PreferredName>
        <Version>1</Version>
        <LongName>Infertility</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3836</PREFERRED_NAME>
            <LONG_NAME>Infertility</LONG_NAME>
            <CON_ID>2203765</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2324753</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15368</PreferredName>
        <Version>1</Version>
        <LongName>Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3270332</PublicId>
      <PreferredName>3270332v1.0</PreferredName>
      <PreferredDefinition>The affirmative response to a question or activity._The non-affirmative response to a question._The answer is not known by the person answering._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Yes No Does Not Know Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3270331</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C67142:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Does Not Know Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67142</PREFERRED_NAME>
            <LONG_NAME>Does Not Know</LONG_NAME>
            <CON_ID>2653836</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Don&#39;t know</VALIDVALUE>
          <VALUEMEANING>Don&#39;t Know/Refused</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you taken a drug for inf</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you taken a drug for infertility (to try to become pregnant)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="768">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3691914</PUBLICID>
    <LONGNAME>Agent Change Day Count</LONGNAME>
    <PREFERREDNAME>DAYSCHG</PREFERREDNAME>
    <PREFERREDDEFINITION>the number of days related to the act of alteration or modification of an agent that produces a specific effect.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2186047</PublicId>
      <PreferredName>2223333v1.0:2239855v1.0</PreferredName>
      <PreferredDefinition>The act of alteration or modification of an agent, an active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.</PreferredDefinition>
      <LongName>Agent Change</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223333</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1708</PreferredName>
        <Version>1</Version>
        <LongName>Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446</PreferredName>
        <Version>1</Version>
        <LongName>Change</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018594</PublicId>
      <PreferredName>D_CT</PreferredName>
      <PreferredDefinition>the quantity of days.</PreferredDefinition>
      <LongName>Day Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2207941</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25301:C25463</PreferredName>
        <Version>1</Version>
        <LongName>Day Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25301</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2202680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total number of days omitted</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Total number of days omitted</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Total number of days missed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of days missed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DAYSCHG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="769">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3704271</PUBLICID>
    <LONGNAME>MD Anderson Symptom Inventory Head and Neck Past 24 Hours Severity Mouth or Throat Sores at its Worst Score 11 Point Likert Scale</LONGNAME>
    <PREFERREDNAME>MDASIHN_P24HSV_SORWST_11PT_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated perception of the severity of their mouth or throat sores at the worst in the last 24 hours, using an eleven-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MDASI:M.D. Anderson Symptom Inventory, Cleeland et al., 2000</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3704085</PublicId>
      <PreferredName>3698757v1.0:3704083v1.0</PreferredName>
      <PreferredDefinition>A self-administered questionnaire designed specifically for evaluating the severity of symptoms related to head and neck cancer._Past; before the present time._A number with no fractional part, including the negative and positive numbers as well as zero.::24_In modern usage, an hour is defined as a unit of time 60 minutes, or 3600 seconds in length. It is approximately 1/24 of a median day._Severity; used of the degree of something undesirable e.g. pain or weather._A question about an individual&#39;s mouth or throat sores at its worst._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>MD Anderson Symptom Inventory Head and Neck Past 24 Hours Severity Mouth or Throat Sores at its Worst Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3698757</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C105551</PreferredName>
        <Version>1</Version>
        <LongName>MD Anderson Symptom Inventory - Head and Neck</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C105551</PREFERRED_NAME>
            <LONG_NAME>MD Anderson Symptom Inventory - Head and Neck</LONG_NAME>
            <CON_ID>3698694</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3704083</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3704083v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Past Integer::24 Hour Severity Mouth or Throat Sores at its Worst Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::24</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25529</PREFERRED_NAME>
            <LONG_NAME>Hour</LONG_NAME>
            <CON_ID>2203682</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C105550</PREFERRED_NAME>
            <LONG_NAME>Mouth or Throat Sores at its Worst Question</LONG_NAME>
            <CON_ID>3698705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MDASI:M.D. Anderson Symptom Inventory, Cleeland et al., 2000</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3698754</PublicId>
      <PreferredName>3698754v1.0</PreferredName>
      <PreferredDefinition>Subjective evidence of disease perceived by the patient._Used of the degree of something undesirable e.g. pain or weather; also, strictness._A number or range of numeric values measuring performance, function, quality, or ability._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The precise location of something; a spatially limited location._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Symptom Severity Score 11 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>10</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>MDASI:M.D. Anderson Symptom Inventory, Cleeland et al., 2000</Origin>
      <Representation>
        <PublicId>3704131</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3704131v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Symptom Severity Score Integer::11 Point Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70656</PREFERRED_NAME>
            <LONG_NAME>Point</LONG_NAME>
            <CON_ID>2710246</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 2</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 2 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91291, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 3</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 3 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91292, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 4</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 4 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91293, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 5</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 5 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91294, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 6</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 6 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103507, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 7</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 7 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103508, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 8</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 8 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103509, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704143</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Absent To As Bad as You Can Imagine 11 Range Likert Score 9</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 9 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103510, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not Present To As Bad as You Can Imagine 11 Range Likert Score 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time._Used as a function word to indicate direction, purpose, or movement._A response indicating the something is as bad as can be expected or imagined._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The difference between the lowest and highest numerical values; the limits or scale of variation._A subjective score of 1 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103506, C38013, C45255::11, C104610, C65107, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>As Bad as You Can Imagine</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating the something is as bad as can be expected or imagined.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Your mouth/throat sores at th</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Your mouth/throat sores at their WORST?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5024211</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MD Anderson Measures</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDASI-HN (M.D. Anderson Symptom Inventory - Head &amp; Neck)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5024232</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MD Anderson Symptom Inventory-HN (MDASI-HN)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918054</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="770">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3725273</PUBLICID>
    <LONGNAME>Lymphedema and Breast Cancer Questionnaire During Past Year Have Aching Experience Indicator</LONGNAME>
    <PREFERREDNAME>3722555v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated perception of whether or not during the past year they have or had aching in their arm, breast, or chest, using a yes or no indicator.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>LBCQ: Lymphedema and Breast Cancer Questionnaire, Jane M. Armer</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3722555</PublicId>
      <PreferredName>3718831v1.0:3722553v1.0</PreferredName>
      <PreferredDefinition>A condensed version of a self-administered or structured interview questionnaire designed specifically for evaluating lymphedema symptoms after surgery for breast cancer._At some point in a given period of time._Past; before the present time._The period of time that it takes for Earth to make a complete revolution around the sun; a period of time containing 365 days._A question about whether an individual has or had aching._The accumulation of knowledge or skill that results from direct participation in events or activities.</PreferredDefinition>
      <LongName>Lymphedema and Breast Cancer Questionnaire During Past Year Have Aching Experience</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3718831</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C105763</PreferredName>
        <Version>1</Version>
        <LongName>Lymphedema and Breast Cancer Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C105763</PREFERRED_NAME>
            <LONG_NAME>Lymphedema and Breast Cancer Questionnaire</LONG_NAME>
            <CON_ID>3715997</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3722553</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3722553v1.0</PreferredName>
        <Version>1</Version>
        <LongName>During Past Year Have Aching Experience</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29848</PREFERRED_NAME>
            <LONG_NAME>Year</LONG_NAME>
            <CON_ID>2203986</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C105779</PREFERRED_NAME>
            <LONG_NAME>Have Aching Question</LONG_NAME>
            <CON_ID>3715841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54627</PREFERRED_NAME>
            <LONG_NAME>Experience</LONG_NAME>
            <CON_ID>2731931</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>LBCQ: Lymphedema and Breast Cancer Questionnaire, Jane M. Armer</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you experienced aching d</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you experienced aching during the past year?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3704455</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LBCQ</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LBCQ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3704456</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="771">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3733194</PUBLICID>
    <LONGNAME>Patient Myeloid Clinical Trial Eligibility Criteria Yes No Indicator</LONGNAME>
    <PREFERREDNAME>PtMldIND2</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator related to a patient&#39;s non-lymphocyte white blood cells found in the bone marrow to allow an individual to participate in a clinical trial..</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3733193</PublicId>
      <PreferredName>PtMld</PreferredName>
      <PreferredDefinition>information related to a patient&#39;s non-lymphocyte white blood cells found in the bone marrow to allow an individual to participate in a clinical trial.</PreferredDefinition>
      <LongName>Patient Myeloid Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3738936</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13349:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Myeloid Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13349</PREFERRED_NAME>
            <LONG_NAME>Myeloid</LONG_NAME>
            <CON_ID>2459024</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have any circula</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have any circulating myeloid precursors?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="772">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3760752</PUBLICID>
    <LONGNAME>Statistics Analysis Plan Version Status Date and Time ISO21090.TS.DATETIME.v1.0</LONGNAME>
    <PREFERREDNAME>3759978v1.0:3148148v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The date that the statistical analysis plan version entered the current status.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3759978</PublicId>
      <PreferredName>3757167v1.0:2437776v1.0</PreferredName>
      <PreferredDefinition>A branch of applied mathematics concerned with the collection and interpretation of quantitative data and the use of probability theory to estimate population parameters.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:To devise, contrive, or form in design.:A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications.:A condition or state at a particular time._An expression of both date and time that an event has happened or will happened.</PreferredDefinition>
      <LongName>Statistics Analysis Plan Version Status Date and Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3757167</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3757167v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Statistics Analysis Plan Version Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17167</PREFERRED_NAME>
            <LONG_NAME>Statistics</LONG_NAME>
            <CON_ID>2542369</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25619</PREFERRED_NAME>
            <LONG_NAME>Plan</LONG_NAME>
            <CON_ID>2203947</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2437776</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date and Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3148148</PublicId>
      <PreferredName>3148148v1.0</PreferredName>
      <PreferredDefinition>Constrains TS so that it&#39;s precision can not be more precise than seconds.</PreferredDefinition>
      <LongName>ISO21090.TS.DATETIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090TSDTTIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Statistics Analysis Plan Version Status Date and Time ISO21090.TS.DATETIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Statistics Analysis Plan Version Status Date and Time ISO21090.TS.DATETIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StatisticalAnalysisSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StatisticalAnalysisPlanVersionStatus:date</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StatisticalAnalysisSubDomain.StatisticalAnalysisPlanVersionStatus.date</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StatisticalAnalysisPlanVersion.versionDate</AlternateName>
        <AlternateNameType>Map:Statistics v1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="773">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3761001</PUBLICID>
    <LONGNAME>Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity Repeat Frequency Ratio ISO21090.RTO.INT.NONNEG,PQ.TIME.v1.0</LONGNAME>
    <PREFERREDNAME>3175477v1.0:3152483v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity defined at a global library level that identifies one of a set of conditions that a subject must meet in order to participate in a study, or that a study subject must meet into order to participate in a certain part of the study. A ratio representing the number of occurrences of an activity within a given time period. EXAMPLE(S): Once per 12 hours, 2 times per day.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175477</PublicId>
      <PreferredName>3174207v1.0:3174538v1.0</PreferredName>
      <PreferredDefinition>Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.:Watching something and taking note of what happens.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._Make or do or perform again.:The number of occurrences of something within a given time period.:Quotient of quantities of the same kind for different components within the same system.</PreferredDefinition>
      <LongName>Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity Repeat Frequency Ratio</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174207v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3174538</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47886:C25515:C44256</PreferredName>
        <Version>1</Version>
        <LongName>Repeat Frequency Ratio</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47886</PREFERRED_NAME>
            <LONG_NAME>Repeat</LONG_NAME>
            <CON_ID>2415563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44256</PREFERRED_NAME>
            <LONG_NAME>Ratio</LONG_NAME>
            <CON_ID>2230969</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3152483</PublicId>
      <PreferredName>3152483v1.0</PreferredName>
      <PreferredDefinition>Quantity quotient of a numerator of type INT.NONNEG divided by a denominator of type PQ.TIME.</PreferredDefinition>
      <LongName>ISO21090.RTO.INT.NONNEG,PQ.TIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090RTOv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity Repeat Frequency Ratio ISO21090.RTO.INT.NONNEG,PQ.TIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Clinical Trial Eligibility Criteria Observation Reuse Template Study Activity Repeat Frequency Ratio ISO21090.RTO.INT.NONNEG,PQ.TIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.DefinedEligibilityCriterion.repeatFrequencyRatio</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedEligibilityCriterion:repeatFrequencyRatio</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="774">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3761145</PUBLICID>
    <LONGNAME>Administration Reuse Template Study Activity Repeat Frequency Ratio ISO21090.RTO.INT.NONNEG,PQ.TIME.v1.0</LONGNAME>
    <PREFERREDNAME>3175028v1.0:3152483v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity defined at a global library level that is not directly related to hypothesis evaluation or testing, but is typically essential to the efficient and/or effective coordination and execution of a study. EXAMPLE(S): assignment to a treatment arm, registration to a study, start of on-study period, end of on-study period, obtain informed consent, verify eligibility criteria, enroll, randomize, complete study visits, exit trial, break treatment blind, protocol violation, premature withdrawal A ratio representing the number of occurrences of an activity within a given time period. EXAMPLE(S): Once per 12 hours, 2 times per day</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175028</PublicId>
      <PreferredName>3174174v1.0:3174538v1.0</PreferredName>
      <PreferredDefinition>Performing or possessing executive duties; acting as a supervisor or manager.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._Make or do or perform again.:The number of occurrences of something within a given time period.:Quotient of quantities of the same kind for different components within the same system.</PreferredDefinition>
      <LongName>Administration Reuse Template Study Activity Repeat Frequency Ratio</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174174</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174174v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Administration Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48905</PREFERRED_NAME>
            <LONG_NAME>Administration, Management</LONG_NAME>
            <CON_ID>2528523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3174538</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47886:C25515:C44256</PreferredName>
        <Version>1</Version>
        <LongName>Repeat Frequency Ratio</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47886</PREFERRED_NAME>
            <LONG_NAME>Repeat</LONG_NAME>
            <CON_ID>2415563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44256</PREFERRED_NAME>
            <LONG_NAME>Ratio</LONG_NAME>
            <CON_ID>2230969</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3152483</PublicId>
      <PreferredName>3152483v1.0</PreferredName>
      <PreferredDefinition>Quantity quotient of a numerator of type INT.NONNEG divided by a denominator of type PQ.TIME.</PreferredDefinition>
      <LongName>ISO21090.RTO.INT.NONNEG,PQ.TIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090RTOv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Administration Reuse Template Study Activity Repeat Frequency Ratio ISO21090.RTO.INT.NONNEG,PQ.TIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Administration Reuse Template Study Activity Repeat Frequency Ratio ISO21090.RTO.INT.NONNEG,PQ.TIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedAdministrativeActivity:repeatFrequencyRatio</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.DefinedAdministrativeActivity.repeatFrequencyRatio</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="775">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3761250</PUBLICID>
    <LONGNAME>Data Monitoring Committee Responsibility Document Version Keyword Code ISO21090.DSET.CD.v1.0</LONGNAME>
    <PREFERREDNAME>3760456v1.0:2803321v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A key document that, together with the study protocol and Statistical Analysis Plan (SAP), prospectively defines the study&#39;s Data Monitoring Committee (DMC) infrastructure and, in particular, the DMC&#39;s responsibilities; stipulates who sees blinded results and who sees unblinded results; and establishes a method for communication between the DMC and the sponsor. A coded value specifying the words or phrases that best describe the document and/or its context. Keywords help users find documents of interest. EXAMPLE(S): species, indication, biocompatibility, drug substance, drug product.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3760456</PublicId>
      <PreferredName>3757160v1.0:2867935v1.0</PreferredName>
      <PreferredDefinition>A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.:The act of observing something (and sometimes keeping a record of it).:A group delegated to consider some matter; a self-constituted organization to promote something.:A duty, obligation, or burden; something for which one is responsible.:A physical object, or electronic counterpart, that is characterized by containing writing which is meant to be human-readable.:A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications._A small set of words designed to convey the subject of a technical article.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Data Monitoring Committee Responsibility Document Version Keyword Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3757160</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3757160v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Data Monitoring Committee Responsibility Document Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61256</PREFERRED_NAME>
            <LONG_NAME>Monitoring</LONG_NAME>
            <CON_ID>2691603</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78508</PREFERRED_NAME>
            <LONG_NAME>Study Related Committee</LONG_NAME>
            <CON_ID>2867572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C90023</PREFERRED_NAME>
            <LONG_NAME>Responsibility</LONG_NAME>
            <CON_ID>3114658</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19498</PREFERRED_NAME>
            <LONG_NAME>Document</LONG_NAME>
            <CON_ID>2223216</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867935</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43513:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Keyword Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43513</PREFERRED_NAME>
            <LONG_NAME>Keyword</LONG_NAME>
            <CON_ID>2223202</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803321</PublicId>
      <PreferredName>2803321v1.0</PreferredName>
      <PreferredDefinition>A collection containing unordered distinct/discrete values of the type CD.</PreferredDefinition>
      <LongName>ISO21090.DSET.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090DSETv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Data Monitoring Committee Responsibility Document Version Keyword Code ISO21090.DSET.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Data Monitoring Committee Responsibility Document Version Keyword Code ISO21090.DSET.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StatisticalAnalysisSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DataMonitoringCommitteeCharterVersion:keywordCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StatisticalAnalysisSubDomain.DataMonitoringCommitteeCharterVersion.keywordCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="776">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3761279</PUBLICID>
    <LONGNAME>Material Process Intervention or Procedure Reuse Template Study Activity Repeat Quantity Range ISO21090.URG.INT.NONNEG.v1.0</LONGNAME>
    <PREFERREDNAME>3760484v1.0:3152485v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity defined at a global library level that is an action of processing a material. EXAMPLE(S): freezing, thawing, spinning, embedding, dividing, aliquot, adding additives or growth factors OTHER NAME(S): product manipulation NOTE(S): Material process may be performed on any kind of material, such as a specimen, nanomaterial, or biologic. The result of the process may a similar or different kind of material, for instance a specimen may be the result of a specimen processing step (e.g., aliquot or division of a specimen), or alternatively a blood product has anticoagulants added to it to preserve the product. Other processing steps, such as adding growth factor to induce cell growth, may be performed on the blood product. An integer falling within minimum and maximum bounds that specifies how many times the activity occurs. NOTE(S): If the frequency is more than once a day, this is still interpreted per time, e.g. BID for 5 days = 10 repeats.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3760484</PublicId>
      <PreferredName>3757183v1.0:3758613v1.0</PreferredName>
      <PreferredDefinition>The tangible substance that goes into the makeup of a physical object.:A sequence of events which produces some outcome.:An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An active process; excludes processes and mechanisms which fulfill biological functions._Make or do or perform again.:How much there is of something that you can measure; the total amount or number.:The difference between the lowest and highest numerical values; the limits or scale of variation.</PreferredDefinition>
      <LongName>Material Process Intervention or Procedure Reuse Template Study Activity Repeat Quantity Range</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3757183</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3757183v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Material Process Intervention or Procedure Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48187</PREFERRED_NAME>
            <LONG_NAME>Material</LONG_NAME>
            <CON_ID>2514541</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29862</PREFERRED_NAME>
            <LONG_NAME>Process</LONG_NAME>
            <CON_ID>2202628</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3758613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47886:C25256:C38013</PreferredName>
        <Version>1</Version>
        <LongName>Repeat Quantity Range</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47886</PREFERRED_NAME>
            <LONG_NAME>Repeat</LONG_NAME>
            <CON_ID>2415563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38013</PREFERRED_NAME>
            <LONG_NAME>Range</LONG_NAME>
            <CON_ID>2204649</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3152485</PublicId>
      <PreferredName>3152485v1.0</PreferredName>
      <PreferredDefinition>Constrains URG so that the values are non-negative integers.</PreferredDefinition>
      <LongName>ISO21090.URG.INT.NONNEG.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090URGv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2433737</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45255</PreferredName>
        <Version>1</Version>
        <LongName>Integer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Material Process Intervention or Procedure Reuse Template Study Activity Repeat Quantity Range ISO21090.URG.INT.NONNEG.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Material Process Intervention or Procedure Reuse Template Study Activity Repeat Quantity Range ISO21090.URG.INT.NONNEG.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.DefinedMaterialProcessStep.repeatQuantityRange</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedMaterialProcessStep:repeatQuantityRange</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="777">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3761512</PUBLICID>
    <LONGNAME>Investigational Entity Allocation Administration Performed Study Activity Status Date and Time ISO21090.TS.DATETIME.v1.0</LONGNAME>
    <PREFERREDNAME>3760708v1.0:3148148v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The completed action that is the assignment of an experimental unit to a portion of the study, such as an arm or a portion of an arm (when secondary allocations may occur). EXAMPLE(S): Mrs. Smith is assigned to Arm A. The date (and time) on which the status is assigned to the activity.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3760708</PublicId>
      <PreferredName>3757327v1.0:2867759v1.0</PreferredName>
      <PreferredDefinition>In the process of being studied; experimental.:An independently existing thing (living or nonliving).:The distribution of resources over various time periods, products, operations, or investments.:Performing or possessing executive duties; acting as a supervisor or manager.:Executed and carried through to completion.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An active process; excludes processes and mechanisms which fulfill biological functions._A condition or state at a particular time.:An expression of both date and time that an event has happened or will happen.</PreferredDefinition>
      <LongName>Investigational Entity Allocation Administration Performed Study Activity Status Date and Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3757327</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3757327v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Investigational Entity Allocation Administration Performed Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28041</PREFERRED_NAME>
            <LONG_NAME>Investigational</LONG_NAME>
            <CON_ID>2422346</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52580</PREFERRED_NAME>
            <LONG_NAME>Allocation</LONG_NAME>
            <CON_ID>2443113</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48905</PREFERRED_NAME>
            <LONG_NAME>Administration, Management</LONG_NAME>
            <CON_ID>2528523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867759</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688:C37939</PreferredName>
        <Version>1</Version>
        <LongName>Status Date and Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3148148</PublicId>
      <PreferredName>3148148v1.0</PreferredName>
      <PreferredDefinition>Constrains TS so that it&#39;s precision can not be more precise than seconds.</PreferredDefinition>
      <LongName>ISO21090.TS.DATETIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090TSDTTIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Investigational Entity Allocation Administration Performed Study Activity Status Date and Time ISO21090.TS.DATETIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Investigational Entity Allocation Administration Performed Study Activity Status Date and Time ISO21090.TS.DATETIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedExperimentalUnitAllocation:statusDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain.PerformedExperimentalUnitAllocation.statusDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="778">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3761533</PUBLICID>
    <LONGNAME>Or Adverse Event Product Problem Safety Report Document Version Date and Time ISO21090.TS.DATETIME.v1.0</LONGNAME>
    <PREFERREDNAME>3760728v1.0:3148148v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A report that provides notification of an adverse event, product problem, and/or information that is relevant to either. A report typically includes causal association, management strategies, authorship, sender/receiver organizations, subject or study subject of adverse event, or name of product. EXAMPLE(S): An Expedited AE report - a report of a serious and unexpected adverse event that must be submitted within specific timeframes to the sponsor and regulatory agencies. The date (and time) on which the document is versioned.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3760728</PublicId>
      <PreferredName>3174126v1.0:2437776v1.0</PreferredName>
      <PreferredDefinition>An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s).:The end result of a manufacturing process; anything that is produced.:A difficulty, disorder, or condition needing resolution.:The state of being certain that adverse effects will not be caused by some agent under defined conditions.:A short textual account; having provided a short account.:An organized collection of records that describe a particular body of work.:A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications._An expression of both date and time that an event has happened or will happened.</PreferredDefinition>
      <LongName>Or Adverse Event Product Problem Safety Report Document Version Date and Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174126</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174126v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Or Adverse Event Product Problem Safety Report Document Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>7</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51980</PREFERRED_NAME>
            <LONG_NAME>Product</LONG_NAME>
            <CON_ID>2527882</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28020</PREFERRED_NAME>
            <LONG_NAME>Problem</LONG_NAME>
            <CON_ID>2203953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60828</PREFERRED_NAME>
            <LONG_NAME>Safety</LONG_NAME>
            <CON_ID>2612105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19498</PREFERRED_NAME>
            <LONG_NAME>Document</LONG_NAME>
            <CON_ID>2223216</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2437776</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date and Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3148148</PublicId>
      <PreferredName>3148148v1.0</PreferredName>
      <PreferredDefinition>Constrains TS so that it&#39;s precision can not be more precise than seconds.</PreferredDefinition>
      <LongName>ISO21090.TS.DATETIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090TSDTTIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Or Adverse Event Product Problem Safety Report Document Version Date and Time ISO21090.TS.DATETIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Or Adverse Event Product Problem Safety Report Document Version Date and Time ISO21090.TS.DATETIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.AdverseEventSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.AdverseEventSubDomain.SafetyReportVersion.date</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SafetyReportVersion:date</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="779">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3776020</PUBLICID>
    <LONGNAME>Charlson Comorbidity Index Chart Review Version Has Moderate or Severe Liver Disease Indicator</LONGNAME>
    <PREFERREDNAME>CCI_ SEVERELIVER_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator to signify whether or not an individual has moderate liver disease consisting of cirrhosis with portal hypertension, but without bleeding or severe liver disease including ascites, chronic jaundice, portal hypertension or a history of variceal bleeding or requiring liver transplant, determined by reviewing information from the medical record.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCI:Charlson Comorbidity Index, Charlson, ME, 1987</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3775764</PublicId>
      <PreferredName>3775629v1.0:3775762v1.0</PreferredName>
      <PreferredDefinition>A method of predicting mortality by weighting comorbid conditions calculated by reviewing an individual&#39;s chart._A question about whether an individual has or had moderate or severe liver disease.</PreferredDefinition>
      <LongName>Charlson Comorbidity Index Chart Review Version Has Moderate or Severe Liver Disease</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20047</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic or Prognostic Factor</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3775629</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C106374</PreferredName>
        <Version>1</Version>
        <LongName>Charlson Comorbidity Index Chart Review Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C106374</PREFERRED_NAME>
            <LONG_NAME>Charlson Comorbidity Index Derived from Chart Review</LONG_NAME>
            <CON_ID>3774596</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3775762</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C106385</PreferredName>
        <Version>1</Version>
        <LongName>Has Moderate or Severe Liver Disease</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C106385</PREFERRED_NAME>
            <LONG_NAME>Has Moderate or Severe Liver Disease Question</LONG_NAME>
            <CON_ID>3774613</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCI:Charlson Comorbidity Index, Charlson, ME, 1987</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does the patient have moderat</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does the patient have moderate to severe liver disease? (SEVERELIVER)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Moderate or severe liver disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3775608</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3775609</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3835419</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Pharmacovigilance</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Baseline</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3835421</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1221</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104935</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCI_ SEVERELIVER_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="780">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3830595</PUBLICID>
    <LONGNAME>Local-Regional Cancer Progression Recurrence Anatomic Site Location Type</LONGNAME>
    <PREFERREDNAME>LR_CA_PROG_REC_LOC_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Text field to represent type of location for local or regional cancer progression or recurrence.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCISTD: NCI CRF Harmonization and Standards Initiative</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3830594</PublicId>
      <PreferredName>5915431v1.0:5915865v1.0</PreferredName>
      <PreferredDefinition>A disease process that is increasing in scope or severity._The return of a disease after a period of remission._Of or belonging to a restricted area or locality._The area of the body exposed to radiation during radiation therapy.</PreferredDefinition>
      <LongName>Progressive Disease Recurrent Disease Local Radiation Field</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5915431</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C35571:C38155</PreferredName>
        <Version>1</Version>
        <LongName>Progressive Disease Recurrent Disease</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C35571</PREFERRED_NAME>
            <LONG_NAME>Progressive Disease</LONG_NAME>
            <CON_ID>2202776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38155</PREFERRED_NAME>
            <LONG_NAME>Recurrent Disease</LONG_NAME>
            <CON_ID>2202887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5915865</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C67263:C54648</PreferredName>
        <Version>1</Version>
        <LongName>Local Radiation Field</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67263</PREFERRED_NAME>
            <LONG_NAME>Local</LONG_NAME>
            <CON_ID>2676068</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54648</PREFERRED_NAME>
            <LONG_NAME>Radiation Field</LONG_NAME>
            <CON_ID>2479357</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCI CRF Standards</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3603580</PublicId>
      <PreferredName>3603580v1.0</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities for the first progression of disease location.</PreferredDefinition>
      <LongName>First Progression Location Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Marginal</VALIDVALUE>
          <VALUEMEANING>Marginal</VALUEMEANING>
          <MEANINGDESCRIPTION>Marginal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>In-field</VALIDVALUE>
          <VALUEMEANING>Within Field</VALUEMEANING>
          <MEANINGDESCRIPTION>On the inside; contained in.: The region in which a particular type of force can be observed, often viewed as a space which was modified by the sources of the force which the field represents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70773, C25282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3603581</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Out-of-field</VALIDVALUE>
          <VALUEMEANING>Negation Within Field</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: On the inside; contained in.: The region in which a particular type of force can be observed, often viewed as a space which was modified by the sources of the force which the field represents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70773, C25282, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3603582</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-10-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3371379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Location of Recurrence/Progre</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Location of Recurrence/Progression following RT</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Progression CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3828992</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="781">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3838317</PUBLICID>
    <LONGNAME>Chronic Myelogenous Leukemia Phase Status Diseases and Disorders Count</LONGNAME>
    <PREFERREDNAME>3838316v1.0:2675117v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The total number of chronic myelogenous leukemia disease phases.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3838316</PublicId>
      <PreferredName>2500393v1.0:2320064v1.0</PreferredName>
      <PreferredDefinition>A chronic myeloproliferative neoplasm characterized by the expression of the BCR-ABL1 fusion gene. It presents with neutrophilic leukocytosis. It can appear at any age, but it mostly affects middle aged and older individuals. Patients usually present with fatigue, weight loss, anemia, night sweats, and splenomegaly. If untreated, it follows a biphasic or triphasic natural course; an initial indolent chronic phase which is followed by an accelerated phase, a blast phase, or both. Allogeneic stem cell transplantation and tyrosine kinase inhibitors delay disease progression and prolong overall survival._A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Chronic Myelogenous Leukemia Phase Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2500393</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3174</PreferredName>
        <Version>1</Version>
        <LongName>CML</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3174</PREFERRED_NAME>
            <LONG_NAME>Chronic Myeloid Leukemia, BCR-ABL1 Positive</LONG_NAME>
            <CON_ID>2202712</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3946431</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25257:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Phase Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25257</PREFERRED_NAME>
            <LONG_NAME>Phase</LONG_NAME>
            <CON_ID>2203949</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2675117</PublicId>
      <PreferredName>DS_ST_CT</PreferredName>
      <PreferredDefinition>A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown._A condition or state at a particular time._To determine the number or amount of something; the result of this activity.</PreferredDefinition>
      <LongName>Diseases and Disorders Status Count</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2677056</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C25688:C25463</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders Status Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3rd or higher</VALIDVALUE>
          <VALUEMEANING>Greater Third</VALUEMEANING>
          <MEANINGDESCRIPTION>Notable in size, number, measure, magnitude, degree, or effectiveness.: Following the second position in an ordering or series.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25260, C61421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2675118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1st</VALIDVALUE>
          <VALUEMEANING>First</VALUEMEANING>
          <MEANINGDESCRIPTION>Preceding all others in time or space or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2nd</VALIDVALUE>
          <VALUEMEANING>Second:C25666</VALUEMEANING>
          <MEANINGDESCRIPTION>Coming next after the first in position in space or time or degree or magnitude.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What were the number of the C</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What were the number of the CML phase status?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG Mapping for CDE:3838317</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>&quot;PerformedMedicalConditionResult.value WHERE PerformedMedicalConditionResult &gt; PerformedObservation &gt; DefinedObservation.nameCode = &quot;&quot;assess diagnosis&quot;&quot;  AND PerformedObservation &gt; AssessedResultRelationship &gt; PerformedDiagnosis.value = &quot;&quot;Chronic Myelogenous Leukemia(CML)&quot;&quot; AND PerformedObservation.dateRange IS EQUAL TO {transplant date}  {transplant date} is determiend by: PerformedDiagnosis &gt; PerformedSubstanceAdministration.dateRange WHERE PerformedSubstanceAdministration &gt; DefinedSubstranceAdministration.nameCode = &quot;&quot;Administer Hematopoietic Cell Product{ Transplantation}&quot;&quot;&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_prime_dis_hct_cml_remiss_count</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedMedicalConditionResult:value</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_CML_remiss_count</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="782">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3870402</PUBLICID>
    <LONGNAME>Neoplasm Imaging Assessment Yes No Indicator</LONGNAME>
    <PREFERREDNAME>3870401v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator related to the assessment of a tumor by clinical imaging.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3870401</PublicId>
      <PreferredName>2176931v1.0:3870399v1.0</PreferredName>
      <PreferredDefinition>The information related to clinical imaging of a tumor.</PreferredDefinition>
      <LongName>Neoplasm Imaging Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176931</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Tumor</PreferredName>
        <Version>1</Version>
        <LongName>Tumor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3870399</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL024911:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Imaging Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL024911</PREFERRED_NAME>
            <LONG_NAME>Imaging</LONG_NAME>
            <CON_ID>2203543</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was tumor assessed by clinica</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was tumor assessed by clinical imaging at this time point</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="783">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3871786</PUBLICID>
    <LONGNAME>OARS Multidimensional Functional Assessment IADL Questionnaire Get to Places Out of Walking Distance Score</LONGNAME>
    <PREFERREDNAME>OARS_IADL_WALK_SCR</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s response to a question about their ability to get to places out of walking distance.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>OAMFQ:Older Americans Resource Scale (OARS) Multidimensional Functional Assessment Questionnaire, Fillenbaum, G.G. &amp; Smyer, M., 1981</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3871769</PublicId>
      <PreferredName>3871763v1.0:3871767v1.0</PreferredName>
      <PreferredDefinition>A questionnaire that seeks information both on a person&#39;s level of functioning and on their need and utilization of services._A section of the Older Americans Resource Scale Multidimensional Functional Assessment Questionnaire (OMFAQ) that seeks information about a person&#39;s functional ability to conduct the complex activities of daily living that allow for independent living within a community._A question about whether an individual is able to get to places beyond walking distance.</PreferredDefinition>
      <LongName>OARS Multidimensional Functional Assessment IADL Questionnaire Get to Places Out of Walking Distance</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3871763</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C110946</PreferredName>
        <Version>1</Version>
        <LongName>Older Americans Resource Scale Multidimensional Functional Assessment Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110946</PREFERRED_NAME>
            <LONG_NAME>Older Americans Resource Scale Multidimensional Functional Assessment Questionnaire</LONG_NAME>
            <CON_ID>3863071</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3871767</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C110966:C110949</PreferredName>
        <Version>1</Version>
        <LongName>Instrumental Activities of Daily Living Get to Places Out of Walking Distance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110966</PREFERRED_NAME>
            <LONG_NAME>Instrumental Activities of Daily Living</LONG_NAME>
            <CON_ID>3871072</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110949</PREFERRED_NAME>
            <LONG_NAME>Can Get to Places Out of Walking Distance Question</LONG_NAME>
            <CON_ID>3863074</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>OAMFQ:Older Americans Resource Scale (OARS) Multidimensional Functional Assessment Questionnaire, Fillenbaum, G.G. &amp; Smyer, M., 1981</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3871719</PublicId>
      <PreferredName>IADL_WALK_SCR</PreferredName>
      <PreferredDefinition>A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>IADL Walking Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>OAMFQ:Older Americans Resource Scale (OARS) Multidimensional Functional Assessment Questionnaire, Fillenbaum, G.G. &amp; Smyer, M., 1981</Origin>
      <Representation>
        <PublicId>2193207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>99</VALIDVALUE>
          <VALUEMEANING>Not answered</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that no answer was given.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3871711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>are you unable to travel unless emergency arrangements are made for a specialized vehicle like an ambulance?</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is completely unable to do something.: A question about whether an individual is able to get to places beyond walking distance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110949, C110958</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3871720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>with some help (need someone to help you or go with you when traveling)</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something only with assistance.: A question about whether an individual is able to get to places beyond walking distance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110949, C110957</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3871721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>without help (can travel alone on buses, taxis, or drive your own car)</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something without assistance.: A question about whether an individual is able to get to places beyond walking distance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110949, C110956</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3871722</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Can you get to places out of</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Can you get to places out of walking distance?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3863413</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>OAMFQ</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Activities of Daily Living (ADL)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3863414</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3863413</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>OAMFQ</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Instrumental Activities of Daily Living (IADL)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3867574</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OARS_IADL_WALK_SCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="784">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3883054</PUBLICID>
    <LONGNAME>HTLV-1 And/Or HTLV-2 Antibody Laboratory Procedure Performed Laboratory Finding Result</LONGNAME>
    <PREFERREDNAME>3883053v1.0:2676304v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The outcome of the laboratory procedure related to the assessment of the HTLV-1 and/or HTLV-2 antibody.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3883053</PublicId>
      <PreferredName>3883051v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>A type of virus that infects T cells (a type of white blood cell) and can cause leukemia and lymphoma. HTLV-1 is spread by sharing syringes or needles, through blood transfusions or sexual contact, and from mother to child during birth or breast-feeding._Used to indicate that either or both of two items or options may be valid._A human deltaretrovirus related to HTLV-1. Although human T-lymphotropic virus-2 (HTVL-2) has been isolated in association with specific diseases it has not been shown to have a causal relationship with any disease._A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.</PreferredDefinition>
      <LongName>HTLV-1 And/Or HTLV-2 Antibody Laboratory Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3883051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3883051v1.0</PreferredName>
        <Version>1</Version>
        <LongName>HTLV-1 And/Or HTLV-2 Antibody Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14223</PREFERRED_NAME>
            <LONG_NAME>HTLV-1</LONG_NAME>
            <CON_ID>2693350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48928</PREFERRED_NAME>
            <LONG_NAME>And/Or</LONG_NAME>
            <CON_ID>2431163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14224</PREFERRED_NAME>
            <LONG_NAME>HTLV-2</LONG_NAME>
            <CON_ID>2693351</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16295</PREFERRED_NAME>
            <LONG_NAME>Antibody</LONG_NAME>
            <CON_ID>2202301</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2676304</PublicId>
      <PreferredName>LAB_RSLT</PreferredName>
      <PreferredDefinition>The outcome of a laboratory test._Outcome; a phenomenon that follows and is caused by some previous phenomenon.</PreferredDefinition>
      <LongName>Laboratory Finding Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>41</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2876957</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C36292:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test Result Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C36292</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Result</LONG_NAME>
            <CON_ID>2451822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated</VALIDVALUE>
          <VALUEMEANING>Elevated</VALUEMEANING>
          <MEANINGDESCRIPTION>Elevated; raised or increased.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-05</PVBEGINDATE>
          <PVENDDATE>2013-09-04</PVENDDATE>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes: C49488</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never below</VALIDVALUE>
          <VALUEMEANING>Never Less Than</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).: A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61585, C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2682054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reactive</VALIDVALUE>
          <VALUEMEANING>Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported reactive, not tested</VALIDVALUE>
          <VALUEMEANING>Previous Report Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.: Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637, C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not reported</VALIDVALUE>
          <VALUEMEANING>Not Report</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not performed; HIV NAT testing performed</VALIDVALUE>
          <VALUEMEANING>Human Immunodeficiency Virus Nucleic Acid Amplification Test Performed</VALUEMEANING>
          <MEANINGDESCRIPTION>Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME.: Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.: Performed; carried out.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38000, C20055, C14219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2727600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-reactive</VALIDVALUE>
          <VALUEMEANING>Not Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2617835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known</VALIDVALUE>
          <VALUEMEANING>Laboratory Finding Received</VALUEMEANING>
          <MEANINGDESCRIPTION>The outcome of a laboratory test._To take, accept, or get something offered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25639, C36292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2729916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low</VALIDVALUE>
          <VALUEMEANING>Low</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimum level or position or degree; less than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inconclusive</VALIDVALUE>
          <VALUEMEANING>Uncertain</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2749725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate/equivocal</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-09</PVBEGINDATE>
          <PVENDDATE>2013-12-17</PVENDDATE>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline</VALIDVALUE>
          <VALUEMEANING>Borderline</VALUEMEANING>
          <MEANINGDESCRIPTION>Straddling the dividing line between two categories.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reduced; decreased</VALIDVALUE>
          <VALUEMEANING>Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Made less in size or amount or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-09</PVBEGINDATE>
          <PVENDDATE>2012-06-29</PVENDDATE>
          <VMPUBLICID>3135563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3079341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invalid neutralization</VALIDVALUE>
          <VALUEMEANING>Unacceptable Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>Failing to satisfy an established set of qualifying measures.: The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533, C63354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutralized</VALIDVALUE>
          <VALUEMEANING>Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not neutralizable</VALIDVALUE>
          <VALUEMEANING>Negation Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Increased</VALIDVALUE>
          <VALUEMEANING>Increase</VALUEMEANING>
          <MEANINGDESCRIPTION>Increase; a process of becoming larger or more numerous or more important.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decreased</VALIDVALUE>
          <VALUEMEANING>Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Made less in size or amount or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3135563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Severe</VALIDVALUE>
          <VALUEMEANING>Severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely or extremely bad or unpleasant in degree, quality, or extent; life threatening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2842706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mild</VALIDVALUE>
          <VALUEMEANING>Mild</VALUEMEANING>
          <MEANINGDESCRIPTION>Not severe or strong; far from extreme; not serious enough to endanger life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High</VALIDVALUE>
          <VALUEMEANING>High</VALUEMEANING>
          <MEANINGDESCRIPTION>High; greater than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not evaluable</VALIDVALUE>
          <VALUEMEANING>Not Assessable/Not Evaluable</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to be evaluated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carrier of the trait</VALIDVALUE>
          <VALUEMEANING>Genetic Carrier Trait</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who carries an inheritable genetic mutation without manifestation of the associated condition.: Any genetically determined characteristic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85496, C111031</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3872849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate/equivocal</VALIDVALUE>
          <VALUEMEANING>Indeterminate Or Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071, C37998, C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4012172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resolved</VALIDVALUE>
          <VALUEMEANING>Resolved</VALUEMEANING>
          <MEANINGDESCRIPTION>Return to the normal structure and/or function, e.g. the subsidence of a pathologic process, as the subsidence of an inflammatory lesion or new growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2936016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Improved</VALIDVALUE>
          <VALUEMEANING>Better</VALUEMEANING>
          <MEANINGDESCRIPTION>In an improved condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Worse</VALIDVALUE>
          <VALUEMEANING>Worse</VALUEMEANING>
          <MEANINGDESCRIPTION>In an declined condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unchanged</VALIDVALUE>
          <VALUEMEANING>About the same</VALUEMEANING>
          <MEANINGDESCRIPTION>In an unchanged or similar condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3178174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Involved</VALIDVALUE>
          <VALUEMEANING>Involvement</VALUEMEANING>
          <MEANINGDESCRIPTION>To have a connection by participation or association or use; sharing in an activity or process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4244451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not available</VALIDVALUE>
          <VALUEMEANING>Negation Availability</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Available; obtainable or accessible and ready for use or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25429, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested</VALIDVALUE>
          <VALUEMEANING>Not Tested</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a test was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3918247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-secretory</VALIDVALUE>
          <VALUEMEANING>Non-Secretory Myeloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare type of multiple myeloma in which the plasma cells synthesize but do not secrete immunoglobulins.  As a result, none of the immunoglobulins appear out of the normal range.  The symptoms are generally the same with those of immunoglobulin-secreting myeloma; however, the incidence of renal insufficiency is lower in non-secretory myeloma.  The diagnosis can be missed because of the absence of monoclonal immunoglobulin in the serum or urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4734</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive/Suggestive</VALIDVALUE>
          <VALUEMEANING>Positive Finding And/Or Characteristic</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.: Used to indicate that either or both of two items or options may be valid.: The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25447, C48928, C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5036957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inconclusive / equivocal</VALIDVALUE>
          <VALUEMEANING>Uncertain And/Or Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.: Used to indicate that either or both of two items or options may be valid.: Open to question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071, C48928, C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suggestive</VALIDVALUE>
          <VALUEMEANING>Suggestion</VALUEMEANING>
          <MEANINGDESCRIPTION>A proposal offered for acceptance or rejection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5070731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not assessed</VALIDVALUE>
          <VALUEMEANING>Negation Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The final result of a determination of the value, significance, or extent of.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25594, C25217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4982117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Confirmed positive</VALIDVALUE>
          <VALUEMEANING>Confirmation Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>Having been established or verified.: A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758, C25458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5677531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No growth</VALIDVALUE>
          <VALUEMEANING>Negation Growth</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: A process of becoming larger or longer or more numerous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64379, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5653622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pending</VALIDVALUE>
          <VALUEMEANING>Pending</VALUEMEANING>
          <MEANINGDESCRIPTION>Not yet decided or settled; awaiting conclusion or confirmation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2784518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unsatisfactory</VALIDVALUE>
          <VALUEMEANING>Unsatisfactory</VALUEMEANING>
          <MEANINGDESCRIPTION>Failing to meet the quantitative or qualitative measures for the needs of a situation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5255277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No result</VALIDVALUE>
          <VALUEMEANING>Negation Laboratory Test Result</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The outcome of a laboratory test.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36292, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7096109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Contraindicated</VALIDVALUE>
          <VALUEMEANING>Contraindicated</VALUEMEANING>
          <MEANINGDESCRIPTION>State of a particular method of treatment, regimen, procedure, medication, etc. of being unsuitable and inadvisable, often because of a likely adverse reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14665139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Equivocal</VALIDVALUE>
          <VALUEMEANING>Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What were the results for the</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What were the results for the HTLV-1 and/or HTLV-2 assessment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Anti-HTLV I / II</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Anti-HTLV I / II</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Anti-HTLV I / II</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Anti-HTLV I / II</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG Mapping for CDE:3883054</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedClinicalResult.value(ANY=&gt;CD)  WHERE PerformedClinicalResult &gt; PerformedObservation &gt; DefinedObservation.nameCode = &quot;test for Infectious Disease Marker of HTLV-1 or HTLV-2&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>HTLV 1 Serology Results</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>HTLV 2 Serology Results</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_htlv1_2_antibody_result</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedClinicalResult:value</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HTLVAbRslt</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="785">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3902280</PUBLICID>
    <LONGNAME>Legs Plaque Body Surface Involvement Subtotal Percentage</LONGNAME>
    <PREFERREDNAME>LEG_PLQ_SUBTTL_PCT</PREFERREDNAME>
    <PREFERREDDEFINITION>Percentage value to describe the percent of an individual&#39;s legs affected by plaque multiplied by a modifier to yield a calculated percent of affected area on the legs.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3902201</PublicId>
      <PreferredName>3902161v1.0:3902193v1.0</PreferredName>
      <PreferredDefinition>One of the two lower extremities in humans used for locomotion and support._Abnormal tissue that results from the progressive accumulation or deposit of certain substances in a body cavity, surface, or lumen._The surface of an external body region._To have a connection by participation or association or use; sharing in an activity or process._The total of part of a series of numbers.</PreferredDefinition>
      <LongName>Legs Plaque Body Surface Involvement Subtotal</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3902161</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C32974:C95603</PreferredName>
        <Version>1</Version>
        <LongName>Leg Plaque</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C32974</PREFERRED_NAME>
            <LONG_NAME>Leg</LONG_NAME>
            <CON_ID>2516717</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95603</PREFERRED_NAME>
            <LONG_NAME>Plaque</LONG_NAME>
            <CON_ID>3902150</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3902193</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29667:C25548:C60760</PreferredName>
        <Version>1</Version>
        <LongName>Body Surface Involvement Subtotal</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29667</PREFERRED_NAME>
            <LONG_NAME>Body Surface</LONG_NAME>
            <CON_ID>2598059</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60760</PREFERRED_NAME>
            <LONG_NAME>Subtotal</LONG_NAME>
            <CON_ID>3122671</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3902226</PublicId>
      <PreferredName>PLAQ_CALC_INVLT_PTG</PreferredName>
      <PreferredDefinition>A calculated measure of skin involvement (BSA) with skin plaque(s).</PreferredDefinition>
      <LongName>Plaque Calculated Involvement Percentage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>99.99</DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>3</MinimumLength>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue>40.00</MaximumValue>
      <MinimumValue>0.00</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2239955</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613</PreferredName>
        <Version>1</Version>
        <LongName>Percentage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Legs % affected area x modifi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Legs % affected area x modifier</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="786">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3919905</PUBLICID>
    <LONGNAME>Prior Chemotherapy Somatostatin Analog Therapy Administered Type</LONGNAME>
    <PREFERREDNAME>SOMATOSTATIN_ANALOGUE</PREFERREDNAME>
    <PREFERREDDEFINITION>Type of prior Somatostatin analog therapy administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3913841</PublicId>
      <PreferredName>3654832v1.00:3913839v1.00</PreferredName>
      <PreferredDefinition>Previous chemotherapy administered as treatment for this cancer.:Endocrine drug therapy that uses analogs of somatostatin to treat neuroendocrine tumors._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Prior Chemotherapy Somatostatin Analog Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3654832</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16171</PreferredName>
        <Version>1</Version>
        <LongName>Prior Chemotherapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16171</PREFERRED_NAME>
            <LONG_NAME>Prior Chemotherapy</LONG_NAME>
            <CON_ID>3647681</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3913839</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15449:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Somatostatin Analog Therapy Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15449</PREFERRED_NAME>
            <LONG_NAME>Somatostatin Analog Therapy</LONG_NAME>
            <CON_ID>3913838</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3919464</PublicId>
      <PreferredName>3919464v1.0</PreferredName>
      <PreferredDefinition>Type of Somatostatin Analog Therapy</PreferredDefinition>
      <LongName>Somatostatin Analog Therapy Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3919463</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15449:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Somatostatin Analog Therapy Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15449</PREFERRED_NAME>
            <LONG_NAME>Somatostatin Analog Therapy</LONG_NAME>
            <CON_ID>3913838</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pasireotide</VALIDVALUE>
          <VALUEMEANING>Pasireotide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic long-acting cyclic peptide with somatostatin-like activity. Pasireotide activates a broad spectrum of somatostatin receptors, exhibiting a much higher binding affinity for somatostatin receptors 1, 3, and 5 than octreotide in vitro, as well as a comparable binding affinity for somatostatin receptor 2. This agent is more potent than somatostatin in inhibiting the release of human growth hormone (HGH), glucagon, and insulin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3564437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lanreotide</VALIDVALUE>
          <VALUEMEANING>Lanreotide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic cyclic octapeptide analogue of somatostatin. Lanreotide binds to somatostatin receptors (SSTR), specifically SSTR-2 and also to SSTR-5 with a lesser affinity. However, compare with octreotide, this agent is less potent in inhibiting the release of growth hormone from the pituitary gland. Furthermore, lanreotide has an acute effect on decreasing circulating total and free insulin-like growth factor 1 (IGF-I).  This agent is usually given as a prolonged-release microparticle or Autogel formulation for the treatment of acromegaly and to relieve the symptoms of neuroendocrine tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Octreotide LAR</VALIDVALUE>
          <VALUEMEANING>Octreotide Acetate</VALUEMEANING>
          <MEANINGDESCRIPTION>The acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Octreotide is a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Similar to somatostatin, this agent also suppresses the luteinizing hormone response to gonadotropin-releasing hormone, decreases splanchnic blood flow, and inhibits the release of serotonin, gastrin, vasoactive intestinal peptide (VIP), secretin, motilin, pancreatic polypeptide, and thyroid stimulating hormone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53447</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3919466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Octreotide short acting</VALIDVALUE>
          <VALUEMEANING>Octreotide</VALUEMEANING>
          <MEANINGDESCRIPTION>The synthetic acetate salt of a long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Similar to somatostatin, octreotide suppresses the luteinizing hormone response to gonadotropin-releasing hormone, decreases splanchnic blood flow, and inhibits the release of serotonin, gastrin, vasoactive intestinal peptide (VIP), secretin, motilin, pancreatic polypeptide, and thyroid stimulating hormone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Somatostatin analogue</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Somatostatin analogue</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="787">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4030793</PUBLICID>
    <LONGNAME>Lung Disease Other Personal Medical History Assessment Specify</LONGNAME>
    <PREFERREDNAME>LUNG_DZ_MED_HX_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>Text to capture physician diagnosed other lung disease within a patient.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3908123</PublicId>
      <PreferredName>2970303v1.0:2961557v1.0</PreferredName>
      <PreferredDefinition>A non-neoplastic or neoplastic condition affecting the lung.  Representative examples of non-neoplastic conditions include chronic obstructive pulmonary disease and pneumonia.  Representative examples of neoplastic conditions include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung)._Different than the one(s) previously specified or mentioned._ An account of all medical events and problems a person has experienced.</PreferredDefinition>
      <LongName>Lung Disease Other Personal Medical History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2970303</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3198</PreferredName>
        <Version>1</Version>
        <LongName>Lung Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3198</PREFERRED_NAME>
            <LONG_NAME>Lung Disorder</LONG_NAME>
            <CON_ID>2689692</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2961557</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C18772</PreferredName>
        <Version>1</Version>
        <LongName>Other Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018806</PublicId>
      <PreferredName>ASSESS_SPEC</PreferredName>
      <PreferredDefinition>The free text field to specify the assessment performed.</PreferredDefinition>
      <LongName>Assessment Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="788">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4143613</PUBLICID>
    <LONGNAME>Radiation Therapy Other Site Specify</LONGNAME>
    <PREFERREDNAME>4143612v1.0:2666713v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The specific location of radiotherapy administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4143612</PublicId>
      <PreferredName>2403872v1.0:2739568v1.0</PreferredName>
      <PreferredDefinition>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._Not otherwise specified._A position in relation to its surroundings._Different than the one(s) previously specified or mentioned.</PreferredDefinition>
      <LongName>Radiation Therapy Other Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2403872</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15313</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2739568</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C37901</PreferredName>
        <Version>1</Version>
        <LongName>Other Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37901</PREFERRED_NAME>
            <LONG_NAME>Site</LONG_NAME>
            <CON_ID>2202394</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666713</PublicId>
      <PreferredName>2666713v1.0</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Other Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength>25</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If &quot;Other&quot; location, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If &quot;Other&quot; location, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="789">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4179096</PUBLICID>
    <LONGNAME>Eastern Cooperative Oncology Group Performance Status Questionnaire Performed Yes No Indicator</LONGNAME>
    <PREFERREDNAME>4179095v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator related to whether or not an ECOG performance status was obtained.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4179095</PublicId>
      <PreferredName>4179093v1.0:2177693v1.0</PreferredName>
      <PreferredDefinition>Eastern Cooperative Oncology Group (ECOG) Performance Status (Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 Dec;5(6):649-55)._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Eastern Cooperative Oncology Group Performance Status Questionnaire Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4179093</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102116</PreferredName>
        <Version>1</Version>
        <LongName>Eastern Cooperative Oncology Group Performance Status Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102116</PREFERRED_NAME>
            <LONG_NAME>Eastern Cooperative Oncology Group Performance Status Clinical Classification</LONG_NAME>
            <CON_ID>4179092</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177693</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Performed</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was ECOG performance status c</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was ECOG performance status collected</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="790">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4180819</PUBLICID>
    <LONGNAME>Patient Alcohol Consumption Related Injury Indicator</LONGNAME>
    <PREFERREDNAME>PT_ALCCONS_RELAT_INJ_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The determination of whether or not an incident has taken place where damage to the self or another individual is inflicted on the body as a direct or indirect result connected with behavior involving the drinking of beverages or other liquids containing ethanol or other alcohols as reported by a person receiving medical care or treatment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDA</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4180092</PublicId>
      <PreferredName>PT_ALCCONS_RELAT_INJ</PreferredName>
      <PreferredDefinition>The reporting of incident(s) where damage to the self or another individual is inflicted on the body as a direct or indirect result connected with behavior involving the drinking of beverages or other liquids containing ethanol or other alcohols as reported by a person receiving medical care or treatment.</PreferredDefinition>
      <LongName>Patient Alcohol Consumption Related Injury</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDA</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4179983</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C16273</PreferredName>
        <Version>1</Version>
        <LongName>Patient Alcohol Consumption</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16273</PREFERRED_NAME>
            <LONG_NAME>Alcohol Consumption</LONG_NAME>
            <CON_ID>2204017</CON_ID>
            <DEFINITION_SOURCE>NCIt</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4180090</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25648:C3671</PreferredName>
        <Version>1</Version>
        <LongName>Relationship Injury</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3671</PREFERRED_NAME>
            <LONG_NAME>Injury</LONG_NAME>
            <CON_ID>2202560</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4180628</PublicId>
      <PreferredName>ALCCONS_P_EVNT_IND</PreferredName>
      <PreferredDefinition>the determination of whether a certain condition or situation exists or has taken place before the present time that is related to the drinking of beverages or other liquids containing ethanol or other alcohols.</PreferredDefinition>
      <LongName>Alcohol Consumption Past Event Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDA</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>4180627</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16273:C25609:C25499:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Alcohol Consumption Past Event Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16273</PREFERRED_NAME>
            <LONG_NAME>Alcohol Consumption</LONG_NAME>
            <CON_ID>2204017</CON_ID>
            <DEFINITION_SOURCE>NCIt</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, but not in the last year</VALIDVALUE>
          <VALUEMEANING>Yes, but not in the last year</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4180652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, during the last year</VALIDVALUE>
          <VALUEMEANING>Yes, during the last year</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.::0: Before the present time.::2: A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29848, C25609, C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4180653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you or someone else been</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you or someone else been injured because of your drinking?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3952293</PublicId>
          <ContextName>NIDA</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDA CTN Usage</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Research</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3952294</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="791">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4262247</PUBLICID>
    <LONGNAME>Normal Triglyceride Measurement Laboratory Procedure Occurrence Indicator</LONGNAME>
    <PREFERREDNAME>4262242v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not laboratory procedure triclycerides was normal.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4262242</PublicId>
      <PreferredName>4262240v1.0:2234856v1.0</PreferredName>
      <PreferredDefinition>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm._A quantitative measurement of the amount of triglyceride present in a sample._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Normal Triglyceride Measurement Laboratory Procedure Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4262240</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14165:C64812:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Normal Triglyceride Measurement Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14165</PREFERRED_NAME>
            <LONG_NAME>Normal</LONG_NAME>
            <CON_ID>2204843</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64812</PREFERRED_NAME>
            <LONG_NAME>Triglyceride Measurement</LONG_NAME>
            <CON_ID>3202526</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did a normal triclycerides la</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did a normal triclycerides laboratory procedure occur?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Normal triglycerides</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Normal triglycerides</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Normal triglycerides</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Normal triglycerides</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpre_therapy_multi_triglyceride_normal_ynu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="792">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4273651</PUBLICID>
    <LONGNAME>Recurrent Tumor Prior EGFRvIII Vaccine Positive EGFR Gene Amplification Indicator</LONGNAME>
    <PREFERREDNAME>RECUR_TMR_EGFR_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether or not the recurrent tumor is positive for EGFR gene amplicication in patients with prior EGFRvIII vaccine.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ABTC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4273634</PublicId>
      <PreferredName>4273631v1.0:4273632v1.0</PreferredName>
      <PreferredDefinition>The return of a disease after a period of remission._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Earlier in time or order._An antineoplastic vaccine directed against a peptide found in the epidermal growth factor receptor class III variant (EGFRvIII), a constitutively activated mutant of the wild-type tyrosine kinase. This protein variant is present in a substantial proportion of malignant gliomas and other human cancers._An observation confirming something, such as the presence of a disease, condition, or microorganism._This gene is involved in the epidermal growth factor signal transduction pathway._A cellular process characterized by the production of multiple copies of a particular gene or genes in the genome.</PreferredDefinition>
      <LongName>Recurrent Disease Neoplasm Prior EGFRvIII Vaccine Positive EGFR Gene Amplification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ABTC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4273631</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38155:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Recurrent Disease Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38155</PREFERRED_NAME>
            <LONG_NAME>Recurrent Disease</LONG_NAME>
            <CON_ID>2202887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4273632</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4273632v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Prior EGFRvIII Peptide Vaccine Positive Finding EGFR Gene Gene Amplification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C114755</PREFERRED_NAME>
            <LONG_NAME>EGFRvIII Peptide Vaccine</LONG_NAME>
            <CON_ID>4266852</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38758</PREFERRED_NAME>
            <LONG_NAME>Positive Finding</LONG_NAME>
            <CON_ID>2516404</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17757</PREFERRED_NAME>
            <LONG_NAME>EGFR Gene</LONG_NAME>
            <CON_ID>2240633</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16605</PREFERRED_NAME>
            <LONG_NAME>Gene Amplification</LONG_NAME>
            <CON_ID>2991393</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506036</PublicId>
      <PreferredName>YES_NO_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.</PreferredDefinition>
      <LongName>Yes No Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694966</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49797</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3b</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49797</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Not Applicable Response</LONG_NAME>
            <CON_ID>2694965</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is the recurrent tumor positi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the recurrent tumor positive for EGFR gene amplification for patients with prior EGFRvIII vaccine?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3335728</PublicId>
          <ContextName>ABTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocols</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ABTC 1302</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4264871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="793">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4280769</PUBLICID>
    <LONGNAME>Mediastinal Cervical Node Radiation Therapy Administered Total Dose</LONGNAME>
    <PREFERREDNAME>Medi_Cerv_Node_Radi_Admi_Tota_</PREFERREDNAME>
    <PREFERREDDEFINITION>The total dose of Radiation to be administered to the mediasinal/cervical lymph node as per assignment at study entry.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NRG CRF:NRG Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4280763</PublicId>
      <PreferredName>Medi_Cerv_Node_Radi_Admi</PreferredName>
      <PreferredDefinition>Information related to radiation therapy administered to the mediastianl/cervical lymph node</PreferredDefinition>
      <LongName>Mediastinal Cervical Node Radiation Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4280761</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25310:C12844:C45804:C15313</PreferredName>
        <Version>1</Version>
        <LongName>Mediastinal Cervical Node Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25310</PREFERRED_NAME>
            <LONG_NAME>Mediastinal</LONG_NAME>
            <CON_ID>2205417</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12844</PREFERRED_NAME>
            <LONG_NAME>Cervical</LONG_NAME>
            <CON_ID>2205294</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45804</PREFERRED_NAME>
            <LONG_NAME>Node</LONG_NAME>
            <CON_ID>2341859</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NRG CRF:NRG Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4265174</PublicId>
      <PreferredName>Tota_Dose</PreferredName>
      <PreferredDefinition>The list representing total doses of Radiation Therapy and reasons why the dose was not administered</PreferredDefinition>
      <LongName>Total Dose</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>75</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2960575</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15313:C25304:C25488</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Therapy Total Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25304</PREFERRED_NAME>
            <LONG_NAME>Total</LONG_NAME>
            <CON_ID>2204938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15Gy x 3 Fractions (45Gy)</VALIDVALUE>
          <VALUEMEANING>15Gy x 3 Fractions (45Gy)</VALUEMEANING>
          <MEANINGDESCRIPTION>15Gy x 3 Fractions (45Gy)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14Gy x 3 Fractions (42Gy)</VALIDVALUE>
          <VALUEMEANING>14Gy x 3 Fractions (42Gy)</VALUEMEANING>
          <MEANINGDESCRIPTION>14Gy x 3 Fractions (42Gy)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Does not have metastasis to this site</VALIDVALUE>
          <VALUEMEANING>Does not have metastasis to this site</VALUEMEANING>
          <MEANINGDESCRIPTION>Does not have metastasis to this site</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Closed to Protocol Treatment</VALIDVALUE>
          <VALUEMEANING>Closed to Protocol Treatment</VALUEMEANING>
          <MEANINGDESCRIPTION>Closed to Protocol Treatment</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10Gy x 5 Fractions (50Gy)</VALIDVALUE>
          <VALUEMEANING>10Gy x 5 Fractions (50Gy)</VALUEMEANING>
          <MEANINGDESCRIPTION>10Gy x 5 Fractions (50Gy)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9.5 Gy x 5 Fractions (47.5Gy)</VALIDVALUE>
          <VALUEMEANING>9.5 Gy x 5 Fractions (47.5Gy)</VALUEMEANING>
          <MEANINGDESCRIPTION>9.5 Gy x 5 Fractions (47.5Gy)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9Gy x 3 Fractions (27Gy)</VALIDVALUE>
          <VALUEMEANING>9Gy x 3 Fractions (27Gy)</VALUEMEANING>
          <MEANINGDESCRIPTION>9Gy x 3 Fractions (27Gy)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10Gy x 3 Fractions (30Gy)</VALIDVALUE>
          <VALUEMEANING>10Gy x 3 Fractions (30Gy)</VALUEMEANING>
          <MEANINGDESCRIPTION>10Gy x 3 Fractions (30Gy)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Dose to Mediastinal/Cervical</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Dose to Mediastinal/Cervical lymph node</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Medi_Cerv_Node_Radi_Admi_Tota_</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="794">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4285215</PUBLICID>
    <LONGNAME>Cluster of Differentiation Laboratory Procedure Performed Finding Status Indicator</LONGNAME>
    <PREFERREDNAME>2802724v1.0:3436461v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the status of the laboratory results for cluster of differentiation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2802724</PublicId>
      <PreferredName>CD_LP_PF</PreferredName>
      <PreferredDefinition>A designation for cell surface molecules present on leukocytes._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Cluster of Differentiation Laboratory Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2802721</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C78347:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Cluster of Differentiation Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78347</PREFERRED_NAME>
            <LONG_NAME>Cluster of Differentiation</LONG_NAME>
            <CON_ID>2801986</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3436461</PublicId>
      <PreferredName>3436461v1.0</PreferredName>
      <PreferredDefinition>The result of an examination or inquiry._A condition or state at a particular time._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Finding Status Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3436460</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61036:C25688:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Finding Status Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61036</PREFERRED_NAME>
            <LONG_NAME>Investigation Finding</LONG_NAME>
            <CON_ID>2528540</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not known</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-11</PVBEGINDATE>
          <PVENDDATE>2013-03-12</PVENDDATE>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known</VALIDVALUE>
          <VALUEMEANING>Known</VALUEMEANING>
          <MEANINGDESCRIPTION>Recognized, familiar, or within the scope of knowledge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2934435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3371379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-03-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the status of the clu</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the status of the cluster of differentiation finding?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the status of the lymphocyte analysis finding?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the status of the lymphocyte analysis finding?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cd4_pos_cd45ra_pos_mem_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymp_anal_diag_cd4_pos_cd45ra_pos_naive_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymp_anal_prep_cd4_pos_cd45ra_pos_mem_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymp_anal_prep_cd4_pos_cd45ra_pos_naive_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymph_analy_diag_cd20_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymph_analy_diag_cd3_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymph_analy_diag_cd4_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymph_analy_diag_cd56_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymph_analy_diag_cd8_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymph_analy_prep_cd20_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymph_analy_prep_cd3_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymph_analy_prep_cd4_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymph_analy_prep_cd56_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymph_analy_prep_cd8_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="795">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4331014</PUBLICID>
    <LONGNAME>Agent Potency Unit of Measure Abbreviated Descriptive Text</LONGNAME>
    <PREFERREDNAME>AGT_ADM_DOS_UOM_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>Brief text that describes a medical product or other agent dosage units of measure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2715306</PublicId>
      <PreferredName>2715181v1.0:2715127v1.0</PreferredName>
      <PreferredDefinition>A description of applying, dispensing or tendering a medical product or other agent to a clinical study subject._The basic quantity or increment used to describe the strength of a product or amount of product in a package.:A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of same kinds.</PreferredDefinition>
      <LongName>Agent Administration Potency Unit Unit of Measure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2715181</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70962</PreferredName>
        <Version>1</Version>
        <LongName>Agent Administration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70962</PREFERRED_NAME>
            <LONG_NAME>Agent Administration</LONG_NAME>
            <CON_ID>2714997</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2715127</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48470:C25709</PreferredName>
        <Version>1</Version>
        <LongName>Potency Unit Unit of Measure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48470</PREFERRED_NAME>
            <LONG_NAME>Potency Unit</LONG_NAME>
            <CON_ID>2714998</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25709</PREFERRED_NAME>
            <LONG_NAME>Unit of Measure</LONG_NAME>
            <CON_ID>2203864</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2199393</PublicId>
      <PreferredName>ABB_DESC_TXT</PreferredName>
      <PreferredDefinition>Brief text that provides a description of a topic.</PreferredDefinition>
      <LongName>Abbreviated Descriptive Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Dose Unit of Measure</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Dose Unit of Measure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Alternate Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Units of measure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caAERS Rave Integration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4358257</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858960</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Adopted</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAE</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5858965</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRDS</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="796">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4342836</PUBLICID>
    <LONGNAME>Neoplasm Thyroid Gland Follicular Carcinoma Present Yes No Unknown Indicator</LONGNAME>
    <PREFERREDNAME>FOLLICULAR</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no/unknown indicator related to a neoplasm in the thyroid gland with a follicular histologic component, a differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4342834</PublicId>
      <PreferredName>FOLLICULAR</PreferredName>
      <PreferredDefinition>Information related to a neoplasm in the thyroid gland with a follicular histologic component, a differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.</PreferredDefinition>
      <LongName>Neoplasm Thyroid Gland Follicular Carcinoma Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2195180</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Neoplasm</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4342832</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C8054:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Thyroid Gland Follicular Carcinoma Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C8054</PREFERRED_NAME>
            <LONG_NAME>Thyroid Gland Follicular Carcinoma</LONG_NAME>
            <CON_ID>3248466</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Follicular</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Follicular</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FOLLICULAR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="797">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4385952</PUBLICID>
    <LONGNAME>Initial Adverse Event Reporter Geographic Area Fax Number</LONGNAME>
    <PREFERREDNAME>4385853v1.0:2016228v4.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Preceding all others in time or space or degree._Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s)._Somebody who makes a report of any kind, e.g. a person who is authorized to gather and give a formal or official account or description of findings, events, issues and other information regarding clinical study, drug adverse effect, preclinical research results, data and safety monitoring, etc. to appropriate agency or institution._All of the continents and every country situated within, the UNITED STATES and each of the constituent states arranged by region, CANADA and each of its provinces, AUSTRALIA and each of its states, the major bodies of water and major islands on both hemispheres, and selected major cities. Although the geographic locations are not printed in INDEX MEDICUS as main headings, in indexing they are significant in epidemiologic studies and historical articles and for locating administrative units in education and the delivery of health care._the fax number for a person or organization.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ONC SDC Project</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4385853</PublicId>
      <PreferredName>4385851v1.0:2405417v1.0</PreferredName>
      <PreferredDefinition>Preceding all others in time or space or degree._Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s)._Somebody who makes a report of any kind, e.g. a person who is authorized to gather and give a formal or official account or description of findings, events, issues and other information regarding clinical study, drug adverse effect, preclinical research results, data and safety monitoring, etc. to appropriate agency or institution._All of the continents and every country situated within, the UNITED STATES and each of the constituent states arranged by region, CANADA and each of its provinces, AUSTRALIA and each of its states, the major bodies of water and major islands on both hemispheres, and selected major cities. Although the geographic locations are not printed in INDEX MEDICUS as main headings, in indexing they are significant in epidemiologic studies and historical articles and for locating administrative units in education and the delivery of health care.</PreferredDefinition>
      <LongName>Initial Adverse Event Reporter Geographic Area</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ONC SDC Project</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008543</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>GEO_LCTNS</PreferredName>
        <Version>1</Version>
        <LongName>Geographic Locations</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4385851</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C41331:C41191</PreferredName>
        <Version>1</Version>
        <LongName>First Adverse Event Reporter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41191</PREFERRED_NAME>
            <LONG_NAME>Reporter</LONG_NAME>
            <CON_ID>2224868</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2405417</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16632</PreferredName>
        <Version>1</Version>
        <LongName>Geographic Area</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16632</PREFERRED_NAME>
            <LONG_NAME>Geographic Area</LONG_NAME>
            <CON_ID>2202413</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016228</PublicId>
      <PreferredName>FX_NUM</PreferredName>
      <PreferredDefinition>the fax number for a person or organization.</PreferredDefinition>
      <LongName>Fax Number</LongName>
      <Version>4</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008544</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TELECOMMUNICATIONS</PreferredName>
        <Version>1</Version>
        <LongName>Telecommunications</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>7</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184315</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Number</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Initial Reporter Fax Number</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Initial Reporter Fax Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4272090</PublicId>
          <ContextName>ONC SDC Project</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MedWatch Form FDA 3500A</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Initial Reporter</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4382696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="798">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4420675</PUBLICID>
    <LONGNAME>Laboratory Procedure DNTT Antibody Result</LONGNAME>
    <PREFERREDNAME>TdTAbRslt</PREFERREDNAME>
    <PREFERREDDEFINITION>the outcome related to the evaluation of human DNTT wild-type allele/TdT in response to an antigen which is located within 10q23-q24 and is approximately 34 kb in length. This allele, which encodes DNA nucleotidylexotransferase protein, plays a role in the template direction-independent addition of deoxyribonucleotides to the 3&#39;-hydroxyl terminus of oligonucleotide primers.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4420674</PublicId>
      <PreferredName>TdTAbEvl</PreferredName>
      <PreferredDefinition>information related to the evaluation of human DNTT wild-type allele/TdT in response to an antigen which is located within 10q23-q24 and is approximately 34 kb in length. This allele, which encodes DNA nucleotidylexotransferase protein, plays a role in the template direction-independent addition of deoxyribonucleotides to the 3&#39;-hydroxyl terminus of oligonucleotide primers.</PreferredDefinition>
      <LongName>Laboratory Procedure DNTT Antibody Evaluation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4420672</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C51333:C16295:C25214</PreferredName>
        <Version>1</Version>
        <LongName>DNTT wt Allele Antibody Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51333</PREFERRED_NAME>
            <LONG_NAME>DNTT wt Allele</LONG_NAME>
            <CON_ID>4420671</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16295</PREFERRED_NAME>
            <LONG_NAME>Antibody</LONG_NAME>
            <CON_ID>2202301</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2676304</PublicId>
      <PreferredName>LAB_RSLT</PreferredName>
      <PreferredDefinition>The outcome of a laboratory test._Outcome; a phenomenon that follows and is caused by some previous phenomenon.</PreferredDefinition>
      <LongName>Laboratory Finding Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>41</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2876957</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C36292:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test Result Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C36292</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Result</LONG_NAME>
            <CON_ID>2451822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated</VALIDVALUE>
          <VALUEMEANING>Elevated</VALUEMEANING>
          <MEANINGDESCRIPTION>Elevated; raised or increased.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-05</PVBEGINDATE>
          <PVENDDATE>2013-09-04</PVENDDATE>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes: C49488</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never below</VALIDVALUE>
          <VALUEMEANING>Never Less Than</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).: A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61585, C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2682054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reactive</VALIDVALUE>
          <VALUEMEANING>Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported reactive, not tested</VALIDVALUE>
          <VALUEMEANING>Previous Report Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.: Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637, C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not reported</VALIDVALUE>
          <VALUEMEANING>Not Report</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not performed; HIV NAT testing performed</VALIDVALUE>
          <VALUEMEANING>Human Immunodeficiency Virus Nucleic Acid Amplification Test Performed</VALUEMEANING>
          <MEANINGDESCRIPTION>Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME.: Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.: Performed; carried out.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38000, C20055, C14219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2727600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-reactive</VALIDVALUE>
          <VALUEMEANING>Not Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2617835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known</VALIDVALUE>
          <VALUEMEANING>Laboratory Finding Received</VALUEMEANING>
          <MEANINGDESCRIPTION>The outcome of a laboratory test._To take, accept, or get something offered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25639, C36292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2729916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low</VALIDVALUE>
          <VALUEMEANING>Low</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimum level or position or degree; less than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inconclusive</VALIDVALUE>
          <VALUEMEANING>Uncertain</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2749725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate/equivocal</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-09</PVBEGINDATE>
          <PVENDDATE>2013-12-17</PVENDDATE>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline</VALIDVALUE>
          <VALUEMEANING>Borderline</VALUEMEANING>
          <MEANINGDESCRIPTION>Straddling the dividing line between two categories.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reduced; decreased</VALIDVALUE>
          <VALUEMEANING>Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Made less in size or amount or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-09</PVBEGINDATE>
          <PVENDDATE>2012-06-29</PVENDDATE>
          <VMPUBLICID>3135563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3079341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invalid neutralization</VALIDVALUE>
          <VALUEMEANING>Unacceptable Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>Failing to satisfy an established set of qualifying measures.: The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533, C63354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutralized</VALIDVALUE>
          <VALUEMEANING>Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not neutralizable</VALIDVALUE>
          <VALUEMEANING>Negation Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Increased</VALIDVALUE>
          <VALUEMEANING>Increase</VALUEMEANING>
          <MEANINGDESCRIPTION>Increase; a process of becoming larger or more numerous or more important.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decreased</VALIDVALUE>
          <VALUEMEANING>Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Made less in size or amount or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3135563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Severe</VALIDVALUE>
          <VALUEMEANING>Severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely or extremely bad or unpleasant in degree, quality, or extent; life threatening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2842706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mild</VALIDVALUE>
          <VALUEMEANING>Mild</VALUEMEANING>
          <MEANINGDESCRIPTION>Not severe or strong; far from extreme; not serious enough to endanger life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High</VALIDVALUE>
          <VALUEMEANING>High</VALUEMEANING>
          <MEANINGDESCRIPTION>High; greater than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not evaluable</VALIDVALUE>
          <VALUEMEANING>Not Assessable/Not Evaluable</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to be evaluated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carrier of the trait</VALIDVALUE>
          <VALUEMEANING>Genetic Carrier Trait</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who carries an inheritable genetic mutation without manifestation of the associated condition.: Any genetically determined characteristic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85496, C111031</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3872849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate/equivocal</VALIDVALUE>
          <VALUEMEANING>Indeterminate Or Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071, C37998, C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4012172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resolved</VALIDVALUE>
          <VALUEMEANING>Resolved</VALUEMEANING>
          <MEANINGDESCRIPTION>Return to the normal structure and/or function, e.g. the subsidence of a pathologic process, as the subsidence of an inflammatory lesion or new growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2936016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Improved</VALIDVALUE>
          <VALUEMEANING>Better</VALUEMEANING>
          <MEANINGDESCRIPTION>In an improved condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Worse</VALIDVALUE>
          <VALUEMEANING>Worse</VALUEMEANING>
          <MEANINGDESCRIPTION>In an declined condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unchanged</VALIDVALUE>
          <VALUEMEANING>About the same</VALUEMEANING>
          <MEANINGDESCRIPTION>In an unchanged or similar condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3178174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Involved</VALIDVALUE>
          <VALUEMEANING>Involvement</VALUEMEANING>
          <MEANINGDESCRIPTION>To have a connection by participation or association or use; sharing in an activity or process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4244451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not available</VALIDVALUE>
          <VALUEMEANING>Negation Availability</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Available; obtainable or accessible and ready for use or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25429, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested</VALIDVALUE>
          <VALUEMEANING>Not Tested</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a test was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3918247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-secretory</VALIDVALUE>
          <VALUEMEANING>Non-Secretory Myeloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare type of multiple myeloma in which the plasma cells synthesize but do not secrete immunoglobulins.  As a result, none of the immunoglobulins appear out of the normal range.  The symptoms are generally the same with those of immunoglobulin-secreting myeloma; however, the incidence of renal insufficiency is lower in non-secretory myeloma.  The diagnosis can be missed because of the absence of monoclonal immunoglobulin in the serum or urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4734</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive/Suggestive</VALIDVALUE>
          <VALUEMEANING>Positive Finding And/Or Characteristic</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.: Used to indicate that either or both of two items or options may be valid.: The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25447, C48928, C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5036957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inconclusive / equivocal</VALIDVALUE>
          <VALUEMEANING>Uncertain And/Or Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.: Used to indicate that either or both of two items or options may be valid.: Open to question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071, C48928, C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suggestive</VALIDVALUE>
          <VALUEMEANING>Suggestion</VALUEMEANING>
          <MEANINGDESCRIPTION>A proposal offered for acceptance or rejection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5070731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not assessed</VALIDVALUE>
          <VALUEMEANING>Negation Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The final result of a determination of the value, significance, or extent of.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25594, C25217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4982117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Confirmed positive</VALIDVALUE>
          <VALUEMEANING>Confirmation Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>Having been established or verified.: A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758, C25458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5677531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No growth</VALIDVALUE>
          <VALUEMEANING>Negation Growth</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: A process of becoming larger or longer or more numerous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64379, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5653622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pending</VALIDVALUE>
          <VALUEMEANING>Pending</VALUEMEANING>
          <MEANINGDESCRIPTION>Not yet decided or settled; awaiting conclusion or confirmation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2784518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unsatisfactory</VALIDVALUE>
          <VALUEMEANING>Unsatisfactory</VALUEMEANING>
          <MEANINGDESCRIPTION>Failing to meet the quantitative or qualitative measures for the needs of a situation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5255277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No result</VALIDVALUE>
          <VALUEMEANING>Negation Laboratory Test Result</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The outcome of a laboratory test.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36292, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7096109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Contraindicated</VALIDVALUE>
          <VALUEMEANING>Contraindicated</VALUEMEANING>
          <MEANINGDESCRIPTION>State of a particular method of treatment, regimen, procedure, medication, etc. of being unsuitable and inadvisable, often because of a likely adverse reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14665139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Equivocal</VALIDVALUE>
          <VALUEMEANING>Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other - TdT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other - TdT</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="799">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4457326</PUBLICID>
    <LONGNAME>Surgical Procedure Repeat Questionnaire Collected Indicator</LONGNAME>
    <PREFERREDNAME>Surg_Repe_Ques_Coll_YES_NO_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator relating to information regarding collecting a Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument again around the time of a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4457325</PublicId>
      <PreferredName>Surg_Repe_Ques_Coll</PreferredName>
      <PreferredDefinition>Information regarding collecting a Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument again around the time of a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue.</PreferredDefinition>
      <LongName>Surgical Procedure Repeat Questionnaire Collected</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2322305</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4457323</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47886:C17048:C25452</PreferredName>
        <Version>1</Version>
        <LongName>Repeat Questionnaire Collected</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47886</PREFERRED_NAME>
            <LONG_NAME>Repeat</LONG_NAME>
            <CON_ID>2415563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17048</PREFERRED_NAME>
            <LONG_NAME>Questionnaire</LONG_NAME>
            <CON_ID>2202367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25452</PREFERRED_NAME>
            <LONG_NAME>Collected</LONG_NAME>
            <CON_ID>2203888</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did questionnaire have to be</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did questionnaire have to be repeated within 14 days of surgery?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NRG-CC002</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4471913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NRG-CC002</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE2</ClassificationSchemeItemType>
        <CsiPublicId>4514847</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NRG-CC002</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Surg_Repe_Ques_Coll_YES_NO_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="800">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4459375</PUBLICID>
    <LONGNAME>Medical Outcomes Study Social Activities Age Comparison Interference with Social Activities Due To Physical Health or Emotional Problems Score Category</LONGNAME>
    <PREFERREDNAME>MOS_AGECMP_SOCINF_CATE</PREFERREDNAME>
    <PREFERREDDEFINITION>A survey of multiple dimensions of support, representing the social activities scale._How long something has existed; elapsed time since birth._The examination of two or more people or things in order to detect similarities and differences._The act of impeding a person from their normal social activities._Caused by or resulting from._The state of a person&#39;s physical and emotional well-being._A number or range of numeric values measuring performance, function, quality, or ability._The act of impeding a person from their normal social activities._A grouping of items based on some commonality or by user defined characteristics.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MOS:Medical Outcomes Study, Sherbourne, C. D., 1991 and Stewart, A. L. and J. E. Ware, Jr., Eds. 1992</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3874641</PublicId>
      <PreferredName>3874631v1.0:3874639v1.0</PreferredName>
      <PreferredDefinition>A survey of multiple dimensions of support, representing the social activities scale._How long something has existed; elapsed time since birth._The examination of two or more people or things in order to detect similarities and differences._The act of impeding a person from their normal social activities._Caused by or resulting from._The state of a person&#39;s physical and emotional well-being._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Medical Outcomes Study Social Activities Age Comparison Interference with Social Activities Due To Physical Health or Emotional Problems Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3874631</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C110968</PreferredName>
        <Version>1</Version>
        <LongName>Medical Outcomes Study Social Activities</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110968</PREFERRED_NAME>
            <LONG_NAME>Medical Outcomes Study Social Activities</LONG_NAME>
            <CON_ID>3871095</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3874639</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3874639v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Age Comparison Interference with Social Activities Due To Physical Health or Emotional Problems Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25150</PREFERRED_NAME>
            <LONG_NAME>Age</LONG_NAME>
            <CON_ID>2202837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49156</PREFERRED_NAME>
            <LONG_NAME>Comparison</LONG_NAME>
            <CON_ID>2528577</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110989</PREFERRED_NAME>
            <LONG_NAME>Interference with Social Activities</LONG_NAME>
            <CON_ID>3871099</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C89272</PREFERRED_NAME>
            <LONG_NAME>Due To</LONG_NAME>
            <CON_ID>3111313</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110988</PREFERRED_NAME>
            <LONG_NAME>Physical Health or Emotional Problems</LONG_NAME>
            <CON_ID>3871098</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MOS:Medical Outcomes Study, Sherbourne, C. D., 1991 and Stewart, A. L. and J. E. Ware, Jr., Eds. 1992</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4459374</PublicId>
      <PreferredName>Inte_Cate</PreferredName>
      <PreferredDefinition>The act of impeding a person from their normal social activities._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Interference with Social Activities Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>4459373</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C110989:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Interference with Social Activities Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110989</PREFERRED_NAME>
            <LONG_NAME>Interference with Social Activities</LONG_NAME>
            <CON_ID>3871099</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Much Less Limited Than Others</VALIDVALUE>
          <VALUEMEANING>Much Less Limited Than Others</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual feels much less limited than others.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111004</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat Less Limited Than Others</VALIDVALUE>
          <VALUEMEANING>Somewhat Less Limited Than Others</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual feels somewhat less limited than others.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111003</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>About The Same As Others</VALIDVALUE>
          <VALUEMEANING>About The Same As Others</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual feels about the same limitations as others.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat More Limited Than Others</VALIDVALUE>
          <VALUEMEANING>Somewhat More Limited Than Others</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual feels somewhat more limited than others.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111001</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Much More Limited Than Others</VALIDVALUE>
          <VALUEMEANING>Much More Limited Than Others</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual feels much more limited than others.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Compared to others your age,</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Compared to others your age, are your social activities more or less limited because of your physical health or emotional problems?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NRG-CC002</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4471913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NRG-CC002</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE2</ClassificationSchemeItemType>
        <CsiPublicId>4514847</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NRG-CC002</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MOS_AGECMP_SOCINF_CATE</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="801">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4553792</PUBLICID>
    <LONGNAME>FACT-G Questionnaire Version 4 GF7 How True Past Seven Days Content with Quality of Life Right Now Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>FACTG_V4_GF7_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of how true in the past 7 days they were content with the quality of their life right now, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FACT-G:Functional Assessment of Cancer Therapy - General, David Cella, Ph.D., Version 4, Nov. 2007</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3144257</PublicId>
      <PreferredName>2552005v1.0:3144225v1.0</PreferredName>
      <PreferredDefinition>A general quality of life instrument intended for use with a variety of chronic illness conditions. A core instrument in the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System, a system which has multiple disease-, treatment-, and condition-specific subscales to complement the FACT-G._A natural number greater than 6 and less than 8 and the quantity that it denotes: the sum of six and one._Before the present time._The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day._A question about whether an individual is or was content with the quality of their life._A question about an individual&#39;s agreement with a statement._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>FACT-G Questionnaire Seven Past Day Content with Quality of Life How True Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2552005</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45899</PreferredName>
        <Version>1</Version>
        <LongName>FACT-G Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45899</PREFERRED_NAME>
            <LONG_NAME>FACT-G Questionnaire</LONG_NAME>
            <CON_ID>2552004</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3144225</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3144225v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Seven Past Day Content with Quality of Life How True Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66838</PREFERRED_NAME>
            <LONG_NAME>Seven</LONG_NAME>
            <CON_ID>2689988</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25301</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2202680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91114</PREFERRED_NAME>
            <LONG_NAME>Content with Quality of Life Question</LONG_NAME>
            <CON_ID>3124811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91781</PREFERRED_NAME>
            <LONG_NAME>How True Question</LONG_NAME>
            <CON_ID>3133350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>FACT-G:Functional Assessment of Cancer Therapy - General, David Cella, Ph.D., Version 4, Nov. 2007</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4552765</PublicId>
      <PreferredName>4552765v1.0</PreferredName>
      <PreferredDefinition>Numeric scores from 0 (Not at all) to 4 (Very Much) on a Likert scale used on FACT questionnaires.</PreferredDefinition>
      <LongName>FACT Score 5 Point Likert Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>FACT-G:Functional Assessment of Cancer Therapy - General, David Cella, Ph.D., Version 4, Nov. 2007</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Some-what</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a great amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I am content with the quality</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I am content with the quality of my life right now</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACT-G</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>General Question #28 of 28</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring and Interpretation Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Scoring and Interpretation materials are accessible after registration on the FACIT website.</DocumentText>
        <URL>http://www.facit.org/FACITOrg/Questionnaires</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCCN-FACT FCSI-19</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (19)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FCSI</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (9)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCCN-FACT FBrSI</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (24)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACT-Taxane</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (28)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCCN-FACT FHNSI-22</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (22)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACT-P</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (28)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACT-C</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (28)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCCN-FACT FBSI-16</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (16)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACT/GOG-NTX-12</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (28)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACIT-AD</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (28)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACT-B+4</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (28)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCCN-FACT FOSI-18</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (18)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACT/GOG-NTX</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (28)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FBSI</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (7)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCCN-FACT FPSI-17</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (17)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCCN-FACT FLSI-17</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I am content with the quality of my life right now (17)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Medidata ePRO CDE</Name>
        <DocumentType>ePRO Compliant</DocumentType>
        <DocumentText>This CDE has been validated for use with the Medidata Rave ePRO module.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measure CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718286</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Br </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718290</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT&amp;GOG-Ntx </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718474</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-B </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718475</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Cx </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718477</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-E </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-En </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718479</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Es </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718480</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-H&amp;N </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718481</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Hep </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718482</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-L </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718483</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-O </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718484</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-P </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4718485</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-G</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4719032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACIT-AD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4719033</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-C </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4997411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-B+4 </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4997412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Taxane </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4997414</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FCSI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4997551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Symptom Scale</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000343</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000349</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000708</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-G (Functional Assessment of Cancer Therapy - General)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4551764</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT G7 (Functional Assessment of Cancer Therapy - General 7 Item)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4551838</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FBSI (Functional Assessment of Cancer Therapy Breast Symptom Index)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916694</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FCSI (Functional Assessment of Cancer Therapy Colorectal Symptom Index)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916695</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NCCN-FACT FBrSI (National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy - Breast Symptom Index)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916703</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NCCN-FACT FBSI-16 (National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy - Breast Symptom Index 16)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916704</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NCCN-FACT FCSI-19 (National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy - Colorectal Symptom Index 19)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916705</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NCCN-FACT FHNSI-22 (National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy - Head and Neck Symptom Index 22)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916706</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NCCN-FACT FLSI-17 (National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy - Lung Symptom Index 17)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NCCN-FACT FOSI-18 (National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy - Ovarian Symptom Index 18)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916708</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NCCN-FACT FPSI-17 (National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy Prostate Symptom Index 17)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916709</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711251</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACIT/FACT</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5918014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-MM (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-O (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918029</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-P (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918030</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACIT-AD (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Br (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918033</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Cx (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-E (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918036</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-ES (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918037</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-En (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918038</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-G (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-G7 (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918040</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-HN (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Hep (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918042</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-L (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT/GOG NTX-13 (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918044</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT/GOG-NTX (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918045</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT/GOG-NTX-12 (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5918046</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-C (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6355942</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-Leu (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>6409621</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6051063</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Electronic PROs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-P</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3638605</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000686</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FACTG_V4_GF7_SCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FAHI0130_QSORRES</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FAC00127_QSORRES</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="802">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4580873</PUBLICID>
    <LONGNAME>Dose Level Category</LONGNAME>
    <PREFERREDNAME>3597794v1.0:4580872v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>information related to the dose level assignment of a protocol agent.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PBTC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3597794</PublicId>
      <PreferredName>2223333v1.0:3597792v1.0</PreferredName>
      <PreferredDefinition>information related to the dose level assignment of a protocol agent.</PreferredDefinition>
      <LongName>Agent Dose Level Assignment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223333</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1708</PreferredName>
        <Version>1</Version>
        <LongName>Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3597792</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488:C25554:C25426</PreferredName>
        <Version>1</Version>
        <LongName>Dose Level Assignment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25554</PREFERRED_NAME>
            <LONG_NAME>Level</LONG_NAME>
            <CON_ID>2202440</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25426</PREFERRED_NAME>
            <LONG_NAME>Assignment</LONG_NAME>
            <CON_ID>2204040</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4580872</PublicId>
      <PreferredName>4580872v1.0</PreferredName>
      <PreferredDefinition>Dose level description.</PreferredDefinition>
      <LongName>Dose Level Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PBTC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>4580871</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488:C25554:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Dose Level Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25554</PREFERRED_NAME>
            <LONG_NAME>Level</LONG_NAME>
            <CON_ID>2202440</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Dose Level</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Dose Level</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="803">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4616432</PUBLICID>
    <LONGNAME>International Neuroblastoma Pathology Classification Histopathologic Diagnostic Category</LONGNAME>
    <PREFERREDNAME>3521379v1.0:4616431v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that represents the component of the International Neuroblastoma Pathology Classification (INPC) for histopathologic diagnostic category (reflects tumor and stromal content).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3521379</PublicId>
      <PreferredName>2961432v1.0:3521377v1.0</PreferredName>
      <PreferredDefinition>Neuroblastoma is a specific type of neuroblastic tumor which is characterized by the presense of neuroblastic cells forming groups or nests separated by delicate stromal septa without prominent Schwannian stroma. (Adapted from WHO.)_A classification system established by adopting the original system proposed by Shimada with subsequent revisions. The INPC distinguishes favorable and unfavorable histology groups._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.</PreferredDefinition>
      <LongName>Neuroblastoma International Neuroblastoma Pathology Classification Histology</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2961432</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3270</PreferredName>
        <Version>1</Version>
        <LongName>Neuroblastoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3270</PREFERRED_NAME>
            <LONG_NAME>Neuroblastoma</LONG_NAME>
            <CON_ID>2479017</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3521377</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102562:C16681</PreferredName>
        <Version>1</Version>
        <LongName>International Neuroblastoma Pathology Classification Histology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102562</PREFERRED_NAME>
            <LONG_NAME>International Neuroblastoma Pathology Classification</LONG_NAME>
            <CON_ID>3519781</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16681</PREFERRED_NAME>
            <LONG_NAME>Histology</LONG_NAME>
            <CON_ID>2202345</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4616431</PublicId>
      <PreferredName>4616431v1.0</PreferredName>
      <PreferredDefinition>A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>International Neuroblastoma Pathology Classification Histopathologic Diagnostic Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>80</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2433877</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25372</PreferredName>
        <Version>1</Version>
        <LongName>Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuroblastoma</VALIDVALUE>
          <VALUEMEANING>Neuroblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Neuroblastoma is a specific type of neuroblastic tumor which is characterized by the presense of neuroblastic cells forming groups or nests separated by delicate stromal septa without prominent Schwannian stroma. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganglioneuroblastoma, intermixed</VALIDVALUE>
          <VALUEMEANING>Ganglioneuroblastoma, Intermixed</VALUEMEANING>
          <MEANINGDESCRIPTION>A ganglioneuroblastoma characterized by the presence of neuroblastic cells in a Schwannian stroma, without the presence of hemorrhagic neuroblastic nodules.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42057</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3521373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganglioneuroma, maturing subtype OR Ganglioneuroblastoma, well differentiated</VALIDVALUE>
          <VALUEMEANING>Ganglioneuroma (Schwannian stroma-dominant), maturing subtype OR Ganglioneuroblastoma, well differentiated (Schwannian stroma-rich)</VALUEMEANING>
          <MEANINGDESCRIPTION>Ganglioneuroma (Schwannian stroma-dominant), maturing subtype OR Ganglioneuroblastoma, well differentiated (Schwannian stroma-rich)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3521371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganglioneuroma</VALIDVALUE>
          <VALUEMEANING>Ganglioneuroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign neuroblastic tumor of the sympathetic nervous system that occurs in childhood. Ganglioneuroma typically arises from the sympathetic trunk in the mediastinum. Histologic features include spindle cell proliferation (resembling a neurofibroma) and the presence of large ganglion cells. Common presenting features include a palpable abdominal mass, hepatomegaly, and a thoracic mass detected on routine chest X-ray.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3049</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2964423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganglioneuroblastoma, well differentiated</VALIDVALUE>
          <VALUEMEANING>Well Differentiated Ganglioneuroblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.: A neuroblastic tumor characterized by the presence of neuroblastic cells, ganglion cells, and a stroma with Schwannian differentiation constituting more than fifty-percent of the tumor volume.  There are two histologic subtypes identified: ganglioneuroblastoma, intermixed and ganglioneuroblastoma, nodular.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3790, C14171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4616433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Diagnostic Category (Revised</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Diagnostic Category (Revised INPC)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>TARGET Instruction</Name>
        <DocumentType>NOTE</DocumentType>
        <DocumentText>If INPC diagnostic category is missing, then this is Shimada diagnostic category.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5650570</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TARGET</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NBL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5650574</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="804">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4617693</PUBLICID>
    <LONGNAME>Endocrine Therapy Administered Yes No Indicator</LONGNAME>
    <PREFERREDNAME>ENDOTX</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator for information related to the administration of endocrine therapy, which is/are various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4617692</PublicId>
      <PreferredName>ENDOTX</PreferredName>
      <PreferredDefinition>Information related to the administration of endocrine therapy, which is/are various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy.</PreferredDefinition>
      <LongName>Endocrine Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4613671</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15445:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Endocrine Therapy Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15445</PREFERRED_NAME>
            <LONG_NAME>Hormone Therapy</LONG_NAME>
            <CON_ID>2202373</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Endocrine therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient initiated an endocrine therapy drug within the 6 months prior to registration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Therapy administered</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Therapy administered</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Receipt of endocrine therapy at the time of study registration</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient taking a once daily endocrine therapy drug that was initiated within the 6 months (i.e ≤183 days) prior to registration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance-2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient taking a once daily endocrine therapy drug that was initiated within the 6 months (i.e. less than or equal to 183 days) prior to registration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="805">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4630244</PUBLICID>
    <LONGNAME>Recurrent Disease Testis Present Indicator</LONGNAME>
    <PREFERREDNAME>3229387v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator to represent the return of a sign, symptom, or disease in one or both testis after a remission.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3229387</PublicId>
      <PreferredName>2678101v1.0:3229385v1.0</PreferredName>
      <PreferredDefinition>the return of a sign, symptom, or disease after a remission._Either of the paired male reproductive glands that produce the male germ cells and the male hormones._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Recurrent Disease Testis Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2678101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38155</PreferredName>
        <Version>1</Version>
        <LongName>Recurrent Disease</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38155</PREFERRED_NAME>
            <LONG_NAME>Recurrent Disease</LONG_NAME>
            <CON_ID>2202887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3229385</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12412:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Testis Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12412</PREFERRED_NAME>
            <LONG_NAME>Testis</LONG_NAME>
            <CON_ID>2202856</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Relapse in testes (male only)</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Relapse in testes (male only)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5650570</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TARGET</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ALL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5650571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="806">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4633456</PUBLICID>
    <LONGNAME>PROMIS Adult Short Form 8a Pain Interference v1.0 PAININ12 5 Past 7 Days How Much Did Pain Interfere with Things Usually Done for Fun Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>4632716v1.0:4633023v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how much in the past 7 days pain interfered with things usually done for fun, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDA</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4632716</PublicId>
      <PreferredName>4632691v1.0:4662053v1.0</PreferredName>
      <PreferredDefinition>Information related to the questionnaire that measures an adult patient&#39;s self-reported health status related to pain and how that pain interferes with the patient&#39;s participation or enjoyment of fun or pleasurable activities.</PreferredDefinition>
      <LongName>PROMIS Adult Short Form - Pain Interference Past Week How Much Did Pain Interfere with Things Usually Done for Fun Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDA</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4632691</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C119613</PreferredName>
        <Version>1</Version>
        <LongName>PROMIS Adult Short Form - Pain Interference</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C119613</PREFERRED_NAME>
            <LONG_NAME>PROMIS Adult Short Form - Pain Interference</LONG_NAME>
            <CON_ID>4632134</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4662053</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C119978:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week How Much Did Pain Interfere with Things Usually Done for Fun Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C119978</PREFERRED_NAME>
            <LONG_NAME>How Much Did Pain Interfere with Things Usually Done for Fun Question</LONG_NAME>
            <CON_ID>4659074</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4633023</PublicId>
      <PreferredName>4633023v1.0</PreferredName>
      <PreferredDefinition>the PROMIS pain interference scale for rating a patient&#39;s pain during the last seven days.</PreferredDefinition>
      <LongName>PROMIS Adult Pain Interference 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDA</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How much did pain interfere w</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How much did pain interfere with the things you usually do for fun?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Item PAININ12 5</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #5 of 8</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3952293</PublicId>
          <ContextName>NIDA</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDA CTN Usage</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Research</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3952294</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="807">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4661752</PUBLICID>
    <LONGNAME>Person Glucose Intolerance Stable Treatment Regimen Monitoring Clinical Trial Eligibility Criteria Yes No Indicator</LONGNAME>
    <PREFERREDNAME>PtGluIntolStbTmtIND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to person with glucose intolerance being on a stable treatment regimens and monitored for the purpose of eligibility on a clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4661693</PublicId>
      <PreferredName>PtGluIntolStbTmtEligCrit</PreferredName>
      <PreferredDefinition>information related to person with glucose intolerance being on a stable treatment regimens and monitored for the purpose of eligibility on a clinical trial.</PreferredDefinition>
      <LongName>Person Glucose Intolerance Stable Treatment Regimen Monitoring Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4661691</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4661691v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Glucose Intolerance Stable Treatment Regimen Monitoring Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C34646</PREFERRED_NAME>
            <LONG_NAME>Glucose Intolerance</LONG_NAME>
            <CON_ID>2923321</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C30103</PREFERRED_NAME>
            <LONG_NAME>Stable</LONG_NAME>
            <CON_ID>2204880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15697</PREFERRED_NAME>
            <LONG_NAME>Treatment Regimen</LONG_NAME>
            <CON_ID>2203773</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61256</PREFERRED_NAME>
            <LONG_NAME>Monitoring</LONG_NAME>
            <CON_ID>2691603</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is patient with glucose intol</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is patient with glucose intolerance on a stable regimen and being monitored</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase 1/Pilot Consortium</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3303197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="808">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4718270</PUBLICID>
    <LONGNAME>EQ-5D-Y Questionnaire v1.0 4 Pain or Discomfort Today Status 3 Point Scale</LONGNAME>
    <PREFERREDNAME>EQ5DYL_PAIN_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Youths&#39; stated observation of their health state today related to pain or discomfort, using a 3 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>EQ-5D-Y:EuroQol Group, 5 Dimension, 3 Level, Health Questionnaire Version 1.0, Sample English Version for the UK, 2008</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4718210</PublicId>
      <PreferredName>4718201v1.0:4716880v1.0</PreferredName>
      <PreferredDefinition>A standardized rating scale which is used as a measure of health outcome for children and adolescents aged 8-18. This instrument is a descriptive system consisting of 5 dimensions: mobility, self-care, usual activity, pain/discomfort, and anxiety/depression. Each dimension has 3 levels ranging from no problem to extreme problem or incapable, which are assessed by the patient._A question about an individual&#39;s current pain or discomfort._A condition or state at a particular time.</PreferredDefinition>
      <LongName>European Quality of Life Five Dimension Three Level Youth Questionnaire Pain or Discomfort Today Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4718201</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C120225</PreferredName>
        <Version>1</Version>
        <LongName>European Quality of Life Five Dimension Three Level Youth Questionnaire </LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120225</PREFERRED_NAME>
            <LONG_NAME>European Quality of Life Five Dimension Three Level Youth Questionnaire</LONG_NAME>
            <CON_ID>4711083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4716880</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C120240:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Pain or Discomfort Today Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120240</PREFERRED_NAME>
            <LONG_NAME>Pain or Discomfort Today Question</LONG_NAME>
            <CON_ID>4711103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>EQ-5D-Y:EuroQol Group, 5 Dimension, 3 Level, Health Questionnaire Version 1.0, Sample English Version for the UK, 2008</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4718193</PublicId>
      <PreferredName>EQ5DYL_PAIN_SCL</PreferredName>
      <PreferredDefinition>A three point ordered reference standard that describes current health state related to pain or discomfort using the EQ-5D-Y questionnaire.</PreferredDefinition>
      <LongName>EQ-5D-Y Pain or Discomfort 3 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>34</MaximumLength>
      <MinimumLength>28</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>EQ-5D-Y:EuroQol Group, 5 Dimension, 3 Level, Health Questionnaire Version 1.0, Sample English Version for the UK, 2008</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I have a lot of pain or discomfort</VALIDVALUE>
          <VALUEMEANING>A Lot of Pain or Discomfort</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had a lot of pain or discomfort.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4718194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I have some pain or discomfort</VALIDVALUE>
          <VALUEMEANING>Some Pain or Discomfort</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had some pain or discomfort.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120249</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4718195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I have no pain or discomfort</VALIDVALUE>
          <VALUEMEANING>No Pain or Discomfort</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had no pain or discomfort.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111672</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3930565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Having pain or discomfort</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Having pain or discomfort</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How to Use EQ-5D</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Scoring information for EQ-5D</DocumentText>
        <URL>http://www.euroqol.org/about-eq-5d/how-to-use-eq-5d.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>EQ-5D-Y</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Having pain or discomfort (4)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EQ-5D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3539834</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measure CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718286</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Utility Measure</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000600</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EQ-5D-Y</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>10000706</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Utility Measure</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551593</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EQ-5D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4643054</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EQ-5D-Y</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4690295</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Utility Measure</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711250</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EQ-5D-Y-3L</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5778775</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EQ-5D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="809">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4723676</PUBLICID>
    <LONGNAME>Patient PARP1 Gene PARP2 Gene Mutation Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>PARP_1_2_MU_CD_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded response indicating whether the patient meets the eligibility criteria with regards to PARP 1 and PARP 2 mutations.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4723540</PublicId>
      <PreferredName>2177068v1.0:4723538v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._This gene is involved in cellular repair and apoptosis._This gene is involved in base excision repair of DNA._change occurring in one gene._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Patient PARP1 Gene PARP2 Gene Mutation Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4723538</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48684:C104717:C18093:C16112</PreferredName>
        <Version>1</Version>
        <LongName>PARP1 Gene PARP2 Gene Gene Mutation Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48684</PREFERRED_NAME>
            <LONG_NAME>PARP1 Gene</LONG_NAME>
            <CON_ID>3160445</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104717</PREFERRED_NAME>
            <LONG_NAME>PARP2 Gene</LONG_NAME>
            <CON_ID>4723537</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18093</PREFERRED_NAME>
            <LONG_NAME>Gene Mutation</LONG_NAME>
            <CON_ID>3086322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have mutations i</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have mutations in the PARP 1 and 2 enzymes?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876352</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Inclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status &amp; Genetics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3876422</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="810">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4736059</PUBLICID>
    <LONGNAME>California Verbal Learning Test - Second Edition Long Delay Free Recall Z Score Value</LONGNAME>
    <PREFERREDNAME>CVLTII_LONG_ZSCR_VL</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric representation of the Z score for the Long Delay Free Recall subtest in the California Verbal Learning Test - Second Edition.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CVLT-II:California Verbal Learning Test-Second Edition. Delis, D., Kramar, J., Kaplan, E., and Ober, B., The Psychological Corporation: San Antonio, TX. 2000</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4736050</PublicId>
      <PreferredName>4735575v1.0:4736048v1.0</PreferredName>
      <PreferredDefinition>The second version of California Verbal Learning Test, a neuropsychological test developed to make a comprehensive and detailed assessment of verbal learning and memory in individuals ranging in age from 16 to 89 years._The fourth part of the California Verbal Learning Test - Second Edition. After a 20-minute non-verbal task, the subject is asked to recall as many words as he or she can from List A._Indicates how far and in what direction an item deviates from its distribution&#39;s mean, expressed in units of its distribution&#39;s standard deviation.</PreferredDefinition>
      <LongName>California Verbal Learning Test - Second Edition Long Delay Free Recall Z-Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4735575</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C120257</PreferredName>
        <Version>1</Version>
        <LongName>California Verbal Learning Test - Second Edition</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120257</PREFERRED_NAME>
            <LONG_NAME>California Verbal Learning Test - Second Edition</LONG_NAME>
            <CON_ID>4711081</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4736048</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C120548:C68741</PreferredName>
        <Version>1</Version>
        <LongName>Long Delay Free Recall (CVLT-II) Z-Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120548</PREFERRED_NAME>
            <LONG_NAME>Long Delay Free Recall (CVLT-II)</LONG_NAME>
            <CON_ID>4735933</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68741</PREFERRED_NAME>
            <LONG_NAME>Z-Score</LONG_NAME>
            <CON_ID>2671501</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CVLT-II:California Verbal Learning Test-Second Edition. Delis, D., Kramar, J., Kaplan, E., and Ober, B., The Psychological Corporation: San Antonio, TX. 2000</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4735465</PublicId>
      <PreferredName>CVLT_ZSCORE_VAL</PreferredName>
      <PreferredDefinition>A numerical quantity that indicates how far and in what direction an item deviates from its distribution&#39;s mean, expressed in units of standard deviation. Calculation of a z-score requires knowledge about the population&#39;s standard deviation and mean.</PreferredDefinition>
      <LongName>CVLT Z Score Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CVLT-C:California Verbal Learning Test-Children&#39;s Version. Delis, D., Kramar, J., Kaplan, E., and Ober, B., Pearson Assessments: San Antonio, TX. 1994</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>California Verbal Learning Te</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>California Verbal Learning Test, Second Edition (CVTL-II) - Long Delay Free Recall Z-score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>California Verbal Learning Test, Second Edition (CVLT-II) - Long Delay Free Recall Z-score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="811">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4749913</PUBLICID>
    <LONGNAME>Adaptive Behavior Assessment System Adult Rating Form Leisure Skills Scaled Score Value</LONGNAME>
    <PREFERREDNAME>ABAS_SR_LESR_SSCR</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric representation of the scaled score for Leisure Skills in the Adaptive Behavior Assessment System Adult Form.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ABAS Adult Form:Adaptive Behavior Assessment System, Adult Form. Harrison, P.L., &amp; Oakland, T. The Psychological Corporation, San Antonio, TX, 2003.</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4749736</PublicId>
      <PreferredName>5243449v1.0:5243434v1.0</PreferredName>
      <PreferredDefinition>A comprehensive norm-referenced assessment of the adaptive skills of individuals ages 16 to 89 years that is used to evaluate adults with intellectual and developmental disabilities. This form is completed by family members, professional caregivers, supervisors, or the individual._An assessment of the Adaptive Behavior Assessment System, where leisure skills such as planning recreational activities, playing with others, and following rules of games are evaluated._Conversion of a raw score on a test to a common scale that allows for a numerical comparison.</PreferredDefinition>
      <LongName>Adaptive Behavior Assessment System, Adult Rating Form Leisure Skills Scaled Score</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5243449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121187:C121195</PreferredName>
        <Version>1</Version>
        <LongName>Adaptive Behavior Assessment System, Adult Rating Form Leisure Skills</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121187</PREFERRED_NAME>
            <LONG_NAME>Adaptive Behavior Assessment System, Adult Rating Form</LONG_NAME>
            <CON_ID>4747480</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121195</PREFERRED_NAME>
            <LONG_NAME>Leisure Skills</LONG_NAME>
            <CON_ID>4747488</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5243434</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C120341</PreferredName>
        <Version>1</Version>
        <LongName>Scaled Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120341</PREFERRED_NAME>
            <LONG_NAME>Scaled Score</LONG_NAME>
            <CON_ID>4723451</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4744131</PublicId>
      <PreferredName>ABAS_SCL_SCR_VL</PreferredName>
      <PreferredDefinition>A numerical quantity that represents the conversion of a raw score to a common scale from the  Adaptive Behavior Assessment System.</PreferredDefinition>
      <LongName>ABAS Scaled Score Value</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ABAS Adult Form:Adaptive Behavior Assessment System, Adult Form. Harrison, P.L., &amp; Oakland, T. The Psychological Corporation, San Antonio, TX, 2003.</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Adaptive Behavior Assessment</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Adaptive Behavior Assessment System - Leisure scaled score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ABAS-II</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Adaptive Behavior Assessment System - Second Edition (ABAS-II) - Leisure scaled score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ABAS-III</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Adaptive Behavior Assessment System - Third Edition (ABAS-III) - Leisure scaled score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5236432</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ABAS and BASC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ABAS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5236433</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="812">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4757193</PUBLICID>
    <LONGNAME>Behavior Assessment System for Children Self-Report of Personality Locus of Control Scale T-Score Value</LONGNAME>
    <PREFERREDNAME>BASC_SRP_LCUS_TSCR</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric representation of the T-score for the Locus of Control Scale in the Behavior Assessment System for Children Self-Report of Personality Form.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BASC SRP:Behavior Assessment System for Children, Self-Report of Personality. Reynolds, C.R., &amp; Kamphaus, R.W., AGS Publishing, Circle Pines, MN, 2004.</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4755117</PublicId>
      <PreferredName>5236714v1.0:5241839v1.0</PreferredName>
      <PreferredDefinition>A comprehensive set of rating scales designed to facilitate the differential diagnosis and classification of a variety of emotional and behavioral disorders of children, aid in the design of treatment plans, and provide insight into an individual&#39;s thoughts and feelings._A clinical assessment tool that uses targeted forms for monitoring changes in behavior or emotional status. It provides insight into a child&#39;s or adult&#39;s thoughts and feelings._A rating scale included in the Behavior Assessment System for Children that measures the subject&#39;s belief that rewards and punishment are controlled by external stimulus._A method for converting an individual score into a standard form. While similar to a z-score, t-score is used when the conversion is made without knowledge of the population standard deviation and mean.</PreferredDefinition>
      <LongName>Behavior Assessment System for Children Self-Report of Personality Locus of Control Scale T-Score</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5236714</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121269:C121270</PreferredName>
        <Version>1</Version>
        <LongName>Behavior Assessment System for Children Self-Report of Personality</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121269</PREFERRED_NAME>
            <LONG_NAME>Behavior Assessment System for Children, Second Edition</LONG_NAME>
            <CON_ID>4748791</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121270</PREFERRED_NAME>
            <LONG_NAME>Self-Report of Personality</LONG_NAME>
            <CON_ID>4748793</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5241839</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121274:C120401</PreferredName>
        <Version>1</Version>
        <LongName>Locus of Control Scale T-Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121274</PREFERRED_NAME>
            <LONG_NAME>Locus of Control Scale</LONG_NAME>
            <CON_ID>4748795</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120401</PREFERRED_NAME>
            <LONG_NAME>T-Score</LONG_NAME>
            <CON_ID>4733378</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4753677</PublicId>
      <PreferredName>BASC_TSCORE_VAL</PreferredName>
      <PreferredDefinition>A numerical quantity that represents the conversion of an individual score into a standard form made without knowledge of the population standard deviation and mean.</PreferredDefinition>
      <LongName>BASC T Score Value</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>BASC PRS:Behavior Assessment System for Children, Parent Rating Form. Reynolds, C.R., &amp; Kamphaus, R.W., AGS Publishing, Circle Pines, MN, 2004.</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BASC-2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Behavior Assessment System for Children, Second Edition (BASC-2) - Locus of Control T-score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BASC-3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Behavior Assessment System for Children, Third Edition (BASC-3) - Locus of Control T-score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Behavior Assessment System fo</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Behavior Assessment System for Children - Locus of Control T-score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5236432</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ABAS and BASC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BASC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5236434</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="813">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4798591</PUBLICID>
    <LONGNAME>Patient Histologically Confirmed Metastatic Progressive Urothelial Carcinoma Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>CONF_MET_URO_CAR_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded response indicating whether a patient meets the eligibility criteria with regards to a histologically confirmed diagnosis of metastatic progressive urothelial carcinoma.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4794119</PublicId>
      <PreferredName>2233604v1.0:4794117v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Involving the use of histology or histological techniques._Having been established or verified._Having to do with metastasis, which is the spread of cancer from the primary site (place where it started) to other places in the body._Advancing in extent or severity._A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis). It is frequently papillary._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Patient Histologically Confirmed Metastatic Progressive Urothelial Carcinoma Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4794117</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4794117v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Histologically Confirmation Metastatic Progressive Urothelial Carcinoma Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25527</PREFERRED_NAME>
            <LONG_NAME>Histologically</LONG_NAME>
            <CON_ID>2206235</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25458</PREFERRED_NAME>
            <LONG_NAME>Confirmation</LONG_NAME>
            <CON_ID>2203883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14174</PREFERRED_NAME>
            <LONG_NAME>Metastatic</LONG_NAME>
            <CON_ID>2204914</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25254</PREFERRED_NAME>
            <LONG_NAME>Progressive</LONG_NAME>
            <CON_ID>2206352</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4030</PREFERRED_NAME>
            <LONG_NAME>Urothelial Carcinoma</LONG_NAME>
            <CON_ID>2856423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have histologica</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have histologically confirmed diagnosis of metastatic, progressive urothelial carcinoma of the bladder, urethra, ureter, or renal pelvis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have histologically or cytologically confirmed metastatic urothelial carcinoma?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have histologically confirmed locally advanced or metastatic Transitional Cell Carcinoma (TCC, also known as urothelial carcinoma)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient is in the expansion cohort, does patient have histologically confirmed diagnosis of  urothelial carcinoma of the bladder, urethra, ureter, renal pelvis OR Clear cell renal cell carcinoma OR Adenocarcinoma of the bladder OR Squamous cell carcinoma of the bladder?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient is in the expansion cohort, does patient have histologically confirmed diagnosis of urothelial carcinoma of the bladder, urethra, ureter, renal pelvis OR Clear cell renal cell carcinoma OR Adenocarcinoma of the bladder OR Non-resectable squamous cell carnicinoma of the penis OR Squamous cell carcinoma of the bladder?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient is in the expansion cohort, does patient have histologically confirmed diagnosis of metatstatic urothelial carcinoma of the bladder, urethra, ureter, renal pelvis OR Clear cell renal cell carcinoma OR Adenocarcinoma of the bladder OR Non-resectable squamous cell carnicinoma of the penis OR Squamous cell carcinoma of the bladder?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have histologically confirmed diagnosis of urothelial carcinoma of the urothelial tract/bladder cancer?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient is in the expansion cohort, does patient have histologically confirmed diagnosis of  metatstatic urothelial carcinoma of the bladder, urethra, ureter, renal pelvis OR Clear cell renal cell carcinoma OR Adenocarcinoma of the bladder OR Non-resectable squamous cell carnicinoma of the penis OR  Squamous or small cell carcinoma of the bladder, renal medullary carcinoma (RMC), sarcomatoid bladder and renal cell carcinomas, plasmacytoid carcinoma of the bladder or other rare bladder/kidney cancer histology?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient is in the expansion cohort of the triplet combination at MTD/RP2D and has histologically confirmed advanced or unresectable urothelial carcinoma, does evaluated sample contain greater than or equal to 50% urothelial histology?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876352</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Inclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status &amp; Genetics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3876422</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Theradex</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Theradex</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="814">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4835823</PUBLICID>
    <LONGNAME>Patient Bone age Evaluation Yes No Unknown Not Applicable Indicator</LONGNAME>
    <PREFERREDNAME>PtBnAgeEval_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A Yes No Unknown Not Applicable Indicator of an evaluation of a person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary to indicate the bone age.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4835814</PublicId>
      <PreferredName>PtBnAgeEval</PreferredName>
      <PreferredDefinition>An evaluation of a person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary to indicate the bone age.</PreferredDefinition>
      <LongName>Patient Bone age Evaluation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4848551</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL110405:C25214</PreferredName>
        <Version>1</Version>
        <LongName>Bone age Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL110405</PREFERRED_NAME>
            <LONG_NAME>Bone age</LONG_NAME>
            <CON_ID>2615811</CON_ID>
            <DEFINITION_SOURCE>SNOMEDCT_2004_01_31</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have adequate bo</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have adequate bone age?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="815">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4844031</PUBLICID>
    <LONGNAME>Cardiopulmonary Exercise Testing Assessment Timepoint Type</LONGNAME>
    <PREFERREDNAME>CARDIO_EXER_TMPT_TYP</PREFERREDNAME>
    <PREFERREDDEFINITION>The response that indicates the timepoint the measurements were made during the cardiopulmonary exercise testing.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCI CRF:  Duke Cancer Institute Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4843955</PublicId>
      <PreferredName>4843952v1.0:2465182v1.0</PreferredName>
      <PreferredDefinition>A clinical tool to evaluate exercise capacity and to assess cardiac function under stress._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Cardiopulmonary Exercise Testing Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4843952</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C116517</PreferredName>
        <Version>1</Version>
        <LongName>Cardiopulmonary Exercise Testing</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C116517</PREFERRED_NAME>
            <LONG_NAME>Cardiopulmonary Exercise Testing</LONG_NAME>
            <CON_ID>4843951</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2465182</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25217</PreferredName>
        <Version>1</Version>
        <LongName>Assessed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCI CRF:  Duke Cancer Institute Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3638917</PublicId>
      <PreferredName>EXCSE_TMPT_TP</PreferredName>
      <PreferredDefinition>A specific point in the time continuum, including those established relative to an event._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Exercise Timepoint Type</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2787404</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68568:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Timepoint Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68568</PREFERRED_NAME>
            <LONG_NAME>Timepoint</LONG_NAME>
            <CON_ID>2656619</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Integer::6 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Integer::3 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Integer::5 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::5: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4654631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Integer::4 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::4: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4654632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Integer::2 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4654633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Integer::1 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4654634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recovery 2</VALIDVALUE>
          <VALUEMEANING>Recovery Integer::2 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury.: A number with no fractional part, including the negative and positive numbers as well as zero.::2: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::2, C25746</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4654635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recovery 1</VALIDVALUE>
          <VALUEMEANING>Recovery Integer::1 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury.: A number with no fractional part, including the negative and positive numbers as well as zero.::1: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::1, C25746</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4654636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Attempt 3 (80-85% 1Rm)</VALIDVALUE>
          <VALUEMEANING>Third Attempt</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the second position in an ordering or series; coming next after the second and just before the fourth in position.: An activity intended to do or accomplish something.  Routinely used as in &quot;number of tries to complete a procedure&quot;.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39769, C25260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4844905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Attempt 2 (80-85% 1Rm)</VALIDVALUE>
          <VALUEMEANING>Second Attempt</VALUEMEANING>
          <MEANINGDESCRIPTION>Coming next after the first in position in space or time or degree or magnitude.: An activity intended to do or accomplish something.  Routinely used as in &quot;number of tries to complete a procedure&quot;.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39769, C25666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4844906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Attempt 1 (80-85% 1Rm)</VALIDVALUE>
          <VALUEMEANING>First Attempt</VALUEMEANING>
          <MEANINGDESCRIPTION>Preceding all others in time or space or degree.: An activity intended to do or accomplish something.  Routinely used as in &quot;number of tries to complete a procedure&quot;.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39769, C25509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4844907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Priming (50-60% 1Rm)</VALIDVALUE>
          <VALUEMEANING>Priming Exercise</VALUEMEANING>
          <MEANINGDESCRIPTION>High-intensity exercise performed to enhance performance during subsequent high-intensity exercise by accelerating oxygen uptake.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4844908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Warm Up (30-40% 1Rm)</VALIDVALUE>
          <VALUEMEANING>Warm-Up</VALUEMEANING>
          <MEANINGDESCRIPTION>A period of lower-intensity activity designed to prepare the body for more vigorous exercise.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122029</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4844909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Post-test</VALIDVALUE>
          <VALUEMEANING>Post Test</VALUEMEANING>
          <MEANINGDESCRIPTION>Happening at a time subsequent to a reference time; later in time or order.: A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47891, C38008</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4843071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>Integer::18 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::18: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>Integer::17 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::17: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>Integer::16 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::16: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>Integer::15 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::15: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>Integer::14 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::14: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>Integer::13 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::13: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>Integer::12 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>Integer::11 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>Integer::10 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::10: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Integer::8 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Integer::8 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Integer::7 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3 Minutes</VALIDVALUE>
          <VALUEMEANING>Integer::3 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pre-test</VALIDVALUE>
          <VALUEMEANING>Prior Test</VALUEMEANING>
          <MEANINGDESCRIPTION>Earlier in time or order.: A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47891, C25629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4843072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Post Exercise</VALIDVALUE>
          <VALUEMEANING>Post Exercise</VALUEMEANING>
          <MEANINGDESCRIPTION>Happening at a time subsequent to a reference time; later in time or order.: Activity that requires physical or mental exertion, especially when performed to develop or maintain fitness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16567, C38008</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4843131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resting</VALIDVALUE>
          <VALUEMEANING>Resting</VALUEMEANING>
          <MEANINGDESCRIPTION>Freedom from activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4654637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rest</VALIDVALUE>
          <VALUEMEANING>Resting Stage</VALUEMEANING>
          <MEANINGDESCRIPTION>Freedom from activity.: Any distinct time period in a sequence of events.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48308, C28185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>Integer::30 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::30: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::30</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5029322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>Integer::29 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::29: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5029323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>Integer::28 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::28: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5029324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>Integer::27 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::27: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5029325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>Integer::26 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::26: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5029326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>Integer::25 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::25: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5029327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>Integer::24 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5029328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>Integer::23 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::23: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5029329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>Integer::21 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5029330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>Integer::21 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5029331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>Integer::20 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::20: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5029332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>Integer::19 Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::19: A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5029333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Time</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Time</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="816">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4861320</PUBLICID>
    <LONGNAME>PROMIS Version 2.0 Adult Social Health Ability to Participate in Social Roles and Activities SRPPER28r1 Have to Limit Regular Activities with Friends Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PROMISV2_SRPR28r1_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of how often they have to limit their regular activities with friends, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4861311</PublicId>
      <PreferredName>4861095v1.0:4810264v1.0</PreferredName>
      <PreferredDefinition>A Patient Reported Outcomes Measurement Information System (PROMIS) domain that assesses the status of an individual&#39;s social health._The collection of PROMIS item scales that assess an individual&#39;s perceived ability to perform their usual social roles and activities._A question about whether an individual has or had to limit their regular activities with friends._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>PROMIS Adult Social Health Domain Ability to Participate in Social Roles and Activities Have to Limit Regular Activities with Friends Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4861095</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C122340:C122341</PreferredName>
        <Version>1</Version>
        <LongName>PROMIS Adult Social Health Domain Ability to Participate in Social Roles and Activities Subordinate Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122340</PREFERRED_NAME>
            <LONG_NAME>PROMIS Adult Social Health Domain</LONG_NAME>
            <CON_ID>4860291</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122341</PREFERRED_NAME>
            <LONG_NAME>Ability to Participate in Social Roles and Activities Subordinate Domain</LONG_NAME>
            <CON_ID>4860292</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4810264</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121722:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Have to Limit Regular Activities with Friends Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121722</PREFERRED_NAME>
            <LONG_NAME>Have to Limit Regular Activities with Friends Question</LONG_NAME>
            <CON_ID>4809811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4810050</PublicId>
      <PreferredName>PROMIS_PARTICPT_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used with the PROMIS items that describes a range of subjective scores for representing an individual&#39;s participation in social activities from 1: Always, to 5: Never.</PreferredDefinition>
      <LongName>PROMIS Participate Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Usually</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4270313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Ability to Participate in Social Roles and Activities - Short Form 8a</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #6 of 8</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I have to limit my regular ac</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I have to limit my regular activities with friends</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring Manual Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>https://www.assessmentcenter.net/documents/PROMIS%20Ability%20to%20Participate%20in%20Social%20Roles%20and%20Activities%20Scoring%20Manual.pdf</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4857911</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PROMIS Item Banks</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult Social Health</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4857914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4857911</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PROMIS Item Banks</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ability to Participate in Social Roles and Activities</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4861299</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ability to Participate in Social Roles and Activities</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16012650</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="817">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4888112</PUBLICID>
    <LONGNAME>PROMIS Version 2.0 Adult Physical Health Domain Physical Function PFC36r1 Current Health Limits Walking More Than a Mile Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PROMISV2_PFC36r1_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of how much their health now limits them in walking more than a mile (1.6km), using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4888077</PublicId>
      <PreferredName>4888071v1.0:4888075v1.0</PreferredName>
      <PreferredDefinition>A Patient Reported Outcomes Measurement Information System (PROMIS) domain that assesses the status of an individual&#39;s physical health._The collection of PROMIS item scales that assess an individual&#39;s ability to carry out activities that require physical actions including more complex activities that require a combination of skills, often within a social context._A question about whether an individual&#39;s current health limits them in walking more than a mile._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>PROMIS Adult Physical Health Domain Physical Function Current Health Limits Walking More Than a Mile Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4888071</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C122346:C122356</PreferredName>
        <Version>1</Version>
        <LongName>PROMIS Adult Physical Health Domain Physical Function Subordinate Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122346</PREFERRED_NAME>
            <LONG_NAME>PROMIS Adult Physical Health Domain</LONG_NAME>
            <CON_ID>4860856</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122356</PREFERRED_NAME>
            <LONG_NAME>Physical Function Subordinate Domain</LONG_NAME>
            <CON_ID>4860871</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4888075</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C122358:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Current Health Limits Walking More Than a Mile Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122358</PREFERRED_NAME>
            <LONG_NAME>Current Health Limits Walking More Than a Mile Question</LONG_NAME>
            <CON_ID>4860893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4809951</PublicId>
      <PreferredName>PROMIS_LIMIT_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used with the PROMIS items that describes a range of subjective scores for representing how much an individual is limited from doing a specific activity because of their health from 1: Cannot do, to 5: Not at all.</PreferredDefinition>
      <LongName>PROMIS Health Limitation Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Quite a lot</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Cannot Do</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual cannot do something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very little</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something for the smallest amount of effort or duration of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121746</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does your health now limit you in walking more than a mile (1.6 km)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Physical Function - SF 10a</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #2 of 10</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring and Interpretation Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Scoring and Interpretation materials are available from the PROMIS Assessment Center.</DocumentText>
        <URL>https://www.assessmentcenter.net/documents/PROMIS%20Physical%20Function%20Scoring%20Manual.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551591</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measure CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718286</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PROMIS Item Bank v1.0 - Physical Function - Short Form 10a</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4887912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PROMIS Item Bank v1.0 - Physical Function - Short Form 10a</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>10000292</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000428</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4857911</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PROMIS Item Banks</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical Function</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4857918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711235</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical Function</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14951259</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="818">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4920542</PUBLICID>
    <LONGNAME>Person North American Association of Central Cancer Registries Race Code</LONGNAME>
    <PREFERREDNAME>NAACCRRaceCd</PREFERREDNAME>
    <PREFERREDDEFINITION>A numbered categories of racial groups for a person official written in North American Association of Central Cancer Registries(NAACCR).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4920533</PublicId>
      <PreferredName>2236731v1.0:4920652v1.0</PreferredName>
      <PreferredDefinition>information related to the racial groups of a person official written in North American Association of Central Cancer Registries(NAACCR).</PreferredDefinition>
      <LongName>Person North American Association of Central Cancer Registries Race</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4920652</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C82178:C17049</PreferredName>
        <Version>1</Version>
        <LongName>North American Association of Central Cancer Registries Race</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82178</PREFERRED_NAME>
            <LONG_NAME>North American Association of Central Cancer Registries</LONG_NAME>
            <CON_ID>2967403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17049</PREFERRED_NAME>
            <LONG_NAME>Race</LONG_NAME>
            <CON_ID>2202465</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4920541</PublicId>
      <PreferredName>4920541v1.0</PreferredName>
      <PreferredDefinition>A system of racial groups official written in North American Association of Central Cancer Registries(NAACCR).</PreferredDefinition>
      <LongName>Race Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>White</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes person with European, Middle Eastern, or North African ancestral origin who identifies, or is identified, as White.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Hawaiian</VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in any of the original peoples of Hawaii.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Filipino</VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in the Philippine Islands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Japanese</VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in any of the original peoples of Japan.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570994</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Chinese</VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in any of the original peoples of China.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570992</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>American Indian, Aleutian, Eskimo</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes a person having origins in one of the indigenous peoples of North America, who lived on the continent prior to the European colonization. The term includes individuals belonging to a large number of tribes, states, and ethnic groups, many of them still enduring as communities.: Aleutian - a person having origins from the Aleut indigenous group of Alaska and their descendants and who maintains tribal affiliation, or community or cultural attachment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43389, C43877</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4920882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>African American</VALUEMEANING>
          <MEANINGDESCRIPTION>African American; term used in the United States to categorize a population group comprised of persons having origins in any of the black racial groups of Africa, most of whose ancestors were brought from Africa to the Americas as slaves between the sixteenth and nineteenth centuries. Includes population subgroups, e.g. Kenyan, Nigerian, or Haitian. The concept refers also to individuals who classify themselves as described.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>Micronesian, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes a person from any of the islands in the western pacific encompassing the area from the Philippines in the west, Indonesia to the south west, Papua New Guinea and Melanesia to the south, and Polynesia to the south-east and east.: Not characterized in any other way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594, C43402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4920883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>Thai</VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in any of the original peoples of Thailand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570997</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>Cambodian</VALUEMEANING>
          <MEANINGDESCRIPTION>A person from Cambodia (formerly Kampuchea) or of that ancestry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>Hmong</VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in any of the original Hmong people originating in China around the Yellow River or Hoang Ho.  Early in the 19th century, the Hmong migrated to French Indochina, which comprised Vietnam, Cambodia and Laos.  In 1947, Hmong officially became citizens of Loas.  Later a number of Hmong emigrated to Thailand and the United States.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>Laotian</VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in any of the original peoples of Laos.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570996</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>Vietnamese</VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in any of the original peoples of Vietnam.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43396</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570998</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Asian Indian, Pakistani</VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in the original peoples of the Indian sub-continent.: Primarily refers to a person having origins in the original peoples of the Indian sub-continent, a subset of which formed Pakistan.  The term also refers to a person from Pakistan, whether or not ancestors were from India.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43427, C41262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3008992</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Korean</VALUEMEANING>
          <MEANINGDESCRIPTION>A person having origins in any of the original peoples of Korea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570995</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>99</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>98</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>97</VALIDVALUE>
          <VALUEMEANING>Pacific Islander, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Pacific Islander, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2634561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>96</VALIDVALUE>
          <VALUEMEANING>Other Asian</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent, including Cambodia, China, India, Japan, Korea, Malaysia, Mongolia, Pakistan, the Philippine Islands, Thailand, and Vietnam. The concept refers also to individuals who classify themselves as described below.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41260, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3009514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32</VALIDVALUE>
          <VALUEMEANING>New Guinean</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes the inhabitants of Papua New Guinea, a person from there, or their descendants elsewhere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4921073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>Fiji Islander</VALUEMEANING>
          <MEANINGDESCRIPTION>A person from Fiji or of that ancestry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>Melanesian, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes a person from any of the islands in the region extending from the west Pacific to the Arafura Sea, north and north-east of Australia. or of that ancestry.: Not characterized in any other way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594, C43409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4921074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>Tongan</VALUEMEANING>
          <MEANINGDESCRIPTION>A person from Tonga or of that ancestry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571001</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>Samoan</VALUEMEANING>
          <MEANINGDESCRIPTION>A person from Samoa or of that ancestry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>Tahitian</VALUEMEANING>
          <MEANINGDESCRIPTION>A person from Tahiti or of that ancestry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2634551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>Polynesian, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes a person from any of the over 1,000 islands in the central and southern Pacific Ocean bounded by a triangle with its three corners at Hawaii, New Zealand, and Easter Island or a person of that ancestry.: Not characterized in any other way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594, C43405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4921075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>Guamanian, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes the inhabitants of Guam, a person from there, or their descendants elsewhere.: Not characterized in any other way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594, C43404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4921076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>Chamorran</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the indigenous Chamorro people of Guam and the Mariana Islands or persons of that ancestry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2634555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR Race:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>NAACCR Race:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="819">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5002015</PUBLICID>
    <LONGNAME>Plan Stem Cell Mobilization Therapy Administered End Date</LONGNAME>
    <PREFERREDNAME>5002013v1.0:2928085v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The month, day, and year the planned stem cell mobilization therapy ended.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5002013</PublicId>
      <PreferredName>5002011v1.0:2233610v1.0</PreferredName>
      <PreferredDefinition>To devise, contrive, or form in design._Information related to the administration of therapy to cause release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of collection. Hematopoietic growth factors or chemotherapeutic agents often are used to stimulate the mobilization.</PreferredDefinition>
      <LongName>Plan Stem Cell Mobilization Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5002011</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25619:C62604</PreferredName>
        <Version>1</Version>
        <LongName>Plan Stem Cell Mobilization Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25619</PREFERRED_NAME>
            <LONG_NAME>Plan</LONG_NAME>
            <CON_ID>2203947</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62604</PREFERRED_NAME>
            <LONG_NAME>Stem Cell Mobilization Therapy</LONG_NAME>
            <CON_ID>2521765</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2928085</PublicId>
      <PreferredName>END_DT</PreferredName>
      <PreferredDefinition>The point or place at which something terminates in time, space, or extent._a particular day specified as the time something has, or will, happen.</PreferredDefinition>
      <LongName>End Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY-MM-DD</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2459822</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25496:C25164</PreferredName>
        <Version>1</Version>
        <LongName>End Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the date the planned</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the date the planned stem cell mobilization therapy ended?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="820">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5004251</PUBLICID>
    <LONGNAME>NCCN-FACT FPSI-17 Questionnaire Version 2 NCCN3 How True Past Seven Days Pain Have Weakness in My Legs Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>NCCN_FPSI_NCCN3_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of how true in the past 7 days they have weakness in their legs, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCCN-FACT Index:National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy Index, David Cella, Ph.D., et.al., March 3, 2010.</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4994214</PublicId>
      <PreferredName>4994211v1.0:4994212v1.0</PreferredName>
      <PreferredDefinition>A 10 item symptom index scale developed from the FACT H&amp;N questionnaire with the National Comprehensive Cancer Network to evaluate response to chemotherapy for patients with prostate cancer._A question about an individual&#39;s agreement with a statement._The most recent week, including today._A question about whether an individual has or had weakness in their legs._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>NCCN-FACT FPSI-17 Questionnaire How True Past Seven Days Have Weakness in Legs Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4994211</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C122983</PreferredName>
        <Version>1</Version>
        <LongName>National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy Prostate Symptom Index</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122983</PREFERRED_NAME>
            <LONG_NAME>National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy Prostate Symptom Index</LONG_NAME>
            <CON_ID>4928123</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4994212</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C91781:C95402:C122984:C25338</PreferredName>
        <Version>1</Version>
        <LongName>How True Past Week Have Weakness in Legs Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91781</PREFERRED_NAME>
            <LONG_NAME>How True Question</LONG_NAME>
            <CON_ID>3133350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122984</PREFERRED_NAME>
            <LONG_NAME>Have Weakness in Legs Question</LONG_NAME>
            <CON_ID>4928124</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCN-FACT Index:National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy Index, David Cella, Ph.D., et.al., March 3, 2010.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4552765</PublicId>
      <PreferredName>4552765v1.0</PreferredName>
      <PreferredDefinition>Numeric scores from 0 (Not at all) to 4 (Very Much) on a Likert scale used on FACT questionnaires.</PreferredDefinition>
      <LongName>FACT Score 5 Point Likert Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>FACT-G:Functional Assessment of Cancer Therapy - General, David Cella, Ph.D., Version 4, Nov. 2007</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Some-what</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a great amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCCN-FACT FPSI-17</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>I have weakness in my legs (7)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQol Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring and Interpretation Links</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Scoring and Interpretation materials are accessible after registration on the FACIT website.</DocumentText>
        <URL>http://www.facit.org/FACITOrg/Questionnaires</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I have weakness in my legs</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I have weakness in my legs</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NCCN-FACT FPSI-17 (National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy Prostate Symptom Index 17)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916709</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="821">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5034396</PUBLICID>
    <LONGNAME>Agent Dose Modification Reason</LONGNAME>
    <PREFERREDNAME>AGENT_DOSE_MOD_RSN</PREFERREDNAME>
    <PREFERREDDEFINITION>Explanation of the cause for a study drug dose modification.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>C3D:Central Cancer Clinical Database</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2008655</PublicId>
      <PreferredName>AGT_DOSE_MOD_RSN</PreferredName>
      <PreferredDefinition>Reason for the modification of a dose of agent.</PreferredDefinition>
      <LongName>Agent Dose Modification Reason</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2390594</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1708:C25488:C25572</PreferredName>
        <Version>1</Version>
        <LongName>Agent Dose Modification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25572</PREFERRED_NAME>
            <LONG_NAME>Modification</LONG_NAME>
            <CON_ID>2203850</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2390595</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5034327</PublicId>
      <PreferredName>AGENT_MOD_RSN</PreferredName>
      <PreferredDefinition>An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Agent Modification Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2240632</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose increased per protocol guidelines</VALIDVALUE>
          <VALUEMEANING>Dose Increased per Protocol Guidelines</VALUEMEANING>
          <MEANINGDESCRIPTION>A process of becoming larger, more numerous, more important, or more likely.: A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the trial, but these could be represented in other protocol referenced documents.: A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25488, C25320, C25533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5034328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Therapy discontinued</VALIDVALUE>
          <VALUEMEANING>Therapy discontinued</VALUEMEANING>
          <MEANINGDESCRIPTION>To stop or end, permanently or temporarily.: A type of study protocol designed to evaluate intervention(s) for disease treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49656, C25484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5034329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose held per protocol guidelines</VALIDVALUE>
          <VALUEMEANING>Dose Held per Protocol Guidelines</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: Transfer possession of something to some person or group.: A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the trial, but these could be represented in other protocol referenced documents.: A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25488, C25320, C64974, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5034330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose held for adverse event</VALIDVALUE>
          <VALUEMEANING>Dose Held for Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: Transfer possession of something to some person or group.: Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).: A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25488, C41331, C64974, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5034331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No change</VALIDVALUE>
          <VALUEMEANING>No Change</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: The act of alteration or modification; changed or altered in form or character.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25446, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3578163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A</VALIDVALUE>
          <VALUEMEANING>NA (The patient is unable to complete a questionnaire in English or Spanish or French.)</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5026035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient non-compliant</VALIDVALUE>
          <VALUEMEANING>Patient Noncompliance</VALUEMEANING>
          <MEANINGDESCRIPTION>Failure of a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dose reduced per protocol guidelines</VALIDVALUE>
          <VALUEMEANING>Dose Reduced per Protocol Guidelines</VALUEMEANING>
          <MEANINGDESCRIPTION>Made less in size or amount or degree.: A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the trial, but these could be represented in other protocol referenced documents.: A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25488, C25320, C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5034394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-convulsant type change</VALIDVALUE>
          <VALUEMEANING>Anticonvulsant Change</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug or other substance used to prevent or stop seizures or convulsions.: The act of alteration or modification; changed or altered in form or character.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25446, C264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5034395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dosing error</VALIDVALUE>
          <VALUEMEANING>Dose Error</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.: A discrepancy between a computed, observed, or measured value or condition and the true, specified, or theoretically correct value or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43369, C25488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5034393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Reason for dose modification</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Reason for dose modification</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason for dose modification:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="822">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5042494</PUBLICID>
    <LONGNAME>ATARiS Gene Solution Name</LONGNAME>
    <PREFERREDNAME>5039794v1.0:5042358v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text that represents the ATARiS solution name, including the binary indicator of which shRNA is used.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CTD2:Cancer Target Discovery and Development</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5039794</PublicId>
      <PreferredName>5039791v1.0:5039792v1.0</PreferredName>
      <PreferredDefinition>A computational method designed to analyze phenotypic readouts from multiple-sample RNAi screens in which each gene is targeted by multiple RNAi reagents. ATARiS takes advantage of patterns in RNAi data across multiple samples in order to enrich for RNAi reagents whose phenotypic effects relate to suppression of their intended targets. By summarizing only such reagent effects for each gene, ATARiS produces quantitative, gene-level phenotype values, which provide a measure of the effect of gene suppression in each sample._A type of ATARiS output for RNAi reagents that produce a significantly similar phenotypic pattern across the screened samples. It consists of one phenotype value for each sample, representing the phenotypic outcome of suppressing the target gene in that sample relative to the outcome in other screened samples.</PreferredDefinition>
      <LongName>Analytic Technique for Assessment of RNAi by Similarity Gene Solution</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435027</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16612</PreferredName>
        <Version>1</Version>
        <LongName>Gene</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5039791</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C123896</PreferredName>
        <Version>1</Version>
        <LongName>Analytic Technique for Assessment of RNAi by Similarity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C123896</PREFERRED_NAME>
            <LONG_NAME>Analytic Technique for Assessment of RNAi by Similarity</LONG_NAME>
            <CON_ID>5036429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5039792</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C123897</PreferredName>
        <Version>1</Version>
        <LongName>Gene Solution</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C123897</PREFERRED_NAME>
            <LONG_NAME>Gene Solution</LONG_NAME>
            <CON_ID>5036430</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CTD2:Cancer Target Discovery and Development</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5042358</PublicId>
      <PreferredName>5042358v1.0</PreferredName>
      <PreferredDefinition>The words or language units by which the ATARiS solution name, including the binary indicator of which shRNA is used is known.</PreferredDefinition>
      <LongName>Gene Solution Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435028</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C26548</PreferredName>
        <Version>1</Version>
        <LongName>Gene Product</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTD2:Cancer Target Discovery and Development</Origin>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ataris_gene_solution_name</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>ataris_gene_solution_name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5646652</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTD-2</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Approved CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5092552</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="823">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5043218</PUBLICID>
    <LONGNAME>Malignant Neoplasm Bone Assessment Yes No Indicator</LONGNAME>
    <PREFERREDNAME>BONEASSESS</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator for information related to the assessment of a malignant neoplasm of the bone.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5043217</PublicId>
      <PreferredName>BONEASSESS</PreferredName>
      <PreferredDefinition>Information related to the assessment of a malignant neoplasm of the bone.</PreferredDefinition>
      <LongName>Malignant Neoplasm Bone Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2186369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5043215</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12366:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Bone Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12366</PREFERRED_NAME>
            <LONG_NAME>Bone</LONG_NAME>
            <CON_ID>2202686</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Bone lesion assessed</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Bone lesion assessed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>bone lesions present</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="824">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5046517</PUBLICID>
    <LONGNAME>Series Sentinel Lymph Node Biopsy Yes No Indicator</LONGNAME>
    <PREFERREDNAME>5046468v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator related to eligibility for patients who have a series of possible sentinel lymph node biopsy outcomes</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5046468</PublicId>
      <PreferredName>2181780v1.0:5046466v1.0</PreferredName>
      <PreferredDefinition>Information related to a series of conditions for a sentinel lymph node biopsy had by the patient</PreferredDefinition>
      <LongName>Series Sentinel Lymph Node Biopsy</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2181780</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Series</PreferredName>
        <Version>1</Version>
        <LongName>Series</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25674</PREFERRED_NAME>
            <LONG_NAME>Series</LONG_NAME>
            <CON_ID>2202620</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5046466</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15667</PreferredName>
        <Version>1</Version>
        <LongName>Sentinel Lymph Node Biopsy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15667</PREFERRED_NAME>
            <LONG_NAME>Sentinel Lymph Node Biopsy</LONG_NAME>
            <CON_ID>2204871</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the patient have sentinel</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the patient have sentinel lymph node biopsy performed before neoadjuvant chemotherapy: sentinel node biopsy alone if negative or if lymph nodes only contain micrometastases (&lt;2.0mm) or positive sentinel lymph node biopsy followed by axillary node dissection or axillary nodal radiotherapy following completion of neoadjuvant chemotherapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="825">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5116087</PUBLICID>
    <LONGNAME>Last Contact Month Number</LONGNAME>
    <PREFERREDNAME>2188672v1.0:2895904v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value that represents the month of the last contact with the patient.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188672</PublicId>
      <PreferredName>PT_LAST_CONTACT</PreferredName>
      <PreferredDefinition>information related to the last contact with a patient.</PreferredDefinition>
      <LongName>Patient Last Contact</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207245</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25551:C25461</PreferredName>
        <Version>1</Version>
        <LongName>Last Contact</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25551</PREFERRED_NAME>
            <LONG_NAME>Last</LONG_NAME>
            <CON_ID>2206286</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25461</PREFERRED_NAME>
            <LONG_NAME>Contact Person</LONG_NAME>
            <CON_ID>2202621</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2895904</PublicId>
      <PreferredName>EVT_MON_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks._A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Event Month Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2895903</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C29846:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Month Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>One of ten equal parts; a quantity corresponding to one tenth of the whole.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C81010</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the fifth position in an ordering or series; coming next after the fifth and just before the seventh in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54568</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the fourth position in an ordering or series; coming next after the fourth and just before the sixth in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54567</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the third position in an ordering or series; coming next after the third and just before the fifth in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the second position in an ordering or series.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Coming next after the first in position in space or time or degree or magnitude.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Preceding all others in time or space or degree.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Most Recent Month of Last Con</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Most Recent Month of Last Contact</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="826">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5119455</PUBLICID>
    <LONGNAME>Attitudes and Preferences Questionnaire How Important Treatment Based on Tumor Molecular Profile Improves Quality of Life Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>A&amp;P_MOL_QUALITY_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated observation of how important it is that treatment based on molecular profile, improves quality of life, based on a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>LCC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5119351</PublicId>
      <PreferredName>5119339v1.0:5119349v1.0</PreferredName>
      <PreferredDefinition>A habitual or characteristic mental attitude that determines how a person will interpret and respond to situations._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable._Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument._A question about how an individual rates the importance that treatment based on the molecular profile of their specific tumor improves quality of life._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Attitudes and Preferences Questionnaire How Important Treatment Based on Tumor Molecular Profile Improves Quality of Life Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>LCC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5119339</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C72885:C37912:C41187:C17048</PreferredName>
        <Version>1</Version>
        <LongName>Outlook And Preference Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C72885</PREFERRED_NAME>
            <LONG_NAME>Outlook</LONG_NAME>
            <CON_ID>2734006</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37912</PREFERRED_NAME>
            <LONG_NAME>And</LONG_NAME>
            <CON_ID>2528554</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41187</PREFERRED_NAME>
            <LONG_NAME>Preference</LONG_NAME>
            <CON_ID>2435947</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17048</PREFERRED_NAME>
            <LONG_NAME>Questionnaire</LONG_NAME>
            <CON_ID>2202367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5119349</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C125534:C25338</PreferredName>
        <Version>1</Version>
        <LongName>How Important Treatment Based on Tumor Molecular Profile Improves Quality of Life Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125534</PREFERRED_NAME>
            <LONG_NAME>How Important that Treatment Based on Tumor Molecular Profile Improves Quality of Life Question</LONG_NAME>
            <CON_ID>5119274</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5119311</PublicId>
      <PreferredName>A&amp;P_IMPORTANCE_SCL</PreferredName>
      <PreferredDefinition>Numeric scores from 0 (Not at all important) to 4 (Extremely important) on a Likert scale used on the Attitudes and Preferences questionnaire.</PreferredDefinition>
      <LongName>Attitudes and Preferences Questionnaire Importance Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>LCC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Importance Rating Score 2</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 2 on a scale that ranges from 0: Not at all important to 4: Extremely important.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5119314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Importance Rating Score 4</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 4 on a scale that ranges from 0: Not at all important to 4: Extremely important.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5119312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Importance Rating Score 3</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 3 on a scale that ranges from 0: Not at all important to 4: Extremely important.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5119313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Importance Rating Score 1</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 1 on a scale that ranges from 0: Not at all important to 4: Extremely important.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125544</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5119315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Importance Rating Score 0</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 0 on a scale that ranges from 0: Not at all important to 4: Extremely important.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5119316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Improves quality of life</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Improves quality of life</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="827">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5126979</PUBLICID>
    <LONGNAME>Memorial Symptom Assessment Scale F10 Past Week How Often Difficulty Sleeping Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>MSAS_F_SLEEP_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated observation in the past week how often they had difficulty sleeping, using a four-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5114502</PublicId>
      <PreferredName>5114473v1.0:5114500v1.0</PreferredName>
      <PreferredDefinition>A patient-rated instrument developed to provide multidimensional information about a diverse group of common symptoms. This 32-question, self-rated questionnaire evaluates the prevalence, characteristics, and distress associated with each of the symptoms._The most recent week, including today._A question about how often an individual has or had difficulty sleeping._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale Past Week How Often Difficulty Sleeping Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5114473</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C125238</PreferredName>
        <Version>1</Version>
        <LongName>Memorial Symptom Assessment Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125238</PREFERRED_NAME>
            <LONG_NAME>Memorial Symptom Assessment Scale</LONG_NAME>
            <CON_ID>5109052</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5114500</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C125275:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week How Often Difficulty Sleeping Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125275</PREFERRED_NAME>
            <LONG_NAME>How Often Difficulty Sleeping Question</LONG_NAME>
            <CON_ID>5109061</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5114451</PublicId>
      <PreferredName>MSAS_FREQ_SCL</PreferredName>
      <PreferredDefinition>Numeric scores from 1 (Rarely) to 4 (Almost Constantly) on a Likert scale used on the Memorial Symptom Assessment Scale questionnaire.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale Frequency Score 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Almost Constantly</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something was occurring or recurring nearly continually without interruption.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5116221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Frequently</VALUEMEANING>
          <MEANINGDESCRIPTION>Coming at short intervals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3826571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Occasionally</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3391175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How OFTEN did you have diffic</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How OFTEN did you have difficulty sleeping?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MSAS</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #34 of 126</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure.  The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents.  Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS (Memorial Symptom Assessment Scale)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5115651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840828</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS (Memorial Symptom Assessment Scale)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCI Standards</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="828">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5156168</PUBLICID>
    <LONGNAME>Correlative Study Results Availability Date</LONGNAME>
    <PREFERREDNAME>CORR_STDY_RSL_AVL_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>Calendar date on which the results from a correlative study designed to translate basic science findings into clinically use tools were available.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>C3D:Central Cancer Clinical Database</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5156162</PublicId>
      <PreferredName>5156159v1.0:5156160v1.0</PreferredName>
      <PreferredDefinition>A type of study that tests for a relationship between a condition and a potential causal factor of the condition._The outcome of an experiment or set of experiments, including observations and primary, processed, and analyzed data._The quality of being obtainable or accessible and ready for use or service._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Correlative Study Results Availability Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5156159</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16100:C76125</PreferredName>
        <Version>1</Version>
        <LongName>Correlative Study Experimental Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16100</PREFERRED_NAME>
            <LONG_NAME>Correlative Study</LONG_NAME>
            <CON_ID>2206187</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C76125</PREFERRED_NAME>
            <LONG_NAME>Experimental Result</LONG_NAME>
            <CON_ID>3099511</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5156160</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25429:C25275</PreferredName>
        <Version>1</Version>
        <LongName>Availability Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25429</PREFERRED_NAME>
            <LONG_NAME>Availability</LONG_NAME>
            <CON_ID>2204038</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017121</PublicId>
      <PreferredName>CTMS_DT</PreferredName>
      <PreferredDefinition>Date as required for Clinical Trials Monitoring Service submissions.  Exchange format is YYYYMMDD.  Display format is DDMMMYYYY, with the month display the first three letters of each month (Jan, Feb, Mar, etc.).</PreferredDefinition>
      <LongName>CTMS Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>DD/MON/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Correlative Study results Date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Correlative Study results Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="829">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5159817</PUBLICID>
    <LONGNAME>Surgical Procedure Protocol Week Performed 100 Character Text</LONGNAME>
    <PREFERREDNAME>SrglPdrPrtWkPrfmdTxt</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the protocol week of when a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5159612</PublicId>
      <PreferredName>2322305v1.0:5159610v1.0</PreferredName>
      <PreferredDefinition>Information related to the protocol week of when a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.</PreferredDefinition>
      <LongName>Surgical Procedure Protocol Week Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008536</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2322305</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5159610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42651:C29844:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Week Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42651</PREFERRED_NAME>
            <LONG_NAME>Protocol</LONG_NAME>
            <CON_ID>2211236</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29844</PREFERRED_NAME>
            <LONG_NAME>Week</LONG_NAME>
            <CON_ID>2203710</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666622</PublicId>
      <PreferredName>2666622v2.0</PreferredName>
      <PreferredDefinition>Text; the words of something written.</PreferredDefinition>
      <LongName>100 Character Text</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008581</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PropertiesOrAttributes</PreferredName>
        <Version>1</Version>
        <LongName>Properties or Attributes</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Protocol week in which surger</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Protocol week in which surgery was performed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="830">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5189797</PUBLICID>
    <LONGNAME>Human Activity Profile 62 Climbing 36 Steps Nonstop 3 Point Scale</LONGNAME>
    <PREFERREDNAME>HAP_Q62_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of their ability to climb 36 steps (nonstop), using a three point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5189144</PublicId>
      <PreferredName>5188571v1.0:5189142v1.0</PreferredName>
      <PreferredDefinition>A self-administered instrument designed to measure energy expenditure or physical fitness. It was originally developed to measure quality of life achieved by patients in rehabilitation programs for chronic obstructive pulmonary disease, but has also been used as a measure of physical activity in both healthy and impaired populations. The profile consists of 94 common daily activities listed in ascending order according to the energy required to perform them. Activities including self-care tasks, personal/household work, entertainment/social activities, and independent exercise pursuits and respondents are requested to indicate if they are currently able to perform the activity (unassisted), they have stopped performing the activity, or they have never performed the activity._A question about an individual&#39;s ability to climb 36 steps nonstop.</PreferredDefinition>
      <LongName>Human Activity Profile Climbing 36 Steps Nonstop</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5188571</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48948</PreferredName>
        <Version>1</Version>
        <LongName>Human Activity Profile</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48948</PREFERRED_NAME>
            <LONG_NAME>Human Activity Profile</LONG_NAME>
            <CON_ID>5168044</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5189142</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C126198</PreferredName>
        <Version>1</Version>
        <LongName>Climbing 36 Steps Nonstop</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126198</PREFERRED_NAME>
            <LONG_NAME>Climbing 36 Steps Nonstop Question</LONG_NAME>
            <CON_ID>5168253</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5188567</PublicId>
      <PreferredName>HAP_SCALE</PreferredName>
      <PreferredDefinition>an ordered reference standard.</PreferredDefinition>
      <LongName>HAP Activity 3 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>32</MaximumLength>
      <MinimumLength>23</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never Did This Activity</VALIDVALUE>
          <VALUEMEANING>Never Did This Activity</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is never did an activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5188568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Have Stopped Doing This Activity</VALIDVALUE>
          <VALUEMEANING>Have Stopped Doing This Activity</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has stopped doing an activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5188569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Still Doing This Activity</VALIDVALUE>
          <VALUEMEANING>Still Doing This Activity</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is still doing an activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5188570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Climbing 36 steps (nonstop)</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Climbing 36 steps (nonstop)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Human Activity Profile (HAP)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question 62 of 94</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions. Questions used in this manner do not represent the original measure and should not be referenced by the measure’s name.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>2</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5187973</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HAP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HAP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5187974</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Human Activity Profile (HAP)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900309</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="831">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5227775</PUBLICID>
    <LONGNAME>Standard Operating Procedure Blood Collection Requirement Fulfill Indicator</LONGNAME>
    <PREFERREDNAME>SOP_BLOOD_REQ_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The response that indicates whether the minimum number of pre-operative plasma and whole cell pellet aliquots were collected according to the standard operating procedure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>BBRB</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BPV: Biospecimen Pre-analytical Variables (BPV) Program</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5226152</PublicId>
      <PreferredName>2772260v1.0:5226150v1.0</PreferredName>
      <PreferredDefinition>An established procedure to be followed in carrying out a given operation or in a given situation._A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood._The act of gathering things together; having been brought together in one place._Something that is a necessary condition; something that is obligatory._Satisfy the requirements or expectations of.</PreferredDefinition>
      <LongName>Standard Operating Procedure Blood Collection Requirement Fulfill</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>BBRB</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2230266</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TISSUE BANKING</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Banking</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2772260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48443</PreferredName>
        <Version>1</Version>
        <LongName>Standard Operating Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48443</PREFERRED_NAME>
            <LONG_NAME>Standard Operating Procedure</LONG_NAME>
            <CON_ID>2612106</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5226150</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12434:C25453:C25652:C87531</PreferredName>
        <Version>1</Version>
        <LongName>Blood Collection Requirement Fulfill</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12434</PREFERRED_NAME>
            <LONG_NAME>Blood</LONG_NAME>
            <CON_ID>2202587</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25652</PREFERRED_NAME>
            <LONG_NAME>Requirement</LONG_NAME>
            <CON_ID>2204014</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C87531</PREFERRED_NAME>
            <LONG_NAME>Fulfill</LONG_NAME>
            <CON_ID>3017448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BPV: Biospecimen Pre-analytical Variables (BPV) Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>The minimum requirement was m</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>The minimum requirement was met for pre-operative blood collection as per the SOP (EDTA Tube)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BPV - Tumor Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Blood Collection and Processing</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736415</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BBRB</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BBRB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="832">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5250506</PUBLICID>
    <LONGNAME>Biospecimen Ileum Anatomic Subsite Other Specify</LONGNAME>
    <PREFERREDNAME>ILEUM_SSIT_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>The location of the ileum from which the specimen was collected that has not been previously listed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>BBRB</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5242545</PublicId>
      <PreferredName>2859635v1.0:5242543v1.0</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._The final section of the small intestine._Relating to anatomy._A position within another named site.</PreferredDefinition>
      <LongName>Biospecimen Ileum Anatomic Subsite</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>BBRB</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5242543</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12387:C25421:C45966</PreferredName>
        <Version>1</Version>
        <LongName>Ileum Anatomic Subsite</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12387</PREFERRED_NAME>
            <LONG_NAME>Ileum</LONG_NAME>
            <CON_ID>3242837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25421</PREFERRED_NAME>
            <LONG_NAME>Anatomic</LONG_NAME>
            <CON_ID>2202601</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45966</PREFERRED_NAME>
            <LONG_NAME>Subsite</LONG_NAME>
            <CON_ID>3170276</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666713</PublicId>
      <PreferredName>OTH_SPEC</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Other Specify</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCI CRF Standards</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other ileum location</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify other ileum location</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GTEx - Postmortem Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Recovery Case Report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736405</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BBRB</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BBRB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="833">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5255942</PUBLICID>
    <LONGNAME>Cardiac Condition Antiarrhythmic Therapy Yes No Indicator</LONGNAME>
    <PREFERREDNAME>4363904v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator related to a patient using anti-arrhythmic therapy</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4363904</PublicId>
      <PreferredName>4363835v1.0:4363902v1.0</PreferredName>
      <PreferredDefinition>Having to do with the heart._A state of being, such as a state of health._Agents used for the treatment or prevention of cardiac arrhythmias; they may effect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.</PreferredDefinition>
      <LongName>Cardiac Condition Antiarrhythmic Therapy</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4363835</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13306:C25457</PreferredName>
        <Version>1</Version>
        <LongName>Cardiac Condition</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13306</PREFERRED_NAME>
            <LONG_NAME>Cardiac</LONG_NAME>
            <CON_ID>2204960</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25457</PREFERRED_NAME>
            <LONG_NAME>Condition</LONG_NAME>
            <CON_ID>2202899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4363902</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47793:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Antiarrhythmic Agent Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47793</PREFERRED_NAME>
            <LONG_NAME>Antiarrhythmic Agent</LONG_NAME>
            <CON_ID>4363901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If used, will anti-arrhythmic</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If used, will anti-arrhythmic therapy other than beta blockers or digoxin be discontinued for the duration of treatment with copanlisib?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="834">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5260310</PUBLICID>
    <LONGNAME>Neurologic Examination Face Sensory Performed Result Type</LONGNAME>
    <PREFERREDNAME>NEURO_ASSESS_FCL_SNS_RSLT</PREFERREDNAME>
    <PREFERREDDEFINITION>The assessment of the functionality of the brain, spinal column, and nerves._The anterior portion of the head extending from the forehead to the chin and ear to ear. The facial structures contain the eyes, nose and mouth, cheeks and jaws._Having to do with the senses._Executed and carried through to completion._the result of a neurological assessment of the patient.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5259976</PublicId>
      <PreferredName>5259325v1.0:5259974v1.0</PreferredName>
      <PreferredDefinition>The assessment of the functionality of the brain, spinal column, and nerves._The anterior portion of the head extending from the forehead to the chin and ear to ear. The facial structures contain the eyes, nose and mouth, cheeks and jaws._Having to do with the senses._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Neurologic Examination Face Sensory Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5259325</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C81313</PreferredName>
        <Version>1</Version>
        <LongName>Neurologic Examination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C81313</PREFERRED_NAME>
            <LONG_NAME>Neurologic Examination</LONG_NAME>
            <CON_ID>3192586</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5259974</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13071:C28259:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Face Sensory Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13071</PREFERRED_NAME>
            <LONG_NAME>Face</LONG_NAME>
            <CON_ID>2451131</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28259</PREFERRED_NAME>
            <LONG_NAME>Sensory</LONG_NAME>
            <CON_ID>2206369</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018985</PublicId>
      <PreferredName>NEU_ASSESS_RESULT_TP</PreferredName>
      <PreferredDefinition>the result of a neurological assessment of the patient.</PreferredDefinition>
      <LongName>Neurological Assessment Result Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating from the norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown/not tested</VALIDVALUE>
          <VALUEMEANING>Unknown/not tested</VALUEMEANING>
          <MEANINGDESCRIPTION>Unknown/not tested</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-06-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566029</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Facial sensation (V):</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Facial sensation (V):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="835">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5271324</PUBLICID>
    <LONGNAME>Current Moderate Exercise Assessment Average Daily Hours Number</LONGNAME>
    <PREFERREDNAME>5271284v1.0:2233199v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to Moderate exercise as an assessment of current physical activity._Number to represent the number of hours per day spent in a specified activity.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5271284</PublicId>
      <PreferredName>5271280v1.0:5271274v1.0</PreferredName>
      <PreferredDefinition>Information related to Moderate exercise as an assessment of current physical activity.</PreferredDefinition>
      <LongName>Current Physical Activity Moderate Exercise Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5271280</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25471:C17708</PreferredName>
        <Version>1</Version>
        <LongName>Current Physical Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17708</PREFERRED_NAME>
            <LONG_NAME>Physical Activity</LONG_NAME>
            <CON_ID>2202366</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5271274</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C39772:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Moderate Exercise Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39772</PREFERRED_NAME>
            <LONG_NAME>Moderate Exercise</LONG_NAME>
            <CON_ID>2202324</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2233199</PublicId>
      <PreferredName>ACT_AVG_DAY_HR_NUM</PreferredName>
      <PreferredDefinition>Number to represent the number of hours per day spent in a specified activity.</PreferredDefinition>
      <LongName>Activity Average Daily Hours Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177868</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Number</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Exercising moderately</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Exercising moderately</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="836">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5286048</PUBLICID>
    <LONGNAME>Cancer Patient Tobacco Use Questionnaire 20a Past 30 Days Lived in Place Where Other People Smoked Cigarettes Indoors Indicator</LONGNAME>
    <PREFERREDNAME>CTUQ_Q20A_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of whether or not they lived in a place where other people smoked cigarettes indoors.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>C-TUQ:Cancer Patient Tobacco Use Questionnaire. NCI-AACR Cancer Patient Tobacco Use Assessment Task Force, 6/19/2015</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5285588</PublicId>
      <PreferredName>5285223v1.0:5285586v1.0</PreferredName>
      <PreferredDefinition>A questionnaire developed for the baseline and longitudinal assessment of tobacco use in the cancer setting. Domains include cigarette smoking history and current use, use relative to cancer diagnosis and treatment, other tobacco product use, cessation, and second-hand exposure._A question about whether an individual has lived in a place where other people smoked cigarettes indoors in the past 30 days.</PreferredDefinition>
      <LongName>Cancer Patient Tobacco Use Questionnaire Lived in Place Where Other People Smoked Cigarettes Indoors Past 30 Days</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5285223</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C127024</PreferredName>
        <Version>1</Version>
        <LongName>Cancer Patient Tobacco Use Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C127024</PREFERRED_NAME>
            <LONG_NAME>Cancer Patient Tobacco Use Questionnaire</LONG_NAME>
            <CON_ID>5279991</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5285586</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C127103</PreferredName>
        <Version>1</Version>
        <LongName>Lived in Place Where Other People Smoked Cigarettes Indoors Past 30 Days</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C127103</PREFERRED_NAME>
            <LONG_NAME>Lived in Place Where Other People Smoked Cigarettes Indoors Past 30 Days Question</LONG_NAME>
            <CON_ID>5280033</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>C-TUQ:Cancer Patient Tobacco Use Questionnaire. NCI-AACR Cancer Patient Tobacco Use Assessment Task Force, 6/19/2015</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>C-TUQ Question Sequence</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>42 of 47</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lived in a place where other</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Lived in a place where other people smoked cigarettes indoors?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value sets in order to retain the validity and reliability associated with the measure. Changes may not be made to these CDEs.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C-TUQ (Cancer Patient Tobacco Use Questionnaire)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>5285152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="837">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5292940</PUBLICID>
    <LONGNAME>Combs Prognostic Index Score</LONGNAME>
    <PREFERREDNAME>COMBS_PROG_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric score to predict the outcome of reirradiation for recurrent glioma which includes elements of histology, age of the individual and the time between initial radiation therapy and reirradiation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Combs Prognostic Index:Stephanie E. Combs, et.al., 2013</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5292939</PublicId>
      <PreferredName>5292937v1.0:2322175v1.0</PreferredName>
      <PreferredDefinition>A prognostic index developed to predict the outcome of reirradiation for recurrent glioma. The index accounts for histology, patient age, and time between initial radiation and re-irradiation._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Combs Prognostic Index Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20047</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic or Prognostic Factor</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5292937</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C127861</PreferredName>
        <Version>1</Version>
        <LongName>Combs Prognostic Index</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C127861</PREFERRED_NAME>
            <LONG_NAME>Combs Prognostic Index</LONG_NAME>
            <CON_ID>5292914</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2322175</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Combs Prognostic Index:Stephanie E. Combs, et.al., 2013</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5292931</PublicId>
      <PreferredName>COMBS_SCL</PreferredName>
      <PreferredDefinition>an ordered reference standard.</PreferredDefinition>
      <LongName>Combs Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20047</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic or Prognostic Factor</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>Combs Prognostic Index:Stephanie E. Combs, et.al., 2013</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very Poor Survival after Reirradiation</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 4 on the Combs Prognostic Index scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5292932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Poor Survival after Reirradiation</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 3 on the Combs Prognostic Index scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127868</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5292933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Moderate Survival after Reirradiation</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 2 on the Combs Prognostic Index scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127866</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5292934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Good Survival after Reirradiation</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 1 on the Combs Prognostic Index scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127865</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5292935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Excellent Survival after Reirradiation</VALUEMEANING>
          <MEANINGDESCRIPTION>A score of 0 on the Combs Prognostic Index scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127863</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5292936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Combs Score</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Combs Score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="838">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5300851</PUBLICID>
    <LONGNAME>Hospital Experience Assessment Rate</LONGNAME>
    <PREFERREDNAME>HOSP_EXP_ASSESS_RATE</PREFERREDNAME>
    <PREFERREDDEFINITION>An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured._The accumulation of knowledge or skill that results from direct participation in events or activities._The final result of a determination of the value, significance, or extent of._the status of the patient&#39;s general health._An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured._The accumulation of knowledge or skill that results from direct participation in events or activities._A measurement of degree, speed, or frequency relative to time.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5300817</PublicId>
      <PreferredName>5300815v1.0:2465182v1.0</PreferredName>
      <PreferredDefinition>An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured._The accumulation of knowledge or skill that results from direct participation in events or activities._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Hospital Experience Assessment</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5300815</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16696:C54627</PreferredName>
        <Version>1</Version>
        <LongName>Hospital Experience</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16696</PREFERRED_NAME>
            <LONG_NAME>Hospital</LONG_NAME>
            <CON_ID>2202656</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54627</PREFERRED_NAME>
            <LONG_NAME>Experience</LONG_NAME>
            <CON_ID>2731931</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2465182</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25217</PreferredName>
        <Version>1</Version>
        <LongName>Assessed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5300835</PublicId>
      <PreferredName>HOSP_EXPE_RATE</PreferredName>
      <PreferredDefinition>the status of the patient&#39;s general health._An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured._The accumulation of knowledge or skill that results from direct participation in events or activities._A measurement of degree, speed, or frequency relative to time.</PreferredDefinition>
      <LongName>Hospital Experience Rate</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>225</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>Alliance Case Report Form</Origin>
      <Representation>
        <PublicId>5300834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16696:C54627:C25636</PreferredName>
        <Version>1</Version>
        <LongName>Hospital Experience Rate</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16696</PREFERRED_NAME>
            <LONG_NAME>Hospital</LONG_NAME>
            <CON_ID>2202656</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54627</PREFERRED_NAME>
            <LONG_NAME>Experience</LONG_NAME>
            <CON_ID>2731931</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25636</PREFERRED_NAME>
            <LONG_NAME>Rate</LONG_NAME>
            <CON_ID>2203725</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Excellent</VALIDVALUE>
          <VALUEMEANING>Excellent</VALUEMEANING>
          <MEANINGDESCRIPTION>Conforming to the highest quality or standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fair</VALIDVALUE>
          <VALUEMEANING>Fair</VALUEMEANING>
          <MEANINGDESCRIPTION>Having no exceptional quality or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Good</VALIDVALUE>
          <VALUEMEANING>Good</VALUEMEANING>
          <MEANINGDESCRIPTION>Valuable or useful or agreeable or pleasing.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poor</VALIDVALUE>
          <VALUEMEANING>Poor</VALUEMEANING>
          <MEANINGDESCRIPTION>Of low value or worth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3115746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very good</VALIDVALUE>
          <VALUEMEANING>Very much Good</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.: Valuable or useful or agreeable or pleasing.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64975, C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3291261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How would you rate your hospi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How would you rate your hospital experience?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="839">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5334815</PUBLICID>
    <LONGNAME>Event was associated with a handover</LONGNAME>
    <PREFERREDNAME>5329094v1.0:5333451v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Determination if the event was associated with a handover/handoff.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AHRQ</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AHRQ:AHRQ Common Formats</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5329094</PublicId>
      <PreferredName>5329092v1.0</PreferredName>
      <PreferredDefinition>No Value Exists</PreferredDefinition>
      <LongName>Event was associated with a handover</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ONC SDC Project</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5329092</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>74568-7</PreferredName>
        <Version>1</Version>
        <LongName>Event was associated with a handover:Find:Pt:^Event:Ord:AHRQ</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>74568-7</PREFERRED_NAME>
            <LONG_NAME>Event was associated with a handover:Find:Pt:^Event:Ord:AHRQ</LONG_NAME>
            <CON_ID>5329091</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>LOINC_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7318108</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38046:C42605</PreferredName>
        <Version>1</Version>
        <LongName>Unspecified Property</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38046</PREFERRED_NAME>
            <LONG_NAME>Unspecified</LONG_NAME>
            <CON_ID>2230154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42605</PREFERRED_NAME>
            <LONG_NAME>Property</LONG_NAME>
            <CON_ID>2231569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AHRQ:AHRQ Common Formats</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5333451</PublicId>
      <PreferredName>5333451v1.0</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Yes No Unknown Response Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ONC SDC Project</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>HL7CDv3</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>3</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AHRQ:AHRQ Common Formats</Origin>
      <Representation>
        <PublicId>5333131</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A15</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3006497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A18</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-07-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5349775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UNK</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the event associated with</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the event associated with a handover/handoff?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SIR|74501-8</Name>
        <DocumentType>AHRQ Form</DocumentType>
        <DocumentText>AHRQ Summary of Initial Report|Patient safety event report - hospital: summary of initial report (SIR) - version 1.2 [AHRQ]</DocumentText>
        <URL>https://www.psoppc.org/psoppc_web/DLMS/downloadDocument?groupId&amp;#61;95&amp;amp;pageName&amp;#61;common%20formats%20version%201.2%20technical%20specifications</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4382693</PublicId>
          <ContextName>AHRQ</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AHRQ Common Formats</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SIR 1.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5406423</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ONC SDC Project</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DE96</AlternateName>
        <AlternateNameType>AHRQ Identifier</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="840">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5358352</PUBLICID>
    <LONGNAME>Binet Staging System Stage Finding Status Indicator</LONGNAME>
    <PREFERREDNAME>2848643v1.0:3436461v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the status of the laboratory results for Binet staging.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2848643</PublicId>
      <PreferredName>BINET_STAGE</PreferredName>
      <PreferredDefinition>A staging system for Chronic Lymphocytic Leukemia; it is based upon the presence or absence of anemia and/or thrombocytopenia, and involvement of lymphoid tissues, including splenic lymphoid tissue._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.</PreferredDefinition>
      <LongName>Binet Staging System Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2848641</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20114</PreferredName>
        <Version>1</Version>
        <LongName>Binet Staging System</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20114</PREFERRED_NAME>
            <LONG_NAME>Binet Staging System</LONG_NAME>
            <CON_ID>2848072</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2224086</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16899</PreferredName>
        <Version>1</Version>
        <LongName>Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3436461</PublicId>
      <PreferredName>3436461v1.0</PreferredName>
      <PreferredDefinition>The result of an examination or inquiry._A condition or state at a particular time._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Finding Status Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3436460</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61036:C25688:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Finding Status Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61036</PREFERRED_NAME>
            <LONG_NAME>Investigation Finding</LONG_NAME>
            <CON_ID>2528540</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not known</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-11</PVBEGINDATE>
          <PVENDDATE>2013-03-12</PVENDDATE>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known</VALIDVALUE>
          <VALUEMEANING>Known</VALUEMEANING>
          <MEANINGDESCRIPTION>Recognized, familiar, or within the scope of knowledge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2934435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3371379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-03-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the status of the Bin</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the status of the Binet staging finding?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Binet stage</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Binet stage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Binet stage</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Binet stage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_DADX_binet_stage_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="841">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5408734</PUBLICID>
    <LONGNAME>Biospecimen Normal Adjacent Tissue Barcode Identifier</LONGNAME>
    <PREFERREDNAME>NML_ADJ_TIS_BCOD_ID</PREFERREDNAME>
    <PREFERREDDEFINITION>A sequence of characters that specifically identifies a particular normal adjacent tissue specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>BBRB</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BPV: Biospecimen Pre-analytical Variables (BPV) Program</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5408733</PublicId>
      <PreferredName>2859635v1.0:5408731v1.0</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm._Next to or adjoining._An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function._A machine-readable representation of information in a visual format on a surface.</PreferredDefinition>
      <LongName>Biospecimen Normal Adjacent Tissue Barcode</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>BBRB</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2230266</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TISSUE BANKING</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Banking</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5408731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14165:C25408:C12801:C43361</PreferredName>
        <Version>1</Version>
        <LongName>Normal Adjacent Tissue Barcode</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14165</PREFERRED_NAME>
            <LONG_NAME>Normal</LONG_NAME>
            <CON_ID>2204843</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25408</PREFERRED_NAME>
            <LONG_NAME>Adjacent</LONG_NAME>
            <CON_ID>2206154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12801</PREFERRED_NAME>
            <LONG_NAME>Tissue</LONG_NAME>
            <CON_ID>2202489</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43361</PREFERRED_NAME>
            <LONG_NAME>Barcode</LONG_NAME>
            <CON_ID>2236527</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BPV: Biospecimen Pre-analytical Variables (BPV) Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018694</PublicId>
      <PreferredName>ID</PreferredName>
      <PreferredDefinition>One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177869</PublicId>
        <ContextName>EDRN</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Identifier</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Barcode ID</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Barcode ID</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BPV - Tumor Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188870</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BPV - Tumor Biospecimen Acquis</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Processing Wksht</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736429</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BBRB</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BBRB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="842">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5628076</PUBLICID>
    <LONGNAME>Neonate birth date</LONGNAME>
    <PREFERREDNAME>5622069v1.0:5332931v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Documentation of the month, day, and year the neonate was born.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AHRQ</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AHRQ:AHRQ Common Formats</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5622069</PublicId>
      <PreferredName>5622065v1.0:2193333v1.0</PreferredName>
      <PreferredDefinition>An infant during the first month after birth._A human being._The event of being born.</PreferredDefinition>
      <LongName>Neonate Person Birth</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ONC SDC Project</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5622065</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16731:C25190</PreferredName>
        <Version>1</Version>
        <LongName>Newborn Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16731</PREFERRED_NAME>
            <LONG_NAME>Newborn</LONG_NAME>
            <CON_ID>2480623</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2193333</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Birth</PreferredName>
        <Version>1</Version>
        <LongName>Birth</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25155</PREFERRED_NAME>
            <LONG_NAME>Birth</LONG_NAME>
            <CON_ID>2202896</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AHRQ:AHRQ Common Formats</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5332931</PublicId>
      <PreferredName>5332931v1.0</PreferredName>
      <PreferredDefinition>A data type comprised of a date and time value that corresponds with a specific point in the time continuum._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Point in Time Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ONC SDC Project</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>HL7TSv3</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AHRQ:AHRQ Common Formats</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Neonate&#39;s Date of Birth</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Neonate&#39;s Date of Birth</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>HERF|74495-3|74771-7</Name>
        <DocumentType>AHRQ Form</DocumentType>
        <DocumentText>AHRQ Healthcare Event Reporting Form|Patient safety event report - hospital: healthcare event reporting form (HERF) - version 1.2 [AHRQ]</DocumentText>
        <URL>https://www.psoppc.org/psoppc_web/DLMS/downloadDocument?groupId=93&amp;amp;pageName=common%20formats%20version%201.2%20technical%20specifications</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4382693</PublicId>
          <ContextName>AHRQ</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AHRQ Common Formats</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HERF 1.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5406422</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ONC SDC Project</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DE37</AlternateName>
        <AlternateNameType>AHRQ Identifier</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="843">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5629054</PUBLICID>
    <LONGNAME>Pediatric Quality of Life Inventory Version 4 Past One Month Quantity Have Trouble Keeping Up with Schoolwork Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PQL_IN_V4_SCF3_5P_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how much of a problem it has been in the past one month keeping up with schoolwork, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PedsQL: Pediatric Quality of Life, James W. Varni, Ph.D., 1998</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5614376</PublicId>
      <PreferredName>3202917v1.0:5628120v1.0</PreferredName>
      <PreferredDefinition>A parent report or patient self report for measuring health-related quality of life (HRQOL) in healthy children and adolescents and those with acute and chronic health conditions. The PedsQL Measurement Model uses a modular approach that integrates both generic core scales and disease-specific modules into one measurement system. (Copyright 1998-2008 James W. Varni, Ph.D.)_A period of time consisting of the 30 days before the present._How much there is of something that you can measure; the total amount or number._A question about whether an individual has trouble keeping up with schoolwork._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Pediatric Quality of Life Inventory Past 30 Days Quantity Have Trouble Keeping Up with Schoolwork Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3202917</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C78652</PreferredName>
        <Version>1</Version>
        <LongName>Pediatric Quality of Life Inventory</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78652</PREFERRED_NAME>
            <LONG_NAME>Pediatric Quality of Life Inventory</LONG_NAME>
            <CON_ID>2808023</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5628120</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C131330:C25256:C131247:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past 30 Days Quantity Have Trouble Keeping Up with Schoolwork Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131330</PREFERRED_NAME>
            <LONG_NAME>Past 30 days</LONG_NAME>
            <CON_ID>5615928</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131247</PREFERRED_NAME>
            <LONG_NAME>Have Trouble Keeping Up with Schoolwork Question</LONG_NAME>
            <CON_ID>5612574</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PedsQL: Pediatric Quality of Life, James W. Varni, Ph.D., 1998</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5627410</PublicId>
      <PreferredName>PEDSQL_5_POINT_SCALE</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Pediatric Quality of Life Inventory Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>PedsQL: Pediatric Quality of Life, James W. Varni, Ph.D., 1998</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Almost All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened almost all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Often</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something occurs frequently.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5628246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Almost Never</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something rarely happens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring Manual Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure</DocumentText>
        <URL>http://www.pedsql.org/score.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PedsQL Pediatric Quality of Life Inventory Parent Report (2-4)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #1 of 3 (School Functioning)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pediatric QoL Inventory (8-12)(13-18)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>I have trouble keeping up with my schoolwork</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pediatric QoL Inventory Parent (5-7)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Keeping up with school activities</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pediatric QoL Inventory Parent (8-12)(13-18)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Keeping up with schoolwork</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pediatric QoL Inventory (8-12)(13-18)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #3 of 5 (About School)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pediatric QoL Inventory Parent (5-7)(8-12)(13-18)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #3 of 5 (Social Functioning)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I have trouble keeping up wit</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I have trouble keeping up with my schoolwork</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pediatric QoL Inventory Parent (2-4)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Doing the same school activities as peers</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Keeping up with work or studies</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>I have trouble keeping up with my work or studies</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Core Scales</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5845468</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Condition Specific Modules</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5845469</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_SCHL</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_SCHLACTVT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="844">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5630748</PUBLICID>
    <LONGNAME>Pediatric Quality of Life Inventory-Multidimensional Fatigue CF1 Past One Month Quantity Hard to Keep Attention on Things Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PQOL_F_CF1_5PT_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how much of a problem it has been in the past one month with keeping their attention on things, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PedsQL: Pediatric Quality of Life, James W. Varni, Ph.D., 1998</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5630522</PublicId>
      <PreferredName>5633962v1.0:5630520v1.0</PreferredName>
      <PreferredDefinition>An 18 item component of the Pediatric Quality of Life Inventory is a generic symptom-specific instrument to measure fatigue in pediatric patients ages 2?18 comprised of General Fatigue, Sleep/Rest Fatigue, and Cognitive Fatigue domains._A period of time consisting of the 30 days before the present._How much there is of something that you can measure; the total amount or number._A question about whether an individual finds or found it hard to keep their attention on things._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Pediatric Quality of Life Inventory-Multidimensional Fatigue Scale Past 30 Days Quantity Hard to Keep Attention on Things Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5633962</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C131369</PreferredName>
        <Version>1</Version>
        <LongName>Pediatric Quality of Life Inventory-Multidimensional Fatigue Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131369</PREFERRED_NAME>
            <LONG_NAME>Pediatric Quality of Life Inventory-Multidimensional Fatigue Scale</LONG_NAME>
            <CON_ID>5633959</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5630520</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C131330:C25256:C131380:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past 30 Days Quantity Hard to Keep Attention on Things Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131330</PREFERRED_NAME>
            <LONG_NAME>Past 30 days</LONG_NAME>
            <CON_ID>5615928</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131380</PREFERRED_NAME>
            <LONG_NAME>Hard to Keep Attention on Things Question</LONG_NAME>
            <CON_ID>5621350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PedsQL: Pediatric Quality of Life, James W. Varni, Ph.D., 1998</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5627410</PublicId>
      <PreferredName>PEDSQL_5_POINT_SCALE</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Pediatric Quality of Life Inventory Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>PedsQL: Pediatric Quality of Life, James W. Varni, Ph.D., 1998</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Almost All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened almost all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Often</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something occurs frequently.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5628246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Almost Never</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something rarely happens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>It is hard for me to keep my</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>It is hard for me to keep my attention on things</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PedsQL (8-12)(13-18) Fatigue</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>It is hard for me to keep my attention on things</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PedsQL Parent (2-4)(5-7)(8-12)(13-18) Fatigue</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Difficulty keeping his/her attention on things</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring Manual Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure.</DocumentText>
        <URL>http://www.pedsql.org/score.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PedsQL Multidimensional Fatigue Scale (8-12)(13-18)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #1 of 6 (Cognitive Fatigue)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PedsQL Multidimensional Fatigue Scale Parent Report (2-4)(5-7)(8-12)(13-18)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #1 of 6 (Cognitive Fatigue)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Condition Specific Modules</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5845469</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="845">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5632762</PUBLICID>
    <LONGNAME>Full Vial Disposal Indicator</LONGNAME>
    <PREFERREDNAME>5632761v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not full vials were disposed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5632761</PublicId>
      <PreferredName>5632758v1.0:5632759v1.0</PreferredName>
      <PreferredDefinition>Containing as much or as many as is possible or normal._A small, often stoppered glass or plastic bottle for holding medicines and chemicals._The act or means of getting rid of something.</PreferredDefinition>
      <LongName>Full Vial Disposal</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5632758</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25517:C41275</PreferredName>
        <Version>1</Version>
        <LongName>Full Vial</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25517</PREFERRED_NAME>
            <LONG_NAME>Full</LONG_NAME>
            <CON_ID>2206221</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41275</PREFERRED_NAME>
            <LONG_NAME>Vial</LONG_NAME>
            <CON_ID>2486072</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5632759</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48166</PreferredName>
        <Version>1</Version>
        <LongName>Disposal</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48166</PREFERRED_NAME>
            <LONG_NAME>Disposal</LONG_NAME>
            <CON_ID>2513279</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a full vial(s) disposed?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was a full vial(s) disposed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Full vial(s) discarded?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Full vial(s) discarded?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Full vial(s) discarded?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Full vial(s) discarded?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="846">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5750340</PUBLICID>
    <LONGNAME>Patient Missed Dose Fell Asleep Early Slept During Dose Reason Data Unknown Text</LONGNAME>
    <PREFERREDNAME>PT_MIS_DOSE_FL_ASLP_SLPT_RSN_D</PREFERREDNAME>
    <PREFERREDDEFINITION>A single character text field to indicate if the patient missed doses for the reason of fell asleep too early or slept through the dose.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5750339</PublicId>
      <PreferredName>PT_MIS_DOSE_FL_ASLP_SLPT_RSN</PreferredName>
      <PreferredDefinition>A dose of medicine that was not taken at the prescribed dosing interval._A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._An event which results in an individual coming to rest inadvertently on the ground or lower object. (WHO)_A natural and periodic state of rest during which consciousness of the world is suspended._At or near the beginning of a period of time or course of events._A natural and periodic state of rest during which consciousness of the world is suspended._At some point in a given period of time._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Patient Missed Dose Fell Asleep Early Slept During Dose Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5750300</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50429:C16960</PreferredName>
        <Version>1</Version>
        <LongName>Missed Dose Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50429</PREFERRED_NAME>
            <LONG_NAME>Missed Dose</LONG_NAME>
            <CON_ID>3134577</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5750337</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5750337v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Fall Sleep Early Sleep During Dose Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50558</PREFERRED_NAME>
            <LONG_NAME>Fall</LONG_NAME>
            <CON_ID>2944775</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73425</PREFERRED_NAME>
            <LONG_NAME>Sleep</LONG_NAME>
            <CON_ID>2736838</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61589</PREFERRED_NAME>
            <LONG_NAME>Early</LONG_NAME>
            <CON_ID>2528521</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73425</PREFERRED_NAME>
            <LONG_NAME>Sleep</LONG_NAME>
            <CON_ID>2736838</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200608</PublicId>
      <PreferredName>DATA_UNKNOWN_TEXT</PreferredName>
      <PreferredDefinition>a single character text field to record data.</PreferredDefinition>
      <LongName>Data Unknown Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Fell asleep too early/slept t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Fell asleep too early/slept through dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="847">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5777374</PUBLICID>
    <LONGNAME>Chemotherapy Dose Reduced Or Therapy Delayed Dose Modification Indicator</LONGNAME>
    <PREFERREDNAME>Chx_Ds_Rdc_Tx_Dly_Ds_Mod_Ind</PREFERREDNAME>
    <PREFERREDDEFINITION>The response that indicates whether there were any planned or unplanned chemotherapy dose reductions or treatment delays.</PREFERREDDEFINITION>
    <VERSION>1.1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5777367</PublicId>
      <PreferredName>2404910v1.00:5777365v1.00</PreferredName>
      <PreferredDefinition>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.:An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._An indication that a therapy was either delayed or prolonged._Change, alteration, or adjustment of a dose specified in a treatment plan or/and administered to a patient.</PreferredDefinition>
      <LongName>Chemotherapy Dose Reduced Or Therapy Delayed Or Prolonged Dose Modification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404910</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15632</PreferredName>
        <Version>1</Version>
        <LongName>Chemotherapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15632</PREFERRED_NAME>
            <LONG_NAME>Chemotherapy</LONG_NAME>
            <CON_ID>2202708</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5777365</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49505:C37998:C50425:C54346</PreferredName>
        <Version>1</Version>
        <LongName>Dose Reduced Or Therapy Delayed Or Prolonged Dose Modification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49505</PREFERRED_NAME>
            <LONG_NAME>Dose Reduced</LONG_NAME>
            <CON_ID>2452860</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50425</PREFERRED_NAME>
            <LONG_NAME>Therapy Delayed or Prolonged</LONG_NAME>
            <CON_ID>5733033</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54346</PREFERRED_NAME>
            <LONG_NAME>Dose Modification</LONG_NAME>
            <CON_ID>2715003</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5777369</PublicId>
      <PreferredName>5777369v1.0</PreferredName>
      <PreferredDefinition>Change, alteration, or adjustment of a dose specified in a treatment plan or/and administered to a patient._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Dose Modification Indicator</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>5777368</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54346:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Dose Modification Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54346</PREFERRED_NAME>
            <LONG_NAME>Dose Modification</LONG_NAME>
            <CON_ID>2715003</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, unplanned treatment delay</VALIDVALUE>
          <VALUEMEANING>Yes, unplanned treatment delay</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, unplanned treatment delay</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, planned treatment delay</VALIDVALUE>
          <VALUEMEANING>Yes, planned treatment delay</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, planned treatment delay</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, unplanned dose reduction</VALIDVALUE>
          <VALUEMEANING>Yes, unplanned dose reduction</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, unplanned dose reduction</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, planned dose reduction</VALIDVALUE>
          <VALUEMEANING>Yes, planned dose reduction</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, planned dose reduction</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, not according to protocol</VALIDVALUE>
          <VALUEMEANING>Yes, not according to protocol</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, not according to protocol</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6112309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, according to protocol</VALIDVALUE>
          <VALUEMEANING>Yes, according to protocol</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, according to protocol</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6112310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were there any chemotherapy d</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Were there any chemotherapy dose reductions or treatment delays during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the treatment delay at the start of isotretinoin therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were there any dose reductions or omissions in chemotherapy this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="848">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5849621</PUBLICID>
    <LONGNAME>Memorial Symptom Assessment Scale (MSAS) 10-18 Past Week How Much Distress Feeling Drowsy Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>MSAS10_18_D_DROWS_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated observation in the past week of how much distress they had from symptoms of feeling drowsy, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MSAS 10-18:  Memorial Symptom Assessment Scale (10-18). J. Collins, et al. Journal of Pain and Symptom Management. 2000 May; 19(5): 363-377</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5844557</PublicId>
      <PreferredName>5840805v1.0:5114572v1.0</PreferredName>
      <PreferredDefinition>A patient-rated questionnaire designed to evaluate the prevalence, characteristics, and distress to children with cancer aged 10-18. This 30-question instrument was adapted from a previously-validated adult version._The most recent week, including today._A question about an individual&#39;s distress from feeling of drowsy._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale (MSAS) 10-18 Past Week How Much Distress Feeling Drowsy Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5840805</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C134965</PreferredName>
        <Version>1</Version>
        <LongName>Memorial Symptom Assessment Scale (MSAS) 10-18</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C134965</PREFERRED_NAME>
            <LONG_NAME>Memorial Symptom Assessment Scale (MSAS) 10-18</LONG_NAME>
            <CON_ID>5840197</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5114572</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C125337:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week How Much Distress Feeling Drowsy Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125337</PREFERRED_NAME>
            <LONG_NAME>How Much Distress Feeling Drowsy Question</LONG_NAME>
            <CON_ID>5109175</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MSAS 10-18:  Memorial Symptom Assessment Scale (10-18). J. Collins, et al. Journal of Pain and Symptom Management. 2000 May; 19(5): 363-377</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5114472</PublicId>
      <PreferredName>MSAS_DISTRESS_SCL</PreferredName>
      <PreferredDefinition>Numeric scores from 0 (Not at all) to 4 (Very Much) on a Likert scale used on the Memorial Symptom Assessment Scale questionnaire.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale Distress Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How much did the feeling of b</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How much did the feeling of being drowsy bother or distress you?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MSAS 10-18</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #32 of 112</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840828</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS 10-18 (Memorial Symptom Assessment Scale 10-18)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840838</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_BTHRDSTRSS_DRWSY</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="849">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5852858</PUBLICID>
    <LONGNAME>Memorial Symptom Assessment Scale (MSAS) 10-18 Past Week How Much Distress Vomiting Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>MSAS10_18_D_VOMIT_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated observation in the past week of how much distress they had from symptoms of vomiting, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MSAS 10-18:  Memorial Symptom Assessment Scale (10-18). J. Collins, et al. Journal of Pain and Symptom Management. 2000 May; 19(5): 363-377</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5844838</PublicId>
      <PreferredName>5840805v1.0:5114587v1.0</PreferredName>
      <PreferredDefinition>A patient-rated questionnaire designed to evaluate the prevalence, characteristics, and distress to children with cancer aged 10-18. This 30-question instrument was adapted from a previously-validated adult version._The most recent week, including today._A question about an individual&#39;s distress from their vomiting._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale (MSAS) 10-18 Past Week How Much Distress Vomiting Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5840805</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C134965</PreferredName>
        <Version>1</Version>
        <LongName>Memorial Symptom Assessment Scale (MSAS) 10-18</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C134965</PREFERRED_NAME>
            <LONG_NAME>Memorial Symptom Assessment Scale (MSAS) 10-18</LONG_NAME>
            <CON_ID>5840197</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5114587</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C125342:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week How Much Distress Vomiting Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125342</PREFERRED_NAME>
            <LONG_NAME>How Much Distress Vomiting Question</LONG_NAME>
            <CON_ID>5109180</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MSAS 10-18:  Memorial Symptom Assessment Scale (10-18). J. Collins, et al. Journal of Pain and Symptom Management. 2000 May; 19(5): 363-377</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5114472</PublicId>
      <PreferredName>MSAS_DISTRESS_SCL</PreferredName>
      <PreferredDefinition>Numeric scores from 0 (Not at all) to 4 (Very Much) on a Likert scale used on the Memorial Symptom Assessment Scale questionnaire.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale Distress Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MSAS 10-18</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #48 of 112</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How much did the vomiting or</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How much did the vomiting or throwing up bother or distress you?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840828</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS 10-18 (Memorial Symptom Assessment Scale 10-18)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840838</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_BTHRDSTRSS_VOMIT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="850">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5853757</PUBLICID>
    <LONGNAME>Memorial Symptom Assessment Scale (MSAS) 10-18 Past Week Feel Worry Coded Indicator</LONGNAME>
    <PREFERREDNAME>MSAS10_18_WORRY_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated observation of whether or not they were worrying, within the past week, using a coded yes or no response.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MSAS 10-18:  Memorial Symptom Assessment Scale (10-18). J. Collins, et al. Journal of Pain and Symptom Management. 2000 May; 19(5): 363-377</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5845134</PublicId>
      <PreferredName>5840805v1.0:5115373v1.0</PreferredName>
      <PreferredDefinition>A patient-rated questionnaire designed to evaluate the prevalence, characteristics, and distress to children with cancer aged 10-18. This 30-question instrument was adapted from a previously-validated adult version._The most recent week, including today._A question about whether an individual feels or felt worried.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale (MSAS) 10-18 Past Week Feel Worry</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5840805</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C134965</PreferredName>
        <Version>1</Version>
        <LongName>Memorial Symptom Assessment Scale (MSAS) 10-18</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C134965</PREFERRED_NAME>
            <LONG_NAME>Memorial Symptom Assessment Scale (MSAS) 10-18</LONG_NAME>
            <CON_ID>5840197</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5115373</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C104304</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Feel Worry</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104304</PREFERRED_NAME>
            <LONG_NAME>Feel Worried Question</LONG_NAME>
            <CON_ID>3673413</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MSAS 10-18:  Memorial Symptom Assessment Scale (10-18). J. Collins, et al. Journal of Pain and Symptom Management. 2000 May; 19(5): 363-377</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2183836</PublicId>
      <PreferredName>YES_NO_CD_IND</PreferredName>
      <PreferredDefinition>Yes or No response to a question coded as 1 (Yes) or 2 (No).</PreferredDefinition>
      <LongName>Yes No Coded Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2183782</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>NCIP</PreferredName>
        <Version>1</Version>
        <LongName>NCIP</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did you have any worrying?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did you have any worrying?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MSAS 10-18</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #65 of 112</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840828</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS 10-18 (Memorial Symptom Assessment Scale 10-18)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840838</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_WRRD</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="851">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5858955</PUBLICID>
    <LONGNAME>Anti-diarrheal Agent Current Cycle First Dose Date</LONGNAME>
    <PREFERREDNAME>ANTDIAR_AGT_FRST_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>Date of the first dose of anti-diarrheal medication in the current treatment cycle.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>LCC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5858713</PublicId>
      <PreferredName>5096236v1.0:5858711v1.0</PreferredName>
      <PreferredDefinition>A pharmacological agent that may ameliorate the symptoms of diarrhetic illnesses._The name of the therapy that is currently being administered._An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence._Preceding all others in time or space or degree._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.</PreferredDefinition>
      <LongName>Antidiarrheal Agent Current Therapy Cycle First Dose</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>LCC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5096236</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C266</PreferredName>
        <Version>1</Version>
        <LongName>Antidiarrheal Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C266</PREFERRED_NAME>
            <LONG_NAME>Antidiarrheal Agent</LONG_NAME>
            <CON_ID>2869449</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5858711</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C85582:C25472:C25509:C25488</PreferredName>
        <Version>1</Version>
        <LongName>Current Therapy Cycle First Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85582</PREFERRED_NAME>
            <LONG_NAME>Current Therapy</LONG_NAME>
            <CON_ID>3269945</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25472</PREFERRED_NAME>
            <LONG_NAME>Cycle</LONG_NAME>
            <CON_ID>2202487</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017121</PublicId>
      <PreferredName>CTMS_DT</PreferredName>
      <PreferredDefinition>Date as required for Clinical Trials Monitoring Service submissions.  Exchange format is YYYYMMDD.  Display format is DDMMMYYYY, with the month display the first three letters of each month (Jan, Feb, Mar, etc.).</PreferredDefinition>
      <LongName>CTMS Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>DD/MON/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of first dose in this cy</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of first dose in this cycle:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="852">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5915915</PUBLICID>
    <LONGNAME>Treatment Cohort Study 10056 Code</LONGNAME>
    <PREFERREDNAME>TX_COH_SDY_10056</PREFERREDNAME>
    <PREFERREDDEFINITION>The code that represents the information pertaining to protocol 10056 in which subsets of a defined population are identified.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2497526</PublicId>
      <PreferredName>TX_COHORT_STDY</PreferredName>
      <PreferredDefinition>Medical care intended to treat or cure a condition or lessen its symptoms. This includes the administration of drugs, surgical procedures, physical or psychotherapy, or the use of therapeutic devices.:A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).</PreferredDefinition>
      <LongName>Therapeutic Procedure Cohort Study</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2497524</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15208</PreferredName>
        <Version>1</Version>
        <LongName>Cohort Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15208</PREFERRED_NAME>
            <LONG_NAME>Cohort Study</LONG_NAME>
            <CON_ID>2497523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5915913</PublicId>
      <PreferredName>5915913v1.0</PreferredName>
      <PreferredDefinition>A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.</PreferredDefinition>
      <LongName>10056 Cohort Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>250</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
      <Representation>
        <PublicId>4386398</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61512:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Cohort Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61512</PREFERRED_NAME>
            <LONG_NAME>Cohort</LONG_NAME>
            <CON_ID>2555083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cohort 1</VALIDVALUE>
          <VALUEMEANING>liposarcoma (excluding myxoid liposarcoma)</VALUEMEANING>
          <MEANINGDESCRIPTION>liposarcoma (excluding myxoid liposarcoma)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5915914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cohort 2</VALIDVALUE>
          <VALUEMEANING>leiomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>leiomyosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cohort 3</VALIDVALUE>
          <VALUEMEANING>Undifferentiated pleomorphic sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Undifferentiated pleomorphic sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4250435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cohort Selection</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cohort Selection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="853">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5947653</PUBLICID>
    <LONGNAME>Laboratory Procedure Beta-2 Microglobulin Measurement Outcome Unspecified Value</LONGNAME>
    <PREFERREDNAME>5947629v1.0:5947643v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The determination of the amount of beta-2 microglobulin present in a sample._The result of an action._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Not stated explicitly or in detail.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5947629</PublicId>
      <PreferredName>2543047v1.0:5947627v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The determination of the amount of beta-2 microglobulin present in a sample._The result of an action.</PreferredDefinition>
      <LongName>Laboratory Procedure Beta-2 Microglobulin Measurement Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5947627</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C81980:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Beta-2 Microglobulin Measurement Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C81980</PREFERRED_NAME>
            <LONG_NAME>Beta-2 Microglobulin Measurement</LONG_NAME>
            <CON_ID>5947626</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5947643</PublicId>
      <PreferredName>5947643v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Not stated explicitly or in detail.</PreferredDefinition>
      <LongName>Laboratory Procedure Unspecified Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>5947642</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294:C38046:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Unspecified Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38046</PREFERRED_NAME>
            <LONG_NAME>Unspecified</LONG_NAME>
            <CON_ID>2230154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Beta 2-Microglobulin (B2M)</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Beta 2-Microglobulin (B2M)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="854">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5947657</PUBLICID>
    <LONGNAME>Laboratory Procedure Gamma Globulin Measurement Outcome Unspecified Value</LONGNAME>
    <PREFERREDNAME>5947641v1.0:5947643v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The determination of the amount of gamma globulin present in a sample._The result of an action._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Not stated explicitly or in detail.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5947641</PublicId>
      <PreferredName>2543047v1.0:5947639v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The determination of the amount of gamma globulin present in a sample._The result of an action.</PreferredDefinition>
      <LongName>Laboratory Procedure Gamma Globulin Measurement Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5947639</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C92257:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Gamma Globulin Measurement Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C92257</PREFERRED_NAME>
            <LONG_NAME>Gamma Globulin Measurement</LONG_NAME>
            <CON_ID>5947638</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5947643</PublicId>
      <PreferredName>5947643v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Not stated explicitly or in detail.</PreferredDefinition>
      <LongName>Laboratory Procedure Unspecified Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>5947642</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294:C38046:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Unspecified Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38046</PREFERRED_NAME>
            <LONG_NAME>Unspecified</LONG_NAME>
            <CON_ID>2230154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Gamma Region</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Gamma Region</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="855">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5947673</PUBLICID>
    <LONGNAME>Laboratory Procedure Beta Globulin Measurement Outcome Percentage Value</LONGNAME>
    <PREFERREDNAME>5947637v1.0:2180234v1.1</PREFERREDNAME>
    <PREFERREDDEFINITION>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The determination of the amount of beta globulin present in a sample._The result of an action._the value as a percentage of 100.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5947637</PublicId>
      <PreferredName>2543047v1.0:5947635v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The determination of the amount of beta globulin present in a sample._The result of an action.</PreferredDefinition>
      <LongName>Laboratory Procedure Beta Globulin Measurement Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5947635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C92256:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Beta Globulin Measurement Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C92256</PREFERRED_NAME>
            <LONG_NAME>Beta Globulin Measurement</LONG_NAME>
            <CON_ID>5947634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180234</PublicId>
      <PreferredName>LAB_PTG_VAL</PreferredName>
      <PreferredDefinition>the value as a percentage of 100.</PreferredDefinition>
      <LongName>Lab Percentage Value</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Beta Region%</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Beta Region%</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="856">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6011855</PUBLICID>
    <LONGNAME>Breast Reconstructive Surgery Comparison Edema Assessment Grade</LONGNAME>
    <PREFERREDNAME>6011854v1.0:4867450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Grade information related to comparison assessment of edema from the surgical restoration of the breast.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6011854</PublicId>
      <PreferredName>3196243v1.0:6011852v1.0</PreferredName>
      <PreferredDefinition>One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest._Surgical restoration of function or form of a part._The examination of two or more people or things in order to detect similarities and differences._Accumulation of an excessive amount of fluid in cells or intercellular tissues._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Breast Reconstructive Surgery Comparison Edema Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3196243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12971:C25351</PreferredName>
        <Version>1</Version>
        <LongName>Breast Reconstruction</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12971</PREFERRED_NAME>
            <LONG_NAME>Breast</LONG_NAME>
            <CON_ID>2202571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25351</PREFERRED_NAME>
            <LONG_NAME>Reconstructive Surgery</LONG_NAME>
            <CON_ID>2203958</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6011852</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49156:C3002:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Comparison Edema Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49156</PREFERRED_NAME>
            <LONG_NAME>Comparison</LONG_NAME>
            <CON_ID>2528577</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3002</PREFERRED_NAME>
            <LONG_NAME>Edema</LONG_NAME>
            <CON_ID>2202735</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4867450</PublicId>
      <PreferredName>GR_IND</PreferredName>
      <PreferredDefinition>Grade Value Indicator</PreferredDefinition>
      <LongName>Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2453188</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48309</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grade 3</VALIDVALUE>
          <VALUEMEANING>Grade 3</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28079</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grade 2</VALIDVALUE>
          <VALUEMEANING>Grade 2</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grade 1</VALIDVALUE>
          <VALUEMEANING>Grade 1</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28077</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grade 0</VALIDVALUE>
          <VALUEMEANING>Grade 0</VALUEMEANING>
          <MEANINGDESCRIPTION>Grade 0</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-06-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2632183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grade 4</VALIDVALUE>
          <VALUEMEANING>Grade 4</VALUEMEANING>
          <MEANINGDESCRIPTION>Ulceration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4756475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grade 5</VALIDVALUE>
          <VALUEMEANING>Grade 5</VALUEMEANING>
          <MEANINGDESCRIPTION>Death directly related to radiation late effects.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4756476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BREAST EDEMA:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>BREAST EDEMA:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="857">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6025333</PUBLICID>
    <LONGNAME>BREAST-Q Mastectomy How Often Feel Sexually Attractive in Your Clothes Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>BREASTQ_MASQA_SX_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation about how often they generally feel sexually attractive in their clothes, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BREAST-Q Version 2.0:Pusic, Klassen, et.al., Memorial Sloan Kettering Cancer Center and the University of British Columbia, 2017.</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6025313</PublicId>
      <PreferredName>6012909v1.0:6025311v1.0</PreferredName>
      <PreferredDefinition>A patient-reported outcome measure designed to provide information about the impact and effectiveness of breast surgery. It consists of 5 modules: augmentation, reduction (or mastopexy), breast conserving therapy, mastectomy, and post-mastectomy reconstruction. Each module is divided into multiple scales that can be used independently._Surgical removal of the breast._A question about how often an individual feels sexually attractive in their clothes._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>BREAST-Q Mastectomy How Often Feel Sexually Attractive in Your Clothes Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6012909</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C141134</PreferredName>
        <Version>1</Version>
        <LongName>BREAST-Q</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C141134</PREFERRED_NAME>
            <LONG_NAME>BREAST-Q</LONG_NAME>
            <CON_ID>6012031</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6025311</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15277:C140800:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Mastectomy How Often Feel Sexually Attractive in Your Clothes Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15277</PREFERRED_NAME>
            <LONG_NAME>Mastectomy</LONG_NAME>
            <CON_ID>2204820</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C140800</PREFERRED_NAME>
            <LONG_NAME>How Often Feel Sexually Attractive in Your Clothes Question</LONG_NAME>
            <CON_ID>6009401</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BREAST-Q Version 2.0:Pusic, Klassen, et.al., Memorial Sloan Kettering Cancer Center and the University of British Columbia, 2017.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6012907</PublicId>
      <PreferredName>BREASTQ_5_PT_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>BREAST-Q 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>BREAST-Q Version 2.0:Pusic, Klassen, et.al., Memorial Sloan Kettering Cancer Center and the University of British Columbia, 2017.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A Little of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a little of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Some of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened some of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Sexually attractive in your c</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Sexually attractive in your clothes?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BREAST-Q Version 2.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6011949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mastectomy Module</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6024499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="858">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6025334</PUBLICID>
    <LONGNAME>BREAST-Q Mastectomy How Often Feel Comfortable or at Ease During Sexual Activity Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>BREASTQ_MASQB_SX_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation about how often they generally feel comfortable/at ease during sexual activity, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BREAST-Q Version 2.0:Pusic, Klassen, et.al., Memorial Sloan Kettering Cancer Center and the University of British Columbia, 2017.</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6025319</PublicId>
      <PreferredName>6012909v1.0:6025317v1.0</PreferredName>
      <PreferredDefinition>A patient-reported outcome measure designed to provide information about the impact and effectiveness of breast surgery. It consists of 5 modules: augmentation, reduction (or mastopexy), breast conserving therapy, mastectomy, and post-mastectomy reconstruction. Each module is divided into multiple scales that can be used independently._Surgical removal of the breast._A question about how often an individual feels comfortable or at ease during sexual activity._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>BREAST-Q Mastectomy How Often Feel Comfortable or at Ease During Sexual Activity Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6012909</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C141134</PreferredName>
        <Version>1</Version>
        <LongName>BREAST-Q</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C141134</PREFERRED_NAME>
            <LONG_NAME>BREAST-Q</LONG_NAME>
            <CON_ID>6012031</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6025317</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15277:C140806:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Mastectomy How Often Feel Comfortable or at Ease During Sexual Activity Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15277</PREFERRED_NAME>
            <LONG_NAME>Mastectomy</LONG_NAME>
            <CON_ID>2204820</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C140806</PREFERRED_NAME>
            <LONG_NAME>How Often Feel Comfortable or at Ease During Sexual Activity Question</LONG_NAME>
            <CON_ID>6009402</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BREAST-Q Version 2.0:Pusic, Klassen, et.al., Memorial Sloan Kettering Cancer Center and the University of British Columbia, 2017.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6012907</PublicId>
      <PreferredName>BREASTQ_5_PT_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>BREAST-Q 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>BREAST-Q Version 2.0:Pusic, Klassen, et.al., Memorial Sloan Kettering Cancer Center and the University of British Columbia, 2017.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A Little of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a little of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Some of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened some of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Comfortable/at ease during se</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Comfortable/at ease during sexual activity?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BREAST-Q Version 2.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6011949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mastectomy Module</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6024499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="859">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6042226</PUBLICID>
    <LONGNAME>Stereotactic Body Radiation Therapy Liver Mean Dose Administered Value</LONGNAME>
    <PREFERREDNAME>SBRT_LIV_MDS_VL</PREFERREDNAME>
    <PREFERREDDEFINITION>Number value of the stereotactic body radiation mean dose given to the liver.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Princess Margaret Cancer Centre, Toronto, ON</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6042012</PublicId>
      <PreferredName>6028394v1.0:6042010v1.0</PreferredName>
      <PreferredDefinition>Stereotactic radiation therapy in which one or several maximum dose radiation treatments are delivered targeting cancers of the body, excluding the brain or spine._A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate._The sum of a set of values divided by the number of values in the set._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Stereotactic Body Radiation Therapy Liver Mean Dose Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6028394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C118286</PreferredName>
        <Version>1</Version>
        <LongName>Stereotactic Body Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C118286</PREFERRED_NAME>
            <LONG_NAME>Stereotactic Body Radiation Therapy</LONG_NAME>
            <CON_ID>5477162</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6042010</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12392:C53319:C25488:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Liver Mean Dose Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12392</PREFERRED_NAME>
            <LONG_NAME>Liver</LONG_NAME>
            <CON_ID>2202332</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53319</PREFERRED_NAME>
            <LONG_NAME>Arithmetic Mean</LONG_NAME>
            <CON_ID>2528578</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Princess Margaret Cancer Centre, Toronto, ON</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2834340</PublicId>
      <PreferredName>2834340v1.0</PreferredName>
      <PreferredDefinition>the numerical quantity measured or assigned or computed with a max of 5 characters and 2 decimals, units of measure not specified.</PreferredDefinition>
      <LongName>5, 2 Unspecified Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>999.99</DisplayFormat>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2586710</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38046:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Unspecified Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38046</PREFERRED_NAME>
            <LONG_NAME>Unspecified</LONG_NAME>
            <CON_ID>2230154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Mean SBRT Liver Dose</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Mean SBRT Liver Dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Mean Liver dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>16445930</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PMCC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PMCC Curation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16445931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Theradex</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Theradex</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="860">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6044561</PUBLICID>
    <LONGNAME>Prior Hepatic Artery Embolization Performed Date</LONGNAME>
    <PREFERREDNAME>6044559v1.0:2018550v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A response used to determine the date on which a therapeutic procedure involving the injection or deployment of blocking agents in the hepatic artery to treat tumors was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6044559</PublicId>
      <PreferredName>6044557v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>Earlier in time or order._A therapeutic procedure involving the injection or deployment of blocking agents in the hepatic artery to treat tumors._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Prior Hepatic Artery Embolization Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6044557</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C66902</PreferredName>
        <Version>1</Version>
        <LongName>Prior Hepatic Artery Embolization</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66902</PREFERRED_NAME>
            <LONG_NAME>Hepatic Artery Embolization</LONG_NAME>
            <CON_ID>6044556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of prior hepatic artery</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of prior hepatic artery embolization</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3852751</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Therapeutic</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prior Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000584</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="861">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6091937</PUBLICID>
    <LONGNAME>Person Left Arm Circumference Antecubital Fossa Volume Measurement</LONGNAME>
    <PREFERREDNAME>ARM_VOL_CIRC_3_LA</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric annotation to indicate left arm circumference volume at the antecubital fossa measured in cm.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCTG: Canadian Cancer Trials Group</ORIGIN>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6078914</PublicId>
      <PreferredName>2236731v1.0:6091936v1.0</PreferredName>
      <PreferredDefinition>A human being._The portion of the upper extremity between the shoulder and the wrist and located on the left side of the body._The length of the closed curve of a circle; the size of something as given by the distance around it._A triangular space on the anterior side of the elbow joint. Three main veins of the arm, the brachial artery, the medial nerve and the tendon of the biceps pass through this space._The amount of three dimensional space occupied by an object or the capacity of a space or container.</PreferredDefinition>
      <LongName>Person Left Arm Circumference Antecubital Fossa Volume</LongName>
      <Version>1</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6091936</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C105633:C64265:C103238:C25335</PreferredName>
        <Version>1</Version>
        <LongName>Left Arm Circumference Antecubital Fossa Volume</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C105633</PREFERRED_NAME>
            <LONG_NAME>Left Arm</LONG_NAME>
            <CON_ID>4592234</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64265</PREFERRED_NAME>
            <LONG_NAME>Circumference</LONG_NAME>
            <CON_ID>2583594</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C103238</PREFERRED_NAME>
            <LONG_NAME>Antecubital Fossa</LONG_NAME>
            <CON_ID>3625828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25335</PREFERRED_NAME>
            <LONG_NAME>Volume</LONG_NAME>
            <CON_ID>2203979</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCTG: Canadian Cancer Trials Group</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6078928</PublicId>
      <PreferredName>6078928v1.0</PreferredName>
      <PreferredDefinition>The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb._Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.</PreferredDefinition>
      <LongName>Arm Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>cm</UnitOfMeasure>
      <DisplayFormat>99.9</DisplayFormat>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCTG: Canadian Cancer Trials Group</Origin>
      <Representation>
        <PublicId>6078927</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C32141:C25209</PreferredName>
        <Version>1</Version>
        <LongName>Arm Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C32141</PREFERRED_NAME>
            <LONG_NAME>Arm</LONG_NAME>
            <CON_ID>2202427</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>At the antecubital fossa (main elbow crease)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Arm Circumference - At the an</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Arm Circumference - At the antecubital fossa - left arm</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="862">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6141398</PUBLICID>
    <LONGNAME>Prior First-Line Therapy Other Administered Ind</LONGNAME>
    <PREFERREDNAME>6133497v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A response used to determine whether or not a therapy different than the ones previously specified was given at an earlier time as the preferred standard treatment for a particular condition.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6133497</PublicId>
      <PreferredName>5720345v1.0:2207818v1.0</PreferredName>
      <PreferredDefinition>Earlier in time or order._The preferred standard treatment for a particular condition._Different than the one(s) previously specified or mentioned._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Prior First-Line Therapy Other Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5720345</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C45792</PreferredName>
        <Version>1</Version>
        <LongName>Prior First-Line Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45792</PREFERRED_NAME>
            <LONG_NAME>First-Line Therapy</LONG_NAME>
            <CON_ID>2229260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207818</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Other Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3852751</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Therapeutic</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prior Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000584</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="863">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6141659</PUBLICID>
    <LONGNAME>Person Receive Prior Treatment Regimen Containing Bevacizumab Clinical Trial Eligibility Criteria Ind</LONGNAME>
    <PREFERREDNAME>PRTX_CONTAIN_BEVZB_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator to determine eligibility for clinical trial participation for questions related to the prior receipt of any bevacizumab-containing regimen as outlined in the study protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACRIN:American College of Radiology Imaging Network</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6141640</PublicId>
      <PreferredName>2236731v1.0:6141638v1.0</PreferredName>
      <PreferredDefinition>A human being._To take, accept, or get something offered._Earlier in time or order._A treatment plan that specifies the dosage, the schedule, and the duration of treatment._Include or hold; have within or as a component._A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine.  Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Person Receive Prior Treatment Regimen Contain Bevacizumab Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6141638</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>6141638v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Receive Prior Treatment Regimen Contain Bevacizumab Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15697</PREFERRED_NAME>
            <LONG_NAME>Treatment Regimen</LONG_NAME>
            <CON_ID>2203773</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79873</PREFERRED_NAME>
            <LONG_NAME>Contain</LONG_NAME>
            <CON_ID>2961747</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2039</PREFERRED_NAME>
            <LONG_NAME>Bevacizumab</LONG_NAME>
            <CON_ID>2202398</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the patient previously re</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the patient previously received any bevacizumab-containing regimen?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ACRIN - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient previously received any bevacizumab-containing regimen or its biosimilars?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRTX_CONTAIN_BEVZB_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="864">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6141692</PUBLICID>
    <LONGNAME>Person Treatment Plan Immunotherapeutic Agent Administration Clinical Trial Eligibility Criteria Ind</LONGNAME>
    <PREFERREDNAME>TXPLN_IMUTX_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator to determine eligibility for clinical trial participation for questions related to the planned treatment with immunotherapies as outlined in the study protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACRIN:American College of Radiology Imaging Network</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6141686</PublicId>
      <PreferredName>2236731v1.0:6141684v1.0</PreferredName>
      <PreferredDefinition>A human being._A document outlining the essential treatment issues which will be addressed. This may include the problem to be addressed, the proposed treatment, the treatment goal, the time frame to meet goals, and an estimate of the costs._Any substance that induces, enhances, restores or suppresses the host&#39;s immune system, or an agent that utilizes or is derived from a component of the immune system._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Person Treatment Plan Immunotherapeutic Agent Administration Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6141684</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C60735:C308:C25409:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Treatment Plan Immunotherapeutic Agent Administration Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60735</PREFERRED_NAME>
            <LONG_NAME>Treatment Plan</LONG_NAME>
            <CON_ID>2919103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C308</PREFERRED_NAME>
            <LONG_NAME>Immunotherapeutic Agent</LONG_NAME>
            <CON_ID>2426121</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does the patient have planned</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does the patient have planned treatment with immunotherapies (vaccines, checkpoint inhibitors, T-cells)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient received genetically engineered Tcells except prior GD2 CAR T cell therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TXPLN_IMUTX_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="865">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6142405</PUBLICID>
    <LONGNAME>Molecular Analysis Cytoband Text</LONGNAME>
    <PREFERREDNAME>cytoband</PREFERREDNAME>
    <PREFERREDDEFINITION>An alphanumeric value used to describe the cytoband or chromosomal location targeted or included in molecular analysis.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Pediatric Cancer</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>GDC:NCI Genomic Data Commons</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6140893</PublicId>
      <PreferredName>2626369v1.0:2528616v1.0</PreferredName>
      <PreferredDefinition>A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level._Chromosomal bands observed after staining with specific dyes.  The band pattern is the result of differential interactions between the dye and nonadjacent chromosomal regions.</PreferredDefinition>
      <LongName>Molecular Analysis Chromosome Band</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>GDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2626369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19770</PreferredName>
        <Version>1</Version>
        <LongName>Molecular Analysis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19770</PREFERRED_NAME>
            <LONG_NAME>Molecular Analysis</LONG_NAME>
            <CON_ID>2528322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528616</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13432</PreferredName>
        <Version>1</Version>
        <LongName>Chromosome Band</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13432</PREFERRED_NAME>
            <LONG_NAME>Chromosome Band</LONG_NAME>
            <CON_ID>2223230</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>GDC:NCI Genomic Data Commons</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>11555648</PublicId>
      <PreferredName>11555648v1.00</PreferredName>
      <PreferredDefinition>The words of something written.</PreferredDefinition>
      <LongName>25 Character Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CRDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CRDC:Cancer Research Data Commons</Origin>
      <Representation>
        <PublicId>2184342</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Text</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cytoband</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Format and Example</Name>
        <DocumentType>EXAMPLE</DocumentType>
        <DocumentText>Format: [chromosome][chromosome arm].[band+sub-bands]. Example: 17p13.1.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Ped Cancer Example</Name>
        <DocumentType>EXAMPLE</DocumentType>
        <DocumentText>17p13.1</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Ped Cancer Instructions</Name>
        <DocumentType>Instructions</DocumentType>
        <DocumentText>Format [chromosome][chromosome arm].[band+sub-bands].</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Ped Core Tier</Name>
        <DocumentType>Tier</DocumentType>
        <DocumentText>Conditional</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5428034</PublicId>
          <ContextName>GDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Molecular Test</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6142391</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>10429357</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GDC (Genomic Data Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Candidate New GDC CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14506028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>12173174</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>12173174v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>12173177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>12173174</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>12173174v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Genetic Analysis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>12173196</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594093</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Molecular Test</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594226</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13954630</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>All Pediatric Core CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Molecular</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14599261</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CYTOGENETIC_LOCATION</AlternateName>
        <AlternateNameType>PCDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cytoband</AlternateName>
        <AlternateNameType>CCDI Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Cytoband</AlternateName>
        <AlternateNameType>Ped Cancer Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>molecular_test</AlternateName>
        <AlternateNameType>CCDI Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>GDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cytoband</AlternateName>
        <AlternateNameType>GDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="866">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6260947</PUBLICID>
    <LONGNAME>Additional Participating Clinical Study Site Name</LONGNAME>
    <PREFERREDNAME>6041590v1.0:6260946v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A response used to determine the name of an added organization that is participating in activities conducted in a framework of a particular clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6041590</PublicId>
      <PreferredName>6041587v1.0:6041588v1.0</PreferredName>
      <PreferredDefinition>Added; extra; further._An organization that participates in activities conducted in a framework of a particular clinical trial.</PreferredDefinition>
      <LongName>Additional Participating Clinical Study Organization</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6041587</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25406</PreferredName>
        <Version>1</Version>
        <LongName>Additional</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25406</PREFERRED_NAME>
            <LONG_NAME>Additional</LONG_NAME>
            <CON_ID>2206153</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6041588</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70791</PreferredName>
        <Version>1</Version>
        <LongName>Participating Clinical Study Organization</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70791</PREFERRED_NAME>
            <LONG_NAME>Participating Clinical Study Organization</LONG_NAME>
            <CON_ID>5892444</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6260946</PublicId>
      <PreferredName>6260946v1.0</PreferredName>
      <PreferredDefinition>The name of a healthcare facility.</PreferredDefinition>
      <LongName>Healthcare Facility Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Please select the expansion s</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Please select the expansion site.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="867">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6279952</PUBLICID>
    <LONGNAME>Adult Comorbidity Evaluation-27 1 Myocardial Infarction Severity Assessment Grade</LONGNAME>
    <PREFERREDNAME>ACE27_1_GRD</PREFERREDNAME>
    <PREFERREDDEFINITION>Assessment of the severity of comorbidity associated with myocardial infarction, using a 3 grade scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACE-27: Adult Comorbidity Evaluation-27</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6274855</PublicId>
      <PreferredName>6272437v1.0:6273582v1.0</PreferredName>
      <PreferredDefinition>A 27-item comorbidity index for patients with cancer. ACE27 includes comorbid conditions of various organ systems, as well as malignancy, substance abuse, and body weight._Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis._Used of the degree of something undesirable e.g. pain or weather; also, strictness._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Adult Comorbidity Evaluation-27 Myocardial Infarction Severity Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6272437</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C148417</PreferredName>
        <Version>1</Version>
        <LongName>Adult Comorbidity Evaluation-27</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C148417</PREFERRED_NAME>
            <LONG_NAME>Adult Comorbidity Evaluation-27</LONG_NAME>
            <CON_ID>6208732</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6273582</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C27996:C25676:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Myocardial Infarction Severity Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C27996</PREFERRED_NAME>
            <LONG_NAME>Myocardial Infarction</LONG_NAME>
            <CON_ID>2202873</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACE-27: Adult Comorbidity Evaluation-27</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6272299</PublicId>
      <PreferredName>ACE27_DECOM_GD</PreferredName>
      <PreferredDefinition>Decomposition Grade 1 through 3 ranging from Grade 1: Mild Decompensation through Grade 3: Severe Decompensation.</PreferredDefinition>
      <LongName>ACE-27 Decomposition Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>31</MaximumLength>
      <MinimumLength>33</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ACE-27: Adult Comorbidity Evaluation-27</Origin>
      <Representation>
        <PublicId>6272298</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C150047:C48309</PreferredName>
        <Version>1</Version>
        <LongName>Decompensation Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C150047</PREFERRED_NAME>
            <LONG_NAME>Decompensation</LONG_NAME>
            <CON_ID>6237639</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grade 1 - Mild Decompensation</VALIDVALUE>
          <VALUEMEANING>Mild Decompensation</VALUEMEANING>
          <MEANINGDESCRIPTION>Gentle or temperate in nature or degree.: The inability of an organ or organ system to maintain homeostasis due to functional overload, often caused by the presence of disease intrinsic to the organ or organ system, or dysfunction in other organ systems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150047, C70666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6272302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grade 2 - Moderate Decompensation</VALIDVALUE>
          <VALUEMEANING>Moderate Decompensation</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.: The inability of an organ or organ system to maintain homeostasis due to functional overload, often caused by the presence of disease intrinsic to the organ or organ system, or dysfunction in other organ systems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150047, C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6272301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grade 3 - Severe Decompensation</VALIDVALUE>
          <VALUEMEANING>Severe Decompensation</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely bad or unpleasant in degree, quality or extent.: The inability of an organ or organ system to maintain homeostasis due to functional overload, often caused by the presence of disease intrinsic to the organ or organ system, or dysfunction in other organ systems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150047, C70667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6272300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Myocardial Infarct</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Myocardial Infarct</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Adult Comorbidity Evaluation-27</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #1 of 27</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult Comorbidity Evaluation-27 (ACE-27)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14858469</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6235436</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ACE-27</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ACE-27</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6235438</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="868">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6295992</PUBLICID>
    <LONGNAME>Patient Hypersensitivity Or Intolerance Disease Therapeutic Procedure Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>PT_HYPER_INTOL_DZ_THPY_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded indicator to determine clinical trial participation for questions related to allergic reactions, hypersensitivities, abnormal conditions of the body or mind, and treatments.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6295991</PublicId>
      <PreferredName>2233604v1.0:6295989v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._An inability to absorb or metabolize certain substances in the normal way._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Patient Hypersensitivity Or Intolerance Disease or Disorder Therapeutic Procedure Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6295989</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>6295989v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Hypersensitivity Or Intolerance Disease or Disorder Therapeutic Procedure Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3114</PREFERRED_NAME>
            <LONG_NAME>Hypersensitivity</LONG_NAME>
            <CON_ID>2203756</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71437</PREFERRED_NAME>
            <LONG_NAME>Intolerance</LONG_NAME>
            <CON_ID>3441899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If patient has allergy or int</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If patient has allergy or intolerance to docetaxel or grade 2 neuropathy and is randomized to Arm A, patient will receive carboplatin as a single agent (AUC 5) rather than docetaxel+carboplatin?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a history of allergy to/intolerance of MLN7243 (TAK-243) or any other component in this formulation?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have a history of allergy or intolerance to flucytosine?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a history of allergy to/intolerance of MLN7243 (TAK-243) or any other component in this formulation OR history of allergic reactions attributed to compounds of similar chemical or biologic composition to MLN7243 (TAK-243)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have history of allergic reactions attributed to compounds of similar chemical or biologic composition to MLN7243 (TAK-243)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to abemaciclib or other agents (5-FU) used in this study such as previous intolerance to 5-FU or capecitabine, including patients with known or suspected dihydropyrimidine dehydrogenase deficiency?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient unable to take spironolactone or eplerenone due to intolerance, allergy, drug-drug interactions, or for any other reason?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876352</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Inclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prior Treatments</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000494</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="869">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6306947</PUBLICID>
    <LONGNAME>Inotuzumab Ozogamicin Cycle Administered Count</LONGNAME>
    <PREFERREDNAME>6337034v1.0:2018392v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of inotuzumab ozogamicin cycles that were administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6337034</PublicId>
      <PreferredName>5724182v1.0:2763971v1.0</PreferredName>
      <PreferredDefinition>A CD22-targeted cytotoxic immunoconjugate composed of a humanized IgG4 anti-CD22 antibody covalently linked to N-acetyl-gamma-calicheamicin dimethyl hydrazide (CalichDMH) with potential antineoplastic activity. Inotuzumab ozogamicin is rapidly internalized upon binding of the antibody moiety to B cell-specific CD22 receptors, delivering the conjugated CalichDMH intracellularly; the CalichDMH moiety binds to the minor groove of DNA in a sequence-specific manner, resulting in double-strand DNA breaks and apoptosis. CalichDMH is a derivative of gamma calicheamicin, a cytotoxic antibiotic produced by the bacterium Micromonospora echinospora._An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Inotuzumab Ozogamicin Cycle Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5724182</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71542</PreferredName>
        <Version>1</Version>
        <LongName>Inotuzumab Ozogamicin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71542</PREFERRED_NAME>
            <LONG_NAME>Inotuzumab Ozogamicin</LONG_NAME>
            <CON_ID>5576812</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2763971</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25472:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Cycle Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25472</PREFERRED_NAME>
            <LONG_NAME>Cycle</LONG_NAME>
            <CON_ID>2202487</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018392</PublicId>
      <PreferredName>CT</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the number of inotuz</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the number of inotuzumab ozogamicin cycles that were administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of cycles:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of cycles:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of cycles:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Number of cycles:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>INOT_INO_ino_gt1_cyc_adm_cnt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="870">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6341137</PUBLICID>
    <LONGNAME>Exposure Start Date</LONGNAME>
    <PREFERREDNAME>EXSTDAT</PREFERREDNAME>
    <PREFERREDDEFINITION>The [start] date of study treatment represented in an unambiguous date format (e.g., DD-MON-YYYY).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6390001</PublicId>
      <PreferredName>6384837v1.0:6389999v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to exposure._The date on which the exposure begins.</PreferredDefinition>
      <LongName>Exposure Domain Exposure Start Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6384837</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49587</PreferredName>
        <Version>1</Version>
        <LongName>Exposure Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49587</PREFERRED_NAME>
            <LONG_NAME>Exposure Domain</LONG_NAME>
            <CON_ID>2469061</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6389999</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83127</PreferredName>
        <Version>1</Version>
        <LongName>Exposure Start Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83127</PREFERRED_NAME>
            <LONG_NAME>Exposure Start Date</LONG_NAME>
            <CON_ID>6389998</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338240</PublicId>
      <PreferredName>CDISCDAT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>11</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396655</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25164</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the [intended/actual</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the [intended/actual] [study treatment/dose] [start] date?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Prompt</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[Start] Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form Completion Instructions</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the start date of the study treatment administration using this format (DD-MON-YYYY).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>Date when constant dosing interval of the study treatment started or single administration occurred. When collecting the date for an individual dose, the word &quot;start&quot; may be omitted from the Question Text and Prompt.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>EXSTDTC</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable EXSTDTC in ISO 8601 format.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Expected</Name>
        <DocumentType>SDTM Core</DocumentType>
        <DocumentText>Expected</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Template Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Start Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 3028744 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Treatment start date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 100</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the actual treatment start date?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 001</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Actual Treatment Start Date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the start date of blinatumomab bag being administered at onset date of SEPSIS?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the start date of the blinatumomab bag being administered at onset date of sepsis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exposure (EX) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329797</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Highly Recommended Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329800</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Study Agent Administration - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318386</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EX.EXSTDAT</AlternateName>
        <AlternateNameType>Map:CDASHv1.1</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EX_EXSTDAT_IMAT_DASA</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="871">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6355806</PUBLICID>
    <LONGNAME>Comment</LONGNAME>
    <PREFERREDNAME>COVAL</PREFERREDNAME>
    <PREFERREDDEFINITION>A free text comment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6411838</PublicId>
      <PreferredName>6411834v1.0:6411836v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to comments._The importance assigned to a particular remark.</PreferredDefinition>
      <LongName>Comment Domain Comment Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6411834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49569</PreferredName>
        <Version>1</Version>
        <LongName>Comment Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49569</PREFERRED_NAME>
            <LONG_NAME>Comment Domain</LONG_NAME>
            <CON_ID>2469051</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6411836</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83241</PreferredName>
        <Version>1</Version>
        <LongName>Comment Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83241</PREFERRED_NAME>
            <LONG_NAME>Comment Value</LONG_NAME>
            <CON_ID>6411835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Note</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>Text over 200 characters can be added to additional columns COVAL1-COVALn. When the comment text is longer than 200 characters, the first 200 characters of the comment will be in COVAL, the next 200 in COVAL1, and additional text stored as needed to COVALn.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Required</Name>
        <DocumentType>SDTM Core</DocumentType>
        <DocumentText>Required</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>[protocol specified targeted</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>[protocol specified targeted question]</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Prompt</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[abbreviated version of the protocol specified targeted question]</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex-CTMS 4.0</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCI Standard Template Forms</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Template Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>iRECIST</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Please use the following fields to express any comment you might have on the data on this form</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>irRC</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>irRECIST</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>RECIST</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 797 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comments</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 100</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comments:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason inevaluable:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What are the comments?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What are the comments?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Comments</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comments</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason inevaluable for the endpoint:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>[protocol specified targeted question]</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[protocol specified targeted question]</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>[abbreviated version of the protocol specified targeted question]</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[abbreviated version of the protocol specified targeted question]</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify reason patient is not evaluable:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG-TEXT-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Yes above, provide details:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Findings:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Provide details:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comments regarding tumor sequencing results:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comments regarding ALK FISH results:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comments regarding germline sequencing results:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PMI text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comments</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PMI text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What are the comments?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Comment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the comment?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the comment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_02</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other relevant details</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Any additional comments:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>SDGC Comments</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Comments (CO) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329789</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Semantically Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685479</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RECIST - CDISC Aligned </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6921972</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>irRC - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6921973</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>iRECIST - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6921974</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>irRECIST - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6921975</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RECISTv1.1 - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6921976</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Response - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318366</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7312662</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000686</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Vital Signs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7473989</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC RECIST v1.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7473993</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Lab Test Results</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7554864</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC AE SAE CTCAEv4.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7554866</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC AE SAE CTCAEv5.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7554867</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7590138</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7765162</PublicId>
          <ContextName>PMI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Precision Medicine Initiative</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PMI CDISC STMF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>8176711</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13140248</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>13140248v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTSU CDISC Protocol Deviation v2.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15018483</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Comments (CO) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943373</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Theradex</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Theradex</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRDS</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_COVAL1</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_COVAL4</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_COVAL2</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_COVAL3</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_COVAL5</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_KMT2A</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_ETV6</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_TRI4</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_TRI10</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_BCR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_Arry</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RADIO_UPD</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPDS_QVAL_DSREAS_SC_INEVL</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_SC_ELIGIBILITY</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_REAS</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CO_COVAL_[FormOID]</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CO_COVAL</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>COVAL</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_WITHDRAWAL_DS</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_LOST_DS</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PSURG_PR</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCTG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_MH</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_MOD_EC</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_DEATH_DD</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_NEWTX_PR</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_DOSADJ_PR</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_TAR_TR</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_FUP</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_INST_PATH</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RELAPSE_PROG</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_REVIEW_BE</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_ONSTUDY</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PMI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COVAL_STMF</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_SMN</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_DEATH</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_NOTX</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_TX_CONF_PRETX</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_SC_INEVL</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_MRD</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_CONSENT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_STF</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_CENT_PATH</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_SCREV_DLT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_DEF_RLP</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_CR_CYTO</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_FUP_HSCT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_STF_CORR_IMM_OPT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_DZ_EV</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_MTX_24HR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_MTX_36HR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_MTX_42HR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_MTX_48HR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_IMMTX_CM_X1</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_IMMTX_CM_X2</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_QOL</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_SCELIG_REV</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_COVID_DV</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL as a CDE alt name</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_CENTREV_Radiology</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_SIGCOL_TR</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_SIGCOL</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RS</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_TU_TR</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PR_EBRT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PR_SBRT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PR_LDR</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PR_HDR</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PR_TRTMOD</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_CE</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_CE_MMP</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_ECARAT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_ECADT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_KMT2ARRES</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_CALLB1</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_CALLB2</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_CALLB3</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_OPTMRD</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_HTSMRD</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_KMT2AG</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_KMT2AR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_ASPGNDLVTOX</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_POST_CALLB3</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_OVRLRESP_RS</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PSAKIN_RS</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RS_ECOG</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RS_PSA</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RS_BONE</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PR_CM</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_EC_DTX</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_EC_ARPI</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_EC_ADT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_EC</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_OLIGO_TR</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_EWSSURG</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_EWS_RT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_EWS_ONSTUDY_REL _PD</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_TX_CONF_CALLB</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_EWS_INITIAL_DX</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_EWS_TXCHEMO</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PRO</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_LCSX</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_LCRT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_MCI</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RPAE</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_AETX</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_AEFUP</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_EWS_PATHMOLDTL</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_EWS_STF</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RPIND</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RP</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_CALLBACK</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_FORMOID_X1</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_EOILESASSESS</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_INSTSURG_METS</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_WOUND_X1</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_WOUND</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_INSTPATH_METS</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_TDM_UPD</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_MEDDIARY_X1</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_MED_DIARY_X2</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_REL_PD</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_SUPPRPT_IMMFUNC</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_TX_CONFIRM_F</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_TX_CONFIRM_E</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_INSTPATH_BX</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RPINDCTCONSD</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RPMAINT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_INSTSURG_BX</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_STFPK</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PREENROLL_ELIGSCR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PREENROLL_FILE_X1</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PREENROLL_FILE_X2</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PREENROLL_FILE_X3</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PREENROLL_FILE_X4</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_LGG_ELIGREV</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_MCI_INFO</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RPCONSOLIDATION</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RPREGA</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RPREGB</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_RPMETSRT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_FACTG</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_ADULTPRO</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_PEDPRO</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_ECG_EG</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CO_COVAL_TX_CONFIRM</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="872">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6365250</PUBLICID>
    <LONGNAME>Medical Condition Performed Observation Outcome Data PCORnet CDM Medical Condition Code</LONGNAME>
    <PREFERREDNAME>CONDITION</PREFERREDNAME>
    <PREFERREDDEFINITION>Relating to the study or practice of medicine.:A state of being, such as a state of health.:Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._Condition code.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3760545</PublicId>
      <PreferredName>3757329v1.0:2423441v1.0</PreferredName>
      <PreferredDefinition>Relating to the study or practice of medicine.:A state of being, such as a state of health.:Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.</PreferredDefinition>
      <LongName>Medical Condition Performed Observation Outcome Data</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3757329</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3757329v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Medical Condition Performed Observation Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25261</PREFERRED_NAME>
            <LONG_NAME>Medical</LONG_NAME>
            <CON_ID>2202452</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25457</PREFERRED_NAME>
            <LONG_NAME>Condition</LONG_NAME>
            <CON_ID>2202899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2423441</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25474</PreferredName>
        <Version>1</Version>
        <LongName>Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6345388</PublicId>
      <PreferredName>6345388v1.0</PreferredName>
      <PreferredDefinition>Condition code.</PreferredDefinition>
      <LongName>PCORnet CDM Medical Condition Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>18</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Condition Code</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Condition Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6093453</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PCORnet CDM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Condition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>8003778</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CONDITION</AlternateName>
        <AlternateNameType>PCORNet Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CONDITION</AlternateName>
        <AlternateNameType>PCORnet Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="873">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6400803</PUBLICID>
    <LONGNAME>Concomitant Meds Dose Unit</LONGNAME>
    <PREFERREDNAME>CMDOSU</PREFERREDNAME>
    <PREFERREDDEFINITION>The unit associated with the concomitant medication/treatment/therapy taken (e.g., mg in &quot;2mg three times per day&quot;).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6400440</PublicId>
      <PreferredName>4550855v1.0:6400438v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration._The unit of measure for the concomitant medication dose.</PreferredDefinition>
      <LongName>Concomitant Medication Domain Concomitant Medication Dose Unit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4550855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49568</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Medication Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49568</PREFERRED_NAME>
            <LONG_NAME>Concomitant Medication Domain</LONG_NAME>
            <CON_ID>2469052</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6400438</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83034</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Medication Dose Unit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83034</PREFERRED_NAME>
            <LONG_NAME>Concomitant Medication Dose Unit</LONG_NAME>
            <CON_ID>3159251</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6400801</PublicId>
      <PreferredName>CMDOSU</PreferredName>
      <PreferredDefinition>A terminology subset of the CDISC Study Data Tabulation Model (SDTM) Unit codelist created for Clinical Data Acquisition Standards Harmonization (CDASH) Concomitant Medication Dose Units terminology._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>CDISC CDASH Concomitant Medication Dose Units Terminology Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6400800</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C78417:C25284</PreferredName>
        <Version>1</Version>
        <LongName>CDISC CDASH Concomitant Medication Dose Units Terminology Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78417</PREFERRED_NAME>
            <LONG_NAME>CDISC CDASH Concomitant Medication Dose Units Terminology</LONG_NAME>
            <CON_ID>6400799</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IU</VALIDVALUE>
          <VALUEMEANING>International Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The unitage assigned by the WHO to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization (e.g. hormones, enzymes, and vaccines), to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48579</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAPSULE</VALIDVALUE>
          <VALUEMEANING>Capsule Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of active ingredient(s) contained in a capsule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g</VALIDVALUE>
          <VALUEMEANING>Gram</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass equal to one thousandth of a kilogram. One gram equals approximately 15.432 grains or 0.035 273 966 ounce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5035620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg</VALIDVALUE>
          <VALUEMEANING>Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass equal to one thousandth of a gram or 1000 micrograms. One milligram equals approximately 0.015 432 grain or 35.274 x 10E-6 ounce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5035619</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL</VALIDVALUE>
          <VALUEMEANING>Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of volume equal to one millionth (10E-6) of a cubic meter, one thousandth of a liter, one cubic centimeter, or 0.061023 7 cubic inch. A cubic centimeter is the CGS unit of volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28254</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5035618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PUFF</VALIDVALUE>
          <VALUEMEANING>Puff Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to a metered dose of medicinal substance(s) that is delivered in uniform quantity upon each activation of a medical device (e.g. an inhaler), in which the dosage form is contained.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TABLET</VALIDVALUE>
          <VALUEMEANING>Tablet Dosing Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A dosing unit equal to the amount of medicinal substance(s) contained in a single item of a tablet dosage form comprising of compressed medicinal substance(s) with or without suitable diluents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug</VALIDVALUE>
          <VALUEMEANING>Microgram</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass equal to one millionth of a gram or one thousandth of a milligram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48152</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5656837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the unit (for the dos</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the unit (for the dose of concomitant [medication/treatment/therapy])?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>(Dose) Unit</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex-CTMS 4.0</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Unit</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex 2-CTMS 4.0</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Dose Unit</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form Completion Instructions</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the dose unit of the dose of concomitant [medication/treatment/therapy] taken (e.g., mg.).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>When sponsors collect data for amount of dose taken (i.e., Dose, Total Daily Dose), Unit must be collected as well (if applicable).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CMDOSU</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC CDASH Concomitant Medication Dose Units Terminology</Name>
        <DocumentType>VALID_VALUE_SOURCE</DocumentType>
        <DocumentText>A terminology subset of the CDISC Study Data Tabulation Model (SDTM) Unit codelist created for Clinical Data Acquisition Standards Harmonization (CDASH) Concomitant Medication Dose Units terminology.</DocumentText>
        <URL>https://ncit.nci.nih.gov/ncitbrowser/ajax?action=create_src_vs_tree&amp;amp;vsd_uri=http%3A//evs.nci.nih.gov/valueset/CDISC/C78417</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 3028750 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Template Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Units of Measure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Units:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the unit?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the unit?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Dose unit</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Dose unit</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the unit (for the dose of [medication/treatment/therapy])?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>(Dose) Unit</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the unit (for the dose of concomitant [medication/treatment/therapy])?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Concomitant Medication (CM) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329788</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Recommended/Conditional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329810</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Semantically Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685479</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Concomitant Medication</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7473999</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Prior Therapies</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7554869</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Concomitant Medication (CM) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Theradex</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Theradex</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CM.CMDOSU</AlternateName>
        <AlternateNameType>Map:CDASHv1.1</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRDS</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CM_CMDOSU</AlternateName>
        <AlternateNameType>OID, NRDS Standard</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMDOSU</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CM_CMDOSU</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="874">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6408511</PUBLICID>
    <LONGNAME>Brief Appraisal Inventory 1 How Often Did You Think About Maintain Positive Outlook, Even When Things are Going Badly Score 7 Point Scale</LONGNAME>
    <PREFERREDNAME>BAI_1_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation about how often they think about maintaining a positive outlook, even when things are going badly, using a 7 point Likert Scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BAI: Brief Appraisal Inventory; Rapkin, B.D. et al.; Qual Life Res (2018)</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6407615</PublicId>
      <PreferredName>6407612v1.0:6407613v1.0</PreferredName>
      <PreferredDefinition>A questionnaire designed to account for quality-of-life issues and assess their impact on responses in patient-reported outcome surveys._A question about the frequency that a person thought about a particular thing._A question about how often a person thought about maintaining a positive outlook, even when things are going badly._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Brief Appraisal Inventory How Often Did You Think About Maintain Positive Outlook, Even When Things are Going Badly Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407612</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C154238</PreferredName>
        <Version>1</Version>
        <LongName>Brief Appraisal Inventory</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C154238</PREFERRED_NAME>
            <LONG_NAME>Brief Appraisal Inventory</LONG_NAME>
            <CON_ID>6402446</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6407613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C154239:C154240:C25338</PreferredName>
        <Version>1</Version>
        <LongName>How Often Did You Think About Maintain Positive Outlook, Even When Things are Going Badly Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C154239</PREFERRED_NAME>
            <LONG_NAME>How Often Did You Think About Question</LONG_NAME>
            <CON_ID>6402447</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C154240</PREFERRED_NAME>
            <LONG_NAME>Maintain Positive Outlook, Even When Things are Going Badly Question</LONG_NAME>
            <CON_ID>6402448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BAI: Brief Appraisal Inventory; Rapkin, B.D. et al.; Qual Life Res (2018)</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6407530</PublicId>
      <PreferredName>BAI_7PT_SCL</PreferredName>
      <PreferredDefinition>An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Something distinguishable as an identifiable class based on common qualities._Something distinguishable as an identifiable class based on common qualities._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>BAI 7 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>18</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>BAI: Brief Appraisal Inventory; Rapkin, B.D. et al.; Qual Life Res (2018)</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>88</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>99</VALIDVALUE>
          <VALUEMEANING>Response Declined</VALUEMEANING>
          <MEANINGDESCRIPTION>Used to indicate when a respondent makes a decision to not answer a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51024</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Often</VALUEMEANING>
          <MEANINGDESCRIPTION>On many occasions, or in many situations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2889147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Maintaining a positive outloo</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Maintaining a positive outlook, even when things are going badly.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="875">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6408618</PUBLICID>
    <LONGNAME>Prior Procedure</LONGNAME>
    <PREFERREDNAME>PRPRIOR</PREFERREDNAME>
    <PREFERREDDEFINITION>Indication the procedure occurred prior to [PRSTTPT] or prior to the date in DM.RFSTDTC.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6408526</PublicId>
      <PreferredName>6407261v1.0:3147615v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._Earlier in time or order._An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.</PreferredDefinition>
      <LongName>Procedure Domain Prior Intervention or Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102700</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102700</PREFERRED_NAME>
            <LONG_NAME>Procedure Domain</LONG_NAME>
            <CON_ID>6407260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3147615</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C25218</PreferredName>
        <Version>1</Version>
        <LongName>Prior Intervention or Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6343337</PublicId>
      <PreferredName>NY</PreferredName>
      <PreferredDefinition>Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6343336</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66742:C25180</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66742</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</LONG_NAME>
            <CON_ID>4852475</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5676138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the procedure performed p</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the procedure performed prior to [PRSTTPT]?; Was the procedure performed prior to study start?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</Name>
        <DocumentType>VALID_VALUE_SOURCE</DocumentType>
        <DocumentText>Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model.</DocumentText>
        <URL>https://ncit.nci.nih.gov/ncitbrowser/ajax?action=create_src_vs_tree&amp;amp;vsd_uri=http%3A//evs.nci.nih.gov/valueset/CDISC/C66742</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Check if the procedure was started before the specified point in time.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PRSTRTPT; PRSTRF</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>This does not map directly to an SDTMIG variable. May be used to populate a value into an SDTM relative timing variable such as PRSTRF or PRSTRTPT. When populating PRSTRF, or PRSTRTPT, if the value of the CDASH field PRPRIOR is &quot;Y&quot; a value from the CDISC CT (STENRF) may be used. When PRPRIOR refers to the Study Reference Period (defined in DM.RFSTDTC to DM.RFENDTC) the SDTM variable PRSTRF should be populated. When PRPRIOR is compared to any other time point, the SDTM variables PRSTRTPT and PRSTTPT should be used. Note: PRSTRTPT must refer to the time point anchor described in PRSTTPT.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>See section on Mapping Relative Times from Collection to Submissions and the SDTMIG for more information.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior to [PRSTTPT]; Prior to study</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient have prior treatment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior Treatment:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient received prior MEK inhibitor therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient received prior Vinblastine therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient had prior treatment with TKIs before study entry with the exception of imatinib or dasatinib?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the procedure performed prior to study start?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Procedures (PR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329808</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Procedures (PR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943401</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PR_PRPRIOR</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="876">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6413041</PUBLICID>
    <LONGNAME>Category for Subject Characteristic</LONGNAME>
    <PREFERREDNAME>[SCTESTCD]_SCCAT</PREFERREDNAME>
    <PREFERREDDEFINITION>A grouping of topic-variable values based on user defined characteristics.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6413005</PublicId>
      <PreferredName>6408455v1.0:6413003v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject characteristics._A character or string that represents the short code name of the subject characteristics test._A classification of subject characteristics data.</PreferredDefinition>
      <LongName>Subject Characteristics Domain Subject Characteristics Test Code Subject Characteristics Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6408455</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49610</PreferredName>
        <Version>1</Version>
        <LongName>Subject Characteristics Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49610</PREFERRED_NAME>
            <LONG_NAME>Subject Characteristics Domain</LONG_NAME>
            <CON_ID>2469075</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6413003</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83409:C83396</PreferredName>
        <Version>1</Version>
        <LongName>Subject Characteristics Test Code Subject Characteristics Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83409</PREFERRED_NAME>
            <LONG_NAME>Subject Characteristics Test Code</LONG_NAME>
            <CON_ID>6408456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83396</PREFERRED_NAME>
            <LONG_NAME>Subject Characteristics Category</LONG_NAME>
            <CON_ID>6413002</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6380819</PublicId>
      <PreferredName>CDISCCAT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396783</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25372</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the category of the</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the category of the subject characteristics?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the subject characteristics category, if not pre-printed on the CRF.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SCCAT</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>Sponsor-defined Controlled Terminology. This would most commonly be either a heading, or a pre-printed category value on the CRF and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as &quot;Category&quot; can be included as the column header. This CDASH variable name is an example of what &quot;variable name&quot; can be used in a denormalized data structure.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[Subject Characteristics Category]; NULL</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the category of the subject characteristics?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Subject Characteristics (SC) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329811</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Subject Characteristics (SC) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943406</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SC_SCCAT_SCTESTCD</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="877">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6413065</PUBLICID>
    <LONGNAME>Subcategory for Skin Response Test</LONGNAME>
    <PREFERREDNAME>SRSCAT</PREFERREDNAME>
    <PREFERREDDEFINITION>A sub-division of the SRCAT values based on user defined characteristics.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6412934</PublicId>
      <PreferredName>6407705v1.0:6412932v1.0</PreferredName>
      <PreferredDefinition>A findings domain for assessments that determine whether a therapy induced an immune response._A subdivision of skin response data.</PreferredDefinition>
      <LongName>Skin Response Domain Skin Response Subcategory</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407705</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C112420</PreferredName>
        <Version>1</Version>
        <LongName>Skin Response Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C112420</PREFERRED_NAME>
            <LONG_NAME>Skin Response Domain</LONG_NAME>
            <CON_ID>6407704</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6412932</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117678</PreferredName>
        <Version>1</Version>
        <LongName>Skin Response Subcategory</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117678</PREFERRED_NAME>
            <LONG_NAME>Skin Response Subcategory</LONG_NAME>
            <CON_ID>6412931</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the subcategory of t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the subcategory of the skin response?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[Skin Response Subcategory]; NULL</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the skin response subcategory, if not pre-printed on the CRF.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SRSCAT</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>Sponsor-defined Controlled Terminology. This would most commonly be either a heading, or a pre-printed category value on the CRF and not a question to which the site would provide an answer. If a question is asked, the response would typically be a sponsor-defined codelist. If the form is laid out as a grid, then words such as &quot;Subcategory&quot; can be included as the column header. SRSCAT can only be used if there is an SRCAT and it must be a subcategorization of SRCAT.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[Skin Response Subcategory]; NULL</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Skin Response (SR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Skin Response (SR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943407</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SR_SRSCAT</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="878">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6421457</PUBLICID>
    <LONGNAME>Diastolic Blood Pressure</LONGNAME>
    <PREFERREDNAME>DIABP_VSORRES</PREFERREDNAME>
    <PREFERREDDEFINITION>Result of the vital signs measurement as originally received or collected.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6421421</PublicId>
      <PreferredName>6354444v1.0:6421419v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to vital sign._The minimum pressure exerted into the systemic arterial circulation during cardiac ventricular relaxation and filling._The outcome of the vital signs assessment.</PreferredDefinition>
      <LongName>Vital Signs Domain Diastolic Blood Pressure Vital Signs Original Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6354444</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49622</PreferredName>
        <Version>1</Version>
        <LongName>Vital Signs Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49622</PREFERRED_NAME>
            <LONG_NAME>Vital Signs Domain</LONG_NAME>
            <CON_ID>2469086</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6421419</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25299:C83108</PreferredName>
        <Version>1</Version>
        <LongName>Diastolic Blood Pressure Vital Signs Original Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25299</PREFERRED_NAME>
            <LONG_NAME>Diastolic Blood Pressure</LONG_NAME>
            <CON_ID>2206198</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83108</PREFERRED_NAME>
            <LONG_NAME>Vital Signs Original Result</LONG_NAME>
            <CON_ID>6421406</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6400810</PublicId>
      <PreferredName>CDISCRES</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The result of an action.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6400811</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C20200</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the vital sign result.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>VSORRES; VSTEST; VSTESTCD</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable. In addition to the SDTMIG variable VSORRES, create VSTESTCD from the CDASH variable name and determine the value of VSTEST from VSTESTCD. The CDASH prompt may also contain the VSTEST.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Diastolic Blood Pressure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the result of the di</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the result of the diastolic blood pressure measurement?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the subject&#39;s diastolic blood pressure?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the subject&#39;s diastolic blood pressure?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Diastolic blood pressure</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Diastolic blood pressure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the average result of the three diastolic blood pressure measurements?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Diastolic Blood Pressure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_02</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Diastolic Blood Pressure (mmHg)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the result of the diastolic blood pressure measurement?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Highly Recommended Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329800</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vital Signs (VS) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329814</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Vital Signs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7473989</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Vital Signs (VS) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943413</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>VS_VSORRES_DIABP</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VSORRES_DIABP</AlternateName>
        <AlternateNameType>OID, Alliance</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="879">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6421534</PUBLICID>
    <LONGNAME>Reason Procedure Interrupted</LONGNAME>
    <PREFERREDNAME>PRITRPRS</PREFERREDNAME>
    <PREFERREDDEFINITION>An indication why the intervention was interrupted.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6421245</PublicId>
      <PreferredName>6407261v1.0:5610034v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._A time interval during which there is a temporary cessation of something._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Procedure Domain Interruption Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102700</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102700</PREFERRED_NAME>
            <LONG_NAME>Procedure Domain</LONG_NAME>
            <CON_ID>6407260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5610034</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25542:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Interruption Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25542</PREFERRED_NAME>
            <LONG_NAME>Interruption</LONG_NAME>
            <CON_ID>2203831</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the reason the procedure was interrupted.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SUPPPR.QVAL</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>his information could be submitted in a SUPPPR dataset as the value of SUPPPR.QVAL where SUPPPR.QNAM = &quot;PRITRPRS&quot; and SUPPPR.QLABEL =&quot;Reason Intervention Interrupted&quot;. Refer to the current SDTM and SDTMIG for instructions on placement of non-standard variables in SDTM domains.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>This CDASH field is use to collected the reason why an intervention was interrupted. The sponsor may define their own controlled terminology.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason Procedure Interrupted</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Why was the procedure interru</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Why was the procedure interrupted?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Why was the procedure interrupted?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Procedures (PR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329808</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Procedures (PR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943401</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PR_PRITRPRS</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="880">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6422467</PUBLICID>
    <LONGNAME>Protocol Agent Transfer Administration, Management Performed Study Activity Ordered Repeats OMOP CDM Refill Number</LONGNAME>
    <PREFERREDNAME>refills</PREFERREDNAME>
    <PREFERREDDEFINITION>A medical product, practice, or application that is tested in a clinical trial._The act of conveying or transporting from one place to another._Performing or possessing executive duties; acting as a supervisor or manager._Executed and carried through to completion._A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it._An active process; excludes processes and mechanisms which fulfill biological functions._The act of requesting that a person, business, or organization do or supply something._Make or do or perform again._A numeral or string of numerals expressing value, quantity, or identification._The number of refills after the initial prescription. The initial prescription is not counted, values start with 0.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>OMOP CDM:The Observational Medical Outcomes Partnership (OMOP) Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6420987</PublicId>
      <PreferredName>3174247v1.0:6420985v1.0</PreferredName>
      <PreferredDefinition>A medical product, practice, or application that is tested in a clinical trial._The act of conveying or transporting from one place to another._Performing or possessing executive duties; acting as a supervisor or manager._Executed and carried through to completion._A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it._An active process; excludes processes and mechanisms which fulfill biological functions._The act of requesting that a person, business, or organization do or supply something._Make or do or perform again.</PreferredDefinition>
      <LongName>Protocol Agent Transfer Administration, Management Performed Study Activity Order Repeat</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174247</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174247v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Agent Transfer Administration Performed Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41161</PREFERRED_NAME>
            <LONG_NAME>Protocol Agent</LONG_NAME>
            <CON_ID>2390873</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48167</PREFERRED_NAME>
            <LONG_NAME>Transfer</LONG_NAME>
            <CON_ID>2422624</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48905</PREFERRED_NAME>
            <LONG_NAME>Administration, Management</LONG_NAME>
            <CON_ID>2528523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7050276</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48906:C47886</PreferredName>
        <Version>1</Version>
        <LongName>Order Repeat</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48906</PREFERRED_NAME>
            <LONG_NAME>Order</LONG_NAME>
            <CON_ID>2534953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47886</PREFERRED_NAME>
            <LONG_NAME>Repeat</LONG_NAME>
            <CON_ID>2415563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6382925</PublicId>
      <PreferredName>6382925v1.0</PreferredName>
      <PreferredDefinition>The number of refills after the initial prescription. The initial prescription is not counted, values start with 0.</PreferredDefinition>
      <LongName>OMOP CDM Refill Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <Datatype>Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Refills</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Refills</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5279492</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>OMOP 5.31</PreferredName>
          <Version>5.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Drug Exposure</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>8003198</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>refills</AlternateName>
        <AlternateNameType>OMOP Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DRUG_EXPOSURE</AlternateName>
        <AlternateNameType>OMOP Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="881">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6425429</PUBLICID>
    <LONGNAME>Common Toxicity Criteria Adverse Event Seizure Type</LONGNAME>
    <PREFERREDNAME>2194886v1.0:6424623v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the common toxicity criteria adverse event seizure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2194886</PublicId>
      <PreferredName>CTC_AE_SEIZURE</PreferredName>
      <PreferredDefinition>information related to the CTC adverse event of seizure.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Seizure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2194884</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Seizure</PreferredName>
        <Version>1</Version>
        <LongName>Seizure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2962</PREFERRED_NAME>
            <LONG_NAME>Seizure</LONG_NAME>
            <CON_ID>2203622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6424623</PublicId>
      <PreferredName>6424623v1.0</PreferredName>
      <PreferredDefinition>Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Seizure Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>6424622</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2962:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Seizure Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2962</PREFERRED_NAME>
            <LONG_NAME>Seizure</LONG_NAME>
            <CON_ID>2203622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complex partial</VALIDVALUE>
          <VALUEMEANING>Complex Partial Seizure</VALUEMEANING>
          <MEANINGDESCRIPTION>A seizure that originates in a single area of the brain that affects consciousness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C155290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other type</VALIDVALUE>
          <VALUEMEANING>Other Seizure</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2962, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Simple partial</VALIDVALUE>
          <VALUEMEANING>Partial Seizure</VALUEMEANING>
          <MEANINGDESCRIPTION>A transitory alteration in movement, sensation or autonomic nerve function due to abnormal electric activity in a localized area of the cerebral cortex, usually without change in awareness or alertness. Symptoms vary with different lesion locations and may include but not limited to the motor (e.g. rhythmic muscle contractions in one area of the body), somatosensory and sensory alterations manifested by abnormal numbness, paresthesias or other hallucinations, including several types of aura; autonomic and psychic symptoms, e.g. with changes in speech, thought, personality, mood, sensation of deja vu or hallucinations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50689</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Generalized tonic-clonic</VALIDVALUE>
          <VALUEMEANING>Grand Mal Seizure</VALUEMEANING>
          <MEANINGDESCRIPTION>A generalized tonic-clinic seizure, characterized by loss of consciousness. This type of seizure may be preceded by an aura and is frequently followed by a period of confusion and lethargy (post-ictal state). </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Status epilepticus</VALIDVALUE>
          <VALUEMEANING>Status Epilepticus</VALUEMEANING>
          <MEANINGDESCRIPTION>A life-threatening situation in which the brain is in a continuous state of seizure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85079</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-convulsive status epilepticus</VALIDVALUE>
          <VALUEMEANING>Non-Convulsive Status Epilepticus</VALUEMEANING>
          <MEANINGDESCRIPTION>Status epilepticus without prominent motor symptoms, the duration of which is at least ten minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C155291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Subclinical</VALIDVALUE>
          <VALUEMEANING>Subclinical Seizure</VALUEMEANING>
          <MEANINGDESCRIPTION>A seizure with no apparent symptoms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191838</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12213925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the type of common t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the type of common toxicity criteria adverse event seizure?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Type</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Type</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the type of seizure</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the type of seizure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify type of seizure</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify type of seizure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_seizure_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="882">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6438199</PUBLICID>
    <LONGNAME>Esophagus and Esophagogastric Junction Squamous Cell Carcinoma AJCC Edition 8 Clinical Tumor T Category</LONGNAME>
    <PREFERREDNAME>ESCC_AJC8_CLN_T_CAT</PREFERREDNAME>
    <PREFERREDDEFINITION>Extent of the primary esophageal and esophagogastric junction squamous cell carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6438170</PublicId>
      <PreferredName>6438168v1.0:2207100v1.0</PreferredName>
      <PreferredDefinition>A squamous cell carcinoma arising from the esophagus.  It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30.  The median age is around 65 in both males and females.  It is located mostly in the middle and lower third of the esophagus.  Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described.  The microscopic features are the same as in other squamous cell carcinomas.  Any degree of differentiation may occur, and variation within a single tumor is common.  The prognosis is poor._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).</PreferredDefinition>
      <LongName>Esophageal Squamous Cell Carcinoma Clinical T Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6438168</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4024</PreferredName>
        <Version>1</Version>
        <LongName>Esophageal Squamous Cell Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4024</PREFERRED_NAME>
            <LONG_NAME>Esophageal Squamous Cell Carcinoma</LONG_NAME>
            <CON_ID>4722727</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207100</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25398:C25728</PreferredName>
        <Version>1</Version>
        <LongName>Clinical T Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25728</PREFERRED_NAME>
            <LONG_NAME>T Category</LONG_NAME>
            <CON_ID>2202382</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6437843</PublicId>
      <PreferredName>6437843v1.0</PreferredName>
      <PreferredDefinition>A finding about one or more characteristics of esophagus and esophagogastric junction cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to carcinomas including squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, undifferentiated carcinoma, neuroendocrine cancers, and adenocarcinoma with neuroendocrine features. Sarcomas, nonepithelial cancers, and gastrointestinal stromal tumors are not staged using this staging system. (from AJCC 8th Ed.)_One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Esophagus and Esophagogastric Junction Carcinoma American Joint Committee on Cancer Edition 8 T Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
      <Representation>
        <PublicId>6437842</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C133365:C25728:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Esophagus and Esophagogastric Junction Cancer TNM Finding v8 T Category Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C133365</PREFERRED_NAME>
            <LONG_NAME>Esophagus and Esophagogastric Junction Cancer TNM Finding v8</LONG_NAME>
            <CON_ID>6437841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25728</PREFERRED_NAME>
            <LONG_NAME>T Category</LONG_NAME>
            <CON_ID>2202382</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T4b</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pT4b TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with tumor invading other adjacent structures, such as the aorta, vertebral body, or airway. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T4a</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pT4a TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with tumor invading the pleura, pericardium, azygos vein, diaphragm, or peritoneum. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T4</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pT4 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with tumor invading adjacent structures. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T3</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pT3 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with tumor invading adventitia. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T2</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pT2 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with tumor invading the muscularis propria. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T1b</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pT1b TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with tumor invading the submucosa. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T1</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pT1 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with tumor invading the lamina propria, muscularis mucosae, or submucosa. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tis</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pTis TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with a finding of high-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T0</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pT0 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with no evidence of primary tumor. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TX</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pTX TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133374</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T1a</VALIDVALUE>
          <VALUEMEANING>Esophagus and Esophagogastric Junction Cancer pT1a TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Esophagus and esophagogastric junction cancer with tumor invading the lamina propria or muscularis mucosae. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6437857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Clinical T category</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Clinical T category</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AJCC Edition 8</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6005920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Esophagus and Esophagogastric Junction</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6437866</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="883">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6580613</PUBLICID>
    <LONGNAME>Cervical Cancer AJCC Edition 8 Pathologic Regional Lymph Node N Category</LONGNAME>
    <PREFERREDNAME>CRVX_AJC8_PTH_N_CAT</PREFERREDNAME>
    <PREFERREDDEFINITION>Extent of the regional lymph node involvement for cervical carcinoma based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2434812</PublicId>
      <PreferredName>CERVICAL_TUMOR_P_N_S</PreferredName>
      <PreferredDefinition>Information related to pathologic N stage of a cervical tumor (or cancer of the uterine cervix).</PreferredDefinition>
      <LongName>Cervical Tumor Pathologic N Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2434808</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12844:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Cervical Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12844</PREFERRED_NAME>
            <LONG_NAME>Cervical</LONG_NAME>
            <CON_ID>2205294</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2428379</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25610:C25580</PreferredName>
        <Version>1</Version>
        <LongName>Pathologic N Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25610</PREFERRED_NAME>
            <LONG_NAME>Pathologic</LONG_NAME>
            <CON_ID>2204850</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25580</PREFERRED_NAME>
            <LONG_NAME>N Category</LONG_NAME>
            <CON_ID>2204625</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6577378</PublicId>
      <PreferredName>6577378v1.0</PreferredName>
      <PreferredDefinition>A finding about one or more characteristics of cervical cancer, following the rules of the TNM AJCC v8 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Cervical Carcinoma American Joint Committee on Cancer Edition 8 N Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>6</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
      <Representation>
        <PublicId>6577377</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C139682:C39315:C25580:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Cervical Cancer TNM Finding v8 American Joint Committee on Cancer N Category Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C139682</PREFERRED_NAME>
            <LONG_NAME>Cervical Cancer TNM Finding v8</LONG_NAME>
            <CON_ID>6577317</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39315</PREFERRED_NAME>
            <LONG_NAME>American Joint Committee on Cancer</LONG_NAME>
            <CON_ID>2554142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25580</PREFERRED_NAME>
            <LONG_NAME>N Category</LONG_NAME>
            <CON_ID>2204625</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N1</VALIDVALUE>
          <VALUEMEANING>Cervical Cancer pN1 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Cervical cancer with regional lymph node metastasis. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6577380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N0(i+)</VALIDVALUE>
          <VALUEMEANING>Cervical Cancer pN0(i+) TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Cervical cancer with isolated tumor cells in regional lymph node(s) no greater than 0.2 mm. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139728</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6577382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N0</VALIDVALUE>
          <VALUEMEANING>Cervical Cancer pN0 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Cervical cancer with no regional lymph node metastasis. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6577384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NX</VALIDVALUE>
          <VALUEMEANING>Cervical Cancer pNX TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Cervical cancer in which the regional lymph nodes cannot be assessed. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6577386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pathologic N category</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pathologic N category</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CPTAC-BSLN-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Pathologic Regional Lymph Node Status (pN)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AJCC Edition 8</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6005920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cervix</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000442</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cervix</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6570063</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC Baseline</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6779609</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCCPR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCCPR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="884">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6584919</PUBLICID>
    <LONGNAME>Biospecimen Biopathology Center Submitter Identifier</LONGNAME>
    <PREFERREDNAME>BPC_SUBMITTER_ID</PREFERREDNAME>
    <PREFERREDDEFINITION>Biopathology center generated identifier for the individual submitting tissue</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HCMI:Human Cancer Models Initiative</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6584246</PublicId>
      <PreferredName>2859635v1.0:6584244v1.0</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._A College of American Pathologists (CAP) accredited biorepository with the primary objective of long-term acquisition and storage of a large number of cancer, normal and diseased biospecimens obtained from patients with Informed Consent, and related data for the purpose of supporting cutting edge research._A person who presents or submits something (e.g., a proposal or protocol) for formal consideration or review by others.</PreferredDefinition>
      <LongName>Biospecimen Biopathology Center Submitter</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2230266</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TISSUE BANKING</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Banking</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6584244</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C103854:C54269</PreferredName>
        <Version>1</Version>
        <LongName>Biopathology Center Submitter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C103854</PREFERRED_NAME>
            <LONG_NAME>Biopathology Center</LONG_NAME>
            <CON_ID>3641114</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54269</PREFERRED_NAME>
            <LONG_NAME>Submitter</LONG_NAME>
            <CON_ID>2523383</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HCMI:Human Cancer Models Initiative</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2728596</PublicId>
      <PreferredName>ID</PreferredName>
      <PreferredDefinition>Unique identifier for an object.</PreferredDefinition>
      <LongName>Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BPC submitter ID (if availabl</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>BPC submitter ID (if available)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rare Cancers</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7589449</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="885">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6587733</PUBLICID>
    <LONGNAME>Lesion Score Scale Prior Biopsy Other Specify</LONGNAME>
    <PREFERREDNAME>LES_SCR_PR_BX_TX</PREFERREDNAME>
    <PREFERREDDEFINITION>A text field that specifies other reasons for lesion score prior to biopsy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6586864</PublicId>
      <PreferredName>2732373v1.0:6586866v1.0</PreferredName>
      <PreferredDefinition>Any observable abnormal structural change in a bodily part._A number or range of numeric values measuring performance, function, quality, or ability._An ordered reference standard used to measure incremental changes._Earlier in time or order._The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.</PreferredDefinition>
      <LongName>Lesion Score Scale Prior Biopsy</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2732373</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71163</PreferredName>
        <Version>1</Version>
        <LongName>Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71163</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2730290</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6586866</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338:C25664:C25629:C15189</PreferredName>
        <Version>1</Version>
        <LongName>Score Scale Prior Biopsy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15189</PREFERRED_NAME>
            <LONG_NAME>Biopsy Procedure</LONG_NAME>
            <CON_ID>2202502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666713</PublicId>
      <PreferredName>OTH_SPEC</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Other Specify</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCI CRF Standards</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other Reason for pre-biopsy s</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other Reason for pre-biopsy score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="886">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6594250</PUBLICID>
    <LONGNAME>Autologous Hematopoietic Stem Cell Transplantation Disease Response Assessment Stratification Code</LONGNAME>
    <PREFERREDNAME>6594245v1.0:6594247v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Stratification code representing the response to stem cell transfer or transplantation in which the patient is his own donor.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>SWOG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6594245</PublicId>
      <PreferredName>2658699v1.0:6594243v1.0</PreferredName>
      <PreferredDefinition>Stem cell transfer or transplantation in which the patient is his own donor._The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Autologous Hematopoietic Stem Cell Transplantation Disease Response Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SWOG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2658699</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16039</PreferredName>
        <Version>1</Version>
        <LongName>Autologous Stem Cell Transplantation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16039</PREFERRED_NAME>
            <LONG_NAME>Autologous Hematopoietic Stem Cell Transplantation</LONG_NAME>
            <CON_ID>2527546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6594243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50995:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50995</PREFERRED_NAME>
            <LONG_NAME>Disease Response</LONG_NAME>
            <CON_ID>2459436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6594247</PublicId>
      <PreferredName>6594247v1.0</PreferredName>
      <PreferredDefinition>Stratification code representing the response to stem cell transfer or transplantation in which the patient is his own donor.</PreferredDefinition>
      <LongName>Autologous Hematopoietic Stem Cell Transplantation Disease Response Stratification Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SWOG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>6594246</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16039:C50995:C25689:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Autologous Hematopoietic Stem Cell Transplantation Disease Response Stratification Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16039</PREFERRED_NAME>
            <LONG_NAME>Autologous Hematopoietic Stem Cell Transplantation</LONG_NAME>
            <CON_ID>2527546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50995</PREFERRED_NAME>
            <LONG_NAME>Disease Response</LONG_NAME>
            <CON_ID>2459436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25689</PREFERRED_NAME>
            <LONG_NAME>Stratification</LONG_NAME>
            <CON_ID>2203803</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>VGPR or better</VALUEMEANING>
          <MEANINGDESCRIPTION>VGPR or better</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6597232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>MRD negative and in VGPR or better</VALUEMEANING>
          <MEANINGDESCRIPTION>MRD negative and in VGPR or better</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6594248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Otherwise</VALUEMEANING>
          <MEANINGDESCRIPTION>Otherwise</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6594249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Best response to ASCT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Best response to ASCT</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="887">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6597501</PUBLICID>
    <LONGNAME>CHAMPS Activities Questionnaire for Older Adults 28 During Past 4 Weeks Walk Leisurely for Exercise or Pleasure Indicator</LONGNAME>
    <PREFERREDNAME>CHAMPS_28_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s response indicating whether or not they walked leisurely for exercise or pleasure, during the past 4 weeks.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CHAMPS Activities Questionnaire for Older Adults</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6597310</PublicId>
      <PreferredName>6597170v1.0:6597308v1.0</PreferredName>
      <PreferredDefinition>A self-report physical activity questionnaire for older men and women, developed to evaluate the outcomes of the Community Healthy Activities Model Program for Seniors (CHAMPS), an intervention to increase physical activity._At some point in a given period of time._A period of time consisting of the 28 days before the present._A question about whether an individual walked leisurely for exercise or pleasure.</PreferredDefinition>
      <LongName>CHAMPS Activities Questionnaire for Older Adults During Past 4 Weeks Walk Leisurely for Exercise or Pleasure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6597170</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C156957</PreferredName>
        <Version>1</Version>
        <LongName>CHAMPS Activities Questionnaire for Older Adults</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C156957</PREFERRED_NAME>
            <LONG_NAME>CHAMPS Activities Questionnaire for Older Adults</LONG_NAME>
            <CON_ID>6597008</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6597308</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25490:C110986:C156992</PreferredName>
        <Version>1</Version>
        <LongName>During Past 4 Weeks Walk Leisurely for Exercise or Pleasure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110986</PREFERRED_NAME>
            <LONG_NAME>Past 4 Weeks</LONG_NAME>
            <CON_ID>3871096</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C156992</PREFERRED_NAME>
            <LONG_NAME>Walk Leisurely for Exercise or Pleasure Question</LONG_NAME>
            <CON_ID>6597036</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CHAMPS Activities Questionnaire for Older Adults</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Walk leisurely for exercise o</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Walk leisurely for exercise or pleasure?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CHAMPS</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question 82  of 124</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions. Questions used in this manner do not represent the original measure and should not be referenced by the measure’s name.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>2</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>3</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Community Healthy Activities Model Program Physical Activities Questionnaire for Older Adults (CHAMPS)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14888185</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6607641</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CHAMPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CHAMPS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6607647</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="888">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6602145</PUBLICID>
    <LONGNAME>Patient Bilateral Oophorectomy Occurrence Clinical Trial Eligibility Criteria Indicator</LONGNAME>
    <PREFERREDNAME>BIL_OOPH_OCUR_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator to address the surgical removal of both ovaries, as outlined in the study protocol, to determine patient eligibility for clinical trial participation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6602138</PublicId>
      <PreferredName>2233604v1.0:6602136v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Affecting both sides of the body or a matched pair of organs._The surgical removal of one or both ovaries._An instance of something happening, such as an event or incident._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Patient Bilateral Oophorectomy Occurrence Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6602136</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13332:C15291:C25275:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Bilateral Oophorectomy Occurrence Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13332</PREFERRED_NAME>
            <LONG_NAME>Bilateral</LONG_NAME>
            <CON_ID>2204746</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15291</PREFERRED_NAME>
            <LONG_NAME>Oophorectomy</LONG_NAME>
            <CON_ID>2211765</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the patient had a bilater</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the patient had a bilateral oophorectomy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="889">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6619078</PUBLICID>
    <LONGNAME>Patient Referral Edmonton Frail Scale Outcome To Social Worker Indicator</LONGNAME>
    <PREFERREDNAME>EFS_REF_SOCWRKR_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether a patient was referred to a social worker based on the results of the Edmonton Frail Scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6618945</PublicId>
      <PreferredName>2918946v1.0:6619056v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Sending a patient from one practitioner to another for health care services._An assessment tool designed to be used by clinicians to assess the frailty of older patients. It assesses 10 domains including cognitive impairment and balance and mobility._The result of an action._Used as a function word to indicate direction, purpose, or movement._A professionally trained person who is employed in the administration of charity, social service, and welfare. The assistance this professional provides helps disadvantaged individuals and families adjust themselves to the community. Social workers work closely with health agencies, and are often employed by the government.</PreferredDefinition>
      <LongName>Patient Referral Edmonton Frail Scale Outcome To Social Worker</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2918946</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C52582</PreferredName>
        <Version>1</Version>
        <LongName>Patient Referral</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52582</PREFERRED_NAME>
            <LONG_NAME>Referral</LONG_NAME>
            <CON_ID>2443156</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6619056</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C157011:C20200:C65107:C28190</PreferredName>
        <Version>1</Version>
        <LongName>Edmonton Frail Scale Outcome To Social Worker</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C157011</PREFERRED_NAME>
            <LONG_NAME>Edmonton Frail Scale</LONG_NAME>
            <CON_ID>6597509</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C65107</PREFERRED_NAME>
            <LONG_NAME>To</LONG_NAME>
            <CON_ID>2672667</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28190</PREFERRED_NAME>
            <LONG_NAME>Social Worker</LONG_NAME>
            <CON_ID>2405367</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Referral to a social worker?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Referral to a social worker?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="890">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6631731</PUBLICID>
    <LONGNAME>End Reference Time Point</LONGNAME>
    <PREFERREDNAME>PRENTPT</PREFERREDNAME>
    <PREFERREDDEFINITION>A point in time that indicates the conclusion of a procedure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6631702</PublicId>
      <PreferredName>6407261v1.0:6631700v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._A point in time that indicates the conclusion of a procedure.</PreferredDefinition>
      <LongName>Procedure Domain Procedure End Reference Time Point</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102700</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102700</PREFERRED_NAME>
            <LONG_NAME>Procedure Domain</LONG_NAME>
            <CON_ID>6407260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6631700</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117542</PreferredName>
        <Version>1</Version>
        <LongName>Procedure End Reference Time Point</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117542</PREFERRED_NAME>
            <LONG_NAME>Procedure End Reference Time Point</LONG_NAME>
            <CON_ID>6631699</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Permissible</Name>
        <DocumentType>SDTM Core</DocumentType>
        <DocumentText>Permissible</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>End Reference Time Point</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>End Reference Time Point</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDTM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7218795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Procedures (PR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000444</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR.PRENTPT</AlternateName>
        <AlternateNameType>Map:SDTM IGv3.2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRENTPT</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="891">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6635887</PUBLICID>
    <LONGNAME>Sponsor-Defined Identifier</LONGNAME>
    <PREFERREDNAME>PCSPID</PREFERREDNAME>
    <PREFERREDDEFINITION>One or more sponsor defined characters used to identify, name, or characterize the pharmacokinetic concentration assessment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6635845</PublicId>
      <PreferredName>6408442v1.0:6635843v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to pharmacokinetic concentration._One or more sponsor defined characters used to identify, name, or characterize the pharmacokinetic concentration assessment.</PreferredDefinition>
      <LongName>Pharmacokinetic Concentration Domain Pharmacokinetic Concentration Sponsor Defined Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6408442</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49606</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacokinetic Concentration Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49606</PREFERRED_NAME>
            <LONG_NAME>Pharmacokinetic Concentration Domain</LONG_NAME>
            <CON_ID>2469071</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6635843</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C87969</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacokinetic Concentration Sponsor Defined Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C87969</PREFERRED_NAME>
            <LONG_NAME>Pharmacokinetic Concentration Sponsor Defined Identifier</LONG_NAME>
            <CON_ID>6635842</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6353492</PublicId>
      <PreferredName>CDISCID</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396665</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25364</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Sponsor-Defined Identifier</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Sponsor-Defined Identifier</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Permissible</Name>
        <DocumentType>SDTM Core</DocumentType>
        <DocumentText>Permissible</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[Line Number/PC number]</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDTM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7218795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pharmacokinetics Concentrations (PC) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000717</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Pharmacokinetics Concentrations (PC) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943398</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PC</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCSPID</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PC_PCSPID</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="892">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6642238</PUBLICID>
    <LONGNAME>Character Result/Finding in Std Format</LONGNAME>
    <PREFERREDNAME>DDSTRESC</PREFERREDNAME>
    <PREFERREDDEFINITION>The standard character or string for representation and reporting of death diagnosis data.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6640795</PublicId>
      <PreferredName>6408103v1.0:6640793v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to death diagnosis._The standard character or string for representation and reporting of death diagnosis data.</PreferredDefinition>
      <LongName>Death Diagnosis Domain Death Diagnosis Character Result in Standard Format</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6408103</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95087</PreferredName>
        <Version>1</Version>
        <LongName>Death Diagnosis Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95087</PREFERRED_NAME>
            <LONG_NAME>Death Diagnosis Domain</LONG_NAME>
            <CON_ID>6408102</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6640793</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117547</PreferredName>
        <Version>1</Version>
        <LongName>Death Diagnosis Character Result in Standard Format</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117547</PREFERRED_NAME>
            <LONG_NAME>Death Diagnosis Character Result in Standard Format</LONG_NAME>
            <CON_ID>6640792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Expected</Name>
        <DocumentType>SDTM Core</DocumentType>
        <DocumentText>Expected</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Character Result/Finding in S</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Character Result/Finding in Std Format</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDTM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7218795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Death (DD) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DD.DDSTRESC</AlternateName>
        <AlternateNameType>Map:SDTM IGv3.2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DD</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DDSTRESC</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="893">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6643155</PUBLICID>
    <LONGNAME>Numeric Result/Finding in Standard Units</LONGNAME>
    <PREFERREDNAME>MISTRESN</PREFERREDNAME>
    <PREFERREDDEFINITION>The numerical identifier of microscopic findings result in standard units.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6641123</PublicId>
      <PreferredName>6407670v1.0:6641121v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings._The numerical identifier of microscopic findings result in standard units.</PreferredDefinition>
      <LongName>Microscopic Findings Domain Microscopic Findings Numeric Result in Standard Unit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407670</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95095</PreferredName>
        <Version>1</Version>
        <LongName>Microscopic Findings Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95095</PREFERRED_NAME>
            <LONG_NAME>Microscopic Findings Domain</LONG_NAME>
            <CON_ID>6407669</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6641121</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117585</PreferredName>
        <Version>1</Version>
        <LongName>Microscopic Findings Numeric Result in Standard Unit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117585</PREFERRED_NAME>
            <LONG_NAME>Microscopic Findings Numeric Result in Standard Unit</LONG_NAME>
            <CON_ID>6641120</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6659693</PublicId>
      <PreferredName>CDISCFLT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._A number that can have its decimal point in any position.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Float</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6659692</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C48150</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Float</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48150</PREFERRED_NAME>
            <LONG_NAME>Float</LONG_NAME>
            <CON_ID>2433734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Numeric Result/Finding in Sta</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Numeric Result/Finding in Standard Units</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Permissible</Name>
        <DocumentType>SDTM Core</DocumentType>
        <DocumentText>Permissible</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDTM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7218795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Microscopic Findings (MI) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000098</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MI.MISTRESN</AlternateName>
        <AlternateNameType>Map:SDTM IGv3.2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MI</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MISTRESN</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="894">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6660880</PUBLICID>
    <LONGNAME>Tissue Donor Source Priority Revision Count</LONGNAME>
    <PREFERREDNAME>6660871v1.0:2018392v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of times the priority ranking of the donor source was revised.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6660871</PublicId>
      <PreferredName>6663741v1.0:2928475v1.0</PreferredName>
      <PreferredDefinition>Someone who gives blood or tissue or an organ to be used in another person._Where something is available or from where it originates._A status established by order of importance or urgency._An act of alteration involving reconsideration and modification.</PreferredDefinition>
      <LongName>Tissue Donor Source Priority Revision</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6663741</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25168:C25683:C48911</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Donor Source Priority</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25683</PREFERRED_NAME>
            <LONG_NAME>Source</LONG_NAME>
            <CON_ID>2202479</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48911</PREFERRED_NAME>
            <LONG_NAME>Priority</LONG_NAME>
            <CON_ID>2629624</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2928475</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54087</PreferredName>
        <Version>1</Version>
        <LongName>Revision</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54087</PREFERRED_NAME>
            <LONG_NAME>Revision</LONG_NAME>
            <CON_ID>2475253</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018392</PublicId>
      <PreferredName>CT</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How many times has the donor</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How many times has the donor source priority been revised?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What number revision was this in the month?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What number revision was this in the month?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What number revision was this in the month?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>What number revision was this in the month?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="895">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6662712</PUBLICID>
    <LONGNAME>Date of Reference Time Point</LONGNAME>
    <PREFERREDNAME>CMRFTDAT</PREFERREDNAME>
    <PREFERREDDEFINITION>The point in time that acts as a fixed reference point to an event.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Incomplete</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6662692</PublicId>
      <PreferredName>4550855v1.0:6662690v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration._The point in time that acts as a fixed reference point to an event.</PreferredDefinition>
      <LongName>Concomitant Medication Domain Reference Time Point</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4550855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49568</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Medication Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49568</PREFERRED_NAME>
            <LONG_NAME>Concomitant Medication Domain</LONG_NAME>
            <CON_ID>2469052</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6662690</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C82576</PreferredName>
        <Version>1</Version>
        <LongName>Reference Time Point</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82576</PREFERRED_NAME>
            <LONG_NAME>Reference Time Point</LONG_NAME>
            <CON_ID>6662689</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338240</PublicId>
      <PreferredName>CDISCDAT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>11</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396655</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25164</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Reference Time Point</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of Reference Time Point</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the date of the [Reference Time point]?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDTM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7218795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Concomitant Medication (CM) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329788</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Concomitant Medications (CM) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7331372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Concomitant Medication (CM) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMRFTDAT</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CM</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CM_CMRFTDAT</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="896">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6665512</PUBLICID>
    <LONGNAME>Neurocognitive Function Quality of Life Assessment Ineligibility Reason Category</LONGNAME>
    <PREFERREDNAME>NEURCOG_QOL_INELIG_RSN</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicated reason that the patient was not eligible to participate in the neurocognitive funciton and quality of life assessments</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6651797</PublicId>
      <PreferredName>6651794v1.0:6651795v1.0</PreferredName>
      <PreferredDefinition>Having to do with the ability to think and reason. This includes the ability to concentrate, remember things, process information, learn, speak, and understand._The normal action performed by a structure or device._The subjective measurement of an individual&#39;s sense of well-being and ability to enjoy life. The concept holds varying meanings for different people and may evolve over time. For some individuals it implies autonomy, empowerment, capability, and choice; for others, security, social integration, or freedom from stress or illness._The final result of a determination of the value, significance, or extent of._The state or quality of being disqualified by law, rule, or provision._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Neurocognitive Function Quality of Life Assessment Ineligibility Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6651794</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C94321:C25518:C17047:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Neurocognitive Function Quality of Life Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94321</PREFERRED_NAME>
            <LONG_NAME>Neurocognitive</LONG_NAME>
            <CON_ID>3392412</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25518</PREFERRED_NAME>
            <LONG_NAME>Function</LONG_NAME>
            <CON_ID>2202643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17047</PREFERRED_NAME>
            <LONG_NAME>Quality of Life</LONG_NAME>
            <CON_ID>2202504</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6651795</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C40412:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Ineligibility Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40412</PREFERRED_NAME>
            <LONG_NAME>Ineligibility</LONG_NAME>
            <CON_ID>2204007</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6651817</PublicId>
      <PreferredName>6651817v1.0</PreferredName>
      <PreferredDefinition>The state or quality of being disqualified by law, rule, or provision._An explanation of the cause of some phenomenon or action._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Ineligibility Reason Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>6651816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C40412:C25638:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Ineligibility Reason Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40412</PREFERRED_NAME>
            <LONG_NAME>Ineligibility</LONG_NAME>
            <CON_ID>2204007</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Motor impairment that would prevent computer use or recognition of visual stimuli at the time of assessment</VALIDVALUE>
          <VALUEMEANING>Motor impairment that would prevent computer use or recognition of visual stimuli at the time of assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>Motor impairment that would prevent computer use or recognition of visual stimuli at the time of assessment</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6651818</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Significant visual impairment that would prevent computer use or recognition of visual stimuli at the time of assessment</VALIDVALUE>
          <VALUEMEANING>Significant visual impairment that would prevent computer use or recognition of visual stimuli at the time of assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>Significant visual impairment that would prevent computer use or recognition of visual stimuli at the time of assessment</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6651819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known history of neurodevelopmental disorder (besides NF1) prior to diagnosis of LGG</VALIDVALUE>
          <VALUEMEANING>Known history of neurodevelopmental disorder (besides NF1) prior to diagnosis of LGG</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient has a known history of neurodevelopmental disorder (besides NF1) prior to diagnosis of LGG</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6651820</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not English or Spanish speaking</VALIDVALUE>
          <VALUEMEANING>Not English or Spanish speaking</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient does not speak English or Spanish</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6651821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>History of neurodevelopmental disorder</VALIDVALUE>
          <VALUEMEANING>Known history of neurodevelopmental disorder prior to diagnosis of LGG</VALUEMEANING>
          <MEANINGDESCRIPTION>Known history of neurodevelopmental disorder prior to diagnosis of LGG</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7041736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not English, Spanish, or French</VALIDVALUE>
          <VALUEMEANING>Not English, Spanish, or French speaking</VALUEMEANING>
          <MEANINGDESCRIPTION>Not English, Spanish, or French speaking</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7041737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known history of neurodevelopmental disorder prior to diagnosis of NGGCT</VALIDVALUE>
          <VALUEMEANING>Known history of neurodevelopmental disorder prior to diagnosis of NGGCT</VALUEMEANING>
          <MEANINGDESCRIPTION>Known history of neurodevelopmental disorder prior to diagnosis of NGGCT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2021-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7604706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parent language/language skills</VALIDVALUE>
          <VALUEMEANING>Parent Language Comprehension</VALUEMEANING>
          <MEANINGDESCRIPTION>A mother or a father; an immediate progenitor.: A systematic means of communicating by the use of sounds, symbols, or gestures.: An ability to understand the meaning or importance of something (or the knowledge acquired as a result).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86022, C16779, C42709</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7788586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Index child age</VALIDVALUE>
          <VALUEMEANING>Child Age</VALUEMEANING>
          <MEANINGDESCRIPTION>An age group comprised of individuals who are not yet an adult. The specific cut-off age will vary by purpose.: How long something has existed; elapsed time since birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25150, C16423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7788587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parent age</VALIDVALUE>
          <VALUEMEANING>Parent Age</VALUEMEANING>
          <MEANINGDESCRIPTION>A mother or a father; an immediate progenitor.: How long something has existed; elapsed time since birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25150, C42709</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7788588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Index child not receiving induction therapy at enrolling institution</VALIDVALUE>
          <VALUEMEANING>Child Negation Receive Induction Therapy Enrollment</VALUEMEANING>
          <MEANINGDESCRIPTION>An age group comprised of individuals who are not yet an adult. The specific cut-off age will vary by purpose.: An operation in which a term denies or inverts the meaning of another term or construction.: To take, accept, or get something offered.: The first choice of treatment for a particular type of cancer.: The act of registration, entering in a list, catalog, group, study; also, the number of subjects enrolled.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37948, C158876, C25639, C25594, C16423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7788589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Index child diagnosis or characteristics</VALIDVALUE>
          <VALUEMEANING>Child Diagnosis Characteristic</VALUEMEANING>
          <MEANINGDESCRIPTION>An age group comprised of individuals who are not yet an adult. The specific cut-off age will vary by purpose.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.: The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25447, C15220, C16423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7788590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Reason patient was ineligible</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Reason patient was ineligible for the neurocognitive function and quality of life assessments:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 001</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason why the patient is not eligible for the neurocognitive function and quality of life assessments:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason why the patient was ineligible for the neurocognitive function and quality of life assessments:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="897">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6681716</PUBLICID>
    <LONGNAME>Bone Marrow Transplant Yes No Indicator</LONGNAME>
    <PREFERREDNAME>BM_TPLT_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indication of if the patient received a bone marrow transplant after completing protocol therapy.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7708678</PublicId>
      <PreferredName>2721811v1.0:2512762v1.0</PreferredName>
      <PreferredDefinition>The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes._Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.</PreferredDefinition>
      <LongName>Bone Marrow Transplant</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2721811</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12431</PreferredName>
        <Version>1</Version>
        <LongName>Bone Marrow</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12431</PREFERRED_NAME>
            <LONG_NAME>Bone Marrow</LONG_NAME>
            <CON_ID>2202685</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2512762</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15342</PreferredName>
        <Version>1</Version>
        <LongName>Transplantation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the patient have a bone m</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the patient have a bone marrow transplant following protocol therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="898">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6700737</PUBLICID>
    <LONGNAME>Child Supportive Care Questionnaire How Much Effort Did it Take Provide Emotional Support for Your Child with Cancer Scale</LONGNAME>
    <PREFERREDNAME>EMOTNL_SUPPRT_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s response that indicates how much effort it took to provide emotional support for their child with cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6694719</PublicId>
      <PreferredName>6692867v1.0:6694717v1.0</PreferredName>
      <PreferredDefinition>A person who is not yet an adult. The specific cut-off age will vary by purpose._Supportive care is that which helps the patient and their family to cope with cancer and treatment of it from pre-diagnosis, through the process of diagnosis and treatment, to cure, continuing illness or death and into bereavement. It helps the patient to maximize the benefits of treatment and to live as well as possible with the effects of the disease. Supportive therapy may provide a patient with friendship, encouragement, practical advice such as access to community resources or how to develop a more active social life, vocational counseling, suggestions for minimizing friction with family members, and, above all, hope that the life of the patient may be improved. In all situations, supportive therapy involves the teaching of such life skills as managing medication, learning to socialize, handling finances, and getting a job._A predetermined set of questions._A question about how difficult it was to do something._A question about an individual providing emotional support for their child with cancer.</PreferredDefinition>
      <LongName>Child Supportive Care Questionnaire How Much Effort Did it Take Provide Emotional Support for Your Child with Cancer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6692867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16423:C15747:C17048</PreferredName>
        <Version>1</Version>
        <LongName>Child Supportive Care Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16423</PREFERRED_NAME>
            <LONG_NAME>Child</LONG_NAME>
            <CON_ID>2205406</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15747</PREFERRED_NAME>
            <LONG_NAME>Supportive Care</LONG_NAME>
            <CON_ID>2205256</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17048</PREFERRED_NAME>
            <LONG_NAME>Questionnaire</LONG_NAME>
            <CON_ID>2202367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6694717</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C159343:C159380</PreferredName>
        <Version>1</Version>
        <LongName>How Much Effort Did it Take Provide Emotional Support for Your Child with Cancer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159343</PREFERRED_NAME>
            <LONG_NAME>How Much Effort Did it Take Question</LONG_NAME>
            <CON_ID>6690888</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159380</PREFERRED_NAME>
            <LONG_NAME>Provide Emotional Support for Your Child with Cancer Question</LONG_NAME>
            <CON_ID>6690904</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6696870</PublicId>
      <PreferredName>6696870v1.0</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Effort Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NONE</VALIDVALUE>
          <VALUEMEANING>No Effort</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something took no effort.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6696871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A SMALL AMOUNT</VALIDVALUE>
          <VALUEMEANING>A Small Amount of Effort</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something took only a small amount of effort.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6696872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MODERATE</VALIDVALUE>
          <VALUEMEANING>A Moderate Amount of Effort</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something took a moderate amount of effort.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6696873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>QUITE A LOT</VALIDVALUE>
          <VALUEMEANING>Quite a lot of Effort</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something took quite a lot of effort.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6696874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A GREAT DEAL</VALIDVALUE>
          <VALUEMEANING>A Great Deal of Effort</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something took a great deal of effort.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159396</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6696875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>HOW MUCH EFFORT/DIFFICULTY DI</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>HOW MUCH EFFORT/DIFFICULTY DID IT TAKE PROVIDING EMOTIONAL SUPPORT FOR YOUR CHILD WITH CANCER?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="899">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6702039</PUBLICID>
    <LONGNAME>Child Current School Grade Text</LONGNAME>
    <PREFERREDNAME>CURR_SCH_GRADE_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>Text to indicate current grade in school.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6689265</PublicId>
      <PreferredName>2793416v1.0:6689263v1.0</PreferredName>
      <PreferredDefinition>A person who is not yet an adult. The specific cut-off age will vary by purpose._Occurring in or belonging to the present time._An educational institution._A position on a scale of intensity or amount or quality.</PreferredDefinition>
      <LongName>Child Current School Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2793416</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16423</PreferredName>
        <Version>1</Version>
        <LongName>Child</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16423</PREFERRED_NAME>
            <LONG_NAME>Child</LONG_NAME>
            <CON_ID>2205406</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6689263</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25471:C17118:C48309</PreferredName>
        <Version>1</Version>
        <LongName>Current School Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17118</PREFERRED_NAME>
            <LONG_NAME>School</LONG_NAME>
            <CON_ID>2436198</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666622</PublicId>
      <PreferredName>2666622v2.0</PreferredName>
      <PreferredDefinition>Text; the words of something written.</PreferredDefinition>
      <LongName>100 Character Text</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008581</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PropertiesOrAttributes</PreferredName>
        <Version>1</Version>
        <LongName>Properties or Attributes</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Child&#39;s current grade in school (fill in the blank):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Child&#39;s current grade in scho</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Child&#39;s current grade in school:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="900">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6729418</PUBLICID>
    <LONGNAME>Behavior Rating Inventory of Executive Function, Adult Version Initiate Scale Raw Score Value</LONGNAME>
    <PREFERREDNAME>BRIEFA_INITIATE_RSCR</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric representation of the Behavior Rating Inventory of Executive Function-Adult Version - Initiate Scale Raw Score.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>BRIEF-A:Behavior Rating Inventory of Executive Function-Adult Version. Robert M. Roth, PhD, Peter K. Isquith, PhD, Gerard A. Gioia, PhD, Psychological Assessment Resources, Lutz, FL, 2005</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6691642</PublicId>
      <PreferredName>4770485v1.0:6691640v1.0</PreferredName>
      <PreferredDefinition>A standardized measure that assesses the executive functions of adults aged 18-90 years in their everyday environment. Both a self-report and an informant report are used._A rating scale included in the Behavior Rating Inventory of Executive Function that reflects an individual&#39;s ability to begin a task or activity and to independently generate ideas, responses, or problem-solving strategies._A single score that is derived from a test or an observation and that has not been transformed or altered.</PreferredDefinition>
      <LongName>Behavior Rating Inventory of Executive Function, Adult Version Initiate Scale Raw Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4770485</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121460</PreferredName>
        <Version>1</Version>
        <LongName>Behavior Rating Inventory of Executive Function, Adult Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121460</PREFERRED_NAME>
            <LONG_NAME>Behavior Rating Inventory of Executive Function, Adult Version</LONG_NAME>
            <CON_ID>4769215</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6691640</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121467:C159275</PreferredName>
        <Version>1</Version>
        <LongName>Initiate Scale Raw Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121467</PREFERRED_NAME>
            <LONG_NAME>Initiate Scale</LONG_NAME>
            <CON_ID>4769223</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159275</PREFERRED_NAME>
            <LONG_NAME>Raw Score</LONG_NAME>
            <CON_ID>6689874</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>BRIEF-A:Behavior Rating Inventory of Executive Function-Adult Version. Robert M. Roth, PhD, Peter K. Isquith, PhD, Gerard A. Gioia, PhD, Psychological Assessment Resources, Lutz, FL, 2005</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4757289</PublicId>
      <PreferredName>BRIEF_TSCORE_VAL</PreferredName>
      <PreferredDefinition>A numerical quantity that represents the conversion of an individual score into a standard form made without knowledge of the population standard deviation and mean for the Behavior Rating Inventory of Executive Function.</PreferredDefinition>
      <LongName>BRIEF T Score Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>BRIEF-SR: Behavior Rating Inventory of Executive Function-Self-Report Version. Steven C. Guy, PhD, Peter K. Isquith, PhD, Gerard A. Gioia, PhD, Psychological Assessment Resources, 2004</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Behavior Rating Inventory of</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) - Initiate Raw score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="901">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6753903</PUBLICID>
    <LONGNAME>Lymphedema Symptom Intensity and Distress Survey-Arm V 2.0 During Past Week Have Achiness in Your Arm Intensity Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>LSIDSA_7.1_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation about the intensity level of the achiness in their arm during the past week, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>LSIDS-A:Lymphedema Symptom and Intensity Survey-Arm; SH Ridner et al., Support Care Cancer (2015)</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6753175</PublicId>
      <PreferredName>6752947v1.0:6753173v1.0</PreferredName>
      <PreferredDefinition>A self-report tool designed to evaluate arm lymphedema and associated symptoms in breast cancer survivors._At some point in a given period of time._The most recent week. May include the present day._A question about whether an individual experiences or experienced achiness in their arm._The degree or magnitude of strength, energy, or feeling._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Lymphedema Symptom Intensity and Distress Survey-Arm During Past Week Have Achiness in Your Arm Intensity Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6752947</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C159908</PreferredName>
        <Version>1</Version>
        <LongName>Lymphedema Symptom Intensity and Distress Survey-Arm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159908</PREFERRED_NAME>
            <LONG_NAME>Lymphedema Symptom Intensity and Distress Survey - Arm</LONG_NAME>
            <CON_ID>6751805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6753173</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>6753173v1.0</PreferredName>
        <Version>1</Version>
        <LongName>During Past Week Have Achiness in Your Arm Intensity Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159917</PREFERRED_NAME>
            <LONG_NAME>Have Achiness in Your Arm Question</LONG_NAME>
            <CON_ID>6751812</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25539</PREFERRED_NAME>
            <LONG_NAME>Intensity</LONG_NAME>
            <CON_ID>2202454</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>LSIDS-A:Lymphedema Symptom and Intensity Survey-Arm; SH Ridner et al., Support Care Cancer (2015)</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6753779</PublicId>
      <PreferredName>6753779v1.0</PreferredName>
      <PreferredDefinition>A scale for the subjective scoring of a symptom&#39;s intensity and distress that ranges from 1: Slight to 5: Severe._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Symptoms Intensity and Distress 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>LSIDS-A:Lymphedema Symptom and Intensity Survey-Arm; SH Ridner et al., Support Care Cancer (2015)</Origin>
      <Representation>
        <PublicId>6753778</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C159934:C25664</PreferredName>
        <Version>1</Version>
        <LongName>Symptoms Intensity and Distress Likert Scale Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159934</PREFERRED_NAME>
            <LONG_NAME>Symptoms Intensity and Distress Likert Scale</LONG_NAME>
            <CON_ID>6751835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5 Severe</VALIDVALUE>
          <VALUEMEANING>Intensity and Distress 5</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 5 on a symptom&#39;s intensity and distress scale that ranges from 1: Slight to 5: Severe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159939</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6753780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Intensity and Distress 4</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 4 on a symptom&#39;s intensity and distress scale that ranges from 1: Slight to 5: Severe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159938</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6753781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Intensity and Distress 3</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 3 on a symptom&#39;s intensity and distress scale that ranges from 1: Slight to 5: Severe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159937</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6753782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Intensity and Distress 2</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 2 on a symptom&#39;s intensity and distress scale that ranges from 1: Slight to 5: Severe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159936</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6753783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 Slight</VALIDVALUE>
          <VALUEMEANING>Intensity and Distress 1</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 1 on a symptom&#39;s intensity and distress scale that ranges from 1: Slight to 5: Severe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159935</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6753785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Intensity</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Intensity</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lymphedema Symptom Intensity and Distress Survey-Arm Version 2.0</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #20 of 90</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphedema Symptom Intensity and Distress Survey-Arm (LSIDS-A)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900320</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6736342</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LSIDS-A</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LSIDS-A</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6736343</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="902">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6759626</PUBLICID>
    <LONGNAME>CD3 Complex CD4 Antigen Laboratory Procedure Viable Cell Count Performed Percentage Value</LONGNAME>
    <PREFERREDNAME>6759624v1.0:2729199v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The numeric laboratory percentage value measured, assigned or computed related to the assessment of viability of cells for CD3+CD4+ cells.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6759624</PublicId>
      <PreferredName>3955951v1.0:6758813v1.0</PreferredName>
      <PreferredDefinition>Consisting of cell surface type I membrane Delta, Epsilon, Gamma, Zeta, and Eta protein subunits with ITAM domains and noncovalently associated with the disulfide bound heterodimeric alpha/beta and gamma/delta TCR, the CD3 complex couples receptor antigen recognition to signal transduction pathways during T-cell activation. During TCR engagement with MHC-associated antigen on host cell surfaces and synapse formation, CD3 activity leads to Tyr-phosphorylated CD3 subunits, Tyr phosphorylation of LAT colocalized in lipid rafts, and MAPK activation. CD3 signal transduction appears to involve LCK, ZAP70, Nck, SLA, SLA2, and DOCK2. CD3 subunits may also associate with the cytoskeleton. CD3 also mediates TCR signal transduction during the developmental transition through positive selection of immature thymocytes to mature CD4+ or CD8+ T cells. (NCI)_T-cell surface glycoprotein CD4 (458 aa, ~51 kDa) is encoded by the human CD4 gene. This protein plays a role in antigen recognition and HIV entry._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The determination of the number of viable cells in a sample._Executed and carried through to completion.</PreferredDefinition>
      <LongName>CD3 Complex CD4 Antigen Laboratory Procedure Viable Cell Count Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3955951</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38897:C16300:C25294</PreferredName>
        <Version>1</Version>
        <LongName>CD3 Complex CD4 Antigen Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38897</PREFERRED_NAME>
            <LONG_NAME>CD3 Complex</LONG_NAME>
            <CON_ID>2593496</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16300</PREFERRED_NAME>
            <LONG_NAME>T-Cell Surface Glycoprotein CD4</LONG_NAME>
            <CON_ID>2593503</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6758813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C130166:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Viable Cell Count Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C130166</PREFERRED_NAME>
            <LONG_NAME>Viable Cell Count</LONG_NAME>
            <CON_ID>5627576</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2729199</PublicId>
      <PreferredName>VBL_CL_PRCNT_VAL</PreferredName>
      <PreferredDefinition>Capable of life or normal growth and development._The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._A fraction or ratio with 100 understood as the denominator._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Viable Cell Percentage Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>%</DisplayFormat>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2729198</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25324:C12508:C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Viable Cell Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25324</PREFERRED_NAME>
            <LONG_NAME>Viable</LONG_NAME>
            <CON_ID>2206271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12508</PREFERRED_NAME>
            <LONG_NAME>Cell</LONG_NAME>
            <CON_ID>2202900</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Viability of CD3+CD4+ cells:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Viability of CD3+CD4+ cells:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Viability of CD3+CD4+ cells:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Viability of CD3+CD4+ cells:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the value of the viab</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the value of the viability of cells for CD3+CD4+ cells?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_prod_an_cd3_4_viab_pct_val</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="903">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6769995</PUBLICID>
    <LONGNAME>Janus Kinase Family Sequence Analysis Outcome</LONGNAME>
    <PREFERREDNAME>JAK_SEQ_OUTC</PREFERREDNAME>
    <PREFERREDDEFINITION>The response to a question asking for the outcomes from JAK sequence analysis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6769989</PublicId>
      <PreferredName>6771016v1.0:6771017v1.0</PreferredName>
      <PreferredDefinition>A family of intracellular, non-receptor tyrosine-protein kinases. These enzymes transduce signals from certain cytokine receptors by phosphorylating and activating members of the Signal Transducer and Activator of Transcription (STAT) family of transcription factor proteins._A serial arrangement in which things follow in logical order or a recurrent pattern._Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.</PreferredDefinition>
      <LongName>Janus Kinase Family Sequence Analysis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6771016</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C129387</PreferredName>
        <Version>1</Version>
        <LongName>Janus Kinase Family</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C129387</PREFERRED_NAME>
            <LONG_NAME>Janus Kinase Family</LONG_NAME>
            <CON_ID>5601330</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6771017</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25673:C25391</PreferredName>
        <Version>1</Version>
        <LongName>Sequence Analysis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25673</PREFERRED_NAME>
            <LONG_NAME>Sequence</LONG_NAME>
            <CON_ID>2203798</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6769994</PublicId>
      <PreferredName>6769994v1.0</PreferredName>
      <PreferredDefinition>The result of an action.</PreferredDefinition>
      <LongName>Sequence Analysis Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2476191</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20200</PreferredName>
        <Version>1</Version>
        <LongName>Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Variant of unknown significance</VALIDVALUE>
          <VALUEMEANING>Variation Significant Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>An alteration or difference from a norm or standard.: A term applied to differences, correlations, cause-and-effect relationships, etc., to indicate that they are noticeable, probably too closely correlated to be attributed to chance and therefore indicating a systematic relation: substantial, fairly large; also having consequence or import, important in effect or meaning. In statistics significant ordinarily indicates a probability of not less than 95 percent, while highly significant indicates a probability of not less than 99 percent.: Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998, C41130, C25713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6770006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive for known pathogenic variant</VALIDVALUE>
          <VALUEMEANING>Known Pathogen Variation Positive</VALUEMEANING>
          <MEANINGDESCRIPTION>Recognized, familiar, or within the scope of knowledge.: An agent of disease; a disease producer.: An alteration or difference from a norm or standard.: Involving advantage or good.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80137, C25246, C25713, C80324</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>3, 0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6770007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4163021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unsatisfactory</VALIDVALUE>
          <VALUEMEANING>Unsatisfactory</VALUEMEANING>
          <MEANINGDESCRIPTION>Failing to meet the quantitative or qualitative measures for the needs of a situation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5255277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative</VALUEMEANING>
          <MEANINGDESCRIPTION>Negative; involving disadvantage or harm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2932593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>JAK sequence analysis:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>JAK sequence analysis:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="904">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6790405</PUBLICID>
    <LONGNAME>Start Time of Procedure</LONGNAME>
    <PREFERREDNAME>PRSTTIM</PREFERREDNAME>
    <PREFERREDDEFINITION>The time at which a procedure is to start or did start.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6790389</PublicId>
      <PreferredName>6407261v1.0:6790387v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The time at which something is to start or did start.</PreferredDefinition>
      <LongName>Procedure Domain Therapeutic Procedure Start Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102700</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102700</PREFERRED_NAME>
            <LONG_NAME>Procedure Domain</LONG_NAME>
            <CON_ID>6407260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6790387</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236:C78441</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure Start Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78441</PREFERRED_NAME>
            <LONG_NAME>Start Time</LONG_NAME>
            <CON_ID>2975813</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>RADLEX_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6341396</PublicId>
      <PreferredName>CDISCTIM</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The continuum of experience in which events pass from the future through the present to the past.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396937</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25207</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Start Time of Procedure</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Start Time of Procedure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 2004095 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Template Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Start Time</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the surgery start time?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the surgery start time?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Surgery start time</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Surgery start time</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Time of SPECT/CT:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the start time of the [PRTRT]?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Start time</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What [is/was] the [intended/actual] [intervention] [start/admission] time?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the PET scan start time?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>PET scan start time</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the procedure start time?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the procedure start time?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDTM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7218795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Procedures (PR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000444</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Radiation Therapy - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318364</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Surgery - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318387</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Surgery</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7473988</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Imaging Administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7590128</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC PET Scan</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7590133</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Radiation Therapy</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>11422153</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Procedures (PR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943401</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PR_PRSTTIM</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PR_PRSTTIM_PET</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRSTTIM</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="905">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6841885</PUBLICID>
    <LONGNAME>Breast Graft, Prosthesis, or Flap Failure Occurrence Laterality Anatomic Site</LONGNAME>
    <PREFERREDNAME>6841868v1.0:6841876v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the laterality location of a breast graft, flap, or prosthesis failure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6841868</PublicId>
      <PreferredName>2411756v1.0:6841866v1.0</PreferredName>
      <PreferredDefinition>One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest._A failure of function of a graft, flap, or prosthesis._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Breast Graft, Prosthesis, or Flap Failure Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2411756</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12971</PreferredName>
        <Version>1</Version>
        <LongName>Breast</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12971</PREFERRED_NAME>
            <LONG_NAME>Breast</LONG_NAME>
            <CON_ID>2202571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6841866</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C141244:C25275</PreferredName>
        <Version>1</Version>
        <LongName>Graft, Prosthesis, or Flap Failure Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C141244</PREFERRED_NAME>
            <LONG_NAME>Graft, Prosthesis, or Flap Failure</LONG_NAME>
            <CON_ID>6024574</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6841876</PublicId>
      <PreferredName>6841876v1.0</PreferredName>
      <PreferredDefinition>The laterality location of a breast graft, flap, or prosthesis failure.</PreferredDefinition>
      <LongName>Breast Graft, Prosthesis, or Flap Failure Laterality Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>Alliance Case Report Form</Origin>
      <Representation>
        <PublicId>2519596</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Both</VALIDVALUE>
          <VALUEMEANING>Both</VALUEMEANING>
          <MEANINGDESCRIPTION>One and the other; relating to or being two in conjunction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Contralateral breast</VALIDVALUE>
          <VALUEMEANING>Contralateral breast</VALUEMEANING>
          <MEANINGDESCRIPTION>On or relating to the opposite side (of the body): One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12971, C25307</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4614333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ipsilateral breast</VALIDVALUE>
          <VALUEMEANING>Ipsilateral Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the same side of the body.: One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25308, C12971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3722694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>laterality</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>laterality</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="906">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6847542</PUBLICID>
    <LONGNAME>Eligibility Criteria Disease or Disorder Personal Medical History Indicator</LONGNAME>
    <PREFERREDNAME>ELIG_DISRDR_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator for whether or not patient had history of specific diseases or disorders.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ABTC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ABTC: Adult Brain Tumor Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6847541</PublicId>
      <PreferredName>2767728v1.0:2660707v1.0</PreferredName>
      <PreferredDefinition>Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A record of a patient&#39;s background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.</PreferredDefinition>
      <LongName>Clinical Trial Eligibility Criteria Disease or Disorder Personal Medical History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ABTC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2767728</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16112</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660707</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C18772</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does the patient have a histo</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does the patient have a history or current evidence of the following conditions: neuromuscular disorder with associated elevated CK (e.g. inflammatory myopathies, muscular dystrophy, amyotrophic lateral sclerosis, spinal muscular atrophy), pancreatitis, retinal vein occlusion, uncontrolled HIV, or Hepatitis B/C? An exception will be made for (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months and for subjects with cleared HBV and HCV infections, who may enroll in the study.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4280691</PublicId>
          <ContextName>ABTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Checklist</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4280724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="907">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6848402</PUBLICID>
    <LONGNAME>Tumor Mass Cervical Anatomic Site</LONGNAME>
    <PREFERREDNAME>TMR_CESC_ANAT_SITE</PREFERREDNAME>
    <PREFERREDDEFINITION>The named locations of a benign or malignant pathologic structure that affects the cervix.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCCPR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CPTAC: Clinical Proteomic Tumor Analysis Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6796604</PublicId>
      <PreferredName>4976411v1.0:6796602v1.0</PreferredName>
      <PreferredDefinition>A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells._The anatomic site of the tumor.</PreferredDefinition>
      <LongName>Tumor Mass Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4976411</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C98275</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Mass</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C98275</PREFERRED_NAME>
            <LONG_NAME>Tumor Mass</LONG_NAME>
            <CON_ID>3741976</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6796602</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C157120</PreferredName>
        <Version>1</Version>
        <LongName>Site of Tumor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C157120</PREFERRED_NAME>
            <LONG_NAME>Site of Tumor</LONG_NAME>
            <CON_ID>6770811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6841677</PublicId>
      <PreferredName>6841677v1.0</PreferredName>
      <PreferredDefinition>A benign or malignant neoplasm that affects the cervix. Representative examples include endocervical polyp, rhabdomyoma, carcinoma, and melanoma._Named locations of or within the body.</PreferredDefinition>
      <LongName>Cervical Tumor Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
      <Representation>
        <PublicId>6841676</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2940:C13717</PreferredName>
        <Version>1</Version>
        <LongName>Cervical Neoplasm Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2940</PREFERRED_NAME>
            <LONG_NAME>Cervical Neoplasm</LONG_NAME>
            <CON_ID>2593181</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocervix</VALIDVALUE>
          <VALUEMEANING>Endocervix Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that the tumor is in the endocervix.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159624</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6841678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Exocervix</VALIDVALUE>
          <VALUEMEANING>Exocervix Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that the tumor is in the exocervix.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6841679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tumor site</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tumor site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cervix</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6570063</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC Baseline</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6779609</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC Local Pathology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6779610</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC Pathology Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6779611</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="908">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6848406</PUBLICID>
    <LONGNAME>Tumor Mass Stomach Anatomic Site</LONGNAME>
    <PREFERREDNAME>TMR_STAD_ANAT_SITE</PREFERREDNAME>
    <PREFERREDDEFINITION>The named locations of a benign or malignant pathologic structure involving the stomach.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCCPR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CPTAC: Clinical Proteomic Tumor Analysis Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6796604</PublicId>
      <PreferredName>4976411v1.0:6796602v1.0</PreferredName>
      <PreferredDefinition>A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells._The anatomic site of the tumor.</PreferredDefinition>
      <LongName>Tumor Mass Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4976411</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C98275</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Mass</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C98275</PREFERRED_NAME>
            <LONG_NAME>Tumor Mass</LONG_NAME>
            <CON_ID>3741976</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6796602</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C157120</PreferredName>
        <Version>1</Version>
        <LongName>Site of Tumor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C157120</PREFERRED_NAME>
            <LONG_NAME>Site of Tumor</LONG_NAME>
            <CON_ID>6770811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6841701</PublicId>
      <PreferredName>6841701v1.0</PreferredName>
      <PreferredDefinition>A benign or malignant neoplasm involving the stomach._Named locations of or within the body.</PreferredDefinition>
      <LongName>Stomach Tumor Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
      <Representation>
        <PublicId>6841700</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3387:C13717</PreferredName>
        <Version>1</Version>
        <LongName>Gastric Neoplasm Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3387</PREFERRED_NAME>
            <LONG_NAME>Gastric Neoplasm</LONG_NAME>
            <CON_ID>2593171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Specify Other</VALUEMEANING>
          <MEANINGDESCRIPTION>A directive to indicate a response not listed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157106</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6782229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach, NOS</VALIDVALUE>
          <VALUEMEANING>Stomach, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>An area of the stomach, not otherwise specified.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159568</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6849091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pylorus</VALIDVALUE>
          <VALUEMEANING>Pylorus</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the stomach that connects to the duodenum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antrum</VALIDVALUE>
          <VALUEMEANING>Antrum Pylori</VALUEMEANING>
          <MEANINGDESCRIPTION>The initial part of the pyloric canal of the stomach.  This site contains endocrine cells that produce gastrin and somatostatin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12259</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Body</VALIDVALUE>
          <VALUEMEANING>Body of Stomach</VALUEMEANING>
          <MEANINGDESCRIPTION>The main section of the digestive tube that connects the esophagus to the small intestine. The body proper excludes the upper and lower sections of the fundus and pyloric portion respectively.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12258</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fundus</VALIDVALUE>
          <VALUEMEANING>Fundus of the Stomach</VALUEMEANING>
          <MEANINGDESCRIPTION>The superior portion of the body of the stomach above the level of the cardiac notch.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12257</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastroesophageal Junction</VALIDVALUE>
          <VALUEMEANING>Gastroesophageal Junction</VALUEMEANING>
          <MEANINGDESCRIPTION>The anatomical location where the esophagus joins to the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131339</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tumor Site</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tumor Site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Stomach</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6570064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD Baseline</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6779566</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD Local Pathology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6779567</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD Pathology Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6779568</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="909">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6930783</PUBLICID>
    <LONGNAME>Standard Toxicity Grade 3 Physiologic Resolution Date</LONGNAME>
    <PREFERREDNAME>6930781v1.0:2532012v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The month, day, and year the grade 3 toxicity resolved.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6930781</PublicId>
      <PreferredName>5799402v1.0:2503262v1.0</PreferredName>
      <PreferredDefinition>An adverse event experience that requires intensive therapeutic intervention and interrupts usual daily activities._Return to the normal structure and/or function, e.g. the subsidence of a pathologic process, as the subsidence of an inflammatory lesion or new growth.</PreferredDefinition>
      <LongName>Standard Toxicity Grade 3 Physiologic Resolution</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5799402</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41340</PreferredName>
        <Version>1</Version>
        <LongName>Severe Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41340</PREFERRED_NAME>
            <LONG_NAME>Severe Adverse Event</LONG_NAME>
            <CON_ID>2389416</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2503262</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25655</PreferredName>
        <Version>1</Version>
        <LongName>Resolution</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25655</PREFERRED_NAME>
            <LONG_NAME>Physiologic Resolution</LONG_NAME>
            <CON_ID>2202897</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2532012</PublicId>
      <PreferredName>DATE</PreferredName>
      <PreferredDefinition>The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY-MM-DD</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the date the grade 3</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the date the grade 3 toxicity resolved?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date resolved:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date resolved:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date resolved:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Date resolved:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_GRTT_gd3_toxic_res_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="910">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6974988</PUBLICID>
    <LONGNAME>Trial Screening Criterion Fulfill Indicator</LONGNAME>
    <PREFERREDNAME>IEMTALNY</PREFERREDNAME>
    <PREFERREDDEFINITION>An indication whether or not the trial screening criteria was fulfilled.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCI CRF Standards</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6974979</PublicId>
      <PreferredName>6408437v1.0:6974977v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to the violation of trial inclusion and exclusion criteria of a subject._A process of active consideration of potential subjects for enrollment in a trial._That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison._Satisfy the requirements or expectations of.</PreferredDefinition>
      <LongName>Inclusion Exclusion Criteria Not Met Domain Trial Screening Criterion Fulfill</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6408437</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61536</PreferredName>
        <Version>1</Version>
        <LongName>Inclusion Exclusion Criteria Not Met Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61536</PREFERRED_NAME>
            <LONG_NAME>Inclusion Exclusion Criteria Not Met Domain</LONG_NAME>
            <CON_ID>2553496</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6974977</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48262:C25466:C87531</PreferredName>
        <Version>1</Version>
        <LongName>Trial Screening Criterion Fulfill</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48262</PREFERRED_NAME>
            <LONG_NAME>Trial Screening</LONG_NAME>
            <CON_ID>2838541</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25466</PREFERRED_NAME>
            <LONG_NAME>Criterion</LONG_NAME>
            <CON_ID>2203889</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C87531</PREFERRED_NAME>
            <LONG_NAME>Fulfill</LONG_NAME>
            <CON_ID>3017448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCI CRF Standards</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6343337</PublicId>
      <PreferredName>NY</PreferredName>
      <PreferredDefinition>Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6343336</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66742:C25180</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66742</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</LONG_NAME>
            <CON_ID>4852475</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5676138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 2960675 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does the participant meet all</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does the participant meet all screening criteria?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were all required samples submitted?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were all the scans needed for this evaluation time point received?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient eligible?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Based on pathology review, is the patient eligible to continue on to molecular screening?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Screening - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="911">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6986590</PUBLICID>
    <LONGNAME>Sensitizing EGFR Gene Mutation Laboratory Test Result Type</LONGNAME>
    <PREFERREDNAME>6984727v1.0:6986559v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A response used to determine the outcome of a laboratory test that identifies the change in the sequence of the EGFR gene that results in increased sensitivity to EGFR inhibitory agents.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6984727</PublicId>
      <PreferredName>6984725v1.0:2451823v1.0</PreferredName>
      <PreferredDefinition>A change in the sequence of the EGFR gene that results in increased sensitivity to EGFR inhibitory agents._The outcome of a laboratory test.</PreferredDefinition>
      <LongName>Sensitizing EGFR Gene Mutation Laboratory Test Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6984725</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C153232</PreferredName>
        <Version>1</Version>
        <LongName>Sensitizing EGFR Gene Mutation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C153232</PREFERRED_NAME>
            <LONG_NAME>Sensitizing EGFR Gene Mutation</LONG_NAME>
            <CON_ID>6380865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2451823</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C36292</PreferredName>
        <Version>1</Version>
        <LongName>Test Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C36292</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Result</LONG_NAME>
            <CON_ID>2451822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6986559</PublicId>
      <PreferredName>6986559v1.0</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Mutation Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L858R and/or Exon 19 Deletion</VALIDVALUE>
          <VALUEMEANING>EGFR NP_005219.2:p.L858R And/Or EGFR Exon 19 Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>A change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.: Used to indicate that either or both of two items or options may be valid.: In-frame deletions occurring within the exon 19-encoded part of the epidermal growth factor receptor (EGFR) kinase domain. These mutations are commonly seen in non-small cell lung cancer and are associated with increased sensitivity to EGFR tyrosine kinase inhibitors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126892, C48928, C98515</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6986560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Type of sensitizing EGFR muta</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Type of sensitizing EGFR mutation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314494</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="912">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7006025</PUBLICID>
    <LONGNAME>Upload molecular report</LONGNAME>
    <PREFERREDNAME>MOLXFN</PREFERREDNAME>
    <PREFERREDDEFINITION>A free-text field to address the upload of a molecular analysis report for specimen tracking.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6983055</PublicId>
      <PreferredName>6982657v1.0:6983053v1.0</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._The act or process of following a person, animal, or object through space or time._A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level._A short textual account; having provided a short account._To transfer a file or program to a central computer from a smaller computer or a computer at a remote location.</PreferredDefinition>
      <LongName>Biospecimen Tracking Molecular Analysis Report Upload</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6982657</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699:C45275</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Tracking</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45275</PREFERRED_NAME>
            <LONG_NAME>Tracking</LONG_NAME>
            <CON_ID>2598128</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6983053</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19770:C25375:C48914</PreferredName>
        <Version>1</Version>
        <LongName>Molecular Analysis Report Upload</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19770</PREFERRED_NAME>
            <LONG_NAME>Molecular Analysis</LONG_NAME>
            <CON_ID>2528322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48914</PREFERRED_NAME>
            <LONG_NAME>Upload</LONG_NAME>
            <CON_ID>2629623</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6001805</PublicId>
      <PreferredName>2666622v2.0</PreferredName>
      <PreferredDefinition>Text; the words of something written.</PreferredDefinition>
      <LongName>200 Character Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008581</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PropertiesOrAttributes</PreferredName>
        <Version>1</Version>
        <LongName>Properties or Attributes</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength>0</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Upload specimen relevant molecular report (PDF or JPG only)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Upload specimen relevant mole</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Upload specimen relevant molecular report</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="913">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7010147</PUBLICID>
    <LONGNAME>Investigator&#39;s Email</LONGNAME>
    <PREFERREDNAME>EMAIL_TRTINV</PREFERREDNAME>
    <PREFERREDDEFINITION>A free-text field to provide the email address of the investigator who is responsible for all aspects of the conduct of a study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7010146</PublicId>
      <PreferredName>2436717v1.0:2223457v1.0</PreferredName>
      <PreferredDefinition>An investigator who is responsible for all aspects of the conduct of a study._A text string identifier for a location to which e-mail can be delivered.</PreferredDefinition>
      <LongName>Principal Investigator E-mail Address</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2436717</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19924</PreferredName>
        <Version>1</Version>
        <LongName>Principal Investigator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19924</PREFERRED_NAME>
            <LONG_NAME>Principal Investigator</LONG_NAME>
            <CON_ID>2202387</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223457</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42775</PreferredName>
        <Version>1</Version>
        <LongName>Email Address</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42775</PREFERRED_NAME>
            <LONG_NAME>E-mail Address</LONG_NAME>
            <CON_ID>2223429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666622</PublicId>
      <PreferredName>2666622v2.0</PreferredName>
      <PreferredDefinition>Text; the words of something written.</PreferredDefinition>
      <LongName>100 Character Text</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008581</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PropertiesOrAttributes</PreferredName>
        <Version>1</Version>
        <LongName>Properties or Attributes</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Investigator&#39;s Email</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Investigator&#39;s Email</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="914">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7074614</PUBLICID>
    <LONGNAME>Laboratory Procedure Alkaline Phosphatase Assessment Value</LONGNAME>
    <PREFERREDNAME>LAB_PROC_AP_ASSES_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>A lab procedure that involves testing or manipulating a sample of blood to determine the numerical quantity of alkaline phosphatase present in a sample.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3120595</PublicId>
      <PreferredName>2543047v1.0:3120593v1.0</PreferredName>
      <PreferredDefinition>information related assessment by medical procedure that involves testing a sample of blood for alkaline phosphatase, an enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate.</PreferredDefinition>
      <LongName>Laboratory Procedure Alkaline Phosphatase Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3120593</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16276:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Alkaline Phosphatase Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16276</PREFERRED_NAME>
            <LONG_NAME>Alkaline Phosphatase</LONG_NAME>
            <CON_ID>2202871</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2183361</PublicId>
      <PreferredName>NUM_12_5_VAL</PreferredName>
      <PreferredDefinition>Value expressed as a number with 12 digits total, with 5 after the decimal.</PreferredDefinition>
      <LongName>Number 12 digits 5 Decimal Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>12</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>5</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alkaline Phosphatase, Total</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Alkaline Phosphatase, Total</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="915">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7108428</PUBLICID>
    <LONGNAME>Other Acute Myeloid Leukemia with Recurrent Genetic Abnormalities Classification Other Specify</LONGNAME>
    <PREFERREDNAME>OTH_RP_ABN_RLT_TEXT</PREFERREDNAME>
    <PREFERREDDEFINITION>Text information of laboratory finding regarding a group of acute myeloid leukemias characterized by recurrent genetic abnormalities, mainly balanced translocations.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7108417</PublicId>
      <PreferredName>2719429v1.0:7108415v1.0</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._A group of acute myeloid leukemias characterized by recurrent genetic abnormalities, mainly balanced translocations.  (WHO, 2001)_A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.</PreferredDefinition>
      <LongName>Other Acute Myeloid Leukemia with Recurrent Genetic Abnormalities Classification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2719429</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649</PreferredName>
        <Version>1</Version>
        <LongName>Other</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7108415</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7175:C25161</PreferredName>
        <Version>1</Version>
        <LongName>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities Classification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C7175</PREFERRED_NAME>
            <LONG_NAME>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities</LONG_NAME>
            <CON_ID>2836815</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25161</PREFERRED_NAME>
            <LONG_NAME>Classification</LONG_NAME>
            <CON_ID>2203879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666713</PublicId>
      <PreferredName>OTH_SPEC</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Other Specify</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCI CRF Standards</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other, Specify:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, Specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="916">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7122469</PUBLICID>
    <LONGNAME>Transplant Graft Versus Host Disease Severity Type</LONGNAME>
    <PREFERREDNAME>GVHD_MAX_SVRT</PREFERREDNAME>
    <PREFERREDDEFINITION>the max severe level of chronic (long term) graft versus host disease reported for a patient who received a transplant.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195812</PublicId>
      <PreferredName>TSPL_GVHD_SVRTY</PreferredName>
      <PreferredDefinition>information related to the severity of graft versus host disease following transplant.</PreferredDefinition>
      <LongName>Transplant Graft Versus Host Disease Severity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206902</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12981:C0018133</PreferredName>
        <Version>1</Version>
        <LongName>Transplant Graft Versus Host Disease</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0018133</PREFERRED_NAME>
            <LONG_NAME>Graft Versus Host Disease</LONG_NAME>
            <CON_ID>2203063</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177355</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Severity</PreferredName>
        <Version>1</Version>
        <LongName>Severity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7122467</PublicId>
      <PreferredName>7122467v1.0</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Severe</VALIDVALUE>
          <VALUEMEANING>Severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Severe</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mild</VALIDVALUE>
          <VALUEMEANING>Mild</VALUEMEANING>
          <MEANINGDESCRIPTION>Mild</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3141244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the maximum severity</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the maximum severity of cGVHD?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="917">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7153779</PUBLICID>
    <LONGNAME>Diagnostic Imaging Epiphysial Cartilage Performed Indicator</LONGNAME>
    <PREFERREDNAME>XRAY_PERF_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Yes/No indicator related to if an tibial growth plate x-ray was obtained.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3439573</PublicId>
      <PreferredName>2321520v1.0:3447649v1.0</PreferredName>
      <PreferredDefinition>Information related to the radiographic assessment of epiphysial cartilage (growth plates).</PreferredDefinition>
      <LongName>Diagnostic Imaging Epiphysial Cartilage Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2321520</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16502</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic Imaging</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16502</PREFERRED_NAME>
            <LONG_NAME>Diagnostic Imaging Testing</LONG_NAME>
            <CON_ID>2321519</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3447649</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C32529:C12373:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Epiphysis of the Bone Cartilage Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C32529</PREFERRED_NAME>
            <LONG_NAME>Epiphysis of the Bone</LONG_NAME>
            <CON_ID>3447594</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12373</PREFERRED_NAME>
            <LONG_NAME>Cartilage</LONG_NAME>
            <CON_ID>3205847</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was an x-ray of the tibial gr</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was an x-ray of the tibial growth plate obtained at time of enrollment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was an x-ray of the tibial growth plate obtained at this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="918">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7155065</PUBLICID>
    <LONGNAME>Conditioning Regimen Per Protocol BMT CTN 1702 QoL Study Subgroup Inclusion Criteria Administered Indicator</LONGNAME>
    <PREFERREDNAME>7155064v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not a conditioning regimen per protocol BMT CTN 1702 QoL study subgroup inclusion criteria was administered.  </PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7155064</PublicId>
      <PreferredName>2594982v1.00:7155062v1.00</PreferredName>
      <PreferredDefinition>Administration of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy, to a transplant recipient prior to a bone marrow or hematopoietic stem cell transplant.  Conditioning destroys the patient&#39;s abnormal blood cells or cancer, as well as slows the patient&#39;s immune response against the donor bone marrow (graft rejection).:For each, generally denoting a ratio._A rule which guides how an activity should be performed._The subjective measurement of an individual&#39;s sense of well-being and ability to enjoy life. The concept holds varying meanings for different people and may evolve over time. For some individuals it implies autonomy, empowerment, capability, and choice; for others, security, social integration, or freedom from stress or illness._Relatively uniform groups (e.g. etiologically and pathogenetically more homogeneous, racial, ethnic, or sex-specific, or the disease- or condition-specific) of study subjects formed within a clinical study population for a separate analysis. The selection of the subgroups, methods of subgroup analysis, and anticipated difference in observation outcome(s) have to be defined and justified in the study protocol and based on known biological mechanisms, and/or findings in previous studies._Medical and/or social characteristics which are necessary for a subject to be allowed to participate in a clinical study, as outlined in the study protocol. Meeting inclusion criteria is not a sufficient condition for entry or recruitment of a subject into the study. Characteristics limiting the eligibility of a subject for the clinical study must be considered._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Conditioning Regimen Per Protocol BMT CTN 1702 QoL Study Subgroup Inclusion Criteria Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2594982</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C64468</PreferredName>
        <Version>1</Version>
        <LongName>Transplant Conditioning</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64468</PREFERRED_NAME>
            <LONG_NAME>Transplant Conditioning</LONG_NAME>
            <CON_ID>2590852</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7155062</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>7155062v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Per Protocol Quality of Life Clinical Study Population Subgroup Inclusion Criteria Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C65039</PREFERRED_NAME>
            <LONG_NAME>Per</LONG_NAME>
            <CON_ID>2679568</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42651</PREFERRED_NAME>
            <LONG_NAME>Protocol</LONG_NAME>
            <CON_ID>2211236</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17047</PREFERRED_NAME>
            <LONG_NAME>Quality of Life</LONG_NAME>
            <CON_ID>2202504</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70730</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Population Subgroup</LONG_NAME>
            <CON_ID>2714927</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25532</PREFERRED_NAME>
            <LONG_NAME>Inclusion Criteria</LONG_NAME>
            <CON_ID>2202445</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a conditioning regimen pe</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was a conditioning regimen per protocol BMT CTN 1702 QoL study subgroup inclusion criteria administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Will the recipient receive a conditioning regimen listed in the 1702 protocol&#39;s Quality of Life Substudy inclusion criteria?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Will the recipient receive a conditioning regimen listed in the 1702 protocol&#39;s Quality of Life Substudy inclusion criteria?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Will the recipient receive a conditioning regimen listed in the 1702 protocol&#39;s Quality of Life Substudy inclusion criteria?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Will the recipient receive a conditioning regimen listed in the 1702 protocol&#39;s Quality of Life Substudy inclusion criteria?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15689233</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HHS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Completed</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15910169</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="919">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7155636</PUBLICID>
    <LONGNAME>Referring Physician Specialty Type</LONGNAME>
    <PREFERREDNAME>7155633v1.0:7155634v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A response used to determine the area of specialized study within the broader practice of medicine and surgery of a physician that directs a patient to an additional source of medical expertise for assistance, examination, information, or treatment.s.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7155633</PublicId>
      <PreferredName>7155631v1.0:2714870v1.0</PreferredName>
      <PreferredDefinition>A physician that directs a patient to an additional source of medical expertise for assistance, examination, information, or treatment._An area of specialized study within the broader practice of medicine and surgery.</PreferredDefinition>
      <LongName>Referring Physician Medical Specialty</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008545</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>JOBS</PreferredName>
        <Version>1</Version>
        <LongName>Jobs</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7155631</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C51860</PreferredName>
        <Version>1</Version>
        <LongName>Referring Physician</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51860</PREFERRED_NAME>
            <LONG_NAME>Referring Physician</LONG_NAME>
            <CON_ID>2479841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2714870</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17153</PreferredName>
        <Version>1</Version>
        <LongName>Specialty</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17153</PREFERRED_NAME>
            <LONG_NAME>Medical Specialty</LONG_NAME>
            <CON_ID>2203801</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7155634</PublicId>
      <PreferredName>7155634v1.0</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Medical Specialty Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008545</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>JOBS</PreferredName>
        <Version>1</Version>
        <LongName>Jobs</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Family Practice</VALIDVALUE>
          <VALUEMEANING>Family Practice</VALUEMEANING>
          <MEANINGDESCRIPTION>A medical specialty concerned with the provision of continuing, comprehensive primary health care for the entire family.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0015607</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Primary Care</VALIDVALUE>
          <VALUEMEANING>Primary Care Primary Care</VALUEMEANING>
          <MEANINGDESCRIPTION>Health services that meet most basic health care needs over time. Primary care includes physical exams, treatment of common medical conditions, and preventive care such as immunizations and screenings. Primary care doctors are usually the first health professionals patients see for basic medical care. They may refer a patient to a specialist if needed.: Health services that meet most basic health care needs over time. Primary care includes physical exams, treatment of common medical conditions, and preventive care such as immunizations and screenings. Primary care doctors are usually the first health professionals patients see for basic medical care. They may refer a patient to a specialist if needed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94340, C94340</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7155635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medical Oncologist</VALIDVALUE>
          <VALUEMEANING>Medical Oncologist</VALUEMEANING>
          <MEANINGDESCRIPTION>(on-KOL-o-jist) A doctor who specializes in diagnosing and treating cancer using chemotherapy, hormonal therapy, and biological therapy. A medical oncologist often is the main caretaker of someone who has cancer and coordinates treatment provided by other specialists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17838</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastroenterologist</VALIDVALUE>
          <VALUEMEANING>Gastroenterologist</VALUEMEANING>
          <MEANINGDESCRIPTION>(GAS-tro-en-ter-AHL-o-jist) A doctor who specializes in diagnosing and treating disorders of the digestive system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17818</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiologist</VALIDVALUE>
          <VALUEMEANING>Radiologist</VALUEMEANING>
          <MEANINGDESCRIPTION>(RAY-dee-OL-o-jist) A doctor who specializes in creating and interpreting pictures of areas inside the body. The pictures are produced with x-rays, sound waves, or other types of energy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17824</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3237474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surgeon</VALIDVALUE>
          <VALUEMEANING>Surgeon</VALUEMEANING>
          <MEANINGDESCRIPTION>A physician who treats disease, injury, and deformity by operation or manipulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Referring Physician Specialty</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Referring Physician Specialty</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="920">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7284003</PUBLICID>
    <LONGNAME>Acute Chest Syndrome Occurrence Indicator</LONGNAME>
    <PREFERREDNAME>7284002v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not acute chest syndrome occurred.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7284002</PublicId>
      <PreferredName>7284000v1.0:2234856v1.0</PreferredName>
      <PreferredDefinition>A vaso-occlusive crisis of the pulmonary vasculature occurring in patients with sickle cell disease. It is characterized by the presence of a new radiodensity on a chest radiograph accompanied by fever, cough, sputum production, dyspnea, or hypoxia._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Acute Chest Syndrome Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7284000</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C138179</PreferredName>
        <Version>1</Version>
        <LongName>Acute Chest Syndrome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C138179</PREFERRED_NAME>
            <LONG_NAME>Acute Chest Syndrome</LONG_NAME>
            <CON_ID>5947616</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did acute chest syndrome occu</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did acute chest syndrome occur?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has acute chest syndrome (ACS) occurred?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Has acute chest syndrome (ACS) occurred?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has acute chest syndrome (ACS) occurred in the last two years?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has acute chest syndrome (ACS) occurred in the last two years?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has acute chest syndrome occurred since date of last report?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has acute chest syndrome occurred since date of last report?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="921">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7342318</PUBLICID>
    <LONGNAME>BCG Regimen Dose 6 Administered Date</LONGNAME>
    <PREFERREDNAME>7341880v1.0:2018550v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The date on which BCG regimen dose 6 was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7341880</PublicId>
      <PreferredName>7341703v1.0:7341878v1.0</PreferredName>
      <PreferredDefinition>An immunotherapy regimen consisting of Bacillus Calmette-Guerin (BCG) that may be used in the treatment of bladder cancer._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._A number with no fractional part, including the negative and positive numbers as well as zero.::6_The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>BCG Regimen Dose 6 Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7341703</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C159996</PreferredName>
        <Version>1</Version>
        <LongName>BCG Regimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159996</PREFERRED_NAME>
            <LONG_NAME>BCG Regimen</LONG_NAME>
            <CON_ID>6859311</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7341878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488:C45255::6:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Dose Integer::6 Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::6</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of BCG Dose 6</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of BCG Dose 6</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="922">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7344422</PUBLICID>
    <LONGNAME>Anticoagulant Agent Postoperative Administered Indicator</LONGNAME>
    <PREFERREDNAME>ACOAG_POSTOP_ADM_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator if anticoagulant agent was given immediately following a surgical operation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Princess Margaret Cancer Centre, Toronto, ON</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7344421</PublicId>
      <PreferredName>2184079v1.0:2514281v1.0</PreferredName>
      <PreferredDefinition>Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs._Relating to or occurring during the period immediately following a surgical operation._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Anticoagulant Agent Postoperative Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2184079</PublicId>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Anticoagulant Agent</PreferredName>
        <Version>1</Version>
        <LongName>Anticoagulant Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C263</PREFERRED_NAME>
            <LONG_NAME>Anticoagulant Agent</LONG_NAME>
            <CON_ID>2202376</CON_ID>
            <DEFINITION_SOURCE>MSH2002_06_01</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2514281</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28006:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Postoperative Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28006</PREFERRED_NAME>
            <LONG_NAME>Postoperative</LONG_NAME>
            <CON_ID>2211921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Princess Margaret Cancer Centre, Toronto, ON</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Prophylactic anticoagulant po</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Prophylactic anticoagulant post-operatively</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>16445930</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PMCC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PMCC Curation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16445931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="923">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7350644</PUBLICID>
    <LONGNAME>Tumor Identifier Domain Biospecimen Necrotic Process Percentage Value</LONGNAME>
    <PREFERREDNAME>TU_TUORRES_NECPCT</PREFERREDNAME>
    <PREFERREDDEFINITION>Indication as to the percentage of necrosis found in a specimen/sample.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7350643</PublicId>
      <PreferredName>6607938v1.0:7350641v1.0</PreferredName>
      <PreferredDefinition>A domain that represents the data that uniquely identifies tumors._Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents._A fraction or ratio with 100 understood as the denominator.</PreferredDefinition>
      <LongName>Tumor Identifier Domain Biospecimen Necrotic Process Percentage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6607938</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C106577</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Identifier Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C106577</PREFERRED_NAME>
            <LONG_NAME>Tumor Identifier Domain</LONG_NAME>
            <CON_ID>6607937</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7350641</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699:C16897:C25613</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Necrotic Process Percentage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16897</PREFERRED_NAME>
            <LONG_NAME>Necrotic Process</LONG_NAME>
            <CON_ID>2202853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6412664</PublicId>
      <PreferredName>CDISCVL</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6412663</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25712</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Percent of necrosis in specme</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Percent of necrosis in specmen:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Percent necrosis in tested sample:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Percent of necrosis in sample:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Percentage of necrosis found during central review</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="924">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7351430</PUBLICID>
    <LONGNAME>Emtricitabine Administration Indicator</LONGNAME>
    <PREFERREDNAME>EMTRIVA_CMOCCUR</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether or not the participant is receiving emtricitabine.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7351421</PublicId>
      <PreferredName>7351419v1.0:2320521v1.0</PreferredName>
      <PreferredDefinition>A synthetic fluoro derivative of thiacytidine with potent antiviral activity. Emtricitabine is phosphorylated to form emtricitabine 5&#39;-triphosphate within the cell. This metabolite inhibits the activity of human immunodeficiency virus (HIV) reverse transcriptase both by competing with the natural substrate deoxycytidine 5&#39;-triphosphate and by incorporation into viral DNA causing a termination of DNA chain elongation (due to the lack of the essential 3&#39;-OH group)._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.</PreferredDefinition>
      <LongName>Emtricitabine Administration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>AMC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435024</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1908</PreferredName>
        <Version>1</Version>
        <LongName>Drug or Chemical</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7351419</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47509</PreferredName>
        <Version>1</Version>
        <LongName>Emtricitabine</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47509</PREFERRED_NAME>
            <LONG_NAME>Emtricitabine</LONG_NAME>
            <CON_ID>3282250</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2320521</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25409</PreferredName>
        <Version>1</Version>
        <LongName>Administration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AMC CRF:AIDS Malignancy Consortium Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6343337</PublicId>
      <PreferredName>NY</PreferredName>
      <PreferredDefinition>Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6343336</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66742:C25180</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66742</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</LONG_NAME>
            <CON_ID>4852475</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5676138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Currently receiving Emtriva?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Currently receiving Emtriva?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Baseline Evaluations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7283433</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="925">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7352233</PUBLICID>
    <LONGNAME>Absolute Reticulocyte Count Laboratory Procedure Outcome Measurement Test Method Type</LONGNAME>
    <PREFERREDNAME>7352219v1.0:7352222v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the absolute reticulocyte assessment method type.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7352219</PublicId>
      <PreferredName>7434287v1.0:2224045v1.0</PreferredName>
      <PreferredDefinition>The number of reticulocytes present in a cubic millimeter of blood, expressed as the product of the reticulocyte percentage and the red blood cell count._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The result of an action.</PreferredDefinition>
      <LongName>Absolute Reticulocyte Count Laboratory Procedure Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7434287</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C173537:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Absolute Reticulocyte Count Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C173537</PREFERRED_NAME>
            <LONG_NAME>Absolute Reticulocyte Count</LONG_NAME>
            <CON_ID>7351843</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2224045</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20200</PreferredName>
        <Version>1</Version>
        <LongName>Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7352222</PublicId>
      <PreferredName>7352222v1.0</PreferredName>
      <PreferredDefinition>The number of reticulocytes present in a cubic millimeter of blood, expressed as the product of the reticulocyte percentage and the red blood cell count._Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard._The technique used to administer a particular examination or assessment._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Absolute Reticulocyte Count Measurement Test Method Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435033</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16847</PreferredName>
        <Version>1</Version>
        <LongName>Techniques</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>7352221</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C173537:C25209:C82535:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Absolute Reticulocyte Count Measurement Test Method Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C173537</PREFERRED_NAME>
            <LONG_NAME>Absolute Reticulocyte Count</LONG_NAME>
            <CON_ID>7351843</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82535</PREFERRED_NAME>
            <LONG_NAME>Test Method</LONG_NAME>
            <CON_ID>4291134</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Automated</VALIDVALUE>
          <VALUEMEANING>Automatic</VALUEMEANING>
          <MEANINGDESCRIPTION>Operating with minimal human intervention; independent of external control.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2919513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Manual</VALIDVALUE>
          <VALUEMEANING>Manual</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or related to the hands; reference to a task or activity being done by hand (as opposed as being performed with the assistance of automation or other supportive means).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2674649</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the absolute reticul</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the absolute reticulocyte assessment method?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify method of measurement</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify method of measurement</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify method of measurement</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify method of measurement</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="926">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7365514</PUBLICID>
    <LONGNAME>Sign or Symptom At Biospecimen Collection Present Indicator</LONGNAME>
    <PREFERREDNAME>SGN_SYMPT_SPECCOLL_PSNT_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not if there were any signs or symptoms present at time of the biospecimen collection.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7365513</PublicId>
      <PreferredName>5255344v1.0:7365511v1.0</PreferredName>
      <PreferredDefinition>Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom)._Used to indicate position, location, or state._The act or process of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Sign or Symptom At Biospecimen Collection Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5255344</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C100104</PreferredName>
        <Version>1</Version>
        <LongName>Sign or Symptom</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C100104</PREFERRED_NAME>
            <LONG_NAME>Sign or Symptom</LONG_NAME>
            <CON_ID>3645797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7365511</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25427:C70945:C25626</PreferredName>
        <Version>1</Version>
        <LongName>At Biospecimen Collection Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25427</PREFERRED_NAME>
            <LONG_NAME>At</LONG_NAME>
            <CON_ID>2261927</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70945</PREFERRED_NAME>
            <LONG_NAME>Biospecimen Collection</LONG_NAME>
            <CON_ID>2714902</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were any signs or symptoms pr</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Were any signs or symptoms present at time of the biospecimen collection?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Any symptoms or signs at time of specimen collection that resulted in first laboratory confirmation?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Any symptoms or signs at time of specimen collection that resulted in first laboratory confirmation?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7244861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COVID-19</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>WHO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7247342</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="927">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7373690</PUBLICID>
    <LONGNAME>Diagnostic Imaging Radiology Visceral Kaposi Sarcoma Evaluation Indicator</LONGNAME>
    <PREFERREDNAME>QPERF_OTH</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether or not a diagnostic evaluation of visceral Kaposi sarcoma was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7373689</PublicId>
      <PreferredName>2321520v1.0:7373687v1.0</PreferredName>
      <PreferredDefinition>Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation._The branch of medical science dealing with the medical use of X-rays or other penetrating radiation._Of, or relating to, or affecting the internal organs._A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS)._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.</PreferredDefinition>
      <LongName>Diagnostic Imaging Radiology Visceral Kaposi Sarcoma Evaluation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>AMC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2321520</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16502</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic Imaging</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16502</PREFERRED_NAME>
            <LONG_NAME>Diagnostic Imaging Testing</LONG_NAME>
            <CON_ID>2321519</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7373687</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17059:C25315:C9087:C25214</PreferredName>
        <Version>1</Version>
        <LongName>Radiology Visceral Kaposi Sarcoma Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17059</PREFERRED_NAME>
            <LONG_NAME>Radiology</LONG_NAME>
            <CON_ID>2202795</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25315</PREFERRED_NAME>
            <LONG_NAME>Visceral</LONG_NAME>
            <CON_ID>2202888</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9087</PREFERRED_NAME>
            <LONG_NAME>Kaposi Sarcoma</LONG_NAME>
            <CON_ID>2637488</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AMC CRF:AIDS Malignancy Consortium Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6343337</PublicId>
      <PreferredName>NY</PreferredName>
      <PreferredDefinition>Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6343336</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66742:C25180</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66742</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</LONG_NAME>
            <CON_ID>4852475</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5676138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a radiographic or other o</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was a radiographic or other objective evaluation for other visceral KS disease sites done at this visit?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7312662</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="928">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7375419</PUBLICID>
    <LONGNAME>Thoracic Spine Curie mIBG Score</LONGNAME>
    <PREFERREDNAME>TRORRES_SPD_CSR3</PREFERREDNAME>
    <PREFERREDDEFINITION>The Curie mIBG score assigned to the thoracic spine segment to indicate the quantity of metastases, as defined by the sponsor.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7375373</PublicId>
      <PreferredName>6607916v1.0:7375371v1.0</PreferredName>
      <PreferredDefinition>A findings domain that represents quantitative measurements and/or qualitative assessments of the tumors identified in the TU domain._The vertebrae of the thoracic spine, numbered one through twelve in man._A score assigned to a Curie body segment to indicate the quantity of metastases._The outcome of the tumor results assessment as originally received or collected.</PreferredDefinition>
      <LongName>Tumor Results Domain Thoracic Spine Curie Extension Score Tumor Results Original Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6607916</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C106578</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Results Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C106578</PREFERRED_NAME>
            <LONG_NAME>Tumor Results Domain</LONG_NAME>
            <CON_ID>6607915</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7375371</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C69315:C133467:C117416</PreferredName>
        <Version>1</Version>
        <LongName>Thoracic Spine Curie Extension Score Tumor Results Original Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C69315</PREFERRED_NAME>
            <LONG_NAME>Thoracic Spine</LONG_NAME>
            <CON_ID>2677047</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C133467</PREFERRED_NAME>
            <LONG_NAME>Curie Extension Score</LONG_NAME>
            <CON_ID>5768600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117416</PREFERRED_NAME>
            <LONG_NAME>Tumor Results Original Result</LONG_NAME>
            <CON_ID>6641911</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7375364</PublicId>
      <PreferredName>TRORRES_SCOR_SPD</PreferredName>
      <PreferredDefinition>The outcome of the tumor results assessment as originally received or collected._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Tumor Results Original Result Clinical Study Sponsor Defined Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>7377996</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117416:C70793:C165683:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Results Original Result Clinical Study Sponsor Defined Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117416</PREFERRED_NAME>
            <LONG_NAME>Tumor Results Original Result</LONG_NAME>
            <CON_ID>6641911</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70793</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Sponsor</LONG_NAME>
            <CON_ID>2715021</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C165683</PREFERRED_NAME>
            <LONG_NAME>Defined</LONG_NAME>
            <CON_ID>7050024</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Curie Extension Score 3</VALUEMEANING>
          <MEANINGDESCRIPTION>Diffuse involvement within a segment (&gt;50% of the segment).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5796792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Curie Extension Score 2</VALUEMEANING>
          <MEANINGDESCRIPTION>More than one metastatic site within a segment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5796793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Curie Extension Score 1</VALUEMEANING>
          <MEANINGDESCRIPTION>One metastatic site within a segment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5796794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Curie Extension Score 0</VALUEMEANING>
          <MEANINGDESCRIPTION>No metastatic sites within a segment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5796795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>T-spine</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>T-spine</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="929">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7449410</PUBLICID>
    <LONGNAME>Buccal Swab Frozen Specimen Date and Time</LONGNAME>
    <PREFERREDNAME>7413331v1.0:7414605v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The date or date and time the buccal swab specimen was immobilized by severe cold.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCCPR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CPTAC: Clinical Proteomic Tumor Analysis Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7413331</PublicId>
      <PreferredName>6199660v1.0:5230074v1.0</PreferredName>
      <PreferredDefinition>The collection of cells from the inside of a person&#39;s cheek using a swab collection device._A specimen that has been subjected to and immobilized by severe cold.</PreferredDefinition>
      <LongName>Buccal Swab Frozen Specimen</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435033</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16847</PreferredName>
        <Version>1</Version>
        <LongName>Techniques</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6199660</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C113747</PreferredName>
        <Version>1</Version>
        <LongName>Buccal Swab</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113747</PREFERRED_NAME>
            <LONG_NAME>Buccal Swab</LONG_NAME>
            <CON_ID>4920234</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5230074</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70717</PreferredName>
        <Version>1</Version>
        <LongName>Frozen Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70717</PREFERRED_NAME>
            <LONG_NAME>Frozen Specimen</LONG_NAME>
            <CON_ID>2960212</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7414605</PublicId>
      <PreferredName>7414605v1.0</PreferredName>
      <PreferredDefinition>The date or date and time that an event has happened or will happen.</PreferredDefinition>
      <LongName>Date and Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>255</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date/Time of freezing buccal</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date/Time of freezing buccal swabs:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>All Procurement CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7409064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6601273</PublicId>
          <ContextName>OCCPR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CPTAC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AML Specimen</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7409066</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="930">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7532269</PUBLICID>
    <LONGNAME>Autoinflammatory Disorder Present Name</LONGNAME>
    <PREFERREDNAME>AUTOINFL_DS_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that represents the name of the autoinflammatory syndrome or disorder.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7529198</PublicId>
      <PreferredName>7529196v1.0:2233878v1.0</PreferredName>
      <PreferredDefinition>A group of disorders of the innate immune system characterized by attacks of seemingly unprovoked inflammation without significant levels of either autoantibodies or autoreactive T cells more characteristic of autoimmune disease._Being or existing in a specified place or at the specified time. (NCI)</PreferredDefinition>
      <LongName>Autoinflammatory Syndrome Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7529196</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C119050</PreferredName>
        <Version>1</Version>
        <LongName>Autoinflammatory Syndrome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C119050</PREFERRED_NAME>
            <LONG_NAME>Autoinflammatory Syndrome</LONG_NAME>
            <CON_ID>7529195</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7531546</PublicId>
      <PreferredName>AUTOINFLM_NM</PreferredName>
      <PreferredDefinition>The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Autoinflammatory Disorder Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rheumatoid arthritis</VALIDVALUE>
          <VALUEMEANING>Rheumatoid Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2884</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recurrent high grade fevers</VALIDVALUE>
          <VALUEMEANING>Recurrent High Grade Fever</VALUEMEANING>
          <MEANINGDESCRIPTION>Recurrent High Grade Fever</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-12-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7531547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyarthritis</VALIDVALUE>
          <VALUEMEANING>Polyarticular Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>An arthritis affecting five or more separate joints.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26996</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7531549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutrophilic dermatosis</VALIDVALUE>
          <VALUEMEANING>Neutrophilic Dermatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Neutrophilic Dermatosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-12-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7531550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arthritis</VALIDVALUE>
          <VALUEMEANING>Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2883</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3292693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Autoinflammatory disorders</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Autoinflammatory disorders</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="931">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7544340</PUBLICID>
    <LONGNAME>Biospecimen Group ID</LONGNAME>
    <PREFERREDNAME>BEGRPID</PREFERREDNAME>
    <PREFERREDDEFINITION>A character or string that represents a biospecimen group.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7544339</PublicId>
      <PreferredName>6983057v1.0:7544337v1.0</PreferredName>
      <PreferredDefinition>An events domain that documents biospecimen collection and storage information._Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._A sequence of characters that represents a particular group.</PreferredDefinition>
      <LongName>Biospecimen Events Domain Biospecimen Group ID</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6983057</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C111138</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Events Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C111138</PREFERRED_NAME>
            <LONG_NAME>Biospecimen Events Domain</LONG_NAME>
            <CON_ID>6983056</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7544337</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699:C82529</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Group ID</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82529</PREFERRED_NAME>
            <LONG_NAME>Group ID</LONG_NAME>
            <CON_ID>7544336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6353492</PublicId>
      <PreferredName>CDISCID</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396665</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25364</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Group ID</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Group ID</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of passes for this specimen type during the biopsy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Block Number of Tissue Sample:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="932">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7592170</PUBLICID>
    <LONGNAME>Cancer Incidence Rate Geographic Area 100 Character Text</LONGNAME>
    <PREFERREDNAME>7592089v1.0:2666622v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text describing the county and state associated with the cancer incidence rate during a specified time period as determined by the patient&#39;s primary residence zip code.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>HTAN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HTAN:Human Tumor Atlas Network</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7592089</PublicId>
      <PreferredName>2186369v1.0:7592087v1.0</PreferredName>
      <PreferredDefinition>A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._The frequency of new occurrences of an event during a specified time period._Any demarcated area of the Earth; may be determined by both natural and human boundaries.</PreferredDefinition>
      <LongName>Cancer Incidence Rate Geographic Area</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>HTAN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008543</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>GEO_LCTNS</PreferredName>
        <Version>1</Version>
        <LongName>Geographic Locations</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2186369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7592087</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C53348:C16632</PreferredName>
        <Version>1</Version>
        <LongName>Incidence Rate Geographic Area</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53348</PREFERRED_NAME>
            <LONG_NAME>Incidence Rate</LONG_NAME>
            <CON_ID>7591769</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16632</PREFERRED_NAME>
            <LONG_NAME>Geographic Area</LONG_NAME>
            <CON_ID>2202413</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HTAN:Human Tumor Atlas Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666622</PublicId>
      <PreferredName>2666622v2.0</PreferredName>
      <PreferredDefinition>Text; the words of something written.</PreferredDefinition>
      <LongName>100 Character Text</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008581</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PropertiesOrAttributes</PreferredName>
        <Version>1</Version>
        <LongName>Properties or Attributes</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>County and state location for</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>County and state location for cancer incidence data</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>HTAN-Instruction</Name>
        <DocumentType>Coding Instructions</DocumentType>
        <DocumentText>Record the county and state as they appear in the incidence box from which the cancer_incidence data is obtained in the https://gis.cancer.gov/canceratlas/app/ website.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7639423</PublicId>
          <ContextName>HTAN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>SRRS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SRRS Diversity</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7639429</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>HTAN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cancer_incidence_location</AlternateName>
        <AlternateNameType>HTAN Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="933">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7622266</PUBLICID>
    <LONGNAME>First Antiviral Agent Administered Antiviral Agent Type</LONGNAME>
    <PREFERREDNAME>7622265v1.0:5073167v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the first antiviral agent that was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7622265</PublicId>
      <PreferredName>7622263v1.0:2233610v1.0</PreferredName>
      <PreferredDefinition>Preceding all others in time or space or degree._Drugs used to treat infections caused by viruses._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>First Antiviral Agent Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7622263</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C281</PreferredName>
        <Version>1</Version>
        <LongName>First Antiviral Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C281</PREFERRED_NAME>
            <LONG_NAME>Antiviral Agent</LONG_NAME>
            <CON_ID>2593907</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5073167</PublicId>
      <PreferredName>5073167v1.0</PreferredName>
      <PreferredDefinition>Drugs used to treat infections caused by viruses._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Antiviral Agent Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>5073166</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C281:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Antiviral Agent Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C281</PREFERRED_NAME>
            <LONG_NAME>Antiviral Agent</LONG_NAME>
            <CON_ID>2593907</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Valacyclovir</VALIDVALUE>
          <VALUEMEANING>Valacyclovir</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt of the L-valyl ester of the antiviral drug acyclovir. Orally administered, valacyclovir is rapidly converted to acyclovir which inhibits viral DNA replication after further conversion to the nucleotide analog acyclovir triphosphate by viral thymidine kinase, cellular guanyl cyclase, and a number of other cellular enzymes. Acyclovir triphosphate competitively inhibits viral DNA polymerase; incorporates into and terminates the growing viral DNA chain; and inactivates viral DNA polymerase. The greater antiviral activity of acyclovir against herpes simplex virus (HSV) compared with varicella-zoster virus (VZV) is due to its more efficient phosphorylation by HSV thymidine kinase.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28235</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2743501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acyclovir</VALIDVALUE>
          <VALUEMEANING>Acyclovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic analog of the purine nucleoside, guanosine, with potent antiviral activity against herpes simplex viruses type 1 and 2, varicella-zoster virus and other viruses of the herpesvirus family. After conversion in vivo to the active metabolite acyclovir triphosphate by viral thymidine kinase, acyclovir competitively inhibits viral DNA polymerase by incorporating into the growing viral DNA chain and terminating further polymerization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5073168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Valganciclovir</VALIDVALUE>
          <VALUEMEANING>Valganciclovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic prodrug of ganciclovir, a nucleoside analogue of 2&#39;-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575724</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganciclovir</VALIDVALUE>
          <VALUEMEANING>Ganciclovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic guanine derivative with antiviral activity.  As the active metabolite of ganciclovir, ganciclovir-5-triphosphate (ganciclovir-TP) appears to inhibit viral DNA synthesis by competitive inhibition of viral DNA polymerases and incorporation into viral DNA, resulting in eventual termination of viral DNA elongation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Famciclovir</VALIDVALUE>
          <VALUEMEANING>Famciclovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A diacetyl 6-deoxy prodrug analog of the antiviral agent penciclovir.  Orally administered, famciclovir in vivo is converted to penciclovir triphosphate, which is active against the Herpes viruses, including herpes simplex 1 and 2 and varicella-zoster.  This agent inhibits the replication of viral DNA by interfering competitively with DNA polymerase. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29044</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other antiviral drug</VALIDVALUE>
          <VALUEMEANING>Other Antiviral Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._Any agent that can treat or prevent viral infections by interfering with the viral replication cycle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C281, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5073181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Letermovir</VALIDVALUE>
          <VALUEMEANING>Letermovir</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, non-nucleoside, 3,4-dihydroquinazolinyl acetic acid and inhibitor of the pUL56 subunit of the viral terminase complex of cytomegalovirus (CMV), with potential CMV-specific antiviral activity. Upon oral administration, letermovir binds to the pUL56 subunit of the viral terminase complex of CMV and prevents the cleavage of concatemeric DNA into monomeric genome length DNA. As this agent interferes with viral DNA processing and subsequent viral DNA packaging into procapsids, CMV replication is blocked and CMV infection is prevented.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C115099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5073183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brincidofovir</VALIDVALUE>
          <VALUEMEANING>Brincidofovir</VALUEMEANING>
          <MEANINGDESCRIPTION>An alkoxyalkyl ester prodrug containing the synthetic, acyclic nucleoside monophosphate analog cidofovir linked, through its phosphonate group, to a lipid, 3-hexadecyloxy-1-propanol, with antiviral activity against double-stranded DNA viruses. Upon oral administration, brincidofovir crosses the intestinal wall and penetrates target viral-infected cells before being cleaved to the free antiviral agent cidofovir. In turn, cidofovir is phosphorylated by pyruvate kinases to its active metabolite cidofovir diphosphate. Cidofovir diphosphate, bearing structural similarity to nucleotides, competes with deoxycytosine-5-triphosphate (dCTP) for viral DNA polymerase and gets incorporated into the growing viral DNA strands. As a result, it prevents further DNA polymerization and disrupts DNA replication of viruses. Compared to cidofovir, which is given intravenously, hexadecyloxypropyl-cidofovir shows better oral bioavailability, less toxicity and enhanced cellular penetration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5073185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zanamivir</VALIDVALUE>
          <VALUEMEANING>Zanamivir</VALUEMEANING>
          <MEANINGDESCRIPTION>A sialic acid-analogue neuraminidase inhibitor with antiviral activity. Administered into the respiratory tract by aerosol inhalation, zanamivir selectively binds to and inhibits influenza A and B virus neuraminidase-mediated cleavage of sialic acid residues in host cell membrane-bound glycoprotein receptors for influenza viruses, preventing the release of progeny viruses from host cell surfaces and, so, further viral replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5633387</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rimantadine</VALIDVALUE>
          <VALUEMEANING>Rimantadine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cyclic amine and alpha-methyl derivative of amantadine with antiviral activity. Although the exact mechanism of action of rimantadine is not understood, this agent appears to exert its antiviral effect against influenza A virus by interfering with the function of the transmembrane domain of the viral M2 protein, thereby preventing the uncoating of the virus and subsequent release of infectious viral nucleic acids into the cytoplasm of infected cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61927</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5633389</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ribavirin</VALIDVALUE>
          <VALUEMEANING>Ribavirin</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic nucleoside analog of ribofuranose with activity against hepatitis C virus and other RNA viruses. Ribavirin is incorporated into viral RNA, thereby inhibiting viral RNA synthesis, inducing viral genome mutations, and inhibiting normal viral replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5633390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palivizumab</VALIDVALUE>
          <VALUEMEANING>Palivizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody against the fusion protein (F protein) of human respiratory syncytial virus (RSV), with prophylactic application in respiratory syncytial virus infections. RSV F protein, a small envelop glycoprotein, is not only required for cytopathic syncytia resulting from cell-to-cell fusion, but is also necessary for viral spreading and evading neutralizing antibody. Palivizumab neutralizes and inhibits fusion activity of RSV, thereby preventing syncytia formation. Administration of this antibody does not interfere with other immunizations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5633392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peramivir</VALIDVALUE>
          <VALUEMEANING>Peramivir</VALUEMEANING>
          <MEANINGDESCRIPTION>A cyclopentane derivative with activity against influenza A and B viruses. Peramivir is a neuraminidase inhibitor which prevents normal processing of virus particles such that virus particles are not released from infected cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5633394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oseltamivir</VALIDVALUE>
          <VALUEMEANING>Oseltamivir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative prodrug of ethyl ester with antiviral activity. Osetamivir blocks neuraminidases on the surfaces of influenza viruses, interfering with host cell release of complete viral particles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62061</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5633395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amantadine</VALIDVALUE>
          <VALUEMEANING>Amantadine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic tricyclic amine with antiviral, antiparkinsonian, and antihyperalgesic activities. Amantadine appears to exert its antiviral effect against the influenza A virus by interfering with the function of the transmembrane domain of the viral M2 protein, thereby preventing the release of infectious viral nucleic acids into host cells. Furthermore, this agent prevents virus assembly during virus replication. Amantadine exerts its antiparkinsonian effects by stimulating the release of dopamine from striatal dopaminergic nerve terminals and inhibiting its pre-synaptic reuptake. This agent may also exert some anticholinergic effect through inhibition of N-methyl-D-aspartic acid (NMDA) receptor-mediated stimulation of acetylcholine, resulting in antihyperalgesia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5633397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maribavir</VALIDVALUE>
          <VALUEMEANING>Maribavir</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV that are resistant to standard anti-CMV agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82254</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5632012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cidofovir</VALIDVALUE>
          <VALUEMEANING>Cidofovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, acyclic, monophosphate nucleotide analog of deoxycytidine with antiviral activity, and mostly used against cytomegalovirus (CMV). After incorporation into the host cell, cidofovir is phosphorylated by pyruvate kinases to its active metabolite cidofovir diphosphate. Cidofovir diphosphate, bearing structural similarity to nucleotides, competes with deoxycytosine-5-triphosphate (dCTP) for viral DNA polymerase and gets incorporated into the growing viral DNA strands. As a result, it prevents further DNA polymerization and disrupts DNA replication of viruses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5632014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foscarnet</VALIDVALUE>
          <VALUEMEANING>Foscarnet</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic organic analog of inorganic pyrophosphate with activity against several types of viruses, but primarily used for the treatment of cytomegalovirus retinitis. Foscarnet selectively blocks the pyrophosphate binding site of virus-specific DNA polymerases at concentrations that do not affect cellular DNA polymerases. Because this agent crosses the blood brain barrier, it may be used in the treatment of viral infections of the central nervous system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71630</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5632013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytogam/IVIG</VALIDVALUE>
          <VALUEMEANING>Human Cytomegalovirus Immune Globulin And/Or Intravenous Immunoglobulin Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A sterilized solution containing immunoglobulins (IGs) against cytomegalovirus (CMV) that is derived from human plasma of donors infected with CMV and can be used for passive immunization against CMV. Upon administration, human CMVIG is used to help prevent or treat infection by CMV._Used to indicate that either or both of two items or options may be valid._The administration of a blood product derived from pooled IgG antibodies extracted from donor plasma delivered intravenously. It is used to treat multiple disorders, including immunodeficiencies, autoimmune disorders, and active infections.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121331, C48928, C80826</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13368987</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leflunomide</VALIDVALUE>
          <VALUEMEANING>Leflunomide</VALUEMEANING>
          <MEANINGDESCRIPTION>A derivative of isoxazole used for its immunosuppressive and anti-inflammatory properties.  As a prodrug, leflunomide is converted to an active metabolite, A77 1726, which blocks dihydroorotate dehydrogenase, a key enzyme of de novo pyrimidine synthesis, thereby preventing the expansion of activated T lymphocytes.  This agent also inhibits various protein tyrosine kinases, such as protein kinase C (PKC), thereby inhibiting cell proliferation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1128</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13368988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytotoxic T-Lymphocyte</VALIDVALUE>
          <VALUEMEANING>Cytotoxic T-Lymphocyte</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. These cells are distinct from natural killer cells and from killer cells mediating antibody-dependent cell cytotoxicity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3453291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cellular therapy</VALIDVALUE>
          <VALUEMEANING>Cellular Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70601</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4666954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the first antiviral</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the first antiviral agent that was administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the first antiviral drug given</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify the first antiviral drug given</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the first antiviral drug given</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the first antiviral drug given</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Which antiviral was started first?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the first antiviral drug given as prophylaxis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_IP_frst_antivir_agt_typ</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="934">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7652925</PUBLICID>
    <LONGNAME>Pharmacogenomics Biomarker Domain Biomarker Name</LONGNAME>
    <PREFERREDNAME>PB_PBMRKR_NAME</PREFERREDNAME>
    <PREFERREDDEFINITION>Text name of an individual biomarker used for analysis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7652923</PublicId>
      <PreferredName>7652921v1.0:2557775v1.0</PreferredName>
      <PreferredDefinition>A special purpose domain and reference dataset that associates observed genetic mutations with medical conclusions (e.g. disease diagnosis, drug resistance)._A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Pharmacogenomics Biomarker Domain Biomarker Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7652921</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C106552</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacogenomics Biomarker Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C106552</PREFERRED_NAME>
            <LONG_NAME>Pharmacogenomics Biomarker Domain</LONG_NAME>
            <CON_ID>7652920</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2557775</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16342:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Biomarker Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16342</PREFERRED_NAME>
            <LONG_NAME>Biomarker</LONG_NAME>
            <CON_ID>2202308</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7652919</PublicId>
      <PreferredName>7652919v1.0</PreferredName>
      <PreferredDefinition>A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Neoplasm Biomarker Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435027</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16612</PreferredName>
        <Version>1</Version>
        <LongName>Gene</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>7652918</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3262:C16342:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm Biomarker Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16342</PREFERRED_NAME>
            <LONG_NAME>Biomarker</LONG_NAME>
            <CON_ID>2202308</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lactate Dehydrogenase</VALIDVALUE>
          <VALUEMEANING>Lactate Dehydrogenase</VALUEMEANING>
          <MEANINGDESCRIPTION>A family of homotetrameric cytoplasmic enzymes involved in the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25184</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3364697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, specify:</VALIDVALUE>
          <VALUEMEANING>Other Specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Be specific about something; define clearly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4188777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-human chorionic gonadotropin</VALIDVALUE>
          <VALUEMEANING>Human Chorionic Gonadotropin Beta Subunit</VALUEMEANING>
          <MEANINGDESCRIPTION>The beta subunit of human chorionic gonadotropin. It is used as a clinical marker to facilitate early detection of normal pregnancy and significantly contributes to the diagnosis of various pregnancy-related disorders, such as ectopic pregnancy, spontaneous abortion, hydatidiform mole, choriocarcinoma, or Trisomy 21. Further, determination of this marker is immensely helpful to guide curative intervention in testicular cancer. Other possible clinical uses includes as a marker of cancers of the bladder, pancreas, or biliary tract. (Scan J Clin Lab Invest Suppl 1993;216:97-104)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17479</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2633458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoembryonic Antigen</VALIDVALUE>
          <VALUEMEANING>Carcinoembryonic Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer-specific antigen associated with both tumors and the developing fetus. The main use of this antigen is as a tumor marker, especially with respect to intestinal cancers. Production of the antigen ceases shortly before birth, but may reappear in people who develop certain types of cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5438713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-fetoprotein</VALIDVALUE>
          <VALUEMEANING>Alpha-Fetoprotein</VALUEMEANING>
          <MEANINGDESCRIPTION>Alpha-fetoprotein (609 aa, ~69 kDa) is encoded by the human AFP gene. This protein plays a role in the binding to copper, nickel, bilirubin and fatty acids in the fetal circulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2633460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the biomarker name?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the biomarker name?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Biomarker Name:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="935">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7701786</PUBLICID>
    <LONGNAME>Negation Alteration Product Cryopreservation Performed Indicator</LONGNAME>
    <PREFERREDNAME>7701785v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the non altered product (e.g.,human drugs; therapeutic biologics; allergenics; cells, tissue and gene therapy products; blood components and blood derivative products) was cryopreserved.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7701785</PublicId>
      <PreferredName>7701783v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>An operation in which a term denies or inverts the meaning of another term or construction._A thing produced by or resulting from a process. EXAMPLE(S): drug, device. The FDA list of regulated products: animal and human drugs; therapeutic biologics; allergenics; cell, tissue and gene therapy products; blood components; blood derivative products; devices; and animal (pets and livestock) and human food/feed (medicated and un-medicated); cosmetics; pet treats; and dietary supplements._The end result of a manufacturing process; anything that is produced._Preservation of cells, tissues, organs, or embryos by storage at low temperatures._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Negation Alteration Product Cryopreservation Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7701783</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C28344:C51980:C16475</PreferredName>
        <Version>1</Version>
        <LongName>Negation Alteration Product Cryopreservation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28344</PREFERRED_NAME>
            <LONG_NAME>Alteration</LONG_NAME>
            <CON_ID>2204020</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51980</PREFERRED_NAME>
            <LONG_NAME>Product</LONG_NAME>
            <CON_ID>2527882</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16475</PREFERRED_NAME>
            <LONG_NAME>Cryopreservation</LONG_NAME>
            <CON_ID>2205413</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the non altered product w</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the non altered product was cryopreserved?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the unmanipulated (&quot;back-up&quot;) portion of the product cryopreserved?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Was the unmanipulated (&quot;back-up&quot;) portion of the product cryopreserved?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the unmanipulated (&quot;back-up&quot;) portion of the product cryopreserved?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the unmanipulated (&quot;back-up&quot;) portion of the product cryopreserved?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="936">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7736613</PUBLICID>
    <LONGNAME>Diagnosis Date Day Number</LONGNAME>
    <PREFERREDNAME>DX_DAY</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value that represents the day of the diagnosis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCG:Center for Cancer Genomics</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7736608</PublicId>
      <PreferredName>2442484v1.0:2192971v1.0</PreferredName>
      <PreferredDefinition>The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Diagnosis Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2442484</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2192971</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCG:Center for Cancer Genomics</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896868</PublicId>
      <PreferredName>EVT_DAY_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._time for Earth to make a complete rotation on its axis._A numeral or string of numerals expressing value, quantity, or identification</PreferredDefinition>
      <LongName>Event Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C0439228:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Day Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0439228</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2204684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>22nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::22: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::22</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>21st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>20th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::20: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>19th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::19: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>18th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::18: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>17th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::17: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>16th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::16: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>15th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::15: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>14th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::14: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>13th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::13: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::10: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::4: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::5: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>31st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::31: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::31</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>30th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::30: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::30</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>29th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::29: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>28th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::28: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>27th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::27: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>26th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::26: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>25th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::25: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>24th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>23rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::23: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the day of the diagn</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the day of the diagnosis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6705584</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCG_PTCL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HOPE-CARE</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7715738</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6705584</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCG_PTCL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MILD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13461199</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="937">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7765089</PUBLICID>
    <LONGNAME>Patient Concurrent Enrollment Clinical Trial Eligibility Criteria Indicator</LONGNAME>
    <PREFERREDNAME>CONCPROT</PREFERREDNAME>
    <PREFERREDDEFINITION>The response that indicates the patient meets the eligibility requirements for participation in a clinical trial with regards to enrollment in a concurrent clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7058600</PublicId>
      <PreferredName>2233604v1.0:7058598v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Occurring or operating at the same time._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria._The act of registration, entering in a list, catalog, group, study; also, the number of subjects enrolled.</PreferredDefinition>
      <LongName>Patient Concurrent Enrollment Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7058598</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25456:C37948:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Concurrent Enrollment Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25456</PREFERRED_NAME>
            <LONG_NAME>Concurrent</LONG_NAME>
            <CON_ID>2206181</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37948</PREFERRED_NAME>
            <LONG_NAME>Enrollment</LONG_NAME>
            <CON_ID>2203918</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6343337</PublicId>
      <PreferredName>NY</PreferredName>
      <PreferredDefinition>Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6343336</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66742:C25180</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66742</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</LONG_NAME>
            <CON_ID>4852475</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5676138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is the participant enrolled i</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the participant enrolled in an AMC interventional protocol?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Checklist</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7283432</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="938">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7765648</PUBLICID>
    <LONGNAME>Positron Emission Tomography Diagnostic Imaging Head and Neck Curie Extension Score</LONGNAME>
    <PREFERREDNAME>PET_CUR_SCR_RGN1_OTC</PREFERREDNAME>
    <PREFERREDDEFINITION>The curie extension score of the head and neck region using PET.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7765129</PublicId>
      <PreferredName>2603746v1.0:7765127v1.0</PreferredName>
      <PreferredDefinition>A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered._Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation._For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas._A score assigned to a Curie body segment to indicate the quantity of metastases.</PreferredDefinition>
      <LongName>Positron Emission Tomography Diagnostic Imaging Head and Neck Curie Extension Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2603746</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17007:C16502</PreferredName>
        <Version>1</Version>
        <LongName>Positron Emission Tomography Diagnostic Imaging</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17007</PREFERRED_NAME>
            <LONG_NAME>Positron Emission Tomography</LONG_NAME>
            <CON_ID>2224887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16502</PREFERRED_NAME>
            <LONG_NAME>Diagnostic Imaging Testing</LONG_NAME>
            <CON_ID>2321519</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7765127</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12418:C133467</PreferredName>
        <Version>1</Version>
        <LongName>Head and Neck Curie Extension Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12418</PREFERRED_NAME>
            <LONG_NAME>Head and Neck</LONG_NAME>
            <CON_ID>2203706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C133467</PREFERRED_NAME>
            <LONG_NAME>Curie Extension Score</LONG_NAME>
            <CON_ID>5768600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7765647</PublicId>
      <PreferredName>7765647v1.0</PreferredName>
      <PreferredDefinition>A score assigned to a Curie body segment to indicate the quantity of metastases._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Curie Extension Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>7765646</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C133467:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Curie Extension Score Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C133467</PREFERRED_NAME>
            <LONG_NAME>Curie Extension Score</LONG_NAME>
            <CON_ID>5768600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Curie Extension Score 0</VALUEMEANING>
          <MEANINGDESCRIPTION>No metastatic sites within a segment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5796795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Curie Extension Score 1</VALUEMEANING>
          <MEANINGDESCRIPTION>One metastatic site within a segment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5796794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Curie Extension Score 2</VALUEMEANING>
          <MEANINGDESCRIPTION>More than one metastatic site within a segment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5796793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Curie Extension Score 3</VALUEMEANING>
          <MEANINGDESCRIPTION>Diffuse involvement within a segment (&gt;50% of the segment).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5796792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Curie PET Score Region 1: Hea</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Curie PET Score Region 1: Head/Neck</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="939">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7784436</PUBLICID>
    <LONGNAME>Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Walked for Exercise Indicator How Often Specify</LONGNAME>
    <PREFERREDNAME>JHFAC_WALK_EXCSE_SP</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated response, during the past two weeks, of how often they have walked for exercise.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7784433</PublicId>
      <PreferredName>7784396v1.0:7784431v1.0</PreferredName>
      <PreferredDefinition>A standardized assessment tool that assesses frailty by measuring five phenotypic criteria: unintentional weight loss, exhaustion, low energy expenditure, low grip strength, and/or slowed walking speed. A single score is automatically generated and interpreted as either frail (score 3-5), pre-frail (score 1 or 2), or non-frail or robust (score 0)._At some point in a given period of time._A period of time consisting of the 14 days before the present._A question about whether an individual has walked for exercise._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Johns Hopkins Frailty Assessment Calculator During Past 2 Weeks Walked for Exercise Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7784396</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C181867</PreferredName>
        <Version>1</Version>
        <LongName>Johns Hopkins Frailty Assessment Calculator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C181867</PREFERRED_NAME>
            <LONG_NAME>Johns Hopkins Frailty Assessment Calculator</LONG_NAME>
            <CON_ID>7784330</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7784431</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25490:C126890:C181883:C25180</PreferredName>
        <Version>1</Version>
        <LongName>During Past 2 Weeks Walked for Exercise Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126890</PREFERRED_NAME>
            <LONG_NAME>Past 2 Weeks</LONG_NAME>
            <CON_ID>5271604</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C181883</PREFERRED_NAME>
            <LONG_NAME>Walked for Exercise Question</LONG_NAME>
            <CON_ID>7784357</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7782008</PublicId>
      <PreferredName>HOW_OFTEN_SP</PreferredName>
      <PreferredDefinition>A question about the frequency of an event or behavior._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>How Often Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>7782007</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C118873:C25685</PreferredName>
        <Version>1</Version>
        <LongName>How Often Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C118873</PREFERRED_NAME>
            <LONG_NAME>How Often Question</LONG_NAME>
            <CON_ID>4615091</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If yes, how often</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If yes, how often</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="940">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7784995</PUBLICID>
    <LONGNAME>Child Acute Lymphoblastic Leukemia Therapeutic Procedure Intensive Care Unit Admission Status Yes No Unknown Indicator</LONGNAME>
    <PREFERREDNAME>CH_ALL_TX_ADMT_ICU_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether or not a child being treated for Acute Lymphoblastic Leukemia has been admitted to the intensive care unit.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7784994</PublicId>
      <PreferredName>2793416v1.0:7784992v1.0</PreferredName>
      <PreferredDefinition>An age group comprised of individuals who are not yet an adult. The specific cut-off age will vary by purpose._Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._An indication of whether the subject was admitted to the intensive care unit.</PreferredDefinition>
      <LongName>Child Acute Lymphoblastic Leukemia Therapeutic Procedure Intensive Care Unit Admission Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2793416</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16423</PreferredName>
        <Version>1</Version>
        <LongName>Child</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16423</PREFERRED_NAME>
            <LONG_NAME>Child</LONG_NAME>
            <CON_ID>2205406</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7787687</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3167:C49236:C173316</PreferredName>
        <Version>1</Version>
        <LongName>Acute Lymphoblastic Leukemia Therapeutic Procedure Intensive Care Unit Admission Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3167</PREFERRED_NAME>
            <LONG_NAME>Acute Lymphoblastic Leukemia</LONG_NAME>
            <CON_ID>2202314</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C173316</PREFERRED_NAME>
            <LONG_NAME>Intensive Care Unit Admission Status</LONG_NAME>
            <CON_ID>7784991</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the index child ever admi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the index child ever admitted to ICU during the course of their treatment for ALL?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="941">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7797710</PUBLICID>
    <LONGNAME>Raw Data File Format Type</LONGNAME>
    <PREFERREDNAME>7781956v1.0:7797709v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The file format type containing the original information collected from the primary source.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>HTAN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HTAN:Human Tumor Atlas Network</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7781956</PublicId>
      <PreferredName>7781948v1.0:7781954v1.0</PreferredName>
      <PreferredDefinition>The original information, collected from the primary source._The format of an electronic file.</PreferredDefinition>
      <LongName>Raw Data File Format</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>HTAN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7781948</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C142663</PreferredName>
        <Version>1</Version>
        <LongName>Raw Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C142663</PREFERRED_NAME>
            <LONG_NAME>Raw Data</LONG_NAME>
            <CON_ID>6352256</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7781954</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C171252</PreferredName>
        <Version>1</Version>
        <LongName>Electronic File Format</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C171252</PREFERRED_NAME>
            <LONG_NAME>Electronic File Format</LONG_NAME>
            <CON_ID>7781953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HTAN:Human Tumor Atlas Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7797709</PublicId>
      <PreferredName>7797709v1.0</PreferredName>
      <PreferredDefinition>The format of an electronic file._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>File Format Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>HTAN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008558</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>UOM</PreferredName>
        <Version>1</Version>
        <LongName>Units of Measure</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>HTAN:Human Tumor Atlas Network</Origin>
      <Representation>
        <PublicId>7797708</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C171252:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Electronic File Format Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C171252</PREFERRED_NAME>
            <LONG_NAME>Electronic File Format</LONG_NAME>
            <CON_ID>7781953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>txt</VALIDVALUE>
          <VALUEMEANING>TEXT</VALUEMEANING>
          <MEANINGDESCRIPTION>The words of something written.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>bam</VALIDVALUE>
          <VALUEMEANING>Binary Alignment Map</VALUEMEANING>
          <MEANINGDESCRIPTION>A binary representation of a sequence alignment map (SAM), a compact and indexable representation of nucleotide sequence alignments, compressed by the BGZF (Blocked GNU Zip Format) library.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153249</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6356231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fastq</VALIDVALUE>
          <VALUEMEANING>FASTQ Format</VALUEMEANING>
          <MEANINGDESCRIPTION>A text-based format for storing a biological sequence that encodes the nucleotide calls as well as their quality scores.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6356232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>csv</VALIDVALUE>
          <VALUEMEANING>Comma Separated Values Format</VALUEMEANING>
          <MEANINGDESCRIPTION>A text file format that separates data elements with commas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C182456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>File Format</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>File Format</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7639423</PublicId>
          <ContextName>HTAN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>SRRS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SRRS Imaging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7639428</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7788578</PublicId>
          <ContextName>HTAN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging Data Tier 2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7788582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>HTAN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>fileFormat</AlternateName>
        <AlternateNameType>HTAN Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="942">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7801224</PUBLICID>
    <LONGNAME>Malignant Neoplasm Diagnosis Histology Name</LONGNAME>
    <PREFERREDNAME>MLG_NPL_HX_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>The histologic cell type used to diagnosis the abnormal morphologic characteristics of a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3813790</PublicId>
      <PreferredName>2186369v1.0:2239981v1.0</PreferredName>
      <PreferredDefinition>A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin&#39;s and non-Hodgkin&#39;s lymphomas, leukemias, melanomas, and sarcomas. -- 2004_The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</PreferredDefinition>
      <LongName>Malignant Neoplasm Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2186369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239981</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7801222</PublicId>
      <PreferredName>MLG_NPL_HX_NM</PreferredName>
      <PreferredDefinition>A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin&#39;s and non-Hodgkin&#39;s lymphomas, leukemias, melanomas, and sarcomas. -- 2004_Histology is the study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Malignant Neoplasm Histology Name</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>TCGA:The Cancer Genome Atlas</Origin>
      <Representation>
        <PublicId>3081849</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305:C0344441:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm Histology Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0344441</PREFERRED_NAME>
            <LONG_NAME>Histology</LONG_NAME>
            <CON_ID>2204129</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basaloid squamous cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Basaloid Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A squamous cell carcinoma characterized by the presence of cells with hyperchromatic nuclei, scant amount of cytoplasm, and peripheral nuclear palisading.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biphasic mesothelioma</VALIDVALUE>
          <VALUEMEANING>Biphasic Mesothelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic epithelioid cells and sarcomatoid features.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biphenotypic sinonasal sarcoma</VALIDVALUE>
          <VALUEMEANING>Biphenotypic Sinonasal Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, slow-growing, low-grade soft tissue sarcoma arising from the sinonasal tract. It presents with non-specific obstructive nasal symptoms. Morphologically, it is an infiltrative, cellular spindle cell neoplasm. It is associated with rearrangement of the PAX3 gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C164205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6943208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brenner tumor, borderline/atypical proliferative Brenner tumor</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Brenner Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A Brenner tumor of the ovary characterized by papillary structures, nuclear cytologic atypia, and absense of stromal invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brenner tumor; malignant</VALIDVALUE>
          <VALUEMEANING>Malignant Brenner Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.: A usually benign tumor composed of solid and cystic nests of epithelial cells resembling transitional epithelium; it is surrounded by an abundant stromal component that is dense and fibroblastic in nature.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39954, C14143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchoalveolar</VALIDVALUE>
          <VALUEMEANING>Bronchioloalveolar Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A well or moderately differentiated morphologic variant of lung adenocarcinoma characterized by tumor growth along the alveolar structures without stromal, vascular, or pleural invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2923</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2837829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Burkitt lymphoma (BL), atypical morphology</VALIDVALUE>
          <VALUEMEANING>Atypical Burkitt/Burkitt-Like Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of Burkitt lymphoma characterized by marked nuclear pleomorphism, abundant apoptotic debris, and the presence of tangible body macrophages.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6917</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3322767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Burkitt lymphoma (BL), classic morphology</VALIDVALUE>
          <VALUEMEANING>Classic Burkitt Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mature B cell, lymphoblastic, starry sky effect</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C21917</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Burkitt Lymphoma, NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Burkitt Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures.  It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients.  Three morphologic variants are recognized: classical Burkitt lymphoma, Burkitt lymphoma with plasmacytoid differentiation, and atypical Burkitt/Burkitt-like lymphoma.  All cases express the MYC translocation [t(8;14)]. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2912, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5271753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoid tumor; atypical</VALIDVALUE>
          <VALUEMEANING>Atypical Carcinoid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoid tumor characterized by a high mitotic rate, often associated with the presence of necrosis and nuclear pleomorphism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C72074</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoid tumor; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Carcinoid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way._A well-differentiated neuroendocrine neoplasm of low, intermediate, or high grade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C188218, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoid tumor; typical</VALIDVALUE>
          <VALUEMEANING>Usual Carcinoid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>That which is considered customary._A well-differentiated neuroendocrine neoplasm of low, intermediate, or high grade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C188218, C102843</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma arising from a teratoma</VALIDVALUE>
          <VALUEMEANING>Ovarian Dermoid Cyst with Secondary Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A secondary carcinoma that has developed in an ovarian dermoid cyst.  In the majority of cases, the secondary carcinoma is a squamous cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39997</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma cuniculatum</VALIDVALUE>
          <VALUEMEANING>Oral Cavity Verrucous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A well differentiated squamous cell carcinoma arising from the oral cavity.  It is an exophytic, warty, slow growing tumor, usually affecting older males.  Chronic use of smokeless tobacco is associated with the development of verrucous carcinoma in the oral cavity.  Five year disease-free survival rates between 80% and 90% have been reported in patients who underwent extensive surgical removal of the tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma with lymphoid stroma (medullary carcinoma)</VALIDVALUE>
          <VALUEMEANING>Gastric Carcinoma with Lymphoid Stroma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare adenocarcinoma that arises from the gastric mucosa and is characterized by the presence of prominent lymphocytic stromal infiltration and poorly formed tubular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6270498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma, small cell, NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Small Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble &quot;oat cells&quot; under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3915, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4928894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma, subtype cannot be determined</VALIDVALUE>
          <VALUEMEANING>CUPS - 199.1; Carcinoma Unknown Primary</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma which has metastasized from an unknown primary anatomic site.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3812</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma, type cannot be determined</VALIDVALUE>
          <VALUEMEANING>Undetermined Type Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A term referring to the lack of definitive criteria for classification of a finding.: Something distinguishable as an identifiable class based on common qualities.: A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2916, C25284, C124294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6029500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; adenosquamous</VALIDVALUE>
          <VALUEMEANING>Adenosquamous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2836818</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; anaplastic; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Undifferentiated Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3692, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; basal cell; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Basal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: Basal cell carcinoma is the most frequently seen skin cancer.  It arises from basal cells of the epidermis and pilosebaceous units.  Clinically it is divided into the following types: nodular, ulcerative, superficial, multicentric, erythematous, and sclerosing or morphea-like.. More than 95% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck and the remaining 15% on the trunk and extremities.  Basal cell carcinoma usually grows in a slow and indolent fashion.  However, if untreated, the tumor may invade the subcutaneous fat, skeletal muscle and bone.  Distant metastases are rare.  Excision, curettage and  irradiation cure most basal cell carcinomas. --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>CL066969, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; clear cell</VALIDVALUE>
          <VALUEMEANING>Clear Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A cell with empty-appearing cytoplasm when viewed with a light microscope.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2916, C12478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704625</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma; synovial; monophasic fibrous</VALIDVALUE>
          <VALUEMEANING>Monophasic Synovial Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A synovial sarcoma characterized by the presence of an epithelial or a spindle cell component only.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6534</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma; synovial; poorly differentiated</VALIDVALUE>
          <VALUEMEANING>Poorly Differentiated Synovial Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.: A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3400, C14167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3835972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcomatoid mesothelioma</VALIDVALUE>
          <VALUEMEANING>Sarcomatoid Mesothelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A diffuse malignant mesothelioma arising from the pleura and less often the peritoneum.  It is characterized by the presence of spindle cells.  Anaplastic morphologic features and multinucleated malignant cells may also be seen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sebaceous adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Head and Neck Sebaceous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A sebaceous carcinoma that arises from the skin in the head and neck.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160978</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Secretory carcinoma</VALIDVALUE>
          <VALUEMEANING>Mammary Analog Secretory Carcinoma of Salivary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, low-grade carcinoma of the salivary gland with favorable clinical outcome.  It usually arises from the parotid gland and less often from the minor salivary glands.  It shares the same histopathologic features and molecular characteristics (ETV6 gene rearrangement) with secretory breast carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seminoma; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Seminoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A radiosensitive malignant germ cell tumor found in the testis (especially undescended), and extragonadal sites (anterior mediastinum and pineal gland).  It is characterized by the presence of uniform cells with clear or dense cytoplasm which contains glycogen, and by a large nucleus which contains one or more nucleoli.  The neoplastic germ cells form aggregates separated by fibrous septa.  The fibrous septa contain chronic inflammatory cells, mainly lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9309, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seromucinous borderline tumor/atypical proliferative seromucinous tumor</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Mixed Epithelial Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade ovarian epithelial tumor composed of an admixture of two or more of the five major cell types: serous, mucinous, endometrioid, clear cell, and Brenner/transitional.  The second or second and third cell types must comprise alone or together at least 10% of the tumor epithelium. The majority of patients present with stage I tumor and a minority present with bilateral disease. Morphologically, it shows papillae with detached cell clusters.  Microinvasion may be seen rarely. (WHO 2003)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seromucinous borderline tumor/atypical proliferative seromucinous tumor with microinvasion</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor with Microinvasion</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic serous and mucinous epithelial cells, atypia, and the presence of microinvasion of the ovarian stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6691993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seromucinous carcinoma</VALIDVALUE>
          <VALUEMEANING>Ovarian Seromucinous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant mixed epithelial neoplasm that arises from the ovary and is composed predominantly of serous and endocervical-type mucinous epithelium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40090</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5210929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serous borderline tumor-micropapillary variant/noninvasive low-grade serous carcinoma</VALIDVALUE>
          <VALUEMEANING>SEROUS TUMOR OF LOW MALIGNANT POTENTIAL</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive serous neoplasm that arises from the ovary and shows micropapillary and/or cribriform architectural patterns.  It is composed of round epithelial cells with scant cytoplasm and moderate nuclear atypia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serous borderline tumor/atypical proliferative serous tumor</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive serous neoplasm that arises from the ovary and shows greater cellular proliferation and cytologic atypia as compared to benign ovarian serous tumors, but less as compared to low-grade ovarian serous carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6691995</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serous borderline tumor/atypical proliferative serous tumor with microinvasion</VALIDVALUE>
          <VALUEMEANING>Borderline Tumors With Microinvasion</VALUEMEANING>
          <MEANINGDESCRIPTION>An ovarian epithelial tumor characterized by the presence of neoplastic serous epithelial cells, atypia, and microinvasion of the ovarian stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serous Cystadenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Serous Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant serous cystic neoplasm usually involving the ovary or the pancreas. It is characterized by the presence of invasive malignant glandular epithelial cells which often form papillary structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3778</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serous endometrial adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Endometrial Serous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A high grade, aggressive adenocarcinoma arising from the endometrium.  It is characterized by the presence of complex papillary patterns with cellular budding.  Atypical mitoses, necrosis, and psammoma bodies may be present.  It is classified as type II endometrial carcinoma and it is not associated with endometrial hyperplasia.  It tends to invade deeply into the myometrium and spreads into the lymphatic vessels.  Patients frequently present with spread of the tumor beyond the uterus at the time of diagnosis.  The prognosis is usually poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27838</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serous endometrial intraepithelial carcinoma</VALIDVALUE>
          <VALUEMEANING>Serous Endometrial Intraepithelial Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A precursor of endometrial serous adenocarcinoma characterized by the replacement of the normal endometrial cells by malignant glandular cells that resemble the malignant cells of invasive serous adenocarcinoma. The endometrial neoplastic process is non-invasive. It may coexist with invasive endometrial adenocarcinoma or can be associated with metastases outside the uterus, in the absence of invasive endometrial carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40152</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serous tubal intraepithelial carcinoma (STIC)</VALIDVALUE>
          <VALUEMEANING>Serous Tubal Intraepithelial Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive serous carcinoma arising from the fallopian tube.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6690573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serrated Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Serrated Glandular Architecture Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The common saw-tooth architectural pattern observed within hyperplastic polyps.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C42599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6029502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sertoli-Leydig cell tumor</VALIDVALUE>
          <VALUEMEANING>Ovarian Sertoli-Leydig Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant sex cord-stromal tumor arising from the ovary. It is characterized by the presence of neoplastic Leydig cells. Signs and symptoms include hirsutism, menorrhagia and metrorrhagia. It may be associated with trisomy 8.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2880</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Signet Ring Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Signet Ring Cell Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An epithelial neoplastic cell containing cytoplasmic mucin. The presence of mucin pushes the nucleus of the cell to the periphery, assuming a configuration resembling a signet ring.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C12487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Signet ring Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Signet Ring Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3774</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sinonasal undifferentiated carcinoma</VALIDVALUE>
          <VALUEMEANING>Sinonasal Undifferentiated Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, highly aggressive carcinoma that arises from the sinonasal tract.  It is characterized by the presence of small to medium size malignant cells.  The prognosis is poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small cell carcinoma, hypercalcemic type</VALIDVALUE>
          <VALUEMEANING>Ovarian Small Cell Carcinoma, Hypercalcemic Type</VALUEMEANING>
          <MEANINGDESCRIPTION>An undifferentiated small cell carcinoma that arises from the ovary and is associated with hypercalcemia.  Electron microscopic studies show neurosecretory granules are either absent or, when present, are in small numbers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small Cell Carcinoma, NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Small Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble &quot;oat cells&quot; under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3915, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4928894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small cell carcinoma, pulmonary type</VALIDVALUE>
          <VALUEMEANING>Ovarian Small Cell Carcinoma, Pulmonary Type</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive small cell neuroendocrine carcinoma that arises from the ovary.  Morphologically, it resembles the small cell carcinoma that arises from the lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6742165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small cell neuroendocrine carcinoma</VALIDVALUE>
          <VALUEMEANING>Colorectal Small Cell Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the colon or rectum.  It is characterized by the presence of malignant small cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6036355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small cell neuroendocrine carcinoma, HPV negative</VALIDVALUE>
          <VALUEMEANING>Human Papillomavirus Negative Small Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that human papillomavirus has not been detected in a sample.: A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble &quot;oat cells&quot; under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3915, C131488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small cell neuroendocrine carcinoma, HPV positive</VALIDVALUE>
          <VALUEMEANING>Human Papillomavirus Positive Small Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that human papillomavirus has been detected in a sample.: A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble &quot;oat cells&quot; under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128839, C3915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small Cell Squamous Cell</VALIDVALUE>
          <VALUEMEANING>Squamous Cell Lung Carcinoma, Small Cell Variant </VALUEMEANING>
          <MEANINGDESCRIPTION>A poorly differentiated morphologic variant of squamous cell lung carcinoma characterized by the presence of small tumor cells with focal squamous differentiation. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3081852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Solid adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Solid Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The state in which a substance has no tendency to flow under moderate stress; resists forces (such as compression) that tend to deform it; and retains a definite size and shape.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C45300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6077905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Solid pseudopapillary neoplasm</VALIDVALUE>
          <VALUEMEANING>Solid Pseudopapillary Neoplasm of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>A low-grade malignant neoplasm that arises from the exocrine pancreas. It is characterized by the presence of uniform cells that form solid and pseudopapillary patterns, cystic changes, and hemorrhage. Perineural invasion, vascular invasion, and invasion into surrounding tissues may be present. It usually presents as an encapsulated, solitary, and lobulated pancreatic mass. It is usually found incidentally during physical examination or it may present with abdominal discomfort and pain. It occurs predominantly in young women. Complete removal of the tumor is curative in the majority of cases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spindle Cell</VALIDVALUE>
          <VALUEMEANING>Spindle Cell Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A melanoma characterized by the presence of malignant spindle-shaped melanocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3729980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spindle cell carcinoma; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Sarcomatoid Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A malignant epithelial neoplasm characterized by the presence of spindle cells and anaplastic morphologic features. Giant cells and a sarcomatous component may also be present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27004, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spindle cell squamous cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Spindle Cell (Sarcomatoid) Squamous Cell Skin Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A squamous cell carcinoma of the skin with a prominent spindle cell component.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774948</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Ovarian Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually high grade squamous cell carcinoma that arises from the ovary and is not associated with a germ cell tumor.  The prognosis is poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40093</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5210918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous cell carcinoma, conventional</VALIDVALUE>
          <VALUEMEANING>Convention Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Something regarded as a normative example.: A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2929, C61300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6788531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous cell carcinoma, nonkeratinizing</VALIDVALUE>
          <VALUEMEANING>Non-Keratinizing Sinonasal Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A squamous cell carcinoma of the sinonasal tract characterized by a plexiform or ribbon-like growth pattern, cytological atypia, and lack of histological evidence of keratinization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54287</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Cell Carcinoma, Not Otherwise Specified</VALIDVALUE>
          <VALUEMEANING>Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma derived from stratified squamous epithelium. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2929</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous cell carcinoma, primary</VALIDVALUE>
          <VALUEMEANING>Primary Neoplasm Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A tumor at the original site of origin.: A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2929, C8509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Cell Carcinoma; Keratinizing</VALIDVALUE>
          <VALUEMEANING>Keratinizing Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinomas with morphologically prominent production of keratin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4105</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; follicular; NOS</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland Follicular Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  The nuclear features which characterise the thyroid gland papillary carcinoma are absent.  It is linked to radiation and comprises approximately 10% to 15% of thyroid cancers.  Clinically, it usually presents as a solitary mass in the thyroid gland.  It is generally unifocal and thickly encapsulated and shows invasion of the capsule or the vessels.  Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound and fine needle biopsy. Treatment options include: partial or complete thyroidectomy.  Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8054</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; granulosa cell</VALIDVALUE>
          <VALUEMEANING>Granulosa Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A slow-growing, malignant tumor, characterize by the presence of granulosa-like cells and Call-Exner bodies, that is almost always found in the ovary. In rare cases, it has also been found in the testicle.  There are two types of granulosa cell tumor that can be distinguished under the microscope: the adult and the juvenile.  The testicular juvenile granulosa cell tumors are perhaps the most common congenital testicular neoplasms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3070</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; intracystic; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Intracystic Papillary Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: An intraductal breast carcinoma characterized by a papillary growth within a large cystic duct. There is no evidence of invasion of the breast parenchyma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7645, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; large cell; neuroendocrine</VALIDVALUE>
          <VALUEMEANING>Large Cell Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838592</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; large cell; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Large Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: These represent the least common histologic subtype of lung cancers comprising approximately 15% of all lung cancers.  The frequency is decreasing with improved classification through refined histopathological analysis of these tumors as poorly differentiated squamous cell carcinomas or adenocarcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3780, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; medullary; NOS</VALIDVALUE>
          <VALUEMEANING>Medullary Carcinoma, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>A term referring to medullary carcinomas which can develop in various anatomic sites such as the thyroid gland, breast, colon, rectum, and small intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; Merkel cell</VALIDVALUE>
          <VALUEMEANING>Merkel Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare malignant cutaneous tumor seen in elderly patients.  Its usual location is on the head, neck and extremities.  The tumor is composed of small round cells with scanty cytoplasm arranged in a trabecular pattern, or in ill-defined nodules or in a diffuse pattern.  The tumor cells contain cytoplasmic membrane-bound dense core granules resembling neurosecretory granules.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210716</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; mixed; adenocarcinoma and squamous cell</VALIDVALUE>
          <VALUEMEANING>Adenocarcinoma with Squamous Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma characterized by the presence of focal or extensive transformation of malignant glandular cells to squamous epithelial cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2837862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; mucoepidermoid</VALIDVALUE>
          <VALUEMEANING>Mucoepidermoid Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3772</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; neuroendocrine; NOS</VALIDVALUE>
          <VALUEMEANING>Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neuroendocrine tumor composed of cells containing secretory granules that stain positive for NSE and chromogranin.  Tumor cells are often round and form clusters or trabecular sheets.  Representative examples are carcinoid tumor, small cell carcinoma, and Merkel cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3773</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2916, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3536390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; papillary; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Papillary Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: of or relating to or resembling papilla.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2916, C14166, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; papillary; serous primary; peritoneum</VALIDVALUE>
          <VALUEMEANING>Peritoneal Papillary Serous Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the peritoneum.: A malignant cystic serous epithelial neoplasm characterized by the presence of malignant glandular epithelial cells forming papillary structures. Stromal invasion is present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8377, C25313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; papillary; serous surface</VALIDVALUE>
          <VALUEMEANING>Serous Surface Papillary Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive serous adenocarcinoma arising from the ovary. Cases with identical morphology have been described arising in the peritoneum, almost exclusively in women. Morphologically, it may be a well, moderately, or poorly differentiated neoplasm. It is characterized by a papillary growth pattern often associated with the presence of psammoma bodies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704619</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; renal cell; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9385, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; serous; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Serous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: Of or producing or containing serum.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2916, C14168, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; small cell; gastric neuroendocrine</VALIDVALUE>
          <VALUEMEANING>Gastric Small Cell Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the stomach.  It is characterized by the presence of malignant small cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6270496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; squamous cell; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: Flat cell that looks like a fish scale under a microscope. These cells cover inside and outside surfaces of the body. They are found in the tissues that form the surface of the skin, the lining of the hollow organs of the body (such as the bladder, kidney, and uterus), and the passages of the respiratory and digestive tracts.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594, C2916, C12849</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>2, 0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; urothelial; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Urothelial Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).  It is frequently papillary. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4030, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinosarcoma</VALIDVALUE>
          <VALUEMEANING>Carcinosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor composed of a mixture of carcinomatous and sarcomatous elements.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34448</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical Squamous Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Cervical Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A squamous cell carcinoma arising from the cervical epithelium. It usually evolves from a precancerous cervical lesion. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors for cervical squamous cell carcinoma. The following histologic patterns have been described: Conventional squamous cell carcinoma, papillary squamous cell carcinoma, transitional cell carcinoma, lymphoepithelioma-like carcinoma, verrucous carcinoma, condylomatous carcinoma and spindle cell carcinoma. Survival is most closely related to the stage of disease at the time of diagnosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4028</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3521937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholangiocarcinoma</VALIDVALUE>
          <VALUEMEANING>Cholangiocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An malignant tumor composed of cells resembling those of bile ducts. Cholangiocarcinoma is a relatively rare tumor in most populations. It can arise from any portion of the intrahepatic bile duct epithelium or the hepatic ducts. Grossly, the lesions are nodular, grayish-white firm and solid. Microscopically, the vast majority of cholangiocarcinomas are adenocarcinomas showing tubular and/or papillary structures. Early detection of cholangiocarcinomas is difficult, and the overall prognosis after resection is poor (adapted from WHO, 2000).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3165468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholangiocarcinoma; distal</VALIDVALUE>
          <VALUEMEANING>Distal Bile Duct Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that arises from the distal part of the extrahepatic bile duct.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7109</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4039072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholangiocarcinoma; hilar/perihilar</VALIDVALUE>
          <VALUEMEANING>Hilar Cholangiocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A cholangiocarcinoma arising from the hilar ducts located at the hilar area of the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36077</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211149</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholangiocarcinoma; intrahepatic</VALIDVALUE>
          <VALUEMEANING>Intrahepatic Cholangiocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that arises from the intrahepatic bile duct epithelium in any site of the intrahepatic biliary tree.  Grossly, the malignant lesions are solid, nodular, and grayish.  Morphologically, the vast majority of cases are adenocarcinomas.  Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats.  Early detection is difficult and the prognosis is generally poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chondrosarcoma; myxoid</VALIDVALUE>
          <VALUEMEANING>Adult Myxoid Chondrosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An extraskeletal myxoid chondrosarcoma occurring in adults.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7924</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Choriocarcinoma, non-gestational</VALIDVALUE>
          <VALUEMEANING>Non-Gestational Ovarian Choriocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant germ cell tumor that arises from the ovary and is composed of cytotrophoblasts, syncytiotrophoblasts, and extravillous trophoblasts.  The prognosis is less favorable than gestational choriocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6742167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chromophobe Renal Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Chromophobe Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical) or eosinophilic.  It has a much better prognosis than other renal cell carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5118714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)</VALIDVALUE>
          <VALUEMEANING>Chronic Lymphocytic Leukemia And/Or Small Lymphocytic Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001): Used to indicate that either or both of two items or options may be valid.: A non-Hodgkin lymphoma composed of monomorphic small, round B-lymphocytes in the lymph nodes.  When the lymphoid process predominantly involves the bone marrow and the peripheral blood it is called chronic lymphocytic leukemia. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7540, C48928, C3163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesothelioma (NOS)</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Mesothelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way._A neoplasm characterized by the proliferation of neoplastic mesothelial cells. It usually arises from the pleura or peritoneum. This category includes malignant mesothelioma, adenomatoid tumor (benign mesothelioma), well differentiated papillary mesothelial tumor, and multicystic mesothelioma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3786, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7589471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metaplastic Ductal Carcinoma</VALIDVALUE>
          <VALUEMEANING>Metaplastic Ductal Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to or characterized by metaplasia.: A carcinoma arising from the ducts.  While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast.  Ductal carcinomas account for about two thirds of all breast cancers.  Two types of ductal carcinomas have been described: Ductal carcinoma in situ (DCIS) and invasive ductal carcinoma, not otherwise specified.  The latter often spreads to the axillary lymph nodes and other anatomic sites.  The two forms of ductal carcinoma often coexist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4017, C25566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686426</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metaplastic Carcinoma</VALIDVALUE>
          <VALUEMEANING>Metaplastic Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A general term used to describe carcinomas arising from epithelial cells that have been transformed into another cells type (metaplastic epithelial cells). A representative example is the adenocarcinoma arising in Barrett esophagus. This term is also used to describe carcinomas in which the malignant epithelial cells show differentiation towards another cell type. A representative example of the latter is the metaplastic breast carcinoma in which the malignant glandular cells show squamous, spindle cell, or chondroid/osseous differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248487</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Micropapillary carcinoma</VALIDVALUE>
          <VALUEMEANING>Micropapillary Pattern Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the presence of an architectural pattern dominated by the presence of small papillary structures.: A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2916, C36181</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6036356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Minimally invasive adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Minimally Invasive Lesion Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A lesion in which the neoplastic epithelial cells invade into but not through the capsule that surround the neoplasm, or invade the entire thickness of the capsule, or invade vessels surrounding the capsule.  Unlike widely invasive lesions, the minimally invasive lesions cannot be recognized as carcinomas on clinical and surgical grounds.  The diagnosis can only be established microscopically.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C60986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4928893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Minimally invasive adenocarcinoma, mucinous</VALIDVALUE>
          <VALUEMEANING>Mucinous Bronchioloalveolar Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of minimally invasive lung adenocarcinoma characterized by tall columnar cells and mucin production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5438094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Minimally invasive adenocarcinoma, nonmucinous</VALIDVALUE>
          <VALUEMEANING>Non-Mucinous Bronchioloalveolar Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of bronchiolo-alveolar lung carcinoma characterized by the presence of Clara cells and/or type II cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5210953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Minor salivary gland carcinoma</VALIDVALUE>
          <VALUEMEANING>Minor Salivary Gland Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that arises from the minor salivary glands.  Representative examples include adenoid cystic carcinoma, acinic cell carcinoma, polymorphous low grade adenocarcinoma, and mucinous adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5957</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MiT family translocation renal cell carcinoma</VALIDVALUE>
          <VALUEMEANING>MiT Family Translocation-Associated Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A renal cell carcinoma (RCC) usually seen in children or young adults. It is characterized by papillary, alveolar and nested growth patterns with clear and eosinophilic cells. The carcinomas range from microscopic lesions to clinically symptomatic tumors. It is associated with translocations/gene fusions involving members of the MiT family of transcription factors, including TFE3 and TFEB. There are two subtypes; RCCs associated with Xp11 translocations and TFE3 gene fusions and RCCs with t(6:11) translocations resulting in MALAT1-TFEB gene fusions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6789039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed acinar-ductal carcinoma</VALIDVALUE>
          <VALUEMEANING>Mixed Acinar-Ductal Carcinoma of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that arises from the pancreas showing either extensive mucin accumulation and acinar neoplastic cells or a mixture of columnar or signet-ring cells and acinar neoplastic cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5983662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed acinar-neuroendocrine carcinoma</VALIDVALUE>
          <VALUEMEANING>Mixed Acinar-Endocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that arises from the pancreas showing a mixture of acinar and neuroendocrine malignant cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6878</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed Ductal and Lobular</VALIDVALUE>
          <VALUEMEANING>Mixed Ductal And Lobular</VALUEMEANING>
          <MEANINGDESCRIPTION>Involving or composed of different kinds.: Related to, or having the quality of, a duct.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Of or relating to or resembling a lobule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25557, C37912, C25732, C25259</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5724607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed ductal-neuroendocrine carcinoma</VALIDVALUE>
          <VALUEMEANING>Mixed Ductal-Endocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that arises from the pancreas showing a mixture of ductal and neuroendocrine malignant cells in both the primary tumor and in the metastatic sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6879</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed epithelial borderline (atypical proliferative) tumor</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Mixed Epithelial Tumor/Atypical Proliferative Ovarian Mixed Epithelial Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade, non-invasive mixed epithelial proliferative neoplasm that arises from the ovary. In most cases is composed of serous and endocervical-type mucinous cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158616</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6693103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Classic MB</VALIDVALUE>
          <VALUEMEANING>Classic Medulloblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A medulloblastoma composed of malignant cells with hyperchromatic nucleus and scanty cytoplasm.  Homer Wright rosettes may be present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54039</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6003575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Classical/Usual (Papillary NOS)</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland Papillary Carcinoma, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  It is linked to radiation exposure and is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound, and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.  Depending on the size and spread of the disease, surgical options include lobectomy, and partial or complete thyroidectomy.  Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4035, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clear Cell Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Clear Cell Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>(kar-sin-O-ma) A rare type of tumor of the female genital tract in which the inside of the cells looks clear when viewed under a microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3766</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3081856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clear cell borderline tumor/atypical proliferative clear cell tumor</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive clear cell adenofibromatous neoplasm that arises from the ovary. It is characterized by the presence of atypia in the glandular epithelium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clear cell papillary renal cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Clear Cell Papillary Renal Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>An encapsulated epithelial neoplasm that arises from the kidney. It is composed of cytologically bland epithelial cells with clear cytoplasm forming tubular and papillary patterns. The nuclei are arranged linearly away from the basement membrane. Tumor necrosis, perirenal invasion, and vascular invasion are not present. The clinical course is indolent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121955</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6789032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clear Cell Renal Carcinoma</VALIDVALUE>
          <VALUEMEANING>Clear Cell Renal Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A cell with empty-appearing cytoplasm when viewed with a light microscope.: A carcinoma arising from the epithelium of the renal parenchyma (renal cell carcinoma) or the renal pelvis (renal pelvis carcinoma).  The vast majority of renal cell carcinomas are adenocarcinomas.  The vast majority of renal pelvis carcinomas are transit</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9384, C12478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed malignant germ cell tumor</VALIDVALUE>
          <VALUEMEANING>Ovarian Mixed Germ Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An ovarian malignant germ cell tumor characterized by the presence of at least two different germ cell tumor components. The most common combination of germ cell tumors is dysgerminoma and yolk sac tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8114</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed serous and endometrioid</VALIDVALUE>
          <VALUEMEANING>Mixed Endometrial Serous Adenocarcinoma And Endometrioid Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Involving or composed of different kinds.: A high grade, aggressive adenocarcinoma arising from the endometrium.  It is characterized by the presence of complex papillary patterns with cellular budding.  Atypical mitoses, necrosis, and psammoma bodies may be present.  It is classified as type II endometrial carcinoma and it is not associated with endometrial hyperplasia.  It tends to invade deeply into the myometrium and spreads into the lymphatic vessels.  Patients frequently present with spread of the tumor beyond the uterus at the time of diagnosis.  The prognosis is usually poor.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3769, C37912, C27838, C25259</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3263635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately-differentiated neuroendocrine carcinoma</VALIDVALUE>
          <VALUEMEANING>Moderately Differentiated Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells.: A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3773, C14162</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6324222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucin-depleted Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Mucin Depletion Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic and histochemical finding indicating depletion of mucin in the glands.: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C82974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3521939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucinous (Colloid) Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Mucinous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucinous (Colloid) Carcinoma</VALIDVALUE>
          <VALUEMEANING>Mucinous Adenocarcinoma </VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3081857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucinous Adenocarcinoma of Endocervical Type</VALIDVALUE>
          <VALUEMEANING>Endocervix Type Mucinous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the cervix which is lined by single columnar epithelium (mucosa).: Something distinguishable as an identifiable class based on common qualities.: An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26712, C25284, C12309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3521931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucinous borderline tumor/atypical proliferative mucinous tumor</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive neoplasm that arises from the ovary and is composed of gastrointestinal-type, mucin-containing epithelial cells.  It shows greater cellular proliferation and cytologic atypia as compared to benign ovarian mucinous tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6691992</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucinous borderline tumor/atypical proliferative mucinous tumor with intraepithelial carcinoma</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Intraepithelial Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic mucinous epithelial cells, atypia, and the presence of intraepithelial carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159312</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucinous borderline tumor/atypical proliferative mucinous tumor with microinvasion</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Microinvasion</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic mucinous epithelial cells, atypia, and microinvasion of the ovarian stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucinous Carcinoma</VALIDVALUE>
          <VALUEMEANING>Mucinous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3293710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucinous Cystadenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Mucinous Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma characterized by cystic changes and the presence of malignant glandular cells which contain intracytoplasmic mucin. It may arise from the ovary, pancreas, appendix, and lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3776</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3027126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucinous cystic neoplasm with an associated invasive carcinoma</VALIDVALUE>
          <VALUEMEANING>Bile Duct Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A mucinous cystic neoplasm that arises from the intrahepatic or extrahepatic bile ducts and it is associated with an invasive carcinomatous component.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucinous cystic neoplasms (MCN)</VALIDVALUE>
          <VALUEMEANING>Pancreatic Mucinous-Cystic Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive or invasive cystic epithelial neoplasm that affects almost exclusively females.  It is characterized by the presence of columnar mucin-producing epithelial cells and ovarian-type stroma formation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucinous tubular and spindle renal cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Mucinous Tubular and Spindle Cell Carcinoma of the Kidney</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade carcinoma of the kidney characterized by the presence of tubules which are separated by mucinous stroma. Often the tubular structures have a spindle cell appearance.  Patients are usually asymptomatic and occasionally they may present with hematuria or flank pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5210420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucoepidermoid carcinoma</VALIDVALUE>
          <VALUEMEANING>Mucoepidermoid Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3772</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucosal melanoma</VALIDVALUE>
          <VALUEMEANING>Mucosal Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A melanoma that arises from a mucosal site.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4319892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multilocular cystic clear cell renal cell neoplasm of low malignant potential</VALIDVALUE>
          <VALUEMEANING>Multilocular Cystic Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare type of renal cell carcinoma.  It is a well-circumscribed multicystic mass without solid areas.  The inner lining of the cystic structures is composed of clear cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5210418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acantholytic Cuniculatum</VALIDVALUE>
          <VALUEMEANING>Acantholytic Cuniculatum</VALUEMEANING>
          <MEANINGDESCRIPTION>Acantholytic Cuniculatum</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acantholytic squamous cell skin carcinoma</VALIDVALUE>
          <VALUEMEANING>Acantholytic Squamous Cell Skin Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A histologic variant of squamous cell carcinoma that arises from the skin. It is characterized by loosening of the intercellular bridges between the malignant cells which results in acantholysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4460</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4263939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acinar cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Acinar Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acinar cell cystadenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Pancreatic Acinar Cell Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A cystic adenocarcinoma characterized by the presence of relatively uniform neoplastic cells which produce pancreatic enzymes and are arranged in acinar patterns. Signs and symptoms include abdominal pain, weight loss, nausea, and diarrhea. It usually has an aggressive clinical course.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acquired cystic disease associated renal cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Acquired Cystic Disease-Associated Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The most common renal cell carcinoma that develops in patients with end-stage renal disease and acquired cystic disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6789034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Cell Carcinoma; Lymphoepithelioma-like</VALIDVALUE>
          <VALUEMEANING>Cervical Lymphoepithelioma-Like Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A variant of cervical squamous cell carcinoma characterized by the presence of islands of cells with uniform, vesicular nuclei and prominent nucleoli and a dense lymphocytic infiltrate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4928862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Cell Carcinoma; Non-Keratinizing</VALIDVALUE>
          <VALUEMEANING>Non-Keratinizing Malignant Squamous Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant squamous cell that does not produce keratin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36792</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4928867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Cell Carcinoma; Squamotransitional</VALIDVALUE>
          <VALUEMEANING>Cervical Squamotransitional Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A human papillomavirus-related cervical squamous cell carcinoma characterized by the presence of papillary structures with fibrovascular cores. It is covered with multiple layers of atypical cells that resemble cervical intraepithelial neoplasia 3.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4928861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Cell Carcinoma; Verrucous</VALIDVALUE>
          <VALUEMEANING>Verrucous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A well differentiated squamous cell carcinoma characterized by a papillary growth pattern, acanthosis, mild cytologic atypia, and pushing tumor margins. The most commonly affected anatomic sites are the oral cavity, nasal cavity, larynx, esophagus, anus, vagina, vulva, and the plantar region of the foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3781</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4928866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Cell Carcinoma; Warty</VALIDVALUE>
          <VALUEMEANING>Cervical Warty Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A human papillomavirus-related cervical squamous cell carcinoma characterized by the presence of a warty surface and koilocytotic atypia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40191</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4928864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach Adenocarcinoma, Signet Ring Type</VALIDVALUE>
          <VALUEMEANING>Signet Ring Cell Carcinoma Gastric Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.: An adenocarcinoma arising from the stomach glandular epithelium. Gastric adenocarcinoma is primarily a disease of older individuals, most commonly develops after a long period of atrophic gastritis and is strongly associated with Helicobacter pylori infection. The lack of early symptoms often delays the diagnosis of gastric cancer. The majority of patients present with advanced tumors which have poor rates of curability. Microscopically, two important histologic types of gastric adenocarcinoma are recognized: the intestinal and diffuse type. The overall prognosis of gastric adenocarcinomas is poor, even in patients who receive a &quot;curative&quot; resection (adapted from Sternberg&#39;s Surgical Pathology, 3rd ed., 1999).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4004, C3774</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3333077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach, Adenocarcinoma, Diffuse Type</VALIDVALUE>
          <VALUEMEANING>Diffuse Gastric Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma arising from the stomach.  Microscopically, it is characterized by the presence of a diffuse infiltrate, composed of individual adenocarcinoma cells or groups of adenocarcinoma cells in a fibrous or mucoid stroma.  Many cells contain mucin droplets, producing a signet-ring configuration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)</VALIDVALUE>
          <VALUEMEANING>Gastric Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma arising from the stomach glandular epithelium. Gastric adenocarcinoma is primarily a disease of older individuals, most commonly develops after a long period of atrophic gastritis and is strongly associated with Helicobacter pylori infection. The lack of early symptoms often delays the diagnosis of gastric cancer. The majority of patients present with advanced tumors which have poor rates of curability. Microscopically, two important histologic types of gastric adenocarcinoma are recognized: the intestinal and diffuse type. The overall prognosis of gastric adenocarcinomas is poor, even in patients who receive a &quot;curative&quot; resection (adapted from Sternberg&#39;s Surgical Pathology, 3rd ed., 1999).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4004</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach, Intestinal Adenocarcinoma, Mucinous Type</VALIDVALUE>
          <VALUEMEANING>Mucinous Gastric Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A variant of gastric adenocarcinoma with more than half of the tumor containing extracellular mucinous pools.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5248</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)</VALIDVALUE>
          <VALUEMEANING>Gastric Intestinal Type Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma of the stomach arising on a background of intestinal metaplasia.  Microscopically, it is characterized by a glandular pattern and it closely resembles a colonic adenocarcinoma.  Grossly, it tends to be nodular, polypoid or ulcerated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206056</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach, Intestinal Adenocarcinoma, Papillary Type</VALIDVALUE>
          <VALUEMEANING>Gastric Papillary Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A variant of gastric adenocarcinoma with exophytic growth and elongated finger-like processes lined by cylindrical or cuboidal cells supported by fibrovascular connective tissue cores.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach, Intestinal Adenocarcinoma, Tubular Type</VALIDVALUE>
          <VALUEMEANING>Gastric Tubular Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A variant of gastric adenocarcinoma characterized by prominent dilated or slit-like tubules.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3206062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Succinate dehydrogenase (SDH) deficient renal cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Succinate Dehydrogenase-Deficient Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A very rare renal cell carcinoma that usually affects young adults. It is characterized by the presence of vacuolated, eosinophilic to clear neoplastic cells and loss of immunohistochemical expression of succinate dehydrogenase (SDH) B. In most cases germline mutations in an SDH gene (SDHA, SDHB, SDHC, or SDHD gene) are present. It has a relatively good prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6789028</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Superficial spreading melanoma</VALIDVALUE>
          <VALUEMEANING>Superficial Spreading Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of melanoma that typically occurs in light-skinned individuals ranging in age from young adults to the elderly.  Risk factors include extensive sun exposure during childhood, a family history of melanoma, and the presence of dysplastic nevi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9152</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4264987</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Synovial Sarcoma</VALIDVALUE>
          <VALUEMEANING>Poorly Differentiated Synovial Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.: A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3400, C14167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3835972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Synovial Sarcoma - Biphasic</VALIDVALUE>
          <VALUEMEANING>Biphasic Synovial Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A synovial sarcoma characterized by the presence of both an epithelial and a spindle cell component.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3835971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Synovial Sarcoma - Monophasic</VALIDVALUE>
          <VALUEMEANING>Monophasic Synovial Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A synovial sarcoma characterized by the presence of an epithelial or a spindle cell component only.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6534</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(6;11) renal cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB</VALUEMEANING>
          <MEANINGDESCRIPTION>An extremely rare renal cell carcinoma affecting young patients. It is characterized by the presence of the specific chromosomal translocation t(6;11);(p21;q12) which fuses the MALAT1 gene with the TFEB transcription factor gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6789037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymoma; Type A</VALIDVALUE>
          <VALUEMEANING>Thymoma Type A</VALUEMEANING>
          <MEANINGDESCRIPTION>A thymic epithelial neoplasm characterized by the presence of spindle and/or oval neoplastic epithelial cells. Lymphocytic infiltration is minimal or absent. It may be associated with myasthenia gravis or pure red cell aplasia. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. Approximately 20% of the cases occur as stage II or stage III tumors. Type A thymoma generally behaves as a benign tumor and the overall survival is reported to be 100% at 5 and 10 years.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4039068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymoma; Type AB</VALIDVALUE>
          <VALUEMEANING>Thymoma Type AB</VALUEMEANING>
          <MEANINGDESCRIPTION>A thymic epithelial neoplasm characterized by the presence of a lymphocyte-poor component similar to that seen in type A thymoma and a lymphocyte-rich component which contains neoplastic small polygonal epithelial cells. It may be associated with myasthenia gravis and pure red cell aplasia. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. A minority of the cases occur as stage II or stage III tumors. The overall survival is reported to be 80-100% at 5 and 10 years.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6885</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4039066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymoma; Type B1</VALIDVALUE>
          <VALUEMEANING>Thymoma Type B1</VALUEMEANING>
          <MEANINGDESCRIPTION>A thymic epithelial neoplasm characterized by the presence of expanded areas which resemble the normal thymic cortex. The neoplastic epithelial cells are small and scant and there is a dense T-lymphocytic component present. Areas of medullary differentiation with or without Hassall&#39;s corpuscles are also present. It may be associated with myasthenia gravis, pure red cell aplasia, and hypogammaglobulinemia. It has a low grade malignant potential. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. A minority of the cases occur as stage II tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4039064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymoma; Type B2</VALIDVALUE>
          <VALUEMEANING>Thymoma Type B2</VALUEMEANING>
          <MEANINGDESCRIPTION>A thymic epithelial neoplasm characterized by the presence of neoplastic large, polygonal epithelial cells with large vesicular nuclei and prominent nucleoli. The neoplastic cells are arranged around perivascular spaces and along septa. Immature T-lymphocytes are also present. It may be associated with myasthenia gravis, pure red cell aplasia, and hypogammaglobulinemia. It is a tumor of moderate malignancy. The majority of cases occur in the anterior mediastinum as Masaoka stage I, stage II, or stage III tumors. Metastatic, stage IV tumors occur less frequently.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6888</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4039062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymoma; Type B3</VALIDVALUE>
          <VALUEMEANING>Thymoma Type B3</VALUEMEANING>
          <MEANINGDESCRIPTION>Also known as well-differentiated thymic carcinoma, atypical thymoma, or epithelial thymoma, this type of thymoma displays morphologic characteristics of a well-differentiated carcinoma.  The majority of cases occur in the anterior mediastinum as Masaoka stage II or stage III tumors.  It is almost always invasive, it recurs frequently, and metastasizes in approximately 20% of the cases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7997</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4039060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymoma; Type C</VALIDVALUE>
          <VALUEMEANING>Thymic Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A diverse group of carcinomas of the thymus gland, previously known as thymoma type C (WHO-1999).  It includes morphologic variants derived from purely epithelial cells, as well as from cells with neuroendocrine differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroid Papillary Carcinoma - Classical/usual</VALIDVALUE>
          <VALUEMEANING>Conventional Thyroid Gland Papillary Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Something regarded as a normative example.: A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  It is linked to radiation exposure and is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound, and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.  Depending on the size and spread of the disease, surgical options include lobectomy, and partial or complete thyroidectomy.  Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4035, C61300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3166450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transitional cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Ovarian Transitional Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that resemble malignant urothelial cells.  There is no morphologic evidence of a benign or borderline Brenner tumor component present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5210915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Treated primary GBM</VALIDVALUE>
          <VALUEMEANING>Primary Glioblastoma, Treated</VALUEMEANING>
          <MEANINGDESCRIPTION>Subject to a process with the aim of readying for some purpose, improving, or remedying a condition.: Occurring first in time or sequence; original; of greatest rank or importance or value.: The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma). Two histologic variants are recognized: giant cell glioblastoma and gliosarcoma. (WHO) </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3058, C25251, C70742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tubular Carcinoma</VALIDVALUE>
          <VALUEMEANING>Tubular Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A melanoma of the skin characterized by single cell infiltration of the papillary dermis by atypical melanocytes, in a background of lentigo maligna changes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9135</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tubulocystic renal cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Tubulocystic Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, cytologically high grade carcinoma that arises from the renal parenchyma. It is characterized by the presence of prominently dilated cystic spaces in a bland, fibrotic stroma. The lining cells have large irregular nuclei with prominent nucleoli and abundant eosinophilic cytoplasm. Necrosis and mitotic figures are not present. It rarely metastasizes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126303</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6789035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tubulolobular Carcinoma</VALIDVALUE>
          <VALUEMEANING>Invasive Lobular Breast Carcinoma, Tubulolobular Variant</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells forming small tubular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97053</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unclassifiable B-cell lymphoma</VALIDVALUE>
          <VALUEMEANING>Unclassified B-Cell Non-Hodgkin Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not arranged or included in any specific grouping.: The most common type of non-Hodgkin lymphoma.  It includes the most frequently seen morphologic variants which are: diffuse large B-cell lymphoma, follicular lymphoma, small lymphocytic lymphoma and marginal zone B-cell lymphoma. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3457, C64486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5054335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unclassified (Renal Cell Carcinoma NOS)</VALIDVALUE>
          <VALUEMEANING>Unclassified Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A renal cell carcinoma that cannot be classified into one of the established subtypes of renal cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5118711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Undifferentiated Carcinoma</VALIDVALUE>
          <VALUEMEANING>Undifferentiated Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Undifferentiated Pleomorphic Sarcoma (UPS)</VALIDVALUE>
          <VALUEMEANING>Storiform-Pleomorphic Malignant Fibrous Histiocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An undifferentiated soft tissue sarcoma characterized by the presence of a pleomorphic malignant cellular infiltrate.  It is also known as malignant fibrous histiocytoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Undifferentiated uterine/endometrial sarcoma</VALIDVALUE>
          <VALUEMEANING>Uterine Corpus Undifferentiated Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, high grade sarcoma that arises from the endometrial stroma or myometrium without a specific type of differentiation. It was previously also known as high grade endometrial stromal sarcoma. In 2014, high grade endometrial stromal sarcoma was reclassified and is currently considered a distinct and rare neoplasm. Undifferentiated uterine sarcoma has a worse prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Untreated primary (de novo) GBM</VALIDVALUE>
          <VALUEMEANING>Primary Glioblastoma, Untreated</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Subject to a process with the aim of readying for some purpose, improving, or remedying a condition.: Occurring first in time or sequence; original; of greatest rank or importance or value.: The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma). Two histologic variants are recognized: giant cell glioblastoma and gliosarcoma. (WHO) </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3058, C25251, C70742, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clear cell renal cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Clear Cell Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network.  The tumor may metastasize to unusual sites and late metastasis is common.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4033</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clear Cell Squamous Cell</VALIDVALUE>
          <VALUEMEANING>Squamous Cell Carcinoma, Clear Cell Type</VALUEMEANING>
          <MEANINGDESCRIPTION>A squamous cell carcinoma characterized by the presence of malignant cells with clear cytoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65180</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3081853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Collecting duct carcinoma</VALIDVALUE>
          <VALUEMEANING>Carcinoma of the Collecting Ducts of Bellini</VALUEMEANING>
          <MEANINGDESCRIPTION>Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Collecting Duct Renal Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Collecting Tube Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The final section of a renal tubule in the nephron between the distal convoluted tubule and the ureter comprising of principal and intercalated cells. The collecting tube acts to reabsorb sodium and water while secreting potassium and maintaining acid-base homeostasis.: The most common type of kidney cancer. It begins in the lining of the renal tubules in the kidney. The renal tubules filter the blood and produce urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9385, C32344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5118713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colloid adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Lung Mucinous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of lung adenocarcinoma characterized by the presence of mucin pools containing islands of well differentiated adenocarcinoma cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5210947</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colon Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Colon Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma arising from the colon.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well differentiated, moderately, and poorly differentiated.  Morphologic variants include the mucinous adenocarcinoma and signet-ring adenocarcinoma.  Lymphatic or hematogenous spread can occur early in the process and lead to systemic disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colon Mucinous Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Colon Mucinous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma of the colon characterized by the presence of pools of extracellular mucin.  Malignant glandular epithelial cells are present in the mucin collections.  Mucin constitutes more than 50% of the lesion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Combined hepatocellular-cholangiocarcinoma</VALIDVALUE>
          <VALUEMEANING>Combined Hepatocellular Carcinoma and Cholangiocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare tumor containing unequivocal elements of both hepatocellular and cholangiocarcinoma that are intimately admixed.  This tumor should be distinguished from separate hepatocellular carcinoma and cholangiocarcinoma arising in the same liver.  The prognosis of this tumor is poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Conventional leiomyosarcoma</VALIDVALUE>
          <VALUEMEANING>Conventional Leiomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon, aggressive malignant smooth muscle neoplasm.  It is characterized by the presence of atypical large spindle or round cells, nuclear palisading, tumor cell necrosis, mitotic figures and may be associated with vascular invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3521460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>De-differentiated carcinoma</VALIDVALUE>
          <VALUEMEANING>Endometrial Dedifferentiated Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that arises from the endometrium and is characterized by the presence of an undifferentiated carcinomatous component and a second component of either FIGO grade 1 or 2 endometrioid carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126769</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7024616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dedifferentiated liposarcoma</VALIDVALUE>
          <VALUEMEANING>Dedifferentiated Liposarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A liposarcoma of any histologic subtype mixed with a non-lipomatous, high grade sarcomatous component.  The non-lipomatous component may be present in the primary lesion or at the site of metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3162600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desmoid Sarcoma</VALIDVALUE>
          <VALUEMEANING>Deep Fibromatosis/Desmoid Tumor Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An insidious, locally aggressive, poorly circumscribed neoplasm arising from the deep soft tissues. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It lacks metastatic potential.: A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9118, C9182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6333793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desmoid Tumor</VALIDVALUE>
          <VALUEMEANING>Deep Fibromatosis/Desmoid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An insidious, locally aggressive, poorly circumscribed neoplasm arising from the deep soft tissues. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It lacks metastatic potential.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desmoplastic melanoma</VALIDVALUE>
          <VALUEMEANING>Desmoplastic Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A melanoma of the skin characterized by a proliferation of atypical spindled melanocytes in the dermis, in a background of abundant collagen. It usually presents as an amelanotic raised nodular lesion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37257</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desmoplastic mesothelioma</VALIDVALUE>
          <VALUEMEANING>Desmoplastic Mesothelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of a dense collagenous tissue and atypical neoplastic cells. Sarcomatoid features, collagenous necrosis, and infiltration of muscle and adipose tissue may be present. It occurs in the pleura and less commonly in the peritoneum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)</VALIDVALUE>
          <VALUEMEANING>Diffuse Large B-Cell Lymphoma Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>This non-Hodgkin&#39;s lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin&#39;s lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003: Not characterized in any other way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594, C8851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diffuse malignant mesothelioma - Biphasic</VALIDVALUE>
          <VALUEMEANING>Diffuse Malignant Mesothelioma, Biphasic</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant mesothelioma characterized by the presence of epithelioid and sarcomatoid components, with each component representing at least 10% of the tumor._A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8420, C4282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diffuse malignant mesothelioma - Desmoplastic</VALIDVALUE>
          <VALUEMEANING>Diffuse Malignant Mesothelioma, Desmoplastic</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of a dense collagenous tissue and atypical neoplastic cells. Sarcomatoid features, collagenous necrosis, and infiltration of muscle and adipose tissue may be present. It occurs in the pleura and less commonly in the peritoneum._A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8420, C6747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diffuse malignant mesothelioma - Epithelioid</VALIDVALUE>
          <VALUEMEANING>Diffuse Malignant Mesothelioma, Epithelioid</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of cells with epithelioid morphology. The epithelioid cells usually have eosinophilic cytoplasm, bland nuclei, and form tubulopapillary, microglandular, or sheet-like patterns._A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8420, C7985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diffuse malignant mesothelioma - NOS</VALIDVALUE>
          <VALUEMEANING>Diffuse Malignant Mesothelioma, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way._A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8420, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diffuse malignant mesothelioma -Sarcomatoid</VALIDVALUE>
          <VALUEMEANING>Diffuse Malignant Mesothelioma, Sarcomatoid</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of spindle cells. Anaplastic morphologic features and multinucleated malignant cells may also be seen._A diffuse malignant neoplasm that arises from mesothelial cells, usually in the pleura or peritoneum. Histologic variants include biphasic, epithelioid, sarcomatoid, and desmoplastic mesothelioma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8420, C45655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DLBCL associated with chronic inflammation</VALIDVALUE>
          <VALUEMEANING>Chronic Inflammation Associated With Diffuse Large B-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A disease or condition that persists or progresses over a long period of time.: A localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation. --2004: Joined in some kind of relationship.: Used to indicate the presence of something or someone.: This non-Hodgkin&#39;s lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin&#39;s lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8851, C62355, C25281, C3137, C14141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ductal breast carcinoma in situ</VALIDVALUE>
          <VALUEMEANING>Ductal Breast Carcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>Ductal carcinoma in situ (DCIS) is a carcinoma entirely confined to the mammary ducts. There is no evidence of invasion of the basement membrane. Currently, DCIS is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS. --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2924</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dysgerminoma</VALIDVALUE>
          <VALUEMEANING>Ovarian Dysgerminoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant germ cell tumor arising from the ovary.  Morphologically, it is identical to seminoma and consists of a monotonous population of germ cells with abundant pale cytoplasm and uniform nuclei.  The stroma invariably contains chronic inflammatory cells, mostly T-lymphocytes. It responds to chemotherapy or radiotherapy and the prognosis relates to the tumor stage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8106</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4722795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EBV positive DLBCL of the elderly</VALIDVALUE>
          <VALUEMEANING>Elderly Epstein-Barr Virus Positive Finding Diffuse Large B-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An age group comprised by people 65 years of age and older.: A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt&#39;s lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations. (On-line Medical Dictionary): An observation confirming something, such as the presence of a disease, condition, or microorganism.: This non-Hodgkin&#39;s lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin&#39;s lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8851, C38758, C14204, C16268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Embryonal carcinoma</VALIDVALUE>
          <VALUEMEANING>Embryonal Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed &amp; Holland et al., Cancer Medicine, 3d ed, p1595)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocervical Adenocarcinoma of the Usual Type</VALIDVALUE>
          <VALUEMEANING>Endocervical Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma arising from the endocervical glandular epithelium. It is classified as either human papillomavirus-related or human papillomavirus-independent adenocarcinoma. Histologic variants include usual-type, mucinous, mesonephric, serous, clear cell, and endometrioid adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4029</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3521935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocervical Type of Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Endocervix Type Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the cervix which is lined by single columnar epithelium (mucosa).: Something distinguishable as an identifiable class based on common qualities.: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C25284, C12309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3521933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrial rhabdomyosarcoma</VALIDVALUE>
          <VALUEMEANING>Endometrial rhabdomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare malignant heterologous neoplasm with skeletal muscle differentiation arising from the uterine corpus. It usually manifests with vaginal bleeding. The prognosis is poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7024614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrial stromal sarcoma</VALIDVALUE>
          <VALUEMEANING>Endometrioid Stromal Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant, infiltrating mesenchymal tumor arising from the uterine corpus, cervix, vagina, and the ovary. Based on its morphologic characteristics, it is classified as either a low grade or an undifferentiated (high grade) stromal sarcoma. The low grade endometrioid stromal sarcoma is characterized by the presence of oval to spindle-shape cells that resemble the cells of the endometrial stroma, without evidence of significant atypia and pleomorphism. Numerous small vessels are also present. The undifferentiated stromal sarcoma is characterized by an aggressive clinical course, the presence of significant cellular atypia, pleomorphism, and high mitotic activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrial stromal sarcoma with glandular elements</VALIDVALUE>
          <VALUEMEANING>Endometrioid Stromal Sarcoma Glandular Differentiation</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.: A microscopic finding indicating the presence of cells with glandular differentiation in a tumor sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43573, C8973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrial stromal sarcoma with sex cord elements</VALIDVALUE>
          <VALUEMEANING>Endometrioid Stromal Sarcoma Sex Cord-Like Pattern</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.: No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35932, C8973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrial stromal sarcoma with smooth muscle differentiation</VALIDVALUE>
          <VALUEMEANING>Endometrioid Stromal Sarcoma Smooth Muscle Cell Cellular Differentiation</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.: An elongated spindle-shaped contractile cell, peculiar to an involuntary muscle, containing a single nucleus and longitudinally arranged myofibrils.: In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18314, C13001, C8973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrioid Adenocarcinoma of Endocervix</VALIDVALUE>
          <VALUEMEANING>Endocervix Endometrioid Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the cervix which is lined by single columnar epithelium (mucosa).: An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3769, C12309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3521932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrioid borderline tumor/atypical proliferative endometrioid tumor</VALIDVALUE>
          <VALUEMEANING>Borderline Tumors With Microinvasion Endometrioid</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm of low malignant potential arising from the ovary. It is characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. The surrounding ovarian stroma is often fibrotic. There is no evidence of stromal invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrioid borderline tumor/atypical proliferative endometrioid tumor with microinvasion</VALIDVALUE>
          <VALUEMEANING>Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor with Microinvasion</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade ovarian epithelial neoplasm characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells, and microinvasion of the ovarian stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6693102</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrioid carcinoma</VALIDVALUE>
          <VALUEMEANING>Ovarian Endometrioid Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An endometrioid adenocarcinoma arising from the ovary.  It comprises 10% to 25% of all primary ovarian carcinomas.  Grossly, endometrioid carcinoma may present as a cystic or solid mass.  Microscopically, the tumor greatly resembles the appearance of the ordinary type of endometrial adenocarcinoma.  As a group, endometrioid carcinoma has a prognosis twice as good as that of serous or mucinous carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7979</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5210934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Muscle invasive urothelial carcinoma (pT2 or above)</VALIDVALUE>
          <VALUEMEANING>Bladder Cancer pT2 TNM Finding v7 Urothelial Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Bladder cancer with tumor invading the muscularis propria. (from AJCC 7th Ed.): A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).  It is frequently papillary. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4030, C89352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myoepithelial carcinoma</VALIDVALUE>
          <VALUEMEANING>Malignant Myoepithelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>An infiltrating malignant epithelial neoplasm characterized by the presence of atypical cells with myoepithelial differentiation. Representative examples include malignant breast myoepithelioma and salivary gland myoepithelial carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7596</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myxofibrosarcoma</VALIDVALUE>
          <VALUEMEANING>Myxofibrosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A spectrum of malignant mesenchymal neoplasms arising from the soft tissues. It is characterized by the presence of spindle-shaped malignant cells, nuclear pleomorphism, thin-walled blood vessels, fibrous septa, and myxoid stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasopharyngeal papillary adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Nasopharyngeal Papillary Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, low-grade exophytic adenocarcinoma with papillary growth that arises from the epithelium of the nasopharynx.  If it is completely removed, the prognosis is excellent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nerve sheath tumor; malignant peripheral</VALIDVALUE>
          <VALUEMEANING>Malignant Peripheral Nerve Sheath Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuroendocrine Carcinoma (poorly differentiated)</VALIDVALUE>
          <VALUEMEANING>Poorly Differentiated Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.: A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3773, C14167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6029501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuroendocrine carcinoma, large cell</VALIDVALUE>
          <VALUEMEANING>Large Cell Carcinoma Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant epithelial neoplasm composed of large, atypical cells.: A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3773, C3780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6324220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuroendocrine carcinoma, small cell</VALIDVALUE>
          <VALUEMEANING>Small Cell Carcinoma Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble &quot;oat cells&quot; under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.: A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3773, C3915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6324221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuroendocrine prostate carcinoma (NEPC)</VALIDVALUE>
          <VALUEMEANING>Prostate Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A small cell or rarely a large cell neuroendocrine carcinoma that arises from the prostate gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158912</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6814231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nevoid melanoma</VALIDVALUE>
          <VALUEMEANING>Nevoid Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare variant of melanoma occurring mostly in adults in their fifth decade. Morphologically it resembles an ordinary compound or dermal nevus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54662</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nodular melanoma</VALIDVALUE>
          <VALUEMEANING>Nodular Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive form of melanoma, frequently metastasizing to the lymph nodes. It presents as a papular or nodular raised skin lesion. It comprises approximately 10-15% of melanomas. Morphologically, it often displays an epithelioid appearance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-intestinal adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Sinonasal Adenocarcinoma, Non-Intestinal-Type</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma that arises from the sinonasal tract. It is characterized by the absence of features that resemble intestinal adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160977</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-Seminoma; Choriocarcinoma</VALIDVALUE>
          <VALUEMEANING>Testicular Choriocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant germ cell tumor arising from the testis.  It represents the rarest of the testicular germ cell tumors. Histologically it is characterized by the presence of syncytiotrophoblasts and cytotrophoblasts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7733</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3895708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-Seminoma; Embryonal Carcinoma</VALIDVALUE>
          <VALUEMEANING>Testicular Embryonal Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant germ cell neoplasm arising from the testis.  It is composed of primitive epithelial cells arranged in solid, papillary, and glandular configurations.  Most patients present with a testicular mass, which may be associated with pain.  More than half of the patients have metastatic disease at diagnosis.  The form of treatment following radical orchiectomy is stage dependent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6341</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3895706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-Seminoma; Teratoma (Immature)</VALIDVALUE>
          <VALUEMEANING>Immature Testicular Teratoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A teratoma that arises from the testis and is composed of immature, fetal type-tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3895700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-Seminoma; Teratoma (Mature)</VALIDVALUE>
          <VALUEMEANING>Mature Testicular Teratoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A teratoma that arises from the testis and is composed of well differentiated, adult-type tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3895702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-Seminoma; Yolk Sac Tumor</VALIDVALUE>
          <VALUEMEANING>Testicular Yolk Sac Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-seminomatous malignant germ cell tumor arising from the testis.  It affects infants, young children, and postpubertal males.  It is the most frequently seen testicular neoplasm during childhood.  The vast majority of patients present with an asymptomatic scrotal mass.  The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP).  It metastasizes to distant anatomic sites.  Prognostic factors relate to the clinical stage and the degree of AFP elevation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3895704</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-Small Cell Lung Cancer (NOS)</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Non-Small Cell Lung Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A group of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.  Non-small cell lung carcinomas have a poor response to conventional chemotherapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2926, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4928895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-squamous cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Non-squamous cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A poorly differentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular or squamous differentiation.  There is a male predilection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2932105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2853071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable (no minor component)</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination that a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable - liquid tumor</VALIDVALUE>
          <VALUEMEANING>Not Applicable Liquid Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.: A malignant tumor that originates from myeloid or lymphoid cells i.e., leukemias and lymphomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116915, C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4419915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NUT carcinoma</VALIDVALUE>
          <VALUEMEANING>NUT Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, highly aggressive and lethal carcinoma that affects children and young adults.  It arises from midline epithelial structures, most commonly the head, neck, and mediastinum.  It is a poorly differentiated carcinoma and is characterized by mutations and rearrangement of the NUT gene.  A balanced translocation t(15;19) is present that results in the creation of a fusion gene involving the NUT gene, most commonly BRD4-NUT fusion gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45716</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oligoastrocytoma</VALIDVALUE>
          <VALUEMEANING>Oligoastrocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A WHO grade II tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4050</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oligodendroglioma</VALIDVALUE>
          <VALUEMEANING>Oligodendroglioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A well-differentiated (WHO grade II), diffusely infiltrating neuroglial tumor, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm (&#39;honeycomb&#39; appearance). (Adapted from WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838655</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oncocytic carcinoma</VALIDVALUE>
          <VALUEMEANING>Oxyphilic Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma characterized by the presence of large malignant epithelial cells with abundant granular eosinophilic cytoplasm (oncocytes). Representative examples include thyroid gland oncocytic follicular carcinoma, oncocytic breast carcinoma, and salivary gland oncocytic carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3679</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248544</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oropharyngeal squamous cell carcinoma, HPV status unknown</VALIDVALUE>
          <VALUEMEANING>Oropharyngeal Carcinoma Human Papillomavirus Status Unknown Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoma, predominantly squamous cell, arising from the epithelial cells of the oropharynx.: A strain of papillomavirus that can infect the skin and mucous membranes of humans.: A condition or state at a particular time.: Not known, not observed, not recorded, or refused.: A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2929, C17998, C25688, C14226, C9105</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteosarcoma; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Osteosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A usually aggressive malignant bone-forming mesenchymal tumor, predominantly affecting adolescents and young adults.  It usually involves bones and less frequently extraosseous sites.  It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus).  Pain with or without a palpable mass is the most frequent clinical symptom.  It may spread to other anatomic sites, particularly the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9145, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreas-Adenocarcinoma Ductal Type</VALIDVALUE>
          <VALUEMEANING>Pancreatic Ductal Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma occurring almost exclusively in adults that probably arises from the pancreatic duct epithelium.  Most pancreatic carcinomas are ductal adenocarcinomas of which about two-thirds involve the head, with the remainder in the body and tail of the pancreas.  The patients are usually over 50 years of age.  Pain, jaundice, and loss of weight are the most common manifestations.  Ductal adenocarcinomas usually grow rapidly and are discovered after they have already spread beyond the pancreas.  Grossly, ductal adenocarcinomas are firm and poorly defined masses.  Microscopically, most ductal adenocarcinomas are characterized by well-developed glandular structures embedded in a desmoplastic stroma.  Ductal adenocarcinomas are fatal in the vast majority of cases (WHO 2000). --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9120</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreas-Adenosquamous Carcinoma</VALIDVALUE>
          <VALUEMEANING>Pancreas Adenosquamous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-encapsulated elongated and lobulated organ, extending from the concavity of the duodenum to the spleen; it consists of a head, an elongated body, and a tail. It contains two functional components: an exocrine component that secretes juices into the intestine and an endocrine component that secretes hormones (insulin and glucagon).: A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3727, C12393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3402731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreas-Carcinoma with Osteoclast-like Giant Cells</VALIDVALUE>
          <VALUEMEANING>Pancreatic Osteoclast-Like Giant Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare variant of undifferentiated pancreatic carcinoma characterized by the presence of non-neoplastic osteoclast-like giant cells.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5723</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3402722</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreas-Colloid (mucinous non-cystic) Carcinoma</VALIDVALUE>
          <VALUEMEANING>Pancreatic Mucinous Noncystic Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A pancreatic adenocarcinoma, clinicopathologically distinct from conventional pancreatic ductal adenocarcinomas, with a relatively indolent behavior (5-year survival of 55%).  It often arises in association with intraductal pancreatic mucinous neoplasms. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreas-Hepatoid Carcinoma</VALIDVALUE>
          <VALUEMEANING>Pancreatic Hepatoid Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare adenocarcinoma that arises from the pancreas.  It is characterized by marked hepatocellular differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3402730</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acral lentiginous melanoma</VALIDVALUE>
          <VALUEMEANING>Acral Lentiginous Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of melanoma occurring most often on the plantar, palmar, subungual, and periungual skin.  It presents as a pigmented macular lesion with irregular borders.  Morphologically, it consists of atypical spindled and dendritic melanocytes.  The epidermis is often hyperplastic and there is pagetoid infiltration of the epidermis by anaplastic cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4022</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4263936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma in situ, mucinous</VALIDVALUE>
          <VALUEMEANING>Mucinous Lung Adenocarcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>A very rare lung adenocarcinoma in situ variant characterized by the presence of tall columnar cells with basal nuclei and abundant cytoplasmic mucin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6077902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma in situ, nonmucinous</VALIDVALUE>
          <VALUEMEANING>Non-Mucinous Lung Adenocarcinoma In Situ</VALUEMEANING>
          <MEANINGDESCRIPTION>Lung adenocarcinoma in situ characterized by the presence of type II pneumocyte and/or Clara cell differentiation. Almost all cases of lung adenocarcinoma in situ are non-mucinous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136716</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6077900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma with peculiar aspects</VALIDVALUE>
          <VALUEMEANING>Unusual Aspect Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Out of the ordinary, uncommon, or unexpected.: A characteristic to be considered; a distinct feature or element.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C61468, C77967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6324225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma, biliary type</VALIDVALUE>
          <VALUEMEANING>Extrahepatic Bile Duct Adenocarcinoma, Biliary Type</VALUEMEANING>
          <MEANINGDESCRIPTION>A well or moderately differentiated adenocarcinoma that arises from the extrahepatic bile ducts.  It is characterized by the presence of malignant tubular glands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96936</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma, gastric foveolar type</VALIDVALUE>
          <VALUEMEANING>Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type</VALUEMEANING>
          <MEANINGDESCRIPTION>A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that are similar to gastric foveolar epithelial cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5529208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma, intestinal type</VALIDVALUE>
          <VALUEMEANING>Intestinal-Type Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma arising from epithelium which has undergone intestinal metaplasia. Representative examples include gastric, gallbladder, and ampulla of Vater intestinal type adenocarcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4126</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408774</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma, Not Otherwise Specified</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Adenocarcinoma </VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3081859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma, prostate ductal</VALIDVALUE>
          <VALUEMEANING>Prostate Ductal Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive invasive adenocarcinoma of the prostate gland composed of large glands containing tall columnar cells.  The columnar cells have abundant cytoplasm and are reminiscent of endometrial carcinoma.  This type of adenocarcinoma has a tendency to metastasize to the lung and penis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma; clear cell</VALIDVALUE>
          <VALUEMEANING>Clear Cell Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3766</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4039074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma; endometrioid; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Endometrioid Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3769, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma; mixed</VALIDVALUE>
          <VALUEMEANING>Mixed Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Involving or composed of different kinds.: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C25259</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma; mixed; adenocarcinoma and squamous cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Mixed Squamous Cell Carcinoma And Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Involving or composed of different kinds.: A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C37912, C2929, C25259</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma; mucinous; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Mucinous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26712, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3704509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma; papillary</VALIDVALUE>
          <VALUEMEANING>Papillary Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of adenocarcinoma. It is characterized by the presence of a papillary growth pattern. Representative examples include thyroid gland papillary carcinoma, invasive papillary breast carcinoma, and ovarian serous surface papillary adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma; serous</VALIDVALUE>
          <VALUEMEANING>Serous Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant serous cystic neoplasm usually involving the ovary or the pancreas. It is characterized by the presence of invasive malignant glandular epithelial cells which often form papillary structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3778</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinoma; Solid Pattern Predominant</VALIDVALUE>
          <VALUEMEANING>Solid Growth Pattern Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopic finding indicating that the neoplastic cells are arranged in solid sheets in a tumor sample.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C36182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4039073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenocarcinomas (non-salivary gland type)</VALIDVALUE>
          <VALUEMEANING>Negation Salivary Gland Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: An exocrine gland that secretes saliva. Salivary glands are mostly located in and around the oral cavity.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C12426, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoid Basal Carcinoma</VALIDVALUE>
          <VALUEMEANING>Cervical Adenoid Basal Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, low grade carcinoma that arises from the cervix. It is characterized by the presence of nests of basaloid cells with focal glandular formations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4928860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoid Cystic Carcinoma</VALIDVALUE>
          <VALUEMEANING>Adenoid Cystic Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor arising from the epithelial cells.  Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma).  Adenoid cystic carcinomas mostly occur in the salivary glands.  Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs.  Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur.  Lymph node metastases are unusual; hematogenous tumor spread is characteristic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4264017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenosarcoma</VALIDVALUE>
          <VALUEMEANING>Adenosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenosarcoma with cartilaginous differentiation</VALIDVALUE>
          <VALUEMEANING>Adenosarcoma Cartilaginous Differentiation</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.: No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53445, C9474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenosarcoma with osseous differentiation</VALIDVALUE>
          <VALUEMEANING>Adenosarcoma Osseous Differentiation</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.: No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53444, C9474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenosarcoma with rhabdomyoblastic differentiation</VALIDVALUE>
          <VALUEMEANING>Adenosarcoma Rhabdomyosarcomatous Differentiation</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.: No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35937, C9474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenosarcoma with sarcomatous overgrowth</VALIDVALUE>
          <VALUEMEANING>Adenosarcoma Sarcomatous Component Present</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites.: A histopathologic finding characterized by the presence of malignant cells of connective tissue origin in a tumor sample.  Examples of connective tissue cells that can undergo malignant transformation include smooth and skeletal muscle cells, adipose tissue cells, osteocytes, and chondrocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54727, C9474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenosquamous</VALIDVALUE>
          <VALUEMEANING>Adenosquamous Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2836818</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenocortical Carcinoma- Myxoid Type</VALIDVALUE>
          <VALUEMEANING>Adrenal Cortex Carcinoma, Myxoid Changes Present</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating the presence of myxoid changes in a tissue sample._A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing&#39;s syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9325, C39744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenocortical Carcinoma- Oncocytic Type</VALIDVALUE>
          <VALUEMEANING>Adrenal Cortex Carcinoma, Malignant Oncocyte</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant epithelial cell with abundant eosinophilic or clear granular cytoplasm._A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing&#39;s syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9325, C36942</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenocortical carcinoma- Usual Type</VALIDVALUE>
          <VALUEMEANING>Well Differentiated Adrenal Cortex Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adrenal cortex carcinoma characterized by the presence of morphologic and cytologic features reminiscent of the normal adrenal cortex and absence of sarcomatous or anaplastic features.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Astrocytoma</VALIDVALUE>
          <VALUEMEANING>Astrocytoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>A tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60781</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2837827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B-cell lymphoma (unclassifiable) with features intermediate between DLBCL and Burkitt lymphoma</VALIDVALUE>
          <VALUEMEANING>High Grade B-Cell Lymphoma, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive lymphoma with morphologic features of both diffuse large B-cell lymphoma and Burkitt lymphoma, but without rearrangement of MYC gene, BCL2 gene and/or BCL6 gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3928524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basal cell adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Salivary Gland Basal Cell Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare adenocarcinoma of the major and minor salivary glands, originating from basaloid, myoepithelial and ductal cells.  While morphologically resembling basal cell carcinomas, it is a distinct entity.  The tumor is not encapsulated, may invade locally, and less frequently may metastasize.  It usually occurs in older patients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3678</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5053392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basaloid Squamous Cell</VALIDVALUE>
          <VALUEMEANING>Basaloid Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A squamous cell carcinoma characterized by the presence of cells with hyperchromatic nuclei, scant amount of cytoplasm, and peripheral nuclear palisading.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3081851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Uterine Carcinosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A usually aggressive malignant neoplasm arising from the uterine corpus and less often the cervix.  It is characterized by the presence of two components: a malignant epithelial component and a sarcomatous component.  In the uterine corpus the epithelial component is usually glandular whereas in the cervix is usually non-glandular.  Carcinosarcoma of the cervix, although it is aggressive, it may have a better prognosis compared to the uterine corpus carcinosarcoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42700, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uterine Carcinosarcoma/ MMMT: Heterologous Type</VALIDVALUE>
          <VALUEMEANING>Malignant Mixed Mesodermal (Mullerian) Tumor Heterologous Elements Present Uterine Carcinosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive malignant tumor of the female reproductive system, affecting predominantly elderly menopausal women.  The endometrium and ovary are the most common sites of tumor origin.  Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements._A morphologic finding indicating the presence of tissues that do not normally occur in the specific anatomic site or are found admixed with a neoplastic cellular infiltrate of a different cellular origin._A usually aggressive malignant neoplasm arising from the uterine corpus and less often the cervix.  It is characterized by the presence of two components: a malignant epithelial component and a sarcomatous component.  In the uterine corpus the epithelial component is usually glandular whereas in the cervix is usually non-glandular.  Carcinosarcoma of the cervix, although it is aggressive, it may have a better prognosis compared to the uterine corpus carcinosarcoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42700, C54559, C8975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uterine Carcinosarcoma/MMMT: Homologous Type</VALIDVALUE>
          <VALUEMEANING>Uterine Carcinosarcoma, Homologous Type</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinosarcoma of the uterus characterized by the presence of sarcomatous elements that arise from the tissues of the uterus.: An aggressive malignant tumor of the female reproductive system, affecting predominantly elderly menopausal women.  The endometrium and ovary are the most common sites of tumor origin.  Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8975, C113238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4039058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uterine serous endometrial adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Endometrial Serous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A high grade, aggressive adenocarcinoma arising from the endometrium.  It is characterized by the presence of complex papillary patterns with cellular budding.  Atypical mitoses, necrosis, and psammoma bodies may be present.  It is classified as type II endometrial carcinoma and it is not associated with endometrial hyperplasia.  It tends to invade deeply into the myometrium and spreads into the lymphatic vessels.  Patients frequently present with spread of the tumor beyond the uterus at the time of diagnosis.  The prognosis is usually poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27838</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uveal Melanoma</VALIDVALUE>
          <VALUEMEANING>Uveal Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uveal Melanoma; Epithelioid Cell</VALIDVALUE>
          <VALUEMEANING>Uveal Melanoma Epithelioid Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.: A melanoma characterized by the presence of malignant large epithelioid melanocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4236, C7712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5102451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uveal Melanoma; Spindle Cell</VALIDVALUE>
          <VALUEMEANING>Uveal Melanoma Spindle Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.: A melanoma characterized by the presence of malignant spindle-shaped melanocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4237, C7712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5102452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Well-differentiated leiomyosarcoma (resembling leiomyoma)</VALIDVALUE>
          <VALUEMEANING>Well Differentiated Leiomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Grade I malignant smooth muscle neoplasm.  It is characterized by a proliferation of neoplastic spindle cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Well-differentiated neuroendocrine carcinoma</VALIDVALUE>
          <VALUEMEANING>Well Differentiated Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.: A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3773, C14171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6324223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Xp11 translocation renal cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of kidney carcinomas characterized by the presence of different translocations involving the chromosome Xp11.2.  These translocations result in the creation of gene fusions involving the TFE3 gene.  Patients are usually children and young adults.  Morphologically, the malignant epithelial cells form papillary patterns.  The clinical behavior of this group of carcinomas is largely unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27891</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5210414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yolk sac tumor (endodermal sinus tumor)</VALIDVALUE>
          <VALUEMEANING>Ovarian Yolk Sac Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually rapidly growing malignant germ cell tumor arising from the ovary.  It usually occurs in children and adolescents.  Signs and symptoms include abdominal pain and a large abdominal or pelvic mass.  The serum alpha-fetoprotein is almost always elevated preoperatively.  Morphologically, there is marked heterogeneity due to numerous patterns of differentiation coexisting in the same tumor.  The most common pattern is reticular.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8107</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692776</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large Cell/Anaplastic Medulloblastoma</VALIDVALUE>
          <VALUEMEANING>Large Cell/Anaplastic Medulloblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A medulloblastoma composed of sheets of large cells mixed with cells characterized by marked nuclear pleomorphism and high mitotic activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6028604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma; small-cell prostate neuroendocrine</VALIDVALUE>
          <VALUEMEANING>Prostate Small Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neuroendocrine carcinoma of the prostate gland with unfavorable prognosis. It is composed of small cells containing neurosecretory granules.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6766</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrioid carcinoma with secretory differentiation</VALIDVALUE>
          <VALUEMEANING>Endometrial Endometrioid Adenocarcinoma, Secretory Variant</VALUEMEANING>
          <MEANINGDESCRIPTION>An endometrioid adenocarcinoma arising from the endometrium. Morphologically it is characterized by the presence of malignant glandular cells containing glycogen vacuoles which are usually subnuclear and reminiscent of early secretory endometrium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27839</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrioid carcinoma with squamous differentiation</VALIDVALUE>
          <VALUEMEANING>Endometrial Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A primary carcinoma of the endometrium characterized by the presence of malignant squamous cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrioid carcinoma, NOS</VALIDVALUE>
          <VALUEMEANING>Endometrial Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5581346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrioid carcinoma, villoglandular variant</VALIDVALUE>
          <VALUEMEANING>Villoglandular Endometrial Endometrioid Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A primary endometrioid adenocarcinoma of the endometrium characterized by the presence of numerous finger-like villi lined by neoplastic columnar cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrioid endometrial adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Endometrial Endometrioid Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A primary endometrial adenocarcinoma composed of neoplastic cells that form complex glandular patterns associated with budding and branching of the neoplastic glands.  The neoplastic glands resemble those of the normal endometrium and may or may not be associated with sheet-like proliferation of malignant cells.  Endometrioid adenocarcinoma is the most commonly seen morphologic variant of endometrial adenocarcinoma. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6287</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3475265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enteric adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Lung Enteric Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A well-differentiated adenocarcinoma located in the lung periphery. It resembles colorectal adenocarcinoma with acinar and/or cribriform architecture and papillotubular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136710</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6077904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ependymoma; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Ependymoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: Ependymoma (WHO grade II) is the most common ependymal neoplasm. It is a slow growing tumor of children and young adults and is usually located intraventricularly.  It often causes clinical symptoms by blocking CSF pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes.(Adapted from WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3017, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2861350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epithelial-myoepithelial carcinoma</VALIDVALUE>
          <VALUEMEANING>Epithelial-Myoepithelial Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm which occurs mostly in the major salivary glands (most frequently in the parotid gland), but also in the minor salivary glands of the oral mucosa and the tracheobronchial tree. It is characterized by the presence of ductal structures which are lined by an inner layer of cuboidal epithelial-type cells and an outer layer of myoepithelial cells with clear or eosinophilic cytoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epithelioid Cell</VALIDVALUE>
          <VALUEMEANING>Epithelioid Cell Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A melanoma characterized by the presence of malignant large epithelioid melanocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3729982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epithelioid mesothelioma</VALIDVALUE>
          <VALUEMEANING>Epithelioid Mesothelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic cells with an epithelioid appearance. In the majority of cases, the neoplastic epithelioid cells lack significant cytologic atypia; mitotic figures are infrequently seen. In a minority of cases, the neoplastic cells are poorly differentiated and there is evidence of nuclear atypia and increased mitotic activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus Adenocarcinoma, NOS</VALIDVALUE>
          <VALUEMEANING>Esophagus Adenocarcinoma Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.: A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.: Not characterized in any other way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594, C2852, C12389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3295793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus Squamous Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Esophagus Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.: A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2929, C12389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3295792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ETMR</VALIDVALUE>
          <VALUEMEANING>Ependymoblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive malignant embryonal neoplasm arising from the central nervous system. It is characterized by the presence of multilayered rosettes formation, and increased cellularity. Symptoms include increased intracranial pressure, hydrocephalus, and focal neurological signs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fetal Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Fetal Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A very rare, well differentiated morphologic variant of lung adenocarcinoma characterized by the presence of glandular structures containing glycogen-rich cells forming tubules that resemble fetal lung tubules.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3081858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrolamellar Carcinoma</VALIDVALUE>
          <VALUEMEANING>Fibrolamellar Hepatocellular Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibrolamellar carcinoma is a distinctive morphologic variant of liver cell carcinoma seen predominantly in young patients without cirrhosis and associated with favorable prognosis.  The tumor cells are polygonal and deeply eosinophilic embedded in a fibrous stroma.  Over half of the fibrolamellar carcinomas are resectable, and the cure rate is about 50%.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3165470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrolamellar hepatocellular carcinoma</VALIDVALUE>
          <VALUEMEANING>Fibrolamellar Hepatocellular Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibrolamellar carcinoma is a distinctive morphologic variant of liver cell carcinoma seen predominantly in young patients without cirrhosis and associated with favorable prognosis.  The tumor cells are polygonal and deeply eosinophilic embedded in a fibrous stroma.  Over half of the fibrolamellar carcinomas are resectable, and the cure rate is about 50%.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3165470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibrosarcoma; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Fibrosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A malignant mesenchymal tumor affecting soft tissues and bone. It is classified as adult or infantile.  Infantile fibrosarcomas generally have a much more favorable prognosis than adult fibrosarcomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3043, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3783687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Follicular lymphoma</VALIDVALUE>
          <VALUEMEANING>Follicular Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm of follicle centre B cells which has at least a partial follicular pattern.  Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide.  Most patients have widespread disease at diagnosis.  Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present.  The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)].  Histological grade correlates with prognosis.  Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088584</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal stromal tumor; malignant</VALIDVALUE>
          <VALUEMEANING>Malignant Gastrointestinal Stromal Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.: A mesenchymal neoplasm most commonly seen in the gastrointestinal tract. Cases involving tissues outside the gastrointestinal tract have also been reported (extragastrointestinal gastrointestinal stromal tumor). It is a specific KIT-expressing and KIT-signaling-driven mesenchymal tumor. Until recently, surgery has been the only effective therapy for this tumor. However, many patients still experience recurrence. Conventional chemotherapy and radiation therapy have been of limited value. A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3868, C14143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Germ cell tumor; mixed</VALIDVALUE>
          <VALUEMEANING>Mixed Germ Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant germ cell tumor characterized by the presence of at least two different germ cell components. The different germ cell components include choriocarcinoma, embryonal carcinoma, yolk sac tumor, teratoma, and seminoma. It occurs in the ovary, testis, and extragonadal sites including central nervous system and mediastinum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Germ cell tumor; non-seminomatous</VALIDVALUE>
          <VALUEMEANING>Testicular Non-Seminomatous Germ Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A testicular germ cell tumor characterized by the absence of a seminomatous component. It includes embryonal carcinoma, yolk sac tumor, choriocarcinoma, teratoma, and mixed forms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2986280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Giant cell &#39;MFH&#39; / Undifferentiated pleomorphic sarcoma with giant cells</VALIDVALUE>
          <VALUEMEANING>Giant Cell Fibrous Histiocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An undifferentiated pleomorphic sarcoma characterized by the presence of osteoclast-like giant cells and cellular pleomorphism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3836181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glassy Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Glassy Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant epithelial neoplasm composed of atypical cells with glassy cytoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3536384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glioblastoma Multiforme (GBM)</VALIDVALUE>
          <VALUEMEANING>Glioblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma). Two histologic variants are recognized: giant cell glioblastoma and gliosarcoma. (WHO) </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulosa cell tumor, adult type</VALIDVALUE>
          <VALUEMEANING>Adult Type Ovarian Granulosa Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A granulosa cell tumor that affects middle aged or postmenopausal women.  Patients may present with uterine bleeding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulosa cell tumor, juvenile type</VALIDVALUE>
          <VALUEMEANING>Juvenile Type Ovarian Granulosa Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A granulosa cell tumor that affects females in the first three decades of life.  In young girls it may present with pseudoprecocity.  In women during reproductive years, it may present with menstrual abnormalities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692778</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulosa cell tumor; malignant</VALIDVALUE>
          <VALUEMEANING>Malignant Granulosa Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A granulosa cell tumor which has an aggressive clinical course and metastasizes to other anatomic sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granulosa cell tumor; Sarcomatoid</VALIDVALUE>
          <VALUEMEANING>Sarcomatoid Features Granulosa Cell Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopic finding indicating the presence of cells with sarcomatoid, usually spindle cell differentiation in a tumor sample.: A slow-growing, malignant tumor, characterize by the presence of granulosa-like cells and Call-Exner bodies, that is almost always found in the ovary. In rare cases, it has also been found in the testicle.  There are two types of granulosa cell tumor that can be distinguished under the microscope: the adult and the juvenile.  The testicular juvenile granulosa cell tumors are perhaps the most common congenital testicular neoplasms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3070, C39694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatocellular Carcinoma</VALIDVALUE>
          <VALUEMEANING>Hepatocellular Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatocholangiocarcinoma (Mixed)</VALIDVALUE>
          <VALUEMEANING>Cholangiocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An malignant tumor composed of cells resembling those of bile ducts. Cholangiocarcinoma is a relatively rare tumor in most populations. It can arise from any portion of the intrahepatic bile duct epithelium or the hepatic ducts. Grossly, the lesions are nodular, grayish-white firm and solid. Microscopically, the vast majority of cholangiocarcinomas are adenocarcinomas showing tubular and/or papillary structures. Early detection of cholangiocarcinomas is difficult, and the overall prognosis after resection is poor (adapted from WHO, 2000).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4436</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3165468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatoid adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Hepatoid Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma with morphologic characteristics similar to hepatocellular carcinoma, arising from an anatomic site other than the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Hereditary Leiomyomatosis and Renal Cell Cancer</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant inherited syndrome caused by germline mutations in the FH gene. It is characterized by predisposition to leiomyomas of the skin and uterus, renal cell carcinoma, and leiomyosarcoma of the uterus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51302</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6789030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High grade serous carcinoma</VALIDVALUE>
          <VALUEMEANING>High Grade Ovarian Serous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.: An adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that, in well differentiated tumors, resemble the epithelium of the fallopian tube or, in poorly differentiated tumors, show anaplastic features and marked nuclear atypia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7550, C14158</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6742161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High-grade neuroendocrine carcinoma (small cell type)</VALIDVALUE>
          <VALUEMEANING>Pancreatic Small Cell Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas.  It is characterized by the presence of malignant small cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hodgkin lymphoma; nodular sclerosis; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Nodular Sclerosis Hodgkin Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A subtype of classical Hodgkin lymphoma characterized by collagen bands surrounding lymphoid nodules. The lymphoid nodules contain lacunar and Reed-Sternberg cells.  Mediastinal involvement occurs in 80% of patients.  The prognosis of nodular sclerosis Hodgkin lymphoma is slightly better than that of mixed cellularity or lymphocyte depleted subtype. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3518, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPV-mediated squamous cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A squamous cell carcinoma associated with human papilloma type 16 virus, arising from the oropharynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C87055</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPV-unrelated squamous cell carcinoma</VALIDVALUE>
          <VALUEMEANING>p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An oropharyngeal squamous cell carcinoma which is negative for p16INK4a by immunohistochemistry. This negative immunohistochemistry result does not exclude human papillomavirus infection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hybrid squamous cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Hybrid Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Being comprised of mixed attributes or parts.: Flat cell that looks like a fish scale under a microscope. These cells cover inside and outside surfaces of the body. They are found in the tissues that form the surface of the skin, the lining of the hollow organs of the body (such as the bladder, kidney, and uterus), and the passages of the respiratory and digestive tracts.: A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2916, C12849, C128790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6769947</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreas-Medullary</VALIDVALUE>
          <VALUEMEANING>Pancreatic Medullary Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A pancreatic ductal adenocarcinoma characterized by poor differentiation and a prominent syncytial growth pattern.  The prognosis is more favorable compared to conventional pancreatic ductal adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3402728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreas-Signet Ring Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Pancreatic Signet Ring Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare pancreatic ductal adenocarcinoma with poor prognosis.  It is characterized by the presence of malignant signet ring cells infiltrating the pancreatic parenchyma in an individual cell pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3402726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreas-Undifferentiated Carcinoma</VALIDVALUE>
          <VALUEMEANING>Undifferentiated Pancreatic Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma with poor prognosis that arises from the pancreas.  It is characterized by the presence of a significant malignant component that does not show differentiation.  The malignant cells represent a mixture of large, pleomorphic cells and giant cells, or adenocarcinoma cells and spindle cells, or spindle cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3402724</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatoblastoma</VALIDVALUE>
          <VALUEMEANING>Pancreatoblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare malignant epithelial neoplasm arising from the pancreas. The vast majority of cases occur during childhood. It is characterized by acinar differentiation, the formation of squamoid corpuscles, and the formation of stromal bands. Patients may present with an abdominal mass. Symptoms include pain, weight loss, and diarrhea. It may metastasize to lymph nodes, liver, and distant anatomic sites. Children who do not have metastatic disease at the time of diagnosis usually have a favorable clinical outcome when treated with a combination of surgery and chemotherapy. However, children with metastatic disease at presentation or adult patients usually have a poor prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3251704</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papillary Renal Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Papillary Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papillary renal cell carcinoma, Type 1</VALIDVALUE>
          <VALUEMEANING>Type 1 papillary renal cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A papillary renal cell carcinoma characterized by the presence of papillae covered by small cells with scant amount of cytoplasm. The cells are arranged in a single layer on the basement membrane of the papillae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27886</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papillary renal cell carcinoma, Type 2</VALIDVALUE>
          <VALUEMEANING>Type 2 papillary renal cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A papillary renal cell carcinoma characterized by the presence of papillae covered by cells of a higher nuclear grade as compared to type 1 papillary renal cell carcinoma. The cells have eosinophilic cytoplasm and pseudostratified nuclei.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papillary Squamous Cell</VALIDVALUE>
          <VALUEMEANING>Papillary Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A well differentiated squamous cell carcinoma characterized by a papillary, exophytic growth pattern and hyperkeratosis. The most commonly affected anatomic sites are the larynx, penis, cervix, vagina, and vulva.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3081854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papillary Squamous Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Papillary Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A well differentiated squamous cell carcinoma characterized by a papillary, exophytic growth pattern and hyperkeratosis. The most commonly affected anatomic sites are the larynx, penis, cervix, vagina, and vulva.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3081854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraganglioma</VALIDVALUE>
          <VALUEMEANING>Paraganglioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant neoplasm arising from paraganglia located along the sympathetic or parasympathetic nerves.  Infrequently, it may arise outside the usual distribution of the sympathetic and parasympathetic paraganglia.  Tumors arising from the adrenal gland medulla are called pheochromocytomas.  Morphologically, paragangliomas usually display a nesting (Zellballen) growth pattern.  There are no reliable morphologic criteria to distinguish between benign and malignant paragangliomas.  The only definitive indicator of malignancy is the presence of regional or distant metastases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraganglioma; Extra-adrenal Pheochromocytoma</VALIDVALUE>
          <VALUEMEANING>Extra-Adrenal Paraganglioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant paraganglioma arising from sympathetic or parasympathetic paraganglia outside the adrenal gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4039070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pheochromocytoma</VALIDVALUE>
          <VALUEMEANING>Adrenal Gland Pheochromocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant neuroendocrine neoplasm of the sympathetic nervous system that secretes catecholamines.  It arises from the chromaffin cells of the adrenal medulla.  Clinical presentation includes headaches, palpitations, chest and abdominal pain, hypertension, fever, and tremor.  Microscopically, a characteristic nesting (zellballen) growth pattern is usually seen.  Other growth patterns including trabecular pattern may also be present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phyllodes Tumor</VALIDVALUE>
          <VALUEMEANING>Phyllodes Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, borderline, or malignant fibroepithelial neoplasm arising from the breast and rarely the prostate gland.  It may recur following resection.  The recurrence rates are higher for borderline and malignant phyllodes tumors.  In borderline and malignant phyllodes tumors metastases to distant anatomic sites can occur.  The incidence of metastases is higher in malignant phyllodes tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2977</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3293674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasmacytoma; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Plasmacytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A malignant (clonal) proliferation of plasma cells that are cytologically and immunophenotypically identical to those of plasma cell myeloma, but manifest a localized osseous or extraosseous growth pattern. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9349, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleomorphic &#39;MFH&#39; / Undifferentiated pleomorphic sarcoma</VALIDVALUE>
          <VALUEMEANING>Storiform-Pleomorphic Malignant Fibrous Histiocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An undifferentiated soft tissue sarcoma characterized by the presence of a pleomorphic malignant cellular infiltrate.  It is also known as malignant fibrous histiocytoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3179380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polymorphous adenocarcinoma, classic</VALIDVALUE>
          <VALUEMEANING>Salivary Gland Polymorphous Low Grade Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A low grade malignant epithelial neoplasm arising from the salivary gland. It usually arises from the oral cavity, with approximately 60% of the cases involving the palate. The most common presenting sign is a painless mass in the palate. It is characterized by the presence of uniform, small to medium size malignant epithelial cells and an infiltrating pattern. There is a variety of morphologic patterns which may be present within an individual tumor, including lobular, papillary, papillary-cystic, cribriform, and trabecular pattern. It usually has a favorable clinical outcome and a low metastatic potential.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polymorphous adenocarcinoma, cribriform</VALIDVALUE>
          <VALUEMEANING>Cribriform Adenocarcinoma of Minor Salivary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A minor salivary gland adenocarcinoma characterized by a cribriform pattern. It often metastasizes to the neck lymph nodes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poorly differentiated carcinoma, large cell neuroendocrine</VALIDVALUE>
          <VALUEMEANING>Head and Neck Large Cell Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A large cell neuroendocrine carcinoma that arises from the head and neck.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160982</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poorly differentiated carcinoma, small cell neuroendocrine</VALIDVALUE>
          <VALUEMEANING>Head and Neck Small Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A small cell carcinoma that arises from the head and neck.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poorly differentiated neuroendocrine carcinoma, large cell</VALIDVALUE>
          <VALUEMEANING>Large Cell Neuroendocrine Carcinoma Poorly Differentiated</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.: Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14167, C6875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poorly differentiated neuroendocrine carcinoma, small cell</VALIDVALUE>
          <VALUEMEANING>Poorly Differentiated Small Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.: A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble &quot;oat cells&quot; under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3915, C14167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6775247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poorly differentiated/ pleomorphic/ epithelioid leiomyosarcoma</VALIDVALUE>
          <VALUEMEANING>Conventional Leiomyosarcoma Epithelioid Leiomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon, aggressive malignant smooth muscle neoplasm.  It is characterized by the presence of atypical large spindle or round cells, nuclear palisading, tumor cell necrosis, mitotic figures and may be associated with vascular invasion.: A morphologic variant of leiomyosarcoma characterized by the presence of epithelioid round cells with eosinophilic to clear cytoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3700, C9428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686282</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Primary cutaneous DLBCL leg type</VALIDVALUE>
          <VALUEMEANING>Primary Cutaneous Leg Type Diffuse Large B-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring first in time or sequence; original. (American Heritage Dictionary): (kyoo-TAY-nee-us) Having to do with the skin.: Commonly used to refer to the whole lower limb but technically only the part between the knee and ankle.: Type; a subdivision of a particular kind of thing.: This non-Hodgkin&#39;s lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin&#39;s lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8851, C25284, C32974, C13316, C25251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361339</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Primary DLBCL of the CNS</VALIDVALUE>
          <VALUEMEANING>Central Nervous System Primary Diffuse Large B-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.: Occurring first in time or sequence; original. (American Heritage Dictionary): This non-Hodgkin&#39;s lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin&#39;s lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8851, C25251, C12438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361340</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Primary mediastinal (thymic) DLBCL</VALIDVALUE>
          <VALUEMEANING>Primary Mediastinal Diffuse Large B-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring first in time or sequence; original. (American Heritage Dictionary): Mediastinal; related to the mediastinum.: This non-Hodgkin&#39;s lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin&#39;s lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8851, C25310, C25251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Prostate Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumors afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2919</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3320078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate Adenocarcinoma Acinar Type</VALIDVALUE>
          <VALUEMEANING>Acinar Prostate Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma of the prostate gland composed of secretory cells.  It is the most common histologic type of prostate adenocarcinoma.  Several morphologic variants exist, including atrophic, pseudohyperplastic, foamy gland, and oncocytic variants.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5596</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686425</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectal Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Rectal Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenocarcinoma arising from the rectum.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, rectal adenocarcinomas are divided into well differentiated, moderately, and poorly differentiated.  Morphologic variants include the mucinous adenocarcinoma and signet-ring adenocarcinoma.  Lymphatic or hematogenous spread can occur early in the process and lead to systemic disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectal Mucinous Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Rectal Mucinous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma of the rectum characterized by the presence of pools of extracellular mucin.  Malignant glandular epithelial cells are present in the mucin collections.  Mucin constitutes more than 50% of the lesion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renal cell carcinoma, unclassified</VALIDVALUE>
          <VALUEMEANING>Unclassified Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A renal cell carcinoma that cannot be classified into one of the established subtypes of renal cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5118711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renal medullary carcinoma</VALIDVALUE>
          <VALUEMEANING>Kidney Medullary Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A recently described type of renal carcinoma, affecting mostly young African-Americans.  It is located in the medulla of the kidney, and follows an aggressive clinical course.  Most reported cases have shown metastatic disease at the time of diagnosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7572</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5210416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rhabdomyosarcoma</VALIDVALUE>
          <VALUEMEANING>Rhabdomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265253</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Salivary duct carcinoma</VALIDVALUE>
          <VALUEMEANING>Salivary Duct Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive, high grade adenocarcinoma that arises from the salivary glands. It usually affects elderly males and presents as a rapidly enlarging mass. It metastasizes to regional lymph nodes and distant anatomic sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Salivary oncocytic carcinoma</VALIDVALUE>
          <VALUEMEANING>Salivary Gland Oncocytic Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A high grade adenocarcinoma that arises from the salivary glands. The vast majority of cases have been described in the parotid gland.  It is characterized by the presence of malignant oncocytes.  It recurs and metastasizes to regional or distant anatomic sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6921703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma; endometrial; stromal; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Endometrial Stromal Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A malignant, infiltrating mesenchymal tumor arising from the uterine corpus, cervix, vagina, and the ovary. Based on its morphologic characteristics, it is classified as either a low grade or an undifferentiated (high grade) stromal sarcoma. The low grade endometrial stromal sarcoma is characterized by the presence of oval to spindle-shape cells that resemble the cells of the endometrial stroma, without evidence of significant atypia and pleomorphism. Numerous small vessels are also present. The undifferentiated stromal sarcoma is characterized by an aggressive clinical course, the presence of significant cellular atypia, pleomorphism, and high mitotic activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8973, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9118, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma; pleomorphic cell</VALIDVALUE>
          <VALUEMEANING>Pleomorphic Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring in various distinct forms.  In terms of cells, having variation in the size and shape of cells or their nuclei.: A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9118, C28109</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sarcoma; stromal; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Stromal Sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A malignant neoplasm characterized by the presence of atypical mesenchymal-stromal cells. Representative examples include endometrial stromal sarcoma and prostate stromal sarcoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6926, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Digestive system mixed adenoneuroendocrine carcinoma</VALIDVALUE>
          <VALUEMEANING>Digestive System Mixed Adenoneuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that arises from the digestive system and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30% of either component should be present for the diagnosis to be made.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6324219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastric mixed adenoneuroendocrine carcinoma</VALIDVALUE>
          <VALUEMEANING>Gastric Mixed Adenoneuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma that arises from the stomach and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95886</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6270494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Undifferentiated ovarian carcinoma</VALIDVALUE>
          <VALUEMEANING>Undifferentiated Ovarian Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive carcinoma arising from the ovary.  Most patients present with advanced disease.  Microscopically, it is characterized by significant cytologic atypia, increased mitotic activity, and necrosis.  The prognosis is usually poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5210913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypopharyngeal squamous cell carcinoma</VALIDVALUE>
          <VALUEMEANING>Hypopharyngeal Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A squamous cell carcinoma arising from the hypopharynx.  Signs and symptoms include dysphagia, hemoptysis, and the presence of a neck mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4043</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immature teratoma</VALIDVALUE>
          <VALUEMEANING>Immature Ovarian Teratoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An immature teratoma arising from the ovary.  It usually affects females in their first two decades of life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8111</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692774</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate MB</VALIDVALUE>
          <VALUEMEANING>Indeterminate Medulloblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.: A malignant, invasive embryonal neoplasm arising from the cerebellum. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3222, C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6004379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infiltrating Carcinoma NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Invasive Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women. --2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9245, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infiltrating Ductal Carcinoma</VALIDVALUE>
          <VALUEMEANING>Invasive Ductal Carcinoma, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>Invasive ductal carcinoma is the most common type of invasive breast carcinoma (accounting for approximately 70% of breast carcinomas). The gross appearance is usually typical with an irregular stellate outline. Microscopically, randomly arranged epithelial elements are seen. When large sheets of malignant cells are present, necrosis may be seen. With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma. The in situ component is nearly always ductal but occasionally may be lobular or both. --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infiltrating Lobular Carcinoma</VALIDVALUE>
          <VALUEMEANING>Invasive Lobular Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An infiltrating lobular adenocarcinoma.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures. --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammatory &#39;MFH&#39; / Undifferentiated pleomorphic sarcoma with prominent inflammation</VALIDVALUE>
          <VALUEMEANING>Inflammatory Malignant Fibrous Histiocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive sarcoma characterized by the presence of occasional atypical cells which are admixed with numerous inflammatory cells.  The most common site of involvement is the retroperitoneum. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3836183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inflammatory myofibroblastic tumor</VALIDVALUE>
          <VALUEMEANING>Inflammatory Myofibroblastic Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>A multinodular intermediate fibrocytic neoplasm that arises from soft tissue or viscera, in children and young adults.  It is characterized by the presence of spindle-shaped myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3249211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intermediate Atypical Carcinoma</VALIDVALUE>
          <VALUEMEANING>Intermediate Atypical Prostate Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive, castration-resistant, histologically distinct, metastatic carcinoma arising from the prostate gland. It is characterized by the presence of a pure population of cytologically bland malignant epithelial cells with moderate to abundant cytoplasm and rare mitotic figures. The prognosis is poor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5916883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intestinal adenocarcinoma, colonic pattern</VALIDVALUE>
          <VALUEMEANING>Sinonasal Adenocarcinoma, Intestinal-Type with Colonic Pattern</VALUEMEANING>
          <MEANINGDESCRIPTION>An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a tubuloglandular growth pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785145</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intestinal adenocarcinoma, mixed pattern</VALIDVALUE>
          <VALUEMEANING>Sinonasal Adenocarcinoma, Intestinal-Type with Mixed Pattern</VALUEMEANING>
          <MEANINGDESCRIPTION>An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a mixture of growth patterns.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intestinal adenocarcinoma, mucinous pattern</VALIDVALUE>
          <VALUEMEANING>Sinonasal Adenocarcinoma, Intestinal-Type with Mucinous Pattern</VALUEMEANING>
          <MEANINGDESCRIPTION>An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of malignant glandular cells with intracytoplasmic mucin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160995</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785143</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intestinal adenocarcinoma, papillary pattern</VALIDVALUE>
          <VALUEMEANING>Sinonasal Adenocarcinoma, Intestinal-Type with Papillary Pattern</VALUEMEANING>
          <MEANINGDESCRIPTION>An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a papillary growth pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160984</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intestinal adenocarcinoma, solid pattern</VALIDVALUE>
          <VALUEMEANING>Sinonasal Adenocarcinoma, Intestinal-Type with Solid Pattern</VALUEMEANING>
          <MEANINGDESCRIPTION>An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a solid growth pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraductal carcinoma</VALIDVALUE>
          <VALUEMEANING>Salivary Gland Low Grade Cribriform Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, low-grade adenocarcinoma that arises from the salivary glands.  It is characterized by the presence of cystic structures lined by ductal cells which are arranged in cribriform patterns.  Adjacent ducts show intraductal proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraductal papillary mucinous neoplasm (IPMN, main duct/mixed)</VALIDVALUE>
          <VALUEMEANING>Pancreatic Intraductal Papillary-Mucinous Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually slow-growing epithelial neoplasm with ductal differentiation that arises from the exocrine pancreas and grows mostly within the pancreatic ducts. Grossly, it is characterized by the presence of intraductal masses. Morphologically, there is proliferation of mucin-producing cells within the pancreatic ducts, intraductal accumulation of mucin, and a papillary growth pattern. It may be associated with the presence of an invasive carcinoma. It usually occurs in older patients. Signs and symptoms include epigastric pain, weight loss, jaundice, chronic pancreatitis, and diabetes mellitus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38342</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5611394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraductal papillary mucinous neoplasm (IPMN, Side duct)</VALIDVALUE>
          <VALUEMEANING>Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>An intraductal papillary-mucinous neoplasm of the pancreas that arises in one of the branches of the main pancreatic duct.  It usually has an indolent behavior.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5656781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraductal papillary neoplasm with an associated invasive carcinoma</VALIDVALUE>
          <VALUEMEANING>Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A papillary epithelial neoplasm that arises from the epithelium of the intrahepatic or extrahepatic bile ducts and it is associated with an invasive carcinomatous component.  For intraductal papillary neoplasms of the intrahepatic bile ducts, the carcinomatous component is an intrahepatic cholangiocarcinoma; for intraductal papillary neoplasms of the extrahepatic bile ducts, the carcinomatous component is an adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96810</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408776</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Invasive Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Marked by a tendency to spread, especially into healthy surrounding tissue.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C14159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4117371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive adenocarcinoma arising from IPMN</VALIDVALUE>
          <VALUEMEANING>Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of a focal or multifocal invasive carcinomatous component.  The invasive carcinoma is either colloid or ductal adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5983664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive carcinoma arising in MCN</VALIDVALUE>
          <VALUEMEANING>Pancreatic Invasive Mucinous Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A cystic epithelial neoplasm characterized by the presence of columnar mucin-producing epithelial cells, ovarian-type stroma formation, and a focal or extensive invasive carcinomatous component.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive Carcinoma With Ductal And Lobular Features</VALIDVALUE>
          <VALUEMEANING>Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ Invasive Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>The co-existence of ductal and lobular carcinoma in situ in the breast, without evidence of stromal invasion.: A carcinoma that is not confined to the epithelium, and has spread to the surrounding stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9480, C4195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3316553</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive Carcinoma: Type Cannot Be Determined</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Invasive Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A carcinoma that is not confined to the epithelium, and has spread to the surrounding stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9480, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3316550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive Cribiform Carcinoma</VALIDVALUE>
          <VALUEMEANING>Invasive Cribriform Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive Ductal Carcinoma</VALIDVALUE>
          <VALUEMEANING>Invasive Ductal Carcinoma, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>Invasive ductal carcinoma is the most common type of invasive breast carcinoma (accounting for approximately 70% of breast carcinomas). The gross appearance is usually typical with an irregular stellate outline. Microscopically, randomly arranged epithelial elements are seen. When large sheets of malignant cells are present, necrosis may be seen. With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma. The in situ component is nearly always ductal but occasionally may be lobular or both. --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive Lobular Carcinoma</VALIDVALUE>
          <VALUEMEANING>Invasive Lobular Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An infiltrating lobular adenocarcinoma.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures. --2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive Micropapillary Carcinoma</VALIDVALUE>
          <VALUEMEANING>Invasive Intraductal Micropapillary Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Marked by a tendency to spread especially into healthy tissue.: An intraductal papillary carcinoma in which the neoplastic epithelial cells are arranged in micropapillary patterns.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C5139, C14159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3316551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive Papillary Carcinoma</VALIDVALUE>
          <VALUEMEANING>Invasive Papillary Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Marked by a tendency to spread especially into healthy tissue.: A malignant epithelial neoplasm characterized by a papillary growth pattern. A papillary carcinoma may be composed of glandular cells (papillary adenocarcinoma), squamous cells (papillary squamous cell carcinoma), or transitional cells (papillary transitional cell carcinoma). Bladder carcinoma is a representative example of papillary transitional cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2927, C14159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3316552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Isolated intraductal carcinoma</VALIDVALUE>
          <VALUEMEANING>Isolation Intraductal Prostate Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A state of separation; the act of isolating something; setting something apart from others; marked by separation of or from usually contiguous elements.: An intra-acinar and/or intraductal neoplastic epithelial proliferation in the prostate gland that has some features of high-grade prostatic intraepithelial neoplasia but exhibits much greater architectural and/or cytological atypia, typically associated with high-grade, high-stage prostate carcinoma. (WHO 2016)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161022, C25549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6814232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney Chromophobe</VALIDVALUE>
          <VALUEMEANING>Chromophobe Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of carcinoma that comprises a minority of renal cell carcinomas.  It is characterized by loss of chromosomes 1 and Y.  Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical) or eosinophilic.  It has a much better prognosis than other renal cell carcinomas.  -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney Clear Cell Renal Carcinoma</VALIDVALUE>
          <VALUEMEANING>Conventional (Clear Cell) Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network.  The tumor may metastasize to unusual sites and late metastasis is common.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4033</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney Papillary Renal Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Papillary Renal Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma. -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large cell neuroendocrine carcinoma, HPV negative</VALIDVALUE>
          <VALUEMEANING>Human Papillomavirus Negative Large Cell Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that human papillomavirus has not been detected in a sample.: A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6875, C131488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large cell neuroendocrine carcinoma, HPV positive</VALIDVALUE>
          <VALUEMEANING>Human Papillomavirus Positive Large Cell Neuroendocrine Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that human papillomavirus has been detected in a sample.: A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6875, C128839</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leiomyosarcoma (LMS)</VALIDVALUE>
          <VALUEMEANING>Leiomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women. It is characterized by a proliferation of neoplastic spindle cells. Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3158</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leiomyosarcoma, epithelioid type</VALIDVALUE>
          <VALUEMEANING>Epithelioid Leiomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of leiomyosarcoma characterized by the presence of epithelioid round cells with eosinophilic to clear cytoplasm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3700</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leiomyosarcoma, myxoid type</VALIDVALUE>
          <VALUEMEANING>Myxoid Leiomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of leiomyosarcoma characterized by the presence of cellular pleomorphism, malignant cells with large nuclei, and a myxoid stroma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3701</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lentigo maligna melanoma</VALIDVALUE>
          <VALUEMEANING>Lentigo Maligna Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>(A melanoma of the skin characterized by single cell infiltration of the papillary dermis by atypical melanocytes, in a background of lentigo maligna changes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9151</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver - Fibrolamellar hepatocellular carcinoma</VALIDVALUE>
          <VALUEMEANING>Fibrolamellar Hepatocellular Carcinoma Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibrolamellar carcinoma is a distinctive morphologic variant of liver cell carcinoma seen predominantly in young patients without cirrhosis and associated with favorable prognosis.  The tumor cells are polygonal and deeply eosinophilic embedded in a fibrous stroma.  Over half of the fibrolamellar carcinomas are resectable, and the cure rate is about 50%.: A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392, C4131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lepidic predominant adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Lepidic Predominant Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A lung adenocarcinoma characterized by the presence of mildly and moderately differentiated adenocarcinoma cells across the alveolar walls with at least one focus of invasive carcinoma measuring more than 5 mm in greatest dimension.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4928891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver - Hepatocellular carcinoma</VALIDVALUE>
          <VALUEMEANING>Hepatocellular Carcinoma Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.: A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392, C3099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686429</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver - Hepatocholangiocarcinoma (mixed)</VALIDVALUE>
          <VALUEMEANING>Combined Hepatocellular Carcinoma and Cholangiocarcinoma Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare tumor containing unequivocal elements of both hepatocellular and cholangiocarcinoma that are intimately admixed.  This tumor should be distinguished from separate hepatocellular carcinoma and cholangiocarcinoma arising in the same liver.  The prognosis of this tumor is poor.: A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392, C3828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low grade serous carcinoma</VALIDVALUE>
          <VALUEMEANING>Low Grade Ovarian Serous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A slow-growing serous adenocarcinoma that arises from the ovary.  It usually originates from borderline neoplastic processes or adenofibromas.  It is characterized by the presence of low grade cytologic features and infrequent mitotic figures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105556</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6742163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Acinar Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Lung Acinar Cell Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: A secreting cell that lines an acinus (i.e. a small sac or sac-like structure).  A representative example is the acinar cell located in the pancreas that produces pancreatic enzymes and juices.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C13077, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Adenocarcinoma Mixed Subtype</VALIDVALUE>
          <VALUEMEANING>Lung Mixed Subtype Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: Involving or composed of different kinds.: Subtype; a group forming a type within a larger type.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C25696, C25259, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Adenocarcinoma- Not Otherwise Specified (NOS)</VALIDVALUE>
          <VALUEMEANING>Lung Not Otherwise Specified Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: Not characterized in any other way.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C19594, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Adenosquamous Carcinoma</VALIDVALUE>
          <VALUEMEANING>Adenosquamous Carcinoma Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma composed of malignant glandular cells and malignant squamous cells. : One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12468, C3727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3686427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Basaloid Squamous Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Squamous Cell Lung Carcinoma, Basaloid Variant</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of squamous cell lung carcinoma characterized by nuclear palisading. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Bronchioloalveolar Carcinoma Mucinous</VALIDVALUE>
          <VALUEMEANING>Lung Mucinous Bronchioloalveolar Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: containing or resembling mucin.: A well or moderately differentiated morphologic variant of lung adenocarcinoma characterized by tumor growth along the alveolar structures without stromal, vascular, or pleural invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2923, C14163, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Bronchioloalveolar Carcinoma Nonmucinous</VALIDVALUE>
          <VALUEMEANING>Lung Not Mucinous Bronchioloalveolar Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.: An operation in which a term denies or inverts the meaning of another term or construction.: containing or resembling mucin.: A well or moderately differentiated morphologic variant of lung adenocarcinoma characterized by tumor growth along the alveolar structures without stromal, vascular, or pleural invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2923, C14163, C25594, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139417</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Clear Cell Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Lung Clear Cell Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: A cell with empty-appearing cytoplasm when viewed with a light microscope.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C12478, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Clear Cell Squamous Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Squamous Cell Lung Carcinoma, Clear Cell Variant</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of squamous cell lung carcinoma characterized by the presence of clear cells. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Fetal Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Lung Fetus Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: An unborn or unhatched vertebrate in the later stages of development showing the main recognizable features of the mature animal.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C13235, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Micropapillary Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Lung Micropapillary Pattern Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border._A morphologic finding indicating the presence of a growth pattern dominated by the presence of small papillary structures._A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C36181, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Mucinous Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Lung Mucinous Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: containing or resembling mucin.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C14163, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Mucinous Cystadenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Lung Mucinous Cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: containing or resembling mucin.: A malignant cystic epithelial neoplasm arising from the glandular epithelium.  The malignant epithelial cells invade the stroma.  The cystic spaces contain serous or mucinous fluid.  Representative examples include ovarian and pancreatic cystadenocarcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2971, C14163, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Papillary Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Lung Papillary Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: of or relating to or resembling papilla.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C14166, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Signet Ring Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Lung Signet Ring Cell Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: An epithelial neoplastic cell containing cytoplasmic mucin. The presence of mucin pushes the nucleus of the cell to the periphery, assuming a configuration resembling a signet ring.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C12487, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Small Cell Squamous Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Squamous Cell Lung Carcinoma, Small Cell Variant</VALUEMEANING>
          <MEANINGDESCRIPTION>A poorly differentiated morphologic variant of squamous cell lung carcinoma characterized by the presence of small tumor cells with focal squamous differentiation. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Solid Pattern Predominant Adenocarcinoma</VALIDVALUE>
          <VALUEMEANING>Lung Solid Pattern Dominant Adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.: The state in which a substance has no tendency to flow under moderate stress; resists forces (such as compression) that tend to deform it; and retains a definite size and shape.: Pattern; anything characterized by repetition.: Exercising influence or control.: carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2852, C25487, C25336, C45300, C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Squamous Cell Lung Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A carcinoma arising from malignant squamous bronchial epithelial cells and characterized by the presence of keratinization and/or intercellular bridges.  Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3493, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoepithelial carcinoma</VALIDVALUE>
          <VALUEMEANING>Nasopharyngeal Type Undifferentiated Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A nonkeratinizing carcinoma which occurs predominantly in the nasopharynx but also in the tonsils and rarely in other anatomic sites.  It is characterized by the presence of large malignant cells with vesicular nuclei, prominent nucleoli, syncytial growth pattern, and a lymphoplasmacytic infiltrate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4107</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma; B-cell; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified B-Cell Neoplasm Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A type of cancer that forms in B cells (a type of immune system cell). B-cell lymphomas usually occur in adults and may be either indolent (slow-growing) or aggressive (fast-growing). There are many different types of B-cell lymphomas, and prognosis and treatment depend on the type and stage of cancer.: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3208, C27907, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma; mantle cell</VALIDVALUE>
          <VALUEMEANING>Mantle Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive, usually diffuse non-Hodgkin lymphoma composed of small to medium sized B-lymphocytes (centrocytes).  Most patients present with advanced stage disease with lymphadenopathy, hepatosplenomegaly, and bone marrow involvement.  The gastrointestinal tract is the most commonly affected extranodal site by this type of non-Hodgkin lymphoma.  The vast majority of cases express the t(11;14)(q13;q32) resulting in the rearrangement of the BCL-1 gene and the overexpression of cyclin D1 mRNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4337</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma; marginal zone; splenic; NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Splenic Marginal Zone B-Cell Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A B-cell non-Hodgkin lymphoma composed of small lymphocytes which surround and replace the splenic white pulp germinal centers.  It involves the spleen and splenic hilar lymph nodes, bone marrow, and often the peripheral blood.  The patients present with splenomegaly and the clinical course is indolent.  (WHO, 2001) -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4663, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma; plasmablastic</VALIDVALUE>
          <VALUEMEANING>Plasmablastic Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive diffuse large B-cell lymphoma usually arising in the setting of HIV infection and characterized by the presence of large neoplastic cells resembling B-immunoblasts which have the immunophenotypic profile of plasma cells.  Sites of involvement include the oral cavity, sinonasal cavity, skin, soft tissues, gastrointestinal tract, and bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malignant Peripheral Nerve Sheath Tumors (MPNST)</VALIDVALUE>
          <VALUEMEANING>Malignant Peripheral Nerve Sheath Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malignant perivascular epithelioid cell tumor</VALIDVALUE>
          <VALUEMEANING>Malignant Perivascular Epithelioid Cell Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.: A perivascular cell with abundant clear or eosinophilic cytoplasm that contains glycogen. -- 2005: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3262, C45634, C14143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Marginal zone lymphoma, NOS</VALIDVALUE>
          <VALUEMEANING>Marginal Zone Lymphoma Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>A usually indolent mature B-cell lymphoma, arising from the marginal zone of lymphoid tissues.  It is characterized by the presence of small to medium sized atypical lymphocytes.  It comprises three entities, according to the anatomic sites involved: extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue, which affects extranodal sites (most often stomach, lung, skin, and ocular adnexa); nodal marginal zone B-cell lymphoma, which affects lymph nodes without evidence of extranodal disease; and splenic marginal zone B-cell lymphoma, which affects the spleen and splenic hilar lymph nodes, bone marrow, and often the peripheral blood.: Not characterized in any other way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594, C4341</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medullary Carcinoma</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland Medullary Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neuroendocrine carcinoma arising from the C-cells of the thyroid gland.  It is closely associated with multiple endocrine neoplasia syndromes.  Approximately 10% to 20% of medullary thyroid carcinomas are familial.  Patients usually present with a thyroid nodule that is painless and firm.  In the majority of cases nodal involvement is present at diagnosis.  Surgery is the preferred treatment for both primary lesions and recurrences.  This carcinoma is generally not very sensitive to radiation and almost unresponsive to chemotherapy.  - 2002</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3879</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2861420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medullary Carcinoma, NOS</VALIDVALUE>
          <VALUEMEANING>Medullary Carcinoma, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>A term referring to medullary carcinomas which can develop in various anatomic sites such as the thyroid gland, breast, colon, rectum, and small intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3248489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melanoma</VALIDVALUE>
          <VALUEMEANING>Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melanoma arising from blue nevus</VALIDVALUE>
          <VALUEMEANING>Blue Nevus-Like Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A melanoma of the skin resembling a benign blue nevus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melanoma arising in a giant congenital nevus</VALIDVALUE>
          <VALUEMEANING>Melanoma Arising in Giant Congenital Nevus</VALUEMEANING>
          <MEANINGDESCRIPTION>A melanoma arising in a giant congenital melanocytic nevus. The risk of developing a melanoma in a giant congenital melanocytic nevus has been reported to be between 5% and 50%. The incidence of developing melanoma is higher before the age of 10 and in adult life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4235</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melanoma, NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3224, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6408777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesothelioma</VALIDVALUE>
          <VALUEMEANING>Mesothelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A neoplasm characterized by the proliferation of neoplastic mesothelial cells. It usually arises from the pleura or peritoneum. This category includes malignant mesothelioma, adenomatoid tumor (benign mesothelioma), well differentiated papillary mesothelial tumor, and multicystic mesothelioma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung Papillary Squamous Cell Carcinoma</VALIDVALUE>
          <VALUEMEANING>Squamous Cell Lung Carcinoma, Papillary Variant</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of squamous cell lung carcinoma characterized by the presence of papillary structures. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glioma</VALIDVALUE>
          <VALUEMEANING>Glioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3059</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meningioma</VALIDVALUE>
          <VALUEMEANING>Meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade I tumors, and some are WHO grade II or III tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3230</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265263</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ovarian Carcinoma</VALIDVALUE>
          <VALUEMEANING>Ovarian Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive poorly diff adenoma</VALIDVALUE>
          <VALUEMEANING>Invasive Poorly Differentiated Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Marked by a tendency to spread, especially into healthy surrounding tissue._Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread._A neoplasm arising from the epithelium.  It may be encapsulated or non-encapsulated but non-invasive.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  In the gastrointestinal tract, when dysplasia becomes severe it is sometimes called carcinoma in situ.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2855, C14167, C14159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14891601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive moderately diff adenoma</VALIDVALUE>
          <VALUEMEANING>Invasive Moderately Differentiated Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Marked by a tendency to spread, especially into healthy surrounding tissue._Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells._A neoplasm arising from the epithelium.  It may be encapsulated or non-encapsulated but non-invasive.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  In the gastrointestinal tract, when dysplasia becomes severe it is sometimes called carcinoma in situ.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2855, C14162, C14159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14891600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poorly differentiated adenoma</VALIDVALUE>
          <VALUEMEANING>Poorly Differentiated Adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread._A neoplasm arising from the epithelium.  It may be encapsulated or non-encapsulated but non-invasive.  The neoplastic epithelial cells may or may not display cellular atypia or dysplasia.  In the gastrointestinal tract, when dysplasia becomes severe it is sometimes called carcinoma in situ.  Representative examples are pituitary gland adenoma, follicular adenoma of the thyroid gland, and adenomas (or adenomatous polyps) of the gastrointestinal tract.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2855, C14167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14891599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other histologic type</VALIDVALUE>
          <VALUEMEANING>Other Histologic Type</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Refers to the type of tissue in which a tumor originated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C61478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3371402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous cell carcinoma with sarcomatoid/spindle cell features</VALIDVALUE>
          <VALUEMEANING>Spindle Cell Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A poorly differentiated squamous cell carcinoma characterized by the presence of malignant cells with spindle cell features.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27084</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13628739</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Histology</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPCE_QVAL_HISTO</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="943">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7802655</PUBLICID>
    <LONGNAME>HEAR-QL-26 2 Hard to Hear Friends at Recess Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>HEARQL26_2_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated response of whether it is hard to hear friends at recess, using a 5-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HEAR-QL:Hearing Environments And Reflection on Quality of Life Measurement for Children aged from Preschool through Adolescense;A. Umansky et al., J Am Acad Audiology</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7802654</PublicId>
      <PreferredName>7802646v1.0:7805077v1.0</PreferredName>
      <PreferredDefinition>A questionnaire designed to assess how a child is affected by their hearing loss, and to aid a clinician in determining where intervention is warranted to improve the child&#39;s overall wellbeing._A question about whether an individual has or had a hard time hearing their friends at recess._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Hearing Environments and Reflection on Quality of Life for Children Hard to Hear Friends at Recess Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7802646</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C183180</PreferredName>
        <Version>1</Version>
        <LongName>Hearing Environments and Reflection on Quality of Life for Children</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C183180</PREFERRED_NAME>
            <LONG_NAME>Hearing Environments and Reflection on Quality of Life for Children</LONG_NAME>
            <CON_ID>7801478</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7805077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C183218:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Hard to Hear Friends at Recess Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C183218</PREFERRED_NAME>
            <LONG_NAME>Hard to Hear Friends at Recess Question</LONG_NAME>
            <CON_ID>7801774</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HEAR-QL:Hearing Environments And Reflection on Quality of Life Measurement for Children aged from Preschool through Adolescense;A. Umansky et al., J Am Acad Audiology</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7801521</PublicId>
      <PreferredName>HEAR_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes from 0 (Almost Always) to 4 (Never) on a 5-point Likert scale.</PreferredDefinition>
      <LongName>Hearing Environments And Reflection on Quality of Life 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>HEAR-QL:Hearing Environments And Reflection on Quality of Life Measurement for Children aged from Preschool through Adolescense;A. Umansky et al., J Am Acad Audiology</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Almost All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened almost all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Almost Never</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something rarely happens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2889147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Often</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something occurs frequently.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5628246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hearing Environments and Reflection on Quality of Life for Children</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #2 of 26</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Do you have a hard time heari</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Do you have a hard time hearing your friends at recess?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HEAR-QL-26</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900312</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7801527</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HEAR-QL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HEAR-QL-26</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7801529</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="944">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7805108</PUBLICID>
    <LONGNAME>HEAR-QL-26 10 Hard to Hear My Family Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>HEARQL26_10_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated response of whether it is hard to hear their family, using a 5-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HEAR-QL:Hearing Environments And Reflection on Quality of Life Measurement for Children aged from Preschool through Adolescense;A. Umansky et al., J Am Acad Audiology</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7805107</PublicId>
      <PreferredName>7802646v1.0:7805105v1.0</PreferredName>
      <PreferredDefinition>A questionnaire designed to assess how a child is affected by their hearing loss, and to aid a clinician in determining where intervention is warranted to improve the child&#39;s overall wellbeing._A question about whether an individual has or had a hard time hearing their family._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Hearing Environments and Reflection on Quality of Life for Children Hard to Hear My Family Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7802646</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C183180</PreferredName>
        <Version>1</Version>
        <LongName>Hearing Environments and Reflection on Quality of Life for Children</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C183180</PREFERRED_NAME>
            <LONG_NAME>Hearing Environments and Reflection on Quality of Life for Children</LONG_NAME>
            <CON_ID>7801478</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7805105</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C183226:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Hard to Hear My Family Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C183226</PREFERRED_NAME>
            <LONG_NAME>Hard to Hear My Family Question</LONG_NAME>
            <CON_ID>7801783</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HEAR-QL:Hearing Environments And Reflection on Quality of Life Measurement for Children aged from Preschool through Adolescense;A. Umansky et al., J Am Acad Audiology</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7801521</PublicId>
      <PreferredName>HEAR_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes from 0 (Almost Always) to 4 (Never) on a 5-point Likert scale.</PreferredDefinition>
      <LongName>Hearing Environments And Reflection on Quality of Life 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>HEAR-QL:Hearing Environments And Reflection on Quality of Life Measurement for Children aged from Preschool through Adolescense;A. Umansky et al., J Am Acad Audiology</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Almost All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened almost all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Almost Never</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something rarely happens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2889147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Often</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something occurs frequently.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5628246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is it hard to hear your famil</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is it hard to hear your family (mom, dad, brother, sister)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hearing Environments and Reflection on Quality of Life for Children</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #10 of 26</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HEAR-QL-26</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900312</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7801527</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HEAR-QL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HEAR-QL-26</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7801529</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="945">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7847615</PUBLICID>
    <LONGNAME>Variant Allele Frequency ALK Positive Present Percentage Value</LONGNAME>
    <PREFERREDNAME>VAR_ALEL_FRQ_ALK_PCT_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>A percentage value to describe the ALK positive variant allele frequency.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7847607</PublicId>
      <PreferredName>6430144v1.0:7847605v1.0</PreferredName>
      <PreferredDefinition>The relative rate of occurrence of a specific variant allele within a population._Indicates that ALK expression has been detected in a sample._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Variant Allele Frequency ALK Positive Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435027</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16612</PreferredName>
        <Version>1</Version>
        <LongName>Gene</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6430144</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C154665</PreferredName>
        <Version>1</Version>
        <LongName>Variant Allele Frequency</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C154665</PREFERRED_NAME>
            <LONG_NAME>Variant Allele Frequency</LONG_NAME>
            <CON_ID>6425598</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7847605</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C128831:C25626</PreferredName>
        <Version>1</Version>
        <LongName>ALK Positive Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C128831</PREFERRED_NAME>
            <LONG_NAME>ALK Positive</LONG_NAME>
            <CON_ID>5476715</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2199529</PublicId>
      <PreferredName>PTG_VAL</PreferredName>
      <PreferredDefinition>A fraction or ratio with 100 understood as the denominator._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Percentage Value</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the percentage value</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the percentage value for the ALK positive variant allele frequency?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If tumor is positive for activating variant, what was the variant allele frequency?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="946">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7847771</PUBLICID>
    <LONGNAME>Person Other Than Health Care Professional Essential Worker Indicator</LONGNAME>
    <PREFERREDNAME>PRSN_NOT_HCP_EW_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>An indication whether or not the person is employed as an essential worker other than in healthcare.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7847768</PublicId>
      <PreferredName>2236731v1.0:7847766v1.0</PreferredName>
      <PreferredDefinition>A human being._Distinct from those already mentioned, listed, or considered._A person qualified to be engaged in activity directed at preservation of mental and physical health by diseases prevention and treatment as a source of livelihood._A worker employed in operations and services that are essential to ensure the continuity of critical infrastructure operations.</PreferredDefinition>
      <LongName>Person Other Than Health Care Professional Essential Worker</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7847766</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C151896:C53287:C179411</PreferredName>
        <Version>1</Version>
        <LongName>Other Than Health Care Professional Essential Worker</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C151896</PREFERRED_NAME>
            <LONG_NAME>Other Than</LONG_NAME>
            <CON_ID>6349268</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53287</PREFERRED_NAME>
            <LONG_NAME>Health Care Professional</LONG_NAME>
            <CON_ID>2713416</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C179411</PREFERRED_NAME>
            <LONG_NAME>Essential Worker</LONG_NAME>
            <CON_ID>7653763</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7557024</PublicId>
      <PreferredName>YES_NO_UNK_IND</PreferredName>
      <PreferredDefinition>The Value Domain with LOINC codes to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LA4489-6</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2960664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LA32-8</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LA33-6</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Are you a frontline or essent</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Are you a frontline or essential worker other than healthcare?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7244861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COVID-19</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>8038915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7244861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COVID-19</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Project 5 CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>8038916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7977821</PublicId>
          <ContextName>NIH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Project 5 COVID</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tier 1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7977823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Other Frontline or Essential Worker Indicator</AlternateName>
        <AlternateNameType>NIH COVID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="947">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7848501</PUBLICID>
    <LONGNAME>COVID-19 Infection Psychosocial Effect Symptom Type</LONGNAME>
    <PREFERREDNAME>COV_PSYCH_SYMP_TYP</PREFERREDNAME>
    <PREFERREDDEFINITION>A textual description of the physical, psychological, cognitive symptom or social consequence of the disease, including stigmatization of persons affected.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7848488</PublicId>
      <PreferredName>7848486v1.0:2425598v1.0</PreferredName>
      <PreferredDefinition>An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction._Having to do with the physical, psychological, cognitive, and social consequences of disease, including stigmatization of persons affected._Subjective evidence of disease perceived by the patient.</PreferredDefinition>
      <LongName>COVID-19 Infection Psychosocial Effect Symptom</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7848486</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C171133:C17873</PreferredName>
        <Version>1</Version>
        <LongName>COVID-19 Infection Psychosocial Effect</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C171133</PREFERRED_NAME>
            <LONG_NAME>COVID-19 Infection</LONG_NAME>
            <CON_ID>7252794</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17873</PREFERRED_NAME>
            <LONG_NAME>Psychosocial Effect</LONG_NAME>
            <CON_ID>2918885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2425598</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4876</PreferredName>
        <Version>1</Version>
        <LongName>Symptom</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7848492</PublicId>
      <PreferredName>PSYCHO_SYMP_TYP</PreferredName>
      <PreferredDefinition>Having to do with the physical, psychological, cognitive, and social consequences of disease, including stigmatization of persons affected._Subjective evidence of disease perceived by the patient._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Psychosocial Effect Symptom Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>120</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>7848491</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17873:C4876:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Psychosocial Effect Symptom Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17873</PREFERRED_NAME>
            <LONG_NAME>Psychosocial Effect</LONG_NAME>
            <CON_ID>2918885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, Specify</VALIDVALUE>
          <VALUEMEANING>If Other, Specify</VALUEMEANING>
          <MEANINGDESCRIPTION>A directive to specify when the listed responses are not sufficient.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7557010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Feeling that they have been treated differently because of COVID-19</VALIDVALUE>
          <VALUEMEANING>Feeling of Being Treated Differently</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual feels that they have been treated differently.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178624</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Comfortable with the amount of preparation for COVID-19 in their community or neighborhood by the local government</VALIDVALUE>
          <VALUEMEANING>Comfortable with Local Government Preparation</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is comfortable with the amount of preparation by the local government for their community or neighborhood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Worried that if they get sick they will not be able to get good medical care</VALIDVALUE>
          <VALUEMEANING>Worried about Not Getting Good Medical Care if Sick</VALUEMEANING>
          <MEANINGDESCRIPTION>A question about whether an individual is worried that they will not be able to get good medical care if they get sick.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Staying at home more than they are used to</VALIDVALUE>
          <VALUEMEANING>Staying Home More than Usual</VALUEMEANING>
          <MEANINGDESCRIPTION>A question about whether an individual is staying home more than they used to.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Worried that COVID-19 will make them unable to pay their bills</VALIDVALUE>
          <VALUEMEANING>Worried about Being Unable to Pay Bills</VALUEMEANING>
          <MEANINGDESCRIPTION>A question about whether an individual is worried that something will make them unable to pay their bills.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Worried about working at home, taking sick leave, or being asked to take sick leave because of COVID-19</VALIDVALUE>
          <VALUEMEANING>Worried about Working at Home or Taking or Being Asked to Take Sick Leave</VALUEMEANING>
          <MEANINGDESCRIPTION>A question about whether an individual is worried about working at home, taking sick leave, or being asked to take sick leave.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178621</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Worried that COVID-19 will affect their health</VALIDVALUE>
          <VALUEMEANING>Worried that it will Affect Health</VALUEMEANING>
          <MEANINGDESCRIPTION>A question about whether an individual is worried that something will affect their health.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C178620</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the psychosocial sym</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the psychosocial symptom of COVID-19 infection?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>As a consequence of the COVID-19 pandemic, has the person been:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>As a consequence of the COVID-19 pandemic, has the person been:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7244861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COVID-19</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>8038915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7244861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COVID-19</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Project 5 CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>8038916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7977821</PublicId>
          <ContextName>NIH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Project 5 COVID</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tier 1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7977823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COVID-19 Psychosocial Symptom Type</AlternateName>
        <AlternateNameType>NIH COVID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="948">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7849205</PUBLICID>
    <LONGNAME>Physical Examination Finding Type</LONGNAME>
    <PREFERREDNAME>PHY_EXM_FND_TYP</PREFERREDNAME>
    <PREFERREDDEFINITION>The findings observed during a physical exam.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3143255</PublicId>
      <PreferredName>PGYS_EXAM_FINDING</PreferredName>
      <PreferredDefinition>The results of a physical examination</PreferredDefinition>
      <LongName>Physical Examination Finding</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2411342</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20989</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2774081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61036</PreferredName>
        <Version>1</Version>
        <LongName>Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61036</PREFERRED_NAME>
            <LONG_NAME>Investigation Finding</LONG_NAME>
            <CON_ID>2528540</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7849185</PublicId>
      <PreferredName>PHY_EXAM_FND_TYP</PreferredName>
      <PreferredDefinition>A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual&#39;s health assessment._Clinical, laboratory or molecular evidence, or absence of evidence of disease._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Physical Examination Finding Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>115</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>7849184</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20989:C3367:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Physical Examination Finding Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3367</PREFERRED_NAME>
            <LONG_NAME>Finding</LONG_NAME>
            <CON_ID>2202448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdominal pain</VALIDVALUE>
          <VALUEMEANING>Abdominal Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Painful sensation in the abdominal region. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alopecia (hair loss)</VALIDVALUE>
          <VALUEMEANING>Alopecia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hair loss usually from the scalp. It may result in bald spots or spread to the entire scalp or the entire epidermis. It may be androgenetic or caused by chemotherapeutic agents, compulsive hair pulling, autoimmune disorders or congenital conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50575</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anorexia (decrease in appetite)</VALIDVALUE>
          <VALUEMEANING>Anorexia</VALUEMEANING>
          <MEANINGDESCRIPTION>Loss of appetite.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asymptomatic</VALIDVALUE>
          <VALUEMEANING>Asymptomatic</VALUEMEANING>
          <MEANINGDESCRIPTION>Without clinical signs or indications that raise the possibility of a particular disorder or dysfunction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blackouts</VALIDVALUE>
          <VALUEMEANING>Blacking Out</VALUEMEANING>
          <MEANINGDESCRIPTION>A temporary loss of consciousness or a temporary state of altered consciousness that results in memory loss.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C180702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cannot move and/or feel one side of body or face</VALIDVALUE>
          <VALUEMEANING>Hemiplegia Or Unilateral Numbness</VALUEMEANING>
          <MEANINGDESCRIPTION>Paralysis of one side of the body.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Having to do with one side of the body.: A loss of the sensation of feeling in an area of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34857, C28012, C37998, C64329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848824</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cephalgia (Headache)</VALIDVALUE>
          <VALUEMEANING>Headache</VALUEMEANING>
          <MEANINGDESCRIPTION>Pain in various parts of the head, not confined to the area of distribution of any nerve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34661</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Changes in hands and feet (Peripheral extremity changes) other than swelling</VALIDVALUE>
          <VALUEMEANING>Other Than Swelling Peripheral Limb Change</VALUEMEANING>
          <MEANINGDESCRIPTION>Distinct from those already mentioned, listed, or considered.: Enlargement; expansion in size; sign of inflammation: On or near an edge or constituting an outer boundary; the outer area.: A body region referring to an upper or lower extremity.: The act of alteration or modification; changed or altered in form or character.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25446, C12429, C25233, C3399, C151896</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest pain</VALIDVALUE>
          <VALUEMEANING>Chest Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Pain in the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chills</VALIDVALUE>
          <VALUEMEANING>Chills</VALUEMEANING>
          <MEANINGDESCRIPTION>Chills; a sensation of cold that often marks the start of an infection and the development of a fever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cognitive issues (Hypoxia - Impaired judgment, memory loss, impaired motor coordination)</VALIDVALUE>
          <VALUEMEANING>Hypoxia Problem Cognitive</VALUEMEANING>
          <MEANINGDESCRIPTION>A decrease in the amount of oxygen in the body. Symptoms range from mild (impaired judgment, memory loss, impaired motor coordination) to severe (seizures and coma).: A difficulty, disorder, or condition needing resolution.: Of or being or relating to or involving cognition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37926, C28020, C3890</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Conjunctivitis</VALIDVALUE>
          <VALUEMEANING>Conjunctivitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Conjunctivitis; inflammation of the conjunctiva of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cough</VALIDVALUE>
          <VALUEMEANING>Cough</VALUEMEANING>
          <MEANINGDESCRIPTION>A sudden, often repetitive, spasmodic contraction of the thoracic cavity, resulting in violent release of air from the lungs, and usually accompanied by a distinctive sound.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37935</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562655</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COVID-19-associated ageusia (loss of taste)</VALIDVALUE>
          <VALUEMEANING>COVID-19-Associated Ageusia</VALUEMEANING>
          <MEANINGDESCRIPTION>Ageusia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C173629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COVID-19-associated anosmia (smell)</VALIDVALUE>
          <VALUEMEANING>COVID-19-Associated Anosmia</VALUEMEANING>
          <MEANINGDESCRIPTION>Anosmia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C171558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7351149</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyanosis (bluish lips/face)</VALIDVALUE>
          <VALUEMEANING>Cyanosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A bluish or purplish discoloration of the skin and mucous membranes resulting from a reduced amount of oxygenated hemoglobin in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dizziness</VALIDVALUE>
          <VALUEMEANING>Dizziness</VALUEMEANING>
          <MEANINGDESCRIPTION>A sensation of lightheadedness, unsteadiness, turning, spinning or rocking.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37943</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5734015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dysphonia (hoarse voice)</VALIDVALUE>
          <VALUEMEANING>Dysphonia</VALUEMEANING>
          <MEANINGDESCRIPTION>A speech disorder resulting in impaired utterance of sounds by the vocal folds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848810</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dyspnea (shortness of breath)</VALIDVALUE>
          <VALUEMEANING>Dyspnea</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncomfortable sensation of difficulty breathing. It may present as an acute or chronic sign of an underlying respiratory or heart disorder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ear pain</VALIDVALUE>
          <VALUEMEANING>Earache</VALUEMEANING>
          <MEANINGDESCRIPTION>Earache; a pain localized in the middle or inner ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Expectoration (sputum production/increase of new phlegm)</VALIDVALUE>
          <VALUEMEANING>Expectorate</VALUEMEANING>
          <MEANINGDESCRIPTION>To clear material from the throat or lungs by coughing it up and spitting it out.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85859</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fatigue</VALIDVALUE>
          <VALUEMEANING>Fatigue</VALUEMEANING>
          <MEANINGDESCRIPTION>Overall tiredness and lack of energy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3036</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Feeling of heaviness in arms or legs</VALIDVALUE>
          <VALUEMEANING>Arm Or Leg Have Heaviness</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The portion of the lower extremity between the knee and the ankle. For clinical purposes this term is also used to refer to the whole inferior limb.: A question about whether an individual has or had heaviness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105776, C32974, C37998, C32141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemorrhage (bleeding)</VALIDVALUE>
          <VALUEMEANING>Hemorrhage</VALUEMEANING>
          <MEANINGDESCRIPTION>The flow of blood from a ruptured blood vessel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insomnia (difficulty sleeping)</VALIDVALUE>
          <VALUEMEANING>Insomnia</VALUEMEANING>
          <MEANINGDESCRIPTION>A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Irritability</VALIDVALUE>
          <VALUEMEANING>Irritability</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal responsiveness or morbid excitability of an organ, its part, or entire organism or its part to stimuli.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Joint pain</VALIDVALUE>
          <VALUEMEANING>Have Painful Joints</VALUEMEANING>
          <MEANINGDESCRIPTION>A question about whether an individual has or had painful joints.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848816</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphadenopathy (swollen glands)</VALIDVALUE>
          <VALUEMEANING>Lymphadenopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>An enlarged lymph node. Causes include viral and bacterial infections and cancers that affect the lymph nodes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4291752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Malaise</VALIDVALUE>
          <VALUEMEANING>Malaise</VALUEMEANING>
          <MEANINGDESCRIPTION>A feeling of general discomfort or uneasiness, an out-of-sorts feeling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myalgia (muscle pain)</VALIDVALUE>
          <VALUEMEANING>Myalgia</VALUEMEANING>
          <MEANINGDESCRIPTION>Painful sensation originating from a muscle or group of muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27009</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nausea and vomiting</VALIDVALUE>
          <VALUEMEANING>Nausea and Vomiting</VALUEMEANING>
          <MEANINGDESCRIPTION>Expelling the contents of the stomach and the sensations associated with it. They are symptoms of an underlying disease or condition and not a specific illness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3259</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Orthostasis (dizziness/lightheadedness/blackouts on sitting up or standing)</VALIDVALUE>
          <VALUEMEANING>Orthostatic Intolerance</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition characterized by development of symptoms while standing. It is an autonomic nervous system disorder and the symptoms are relieved once the person sits back down. Symptoms include heart palpitations, sweating, anxiety, lightheadedness, hyperpnea, anxiety, and blurred vision.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, Specify</VALIDVALUE>
          <VALUEMEANING>If Other, Specify</VALUEMEANING>
          <MEANINGDESCRIPTION>A directive to specify when the listed responses are not sufficient.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7557010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palpitations</VALIDVALUE>
          <VALUEMEANING>Palpitation</VALUEMEANING>
          <MEANINGDESCRIPTION>Palpitations; unpleasant sensation of irregular and/or forceful beating of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37999</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paresthesia (numbness or tingling somewhere in the body)</VALIDVALUE>
          <VALUEMEANING>Paresthesia</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal cutaneous sensations of tingling, numbness, pressure, cold, and warmth that an individual experiences without the presence of a stimulus. It results from functional disturbances of sensory neurons. Causes include peripheral vascular disease, peripheral neuropathy, and nerve damage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28177</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Problem with gait/falls</VALIDVALUE>
          <VALUEMEANING>Gait Disturbance Or Fall</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding referring to walking difficulties.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A sudden movement downward, usually resulting in injury.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50558, C37998, C78303</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Problems with balance</VALIDVALUE>
          <VALUEMEANING>Impaired Balance</VALUEMEANING>
          <MEANINGDESCRIPTION>A deficit in equilibrium, which may manifest as unsteady ambulation or inability to maintain an upright position.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122435</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rhinorrhea (nasal congestion or runny nose)</VALIDVALUE>
          <VALUEMEANING>Rhinorrhea</VALUEMEANING>
          <MEANINGDESCRIPTION>A discharge of fluid from the nose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rigors</VALIDVALUE>
          <VALUEMEANING>Rigor</VALUEMEANING>
          <MEANINGDESCRIPTION>Severe chills accompanied by vigorous shaking.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5229200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin rashes</VALIDVALUE>
          <VALUEMEANING>Skin Rash</VALUEMEANING>
          <MEANINGDESCRIPTION>Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sore throat</VALIDVALUE>
          <VALUEMEANING>Sore Throat</VALUEMEANING>
          <MEANINGDESCRIPTION>Any kind of inflammatory process of the tonsils, pharynx, or/and larynx characterized by pain in swallowing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Subjective fever</VALIDVALUE>
          <VALUEMEANING>Subjective Fever</VALUEMEANING>
          <MEANINGDESCRIPTION>A symptom report of fever without an objective temperature measurement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C173825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7374405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Swelling of hands or feet</VALIDVALUE>
          <VALUEMEANING>Hand Or Foot Swelling</VALUEMEANING>
          <MEANINGDESCRIPTION>The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The structure found below the ankle joint required for locomotion.: Enlargement; expansion in size; sign of inflammation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3399, C32622, C37998, C32712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Toe rashes (red/purple sores or blisters on the feet, including the toes)</VALIDVALUE>
          <VALUEMEANING>COVID Toes</VALUEMEANING>
          <MEANINGDESCRIPTION>A self-limited dermatologic manifestation seen on the toes of some patients with COVID-19 that resembles chilblains (perniosis). The lesions may be pink, red, blue or purple and have a similar appearance to frostbite. It appears to resolve once the infection has been cleared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172128</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Weight loss</VALIDVALUE>
          <VALUEMEANING>Weight Loss</VALUEMEANING>
          <MEANINGDESCRIPTION>A reduction in overall body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wheezing</VALIDVALUE>
          <VALUEMEANING>Wheezing</VALUEMEANING>
          <MEANINGDESCRIPTION>A symptom and a finding during physical examination, characterized by a high-pitched, whistling sound during breathing. It results from the narrowing or obstruction of the respiratory airways. The most common causes of wheezing are asthma, chronic obstructive pulmonary disease, tracheobronchitis, and pulmonary edema.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2943827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Xerosis (dry skin)</VALIDVALUE>
          <VALUEMEANING>Dry Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>The pores are generally fine with a papery thin texture that feels dry to the touch. Usually flaky and dull looking.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74592</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2919162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Persistent cough</VALIDVALUE>
          <VALUEMEANING>Persistent Cough</VALUEMEANING>
          <MEANINGDESCRIPTION>Retained; never-ceasing.: A sudden, often repetitive, spasmodic contraction of the thoracic cavity, resulting in violent release of air from the lungs, and usually accompanied by a distinctive sound.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37935, C43623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2976256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Forgetfulness</VALIDVALUE>
          <VALUEMEANING>Am Forgetful</VALUEMEANING>
          <MEANINGDESCRIPTION>A question about whether an individual is forgetful.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C173922</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7849186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trouble in concentrating</VALIDVALUE>
          <VALUEMEANING>Have Trouble Concentrating</VALUEMEANING>
          <MEANINGDESCRIPTION>A question about whether an individual has or had trouble concentrating.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99794</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7849187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Altered level of consciousness/confusion</VALIDVALUE>
          <VALUEMEANING>Altered Level of Consciousness Or Confusion</VALUEMEANING>
          <MEANINGDESCRIPTION>A level of awareness and arousal other than normal.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A mental state characterized by a lack of clear and orderly thought and behavior.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37928, C37998, C121627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7849188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Night Sweats</VALIDVALUE>
          <VALUEMEANING>Night Sweats</VALUEMEANING>
          <MEANINGDESCRIPTION>Nocturnal periods of profuse diaphoresis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3055865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Failure of expected linear growth</VALIDVALUE>
          <VALUEMEANING>Growth Failure</VALUEMEANING>
          <MEANINGDESCRIPTION>Less than normal linear growth in an infant or child.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113100</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7849190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Failure of expected weight gain</VALIDVALUE>
          <VALUEMEANING>History of Failure to Gain Weight</VALUEMEANING>
          <MEANINGDESCRIPTION>A history of less than normal weight gain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168252</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7849192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Muscle weakness</VALIDVALUE>
          <VALUEMEANING>Muscle Weakness</VALUEMEANING>
          <MEANINGDESCRIPTION>A reduction in the strength of one or more muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4394508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hallucinations (seeing or hearing things others dont see or hear) [should not be completed for children &lt;15yrs]</VALIDVALUE>
          <VALUEMEANING>Hallucination</VALUEMEANING>
          <MEANINGDESCRIPTION>A false sensory perception in the absence of an external stimulus, as distinct from an illusion which is a misperception of an external stimulus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37961</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Depressed mood</VALIDVALUE>
          <VALUEMEANING>Depressed Mood</VALUEMEANING>
          <MEANINGDESCRIPTION>An emotional state characterized by feelings of sadness, emptiness, and/or tearfulness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7849194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythema of the oral/pharyngeal mucosa</VALIDVALUE>
          <VALUEMEANING>Erythema of the Oropharyngeal Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>Erythema of the mucus membranes lining the part of the pharynx located between the soft palate and the upper portion of the epiglottis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C180690</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7849195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strawberry tongue</VALIDVALUE>
          <VALUEMEANING>Strawberry Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>A pathological finding in which inflammation, hyperemia and enlarged papillae of the dorsum of the tongue resemble a strawberry. It may be seen in variety of bacterial and viral disorders, and in non-infectious disorders such as Kawasaki disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168443</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7849197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Swollen, red, or cracked lips</VALIDVALUE>
          <VALUEMEANING>Cheilitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process affecting the lip.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oral mucosal change</VALIDVALUE>
          <VALUEMEANING>Oral Mucosa Change</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or relating to, or affecting, or for use in the mouth.: Mucous membrane.: The act of alteration or modification; changed or altered in form or character.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25446, C13166, C25311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7849198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical lymphadenopathy (at least 1.5 cm in diameter)</VALIDVALUE>
          <VALUEMEANING>Cervical Lymphadenopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Enlargement of the cervical lymph nodes usually due to infections or involvement by malignant neoplasms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40989</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7849200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intercostal retractions (lower chest wall indrawing)</VALIDVALUE>
          <VALUEMEANING>Intercostal Retractions</VALUEMEANING>
          <MEANINGDESCRIPTION>The marked inward movement of the muscles between the ribs during inhalation, indicating that there is reduced pressure in the thoracic cavity, and which can be a sign of breathing difficulties.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C87087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7849202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Crackles and rales</VALIDVALUE>
          <VALUEMEANING>Rales</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal breath sounds (crackles) heard on auscultation, indicating inflammation, fluid, or infection of the lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7849204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperpyrexia (fever &gt; 100.4 Degree F)</VALIDVALUE>
          <VALUEMEANING>Hyperpyrexia</VALUEMEANING>
          <MEANINGDESCRIPTION>Body temperature of 106 degrees Fahrenheit (41.1 degrees Celsius) or higher.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111817</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diarrhea (&gt;=3  loose stools/24 hr. period)</VALIDVALUE>
          <VALUEMEANING>Diarrhea</VALUEMEANING>
          <MEANINGDESCRIPTION>Watery bowel movements.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allodynia (pain out of proportion to the stimulus)</VALIDVALUE>
          <VALUEMEANING>Allodynia</VALUEMEANING>
          <MEANINGDESCRIPTION>Pain caused by a stimulus that would not normally provoke pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C180616</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anxiety</VALIDVALUE>
          <VALUEMEANING>Anxiety</VALUEMEANING>
          <MEANINGDESCRIPTION>Apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neck pains</VALIDVALUE>
          <VALUEMEANING>Neck Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Painful sensation in the neck area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50663</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945778</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What were the physical exam f</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What were the physical exam findings?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7244861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COVID-19</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>8038915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7244861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COVID-19</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Project 5 CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>8038916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7977821</PublicId>
          <ContextName>NIH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Project 5 COVID</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tier 1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7977823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Physical Exam Findings/Sign Type</AlternateName>
        <AlternateNameType>NIH COVID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="949">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7992806</PUBLICID>
    <LONGNAME>Hearing Devices Type</LONGNAME>
    <PREFERREDNAME>HR_AID_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>An indication of the type of hearing aid device used by a patient.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7992527</PublicId>
      <PreferredName>7800972v1.0:2223243v1.0</PreferredName>
      <PreferredDefinition>Devices that are used to enhance hearing._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Hearing Devices Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7800972</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C157872</PreferredName>
        <Version>1</Version>
        <LongName>Hearing Devices</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C157872</PREFERRED_NAME>
            <LONG_NAME>Hearing Devices</LONG_NAME>
            <CON_ID>7800971</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7992456</PublicId>
      <PreferredName>7992456v1.0</PreferredName>
      <PreferredDefinition>Devices that are used to enhance hearing._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Hearing Devices Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>300</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>7800975</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C157872:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Hearing Devices Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C157872</PREFERRED_NAME>
            <LONG_NAME>Hearing Devices</LONG_NAME>
            <CON_ID>7800971</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FM or DM system</VALIDVALUE>
          <VALUEMEANING>FM System Or DM Hearing Aid System</VALUEMEANING>
          <MEANINGDESCRIPTION>A wireless electronic device designed to improve hearing, especially in noisy environments, by transmitting sound over a distance from a microphone to a receiver using radio waves.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A wireless electronic device designed to improve hearing, especially in noisy environments, by transmitting sound over a distance from a microphone to a receiver using digital signals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C185116, C37998, C183183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7993455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BAHA device</VALIDVALUE>
          <VALUEMEANING>Bone-anchored Hearing Aid</VALUEMEANING>
          <MEANINGDESCRIPTION>A hearing device that includes a sound processor and a small titanium fixture that is surgically-implanted behind the ear to transfer sound vibrations to a functioning cochlea through direct bone conduction, typically in individuals with outer or middle ear malformations or unilateral hearing loss. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C185117</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7993456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CROS device</VALIDVALUE>
          <VALUEMEANING>Contralateral Routing of Signal Device</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of hearing aid designed for individuals with unilateral hearing loss that transmits sound from the abnormally functioning ear to the normally functioning ear without amplification using wired, wireless, or transcranial conduction. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C185115</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7993457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right ear cochlear implant</VALIDVALUE>
          <VALUEMEANING>Right Ear Cochlea Implant</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the east when facing north.: A sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contains the ossicles (malleus, incus and stapes). The inner ear is made up of the cochlea needed for hearing and the vestibular apparatus required for balance.: The part of the internal ear that is concerned with hearing. It forms the anterior part of the labyrinth, is conical, and is placed almost horizontally anterior to the vestibule.: A prosthesis placed permanently in tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41075, C12395, C12394, C25228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7992457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right ear hearing aid</VALIDVALUE>
          <VALUEMEANING>Right Ear Hearing Aid</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the east when facing north.: A sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contains the ossicles (malleus, incus and stapes). The inner ear is made up of the cochlea needed for hearing and the vestibular apparatus required for balance.: A battery-powered electronic device designed to improve hearing. Most are worn in or behind the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C183182, C12394, C25228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7992458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left ear hearing aid</VALIDVALUE>
          <VALUEMEANING>Left Ear Hearing Aid</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the west when facing north.: A sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contains the ossicles (malleus, incus and stapes). The inner ear is made up of the cochlea needed for hearing and the vestibular apparatus required for balance.: A battery-powered electronic device designed to improve hearing. Most are worn in or behind the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C183182, C12394, C25229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7992459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Audio streaming device</VALIDVALUE>
          <VALUEMEANING>Transmission Sound Device</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of sending a message; causing a message to be transmitted.: Mechanical vibrations transmitted by an elastic medium; the subjective sensation of hearing something; an audible event.: An object contrived for a specific purpose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62103, C64383, C71292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7992460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No longer use</VALIDVALUE>
          <VALUEMEANING>Discontinue Use</VALUEMEANING>
          <MEANINGDESCRIPTION>To stop or end, permanently or temporarily.: To put into action or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95018, C25484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7992461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never used</VALIDVALUE>
          <VALUEMEANING>Not Used</VALUEMEANING>
          <MEANINGDESCRIPTION>Not employed or utilized.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69062</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left ear cochlear implant</VALIDVALUE>
          <VALUEMEANING>Left Ear Cochlea Implant</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the west when facing north.: A sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contains the ossicles (malleus, incus and stapes). The inner ear is made up of the cochlea needed for hearing and the vestibular apparatus required for balance.: The part of the internal ear that is concerned with hearing. It forms the anterior part of the labyrinth, is conical, and is placed almost horizontally anterior to the vestibule.: A prosthesis placed permanently in tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41075, C12395, C12394, C25229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7992462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If you use a hearing device,</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If you use a hearing device, please indicate the type(s) of device(s) you use:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If your child wears a hearing device, please indicate the type(s) of device(s) that your child uses:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="950">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>8042087</PUBLICID>
    <LONGNAME>PROMIS Adult Physical Health Neuropathic Pain Quality PAQUAL31r Past 7 Days Pain Felt Electrical Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PROMIS_PAQUAL31r_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation in the past 7 days of whether their pain felt electrical, using a 5-point scale.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>8040111</PublicId>
      <PreferredName>16022163v1.00:8042103v1.00</PreferredName>
      <PreferredDefinition>A Patient Reported Outcomes Measurement Information System (PROMIS) domain that assesses the status of an individual&#39;s physical health._A five-item measure  to identify patients more likely to have neuropathic pain and to distinguish their levels of neuropathic pain.:The most recent week. May include the present day._A question about whether an individual&#39;s pain felt electrical._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>PROMIS Adult Physical Health Domain Neuropathic Pain Quality Scale Past Week Pain Felt Electrical Question Score</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>16022163</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C122346:C185388</PreferredName>
        <Version>1</Version>
        <LongName>PROMIS Adult Physical Health Domain Neuropathic Pain Quality Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122346</PREFERRED_NAME>
            <LONG_NAME>PROMIS Adult Physical Health Domain</LONG_NAME>
            <CON_ID>4860856</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C185388</PREFERRED_NAME>
            <LONG_NAME>Neuropathic Pain Quality Scale</LONG_NAME>
            <CON_ID>8029676</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>8042103</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C185386:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Pain Felt Electrical Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C185386</PREFERRED_NAME>
            <LONG_NAME>Pain Felt Electrical Question</LONG_NAME>
            <CON_ID>8029680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4633023</PublicId>
      <PreferredName>4633023v1.0</PreferredName>
      <PreferredDefinition>the PROMIS pain interference scale for rating a patient&#39;s pain during the last seven days.</PreferredDefinition>
      <LongName>PROMIS Adult Pain Interference 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDA</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did your pain feel electrical?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PROMIS Scale v2.0 – Neuropathic Pain Quality 5a</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #4 of 5</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4857911</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PROMIS Item Banks</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pain Quality</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>8046463</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pain Quality</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14951162</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="951">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>8049723</PUBLICID>
    <LONGNAME>Prior Third-Line Therapy Administered Agent Name</LONGNAME>
    <PREFERREDNAME>PRTX_THIRD_LN_NAM</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term used to represent the name of the prior third-line therapy administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>8049617</PublicId>
      <PreferredName>8049615v1.0:2233610v1.0</PreferredName>
      <PreferredDefinition>Earlier in time or order._Treatment that is given when both initial treatment (first-line therapy) and subsequent treatment (second-line therapy) don&#39;t work, or stop working._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Prior Third-Line Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>AMC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435016</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12218</PreferredName>
        <Version>1</Version>
        <LongName>Chemotherapy Regimen</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>8049615</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C94628</PreferredName>
        <Version>1</Version>
        <LongName>Prior Third-Line Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94628</PREFERRED_NAME>
            <LONG_NAME>Third-Line Therapy</LONG_NAME>
            <CON_ID>5555728</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AMC CRF:AIDS Malignancy Consortium Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2939030</PublicId>
      <PreferredName>PRI_TX_AGT_NM</PreferredName>
      <PreferredDefinition>Prior action or administration of therapeutic agents that produced an effect that is intended to alter or stop a pathologic process._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)_The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Prior Therapy Agent Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2939029</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16124:C1708:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Prior Therapy Agent Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16124</PREFERRED_NAME>
            <LONG_NAME>Prior Therapy</LONG_NAME>
            <CON_ID>2202433</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MEGF0444A</VALIDVALUE>
          <VALUEMEANING>MEGF0444A (Humanized IgG1 Antibody)</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized IgG1 monoclonal antibody directed against the epidermal growth factor-like domain multiple 7 (EGFL7) with potential antineoplastic activity. Parsatuzumab binds to EGFL7, thereby preventing the activities of EGFL7 on endothelial cells and inhibiting the survival and migration of endothelial cells during angiogenesis. EGFL7, a vascular-restricted extracellular matrix protein which is upregulated during angiogenesis and which regulates vascular development, may be overexpressed on the cell surfaces of various solid tumor cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90567</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3076402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Montelukast</VALIDVALUE>
          <VALUEMEANING>Montelukast Sodium (Singulair)</VALUEMEANING>
          <MEANINGDESCRIPTION>The monosodium salt of montelukast, a selective and orally active leukotriene receptor antagonist with anti-inflammatory and bronchodilator activity. Montelukast sodium selectively and competitively blocks the cysteinyl leukotriene 1 (CysLT1) receptor, thereby preventing leukotriene D4 from binding to its receptor. This prevents leukotriene-mediated activities, including enhanced migration of eosinophils and neutrophils, increased adhesion of leukocytes, increased monocyte and neutrophil aggregation, increased airway edema, increased capillary permeability and bronchoconstriction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmicort</VALIDVALUE>
          <VALUEMEANING>Budesonide</VALUEMEANING>
          <MEANINGDESCRIPTION>A glucocorticoid used in the management of asthma, the treatment of various skin disorders, and allergic rhinitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ipratropium</VALIDVALUE>
          <VALUEMEANING>Ipratropium</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of the alkaloid atropine with anticholinergic properties. Ipratropium antagonizes the actions of acetylcholine at parasympathetic postganglionic effector cell junctions. When inhaled, ipratropium binds competitively to cholinergic receptors in the bronchial smooth muscle thereby blocking the bronchoconstrictor actions of the acetylcholine (Ach) mediated vagal impulses. Inhibition of the vagal tone leads to dilation of the large central airways resulting in bronchodilation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61794</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3076449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Levalbuterol</VALIDVALUE>
          <VALUEMEANING>Levalbuterol (Xopenex)</VALUEMEANING>
          <MEANINGDESCRIPTION>A short-acting sympathomimetic beta-2 adrenergic receptor agonist with bronchodilator activity. Levalbuterol binds to beta-2 adrenergic receptors in bronchial smooth muscle and activates intracellular adenyl cyclase, an enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3&#39;,5&#39;-adenosine monophosphate (cAMP). Increased cAMP levels lead to the activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation of bronchial smooth muscles. The increased cAMP concentrations also inhibit the release of inflammatory mediators, especially from mast cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3076450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tiotropium</VALIDVALUE>
          <VALUEMEANING>Tiotropium Bromide Monohydrate</VALUEMEANING>
          <MEANINGDESCRIPTION>The monohydrate bromide salt form of tiotropium, a quaternary ammonium derivative of atropine and a long-acting muscarinic receptor antagonist, with bronchodilating activity. Upon inhalation, tiotropium binds to and blocks mainly muscarinic M3 receptors located on smooth muscle cells, thereby preventing smooth muscle contraction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3076452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Technetium Tc-99m Apcitide</VALIDVALUE>
          <VALUEMEANING>Technetium Tc-99m Apcitide</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioconjugate comprised of the small peptide apcitide labeled with the gamma-emitting technetium TC99m (metastable Tc-99). Apcitide binds to platelet glycoprotein (GP) GPIIb/IIIa receptors on the surface of activated platelets. Labeling apcitide with TC99m allows localization of thrombus formation by gamma-ray imaging equipment and the ability to distinguish between old, inactive thrombi and new, active thrombi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iodine-131</VALIDVALUE>
          <VALUEMEANING>Iodine I 131</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1639</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fostamatinib Disodium</VALIDVALUE>
          <VALUEMEANING>Fostamatinib Disodium</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available disodium salt of the Syk kinase inhibitor fostamatinib with potential anti-inflammatory and immunomodulating activities. Fostamatinib inhibits Syk kinase-mediated IgG Fc gamma receptor signaling, resulting in inhibition of the activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage. Syk kinase, widely expressed in hematopoietic cells, is a nonreceptor tyrosine kinase that is involved in coupling activated immunoreceptors to signal downstream events that mediate diverse cellular responses, including proliferation, differentiation, and phagocytosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69128</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-IGF-1R Recombinant Monoclonal Antibody SCH 717454</VALIDVALUE>
          <VALUEMEANING>Anti-IGF-1R Recombinant Monoclonal Antibody SCH 717454</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, fully human monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Anti-IGF-1R fully human monoclonal antibody SCH 717454 binds to membrane-bound IGF-1R, preventing binding of the ligand IGF-1 and the subsequent triggering of the PI3K/Akt signaling pathway; downregulation of this survival pathway may result in the induction of apoptosis and decreased cellular proliferation. The activation of IGF-1R, a tyrosine kinase and a member of the insulin receptor family, stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis; IGF-1R signaling has been highly implicated in tumorigenesis and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2958646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine</VALIDVALUE>
          <VALUEMEANING>Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine</VALUEMEANING>
          <MEANINGDESCRIPTION>Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-11-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2958647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRICOM</VALIDVALUE>
          <VALUEMEANING>TRICOM</VALUEMEANING>
          <MEANINGDESCRIPTION>TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3).  An immunostimulant.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3013193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ch 14.18 Monoclonal Antibody</VALIDVALUE>
          <VALUEMEANING>Ch 14.18 Monoclonal Antibody (Anti-GD-2 Monoclonal Antibody)</VALUEMEANING>
          <MEANINGDESCRIPTION>Ch 14.18 Monoclonal Antibody (Anti-GD-2 Monoclonal Antibody)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PG13-CEA_TCR</VALIDVALUE>
          <VALUEMEANING>PG13-CEA_TCR</VALUEMEANING>
          <MEANINGDESCRIPTION>PG13-CEA_TCR</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hsp90 Inhibitor STA-9090</VALIDVALUE>
          <VALUEMEANING>Hsp90 Inhibitor STA-9090</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity. Hsp90 inhibitor STA-9090 binds to and inhibits Hsp90, resulting in the proteasomal degradation of oncogenic client proteins, the inhibition of cell proliferation and the elevation of heat shock protein 72 (Hsp72); it may inhibit the activity of multiple kinases, such as c-Kit, EGFR, and Bcr-Abl, which as client proteins depend on functional HsP90 for maintenance. Hsp90, a 90 kDa molecular chaperone upregulated in a variety of tumor cells, plays a key role in the conformational maturation, stability and function of &quot;client&quot; proteins within the cell, many of which are involved in signal transduction, cell cycle regulation and apoptosis, including kinases, transcription factors and hormone receptors.  Hsp72 exhibits anti-apoptotic functions; its up-regulation may be used as a surrogate marker for Hsp90 inhibition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77872</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3061618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extracorporeal Photopheresis</VALIDVALUE>
          <VALUEMEANING>Extracorporeal Photopheresis</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure in which blood is removed from the body and treated with ultraviolet light and drugs that become active when exposed to light. The blood is then returned to the body. It is being studied in the treatment of some blood and bone marrow diseases and graft-vs-host disease (GVHD).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2777671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NY-ESO-1 Peptide Vaccine</VALIDVALUE>
          <VALUEMEANING>NY-ESO-1 Peptide Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various tumors. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response to cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2657</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3061104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Albuterol</VALIDVALUE>
          <VALUEMEANING>Albuterol (Proventil, Ventolin, Volmax)</VALUEMEANING>
          <MEANINGDESCRIPTION>A racemic mixture with a 1:1 ratio of the r-isomer, levalbuterol, and s-albuterol. It is a short-acting beta2-adrenergic agonist with its main clinical use in asthma. (MeSH)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluticasone</VALIDVALUE>
          <VALUEMEANING>Fluticasone Propionate (Flovent)</VALUEMEANING>
          <MEANINGDESCRIPTION>The propionate salt form of fluticasone, a synthetic trifluorinated glucocorticoid receptor agonist with antiallergic, antiinflammatory and antipruritic effects. Binding and activation of the glucocorticoid receptor results in the activation of lipocortin that in turn inhibits cytosolic phospholipase A2, which triggers cascade of reactions involved in synthesis of inflammatory mediators, such as prostaglandins and leukotrienes. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leads to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production.: A synthetic trifluorinated glucocorticoid receptor agonist with antiallergic, antiinflammatory and antipruritic effects. Fluticasone binds and activates glucocorticoid receptor, resulting in the activation of lipocortin. Lipocortin, in turn, inhibits cytosolic phospholipase A2, which triggers a cascade of reactions involved in the synthesis of inflammatory mediators, such as prostaglandins and leukotrienes. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leads to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61767, C29061</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3076454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Azithromycin</VALIDVALUE>
          <VALUEMEANING>Azithromycin (Zithromax)</VALUEMEANING>
          <MEANINGDESCRIPTION>An azalide, derived from erythromycin, and a member of a subclass of macrolide antibiotics with bacteriocidal and bacteriostatic activities. Azithromycin reversibly binds to the 50S ribosomal subunit of the 70S ribosome of sensitive microorganisms, thereby inhibiting the translocation step of protein synthesis, wherein a newly synthesized peptidyl tRNA molecule moves from the acceptor site on the ribosome to the peptidyl (donor) site, and consequently inhibiting RNA-dependent protein synthesis leading to cell growth inhibition and cell death. [Source: NCI]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3076456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytarabine</VALIDVALUE>
          <VALUEMEANING>Cytarabine (Ara C, Cytosine Arabinoside)</VALUEMEANING>
          <MEANINGDESCRIPTION>An anticancer drug that belongs to the family of drugs called antimetabolites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2960387</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxandrolone</VALIDVALUE>
          <VALUEMEANING>Oxandrolone (Oxandrin)</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, anabolic steroid hormone analog of testosterone. Similar to testosterone, oxandrolone binds to and activates specific nuclear receptors. This agent may be used for testosterone replacement therapy in hypogonadal men, in HIV-wasting syndrome, and in other conditions in order to increase nitrogen retention and fat-free muscle mass. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3076461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reolysin</VALIDVALUE>
          <VALUEMEANING>Reolysin</VALUEMEANING>
          <MEANINGDESCRIPTION>A serotype 3 Dearing strain (T3D) of reovirus (Respiratory Enteric Orphan VIRUS). Reovirus, a dsRNA virus, is able to replicate specifically in cancer cells bearing an activated Ras pathway. In contrast to normal cells, two-thirds of human cancer cells are Ras-activated, and are deficient in their ability to trigger the antiviral response mediated by the host cellular protein, double-stranded RNA-dependent protein kinase (PKR). In Ras-activated cancer cells, reovirus is able to freely replicate and subsequently cause apoptosis in the tumor cells. Cell lysis frees progeny viral particles to infect surrounding cancer cells. This cycle of infection, replication and cell death is believed to be repeated until no more Ras-activated tumor cells are available. Because the reovirus kills Ras-activated cancer cells, this is a potential therapeutic for malignant glioma, pancreatic, colon and some lung cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60774</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3124280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foretinib</VALIDVALUE>
          <VALUEMEANING>Multitargeted Tyrosine Kinase Inhibitor GSK1363089</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable small molecule with potential antineoplastic activity. MET/VEGFR2 inhibitor GSK1363089 binds to and selectively inhibits hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of tumor angiogenesis, tumor cell proliferation and metastasis. The proto-oncogene c-MET has been found to be over-expressed in a variety of cancers. VEGFR2 is found on endothelial and hematopoietic cells and mediates the development of the vasculature and hematopoietic cells through VEGF signaling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3124282</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CHK1 Inhibitor PF-477736</VALIDVALUE>
          <VALUEMEANING>CHK1 Inhibitor PF-477736</VALUEMEANING>
          <MEANINGDESCRIPTION>A proprietary compound targeting cell cycle checkpoint kinase 1 (chk1) with potential chemopotentiation activity. Chk1 inhibitor PF-477736 inhibits chk1, an ATP-dependent serine-threonine kinase that is a key component in the DNA replication-monitoring S/G2 checkpoint system. By overriding the last checkpoint defense against DNA damaging agent-induced lethal damage, chk1 inhibitor PF-477736 may potentiate the antitumor efficacy of various chemotherapeutic agents against tumor cells with intrinsic checkpoint defects.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68820</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3143932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Belagenpumatucel-L</VALIDVALUE>
          <VALUEMEANING>Belagenpumatucel-L (Lucanix)</VALUEMEANING>
          <MEANINGDESCRIPTION>A transforming growth factor beta2 (TGF-beta2) antisense gene-modified allogeneic tumor cell vaccine with potential immunostimulatory and antineoplastic activities. Belagenpumatucel-L is prepared by transfecting allogeneic non-small cell lung cancer (NSCLC) cells with a plasmid containing a TGF-beta2 antisense transgene, expanding the cells, and then irradiating and freezing them. Upon administration, this agent may elicit a cytotoxic T lymphocyte (CTL) response against host NSCLC cells, resulting in decreased tumor cell proliferation; vaccine immunogenicity may be potentiated by suppression of tumor TGF-beta2 production by antisense RNA expressed by the vaccine plasmid TGF-beta2 antisense transgene. Elevated levels of TGF-beta2 are frequently linked to immunosuppression in cancer patients and may be inversely correlated with prognosis in patients with NSCLC.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3140555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recombinant Interleukin-18</VALIDVALUE>
          <VALUEMEANING>Recombinant Interleukin-18</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-18 (IL-18). Produced primarily by macrophages, IL-18 induces the production of interferon-gamma (IFN-gamma), and enhances the activity of natural killer (NK) and cytotoxic T lymphocytes (CTL).  As a potential immunotherapeutic agent, IL-18 displays antitumor effects in vitro and in animal models. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-10-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3147595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PARP Inhibitor MK4827</VALIDVALUE>
          <VALUEMEANING>Niraparib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of poly (ADP-ribose) polymerase (PARP) types 1 and 2 (PARP-1 and -2), with antineoplastic activity. Upon administration, niraparib binds to and inhibits the activity of PARP-1 and -2, thereby inhibiting PARP-1 and -2-mediated DNA repair, enhancing the accumulation of DNA strand breaks, promoting genomic instability and resulting in apoptosis. The PARP family of proteins catalyzes post-translational ADP-ribosylation of nuclear proteins and is activated by single-strand DNA (ssDNA) breaks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80059</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-10-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3153580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TDL (Tumor Derived Lymphocytes)</VALIDVALUE>
          <VALUEMEANING>Tumor Derived Lymphocytes</VALUEMEANING>
          <MEANINGDESCRIPTION>A population of lymphocytes therapeutically administered to a recipient individual who is genetically distinct from a donor of the same species. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28676</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>XL184</VALIDVALUE>
          <VALUEMEANING>XL184 (Cabozantinib-S-malate)</VALUEMEANING>
          <MEANINGDESCRIPTION>The s-malate salt form of cabozantinib, an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (MET), RET (rearranged during transfection), vascular endothelial growth factor receptor types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97938</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3134357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062</VALIDVALUE>
          <VALUEMEANING>Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunoconjugate consisting of a monoclonal antibody directed against a highly-expressed myeloma cell surface antigen covalently attached to the maytansinoid DM4, a derivative of the cytotoxic agent maytansine (DM1), with potential antineoplastic activity. Anti-myeloma cell surface antigen immunoconjugate BT-062 binds to an unspecified cell surface antigen highly expressed on myeloma cells; upon internalization the DM4 moiety is released, binding to tubulin and disrupting microtubule assembly/disassembly dynamics, which may result in the inhibition of cell division and cell growth of myeloma tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78840</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tivozanib</VALIDVALUE>
          <VALUEMEANING>Tivozanib (AV-951)</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities. Tivozanib binds to and inhibits VEGFRs 1, 2 and 3, which may result in the inhibition of endothelial cell migration and proliferation, inhibition of tumor angiogenesis and tumor cell death. VEGFR tyrosine kinases, frequently overexpressed by a variety of tumor cell types, play a key role in angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3134818</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axitinib</VALIDVALUE>
          <VALUEMEANING>Axitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable tyrosine kinase inhibitor. Axitinib inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3187559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Selumetinib</VALIDVALUE>
          <VALUEMEANING>Selumetinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally active, small molecule with potential antineoplastic activity. Selumetinib is an ATP-independent inhibitor of mitogen-activated protein kinase kinase (MEK or MAPK/ERK kinase) 1 and 2. MEK 1 and 2 are dual specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various cancer cells, and are drivers of diverse cellular responses, including proliferation. Inhibition of both MEK1 and 2 by selumetinib prevents the activation of MEK1/2 dependent effector proteins and transcription factors, thereby leading to an inhibition of cellular proliferation in various cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66939</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3238481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amrubicin Hydrochloride</VALIDVALUE>
          <VALUEMEANING>Amrubicin Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt of a third-generation synthetic 9-amino-anthracycline with antineoplastic activity. Amrubicin intercalates into DNA and inhibits the activity of topoisomerase II, resulting in inhibition of DNA replication, and RNA and protein synthesis, followed by cell growth inhibition and cell death. This agent has demonstrated a higher level of anti-tumor activity than conventional anthracycline drugs without exhibiting any indication of the cumulative cardiac toxicity common to this class of compounds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3238483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-PDGFR alpha Monoclonal Antibody IMC-3G3</VALIDVALUE>
          <VALUEMEANING>Anti-PDGFR alpha Monoclonal Antibody IMC-3G3</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human IgG1 monoclonal antibody directed against the platelet-derived growth factor receptor alpha (PDGFR alpha) with potential antineoplastic activity. Anti-PDGFR alpha monoclonal antibody IMC-3G3 selectively binds to PDGFR alpha, .blocking the binding of its ligand, PDGF; signal transduction downstream of PDGFR through the MAPK and PI3K pathways is inhibited, which may result in inhibition of angiogenesis and tumor cell proliferation. Overexpressed by various cancer cell types, PDGFR is a transmembrane protein tyrosine kinase receptor, consisting of isoforms A and B that is important in regulating cellular growth and differentiation and angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3178312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eribulin Mesylate</VALIDVALUE>
          <VALUEMEANING>Eribulin Mesylate</VALUEMEANING>
          <MEANINGDESCRIPTION>The mesylate salt of a synthetic analogue of halichondrin B, a substance derived from a marine sponge (Lissodendoryx sp.) with antineoplastic activity. Eribulin binds to the vinca domain of tubulin and inhibits the polymerization of tubulin and the assembly of microtubules, resulting in inhibition of mitotic spindle assembly, induction of cell cycle arrest at G2/M phase, and, potentially, tumor regression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Denosumab</VALIDVALUE>
          <VALUEMEANING>Denosumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human monoclonal antibody directed against the receptor activator of nuclear factor kappa beta ligand (RANKL) with antiosteoclast activity. Denosumab specifically binds to RANKL and blocks the interaction of RANKL with RANK, a receptor located on osteoclast cell surfaces, resulting in inhibition of osteoclast activity, a decrease in bone resorption, and a potential increase in bone mineral density. RANKL, a protein expressed by osteoblastic cells, plays an important role in osteoclastic differentiation and activation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urelumab</VALIDVALUE>
          <VALUEMEANING>Urelumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized agonistic monoclonal antibody targeting the CD137 receptor with potential immunostimulatory and antineoplastic activities. Anti-CD137 monoclonal antibody specifically binds to and activates CD137-expressing immune cells, stimulating an immune response, in particular a cytotoxic T cell response, against tumor cells. CD137 is a member of the tumor necrosis factor (TNF)/nerve growth factor (NGF) family of receptors and is expressed by activated T- and B-lymphocytes and monocytes; its ligand has been found to play an important role in the regulation of immune responses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3237476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Degarelix</VALIDVALUE>
          <VALUEMEANING>Degarelix</VALUEMEANING>
          <MEANINGDESCRIPTION>A long-acting, synthetic peptide with gonadotrophin-releasing hormone (GnRH) antagonistic properties. Degarelix targets and blocks GnRH receptors located on the surfaces of gonadotroph cells in the anterior pituitary, thereby reducing secretion of luteinizing hormone (LH) by pituitary gonadotroph cells and so decreasing testosterone production by interstitial (Leydig) cells in the testes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3240855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brentuximab Vedotin</VALIDVALUE>
          <VALUEMEANING>Brentuximab Vedotin</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody-drug conjugate (ADC) directed against the tumor necrosis factor (TNF) receptor CD30 with potential antineoplastic activity. Brentuximab vedotin is generated by conjugating the humanized anti-CD30 monoclonal antibody SGN-30 to the cytotoxic agent monomethyl auristatin E (MMAE) via a valine-citrulline peptide linker. Upon administration and internalization by CD30-positive tumor cells, brentuximab vedotin undergoes enzymatic cleavage, releasing MMAE into the cytosol; MMAE binds to tubulin and inhibits tubulin polymerization, which may result in G2/M phase arrest and tumor cell apoptosis. Transiently activated during lymphocyte activation, CD30 (tumor necrosis factor receptor superfamily, member 8;TNFRSF8) may be constitutively expressed in hematologic malignancies including Hodgkin lymphoma and some T-cell non-Hodgkin lymphomas. The linkage system in brentuximab vedotin is highly stable in plasma, resulting in cytotoxic specificity for CD30-positive cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sodium Metaarsenite</VALIDVALUE>
          <VALUEMEANING>Sodium Metaarsenite</VALUEMEANING>
          <MEANINGDESCRIPTION>A highly soluble, orally available trivalent arsenic-containing telomerase inhibitor with potential antitumor activity. Although the exact mechanism through which sodium metaarsenite exerts its effect has yet to be fully elucidated, this agent appears to target and bind to telomeric sequences, specifically TTAGGG repeats, leading to a shortening of telomeres, and subsequent induction of apoptosis and inhibition of tumor cell growth. In addition, sodium metaarsenite also leads to the translocation of the catalytic subunit of telomerase into the cytoplasm and inhibition of the activity of telomerase. Telomerase is active in most tumors cells and is responsible for the maintenance of telomere length and plays a key role in cellular proliferation, but is quiescent in normal, healthy cells. The susceptibility to sodium metaarsenite seems to be inversely correlated with initial length of telomeres.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91098</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganitumab</VALIDVALUE>
          <VALUEMEANING>Ganitumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, fully human monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Ganitumab binds to membrane-bound IGF-1R, preventing binding of the ligand IGF-1 and the subsequent triggering of the PI3K/Akt signaling pathway; inhibition of this survival signaling pathway may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. IGF-1R is a tyrosine kinase and a member of the insulin receptor family. IGF-1R activation stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis; IGF-1R signaling has been highly implicated in tumorigenesis and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71531</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CDK2/TRKA Inhibitor PHA-848125 AC</VALIDVALUE>
          <VALUEMEANING>CDK2/TRKA Inhibitor PHA-848125 AC</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of cyclin-dependent kinases (CDKs) and thropomyosin receptor kinase A (TRKA), with potential antineoplastic activity. CDK2/TRKA inhibitor PHA-848125 AC potently inhibits cyclin-dependent kinase 2 (CDK2) and exhibits activity against other CDKs including CDK1 and CDK4, in addition to TRKA. Inhibition of these kinases may result in cell cycle arrest and apoptosis of tumor cells that express these kinases. CDKs are serine/threonine kinases involved in regulation of the cell cycle and may be overexpressed in some cancer cell types. The neurotrophin receptor TRKA is mutated in a variety of cancer cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88312</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Survivin Inhibitor YM155</VALIDVALUE>
          <VALUEMEANING>Survivin Inhibitor YM155</VALUEMEANING>
          <MEANINGDESCRIPTION>A small-molecule proapoptotic agent with potential antineoplastic activity. Survivin inhibitor YM155 selectively inhibits survivin expression in tumor cells, resulting in inhibition of survivin antiapoptotic activity (via the extrinsic or intrinsic apoptotic pathways) and tumor cell apoptosis. Survivin, a member of the inhibitor of apoptosis (IAP) gene family, is expressed during embryonal development and is absent in most normal, terminally differentiated tissues; upregulated in a variety of human cancers, its expression in tumors is associated with a more aggressive phenotype, shorter survival times, and a decreased response to chemotherapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61091</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KSP Inhibitor ARRY-520</VALIDVALUE>
          <VALUEMEANING>KSP Inhibitor ARRY-520</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, small molecule targeting the kinesin spindle protein (KSP) with potential antineoplastic activity. KSP inhibitor ARRY-520 specifically inhibits KSP (kinesin-5 or Eg5), resulting in activation of the spindle assembly checkpoint, induction of cell cycle arrest during the mitotic phase, and consequently cell death in tumor cells that are actively dividing. Because KSP is not involved in postmitotic processes, such as neuronal transport, this agent does not cause the peripheral neuropathy that is often associated with tubulin-targeting agents. KSP is an ATP-dependent microtubule motor protein that is essential for the formation of bipolar spindles and the proper segregation of sister chromatids during mitosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68937</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polymeric Camptothecin Prodrug XMT-1001</VALIDVALUE>
          <VALUEMEANING>Polymeric Camptothecin Prodrug XMT-1001</VALUEMEANING>
          <MEANINGDESCRIPTION>A polymeric prodrug of camptothecin (CPT) with potential antineoplastic activity. Polymeric camptothecin prodrug XMT-1001 consists of CPT conjugated to the 60-70 kDa, inert, bio-degradable, hydrophilic copolymer poly[1-hydroxymethylene hydroxymethyl formal] (PHF). Through a dual-phase, non-enzymatic release mechanism, CPT is first released in plasma from XMT-1001 as the lipophilic prodrugs CPT-SI (a succinimidoglycinate derivative) and CPT-SA (a succinamidoyl glycinate derivative), which are then hydrolyzed within tissues to release the lactone form of CPT. CPT inhibits the catalytic activity of DNA topoisomerase I, thereby inhibiting DNA replication and inducing apoptosis. This agent may exhibit a more favorable pharmacokinetic profile than other agents in the same class.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69079</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232388</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Checkpoint Kinase Inhibitor AZD7762</VALIDVALUE>
          <VALUEMEANING>Checkpoint Kinase Inhibitor AZD7762</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic small molecule inhibitor of checkpoint kinases (Chks) with potential chemosensitizing activity. AZD7762 binds to and inhibits Chks, which may prevent cell cycle arrest and subsequent nucleotide excision repair in DNA-damaged tumor cells, resulting in tumor cell apoptosis. This agent may enhance the cytotoxicity of DNA-damaging agents. Chks are protein kinases that regulate either G1/S or G2/M transitions in the cell cycle. In the presence of DNA damage or incomplete DNA replication, Chks become activated and initiate cell cycle arrest to allow DNA repair or the completion of DNA replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66961</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin</VALIDVALUE>
          <VALUEMEANING>Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin</VALUEMEANING>
          <MEANINGDESCRIPTION>A polyethylene glycol (PEG) conjugate of 7-ethyl-10-hydroxycamptothecin with potential antineoplastic activity. After hydrolysis in vivo, 7-ethyl-10-hydroxycamptothecin (SN38), an active metabolite of irinotecan, is released from polyethyleneglycol-7-ethyl-10-hydroxycamptothecin (PEG-SN38); 7-ethyl-10-hydroxycamptothecin selectively stabilizes topoisomerase I-DNA covalent complexes, resulting in single-stranded and double-stranded DNA breaks, the inhibition of DNA replication, and the induction of apoptosis. This agent is designed to deliver the active metabolite to tumor cells without the need for conversion as is the case with irinotecan. Compared to unPEGylated 7-ethyl-10-hydroxycamptothecin, PEGylation improves solubility and allows for parental delivery, and may result in a longer half-life and higher exposure for tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70651</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Topoisomerase I Inhibitor LMP400</VALIDVALUE>
          <VALUEMEANING>Topoisomerase I Inhibitor LMP400</VALUEMEANING>
          <MEANINGDESCRIPTION>An indenoisoquinoline and non-camptothecin inhibitor of topoisomerase I (Top I) with potential antineoplastic activity. Topoisomerase I inhibitor LMP400 binds to the topoisomerase I-DNA covalent cleavage complexes, and inhibits repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations. Compared to camptothecins, indenoisoquinolines are chemically stable, produce stable Top I-DNA cleavage complexes, induce unique DNA cleavage sites and appear more resistant to multidrug efflux pumps.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3234540</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Topoisomerase I Inhibitor LMP776</VALIDVALUE>
          <VALUEMEANING>Topoisomerase I Inhibitor LMP776</VALUEMEANING>
          <MEANINGDESCRIPTION>An indenoisoquinoline and non-camptothecin inhibitor of topoisomerase I (Top I) with potential antineoplastic activity. Topoisomerase I inhibitor LMP776 binds to the topoisomerase I-DNA covalent cleavage complexes, and inhibits repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations. Compared to camptothecins, indenoisoquinolines are chemically stable, produce stable Top I-DNA cleavage complexes, induce unique DNA cleavage sites and appear more resistant to multidrug efflux pumps.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3234542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5-Iodo-2-pyrimidinone-2&#39;-deoxyribose</VALIDVALUE>
          <VALUEMEANING>5-Iodo-2-pyrimidinone-2&#39;-deoxyribose</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available thymidine analogue and prodrug of 5-iododeoxyuridine (IUdR), an iodinated analogue of deoxyuridine, with radiosensitizing activity. Ropidoxuridine is efficiently converted to IUdR by a hepatic aldehyde oxidase. IUdR is incorporated into DNA during replication and sensitizing cells to ionizing radiation by increasing DNA strand breaks. Compared to IUdR, ropidoxuridine is associated with a lower toxicity profile and improved anti-tumor activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3191821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoviral Vector Ad5-CEA(6D) Vaccine</VALIDVALUE>
          <VALUEMEANING>Adenoviral Vector Ad5-CEA(6D) Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A replication-defective, E1- and E2b-deleted oncolytic adenoviral serotype 5 (Ad5) encoding an epitope of human carcinoembryonic antigen (CEA) with potential antineoplastic activity. Adenoviral vector Ad5-CEA(6D) vaccine expresses a highly immunogenic analogue of CEA [CAP1-(6D)]. Upon administration, this vaccine may induce both humoral and cellular immune responses against tumor cells expressing the CEA antigen, thereby resulting in the immune-mediated inhibition of tumor cell proliferation and tumor cell death. CEA, a tumor-associated antigen, is overexpressed in various tumor cell types. Deletion of early genes E1 and E2b in Ad5 potentially circumvent pre-existing anti-adenovirus immunity and is capable of inducing strong immune responses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91373</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hsp90 Inhibitor AT13387</VALIDVALUE>
          <VALUEMEANING>Hsp90 Inhibitor AT13387</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, orally bioavailable, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity. Hsp90 inhibitor AT13387 selectively binds to Hsp90, thereby inhibiting its chaperone function and promoting the degradation of oncogenic signaling proteins involved in tumor cell proliferation and survival. Hsp90, a chaperone protein upregulated in a variety of tumor cells, regulates the folding, stability and degradation of many oncogenic signaling proteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aurora A Kinase Inhibitor MLN8237</VALIDVALUE>
          <VALUEMEANING>Aurora A Kinase Inhibitor MLN8237</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation, orally bioavailable, highly selective small molecule inhibitor of the serine/threonine protein kinase Aurora A kinase with potential antineoplastic activity. Aurora kinase inhibitor MLN8237 binds to and inhibits Aurora A kinase, which may result in disruption of the assembly of the mitotic spindle apparatus, disruption of chromosome segregation, and inhibition of cell proliferation. Aurora A kinase localizes to the spindle poles and to spindle microtubules during mitosis, and is thought to regulate spindle assembly. Aberrant expression of Aurora kinases occurs in a wide variety of cancers, including colon and breast cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3205718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angiopoietin 1/2-Neutralizing Peptibody AMG 386</VALIDVALUE>
          <VALUEMEANING>Angiopoietin 1/2-Neutralizing Peptibody AMG 386</VALUEMEANING>
          <MEANINGDESCRIPTION>An angiopoietin (Ang) 1 and 2 neutralizing peptibody, with potential antiangiogenic activity. AMG 386 targets and binds to Ang1 and Ang2, thereby preventing the interaction of the angiopoietins with their target tie2 receptors. This may inhibit angiogenesis and may eventually lead to an inhibition of tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3205720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abiraterone</VALIDVALUE>
          <VALUEMEANING>Abiraterone (Zytiga)</VALUEMEANING>
          <MEANINGDESCRIPTION>A steroidal compound with antiandrogen activity. Abiraterone inhibits the enzymatic activity of steroid 17alpha-monooxygenase (17alpha-hydrolase/C17,20 lyase complex; CYP17A1), a member of the cytochrome p450 family that catalyzes the 17alpha-hydroxylation of steroid intermediates involved in testosterone synthesis. Administration of this agent may suppress testosterone production by both the testes and the adrenals to castrate-range levels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77333</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3263351</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Saracatinib</VALIDVALUE>
          <VALUEMEANING>Saracatinib (AZD0530)</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available 5-, 7-substituted anilinoquinazoline with anti-invasive and anti-tumor activities. Saracatinib is a dual-specific inhibitor of Src and Abl, protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. This agent binds to and inhibits these tyrosine kinases and affects cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, Saracatinib inhibits Src kinase-mediated osteoclast bone resorption.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3263353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dimethyl Sulfoxide</VALIDVALUE>
          <VALUEMEANING>Dimethyl Sulfoxide</VALUEMEANING>
          <MEANINGDESCRIPTION>A highly polar organic liquid that is used widely as a chemical solvent and a free radical scavenger. It shows a range of pharmacological activity including analgesia and anti-inflammation. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect cells and tissue during cryopreservation and has been used to treat extravasation damage caused by anthracycline-based chemotherapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C437</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-10-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3192059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Z-Endoxifen Hydrochloride</VALIDVALUE>
          <VALUEMEANING>Z-Endoxifen Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt and the z (cis-) stereoisomer of endoxifen with potential antineoplastic activity. Endoxifen, the active metabolite of tamoxifen, competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA and thus reducing DNA synthesis. Unlike tamoxifen, however, which relies on CYP2D6 activity for its conversion to the active metabolite endoxifen, the direct administration of endoxifen bypasses the CYP2D6 route. As CYP2D6 activity can vary widely among individuals due to genetic CYP2D6 polymorphisms, endoxifen is therefore theoretically more potent and more uniform in its bioavailability across patient populations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-10-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3295775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BTK Inhibitor PCI-32765</VALIDVALUE>
          <VALUEMEANING>BTK Inhibitor PCI-32765</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable small-molecule inhibitor of Bruton&#39;s tyrosine kinase (BTK) with potential antineoplastic activity. BTK inhibitor PCI-32765 binds to and inhibits BTK activity, preventing B-cell activation and B-cell-mediated signaling and inhibiting the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is required for B cell receptor (BCR) signaling, plays a key role in B-cell maturation, and is overexpressed in a number of B-cell malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ofatumumab</VALIDVALUE>
          <VALUEMEANING>Ofatumumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human, high-affinity IgG1 monoclonal antibody directed against the B cell CD20 cell surface antigen with potential antineoplastic activity. Ofatumumab binds specifically to CD20 on the surfaces of B cells, triggering complement-dependent cell lysis (CDCL) and antibody-dependent cell-mediated cytotoxicity (ADCC) of B cells overexpressing CD20. The CD20 antigen, found on over 90% of B cells, B cell lymphomas, and other B cells of lymphoid tumors of B cell origin, is a non-glycosylated cell surface phosphoprotein that acts a calcium ion channel; it is exclusively expressed on B cells during most stages of B cell development.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66952</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-10-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dimethane sulfonate (DMS612)</VALIDVALUE>
          <VALUEMEANING>Dimethane sulfonate (DMS612)</VALUEMEANING>
          <MEANINGDESCRIPTION>A dimethane sulfonate derivative and alkylating agent with a structure similar to other alkylating agents such as chlorambucil, busulfan and melphalan, with potential antineoplastic activity. Although the exact mechanism of action has yet to be fully elucidated, benzaldehyde dimethane sulfonate alkylates DNA, which results in DNA double strand breaks, inhibition of DNA replication, cell cycle arrest and cell death. In addition, this agent is metabolized by the enzyme aldehyde dehydrogenase (ALDH) into the active carboxylic acid metabolite benzoic acid dimethane sulfonate (BA), which further contributes to its alkylating activity. Unlike other alkylating agents, benzaldehyde dimethane sulfonate has demonstrated antitumor activity in renal cell carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107164</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243438</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Steroid 17alpha-monooxygenase TAK-700</VALIDVALUE>
          <VALUEMEANING>Steroid 17alpha-monooxygenase TAK-700</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable non-steroidal androgen synthesis inhibitor of steroid 17alpha-monooxygenase (17,20 lyase) with potential antiandrogen activity. TAK-700 binds to and inhibits the steroid 17alpha-monooxygenase in both the testes and adrenal glands, thereby inhibiting androgen production. This may decrease androgen-dependent growth signaling and may inhibit cell proliferation of androgen-dependent tumor cells. The cytochrome P450 enzyme CYP17A1 (P450C17), localized to the endoplasmic reticulum (ER), exhibits both 17alpha-hydroxylase and 17,20-lyase activities, and plays a key role in the steroidogenic pathway that produces steroidal hormones, such as progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90582</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3259298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MDV3100</VALIDVALUE>
          <VALUEMEANING>Selective Androgen Receptor Modulator MDV3100 (Enzalutamide)</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, selective androgen receptor modulator MDV3100 inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3441945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sipuleucel-T</VALIDVALUE>
          <VALUEMEANING>APC8015 Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cell-based vaccine composed of autologous antigen-presenting peripheral blood mononuclear cells (enriched for a dendritic cell fraction) that have been exposed to a recombinant protein consisting of granulocyte-macrophage colony-stimulating factor (GM-CSF) fused to prostatic-acid phosphatase (PAP), a protein expressed by prostate cancer cells.  Upon administration, the vaccine may stimulate an antitumor T-cell response against tumor cells expressing PAP. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3439565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pentostatin</VALIDVALUE>
          <VALUEMEANING>Pentostatin</VALUEMEANING>
          <MEANINGDESCRIPTION>An anticancer drug that belongs to the family of drugs called antimetabolites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C732</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CBDCA</VALIDVALUE>
          <VALUEMEANING>CBDCA (Carboplatin)</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAT-8015</VALIDVALUE>
          <VALUEMEANING>Moxetumomab Pasudotox</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant immunotoxin consisting of the Fv portion of the anti-CD22 antibody covalently fused to a 38 KDa fragment of Pseudomonas exotoxin-A (PE38) with potential antineoplastic activity. The Fv portion of anti-CD22 immunotoxin CAT-8015 binds to CD22, a cell surface receptor expressed on a variety of malignant B-cells, thereby delivering the toxin moiety PE38 directly to tumor cells. Once internalized, PE38 induces caspase-mediated apoptosis via a mechanism involving mitochondrial damage and blocks translational elongation by binding to elongation factor 2 (EF-2). Anti-CD22 immunotoxin CAT-8015 exhibits a greater affinity for CD22 than its predecessor, anti-CD22 immunotoxin CAT-3888 (BL22 immunotoxin), and hence may be more effective against tumor cells expressing lower levels of CD22.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68819</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CHOP</VALIDVALUE>
          <VALUEMEANING>CHOP Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAMFTP</VALIDVALUE>
          <VALUEMEANING>Conjugated Estrogens/Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Tamoxifen</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10113</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAI/Paclitaxel</VALIDVALUE>
          <VALUEMEANING>Carboxyamidotriazole/Paclitaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10924</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAI</VALIDVALUE>
          <VALUEMEANING>Carboxyamidotriazole</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally-active agent with potential antineoplastic activity.  Carboxyamidotriazole binds to and inhibits non-voltage-operated Ca2+ channels, blocking both Ca2+ influx into cells and Ca2+ release from intracellular stores and resulting in the disruption of calcium channel-mediated signal transduction and inhibition of vascular endothelial growth factor (VEGF) signaling, endothelial proliferation, and angiogenesis.  This agent may also inhibit tumor cell growth, invasion and metastasis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAF</VALIDVALUE>
          <VALUEMEANING>CAF Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of cyclophosphamide, doxorubicin hdrochloride (Adriamycin), and fluorouracil, which may be used in the adjuvant setting for the treatment of nonmetastatic breast cancer or alone for the treatment of metastatic breast cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BuMelt</VALIDVALUE>
          <VALUEMEANING>Busulfan/Melphalan/Thiotepa</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bromocriptine</VALIDVALUE>
          <VALUEMEANING>Bromocriptine</VALUEMEANING>
          <MEANINGDESCRIPTION>Bromocriptine belongs to the group of medicines known as ergot alkaloids. It acts as a dopamine agonist primarily activating the dopamine D2 receptors. It blocks release of prolactin from the pituitary gland, and is used in the therapy of amenorrhea, infertility in women, abnormal breast milk discharge, hypogonadism, Parkinsons disease, and acromegaly. It is also used in the treatment of pituitary prolactinoma, neuroleptic malignant syndrome, cocaine addiction, and painful breast condition. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C317</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577766</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bendamustine HCl</VALIDVALUE>
          <VALUEMEANING>Bendamustine Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt of bendamustine, a bifunctional mechlorethamine derivative with alkylator and antimetabolite activities. Bendamustine possesses three active moieties: an alkylating group; a benzimidazole ring, which may act as a purine analogue; and a butyric acid side chain. Although its exact mechanism of action is unknown this agent appears to act primarily as an alkylator. Bendamustine metabolites alkylate and crosslink macromolecules, resulting in DNA, RNA and protein synthesis inhibition, and, subsequently, apoptosis. Bendamustine may differ from other alkylators in that it may be more potent in activating p53-dependent stress pathways and inducing apoptosis; it may induce mitotic catastrophe; and it may activate a base excision DNA repair pathway rather than an alkyltransferase DNA repair mechanism. Accordingly, this agent may be more efficacious and less susceptible to drug resistance than other alkylators.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61565</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378217</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bactrim</VALIDVALUE>
          <VALUEMEANING>Trimethoprim-Sulfamethoxazole</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination of two anti-infection drugs, sulfamethoxazole and trimethoprim. It is used to fight bacterial and protozoal infections.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C909</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bacillus Calmette-Guerin (BCG)</VALIDVALUE>
          <VALUEMEANING>Bacillus Calmette-Guerin Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>An antigen preparation derived from Bacillus Calmette-Guerin, used as a component of BCG vaccine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77178</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BMT, Autologous</VALIDVALUE>
          <VALUEMEANING>Autologous Bone Marrow Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>Bone marrow transfer in which the patient is his own donor.  Bone marrow is removed prior to bone marrow ablation treatment and then returned to reconstitute the hematopoietic system. Prior to reinfusion the bone marrow is often treated to purge it of residual tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CpG</VALIDVALUE>
          <VALUEMEANING>CpG Dinucleotide</VALUEMEANING>
          <MEANINGDESCRIPTION>A dinucleotide consisting of cytosine followed by guanine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Corticosteroids</VALIDVALUE>
          <VALUEMEANING>Corticosteroids</VALUEMEANING>
          <MEANINGDESCRIPTION>Hormones that have antitumor activity in lymphomas and lymphoid leukemias; in addition, corticosteroids (steroids) may be used for hormone replacement and for the management of some of the complications of cancer and its treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Combivir</VALIDVALUE>
          <VALUEMEANING>Lamivudine/Zidovudine</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination of two synthetic nucleoside analogues with synergistic antiviral properties.  Lamivudine is phosphorylated intracellularly to its active 5&#39;-triphosphate metabolite, lamivudine triphosphate (L-TP); zidovudine is phosphorylated to its active 5&#39;-triphosphate metabolite, zidovudine triphosphate (ZDV-TP). These active metabolites inhibit human immunodeficiency virus (HIV) viral reverse transcriptase (RT) by incorporating into viral DNA and terminating viral DNA chain elongation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28939</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colesevelam HCl</VALIDVALUE>
          <VALUEMEANING>Colesevelam Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>A polymeric synthetic polyallylamine derivative cross-linked with epichlorohydrin, Colesevelam Hydrochloride is a non-absorbed, water-insoluble, lipid-lowering, hydrophilic agent that binds intestinal bile acids and impedes their reabsorption. Used alone or with other medications, Colesevelam increases cholesterol metabolism and decreases its plasma concentration. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28937</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Co-trimoxazole</VALIDVALUE>
          <VALUEMEANING>Trimethoprim-Sulfamethoxazole</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination of two anti-infection drugs, sulfamethoxazole and trimethoprim. It is used to fight bacterial and protozoal infections.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C909</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cloretazine</VALIDVALUE>
          <VALUEMEANING>Laromustine</VALUEMEANING>
          <MEANINGDESCRIPTION>A sulfonyl hydrazine prodrug with antineoplastic activity. Laromustine releases the DNA chloroethylating agent 90CE after entering the blood stream; 90CE chloroethylates alkylates the O6 position of guanine, resulting in DNA crosslinking, strand breaks, chromosomal aberrations, and disruption of DNA synthesis. Intracellular metabolism of this agent also releases methyl isocyanate which inhibits O6-alkyl-guanine transferase, an enzyme involved with DNA repair.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2653</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Paclitax/Cyclophos/Thalidomide</VALIDVALUE>
          <VALUEMEANING>Cisplatin Paclitaxel Cyclophosphamide Thalidomide Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04): A compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity.  Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division.  This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A synthetic derivative of glutamic acid (alpha-phthalimido-glutarimide) with teratogenic, immunomodulatory, anti-inflammatory and anti-angiogenic properties.  Thalidomide acts primarily by inhibiting both the production of tumor necrosis factor alpha (TNF-alpha) in stimulated peripheral monocytes and the activities of interleukins and interferons.  This agent also inhibits polymorphonuclear chemotaxis and monocyte phagocytosis.  Thalidomide inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), thereby inhibiting angiogenesis. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C870, C405, C1411, C376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Pacli/Cyclo/GCSF</VALIDVALUE>
          <VALUEMEANING>Cisplatin Paclitaxel Cyclophosphamide Granulocyte Colony Stimulating Factor Measurement Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04): A compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity.  Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division.  This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): The determination of the amount of granulocyte colony stimulating factor present in a sample.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C82018, C405, C1411, C376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Interferon</VALIDVALUE>
          <VALUEMEANING>Cisplatin Interferon Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04): Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C20493, C376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Etoposide</VALIDVALUE>
          <VALUEMEANING>Cisplatin Etoposide Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04): A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C491, C376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Doxorubicin</VALIDVALUE>
          <VALUEMEANING>Cisplatin Doxorubicin Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04): An anthracycline antineoplastic antibiotic isolated from the fungus Streptococcus peucetius var. caesius.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.  The hydrochloride salt doxorubicin hydrochloride is the therapeutic form of doxorubicin. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C456, C376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Cyclophosphamide</VALIDVALUE>
          <VALUEMEANING>Cisplatin Cyclophosphamide Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C405, C376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Paclitaxel/Cyclophosphamide</VALIDVALUE>
          <VALUEMEANING>Cisplatin/Cyclophosphamide/Paclitaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10604</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Vinblastine</VALIDVALUE>
          <VALUEMEANING>Cisplatin/Vinblastine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Topotecan</VALIDVALUE>
          <VALUEMEANING>Cisplatin/Topotecan</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10653</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Paclitaxel</VALIDVALUE>
          <VALUEMEANING>Cisplatin/Paclitaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Gemcitabine</VALIDVALUE>
          <VALUEMEANING>Cisplatin/gemcitabine Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Definition not available.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C11117</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboplatin</VALIDVALUE>
          <VALUEMEANING>Carboplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378841</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carfilzomib</VALIDVALUE>
          <VALUEMEANING>Carfilzomib</VALUEMEANING>
          <MEANINGDESCRIPTION>An epoxomicin derivate with potential antineoplastic activity. Carfilzomib irreversibly binds to and inhibits the chymotrypsin-like activity of the 20S catalytic core subunit of the proteasome, a protease complex responsible for degrading a large variety of cellular proteins. Inhibition of proteasome-mediated proteolysis results in an accumulation of polyubiquinated proteins, which may lead to cell cycle arrest, induction of apoptosis, and inhibition of tumor growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carprofen</VALIDVALUE>
          <VALUEMEANING>Carprofen</VALUEMEANING>
          <MEANINGDESCRIPTION>A propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic activities, used exclusively in veterinary medicine. Carprofen inhibits the activity of the enzymes cyclo-oxygenase (COX) I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. This inhibits the formation of prostaglandins, by prostaglandin synthase, that are involved in pain, inflammation and fever. Ibuprofen also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin</VALIDVALUE>
          <VALUEMEANING>Cisplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225735</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cimetidine</VALIDVALUE>
          <VALUEMEANING>Cimetidine</VALUEMEANING>
          <MEANINGDESCRIPTION>A histamine H(2)-receptor antagonist.  Enhancing anti-tumor cell-mediated responses, cimetidine blocks histamine&#39;s ability to stimulate suppressor T lymphocyte activity and to inhibit natural killer (NK) cell activity and interleukin-2 production.  Cimetidine also may inhibit tumor growth by suppressing histamine&#39;s growth-factor activity and blocking histamine-induced stimulation of vascular endothelial growth factor (VEGF), a pro-angiogenic growth factor. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C374</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577816</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cilengitide</VALIDVALUE>
          <VALUEMEANING>Cilengitide</VALUEMEANING>
          <MEANINGDESCRIPTION>A cyclic Arg-Gly-Asp peptide with potential antineoplastic activity.  Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cidofovir</VALIDVALUE>
          <VALUEMEANING>Cidofovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic nucleotide analog with antiviral activity against cytomegalovirus (CMV).  After conversion to the active metabolite cidofovir diphosphate, cidofovir selectively inhibits CMV DNA polymerase and incorporates into the growing viral DNA chain ultimately inhibiting viral DNA synthesis. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chlorambucil</VALIDVALUE>
          <VALUEMEANING>Chlorambucil</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally-active antineoplastic aromatic nitrogen mustard. Chlorambucil alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Catumaxomab</VALIDVALUE>
          <VALUEMEANING>Catumaxomab</VALUEMEANING>
          <MEANINGDESCRIPTION>A trifunctional bispecific monoclonal antibody with potential antineoplastic activity. Catumaxomab has two antigen-recognition sites: one for human CD3, a T cell surface antigen; and one for human epithelial cell adhesion molecule (EpCAM), a cell surface antigen expressed by a variety of epithelial tumor cells. In addition, the modified Fc portion of this antibody binds Fc receptors on antigen presenting cells (APCs) such as macrophages and dendritic cells (DCs). Catumaxomab brings T cells, EpCAM-expressing epithelial tumor cells and APCs together into tricellular complexes, which may result in a potent cytotoxic T-lymphocyte (CTL) response against EpCAM-expressing epithelial tumor cells. Fc-mediated binding of APCs in the tricellular complex potentiates EpCAM antigen presentation to T cells and the activation of anti-tumor cytotoxic T cell functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cediranib</VALIDVALUE>
          <VALUEMEANING>Cediranib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable indole ether quinazoline derivative and vascular endothelial growth factor receptor (VEGFR) inhibitor, with potential antineoplastic activity. Upon oral administration, cediranib binds to and inhibits the three VEGFR subtypes 1 (VEGFR-1), 2 (VEGFR-2) and 3 (VEGFR-3), thereby blocking VEGF-signaling, angiogenesis, and tumor cell growth. Expression of VEGFRs may be upregulated in a variety of tumor cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80867</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cefadroxil</VALIDVALUE>
          <VALUEMEANING>Cefadroxil</VALUEMEANING>
          <MEANINGDESCRIPTION>A semi-synthetic, beta-lactam, first-generation cephalosporin antibiotic with bactericidal activity. Cefadroxil binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28912</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3134035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DMP-266</VALIDVALUE>
          <VALUEMEANING>(DMP-266) Efavirenz</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic non-nucleoside reverse transcriptase (RT) inhibitor with antiviral properties.  Efavirenz binds directly to the human immunodeficiency virus type 1 (HIV-1) RT, an RNA-dependent DNA polymerase, blocking its function in viral DNA replication.  In combination with other antiretroviral drugs, this agent has been shown to significantly reduce HIV viral loads, therefore retarding or preventing damage to the immune system, and reducing the risk of developing AIDS.  Efavirenz induces activity of the cytochrome P450 system, thereby accelerating its own metabolism. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DMAC</VALIDVALUE>
          <VALUEMEANING>Dexamethasone Melphalan Cytarabine Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04) [Source: NCI]: An orally available phenylalanine derivative of nitrogen mustard with antineoplastic activity. Melphalan alkylates DNA at the N7 position of guanine and induces DNA inter-strand cross-linkages, resulting in the inhibition of DNA and RNA synthesis and cytotoxicity against both dividing and non-dividing tumor cells. (NCI04): An anticancer drug that belongs to the family of drugs called antimetabolites.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C408, C633, C422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DHAP</VALIDVALUE>
          <VALUEMEANING>Cisplatin/Cytarabine/Dexamethasone</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DES</VALIDVALUE>
          <VALUEMEANING>Diethylstilbestrol</VALUEMEANING>
          <MEANINGDESCRIPTION>DES; the acronym for diethylstilbestrol, a synthetic, nonsteroidal form of estrogen.  A well-known teratogen and carcinogen, DES inhibits the hypothalamic-pituitary-gonadal axis, thereby blocking the testicular synthesis of testosterone, lowering plasma testosterone, and inducing a chemical castration. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D4T</VALIDVALUE>
          <VALUEMEANING>Stavudine</VALUEMEANING>
          <MEANINGDESCRIPTION>A nucleoside reverse transcriptase inhibitor analog of thymidine. Stavudine has been recommended to undergo phase-out management due to its long-term, irreversible side-effects.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D1694</VALIDVALUE>
          <VALUEMEANING>Raltitrexed</VALUEMEANING>
          <MEANINGDESCRIPTION>A quinazoline folate analogue with antineoplastic activity.  After transport into cells via the reduced folate carrier, raltitrexed undergoes intracellular polyglutamation and blocks the folate-binding site of thymidylate synthase, thereby inhibiting tetrahydrofolate activity and DNA replication and repair and resulting in cytotoxicity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1804</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fowlpox/Tyrosinase HDL 2</VALIDVALUE>
          <VALUEMEANING>Fowlpox Virus Vaccine/Interleukin-2/Vaccinia-Tyrosinase Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FUDR</VALIDVALUE>
          <VALUEMEANING>Floxuridine</VALUEMEANING>
          <MEANINGDESCRIPTION>A fluorinated pyrimidine monophosphate analogue of 5-fluoro-2&#39;-deoxyuridine-5&#39;-phosphate (FUDR-MP) with antineoplastic activity. As an antimetabolite, floxuridine inhibits thymidylate synthase, resulting in disruption of DNA synthesis and cytotoxicity. This agent is also metabolized to fluorouracil and other metabolites that can be incorporated into RNA and inhibit the utilization of preformed uracil in RNA synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FOLFOX</VALIDVALUE>
          <VALUEMEANING>Fluorouracil/Leucovorin Calcium/Oxaliplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>One of several chemotherapy regimens that include leucovorin calcium (calcium folinate), 5-fluorouracil and oxaliplatin and which may be used in the treatment of advanced-stage and metastatic colorectal cancer. FOLFOX regimens differ in agent dosing and administration schedule and include FOLFOX 4, FOLFOX 6, modified FOLFOX 6 (mFOLFOX 6) and FOLFOX 7.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3171720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FOLFIRI/Bevacizumab</VALIDVALUE>
          <VALUEMEANING>Bevacizumab FOLFIRI Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor.: An abbreviation for a chemotherapy combination used to treat advanced colorectal cancer that has spread. It is also being studied in the treatment of other types of cancer. It includes the drugs leucovorin calcium (folinic acid), fluorouracil, and irinotecan hydrochloride.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63593, C2039</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLT3-Ligand</VALIDVALUE>
          <VALUEMEANING>FLT3 Ligand</VALUEMEANING>
          <MEANINGDESCRIPTION>Flt3 ligand is a novel hematopoietic growth factor ligand for the FLT3 tyrosine kinase receptor.  This growth factor stimulates the proliferation of hematopoietic progenitor cells.  FLT3 (FLK2) is a tyrosine kinase receptor structurally related to CSF1 and KIT.  (from OMIM 600007 and NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379042</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLAC</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Doxorubicin/Fluorouracil/Leucovorin Calcium</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FDG</VALIDVALUE>
          <VALUEMEANING>Fludeoxyglucose F 18</VALUEMEANING>
          <MEANINGDESCRIPTION>The radioactive form of glucose used in positron emission tomography (PET), a diagnostic imaging procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C964</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FAC</VALIDVALUE>
          <VALUEMEANING>Fluorouracil Doxorubicin Cyclophosphamide Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity.  Fluorouracil and its metabolites possess a number of different mechanisms of action.  In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth.  Another active metabolite, 5-5-fluoro-2&#39;-deoxyuridine-5&#39;-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), a necessary constituent of DNA.  Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both the processing and functions of RNA. (NCI04): An anthracycline antineoplastic antibiotic isolated from the fungus Streptococcus peucetius var. caesius.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.  The hydrochloride salt doxorubicin hydrochloride is the therapeutic form of doxorubicin. (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C405, C456, C505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379046</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>F-ddA</VALIDVALUE>
          <VALUEMEANING>2&#39;-Fluoro-2&#39;,3&#39;-Dideoxyadenosine</VALUEMEANING>
          <MEANINGDESCRIPTION>A fluoro-substituted analog of dideoxyadenosine that inhibits reverse transcriptase, thereby inhibiting telomerase activity and subsequent cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379047</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Etretinate</VALIDVALUE>
          <VALUEMEANING>Etretinate</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic oral retinoid that is a prodrug of acitretin.  Etretinate activates retinoid receptors, causing an induction of cell differentiation, inhibition of cell proliferation, and inhibition of tissue infiltration by inflammatory cells.  Etretinate is no longer commercially available in the U.S. due to the extended potential for teratogenic effects related to its long half-life. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29036</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379048</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Etop/Cyt/Vcr/Mtx/Ifo/Dxm</VALIDVALUE>
          <VALUEMEANING>Etoposide Cyclophosphamide Vincristine Methotrexate Ifosfamide Dexamethasone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04): An antimetabolite with antineoplastic and immunomodulating properties.  Methotrxate inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses.  Methotrexate also exhibits potent immunosuppressant properties. (NCI04): A synthetic analogue of the nitrogen mustard cyclophosphamide with antineoplastic activity. Ifosfamide alkylates and forms DNA crosslinks, thereby preventing DNA strand separation and DNA replication.  This agent is a prodrug that must be activated through hydroxylation by hepatic microsomal enzymes. (NCI04): A synthetic adrenal corticostero</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C422, C564, C642, C933, C405, C491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379049</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethambutol HCl</VALIDVALUE>
          <VALUEMEANING>Ethambutol Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt form of ethambutol, an ethylenediamine derivative with antibacterial activity, specifically effective against mycobacteria. Although the exact mechanism of action of ethambutol hydrochloride is unknown, ethambutol hydrochloride inhibits the transfer of mycolic acids into the cell wall of bacteria, which impedes bacterial cell growth. This agent may also interfere with RNA synthesis or inhibit other cell metabolism, thereby preventing cell multiplication and causing cell death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29033</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379050</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estrogen</VALIDVALUE>
          <VALUEMEANING>Estrogen</VALUEMEANING>
          <MEANINGDESCRIPTION>A class of sex hormones associated with the development and maintenance of secondary female sex characteristics and control of the cyclical changes in the reproductive cycle. They are also required for pregnancy maintenance and have an anabolic effect on protein metabolism and water retention.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Etanercept</VALIDVALUE>
          <VALUEMEANING>Etanercept</VALUEMEANING>
          <MEANINGDESCRIPTION>A dimeric fusion protein comprised of a recombinant form of the extracellular ligand-binding portion of the human 75-kilodalton tumor necrosis factor receptor linked to the Fc portion of human immunoglobulin G1 (IgG1).  Clinical Use: Juvenile Arthritis, Psoriatic Arthritis, and Rheumatoid Arthritis.  Clinical Trial: Bone Marrow Transplant and Adjuvant use for Caner-related Anorexia, Cachexia, and Stomatitis.(NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567429</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Exemestane</VALIDVALUE>
          <VALUEMEANING>Exemestane</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic androgen analogue.  Exemestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the conversion of cholesterol to pregnenolone and the peripheral aromatization of androgenic precursors into estrogens. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3145843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Etoposide</VALIDVALUE>
          <VALUEMEANING>Etoposide</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Famciclovir</VALIDVALUE>
          <VALUEMEANING>Famciclovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A diacetyl 6-deoxy prodrug analog of the antiviral agent penciclovir.  Orally administered, famciclovir in vivo is converted to penciclovir triphosphate, which is active against the Herpes viruses, including herpes simplex 1 and 2 and varicella-zoster.  This agent inhibits the replication of viral DNA by interfering competitively with DNA polymerase. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29044</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fazarabine</VALIDVALUE>
          <VALUEMEANING>Fazarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally-active pyrimidine analogue of an aza-substituted cytidine in which the ribose moiety is replaced by an arabinose sugar. Similar in action to cytarabine, fazarabine is phosphorylated by deoxycytidine kinase to a triphosphate form which competes with thymidine for incorporation into DNA; its incorporation into DNA inhibits DNA synthesis, resulting in tumor cell death and tumor necrosis. The presence of deoxycytidine kinase in a tumor is a determinant of tumor sensitivity to this drug. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fenretinide</VALIDVALUE>
          <VALUEMEANING>Fenretinide</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally-active synthetic phenylretinamide analogue of retinol (vitamin A) with potential antineoplastic and chemopreventive activities.  Fenretinide binds to and activates retinoic acid receptors (RARs), thereby inducing cell differentiation and apoptosis in some tumor cell types.  This agent also inhibits tumor growth by modulating angiogenesis-associated growth factors and their receptors and exhibits retinoid receptor-independent apoptotic properties. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1098</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565816</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BMT, Allogeneic</VALIDVALUE>
          <VALUEMEANING>Allogeneic Bone Marrow Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>(AL-o-jen-AY-ik) A procedure in which a person receives stem cells, the cells from which all blood cell develop, from a compatible, though not genetically identical, donor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BMS 247550</VALIDVALUE>
          <VALUEMEANING>BMS 247550 (Ixabepilone)</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable semisynthetic analogue of epothilone B with antineoplastic activity. Ixabepilone binds to tubulin and promotes tubulin polymerization and microtubule stabilization, thereby arresting cells in the G2-M phase of the cell cycle and inducing tumor cell apoptosis. This agent demonstrates antineoplastic activity against taxane-resistant cell lines.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3145834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estramustine/Vinblastine</VALIDVALUE>
          <VALUEMEANING>Estramustine Vinblastine Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic molecule combining estradiol and nornitrogen mustard through a carbamate link. Estramustine and its major metabolite estramustine bind to microtubule-associated proteins (MAPs) and tubulin, thereby inhibiting microtubule dynamics and leading to anaphase arrest in a dose-dependent fashion. This agent also exhibits anti-androgenic effects. (NCI04): A natural alkaloid isolated from the plant Vinca rosea Linn. Vinblastine binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and arrest of tumor cells in the M phase of the cell cycle. This agent may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C930, C479</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estradiol</VALIDVALUE>
          <VALUEMEANING>Estradiol</VALUEMEANING>
          <MEANINGDESCRIPTION>Estradiol (E2). beta-estradiol; 17 beta-estradiol; 1,3,5(10)-estratriene-3,17 beta-diol; the most potent naturally occurring estrogen in mammals, formed by the ovary, placenta, testis, and possibly the adrenal cortex; therapeutic indications for estradiol are those typical of an estrogen. alpha-Estradiol, (17 alpha-estradiol), exhibits considerably less biologic activity. Estradiol is used in the treatment of menstrual disorders, menopause problems, etc. SYN estrogenic hormone, oestradiol.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epothilone D</VALIDVALUE>
          <VALUEMEANING>Epothilone D</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural polyketide compound isolated from the myxobacterium Sorangium cellulosum. Also known as desoxyepothilone B, epothilone D binds to tubulin and inhibits the disassembly of microtubules, resulting in the inhibition of mitosis, cellular proliferation, and cell motility. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2672</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epidermal Growth Factor (EGFR)</VALIDVALUE>
          <VALUEMEANING>Epidermal Growth Factor</VALUEMEANING>
          <MEANINGDESCRIPTION>Epidermal Growth Factor, encoded by the EGF gene, has a profound effect on the differentiation of specific cells in vivo and is a potent mitogenic factor for a variety of cultured cells of both ectodermal and mesodermal origin. The EGF precursor is believed to exist as a membrane-bound molecule that is proteolytically cleaved to generate the 53-amino acid peptide hormone that stimulates cells to divide. (From LocusLink)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MGCD265</VALIDVALUE>
          <VALUEMEANING>Multitargeted Tyrosine Kinase Inhibitor MGCD265</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, small-molecule, multitargeted tyrosine kinase inhibitor with potential antineoplastic activity. Multitargeted tyrosine kinase inhibitor MGCD265 binds to and inhibits the phosphorylation of several receptor tyrosine kinases (RTKs), including the c-Met receptor (hepatocyte growth factor receptor); the Tek/Tie-2 receptor; vascular endothelial growth factor receptor (VEGFR) types 1, 2, and 3; and the macrophage-stimulating 1 receptor (MST1R or RON). Inhibition of these RTKs and their downstream signaling pathways may result in the inhibition of tumor angiogenesis and tumor cell proliferation in tumors overexpressing these RTKs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3434560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enfuvirtide</VALIDVALUE>
          <VALUEMEANING>Enfuvirtide</VALUEMEANING>
          <MEANINGDESCRIPTION>A short polypeptide with activity against human immunodeficiency virus (HIV). Enfuvirtide binds to the first heptad-repeat (HR1) in the gp41 viral envelope glycoprotein, thereby preventing conformational changes required for fusion of viral and cellular membranes and preventing the virus from entering a host cell.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2105</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Efavirenz/Emtricitabine/Tenofovir</VALIDVALUE>
          <VALUEMEANING>Efavirenz Emtricitabine Tenofovir Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic non-nucleoside reverse transcriptase (RT) inhibitor with antiviral properties.  Efavirenz binds directly to the human immunodeficiency virus type 1 (HIV-1) RT, an RNA-dependent DNA polymerase, blocking its function in viral DNA replication.  In combination with other antiretroviral drugs, this agent has been shown to significantly reduce HIV viral loads, therefore retarding or preventing damage to the immune system, and reducing the risk of developing AIDS.  Efavirenz induces activity of the cytochrome P450 system, thereby accelerating its own metabolism. (NCI04): A synthetic fluoro derivative of thiacytidine with potent antiviral activity. Emtricitabine is phosphorylated to form emtricitabine 5&#39;-triphosphate within the cell. This metabolite inhibits the activity of human immunodeficiency virus (HIV) reverse transcriptase both by competing with the natural substrate deoxycytidine 5&#39;-triphosphate and by incorporation into viral DNA causing a termination of DNA chain elongation (due to the lack of the essential 3&#39;-OH group).: A synthetic antiviral acyclic nucleotide analogue of adenosine 5-monophosphate.  Tenofovir is incorporated into human immunodeficiency viral DNA instead of the natural substrate deoxyadenosine 5-triphosphate, thereby inhibiting HIV-1 reverse transcriptase (RT), an RNA-dependent DNA polymerase, and resulting in DNA chain termination and impairment of viral replication and propagation.  This agent prevents HIV from reproducing in uninfected cells only.  Tenofovir exhibits activity against the hepatitis B virus (HBV). (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C29490, C47509, C29027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epzicom</VALIDVALUE>
          <VALUEMEANING>Epzicom</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed combination of abacavir sulfate, a nucleoside reverse transcriptase inhibitor (NRTI) analog of guanosine and lamivudine, an NRTI analog of cytidine, that is used to treat human immunodeficiency virus (HIV) infection. Upon oral administration, abacavir and lamivudine are phosphorylated into active metabolites that compete for incorporation into viral DNA. These metabolites inhibit the HIV reverse transcriptase (RT) enzyme competitively and act as a chain terminator of DNA synthesis. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erlotinib</VALIDVALUE>
          <VALUEMEANING>Erlotinib</VALUEMEANING>
          <MEANINGDESCRIPTION>A quinazoline derivative with antineoplastic properties.  Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65530</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3237464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estramustine</VALIDVALUE>
          <VALUEMEANING>Estramustine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic molecule combining estradiol and nornitrogen mustard through a carbamate link. Estramustine and its major metabolite estramustine bind to microtubule-associated proteins (MAPs) and tubulin, thereby inhibiting microtubule dynamics and leading to anaphase arrest in a dose-dependent fashion. This agent also exhibits anti-androgenic effects. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C479</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>rhuMAB 2C4</VALIDVALUE>
          <VALUEMEANING>Pertuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized recombinant monoclonal antibody directed against the extracellular dimerization domain of the HER-2 tyrosine kinase receptor. Binding of the antibody to the dimerization domain of the HER-2 tyrosine kinase receptor protein directly inhibits the ability of the HER-2 tyrosine kinase receptor protein (the most common pairing partner) to dimerize with other HER tyrosine kinase receptor proteins; inhibiting receptor protein dimerization prevents the activation of HER signaling pathways, resulting in tumor cell apoptosis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cladribine</VALIDVALUE>
          <VALUEMEANING>Cladribine</VALUEMEANING>
          <MEANINGDESCRIPTION>A purine nucleoside antimetabolite analogue. Cladribine triphosphate, a phosphorylated metabolite of cladribine, incorporates into DNA, resulting in single-strand breaks in DNA, depletion of nicotinamide adenine dinucleotide (NAD) and adenosine triphosphate (ATP), and apoptosis.  Because this agent is resistant to adenosine deaminase, an enzyme that inactivates some antineoplastic agents, it is selectively toxic to lymphocytes and monocytes which exhibit little deoxynucleotide deaminase activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2829877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clofarabine</VALIDVALUE>
          <VALUEMEANING>Clofarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A second generation purine nucleoside analog with antineoplastic activity. Clofarabine is phosphorylated intracellularly to the cytotoxic active 5&#39;-triphosphate metabolite, which inhibits the enzymatic activities of ribonucleotide reductase and DNA polymerase, resulting in inhibition of DNA repair and synthesis of DNA and RNA. This nucleoside analog also disrupts mitochondrial function and membrane integrity, resulting in the release of pre-apoptotic factors, including cytochrome C and apoptotic-inducing factors, which activate apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clofazimine</VALIDVALUE>
          <VALUEMEANING>Clofazimine</VALUEMEANING>
          <MEANINGDESCRIPTION>A phenazine dye with anti-mycobacterial and anti-inflammatory activity. The exact mechanism through which clofazime exerts its effect is unknown.  However, it binds preferentially to mycobacterial DNA, thereby inhibiting DNA replication and cell growth. Clofazimine has a slow bactericidal effect on Mycobacterium leprae and is active against various other Mycobacteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colchicine</VALIDVALUE>
          <VALUEMEANING>Colchicine</VALUEMEANING>
          <MEANINGDESCRIPTION>An alkaloid isolated from Colchicum autumnale L. and in other Colchicum species. Colchicine binds to tubulin, thereby inhibiting microtubule assembly, inducing microtubule disassembly, and disrupting mitosis. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PS IL-10/Placebo</VALIDVALUE>
          <VALUEMEANING>PS IL-10/Placebo</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pred/Cyclo/Etop/Dox (PACE)</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Doxorubicin/Etoposide/Prednisone</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10861</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>S-1/Cisplatin</VALIDVALUE>
          <VALUEMEANING>SI/ Cisplatin Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable fluoropyrimidine antagonist composed of tegafur combined with two modulators of 5-flurouracil (5-FU) activity, gimeracil and potassium oxonate, in a molar ratio of 1:0.4:1. Tegafur is a prodrug of 5-fluorouracil, an antimetabolite that inhibits thymidylate synthase, DNA synthesis and cell division, and competes with uridine triphosphate, thus inhibiting RNA and protein synthesis. Gimeracil is a reversible inhibitor of dihydropyrimidine dehydrogenase (DPD), the liver enzyme responsible for rapid catabolism of 5-FU into inactive metabolites. Potassium oxonate preferentially localizes in the gut and inhibits the enzyme orotate phosphoribosyl-transferase (OPRT), thereby decreasing activation of 5-FU in the gut and activated 5-FU-related gastrointestinal toxicity.: An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C376, C1833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hycaptmn</VALIDVALUE>
          <VALUEMEANING>Hycaptmn</VALUEMEANING>
          <MEANINGDESCRIPTION>Hycaptmn</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Humanized AntiTac Toxin</VALIDVALUE>
          <VALUEMEANING>LMB-2 Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>A fusion protein consisting of the Fv portion of a monoclonal antibody attached to a 38-kDa fragment of the Pseudomonas exotoxin A (with amino acids 365-380 deleted).  LMB-2 immunotoxin targets the interleukin 2 receptor (also known as IL-2R or CD25) which is expressed on activated normal T and B cells and macrophages and on the cells of various hematologic malignancies.  The antibody attaches to the IL-2R on the cell membrane, facilitating the entry of the exotoxin. The exotoxin moiety induces caspase-mediated apoptosis of tumor cells via a mechanism involving mitochondrial damage; it also catalyzes the transfer of ADP ribose from nicotinamide adenine dinucleotide (NAD) to elongation factor-2 in eukaryotic cells, thereby inactivating elongation factor 2 and inhibiting protein synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GMX177</VALIDVALUE>
          <VALUEMEANING>Teglarinad Chloride</VALUEMEANING>
          <MEANINGDESCRIPTION>A water-soluble prodrug of a cyanoguanidine compound with potential antineoplastic activity. In vivo, teglarinad chloride is rapidly converted into active drug through hydrolytic cleavage of a carbonate ester bond. Although the exact mechanism of action has yet to be fully elucidated, the active drug appears to antagonize nuclear factor-kappa B (NF-kB) transcription, resulting in the induction of tumor cell apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68931</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443983</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Finasteride</VALIDVALUE>
          <VALUEMEANING>Finasteride</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic azasteroid compound.  Finasteride binds to and inhibits 5-alpha-reductase, thereby interfering with the enzymatic conversion of testosterone to 5-dihydrotestosterone, ultimately interfering with prostate growth. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flavopiridol</VALIDVALUE>
          <VALUEMEANING>Flavopiridol</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic N-methylpiperidinyl chlorophenyl flavone compound. As an inhibitor of cyclin-dependent kinase, flavopiridol induces cell cycle arrest by preventing phosphorylation of cyclin-dependent kinases (cdk) and by down-regulating cyclin D1 and D3 expression, resulting in G1 cell cycle arrest and apoptosis.  This agent is also a competitive inhibitor of adenosine triphosphate activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fludarabine</VALIDVALUE>
          <VALUEMEANING>Fludarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A fluorinated nucleotide antimetabolite analog of the antiviral agent vidarabine (ara-A) with antineoplastic activity. Administered parenterally as a phosphate salt, fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite may inhibit DNA polymerase alpha, ribonucleotide reductase and DNA primase, thereby interrupting DNA synthesis and inhibiting tumor cell growth.  </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1094</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluocinonide</VALIDVALUE>
          <VALUEMEANING>Fluocinonide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic glucocorticoid and derivative of fluocinolone acetonide with anti-inflammatory and antipruritic activities. Fluocinonide binds the glucocorticoid receptor, followed by translocation of the ligand-receptor complex to the nucleus and transcription activation of genes containing glucocorticoid-responsive elements. Lipocortin-1 is one factor induced by fluocinonide that interacts and inhibits cytosolic phospholipase 2 alpha, thereby preventing phospholipase translocation to the perinuclear membrane and subsequent release and conversion of arachidonic acid to inflammatory prostaglandins. In addition, MAPK phosphatase 1 is induced, thereby preventing the triggering of the MAPK cascade resulting in pro-inflammatory effects via Jun N-terminal kinase and c-Jun. Finally, fluocinonide binds to and inhibits nuclear factor kappa-B directly, resulting in inhibition of cyclooxygenase 2 transcription and subsequent prostaglandin synthesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29056</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flutamide</VALIDVALUE>
          <VALUEMEANING>Flutamide</VALUEMEANING>
          <MEANINGDESCRIPTION>An anticancer drug that belongs to the family of drugs called antiandrogens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluoxymesterone</VALIDVALUE>
          <VALUEMEANING>Fluoxymesterone</VALUEMEANING>
          <MEANINGDESCRIPTION>An anabolic steroid that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FOLFIRI</VALIDVALUE>
          <VALUEMEANING>FOLFIRI Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An abbreviation for a chemotherapy combination used to treat advanced colorectal cancer that has spread. It is also being studied in the treatment of other types of cancer. It includes the drugs leucovorin calcium (folinic acid), fluorouracil, and irinotecan hydrochloride.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63593</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fortovase</VALIDVALUE>
          <VALUEMEANING>Fortovase (Saquinavir)</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic antiviral agent.  Saquinavir, a peptide-like substrate, selectively binds to and inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tipranavir</VALIDVALUE>
          <VALUEMEANING>Tipranavir</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-peptidomimetic agent that inhibits both wild type and drug resistant forms of human immunodeficiency virus (HIV) protease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tipifarnib (Zarnestra)</VALIDVALUE>
          <VALUEMEANING>Tipifarnib</VALUEMEANING>
          <MEANINGDESCRIPTION>A nonpeptidomimetic quinolinone with potential antineoplastic activity. Tipifarnib binds to and inhibits the enzyme farnesyl protein transferase, an enzyme involved in protein processing (farnesylation) for signal transduction.  By inhibiting the farnesylation of proteins, this agent prevents the activation of Ras oncogenes, inhibits cell growth, induces apoptosis, and inhibits angiogenesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1703</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyrotropin Alfa</VALIDVALUE>
          <VALUEMEANING>Recombinant Thyrotropin Alfa</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of thyroid-stimulating hormone (TSH) that is made in the laboratory. It is used to test for remaining or recurring cancer cells in patients who have been treated for thyroid cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61322</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thiotepa</VALIDVALUE>
          <VALUEMEANING>Thiotepa</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic alkylating agent. Related to nitrogen mustard, thiotepa alkylates and crosslinks DNA, resulting in the inhibition of DNA replication. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739553</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Theratope Vaccine</VALIDVALUE>
          <VALUEMEANING>Sialyl Tn-KLH Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A vaccine composed of a substance that enhances immunity plus an antigen found on some tumors of the colon, breast, lung, ovary, pancreas, and stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1690</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tetrathiomylybdate (TM)</VALIDVALUE>
          <VALUEMEANING>Ammonium Tetrathiomolybdate</VALUEMEANING>
          <MEANINGDESCRIPTION>An ammonium salt with potential antiangiogenic and antitumor activities. Tetrathiomolybdate has been found to deplete systemic copper reserves through an unknown mechanism. This agent has been shown to inhibit the activities of cuproenzymes, including superoxide dismutase 1 (SOD1) and cytochrome c oxidase (COX), which may contribute to its antiangiogenic and antitumor effects.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74001</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Teniposide (VM-26)</VALIDVALUE>
          <VALUEMEANING>Teniposide</VALUEMEANING>
          <MEANINGDESCRIPTION>An anticancer drug that is a podophyllotoxin derivative and belongs to the family of drugs called mitotic inhibitors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C857</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pyrazinamide</VALIDVALUE>
          <VALUEMEANING>Pyrazinamide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic pyrazinoic acid amide derivative with bactericidal property. Pyrazinamide is particularly active against slowly multiplying intracellular bacilli (unaffected by other drugs) by an unknown mechanism of action. Its bactericidal action is dependent upon the presence of bacterial pyrazinamidase, which removes the amide group to produce active pyrazinoic acid. Pyrazinamide is an important component of multidrug therapy for tuberculosis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EPOCH/FR</VALIDVALUE>
          <VALUEMEANING>EPOCH Regimen Fludarabine Rituximab Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of etoposide, prednisone, vincristine (Oncovin) and doxorubicin hydrochloride (hydroxydaunorubicin hycrochloride), which may be used in combination with rituximab (R-EPOCH) for the treatment of various aggressive B cell and T cell non-Hodgkin lymphomas.: A fluorinated nucleotide antimetabolite analog of the antiviral agent vidarabine (ara-A) with antineoplastic activity. Administered parenterally as a phosphate salt, fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite may inhibit DNA polymerase alpha, ribonucleotide reductase and DNA primase, thereby interrupting DNA synthesis and inhibiting tumor cell growth.  : A recombinant chimeric murine/human antibody directed against the CD20 antigen, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes. Following binding, rituximab triggers a host cytotoxic immune response against CD20-positive cells. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1702, C1094, C63779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Emtric/Tenof Dis Fumarate (Truvada)</VALIDVALUE>
          <VALUEMEANING>Emtricitabine Tenofovir Disoproxil Fumarate Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic fluoro derivative of thiacytidine with potent antiviral activity. Emtricitabine is phosphorylated to form emtricitabine 5&#39;-triphosphate within the cell. This metabolite inhibits the activity of human immunodeficiency virus (HIV) reverse transcriptase both by competing with the natural substrate deoxycytidine 5&#39;-triphosphate and by incorporation into viral DNA causing a termination of DNA chain elongation (due to the lack of the essential 3&#39;-OH group).: A pro-drug, fumaric acid salt form of tenofovir, a nucleoside reverse transcriptase inhibitor analog of adenosine. Tenofovir disoproxil fumarate is prescribed to treat HIV and chronic hepatitis B virus (HBV) in adults.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C47747, C47509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CGN-15/Taxotere</VALIDVALUE>
          <VALUEMEANING>CGN-15/Taxotere</VALUEMEANING>
          <MEANINGDESCRIPTION>CGN-15/Taxotere</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboplatin/Gemcitabine</VALIDVALUE>
          <VALUEMEANING>Carboplatin/Gemcitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BMS 599626</VALIDVALUE>
          <VALUEMEANING>pan-HER Kinase Inhibitor AC480</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable pan-HER tyrosine kinase inhibitor with potential antineoplastic activity. BMS-599626 inhibits human epidermal growth factor receptors (HER) HER1, HER2 and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443990</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5-Fluorodeoxycytadine</VALIDVALUE>
          <VALUEMEANING>5-Fluorodeoxycytadine</VALUEMEANING>
          <MEANINGDESCRIPTION>5-Fluorodeoxycytadine</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vemurafenib</VALIDVALUE>
          <VALUEMEANING>Vemurafenib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, ATP-competitive, small-molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity. Vemurafenib selectively binds to the ATP-binding site of BRAF(V600E) kinase and inhibits its activity, which may result in an inhibition of an over-activated MAPK signaling pathway downstream in BRAF(V600E) kinase-expressing tumor cells and a reduction in tumor cell proliferation. Approximately 90% of BRAF gene mutations involve a valine-to-glutamic acid mutation at residue 600 (V600E); the oncogene protein product, BRAF(V600E) kinase, exhibits a markedly elevated activity that over-activates the MAPK signaling pathway. The BRAF(V600E) gene mutation has been found to occur in approximately 60% of melanomas, and in about 8% of all solid tumors, including melanoma, colorectal, thyroid and other cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3422122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thalidomide/Placebo</VALIDVALUE>
          <VALUEMEANING>Thalidomide Placebo Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of glutamic acid (alpha-phthalimido-glutarimide) with teratogenic, immunomodulatory, anti-inflammatory and anti-angiogenic properties.  Thalidomide acts primarily by inhibiting both the production of tumor necrosis factor alpha (TNF-alpha) in stimulated peripheral monocytes and the activities of interleukins and interferons.  This agent also inhibits polymorphonuclear chemotaxis and monocyte phagocytosis.  Thalidomide inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), thereby inhibiting angiogenesis. (NCI04): An inactive substance, treatment or procedure that is intended to mimic as closely as possible a therapy in a clinical trial.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C753, C870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443996</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Study Med 98C0118</VALIDVALUE>
          <VALUEMEANING>StudyMed 98C0118</VALUEMEANING>
          <MEANINGDESCRIPTION>StudyMed 98C0118</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443997</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Study Med 00C0080</VALIDVALUE>
          <VALUEMEANING>StudyMed 00C0080</VALUEMEANING>
          <MEANINGDESCRIPTION>StudyMed 00C0080</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3443998</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strontium</VALIDVALUE>
          <VALUEMEANING>Strontium</VALUEMEANING>
          <MEANINGDESCRIPTION>An element with atomic symbol Sr, atomic number 38, and atomic weight 87.62.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Streptozocin</VALIDVALUE>
          <VALUEMEANING>Streptozocin</VALUEMEANING>
          <MEANINGDESCRIPTION>A methylnitrosourea antineoplastic antibiotic isolated from the bacterium Streptomyces achromogenes.  Streptozocin alkylates DNA, forming inter-strand DNA cross-links and inhibiting DNA synthesis.  Due to its glucose moiety, this agent is readily taken up by pancreatic beta cells, inducing diabetes mellitus at high concentrations.  Unlike other nitrosoureas, streptozocin causes little myelosuppression. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C845</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stem Cell Transplant</VALIDVALUE>
          <VALUEMEANING>Stem Cell Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of replacing the immature blood-forming cells lost due to high-dose chemotherapy, and possibly radiation therapy, used to destroy leukemia cells.  The stem cells are given to the patient after treatment to help the bone marrow recover and continue producing healthy blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sorafenib (Nexavar)</VALIDVALUE>
          <VALUEMEANING>Sorafenib</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SS1(dsFv)-PE38</VALIDVALUE>
          <VALUEMEANING>SS1(dsFv)-PE38 Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant immunotoxin consisting of the single chain anti-mesothelin monoclonal antibody SS1(dsFv) linked to Pseudomonas exotoxin PE-38. The monoclonal antibody moiety of the agent binds to cells that express mesothelin, a cell surface glycoprotein which may be overexpressed in ovarian cancer, mesotheliomas, and some squamous cell carcinomas; after internalization, the exotoxin moiety inactivates eukaryotic translation elongation factor 2, thereby disrupting tumor cell protein synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SNX-6522 (Mesylate)</VALIDVALUE>
          <VALUEMEANING>Hsp90 Inhibitor SNX-5422 Mesylate</VALUEMEANING>
          <MEANINGDESCRIPTION>The orally bioavailable mesylate salt of a synthetic prodrug targeting the human heat-shock protein 90 (Hsp90) with potential antineoplastic activity. Although the mechanism of action remains to be fully elucidated, Hsp90 inhibitor SNX-5422 is rapidly converted to SNX-2112, which accumulates more readily in tumors relative to normal tissues. SNX-2112 inhibits Hsp90, which may result in the proteasomal degradation of oncogenic client proteins, including HER2/ERBB2, and the inhibition of tumor cell proliferation. Hsp90 is a molecular chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, such as HER2/ERBB2, AKT, RAF1, BCR-ABL, and mutated p53, as well as many other molecules that are important in cell cycle regulation or immune responses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91068</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sulfasalazine</VALIDVALUE>
          <VALUEMEANING>Sulfasalazine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic salicylic acid derivative with affinity for connective tissues containing elastin and formulated as a prodrug, antiinflammatory Sulfasalazine acts locally in the intestine through its active metabolites, sulfamide 5-aminosalicylic acid and salicylic acid, by a mechanism that is not clear. It appears inhibit cyclooxygenase and prostaglandin production and is used in the management of inflammatory bowel diseases. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sunitinib Malate</VALIDVALUE>
          <VALUEMEANING>Sunitinib Malate</VALUEMEANING>
          <MEANINGDESCRIPTION>The orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity.  Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation.  This agent also inhibits the phosphorylation of Fms-related tyrosine kinase 3 (FLT3), another receptor tyrosine kinase expressed by some leukemic cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26673</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2679054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suramin</VALIDVALUE>
          <VALUEMEANING>Suramin</VALUEMEANING>
          <MEANINGDESCRIPTION>A polysulphonated naphthylurea with potential antineoplastic activity.  Suramin blocks the binding of various growth factors, including insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and tumor growth factor-beta (TGF-beta), to their receptors, thereby inhibiting endothelial cell proliferation and migration.  This agent also inhibits vascular endothelial growth factor (VEGF)- and basic fibroblast growth factor (bFGF)-induced angiogenesis; retroviral reverse transcriptase; uncoupling of G-proteins from receptors; topoisomerases; cellular folate transport; and steroidogenesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suramin/HC</VALIDVALUE>
          <VALUEMEANING>Hydrocortisone/Suramin</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10154</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suramin/AGT/HC</VALIDVALUE>
          <VALUEMEANING>Aminoglutethimide/Hydrocortisone/Suramin</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WR2721</VALIDVALUE>
          <VALUEMEANING>Amifostine</VALUEMEANING>
          <MEANINGDESCRIPTION>A phosphorylated aminosulfhydryl compound. After dephosphorylation by alkaline phosphatase to an active free sulfhydryl (thiol) metabolite, amifostine binds to and detoxifies cytotoxic platinum-containing metabolites of cisplatin and scavenges free radicals induced by cisplatin and ionizing radiation. The elevated activity of this agent in normal tissues results from both the relative abundance of alkaline phosphatase in normal tissues and the greater vascularity of normal tissues compared to tumor tissues. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380282</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dHER2+ASCI</VALIDVALUE>
          <VALUEMEANING>dHER2 + AS15 candidate Antigen-Specific Cancer Imunotherapeutic (ASCI)</VALUEMEANING>
          <MEANINGDESCRIPTION>dHER2 + AS15 candidate Antigen-Specific Cancer Imunotherapeutic (ASCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vinblastine/Lomustine</VALIDVALUE>
          <VALUEMEANING>Vinblastine Lomustine Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural alkaloid isolated from the plant Vinca rosea Linn. Vinblastine binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and arrest of tumor cells in the M phase of the cell cycle. This agent may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04): A nitrosourea with antineoplastic activity. Lomustine alkylates and crosslinks DNA, thereby inhibiting DNA and RNA synthesis.  This agent also carbamoylates DNA and proteins, resulting in inhibition of DNA and RNA synthesis and disruption of RNA processing.  Lomustine is lipophilic and crosses the blood-brain barrier. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C617, C930</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vinblastine/Lomustine/Pred</VALIDVALUE>
          <VALUEMEANING>Vinblastine Lomustine Prednisone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural alkaloid isolated from the plant Vinca rosea Linn. Vinblastine binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and arrest of tumor cells in the M phase of the cell cycle. This agent may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04): A nitrosourea with antineoplastic activity. Lomustine alkylates and crosslinks DNA, thereby inhibiting DNA and RNA synthesis.  This agent also carbamoylates DNA and proteins, resulting in inhibition of DNA and RNA synthesis and disruption of RNA processing.  Lomustine is lipophilic and crosses the blood-brain barrier. (NCI04): A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C770, C617, C930</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vinblastine/Etoposide/Pred</VALIDVALUE>
          <VALUEMEANING>Etoposide/Prednisone/Vinblastine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vinblastine</VALIDVALUE>
          <VALUEMEANING>Vinblastine</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural alkaloid isolated from the plant Vinca rosea Linn. Vinblastine binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and arrest of tumor cells in the M phase of the cell cycle. This agent may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C930</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VAC</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Doxorubicin/Vincristine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9540</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ursodeoxycholic acid</VALIDVALUE>
          <VALUEMEANING>Ursodiol</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetically-derived form of ursodiol, a bile acid produced by the liver and secreted and stored in the gallbladder.  Also produced by the Chinese black bear liver, ursodiol has been used in the treatment of liver disease for centuries.  This agent dissolves or prevents cholesterol gallstones by blocking hepatic cholesterol production and decreasing bile cholesterol.  Ursodiol also reduces the absorption of cholesterol from the intestinal tract.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1818</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UVB</VALIDVALUE>
          <VALUEMEANING>Ultraviolet B Radiation</VALUEMEANING>
          <MEANINGDESCRIPTION>Ultraviolet B Radiation is the 290 to 320 nanometers portion of the sun&#39;s radiant electromagnetic energy spectrum, partially absorbed by the Earth&#39;s protective stratospheric ozone layer. Recent ozone depletion has permitted more UVB to reach the Earth&#39;s surface with a wide range of potentially damaging health effects related to skin, eyes, and immune system. Evidence shows a dose-response relationship between nonmelanoma skin cancer and cumulative exposure to UVB radiation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Warburg Therapy</VALIDVALUE>
          <VALUEMEANING>Warburg Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The cornerstone of oxygenation therapy is the presumption that human disease, including cancer, is caused by a deficit of tissue oxygen. According to proponents, hypoxia results in anaerobic fermentation, a loss of capacity for oxidative detoxification of toxins and metabolic products, and failure of immune killing of invading bacteria and viruses. To restore ability to carry out these functions, oxygenation promoters propose using chemicals they claim will release oxygen in tissue or act as germicides in vivo.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adefovir</VALIDVALUE>
          <VALUEMEANING>Adefovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A nucleoside reverse transcriptase inhibitor analog of adenosine with activity against hepatitis B virus (HBV), herpes virus, and human immunodeficiency virus (HIV).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575649</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epothilone B</VALIDVALUE>
          <VALUEMEANING>Epothilone B</VALUEMEANING>
          <MEANINGDESCRIPTION>A compound isolated from the myxobacterium Sorangium cellulosum.  Similar to paclitaxel, epothilone B induces microtubule polymerization and stabilizes microtubules against depolymerization conditions.  In addition to promoting tubulin polymerization and stabilization of microtubules, this agent is cytotoxic for cells overexpressing P-glycoprotein, a characteristic that distinguishes it from the taxanes.  Epothilone B may cause complete cell-cycle arrest. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3013195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abacavir Sulfate/Lamivudine</VALIDVALUE>
          <VALUEMEANING>Abacavir Sulfate Lamivudine Combination</VALUEMEANING>
          <MEANINGDESCRIPTION>The sulfate salt form of abacavir, a synthetic carbocyclic nucleoside analog. In vivo, the activated triphosphate metabolite of abacavir is incorporated into the viral DNA instead of the natural substrate deoxyguanosine, thereby inhibiting human immunodeficiency virus (HIV) reverse transcriptase (RT) and, so, the replication of the viral DNA and infectious viral particles. This agent decreases HIV viral loads, retards or prevents the damage to the immune system, and reduces the risk of developing AIDS.: A synthetic nucleoside analogue with activity against hepatitis B virus (HBV) and HIV. Intracellularly, lamivudine is phosphorylated to its active metabolites, lamiduvine triphosphate (L-TP) and lamiduvine monophosphate (L-MP).  In HIV, L-TP inhibits HIV-1 reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleoside analogue into viral DNA.  In HBV, incorporation of L-MP into viral DNA by HBV polymerase results in DNA chain termination. L-TP is a weak inhibitor of mammalian DNA polymerases alpha and beta, and mitochondrial DNA polymerase. (NCI04): A collection of things that have been assembled together to form a new whole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61517, C1471, C28804</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abacavir</VALIDVALUE>
          <VALUEMEANING>Abacavir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic carbocyclic nucleoside analog.  In vivo, the activated triphosphate metabolite of abacavir is incorporated into the viral DNA instead of the natural substrate deoxyguanosine, thereby inhibiting human immunodeficiency virus (HIV) reverse transcriptase (RT) and, so, the replication of the viral DNA and infectious viral particles.  This agent decreases HIV viral loads, retards or prevents the damage to the immune system, and reduces the risk of developing AIDS.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abacavir/AZT/3TC</VALIDVALUE>
          <VALUEMEANING>Abacavir Zidovudine Lamivudine Combination</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic carbocyclic nucleoside analog.  In vivo, the activated triphosphate metabolite of abacavir is incorporated into the viral DNA instead of the natural substrate deoxyguanosine, thereby inhibiting human immunodeficiency virus (HIV) reverse transcriptase (RT) and, so, the replication of the viral DNA and infectious viral particles.  This agent decreases HIV viral loads, retards or prevents the damage to the immune system, and reduces the risk of developing AIDS.: A synthetic dideoxynucleoside. After intracellular phosphorylation to its active metabolite, zidovudine inhibits DNA polymerase, resulting in the inhibition of DNA replication and cell death. This agent also decreases levels of available pyrimidines. (NCI04): A synthetic nucleoside analogue with activity against hepatitis B virus (HBV) and HIV. Intracellularly, lamivudine is phosphorylated to its active metabolites, lamiduvine triphosphate (L-TP) and lamiduvine monophosphate (L-MP).  In HIV, L-TP inhibits HIV-1 reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleoside analogue into viral DNA.  In HBV, incorporation of L-MP into viral DNA by HBV polymerase results in DNA chain termination. L-TP is a weak inhibitor of mammalian DNA polymerases alpha and beta, and mitochondrial DNA polymerase. (NCI04): A collection of things that have been assembled together to form a new whole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61517, C1471, C947, C61523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AZT (Zidovudine)</VALIDVALUE>
          <VALUEMEANING>Zidovudine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic dideoxynucleoside. After intracellular phosphorylation to its active metabolite, zidovudine inhibits DNA polymerase, resulting in the inhibition of DNA replication and cell death. This agent also decreases levels of available pyrimidines. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C947</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3128742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Advair</VALIDVALUE>
          <VALUEMEANING>Fluticasone Salmeterol Combination</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic trifluorinated glucocorticoid receptor agonist with antiallergic, antiinflammatory and antipruritic effects. Fluticasone binds and activates glucocorticoid receptor, resulting in the activation of lipocortin. Lipocortin, in turn, inhibits cytosolic phospholipase A2, which triggers a cascade of reactions involved in the synthesis of inflammatory mediators, such as prostaglandins and leukotrienes. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leads to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production.: A highly selective, long-acting beta-2 adrenergic agonist with bronchodilatory activity. Salmeterol&#39;s benzene moiety resembles the structure of catecholamines, and occupies the active site of beta-2 adrenergic receptor, while the long, lipophilic side chain of salmeterol, binds to the so called &#39;exosite&#39; near the beta-2 adrenergic receptors. The binding at the exosite allows the active portion of the molecule to remain at the receptor site and continually engage and disengage with the receptor, therefore providing a long duration of action. This agent stimulates intracellular adenyl cyclase to catalyze the conversion of adenosine triphosphate to cyclic-3&#39;,5&#39;-adenosine monophosphate (cAMP). Increased cAMP levels result in relaxation of bronchiolar smooth muscle, bronchodilation and increased bronchial airflow.: A collection of things that have been assembled together to form a new whole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61517, C29443, C61767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alphavirus Vector CEA</VALIDVALUE>
          <VALUEMEANING>Vector Carcinoembryonic Antigen Alphavirus</VALUEMEANING>
          <MEANINGDESCRIPTION>A single dimensional array.: Carcinoembryonic antigen. A substance that is sometimes found in an increased amount in the blood of people with certain cancers.: A genus of TOGAVIRIDAE, also known as Group A arboviruses, serologically related to each other but not to other Togaviridae. The viruses are transmitted by mosquitoes. The type species is the SINDBIS VIRUS.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0002331, C25159, C54169</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AZD8055</VALIDVALUE>
          <VALUEMEANING>mTOR Kinase Inhibitor AZD8055</VALUEMEANING>
          <MEANINGDESCRIPTION>An inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. mTOR kinase inhibitor AZD8055 inhibits the serine/threonine kinase activity of mTOR, resulting in decreased expression of mRNAs necessary for cell cycle progression, which may induce cell cycle arrest and tumor cell apoptosis. mTOR phosphorylates transcription factors, such as S6K1 and 4E-BP1, which stimulate protein synthesis and regulate cell growth, proliferation, motility, and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78856</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cabazitaxel</VALIDVALUE>
          <VALUEMEANING>Cabizitaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>A semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity. Cabazitaxel binds to and stabilizes tubulin, resulting in the inhibition of microtubule depolymerization and cell division, cell cycle arrest in the G2/M phase, and the inhibition of tumor cell proliferation. Unlike other taxane compounds, this agent is a poor substrate for the membrane-associated, multidrug resistance (MDR), P-glycoprotein (P-gp) efflux pump and may be useful for treating multidrug-resistant tumors. In addition, cabazitaxel penetrates the blood-brain barrier (BBB).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66937</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939033</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lexatumumb</VALIDVALUE>
          <VALUEMEANING>Lexatumumb</VALUEMEANING>
          <MEANINGDESCRIPTION>Lexatumumb</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetylcysteine</VALIDVALUE>
          <VALUEMEANING>Acetylcysteine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic N-acetyl derivative of the endogenous amino acid L-cysteine, a precursor of the antioxidant enzyme glutathione.  Acetylcysteine regenerates liver stores of glutathione. This agent also reduces disulfide bonds in mucoproteins, resulting in liquification of mucus.  Some evidence suggests that acetylcysteine may exert an anti-apoptotic effect due to its antioxidant activity, possibly preventing cancer cell development or growth.  In addition, acetylcysteine has inhibited viral stimulation by reactive oxygen intermediates, thereby producing antiviral activity in HIV patients. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3128727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acitretin</VALIDVALUE>
          <VALUEMEANING>Acitretin</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally-active metabolite of the synthetic aromatic retinoic acid agent etretinate with potential antineoplastic, chemopreventive, anti-psoratic, and embryotoxic properties.  Acitretin activates nuclear retinoic acid receptors (RAR), resulting in induction of cell differentiation, inhibition of cell proliferation, and inhibition of tissue infiltration by inflammatory cells.  This agent may also inhibit tumor angiogenesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acivicin</VALIDVALUE>
          <VALUEMEANING>Acivicin</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified amino acid and structural analog of glutamine.  Acivicin inhibits glutamine amidotransferases in the purine and pyrimidine biosynthetic pathways, thereby inhibiting tumor growth in cell lines dependent on glutamine metabolism. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aminoglutethimide/Hydrocortisone</VALIDVALUE>
          <VALUEMEANING>Aminoglutethimide Cortisol Combination</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of the sedative and anticonvulsant glutethimide with anti-steroid properties.  Originally used as an anticonvulsant, aminoglutethimide also blocks adrenal steroidogenesis by inhibiting the enzymatic conversion of cholesterol to pregnenolone.  In addition, this agent blocks the peripheral aromatization of androgenic precursors to estrogens.  Aminoglutethimide does not suppress ovarian estrogen production.: The main glucocorticoid secreted by the adrenal cortex. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.: A collection of things that have been assembled together to form a new whole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61517, C2290, C233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1, 3-galactosyltransferase</VALIDVALUE>
          <VALUEMEANING>Alpha-1, 3-galactosyltransferase</VALUEMEANING>
          <MEANINGDESCRIPTION>Alpha-1, 3-galactosyltransferase</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BACOD</VALIDVALUE>
          <VALUEMEANING>Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Vincristine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B3 (Monoclonal Antibody B3)</VALIDVALUE>
          <VALUEMEANING>Monoclonal Antibody B3</VALUEMEANING>
          <MEANINGDESCRIPTION>A murine IgG1 monoclonal antibody directed against Lewis Y antigen and related carbohydrate antigens of cell surface glycoproteins found in many tumor cells.  Monoclonal antibody B3 can be conjugated with various toxins in order to target their cytotoxic activity to tumor cells expressing these carbohydrate antigens. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antineoplaston</VALIDVALUE>
          <VALUEMEANING>Antineoplaston Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>A peptide, amino acid derivative, and/or organic acid extracted from blood serum, urine, or synthesized chemically, that inhibits the methylation of nucleic acids and the incorporation of L-glutamine into tumor-cell proteins. These agents also intercalate into DNA, leading to cell cycle arrest in the G1 phase and inhibition of mitosis and terminal cell differentiation. In addition, antineoplastons may inhibit RAS oncogene expression and activate the tumor suppressor gene p53, resulting in cell differentiation and apoptosis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Altretamine</VALIDVALUE>
          <VALUEMEANING>Hexamethylmelamine (Altretamine)</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic cytotoxic s-triazine derivative similar in structure to alkylating agent triethylenemelamin with antineoplastic activity.  Although the precise mechanism by which altretamine exerts its cytotoxic effect is unknown, N-demethylation of altretamine may produce reactive intermediates which covalently bind to DNA, resulting in DNA damage. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C544</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alternative Therapy</VALIDVALUE>
          <VALUEMEANING>Alternative Medicine, Indirect</VALUEMEANING>
          <MEANINGDESCRIPTION>Medical substance or procedure in the process of becoming accepted by orthodox western medicine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19937</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aldesleukin</VALIDVALUE>
          <VALUEMEANING>Aldesleukin</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant therapeutic agent which is chemically identical to or similar to the endogenous human cytokine interleukin-2 with potential antineoplastic activity.  Aldesleukin enhances lymphocyte mitogenesis, stimulates long-term growth of human IL-2 dependent cell lines, enhances lymphocyte cytotoxicity, induces lymphokine-activated killer (LAK) cell and natural killer (NK) cell activities, and induces expression of interferon-gamma. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vincristine</VALIDVALUE>
          <VALUEMEANING>Vincristine</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vindesine</VALIDVALUE>
          <VALUEMEANING>Vindesine</VALUEMEANING>
          <MEANINGDESCRIPTION>Vinblastine derivative with antineoplastic activity against acute leukemia, lung cancer, carcinoma of the breast, squamous cell carcinoma of the esophagus, head, and neck, and Hodgkin&#39;s and non-Hodgkin&#39;s lymphomas. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vinorelbine</VALIDVALUE>
          <VALUEMEANING>Vinorelbine</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic vinca alkaloid. Vinorelbine binds to tubulin and prevents formation of the mitotic spindle,resulting in the arrest of tumor cell growth in metaphase. This agent may also interfere with amino acid, cyclic AMP. and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin B12</VALIDVALUE>
          <VALUEMEANING>Vitamin B12</VALUEMEANING>
          <MEANINGDESCRIPTION>A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C939</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vorinostat</VALIDVALUE>
          <VALUEMEANING>Vorinostat</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic hydroxamic acid derivative with antineoplastic activity. Vorinostat, a second generation polar-planar compound, binds to the catalytic domain of the histone deacetylases (HDACs). This allows the hydroxamic moiety to chelate zinc ion located in the catalytic pockets of HDAC, thereby inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors. Hyperacetylation of histone proteins results in the upregulation of the cyclin-dependant kinase p21, followed by G1 arrest. Hyperacetylation of non-histone proteins such as tumor suppressor p53, alpha tubulin, and heat-shock protein 90 produces additional anti-proliferative effects. This agent also induces apoptosis and sensitizes tumor cells to cell death processes. Vorinostat crosses the blood-brain barrier.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ddI</VALIDVALUE>
          <VALUEMEANING>Didanosine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic nucleoside analogue of deoxyadenosine in which the 3&#39; hydroxyl on the ribose moiety is replaced by a hydrogen atom. In vivo, didanosine is converted to the active triphosphate form, which is incorporated into DNA. The absence of the 3&#39; hydroxyl inhibits DNA elongation because phosphodiester bonds cannot be made with the substituted hydrogen. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VNP 20009</VALIDVALUE>
          <VALUEMEANING>Salmonella VNP20009</VALUEMEANING>
          <MEANINGDESCRIPTION>A genetically stable Salmonella typhimurium strain, attenuated by chromosomal deletion of the purI and msbB genes, with tumor-targeting activity. In rodent models, salmonella VNP20009 has been shown to selectively accumulate and grow in a variety of tumor types, inhibiting the growth of primary and metastatic tumors. This agent may be genetically engineered to contain transgenes that express therapeutic agents or cell surface tumor-associated antigen-specific antibodies, such as CEA-specific antibodies, which may improve its tumor targeting and therapeutic potential.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2556</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380351</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VEGF</VALIDVALUE>
          <VALUEMEANING>Recombinant Vascular Endothelial Growth Factor</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant therapeutic agent which is chemically identical to or similar to endogenous vascular endothelial growth factor (VEGF).  Produced by a wide variety of cell types, endogenous VEGF is a homodimeric, glycosylated protein that is a highly specific mitogen for vascular endothelial cells; significantly influences vascular permeability; appears to play a role in neovascularisation under physiological conditions; is a potent chemoattractant; has pro-coagulatory activities; and is hypoxia-inducible.  Therapeutic VEGF may be used to induce angiogenesis in the treatment of ischemic conditions and may have a role in stimulating nerve regeneration. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VEG102616 (Pazopanib)</VALIDVALUE>
          <VALUEMEANING>Pazopanib Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt of a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VEG10006</VALIDVALUE>
          <VALUEMEANING>Pazopanib</VALUEMEANING>
          <MEANINGDESCRIPTION>A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VAD</VALIDVALUE>
          <VALUEMEANING>VAD Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of vincristine, doxorubicin and dexamethasone used as induction treatment for multiple myeloma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VATH</VALIDVALUE>
          <VALUEMEANING>Doxorubicin/Fluoxymesterone/Thiotepa/Vinblastine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VACOP</VALIDVALUE>
          <VALUEMEANING>Etoposide Doxorubicin Cyclophosphamide Vincristine Prednisone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04): An anthracycline antineoplastic antibiotic isolated from the fungus Streptococcus peucetius var. caesius.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.  The hydrochloride salt doxorubicin hydrochloride is the therapeutic form of doxorubicin. (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04): A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and a</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C770, C933, C405, C456, C491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yttrium 90</VALIDVALUE>
          <VALUEMEANING>Yttrium 90</VALUEMEANING>
          <MEANINGDESCRIPTION>Radioactive isotope of yttrium.  A beta/gamma-emitter with a half life of 2.7 days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y90-B3</VALIDVALUE>
          <VALUEMEANING>Yttrium Y 90 Monoclonal Antibody B3</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioimmunoconjugate of monoclonal antibody (MoAb) B3 conjugated with isotope yttrium 90. MoAb B3 is a murine MoAb that recognizes a Lewis Y carbohydrate antigen present on the surface of many carcinomas. This radioimmunoconjugate emits beta particles that causes cytotoxicity in tumor cells and has both diagnostic and therapeutic uses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2614</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zoladex</VALIDVALUE>
          <VALUEMEANING>Goserelin Acetate</VALUEMEANING>
          <MEANINGDESCRIPTION>The acetate salt of a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH).  Continuous, prolonged administration of goserelin in males results in inhibition of pituitary gonadotropin secretion, leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>XR9576</VALIDVALUE>
          <VALUEMEANING>Tariquidar</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthranilamide derivative with multidrug resistance properties.  Tariquidar non-competitively binds to the p-glycoprotein transporter, thereby inhibiting transmembrane transport of anticancer drugs.  Inhibition of transmembrane transport may result in increased intracellular concentrations of an anticancer drug, thereby augmenting its cytotoxicity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>XL999</VALIDVALUE>
          <VALUEMEANING>XL999</VALUEMEANING>
          <MEANINGDESCRIPTION>A small molecule inhibitor of numerous tyrosine kinases (TKs) including fibroblast growth factor receptor (FGFR), vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), FMS-related tyrosine kinase 3 (FLT3), and SRC, with potential antineoplastic activity. Upon administration, XL999 binds to and inhibits the activity of these TKs, thereby preventing both the activation of downstream signaling pathways and the proliferation of tumor cells overexpressing these TKs. FGFR, VEGFR, PDGFR, FLT-3, and SRC are upregulated in a variety of cancer cell types and play key roles in tumor cell proliferation, angiogenesis, and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Folate Receptor-Targeted Vinca Alkaloid EC0489</VALIDVALUE>
          <VALUEMEANING>Folate Receptor-Targeted Vinca Alkaloid EC0489</VALUEMEANING>
          <MEANINGDESCRIPTION>A folate receptor-targeting cytotoxic drug conjugate consisting of a folate vitamin analogue linked to a vinca alkaloid microtubule destabilizing agent with potential antineoplastic activity. Mediated through its folate moiety, folate receptor-targeted vinca alkaloid EC0489 delivers the cytotoxic vinca alkaloid moiety directly to cells expressing folic acid receptors, frequently upregulated in many types of tumor cells. After ligand-receptor internalization, the vinca alkaloid moiety binds to tubulin and disrupts microtubule assembly-disassembly dynamics, resulting in cell cycle arrest and apoptosis. The relative tumor cell specificity of this agent reduces the toxicity profile of its vinca alkaloid moiety.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81935</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vesanoid</VALIDVALUE>
          <VALUEMEANING>ATRA</VALUEMEANING>
          <MEANINGDESCRIPTION>A naturally-occurring acid of retinol.  Vitamin A acid binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of carcinogenesis.  This agent also inhibits telomerase, resulting in telomere shortening and eventual apoptosis of some cancer cell types.  The oral form of vitamin A acid has teratogenic and embryotoxic properties.(NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2764385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vbl/Cyt/Etop/Dxm</VALIDVALUE>
          <VALUEMEANING>Vinblastine Cyclophosphamide Etoposide Dexamethasone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural alkaloid isolated from the plant Vinca rosea Linn. Vinblastine binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and arrest of tumor cells in the M phase of the cell cycle. This agent may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04): A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04) [Source: NCI]: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C422, C491, C405, C930</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Valganciclovir</VALIDVALUE>
          <VALUEMEANING>Valganciclovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic prodrug of ganciclovir, a nucleoside analogue of 2&#39;-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575724</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Valacyclovir HCl</VALIDVALUE>
          <VALUEMEANING>Valacyclovir Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt of valacyclovir. Valacyclovir is an acyclovir prodrug that, after metabolization, inhibits viral DNA replication. It is used in the management of herpes simplex and varicella zoster infections, as well as prophylactically for human cytomegalovirus infections.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vaccinia/Tyrosinase</VALIDVALUE>
          <VALUEMEANING>Vaccinia Virus Tyrosinase Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>DNA viruses used in several biotechnology applications, including expression vector systems.: A group of copper proteins that also catalyze the reaction of EC 1.10.3.1 catechol oxidase, if only 1,2-benzenediols are available as substrate. (from IUBMB): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C17226, C14281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vaccine</VALIDVALUE>
          <VALUEMEANING>Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>Suspensions of killed or attentuated microorganisms (bacteria, viruses, or rickettsiae), or of antigenic proteins derived from them, administered for the prevention, amelioration, or treatment of infectious diseases or cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C923</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2958076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VELCAP</VALIDVALUE>
          <VALUEMEANING>Etoposide Doxorubicin Cyclophosphamide Vincristine Prednisone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04): An anthracycline antineoplastic antibiotic isolated from the fungus Streptococcus peucetius var. caesius.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.  The hydrochloride salt doxorubicin hydrochloride is the therapeutic form of doxorubicin. (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04): A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and a</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C770, C933, C405, C456, C491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyper-CVAD</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Dexamethasone/Doxorubicin/Verapamil/Vincristine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>p53</VALIDVALUE>
          <VALUEMEANING>Tumor Protein p53</VALUEMEANING>
          <MEANINGDESCRIPTION>A homo-tetrameric, DNA-binding, trans-activator of genes involved in cell division. p53 induces growth arrest or apoptosis and is mutated or inactivated in about 60% of cancers. JNK-p53 and mdm2-p53 complexes regulate ubiquitination and degradation of p53. (from SWISS-PROT P04637, OMIM 191170, and NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2669809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>gp-120</VALIDVALUE>
          <VALUEMEANING>gp-120 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant HIV gp120 envelope protein with potential use in HIV vaccine therapy. Gp-120 antigen is used to elicit a gp120-specific T-cell response. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ERB-38</VALIDVALUE>
          <VALUEMEANING>ERB-38 Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>A bivalent fusion protein consisting of disulfide-stabilized Fv fragments of an anti-HER2 (erbB2) monoclonal antibody (e23) and a truncated version of the M(r) 38 fragment of Pseudomonas exotoxin that lacks the toxin&#39;s cell binding domain. ERB-38 immunotoxin binds specifically to cells that overexpress HER2, the antigenic target of the monoclonal antibody; the exotoxin portion of the immunotoxin then lyses the cells bound by the antibody portion. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2453</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380799</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ddc</VALIDVALUE>
          <VALUEMEANING>Zalcitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic dideoxynucleoside. After intracellular phosphorylation to its active metabolite, zalcitabine preferentially inhibits the gamma form of DNA polymerase present in tumor cell mitochondria, resulting in the inhibition of tumor cell mitochondrial DNA replication and tumor cell death. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zoledronic Acid</VALIDVALUE>
          <VALUEMEANING>Zoledronate</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug that belongs to the family of drugs called bisphosphonates. It is used to prevent bone fractures and reduce bone pain in people who have cancer that has spread to the bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1699</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zinc Finger</VALIDVALUE>
          <VALUEMEANING>Zinc-Binding, DNA-Binding Motif</VALUEMEANING>
          <MEANINGDESCRIPTION>Zinc-binding, DNA-binding motifs in proteins contain amino acids that are folded into a single DNA-binding structural unit around a zinc atom.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380801</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ZD6474</VALIDVALUE>
          <VALUEMEANING>Vandetanib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380803</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ZD1839</VALIDVALUE>
          <VALUEMEANING>Gefitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase-dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in inhibition of signal transduction. Gefitinib may also induce cell cycle arrest and inhibit angiogenesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3237466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Akt Inhibitor MK2206</VALIDVALUE>
          <VALUEMEANING>Akt Inhibitor MK2206</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable allosteric inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor MK2206 binds to and inhibits the activity of Akt in a non-ATP competitive manner, which may result in the inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90581</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3374409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>177 Lu-CC49</VALIDVALUE>
          <VALUEMEANING>Lutetium Lu 177 Monoclonal Antibody CC49</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioimmunoconjugate of the humanized monoclonal antibody (MoAb) CC49 labeled with lutetium 131 (Lu-177). MoAb CC49 binds to the pancarcinoma tumor-associated glycoprotein (TAG)-72 with high affinity. Lu-177 MoAb CC49 delivers gamma radiation emitting Lu-177 nuclide directly to tumor cells that express TAG-72, and so may be used in radioimmunotherapeutic treatment of cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2598</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17-DMAG</VALIDVALUE>
          <VALUEMEANING>17-Dimethylaminoethylamino-17-Demethoxygeldanamycin</VALUEMEANING>
          <MEANINGDESCRIPTION>An analogue of the benzoquinone antineoplastic antibiotic geldanamycin.  17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin binds to HSP90, a chaperone protein that aids in the assembly, maturation and folding of proteins.  Subsequently, the function of Hsp90 is inhibited, leading to the degradation and depletion of its client proteins such as kinases and transcription factors involved with cell cycle regulation and signal transduction.  (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>131-I-TM-601</VALIDVALUE>
          <VALUEMEANING>Iodine I 131 Tositumomab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody (tositumomab) that has been chemically changed by adding radioactive iodine, and that is used in the treatment of certain types of non-Hodgkin lymphoma. It belongs to the family of drugs called radioconjugated monoclonal antibodies. When iodine I 131 tositumomab and tositumomab are given together, the combination is called the Bexxar regimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>111 In-B3</VALIDVALUE>
          <VALUEMEANING>In 111 Monoclonal Antibody B3</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioimmunoconjugate of monoclonal antibody (MoAb) B3 labeled with Indium 111 (In-111). MoAb B3 is a murine MoAb that recognizes a Lewis Y carbohydrate antigen present on the surface of many carcinomas. This radioimmunoconjugate emits gamma radiation and X-Ray photons that can be captured by gamma camera, allowing imaging of Lewis Y expressing tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2615</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ABVD</VALIDVALUE>
          <VALUEMEANING>ABVD Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of doxorubicin hydrochloride (Adriamycin), bleomycin, vinblastine and dacarbazine, used alone or in combination with radiation therapy, for the primary treatment of Hodgkin lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377419</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5-Fluorouracil</VALIDVALUE>
          <VALUEMEANING>Fluorouracil</VALUEMEANING>
          <MEANINGDESCRIPTION>An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity.  Fluorouracil and its metabolites possess a number of different mechanisms of action.  In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth.  Another active metabolite, 5-5-fluoro-2&#39;-deoxyuridine-5&#39;-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), a necessary constituent of DNA.  Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both the processing and functions of RNA. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ARQ 197 (Tivantinib)</VALIDVALUE>
          <VALUEMEANING>Tivantinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity. c-Met inhibitor ARQ 197 binds to the c-Met protein and disrupts c-Met signal transduction pathways, which may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met protein, the product of the proto-oncogene c-Met, is a receptor tyrosine kinase also known as hepatocyte growth factor receptor (HGFR); this protein is overexpressed or mutated in many tumor cell types and plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62437</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ATS (Anti-Thymocyte Globulin)</VALIDVALUE>
          <VALUEMEANING>Anti-Thymocyte Globulin</VALUEMEANING>
          <MEANINGDESCRIPTION>Purified gamma globulin, with immunosuppressive activity. Obtained from animals that have been immunized with human thymocytes, antithymocyte globulin (ATG) specifically recognizes and destroys T lymphocytes. Although not completely understood, the mechanism of action appears to involve T lymphocyte clearance from the circulation and modulation of T lymphocyte activity. Administering ATG with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host (GVH) disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3253646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9-AC (Aminocamptothecin)</VALIDVALUE>
          <VALUEMEANING>Aminocamptothecin</VALUEMEANING>
          <MEANINGDESCRIPTION>A water-insoluble camptothecin derivative.  Aminocamptothecin binds to the nuclear enzyme topoisomerase I, thereby inhibiting repair of single-strand DNA breakages.  Because the terminal lactone ring of aminocamptothecin required for the agent&#39;s antitumor activity spontaneously opens under physiological conditions to an inactive carboxy form, the drug must be administered over an extended period of time to achieve effective cytotoxicity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AZD2281</VALIDVALUE>
          <VALUEMEANING>Olaparib</VALUEMEANING>
          <MEANINGDESCRIPTION>A small molecule inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib selectively binds to and inhibits PARP, inhibiting PARP-mediated repair of single strand DNA breaks; PARP inhibition may enhance the cytotoxicity of DNA-damaging agents and may reverse tumor cell chemoresistance and radioresistance. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins and can be activated by single-stranded DNA breaks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71721</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AZD6244</VALIDVALUE>
          <VALUEMEANING>Selumetinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally active, small molecule with potential antineoplastic activity. Selumetinib is an ATP-independent inhibitor of mitogen-activated protein kinase kinase (MEK or MAPK/ERK kinase) 1 and 2. MEK 1 and 2 are dual specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various cancer cells, and are drivers of diverse cellular responses, including proliferation. Inhibition of both MEK1 and 2 by selumetinib prevents the activation of MEK1/2 dependent effector proteins and transcription factors, thereby leading to an inhibition of cellular proliferation in various cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66939</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3238481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acyclovir</VALIDVALUE>
          <VALUEMEANING>Acyclovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic analog of the purine nucleoside, guanosine, with potent antiviral activity against herpes simplex viruses type 1 and 2, varicella-zoster virus and other viruses.  After conversion in vitro to the active metabolite acyclovir triphosphate, acyclovir competitively inhibits viral DNA polymerase, incorporates into and terminates the growing viral DNA chain, and inactivates viral DNA polymerase. The greater antiviral activity of acyclovir against HSV compared to VZV is due to its more efficient phosphorylation by the thymidine kinase of HSV. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alprostadil</VALIDVALUE>
          <VALUEMEANING>Alprostadil</VALUEMEANING>
          <MEANINGDESCRIPTION>The naturally occuring prostaglandin E1 (PGE1) which displays a variety of pharmacologic actions.  Alprostadil is a potent vasodilator agent that increases peripheral blood flow, inhibits platelet aggregation, and induces bronchodilation. Used in the treatment of erectile dysfunction, this agent produces corporal smooth muscle relaxation by binding to PGE receptors, resulting in the activation of adenylate cyclase and the subsequent accumulation of 3&#39;5&#39;-cAMP.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576910</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amifostine</VALIDVALUE>
          <VALUEMEANING>Amifostine</VALUEMEANING>
          <MEANINGDESCRIPTION>The trihydrate form of a phosphorylated aminosulfhydryl compound. After dephosphorylation of amifostine by alkaline phosphatase to an active free sulfhydryl (thiol) metabolite, the thiol metabolite binds to and detoxifies cytotoxic platinum-containing metabolites of cisplatin and scavenges free radicals induced by cisplatin and ionizing radiation. The elevated activity of this agent in normal tissues results from both the relative abundance of alkaline phosphatase in normal tissues and the greater vascularity of normal tissues compared to tumor tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aminoglutethimide</VALIDVALUE>
          <VALUEMEANING>Aminoglutethimide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of the sedative and anticonvulsant glutethimide with anti-steroid properties.  Originally used as an anticonvulsant, aminoglutethimide also blocks adrenal steroidogenesis by inhibiting the enzymatic conversion of cholesterol to pregnenolone.  In addition, this agent blocks the peripheral aromatization of androgenic precursors to estrogens.  Aminoglutethimide does not suppress ovarian estrogen production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amprenavir</VALIDVALUE>
          <VALUEMEANING>Amprenavir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic antiviral agent.  As a derivative of hydroxyethylamine sulfonamide, amprenavir selectively binds to and inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28824</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anastrozole</VALIDVALUE>
          <VALUEMEANING>Anastrozole</VALUEMEANING>
          <MEANINGDESCRIPTION>A nonsteroidal inhibitor of estrogen synthesis that resembles paclitaxel in chemical structure.  As a third-generation aromatase inhibitor, anastrozole selectively and reversibly inhibits aromatase, a cytochrome P-450 enzyme complex found in many tissues including those of the premenopausal ovary, liver, and breast; aromatase catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis.  In estrogen-dependent breast cancers, ananstrozole may inhibit tumor growth. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1607</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3145842</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anthralin</VALIDVALUE>
          <VALUEMEANING>Anthralin</VALUEMEANING>
          <MEANINGDESCRIPTION>An anti-inflammatory anthracene derivative used for the treatment of dermatoses, especially psoriasis. It may cause folliculitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28827</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antibody</VALIDVALUE>
          <VALUEMEANING>Antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>(AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apolizumab</VALIDVALUE>
          <VALUEMEANING>Apolizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against 1D10, a polymorphic determinant on the HLA-DR beta chain that is expressed on normal and neoplastic B cells. Apolizumab induces complement-mediated cytotoxicity, antibody-dependent cell-mediated cytotoxicity, and apoptosis of 1D10 antigen-positive B cells in vitro.  (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arsenic Trioxide</VALIDVALUE>
          <VALUEMEANING>Arsenic Trioxide</VALUEMEANING>
          <MEANINGDESCRIPTION>A small-molecule arsenic compound with antineoplastic activity.  The mechanism of action of arsenic trioxide is not completely understood. This agent causes damage to or degradation of the promyelocytic leukemia protein/retinoic acid receptor-alpha (PML/RARa) fusion protein; induces apoptosis in acute promyelocytic leukemia (APL) cells and in many other tumor cell types; promotes cell differentiation and suppresses cell proliferation in many different tumor cell types; and is pro-angiogenic. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1005</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377438</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asparaginase</VALIDVALUE>
          <VALUEMEANING>Asparaginase</VALUEMEANING>
          <MEANINGDESCRIPTION>An enzyme isolated from the bacterium Escherichia coli or the bacterium Erwinia carotovora with antileukemic activity. Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia in leukemic cells, resulting in the depletion of asparagine, inhibition of protein synthesis, cell cycle arrest in the G1 phase, and apoptosis in susceptible leukemic cell populations. Asparagine is critical to protein synthesis in leukemic cells; some leukemic cells cannot synthesize this amino acid de novo due to the absent or deficient expression of the enzyme asparagine synthase. The E. carotovora-derived form of asparaginase is typically reserved for cases of asparaginase hypersensitivity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atazanavir Sulfate</VALIDVALUE>
          <VALUEMEANING>Atazanavir Sulfate</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic antiviral agent.  As a symmetric azapeptide agent structurally different from other HIV protease inhibitors, atazanavir selectively binds to and inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions.  This agent does not elevate serum lipids, a common problem with other protease inhibitors. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Azacitidine</VALIDVALUE>
          <VALUEMEANING>Azacitidine</VALUEMEANING>
          <MEANINGDESCRIPTION>A pyrimidine nucleoside analogue of cytidine with antineoplastic activity. Azacitidine is incorporated into DNA, where it reversibly inhibits DNA methyltransferase, thereby blocking DNA methylation.  Hypomethylation of DNA by azacitidine may activate tumor suppressor genes silenced by hypermethylation, resulting in an antitumor effect. This agent is also incorporated into RNA, thereby disrupting normal RNA function and impairing tRNA cytosine-5-methyltransferase activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3013054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Azathioprine</VALIDVALUE>
          <VALUEMEANING>Azathioprine</VALUEMEANING>
          <MEANINGDESCRIPTION>A purine analogue with cytotoxic and immunosuppressive activity. Azathioprine is a prodrug that is converted by hepatic xanthine oxidase to its active metabolite 6-mercaptopurine (6-MP). 6-MP is further metabolized by hypoxanthine-guanine phosphoribosyltransferase (HGPRT) into 6-thioguanosine-5&#39;-phosphate (6-thio-GMP) and 6-thioinosine monophosphate (6-thio-IMP), both inhibit nucleotide conversions and de novo purine synthesis. This leads to inhibition of DNA, RNA, and protein synthesis. As a result, cell proliferation may be inhibited, particularly in lymphocytes and leukocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3128751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alendronate</VALIDVALUE>
          <VALUEMEANING>Alendronic Acid</VALUEMEANING>
          <MEANINGDESCRIPTION>A second generation bisphosphonate and synthetic analog of pyrophosphate with anti-bone-resorption activity. Alendronic acid binds to and inhibits the activity of farnesyl pyrophosphate synthetase, an enzyme involved in terpenoid biosynthesis. Inhibition of this enzyme prevents the biosynthesis of isoprenoid lipids, donor substrates of farnesylation and geranylgeranylation during the post-translational modification of small GTPase signalling proteins, which are important in the process of osteoclast turnover. As a result, bone resorption and turnover are reduced.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BFM 90</VALIDVALUE>
          <VALUEMEANING>NHL-BFM-90 Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen used for the treatment of localized aggressive forms of childhood B-cell non-Hodgkin&#39;s lymphoma, including lymphoblastic lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BEAM</VALIDVALUE>
          <VALUEMEANING>Carmustine/Cytarabine/Etoposide/Melphalan</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377446</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BEACOPP</VALIDVALUE>
          <VALUEMEANING>BEACOPP Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of bleomycin, etoposide, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine and prednisone, used for the treatment of advanced-stage Hodgkin lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti CD3</VALIDVALUE>
          <VALUEMEANING>Antibody CD3 Complex</VALUEMEANING>
          <MEANINGDESCRIPTION>(AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.: Consisting of cell surface type I membrane Delta, Epsilon, Gamma, Zeta, and Eta protein subunits with ITAM domains and noncovalently associated with the disulfide bound heterodimeric alpha/beta and gamma/delta TCR, the CD3 complex couples receptor antigen recognition to signal transduction pathways during T-cell activation. During TCR engagement with MHC-associated antigen on host cell surfaces and synapse formation, CD3 activity leads to Tyr-phosphorylated CD3 subunits, Tyr phosphorylation of LAT colocalized in lipid rafts, and MAPK activation. CD3 signal transduction appears to involve LCK, ZAP70, Nck, SLA, SLA2, and DOCK2. CD3 subunits may also associate with the cytoskeleton. CD3 also mediates TCR signal transduction during the developmental transition through positive selection of immature thymocytes to mature CD4+ or CD8+ T cells. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38897, C16295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-MUC-1</VALIDVALUE>
          <VALUEMEANING>Anti-MUC-1 Monoclonal Antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody recognizing human mucin, a cell surface antigen encoded by the MUC-1 gene. In normal tissue, mucin exists as heavily glycosylated form, while tumor-associated mucin molecules are hypo-glycosylated. Hypo-glycosylation exposes the normally cryptic tandem peptide repeats in cancer-associated mucin, thereby allows antigen-antibody interaction with MUC-1 antibody. As a result, the MUC-1 antibody inhibits the initiation of the immunosuppressive cascade triggered by mucin, including production and secretion of prostaglandin E2 (PGE2), followed by VEGF induction and suppression of natural killer cell, lymphokine-activated killer cell and cytotoxic T cell activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti B4bR</VALIDVALUE>
          <VALUEMEANING>Anti-B4 Blocked Ricin Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunotoxin comprised of an anti-B4 (anti-CD19) murine monoclonal antibody linked to the modified plant-derived toxin blocked ricin. The antibody moiety of anti-B4 blocked ricin immunotoxin binds to B lymphocytes that express B4; after internalization of the immunotoxin by the B4-expressing B cell, the ricin moiety cleaves the N-glycosidic bond between the ribose and adenine base at position 4324 in the B lymphocyte 28S ribosomal RNA, resulting in ribosome inactivation, inhibition of protein synthesis, and cell death. Blocked ricin is ricin which has been chemically modified such that the lectin binding sites of the B chain (galactose-binding sites) have been blocked by covalent attachment of affinity ligands, leaving the ribosome-inactivating activity of the ricin A chain intact.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-Tac</VALIDVALUE>
          <VALUEMEANING>Daclizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody that is being studied for treatment of adult T-cell leukemia.  Also called dacliximab.  Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968</VALIDVALUE>
          <VALUEMEANING>Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic antisense oligodeoxynucleotide (AS ODN) targeting hypoxia-inducible factor-1alpha (HIF-1alpha) with potential antineoplastic activity. Anti-HIF-1alpha LNA antisense oligonucleotide EZN-2968 hybridizes with HIF-1alpha mRNA and blocks t HIF-1 alpha protein expression, which may result in the inhibition of angiogenesis, the inhibition of tumor cell proliferation, and apoptosis. HIF-1alpha, normally activated in response to hypoxia-induced stress, is a key transcription regulator of a large number of genes important in cellular adaptation to low-oxygen conditions, including angiogenesis, cell proliferation, apoptosis, and cell invasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68930</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3422118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Crenolanib</VALIDVALUE>
          <VALUEMEANING>Crenolanib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable small molecule, targeting the platelet-derived growth factor receptor (PDGFR), with potential antineoplastic activity. Crenolanib binds to and inhibits PDGFR, which may result in the inhibition of PDGFR-related signal transduction pathways, and, so, the inhibition of tumor angiogenesis and tumor cell proliferation. PDGFR, up-regulated in many tumor cell types, is a receptor tyrosine kinase essential to cell migration and the development of the microvasculature.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64639</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3422120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gemtuzumab Ozogamicin</VALIDVALUE>
          <VALUEMEANING>Gemtuzumab Ozogamicin</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin.  In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CBDCA/GM-CSF/IL-6</VALIDVALUE>
          <VALUEMEANING>Carboplatin/Interleukin-6/Sargramostim</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10829</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CC5013</VALIDVALUE>
          <VALUEMEANING>CC 5013 (Lenalidomide)</VALUEMEANING>
          <MEANINGDESCRIPTION>A thalidomide analog with potential antineoplastic activity.  Lenalidomide inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis.  This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2662266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CBDCA/Paclitaxel</VALIDVALUE>
          <VALUEMEANING>Carboplatin/Paclitaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>Definition not available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10662</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CBDCA/Cyclophosphamide/Thiotepa</VALIDVALUE>
          <VALUEMEANING>Carboplatin Cyclophosphamide Thiotepa Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A synthetic alkylating agent. Related to nitrogen mustard, thiotepa alkylates and crosslinks DNA, resulting in the inhibition of DNA replication. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C875, C405, C1282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CBDCA/Cyclophosphamide</VALIDVALUE>
          <VALUEMEANING>Carboplatin Cyclophosphamide Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C405, C1282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378374</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bay 43-9006</VALIDVALUE>
          <VALUEMEANING>Sorafenib Tosylate</VALUEMEANING>
          <MEANINGDESCRIPTION>The tosylate salt of sorafenib, a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378376</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Batracylin</VALIDVALUE>
          <VALUEMEANING>Daniquidone</VALUEMEANING>
          <MEANINGDESCRIPTION>A water-insoluble heterocyclic amide with potential antineoplastic activity. Daniquidone inhibits topoisomerases I and II, thereby inhibiting DNA replication and repair, and RNA and protein synthesis. The acetylated form of daniquidone is highly toxic and is capable of inducing unscheduled DNA synthesis; rapid acetylators are more likely to experience toxicity with this agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66984</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BVCPP</VALIDVALUE>
          <VALUEMEANING>Carmustine/Cyclophosphamide/Prednisone/Procarbazine/Vinblastine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9530</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BUDr (Bromodeoxyuridine)</VALIDVALUE>
          <VALUEMEANING>Bromodeoxyuridine</VALUEMEANING>
          <MEANINGDESCRIPTION>A halogenated pyrimidine analogue that has been investigated for antineoplastic and radiosenstizing activities.  Bromodeoxyuridine competes with thymidine for incorporation into DNA, resulting in DNA mutation and inhibition of cell proliferation.  As a radiosensitizer, this agent induces the formation of reactive uracil radicals, resulting in DNA strand breaks and, ultimately, disruption of the cell cycle. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378381</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BOPP</VALIDVALUE>
          <VALUEMEANING>Carmustine Vincristine Sulfate Procarbazine Cisplatin Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An antineoplastic nitrosourea. Carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  This agent also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect.  Carmustine is highly lipophilic and crosses the blood-brain barrier readily. (NCI04): The sulfate salt of a natural alkaloid isolated from the plant Catharanthus roseus (Vinca rosea L.) with antimitotic and antineoplastic activities. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca(2+)-activated ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis.: A methylhydrazine derivative with antineoplastic and mutagenic activities. Although the exact mode of cytotoxicity has not been elucidated, procarbazine, after metabolic activation, appears to inhibit the trans-methylation of methionine into transfer RNA (t-RNA), thereby preventing protein synthesis and consequently DNA and RNA synthesis. This agent may also undergo auto-oxidation, resulting in the formation of cytotoxic free radicals which damage DNA through an alkylation reaction.: An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C376, C62072, C1739, C349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378383</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemotherapy Embolization</VALIDVALUE>
          <VALUEMEANING>Chemoembolization</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure in which the blood supply to the tumor is blocked surgically or mechanically and anticancer drugs are administered directly into the tumor. This permits a higher concentration of drug to be in contact with the tumor for a longer period of time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cetuximab</VALIDVALUE>
          <VALUEMEANING>Cetuximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody specific for the epidermal growth factor receptor (EGFR), a tyrosine kinase that triggers cell division.  Cetuximab binds to and inhibits EGFRs, which are overexpressed on the cell surfaces of many types of tumors.  This agent blocks the tumor growth, invasion, and metastasis associated with the overexpression of cell-surface EGFRs. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1723</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerivastatin Sodium</VALIDVALUE>
          <VALUEMEANING>Cerivastatin Sodium</VALUEMEANING>
          <MEANINGDESCRIPTION>The sodium salt of a synthetic lipid-lowering agent.  Cerivastatin sodium competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis.  This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. Muscle toxicity (myopathy and rhabdomyolysis) precludes the clinical use of this agent. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28919</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577803</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Celecoxib (Celebrex)</VALIDVALUE>
          <VALUEMEANING>Celecoxib</VALUEMEANING>
          <MEANINGDESCRIPTION>A nonsteroidal anti-inflammatory drug (NSAID) with a diaryl-substituted pyrazole structure. Celecoxib selectively inhibits cyclo-oxygenase-2 activity (COX-2); COX-2 inhibition may result in apoptosis and a reduction in tumor angiogenesis and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1728</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577801</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carmustine/Polifeprosan 20</VALIDVALUE>
          <VALUEMEANING>Polifeprosan 20 with Carmustine Implant</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, biodegradable wafer containing the agent carmustine with antineoplastic activity. Used to deliver drug directly into a brain tumor site and typically implanted post-surgically, the wafer is made of a biodegradable poly-anhydride copolymer and contains the nitrosourea carmustine.  As an antineoplastic nitrosourea, carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  Carmustine also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect.  Carmustine is highly lipophilic and crosses the blood-brain barrier readily. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carmustine (BCNU)</VALIDVALUE>
          <VALUEMEANING>Carmustine</VALUEMEANING>
          <MEANINGDESCRIPTION>An antineoplastic nitrosourea. Carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  This agent also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect.  Carmustine is highly lipophilic and crosses the blood-brain barrier readily. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboplatin/Taxotere</VALIDVALUE>
          <VALUEMEANING>Carboplatin Docetaxel Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04): A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata.  Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death.  This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response.  Docetaxel has been studied for use as a radiation-sensitizing agent. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1526, C1282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378824</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboplatin/Paclitaxel/Doxorubicin</VALIDVALUE>
          <VALUEMEANING>Carboplatin Paclitaxel Doxorubicin Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04): A compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity.  Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division.  This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). (NCI04): An anthracycline antineoplastic antibiotic isolated from the fungus Streptococcus peucetius var. caesius.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.  The hydrochloride salt doxorubicin hydrochloride is the therapeutic form of doxorubicin. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C456, C1411, C1282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboplatin/Gemcitabine/Paclitaxel</VALIDVALUE>
          <VALUEMEANING>Carboplatin Gemcitabine Paclitaxel Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04): An anticancer drug that belongs to the family of drugs called antimetabolites.: A compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity.  Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division.  This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1411, C66876, C1282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Darboplatin/Gemcitabine</VALIDVALUE>
          <VALUEMEANING>Carboplatin Gemcitabine Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04): An anticancer drug that belongs to the family of drugs called antimetabolites.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C66876, C1282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboplatin/Cisplatin</VALIDVALUE>
          <VALUEMEANING>Carboplatin Cisplatin Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04): An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C376, C1282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378828</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboplatin/Paclitaxel</VALIDVALUE>
          <VALUEMEANING>Carboplatin/Paclitaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>Definition not available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10662</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Capecitabine/Radiation</VALIDVALUE>
          <VALUEMEANING>Capecitabine Radiation Therapy Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A fluoropyrimidine carbamate belonging to the class of antineoplastic agents called antimetabolites.  As a prodrug, capecitabine is selectively activated by tumor cells to its cytotoxic moiety, 5-fluorouracil (5-FU); subsequently, 5-FU is metabolized to two active metabolites, 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP) by both tumor cells and normal cells.  FdUMP inhibits DNA synthesis and cell division by reducing normal thymidine production, while FUTP inhibits RNA and protein synthesis by competing with uridine triphosphate. (NCI04): Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C15313, C1794</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CVP</VALIDVALUE>
          <VALUEMEANING>CVP Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of cyclophosphamide, vincristine and prednisone used to treat indolent forms of non-Hodgkin&#39;s lymphoma; also used for the treatment of chronic lymphocytic leukemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3366718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CVAD</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Dexamethasone/Doxorubicin/Verapamil/Vincristine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CT-322</VALIDVALUE>
          <VALUEMEANING>Pegdinetanib</VALUEMEANING>
          <MEANINGDESCRIPTION>A pegylated form of a thermostable and protease resistant peptide targeting human vascular endothelial growth factor receptor-2 (VEGFR-2) with potential antiangiogenic activity. Derived from the 10th type III domain of human fibronectin and one of the natural ligands, pegdinetanib binds to VEGFR-2 and prevents activation of VEGFR-2 by other activating ligands. This may inhibit the growth of new tumor blood vessels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CPE-C</VALIDVALUE>
          <VALUEMEANING>Cyclopentenyl Cytosine</VALUEMEANING>
          <MEANINGDESCRIPTION>A pro-drug carbocyclic analogue of cytidine with antineoplastic and antiviral activities. Cyclopentenyl cytosine (CPEC) is converted to the active metabolite cyclopentenyl cytosine 5&#39;-triphosphate (CPEC-TP); CPEC-TP competitively inhibits cytidine triphosphate (CTP) synthase, thereby depleting intracellular cytidine pools and inhibiting DNA and RNA synthesis. This agent may also induce differentiation of some tumor cell types. The antiviral activity of this agent is broad-spectrum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>rhGH</VALIDVALUE>
          <VALUEMEANING>Somatropin</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant form of endogenous human growth hormone (GH), a polypeptide produced by the anterior lobe of the human pituitary gland. GH exhibits growth-promoting effects and metabolic effects on carbohydrate, fat, protein and bone metabolism. GH stimulates protein synthesis and the uptake of amino acids into cells, and induces lipolysis in adipose tissues. The secretion of GH increases with sexual maturation and then declines steadily.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cabergoline</VALIDVALUE>
          <VALUEMEANING>Cabergoline</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic ergoline derivative and a long-acting dopamine receptor agonist with high affinity for the dopamine D2 receptor. Cabergoline exerts an inhibitory effect on prolactin secretion by acting on dopamine receptors present in pituitary lactotrophs. This drug also binds to dopamine D2 receptors in the corpus striatum, thereby mimicking the actions of dopamine on motor control. Cabergoline also possesses antioxidant and neuroprotective properties due to its free radical scavenging activity. Cabergoline is used in the treatment of Parkinson&#39;s disease and in the treatment of hyperprolactinemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcipotriene</VALIDVALUE>
          <VALUEMEANING>Calcipotriene</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic vitamin D derivative usually formulated for topical dermatological use, antipsoriatic Calcipotriene (calcipotriol) competes equally with active 1,25-hydroxy-2D3 (the natural form of vitamin D) for 1,25-hydroxy-2D3 receptors in regulating cell proliferation and differentiation. It induces differentiation and suppresses proliferation of keratinocytes, reversing abnormal keratinocyte changes in psoriasis, and leads to normalization of epidermal growth. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcitriol</VALIDVALUE>
          <VALUEMEANING>Calcitriol</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic physiologically-active analog of vitamin D, specifically the vitamin D3 form.  Calcitriol regulates calcium in vivo by promoting absorption in the intestine, reabsorption in the kidneys, and, along with parathyroid hormone, regulation of bone growth.  A calcitriol receptor-binding protein appears to exist in the mucosa of human intestine. Calcitriol also induces cell cycle arrest at G0/G1 phase of the cell cycle, cell differentiation, and apoptosis, resulting in inhibition of proliferation of some tumor cell types.  This agent may be chemopreventive for colon and prostate cancers. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C330</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Capecitabine</VALIDVALUE>
          <VALUEMEANING>Capecitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A fluoropyrimidine carbamate belonging to the class of antineoplastic agents called antimetabolites.  As a prodrug, capecitabine is selectively activated by tumor cells to its cytotoxic moiety, 5-fluorouracil (5-FU); subsequently, 5-FU is metabolized to two active metabolites, 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP) by both tumor cells and normal cells.  FdUMP inhibits DNA synthesis and cell division by reducing normal thymidine production, while FUTP inhibits RNA and protein synthesis by competing with uridine triphosphate. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1794</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2718478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-Deosycoformycin</VALIDVALUE>
          <VALUEMEANING>2-Deoxycoformycin (Pentostatin)</VALUEMEANING>
          <MEANINGDESCRIPTION>An anticancer drug that belongs to the family of drugs called antimetabolites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C732</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4-HPR</VALIDVALUE>
          <VALUEMEANING> 4-HPR (Fenretinide)</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally-active synthetic phenylretinamide analogue of retinol (vitamin A) with potential antineoplastic and chemopreventive activities.  Fenretinide binds to and activates retinoic acid receptors (RARs), thereby inducing cell differentiation and apoptosis in some tumor cell types.  This agent also inhibits tumor growth by modulating angiogenesis-associated growth factors and their receptors and exhibits retinoid receptor-independent apoptotic properties.(NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1098</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5-Fluoro-2-Deoxycytidine</VALIDVALUE>
          <VALUEMEANING>5-Fluoro-2-Deoxycytidine</VALUEMEANING>
          <MEANINGDESCRIPTION>An antimetabolite consisting of a fluorinated pyrimidine analog with potential antineoplastic activity. As a prodrug, 5-fluoro-2-deoxycytidine is converted by intracellular deaminases to the cytotoxic agent 5-Fluorouracil (5-FU). 5-FU is subsequently metabolized to active metabolites including 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP). FdUMP binds to and inhibits thymidylate synthase, thereby reducing the production of thymidine monophosphate, which leads to depletion of thymidine triphosphate. This inhibits DNA synthesis and cell division. FUTP competes with uridine triphosphate for incorporation into the RNA strand thus leading to an inhibition of RNA and protein synthesis. Other fluorouracil metabolites also get incorporated into both DNA and RNA, thereby further hampering cellular growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3TC</VALIDVALUE>
          <VALUEMEANING>Lamivudine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic nucleoside analogue with activity against hepatitis B virus (HBV) and HIV. Intracellularly, lamivudine is phosphorylated to its active metabolites, lamiduvine triphosphate (L-TP) and lamiduvine monophosphate (L-MP).  In HIV, L-TP inhibits HIV-1 reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleoside analogue into viral DNA.  In HBV, incorporation of L-MP into viral DNA by HBV polymerase results in DNA chain termination. L-TP is a weak inhibitor of mammalian DNA polymerases alpha and beta, and mitochondrial DNA polymerase. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2CDA</VALIDVALUE>
          <VALUEMEANING>Cladribine</VALUEMEANING>
          <MEANINGDESCRIPTION>A purine nucleoside antimetabolite analogue. Cladribine triphosphate, a phosphorylated metabolite of cladribine, incorporates into DNA, resulting in single-strand breaks in DNA, depletion of nicotinamide adenine dinucleotide (NAD) and adenosine triphosphate (ATP), and apoptosis.  Because this agent is resistant to adenosine deaminase, an enzyme that inactivates some antineoplastic agents, it is selectively toxic to lymphocytes and monocytes which exhibit little deoxynucleotide deaminase activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2829877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MOPP</VALIDVALUE>
          <VALUEMEANING>MOPP Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of mechlorethamine, vincristine (Oncovin), procarbazine and prednisone, used alone or in combination with radiation therapy for the treatment of stage I-IV Hodgkin lymphoma. Due to the increased risk of gonadal toxicity, this regimen has been widely replaced by the ABVD regimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MINE</VALIDVALUE>
          <VALUEMEANING>Etoposide/Ifosfamide/Mesna/Mitoxantrone</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAVE</VALIDVALUE>
          <VALUEMEANING>Doxorubicin/Etoposide/Mitotane/Vincristine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MORab-0003</VALIDVALUE>
          <VALUEMEANING>Farletuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized, immunoglobulin G1 monoclonal antibody with potential antitumor activity. Farletuzumab specifically targets at glycoprotein 3 (GP-3), a cell surface antigen that is overexpressed on many epithelial-derived cancer cells. Upon binding to the GP-3 antigen, farletuzumab triggers a host immune response against GP-3 expressing cells resulting in cell lysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MS-275</VALIDVALUE>
          <VALUEMEANING>Entinostat</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic benzamide derivative with potential antineoplastic activity. Entinostat binds to and inhibits histone deacetylase, an enzyme that regulates chromatin structure and gene transcription. This agent appears to exert dose-dependent effects in human leukemia cells including cyclin-dependent kinase inhibitor 1A (p21/CIP1/WAF1)-dependent growth arrest and differentiation at low drug concentrations; a marked induction of reactive oxygen species (ROS); mitochondrial damage; caspase activation; and, at higher concentrations, apoptosis. In normal cells, cyclin-dependent kinase inhibitor 1A expression has been associated with cell-cycle exit and differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1863</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MVAC</VALIDVALUE>
          <VALUEMEANING>Cisplatin/Doxorubicin/Methotrexate/Vinblastine Treatment Regimen (MVAC)</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of methotrexate, vinblastine, doxorubicin and cisplatin used for the treatment of advanced-stage bladder and urothelial cancer._A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C63486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medroxyprogesterone</VALIDVALUE>
          <VALUEMEANING>Medroxyprogesterone</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of progesterone administered as an acetate salt (medroxyprogesterone acetate) with antiestrogenic activity. As a do all progestins, medroxyprogesterone binds to and activates nuclear receptors which subsequently bind to and activate target genes for transcription. As an antiestrogen, this agent may inhibit the growth-stimulating effects of estrogen on estrogen-sensitive tumor cells. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Megace</VALIDVALUE>
          <VALUEMEANING>Megestrol Acetate</VALUEMEANING>
          <MEANINGDESCRIPTION>The acetate salt form of megestrol, a synthetic derivative of the naturally occurring female sex hormone progesterone with anti-estrogenic activity and used in breast cancer treatment. Mimicking the action of progesterone, megestrol acetate binds to and activates nuclear progesterone receptors in the reproductive system, and causes the ligand-receptor complex to be translocated to the nucleus where it binds to and promotes expression of target genes. This leads to an alteration in protein synthesis, which modulates cell growth of reproductive tissues. Due to the negative feedback mechanism seen with progesterone, megestrol also blocks luteinizing hormone (LH) release from the pituitary gland, thereby leading to an inhibition of ovulation and an alteration in the cervical mucus and endometrium. Furthermore, without stimulation of LH, estrogen release from the ovaries is stopped, hence impedes the growth of estrogen-sensitive tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1156</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxymorphone</VALIDVALUE>
          <VALUEMEANING>Oxymorphone</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic narcotic analgesic related to hydromorphone and other opiates, Oxymorphone, hydroxy-dihydromorphinone, affects the central nervous system and smooth muscles by activation of specific opiate receptors. Similar to morphine, but more potent and without cough suppressant activity, it is used in treatment of moderate to severe pain, including obstetrical pain, or as an adjunct to anaesthesia. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxygen</VALIDVALUE>
          <VALUEMEANING>Oxygen</VALUEMEANING>
          <MEANINGDESCRIPTION>use this term only for elemental or gaseous oxygen (02); for other compounds see OXYGEN COMPOUND.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oxaliplatin</VALIDVALUE>
          <VALUEMEANING>Oxaliplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane (DACH) and with an oxalate ligand as a &#39;leaving group.&#39; A &#39;leaving group&#39; is an atom or a group of atoms that is displaced as a stable species taking with it the bonding electrons. After displacement of the labile oxalate ligand leaving group, active oxaliplatin derivatives, such as monoaquo and diaquo DACH platinum, alkylate macromolecules, forming both inter- and intra-strand platinum-DNA crosslinks, which result in inhibition of DNA replication and transcription and cell-cycle nonspecific cytotoxicity. The DACH side chain appears to inhibit alkylating-agent resistance. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1181</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Octreotide</VALIDVALUE>
          <VALUEMEANING>Octreotide</VALUEMEANING>
          <MEANINGDESCRIPTION>The synthetic acetate salt of a long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Similar to somatostatin, octreotide suppresses the luteinizing hormone response to gonadotropin-releasing hormone, decreases splanchnic blood flow, and inhibits the release of serotonin, gastrin, vasoactive intestinal peptide (VIP), secretin, motilin, pancreatic polypeptide, and thyroid stimulating hormone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oblimersen Sodium</VALIDVALUE>
          <VALUEMEANING>Oblimersen Sodium</VALUEMEANING>
          <MEANINGDESCRIPTION>The sodium salt of a phosphorothioate antisense oligonucleotide targeted to the initiation codon region of mRNA for the anti-apoptotic gene Bcl-2. Oblimersen inhibits Bcl-2 mRNA translation, which may result in decreased expression of the Bcl-2 protein and tumor cell apoptosis. This agent may enhance the efficacy of standard cytotoxic chemotherapy. The anti-apoptotic bcl-2 protein is an integral outer mitochondrial membrane protein (OMMP) that is overexpressed in some cancer cell types and is linked to tumor drug resistance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379282</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methotrexate/Cytarabine</VALIDVALUE>
          <VALUEMEANING>Methotrexate Cytarabine Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An antimetabolite with antineoplastic and immunomodulating properties.  Methotrxate inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses.  Methotrexate also exhibits potent immunosuppressant properties. (NCI04): An anticancer drug that belongs to the family of drugs called antimetabolites.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C408, C642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melphalan/Prednisone</VALIDVALUE>
          <VALUEMEANING>Melphalan Prednisone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available phenylalanine derivative of nitrogen mustard with antineoplastic activity. Melphalan alkylates DNA at the N7 position of guanine and induces DNA inter-strand cross-linkages, resulting in the inhibition of DNA and RNA synthesis and cytotoxicity against both dividing and non-dividing tumor cells. (NCI04): A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C770, C633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melphalan/Cisplatin</VALIDVALUE>
          <VALUEMEANING>Melphalan Cisplatin Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available phenylalanine derivative of nitrogen mustard with antineoplastic activity. Melphalan alkylates DNA at the N7 position of guanine and induces DNA inter-strand cross-linkages, resulting in the inhibition of DNA and RNA synthesis and cytotoxicity against both dividing and non-dividing tumor cells. (NCI04): An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C376, C633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melanoma Vaccine</VALIDVALUE>
          <VALUEMEANING>Melanoma Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer vaccine prepared from human melanoma cancer cells. It can be used alone or with other therapy in treating melanoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mechlorethamine HCl</VALIDVALUE>
          <VALUEMEANING>Nitrogen Mustard</VALUEMEANING>
          <MEANINGDESCRIPTION>A vesicant and necrotizing irritant destructive to mucous membranes. It was formerly used as a war gas. The hydrochloride is used as an antineoplastic in Hodgkin&#39;s disease and lymphomas. It causes severe gastrointestinal and bone marrow damage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567424</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mab 131l mel-14F(ab&#39;) 2</VALIDVALUE>
          <VALUEMEANING>131l mel-14F(ab&#39;) 2 mAb</VALUEMEANING>
          <MEANINGDESCRIPTION>131l mel-14F(ab&#39;) 2 Monoclonal Antibody</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mab 123l Mu81c6</VALIDVALUE>
          <VALUEMEANING>131I-mu81C6 mAb</VALUEMEANING>
          <MEANINGDESCRIPTION>131I-mu81C6 Monoclonal Antibody</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melphalan</VALIDVALUE>
          <VALUEMEANING>Melphalan</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available phenylalanine derivative of nitrogen mustard with antineoplastic activity. Melphalan alkylates DNA at the N7 position of guanine and induces DNA inter-strand cross-linkages, resulting in the inhibition of DNA and RNA synthesis and cytotoxicity against both dividing and non-dividing tumor cells. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mercaptopurine</VALIDVALUE>
          <VALUEMEANING>Mercaptopurine</VALUEMEANING>
          <MEANINGDESCRIPTION>A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities.  Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5&#39;-phosphate (6-thioGMP) and 6-thioinosine (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis.  This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesna</VALIDVALUE>
          <VALUEMEANING>Mesna</VALUEMEANING>
          <MEANINGDESCRIPTION>A sulfhydryl compound that is used to reduce the incidence of hemorrhagic cystitis associated with certain chemotherapeutic agents.  Mesna is converted to a free thiol compound in the kidney, where it binds to and inactivates acrolein and other urotoxic metabolites of ifosfamide and cyclophosphamide, thereby reducing their toxic effects on the urinary tract during urinary excretion. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methotrexate</VALIDVALUE>
          <VALUEMEANING>Methotrexate</VALUEMEANING>
          <MEANINGDESCRIPTION>An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567426</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methylprednisolone</VALIDVALUE>
          <VALUEMEANING>Methylprednisolone</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic corticosteroid with anti-inflammatory and immunomodulating properties.  Methylprednisolone binds to and activates specific nuclear receptors, resulting in altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C647</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hsp90 Inhibitor PU-H71</VALIDVALUE>
          <VALUEMEANING>Heat shock protein 90 (Hsp90) inhibitor PU-H71</VALUEMEANING>
          <MEANINGDESCRIPTION>Any agent that inhibits heat shock protein (Hsp) 90.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156880</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3431123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AQ4N (Banoxantrone)</VALIDVALUE>
          <VALUEMEANING>Banoxantrone</VALUEMEANING>
          <MEANINGDESCRIPTION>A bioreductive, alkylaminoanthraquinone prodrug with antineoplastic activity. Under hypoxic conditions, often seen in solid tumors, banoxantrone (AQ4N) is converted and activated by cytochrome P450 enzymes, which are upregulated in certain tumors, to the cytotoxic DNA-binding agent AQ4. Banoxantrone intercalates into and crosslinks DNA, and inhibits topoisomerase II. This results in an inhibition of DNA replication and repair in tumor cells. Combined with conventional therapeutic agents, both oxygenic and hypoxic regions of tumors can be targeted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AP23573</VALIDVALUE>
          <VALUEMEANING>Ridaforolimus</VALUEMEANING>
          <MEANINGDESCRIPTION>A small molecule and non-prodrug analogue of the lipophilic macrolide antibiotic rapamycin with potential antitumor activity. Ridaforolimus binds to and inhibits the mammalian target of rapamycin (mTOR), which may result in cell cycle arrest and, consequently, the inhibition of tumor cell growth and proliferation. Upregulated in some tumors, mTOR is a serine/threonine kinase involved in regulating cellular proliferation, motility, and survival that is located downstream of the PI3K/Akt signaling pathway.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49061</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AMG 102</VALIDVALUE>
          <VALUEMEANING>Rilotumumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human IgG2 monoclonal antibody directed against the human hepatocyte growth factor (HGF) with potential antineoplastic activity. Anti-HGF monoclonal antibody AMG 102 binds to and neutralizes HGF, preventing the binding of HGF to its receptor c-Met and so c-Met activation; inhibition of c-Met-mediated signal transduction may result in the induction of apoptosis in cells expressing c-Met. c-Met (HGF receptor or HGFR), a receptor tyrosine kinase overexpressed or mutated in a variety of epithelial cancer cell types, plays a key role in cancer cell growth, survival, angiogenesis, invasion, and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67079</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AGN 195183</VALIDVALUE>
          <VALUEMEANING>AGN 195183</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1527761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AEE788</VALIDVALUE>
          <VALUEMEANING>AEE788</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable multiple-receptor tyrosine kinase inhibitor. AEE788 inhibits phosphorylation of the tyrosine kinases of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and vascular endothelial growth factor receptor 2 (VEGF2), resulting in receptor inhibition, the inhibition of cellular proliferation, and induction of tumor cell and tumor-associated endothelial cell apoptosis. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ABT-888</VALIDVALUE>
          <VALUEMEANING>Veliparib</VALUEMEANING>
          <MEANINGDESCRIPTION>A poly(ADP-ribose) polymerase (PARP) -1 and -2 inhibitor with chemosensitizing and antitumor activities. With no antiproliferative effects as a single agent at therapeutic concentrations, ABT-888 inhibits PARPs, thereby inhibiting DNA repair and potentiating the cytotoxicity of DNA-damaging agents. PARP nuclear enzymes are activated by DNA single or double strand breaks, resulting in the poly(ADP-ribosyl)ation of other nuclear DNA binding proteins involved in DNA repair; poly(ADP-ribosyl)ation contributes to efficient DNA repair and to survival of proliferating cells exposed to mild genotoxic stresses as induced by as oxidants, alkylating agents or ionizing radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ABT-263</VALIDVALUE>
          <VALUEMEANING>Navitoclax</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally active, synthetic small molecule and an antagonist of a subset of the B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. Navitoclax selectively binds to apoptosis suppressor proteins Bcl-2, Bcl-XL, and Bcl-w, which are frequently overexpressed in a wide variety of cancers, including those of the lymph, breast, lung, prostate, and colon, and are linked to tumor drug resistance. Inhibition of these apoptosis suppressors prevents their binding to the apoptotic effectors Bax and Bak proteins, thereby triggering apoptotic processes in cells overexpressing Bcl-2, Bcl-XL, and Bcl-w. This eventually reduces tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64776</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>90 Y-B3</VALIDVALUE>
          <VALUEMEANING>Yttrium Y 90 Monoclonal Antibody B3</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioimmunoconjugate of monoclonal antibody (MoAb) B3 conjugated with isotope yttrium 90. MoAb B3 is a murine MoAb that recognizes a Lewis Y carbohydrate antigen present on the surface of many carcinomas. This radioimmunoconjugate emits beta particles that causes cytotoxicity in tumor cells and has both diagnostic and therapeutic uses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2614</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9-cis-Retinoic Acid</VALIDVALUE>
          <VALUEMEANING>Alitretinoin</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally- and topically-active naturally-occurring retinoic acid with antineoplastic, chemopreventive, teratogenic, and embryotoxic activities. Alitretinoin binds to and activates nuclear retinoic acid receptors (RAR) and retinoid X receptors (RXR); these activated receptors act as transcription factors, regulating gene expression that results in the inhibition of cell proliferation, induction of cell differentiation, and apoptosis of both normal cells and tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BL22</VALIDVALUE>
          <VALUEMEANING>BL22 Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant immunotoxin consisting of the Fv portion of the anti-CD22 antibody RFB4 fused to a fragment of Pseudomonas exotoxin-A with potential antineoplastic activity.  BL22 immunotoxin binds to CD22, an antigen expressed in B-cell malignancies, thereby delivering its toxin directly to tumor cells.  The toxin moiety induces caspase-mediated apoptosis of tumor cells via a mechanism involving mitochondrial damage; it also blocks translational elongation via binding to elongation factor-2 in eukaryotic cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1842</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Belinostat</VALIDVALUE>
          <VALUEMEANING>Belinostat</VALUEMEANING>
          <MEANINGDESCRIPTION>A novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity. Belinostat targets HDAC enzymes, thereby inhibiting tumor cell proliferation, inducing apoptosis, promoting cellular differentiation, and inhibiting angiogenesis. This agent may sensitize drug-resistant tumor cells to other antineoplastic agents, possibly through a mechanism involving the down-regulation of thymidylate synthase.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48812</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bevacizumab</VALIDVALUE>
          <VALUEMEANING>Bevacizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody that may prevent the growth of blood vessels from surrounding tissue to a solid tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2039</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bleomycin</VALIDVALUE>
          <VALUEMEANING>Bleomycin</VALUEMEANING>
          <MEANINGDESCRIPTION>A mixture of glycopeptide antineoplastic antibiotics isolated from the fungus Streptomyces verticillus.  Bleomycin forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals which cause single- and double-stranded breaks in DNA; these reactive oxygen species also induce lipid peroxidation, carbohydrate oxidation, and alterations in prostaglandin synthesis and degradation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739540</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bexarotene</VALIDVALUE>
          <VALUEMEANING>Bexarotene</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic retinoic acid agent with potential antineoplastic, chemopreventive, teratogenic and embryotoxic properties.  Bexarotene selectively binds to and activates retinoid X receptors (RXRs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, apoptosis of some cancer cell types, and tumor regression. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bicalutamide</VALIDVALUE>
          <VALUEMEANING>Bicalutamide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, nonsteroidal antiandrogen.  Bicalutamide competitively binds to cytosolic androgen receptors in target tissues, thereby inhibiting the receptor binding of androgens. This agent does not bind to most mutated forms of androgen receptors. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bortezomib</VALIDVALUE>
          <VALUEMEANING>Bortezomib</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified dipeptidyl boronic acid with antineoplastic activity. Via boronic acid moiety, bortezomib reversibly binds to the 26S proteasome, where degradation of ubiquinated proteins occurs. By blocking the targeted proteolysis normally performed by the proteasome, bortezomib disrupts various cell signaling pathways, leading to cell cycle arrest, apoptosis, and inhibition of angiogenesis.  Specifically, the agent inhibits nuclear factor (NF)-kappaB, a protein that is constitutively activated in some cancers, thereby interfering with NF-kappaB-mediated cell survival, tumor growth, and angiogenesis. In vivo, bortezomib delays tumor growth and enhances the cytotoxic effects of radiation and chemotherapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brimonidine</VALIDVALUE>
          <VALUEMEANING>Brimonidine</VALUEMEANING>
          <MEANINGDESCRIPTION>An imidazole derivative and a selective alpha-2 adrenergic receptor agonist. Upon ocular administration, brimonidine acts on the blood vessels causing them to constrict which leads to a decrease in the production of aqueous humor. Brimonidine also enhances the uveoscleral outflow of aqueous humor. This reduces intraocular pressure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brivanib Alaninate</VALIDVALUE>
          <VALUEMEANING>Brivanib Alaninate</VALUEMEANING>
          <MEANINGDESCRIPTION>The alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Busulfan</VALIDVALUE>
          <VALUEMEANING>Busulfan</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of dimethane-sulfonate with antineoplastic and cytotoxic properties.  Although its mechanism of action is not fully understood, busulfan appears to act through the alkylation of DNA.  Following systemic absorption of busulfan, carbonium ions are formed, resulting in DNA alkylation and DNA breaks and inhibition of DNA replication and RNA transcription. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C321</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>rhIGH-1</VALIDVALUE>
          <VALUEMEANING>IGF1R Gene </VALUEMEANING>
          <MEANINGDESCRIPTION>This gene is involved in the regulation of apoptosis and cell proliferation and plays a role in cellular transformation and malignancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20135</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>rCD4/IgG</VALIDVALUE>
          <VALUEMEANING>Recombinant Soluble Human CD4 Protein IgG Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant human soluble CD4 with antiviral activity. Recombinant human soluble CD4 has the amino terminus but not the T-cell binding domain of the endogenous CD4 antigen. This soluble CD4 protein competitively binds to envelope glycoprotein (gp120) of human immunodeficiency virus (HIV) resulting in inhibition of interaction between gp120 and the endogenous CD4 antigen, thereby blocking viral recognition of CD4 and subsequent entry of HIV into CD4 bearing cells.: An immunoglobulin isotype (subclass) that characterizes secondary immune responses.  This isotype is further broken down into several smaller subclasses (IgG1, IgG2a, IgG2b, IgG3 in the mouse; IgG1-4 in the human), and each subclass is differentially synthesized and secreted into the serum upon differential immune stimuli.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C568, C2342</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide/Thiotepa/Carboplatin</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide Thiotepa Carboplatin Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A synthetic alkylating agent. Related to nitrogen mustard, thiotepa alkylates and crosslinks DNA, resulting in the inhibition of DNA replication. (NCI04): A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1282, C875, C405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide/Pentostatin</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide Pentostatin Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): An anticancer drug that belongs to the family of drugs called antimetabolites.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C732, C405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide/Gemcitabine</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide Gemcitabine Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): An anticancer drug that belongs to the family of drugs called antimetabolites.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C66876, C405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CyVE</VALIDVALUE>
          <VALUEMEANING>Cytarabine/Etoposide</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide/Fludarabine/Genasense</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide Fludarabine Oblimersen Sodium Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A fluorinated nucleotide antimetabolite analog of the antiviral agent vidarabine (ara-A) with antineoplastic activity. Administered parenterally as a phosphate salt, fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite may inhibit DNA polymerase alpha, ribonucleotide reductase and DNA primase, thereby interrupting DNA synthesis and inhibiting tumor cell growth.  : The sodium salt of a phosphorothioate antisense oligonucleotide targeted to the initiation codon region of mRNA for the anti-apoptotic gene Bcl-2. Oblimersen inhibits Bcl-2 mRNA translation, which may result in decreased expression of the Bcl-2 protein and tumor cell apoptosis. This agent may enhance the efficacy of standard cytotoxic chemotherapy. The anti-apoptotic bcl-2 protein is an integral outer mitochondrial membrane protein (OMMP) that is overexpressed in some cancer cell types and is linked to tumor drug resistance.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C66722, C1094, C405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide/Daunomycin</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide Daunorubicin Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): An anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin.  Daunorubicin exhibits cytotoxic activity through topoisomerase-mediated interaction with DNA, thereby inhibiting DNA replication and repair and RNA and protein synthesis.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C62091, C405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>rhuMabVEGF</VALIDVALUE>
          <VALUEMEANING>Recombinant Vascular Endothelial Growth Factor Monoclonal Antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant therapeutic agent which is chemically identical to or similar to endogenous vascular endothelial growth factor (VEGF).  Produced by a wide variety of cell types, endogenous VEGF is a homodimeric, glycosylated protein that is a highly specific mitogen for vascular endothelial cells; significantly influences vascular permeability; appears to play a role in neovascularisation under physiological conditions; is a potent chemoattractant; has pro-coagulatory activities; and is hypoxia-inducible.  Therapeutic VEGF may be used to induce angiogenesis in the treatment of ischemic conditions and may have a role in stimulating nerve regeneration. (NCI04): An antibody produced by a clone or genetically homogenous population of hybrid cells i.e., hybridoma; hybrid cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis and treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20401, C1272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>y2B8</VALIDVALUE>
          <VALUEMEANING>IDEC-Y2B8 Monoclonal Antibody/Rituximab</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide/Vincristine</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Vincristine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide/Prednisone</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Prednisone</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide/Fludarabine</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Fludarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclosporine</VALIDVALUE>
          <VALUEMEANING>Cyclosporine</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural cyclic polypeptide immunosuppressant isolated from the fungus Beauveria nivea. The exact mechanism of action of cyclosporine is not known but may involve binding to the cellular protein cytophilin, resulting in inhibition of the enzyme calcineurin. This agent appears to specifically and reversibly inhibit immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited with T-helper cells as the primary target. Cyclosporine also inhibits lymphokine production and release. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3253643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daclizumab</VALIDVALUE>
          <VALUEMEANING>Daclizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody that is being studied for treatment of adult T-cell leukemia.  Also called dacliximab.  Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dactinomycin</VALIDVALUE>
          <VALUEMEANING>Dactinomycin</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromopeptide antineoplastic antibiotic isolated from the bacterium Streptomyces parvulus.  Dactinomycin intercalates between adjacent guanine-cytosine base pairs, blocking the transcription of DNA by RNA polymerase; it also causes single-strand DNA breaks, possibly via a free-radical intermediate or an interaction with topoisomerase II. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Darbepoetin Alfa</VALIDVALUE>
          <VALUEMEANING>Darbepoetin Alfa</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant analog of the endogenous cytokine erythropoietin, an erythropoiesis-stimulating protein.  Due to the addition of two carbohydrate chains, darbepoetin alfa exhibits a three-fold greater half-life than does erythropoietin.  Similar to erythropoietin, darbopoietin alfa binds to and activates epoetin receptors, thereby inducing the differentiation and maturation of erythrocyte progenitors, stimulating endothelial cell proliferation, and stimulating B-cell proliferation and immunoglobulin production. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1878</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Darunavir</VALIDVALUE>
          <VALUEMEANING>Darunavir</VALUEMEANING>
          <MEANINGDESCRIPTION>A human immunodeficiency virus type 1 (HIV-1) protease nonpeptidic inhibitor, with activity against HIV. Upon oral administration, darunavir selectively targets and binds to the active site of HIV-1 protease, and inhibits the dimerization and catalytic activity of HIV-1 protease. This inhibits the proteolytic cleavage of viral Gag and Gag-Pol polyproteins in HIV-infected cells. This inhibition leads to the production of immature, non-infectious viral proteins that are unable to form mature virions, and prevents HIV replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65364</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decitabine</VALIDVALUE>
          <VALUEMEANING>Decitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytidine antimetabolite analogue with potential antineoplastic activity. Decitabine incorporates into DNA and inhibits DNA methyltransferase, resulting in hypomethylation of DNA and intra-S-phase arrest of DNA replication. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Delavirdine Mesylate</VALIDVALUE>
          <VALUEMEANING>Delavirdine Mesylate</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, non-nucleoside reverse transcriptase (RT) inhibitor with antiviral properties.  Delavirdine binds directly to the human immunodeficiency virus type 1 (HIV-1) RT, an RNA-dependent DNA polymerase, blocking its function in viral DNA replication.  In combination with at least two other anti-retroviral drugs, this agent has been shown to reduce HIV viral load and increase CD4 leukocyte counts in the majority of patients.  As an inhibitor of the cytochrome P450 system, delavirdine may result in increased serum levels of those co-administered protease inhibitors metabolized by the cytochrome P450 system. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dexamethasone</VALIDVALUE>
          <VALUEMEANING>Dexamethasone</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04) [Source: NCI]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028376</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dexrazoxane</VALIDVALUE>
          <VALUEMEANING>Dexrazoxane</VALUEMEANING>
          <MEANINGDESCRIPTION>A bisdioxopiperazine with iron-chelating, chemoprotective, cardioprotective, and antineoplastic activities. After hydrolysis to an active form that is similar to ethylenediaminetetraacetic acid (EDTA), dexrazoxane chelates iron, limiting the formation of free radical-generating anthracycline-iron complexes, which may minimize anthracycline-iron complex-mediated oxidative damage to cardiac and soft tissues. This agent also inhibits the catalytic activity of topoisomerase II, which may result in tumor cell growth inhibition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1333</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Didanosine</VALIDVALUE>
          <VALUEMEANING>Didanosine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic nucleoside analogue of deoxyadenosine in which the 3&#39; hydroxyl on the ribose moiety is replaced by a hydrogen atom. In vivo, didanosine is converted to the active triphosphate form, which is incorporated into DNA. The absence of the 3&#39; hydroxyl inhibits DNA elongation because phosphodiester bonds cannot be made with the substituted hydrogen. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diaziquone</VALIDVALUE>
          <VALUEMEANING>Diaziquone</VALUEMEANING>
          <MEANINGDESCRIPTION>A water-soluble, synthetic aziridinylbenzoquinone with potential antineoplastic activity. Bioactivation of aziridinylbenzoquinone RH1 occurs through the two-electron reduction of the quinone to the hydroquinone by the two-electron quinone reductase DT-diaphorase (DTD). The resultant hydroquinone selectively alkylates and cross-links DNA at the 5&#39;-GNC-3&#39; sequence, inihibiting DNA replication, inducing apoptosis, and inhibiting tumor cell proliferation. DTD is over-expressed in many tumors relative to normal tissue, including lung, colon, breast and liver tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Docetaxel/Doxorubicin</VALIDVALUE>
          <VALUEMEANING>Docetaxel/Doxorubicin</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EM-1421</VALIDVALUE>
          <VALUEMEANING>Terameprocol</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic tetra-methylated derivative of nordihydroguaiaretic acid (NDGA) and transcriptional inhibitor with potential antiviral, antiangiogenic, and antineoplastic activities. Terameprocol competes with the transcription factor Sp1 for specific Sp1 DNA binding domains within gene promoter regions during DNA synthesis. In virally-infected cells, blocking of the Sp1 binding site suppresses Sp1-regulated viral promoter activity and gene expression, thereby inhibiting viral transcription and replication. In tumor cells, blockage of Sp1 binding sites by this agent interferes with the transcription of the Sp1-dependant genes cyclin-dependant kinase (Cdc2), survivin, and vascular endothelial growth factor (VEGF), which are overexpressed in a variety of cancers. By suppressing Sp1-regulated transcription of these genes, terameprocol may reduce tumor angiogenesis and tumor cell proliferation and induce tumor cell apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Denileukin Diftitox</VALIDVALUE>
          <VALUEMEANING>Denileukin Diftitox</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytotoxic recombinant protein consisting of interleukin-2 (IL-2) protein sequences fused to diphtheria toxin. The IL-2 protein sequence moiety of denileukin difitox directs the cytocidal action of diphtheria toxin to cells that express IL-2 receptors. After the toxin moiety is internalized into target IL-2 receptor-expressing cells, its catalytic domain catalyzes the transfer of the ADP-ribose moiety of NAD to a posttranslationally modified histidine residue of elongation factor 2 (EF-2), called diphthamine. This covalent modification inactivates EF-2 and disrupts polypeptide chain elongation, resulting in cell death. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dendritic Cell Therapy</VALIDVALUE>
          <VALUEMEANING>Dendritic Cell Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>A special type of antigen-presenting cell (APC) that activates T lymphocytes.: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C12583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daunorubicin Citrate Liposome</VALIDVALUE>
          <VALUEMEANING>Liposomal Daunorubicin Citrate</VALUEMEANING>
          <MEANINGDESCRIPTION>A liposome-encapsulated form of the citrate salt of the anthracycline antineoplastic antibiotic daunorubicin. Daunorubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. Liposomal delivery of doxorubicin citrate improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of therapeutic drug effects.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dasatinib (Sprycel)</VALIDVALUE>
          <VALUEMEANING>Dasatinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases.  Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sulindac</VALIDVALUE>
          <VALUEMEANING>Sulindac</VALUEMEANING>
          <MEANINGDESCRIPTION>A sulfinylindene derivative prodrug with potential antineoplastic activity. Converted in vivo to an active metabolite, sulindac, a nonsteroidal anti-inflammatory drug (NSAID), blocks cyclic guanosine monophosphate-phosphodiesterase (cGMP-PDE), an enzyme that inhibits the normal apoptosis signal pathway; this inhibition permits the apoptotic signal pathway to proceed unopposed, resulting in apoptotic cell death. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C850</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3340618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>c-Met Inhibitor LY2801653</VALIDVALUE>
          <VALUEMEANING>c-Met Inhibitor LY2801653</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available, small molecule inhibitor of the proto-oncogene c-Met (mesenchymal-epithelial transition, also known as hepatocyte growth factor receptor (HGFR)) with potential antineoplastic activity. c-Met inhibitor LY2801653 selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transduction pathways. This may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. This agent has potent anti-tumor efficacy in mono and combination therapy in a broad range of cancers. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays key roles in tumor cell proliferation, survival, invasion, metastasis, and tumor angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3395962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin-15</VALIDVALUE>
          <VALUEMEANING>Interleukin-15</VALUEMEANING>
          <MEANINGDESCRIPTION>Interleukin-15, encoded by the IL15 gene, is a cytokine that regulates T and natural killer cell activation and proliferation. This cytokine and interleukin 2 share many biological activities. They are found to bind common hematopoietin receptor subunits, and may compete for the same receptor, and thus negatively regulate each other&#39;s activity. The number of CD8+ memory cells is controlled by a balance between this cytokine and IL2. This cytokine induces the activation of JAK kinases, as well as the phosphorylation and activation of transcription activators STAT3, STAT5, and STAT6. Three alternatively spliced transcript variants of this gene encoding two distinct isoforms have been reported. (From LocusLink)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3316598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-PD-1 Human Monoclonal Antibody MDX-1106</VALIDVALUE>
          <VALUEMEANING>Anti-PD-1 Human Monoclonal Antibody (Anti-PD-1 Human Monoclonal Antibody MDX-1106)</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human monoclonal antibody directed against the negative immunoregulatory human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1/PCD-1) with immunopotentiation activity. Anti-PD-1 human monoclonal antibody MDX-1106 binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands PD-L1 and PD-L2, resulting in the activation of T-cells and cell-mediated immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and effector function through the suppression of P13k/Akt pathway activation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3316600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dartmouth Regimen</VALIDVALUE>
          <VALUEMEANING>Dartmouth Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of tamoxifen, cisplatin, dacarbazine and carmustine used for the treatment of advanced-stage or metastatic malignant melanoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63781</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DTPACE</VALIDVALUE>
          <VALUEMEANING>Cisplatin/Cyclophosphamide/Dexamethasone/Doxorubicin/Etoposide/Thalidomide</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DTIC/Mesna</VALIDVALUE>
          <VALUEMEANING>Dacarbazine/Mesna</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dacarbazine (DTIC)</VALIDVALUE>
          <VALUEMEANING>Dacarbazine</VALUEMEANING>
          <MEANINGDESCRIPTION>A triazene derivative with antineoplastic activity. Dacarbazine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DSAP</VALIDVALUE>
          <VALUEMEANING>Anti-Dopamine-b-Hydroxylase Monoclonal Antibody-Saporin</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunoconjugate of the anti-dopamine-b-hydroxylase monoclonal antibody covalently linked to the ribosome-inactivating protein (RIP) saporin derived from Saponaria officinalis. The monoclonal antibody component recognizes and attaches to the membrane-associated antigen, dopamine-b-hydroxylase, resulting in the conjugate being internalized by receptor-mediated endocytosis. The saporin toxin is then released from the complex, and binds to ribosomal subunits, thereby halts protein synthesis, and results in cell death. This immunoconjugate targets the dopamine-beta-hydroxylase enzyme localized on adrenergic nerves in the brainstem particular medulla and pons, thereby could be used to study neurodegenerative disorders and/or address fundamental neurobiological questions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daunorubicin</VALIDVALUE>
          <VALUEMEANING>Daunorubicin</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin.  Daunorubicin exhibits cytotoxic activity through topoisomerase-mediated interaction with DNA, thereby inhibiting DNA replication and repair and RNA and protein synthesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62091</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2724326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deoxythioguanosine</VALIDVALUE>
          <VALUEMEANING>Beta-Thioguanine Deoxyriboside</VALUEMEANING>
          <MEANINGDESCRIPTION>A thiopurine nucleoside derivative with antineoplastic activity. After conversion to the triphosphate, beta-thioguanine deoxyriboside is incorporated into DNA, resulting in inhibition of DNA replication.  This agent is cytotoxic against leukemia cell lines and has demonstrated some activity against leukemia cells in vivo.  Beta-thioguanine deoxyriboside demonstrates antineoplastic activity against 6-thioguanine-resistant tumor cells. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Depsipeptide</VALIDVALUE>
          <VALUEMEANING>Depsipeptide Antineoplastic Antibiotic</VALUEMEANING>
          <MEANINGDESCRIPTION>A bicyclic peptide antibiotic with one or more amide bonds replaced by ester bonds. Depsipeptide antibiotics act as histone deacetylase inhibitors and regulate chromatin structure and transcription by increasing histone acetylation, thereby resulting in alterations in gene expression and inducing cell differentiation, cell cycle arrest, and apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1976</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Di-dgA-RFB4</VALIDVALUE>
          <VALUEMEANING>Di-dgA-RFB4 Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunotoxin of monoclonal antibody (MoAb) RFB4 covalently linked to two deglycosylated ricin toxin A-chain (Di-dgA). This agent can be extracted from castor beans. MoAb RFB4 recognizes CD22 antigen, a B-cell adhesion protein expressed on malignant cells in about 70 percent of non-Hodgkin&#39;s lymphoma and chronic lymphocytic leukemia. Ricin toxin A-chain, a potent protein synthesis inhibitor, was deglycosylated and was used in this immunoconjugate to avoid hepatic entrapment. This Di-dgA conjugated MoAb RFB4 delivers 7 fold more cytotoxicity than the single dgA immunotoxin against CD22-positive malignant cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Docetaxel</VALIDVALUE>
          <VALUEMEANING>Docetaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata.  Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death.  This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response.  Docetaxel has been studied for use as a radiation-sensitizing agent. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diphencyprone</VALIDVALUE>
          <VALUEMEANING>Diphencyprone</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, potent allergic contact sensitizer with potential immunostimulatory activity. After sensitization process by repeated topical application of diphencyprone to a specific area, further application of this agent to the affected area may stimulate an immune response and may potentially be useful to clear the affected area from infection or cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dorzolamide</VALIDVALUE>
          <VALUEMEANING>Dorzolamide</VALUEMEANING>
          <MEANINGDESCRIPTION>An inhibitor of carbonic anhydrase, a zinc-containing enzyme that catalyzes the rapid conversion of carbon dioxide and water into carbonic acid, protons and bicarbonate ions.  Distributed throughout many cells and tissues, various carbonic anhydrases play important roles in mineral and metabolic homeostasis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62026</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378948</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxorubicin</VALIDVALUE>
          <VALUEMEANING>Doxorubicin</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthracycline antineoplastic antibiotic isolated from the fungus Streptococcus peucetius var. caesius.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.  The hydrochloride salt doxorubicin hydrochloride is the therapeutic form of doxorubicin. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2744954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dutasteride</VALIDVALUE>
          <VALUEMEANING>Dutasteride</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic 4-azasteroid compound. Dutasteride competitively and specificly inhibits both 5-alpha-reductase 1 and 2 isoenzymes that convert testosterone to dihydrotestosterone. The type 2 isoenzyme is primarily active in the reproductive tissues, while the type 1 isoenzyme is also responsible for conversion of testosterone in the skin and liver. Inhibition of 5-alpha reductase leads to a reduction of dihydrotestosterone formation and subsequently prevents the enlargement of the prostate gland. Dutasteride is used in the treatment of benign prostatic hyperplasia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Docetaxel/Gemcitabine</VALIDVALUE>
          <VALUEMEANING>Docetaxel-Gemcitabine Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of docetaxel and gemcitabine that can be used for the treatment of bone and non-small cell lung cancer, occult primary and small bowel adenocarcinoma, and soft tissue and uterine sarcoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxorubicin/Ifosfamide</VALIDVALUE>
          <VALUEMEANING>Doxorubicin Ifosfamide Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthracycline antineoplastic antibiotic isolated from the fungus Streptococcus peucetius var. caesius.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.  The hydrochloride salt doxorubicin hydrochloride is the therapeutic form of doxorubicin. (NCI04): A synthetic analogue of the nitrogen mustard cyclophosphamide with antineoplastic activity. Ifosfamide alkylates and forms DNA crosslinks, thereby preventing DNA strand separation and DNA replication.  This agent is a prodrug that must be activated through hydroxylation by hepatic microsomal enzymes. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C564, C456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dox/Vcr/Cyt/Etop/Dxm</VALIDVALUE>
          <VALUEMEANING>Doxorubicin Vincristine Cyclophosphamide Etoposide Dexamethasone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthracycline antineoplastic antibiotic isolated from the fungus Streptococcus peucetius var. caesius.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.  The hydrochloride salt doxorubicin hydrochloride is the therapeutic form of doxorubicin. (NCI04): A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04): A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation a</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C422, C491, C405, C933, C456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxorubicin/Dacarbazine</VALIDVALUE>
          <VALUEMEANING>Doxorubicin Dacarbazine Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthracycline antineoplastic antibiotic isolated from the fungus Streptococcus peucetius var. caesius.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.  The hydrochloride salt doxorubicin hydrochloride is the therapeutic form of doxorubicin. (NCI04): A triazene derivative with antineoplastic activity. Dacarbazine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C411, C456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378959</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxorubicin/Cyclophosphamide</VALIDVALUE>
          <VALUEMEANING>Doxorubicin Cyclophosphamide Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthracycline antineoplastic antibiotic isolated from the fungus Streptococcus peucetius var. caesius.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.  The hydrochloride salt doxorubicin hydrochloride is the therapeutic form of doxorubicin. (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C405, C456</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxorubicin Lipos/RFA</VALIDVALUE>
          <VALUEMEANING>Doxorubicin Hydrochloride Liposome Radiofrequency Ablation Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A liposome-encapsulated form of the hydrochloride salt of the anthracycline antineoplastic antibiotic doxorubicin.  Liposomal delivery of doxorubicin HCL improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of therapeutic drug effects.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, consequently inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation. (NCI04): A therapeutic procedure to eradicate or reduce small tumors using radiowaves to generate heat. The procedure is performed by the insertion of a thin needle through the skin and into a tumor, which is guided by computed tomography (CT) or ultrasound. Electrical energy delivered through this needle (electrode) heats and destroys the tumor. This therapeutic option is widely utilized by patients that have inoperable cancers, or are unsuitable chemotherapy candidates.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C15666, C1555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxorubicin/Gemcitabine</VALIDVALUE>
          <VALUEMEANING>Doxorubicin/Gemcitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11312</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxorubicin Liposome</VALIDVALUE>
          <VALUEMEANING>Doxorubicin Hydrochloride Liposome</VALUEMEANING>
          <MEANINGDESCRIPTION>A liposome-encapsulated form of the hydrochloride salt of the anthracycline antineoplastic antibiotic doxorubicin.  Liposomal delivery of doxorubicin HCL improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of therapeutic drug effects.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, consequently inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxorubicin Liposomal/Gemcitabine</VALIDVALUE>
          <VALUEMEANING>Doxorubicin Hcl Liposome/Gemcitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Donor Lymphocyte Infusion (DLI)</VALIDVALUE>
          <VALUEMEANING>Donor Leukocyte Infusion</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of therapy in which lymphocytes from the blood of a donor are given to a patient who has already received a stem cell transplant from the same donor. The donor lymphocytes may kill remaining cancer cells. Donor lymphocyte infusion is used to treat chronic myelogenous leukemia (CML) that has come back and myeloma. It is being studied in the treatment of other types of cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16145</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2866902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Docetaxel/Flavopiridol</VALIDVALUE>
          <VALUEMEANING>Docetaxel Flavopiridol Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata.  Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death.  This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response.  Docetaxel has been studied for use as a radiation-sensitizing agent. (NCI04): A synthetic N-methylpiperidinyl chlorophenyl flavone compound. As an inhibitor of cyclin-dependent kinase, flavopiridol induces cell cycle arrest by preventing phosphorylation of cyclin-dependent kinases (cdk) and by down-regulating cyclin D1 and D3 expression, resulting in G1 cell cycle arrest and apoptosis.  This agent is also a competitive inhibitor of adenosine triphosphate activity. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1571, C1526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Docetaxel/Vaccine</VALIDVALUE>
          <VALUEMEANING>Docetaxel Vaccine Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata.  Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death.  This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response.  Docetaxel has been studied for use as a radiation-sensitizing agent. (NCI04): Suspensions of killed or attentuated microorganisms (bacteria, viruses, or rickettsiae), or of antigenic proteins derived from them, administered for the prevention, amelioration, or treatment of infectious diseases or cancer.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C923, C1526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Docetaxel/Tariquidar (XR9576)</VALIDVALUE>
          <VALUEMEANING>Docetaxel Tariquidar Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata.  Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death.  This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response.  Docetaxel has been studied for use as a radiation-sensitizing agent. (NCI04): An anthranilamide derivative with multidrug resistance properties.  Tariquidar non-competitively binds to the p-glycoprotein transporter, thereby inhibiting transmembrane transport of anticancer drugs.  Inhibition of transmembrane transport may result in increased intracellular concentrations of an anticancer drug, thereby augmenting its cytotoxicity. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C2246, C1526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378969</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Docetaxel/Trastuzumab</VALIDVALUE>
          <VALUEMEANING>Docetaxel/Trastuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ESHAP</VALIDVALUE>
          <VALUEMEANING>Cisplatin/Cytarabine/Etoposide/Methylprednisolone</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9720</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EPOCH/R</VALIDVALUE>
          <VALUEMEANING>EPOCH Regimen Rituximab Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of etoposide, prednisone, vincristine (Oncovin) and doxorubicin hydrochloride (hydroxydaunorubicin hycrochloride), which may be used in combination with rituximab (R-EPOCH) for the treatment of various aggressive B cell and T cell non-Hodgkin lymphomas.: A recombinant chimeric murine/human antibody directed against the CD20 antigen, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes. Following binding, rituximab triggers a host cytotoxic immune response against CD20-positive cells. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1702, C63779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EPOCH</VALIDVALUE>
          <VALUEMEANING>EPOCH Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of etoposide, prednisone, vincristine (Oncovin) and doxorubicin hydrochloride (hydroxydaunorubicin hycrochloride), which may be used in combination with rituximab (R-EPOCH) for the treatment of various aggressive B cell and T cell non-Hodgkin lymphomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Efavirenz</VALIDVALUE>
          <VALUEMEANING>Efavirenz</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic non-nucleoside reverse transcriptase (RT) inhibitor with antiviral properties.  Efavirenz binds directly to the human immunodeficiency virus type 1 (HIV-1) RT, an RNA-dependent DNA polymerase, blocking its function in viral DNA replication.  In combination with other antiretroviral drugs, this agent has been shown to significantly reduce HIV viral loads, therefore retarding or preventing damage to the immune system, and reducing the risk of developing AIDS.  Efavirenz induces activity of the cytochrome P450 system, thereby accelerating its own metabolism. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Emtricitabine</VALIDVALUE>
          <VALUEMEANING>Emtricitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic fluoro derivative of thiacytidine with potent antiviral activity. Emtricitabine is phosphorylated to form emtricitabine 5&#39;-triphosphate within the cell. This metabolite inhibits the activity of human immunodeficiency virus (HIV) reverse transcriptase both by competing with the natural substrate deoxycytidine 5&#39;-triphosphate and by incorporation into viral DNA causing a termination of DNA chain elongation (due to the lack of the essential 3&#39;-OH group).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282251</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enzastaurin</VALIDVALUE>
          <VALUEMEANING>Enzastaurin</VALUEMEANING>
          <MEANINGDESCRIPTION>A substance being studied in the treatment of certain types of cancer, including non-Hodgkin lymphoma, breast, colon, lung, ovarian, and prostate. Enzastaurin blocks certain cell signaling pathways, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of serine threonine kinase inhibitor and a type of antiangiogenesis agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378983</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epirubicin</VALIDVALUE>
          <VALUEMEANING>Epirubicin</VALUEMEANING>
          <MEANINGDESCRIPTION>A 4&#39;-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin.  Epirubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62028</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epoetin Alfa</VALIDVALUE>
          <VALUEMEANING>Epoetin Alfa</VALUEMEANING>
          <MEANINGDESCRIPTION>A colony-stimulating factor that is made in the laboratory. It increases the production of red blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2695</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HGS-ETR2</VALIDVALUE>
          <VALUEMEANING>HGS-ETR2 (Lexatumumab)</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human monoclonal agonistic antibody directed against tumor necrosis factor-alpha (TNF-alpha)-related apoptosis-inducing ligand receptor-2 (TRAIL-R2) with potential antitumor activity. Mimicking the natural ligand TRAIL, lexatumumab binds to and activates TRAIL-R2, which may trigger apoptosis in and inhibit the growth of TRAIL-R2-expressing tumor cells. TRAIL-R2, also known as death receptor 5 (DR5), is a member of the TNF receptor family and is expressed on many malignant cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64621</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HeFi-1</VALIDVALUE>
          <VALUEMEANING>Monoclonal Antibody HeFi-1</VALUEMEANING>
          <MEANINGDESCRIPTION>A murine monoclonal antibody with potential antineoplastic activity. Monoclonal antibody HeFi-1 binds to CD30, a cell surface antigen found on mitogen-activated B-cells and T-cells, and Reed-Sternberg cells.  Monoclonal antibody HeFi-1 has been shown to arrest tumor growth and prevent metastasis in animal models. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gene Therapy</VALIDVALUE>
          <VALUEMEANING>Gene Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Application of genetic material (usually DNA) into cells in order to permanently correct an inherited disease or an acquired disease such as cancer.  The genetic material as &#39;naked&#39; DNA can be delivered into the cells alone or can be delivered into cells by different types of vectors such as viruses which may contain DNA or RNA.  Gene therapy techniques attempt to replace a faulty/missing gene associated with a particular disease, mediate localized delivery of a protein producing specified therapeutic effects, or introduce new cellular functions.  Gene therapies are designed to deliver genetic material into somatic cells and not germ cells, so that only cells of patients and not those of their offspring contain and express the genetic material delivered. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3082843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Herceptin</VALIDVALUE>
          <VALUEMEANING>Trastuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized recombinant monoclonal antibody directed against the HER2- receptor protein.  Trastuzumab binds to the extracellular domain of the growth factor protein HER2, thereby inhibiting proliferation of HER2 overexpressing tumor cells.  Binding with HER2 protein also initiates an antibody-dependent cell cytotoxicity.(NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1647</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gallium Nitrate</VALIDVALUE>
          <VALUEMEANING>Gallium Nitrate</VALUEMEANING>
          <MEANINGDESCRIPTION>A hydrated nitrate salt of the group IIIa element gallium with potential use in the treatment of malignancy-associated hypercalcemia.  Gallium nitrate localizes preferentially to areas of bone resorption and remodeling and inhibits osteoclast-mediated resorption by enhancing hydroxyapatite crystallization and reduction of bone mineral solubility.  This agent also increases calcium and phosphorous deposition into bone and may increase collagen synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1109</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GC1008</VALIDVALUE>
          <VALUEMEANING>Fresolimumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A pan-specific, recombinant, fully human monoclonal antibody directed against human transforming growth factor (TGF) -beta 1, 2 and 3 with potential antineoplastic activity. Fresolimumab binds to and inhibits the activity of all isoforms of TGF-beta, which may result in the inhibition of tumor cell growth, angiogenesis, and migration. TGF-beta, a cytokine often over-expressed in various malignancies, may play an important role in promoting the growth, progression, and migration of tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GM-CSF</VALIDVALUE>
          <VALUEMEANING>GM-CSF</VALUEMEANING>
          <MEANINGDESCRIPTION>Granulocyte-macrophage colony-stimulating factor. A colony-stimulating factor that stimulates the production of white blood cells, especially granulocytes and macrophages, and cells (in the bone marrow) that are precursors of platelets. It is a cytokine that belongs to the family of drugs called hematopoietic (blood-forming) agents. Also called sargramostim.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fosamprenavir Calcium</VALIDVALUE>
          <VALUEMEANING>Fosamprenavir Calcium</VALUEMEANING>
          <MEANINGDESCRIPTION>The calcium salt form of fosamprenavir, prodrug of amprenavir, and a human immunodeficiency virus (HIV) protease inhibitor with antiviral property. Fosamprenavir is converted to amprenavir by cellular phosphatases in the epithelial cells of the intestine. Then amprenavir binds to the active site of HIV-1 protease, thereby preventing the proteolytic cleavage of viral Gag-Pol polypeptide into individual functional proteins, thereby leading to the formation of immature non-infectious viral particles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61771</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foscarnet</VALIDVALUE>
          <VALUEMEANING>Foscarnet</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic organic analogue of inorganic pyrophosphate with antiviral properties.  Foscarnet selectively blocks the pyrophosphate binding site of virus-specific DNA polymerases at concentrations that do not affect cellular DNA polymerases.  Because this agent crosses the blood brain barrier, it may be used in the treatment of viral infections of the CNS.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71630</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2794945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fulvestrant</VALIDVALUE>
          <VALUEMEANING>Fulvestrant</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic estrogen receptor antagonist.  Unlike tamoxifen (which has partial agonist effects) and the aromatase inhibitors (which reduce the estrogen available to tumor cells), fulvestrant binds competitively to estrogen receptors in breast cancer cells, resulting in estrogen receptor deformation and decreased estrogen binding. In vitro studies indicate that fulvestrant reversibly inhibits the growth of tamoxifen-resistant, estrogen-sensitive, human breast cancer cell lines. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G-CSF</VALIDVALUE>
          <VALUEMEANING>Filgrastim</VALUEMEANING>
          <MEANINGDESCRIPTION>A colony-stimulating factor that stimulates the production of neutrophils (a type of white blood cell). It is a cytokine that belongs to the family of drugs called hematopoietic (blood-forming) agents. Also called granulocyte colony-stimulating factor (G-CSF).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganciclovir</VALIDVALUE>
          <VALUEMEANING>Ganciclovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic guanine derivative with antiviral activity.  As the active metabolite of ganciclovir, ganciclovir-5-triphosphate (ganciclovir-TP) appears to inhibit viral DNA synthesis by competitive inhibition of viral DNA polymerases and incorporation into viral DNA, resulting in eventual termination of viral DNA elongation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gefitinib</VALIDVALUE>
          <VALUEMEANING>Gefitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase-dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in inhibition of signal transduction. Gefitinib may also induce cell cycle arrest and inhibit angiogenesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3237466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gemcitabine</VALIDVALUE>
          <VALUEMEANING>Gemcitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>An anticancer drug that belongs to the family of drugs called antimetabolites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3145831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Goserelin</VALIDVALUE>
          <VALUEMEANING>Goserelin</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH) with antineoplastic activity. Goserelin inhibits the secretion of pituitary gonadotropin, thereby decreasing levels of testosterone (in males) and estradiol (in females).  Administration of this agent in a depot formulation may result in the regression of sex hormone-sensitive tumors and a reduction in sex organ size and function. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1374</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2921026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hexamethylmelamine</VALIDVALUE>
          <VALUEMEANING>Hexamethylmelamine (Altretamine)</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic cytotoxic s-triazine derivative similar in structure to alkylating agent triethylenemelamin with antineoplastic activity.  Although the precise mechanism by which altretamine exerts its cytotoxic effect is unknown, N-demethylation of altretamine may produce reactive intermediates which covalently bind to DNA, resulting in DNA damage. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C544</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HIV Peptide Vaccine</VALIDVALUE>
          <VALUEMEANING>HIV Peptide Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A vaccine containing one or more peptides derived from the human immunodeficiency virus (HIV). As a vaccine antigen, an HIV peptide may stimulate the host immune response against HIV, thereby preventing or treating HIV infection. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29085</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gemcitabine/Vinorelbine Tartrate</VALIDVALUE>
          <VALUEMEANING>Gemcitabine Vinorelbine Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An anticancer drug that belongs to the family of drugs called antimetabolites.: A semisynthetic vinca alkaloid. Vinorelbine binds to tubulin and prevents formation of the mitotic spindle,resulting in the arrest of tumor cell growth in metaphase. This agent may also interfere with amino acid, cyclic AMP. and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1275, C66876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IFN/5FU/IL2</VALIDVALUE>
          <VALUEMEANING>Interferon Fluorouracil Interleukin-2 Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570): An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity.  Fluorouracil and its metabolites possess a number of different mechanisms of action.  In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth.  Another active metabolite, 5-5-fluoro-2&#39;-deoxyuridine-5&#39;-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), a necessary constituent of DNA.  Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both the processing and functions of RNA. (NCI04): Encoded by human IL2 Gene, Interleukin-2 is a secreted cytokine important for proliferation of T and B lymphocytes. The receptor of this cytokine is a heterotrimeric protein complex whose gamma chain is also shared by interleukin 4 (IL4) and interleukin 7 (IL7). IL2 expression in mature thymocytes is monoallelic, which represents an unusual regulatory mode for controlling expression of a single gene. Targeted disruption of a similar gene in mice leads to</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C20507, C505, C20493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IFN/5FU</VALIDVALUE>
          <VALUEMEANING>Interferon Fluorouracil Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570): An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity.  Fluorouracil and its metabolites possess a number of different mechanisms of action.  In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth.  Another active metabolite, 5-5-fluoro-2&#39;-deoxyuridine-5&#39;-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), a necessary constituent of DNA.  Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both the processing and functions of RNA. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C505, C20493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL-2</VALIDVALUE>
          <VALUEMEANING>Interleukin-2</VALUEMEANING>
          <MEANINGDESCRIPTION>Encoded by human IL2 Gene, Interleukin-2 is a secreted cytokine important for proliferation of T and B lymphocytes. The receptor of this cytokine is a heterotrimeric protein complex whose gamma chain is also shared by interleukin 4 (IL4) and interleukin 7 (IL7). IL2 expression in mature thymocytes is monoallelic, which represents an unusual regulatory mode for controlling expression of a single gene. Targeted disruption of a similar gene in mice leads to ulcerative colitis-like disease, which suggests an essential role in the immune response to antigenic stimuli. (From LocusLink)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL-13</VALIDVALUE>
          <VALUEMEANING>Interleukin-13</VALUEMEANING>
          <MEANINGDESCRIPTION>Interleukin-13, encoded by the IL13 gene, is an immunoregulatory cytokine produced primarily by activated Th2 cells. This cytokine is involved in several stages of B-cell maturation and differentiation. It up-regulates CD23 and MHC class II expression, and promotes IgE isotype switching of B cells. This cytokine down-regulates macrophage activity, thereby inhibits the production of pro-inflammatory cytokines and chemokines. Interleukin-13 is found to be critical to the pathogenesis of allergen-induced asthma but operates through mechanisms independent of IgE and eosinophils. This gene, IL3, IL5, IL4, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL4. (From LocusLink)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20515</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL-12</VALIDVALUE>
          <VALUEMEANING>Interleukin-12</VALUEMEANING>
          <MEANINGDESCRIPTION>Exhibiting a broad range of biological activities on T and natural killer cells, Interleukin-12 is a disulfide-bonded heterodimeric cytokine composed of a 35-kD IL12A subunit (IL-6 Superfamily) and a 40-kDa IL12B subunit (Type I Cytokine Receptor 3 Family). IL12 stimulates T-cell-independent production of IFN-gamma by PBMCs, enhances NK cell lytic activity, acts as a growth factor for T- and NK-cells, and is important for Th1 and Th2 cell differentiation. Lymphocyte responses to IL12 require NOS2A and are mediated by STAT4 activator of transcription. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL-10</VALIDVALUE>
          <VALUEMEANING>Interleukin-10</VALUEMEANING>
          <MEANINGDESCRIPTION>Expressed primarily in monocytes and less in lymphocytes by human IL10 Gene, Interleukin-10 is a cytokine with pleiotropic effects in immunoregulation and inflammation. It down-regulates expression of Th1 cytokines, MHC class II antigens, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Studies in mice suggest that this cytokine as an essential immunoregulator in the intestinal tract. (From LocusLink)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3259396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL-1</VALIDVALUE>
          <VALUEMEANING>Interleukin-1</VALUEMEANING>
          <MEANINGDESCRIPTION>Human interleukin-1 protein (271 aa, 31 kD precursor) is encoded by the human interleukin-1 (IL1) gene. This soluble protein is produced primarily by monocytes and macrophages. It activates and potentiates T-lymphocyte responses to mitogens or antigens. This protein is also capable of replacing macrophage requirements for T-cell activation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ICE</VALIDVALUE>
          <VALUEMEANING>ICE Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of ifosfamide, carboplatin and etoposide used in the treatment of relapsed and refractory non-Hodgkin and Hodgkin lymphomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3366711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I131-COL1</VALIDVALUE>
          <VALUEMEANING>I131-COL1</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioimmunoconjugate of a murine monoclonal antibody (MoAb) COL1, labeled with iodine 131 (I-131). COL1 recognizes an epitope of carcinoembryonic antigen (CEA), which is over-expressed in many tumor cell types. I-131 MoAb COL1 delivers beta and gamma radiation emitting I-131 nuclide directly to tumor cells that express CEA, thereby allowing imaging and/or treatment of cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29106</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydroxyurea</VALIDVALUE>
          <VALUEMEANING>Hydroxyurea</VALUEMEANING>
          <MEANINGDESCRIPTION>A monohydroxyl-substituted urea (hydroxycarbamate) antimetabolite. Hydroxyurea selectively inhibits ribonucleoside diphosphate reductase, an enzyme required to convert ribonucleoside diphosphates into deoxyribonucleoside diphosphates, thereby preventing cells from leaving the G1/S phase of the cell cycle.  This agent also exhibits radiosensitizing activity by maintaining cells in the radiation-sensitive G1 phase and interfering with DNA repair. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydrocortisone</VALIDVALUE>
          <VALUEMEANING>Cortisol</VALUEMEANING>
          <MEANINGDESCRIPTION>A hormone made by the adrenal cortex (the outer layer of the adrenal gland). It helps the body use glucose (a sugar), protein, and fats. Cortisol made in the laboratory is called hydrocortisone. It is used to treat many conditions, including inflammation, allergies, and some cancers. Cortisol is a type of glucocorticoid hormone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3303092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydrazine</VALIDVALUE>
          <VALUEMEANING>Hydrazine</VALUEMEANING>
          <MEANINGDESCRIPTION>A highly reactive base and reducing agent used in many industrial and medical applications.  In biological applications, hydrazine and its derivatives exhibit antidepressant properties by inhibiting monoamine oxidase (MAO), an enzyme that catalyzes the deamination and inactivation of certain stimulatory neurotransmitters such as norepinephrine and dopamine.  In psychiatry, the use of hydrazine derivatives is limited due to the emergence of the tricyclic antidepressants. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydroxychloroquine</VALIDVALUE>
          <VALUEMEANING>Hydroxychloroquine</VALUEMEANING>
          <MEANINGDESCRIPTION>A substance that decreases immune responses in the body.  It is used to treat some autoimmune diseases, and is being studied as a treatment for graft-versus-host disease. Hydroxychloroquine belongs to the family of drugs called antiprotozoals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LMB-2</VALIDVALUE>
          <VALUEMEANING>LMB-2 Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>A fusion protein consisting of the Fv portion of a monoclonal antibody attached to a 38-kDa fragment of the Pseudomonas exotoxin A (with amino acids 365-380 deleted).  LMB-2 immunotoxin targets the interleukin 2 receptor (also known as IL-2R or CD25) which is expressed on activated normal T and B cells and macrophages and on the cells of various hematologic malignancies.  The antibody attaches to the IL-2R on the cell membrane, facilitating the entry of the exotoxin. The exotoxin moiety induces caspase-mediated apoptosis of tumor cells via a mechanism involving mitochondrial damage; it also catalyzes the transfer of ADP ribose from nicotinamide adenine dinucleotide (NAD) to elongation factor-2 in eukaryotic cells, thereby inactivating elongation factor 2 and inhibiting protein synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon gamma (IFN-G)</VALIDVALUE>
          <VALUEMEANING>Interferon Gamma</VALUEMEANING>
          <MEANINGDESCRIPTION>Interferon gamma (IFNg) is produced by activated T cells and is an important immunoregulatory molecule, particularly in allergic diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon beta (IFN-B)</VALIDVALUE>
          <VALUEMEANING>Interferon Beta</VALUEMEANING>
          <MEANINGDESCRIPTION>A class of interferon elaborated by fibroblasts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interferon alfa (IFN-A)</VALIDVALUE>
          <VALUEMEANING>Interferon Alpha</VALUEMEANING>
          <MEANINGDESCRIPTION>A class of interferon (leukocyte interferon) produced predominantly by B lymphocytes.  Located in a cluster on 9p22 there are at least 13 functional genes and 1 pseudogene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL-7</VALIDVALUE>
          <VALUEMEANING>Interleukin-7</VALUEMEANING>
          <MEANINGDESCRIPTION>Encoded by human IL7 Gene, Interleukin-7 is an important cytokine for B and T cell development. This cytokine and HGF form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor. IL7 is a cofactor for V(D)J rearrangement of T cell receptor beta (TCRB) during early T cell development. IL7 can be produced locally by intestinal epithelial and epithelial goblet cells, and may be a regulatory factor for intestinal mucosal lymphocytes. Studies in mice suggest that IL7 plays an essential role in lymphoid cell survival. (From LocusLink)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL-6</VALIDVALUE>
          <VALUEMEANING>Interleukin-6</VALUEMEANING>
          <MEANINGDESCRIPTION>Interleukin-6 (IL-6), a glycoprotein produced by activated T-cells and a variety of other cells, induces the production of IgM by B-cells and can be used to replace feeder cells for the growth and maintenance of B-cell hybridomas in vitro.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20451</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL-3</VALIDVALUE>
          <VALUEMEANING>Interleukin-3</VALUEMEANING>
          <MEANINGDESCRIPTION>Human interleukin-3 (152 aa, 17 kDa precursor) is encoded by the human interleukin-3 (IL3) gene. This protein is a potent growth-promoting cytokine that enhances the ability of the immune system to fight tumor cells. IL-3 supports proliferation of many hematopoietic cell types. It is involved in cell growth, differentiation and apoptosis in addition to possessing neurotrophic activity. Abnormalities in this protein may be associated with neurologic disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IFN/5FU/IL2/Leucovorin</VALIDVALUE>
          <VALUEMEANING>Interferon Fluorouracil Interleukin-2 Leucovorin Calcium Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570): An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity.  Fluorouracil and its metabolites possess a number of different mechanisms of action.  In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth.  Another active metabolite, 5-5-fluoro-2&#39;-deoxyuridine-5&#39;-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), a necessary constituent of DNA.  Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both the processing and functions of RNA. (NCI04): Encoded by human IL2 Gene, Interleukin-2 is a secreted cytokine important for proliferation of T and B lymphocytes. The receptor of this cytokine is a heterotrimeric protein complex whose gamma chain is also shared by interleukin 4 (IL4) and interleukin 7 (IL7). IL2 expression in mature thymocytes is monoallelic, which represents an unusual regulatory mode for controlling expression of a single gene. Targeted disruption of a similar gene in mice leads to</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C607, C20507, C505, C20493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379079</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IFN/5FU/Leucovorin</VALIDVALUE>
          <VALUEMEANING>Interferon Fluorouracil Leucovorin Calcium Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570): An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity.  Fluorouracil and its metabolites possess a number of different mechanisms of action.  In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth.  Another active metabolite, 5-5-fluoro-2&#39;-deoxyuridine-5&#39;-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), a necessary constituent of DNA.  Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both the processing and functions of RNA. (NCI04): An active metabolite of folic acid (also called folinic acid and citrovorum factor), which does not require metabolism by dihydrofolate reductase, the molecular target of folate antagonist-type chemotherapeutic drugs.  Leucovorin calcium counteracts the toxic effects of these medications, &#39;rescuing&#39; the patient while permitting the antitumor activity of the folate antagonist. This agent also potentiates the effects of fluorouracil and its derivatives by </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C607, C505, C20493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Humanized MiK-beta-1</VALIDVALUE>
          <VALUEMEANING>Monoclonal Antibody Mik-Beta-1</VALUEMEANING>
          <MEANINGDESCRIPTION>A murine monoclonal antibody directed against of the beta subunit of interleukin-2 receptor (IL-2R), expressed on resting T-lymphocytes, natural killer (NK) cells, and some leukemic cell types.  Monoclonal antibody Mik-Beta-1 prevents the binding of IL-2 to IL-2R beta, thereby inhibiting the IL-2-mediated proliferation and activation of T-cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ipilimumab</VALIDVALUE>
          <VALUEMEANING>Ipilimumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody directed against cytotoxic T-lymphocyte-associated antigen-4 (CTLA4), an antigen that is expressed on activated T-cells and exhibits affinity for B7 co-stimulatory molecules. By binding CTLA4, ipilimumab enhances T-cell activation and blocks B7-1 and B7-2 T-cell co-stimulatory pathways.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3185135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ifosfamide</VALIDVALUE>
          <VALUEMEANING>Ifosfamide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic analogue of the nitrogen mustard cyclophosphamide with antineoplastic activity. Ifosfamide alkylates and forms DNA crosslinks, thereby preventing DNA strand separation and DNA replication.  This agent is a prodrug that must be activated through hydroxylation by hepatic microsomal enzymes. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Imetelstat</VALIDVALUE>
          <VALUEMEANING>Imetelstat</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic lipid-conjugated, 13-mer oligonucleotide N3&#39;-P5&#39;-thio-phosphoramidate with potential antineoplastic activity. Complementary to the template region of telomerase (hTR) RNA, imetelstat acts as a competitive enzyme inhibitor that binds and blocks the active site of the enzyme (a telomerase template antagonist), a mechanism of action which differs from that for the antisense oligonucleotide-mediated inhibition of telomerase activity through telomerase mRNA binding. Inhibition of telomerase activity in tumor cells by imetelstat results in telomere shortening, which leads to cell cycle arrest or apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49084</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Imatinib Mesylate</VALIDVALUE>
          <VALUEMEANING>Imatinib Mesylate</VALUEMEANING>
          <MEANINGDESCRIPTION>The mesylate salt of an antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain the Philadelphia chromosome.  Imatinib also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and stem cell factor (SCF)/c-kit; the SCF/c-kit receptor tyrosine kinase is activated in gastrointestinal stromal tumor (GIST).  This agent inhibits proliferation and induces apoptosis in cells that overexpress these oncoproteins. It is also known as Gleevec.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indinavir</VALIDVALUE>
          <VALUEMEANING>Indinavir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic hydroxyaminopentane amide agent that selectively inhibits the protease of both human immunodeficiency virus 1 and 2. The incorporation of a basic amine into the hydroxyethylene backbone improves its aqueous solubility and its oral bioavailability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66877</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infliximab</VALIDVALUE>
          <VALUEMEANING>Infliximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody that inhibits the function of TNF-alpha.  It is used in the treatment of rheumatoid arthritis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Irofulven</VALIDVALUE>
          <VALUEMEANING>Irofulven</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic sesquiterpene derivative of illudin S, a natural toxin isolated from the fungus Omphalotus illudens.  Irofulven alkylates DNA and protein macromolecules, forms adducts, and arrests cells in the S-phase of the cell cycle.  This agent requires NADPH-dependent metabolism by alkenal/one oxidoreductase for activity. Irofulven is more active in vitro against tumor cells of epithelial origin and is more resistant to deactivation by p53 loss and MDR1 than other alkylating agents. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Isotretinoin</VALIDVALUE>
          <VALUEMEANING>Isotretinoin</VALUEMEANING>
          <MEANINGDESCRIPTION>A naturally-occurring retinoic acid with potential antineoplastic activity. Isotretinoin binds to and activates nuclear retinoic acid receptors (RARs); activated RARs serve as transcription factors that promote cell differentiation and apoptosis. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ispinesib</VALIDVALUE>
          <VALUEMEANING>Ispinesib</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic small molecule, derived from quinazolinone, with antineoplastic properties. Ispinesib selectively inhibits the mitotic motor protein, kinesin spindle protein (KSP), resulting in inhibition of mitotic spindle assembly, induction of cell cycle arrest during the mitotic phase, and cell death in tumor cells that are actively dividing. Because KSP is not involved in nonmitotic processes, such as neuronal transport, ispinesib may be less likely to cause the peripheral neuropathy often associated with the tubulin-targeting agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379089</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ixabepilone</VALIDVALUE>
          <VALUEMEANING>Ixabepilone</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable semisynthetic analogue of epothilone B with antineoplastic activity. Ixabepilone binds to tubulin and promotes tubulin polymerization and microtubule stabilization, thereby arresting cells in the G2-M phase of the cell cycle and inducing tumor cell apoptosis. This agent demonstrates antineoplastic activity against taxane-resistant cell lines.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KNI-272</VALIDVALUE>
          <VALUEMEANING>KNI-272</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic peptide-based antiviral agent.  As a peptidomimetic substrate containing an unnatural amino acid, allophenylnorstatine, KNI-272 selectively binds to and inhibits the human immunodeficiency virus (HIV) 1 and 2 proteases, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ketoconazole</VALIDVALUE>
          <VALUEMEANING>Ketoconazole</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of phenylpiperazine with broad antifungal properties and potential antineoplastic activity.  Ketoconazole inhibits sterol 14-a-dimethylase, a microsomal cytochrome P450-dependent enzyme, thereby disrupting synthesis of ergosterol, an important component of the fungal cell wall. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C605</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LMB-1</VALIDVALUE>
          <VALUEMEANING>LMB-1 Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>A chimeric protein consisting of the Fv portion of a monoclonal antibody attached to a fragment of Pseudomonas exotoxin A without its cell-binding region.  LMB-1 immunotoxin targets B3, a Lewis Y-related carbohydrate epitope found on some solid tumors.  The antibody attaches to the tumor cell and the exotoxin stops protein synthesis by inactivating elongation factor 2. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL2/IFN</VALIDVALUE>
          <VALUEMEANING>Interleukin-2 Interferon Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Encoded by human IL2 Gene, Interleukin-2 is a secreted cytokine important for proliferation of T and B lymphocytes. The receptor of this cytokine is a heterotrimeric protein complex whose gamma chain is also shared by interleukin 4 (IL4) and interleukin 7 (IL7). IL2 expression in mature thymocytes is monoallelic, which represents an unusual regulatory mode for controlling expression of a single gene. Targeted disruption of a similar gene in mice leads to ulcerative colitis-like disease, which suggests an essential role in the immune response to antigenic stimuli. (From LocusLink): Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C20493, C20507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Irinotecan HCl</VALIDVALUE>
          <VALUEMEANING>Irinotecan Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt of a semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata.  Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme.  One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death.  Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL2/LAK</VALIDVALUE>
          <VALUEMEANING>Interleukin-2/Lymphokine-Activated Killer Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Id Lymph Skin test vaccine</VALIDVALUE>
          <VALUEMEANING>Skin Test Lymphoma Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A preparation of an antigenic component of an infectious agent that is administered to a patient in order to determine whether previous exposure to the agent has occurred, and/or to assess the integrity of the patient&#39;s cellular immune system.  Depending on the clinical situation, the appearance of a delayed (cellular) hypersensitivity response, which manifests as an area of induration and erythema at the injection site, i.e. a positive test result, may indicate previous exposure to a particular infectious agent. (NCI04): A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.: Suspensions of killed or attentuated microorganisms (bacteria, viruses, or rickettsiae), or of antigenic proteins derived from them, administered for the prevention, amelioration, or treatment of infectious diseases or cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C923, C3208, C17137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379102</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Id KLH Myeloma</VALIDVALUE>
          <VALUEMEANING>Intradermal Plasma Cell Myeloma Keyhole Limpet Hemocyanin</VALUEMEANING>
          <MEANINGDESCRIPTION>Within the dermis, which is the layer of skin below the epidermis (outermost layer).: A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001): A natural protein isolated from the marine mollusc keyhole limpet.  Keyhole limpet hemocyanin is an immunogenic carrier protein that, in vivo, increases antigenic immune responses to haptens and other weak antigens such as idiotype proteins. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1139, C3242, C28213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Id KLH Lymphoma</VALIDVALUE>
          <VALUEMEANING>Intradermal Lymphoma Keyhole Limpet Hemocyanin</VALUEMEANING>
          <MEANINGDESCRIPTION>Within the dermis, which is the layer of skin below the epidermis (outermost layer).: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.: A natural protein isolated from the marine mollusc keyhole limpet.  Keyhole limpet hemocyanin is an immunogenic carrier protein that, in vivo, increases antigenic immune responses to haptens and other weak antigens such as idiotype proteins. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1139, C3208, C28213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ibritumomab Tiuxetan</VALIDVALUE>
          <VALUEMEANING>Ibritumomab Tiuxetan</VALUEMEANING>
          <MEANINGDESCRIPTION>ZEVALIN (Ibritumomab Tiuxetan) is the immunoconjugate resulting from a stable thiourea covalent bond between the monoclonal antibody Ibritumomab and the linker-chelator tiuxetan.  This linker-chelator provides a high affinity, conformationally restricted chelation site for Indium-111 or Yttrium-90.  The ZEVALIN therapeutic regimen is administered in two steps: Step 1 includes one infusion of Rituximab preceding In-111 ZEVALIN. Step 2 follows Step 1 by seven to nine days and consists of a second infusion of Rituximab followed by Y-90 ZEVALIN.  ZEVALIN is supplied as two separate and distinctly labeled kits that contain all of the non-radioactive ingredients necessary to produce a single dose of In-111 ZEVALIN and a single dose of Y-90 ZEVALIN, both essential components of the ZEVALIN therapeutic regimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IUdr</VALIDVALUE>
          <VALUEMEANING>Idoxuridine</VALUEMEANING>
          <MEANINGDESCRIPTION>An iodinated analog of deoxyuridine originally developed as a chemotherapeutic agent, but more commonly used as a treatment for conditions of herpes virus infection. Idoxuridine inhibits thymidylate phosphorylase and viral DNA polymerases. It is converted in vivo to its mono-, di-, and triphosphate forms and is incorporated into DNA by competition with thymidine. Once incorporated into DNA it creates a faulty template and disrupts viral replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379106</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INO-1001</VALIDVALUE>
          <VALUEMEANING>INO-1001</VALUEMEANING>
          <MEANINGDESCRIPTION>A isoindolinone derivative and potent inhibitor of the nuclear enzyme poly (ADP-ribose) polymerase (PARP) with chemosensitization and radiosensitization properties. INO-1001 inhibits PARP, which may result in inhibition of tumor cell DNA repair mechanisms and, so, tumor cell resistance to chemotherapy and radiation therapy. PARP enzymes are activated by DNA breaks and have been implicated in the repair of DNA single-strand breaks (SSB).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379108</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMC-A12</VALIDVALUE>
          <VALUEMEANING>Cixutumumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human IgG1 monoclonal antibody directed against the human insulin-like growth factor-1 receptor (IGF-1R) with potential antineoplastic activity. Cixutumumab selectively binds to membrane-bound IGF-1R, thereby preventing the binding of the natural ligand IGF-1 and the subsequent activation of PI3K/AKT signaling pathway. Downregulation of the PI3K/AKT survival pathway may result in the induction of cancer cell apoptosis and may decrease cancer cellular proliferation. IGF-1R, a receptor tyrosine kinase of the insulin receptor superfamily overexpressed by many cancer cell types, stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis; IGF-1R signaling has been implicated in tumorigenesis and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL2/MDX</VALIDVALUE>
          <VALUEMEANING>Interleukin-2 Monoclonal Antibody Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Encoded by human IL2 Gene, Interleukin-2 is a secreted cytokine important for proliferation of T and B lymphocytes. The receptor of this cytokine is a heterotrimeric protein complex whose gamma chain is also shared by interleukin 4 (IL4) and interleukin 7 (IL7). IL2 expression in mature thymocytes is monoallelic, which represents an unusual regulatory mode for controlling expression of a single gene. Targeted disruption of a similar gene in mice leads to ulcerative colitis-like disease, which suggests an essential role in the immune response to antigenic stimuli. (From LocusLink): An antibody produced by a clone or genetically homogenous population of hybrid cells i.e., hybridoma; hybrid cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis and treatment.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C20401, C20507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL2/LAK/IFN</VALIDVALUE>
          <VALUEMEANING>Interleukin-2 Lymphokine-Activated Killer Cells Interferon Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Encoded by human IL2 Gene, Interleukin-2 is a secreted cytokine important for proliferation of T and B lymphocytes. The receptor of this cytokine is a heterotrimeric protein complex whose gamma chain is also shared by interleukin 4 (IL4) and interleukin 7 (IL7). IL2 expression in mature thymocytes is monoallelic, which represents an unusual regulatory mode for controlling expression of a single gene. Targeted disruption of a similar gene in mice leads to ulcerative colitis-like disease, which suggests an essential role in the immune response to antigenic stimuli. (From LocusLink): Killer cell lymphocytes activated in the presence of interleukin-2 (IL-2).  Lymphokine-activated killer cells (LAKs) are cytotoxic effector cells with an exceptionally wide target cell spectrum including normal and malignant cells of different origins.  LAK cells exhibit a profound heterogeneity with regard to phenotype surface marker expression; it remains to be determined if they represent a unique cell lineage.: Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C20493, C13008, C20507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LY573636</VALIDVALUE>
          <VALUEMEANING>Tasisulam</VALUEMEANING>
          <MEANINGDESCRIPTION>An acyl-sulfonamide with potential antineoplastic activity. Selectively toxic towards tumor cells, tasisulam appears to induce tumor cell apoptosis by a mitochondrial-targeted mechanism involving the loss of mitochondrial membrane potential and induction of reactive oxygen species (ROS). In combination with an angiogenesis inhibitor, this agent may exhibit synergistic antiangiogenic activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62794</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LY317615</VALIDVALUE>
          <VALUEMEANING>Enzastaurin Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt of enzastaurin, a synthetic macrocyclic bisindolemaleimide with potential antineoplastic activity.  Binding to the ATP-binding site, enzastaurin selectively inhibits protein kinase C beta, an enzyme involved in the induction of vascular endothelial growth factor (VEGF)-stimulated neo-angiogenesis. This agent may decrease tumor blood supply and so tumor burden.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LMB-7</VALIDVALUE>
          <VALUEMEANING>LMB-7 Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>A single chain chimeric protein consisting of a monoclonal antibody fragment attached to a portion of the Pseudomonas exotoxin A. LMB-7 immunotoxin attaches to B3, a Lewis Y-related carbohydrate epitope on some solid tumor cells.  The antibody attaches to the cell and the exotoxin inhibits protein synthesis by inactivating elongation factor 2. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LMB-9</VALIDVALUE>
          <VALUEMEANING>LMB-9 Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant disulfide stabilized anti-Lewis Y IgG immunotoxin containing a 38 KD toxic element derived from the Pseudomonas aeruginosa exotoxin A and a monoclonal antibody fragment, designed to target adenocarcinomas expressing Lewis Y. LMB-9 immunotoxin attaches to tumor cells, facilitating he entry of the exotoxin. The exotoxin moiety induces caspase-mediated apoptosis of tumor cells via a mechanism involving mitochondrial damage; it also catalyzes the transfer of ADP ribose from nicotinamide adenine dinucleotide (NAD) to elongation factor-2 in eukaryotic cells, thereby inactivating elongation factor 2 and inhibiting protein synthesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ketoconazole/Prednisone</VALIDVALUE>
          <VALUEMEANING>Ketoconazole Prednisone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of phenylpiperazine with broad antifungal properties and potential antineoplastic activity.  Ketoconazole inhibits sterol 14-a-dimethylase, a microsomal cytochrome P450-dependent enzyme, thereby disrupting synthesis of ergosterol, an important component of the fungal cell wall. (NCI04): A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C770, C605</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Karenitecin</VALIDVALUE>
          <VALUEMEANING>Cositecan</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug being studied in the treatment of cancer.  It belongs to a family of drugs called topoisomerase inhibitors. It is related to the anticancer drug camptothecin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1877</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kaletra (Lopinavir/Ritonavir)</VALIDVALUE>
          <VALUEMEANING>Lopinavir/Ritonavir</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination anti-HIV protease inhibitor from Abbott Laboratories.  Brand name is Kaletra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IgG-RFB4-SMPT-dgA</VALIDVALUE>
          <VALUEMEANING>Di-dgA-RFB4 Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunotoxin of monoclonal antibody (MoAb) RFB4 covalently linked to two deglycosylated ricin toxin A-chain (Di-dgA). This agent can be extracted from castor beans. MoAb RFB4 recognizes CD22 antigen, a B-cell adhesion protein expressed on malignant cells in about 70 percent of non-Hodgkin&#39;s lymphoma and chronic lymphocytic leukemia. Ricin toxin A-chain, a potent protein synthesis inhibitor, was deglycosylated and was used in this immunoconjugate to avoid hepatic entrapment. This Di-dgA conjugated MoAb RFB4 delivers 7 fold more cytotoxicity than the single dgA immunotoxin against CD22-positive malignant cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IgG-HD37-SMPT-dgA</VALIDVALUE>
          <VALUEMEANING>Monoclonal Antibody HD37-SMPT-dgA Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunotoxin consisting of the murine anti-CD19 monoclonal antibody HD37 conjugated to a deglycosylated ricin A chain (dgA) via the linking molecule N-succinimidyl-oxycarbonyl-alpha-methyl-alpha-(2-pyridyldithio) toluene (SMPT).  The HD37 component binds to CD19, a B-cell restricted antigen, thereby targeting the delivery of the cytotoxic ricin A chain to B-cells. The ricin A chain component binds to B-cells and disrupts ribosomal activity and protein synthesis and induces cell cycle arrest. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Irinotecan/Cetuximab</VALIDVALUE>
          <VALUEMEANING>Irinotecan Cetuximab Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata.  Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme.  One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death.  Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent.: A monoclonal antibody specific for the epidermal growth factor receptor (EGFR), a tyrosine kinase that triggers cell division.  Cetuximab binds to and inhibits EGFRs, which are overexpressed on the cell surfaces of many types of tumors.  This agent blocks the tumor growth, invasion, and metastasis associated with the overexpression of cell-surface EGFRs. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1723, C62040</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ifosfa/Mesna/Etop</VALIDVALUE>
          <VALUEMEANING>Ifosfamide Mesna Etoposide Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic analogue of the nitrogen mustard cyclophosphamide with antineoplastic activity. Ifosfamide alkylates and forms DNA crosslinks, thereby preventing DNA strand separation and DNA replication.  This agent is a prodrug that must be activated through hydroxylation by hepatic microsomal enzymes. (NCI04): A sulfhydryl compound that is used to reduce the incidence of hemorrhagic cystitis associated with certain chemotherapeutic agents.  Mesna is converted to a free thiol compound in the kidney, where it binds to and inactivates acrolein and other urotoxic metabolites of ifosfamide and cyclophosphamide, thereby reducing their toxic effects on the urinary tract during urinary excretion. (NCI04): A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C491, C192, C564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Idarubicin HCl</VALIDVALUE>
          <VALUEMEANING>Idarubicin Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt of the anthracycline antineoplastic antibiotic idarubicin.  Idarubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis.  Due to its high lipophilicity, idarubicin penetrates cell membranes more efficiently than other anthracycline antibiotic compounds</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Id/IL-2 vaccine</VALIDVALUE>
          <VALUEMEANING>Interleukin-2 Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>Encoded by human IL2 Gene, Interleukin-2 is a secreted cytokine important for proliferation of T and B lymphocytes. The receptor of this cytokine is a heterotrimeric protein complex whose gamma chain is also shared by interleukin 4 (IL4) and interleukin 7 (IL7). IL2 expression in mature thymocytes is monoallelic, which represents an unusual regulatory mode for controlling expression of a single gene. Targeted disruption of a similar gene in mice leads to ulcerative colitis-like disease, which suggests an essential role in the immune response to antigenic stimuli. (From LocusLink): Suspensions of killed or attentuated microorganisms (bacteria, viruses, or rickettsiae), or of antigenic proteins derived from them, administered for the prevention, amelioration, or treatment of infectious diseases or cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C923, C20507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Id MM Skin test vaccine</VALIDVALUE>
          <VALUEMEANING>Skin Test Plasma Cell Myeloma Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A preparation of an antigenic component of an infectious agent that is administered to a patient in order to determine whether previous exposure to the agent has occurred, and/or to assess the integrity of the patient&#39;s cellular immune system.  Depending on the clinical situation, the appearance of a delayed (cellular) hypersensitivity response, which manifests as an area of induration and erythema at the injection site, i.e. a positive test result, may indicate previous exposure to a particular infectious agent. (NCI04): A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001): Suspensions of killed or attentuated microorganisms (bacteria, viruses, or rickettsiae), or of antigenic proteins derived from them, administered for the prevention, amelioration, or treatment of infectious diseases or cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C923, C3242, C17137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Laetrille</VALIDVALUE>
          <VALUEMEANING>Laetrille</VALUEMEANING>
          <MEANINGDESCRIPTION>Originally, the name laetrile was the contraction of laevo-mandelonitrile glucoside, a cyanogenic glycoside found naturally in some plants.  Over the years the meaning of laetrile has changed.  There are now preparations called Laetrile where amygdalin is the major constituent.  Laetrile and amygdalin are often used interchangeably, but are different agents.  Cyanide and benzaldehyde are metabolites of both laetrile and amygdalin.  Both metabolites may possess antineoplastic properties.  Laetrile has been used as an anticancer treatment in humans worldwide, but scientific evidence does not support its effectiveness.  It is not approved for use in the United States. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29149</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Letrozole</VALIDVALUE>
          <VALUEMEANING>Letrozole</VALUEMEANING>
          <MEANINGDESCRIPTION>A nonsteroidal inhibitor of estrogen synthesis that resembles paclitaxel in chemical structure.  As a third-generation aromatase inhibitor, letrozole selectively and reversibly inhibits aromatase, a cytochrome P-450 enzyme complex found in many tissues including those of the premenopausal ovary, liver, and breast; aromatase catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis.  In estrogen-dependent breast cancers, ananstrozole may inhibit tumor growth. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2921027</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leucovorin Calcium</VALIDVALUE>
          <VALUEMEANING>Leucovorin Calcium</VALUEMEANING>
          <MEANINGDESCRIPTION>An active metabolite of folic acid (also called folinic acid and citrovorum factor), which does not require metabolism by dihydrofolate reductase, the molecular target of folate antagonist-type chemotherapeutic drugs.  Leucovorin calcium counteracts the toxic effects of these medications, &#39;rescuing&#39; the patient while permitting the antitumor activity of the folate antagonist. This agent also potentiates the effects of fluorouracil and its derivatives by stabilizing the binding of the drug&#39;s metabolite to its target enzyme, thus prolonging drug activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C607</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leuprolide</VALIDVALUE>
          <VALUEMEANING>Leuprolide</VALUEMEANING>
          <MEANINGDESCRIPTION>The active ingredient in a drug used to treat symptoms of advanced prostate cancer. It is also used to treat early puberty in children and certain gynecologic conditions. It is being studied in the treatment of other conditions and types of cancer. Leuprolide blocks the body from making testosterone (a male hormone) and estradiol (a female hormone). It may stop the growth of prostate cancer cells that need testosterone to grow. It is a type of gonadotropin-releasing hormone analog.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2921029</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Levamisole</VALIDVALUE>
          <VALUEMEANING>Levamisole</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthelmintic drug. Co-administered with fluorouracil in the treatment of Dukes&#39; stage C colon cancer, levamisole restores immune function through stimulating antibody formation, enhancing T-cell activity, and potentiating macrophage function. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Levobunolol</VALIDVALUE>
          <VALUEMEANING>Levobunolol</VALUEMEANING>
          <MEANINGDESCRIPTION>A naphthalenone and non-cardioselective adrenergic beta-receptor antagonist with anti-glaucoma activity. Upon administration in the eye, levobunolol blocks beta-adrenergic receptors, thereby causing vasoconstriction. Levobunolol also decreases ciliary&#39;s body production of aqueous humor, leading to a decrease in aqueous humor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62043</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liarozole</VALIDVALUE>
          <VALUEMEANING>Liarozole</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally-active benzimidazole derivative with potential antineoplastic activity. As a retinoic acid metabolism blocking agent, liarozole inhibits cytochrome P450-dependent all-trans-retinoic acid (ATRA)-4-hydroxylase, resulting in an increase in endogenous ATRA production, inhibition of cell proliferation, and induction of cell differentiation. This agent also inhibits aromatase, the enzyme that catalyzes the final, rate-limiting step in estrogen biosynthesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liposomal Daunorubicin</VALIDVALUE>
          <VALUEMEANING>Liposomal Daunorubicin Citrate</VALUEMEANING>
          <MEANINGDESCRIPTION>A liposome-encapsulated form of the citrate salt of the anthracycline antineoplastic antibiotic daunorubicin. Daunorubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. Liposomal delivery of doxorubicin citrate improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of therapeutic drug effects.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liposomal Doxorubicin</VALIDVALUE>
          <VALUEMEANING>Doxorubicin Hydrochloride Liposome</VALUEMEANING>
          <MEANINGDESCRIPTION>A liposome-encapsulated form of the hydrochloride salt of the anthracycline antineoplastic antibiotic doxorubicin.  Liposomal delivery of doxorubicin HCL improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of therapeutic drug effects.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, consequently inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379143</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lapatinib</VALIDVALUE>
          <VALUEMEANING>Lapatinib</VALUEMEANING>
          <MEANINGDESCRIPTION>The ditosylate salt of a synthetic, orally-active quinazoline with potential antineoplastic properties. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26653</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2647015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MOPP/ABVD</VALIDVALUE>
          <VALUEMEANING>MOPP Regimen ABVD Regimen Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of mechlorethamine, vincristine (Oncovin), procarbazine and prednisone, used alone or in combination with radiation therapy for the treatment of stage I-IV Hodgkin lymphoma. Due to the increased risk of gonadal toxicity, this regimen has been widely replaced by the ABVD regimen.: A chemotherapy regimen consisting of doxorubicin hydrochloride (Adriamycin), bleomycin, vinblastine and dacarbazine, used alone or in combination with radiation therapy, for the primary treatment of Hodgkin lymphoma.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C9509, C9619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MONO dgA RFB4</VALIDVALUE>
          <VALUEMEANING>Di-dgA-RFB4 Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunotoxin of monoclonal antibody (MoAb) RFB4 covalently linked to two deglycosylated ricin toxin A-chain (Di-dgA). This agent can be extracted from castor beans. MoAb RFB4 recognizes CD22 antigen, a B-cell adhesion protein expressed on malignant cells in about 70 percent of non-Hodgkin&#39;s lymphoma and chronic lymphocytic leukemia. Ricin toxin A-chain, a potent protein synthesis inhibitor, was deglycosylated and was used in this immunoconjugate to avoid hepatic entrapment. This Di-dgA conjugated MoAb RFB4 delivers 7 fold more cytotoxicity than the single dgA immunotoxin against CD22-positive malignant cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MK-0158 (Raltegravir)</VALIDVALUE>
          <VALUEMEANING>Raltegravir</VALUEMEANING>
          <MEANINGDESCRIPTION>A small molecule with activity against human immunodeficiency virus (HIV). Raltegravir is an integrase inhibitor that blocks the integration of the viral genome into the host DNA, a critical step in the pathogenesis of HIV.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C72837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MINE/ESHAP</VALIDVALUE>
          <VALUEMEANING>Etoposide/Ifosfamide/Mesna/Mitoxantrone Cisplatin/Cytarabine/Etoposide/Methylprednisolone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists: No Value Exists: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C9720, C11137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MIME</VALIDVALUE>
          <VALUEMEANING>Etoposide/Ifosfamide/Methotrexate/Mitoguazone</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9615</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MICE</VALIDVALUE>
          <VALUEMEANING>Cytarabine Etoposide Everolimus Idarubicin Mitoxantrone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An anticancer drug that belongs to the family of drugs called antimetabolites.: A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04): A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. (NCI05): A semisynthetic anthracycline antineoplastic antibiotic derived from daunorubicin.  Idarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  Due to its high lipophilicity, idarubicin penetrates cell membranes better than other anthracycline antibiotics.  Idarubicin hydrochloride is the therapeutic form of this drug. (NCI04): An anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication. This agent also binds to topoisomerase II, resulting in DNA strand breaks and inhibition of DNA repair. Mitoxantrone is less cardiotoxic compared to doxorubicin.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C62050, C562, C48387, C491, C408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MGI-114</VALIDVALUE>
          <VALUEMEANING>Irofulven</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic sesquiterpene derivative of illudin S, a natural toxin isolated from the fungus Omphalotus illudens.  Irofulven alkylates DNA and protein macromolecules, forms adducts, and arrests cells in the S-phase of the cell cycle.  This agent requires NADPH-dependent metabolism by alkenal/one oxidoreductase for activity. Irofulven is more active in vitro against tumor cells of epithelial origin and is more resistant to deactivation by p53 loss and MDR1 than other alkylating agents. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MGCD0103 HDAC</VALIDVALUE>
          <VALUEMEANING>Mocetinostat</VALUEMEANING>
          <MEANINGDESCRIPTION>A rationally designed, orally available, Class 1-selective, small molecule, 2-aminobenzamide HDAC inhibitor with potential antineoplastic activity. Mocetinostat binds to and inhibits Class 1 isoforms of HDAC, specifically HDAC 1, 2 and 3, which may result in epigenetic changes in tumor cells and so tumor cell death; although the exact mechanism has yet to be defined, tumor cell death may occur through the induction of apoptosis, differentiation, cell cycle arrest, inhibition of DNA repair, upregulation of tumor suppressors, down regulation of growth factors, oxidative stress, and autophagy, among others. Overexpression of Class I HDACs 1, 2 and 3 has been found in many tumors and has been correlated with a poor prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62521</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MEDI-547</VALIDVALUE>
          <VALUEMEANING>Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547</VALUEMEANING>
          <MEANINGDESCRIPTION>An auristatin analogue immunoconjugate directed against Eph receptor A2 (EphA2)-positive cancer cells with potential antineoplastic activity. Anti-EphA2 monoclonal antibody-MMAF immunoconjugate MEDI-547 is generated by conjugating the fully human IgG1 anti-EphA2 monoclonal antibody (1C1) to the small-molecule microtubule inhibitor monomethyl auristatin phenylalanine (MMAF) via the stable linker maleimidocaproyl (mc) (1C1-mcMMAF). The monoclonal antibody moiety of this agent selectively binds to cells expressing the EphA2 receptor. After internalization and enzymatic cleavage of the immunoconjugate within the tumor cell cytosol, free MMAF binds to tubulin and inhibits its polymerization, which may result in G2/M phase arrest and tumor cell apoptosis. The cell-surface receptor EphA2, a member of the ephrin family of receptor tyrosine kinases (RTKs) involved in mammalian development, is overexpressed by a variety of different cancer cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79836</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MEDI-507</VALIDVALUE>
          <VALUEMEANING>Siplizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal immunoglobulin G1 antibody with potential antineoplastic activity. Siplizumab binds to CD2, a specific receptor found in T cells and NK cells, thereby triggering a host immune response that results in lysis of CD2+ cells, selective suppression of the immune system, and control of activated T cell growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MDX-H210</VALIDVALUE>
          <VALUEMEANING>Bispecific Antibody MDX-H210</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized bivalent antibody directed against both cytotoxic effector cells expressing Fc gamma receptor type I (Fc gammaRI, or CD64) and HER2/neu-overexpressing tumor cells with potential antineoplastic activity. Bispecific antibody MDX-H210 was constructed by chemically linking Fab&#39; fragments of the anti-HER2/neu-specific monoclonal antibody 520C9 and the Fab&#39; fragments of the anti-Fc gammaRI-specific monoclonal antibody H22. This agent selectively binds to both HER2/neu-expressing tumor cells and Fc gammaRI-expressing cytotoxic effector cells, which may trigger antibody-dependent cell-mediated cytotoxicity (ADCC) and cell lysis of HER2/neu-expressing tumor cells. While HER2/neu is overexpressed in a variety of epithelial malignancies, expression of Fc gammaRI is primarily found in cytotoxic immune cells, including monocytes, macrophages, and cytokine-activated polymorphonuclear (PMN) cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1578</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MDX-CTLA</VALIDVALUE>
          <VALUEMEANING>Ipilimumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody directed against cytotoxic T-lymphocyte-associated antigen-4 (CTLA4), an antigen that is expressed on activated T-cells and exhibits affinity for B7 co-stimulatory molecules. By binding CTLA4, ipilimumab enhances T-cell activation and blocks B7-1 and B7-2 T-cell co-stimulatory pathways.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3185135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mab 211At-ch81C6</VALIDVALUE>
          <VALUEMEANING>At 211 Monoclonal Antibody 81C6</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioimmunoconjugate of a human-murine chimeric IgG2 monoclonal antibody (MoAb) 81C6 labeled with an alpha-emitting radionuclide Astatine 211 (At-211), with imaging and radioimmunotherapeutic properties. MoAb 81C6 recognizes the extracellular matrix antigen tenascin (hexabrachion), which is up-regulated in gliomas and other cancers. Using MoAb 81C6 as a carrier for At-211 results in the targeted imaging and/or destruction of cells expressing tenascin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mab 131I-mu81C6</VALIDVALUE>
          <VALUEMEANING>Iodine I 131 Monoclonal Antibody 81C6</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioimmunoconjugate consisting of 81C6, a murine IgG2 anti-tenascin monoclonal antibody labeled with iodine 131 (I-131), with radioimaging and radioimmunotherapeutic activities. Using monoclonal antibody 81C6 as a carrier for I-131 results in the targeted imaging and/or destruction of cells expressing tenascin. Tenascin is an extracellular matrix protein which is overexpressed in gliomas and other cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mab 131I-ch81C6</VALIDVALUE>
          <VALUEMEANING>(131)I-ch81C6</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1723325</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAVE/Taraquidar (XR9576)</VALIDVALUE>
          <VALUEMEANING>Doxorubicin/Etoposide/Mitotane/Vincristine Tariquidar Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists: An anthranilamide derivative with multidrug resistance properties.  Tariquidar non-competitively binds to the p-glycoprotein transporter, thereby inhibiting transmembrane transport of anticancer drugs.  Inhibition of transmembrane transport may result in increased intracellular concentrations of an anticancer drug, thereby augmenting its cytotoxicity. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C2246, C10800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAID</VALIDVALUE>
          <VALUEMEANING>Dacarbazine/Doxorubicin/Ifosfamide/Mesna</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11179</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MACOP-B</VALIDVALUE>
          <VALUEMEANING>MACOP-B Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine and prednisone, used to treat aggressive forms of non-Hodgkin&#39;s lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3366705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lopinavir/Ritonavir</VALIDVALUE>
          <VALUEMEANING>Lopinavir/Ritonavir</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination anti-HIV protease inhibitor from Abbott Laboratories.  Brand name is Kaletra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lonafarnib (Sch66336)</VALIDVALUE>
          <VALUEMEANING>Lonafarnib</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic tricyclic derivative of carboxamide with antineoplastic properties.  Lonarfanib binds to and inhibits farnesyl transferase, an enzyme involved in the post-translational modification and activation of Ras proteins.  Ras proteins participate in numerous signalling pathways (proliferation, cytoskeletal organization), and play an important role in oncogenesis.  Mutated ras proteins have been found in a wide range of human cancers. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1829</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lomustine/Prednisone</VALIDVALUE>
          <VALUEMEANING>Lomustine Prednisone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A nitrosourea with antineoplastic activity. Lomustine alkylates and crosslinks DNA, thereby inhibiting DNA and RNA synthesis.  This agent also carbamoylates DNA and proteins, resulting in inhibition of DNA and RNA synthesis and disruption of RNA processing.  Lomustine is lipophilic and crosses the blood-brain barrier. (NCI04): A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C770, C617</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lomustine (BCNU)</VALIDVALUE>
          <VALUEMEANING>Lomustine</VALUEMEANING>
          <MEANINGDESCRIPTION>A nitrosourea with antineoplastic activity. Lomustine alkylates and crosslinks DNA, thereby inhibiting DNA and RNA synthesis.  This agent also carbamoylates DNA and proteins, resulting in inhibition of DNA and RNA synthesis and disruption of RNA processing.  Lomustine is lipophilic and crosses the blood-brain barrier. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C617</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Micellar Paclitaxel</VALIDVALUE>
          <VALUEMEANING>Micellar Paclitaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>A systemic administered polymeric micelle containing paclitaxel that may be used for chronic inflammatory diseases, such as rheumatoid arthritis and psoriasis. Paclitaxel, a toxoid, binds to and stabilizes tubulin and inhibits the disassembly of microtubules, thereby inhibiting cell division. Paclitaxel also inhibits metalloproteinase, thereby blocking the activities of matrix metalloproteinases (MMPs) and preventing collagen degradation in cartilage and bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mitomycin</VALIDVALUE>
          <VALUEMEANING>Mitomycin C</VALUEMEANING>
          <MEANINGDESCRIPTION>A methylazirinopyrroloindoledione antineoplastic antibiotic isolated from the bacterium Streptomyces caespitosus and other Streptomyces bacterial species.  Bioreduced mitomycin C generates oxygen radicals, alkylates DNA, and produces interstrand DNA cross-links, thereby inhibiting DNA synthesis.  Preferentially toxic to hypoxic cells, mitomycin C also inhibits RNA and protein synthesis at high concentrations. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1820</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mitotane</VALIDVALUE>
          <VALUEMEANING>Mitotane</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of the insecticide dichlorodiphenyl trichloroethane (DDT) with anti-adrenocorticoid properties.  Following its metabolism in the adrenal cortex to a reactive acyl chloride intermediate, mitotane covalently binds to adrenal proteins, specifically inhibiting adrenal cortical hormone production. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C664</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mitoxantrone</VALIDVALUE>
          <VALUEMEANING>Mitoxantrone</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication.  This agent also binds to topoisomerase II, resulting in DNA strand breaks and inhibition of DNA repair.  Mitoxantrone is less cardiotoxic compared to doxorubicin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62050</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mometasone Furoate</VALIDVALUE>
          <VALUEMEANING>Mometasone Furoate</VALUEMEANING>
          <MEANINGDESCRIPTION>The furoate salt form of mometasone, a synthetic topical glucocorticosteroid receptor agonist with anti-inflammatory, anti-pruritic and vasoconstrictive properties. Mometasone furoate exerts its effect by binding to cytoplasmic glucocorticoid receptors and subsequently activates glucocorticoid receptor mediated gene expression.  This results in synthesis of certain anti-inflammatory proteins, while inhibiting the synthesis of certain inflammatory mediators.. Specifically, mometasone furoate appears to induce phospholipase A2 inhibitory proteins, thereby controlling the release of the inflammatory precursor arachidonic acid from phospholipid membrane by phospholipase A2.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mycophenolate Mofetil</VALIDVALUE>
          <VALUEMEANING>Mycophenolate Mofetil</VALUEMEANING>
          <MEANINGDESCRIPTION>The morpholinoethyl ester of mycophenolic acid (MPA) with potent immunosuppressive properties.  Mycophenolate stops T-cell and B-cell proliferation through selective inhibition of the de novo pathway of purine biosynthesis.  In vivo, the active metabolite, MPA, reversibly inhibits inosine 5&#39;-monophosphate dehydrogenase, an enzyme involved in the de novo synthesis of guanine nucleotides.  MPA displays high lymphocyte specificity and cytotoxicity due to the higher dependence of activated lymphocytes on both salvage and de novo synthesis of guanine nucleotides relative to other cell types. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nelfinavir</VALIDVALUE>
          <VALUEMEANING>Nelfinavir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic antiviral agent.  Nelfinavir selectively inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions.  In vivo, this agent exhibits broad tissue distribution compared to related agents. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29285</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nevirapine</VALIDVALUE>
          <VALUEMEANING>Nevirapine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, non-nucleoside reverse transcriptase (RT) inhibitor with antiviral properties.  Nevirapine binds directly to the human immunodeficiency virus type 1 (HIV-1) RT, an RNA-dependent DNA polymerase, blocking its function in viral DNA replication.  In combination with other antiretroviral drugs, this agent reduces HIV viral loads and increases CD4 counts, thereby retarding or preventing the damage to the immune system and reducing the risk of developing AIDS. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oatmeal Powder</VALIDVALUE>
          <VALUEMEANING>Oatmeal Powder</VALUEMEANING>
          <MEANINGDESCRIPTION>Colloidal oatmeal, whole oats milled to a fine powder, with anti-pruritic activity. Oatmeal powder, especially when added to a warm bath, is used to provide temporary relief of itching and irritation caused by insect bites, eczema, sun burns, reactions to poisonous plants and various other skin rashes and allergies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nilotinib</VALIDVALUE>
          <VALUEMEANING>Nilotinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available aminopyrimidine with antineoplastic activity. Designed to overcome imatinib resistance, Nilotinib is a tyrosine kinase inhibitor that binds to and inhibits the Bcr-Abl fusion protein, an abnormal chimeric tyrosine kinase expressed in Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) cells. This agent also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and for c-kit, a receptor tyrosine kinase activated in gastrointestinal stromal tumor (GIST). Nilotinib interrupts phosphorylation of these tyrosine kinases and their downstream signaling targets, resulting in decreased cellular proliferation and the induction of apoptosis. This agent is more potent than imatinib against Ph+ CML cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nilutamide</VALIDVALUE>
          <VALUEMEANING>Nilutamide</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug that blocks the effects of male hormones in the body.  It belongs to the family of drugs called antiandrogens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3335142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Noscapine</VALIDVALUE>
          <VALUEMEANING>Noscapine</VALUEMEANING>
          <MEANINGDESCRIPTION>A phthalide isoquinoline non-narcotic alkaloid derived from the opium poppy Papaver somniferum, with mild analgesic, antitussive, and potential antineoplastic activities. Noscapine exerts its antitussive effects through the activation of sigma opioid receptors. This agent appears to exert its antimitotic effect by binding to tubulin, resulting in a disruption of microtubule assembly dynamics and subsequently, the inhibition of mitosis and tumor cell death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3293803</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>O6-Benzylguanine</VALIDVALUE>
          <VALUEMEANING>O6-Benzylguanine</VALUEMEANING>
          <MEANINGDESCRIPTION>A guanine analogue with antineoplastic activity. O6-benzylguanine binds the DNA repair enzyme O(6)-alkylguanine DNA alkyltransferase (AGT), transferring the benzyl moiety to the active-site cysteine and resulting in inhibition of AGT-mediated DNA repair. Co-administration of this agent potentiates the effects of other chemotherapeutic agents that damage DNA. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ON 01910.Na</VALIDVALUE>
          <VALUEMEANING>Polo-like kinase 1 Inhibitor ON 01910.Na</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic benzyl styryl sulfone analogue with potential antineoplastic activity. Polo-like kinase 1 inhibitor ON 01910.Na inhibits polo-like kinase1 (Plk1), inducing selective G2/M arrest followed by apoptosis in a variety of tumor cells while causing reversible cell arrest at the G1 and G2 stage without apoptosis in normal cells. This agent may exhibit synergistic antitumor activity in combination with other chemotherapeutic agents. Plk1, named after the polo gene of Drosophila melanogaster, is a serine/threonine protein kinase involved in regulating mitotic spindle function in a non-ATP competitive manner.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TNF</VALIDVALUE>
          <VALUEMEANING>Tumor Necrosis Factor Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A biological therapy that involves the use of anti-tumor necrosis factor antagonists. It results in the inhibition of tumor necrosis factor and the decrease of the inflammatory response in autoimmune disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TMC-125 (Etravirine)</VALIDVALUE>
          <VALUEMEANING>Etravirine</VALUEMEANING>
          <MEANINGDESCRIPTION>A diarylpyrimidine non-nucleoside reverse transcriptase inhibitor. Etravirine is designed to be active against HIV isolates with mutations that confer resistance to the two most commonly prescribed first-generation NNRTIs. It can bind the enzyme reverse transcriptase (RT) in multiple conformations, both for native and mutant RT, thereby blocking the enzymatic activity of RT.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TIL/DTIC/Cisplat/Tam/IFN</VALIDVALUE>
          <VALUEMEANING>Tumor Infiltrating Lymphocyte Dacarbazine Cisplatin Tamoxifen Interferon Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer.: A triazene derivative with antineoplastic activity. Dacarbazine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. (NCI04): An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04): An antineoplastic nonsteroidal selective estrogen receptor modulator (SERM).  Tamoxifen competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA.  The result is a reduction in DNA synthesis and cellular response to estrogen.  In addition, tamoxifen up-regulates the production of transforming growth factor B (TGFb), a factor that inhibits tumor cell growth, and down-regulates insulin-like growth factor 1 (IGF-1), a factor that stimulates breast cancer cell growth. (NCI04): Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C20493, C855, C376, C411, C12546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TH2 cells</VALIDVALUE>
          <VALUEMEANING>Type 2 Helper Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Type 2 Helper Cells are a subset of helper-inducer T-lymphocytes which synthesize and secrete the interleukins IL-4, IL-5, IL-6, and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12540</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TAS-106</VALIDVALUE>
          <VALUEMEANING>3&#39;-C-ethynylcytidine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic cytidine nucleoside containing a covalently bound ethynyl group with potential antineoplastic and radiosensitizing activities. 3&#39;-C-ethynylcytidine is metabolized in tumor cells to ethynylcytidine triphosphate (ECTP), which inhibits RNA synthesis by competitive inhibition of RNA polymerases I, II and III; subsequently, RNase L is activated, resulting in apoptosis. RNase L is a potent antiviral and antiproliferative endoribonuclease that cleaves singled stranded RNA, causes 28s rRNA fragmentation, and activates Janus Kinase (JAK), a mitochondrial-dependent apoptosis signaling molecule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suramin/HC/Flut</VALIDVALUE>
          <VALUEMEANING>Flutamide/Hydrocortisone/Suramin</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Comtrex</VALIDVALUE>
          <VALUEMEANING>Comtrex</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination preparation containing the analgesic acetaminophen and a combination of one or more of the following agents: an antihistamine (chlorpheniramine maleate or brompheniramine maleate), the expectorant guaifenesin, the antitussive dextromethorphan maleate and/or the decongestant pseudoephedrine hydrochloride or phenylephrine hydrochloride. These preparations are used to relieve symptoms of cold, cough and flu.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28940</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>O-Chloroacetylcarbamoylfumagillol</VALIDVALUE>
          <VALUEMEANING>O-Chloroacetylcarbamoylfumagillol</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic analog of fumagillin, an antibiotic isolated from the fungus Aspergillus fumigatus fresenius with antineoplastic activity.  TNP-470 binds to and irreversibly inactivates methionine aminopeptidase-2 (MetAP2), resulting in endothelial cell cycle arrest late in the G1 phase and inhibition of tumor angiogenesis.  This agent may also induce the p53 pathway, thereby stimulating the production of cyclin-dependent kinase inhibitor p21 and inhibiting angiogenesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tazarotene</VALIDVALUE>
          <VALUEMEANING>Tazarotene</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, topical retinoid.  Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene.  In psoriasis, tazarotene normalizes abnormal keratinocyte differentiation and reduces their hyperproliferation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tandutinib</VALIDVALUE>
          <VALUEMEANING>Tandutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>A piperazinyl quinazoline receptor tyrosine kinase inhibitor with antineoplastic activity. Tandutinib inhibits the autophosphorylation of FLT3 (FMS-Like Tyrosine kinase-3), c-KIT and PDGF (platelet-derived growth factor) receptor tyrosine kinases, thereby inhibiting cellular proliferation and inducing apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tamsulosin HCl</VALIDVALUE>
          <VALUEMEANING>Tamsulosin Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt of tamsulosin, a sulfonamide derivative with adrenergic antagonist activity. Tamsulosin selectivity binds to and blocks the activity of alpha1 adrenoreceptors in the human prostate and bladder neck; blockade of these adrenoceptors can cause smooth muscle in the prostate and bladder neck to relax, resulting in an improvement in urinary flow rate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tamoxifen</VALIDVALUE>
          <VALUEMEANING>Tamoxifen</VALUEMEANING>
          <MEANINGDESCRIPTION>An antineoplastic nonsteroidal selective estrogen receptor modulator (SERM).  Tamoxifen competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA.  The result is a reduction in DNA synthesis and cellular response to estrogen.  In addition, tamoxifen up-regulates the production of transforming growth factor B (TGFb), a factor that inhibits tumor cell growth, and down-regulates insulin-like growth factor 1 (IGF-1), a factor that stimulates breast cancer cell growth. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2897675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Talampanel</VALIDVALUE>
          <VALUEMEANING>Talampanel</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of dioxolo-benzodiazepine with anti-seizure activity.  Talampanel antagonizes the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) subtype of glutamate excitatory amino acid receptors and may inhibit the growth of gliomas by interfering with neurotransmitters involved in brain tumor growth. This agent may also protect against traumatic brain injury.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38139</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Talactoferrin alfa</VALIDVALUE>
          <VALUEMEANING>Talactoferrin</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug being studied in the treatment of kidney cancer that has spread. It is also being studied in the treatment of other types of cancer and other conditions. Talactoferrin increases the activity of dendritic cells (a type of immune cell) to help kill cancer cells. It is a form of human lactoferrin (a protein found in milk, tears, mucus, bile, and some white blood cells) that is made in the laboratory. Talactoferrin is a type of recombinant protein and a type of immunomodulatory protein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78460</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TP-38</VALIDVALUE>
          <VALUEMEANING>TGFa-PE38 Immunotoxin</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, chimeric toxin composed of human transforming growth factor alpha (TGF-alpha) fused to a fragment of Pseudomonas exotoxin (PE38) without its cell-binding domain.  The TGF-alpha moiety of the agent attaches to tumor cells expressing the epithelial growth factor receptor (EGFR); the exotoxin induces caspase-mediated apoptosis of tumor cells via a mechanism involving mitochondrial damage; it also catalyzes the transfer of ADP ribose from nicotinamide adenine dinucleotide (NAD) to elongation factor-2 in eukaryotic cells, thereby inactivating elongation factor 2 and inhibiting protein synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TNP-470</VALIDVALUE>
          <VALUEMEANING>O-Chloroacetylcarbamoylfumagillol</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic analog of fumagillin, an antibiotic isolated from the fungus Aspergillus fumigatus fresenius with antineoplastic activity.  TNP-470 binds to and irreversibly inactivates methionine aminopeptidase-2 (MetAP2), resulting in endothelial cell cycle arrest late in the G1 phase and inhibition of tumor angiogenesis.  This agent may also induce the p53 pathway, thereby stimulating the production of cyclin-dependent kinase inhibitor p21 and inhibiting angiogenesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tacrolimus</VALIDVALUE>
          <VALUEMEANING>Tacrolimus</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug used to help reduce the risk of rejection by the body of organ and bone marrow transplants.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3305284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Temozolomide</VALIDVALUE>
          <VALUEMEANING>Temozolomide</VALUEMEANING>
          <MEANINGDESCRIPTION>A triazene analog of dacarbazine with antineoplastic activity.  As a cytotoxic alkylating agent, temozolomide is converted at physiologic pH to the short-lived active compound, monomethyl triazeno imidazole carboxamide (MTIC). The cytotoxicity of MTIC is due primarily to methylation of DNA at the O6 and N7 positions of guanine, resulting in inhibition of  DNA replication.  Unlike dacarbazine, which is metabolized to MITC only in the liver, temozolomide is metabolized to MITC at all sites. Temozolomide is administered orally and penetrates well into the central nervous system. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lopinavir</VALIDVALUE>
          <VALUEMEANING>Lopinavir</VALUEMEANING>
          <MEANINGDESCRIPTION>An anti-HIV protease inhibitor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2095</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lovastatin</VALIDVALUE>
          <VALUEMEANING>Lovastatin</VALUEMEANING>
          <MEANINGDESCRIPTION>A lactone metabolite isolated from the fungus Aspergillus terreus with cholesterol-lowering activity and potential antineoplastic activity. Lovastatin is hydrolyszed to the active beta-hydroxyacid form, which competitively inhibits 3-hydroxyl-3-methylgutarylcoenzyme A (HMG-CoA) reductase, an enzyme involved in the cholesterol biosynthesis.  In addition, this agent may inhibit tumor cell proliferation and reduce tumor cell invasiveness, thereby decreasing tumor metastatic potential; induce tumor cell apoptosis, possibly by inhibiting protein geranylgeranylation and; arrest cells in the G1 phase of the cell cycle, an effect that sensitizes tumor cells to the cytotoxic effects of ionizing radiation.  (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C620</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lenalidomide (Revlimid)</VALIDVALUE>
          <VALUEMEANING>Lenalidomide</VALUEMEANING>
          <MEANINGDESCRIPTION>A thalidomide analog with potential antineoplastic activity.  Lenalidomide inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis.  This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Temsirolimus</VALIDVALUE>
          <VALUEMEANING>Temsirolimus</VALUEMEANING>
          <MEANINGDESCRIPTION>An ester analog of rapamycin. Temsirolimus binds to and inhibits the mammalian target of rapamycin (mTOR), resulting in decreased expression of mRNAs necessary for cell cycle progression and arresting cells in the G1 phase of the cell cycle. mTOR is a serine/threonine kinase which plays a role in the PI3K/AKT pathway that is upregulated in some tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testosterone</VALIDVALUE>
          <VALUEMEANING>Testosterone</VALUEMEANING>
          <MEANINGDESCRIPTION>(tes-TOS-ter-own) A hormone that promotes the development and maintenance of male sex characteristics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2299</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tenofovir</VALIDVALUE>
          <VALUEMEANING>Tenofovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic antiviral acyclic nucleotide analogue of adenosine 5-monophosphate.  Tenofovir is incorporated into human immunodeficiency viral DNA instead of the natural substrate deoxyadenosine 5-triphosphate, thereby inhibiting HIV-1 reverse transcriptase (RT), an RNA-dependent DNA polymerase, and resulting in DNA chain termination and impairment of viral replication and propagation.  This agent prevents HIV from reproducing in uninfected cells only.  Tenofovir exhibits activity against the hepatitis B virus (HBV). (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tenofovir Disoproxil Fumarate</VALIDVALUE>
          <VALUEMEANING>Tenofovir Disoproxil Fumarate</VALUEMEANING>
          <MEANINGDESCRIPTION>A pro-drug, fumaric acid salt form of tenofovir, a nucleoside reverse transcriptase inhibitor analog of adenosine. Tenofovir disoproxil fumarate is prescribed to treat HIV and chronic hepatitis B virus (HBV) in adults.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tetrahydrouridine</VALIDVALUE>
          <VALUEMEANING>Tetrahydrouridine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic pyrimidine nucleoside analogue with biomodulating activity. Tetrahydrouridine increases the efficacy of the radiosensitizer cytochlor (5-chloro-2&#39;-deoxycytidine) by inhibiting the enzyme deoxycytidine monophosphate (dCMP) deaminase and preventing the premature deamination of the cytochlor metabolite 5-chloro-2&#39;-deoxycytidine monophosphate (CldCMP) to 5-chloro-2&#39;-deoxyuridine monophosphate (CldUMP); in turn, this increases tumor concentrations of CldUMP which is then further anabolized and incorporated selectively into tumor DNA as CldU (5-chloro-2&#39;-deoxyuridine). (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C868</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thalidomide</VALIDVALUE>
          <VALUEMEANING>Thalidomide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of glutamic acid (alpha-phthalimido-glutarimide) with teratogenic, immunomodulatory, anti-inflammatory and anti-angiogenic properties.  Thalidomide acts primarily by inhibiting both the production of tumor necrosis factor alpha (TNF-alpha) in stimulated peripheral monocytes and the activities of interleukins and interferons.  This agent also inhibits polymorphonuclear chemotaxis and monocyte phagocytosis.  Thalidomide inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), thereby inhibiting angiogenesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3253641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thioguanine</VALIDVALUE>
          <VALUEMEANING>Thioguanine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic guanosine analogue antimetabolite. Phosphorylated by hypoxanthine-guanine phosphoribosyltransferase, thioguanine incorporates into DNA and RNA, resulting in inhibition of DNA and RNA syntheses and cell death. This agent also inhibits glutamine-5-phosphoribosylpyrophosphate amidotransferase, thereby inhibiting purine synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2744957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PEP-3-KLH (CDX-110)</VALIDVALUE>
          <VALUEMEANING>Rindopepimut</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer vaccine consisting of a human epidermal growth factor receptor variant III (EGFRvIIi)-specific peptide conjugated to the non-specific immunomodulator keyhole limpet hemocyanin (KLH) with potential antineoplastic activity. Vaccination with anti-EGFRvIII vaccine CDX-110 may elicit a cytotoxic T-lymphocyte (CTL) immune response against tumor cells expressing EGFRvIII. EGFRvIII, a functional variant of EGFR that is not expressed in normal tissues, was originally discovered in glioblastoma multiforme (GBM) and has also been found in various other cancers such as breast, ovarian, metastatic prostate, colorectal, and head and neck cancers. EGFRvIII contains an 83 amino acid deletion in its extracellular domain and has been shown to transform NIH/3T3 mouse embryonic fibroblast cells in vitro.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69076</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pentostatin/Rituximab</VALIDVALUE>
          <VALUEMEANING>Pentostatin/Rituximab</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12074</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pentosan</VALIDVALUE>
          <VALUEMEANING>Pentosan Polysulfate Sodium</VALUEMEANING>
          <MEANINGDESCRIPTION>The sodium salt of a semisynthetic heparin-like glucosaminoglycan.  Although its mechanism of action is unknown, pentosan polysulfate may act as a buffer to control cell permeability by preventing irritating solutes from reaching cells coated with it. Administered orally, excreted pentosan polysulfate adheres to the urinary bladder wall, preventing irritants from entering bladder cells and the development or progression of interstitial cystitis (IC), a complication of some chemotherapies. This agent also exhibits anticoagulant and fibrinolytic properties.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C946</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peginterferon Alfa-2a</VALIDVALUE>
          <VALUEMEANING>Peginterferon Alfa-2a</VALUEMEANING>
          <MEANINGDESCRIPTION>A covalent conjugate of recombinant interferon alfa, subtype 2a, and polyethylene glycol (PEG), used as an antiviral and antineoplastic agent. The biological activity of this agent is derived from its interferon alpha-2a protein moiety. Interferons alfa bind to specific cell-surface receptors, leading to the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer and immune-modulating effects. The PEG moiety lowers the clearance of interferon alpha-2a, thereby extending the duration of its therapeutic effects, but may also reduce interferon-mediated stimulation of an immune response. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peginterferon Alfa-2b</VALIDVALUE>
          <VALUEMEANING>Peginterferon Alfa-2b</VALUEMEANING>
          <MEANINGDESCRIPTION>A covalent conjugate of recombinant interferon alpha, subtype 2b, and polyethylene glycol (PEG), used as an antiviral and antineoplastic agent. The biological activity of this agent is derived from its interferon alpha-2b protein moiety. Interferons alfa bind to specific cell-surface receptors, leading to the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer, and immune-modulating effects. The PEG moiety lowers the clearance of interferon alpha-2b, thereby extending the duration of its therapeutic effects, but may also reduce the interferon-mediated stimulation of an immune response. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1845</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pegamotecan</VALIDVALUE>
          <VALUEMEANING>pegamotecan</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0758797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Panzem (2-Methoxyestradiol )</VALIDVALUE>
          <VALUEMEANING>2-Methoxyestradiol</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable estradiol metabolite with potential antineoplastic activity.  2-Methoxyestradiol inhibits angiogenesis by reducing endothelial cell proliferation and inducing endothelial cell apoptosis.  This agent also inhibits tumor cell growth by binding to tubulin, resulting in antimitotic activity, and by inducing caspase activation, resulting in cell cycle arrest in the G2 phase, DNA fragmentation, and apoptosis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paclitaxel Protein-Bound (Abraxane)</VALIDVALUE>
          <VALUEMEANING>Paclitaxel Albumin-Stabilized Nanoparticle Formulation</VALUEMEANING>
          <MEANINGDESCRIPTION>A Cremophor EL-free, albumin-stabilized nanoparticle formulation of the natural taxane paclitaxel with antineoplastic activity. Paclitaxel binds to and stabilizes microtubules, preventing their depolymerization and so inhibiting cellular motility, mitosis, and replication. This formulation solubilizes paclitaxel without the use of the solvent Cremophor, thereby permitting the administration of larger doses of paclitaxel while avoiding the toxic effects associated with Cremophor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paclitaxel (Taxol)</VALIDVALUE>
          <VALUEMEANING>Paclitaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>A compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity.  Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division.  This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PUVA</VALIDVALUE>
          <VALUEMEANING>PUVA Photochemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Phototherapy that combines the use of psoralen with UVA light as a treatment for various skin conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PTK-787/ZK-222584 (Vatalanib)</VALIDVALUE>
          <VALUEMEANING>Vatalanib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable anilinophthalazine with potential antineoplastic activity.  Vatalanib binds to and inhibits the protein kinase domain of vascular endothelial growth factor receptors 1 and 2; both receptor tyrosine kinases are involved in angiogenesis.  This agent also binds to and inhibits related receptor tyrosine kinases, including platelet-derived growth factor (PDGF) receptor, c-Kit, and c-Fms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1868</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PSC/Vinblastine</VALIDVALUE>
          <VALUEMEANING>PSC 833/Vinblastine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PSC/Paclitaxel</VALIDVALUE>
          <VALUEMEANING>Paclitaxel/PSC 833 Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C10855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PSC 833</VALIDVALUE>
          <VALUEMEANING>Valspodar</VALUEMEANING>
          <MEANINGDESCRIPTION>An analogue of cyclosporin-A. Valspodar inhibits p-glycoprotein, the multidrug resistance efflux pump, thereby restoring the retention and activity of some drugs in some drug-resistant tumor cells. This agent also induces caspase-mediated apoptosis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PSA Vaccine/GMCSF</VALIDVALUE>
          <VALUEMEANING>PSA RNA-Pulsed Dendritic Cell Vaccine Colony Stimulating Factor 2 Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An autologous dendritic cell vaccine with potential immunostimulatory activity. Dendritic cells harvested from a prostate cancer patient are transfected with the mRNA encoding for prostate specific antigen (PSA), a tumor marker secreted by prostatic epithelial and ductal cells. When reintroduced back to the patient, these PSA RNA pulsed autologous dendritic cells may elicit a cytotoxic T-cell (CTL) response against PSA-positive prostate cancer cells.: An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C20545, C2236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PMEA</VALIDVALUE>
          <VALUEMEANING>Adefovir</VALUEMEANING>
          <MEANINGDESCRIPTION>An acyclic nucleotide adenine analogue of adenosine monophosphate and reverse transcriptase inhibitor with potent antiviral activity against hepatitis B virus (HBV). Adefovir is activated in vivo to a diphosphate metabolite by cellular kinases. In turn, adefovir diphosphate competes with the natural substrate deoxyadenosine triphosphate (dATP) for incorporation into viral DNA by competing with the natural substrate deoxyadenosine triphosphate (dATP), leading to viral RNA-dependent HBV DNA polymerase inhibition, DNA chain termination and impairment of viral replication.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3134027</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PIXY</VALIDVALUE>
          <VALUEMEANING>Milodistim</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant fusion protein derived from the coding sequences of two growth factors, interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF).  Milodistim exhibits greater receptor binding affinity and colony stimulating activity than its parent cytokines.  This agent stimulates proliferation of immature hematopoietic cells and allows the stimulation and expansion of multi-lineage hematopoiesis from immature bone marrow progenitor cells. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379424</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PF-00299804</VALIDVALUE>
          <VALUEMEANING>Dacomitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>A highly selective, orally bioavailable small-molecule inhibitor of the HER family of tyrosine kinases with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human Her-1, Her-2, and Her-4, resulting in the proliferation inhibition and apoptosis of tumor cells that overexpress these receptors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379426</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PEG-L-asparaginase</VALIDVALUE>
          <VALUEMEANING>Pegaspargase</VALUEMEANING>
          <MEANINGDESCRIPTION>A complex of polyethylene glycol conjugated with L-asparaginase.  Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting these cells of asparagine and blocking protein synthesis and tumor cell proliferation, especially in the G1 phase of the cell cycle.  The agent also induces apoptosis in tumor cells. Pegylation decreases the enzyme&#39;s antigenicity. Asparagine is critical to protein synthesis in leukemic cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PCLUS 6.1-18MN</VALIDVALUE>
          <VALUEMEANING>PCLUS 6.1-18MN</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic HIV-1 envelope peptide that was developed for use as a vaccine.  Vaccination with PCLUS 6.1-18MN may stimulate the host immune system to mount cytotoxic T lymphocyte (CTL) and T helper cell responses, and induce the production of neutralizing antibodies. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2787</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PCLUS 3-18MN</VALIDVALUE>
          <VALUEMEANING>PCLUS 3-18MN</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic HIV-1 envelope peptide that was developed for use as a vaccine.  Vaccination with PCLUS 3-18MN may stimulate the host immune system to mount cytotoxic T lymphocyte (CTL) and T helper cell responses, and induce the production of neutralizing antibodies. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PCK3145</VALIDVALUE>
          <VALUEMEANING>PSP-94-Derived Peptide PCK3145</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic 15-mer peptide corresponding to amino acids 31-45 of the 94-amino acid isoform of human prostate secretory protein (PSP-94) with potential anti-metastasis and anti-angiogenesis activities. PSP-94-derived peptide PCK3145 may inhibit the secretion of the metastasis-related protein matrix metalloproteinase-9 (MMP-9) and its potential binding to its cell surface receptor CD44; may interfere with the vascular endothelial growth factor (VEGF) signaling pathway, resulting in an anti-angiogenesis effect; and may reduce the levels of parathyroid hormone-related protein (PTHrP), decreasing plasma calcium levels. PSP-94, one of three predominant proteins found in seminal fluid, may be down-regulated in prostate cancer, representing a potential survival mechanism for prostate cancer cells. MMP-9 is implicated in the invasion and metastasis of cancer. PTHrP may be expressed by various tumor cell types, resulting in the hypercalcemia of malignancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PC-SPES</VALIDVALUE>
          <VALUEMEANING>PC-SPES</VALUEMEANING>
          <MEANINGDESCRIPTION>An herbal mixture with potential antineoplastic effects. PC-SPES, an herbal supplement containing extracts from 8 herbs including Chrysanthemum morifolium, Ganoderma lucidum (a root fungus), Glycyrrhiza glabra (Spanish liquorice), Isatis indigotica, Panax pseudoginseng, Rabdosia rubescens, Scutellaria baicalensis, and Serona repens (saw palmetto), with potential antineoplastic and antiproliferative effects, specifically in prostate cancer cells. Its exact pharmacology is not fully understood due to the complexity of the herbal mixture and may involve multiple metabolic pathways. Exposure to PC-SPES in vitro has resulted in a decreased expression of genes encoding cell cycle regulatory proteins as well as an upregulation of genes that modulate apoptosis in both androgen-dependent and androgen-independent cells. The PC in the acronym PC-SPES stands for Prostate Cancer, while SPES is the Latin word for hope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PBSCT, Autologous</VALIDVALUE>
          <VALUEMEANING>Autologous Peripheral Blood Stem Cell Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>(aw-TAHL-o-gus) Taken from an individual&#39;s own tissues, cells, or DNA.: Similar to bone marrow transplantation, peripheral stem cell transplantation is a method of replacing the blood-forming cells lost due to high-dose chemotherapy, and possibly radiation therapy, used to destroy leukemia cells. Certain immature circulating blood cells, similar to stem cells in the bone marrow, are removed before treatment. The cells are then given to the patient after treatment to help the bone marrow recover and continue producing healthy blood cells.  Transplantation may be autologous (the patient&#39;s own blood cells are used), allogeneic (blood cells are donated by someone else), or syngeneic (blood cells are donated by an identical twin).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15430, C28000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PCV</VALIDVALUE>
          <VALUEMEANING>Lomustine/Procarbazine/Vincristine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Panretin</VALIDVALUE>
          <VALUEMEANING>Alitretinoin</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally- and topically-active naturally-occurring retinoic acid with antineoplastic, chemopreventive, teratogenic, and embryotoxic activities. Alitretinoin binds to and activates nuclear retinoic acid receptors (RAR) and retinoid X receptors (RXR); these activated receptors act as transcription factors, regulating gene expression that results in the inhibition of cell proliferation, induction of cell differentiation, and apoptosis of both normal cells and tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Panitumumab (ABX-EGF)</VALIDVALUE>
          <VALUEMEANING>Panitumumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A human monoclonal antibody produced in transgenic mice that attaches to the transmembrane epidermal growth factor (EGF) receptor. Panitumumab may inhibit autocrine EGF stimulation of tumor cells that express the EGF receptor, thereby inhibiting tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1857</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PANVAC-V/PANVAC-F/GM-CSF</VALIDVALUE>
          <VALUEMEANING>Falimarev Inalimarev Recombinant Granulocyte-Macrophage Colony-Stimulating Factor Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer vaccine comprised of a recombinant fowlpox viral vector encoding the carcinoembryonic antigen (CEA), MUC-1, a transmembrane glycoprotein secreted by glandular epithelial tissues, and TRICOM, comprised of three co-stimulatory molecule transgenes (B7-1, ICAM-1 and LFA-3). This agent may enhance CEA and MUC-1 presentation to antigen-presenting cells (APC) and may activate a cytotoxic T-cell response against CEA- and MUC-1-expressing tumor cells.: A cancer vaccine comprised of a recombinant vaccinia viral vector encoding the carcinoembryonic antigen (CEA), MUC-1 (mucin-1), a transmembrane glycoprotein secreted by glandular tissues, and TRICOM, comprised of the three co-stimulatory molecule transgenes B7-1, ICAM-1 and LFA-3. Upon administration, inalimarev may enhance CEA and MUC-1 presentation to antigen presenting cells (APC) and may activate a cytotoxic T lymphocyte (CTL) response against CEA- and MUC-1-expressing tumor cells.: Granulocyte-macrophage colony-stimulating factor. A colony-stimulating factor that stimulates the production of white blood cells, especially granulocytes and macrophages, and cells (in the bone marrow) that are precursors of platelets. It is a cytokine that belongs to the family of drugs called hematopoietic (blood-forming) agents. Also called sargramostim.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1288, C29317, C29316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PS-341</VALIDVALUE>
          <VALUEMEANING>Bortezomib</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified dipeptidyl boronic acid with antineoplastic activity. Via boronic acid moiety, bortezomib reversibly binds to the 26S proteasome, where degradation of ubiquinated proteins occurs. By blocking the targeted proteolysis normally performed by the proteasome, bortezomib disrupts various cell signaling pathways, leading to cell cycle arrest, apoptosis, and inhibition of angiogenesis.  Specifically, the agent inhibits nuclear factor (NF)-kappaB, a protein that is constitutively activated in some cancers, thereby interfering with NF-kappaB-mediated cell survival, tumor growth, and angiogenesis. In vivo, bortezomib delays tumor growth and enhances the cytotoxic effects of radiation and chemotherapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PALA</VALIDVALUE>
          <VALUEMEANING>Sparfosic Acid</VALUEMEANING>
          <MEANINGDESCRIPTION>A stable transition state analogue for an aspartate transcarbamylase-catalyzed reaction with antineoplastic activity. Sparfosic acid is a stable transition analogue of the activated complex for the reaction catalyzed by aspartate transcarbamylase, the first step in the pyrimidine biosynthetic pathway. This agent inhibits de novo pyrimidine biosynthesis and increases the extent to which fluorouracil metabolites are incorporated into RNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PACE BOM</VALIDVALUE>
          <VALUEMEANING>Prednisolone Doxorubicin Cyclophosphamide Etoposide Bleomycin Vincristine Methotrexate Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisolone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI04): An anthracycline antineoplastic antibiotic isolated from the fungus Streptococcus peucetius var. caesius.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.  The hydrochloride salt doxorubicin hydrochloride is the therapeutic form of doxorubicin. (NCI04): A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04): A mixture of glycopeptide antineoplastic antibiotics isolated from the fungus Streptomyces verticillus.  Bleomycin forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals w</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C642, C933, C313, C491, C405, C456, C769</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6, 7</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379446</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>P6 Regimen</VALIDVALUE>
          <VALUEMEANING>Radiation Therapy Thiotepa Carboplatin Autologous Stem Cell Rescue Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.: A synthetic alkylating agent. Related to nitrogen mustard, thiotepa alkylates and crosslinks DNA, resulting in the inhibition of DNA replication. (NCI04): A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04): A type of autologous hematopoietic stem cell
transplantation designed to promote recovery if a prior hematopoietic stem cell transplantation fails or is not adequate.
: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C82054, C1282, C875, C15313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379447</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>P-32</VALIDVALUE>
          <VALUEMEANING>Phosphorus P-32</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioactive isotope of phosphorus with beta particle-emitting radiocytotoxic activity. Emitted by phosphorus P32, beta particles directly damage cellular DNA and, by ionizing intracellular water to produce several types of cytotoxic free radicals and superoxides, indirectly damage intracellular biological macromolecules, resulting in tumor cell death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OSI 774 (Tarceva)</VALIDVALUE>
          <VALUEMEANING>Erlotinib</VALUEMEANING>
          <MEANINGDESCRIPTION>A quinazoline derivative with antineoplastic properties.  Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2693</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nutritional supplement</VALIDVALUE>
          <VALUEMEANING>Supplements/Vitamins</VALUEMEANING>
          <MEANINGDESCRIPTION>Oral preparations containing dietary ingredient(s) intended to supplement the diet.  Dietary ingredients include vitamins, minerals, herbs, amino acids, extracts and metabolites._Used to indicate that either or both of two items or options may be valid._A group of organic food substances found in animals and plants in small quantities. They must be supplied in diet or dietary supplement and are essential for normal metabolism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C944, C48928, C1505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3335130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nitrocamptothecin</VALIDVALUE>
          <VALUEMEANING>Rubitecan</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic agent related to camptothecin with potent antitumor and antiviral properties.  Rubitecan binds to and inhibits the enzyme topoisomerase I and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells; this agent also prevents repair of reversible single-strand DNA breaks. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1485</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MoAB</VALIDVALUE>
          <VALUEMEANING>Monoclonal Antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody produced by a clone or genetically homogenous population of hybrid cells i.e., hybridoma; hybrid cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis and treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2829937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mitoxantrone/Prednisone</VALIDVALUE>
          <VALUEMEANING>Mitoxantrone Prednisone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication. This agent also binds to topoisomerase II, resulting in DNA strand breaks and inhibition of DNA repair. Mitoxantrone is less cardiotoxic compared to doxorubicin.: A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C770, C62050</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mini-BEAM</VALIDVALUE>
          <VALUEMEANING>Carmustine/Cytarabine/Etoposide/Melphalan</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377446</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Panobinostat</VALIDVALUE>
          <VALUEMEANING>Panobinostat</VALUEMEANING>
          <MEANINGDESCRIPTION>A cinnamic hydroxamic acid analogue with potential antineoplastic activity. Panobinostat selectively inhibits histone deacetylase (HDAC), inducing hyperacetylation of core histone proteins, which may result in modulation of cell cycle protein expression, cell cycle arrest in the G2/M phase and apoptosis. In addition, this agent appears to modulate the expression of angiogenesis-related genes, such as hypoxia-inducible factor-1alpha (HIF-1a) and vascular endothelial growth factor (VEGF), thus impairing endothelial cell chemotaxis and invasion. HDAC is an enzyme that deacetylates chromatin histone proteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clarithromycin</VALIDVALUE>
          <VALUEMEANING>Clarithromycin</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic 14-membered ring macrolide antibiotic.  Clarithromycin binds to the 50S ribosomal subunit and inhibits RNA-dependent protein synthesis in susceptible organisms.  Clarithromycin has been shown to eradicate gastric MALT (mucosa-associated lymphoid tissue) lymphomas, presumably due to the eradication of tumorigenic Helicobacter pylori infection. This agent also acts as a biological response modulator, possibly inhibiting angiogenesis and tumor growth through alterations in growth factor expression. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1054</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rifabutin</VALIDVALUE>
          <VALUEMEANING>Rifabutin</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic ansamycin antibiotic with potent antimycobacterial properties.  Rifabutin inhibits bacterial DNA-dependent RNA polymerase, thereby suppressing the initiation of RNA formation and leading to inhibition of RNA synthesis and transcription. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amikacin</VALIDVALUE>
          <VALUEMEANING>Amikacin</VALUEMEANING>
          <MEANINGDESCRIPTION>A broad-spectrum semi-synthetic aminoglycoside antibiotic, derived from kanamycin with antimicrobial property. Amikacin irreversibly binds to the bacterial 30S ribosomal subunit, specifically locking 16S rRNA and S12 protein within the 30S subunit. This leads to interference with translational initiation complex and , misreading of mRNA, thereby hampering protein synthesis and resulting in bactericidal effect. This agent is usually used in short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61615</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ciprofloxacin</VALIDVALUE>
          <VALUEMEANING>Ciprofloxacin</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic broad spectrum fluoroquinolone antibiotic. Ciprofloxacin binds to and inhibits bacterial DNA gyrase, an enzyme essential for DNA replication.  This agent is more active against Gram-negative bacteria than Gram-positive bacteria. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pamidronate Disodium</VALIDVALUE>
          <VALUEMEANING>Pamidronate Disodium</VALUEMEANING>
          <MEANINGDESCRIPTION>The disodium salt of the synthetic bisphosphonate pamidronate. Although its mechanism of action is not completely understood, pamidronate appears to adsorb to calcium phosphate crystals in bone, blocking their dissolution by inhibiting osteoclast-mediated bone resorption. This agent does not inhibit bone mineralization and formation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PNU-214565</VALIDVALUE>
          <VALUEMEANING>PNU-214565</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant fusion protein of the bacterial superantigen Staphylococcal enterotoxin A (SEA) and the variable Fab fragment of the C242 monoclonal antibody. Upon administering PNU-214565, the Fab fragment binds to Lewis antigen, a glycoprotein overexpressed in human colon and pancreatic carcinoma cell surfaces, thereby directing PNU-214565 to the tumor target area and providing tumor specificity. Superantigen staphylococcal enterotoxin A (SEA) promotes the crosslinking of T-cell receptor (TCR) Vb regions with major histocompatibility complex (MHC) class II molecules on antigen presenting cells, thereby enhancing cytotoxic T-lymphocyte activation, cytokine production and tumor cell lysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pazopanib</VALIDVALUE>
          <VALUEMEANING>Pazopanib</VALUEMEANING>
          <MEANINGDESCRIPTION>A small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3107591</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pegfilgrastim</VALIDVALUE>
          <VALUEMEANING>Pegfilgrastim</VALUEMEANING>
          <MEANINGDESCRIPTION>A long-acting pegylated form of a recombinant therapeutic agent which is chemically identical to or similar to an endogenous human granulocyte colony-stimulating factor (G-CSF). Produced endogenously by monocytes, fibroblasts, and endothelial cells, G-CSF binds to and activates specific cell surface receptors, stimulating neutrophil progenitor proliferation and differentiation and selected neutrophil functions. Conjugation of the cytokine with a branched polyethylene glycol molecule (pegylation) significantly increases its therapeutic half-life. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1854</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2775105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pemetrexed</VALIDVALUE>
          <VALUEMEANING>Pemetrexed</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic pyrimidine-based antifolate. Pemetrexed binds to and inhibits the enzyme thymidylate synthase (TS), which catalyses the methylation of 2&#39;-deoxyuridine-5&#39;-monophosphate (dUMP) to 2&#39;-deoxythymidine-5&#39;-monophosphate (dTMP), an essential precursor in DNA synthesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61614</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3237462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pentoxifylline</VALIDVALUE>
          <VALUEMEANING>Pentoxifylline</VALUEMEANING>
          <MEANINGDESCRIPTION>A methylxanthine derivative with hemorrheologic and immunomodulating properties. Pentoxifylline inhibits phosphodiesterase, resulting in increased levels of cyclic adenosine monophosphate (cAMP) in erythrocytes, endothelium, and the surrounding tissues. This leads to vasodilation, improves erythrocyte flexibility, and enhances blood flow. In addition, the increased level of cAMP in platelets inhibits platelet aggregation, which may contribute to a reduction in blood viscosity. This agent also inhibits production of tumor necrosis factor-alpha and interferon-gamma, while it induces Th2-like (T-helper 2) cytokine production, thereby inhibiting Th1-mediated (T-helper 1) inflammatory and autoimmune responses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C733</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paclitaxel/Doxorubicin</VALIDVALUE>
          <VALUEMEANING>Doxorubicin/Paclitaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paclitaxel/Cyclophosphamide</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Paclitaxel</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paclitaxel/Vinorelbine Tartrate</VALIDVALUE>
          <VALUEMEANING>Paclitaxel/Vinorelbine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11115</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Perifosine</VALIDVALUE>
          <VALUEMEANING>Perifosine</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally active alkyl-phosphocholine compound with potential antineoplastic activity.  Targeting cellular membranes, perifosine modulates membrane permeability, membrane lipid composition, phospholipid metabolism, and mitogenic signal transduction, resulting in cell differentiation and inhibition of cell growth.  This agent also inhibits the anti-apoptotic mitogen-activated protein kinase (MAPK) pathway and modulates the balance between the MAPK and pro-apoptotic stress-activated protein kinase (SAPK/JNK) pathways, thereby inducing apoptosis.  Perifosine has a lower gastrointestinal toxicity profile than the related agent miltefosine. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peripheral Blood Stem Cell Transplantation</VALIDVALUE>
          <VALUEMEANING>Peripheral Blood Stem Cell Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>Similar to bone marrow transplantation, peripheral stem cell transplantation is a method of replacing the blood-forming cells lost due to high-dose chemotherapy, and possibly radiation therapy, used to destroy leukemia cells. Certain immature circulating blood cells, similar to stem cells in the bone marrow, are removed before treatment. The cells are then given to the patient after treatment to help the bone marrow recover and continue producing healthy blood cells.  Transplantation may be autologous (the patient&#39;s own blood cells are used), allogeneic (blood cells are donated by someone else), or syngeneic (blood cells are donated by an identical twin).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pertuzumab</VALIDVALUE>
          <VALUEMEANING>Pertuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized recombinant monoclonal antibody directed against the extracellular dimerization domain of the HER-2 tyrosine kinase receptor. Binding of the antibody to the dimerization domain of the HER-2 tyrosine kinase receptor protein directly inhibits the ability of the HER-2 tyrosine kinase receptor protein (the most common pairing partner) to dimerize with other HER tyrosine kinase receptor proteins; inhibiting receptor protein dimerization prevents the activation of HER signaling pathways, resulting in tumor cell apoptosis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Petrolatum Hydrophilic</VALIDVALUE>
          <VALUEMEANING>Petrolatum Hydrophilic</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-polar semi-solid mixture of hydrocarbons that is derived from petroleum. This agent has application as a lubricant, emollient, and a carrier for other agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pheniramine Maleate</VALIDVALUE>
          <VALUEMEANING>Pheniramine Maleate</VALUEMEANING>
          <MEANINGDESCRIPTION>The maleate salt form of pheniramine, an alkylamine derivative with antihistaminic and vasodilatory properties. Pheniramine maleate binds to histamine H1 receptors, thereby inhibiting phospholipase A2 and production of endothelium-derived relaxing factor, nitric oxide. Subsequent lack of activation of guanylyl cyclase through nitric oxide results in decreased cyclic GMP (cGMP) levels, thereby inhibiting constriction of smooth muscle tissue, and decreased capillary permeability and histamine-activated allergic reactions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29358</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenoxodiol</VALIDVALUE>
          <VALUEMEANING>Idronoxil</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic flavonoid derivative. Idronoxil activates the mitochondrial caspase system, inhibits X-linked inhibitor of apoptosis (XIAP), and disrupts FLICE inhibitory protein (FLIP) expression, resulting in tumor cell apoptosis. This agent also inhibits DNA topoisomerase II by stabilizing the cleavable complex, thereby preventing DNA replication and resulting in tumor cell death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenylacetate</VALIDVALUE>
          <VALUEMEANING>Phenylacetate</VALUEMEANING>
          <MEANINGDESCRIPTION>An aromatic fatty acid metabolite of phenylalanine with potential antineoplastic activity.  Naturally occurring in mammals, phenylacetate induces differentiation, growth inhibition, and apoptosis in tumor cells.  Implicated mechanisms of action include decreased protein prenylation, activation of the peroxisome proliferation-activated receptors, inhibition of DNA methylation, and depletion of glutamine. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phenylbutyrate</VALIDVALUE>
          <VALUEMEANING>Sodium Phenylbutyrate</VALUEMEANING>
          <MEANINGDESCRIPTION>The sodium salt of phenylbutyrate, a derivative of the short-chain fatty acid butyrate, with potential antineoplastic activity. Phenylbutyrate reversibly inhibits class I and II histone deacetylases (HDACs), which may result in a global increase in gene expression, decreased cellular proliferation, increased cell differentiation, and the induction of apoptosis in susceptible tumor cell populations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pirfenidone</VALIDVALUE>
          <VALUEMEANING>Pirfenidone</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally active synthetic antifibrotic agent structurally similar to pyridine 2,4-dicarboxylate. Pirfenidone inhibits fibroblast, epidermal, platelet-derived, and transforming beta-1 growth factors, thereby slowing tumor cell proliferation. This agent also inhibits DNA synthesis and the production of mRNA for collagen types I and III, resulting in a reduction in radiation-induced fibrosis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Piritrexim</VALIDVALUE>
          <VALUEMEANING>Piritrexim</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic antifolate agent with antiparasitic, antipsoriatic and antitumor properties. Piritrexim inhibits the enzyme dihydrofolate reductase enzyme, thereby disrupting folate metabolism and DNA synthesis and cell division. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1031</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Piroxicam</VALIDVALUE>
          <VALUEMEANING>Piroxicam</VALUEMEANING>
          <MEANINGDESCRIPTION>A nonsteroidal oxicam derivative with anti-inflammatory, antipyretic and analgesic properties. As a non-selective, nonsteroidal anti-inflammatory drug (NSAID), piroxicam binds and chelates both isoforms of cyclooxygenases (COX1 and COX2), thereby stalling phospholipase A2 activity and conversion of arachidonic acid into prostaglandin precursors at the rate limiting cyclooxygenase enzyme step. This results in inhibition of prostaglandin biosynthesis. As a second, independent effect, piroxicam inhibits the activation of neutrophils thereby contributing to its overall anti-inflammatory effects.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379484</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plicamycin</VALIDVALUE>
          <VALUEMEANING>Plicamycin</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibiotic isolated from the bacterium Streptomyces plicatus with antineoplastic activity. Plicamycin, also known as mithramycin, binds to the minor groove of DNA at GC-rich sites, resulting in inhibition of RNA synthesis; this agent also inhibits mRNA expression, resulting in a reduction in protein synthesis. In addition, plicamycin may inhibit bone resorption by down regulating transcription of c-src, an oncogene involved in bone metabolism and resorption. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379486</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Poly ICLC</VALIDVALUE>
          <VALUEMEANING>Poly ICLC</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic complex of carboxymethylcellulose, polyinosinic-polycytidylic acid, and poly-L-lysine double-stranded RNA. Poly ICLC may stimulate the release of cytotoxic cytokines and, by inducing interferon-gamma production, may increase the tumoricidal activities of various immunohematopoietic cells. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1198</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pralatrexate</VALIDVALUE>
          <VALUEMEANING>10-Propargyl-10-Deazaaminopterin</VALUEMEANING>
          <MEANINGDESCRIPTION>A folate analogue inhibitor of dihydrofolate reductase (DHFR) exhibiting high affinity for reduced folate carrier-1 (RFC-1) with antineoplastic and immunosuppressive activities. Pralatrexate selectively enters cells expressing RFC-1; intracellularly, this agent is highly polyglutamylated and competes for the folate binding site of DHFR, blocking tetrahydrofolate synthesis, which may result in depletion of nucleotide precursors; inhibition of DNA, RNA and protein synthesis; and apoptotic tumor cell death. Efficient intracellular polyglutamylation of pralatrexate results in higher intracellular concentrations compared to non-polyglutamylated pralatrexate, which is more readily effuxed by the MRP (multidrug resistance protein) drug efflux pump. RFC-1, an oncofetal protein expressed at highest levels during embryonic development, may be over-expressed on the cell surfaces of various cancer cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pravastatin</VALIDVALUE>
          <VALUEMEANING>Pravastatin</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic lipid-lowering agent. Pravastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. Pravastatin lowers plasma cholesterol and lipoprotein levels, and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62070</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PACE (Cyclophosphamide/Doxorubicin/Etoposide/Prednisone)</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Doxorubicin/Etoposide/Prednisone</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10861</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prednisone</VALIDVALUE>
          <VALUEMEANING>Prednisone</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prednisone/Etoposide</VALIDVALUE>
          <VALUEMEANING>Etoposide/Prednisone</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ProMACE</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Prednisone</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9771</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Procarbazine</VALIDVALUE>
          <VALUEMEANING>Procarbazine</VALUEMEANING>
          <MEANINGDESCRIPTION>A methylhydrazine derivative with antineoplastic and mutagenic activities. Although the exact mode of cytotoxicity has not been elucidated, procarbazine, after metabolic activation, appears to inhibit the trans-methylation of methionine into transfer RNA (t-RNA), thereby preventing protein synthesis and consequently DNA and RNA synthesis. This agent may also undergo auto-oxidation, resulting in the formation of cytotoxic free radicals which damage DNA through an alkylation reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62072</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Psoralen</VALIDVALUE>
          <VALUEMEANING>Psoralen</VALUEMEANING>
          <MEANINGDESCRIPTION>A furocoumarin that intercalates with DNA, inhibiting DNA synthesis and cell division.  Psoralen is used in Photochemotherapy or PUVA (Psoralen with high-intensity long-wavelength UVA irradiation). (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3293804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinoids</VALIDVALUE>
          <VALUEMEANING>Retinoid</VALUEMEANING>
          <MEANINGDESCRIPTION>Class of compounds consisting of four isoprenoid units joined in a head-to-tail manner and customarily containing five conjugated double bonds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68299</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinoic acid, trans-</VALIDVALUE>
          <VALUEMEANING>ATRA</VALUEMEANING>
          <MEANINGDESCRIPTION>A naturally-occurring acid of retinol.  Vitamin A acid binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of carcinogenesis.  This agent also inhibits telomerase, resulting in telomere shortening and eventual apoptosis of some cancer cell types.  The oral form of vitamin A acid has teratogenic and embryotoxic properties.(NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2764385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinoic acid, cis-</VALIDVALUE>
          <VALUEMEANING>Retinoic Acid Binding</VALUEMEANING>
          <MEANINGDESCRIPTION>Retinoic Acid Binding consists of a biophysical interaction between retinoic acid (ligand) and a biological molecule, such as specific steroid receptor-like transcriptional regulator proteins containing an N-terminal modulating domain, a DNA-binding domain, and a C-terminal ligand-binding domain. The ligand-activated receptor complexes selectively bind as homodimers or heterodimers (with other steroid family receptors) to DNA response elements in target gene promoters, enhance transcriptional activity with coactivators, and mediate tissue growth and differentiation in embryogenesis, organogenesis, limb development, bone growth, and maintenance of normal epithelia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26052</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinoic acid, 13-cis</VALIDVALUE>
          <VALUEMEANING>Isotretinoin</VALUEMEANING>
          <MEANINGDESCRIPTION>A naturally-occurring retinoic acid with potential antineoplastic activity. Isotretinoin binds to and activates nuclear retinoic acid receptors (RARs); activated RARs serve as transcription factors that promote cell differentiation and apoptosis. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinoic acid, 9-cis</VALIDVALUE>
          <VALUEMEANING>Alitretinoin</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally- and topically-active naturally-occurring retinoic acid with antineoplastic, chemopreventive, teratogenic, and embryotoxic activities. Alitretinoin binds to and activates nuclear retinoic acid receptors (RAR) and retinoid X receptors (RXR); these activated receptors act as transcription factors, regulating gene expression that results in the inhibition of cell proliferation, induction of cell differentiation, and apoptosis of both normal cells and tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recombinant Vaccinia-CEA</VALIDVALUE>
          <VALUEMEANING>Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A vaccine consisting of recombinant vaccinia virus encoding the tumor-associated antigen carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1, and LFA-3; also called TRICOM). Vaccination with recombinant vaccinia-CEA(6D)-TRICOM vaccine stimulates the host immune system to mount a T-cell response against tumor cells expressing the CEA antigen. The use of TRICOM in the vaccine may elicit a greater antitumor cytotoxic T lymphocyte (CTL) immune response compared to the use of vaccinia-CEA alone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recombinant Vaccinia-PSA</VALIDVALUE>
          <VALUEMEANING>Recombinant Vaccinia PSA Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A vaccine consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA). Vaccination with recombinant vaccinia prostate-specific antigen vaccine stimulates the host immune system to mount a cytotoxic T-cell response against tumor cells expressing PSA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recombinant Vaccinia-B7.1</VALIDVALUE>
          <VALUEMEANING>Recombinant Vaccinia-B7.1 Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant vaccinia virus encoding the T-cell co-stimulatory molecule B7-1. Co-administration of recombinant vaccinia-B7.1 and a tumor-associated antigen vaccine may enhance tumor-associated antigen-specific T-cell responses. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Raloxifene HCl</VALIDVALUE>
          <VALUEMEANING>Raloxifene Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt form of raloxifene, a selective benzothiophene estrogen receptor modulator (SERM) with lipid lowering effects and activity against osteoporosis. Raloxifene hydrochloride specifically binds to estrogen receptors in responsive tissue, including liver, bone, breast, and endometrium. The resulting ligand-receptor complex is translocated to the nucleus where, depending on the tissue type, it promotes or suppresses the transcription of estrogen-regulated genes, thereby exerting its agonistic or antagonistic effects. This agent functions as an estrogen agonist in lipid metabolism, thereby decreasing total and LDL cholesterol levels. In tissue like bone, it decreases bone resorption and bone turnover and increases bone mineral density. Raloxifene hydrochloride acts as an estrogen antagonist in uterine and breast tissue. This agent also exerts an anti-proliferative effect on estrogen-sensitive breast cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1762</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ras</VALIDVALUE>
          <VALUEMEANING>RAS Family Oncogene</VALUEMEANING>
          <MEANINGDESCRIPTION>Family of retrovirus-associated DNA sequences (ras) originally isolated from Harvey (H-ras, Ha-ras, rasH) and Kirsten (K-ras, Ki-ras, rasK) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein. Critically involved in cell activation and replication in many cell types, and disruption of its regulation can lead to uncontrolled growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17061</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RAD001 (Everolimus)</VALIDVALUE>
          <VALUEMEANING>Everolimus</VALUEMEANING>
          <MEANINGDESCRIPTION>A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R1507</VALIDVALUE>
          <VALUEMEANING>Anti-IGF-1R Monoclonal Antibody R1507</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, fully human monoclonal antibody directed against the insulin-like growth factor-1 receptor (IGF-1R) with potential antineoplastic activity. Teprotumumab binds to membrane-bound IGF-1R, preventing the binding of the natural ligand IGF-1 and the activation of PI3K/AKT signal transduction; downregulation of the PI3K/AKT survival pathway may result in the induction of apoptosis and decreased cellular proliferation. The activation of IGF-1R, a receptor tyrosine kinase of the insulin receptor superfamily, stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis; IGF-1R signaling has been implicated in tumorigenesis and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R115777</VALIDVALUE>
          <VALUEMEANING>Tipifarnib</VALUEMEANING>
          <MEANINGDESCRIPTION>A nonpeptidomimetic quinolinone with potential antineoplastic activity. Tipifarnib binds to and inhibits the enzyme farnesyl protein transferase, an enzyme involved in protein processing (farnesylation) for signal transduction.  By inhibiting the farnesylation of proteins, this agent prevents the activation of Ras oncogenes, inhibits cell growth, induces apoptosis, and inhibits angiogenesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1703</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R/ICE</VALIDVALUE>
          <VALUEMEANING>Rituximab ICE Regimen Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant chimeric murine/human antibody directed against the CD20 antigen, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes. Following binding, rituximab triggers a host cytotoxic immune response against CD20-positive cells. (NCI04): A chemotherapy regimen consisting of ifosfamide, carboplatin and etoposide used in the treatment of relapsed and refractory non-Hodgkin and Hodgkin lymphomas.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C10345, C1702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R-Verapamil</VALIDVALUE>
          <VALUEMEANING>Verapamil</VALUEMEANING>
          <MEANINGDESCRIPTION>A phenylalkylamine calcium channel blocking agent. Verapamil inhibits the transmembrane influx of extracellular calcium ions into myocardial and vascular smooth muscle cells, causing dilatation of the main coronary and systemic arteries and decreasing myocardial contractility.  This agent also inhibits the drug efflux pump P-glycoprotein which is overexpressed in some multi-drug resistant tumors and may improve the efficacy of some antineoplastic agents. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C928</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3128735</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R-Verap/EPOCH</VALIDVALUE>
          <VALUEMEANING>Verapamil EPOCH Regimen Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A phenylalkylamine calcium channel blocking agent. Verapamil inhibits the transmembrane influx of extracellular calcium ions into myocardial and vascular smooth muscle cells, causing dilatation of the main coronary and systemic arteries and decreasing myocardial contractility.  This agent also inhibits the drug efflux pump P-glycoprotein which is overexpressed in some multi-drug resistant tumors and may improve the efficacy of some antineoplastic agents. (NCI04): A chemotherapy regimen consisting of etoposide, prednisone, vincristine (Oncovin) and doxorubicin hydrochloride (hydroxydaunorubicin hycrochloride), which may be used in combination with rituximab (R-EPOCH) for the treatment of various aggressive B cell and T cell non-Hodgkin lymphomas.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C63779, C928</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ProMACE/MOPP</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Prednisone MOPP Regimen Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of prednisone, methotrexate, doxorubicin, cyclophosphamide and etoposide that may be used in the treatment of non-Hodgkin lymphoma (NHL)._A chemotherapy regimen consisting of mechlorethamine, vincristine (Oncovin), procarbazine and prednisone, used alone or in combination with radiation therapy for the treatment of stage I-IV Hodgkin lymphoma. Due to the increased risk of gonadal toxicity, this regimen has been widely replaced by the ABVD regimen._A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C9619, C9771</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ProMACE/Cytabom</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Prednisone Bleomycin/Cytarabine/Methotrexate/Vincristine Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of prednisone, methotrexate, doxorubicin, cyclophosphamide and etoposide that may be used in the treatment of non-Hodgkin lymphoma (NHL)._A chemotherapy regimen consisting of cytarabine, bleomycin, methotrexate, and vincristine for the treatment of non-Hodgkin lymphoma (NHL)._A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C10007, C9771</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ProMACE/Cyclophosphamide</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Prednisone Cyclophosphamide Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of prednisone, methotrexate, doxorubicin, cyclophosphamide and etoposide that may be used in the treatment of non-Hodgkin lymphoma (NHL)._A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death._A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C405, C9771</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rebeccamycin</VALIDVALUE>
          <VALUEMEANING>Rebeccamycin</VALUEMEANING>
          <MEANINGDESCRIPTION>An indolocarbazole glycoside antineoplastic antibiotic isolated from the bacterium Saccharothrix aerocolonigenes.  Rebeccamycin intercalates into DNA and stabilizes the DNA-topoisomerase I complex, thereby interfering with the topoisomerase I-catalyzed DNA breakage-reunion reaction and initiating DNA cleavage and apoptosis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recombinant Fowlpox-PSA</VALIDVALUE>
          <VALUEMEANING>Recombinant Fowlpox-Prostate Specific Antigen Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer vaccine consisting of a recombinant fowlpox virus encoding human prostate-specific antigen (PSA). Administration of this agent may stimulate a cytotoxic T cell response against PSA-expressing tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2675</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recombinant Fowlpox-GM-CSF</VALIDVALUE>
          <VALUEMEANING>Recombinant Fowlpox GM-CSF Vaccine Adjuvant</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer vaccine adjuvant consisting of a recombinant fowlpox virus encoding human granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF binds to specific cell surface receptors on various immuno-hematopoietic cell types, enhancing their proliferation and differentiation and stimulating macrophage and dendritic cell functions in antigen presentation and antitumor cell-mediated immunity. Administration of recombinant fowlpox GM-CSF vaccine adjuvant may induce an immune response against tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recombinant Fowlpox-CEA</VALIDVALUE>
          <VALUEMEANING>Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). This agent may enhance CEA presentation to antigen presenting cells (APC) and activate cytotoxic T-cells against CEA-expressing tumors. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2620</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retinoic Acid</VALIDVALUE>
          <VALUEMEANING>Retinoic Acid</VALUEMEANING>
          <MEANINGDESCRIPTION>Retinoid with a carboxylic acid group.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ritonavir</VALIDVALUE>
          <VALUEMEANING>Ritonavir</VALUEMEANING>
          <MEANINGDESCRIPTION>A peptidomimetic agent that inhibits both HIV-1 and HIV-2 proteases. Ritonavir is highly inhibited by serum proteins but boosts the effect of other HIV proteases by blocking their degradation by cytochrome P450.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rituximab</VALIDVALUE>
          <VALUEMEANING>Rituximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of monoclonal antibody used in cancer detection or therapy. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Saquinavir</VALIDVALUE>
          <VALUEMEANING>Saquinavir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic antiviral agent.  Saquinavir, a peptide-like substrate, selectively binds to and inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379546</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Satraplatin</VALIDVALUE>
          <VALUEMEANING>Satraplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally administered third generation platinum compound with potential antineoplastic activity. Satraplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups in DNA, inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in cell growth inhibition and apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sirolimus</VALIDVALUE>
          <VALUEMEANING>Sirolimus</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug used to help prevent rejection of organ and bone marrow transplants by the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2760061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STI571</VALIDVALUE>
          <VALUEMEANING>Imatinib Mesylate</VALUEMEANING>
          <MEANINGDESCRIPTION>The mesylate salt of an antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain the Philadelphia chromosome.  Imatinib also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and stem cell factor (SCF)/c-kit; the SCF/c-kit receptor tyrosine kinase is activated in gastrointestinal stromal tumor (GIST).  This agent inhibits proliferation and induces apoptosis in cells that overexpress these oncoproteins. It is also known as Gleevec.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SKI-606</VALIDVALUE>
          <VALUEMEANING>Bosutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity. Unlike imatinib, bosutinib inhibits the autophosphorylation of both Abl and Src kinases, resulting in inhibition of cell growth and apoptosis. Because of the dual mechanism of action, this agent may have activity in resistant CML disease, other myeloid malignancies and solid tumors. Abl kinase is upregulated in the presence of the abnormal Bcr-abl fusion protein which is commonly associated with chronic myeloid leukemia (CML). Overexpression of specific Src kinases is also associated with the imatinib-resistant CML phenotype.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SCAB</VALIDVALUE>
          <VALUEMEANING>Bleomycin/Doxorubicin/Lomustine/Streptozocin</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ricin Conjugate Murine MCA</VALIDVALUE>
          <VALUEMEANING>Murine MCA Ricin Conjugate</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunotoxin consisting of a murine monoclonal antibody (MCA) conjugated to the toxin ricin. The monoclonal antibody component binds to cell surface antigens, thereby targeting delivery of cytotoxic ricin to a specific cell type. The ricin component binds to cells and disrupts ribosomal activity and protein synthesis and induces cell cycle arrest. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Samarium</VALIDVALUE>
          <VALUEMEANING>Samarium</VALUEMEANING>
          <MEANINGDESCRIPTION>Samarium. An element of the rare earth family of metals. It has the atomic symbol Sm, atomic number 62, and atomic weight 150.36. The oxide is used in the control rods of some nuclear reactors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0036147</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somatuline</VALIDVALUE>
          <VALUEMEANING>Lanreotide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic cyclic octapeptide analogue of somatostatin. Lanreotide binds to somatostatin receptors (SSTR), specifically SSTR-2 and also to SSTR-5 with a lesser affinity. However, compare with octreotide, this agent is less potent in inhibiting the release of growth hormone from the pituitary gland. Furthermore, lanreotide has an acute effect on decreasing circulating total and free insulin-like growth factor 1 (IGF-I).  This agent is usually given as a prolonged-release microparticle or Autogel formulation for the treatment of acromegaly and to relieve the symptoms of neuroendocrine tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1523</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UCN-01</VALIDVALUE>
          <VALUEMEANING>7-Hydroxystaurosporine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of staurosporine with antineoplastic activity. 7-hydroxystaurosporine inhibits many phosphokinases, including the serine/threonine kinase AKT, calcium-dependent protein kinase C, and cyclin-dependent kinases. This agent arrests tumor cells in the G1/S of the cell cycle and prevents nucleotide excision repair by inhibiting the G2 checkpoint kinase chk1, resulting in apoptosis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Triptorelin</VALIDVALUE>
          <VALUEMEANING>Triptorelin</VALUEMEANING>
          <MEANINGDESCRIPTION>A drug that is used to treat advanced prostate cancer, and is being studied in the treatment of breast cancer. It belongs to the family of hormonal drugs called gonadotropin-releasing hormone analogs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trimetrexate Glucuronate</VALIDVALUE>
          <VALUEMEANING>Trimetrexate Glucuronate</VALUEMEANING>
          <MEANINGDESCRIPTION>A lipid soluble methotrexate derivative with potential antineoplastic activity.  Trimetrexate glucuronate inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylate, with subsequent inhibition of DNA and RNA synthesis.  Trimetrexate glucuronate also exhibits antiviral activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trastuzumab/Gemcitabine</VALIDVALUE>
          <VALUEMEANING>Gemcitabine/Trastuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37808</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trastuzumab/Vinorelbine</VALIDVALUE>
          <VALUEMEANING>Trastuzumab/Vinorelbine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trastuzumab</VALIDVALUE>
          <VALUEMEANING>Trastuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized recombinant monoclonal antibody directed against the HER2- receptor protein.  Trastuzumab binds to the extracellular domain of the growth factor protein HER2, thereby inhibiting proliferation of HER2 overexpressing tumor cells.  Binding with HER2 protein also initiates an antibody-dependent cell cytotoxicity.(NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1647</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tramadol</VALIDVALUE>
          <VALUEMEANING>Tramadol</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic codeine analogue, Tramadol has central analgesic properties with effects similar to opioids, such as morphine and codeine, acting on specific opioid receptors. Used as a narcotic analgesic for severe pain, it can be addictive and weakly inhibits norepinephrine and serotonin reuptake. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trabectedin</VALIDVALUE>
          <VALUEMEANING>Trabectedin</VALUEMEANING>
          <MEANINGDESCRIPTION>A tetrahydroisoquinoline alkaloid isolated from the marine tunicate Ecteinascidia turbinata with potential antineoplastic activity. Binding to the minor groove of DNA, trabectedin interferes with the transcription-coupled nucleotide excision repair machinery to induce lethal DNA strand breaks and blocks the cell cycle in the G2 phase.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tositumomab</VALIDVALUE>
          <VALUEMEANING>Tositumomab</VALUEMEANING>
          <MEANINGDESCRIPTION>A murine IgG2 monoclonal antibody directed against the CD20 antigen, found on the surface of B-cells.  Tositumomab binds to the CD20 surface membrane antigen, resulting in apoptosis, and may stimulate antitumoral cell-mediated and/or antibody-dependent cytotoxicity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2741550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Toremifene</VALIDVALUE>
          <VALUEMEANING>Toremifene</VALUEMEANING>
          <MEANINGDESCRIPTION>An anticancer drug that belongs to the family of drugs called antiestrogens. Toremifene blocks the effect of the hormone estrogen in the body. It may help control some cancers from growing, and it may delay or reduce the risk of cancer recurrence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3145844</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Topotecan/Vinorelbine Tartrate</VALIDVALUE>
          <VALUEMEANING>Topotecan Vinorelbine Tartrate Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Topotecan inhibits topoisomerase I activity by stabilizing the topoisomerase I-DNA covalent complexes during S phase of cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery.: The ditartrate salt of a semisynthetic vinca alkaloid derived from the leaves of the periwinkle plant (Vinca rosea) with antineoplastic properties.  Vinorelbine binds to tubulin, thereby inhibiting tubulin polymerization into microtubules and spindle formation and resulting in apoptosis of susceptible cancer cells. Inhibition of mitotic microtubules correlates with antitumor activity, whereas inhibition of axonal microtubules seems to correlate with vinorelbine&#39;s neurotoxicity. Compared to related vinca alkaloids, vinorelbine is more selective against mitotic than axonal microtubules in vitro, which may account for its decreased neurotoxicity.  This agent is also a radiation-sensitizing agent. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1395, C1413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Topotecan</VALIDVALUE>
          <VALUEMEANING>Topotecan</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Topotecan inhibits topoisomerase I activity by stabilizing the topoisomerase I-DNA covalent complexes during S phase of cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Topical Corticosteroids</VALIDVALUE>
          <VALUEMEANING>Corticosteroid</VALUEMEANING>
          <MEANINGDESCRIPTION>Hormones synthesized in the cortex of the adrenal gland and consist of two subclasses, glucocorticoids (carbohydrate regulation) and mineralocorticoids (electrolyte regulation).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2322</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STAMP V</VALIDVALUE>
          <VALUEMEANING>Carmustine/Cisplatin/Cyclophosphamide</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Campath</VALIDVALUE>
          <VALUEMEANING>Alemtuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant DNA-derived humanized monoclonal antibody directed against the cell surface glycoprotein, CD52. Alemtuzumab is an IgG1 kappa with human variable framework and constant regions, and complementarity-determining regions derived from a rat monoclonal antibody. This agent selectively binds to CD52, thereby triggering a host immune response that results in lysis of CD52 + cells. CD52 is a glycoprotein expressed on the surface of essentially all normal and malignant B and T cells, a majority of monocytes, macrophages and natural killer (NK) cells, a subpopulation of granulocytes, and tissues of the male reproductive system. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suramin/Somatuline</VALIDVALUE>
          <VALUEMEANING>Suramin Lanreotide Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A polysulphonated naphthylurea with potential antineoplastic activity.  Suramin blocks the binding of various growth factors, including insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and tumor growth factor-beta (TGF-beta), to their receptors, thereby inhibiting endothelial cell proliferation and migration.  This agent also inhibits vascular endothelial growth factor (VEGF)- and basic fibroblast growth factor (bFGF)-induced angiogenesis; retroviral reverse transcriptase; uncoupling of G-proteins from receptors; topoisomerases; cellular folate transport; and steroidogenesis. (NCI04): A synthetic cyclic octapeptide analogue of somatostatin. Lanreotide binds to somatostatin receptors (SSTR), specifically SSTR-2 and also to SSTR-5 with a lesser affinity. However, compare with octreotide, this agent is less potent in inhibiting the release of growth hormone from the pituitary gland. Furthermore, lanreotide has an acute effect on decreasing circulating total and free insulin-like growth factor 1 (IGF-I).  This agent is usually given as a prolonged-release microparticle or Autogel formulation for the treatment of acromegaly and to relieve the symptoms of neuroendocrine tumors.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1523, C853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Crizotinib</VALIDVALUE>
          <VALUEMEANING>Crizotinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available aminopyridine-based inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the c-Met/hepatocyte growth factor receptor (HGFR) with antineoplastic activity. Crizotinib, in an ATP-competitive manner, binds to and inhibits ALK kinase and ALK fusion proteins. In addition, crizotinib inhibits c-Met kinase, and disrupts the c-Met signaling pathway. Altogether, this agent inhibits tumor cell growth. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a series of tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74061</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5FU/Leucovorin/Irinotecan</VALIDVALUE>
          <VALUEMEANING>Fluorouracil/Irinotecan/Leucovorin Calcium</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10836</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5FU/Leucovorin/Levamasole</VALIDVALUE>
          <VALUEMEANING>Fluorouracil/Leucovorin Calcium/Levamasole</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5FU/Levamisole</VALIDVALUE>
          <VALUEMEANING>Fluorouracil/Levamisole</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5FU/Interferon</VALIDVALUE>
          <VALUEMEANING>Fluorouracil/Interferon Alfa</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5FU/Leucovorin</VALIDVALUE>
          <VALUEMEANING>FU-LV Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of fluorouracil and leucovorin, used in both the adjuvant and metastatic disease setting, for the treatment of colorectal cancer. This regimen is also combined with radiation for the treatment of gastric and esophageal cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5FU/Leucovorin/Gemcitabine</VALIDVALUE>
          <VALUEMEANING>Fluorouracil/Gemcitabine/Leucovorin Calcium</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378088</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5FU/Epirubicin/Cyclophosphamide (FEC)</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Epirubicin/Fluorouracil</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination chemotherapy comprised of the agents cyclophosphamide, epirubicin and fluorouracil that has been used in the treatment of breast cancer.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378089</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5FU/Cisplatin</VALIDVALUE>
          <VALUEMEANING>Fluorouracil Cisplatin Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity.  Fluorouracil and its metabolites possess a number of different mechanisms of action.  In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth.  Another active metabolite, 5-5-fluoro-2&#39;-deoxyuridine-5&#39;-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), a necessary constituent of DNA.  Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both the processing and functions of RNA. (NCI04): An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity.  In the body, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as and DNA-protein cross-links. These cisplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C376, C505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>506U78</VALIDVALUE>
          <VALUEMEANING>Nelarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>An arabinonucleoside antimetabolite with antineoplastic activity. Nelarabine is demethoxylated by adenosine deaminase to become biologically active 9-beta-D-arabinosylguanine (ara-G); ara-G incorporates into DNA, thereby inhibiting DNA synthesis and inducing an S phase-dependent apoptosis of tumor cells. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COPP</VALIDVALUE>
          <VALUEMEANING>COPP Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A derivative of the original MOPP regimen consisting of cyclophosphamide, vincristine, procarbazine and prednisone used as an initial treatment for Hodgkin&#39;s lymphoma. Also used for the treatment of non-Hodgkin&#39;s lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9567</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3368104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COPAdM</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide Vincristine Prednisolone Doxorubicin Methotrexate Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04): A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisolone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI04): An anthracycline antineoplastic antibiotic isolated from the fungus Streptococcus peucetius var. caesius.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.  The hydrochloride salt doxorubicin hydrochloride is the therapeutic form of doxorubicin. (NCI04): An antimetabolite with antineoplastic and immunomodulating properties.  Methotrxate inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C642, C456, C769, C933, C405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COP</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide Vincristine Sulfate Prednisone Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04): The sulfate salt of a natural alkaloid isolated from the plant Catharanthus roseus (Vinca rosea L.) with antimitotic and antineoplastic activities. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca(2+)-activated ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis.: A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C770, C1739, C405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COL-3</VALIDVALUE>
          <VALUEMEANING>Incyclinide</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemically-modified tetracycline with potential antineoplastic activity. Incyclinide inhibits matrix metalloproteinases (MMPs), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. This agent also causes mitochondrial depolarization in tumor cells and induces both cellular apoptosis and tissue necrosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COL-1</VALIDVALUE>
          <VALUEMEANING>Monoclonal Antibody COL-1</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant immunoglobulin antibody directed against the tumor-associated antigen carcinoembryonic antigen (CEA). CEA is a cell surface glycoprotein expressed at high levels in embryonic and fetal digestive epithelial tissue, breast carcinoma, and squamous cell carcinoma of the head and neck. Except for some reactivity to skin and gastric and colon mucosa, monoclonal antibody COL-1COL-1 does not appear to react with normal tissues. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28893</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CODOX-MIVAC</VALIDVALUE>
          <VALUEMEANING>CODOX-M/IVAC Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of cyclophosphamide, vincristine, doxorubicin and high-dose methotrexate (CODOX-M) alternating with ifosfamide, etoposide and high-dose cytarabine (IVAC), used as a treatment for aggressive forms of non-Hodgkin&#39;s lymphoma; also used as primary treatment for AIDS-related and high-risk Burkitt&#39;s lymphoma.  Intrathecal cytarabine and methotrexate are included in this regimen as either prophylaxis or treatment for central nervous system (CNS) involvement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63448</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CNOP/Rituximab</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Mitoxantrone/Prednisone/Vincristine Rituximab Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists: A recombinant chimeric murine/human antibody directed against the CD20 antigen, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes. Following binding, rituximab triggers a host cytotoxic immune response against CD20-positive cells. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1702, C10211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CMOPP</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Mechlorethamine/Prednisone/Procarbazine/Vincristine</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy combination consisting of cyclophosphamide, mechlorethamine, prednisone, procarbazine, and vincristine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28890</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CMFVP</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone/Vincristine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CMFP</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CMF</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Fluorouracil/Methotrexate</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination drug therapy used in the treatment of breast cancer. The treatment is administrated over a four-week cycle. On days 1 and 8 methotraxate and 5-FU are given as injections. Cyclophosphamide may be also administered intravenously in conjunction with these drugs, or may be taken as an oral tablet, taken once every-day for the first 14 days of each cycle.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9874</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CHOP/R</VALIDVALUE>
          <VALUEMEANING>CHOP Regimen Rituximab Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.: A recombinant chimeric murine/human antibody directed against the CD20 antigen, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes. Following binding, rituximab triggers a host cytotoxic immune response against CD20-positive cells. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C1702, C9549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CHOP/R/Bleomycin</VALIDVALUE>
          <VALUEMEANING>CHOP Regimen Rituximab Bleomycin Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.: A recombinant chimeric murine/human antibody directed against the CD20 antigen, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes. Following binding, rituximab triggers a host cytotoxic immune response against CD20-positive cells. (NCI04): A mixture of glycopeptide antineoplastic antibiotics isolated from the fungus Streptomyces verticillus.  Bleomycin forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals which cause single- and double-stranded breaks in DNA; these reactive oxygen species also induce lipid peroxidation, carbohydrate oxidation, and alterations in prostaglandin synthesis and degradation. (NCI04): A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C313, C1702, C9549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dual PI3 Kinase/mTOR Inhibitor GDC-0980</VALIDVALUE>
          <VALUEMEANING>Dual PI3 Kinase/mTOR Inhibitor GDC-0980</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available agent targeting phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinase in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. PI3K/mTOR kinase inhibitor GDC-0980 inhibits both PI3K kinase and mTOR kinase, which may result in tumor cell apoptosis and growth inhibition of cancer cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated in a PI3K-independent fashion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91731</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3630833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trebananib</VALIDVALUE>
          <VALUEMEANING>Angiopoietin 1/2-Neutralizing Peptibody AMG 386</VALUEMEANING>
          <MEANINGDESCRIPTION>An angiopoietin (Ang) 1 and 2 neutralizing peptibody, with potential antiangiogenic activity. AMG 386 targets and binds to Ang1 and Ang2, thereby preventing the interaction of the angiopoietins with their target tie2 receptors. This may inhibit angiogenesis and may eventually lead to an inhibition of tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3205720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GM-K562 Cell Vaccine</VALIDVALUE>
          <VALUEMEANING>GM-K562 Cell Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cell-based vaccine comprised of K562 cells transfected with the granulocyte macrophage-colony stimulating factor (GM-CSF) gene with potential immunopotentiating properties. Vaccination with GM-K562 cells may stimulate the host immune system to produce an antitumoral T-lymphocyte response, thereby inhibiting tumor growth. K562 cells are derived from the human erythroleukemia cell line K562. GM-CSF (also known as sagramostim) expressed by vaccine cells binds to specific cell surface receptors, modulating the proliferation and differentiation of a variety of hematopoietic progenitor cells with some specificity towards stimulation of leukocyte production. GM-CSF also promotes antigen presentation, up-regulates antibody-dependent cellular cytotoxicity (ADCC), and increases interleukin-2-mediated lymphokine-activated killer cell function; it may also augment host antitumoral immunity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3631678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ST1306</VALIDVALUE>
          <VALUEMEANING>ST1306</VALUEMEANING>
          <MEANINGDESCRIPTION>ST1306</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3462017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Linsitinib</VALIDVALUE>
          <VALUEMEANING>Linsitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Linsitinib selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Overexpressed in a variety of human cancers, IGFR-1 stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70982</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3444804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AZD7451</VALIDVALUE>
          <VALUEMEANING>Tropomyosin Receptor Kinase Inhibitor AZD7451</VALUEMEANING>
          <MEANINGDESCRIPTION>A tropomyosin receptor kinase (TRK) inhibitor with potential antineoplastic activity. AZD7451 binds to TRK, thereby preventing the neurotrophin-TRK interaction and subsequent TRK activation. This may eventually result in an inhibition of tumor cell proliferation in TRK-expressing tumor cells. TRK, a receptor tyrosine kinase activated by neurotrophins, is mutated in a variety of cancer cell types and plays an important role in tumor cell growth, invasion and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3444806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VB-111</VALIDVALUE>
          <VALUEMEANING>VB-111</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-replicating adenovirus 5 (Ad-5, El-deleted) encoding a human Fas-chimera (Fas-c) transgene under the control of a modified murine pre-proendothelin-1 (PPE-1) promoter, with potential anti-angiogenic activity. Upon the administration of ofranergene obadenovec, the modified murine PPE-1 promoter is specifically activated in PPE-1-expressing angiogenic endothelial cells residing in the tumor microvasculature.  Subsequently, the Fas-c pro-apoptotic transgene, containing the human tumor necrosis factor (TNF) receptor 1 (TNFR-1/p55) and the signaling domain of Fas, is expressed in angiogenic endothelial cells.  Fas-mediated apoptosis is activated via binding of the TNFR-1 receptor with TNF-alpha, which is more abundant in the tumor microenvironment (TME), enhancing specificity and limiting systemic toxicities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71539</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3461372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IAP Inhibitor AT-406</VALIDVALUE>
          <VALUEMEANING>IAP Inhibitor AT-406</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of IAP (Inhibitor of Apoptosis Protein) family of proteins with potential apoptotic inducing and antineoplastic activity. IAP inhibitor AT-406 selectively inhibits the biological activity of IAP proteins, including X chromosome-linked IAP (XIAP), the cellular IAPs 1 (c-IAP1) and 2 (c-IAP2) and melanoma inhibitor of apoptosis protein (ML-IAP). This may restore and promote the induction of apoptosis through apoptotic signaling pathways. AT-406 may work synergistically with cytotoxic drugs to overcome tumor cell resistance to apoptosis. IAPs are overexpressed by many cancer cell types, suppressing apoptosis by binding and inhibiting active caspases-3, -7 and -9 via their BIR (baculoviral lAP repeat) domains.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3614156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-Endosialin Monoclonal Antibody MORAb-004</VALIDVALUE>
          <VALUEMEANING>Anti-Endosialin Monoclonal Antibody MORAb-004</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized IgG1 monoclonal antibody directed against human endosialin/TEM1 (tumor endothelial marker;CD248) with potential anti-angiogenic and antineoplastic activities. Anti-endosialin/TEM1 monoclonal antibody MORAb-004 binds to and inhibits the activity of cell surface protein endosialin/TEM1, which may result in the inhibition of angiogenesis, tumor cell proliferation and metastasis. Endosialin/TEM1 plays a key role in angiogenesis and may be overexpressed on tumor stromal cells and endothelial cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3614158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Simvastatin (Zocor)</VALIDVALUE>
          <VALUEMEANING>Simvastatin</VALUEMEANING>
          <MEANINGDESCRIPTION>A lipid-lowering agent derived synthetically from a fermentation product of the fungus Aspergillus terreus.  Hydrolyzed in vivo to an active metabolite, simvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis.  This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3626719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PD-0332991</VALIDVALUE>
          <VALUEMEANING>PD-0332991</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. PD-0332991 selectively inhibits cyclin-dependent kinases (particularly Cdk4/cyclin D1 kinase), which may inhibit retinoblastoma (Rb) protein phosphorylation; inhibition of Rb phosphorylation prevents Rb-positive tumor cells from entering the S phase of the cell cycle (arrest in the G1 phase), resulting in suppression of DNA replication and decreased tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49176</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3564160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ramucirumab</VALIDVALUE>
          <VALUEMEANING>Ramucirumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, fully human monoclonal antibody directed against human vascular endothelial growth factor receptor 2 (VEGFR-2) with antiangiogenesis activity. Ramucirumab specifically binds to and inhibits VEGFR-2, which may result in an in inhibition of tumor angiogenesis and a decrease in tumor nutrient supply. VEGFR-2 is a pro-angiogenic growth factor receptor tyrosine kinase expressed by endothelial cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70792</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3553252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thapsigargin Prodrug G-202</VALIDVALUE>
          <VALUEMEANING>Thapsigargin Prodrug G-202</VALUEMEANING>
          <MEANINGDESCRIPTION>A soluble, thapsigargin prodrug containing the cytotoxic analog of thapsigargin, 8-O-(12Aminododecanoyl)-8-O debutanoylthapsigargin (12-ADT) linked, via a carboxyl group, to the targeting peptide containing aspartic acid with potential antineoplastic activity. Upon intravenous administration, the non-toxic prodrug targets prostate specific membrane antigen (PSMA), a type II membrane carboxypeptidase, which is overexpressed in prostate cancer cells and in the neovasculature of most solid tumors but not in normal blood vessels. G-202 is subsequently converted, through hydrolysis, into the active cytotoxic analog of thapsigargin 12-ADT-Asp. 12-ADT binds to and blocks the Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase (SERCA) pump, thereby increasing the concentration of cytosolic calcium which leads to an induction of apoptosis. By preventing nutrient supply to tumor cells, G-202 may be able to inhibit tumor growth. Compared to thapsigargin alone, thapsigargin prodrug G-202 is able to achieve higher concentrations of the active agents at the tumor site while avoiding systemic toxicity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3461702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207</VALIDVALUE>
          <VALUEMEANING>Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant Listeria-based cancer vaccine containing a live-attenuated strain of the facultative intracellular bacterium Listeria monocytogenes (Lm) expressing human mesothelin with potential immunostimulatory and antineoplastic activities. Upon administration of this vaccine, Listeria invade professional phagocytes within the immune system and express mesothelin, which may activate a cytotoxic T-lymphocyte (CTL) response against mesothelin-expressing tumor cells, resulting in tumor cell lysis. In addition, the Listeria vector itself may induce a potent innate and adaptive immunity unrelated to mesothelin expression. Mesothelin is a cell surface glycoprotein involved in cell adhesion and is overexpressed in many epithelial-derived cancers, including pancreatic, ovarian and lung cancers, and malignant mesotheliomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74055</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3461704</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ICT-107</VALIDVALUE>
          <VALUEMEANING>ICT-107</VALUEMEANING>
          <MEANINGDESCRIPTION>A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with six synthetic glioblastoma (GBM) peptides: absent in melanoma 2 (AIM-2), melanoma-associated antigen 1 (MAGE-1), tyrosinase-related protein 2 (TRP-2), glycoprotein 100 (gp100), epidermal growth factor receptor 2 (HER-2), interleukin-13 receptor subunit alpha-2 (IL-13Ra2), with potential immunostimulatory and antineoplastic activities. Mononuclear cells obtained via leukapheresis are differentiated into DCs, and pulsed with the GBM-associated peptides. Upon administration, multi-glioblastoma-peptide-targeting autologous DC vaccine ICT-107 exposes the immune system to GBM-associated antigens, which activates a specific cytotoxic T-lymphocyte (CTL) response against GBM cells. This leads to GBM cell lysis. The six peptides are derived from tumor associated antigens (TAA) expressed on GBM cells and cancer stem cells (CSCs). GBM stem-like cells contain a specific range of antigens that are essential for the neoplastic growth and survival of GBM cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124054</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3515397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Placebo</VALIDVALUE>
          <VALUEMEANING>Placebo</VALUEMEANING>
          <MEANINGDESCRIPTION>An inactive substance, treatment or procedure that is intended to mimic as closely as possible a therapy in a clinical trial.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C753</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BIBW2992 (Afatinib)</VALIDVALUE>
          <VALUEMEANING>Afatinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable dual receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Afatinib irreversibly binds to and inhibits human epidermal growth factor receptors 1 and 2 (EGFR-1; HER2), which may result in the inhibition of tumor growth and angiogenesis. EGFR/HER2 are RTKs that belong to the EGFR superfamily; both play major roles in tumor cell proliferation and tumor vascularization and are overexpressed in many cancer cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66940</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3462019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PEPvIII loaded Dendritic Cell (DC) vaccine</VALIDVALUE>
          <VALUEMEANING>Dendritic Cell Tumor Peptide Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A vaccine composed of dendritic cells pulsed with peptide epitopes that stimulate cytotoxic T lymphocyte anti-tumor activity. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3462021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brain Tumor Stem Cell (BTSC)/total tumor RNA Dendritic Cell (ttRNA DC) vaccine</VALIDVALUE>
          <VALUEMEANING>Brain Tumor Stem Cell (BTSC)/total tumor RNA Dendritic Cell (ttRNA DC) vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>Brain Tumor Stem Cell (BTSC)/total tumor RNA Dendritic Cell (ttRNA DC) vaccine</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3462022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Total tumor RNA Dendritic cell (ttRNA DC) vaccine with antigen specific ALT</VALIDVALUE>
          <VALUEMEANING>Total tumor RNA Dendritic cell (ttRNA DC) vaccine with antigen specific Autologous Lymphocyte Transfer (ALT)</VALUEMEANING>
          <MEANINGDESCRIPTION>Total tumor RNA Dendritic cell (ttRNA DC) vaccine with antigen specific Autologous Lymphocyte Transfer (ALT)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3462023</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pp65 DC vaccine with antigen specific ALT</VALIDVALUE>
          <VALUEMEANING>pp65 DC vaccine with antigen specific Autologous Lymphocyte Transfer (ALT)</VALUEMEANING>
          <MEANINGDESCRIPTION>pp65 DC vaccine with antigen specific Autologous Lymphocyte Transfer (ALT)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3462024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pp65 DC vaccine</VALIDVALUE>
          <VALUEMEANING>pp65 DC vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>pp65 DC vaccine</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3462025</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vadimezan</VALIDVALUE>
          <VALUEMEANING>Vadimezan</VALUEMEANING>
          <MEANINGDESCRIPTION>A fused tricyclic analogue of flavone acetic acid with potential antineoplastic activity. Vadimezan induces the cytokines tumor necrosis alpha (TNF-alpha), serotonin and nitric oxide, resulting in hemorrhagic necrosis and a decrease in angiogenesis.  This agent also stimulates the anti-tumor activity of tumor-associated macrophages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3481458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunocytokine NHS-IL12</VALIDVALUE>
          <VALUEMEANING>Immunocytokine NHS-IL12</VALUEMEANING>
          <MEANINGDESCRIPTION>A fusion protein consisting of the heavy-chains of the human antibody NHS76, raised against DNA released by necrotic tumor cells, and fused to two molecules of a genetically modified human interleukin-12 (IL-12) with potential immunostimulating and antineoplastic activities. Upon administration, the antibody moiety of immunocytokine NHS-IL12 binds to DNA released from necrotic tumor cells located primarily at the core of necrotic solid tumors, thereby delivering the IL-12 moiety. In turn, the IL-12 moiety of this agent stimulates the host immune system to mount an immune response against tumor cells, thereby inhibiting tumor growth. IL-12 is a proinflammatory cytokine with numerous immunoregulatory functions and may augment host immune responses to tumor cells. By targeting tumor cells, NHS-IL-12 may reduce the toxicity associated with systemic administration of recombinant human IL-12.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97961</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3595594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-mesothelin Antibody-Drug Conjugate BAY 94-9343</VALIDVALUE>
          <VALUEMEANING>Anti-mesothelin Antibody-Drug Conjugate BAY 94-9343</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human IgG1 monoclonal antibody directed against the cell surface glycoprotein mesothelin and conjugated to the maytansinoid DM4 with potential antineoplastic activity. The monoclonal antibody moiety of anti-mesothelin antibody-drug conjugate BAY 94-9343 targets and binds to the tumor associated antigen mesothelin; upon internalization, the DM4 moiety binds to tubulin and disrupts microtubule assembly/disassembly dynamics, resulting in inhibition of cell division and cell growth of mesothelin-expressing tumor cells. Mesothelin is overexpressed on all mesotheliomas as well as many ovarian and pancreatic cancers while minimally expressed on normal tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3595596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hsp90 Inhibitor AUY922</VALIDVALUE>
          <VALUEMEANING>Hsp90 Inhibitor AUY922</VALUEMEANING>
          <MEANINGDESCRIPTION>A derivative of 4,5-diarylisoxazole and a third-generation heat shock protein 90 (Hsp90) inhibitor with potential antineoplastic activity. Hsp90 inhibitor AUY922 has been shown to bind with high affinity to and inhibit Hsp90, resulting in the proteasomal degradation of oncogenic client proteins; the inhibition of cell proliferation; and the elevation of heat shock protein 72 (Hsp72) in a wide range of human tumor cell lines. Hsp90, a 90 kDa molecular chaperone, plays a key role in the conformational maturation, stability and function of other substrate or &quot;client&quot; proteins within the cell, many of which are involved in signal transduction, cell cycle regulation and apoptosis, including kinases, transcription factors and hormone receptors.  Hsp72 exhibits anti-apoptotic functions; its up-regulation may be used as a surrogate marker for Hsp90 inhibition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3523218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trametinib</VALIDVALUE>
          <VALUEMEANING>Trametinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MEK MAPK/ERK kinase) with potential antineoplastic activity. Trametinib specifically binds to and inhibits MEK 1 and 2, resulting in an inhibition of growth factor-mediated cell signaling and cellular proliferation in various cancers. MEK 1 and 2, dual specificity threonine/tyrosine kinases often upregulated in various cancer cell types, play a key role in the activation of the RAS/RAF/MEK/ERK signaling pathway that regulates cell growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3523220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>K-562</VALIDVALUE>
          <VALUEMEANING>K-562</VALUEMEANING>
          <MEANINGDESCRIPTION>The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. The K562 line is composed of undifferentiated blast cells that are rich in glycophorin and may be induced to produce fetal and embryonic hemoglobin in the presence of hemin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19437</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3673376</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blinatumomab</VALIDVALUE>
          <VALUEMEANING>Blinatumomab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, single-chain, anti-CD19/anti-CD3 bispecific monoclonal antibody with potential immunostimulating and antineoplastic activities. Blinatumomab possesses two antigen-recognition sites, one for the CD3 complex, a group of T cell surface glycoproteins that complex with the T cell receptor (TCR), and one for CD19, a tumor-associated antigen (TAA) overexpressed on the surface of B cells. This bispecific monoclonal antibody brings CD19-expressing tumor B-cells and cytotoxic T lymphocytes (CTLs) and helper T lymphocytes (HTLs) together, which may result in the CTL- and HTL-mediated cell death of CD19-expressing B-lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3690103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-Endoglin Chimeric Monoclonal Antibody TRC105</VALIDVALUE>
          <VALUEMEANING>Anti-Endoglin Chimeric Monoclonal Antibody TRC105</VALUEMEANING>
          <MEANINGDESCRIPTION>A human/murine chimeric monoclonal antibody directed against endoglin (CD105) with potential antiangiogenic and antineoplastic activities. Anti-endoglin monoclonal antibody TRC105 binds to endoglin, which may result in inhibition of tumor angiogenesis and decreased tumor cell proliferation. The glycoprotein endoglin is a transforming growth factor beta-1 (TGF beta-1) accessory receptor that is highly expressed on tumor vessel endothelial cells and appears to be essential for angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74010</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3690105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MEK inhibitor GDC-0973</VALIDVALUE>
          <VALUEMEANING>MEK inhibitor GDC-0973</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable small-molecule inhibitor of mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1), with potential antineoplastic activity. MEK inhibitor GDC-0973 specifically binds to and inhibits the catalytic activity of MEK1, resulting in inhibition of extracellular signal-related kinase 2 (ERK2) phosphorylation and activation and decreased tumor cell proliferation. Preclinical studies have demonstrated that this agent is effective in inhibiting the growth of tumor cells bearing a B-RAF mutation, which has been found to be associated with many tumor types. A threonine-tyrosine kinase and a key component of the RAS/RAF/MEK/ERK signaling pathway that is frequently activated in human tumors, MEK1 is required for the transmission of growth-promoting signals from numerous receptor tyrosine kinases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68923</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PI3K Inhibitor GDC-0941 Bismesylate</VALIDVALUE>
          <VALUEMEANING>PI3K Inhibitor GDC-0941 Bismesylate</VALUEMEANING>
          <MEANINGDESCRIPTION>The orally bioavailable bismesylate salt of a potent small-molecule thieno[3,2-d]pyrimidine inhibitor of the class I phosphatidylinositol 3 kinase (PI3K) isoforms p100alpha and p100delta with potential antineoplastic activity. PI3K inhibitor GDC-0941 selectively binds to PI3K isoforms in an ATP-competitive manner, inhibiting the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3) and activation of the PI3K/Akt signaling pathway; inhibition of tumor cell growth, motility and survival in susceptible tumor cell populations may result. Activation of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis; dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-KIR Monoclonal Antibody IPH 2101</VALIDVALUE>
          <VALUEMEANING>Anti-KIR Monoclonal Antibody IPH 2101</VALUEMEANING>
          <MEANINGDESCRIPTION>A human monoclonal antibody directed against the human inhibitory killer IgG-like receptor (KIR) with potential immunostimulating and antineoplastic activities. Anti-KIR monoclonal antibody IPH 2101 binds to the KIR receptor expressed on human natural killer (NK) cells, which may prevent KIR-mediated inhibition of NK cells and permit NK cell-mediated anti-tumor cytotoxicity. KIRs are surface glycoproteins that bind to major histocompatibility complex (MHC)/human leukocyte antigen (HLA) class I subtypes on target cells; binding of KIRs inhibits NK cell-mediated cytotoxicity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3640461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-MART-1 F5 Cells</VALIDVALUE>
          <VALUEMEANING>Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes</VALUEMEANING>
          <MEANINGDESCRIPTION>Human autologous peripheral blood lymphocytes (PBLs) transduced with a melanoma antigen MART-1 epitope-determined T cell receptor (TCR) gene, with potential antineoplastic activity. PBLs are isolated from a melanoma patient and pulsed with a viral vector that encodes the TCR specific for an epitope of MART-1 (F5 TCR). After expansion ex vivo, the transduced autologous PBLs, expressing this specific TCR, are reintroduced into the patient, and bind to melanoma cells expressing the MART-1 antigen, which may result in specific cytotoxic T-lymphocyte (CTL) killing of MART-1-expressing melanoma cells. MART-1 (melanoma antigen recognized by T cells 1), also known as Melan-A, is a melanocyte lineage-specific transmembrane protein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3673373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MART-1 Antigen</VALIDVALUE>
          <VALUEMEANING>MART-1 Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>A tumor-associated melanocytic differentiation antigen. Vaccination with MART-1 antigen may stimulate a host cytotoxic T-cell response against tumor cells expressing the melanocytic differentiation antigen, resulting in tumor cell lysis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28724</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TIL</VALIDVALUE>
          <VALUEMEANING>Tumor Infiltrating Lymphocyte</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3534177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neratinib</VALIDVALUE>
          <VALUEMEANING>Neratinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available, 6,7-disubstituted-4-anilinoquinoline-3-carbonitrile irreversible inhibitor of the HER-2 receptor tyrosine kinase with potential antineoplastic activity. Neratinib binds to the HER-2 receptor irreversibly, thereby reducing autophosphorylation in cells, apparently by targeting a cysteine residue in the ATP-binding pocket of the receptor. Treatment of cells with this agent results in inhibition of downstream signal transduction events and cell cycle regulatory pathways; arrest at the G1-S (Gap 1/DNA synthesis)-phase transition of the cell division cycle; and ultimately decreased cellular proliferation. Neratinib also inhibits the epidermal growth factor receptor (EGFR) kinase and the proliferation of EGFR-dependent cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49094</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3720773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iodine I 124-labeled Hsp90 Inhibitor PUH71</VALIDVALUE>
          <VALUEMEANING>Iodine I 124-labeled Hsp90 Inhibitor PUH71</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioconjugate containing the purine scaffold heat shock protein 90 (Hsp90) inhibitor PUH71 labeled with the radioisotope iodine I 124, with positron emitting activity. Hsp90 inhibitor PUH71 is thought to bind to cytosolic Hsp90 and the endoplasmic reticulum paralogue gp96 (HSP90B1), thereby inhibiting its molecular chaperone function and promoting the degradation of the oncogenic signaling proteins. This induces caspase-dependent apoptosis. The iodine I 124 moiety can be visualized using Positron emission tomography (PET) imaging, thereby allowing an assessment of the accumulation of PUH71 in vivo, particularly in tumors. Hsp90, a chaperone protein upregulated in a variety of tumor cells, regulates the folding, stability and degradation of many oncogenic signaling proteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3698433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plerixafor</VALIDVALUE>
          <VALUEMEANING>Plerixafor</VALUEMEANING>
          <MEANINGDESCRIPTION>A bicyclam with hematopoietic stem cell-mobilizing activity. Plerixafor blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3631680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Levofloxacin</VALIDVALUE>
          <VALUEMEANING>Levofloxacin</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of quinolone antibiotic. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Linezolid</VALIDVALUE>
          <VALUEMEANING>Linezolid</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic oxazolidinone derivative, Linezolid selectively inhibits an early step in bacterial protein synthesis and affects blood pressure through monoamine oxidase inhibition. It is effective against Gram-positive organisms, including methicillin-resistant Staphylococcus aureus strains, coagulase-negative Staphylococci, vancomycin-resistant Enterococci, and penicillin-resistant Streptococcus pneumoniae strains. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29158</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moxifloxacin</VALIDVALUE>
          <VALUEMEANING>Moxifloxacin</VALUEMEANING>
          <MEANINGDESCRIPTION>A fluoroquinolone antibiotic with antibacterial activity. Moxifloxacin binds to and inhibits the bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV, resulting in inhibition of DNA replication and repair and cell death in sensitive bacterial species.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62052</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2743466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rifampin</VALIDVALUE>
          <VALUEMEANING>Rifampin</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic derivative of rifamycin with broad antibacterial activity. Rifampin inhibits DNA-dependent RNA polymerase in susceptible bacteria and is often used in combination with other antibiotics for various infections including tuberculosis. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C811</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ruxolitinib</VALIDVALUE>
          <VALUEMEANING>Ruxolitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib pecifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77888</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3693066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-PD-L1 Monoclonal Antibody MDX-1105</VALIDVALUE>
          <VALUEMEANING>Anti-PD-L1 Monoclonal Antibody MDX-1105</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human monoclonal antibody directed against the protein ligand PD-L1 (Programmed Death-1 Ligand 1) with immunomodulating and potential antineoplastic activities. Anti-PD-L1 monoclonal antibody MDX-1105 binds to PD-L1, blocking its binding to and activation of its receptor, PD-1 (Programmed Death 1), which may enhance the T-cell-mediated immune response to neoplasms and reverse T-cell inactivation in chronic infectious disease.  PD-L1 is expressed broadly on hematopoietic and parenchymal tissues; PD-1, a transmembrane protein, is a negative regulator of the immune system that limits the expansion and survival of CD8+ T cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3773962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regorafenib</VALIDVALUE>
          <VALUEMEANING>Regorafenib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3729312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retaspimycin</VALIDVALUE>
          <VALUEMEANING>Retaspimycin</VALUEMEANING>
          <MEANINGDESCRIPTION>A small-molecule inhibitor of heat shock protein 90 (HSP90) with antiproliferative and antineoplastic activities. Retaspimycin binds to and inhibits the cytosolic chaperone functions of HSP90, which maintains the stability and functional shape of many oncogenic signaling proteins and may be overexpressed or overactive in tumor cells. Retaspimycin-mediated inhibition of HSP90 promotes the proteasomal degradation of oncogenic signaling proteins in susceptible tumor cell populations, which may result in the induction of apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3813173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gamma Secretase Inhibitor PF-03084014</VALIDVALUE>
          <VALUEMEANING>Gamma Secretase Inhibitor PF-03084014</VALUEMEANING>
          <MEANINGDESCRIPTION>A selective gamma secretase (GS) inhibitor with potential antitumor activity. Gamma secretase inhibitor PF-03084014 binds to GS, blocking proteolytic activation of Notch receptors; Notch signaling pathway inhibition may follow, which may result in the induction of apoptosis in tumor cells that overexpress Notch. The integral membrane protein GS is a multi-subunit protease complex that cleaves single-pass transmembrane proteins, such as Notch receptors, at residues within their transmembrane domains. Overexpression of the Notch signaling pathway has been correlated with increased tumor cell growth and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3813175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dovitinib Lactate</VALIDVALUE>
          <VALUEMEANING>Dovitinib Lactate</VALUEMEANING>
          <MEANINGDESCRIPTION>The orally bioavailable lactate salt of a benzimidazole-quinolinone compound with potential antineoplastic activity. Dovitinib strongly binds to fibroblast growth factor receptor 3 (FGFR3) and inhibits its phosphorylation, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell death. In addition, this agent may inhibit other members of the RTK superfamily, including the vascular endothelial growth factor receptor; fibroblast growth factor receptor 1; platelet-derived growth factor receptor type 3; FMS-like tyrosine kinase 3; stem cell factor receptor (c-KIT); and colony-stimulating factor receptor 1; this may result in an additional reduction in cellular proliferation and angiogenesis, and the induction of tumor cell apoptosis. The activation of FGFR3 is associated with cell proliferation and survival in certain cancer cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62435</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3813177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WEE1 Inhibitor MK-1775</VALIDVALUE>
          <VALUEMEANING>Adavosertib</VALUEMEANING>
          <MEANINGDESCRIPTION>A small molecule inhibitor of the tyrosine kinase WEE1 with potential antineoplastic sensitizing activity. Adavosertib selectively targets and inhibits WEE1, a tyrosine kinase that phosphorylates cyclin-dependent kinase 1 (CDK1, CDC2) to inactivate the CDC2/cyclin B complex. Inhibition of WEE1 activity prevents the phosphorylation of CDC2 and impairs the G2 DNA damage checkpoint. This may lead to apoptosis upon treatment with DNA damaging chemotherapeutic agents. Unlike normal cells, most p53 deficient or mutated human cancers lack the G1 checkpoint as p53 is the key regulator of the G1 checkpoint and these cells rely on the G2 checkpoint for DNA repair to damaged cells. Annulment of the G2 checkpoint may therefore make p53 deficient tumor cells more vulnerable to antineoplastic agents and enhance their cytotoxic effect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91725</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3718072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Choline Kinase Alpha Inhibitor TCD-717</VALIDVALUE>
          <VALUEMEANING>Choline Kinase Alpha Inhibitor TCD-717</VALUEMEANING>
          <MEANINGDESCRIPTION>A small-molecule inhibitor of choline kinase alpha (CHKA), with potential antineoplastic activity. TCD-717 targets and binds to CHKA, an enzyme that plays a key role in the synthesis of phosphatidylcholine, the major phospholipid in eukaryotic cell membranes. Blockade of this enzyme induces cells to activate a different route for phospholipid production which causes a toxic effect and eventually leads to cell destruction. CHKA, overexpressed in human cancer cells while only minimally expressed in normal cells, appears to play a significant role in cellular proliferation, evasion of apoptosis, increased cell motility and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3718074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor Infiltrating Lymphocyte</VALIDVALUE>
          <VALUEMEANING>Tumor Infiltrating Lymphocyte</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3534177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AAV-DC-CTL Tumor Cell Targeting Therapy (ACTL)</VALIDVALUE>
          <VALUEMEANING>AAV-DC-CTL Tumor Cell Targeting Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A tumor-targeted therapy consisting of cytotoxic T lymphocytes (CTLs) that are exposed ex vivo to dendritic cells (DCs) transfected with a recombinant adeno-associated virus (rAAV) encoding a specific tumor associated antigen (TAA) gene. Autologous peripheral blood mononuclear cells (PBMC) are collected and separated into monocytes and lymphocytes. The monocytes are infected with the rAAV that carries the TAA gene; this is followed by co-culture of the monocyte-derived, mature rAAV-transfected DCs and the isolated lymphocytes to generate CTLs against the specific TAA. These CTLs are transfused back into the patient for cancer therapy. The CTLs specifically kill tumor cells expressing the TAA, which results in a reduction of tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107677</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3855951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dicycloplatin</VALIDVALUE>
          <VALUEMEANING>Dicycloplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>A third-generation, supramolecular platinum-based compound composed of carboplatin linked, by a strong hydrogen bond, to 1,1-cyclobutane dicarboxylate (CBDCA), with potential  antineoplastic activity.  Although the exact mechanism of action has yet to be fully elucidated, dicycloplatin appears to have a mechanism of action similar to that of other platinum-based compounds, which involves both DNA binding and the formation of DNA crosslinks.  This mechanism results in the induction of apoptosis and cell growth inhibition.  Compared to carboplatin alone, dicycloplatin shows enhanced solubility and stability in aqueous solution and appears to have a more favorable toxicity profile.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107676 </MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3855895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ziv-Aflibercept</VALIDVALUE>
          <VALUEMEANING>Aflibercept</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant protein comprised of epitopes of the extracellular domains of human vascular endothelial growth factor receptors (VEGFR) fused to the constant region (Fc) of human IgG1 with potential antiangiogenic activity. Afilbercept, functioning as a soluble decoy receptor, binds to pro-angiogenic vascular endothelial growth factors (VEGFs), thereby preventing VEGFs from binding to their endogenous receptors. Disruption of the binding of VEGFs to their cellular receptors may result in the inhibition of tumor angiogenesis, metastasis, and ultimately tumor regression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3880514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IL-2 Recombinant Fusion Protein ALT-801</VALIDVALUE>
          <VALUEMEANING>IL-2 Recombinant Fusion Protein ALT-801</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant protein consisting of the cytokine interleukin-2 (IL-2) fused to a humanized soluble T-cell receptor (TCR) directed against a tumor suppressor p53-derived antigen with potential immunopotentiating and antineoplastic activities. The TCR moiety of IL-2 recombinant fusion protein ALT-801 binds to tumor cells displaying p53 epitope/MHC complexes; subsequently, the tumor cell-localized IL-2 moiety may stimulate natural killer (NK) cell and T cell cytotoxic immune responses against p53-expressing tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71743</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3896160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autologous Dendritic Cell-Adenovirus P53 Vaccine</VALIDVALUE>
          <VALUEMEANING>Autologous Dendritic Cell-Adenovirus P53 Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>An autologous vaccine composed of dendritic cells (DC) that have been transduced with a p53 tumor suppressor gene-modified virus. When the autologous dendritic cell-adenovirus p53 vaccine is administered, the host cytotoxic T lymphocytes (CTL) are directed against p53-positive tumor cells, which may result in tumor cell death and decreased tumor growth. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3911935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lambrolizumab</VALIDVALUE>
          <VALUEMEANING>Lambrolizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal immunoglobulin (Ig) G4 antibody directed against human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1) with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, pembrolizumab binds to PD-1, an inhibitory signaling receptor expressed on the surface of activated T cells, and blocks the binding to and activation of PD-1 by its ligands, which results in the activation of T-cell-mediated immune responses against tumor cells. The ligands for PD-1 include programmed cell death ligand 1 (PD-L1), overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on APCs. Activated PD-1 negatively regulates T-cell activation and plays a key role in in tumor evasion from host immunity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-01</PVBEGINDATE>
          <PVENDDATE>2020-12-10</PVENDDATE>
          <VMPUBLICID>3911937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-CD19-CAR-CD3zeta-4-1BB-Expressing Allogenic Natural Killer Cells</VALIDVALUE>
          <VALUEMEANING>Anti-CD19-CAR-CD3zeta-4-1BB-Expressing Allogenic Natural Killer Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Allogeneic natural killer (NK) cells transduced with an mRNA expressing a chimeric antigen receptor (CAR) consisting of an anti-CD19 scFv (single chain variable fragment) and the zeta chain of the TCR/CD3 complex (CD3-zeta), coupled to the signaling domain of 4-1BB (CD137), with potential immunomodulating and antineoplastic activities. NK cells from haploidentical donors are expanded in culture and electroporated with the CAR mRNA. Upon transfusion of the transduced cultured cells, CD19CAR-CD3zeta-4-1BB-expressing allogeneic NK cells bind to and induce selective cytotoxicity in CD19-expressing tumor cells. The 4-1BB co-stimulatory molecule signaling domain enhances activation and signaling after recognition of CD19. Its inclusion may also increase antitumor activity, when compared to the inclusion of the CD3-zeta chain alone. CD19 antigen is a B-cell specific cell surface antigen expressed in all B-cell lineage malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112179</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4037975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dacetuzumab</VALIDVALUE>
          <VALUEMEANING>Dacetuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against the CD40 receptor with potential antineoplastic activity. Dacetuzumab specifically binds to and inhibits the CD40 receptor, thereby inducing apoptosis and inhibiting cellular proliferation via antibody-dependent cellular cytotoxicity (ADCC) in cells that overexpress this receptor. The CD40 receptor, a member of the tumor necrosis factor (TNF) receptor super-family, is highly expressed on most B lineage hematologic malignancies including multiple myeloma, non-Hodgkin&#39;s lymphoma, chronic lymphocytic leukemia, Hodgkin&#39;s disease and acute lymphoblastic leukemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62179</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-11-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3950197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Talaporfin Sodium</VALIDVALUE>
          <VALUEMEANING>Talaporfin Sodium</VALUEMEANING>
          <MEANINGDESCRIPTION>An agent consisting of chlorin e6, derived from chlorophyll, and L-aspartic acid with photosensitizing activity.  After intratumoral activation by light emitting diodes, taporfin sodium forms an extended high energy conformational state that generates singlet oxygen, resulting in free radical-mediated cell death. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26675</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3977275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amrubicin</VALIDVALUE>
          <VALUEMEANING>Amrubicin</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic 9-amino-anthracycline with antineoplastic activity. Amrubicin intercalates into DNA and inhibits the activity of topoisomerase II, resulting in inhibition of DNA replication, and RNA and protein synthesis, followed by cell growth inhibition and cell death. This agent has demonstrated a higher level of anti-tumor activity than conventional anthracycline drugs without exhibiting any indication of the cumulative cardiac toxicity common to this class of compounds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4076475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-human GITR Monoclonal Antibody TRX518</VALIDVALUE>
          <VALUEMEANING>Anti-human GITR Monoclonal Antibody TRX518</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized, Fc disabled anti-human glucocorticoid-induced tumor necrosis factor receptor (GITR) monoclonal antibody (MoAb) with immunomodulating activity. Anti-human GITR MoAb TRX518 blocks the interaction of GITR, found on multiple types of T cells, with its ligand, thereby inducing both the activation of tumor-antigen-specific T effector cells, as well as abrogating the suppression induced by inappropriately activated T regulatory cells. This agent is shown to act synergistically with chemotherapeutic drugs in multiple cancer models.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95023</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3944882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Valrubicin</VALIDVALUE>
          <VALUEMEANING>Valrubicin</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic derivative of the antineoplastic anthracycline antibiotic doxorubicin. With a mechanism of action that appears to differ from doxorubicin, valrubicin is converted intracytoplasmically into N-trifluoroacetyladriamycin, which interacts with topoisomerase II, stabilizing the complex between the enzyme and DNA; consequently, DNA replication and repair and RNA and protein synthesis are inhibited and the cell cycle is arrested in the G2 phase. In addition, this agent accumulates in the cell cytoplasm where it inhibits protein kinase C (PKC). Valrubicin is less cardiotoxic than doxorubicin when administered systemically; applied topically, this agent shows excellent tissue penetration. Structurally, the trifluoro-acetyl moiety on the amino group of the glycoside and the valerate moiety appear to result in a lipophilicity that is greater than of doxorubicin, resulting in increased intracytoplasmic concentrations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1340</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4337185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methoxyamine</VALIDVALUE>
          <VALUEMEANING>Methoxyamine</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable small molecule inhibitor with potential adjuvant activity. Methoxyamine covalently binds to apurinic/apyrimidinic (AP) DNA damage sites and inhibits base excision repair (BER), which may result in an increase in DNA strand breaks and apoptosis. This agent may potentiate the anti-tumor activity of alkylating agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78084</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4255112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trastuzumab Emtansine</VALIDVALUE>
          <VALUEMEANING>Trastuzumab Emtansine</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody-drug conjugate (ADC) consisting of the recombinant anti-epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab conjugated to the maytansinoid DM1 via a nonreducible thioether linkage (MCC) with potential antineoplastic activity. The trastuzumab moiety of this ADC binds to HER2 on tumor cell surfaces; upon internalization, the DM1 moiety is released and binds to tubulin, thereby disrupting microtubule assembly/disassembly dynamics and inhibiting cell division and the proliferation of cancer cells that overexpress HER2. Linkage of antibody and drug through a nonreducible linker has been reported to contribute to the improved efficacy and reduced toxicity of this ADC compared to similar ADCs constructed with reducible linkers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4255113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Programmed Cell Death 1 Ligand 1</VALIDVALUE>
          <VALUEMEANING>Programmed Cell Death 1 Ligand 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Programmed cell death 1 ligand 1 (290 aa, ~33 kDa) is encoded by the human CD274 gene. This protein is involved in the mediation of both the activation and proliferation of T cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96024</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3377565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rucaparib Phosphate</VALIDVALUE>
          <VALUEMEANING>Rucaparib Phosphate</VALUEMEANING>
          <MEANINGDESCRIPTION>A tricyclic indole poly(ADP-Ribose) polymerase (PARP1) inhibitor with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Rucaparib selectively binds to PARP1 and inhibits PARP1-mediated DNA repair, thereby enhancing the accumulation of DNA strand breaks and promoting genomic instability and apoptosis. This may enhance the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapy and radiation therapy. PARP1 catalyzes post-translational ADP-ribosylation of nuclear proteins and is activated by single-strand DNA (ssDNA) breaks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78186</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4273832</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Afatinib</VALIDVALUE>
          <VALUEMEANING>Afatinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, with antineoplastic activity. Upon administration, afatinib selectively and irreversibly binds to and inhibits the epidermal growth factor receptors 1 (ErbB1; EGFR), 2 (ErbB2; HER2), and 4 (ErbB4; HER4), and certain EGFR mutants, including those caused by EGFR exon 19 deletion mutations or exon 21 (L858R) mutations. This may result in the inhibition of tumor growth and angiogenesis in tumor cells overexpressing these RTKs. Additionally, afatinib inhibits the EGFR T790M gatekeeper mutation which is resistant to treatment with first-generation EGFR inhibitors. EGFR, HER2 and HER4 are RTKs that belong to the EGFR superfamily; they play major roles in both tumor cell proliferation and tumor vascularization and are overexpressed in many cancer cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66940</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4713538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dabrafenib</VALIDVALUE>
          <VALUEMEANING>Dabrafenib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-10-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4539014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PG13-CD19-H3</VALIDVALUE>
          <VALUEMEANING>PG13-CD19-H3 (anti-CD19 CAR)</VALUEMEANING>
          <MEANINGDESCRIPTION>PG13-CD19-H3 (anti-CD19 CAR)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-06-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4865851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glutaminase Inhibitor CB-839</VALIDVALUE>
          <VALUEMEANING>Glutaminase Inhibitor CB-839</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of glutaminase, with potential antineoplastic activity. Upon oral administration, CB-839 selectively and irreversibly inhibits glutaminase, a mitochondrial enzyme that is essential for the conversion of the amino acid glutamine into glutamate. By blocking glutamine utilization, proliferation in rapidly growing cells is impaired. Glutamine-dependent tumors rely on the conversion of exogenous glutamine into glutamate and glutamate metabolites to both provide energy and generate building blocks for the production of macromolecules, which are needed for cellular growth and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4783196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oprozomib</VALIDVALUE>
          <VALUEMEANING>Oprozomib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable proteasome inhibitor with potential antineoplastic activity. Proteasome inhibitor ONX 0912 inhibits the activity of the proteasome, thereby blocking the targeted proteolysis normally performed by the proteasome; this may result in an accumulation of unwanted or misfolded proteins. Disruption of various cell signaling pathways may follow, eventually leading to the induction of apoptosis and inhibition of tumor growth. Proteasomes are large protease complexes that degrade unneeded or damaged proteins that have been ubiquitinated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4740632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pomalidomide</VALIDVALUE>
          <VALUEMEANING>Pomalidomide</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities. Although its exact mechanism of action has yet to be fully elucidated, pomalidomide appears to inhibit TNF-alpha production, enhance the activity of T cells and natural killer (NK) cells and enhance antibody-dependent cellular cytotoxicity (ADCC). In addition, pomalidomide may inhibit tumor angiogenesis, promote cell cycle arrest in susceptible tumor cell populations, and stimulate erythropoeisis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C72560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3944871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lenvatinib Mesylate</VALIDVALUE>
          <VALUEMEANING>Lenvatinib Mesylate</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. E7080 blocks VEGFR2 activation by VEGF, resulting in inhibition of the VEGF receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4828174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Binimetinib</VALIDVALUE>
          <VALUEMEANING>Binimetinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available inhibitor of mitogen-activated protein kinase kinase 1 and 2 (MEK1/2) with potential antineoplastic activity. Binimetinib, noncompetitive with ATP, binds to and inhibits the activity of MEK1/2. Inhibition of MEK1/2 prevents the activation of MEK1/2 dependent effector proteins and transcription factors, which may result in the inhibition of growth factor-mediated cell signaling. This may eventually lead to an inhibition of tumor cell proliferation and an inhibition in production of various inflammatory cytokines including interleukin-1, -6 and tumor necrosis factor. MEK1/2 are dual-specificity threonine/tyrosine kinases that play key roles in the activation of the RAS/RAF/MEK/ERK pathway and are often upregulated in a variety of tumor cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84865</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4828187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alectinib</VALIDVALUE>
          <VALUEMEANING>Alectinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, alectinib binds to and inhibits ALK kinase, ALK fusion proteins as well as the gatekeeper mutation ALKL1196M known as one of the mechanisms of acquired resistance to small-molecule kinase inhibitors. The inhibition leads to disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a series of tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4828189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glembatumumab Vedotin</VALIDVALUE>
          <VALUEMEANING>Glembatumumab Vedotin</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody-drug conjugate, consisting of the fully human monoclonal antibody CR011 directed against glycoprotein NMB (GPNMB) and conjugated via a cathepsin B-sensitive valine-citrulline (vc) linkage to the cytotoxic agent monomethyl auristatin E (MMAE), with potential antineoplastic activity. Upon administration, the monoclonal antibody CR011 moiety binds to glycoprotein nmb (GPNMB), expressed on the surfaces of a variety of cancer cell types; upon endocytosis, the synthetic dolastin analogue MMAE is released via enzymatic cleavage into the tumor cell cytosol, where it binds to tubulin and inhibits tubulin polymerization, which may result in G2/M phase arrest and apoptosis. The vc linkage system is highly stable in serum, rendering the cytotoxicity of glembatumumab vedotin specific for GPNMB-positive cells. GPNMB is a transmembrane protein overexpressed on the surfaces of various cancer cell types, including melanoma, breast, and prostate cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4925571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Donor Cellular Infusion</VALIDVALUE>
          <VALUEMEANING>Donor Cellular Infusion</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-08-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4926573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tretinoin</VALIDVALUE>
          <VALUEMEANING>Tretinoin (ATRA)</VALUEMEANING>
          <MEANINGDESCRIPTION>A naturally-occurring acid of retinol. Tretinoin binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of tumorigenesis.  This agent also inhibits telomerase, resulting in telomere shortening and eventual apoptosis of some tumor cell types.  The oral form of tretinoin has teratogenic and embryotoxic properties.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4763631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Obinutuzumab</VALIDVALUE>
          <VALUEMEANING>Obinutuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A glycoengineered, humanized IgG1 monoclonal antibody with potential antineoplastic activity. Afutuzumab, a third generation type II anti-CD20 antibody, selectivity binds to the extracellular domain of the human CD20 antigen on malignant human B cells. The Fc region carbohydrates of the antibody, enriched in bisected non-fucosylated glycosylation variants, contribute to its higher binding affinity for human FcgammaRIII receptors compared to non-glycoengineered antibodies, resulting in enhanced antibody-dependent cellular cytotoxicity (ADCC) and caspase-independent apoptosis. In addition, modification of elbow hinge sequences within the antibody variable framework regions may account for the strong apoptosis-inducing activity of R7159 upon binding to CD20 on target cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ATR Kinase Inhibitor VX-970</VALIDVALUE>
          <VALUEMEANING>ATR Kinase Inhibitor VX-970</VALUEMEANING>
          <MEANINGDESCRIPTION>An inhibitor of ataxia telangiectasia and rad3-related (ATR) kinase, a DNA damage response kinase, with potential antineoplastic activity. ATR kinase inhibitor VX-970 selectively inhibits ATR kinase activity and prevents ATR-mediated signaling in the ATR-checkpoint kinase 1 (Chk1) signaling pathway. This prevents DNA damage checkpoint activation, disrupts DNA damage repair, and induces tumor cell apoptosis. In addition, VX-970 sensitizes tumor cells to chemo- and radiotherapy. ATR, a serine/threonine protein kinase upregulated in a variety of cancer cell types, plays a key role in DNA repair, cell cycle progression, and survival; it is activated by DNA damage caused during DNA replication-associated stress.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5260852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclodextrin-Based Polymer-Camptothecin CRLX101</VALIDVALUE>
          <VALUEMEANING>Cyclodextrin-Based Polymer-Camptothecin CRLX101</VALUEMEANING>
          <MEANINGDESCRIPTION>A formulation of camptothecin, an alkaloid isolated from the Chinese tree Camptotheca acuminata, conjugated with to a hydrophilic, cyclodextrin-based linear polymer with potential antineoplastic activity. Upon intravenous administration, camptothecin is slowly released from the formulation at the tumor site and taken up by tumor cells. During the S phase of the cell cycle, camptothecin selectively stabilizes topoisomerase I-DNA covalent complexes, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery. Compared to camptothecin alone, the cyclodextrin-based polymer formulation has a prolonged half life and greatly improves the biodistribution of camptothecin resulting in an accumulation of camptothecin at the tumor site, which enhances tumor exposure while greatly reducing toxic side effects. In addition, cyclodextrin-based polymer-camptothecin may be able to overcome certain kinds of multidrug resistance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5260854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multitargeted Tyrosine Kinase Inhibitor PLX3397</VALIDVALUE>
          <VALUEMEANING>Multitargeted Tyrosine Kinase Inhibitor PLX3397</VALUEMEANING>
          <MEANINGDESCRIPTION>A capsule formulation containing a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity. Multitargeted tyrosine kinase inhibitor PLX3397 binds to and inhibits phosphorylation of stem cell factor receptor (KIT), colony-stimulating factor-1 receptor (CSF1R) and FMS-like tyrosine kinase 3 (FLT3), which may result in the inhibition of tumor cell proliferation and down-modulation of macrophages, osteoclasts and mast cells involved in the osteolytic metastatic disease. FLT3, CSF1R and FLT3 are overexpressed or mutated in many cancer cell types and play major roles in tumor cell proliferation and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88303</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5260856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osimertinib</VALIDVALUE>
          <VALUEMEANING>Osimertinib</VALUEMEANING>
          <MEANINGDESCRIPTION>A third-generation, orally available, irreversible, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Upon oral administration, osimertinib covalently binds to and inhibits the activity of mutant forms of EGFR, including the T790M EGFR mutant, thereby preventing EGFR-mediated signaling. This may both induce cell death and inhibit tumor growth in EGFR-overexpressing tumor cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization. AZD9291 preferentially inhibits mutated forms of EGFR including T790M, a secondarily-acquired resistance mutation, and may have enhanced anti-tumor effects in tumors with T790M-mediated resistance when compared to other EGFR tyrosine kinase inhibitors. As this agent is selective towards mutant forms of EGFR, its toxicity profile may be reduced when compared to non-selective EGFR inhibitors which also inhibit wild-type EGFR.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5305951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liposomal Cytarabine</VALIDVALUE>
          <VALUEMEANING>Liposomal Cytarabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A liposomal intrathecal formulation of the antimetabolite cytarabine. As an S-phase-specific antimetabolite, cytarabine is phosphorylated by deoxycytidine kinase to a triphosphate form which competes with thymidine for incorporation into DNA; the incorporation of cytarabine triphosphate into DNA appears to inhibit DNA polymerase and so DNA synthesis, resulting in cell death. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5255884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prior therapy, NOS</VALIDVALUE>
          <VALUEMEANING>Prior Therapy Not Otherwise Specified </VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: An indicator that a person has been previously treated for the same condition or with the same therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16124, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5579092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epratuzumab </VALIDVALUE>
          <VALUEMEANING>Epratuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, humanized monoclonal antibody directed against CD22, a cell surface glycoprotein present on mature B-cells and on many types of malignant B-cells.  After binding to CD22, epratuzumab&#39;s predominant antitumor activity appears to be mediated through antibody-dependent cellular cytotoxicity (ADCC).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chimeric antigen receptor T cells</VALIDVALUE>
          <VALUEMEANING>Chimeric Antigen Receptor T-Lymphocyte</VALUEMEANING>
          <MEANINGDESCRIPTION>A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.: A thymocyte-derived lymphocyte of immunological importance that is long-lived (months to years) and is responsible for cell-mediated immunity. T lymphocyte cells form rosettes with sheep erythrocytes and, in the presence of transforming agents (mitogens), differentiate and divide. These cells have the characteristic T3 surface marker and may be further divided into subsets according to function, such as helper, cytotoxic, etc.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12476, C126108</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5578587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxorubicin Hydrochloride Liposome</VALIDVALUE>
          <VALUEMEANING>Doxorubicin Hydrochloride Liposome</VALUEMEANING>
          <MEANINGDESCRIPTION>A liposome-encapsulated form of the hydrochloride salt of the anthracycline antineoplastic antibiotic doxorubicin.  Liposomal delivery of doxorubicin HCL improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of therapeutic drug effects.  Doxorubicin intercalates into DNA and interacts with topoisomerase II, consequently inhibiting DNA replication and repair and RNA and protein synthesis.  This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vintafolide</VALIDVALUE>
          <VALUEMEANING>Vintafolide</VALUEMEANING>
          <MEANINGDESCRIPTION>A water-soluble, folate-receptor-targeted conjugate of folate and the vinca alkaloid desacetylvinblastine monohydrazide (DAVLBH) with potential antineoplastic activity. The folate moiety of vintafolide binds to folic acid receptors on the tumor cell surface and the agent is internalized via folate receptor-mediated endocytosis, delivering the tubulin-binding DAVLBH moiety directly into the tumor cell; DAVLBH binding to tubulin results in the disruption of microtubule assembly-disassembly dynamics, cell cycle arrest, and tumor cell apoptosis. Folic acid receptors are frequently upregulated on the surfaces of many tumor cell types. DAVLBH is a derivative of the natural product vinblastine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5808439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PNC-27</VALIDVALUE>
          <VALUEMEANING>PNC-27</VALUEMEANING>
          <MEANINGDESCRIPTION>A human double minute 2 (HDM2)-binding peptide comprised of a carboxy terminal p53 leader sequence (amino acids 12-26) linked to a membrane residency peptide (MRP), which facilitates penetration of the tumor cell plasma membrane, with potential antineoplastic activity. HDM2-binding peptide PNC-27 binds to HDM2, which is expressed in the plasma membrane of certain cancer cells, and induces transmembrane pore formation, resulting in tumor cell necrosis that is independent of p53 activity. HDM2, a zinc finger protein and negative regulator of the p53 pathway, is often overexpressed by cancer cells and has been implicated in cancer cell proliferation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136515</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5887266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tremelimumab </VALIDVALUE>
          <VALUEMEANING>Tremelimumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A human IgG2 monoclonal antibody directed against the T-cell receptor protein cytotoxic T-lymphocyte-associated protein 4 (CTLA4). Tremelimumab binds to CTLA4 and blocks the binding of the antigen-presenting cell ligands B7-1 and B7-2 to CTLA4, resulting in inhibition of B7-CTLA4-mediated downregulation of T-cell activation; subsequently, B7-1 or B7-2 may interact with another T-cell surface receptor protein, CD28, resulting in a B7-CD28-mediated T-cell activation unopposed by B7-CTLA4-mediated inhibition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49085</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3185137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Durvalumab</VALIDVALUE>
          <VALUEMEANING>Durvalumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody directed against B7H1 (B7 homolog 1; programmed cell death ligand 1) with potential immunostimulating activity. Upon intravenous administration, durvalumab binds to the cell surface antigen B7H1, thereby blocking B7H1 signaling. This may activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against B7H1-expressing tumor cells. B7H1, a member of the B7 protein superfamily and a negative regulator of cytokine synthesis, is overexpressed on certain tumor cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5755432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nivolumab</VALIDVALUE>
          <VALUEMEANING>Nivolumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1,) with immune checkpoint inhibitory and antineoplastic activities. Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands programmed cell death ligand 1 (PD-L1), overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on APCs. This results in the activation of T-cells and cell-mediated immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and and plays a key role in in tumor evasion from host immunity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5076694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radium Ra 223 Dichloride</VALIDVALUE>
          <VALUEMEANING>Radium Chloride Ra-223</VALUEMEANING>
          <MEANINGDESCRIPTION>A radiopharmaceutic of short-lived radium-223 with potential anti-tumor activity. Radium preferentially binds to and accumulates in bone tissue. The radioisotope radium-223 may kill bone cancer cells through the local emission of high energy alpha particles, thereby potentially decreasing tumor progression in the skeleton.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3788420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PF-04136309</VALIDVALUE>
          <VALUEMEANING>CCR2 Antagonist PF-04136309</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available human chemokine receptor 2 (CCR2) antagonist with potential immunomodulating and antineoplastic activities. Upon oral administration, CCR2 antagonist PF-04136309 specifically binds to CCR2 and prevents binding of the endothelium-derived chemokine ligand CLL2 (monocyte chemoattractant protein-1 or MCP1) to its receptor CCR2, which may result in inhibition of CCR2 activation and signal transduction. This may inhibit inflammatory processes as well as angiogenesis, tumor cell migration, and tumor cell proliferation. The G-protein coupled receptor CCR2 is expressed on the surface of monocytes and macrophages, stimulates the migration and infiltration of these cell types, and plays an important role in inflammation, angiogenesis, and tumor cell migration and proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IDH305</VALIDVALUE>
          <VALUEMEANING>IDH1(R132) Inhibitor IDH305</VALUEMEANING>
          <MEANINGDESCRIPTION>An inhibitor of the citric acid cycle enzyme isocitrate dehydrogenase [NADP] cytoplasmic (isocitrate dehydrogenase 1; IDH1) with mutations at residue R132 (IDH1(R132)), with potential antineoplastic activity. Upon administration, IDH305 specifically inhibits IDH1(R132) mutant forms in the cytoplasm, which inhibits the formation of the oncometabolite 2-hydroxyglutarate (2HG). This may lead to both an induction of cellular differentiation and an inhibition of cellular proliferation in IDH1(R132)-expressing tumor cells. IDH1(R132) mutations are highly expressed in certain malignancies, including gliomas; they initiate and drive cancer growth by both blocking cell differentiation and catalyzing the formation of 2HG.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FOLFIRINOX</VALIDVALUE>
          <VALUEMEANING>Folfirinox Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of fluorouracil, irinotecan hydrochloride, leucovorin calcium and oxaliplatin used for the treatment of pancreatic cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5153133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CCX872-B</VALIDVALUE>
          <VALUEMEANING>CCR2 Antagonist CCX872-B</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available human C-C chemokine receptor type 2 (CCR2) antagonist, with potential immunomodulating and antineoplastic activities. Upon oral administration, CCR2 antagonist CCX872-B specifically binds to CCR2 and prevents the binding its cognate endothelium-derived chemokine ligand CCL2 (monocyte chemoattractant protein-1 or MCP1). This may result in the inhibition of both CCR2 activation and CCR2-mediated signal transduction, which may inhibit inflammatory processes, angiogenesis, tumor cell migration, and tumor cell proliferation. The G-protein coupled receptor CCR2 is expressed on the surface of monocytes and macrophages, and stimulates their migration and infiltration; it plays a key role in inflammation. CCR2 is overexpressed in certain cancer cell types, where it is involved in angiogenesis, tumor cell migration and proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120302</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5777021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trifluridine/Tipiracil Hydrochloride</VALIDVALUE>
          <VALUEMEANING>Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable combination agent composed of the cytotoxic pyrimidine analog trifluridine (5-trifluoro-2&#39;-deoxythymidine or TFT) and a thymidine phosphorylase inhibitor (TPI) tipiracil hydrochloride, in a molar ratio of 1.0:0.5 (TFT:TPI), with potential antineoplastic activity. After oral administration of TAS-102, TFT is phosphorylated to the active monophosphate form TF-TMP, which binds covalently to the active site of thymidylate synthase, thereby reducing the nucleotide pool levels required for DNA replication. Furthermore, the triphosphate form TF-TTP can be incorporated into DNA, which induces DNA fragmentation and leads to the inhibition of tumor growth. TPI exhibits a dual effect: 1) an anti-angiogenic effect mediated through the inhibition of thymidine phosphorylase, which plays important role in nucleotide metabolism and a variety of development processes, including angiogenesis, 2) increased bioavailability of the normally short-lived antimetabolite TFT by preventing its degradation into the inactive form trifluorothymine (TF-Thy). The synergistic effect of the components in TAS-10 may demonstrate antitumor activity in 5-FU-resistant cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5831612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Capecitabine/Oxaliplatin</VALIDVALUE>
          <VALUEMEANING>Capecitabine/Oxaliplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5981301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Capecitabine/Irinotecan</VALIDVALUE>
          <VALUEMEANING>XELIRI Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen containing capecitabine and irinotecan used in the treatment of colorectal, esophageal and gastric cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C11602</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5981303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pimasertib</VALIDVALUE>
          <VALUEMEANING>Pimasertib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity. Pimasertib selectively binds to and inhibits the activity of MEK1/2, preventing the activation of MEK1/2-dependent effector proteins and transcription factors, which may result in the inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK1/2 (MAP2K1/K2) are dual-specificity threonine/tyrosine kinases that play key roles in the activation of the RAS/RAF/MEK/ERK pathway and are often upregulated in a variety of tumor cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84864</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6024061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-CEA BiTE</VALIDVALUE>
          <VALUEMEANING>Anti-CEA BiTE Monoclonal Antibody AMG211</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, proprietary bispecific T-cell engagers (BiTE) antibody directed against human carcinoembryonic antigen (CEA), with potential immunostimulating and antineoplastic activities. Anti-CEA BiTE monoclonal antibody AMG211 possesses two antigen-recognition sites, one for CEA and one for the CD3 complex, a group of T cell surface glycoproteins that complex with the T cell receptor (TCR). This bispecific monoclonal antibody brings CEA-expressing tumor cells and cytotoxic T lymphocytes (CTLs) and helper T lymphocytes (HTLs) together, which may result in the CTL- and HTL-mediated cell death of CEA-expressing cells. CEA, a tumor associated antigen, is overexpressed in many cancer types, including gastrointestinal, breast, non-small cell lung, and thyroid cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95728</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6024059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Evofosfamide</VALIDVALUE>
          <VALUEMEANING>Evofosfamide</VALUEMEANING>
          <MEANINGDESCRIPTION>A hypoxia-activated prodrug of the cytotoxin bromo-isophosphoramide mustard (Br-IPM) conjugated with 2-nitroimidazole, with potential antineoplastic activity. When exposed to hypoxic conditions, such as those found in hypoxic tumors, the 2-nitroimidazole moiety of evofosfamide is reduced. This releases the DNA-alkylating Br-IPM moiety, which introduces intra- and inter-strand DNA crosslinks in nearby cells; the crosslinks inhibit both DNA replication and cell division, and may lead to apoptosis of cells in the tumor. The inactive form of the prodrug is stable under normoxic conditions, which may limit systemic toxicity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6024063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bavituximab/Placebo</VALIDVALUE>
          <VALUEMEANING>Bavituximab/Placebo</VALUEMEANING>
          <MEANINGDESCRIPTION>A chimeric, IgG1 monoclonal antibody directed against anionic phospholipids with potential antineoplastic activity. Bavituximab binds to anionic phospholipids in a beta 2-glycoprotein I-dependent manner, inhibiting tumor growth by stimulating antibody-dependent cellular cytotoxicity (ADCC) to tumor vessels.: An inactive substance, treatment or procedure that is intended to provide baseline measurements for the experimental protocol of a clinical trial.: A treatment plan that specifies the dosage, the schedule, and the duration of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C753, C49088</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6046295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunoglobulin</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the structurally related glycoproteins that function as antibodies. They are divided into five classes (IGA, IGD, IGE, IGG, IGM) on the basis of structure and biological activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C572</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5143295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ponatinib</VALIDVALUE>
          <VALUEMEANING>Ponatinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities. Ponatinib inhibits unmutated and all mutated forms of Bcr-Abl, including T315I, the highly drug therapy-resistant missense mutation of Bcr-Abl. This agent also inhibits other tyrosine kinases including those associated with vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs); in addition, it inhibits the tyrosine kinase receptor TIE2 and FMS-related tyrosine kinase receptor-3 (Flt3). RTK inhibition by ponatinib may result in the inhibition of cellular proliferation and angiogenesis and may induce cell death. Bcr-Abl is a fusion tyrosine kinase encoded by the Philadelphia chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3776076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elotuzumab</VALIDVALUE>
          <VALUEMEANING>Elotuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against the human CS1 (CD2 subset 1, CRACC, SLAMF7) antigen with potential antineoplastic activity. Elotuzumab binds to the CS1 antigen, which may trigger antibody-dependent cellular cytotoxicity (ADCC) in cells expressing CS1. CS1 is a cell surface glycoprotein belonging to the CD2 subset of the immunoglobulin superfamily (IgSF) and is highly expressed by multiple myeloma cells, but minimally expressed by normal cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66982</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daratumumab</VALIDVALUE>
          <VALUEMEANING>Daratumumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human monoclonal antibody directed against the cell surface glycoprotein CD-38 with potential antineoplastic activity. The binding of anti-CD38 monoclonal antibody to natural killer (NK) cells mimics the normal CD38-CD31 interaction on the NK cell surface. CD38 is also present on multiple myeloma (MM) cells and plasma leukemia cells; this agent may preferentially bind these cells, triggering antitumoral antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). CD38, a cell surface glycoprotein, is present on various immune cells and has been shown to regulate the cytotoxic response of activated NK cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Marizomib</VALIDVALUE>
          <VALUEMEANING>Marizomib</VALUEMEANING>
          <MEANINGDESCRIPTION>A naturally-occurring salinosporamide, isolated from the marine actinomycete Salinospora tropica, with potential antineoplastic activity. Marizomib irreversibly binds to and inhibits the 20S catalytic core subunit of the proteasome by covalently modifying its active site threonine residues; inhibition of ubiquitin-proteasome mediated proteolysis results in an accumulation of poly-ubiquitinated proteins, which may result in the disruption of cellular processes, cell cycle arrest, the induction of apoptosis, and the inhibition of tumor growth and angiogenesis. This agent more may more potent and selective than the proteasome inhibitor bortezomib.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nintedanib</VALIDVALUE>
          <VALUEMEANING>Nintedanib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, indolinone-derived, receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities. Multitargeted tyrosine kinase inhibitor BIBF 1120 selectively binds to and inhibits vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR) and platelet-derived growth factor receptor (PDGFR) tyrosine kinases, which may result in the induction of endothelial cell apoptosis; a reduction in tumor vasculature; and the inhibition of tumor cell proliferation and migration. In addition, this agent also inhibits members of the Src family of tyrosine kinases, including Src, Lck, Lyn, and FLT-3 (fms-like tyrosine kinase 3). VEGFR, FGFR and PDGFR RTKs play key roles in tumor angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3718802</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buparlisib</VALIDVALUE>
          <VALUEMEANING>PI3K Inhibitor BKM120</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable specific oral inhibitor of the pan-class I phosphatidylinositol 3-kinase (PI3K) family of lipid kinases with potential antineoplastic activity. Buparlisib specifically inhibits class I PI3K in the PI3K/AKT kinase (or protein kinase B) signaling pathway in an ATP-competitive manner, thereby inhibiting the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate and activation of the PI3K signaling pathway. This may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis. Dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90565</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3788416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Necitumumab</VALIDVALUE>
          <VALUEMEANING>Necitumumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human IgG1 monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Necitumumab binds to and blocks the ligand binding site of EGFR, thereby preventing the activation and subsequent dimerization of the receptor. This may lead to an inhibition of EGFR-dependent downstream pathways and so inhibition of EGFR-dependent tumor cell proliferation and metastasis.  EGFR, a member of the epidermal growth factor family of extracellular protein ligands, may be overexpressed on the cell surfaces of various tumor cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6084996</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mirvetuximab Soravtansine</VALIDVALUE>
          <VALUEMEANING>Mirvetuximab Soravtansine</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunoconjugate consisting of the humanized monoclonal antibody M9346A against folate receptor 1 (FOLR1) conjugated, via the disulfide-containing cleavable linker sulfo-SPDB, to the cytotoxic maytansinoid DM4, with potential antineoplastic activity. The anti-FOLR1 monoclonal antibody moiety of mirvetuximab soravtansine targets and binds to the cell surface antigen FOLR1. After antibody-antigen interaction and internalization, the immunoconjugate releases DM4, which binds to tubulin and disrupts microtubule assembly/disassembly dynamics, thereby inhibiting cell division and cell growth of FOLR1-expressing tumor cells. FOLR1, a member of the folate receptor family is overexpressed on a variety of epithelial-derived cancer cells. The sulfo-SPDB linker prevents cleavage in the bloodstream and may improve this agent&#39;s efficacy in multidrug resistant tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6199771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epacadostat</VALIDVALUE>
          <VALUEMEANING>Epacadostat</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available hydroxyamidine and inhibitor of indoleamine 2,3-dioxygenase (IDO1), with potential immunomodulating and antineoplastic activities. Epacadostat targets and binds to IDO1, an enzyme responsible for the oxidation of tryptophan into kynurenine. By inhibiting IDO1 and decreasing kynurenine in tumor cells, INCB024360 increases and restores the proliferation and activation of various immune cells, including dendritic cells (DCs), NK cells, and T-lymphocytes, as well as interferon (IFN) production, and a reduction in tumor-associated regulatory T cells (Tregs). Activation of the immune system, which is suppressed in many cancers, may inhibit the growth of IDO1-expressing tumor cells. IDO1 is overexpressed by a variety of tumor cell types and DCs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92582</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6199773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ustekinumab</VALIDVALUE>
          <VALUEMEANING>Ustekinumab</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available, human, IgG1kappa, monoclonal antibody directed against the p40 protein subunit of both interleukin-12 (IL-12) and IL-23, with immunomodulating activity. Upon administration, ustekinumab binds to the p40 subunit of IL-12 and IL-23, blocking the binding of IL-12 and IL-23 to their interleukin receptors. This inhibits IL-12- and IL-23-mediated signaling and inhibits differentiation of CD4 positive T-cells into Th1 and Th17 cells. This prevents Th1- and Th17-mediated responses and cytokine production. This may prevent graft versus host disease (GVHD). IL-12 and IL-23, cytokines that play a key role in the regulation of the immune system, are upregulated in immune-mediated inflammatory disorders. Both Th1 and Th17 cells play a crucial role in GVHD.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6199775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atezolizumab</VALIDVALUE>
          <VALUEMEANING>Atezolizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized, Fc optimized, monoclonal antibody directed against the protein ligand PD-L1 (programmed cell death-1 ligand 1), with potential immune checkpoint inhibitory and antineoplastic activities. Atezolizumab binds to PD-L1, blocking its binding to and activation of its receptor programmed death 1 (PD-1) expressed on activated T-cells, which may enhance the T-cell-mediated immune response to neoplasms and reverse T-cell inactivation. In addition, by binding to PD-L1, MPDL3280A also prevents binding of this ligand to B7.1 expressed on activated T cells, which further enhances the T-cell-mediated immune response. PD-L1 is overexpressed on many human cancer cell types and on various tumor-infiltrating immune cells. PD-L1 binding to PD-1 on T-cells suppresses the immune system and results in increased immune evasion. PD-1, a transmembrane protein, is a negative regulator of the immune system that limits the expansion and survival of CD8+ T cells. The Fc region of MPDL3280A is modified in such a way that it does not induce either antibody-dependent cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5242662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antibody-drug Conjugate PF-06647020</VALIDVALUE>
          <VALUEMEANING>Antibody-drug Conjugate PF-06647020</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody-drug conjugate (ADC) composed of a proprietary monoclonal antibody against an unnamed tumor-associated antigen (TAA) linked to an as of yet undisclosed cytotoxic agent, with potential antineoplastic activity. Upon intravenous administration, the monoclonal antibody moiety of PF-06647020 targets and binds to the TAA expressed on tumor cells. Upon binding and internalization, the cytotoxic agent is released and kills the TAA-expressing cancer cells, through an as of yet unknown mechanism of action.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6199777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prexasertib</VALIDVALUE>
          <VALUEMEANING>Prexasertib</VALUEMEANING>
          <MEANINGDESCRIPTION>An inhibitor of checkpoint kinase 1 (chk1) with potential antineoplastic activity. Upon administration, prexasertib selectively binds to chk1, thereby preventing activity of chk1 and abrogating the repair of damaged DNA. This may lead to an accumulation of damaged DNA and may promote genomic instability and apoptosis. Prexasertib may potentiate the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapeutic agents. Chk1, a serine/threonine kinase, mediates cell cycle checkpoint control and is essential for DNA repair and plays a key role in resistance to chemotherapeutic agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6199779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T-VEC</VALIDVALUE>
          <VALUEMEANING>Talimogene Laherparepvec</VALUEMEANING>
          <MEANINGDESCRIPTION>An ICP34.5, ICP47-deleted, oncolytic herpes simplex type-1 virus (HSV-1) based on the JS1 strain, and encoding the immunostimulating factor human cytokine granulocyte-macrophage colony stimulating factor (GM-CSF) with potential immunostimulating and antineoplastic activities. Upon intratumoral injection, talimogene laherparepvec selectively infects and replicates in tumor cells, thereby inducing tumor cell lysis. In addition, GM-CSF attracts dendritic cells (DCs) and may stimulate a cytotoxic T cell response against tumor cells, which results in immune-mediated tumor cell death. Deletion of the gene encoding for ICP34.5 provides tumor selectivity and prevents replication in healthy cells. As ICP47 blocks antigen presentation in HSV-infected cells, deletion of this gene may induce a more potent antitumor immune response in the tumor cells. Additionally, deletion of ICP47 causes increased expression of the HSV US11 gene and allows US11 to be expressed as an immediate early and not a late gene. This further enhances the degree of viral replication and oncolysis of tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6365953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Instiladrin</VALIDVALUE>
          <VALUEMEANING>Nadofaragene Firadenovec/Syn3</VALUEMEANING>
          <MEANINGDESCRIPTION>A replication-deficient recombinant adenovirus encoding human interferon alpha-2b with potential antineoplastic activity. Upon intravesical administration, nadofaragene firadenovec infects nearby tumor cells and expresses INF alpha-2b intracellularly which activates the transcription and translation of genes whose products mediate antiviral, antiproliferative, antitumor, and immune-modulating effects.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6661769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Napabucasin</VALIDVALUE>
          <VALUEMEANING>Napabucasin</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available cancer cell stemness inhibitor with potential antineoplastic activity. Even though the exact target has yet to be fully elucidated, napabucasin appears to target and inhibit multiple pathways involved in cancer cell stemness. This may ultimately inhibit cancer stemness cell (CSC) growth as well as heterogeneous cancer cell growth. CSCs, self-replicating cells that are able to differentiate into heterogeneous cancer cells, appear to be responsible for the malignant growth, recurrence and resistance to conventional chemotherapies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6148644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DPX-Survivac</VALIDVALUE>
          <VALUEMEANING>Survivin Antigen Vaccine DPX-Survivac</VALUEMEANING>
          <MEANINGDESCRIPTION>A lipid depot-based therapeutic cancer vaccine composed of survivin epitopes, a universal T Helper peptide and a polynucleotide adjuvant encapsulated in liposomes and then formulated in the hydrophobic carrier Montanide ISA51 VG, with potential immunopotentiating and antineoplastic activities. Upon injection of the survivin antigen vaccine DPX-Survivac, a depot is created at the injection site from which the antigens and adjuvant are released. This vaccine may elicit a long lasting cellular response against survivin-expressing cancers, resulting in a decrease in tumor cell proliferation and an induction of tumor cell death. Survivin, a member of the inhibitor of apoptosis (IAP) family expressed during embryonic development, is upregulated in a variety of human cancers while absent in most normal adult cells; its expression in tumors is associated with a more aggressive phenotype, decreased survival, and increased resistance to chemotherapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6687978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ipafricept</VALIDVALUE>
          <VALUEMEANING>Ipafricept</VALUEMEANING>
          <MEANINGDESCRIPTION>A proprietary fusion protein comprised of the cysteine-rich domain of frizzled family receptor 8 (Fzd8) fused to the human immunoglobulin Fc domain with potential antineoplastic activity. Upon intravenous administration, ipafricept competes with the membrane-bound Fzd8 receptor for its ligand, Wnt proteins, thereby antagonizing Wnt signaling. This may result in the inhibition of Wnt-driven tumor growth. Fzd8, a member of the Frizzled family of G protein-coupled receptors, is one of the components in the Wnt/beta-catenin signaling pathway that plays key roles in embryogenesis and cancer growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102565</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6687980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metformin</VALIDVALUE>
          <VALUEMEANING>Metformin</VALUEMEANING>
          <MEANINGDESCRIPTION>An agent belonging to the biguanide class of antidiabetics with antihyperglycemic activity. Metformin is associated with a very low incidence of lactic acidosis. This agent helps reduce LDL cholesterol and triglyceride levels, and is not associated with weight gain, and prevents the cardiovascular complications of diabetes. Metformin is not metabolized and is excreted unchanged by the kidneys.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3189685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cemiplimab</VALIDVALUE>
          <VALUEMEANING>Cemiplimab</VALUEMEANING>
          <MEANINGDESCRIPTION>A human monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 (PD-1, PCD-1) protein, with potential immune checkpoint inhibitory and antineoplastic activity. Upon administration, cemiplimab binds to PD-1, inhibits its binding to the PD-1 ligand programmed cell death-1 ligand 1 (PD-L1), and prevents the activation of its downstream signaling pathways. This may restore immune function through the activation of cytotoxic T-cells. PD-1, a transmembrane protein in the immunoglobulin superfamily expressed on activated T-cells, negatively regulates T-cell activation and effector function when activated by its ligand; it plays an important role in tumor evasion from host immunity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121540</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6687982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Venetoclax</VALIDVALUE>
          <VALUEMEANING>Venetoclax</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, selective small molecule inhibitor of the anti-apoptotic protein Bcl-2, with potential antineoplastic activity. Venetoclax mimics BH3-only proteins, the native ligands of Bcl-2 and apoptosis activators, by binding to the hydrophobic groove of Bcl-2 proteins thereby repressing Bcl-2 activity and restoring apoptotic processes in tumor cells. Bcl-2 protein is overexpressed in some cancers and plays an important role in the regulation of apoptosis; its expression is associated with increased drug resistance and tumor cell survival. Compared to the Bcl-2 inhibitor navitoclax, this agent does not inhibit bcl-XL and does not cause bcl-XL-mediated thrombocytopenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103147</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5944045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abemaciclib</VALIDVALUE>
          <VALUEMEANING>Abemaciclib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. Abemaciclib specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation in early G1. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of the serine/threonine kinases CDK4/6, as seen in certain types of cancer, causes cell cycle deregulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6148605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PolyPEPI1018</VALIDVALUE>
          <VALUEMEANING>Colorectal Cancer Peptide Vaccine PolyPEPI1018</VALUEMEANING>
          <MEANINGDESCRIPTION>A peptide cancer vaccine consisting of a combination of six synthetic polypeptides directed against cancer testis antigens (CTAs) frequently expressed in colorectal cancers, with potential antineoplastic and immunostimulatory activities. Colorectal cancer peptide vaccine PolyPEPI1018 potentially elicits a cytotoxic T-lymphocyte response against colorectal tumors expressing the CTAs associated with the vaccine, which may result in a reduction in tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6688090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Humanized High-chimeric Antibody CD47</VALIDVALUE>
          <VALUEMEANING>Chimeric Humanized Anti-CD47 Antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized, high-chimeric antibody targeting the human cell surface antigen CD47, with potential phagocytosis-inducing and antineoplastic activities. Upon administration, chimeric humanized anti-CD47 antibody selectively binds to CD47 expressed on tumor cells and blocks the interaction of CD47 with signal regulatory protein alpha (SIRPa), a protein expressed on phagocytic cells. This prevents CD47/SIRPa-mediated signaling and abrogates the CD47/SIRPa-mediated inhibition of phagocytosis. This induces pro-phagocytic signaling mediated by the binding of calreticulin (CRT), which is specifically expressed on the surface of tumor cells, to low-density lipoprotein (LDL) receptor-related protein-1 (LRP-1), expressed on macrophages. This results in macrophage activation and the specific phagocytosis of tumor cells. In addition, blocking CD47 signaling activates both an anti-tumor T-lymphocyte immune response and T cell-mediated killing of CD47-expressing tumor cells. CD47, also called integrin-associated protein (IAP), is a tumor-associated antigen (TAA) expressed on normal, healthy hematopoietic stem cells (HSC) and overexpressed on the surface of a variety of cancer cells. Expression of CD47, and its interaction with SIRPa, leads to the inhibition of macrophage activation and protects cancer cells from phagocytosis, which allows cancer cells to proliferate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6688526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-CD47 MAb SRF-231</VALIDVALUE>
          <VALUEMEANING>Anti-CD47 Monoclonal Antibody SRF231</VALUEMEANING>
          <MEANINGDESCRIPTION>A human monoclonal antibody targeting the human cell surface antigen CD47, with potential phagocytosis-inducing and antineoplastic activities. Upon administration, anti-CD47 monoclonal antibody SRF231 selectively binds to CD47 on tumor cells and blocks the interaction of CD47 with signal regulatory protein alpha (SIRPalpha), an inhibitory protein expressed on macrophages. This prevents CD47/SIRPalpha-mediated signaling and abrogates the CD47/SIRPa-mediated inhibition of phagocytosis. This induces pro-phagocytic signaling mediated by the binding of calreticulin (CRT), which is specifically expressed on the surface of tumor cells, to low-density lipoprotein (LDL) receptor-related protein (LRP), expressed on macrophages. This results in macrophage activation and the specific phagocytosis of tumor cells. In addition, blocking CD47 signaling activates both an anti-tumor T-lymphocyte immune response and T cell-mediated killing of CD47-expressing tumor cells. CD47, also called integrin-associated protein (IAP), is a tumor-associated antigen (TAA) expressed on normal, healthy hematopoietic stem cells (HSCs) and overexpressed on the surface of a variety of cancer cells. Expression of CD47, and its interaction with SIRPalpha, leads to the inhibition of macrophage activation and protects cancer cells from phagocytosis, which allows cancer cells to proliferate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C155976</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6688528</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-CD47 MAb IBI-188</VALIDVALUE>
          <VALUEMEANING>Anti-CD47 Monoclonal Antibody IBI188</VALUEMEANING>
          <MEANINGDESCRIPTION>A human immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47 with potential immunostimulating and antineoplastic activities. Upon intravenous administration, anti-CD47 monoclonal antibody IBI188 selectively binds to CD47 expressed on tumor cells and blocks the interaction of CD47 with signal regulatory protein alpha (SIRPa), a protein expressed on phagocytic cells. This prevents CD47/SIRPa-mediated signaling and abrogates the CD47/SIRPa-mediated inhibition of phagocytosis. This induces pro-phagocytic signaling mediated by the binding of calreticulin (CRT), which is specifically expressed on the surface of tumor cells, to low-density lipoprotein (LDL) receptor-related protein (LRP), expressed on macrophages. This results in macrophage activation and the specific phagocytosis of tumor cells. In addition, blocking CD47 signaling activates both an anti-tumor T-lymphocyte immune response and T cell-mediated killing of CD47-expressing tumor cells. CD47, also called integrin-associated protein (IAP), is a tumor-associated antigen (TAA) expressed on normal, healthy hematopoietic stem cells (HSCs) and overexpressed on the surface of a variety of cancer cells. Expression of CD47, and its interaction with SIRPa, leads to the inhibition of macrophage activation and protects cancer cells from phagocytosis, which allows cancer cells to proliferate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6688530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-CD47 MAb CC-90002</VALIDVALUE>
          <VALUEMEANING>Anti-CD47 Monoclonal Antibody CC-90002</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody targeting the human cell surface antigen CD47, with potential phagocytosis-inducing and antineoplastic activities. Upon administration, anti-CD47 monoclonal antibody CC-90002 selectively binds to CD47 expressed on tumor cells and blocks the interaction of CD47 with signal regulatory protein alpha (SIRPa), a protein expressed on phagocytic cells. This prevents CD47/SIRPa-mediated signaling and abrogates the CD47/SIRPa-mediated inhibition of phagocytosis. This induces pro-phagocytic signaling mediated by the binding of calreticulin (CRT), which is specifically expressed on the surface of tumor cells, to low-density lipoprotein (LDL) receptor-related protein (LRP), expressed on macrophages. This results in macrophage activation and the specific phagocytosis of tumor cells. In addition, blocking CD47 signaling activates both an anti-tumor T-lymphocyte immune response and T cell-mediated killing of CD47-expressing tumor cells. CD47, also called integrin-associated protein (IAP), is a tumor-associated antigen (TAA) expressed on normal, healthy hematopoietic stem cells (HSC) and overexpressed on the surface of a variety of cancer cells. Expression of CD47, and its interaction with SIRPa, leads to the inhibition of macrophage activation and protects cancer cells from phagocytosis, which allows cancer cells to proliferate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6688532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-CD47 Hu5F9-G4</VALIDVALUE>
          <VALUEMEANING>Anti-CD47 Monoclonal Antibody Hu5F9-G4</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody targeting the human cell surface antigen CD47, with potential immunostimulating and antineoplastic activities. Upon administration, anti-CD47 monoclonal antibody Hu5F9-G4 selectively binds to CD47 expressed on tumor cells and blocks the interaction of CD47 with its ligand signal regulatory protein alpha (SIRPa), a protein expressed on phagocytic cells. This prevents CD47/SIRPa-mediated signaling, allows the activation of macrophages, through the induction of pro-phagocytic signaling mediated by calreticulin, which is specifically expressed on the surface of tumor cells, and results in specific tumor cell phagocytosis. In addition, blocking CD47 signaling activates an anti-tumor T-lymphocyte immune response and T-mediated cell killing. CD47, a tumor associated antigen expressed on normal, healthy hematopoietic stem cells (HSC), is overexpressed on the surface of a variety of cancer cells. Expression of CD47, and interaction with SIRP-alpha, leads to inhibition of macrophages and protects cancer cells from phagocytosis thereby allowing cancer cells to proliferate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117730</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6688534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboplatin/Pemetrexed</VALIDVALUE>
          <VALUEMEANING>Carboplatin/Pemetrexed Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of carboplatin and pemetrexed that is used for the treatment of non-small cell lung cancer (NSCLC).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136284</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CD70+CAR-T</VALIDVALUE>
          <VALUEMEANING>Anti-CD70 CAR-expressing T Lymphocytes (CD70 CAR-T)</VALUEMEANING>
          <MEANINGDESCRIPTION>A preparation of human T-lymphocytes transduced with a recombinant viral vector encoding a chimeric T-cell receptor (chimeric antigen receptor or CAR) consisting of one or more binding domains that target the tumor-associated antigen (TAA) CD70 (CD27 ligand; tumor necrosis factor superfamily member 7; TNFSF7) fused to one or more co-stimulatory TCR-signaling domains, with potential immunostimulating and antineoplastic activities. Upon administration, the anti-CD70 CAR-expressing T-lymphocytes, express anti-CD70-CAR on their cell surfaces and bind to the CD70 antigen on tumor cell surfaces thereby neutralizing the activity of CD70. This may induce antibody-dependent cellular cytotoxicity (ADCC) against CD70-expressing tumor cells. CD70, a cytokine belonging to the tumor necrosis superfamily (TNFSF) and the ligand for the costimulatory receptor CD27, is expressed on the surfaces of various types of cancer cells; its overexpression may play an important role in the evasion of immune surveillance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C162699</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6841671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Romidepsin</VALIDVALUE>
          <VALUEMEANING>Romidepsin</VALUEMEANING>
          <MEANINGDESCRIPTION>A bicyclic depsipeptide antibiotic isolated from the bacterium Chromobacterium violaceum with antineoplastic activity. After intracellular activation, romidepsin binds to and inhibits histone deacetylase (HDAC), resulting in alterations in gene expression and the induction of cell differentiation, cell cycle arrest, and apoptosis. This agent also inhibits hypoxia-induced angiogenesis and depletes several heat shock protein 90 (Hsp90)-dependent oncoproteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1544</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5342172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abatacept</VALIDVALUE>
          <VALUEMEANING>Abatacept</VALUEMEANING>
          <MEANINGDESCRIPTION>A soluble fusion protein consisting of the extracellular domain of human cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) linked to a modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1) with immunosuppressive activity. Abatacept binds CD80 and CD86 on antigen presenting cells (APCs), blocking interaction with CD28 on T lymphocytes, which initiates a co-stimulatory signal required for full activation of T lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ixazomib</VALIDVALUE>
          <VALUEMEANING>Ixazomib</VALUEMEANING>
          <MEANINGDESCRIPTION>An active metabolite of MLN9708, a second generation, boron containing peptide proteasome inhibitor (PI) with potential antineoplastic activity. Ixazomib binds to and inhibits the 20S catalytic core of the proteasome, thereby blocking the targeted proteolysis normally performed by the proteasome, which results in an accumulation of unwanted or misfolded proteins; disruption of various cell signaling pathways may follow, resulting in the induction of apoptosis. Compared to first generation PIs, second generation PIs may have an improved pharmacokinetic profile with increased potency and less toxicity. Proteasomes are large protease complexes that degrade unneeded or damaged proteins that have been ubiquinated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97940</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5944043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Photodynamic therapy</VALIDVALUE>
          <VALUEMEANING>Photodynamic therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Use of light activated drugs (photosensitizing agents) to kill cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPV vaccine</VALIDVALUE>
          <VALUEMEANING>Human Papilloma Virus Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant vaccine of different types of HPV proteins which are well-conserved within types with a significant inter-type variation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6847006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indole 3 carbinol</VALIDVALUE>
          <VALUEMEANING>Indole-3-Carbinol</VALUEMEANING>
          <MEANINGDESCRIPTION>A naturally occurring, orally available cleavage product of the glucosinolate glucobrassicanin, a natural compound present in a wide variety of plant food substances including members of the family Cruciferae with antioxidant and potential chemopreventive properties. Indole-3-carbinol scavenges free radicals and induces various hepatic cytochrome P450 monooxygenases. Specifically, this agent induces the hepatic monooxygenase cytochrome P4501A1 (CYP1A1), resulting in increased 2-hydroxylation of estrogens and increased production of the chemoprotective estrogen 2-hydroxyestrone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1135</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6847008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PBSCT, Allogeneic</VALIDVALUE>
          <VALUEMEANING>Allogeneic Peripheral Blood Stem Cell Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>Taken from different individuals of the same species.: Similar to bone marrow transplantation, peripheral stem cell transplantation is a method of replacing the blood-forming cells lost due to high-dose chemotherapy, and possibly radiation therapy, used to destroy leukemia cells. Certain immature circulating blood cells, similar to stem cells in the bone marrow, are removed before treatment. The cells are then given to the patient after treatment to help the bone marrow recover and continue producing healthy blood cells.  Transplantation may be autologous (the patient&#39;s own blood cells are used), allogeneic (blood cells are donated by someone else), or syngeneic (blood cells are donated by an identical twin).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15430, C28343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6847009</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CDX1127-01</VALIDVALUE>
          <VALUEMEANING>Varlilumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A human agonistic monoclonal antibody (MoAb) specific for CD27, with potential immunostimulating and antineoplastic activity. Upon administration of varlilumab, this MoAb binds to CD27 and may potentiate the immune response by increasing the cytotoxic T-lymphocyte (CTL) response against CD27-expressing tumor cells. This may lead to growth inhibition of CD27-expressing tumor cells. In addition, this agent may increase the proliferation and activation of antigen-specific T lymphocytes upon co-administration of TAA-containing vaccines, such as dendritic cell vaccines. CD27, a co-stimulatory molecule and member of the tumor necrosis factor family overexpressed in certain tumor cell types, is constitutively expressed on mature T-lymphocytes, memory B cells and natural killer cells and plays an important role in NK cell mediated cytolytic activity and T and B lymphocyte proliferation and activation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99127</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6847011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RO6958688</VALIDVALUE>
          <VALUEMEANING>Cibisatamab</VALUEMEANING>
          <MEANINGDESCRIPTION>An anti-carcinoembryonic antigen (CEA)/anti-CD3 bispecific monoclonal antibody with potential antineoplastic activity. Cibisatamab contains two antigen-recognition sites: one for human CD3, a T-cell surface antigen, and one for human CEA, a tumor-associated antigen that is specifically expressed on certain tumor cells. Upon intravenous administration, cibisatamab binds to both T-cells and CEA-expressing tumor cells, which cross-links the T-cells with the tumor cells. This may result in a potent cytotoxic T-lymphocyte (CTL) response against CEA-expressing tumor cells. CEA is overexpressed in many cancer cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6847013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apremilast</VALIDVALUE>
          <VALUEMEANING>Apremilast</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, small molecule inhibitor of phosphodiesterase 4 (PDE4), with potential anti-inflammatory activity. Upon oral administration, apremilast targets, binds to and inhibits the activity of PDE4, thereby blocking cyclic adenosine monophosphate (cAMP) degradation and increasing intracellular cAMP levels. This may decrease the production of the proinflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha). PDE4 is an enzyme that plays an important role in the degradation of cAMP and in cytokine production in inflammatory cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147044</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6847015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TCHP</VALIDVALUE>
          <VALUEMEANING>Docetaxel/Carboplatin/Trastuzumab/Pertuzumab Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of docetaxel, carboplatin, trastuzumab and pertuzumab, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C138047</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6005249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ETBX-051</VALIDVALUE>
          <VALUEMEANING>Adenoviral Brachyury Vaccine ETBX-051</VALUEMEANING>
          <MEANINGDESCRIPTION>A therapeutic cancer vaccine composed of a replication-defective, serotype 5 adenovirus (Ad5) with the viral genes early 1 (E1), early 2b (E2b), and early 3 (E3) deleted, and the human transcription factor brachyury encoded, with potential immunostimulating and antineoplastic activities. Upon subcutaneous administration, the adenoviral brachyury vaccine ETBX-051 expresses the brachyury protein. The expressed brachyury may induce a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells expressing brachyury, thereby resulting in both immune-mediated inhibition of tumor cell proliferation and tumor cell death. Deletion of the E1, E2b and E3 genes from Ad5 prevents anti-adenovirus immune responses. Brachyury, a tumor-associated antigen (TAA) and member of the T-box family of transcription factors, is overexpressed in a variety of tumor types. It plays an important role in cancer progression and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C143034</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6856470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ETBX-061</VALIDVALUE>
          <VALUEMEANING>Adenoviral MUC1 Vaccine ETBX-061</VALUEMEANING>
          <MEANINGDESCRIPTION>A therapeutic cancer vaccine composed of a replication-defective, serotype 5 adenovirus (Ad5) with the viral genes early 1 (E1), early 2b (E2b), and early 3 (E3) deleted, and the human glycoprotein mucin 1 (MUC1) encoded, with potential immunostimulating and antineoplastic activities. Upon subcutaneous administration, the adenoviral MUC1 vaccine ETBX-061 expresses the MUC1 protein. The expressed MUC1 may induce a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells expressing MUC1, thereby resulting in both immune-mediated inhibition of tumor cell proliferation and tumor cell death. Deletion of the E1, E2b and E3 genes from Ad5 prevents anti-adenovirus immune responses. MUC1, a tumor-associated antigen (TAA) and type I transmembrane protein, is overexpressed in a variety of tumor types. It plays an important role in cancer progression and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C143035</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6856472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Pemetrexed</VALIDVALUE>
          <VALUEMEANING>Pemetrexed-Cisplatin Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of pemetrexed and cisplatin used for the treatment of malignant mesothelioma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63788</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3557952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MVA/FPV-Brachyury-TRICOM</VALIDVALUE>
          <VALUEMEANING>MVA-BN-Brachyury-TRICOM Vaccine And FPV-Brachyury-TRICOM Vaccine Treatment Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer priming vaccine consisting of a proprietary version of the recombinant vaccinia viral vector, modified vaccinia Ankara-Bavarian Nordic (MVA-BN), encoding the human transcription factor and tumor-associated antigen (TAA) brachyury, and a triad of T-cell co-stimulatory molecules (TRICOM), which is comprised of the three human immune-enhancing co-stimulatory molecules B7-1, ICAM-1 and LFA-3, with potential immunostimulatory and antineoplastic activities. Upon subcutaneous administration of MVA-BN-brachyury vaccine, the vector expresses the brachyury protein. The expressed brachyury protein may induce a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells expressing brachyury. The MVA-BN-brachyury vaccine, which is a priming vaccine, is followed by multiple boosting doses of the fowlpox virus (FPV)-brachyury vaccine. The expression of brachyury, a member of the T-box family of transcription factors that is overexpressed in numerous cancer cell types, is correlated with increased epithelial-mesenchymal transition (EMT), cancer resistance, cancer progression and metastasis. TRICOM enhances antigen-specific T-cell activation.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A cancer vaccine consisting of a recombinant fowlpox viral (FPV) vector encoding the human transcription factor and tumor-associated antigen (TAA) brachyury, and a triad of T-cell co-stimulatory molecules (TRICOM), which is comprised of the three human immune-enhancing co-stimulatory molecules B7-1, ICAM-1 and LFA-3, with potential immunostimulatory and antineoplastic activities. Upon subcutaneous administration occurring after the administration of a proprietary modified vaccinia Ankara developed by Bavarian Nordic-based prime vaccine (MVA-BN-brachyury), the booster vaccine FPV-brachyury vaccine potentiates a cytotoxic T-lymphocyte (CTL) response against bra</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15697, C148402, C37912, C148400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6753165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guadecitabine</VALIDVALUE>
          <VALUEMEANING>Guadecitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A dinucleotide antimetabolite of a decitabine linked via phosphodiester bond to a guanosine, with potential antineoplastic activity. Following metabolic activation by phosphorylation and incorporation into DNA, guadecitabine inhibits DNA methyltransferase, thereby causing genome-wide and non-specific hypomethylation, and inducing cell cycle arrest at S-phase. This agent is resistant to cytidine deaminase, hence may result in gradual release of decitabine both extra and intracellularly, leading to more prolonged exposures to decitabine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6753167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide/Vincristine/Cisplatin/Etoposide</VALIDVALUE>
          <VALUEMEANING>COPE Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of cyclophosphamide, vincristine, cisplatin, and etoposide that may be used in the treatment of small cell lung cancer (SCLC).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9714</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7070277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CCNU/Bevacizumab</VALIDVALUE>
          <VALUEMEANING>Bevacizumab/Lomustine Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of bevacizumab and lomustine that can be used for the treatment of glioblastoma (GBM).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7070275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemotherapy (NOS)</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way._The use of synthetic or naturally-occurring chemicals for the treatment of diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15632, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6617617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Cyclophosphamide/Etoposide</VALIDVALUE>
          <VALUEMEANING>Cisplatin/Cyclophosphamide/Etoposide Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of Cisplatin, Cyclophosphamide, and Etoposide that can be used for the treatment of extensive-stage small cell lung cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7070278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vismodegib</VALIDVALUE>
          <VALUEMEANING>Vismodegib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable small molecule with potential antineoplastic activity. Hedgehog antagonist GDC-0449 targets the Hedgehog signaling pathway, blocking the activities of the Hedgehog-ligand cell surface receptors PTCH and/or SMO and suppressing Hedgehog signaling. The Hedgehog signaling pathway plays an important role in tissue growth and repair; aberrant constitutive activation of Hedgehog pathway signaling and uncontrolled cellular proliferation may be associated with mutations in the Hedgehog-ligand cell surface receptors PTCH and SMO.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74038</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GSK2256098</VALIDVALUE>
          <VALUEMEANING>FAK Inhibitor GSK2256098</VALUEMEANING>
          <MEANINGDESCRIPTION>A focal adhesion kinase-1 (FAK) inhibitor with potential antiangiogenic and antineoplastic activities. FAK inhibitor GSK2256098 inhibits FAK, which may prevent the integrin-mediated activation of several downstream signal transduction pathways, including ERK, JNK/MAPK and PI3K/Akt, thereby inhibiting tumor cell migration, proliferation and survival, and tumor angiogenesis. The tyrosine kinase FAK is normally activated by binding to integrins in the extracellular matrix (ECM) but may be upregulated and constitutively activated in various tumor cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88346</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7070279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HuMax-IL8</VALIDVALUE>
          <VALUEMEANING>Anti-IL-8 Monoclonal Antibody HuMax-IL8</VALUEMEANING>
          <MEANINGDESCRIPTION>A human monoclonal antibody against the pro-inflammatory mediator interleukin-8 (IL-8; CXCL8), with potential antineoplastic activities. Upon administration, HuMax-IL8 directly binds to IL-8, thereby inhibiting the binding of IL-8 to its receptors CXCR1 and CXCR2. This inhibits activation of IL-8-mediated signaling transduction pathways, which decreases proliferation of susceptible tumor cells. Also, HuMax-IL8 effectively blocks binding of IL-8 to neutrophils and inhibits neutrophil activation and recruitment towards sites of inflammation, which reduces inflammation. IL-8, a member of the CXC chemokine family, is upregulated in a variety of cancer cell types and inflammatory diseases; it plays a key role in tumor cell proliferation, endothelial cell proliferation, and cancer stem cell (CSC) renewal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7070281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MVA Brachyury-TRICOM vaccine</VALIDVALUE>
          <VALUEMEANING>Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer vaccine composed of a replication-deficient, attenuated derivative of the vaccinia virus strain Ankara expressing both a CD8+ T-cell epitope from the brachyury protein and a triad of T-cell co-stimulatory molecules (MVA Brachyury-TRICOM), with potential immunomodulating and antineoplastic activities. Upon subcutaneous administration of the brachyury-expressing modified vaccinia Ankara (MVA)-TRICOM vaccine, the expressed brachyury protein induces specific CD8+ and CD4+ T-cell responses against brachyury-expressing tumor cells. This causes both tumor cell lysis and a decrease in the growth of brachyury-expressing tumor cells. Brachyury, a member of the T-box family of transcription factors that is overexpressed in numerous cancer cell types, is correlated with increased epithelial-mesenchymal transition (EMT), cancer resistance and cancer progression. TRICOM, a triad of three human T-cell co-stimulatory molecules, B7.1, ICAM-1 and LFA-3, enhances antigen-specific T-cell activation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7070283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BXQ-350</VALIDVALUE>
          <VALUEMEANING>BXQ-350 Nanovesicle Formulation</VALUEMEANING>
          <MEANINGDESCRIPTION>A stable, nanovesicle formulation composed of a synthetic form of the human glycoprotein saposin C (SapC) linked to the phospholipid dioleoylphosphatidylserine (DOPS), with potential antineoplastic activity. Upon intravenous administration, the BXQ-350 nanovesicle formulation selectively targets and preferentially accumulates in tumor vessels and cells, due to the leaky nature of tumor vasculature and the presence of phosphatidylserine (PS) lipids in tumor cell membranes. Upon binding to the phospholipids in the tumor cell membrane, SapC fuses with the membrane and is internalized leading to its accumulation within the internal membrane. SapC becomes active in the acidic tumor microenvironment and as a lysosomal sphingolipid activator protein, activates lysosomal enzymes, such as beta-glucosidase, acid sphingomyelinase, and beta-galactosylceramidase. This leads to the degradation of glucosylceramide and sphingomyelin, and the conversion of galactosylceramide to ceramide, respectively. This elevates intracellular ceramide levels, activates caspases and induces ceramide-mediated apoptosis, which together lead to an inhibition of tumor cell growth. SapC plays key roles in lipid transport and organization of biological membranes and has strong lipid membrane binding activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7071769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Utomilumab</VALIDVALUE>
          <VALUEMEANING>Utomilumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A human, agonistic immunoglobulin (Ig) G2 monoclonal antibody (mAb) targeting 4-1BB (CD137, TNFRSF9), with potential immunostimulating activity. Upon administration, utomilumab binds to and activates 4-1BB expressed on various immune cells, such as CD8-positive and CD4-positive T cells and natural killer (NK) cells. This enhances 4-1BB-mediated signaling, induces cytokine production and promotes anti-tumor immune responses. 4-1BB, a member of the tumor necrosis factor (TNF)/nerve growth factor (NGF) family of receptors, plays an important role in the regulation of immune responses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7154920</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hATG (Horse Anti-thymocyte)</VALIDVALUE>
          <VALUEMEANING>Equine Thymocyte Immune Globulin (Atgam)</VALUEMEANING>
          <MEANINGDESCRIPTION>A purified, concentrated and sterile solution of horse-derived gamma globulin obtained by the immunization of horses with human T-lymphocytes, with T-cell depleting and immunosuppressive activities. Upon administration, horse anti-thymocyte globulin (hATG) specifically recognizes, modulates and destroys T-lymphocytes. Although the exact mechanism of action by which hATG causes immunosuppression is not completely understood, it is likely caused by a combination of T-lymphocyte depletion, reduction in T-cell activation and modulation of their cytotoxic activities. Administering of hATG prior to transplantation may reduce the risk of graft-versus-host disease (GvHD).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80824</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7094883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Siltuximab</VALIDVALUE>
          <VALUEMEANING>Siltuximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A chimeric, human-murine, monoclonal antibody targeting the pro-inflammatory cytokine interleukin 6 (IL-6), with antitumor and anti-inflammatory activities. Upon intravenous administration of siltuximab, this agent targets and binds to IL-6. This inhibits the binding of IL-6 to the IL-6 receptor (IL-6R), which results in the blockade of the IL-6/IL-6R-mediated signal transduction pathway. This inhibits cancer cell growth in tumors overexpressing IL-6.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61084</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Lomustine/Cytoxan/Mesna</VALIDVALUE>
          <VALUEMEANING>Cisplatin/Lomustine/Cyclophosphamide/Mesna</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of Cisplatin, Loumustine, Cyclophosphamide (Cytoxan), and Mesna.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7070292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-KRAS G12V PBL</VALIDVALUE>
          <VALUEMEANING>Anti-K-RAS G12V mTCR-transduced Autologous Peripheral Blood Lymphocytes</VALUEMEANING>
          <MEANINGDESCRIPTION>Autologous peripheral blood lymphocytes (PBLs) transduced with an HLA class I histocompatibility antigen A*11:01 (HLA-A1101)-restricted murine T-cell receptor (mTCR) that recognizes the glycine to valine point mutation at position 12 (G12V) variant of K-RAS, with potential antineoplastic activity. HLA-A1101 positive PBLs are harvested from a K-RAS G12V-expressing cancer patient and transfected with a retroviral vector that encodes anti-K-RAS G12V mTCR. The transduced PBLs are then expanded in culture. When reintroduced to the patient, these anti-K-RAS G12V mTCR-expressing PBLs target and bind to K-RAS G12V-overexpressing tumor cells, which results in both cytokine secretion and tumor cell lysis. K-RAS, a member of the RAS family of oncogenes, serves an important role in cell signaling, division and differentiation. Mutation of K-RAS may induce constitutive signal transduction leading to tumor cell growth, proliferation, invasion, and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142888</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7235715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-KRAS G12D PBL</VALIDVALUE>
          <VALUEMEANING>Anti-K-RAS G12D mTCR-transduced Autologous Peripheral Blood Lymphocytes</VALUEMEANING>
          <MEANINGDESCRIPTION>Autologous peripheral blood lymphocytes (PBLs) transduced with a retroviral vector encoding for an HLA class I histocompatibility antigen A*11:01 (HLA-A1101)-restricted murine T-cell receptor (mTCR) that recognizes the glycine (Gly, G) to aspartic acid (Asp, D) point mutation at position 12 (G12D) variant of K-RAS (KRAS), with potential immunomodulating and antineoplastic activities. HLA-A1101-positive PBLs are harvested from a K-RAS G12D-expressing cancer patient and transfected with a retroviral vector that encodes anti-K-RAS G12D mTCR. The transduced PBLs are then expanded in culture. When reintroduced to the patient, these anti-K-RAS G12D mTCR-expressing PBLs target and bind to K-RAS G12D-overexpressing tumor cells, which results in both cytokine secretion, including interferon-gamma (IFN-g), and tumor cell lysis. K-RAS, a member of the RAS family of oncogenes, serves an important role in cell signaling, division and differentiation. Mutation of K-RAS may induce constitutive signal transduction leading to tumor cell growth, proliferation, invasion, and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156889</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7235717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Midostaurin</VALIDVALUE>
          <VALUEMEANING>Midostaurin</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic indolocarbazole multikinase inhibitor with potential antiangiogenic and antineoplastic activities. Midostaurin inhibits protein kinase C alpha (PKCalpha), vascular endothelial growth factor receptor 2 (VEGFR2), c-kit, platelet-derived growth factor receptor (PDGFR) and FMS-like tyrosine kinase 3 (FLT3) tyrosine kinases, which may result in disruption of the cell cycle, inhibition of proliferation, apoptosis, and inhibition of angiogenesis in susceptible tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1872</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5805895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CD19/CD22 CAR-T</VALIDVALUE>
          <VALUEMEANING>Autologous Bispecific CD19/CD22-targeted CAR-T Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A preparation of autologous human T-lymphocytes engineered to express a chimeric T-cell receptor (chimeric antigen receptor or CAR) consisting of one or more binding domains targeting the tumor-associated antigens (TAAs) CD19 and CD22 and fused to one or more co-stimulatory TCR-signaling domains, with potential immunostimulating and antineoplastic activities. Upon administration, the autologous CD19/CD22 CAR T-cells bind to CD19 and CD22 on the surface of, and induce selective toxicity against, tumor cells expressing CD19 and CD22. CD19 and CD22, both transmembrane phosphoglycoproteins expressed on the surface of cells in the B lineage, are overexpressed on malignant B-cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7347497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Treosulfan</VALIDVALUE>
          <VALUEMEANING>Treosulfan</VALUEMEANING>
          <MEANINGDESCRIPTION>The prodrug of a bifunctional sulfonate alkylating agent with myeloablative, immunosuppressive, and antineoplastic activities. Under physiological conditions, treosulfan converts nonenzymatically to L-diepoxybutane via a monoepoxide intermediate. The monoepoxide intermediate and L-diepoxybutane alkylate DNA at guanine residues and produce DNA interstrand crosslinks, resulting in DNA fragmentation and apoptosis. In escalated doses, this agent also exhibits myeloablative and immunosuppressive activities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1257</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3922372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inotuzumab</VALIDVALUE>
          <VALUEMEANING>Inotuzumab Ozogamicin</VALUEMEANING>
          <MEANINGDESCRIPTION>A CD22-targeted cytotoxic immunoconjugate composed of a humanized IgG4 anti-CD22 antibody covalently linked to N-acetyl-gamma-calicheamicin dimethyl hydrazide (CalichDMH) with potential antineoplastic activity. Inotuzumab ozogamicin is rapidly internalized upon binding of the antibody moiety to B cell-specific CD22 receptors, delivering the conjugated CalichDMH intracellularly; the CalichDMH moiety binds to the minor groove of DNA in a sequence-specific manner, resulting in double-strand DNA breaks and apoptosis. CalichDMH is a derivative of gamma calicheamicin, a cytotoxic antibiotic produced by the bacterium Micromonospora echinospora.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5577157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erwinia</VALIDVALUE>
          <VALUEMEANING>Asparaginase Erwinia chrysanthemi</VALUEMEANING>
          <MEANINGDESCRIPTION>An enzyme isolated from the bacterium Erwinia chrysanthemi (E. carotovora). Asparagine is critical to protein synthesis in leukemic cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting leukemic cells of asparagine and blocking protein synthesis and tumor cell proliferation, especially in the G1 phase of the cell cycle.  This agent also induces apoptosis in tumor cells. The Erwinia-derived product is often used for those patients who have experienced a hypersensitivity reaction to the E. Coli formulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7331406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAR T-cell infusion with Kymriah</VALIDVALUE>
          <VALUEMEANING>CD19CAR-CD3zeta-4-1BB-expressing Autologous T-lymphocytes</VALUEMEANING>
          <MEANINGDESCRIPTION>Autologous T-lymphocytes transduced with a modified lentiviral vector expressing a chimeric antigen receptor (CAR) consisting of an anti-CD19 scFv (single chain variable fragment) and the zeta chain of the TCR/CD3 complex (CD3-zeta), coupled to the signaling domain of 4-1BB (CD137), with potential immunomodulating and antineoplastic activities. Upon transfusion, CD19CAR-CD3zeta-4-1BB-expressing autologous T-lymphocytes direct the T-lymphocytes to CD19-expressing tumor cells, thereby inducing a selective toxicity in CD19-expressing tumor cells. The 4-1BB co-stimulatory molecule signaling domain enhances activation and signaling after recognition of CD19 and the inclusion of this signaling domain may increase the antitumor activity compared to the inclusion of the CD3-zeta chain alone. CD19 antigen is a B-cell specific cell surface antigen expressed in all B-cell lineage malignancies. CD3-zeta (or CD247) is a transmembrane signaling adaptor polypeptide that regulates the assembly of complete TCR complexes and their expression on the cell surface.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CD19CAR</VALIDVALUE>
          <VALUEMEANING>Autologous CD19/CD22 Chimeric Antigen Receptor T-cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A preparation of autologous human T-lymphocytes engineered to express a chimeric T-cell receptor (chimeric antigen receptor or CAR) consisting of one or more binding domains targeting the tumor-associated antigens (TAAs) CD19 and CD22 and fused to one or more co-stimulatory TCR-signaling domains, with potential immunostimulating and antineoplastic activities. Upon administration, the autologous CD19/CD22 CAR T-cells bind to CD19 and CD22 on the surface of, and induce selective toxicity against, tumor cells expressing CD19 and CD22. CD19 and CD22, both transmembrane phosphoglycoproteins expressed on the surface of cells in the B lineage, are overexpressed on malignant B-cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7331408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymoglobulin</VALIDVALUE>
          <VALUEMEANING>Lapine T-Lymphocyte Immune Globulin</VALUEMEANING>
          <MEANINGDESCRIPTION>A preparation of purified, pasteurized, gamma globulin obtained by the immunization of rabbits with human thymocytes, with T-cell depleting and immunosuppressive activities. Upon administration, rabbit anti-thymocyte globulin (rATG) specifically recognizes, modulates and destroys T-lymphocytes. Although the exact mechanism of action by which rATG causes immunosuppression is not completely understood, it is likely caused by a combination of T-lymphocyte depletion and reduction in T-cell activation and their cytotoxic activities. Administering ATG with chemotherapy prior to stem cell transplantation may reduce the risk of graft-versus-host disease (GvHD).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7331410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Marquibo</VALIDVALUE>
          <VALUEMEANING>Vincristine Sulfate Liposome</VALUEMEANING>
          <MEANINGDESCRIPTION>A sphingomyelin/cholesterol liposomal formulation of vincristine sulfate with potential antineoplastic activity. Vincristine, a vinca alkaloid isolated from the plant Vinca rosea, irreversibly binds to and stabilizes tubulin, thereby interrupting microtubule assembly/disassembly dynamics, thereby preventing the formation of the mitotic spindle and leading to cell cycle arrest in metaphase. Liposomal encapsulation prolongs bioavailability of vincristine, increases its delivery to tumor tissues and reduces its toxicity profile. Compared to standard liposomal delivery, sphingosomal drug delivery further increases circulation time of serum drug and enhances drug accumulation at tumor sites, thereby leading to a further increase in efficacy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7331412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAR-T Infusion</VALIDVALUE>
          <VALUEMEANING>Chimeric Antigen Receptor T-Cell Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of treatment in which a patient&#39;s T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient&#39;s blood. Then the gene for a special receptor that binds to a certain protein on the patient&#39;s cancer cells is added in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. Chimeric antigen receptor T-cell therapy is being studied in the treatment of some types of cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7331413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MSB0011359C</VALIDVALUE>
          <VALUEMEANING>Bintrafusp Alfa</VALUEMEANING>
          <MEANINGDESCRIPTION>A bifunctional fusion protein composed of avelumab, an anti-programmed death ligand 1 (PD-L1) human monoclonal antibody, bound to the soluble extracellular domain of human transforming growth factor beta (TGFbeta) receptor type II (TGFbetaRII), with potential antineoplastic and immune checkpoint modulating activities. Upon administration, the TGFbetaRII moiety of bintrafusp alfa binds to and neutralizes TGFbeta while the avelumab moiety simultaneously binds to PD-L1. This prevents TGFbeta- and PD-L1-mediated signaling, and increases natural killer (NK) cell and cytotoxic T-lymphocyte (CTL) activities. This inhibits tumor cell proliferation in susceptible tumor cells. TGFbeta and PD-L1 are both upregulated in certain types of cancers; their overexpression is associated with increased evasion of immune surveillance and contributes to poor prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7405919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CV301</VALIDVALUE>
          <VALUEMEANING>CEA-MUC-1-TRICOM Vaccine CV301</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer prime/boost vaccine-based immunotherapeutic consisting of a prime, which is comprised of a proprietary version of the recombinant vaccinia viral vector, modified vaccinia Ankara-Bavarian Nordic (MVA-BN) and a recombinant fowlpox viral vector, used for the boosts, encoding both the two tumor-associated antigens (TAA), carcinoembryonic antigen (CEA) and mucin-1 (MUC-1), and TRICOM, which is comprised of three immune-enhancing co-stimulatory molecules, B7-1, ICAM-1 and LFA-3, with potential immunostimulatory and antineoplastic activities. The administration of the vaccinia priming dose is followed by multiple boosting doses of the fowlpox vector. CEA-MUC-1-TRICOM Vaccine CV301 may enhance presentation of CEA and MUC-1 to antigen-presenting cells (APCs) and may activate a cytotoxic T-lymphocyte (CTL) response against CEA- and MUC-1-expressing tumor cells. In addition, CV301 upregulates the expression of PD-L1 due to CTL-mediated tumor attack; additionally, when combined with a PD-1 immune checkpoint inhibitor, the antitumor effect may be increased. CEA and MUC-1 are overexpressed in certain cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7405921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostvac</VALIDVALUE>
          <VALUEMEANING>Rilimogene Galvacirepvec/Rilimogene Glafolivec</VALUEMEANING>
          <MEANINGDESCRIPTION>A vaccine formulation consisting of rilimogene galvacirepvec (V-PSA-TRICOM; PROSTVAC-V), a recombinant vaccinia virus, and rilimogene glafolivec (F-PSA-TRICOM; PROSTVAC-F), a recombinant fowlpox virus, with potential immunostimulating and antineoplastic activities. Both viruses encode modified forms of human prostate specific antigen (PSA) and the three co-stimulatory molecule transgenes (TRIad of COstimulatory Molecules; TRICOM), B7.1 (CD80), intercellular adhesion molecule-1 (ICAM-1), and lymphocyte function-associated antigen-3 (LFA-3). Using a prime-boost vaccine regimen, with a primary vaccination of rilimogene galvacirepvec followed by multiple booster vaccinations of rilimogene glafolivec, the PSA-TRICOM vaccines infect antigen-presenting cells (APCs), such as dendritic cells (DCs). Upon processing and expression of the PSA and TRICOM proteins on their surfaces, the DCs are able to initiate cytotoxic T-lymphocyte (CTL) responses against PSA-expressing cancer cells. The combination of PSA and TRICOM greatly enhances T-cell activation and T-cell-mediated tumor cell killing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7405923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cabiralizumab</VALIDVALUE>
          <VALUEMEANING>Cabiralizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against the tyrosine kinase receptor colony stimulating factor 1 receptor (CSF1R; CSF-1R), also known as macrophage colony-stimulating factor receptor (M-CSFR) and CD115 (cluster of differentiation 115), with potential antineoplastic activity. Upon administration, anti-CSF1R monoclonal antibody FPA008 binds to CSF1R expressed on monocytes, macrophages, and osteoclasts and inhibits the binding of the CSF1R ligands colony-stimulating factor-1 (CSF-1) and interleukin-34 (IL-34), to CSF1R. This prevents CSF1R activation and CSF1R-mediated signaling in these cells. This blocks the production of inflammatory mediators by macrophages and monocytes and reduces inflammation. By blocking the recruitment to the tumor microenvironment and activity of CSF1R-dependent tumor-associated macrophages (TAMs), FPA008 enhances T-cell infiltration and antitumor T-cell immune responses, which inhibits the proliferation of tumor cells. Additionally, FPA008 prevents the activation of osteoclasts and blocks bone destruction. TAMs play key roles in immune suppression and promoting inflammation, tumor cell proliferation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123831</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7431039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Samrotamab Vedotin</VALIDVALUE>
          <VALUEMEANING>Samrotamab Vedotin</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody-drug conjugate (ADC) composed of a proprietary monoclonal antibody against a tumor-associated antigen (TAA) linked to an as of yet undisclosed cytotoxic agent, with potential antineoplastic activity. Upon intravenous administration, the monoclonal antibody moiety of ABBV-085 targets and binds to the TAA expressed on tumor cells. Upon binding and internalization, the cytotoxic agent is released and kills the TAA-expressing cancer cells, through an as of yet unknown mechanism of action.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124134</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7431041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pegaspargase</VALIDVALUE>
          <VALUEMEANING>Pegaspargase</VALUEMEANING>
          <MEANINGDESCRIPTION>A complex of polyethylene glycol conjugated with L-asparaginase.  Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting these cells of asparagine and blocking protein synthesis and tumor cell proliferation, especially in the G1 phase of the cell cycle.  The agent also induces apoptosis in tumor cells. Pegylation decreases the enzyme&#39;s antigenicity. Asparagine is critical to protein synthesis in leukemic cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1200</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pembrolizumab</VALIDVALUE>
          <VALUEMEANING>Pembrolizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal immunoglobulin (Ig) G4 antibody directed against human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1) with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, pembrolizumab binds to PD-1, an inhibitory signaling receptor expressed on the surface of activated T cells, and blocks the binding to and activation of PD-1 by its ligands, which results in the activation of T-cell-mediated immune responses against tumor cells. The ligands for PD-1 include programmed cell death ligand 1 (PD-L1), overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on APCs. Activated PD-1 negatively regulates T-cell activation and plays a key role in in tumor evasion from host immunity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5076693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Duvelisib</VALIDVALUE>
          <VALUEMEANING>Duvelisib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. Upon administration, duvelisib prevents the activation of the PI3K delta/gamma-mediated signaling pathways which may lead to a reduction in cellular proliferation in PI3K delta/gamma-expressing tumor cells. Unlike other isoforms of PI3K, the delta and gamma isoforms are overexpressed primarily in hematologic malignancies and inflammatory and autoimmune diseases. By selectively targeting these PI3K isoforms, PI3K signaling in normal, non-neoplastic cells is minimally or not affected which would result in a more favorable side effect profile.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7464061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AVD</VALIDVALUE>
          <VALUEMEANING>AVD Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of doxorubicin, vinblastine and dacarbazine that can be used for the treatment of Hodgkin lymphoma (HL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140093</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6002270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aminocaproic Acid</VALIDVALUE>
          <VALUEMEANING>Aminocaproic Acid</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic lysine derivative with antifibrinolytic activity. Aminocaproic acid competitively inhibits activation of plasminogen, thereby reducing conversion of plasminogen to plasmin (fibrinolysin), an enzyme that degrades fibrin clots as well as fibrinogen and other plasma proteins including the procoagulant factors V and VIII. Aminocaproic acid competitively reduces the conversion of plasminogen to plasmin by plasminogen activators. It directly inhibits proteolytic activity of plasmin, but higher doses are required than are needed to reduce plasmin formation. Aminocaproic acid is used in the treatment of hemorrhage and prophylactically against hemorrhage, including hyperfibrinolysis-induced hemorrhage and postsurgical hemorrhage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3128754</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meloxicam</VALIDVALUE>
          <VALUEMEANING>Meloxicam</VALUEMEANING>
          <MEANINGDESCRIPTION>An oxicam derivative and a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activities. Unlike traditional nonselective NSAIDs, meloxicam preferentially inhibits the activity of cyclo-oxygenase II (COX-II), resulting in a decreased conversion of arachidonic acid into prostaglandin precursors. The resulting decrease in prostaglandin synthesis is responsible for the therapeutic effects of meloxicam.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polysulfated Glycosaminoglycan</VALIDVALUE>
          <VALUEMEANING>Polysulfated Glycosaminoglycan (Adequan Canine, PSGAG)</VALUEMEANING>
          <MEANINGDESCRIPTION>A semi-synthetic glycosaminoglycan (GAG) prepared by extracting GAGs from bovine tracheal cartilage and consisting of mostly chondroitin sulfate, with anti-arthritic activities in animals including dogs. Upon administration, polysulfated GAG (PSGAG), a proteolytic enzyme inhibitor, may inhibit various processes that lead to the loss of cartilaginous mucopolysaccharides. This may include the inhibition of interleukin-1 (IL-1)-mediated inflammation and degradation of cartilage proteoglycans and collagen. PSGAG may also stimulate the synthesis of protein, collagen, proteoglycans, and hyaluronic acid, which may improve joint function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C175559</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7485295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Isatuximab</VALIDVALUE>
          <VALUEMEANING>Isatuximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized IgG1 monoclonal antibody directed against the cell surface glycoprotein CD-38 with potential antineoplastic activity. Isatuximab specifically binds to CD38 on CD38-positive tumor cells. This may trigger antitumoral antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC) and apoptosis eventually leading to cell lysis in CD38-expressing tumor cells. CD38, a type II transmembrane glycoprotein, is present on various immune cells and hematologic malignancies, and its expression has been correlated with poor prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90578</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6618086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dubermatinib</VALIDVALUE>
          <VALUEMEANING>Dubermatinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available and selective inhibitor of the receptor tyrosine kinase AXL (UFO), with potential antineoplastic activity. Upon administration, dubermatinib targets and binds to AXL and prevents its activity. This blocks AXL-mediated signal transduction pathways and inhibits the epithelial-mesenchymal transition (EMT), which, in turn, inhibits tumor cell proliferation and migration. In addition, TP-0903 enhances chemo-sensitivity to certain other chemotherapeutic agents. AXL, a member of the Tyro3, AXL and Mer (TAM) family of receptor tyrosine kinases and overexpressed by many tumor cell types, plays a key role in tumor cell proliferation, survival, invasion and metastasis; its expression is associated with drug resistance and poor prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-05-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7656772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sotorasib</VALIDVALUE>
          <VALUEMEANING>Sotorasib (AMG510)</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available inhibitor of the specific KRAS mutation, p.G12C, with potential antineoplastic activity. Upon oral administration, sotorasib selectively targets, binds to and inhibits the activity of the KRAS p.G12C mutant. This may inhibit growth in KRAS p.G12C-expressing tumor cells. The KRAS p.G12C mutation is seen in some tumor cell types and plays a key role in tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154287</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-05-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7656774</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eltrombopag</VALIDVALUE>
          <VALUEMEANING>Eltrombopag</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally active thrombopoietin receptor agonist with megakaryopoiesis stimulating activity. Eltrombopag binds to and stimulates the platelet thrombopoietin receptor (TPO-R or CD110), a member of the hematopoietin receptor superfamily. Activation of TPO-R leads to the proliferation and differentiation of megakaryocytes, thereby increasing the production of blood platelets.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-05-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3173720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Encorafenib</VALIDVALUE>
          <VALUEMEANING>Encorafenib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available Raf kinase inhibitor with potential antineoplastic activity. Encorafenib specifically inhibits Raf kinase, a serine/threonine enzyme in the RAF/mitogen-activated protein kinase kinase (MEK)/extracellular signal-related kinase (ERK) signaling pathway. By inhibiting the activation of the RAF/MEK/ERK signaling pathway, the administration of LGX818 may result in a decrease in proliferation of tumor cells. The Raf mutation BRAF V600E is frequently upregulated in a variety of human tumors and results in the constitutive activation of the RAF/MEK/ERK signaling pathway that regulates cellular proliferation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98283</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-06-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7679543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mogamulizumab</VALIDVALUE>
          <VALUEMEANING>Mogamulizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against C-C chemokine receptor 4 (CCR4) with potential anti-inflammatory and antineoplastic activities. Mogamulizumab selectively binds to and blocks the activity of CCR4, which may inhibit CCR4-mediated signal transduction pathways and, so, chemokine-mediated cellular migration and proliferation of T cells, and chemokine-mediated angiogenesis. In addition, this agent may induce antibody-dependent cell-mediated cytotoxicity (ADCC) against CCR4-positive T cells. CCR4, a G-coupled-protein receptor for C-C chemokines such MIP-1, RANTES, TARC and MCP-1, is expressed on the surfaces of some types of T cells, endothelial cells, and some types of neurons. CCR4, also known as CD194, may be overexpressed on adult T-cell lymphoma (ATL) and peripheral T-cell lymphoma (PTCL) cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-04-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5944042</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HiDAC</VALIDVALUE>
          <VALUEMEANING>High-Dose Cytarabine Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of high-dose cytarabine that may be used in the treatment of acute myeloid leukemia (AML) and primary central nervous system (CNS) lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7775255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enfortumab Vedotin</VALIDVALUE>
          <VALUEMEANING>Enfortumab Vedotin</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody drug conjugate (ADC) containing a human monoclonal antibody AGS-22 targeting the cell adhesion molecule nectin-4 and conjugated to the cytotoxic agent monomethyl auristatin E (MMAE), via a proprietary enzyme-cleavable linker (AGS-22CE), with potential antineoplastic activity. The monoclonal antibody moiety of enfortumab vedotin selectively binds to nectin-4. After internalization and proteolytic cleavage, MMAE binds to tubulin and inhibits its polymerization, which results in G2/M phase arrest and induces apoptosis in nectin-4 overexpressing tumor cells. Nectin-4, a tumor associated antigen belonging to the nectin family, is overexpressed in a variety of cancers, including breast, bladder, lung and pancreatic cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-08-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7775224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erdafitinib</VALIDVALUE>
          <VALUEMEANING>Erdafitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity. Upon oral administration, erdafitinib binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal transduction pathways and thus the inhibition of tumor cell proliferation and tumor cell death in FGFR-overexpressing tumor cells. FGFR, upregulated in many tumor cell types, is a receptor tyrosine kinase essential to tumor cell proliferation, differentiation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-08-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7775226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sacituzumab</VALIDVALUE>
          <VALUEMEANING>Sacituzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C152280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7792993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TEDDI-R</VALIDVALUE>
          <VALUEMEANING>Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R)</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemoimmunotherapy regimen consisting of dexamethasone, pegylated liposomal doxorubicin, etoposide, ibrutinib, rituximab and temozolomide that may be used in the treatment of central nervous system (CNS) lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C180769</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7740110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Idelalisib</VALIDVALUE>
          <VALUEMEANING>Idelalisib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, small molecule inhibitor of the delta isoform of the 110 kDa catalytic subunit of class I phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities.  Idelalisib inhibits the production of the second messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3), preventing the activation of the PI3K signaling pathway and inhibiting tumor cell proliferation, motility, and survival. Unlike other isoforms of PI3K, PI3K-delta is expressed primarily in hematopoietic lineages. The targeted inhibition of PI3K-delta is designed to preserve PI3K signaling in normal, non-neoplastic cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polatuzumab Vedotin</VALIDVALUE>
          <VALUEMEANING>Polatuzumab Vedotin</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against B-cell antigen receptor complex-associated protein beta chain (CD79B) conjugated, via a protease-cleavable peptide linker, to monomethyl auristatin E (MMAE), an auristatin derivative and a potent microtubule inhibitor, with potential antineoplastic activity.  Upon administration, the monoclonal antibody moiety of polatuzumab vedotin selectively binds to CD79B, a protein which is abundantly expressed on the surface of B-cells. Upon internalization and proteolytic cleavage, MMAE binds to tubulin and inhibits its polymerization, resulting in G2/M phase arrest and tumor cell apoptosis. CD79B, a component of the B-cell receptor (BCR), plays a key role in B-cell receptor signaling and is expressed on the surface of almost all types of malignant B-cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104153</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7739453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SIRPa-IgG4-Fc Fusion Protein TTI-622</VALIDVALUE>
          <VALUEMEANING>SIRPa-IgG4-Fc Fusion Protein TTI-622</VALUEMEANING>
          <MEANINGDESCRIPTION>A soluble recombinant antibody-like fusion protein composed of the N-terminal CD47 binding domain of human signal-regulatory protein alpha (SIRPa; CD172a) linked to an Fc domain derived from human immunoglobulin G subtype 4 (IgG4), with potential immune checkpoint inhibitory, phagocytosis-inducing and antineoplastic activities. Upon administration, the SIRPa-IgG4-Fc fusion protein TTI-622 selectively targets and binds to CD47 expressed on tumor cells and blocks the interaction of CD47 with endogenous SIRPa, a cell surface protein expressed on macrophages. This prevents CD47/SIRPa-mediated signaling and abrogates the CD47/SIRPa-mediated inhibition of macrophage activation. This induces pro-phagocytic signaling resulting from the binding of calreticulin (CRT), which is specifically expressed on the surface of tumor cells, to low-density lipoprotein (LDL) receptor-related protein-1 (LRP-1) expressed on macrophages, and results in macrophage activation and the specific phagocytosis of tumor cells. CD47, also called integrin-associated protein (IAP), is a tumor-associated antigen (TAA) expressed on normal, healthy hematopoietic stem cells (HSC) and overexpressed on the surface of a variety of cancer cells. Expression of CD47, and its interaction with SIRPa, leads to the inhibition of macrophage activation and protects tumor cells from phagocytosis, thereby allowing these cells to proliferate and survive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7739455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TEDD-R</VALIDVALUE>
          <VALUEMEANING>Temozolomide, Etoposide, Doxil, Dexamethasone and Rituximab (TEDD-R)</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemoimmunotherapy regimen consisting of dexamethasone, pegylated liposomal doxorubicin, etoposide, rituximab and temozolomide that may be used in the treatment of central nervous system (CNS) lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C180731</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7736635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lurbinectedin</VALIDVALUE>
          <VALUEMEANING>Lurbinectedin</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic tetrahydropyrrolo [4, 3, 2-de]quinolin-8(1H)-one alkaloid analogue with potential antineoplastic activity. Lurbinectedin covalently binds to residues lying in the minor groove of DNA, which may result in delayed progression through S phase, cell cycle arrest in the G2/M phase and cell death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7685533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Avapritinib</VALIDVALUE>
          <VALUEMEANING>Avapritinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of specific mutated forms of platelet-derived growth factor receptor alpha (PDGFR alpha; PDGFRa) and mast/stem cell factor receptor c-Kit (SCFR), with potential antineoplastic activity. Upon oral administration, avapritinib specifically binds to and inhibits specific mutant forms of PDGFRa and c-Kit, including the PDGFRa D842V mutant and various KIT exon 17 mutants. This results in the inhibition of PDGFRa- and c-Kit-mediated signal transduction pathways and the inhibition of proliferation in tumor cells that express these PDGFRa and c-Kit mutants. PDGFRa and c-Kit, protein tyrosine kinases and tumor-associated antigens (TAAs), are mutated in various tumor cell types; they play key roles in the regulation of cellular proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123827</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7685535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ripretinib</VALIDVALUE>
          <VALUEMEANING>Ripretinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable switch pocket control inhibitor of wild-type and mutated forms of the tumor-associated antigens (TAA) mast/stem cell factor receptor (SCFR) KIT and platelet-derived growth factor receptor alpha (PDGFR-alpha; PDGFRa), with potential antineoplastic activity. Upon oral administration, ripretinib targets and binds to both wild-type and mutant forms of KIT and PDGFRa specifically at their switch pocket binding sites, thereby preventing the switch from inactive to active conformations of these kinases and inactivating their wild-type and mutant forms. This abrogates KIT/PDGFRa-mediated tumor cell signaling and prevents proliferation in KIT/PDGFRa-driven cancers. DCC-2618 also inhibits several other kinases, including vascular endothelial growth factor receptor type 2 (VEGFR2; KDR), angiopoietin-1 receptor (TIE2; TEK), PDGFR-beta and macrophage colony-stimulating factor 1 receptor (FMS; CSF1R), thereby further inhibiting tumor cell growth. KIT and PDGFRa are tyrosine kinase receptors that are upregulated or mutated in a variety of cancer cell types; mutated forms play a key role in the regulation of tumor cell proliferation and resistance to chemotherapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124067</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7685537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acalabrutinib</VALIDVALUE>
          <VALUEMEANING>Acalabrutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available inhibitor of Bruton&#39;s tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, acalabrutinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6028593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antiandrogen Therapy (ADT)</VALIDVALUE>
          <VALUEMEANING>Antiandrogen Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment with drugs used to block production or interfere with the action of male sex hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5053421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rilimogene Glafolivec</VALIDVALUE>
          <VALUEMEANING>Rilimogene Glafolivec</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer vaccine consisting of a recombinant fowlpox virus encoding fragment of human prostate-specific antigen (PSA), PSA:154-163 (155L), and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM).  Administration of this agent may induce a cytotoxic T cell response against PSA-expressing tumor cells. Dendritic cells infected with TRICOM vectors greatly enhance naive T-cell activation and peptide-specific T-cell stimulation. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8024222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rilimogene Galvacirepvec</VALIDVALUE>
          <VALUEMEANING>Rilimogene Galvacirepvec</VALUEMEANING>
          <MEANINGDESCRIPTION>A vaccine formulation consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA) and recombinant vaccinia virus encoding three co-stimulatory molecule transgenes B7.1, ICAM-1, and LFA-3 (TRICOM). Vaccination with PSA in combination with TRICOM may enhance antigen presentation, resulting in the augmentation of a cytotoxic T cell (CTL) immune response against tumor cells expressing PSA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6159909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CXCR1/2 Inhibitor SX-682</VALIDVALUE>
          <VALUEMEANING>CXCR1/2 Inhibitor SX-682</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, selective and reversible antagonist of C-X-C motif chemokine receptors 1 (CXCR1) and 2 (CXCR2), with potential anti-inflammatory and antineoplastic activities. Upon administration CXCR1/2 inhibitor SX-682 selectively and allosterically binds to CXCR 1 and 2 and inhibits their activation by tumor-secreted chemokines. This inhibits CXCR1/2-mediated signaling, reduces both recruitment and migration of immunosuppressive myeloid-derived suppressor cells (MDSCs) and neutrophils in the tumor microenvironment (TME), inhibits inflammatory processes and abrogates the immunosuppressive-induced nature of the TME. This allows effector cells, such as natural killer (NK) cells and cytotoxic T-lymphocytes (CTLs), to kill and eliminate cancer cells. This inhibits tumor cell migration, metastasis, angiogenesis and tumor cell proliferation. CXCR1 and 2, G protein-coupled receptor proteins located on myeloid cells and certain tumor cells, play key roles in the immunosuppressive nature of the TME, tumor metastasis, therapy-resistance and myeloid cell suppression. They play a key role in inflammation and their expression is elevated in several inflammatory-driven diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-02-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8049068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ivosidenib</VALIDVALUE>
          <VALUEMEANING>Ivosidenib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1), with potential antineoplastic activity. Upon administration, AG-120 specifically inhibits a mutated form of IDH1 in the cytoplasm, which inhibits the formation of the oncometabolite, 2-hydroxyglutarate (2HG). This may lead to both an induction of cellular differentiation and an inhibition of cellular proliferation in IDH1-expressing tumor cells. IDH1, an enzyme in the citric acid cycle, is mutated in a variety of cancers; it initiates and drives cancer growth by both blocking cell differentiation and catalyzing the formation of 2HG.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ALT-803</VALIDVALUE>
          <VALUEMEANING>Nogapendekin Alfa</VALUEMEANING>
          <MEANINGDESCRIPTION>A fusion protein complex composed of a mutated form of the cytokine interleukin (IL)-15 (IL-15N72D) and a soluble, dimeric IL-15 receptor alpha (IL-15Ra) Fc fusion protein (IL-15Ra-Fc) (IL-15N72D/IL-15Ra-Fc), with potential antineoplastic activity. Upon administration, superagonist interleukin-15:interleukin-15 receptor alphaSu/Fc fusion complex ALT-803 binds to the IL-2/IL-15 receptor beta-common gamma chain (IL-2Rbetagamma) receptor on natural killer (NK) and CD8+ T lymphocytes, which activates and increases the levels of NK cells and memory CD8+(CD44high) T-cells. The memory T-cells enhance the secretion of the cytokine interferon-gamma (IFN-g), which further potentiates the immune response against tumor cells. This may increase tumor cell killing and decrease tumor cell proliferation. IL-15 regulates CD8+ T and NK cell development, activation and proliferation. By coupling IL-15 to IL15Ra-Fc, this agent has a prolonged drug half-life and shows an increased ability to bind IL-2Rbetagamma, which enhances its immune stimulatory activity as compared to IL-15 alone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6004367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CALGB 10403 Regimen</VALIDVALUE>
          <VALUEMEANING>CALGB 10403 Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>CALGB 10403 Regimen</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-07-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10694589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apalutamide</VALIDVALUE>
          <VALUEMEANING>Apalutamide</VALUEMEANING>
          <MEANINGDESCRIPTION>A small molecule and androgen receptor (AR) antagonist with potential antineoplastic activity. Apalutamide binds to AR in target tissues thereby preventing androgen-induced receptor activation and facilitating the formation of inactive complexes that cannot be translocated to the nucleus. This prevents binding to and transcription of AR-responsive genes. This ultimately inhibits the expression of genes that regulate prostate cancer cell proliferation and may lead to an inhibition of cell growth in AR-expressing tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5811375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Darolutamide</VALIDVALUE>
          <VALUEMEANING>Darolutamide</VALUEMEANING>
          <MEANINGDESCRIPTION>A formulation containing an androgen receptor (AR) antagonist with potential antineoplastic activity. Darolutamide binds to ARs in target tissues; subsequently, inhibiting androgen-induced receptor activation and facilitating the formation of inactive complexes that cannot translocate to the nucleus. This prevents binding to and transcription of AR-responsive genes that regulate prostate cancer cell proliferation. This ultimately leads to an inhibition of growth in AR-expressing prostate cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6159883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Belumosudil</VALIDVALUE>
          <VALUEMEANING>Belumosudil</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally administered inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2; ROCK-II), with potential immunomodulating activity. Upon administration, belumosudil binds to and inhibits the serine/threonine kinase activity of ROCK2. This inhibits ROCK2-mediated signal transduction pathways and modulates various pro- and anti-inflammatory immune cell responses. ROCK2 is upregulated in various diseases, including various fibrotic, neurodegenerative and autoimmune diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7614732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Darunavir Ethanolate/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate</VALIDVALUE>
          <VALUEMEANING>Darunavir Ethanolate/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate</VALUEMEANING>
          <MEANINGDESCRIPTION>A four-drug fixed combination of the ethanolate salt form of darunavir, a human immunodeficiency virus type 1 (HIV-1) protease nonpeptidic inhibitor; cobicistat, a cytochrome P450 3A (CYP3A) inhibitor; emtricitabine, a nucleoside reverse transcriptase (RT) inhibitor (NRTI) analog of cytidine; and tenofovir alafenamide fumarate, the fumarate salt form of the lipophilic phosphonamidate prodrug of tenofovir, a NRTI analog of adenosine monophosphate, that is used to treat human immunodeficiency virus (HIV) infection. Upon oral administration of darunavir ethanolate/cobicistat/emtricitabine/tenofovir alafenamide fumarate, darunavir selectively targets and binds to the active site of HIV-1 protease and inhibits the dimerization and catalytic activity of HIV-1 protease. This inhibits the proteolytic cleavage of viral Gag and Gag-Pol polyproteins in HIV-infected cells. This inhibition leads to the production of immature, non-infectious viral proteins that are unable to form mature virions, and prevents HIV replication. Cobicistat inhibits CYP3A, thereby limiting the oxidative metabolism of darunavir and increases its systemic exposure. Emtricitabine and tenofovir alafenamide, after being converted in vivo to tenofovir, inhibit the activity of HIV RT by competing with natural deoxyribonucleosides for incorporation into the growing viral DNA chain and resulting in early chain termination. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C173644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11289980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dolutegravir Sodium/Rilpivirine Hydrochloride</VALIDVALUE>
          <VALUEMEANING>Dolutegravir Sodium/Rilpivirine Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed two-agent combination of the sodium salt form of dolutegravir, a human immunodeficiency virus type 1 (HIV-1) integrase strand-transfer inhibitor (INSTI) and the hydrochloride salt form of rilpivirine, a non-nucleoside reverse transcriptase (RT) inhibitor (NNRTI), that may be used to treat HIV infection. Upon oral administration of dolutegravir sodium/rilpivirine hydrochloride, dolutegravir binds to the active site of integrase, an HIV enzyme that catalyzes the transfer of viral genetic material into human chromosomes. This prevents integrase from binding to retroviral deoxyribonucleic acid (DNA), and blocks the strand transfer step, which is essential for the HIV replication cycle. Rilpivirine binds to HIV RT, thereby blocking RNA and DNA-dependent DNA polymerase activities including viral replication, thereby further preventing HIV-1 replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11289984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Molnupiravir </VALIDVALUE>
          <VALUEMEANING>Molnupiravir</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable prodrug of EIDD-1931, the synthetic ribonucleoside derivative N4-hydroxycytidine and ribonucleoside analog, with potential antiviral activity against a variety of RNA viruses. Upon oral administration, molnupiravir, being a prodrug, is metabolized into its active form EIDD-1931 and converted into its triphosphate (TP) form. The TP form of EIDD-1931 is incorporated into RNA and inhibits the action of viral RNA-dependent RNA polymerase. This results in the termination of RNA transcription and decreases viral RNA production, and viral RNA replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172633</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8062014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Imipenem-Cilastatin-Relebactam</VALIDVALUE>
          <VALUEMEANING>Imipenem-Cilastatin-Relebactam</VALUEMEANING>
          <MEANINGDESCRIPTION>A parenteral antibiotic preparation containing imipenem, cilastatin sodium and relebactam, with bactericidal activity. Imipenem, a broad spectrum beta-lactam carbapenem antibiotic, binds to and inactivates penicillin-binding proteins (PBP) on the inner membrane of the bacterial cell wall, thereby interfering with the cross-linkage of peptidoglycan chains critical for bacterial cell wall strength and rigidity. Cilastatin sodium, a renal dehydropeptidase inhibitor, reduces the breakdown of imipenem by renal dehydropeptidase. Relebactam, a beta-lactamase inhibitor, reduces the breakdown of imipenem by certain serine beta-lactamases among gram-negative bacteria. Imipenem is active against a wide range of gram-positive and gram-negative organisms, and the imipenem, cilastatin sodium and relebactam combination may be used to treat infections caused by resistant gram-negative bacteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181013</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11289981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tedizolid</VALIDVALUE>
          <VALUEMEANING>Tedizolid</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7094876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meropenem Trihydrate/Vaborbactam</VALIDVALUE>
          <VALUEMEANING>Meropenem Trihydrate/Vaborbactam</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed two-agent injectable combination of the trihydrate form of meropenem, a broad-spectrum synthetic beta-lactam carbapenem antibiotic, and vaborbactam, a cyclic boronic acid beta-lactamase inhibitor, with antibacterial activity against susceptible bacteria. Upon administration of meropenem trihydrate/vaborbactam, meropenem binds to and inactivates penicillin-binding proteins (PBPs) on the inner membrane of the bacterial cell wall, thereby interfering with the cross-linkage of peptidoglycan chains critical for bacterial cell wall strength and rigidity. This interrupts bacterial cell wall synthesis and results in the weakening of the bacterial cell wall and causes cell lysis. Vaborbactam binds to and inhibits beta-lactamase, thereby inhibiting the breakdown of meropenem, and increases the activity and therapeutic effect of meropenem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189976</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11289982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetaminophen/Tramadol</VALIDVALUE>
          <VALUEMEANING>Acetaminophen/Tramadol (Tramacet)</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination preparation of the non-opiate, non-salicylate analgesic acetaminophen and the centrally acting synthetic opioid analgesic tramadol, with analgesic activity. Upon oral administration, acetaminophen exerts its analgesic activity by inhibiting prostaglandin synthesis, while tramadol exerts its analgesic activity by multiple mechanisms including the binding to the mu-opioid receptors in the central nervous system (CNS) and the weak inhibition of norepinephrine and serotonin reuptake.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C190844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12093849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enclomiphene Citrate</VALIDVALUE>
          <VALUEMEANING>Enclomiphene Citrate (Androxal)</VALUEMEANING>
          <MEANINGDESCRIPTION>The orally bioavailable citrate salt of enclomiphene, the trans-isomer of the nonsteroidal triphenylethylene compound clomiphene, with tissue-selective estrogenic and antiestrogenic activities. As a selective estrogen receptor modulator (SERM), enclomiphene binds to hypothalamic estrogen receptors, blocking the negative feedback of endogenous estrogens and stimulating the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus; released GnRH subsequently stimulates the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary, resulting in ovulation. In addition, this agent may bind to estrogen receptors on breast cancer cells, resulting in the inhibition of estrogen-stimulated proliferation in susceptible cell populations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12093850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ibutamoren Mesylate</VALIDVALUE>
          <VALUEMEANING>Ibutamoren Mesylate (Nutrobal)</VALUEMEANING>
          <MEANINGDESCRIPTION>The mesylate salt form of ibutamoren, an orally bioavailable, small molecule, non-peptide growth hormone secretagogue (GHS). Upon administration, ibutamoren promotes the release of growth hormone (GH) from the pituitary gland, thereby increasing plasma GH levels. This may counteract GH deficiency. GH plays an important role in many biological processes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12093851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methionine/Inositol/Choline Chloride/Cyanocobalamin Injection</VALIDVALUE>
          <VALUEMEANING>Methionine/Inositol/Choline Chloride/Cyanocobalamin Injection (Lipo-B (MIC) injection)</VALUEMEANING>
          <MEANINGDESCRIPTION>An injectable preparation composed of the four ingredients methionine, inositol, choline chloride and cyanocobalamin, with potential lipotropic activity. Upon administration of methionine/inositol/choline chloride/cyanocobalamin injection, the active ingredients may exert lipotropic effects.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C190845</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12093852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cobalamin</VALIDVALUE>
          <VALUEMEANING>Vitamin B12</VALUEMEANING>
          <MEANINGDESCRIPTION>A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C939</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Copanlisib</VALIDVALUE>
          <VALUEMEANING>Copanlisib Hydrochloride (Aliqopa)</VALUEMEANING>
          <MEANINGDESCRIPTION>The dihydrochloride salt form of copanlisib, a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C138994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-11-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12117784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vortioxetine Hydrobromide</VALIDVALUE>
          <VALUEMEANING>Vortioxetine Hydrobromide (Trintellix)</VALUEMEANING>
          <MEANINGDESCRIPTION>A hydrobromide salt form of vortioxetine, a serotonin (5-HT) modulator and stimulator (SMS), with antidepressant activity. Vortioxetine inhibits the reuptake of serotonin and norepinephrine from the synaptic cleft and acts variably as a serotonin receptor agonist (5-HT1A), partial agonist (5-HT1B) or antagonist (5-HT3, 5-HT1D and 5-HT7). It is not clear how this agent&#39;s purported multimodal mechanism of action contributes to its antidepressant effect; however, it is presumed to increase the synaptic availability of serotonin and norepinephrine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125653</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12127874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carboxymethylcellulose Sodium-containing Eye Drop</VALIDVALUE>
          <VALUEMEANING>Carboxymethylcellulose Sodium-containing Eye Drop</VALUEMEANING>
          <MEANINGDESCRIPTION>An eye drop solution containing the sodium salt form of carboxymethylcellulose (CMC) used as artificial tears. Upon application of the drops into the eye, carboxymethylcellulose sodium lubricates the eye and prevents or relieves dryness and irritation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3777004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polyethylene Glycol 400/Propylene Glycol-containing Eye Drop</VALIDVALUE>
          <VALUEMEANING>Polyethylene Glycol 400/Propylene Glycol-containing Eye Drop (Systane)</VALUEMEANING>
          <MEANINGDESCRIPTION>An eye drop solution containing polyethylene glycol (PEG) 400 and propylene glycol used for the relief of dry eye. Upon application of the drops into the eye, PEG 400 and propylene glycol lubricate the eye and relieve dryness and irritation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12173256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oportuzumab Monatox</VALIDVALUE>
          <VALUEMEANING>Oportuzumab Monatox (Vicinium)</VALUEMEANING>
          <MEANINGDESCRIPTION>A fusion protein immunotoxin consisting of a humanized, single-chain monoclonal antibody fragment specific for the epithelial cell adhesion molecule (EpCAM) conjugated with a truncated form of Pseudomonas exotoxin A with potential antineoplastic activity. Oportuzumab monatox binds to Ep-CAM-positive tumor cells, thereby delivering the Pseudomonas exotoxin A moiety specifically; the Pseudomonas exotoxin A moiety then inactivates elongation factor 2 (EF-2) through ADP ribosylation, resulting in inhibition of protein synthesis in target cells. EpCAM, a cell surface protein, is expressed by a variety of tumor cells and is frequently found in head and neck cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61307</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12187520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alfuzosin Hydrochloride</VALIDVALUE>
          <VALUEMEANING>Alfuzosin Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt of alfuzosin, a quinazoline compound with smooth muscle-relaxing activity. Alfuzosin selectively binds to and antagonizes post-synaptic alpha-1-adrenoreceptors in smooth muscle of the prostate, bladder base, bladder neck, prostatic capsule, and prostatic urethra, initiating relaxation of smooth muscle and resulting in improvement of urine flow and the symptoms of benign prostatic hyperplasia (BPH). This agent also blocks alpha-1-adrenoreceptors in peripheral vascular smooth muscle, resulting in vasodilatation and a decrease in peripheral vascular resistance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12203720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mepivacaine Hydrochloride</VALIDVALUE>
          <VALUEMEANING>Mepivacaine Hydrochloride (Carbocaine)</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt form of mepivacaine, an amide derivative with local anesthetic properties.  At the injection site, mepivacaine hydrochloride acts by binding to specific membrane sodium ion channels in the neuronal cell membranes, thereby inhibiting sodium influx. This leads to a blockage of nerve impulse conduction and results in a loss of sensation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47602</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12267130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vedolizumab</VALIDVALUE>
          <VALUEMEANING>Vedolizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against the human lymphocyte Peyer&#39;s patch adhesion molecule 1 (LPAM-1; alpha4beta7; a4b7), with immunomodulating, anti-inflammatory, and potential antineoplastic activities. Upon administration, vedolizumab selectively binds to integrin a4b7 and prevents the binding of a4b7, expressed on the surface of a subset of T-lymphocytes, to its natural ligand, mucosal addressin cell adhesion molecule-1 (MAdCAM-1), which is mainly expressed on the surface of gut endothelial cells. This prevents a4b7-mediated signaling, adhesion of lymphocytes to the endothelium and the migration of T-lymphocytes across the endothelium into inflamed gastrointestinal (GI) tissue. By preventing this infiltration to the affected area, inflammation is reduced. The human lymphocyte a4b7 integrin, plays a key role in gastrointestinal (GI) inflammation; it is overexpressed in certain types of cancer cells. The alpha4beta7/MAdCAM-1 signaling pathway plays a critical role in the homing of T-lymphocytes to intestinal tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-02-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8115529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retifanlimab</VALIDVALUE>
          <VALUEMEANING>Retifanlimab (Zynyz)</VALUEMEANING>
          <MEANINGDESCRIPTION>A proprietary humanized monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 (PD-1), with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, retifanlimab binds to and inhibits PD-1 and its downstream signaling pathways. This may restore immune function through the activation of T-cells and cell-mediated immune responses against tumor cells. PD-1, a transmembrane protein in the immunoglobulin superfamily (IgSF) expressed on T-cells, functions as an immune checkpoint that negatively regulates T-cell activation and effector function when activated by its ligands programmed cell death ligand 1 (PD-L1) or 2 (PD-L2); it plays an important role in tumor evasion from host immunity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13314837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bleomycin, Etoposide and Platinum</VALIDVALUE>
          <VALUEMEANING>BEP Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of bleomycin, etoposide and cisplatin used for the treatment of ovarian and testicular germ cell tumors (GCTs).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13336614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abacavir sulfate</VALIDVALUE>
          <VALUEMEANING>Abacavir Sulfate</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic carbocyclic nucleoside analog.  In vivo, the activated triphosphate metabolite of abacavir is incorporated into the viral DNA instead of the natural substrate deoxyguanosine, thereby inhibiting human immunodeficiency virus (HIV) reverse transcriptase (RT) and, so, the replication of the viral DNA and infectious viral particles.  This agent decreases HIV viral loads, retards or prevents the damage to the immune system, and reduces the risk of developing AIDS. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28804</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abacavir sulfate/Lamivudine regimen</VALIDVALUE>
          <VALUEMEANING>Abacavir Sulfate/Lamivudine</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed combination of abacavir sulfate, a nucleoside reverse transcriptase inhibitor (NRTI) analog of guanosine and lamivudine, an NRTI analog of cytidine, that is used to treat human immunodeficiency virus (HIV) infection. Upon oral administration, abacavir and lamivudine are phosphorylated into active metabolites that compete for incorporation into viral DNA. These metabolites inhibit the HIV reverse transcriptase (RT) enzyme competitively and act as a chain terminator of DNA synthesis. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763492</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cobicistat</VALIDVALUE>
          <VALUEMEANING>Cobicistat</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytochrome P450 3A (CYP3A) inhibitor that can be used to enhance the pharmacokinetic profile of certain anti-HIV-1 agents. Upon administration, cobicistat inhibits the liver enzyme CYP3A4 and limits the breakdown of co-administered agents that are metabolized by CYP3A4, and increases the concentration, systemic exposure and efficacy of the co-administered agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Darunavir ethanolate</VALIDVALUE>
          <VALUEMEANING>Darunavir Ethanolate</VALUEMEANING>
          <MEANINGDESCRIPTION>The ethanolate form of darunavir, a human immunodeficiency virus type 1 (HIV-1) protease nonpeptidic inhibitor, with activity against HIV. Upon oral administration, darunavir selectively targets and binds to the active site of HIV-1 protease, and inhibits the dimerization and catalytic activity of HIV-1 protease. This inhibits the proteolytic cleavage of viral Gag and Gag-Pol polyproteins in HIV-infected cells. This inhibition leads to the production of immature, non-infectious viral proteins that are unable to form mature virions, and prevents HIV replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Emtricitabine/Tenofovir alafenamide fumarate regimen</VALIDVALUE>
          <VALUEMEANING>Emtricitabine/Tenofovir Alafenamide Fumarate</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed combination of emtricitabine, a nucleoside reverse transcriptase (RT) inhibitor (NRTI) analog of cytidine and tenofovir alafenamide fumarate, the fumarate salt form of the lipophilic phosphonamidate prodrug of tenofovir, a NRTI analog of adenosine monophosphate, that is used to treat human immunodeficiency virus (HIV) infection. Upon oral administration, emtricitabine and tenofovir inhibit the activity of HIV RT by competing with natural deoxyribonucleosides for incorporation into the growing viral DNA chain resulting in early chain termination. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157538</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dolutegravir sodium</VALIDVALUE>
          <VALUEMEANING>Dolutegravir Sodium</VALUEMEANING>
          <MEANINGDESCRIPTION>The sodium salt form of dolutegravir, an orally bioavailable integrase strand-transfer inhibitor (INSTI), with activity against human immunodeficiency virus type 1 (HIV-1) infection. Upon oral administration, dolutegravir binds to the active site of integrase, an HIV enzyme that catalyzes the transfer of viral genetic material into human chromosomes. This prevents integrase from binding to retroviral deoxyribonucleic acid (DNA), and blocks the strand transfer step, which is essential for the HIV replication cycle. This prevents HIV-1 replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C148408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doravirine</VALIDVALUE>
          <VALUEMEANING>Doravirine</VALUEMEANING>
          <MEANINGDESCRIPTION>A pyridinone non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1), that is used to treat HIV infection. Upon oral administration, doravirine non-competitively inhibits HIV-1 reverse transcriptase (RT), thereby inhibiting HIV-1 viral replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C171848</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Efavirenz/Emtricitabine/Tenofovir disoproxil fumarate</VALIDVALUE>
          <VALUEMEANING>Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed combination of efavirenz, a non-nucleoside reverse transcriptase (RT) inhibitor (NNRTI); emtricitabine, a nucleoside RT inhibitor (NRTI) analog of cytidine; and tenofovir disoproxil fumarate, an NRTI analog of adenosine monophosphate, that is used to treat human immunodeficiency virus (HIV) infection. Upon oral administration, efavirenz, emtricitabine, and tenofovir disoproxil fumarate inhibit the activity of HIV RT by competing with natural deoxyribonucleosides for incorporation into the growing viral DNA chain resulting in early chain termination. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elvitegravir</VALIDVALUE>
          <VALUEMEANING>Elvitegravir</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified quinolone antibiotic with activity against human immunodeficiency virus 1. Elvitegravir is an inhibitor of viral integrase and retains activity against integrase mutants that are resistant to Raltegravir.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C76493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Emtracitabine/Tenofovir disoproxil fumarate</VALIDVALUE>
          <VALUEMEANING>Emtricitabine/Tenofovir Disoproxil Fumarate</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed combination of emtricitabine, a nucleoside reverse transcriptase (RT) inhibitor (NRTI) analog of cytidine, and tenofovir disoproxil fumarate, an NRTI analog of adenosine monophosphate, that is used to treat human immunodeficiency virus (HIV) infection. Upon oral administration, emtricitabine and tenofovir inhibit the activity of HIV RT by competing with natural deoxyribonucleosides for incorporation into the growing viral DNA chain resulting in early chain termination. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Etravirine</VALIDVALUE>
          <VALUEMEANING>Etravirine</VALUEMEANING>
          <MEANINGDESCRIPTION>A diarylpyrimidine non-nucleoside reverse transcriptase inhibitor. Etravirine is designed to be active against HIV isolates with mutations that confer resistance to the two most commonly prescribed first-generation NNRTIs. It can bind the enzyme reverse transcriptase (RT) in multiple conformations, both for native and mutant RT, thereby blocking the enzymatic activity of RT.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atazanavir/Cobicistat</VALIDVALUE>
          <VALUEMEANING>Atazanavir/Cobicistat</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed combination of atazanavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, and cobicistat, a cytochrome P450 3A (CYP3A) inhibitor that may be used to treat HIV-1 infection. Upon oral administration, atazanavir selectively binds to the active site of HIV-1 protease and inhibits the proteolytic cleavage of viral Gag and Gag-Pol polyproteins in HIV-infected cells. This inhibition leads to the production of immature, non-infectious viral proteins that are unable to form mature virions. Cobicistat inhibits CYP3A, thereby limiting the metabolism of atazanavir and increasing its systemic exposure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157541</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fostemsavir tromethamine</VALIDVALUE>
          <VALUEMEANING>Fostemsavir Tromethamine</VALUEMEANING>
          <MEANINGDESCRIPTION>The tromethamine salt form of fostemsavir, an orally bioavailable phosphonooxymethyl prodrug of the human immunodeficiency virus type 1 (HIV-1) attachment inhibitor temsavir, with activity against HIV. Upon oral administration, fostemsavir is hydrolyzed to the active moiety temsavir. Temsavir targets and binds to the gp120 subunit within the HIV-1 envelope glycoprotein gp160. This selectively inhibits the interaction between HIV-1 virus and host cellular CD4 receptors, thereby preventing HIV-1 virus attachment. This also inhibits gp120-dependent post-attachment steps that are needed for HIV-1 viral entry into host cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166604</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide fumarate</VALIDVALUE>
          <VALUEMEANING>Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed combination of elvitegravir, a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI); cobicistat, a cytochrome P450 3A (CYP3A) inhibitor; emtricitabine, a nucleoside reverse transcriptase (RT) inhibitor (NRTI) analog of cytidine; and tenofovir alafenamide fumarate, the fumarate salt form of the lipophilic phosphonamidate prodrug of tenofovir, a NRTI analog of adenosine monophosphate, that is used to treat human immunodeficiency virus (HIV) infection. Upon oral administration, elvitegravir inhibits the activity of integrase, an HIV-1 coded enzyme that is necessary for viral replication. Inhibition of integrase prevents the integration of HIV-1 DNA into host genomic DNA. Cobicistat inhibits CYP3A, thereby limiting the oxidative metabolism of elvitegravir and increases its systemic exposure. Emtricitabine and tenofovir inhibit the activity of HIV RT by competing with natural deoxyribonucleosides for incorporation into the growing viral DNA chain resulting in early chain termination. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157537</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8024216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ibalizumab-uiyk</VALIDVALUE>
          <VALUEMEANING>Ibalizumab-uiyk (Trogarzo)</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody against CD4, with anti-human immunodeficiency virus (HIV) activity. Ibalizumab binds to CD4, the primary receptor for HIV, thereby inhibiting HIV entry into CD4-positive T-cells. This leads to a reduction in viral load.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lamivudine</VALIDVALUE>
          <VALUEMEANING>Lamivudine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic nucleoside analogue with activity against hepatitis B virus (HBV) and HIV. Intracellularly, lamivudine is phosphorylated to its active metabolites, lamiduvine triphosphate (L-TP) and lamiduvine monophosphate (L-MP).  In HIV, L-TP inhibits HIV-1 reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleoside analogue into viral DNA.  In HBV, incorporation of L-MP into viral DNA by HBV polymerase results in DNA chain termination. L-TP is a weak inhibitor of mammalian DNA polymerases alpha and beta, and mitochondrial DNA polymerase. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lamivudine/Zidovudine</VALIDVALUE>
          <VALUEMEANING>Lamivudine/Zidovudine</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination of two synthetic nucleoside analogues with synergistic antiviral properties.  Lamivudine is phosphorylated intracellularly to its active 5&#39;-triphosphate metabolite, lamivudine triphosphate (L-TP); zidovudine is phosphorylated to its active 5&#39;-triphosphate metabolite, zidovudine triphosphate (ZDV-TP). These active metabolites inhibit human immunodeficiency virus (HIV) viral reverse transcriptase (RT) by incorporating into viral DNA and terminating viral DNA chain elongation. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28939</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lenacapavir sodium</VALIDVALUE>
          <VALUEMEANING>Lenacapavir Sodium</VALUEMEANING>
          <MEANINGDESCRIPTION>The sodium salt form of lenacapavir, an inhibitor of human immunodeficiency virus type 1 (HIV-1) capsid function, with activity against HIV. Upon administration, lenacapavir targets and binds to the interface between HIV capsid protein (p24) subunits in hexamers. This inhibits capsid function, including capsid-mediated nuclear uptake of preintegration complexes, virion production and proper capsid core formation, thereby inhibiting HIV-1 replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maraviroc</VALIDVALUE>
          <VALUEMEANING>Maraviroc</VALUEMEANING>
          <MEANINGDESCRIPTION>A C-C Chemokine Receptor Type 5 (CCR5) antagonist with activity against human immunodeficiency virus (HIV). Maraviroc inhibits HIV-1 entry via CCR5 coreceptor interaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73144</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Emtricitabine/Rilpivirine/Tenofovir alafenamide fumarate</VALIDVALUE>
          <VALUEMEANING>Emtricitabine/Rilpivirine/Tenofovir Alafenamide Fumarate</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed combination of emtricitabine, a nucleoside reverse transcriptase (RT) inhibitor (NRTI) analog of cytidine; rilpivirine, a diarylpyrimidine derivative and non-nucleoside RT inhibitor (NNRTI); and tenofovir alafenamide fumarate, the fumarate salt form of the lipophilic phosphonamidate prodrug of tenofovir, a NRTI analog of adenosine monophosphate, that is used to treat human immunodeficiency virus (HIV) infection. Upon oral administration, emtricitabine and tenofovir inhibit the activity of HIV RT by competing with natural deoxyribonucleosides for incorporation into the growing viral DNA chain resulting in early chain termination. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions. Rilpivirine, a non-competitive NNRTI binds to RT and inhibits RNA and DNA-dependent polymerase activities, including viral replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157539</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763544</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Raltegravir potassium</VALIDVALUE>
          <VALUEMEANING>Raltegravir Potassium</VALUEMEANING>
          <MEANINGDESCRIPTION>The orally bioavailable potassium salt of a human immunodeficiency virus (HIV) integrase strand transfer inhibitor (HIV-1 INSTI) with HIV-1 antiviral activity. Raltegravir binds to and inhibits integrase, an HIV enzyme that inserts viral genetic material into the genetic material of the infected human cell. Inhibition of integrase prevents insertion of HIV DNA into the human DNA genome, thus blocking HIV replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73823</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Darunavir/Cobicistat</VALIDVALUE>
          <VALUEMEANING>Darunavir/Cobicistat</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed combination of darunavir, an inhibitor of the human immunodeficiency virus (HIV) protease; and cobicistat, a cytochrome P450 3A (CYP3A) inhibitor that may be used to treat HIV infection. Upon oral administration, darunavir binds to and inhibits the dimerization and catalytic activity of the HIV aspartyl protease. This inhibits the cleavage of HIV-encoded Gag and Gag-Pol polyproteins in virus-infected cells, which prevents the formation of mature infectious virions. Cobicistat inhibits CYP3A, thereby limiting the metabolism of darunavir and increases its systemic exposure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157536</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763546</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rilpivirine</VALIDVALUE>
          <VALUEMEANING>Rilpivirine</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation non-nucleoside reverse transcriptase inhibitor. Rilpivirine is a diarylpyrimidine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C76929</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate</VALIDVALUE>
          <VALUEMEANING>Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed combination of elvitegravir, a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI); cobicistat, a cytochrome P450 3A (CYP3A) inhibitor; emtricitabine, a nucleoside reverse transcriptase (RT) inhibitor (NRTI) analog of cytidine; and tenofovir disoproxil fumarate, an NRTI analog of adenosine monophosphate, that is used to treat HIV infection. Upon oral administration, elvitegravir inhibits the activity of integrase, an HIV-1 coded enzyme that is necessary for viral replication. Inhibition of integrase prevents the integration of HIV-1 DNA into host genomic DNA. Cobicistat inhibits CYP3A, thereby limiting the oxidative metabolism of elvitegravir and increases its systemic exposure. Emtricitabine and tenofovir disoproxil fumarate inhibit the activity of HIV RT by competing with natural deoxyribonucleosides for incorporation into the growing viral DNA chain resulting in early chain termination. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tenofovir alafenamide</VALIDVALUE>
          <VALUEMEANING>Tenofovir Alafenamide</VALUEMEANING>
          <MEANINGDESCRIPTION>A lipophilic phosphonamidate prodrug of tenofovir, a synthetic antiviral acyclic nucleotide analog of adenosine 5-monophosphate and a nucleoside reverse transcriptase inhibitor (NRTI), with antiviral activity against hepatitis B virus (HBV) and potentially against human immunodeficiency virus (HIV). Upon oral administration, tenofovir alafenamide is taken up by hepatocytes through passive diffusion and through the hepatic uptake transporters organic anion transporting polypeptides 1B1 (OATP1B1) and 1B3 (OATP1B3). Inside the hepatocytes, tenofovir alafenamide is hydrolyzed and converted to tenofovir by carboxylesterase 1 (CES1). Intracellular tenofovir is phosphorylated by cellular kinases to its pharmacologically active form, tenofovir diphosphate. Tenofovir diphosphate is incorporated into viral DNA instead of the natural substrate deoxyadenosine 5-triphosphate, and inhibits HBV reverse transcriptase, resulting in DNA chain-termination and inhibition of HBV replication. In addition, tenofovir diphosphate is incorporated into HIV DNA instead of the natural substrate deoxyadenosine 5-triphosphate, thereby inhibiting HIV-1 reverse transcriptase (RT) and resulting in DNA chain termination and impairment of HIV replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C148276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abacavir/Dolutegravir/Lamivudine</VALIDVALUE>
          <VALUEMEANING>Abacavir/Dolutegravir/Lamivudine</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed combination of abacavir sulfate, a nucleoside reverse transcriptase inhibitor (NRTI) analog of guanosine; dolutegravir, an integrase strand-transfer inhibitor (INSTI); and lamivudine, an NRTI analog of cytidine, that may be used to treat human immunodeficiency virus (HIV) infection. Upon oral administration, abacavir and lamivudine are phosphorylated into active metabolites that inhibit the HIV reverse transcriptase (RT) enzyme competitively and act as a chain terminator of DNA synthesis. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions. Dolutegravir binds to the active site of integrase, an HIV enzyme that catalyzes the transfer of viral genetic material into human chromosomes. This prevents integrase from binding to retroviral deoxyribonucleic acid (DNA), and blocks the strand transfer step, which is essential for the HIV replication cycle. This further prevents HIV-1 replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13763550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zidovudine</VALIDVALUE>
          <VALUEMEANING>Zidovudine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic dideoxynucleoside. After intracellular phosphorylation to its active metabolite, zidovudine inhibits DNA polymerase, resulting in the inhibition of DNA replication and cell death. This agent also decreases levels of available pyrimidines. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C947</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3128742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate</VALIDVALUE>
          <VALUEMEANING>Bictegravir Sodium/Emtricitabine/Tenofovir Alafenamide Fumarate</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable fixed combination of bictegravir sodium, the sodium salt form of the human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI) bictegravir, emtricitabine, a nucleoside reverse transcriptase (RT) inhibitor (NRTI) analog of cytidine, and tenofovir alafenamide fumarate, the fumarate salt form of the lipophilic phosphonamidate prodrug of tenofovir, a NRTI analog of adenosine monophosphate, that is used to treat human immunodeficiency virus (HIV) infection. Upon oral administration of bictegravir/emtricitabine/tenofovir alafenamide, bictegravir inhibits the strand transfer activity of HIV-1 integrase, an HIV-1 coded enzyme that is necessary for viral replication. Inhibition of integrase prevents the integration of linear HIV-1 DNA into host genomic DNA. Emtricitabine and tenofovir inhibit the activity of HIV RT by competing with natural deoxyribonucleosides for incorporation into the growing viral DNA chain resulting in early chain termination. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199579</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13795017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cabotegravir and Rilpivirine Injections</VALIDVALUE>
          <VALUEMEANING>Cabotegravir/Rilpivirine</VALUEMEANING>
          <MEANINGDESCRIPTION>An extended-release injectable formulation of cabotegravir, a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI), and rilpivirine, a non-nucleoside reverse transcriptase (RT) inhibitor (NNRTI), that may be used to treat HIV infection. Upon intramuscular administration of cabotegravir/rilpivirine, cabotegravir binds to and blocks the active site of HIV integrase, an HIV-1 coded enzyme that is necessary for viral replication, thereby inhibiting its activity. Inhibition of integrase prevents the integration of HIV-1 DNA into host genomic DNA. Rilpivirine binds to HIV RT, thereby blocking RNA and DNA-dependent DNA polymerase activities including viral replication, thereby further preventing HIV-1 replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13795018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate</VALIDVALUE>
          <VALUEMEANING>Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable fixed combination of doravirine, a pyridinone non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1), lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI) analog of cytidine, and the fumarate salt form of the prodrug tenofovir disoproxil, an NRTI analog of adenosine monophosphate, that is used to treat human immunodeficiency virus (HIV) infection. Upon oral administration of doravirine/lamivudine/tenofovir disoproxil, doravirine non-competitively inhibits HIV-1 reverse transcriptase (RT), thereby inhibiting HIV-1 viral replication. Lamivudine is phosphorylated intracellularly to its active 5&#39;-triphosphate metabolite, lamivudine triphosphate (L-TP), that competes for incorporation into viral DNA, and tenofovir disoproxil, upon conversion into tenofovir, also competes with natural deoxyribonucleosides for incorporation into the growing viral DNA chain, thereby inhibiting the HIV RT competitively and resulting in early chain termination. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199582</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13795019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dolutegravir/Lamivudine</VALIDVALUE>
          <VALUEMEANING>Dolutegravir Sodium/Lamivudine</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable fixed combination of the sodium salt form of dolutegravir, an integrase strand-transfer inhibitor (INSTI), and lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI) analog of cytidine, that may be used to treat human immunodeficiency virus (HIV) infection. Upon oral administration of dolutegravir/lamivudine, dolutegravir binds to the active site of integrase, an HIV enzyme that catalyzes the transfer of viral genetic material into human chromosomes. This prevents integrase from binding to retroviral deoxyribonucleic acid (DNA), and blocks the strand transfer step, which is essential for the HIV replication cycle. Lamivudine is phosphorylated into its active 5&#39;-triphosphate metabolite, lamivudine triphosphate (L-TP), which inhibits the HIV reverse transcriptase (RT) enzyme competitively and acts as a chain terminator of DNA synthesis. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199581</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13795020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Emtricitabine/Rilpivirine Hydrochloride/Tenofovir Disoproxil Fumarate</VALIDVALUE>
          <VALUEMEANING>Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate</VALUEMEANING>
          <MEANINGDESCRIPTION>A fixed combination of emtricitabine, a nucleoside reverse transcriptase (RT) inhibitor (NRTI) analog of cytidine; rilpivirine, a non-nucleoside RT inhibitor (NNRTI); and tenofovir disoproxil fumarate, an NRTI analog of adenosine monophosphate, that is used to treat human immunodeficiency virus (HIV) infection. Upon oral administration, rilpivirine binds to HIV RT, thereby blocking RNA and DNA-dependent DNA polymerase activities including viral replication. Emtricitabine and tenofovir disoproxil fumarate inhibit the activity of HIV RT by competing with natural deoxyribonucleosides for incorporation into the growing viral DNA chain resulting in early chain termination. This interferes with the generation of DNA copies of viral RNA, which is necessary for the synthesis of new virions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13795037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PRGN-2009</VALIDVALUE>
          <VALUEMEANING>Gorilla-derived Adenovirus-expressing HPV-16/18 E6/E7 Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>An off-the-shelf (OTS) cancer vaccine comprised of a genetically engineered, replication-deficient gorilla-derived adenovirus encoding human papillomavirus (HPV) types 16 and 18 E6/E7 antigens, with potential immunostimulating and antineoplastic activities. Upon administration of gorilla-derived adenovirus expressing HPV-16/18 E6/E7 vaccine PRGN-2009, the adenovirus infects and expresses the HPV-16/18 E6/E7 proteins. The expressed proteins stimulate the host immune system to produce antigen-specific neutralizing antibodies and to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing HPV-16/18 E6/E7 antigens, thereby inducing tumor cell lysis. HPV oncoproteins play a key role in the development of cervical intraepithelial neoplasia (CIN) and cervical carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172914</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13966077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PRGN-2012</VALIDVALUE>
          <VALUEMEANING>Gorilla-derived Adenovirus-expressing HPV-6/11 Vaccine PRGN-2012</VALUEMEANING>
          <MEANINGDESCRIPTION>An off-the-shelf (OTS) cancer vaccine comprised of a genetically engineered, replication-deficient gorilla-derived adenovirus encoding human papillomavirus (HPV) types 6 and 11, with potential immunostimulating and antineoplastic activities. Upon administration of gorilla-derived adenovirus-expressing HPV-6/11 vaccine PRGN-2012, the adenovirus infects and expresses the HPV-6/11 proteins. The expressed proteins stimulate the host immune system to produce antigen-specific neutralizing antibodies and to mount a cytotoxic T-lymphocyte (CTL) response against cells infected with HPV-6/11, thereby inducing tumor cell lysis. HPV6/11 play a key role in the development of recurrent respiratory papillomatosis (RRP).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177305</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13966078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-CCR8 Monoclonal Antibody LM-108</VALIDVALUE>
          <VALUEMEANING>Anti-CCR8 Monoclonal Antibody LM-108</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody against C-C-chemokine receptor 8 (CCR8), with potential immunomodulating and antineoplastic activities. Upon administration, anti-CCR8 monoclonal antibody LM-108 targets, binds to and blocks the activity of CCR8 on CCR8-positive tumor-infiltrating regulatory T-cells (Tregs) in the tumor microenvironment (TME) and prevents chemokine ligand 1 (CCL1)-CCR8-mediated signaling. This may reactivate antitumor immune responses. CCR8 is specifically expressed by tumor-infiltrating Tregs in multiple types of cancer and plays a key role in immunosuppression. High expression is correlated with poor prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186374</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13971232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alvimopan</VALIDVALUE>
          <VALUEMEANING>Alvimopan</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine with peripherally selective opioid mu receptor antagonist activity. Alvimopan is a selective and competitive antagonist at mu-opioid receptors, found in myenteric and submucosal neurons and the immune cells of the lamina propria in the human gut. Upon administration, this agent binds to mu-opioid receptors in the gut, thereby reversing opioid-related disturbances in gut motility. Alvimopan is approximately three to nine times more potent than naloxone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14056144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bedaquiline fumurate</VALIDVALUE>
          <VALUEMEANING>Bedaquiline Fumarate</VALUEMEANING>
          <MEANINGDESCRIPTION>The fumarate salt form of bedaquiline, an orally bioavailable diarylquinoline antimycobacterial agent, that can be used in the treatment of pulmonary multi-drug resistant tuberculosis (MDR-TB). Upon oral administration, bedaquiline specifically binds to subunit c of Mycobacterium tuberculosis (M. tuberculosis) adenosine 5&#39;-triphosphate (ATP) synthase, thereby preventing ATP synthase activity. This inhibits ATP synthesis in M. tuberculosis, thereby blocking its energy metabolism and killing M. tuberculosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14056247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lifitegrast</VALIDVALUE>
          <VALUEMEANING>Lifitegrast (Xiidra)</VALUEMEANING>
          <MEANINGDESCRIPTION>A tetrahydroisoquinoline derivative and lymphocyte function-associated antigen-1 (LFA-1) antagonist, that can be used as an ophthalmic solution for the treatment of dry eye disease (DED; keratoconjunctivitis sicca; dry eye syndrome). Upon ocular administration and although the exact mechanism of action of lifitegrast in DED is not fully known, lifitegrast targets and binds to the integrin LFA-1, a cell surface protein found on leukocytes. This prevents the interaction of LFA-1 with its cognate ligand intercellular adhesion molecule-1 (ICAM-1). As ICAM-1 may be overexpressed in corneal and conjunctival tissues in DED, the blockage of the LFA-1/ICAM-1 interaction by lifitegrast may inhibit T-cell adhesion to ICAM-1 and may abrogate the formation of an immunological synapse. This may prevent T-cell proliferation, activation and migration and the release of pro-inflammatory cytokines in the corneal and conjunctival tissues. This may reduce inflammation, protect the corneal surface from inflammatory-mediated damage and reduce the symptoms of DED.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C175726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14059580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gilteritinib</VALIDVALUE>
          <VALUEMEANING>Gilteritinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of the receptor tyrosine kinases (RTKs) FMS-related tyrosine kinase 3 (FLT3, STK1, or FLK2), AXL (UFO or JTK11) and anaplastic lymphoma kinase (ALK or CD246), with potential antineoplastic activity. Gilteritinib binds to and inhibits both the wild-type and mutated forms of FLT3, AXL and ALK. This may result in an inhibition of FLT3, AXL, and ALK-mediated signal transduction pathways and reduces tumor cell proliferation in cancer cell types that overexpress these RTKs. FLT3, AXL and ALK, overexpressed or mutated in a variety of cancer cell types, play a key role in tumor cell growth and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Witch Hazel Rectal Pads</VALIDVALUE>
          <VALUEMEANING>Witch Hazel-containing Anti-Hemorroidal Formulation Rectal Pad Dosage Form</VALUEMEANING>
          <MEANINGDESCRIPTION>A preparation containing witch hazel (Hamamelis virginiana) extract, with anti-pruritic activity. Witch hazel extract has been shown to inhibit alpha-glucosidase as well as human leukocyte elastase, enzymes which contribute to the degradation of connective tissue. Tucks hemorrhoidal wipes are used to relieve and soothe the irritation, burning and pruritis of hemorrhoidal tissue._Of or pertaining to the rectum._A solid composed of a soft, non-adhesive and absorbent piece of fabric or other material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69016, C25224, C29525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14114585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asciminib</VALIDVALUE>
          <VALUEMEANING>Asciminib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, allosteric Bcr-Abl1 tyrosine kinase inhibitor, with antineoplastic activity. Upon administration, asciminib targets and binds to the myristoyl pocket of the Bcr-Abl1 fusion protein at a location that is distinct from the ATP-binding domain, thereby inhibiting the activity of both wild-type Bcr-Abl and certain mutation forms, including the T315I mutation. This binding results in the inhibition of Bcr-Abl1-mediated proliferation and enhanced apoptosis of Philadelphia chromosome-positive (Ph+) hematological malignancies. The Bcr-Abl1 fusion protein tyrosine kinase is an abnormal enzyme produced by leukemia cells that contain the Philadelphia chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114494</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13597046</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bebtelovimab</VALIDVALUE>
          <VALUEMEANING>Bebtelovimab</VALUEMEANING>
          <MEANINGDESCRIPTION>A neutralizing human immunoglobulin G1 (IgG1) monoclonal antibody, isolated from a patient who has recovered from the Coronavirus disease 2019 (COVID-19), directed against the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19. Upon administration, bebtelovimab specifically targets and binds to the receptor-binding domain (RBD) of SARS-CoV-2 S protein, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2. S protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C182122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14256422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HER2 Tri-specific Natural Killer Cell Engager DF1001</VALIDVALUE>
          <VALUEMEANING>HER2 Tri-specific Natural Killer Cell Engager DF1001</VALUEMEANING>
          <MEANINGDESCRIPTION>An engineered molecule based on tri-specific natural killer (NK) cell engager therapies (TriNKET) that is directed against human epidermal growth factor receptor 2 (EGFR2; HER2; ErbB2), with potential immunostimulating and antineoplastic activities. Upon administration, HER2 tri-specific NK cell engager DF1001 targets and binds to HER2 on tumor cells and simultaneously binds to NK cells, thereby bringing HER2-expressing tumor cells and NK cells together, which stimulates the NK cells and results in the selective NK cell-mediated tumor cell lysis of HER2-expressing tumor cells. The binding of HER2-expressing tumor cells and NK cells may also lead to the activation of T-cells and B-cells, potentiating the immune response against HER2-expressing tumor cells. HER2, a receptor tyrosine kinase (RTK) mutated or overexpressed in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13660287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Docusate Sodium-Senna</VALIDVALUE>
          <VALUEMEANING>Docusate Sodium-Senna </VALUEMEANING>
          <MEANINGDESCRIPTION>A combination preparation composed of a standardized senna concentrate and the sodium salt form of the emollient laxative docusate, with laxative and stool softening activity. Senna concentrate consists of the anthraquinone glycosides sennosides extracted from senna leaves. Sennosides act on and irritate the lining of the intestine wall, thereby causing increased intestinal muscle contractions leading to vigorous bowel movement and relief of constipation. Docusate, an anionic surfactant, decreases surface tension and emulsification of fecal matter and allows water to penetrate and mix with stool. This softens the stool for smoother and easier evacuation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7130497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Melatonin/Magnesium Citrate</VALIDVALUE>
          <VALUEMEANING>Melatonin/Magnesium Citrate</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination agent containing melatonin, a serotonin-derived neurohormone, and the citrate salt of the element magnesium, that could potentially be used to promote relaxation and sleep. Upon oral administration, melatonin is involved in numerous biological functions including circadian rhythm, sleep, and the stress response. Magnesium may promote relaxation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C200662</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14318387</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Escitalopram</VALIDVALUE>
          <VALUEMEANING>Escitalopram</VALUEMEANING>
          <MEANINGDESCRIPTION>The active S-stereoisomer of the selective serotonin reuptake inhibitor (SSRI) citalopram with antidepressant, anti-obsessive-compulsive and antibulimic properties. Escitalopram inhibits the reuptake of the neurotransmitter serotonin (5-HT) at the serotonin reuptake pump of the neuronal membrane of the presynaptic cell, thereby increasing levels of 5-HT within the synaptic cleft and enhancing the actions of serotonin on 5HT1A autoreceptors. Unlike other SSRIs, escitalopram appears to not only bind to a primary high-affinity site on the serotonin transporter protein but also to a secondary lower-affinity allosteric site that is considered to stabilize and prolong drug binding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7460883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beclomethasone Dipropionate</VALIDVALUE>
          <VALUEMEANING>Beclomethasone Dipropionate</VALUEMEANING>
          <MEANINGDESCRIPTION>The dipropionate salt of a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, beclomethasone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C299</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Potassium Citrate</VALIDVALUE>
          <VALUEMEANING>Potassium Citrate</VALUEMEANING>
          <MEANINGDESCRIPTION>The potassium salt form of citrate with alkalinizing property. Following absorption, potassium citrate causes increased plasma bicarbonate concentration, thereby raising blood and urinary pH. A simultaneous decrease in calcium ion activity occurs as a result of increasing calcium complex formation with dissociated anions. Levels of urinary citrate are increased due to modification of the renal handling of citrate. By promoting excretion of free bicarbonate ion and by increasing urinary pH in addition to an increased ionization of uric acid to more soluble urate ions, this agent exerts the alkalizing and anti-urolithic effect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7060586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-Sitosterol/Boron/Silica/Vitamin D3/Calcium/Zinc/Selenium/Copper/Manganese/Chromium/Molybdenum-containing Supplement</VALIDVALUE>
          <VALUEMEANING>Beta-Sitosterol/Boron/Silica/Vitamin D3/Calcium/Zinc/Selenium/Copper/Manganese/Chromium/Molybdenum-containing Supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>A formulation composed of the phytosterol beta-sitosterol, cholecalciferol, calcium, zinc, selenium, copper, manganese, chromium, molybdenum and boron, that can potentially be used to support a healthy prostate. Upon oral administration, the formulation may help support and maintain prostate function and promote less urges to urinate and improve bladder emptying.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C200663</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14318388</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Omega-3-containing Krill Oil Supplement</VALIDVALUE>
          <VALUEMEANING>Omega-3-containing Krill Oil Supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>A supplement composed of omega-3 fatty acids derived from krill oil, that can be used for omega-3 fatty acid supplementation. Upon oral administration, omega-3 containing krill oil supplement provides omega-3 fatty acids. Omega-3 fatty acids get incorporated into and are a critical part of cellular membranes where they influence membrane fluidity and deformability. Omega-3 fatty acids play an important role in the proper functioning of heart, brain, blood vessels, lungs, immune system, and endocrine system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C200664</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14318389</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cholecalciferol</VALIDVALUE>
          <VALUEMEANING>Cholecalciferol</VALUEMEANING>
          <MEANINGDESCRIPTION>A steroid hormone produced in the skin when exposed to ultraviolet light or obtained from dietary sources. The active form of cholecalciferol, 1,25-dihydroxycholecalciferol (calcitriol) plays an important role in maintaining blood calcium and phosphorus levels and mineralization of bone. The activated form of cholecalciferol binds to vitamin D receptors and modulates gene expression. This leads to an increase in serum calcium concentrations by increasing intestinal absorption of phosphorus and calcium, promoting distal renal tubular reabsorption of calcium and increasing osteoclastic resorption.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3237531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Magnesium Malate</VALIDVALUE>
          <VALUEMEANING>Magnesium Malate</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C87336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14318390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zinc Oxide-containing Paste</VALIDVALUE>
          <VALUEMEANING>Zinc Oxide-containing Paste</VALUEMEANING>
          <MEANINGDESCRIPTION>A topical paste containing zinc oxide, that can be used to protect the skin. Upon application to the affected area(s), zinc oxide forms a thick, protective barrier to help heal and soothe the diaper rash discomfort.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C200665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14318391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amlodipine</VALIDVALUE>
          <VALUEMEANING>Amlodipine</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic dihydropyridine and a calcium channel blocker with antihypertensive and antianginal properties. Amlodipine inhibits the influx of extracellular calcium ions into myocardial and peripheral vascular smooth muscle cells, thereby preventing vascular and myocardial contraction. This results in a dilatation of the main coronary and systemic arteries, decreased myocardial contractility, increased blood flow and oxygen delivery to the myocardial tissue, and decreased total peripheral resistance. This agent may also modulate multi-drug response (MDR) activity through inhibition of the p-glycoprotein efflux pump.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7060445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atorvastatin</VALIDVALUE>
          <VALUEMEANING>Atorvastatin</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic lipid-lowering agent. Atorvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. Atorvastatin also increases the number of LDL receptors on hepatic cell surfaces to enhance uptake and catabolism of LDL and reduces LDL production and the number of LDL particles. This agent lowers plasma cholesterol and lipoprotein levels and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14318392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ciclesonide</VALIDVALUE>
          <VALUEMEANING>Ciclesonide (Omnaris)</VALUEMEANING>
          <MEANINGDESCRIPTION>A nonhalogenated, synthetic, inhaled corticosteroid (ICS) with anti-inflammatory and potential antiviral activities. Upon administration by oral inhalation into the lungs, ciclesonide (CIC) is converted by local esterases to its active metabolite desisobutyryl-ciclesonide (des-CIC), which binds to intracellular glucocorticoid receptors (GRs). The ligand-bound GRs regulate gene expressions, which lead to inhibitory activities against multiple cell types, such as mast cells, eosinophils, basophils, lymphocytes, macrophages and neutrophils, and various mediators associated with inflammation, such as histamine, eicosanoids, leukotrienes and cytokines. In addition, ciclesonide may suppress the replication of human coronavirus by targeting viral nonstructural protein 15 (NSP15).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14295565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Efineptakin alpha</VALIDVALUE>
          <VALUEMEANING>Efineptakin alfa</VALUEMEANING>
          <MEANINGDESCRIPTION>A long-acting immunoglobulin (Ig) fusion protein composed of a recombinant form of the endogenous human protein interleukin-7 (rhIL-7) and fused to a hybrid Fc (hyFc) region of a human antibody, with hematopoietic and immunopotentiating activities. Upon administration of efineptakin alfa, IL-7 stimulates the proliferation, differentiation, trafficking and survival of a variety of T-cell subsets, including naive, central memory (CM), effector memory (EM), terminally differentiated effector memory (TEMRA) and natural killer (NK) T-cells, and enhances T-cell-mediated anti-tumor immune responses. Compared to rhIL-7 alone, fusion to the hyFc region enhances the half-life of IL-7. The hyFc region is composed of the hinge and N-terminal portion of heavy chain constant (CH) region 2 (hinge-CH2) of human IgD, which is fused to the C-terminal region of CH2 and the entire CH3 region of human IgG4.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C151927</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14318393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liposomal Doxorubicin/Pomalidomide Regimen</VALIDVALUE>
          <VALUEMEANING>Liposomal Doxorubicin/Pomalidomide Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of liposomal doxorubicin and pomalidomide that may be used in the treatment of Kaposi sarcoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C200666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14318394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lutetium Lu 177 Dotatate</VALIDVALUE>
          <VALUEMEANING>Lutetium Lu 177 Dotatate</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioconjugate consisting of the tyrosine-containing somatostatin analog Tyr3-octreotate (TATE) conjugated with the bifunctional, macrocyclic chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA) and radiolabeled with the beta-emitting radioisotope lutetium Lu 177, with potential imaging and antineoplastic activities. Lutetium Lu 177 dotatate binds to somatostatin receptors (SSTRs), with high affinity to type 2 SSTR, present on the cell membranes of many types of neuroendocrine tumor (NET) cells. Upon binding and internalization, this radioconjugate specifically delivers a cytotoxic dose of beta radiation to SSTR-positive cells. Tyr3-octreotate (TATE) is an octreotide derivative in which phenylalanine at position 3 is substituted by tyrosine and position 8 threoninol is replaced with threonine. SSTRs have been shown to be present in large numbers on NET and their metastases, while most other normal tissues express low levels of SSTRs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95020</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13689512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Talazoparib</VALIDVALUE>
          <VALUEMEANING>Talazoparib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity. Talazoparib selectively binds to PARP and prevents PARP-mediated DNA repair of single strand DNA breaks via the base-excision repair pathway. This enhances the accumulation of DNA strand breaks, promotes genomic instability and eventually leads to apoptosis. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins that signal and recruit other proteins to repair damaged DNA and is activated by single-strand DNA breaks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95733</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6159964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vepdegestrant</VALIDVALUE>
          <VALUEMEANING>Vepdegestrant</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available hetero-bifunctional molecule and selective estrogen receptor (ER) alpha-targeted protein degrader, using the proteolysis targeting chimera (PROTAC) technology, with potential antineoplastic activity. Vepdegestrant is composed of an ER alpha ligand attached to an E3 ligase recognition moiety. Upon oral administration,vepdegestrant targets and binds to the ER ligand binding domain on ER alpha. E3 ligase is recruited to the ER by the E3 ligase recognition moiety and ER alpha is tagged by ubiquitin. This causes ubiquitination and degradation of ER alpha by the proteasome. This decreases ER alpha protein levels, decreases the expression of ER alpha-target genes and halts ER-mediated signaling. This results in an inhibition of proliferation in ER alpha-overexpressing tumor cells. In addition, the degradation of the ER alpha protein releases the ARV-471 and can bind to additional ER alpha target proteins. ER alpha is overexpressed in a variety of cancers and plays a key role in cancer cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-08-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13961725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PDS0101</VALIDVALUE>
          <VALUEMEANING>Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101</VALUEMEANING>
          <MEANINGDESCRIPTION>A liposomal nanoparticle-based therapeutic vaccine composed of the cationic lipid R-DOTAP (R-enantiomer of 1,2-dioleoyl-3-trimethylammonium-propane chloride) encapsulating six human papillomavirus 16 (HPV-16) E6 and E7 peptides, with potential immunostimulating activity. Upon subcutaneous administration of the liposomal HPV-16 E6 and E7 multipeptide vaccine, the nanoparticles are taken up by antigen presenting cells (APCs), specifically dendritic cells (DCs), which may stimulate the immune system to induce a cytotoxic T-lymphocyte response (CTL) against HPV-16 E6 and E7-expressing tumor cells. HPV-16 E6 and E7 are oncoproteins that play a key role in the tumorigenesis of a variety of cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13679605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monalizumab</VALIDVALUE>
          <VALUEMEANING>Monalizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized immunoglobulin G4 (IgG4) monoclonal antibody against the human natural killer (NK) and T-lymphocyte cell checkpoint inhibitor killer cell lectin-like receptor subfamily C member 1 (NKG2A), with potential antineoplastic activity. Upon administration, monalizumab binds to NKG2A and prevents the binding of NKG2A to its ligand human leukocyte antigen-E (HLA-E), which is overexpressed on tumor cells. This blocks the HLA-E-mediated inhibition of NKG2A-positive infiltrating NK and cytotoxic T-lymphocytes (CTLs) and induces a NK and CTL-mediated immune response against the cancer cells leading to their destruction. Human NKG2A, an inhibitory cell surface receptor covalently bound to CD94, is expressed by NK cells and CTLs. Stimulation of the CD94/NKG2A complex inhibits the cytotoxic activity of these cells. HLA-E, a nonclassical HLA class Ib molecule, is often overexpressed on tumor cells and is associated with poor prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6159859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LN-145</VALIDVALUE>
          <VALUEMEANING>Autologous Tumor Infiltrating Lymphocytes LN-145</VALUEMEANING>
          <MEANINGDESCRIPTION>A proprietary preparation of autologous tumor infiltrating lymphocytes (TILs), with potential immunomodulating activity. The autologous TILs are isolated from an autologous tumor sample and expanded ex vivo in the presence of interleukin-2 (IL-2). Upon infusion of the autologous TILs LN-145 back into the patient, the cells specifically recognize, target and kill the patient&#39;s tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13606187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CDX-1140</VALIDVALUE>
          <VALUEMEANING>Anti-CD40 Agonist Monoclonal Antibody CDX-1140</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human immunoglobulin G2 (IgG2) agonistic monoclonal antibody targeting the B-cell surface antigen CD40, with potential immunostimulatory and antineoplastic activities. Upon administration, CDX-1140 targets and binds to CD40 on a variety of immune cell types. This induces CD40-dependent signaling pathways, triggers the proliferation and activation of antigen-presenting cells (APCs) and activates T-cells. This results in an enhanced cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells. CD40, a cell surface receptor and member of the tumor necrosis factor receptor superfamily (TNFRSF), is expressed on various immune cells, such as dendritic cells (DCs), macrophages and B-cells, and plays a key role in the activation of the immune system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13596647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluorouracil/Leucovorin/Oxaliplatin/Docetaxel</VALIDVALUE>
          <VALUEMEANING>FLOT Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of 5-fluorouracil, leucovorin, oxaliplatin and docetaxel that can be used in the treatment of gastric, esophageal and esophagogastric junction cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160565</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13456564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Doxycycline</VALIDVALUE>
          <VALUEMEANING>Doxycycline</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic tetracycline derivative exhibiting antimicrobial activity.  Doxycycline blocks binding of aminoacyl-tRNA to the mRNA-ribosome complex, thereby inhibiting protein synthesis.  In addition, this agent has exhibited inhibition of collagenase activity. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3874894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lutetium Lu 177 Vipivotide Tetraxetan</VALIDVALUE>
          <VALUEMEANING>Lutetium Lu 177 Vipivotide Tetraxetan</VALUEMEANING>
          <MEANINGDESCRIPTION>A radioconjugate composed of PSMA-617, a human prostate-specific membrane antigen (PSMA)-targeting ligand, conjugated to the beta-emitting radioisotope lutetium Lu 177 (177Lu), with potential antineoplastic activity against PSMA-expressing tumor cells. Upon intravenous administration of lutetium Lu 177  vipivotide tetraxetan, vipivotide tetraxetan targets and binds to PSMA-expressing tumor cells. Upon binding, PSMA-expressing tumor cells are destroyed by 177Lu through the specific delivery of beta particle radiation. PSMA, a tumor-associated antigen and type II transmembrane protein, is expressed on the membrane of prostatic epithelial cells and overexpressed on prostate tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C148145</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13961776</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anakinra</VALIDVALUE>
          <VALUEMEANING>Anakinra</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant human nonglycosylated interleukin-1 (IL-1) receptor antagonist with potential antineoplastic activity. Anakinra binds to the IL-1 receptor, thereby blocking the binding of the IL-1 to and activation of its receptor. Blockade of IL-1 activity may inhibit the cascade of downstream pro-angiogenic factors such as vascular endothelial cell growth factor, tumor necrosis factor-alpha, and IL-6, resulting in inhibition of tumor angiogenesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7092700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apoaequorin/Vitamin D Supplement</VALIDVALUE>
          <VALUEMEANING>Apoaequorin/Vitamin D Supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>A dietary supplement composed of synthetic form of the naturally-occurring protein apoaequorin and vitamin D, that may potentially be used to improve memory. Upon oral administration of apoaequorin/vitamin D supplement, apoaequorin, a calcium binding protein naturally found in luminescent jellyfish (Aequorea victoria), may potentially improve memory through the regulation of intracellular calcium in neuronal cells, though it has not been shown to be able to cross the blood brain barrier (BBB).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201815</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14540948</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liraglutide</VALIDVALUE>
          <VALUEMEANING>Liraglutide</VALUEMEANING>
          <MEANINGDESCRIPTION>A long-acting, fatty acylated glucagon-like peptide-1 (GLP-1) analog administered subcutaneously, with antihyperglycemic activity. Liraglutide&#39;s prolonged action and half-life of 11-15 hours are attributed to the attachment of the fatty acid palmitic acid to GLP-1 that reversibly binds to albumin. Albumin binding protects liraglutide from immediate degradation and elimination and causes GLP-1 to be released from abumin in a slow and consistent manner. This agent may cause thyroid C-cell tumors and increases the risk of acute pancreatitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14554869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-spike Protein SARS-CoV-2 Monoclonal Antibody</VALIDVALUE>
          <VALUEMEANING>Anti-spike Protein SARS-CoV-2 Monoclonal Antibody</VALUEMEANING>
          <MEANINGDESCRIPTION>Any monoclonal antibody that is directed against the spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C173741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14554870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tocilizumab</VALIDVALUE>
          <VALUEMEANING>Tocilizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, humanized IgG1 monoclonal antibody directed against the interleukin-6 receptor (IL-6R) with immunosuppressant activity. Tocilizumab targets and binds to both the soluble form of IL-6R (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of IL-6 to its receptor. This prevents IL-6-mediated signaling. Il-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders and certain types of cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4618052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAR NK Cells (PD-L1 CAR-NK cells)</VALIDVALUE>
          <VALUEMEANING>Chimeric Antigen Receptor Natural Killer Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A preparation of natural killer (NK) cells that are engineered to contain a chimeric antigen receptor (CAR).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-10-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14588665</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epcoritamab</VALIDVALUE>
          <VALUEMEANING>Epcoritamab</VALUEMEANING>
          <MEANINGDESCRIPTION>A bispecific monoclonal antibody, with potential immunomodulating and antineoplastic activities. Epcoritamab contains two antigen-recognition sites: one for human CD3, a T-cell surface antigen, and one for human CD20, a tumor-associated antigen (TAA) that is exclusively expressed on B-cells during most stages of B-cell development and is often overexpressed in B-cell malignancies. Upon administration, epcoritamab binds to both T-cells and CD20-expressing B-lineage tumor cells. The resulting cross-linkage may trigger a potent cytotoxic T-lymphocyte (CTL) response against the CD20-expressing tumor B-cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C163022</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13634215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zanubrutinib</VALIDVALUE>
          <VALUEMEANING>Zanubrutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An inhibitor of Bruton&#39;s tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, zanubrutinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways, which leads to the inhibition of the growth of malignant B-cells that overexpress BTK. BTK, a member of the Src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B-lymphocyte development, activation, signaling, proliferation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13744151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mosunetuzumab</VALIDVALUE>
          <VALUEMEANING>Mosunetuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A bispecific, humanized monoclonal antibody with potential antineoplastic activity. Mosunetuzumab contains two antigen-recognition sites: one for human CD3, a T-cell surface antigen, and one for human CD20, a tumor-associated antigen (TAA) that is exclusively expressed on B-cells during most stages of B-cell development and is often overexpressed in B-cell malignancies. Upon administration, mosunetuzumab binds to both T-cells and CD20-expressing tumor B-cells; this cross-links T-cells to tumor cells, and may result in a potent cytotoxic T-lymphocyte (CTL) response against CD20-expressing tumor B-cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129691</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13699255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tafasitamab</VALIDVALUE>
          <VALUEMEANING>Tafasitamab</VALUEMEANING>
          <MEANINGDESCRIPTION>An Fc engineered, humanized anti-CD19 monoclonal antibody directed against the B-cell-specific membrane protein CD19 with potential immunostimulating and antineoplastic activities.Tafasitamab targets and binds to CD19, thereby depleting and eliminating CD19-expressing B-cells. The modified Fc region of XmAb5574 increases binding affinity to Fc-gamma receptors of effector cells and thereby enhances antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cell-mediated phagocytosis (ADCP). CD19 is widely expressed during B-cell development, from pro-B-cell to early plasma cell stages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13743975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Loncastuximab</VALIDVALUE>
          <VALUEMEANING>Loncastuximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized immunoglobulin (Ig) G1 monoclonal antibody directed against the tumor-associated antigen (TAA) CD19, with potential antineoplastic activity. Upon administration, loncastuximab targets and binds to CD19 expressed on tumor cells. This may inhibit the proliferation of CD19-overexpressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen overexpressed in B-cell lineage malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14623885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bictegravir</VALIDVALUE>
          <VALUEMEANING>Bictegravir</VALUEMEANING>
          <MEANINGDESCRIPTION>A human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI), that is used to treat HIV infection. Upon oral administration, bictegravir inhibits the strand transfer activity of HIV-1 integrase, an HIV-1 coded enzyme that is necessary for viral replication. Inhibition of integrase prevents the integration of linear HIV-1 DNA into host genomic DNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C171719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14650182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tetracaine Hydrochloride</VALIDVALUE>
          <VALUEMEANING>Tetracaine Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75104</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14650183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Potassium Phosphate/Sodium Phosphate</VALIDVALUE>
          <VALUEMEANING>Potassium Phosphate/Sodium Phosphate</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination preparation containing potassium phosphate and sodium phosphate used for electrolyte-replacement purposes, dietary supplementation and to acidify urine. Phosphate, a predominant intracellular anion, plays an important role in energy storage, osteoblastic and osteoclastic activities, regulating serum calcium concentrations and numerous cellular phosphate-transfer reactions. Potassium phosphate and sodium phosphate are used to acidify the urine and lower the urinary calcium concentration. This may reduce rash and odor caused by ammonium in the urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dupilumab</VALIDVALUE>
          <VALUEMEANING>Dupilumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant human monoclonal immunoglobulin G4 (IgG4) antibody directed against the alpha chain of the interleukin-4 receptor (IL-4R alpha) with potential immunomodulatory activities. Upon injection, dupilumab selectively binds to the IL-4R alpha chain. This disrupts IL-4/IL-13 signaling and prevents the activation of downstream pathways that mediate type 2 inflammation and may potentially inhibit tumor cell proliferation, survival, and metastasis. IL-4 and IL-13 receptors are present on the surface of numerous cells involved in the pathophysiology of type-2 helper T-cell (Th2) allergic responses, including B-lymphocytes, eosinophils, dendritic cells (DCs), monocytes, macrophages, basophils, keratinocytes, bronchial epithelial cells, endothelial cells, fibroblasts, and airway smooth muscle cells. Additionally, both IL-4 and IL-13 receptors are overexpressed in a variety of cancers and IL-4 and IL-13 and may serve as biomarkers for cancer aggressiveness. IL-4 and IL-13 are thought to be key regulatory cytokines in the tumor microenvironment (TME) and may play a role in the activation of tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) that mediate tumor cell survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C162455</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13634130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-1-Proteinase Inhibitor Human</VALIDVALUE>
          <VALUEMEANING>Alpha-1-Proteinase Inhibitor Human</VALUEMEANING>
          <MEANINGDESCRIPTION>Human serum-derived alpha-1 proteinase inhibitor (alpha-1-antitrypsin or AAT) with immunomodulating and anti-inflammatory activity. Upon administration, AAT reduces the production of proinflammatory cytokines, such as tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-32, IL-6, and proteinase 3, and induces the production of anti-inflammatory cytokines, such as IL-10 and the IL-1 receptor antagonist IL-1RN. This agent also downregulates heparan sulfate and reduces the expansion of cytotoxic effector T cells, interferes with the maturation of dendritic cells and increases T regulatory cells. Altogether, AAT may attenuate acute graft-versus-host disease (GvHD) and may facilitate graft acceptance and survival. In addition, AAT enhances levels of cAMP and activation of cAMP-dependent protein kinase A. AAT, a 52kD protein and serine protease inhibitor, belongs to the serpin superfamily.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82258</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7631837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nitazoxanide</VALIDVALUE>
          <VALUEMEANING>Nitazoxanide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic benzamide with antiprotozoal activity. Nitazoxanide exerts its antiprotozoal activity by interfering with the pyruvate ferredoxin/flavodoxin oxidoreductase dependent electron transfer reaction, which is essential to anaerobic energy metabolism. PFOR enzyme reduces nitazoxanide, thereby impairing the energy metabolism. However, interference with the PFOR enzyme-dependent electron transfer reaction may not be the only pathway by which nitazoxanide exhibits antiprotozoal activity. Nitazoxanide is active against Giardia lamblia and Cryptosporidium parvum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3944878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vibegron</VALIDVALUE>
          <VALUEMEANING>Vibegron (Gemtesa)</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C152872</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14672740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5-Hydroxytryptophan, DL-</VALIDVALUE>
          <VALUEMEANING>5-Hydroxytryptophan, DL-</VALUEMEANING>
          <MEANINGDESCRIPTION>A racemic mixture of 5-hydroxytryptophan (5-HTP), a precursor to the neurotransmitter serotonin with anti-depressant, analgesic and appetite-suppressant activities. DL-5-HTP is decarboxylated to serotonin by aromatic-L-amino-acid decarboxylase, and results in increased serotonin levels within the brain. Mediated through serotonin receptors, elevated levels of serotonin causes increased serotonin neurotransmissions, hence leading to release of depression, pain and appetite.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Activated Charcoal</VALIDVALUE>
          <VALUEMEANING>Activated Charcoal</VALUEMEANING>
          <MEANINGDESCRIPTION>Carbon that has been treated to create small, low-volume pores that increase the surface area available for adsorption.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5206952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cultured Lentinula edodes Mycelia Extract</VALIDVALUE>
          <VALUEMEANING>Cultured Lentinula edodes Mycelia Extract</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable capsule-based formulation of a standardized extract of cultured Lentinula edodes (Shiitake mushroom) mycelia (ECLM), which is high in the polysaccharides beta- and alpha-glucans, with potential antioxidant, immunomodulating and antineoplastic activities. Upon oral administration, the cultured Lentinula edodes mycelia extract activates the immune system, by binding to toll-like receptors (TLRs), specifically TLR-4, and induces the activation of dendritic cells (DCs), natural killer (NK) cells, macrophages and T-cells and the release of cytokines. This may clear human papillomavirus (HPV) infections.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C179283</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Garlic Extract/Olive Leaf Extract/Elderberry/Oregano Oil/Arabinogalactans/Rosemary Oil-based Supplement</VALIDVALUE>
          <VALUEMEANING>Garlic Extract/Olive Leaf Extract/Elderberry/Oregano Oil/Arabinogalactans/Rosemary Oil-based Supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable herbal combination formulation containing garlic (Allium sativum) bulb extract, olive (Olea europaea) leaf extract, elderberry (Sambucus nigra), oregano (Origanum vulgare) oil, arabinogalactans from the Larch tree (Larix laricina), and rosemary (Rosmarinus officinalis) oil.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin A/C/E-Zinc/Copper-based Supplement</VALIDVALUE>
          <VALUEMEANING>Vitamin A/C/E-Zinc/Copper-based Supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable combination formulation containing the vitamins A, C and E, as well as the minerals zinc and copper.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Artemisinin</VALIDVALUE>
          <VALUEMEANING>Artemisinin</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78093</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Berberine</VALIDVALUE>
          <VALUEMEANING>Berberine</VALUEMEANING>
          <MEANINGDESCRIPTION>A quaternary ammonium salt of an isoquinoline alkaloid and active component of various Chinese herbs, with potential antineoplastic, radiosensitizing, anti-inflammatory, anti-lipidemic and antidiabetic activities. Although the mechanisms of action through which berberine exerts its effects are not yet fully elucidated, upon administration this agent appears to suppress the activation of various proteins and/or modulate the expression of a variety of genes involved in tumorigenesis and inflammation, including, but not limited to transcription factor nuclear factor-kappa B (NF-kB), myeloid cell leukemia 1 (Mcl-1), B-cell lymphoma 2 (Bcl-2), B-cell lymphoma-extra large (Bcl-xl), cyclooxygenase (COX)-2, tumor necrosis factor (TNF), interleukin (IL)-6, IL-12, inducible nitric oxide synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1), E-selectin, monocyte chemoattractant protein-1 (MCP-1), C-X-C motif chemokine 2 (CXCL2), cyclin D1, activator protein (AP-1), hypoxia-inducible factor 1 (HIF-1), signal transducer and activator of transcription 3 (STAT3), peroxisome proliferator-activated receptor (PPAR), arylamine N-acetyltransferase (NAT), and DNA topoisomerase I and II. The modulation of gene expression may induce cell cycle arrest and apoptosis, and inhibit cancer cell proliferation. In addition, berberine modulates lipid and glucose metabolism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C83551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Papaverine Hydrochloride/Phentolamine Mesylate Injectable Formulation</VALIDVALUE>
          <VALUEMEANING>Papaverine Hydrochloride/Phentolamine Mesylate Injectable Formulation</VALUEMEANING>
          <MEANINGDESCRIPTION>An injectable formulation composed of the hydrochloride (HCl) salt form of papaverine, an opiate alkaloid isolated from the plant Papaver somniferum and produced synthetically, and the mesylate salt form of phentolamine, a synthetic imidazoline and alpha-adrenergic antagonist, that can be used in the treatment of erectile dysfunction (ED). Upon injection of the papaverine HCl/phentolamine mesylate injectable formulation directly into the corpus cavernosum, the two active ingredients work synergistically. Papaverine non-selectively inhibits phosphodiesterases (PDE), increases cyclic adenosine monophosphate (cAMP) production, relaxes penile smooth muscles, causes vasodilation, and increases blood flow to the penis. This causes an erection. Phentolamine binds to and inhibits alpha-1 and alpha-2 adrenergic receptors, resulting in a decrease in peripheral vascular resistance, relaxes penile smooth muscles, causes vasodilatation, and increases blood flow to the penis, thereby simultaneously causing an erection.�</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mycophenolate Mofetil</VALIDVALUE>
          <VALUEMEANING>Mycophenolate Mofetil (MMF)</VALUEMEANING>
          <MEANINGDESCRIPTION>The morpholinoethyl ester of mycophenolic acid (MPA) with potent immunosuppressive properties.  Mycophenolate stops T-cell and B-cell proliferation through selective inhibition of the de novo pathway of purine biosynthesis.  In vivo, the active metabolite, MPA, reversibly inhibits inosine 5&#39;-monophosphate dehydrogenase, an enzyme involved in the de novo synthesis of guanine nucleotides.  MPA displays high lymphocyte specificity and cytotoxicity due to the higher dependence of activated lymphocytes on both salvage and de novo synthesis of guanine nucleotides relative to other cell types. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5511068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cinacalcet Hydrochloride</VALIDVALUE>
          <VALUEMEANING>Cinacalcet Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The orally bioavailable hydrochloride salt of the calcimimetic cinacalcet. Cinacalcet increases the sensitivity of calcium-sensing receptors on chief cells in the parathyroid gland to extracellular calcium, thereby reducing parathyroid hormone (PTH) secretion. A reduction in PTH levels inhibits osteoclast activity, which may result in a decrease in cortical bone turnover and bone fibrosis, and normalization of serum calcium and phosphorus levels. In addition, by reducing PTH levels, cinacalcet may reduce PSA levels; PTH appears to raise PSA levels and may increase prostate cancer cell growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13633926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clomipramine Hydrochloride</VALIDVALUE>
          <VALUEMEANING>Clomipramine Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt form of clomipramine, a tertiary amine salt derivative of dibenzazepine. Clomipramine hydrochloride is a tricyclic antidepressant that acts by reducing the re-uptake of norepinephrine and serotonin in the central nervous system, thereby enhancing the effects of these neurotransmitters. This drug also binds to alpha-adrenergic, histaminergic, and cholinergic receptors which are responsible for the many side effects seen with this agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dorzolamide Hydrochloride/Timolol Maleate Ophthalmic Solution</VALIDVALUE>
          <VALUEMEANING>Dorzolamide Hydrochloride/Timolol Maleate Ophthalmic Solution</VALUEMEANING>
          <MEANINGDESCRIPTION>An ophthalmic combination agent composed of the hydrochloride salt form of dorzolamide, an inhibitor of carbonic anhydrase II, and the maleate salt form of timolol, a propanolamine derivative and a non-selective beta-adrenergic antagonist, with intraocular pressure-reducing activity. Upon topical administration of dorzolamide hydrochloride/timolol maleate ophthalmic solution, dorzolamide targets, binds to and inhibits carbonic anhydrase II, a zinc-containing enzyme that catalyzes the rapid conversion of carbon dioxide and water into carbonic acid, protons and bicarbonate ions, in the eye.� This decreases aqueous humor secretion, and reduces sodium and fluid transport. Although the precise mechanism of action of timolol is not clearly established, timolol targets, binds to and inhibits beta adrenoceptors in the ciliary body of the eye which may decrease aqueous humor production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Docusate Sodium</VALIDVALUE>
          <VALUEMEANING>Docusate Sodium</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sacubitril/Valsartan</VALIDVALUE>
          <VALUEMEANING>Sacubitril/Valsartan</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination of sacubitril and valsartan with natriuretic and anti-hypertensive properties. Upon administration, sacubitril is metabolized by esterases to its active metabolite, LBQ657 (sacubitrilat), which inhibits neprilysin, a neutral endopeptidase that cleaves natriuretic peptides such as atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and c-type natriuretic peptide (CNP), as well as certain vasoconstricting peptides including as angiotensin I and II, and endothelin-1. Inhibition of neprilysin leads to increased concentrations of endogenous natriuretic peptides, which function to activate downstream receptors that promote vasodilation, natriuresis and diuresis, while simultaneously increasing the concentration of vasoconstricting peptides such as angiotensin II. Co-administration with valsartan, an angiotensin II receptor blocker, prevents the vasoconstrictive effects of neprilysin inhibition and promotes a decrease in vascular resistance and blood pressure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C162629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13961838</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Azelaic Acid</VALIDVALUE>
          <VALUEMEANING>Azelaic Acid</VALUEMEANING>
          <MEANINGDESCRIPTION>A naturally occurring dicarboxylic acid produced by Malassezia furfur and found in whole grain cereals, rye, barley and animal products.  Azelaic acid possesses antibacterial, keratolytic, comedolytic, and anti-oxidant activity. Azelaic acid is bactericidal against Proprionibacterium acnes and Staphylococcus epidermidis due to its inhibitory effect on the synthesis of microbial cellular proteins. Azelaic acid exerts its keratolytic and comedolytic effects by reducing the thickness of the stratum corneum and decreasing the number of keratohyalin granules by reducing the amount and distribution of filaggrin in epidermal layers. Azelaic acid also possesses a direct anti-inflammatory effect due to its scavenger activity of free oxygen radical. This drug is used topically to reduce inflammation associated with acne and rosacea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ginger</VALIDVALUE>
          <VALUEMEANING>Ginger</VALUEMEANING>
          <MEANINGDESCRIPTION>A fresh, dried or processed form of the rhizome of the Asian perennial plant Zingiber officinale (ginger) with potential anti-emetic activity. Ginger is mainly used in cooking due to its unique fragrance and flavor and has been studied for its use in the treatment of nausea and vomiting. The gingeroles and shoagoles found in ginger may be responsible for ginger&#39;s anti-emetic effect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66725</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arginine</VALIDVALUE>
          <VALUEMEANING>Arginine</VALUEMEANING>
          <MEANINGDESCRIPTION>An essential amino acid in juvenile humans, Arginine is a complex amino acid, often found at active site in proteins and enzymes due to its amine-containing side chain. Arginine may prevent or treat heart and circulatory diseases, combat fatigue, and stimulate the immune system. It also boosts production of nitric oxide, relaxing blood vessels, and treating angina and other cardiovascular problems. Arginine is also an important intermediate in the urea cycle and in detoxification of nitrogenous wastes. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62008</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3256941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Levomilnacipran Hydrochloride</VALIDVALUE>
          <VALUEMEANING>Levomilnacipran Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zinc Monomethionine/Copper-based Supplement</VALIDVALUE>
          <VALUEMEANING>Zinc Monomethionine/Copper-based Supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable combination of the minerals zinc, which is complexed with the essential amino acid methionine, and copper.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Marigold Extract/Saffron Extract-based Supplement</VALIDVALUE>
          <VALUEMEANING>Marigold Extract/Saffron Extract-based Supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable combination of saffron (Crocus sativus) stigma extract and Marigold (Tagetes erecta) flower extract which provides lutein, (meso-)zeaxanthin, phospholipids, and mixed carotenoids, including alpha-carotene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dronedarone Hydrochloride</VALIDVALUE>
          <VALUEMEANING>Dronedarone Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12399014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sodium Borate</VALIDVALUE>
          <VALUEMEANING>Sodium Borate</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nattokinase/Serrapeptase-based Supplement</VALIDVALUE>
          <VALUEMEANING>Nattokinase/Serrapeptase-based Supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>A dietary supplement formulation composed of two proteolytic enzymes nattokinase, a serine protease derived from Bacillus subtilis and produced during natto&#39;s fermentation process, and serrapeptase, which is derived from the non-pathogenic enterobacteria Serratia E15.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nicotine Gum</VALIDVALUE>
          <VALUEMEANING>Nicotine Gum</VALUEMEANING>
          <MEANINGDESCRIPTION>A chewing gum containing nicotine used as a substitute for the active ingredient in tobacco. Nicotine chewing gum reduces the withdrawal symptoms associated with smoking cessation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15663</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3276683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ocrelizumab</VALIDVALUE>
          <VALUEMEANING>Ocrelizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A Fc-modified, humanized monoclonal antibody directed against the B-cell CD20 cell surface antigen, with immunosuppressive activity. Ocrelizumab binds to CD20 on the surfaces of B-cells, triggering complement-dependent cell lysis (CDCL) and antibody-dependent cell-mediated cytotoxicity (ADCC) of B-cells overexpressing CD20. The CD20 antigen, a non-glycosylated cell surface phosphoprotein that acts as a calcium ion channel, is found on over 90% of B-cells, B-cell lymphomas, and other lymphoid tumor cells of B-cell origin; it plays an important role in B-cell functioning.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13714642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pomegranate</VALIDVALUE>
          <VALUEMEANING>Pomegranate</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73929</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Saw Palmetto Berry Extract/Lycopene/Beta-Sitosterol/Vitamin D3/Zinc/Selenium/Quercetin-based Supplement</VALIDVALUE>
          <VALUEMEANING>Saw Palmetto Berry Extract/Lycopene/Beta-Sitosterol/Vitamin D3/Zinc/Selenium/Quercetin-based Supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>A dietary supplement formulation composed of saw palmetto berry extract, lycopene, beta-sitosterol, vitamin D3, zinc, selenium, and quercetin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pygeum Extract</VALIDVALUE>
          <VALUEMEANING>Pygeum Extract</VALUEMEANING>
          <MEANINGDESCRIPTION>An herbal extract derived from the African prune tree Pygeum africanum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Red Yeast Rice Extract</VALIDVALUE>
          <VALUEMEANING>Red Yeast Rice Extract</VALUEMEANING>
          <MEANINGDESCRIPTION>An extract derived from rice that has been fermented with the yeast Monascus purpureus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resveratrol</VALIDVALUE>
          <VALUEMEANING>Resveratrol</VALUEMEANING>
          <MEANINGDESCRIPTION>A phytoalexin derived from grapes and other food products with antioxidant and potential chemopreventive activities. Resveratrol induces phase II drug-metabolizing enzymes (anti-initiation activity); mediates anti-inflammatory effects and inhibits cyclooxygenase and hydroperoxidase functions (anti-promotion activity); and induces promyelocytic leukemia cell differentiation (anti-progression activity), thereby exhibiting activities in three major steps of carcinogenesis. This agent may inhibit TNF-induced activation of NF-kappaB in a dose- and time-dependent manner. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3630009</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Riboflavin</VALIDVALUE>
          <VALUEMEANING>Riboflavin</VALUEMEANING>
          <MEANINGDESCRIPTION>An essential human nutrient that is a heat-stable and water-soluble flavin belonging to the vitamin B family. Riboflavin is a precursor of the coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). These coenzymes are of vital importance in normal tissue respiration, pyridoxine activation, tryptophan to niacin conversion, fat, carbohydrate, and protein metabolism, and glutathione reductase mediated detoxification. Riboflavin may also be involved in maintaining erythrocyte integrity. This vitamin is essential for healthy skin, nails, and hair.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C808</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Selenium/Fermented Organic Mushroom Blend/Uncaria tomentosa Bark-based supplement</VALIDVALUE>
          <VALUEMEANING>Selenium/Fermented Organic Mushroom Blend/Uncaria tomentosa Bark-based supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>A dietary supplement formulation composed of fermented organic mushroom blend, including Maitake (Grifola frondosa) mycelia, Shiitake (Lentinula eddoes) mycelia and Reishi (Ganoderma lucidum) mycelia, selenium, and Uncaria tomentosa (cat�s claw) bark.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zopiclone</VALIDVALUE>
          <VALUEMEANING>Zopiclone</VALUEMEANING>
          <MEANINGDESCRIPTION>The racemic form of a nonbenzodiazepine, cyclopyrrolone with hypnotic and sedative activity and without significant anxiolytic activity. Although the exact mechanism of action remains to be fully elucidated, zopiclone is able to bind to and activate the omega-1 subtype of the alpha subunit of the gamma-aminobutyric acid-benzodiazepine GABA receptor complex (GABA-A), a chloride ionophore complex in the central nervous system (CNS). This leads to the opening of chloride channels, causing hyperpolarization, inhibition of neuronal firing, and enhancement of the inhibitory effect of GABA. This eventually leads to a hypnotic effect and allows for an induction of sleep.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mushroom Extract</VALIDVALUE>
          <VALUEMEANING>Mushroom Extract</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14675364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prebiotic supplements</VALIDVALUE>
          <VALUEMEANING>Synbiotic Supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>A nutritional supplement comprised of prebiotic and probiotic ingredients, with potential immunomodulating and gastrointestinal (GI) flora restoring activity. Upon ingestion of the synbiotic supplement, the prebiotics and probiotics work synergistically in the GI tract, thereby modulating the GI flora ecosystem and may improve the functions of the intestinal barrier. In addition, synbiotics may have a beneficial effect on the immune system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99230</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14688620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alrizomadlin</VALIDVALUE>
          <VALUEMEANING>Alrizomadlin</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available inhibitor of human homolog of double minute 2 (HDM2; mouse double minute 2 homolog; MDM2), with potential antineoplastic activity. Upon oral administration,alrizomadlin binds to HDM2, preventing the binding of the HDM2 protein to the transcriptional activation domain of the tumor suppressor protein p53. By preventing this HDM2-p53 interaction, the proteasome-mediated enzymatic degradation of p53 is inhibited and the transcriptional activity of p53 is restored. This may result in the restoration of p53 signaling and lead to the p53-mediated induction of tumor cell apoptosis. HDM2, a zinc finger protein and a negative regulator of the p53 pathway, is often overexpressed in cancer cells. It has been implicated in cancer cell proliferation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13961798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alogliptin</VALIDVALUE>
          <VALUEMEANING>Lactation Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder not necessarily related to pregnancy that is observed in females and males. It is characterized by disturbances of milk secretion. Causes include damage to the breast parenchyma due to inflammation, medications, pituitary tumors, and hypothyroidism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79606</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zotiraciclib Citrate</VALIDVALUE>
          <VALUEMEANING>Zotiraciclib Citrate</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable citrate salt form of zotiraciclib a multi-kinase inhibitor for cyclin dependent kinase (CDK) subtypes 1, 2, 7 and 9, Janus-associated kinase 2 (JAK2), FMS-related tyrosine kinase 3 (FLT3, FLK2, STK1), with potential antineoplastic activity. Upon oral administration, CDK/JAK2/FLT3 Inhibitor TG02 binds to and inhibits the CDK subtypes, JAK2, and FLT3. TG02 also inhibits, to a lesser extent, TYK2, TYRO3, STAT5 and P38delta. This may result in both an induction of apoptosis and an inhibition of tumor cell proliferation in cancer cells that overexpress these kinases. JAK2, often upregulated or mutated in a variety of cancer cells, mediates STAT3 activation and plays a key role in tumor cell proliferation and survival. CDKs are serine/threonine kinases that play key roles in the regulation of the cell cycle and cellular proliferation. FLT3, a class III tyrosine kinase receptor, is overexpressed or mutated in most B lineage and acute myeloid leukemias.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13746575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NovoTTF-100A Device</VALIDVALUE>
          <VALUEMEANING>NovoTTF-100A Device</VALUEMEANING>
          <MEANINGDESCRIPTION>A portable, battery-operated device that is used to apply low intensity, alternating electric fields, also called tumor treatment fields (TTFs; TTFields), that can potentially be used to kill cancer cells. Upon placement of the insulated electrodes of the NovoTTF-100A device on the skin&#39;s surface encircling the tumor area, electrical charges are delivered, and the resulting electrical fields interfere with cell division. This induces cell death in and inhibits proliferation of tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7717906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Valproic Acid</VALIDVALUE>
          <VALUEMEANING>Valproic Acid</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of propylpentanoic acid with antiepileptic properties and potential antineoplastic and antiangiogenesis activities.  In epilepsy, valproic acid appears to act by increasing the concentration of gamma-aminobutyric acid (GABA) in the brain. This agent&#39;s antitumor and antiangiogenesis activities may be related to the inhibition of histone deacetylases and nitric oxide synthase, which results in the inhibition of nitric oxide synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29536</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7460887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Topical Leptospermum Honey</VALIDVALUE>
          <VALUEMEANING>Topical Leptospermum Honey</VALUEMEANING>
          <MEANINGDESCRIPTION>A topical formulation composed of active Leptospermum honey (ALH), a monofloral honey produced by bees fed on the flowers of the New Zealand Manuka bush (Leptospermum scoparium), with potential wound repair, antibacterial, anti-inflammatory, and protective activities. Upon administration of topical Leptospermum honey, the active ingredients in this honey may promote healing, and prevent inflammation and infection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203678</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14737557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DRD2 Antagonist/ClpP Agonist ONC206</VALIDVALUE>
          <VALUEMEANING>DRD2 Antagonist/ClpP Agonist ONC206</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, selective bitopic dopamine receptor D2 (DRD2) antagonist and mitochondrial caseinolytic protease P (ClpP) agonist, with potential antineoplastic activity. Upon administration, DRD2 antagonist/ClpP agonist ONC206 targets, binds to and inhibits the activity of DRD2. This may inactivate Akt (protein kinase B) and extracellular signal-regulated kinase (ERK), which may result in inhibition of the phosphatidylinositol 3-kinase (PI3K)/Akt signal transduction pathway as well as the mitogen-activated protein kinase (MAPK)/ERK-mediated pathway. This may lead to the induction of tumor cell apoptosis mediated by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)/death receptor type 5 (DR5; TRAIL receptor 2) signaling in tumor cells. In addition, ONC206 targets and binds to ClpP and induces proteolysis. This may disrupt mitochondrial structure and function in tumor cells and lead to tumor cell death. DRD2, a G protein-coupled receptor (GPCR), is overexpressed in various malignancies. It is activated by dopamine produced by the tumor cells or present in the tumor microenvironment (TME) and plays an important role in the pro-survival and stress signaling pathways. ONC206 is able to cross the blood-brain barrier (BBB).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14483679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protein Phosphatase 2A Inhibitor LB-100</VALIDVALUE>
          <VALUEMEANING>Protein Phosphatase 2A Inhibitor LB-100</VALUEMEANING>
          <MEANINGDESCRIPTION>A water soluble inhibitor of the protein phosphatase 2A (PP2A), with potential chemo- and radiotherapy enhancing activity. Upon injection, PP2A inhibitor LB-100 inhibits the removal of phosphate groups from proteins essential for cell cycle progression. When used with radio- or chemotherapy treatment, this agent prevents the activation of PP2A-mediated repair mechanisms and allows for malignant cells to progress through the cell cycle without having their damaged DNA repaired. This enhances the cytotoxic effect of the chemotherapeutic or radiotherapeutic agent and results in tumor cell apoptosis. PP2A, a serine/threonine phosphatase that plays a key role in the control of cell growth and DNA damage repair.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13724985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Galcanezumab-gnlm</VALIDVALUE>
          <VALUEMEANING>Galcanezumab</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14741291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pamiparib</VALIDVALUE>
          <VALUEMEANING>Pamiparib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP), with potential antineoplastic activity. Upon administration, pamiparib selectively binds to PARP and prevents PARP-mediated repair of single-strand DNA breaks via the base-excision repair (BER) pathway. This enhances the accumulation of DNA strand breaks, promotes genomic instability, and eventually leads to apoptosis. PARP is activated by single-strand DNA breaks and, subsequently, catalyzes post-translational ADP-ribosylation of nuclear proteins which then transduce signals to recruit other proteins to repair damaged DNA. Pamiparib may both potentiate the cytotoxicity of DNA-damaging agents and reverse tumor cell chemo- and radioresistance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13715000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lirafugratinib</VALIDVALUE>
          <VALUEMEANING>Lirafugratinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of the fibroblast growth factor receptor 2 (FGFR2), with potential antineoplastic activity. Upon oral administration, lirafugratinib binds to and inhibits FGFR2, which results in the inhibition of FGFR2-mediated signal transduction pathways. This inhibits the proliferation of FGFR2-overexpressing tumor cells. FGFR2, a receptor tyrosine kinase upregulated in many tumor cell types, plays a key role in cellular proliferation, migration and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13961738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Devimistat</VALIDVALUE>
          <VALUEMEANING>Devimistat</VALUEMEANING>
          <MEANINGDESCRIPTION>A racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities. Although the exact mechanism of action is unknown, devimistat has been shown to inhibit metabolic and regulatory processes required for cell growth in solid tumors. Both enantiomers in the racemic mixture exhibit antineoplastic activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80039</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13634059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brinzolamide</VALIDVALUE>
          <VALUEMEANING>Brinzolamide (Azopt)</VALUEMEANING>
          <MEANINGDESCRIPTION>A sulfonamide and carbonic anhydrase inhibitor with specific affinity for carbonic anhydrase II. Following topical ocular administration, brinzolamide inhibits carbonic anhydrase II, an enzyme that is responsible for the movement of sodium and fluid transport in the eye. This inhibition leads to a decrease in aqueous humor secretion, probably by slowing the formation of bicarbonate ions, and results in a reduction in intraocular pressure. Brinzolamide is used to treat increased pressure in the eye caused by open-angle glaucoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14770128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pexastimogene Devacirepvec</VALIDVALUE>
          <VALUEMEANING>Pexastimogene Devacirepvec</VALUEMEANING>
          <MEANINGDESCRIPTION>An oncolytic thymidine kinase (TK)-deleted vaccinia poxvirus expressing human GM-CSF (hGM-CSF) with antineoplastic activity. Upon intratumoral or intravenous administration, pexastimogene devacirepvec selectively infects and lyses tumor cells. While vaccinia displays a natural tumor cell tropism, deletion of the TK gene increases the tumor selectivity of vaccinia by limiting viral replication to cells expressing high levels of TK, such as certain cancer cells. hGM-CSF expression by this agent helps recruit antigen presenting cells (APCs), such as dendritic cells (DCs) and macrophages, to virally infected tumor cells, thereby initiating an antitumoral immune response.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13722187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Memantine</VALIDVALUE>
          <VALUEMEANING>Memantine</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4599972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mefloquine</VALIDVALUE>
          <VALUEMEANING>Mefloquine</VALUEMEANING>
          <MEANINGDESCRIPTION>A quinolinemethanol derivative with antimalarial, anti-inflammatory, and potential chemosensitization and radiosensitization activities. Although the exact mechanism remains to be elucidated, mefloquine, a weak base, preferentially accumulates in lysosomes and disrupts lysosomal function and integrity, thereby leading to host cell death. Similar to chloroquine, the chemosensitizing and radiosensitizing activities of this agent may be related to its inhibition of autophagocytosis, a cellular mechanism involving lysosomal degradation that minimizes the production of reactive oxygen species (ROS) related to tumor reoxygenation and tumor exposure to chemotherapeutic agents and radiation. Compared to chloroquine, mefloquine has better blood-brain-barrier (BBB) penetration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61827</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4144094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623</VALIDVALUE>
          <VALUEMEANING>Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623</VALUEMEANING>
          <MEANINGDESCRIPTION>A live-attenuated, double-deleted strain of the Gram-positive bacterium Listeria monocytogenes (Lm) encoding a mutant form of the tumor associated antigens, epidermal growth factor receptor (EGFRvIII) and the cancer/testis antigen NY-ESO-1, with potential immunostimulatory and antineoplastic activities. Upon intravenous administration, live-attenuated Listeria monocytogenes encoding EGFRvIII-NY-ESO-1 vaccine targets dendritic cells and expresses EGFRvIII and NY-ESO-1. This promotes both a potent innate immune response and an adaptive immune response involving the recruitment and activation of T lymphocytes against EGFRvIII and NY-ESO-1-expressing tumor cells, which results in tumor cell lysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13682331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vorasidenib</VALIDVALUE>
          <VALUEMEANING>Vorasidenib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available inhibitor of mutated forms of both isocitrate dehydrogenase type 1 (IDH1, IDH1 [NADP+] soluble) in the cytoplasm and type 2 (IDH2, isocitrate dehydrogenase [NADP+], mitochondrial) in the mitochondria, with potential antineoplastic activity. Upon administration, vorasidenib specifically inhibits mutant forms of IDH1 and IDH2, thereby inhibiting the formation of the oncometabolite 2-hydroxyglutarate (2HG) from alpha-ketoglutarate (a-KG). This prevents 2HG-mediated signaling and leads to both an induction of cellular differentiation and an inhibition of cellular proliferation in tumor cells expressing IDH mutations. In addition, vorasidenib is able to penetrate the blood-brain barrier (BBB). IDH1 and 2, metabolic enzymes that catalyze the conversion of isocitrate into a-KG, play key roles in energy production and are mutated in a variety of cancer cell types. In addition, mutant forms of IDH1 and 2 catalyze the formation of 2HG and drive cancer growth by blocking cellular differentiation and inducing cellular proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C152914</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13746536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Upadacitinib</VALIDVALUE>
          <VALUEMEANING>Upadacitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C152802</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14796888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adalimumab</VALIDVALUE>
          <VALUEMEANING>Adalimumab (Humira)</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, human IgG1 monoclonal antibody directed against tumor necrosis factor-alpha (TNF-alpha), with immunomodulating activity. Upon administration, adalimumab binds to TNF-alpha, thereby preventing its binding to the p55 and p75 TNF cell surface receptors and inhibiting TNF-mediated immune responses. TNF-alpha, a pro-inflammatory cytokine, is upregulated in various autoimmune diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5608404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enasidenib</VALIDVALUE>
          <VALUEMEANING>Enasidenib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available inhibitor of specific mutant forms of the mitochondrial enzyme isocitrate dehydrogenase type 2 (IDH2), with potential antineoplastic activity. Upon administration, enasidenib specifically inhibits various mutant forms of IDH2, including the IDH2 variants R140Q, R172S, and R172K, which inhibits the formation of 2-hydroxyglutarate (2HG). This may lead to both an induction of cellular differentiation and an inhibition of cellular proliferation in IDH2-expressing tumor cells. IDH2, an enzyme in the citric acid cycle, is mutated in a variety of cancers; it initiates and drives cancer growth by blocking differentiation and the production of the oncometabolite 2HG.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429528</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytarabine/Hydrocortisone/Methotrexate Regimen</VALIDVALUE>
          <VALUEMEANING>Cytarabine/Hydrocortisone/Methotrexate Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of cytarabine, hydrocortisone, and methotrexate that may be used in the treatment and prevention of central nervous system (CNS) involvement in leukemias and lymphomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10201</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-03-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14846679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flumazenil</VALIDVALUE>
          <VALUEMEANING>Flumazenil</VALUEMEANING>
          <MEANINGDESCRIPTION>An imidazo-benzodiazepine derivative, effective in reversing benzodiazepine-induced activities. Flumazenil antagonizes the benzodiazepine binding site of the gamma-aminobutyric acid (GABA)/benzodiazepine receptor complex in the central nervous system (CNS), thereby preventing the chloride channel opening events and inhibiting neuronal hyperpolarization. As a result, flumazenil reverses benzodiazepine-induced effects including sedation, psychomotor deficits, amnesia, and hypoventilation in a dose-dependent manner.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47534</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-03-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14846703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Silmitasertib</VALIDVALUE>
          <VALUEMEANING>Silmitasertib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable small-molecule inhibitor of the enzyme casein kinase II (CK2), with potential antineoplastic, anti-viral and immunomodulatory activities. Upon oral administration, silmitasertib selectively binds to and inhibits the activity of CK2. This may inhibit proliferation of CK2-expressing tumor cells, and may also inhibit the replication of severe acute respiratory syndrome coronavirus-2 (SARS-COV-2). In addition, this may restore normal host cell cytokine regulation, prevent cytokine storm and suppress the hyperactivation of the innate immune system. CK2, a protein kinase often overexpressed in a variety of cancer cell types, appears to be correlated with malignant transformation, tumor growth and survival. CK2 regulates a diverse array of pro-survival cellular processes including epidermal growth factor receptor (EGFR) signaling, PI3K/AKT/mTOR signaling, hedgehog (Hh) signaling, Hsp90 machinery, hypoxia, and interleukin (IL)-6 expression. CK2 also regulates the activity of XRCC1 and MDC1, two mediator/adaptor proteins that are essential for DNA repair. CK2 is upregulated by SARS-COV-2 and is associated with SARS-COV-2 viral replication and the development of cytokine storm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98054</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14889563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AVM0703</VALIDVALUE>
          <VALUEMEANING>AVM0703</VALUEMEANING>
          <MEANINGDESCRIPTION>A supra-pharmacologic, high-volume formulation containing the sodium phosphate form of the corticosteroid dexamethasone, with potential antineoplastic and lymphoablative, and with anti-inflammatory and immunomodulating activities. Upon administration of supra-pharmacologic dexamethasone sodium phosphate AVM0703, dexamethasone targets and binds to the cytoplasmic glucocorticoid receptor (GR); then the receptor-ligand complex is translocated to the nucleus where it initiates the transcription of genes encoding for anti-inflammatory mediators, such as cytokines and lipocortins. More importantly, AVM0703 is able to supercharge and mobilize various lymphocytes and monocytes, such as natural killer T-cells (NK/T), gamma delta T-cells and dendritic cells (DCs). These immune cells, in turn, invade and destroy certain tumor cells.  In addition, these immune cells that are induced by AVM0703 may also be able to kill viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By depleting monocytes, AVM0703 may also reduce cytokine-release syndrome (CRS). AVM0703 also lympho-ablates both T and B lymphocytes for &#39;immune reset&#39; via receptor mediated induction of caspase dependent apoptosis. This specific dexamethasone formulation contains about twenty-five times the dose of other dexamethasone formulations. AVM0703 does not have an effect on red blood cells (RBCs), platelets, and hematopoietic stem cells (HSCs).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172928</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14943434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HCW9218</VALIDVALUE>
          <VALUEMEANING>Bifunctional TGF-beta Antagonist/IL-15 Protein Complex HCW9218</VALUEMEANING>
          <MEANINGDESCRIPTION>A heterodimeric, bifunctional fusion protein composed of the ectodomains of the transforming growth factor (TGF) beta (TGF-beta; TGFb) receptor II (TGFbRII;TGFBR2) fused to a human immunostimulatory cytokine interleukin-15 (IL-15)/ IL-15 receptor alpha complex, with potential immunostimulatory and antineoplastic activities. Upon administration of the bifunctional TGF-beta antagonist/IL-15 protein complex HCW9218, the TGFbRII moiety specifically and selectively targets, binds to and neutralizes TGF-beta, an immunosuppressive cytokine secreted by tumors. This prevents TGF-beta from binding to TGF receptors and prevents TGFb-mediated signaling. This abrogates TGFb-mediated immunosuppression in the tumor microenvironment (TME), enhances immune cell infiltration and anti-tumor immunity in the TME, and promotes a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells leading to tumor cell death. This may lead to a reduction in TGFb-dependent proliferation of cancer cells. The IL-15 moiety stimulates the proliferation and cytotoxic activity of natural killer (NK) cells, cytotoxic T-lymphocytes (CTLs) and memory T-cells locally in the TME, which further induces an anti-tumor immune response, and increases tumor cell killing. In addition, by stimulating the immune system and NK cell activation, HCW9218 may eliminate chemotherapy-induced senescent cells in tumors and normal tissues, may reduce senescence-associated secretory phenotype (SASP) factor activity, and may reduce therapy-induced senescence (TIS)-mediated proinflammatory side effects in normal tissues. TGFb, overproduced in many types of cancer, plays a key role in immunosuppression in the TME, enhances tumor cell proliferation, and promotes cancer progression. IL-15 regulates CD8+ T and NK cell development, activation and proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14950946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axatilimab</VALIDVALUE>
          <VALUEMEANING>Axatilimab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized immunoglobulin (Ig) G4 monoclonal antibody directed against colony-stimulating factor 1 receptor (CSF-1R), with potential antineoplastic activity. Upon intravenous administration, axatilimab binds to the ligand binding domain of CSF-1R, preventing binding and consequent activation by its natural ligands, IL-34 and colony-stimulating factor 1 (CSF-1). Inhibition of CSF-1R activation may disrupt the activity of tumor-associated macrophages (TAMs), which promote initiation and metastasis of tumor cells, inhibit T-cell responses, and stimulate tumor angiogenesis and disease progression. CSF-1R, also known as macrophage colony-stimulating factor receptor (M-CSFR) and cluster of differentiation 115 (CD115), is a tyrosine-protein kinase that plays an essential role in the regulation, proliferation, survival and differentiation of tissue macrophages as well as TAMs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C155813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13606197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sodium Zirconium Cyclosilicate</VALIDVALUE>
          <VALUEMEANING>Sodium Zirconium Cyclosilicate (Lokelma)</VALUEMEANING>
          <MEANINGDESCRIPTION>An insoluble, non-absorbed inorganic material used as a potassium binder and a treatment for hyperkalemia. Upon administration as an oral suspension, sodium zirconium cyclosilicate selectively targets and binds to potassium in the gastrointestinal (GI) tract, exchanging its sodium ions for potassium ions. This increases fecal potassium excretion, decreases the concentration of free potassium in the GI lumen, and lowers serum potassium levels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C152381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14968509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cetirizine</VALIDVALUE>
          <VALUEMEANING>Cetirizine</VALUEMEANING>
          <MEANINGDESCRIPTION>Cetirizine is a metabolite of hydroxyzine and a selective peripheral histamine H1-receptor antagonist. It is used for symptomatic treatment of seasonal and perennial allergic rhinitis and for chronic urticaria. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577799</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Budesonide/Formoterol Fumarate Dihydrate Inhalation Aerosol</VALIDVALUE>
          <VALUEMEANING>Budesonide/Formoterol Fumarate Dihydrate Inhalation Aerosol</VALUEMEANING>
          <MEANINGDESCRIPTION>An inhalation aerosol formulation containing budesonide and the fumarate dihydrate salt of formoterol with anti-inflammatory and bronchial smooth muscle-relaxing activities. The synthetic corticosteroid steroid budesonide binds to intracellular glucocorticosteroid receptors (GRs), exhibiting inhibitory activities against multiple cell types and mediators associated with allergic inflammation. The long-acting beta-adrenergic receptor agonist formoterol selectively binds to beta-2 adrenergic receptors in bronchial smooth muscle, activating intracellular adenyl cyclase, an enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3&#39;,5&#39;-adenosine monophosphate (cAMP); increased intracellular cAMP result in the relaxation of bronchial smooth muscle and inhibition of the cellular release of mediators of immediate hypersensitivity, especially from mast cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71534</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3238485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Triamcinolone</VALIDVALUE>
          <VALUEMEANING>Triamcinolone</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. Upon cell entry, triamcinolone binds to and activates the glucocorticoid receptor, which leads to translocation of the ligand-receptor complex to the nucleus and induces expression of glucocorticoid-responsive genes such as lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes, both mediators of inflammation. In addition, pro-inflammatory cytokine production, including interleukin (IL)-1and IL-6, and the activation of cytotoxic T-lymphocytes is also inhibited. T-cells are prevented from making IL-2 and proliferating. This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis through increasing Ikappa-B expression and curtailing activation of nuclear factor (NF)kappa-B.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3305278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Umeclidinium Bromide</VALIDVALUE>
          <VALUEMEANING>Umeclidinium Bromide (Incruse)</VALUEMEANING>
          <MEANINGDESCRIPTION>The bromide salt form of umeclidinium, a muscarinic receptor antagonist, with bronchodilator activity. Although it does not display selectivity for specific muscarinic receptors, on topical application, umeclidinium acts mainly on M3 muscarinic receptors located on smooth muscle cells, thereby preventing smooth muscle contraction and resulting in bronchodilatory effect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C152797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14970093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Teriparatide</VALIDVALUE>
          <VALUEMEANING>Teriparatide</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14970092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Baricitinib</VALIDVALUE>
          <VALUEMEANING>Baricitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory, immunomodulating and antineoplastic activities. Upon administration, baricitinib binds to JAK1/2, which inhibits JAK1/2 activation and leads to the inhibition of the JAK-signal transducers and activators of transcription (STAT) signaling pathway. This decreases the production of inflammatory cytokines and may prevent an inflammatory response. In addition, baricitinib may induce apoptosis and reduce proliferation of JAK1/2-expressing tumor cells. JAK kinases are intracellular enzymes involved in cytokine signaling, inflammation, immune function and hematopoiesis; they are also upregulated and/or mutated in various tumor cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127012</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13606220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Romiplostim</VALIDVALUE>
          <VALUEMEANING>Romiplostim (Nplate)</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant protein with megakaryopoiesis stimulating activity. Romiplostim mimics endogenous thrombopoietin (TPO), directly binding to and activating the platelet thrombopoietin receptor (TpoR, Mpl, or CD110 antigen), a cytokine receptor belonging to the hematopoietin receptor superfamily. Activation of TpoR stimulates the proliferation and differentiation of megakaryocytes, resulting in an increase in the production of blood platelets.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Copaxone</VALIDVALUE>
          <VALUEMEANING>Glatiramer Acetate (Copaxone)</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65805</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3640459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Isavuconazonium sulfate</VALIDVALUE>
          <VALUEMEANING>Isavuconazonium Sulfate (CRESEMBA)</VALUEMEANING>
          <MEANINGDESCRIPTION>The sulfate ester form of isavuconazonium, a prodrug of the triazole antifungal agent isavuconazole, with broad-spectrum antifungal activity. Upon administration, isavuconazonium sulfate is hydrolyzed by plasma esterases to yield the active moiety isavuconazole. Isavuconazole binds to and inhibits the fungal cytochrome P450 family enzyme lanosterol 14-alpha-demethylase (CYP51), which catalyzes the demethylation of lanosterol to yield ergosterol, an important component of the fungal cell membrane. Inhibition of CYP51 leads to a decrease in fungal ergosterol production and disrupts synthesis of the fungal cell membrane, which decreases membrane integrity, increases cell membrane permeability and promotes the loss of essential intracellular elements. This results in fungal cell lysis and death.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14994659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deferoxamine</VALIDVALUE>
          <VALUEMEANING>Deferoxamine</VALUEMEANING>
          <MEANINGDESCRIPTION>An iron-chelating agent that binds free iron in a stable complex, preventing it from engaging in chemical reactions. Deferoxamine chelates iron from intra-lysosomal ferritin and siderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile.  This agent does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7135786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tofacitinib</VALIDVALUE>
          <VALUEMEANING>Tofacitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available inhibitor of Janus kinases (JAK), with immunomodulatory and anti-inflammatory activities. Upon administration, tofacitinib binds to JAK and prevents the activation of the JAK-signal transducers and activators of transcription (STAT) signaling pathway. This may decrease the production of pro-inflammatory cytokines, such as interleukin (IL)-6, -7, -15, -21, interferon-alpha and -beta, and may prevent both an inflammatory response and the inflammation-induced damage caused by certain immunological diseases. JAK kinases are intracellular enzymes involved in signaling pathways affecting hematopoiesis, immunity and inflammation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15005166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Omadacycline Tosylate</VALIDVALUE>
          <VALUEMEANING>Omadacycline Tosylate (Nuzyra)</VALUEMEANING>
          <MEANINGDESCRIPTION>The tosylate salt form of omadacycline, an aminomethylcycline and a semisynthetic tetracycline derivative, with antimicrobial activity. Upon administration, omadacycline binds to the bacterial 30S ribosomal subunit and inhibits bacterial protein synthesis. Omadacycline is engineered to overcome certain tetracycline resistance mechanisms, including tetracycline-specific efflux pumps and ribosomal protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98034</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15005666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Integrin Alpha V Beta 3-targeting Protein ACT50</VALIDVALUE>
          <VALUEMEANING>Integrin Alpha V Beta 3-targeting Protein ACT50 (ProAgio)</VALUEMEANING>
          <MEANINGDESCRIPTION>An integrin alpha V beta 3-targeting protein, with potential pro-apoptotic, anti-angiogenic and antineoplastic activities. Upon administration, integrin alpha V beta 3-targeting protein ACT50 targets the cell surface receptor integrin alpha V beta 3, at a site other than the ligand-binding site, expressed on angiogenic endothelial cells (aECs) and cancer-associated fibroblasts (CAFs) in the tumor microenvironment (TME), and recruits and activates caspase 8. This leads to the apoptosis of alpha V beta 3-expressing aECs and CAFs, and may inhibit tumor growth, angiogenesis, and metastasis. Alpha V beta 3 integrin, a cell adhesion and signaling receptor, is expressed on the surface of aECs, CAFs and some tumor cells and has been associated with increased proliferation, migration and invasion of tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15008950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancrelipase</VALIDVALUE>
          <VALUEMEANING>Pancrelipase</VALUEMEANING>
          <MEANINGDESCRIPTION>A standardized enzyme concentrate containing the pancreatic enzymes, lipase, protease and amylase used in enzyme substitution therapy. Lipase, protease and amylase break down fat, protein, and starches, respectively in the small intestine, thereby promoting digestion. Pancrelipase is used to reduce malabsorption when the pancreas is unable to secrete sufficient amounts of these enzymes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7060536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abiraterone acetate</VALIDVALUE>
          <VALUEMEANING>Abiraterone Acetate</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally active acetate salt of the steroidal compound abiraterone with antiandrogen activity. Abiraterone inhibits the enzymatic activity of steroid 17alpha-monooxygenase (17alpha-hydrolase/C17,20 lyase complex), a member of the cytochrome p450 family that catalyzes the 17alpha-hydroxylation of steroid intermediates involved in testosterone synthesis. Administration of this agent may suppress testosterone production by both the testes and the adrenals to castrate-range levels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68845</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5425971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colostrum High-IG</VALIDVALUE>
          <VALUEMEANING>Colostrum High-IG</VALUEMEANING>
          <MEANINGDESCRIPTION>A dietary supplement consisting of bovine colostrum, containing high titers of immunoglobulins (Igs), with immunostimulating and anti-infective activities. Hyperimmune bovine colostrum is harvested during the first days after calving from cows that have been inoculated repeatedly with specific pathogens during pregnancy. In addition to high titers of anti-pathogen specific antibodies, hyperimmune colostrum is also rich in other immune factors, proline-rich polypeptides (PRP), lactoferrin, glycoproteins, lactalbumins, cytokines, growth factors, vitamins, and minerals. This dietary supplement may exhbit anti-infective activity in immunocompromised patients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15015166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Itacitinib</VALIDVALUE>
          <VALUEMEANING>Itacitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of Janus-associated kinase 1 (JAK1) with potential antineoplastic and immunomodulating activities. Upon oral administration, itacitinib selectively inhibits JAK-1, thereby inhibiting the phosphorylation of signal transducer and activator of transcription (STAT) proteins and the production of proinflammatory factors induced by other cytokines, including interleukin-23 (IL-23) and interleukin-6 (IL-6). The JAK-STAT pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8123275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Potassium Chloride Extended-Release</VALIDVALUE>
          <VALUEMEANING>Potassium Chloride Extended-Release</VALUEMEANING>
          <MEANINGDESCRIPTION>An extended-release (ER) formulation of potassium chloride, the metal halide salt composed of potassium and chloride, that is used for the treatment and prophylaxis of hypokalemia. Upon oral administration, potassium chloride provides potassium. Potassium maintains normal fluid and electrolyte balance, regulates the proper functioning of heart and muscle contractions, supports healthy bone density and blood pressure. It also plays an important role in the transmission of nerve impulses and energy production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C207906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15015165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient Controlled Analgesia (PCA) Morphine</VALIDVALUE>
          <VALUEMEANING>Patient Controlled Analgesia (PCA) Morphine</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of intravenous narcotic analgesic delivery that uses a pump or similar delivery system that allows the patient, or in the absence of the patient&#39;s ability to do so the patient&#39;s nurse or family members, to administer predetermined doses of analgesic as needed to maintain adequate pain control.  This method allows the patient and/or family to have increased autonomy.  Further, research has shown improved pain control and reductions in narcotics necessary to maintain pain control to be associated with this delivery method._The sulfate salt of morphine, an opiate alkaloid isolated from the plant Papaver somniferum and produced synthetically. Morphine binds to and activates specific opiate receptors (delta, mu and kappa), each of which are involved in controlling different brain functions. In the central nervous and gastrointestinal systems, this agent has widespread effects including analgesia, anxiolysis, euphoria, sedation, respiratory depression, and gastrointestinal system smooth muscle contraction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C669, C21060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15015164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bosutinib</VALIDVALUE>
          <VALUEMEANING>Bosutinib (BOSULIF)</VALUEMEANING>
          <MEANINGDESCRIPTION>The monohydrate form of bosutinib, a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity. Unlike imatinib, bosutinib inhibits the autophosphorylation of both Abl and Src kinases, resulting in inhibition of cell growth and apoptosis. Because of the dual mechanism of action, this agent may have activity in resistant CML disease, other myeloid malignancies and solid tumors. Abl kinase is upregulated in the presence of the abnormal Bcr-abl fusion protein which is commonly associated with chronic myeloid leukemia (CML). Overexpression of specific Src kinases is also associated with the imatinib-resistant CML phenotype.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13614604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biotene gel</VALIDVALUE>
          <VALUEMEANING>Biotene gel</VALUEMEANING>
          <MEANINGDESCRIPTION>An edible, gel-based formulation containing glycerin, water, sorbitol, xylitol, carbomer, hydroxyethyl cellulose and sodium hydroxide, with potential anti-xerostomia activity. Upon application, the oral moisturizing gel keeps the mouth moist, and relieves the symptoms of dry mouth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C207897</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15015163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dalbavancin</VALIDVALUE>
          <VALUEMEANING>Dalbavancin</VALUEMEANING>
          <MEANINGDESCRIPTION>A second-generation, semi-synthetic lipoglycopeptide antibiotic, with bactericidal activity against a variety of gram-positive bacteria. Upon administration, dalbavancin binds, at a site different from that of penicillins and cephalosporins, tightly to the D-alanyl-D-alanine portion of peptidoglycan chains, thereby preventing peptidoglycan elongation and interfering with bacterial cell wall synthesis. This leads to activation of bacterial autolysins and induces cell wall lysis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14652335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sotrovimab</VALIDVALUE>
          <VALUEMEANING>Sotrovimab</VALUEMEANING>
          <MEANINGDESCRIPTION>A neutralizing human monoclonal antibody directed against the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for passive immunization against Coronavirus disease 2019 (COVID-19). Upon administration, sotrovimab specifically targets and binds to an epitope on the SARS-CoV-2 S protein that is shared with SARS-CoV-1, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2. S protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177059</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15015520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperbaric Oxygen Therapy</VALIDVALUE>
          <VALUEMEANING>Hyperbaric Oxygen Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of a pressurized chamber for the delivery of oxygen in higher concentrations for therapeutic benefit. Useful in the treatment of severe burns, peripheral vascular disease, carbon monoxide poisoning and decompression illness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38065</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STAT3 Inhibitor C-188-9</VALIDVALUE>
          <VALUEMEANING>STAT3 Inhibitor C-188-9</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, binaphthol-sulfonamide-based inhibitor of signal transducer and activator of transcription 3 (STAT3), with potential antineoplastic activity. Upon oral administration, the STAT3 inhibitor C-188-9 specifically targets and binds to the phosphotyrosyl peptide binding site within the Src homology 2 (SH2) domain of STAT3. This inhibits the Janus kinase (JAK)-mediated tyrosine phosphorylation and activation of STAT3. This impedes nuclear translocation of STAT3, prevents STAT3 binding to responsive gene promoters and blocks STAT3-mediated regulation of gene expression. STAT3 regulates the transcription of genes involved in several cellular functions. STAT3 is constitutively activated in a variety of human cancers and plays a key role in neoplastic transformation, uncontrolled tumor cell proliferation, resistance to apoptosis, metastasis, immune evasion, tumor angiogenesis, epithelial-mesenchymal transition (EMT) and the Warburg effect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C151932</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13961849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoclonal Antibody TRK-950</VALIDVALUE>
          <VALUEMEANING>Monoclonal Antibody TRK-950</VALUEMEANING>
          <MEANINGDESCRIPTION>A proprietary monoclonal antibody targeting an as of yet undisclosed tumor-associated antigen (TAA), with potential antineoplastic activity. Although the mechanism of action has not been elucidated presumably monoclonal antibody TRK-950 binds to a specific TAA on the cell surface of tumor cells and may induce complement-dependent cytotoxicity (CDC) and antibody-dependent cell-mediated cytotoxicity (ADCC). This may lead to the death of tumor cells expressing the TAA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142826</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13699249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pirtobrutinib</VALIDVALUE>
          <VALUEMEANING>Pirtobrutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available, selective, non-covalent Bruton&#39;s tyrosine kinase (BTK) inhibitor with potential antineoplastic activity. Upon oral administration, pirtobrutinib selectively and reversibly binds to BTK. This prevents both the activation of the B-cell antigen receptor (BCR) signaling pathway and BTK-mediated activation of downstream survival pathways, thereby inhibiting the growth of malignant B-cells that overexpress BTK. Reversible binding of LOXO-305 may preserve antitumor activity in the presence of certain acquired resistance mutations, including C481 mutated BTK, and limit toxicity associated with inhibition of other non-BTK kinases. BTK, a member of the Src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed or mutated in B-cell malignancies; it plays an important role in the development, activation, signaling, proliferation and survival of B-lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158617</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13956445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tazemetostat</VALIDVALUE>
          <VALUEMEANING>Tazemetostat (Tazverik)</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrobromide salt form of tazemetostat, an orally available, small molecule selective and S-adenosyl methionine (SAM) competitive inhibitor of histone methyl transferase EZH2, with potential antineoplastic activity. Upon oral administration, tazemetostat selectively inhibits the activity of both wild-type and mutated forms of EZH2. Inhibition of EZH2 specifically prevents the methylation of histone H3 lysine 27 (H3K27). This decrease in histone methylation alters gene expression patterns associated with cancer pathways and results in decreased tumor cell proliferation in EZH2 mutated cancer cells. EZH2, which belongs to the class of histone methyltransferases (HMTs), is overexpressed or mutated in a variety of cancer cells and plays a key role in tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166954</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15019301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Danazol</VALIDVALUE>
          <VALUEMEANING>Danazol</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic androgen derived from ethinyl testosterone.  Danazol indirectly reduces estrogen production by decreasing pituitary secretion of follicle-stimulating hormone and luteinizing hormone, and binds to sex hormone receptors in target tissues, thereby exhibiting antiestrogenic, anabolic and weakly androgenic effects. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C414</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cladribine/Cytarabine/G-CSF/Mitoxantrone (CLAG-M)</VALIDVALUE>
          <VALUEMEANING>Cladribine/Cytarabine/G-CSF/Mitoxantrone (CLAG-M)</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of cladribine, cytarabine, filgrastim, and mitoxantrone that may be used in the treatment o f acute myeloid leukemia (AML)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15020113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decitabine/Cedazuridine</VALIDVALUE>
          <VALUEMEANING>Decitabine/Cedazuridine (Inqovi)</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available fixed-dose combination agent containing cedazuridine, a cytidine deaminase (CDA) inhibitor, and the cytidine antimetabolite decitabine, with potential antineoplastic activity. Upon oral administration of tdecitabine and cedazuridine, cedazuridine binds to and inhibits CDA, an enzyme primarily found in the gastrointestinal (GI) tract and liver that catalyzes the deamination of cytidine and cytidine analogs. This prevents the breakdown of decitabine, increases its bioavailability and efficacy while decreasing GI toxicity due to the administration of lower doses of decitabine. Decitabine exerts its antineoplastic activity through the incorporation of its triphosphate form into DNA, which inhibits DNA methyltransferase and results in hypomethylation of DNA. This interferes with DNA replication and decreases tumor cell growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C115102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15020114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cilgavimab/Tixagevimab</VALIDVALUE>
          <VALUEMEANING>Cilgavimab/Tixagevimab (AZD7442, Evusheld)</VALUEMEANING>
          <MEANINGDESCRIPTION>A combination of two neutralizing human monoclonal antibodies cilgavimab and tixagevimab, that are isolated from convalescent patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, and directed against the spike (S) protein, that can potentially be used for passive immunization against Coronavirus disease 2019 (COVID-19). Upon administration of cilgavimab/tixagevimab, both antibodies specifically target and bind to the SARS-CoV-2 S protein, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2. S protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C175229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15020115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enasidenib Mesylate</VALIDVALUE>
          <VALUEMEANING>Enasidenib Mesylate (AG-221 Mesylate)</VALUEMEANING>
          <MEANINGDESCRIPTION>The mesylate salt form of enasidenib, an orally available inhibitor of specific mutant forms of the mitochondrial enzyme isocitrate dehydrogenase type 2 (IDH2), with potential antineoplastic activity. Upon administration, enasidenib specifically inhibits various mutant forms of IDH2, including the IDH2 variants R140Q, R172S, and R172K, which inhibits the formation of 2-hydroxyglutarate (2HG). This may lead to both an induction of cellular differentiation and an inhibition of cellular proliferation in IDH2-expressing tumor cells. IDH2, an enzyme in the citric acid cycle, is mutated in a variety of cancers; it initiates and drives cancer growth by blocking differentiation and the production of the oncometabolite 2HG.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C137825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15020118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ledipasvir/Sofosbuvir</VALIDVALUE>
          <VALUEMEANING>Ledipasvir/Sofosbuvir (Harvoni)</VALUEMEANING>
          <MEANINGDESCRIPTION>A tablet containing a fixed dose combination of ledipasvir, an inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, and the prodrug sofosbuvir, an inhibitor of HCV NS5B polymerase, with activity against HCV. Upon oral administration of ledipasvir/sofosbuvir and intracellular uptake, ledipasvir binds to and blocks the activity of the NS5A protein. This results in the disruption of the viral RNA replication complex, blockage of HCV RNA production, and inhibition of viral replication. Sofosbuvir is converted to its active triphosphate form, and competes with uridine triphosphate for incorporation into RNA, thereby inhibiting NS5B polymerase and preventing viral replication. This may eradicate HCV and prevent HCV-mediated tumorigenesis. NS5A, a zinc-binding and proline-rich hydrophilic phosphoprotein, plays a crucial role in HCV RNA replication. The HCV NS5B protein, an RNA-dependent RNA polymerase, is essential for the replication of the viral HCV RNA genome. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family; HCV infection is associated with the development of certain tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15020144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pacritinib</VALIDVALUE>
          <VALUEMEANING>Pacritinib (Vonjo)</VALUEMEANING>
          <MEANINGDESCRIPTION>The citrate salt form of pacritinib, an orally bioavailable inhibitor of Janus kinase 2 (JAK2), the JAK2 mutant JAK2V617F and FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2), with potential antineoplastic activity. Upon oral administration of pacritinib citrate, pacritinib competes with JAK2 and the JAK2 mutant JAK2V617F for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-signal transducer and activator of transcription (STAT) signaling pathway, and the induction of apoptosis. In addition, pacritinib targets, binds to and inhibits the activity of FLT3. This inhibits FLT3-mediated signaling and the proliferation of FLT3-expressing cancer cells. JAK2, often upregulated or mutated in a variety of cancer cells, plays a key role in tumor cell proliferation and survival. The JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The JAK-STAT signaling pathway is a major mediator of cytokine activity. FLT3, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias. In addition, JAK2 and FLT3 play a key role in the regulation of the inflammatory response and dendritic cell (DC) proliferation, differentiation and function. Inhibition of JAK2- and FLT3-mediated signaling may suppress the generation and differentiation of DCs, and may regulate inflammatory and immune responses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C185891</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15021760</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tisotumab Vedotin</VALIDVALUE>
          <VALUEMEANING>Tisotumab Vedotin</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody-drug conjugate (ADC) comprised of tisotumab, a monoclonal antibody against human tissue factor (TF) covalently coupled, via a protease-cleavable peptide linker, to monomethyl auristatin E (MMAE), an auristatin derivative and potent microtubule disrupting agent, with potential antiangiogenic, anticoagulant and antineoplastic activities. Upon administration of tisotumab vedotin, the tisotumab moiety binds to cell surface TF and is internalized. Tisotumab binds to factor VIIa (FVIIa), which interferes with the activation of factor X (FX) into FXa. This may prevent thrombin formation and cancer-associated venous thromboembolism, and may inhibit angiogenesis and tumor cell proliferation. After internalization of the agent, the MMAE moiety is released by proteolytic cleavage. It then binds to tubulin and inhibits its polymerization, which results in G2/M phase arrest and apoptosis. TF, a transmembrane protein and initiator of the coagulation cascade, is overexpressed in many tumor cells and tumor-resident endothelial cells. Expression of TF is correlated with metastasis, angiogenesis, tumor cell growth and tumor-associated thrombosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113164</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13744160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-tocopheryloxyacetic Acid</VALIDVALUE>
          <VALUEMEANING>Alpha-tocopheryloxyacetic Acid</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable vitamin E derivative with potential antineoplastic and immunostimulating activities. Upon administration, alpha-tocopheryloxyacetic acid (alpha-TEA) induces tumor autophagy; the autophagosomes formed, which carry tumor associated antigens (TAAs), allow for increased cross-presentation of TAAs by professional antigen-presenting cells (APCs). This activates a T cell-mediated T helper type 1 (TH1) response, generates a cytotoxic T-lymphocyte (CTL) response against cancer cells, and reduces the frequency of regulatory T-cell (Treg) differentiation. In addition, alpha-TEA modulates the release of various cytokines and chemokines and induces tumor cell apoptosis. Altogether, this results in decreased tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13596458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tuberculin PPD</VALIDVALUE>
          <VALUEMEANING>Tuberculin PPD</VALUEMEANING>
          <MEANINGDESCRIPTION>Extracts of Mycobacterium tuberculosis that are used in skin testing to identify individuals who have a latent or active tuberculosis infection._A purified protein extract derived from the bacterium Mycobacterium tuberculosis. Intradermally-administered, PPD stimulates preprimed CD4 T cells in immunologically competent subjects previously exposed to the bacterium Mycobacterium tuberculosis; these activated CD4 T cells secrete various cytokines that attract granulocytes, monocytes, and macrophages in an inflammatory response known as delayed hypersensitivity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29329, C85502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15035846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Turmeric supplement</VALIDVALUE>
          <VALUEMEANING>Turmeric supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists._Oral preparations containing dietary ingredient(s) intended to supplement the diet.  Dietary ingredients include vitamins, minerals, herbs, amino acids, extracts and metabolites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1505, C73983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15035845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aspirin</VALIDVALUE>
          <VALUEMEANING>Acetylsalicylic Acid</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally administered non-steroidal antiinflammatory agent that inhibits cyclooxygenase synthesis of prostaglandin, preventing the formation of platelet aggregation and inflammation. It has analgesic and antipyretic properties. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C287</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytarabine, MTX, Steroid IT</VALIDVALUE>
          <VALUEMEANING>Cytarabine, MTX, Steroid IT</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of intrathecal cytarabine that may be used in the treatment of acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN)._A regimen consisting of intrathecal methotrexate that may be used in the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN), acute lymphoblastic, chronic lymphocytic and acute myeloid leukemias; and diffuse large B-cell and small lymphocytic lymphomas, with central nervous system (CNS) involvement._The use of exogenous steroids for the treatment of any disease or disorder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15370, C160066, C160015</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>XRT to Chest</VALIDVALUE>
          <VALUEMEANING>XRT to Chest</VALUEMEANING>
          <MEANINGDESCRIPTION>Radiation therapy that is directed at structures in the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C201125</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VCR/Dex/Ponatinib</VALIDVALUE>
          <VALUEMEANING>VCR/Dex/Ponatinib</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of dexamethasone and vincristine that may be used in the treatment of acute lymphoblastic leukemia (ALL)._A regimen consisting of ponatinib that may be used in the treatment of chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL), gastrointestinal stromal tumors (GIST), and myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C192193, C160111</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TT1-621 CD47 Targeted</VALIDVALUE>
          <VALUEMEANING>Ontorpacept</VALUEMEANING>
          <MEANINGDESCRIPTION>A soluble recombinant antibody-like fusion protein composed of the N-terminal CD47 binding domain of human signal-regulatory protein alpha (SIRPa) linked to the Fc domain of human immunoglobulin G1 (IgG1), with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, ontorpacept selectively targets and binds to CD47 expressed on tumor cells and blocks the interaction of CD47 with endogenous SIRPa, a cell surface protein expressed on macrophages. This prevents CD47/SIRPa-mediated signaling and abrogates the CD47/SIRPa-mediated inhibition of macrophage activation and phagocytosis of cancer cells. This induces pro-phagocytic signaling mediated by the binding of calreticulin (CRT), which is specifically expressed on the surface of tumor cells, to low-density lipoprotein (LDL) receptor-related protein-1 (LRP-1), expressed on macrophages, and results in macrophage activation and the specific phagocytosis of tumor cells. CD47, also called integrin-associated protein (IAP), is a tumor-associated antigen (TAA) expressed on normal, healthy hematopoietic stem cells (HSC) and overexpressed on the surface of a variety of cancer cells. Expression of CD47, and its interaction with SIRPa, leads to the inhibition of macrophage activation and protects cancer cells from phagocytosis, thereby allowing cancer cells to proliferate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13714905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Triamcinolone/Desonide</VALIDVALUE>
          <VALUEMEANING>Triamcinolone/Desonide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. Upon cell entry, triamcinolone binds to and activates the glucocorticoid receptor, which leads to translocation of the ligand-receptor complex to the nucleus and induces expression of glucocorticoid-responsive genes such as lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes, both mediators of inflammation. In addition, pro-inflammatory cytokine production, including interleukin (IL)-1and IL-6, and the activation of cytotoxic T-lymphocytes is also inhibited. T-cells are prevented from making IL-2 and proliferating. This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis through increasing Ikappa-B expression and curtailing activation of nuclear factor (NF)kappa-B._A synthetic glucocorticosteroid for topical use, with anti-inflammatory activity. Desonide binds to glucocorticoid receptors in the cytoplasm, and the ligand-receptor complex is translocated as a homodimer into the nucleus, where transcription activation via glucocorticoid response elements within glucocorticoid-responsive genes occur. This agent induces transcription of genes coding for anti-inflammatory proteins, including lipocortin-1, interleukin-10, interleukin-1 receptor antagonist and neutral endopeptidase. Increased synthesis of lipocortin-1 has an inhibitory effect on phospholipase A2, which in turn inhibits the release arachidonic acid, thereby controlling the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61702, C901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serum Tears</VALIDVALUE>
          <VALUEMEANING>Serum Tears</VALUEMEANING>
          <MEANINGDESCRIPTION>An eye drop solution containing serum and derived from a patient’s own blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scleral Lenses</VALIDVALUE>
          <VALUEMEANING>Scleral Lenses</VALUEMEANING>
          <MEANINGDESCRIPTION>A rigid gas permeable contact lens with a large diameter that is designed to vault over the cornea and rest on the scleral conjunctiva.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209302</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R-Mini-hyper-CVD</VALIDVALUE>
          <VALUEMEANING>R-Mini-hyper-CVD</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of cyclophosphamide, vincristine and dexamethasone, administered on a hyperfractionated schedule and in lower doses than hyper-CVAD regimen, that may be used to treat acute lymphoblastic leukemia (ALL)._A regimen consisting of rituximab that may be used in the treatment of chronic lymphocytic leukemia (CLL) and hairy cell leukemia, small lymphocytic, diffuse large B-cell, follicular (grade 1-2), and mucosa-associated lymphoid tissue (MALT) lymphomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160115, C209344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042519</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R-ICE/Lenalidomide</VALIDVALUE>
          <VALUEMEANING>R-ICE/Lenalidomide</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of rituximab, ifosfamide, carboplatin, etoposide, and lenalidomide that may be used for the treatment of diffuse large B-cell lymphoma (DLBCL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R-ICE</VALIDVALUE>
          <VALUEMEANING>R-ICE Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemoimmunotherapy regimen consisting of rituximab, ifosfamide, carboplatin and etoposide used to treat indolent and aggressive forms of non-Hodgkin&#39;s lymphoma; also used to treat relapsed and refractory non-Hodgkin&#39;s lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6010539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R-Hyper-CVAD</VALIDVALUE>
          <VALUEMEANING>R-Hyper-CVAD Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of cyclophosphamide, vincristine, doxorubicin and dexamethasone, administered on a hyperfractionated schedule, plus rituximab that is used to treat some types of non-Hodgkin lymphoma (NHL) and acute lymphoblastic leukemia (ALL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140104</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6002977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RD-PACE</VALIDVALUE>
          <VALUEMEANING>RD-PACE</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of lenalidomide, dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide that may be used as a salvage regimen for plasma cell (multiple) myeloma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209365</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042521</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R-CVP (rituximab-cyclophosphamide/vincristine sulfate/prednisone)</VALIDVALUE>
          <VALUEMEANING>R-CVP Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of rituximab, cyclophosphamide, vincristine, and prednisone used to treat indolent non-Hodgkin&#39;s lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6002912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prednisolone Eye Drops</VALIDVALUE>
          <VALUEMEANING>Prednisolone Eye Drops</VALUEMEANING>
          <MEANINGDESCRIPTION>The acetate salt form of prednisolone, a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. As a glucocorticoid receptor agonist, prednisolone acetate binds to specific intracellular glucocorticoid receptors, and causes the ligand-receptor complex to be translocated to the nucleus where it initiates the transcription of glucocorticoid-responsive genes such as various cytokines and lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes, both potent mediators of inflammation. This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations._A sterile solution containing a substance or multiple substances administered to the external eye, usually in the form of droplets. An ophthalmic solution may contain different drugs with different mechanisms of actions, to target symptoms and their underlying cause. Classes of pharmacological agents used may include antibiotics, beta-adrenergic agents, antihistamines, corticosteroids and prostanoids. The ophthalmic solution may be used to treat increased intraocular pressure, symptoms of allergic conjunctivitis, and ocular bacterial infections, among others.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29302, C1202</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PBSC DCI (peripheral blood stem cells donor cell infusion)</VALIDVALUE>
          <VALUEMEANING>PBSC DCI (peripheral blood stem cells donor cell infusion)</VALUEMEANING>
          <MEANINGDESCRIPTION>An immature (progenitor) cell circulating in the peripheral blood.  It has the capacity for replication and differentiation to mature blood cells._A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77273, C12946</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ninlaro/Revilimid/Dexamethasone</VALIDVALUE>
          <VALUEMEANING>Ninlaro/Revilimid/Dexamethasone</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of ixazomib, lenalidomide and dexamethasone that may be used for the treatment of plasma cell (multiple) myeloma and systemic light chain (AL) amyloidosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mini-hyper-CVD/Inotuzumab</VALIDVALUE>
          <VALUEMEANING>Mini-hyper-CVD/Inotuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of cyclophosphamide, vincristine and dexamethasone, administered on a hyperfractionated schedule and in lower doses than hyper-CVAD regimen, that may be used to treat acute lymphoblastic leukemia (ALL)._A regimen consisting of inotuzumab ozogamicin that can be used for the treatment of acute lymphoblastic leukemia (ALL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186420, C209344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methylprednisolone drops</VALIDVALUE>
          <VALUEMEANING>Methylprednisolone drops</VALUEMEANING>
          <MEANINGDESCRIPTION>The sodium succinate salt of a synthetic glucocorticoid receptor agonist with immunosuppressive and anti-inflammatory effects. Methylprednisolone sodium succinate is converted into active prednisolone in the body, which activates glucocorticoid receptor mediated gene expression. This includes inducing synthesis of anti-inflammatory protein IkappaB-alpha and inhibiting synthesis of nuclear factor kappaB (NF-kappaB). As a result, proinflammatory cytokine production such as IL-1, IL-2 and IL-6 is down-regulated and cytotoxic T-lymphocyte activation is inhibited. Therefore, an overall reduction in chronic inflammation and autoimmune reactions may be achieved._A sterile solution containing a substance or multiple substances administered to the external eye, usually in the form of droplets. An ophthalmic solution may contain different drugs with different mechanisms of actions, to target symptoms and their underlying cause. Classes of pharmacological agents used may include antibiotics, beta-adrenergic agents, antihistamines, corticosteroids and prostanoids. The ophthalmic solution may be used to treat increased intraocular pressure, symptoms of allergic conjunctivitis, and ocular bacterial infections, among others.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29302, C48004</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methotrexate/6MP (6-mercaptopurine)</VALIDVALUE>
          <VALUEMEANING>Methotrexate/6MP (6-mercaptopurine)</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of mercaptopurine and methotrexate that may be used in the treatment of acute lymphoblastic leukemia (ALL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C10256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maxitrol eye drops</VALIDVALUE>
          <VALUEMEANING>Neomycin Sulfate/Polymyxin B Sulfate/Dexamethasone</VALUEMEANING>
          <MEANINGDESCRIPTION>A topical combination preparation containing the sulfate salt form of the aminoglycoside antibiotic neomycin, the sulfate salt form of the polypeptide antibiotic polymyxin B, and the glucocorticoid dexamethasone, with antimicrobial, anti-infective and anti-inflammatory activities. Upon topical application, neomycin irreversibly binds to the bacterial 30S ribosomal subunit, thereby preventing mRNA from binding, causing both misreading and the inhibition of protein synthesis. Polymyxin B binds, with its positively charged amino groups, to negatively charged phospholipids in the outer cell membrane of Gram-negative bacteria, thereby disrupting cell wall integrity and altering the permeability of the bacterial cytoplasmic membrane. Dexamethasone binds to the cytoplasmic glucocorticoid receptor, and this receptor-ligand complex is translocated to the nucleus where it initiates the transcription of genes encoding for anti-inflammatory mediators, such as cytokines and lipocortins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121617</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7060413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Loteprednol Etabonate</VALIDVALUE>
          <VALUEMEANING>Loteprednol Etabonate</VALUEMEANING>
          <MEANINGDESCRIPTION>The etabonate salt form of loteprednol, an ophthalmic analog of the corticosteroid prednisolone with anti-inflammatory activity. Loteprednol etabonate exerts its effect by interacting with specific intracellular receptors and subsequently binds to DNA to modify gene expression. This results in an induction of the synthesis of certain anti-inflammatory proteins while inhibiting the synthesis of certain inflammatory mediators. Loteprednol etabonate specifically induces phospholipase A2 inhibitory proteins (collectively called lipocortins), which inhibit the release of arachidonic acid, thereby inhibiting the biosynthesis of potent mediators of inflammation, such as prostaglandins and leukotrienes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282724</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lacrilube eye ointment</VALIDVALUE>
          <VALUEMEANING>Mineral Oil/Petrolatum-containing Eye Ointment</VALUEMEANING>
          <MEANINGDESCRIPTION>A commercial combination preparation, by Allergan, containing mineral oil and white petrolatum. Refresh PM Lubricant, an ointment, is used to moisturize and relieve discomfort due to ocular dryness and irritation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7063371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Itacitinib/Everolimus</VALIDVALUE>
          <VALUEMEANING>Itacitinib/Everolimus</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of everolimus and imatinib that can be used for the treatment of gastrointestinal stromal tumors (GIST).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042528</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IT Chemotherapy (Intrathecal Chemo)</VALIDVALUE>
          <VALUEMEANING>Intrathecal Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment in which anticancer drugs are injected into the fluid-filled space between the thin layers of tissue that cover the brain and spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5143296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hyper-CVAD/MA</VALIDVALUE>
          <VALUEMEANING>HyperCVAD/HD MTX AraC Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of cyclophosphamide, vincristine, doxorubicin and dexamethasone (Hyper-CVAD) administered on a hyperfractionated schedule, followed by high dose methotrexate and cytarabine, and used to treat Burkitt&#39;s lymphoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6010540</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hyper-CVAD module B1</VALIDVALUE>
          <VALUEMEANING>HD-MTX/ARA-C Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of high-dose (HD) methotrexate (MTX) plus HD cytarabine (AraC) that can be used in the treatment of central nervous system (CNS) lymphoma and refractory or relapsed (RR) non-Hodgkin lymphoma (NHL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6002980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hydrocortisone Cream</VALIDVALUE>
          <VALUEMEANING>Hydrocortisone Cream</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic or semisynthetic analog of natural hydrocortisone hormone produced by the adrenal glands with primary glucocorticoid and minor mineralocorticoid effects. As a glucocorticoid receptor agonist, hydrocortisone promotes protein catabolism, gluconeogenesis, capillary wall stability, renal excretion of calcium, and suppresses immune and inflammatory responses. (NCI04)_A semi-solid composed of an emulsion of lipids, hydrocarbons, waxes, or polyols in water.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28944, C555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLAG/Idarubicin</VALIDVALUE>
          <VALUEMEANING>FLAG/Idarubicin</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of idarubicin, fludarabine, high-dose cytarabine and filgrastim (G-CSF) that can be used as a treatment of childhood acute myeloid leukemia (AML) and acute lymphoblastic leukemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLAG (fludarabine, cytarabine, G-CSF)</VALIDVALUE>
          <VALUEMEANING>FLAG (fludarabine, cytarabine, G-CSF)</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of high-dose cytarabine, filgrastim (G-CSF) and fludarabine that can be used as a treatment of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FAM (Fluticasone/Azithromycin/Montelukast)</VALIDVALUE>
          <VALUEMEANING>FAM (Fluticasone/Azithromycin/Montelukast)</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic trifluorinated glucocorticoid receptor agonist with antiallergic, antiinflammatory and antipruritic effects. Fluticasone binds and activates glucocorticoid receptor, resulting in the activation of lipocortin. Lipocortin, in turn, inhibits cytosolic phospholipase A2, which triggers a cascade of reactions involved in the synthesis of inflammatory mediators, such as prostaglandins and leukotrienes. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leads to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production._An azalide, derived from erythromycin, and a member of a subclass of macrolide antibiotics with bacteriocidal and bacteriostatic activities. Azithromycin reversibly binds to the 50S ribosomal subunit of the 70S ribosome of sensitive microorganisms, thereby inhibiting the translocation step of protein synthesis, wherein a newly synthesized peptidyl tRNA molecule moves from the acceptor site on the ribosome to the peptidyl (donor) site, and consequently inhibiting RNA-dependent protein synthesis leading to cell growth inhibition and cell death._A selective cysteinyl leukotriene receptor antagonist with anti-inflammatory and bronchodilating activities. Upon administration, montelukast selectively and competitively blocks the cysteinyl leukotriene 1 (CysLT1) receptor, preventing binding of the inflammatory mediator leukotriene D4 (LTD4). Inhibition of LTD4 activity results in inhibition of leukotriene-mediated inflammatory events including migration of eosinophils and neutrophils, adhesion of leukocytes to vascular endothelium, monocyte and neutrophil aggregation, increased airway edema, increased capillary permeability, and bronchoconstriction. The CysLT1 receptor is found in a number of tissues including spleen, lung, placenta, small intestine, and nasal mucosa, and in a variety of cell types including monocyte/macrophages, mast cells, eosinophils, CD34-positive hemopoietic progenitor cells, neutrophils and endothelial cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66189, C28844, C61767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Etoposide/TBI (total body irradiation)</VALIDVALUE>
          <VALUEMEANING>Etoposide Total-Body Irradiation</VALUEMEANING>
          <MEANINGDESCRIPTION>A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04): Radiation therapy to the entire body. It is usually followed by bone marrow or peripheral stem cell transplantation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15350, C491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6346967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erythropoietin</VALIDVALUE>
          <VALUEMEANING>Erythropoietin</VALUEMEANING>
          <MEANINGDESCRIPTION>Glycoprotein hormone, secreted chiefly by the kidney in the adult and the liver in the fetus, that acts on erythroid stem cells of the bone marrow to stimulate proliferation and differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2644085</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EPOCH_F</VALIDVALUE>
          <VALUEMEANING>EPOCH_F</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and fludarabine that may be used in the treatment of multiple myeloma (MM) before allogeneic stem cell transplantation (alloSCT).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EDO-S101</VALIDVALUE>
          <VALUEMEANING>Tinostamustine</VALUEMEANING>
          <MEANINGDESCRIPTION>An alkylating histone-deacetylase inhibitor (HDACi) fusion molecule composed of the alkylating agent bendamustine fused to the pan-HDACi vorinostat, with potential bi-functional antineoplastic activity. Upon administration of tinostamustine the vorinostat moiety targets and binds to HDACs. This leads to an accumulation of highly acetylated histones, which results in an induction of chromatin remodeling, a modulation of gene expression, an inhibition of tumor cell division and the induction of tumor cell apoptosis. The bendamustine moiety binds to, alkylates and crosslinks macromolecules, inhibiting DNA, RNA and protein synthesis, which also results in tumor cell apoptosis. Thus, tinostamustine shows superior efficacy compared to the activity of either agent alone. In addition, the inhibition of HDAC6 activity by tinostamustine induces the activation of inositol-requiring enzyme 1 (IRE-1), the key regulatory protein for the unfolded protein response (UPR). Induction of the UPR increases the sensitivity of certain cancer cell types to certain chemotherapeutic agents, such as proteasome inhibitors. Therefore, tinostamustine may work synergistically with proteasome inhibitors. HDACs, enzymes that deacetylate chromatin histone proteins, are overexpressed in various cancers and play a key role in proliferation and resistance of tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126105</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13744082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>E2993</VALIDVALUE>
          <VALUEMEANING>E2993</VALUEMEANING>
          <MEANINGDESCRIPTION>A trial that is part of an international study for the treatment of acute lymphoblastic leukemia (ALL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dexamethasone Oral Solution</VALIDVALUE>
          <VALUEMEANING>Dexamethasone Oral Solution</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04)_A solution intended for oral administration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68996, C422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DA-EPOCH_R</VALIDVALUE>
          <VALUEMEANING>R-DA-EPOCH  Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab (EPOCH-R) in a dose-adjusted (DA) version that can be used for the treatment of non-Hodgkin lymphoma (NHL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6002924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DA-EPOCH</VALIDVALUE>
          <VALUEMEANING>DA-EPOCH</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (EPOCH) in a dose-adjusted (DA) version that may be used in the treatment of AIDS-related B-cell lymphomas, diffuse large B-cell lymphoma (DLBCL) and T-cell lymphomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C192030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclosporine Ophthalmic Emulsion</VALIDVALUE>
          <VALUEMEANING>Cyclosporine Ophthalmic Emulsion</VALUEMEANING>
          <MEANINGDESCRIPTION>An topical ophthalmic formulation containing cyclosporine, an undecapeptide produced by the fungus Beauveria nivea, with immunosuppressant and anti-inflammatory activities. The exact therapeutic mechanism of action of cyclosporine is not known but may involve binding to the cellular protein cytophilin, resulting in inhibition of the enzyme calcineurin. This agent appears to specifically and reversibly inhibit immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited with T-helper cells as the primary target. Cyclosporine also inhibits lymphokine production and release.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80051</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3564172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclosporine Eye drops</VALIDVALUE>
          <VALUEMEANING>Cyclosporine Eye drops</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural cyclic polypeptide immunosuppressant isolated from the fungus Beauveria nivea. The exact mechanism of action of cyclosporine is not known but may involve binding to the cellular protein cytophilin, resulting in inhibition of the enzyme calcineurin. This agent appears to specifically and reversibly inhibit immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited with T-helper cells as the primary target. Cyclosporine also inhibits lymphokine production and release. (NCI04)_A sterile solution containing a substance or multiple substances administered to the external eye, usually in the form of droplets. An ophthalmic solution may contain different drugs with different mechanisms of actions, to target symptoms and their underlying cause. Classes of pharmacological agents used may include antibiotics, beta-adrenergic agents, antihistamines, corticosteroids and prostanoids. The ophthalmic solution may be used to treat increased intraocular pressure, symptoms of allergic conjunctivitis, and ocular bacterial infections, among others.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29302, C406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cyclophosphamide/Etoposide</VALIDVALUE>
          <VALUEMEANING>Cyclophosphamide/Etoposide Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemotherapy regimen consisting of high-dose cyclophosphamide and etoposide that may be used in the treatment of refractory acute myeloid leukemia (AML).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7343395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Consolidation Radiation Therapy</VALIDVALUE>
          <VALUEMEANING>Consolidation Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Radiation therapy treatment that is given after initial therapy to kill any remaining cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clobestasol gel</VALIDVALUE>
          <VALUEMEANING>Clobestasol gel</VALUEMEANING>
          <MEANINGDESCRIPTION>The propionate salt form of clobetasol, a topical synthetic corticosteroid with anti-inflammatory, anti-pruritic, and vasoconstrictive properties. Clobetasol propionate exerts its effect by binding to cytoplasmic glucocorticoid receptors and subsequently activates glucocorticoid receptor mediated gene expression. This results in synthesis of certain anti-inflammatory proteins, while inhibiting the synthesis of certain inflammatory mediators. Specifically, clobetasol propionate appears to induce phospholipase A2 inhibitory proteins, thereby controlling the release of the inflammatory precursor arachidonic acid from membrane phospholipids by phospholipase A2._A semi-solid composed of a solid, three dimensional, cross linked matrix of polymers within a liquid, yielding a jelly-like material unable to flow at steady state.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42934, C28934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Gemcitabine/Decadron</VALIDVALUE>
          <VALUEMEANING>GDP Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of gemcitabine, dexamethasone and cisplatin that can be used in the treatment of Hodgkin lymphoma (HL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140100</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6002934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Camidanlumab</VALIDVALUE>
          <VALUEMEANING>Camidanlumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A human immunoglobulin (Ig) G1 monoclonal antibody directed against the alpha subunit of the interleukin-2 receptor (IL-2R alpha or CD25). Upon administration, camidanlumab specifically targets and binds to the cell surface antigen CD25. CD25, a transmembrane receptor and tumor-associated antigen (TAA), is expressed on certain cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C169821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042540</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CALGB10403</VALIDVALUE>
          <VALUEMEANING>CALGB10403</VALUEMEANING>
          <MEANINGDESCRIPTION>A trial that studies drug regimens for the treatment of pediatric acute lymphoblastic leukemia (ALL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basiliximab</VALIDVALUE>
          <VALUEMEANING>Basiliximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, chimeric, human-murine monoclonal antibody directed against the alpha subunit of the interleukin-2 receptor (IL-2R alpha) with immunosuppressant activity. Basiliximab selectively binds to and blocks IL-2R alpha, expressed on the surface of activated T-lymphocytes, thereby preventing interleukin-2 binding and inhibiting the interleukin-2-mediated activation of lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52186</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3944873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AZD9150</VALIDVALUE>
          <VALUEMEANING>Danvatirsen</VALUEMEANING>
          <MEANINGDESCRIPTION>An antisense oligonucleotide targeting signal transducer and activator of transcription 3 (STAT3) with potential antitumor activity. Danvatirsen binds to STAT3 mRNA, thereby inhibiting translation of the transcript. Suppression of STAT3 expression induces tumor cell apoptosis and decreases tumor cell growth. STAT3, a protein overexpressed in a variety of human cancers, plays a critical role in tumor cell growth and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101368</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13634030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anagrelide</VALIDVALUE>
          <VALUEMEANING>Anagrelide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic quinazoline derivative, Anagrelide reduces platelet production through a decrease in megakaryocyte maturation. Anagrelide inhibits cyclic AMP phosphodiesterase, as well as ADP- and collagen-induced platelet aggregation. At therapeutic doses, it does not influence white cell counts or coagulation parameters. Anagrelide is used for treatment of essential thrombocythemia to reduce elevated platelet counts and the risk of thrombosis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AALL113</VALIDVALUE>
          <VALUEMEANING>AALL113</VALUEMEANING>
          <MEANINGDESCRIPTION>A children’s oncology group (COG) trial study designed to evaluate intrathecal triple therapy (ITT), consisting of methotrexate, hydrocortisone and cytarabine, in the treatment of acute lymphoblastic leukemia (ALL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209303</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hyper-CVAD module B2</VALIDVALUE>
          <VALUEMEANING>HD-MTX/ARA-C Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of high-dose (HD) methotrexate (MTX) plus HD cytarabine (AraC) that can be used in the treatment of central nervous system (CNS) lymphoma and refractory or relapsed (RR) non-Hodgkin lymphoma (NHL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6002980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>POMP (6-Mercaptopurine + Vincristine + Methotrexate + Prednisone)</VALIDVALUE>
          <VALUEMEANING>POMP (6-Mercaptopurine + Vincristine + Methotrexate + Prednisone)</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of mercaptopurine, methotrexate, prednisone and vincristine that may be used in the treatment of acute lymphoblastic leukemia (ALL).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C192179</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methotrexate/Cytarabine/Dexamethasone</VALIDVALUE>
          <VALUEMEANING>Methotrexate/Cytarabine/Dexamethasone</VALUEMEANING>
          <MEANINGDESCRIPTION>An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear._An antimetabolite analogue of cytidine with a modified sugar moiety (arabinose instead of ribose). Cytarabine is converted to the triphosphate form within the cell and then competes with cytidine for incorporation into DNA.  Because the arabinose sugar sterically hinders the rotation of the molecule within DNA, DNA replication ceases, specifically during the S phase of the cell cycle.  This agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair. (NCI04)_A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C422, C408, C642</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15042544</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lidocaine with Dexamethasone</VALIDVALUE>
          <VALUEMEANING>Lidocaine With Dexamethasone</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic aminoethylamide with local anesthetic and antiarrhythmic properties. Lidocaine stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels, thereby inhibiting the ionic fluxes required for the initiation and conduction of impulses and effecting local anesthesia._Used to indicate the presence of something or someone._A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C422, C62355, C614</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15063227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Desonide</VALIDVALUE>
          <VALUEMEANING>Desonide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic glucocorticosteroid for topical use, with anti-inflammatory activity. Desonide binds to glucocorticoid receptors in the cytoplasm, and the ligand-receptor complex is translocated as a homodimer into the nucleus, where transcription activation via glucocorticoid response elements within glucocorticoid-responsive genes occur. This agent induces transcription of genes coding for anti-inflammatory proteins, including lipocortin-1, interleukin-10, interleukin-1 receptor antagonist and neutral endopeptidase. Increased synthesis of lipocortin-1 has an inhibitory effect on phospholipase A2, which in turn inhibits the release arachidonic acid, thereby controlling the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3944876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457</VALIDVALUE>
          <VALUEMEANING>DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457</VALUEMEANING>
          <MEANINGDESCRIPTION>A DNA-based combination immunotherapeutic, MEDI0457, composed of VGX-3100, a preparation of DNA plasmids encoding the E6 and E7 genes of human papillomavirus (HPV) subtypes 16 and 18, combined with INO-9012, a DNA plasmid encoding the immune activator and pro-inflammatory cytokine human interleukin-12 (IL-12) with potential immunoactivating and antineoplastic activities. Upon intramuscular delivery by electroporation of VGX-3100, the HPV E6 and E7 proteins are translated in cells and elicit a cytotoxic T-lymphocyte (CTL) response against cancer cells expressing the E6 and E7 antigens, resulting in tumor cell lysis. HPV type 16 and HPV type 18 are associated with the development of certain types of cancer. Upon intramuscular delivery by electroporation of INO-9012, IL-12 is expressed and activates the immune system by promoting the activation of natural killer cells (NK cells), inducing secretion of interferon-gamma (IFN-g) and promoting CTL responses against tumor cells. This boosts the immune response and results in increased CTL-mediated tumor cell death as compared with the administration of VGX-3100 alone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123919</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13634090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPV-16 E7 TCR Expressing T-cells</VALIDVALUE>
          <VALUEMEANING>HPV-16 E7 TCR Expressing T-cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A preparation of allogeneic, genetically engineered T-lymphocytes transduced with a retroviral vector MSGV1 that encodes a T-cell receptor (TCR) targeting a specific epitope of the human papillomavirus (HPV) type 16 oncoprotein E7 (HPV-16 E7 TCR), with potential antineoplastic activity. The TCR especially recognizes and binds with high affinity to the HPV 16 E7 11-19 epitope. Upon administration, HPV-16 E7 expressing T-cells target and bind to tumor cells expressing the HPV-16 E7 antigen leading to selective cytotoxicity in HLA-A2-positive, HPV-16 E7-expressing tumor cells. HPV16 E7, a tumor-associated antigen (TAA), overexpressed in a variety of tumor cell types while not expressed in normal, healthy cells, plays a key role in tumor cell proliferation. E7 11-19 is a naturally processed epitope of HPV-16 E7 that binds specifically to human leukocyte antigen (HLA)-A*02:01 and that has been isolated from the surface of HPV-16 positive, HLA-A*02:01-positive tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128485</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15063796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alirocumab</VALIDVALUE>
          <VALUEMEANING>Alirocumab (Praluent)</VALUEMEANING>
          <MEANINGDESCRIPTION>A human immunoglobulin G1 (IgG1) monoclonal antibody directed against human proprotein convertase subtilisin/kexin type 9 (PCSK9), that can be used in the treatment of hypercholesterolemia. Upon administration, alirocumab targets, binds to and inhibits the activity of PCSK9. This prevents the binding of PCSK9 to low-density lipoprotein receptor (LDLR) on hepatocytes and prevents its degradation. This increases LDLR on hepatocytes and increases the liver&#39;s ability to remove LDL cholesterol (LDL-C) from the blood, thereby lowering LDL-C levels. PCSK9 binds to LDLR on the surface of hepatocytes to promote LDLR degradation within the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174849</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15072829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Emapalumab</VALIDVALUE>
          <VALUEMEANING>Emapalumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A human monoclonal antibody against the cytokine interferon-gamma (IFN-gamma; IFNg), with potential immunomodulating activity. Upon administration, emapalumab binds to and neutralizes IFNg. This inhibits IFNg-mediated signaling pathways and suppresses the activation of the immune system. IFNg, a cell-signaling protein, plays a key role in the regulation and activation of the immune system; its upregulation is associated with certain auto-immune and auto-inflammatory diseases in which the immune system is abnormally activated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127123</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12151552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoviral PSA Vaccine ETBX-071</VALIDVALUE>
          <VALUEMEANING>Adenoviral PSA Vaccine ETBX-071</VALUEMEANING>
          <MEANINGDESCRIPTION>A cancer vaccine composed of a genetically engineered, replication-deficient adenovirus carrying the gene encoding human prostate-specific antigen (PSA), with potential immunostimulating and antineoplastic activities. Upon vaccination with the adenoviral-PSA vaccine ETBX-071, the adenovirus infects cells and expresses PSA. In turn, PSA activates the immune system and induces a cytotoxic T-lymphocyte (CTL) response against PSA-expressing tumor cells. PSA, a tumor associated antigen (TAA), is expressed by prostate epithelial cells and is overexpressed in prostate cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C148142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13956289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-TCR Vb6/Vb10/IL-2 Antibody Fusion Protein</VALIDVALUE>
          <VALUEMEANING>Anti-TCR Vb6/Vb10/IL-2 Antibody Fusion Protein STAR0602</VALUEMEANING>
          <MEANINGDESCRIPTION>A bifunctional antibody fusion protein composed of an agonist antibody targeting the variable (V) beta 6 (Vb6) and beta 10 (Vb10) regions of the T cell receptor (TCR) and fused to the cytokine interleukin-2 (IL-2), with potential immunostimulating and antineoplastic activities. Upon administration, anti-TCR Vb6/Vb10/IL-2 antibody fusion protein STAR0602 selectively targets and binds to the Vb6 and Vb10 regions of the TCR expressed on a subset of alpha/beta T-cells, thereby activating and expanding these alpha/beta T-cells. This promotes T-cell-mediated immune responses against tumor cells. IL-2 targets and binds to the IL-2 receptor IL2R and activates IL-2/IL-2R-mediated signaling, which further activates cytotoxic T-lymphocytes (CTLs) and natural killer (NK) cells, and induces expression of certain cytotoxic cytokines, such as interferon-gamma (IFNg) and transforming growth factor-beta (TGFb). This further enhances T-cell-mediated cytotoxic immune responses against tumor cells. Alpha/beta T-cells play an important role in the adaptive immune response.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C192208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15172415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TLR Agonist Decoy20</VALIDVALUE>
          <VALUEMEANING>TLR Agonist Decoy20</VALUEMEANING>
          <MEANINGDESCRIPTION>A multi-targeted toll-like receptor (TLR) agonist, with potential immunomodulating and antineoplastic activities. Upon administration, TLR agonist Decoy20 activates one or more not yet disclosed TLRs expressed on various immune cells, such as macrophages and plasmacytoid dendritic cells (pDCs), which results in their stimulation, the production of certain pro-inflammatory cytokines, and the upregulation of co-stimulatory molecules. This may lead to enhanced T- and B-cell stimulatory responses, cytotoxic T-cell proliferation, a T-helper 1 (Th1) immune response, and immune-mediated tumor cell killing. TLRs are transmembrane receptors that recognize structurally conserved microbial molecules such as bacterial cell-surface lipopolysaccharides (LPS), lipoproteins, lipopeptides, lipoarabinomannan and flagellin, among others. Immune responses stimulated by TLR activation may result in innate and adaptive immune-mediated tumor cell killing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C192168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15172414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tevimbra</VALIDVALUE>
          <VALUEMEANING>Tislelizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 (PD-1), with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, tislelizumab binds to PD-1 and inhibits the binding of PD-1 to the PD-1 ligands programmed cell death-1 ligand 1 (PD-L1), and PD-1 ligand 2 (PD-L2). This prevents the activation of PD-1 and its downstream signaling pathways. This may restore immune function through the activation of both T-cells and T-cell-mediated immune responses against tumor cells. PD-1, a transmembrane protein in the immunoglobulin (Ig) superfamily expressed on activated T-cells, negatively regulates T-cell activation and effector function when activated by its ligands; it plays an important role in tumor evasion from host immunity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121775</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13744159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surzebiclimab</VALIDVALUE>
          <VALUEMEANING>Surzebiclimab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against the inhibitory T-cell receptor T-cell immunoglobulin and mucin domain-containing protein 3 (TIM-3; TIM3; hepatitis A virus cellular receptor 2; HAVCR2), with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, surzebiclimab binds to TIM-3 expressed on certain T-cells, including tumor-infiltrating lymphocytes (TILs), thereby preventing the engagement of TIM-3 by its ligands, phosphatidylserine (PtdSer) and galectin-9. This abrogates T-cell inhibition, activates antigen-specific T-lymphocytes and enhances cytotoxic T-cell-mediated tumor cell lysis, which results in a reduction in tumor cell proliferation. TIM-3, a transmembrane protein and immune checkpoint receptor, is associated with tumor-mediated immune suppression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13956412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tinactin Antifungal Cream</VALIDVALUE>
          <VALUEMEANING>Tolnaftate</VALUEMEANING>
          <MEANINGDESCRIPTION>A thiocarbamate derivative with either fungicidal or fungistatic property. Tolnaftate is a selective, reversible and non-competitive inhibitor of membrane-bound squalene-2,3- epoxidase, an enzyme involved in the biosynthesis of ergosterol. Inhibition leads to the accumulation of squalene and a deficiency in ergosterol, an essential component of fungal cell walls, thereby increasing membrane permeability, disrupting cellular organization and causing cell death. In addition, this agent may also distort the hyphae and stunts mycelial growth in susceptible fungi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15254955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gingko</VALIDVALUE>
          <VALUEMEANING>Ginkgo</VALUEMEANING>
          <MEANINGDESCRIPTION>A substance derived from the plant Ginkgo biloba.  Ginkgo biloba leaf extract contains potent anti-oxidants and substances believed to improve blood flow to the brain and peripheral tissues.  Ginkgo biloba exocarp polysaccharides (GBEP) can inhibit proliferation and induce apoptosis and differentiation of tumor cells.  As a medicinal herb, ginkgo requires standardization for medicinal use; typically, a 50:1 extract of ginkgo leaf is used in ginkgo supplements. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29072</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VIPOR-P</VALIDVALUE>
          <VALUEMEANING>VIPOR-P Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of ibrutinib, lenalidomide, obinutuzumab, polatuzumab vedotin, prednisone, and venetoclax that may potentially be used in the treatment of certain B-cell lymphomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C211929</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15313148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tivumecirnon</VALIDVALUE>
          <VALUEMEANING>Tivumecirnon</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available, small molecule antagonist of C-C chemokine receptor type 4 (CCR4) with potential immunomodulatory and antineoplastic activities. Upon oral administration, tivumecirnon inhibits the binding of CCR4 to its signaling molecules, thereby blocking the recruitment of regulatory T-cells (Tregs) to the tumor microenvironment (TME). This may abrogate the immunosuppressive effects of Tregs and promote an effective anti-tumor immune response. CCR4, a chemokine receptor normally expressed on circulating and tissue-resident T-cells, is highly expressed on circulating Tregs and is associated with poor prognosis in certain cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15319137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CUE-101</VALIDVALUE>
          <VALUEMEANING>HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101</VALUEMEANING>
          <MEANINGDESCRIPTION>A fusion protein composed of a human leukocyte antigen (HLA) complex, HLA-A*0201, with a peptide epitope derived from the human papillomavirus type 16 (HPV16) E7 protein (amino acid residues 11-20), a reduced affinity human interleukin-2 (IL-2) variant, and an effector attenuated human immunoglobulin G1 (IgG1) Fc domain, with potential antineoplastic and immunostimulatory activities. Upon administration, CUE-101 targets and selectively binds to E7-specific CD8-positive T-cells present in patients with HPV16-driven malignancies. This may induce the secretion of inflammatory cytokines such as interferon gamma (IFN gamma) and promote the activation and expansion of tumor-specific CD8-positive cells, which may lead to T-cell-mediated elimination of tumor cells expressing the HPV16 E7 antigen. The HPV16 E7 oncoprotein is a cell surface glycoprotein and tumor-associated antigen (TAA) that is overexpressed in various HPV-associated cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C162459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13660313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Silver Nitrate</VALIDVALUE>
          <VALUEMEANING>Silver Nitrate</VALUEMEANING>
          <MEANINGDESCRIPTION>An inorganic chemical with antiseptic activity. Silver nitrate can potentially be used as a cauterizing or sclerosing agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77057</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15319136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin/Doxorubicin/Etoposide/Ifosfamide/Methotrexate Regimen</VALIDVALUE>
          <VALUEMEANING>Cisplatin/Doxorubicin/Etoposide/Ifosfamide/Methotrexate Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of cisplatin, doxorubicin, etoposide, ifosfamide and high-dose methotrexate that may potentially be used for the treatment of childhood osteosarcoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C212123</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15358227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Naxitamab</VALIDVALUE>
          <VALUEMEANING>Naxitamab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against the human tumor-associated antigen GD2, with potential antineoplastic activity. Upon vaccination, naxitamab stimulates antibody-dependent cell-mediated cytotoxicity (ADCC) against GD2-expressing tumor cells. GD2, a disialoganglioside with expression in normal tissues restricted primarily to the cerebellum and peripheral nerves, is commonly expressed at high levels on tumors of neuroectodermal origins such as melanomas and neuroblastomas. Compared to the murine monoclonal antibody 3F8 (m3F8), the humanized form does not cause a human anti-mouse antibody (HAMA) response and shows enhanced ADCC activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13961791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cefixime</VALIDVALUE>
          <VALUEMEANING>Cefixime</VALUEMEANING>
          <MEANINGDESCRIPTION>A broad-spectrum, third-generation cephalosporin antibiotic derived semisynthetically from the marine fungus Cephalosporium acremonium with antibacterial activity. As does penicillin, the beta-lactam antibiotic cefixime inhibits bacterial cell wall synthesis by disrupting peptidoglycan synthesis, resulting in a reduction in bacterial cell wall stability and bacterial cell lysis. Stable in the presence of a variety of beta-lactamases, this agent is more active against gram-negative bacteria and less active against gram-positive bacteria compared to second-generation cephalosporins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1100</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3690094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GD2-CAR-expressing Autologous T-lymphocytes</VALIDVALUE>
          <VALUEMEANING>GD2-CAR-expressing Autologous T-lymphocytes</VALUEMEANING>
          <MEANINGDESCRIPTION>Genetically modified, autologous T-lymphocytes transduced with a retroviral vector encoding a 14g2a.zeta chimeric antigen receptor (CAR) directed against the disialoganglioside GD2, with potential immunomodulating and antineoplastic activities. Upon intravenous administration, the activated T-lymphocytes target the GD2 antigen on tumor cells and selectively kill those cells. The tumor-associated antigen GD2 is overexpressed on the surface of almost all tumors of neuroectodermal origin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123820</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15358226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Black seed oil</VALIDVALUE>
          <VALUEMEANING>Black Seed Oil Extract Supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>An oral supplement composed of the oil extracted from the seeds of Nigella sativa, also known as black seed or black cumin, with potential anti-oxidant, anti-inflammatory, hepatoprotective and immunomodulatory activities. Upon administration of black seed oil extract supplement, the main constituent thymoquinone may stimulate various cytoprotective antioxidant enzymes. Thymoquinone may also exert anti-inflammatory activity by decreasing the production of inflammation mediators, such as tumor necrosis factor (TNF)-alpha, interleukin (IL) 1-beta and IL-6, and inhibiting pro-inflammatory enzymes, including cyclooxygenase (COX). In addition, thymoquinone may modulate the activity of various immune cells such as T-cells, B-cells, macrophages, neutrophils, natural killer (NK) cells, and dendritic cells (DCs) in the tumor microenvironment (TME) and may enhance anticancer immune responses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15379378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5-aza-4&#39;-thio-2&#39;-Deoxycytidine (Aza-TdC)</VALIDVALUE>
          <VALUEMEANING>5-Aza-4&#39;-thio-2&#39;-deoxycytidine</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, nucleoside analog and DNA methyltransferase I (DNMT1) inhibitor, with potential DNA hypomethylating and antineoplastic activities. Upon administration, 5-aza-4&#39;-thio-2&#39;-deoxycytidine (Aza-TdC) gets incorporated into DNA, where it binds to the active site of DNMT1, a maintenance methyltransferase that contributes to the hypermethylation and silencing of tumor suppressor genes. The formation of covalent DNMT1-DNA complexes inhibits DNMT1, prevents DNA methylation of CpG sites, causes CpG demethylation, and results in the re-expression and re-activation of silenced tumor suppressor genes. This inhibits tumor cell proliferation. DNMT1, overactivated in tumor cells, plays a key role in tumor cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153479</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13596289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HIPEC (Hyperthermic Intraperitoneal Chemotherapy)</VALIDVALUE>
          <VALUEMEANING>Hyperthermic Intraperitoneal Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure performed in combination with abdominal surgery for cancer that has spread to the abdomen. It involves the infusion of a heated chemotherapy solution that circulates into the abdominal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DSP107 (Dual Signaling Protein)</VALIDVALUE>
          <VALUEMEANING>SIRPa-4-1BBL Fusion Protein DSP107</VALUEMEANING>
          <MEANINGDESCRIPTION>A bi-functional, trimeric, fusion protein consisting of the extracellular domains (ECDs) of human signal-regulatory protein alpha (SIRPalpha; SIRPa; CD172a) fused to a 4-1BB ligand (4-1BBL), with potential immune checkpoint inhibitory, immunostimulating and antineoplastic activities. Upon administration, the SIRPa-4-1BBL fusion protein DSP107 selectively targets and binds to both CD47 expressed on tumor cells and 4-1BB (CD137; tumor necrosis factor receptor superfamily member 9; TNFRSF9) expressed on T-cells and natural killer (NK) cells. Binding to CD47 blocks the interaction of CD47 with endogenous SIRPa, a cell surface protein expressed on macrophages. This prevents CD47/SIRPa-mediated signaling and abrogates the CD47/SIRPa-mediated inhibition of macrophage activation and phagocytosis of cancer cells. This induces pro-phagocytic signaling mediated by the binding of calreticulin (CRT), which is specifically expressed on the surface of tumor cells, to low-density lipoprotein (LDL) receptor-related protein-1 (LRP-1), which is expressed on macrophages, and results in macrophage activation and the specific phagocytosis of tumor cells. The binding of 4-1BBL to 4-1BB activates 4-1BB-mediated signaling, induces cytotoxic T-lymphocyte (CTL) proliferation, cytokine production and promotes a CTL-mediated anti-tumor immune response as well as NK-mediated tumor cell killing. The crosslinking specifically enables the activation of 4-1BB-mediated signaling in T-cells and NK cells in the tumor microenvironment (TME), allowing targeted immune responses in the TME. CD47, also called integrin-associated protein (IAP), is a tumor-associated antigen (TAA) expressed on normal, healthy hematopoietic stem cells (HSC) and overexpressed on the surface of a variety of cancer cells. Expression of CD47, and its interaction with SIRPa, leads to the inhibition of macrophage activation and protects cancer cells from phagocytosis, thereby allowing cancer cells to proliferate. 4-1BB, a surface glycoprotein of the tumor necrosis factor receptor superfamily, is an inducible costimulatory receptor that plays a key role in T-cell proliferation, survival and cytolytic activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13743857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IMP7068 (WEE1 inhibitor)</VALIDVALUE>
          <VALUEMEANING>Wee1 Kinase Inhibitor IMP7068</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of the human tyrosine kinase Wee1 (Wee1-like protein kinase; Wee1A kinase; WEE1hu), with potential antineoplastic activity. Upon oral administration, Wee1 kinase inhibitor IMP7068 targets, binds to and inhibits Wee1. Inhibition of Wee1 inhibits Cdk1 (Cdc2) phosphorylation, promotes both premature mitosis and a prolonged mitotic arrest, which results in the accumulation of unrepaired DNA damage. This leads to apoptosis in susceptible tumor cells, such as p53-deficient or mutated human cancers that lack the G1 checkpoint. Unlike normal cells, most p53-deficient or mutated human cancers lack the G1 checkpoint as p53 is the key regulator of the G1 checkpoint and these cells rely on the G2 checkpoint for DNA repair to damaged cells. Overexpression of Wee1 occurs in several cancer types and high expression of Wee1 is associated with poor outcomes. Wee1 phosphorylates Cdc2 in the Cdc2/cyclin B (CDK1/cyclin B) complex which blocks progression from G2 into mitosis. The Wee1 tyrosine kinase is activated upon DNA damage and regulates the G2-M and S cell cycle checkpoints.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C185675</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15379379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Remdesivir</VALIDVALUE>
          <VALUEMEANING>Remdesivir</VALUEMEANING>
          <MEANINGDESCRIPTION>A prodrug of an adenosine triphosphate (ATP) analog, with potential antiviral activity against a variety of RNA viruses. Upon administration, remdesivir, being a prodrug, is metabolized into its active form GS-441524. As an ATP analog, GS-441524 competes with ATP for incorporation into RNA and inhibits the action of viral RNA-dependent RNA polymerase. This results in the termination of RNA transcription and decreases viral RNA production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C152185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7850277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AR ST 1321</VALIDVALUE>
          <VALUEMEANING>ARST 1321</VALUEMEANING>
          <MEANINGDESCRIPTION>A multi-center study lead by Children&#39;s Oncology Group and NRG Oncology to study the use of pazopanib with either neoadjuvant chemoradiation or radiation therapy in children and adults with unresected intermediate/high-risk trunk and extremity non-rhabdomyosarcoma soft tissue sarcomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C212172</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15379382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Olaratumab (LARTRUVO)</VALIDVALUE>
          <VALUEMEANING>Olaratumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human IgG1 monoclonal antibody directed against the platelet-derived growth factor receptor alpha (PDGFR alpha) with potential antineoplastic activity. Anti-PDGFR alpha monoclonal antibody IMC-3G3 selectively binds to PDGFR alpha, .blocking the binding of its ligand, PDGF; signal transduction downstream of PDGFR through the MAPK and PI3K pathways is inhibited, which may result in inhibition of angiogenesis and tumor cell proliferation. Overexpressed by various cancer cell types, PDGFR is a transmembrane protein tyrosine kinase receptor, consisting of isoforms A and B that is important in regulating cellular growth and differentiation and angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15379381</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D3-002</VALIDVALUE>
          <VALUEMEANING>D3-002</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical trial that evaluated ETC-1922159 as a single agent and in combination with pembrolizumab in advanced solid tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C212178</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15381327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bendamustine</VALIDVALUE>
          <VALUEMEANING>Bendamustine</VALUEMEANING>
          <MEANINGDESCRIPTION>A bifunctional mechlorethamine derivative with alkylating and antimetabolite activities. Although the exact mechanism of action of bendamustine is unknown, this agent appears to alkylate and crosslink macromolecules, resulting in DNA, RNA and protein synthesis inhibition, and eventually the induction of apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4862971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GM-CSF-secreting Lethally Irradiated Tumor Cell Vaccine (GVAX)</VALIDVALUE>
          <VALUEMEANING>GM-CSF-secreting Lethally Irradiated Tumor Cell Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>An autologous or allogeneic cell vaccine comprised of tumor cells which have been lethally irradiated and genetically modified to secrete granulocyte-macrophage colony stimulating factor (GM-CSF), a hormone which plays a key role in stimulating the body&#39;s immune response to vaccines. GM-CSF may stimulate the body&#39;s immune system against tumor cells by attracting and enhancing the activation of antigen-presenting cells (APCs), such as dendritic cells (DCs). This promotes antigen presentation to T-lymphocytes and induces a cytotoxic T-lymphocyte (CTL) response against cells expressing tumor-associated antigens (TAAs).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1978</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15393454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Topoisomerase-1 Inhibitor LMP744</VALIDVALUE>
          <VALUEMEANING>Topoisomerase-1 Inhibitor LMP744</VALUEMEANING>
          <MEANINGDESCRIPTION>An indenoisoquinoline derivative and topoisomerase 1 (Top1) inhibitor, with potential antineoplastic activity. Upon administration, LMP744 binds to and stabilizes cleaved DNA-Top1 complexes, which prevents DNA re-ligation, induces stable, irreversible DNA strand breaks, prevents DNA repair, and leads to cell cycle arrest and apoptosis. As tumor cells proliferate at a much higher rate than normal cells, LMP744 specifically targets cancer cells. Top1, a DNA modifying enzyme essential for transcription, replication, and repair of double-strand DNA breaks, is overexpressed in tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13744187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Modified FOLFIRINOX Regimen</VALIDVALUE>
          <VALUEMEANING>Modified FOLFIRINOX Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified, dose-adjusted regimen consisting of fluorouracil, irinotecan, leucovorin and oxaliplatin (FOLFIRINOX) that can be used for the treatment of colorectal cancers, and occult primary, ampullary, pancreatic, small bowel and appendiceal adenocarcinomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15393455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BRD4 Inhibitor PLX51107</VALIDVALUE>
          <VALUEMEANING>BRD4 Inhibitor PLX51107</VALUEMEANING>
          <MEANINGDESCRIPTION>An inhibitor of the bromodomain-containing protein 4 (BRD4), with potential antineoplastic activity. Upon administration, the BRD4 inhibitor PLX51107 binds to the acetylated lysine recognition motifs in the bromodomains of the BRD4 protein, thereby preventing the binding of BRD4 to acetylated lysines on histones. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an induction of apoptosis and an inhibition of proliferation in BRD4-overexpressing tumor cells. BRD4, a member of the human bromodomain and extra-terminal (BET) family of proteins, is a transcriptional regulator that is overexpressed in certain tumor cells and plays an important role in cellular proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125739</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13614617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ceramide Nanoliposome</VALIDVALUE>
          <VALUEMEANING>Ceramide Nanoliposome</VALUEMEANING>
          <MEANINGDESCRIPTION>A lipid-based nanoparticle formulation composed of the apoptosis-inducing sphingolipid ceramide encapsulated within nanoliposomes, with potential apoptotic and antineoplastic activities. Upon administration, ceramide nanoliposomes accumulate in the tumor environment, due to the unique properties of the tumor vasculature, and easily enter tumor cells. This delivers ceramide inside the tumor cells, where ceramide induces apoptosis. Although the process is not completely understood, ceramide-dependent apoptosis most likely results from the downregulation of nutrient transporter proteins, which prevents cellular access to extracellular nutrients and causes tumor cell starvation. This selectively destroys tumor cells. Ceramide alone is insoluble and has a very short half-life; therefore, the nanoliposome formulation increases its solubility and half-life. Ceramide plays a key role in the regulation of autophagy, apoptosis, survival and proliferation. Serving as a tumor suppressor lipid, the expression of ceramide is inversely correlated with tumor cell growth, survival and metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13633880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100</VALIDVALUE>
          <VALUEMEANING>Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100</VALUEMEANING>
          <MEANINGDESCRIPTION>An anti-mesothelin (MSLN) recombinant cytolytic fusion protein (cFP) composed of a humanized Fab fragment of anti-MSLN monoclonal antibody SS1 linked to a truncated and de-immunized 24 kDa fragment of the Pseudomonas exotoxin (PE) (PE24), with potential antineoplastic activity. Upon intravenous administration of anti-MSLN-PE24 cFP LMB-100, the anti-MSLN moiety targets and binds to MSLN-expressing tumor cells. Upon binding and internalization through endocytosis, the toxin moiety ADP-ribosylates and inactivates eukaryotic elongation factor 2 (eEF2), preventing the elongation step of protein synthesis and leading to both an inhibition of protein synthesis and an induction of MSLN-expressing tumor cell apoptosis. MSLN, a tumor-associated antigen overexpressed in a variety of cancer cell types, plays a key role in tumor cell proliferation and migration. The engineered PE24 portion of LMB-100 does contain the targeting domain and furin cleavage site, which are needed for cytotoxicity, but most of the translocation domain II is deleted and the catalytic domain III contains point mutations, which result in the deletion and silencing of most T- and B-cell epitopes; therefore, the immunogenicity and toxicity is reduced compared to non-engineered PE toxin, which allows for the administration of larger doses of LMB-100.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121653</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13596932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RMC-4630/Cobimetinib</VALIDVALUE>
          <VALUEMEANING>Vociprotafib And Cobimetinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of protein tyrosine phosphatase (PTP) non-receptor type 11 (SHP2; Src homology region 2 domain phosphatase; PTPN11), with potential antineoplastic activity. Upon oral administration, vociprotafib targets, binds to and inhibits the activity of SHP2. This prevents SHP2-mediated signaling, inhibits MAPK signaling and prevents growth of SHP2-expressing tumor cells. SHP2, an oncoprotein overexpressed in a variety of cancer cell types, regulates cell survival, differentiation and proliferation through activation of the RAS-RAF-MEK-ERK signaling pathway. The RAS-MAPK pathway is often hyperactivated in cancer cells due to specific mutations and rearrangements and are dependent on SHP2 for their oncogenic signaling. SHP2 also regulates programmed cell death 1 (PD-1)-mediated signal transduction and is involved in immune checkpoint modulation._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._An orally bioavailable small-molecule inhibitor of mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1), with potential antineoplastic activity. Cobimetinib specifically binds to and inhibits the catalytic activity of MEK1, resulting in inhibition of extracellular signal-related kinase 2 (ERK2) phosphorylation and activation and decreased tumor cell proliferation. Preclinical studies have demonstrated that this agent is effective in inhibiting the growth of tumor cells bearing a B-RAF mutation, which has been found to be associated with many tumor types. A threonine-tyrosine kinase and a key component of the RAS/RAF/MEK/ERK signaling pathway that is frequently activated in human tumors, MEK1 is required for the transmission of growth-promoting signals from numerous receptor tyrosine kinases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68923, C37912, C155850</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15393456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Porcupine Inhibitor CGX1321</VALIDVALUE>
          <VALUEMEANING>Porcupine Inhibitor CGX1321</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of the membrane-bound O-acyltransferase (MBOAT) porcupine (PORCN), with potential antineoplastic, protective and regenerative activities. Upon oral administration, PORCN inhibitor CGX1321 specifically targets and binds to PORCN in the endoplasmic reticulum (ER), thereby inhibiting the post-translational palmitoylation and secretion of Wnt ligands, thus preventing the activation of Wnt-mediated signaling, and inhibiting cell growth in Wnt-driven tumors. In addition, by inhibiting the secretion of Wnt ligands and preventing Wnt-mediated signaling, CGX1321 may also limit fibrosis and promote regeneration of certain tissues upon cell injury. PORCN catalyzes the palmitoylation of Wnt ligands, and plays a key role in Wnt ligand secretion. Wnt signaling is dysregulated in a variety of cancers and plays a key role in tumor cell proliferation. It also plays a key role in tissue regeneration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C146853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13724956</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metarrestin</VALIDVALUE>
          <VALUEMEANING>Metarrestin</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available small molecule inhibitor of perinucleolar compartment (PNC), with potential antineoplastic activities. Although the exact mechanisms(s) through which this agent exerts its effects have yet to be fully elucidated, upon oral administration, metarrestin disrupts the structure of PNC and inhibits RNA polymerase (Pol) I transcription. This leads to the reduction in the prevalence of PNC in cancer cells and decrease in tumor growth and spread. PNC is a subnuclear structure and a phenotypic marker of metastatic cancer cells. A high PNC prevalence has been associated with disease progression and poor patient outcomes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168544</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13696503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ATR inhibitor Bay 1895344</VALIDVALUE>
          <VALUEMEANING>Elimusertib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available ataxia telangiectasia and Rad3-related (ATR)-specific kinase inhibitor, with potential antineoplastic activity. Upon oral administration, elimusertib selectively binds to and inhibits the activity of ATR, which prevents ATR-mediated signaling. This inhibits DNA damage checkpoint activation, disrupts DNA damage repair and induces apoptosis in ATR-overexpressing tumor cells. ATR, a serine/threonine protein kinase upregulated in a variety of cancer cell types, plays a key role in DNA repair, cell cycle progression and cell survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C146807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13956415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MDM2 inhibitor</VALIDVALUE>
          <VALUEMEANING>MDM2 Inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>Any agent that binds to mouse double minute 2 (human double minute 2 homolog; MDM2; HDM2) and/or prevents the interaction with the tumor suppressor protein p53, with potential antineoplastic activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C162996</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15403407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FOLFOXIRI (Folinic Acid/leucovorin, 5-Fluorouracil/5FU, Oxaliplatin, Irinotecan)</VALIDVALUE>
          <VALUEMEANING>FOLFOXIRI Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of fluorouracil, leucovorin, oxaliplatin and irinotecan (FOLFOXIRI) that is used for the treatment of colon cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136252</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15408894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ivabradine</VALIDVALUE>
          <VALUEMEANING>Ivabradine</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, hyperpolarization-activated, cyclic nucleotide-gated (HCN) channel blocker, with negative chronotropic activity. Upon administration, ivabradine selectively binds to the intracellular portion of the HCN channel pore and blocks HCN channels in the pacemaker cells within the sinoatrial (SA) node. This inhibits the If (funny) pacemaker ion current, prevents the inward flow and intracellular accumulation of positively charged ions, reduces pacemaker activity and slows diastolic depolarization. This decreases heart rate, reduces myocardial oxygen demand and allows more time for blood to flow to the myocardium without affecting cardiac contractility. HCN channels, mixed sodium (Na+) and potassium (K+) channels that carry the inward If current, play a key role in the regulation of pacemaker firing rate in the SA node. The If pacemaker current, the inward flow of positively charged Na+-K+ ions, initiates the spontaneous diastolic depolarization phase and modulating heart rate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65995</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15408893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pidilizumab</VALIDVALUE>
          <VALUEMEANING>Pidilizumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against human PD-1 (programmed cell death 1; PDCD1), with immunomodulating and antitumor activities. Pidilizumab blocks interaction between the receptor PD-1 with its ligands, PD-1 ligand 1 (PD-1L1) and PD-1 ligand 2 (PD-1L2), resulting in the attenuation of apoptotic processes in lymphocytes, primarily effector/memory T cells, and the augmentation of the anti-tumor activities of NK cells. PD-1 is an inhibitory receptor belonging to the B7-receptor family that is expressed on lymphocytes and myeloid cells; its ligands, PD-1L1 and PD-1L2, are expressed not only by hematopoietic cells but also by cells in non-lymphoid tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71014</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6159899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regorafenib/Entinostat/Hydroxychloroquine</VALIDVALUE>
          <VALUEMEANING>Regorafenib Entinostat Hydroxychloroquine</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrate form of regorafenib, an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling._A synthetic benzamide derivative with potential antineoplastic activity. Entinostat binds to and inhibits histone deacetylase, an enzyme that regulates chromatin structure and gene transcription. This agent appears to exert dose-dependent effects in human leukemia cells including cyclin-dependent kinase inhibitor 1A (p21/CIP1/WAF1)-dependent growth arrest and differentiation at low drug concentrations; a marked induction of reactive oxygen species (ROS); mitochondrial damage; caspase activation; and, at higher concentrations, apoptosis. In normal cells, cyclin-dependent kinase inhibitor 1A expression has been associated with cell-cycle exit and differentiation._A 4-aminoquinoline with immunosuppressive, antiautophagy, and antimalarial activities. Although the precise mechanism of action is unknown, hydroxychloroquine may suppress immune function by interfering with the processing and presentation of antigens and the production of cytokines. As a lysosomotropic agent, hydroxychloroquine raises intralysosomal pH, impairing autophagic protein degradation; hydroxychloroquine-mediated accumulation of ineffective autophagosomes may result in cell death in tumor cells reliant on autophagy for survival.  In addition, this agent is highly active against the erythrocytic forms of P. vivax and malariae and most strains of P. falciparum but not the gametocytes of P. falciparum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C557, C1863, C184955</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15442567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nivolumab/Relatlimab</VALIDVALUE>
          <VALUEMEANING>Nivolumab/Relatlimab Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of a fixed-dose combination of nivolumab and relatlimab that may be used in the treatment of cutaneous melanoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189867</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15442566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guadecitabine/Irinotecan</VALIDVALUE>
          <VALUEMEANING>Guadecitabine Irinotecan</VALUEMEANING>
          <MEANINGDESCRIPTION>A dinucleotide antimetabolite composed of a decitabine linked via phosphodiester bond to a deoxyguanosine, with potential antineoplastic activity. Following metabolic activation via cleavage of the phosphodiester bond and incorporation of the decitabine moiety into DNA, guadecitabine inhibits DNA methyltransferase, thereby causing non-specific, genome-wide hypomethylation, and induction of cell cycle arrest at S-phase. This agent is resistant to cytidine deaminase, which may result in gradual release of decitabine both extra- and intra-cellularly, leading to prolonged exposure to decitabine._A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata.  Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme.  One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death.  Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62040, C95209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15442565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MEDI4736 (Durvalumab)/Gemcitabine</VALIDVALUE>
          <VALUEMEANING>Durvalumab Gemcitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody directed against B7H1 (B7 homolog 1; programmed cell death ligand 1) with potential immunostimulating activity. Upon intravenous administration, durvalumab binds to the cell surface antigen B7H1, thereby blocking B7H1 signaling. This may activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against B7H1-expressing tumor cells. B7H1, a member of the B7 protein superfamily and a negative regulator of cytokine synthesis, is overexpressed on certain tumor cell types._A broad-spectrum antimetabolite and deoxycytidine analogue with antineoplastic activity. Upon administration, gemcitabine is converted into the active metabolites difluorodeoxycytidine diphosphate (dFdCDP) and difluorodeoxycytidine triphosphate (dFdCTP) by deoxycytidine kinase. dFdCTP competes with deoxycytidine triphosphate (dCTP) and is incorporated into DNA.  This locks DNA polymerase thereby resulting in &quot;masked termination&quot; during DNA replication. On the other hand, dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis. The reduction in the intracellular concentration of dCTP potentiates the incorporation of dFdCTP into DNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66876, C103194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15442564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COP (Cyclophosphamide, Vincristine, Prednisone)/Nivolumab</VALIDVALUE>
          <VALUEMEANING>CVP Regimen Nivolumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of cyclophosphamide, vincristine and prednisone that may be used to treat Castleman disease, post-transplant lymphoproliferative disorders, indolent forms of non-Hodgkin lymphoma, Burkitt lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia._A fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. Upon administration, nivolumab binds to and blocks the activation of PD-1, an immunoglobulin superfamily (IgSF) transmembrane protein, by its ligands programmed cell death ligand 1 (PD-L1), which is overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on antigen-presenting cells (APCs). This results in the activation of T-cells and cell-mediated immune responses against tumor cells. Activated PD-1 negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68814, C9573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15442563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RRX-001 (Nibrozetone)</VALIDVALUE>
          <VALUEMEANING>Nibrozetone</VALUEMEANING>
          <MEANINGDESCRIPTION>A dinitroazetidine derivative with potential radiosensitizing activity. Upon administration, nibrozetone is able to dilate blood vessels, thereby increasing tumor blood flow and thus improving oxygenation to the tumor site. By increasing oxygen levels, these tumor cells may be more susceptible to radiation therapy.  Tumor hypoxia is correlated with tumor aggressiveness, metastasis and resistance to radiotherapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15442562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRC102 (Methoxyamine HCl)</VALIDVALUE>
          <VALUEMEANING>Methoxyamine Hydrochloride</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrochloride salt form of methoxyamine, an alkoxyamine with potential chemotherapeutic adjuvant activity. Methoxyamine covalently binds to apurinic/apyrimidinic DNA damage sites and thereby inhibits base excision repair (BER) process, which may prevent repair of DNA strand breaks and result in an induction of apoptosis. This agent may potentiate the anti-tumor activity of alkylating agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78085</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13697132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin A and D</VALIDVALUE>
          <VALUEMEANING>A and D Ointment</VALUEMEANING>
          <MEANINGDESCRIPTION>A topical preparation containing fat-soluble vitamins A and D usually in a lanolin-petrolatum base, A and D Ointment promotes healing of minor burns, rashes, sunburn, skin irritations, and acne; and prevents diaper rash. Vitamin A is essential for diverse cellular functions, immune system functions, and maintenance of mucous membranes, while vitamin D regulates calcium and phosphorous metabolism. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28794</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-01-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tranexamic Acid</VALIDVALUE>
          <VALUEMEANING>Tranexamic Acid</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of the amino acid lysine with antifibrinolytic activity. With strong affinity for the five lysine-binding sites of plasminogen, tranexamic acid competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti BCMA CAR T-Cell Therapy</VALIDVALUE>
          <VALUEMEANING>Anti-BCMA CAR T Cells Preparation</VALUEMEANING>
          <MEANINGDESCRIPTION>A preparation of CAR-T cells that targets the tumor-associated antigen (TAA)  B-cell maturation antigen (BCMA;TNFRSF17).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176023</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15725200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CWP291</VALIDVALUE>
          <VALUEMEANING>Sam68 Modulator CWP232291</VALUEMEANING>
          <MEANINGDESCRIPTION>A small molecule and prodrug of CWP232204 targeting Src associated in mitosis, of 68 kDa (Sam68 or KHDRBS1), with potential antineoplastic activity. CWP232291 is converted in serum into its active form CWP232204 which binds to Sam68, thereby resulting in the induction of apoptosis in selective cancer cells. Due to the multimodular structure of Sam68, the apoptosis mediated by CWP232204-Sam68 interaction can attribute from 1) activation of transcription factor NF-kB induced by tumor necrosis factor alpha signaling, 2) alternative splicing of BCL-2 apoptosis gene, driving the balance towards pro-apoptotic as opposed to anti-apoptotic isoforms, 3) down-regulation of the anti-apoptotic protein survivin via Wnt signaling. Sam68, a KH domain RNA-binding protein belonging to the signal transduction and activation of RNA (STAR) family, plays a key role in various cellular processes including cell cycle progression and apoptosis; it is upregulated in many types of cancer cells and its expression is associated with increased cell proliferation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97663</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13743777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PrismaSol</VALIDVALUE>
          <VALUEMEANING>PrismaSol</VALUEMEANING>
          <MEANINGDESCRIPTION>A sterile solution free of bacterial endotoxins and composed of water, various combinations of electrolytes, and lactic acid and sodium bicarbonate, that may be used as a replacement solution in hemofiltration and hemodiafiltration in continuous renal replacement therapy (CRRT). Upon administration, sterile hemofiltration/hemodiafiltration replacement solution replaces water and electrolytes removed during hemofiltration and hemodiafiltration, and corrects acid-base balance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C213801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15761334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pedialyte</VALIDVALUE>
          <VALUEMEANING>Pedialyte</VALUEMEANING>
          <MEANINGDESCRIPTION>An oral electrolyte solution composed of water, dextrose and electrolytes, including sodium, potassium, and chloride, with dehydration preventative activity. Upon oral administration, the chloride/dextrose/potassium/sodium-containing oral electrolyte solution replenishes the body&#39;s supply of water and electrolytes, thereby promoting rehydration and preventing dehydration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C213800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15761333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pasireotide</VALIDVALUE>
          <VALUEMEANING>Pasireotide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic long-acting cyclic peptide with somatostatin-like activity. Pasireotide activates a broad spectrum of somatostatin receptors, exhibiting a much higher binding affinity for somatostatin receptors 1, 3, and 5 than octreotide in vitro, as well as a comparable binding affinity for somatostatin receptor 2. This agent is more potent than somatostatin in inhibiting the release of human growth hormone (HGH), glucagon, and insulin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3564437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gelfoam powder</VALIDVALUE>
          <VALUEMEANING>Absorbable Gelatin Sponge</VALUEMEANING>
          <MEANINGDESCRIPTION>A sterile hemostatic agent composed of purified porcine-derived gelatin.  In regional chemotherapy, absorbable gelatin sponge may be used to embolize arteries in the region of a tumor in order to block or retard blood flow; this blockage results in a locally increased concentration of chemotherapeutic agents delivered to the tumor when chemotherapeutic agents are infused into the embolized arterial circulation upstream of the blockage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gadobutrol</VALIDVALUE>
          <VALUEMEANING>Gadobutrol</VALUEMEANING>
          <MEANINGDESCRIPTION>A gadolinium-based, hydrophilic, macrocyclic, electrically neutral contrast agent used in contrast-enhanced MRI (CE-MRI). Gadobutrol is a non-ionic, paramagnetic complex consisting of gadolinium (Gd3+) chelated with the macrocyclic compound dihydroxy-hydroxymethylpropyl-tetraazacyclododecane-triacetic acid (butrol). Following intravenous administration, gadobutrol may increase MRI sensitivity for the detection of tumors and inflammatory and demyelinating diseases of the central nervous system (CNS) that are associated with areas with blood-brain barrier defects due to altered perfusion or an enlarged extracellular space. This agent is eliminated in an unchanged form via the kidneys; extra-renal elimination is negligible.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70675</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15761332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethanol (Ethyl alcohol)</VALIDVALUE>
          <VALUEMEANING>Alcohol</VALUEMEANING>
          <MEANINGDESCRIPTION>A volatile liquid prepared by fermentation of certain carbohydrates. Alcohol acts as a central nervous system (CNS) depressant, a diuretic, and a disinfectant. Although the exact mechanism of CNS depression is unknown, alcohol may act by inhibiting the opening of calcium channels, mediated by the binding of the inhibitory neurotransmitter gamma-amino butyric acid (GABA) to GABA-A receptors, or through inhibitory actions at N-methyl-D-aspartate (NMDA)-type glutamate receptors. Alcohol inhibits the production of antidiuretic hormone, thereby producing diuresis that may lead to dehydration. This agent kills organisms by denaturing their proteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epoprostenol</VALIDVALUE>
          <VALUEMEANING>Epoprostenol</VALUEMEANING>
          <MEANINGDESCRIPTION>An oral prostacyclin and a metabolite of arachidonic acid with antihypertensive and platelet inhibitory properties. Epoprostenol binds to prostacyclin receptors on platelet surfaces, subsequently activating platelet membrane adenyl cyclase and resulting in increased cAMP levels. The elevated cAMP triggers signal transduction that leads to vasodilations. In addition, this agent also functions as an antagonist of thromboxane A2, thereby resulting in direct vasodilation of pulmonary and systemic arterial vascular beds, and inhibition of platelet aggregation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ciforadenant</VALIDVALUE>
          <VALUEMEANING>Ciforadenant</VALUEMEANING>
          <MEANINGDESCRIPTION>A small molecule immune checkpoint inhibitor of the adenosine A2A receptor (ADORA2A) with potential antineoplastic activity. Upon oral administration, ciforadenant binds to adenosine A2A receptors expressed on the surface of immune cells, including T-lymphocytes, natural killer (NK) cells, macrophages and dendritic cells (DCs). This prevents tumor-released adenosine from interacting with the A2A receptors on these key immune surveillance cells, thereby abrogating adenosine-induced immunosuppression in the tumor microenvironment. This may stimulate anti-tumor immune responses, resulting in tumor regression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125659</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13633925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ceralasertib</VALIDVALUE>
          <VALUEMEANING>Ceralasertib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available morpholino-pyrimidine-based inhibitor of ataxia telangiectasia and rad3 related (ATR) kinase, with potential antineoplastic activity. Upon oral administration, Ceralasertib selectively inhibits ATR activity by blocking the downstream phosphorylation of the serine/threonine protein kinase CHK1. This prevents ATR-mediated signaling, and results in the inhibition of DNA damage checkpoint activation, disruption of DNA damage repair, and the induction of tumor cell apoptosis. In addition, AZD6738 sensitizes tumor cells to chemo- and radiotherapy. ATR, a serine/threonine protein kinase upregulated in a variety of cancer cell types, plays a key role in DNA repair, cell cycle progression and survival; it is activated by DNA damage caused during DNA replication-associated stress.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13633879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>anti-gpA33/CD3 monoclonal antibody MGD007</VALIDVALUE>
          <VALUEMEANING>Anti-gpA33/CD3 Monoclonal Antibody MGD007</VALUEMEANING>
          <MEANINGDESCRIPTION>An anti-glycoprotein A33 (gpA33)/anti-CD3 bispecific humanized monoclonal antibody with potential immunostimulatory and antineoplastic activities. Anti-gpA33/CD3 monoclonal antibody MGD007 possesses two antigen-recognition sites, one for the CD3 complex, a group of T-cell surface glycoproteins that complex with the T-cell receptor (TCR), and one for gpA33, a tumor-associated antigen (TAA) overexpressed on the surface of certain tumor cells. Upon administration of MGD007, this bispecific antibody simultaneously binds to both CD3-expressing T-cells and gpA33-expressing cancer cells, thereby crosslinking cytotoxic T-lymphocytes (CTLs) to gpA33-expressing tumor cells. This may result in CTL-mediated cell lysis of the crosslinked tumor cells. The gpA33 antigen, a member of the immunoglobulin superfamily, is expressed in certain malignancies, including colon and gastrointestinal cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13596882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Onyvax-P</VALIDVALUE>
          <VALUEMEANING>Prostate Cancer Vaccine ONY-P1</VALUEMEANING>
          <MEANINGDESCRIPTION>A cell-based vaccine derived from prostate cancer with potential immunopotentiating and antineoplastic activities. Prostate cancer vaccine ONY-P1 is derived from three irradiated allogeneic prostate cancer cell lines that represent different stages of prostate cancer and express a broad range of prostate and prostate cancer antigens. Upon administration, this vaccine may stimulate a host immune response against prostate cancer cells; in the vaccination schedule, the first two vaccinations are co-administered with bacillus Calmette-Guerin (BCG) as an adjuvant.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71723</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13724981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alobresib</VALIDVALUE>
          <VALUEMEANING>Alobresib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of the Bromodomain and Extra-Terminal (BET) family of proteins, with potential antineoplastic activity. Upon oral administration, alobresib binds to the acetylated lysine recognition motifs in the bromodomains of BET proteins, thereby preventing the interaction between the BET proteins and acetylated histones. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an inhibition of proliferation in BET-overexpressing tumor cells. BET proteins, comprised of BRD2, BRD3, BRD4 and BRDT, are transcriptional regulators that play an important role during development and cellular growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13596449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Burixafor Hydrobromide</VALIDVALUE>
          <VALUEMEANING>Burixafor Hydrobromide</VALUEMEANING>
          <MEANINGDESCRIPTION>The hydrobromide salt form of burixafor, an orally bioavailable inhibitor of CXC chemokine receptor 4 (CXCR4) with hematopoietic stem cell (HSC)-mobilization and chemosensitizing activities. Upon administration, burixafor binds to the chemokine receptor CXCR4, thereby preventing the binding of stromal cell-derived factor-1 (SDF-1 or CXCL12) to the CXCR4 receptor and subsequent receptor activation. This may induce the mobilization of hematopoietic stem and progenitor cells from the bone marrow into the peripheral circulation. Additionally, burixafor-mediated mobilization of disseminated tumor cells (DTCs) from the bone marrow into the blood may make these metastatic tumor cells more susceptible to the actions of chemotherapeutic agents. CXCR4, a chemokine receptor belonging to the G protein-coupled receptor (GPCR) gene family, plays an important role in chemotaxis and angiogenesis and is upregulated in several tumor cell types. CXCL12/CXCR4 interaction induces retention of hematopoietic cells in the bone marrow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130049</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13614660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Galunisertib</VALIDVALUE>
          <VALUEMEANING>Galunisertib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available, small molecule antagonist of the tyrosine kinase transforming growth factor-beta (TGF-b) receptor type 1 (TGFBR1), with potential antineoplastic activity. Upon administration, galunisertib specifically targets and binds to the kinase domain of TGFBR1, thereby preventing the activation of TGF-b-mediated signaling pathways. This may inhibit the proliferation of TGF-b-overexpressing tumor cells. Dysregulation of the TGF-b signaling pathway is seen in a number of cancers and is associated with increased cancer cell proliferation, migration, invasion and tumor progression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116891</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13660203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H1299 tumor cell lysate vaccine</VALIDVALUE>
          <VALUEMEANING>H1299 Tumor Cell Lysate Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cell lysate derived from a lung cancer cell line, H1299, with potential immunostimulatory and antineoplastic activities. Upon intramuscular administration, the H1299 tumor cell lysate exposes the immune system to an undefined amount of tumor associated antigens (TAA), particularly cancer testis antigens (CTAs), which may result in the induction of both anti-tumoral cytotoxic T-lymphocytes (CTL) and antibody-dependent responses against TAA-expressing cells, leading to tumor cell lysis. CTAs, such as MAGE, are selectively expressed in a variety of cancers but are not expressed in normal, healthy cells outside the testis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114284</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13660265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Levorphanol</VALIDVALUE>
          <VALUEMEANING>Levorphanol</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of morphine with analgesic activities. Levorphanol mimics the actions of morphine, however, it is about 8 times more potent than morphine. This agent binds to opioid mu receptors, thereby producing analgesia, euphoria, sedation, respiratory depression, miosis, bradycardia, and physical dependence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61810</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15846846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Edoxaban</VALIDVALUE>
          <VALUEMEANING>Edoxaban Tosylate</VALUEMEANING>
          <MEANINGDESCRIPTION>The tosylate salt form of edoxaban, an orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Edoxaban is administered as edoxaban tosylate. This agent has an elimination half-life of 9-11 hours and undergoes renal excretion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15846847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Penciclovir</VALIDVALUE>
          <VALUEMEANING>Penciclovir</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic acyclic guanine derivative with antiviral activity, mainly used to treat infections from herpes simplex virus (HSV) types 1 and 2. In HSV infected cells, penciclovir is phosphorylated by viral thymidine kinase and subsequently converted by cellular kinases into the active metabolite, penciclovir triphosphate, which competitively inhibits viral HSV polymerase by blocking deoxyguanosine triphosphate substrate binding. As a result, herpes viral DNA synthesis and replication are selectively inhibited.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66337</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15846848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ambrisentan</VALIDVALUE>
          <VALUEMEANING>Ambrisentan</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, selective antagonist of the endothelin type-A (ETA) receptor that may be used for the treatment of pulmonary arterial hypertension (PAH). Upon administration, ambrisentan targets and binds to ETA receptor, which prevents the binding of endothelin-1 (ET-1) to the ETA receptor and ET-1/ETA-mediated vasoconstriction and cell proliferation. This may lead to vasodilation. ET-1 concentrations are increased in plasma as well as lung tissue in PAH, and ET-1 may play a key role in the pathogenesis of PAH.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C72694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15846849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Riociguat</VALIDVALUE>
          <VALUEMEANING>Riociguat</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable stimulator of soluble guanylate cyclase (sGC), with vasodilating activity.  Upon oral administration, riociguat directly stimulates the catalytic activity of sGC. In addition, riociguat stabilizes the binding of nitric oxide (NO) to sGC. Altogether this stimulates the NO-sGC-cyclic guanosine monophosphate (cGMP) pathway and increases the formation of the intracellular second messenger cGMP, which results in smooth muscle relaxation and vasodilation. sGC, a heme-containing cytoplasmic signaling enzyme, catalyzes the formation of cGMP from guanosine triphosphate (GTP) in response to NO binding to heme. Riociguat stimulates sGC independently of and synergistically with NO.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C152225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15846850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regadenoson</VALIDVALUE>
          <VALUEMEANING>Regadenoson</VALUEMEANING>
          <MEANINGDESCRIPTION>An adenosine derivative and selective A2A adenosine receptor agonist with coronary vasodilating activity. Upon administration, regadenoson selectively binds to and activates the A2A adenosine receptor, which induces coronary vasodilation. This leads to an increase in coronary blood flow and enhances myocardial perfusion. Compared to adenosine, regadenoson has a longer half-life and shows higher selectivity towards the A2A adenosine receptor. This agent is a very weak agonist for the A1 adenosine receptor and has negligible affinity for the A2B and A3 adenosine receptors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15846851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Actinium-PSMA</VALIDVALUE>
          <VALUEMEANING>Actinium-PSMA</VALUEMEANING>
          <MEANINGDESCRIPTION>Any radiopharmaceutical agent targeting human prostate-specific membrane antigen (PSMA) and labeled with the alpha-emitting radioisotope actinium Ac 225.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C213967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15846852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ARASENS</VALIDVALUE>
          <VALUEMEANING>ARASENS</VALUEMEANING>
          <MEANINGDESCRIPTION>An international, multi-center, double-blind, placebo-controlled phase 3 clinical study investigating the safety and efficacy of darolutamide, an oral antigen receptor inhibitor (ARi), in combination with docetaxel chemotherapy and androgen deprivation therapy (ADT) as treatment for metastatic hormone-sensitive prostate cancer (mHSPC).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C213965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15846853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hexyl methylmethionine</VALIDVALUE>
          <VALUEMEANING>Methylmethionine Sulfonium Chloride</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82926</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15846854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MAPK inhibitor</VALIDVALUE>
          <VALUEMEANING>MEK inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>Any substance that inhibits mitogen-activated protein kinase kinase (MEK), an enzyme that catalyzes the addition of a phosphate group to a mitogen-activated protein kinase. Inhibition of mitogen-activated protein kinase kinase results in the inhibition of cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69145</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4773273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperthermic Extracorporeal Applied Tumor Therapy</VALIDVALUE>
          <VALUEMEANING>Hyperthermic Extracorporeal Applied Tumor Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of hyperthermia treatment that utilizes extracorporeal blood heat exchange devices to increase core body temperature to target and destroy heat-sensitive cancerous cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C213966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15846855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Activin Type 2B Receptor Fc Fusion Protein STM 434</VALIDVALUE>
          <VALUEMEANING>Activin Type 2B Receptor Fc Fusion Protein STM 434</VALUEMEANING>
          <MEANINGDESCRIPTION>A soluble fusion protein containing the extracellular domain of the activin receptor type 2B (ACVR2B or ActRIIB) fused to a human Fc domain, with potential antineoplastic activity. Upon intravenous administration, STM 434 selectively binds to the growth factor activin A, thereby preventing its binding to and the activation of endogenous ActRIIB. This prevents activin A/ActRIIB-mediated signaling and inhibits the proliferation of activin A-overexpressing tumor cells. Activin A, a member of the transforming growth factor beta (TGF-beta) superfamily, is overexpressed in a variety of cancers and plays a key role in promoting cancer cell proliferation, migration, and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13596316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpelisib</VALIDVALUE>
          <VALUEMEANING>Alpelisib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Alpelisib specifically inhibits PI3K in the PI3K/AKT kinase (or protein kinase B) signaling pathway, thereby inhibiting the activation of the PI3K signaling pathway. This may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis. Dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13596451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>antiVEGFr CAR CD8+ PBL</VALIDVALUE>
          <VALUEMEANING>antiVEGFr CAR CD8+ PBL</VALUEMEANING>
          <MEANINGDESCRIPTION>Autologous human CD8-positive T-lymphocytes transduced with a recombinant retroviral vector encoding a chimeric T cell receptor (chimeric antigen receptor or CAR) consisting of an anti-vascular endothelial growth factor receptor type 2 (VEGFR2) scFv (single chain variable fragment), linked to the transmembrane domain of human CD8alpha and coupled to the costimulatory signaling domains of both CD28 and 4-1BB (CD137), and the CD3 zeta chain of the T-cell receptor (TCR), with potential immunostimulating and antineoplastic activities. Autologous peripheral blood lymphocytes (PBLs) from a patient with VEGFR2-positive cancer are pulsed with a retroviral vector that encodes the CAR gene specific for VEGFR2. After expansion in culture and reintroduction into the patient, the anti-VEGFR2 CAR-gene engineered CD8+ lymphocytes express anti-VEGFR2-CAR on their cell surfaces and bind to the VEGFR2 antigen on tumor cell surfaces. Subsequently, VEGFR2-expressing tumor cells are lysed. VEGFR2, a receptor tyrosine kinase (RTK) overexpressed by a variety of cancer cell types, belongs to the VEGFR superfamily and plays key roles in tumor cell proliferation, survival, invasion and tumor angiogenesis. The co-stimulatory molecules are required for optimal T-cell activation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111038</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15881430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lucitanib</VALIDVALUE>
          <VALUEMEANING>Lucitanib</VALUEMEANING>
          <MEANINGDESCRIPTION>A novel dual inhibitor targeting human vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs) with antiangiogenic activity. Lucitanib inhibits VEGFR-1, -2, -3 and FGFR-1, -2 kinases in the nM range, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation, and the induction of tumor cell death. Both VEGFRs and FGFRs belong to the family of receptor tyrosine kinases that may be upregulated in various tumor cell types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13689503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BB1608 STAT3 inhibitor</VALIDVALUE>
          <VALUEMEANING>Napabucasin</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available cancer cell stemness inhibitor with potential antineoplastic activity. Even though the exact target has yet to be fully elucidated, napabucasin appears to target and inhibit multiple pathways involved in cancer cell stemness. This may ultimately inhibit cancer stemness cell (CSC) growth as well as heterogeneous cancer cell growth. CSCs, self-replicating cells that are able to differentiate into heterogeneous cancer cells, appear to be responsible for the malignant growth, recurrence and resistance to conventional chemotherapies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6148644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin C</VALIDVALUE>
          <VALUEMEANING>Vitamin C</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14426894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dichloroacetate sodium</VALIDVALUE>
          <VALUEMEANING>Sodium Dichloroacetate</VALUEMEANING>
          <MEANINGDESCRIPTION>The sodium salt of dichloroacetic acid with potential antineoplastic activity. Dichloroacetate ion inhibits pyruvate dehydrogenase kinase, resulting in the inhibition of glycolysis and a decrease in lactate production. This agent may stimulate apoptosis in cancer cells by restoring normal mitochondrial-induced apoptotic signaling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73591</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13743893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low dose naltrexone</VALIDVALUE>
          <VALUEMEANING>Low dose naltrexone</VALUEMEANING>
          <MEANINGDESCRIPTION>A noroxymorphone derivative and an opioid antagonist, taken at a dose that is up to one-tenth of the dose that is usually taken for opioid addiction, with potential analgesic and anti-inflammatory activities. Upon administration, and although the exact mechanism of action through which low-dose naltrexone exerts its anti-inflammatory activity has not been fully elucidated, low-dose naltrexone may inhibit toll-like receptor 4 (TLR4), thereby inhibiting TLR4-mediated pro-inflammatory cytokine secretion and inflammatory response. At the low dosage level, naltrexone exerts paradoxical analgesic and anti-inflammatory activities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C214844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15881431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ado-traztuzumab</VALIDVALUE>
          <VALUEMEANING>Trastuzumab Emtansine</VALUEMEANING>
          <MEANINGDESCRIPTION>An antibody-drug conjugate (ADC) consisting of the recombinant anti-epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab conjugated to the maytansinoid DM1 via a nonreducible thioether linkage (MCC) with potential antineoplastic activity. The trastuzumab moiety of this ADC binds to HER2 on tumor cell surfaces; upon internalization, the DM1 moiety is released and binds to tubulin, thereby disrupting microtubule assembly/disassembly dynamics and inhibiting cell division and the proliferation of cancer cells that overexpress HER2. Linkage of antibody and drug through a nonreducible linker has been reported to contribute to the improved efficacy and reduced toxicity of this ADC compared to similar ADCs constructed with reducible linkers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4255113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CD4 AMG 199</VALIDVALUE>
          <VALUEMEANING>Vepsitamab</VALUEMEANING>
          <MEANINGDESCRIPTION>A half-life extended (HLE), human bispecific T-cell engager (BiTE) antibody composed of two single-chain variable fragments (scFv), one directed against the tumor-associated antigen (TAA) human mucin 17 (MUC17), and one directed against human CD3, a T-cell surface antigen found on T-lymphocytes, with potential antineoplastic activity. Upon administration vepsitamab binds to both CD3 on T-cells and MUC17 expressed on tumor cells. This results in the cross-linking of T-cells and tumor cells, and induces a potent cytotoxic T-lymphocyte (CTL) response against MUC17-expressing tumor cells. MUC17, a member of the mucin family of glycoproteins, is overexpressed in a variety of tumor cells of epithelial origin and plays a key role in tumor cell dissemination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13956375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pi3ka inhibitor</VALIDVALUE>
          <VALUEMEANING>Pi3ka inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>Any agent that inhibits phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) catalytic subunit alpha (PIK3CA; PI3K p110alpha).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15881432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RLY-2608</VALIDVALUE>
          <VALUEMEANING>Pan-mutant-selective PI3K-alpha Inhibitor RLY-2608</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, pan-mutant selective inhibitor of the class I phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) catalytic subunit alpha (phosphoinositide 3-kinase alpha; PIK3CA; PI3K p110alpha), with potential antineoplastic activity. Upon oral administration, pan-mutant selective PI3K-alpha inhibitor RLY-2608 selectively targets and allosterically binds to PIK3CA mutated forms, thereby preventing the activity of PIK3CA mutants. This prevents mutant PIK3CA-mediated activation of the PI3K/Akt (protein kinase B)/mammalian target of rapamycin (mTOR) pathway. This results in both apoptosis and growth inhibition in PIK3CA-mutant expressing tumor cells. By specifically targeting PIK3CA mutants, RLY-2608 may be more efficacious and less toxic than PI3K-alpha inhibitors that also inhibit the wild-type (WT) form. Dysregulation of the PI3K/Akt/mTOR pathway is often found in solid tumors and results in the promotion of tumor cell growth, survival, and resistance to chemo- and radio-therapy. PIK3CA, one of the most frequently mutated oncogenes, encodes the p110-alpha catalytic subunit of the class I PI3K.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C186533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15881433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aromatase inhibitor</VALIDVALUE>
          <VALUEMEANING>Aromatase inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>An agent that blocks the function of the enzyme aromatase with antineoplastic activity.  Aromatase inhibitors belong to two classes: Type I steroidal drugs are androgen substrate analogues that bind competitively but irreversibly to the enzyme.  Type II nonsteroidal inhibitors fit into the substrate binding site and bind reversibly to the enzyme.  Present in many tissues, aromatases are heme-containing enzymes that catalyze the adrenal conversion of cholesterol to pregnenolone and the peripheral conversion (aromatization) of androgenic precursors to estrogens. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Balstilimab</VALIDVALUE>
          <VALUEMEANING>Balstilimab</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 (PD-1, PCD-1; PDCD1) protein, with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, balstilimab binds to PD-1, and thereby blocks its binding to the PD-1 ligand programmed cell death-1 ligand 1 (PD-L1), and prevents the activation of its downstream signaling pathways. This may restore immune function through the activation of cytotoxic T-cells. PD-1, a transmembrane protein in the immunoglobulin superfamily expressed on activated T-cells, negatively regulates T-cell activation and effector function when activated by its ligand; it plays an important role in tumor evasion from host immunity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136465</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13606215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Botensilimab</VALIDVALUE>
          <VALUEMEANING>Botensilimab</VALUEMEANING>
          <MEANINGDESCRIPTION>An Fc-engineered recombinant human immunoglobulin (Ig) G1 monoclonal antibody directed against the human T-cell receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), with immune checkpoint inhibitory and antineoplastic activities. Upon administration, anti-CTLA-4 monoclonal antibody  botensilimab binds to CTLA-4 expressed on T-cells and inhibits the CTLA-4-mediated downregulation of T-cell activation. This leads to a cytotoxic T-lymphocyte (CTL)-mediated immune response against cancer cells. CTLA-4, an inhibitory receptor and member of the immunoglobulin superfamily, plays a key role in the downregulation of the immune system. The engineered Fc domain increases the stability and half-life of the antibody.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13956347</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PC14586</VALIDVALUE>
          <VALUEMEANING>Rezatapopt</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, small molecule reactivator of the p53 Y220C mutant, with potential antineoplastic activity. Upon oral administration, rezatapopt selectively targets and binds to the crevice created by the p53 Y220C mutation, which normalizes and restores wild-type p53 protein structure and activity. This blocks tumor cell cycle progression and induces apoptosis in tumor cells expressing the p53 Y220C mutant. The p53 gene, a tumor suppressor gene, is mutated in many tumor types. The p53 protein plays a key role in the regulation of apoptosis and cellular proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C203051</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15881434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ipilimumab/Nivolumab</VALIDVALUE>
          <VALUEMEANING>Ipilimumab/Nivolumab Regimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A regimen consisting of ipilimumab and nivolumab that can be used for the treatment of bone, kidney, colorectal, esophageal and esophagogastric junction, head and neck, hepatocellular, and biliary tract cancers, melanoma, non-small cell lung cancer (NSCLC), malignant pleural/peritoneal mesothelioma, soft tissue sarcoma, pancreatic adenocarcinoma, Kaposi sarcoma, and angiosarcoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15975458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brivudine</VALIDVALUE>
          <VALUEMEANING>Brivudine</VALUEMEANING>
          <MEANINGDESCRIPTION>A uridine derivative and nucleoside analog with pro-apoptotic and chemosensitizing properties. In vitro, bromovinyl-deoxyuridine (BVDU) has been shown to downregulate the multifunctional DNA repair enzyme APEX nuclease 1, resulting in the inhibition of DNA repair and the induction of apoptosis. In addition, this agent may inhibit the expression of STAT3 (signal transducer and activator of transcription 3), which may result in the downregulation of vascular endothelial growth factor (VEGF). BVDU has also been found to inhibit the upregulation of chemoresistance genes (Mdr1 and DHFR) during chemotherapy. Overall, the gene expression changes associated with BVDU treatment result in the decrease or prevention of chemoresistance. In addition, this agent has been shown to enhance the cytolytic activity of NK-92 natural killer cells towards a pancreatic cancer cell line in vitro.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67088</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13614623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Breztri</VALIDVALUE>
          <VALUEMEANING>Breztri (Breztri Aerosphere)</VALUEMEANING>
          <MEANINGDESCRIPTION>A pressurized metered dose inhaler formulation containing a fixed combination of the anti-inflammatory agent and synthetic corticosteroid budesonide, the synthetic quaternary ammonium bromide salt and anticholinergic agent glycopyrrolate, and the fumarate dihydrate salt form of formoterol, a long-acting beta-2-adrenergic agonist and bronchodilator, with anti-inflammatory, anti-spasmodic, and bronchial smooth muscle-relaxing activities. Upon oral inhalation of the budesonide/glycopyrrolate/formoterol inhalation aerosol, budesonide targets and binds to intracellular glucocorticoid receptors (GRs), thereby exhibiting inhibitory activities against multiple cell types and mediators associated with both allergic-mediated and non-allergic-mediated inflammation. Glycopyrronium (R,S-enantiomer), the active moiety in glycopyrrolate, competitively binds to M3 muscarinic receptors located on smooth muscle cells, thereby inhibiting cholinergic transmission. This causes smooth muscle relaxation and prevents the occurrence of painful bronchospasms. Formoterol selectively targets and binds to beta-2-adrenergic receptors in bronchial smooth muscle, thereby activating intracellular adenyl cyclase, an enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3&#39;,5&#39;-adenosine monophosphate (cAMP). Increased intracellular cAMP levels result in the relaxation of bronchial smooth muscle, relieve bronchospasms, and inhibit cellular release of mediators of immediate hypersensitivity, especially from mast cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C215174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16022162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mRNA-based Personalized Cancer Vaccine NCI-4650</VALIDVALUE>
          <VALUEMEANING>mRNA-based Personalized Cancer Vaccine NCI-4650</VALUEMEANING>
          <MEANINGDESCRIPTION>An mRNA-based therapeutic personalized cancer vaccine (PCV) targeting up to fifteen tumor-associated antigens (TAAs) that are specifically expressed by a patient&#39;s cancer cells, with potential immunostimulatory and antineoplastic activities. The cells from the patient&#39;s tumor are analyzed and subjected to RNA sequencing to identify mutant and immunogenic epitopes. The neoantigen epitopes are screened to select those that induce a strong immune response in tumor- infiltrating lymphocytes (TILs) isolated from the patient. The selected mRNA sequences encoding up to fifteen neoantigen epitopes are incorporated in a proprietary formulation designed to maximize mRNA delivery and minimize mRNA-triggered immune responses. Upon administration, the mRNA-based PCV NCI-4650 is taken up and the mRNAs are translated by antigen presenting cells (APCs). Then, the expressed epitopes are presented via major histocompatibility complex (MHC) molecules on the surface of the APCs. This induces both cytotoxic T-lymphocyte (CTL)- and memory T-cell-dependent immune responses that specifically target and destroy the patient&#39;s cancer cells that express these neoantigens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C148239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13699265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beroterkib Anhydrous</VALIDVALUE>
          <VALUEMEANING>Beroterkib Anhydrous</VALUEMEANING>
          <MEANINGDESCRIPTION>The anhydrous form of beroterkib, an orally bioavailable inhibitor of the extracellular signal-regulated kinases (ERK) 1 and 2, with potential antineoplastic activity. Upon administration, beroterkib specifically binds to and inhibits both ERK 1 and 2, thereby preventing the activation of mitogen-activated protein kinase (MAPK)/ERK-mediated signal transduction pathways. This results in the inhibition of ERK-dependent tumor cell proliferation and survival. The MAPK/ERK pathway is often upregulated in a variety of tumor cell types and plays a key role in the proliferation, differentiation and survival of tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C155785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16065932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Interleukin-4</VALIDVALUE>
          <VALUEMEANING>Interleukin-4</VALUEMEANING>
          <MEANINGDESCRIPTION>Interleukin-4 (153 aa, ~17 kDa) is encoded by the human IL4 gene. This protein is involved in the regulation of the expression of class II MHC molecules, Fc receptors and cell surface-bound immunoglobulins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6159861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-CTLA-4 Monoclonal Antibody GIGA-564</VALIDVALUE>
          <VALUEMEANING>Anti-CTLA-4 Monoclonal Antibody GIGA-564</VALUEMEANING>
          <MEANINGDESCRIPTION>A human immunoglobulin G1 (IgG1) monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4; CTLA4; CD152), with potential immunomodulatory and antineoplastic activities. Upon administration, anti-CTLA-4 monoclonal antibody GIGA-564 targets and binds to CTLA-4, and may induce Fc receptor (FcR) signaling. This may deplete regulatory T-cells (Tregs) in the tumor microenvironment (TME), decrease the proliferation of the remaining Tregs in the TME, and reactivate antitumor immune responses. CTLA-4, an inhibitory receptor and member of the immunoglobulin superfamily (IgSF), plays a key role in the downregulation of the immune system. GIGA-564 has limited checkpoint inhibitory activity as it only weakly blocks the interaction between CTLA-4 and its B7 ligands CD80 and CD86.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16087707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-LILRB4 Monoclonal Antibody IO-202</VALIDVALUE>
          <VALUEMEANING>Anti-LILRB4 Monoclonal Antibody IO-202</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody directed against the immune inhibitory receptor leukocyte immunoglobulin-like receptor B4 (LILRB4), with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, anti-LILRB4 monoclonal antibody IO-202 targets, binds to and inhibits LILRB4 and its downstream signaling pathways. This may restore immune function through the activation of T-cells and T-cell-mediated immune responses against tumor cells, and inhibit tumor infiltration. LILRB4, an immune inhibitory receptor normally expressed on monocytic cells and highly expressed on monocytic acute myeloid leukemia (AML) cells, functions as an immune checkpoint that negatively regulates T-cell activation as its extracellular domain inhibits T-cell activity. It plays an important role in tumor infiltration in leukemias through multiple signaling pathways.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174485</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13596925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Guselkumab</VALIDVALUE>
          <VALUEMEANING>Guselkumab</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available, human, immunoglobulin G1 (IgG1) kappa, monoclonal antibody directed against the p19 protein subunit of interleukin-23 (IL-23), with immunomodulating activity. Upon administration, guselkumab binds to the p19 subunit of IL-23, thereby blocking the binding of IL-23 to the IL-23 receptor. This inhibits IL-23-mediated signaling and the differentiation of CD4-positive T-cells into Th1 and Th17 cells. This prevents Th1- and Th17-mediated immune responses and inhibits the production of pro-inflammatory cytokines. This may prevent or reduce symptoms and severity of immune-mediated inflammatory disorders. IL-23 plays a key role in the regulation of inflammation and the immune system, and modulates the release of various pro-inflammatory cytokines and chemokines. It is upregulated in various immune-mediated inflammatory disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13660262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nirmatrelvir</VALIDVALUE>
          <VALUEMEANING>Nirmatrelvir</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, peptidomimetic inhibitor of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) main protease (Mpro; 3C-like protease; 3CL protease; 3CLpro; nsp5 protease), with potential antiviral activity against SARS-CoV-2 and other coronaviruses. Upon oral administration, nirmatrelvir selectively targets, binds to, and inhibits the activity of SARS-CoV-2 Mpro. This inhibits the proteolytic cleavage of viral polyproteins, thereby inhibiting the formation of viral proteins including helicase, single-stranded-RNA-binding protein, RNA-dependent RNA polymerase, 20-O-ribose methyltransferase, endoribonuclease and exoribonuclease. This prevents viral transcription and replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C182119</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-05-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16110617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Levonorgestrel</VALIDVALUE>
          <VALUEMEANING>Levonorgestrel (Liletta)</VALUEMEANING>
          <MEANINGDESCRIPTION>The levorotatory form of norgestrel and synthetic progestogen with progestational and androgenic activity. Levonorgestrel binds to the progesterone receptor in the nucleus of target cells, thereby stimulating the resulting hormone-receptor complex, initiating transcription, and increasing the synthesis of certain proteins. This results in a suppression of luteinizing hormone (LH) activity and an inhibition of ovulation, as well as an alteration in the cervical mucus and endometrium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16136775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atogepant</VALIDVALUE>
          <VALUEMEANING>Atogepant</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable calcitonin gene-related peptide (CGRP) receptor antagonist that can be used in the preventive treatment of migraines. Upon oral administration, atogepant targets, binds to and blocks the activity of CGRP receptor, thereby preventing CGRP-mediated signaling. By blocking the CGRP-mediated pathways, atogepant is able to relieve or prevent migraine. CGRP-mediated signaling plays a key role in migraine pathogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C167018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14484341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allogeneic BKV-specific Cytotoxic T-lymphocytes</VALIDVALUE>
          <VALUEMEANING>BK virus-specific T-cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Allogeneic cytotoxic T-lymphocytes (CTLs) that are specifically reactive to BK virus (BKV), with potential antiviral activity. Upon infusion of allogeneic BK-specific CTLs into immunocompromised patients who were infected with BKV after allogeneic stem cell transplantation, these cells exert a specific CTL response against BKV, thereby killing and eliminating the BKV-infected cells. BKV is a member of the polyomavirus family that may cause mild symptoms in normal, healthy people; however, BKV infection can lead to severe disease in immunocompromised patients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-05-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16197190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Relugolix</VALIDVALUE>
          <VALUEMEANING>Relugolix</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH)) antagonist, with potential antineoplastic activity. Relugolix competitively binds to and blocks the GnRH receptor in the anterior pituitary gland, which both prevents GnRH binding to the GnRH receptor and inhibits the secretion and release of both luteinizing hormone (LH) and follicle stimulating hormone (FSH). In males, the inhibition of LH secretion prevents the release of testosterone from Leydig cells in the testes. Since testosterone is required to sustain prostate growth, reducing testosterone levels may inhibit hormone-dependent prostate cancer cell proliferation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13728627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>3rd line of therapy name</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>3rd line of therapy name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Checklist</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7283432</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRLNE3</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="952">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>8052430</PUBLICID>
    <LONGNAME>Participant Urination Straining International Prostate Symptom Score Value</LONGNAME>
    <PREFERREDNAME>PT_URIN_STRAIN_IPSS_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>The international prostate symptom score that describes how often the participant had to push or strain to begin urination.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>8052429</PublicId>
      <PreferredName>2407061v1.0:8052427v1.0</PreferredName>
      <PreferredDefinition>Someone who takes part in an activity._the discharge of urine._The act of making a very hard effort, possibly at one?s limit._In healthcare, a process used to learn about a patient&#39;s condition. This may include a complete medical history, medical tests, a physical exam, a test of learning skills, tests to find out if the patient is able to carry out the tasks of daily living, a mental health evaluation, and a review of social support and community resources available to the patient. [FDA Clinical Outcome Assessment (COA) Glossary]</PreferredDefinition>
      <LongName>Participant Urination Straining Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2407061</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29867</PreferredName>
        <Version>1</Version>
        <LongName>Participant</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29867</PREFERRED_NAME>
            <LONG_NAME>Participant</LONG_NAME>
            <CON_ID>2202627</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>8052427</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25744:C185651:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Urination Straining Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25744</PREFERRED_NAME>
            <LONG_NAME>Urination</LONG_NAME>
            <CON_ID>2203974</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C185651</PREFERRED_NAME>
            <LONG_NAME>Straining</LONG_NAME>
            <CON_ID>8052414</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCP:Division of Cancer Prevention</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>8049610</PublicId>
      <PreferredName>8049610v1.0</PreferredName>
      <PreferredDefinition>A screening tool used to screen for, diagnose, track, and manage the symptoms of benign prostatic hyperplasia._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>International Prostate Symptom Score Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DCP:Division of Cancer Prevention</Origin>
      <Representation>
        <PublicId>8049609</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C113446:C25712</PreferredName>
        <Version>1</Version>
        <LongName>International Prostate Symptom Score Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113446</PREFERRED_NAME>
            <LONG_NAME>International Prostate Symptom Score</LONG_NAME>
            <CON_ID>5842416</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Straining</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Straining</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="953">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>8155754</PUBLICID>
    <LONGNAME>Most Recent Malignant Neoplasm Diagnosis Date</LONGNAME>
    <PREFERREDNAME>HXPRMALIG_MHSTDAT</PREFERREDNAME>
    <PREFERREDDEFINITION>Date of most recent malignant neoplasm diagnosis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>8151598</PublicId>
      <PreferredName>8151596v1.0:2239981v1.0</PreferredName>
      <PreferredDefinition>Nearest to the present._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</PreferredDefinition>
      <LongName>Most Recent Malignant Neoplasm Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>AMC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>8151596</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25577:C9305</PreferredName>
        <Version>1</Version>
        <LongName>Most Recent Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25577</PREFERRED_NAME>
            <LONG_NAME>Most Recent</LONG_NAME>
            <CON_ID>2206311</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239981</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AMC CRF:AIDS Malignancy Consortium Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338240</PublicId>
      <PreferredName>CDISCDAT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>11</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396655</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25164</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Month and year of most recent diagnosis for the recurrence/progression</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Month and year of most recent</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Month and year of most recent diagnosis for the malignancy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Baseline Evaluations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7283433</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RCRPRMAL_MHSTDAT</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="954">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>8156451</PUBLICID>
    <LONGNAME>Disposition Domain Off Treatment Reason</LONGNAME>
    <PREFERREDNAME>SUPPDS_QVAL_OPTREAS</PREFERREDNAME>
    <PREFERREDDEFINITION>The reason a person is not receiving therapy and is considered off treatment.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCI CRF Standards</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6936204</PublicId>
      <PreferredName>2859364v1.0:2679219v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition._When a patient is not receiving therapy they are considered off treatment.  In clinical trials, a dosing schedule may require a patient to stop medication for a period of time, then resume, such as 28 days on and 7 days off.</PreferredDefinition>
      <LongName>Disposition Domain Off Treatment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859364</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49576</PreferredName>
        <Version>1</Version>
        <LongName>Disposition Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49576</PREFERRED_NAME>
            <LONG_NAME>Disposition Domain</LONG_NAME>
            <CON_ID>2469056</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2679219</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25601</PreferredName>
        <Version>1</Version>
        <LongName>Off-Treatment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25601</PREFERRED_NAME>
            <LONG_NAME>Off Treatment</LONG_NAME>
            <CON_ID>2202767</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCI CRF Standards</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>8156448</PublicId>
      <PreferredName>OFF_REASON_D</PreferredName>
      <PreferredDefinition>When a patient is not receiving therapy they are considered off treatment.  In clinical trials, a dosing schedule may require a patient to stop medication for a period of time, then resume, such as 28 days on and 7 days off._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Off Treatment Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008554</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_OTX_RSNS</PreferredName>
        <Version>1</Version>
        <LongName>Treatment/Off-treatment Reasons</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2547685</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25601:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Off-Treatment Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25601</PREFERRED_NAME>
            <LONG_NAME>Off Treatment</LONG_NAME>
            <CON_ID>2202767</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient Refusal (not related to adverse events)</VALIDVALUE>
          <VALUEMEANING>Withdrawal by Subject Patient</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that a study participant has removed themself from the study or from one or more segments of the study.: A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16960, C49634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8156449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adverse Events - related to protocol treatment</VALIDVALUE>
          <VALUEMEANING>Adverse Event Definitely Related to Intervention Adverse Event</VALUEMEANING>
          <MEANINGDESCRIPTION>A characteristic used to qualify the adverse event as certainly related to the medical intervention. According to WHO causality assessment criteria of suspected adverse reactions it is applicable to a clinical event, including laboratory test abnormality, occurring in a plausible time relationship to medical intervention, and which cannot be explained by concurrent disease or other interventions. The response to withdrawal of the medical product (dechallenge) should be clinically plausible. The event must be definitive pharmacologically or phenomenologically, using a satisfactory rechallenge procedure if necessary.: Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41331, C53260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8156450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intercurrent Illness - adverse events unrelated to protocol treatment</VALIDVALUE>
          <VALUEMEANING>Unrelated to Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>A characteristic used to qualify the adverse event as clearly not related to the medical intervention.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3141327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Symptomatic Progression</VALIDVALUE>
          <VALUEMEANING>Disease Progression Symptomatic</VALUEMEANING>
          <MEANINGDESCRIPTION>The worsening of a disease over time.: Having to do with symptoms, which are signs of a condition or disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25269, C17747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5557961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Treatment Completed</VALIDVALUE>
          <VALUEMEANING>Therapeutic Procedure Complete</VALUEMEANING>
          <MEANINGDESCRIPTION>An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25250, C49236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7348673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Progressive Disease (Objective)</VALIDVALUE>
          <VALUEMEANING>Progressive Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Death</VALIDVALUE>
          <VALUEMEANING>Death</VALUEMEANING>
          <MEANINGDESCRIPTION>The cessation of life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3141242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other Reason</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Longer Clinically Benefitting</VALIDVALUE>
          <VALUEMEANING>No Clinical Benefit</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: An effect of a therapeutic intervention that prolongs life, improves function, and/or improves the way a subject feels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142422, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8156592</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Investigator Decision</VALIDVALUE>
          <VALUEMEANING>Decision Investigator</VALUEMEANING>
          <MEANINGDESCRIPTION>A position, opinion, or judgment reached on an issue under consideration.: An individual who conducts scientific research. In a clinical setting this individual actually conducts and/or supervises the clinical investigation and study-related procedures.  The investigator monitors the safety of the trial subjects and investigational staff (under whose immediate direction an agent is administered or dispensed to a subject).  The investigator collects and analyses data and study documents, and provides reports in compliance with applicable requirements.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25936, C53285</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8156593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plan to receive alternate therapy</VALIDVALUE>
          <VALUEMEANING>Plan To Receive Alternative Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>To devise, contrive, or form in design._Used as a function word to indicate direction, purpose, or movement._To take, accept, or get something offered._Available in place of something else._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C25415, C25639, C65107, C25619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14765638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anticipated toxicity of upcoming protocol therapy</VALIDVALUE>
          <VALUEMEANING>Expected Toxicity With Future On Protocol Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Considered likely or probable; anticipated._The finding of bodily harm due to the poisonous effects of something._Used to indicate the presence of something or someone._A time that is yet to come._Subject is receiving treatment based on protocol.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181023, C67527, C62355, C27990, C25501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14765639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adverse Event (not related to clinical progression)</VALIDVALUE>
          <VALUEMEANING>Adverse Event (not related to clinical progression)</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._A state of connectedness between people, objects, or events; to be associated or connected with something._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._A process that manifests as the worsening of a disease over time._Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41331, C17747, C25398, C25648, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15066887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PSA Progression and Clinical Progression</VALIDVALUE>
          <VALUEMEANING>PSA Progression and Clinical Progression</VALUEMEANING>
          <MEANINGDESCRIPTION>The amount of prostate specific antigen is increased, based on pre-defined thresholds._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._A process that manifests as the worsening of a disease over time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17747, C25398, C37912, C123611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15066886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clinical Progression (only)</VALIDVALUE>
          <VALUEMEANING>Clinical Disease Progression</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.: The worsening of a disease over time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17747, C25398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-08-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5750360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Reason Off Protocol Treatment:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Reason Off Protocol Treatment:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason off protocol therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Physician determines it is in the patient&#39;s best interest, specify reason:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCTG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DS_DSDECOD_OPT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DS_DSDECOD_PHYSSPFY</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DS_DSDECOD_OPT_DTX</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DS_DSDECOD_OPT_ARPI</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPDS_QVAL_OPTREAS1</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPDS_QVAL_OPTREAS2</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPDS_QVAL_OPTREAS3</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="955">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>8176749</PUBLICID>
    <LONGNAME>Reason Inevaluable Best Overall Response</LONGNAME>
    <PREFERREDNAME>SUPPRS_QVAL_BRREASNE</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator relating to addition information why a patient is found inevaluable by study chair per protocol._An explanation of the cause of some phenomenon or action._The most clinically favorable response recorded from the start of the study treatment until the end of treatment._Unable to be evaluated.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3521221</PublicId>
      <PreferredName>2430995v1.0:3521219v1.0</PreferredName>
      <PreferredDefinition>Indicator relating to addition information why a patient is found inevaluable by study chair per protocol.</PreferredDefinition>
      <LongName>Clinical Study Additional Information Negation Evaluation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2430995</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15206</PreferredName>
        <Version>1</Version>
        <LongName>Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3521219</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25406:C48191:C25594:C25214</PreferredName>
        <Version>1</Version>
        <LongName>Additional Information Negation Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25406</PREFERRED_NAME>
            <LONG_NAME>Additional</LONG_NAME>
            <CON_ID>2206153</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48191</PREFERRED_NAME>
            <LONG_NAME>Information</LONG_NAME>
            <CON_ID>2422630</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>8176739</PublicId>
      <PreferredName>BEST_INEV_REASON_D</PreferredName>
      <PreferredDefinition>An explanation of the cause of some phenomenon or action._The most clinically favorable response recorded from the start of the study treatment until the end of treatment._Unable to be evaluated.</PreferredDefinition>
      <LongName>Reason Best Overall Response Unevaluable</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>8176738</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638:C94536:C62222</PreferredName>
        <Version>1</Version>
        <LongName>Reason Best Overall Response Unevaluable</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94536</PREFERRED_NAME>
            <LONG_NAME>Best Overall Response</LONG_NAME>
            <CON_ID>3297337</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62222</PREFERRED_NAME>
            <LONG_NAME>Unevaluable</LONG_NAME>
            <CON_ID>2528546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hematology (blasts) not done</VALIDVALUE>
          <VALUEMEANING>Not Done Hematology</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.: The branch of medicine that deals with the blood and blood-forming organs and the diseases thereof.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16673, C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8176740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Marrow not done</VALIDVALUE>
          <VALUEMEANING>Bone Marrow Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.: Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484, C12431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8176741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease Not Assessed</VALIDVALUE>
          <VALUEMEANING>Assessment Not Done Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>The final result of a determination of the value, significance, or extent of.: Indicates a task, process or examination that has either not been initiated or not been completed.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C49484, C25217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8176742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease not assessed, patient withdrew consent</VALIDVALUE>
          <VALUEMEANING>Assessment Not Done Withdrawal by Subject Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>The final result of a determination of the value, significance, or extent of.: Indicates a task, process or examination that has either not been initiated or not been completed.: An indication that a study participant has removed themself from the study or from one or more segments of the study.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C49634, C49484, C25217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8176743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease not assessed, patient death</VALIDVALUE>
          <VALUEMEANING>Disease or Disorder Assessment Not Done Dead</VALUEMEANING>
          <MEANINGDESCRIPTION>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.: The final result of a determination of the value, significance, or extent of.: Indicates a task, process or examination that has either not been initiated or not been completed.: The cessation of life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28554, C49484, C25217, C2991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8176744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease not assessed, off treatment for symptomatic progression</VALIDVALUE>
          <VALUEMEANING>Assessment Not Done Disease Progression Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>The final result of a determination of the value, significance, or extent of.: Indicates a task, process or examination that has either not been initiated or not been completed.: A process that manifests as the worsening of a disease over time.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C17747, C49484, C25217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8176745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease not assessed, off treatment for toxicity</VALIDVALUE>
          <VALUEMEANING>Assessment Not Done Adverse Event Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>The final result of a determination of the value, significance, or extent of.: Indicates a task, process or examination that has either not been initiated or not been completed.: Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C41331, C49484, C25217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8176746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease Assessed, but not per protocol</VALIDVALUE>
          <VALUEMEANING>Not Done Protocol Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.: A rule which guides how an activity should be performed.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C42651, C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8176747</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Minimum time on protocol treatment not met</VALIDVALUE>
          <VALUEMEANING>Minimum Therapeutic Procedure Not Done Time</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest possible quantity.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.: Indicates a task, process or examination that has either not been initiated or not been completed.: The continuum of experience in which events pass from the future through the present to the past.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25207, C49484, C49236, C25570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8176748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ineligible</VALIDVALUE>
          <VALUEMEANING>Ineligible</VALUEMEANING>
          <MEANINGDESCRIPTION>The state or quality of being disqualified by law, rule, or provision.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3785693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Measurable Disease</VALIDVALUE>
          <VALUEMEANING>No Evidence of Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Diagnostic tests fail to detect presence of disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Reason Best Response Inevalua</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Reason Best Response Inevaluable:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="956">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10389197</PUBLICID>
    <LONGNAME>Recurrent Or Progressive Disease or Disorder Central Nervous System Present Type</LONGNAME>
    <PREFERREDNAME>RCC_PRG_CNS_DS_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the recurrent or progressive central nervous system disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>10390539</PublicId>
      <PreferredName>2778143v1.00:3130929v1.00</PreferredName>
      <PreferredDefinition>The return of a disease after a period of remission._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:The part of the nervous system that consists of the brain, spinal cord, and meninges._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Recurrent Or Progressive Disease or Disorder Central Nervous System Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2778143</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38155:C37998:C35571:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Recurrent Disease Or PD Disease or Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38155</PREFERRED_NAME>
            <LONG_NAME>Recurrent Disease</LONG_NAME>
            <CON_ID>2202887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C35571</PREFERRED_NAME>
            <LONG_NAME>Progressive Disease</LONG_NAME>
            <CON_ID>2202776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3130929</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12438:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Central Nervous System Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12438</PREFERRED_NAME>
            <LONG_NAME>Central Nervous System</LONG_NAME>
            <CON_ID>2202492</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5962311</PublicId>
      <PreferredName>CNS_Disease_Typ</PreferredName>
      <PreferredDefinition>The status of central nervous system leukemia at diagnosis.</PreferredDefinition>
      <LongName>Central Nervous System Disease Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2974092</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12438:C2991:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Central Nervous System Disease or Disorder Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12438</PREFERRED_NAME>
            <LONG_NAME>Central Nervous System</LONG_NAME>
            <CON_ID>2202492</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CNS 2</VALIDVALUE>
          <VALUEMEANING>CNS 2</VALUEMEANING>
          <MEANINGDESCRIPTION>The status of central nervous system leukemia at diagnosis, where there are less than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts; or greater than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is considered negative by Steinherz/Bleyer algorithm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CNS 1</VALIDVALUE>
          <VALUEMEANING>CNS 1</VALUEMEANING>
          <MEANINGDESCRIPTION>The status of central nervous system leukemia at diagnosis, where there is an absence of blasts on a cerebral spinal fluid cytospin preparation, regardless of the number of white blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CNS 3</VALIDVALUE>
          <VALUEMEANING>CNS 3</VALUEMEANING>
          <MEANINGDESCRIPTION>The status of central nervous system leukemia at diagnosis, where there are more than 5 white blood cells per microliter on a cerebral spinal fluid cytospin preparation that is positive for blasts; with or without clinical signs of CNS leukemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the recurrent or prog</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the recurrent or progressive central nervous system disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>CNS relapse type:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="957">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10539559</PUBLICID>
    <LONGNAME>NHSPAQII Past Year Weekly Average Time High Intensity Bicycling Duration</LONGNAME>
    <PREFERREDNAME>NHSPAQII_HIBIKE_DUR</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated response about the average time per week they spent bicycling, including stationary machine, at high intensity, during the past year.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>10534417</PublicId>
      <PreferredName>10534406v1.00:10534416v1.00</PreferredName>
      <PreferredDefinition>_A prospective cohort study started in 1989 for single and married female nurses, ages 25 to 42. It looks at the impact on women&#39;s health of oral contraceptives initiated during adolescence, diet and physical activity in adolescence, lifestyle risk factors, as well as the diseases examined in the original nurses&#39; health study. The NHSII cohort is a younger population than the NHS Original Cohort:A period of time consisting of the 12 months before the present._Every week._A question about the average time that an individual spent doing high intensity bicycling.</PreferredDefinition>
      <LongName>Nurses&#39; Health Study II Past Year Weekly Average Time High Intensity Bicycling</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>10534406</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C188144</PreferredName>
        <Version>1</Version>
        <LongName>Nurses&#39; Health Study II</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C188144</PREFERRED_NAME>
            <LONG_NAME>Nurses&#39; Health Study II</LONG_NAME>
            <CON_ID>10497249</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>10534416</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C125217:C67069:C188153</PreferredName>
        <Version>1</Version>
        <LongName>Past Year Weekly Average Time High Intensity Bicycling</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125217</PREFERRED_NAME>
            <LONG_NAME>Past Year</LONG_NAME>
            <CON_ID>5108191</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67069</PREFERRED_NAME>
            <LONG_NAME>Weekly</LONG_NAME>
            <CON_ID>2730407</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C188153</PREFERRED_NAME>
            <LONG_NAME>Average Time High Intensity Bicycling Question</LONG_NAME>
            <CON_ID>10497254</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2970429</PublicId>
      <PreferredName>2970429v1.0</PreferredName>
      <PreferredDefinition>The period of time during which something occurs per week within a given month.</PreferredDefinition>
      <LongName>Week Month Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2970696</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29844:C29846:C25330</PreferredName>
        <Version>1</Version>
        <LongName>Week Month Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29844</PREFERRED_NAME>
            <LONG_NAME>Week</LONG_NAME>
            <CON_ID>2203710</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11 or more hours</VALIDVALUE>
          <VALUEMEANING>11 or more hours</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 11 or more hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7 to 10 hours</VALIDVALUE>
          <VALUEMEANING>7 to 10 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 7 to 10 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4 to 6 hours</VALIDVALUE>
          <VALUEMEANING>4 to 6 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 4 to 6 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2 to 3 hours</VALIDVALUE>
          <VALUEMEANING>2 to 3 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 2 to 3 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 to 1.5 hours</VALIDVALUE>
          <VALUEMEANING>1 to 1.5 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 1 to 1.5 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 hour</VALIDVALUE>
          <VALUEMEANING>1 hour</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 1 hour</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20 to 59 min.</VALIDVALUE>
          <VALUEMEANING>20 to 59 minutes</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 20 to 59 minutes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5 to 19 min.</VALIDVALUE>
          <VALUEMEANING>5 to 19 minutes</VALUEMEANING>
          <MEANINGDESCRIPTION>a period of time lasting 5 to 19 minutes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 to 4 min.</VALIDVALUE>
          <VALUEMEANING>1 to 4 minutes</VALUEMEANING>
          <MEANINGDESCRIPTION>1 to 4 minutes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970438</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zero</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>A mathematical element that when added to another number yields the same number; the cardinal number meaning one less than one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2683226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Bicycling (include stationary machine) 
Intensity: High</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Bicycling (include stationary machine) 
Intensity: High</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="958">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10543036</PUBLICID>
    <LONGNAME>DSQ Past 30 Days How Often Eat Doughnuts, Sweet Rolls, Muffins, Pan Dulce, Danish, or Toaster Pastries Score Frequency</LONGNAME>
    <PREFERREDNAME>DSQ_DONUTS_FRQ</PREFERREDNAME>
    <PREFERREDDEFINITION>A participant&#39;s response about how often they ate doughnuts, sweet rolls, Danish, muffins, pan dulce, or pop­-tarts during the past month.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>10540268</PublicId>
      <PreferredName>10540215v1.00:10540267v1.00</PreferredName>
      <PreferredDefinition>_A 26-item questionnaire, developed by the Risk Factor Assessment Branch of the National Cancer Institute&#39;s Epidemiology and Genomics Research Program, that assesses the frequency of consumption in the past month of fruits and vegetables, added sugar, dairy, whole grains, calcium, fiber, red meat, and processed meat:A period of time consisting of the 30 days before the present._A question about how often an individual eats or ate doughnuts, sweet rolls, muffins, pan dulce, Danish, or toaster pastries._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Dietary Screener Questionnaire Past 30 Days How Often Eat Doughnuts, Sweet Rolls,
Muffins, Pan Dulce, Danish, or Toaster Pastries Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>10540215</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C188186</PreferredName>
        <Version>1</Version>
        <LongName>Dietary Screener Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C188186</PREFERRED_NAME>
            <LONG_NAME>Dietary Screener Questionnaire</LONG_NAME>
            <CON_ID>10538158</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>10540267</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C131330:C188107:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past 30 Days How Often Eat Doughnuts, Sweet Rolls,
Muffins, Pan Dulce, Danish, or Toaster Pastries Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131330</PREFERRED_NAME>
            <LONG_NAME>Past 30 days</LONG_NAME>
            <CON_ID>5615928</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C188107</PREFERRED_NAME>
            <LONG_NAME>How Often Eat Doughnuts, Sweet Rolls, Muffins, Pan Dulce, Danish, or Toaster Pastries Question</LONG_NAME>
            <CON_ID>10471899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>10542248</PublicId>
      <PreferredName>10542248v1.00</PreferredName>
      <PreferredDefinition>The number of occurrences of something within a given time period (month, week day)</PreferredDefinition>
      <LongName>Temporal Frequency</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2443080</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25515</PreferredName>
        <Version>1</Version>
        <LongName>Temporal Frequency</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 time last month</VALIDVALUE>
          <VALUEMEANING>1 time last month</VALUEMEANING>
          <MEANINGDESCRIPTION>1 time last month</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7639571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2­-3 times last month</VALIDVALUE>
          <VALUEMEANING>2­-3 times last month</VALUEMEANING>
          <MEANINGDESCRIPTION>2­-3 times last month</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10542499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 time per week</VALIDVALUE>
          <VALUEMEANING>1 time per week</VALUEMEANING>
          <MEANINGDESCRIPTION>1 time per week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10542500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2 times per week</VALIDVALUE>
          <VALUEMEANING>2 times per week</VALUEMEANING>
          <MEANINGDESCRIPTION>2 times per week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7639569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5­-6 times per week</VALIDVALUE>
          <VALUEMEANING>5-­6 times per week</VALUEMEANING>
          <MEANINGDESCRIPTION>5-­6 times per week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10542502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 time per day</VALIDVALUE>
          <VALUEMEANING>Once a day</VALUEMEANING>
          <MEANINGDESCRIPTION>Scheduled or occurring at a frequency of once per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125004</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5543631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-­3 times per day</VALIDVALUE>
          <VALUEMEANING>2-­3 times per day</VALUEMEANING>
          <MEANINGDESCRIPTION>2-­3 times per day</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10542503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4-­5 times per day</VALIDVALUE>
          <VALUEMEANING>4­-5 times per day</VALUEMEANING>
          <MEANINGDESCRIPTION>4­-5 times per day</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10542504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6 or more times per day</VALIDVALUE>
          <VALUEMEANING>6 or more times per day</VALUEMEANING>
          <MEANINGDESCRIPTION>6 or more times per day</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7639566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3­-4 times per week</VALIDVALUE>
          <VALUEMEANING>3­-4 times per week</VALUEMEANING>
          <MEANINGDESCRIPTION>3­-4 times per week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10542501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2 or more times per day</VALIDVALUE>
          <VALUEMEANING>2 or more times per day</VALUEMEANING>
          <MEANINGDESCRIPTION>2 or more times per day</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10544800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>During the past month, how oft</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>During the past month, how often did you eat doughnuts, sweet rolls, Danish, muffins, pan
dulce, or pop-­tarts? Do not include sugar-free items</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="959">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10672162</PUBLICID>
    <LONGNAME>Laboratory Test Results Supplemental Qualifiers Dataset Abnormal Yes No Indicator</LONGNAME>
    <PREFERREDNAME>SUPPLB_QVAL_LBABN</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator related to the evaluation if a lab test result is abnormal</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>10672160</PublicId>
      <PreferredName>10376423v1.00:5270457v1.00</PreferredName>
      <PreferredDefinition>A dataset containing supplemental information, specifically non-standard variables, to parent records in the laboratory test results domain.:Specifies whether an interpreted event or entity is abnormal.</PreferredDefinition>
      <LongName>Laboratory Test Results Supplemental Qualifiers Dataset Abnormal Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>10376423</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C147220</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test Results Supplemental Qualifiers Dataset</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C147220</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Results Supplemental Qualifiers Dataset</LONG_NAME>
            <CON_ID>10027406</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5270457</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C93491</PreferredName>
        <Version>1</Version>
        <LongName>Abnormal Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C93491</PREFERRED_NAME>
            <LONG_NAME>Abnormal Indicator</LONG_NAME>
            <CON_ID>5270456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Were the results abnormal?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did urine pH drop below 7 after the start of the infusion?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient have a serum carbon dioxide (CO2) or bicarbonate level less than or equal to 16 mEq/L at any time during the 4-week blinatunomab infusion?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPLB_QVAL_LBABNTSH</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPLB_QVAL_LBORRES_URINPH7_YN</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPLB_QVAL_LBCO2HCO3_LE16MEQL</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="960">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>11248841</PUBLICID>
    <LONGNAME>Vitreous Seed Present Type</LONGNAME>
    <PREFERREDNAME>VITRES_SEED_PRSNT_TYP</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the vitreous seeds present.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>11248835</PublicId>
      <PreferredName>11248834v1.00:2233878v1.00</PreferredName>
      <PreferredDefinition>Tumor cells that have spread into the vitreous of the eye.:Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Vitreous Seed Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>11248834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C189882</PreferredName>
        <Version>1</Version>
        <LongName>Vitreous Seed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C189882</PREFERRED_NAME>
            <LONG_NAME>Vitreous Seed</LONG_NAME>
            <CON_ID>11246567</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>11248836</PublicId>
      <PreferredName>VITRES_SEED_TP</PreferredName>
      <PreferredDefinition>Tumor cells that have spread into the vitreous of the eye._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Vitreous Seed Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>11248837</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>11248837v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Vitreous Seed Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C189882</PREFERRED_NAME>
            <LONG_NAME>Vitreous Seed</LONG_NAME>
            <CON_ID>11246567</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dust</VALIDVALUE>
          <VALUEMEANING>Dust Vitreous Seed</VALUEMEANING>
          <MEANINGDESCRIPTION>A histopathologic classification of vitreous seeding that is characterized by small, localized granules of tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189885</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11248838</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spheres</VALIDVALUE>
          <VALUEMEANING>Sphere Vitreous Seed</VALUEMEANING>
          <MEANINGDESCRIPTION>A histopathologic classification of vitreous seeding that is characterized by spherically shaped clusters of tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189883</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11248839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clouds</VALIDVALUE>
          <VALUEMEANING>Cloud Vitreous Seed</VALUEMEANING>
          <MEANINGDESCRIPTION>A histopathologic classification of vitreous seeding that is characterized by diffuse, dense collections of tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189884</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11248840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4001711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What type of vitreous seeds are present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="961">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>12137343</PUBLICID>
    <LONGNAME>Clonal Expansion Infusion Procedure Product Laboratory Procedure Outcome Percentage Integer::0 Decimal Place Value</LONGNAME>
    <PREFERREDNAME>12137341v1.00:3061015v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The numeric laboratory percentage value measured, assigned or computed related to the assessment of clonal expansion in the infused product.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>12137341</PublicId>
      <PreferredName>12137340v1.00:7715625v1.00</PreferredName>
      <PreferredDefinition>Multiplication or reproduction by cell division of a population of identical cells descended from a single progenitor. In immunology, may refer to the clonal proliferation of cells responsive to a specific antigen as part of an immune response. (NCI):Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord._The end result of a manufacturing process; anything that is produced.</PreferredDefinition>
      <LongName>Clonal Expansion Infusion Procedure Product</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>12137340</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20613</PreferredName>
        <Version>1</Version>
        <LongName>Clonal Expansion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20613</PREFERRED_NAME>
            <LONG_NAME>Clonal Expansion</LONG_NAME>
            <CON_ID>10054867</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7715625</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15388:C51980</PreferredName>
        <Version>1</Version>
        <LongName>Infusion Procedure Product</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15388</PREFERRED_NAME>
            <LONG_NAME>Infusion Procedure</LONG_NAME>
            <CON_ID>2203835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51980</PREFERRED_NAME>
            <LONG_NAME>Product</LONG_NAME>
            <CON_ID>2527882</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3061015</PublicId>
      <PreferredName>3061015v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The result of an action._A fraction or ratio with 100 understood as the denominator._A number with no fractional part, including the negative and positive numbers as well as zero.::0_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Laboratory Procedure Outcome Percentage Integer::0 Decimal Place Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <DisplayFormat>%</DisplayFormat>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3061014</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294:C20200:C25613:C45255::0</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Outcome Percentage Integer::0 Decimal Place Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the percentage value of clonal expansion in the infused product?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Clonal expansion:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="962">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>12187535</PUBLICID>
    <LONGNAME>Stem Cell Transplant Type</LONGNAME>
    <PREFERREDNAME>PR_PRSCAT_SCT</PREFERREDNAME>
    <PREFERREDDEFINITION>The type that indicates the Stem cell transplant type received.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>12186064</PublicId>
      <PreferredName>6407261v1.00:12186063v1.00</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure.:Type of stem-cell transplantation the subject received.</PreferredDefinition>
      <LongName>Procedure Domain Type of Stem Cell Transplant</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102700</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102700</PREFERRED_NAME>
            <LONG_NAME>Procedure Domain</LONG_NAME>
            <CON_ID>6407260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>12186063</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C168864</PreferredName>
        <Version>1</Version>
        <LongName>Type of Stem Cell Transplant</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C168864</PREFERRED_NAME>
            <LONG_NAME>Type of Stem Cell Transplant</LONG_NAME>
            <CON_ID>10043344</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>12186071</PublicId>
      <PreferredName>12186071v1.00</PreferredName>
      <PreferredDefinition>A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Hematopoietic Cell Transplantation Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3729871</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15431:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Stem Cell Transplantation Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15431</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Cell Transplantation</LONG_NAME>
            <CON_ID>2512694</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autologous HCT</VALIDVALUE>
          <VALUEMEANING>Autologous Stem Cell Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>The transference of stem cells within the same individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16039</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allogeneic HCT - matched related</VALIDVALUE>
          <VALUEMEANING>Allogeneic Hematopoietic Stem Cell Transplantation Matched Related Donor To Patient</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical treatment in which hematopoietic stem cells (HSCs) are transferred from one genetically dissimilar individual to another._A donor who is related to the transplant recipient, and who is a human leukocyte antigen (HLA) tissue type match._Used as a function word to indicate direction, purpose, or movement._A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16960, C65107, C131675, C46089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12187529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allogeneic HCT - mismatched related (i.e. haploidentical)</VALIDVALUE>
          <VALUEMEANING>Allogeneic Hematopoietic Stem Cell Transplantation Mismatched Related Donor To Patient</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical treatment in which hematopoietic stem cells (HSCs) are transferred from one genetically dissimilar individual to another._A donor who is related to the recipient but is mismatched at at least 1 HLA locus._Used as a function word to indicate direction, purpose, or movement._A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16960, C65107, C163979, C46089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12187531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allogeneic HCT - mismatched unrelated</VALIDVALUE>
          <VALUEMEANING>Allogeneic Hematopoietic Stem Cell Transplantation Mismatched Unrelated Donor To Patient</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical treatment in which hematopoietic stem cells (HSCs) are transferred from one genetically dissimilar individual to another._A donor who is not related to the transplant recipient, and who is not a human leukocyte antigen (HLA) tissue type match at one or more of the following loci: HLA-A, HLA-B, HLA-C, and HLA-DRB1._Used as a function word to indicate direction, purpose, or movement._A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16960, C65107, C131678, C46089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12187532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allogeneic HCT - umbilical cord blood</VALIDVALUE>
          <VALUEMEANING>Allogeneic Hematopoietic Stem Cell Transplantation Umbilical Cord Blood Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical treatment in which hematopoietic stem cells (HSCs) are transferred from one genetically dissimilar individual to another._A therapeutic procedure that involves the transplantation of hematopoietic stem cells collected from the umbilical cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15640, C46089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12187533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, specify</VALIDVALUE>
          <VALUEMEANING>Specify Other</VALUEMEANING>
          <MEANINGDESCRIPTION>A directive to indicate a response not listed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157106</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6782229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allogeneic HCT - matched unrelated</VALIDVALUE>
          <VALUEMEANING>Allogeneic Hematopoietic Stem Cell Transplantation Matched Unrelated Donor To Patient</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical treatment in which hematopoietic stem cells (HSCs) are transferred from one genetically dissimilar individual to another._A donor who is not related to the transplant recipient, but who is a human leukocyte antigen (HLA) tissue type match._Used as a function word to indicate direction, purpose, or movement._A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16960, C65107, C131676, C46089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12187530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the type of stem cell transplant received?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Type of transplant:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="963">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>12197718</PUBLICID>
    <LONGNAME>ECOC Performance Status Assessment Date</LONGNAME>
    <PREFERREDNAME>HHSECGDT</PREFERREDNAME>
    <PREFERREDDEFINITION>The date of ECOG performance assessment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195004</PublicId>
      <PreferredName>15379384v1.00:2261670v1.00</PreferredName>
      <PreferredDefinition>A cooperative group funded primarily by the NCI, one of the largest clinical cancer research organizations in the US, incorporating universities, medical centers, Community Clinical Oncology Programs, and Cooperative Group Outreach Programs with almost 6000 physicians, nurses, pharmacists, statisticians, and clinical research associates from the US, Canada, and South Africa. ECOG has more than 90 active clinical trials in all types of adult malignancies. Annual accrual is 6,000 patients, with more than 20,000 patients in follow-up._A measure of how well a patient is able to perform ordinary tasks and carry out daily activities.:A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual&#39;s health assessment.</PreferredDefinition>
      <LongName>Eastern Cooperative Oncology Group Performance Status Physical Examination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>15379384</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25491:C20641</PreferredName>
        <Version>1</Version>
        <LongName>Eastern Cooperative Oncology Group Performance Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25491</PREFERRED_NAME>
            <LONG_NAME>Eastern Cooperative Oncology Group</LONG_NAME>
            <CON_ID>2205050</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20641</PREFERRED_NAME>
            <LONG_NAME>Performance Status</LONG_NAME>
            <CON_ID>2202910</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2261670</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20989</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338240</PublicId>
      <PreferredName>CDISCDAT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>11</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396655</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25164</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of ECOG performance status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RS_RSDAT_ECOG</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="964">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>12426616</PUBLICID>
    <LONGNAME>Subject Initial Cancer Diagnosis To Last Follow-Up Count</LONGNAME>
    <PREFERREDNAME>12245588v1.00:7069460v2.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of days from the date the initial cancer diagnosis was made to the date of the last followup.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CRDC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDS:Cancer Data Service</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>12245588</PublicId>
      <PreferredName>2442484v1.00:12245587v1.00</PreferredName>
      <PreferredDefinition>A matter or an individual that is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study.:The date of the initial cancer diagnosis._Used as a function word to indicate direction, purpose, or movement._The date on which the temporally most recent follow-up took place.</PreferredDefinition>
      <LongName>Subject Initial Cancer Diagnosis To Last Follow-Up</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CRDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2523466</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41189</PreferredName>
        <Version>1</Version>
        <LongName>Study Subject</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41189</PREFERRED_NAME>
            <LONG_NAME>Study Subject</LONG_NAME>
            <CON_ID>2202706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>12435871</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C157121:C65107:C164549</PreferredName>
        <Version>1</Version>
        <LongName>Initial Cancer Diagnosis Date To Last Follow-Up Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C157121</PREFERRED_NAME>
            <LONG_NAME>Initial Cancer Diagnosis Date</LONG_NAME>
            <CON_ID>6796664</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C65107</PREFERRED_NAME>
            <LONG_NAME>To</LONG_NAME>
            <CON_ID>2672667</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C164549</PREFERRED_NAME>
            <LONG_NAME>Last Follow-Up Date</LONG_NAME>
            <CON_ID>10038629</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDS:Cancer Data Service</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7069460</PublicId>
      <PreferredName>7069460v2.00</PreferredName>
      <PreferredDefinition>To determine the number or amount of something; the result of this activity.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>MCL</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>day</UnitOfMeasure>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>MCL:Molecular and Cellular Characterization of Screened Lesions</Origin>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Days from Initial Diagnosis to Last Followup</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDS</Name>
        <DocumentType>Coding Instructions</DocumentType>
        <DocumentText>Please use natural numbers; do not use abbreviations or units</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>8064110</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GC (General Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>12177497</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>8064110</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GC (General Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14470388</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>days_to_last_followup</AlternateName>
        <AlternateNameType>GC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="965">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>12451375</PUBLICID>
    <LONGNAME>Patient Prior Attenuated Live Virus Vaccine Administered Date</LONGNAME>
    <PREFERREDNAME>4188616v1.00:2018550v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The date on which the live vaccine was previous given.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4188616</PublicId>
      <PreferredName>2233604v1.0:4188614v1.0</PreferredName>
      <PreferredDefinition>information related to the prior administration of a live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strain.</PreferredDefinition>
      <LongName>Patient Prior Attenuated Live Virus Vaccine Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SWOG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4188614</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C1920:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Prior Attenuated Live Virus Vaccine Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1920</PREFERRED_NAME>
            <LONG_NAME>Attenuated Live Virus Vaccine</LONG_NAME>
            <CON_ID>2615805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>SWOG CRF:Southwest Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of live vaccine:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Yes, date of live vaccine</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="966">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>12555940</PUBLICID>
    <LONGNAME>Laboratory Data Domain Genetic Variation Type</LONGNAME>
    <PREFERREDNAME>LB_LBORRES_GENE_VRNT</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the variation type of the genes.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>12555939</PublicId>
      <PreferredName>6401816v1.00:12555938v1.00</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to laboratory data.:Genetic Variation consists of deviation(s) in the nucleotide sequence of the genetic material of an individual from that typical of the group to which the individual belongs, or deviation(s) in the nucleotide sequence of the genetic material of offspring from that of its parents._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Laboratory Data Domain Genetic Variation Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6401816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49592</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Data Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49592</PREFERRED_NAME>
            <LONG_NAME>Laboratory Data Domain</LONG_NAME>
            <CON_ID>2469066</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>12555938</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17248:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Genetic Variation Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17248</PREFERRED_NAME>
            <LONG_NAME>Genetic Variation</LONG_NAME>
            <CON_ID>2223975</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6709572</PublicId>
      <PreferredName>6709572v1.0</PreferredName>
      <PreferredDefinition>An alteration or difference from a norm or standard._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Variation Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>6709571</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25713:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Variation Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25713</PREFERRED_NAME>
            <LONG_NAME>Variation</LONG_NAME>
            <CON_ID>2203982</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wild type/normal</VALIDVALUE>
          <VALUEMEANING>Normal Wild Type Variation</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.: The naturally-occurring, normal, non-mutated version of a gene or genome.: An alteration or difference from a norm or standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25713, C62195, C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6709573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Homozygous variant</VALIDVALUE>
          <VALUEMEANING>Homozygosity Variation</VALUEMEANING>
          <MEANINGDESCRIPTION>Having two identical allelic forms of a gene, one inherited from each parent, on each of the two homologous chromosomes.: An alteration or difference from a norm or standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25713, C45826</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6709574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heterozygous variant</VALIDVALUE>
          <VALUEMEANING>Heterozygosity Variation</VALUEMEANING>
          <MEANINGDESCRIPTION>Having two different allelic forms of a gene, one inherited from each parent, on each of the two homologous chromosomes.: An alteration or difference from a norm or standard.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25713, C45825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6709575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Compound heterozygote</VALIDVALUE>
          <VALUEMEANING>Heterozygosity Compound</VALUEMEANING>
          <MEANINGDESCRIPTION>Having two different allelic forms of a gene, one inherited from each parent, on each of the two homologous chromosomes.: A substance formed by chemical union of two or more elements or ingredients in definite proportion by weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43366, C45825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-07-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7359964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the genetic variation type?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>TPMT variants:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>COG CRF TEXT 1</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NUDT15 variants:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>COG CRF TEXT 2</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBORRES_TPMT_VRNT</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBORRES_NUD15_VRNT</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="967">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>13215415</PUBLICID>
    <LONGNAME>Lab Value Greater Than Platelet Count 50000 Without Platelet Transfusion Present Date</LONGNAME>
    <PREFERREDNAME>PLT_CT_GT_WO_TRNS_PRSNT_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>The month, day and year the lab value for platelet count greater than 50,000 was present without a transfusion.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>13215413</PublicId>
      <PreferredName>2555440v1.00:13215412v1.00</PreferredName>
      <PreferredDefinition>The outcome of a laboratory test.:A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status._Indicates a platelet count of at least 50,000 per cubic millimeter._Used to indicate the absence or lack of something or someone._The infusion of platelets into the bloodstream._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Lab Value Greater Than Platelet Count 50000 Without Platelet Transfusion Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2555440</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C36292</PreferredName>
        <Version>1</Version>
        <LongName>Test Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C36292</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Result</LONG_NAME>
            <CON_ID>2451822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>13215412</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>13215412v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Greater Than Platelet Count 50000 Without Platelet Transfusion Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61584</PREFERRED_NAME>
            <LONG_NAME>Greater Than</LONG_NAME>
            <CON_ID>2620098</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53267</PREFERRED_NAME>
            <LONG_NAME>Platelet Count 50000</LONG_NAME>
            <CON_ID>2512692</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25718</PREFERRED_NAME>
            <LONG_NAME>Without</LONG_NAME>
            <CON_ID>2206274</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15366</PREFERRED_NAME>
            <LONG_NAME>Platelet Transfusion</LONG_NAME>
            <CON_ID>2205020</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the date the lab value for platelet count greater than 50,000 was present without a transfusion?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date first achieved:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date platelet count recovered to greater than 75000/uL without platelet transfusion for 7 days after nadir during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date platelet recovery occurred</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPRS_QVAL_PLATRECOCCUR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="968">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>13279286</PUBLICID>
    <LONGNAME>Diagnosis Primary Anatomic Site</LONGNAME>
    <PREFERREDNAME>11327194v1.00:13279272v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The location within the body where cancer begins.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>Pediatric Cancer</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCDC:Pediatric Cancer Data Commons</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>11327194</PublicId>
      <PreferredName>2442484v1.00:2676075v1.00</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Occurring first in time or sequence; original; of greatest rank or importance or value._Named locations of or within the body.</PreferredDefinition>
      <LongName>Disease Primary Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CRDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2676075</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25251:C13717</PreferredName>
        <Version>1</Version>
        <LongName>Primary Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CRDC:Cancer Research Data Commons</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>13279272</PublicId>
      <PreferredName>13279272v1.00</PreferredName>
      <PreferredDefinition>Named locations of or within the body.</PreferredDefinition>
      <LongName>Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>Pediatric Cancer</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PCDC:Pediatric Cancer Data Commons</Origin>
      <Representation>
        <PublicId>2519596</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pre-auricular Nodes</VALIDVALUE>
          <VALUEMEANING>pre-auricular</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located anterior to the auricle of the ear. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iliac Crest</VALIDVALUE>
          <VALUEMEANING>Iliac Crest</VALUEMEANING>
          <MEANINGDESCRIPTION>A predominate bone structure which borders the ilium wing stretching from the anterior superior iliac spine to the posterior superior iliac spine. (CDISC)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103818</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intrathoracic</VALIDVALUE>
          <VALUEMEANING>Intrathoracic</VALUEMEANING>
          <MEANINGDESCRIPTION>Within the thoracic cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105579</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3691242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Distant Lymph Nodes</VALIDVALUE>
          <VALUEMEANING>Distant Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located distant to the anatomic site of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4206839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oculus Dexter (Right Eye)</VALIDVALUE>
          <VALUEMEANING>Right Eye</VALUEMEANING>
          <MEANINGDESCRIPTION>The eye positioned in the right orbit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119333</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6677711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oculus Sinister (Left Eye)</VALIDVALUE>
          <VALUEMEANING>Left Eye</VALUEMEANING>
          <MEANINGDESCRIPTION>The eye positioned in the left orbit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6677710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oculus Uterque (Both Eyes)</VALIDVALUE>
          <VALUEMEANING>Both Eyes</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to both the left and right eyes,</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119335</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6677709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pectoral Nodes</VALIDVALUE>
          <VALUEMEANING>Pectoral Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>An axillary lymph node located along the lower edge of the pectoralis minor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120322</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7798010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypopharynx</VALIDVALUE>
          <VALUEMEANING>Hypopharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the pharynx that connects to the esophagus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3595986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Duodenum</VALIDVALUE>
          <VALUEMEANING>Duodenum</VALUEMEANING>
          <MEANINGDESCRIPTION>A jointed tube 25-30 cm long that connects the stomach to the jejunum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Middle Ear</VALIDVALUE>
          <VALUEMEANING>Middle Ear</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the ear including the eardrum and ossicles. The middle ear leads to the inner ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12274</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mandible</VALIDVALUE>
          <VALUEMEANING>Mandible</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower jaw bone holding the lower teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retroperitoneum</VALIDVALUE>
          <VALUEMEANING>Retroperitoneum</VALUEMEANING>
          <MEANINGDESCRIPTION>The back of the abdomen where the kidneys lie and the great blood vessels run.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervix</VALIDVALUE>
          <VALUEMEANING>Cervix Uteri</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epididymis</VALIDVALUE>
          <VALUEMEANING>Epididymis</VALUEMEANING>
          <MEANINGDESCRIPTION>A crescent-like structure located in the upper and posterior surfaces of the testis. It consists of the efferent ductules and the duct of the epididymis. It facilitates the maturation of sperm that is produced in the testis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Choroid</VALIDVALUE>
          <VALUEMEANING>Choroid</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood vessel-containing membrane of the eye that lies between the retina and the sclera.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colon</VALIDVALUE>
          <VALUEMEANING>Colon</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small Intestine</VALIDVALUE>
          <VALUEMEANING>Small Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>The section of the intestines between the pylorus and cecum. The small intestine is approximately 20 feet long and consists of the duodenum, the jejunum, and the ileum. Its main function is to absorb nutrients from food as the food is transported to the large intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus</VALIDVALUE>
          <VALUEMEANING>Esophagus</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3292829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectum</VALIDVALUE>
          <VALUEMEANING>Rectum</VALUEMEANING>
          <MEANINGDESCRIPTION>The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach</VALIDVALUE>
          <VALUEMEANING>Stomach</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver</VALIDVALUE>
          <VALUEMEANING>Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>A triangular-shaped organ located under the diaphragm in the right hypochondrium.  It is the largest internal organ of the body, weighting up to 2 kg.  Metabolism and bile secretion are its main functions.  It is composed of cells which have the ability to regenerate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4363637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreas</VALIDVALUE>
          <VALUEMEANING>Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand.  It is a compound gland composed of both exocrine and endocrine tissues.  The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food.  Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4363632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pineal</VALIDVALUE>
          <VALUEMEANING>Pineal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A small endocrine gland in the brain, situated beneath the back part of the corpus callosum, that secretes melatonin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Orbit</VALIDVALUE>
          <VALUEMEANING>Orbit</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa.  Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meninges</VALIDVALUE>
          <VALUEMEANING>Meninges</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of three membranes that surround the brain and spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frontal Lobe</VALIDVALUE>
          <VALUEMEANING>Frontal Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the brain located anterior to the parietal lobes at the front of each cerebral hemisphere. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Temporal Lobe</VALIDVALUE>
          <VALUEMEANING>Temporal Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>Lower lateral part of the cerebral hemisphere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parietal Lobe</VALIDVALUE>
          <VALUEMEANING>Parietal Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the lobes of the cerebral hemisphere located superiorly to the occipital lobe and posteriorly to the frontal lobe. Cognition and visuospatial processing are its main functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occipital Lobe</VALIDVALUE>
          <VALUEMEANING>Occipital Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the four regions of cortex in each cerebral hemisphere. It is located posterior to the temporal lobe and inferior to the parietal lobe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone</VALIDVALUE>
          <VALUEMEANING>Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Connective tissue that forms the skeletal components of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gallbladder</VALIDVALUE>
          <VALUEMEANING>Gallbladder</VALUEMEANING>
          <MEANINGDESCRIPTION>A pear-shaped organ just below the liver that stores the bile secreted by the liver, delivering the bile through the bile ducts into the intestines to help with digestion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3124021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Appendix</VALIDVALUE>
          <VALUEMEANING>Appendix</VALUEMEANING>
          <MEANINGDESCRIPTION>A small, fingerlike pouch that sticks out from the cecum (the first part of the large intestine near the end of the small intestine).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney</VALIDVALUE>
          <VALUEMEANING>Kidney</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the two organs that excrete the urine. The kidneys are bean-shaped organs (about 11 cm long, 5 cm wide, and 3 cm thick) lying on either side of the vertebral column, posterior to the peritoneum, about opposite the twelfth thoracic and first three lumbar vertebrae. SYN ren, nephros.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2965202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ureter</VALIDVALUE>
          <VALUEMEANING>Ureter</VALUEMEANING>
          <MEANINGDESCRIPTION>(yoo-REE-ter) The tube that carries urine from the kidney to the bladder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3181638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head and Neck</VALIDVALUE>
          <VALUEMEANING>Head and Neck</VALUEMEANING>
          <MEANINGDESCRIPTION>For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12418</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4320227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head</VALIDVALUE>
          <VALUEMEANING>Head</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior or superior part of an animal, containing the brain, or chief ganglia of the nervous system, the mouth, and in the higher animals, the chief sensory organs. (On-line Medical Dictionary)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Larynx</VALIDVALUE>
          <VALUEMEANING>Larynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The cartilaginous structure of the respiratory tract between the pharynx and the trachea. It contains elastic vocal cords required for sound production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oral Cavity</VALIDVALUE>
          <VALUEMEANING>Oral Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasopharynx</VALIDVALUE>
          <VALUEMEANING>Nasopharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the pharynx in the back of the throat, at and above the soft palate. The nasopharynx is continuous with the nasal passages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal Cavity</VALIDVALUE>
          <VALUEMEANING>Nasal Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The proximal portion of the respiratory passages on either side of the nasal septum lying between the floor of the cranium and the roof of the mouth and extending from the face to the pharynx. The nasal cavity is lined with ciliated mucosa, extending from the nares to the pharynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Salivary Gland</VALIDVALUE>
          <VALUEMEANING>Salivary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>An exocrine gland that secretes saliva.  Salivary glands are mostly located in and around the oral cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12426</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroid</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fallopian Tube</VALIDVALUE>
          <VALUEMEANING>Fallopian Tube</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of tubes that extend from the uterus to each of the ovaries. Following ovulation the egg travels down the fallopian tube to the uterus where fertilization may or may not occur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4363638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ovary</VALIDVALUE>
          <VALUEMEANING>Ovary</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the paired female reproductive glands containing the ova or germ cells; the ovary&#39;s stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4363633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uterus</VALIDVALUE>
          <VALUEMEANING>Uterus</VALUEMEANING>
          <MEANINGDESCRIPTION>A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3245800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vagina</VALIDVALUE>
          <VALUEMEANING>Vagina</VALUEMEANING>
          <MEANINGDESCRIPTION>The female genital canal, extending from the uterus to the vulva.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2873867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vulva</VALIDVALUE>
          <VALUEMEANING>Vulva</VALUEMEANING>
          <MEANINGDESCRIPTION>The external female genital organs, including the clitoris, vaginal lips, and the opening to the vagina.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3082301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Penis</VALIDVALUE>
          <VALUEMEANING>Penis</VALUEMEANING>
          <MEANINGDESCRIPTION>The male organ of urination and copulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3698693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate</VALIDVALUE>
          <VALUEMEANING>Prostate Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>The walnut shaped accessory sex gland of the male reproductive system.  It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra.  The prostate gland secretes a fluid which is part of the semen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testis</VALIDVALUE>
          <VALUEMEANING>Testicular</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the paired male reproductive glands that produce the male germ cells and the male hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5645389</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bladder</VALIDVALUE>
          <VALUEMEANING>Bladder</VALUEMEANING>
          <MEANINGDESCRIPTION>A distensible musculomembranous organ serving as a receptacle for fluid, as the gallbladder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12414</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parotid</VALIDVALUE>
          <VALUEMEANING>Parotid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest of the three paired salivary glands, located in front of the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trachea</VALIDVALUE>
          <VALUEMEANING>Trachea</VALUEMEANING>
          <MEANINGDESCRIPTION>The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2968448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Marrow</VALIDVALUE>
          <VALUEMEANING>Bone Marrow</VALUEMEANING>
          <MEANINGDESCRIPTION>The soft, sponge-like tissue in the center of bones that produces white blood cells, red blood cells, and platelets.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3227901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spleen</VALIDVALUE>
          <VALUEMEANING>Spleen</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that is part of the lymphatic system. The spleen produces lymphocytes, filters the blood, stores blood cells, and destroys old blood cells. It is located on the left side of the abdomen near the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymus</VALIDVALUE>
          <VALUEMEANING>Thymus Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that is part of the lymphatic system, in which T lymphocytes grow and multiply. The thymus is in the chest behind the breastbone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intra-abdominal</VALIDVALUE>
          <VALUEMEANING>Intra-abdominal</VALUEMEANING>
          <MEANINGDESCRIPTION>Within the abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12492</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Midbrain</VALIDVALUE>
          <VALUEMEANING>Mesencephalon</VALUEMEANING>
          <MEANINGDESCRIPTION>The uppermost portion of the brainstem located between the pons and the diencephalon.  The midbrain contains the cerebral peduncles, oculomotor, trochlear and red nuclei, substantia nigra and various other nuclei and tracts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12510</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pons Varolii</VALIDVALUE>
          <VALUEMEANING>Pons Varolii</VALUEMEANING>
          <MEANINGDESCRIPTION>Part of the central nervous system, located at the base of the brain, between the medulla oblongata and the midbrain. It is part of the brainstem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12511</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdomen</VALIDVALUE>
          <VALUEMEANING>Abdominal Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The cavity located between the lungs and pelvis. It contains the lower esophagus, stomach, pancreas, intestines, liver, gallbladder and spleen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12664</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4320225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenal Gland</VALIDVALUE>
          <VALUEMEANING>Adrenal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4320226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Upper Extremity</VALIDVALUE>
          <VALUEMEANING>Upper Extremity</VALUEMEANING>
          <MEANINGDESCRIPTION>The region of the body that includes the arm, the forearm, and hand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12671</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axilla</VALIDVALUE>
          <VALUEMEANING>Axilla</VALUEMEANING>
          <MEANINGDESCRIPTION>Axilla; the hollow under the arm where it is joined to the shoulder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12674</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchus</VALIDVALUE>
          <VALUEMEANING>Bronchus</VALUEMEANING>
          <MEANINGDESCRIPTION>Tubular structure in continuation with the trachea, serving as air passage. It terminates in the lung (terminal bronchiole).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558344</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carpal Bone</VALIDVALUE>
          <VALUEMEANING>Carpal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The eight bones of the wrist: capitate bone, hamate bone, lunate bone (SEMILUNAR BONE), pisiform bone, SCAPHOID BONE, trapezium bone, trapezoid bone and triquetral bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4199815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cauda Equina Spinal Cord</VALIDVALUE>
          <VALUEMEANING>Cauda Equina</VALUEMEANING>
          <MEANINGDESCRIPTION>The collection of spinal nerve roots, arising from lumbar pairs two through five, sacral pairs one through five, and the coccygeal nerve, that branch off the conus medularis at the termination of the spinal cord, and float freely within the lumbar cistern before exiting the spinal column at the appropriate vertebra. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12689</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebrospinal Fluid</VALIDVALUE>
          <VALUEMEANING>Cerebrospinal Fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>The fluid that flows in and around the hollow spaces of the brain and spinal cord, and between two of the meninges (the thin layers of tissue that cover and protect the brain and spinal cord). CSF is made by tissue called the choroid plexus in the ventricles (hollow spaces) in the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5527714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central Nervous System</VALIDVALUE>
          <VALUEMEANING>Central Nervous System</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the nervous system that consists of the brain, spinal cord, and meninges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5343370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brain</VALIDVALUE>
          <VALUEMEANING>Brain</VALUEMEANING>
          <MEANINGDESCRIPTION>That part of the central nervous system contained within the cranium, comprising the prosencephalon, mesencephalon, and rhombencephalon. It is derived from the anterior part of the embryonic neural tube. Functions include muscle control and coordination, sensory reception and integration, speech production, memory storage, and the elaboration of thought and emotions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2986592</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medulla</VALIDVALUE>
          <VALUEMEANING>Medulla Oblongata</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower portion of the brainstem located between the pons and brainstem.  This structure contains several descending and ascending tracts, lower cranial nerve nuclei, a significant proportion of the reticular system of the brainstem and other structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebellum</VALIDVALUE>
          <VALUEMEANING>Cerebellum</VALUEMEANING>
          <MEANINGDESCRIPTION>(sair-uh-BELL-um) The portion of the brain in the back of the head between the cerebrum and the brain stem. The cerebellum controls balance for walking and standing, and other complex motor functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thalamus</VALIDVALUE>
          <VALUEMEANING>Thalamus</VALUEMEANING>
          <MEANINGDESCRIPTION>(THAL-a-muss) An area of the brain that helps process information from the senses and transmit it to other parts of the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spinal Cord</VALIDVALUE>
          <VALUEMEANING>Spinal Cord</VALUEMEANING>
          <MEANINGDESCRIPTION>The elongated, approximately cylindrical part of the central nervous system of vertebrates that lies in the vertebral canal and from which the spinal nerves emerge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6355851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung</VALIDVALUE>
          <VALUEMEANING>Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5400972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleura</VALIDVALUE>
          <VALUEMEANING>Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin</VALIDVALUE>
          <VALUEMEANING>Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that constitutes the external surface of the body.  It consists of the epidermis, dermis, and skin appendages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4363644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soft Tissue</VALIDVALUE>
          <VALUEMEANING>Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2990372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone or Bone Marrow</VALIDVALUE>
          <VALUEMEANING>Bone Or Bone Marrow</VALUEMEANING>
          <MEANINGDESCRIPTION>The structural organ comprised of specialized connective tissue that forms the skeletal components of the body._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12431, C37998, C12366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13590405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical Vertebra</VALIDVALUE>
          <VALUEMEANING>Cervical Vertebra</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the seven vertebrae that start with C1, connecting the skull to the spine, and ends with C7, which joins the cervical with the thoracic spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12693</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4199814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clavicle</VALIDVALUE>
          <VALUEMEANING>Clavicle</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone of the upper extremity that articulates with the acromion process of the scapula on one end and the sternum on the other.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12695</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Coccyx</VALIDVALUE>
          <VALUEMEANING>Coccyx</VALUEMEANING>
          <MEANINGDESCRIPTION>The last portion of the vertebral column just below the sacrum consisting of 3-5 rudimentary vertebrae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dermis</VALIDVALUE>
          <VALUEMEANING>Dermis</VALUEMEANING>
          <MEANINGDESCRIPTION>The cells and connective tissue from the inner layer of the two main layers of the skin. The dermis has connective tissue, blood vessels, oil and sweat glands, nerves, hair follicles, and other structures. It is made up of a thin upper layer called the papillary dermis, and a thick lower layer called the reticular dermis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12701</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethmoid Bone</VALIDVALUE>
          <VALUEMEANING>Ethmoid Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A light and spongy bone that is cubical in shape. This bone is positioned at the anterior part of the cranium, sitting between the two orbits, at the roof of the nose. It consists of four parts: a horizontal or cribriform plate; a perpendicular plate; and two lateral masses or labyrinths.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eyelid</VALIDVALUE>
          <VALUEMEANING>Eyelid</VALUEMEANING>
          <MEANINGDESCRIPTION>A thin membrane of skin with the purpose of covering and protecting an eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Femur</VALIDVALUE>
          <VALUEMEANING>Femur</VALUEMEANING>
          <MEANINGDESCRIPTION>The longest and largest bone of the skeleton, it is situated between the hip and the knee.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibula</VALIDVALUE>
          <VALUEMEANING>Fibula</VALUEMEANING>
          <MEANINGDESCRIPTION>The bone of the lower leg lateral to and smaller than the tibia. In proportion to its length, it is the most slender of the long bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inguinal</VALIDVALUE>
          <VALUEMEANING>Inguinal Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower region of the anterior abdominal wall located laterally to the pubic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heart</VALIDVALUE>
          <VALUEMEANING>Heart</VALUEMEANING>
          <MEANINGDESCRIPTION>A hollow muscular organ which receives the blood from the veins and propels it into the arteries. It is divided by a musculomembranous septum into two halves -- right or venous and left or arterial -- each of which consists of a receiving chamber (atrium) and an ejecting chamber (ventricle). SYN cor, coeur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Humerus</VALIDVALUE>
          <VALUEMEANING>Humerus</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper arm bone between the shoulder and elbow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12731</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lower Extremity</VALIDVALUE>
          <VALUEMEANING>Lower Extremity</VALUEMEANING>
          <MEANINGDESCRIPTION>The limb that is composed of the hip, thigh, leg and foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3387893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lumbar Vertebra</VALIDVALUE>
          <VALUEMEANING>Lumbar Vertebra</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the five bones situated between the thoracic vertebrae and the sacrum in the lower part of the spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node</VALIDVALUE>
          <VALUEMEANING>Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3387894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinum</VALIDVALUE>
          <VALUEMEANING>Mediastinum</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of organs surrounded by loose connective tissue, separating the two pleural sacs, between the sternum anteriorly and the vertebral column posteriorly as well as from the thoracic inlet superiorly to the diaphragm inferiorly. The mediastinum contains the heart and pericardium, the bases of the great vessels, the trachea and bronchi, esophagus, thymus, lymph nodes, thoracic duct, phrenic and vagus nerves, and other structures and tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metacarpals</VALIDVALUE>
          <VALUEMEANING>Metacarpal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the five bones between the wrist and the fingers that form the skeleton of the palm.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metatarsals</VALIDVALUE>
          <VALUEMEANING>Metatarsal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone belonging to the middle part of the foot located between toes and ankle. There are 5 metatarsal bones and they are numbered from the medial side.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occipital Bone</VALIDVALUE>
          <VALUEMEANING>Occipital Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The trapezoidal-shaped bone that forms the back and part of the base of the skull.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Optic Nerve</VALIDVALUE>
          <VALUEMEANING>Optic Nerve</VALUEMEANING>
          <MEANINGDESCRIPTION>The nerve that carries messages from the retina to the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3698177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oropharynx</VALIDVALUE>
          <VALUEMEANING>Oropharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the pharynx between the soft palate and the upper portion of the epiglottis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12762</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3625361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ear - Lateral Skull Base and Nasopharynx</VALIDVALUE>
          <VALUEMEANING>Ear Lateral Base of the Skull And Nasopharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>A sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contains the ossicles (malleus, incus and stapes). The inner ear is made up of the cochlea needed for hearing and the vestibular apparatus required for balance._Situated at or extending to the side._The portion of the skull that forms the floor on which the brain lies. The internal surface of the cranial base has three large depressions that lie on different levels known as the anterior, middle, and posterior cranial fossae._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._The part of the pharynx in the back of the throat, at and above the soft palate. The nasopharynx is continuous with the nasal passages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12423, C37912, C12493, C25230, C12394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13590410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paranasal Sinus</VALIDVALUE>
          <VALUEMEANING>Paranasal Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the air-filled spaces within the ethmoid, frontal, maxillary, or sphenoid bones, which communicate with the nasal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parathyroid</VALIDVALUE>
          <VALUEMEANING>Parathyroid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two small paired endocrine glands, superior and inferior, usually found embedded in the connective tissue capsule on the posterior surface of the thyroid gland; these glands secrete parathyroid hormone that regulates the metabolism of calcium and phosphorus. The parenchyma is composed of chief and oxyphilic cells arranged in anastomosing cords.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parietal Bone</VALIDVALUE>
          <VALUEMEANING>Parietal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two cranial bones that by their union form the sides and roof of the skull.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12766</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvis</VALIDVALUE>
          <VALUEMEANING>Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3684651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritoneum</VALIDVALUE>
          <VALUEMEANING>Peritoneum</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissue that lines the wall of the abdominal cavity, intestine, and mesentery.  It consists of the parietal peritoneum that covers the inside of the abdominal wall and the visceral peritoneum that covers the surface of the intestine and mesentery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4363646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radius Bone</VALIDVALUE>
          <VALUEMEANING>Radius Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The long bone of the forearm that extends from the lateral aspect of the elbow to the thumb-side of the wrist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rib</VALIDVALUE>
          <VALUEMEANING>Rib</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the paired bones, 12 on either side, extending from the thoracic vertebrae toward the median line on the ventral aspect of the trunk. The long curved bones which form the rib cage. Generally, ribs 1 to 7 are connected to the sternum&#39; by their costal cartilages and are called true ribs, whereas ribs 8 to 12 are termed false ribs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12782</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155321</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scapula</VALIDVALUE>
          <VALUEMEANING>Scapula</VALUEMEANING>
          <MEANINGDESCRIPTION>The flat triangle-shaped bone that connects the humerus with the clavicle in the back of the shoulder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skull</VALIDVALUE>
          <VALUEMEANING>Skull</VALUEMEANING>
          <MEANINGDESCRIPTION>The bones that form the head, made up of the bones of the braincase and face.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4363643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sphenoid Bone</VALIDVALUE>
          <VALUEMEANING>Sphenoid Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The butterfly-shaped bone located at the base of the skull that helps to form the orbit of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sternum</VALIDVALUE>
          <VALUEMEANING>Sternum</VALUEMEANING>
          <MEANINGDESCRIPTION>The long, flat bone connecting with the cartilages of the first seven ribs and the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12793</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tarsal Bone</VALIDVALUE>
          <VALUEMEANING>Tarsal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the seven bones forming the instep of the foot. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Temporal Bone</VALIDVALUE>
          <VALUEMEANING>Temporal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A large irregular bone situated at the base and side of the skull, connected with the mandible via the temporomandibular joint. The temporal bone consists of the squamous, tympanic and petrous parts. The petrous portion of the temporal bone contains the vestibulocochlear organ of the inner ear. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thoracic Vertebra</VALIDVALUE>
          <VALUEMEANING>Thoracic Vertebra</VALUEMEANING>
          <MEANINGDESCRIPTION>One of 12 vertebrae in the human vertebral column. The thoracic vertebrae are situated between the seventh cervical vertebra down to the first lumbar vertebra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thorax</VALIDVALUE>
          <VALUEMEANING>Thorax</VALUEMEANING>
          <MEANINGDESCRIPTION>The division of the body lying between the neck and the abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12799</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3698211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tibia</VALIDVALUE>
          <VALUEMEANING>Tibia</VALUEMEANING>
          <MEANINGDESCRIPTION>The second longest bone of the skeleton. It is located on the medial side of the lower leg, articulating with the FIBULA laterally, the TALUS distally, and the FEMUR proximally.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tonsil</VALIDVALUE>
          <VALUEMEANING>Tonsil</VALUEMEANING>
          <MEANINGDESCRIPTION>The two organs situated in the throat on either side of the narrow passage from the mouth to the pharynx. They are composed of lymphoid tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12802</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trabecular Meshwork</VALIDVALUE>
          <VALUEMEANING>Trabecular Meshwork</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesh-like tissue responsible for draining the aqueous humor from the eye that is located at the iridocorneal angle of the eye, between the anterior chamber and the venous sinus of the sclera.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12803</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13590411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ulna</VALIDVALUE>
          <VALUEMEANING>Ulna</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the bones that comprise the forearm. The largest aspect articulates with the humerus at the elbow joint and the smallest portion of the ulna articulates with the carpal bones in the wrist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Third Ventricle</VALIDVALUE>
          <VALUEMEANING>Third ventricle</VALUEMEANING>
          <MEANINGDESCRIPTION>A centrally placed component of the ventricular system of the brain located in the diencephalon. Cerebrospinal fluid from the lateral ventricles flows into the third ventricle via the foramina of Monroe and exits the third ventricle via the aqueduct of Sylvius. The thalamus and hypothalamus border the lateral walls of the third ventricle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12827</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fourth Ventricle</VALIDVALUE>
          <VALUEMEANING>FOURTH VENTRICLE</VALUEMEANING>
          <MEANINGDESCRIPTION>A diamond-shaped cavity filled with cerebrospinal fluid within the pons extending between the obex in the caudal medulla and the aqueduct of Sylvius in the cerebellum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lateral Ventricle</VALIDVALUE>
          <VALUEMEANING>Lateral ventricle</VALUEMEANING>
          <MEANINGDESCRIPTION>The rostral extensions of the ventricular system of the brain consisting of two cavities, one on each side of the brain within the central regions of each cerebral hemisphere.  Cerebrospinal fluid flows from the lateral ventricles into the centrally third ventricle via the foramen of Monroe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thoracic Spinal Cord</VALIDVALUE>
          <VALUEMEANING>Thoracic Spinal Cord</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the spinal cord located in the thoracic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lumbar Spinal Cord</VALIDVALUE>
          <VALUEMEANING>Lumbar Spinal Cord</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the spinal cord located in the lumbar region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12895</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13590412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Supraclavicular Nodes</VALIDVALUE>
          <VALUEMEANING>Supraclavicular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node which is located above the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axillary Nodes</VALIDVALUE>
          <VALUEMEANING>Axillary Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraspinal</VALIDVALUE>
          <VALUEMEANING>Paraspinal</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to muscles and/or tissue adjacent to the spinal column.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4419323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Breast</VALIDVALUE>
          <VALUEMEANING>Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inferior Limb</VALIDVALUE>
          <VALUEMEANING>Bone of the Lower Extremity</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone of the leg (lower extremity).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12982</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13590413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spine</VALIDVALUE>
          <VALUEMEANING>Vertebral Column</VALUEMEANING>
          <MEANINGDESCRIPTION>A series of bones, muscles, tendons, and other tissues reaching from the base of the skull to the tailbone. The vertebral column forms the axis of the skeleton and encloses as well as protects the spinal cord and the fluid surrounding the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4550853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Female Reproductive System Part</VALIDVALUE>
          <VALUEMEANING>Female Reproductive System Part</VALUEMEANING>
          <MEANINGDESCRIPTION>Any component of the female organs and tissues involved in the production and maturation of gametes and in their union and subsequent development as offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13039</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8167359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ascitic Fluid</VALIDVALUE>
          <VALUEMEANING>Ascites Fluid Sample</VALUEMEANING>
          <MEANINGDESCRIPTION>A biospecimen of ascitic fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13590414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paratesticular</VALIDVALUE>
          <VALUEMEANING>Paratesticular Region</VALUEMEANING>
          <MEANINGDESCRIPTION>A small anatomical compartment that contains the testicular collecting system, and mesothelial and mesenchymal components that represent extensions of the abdominal cavity and retroperitoneum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C162491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epitrochlear</VALIDVALUE>
          <VALUEMEANING>Epitrochlear Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The inner surface of the upper arm adjacent to the elbow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7547206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6431768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frontal Cortex</VALIDVALUE>
          <VALUEMEANING>Frontal Lobe Cortex</VALUEMEANING>
          <MEANINGDESCRIPTION>The grey matter, or outermost layer of the frontal lobe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177766</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13590415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neck</VALIDVALUE>
          <VALUEMEANING>Neck</VALUEMEANING>
          <MEANINGDESCRIPTION>The region that connects the head to the rest of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3192447</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foot Bone</VALIDVALUE>
          <VALUEMEANING>Foot Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The tarsus, metatarsus, and phalanges. (MeSH)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13068</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cheek</VALIDVALUE>
          <VALUEMEANING>Cheek</VALUEMEANING>
          <MEANINGDESCRIPTION>The fleshy part of the face bounded by the eyes, nose, ear, and jaw line.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13070</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Face</VALIDVALUE>
          <VALUEMEANING>Face</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior portion of the head extending from the forehead to the chin and ear to ear. The facial structures contain the eyes, nose and mouth, cheeks and jaws.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cutaneous</VALIDVALUE>
          <VALUEMEANING>Cutaneous</VALUEMEANING>
          <MEANINGDESCRIPTION>(kyoo-TAY-nee-us) Having to do with the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraperitoneal</VALIDVALUE>
          <VALUEMEANING>Intraperitoneal</VALUEMEANING>
          <MEANINGDESCRIPTION>(IN-tra-per-ih-toe-NEE-al) IP.  Within the peritoneal cavity (the area that contains the abdominal organs).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deep Gray (e.g. Basal ganglia or Thalamus)</VALIDVALUE>
          <VALUEMEANING>Deep Gray Matter</VALUEMEANING>
          <MEANINGDESCRIPTION>The gray matter that includes the basal ganglia and/or thalamus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158080</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7113008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occipital Cortex</VALIDVALUE>
          <VALUEMEANING>Occipital Lobe Cortex</VALUEMEANING>
          <MEANINGDESCRIPTION>The grey matter, or outermost layer of the occipital lobe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13590419</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Temporal Cortex</VALIDVALUE>
          <VALUEMEANING>Temporal Lobe Cortex</VALUEMEANING>
          <MEANINGDESCRIPTION>The grey matter, or outermost layer of the temporal lobe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13590420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adjacent Organ</VALIDVALUE>
          <VALUEMEANING>Adjacent Organ</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that is next to an organ of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C180347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13590421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior Skull Base</VALIDVALUE>
          <VALUEMEANING>Anterior Base of Skull</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the skull that is formed laterally by the orbital plates of the frontal bone, medially by the cribriform palate and crista galli of the ethmoid bone, and posteriorly by the planum sphenoidale and lesser wings of the sphenoid bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C180372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Shoulder</VALIDVALUE>
          <VALUEMEANING>Shoulder</VALUEMEANING>
          <MEANINGDESCRIPTION>The region of the body between the neck and the upper arm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242816</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest</VALIDVALUE>
          <VALUEMEANING>Chest</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the human body between the neck and the diaphragm or the corresponding part in other vertebrates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2975272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maxilla</VALIDVALUE>
          <VALUEMEANING>Maxilla</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper jawbone in vertebrates: it is fused to the cranium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Viscera</VALIDVALUE>
          <VALUEMEANING>Viscera</VALUEMEANING>
          <MEANINGDESCRIPTION>The soft internal organs of the body, including the lungs, the heart, and the organs of the digestive, excretory, and reproductive systems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28287</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4254576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetabulum</VALIDVALUE>
          <VALUEMEANING>Acetabulum</VALUEMEANING>
          <MEANINGDESCRIPTION>Two cup shaped areas, one each on the lateral side of the lower pelvis that house the head of the femur to form the ball and socket joint of the hip.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ankle Joint</VALIDVALUE>
          <VALUEMEANING>Ankle Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Upper Arm</VALIDVALUE>
          <VALUEMEANING>Arm</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcaneum</VALIDVALUE>
          <VALUEMEANING>Calcaneum</VALUEMEANING>
          <MEANINGDESCRIPTION>The irregular and largest tarsal bone that forms the heel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4199816</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Schlemm&#39;s Canal</VALIDVALUE>
          <VALUEMEANING>Canal of Schlemm</VALUEMEANING>
          <MEANINGDESCRIPTION>A circular vascular-like structure in the anterior chamber of the eye through which aqueous humor passes when returning to the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13590424</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical Nodes</VALIDVALUE>
          <VALUEMEANING>Cervical Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the lymph nodes located in the neck.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dorsal Spine</VALIDVALUE>
          <VALUEMEANING>Dorsal Curve</VALUEMEANING>
          <MEANINGDESCRIPTION>A spinal curve that originates at the middle of the second thoracic vertebra and terminates at the middle of the last thoracic vertebra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13590425</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elbow Joint</VALIDVALUE>
          <VALUEMEANING>Elbow Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of hinge joint located between the forearm and upper arm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Finger</VALIDVALUE>
          <VALUEMEANING>Fingers (Phalanges)</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the digits of the hand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foot</VALIDVALUE>
          <VALUEMEANING>Foot</VALUEMEANING>
          <MEANINGDESCRIPTION>The structure found below the ankle joint required for locomotion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Forearm</VALIDVALUE>
          <VALUEMEANING>Forearm</VALUEMEANING>
          <MEANINGDESCRIPTION>The structure on the upper limb, between the elbow and the wrist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32628</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frontal Bone</VALIDVALUE>
          <VALUEMEANING>Frontal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone of the skull forming the forehead, root of the nose and the roof of both orbits.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hand</VALIDVALUE>
          <VALUEMEANING>Hand</VALUEMEANING>
          <MEANINGDESCRIPTION>The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibula Head</VALIDVALUE>
          <VALUEMEANING>Head of the Fibula</VALUEMEANING>
          <MEANINGDESCRIPTION>The highest portion of the fibula that articulates with the patella.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4199812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ilium</VALIDVALUE>
          <VALUEMEANING>Ilium</VALUEMEANING>
          <MEANINGDESCRIPTION>The broad, dorsal, upper, and widest of the three principal bones composing either half of the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ischium</VALIDVALUE>
          <VALUEMEANING>Ischium</VALUEMEANING>
          <MEANINGDESCRIPTION>The most posterior and ventral bone making up the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32884</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Knee Joint</VALIDVALUE>
          <VALUEMEANING>Knee Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint connecting the lower part of the femur with the upper part of the tibia. The lower part of the femur and the upper part of the tibia are attached to each other by ligaments. Other structures of the knee joint include the upper part of the fibula, located below and parallel to the tibia, and the patella which moves as the knee bends.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lacrimal Bone</VALIDVALUE>
          <VALUEMEANING>Lacrimal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A small rectangular thin plate forming part of the medial orbit wall. It is located posterior to the frontal process of the maxilla and articulates with the inferior nasal concha, ethmoid, frontal, and maxillary bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leg</VALIDVALUE>
          <VALUEMEANING>Leg</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the two lower extremities in humans used for locomotion and support.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leptomeningeal</VALIDVALUE>
          <VALUEMEANING>Leptomeninges</VALUEMEANING>
          <MEANINGDESCRIPTION>The two innermost layers of tissue that cover the brain and spinal cord, the arachnoid mater and the pia mater.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32979</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal Bone</VALIDVALUE>
          <VALUEMEANING>Nasal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two small oblong bones placed side by side at the middle and upper part of the face.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal Septum</VALIDVALUE>
          <VALUEMEANING>Nasal Septum</VALUEMEANING>
          <MEANINGDESCRIPTION>The thin wall between the two nasal cavities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Omentum</VALIDVALUE>
          <VALUEMEANING>Omentum</VALUEMEANING>
          <MEANINGDESCRIPTION>A fold of peritoneum originating at the stomach and supporting the viscera. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patella</VALIDVALUE>
          <VALUEMEANING>Patella</VALUEMEANING>
          <MEANINGDESCRIPTION>A small flat triangular bone in front of the knee that articulates with the femur and protects the knee joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3134077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Perineum</VALIDVALUE>
          <VALUEMEANING>Perineum</VALUEMEANING>
          <MEANINGDESCRIPTION>The area located between the anus and vulva in females, and anus and scrotum in males.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412540</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleural Effusion</VALIDVALUE>
          <VALUEMEANING>Pleural Effusion</VALUEMEANING>
          <MEANINGDESCRIPTION>Increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumors, connective tissue disorders, and trauma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3331</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sacrococcygeal</VALIDVALUE>
          <VALUEMEANING>Sacrococcygeal Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>The amphiarthrodial joint between the sacrum and coccyx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33506</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7764255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sacrum</VALIDVALUE>
          <VALUEMEANING>Sacrum</VALUEMEANING>
          <MEANINGDESCRIPTION>The wedge-shaped bone consisting of five fused vertebrae, S1-S5 in man, forming the posterior part of the pelvis; its base connects with the lowest lumbar vertebra and its tip with the coccyx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Shoulder Joint</VALIDVALUE>
          <VALUEMEANING>Shoulder Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>A ball-and-socket joint at the upper end of the humerus, located at the junction of humerus and scapula.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Splenic Hilar Nodes</VALIDVALUE>
          <VALUEMEANING>Splenic Hilar Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the hilar region of the spleen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Superior Maxilla</VALIDVALUE>
          <VALUEMEANING>Superior Maxillary Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The facial bone that forms the mediala floor of the orbit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thigh</VALIDVALUE>
          <VALUEMEANING>Thigh</VALUEMEANING>
          <MEANINGDESCRIPTION>A part of the lower limb, located between hip and knee.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Toe</VALIDVALUE>
          <VALUEMEANING>Toes (Phalanges)</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the terminal digits of the foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33788</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4207651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trunk</VALIDVALUE>
          <VALUEMEANING>Trunk</VALUEMEANING>
          <MEANINGDESCRIPTION>The body excluding the head and neck and limbs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Upper Airway</VALIDVALUE>
          <VALUEMEANING>Upper Respiratory System</VALUEMEANING>
          <MEANINGDESCRIPTION>The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33839</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2749967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wrist Joint</VALIDVALUE>
          <VALUEMEANING>Wrist Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint between the distal end of the radius and the proximal row of carpal bones. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3181300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal Tract</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Tract</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2749579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Reported</VALIDVALUE>
          <VALUEMEANING>Not Reported</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zygomatic Bone</VALIDVALUE>
          <VALUEMEANING>Zygomatic Arch</VALUEMEANING>
          <MEANINGDESCRIPTION>The union at the zygomaticotemporal suture of the temporal process of the zygomatic bone and zygomatic process of the temporal bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33897</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13592049</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Shoulder Girdle</VALIDVALUE>
          <VALUEMEANING>Shoulder Girdle</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony arch formed by the collarbones and shoulder blades.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regional Lymph Nodes</VALIDVALUE>
          <VALUEMEANING>Regional Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node that drains lymph from a region of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3422988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hand Phalanges</VALIDVALUE>
          <VALUEMEANING>Hand Phalanx</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone of the hand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52771</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6401067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foot Phalanges</VALIDVALUE>
          <VALUEMEANING>Foot Phalanx</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone of the foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52772</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Talus</VALIDVALUE>
          <VALUEMEANING>Talus</VALUEMEANING>
          <MEANINGDESCRIPTION>The bone of the foot that connects with the tibia and fibula to form the ankle joint. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52799</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Popliteal Nodes</VALIDVALUE>
          <VALUEMEANING>Popliteal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymph node located within the fat layer of the knee joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest Wall</VALIDVALUE>
          <VALUEMEANING>Chest Wall</VALUEMEANING>
          <MEANINGDESCRIPTION>The total system of structures outside the lungs that move as a part of breathing; it includes all structures from the skin to the parietal pleura.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infraclavicular Nodes</VALIDVALUE>
          <VALUEMEANING>Infraclavicular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the area below the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2969629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Face</VALIDVALUE>
          <VALUEMEANING>Facial Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Any bone that contributes to the facial structures, except those bones that are part of the braincase.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63706</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hip</VALIDVALUE>
          <VALUEMEANING>Hip</VALUEMEANING>
          <MEANINGDESCRIPTION>The lateral prominence of the pelvis from the waist to the thigh.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2990374</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Celiac Nodes</VALIDVALUE>
          <VALUEMEANING>Celiac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node at the base of the celiac artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65166</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3916262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical Spine</VALIDVALUE>
          <VALUEMEANING>Cervical Spine</VALUEMEANING>
          <MEANINGDESCRIPTION>Those vertebrae immediately behind (caudal to) the skull, C1-C7 in man.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lumbar Spine</VALIDVALUE>
          <VALUEMEANING>Lumbar Spine</VALUEMEANING>
          <MEANINGDESCRIPTION>Those vertebrae between the ribs and the pelvis, L1-L5 in man.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Waldeyer&#39;s Ring</VALIDVALUE>
          <VALUEMEANING>Waldeyer&#39;s Tonsillar Ring</VALUEMEANING>
          <MEANINGDESCRIPTION>The ring of lymphoid tissue located in the pharynx, consisting of the pharyngeal, tubal, palatine, and lingual tonsils.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anus</VALIDVALUE>
          <VALUEMEANING>Anus</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3625363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypodermis</VALIDVALUE>
          <VALUEMEANING>Skin/Subcutaneous Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>A tissue sample that contains the epidermis, dermis, and subcutaneous adipose tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13592051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphatic Basin</VALIDVALUE>
          <VALUEMEANING>Lymphatic Basin</VALUEMEANING>
          <MEANINGDESCRIPTION>A regional collection of lymph nodes that drains lymph from a specific area of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13592052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraspinal</VALIDVALUE>
          <VALUEMEANING>Intraspinal</VALUEMEANING>
          <MEANINGDESCRIPTION>Within the spine (backbone).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4254578</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parapharyngeal Area</VALIDVALUE>
          <VALUEMEANING>Lateral Pharyngeal Space</VALUEMEANING>
          <MEANINGDESCRIPTION>A cone-shaped lateral neck space with its base on the base of the skull and its apex at the hyoid bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C162818</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13592053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vasculo-Nervous</VALIDVALUE>
          <VALUEMEANING>Neurovascular Bundle</VALUEMEANING>
          <MEANINGDESCRIPTION>A body structure consisting of nerves traveling together with arteries, veins, and/or lymphatics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13592050</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdominal Wall</VALIDVALUE>
          <VALUEMEANING>Abdominal Wall</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissues that surround the organs that are present within the abdominal cavity. The abdominal wall tissue is composed of layers of fat, parietal peritoneum, fascia, and muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesenteric Nodes</VALIDVALUE>
          <VALUEMEANING>Mesenteric Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the mesentery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3778534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Para-Aortic Lymph Nodes</VALIDVALUE>
          <VALUEMEANING>Paraaortic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located adjacent to the lumbar region of the spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Craniospinal</VALIDVALUE>
          <VALUEMEANING>Craniospinal</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to the cranium and the spinal column.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buttock</VALIDVALUE>
          <VALUEMEANING>Buttock</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the fleshy mounds in the rear pelvic area of the human body formed by the gluteal muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scalp</VALIDVALUE>
          <VALUEMEANING>Scalp</VALUEMEANING>
          <MEANINGDESCRIPTION>The skin which covers the top of the head and which is usually covered by hair.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Optic Chiasm</VALIDVALUE>
          <VALUEMEANING>Optic Chiasm</VALUEMEANING>
          <MEANINGDESCRIPTION>An anatomic structure formed by the crossing of the two optic nerves under the hypothalamus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bladder/Prostate</VALIDVALUE>
          <VALUEMEANING>Bladder Prostate Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A distensible musculomembranous organ serving as a receptacle for fluid, as the gallbladder.: A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12410, C12414</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2991833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brain/Leptomeninges</VALIDVALUE>
          <VALUEMEANING>Brain Leptomeninges</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium._The two innermost layers of tissue that cover the brain and spinal cord, the arachnoid mater and the pia mater.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32979, C12439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13592089</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epitrochlear or Brachial Nodes</VALIDVALUE>
          <VALUEMEANING>Epitrochlear Region Or Brachial Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>The inner surface of the upper arm adjacent to the elbow._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._An axillary lymph node along the brachial vein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92221, C37998, C165193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13592090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hip/Inguinal Region</VALIDVALUE>
          <VALUEMEANING>Hip Inguinal Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The lateral prominence of the pelvis from the waist to the thigh._The lower region of the anterior abdominal wall located laterally to the pubic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64193, C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13592091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inguinal or Femoral Nodes</VALIDVALUE>
          <VALUEMEANING>Inguinal Region Or Femoral Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower region of the anterior abdominal wall located laterally to the pubic region._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A lymph node located in the upper inner portion of the thigh.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98183, C37998, C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large Vessels</VALIDVALUE>
          <VALUEMEANING>Large Blood Vessel</VALUEMEANING>
          <MEANINGDESCRIPTION>Of considerable or relatively great size, extent, or capacity._A tubular structure through which the blood circulates in the body. Blood vessels constitute a network composed of arteries, arterioles, capillaries, venules, and veins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12679, C49508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Larynx - Trachea</VALIDVALUE>
          <VALUEMEANING>Larynx And Trachea</VALUEMEANING>
          <MEANINGDESCRIPTION>The cartilaginous structure of the respiratory tract between the pharynx and the trachea. It contains elastic vocal cords required for sound production._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._The fibrocartilaginous, mucous-lined tube passing from the larynx to the bronchi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12420, C12428, C37912</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>2, 0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parietal Cortex</VALIDVALUE>
          <VALUEMEANING>Parietal Lobe Cortex</VALUEMEANING>
          <MEANINGDESCRIPTION>The outermost layer of the parietal lobe, made up primarily of gray matter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C177764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvis/Sacrum</VALIDVALUE>
          <VALUEMEANING>Pelvis And Sacrum</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._The triangular bone, made up of 5 fused bones of the spine, located in the lower area of the spine between the fifth lumbar vertebra and the coccyx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33508, C37912, C12767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleura Thymus</VALIDVALUE>
          <VALUEMEANING>Pleura Thymus Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissue that lines the wall of the thoracic cavity and the surface of the lungs.: A bi-lobed organ surrounded by a connective tissue capsule. It is located in the upper anterior portion of the chest, behind the sternum. It is composed predominantly of lymphocytes and fewer epithelial cells. Connective tissue septa separate the lobes into lobules. The lobules contain an outer portion (cortical zone) which is rich in lymphocytes and an inner portion (medullary zone) which is rich in epithelial cells. It is an organ essential for the development of the immune system. Its function is the maturation of the progenitor lymphoid cells to thymocytes and subsequently to mature T-cells. It reaches its greatest weight at puberty and subsequently begins to involute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12433, C12469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scapula/Clavicle</VALIDVALUE>
          <VALUEMEANING>Scapula And Clavicle</VALUEMEANING>
          <MEANINGDESCRIPTION>The flat triangle-shaped bone that connects the humerus with the clavicle in the back of the shoulder._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._One of a pair of bones linking the scapula and the sternum. The clavicle is part of the pectoral girdle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12695, C37912, C12783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skull and Face Bone</VALIDVALUE>
          <VALUEMEANING>Skull And Facial Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The bones that form the head, made up of the bones of the braincase and face.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Any bone that contributes to the facial structures, except those bones that are part of the braincase.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63706, C37912, C12789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8002342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal Cavity and Paranasal Sinuses</VALIDVALUE>
          <VALUEMEANING>Nasal Cavity And Paranasal Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>The proximal portion of the respiratory passages on either side of the nasal septum lying between the floor of the cranium and the roof of the mouth and extending from the face to the pharynx. The nasal cavity is lined with ciliated mucosa, extending from the nares to the pharynx._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Any one of the air-filled spaces within the ethmoid, frontal, maxillary, or sphenoid bones, which communicate with the nasal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12763, C37912, C12424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soft Tissue, NOS</VALIDVALUE>
          <VALUEMEANING>Soft Tissue Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>A general term comprising tissue that is not hardened or calcified; including muscle, fat, blood vessels, nerves, tendons, ligaments and fascia._Not characterized in any other way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594, C12471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sternum/Chest Wall</VALIDVALUE>
          <VALUEMEANING>Sternum And Chest Wall</VALUEMEANING>
          <MEANINGDESCRIPTION>The long, flat bone connecting with the cartilages of the first seven ribs and the clavicle._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._The total system of structures outside the lungs that move as a part of breathing; it includes all structures from the skin to the parietal pleura.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62484, C37912, C12793</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suprasellar Pituitary</VALIDVALUE>
          <VALUEMEANING>Suprasellar Region Pituitary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>The area above or over the sella turcica._Pea-sized endocrine gland located at the base of the brain in the pituitary fossa. It produces and secretes hormones such as oxytocin and vasopressin, to regulate the activities of the hypothalamus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12399, C42602</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroid and Parathyroid</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland And Parathyroid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._One of two small paired endocrine glands, superior and inferior, usually found embedded in the connective tissue capsule on the posterior surface of the thyroid gland; these glands secrete parathyroid hormone that regulates the metabolism of calcium and phosphorus. The parenchyma is composed of chief and oxyphilic cells arranged in anastomosing cords.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12765, C37912, C12400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trunk - Paraspinal</VALIDVALUE>
          <VALUEMEANING>Trunk And Paraspinal</VALUEMEANING>
          <MEANINGDESCRIPTION>The body excluding the head and neck and limbs._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Pertaining to muscles and/or tissue adjacent to the spinal column.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129461, C37912, C33816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Superior Limb and Shoulder</VALIDVALUE>
          <VALUEMEANING>Superior Limb And Shoulder</VALUEMEANING>
          <MEANINGDESCRIPTION>In anatomy, indicating higher than a given reference point._A body region referring to an upper or lower extremity._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._The region of the body between the neck and the upper arm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25203, C37912, C12429, C25235</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anal/Perianal</VALIDVALUE>
          <VALUEMEANING>Anus And Perianal Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._The skin area around the anus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99148, C37912, C43362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13594071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver/Biliary Tract</VALIDVALUE>
          <VALUEMEANING>Liver And Biliary Tract</VALUEMEANING>
          <MEANINGDESCRIPTION>A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._The system that transports bile from the hepatocytes in the liver to the small intestine. It is comprised of the intrahepatic bile ducts, hepatic ducts, common bile duct, cystic duct, and the gallbladder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12678, C37912, C12392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13751502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Deep Facial Areas</VALIDVALUE>
          <VALUEMEANING>Deep Facial Areas</VALUEMEANING>
          <MEANINGDESCRIPTION>Terminology created by EVS and PCDC to support the OS Radiation Therapy Table._The anterior portion of the head extending from the forehead to the chin and ear to ear. The facial structures contain the eyes, nose and mouth, cheeks and jaws.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13071, C179483</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13779876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foot Joint</VALIDVALUE>
          <VALUEMEANING>Foot Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>The structure found below the ankle joint._The connection point between two bones or skeletal elements. The joint may be fixed or movable.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13044, C32622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13779877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hand Joint</VALIDVALUE>
          <VALUEMEANING>Hand Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits._The connection point between two bones or skeletal elements. The joint may be fixed or movable.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13044, C32712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13779878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lower Arm</VALIDVALUE>
          <VALUEMEANING>Lower Arm</VALUEMEANING>
          <MEANINGDESCRIPTION>The bottom one of two._The structure on the upper limb, between the elbow and the wrist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32628, C25309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13779879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lower Leg</VALIDVALUE>
          <VALUEMEANING>Lower Leg</VALUEMEANING>
          <MEANINGDESCRIPTION>Lower; the bottom one of two.: Commonly used to refer to the whole lower limb but technically only the part between the knee and ankle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32974, C25309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urogenital</VALIDVALUE>
          <VALUEMEANING>Genitourinary</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or related to the genital and urinary organs or their functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hand Bone</VALIDVALUE>
          <VALUEMEANING>Hand Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the carpal, metacarpal, or phalangeal bones located in the hand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C199635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14103246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Primary Anatomic Site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PCDC Description</Name>
        <DocumentType>DESCRIPTION</DocumentType>
        <DocumentText>Specifies the anatomic site of a localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDS</Name>
        <DocumentType>EXAMPLE</DocumentType>
        <DocumentText>Lung, Kidney, Breast</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Ped Core Tier</Name>
        <DocumentType>Tier</DocumentType>
        <DocumentText>Mandatory</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>12173174</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>12173174v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Attributes</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>12173178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>12173174</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>12173174v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tumor Characteristics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>12173197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594093</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13596241</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13954630</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>All Pediatric Core CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14599258</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TUMOR_SITE</AlternateName>
        <AlternateNameType>PCDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>anatomic_site</AlternateName>
        <AlternateNameType>CCDI Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Tumor Site</AlternateName>
        <AlternateNameType>Ped Cancer Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="969">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>13382490</PUBLICID>
    <LONGNAME>Therapeutic Procedure Protocol Radiation Therapy Indicator</LONGNAME>
    <PREFERREDNAME>13381598v1.00:6059598v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>A response to indicate whether or not this radiation therapy administration was part of the treatment protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Pediatric Cancer</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCDC:Pediatric Cancer Data Commons</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>13381598</PublicId>
      <PreferredName>2512834v1.00:13381597v1.00</PreferredName>
      <PreferredDefinition>An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis._Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.</PreferredDefinition>
      <LongName>Therapeutic Procedure Protocol Radiation Therapy</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Pediatric Cancer</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>13381597</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70817:C15313</PreferredName>
        <Version>1</Version>
        <LongName>Study Protocol Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70817</PREFERRED_NAME>
            <LONG_NAME>Study Protocol</LONG_NAME>
            <CON_ID>2753699</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PCDC:Pediatric Cancer Data Commons</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6059598</PublicId>
      <PreferredName>Y_N_UNK_NRPT_IND</PreferredName>
      <PreferredDefinition>An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Yes No Unknown Not Reported Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>GDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>GDC:NCI Genomic Data Commons</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Reported</VALIDVALUE>
          <VALUEMEANING>Not Reported</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5697865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5697866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Protocol Radiation Therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>12173174</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>12173174v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>12173179</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>12173174</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>12173174v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Radiation Therapy</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>12173202</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PROTOCOL_RADIATION_THERAPY</AlternateName>
        <AlternateNameType>PCDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="970">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>13484610</PUBLICID>
    <LONGNAME>Specimen Material Type</LONGNAME>
    <PREFERREDNAME>GFSPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>Identifies the type of genetic material used for the measurement.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PMI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CTEP CDISC Harmonization</ORIGIN>
    <REGISTRATIONSTATUS>Incomplete</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>13484605</PublicId>
      <PreferredName>6944198v1.00:13484604v1.00</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to genomics findings.:Having to do with information that is passed from parents to offspring through genes in sperm and egg cells._The type of a material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes. This includes particular types of cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory substances.</PreferredDefinition>
      <LongName>Genomics Findings Domain Genetic Biospecimen Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PMI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>10380906</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C181320</PreferredName>
        <Version>1</Version>
        <LongName>Genomics Findings Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C181320</PREFERRED_NAME>
            <LONG_NAME>Genomics Findings Domain</LONG_NAME>
            <CON_ID>10049853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>13484604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17938:C70713</PreferredName>
        <Version>1</Version>
        <LongName>Genetic Biospecimen Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17938</PREFERRED_NAME>
            <LONG_NAME>Genetic</LONG_NAME>
            <CON_ID>2206224</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70713</PREFERRED_NAME>
            <LONG_NAME>Biospecimen Type</LONG_NAME>
            <CON_ID>2714914</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>13560110</PublicId>
      <PreferredName>GENSMP</PreferredName>
      <PreferredDefinition>Terminology associated with the genetic sample type codelist of the Clinical Data Interchange Standards Consortium (CDISC) Standard Data Tabulation Model (SDTM)._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>CDISC SDTM Genetic Sample Type Terminology Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PMI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>13484607</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>13484607v1.00</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Genetic Sample Type Terminology Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C111114</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Genetic Sample Type Terminology</LONG_NAME>
            <CON_ID>10009476</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7SK RNA</VALIDVALUE>
          <VALUEMEANING>7SK Small Nuclear RNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A small nuclear RNA encoded by the human RN7SK gene. This oligoribonucleotide may play a role in the regulation of the enzymatic activity of RNA polymerase II.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95951</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13560111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cDNA</VALIDVALUE>
          <VALUEMEANING>cDNA</VALUEMEANING>
          <MEANINGDESCRIPTION>Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. cDNA (i.e., complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C324</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cfDNA</VALIDVALUE>
          <VALUEMEANING>Circulating cell-free DNA</VALUEMEANING>
          <MEANINGDESCRIPTION>DNA found in blood plasma and other bodily fluids that is not associated with cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128274</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cpDNA</VALIDVALUE>
          <VALUEMEANING>Chloroplast DNA</VALUEMEANING>
          <MEANINGDESCRIPTION>The DNA that is located in the photosynthetic, chlorophyll-containing organelle in the cells of young leaves and stems of higher plants.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111158</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13560112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ctDNA</VALIDVALUE>
          <VALUEMEANING>Circulating Tumor-Derived DNA</VALUEMEANING>
          <MEANINGDESCRIPTION>Neoplasm-derived DNA found in blood plasma and other bodily fluids that is not associated with cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113243</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4061103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dsRNA</VALIDVALUE>
          <VALUEMEANING>Double-Stranded RNA</VALUEMEANING>
          <MEANINGDESCRIPTION>An RNA complex consisting of two complementary base-paired strands of RNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95938</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13560113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>gDNA</VALIDVALUE>
          <VALUEMEANING>Genomic DNA</VALUEMEANING>
          <MEANINGDESCRIPTION>The DNA that is part of the normal chromosomal complement of an organism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95940</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6273408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>gRNA</VALIDVALUE>
          <VALUEMEANING>Guide RNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A small RNA involved in post-transcriptional mitochondrial RNA modification (RNA editing) in kinetoplastid protists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95952</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13560114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hnRNA</VALIDVALUE>
          <VALUEMEANING>hnRNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A diverse assortment of nascent, immature, unprocessed RNA transcripts synthesized from DNA templates that are found in eukaryotic nuclei before post-transcriptional modifications.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28454</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13560115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DNA</VALIDVALUE>
          <VALUEMEANING>DNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>miRNA</VALIDVALUE>
          <VALUEMEANING>MicroRNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A sequence of single-stranded RNA, that is 20-25 nucleotides in length, which is transcribed from DNA but is not translated into a protein. This nucleic acid may regulate the transcription or translation of other genes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2938123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mRNA</VALIDVALUE>
          <VALUEMEANING>Messenger RNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2756502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>msDNA</VALIDVALUE>
          <VALUEMEANING>Multicopy Single-stranded DNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A DNA/RNA chimera comprised of a single-stranded DNA molecule covalently bound to an internal guanosine of a RNA molecule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13563468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>msdRNA</VALIDVALUE>
          <VALUEMEANING>msdRNA</VALUEMEANING>
          <MEANINGDESCRIPTION>The RNA portion of the msDNA molecule, which contains two stem-loop structures and varies widely in length across bacterial species.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13563469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mtDNA</VALIDVALUE>
          <VALUEMEANING>Mitochondrial DNA</VALUEMEANING>
          <MEANINGDESCRIPTION>Typically small, circular, intronless, and maternally inherited, mitochondrial DNA (mtDNA) is the multicopy deoxyribonucleic acid genome of mitochondria, intracellular organelles responsible for vital respiratory chain and oxidative phosphorylation reactions in higher eukaryotes. Replicated and transcribed by a separate enzymatic machinery from that of nuclear DNA, mtDNA encodes only a subset of mitochondrial functions. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3852319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pDNA</VALIDVALUE>
          <VALUEMEANING>Plasmid</VALUEMEANING>
          <MEANINGDESCRIPTION>A small cellular inclusion consisting of a ring of DNA that is not in a chromosome but is capable of autonomous replication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13563471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>piRNA</VALIDVALUE>
          <VALUEMEANING>Piwi-Interacting RNA</VALUEMEANING>
          <MEANINGDESCRIPTION>Single-stranded RNA molecules that are expressed in animal cells and form complexes with Piwi proteins. They are involved in transcriptional gene silencing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95953</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13563472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pre-mRNA</VALIDVALUE>
          <VALUEMEANING>Precursor mRNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A primary RNA transcript synthesized from a DNA template in eukaryotic nuclei which is post-transcriptionally modified and spliced to produce a mature mRNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13563473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pri-miRNA</VALIDVALUE>
          <VALUEMEANING>Pri-miRNA</VALUEMEANING>
          <MEANINGDESCRIPTION>The pri-miRNA is a primary transcript derived from a gene whose sole products are miRNA(s). A unique pathway involving the nuclear microprocessor complex participates in the cleavage of such transcripts, which can be substantially longer than the 65-110 nt pre-miRNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13563474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nDNA</VALIDVALUE>
          <VALUEMEANING>Nuclear DNA</VALUEMEANING>
          <MEANINGDESCRIPTION>The DNA that is normally located in the nucleus of a eukaryotic cell.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95941</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13563470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>rDNA</VALIDVALUE>
          <VALUEMEANING>Ribosomal RNA Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>The genomic sequence that encodes a ribosomal RNA molecule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95943</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13565273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RIBOZYME</VALIDVALUE>
          <VALUEMEANING>Ribozyme</VALUEMEANING>
          <MEANINGDESCRIPTION>RNA that contains an intron sequence which has an enzyme-like catalytic activity. This intron sequence has been shown to fold up to form a complex surface that can function like an enzyme in reactions with other RNA molecules and thus synthesize new molecules even in the absence of protein. Synthetic ribozymes can be engineered to specifically cleave a target RNA sequence causing expression down regulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13565274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RNA</VALIDVALUE>
          <VALUEMEANING>Ribonucleic Acid</VALUEMEANING>
          <MEANINGDESCRIPTION>Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C812</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5485589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>rRNA</VALIDVALUE>
          <VALUEMEANING>Ribosomal RNA</VALUEMEANING>
          <MEANINGDESCRIPTION>An RNA molecule that does not contain protein-coding sequence information and constitutes the majority of the cellular RNA (~80%). This nucleic acid associates with multiple proteins to form ribosomes, which are the organelles that drive mRNA-directed protein synthesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13565275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>snoRNA</VALIDVALUE>
          <VALUEMEANING>Small Nucleolar RNA</VALUEMEANING>
          <MEANINGDESCRIPTION>Small RNA molecules that are present in the nucleolus. They associate with proteins to form small nucleolar ribonucleoprotein particles that are involved in modification of other RNAs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13565277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>snRNA</VALIDVALUE>
          <VALUEMEANING>Small Nuclear RNA</VALUEMEANING>
          <MEANINGDESCRIPTION>Small nuclear RNA.  A class of abundant small nuclear RNAs involved in RNA processing (splicing, 3&#39; end maturation).  These snRNAs associate with specific proteins to form the small nuclear ribonucleoprotein particles (snRNP) directly involved in RNA processing.  Seven known snRNAs have been termed U1 through U7 snRNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C815</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SRP RNA</VALIDVALUE>
          <VALUEMEANING>Signal Recognition Particle RNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-coding RNA that is part of the signal recognition particle. It is involved in the co-translational targeting of proteins to membranes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13565278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ssDNA</VALIDVALUE>
          <VALUEMEANING>Single-stranded DNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A long linear single-stranded polymer formed from nucleotides attached to a deoxyribose backbone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13565279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tmRNA</VALIDVALUE>
          <VALUEMEANING>Transfer-Messenger RNA</VALUEMEANING>
          <MEANINGDESCRIPTION>An RNA encoded by the bacterial ssrA gene. It is involved in the recycling of stalled ribosomes and the targeting of both defective mRNA molecules and incomplete nascent proteins for degradation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95954</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13565280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>siRNA</VALIDVALUE>
          <VALUEMEANING>Small Interfering RNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A 20 to 25-nucleotide double-stranded RNA which is involved in a sequence-specific messenger RNA degradation process known as RNA interference.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2191</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13565276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TRANSPOSON</VALIDVALUE>
          <VALUEMEANING>Transposon</VALUEMEANING>
          <MEANINGDESCRIPTION>A genetic element that is able to move from one genomic position to another.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95942</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7477415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tRNA</VALIDVALUE>
          <VALUEMEANING>Transfer RNA</VALUEMEANING>
          <MEANINGDESCRIPTION>A class of short adaptor RNAs that transfers a specific amino acid to a growing polypeptide chain at the ribosomal site of protein synthesis during translation. Each transfer RNA comprises a three-nucleotide sequence that is complementary to the triplet nucleotide coding sequence of an mRNA, conferring specificity to the amino acid being incorporated into the assembling protein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13565281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GERMLINE DNA</VALIDVALUE>
          <VALUEMEANING>Germline DNA</VALUEMEANING>
          <MEANINGDESCRIPTION>The DNA in germ cells (egg and sperm cells that join to form an embryo). Germline DNA is the source of DNA for all other cells in the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94480</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13343332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specimen Material Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="971">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>13714612</PUBLICID>
    <LONGNAME>Intravenous Site Pain Occurrence Severity Grade</LONGNAME>
    <PREFERREDNAME>13707091v1.00:13707076v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the severity grade of the IV site pain that occurred</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>13707091</PublicId>
      <PreferredName>13707090v1.00:2234856v1.00</PreferredName>
      <PreferredDefinition>Into or within a vein. Intravenous usually refers to a way of giving a drug or other substance through a needle or tube inserted into a vein._Named locations of or within the body._The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.:An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Intravenous Site Pain Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>13707090</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13346:C13717:C3303</PreferredName>
        <Version>1</Version>
        <LongName>Intravenous Anatomic Site Pain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13346</PREFERRED_NAME>
            <LONG_NAME>Intravenous</LONG_NAME>
            <CON_ID>2450528</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3303</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>2202326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>13707076</PublicId>
      <PreferredName>13707076v1.00</PreferredName>
      <PreferredDefinition>The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings._Used of the degree of something undesirable e.g. pain or weather; also, strictness._A position on a scale of intensity or amount or quality.</PreferredDefinition>
      <LongName>Pain Severity Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>13707075</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>13707075v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Pain Severity Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3303</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>2202326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>None (grade 0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-05-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13707077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mild</VALIDVALUE>
          <VALUEMEANING>Mild</VALUEMEANING>
          <MEANINGDESCRIPTION>Mild pain not interfering with function (grade 1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-05-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13707078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>Moderate pain interfering with function but not ADL (grade 2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-05-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13707079</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Severe</VALIDVALUE>
          <VALUEMEANING>Severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Severe pain severely interfering with ADL (grade 3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-05-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13707080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disabling</VALIDVALUE>
          <VALUEMEANING>Disabling</VALUEMEANING>
          <MEANINGDESCRIPTION>Disabling (grade 4)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-05-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13707081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the severity grade of the IV site pain that occurred?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>IV site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="972">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>13820342</PUBLICID>
    <LONGNAME>Hypocalcemia Other Symptom Occurrence Indicator</LONGNAME>
    <PREFERREDNAME>13820337v1.00:2784450v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator of whether or not another hypocalcemia symptom occurred.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>13820337</PublicId>
      <PreferredName>13820336v1.00:2234856v1.00</PreferredName>
      <PreferredDefinition>Lower than normal levels of calcium in the circulating blood._A symptom that is not among those been previously noted.:An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Hypocalcemia Other Symptom Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008575</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SM</PreferredName>
        <Version>1</Version>
        <LongName>Symptoms</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>13820336</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37973:C178962</PreferredName>
        <Version>1</Version>
        <LongName>Hypocalcemia Other Symptom</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37973</PREFERRED_NAME>
            <LONG_NAME>Hypocalcemia</LONG_NAME>
            <CON_ID>2203696</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C178962</PREFERRED_NAME>
            <LONG_NAME>Other Symptom</LONG_NAME>
            <CON_ID>8057565</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did a another hypocalcemia symptom occur?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Other symptom(s)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="973">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14411440</PUBLICID>
    <LONGNAME>First Degree Relative Ten Telephone Number</LONGNAME>
    <PREFERREDNAME>14411350v1.00:2016227v3.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The telephone number of the number 10 first direct relative.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14411350</PublicId>
      <PreferredName>2400272v1.00:14411349v1.00</PreferredName>
      <PreferredDefinition>Any relative who is one meiosis away from a particular individual in a family; a relative with whom one half of an individual&#39;s genes is shared (i.e., parent, sibling, offspring) (from Genetics Home Reference glossary):A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one._A sequence of decimal digits (0-9) that is used for identifying a destination telephone line or other device in a telephone network.</PreferredDefinition>
      <LongName>First Degree Relative Ten Telephone Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2400272</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21481</PreferredName>
        <Version>1</Version>
        <LongName>First Degree Relative</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21481</PREFERRED_NAME>
            <LONG_NAME>First Degree Relative</LONG_NAME>
            <CON_ID>2400271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14411349</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C69122:C40978</PreferredName>
        <Version>1</Version>
        <LongName>Ten Telephone Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C69122</PREFERRED_NAME>
            <LONG_NAME>Ten</LONG_NAME>
            <CON_ID>2690611</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40978</PREFERRED_NAME>
            <LONG_NAME>Telephone Number</LONG_NAME>
            <CON_ID>2223426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016227</PublicId>
      <PreferredName>PH_NUM</PreferredName>
      <PreferredDefinition>the telephone number of a person or organization.</PreferredDefinition>
      <LongName>Phone Number</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008544</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TELECOMMUNICATIONS</PreferredName>
        <Version>1</Version>
        <LongName>Telecommunications</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184315</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Number</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FDR 10 Telephone Number</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>FDR 10 Telephone Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="974">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14435697</PUBLICID>
    <LONGNAME>Cytomegaloviral Retinitis Present Yes No Indicator</LONGNAME>
    <PREFERREDNAME>CYTOMGLVRS_RTNITS_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Yes/No Indicator of whether cytomegaloviral retinitis is present.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14435696</PublicId>
      <PreferredName>14435695v1.00:2233878v1.00</PreferredName>
      <PreferredDefinition>Inflammation of the retina due to cytomegalovirus.:Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Cytomegaloviral Retinitis Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>AMC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14435695</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50521</PreferredName>
        <Version>1</Version>
        <LongName>Cytomegaloviral Retinitis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50521</PREFERRED_NAME>
            <LONG_NAME>Cytomegaloviral Retinitis</LONG_NAME>
            <CON_ID>4394263</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cytomegalovirus retinitis present</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cytomegalovirus retinitis (with loss of vision)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HXCYMRET_MHOCCUR</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="975">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14612661</PUBLICID>
    <LONGNAME>Longitudinal Study Temporal Offset Number</LONGNAME>
    <PREFERREDNAME>14612660v1.00:2556190v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>An offset in days from a particular event of significance and a fixed reference point; difference between a set point and the actual reading.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CRDC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDS:Cancer Data Service</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14612660</PublicId>
      <PreferredName>14670287v1.00:14670288v1.00</PreferredName>
      <PreferredDefinition>A study in which participants are followed and repeatedly evaluated over a period of time.:Of or relating to time or limited by time._The distance between a point and a fixed reference point; difference between a set point and the actual reading.</PreferredDefinition>
      <LongName>Longitudinal Study Temporal Offset</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CRDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14670287</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15273</PreferredName>
        <Version>1</Version>
        <LongName>Longitudinal Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15273</PREFERRED_NAME>
            <LONG_NAME>Longitudinal Study</LONG_NAME>
            <CON_ID>2959061</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14670288</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C73990:C47923</PreferredName>
        <Version>1</Version>
        <LongName>Temporal Offset</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73990</PREFERRED_NAME>
            <LONG_NAME>Temporal</LONG_NAME>
            <CON_ID>2753273</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47923</PREFERRED_NAME>
            <LONG_NAME>Offset</LONG_NAME>
            <CON_ID>2388823</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDS:Cancer Data Service</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2556190</PublicId>
      <PreferredName>8_BYTE_NUM</PreferredName>
      <PreferredDefinition>FD:Double precision binary floating point number prepresented in IEEE 754:1985 64-bit Floating Point Number Format. [Standard-based]</PreferredDefinition>
      <LongName>8 Byte Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
      <Representation>
        <PublicId>2556189</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL124470:C48047:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Eight Byte Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL124470</PREFERRED_NAME>
            <LONG_NAME>Eight</LONG_NAME>
            <CON_ID>2208236</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48047</PREFERRED_NAME>
            <LONG_NAME>Byte</LONG_NAME>
            <CON_ID>2556188</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Temporal Offset</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DICOM Tag CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812790</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>8064110</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GC (General Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14470388</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>longitudinal_temporal_event_offset</AlternateName>
        <AlternateNameType>GC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>(0012, 0052)</AlternateName>
        <AlternateNameType>DICOM_TAG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Longitudinal Temporal Offset from Event</AlternateName>
        <AlternateNameType>DICOM Attribute Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="976">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14634419</PUBLICID>
    <LONGNAME>Concomitant Medication Administered Reason</LONGNAME>
    <PREFERREDNAME>CM_ADM_RSN</PREFERREDNAME>
    <PREFERREDDEFINITION>The reason a concomitant medication was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCTG: Canadian Cancer Trials Group</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195361</PublicId>
      <PreferredName>CONCOM_MEDS_ADM</PreferredName>
      <PreferredDefinition>information related to the concomitant medication administered.</PreferredDefinition>
      <LongName>Concomitant Medication Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206481</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25730:C459</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Medication</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25730</PREFERRED_NAME>
            <LONG_NAME>Concomitant</LONG_NAME>
            <CON_ID>2202429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177665</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Administered</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14634418</PublicId>
      <PreferredName>14634418v1.00</PreferredName>
      <PreferredDefinition>A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol&#39;s complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Concomitant Agent Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCTG: Canadian Cancer Trials Group</Origin>
      <Representation>
        <PublicId>14634417</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>14634417v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Agent Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70902</PREFERRED_NAME>
            <LONG_NAME>Concomitant Agent</LONG_NAME>
            <CON_ID>2715024</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oral pain</VALIDVALUE>
          <VALUEMEANING>Oral Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Painful sensation in the mouth, tongue, or lips.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteoporosis</VALIDVALUE>
          <VALUEMEANING>Osteoporosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pain in extremity</VALIDVALUE>
          <VALUEMEANING>Limb Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Painful sensation in the upper or lower extremities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palmar-plantar erythrodysesthesia/hand-foot syndrome</VALIDVALUE>
          <VALUEMEANING>Palmar-Plantar Erythodysthesia</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition characterized by redness, pain, swelling, and tingling in the palms of the hands or the soles of the feet. It may appear as a side effect to chemotherapy agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27177</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palpitations</VALIDVALUE>
          <VALUEMEANING>Palpitation</VALUEMEANING>
          <MEANINGDESCRIPTION>Palpitations; unpleasant sensation of irregular and/or forceful beating of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37999</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatitis</VALIDVALUE>
          <VALUEMEANING>Pancreatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the pancreas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvic pain</VALIDVALUE>
          <VALUEMEANING>Pelvic Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Painful sensation in the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Platelets/thrombocytopenia</VALIDVALUE>
          <VALUEMEANING>Platelet Or Thrombocytopenia</VALUEMEANING>
          <MEANINGDESCRIPTION>An irregular, disc-shaped element in the blood that assists in blood clotting. Platelets are not blood cells, they are fragments of large bone marrow cells called megakaryocytes._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3408, C37998, C12520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pneumonitis</VALIDVALUE>
          <VALUEMEANING>Pneumonitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process affecting the lung parenchyma. It is a milder form of lung inflammation compared to pneumonia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7318722</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pre-treatment prophylaxis</VALIDVALUE>
          <VALUEMEANING>Pre-Therapy Preventive Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring before a therapeutic procedure._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15843, C54734</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pruritus</VALIDVALUE>
          <VALUEMEANING>Pruritus</VALUEMEANING>
          <MEANINGDESCRIPTION>An intense itching sensation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rash</VALIDVALUE>
          <VALUEMEANING>Skin Rash</VALUEMEANING>
          <MEANINGDESCRIPTION>Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdominal distension</VALIDVALUE>
          <VALUEMEANING>Abdominal Distention</VALUEMEANING>
          <MEANINGDESCRIPTION>Swelling of the abdomen resulting from excessive food intake, malnutrition, liver disease, primary abdominal tumors, and tumors metastatic to the abdominal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2943950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectal pain</VALIDVALUE>
          <VALUEMEANING>Rectal Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Pain in the rectal area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acne</VALIDVALUE>
          <VALUEMEANING>Acne</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder of the skin marked by inflammation of oil glands and hair glands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3055811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rhinitis infective</VALIDVALUE>
          <VALUEMEANING>Infectious Rhinitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process affecting the nasal mucosa, usually caused by viruses (e.g., rhinovirus, adenovirus, parainfluenza virus, and coronavirus). It is characterized by chills, headaches, mucopurulent nasal discharge, coughing, and facial pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Agitation</VALIDVALUE>
          <VALUEMEANING>Agitation</VALUEMEANING>
          <MEANINGDESCRIPTION>A state of restlessness associated with unpleasant feelings of irritability and tension. Causes include pain, stress, fever, alcohol and nicotine withdrawal, cocaine and hallucinogenic drugs use, depression, bipolar disorders, and schizophrenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79530</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2943961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sedation</VALIDVALUE>
          <VALUEMEANING>Sedation</VALUEMEANING>
          <MEANINGDESCRIPTION>The process of allaying nervous excitement or the state of being calmed. (Taber&#39;s)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C21097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2751396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allergic reaction/hypersensitivty</VALIDVALUE>
          <VALUEMEANING>Allergies</VALUEMEANING>
          <MEANINGDESCRIPTION>An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3114</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seizure</VALIDVALUE>
          <VALUEMEANING>Seizure</VALUEMEANING>
          <MEANINGDESCRIPTION>Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5026016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sensory neuropathy</VALIDVALUE>
          <VALUEMEANING>Peripheral Sensory Neuropathy</VALUEMEANING>
          <MEANINGDESCRIPTION>functional disturbance or pathological change in the peripheral nervous system; sometimes limited to noninflammatory lesions as opposed to those of neuritis; etiology may be known or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3501</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allergy prophylaxis/seasonal allergy</VALIDVALUE>
          <VALUEMEANING>Allergic Reaction Preventive Intervention Or Seasonal Allergic Rhinitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Allergic rhinitis caused by outdoor allergens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92188, C37998, C15843, C114476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sleep aid</VALIDVALUE>
          <VALUEMEANING>Sleep Assistance</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural and periodic state of rest during which consciousness of the world is suspended._The act of contributing to the fulfillment of a need or furtherance of an effort.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89271, C73425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alopecia</VALIDVALUE>
          <VALUEMEANING>Alopecia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hair loss usually from the scalp. It may result in bald spots or spread to the entire scalp or the entire epidermis. It may be androgenetic or caused by chemotherapeutic agents, compulsive hair pulling, autoimmune disorders or congenital conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50575</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sore throat</VALIDVALUE>
          <VALUEMEANING>Sore Throat</VALUEMEANING>
          <MEANINGDESCRIPTION>Any kind of inflammatory process of the tonsils, pharynx, or/and larynx characterized by pain in swallowing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alternative therapy</VALIDVALUE>
          <VALUEMEANING>Complementary and Alternate medicine</VALUEMEANING>
          <MEANINGDESCRIPTION>Forms of treatment that are used in addition to (complementary) or instead of (alternative) standard treatments. These practices generally are not considered standard medical approaches. Standard treatments go through a long and careful research process to prove they are safe and effective, but less is known about most types of CAM. CAM may include dietary supplements, megadose vitamins, herbal preparations, special teas, acupuncture, massage therapy, magnet therapy, spiritual healing, and meditation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15178</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4163033</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach pain</VALIDVALUE>
          <VALUEMEANING>Stomach Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>A painful sensation in the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78630</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Supplement</VALIDVALUE>
          <VALUEMEANING>Supplement</VALUEMEANING>
          <MEANINGDESCRIPTION>Something added to complete a thing, make up for a deficiency, or extend or strengthen the whole; serving to complete or make an addition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Androgen suppression/LHRH agonist</VALIDVALUE>
          <VALUEMEANING>Androgen Suppression Or Gonadotropin-releasing Hormone Analog</VALUEMEANING>
          <MEANINGDESCRIPTION>Blockage of the production of male hormones._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A synthetic analogue of the endogenous hormone gonadotropin-releasing hormone (GnRH), with potential antineoplastic activity. Upon administration, GnRH analogue mimics endogenous GnRH and strongly binds to and activates pituitary GnRH receptors, which stimulates the synthesis and secretion of the gonadotropic hormones, follicle stimulating hormone (FSH) and luteinizing hormone (LH). Continuous, prolonged activation by the GnRH analogue results in pituitary GnRH receptor desensitization and receptor downregulation. This causes inhibition of pituitary gonadotropin secretion of LH and FSH. In males, the inhibition of LH secretion prevents the production and release of testosterone from Leydig cells in the testes and causes a significant decline in testosterone production that is near the levels seen after castration. This may inhibit androgen receptor-positive tumor progression. In females, this results in a decrease in estradiol production. GnRH, also called luteinizing hormone-releasing hormone (LH-RH), is normally synthesized in and secreted by the hypothalamus. Synthetic analogues of GnRH have a stronger receptor binding affinity than the endogenous form.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1910, C37998, C15676</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Supraventricular arrhythmia</VALIDVALUE>
          <VALUEMEANING>Supraventricular Arrhythmia ECG Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiographic assessment of the atypical cardiac rhythms originating in the atrium, AV node or AV junction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6407016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sweating</VALIDVALUE>
          <VALUEMEANING>Sweating</VALUEMEANING>
          <MEANINGDESCRIPTION>A watery secretion by the sweat glands that is primarily composed of salt, urea and minerals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36172</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anemia/hemoglobin</VALIDVALUE>
          <VALUEMEANING>Anemia Or Hemoglobin</VALUEMEANING>
          <MEANINGDESCRIPTION>A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._The red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the oxygen is readily released and HbO2 becomes Hb.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16676, C37998, C2869</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thrombosis/thrombus/embolism</VALIDVALUE>
          <VALUEMEANING>Thrombosis or Thrombus or Embolism, CTCAE</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C56747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anesthetic</VALIDVALUE>
          <VALUEMEANING>Anesthetic Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>(an-es-THET-iks) Substances that cause loss of feeling or awareness. Local anesthetics cause loss of feeling in a part of the body. General anesthetics put the person to sleep.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C245</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Toothache</VALIDVALUE>
          <VALUEMEANING>Toothache</VALUEMEANING>
          <MEANINGDESCRIPTION>A painful sensation originating from a tooth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angina</VALIDVALUE>
          <VALUEMEANING>Angina</VALUEMEANING>
          <MEANINGDESCRIPTION>A heart condition marked by paroxysms of chest pain due to reduced oxygen to the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor lysis syndrome prophylaxis</VALIDVALUE>
          <VALUEMEANING>Tumor Lysis Syndrome Preventive Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and T cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15843, C3425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anorexia</VALIDVALUE>
          <VALUEMEANING>Anorexia</VALUEMEANING>
          <MEANINGDESCRIPTION>Loss of appetite.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-bacterial</VALIDVALUE>
          <VALUEMEANING>Antibacterial Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>A family of substances capable of destroying or inhibiting the growth of bacteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7848435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor lysis syndrome treatment</VALIDVALUE>
          <VALUEMEANING>Tumor Lysis Syndrome Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and T cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C3425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-coagulant</VALIDVALUE>
          <VALUEMEANING>Anticoagulant Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3191467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor pain</VALIDVALUE>
          <VALUEMEANING>Tumor Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>A painful sensation caused by the tumor growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78656</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-convulsant</VALIDVALUE>
          <VALUEMEANING>Anticonvulsant Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>(an-tee-kon-VUL-sants) Drugs that prevent, reduce, or stop convulsions or seizures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Upper respiratory infection/URTI</VALIDVALUE>
          <VALUEMEANING>Upper Respiratory Tract Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>An infectious process affecting the upper respiratory tract (nose, paranasal sinuses, pharynx, larynx, or trachea). Symptoms include congestion, sneezing, coughing, fever, and sore throat.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-fungal</VALIDVALUE>
          <VALUEMEANING>Antifungal Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>Drugs that treat infections caused by fungi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vaginitis</VALIDVALUE>
          <VALUEMEANING>Vaginitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infectious process affecting the vagina. Symptoms include pain and purulent discharge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26911</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2943897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-inflammatory</VALIDVALUE>
          <VALUEMEANING>Anti-inflammatory</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with reducing inflammation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vomiting prophylaxis</VALIDVALUE>
          <VALUEMEANING>Vomiting Preventive Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>Forceful ejection of the contents of the stomach through the mouth._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15843, C3442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-psychotic</VALIDVALUE>
          <VALUEMEANING>Antipsychotic</VALUEMEANING>
          <MEANINGDESCRIPTION>Also known as neuroleptics, major tranquilizers, or antischizophrenics, natural or synthetic. Antipsychotic Agents relieve and control the symptoms of schizophrenic illness (hallucinations, delusions, dementia). Most antipsychotic agents interfere with various neurotransmitter functions, often blocking dopamine receptors, and induce diverse behavioral, endocrine, motor-kinetic effects. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29710</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-viral</VALIDVALUE>
          <VALUEMEANING>Antiviral Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>Drugs used to treat infections caused by viruses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C281</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3235629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vomiting treatment</VALIDVALUE>
          <VALUEMEANING>Vomiting Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Forceful ejection of the contents of the stomach through the mouth._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C3442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anxiety</VALIDVALUE>
          <VALUEMEANING>Anxiety</VALUEMEANING>
          <MEANINGDESCRIPTION>Apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Watering eye</VALIDVALUE>
          <VALUEMEANING>Excessive Tearing</VALUEMEANING>
          <MEANINGDESCRIPTION>Profuse lacrimation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50552</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4394270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6431768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arrhythmia/dysrhythmia</VALIDVALUE>
          <VALUEMEANING>Arrhythmia Or Irregular Heart Beat</VALUEMEANING>
          <MEANINGDESCRIPTION>Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A clinical finding in which the rhythm of the heart is noted to be abnormal. (ACC/AHA)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168284, C37998, C2881</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arthralgia/joint pain</VALIDVALUE>
          <VALUEMEANING>Arthralgia</VALUEMEANING>
          <MEANINGDESCRIPTION>Pain in a joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arthritis</VALIDVALUE>
          <VALUEMEANING>Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2883</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3292693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asthma</VALIDVALUE>
          <VALUEMEANING>Asthma</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2975594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Atrial fibrillation</VALIDVALUE>
          <VALUEMEANING>Atrial Fibrillation</VALUEMEANING>
          <MEANINGDESCRIPTION>A supraventricular arrhythmia characterized by uncoordinated atrial myocardium activation due to multiple reentry circuits with consequent deterioration of atrial mechanical function. Instead of intermittently contracting, the atria quiver continuously in a chaotic pattern, causing a totally irregular, often tachycardia ventricular rate. On the ECG it is described by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape, and timing, associated with an irregular, frequently rapid ventricular response when atrioventricular conduction is intact.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2760267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autoimmune disorder</VALIDVALUE>
          <VALUEMEANING>Autoimmune Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis). 
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2889</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2585785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Back pain</VALIDVALUE>
          <VALUEMEANING>Back Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Painful sensation in the back region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41830</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone pain</VALIDVALUE>
          <VALUEMEANING>Bone Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Painful sensation in the bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944116</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchospasm</VALIDVALUE>
          <VALUEMEANING>Bronchospasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Sudden contraction of the smooth muscles of the bronchial wall.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardiac prophylaxis</VALIDVALUE>
          <VALUEMEANING>Cardiac Preventive Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15843, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cataract</VALIDVALUE>
          <VALUEMEANING>Cataract</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial or complete opacity of the crystalline lens of one or both eyes that decreases visual acuity and eventually results in blindness.  Some cataracts appear in infancy or in childhood, but most develop in older individuals. (Diagnostic Surgical Pathology, 3rd ed.) --2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2797325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest pain - non-cardiac</VALIDVALUE>
          <VALUEMEANING>Non-Cardiac Chest Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Pain in the chest unrelated to a heart disorder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78504</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest wall pain</VALIDVALUE>
          <VALUEMEANING>Chest Wall Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Painful sensation in the chest wall region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chills</VALIDVALUE>
          <VALUEMEANING>Chills</VALUEMEANING>
          <MEANINGDESCRIPTION>Chills; a sensation of cold that often marks the start of an infection and the development of a fever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2739031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chronic obstructive pulmonary disease/COPD</VALIDVALUE>
          <VALUEMEANING>Chronic Obstructive Pulmonary Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Confusion</VALIDVALUE>
          <VALUEMEANING>Confusion</VALUEMEANING>
          <MEANINGDESCRIPTION>Impaired orientation to person, place or time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37928</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4614753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Constipation prophylaxis</VALIDVALUE>
          <VALUEMEANING>Constipation Preventive Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>Irregular and infrequent or difficult evacuation of the bowels._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15843, C37930</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Constipation treatment</VALIDVALUE>
          <VALUEMEANING>Constipation Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Irregular and infrequent or difficult evacuation of the bowels._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C37930</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cough</VALIDVALUE>
          <VALUEMEANING>Cough</VALUEMEANING>
          <MEANINGDESCRIPTION>A sudden, often repetitive, spasmodic contraction of the thoracic cavity, resulting in violent release of air from the lungs, and usually accompanied by a distinctive sound.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37935</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytokine release syndrome</VALIDVALUE>
          <VALUEMEANING>Cytokine Release Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dehydration prophylaxis</VALIDVALUE>
          <VALUEMEANING>Dehydration Preventive Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15843, C26740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dehydration treatment</VALIDVALUE>
          <VALUEMEANING>Dehydration Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C26740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Depression</VALIDVALUE>
          <VALUEMEANING>Depression</VALUEMEANING>
          <MEANINGDESCRIPTION>Depression; a mental state of depressed mood characterised by feelings of sadness, despair and discouragement. (On-line Medical Dictionary)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2982</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diabetes</VALIDVALUE>
          <VALUEMEANING>Diabetes Mellitus</VALUEMEANING>
          <MEANINGDESCRIPTION>A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3292684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diarrhea prophylaxis</VALIDVALUE>
          <VALUEMEANING>Diarrhea Preventive Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>Watery bowel movements._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15843, C2987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diarrhea treatment</VALIDVALUE>
          <VALUEMEANING>Diarrhea Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Watery bowel movements._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C2987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diuretic</VALIDVALUE>
          <VALUEMEANING>Diuretic</VALUEMEANING>
          <MEANINGDESCRIPTION>A class of agents that increases the production of urine by the kidney. Via various mechanism of actions, diuretics retain water in urine, thus provides a means of forced diuresis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C448</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6422927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dizziness</VALIDVALUE>
          <VALUEMEANING>Lightheadedness or Dizziness</VALUEMEANING>
          <MEANINGDESCRIPTION>A sensation of lightheadedness, unsteadiness, turning, spinning or rocking.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37943</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10134618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dry eye</VALIDVALUE>
          <VALUEMEANING>Dry Eye Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A syndrome characterized by dryness of the cornea and conjunctiva. It is usually caused by a deficiency in tear production. Symptoms include a feeling of burning eyes and a possible foreign body presence in the eye.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944487</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dry mouth</VALIDVALUE>
          <VALUEMEANING>Xerostomia</VALUEMEANING>
          <MEANINGDESCRIPTION>An oral condition in which salivary flow is reduced. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26917</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dry skin</VALIDVALUE>
          <VALUEMEANING>Dry Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>The pores are generally fine with a papery thin texture that feels dry to the touch. Usually flaky and dull looking.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74592</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2919162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dyspepsia/heartburn/acid reflux/GERD</VALIDVALUE>
          <VALUEMEANING>Dyspepsia Heartburn Have Acid Reflux Or Gastroesophageal Reflux Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach pain, bloating, heartburn, nausea, and vomiting. Causes include gastritis, gastric ulcer, gastroesophageal reflux disease, pancreatic disease, and gallbladder disease._Abdominal discomfort with retrosternal pain usually associated with gastroesophageal reflux._A question about whether an individual has or had acid reflux._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26781, C37998, C116988, C34670, C26756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dyspnea</VALIDVALUE>
          <VALUEMEANING>Dyspnea</VALUEMEANING>
          <MEANINGDESCRIPTION>Difficult, painful breathing or shortness of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ear pain/earache</VALIDVALUE>
          <VALUEMEANING>Earache</VALUEMEANING>
          <MEANINGDESCRIPTION>Earache; a pain localized in the middle or inner ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Edema</VALIDVALUE>
          <VALUEMEANING>Edema</VALUEMEANING>
          <MEANINGDESCRIPTION>Accumulation of an excessive amount of watery fluid in cells or intercellular tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3637928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Erectile dysfunction</VALIDVALUE>
          <VALUEMEANING>Impotence</VALUEMEANING>
          <MEANINGDESCRIPTION>Persistent or recurrent inability to achieve or to maintain an erection during sexual activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3133</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5092377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fatigue</VALIDVALUE>
          <VALUEMEANING>Fatigue</VALUEMEANING>
          <MEANINGDESCRIPTION>Overall tiredness and lack of energy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3036</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Febrile neutropenia prophylaxis</VALIDVALUE>
          <VALUEMEANING>Febrile Neutropenia Preventive Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>Neutropenia associated with fever, the latter indicating the presence of an infection._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15843, C35665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Febrile neutropenia treatment</VALIDVALUE>
          <VALUEMEANING>Febrile Neutropenia Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Neutropenia associated with fever, the latter indicating the presence of an infection._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C35665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fever</VALIDVALUE>
          <VALUEMEANING>Fever &gt;100.4 F</VALUEMEANING>
          <MEANINGDESCRIPTION>Elevation of body temperature above normal due to inflammatory or immune responses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3038</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10134616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flu-like symptoms</VALIDVALUE>
          <VALUEMEANING>Flu-Like Symptoms</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of symptoms similar to those observed in patients with the flu. It includes fever, chills, body aches, malaise, loss of appetite, and dry cough. Flu-like symptoms are observed in patients infected with various viruses, including hepatitis virus and HIV (initial phase), and with malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78302</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastritis</VALIDVALUE>
          <VALUEMEANING>Gastritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the lining of the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2746385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>General health/wellbeing</VALIDVALUE>
          <VALUEMEANING>Health Status Or Overall Well-Being</VALUEMEANING>
          <MEANINGDESCRIPTION>The state of a subject&#39;s mental or physical condition._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A question about an individual&#39;s overall well-being.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107400, C37998, C16669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GI/abdominal pain</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Pain Or Abdominal Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Painful sensation in the gastrointestinal region._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Painful sensation in the abdominal region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26682, C37998, C78320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glaucoma</VALIDVALUE>
          <VALUEMEANING>Glaucoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26782</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395747</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head pain/headache</VALIDVALUE>
          <VALUEMEANING>Hurt or Pain Other Than Headache Or Headache</VALUEMEANING>
          <MEANINGDESCRIPTION>A question about whether an individual has or had pain other than headache._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Pain in various parts of the head, not confined to the area of distribution of any nerve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34661, C37998, C156111</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heart failure</VALIDVALUE>
          <VALUEMEANING>Heart Failure</VALUEMEANING>
          <MEANINGDESCRIPTION>Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50577</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4827929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemorrhage</VALIDVALUE>
          <VALUEMEANING>Hemorrhage</VALUEMEANING>
          <MEANINGDESCRIPTION>Bleeding or escape of blood from a vessel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemorrhoids</VALIDVALUE>
          <VALUEMEANING>Hemorrhoid</VALUEMEANING>
          <MEANINGDESCRIPTION>Dilated veins in the rectum and anal area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26792</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945730</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hormone replacement</VALIDVALUE>
          <VALUEMEANING>Hormone Replacement Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>RAEB: Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hot flashes</VALIDVALUE>
          <VALUEMEANING>Hot Flashes</VALUEMEANING>
          <MEANINGDESCRIPTION>A sudden, temporary onset of body warmth, flushing, and sweating (often associated with menopause).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3109</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2751385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypercholesterolemia/high cholesterol</VALIDVALUE>
          <VALUEMEANING>Hypercholesterolemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypercholesterolemia; the presence of an abnormal amount of cholesterol in the cells and plasma of the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2751387</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperlipidemia/high lipids</VALIDVALUE>
          <VALUEMEANING>Hyperlipidemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An excess of lipids in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34707</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2751390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperpigmentation</VALIDVALUE>
          <VALUEMEANING>Skin Hyperpigmentation</VALUEMEANING>
          <MEANINGDESCRIPTION>Darkening of the skin due to excessive melanin deposition. Causes include skin injuries, pregnancy, eczema, and Addison disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79731</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypertension</VALIDVALUE>
          <VALUEMEANING>Hypertension</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormally high blood pressure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3117</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperthyroidism</VALIDVALUE>
          <VALUEMEANING>Hyperthyroidism</VALUEMEANING>
          <MEANINGDESCRIPTION>Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves&#39; disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3123</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperuricemia/high uric acid/gout</VALIDVALUE>
          <VALUEMEANING>Hyperuricemia Increased Uric Acid Level Or Gout</VALUEMEANING>
          <MEANINGDESCRIPTION>Elevated blood concentrations of uric acid._A laboratory test result indicating abnormally high concentration of uric acid in the blood._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34650, C37998, C35105, C3961</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypokalemia/low potassium</VALIDVALUE>
          <VALUEMEANING>Hypokalemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypokalemia; lower than normal levels of potassium in the circulating blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2751400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypomagnesemia/low magnesium</VALIDVALUE>
          <VALUEMEANING>Hypomagnesemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypermagnesemia; lower than normal levels of magnesium in the circulating blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2751401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypopigmentation</VALIDVALUE>
          <VALUEMEANING>Skin Hypopigmentation</VALUEMEANING>
          <MEANINGDESCRIPTION>Loss of skin pigment. Vitiligo, albinism, and leukoderma are among the disorders that are associated with skin hypopigmentation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypotension</VALIDVALUE>
          <VALUEMEANING>Hypotension</VALUEMEANING>
          <MEANINGDESCRIPTION>Blood pressure that is abnormally low.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3128</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypothyroidism</VALIDVALUE>
          <VALUEMEANING>Hypothyroidism</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which the production of thyroid hormone by the thyroid gland is diminished. Signs and symptoms of hypothyroidism include low metabolic rate, tendency to weight gain, somnolence and sometimes myxedema. In the United States, the most common cause of hypothyroidism is Hashimoto&#39;s thyroiditis, an autoimmune disorder. SYN athyrea. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562672</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Incontinence</VALIDVALUE>
          <VALUEMEANING>Incontinence</VALUEMEANING>
          <MEANINGDESCRIPTION>Inability to control the flow of urine from the bladder (urinary incontinence) or the escape of stool from the rectum (fecal incontinence).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4394559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infection prophylaxis</VALIDVALUE>
          <VALUEMEANING>Infection Preventive Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15843, C128320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infection treatment</VALIDVALUE>
          <VALUEMEANING>Infection Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C128320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Injection site reaction</VALIDVALUE>
          <VALUEMEANING>Injection Site Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>An intense reaction (usually immunologic) developing at the site of injection</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2751404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insomnia</VALIDVALUE>
          <VALUEMEANING>Insomnia</VALUEMEANING>
          <MEANINGDESCRIPTION>Difficulty in going to sleep or getting enough sleep.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2751405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Keratitis</VALIDVALUE>
          <VALUEMEANING>Keratitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the cornea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26805</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Motor neuropathy</VALIDVALUE>
          <VALUEMEANING>Peripheral Motor Neuropathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation or degeneration of the peripheral motor nerves. - 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946009</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucositis prophylaxis</VALIDVALUE>
          <VALUEMEANING>Mucositis Preventive Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the mucous membranes._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15843, C115965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucositis treatment</VALIDVALUE>
          <VALUEMEANING>Mucositis Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the mucous membranes._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C115965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Muscle weakness</VALIDVALUE>
          <VALUEMEANING>Muscle Weakness</VALUEMEANING>
          <MEANINGDESCRIPTION>A reduction in the strength of one or more muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4394508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myalgia/muscle pain</VALIDVALUE>
          <VALUEMEANING>Myalgia</VALUEMEANING>
          <MEANINGDESCRIPTION>Painful sensation originating from a muscle or group of muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27009</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal congestion</VALIDVALUE>
          <VALUEMEANING>Nasal Congestion</VALUEMEANING>
          <MEANINGDESCRIPTION>The blockage of the nasal passage due to mucosal edema. It is usually the result of a viral infection or an allergic reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78500</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nausea prophylaxis</VALIDVALUE>
          <VALUEMEANING>Nausea Preventive Intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>Upper abdominal discomfort associated with an urge to vomit._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15843, C3258</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nausea treatment</VALIDVALUE>
          <VALUEMEANING>Nausea Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Upper abdominal discomfort associated with an urge to vomit._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C3258</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14634883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neck pain</VALIDVALUE>
          <VALUEMEANING>Neck Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Painful sensation in the neck area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50663</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945778</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuralgia/nerve pain</VALIDVALUE>
          <VALUEMEANING>Neuralgia</VALUEMEANING>
          <MEANINGDESCRIPTION>Intense painful sensation along a nerve or group of nerves. It is caused by irritation or trauma to a nerve or inflammation of a nerve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79695</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945774</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Obstruction</VALIDVALUE>
          <VALUEMEANING>Obstruction</VALUEMEANING>
          <MEANINGDESCRIPTION>Blockage of a passageway.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3284</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4394905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest pain - cardiac</VALIDVALUE>
          <VALUEMEANING>Cardiac Chest Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart._Pain in the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38665, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14635865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Appetite stimulant</VALIDVALUE>
          <VALUEMEANING>Appetite stimulant</VALUEMEANING>
          <MEANINGDESCRIPTION>Appetite stimulant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-11-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14635866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the reason the concomitant medication was administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Indication</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CM_CMINDC</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="977">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14651962</PUBLICID>
    <LONGNAME>Healthcare Encounter Site of Care Delivery Identifier Data Source Data Value Identifier</LONGNAME>
    <PREFERREDNAME>14635914v1.00:14961549v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Interactions between patients and providers within the context of healthcare delivery.:Any place at which medical services are rendered.  It includes traditional locations such as hospitals, clinics, and nursing homes as well as less traditional sites such as schools, supermarkets, and worksites._The person or authoritative body who provided the information._The information contained in a data field. It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14635914</PublicId>
      <PreferredName>14596371v1.00:14741319v1.00</PreferredName>
      <PreferredDefinition>Interactions between patients and providers within the context of healthcare delivery.:Any place at which medical services are rendered.  It includes traditional locations such as hospitals, clinics, and nursing homes as well as less traditional sites such as schools, supermarkets, and worksites._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._The person or authoritative body who provided the information._The information contained in a data field. It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute.</PreferredDefinition>
      <LongName>Healthcare Encounter Site of Care Delivery Identifier Data Source Data Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14596371</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C154624</PreferredName>
        <Version>1</Version>
        <LongName>Healthcare Encounter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C154624</PREFERRED_NAME>
            <LONG_NAME>Healthcare Encounter</LONG_NAME>
            <CON_ID>6424582</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14741319</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19696:C25364:C16493:C49100</PreferredName>
        <Version>1</Version>
        <LongName>Site of Care Delivery Identifier Data Source Data Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19696</PREFERRED_NAME>
            <LONG_NAME>Site of Care Delivery</LONG_NAME>
            <CON_ID>10056487</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16493</PREFERRED_NAME>
            <LONG_NAME>Data Source</LONG_NAME>
            <CON_ID>2223421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49100</PREFERRED_NAME>
            <LONG_NAME>Data Value</LONG_NAME>
            <CON_ID>2463853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14961549</PublicId>
      <PreferredName>14961549v1.00</PreferredName>
      <PreferredDefinition>One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>SAS Char</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Raw Site Identifier</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14522553</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PCORnet CDM 6.1</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Encounter</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>14522558</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RAW_SITEID</AlternateName>
        <AlternateNameType>PCORNet Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENCOUNTER</AlternateName>
        <AlternateNameType>PCORnet Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="978">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14670399</PUBLICID>
    <LONGNAME>Biospecimen Quantity Float</LONGNAME>
    <PREFERREDNAME>14670323v1.00:14670375v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:The act of gathering things together; having been brought together in one place._How much there is of something that you can measure; the total amount or number.:Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._Occurring or operating at the same time._How much there is of something that you can measure; the total amount or number._A numerical quantity measured or assigned or computed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>OMOP CDM:The Observational Medical Outcomes Partnership (OMOP) Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14670323</PublicId>
      <PreferredName>2859635v1.00:2440114v1.00</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:How much there is of something that you can measure; the total amount or number.</PreferredDefinition>
      <LongName>Biospecimen Quantity</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2440114</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25256</PreferredName>
        <Version>1</Version>
        <LongName>Quantity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14670375</PublicId>
      <PreferredName>14670375v1.00</PreferredName>
      <PreferredDefinition>A number that can have its decimal point in any position.</PreferredDefinition>
      <LongName>Float</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>Floating-point</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2433735</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48150</PreferredName>
        <Version>1</Version>
        <LongName>Float</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48150</PREFERRED_NAME>
            <LONG_NAME>Float</LONG_NAME>
            <CON_ID>2433734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Quantity</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>userGuidance</Name>
        <DocumentType>OMOP CDM User Guidance</DocumentType>
        <DocumentText>The amount of specimen collected from the person.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14522466</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>OMOP 5.4</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Specimen</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>14522486</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>quantity</AlternateName>
        <AlternateNameType>OMOP Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SPECIMEN</AlternateName>
        <AlternateNameType>OMOP Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="979">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14735825</PUBLICID>
    <LONGNAME>Person Radiology Report Available Indicator</LONGNAME>
    <PREFERREDNAME>14735819v1.00:3506034v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>A response to indicate whether or not any radiology reports are available for an individual.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CRDC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CTDC:Clinical Trial Data Commons</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14735819</PublicId>
      <PreferredName>2236731v1.00:14735818v1.00</PreferredName>
      <PreferredDefinition>A human being.:The branch of medical science dealing with the medical use of X-rays or other penetrating radiation._A short textual account; having provided a short account._The quality of being obtainable or accessible and ready for use or service.</PreferredDefinition>
      <LongName>Person Radiology Report Available</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CRDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14735818</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17059:C25375:C25429</PreferredName>
        <Version>1</Version>
        <LongName>Radiology Report Availability</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17059</PREFERRED_NAME>
            <LONG_NAME>Radiology</LONG_NAME>
            <CON_ID>2202795</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25429</PREFERRED_NAME>
            <LONG_NAME>Availability</LONG_NAME>
            <CON_ID>2204038</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CTDC:Clinical Trial Data Commons</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Radiology Report Available</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTDC Model</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14413707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14413709</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>radiology_report_available</AlternateName>
        <AlternateNameType>CTDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="980">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14741968</PUBLICID>
    <LONGNAME>Adverse Event Domain Vascular Injury Resolution Method Type</LONGNAME>
    <PREFERREDNAME>AE_AEACN_METHOD</PREFERREDNAME>
    <PREFERREDDEFINITION>The response to indicate the type of method used for the resolution of the vascular injury.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14741967</PublicId>
      <PreferredName>2514626v1.00:14758285v1.00</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to an adverse event.:Relating to or containing blood vessels._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity._The size of the smallest element that can be separated from neighboring elements._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.</PreferredDefinition>
      <LongName>Adverse Event Domain Vascular Injury Resolution Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2514626</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49562</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Submission Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49562</PREFERRED_NAME>
            <LONG_NAME>Adverse Event Domain</LONG_NAME>
            <CON_ID>2469047</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14758285</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13311:C3671:C47876:C71460</PreferredName>
        <Version>1</Version>
        <LongName>Vascular Injury Resolution Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13311</PREFERRED_NAME>
            <LONG_NAME>Vascular</LONG_NAME>
            <CON_ID>2202503</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3671</PREFERRED_NAME>
            <LONG_NAME>Injury</LONG_NAME>
            <CON_ID>2202560</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47876</PREFERRED_NAME>
            <LONG_NAME>Resolution</LONG_NAME>
            <CON_ID>2669351</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14741962</PublicId>
      <PreferredName>14741962v1.00</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reconstruction</VALIDVALUE>
          <VALUEMEANING>Reconstructive Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgical restoration of function or form of a part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5806828</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suture repair</VALIDVALUE>
          <VALUEMEANING>Repair Suture Device Component</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of returning something to working order.: A natural (e.g., catgut, silk, or linen) or synthetic, or other (e.g., thin metal wire) monofilament or multifilament material used surgically to close a surgical or accidental wound and to secure apposition of the edges and join tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50365, C53611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5806830</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ligation</VALIDVALUE>
          <VALUEMEANING>Ligation</VALUEMEANING>
          <MEANINGDESCRIPTION>(lye-GAY-shun) The process of tying off blood vessels so that blood cannot flow to a part of the body or to a tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2837978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Vascular injury resolution method</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of resolution of vascular injury</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_AEACN_VASCMETHOD</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="981">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14947826</PUBLICID>
    <LONGNAME>Antibody-Drug Conjugate Prior Exposure Indicator</LONGNAME>
    <PREFERREDNAME>14947825v1.00:3506035v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator that answers the question as to whether the patient has had prior exposure to a tumor-targeting antibody conjugated to a cytotoxic agent.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14947825</PublicId>
      <PreferredName>14947824v1.00:3876243v1.00</PreferredName>
      <PreferredDefinition>Any tumor-targeting antibody conjugated to a cytotoxic agent that exerts an antineoplastic effect.:Earlier in time or order._The act of subjecting someone or something to an influencing experience.</PreferredDefinition>
      <LongName>Antineoplastic Antibody-Drug Conjugate Prior Exposure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14947824</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C129823</PreferredName>
        <Version>1</Version>
        <LongName>Antineoplastic Antibody-Drug Conjugate</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C129823</PREFERRED_NAME>
            <LONG_NAME>Antineoplastic Antibody-Drug Conjugate</LONG_NAME>
            <CON_ID>10018844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3876243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C17941</PreferredName>
        <Version>1</Version>
        <LongName>Prior Exposure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17941</PREFERRED_NAME>
            <LONG_NAME>Exposure</LONG_NAME>
            <CON_ID>2203924</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Prior exposure to enfortumab vedotin</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="982">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14981870</PUBLICID>
    <LONGNAME>Specimen Percent of Tumor Cells Value</LONGNAME>
    <PREFERREDNAME>14959192v1.00:3376344v2.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value that represents the percent of tumor cells in a specimen compared to total cells.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CIP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>TCIA:TheCancerImagingArchive</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14959192</PublicId>
      <PreferredName>2859635v1.00:14981869v1.00</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:A quantitative measurement of the percent of tumor cells compared to the number of total cells present in a sample.</PreferredDefinition>
      <LongName>Specimen Percent of Tumor Cells</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14981869</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C159484</PreferredName>
        <Version>1</Version>
        <LongName>Percent of Tumor Cells</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159484</PREFERRED_NAME>
            <LONG_NAME>Percent of Tumor Cells</LONG_NAME>
            <CON_ID>7058690</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>TCIA:TheCancerImagingArchive</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3376344</PublicId>
      <PreferredName>3376344v2.00</PreferredName>
      <PreferredDefinition>A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Value</LongName>
      <Version>2</Version>
      <WorkflowStatus>DRAFT MOD</WorkflowStatus>
      <ContextName>SWOG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Percent of Tumor Cells</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6305258</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TCIA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AURORA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943540</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>10429357</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GDC (Genomic Data Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Candidate New GDC CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14506028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15103644</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>15103644v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Specimen</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15105458</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>Percent Tumor Cells</AlternateName>
        <AlternateNameType>TCIA Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>percent_tumor_cells</AlternateName>
        <AlternateNameType>CRDC Model Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>GDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>percent_tumor_cells</AlternateName>
        <AlternateNameType>GDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="983">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14986456</PUBLICID>
    <LONGNAME>Person Overall Survival Censored Data Month Count</LONGNAME>
    <PREFERREDNAME>14986455v1.00:7801056v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The total number of months of the overall survival of the person involved in the investigation or research study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CIP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>TCIA:TheCancerImagingArchive</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14986455</PublicId>
      <PreferredName>2236731v1.00:14986454v1.00</PreferredName>
      <PreferredDefinition>A human being.:A measure of the time until death from any cause._Points of data for which only partial information is known._One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</PreferredDefinition>
      <LongName>Person Overall Survival Censored Data Month</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14986454</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C125201:C207035:C29846</PreferredName>
        <Version>1</Version>
        <LongName>Overall Survival Censored Data Month</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125201</PREFERRED_NAME>
            <LONG_NAME>Overall Survival</LONG_NAME>
            <CON_ID>5914511</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C207035</PREFERRED_NAME>
            <LONG_NAME>Censored Data</LONG_NAME>
            <CON_ID>14986420</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>TCIA:TheCancerImagingArchive</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7801056</PublicId>
      <PreferredName>7801056v1.0</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>HTAN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>OS Months Censor 180 Months</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6305258</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TCIA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AURORA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943540</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>OS months censor 180 months</AlternateName>
        <AlternateNameType>TCIA Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="984">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15004658</PUBLICID>
    <LONGNAME>Laboratory Procedure Unit of Measure Data Source Data Value OMOP Concept Identifier</LONGNAME>
    <PREFERREDNAME>15003578v1.00:14986466v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds._The person or authoritative body who provided the information._A character or string that represents the information contained in a data field.:An identifier assigned to an external vocabulary item when it has been transformed into the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). It is an integer ID that is used to record data in the CDM event tables._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>OMOP CDM:The Observational Medical Outcomes Partnership (OMOP) Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15003578</PublicId>
      <PreferredName>2543047v1.00:14842090v1.00</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds._The person or authoritative body who provided the information._A character or string that represents the information contained in a data field.</PreferredDefinition>
      <LongName>Laboratory Procedure Unit of Measure Data Source Data Value Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008558</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>UOM</PreferredName>
        <Version>1</Version>
        <LongName>Units of Measure</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14842090</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25709:C16493:C117373</PreferredName>
        <Version>1</Version>
        <LongName>Unit of Measure Data Source Data Value Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25709</PREFERRED_NAME>
            <LONG_NAME>Unit of Measure</LONG_NAME>
            <CON_ID>2203864</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16493</PREFERRED_NAME>
            <LONG_NAME>Data Source</LONG_NAME>
            <CON_ID>2223421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117373</PREFERRED_NAME>
            <LONG_NAME>Data Value Code</LONG_NAME>
            <CON_ID>10012763</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14986466</PublicId>
      <PreferredName>14986466v1.00</PreferredName>
      <PreferredDefinition>An identifier assigned to an external vocabulary item when it has been transformed into the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). It is an integer ID that is used to record data in the CDM event tables._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>OMOP Concept Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>14986465</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>14986465v1.00</PreferredName>
        <Version>1</Version>
        <LongName>OMOP Concept Identifier Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C205058</PREFERRED_NAME>
            <LONG_NAME>OMOP Concept Identifier</LONG_NAME>
            <CON_ID>14931547</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Unit Source Concept Identifier</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Unit Source Concept Identifier</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>userGuidance</Name>
        <DocumentType>OMOP CDM User Guidance</DocumentType>
        <DocumentText>&quot;This is the concept representing the UNIT_SOURCE_VALUE and may not necessarily be standard. This field is discouraged from use in analysis because it is not required to contain Standard Concepts that are used across the OHDSI community, and should only be used when Standard Concepts do not adequately represent the source detail for the Measurement necessary for a given analytic use case. Consider using UNIT_CONCEPT_ID instead to enable standardized analytics that can be consistent across the network.&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>etlConventions</Name>
        <DocumentType>OMOP CDM ETL Conventions</DocumentType>
        <DocumentText>If the UNIT_SOURCE_VALUE is coded in the source data using an OMOP supported vocabulary put the concept id representing the source value here.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14522466</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>OMOP 5.4</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Measurement</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>14522478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MEASUREMENT</AlternateName>
        <AlternateNameType>OMOP Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>unit_source_concept_id</AlternateName>
        <AlternateNameType>OMOP Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="985">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15089947</PUBLICID>
    <LONGNAME>SPARK Current Education Level Type</LONGNAME>
    <PREFERREDNAME>SPARK_CUR_EDUC_LVL_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of an person&#39;s current educational level.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>SPARK: Screening for Poverty and Related Social Determinants and Intervening to Improve Knowledge Links to Resources. Adekoya, I., Delahunty-Pike, A., Howse, D. et al. BMC Prim. Care 24, 247 (2023)</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15089886</PublicId>
      <PreferredName>15088322v1.00:15089885v1.00</PreferredName>
      <PreferredDefinition>A standardized tool for the collection of robust social determinants of health.:Occurring in or belonging to the present time._An indication of the years of schooling completed in graded public, private, or parochial schools, and in colleges, universities, or professional schools.</PreferredDefinition>
      <LongName>Screening for Poverty And Related Social Determinants and Intervening to Improve Knowledge of and Links to Resources Tool Current Education Level</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>15088322</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C210023</PreferredName>
        <Version>1</Version>
        <LongName>Screening for Poverty And Related Social Determinants and Intervening to Improve Knowledge of and Links to Resources Tool</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C210023</PREFERRED_NAME>
            <LONG_NAME>Screening for Poverty And Related Social Determinants and Intervening to Improve Knowledge of and Links to Resources Tool</LONG_NAME>
            <CON_ID>15082867</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15089885</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25471:C17953</PreferredName>
        <Version>1</Version>
        <LongName>Current Education Level</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17953</PREFERRED_NAME>
            <LONG_NAME>Education Level</LONG_NAME>
            <CON_ID>2202380</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>SPARK: Screening for Poverty and Related Social Determinants and Intervening to Improve Knowledge Links to Resources. Adekoya, I., Delahunty-Pike, A., Howse, D. et al. BMC Prim. Care 24, 247 (2023)</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15088354</PublicId>
      <PreferredName>15088354v1.00</PreferredName>
      <PreferredDefinition>An indication of the years of schooling completed in graded public, private, or parochial schools, and in colleges, universities, or professional schools._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Education Level Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>150</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCTG: Canadian Cancer Trials Group</Origin>
      <Representation>
        <PublicId>2435358</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17953:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Education Level Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17953</PREFERRED_NAME>
            <LONG_NAME>Education Level</LONG_NAME>
            <CON_ID>2202380</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prefer not to answer</VALIDVALUE>
          <VALUEMEANING>Prefer Not to Answer</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual prefers or preferred not to answer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5684650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Do not know</VALIDVALUE>
          <VALUEMEANING>Don&#39;t Know</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Postgraduate degree or professional designation (e.g. Master&#39;s, PhD, MD)</VALIDVALUE>
          <VALUEMEANING>Postgraduate Academic Degree Or Professional Occupation Identifier</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, relating to, happening, or engaged in studies beyond a bachelor&#39;s degree._An award conferred by a college, university, or other postsecondary education institution as official recognition for the successful completion of a program of studies._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._An occupation requiring special education, especially in the liberal arts or sciences._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25364, C75558, C37998, C25354, C89835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15088360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Undergraduate degree or some university</VALIDVALUE>
          <VALUEMEANING>College Completion Or Some College Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has attended college and receive a degree._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Indicates that a person has attended college but that they did not receive any degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67137, C37998, C159746</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15088359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>College, CEGEP or other non-university certificate or diploma (or ongoing)</VALIDVALUE>
          <VALUEMEANING>College Completion Or Negation University Diploma</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has attended college and receive a degree._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._An operation in which a term denies or inverts the meaning of another term or construction._A large and diverse institution of higher learning created to educate for life and for a profession and to grant degrees; an establishment where a seat of higher learning is housed, including administrative and living quarters as well as facilities for research and teaching; the body of faculty and students at a university._A document certifying the successful completion of a course of study.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71335, C48647, C25594, C37998, C159746</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15088358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Completed Registered Apprenticeship or other trades certificate or diploma (or ongoing)</VALIDVALUE>
          <VALUEMEANING>Technical School Attendance</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has attended technical school.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C179907</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15088357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High school or high school equivalency certificate (grade 9-12)</VALIDVALUE>
          <VALUEMEANING>High School Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has attended high school and has received a high school diploma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67136</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2733232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some high school, but did not graduate</VALIDVALUE>
          <VALUEMEANING>Not High School Graduate</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a person has attended high school but did not complete high school and did not receive a high school diploma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C76123</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2947076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grade school (grade 1-8)</VALIDVALUE>
          <VALUEMEANING>Grade School</VALUEMEANING>
          <MEANINGDESCRIPTION>A school for young children; usually the first 6 or 8 grades.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2936655</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No formal schooling</VALIDVALUE>
          <VALUEMEANING>No Formal Schooling</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has never attended an educational program or formal schooling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2936661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is your current level of education?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is your current level of education?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_SDOH6</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="986">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15101789</PUBLICID>
    <LONGNAME>Health Status Assessments FASE-P How Confident Able to Prepare to Go to a Restaurant Score 11 Point Scale</LONGNAME>
    <PREFERREDNAME>FASEP_RSNT_OUTNG_11PT_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person’s stated observation of how confident they are able to prepare to go to a restaurant, using an 11-point linear scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FASE-P: Food Allergy Self-Efficacy Scale for Parents, Knibb RC, Barnes C, et al., Parental confidence in managing food allergy: dev and  valid of the Food Allergy Self-Efficacy Scale for Parents (FASE-P). Clin Exp Allergy, 2015</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15101319</PublicId>
      <PreferredName>14936166v1.00:15101318v1.00</PreferredName>
      <PreferredDefinition>Assessments of health-related matters of interest, importance, or worry to a patient, patient&#39;s family, or patient&#39;s healthcare provider that could identify a need, problem, or condition.:A questionnaire design to measure parental confidence (self-efficacy) in managing food allergies in their child._A question about how confident an individual is about something._A question about whether an individual is or will be able to prepare to go to a restaurant._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Health Status Assessment Food Allergy Self-Efficacy Scale for Parents How Confident Able to Prepare to Go to a Restaurant Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14936166</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C205784</PreferredName>
        <Version>1</Version>
        <LongName>Health Status Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C205784</PREFERRED_NAME>
            <LONG_NAME>Health Status Assessment</LONG_NAME>
            <CON_ID>14920961</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15101318</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15101318v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Food Allergy Self-Efficacy Scale for Parents How Confident Able to Prepare to Go to a Restaurant Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C210155</PREFERRED_NAME>
            <LONG_NAME>Food Allergy Self-Efficacy Scale for Parents</LONG_NAME>
            <CON_ID>15098743</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C210156</PREFERRED_NAME>
            <LONG_NAME>How Confident Question</LONG_NAME>
            <CON_ID>15098744</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C210238</PREFERRED_NAME>
            <LONG_NAME>Able to Prepare to Go to a Restaurant Question</LONG_NAME>
            <CON_ID>15098760</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>FASE-P: Food Allergy Self-Efficacy Scale for Parents, Knibb RC, Barnes C, et al., Parental confidence in managing food allergy: dev and  valid of the Food Allergy Self-Efficacy Scale for Parents (FASE-P). Clin Exp Allergy, 2015</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15099245</PublicId>
      <PreferredName>FASEP_11PT_SCL</PreferredName>
      <PreferredDefinition>A questionnaire design to measure parental confidence (self-efficacy) in managing food allergies in their child._An ordered reference standard used to measure incremental changes with ranges from 0 (Cannot do at all) to 100 (Highly certain can do).</PreferredDefinition>
      <LongName>FASE-P 11 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>Integer</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>FASE-P: Food Allergy Self-Efficacy Scale for Parents, Knibb RC, Barnes C, et al., Parental confidence in managing food allergy: dev and  valid of the Food Allergy Self-Efficacy Scale for Parents (FASE-P). Clin Exp Allergy, 2015</Origin>
      <Representation>
        <PublicId>15099244</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15099244v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Food Allergy Self-Efficacy Scale for Parents Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C210155</PREFERRED_NAME>
            <LONG_NAME>Food Allergy Self-Efficacy Scale for Parents</LONG_NAME>
            <CON_ID>15098743</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>90</VALIDVALUE>
          <VALUEMEANING>Ability Score 90</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 90 on an ability scale that goes from 0: Cannot do at all to 100: Highly certain can do.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210255</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15100784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>80</VALIDVALUE>
          <VALUEMEANING>Ability Score 80</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 80 on an ability scale that goes from 0: Cannot do at all to 100: Highly certain can do.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210254</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15100783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>70</VALIDVALUE>
          <VALUEMEANING>Ability Score 70</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 70 on an ability scale that goes from 0: Cannot do at all to 100: Highly certain can do.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15100782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>60</VALIDVALUE>
          <VALUEMEANING>Ability Score 60</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 60 on an ability scale that goes from 0: Cannot do at all to 100: Highly certain can do.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210252</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15100781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>50</VALIDVALUE>
          <VALUEMEANING>Ability Score 50</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 50 on an ability scale that goes from 0: Cannot do at all to 100: Highly certain can do.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210251</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15100780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>40</VALIDVALUE>
          <VALUEMEANING>Ability Score 40</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 40 on an ability scale that goes from 0: Cannot do at all to 100: Highly certain can do.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15100779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>Ability Score 30</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 30 on an ability scale that goes from 0: Cannot do at all to 100: Highly certain can do.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210249</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15100778</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>Ability Score 20</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 20 on an ability scale that goes from 0: Cannot do at all to 100: Highly certain can do.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210248</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15100777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>Ability Score 10</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 10 on an ability scale that goes from 0: Cannot do at all to 100: Highly certain can do.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15100776</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Ability Score 0</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 0 on an ability scale that goes from 0: Cannot do at all to 100: Highly certain can do.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15100775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>100</VALIDVALUE>
          <VALUEMEANING>Ability Score 100</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 100 on an ability scale that goes from 0: Cannot do at all to 100: Highly certain can do.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C210256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15100785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I am confident that I will be able to prepare to go to a restaurant</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I am confident that I will be able to prepare to go to a restaurant</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FASE-P</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question 16 of 21</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions. Questions used in this manner do not represent the original measure and should not be referenced by the measure’s name.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>2</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>3</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prepare to go to a restaurant</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Food Allergy Self-Efficacy Scale for Parents (FASE-P)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15175015</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15099037</PublicId>
          <ContextName>NIAID</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>15099037v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Food Allergy Self-Efficacy Scale for Parents (FASE-P)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15100794</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="987">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15115501</PUBLICID>
    <LONGNAME>Specimen Percent of Monocytes Value</LONGNAME>
    <PREFERREDNAME>15115482v1.00:3376344v2.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value that represents the percent of monocyte accumulation in a material sample compared to total cells.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CRDC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>GDC:NCI Genomic Data Commons</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15115482</PublicId>
      <PreferredName>2859635v1.00:15142236v1.00</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:A quantitative measurement of the percent of monocytes compared to the number of total cells present in a sample.</PreferredDefinition>
      <LongName>Specimen Percent of Monocytes</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CRDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15142236</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C159480</PreferredName>
        <Version>1</Version>
        <LongName>Percent of Monocytes</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159480</PREFERRED_NAME>
            <LONG_NAME>Percent of Monocytes</LONG_NAME>
            <CON_ID>10037768</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>GDC:NCI Genomic Data Commons</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3376344</PublicId>
      <PreferredName>3376344v2.00</PreferredName>
      <PreferredDefinition>A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Value</LongName>
      <Version>2</Version>
      <WorkflowStatus>DRAFT MOD</WorkflowStatus>
      <ContextName>SWOG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Monocyte Infiltration</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>10429357</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GDC (Genomic Data Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Candidate New GDC CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14506028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15103644</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>15103644v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Specimen</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15105458</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>percent_monocyte_infiltration</AlternateName>
        <AlternateNameType>CRDC Model Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>GDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>percent_monocyte_infiltration</AlternateName>
        <AlternateNameType>GDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="988">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15153505</PUBLICID>
    <LONGNAME>Patient Derived Organoid Review Complete Indicator</LONGNAME>
    <PREFERREDNAME>PDO_RV_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A indictor whether or not an organoid that is generated from a patient sample, retaining the genotypic and phenotypic characteristics of the source organ or tissue.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Princess Margaret Cancer Centre, Toronto, ON</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15153504</PublicId>
      <PreferredName>15153503v1.00:8029667v1.00</PreferredName>
      <PreferredDefinition>An organoid that is generated from a patient sample, retaining the genotypic and phenotypic characteristics of the source organ or tissue.:The act of appraisal, evaluation, or analysis._To possess every necessary or normal part or component or step; having come or been brought to a conclusion.</PreferredDefinition>
      <LongName>Patient Derived Organoid Review Complete</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>15153503</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C210719</PreferredName>
        <Version>1</Version>
        <LongName>Patient Derived Organoid</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C210719</PREFERRED_NAME>
            <LONG_NAME>Patient Derived Organoid</LONG_NAME>
            <CON_ID>15151711</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>8029667</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42729:C25250</PreferredName>
        <Version>1</Version>
        <LongName>Review Complete</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42729</PREFERRED_NAME>
            <LONG_NAME>Review</LONG_NAME>
            <CON_ID>2202331</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25250</PREFERRED_NAME>
            <LONG_NAME>Complete</LONG_NAME>
            <CON_ID>2203885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was PDO review completed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>16445930</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PMCC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PMCC Curation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16445931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="989">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15188869</PUBLICID>
    <LONGNAME>Primary Non-Malignant Disease Recurrence Indicator</LONGNAME>
    <PREFERREDNAME>15188868v1.00:2784450v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not there was recurrence of the primary non-malignant disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15188868</PublicId>
      <PreferredName>15188870v1.00:2429043v1.00</PreferredName>
      <PreferredDefinition>Occurring first in time or sequence; original; of greatest rank or importance or value._For neoplasms, a neoplastic process that, at the time of the pathologic diagnosis, does not show evidence of tissue infiltration and may or may not show evidence of atypical morphologic features (e.g., cellular atypia, formation of complex structures, cellular pseudostratification, and increased mitotic activity).  This term encompasses benign neoplastic processes, neoplastic processes with dysplastic features, and borderline processes.  The former do not metastasize and the latter two are associated with a future risk of stromal invasion and metastasis. For other conditions, a process that is not seriously resistant to treatment or dangerous to health._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:The return of a disease after a period of remission.</PreferredDefinition>
      <LongName>Primary Non-Malignant Disease or Disorder Recurrent Disease</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>15188870</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25251:C25588:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Primary Non-Malignant Disease or Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25588</PREFERRED_NAME>
            <LONG_NAME>Non-Malignant</LONG_NAME>
            <CON_ID>2206324</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2429043</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38155</PreferredName>
        <Version>1</Version>
        <LongName>Recurrent Disease</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38155</PREFERRED_NAME>
            <LONG_NAME>Recurrent Disease</LONG_NAME>
            <CON_ID>2202887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was there recurrence of the primary non-malignant disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was there recurrence of the primary non-malignant disease post-infusion?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 2</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Was there recurrence of the primary non-malignant disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_RNMD_recur_prim_nonmal_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods>Was there recurrence of the primary non-malignant disease post-infusion</Methods>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="990">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15501263</PUBLICID>
    <LONGNAME>FACT-C Questionnaire Version 4 C6 How True Past Seven Days Have Good Appetite Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>QS_QSORRES_FAC02329</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how true in the past 7 days they have a good appetite, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDISC Harmonization</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15501262</PublicId>
      <PreferredName>6607890v1.00:15501261v1.00</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire.:A subscale complement to the FACT-G developed specifically for evaluating the quality of life of colorectal cancer patients._The most recent week. May include the present day._A question about an individual&#39;s agreement with a statement._A question about whether an individual has or had a good appetite._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Questionnaire Domain FACT-C Questionnaire Past Week How True Question Have Good Appetite Question Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6607890</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49609</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49609</PREFERRED_NAME>
            <LONG_NAME>Questionnaire Domain</LONG_NAME>
            <CON_ID>2469074</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15501261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15501261v1.00</PreferredName>
        <Version>1</Version>
        <LongName>FACT-C Questionnaire Past Week How True Question Have Good Appetite Question Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113186</PREFERRED_NAME>
            <LONG_NAME>FACT-C Questionnaire</LONG_NAME>
            <CON_ID>4035012</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91781</PREFERRED_NAME>
            <LONG_NAME>How True Question</LONG_NAME>
            <CON_ID>3133350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C99789</PREFERRED_NAME>
            <LONG_NAME>Have Good Appetite Question</LONG_NAME>
            <CON_ID>3377349</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CTEP CDISC Harmonization</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15499545</PublicId>
      <PreferredName>FACT_5PT_SCL</PreferredName>
      <PreferredDefinition>The first outcome of a study questionnaire assessment._A questionnaire, rating and scale (QRS) data type using a 5-point Likert Scale._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>FACT Score 5 Point Likert Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTEP CDISC Harmonization</Origin>
      <Representation>
        <PublicId>15430135</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15430135v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Original Result Likert Scale 5-Point Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83375</PREFERRED_NAME>
            <LONG_NAME>Questionnaire Original Result</LONG_NAME>
            <CON_ID>6641690</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C172596</PREFERRED_NAME>
            <LONG_NAME>Likert Scale 5-Point</LONG_NAME>
            <CON_ID>10042399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>3144289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Some-what</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>3144290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a great amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>3144292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I have a good appetite</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC FACT-P (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>15383909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="991">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15624846</PUBLICID>
    <LONGNAME>Adverse Event Nervous System Disorder Occurrence Indicator</LONGNAME>
    <PREFERREDNAME>AE_NSD_OCC_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not a nervous system disorder adverse event occurred.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15624835</PublicId>
      <PreferredName>2235992v1.00:15624834v1.00</PreferredName>
      <PreferredDefinition>Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).:A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Adverse Event Nervous System Disorder Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2235992</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15624834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C26835:C25275</PreferredName>
        <Version>1</Version>
        <LongName>Nervous System Disorder Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26835</PREFERRED_NAME>
            <LONG_NAME>Nervous System Disorder</LONG_NAME>
            <CON_ID>2469354</CON_ID>
            <DEFINITION_SOURCE>MSH2003_2003_05_12</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did a nervous system disorder adverse event occur?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient have nervous system disorder AE of seizure, encephalopathy, reversible posterior leukoencephalopathy syndrome, leukoencephalopathy, intracranial hemorrhage or stroke during this course?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient have a reportable nervous system disorder or psychiatric adverse event during this course?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="992">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15744731</PUBLICID>
    <LONGNAME>Intervention or Procedure CDISC Variable Terminology Category</LONGNAME>
    <PREFERREDNAME>16334190v1.00:6380819v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Used to define a category of procedure values.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16334190</PublicId>
      <PreferredName>2233215v1.00:6412948v1.00</PreferredName>
      <PreferredDefinition>An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.:A classification of a procedure event.</PreferredDefinition>
      <LongName>Intervention or Procedure Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233215</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25218</PreferredName>
        <Version>1</Version>
        <LongName>Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6412948</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117513</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117513</PREFERRED_NAME>
            <LONG_NAME>Procedure Category</LONG_NAME>
            <CON_ID>6412947</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6380819</PublicId>
      <PreferredName>CDISCCAT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396783</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25372</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>PRCAT</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Procedures (PR)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15744767</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRCAT</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="993">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15744764</PUBLICID>
    <LONGNAME>Healthcare Encounter CDISC SDTM Relationship Type Terminology Text</LONGNAME>
    <PREFERREDNAME>15744713v1.00:15744521v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Interactions between patients and providers within the context of healthcare delivery.:The kind of affiliation between persons, places, things or events.:Terminology associated with the relationship type codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM)._The words of something written.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15744713</PublicId>
      <PreferredName>14596371v1.00:15744712v1.00</PreferredName>
      <PreferredDefinition>Interactions between patients and providers within the context of healthcare delivery.:The kind of affiliation between persons, places, things or events.</PreferredDefinition>
      <LongName>Healthcare Encounter Relationship Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14596371</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C154624</PreferredName>
        <Version>1</Version>
        <LongName>Healthcare Encounter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C154624</PREFERRED_NAME>
            <LONG_NAME>Healthcare Encounter</LONG_NAME>
            <CON_ID>6424582</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15744712</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83393</PreferredName>
        <Version>1</Version>
        <LongName>Relationship Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83393</PREFERRED_NAME>
            <LONG_NAME>Relationship Type</LONG_NAME>
            <CON_ID>10088721</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15744521</PublicId>
      <PreferredName>15744521v1.00</PreferredName>
      <PreferredDefinition>Terminology associated with the relationship type codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM)._The words of something written.</PreferredDefinition>
      <LongName>CDISC SDTM Relationship Type Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>15744520</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15744520v1.00</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Relationship Type Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78737</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Relationship Type Terminology</LONG_NAME>
            <CON_ID>10090052</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ONE</VALIDVALUE>
          <VALUEMEANING>One</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest natural number and quantity it denotes: a single entity, unit, or object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2932887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MANY</VALIDVALUE>
          <VALUEMEANING>Many Relationship Type</VALUEMEANING>
          <MEANINGDESCRIPTION>A side of a dataset-to-dataset relationship that contains more than one element.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C170512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15744522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Relationship Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Related Records for HO (RELRECHO)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15744771</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RELTYPE</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RELRECHO</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="994">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15826922</PUBLICID>
    <LONGNAME>EORTC QLQ-C30 Version 3.0 25 Past Week Have Difficulty Remembering Things Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>QS_QSORRES_EOR0125</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated perception of how often in the past week they had difficulty remembering things, using a four point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDISC Harmonization</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15826916</PublicId>
      <PreferredName>6607890v1.00:15826915v1.00</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire.:A 30-item questionnaire about patient ability to function, symptoms related to the cancer and its treatment, overall health and quality of life, and perceived financial impact of cancer and its treatment._The most recent week. May include the present day._A question about whether an individual has or had trouble remembering things._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Questionnaire Domain European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Past Week Have Trouble Remembering Things Question Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6607890</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49609</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49609</PREFERRED_NAME>
            <LONG_NAME>Questionnaire Domain</LONG_NAME>
            <CON_ID>2469074</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15826915</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C104355:C95402:C99795:C25338</PreferredName>
        <Version>1</Version>
        <LongName>European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Past Week Have Trouble Remembering Things Question Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104355</PREFERRED_NAME>
            <LONG_NAME>European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30</LONG_NAME>
            <CON_ID>3673437</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C99795</PREFERRED_NAME>
            <LONG_NAME>Have Trouble Remembering Things Question</LONG_NAME>
            <CON_ID>3377355</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CTEP CDISC Harmonization</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15792214</PublicId>
      <PreferredName>EORTC_QLQ_4PT_SCL</PreferredName>
      <PreferredDefinition>The first outcome of a study questionnaire assessment._A 30-item questionnaire about patient ability to function, symptoms related to the cancer and its treatment, overall health and quality of life, and perceived financial impact of cancer and its treatment._A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one._The precise location of something; a spatially limited location._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>EORTC QLQ Score 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTEP CDISC Harmonization</Origin>
      <Representation>
        <PublicId>15792213</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15792213v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Original Result European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Four Point Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83375</PREFERRED_NAME>
            <LONG_NAME>Questionnaire Original Result</LONG_NAME>
            <CON_ID>6641690</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104355</PREFERRED_NAME>
            <LONG_NAME>European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30</LONG_NAME>
            <CON_ID>3673437</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66835</PREFERRED_NAME>
            <LONG_NAME>Four</LONG_NAME>
            <CON_ID>2673235</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70656</PREFERRED_NAME>
            <LONG_NAME>Point</LONG_NAME>
            <CON_ID>2710246</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-04-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you had difficulty remembering things?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC EORTC QLQ-H&amp;N35 (Version 1)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>15383911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC EORTC QLQ-C30 (Version 3)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>15383912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="995">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16241249</PUBLICID>
    <LONGNAME>Subject Age in Days at Date of Sixth MRI Count</LONGNAME>
    <PREFERREDNAME>16235669v1.00:7069460v2.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The age of a subject, in days, at the date of the sixth MRI.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CIP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>TCIA:TheCancerImagingArchive</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16235669</PublicId>
      <PreferredName>2523466v1.00:16235668v1.00</PreferredName>
      <PreferredDefinition>A matter or an individual that is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study.:The age of a subject, in days, at the date of the sixth MRI.</PreferredDefinition>
      <LongName>Subject Age in Days at Date of Sixth MRI</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2523466</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41189</PreferredName>
        <Version>1</Version>
        <LongName>Study Subject</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41189</PREFERRED_NAME>
            <LONG_NAME>Study Subject</LONG_NAME>
            <CON_ID>2202706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16235668</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C217267</PreferredName>
        <Version>1</Version>
        <LongName>Age in Days at Date of Sixth MRI</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C217267</PREFERRED_NAME>
            <LONG_NAME>Age in Days at Date of Sixth MRI</LONG_NAME>
            <CON_ID>16174493</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>TCIA:TheCancerImagingArchive</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7069460</PublicId>
      <PreferredName>7069460v2.00</PreferredName>
      <PreferredDefinition>To determine the number or amount of something; the result of this activity.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>MCL</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>day</UnitOfMeasure>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>MCL:Molecular and Cellular Characterization of Screened Lesions</Origin>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Age in Days at Date of 6th MRI</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6305258</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TCIA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MU-Glioma-Post-Clinical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15741978</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>Age in Days at Date of 6th MRI</AlternateName>
        <AlternateNameType>TCIA Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="996">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16277258</PUBLICID>
    <LONGNAME>Vital Signs Record Link Identifier</LONGNAME>
    <PREFERREDNAME>14675212v1.00:15102798v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The logical id of the resource, as used in the URL for the resource. Once assigned, this value never changes.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14675212</PublicId>
      <PreferredName>7547055v1.00:14822132v1.00</PreferredName>
      <PreferredDefinition>Vital signs (such as height, weight, and blood pressure) directly measure an individual&#39;s current state of attributes.:A sequence of characters used as a linkage between related records.</PreferredDefinition>
      <LongName>Vital Signs Record Link Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7547055</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C154628</PreferredName>
        <Version>1</Version>
        <LongName>Vital Signs</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C154628</PREFERRED_NAME>
            <LONG_NAME>Vital Signs</LONG_NAME>
            <CON_ID>6424595</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14822132</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117050</PreferredName>
        <Version>1</Version>
        <LongName>Record Link Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117050</PREFERRED_NAME>
            <LONG_NAME>Record Link Identifier</LONG_NAME>
            <CON_ID>10012201</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15102798</PublicId>
      <PreferredName>15102798v1.00</PreferredName>
      <PreferredDefinition>One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>64</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>ID</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Vital Signs Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16069703</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VitalSigns</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="997">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16277267</PUBLICID>
    <LONGNAME>Vital Signs Person Record Link Identifier</LONGNAME>
    <PREFERREDNAME>14741491v1.00:15102798v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The patient, or group of patients, location, or device this observation is about and into whose record the observation is placed. If the actual focus of the observation is different from the subject (or a sample of, part, or region of the subject), the `focus` element or the `code` itself specifies the actual focus of the observation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14741491</PublicId>
      <PreferredName>7547055v1.00:14961184v1.00</PreferredName>
      <PreferredDefinition>Vital signs (such as height, weight, and blood pressure) directly measure an individual&#39;s current state of attributes.:A human being._A sequence of characters used as a linkage between related records.</PreferredDefinition>
      <LongName>Vital Signs Person Record Link Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7547055</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C154628</PreferredName>
        <Version>1</Version>
        <LongName>Vital Signs</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C154628</PREFERRED_NAME>
            <LONG_NAME>Vital Signs</LONG_NAME>
            <CON_ID>6424595</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14961184</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C117050</PreferredName>
        <Version>1</Version>
        <LongName>Person Record Link Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117050</PREFERRED_NAME>
            <LONG_NAME>Record Link Identifier</LONG_NAME>
            <CON_ID>10012201</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15102798</PublicId>
      <PreferredName>15102798v1.00</PreferredName>
      <PreferredDefinition>One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>64</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Patient ID</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Vital Signs Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16069703</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>subject.reference(http://hl7.org/fhir/us/core/StructureDefinition-us-core-patient.html).id@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VitalSigns</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="998">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16333062</PUBLICID>
    <LONGNAME>Health Status Assessment Subject Characteristics CDISC Variable Terminology Category</LONGNAME>
    <PREFERREDNAME>16330598v1.00:6380819v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Used to define a category of related records.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16330598</PublicId>
      <PreferredName>14936166v1.00:6413006v1.00</PreferredName>
      <PreferredDefinition>Assessments of health-related matters of interest, importance, or worry to a patient, patient&#39;s family, or patient&#39;s healthcare provider that could identify a need, problem, or condition.:A classification of subject characteristics data.</PreferredDefinition>
      <LongName>Health Status Assessment Subject Characteristics Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14936166</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C205784</PreferredName>
        <Version>1</Version>
        <LongName>Health Status Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C205784</PREFERRED_NAME>
            <LONG_NAME>Health Status Assessment</LONG_NAME>
            <CON_ID>14920961</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6413006</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83396</PreferredName>
        <Version>1</Version>
        <LongName>Subject Characteristics Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83396</PREFERRED_NAME>
            <LONG_NAME>Subject Characteristics Category</LONG_NAME>
            <CON_ID>6413002</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6380819</PublicId>
      <PreferredName>CDISCCAT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396783</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25372</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Category for Subject Characteristic</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Subject Characteristics (SC)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15063894</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SC</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SCCAT</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="999">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16333729</PUBLICID>
    <LONGNAME>Healthcare Encounter Occurrence CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LONGNAME>
    <PREFERREDNAME>16333712v1.00:6343337v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Used when the occurrence of specific healthcare encounters is solicited, to indicate whether an encounter occurred. Values are null for spontaneously reported events.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16333712</PublicId>
      <PreferredName>14596371v1.00:6408412v1.00</PreferredName>
      <PreferredDefinition>Interactions between patients and providers within the context of healthcare delivery.:An indication or description of a healthcare encounter occurrence.</PreferredDefinition>
      <LongName>Healthcare Encounter Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14596371</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C154624</PreferredName>
        <Version>1</Version>
        <LongName>Healthcare Encounter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C154624</PREFERRED_NAME>
            <LONG_NAME>Healthcare Encounter</LONG_NAME>
            <CON_ID>6424582</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6408412</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C123982</PreferredName>
        <Version>1</Version>
        <LongName>Healthcare Encounters Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C123982</PREFERRED_NAME>
            <LONG_NAME>Healthcare Encounters Occurrence</LONG_NAME>
            <CON_ID>6408411</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6343337</PublicId>
      <PreferredName>NY</PreferredName>
      <PreferredDefinition>Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6343336</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66742:C25180</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66742</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</LONG_NAME>
            <CON_ID>4852475</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5676138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Healthcare Encounter Occurrence</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Healthcare Encounters (HO)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15063893</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HO</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HOOCCUR</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1000">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16388607</PUBLICID>
    <LONGNAME>Adverse Event Action Taken with Device CDISC Variable Terminology Text</LONGNAME>
    <PREFERREDNAME>6366015v1.00:6338238v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>An action taken with a device as the result of the event. The device may or may not be a device under study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6366015</PublicId>
      <PreferredName>2235992v1.0:6378828v1.0</PreferredName>
      <PreferredDefinition>Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._Describes changes made with respect to the device in the study in response to an event or protocol change.</PreferredDefinition>
      <LongName>Adverse Event Action Taken with Device</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2235992</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6378828</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117037</PreferredName>
        <Version>1</Version>
        <LongName>Action Taken with Device</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117037</PREFERRED_NAME>
            <LONG_NAME>Action Taken with Device</LONG_NAME>
            <CON_ID>6378827</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Action Taken with Device</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events (AE)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15744768</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AEACNDEV</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1001">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>955</PUBLICID>
    <LONGNAME>Malignant Neoplasm Pleura Metastatic Involvement Ind-3</LONGNAME>
    <PREFERREDNAME>MALN_PL_MET_INV_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>a yes/no indicator to ask if evidence is detected for spread of cancer from a tumor composed of atypical neoplastic cells to the covering of the lung and the inner surface of the chest wall.</PREFERREDDEFINITION>
    <VERSION>2.4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2010047</PublicId>
      <PreferredName>MAL_NE_PLRA_MET_INVL</PreferredName>
      <PreferredDefinition>information related to evidence of the spread of cancer from a tumor composed of atypical neoplastic cells to the covering of the lung and the inner surface of the chest wall.</PreferredDefinition>
      <LongName>Malignant Neoplasm Pleura Metastatic Involvement</LongName>
      <Version>2.4</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2186369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2445997</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12469:C14174:C25548</PreferredName>
        <Version>1</Version>
        <LongName>Pleura Metastatic Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12469</PREFERRED_NAME>
            <LONG_NAME>Pleura</LONG_NAME>
            <CON_ID>2202782</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14174</PREFERRED_NAME>
            <LONG_NAME>Metastatic</LONG_NAME>
            <CON_ID>2204914</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pleura</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pleura</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Pleura Metastasis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>1-COMMENT</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>updated for ISO compliance during revisions to provide naming consistency for related elements</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1002">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>1786</PUBLICID>
    <LONGNAME>Colorectal Disease Extent Type</LONGNAME>
    <PREFERREDNAME>COLORECTAL_DZ_EXT_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the extent of invasion of colorectal disease.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188815</PublicId>
      <PreferredName>COLORECTAL_DZ_EXT</PreferredName>
      <PreferredDefinition>information related to the extent of colorectal disease.</PreferredDefinition>
      <LongName>Colorectal Disease Extent</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206589</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13363:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Colorectal Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13363</PREFERRED_NAME>
            <LONG_NAME>Colorectal</LONG_NAME>
            <CON_ID>2202379</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177500</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Extent</PreferredName>
        <Version>1</Version>
        <LongName>Extent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25332</PREFERRED_NAME>
            <LONG_NAME>Extent</LONG_NAME>
            <CON_ID>2203921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015205</PublicId>
      <PreferredName>COLORECTAL_DZ_EXT_TP</PreferredName>
      <PreferredDefinition>the extent of invasion of colorectal disease.</PreferredDefinition>
      <LongName>Colorectal Disease Extent Type</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>130</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carcinoma in situ; intraepithelial or invasion of lamina propria (Tis)</VALIDVALUE>
          <VALUEMEANING>Tis</VALUEMEANING>
          <MEANINGDESCRIPTION>Tissue</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No evidence of primary tumor (T0)</VALIDVALUE>
          <VALUEMEANING>T0</VALUEMEANING>
          <MEANINGDESCRIPTION>A primary tumor TNM finding indicating that there is no evidence of primary tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Primary tumor cannot be assessed (TX)</VALIDVALUE>
          <VALUEMEANING>TX</VALUEMEANING>
          <MEANINGDESCRIPTION>A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor directly invades or is adherent to other organs or structures and/or involves the visceral peritoneum (T4)</VALIDVALUE>
          <VALUEMEANING>T4</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48732</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor invades muscularis propria (T2)</VALIDVALUE>
          <VALUEMEANING>T2</VALUEMEANING>
          <MEANINGDESCRIPTION>A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48724</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor invades submucosa (T1)</VALIDVALUE>
          <VALUEMEANING>T1</VALUEMEANING>
          <MEANINGDESCRIPTION>T1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor invades through the muscularis propria into the subserosa, or into nonperitonealized pericolic or perirectal tissue (T3)</VALIDVALUE>
          <VALUEMEANING>T3</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48728</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Disease Extent</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Disease Extent</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COMMENT_196</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Instruction on pathology form: Local (T category).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Disease Extent</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811933</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1003">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2370</PUBLICID>
    <LONGNAME>Breast Tumor Pathologic T Stage</LONGNAME>
    <PREFERREDNAME>BRST_TUMOR_P_T_ST</PREFERREDNAME>
    <PREFERREDDEFINITION>extent of the primary tumor determined prior to treatment based on evidence obtained from pathological examination of a resected specimen that entails a resection of the primary tumor or biopsy adequate to evaluate the highest category.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189063</PublicId>
      <PreferredName>BRST_TUMOR_P_T</PreferredName>
      <PreferredDefinition>Information related to pathologic T stage of a breast tumor.</PreferredDefinition>
      <LongName>Breast Tumor Pathologic T Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206465</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12971:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Breast Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12971</PREFERRED_NAME>
            <LONG_NAME>Breast</LONG_NAME>
            <CON_ID>2202571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207099</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25610:C25728</PreferredName>
        <Version>1</Version>
        <LongName>Pathologic T Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25610</PREFERRED_NAME>
            <LONG_NAME>Pathologic</LONG_NAME>
            <CON_ID>2204850</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25728</PREFERRED_NAME>
            <LONG_NAME>T Category</LONG_NAME>
            <CON_ID>2202382</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018485</PublicId>
      <PreferredName>BRST_TUMOR_T_ST</PreferredName>
      <PreferredDefinition>the T (tumor) stage of a breast tumor, as defined by the AJCC Cancer Staging Manual, 6th Ed.</PreferredDefinition>
      <LongName>Breast Tumor T Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>12</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184339</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Stage</PreferredName>
        <Version>1</Version>
        <LongName>Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T0</VALIDVALUE>
          <VALUEMEANING>No evidence of primary tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T1</VALIDVALUE>
          <VALUEMEANING>TUMOR 2 CM OR LESS IN GREATEST DIMENSION</VALUEMEANING>
          <MEANINGDESCRIPTION>TUMOR 2 CM OR LESS IN GREATEST DIMENSION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T1a</VALIDVALUE>
          <VALUEMEANING>TUMOR MORE THAN 0.1 CM BUT NOT MORE THAN 0.5 CM IN GREATEST DIMENSION</VALUEMEANING>
          <MEANINGDESCRIPTION>TUMOR MORE THAN 0.1 CM BUT NOT MORE THAN 0.5 CM IN GREATEST DIMENSION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T1b</VALIDVALUE>
          <VALUEMEANING>TUMOR MORE THAN 0.5 CM BUT NOT MORE THAN 1 CM IN GREATEST DIMENSION</VALUEMEANING>
          <MEANINGDESCRIPTION>TUMOR MORE THAN 0.5 CM BUT NOT MORE THAN 1 CM IN GREATEST DIMENSION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T1c</VALIDVALUE>
          <VALUEMEANING>TUMOR MORE THAN 1 CM BUT NOT MORE THAN 2 CM IN GREATEST DIMENSION</VALUEMEANING>
          <MEANINGDESCRIPTION>TUMOR MORE THAN 1 CM BUT NOT MORE THAN 2 CM IN GREATEST DIMENSION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T1mic</VALIDVALUE>
          <VALUEMEANING>MICROINVASION 0.1 CM OR LESS IN GREATEST DIMENSION</VALUEMEANING>
          <MEANINGDESCRIPTION>MICROINVASION 0.1 CM OR LESS IN GREATEST DIMENSION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T2</VALIDVALUE>
          <VALUEMEANING>TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION</VALUEMEANING>
          <MEANINGDESCRIPTION>TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T3</VALIDVALUE>
          <VALUEMEANING>TUMOR MORE THAN 5 CM IN GREATEST DIMENSION</VALUEMEANING>
          <MEANINGDESCRIPTION>TUMOR MORE THAN 5 CM IN GREATEST DIMENSION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T4</VALIDVALUE>
          <VALUEMEANING>TUMOR OF ANY SIZE WITH DIRECT EXTENSION TO THE CHEST WALL AND/OR SKIN</VALUEMEANING>
          <MEANINGDESCRIPTION>TUMOR OF ANY SIZE WITH DIRECT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T4a</VALIDVALUE>
          <VALUEMEANING>EXTENSION TO CHEST WALL</VALUEMEANING>
          <MEANINGDESCRIPTION>EXTENSION TO CHEST WALL</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T4b</VALIDVALUE>
          <VALUEMEANING>EDEMA (INCLUDING PEAU D&#39;ORANGE) OR ULCERATION OF THE SKIN OF THE BREAST OR SATELLITE SKIN NODULES CONFINED TO THE SAME BREAST</VALUEMEANING>
          <MEANINGDESCRIPTION>EDEMA (INCLUDING PEAU D&#39;ORANGE) OR ULCERATION OF THE SKIN OF THE BREAST OR SATELLITE SKIN NODULES CONFINED TO THE SAME BREAST</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T4c</VALIDVALUE>
          <VALUEMEANING>BOTH T4A AND T4B</VALUEMEANING>
          <MEANINGDESCRIPTION>BOTH T4A AND T4B</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T4d</VALIDVALUE>
          <VALUEMEANING>Inflammatory Breast Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d&#39;orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4001</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558969</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TX</VALIDVALUE>
          <VALUEMEANING>PRIMARY TUMOR CANNOT BE ASSESSED</VALUEMEANING>
          <MEANINGDESCRIPTION>PRIMARY TUMOR CANNOT BE ASSESSED</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tis</VALIDVALUE>
          <VALUEMEANING>CARCINOMA IN SITU: INTRADUCTAL CARCINOMA, LOBULAR CARCINOMA IN SITU, OR PAGET&#39;S DISEASE OF THE NIPPLE WITH NO TUMOR</VALUEMEANING>
          <MEANINGDESCRIPTION>CARCINOMA IN SITU: INTRADUCTAL CARCINOMA, LOBULAR CARCINOMA IN SITU, OR PAGET&#39;S DISEASE OF THE NIPPLE WITH NO TUMOR</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tis (DCIS)</VALIDVALUE>
          <VALUEMEANING>Ductal carcinoma in situ</VALUEMEANING>
          <MEANINGDESCRIPTION>A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2924</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tis (LCIS)</VALIDVALUE>
          <VALUEMEANING>Lobular carcinoma in situ</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tis (Paget&#39;s)</VALIDVALUE>
          <VALUEMEANING>Paget&#39;s disease of the nipple with no tumor.  [Note: Paget&#39;s disease associated with a tumor is classified according to the size of the tumor.]</VALUEMEANING>
          <MEANINGDESCRIPTION>Paget&#39;s disease of the nipple with no tumor.  [Note: Paget&#39;s disease associated with a tumor is classified according to the size of the tumor.]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576655</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T1d</VALIDVALUE>
          <VALUEMEANING>T1d</VALUEMEANING>
          <MEANINGDESCRIPTION>T1d</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4115576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tmi</VALIDVALUE>
          <VALUEMEANING>Tmi</VALUEMEANING>
          <MEANINGDESCRIPTION>Tmi</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5053773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T1mi</VALIDVALUE>
          <VALUEMEANING>T1mi</VALUEMEANING>
          <MEANINGDESCRIPTION>T1mi</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5269991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COMMENT_168</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Note: The AJCC staging version to use is protocol specific.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pathologic T Stage</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pathologic T Stage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>T Stage, Pathologic</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Char.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer DataMart</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811932</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ThermoDox Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812723</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Washington</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812731</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FES Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812732</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2548333</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>I-SPY</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C911/C1000</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812254</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716207</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ASCO</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer Adjuvant Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812713</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3461586</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BOLD </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preoperative Elements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3461587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886755</PublicId>
          <ContextName>BOLD</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Preoperative Elements</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preoperative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3902140</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1005</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171062</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BOLD</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BOLD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BRST_TUMOR_P_T_ST</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1004">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2770</PUBLICID>
    <LONGNAME>Adjuvant Radiation Therapy Begin Date</LONGNAME>
    <PREFERREDNAME>ADJ_RT_BEG_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date on which  adjuvant radiation therapy began as part of the primary treatment plan.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2008638</PublicId>
      <PreferredName>ADJ_RT_BEG_OCUR</PreferredName>
      <PreferredDefinition>information related to the begin date or occurrence of adjuvant radiation therapy.</PreferredDefinition>
      <LongName>Adjuvant Radiation Therapy Begin Occurrence</LongName>
      <Version>6</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206630</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2140:C15313</PreferredName>
        <Version>1</Version>
        <LongName>Adjuvant Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2140</PREFERRED_NAME>
            <LONG_NAME>Adjuvant</LONG_NAME>
            <CON_ID>2204993</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207746</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25275</PreferredName>
        <Version>1</Version>
        <LongName>Begin Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188673</PublicId>
      <PreferredName>BEG_DT</PreferredName>
      <PreferredDefinition>The date on which an observation or an event began.</PreferredDefinition>
      <LongName>Begin Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yyyy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Begin Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Adjuvant RT Begin Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date Adjuvant Radiation Thera</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date Adjuvant Radiation Therapy Started</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Radiation therapy start date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0062754</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0065114</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ADJ_RT_BEG_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1005">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>58515</PUBLICID>
    <LONGNAME>Nontarget Lesion Present Ind-2</LONGNAME>
    <PREFERREDNAME>NTARG_LES_PRES_IND-2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator to ask whether any nontarget lesions are present at a baseline or follow-up evaluation.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189938</PublicId>
      <PreferredName>NTARGET_LES_PRES</PreferredName>
      <PreferredDefinition>information related to nontarget lesion being present.</PreferredDefinition>
      <LongName>Nontarget Lesion Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206599</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25592:C3824</PreferredName>
        <Version>1</Version>
        <LongName>Non-Target Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25592</PREFERRED_NAME>
            <LONG_NAME>Non-Target</LONG_NAME>
            <CON_ID>2206327</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177376</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Present</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Are there any nontarget lesio</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Are there any nontarget lesions?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COMMENT_77</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Instruction on baseline form: If no, skip to Comments section below.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Nontarget Lesion</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>2-COMMENT</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Instruction on follow-up form: If no, skip to New Lesions section below.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>2</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Document Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Any non target nodule present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Nontarget lesion present</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does the patient have non-target disease?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have non-target disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF Text#2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If satellite lesions are present, are the satellite lesions less than 2cm and within 1cm of the periphery of the dominant lesion?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF_ Text#1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have less than or equal to 3 satellite lesions?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is any non-target lesion(s) present?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is any non-target lesion(s) present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were there any new non-target lesions reported during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were non-target lesions present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were the non-target lesions assessed on this evaluation?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Are there any new, non target lesions present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>RECIST Forms</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Are there any non-target lesions?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>iRECIST</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have any non-target lesions?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>irRECIST</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Are there any non-target lesions?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>RECIST</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Are there any non-target lesions?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Are there any new non target lesions present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the participant have any non-target lesions other than bone?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_02</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the participant have any non-target lesions at baseline?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_03</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the participant have any OTHER lesions (i.e. in addition to the oligoprogressive lesions) that meet the definition of &#39;Non-Target lesion&#39; according to RECIST 1.1?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_04</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the participant have any OTHER lesions (i.e. in addition to the oligoprogressive lesions) that meet the definition of &#39;Non-Target lesion&#39; according to RECIST 1.1 at baseline?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_05</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the participant have any OTHER lesions (i.e. in addition to the oligoprogressive lesions) that meet the definition of ‘Non-Target lesion’ according to PERCIST 1.0 at baseline?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_06</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the participant have any OTHER lesions (i.e. in addition to the oligoprogressive lesions) that meet the definition of &#39;Non-Target lesion&#39; according to PERCIST 1.0 at baseline?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Upper GI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Lung Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812017</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Esophageal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811789</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Gastric</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811790</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Esophageal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811810</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Cervical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Endometrial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Ovarian</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811819</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811821</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Extensive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811822</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Limited</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Unresect Pancreatic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811827</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Resect Pancreatic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811829</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811884</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811886</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811889</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Localized Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811919</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Non-local Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Local-Reg Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811927</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Stage I-III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Recurrent Gyn</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811938</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hepatobiliary</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3298577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Advanced</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000001</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000027</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma Recur</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Met/Urothelial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000311</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Superficial Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000312</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Curative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000369</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Gastric</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000446</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Muscle Invasive Blad</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000462</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Palliative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000614</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Albert Einstein Medical Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AE_104_085</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Budesonide Lung Nodules</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812102</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Lung Pre-Surgical NSCLC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3152820</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0209</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104888</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0250</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104897</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0213</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000079</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000080</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0213</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000287</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0213</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000288</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RECIST</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5635324</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>iRECIST</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6006601</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>irRECIST</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6006642</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RECISTv1.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6006643</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0063431</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0058710</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0063569</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0058711</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0064901</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0058712</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0065184</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NTARG_LES_PRES_IND-2</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>NTARG_LES_PRES_IND-2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NTARG_LES_PRES_IND_2</AlternateName>
        <AlternateNameType>DCP Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>Does the patient have non-target lesions?</AlternateName>
        <AlternateNameType>Synonym</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NTARG_LES_PRES_IND-2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SWOG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NONTARGETLES</AlternateName>
        <AlternateNameType>OID, SWOG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NTARG_LES_PRES_IND-2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NTARG_LES_PRES_IND-2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCI Standards</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCTG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUYN_NONTARGET</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUYN_NONTARGET_RECIST</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUYN_NONTARGET_PERCIST</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1006">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>61475</PUBLICID>
    <LONGNAME>Gynecologic Malignant Neoplasm Ovary Capsule Rupture Ind</LONGNAME>
    <PREFERREDNAME>GY_MLN_OV_CA_RUP_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>a yes/no indicator to ask if the epithelial lining surrounding one of the female reproductive organs which produce ova has been damaged by disease or surgery to treat atypical neoplastic cell growth.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2010515</PublicId>
      <PreferredName>GYN_MALN_OV_CAP_RUPT</PreferredName>
      <PreferredDefinition>related to tearing or damage to the epithelial lining surrounding one of the female reproductive organs which produce ova by disease or surgical treatment for atypical neoplastic cell growth.</PreferredDefinition>
      <LongName>Gynecologic Malignant Neoplasm Ovary Capsule Rupture</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2450945</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28016:C9305</PreferredName>
        <Version>1</Version>
        <LongName>Gynecologic Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28016</PREFERRED_NAME>
            <LONG_NAME>Gynecologic</LONG_NAME>
            <CON_ID>2202649</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2480658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12404:C25158:C9445</PreferredName>
        <Version>1</Version>
        <LongName>Ovary Capsule Rupture</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12404</PREFERRED_NAME>
            <LONG_NAME>Ovary</LONG_NAME>
            <CON_ID>2202769</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25158</PREFERRED_NAME>
            <LONG_NAME>Capsule Dosage Form</LONG_NAME>
            <CON_ID>2203867</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9445</PREFERRED_NAME>
            <LONG_NAME>Rupture</LONG_NAME>
            <CON_ID>2203794</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015346</PublicId>
      <PreferredName>GY_MLN_OV_CA_RUP_IND</PreferredName>
      <PreferredDefinition>a yes/no indicator to ask if the epithelial lining surrounding one of the female reproductive organs which produce ova has been damaged by disease or surgery to treat atypical neoplastic cell growth.</PreferredDefinition>
      <LongName>Gynecologic Malignant Neoplasm Ovary Capsule Rupture Ind</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTEP CDE Committee</Origin>
      <Representation>
        <PublicId>2188676</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Indicator</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes intra-operatively</VALIDVALUE>
          <VALUEMEANING>YES, INTRA-OPERATIVELY</VALUEMEANING>
          <MEANINGDESCRIPTION>YES, INTRA-OPERATIVELY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes pre-operatively</VALIDVALUE>
          <VALUEMEANING>YES, PRE-OPERATIVELY</VALUEMEANING>
          <MEANINGDESCRIPTION>YES, PRE-OPERATIVELY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the ovary (epithelial lin</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the ovary (epithelial lining) been ruptured?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Ruptured Capsule</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1007">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>64316</PUBLICID>
    <LONGNAME>Lesion Count</LONGNAME>
    <PREFERREDNAME>LES_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>The field to specify the number of lesions.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014063</PublicId>
      <PreferredName>LES_QTY</PreferredName>
      <PreferredDefinition>the number of the patient&#39;s lesions.</PreferredDefinition>
      <LongName>Lesion Quantity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177112</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Lesion</PreferredName>
        <Version>1</Version>
        <LongName>Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177391</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Quantity</PreferredName>
        <Version>1</Version>
        <LongName>Quantity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018596</PublicId>
      <PreferredName>LES_CT</PreferredName>
      <PreferredDefinition>the quantity of specified lesions.</PreferredDefinition>
      <LongName>Lesion Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184284</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Count</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COMMENT_414</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Add 2 instructions to form: If yes,  AND (If multiple specimens, complete separate form for each specimen)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify number of lesions</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify number of lesions</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lesion Count</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify number of metastatic lesions</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>iRECIST</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of lesions observed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF_Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify number of metastatic sites detectable after induction systemic therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of lesions visualized</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total number of Lesion(s)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Total number of Lesion(s)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lesion Number</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lesion Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of Nodule(s):</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of Nodule(s):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How may cysts or tumors were addressed during the current chest procedure?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Lung Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812017</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811936</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metastatic Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812015</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mass General Hospital</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813097</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3461586</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BOLD </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging Elements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3461589</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886754</PublicId>
          <ContextName>BOLD</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging Elements</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3902139</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RECIST</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5635324</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>iRECIST</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6006601</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-Up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000342</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15711259</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>RCI (Rare Cancer Initiative)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15713367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LES_CT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BOLD</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BOLD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LES_CT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCI Standards</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LES_CT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LESNNUM</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NUM_TUM_CHST_PROC</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1008">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>64721</PUBLICID>
    <LONGNAME>Lobular Tumor Histologic Subtype Category</LONGNAME>
    <PREFERREDNAME>LBL_TUM_HIS_SUBT_CAT</PREFERREDNAME>
    <PREFERREDDEFINITION>the specific histologic subtype if the main histologic type is lobular carcinoma.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2192151</PublicId>
      <PreferredName>LBLR_TUM_HIST_SUBTP</PreferredName>
      <PreferredDefinition>information related to the a tumor of lobular histologic subtype.</PreferredDefinition>
      <LongName>Lobular Tumor Histologic Subtype</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206794</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25557:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Lobular Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25557</PREFERRED_NAME>
            <LONG_NAME>Lobular</LONG_NAME>
            <CON_ID>2204813</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207639</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25526:C25696</PreferredName>
        <Version>1</Version>
        <LongName>Histologic Subtype</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25526</PREFERRED_NAME>
            <LONG_NAME>Histologic</LONG_NAME>
            <CON_ID>2206234</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25696</PREFERRED_NAME>
            <LONG_NAME>Subtype</LONG_NAME>
            <CON_ID>2203810</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018445</PublicId>
      <PreferredName>LBL_TUM_HIS_SUBT_CAT</PreferredName>
      <PreferredDefinition>the histologic subcategory or subtype for a lobular tumor.</PreferredDefinition>
      <LongName>Lobular Tumor Histologic Subtype Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184279</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Category</PreferredName>
        <Version>1</Version>
        <LongName>Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alveolar</VALIDVALUE>
          <VALUEMEANING>ALVEOLAR</VALUEMEANING>
          <MEANINGDESCRIPTION>ALVEOLAR</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Classic</VALIDVALUE>
          <VALUEMEANING>CLASSIC</VALUEMEANING>
          <MEANINGDESCRIPTION>CLASSIC</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mixed lobular subtypes</VALIDVALUE>
          <VALUEMEANING>MIXED LOBULAR SUBTYPES</VALUEMEANING>
          <MEANINGDESCRIPTION>MIXED LOBULAR SUBTYPES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not specified</VALIDVALUE>
          <VALUEMEANING>Not specified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleomorphic</VALIDVALUE>
          <VALUEMEANING>PLEOMORPHIC</VALUEMEANING>
          <MEANINGDESCRIPTION>PLEOMORPHIC</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28109</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lobular Histologic Subtype</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lobular Histologic Subtype</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Lobular Histologic Subtype</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1009">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2001887</PUBLICID>
    <LONGNAME>Uncontrolled Hypertension Present Ind-3</LONGNAME>
    <PREFERREDNAME>UNCO_HTN_PRES_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether a patient has uncontrolled hypertension.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2762693</PublicId>
      <PreferredName>UNC_HTN_PRES</PreferredName>
      <PreferredDefinition>the presence of uncontrolled hypertension, an excessive elevation in blood pressure.</PreferredDefinition>
      <LongName>Uncontrolled Hypertension Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2442218</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48932:C3117</PreferredName>
        <Version>1</Version>
        <LongName>Uncontrolled Hypertension</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48932</PREFERRED_NAME>
            <LONG_NAME>Uncontrolled</LONG_NAME>
            <CON_ID>2437662</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3117</PREFERRED_NAME>
            <LONG_NAME>Hypertension</LONG_NAME>
            <CON_ID>2202655</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does the patient have uncontr</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled hypertension?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Uncontrolled hypertension defined as BP &gt; 150/90 on antihypertensive therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled hypertension defined as systolic pressure greater than 150mm Hg or diastolic greater than 100mm Hg?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Uncontrolled high blood pressure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled hypertension defined as systolic pressure greater than 150mm Hg or diastolic greater than 90mm Hg</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Uncontrolled hypertension</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled hypertension defined as systolic pressure greater than 150mm Hg or diastolic greater than 100mm Hg?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled hypertension defined as systolic greater than 140 mm Hg or diastolic greater than 90 mm Hg?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient suffered from uncontrolled hypertension?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have poorly controlled hypertension systolic BP greater than or equal to160 mm Hg or diastolic BP greater than or equal to 100 mm Hg</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled hypertension (SBP greater than 150; DBP greater than 90)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled high blood pressure (defined as systolic BP &gt; 150mmHg or diastolic BP &gt; 90 mmHg) with or without anti-hypertensive medication?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior uncontrolled hypertension?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled hypertension defined as sustained systolic BP greater than 150 mmHg or diastolic BP greater than 90 mmHg?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_eCRF_Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled hypertension (SBP equal or greater than 150; DBP equal or greater than 90)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_eCRF_Text_1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled hypertension (SBP greater than or equal to 150 and/or DBP greater than or equal to 90)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_eCRF_Text_2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled hypertension, defined as systolic greater than 150 mm Hg or diastolic greater than 90 mm Hg despite antihypertensive medications?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF_Text_1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled hypertension (BP greater than or equal to 150/90 mmHg despite medical therapy)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled high blood pressure (defined as systolic BP greater than 160 mmHg or diastolic BP greater than 100 mmHg) with or without anti-hypertensive medication?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF TEXT 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have uncontrolled hypertension, defined as systolic greater than or equal to 160 mm Hg or diastolic greater than or equal to 100 mm Hg?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0240</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104883</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0250</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104897</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-9923</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-9923</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000692</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-9923</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000693</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>UNCO_HTN_PRES_IND3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1010">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2003926</PUBLICID>
    <LONGNAME>Logged Entry Date</LONGNAME>
    <PREFERREDNAME>LOG_ENTRY_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>The date when the protocol staff person received study case report form at the coordination center</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2011663</PublicId>
      <PreferredName>CRF PROTOCOL ADMIN</PreferredName>
      <PreferredDefinition>Information recorded for form processing at coordination center for administration and quality control</PreferredDefinition>
      <LongName>Case Report Form Protocol Administration</LongName>
      <Version>3</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008508</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CTEP</PreferredName>
        <Version>2.31</Version>
        <LongName>CTEP</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7318107</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38046:C41106</PreferredName>
        <Version>1</Version>
        <LongName>Unspecified Object Class</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38046</PREFERRED_NAME>
            <LONG_NAME>Unspecified</LONG_NAME>
            <CON_ID>2230154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41106</PREFERRED_NAME>
            <LONG_NAME>Object Class</LONG_NAME>
            <CON_ID>2223438</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7318108</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38046:C42605</PreferredName>
        <Version>1</Version>
        <LongName>Unspecified Property</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38046</PREFERRED_NAME>
            <LONG_NAME>Unspecified</LONG_NAME>
            <CON_ID>2230154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42605</PREFERRED_NAME>
            <LONG_NAME>Property</LONG_NAME>
            <CON_ID>2231569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017226</PublicId>
      <PreferredName>PROTOCOL ADMIN DT</PreferredName>
      <PreferredDefinition>Date field used to record form processing at coordination center for administration and quality control</PreferredDefinition>
      <LongName>Protocol Administration Date</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYYMMDD</DisplayFormat>
      <MaximumLength>9</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184285</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Date</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Logged Entry Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1011">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2003943</PUBLICID>
    <LONGNAME>Platelet Transfusion Received Most Recent Date</LONGNAME>
    <PREFERREDNAME>PLATTRAN_RCVD_M_R_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the most recent date of received transfer of blood platelets from a donor to a recipient or reinfusion to the donor.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2012949</PublicId>
      <PreferredName>PLATTRANS_RCVD</PreferredName>
      <PreferredDefinition>information related to receiving transfer of blood platelets from a donor to a recipient or reinfusion to the donor.</PreferredDefinition>
      <LongName>Platelet Transfusion Received</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2459124</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15366</PreferredName>
        <Version>1</Version>
        <LongName>Platelet Transfusion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15366</PREFERRED_NAME>
            <LONG_NAME>Platelet Transfusion</LONG_NAME>
            <CON_ID>2205020</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241679</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25639</PreferredName>
        <Version>1</Version>
        <LongName>Received</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188928</PublicId>
      <PreferredName>MOSTRECENT_DT</PreferredName>
      <PreferredDefinition>the most recent date of an event, assessment, or treatment.</PreferredDefinition>
      <LongName>Most Recent Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yyyy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25577:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Most Recent Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25577</PREFERRED_NAME>
            <LONG_NAME>Most Recent</LONG_NAME>
            <CON_ID>2206311</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of most recent platelet</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of most recent platelet transfusion</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of most recent platelet transfusion</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of platelet transfusions:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1012">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2004080</PUBLICID>
    <LONGNAME>Patient No Lung Chemotherapy Eligibility Ind-2</LONGNAME>
    <PREFERREDNAME>PT_NOLNGCT_ELIG_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether the patient has had prior non-platinum based adjuvant or neoadjuvant chemotherapy or immunotherapy for NSCLC.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2442490</PublicId>
      <PreferredName>PT_NOLUNGCHEMO_ELIG</PreferredName>
      <PreferredDefinition>information related to patient eligibility and no prior lung chemotherapy.</PreferredDefinition>
      <LongName>Patient No Lung Chemotherapy Eligibility</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2442488</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0028423:C12468:C15632:C25171</PreferredName>
        <Version>1</Version>
        <LongName>No Lung Chemotherapy Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0028423</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2203161</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12468</PREFERRED_NAME>
            <LONG_NAME>Lung</LONG_NAME>
            <CON_ID>2202738</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15632</PREFERRED_NAME>
            <LONG_NAME>Chemotherapy</LONG_NAME>
            <CON_ID>2202708</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>No prior non-platinum based a</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>No prior non-platinum based adjuvant or neoadjuvant chemotherapy or immunotherapy for NSCLC</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1013">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2005581</PUBLICID>
    <LONGNAME>Common Toxicity Criteria Adverse Event Other Coagulation Grade</LONGNAME>
    <PREFERREDNAME>CTC_AE_OTH_COAGUL_GD</PREFERREDNAME>
    <PREFERREDDEFINITION>in CTC category Coagulation, assessment of the severity of an unlisted adverse event type using a graded scale.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTCAE:Common Terminology Criteria for Adverse Events v3.0</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2193180</PublicId>
      <PreferredName>CTC_AE_O_COAGUL</PreferredName>
      <PreferredDefinition>information related to the CTC adverse event of other coagulation.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Other Coagulation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207566</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C20812</PreferredName>
        <Version>1</Version>
        <LongName>Other Coagulation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20812</PREFERRED_NAME>
            <LONG_NAME>Coagulation</LONG_NAME>
            <CON_ID>2203681</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017781</PublicId>
      <PreferredName>CTC_AE_OTH_COAGUL_GD</PreferredName>
      <PreferredDefinition>in CTC category Coagulation, assessment of the severity of an unlisted adverse event type using a graded scale.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Other Coagulation Grade</LongName>
      <Version>4</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTCAE:Common Terminology Criteria for Adverse Events v3.0</Origin>
      <Representation>
        <PublicId>2184299</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Grade</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Death</VALUEMEANING>
          <MEANINGDESCRIPTION>The absence of life or state of being dead.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Mild</VALUEMEANING>
          <MEANINGDESCRIPTION>Not severe or strong; far from extreme; not serious enough to endanger life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Severe</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Life-threatening; disabling</VALUEMEANING>
          <MEANINGDESCRIPTION>Life-threatening; disabling</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTC Adverse Event Coagulation</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CTC Adverse Event Coagulation-Other (Specify) Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Coagulation-Other Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)</DocumentText>
        <URL>http://ctep.cancer.gov/reporting/ctc.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000132</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>2005581</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1014">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2005839</PUBLICID>
    <LONGNAME>New Cancer Diagnosis ICD-O Code</LONGNAME>
    <PREFERREDNAME>NEW_CA_DX_ICD-O_CD</PREFERREDNAME>
    <PREFERREDDEFINITION>the ICD-O morphology code associated with the patient&#39;s new cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013917</PublicId>
      <PreferredName>CA_DX</PreferredName>
      <PreferredDefinition>the diagnosis of a patient&#39;s cancer.</PreferredDefinition>
      <LongName>Cancer Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177129</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Cancer</PreferredName>
        <Version>1</Version>
        <LongName>Cancer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Diagnosis</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018546</PublicId>
      <PreferredName>ICD_MORPH_CD</PreferredName>
      <PreferredDefinition>ICD-0-3 Morphology Codes</PreferredDefinition>
      <LongName>ICD-0-3 Morphology Codes</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008562</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ICD-O-3</PreferredName>
        <Version>1</Version>
        <LongName>ICD-O-3</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8380-3</VALIDVALUE>
          <VALUEMEANING>8380-3 Endometrioid adenocarcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Endometrioid adenocarcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564376</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8381-0</VALIDVALUE>
          <VALUEMEANING>8381-0 Endometrioid adenofibroma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Endometrioid adenofibroma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8381-1</VALIDVALUE>
          <VALUEMEANING>8381-1 Endometrioid adenofibroma, borderline malignancy</VALUEMEANING>
          <MEANINGDESCRIPTION>Endometrioid adenofibroma, borderline malignancy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8381-3</VALIDVALUE>
          <VALUEMEANING>8381-3 Endometrioid adenofibroma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Endometrioid adenofibroma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8382-3</VALIDVALUE>
          <VALUEMEANING>8382-3 Endometrioid adenocarcinoma, secretory variant</VALUEMEANING>
          <MEANINGDESCRIPTION>Endometrioid adenocarcinoma, secretory variant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8383-3</VALIDVALUE>
          <VALUEMEANING>8383-3 Endometrioid adenocarcinoma, ciliated cell variant</VALUEMEANING>
          <MEANINGDESCRIPTION>Endometrioid adenocarcinoma, ciliated cell variant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564381</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8384-3</VALIDVALUE>
          <VALUEMEANING>8384-3 Adenocarcinoma, endocervical type</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma, endocervical type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>839-842</VALIDVALUE>
          <VALUEMEANING>839-842 ADNEXAL AND SKIN APPENDAGE NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564383</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8390-0</VALIDVALUE>
          <VALUEMEANING>8390-0 Skin appendage adenoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Skin appendage adenoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8390-3</VALIDVALUE>
          <VALUEMEANING>8390-3 Skin appendage carcinoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Skin appendage carcinoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8391-0</VALIDVALUE>
          <VALUEMEANING>8391-0 Follicular fibroma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Follicular fibroma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8392-0</VALIDVALUE>
          <VALUEMEANING>8392-0 Syringofibroadenoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Syringofibroadenoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564387</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8400-0</VALIDVALUE>
          <VALUEMEANING>8400-0 Sweat gland adenoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Sweat gland adenoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564388</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8400-1</VALIDVALUE>
          <VALUEMEANING>8400-1 Sweat gland tumor, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Sweat gland tumor, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564389</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8400-3</VALIDVALUE>
          <VALUEMEANING>8400-3 Sweat gland adenocarcinoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Sweat gland adenocarcinoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8401-0</VALIDVALUE>
          <VALUEMEANING>8401-0 Apocrine adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Apocrine adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8401-3</VALIDVALUE>
          <VALUEMEANING>8401-3 Apocrine adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Apocrine adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8402-3</VALIDVALUE>
          <VALUEMEANING>8402-3 Nodular hidradenoma, malignant (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Nodular hidradenoma, malignant (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8862-0</VALIDVALUE>
          <VALUEMEANING>8862-0 Chondroid lipoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Chondroid lipoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8870-0</VALIDVALUE>
          <VALUEMEANING>8870-0 Myelolipoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Myelolipoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8880-0</VALIDVALUE>
          <VALUEMEANING>8880-0 Hibernoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Hibernoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8881-0</VALIDVALUE>
          <VALUEMEANING>8881-0 Lipoblastomatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Lipoblastomatosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>889-892</VALIDVALUE>
          <VALUEMEANING>889-892 MYOMATOUS NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>MYOMATOUS NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8890-0</VALIDVALUE>
          <VALUEMEANING>8890-0 Leiomyoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Leiomyoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8890-1</VALIDVALUE>
          <VALUEMEANING>8890-1 Leiomyomatosis, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Leiomyomatosis, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8891-0</VALIDVALUE>
          <VALUEMEANING>8891-0 Epithelioid leiomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioid leiomyoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8891-3</VALIDVALUE>
          <VALUEMEANING>8891-3 Epithelioid leiomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioid leiomyosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8892-0</VALIDVALUE>
          <VALUEMEANING>8892-0 Cellular leiomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Cellular leiomyoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8893-0</VALIDVALUE>
          <VALUEMEANING>8893-0 Bizarre leiomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Bizarre leiomyoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8894-0</VALIDVALUE>
          <VALUEMEANING>8894-0 Angiomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Angiomyoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564699</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8894-3</VALIDVALUE>
          <VALUEMEANING>8894-3 Angiomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Angiomyosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8895-0</VALIDVALUE>
          <VALUEMEANING>8895-0 Myoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Myoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8895-3</VALIDVALUE>
          <VALUEMEANING>8895-3 Myosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Myosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8896-3</VALIDVALUE>
          <VALUEMEANING>8896-3 Myxoid leiomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Myxoid leiomyosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8897-1</VALIDVALUE>
          <VALUEMEANING>8897-1 Smooth muscle tumor of uncertain malignant potential</VALUEMEANING>
          <MEANINGDESCRIPTION>Smooth muscle tumor of uncertain malignant potential</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564704</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8898-1</VALIDVALUE>
          <VALUEMEANING>8898-1 Metastasizing leiomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Metastasizing leiomyoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8403-0</VALIDVALUE>
          <VALUEMEANING>8403-0 Eccrine spiradenoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Eccrine spiradenoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8403-3</VALIDVALUE>
          <VALUEMEANING>8403-3 Malignant eccrine spiradenoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant eccrine spiradenoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8404-0</VALIDVALUE>
          <VALUEMEANING>8404-0 Hidrocystoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hidrocystoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8405-0</VALIDVALUE>
          <VALUEMEANING>8405-0 Papillary hidradenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary hidradenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8406-0</VALIDVALUE>
          <VALUEMEANING>8406-0 Papillary syringadenoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary syringadenoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8407-0</VALIDVALUE>
          <VALUEMEANING>8407-0 Syringoma, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Syringoma, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8407-3</VALIDVALUE>
          <VALUEMEANING>8407-3 Sclerosing sweat duct carcinoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Sclerosing sweat duct carcinoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8408-0</VALIDVALUE>
          <VALUEMEANING>8408-0 Eccrine papillary adenoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Eccrine papillary adenoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8408-1</VALIDVALUE>
          <VALUEMEANING>8408-1 Aggressive digital papillary adenoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Aggressive digital papillary adenoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8408-3</VALIDVALUE>
          <VALUEMEANING>8408-3 Eccrine papillary adenocarcinoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Eccrine papillary adenocarcinoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8409-0</VALIDVALUE>
          <VALUEMEANING>8409-0 Eccrine poroma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Eccrine poroma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564405</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8409-3</VALIDVALUE>
          <VALUEMEANING>8409-3 Eccrine poroma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Eccrine poroma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8410-0</VALIDVALUE>
          <VALUEMEANING>8410-0 Sebaceous adenoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Sebaceous adenoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8410-3</VALIDVALUE>
          <VALUEMEANING>8410-3 Sebaceous adenocarcinoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Sebaceous adenocarcinoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8413-3</VALIDVALUE>
          <VALUEMEANING>8413-3 Eccrine adenocarcinoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Eccrine adenocarcinoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8420-0</VALIDVALUE>
          <VALUEMEANING>8420-0 Ceruminous adenoma (C44.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Ceruminous adenoma (C44.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8420-3</VALIDVALUE>
          <VALUEMEANING>8420-3 Ceruminous adenocarcinoma (C44.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Ceruminous adenocarcinoma (C44.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>843</VALIDVALUE>
          <VALUEMEANING>843 MUCOEPIDERMOID NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>MUCOEPIDERMOID NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8430-1</VALIDVALUE>
          <VALUEMEANING>8430-1 Mucoepidermoid tumor [obs]</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucoepidermoid tumor [obs]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8900-0</VALIDVALUE>
          <VALUEMEANING>8900-0 Rhabdomyoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Rhabdomyoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8900-3</VALIDVALUE>
          <VALUEMEANING>8900-3 Rhabdomyosarcoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Rhabdomyosarcoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8901-3</VALIDVALUE>
          <VALUEMEANING>8901-3 Pleomorphic rhabdomyosarcoma, adult type</VALUEMEANING>
          <MEANINGDESCRIPTION>Pleomorphic rhabdomyosarcoma, adult type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8902-3</VALIDVALUE>
          <VALUEMEANING>8902-3 Mixed type rhabdomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed type rhabdomyosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8903-0</VALIDVALUE>
          <VALUEMEANING>8903-0 Fetal rhabdomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Fetal rhabdomyoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8904-0</VALIDVALUE>
          <VALUEMEANING>8904-0 Adult rhabdomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Adult rhabdomyoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8905-0</VALIDVALUE>
          <VALUEMEANING>8905-0 Genital rhabdomyoma (C51._, C52.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Genital rhabdomyoma (C51._, C52.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8910-3</VALIDVALUE>
          <VALUEMEANING>8910-3 Embryonal rhabdomyosarcoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Embryonal rhabdomyosarcoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8912-3</VALIDVALUE>
          <VALUEMEANING>8912-3 Spindle cell rhabdomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Spindle cell rhabdomyosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8920-3</VALIDVALUE>
          <VALUEMEANING>8920-3 Alveolar rhabdomyosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Alveolar rhabdomyosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8921-3</VALIDVALUE>
          <VALUEMEANING>8921-3 Rhabdomyosarcoma with ganglionic differentiation</VALUEMEANING>
          <MEANINGDESCRIPTION>Rhabdomyosarcoma with ganglionic differentiation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564716</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>893-899</VALIDVALUE>
          <VALUEMEANING>893-899 COMPLEX MIXED AND STROMAL NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>COMPLEX MIXED AND STROMAL NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8930-0</VALIDVALUE>
          <VALUEMEANING>8930-0 Endometrial stromal nodule (C54.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Endometrial stromal nodule (C54.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8930-3</VALIDVALUE>
          <VALUEMEANING>8930-3 Endometrial stromal sarcoma, NOS (C54.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Endometrial stromal sarcoma, NOS (C54.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8931-3</VALIDVALUE>
          <VALUEMEANING>8931-3 Endometrial stromal sarcoma, low grade (C54.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Endometrial stromal sarcoma, low grade (C54.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8932-0</VALIDVALUE>
          <VALUEMEANING>8932-0 Adenomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenomyoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8933-3</VALIDVALUE>
          <VALUEMEANING>8933-3 Adenosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564722</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8934-3</VALIDVALUE>
          <VALUEMEANING>8934-3 Carcinofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinofibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8935-0</VALIDVALUE>
          <VALUEMEANING>8935-0 Stromal tumor, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Stromal tumor, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564724</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8935-1</VALIDVALUE>
          <VALUEMEANING>8935-1 Stromal tumor, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Stromal tumor, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>800</VALIDVALUE>
          <VALUEMEANING>800 NEOPLASMS, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>NEOPLASMS, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564106</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8000-0</VALIDVALUE>
          <VALUEMEANING>8000-0 Neoplasm, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Neoplasm, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8000-1</VALIDVALUE>
          <VALUEMEANING>8000-1 Neoplasm, uncertain whether benign or malignant#Neoplasm, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Neoplasm, uncertain whether benign or malignant#Neoplasm, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564108</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8000-3</VALIDVALUE>
          <VALUEMEANING>8000-3 Neoplasm, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Neoplasm, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8000-6</VALIDVALUE>
          <VALUEMEANING>8000-6 Neoplasm, metastatic</VALUEMEANING>
          <MEANINGDESCRIPTION>Neoplasm, metastatic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8000-9</VALIDVALUE>
          <VALUEMEANING>8000-9 Neoplasm, malignant, uncertain whether primary or metastatic</VALUEMEANING>
          <MEANINGDESCRIPTION>Neoplasm, malignant, uncertain whether primary or metastatic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8001-0</VALIDVALUE>
          <VALUEMEANING>8001-0 Tumor cells, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Tumor cells, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8001-1</VALIDVALUE>
          <VALUEMEANING>8001-1 Tumor cells, uncertain whether benign or malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Tumor cells, uncertain whether benign or malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8002-3</VALIDVALUE>
          <VALUEMEANING>8002-3 Malignant tumor, small cell type</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant tumor, small cell type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8003-3</VALIDVALUE>
          <VALUEMEANING>8003-3 Malignant tumor, giant cell type</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant tumor, giant cell type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564116</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8004-3</VALIDVALUE>
          <VALUEMEANING>8004-3 Malignant tumor, spindle cell type</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant tumor, spindle cell type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8005-0</VALIDVALUE>
          <VALUEMEANING>8005-0 Clear cell tumor, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell tumor, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8005-3</VALIDVALUE>
          <VALUEMEANING>8005-3 Malignant tumor, clear cell type</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant tumor, clear cell type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>801-804</VALIDVALUE>
          <VALUEMEANING>801-804 EPITHELIAL NEOPLASMS, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>EPITHELIAL NEOPLASMS, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8010-0</VALIDVALUE>
          <VALUEMEANING>8010-0 Epithelial tumor, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelial tumor, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8010-2</VALIDVALUE>
          <VALUEMEANING>8010-2 Carcinoma in situ, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoma in situ, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8430-3</VALIDVALUE>
          <VALUEMEANING>8430-3 Mucoepidermoid carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucoepidermoid carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>844-849</VALIDVALUE>
          <VALUEMEANING>844-849  CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8440-0</VALIDVALUE>
          <VALUEMEANING>8440-0 Cystadenoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Cystadenoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8440-3</VALIDVALUE>
          <VALUEMEANING>8440-3 Cystadenocarcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Cystadenocarcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564417</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8441-0</VALIDVALUE>
          <VALUEMEANING>8441-0 Serous cystadenoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Serous cystadenoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8441-3</VALIDVALUE>
          <VALUEMEANING>8441-3 Serous cystadenocarcinoma, NOS (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Serous cystadenocarcinoma, NOS (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564419</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8442-1</VALIDVALUE>
          <VALUEMEANING>8442-1 Serous cystadenoma, borderline malignancy (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Serous cystadenoma, borderline malignancy (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8443-0</VALIDVALUE>
          <VALUEMEANING>8443-0 Clear cell cystadenoma (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell cystadenoma (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8444-1</VALIDVALUE>
          <VALUEMEANING>8444-1 Clear cell cystic tumor of borderline malignancy (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell cystic tumor of borderline malignancy (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8450-0</VALIDVALUE>
          <VALUEMEANING>8450-0 Papillary cystadenoma, NOS (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary cystadenoma, NOS (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8450-3</VALIDVALUE>
          <VALUEMEANING>8450-3 Papillary cystadenocarcinoma, NOS (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary cystadenocarcinoma, NOS (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564424</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8451-1</VALIDVALUE>
          <VALUEMEANING>8451-1 Papillary cystadenoma, borderline malignancy (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary cystadenoma, borderline malignancy (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564425</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8452-1</VALIDVALUE>
          <VALUEMEANING>8452-1 Solid pseudopapillary tumor (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Solid pseudopapillary tumor (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564426</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8452-3</VALIDVALUE>
          <VALUEMEANING>8452-3 Solid pseudopapillary carcinoma (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Solid pseudopapillary carcinoma (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8453-0</VALIDVALUE>
          <VALUEMEANING>8453-0 Intraductal papillary-mucinous adenoma (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraductal papillary-mucinous adenoma (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8453-1</VALIDVALUE>
          <VALUEMEANING>8453-1 Intraductal papillary-mucinous tumor with moderate dysplasia (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraductal papillary-mucinous tumor with moderate dysplasia (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564429</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8453-2</VALIDVALUE>
          <VALUEMEANING>8453-2 Intraductal papillary-mucinous carcinoma, non-invasive (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraductal papillary-mucinous carcinoma, non-invasive (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8453-3</VALIDVALUE>
          <VALUEMEANING>8453-3 Intraductal papillary-mucinous carcinoma, invasive (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraductal papillary-mucinous carcinoma, invasive (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8454-0</VALIDVALUE>
          <VALUEMEANING>8454-0 Cystic tumor of atrio-ventricular node (C38.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cystic tumor of atrio-ventricular node (C38.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8460-0</VALIDVALUE>
          <VALUEMEANING>8460-0 Papillary serous cystadenoma, NOS (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary serous cystadenoma, NOS (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8935-3</VALIDVALUE>
          <VALUEMEANING>8935-3 Stromal sarcoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Stromal sarcoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8936-0</VALIDVALUE>
          <VALUEMEANING>8936-0 Gastrointestinal stromal tumor, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Gastrointestinal stromal tumor, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8936-1</VALIDVALUE>
          <VALUEMEANING>8936-1 Gastrointestinal stromal tumor, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Gastrointestinal stromal tumor, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8936-3</VALIDVALUE>
          <VALUEMEANING>8936-3 Gastrointestinal stromal sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Gastrointestinal stromal sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8940-0</VALIDVALUE>
          <VALUEMEANING>8940-0 Pleomorphic adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Pleomorphic adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564730</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8940-3</VALIDVALUE>
          <VALUEMEANING>8940-3 Mixed tumor, malignant, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed tumor, malignant, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8941-3</VALIDVALUE>
          <VALUEMEANING>8941-3 Carcinoma in pleomorphic adenoma (C07._, C08._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoma in pleomorphic adenoma (C07._, C08._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8950-3</VALIDVALUE>
          <VALUEMEANING>8950-3 Mullerian mixed tumor (C54._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mullerian mixed tumor (C54._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564733</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8951-3</VALIDVALUE>
          <VALUEMEANING>8951-3 Mesodermal mixed tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesodermal mixed tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8959-0</VALIDVALUE>
          <VALUEMEANING>8959-0 Benign cystic nephroma (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Benign cystic nephroma (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564735</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8959-1</VALIDVALUE>
          <VALUEMEANING>8959-1 Cystic partially differentiated nephroblastoma (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cystic partially differentiated nephroblastoma (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8960-1</VALIDVALUE>
          <VALUEMEANING>8960-1 Mesoblastic nephroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesoblastic nephroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8960-3</VALIDVALUE>
          <VALUEMEANING>8960-3 Nephroblastoma, NOS (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Nephroblastoma, NOS (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564739</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8963-3</VALIDVALUE>
          <VALUEMEANING>8963-3 Malignant rhabdoid tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant rhabdoid tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8964-3</VALIDVALUE>
          <VALUEMEANING>8964-3 Clear cell sarcoma of kidney (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell sarcoma of kidney (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8965-0</VALIDVALUE>
          <VALUEMEANING>8965-0 Nephrogenic adenofibroma (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Nephrogenic adenofibroma (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8966-0</VALIDVALUE>
          <VALUEMEANING>8966-0 Renomedullary interstitial cell tumor (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Renomedullary interstitial cell tumor (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8967-0</VALIDVALUE>
          <VALUEMEANING>8967-0 Ossifying renal tumor (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Ossifying renal tumor (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8010-3</VALIDVALUE>
          <VALUEMEANING>8010-3 Carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8010-6</VALIDVALUE>
          <VALUEMEANING>8010-6 Carcinoma, metastatic, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoma, metastatic, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8010-9</VALIDVALUE>
          <VALUEMEANING>8010-9 Carcinomatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinomatosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8011-0</VALIDVALUE>
          <VALUEMEANING>8011-0 Epithelioma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8011-3</VALIDVALUE>
          <VALUEMEANING>8011-3 Epithelioma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564127</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8012-3</VALIDVALUE>
          <VALUEMEANING>8012-3 Large cell carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Large cell carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8013-3</VALIDVALUE>
          <VALUEMEANING>8013-3 Large cell neuroendocrine carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Large cell neuroendocrine carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8014-3</VALIDVALUE>
          <VALUEMEANING>8014-3 Large cell carcinoma with rhabdoid phenotype</VALUEMEANING>
          <MEANINGDESCRIPTION>Large cell carcinoma with rhabdoid phenotype</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8015-3</VALIDVALUE>
          <VALUEMEANING>8015-3 Glassy cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Glassy cell carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8020-3</VALIDVALUE>
          <VALUEMEANING>8020-3 Carcinoma, undifferentiated, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoma, undifferentiated, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8021-3</VALIDVALUE>
          <VALUEMEANING>8021-3 Carcinoma, anaplastic, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoma, anaplastic, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8022-3</VALIDVALUE>
          <VALUEMEANING>8022-3 Pleomorphic carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Pleomorphic carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8030-3</VALIDVALUE>
          <VALUEMEANING>8030-3 Giant cell and spindle cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Giant cell and spindle cell carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8031-3</VALIDVALUE>
          <VALUEMEANING>8031-3 Giant cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Giant cell carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8032-3</VALIDVALUE>
          <VALUEMEANING>8032-3 Spindle cell carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Spindle cell carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8033-3</VALIDVALUE>
          <VALUEMEANING>8033-3 Pseudosarcomatous carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Pseudosarcomatous carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8034-3</VALIDVALUE>
          <VALUEMEANING>8034-3 Polygonal cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Polygonal cell carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8035-3</VALIDVALUE>
          <VALUEMEANING>8035-3 Carcinoma with osteoclast-like giant cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoma with osteoclast-like giant cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8040-0</VALIDVALUE>
          <VALUEMEANING>8040-0 Tumorlet, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Tumorlet, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8460-3</VALIDVALUE>
          <VALUEMEANING>8460-3 Papillary serous cystadenocarcinoma (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary serous cystadenocarcinoma (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8461-0</VALIDVALUE>
          <VALUEMEANING>8461-0 Serous surface papilloma (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Serous surface papilloma (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8462-1</VALIDVALUE>
          <VALUEMEANING>8462-1 Serous papillary cystic tumor of borderline malignancy (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Serous papillary cystic tumor of borderline malignancy (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8463-1</VALIDVALUE>
          <VALUEMEANING>8463-1 Serous surface papillary tumor of borderline malignancy (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Serous surface papillary tumor of borderline malignancy (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564438</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8470-0</VALIDVALUE>
          <VALUEMEANING>8470-0 Mucinous cystadenoma, NOS (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucinous cystadenoma, NOS (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8470-1</VALIDVALUE>
          <VALUEMEANING>8470-1 Mucinous cystic tumor with moderate dysplasia (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucinous cystic tumor with moderate dysplasia (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8470-2</VALIDVALUE>
          <VALUEMEANING>8470-2 Mucinous cystadenocarcinoma, non-invasive (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucinous cystadenocarcinoma, non-invasive (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8470-3</VALIDVALUE>
          <VALUEMEANING>8470-3 Mucinous cystadenocarcinoma, NOS (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucinous cystadenocarcinoma, NOS (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8471-0</VALIDVALUE>
          <VALUEMEANING>8471-0 Papillary mucinous cystadenoma, NOS (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary mucinous cystadenoma, NOS (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8471-3</VALIDVALUE>
          <VALUEMEANING>8471-3 Papillary mucinous cystadenocarcinoma (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary mucinous cystadenocarcinoma (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8472-1</VALIDVALUE>
          <VALUEMEANING>8472-1 Mucinous cystic tumor of borderline malignancy (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucinous cystic tumor of borderline malignancy (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8473-1</VALIDVALUE>
          <VALUEMEANING>8473-1 Papillary mucinous cystadenoma, borderline malignancy (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary mucinous cystadenoma, borderline malignancy (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564446</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8480-0</VALIDVALUE>
          <VALUEMEANING>8480-0 Mucinous adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucinous adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564447</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8480-3</VALIDVALUE>
          <VALUEMEANING>8480-3 Mucinous adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucinous adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8480-6</VALIDVALUE>
          <VALUEMEANING>8480-6 Pseudomyxoma peritonei</VALUEMEANING>
          <MEANINGDESCRIPTION>Pseudomyxoma peritonei</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8481-3</VALIDVALUE>
          <VALUEMEANING>8481-3 Mucin-producing adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucin-producing adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8482-3</VALIDVALUE>
          <VALUEMEANING>8482-3 Mucinous adenocarcinoma, endocervical type</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucinous adenocarcinoma, endocervical type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8490-3</VALIDVALUE>
          <VALUEMEANING>8490-3 Signet ring cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Signet ring cell carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8970-3</VALIDVALUE>
          <VALUEMEANING>8970-3 Hepatoblastoma (C22.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatoblastoma (C22.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8971-3</VALIDVALUE>
          <VALUEMEANING>8971-3 Pancreatoblastoma (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pancreatoblastoma (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8972-3</VALIDVALUE>
          <VALUEMEANING>8972-3 Pulmonary blastoma (C34._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pulmonary blastoma (C34._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564747</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8973-3</VALIDVALUE>
          <VALUEMEANING>8973-3 Pleuropulmonary blastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Pleuropulmonary blastoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8974-1</VALIDVALUE>
          <VALUEMEANING>8974-1 Sialoblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Sialoblastoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8980-3</VALIDVALUE>
          <VALUEMEANING>8980-3 Carcinosarcoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinosarcoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8981-3</VALIDVALUE>
          <VALUEMEANING>8981-3 Carcinosarcoma, embryonal</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinosarcoma, embryonal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564751</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8982-0</VALIDVALUE>
          <VALUEMEANING>8982-0 Myoepithelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Myoepithelioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8982-3</VALIDVALUE>
          <VALUEMEANING>8982-3 Malignant myoepithelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant myoepithelioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8983-0</VALIDVALUE>
          <VALUEMEANING>8983-0 Adenomyoepithelioma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenomyoepithelioma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564754</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8990-0</VALIDVALUE>
          <VALUEMEANING>8990-0 Mesenchymoma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesenchymoma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564755</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8990-1</VALIDVALUE>
          <VALUEMEANING>8990-1 Mesenchymoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesenchymoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8990-3</VALIDVALUE>
          <VALUEMEANING>8990-3 Mesenchymoma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesenchymoma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8991-3</VALIDVALUE>
          <VALUEMEANING>8991-3 Embryonal sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Embryonal sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564758</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>900-903</VALIDVALUE>
          <VALUEMEANING>900-903 FIBROEPITHELIAL NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>FIBROEPITHELIAL NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9000-0</VALIDVALUE>
          <VALUEMEANING>9000-0 Brenner tumor, NOS (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Brenner tumor, NOS (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564760</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9000-1</VALIDVALUE>
          <VALUEMEANING>9000-1 Brenner tumor, borderline malignancy (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Brenner tumor, borderline malignancy (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564761</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9000-3</VALIDVALUE>
          <VALUEMEANING>9000-3 Brenner tumor, malignant (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Brenner tumor, malignant (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9010-0</VALIDVALUE>
          <VALUEMEANING>9010-0 Fibroadenoma, NOS (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibroadenoma, NOS (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9011-0</VALIDVALUE>
          <VALUEMEANING>9011-0 Intracanalicular fibroadenoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intracanalicular fibroadenoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564764</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8040-1</VALIDVALUE>
          <VALUEMEANING>8040-1 Tumorlet, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Tumorlet, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8041-3</VALIDVALUE>
          <VALUEMEANING>8041-3 Small cell carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Small cell carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564143</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8042-3</VALIDVALUE>
          <VALUEMEANING>8042-3 Oat cell carcinoma (C34._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Oat cell carcinoma (C34._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8043-3</VALIDVALUE>
          <VALUEMEANING>8043-3 Small cell carcinoma, fusiform cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Small cell carcinoma, fusiform cell</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564145</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8044-3</VALIDVALUE>
          <VALUEMEANING>8044-3 Small cell carcinoma, intermediate cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Small cell carcinoma, intermediate cell</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8045-3</VALIDVALUE>
          <VALUEMEANING>8045-3 Combined small cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Combined small cell carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8046-3</VALIDVALUE>
          <VALUEMEANING>8046-3 Non-small cell carcinoma (C34._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Non-small cell carcinoma (C34._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>805-808</VALIDVALUE>
          <VALUEMEANING>805-808 SQUAMOUS CELL NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>SQUAMOUS CELL NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564149</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8050-0</VALIDVALUE>
          <VALUEMEANING>8050-0 Papilloma, NOS (except papilloma of bladder M-8120-1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papilloma, NOS (except papilloma of bladder M-8120/1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8050-2</VALIDVALUE>
          <VALUEMEANING>8050-2 Papillary carcinoma in situ</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary carcinoma in situ</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8050-3</VALIDVALUE>
          <VALUEMEANING>8050-3 Papillary carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8051-0</VALIDVALUE>
          <VALUEMEANING>8051-0 Verrucous papilloma</VALUEMEANING>
          <MEANINGDESCRIPTION>Verrucous papilloma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8051-3</VALIDVALUE>
          <VALUEMEANING>8051-3 Verrucous carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Verrucous carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8052-0</VALIDVALUE>
          <VALUEMEANING>8052-0 Squamous cell papilloma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell papilloma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8052-2</VALIDVALUE>
          <VALUEMEANING>8052-2 Papillary squamous cell carcinoma, non-invasive</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary squamous cell carcinoma, non-invasive</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8052-3</VALIDVALUE>
          <VALUEMEANING>8052-3 Papillary squamous cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary squamous cell carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8053-0</VALIDVALUE>
          <VALUEMEANING>8053-0 Squamous cell papilloma, inverted</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell papilloma, inverted</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8060-0</VALIDVALUE>
          <VALUEMEANING>8060-0 Squamous papillomatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous papillomatosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8070-2</VALIDVALUE>
          <VALUEMEANING>8070-2 Squamous cell carcinoma in situ, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinoma in situ, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8070-3</VALIDVALUE>
          <VALUEMEANING>8070-3 Squamous cell carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8490-6</VALIDVALUE>
          <VALUEMEANING>8490-6 Metastatic signet ring cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Metastatic signet ring cell carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>850-854</VALIDVALUE>
          <VALUEMEANING>850-854 DUCTAL AND LOBULAR NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>DUCTAL AND LOBULAR NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8500-2</VALIDVALUE>
          <VALUEMEANING>8500-2 Intraductal carcinoma, noninfiltrating, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraductal carcinoma, noninfiltrating, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8500-3</VALIDVALUE>
          <VALUEMEANING>8500-3 Infiltrating duct carcinoma, NOS (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Infiltrating duct carcinoma, NOS (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8501-2</VALIDVALUE>
          <VALUEMEANING>8501-2 Comedocarcinoma, noninfiltrating (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Comedocarcinoma, noninfiltrating (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8501-3</VALIDVALUE>
          <VALUEMEANING>8501-3 Comedocarcinoma, NOS (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Comedocarcinoma, NOS (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8502-3</VALIDVALUE>
          <VALUEMEANING>8502-3 Secretory carcinoma of breast (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Secretory carcinoma of breast (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8503-0</VALIDVALUE>
          <VALUEMEANING>8503-0 Intraductal papilloma</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraductal papilloma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8503-2</VALIDVALUE>
          <VALUEMEANING>8503-2 Noninfiltrating intraductal papillary adenocarcinoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Noninfiltrating intraductal papillary adenocarcinoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8503-3</VALIDVALUE>
          <VALUEMEANING>8503-3 Intraductal papillary adenocarcinoma with invasion (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraductal papillary adenocarcinoma with invasion (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8504-0</VALIDVALUE>
          <VALUEMEANING>8504-0 Intracystic papillary adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Intracystic papillary adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8504-2</VALIDVALUE>
          <VALUEMEANING>8504-2 Noninfiltrating intracystic carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Noninfiltrating intracystic carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8504-3</VALIDVALUE>
          <VALUEMEANING>8504-3 Intracystic carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Intracystic carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8505-0</VALIDVALUE>
          <VALUEMEANING>8505-0 Intraductal papillomatosis, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraductal papillomatosis, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8506-0</VALIDVALUE>
          <VALUEMEANING>8506-0 Adenoma of nipple (C50.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenoma of nipple (C50.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8507-2</VALIDVALUE>
          <VALUEMEANING>8507-2 Intraductal micropapillary carcinoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraductal micropapillary carcinoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8508-3</VALIDVALUE>
          <VALUEMEANING>8508-3 Cystic hypersecretory carcinoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cystic hypersecretory carcinoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8510-3</VALIDVALUE>
          <VALUEMEANING>8510-3 Medullary carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Medullary carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8512-3</VALIDVALUE>
          <VALUEMEANING>8512-3 Medullary carcinoma with lymphoid stroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Medullary carcinoma with lymphoid stroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8513-3</VALIDVALUE>
          <VALUEMEANING>8513-3 Atypical medullary carcinoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Atypical medullary carcinoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9012-0</VALIDVALUE>
          <VALUEMEANING>9012-0 Pericanalicular fibroadenoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pericanalicular fibroadenoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564765</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9013-0</VALIDVALUE>
          <VALUEMEANING>9013-0 Adenofibroma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenofibroma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564766</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9014-0</VALIDVALUE>
          <VALUEMEANING>9014-0 Serous adenofibroma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Serous adenofibroma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9014-1</VALIDVALUE>
          <VALUEMEANING>9014-1 Serous adenofibroma of borderline malignancy</VALUEMEANING>
          <MEANINGDESCRIPTION>Serous adenofibroma of borderline malignancy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9014-3</VALIDVALUE>
          <VALUEMEANING>9014-3 Serous adenocarcinofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Serous adenocarcinofibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9015-0</VALIDVALUE>
          <VALUEMEANING>9015-0 Mucinous adenofibroma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucinous adenofibroma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564770</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9015-1</VALIDVALUE>
          <VALUEMEANING>9015-1 Mucinous adenofibroma of borderline malignancy</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucinous adenofibroma of borderline malignancy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9015-3</VALIDVALUE>
          <VALUEMEANING>9015-3 Mucinous adenocarcinofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucinous adenocarcinofibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9016-0</VALIDVALUE>
          <VALUEMEANING>9016-0 Giant fibroadenoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Giant fibroadenoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9020-0</VALIDVALUE>
          <VALUEMEANING>9020-0 Phyllodes tumor, benign (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Phyllodes tumor, benign (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564774</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9020-1</VALIDVALUE>
          <VALUEMEANING>9020-1 Phyllodes tumor, borderline (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Phyllodes tumor, borderline (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9020-3</VALIDVALUE>
          <VALUEMEANING>9020-3 Phyllodes tumor, malignant (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Phyllodes tumor, malignant (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564776</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9030-0</VALIDVALUE>
          <VALUEMEANING>9030-0 Juvenile fibroadenoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Juvenile fibroadenoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>904</VALIDVALUE>
          <VALUEMEANING>904 SYNOVIAL-LIKE NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>SYNOVIAL-LIKE NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564778</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9040-0</VALIDVALUE>
          <VALUEMEANING>9040-0 Synovioma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Synovioma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9041-3</VALIDVALUE>
          <VALUEMEANING>9041-3 Synovial sarcoma, spindle cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Synovial sarcoma, spindle cell</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9042-3</VALIDVALUE>
          <VALUEMEANING>9042-3 Synovial sarcoma, epithelioid cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Synovial sarcoma, epithelioid cell</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9043-3</VALIDVALUE>
          <VALUEMEANING>9043-3 Synovial sarcoma, biphasic</VALUEMEANING>
          <MEANINGDESCRIPTION>Synovial sarcoma, biphasic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8070-6</VALIDVALUE>
          <VALUEMEANING>8070-6 Squamous cell carcinoma, metastatic, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinoma, metastatic, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8071-3</VALIDVALUE>
          <VALUEMEANING>8071-3 Squamous cell carcinoma, keratinizing, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinoma, keratinizing, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8072-3</VALIDVALUE>
          <VALUEMEANING>8072-3 Squamous cell carcinoma, large cell, nonkeratinizing, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinoma, large cell, nonkeratinizing, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8073-3</VALIDVALUE>
          <VALUEMEANING>8073-3 Squamous cell carcinoma, small cell, nonkeratinizing</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinoma, small cell, nonkeratinizing</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8074-3</VALIDVALUE>
          <VALUEMEANING>8074-3 Squamous cell carcinoma, spindle cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinoma, spindle cell</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8075-3</VALIDVALUE>
          <VALUEMEANING>8075-3 Squamous cell carcinoma, adenoid</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinoma, adenoid</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8076-2</VALIDVALUE>
          <VALUEMEANING>8076-2 Squamous cell carcinoma in situ with questionable stromal invasion</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinoma in situ with questionable stromal invasion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8076-3</VALIDVALUE>
          <VALUEMEANING>8076-3 Squamous cell carcinoma, microinvasive</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinoma, microinvasive</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8077-2</VALIDVALUE>
          <VALUEMEANING>8077-2 Squamous intraepithelial neoplasia, grade III (see Coding Guidelines, page 28)</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous intraepithelial neoplasia, grade III (see Coding Guidelines, page 28)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8078-3</VALIDVALUE>
          <VALUEMEANING>8078-3 Squamous cell carcinoma with horn formation</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinoma with horn formation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8080-2</VALIDVALUE>
          <VALUEMEANING>8080-2 Queyrat erythroplasia (C60._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Queyrat erythroplasia (C60._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8081-2</VALIDVALUE>
          <VALUEMEANING>8081-2 Bowen disease (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Bowen disease (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8082-3</VALIDVALUE>
          <VALUEMEANING>8082-3 Lymphoepithelial carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymphoepithelial carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8083-3</VALIDVALUE>
          <VALUEMEANING>8083-3 Basaloid squamous cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Basaloid squamous cell carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8084-3</VALIDVALUE>
          <VALUEMEANING>8084-3 Squamous cell carcinoma, clear cell type</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinoma, clear cell type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>809-811</VALIDVALUE>
          <VALUEMEANING>809-811 BASAL CELL NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>BASAL CELL NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8090-3</VALIDVALUE>
          <VALUEMEANING>8090-3 Basal cell carcinoma, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Basal cell carcinoma, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8091-3</VALIDVALUE>
          <VALUEMEANING>8091-3  Multifocal superficial basal cell carcinoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Multifocal superficial basal cell carcinoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8514-3</VALIDVALUE>
          <VALUEMEANING>8514-3 Duct carcinoma, desmoplastic type</VALUEMEANING>
          <MEANINGDESCRIPTION>Duct carcinoma, desmoplastic type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8520-2</VALIDVALUE>
          <VALUEMEANING>8520-2 Lobular carcinoma in situ, NOS (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Lobular carcinoma in situ, NOS (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8520-3</VALIDVALUE>
          <VALUEMEANING>8520-3 Lobular carcinoma, NOS (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Lobular carcinoma, NOS (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8521-3</VALIDVALUE>
          <VALUEMEANING>8521-3 Infiltrating ductular carcinoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Infiltrating ductular carcinoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8522-2</VALIDVALUE>
          <VALUEMEANING>8522-2 Intraductal carcinoma and lobular carcinoma in situ (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraductal carcinoma and lobular carcinoma in situ (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8522-3</VALIDVALUE>
          <VALUEMEANING>8522-3 Infiltrating duct and lobular carcinoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Infiltrating duct and lobular carcinoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8524-3</VALIDVALUE>
          <VALUEMEANING>8524-3 Infiltrating lobular mixed with other types of carcinoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Infiltrating lobular mixed with other types of carcinoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8525-3</VALIDVALUE>
          <VALUEMEANING>8525-3 Polymorphous low grade adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Polymorphous low grade adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8530-3</VALIDVALUE>
          <VALUEMEANING>8530-3 Inflammatory carcinoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammatory carcinoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8540-3</VALIDVALUE>
          <VALUEMEANING>8540-3 Paget disease, mammary (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Paget disease, mammary (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8541-3</VALIDVALUE>
          <VALUEMEANING>8541-3 Paget disease and infiltrating duct carcinoma of breast (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Paget disease and infiltrating duct carcinoma of breast (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564484</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8542-3</VALIDVALUE>
          <VALUEMEANING>8542-3 Paget disease, extramammary (except Paget disease of bone)</VALUEMEANING>
          <MEANINGDESCRIPTION>Paget disease, extramammary (except Paget disease of bone)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8543-3</VALIDVALUE>
          <VALUEMEANING>8543-3 Paget disease and intraductal carcinoma of breast (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Paget disease and intraductal carcinoma of breast (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564486</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>855</VALIDVALUE>
          <VALUEMEANING>855 ACINAR CELL NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>ACINAR CELL NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564487</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8550-0</VALIDVALUE>
          <VALUEMEANING>8550-0 Acinar cell adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Acinar cell adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8550-1</VALIDVALUE>
          <VALUEMEANING>8550-1 Acinar cell tumor [obs]</VALUEMEANING>
          <MEANINGDESCRIPTION>Acinar cell tumor [obs]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8550-3</VALIDVALUE>
          <VALUEMEANING>8550-3 Acinar cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Acinar cell carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8551-3</VALIDVALUE>
          <VALUEMEANING>8551-3 Acinar cell cystadenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Acinar cell cystadenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8092-3</VALIDVALUE>
          <VALUEMEANING>8092-3</VALUEMEANING>
          <MEANINGDESCRIPTION>Basal cell carcinoma, morphea (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8093-3</VALIDVALUE>
          <VALUEMEANING>8093-3 Basal cell carcinoma, fibroepithelial (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Basal cell carcinoma, fibroepithelial (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8094-3</VALIDVALUE>
          <VALUEMEANING>8094-3 Basosquamous carcinoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Basosquamous carcinoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8095-3</VALIDVALUE>
          <VALUEMEANING>8095-3 Metatypical carcinoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Metatypical carcinoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8096-0</VALIDVALUE>
          <VALUEMEANING>8096-0 Intraepidermal epithelioma of Jadassohn (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraepidermal epithelioma of Jadassohn (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8097-3</VALIDVALUE>
          <VALUEMEANING>8097-3</VALUEMEANING>
          <MEANINGDESCRIPTION>Basal cell carcinoma, nodular (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8098-3</VALIDVALUE>
          <VALUEMEANING>8098-3 Adenoid basal carcinoma (C53._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenoid basal carcinoma (C53._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8100-0</VALIDVALUE>
          <VALUEMEANING>8100-0 Trichoepithelioma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Trichoepithelioma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8101-0</VALIDVALUE>
          <VALUEMEANING>8101-0 Trichofolliculoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Trichofolliculoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8102-0</VALIDVALUE>
          <VALUEMEANING>8102-0 Trichilemmoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Trichilemmoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8102-3</VALIDVALUE>
          <VALUEMEANING>8102-3 Trichilemmocarcinoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Trichilemmocarcinoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8103-0</VALIDVALUE>
          <VALUEMEANING>8103-0 Pilar tumor (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pilar tumor (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8110-0</VALIDVALUE>
          <VALUEMEANING>8110-0 Pilomatrixoma, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pilomatrixoma, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8110-3</VALIDVALUE>
          <VALUEMEANING>8110-3 Pilomatrix carcinoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pilomatrix carcinoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>812-813</VALIDVALUE>
          <VALUEMEANING>812-813 TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</VALUEMEANING>
          <MEANINGDESCRIPTION>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8120-0</VALIDVALUE>
          <VALUEMEANING>8120-0 Transitional cell papilloma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Transitional cell papilloma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8120-1</VALIDVALUE>
          <VALUEMEANING>8120-1 Urothelial papilloma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Urothelial papilloma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8120-2</VALIDVALUE>
          <VALUEMEANING>8120-2 Transitional cell carcinoma in situ</VALUEMEANING>
          <MEANINGDESCRIPTION>Transitional cell carcinoma in situ</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8120-3</VALIDVALUE>
          <VALUEMEANING>8120-3 Transitional cell carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Transitional cell carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8121-0</VALIDVALUE>
          <VALUEMEANING>8121-0 Schneiderian papilloma, NOS (C30.0, C31._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Schneiderian papilloma, NOS (C30.0, C31._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>856-857</VALIDVALUE>
          <VALUEMEANING>856-857 COMPLEX EPITHELIAL NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>COMPLEX EPITHELIAL NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564492</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8560-0</VALIDVALUE>
          <VALUEMEANING>8560-0 Mixed squamous cell and glandular papilloma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed squamous cell and glandular papilloma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8560-3</VALIDVALUE>
          <VALUEMEANING>8560-3 Adenosquamous carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenosquamous carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8561-0</VALIDVALUE>
          <VALUEMEANING>8561-0 Adenolymphoma (C07._, C08._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenolymphoma (C07._, C08._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8562-3</VALIDVALUE>
          <VALUEMEANING>8562-3 Epithelial-myoepithelial carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelial-myoepithelial carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8570-3</VALIDVALUE>
          <VALUEMEANING>8570-3 Adenocarcinoma with squamous metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma with squamous metaplasia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8571-3</VALIDVALUE>
          <VALUEMEANING>8571-3 Adenocarcinoma with cartilaginous and osseous metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma with cartilaginous and osseous metaplasia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8572-3</VALIDVALUE>
          <VALUEMEANING>8572-3 Adenocarcinoma with spindle cell metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma with spindle cell metaplasia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8573-3</VALIDVALUE>
          <VALUEMEANING>8573-3 Adenocarcinoma with apocrine metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma with apocrine metaplasia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8574-3</VALIDVALUE>
          <VALUEMEANING>8574-3 Adenocarcinoma with neuroendocrine differentiation</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma with neuroendocrine differentiation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8575-3</VALIDVALUE>
          <VALUEMEANING>8575-3 Metaplastic carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Metaplastic carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8576-3</VALIDVALUE>
          <VALUEMEANING>8576-3 Hepatoid adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatoid adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>858 THY</VALIDVALUE>
          <VALUEMEANING>858 THYMIC EPITHELIAL NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>THYMIC EPITHELIAL NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8580-0</VALIDVALUE>
          <VALUEMEANING>8580-0 Thymoma, benign (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, benign (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8580-1</VALIDVALUE>
          <VALUEMEANING>8580-1 Thymoma, NOS (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, NOS (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8580-3</VALIDVALUE>
          <VALUEMEANING>8580-3 Thymoma, malignant, NOS (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, malignant, NOS (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8581-1</VALIDVALUE>
          <VALUEMEANING>8581-1 Thymoma, type A, NOS (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, type A, NOS (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8581-3</VALIDVALUE>
          <VALUEMEANING>8581-3 Thymoma, type A, malignant (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, type A, malignant (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8582-1</VALIDVALUE>
          <VALUEMEANING>8582-1 Thymoma, type AB, NOS (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, type AB, NOS (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8582-3</VALIDVALUE>
          <VALUEMEANING>8582-3 Thymoma, type AB, malignant (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, type AB, malignant (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8121-1</VALIDVALUE>
          <VALUEMEANING>8121-1 Transitional cell papilloma, inverted, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Transitional cell papilloma, inverted, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8121-3</VALIDVALUE>
          <VALUEMEANING>8121-3 Schneiderian carcinoma (C30.0, C31._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Schneiderian carcinoma (C30.0, C31._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8122-3</VALIDVALUE>
          <VALUEMEANING>8122-3 Transitional cell carcinoma, spindle cell</VALUEMEANING>
          <MEANINGDESCRIPTION>Transitional cell carcinoma, spindle cell</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8123-3</VALIDVALUE>
          <VALUEMEANING>8123-3 Basaloid carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Basaloid carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8124-3</VALIDVALUE>
          <VALUEMEANING>8124-3 Cloacogenic carcinoma (C21.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cloacogenic carcinoma (C21.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8130-1</VALIDVALUE>
          <VALUEMEANING>8130-1 Papillary transitional cell neoplasm of low malignant potential (C67._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary transitional cell neoplasm of low malignant potential (C67._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8130-2</VALIDVALUE>
          <VALUEMEANING>8130-2 Papillary transitional cell carcinoma, non-invasive (C67._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary transitional cell carcinoma, non-invasive (C67._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8130-3</VALIDVALUE>
          <VALUEMEANING>8130-3 Papillary transitional cell carcinoma (C67._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary transitional cell carcinoma (C67._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8131-3</VALIDVALUE>
          <VALUEMEANING>8131-3 Transitional cell carcinoma, micropapillary (C67._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Transitional cell carcinoma, micropapillary (C67._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>814-838</VALIDVALUE>
          <VALUEMEANING>814-838 ADENOMAS AND ADENOCARCINOMAS</VALUEMEANING>
          <MEANINGDESCRIPTION>ADENOMAS AND ADENOCARCINOMAS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8140-0</VALIDVALUE>
          <VALUEMEANING>8140-0 Adenoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8140-1</VALIDVALUE>
          <VALUEMEANING>8140-1 Atypical adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Atypical adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8140-2</VALIDVALUE>
          <VALUEMEANING>8140-2 Adenocarcinoma in situ, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma in situ, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8140-3</VALIDVALUE>
          <VALUEMEANING>8140-3 Adenocarcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8140-6</VALIDVALUE>
          <VALUEMEANING>8140-6 Adenocarcinoma, metastatic, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma, metastatic, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8141-3</VALIDVALUE>
          <VALUEMEANING>8141-3 Scirrhous adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Scirrhous adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8142-3</VALIDVALUE>
          <VALUEMEANING>8142-3 Linitis plastica (C16._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Linitis plastica (C16._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564217</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8143-3</VALIDVALUE>
          <VALUEMEANING>8143-3 Superficial spreading adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Superficial spreading adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8144-3</VALIDVALUE>
          <VALUEMEANING>8144-3 Adenocarcinoma, intestinal type (C16._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma, intestinal type (C16._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8583-1</VALIDVALUE>
          <VALUEMEANING>8583-1 Thymoma, type B1, NOS (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, type B1, NOS (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8583-3</VALIDVALUE>
          <VALUEMEANING>8583-3 Thymoma, type B1, malignant (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, type B1, malignant (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8584-1</VALIDVALUE>
          <VALUEMEANING>8584-1 Thymoma, type B2, NOS (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, type B2, NOS (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8584-3</VALIDVALUE>
          <VALUEMEANING>8584-3 Thymoma, type B2, malignant (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, type B2, malignant (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8585-1</VALIDVALUE>
          <VALUEMEANING>8585-1 Thymoma, type B3, NOS (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, type B3, NOS (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8585-3</VALIDVALUE>
          <VALUEMEANING>8585-3 Thymoma, type B3, malignant (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymoma, type B3, malignant (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8586-3</VALIDVALUE>
          <VALUEMEANING>8586-3 Thymic carcinoma, NOS (C37.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thymic carcinoma, NOS (C37.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8587-0</VALIDVALUE>
          <VALUEMEANING>8587-0 Ectopic hamartomatous thymoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Ectopic hamartomatous thymoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564519</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8588-3</VALIDVALUE>
          <VALUEMEANING>8588-3 Spindle epithelial tumor with thymus-like element</VALUEMEANING>
          <MEANINGDESCRIPTION>Spindle epithelial tumor with thymus-like element</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8589-3</VALIDVALUE>
          <VALUEMEANING>8589-3 Carcinoma showing thymus-like element</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoma showing thymus-like element</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564521</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8590-1</VALIDVALUE>
          <VALUEMEANING>8590-1 Sex cord-gonadal stromal tumor, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Sex cord-gonadal stromal tumor, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8591-1</VALIDVALUE>
          <VALUEMEANING>8591-1 Sex cord-gonadal stromal tumor, incompletely differentiated</VALUEMEANING>
          <MEANINGDESCRIPTION>Sex cord-gonadal stromal tumor, incompletely differentiated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8592-1</VALIDVALUE>
          <VALUEMEANING>8592-1 Sex cord-gonadal stromal tumor, mixed forms</VALUEMEANING>
          <MEANINGDESCRIPTION>Sex cord-gonadal stromal tumor, mixed forms</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8593-1</VALIDVALUE>
          <VALUEMEANING>8593-1 Stromal tumor with minor sex cord elements (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Stromal tumor with minor sex cord elements (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8600-0</VALIDVALUE>
          <VALUEMEANING>8600-0 Thecoma, NOS (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thecoma, NOS (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8600-3</VALIDVALUE>
          <VALUEMEANING>8600-3 Thecoma, malignant (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thecoma, malignant (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564528</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8601-0</VALIDVALUE>
          <VALUEMEANING>8601-0 Thecoma, luteinized (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Thecoma, luteinized (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8602-0</VALIDVALUE>
          <VALUEMEANING>8602-0 Sclerosing stromal tumor (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Sclerosing stromal tumor (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8145-3</VALIDVALUE>
          <VALUEMEANING>8145-3 Carcinoma, diffuse type (C16._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoma, diffuse type (C16._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8147-0</VALIDVALUE>
          <VALUEMEANING>8147-0 Basal cell adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Basal cell adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8147-3</VALIDVALUE>
          <VALUEMEANING>8147-3 Basal cell adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Basal cell adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8148-2</VALIDVALUE>
          <VALUEMEANING>8148-2 Glandular intraepithelial neoplasia, grade III</VALUEMEANING>
          <MEANINGDESCRIPTION>Glandular intraepithelial neoplasia, grade III</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8149-0</VALIDVALUE>
          <VALUEMEANING>8149-0 Canalicular adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Canalicular adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8150-0</VALIDVALUE>
          <VALUEMEANING>8150-0 Islet cell adenoma (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Islet cell adenoma (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8150-1</VALIDVALUE>
          <VALUEMEANING>8150-1 Islet cell tumor, NOS (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Islet cell tumor, NOS (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8150-3</VALIDVALUE>
          <VALUEMEANING>8150-3 Islet cell carcinoma (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Islet cell carcinoma (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8151-0</VALIDVALUE>
          <VALUEMEANING>8151-0 Insulinoma, NOS (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Insulinoma, NOS (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8151-3</VALIDVALUE>
          <VALUEMEANING>8151-3 Insulinoma, malignant (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Insulinoma, malignant (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564230</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8152-1</VALIDVALUE>
          <VALUEMEANING>8152-1 Glucagonoma, NOS (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Glucagonoma, NOS (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8152-3</VALIDVALUE>
          <VALUEMEANING>8152-3 Glucagonoma, malignant (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Glucagonoma, malignant (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8153-1</VALIDVALUE>
          <VALUEMEANING>8153-1 Gastrinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Gastrinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8153-3</VALIDVALUE>
          <VALUEMEANING>8153-3 Gastrinoma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Gastrinoma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8154-3</VALIDVALUE>
          <VALUEMEANING>8154-3 Mixed islet cell and exocrine adenocarcinoma (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed islet cell and exocrine adenocarcinoma (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564235</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8155-1</VALIDVALUE>
          <VALUEMEANING>8155-1 Vipoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Vipoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8155-3</VALIDVALUE>
          <VALUEMEANING>8155-3 Vipoma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Vipoma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8156-1</VALIDVALUE>
          <VALUEMEANING>8156-1 Somatostatinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Somatostatinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8610-0</VALIDVALUE>
          <VALUEMEANING>8610-0 Luteoma, NOS (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Luteoma, NOS (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8620-1</VALIDVALUE>
          <VALUEMEANING>8620-1 Granulosa cell tumor, adult type (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Granulosa cell tumor, adult type (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8620-3</VALIDVALUE>
          <VALUEMEANING>8620-3 Granulosa cell tumor, malignant (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Granulosa cell tumor, malignant (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8621-1</VALIDVALUE>
          <VALUEMEANING>8621-1 Granulosa cell-theca cell tumor (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Granulosa cell-theca cell tumor (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8622-1</VALIDVALUE>
          <VALUEMEANING>8622-1 Granulosa cell tumor, juvenile (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Granulosa cell tumor, juvenile (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8623-1</VALIDVALUE>
          <VALUEMEANING>8623-1 Sex cord tumor with annular tubules (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Sex cord tumor with annular tubules (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8630-0</VALIDVALUE>
          <VALUEMEANING>8630-0 Androblastoma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Androblastoma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8630-1</VALIDVALUE>
          <VALUEMEANING>8630-1 Androblastoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Androblastoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8630-3</VALIDVALUE>
          <VALUEMEANING>8630-3 Androblastoma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Androblastoma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8631-0</VALIDVALUE>
          <VALUEMEANING>8631-0 Sertoli-Leydig cell tumor, well differentiated</VALUEMEANING>
          <MEANINGDESCRIPTION>Sertoli-Leydig cell tumor, well differentiated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564540</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8631-1</VALIDVALUE>
          <VALUEMEANING>8631-1 Sertoli-Leydig cell tumor of intermediate differentiation</VALUEMEANING>
          <MEANINGDESCRIPTION>Sertoli-Leydig cell tumor of intermediate differentiation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8631-3</VALIDVALUE>
          <VALUEMEANING>8631-3 Sertoli-Leydig cell tumor, poorly differentiated</VALUEMEANING>
          <MEANINGDESCRIPTION>Sertoli-Leydig cell tumor, poorly differentiated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8632-1</VALIDVALUE>
          <VALUEMEANING>8632-1 Gynandroblastoma (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Gynandroblastoma (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8633-1</VALIDVALUE>
          <VALUEMEANING>8633-1 Sertoli-Leydig cell tumor, retiform</VALUEMEANING>
          <MEANINGDESCRIPTION>Sertoli-Leydig cell tumor, retiform</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564544</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8634-1</VALIDVALUE>
          <VALUEMEANING>8634-1 Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements</VALUEMEANING>
          <MEANINGDESCRIPTION>Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8634-3</VALIDVALUE>
          <VALUEMEANING>8634-3 Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements</VALUEMEANING>
          <MEANINGDESCRIPTION>Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564546</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8640-1</VALIDVALUE>
          <VALUEMEANING>8640-1 Sertoli cell tumor, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Sertoli cell tumor, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8640-3</VALIDVALUE>
          <VALUEMEANING>8640-3 Sertoli cell carcinoma (C62._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Sertoli cell carcinoma (C62._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8641-0</VALIDVALUE>
          <VALUEMEANING>8641-0 Sertoli cell tumor with lipid storage</VALUEMEANING>
          <MEANINGDESCRIPTION>Sertoli cell tumor with lipid storage</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8642-1</VALIDVALUE>
          <VALUEMEANING>8642-1 Large cell calcifying Sertoli cell tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Large cell calcifying Sertoli cell tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8156-3</VALIDVALUE>
          <VALUEMEANING>8156-3 Somatostatinoma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Somatostatinoma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8157-1</VALIDVALUE>
          <VALUEMEANING>8157-1 Enteroglucagonoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Enteroglucagonoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8157-3</VALIDVALUE>
          <VALUEMEANING>8157-3 Enteroglucagonoma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Enteroglucagonoma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564241</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8160-0</VALIDVALUE>
          <VALUEMEANING>8160-0 Bile duct adenoma (C22.1, C24.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Bile duct adenoma (C22.1, C24.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8160-3</VALIDVALUE>
          <VALUEMEANING>8160-3 Cholangiocarcinoma (C22.1, C24.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cholangiocarcinoma (C22.1, C24.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8161-0</VALIDVALUE>
          <VALUEMEANING>8161-0 Bile duct cystadenoma (C22.1, C24.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Bile duct cystadenoma (C22.1, C24.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8161-3</VALIDVALUE>
          <VALUEMEANING>8161-3 Bile duct cystadenocarcinoma (C22.1, C24.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Bile duct cystadenocarcinoma (C22.1, C24.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8162-3</VALIDVALUE>
          <VALUEMEANING>8162-3 Klatskin tumor (C22.1, C24.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Klatskin tumor (C22.1, C24.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8170-0</VALIDVALUE>
          <VALUEMEANING>8170-0 Liver cell adenoma (C22.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Liver cell adenoma (C22.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8170-3</VALIDVALUE>
          <VALUEMEANING>8170-3 Hepatocellular carcinoma, NOS (C22.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatocellular carcinoma, NOS (C22.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8171-3</VALIDVALUE>
          <VALUEMEANING>8171-3 Hepatocellular carcinoma, fibrolamellar (C22.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatocellular carcinoma, fibrolamellar (C22.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8172-3</VALIDVALUE>
          <VALUEMEANING>8172-3 Hepatocellular carcinoma, scirrhous (C22.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatocellular carcinoma, scirrhous (C22.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8173-3</VALIDVALUE>
          <VALUEMEANING>8173-3 Hepatocellular carcinoma, spindle cell variant (C22.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatocellular carcinoma, spindle cell variant (C22.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564251</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8174-3</VALIDVALUE>
          <VALUEMEANING>8174-3 Hepatocellular carcinoma, clear cell type (C22.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatocellular carcinoma, clear cell type (C22.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8175-3</VALIDVALUE>
          <VALUEMEANING>8175-3 Hepatocellular carcinoma, pleomorphic type (C22.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatocellular carcinoma, pleomorphic type (C22.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564253</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8180-3</VALIDVALUE>
          <VALUEMEANING>8180-3 Combined hepatocellular carcinoma and cholangiocarcinoma (C22.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Combined hepatocellular carcinoma and cholangiocarcinoma (C22.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8190-0</VALIDVALUE>
          <VALUEMEANING>8190-0 Trabecular adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Trabecular adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8190-3</VALIDVALUE>
          <VALUEMEANING>8190-3 Trabecular adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Trabecular adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8191-0</VALIDVALUE>
          <VALUEMEANING>8191-0 Embryonal adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Embryonal adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8200-0</VALIDVALUE>
          <VALUEMEANING>8200-0 Eccrine dermal cylindroma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Eccrine dermal cylindroma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8650-0</VALIDVALUE>
          <VALUEMEANING>8650-0 Leydig cell tumor, benign (C62._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Leydig cell tumor, benign (C62._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8650-1</VALIDVALUE>
          <VALUEMEANING>8650-1 Leydig cell tumor, NOS (C62._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Leydig cell tumor, NOS (C62._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8650-3</VALIDVALUE>
          <VALUEMEANING>8650-3 Leydig cell tumor, malignant (C62._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Leydig cell tumor, malignant (C62._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564553</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8660-0</VALIDVALUE>
          <VALUEMEANING>8660-0 Hilus cell tumor (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hilus cell tumor (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564554</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8670-0</VALIDVALUE>
          <VALUEMEANING>8670-0 Lipid cell tumor of ovary (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Lipid cell tumor of ovary (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8670-3</VALIDVALUE>
          <VALUEMEANING>8670-3 Steroid cell tumor, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Steroid cell tumor, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8671-0</VALIDVALUE>
          <VALUEMEANING>8671-0 Adrenal rest tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Adrenal rest tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>868-871</VALIDVALUE>
          <VALUEMEANING>868-871 PARAGANGLIOMAS AND GLOMUS TUMORS</VALUEMEANING>
          <MEANINGDESCRIPTION>PARAGANGLIOMAS AND GLOMUS TUMORS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8680-0</VALIDVALUE>
          <VALUEMEANING>8680-0 Paraganglioma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Paraganglioma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8680-1</VALIDVALUE>
          <VALUEMEANING>8680-1 Paraganglioma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Paraganglioma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8680-3</VALIDVALUE>
          <VALUEMEANING>8680-3 Paraganglioma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Paraganglioma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8681-1</VALIDVALUE>
          <VALUEMEANING>8681-1 Sympathetic paraganglioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Sympathetic paraganglioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8682-1</VALIDVALUE>
          <VALUEMEANING>8682-1 Parasympathetic paraganglioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Parasympathetic paraganglioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8683-0</VALIDVALUE>
          <VALUEMEANING>8683-0 Gangliocytic paraganglioma (C17.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Gangliocytic paraganglioma (C17.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8691-1</VALIDVALUE>
          <VALUEMEANING>8691-1 Aortic body tumor (C75.5)</VALUEMEANING>
          <MEANINGDESCRIPTION>Aortic body tumor (C75.5)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8692-1</VALIDVALUE>
          <VALUEMEANING>8692-1 Carotid body tumor (C75.4)</VALUEMEANING>
          <MEANINGDESCRIPTION>Carotid body tumor (C75.4)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8693-1</VALIDVALUE>
          <VALUEMEANING>8693-1 Extra-adrenal paraganglioma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Extra-adrenal paraganglioma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8693-3</VALIDVALUE>
          <VALUEMEANING>8693-3 Extra-adrenal paraganglioma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Extra-adrenal paraganglioma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8200-3</VALIDVALUE>
          <VALUEMEANING>8200-3 Adenoid cystic carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenoid cystic carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564259</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8201-2</VALIDVALUE>
          <VALUEMEANING>8201-2 Cribriform carcinoma in situ (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cribriform carcinoma in situ (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8201-3</VALIDVALUE>
          <VALUEMEANING>8201-3 Cribriform carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Cribriform carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8202-0</VALIDVALUE>
          <VALUEMEANING>8202-0 Microcystic adenoma (C25._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Microcystic adenoma (C25._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8204-0</VALIDVALUE>
          <VALUEMEANING>8204-0 Lactating adenoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Lactating adenoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564263</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8210-2</VALIDVALUE>
          <VALUEMEANING>8210-2 Adenocarcinoma in situ in adenomatous polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma in situ in adenomatous polyp</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8210-3</VALIDVALUE>
          <VALUEMEANING>8210-3 Adenocarcinoma in adenomatous polyp</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma in adenomatous polyp</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8211-0</VALIDVALUE>
          <VALUEMEANING>8211-0 Tubular adenoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Tubular adenoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8211-3</VALIDVALUE>
          <VALUEMEANING>8211-3 Tubular adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Tubular adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564268</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8212-0</VALIDVALUE>
          <VALUEMEANING>8212-0 Flat adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Flat adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8213-0</VALIDVALUE>
          <VALUEMEANING>8213-0 Serrated adenoma (C18._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Serrated adenoma (C18._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8214-3</VALIDVALUE>
          <VALUEMEANING>8214-3 Parietal cell carcinoma (C16._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Parietal cell carcinoma (C16._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8215-3</VALIDVALUE>
          <VALUEMEANING>8215-3 Adenocarcinoma of anal glands (C21.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma of anal glands (C21.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8220-0</VALIDVALUE>
          <VALUEMEANING>8220-0 Adenomatous polyposis coli (C18._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenomatous polyposis coli (C18._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8220-3</VALIDVALUE>
          <VALUEMEANING>8220-3 Adenocarcinoma in adenomatous polyposis coli (C18._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma in adenomatous polyposis coli (C18._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8221-0</VALIDVALUE>
          <VALUEMEANING>8221-0 Multiple adenomatous polyps</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple adenomatous polyps</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8221-3</VALIDVALUE>
          <VALUEMEANING>8221-3 Adenocarcinoma in multiple adenomatous polyps</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma in multiple adenomatous polyps</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8230-2</VALIDVALUE>
          <VALUEMEANING>8230-2 Ductal carcinoma in situ, solid type (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Ductal carcinoma in situ, solid type (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8700-0</VALIDVALUE>
          <VALUEMEANING>8700-0 Pheochromocytoma, NOS (C74.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pheochromocytoma, NOS (C74.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8700-3</VALIDVALUE>
          <VALUEMEANING>8700-3 Pheochromocytoma, malignant (C74.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pheochromocytoma, malignant (C74.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8710-3</VALIDVALUE>
          <VALUEMEANING>8710-3 Glomangiosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Glomangiosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8711-0</VALIDVALUE>
          <VALUEMEANING>8711-0 Glomus tumor, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Glomus tumor, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8711-3</VALIDVALUE>
          <VALUEMEANING>8711-3 Glomus tumor, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Glomus tumor, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8712-0</VALIDVALUE>
          <VALUEMEANING>8712-0 Glomangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Glomangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8713-0</VALIDVALUE>
          <VALUEMEANING>8713-0 Glomangiomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Glomangiomyoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>872-879</VALIDVALUE>
          <VALUEMEANING>872-879 NEVI AND MELANOMAS</VALUEMEANING>
          <MEANINGDESCRIPTION>NEVI AND MELANOMAS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8720-0</VALIDVALUE>
          <VALUEMEANING>8720-0 Pigmented nevus, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pigmented nevus, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564578</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8720-2</VALIDVALUE>
          <VALUEMEANING>8720-2 Melanoma in situ</VALUEMEANING>
          <MEANINGDESCRIPTION>Melanoma in situ</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8720-3</VALIDVALUE>
          <VALUEMEANING>8720-3 Malignant melanoma, NOS (except juvenile melanoma M-8770-0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant melanoma, NOS (except juvenile melanoma M-8770/0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8721-3</VALIDVALUE>
          <VALUEMEANING>8721-3 Nodular melanoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Nodular melanoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564581</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8722-0</VALIDVALUE>
          <VALUEMEANING>8722-0 Balloon cell nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Balloon cell nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564582</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8722-3</VALIDVALUE>
          <VALUEMEANING>8722-3 Balloon cell melanoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Balloon cell melanoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564583</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8723-0</VALIDVALUE>
          <VALUEMEANING>8723-0 Halo nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Halo nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564584</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8723-3</VALIDVALUE>
          <VALUEMEANING>8723-3 Malignant melanoma, regressing (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant melanoma, regressing (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8725-0</VALIDVALUE>
          <VALUEMEANING>8725-0 Neuronevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Neuronevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8726-0</VALIDVALUE>
          <VALUEMEANING>8726-0 Magnocellular nevus (C69.4)</VALUEMEANING>
          <MEANINGDESCRIPTION>Magnocellular nevus (C69.4)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8727-0</VALIDVALUE>
          <VALUEMEANING>8727-0 Dysplastic nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Dysplastic nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8728-0</VALIDVALUE>
          <VALUEMEANING>8728-0 Diffuse melanocytosis (C70.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Diffuse melanocytosis (C70.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8230-3</VALIDVALUE>
          <VALUEMEANING>8230-3 Solid carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Solid carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8231-3</VALIDVALUE>
          <VALUEMEANING>8231-3 Carcinoma simplex</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoma simplex</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8240-1</VALIDVALUE>
          <VALUEMEANING>8240-1 Carcinoid tumor of uncertain malignant potential</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoid tumor of uncertain malignant potential</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8240-3</VALIDVALUE>
          <VALUEMEANING>8240-3 Carcinoid tumor, NOS (except of appendix M-8240-1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoid tumor, NOS (except of appendix M-8240/1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8241-3</VALIDVALUE>
          <VALUEMEANING>8241-3 Enterochromaffin cell carcinoid</VALUEMEANING>
          <MEANINGDESCRIPTION>Enterochromaffin cell carcinoid</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564282</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8242-1</VALIDVALUE>
          <VALUEMEANING>8242-1 Enterochromaffin-like cell carcinoid, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Enterochromaffin-like cell carcinoid, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8242-3</VALIDVALUE>
          <VALUEMEANING>8242-3 Enterochromaffin-like cell tumor, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Enterochromaffin-like cell tumor, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8243-3</VALIDVALUE>
          <VALUEMEANING>8243-3 Goblet cell carcinoid</VALUEMEANING>
          <MEANINGDESCRIPTION>Goblet cell carcinoid</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8244-3</VALIDVALUE>
          <VALUEMEANING>8244-3 Composite carcinoid</VALUEMEANING>
          <MEANINGDESCRIPTION>Composite carcinoid</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8245-1</VALIDVALUE>
          <VALUEMEANING>8245-1 Tubular carcinoid</VALUEMEANING>
          <MEANINGDESCRIPTION>Tubular carcinoid</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8245-3</VALIDVALUE>
          <VALUEMEANING>8245-3 Adenocarcinoid tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoid tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8246-3</VALIDVALUE>
          <VALUEMEANING>8246-3 Neuroendocrine carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Neuroendocrine carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8247-3</VALIDVALUE>
          <VALUEMEANING>8247-3 Merkel cell carcinoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Merkel cell carcinoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8248-1</VALIDVALUE>
          <VALUEMEANING>8248-1 Apudoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Apudoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8249-3</VALIDVALUE>
          <VALUEMEANING>8249-3 Atypical carcinoid tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Atypical carcinoid tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8250-1</VALIDVALUE>
          <VALUEMEANING>8250-1 Pulmonary adenomatosis (C34._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pulmonary adenomatosis (C34._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8250-3</VALIDVALUE>
          <VALUEMEANING>8250-3 Bronchiolo-alveolar adenocarcinoma, NOS (C34._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Bronchiolo-alveolar adenocarcinoma, NOS (C34._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8251-0</VALIDVALUE>
          <VALUEMEANING>8251-0 Alveolar adenoma (C34._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Alveolar adenoma (C34._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8251-3</VALIDVALUE>
          <VALUEMEANING>8251-3 Alveolar adenocarcinoma (C34._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Alveolar adenocarcinoma (C34._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8252-3</VALIDVALUE>
          <VALUEMEANING>8252-3 Bronchiolo-alveolar carcinoma, non- mucinous (C34._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Bronchiolo-alveolar carcinoma, non- mucinous (C34._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8728-1</VALIDVALUE>
          <VALUEMEANING>8728-1 Meningeal melanocytoma (C70.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Meningeal melanocytoma (C70.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8728-3</VALIDVALUE>
          <VALUEMEANING>8728-3 Meningeal melanomatosis (C70.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Meningeal melanomatosis (C70.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564591</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8730-0</VALIDVALUE>
          <VALUEMEANING>8730-0 Nonpigmented nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Nonpigmented nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564592</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8730-3</VALIDVALUE>
          <VALUEMEANING>8730-3 Amelanotic melanoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Amelanotic melanoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8740-0</VALIDVALUE>
          <VALUEMEANING>8740-0 Junctional nevus, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Junctional nevus, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8740-3</VALIDVALUE>
          <VALUEMEANING>8740-3 Malignant melanoma in junctional nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant melanoma in junctional nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8741-2</VALIDVALUE>
          <VALUEMEANING>8741-2 Precancerous melanosis, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Precancerous melanosis, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8741-3</VALIDVALUE>
          <VALUEMEANING>8741-3 Malignant melanoma in precancerous melanosis (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant melanoma in precancerous melanosis (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8742-2</VALIDVALUE>
          <VALUEMEANING>8742-2 Lentigo maligna (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Lentigo maligna (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8742-3</VALIDVALUE>
          <VALUEMEANING>8742-3 Lentigo maligna melanoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Lentigo maligna melanoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8743-3</VALIDVALUE>
          <VALUEMEANING>8743-3 Superficial spreading melanoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Superficial spreading melanoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8744-3</VALIDVALUE>
          <VALUEMEANING>8744-3 Acral lentiginous melanoma, malignant (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Acral lentiginous melanoma, malignant (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8745-3</VALIDVALUE>
          <VALUEMEANING>8745-3 Desmoplastic melanoma, malignant (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Desmoplastic melanoma, malignant (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564602</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8746-3</VALIDVALUE>
          <VALUEMEANING>8746-3 Mucosal lentiginous melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mucosal lentiginous melanoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8750-0</VALIDVALUE>
          <VALUEMEANING>8750-0 Intradermal nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intradermal nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8760-0</VALIDVALUE>
          <VALUEMEANING>8760-0 Compound nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Compound nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8761-0</VALIDVALUE>
          <VALUEMEANING>8761-0 Small congenital nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Small congenital nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564606</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8761-1</VALIDVALUE>
          <VALUEMEANING>8761-1 Giant pigmented nevus, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Giant pigmented nevus, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8253-3</VALIDVALUE>
          <VALUEMEANING>8253-3  Bronchiolo-alveolar carcinoma, mucinous (C34._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Bronchiolo-alveolar carcinoma, mucinous (C34._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8254-3</VALIDVALUE>
          <VALUEMEANING>8254-3 Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous (C34._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous (C34._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8255-3</VALIDVALUE>
          <VALUEMEANING>8255-3 Adenocarcinoma with mixed subtypes</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma with mixed subtypes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8260-0</VALIDVALUE>
          <VALUEMEANING>8260-0 Papillary adenoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary adenoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8260-3</VALIDVALUE>
          <VALUEMEANING>8260-3 Papillary adenocarcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary adenocarcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8261-0</VALIDVALUE>
          <VALUEMEANING>8261-0 Villous adenoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Villous adenoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8261-2</VALIDVALUE>
          <VALUEMEANING>8261-2 Adenocarcinoma in situ in villous adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma in situ in villous adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8261-3</VALIDVALUE>
          <VALUEMEANING>8261-3 Adenocarcinoma in villous adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma in villous adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8262-3</VALIDVALUE>
          <VALUEMEANING>8262-3 Villous adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Villous adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8263-2</VALIDVALUE>
          <VALUEMEANING>8263-2 Adenocarcinoma in situ in tubulovillous adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma in situ in tubulovillous adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8263-3</VALIDVALUE>
          <VALUEMEANING>8263-3 Adenocarcinoma in tubulovillous adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenocarcinoma in tubulovillous adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8264-0</VALIDVALUE>
          <VALUEMEANING>8264-0 Papillomatosis, glandular</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillomatosis, glandular</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8270-0</VALIDVALUE>
          <VALUEMEANING>8270-0 Chromophobe adenoma (C75.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Chromophobe adenoma (C75.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8270-3</VALIDVALUE>
          <VALUEMEANING>8270-3 Chromophobe carcinoma (C75.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Chromophobe carcinoma (C75.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8271-0</VALIDVALUE>
          <VALUEMEANING>8271-0 Prolactinoma (C75.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Prolactinoma (C75.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8272-0</VALIDVALUE>
          <VALUEMEANING>8272-0 Pituitary adenoma, NOS (C75.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pituitary adenoma, NOS (C75.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8272-3</VALIDVALUE>
          <VALUEMEANING>8272-3 Pituitary carcinoma, NOS (C75.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pituitary carcinoma, NOS (C75.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8280-0</VALIDVALUE>
          <VALUEMEANING>8280-0 Acidophil adenoma (C75.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Acidophil adenoma (C75.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8762-1</VALIDVALUE>
          <VALUEMEANING>8762-1 Proliferative dermal lesion in congenital nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Proliferative dermal lesion in congenital nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8770-0</VALIDVALUE>
          <VALUEMEANING>8770-0 Epithelioid and spindle cell nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioid and spindle cell nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8770-3</VALIDVALUE>
          <VALUEMEANING>8770-3 Mixed epithelioid and spindle cell melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed epithelioid and spindle cell melanoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8771-0</VALIDVALUE>
          <VALUEMEANING>8771-0 Epithelioid cell nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioid cell nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8771-3</VALIDVALUE>
          <VALUEMEANING>8771-3 Epithelioid cell melanoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioid cell melanoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8772-0</VALIDVALUE>
          <VALUEMEANING>8772-0 Spindle cell nevus, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Spindle cell nevus, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8772-3</VALIDVALUE>
          <VALUEMEANING>8772-3 Spindle cell melanoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Spindle cell melanoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8773-3</VALIDVALUE>
          <VALUEMEANING>8773-3 Spindle cell melanoma, type A (C69._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Spindle cell melanoma, type A (C69._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8774-3</VALIDVALUE>
          <VALUEMEANING>8774-3 Spindle cell melanoma, type B (C69._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Spindle cell melanoma, type B (C69._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8780-0</VALIDVALUE>
          <VALUEMEANING>8780-0 Blue nevus, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Blue nevus, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8780-3</VALIDVALUE>
          <VALUEMEANING>8780-3 Blue nevus, malignant (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Blue nevus, malignant (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564619</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8790-0</VALIDVALUE>
          <VALUEMEANING>8790-0 Cellular blue nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cellular blue nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>880</VALIDVALUE>
          <VALUEMEANING>880 SOFT TISSUE TUMORS AND SARCOMAS, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>SOFT TISSUE TUMORS AND SARCOMAS, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8800-0</VALIDVALUE>
          <VALUEMEANING>8800-0 Soft tissue tumor, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Soft tissue tumor, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8800-3</VALIDVALUE>
          <VALUEMEANING>8800-3 Sarcoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Sarcoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8800-9</VALIDVALUE>
          <VALUEMEANING>8800-9 Sarcomatosis, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Sarcomatosis, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8801-3</VALIDVALUE>
          <VALUEMEANING>8801-3 Spindle cell sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Spindle cell sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564625</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8802-3</VALIDVALUE>
          <VALUEMEANING>8802-3 Giant cell sarcoma (except of bone M-9250-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Giant cell sarcoma (except of bone M-9250/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8803-3</VALIDVALUE>
          <VALUEMEANING>8803-3 Small cell sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Small cell sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8280-3</VALIDVALUE>
          <VALUEMEANING>8280-3 Acidophil carcinoma (C75.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Acidophil carcinoma (C75.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8281-0</VALIDVALUE>
          <VALUEMEANING>8281-0 Mixed acidophil-basophil adenoma (C75.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed acidophil-basophil adenoma (C75.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8281-3</VALIDVALUE>
          <VALUEMEANING>8281-3 Mixed acidophil-basophil carcinoma (C75.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed acidophil-basophil carcinoma (C75.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8290-0</VALIDVALUE>
          <VALUEMEANING>8290-0 Oxyphilic adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Oxyphilic adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8290-3</VALIDVALUE>
          <VALUEMEANING>8290-3 Oxyphilic adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Oxyphilic adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564321</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8300-0</VALIDVALUE>
          <VALUEMEANING>8300-0 Basophil adenoma (C75.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Basophil adenoma (C75.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8300-3</VALIDVALUE>
          <VALUEMEANING>8300-3 Basophil carcinoma (C75.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Basophil carcinoma (C75.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8310-0</VALIDVALUE>
          <VALUEMEANING>8310-0 Clear cell adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8310-3</VALIDVALUE>
          <VALUEMEANING>8310-3 Clear cell adenocarcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell adenocarcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8311-1</VALIDVALUE>
          <VALUEMEANING>8311-1 Hypernephroid tumor [obs]</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypernephroid tumor [obs]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8312-3</VALIDVALUE>
          <VALUEMEANING>8312-3 Renal cell carcinoma, NOS (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Renal cell carcinoma, NOS (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8313-0</VALIDVALUE>
          <VALUEMEANING>8313-0 Clear cell adenofibroma (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell adenofibroma (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8313-1</VALIDVALUE>
          <VALUEMEANING>8313-1 Clear cell adenofibroma of borderline malignancy (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell adenofibroma of borderline malignancy (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8313-3</VALIDVALUE>
          <VALUEMEANING>8313-3 Clear cell adenocarcinofibroma (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell adenocarcinofibroma (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8314-3</VALIDVALUE>
          <VALUEMEANING>8314-3 Lipid-rich carcinoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Lipid-rich carcinoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8315-3</VALIDVALUE>
          <VALUEMEANING>8315-3 Glycogen-rich carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Glycogen-rich carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8316-3</VALIDVALUE>
          <VALUEMEANING>8316-3 Cyst-associated renal cell carcinoma (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cyst-associated renal cell carcinoma (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8317-3</VALIDVALUE>
          <VALUEMEANING>8317-3 Renal cell carcinoma, chromophobe type (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Renal cell carcinoma, chromophobe type (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8318-3</VALIDVALUE>
          <VALUEMEANING>8318-3 Renal cell carcinoma, sarcomatoid (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Renal cell carcinoma, sarcomatoid (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8319-3</VALIDVALUE>
          <VALUEMEANING>8319-3 Collecting duct carcinoma (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Collecting duct carcinoma (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564336</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8804-3</VALIDVALUE>
          <VALUEMEANING>8804-3 Epithelioid sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioid sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8805-3</VALIDVALUE>
          <VALUEMEANING>8805-3 Undifferentiated sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Undifferentiated sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8806-3</VALIDVALUE>
          <VALUEMEANING>8806-3 Desmoplastic small round cell tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Desmoplastic small round cell tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>881-883</VALIDVALUE>
          <VALUEMEANING>881-883 FIBROMATOUS NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>FIBROMATOUS NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8810-0</VALIDVALUE>
          <VALUEMEANING>8810-0 Fibroma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibroma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8810-1</VALIDVALUE>
          <VALUEMEANING>8810-1 Cellular fibroma (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cellular fibroma (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8810-3</VALIDVALUE>
          <VALUEMEANING>8810-3 Fibrosarcoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibrosarcoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8811-0</VALIDVALUE>
          <VALUEMEANING>8811-0 Fibromyxoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibromyxoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8811-3</VALIDVALUE>
          <VALUEMEANING>8811-3 Fibromyxosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibromyxosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8812-0</VALIDVALUE>
          <VALUEMEANING>8812-0 Periosteal fibroma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Periosteal fibroma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8812-3</VALIDVALUE>
          <VALUEMEANING>8812-3 Periosteal fibrosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Periosteal fibrosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8813-0</VALIDVALUE>
          <VALUEMEANING>8813-0 Fascial fibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Fascial fibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8813-3</VALIDVALUE>
          <VALUEMEANING>8813-3 Fascial fibrosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Fascial fibrosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8814-3</VALIDVALUE>
          <VALUEMEANING>8814-3 Infantile fibrosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Infantile fibrosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8815-0</VALIDVALUE>
          <VALUEMEANING>8815-0 Solitary fibrous tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Solitary fibrous tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8815-3</VALIDVALUE>
          <VALUEMEANING>8815-3 Solitary fibrous tumor, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Solitary fibrous tumor, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8820-0</VALIDVALUE>
          <VALUEMEANING>8820-0 Elastofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Elastofibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8821-1</VALIDVALUE>
          <VALUEMEANING>8821-1 Aggressive fibromatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Aggressive fibromatosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8822-1</VALIDVALUE>
          <VALUEMEANING>8822-1 Abdominal fibromatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Abdominal fibromatosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8823-0</VALIDVALUE>
          <VALUEMEANING>8823-0 Desmoplastic fibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Desmoplastic fibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8320-3</VALIDVALUE>
          <VALUEMEANING>8320-3 Granular cell carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Granular cell carcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8321-0</VALIDVALUE>
          <VALUEMEANING>8321-0 Chief cell adenoma (C75.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Chief cell adenoma (C75.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8322-0</VALIDVALUE>
          <VALUEMEANING>8322-0 Water-clear cell adenoma (C75.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Water-clear cell adenoma (C75.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564339</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8322-3</VALIDVALUE>
          <VALUEMEANING>8322-3 Water-clear cell adenocarcinoma (C75.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Water-clear cell adenocarcinoma (C75.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564340</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8323-0</VALIDVALUE>
          <VALUEMEANING>8323-0 Mixed cell adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed cell adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8323-3</VALIDVALUE>
          <VALUEMEANING>8323-3 Mixed cell adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed cell adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8324-0</VALIDVALUE>
          <VALUEMEANING>8324-0 Lipoadenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Lipoadenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564343</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8325-0</VALIDVALUE>
          <VALUEMEANING>8325-0 Metanephric adenoma (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Metanephric adenoma (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564344</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8330-0</VALIDVALUE>
          <VALUEMEANING>8330-0 Follicular adenoma (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Follicular adenoma (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564345</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8330-1</VALIDVALUE>
          <VALUEMEANING>8330-1 Atypical follicular adenoma (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Atypical follicular adenoma (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8330-3</VALIDVALUE>
          <VALUEMEANING>8330-3 Follicular adenocarcinoma, NOS (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Follicular adenocarcinoma, NOS (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564347</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8331-3</VALIDVALUE>
          <VALUEMEANING>8331-3 Follicular adenocarcinoma, well differentiated (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Follicular adenocarcinoma, well differentiated (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8332-3</VALIDVALUE>
          <VALUEMEANING>8332-3 Follicular adenocarcinoma, trabecular (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Follicular adenocarcinoma, trabecular (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8333-3</VALIDVALUE>
          <VALUEMEANING>8333-3 Fetal adenocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Fetal adenocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564351</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8334-0</VALIDVALUE>
          <VALUEMEANING>8334-0 Macrofollicular adenoma (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Macrofollicular adenoma (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8335-3</VALIDVALUE>
          <VALUEMEANING>8335-3 Follicular carcinoma, minimally invasive (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Follicular carcinoma, minimally invasive (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8336-0</VALIDVALUE>
          <VALUEMEANING>8336-0 Hyalinizing trabecular adenoma (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hyalinizing trabecular adenoma (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8337-3</VALIDVALUE>
          <VALUEMEANING>8337-3 Insular carcinoma (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Insular carcinoma (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8824-0</VALIDVALUE>
          <VALUEMEANING>8824-0 Myofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Myofibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8824-1</VALIDVALUE>
          <VALUEMEANING>8824-1 Myofibromatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Myofibromatosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564649</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8825-0</VALIDVALUE>
          <VALUEMEANING>8825-0 Myofibroblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Myofibroblastoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8826-0</VALIDVALUE>
          <VALUEMEANING>8826-0 Angiomyofibroblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Angiomyofibroblastoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8827-1</VALIDVALUE>
          <VALUEMEANING>8827-1 Myofibroblastic tumor, peribronchial (C34._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Myofibroblastic tumor, peribronchial (C34._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8830-0</VALIDVALUE>
          <VALUEMEANING>8830-0 Benign fibrous histiocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Benign fibrous histiocytoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8830-1</VALIDVALUE>
          <VALUEMEANING>8830-1 Atypical fibrous histiocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Atypical fibrous histiocytoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564655</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8830-3</VALIDVALUE>
          <VALUEMEANING>8830-3 Malignant fibrous histiocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant fibrous histiocytoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8831-0</VALIDVALUE>
          <VALUEMEANING>8831-0 Histiocytoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Histiocytoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8832-0</VALIDVALUE>
          <VALUEMEANING>8832-0 Dermatofibroma, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Dermatofibroma, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8832-3</VALIDVALUE>
          <VALUEMEANING>8832-3 Dermatofibrosarcoma, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Dermatofibrosarcoma, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8833-3</VALIDVALUE>
          <VALUEMEANING>8833-3 Pigmented dermatofibrosarcoma protuberans (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pigmented dermatofibrosarcoma protuberans (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8834-1</VALIDVALUE>
          <VALUEMEANING>8834-1 Giant cell fibroblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Giant cell fibroblastoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8835-1</VALIDVALUE>
          <VALUEMEANING>8835-1 Plexiform fibrohistiocytic tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Plexiform fibrohistiocytic tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8836-1</VALIDVALUE>
          <VALUEMEANING>8836-1 Angiomatoid fibrous histiocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Angiomatoid fibrous histiocytoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564663</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>884</VALIDVALUE>
          <VALUEMEANING>884 MYXOMATOUS NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>MYXOMATOUS NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8840-0</VALIDVALUE>
          <VALUEMEANING>8840-0 Myxoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Myxoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564665</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8840-3</VALIDVALUE>
          <VALUEMEANING>8840-3 Myxosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Myxosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8340-3</VALIDVALUE>
          <VALUEMEANING>8340-3 Papillary carcinoma, follicular variant (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary carcinoma, follicular variant (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8341-3</VALIDVALUE>
          <VALUEMEANING>8341-3 Papillary microcarcinoma (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary microcarcinoma (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8342-3</VALIDVALUE>
          <VALUEMEANING>8342-3 Papillary carcinoma, oxyphilic cell (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary carcinoma, oxyphilic cell (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8343-3</VALIDVALUE>
          <VALUEMEANING>8343-3 Papillary carcinoma, encapsulated (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary carcinoma, encapsulated (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8344-3</VALIDVALUE>
          <VALUEMEANING>8344-3 Papillary carcinoma, columnar cell (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary carcinoma, columnar cell (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8345-3</VALIDVALUE>
          <VALUEMEANING>8345-3 Medullary carcinoma with amyloid stroma (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Medullary carcinoma with amyloid stroma (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8346-3</VALIDVALUE>
          <VALUEMEANING>8346-3 Mixed medullary-follicular carcinoma (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed medullary-follicular carcinoma (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564362</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8347-3</VALIDVALUE>
          <VALUEMEANING>8347-3 Mixed medullary-papillary carcinoma (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed medullary-papillary carcinoma (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8350-3</VALIDVALUE>
          <VALUEMEANING>8350-3 Nonencapsulated sclerosing carcinoma (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Nonencapsulated sclerosing carcinoma (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8360-1</VALIDVALUE>
          <VALUEMEANING>8360-1 Multiple endocrine adenomas</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple endocrine adenomas</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8361-0</VALIDVALUE>
          <VALUEMEANING>8361-0 Juxtaglomerular tumor (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Juxtaglomerular tumor (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8370-0</VALIDVALUE>
          <VALUEMEANING>8370-0 Adrenal cortical adenoma, NOS (C74.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adrenal cortical adenoma, NOS (C74.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8370-3</VALIDVALUE>
          <VALUEMEANING>8370-3 Adrenal cortical carcinoma (C74.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adrenal cortical carcinoma (C74.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8371-0</VALIDVALUE>
          <VALUEMEANING>8371-0 Adrenal cortical adenoma, compact cell (C74.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adrenal cortical adenoma, compact cell (C74.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8372-0</VALIDVALUE>
          <VALUEMEANING>8372-0 Adrenal cortical adenoma, pigmented (C74.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adrenal cortical adenoma, pigmented (C74.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8373-0</VALIDVALUE>
          <VALUEMEANING>8373-0 Adrenal cortical adenoma, clear cell (C74.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adrenal cortical adenoma, clear cell (C74.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8374-0</VALIDVALUE>
          <VALUEMEANING>8374-0 Adrenal cortical adenoma, glomerulosa cell (C74.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adrenal cortical adenoma, glomerulosa cell (C74.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8375-0</VALIDVALUE>
          <VALUEMEANING>8375-0 Adrenal cortical adenoma, mixed cell (C74.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adrenal cortical adenoma, mixed cell (C74.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8380-0</VALIDVALUE>
          <VALUEMEANING>8380-0 Endometrioid adenoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Endometrioid adenoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564374</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8380-1</VALIDVALUE>
          <VALUEMEANING>8380-1 Endometrioid adenoma, borderline malignancy</VALUEMEANING>
          <MEANINGDESCRIPTION>Endometrioid adenoma, borderline malignancy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8841-1</VALIDVALUE>
          <VALUEMEANING>8841-1 Angiomyxoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Angiomyxoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8842-0</VALIDVALUE>
          <VALUEMEANING>8842-0 Ossifying fibromyxoid tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Ossifying fibromyxoid tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>885-888</VALIDVALUE>
          <VALUEMEANING>885-888  LIPOMATOUS NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>LIPOMATOUS NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564669</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8850-0</VALIDVALUE>
          <VALUEMEANING>8850-0 Lipoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Lipoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8850-1</VALIDVALUE>
          <VALUEMEANING>8850-1 Atypical lipoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Atypical lipoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8850-3</VALIDVALUE>
          <VALUEMEANING>8850-3 Liposarcoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Liposarcoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564672</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8851-0</VALIDVALUE>
          <VALUEMEANING>8851-0 Fibrolipoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibrolipoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8851-3</VALIDVALUE>
          <VALUEMEANING>8851-3 Liposarcoma, well differentiated</VALUEMEANING>
          <MEANINGDESCRIPTION>Liposarcoma, well differentiated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8852-0</VALIDVALUE>
          <VALUEMEANING>8852-0 Fibromyxolipoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibromyxolipoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8852-3</VALIDVALUE>
          <VALUEMEANING>8852-3 Myxoid liposarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Myxoid liposarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8853-3</VALIDVALUE>
          <VALUEMEANING>8853-3 Round cell liposarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Round cell liposarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8854-0</VALIDVALUE>
          <VALUEMEANING>8854-0 Pleomorphic lipoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Pleomorphic lipoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8854-3</VALIDVALUE>
          <VALUEMEANING>8854-3 Pleomorphic liposarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Pleomorphic liposarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8855-3</VALIDVALUE>
          <VALUEMEANING>8855-3 Mixed liposarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed liposarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8856-0</VALIDVALUE>
          <VALUEMEANING>8856-0 Intramuscular lipoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Intramuscular lipoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8857-0</VALIDVALUE>
          <VALUEMEANING>8857-0 Spindle cell lipoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Spindle cell lipoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8857-3</VALIDVALUE>
          <VALUEMEANING>8857-3 Fibroblastic liposarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibroblastic liposarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8858-3</VALIDVALUE>
          <VALUEMEANING>8858-3 Dedifferentiated liposarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Dedifferentiated liposarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8860-0</VALIDVALUE>
          <VALUEMEANING>8860-0 Angiomyolipoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Angiomyolipoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8861-0</VALIDVALUE>
          <VALUEMEANING>8861-0 Angiolipoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Angiolipoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9523-3</VALIDVALUE>
          <VALUEMEANING>9523-3  Olfactory neuroepithelioma (C30.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Olfactory neuroepithelioma (C30.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>953</VALIDVALUE>
          <VALUEMEANING>953 MENINGIOMAS (C70._)</VALUEMEANING>
          <MEANINGDESCRIPTION>MENINGIOMAS (C70._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9530-0</VALIDVALUE>
          <VALUEMEANING>9530-0 Meningioma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Meningioma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9530-1</VALIDVALUE>
          <VALUEMEANING>9530-1 Meningiomatosis, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Meningiomatosis, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9530-3</VALIDVALUE>
          <VALUEMEANING>9530-3 Meningioma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Meningioma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9531-0</VALIDVALUE>
          <VALUEMEANING>9531-0 Meningothelial meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Meningothelial meningioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565023</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9532-0</VALIDVALUE>
          <VALUEMEANING>9532-0 Fibrous meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibrous meningioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9533-0</VALIDVALUE>
          <VALUEMEANING>9533-0 Psammomatous meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Psammomatous meningioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565025</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9534-0</VALIDVALUE>
          <VALUEMEANING>9534-0 Angiomatous meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Angiomatous meningioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9535-0</VALIDVALUE>
          <VALUEMEANING>9535-0 Hemangioblastic meningioma [obs]</VALUEMEANING>
          <MEANINGDESCRIPTION>Hemangioblastic meningioma [obs]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565027</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9537-0</VALIDVALUE>
          <VALUEMEANING>9537-0 Transitional meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Transitional meningioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565028</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9538-1</VALIDVALUE>
          <VALUEMEANING>9538-1 Clear cell meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell meningioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565029</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9538-3</VALIDVALUE>
          <VALUEMEANING>9538-3  Papillary meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary meningioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9539-1</VALIDVALUE>
          <VALUEMEANING>9539-1 Atypical meningioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Atypical meningioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9539-3</VALIDVALUE>
          <VALUEMEANING>9539-3 Meningeal sarcomatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Meningeal sarcomatosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>954-957</VALIDVALUE>
          <VALUEMEANING>954-957 NERVE SHEATH TUMORS</VALUEMEANING>
          <MEANINGDESCRIPTION>NERVE SHEATH TUMORS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565033</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9540-0</VALIDVALUE>
          <VALUEMEANING>9540-0 Neurofibroma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Neurofibroma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9540-1</VALIDVALUE>
          <VALUEMEANING>9540-1 Neurofibromatosis, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Neurofibromatosis, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9540-3</VALIDVALUE>
          <VALUEMEANING>9540-3 Malignant peripheral nerve sheath tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant peripheral nerve sheath tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9501-0</VALIDVALUE>
          <VALUEMEANING>9501-0 Medulloepithelioma, benign (C69.4)</VALUEMEANING>
          <MEANINGDESCRIPTION>Medulloepithelioma, benign (C69.4)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564998</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9501-3</VALIDVALUE>
          <VALUEMEANING>9501-3 Medulloepithelioma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Medulloepithelioma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564999</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9502-0</VALIDVALUE>
          <VALUEMEANING>9502-0 Teratoid medulloepithelioma, benign (C69.4)</VALUEMEANING>
          <MEANINGDESCRIPTION>Teratoid medulloepithelioma, benign (C69.4)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9502-3</VALIDVALUE>
          <VALUEMEANING>9502-3 Teratoid medulloepithelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Teratoid medulloepithelioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565001</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9503-3</VALIDVALUE>
          <VALUEMEANING>9503-3 Neuroepithelioma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Neuroepithelioma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565002</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9504-3</VALIDVALUE>
          <VALUEMEANING>9504-3 Spongioneuroblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Spongioneuroblastoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9505-1</VALIDVALUE>
          <VALUEMEANING>9505-1 Ganglioglioma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Ganglioglioma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9505-3</VALIDVALUE>
          <VALUEMEANING>9505-3 Ganglioglioma, anaplastic</VALUEMEANING>
          <MEANINGDESCRIPTION>Ganglioglioma, anaplastic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9506-1</VALIDVALUE>
          <VALUEMEANING>9506-1 Central neurocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Central neurocytoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9507-0</VALIDVALUE>
          <VALUEMEANING>9507-0 Pacinian tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Pacinian tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9508-3</VALIDVALUE>
          <VALUEMEANING>9508-3 Atypical teratoid-rhabdoid tumor (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Atypical teratoid/rhabdoid tumor (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9510-0</VALIDVALUE>
          <VALUEMEANING>9510-0 Retinocytoma (C69.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Retinocytoma (C69.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565009</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9510-3</VALIDVALUE>
          <VALUEMEANING>9510-3 Retinoblastoma, NOS (C69.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Retinoblastoma, NOS (C69.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9511-3</VALIDVALUE>
          <VALUEMEANING>9511-3 Retinoblastoma, differentiated (C69.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Retinoblastoma, differentiated (C69.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9512-3</VALIDVALUE>
          <VALUEMEANING>9512-3 Retinoblastoma, undifferentiated (C69.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Retinoblastoma, undifferentiated (C69.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9513-3</VALIDVALUE>
          <VALUEMEANING>9513-3 Retinoblastoma, diffuse (C69.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Retinoblastoma, diffuse (C69.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9514-1</VALIDVALUE>
          <VALUEMEANING>9514-1 Retinoblastoma, spontaneously regressed (C69.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Retinoblastoma, spontaneously regressed (C69.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9520-3</VALIDVALUE>
          <VALUEMEANING>9520-3 Olfactory neurogenic tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Olfactory neurogenic tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565015</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9521-3</VALIDVALUE>
          <VALUEMEANING>9521-3 Olfactory neurocytoma (C30.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Olfactory neurocytoma (C30.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9522-3</VALIDVALUE>
          <VALUEMEANING>9522-3 Olfactory neuroblastoma (C30.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Olfactory neuroblastoma (C30.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9541-0</VALIDVALUE>
          <VALUEMEANING>9541-0 Melanotic neurofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Melanotic neurofibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9560-0</VALIDVALUE>
          <VALUEMEANING>9560-0 Neurilemoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Neurilemoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9560-1</VALIDVALUE>
          <VALUEMEANING>9560-1 Neurinomatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Neurinomatosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9560-3</VALIDVALUE>
          <VALUEMEANING>9560-3 Neurilemoma, malignant [obs]</VALUEMEANING>
          <MEANINGDESCRIPTION>Neurilemoma, malignant [obs]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9561-3</VALIDVALUE>
          <VALUEMEANING>9561-3 Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565042</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9562-0</VALIDVALUE>
          <VALUEMEANING>9562-0 Neurothekeoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Neurothekeoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9570-0</VALIDVALUE>
          <VALUEMEANING>9570-0 Neuroma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Neuroma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9571-0</VALIDVALUE>
          <VALUEMEANING>9571-0 Perineurioma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Perineurioma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9571-3</VALIDVALUE>
          <VALUEMEANING>9571-3 Perineurioma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Perineurioma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565046</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>958</VALIDVALUE>
          <VALUEMEANING>958 GRANULAR CELL TUMORS AND ALVEOLAR SOFT PART SARCOMAS</VALUEMEANING>
          <MEANINGDESCRIPTION>GRANULAR CELL TUMORS AND ALVEOLAR SOFT PART SARCOMAS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565047</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9580-0</VALIDVALUE>
          <VALUEMEANING>9580-0 Granular cell tumor, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Granular cell tumor, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565048</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9580-3</VALIDVALUE>
          <VALUEMEANING>9580-3 Granular cell tumor, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Granular cell tumor, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565049</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9581-3</VALIDVALUE>
          <VALUEMEANING>9581-3 Alveolar soft part sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Alveolar soft part sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565050</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9582-0</VALIDVALUE>
          <VALUEMEANING>9582-0 Granular cell tumor of the sellar region (C75.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Granular cell tumor of the sellar region (C75.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>959</VALIDVALUE>
          <VALUEMEANING>959 MALIGNANT LYMPHOMAS, NOS OR DIFFUSE</VALUEMEANING>
          <MEANINGDESCRIPTION>MALIGNANT LYMPHOMAS, NOS OR DIFFUSE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>959-972</VALIDVALUE>
          <VALUEMEANING>959-972 HODGKIN ANNON-HODGKIN LYMPHOMAS</VALUEMEANING>
          <MEANINGDESCRIPTION>HODGKIN ANNON-HODGKIN LYMPHOMAS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9590-3</VALIDVALUE>
          <VALUEMEANING>9590-3 Malignant lymphoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant lymphoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9591-3</VALIDVALUE>
          <VALUEMEANING>9591-3 Malignant lymphoma, non-Hodgkin, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant lymphoma, non-Hodgkin, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9596-3</VALIDVALUE>
          <VALUEMEANING>9596-3 Composite Hodgkin and non-Hodgkin lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Composite Hodgkin and non-Hodgkin lymphoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565056</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>965-966</VALIDVALUE>
          <VALUEMEANING>965-966 HODGKIN LYMPHOMA</VALUEMEANING>
          <MEANINGDESCRIPTION>HODGKIN LYMPHOMA</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9650-3</VALIDVALUE>
          <VALUEMEANING>9650-3 Hodgkin lymphoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9651-3</VALIDVALUE>
          <VALUEMEANING>9651-3 Hodgkin lymphoma, lymphocyte-rich</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, lymphocyte-rich</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9652-3</VALIDVALUE>
          <VALUEMEANING>9652-3 Hodgkin lymphoma, mixed cellularity, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, mixed cellularity, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9653-3</VALIDVALUE>
          <VALUEMEANING>9653-3 Hodgkin lymphoma, lymphocyte depletion, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, lymphocyte depletion, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9654-3</VALIDVALUE>
          <VALUEMEANING>9654-3 Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9655-3</VALIDVALUE>
          <VALUEMEANING>9655-3 Hodgkin lymphoma, lymphocyte depletion, reticular</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, lymphocyte depletion, reticular</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9659-3</VALIDVALUE>
          <VALUEMEANING>9659-3 Hodgkin lymphoma, nodular lymphocyte predominance</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, nodular lymphocyte predominance</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9661-3</VALIDVALUE>
          <VALUEMEANING>9661-3 Hodgkin granuloma [obs]</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin granuloma [obs]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9662-3</VALIDVALUE>
          <VALUEMEANING>9662-3 Hodgkin sarcoma [obs]</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin sarcoma [obs]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9663-3</VALIDVALUE>
          <VALUEMEANING>9663-3 Hodgkin lymphoma, nodular sclerosis, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, nodular sclerosis, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9664-3</VALIDVALUE>
          <VALUEMEANING>9664-3 Hodgkin lymphoma, nodular sclerosis, cellular phase</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, nodular sclerosis, cellular phase</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9665-3</VALIDVALUE>
          <VALUEMEANING>9665-3 Hodgkin lymphoma, nodular sclerosis, grade 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, nodular sclerosis, grade 1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9667-3</VALIDVALUE>
          <VALUEMEANING>9667-3 Hodgkin lymphoma, nodular sclerosis, grade 2</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, nodular sclerosis, grade 2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>967-969</VALIDVALUE>
          <VALUEMEANING>967-969 MATURE B-CELL LYMPHOMAS</VALUEMEANING>
          <MEANINGDESCRIPTION>MATURE B-CELL LYMPHOMAS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>967-972</VALIDVALUE>
          <VALUEMEANING>967-972 NON-HODGKIN LYMPHOMAS</VALUEMEANING>
          <MEANINGDESCRIPTION>NON-HODGKIN LYMPHOMAS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9670-3</VALIDVALUE>
          <VALUEMEANING>9670-3 Malignant lymphoma, small B lymphocytic, NOS (see also M-9823-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant lymphoma, small B lymphocytic, NOS (see also M-9823/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9671-3</VALIDVALUE>
          <VALUEMEANING>9671-3 Malignant lymphoma, lymphoplasmacytic (see also M-9761-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant lymphoma, lymphoplasmacytic (see also M-9761/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9673-3</VALIDVALUE>
          <VALUEMEANING>9673-3 Mantle cell lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mantle cell lymphoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9675-3</VALIDVALUE>
          <VALUEMEANING>9675-3 Malignant lymphoma, mixed small and large cell, diffuse [obs] (see also M-9690-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant lymphoma, mixed small and large cell, diffuse [obs] (see also M-9690/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9678-3</VALIDVALUE>
          <VALUEMEANING>9678-3 Primary effusion lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Primary effusion lymphoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9679-3</VALIDVALUE>
          <VALUEMEANING>9679-3 Mediastinal large B-cell lymphoma (C38.3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mediastinal large B-cell lymphoma (C38.3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9680-3</VALIDVALUE>
          <VALUEMEANING>9680-3 Malignant lymphoma, large B-cell, diffuse, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant lymphoma, large B-cell, diffuse, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565079</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9684-3</VALIDVALUE>
          <VALUEMEANING>9684-3 Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9689-3</VALIDVALUE>
          <VALUEMEANING>9689-3 Splenic marginal zone B-cell lymphoma (C42.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Splenic marginal zone B-cell lymphoma (C42.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9690-3</VALIDVALUE>
          <VALUEMEANING>9690-3 Follicular lymphoma, NOS (see also M-9675-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Follicular lymphoma, NOS (see also M-9675/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565083</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9691-3</VALIDVALUE>
          <VALUEMEANING>9691-3 Follicular lymphoma, grade 2</VALUEMEANING>
          <MEANINGDESCRIPTION>Follicular lymphoma, grade 2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9695-3</VALIDVALUE>
          <VALUEMEANING>9695-3 Follicular lymphoma, grade 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Follicular lymphoma, grade 1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565085</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9698-3</VALIDVALUE>
          <VALUEMEANING>9698-3 Follicular lymphoma, grade 3</VALUEMEANING>
          <MEANINGDESCRIPTION>Follicular lymphoma, grade 3</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9699-3</VALIDVALUE>
          <VALUEMEANING>9699-3 Marginal zone B-cell lymphoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Marginal zone B-cell lymphoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>970-971</VALIDVALUE>
          <VALUEMEANING>970-971 MATURE T- AND NK-CELL LYMPHOMAS</VALUEMEANING>
          <MEANINGDESCRIPTION>MATURE T- AND NK-CELL LYMPHOMAS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565088</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9700-3</VALIDVALUE>
          <VALUEMEANING>9700-3 Mycosis fungoides (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mycosis fungoides (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565089</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9701-3</VALIDVALUE>
          <VALUEMEANING>9701-3 Sezary syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Sezary syndrome</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9702-3</VALIDVALUE>
          <VALUEMEANING>9702-3 Mature T-cell lymphoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Mature T-cell lymphoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9705-3</VALIDVALUE>
          <VALUEMEANING>9705-3 Angioimmunoblastic T-cell lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Angioimmunoblastic T-cell lymphoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9708-3</VALIDVALUE>
          <VALUEMEANING>9708-3 Subcutaneous panniculitis-like T-cell lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Subcutaneous panniculitis-like T-cell lymphoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9709-3</VALIDVALUE>
          <VALUEMEANING>9709-3 Cutaneous T-cell lymphoma, NOS (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cutaneous T-cell lymphoma, NOS (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9044-3</VALIDVALUE>
          <VALUEMEANING>9044-3 Clear cell sarcoma, NOS (except of kidney M-8964-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell sarcoma, NOS (except of kidney M-8964/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>905</VALIDVALUE>
          <VALUEMEANING>905 MESOTHELIAL NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>MESOTHELIAL NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9050-0</VALIDVALUE>
          <VALUEMEANING>9050-0 Mesothelioma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesothelioma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9050-3</VALIDVALUE>
          <VALUEMEANING>9050-3 Mesothelioma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesothelioma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9051-0</VALIDVALUE>
          <VALUEMEANING>9051-0 Fibrous mesothelioma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibrous mesothelioma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9051-3</VALIDVALUE>
          <VALUEMEANING>9051-3 Fibrous mesothelioma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibrous mesothelioma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9052-0</VALIDVALUE>
          <VALUEMEANING>9052-0 Epithelioid mesothelioma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioid mesothelioma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9052-3</VALIDVALUE>
          <VALUEMEANING>9052-3 Epithelioid mesothelioma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioid mesothelioma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9053-3</VALIDVALUE>
          <VALUEMEANING>9053-3 Mesothelioma, biphasic, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesothelioma, biphasic, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9054-0</VALIDVALUE>
          <VALUEMEANING>9054-0 Adenomatoid tumor, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenomatoid tumor, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9055-0</VALIDVALUE>
          <VALUEMEANING>9055-0 Multicystic mesothelioma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Multicystic mesothelioma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9055-1</VALIDVALUE>
          <VALUEMEANING>9055-1 Cystic mesothelioma, NOS (C48._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Cystic mesothelioma, NOS (C48._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>906-909</VALIDVALUE>
          <VALUEMEANING>906-909 GERM CELL NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>GERM CELL NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9060-3</VALIDVALUE>
          <VALUEMEANING>9060-3 Dysgerminoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Dysgerminoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9061-3</VALIDVALUE>
          <VALUEMEANING>9061-3 Seminoma, NOS (C62._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Seminoma, NOS (C62._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9062-3</VALIDVALUE>
          <VALUEMEANING>9062-3 Seminoma, anaplastic (C62._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Seminoma, anaplastic (C62._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564799</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9063-3</VALIDVALUE>
          <VALUEMEANING>9063-3 Spermatocytic seminoma (C62._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Spermatocytic seminoma (C62._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9064-2</VALIDVALUE>
          <VALUEMEANING>9064-2 Intratubular malignant germ cells (C62._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intratubular malignant germ cells (C62._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564801</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9064-3</VALIDVALUE>
          <VALUEMEANING>9064-3 Germinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Germinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564802</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9065-3</VALIDVALUE>
          <VALUEMEANING>9065-3 Germ cell tumor, nonseminomatous (C62._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Germ cell tumor, nonseminomatous (C62._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564803</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9714-3</VALIDVALUE>
          <VALUEMEANING>9714-3 Anaplastic large cell lymphoma, T cell and Null cell type</VALUEMEANING>
          <MEANINGDESCRIPTION>Anaplastic large cell lymphoma, T cell and Null cell type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9716-3</VALIDVALUE>
          <VALUEMEANING>9716-3 Hepatosplenic  ? (gamma-delta) cell lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatosplenic  d (gamma-delta) cell lymphoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9717-3</VALIDVALUE>
          <VALUEMEANING>9717-3 Intestinal T-cell lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Intestinal T-cell lymphoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9718-3</VALIDVALUE>
          <VALUEMEANING>9718-3 Primary cutaneous CD30+ T-cell lymphoproliferative disorder (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Primary cutaneous CD30+ T-cell lymphoproliferative disorder (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9719-3</VALIDVALUE>
          <VALUEMEANING>9719-3 NK-T-cell lymphoma, nasal and nasal-type</VALUEMEANING>
          <MEANINGDESCRIPTION>NK/T-cell lymphoma, nasal and nasal-type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>972</VALIDVALUE>
          <VALUEMEANING>972 PRECURSOR CELL LYMPHOBLASTIC LYMPHOMA</VALUEMEANING>
          <MEANINGDESCRIPTION>PRECURSOR CELL LYMPHOBLASTIC LYMPHOMA</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9727-3</VALIDVALUE>
          <VALUEMEANING>9727-3 Precursor cell lymphoblastic lymphoma, NOS (see also M-9835-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Precursor cell lymphoblastic lymphoma, NOS (see also M-9835/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9728-3</VALIDVALUE>
          <VALUEMEANING>9728-3 Precursor B-cell lymphoblastic lymphoma (see also M-9836-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Precursor B-cell lymphoblastic lymphoma (see also M-9836/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565102</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>973</VALIDVALUE>
          <VALUEMEANING>973 PLASMA CELL TUMORS</VALUEMEANING>
          <MEANINGDESCRIPTION>PLASMA CELL TUMORS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9731-3</VALIDVALUE>
          <VALUEMEANING>9731-3 Plasmacytoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Plasmacytoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9732-3</VALIDVALUE>
          <VALUEMEANING>9732-3 Multiple myeloma (C42.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple myeloma (C42.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565106</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9733-3</VALIDVALUE>
          <VALUEMEANING>9733-3 Plasma cell leukemia (C42.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Plasma cell leukemia (C42.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9734-3</VALIDVALUE>
          <VALUEMEANING>9734-3 Plasmacytoma, extramedullary (not occurring in bone)</VALUEMEANING>
          <MEANINGDESCRIPTION>Plasmacytoma, extramedullary (not occurring in bone)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565108</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>974</VALIDVALUE>
          <VALUEMEANING>974 MAST CELL TUMORS</VALUEMEANING>
          <MEANINGDESCRIPTION>MAST CELL TUMORS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9740-1</VALIDVALUE>
          <VALUEMEANING>9740-1 Mastocytoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Mastocytoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9740-3</VALIDVALUE>
          <VALUEMEANING>9740-3 Mast cell sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mast cell sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9741-3</VALIDVALUE>
          <VALUEMEANING>9741-3 Malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9742-3</VALIDVALUE>
          <VALUEMEANING>9742-3 Mast cell leukemia (C42.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mast cell leukemia (C42.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>975</VALIDVALUE>
          <VALUEMEANING>975 NEOPLASMS OF HISTIOCYTES ANDACCESSORY LYMPHOID CELLS</VALUEMEANING>
          <MEANINGDESCRIPTION>NEOPLASMS OF HISTIOCYTES ANDACCESSORY LYMPHOID CELLS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9070-3</VALIDVALUE>
          <VALUEMEANING>9070-3 Embryonal carcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Embryonal carcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9071-3</VALIDVALUE>
          <VALUEMEANING>9071-3 Yolk sac tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Yolk sac tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564805</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9072-3</VALIDVALUE>
          <VALUEMEANING>9072-3 Polyembryoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Polyembryoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9073-1</VALIDVALUE>
          <VALUEMEANING>9073-1 Gonadoblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Gonadoblastoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9080-0</VALIDVALUE>
          <VALUEMEANING>9080-0 Teratoma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Teratoma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9080-1</VALIDVALUE>
          <VALUEMEANING>9080-1 Teratoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Teratoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9080-3</VALIDVALUE>
          <VALUEMEANING>9080-3 Teratoma, malignant, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Teratoma, malignant, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564810</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9081-3</VALIDVALUE>
          <VALUEMEANING>9081-3 Teratocarcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Teratocarcinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9082-3</VALIDVALUE>
          <VALUEMEANING>9082-3 Malignant teratoma, undifferentiated</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant teratoma, undifferentiated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9083-3</VALIDVALUE>
          <VALUEMEANING>9083-3 Malignant teratoma, intermediate</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant teratoma, intermediate</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9084-0</VALIDVALUE>
          <VALUEMEANING>9084-0 Dermoid cyst, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Dermoid cyst, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9084-3</VALIDVALUE>
          <VALUEMEANING>9084-3 Teratoma with malignant transformation</VALUEMEANING>
          <MEANINGDESCRIPTION>Teratoma with malignant transformation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9085-3</VALIDVALUE>
          <VALUEMEANING>9085-3 Mixed germ cell tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed germ cell tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564816</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9090-0</VALIDVALUE>
          <VALUEMEANING>9090-0 Struma ovarii, NOS (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Struma ovarii, NOS (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9090-3</VALIDVALUE>
          <VALUEMEANING>9090-3 Struma ovarii, malignant (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Struma ovarii, malignant (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564818</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9091-1</VALIDVALUE>
          <VALUEMEANING>9091-1 Strumal carcinoid (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Strumal carcinoid (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>910</VALIDVALUE>
          <VALUEMEANING>910 TROPHOBLASTIC NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>TROPHOBLASTIC NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564820</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9100-0</VALIDVALUE>
          <VALUEMEANING>9100-0 Hydatidiform mole, NOS (C58.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hydatidiform mole, NOS (C58.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9100-1</VALIDVALUE>
          <VALUEMEANING>9100-1 Invasive hydatidiform mole (C58.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Invasive hydatidiform mole (C58.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9750-3</VALIDVALUE>
          <VALUEMEANING>9750-3 Malignant histiocytosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant histiocytosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9751-1</VALIDVALUE>
          <VALUEMEANING>9751-1 Langerhans cell histiocytosis, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Langerhans cell histiocytosis, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565116</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9752-1</VALIDVALUE>
          <VALUEMEANING>9752-1 Langerhans cell histiocytosis, unifocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Langerhans cell histiocytosis, unifocal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9753-1</VALIDVALUE>
          <VALUEMEANING>9753-1 Langerhans cell histiocytosis, multifocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Langerhans cell histiocytosis, multifocal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9754-3</VALIDVALUE>
          <VALUEMEANING>9754-3 Langerhans cell histiocytosis, disseminated</VALUEMEANING>
          <MEANINGDESCRIPTION>Langerhans cell histiocytosis, disseminated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9755-3</VALIDVALUE>
          <VALUEMEANING>9755-3 Histiocytic sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Histiocytic sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9756-3</VALIDVALUE>
          <VALUEMEANING>9756-3 Langerhans cell sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Langerhans cell sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9757-3</VALIDVALUE>
          <VALUEMEANING>9757-3 Interdigitating dendritic cell sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Interdigitating dendritic cell sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9758-3</VALIDVALUE>
          <VALUEMEANING>9758-3 Follicular dendritic cell sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Follicular dendritic cell sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>976</VALIDVALUE>
          <VALUEMEANING>976 IMMUNOPROLIFERATIVE DISEASES</VALUEMEANING>
          <MEANINGDESCRIPTION>IMMUNOPROLIFERATIVE DISEASES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9760-3</VALIDVALUE>
          <VALUEMEANING>9760-3 Immunoproliferative disease, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunoproliferative disease, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9761-3</VALIDVALUE>
          <VALUEMEANING>9761-3 Waldenstrom macroglobulinemia (C42.0) (see also M-9671-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Waldenstrom macroglobulinemia (C42.0) (see also M-9671/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9762-3</VALIDVALUE>
          <VALUEMEANING>9762-3 Heavy chain disease, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Heavy chain disease, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565127</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9764-3</VALIDVALUE>
          <VALUEMEANING>9764-3 Immunoproliferative small intestinal disease (C17._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunoproliferative small intestinal disease (C17._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9765-1</VALIDVALUE>
          <VALUEMEANING>9765-1 Monoclonal gammopathy of undetermined significance</VALUEMEANING>
          <MEANINGDESCRIPTION>Monoclonal gammopathy of undetermined significance</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9766-1</VALIDVALUE>
          <VALUEMEANING>9766-1 Angiocentric immunoproliferative lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>Angiocentric immunoproliferative lesion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9767-1</VALIDVALUE>
          <VALUEMEANING>9767-1 Angioimmunoblastic lymphadenopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Angioimmunoblastic lymphadenopathy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9768-1</VALIDVALUE>
          <VALUEMEANING>9768-1 T-gamma lymphoproliferative disease</VALUEMEANING>
          <MEANINGDESCRIPTION>T-gamma lymphoproliferative disease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9769-1</VALIDVALUE>
          <VALUEMEANING>9769-1 Immunoglobulin deposition disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunoglobulin deposition disease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9101-3</VALIDVALUE>
          <VALUEMEANING>9101-3 Choriocarcinoma combined with other germ cell elements</VALUEMEANING>
          <MEANINGDESCRIPTION>Choriocarcinoma combined with other germ cell elements</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564824</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9102-3</VALIDVALUE>
          <VALUEMEANING>9102-3 Malignant teratoma, trophoblastic</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant teratoma, trophoblastic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9103-0</VALIDVALUE>
          <VALUEMEANING>9103-0 Partial hydatidiform mole (C58.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial hydatidiform mole (C58.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9104-1</VALIDVALUE>
          <VALUEMEANING>9104-1 Placental site trophoblastic tumor (C58.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Placental site trophoblastic tumor (C58.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9105-3</VALIDVALUE>
          <VALUEMEANING>9105-3 Trophoblastic tumor, epithelioid</VALUEMEANING>
          <MEANINGDESCRIPTION>Trophoblastic tumor, epithelioid</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564828</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>911</VALIDVALUE>
          <VALUEMEANING>911 MESONEPHROMAS</VALUEMEANING>
          <MEANINGDESCRIPTION>MESONEPHROMAS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9110-0</VALIDVALUE>
          <VALUEMEANING>9110-0 Mesonephroma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesonephroma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564830</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9110-1</VALIDVALUE>
          <VALUEMEANING>9110-1 Mesonephric tumor, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesonephric tumor, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9110-3</VALIDVALUE>
          <VALUEMEANING>9110-3 Mesonephroma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesonephroma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564832</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>912-916</VALIDVALUE>
          <VALUEMEANING>912-916 BLOOD VESSEL TUMORS</VALUEMEANING>
          <MEANINGDESCRIPTION>BLOOD VESSEL TUMORS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9120-0</VALIDVALUE>
          <VALUEMEANING>9120-0 Hemangioma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Hemangioma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9120-3</VALIDVALUE>
          <VALUEMEANING>9120-3 Hemangiosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Hemangiosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9121-0</VALIDVALUE>
          <VALUEMEANING>9121-0 Cavernous hemangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Cavernous hemangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564836</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9122-0</VALIDVALUE>
          <VALUEMEANING>9122-0 Venous hemangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Venous hemangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9123-0</VALIDVALUE>
          <VALUEMEANING>9123-0 Racemose hemangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Racemose hemangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564838</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9124-3</VALIDVALUE>
          <VALUEMEANING>9124-3 Kupffer cell sarcoma (C22.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Kupffer cell sarcoma (C22.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9125-0</VALIDVALUE>
          <VALUEMEANING>9125-0 Epithelioid hemangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioid hemangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9130-0</VALIDVALUE>
          <VALUEMEANING>9130-0 Hemangioendothelioma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Hemangioendothelioma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564841</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>980</VALIDVALUE>
          <VALUEMEANING>980 LEUKEMIAS, NOS (C42.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>LEUKEMIAS, NOS (C42.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>980-994</VALIDVALUE>
          <VALUEMEANING>980-994 LEUKEMIAS</VALUEMEANING>
          <MEANINGDESCRIPTION>LEUKEMIAS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9800-3</VALIDVALUE>
          <VALUEMEANING>9800-3 Leukemia, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Leukemia, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9801-3</VALIDVALUE>
          <VALUEMEANING>9801-3 Acute leukemia, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute leukemia, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9805-3</VALIDVALUE>
          <VALUEMEANING>9805-3 Acute biphenotypic leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute biphenotypic leukemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>982-983</VALIDVALUE>
          <VALUEMEANING>982-983 LYMPHOID LEUKEMIAS (C42.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>LYMPHOID LEUKEMIAS (C42.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9820-3</VALIDVALUE>
          <VALUEMEANING>9820-3 Lymphoid leukemia, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymphoid leukemia, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9823-3</VALIDVALUE>
          <VALUEMEANING>9823-3 B-cell chronic lymphocytic leukemia-small lymphocytic lymphoma (see also M-9670-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (see also M-9670/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9826-3</VALIDVALUE>
          <VALUEMEANING>9826-3 Burkitt cell leukemia (see also M-9687-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Burkitt cell leukemia (see also M-9687/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9827-3</VALIDVALUE>
          <VALUEMEANING>9827-3 Adult T-cell leukemia-lymphoma (HTLV-1 positive) Includes all variants</VALUEMEANING>
          <MEANINGDESCRIPTION>Adult T-cell leukemia/lymphoma (HTLV-1 positive) Includes all variants</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565143</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9831-1</VALIDVALUE>
          <VALUEMEANING>9831-1 T-cell large granular lymphocytic leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>T-cell large granular lymphocytic leukemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9832-3</VALIDVALUE>
          <VALUEMEANING>9832-3 Prolymphocytic leukemia, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Prolymphocytic leukemia, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565145</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9833-3</VALIDVALUE>
          <VALUEMEANING>9833-3 Prolymphocytic leukemia, B-cell type</VALUEMEANING>
          <MEANINGDESCRIPTION>Prolymphocytic leukemia, B-cell type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9834-3</VALIDVALUE>
          <VALUEMEANING>9834-3 Prolymphocytic leukemia, T-cell type</VALUEMEANING>
          <MEANINGDESCRIPTION>Prolymphocytic leukemia, T-cell type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9835-3</VALIDVALUE>
          <VALUEMEANING>9835-3 Precursor cell lymphoblastic leukemia, NOS (see also M-9727-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Precursor cell lymphoblastic leukemia, NOS (see also M-9727/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9836-3</VALIDVALUE>
          <VALUEMEANING>9836-3 Precursor B-cell lymphoblastic leukemia (see also M-9728-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Precursor B-cell lymphoblastic leukemia (see also M-9728/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565149</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9837-3</VALIDVALUE>
          <VALUEMEANING>9837-3 Precursor T-cell lymphoblastic leukemia (see also M-9729-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Precursor T-cell lymphoblastic leukemia (see also M-9729/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>984-993</VALIDVALUE>
          <VALUEMEANING>984-993 MYELOID LEUKEMIAS (C42.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>MYELOID LEUKEMIAS (C42.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9840-3</VALIDVALUE>
          <VALUEMEANING>9840-3 Acute myeloid leukemia, M6 type</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myeloid leukemia, M6 type</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9860-3</VALIDVALUE>
          <VALUEMEANING>9860-3 Myeloid leukemia, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Myeloid leukemia, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9130-1</VALIDVALUE>
          <VALUEMEANING>9130-1 Hemangioendothelioma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Hemangioendothelioma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564842</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9130-3</VALIDVALUE>
          <VALUEMEANING>9130-3 Hemangioendothelioma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Hemangioendothelioma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9131-0</VALIDVALUE>
          <VALUEMEANING>9131-0 Capillary hemangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Capillary hemangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564844</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9132-0</VALIDVALUE>
          <VALUEMEANING>9132-0 Intramuscular hemangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Intramuscular hemangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564845</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9133-1</VALIDVALUE>
          <VALUEMEANING>9133-1 Epithelioid hemangioendothelioma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioid hemangioendothelioma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9133-3</VALIDVALUE>
          <VALUEMEANING>9133-3 Epithelioid hemangioendothelioma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Epithelioid hemangioendothelioma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9135-1</VALIDVALUE>
          <VALUEMEANING>9135-1 Endovascular papillary angioendothelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Endovascular papillary angioendothelioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9136-1</VALIDVALUE>
          <VALUEMEANING>9136-1 Spindle cell hemangioendothelioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Spindle cell hemangioendothelioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9140-3</VALIDVALUE>
          <VALUEMEANING>9140-3 Kaposi sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Kaposi sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9141-0</VALIDVALUE>
          <VALUEMEANING>9141-0 Angiokeratoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Angiokeratoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9142-0</VALIDVALUE>
          <VALUEMEANING>9142-0 Verrucous keratotic hemangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Verrucous keratotic hemangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9150-0</VALIDVALUE>
          <VALUEMEANING>9150-0 Hemangiopericytoma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Hemangiopericytoma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9150-1</VALIDVALUE>
          <VALUEMEANING>9150-1 Hemangiopericytoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Hemangiopericytoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9150-3</VALIDVALUE>
          <VALUEMEANING>9150-3 Hemangiopericytoma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Hemangiopericytoma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9160-0</VALIDVALUE>
          <VALUEMEANING>9160-0 Angiofibroma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Angiofibroma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9161-0</VALIDVALUE>
          <VALUEMEANING>9161-0 Acquired tufted hemangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Acquired tufted hemangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9161-1</VALIDVALUE>
          <VALUEMEANING>9161-1 Hemangioblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Hemangioblastoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>917</VALIDVALUE>
          <VALUEMEANING>917 LYMPHATIC VESSEL TUMORS</VALUEMEANING>
          <MEANINGDESCRIPTION>LYMPHATIC VESSEL TUMORS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9170-0</VALIDVALUE>
          <VALUEMEANING>9170-0 Lymphangioma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymphangioma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9170-3</VALIDVALUE>
          <VALUEMEANING>9170-3 Lymphangiosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymphangiosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9861-3</VALIDVALUE>
          <VALUEMEANING>9861-3 Acute myeloid leukemia, NOS (FAB or WHO type not specified) (see also M-9930-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myeloid leukemia, NOS (FAB or WHO type not specified) (see also M-9930/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9863-3</VALIDVALUE>
          <VALUEMEANING>9863-3 Chronic myeloid leukemia, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic myeloid leukemia, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9866-3</VALIDVALUE>
          <VALUEMEANING>9866-3 Acute promyelocytic leukemia, t(15;17)(q22;q11-12)</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute promyelocytic leukemia, t(15;17)(q22;q11-12)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9867-3</VALIDVALUE>
          <VALUEMEANING>9867-3 Acute myelomonocytic leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myelomonocytic leukemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9870-3</VALIDVALUE>
          <VALUEMEANING>9870-3 Acute basophilic leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute basophilic leukemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9871-3</VALIDVALUE>
          <VALUEMEANING>9871-3 Acute myeloid leukemia with abnormal marrow eosinophils (Includes all variants)</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myeloid leukemia with abnormal marrow eosinophils (Includes all variants)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9872-3</VALIDVALUE>
          <VALUEMEANING>9872-3 Acute myeloid leukemia, minimal differentiation</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myeloid leukemia, minimal differentiation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9873-3</VALIDVALUE>
          <VALUEMEANING>9873-3 Acute myeloid leukemia without maturation</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myeloid leukemia without maturation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9874-3</VALIDVALUE>
          <VALUEMEANING>9874-3 Acute myeloid leukemia with maturation</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myeloid leukemia with maturation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9875-3</VALIDVALUE>
          <VALUEMEANING>9875-3 Chronic myelogenous leukemia, BCR-ABL positive</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic myelogenous leukemia, BCR/ABL positive</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9876-3</VALIDVALUE>
          <VALUEMEANING>9876-3 Atypical chronic myeloid leukemia, BCR-ABL negative</VALUEMEANING>
          <MEANINGDESCRIPTION>Atypical chronic myeloid leukemia, BCR/ABL negative</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9891-3</VALIDVALUE>
          <VALUEMEANING>9891-3 Acute monocytic leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute monocytic leukemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9895-3</VALIDVALUE>
          <VALUEMEANING>9895-3 Acute myeloid leukemia with multilineage dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myeloid leukemia with multilineage dysplasia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9896-3</VALIDVALUE>
          <VALUEMEANING>9896-3 Acute myeloid leukemia, t(8;21)(q22;q22)</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myeloid leukemia, t(8;21)(q22;q22)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9897-3</VALIDVALUE>
          <VALUEMEANING>9897-3 Acute myeloid leukemia, 11q23 abnormalities</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myeloid leukemia, 11q23 abnormalities</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9910-3</VALIDVALUE>
          <VALUEMEANING>9910-3 Acute megakaryoblastic leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute megakaryoblastic leukemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9920-3</VALIDVALUE>
          <VALUEMEANING>9920-3 Therapy-related acute myeloid leukemia, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Therapy-related acute myeloid leukemia, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9930-3</VALIDVALUE>
          <VALUEMEANING>9930-3 Myeloid sarcoma (see also M-9861-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Myeloid sarcoma (see also M-9861/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9931-3</VALIDVALUE>
          <VALUEMEANING>9931-3 Acute panmyelosis with myelofibrosis (C42.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute panmyelosis with myelofibrosis (C42.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>994</VALIDVALUE>
          <VALUEMEANING>994 OTHER LEUKEMIAS (C42.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>OTHER LEUKEMIAS (C42.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9171-0</VALIDVALUE>
          <VALUEMEANING>9171-0 Capillary lymphangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Capillary lymphangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9172-0</VALIDVALUE>
          <VALUEMEANING>9172-0 Cavernous lymphangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Cavernous lymphangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9173-0</VALIDVALUE>
          <VALUEMEANING>9173-0 Cystic lymphangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Cystic lymphangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9174-0</VALIDVALUE>
          <VALUEMEANING>9174-0 Lymphangiomyoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymphangiomyoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9175-0</VALIDVALUE>
          <VALUEMEANING>9175-0 Hemolymphangioma</VALUEMEANING>
          <MEANINGDESCRIPTION>Hemolymphangioma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>918-924</VALIDVALUE>
          <VALUEMEANING>918-924 OSSEOUS AND CHONDROMATOUS NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>OSSEOUS AND CHONDROMATOUS NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9180-0</VALIDVALUE>
          <VALUEMEANING>9180-0 Osteoma, NOS (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Osteoma, NOS (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9180-3</VALIDVALUE>
          <VALUEMEANING>9180-3 Osteosarcoma, NOS (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Osteosarcoma, NOS (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9181-3</VALIDVALUE>
          <VALUEMEANING>9181-3 Chondroblastic osteosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Chondroblastic osteosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9182-3</VALIDVALUE>
          <VALUEMEANING>9182-3 Fibroblastic osteosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibroblastic osteosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9183-3</VALIDVALUE>
          <VALUEMEANING>9183-3 Telangiectatic osteosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Telangiectatic osteosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9184-3</VALIDVALUE>
          <VALUEMEANING>9184-3 Osteosarcoma in Paget disease of bone (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Osteosarcoma in Paget disease of bone (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9185-3</VALIDVALUE>
          <VALUEMEANING>9185-3 Small cell osteosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Small cell osteosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9186-3</VALIDVALUE>
          <VALUEMEANING>9186-3 Central osteosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Central osteosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9187-3</VALIDVALUE>
          <VALUEMEANING>9187-3 Intraosseous well differentiated osteosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intraosseous well differentiated osteosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9191-0</VALIDVALUE>
          <VALUEMEANING>9191-0 Osteoid osteoma, NOS (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Osteoid osteoma, NOS (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9192-3</VALIDVALUE>
          <VALUEMEANING>9192-3 Parosteal osteosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Parosteal osteosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9193-3</VALIDVALUE>
          <VALUEMEANING>9193-3 Periosteal osteosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Periosteal osteosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9940-3</VALIDVALUE>
          <VALUEMEANING>9940-3 Hairy cell leukemia (C42.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>Hairy cell leukemia (C42.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9945-3</VALIDVALUE>
          <VALUEMEANING>9945-3 Chronic myelomonocytic leukemia, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic myelomonocytic leukemia, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9946-3</VALIDVALUE>
          <VALUEMEANING>9946-3 Juvenile myelomonocytic leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Juvenile myelomonocytic leukemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9948-3</VALIDVALUE>
          <VALUEMEANING>9948-3 Aggressive NK-cell leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Aggressive NK-cell leukemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>995-996</VALIDVALUE>
          <VALUEMEANING>995-996 CHRONIC MYELOPROLIFERATIVE DISORDERS (C42.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>CHRONIC MYELOPROLIFERATIVE DISORDERS (C42.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9950-3</VALIDVALUE>
          <VALUEMEANING>9950-3 Polycythemia vera</VALUEMEANING>
          <MEANINGDESCRIPTION>Polycythemia vera</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9960-3</VALIDVALUE>
          <VALUEMEANING>9960-3 Chronic myeloproliferative disease, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic myeloproliferative disease, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9961-3</VALIDVALUE>
          <VALUEMEANING>9961-3 Myelosclerosis with myeloid metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Myelosclerosis with myeloid metaplasia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9962-3</VALIDVALUE>
          <VALUEMEANING>9962-3 Essential thrombocythemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Essential thrombocythemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9963-3</VALIDVALUE>
          <VALUEMEANING>9963-3 Chronic neutrophilic leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic neutrophilic leukemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9964-3</VALIDVALUE>
          <VALUEMEANING>9964-3 Hypereosinophilic syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypereosinophilic syndrome</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>997</VALIDVALUE>
          <VALUEMEANING>997 OTHER HEMATOLOGIC DISORDERS</VALUEMEANING>
          <MEANINGDESCRIPTION>OTHER HEMATOLOGIC DISORDERS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9970-1</VALIDVALUE>
          <VALUEMEANING>9970-1 Lymphoproliferative disorder, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymphoproliferative disorder, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9975-1</VALIDVALUE>
          <VALUEMEANING>9975-1 Myeloproliferative disease, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Myeloproliferative disease, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>998</VALIDVALUE>
          <VALUEMEANING>998 MYELODYSPLASTIC SYNDROMES (C42.1)</VALUEMEANING>
          <MEANINGDESCRIPTION>MYELODYSPLASTIC SYNDROMES (C42.1)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9982-3</VALIDVALUE>
          <VALUEMEANING>9982-3 Refractory anemia with sideroblasts</VALUEMEANING>
          <MEANINGDESCRIPTION>Refractory anemia with sideroblasts</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9983-3</VALIDVALUE>
          <VALUEMEANING>9983-3 Refractory anemia with excess blasts</VALUEMEANING>
          <MEANINGDESCRIPTION>Refractory anemia with excess blasts</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9984-3</VALIDVALUE>
          <VALUEMEANING>9984-3 Refractory anemia with excess blasts in transformation[obs]</VALUEMEANING>
          <MEANINGDESCRIPTION>Refractory anemia with excess blasts in transformation[obs]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9194-3</VALIDVALUE>
          <VALUEMEANING>9194-3 High grade surface osteosarcoma (C40._,  C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>High grade surface osteosarcoma (C40._,  C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9195-3</VALIDVALUE>
          <VALUEMEANING>9195-3 Intracortical osteosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Intracortical osteosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9200-0</VALIDVALUE>
          <VALUEMEANING>9200-0 Osteoblastoma, NOS (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Osteoblastoma, NOS (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9200-1</VALIDVALUE>
          <VALUEMEANING>9200-1 Aggressive osteoblastoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Aggressive osteoblastoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9210-0</VALIDVALUE>
          <VALUEMEANING>9210-0 Osteochondroma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Osteochondroma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9210-1</VALIDVALUE>
          <VALUEMEANING>9210-1 Osteochondromatosis, NOS (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Osteochondromatosis, NOS (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9220-0</VALIDVALUE>
          <VALUEMEANING>9220-0 Chondroma, NOS (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Chondroma, NOS (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9220-1</VALIDVALUE>
          <VALUEMEANING>9220-1 Chondromatosis, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Chondromatosis, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9220-3</VALIDVALUE>
          <VALUEMEANING>9220-3 Chondrosarcoma, NOS (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Chondrosarcoma, NOS (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9221-0</VALIDVALUE>
          <VALUEMEANING>9221-0 Juxtacortical chondroma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Juxtacortical chondroma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9221-3</VALIDVALUE>
          <VALUEMEANING>9221-3 Juxtacortical chondrosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Juxtacortical chondrosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9230-0</VALIDVALUE>
          <VALUEMEANING>9230-0 Chondroblastoma, NOS (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Chondroblastoma, NOS (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9230-3</VALIDVALUE>
          <VALUEMEANING>9230-3 Chondroblastoma, malignant (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Chondroblastoma, malignant (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9231-3</VALIDVALUE>
          <VALUEMEANING>9231-3 Myxoid chondrosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Myxoid chondrosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9240-3</VALIDVALUE>
          <VALUEMEANING>9240-3 Mesenchymal chondrosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesenchymal chondrosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9241-0</VALIDVALUE>
          <VALUEMEANING>9241-0 Chondromyxoid fibroma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Chondromyxoid fibroma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9242-3</VALIDVALUE>
          <VALUEMEANING>9242-3 Clear cell chondrosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell chondrosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9243-3</VALIDVALUE>
          <VALUEMEANING>9243-3 Dedifferentiated chondrosarcoma (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Dedifferentiated chondrosarcoma (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>925</VALIDVALUE>
          <VALUEMEANING>925 GIANT CELL TUMORS</VALUEMEANING>
          <MEANINGDESCRIPTION>GIANT CELL TUMORS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9250-1</VALIDVALUE>
          <VALUEMEANING>9250-1 Giant cell tumor of bone, NOS (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Giant cell tumor of bone, NOS (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9985-3</VALIDVALUE>
          <VALUEMEANING>9985-3 Refractory cytopenia with multilineage dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Refractory cytopenia with multilineage dysplasia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9986-3</VALIDVALUE>
          <VALUEMEANING>9986-3 Myelodysplastic syndrome with 5q deletion (5q ) syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Myelodysplastic syndrome with 5q deletion (5q ) syndrome</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9987-3</VALIDVALUE>
          <VALUEMEANING>9987-3 Therapy-related myelodysplastic syndrome, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Therapy-related myelodysplastic syndrome, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9989-3</VALIDVALUE>
          <VALUEMEANING>9989-3 Myelodysplastic syndrome, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Myelodysplastic syndrome, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9250-3</VALIDVALUE>
          <VALUEMEANING>9250-3 Giant cell tumor of bone, malignant (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Giant cell tumor of bone, malignant (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9251-1</VALIDVALUE>
          <VALUEMEANING>9251-1 Giant cell tumor of soft parts, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Giant cell tumor of soft parts, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9251-3</VALIDVALUE>
          <VALUEMEANING>9251-3 Malignant giant cell tumor of soft parts</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant giant cell tumor of soft parts</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9252-0</VALIDVALUE>
          <VALUEMEANING>9252-0 Tenosynovial giant cell tumor (C49._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Tenosynovial giant cell tumor (C49._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9252-3</VALIDVALUE>
          <VALUEMEANING>9252-3 Malignant tenosynovial giant cell tumor (C49._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant tenosynovial giant cell tumor (C49._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>926</VALIDVALUE>
          <VALUEMEANING>926 MISCELLANEOUS BONE TUMORS (C40._, C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>MISCELLANEOUS BONE TUMORS (C40._, C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9260-3</VALIDVALUE>
          <VALUEMEANING>9260-3 Ewing sarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Ewing sarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9261-3</VALIDVALUE>
          <VALUEMEANING>9261-3 Adamantinoma of long bones (C40._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Adamantinoma of long bones (C40._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>927-934</VALIDVALUE>
          <VALUEMEANING>927-934 ODONTOGENIC TUMORS (C41._)</VALUEMEANING>
          <MEANINGDESCRIPTION>ODONTOGENIC TUMORS (C41._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564910</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9270-0</VALIDVALUE>
          <VALUEMEANING>9270-0 Odontogenic tumor, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Odontogenic tumor, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9270-1</VALIDVALUE>
          <VALUEMEANING>9270-1 Odontogenic tumor, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Odontogenic tumor, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9270-3</VALIDVALUE>
          <VALUEMEANING>9270-3 Odontogenic tumor, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Odontogenic tumor, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9271-0</VALIDVALUE>
          <VALUEMEANING>9271-0 Ameloblastic fibrodentinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Ameloblastic fibrodentinoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9272-0</VALIDVALUE>
          <VALUEMEANING>9272-0 Cementoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Cementoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9273-0</VALIDVALUE>
          <VALUEMEANING>9273-0 Cementoblastoma, benign</VALUEMEANING>
          <MEANINGDESCRIPTION>Cementoblastoma, benign</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9274-0</VALIDVALUE>
          <VALUEMEANING>9274-0 Cementifying fibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Cementifying fibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9275-0</VALIDVALUE>
          <VALUEMEANING>9275-0 Gigantiform cementoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Gigantiform cementoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9280-0</VALIDVALUE>
          <VALUEMEANING>9280-0 Odontoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Odontoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9350-1</VALIDVALUE>
          <VALUEMEANING>9350-1 Craniopharyngioma (C75.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Craniopharyngioma (C75.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9351-1</VALIDVALUE>
          <VALUEMEANING>9351-1 Craniopharyngioma, adamantinomatous (C75.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Craniopharyngioma, adamantinomatous (C75.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9352-1</VALIDVALUE>
          <VALUEMEANING>9352-1 Craniopharyngioma, papillary (C75.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>Craniopharyngioma, papillary (C75.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9360-1</VALIDVALUE>
          <VALUEMEANING>9360-1 Pinealoma (C75.3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pinealoma (C75.3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9361-1</VALIDVALUE>
          <VALUEMEANING>9361-1 Pineocytoma (C75.3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pineocytoma (C75.3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9362-3</VALIDVALUE>
          <VALUEMEANING>9362-3 Pineoblastoma (C75.3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pineoblastoma (C75.3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9363-0</VALIDVALUE>
          <VALUEMEANING>9363-0 Melanotic neuroectodermal tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Melanotic neuroectodermal tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9364-3</VALIDVALUE>
          <VALUEMEANING>9364-3 Peripheral neuroectodermal tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Peripheral neuroectodermal tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564947</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9365-3</VALIDVALUE>
          <VALUEMEANING>9365-3 Askin tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Askin tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564948</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9370-3</VALIDVALUE>
          <VALUEMEANING>9370-3 Chordoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Chordoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564949</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9371-3</VALIDVALUE>
          <VALUEMEANING>9371-3 Chondroid chordoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Chondroid chordoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9372-3</VALIDVALUE>
          <VALUEMEANING>9372-3 Dedifferentiated chordoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Dedifferentiated chordoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>938-948</VALIDVALUE>
          <VALUEMEANING>938-948 GLIOMAS</VALUEMEANING>
          <MEANINGDESCRIPTION>GLIOMAS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9380-3</VALIDVALUE>
          <VALUEMEANING>9380-3 Glioma, malignant (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Glioma, malignant (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9381-3</VALIDVALUE>
          <VALUEMEANING>9381-3 Gliomatosis cerebri (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Gliomatosis cerebri (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9382-3</VALIDVALUE>
          <VALUEMEANING>9382-3 Mixed glioma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Mixed glioma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564956</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9383-1</VALIDVALUE>
          <VALUEMEANING>9383-1 Subependymoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Subependymoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9384-1</VALIDVALUE>
          <VALUEMEANING>9384-1 Subependymal giant cell astrocytoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Subependymal giant cell astrocytoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9281-0</VALIDVALUE>
          <VALUEMEANING>9281-0 Compound odontoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Compound odontoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564920</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9282-0</VALIDVALUE>
          <VALUEMEANING>9282-0 Complex odontoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Complex odontoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9290-0</VALIDVALUE>
          <VALUEMEANING>9290-0 Ameloblastic fibro-odontoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Ameloblastic fibro-odontoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9290-3</VALIDVALUE>
          <VALUEMEANING>9290-3 Ameloblastic odontosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Ameloblastic odontosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9300-0</VALIDVALUE>
          <VALUEMEANING>9300-0 Adenomatoid odontogenic tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenomatoid odontogenic tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9301-0</VALIDVALUE>
          <VALUEMEANING>9301-0 Calcifying odontogenic cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>Calcifying odontogenic cyst</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9302-0</VALIDVALUE>
          <VALUEMEANING>9302-0 Odontogenic ghost cell tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Odontogenic ghost cell tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9310-0</VALIDVALUE>
          <VALUEMEANING>9310-0 Ameloblastoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Ameloblastoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9310-3</VALIDVALUE>
          <VALUEMEANING>9310-3 Ameloblastoma, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Ameloblastoma, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9311-0</VALIDVALUE>
          <VALUEMEANING>9311-0 Odontoameloblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Odontoameloblastoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9312-0</VALIDVALUE>
          <VALUEMEANING>9312-0 Squamous odontogenic tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous odontogenic tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9320-0</VALIDVALUE>
          <VALUEMEANING>9320-0 Odontogenic myxoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Odontogenic myxoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9321-0</VALIDVALUE>
          <VALUEMEANING>9321-0 Central odontogenic fibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Central odontogenic fibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9322-0</VALIDVALUE>
          <VALUEMEANING>9322-0 Peripheral odontogenic fibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Peripheral odontogenic fibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9330-0</VALIDVALUE>
          <VALUEMEANING>9330-0 Ameloblastic fibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Ameloblastic fibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9330-3</VALIDVALUE>
          <VALUEMEANING>9330-3 Ameloblastic fibrosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Ameloblastic fibrosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9340-0</VALIDVALUE>
          <VALUEMEANING>9340-0 Calcifying epithelial odontogenic tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Calcifying epithelial odontogenic tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9341-1</VALIDVALUE>
          <VALUEMEANING>9341-1 Clear cell odontogenic tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Clear cell odontogenic tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9342-3</VALIDVALUE>
          <VALUEMEANING>9342-3 Odontogenic carcinosarcoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Odontogenic carcinosarcoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>935-937</VALIDVALUE>
          <VALUEMEANING>935-937 MISCELLANEOUS TUMORS</VALUEMEANING>
          <MEANINGDESCRIPTION>MISCELLANEOUS TUMORS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9390-0</VALIDVALUE>
          <VALUEMEANING>9390-0 Choroid plexus papilloma, NOS (C71.5)</VALUEMEANING>
          <MEANINGDESCRIPTION>Choroid plexus papilloma, NOS (C71.5)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564959</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9390-1</VALIDVALUE>
          <VALUEMEANING>9390-1 Atypical choroid plexus papilloma (C71.5)</VALUEMEANING>
          <MEANINGDESCRIPTION>Atypical choroid plexus papilloma (C71.5)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9390-3</VALIDVALUE>
          <VALUEMEANING>9390-3 Choroid plexus carcinoma (C71.5)</VALUEMEANING>
          <MEANINGDESCRIPTION>Choroid plexus carcinoma (C71.5)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9391-3</VALIDVALUE>
          <VALUEMEANING>9391-3 Ependymoma, NOS (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Ependymoma, NOS (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9392-3</VALIDVALUE>
          <VALUEMEANING>9392-3 Ependymoma, anaplastic (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Ependymoma, anaplastic (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9393-3</VALIDVALUE>
          <VALUEMEANING>9393-3 Papillary ependymoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Papillary ependymoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9394-1</VALIDVALUE>
          <VALUEMEANING>9394-1 Myxopapillary ependymoma (C72.0)</VALUEMEANING>
          <MEANINGDESCRIPTION>Myxopapillary ependymoma (C72.0)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9400-3</VALIDVALUE>
          <VALUEMEANING>9400-3 Astrocytoma, NOS (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Astrocytoma, NOS (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9401-3</VALIDVALUE>
          <VALUEMEANING>9401-3 Astrocytoma, anaplastic (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Astrocytoma, anaplastic (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9410-3</VALIDVALUE>
          <VALUEMEANING>9410-3 Protoplasmic astrocytoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Protoplasmic astrocytoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9411-3</VALIDVALUE>
          <VALUEMEANING>9411-3 Gemistocytic astrocytoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Gemistocytic astrocytoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564969</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9412-1</VALIDVALUE>
          <VALUEMEANING>9412-1 Desmoplastic infantile astrocytoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Desmoplastic infantile astrocytoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564970</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9413-0</VALIDVALUE>
          <VALUEMEANING>9413-0 Dysembryoplastic neuroepithelial tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>Dysembryoplastic neuroepithelial tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9420-3</VALIDVALUE>
          <VALUEMEANING>9420-3 Fibrillary astrocytoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibrillary astrocytoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9421-1</VALIDVALUE>
          <VALUEMEANING>9421-1 Pilocytic astrocytoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pilocytic astrocytoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564973</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9423-3</VALIDVALUE>
          <VALUEMEANING>9423-3 Polar spongioblastoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Polar spongioblastoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9424-3</VALIDVALUE>
          <VALUEMEANING>9424-3 Pleomorphic xanthoastrocytoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Pleomorphic xanthoastrocytoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9430-3</VALIDVALUE>
          <VALUEMEANING>9430-3 Astroblastoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Astroblastoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9440-3</VALIDVALUE>
          <VALUEMEANING>9440-3 Glioblastoma, NOS (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Glioblastoma, NOS (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9441-3</VALIDVALUE>
          <VALUEMEANING>9441-3 Giant cell glioblastoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Giant cell glioblastoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9442-1</VALIDVALUE>
          <VALUEMEANING>9442-1 Gliofibroma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Gliofibroma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9442-3</VALIDVALUE>
          <VALUEMEANING>9442-3 Gliosarcoma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Gliosarcoma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9444-1</VALIDVALUE>
          <VALUEMEANING>9444-1 Chordoid glioma (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Chordoid glioma (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9450-3</VALIDVALUE>
          <VALUEMEANING>9450-3 Oligodendroglioma, NOS (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: A well-differentiated (WHO grade II), diffusely infiltrating neuroglial tumor of adults, typically located in the cerebral hemispheres.  It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm (&#39;honeycomb&#39; appearance).  It generally recurs locally, with median post-operative survival times ranging from 3 to 5 years for patients with all histological grades. (Adapted from WHO.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3288, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9451-3</VALIDVALUE>
          <VALUEMEANING>9451-3 Oligodendroglioma, anaplastic (C71._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Oligodendroglioma, anaplastic (C71._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564983</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9460-3</VALIDVALUE>
          <VALUEMEANING>9460-3 Oligodendroblastoma (C71._) [obs]</VALUEMEANING>
          <MEANINGDESCRIPTION>Oligodendroblastoma (C71._) [obs]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9470-3</VALIDVALUE>
          <VALUEMEANING>9470-3 Medulloblastoma, NOS (C71.6)</VALUEMEANING>
          <MEANINGDESCRIPTION>Medulloblastoma, NOS (C71.6)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9471-3</VALIDVALUE>
          <VALUEMEANING>9471-3 Desmoplastic nodular medulloblastoma (C71.6)</VALUEMEANING>
          <MEANINGDESCRIPTION>Desmoplastic nodular medulloblastoma (C71.6)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9472-3</VALIDVALUE>
          <VALUEMEANING>9472-3 Medullomyoblastoma (C71.6)</VALUEMEANING>
          <MEANINGDESCRIPTION>Medullomyoblastoma (C71.6)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564987</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9473-3</VALIDVALUE>
          <VALUEMEANING>9473-3 Primitive neuroectodermal tumor, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Primitive neuroectodermal tumor, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9474-3</VALIDVALUE>
          <VALUEMEANING>9474-3 Large cell medulloblastoma (C71.6)</VALUEMEANING>
          <MEANINGDESCRIPTION>Large cell medulloblastoma (C71.6)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9480-3</VALIDVALUE>
          <VALUEMEANING>9480-3 Cerebellar sarcoma, NOS (C71.6) [obs]</VALUEMEANING>
          <MEANINGDESCRIPTION>Cerebellar sarcoma, NOS (C71.6) [obs]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564990</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>949-952</VALIDVALUE>
          <VALUEMEANING>949-952  NEUROEPITHELIOMATOUS NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>NEUROEPITHELIOMATOUS NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9490-0</VALIDVALUE>
          <VALUEMEANING>9490-0 Ganglioneuroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Ganglioneuroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564992</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9490-3</VALIDVALUE>
          <VALUEMEANING>9490-3 Ganglioneuroblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Ganglioneuroblastoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9491-0</VALIDVALUE>
          <VALUEMEANING>9491-0 Ganglioneuromatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Ganglioneuromatosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564994</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9493-0</VALIDVALUE>
          <VALUEMEANING>9493-0 Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) (C71.6)</VALUEMEANING>
          <MEANINGDESCRIPTION>Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) (C71.6)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564996</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9500-3</VALIDVALUE>
          <VALUEMEANING>9500-3 Neuroblastoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Neuroblastoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564997</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8001-3</VALIDVALUE>
          <VALUEMEANING>8001-3 Tumor cells, malignant</VALUEMEANING>
          <MEANINGDESCRIPTION>Tumor cells, malignant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8090-1</VALIDVALUE>
          <VALUEMEANING>8090-1 Basal cell tumor (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Basal cell tumor (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8146-0</VALIDVALUE>
          <VALUEMEANING>8146-0 Monomorphic adenoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Monomorphic adenoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8210-0</VALIDVALUE>
          <VALUEMEANING>8210-0 Adenomatous polyp, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Adenomatous polyp, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8263-0</VALIDVALUE>
          <VALUEMEANING>8263-0 Tubulovillous adenoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Tubulovillous adenoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8333-0</VALIDVALUE>
          <VALUEMEANING>8333-0 Microfollicular adenoma, NOS (C73.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Microfollicular adenoma, NOS (C73.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8402-0</VALIDVALUE>
          <VALUEMEANING>8402-0 Nodular hidradenoma (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Nodular hidradenoma (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8461-3</VALIDVALUE>
          <VALUEMEANING>8461-3 Serous surface papillary carcinoma (C56.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Serous surface papillary carcinoma (C56.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8523-3</VALIDVALUE>
          <VALUEMEANING>8523-3 Infiltrating duct mixed with other types of carcinoma (C50._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Infiltrating duct mixed with other types of carcinoma (C50._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>859-867</VALIDVALUE>
          <VALUEMEANING>859-867 SPECIALIZED GONADAL NEOPLASMS</VALUEMEANING>
          <MEANINGDESCRIPTION>SPECIALIZED GONADAL NEOPLASMS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8690-1</VALIDVALUE>
          <VALUEMEANING>8690-1 Glomus jugulare tumor, NOS (C75.5)</VALUEMEANING>
          <MEANINGDESCRIPTION>Glomus jugulare tumor, NOS (C75.5)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8761-3</VALIDVALUE>
          <VALUEMEANING>8761-3 Malignant melanoma in giant pigmented nevus (C44._)</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant melanoma in giant pigmented nevus (C44._)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564608</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8825-1</VALIDVALUE>
          <VALUEMEANING>8825-1 Myofibroblastic tumor, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Myofibroblastic tumor, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8890-3</VALIDVALUE>
          <VALUEMEANING>8890-3 Leiomyosarcoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Leiomyosarcoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8959-3</VALIDVALUE>
          <VALUEMEANING>8959-3 Malignant cystic nephroma (C64.9)</VALUEMEANING>
          <MEANINGDESCRIPTION>Malignant cystic nephroma (C64.9)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9040-3</VALIDVALUE>
          <VALUEMEANING>9040-3 Synovial sarcoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Synovial sarcoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9100-3</VALIDVALUE>
          <VALUEMEANING>9100-3 Choriocarcinoma, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Choriocarcinoma, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9174-1</VALIDVALUE>
          <VALUEMEANING>9174-1 Lymphangiomyomatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymphangiomyomatosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9262-0</VALIDVALUE>
          <VALUEMEANING>9262-0 Ossifying fibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Ossifying fibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9373-0</VALIDVALUE>
          <VALUEMEANING>9373-0 Parachordoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Parachordoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9492-0</VALIDVALUE>
          <VALUEMEANING>9492-0 Gangliocytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Gangliocytoma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2564995</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9550-0</VALIDVALUE>
          <VALUEMEANING>9550-0 Plexiform neurofibroma</VALUEMEANING>
          <MEANINGDESCRIPTION>Plexiform neurofibroma</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9687-3</VALIDVALUE>
          <VALUEMEANING>9687-3 Burkitt lymphoma, NOS (see also M-9826-3) Includes all variants</VALUEMEANING>
          <MEANINGDESCRIPTION>Burkitt lymphoma, NOS (see also M-9826/3) Includes all variants</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9729-3</VALIDVALUE>
          <VALUEMEANING>9729-3 Precursor T-cell lymphoblastic lymphoma (see also M-9837-3)</VALUEMEANING>
          <MEANINGDESCRIPTION>Precursor T-cell lymphoblastic lymphoma (see also M-9837/3)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9980-3</VALIDVALUE>
          <VALUEMEANING>9980-3 Refractory anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Refractory anemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9652-3</VALIDVALUE>
          <VALUEMEANING>9652-3 Hodgkin lymphoma, mixed cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, mixed cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13213441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9653-3</VALIDVALUE>
          <VALUEMEANING>9653-3 Hodgkin lymphoma, lymphocyte depletion</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, lymphocyte depletion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13213442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9663-3</VALIDVALUE>
          <VALUEMEANING>9663-3 Hodgkin lymphoma, nodular sclerosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Hodgkin lymphoma, nodular sclerosis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13213443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9975-3</VALIDVALUE>
          <VALUEMEANING>9975-3 Myeloproliferative neoplasm, unclassifiable</VALUEMEANING>
          <MEANINGDESCRIPTION>Myeloproliferative neoplasm, unclassifiable</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14273691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Diagnosis ICD-O code</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Diagnosis ICD-O code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>New cancer morphology code (ICD-O).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Morphology (73-91) ICD-O-1</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>New Cancer Diagnosis ICD-O code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If other, Specify Diagnosis ICD-O Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If yes, ICD-O Morphology:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>New cancer morphology code (ICD-O):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>New cancer diagnosis ICD-O code:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If other, Specify Diagnosis ICD-O Code:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 001</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Morphology (ICD-O code):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase 1/Pilot Consortium</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3303197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>101169</AlternateName>
        <AlternateNameType>COG GDE #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>NwCanIcdoM</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>NEW_CA_DX_ICD-O_CD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1015">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2006606</PUBLICID>
    <LONGNAME>Patient Surgical Resection Date</LONGNAME>
    <PREFERREDNAME>PT_SURGICAL_RESEC_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date that a patient had surgical resection.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014428</PublicId>
      <PreferredName>PT_SURGICAL_RESCTION</PreferredName>
      <PreferredDefinition>information relating to the diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.</PreferredDefinition>
      <LongName>Patient Surgical Procedure Resection</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5285631</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329:C15232</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure Excision</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15232</PREFERRED_NAME>
            <LONG_NAME>Excision</LONG_NAME>
            <CON_ID>2202806</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Resection</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of Resection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of full surgical resection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of surgical resection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of procedure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of surgical resection of cancer?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Resection date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Primary tumor surgical resection date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Metastatic disease surgical resection date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of metastasectomy:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of procedure:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of primary tumor resection:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>date of resection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of surgery for resection of tumor</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of surgical resection:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If yes,  Date of primary tumor resection</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If yes,  Date of primary tumor resection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If yes,  Date of resection</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If yes,  Date of resection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of resection of primary tumor during initial therapy:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of resection of primary tumor during initial therapy:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Surgery CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3123000</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0277</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104900</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0279</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104996</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1010</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171061</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Surgery</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000160</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_SURGICAL_RESEC_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_SURGICAL_RESEC_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SWOG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1016">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2007303</PUBLICID>
    <LONGNAME>Neurological Assessment Facial Result Type</LONGNAME>
    <PREFERREDNAME>NEU_ASSES_FAC_RES_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the result of the patient&#39;s neurologic assessment for facial sensation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014620</PublicId>
      <PreferredName>ASSESS_RESULT</PreferredName>
      <PreferredDefinition>the result of a patient assessment.</PreferredDefinition>
      <LongName>Assessment Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176954</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Assessment</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177339</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Result</PreferredName>
        <Version>1</Version>
        <LongName>Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018985</PublicId>
      <PreferredName>NEU_ASSESS_RESULT_TP</PreferredName>
      <PreferredDefinition>the result of a neurological assessment of the patient.</PreferredDefinition>
      <LongName>Neurological Assessment Result Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating from the norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown/not tested</VALIDVALUE>
          <VALUEMEANING>Unknown/not tested</VALUEMEANING>
          <MEANINGDESCRIPTION>Unknown/not tested</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-06-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566029</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Facial sensation (V)</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Facial sensation (V)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1017">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2008274</PUBLICID>
    <LONGNAME>Specimen Measurement X Medial Lateral Centimeter Measurement</LONGNAME>
    <PREFERREDNAME>SPEC_MED_LAT_CM_MSR</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the medial-lateral size of a specimen.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>SPOREs</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2015000</PublicId>
      <PreferredName>SPEC_MSR</PreferredName>
      <PreferredDefinition>Numeric value to represent the size of a specimen, a bit of tissue or blood or urine that is taken or used for research purposes.
</PreferredDefinition>
      <LongName>Specimen Measurement</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2241613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2188090</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25209</PreferredName>
        <Version>1</Version>
        <LongName>Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019257</PublicId>
      <PreferredName>MED_LAT_MSR</PreferredName>
      <PreferredDefinition>Value resulting from the measurement of the medial-lateral dimension of a specimen.</PreferredDefinition>
      <LongName>Medial Lateral Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>cm</UnitOfMeasure>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548337</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25232:C25230:C25209</PreferredName>
        <Version>1</Version>
        <LongName>Medial Lateral Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25232</PREFERRED_NAME>
            <LONG_NAME>Medial</LONG_NAME>
            <CON_ID>2205045</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25230</PREFERRED_NAME>
            <LONG_NAME>Lateral</LONG_NAME>
            <CON_ID>2205046</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Medial-lateral specimen dimen</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Medial-lateral specimen dimension (cm)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>scenpro test RDName</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>CALGB_150007</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180156</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>NEW CDEs PER STUDY</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ACRIN_CALGB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811981</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2548333</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>I-SPY</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C911/C1000</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812254</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1018">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2178480</PUBLICID>
    <LONGNAME>Course Day Number</LONGNAME>
    <PREFERREDNAME>CRSE_DAY_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>A particular day in a course (cycle) of study-directed activity.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2178478</PublicId>
      <PreferredName>CRSE_DA</PreferredName>
      <PreferredDefinition>A day in a course (cycle) of intervention or treatment, often referenced numerically (such as Course 5, Day 3).</PreferredDefinition>
      <LongName>Course Day</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2178132</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Course</PreferredName>
        <Version>1</Version>
        <LongName>Course</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25379</PREFERRED_NAME>
            <LONG_NAME>Course</LONG_NAME>
            <CON_ID>2202898</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2178475</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Day</PreferredName>
        <Version>1</Version>
        <LongName>Day</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25301</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2202680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178476</PublicId>
      <PreferredName>CRSE_DAY_NUM</PreferredName>
      <PreferredDefinition>The day within a particular course (cycle) of intervention/therapy that a particular event occurred.</PreferredDefinition>
      <LongName>Course Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177868</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Number</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day in Course (Cycle)</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Day in Course (Cycle)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT28</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Course Day Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT29</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cycle Day</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>OHSU Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Day # of modified dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Day of Dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF_TEXT1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cycle Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day in Course</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Day in Course</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMSv3.02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811686</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vital Signs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812491</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR 2011 Template</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248617</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cardiac</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248620</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Chimerism</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248621</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Concomitant Meds/Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248622</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnostic ECG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Extent of Disease Measurement</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248629</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Infection Episode</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248631</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory All</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248632</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Literal Laboratory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248633</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pharmacokinetics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248638</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical Examination</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248639</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Scintigraphy</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248644</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Study Med Administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248646</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Study Med Missed</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248647</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Transfusion</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248649</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Urinary Excretion</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248650</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Radiation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000158</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Surgery</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000159</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000677</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MediData Rave Use</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3308730</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol 10C0052D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3331757</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UC Irvine</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811716</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Albert Einstein Medical Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UPCC 07403</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812574</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DFMO/Sul Colon III UCI 02_06</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCI 0404</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812578</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke 500</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812580</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>P1_CPT_BCNU_RD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Panvec</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812583</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 02452</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812584</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 03058</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812585</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 04251</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Northwestern University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812693</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NU 0943_011</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812695</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Nebraska Med Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812726</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U of Pa Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812727</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AE_104_085</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UNMC 284-04</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812981</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2718902</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ONS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multisite Research Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812728</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857168</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR CRF Collection</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PKs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857168</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR CRF Collection</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Recist Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812286</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857175</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Adopter CDEs for Reuse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS 3.12B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812490</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2931931</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Iloprost Trial</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Iloprost 12079</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2931952</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1308</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104933</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1306</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104937</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CRSE_DAY_NUM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COURS_DAY</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CRSE_DAY_NUM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CRSE_DAY_NUM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CRSE_DAY_NUM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1019">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2178518</PUBLICID>
    <LONGNAME>Quality of Life Household Activity Support Assessment Scale</LONGNAME>
    <PREFERREDNAME>QOL_HA_SUP_ASS_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>the scale used to assess or evaluate whether an individual requires assistance or support in performing the physical activities which are required for our daily existence as a measure of well-being and ability to enjoy life.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2742819</PublicId>
      <PreferredName>QOL_HA_SUP_ASS</PreferredName>
      <PreferredDefinition>information related to the assessment or evaluation of an whether an individual requires assistance or support in performing the physical activities which are required for our daily existence as a measure of well-being and ability to enjoy life.</PreferredDefinition>
      <LongName>Quality of Life Household Activity Support Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2736450</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17047</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17047</PREFERRED_NAME>
            <LONG_NAME>Quality of Life</LONG_NAME>
            <CON_ID>2202504</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2742817</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C53291:C37902:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Household Activity Support Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53291</PREFERRED_NAME>
            <LONG_NAME>Activity of Daily Living</LONG_NAME>
            <CON_ID>2512701</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37902</PREFERRED_NAME>
            <LONG_NAME>Support</LONG_NAME>
            <CON_ID>2202834</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2668559</PublicId>
      <PreferredName>PERS_QOL_SCALE</PreferredName>
      <PreferredDefinition>the scale relating to the quality of life assessment of a person.</PreferredDefinition>
      <LongName>Person Quality of Life Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A great deal of the time</VALIDVALUE>
          <VALUEMEANING>A GREAT DEAL OF THE TIME</VALUEMEANING>
          <MEANINGDESCRIPTION>A GREAT DEAL OF THE TIME</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little, but it doesn&#39;t worry me</VALIDVALUE>
          <VALUEMEANING>A LITTLE, BUT IT DOESN&#39;T WORRY ME</VALUEMEANING>
          <MEANINGDESCRIPTION>A LITTLE, BUT IT DOESN&#39;T WORRY ME</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A lot of the time</VALIDVALUE>
          <VALUEMEANING>A LOT OF THE TIME</VALUEMEANING>
          <MEANINGDESCRIPTION>A LOT OF THE TIME</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>As much as I always could</VALIDVALUE>
          <VALUEMEANING>AS MUCH AS I ALWAYS COULD</VALUEMEANING>
          <MEANINGDESCRIPTION>AS MUCH AS I ALWAYS COULD</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>As much as I ever did</VALIDVALUE>
          <VALUEMEANING>AS MUCH AS I EVER DID</VALUEMEANING>
          <MEANINGDESCRIPTION>AS MUCH AS I EVER DID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Definitely</VALIDVALUE>
          <VALUEMEANING>Definitely</VALUEMEANING>
          <MEANINGDESCRIPTION>Definitely</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Definitely as much</VALIDVALUE>
          <VALUEMEANING>DEFINITELY AS MUCH</VALUEMEANING>
          <MEANINGDESCRIPTION>DEFINITELY AS MUCH</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Definitely less than I used to</VALIDVALUE>
          <VALUEMEANING>DEFINITELY LESS THAN I USED TO</VALUEMEANING>
          <MEANINGDESCRIPTION>DEFINITELY LESS THAN I USED TO</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Definitely not so much now</VALIDVALUE>
          <VALUEMEANING>DEFINITELY NOT SO MUCH NOW</VALUEMEANING>
          <MEANINGDESCRIPTION>DEFINITELY NOT SO MUCH NOW</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561669</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>From time to time but not too often</VALIDVALUE>
          <VALUEMEANING>FROM TIME TO TIME BUT NOT TOO OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>FROM TIME TO TIME BUT NOT TOO OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>From time to time, occasionally</VALIDVALUE>
          <VALUEMEANING>FROM TIME TO TIME, OCCASIONALLY</VALUEMEANING>
          <MEANINGDESCRIPTION>FROM TIME TO TIME, OCCASIONALLY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hardly at all</VALIDVALUE>
          <VALUEMEANING>HARDLY AT ALL</VALUEMEANING>
          <MEANINGDESCRIPTION>HARDLY AT ALL</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561663</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I don&#39;t take so much care as I should</VALIDVALUE>
          <VALUEMEANING>I DON&#39;T TAKE SO MUCH CARE AS I SHOULD</VALUEMEANING>
          <MEANINGDESCRIPTION>I DON&#39;T TAKE SO MUCH CARE AS I SHOULD</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I may not take quite as much care</VALIDVALUE>
          <VALUEMEANING>I MAY NOT TAKE QUITE AS MUCH CARE</VALUEMEANING>
          <MEANINGDESCRIPTION>I MAY NOT TAKE QUITE AS MUCH CARE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I take just as much care as ever</VALIDVALUE>
          <VALUEMEANING>I TAKE JUST AS MUCH CARE AS EVER</VALUEMEANING>
          <MEANINGDESCRIPTION>I TAKE JUST AS MUCH CARE AS EVER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561672</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Most of the time</VALIDVALUE>
          <VALUEMEANING>Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nearly all the time</VALIDVALUE>
          <VALUEMEANING>NEARLY ALL THE TIME</VALUEMEANING>
          <MEANINGDESCRIPTION>NEARLY ALL THE TIME</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not often</VALIDVALUE>
          <VALUEMEANING>NOT OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>NOT OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not quite so much</VALIDVALUE>
          <VALUEMEANING>NOT QUITE SO MUCH</VALUEMEANING>
          <MEANINGDESCRIPTION>NOT QUITE SO MUCH</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not quite so much now</VALIDVALUE>
          <VALUEMEANING>NOT QUITE SO MUCH NOW</VALUEMEANING>
          <MEANINGDESCRIPTION>NOT QUITE SO MUCH NOW</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not very much</VALIDVALUE>
          <VALUEMEANING>NOT VERY MUCH</VALUEMEANING>
          <MEANINGDESCRIPTION>NOT VERY MUCH</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not very often</VALIDVALUE>
          <VALUEMEANING>NOT VERY OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>NOT VERY OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occasionally</VALIDVALUE>
          <VALUEMEANING>OCCASIONALLY</VALUEMEANING>
          <MEANINGDESCRIPTION>OCCASIONALLY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Only a little</VALIDVALUE>
          <VALUEMEANING>ONLY A LITTLE</VALUEMEANING>
          <MEANINGDESCRIPTION>ONLY A LITTLE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Only occasionally</VALIDVALUE>
          <VALUEMEANING>ONLY OCCASIONALLY</VALUEMEANING>
          <MEANINGDESCRIPTION>ONLY OCCASIONALLY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite often</VALIDVALUE>
          <VALUEMEANING>QUITE OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>QUITE OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rather less than I used to</VALIDVALUE>
          <VALUEMEANING>RATHER LESS THAN I USED TO</VALUEMEANING>
          <MEANINGDESCRIPTION>RATHER LESS THAN I USED TO</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Usually</VALIDVALUE>
          <VALUEMEANING>Usually</VALUEMEANING>
          <MEANINGDESCRIPTION>That which is considered customary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102843</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very definitely and quite badly</VALIDVALUE>
          <VALUEMEANING>VERY DEFINITELY AND QUITE BADLY</VALUEMEANING>
          <MEANINGDESCRIPTION>VERY DEFINITELY AND QUITE BADLY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much indeed</VALIDVALUE>
          <VALUEMEANING>VERY MUCH INDEED</VALUEMEANING>
          <MEANINGDESCRIPTION>VERY MUCH INDEED</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very often</VALIDVALUE>
          <VALUEMEANING>VERY OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>VERY OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very often indeed</VALIDVALUE>
          <VALUEMEANING>VERY OFTEN INDEED</VALUEMEANING>
          <MEANINGDESCRIPTION>VERY OFTEN INDEED</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561578</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very seldom</VALIDVALUE>
          <VALUEMEANING>VERY SELDOM</VALUEMEANING>
          <MEANINGDESCRIPTION>VERY SELDOM</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, but not too badly</VALIDVALUE>
          <VALUEMEANING>YES, BUT NOT TOO BADLY</VALUEMEANING>
          <MEANINGDESCRIPTION>YES, BUT NOT TOO BADLY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561665</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a lot</VALIDVALUE>
          <VALUEMEANING>QUITE A LOT</VALUEMEANING>
          <MEANINGDESCRIPTION>QUITE A LOT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately</VALIDVALUE>
          <VALUEMEANING>Moderately</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely</VALIDVALUE>
          <VALUEMEANING>EXTREMELY</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None of the time</VALIDVALUE>
          <VALUEMEANING>None of the time</VALUEMEANING>
          <MEANINGDESCRIPTION>None of the time</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little of the time</VALIDVALUE>
          <VALUEMEANING>A little of the time</VALUEMEANING>
          <MEANINGDESCRIPTION>A little of the time</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570049</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>All of the time</VALIDVALUE>
          <VALUEMEANING>All of the time</VALUEMEANING>
          <MEANINGDESCRIPTION>All of the time</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570083</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some of the time</VALIDVALUE>
          <VALUEMEANING>Some of the time</VALUEMEANING>
          <MEANINGDESCRIPTION>Some of the time</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2927955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-05-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to do</VALIDVALUE>
          <VALUEMEANING>UNABLE To Do</VALUEMEANING>
          <MEANINGDESCRIPTION>UNABLE To Do (Health Activity Questionnaire)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very difficult</VALIDVALUE>
          <VALUEMEANING>Very difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Very difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat difficult</VALIDVALUE>
          <VALUEMEANING>Somewhat difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little difficult</VALIDVALUE>
          <VALUEMEANING>A little difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>A little difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not difficult at all</VALIDVALUE>
          <VALUEMEANING>Not difficult at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not difficult at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Once in a while</VALIDVALUE>
          <VALUEMEANING>Once in a while</VALUEMEANING>
          <MEANINGDESCRIPTION>Once in a while</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-05-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4325606</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never/Rarely</VALIDVALUE>
          <VALUEMEANING>Never/Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Never/Rarely</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-05-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4325607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Bathing or dressing yourself</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Bathing or dressing yourself</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Do you need help with eating, dressing, washing yourself or using the toilet</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Someone to help with daily chores if you were sick</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>I need help in caring for myself (bathing, dressing, eating, etc.)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Wash your back with your affected arm?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Stage I-III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Advanced</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000001</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BR14_FACTBR_SCL</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QOL_HA_SUP_ASS_SC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1020">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2179658</PUBLICID>
    <LONGNAME>Patient Cause of Death Text</LONGNAME>
    <PREFERREDNAME>PT_CAUSE_DEATH_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>The text that describes the cause of death.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2012739</PublicId>
      <PreferredName>DEATH_PRIM_CAUSE</PreferredName>
      <PreferredDefinition>Primary reason or cause of death.</PreferredDefinition>
      <LongName>Death Primary Cause</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008552</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PHYS_DESC_OF_INDS</PreferredName>
        <Version>1</Version>
        <LongName>Physical Description of Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177148</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Death</PreferredName>
        <Version>1</Version>
        <LongName>Death</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28554</PREFERRED_NAME>
            <LONG_NAME>Dead</LONG_NAME>
            <CON_ID>2202731</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207476</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25251:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Primary Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2179498</PublicId>
      <PreferredName>PT_CAUSE_DEATH_TXT</PreferredName>
      <PreferredDefinition>All text that describes the cause of death.</PreferredDefinition>
      <LongName>Patient Cause of Death Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2179409</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>FINDINGS</PreferredName>
        <Version>1</Version>
        <LongName>Findings</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cause of Death</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cause of Death</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient Cause of Death Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Document Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cause of Death other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If other cause of death, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cause of Death-Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CSAERS Review Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811695</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2811734</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SeriousAdverseEvents</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812325</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CSAERS Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812969</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms Version 3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2957372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2190530</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Demonstration Applications</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CIAF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812341</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Budesonide Lung Nodules</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812102</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAMe - Hepatitis C cirrhosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812148</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pancreatic Mucinous Neoplasms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812149</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate - Lycopene</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus - ASA-Esomeprazole</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Sulindac</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sporadic Colorectal Neoplasia - Atrovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812155</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma Pathobiology - Lovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812157</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Hormone Receptor-Negative Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Safety Study of Resiquimod for Atyical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Effect of Finasteride - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812182</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Atrovastatin in Women at High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812183</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Spectral Markers in ASA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812184</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Se-Methyl-Seleno-L-Cystein (MSC) in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812188</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Pre-prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812189</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Acolbifene - High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812190</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ALA PDT - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812194</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Resiquimod - Atypical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DIM - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812202</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Drug and Carcinogen Enzymes - Resveratrol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812258</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Aminolevulinic Acid - Barrett&#39;s Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812364</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812377</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812388</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E for Cervical Ca</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812399</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812415</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Unconjugated Isoflavones in Women at High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Subclinical Neoplastic Lesions</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Bladder Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812539</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>9cUAB30</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EGF Receptor Signaling in ACF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>3, 3-Diindolylmethane Cervical Intraepithelial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812735</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Transdermal 4-OHT vs oral TAM DCIS of the Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812736</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PK and Safety - Novel Retinoid (9cUAB30)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812768</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imiquimod for Atypical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812836</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyethylene Glycol - Colon Carcinogenesis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812843</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Myo-Inositol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812876</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exp. PK Formulations of SR13668</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812998</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac - Increased Risk of Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813002</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ursodeoxycholic Acid - Barrett&#39;s Patients</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2813043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Erlotinib - Lesions of Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2813064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Letrozole - Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2842768</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Sulindac DFMO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2859628</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E in Women w/ Modulation of Arachidonic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2936518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2979172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin Colorectal Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018781</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Resveratrol in Postmenopausal Women</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018782</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSC and L SeMet in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3110219</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cholecalciferol and Genistein</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3114163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Lung Pre-Surgical NSCLC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3152820</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vitamin D - Bioactivity in the Skin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182878</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin - Pre-Prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182879</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barrett&#39;s Esophagus Chemoprevention Metformin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3211792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAB30 in NMSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3293737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pomegranate - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3303133</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896537</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896538</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4111771</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4188651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261112</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5416571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5441476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5598962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-07-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889176</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2017-09-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2017-09-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5981652</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6046252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_CAUSE_DEATH_TXT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1021">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2180275</PUBLICID>
    <LONGNAME>Transplant Discharge Date</LONGNAME>
    <PREFERREDNAME>TSPL_DC_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date on which the patient is discharged from the hospital after completing procedures for a transplant.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2180274</PublicId>
      <PreferredName>TSPL_DC</PreferredName>
      <PreferredDefinition>information regarding transplant discharge.</PreferredDefinition>
      <LongName>Transplant Discharge</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176929</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Transplant</PreferredName>
        <Version>1</Version>
        <LongName>Transplant</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177544</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Discharge</PreferredName>
        <Version>1</Version>
        <LongName>Discharge</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25166</PREFERRED_NAME>
            <LONG_NAME>Patient Discharge</LONG_NAME>
            <CON_ID>2203907</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of Discharge following Transplant</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1022">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2180335</PUBLICID>
    <LONGNAME>Intravenous Treatment Infection Ind-3</LONGNAME>
    <PREFERREDNAME>IV_TX_INFEC_IND-3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator to ask if the patient received intravenous antibiotic medication to treat a reported infection adverse event.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195616</PublicId>
      <PreferredName>IV_TX_INFEC</PreferredName>
      <PreferredDefinition>information related to the IV treatment of infection.</PreferredDefinition>
      <LongName>Intravenous Treatment Infection</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2660543</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13346:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Intravenous Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13346</PREFERRED_NAME>
            <LONG_NAME>Intravenous</LONG_NAME>
            <CON_ID>2450528</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177458</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Infection</PreferredName>
        <Version>1</Version>
        <LongName>Infection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26726</PREFERRED_NAME>
            <LONG_NAME>Infectious Disorder</LONG_NAME>
            <CON_ID>2203837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did patient receive IV antibi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did patient receive IV antibiotic therapy for the infection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient require IV antibiotics or antifungals</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811951</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AML Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000362</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1023">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2180393</PUBLICID>
    <LONGNAME>Transplant Donor Patient Relationship Type</LONGNAME>
    <PREFERREDNAME>TSPL_DON_PT_RELAT_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the relationship between the patient receiving a transplant and the person who donated cells for the procedure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195767</PublicId>
      <PreferredName>TSPL_DON_PT_RELAT</PreferredName>
      <PreferredDefinition>information related to the transplant donor&#39;s relationship to the patient.</PreferredDefinition>
      <LongName>Transplant Donor Patient Relationship</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206477</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12981:C25168</PreferredName>
        <Version>1</Version>
        <LongName>Transplant Donor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660887</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:CL110661</PreferredName>
        <Version>1</Version>
        <LongName>Patient Relationship</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL110661</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2204509</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180392</PublicId>
      <PreferredName>TSPL_DON_RELAT_TP</PreferredName>
      <PreferredDefinition>information regarding relationship between the transplant donor and the transplant recipient.</PreferredDefinition>
      <LongName>Transplant Donor Relationship Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>sibling</VALIDVALUE>
          <VALUEMEANING>SIBLING</VALUEMEANING>
          <MEANINGDESCRIPTION>SIBLING</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>identical twin (or multiple)</VALIDVALUE>
          <VALUEMEANING>identical twin (or multiple)</VALUEMEANING>
          <MEANINGDESCRIPTION>identical twin (or multiple)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568108</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fraternal twin (or multiple)</VALIDVALUE>
          <VALUEMEANING>fraternal twin (or multiple)</VALUEMEANING>
          <MEANINGDESCRIPTION>fraternal twin (or multiple)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>not related</VALIDVALUE>
          <VALUEMEANING>NOT RELATED</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Related; connected or associated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25648, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>parent</VALIDVALUE>
          <VALUEMEANING>parent</VALUEMEANING>
          <MEANINGDESCRIPTION>parent</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>child</VALIDVALUE>
          <VALUEMEANING>child</VALUEMEANING>
          <MEANINGDESCRIPTION>child</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other family member</VALIDVALUE>
          <VALUEMEANING>OTHER FAMILY MEMBER</VALUEMEANING>
          <MEANINGDESCRIPTION>OTHER FAMILY MEMBER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unrelated Cord Blood</VALIDVALUE>
          <VALUEMEANING>Unrelated Cord Blood</VALUEMEANING>
          <MEANINGDESCRIPTION>Unrelated Cord Blood</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4155493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Donor&#39;s relationship to patie</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Donor&#39;s relationship to patient</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Donor&#39;s Relationship to recipient</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1024">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2180408</PUBLICID>
    <LONGNAME>Laboratory Procedure Follicle Stimulating Hormone Result Specified Value</LONGNAME>
    <PREFERREDNAME>LAB_FSH_RSL_SPE_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>the value, in IU/L, for measuring the level of follicle stimulating hormone (FSH) present in the blood of a female patient.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195777</PublicId>
      <PreferredName>LAB_FSH_RSLT</PreferredName>
      <PreferredDefinition>information related to the result of the medical procedure that involves testing a sample of blood for follicle stimulating hormone, a gonadotropic hormone found in the anterior pituitary gland.</PreferredDefinition>
      <LongName>Laboratory Procedure Follicle Stimulating Hormone Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738861</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2286:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Follicle Stimulating Hormone Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2286</PREFERRED_NAME>
            <LONG_NAME>Follicle Stimulating Hormone</LONG_NAME>
            <CON_ID>2525396</CON_ID>
            <DEFINITION_SOURCE>MSH2002_06_01</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180407</PublicId>
      <PreferredName>FSH_SPEC_VAL</PreferredName>
      <PreferredDefinition>the specified FSH value.</PreferredDefinition>
      <LongName>Follicle Stimulating Specified Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>iU/L</UnitOfMeasure>
      <DisplayFormat>99.9</DisplayFormat>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184351</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Value</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>-COMMENT</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Add instruction: IU/L (FSH)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Follicle Stimulating Hormone</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Follicle Stimulating Hormone</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Follicle Stimulating Hormone (FSH):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CHEM_FSH_LAB_SPE_VAL</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1025">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2181827</PUBLICID>
    <LONGNAME>Cerebrospinal Fluid Cytology Performed Ind</LONGNAME>
    <PREFERREDNAME>CSF_CYTOL_PERF_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the indicator that asks whether cerebrospinal fluid cytology was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>Brain CDE Disease Committee</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188989</PublicId>
      <PreferredName>CSF_CYTOLOGY_PERF</PreferredName>
      <PreferredDefinition>information related to cerebrospinal fluid cytology being performed.</PreferredDefinition>
      <LongName>Cerebrospinal Fluid Cytology Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206621</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12692:C16491</PreferredName>
        <Version>1</Version>
        <LongName>Cerebrospinal Fluid Cytology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12692</PREFERRED_NAME>
            <LONG_NAME>Cerebrospinal Fluid</LONG_NAME>
            <CON_ID>2202710</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16491</PREFERRED_NAME>
            <LONG_NAME>Cytology</LONG_NAME>
            <CON_ID>2202726</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177693</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Performed</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181868</PublicId>
      <PreferredName>CSF_IND</PreferredName>
      <PreferredDefinition>the indicator that cerebrospinal fluid is present.</PreferredDefinition>
      <LongName>Cerebrospinal Fluid Ind</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008575</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SM</PreferredName>
        <Version>1</Version>
        <LongName>Symptoms</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2188676</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Indicator</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>not done</VALIDVALUE>
          <VALUEMEANING>NOT DONE</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-05-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>positive</VALIDVALUE>
          <VALUEMEANING>Positive</VALUEMEANING>
          <MEANINGDESCRIPTION>Involving advantage or good.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>negative</VALIDVALUE>
          <VALUEMEANING>Negative</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>undetermined</VALIDVALUE>
          <VALUEMEANING>undetermined</VALUEMEANING>
          <MEANINGDESCRIPTION>undetermined</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568767</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CSF Cytology</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CSF Cytology</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_Text_1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If CSF cytology performed, please provide sample results</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812013</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain Recurr</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1026">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2182074</PUBLICID>
    <LONGNAME>Patient Adjuvant Platinum-Based Chemotherapy Administered End Date</LONGNAME>
    <PREFERREDNAME>PT_ADPBCT_ADM_END_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the end date on which adjuvant chemotherapy treatment with a platinum-based agent was administered to a patient.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2442252</PublicId>
      <PreferredName>PT_ADJPLATBSDCT_ADM</PreferredName>
      <PreferredDefinition>information relating to adjuvant platinum-based chemotherapy administered to a patient.</PreferredDefinition>
      <LongName>Patient Adjuvant Platinum-Based Chemotherapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2442250</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2140:C25620:C15632:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Adjuvant Platinum-Based Chemotherapy Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2140</PREFERRED_NAME>
            <LONG_NAME>Adjuvant</LONG_NAME>
            <CON_ID>2204993</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25620</PREFERRED_NAME>
            <LONG_NAME>Platinum-Based</LONG_NAME>
            <CON_ID>2206345</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15632</PREFERRED_NAME>
            <LONG_NAME>Chemotherapy</LONG_NAME>
            <CON_ID>2202708</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188674</PublicId>
      <PreferredName>END_DT</PreferredName>
      <PreferredDefinition>The date on which an observation or an event ended.</PreferredDefinition>
      <LongName>End Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184285</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Date</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date adjuvant platinum-based</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date adjuvant platinum-based chemotherapy stopped</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of last dose of platinum therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1027">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2182152</PUBLICID>
    <LONGNAME>Lower Limb Assessment Emotional Scale</LONGNAME>
    <PREFERREDNAME>L_LIMB_ASS_EMO_SCALE</PREFERREDNAME>
    <PREFERREDDEFINITION>the assessment of the patient&#39;s emotional acceptance of lower limb function and pain.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2197671</PublicId>
      <PreferredName>LOWER_LIMB_ASSESS</PreferredName>
      <PreferredDefinition>information related to a lower limb assessment.</PreferredDefinition>
      <LongName>Lower Limb Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206949</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25309:C0015385</PreferredName>
        <Version>1</Version>
        <LongName>Lower Limb</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25309</PREFERRED_NAME>
            <LONG_NAME>Lower</LONG_NAME>
            <CON_ID>2205319</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0015385</PREFERRED_NAME>
            <LONG_NAME>Limb</LONG_NAME>
            <CON_ID>2202972</CON_ID>
            <DEFINITION_SOURCE>UWDA155</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177637</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Assessment</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2182149</PublicId>
      <PreferredName>LIMB_ASSE_EMOT_SCALE</PreferredName>
      <PreferredDefinition>information related to a patient&#39;s limb assessment emotional scale.</PreferredDefinition>
      <LongName>Limb Assessment Emotional Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208113</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25495:C25664</PreferredName>
        <Version>1</Version>
        <LongName>Emotional Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25495</PREFERRED_NAME>
            <LONG_NAME>Emotional</LONG_NAME>
            <CON_ID>2206201</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Satisfied</VALIDVALUE>
          <VALUEMEANING>Satisfied</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that an individual is pleased and content.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125072</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568803</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intermediate</VALIDVALUE>
          <VALUEMEANING>INTERMEDIATE</VALUEMEANING>
          <MEANINGDESCRIPTION>Lying between two extremes in time or space or degree.: The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18000, C73705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Accepts</VALIDVALUE>
          <VALUEMEANING>Accepts</VALUEMEANING>
          <MEANINGDESCRIPTION>Accepts</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568804</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dislikes</VALIDVALUE>
          <VALUEMEANING>Dislikes</VALUEMEANING>
          <MEANINGDESCRIPTION>Dislikes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568805</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enthused</VALIDVALUE>
          <VALUEMEANING>Enthused</VALUEMEANING>
          <MEANINGDESCRIPTION>Enthused</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568801</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Likes</VALIDVALUE>
          <VALUEMEANING>Likes</VALUEMEANING>
          <MEANINGDESCRIPTION>Likes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568802</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Emotional Acceptance</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Emotional Acceptance</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811884</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811886</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811889</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000027</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma Recur</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1028">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2182662</PUBLICID>
    <LONGNAME>Last Dose Systemic Protocol Date</LONGNAME>
    <PREFERREDNAME>L_DOSE_SYS_PROT_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date the last dose of systemic therapy as stated by the protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2197812</PublicId>
      <PreferredName>LAST_DOSE_SYS_PROT</PreferredName>
      <PreferredDefinition>information related to the last systemic protocol dose.</PreferredDefinition>
      <LongName>Last Dose Systemic Protocol</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206411</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25551:C25488</PreferredName>
        <Version>1</Version>
        <LongName>Last Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25551</PREFERRED_NAME>
            <LONG_NAME>Last</LONG_NAME>
            <CON_ID>2206286</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207291</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13310:C25320</PreferredName>
        <Version>1</Version>
        <LongName>Systemic Protocol</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13310</PREFERRED_NAME>
            <LONG_NAME>Systemic</LONG_NAME>
            <CON_ID>2204930</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25320</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Protocol</LONG_NAME>
            <CON_ID>2202702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Last Dose of Protocol</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of Last Dose of Protocol Systemic Therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811884</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811886</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811889</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000027</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma Recur</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1029">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2182691</PUBLICID>
    <LONGNAME>QOL Mobility Assessment Status</LONGNAME>
    <PREFERREDNAME>QOL_MOBI_ASSESS_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>the patient&#39;s self-reported level of mobility.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2194432</PublicId>
      <PreferredName>QOL_MOBILITY_ASSESS</PreferredName>
      <PreferredDefinition>information related to the mobility quality of life assessment.</PreferredDefinition>
      <LongName>Quality of Life Mobility Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2194423</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Quality of Life</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17047</PREFERRED_NAME>
            <LONG_NAME>Quality of Life</LONG_NAME>
            <CON_ID>2202504</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660952</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0449580:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Mobility Physical Examination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0449580</PREFERRED_NAME>
            <LONG_NAME>Mobility</LONG_NAME>
            <CON_ID>2615903</CON_ID>
            <DEFINITION_SOURCE>SNOMEDCT_2004_01_31</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2182689</PublicId>
      <PreferredName>QOL_MOBI_ASSESS_STAT</PreferredName>
      <PreferredDefinition>the patient&#39;s self-reported level of mobility.</PreferredDefinition>
      <LongName>QOL Mobility Assessment Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184340</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Status</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I have no problems in walking about</VALIDVALUE>
          <VALUEMEANING>I have no problems in walking about</VALUEMEANING>
          <MEANINGDESCRIPTION>I have no problems in walking about</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-04-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I have some problems in walking about</VALIDVALUE>
          <VALUEMEANING>I have some problems in walking about</VALUEMEANING>
          <MEANINGDESCRIPTION>I have some problems in walking about</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-04-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I am confined to bed</VALIDVALUE>
          <VALUEMEANING>I am confined to bed</VALUEMEANING>
          <MEANINGDESCRIPTION>I am confined to bed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-04-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Mobility</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Mobility</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1216</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104934</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1112</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104993</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0920</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1010</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171061</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0534</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171063</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0815</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0924</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171065</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QOL_MOBI_ASSESS_STAT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1030">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2184773</PUBLICID>
    <LONGNAME>Birth Weight Value</LONGNAME>
    <PREFERREDNAME>BIRTH_WT_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>The value for the weight of a person at birth.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013752</PublicId>
      <PreferredName>2486639v1.0:2422675v1.0</PreferredName>
      <PreferredDefinition>The event of being born._The vertical force exerted by a mass as a result of gravity.</PreferredDefinition>
      <LongName>Birth Weight</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2486639</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25155</PreferredName>
        <Version>1</Version>
        <LongName>Birth</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25155</PREFERRED_NAME>
            <LONG_NAME>Birth</LONG_NAME>
            <CON_ID>2202896</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2422675</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25208</PreferredName>
        <Version>1</Version>
        <LongName>Weight</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25208</PREFERRED_NAME>
            <LONG_NAME>Weight</LONG_NAME>
            <CON_ID>2202868</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178419</PublicId>
      <PreferredName>WEIGHT_POUND_VALUES</PreferredName>
      <PreferredDefinition>values for the measurement of an individual&#39;s weight in pounds.</PreferredDefinition>
      <LongName>Weight Pound Values</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>EDRN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178074</PublicId>
        <ContextName>EDRN</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PHYS_DESC_OF_INDS</PreferredName>
        <Version>1</Version>
        <LongName>Physical Description of Individuals</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>lb</UnitOfMeasure>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2183848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL052797</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL052797</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2204717</CON_ID>
            <DEFINITION_SOURCE>NCI Thesaurus. Bethesda (MD): National Cancer Institute, National Institutes of Health, TDE version, August 2004. Contact: Sherri de Coronado, decorons@osp.nci.nih.gov, http://nci.nih.gov</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Wt at Birth</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Wt at Birth</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1031">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2184934</PUBLICID>
    <LONGNAME>Laboratory Procedure Granulocyte Result Lower Limit of Normal Count</LONGNAME>
    <PREFERREDNAME>LAB_GRA_RSL_LLN_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>the lower limit of normal of a patient&#39;s peripheral granulocyte count.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2464541</PublicId>
      <PreferredName>LAB_GRANULO_RSLT</PreferredName>
      <PreferredDefinition>information related to the result of the medical procedure that involves testing a sample of blood for granulocytes, a leucocyte with conspicuous cytoplasmic granules.</PreferredDefinition>
      <LongName>Laboratory Procedure Granulocyte Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738862</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12530:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Granulocyte Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12530</PREFERRED_NAME>
            <LONG_NAME>Granulocyte</LONG_NAME>
            <CON_ID>2202652</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2184932</PublicId>
      <PreferredName>GRA_CT_LLN</PreferredName>
      <PreferredDefinition>the lower limit of normal of the granulocyte count.</PreferredDefinition>
      <LongName>Granulocyte Lower Limit of Normal Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>mm3</UnitOfMeasure>
      <MaximumLength>6</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2524686</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25555:C25463</PreferredName>
        <Version>1</Version>
        <LongName>LLN Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25555</PREFERRED_NAME>
            <LONG_NAME>Lower Limit of Normal</LONG_NAME>
            <CON_ID>2204652</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Long Name</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Peripheral Granulocytes Count LLN</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1032">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2185865</PUBLICID>
    <LONGNAME>Denture Use Type</LONGNAME>
    <PREFERREDNAME>DENTURE_USE_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of dental dentures.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2185864</PublicId>
      <PreferredName>DENTURE_USE</PreferredName>
      <PreferredDefinition>information related to use of an appliance used as an artificial or prosthetic replacement for missing teeth and adjacent tissues.</PreferredDefinition>
      <LongName>Denture Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2589951</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63720</PreferredName>
        <Version>1</Version>
        <LongName>Denture</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63720</PREFERRED_NAME>
            <LONG_NAME>Denture</LONG_NAME>
            <CON_ID>2547875</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234899</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25340</PreferredName>
        <Version>1</Version>
        <LongName>Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2185863</PublicId>
      <PreferredName>DENTURE_USE_TP</PreferredName>
      <PreferredDefinition>the type of dental dentures used.</PreferredDefinition>
      <LongName>Denture Use Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complete dentures</VALIDVALUE>
          <VALUEMEANING>Complete dentures</VALUEMEANING>
          <MEANINGDESCRIPTION>Complete dentures</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Removable partial dentures</VALIDVALUE>
          <VALUEMEANING>Removable partial dentures</VALUEMEANING>
          <MEANINGDESCRIPTION>Removable partial dentures</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Removable dentures</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Removable dentures</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1033">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2186042</PUBLICID>
    <LONGNAME>Patient Registered Ind-2</LONGNAME>
    <PREFERREDNAME>2186043v1.0:2018320v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether the patient is registered for another research component of a trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2186043</PublicId>
      <PreferredName>PT_REGISTERED</PreferredName>
      <PreferredDefinition>information related to patient being registered.</PreferredDefinition>
      <LongName>Patient Registered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177403</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Registered</PreferredName>
        <Version>1</Version>
        <LongName>Registered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25644</PREFERRED_NAME>
            <LONG_NAME>Registered</LONG_NAME>
            <CON_ID>2203772</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Patients will automatically b</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Patients will automatically be registered to the translational research component of this study at the time of registration (see Section 4.0)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient will automatically be registered to the translational research component of this study at the time of pre-randomization.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>A mandatory translational research component is part of this study,  patients will automatically be registered to the translational research component of this study at the time of registration.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>A mandatory correlative research component for blood is part of this study, the patient will be automatically registered onto this component</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>A mandatory correlative research component is part of this study for all patients, the patient will be automatically registered onto this component</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>A mandatory correlative research component for blood and urine is part of this study; the patient will be automatically registered onto this component</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>All Participants will automatically be registered to the correlative components of this study</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>All Participants will automatically be registered to the correlative components of this study</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the patient assigned to participate in the mandatory PK study?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient will be automatically registered to the mandatory embedded correlative science companion study.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Registration Office personnel will automatically register participants separately to the translational components of the study</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient will be automatically registered to the mandatory embedded Health Behaviors and Patient Reported Outcomes study.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient registering to Arm 3?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2012-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3694151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5592146</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PtPtpPKstdy</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>2186043v1.0:2018320v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1034">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2188290</PUBLICID>
    <LONGNAME>Disease Response Site Status</LONGNAME>
    <PREFERREDNAME>DZ_RESP_SITE_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>the status of a disease response.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188292</PublicId>
      <PreferredName>DZ_RESP_LCTN</PreferredName>
      <PreferredDefinition>the location or anatomic site of the response of a disease to therapy.</PreferredDefinition>
      <LongName>Disease Response Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2767449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25755:C25341</PreferredName>
        <Version>1</Version>
        <LongName>Response Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25755</PREFERRED_NAME>
            <LONG_NAME>Response</LONG_NAME>
            <CON_ID>2202805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188289</PublicId>
      <PreferredName>DZ_RESP_SITE_STAT</PreferredName>
      <PreferredDefinition>the status of a disease response.</PreferredDefinition>
      <LongName>Disease Response Site Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>80</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>New</VALIDVALUE>
          <VALUEMEANING>NEW</VALUEMEANING>
          <MEANINGDESCRIPTION>New; having no previous example or precedent or parallel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Progressive</VALIDVALUE>
          <VALUEMEANING>Progressive Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Cancer that is increasing in scope or severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Currently active</VALIDVALUE>
          <VALUEMEANING>Active</VALUEMEANING>
          <MEANINGDESCRIPTION>Exerting influence or producing an effect; taking part in an activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ever present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never present</VALIDVALUE>
          <VALUEMEANING>Never present</VALUEMEANING>
          <MEANINGDESCRIPTION>Never present</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2678676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unequivocal progression</VALIDVALUE>
          <VALUEMEANING>PROGRESSION</VALUEMEANING>
          <MEANINGDESCRIPTION>The worsening of a disease over time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not evaluable</VALIDVALUE>
          <VALUEMEANING>Not Evaluable</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to be evaluated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unresolved</VALIDVALUE>
          <VALUEMEANING>Unresolved</VALUEMEANING>
          <MEANINGDESCRIPTION>Unresolved</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2947210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>New lesion</VALIDVALUE>
          <VALUEMEANING>New Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>New Lesion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resolved</VALIDVALUE>
          <VALUEMEANING>Resolved</VALUEMEANING>
          <MEANINGDESCRIPTION>Return to the normal structure and/or function, e.g. the subsidence of a pathologic process, as the subsidence of an inflammatory lesion or new growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done/not applicable</VALIDVALUE>
          <VALUEMEANING>Not done/not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Not done/not applicable</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent/resolved</VALIDVALUE>
          <VALUEMEANING>Absent/resolved</VALUEMEANING>
          <MEANINGDESCRIPTION>Absent/resolved</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No change/stable</VALIDVALUE>
          <VALUEMEANING>No change/stable</VALUEMEANING>
          <MEANINGDESCRIPTION>No change/stable</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Increase/worsen</VALIDVALUE>
          <VALUEMEANING>Increase/worsen</VALUEMEANING>
          <MEANINGDESCRIPTION>Increase/worsen</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decrease/improve</VALIDVALUE>
          <VALUEMEANING>Decrease/improve</VALUEMEANING>
          <MEANINGDESCRIPTION>Decrease/improve</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease present</VALIDVALUE>
          <VALUEMEANING>Disease present</VALUEMEANING>
          <MEANINGDESCRIPTION>Disease present</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563820</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No evidence of disease</VALIDVALUE>
          <VALUEMEANING>No evidence of disease</VALUEMEANING>
          <MEANINGDESCRIPTION>No evidence of disease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-01-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suspicious for cancer</VALIDVALUE>
          <VALUEMEANING>Suspicious for Cancer</VALUEMEANING>
          <MEANINGDESCRIPTION>Suspicious for Cancer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complete regression</VALIDVALUE>
          <VALUEMEANING>Complete regression</VALUEMEANING>
          <MEANINGDESCRIPTION>Complete regression</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3355080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial regression</VALIDVALUE>
          <VALUEMEANING>Partial regression</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial regression</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3355081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recurrent</VALIDVALUE>
          <VALUEMEANING>RECURRENT</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring again.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Persistent</VALIDVALUE>
          <VALUEMEANING>Persistent</VALUEMEANING>
          <MEANINGDESCRIPTION>Retained; never-ceasing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3285284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FNA indicates not clearly cancer</VALIDVALUE>
          <VALUEMEANING>FNA indicates not clearly cancer</VALUEMEANING>
          <MEANINGDESCRIPTION>FNA indicates not clearly cancer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3685464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FNA indicates cancer</VALIDVALUE>
          <VALUEMEANING>FNA indicates cancer</VALUEMEANING>
          <MEANINGDESCRIPTION>FNA indicates cancer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3685465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Newly diagnosed</VALIDVALUE>
          <VALUEMEANING>Newly Diagnosed</VALUEMEANING>
          <MEANINGDESCRIPTION>Very recently determined.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stable</VALIDVALUE>
          <VALUEMEANING>Stable</VALUEMEANING>
          <MEANINGDESCRIPTION>Stable; subject to little fluctuation; showing little if any change.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C30103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial Response (PR)</VALIDVALUE>
          <VALUEMEANING>partial response (PR)</VALUEMEANING>
          <MEANINGDESCRIPTION>partial response (PR) -- 50% decrease in peripheral blood lymphocyte count from pretreatment value; at least 50% reduction in lymphodenopathy if present pretreatment; at least 50% reduction in level and spleen size if enlarged pretreatment; one or mor of the following: 1) neutrophils at least 1.5 x 10^9/L or 50% improvement over baseline 2) platelets &gt; 100 x 10^9/L or 50% improvement over baseline 3) hemoglobin &gt; 11.0 g/dL or 50% improvement over baseline</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-06-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2626315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unevaluable</VALIDVALUE>
          <VALUEMEANING>Unevaluable</VALUEMEANING>
          <MEANINGDESCRIPTION>Unevaluable</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-06-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Relapse</VALIDVALUE>
          <VALUEMEANING>Relapse</VALUEMEANING>
          <MEANINGDESCRIPTION>The return of a disease after a period of remission.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Refractory Disease (RD)</VALIDVALUE>
          <VALUEMEANING>Refractory Disease (RD)</VALUEMEANING>
          <MEANINGDESCRIPTION>Refractory Disease (RD)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-06-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4860974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complete Response (CR)</VALIDVALUE>
          <VALUEMEANING>complete response (CR)</VALUEMEANING>
          <MEANINGDESCRIPTION>complete response (CR) -- no lymphadenopathy; no organomegaly; neutrophils &gt; 1.5 x 10^9/L; platelets &gt; 100 x 10^9/L; hemoglobin &gt; 11 g/dL; lymphocytes &lt; 4 x 10^9/L; bone marrow &lt; 30% lymphocytes; absence of constitutional symptoms</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-06-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2626317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Disease status</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Disease status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lesion status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Extent</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Extent</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Metastatic disease status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hepatobiliary</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3298577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Unconjugated Isoflavones in Women at High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SWOG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>S0EXTFU</AlternateName>
        <AlternateNameType>OID, SWOG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DZ_RESP_SITE_STAT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DZ_RESP_SITE_STAT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1035">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2188503</PUBLICID>
    <LONGNAME>Laboratory Procedure Performed Specify</LONGNAME>
    <PREFERREDNAME>LAB_PERF_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify the other laboratory test performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188501</PublicId>
      <PreferredName>LAB_PERF</PreferredName>
      <PreferredDefinition>information related to a laboratory test that was performed.</PreferredDefinition>
      <LongName>Laboratory Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180655</PublicId>
      <PreferredName>LAB_RSLT_SPEC</PreferredName>
      <PreferredDefinition>the free text field to specify a lab value or procedure.</PreferredDefinition>
      <LongName>Lab Result Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_PERF_SPEC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_TEST_OTHER</AlternateName>
        <AlternateNameType>PCDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1036">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2190257</PUBLICID>
    <LONGNAME>NSABP Protocol Other Enrollment Ind-2</LONGNAME>
    <PREFERREDNAME>NSAB_PRO_O_ENRO_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether the patient is enrolled on another NSABP protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2190256</PublicId>
      <PreferredName>NSABP_PROT_O_ENROL</PreferredName>
      <PreferredDefinition>information related to enrollment on another NSABP protocol.</PreferredDefinition>
      <LongName>NSABP Protocol Other Enrollment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206729</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15818:C25320</PreferredName>
        <Version>1</Version>
        <LongName>National Surgical Adjuvant Breast and Bowel Project Protocol</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15818</PREFERRED_NAME>
            <LONG_NAME>National Surgical Adjuvant Breast and Bowel Project</LONG_NAME>
            <CON_ID>2205058</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25320</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Protocol</LONG_NAME>
            <CON_ID>2202702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207737</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C37948</PreferredName>
        <Version>1</Version>
        <LongName>Other Enrollment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37948</PREFERRED_NAME>
            <LONG_NAME>Enrollment</LONG_NAME>
            <CON_ID>2203918</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is this patient also enrolled</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is this patient also enrolled in another NSABP breast cancer protocol?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient also enrolled in another NSABP protocol?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1037">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2191317</PUBLICID>
    <LONGNAME>GOG Specimen Bank Identifier Number</LONGNAME>
    <PREFERREDNAME>GOG_SPEC_BANK_ID_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>the ID number of a GOG specimen bank.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>GOG CRF:Gynecologic Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2191315</PublicId>
      <PreferredName>GOG_SPEC_BANK_ID</PreferredName>
      <PreferredDefinition>information related to the GOG specimen bank ID.</PreferredDefinition>
      <LongName>GOG Specimen Bank Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206776</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25521:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Gynecologic Oncology Group Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25521</PREFERRED_NAME>
            <LONG_NAME>Gynecologic Oncology Group</LONG_NAME>
            <CON_ID>2202396</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2191316</PublicId>
      <PreferredName>GOG_SPEC_BANK_ID_NUM</PreferredName>
      <PreferredDefinition>the ID number of a GOG specimen bank.</PreferredDefinition>
      <LongName>GOG Specimen Bank Identifier Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>GOG CRF:Gynecologic Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2184315</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Number</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>GOG Bank ID#</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>GOG Bank ID#</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0219</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104879</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0263</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229O</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104892</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0250</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104897</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0258</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104898</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0261</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104899</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0277</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104900</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0286B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104901</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0212</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0235</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104930</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104941</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000079</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000080</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000175</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000275</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000276</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0235</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000284</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0235</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0212</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000593</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0212</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000594</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000705</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GOG_SPEC_BANK_ID_NUM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1038">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2192221</PUBLICID>
    <LONGNAME>Other Ethnicity Category Text</LONGNAME>
    <PREFERREDNAME>ETHN_OTHER_CAT_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>The text that describes an ethnicity not included in the Office of Management and Budget (OMB) list for reporting ethnicity data.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2192213</PublicId>
      <PreferredName>ETHN_CAT</PreferredName>
      <PreferredDefinition>Describing the ethnicity of a person.</PreferredDefinition>
      <LongName>Ethnicity Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2192211</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29933</PreferredName>
        <Version>1</Version>
        <LongName>Ethnicity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29933</PREFERRED_NAME>
            <LONG_NAME>Ethnicity</LONG_NAME>
            <CON_ID>2202474</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177576</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Category</PreferredName>
        <Version>1</Version>
        <LongName>Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2192219</PublicId>
      <PreferredName>ETHN_OTHER_TXT</PreferredName>
      <PreferredDefinition>The text that describes an ethnicity not included in the Office of Management and Budget (OMB) list for reporting ethnicity data.</PreferredDefinition>
      <LongName>Other Ethnicity Category Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2192196</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL052754</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL052754</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2204566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Rec for Spec of Race/Ethnicity</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Definition of basic template data elements for Race and Ethnicity.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Ethnicity, other</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Ethnicity, other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ethnicity</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2822285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1039">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2193748</PUBLICID>
    <LONGNAME>Hip Measure Number</LONGNAME>
    <PREFERREDNAME>HIP_MSR_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Hip girth measured at the level of maximal protrusion of the gluteal muscles.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188671</PublicId>
      <PreferredName>PT_VST</PreferredName>
      <PreferredDefinition>information related to a patient&#39;s vital status.</PreferredDefinition>
      <LongName>Patient Vital Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177327</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Vital Status</PreferredName>
        <Version>1</Version>
        <LongName>Vital Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25717</PREFERRED_NAME>
            <LONG_NAME>Vital Status</LONG_NAME>
            <CON_ID>2203980</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2193746</PublicId>
      <PreferredName>HIP_MSR_NUM</PreferredName>
      <PreferredDefinition>The quantitative measurement of an individual&#39;s hip.</PreferredDefinition>
      <LongName>Hip Measure Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008552</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PHYS_DESC_OF_INDS</PreferredName>
        <Version>1</Version>
        <LongName>Physical Description of Individuals</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hip</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Hip</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812205</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AZCC_07_118</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812668</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Aminolevulinic Acid - Barrett&#39;s Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812364</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barrett&#39;s Esophagus Chemoprevention Metformin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3211792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5598962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1040">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2194269</PUBLICID>
    <LONGNAME>Form Not Completed Box</LONGNAME>
    <PREFERREDNAME>FORM_NOT_COMP_BOX</PREFERREDNAME>
    <PREFERREDDEFINITION>The check box that represents that a form or section of a form is not filled out or nothing was reported/examined.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2194267</PublicId>
      <PreferredName>FORM_ACTION_NOT_COMP</PreferredName>
      <PreferredDefinition>A printed or electronic document that was not completed or filled out.</PreferredDefinition>
      <LongName>Form Action Not Completed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2458985</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19464</PreferredName>
        <Version>1</Version>
        <LongName>Form</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19464</PREFERRED_NAME>
            <LONG_NAME>Form</LONG_NAME>
            <CON_ID>2202476</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2971853</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25404:C25594:C25250</PreferredName>
        <Version>1</Version>
        <LongName>Action Negation Complete</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25404</PREFERRED_NAME>
            <LONG_NAME>Action</LONG_NAME>
            <CON_ID>2203586</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25250</PREFERRED_NAME>
            <LONG_NAME>Complete</LONG_NAME>
            <CON_ID>2203885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2182762</PublicId>
      <PreferredName>NONE_IND</PreferredName>
      <PreferredDefinition>An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)</PreferredDefinition>
      <LongName>None Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008573</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Results</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Check Here if not Completed</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Check Here if not Completed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Check here if NO body systems were examined</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Check here if NO body systems were examined</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>At end of study only; check this box if participant did not have any agent modification(s)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>At end of study only; check this box if participant did not have any agent interruption(s)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>None (check this box at the end of study only if participant did not have any interruptions)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Form not returned by the participant</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>No Pre-Intervention symptoms reported</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>No Pre-Intervention symptoms reported</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>No Medical/Surgical history reported</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>At end of study only: check this box if participant did not have any agent interruption(s)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>At end of study only: check this box if participant did not have any agent modification(s)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Agent Interruptions</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Check here if NO body systems were examined:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Form Not Applicable?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms Version 3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2957372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Aminolevulinic Acid - Barrett&#39;s Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812364</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>9cUAB30</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Transdermal 4-OHT vs oral TAM DCIS of the Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812736</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Sulindac DFMO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2859628</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2979172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSC and L SeMet in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3110219</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cholecalciferol and Genistein</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3114163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Lung Pre-Surgical NSCLC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3152820</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barrett&#39;s Esophagus Chemoprevention Metformin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3211792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAB30 in NMSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3293737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pomegranate - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3303133</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896537</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4111771</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4188651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5416571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5441476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5592146</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5598962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5612586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-07-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889176</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2017-09-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6005698</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-08-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6025104</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Check here if test not performed</AlternateName>
        <AlternateNameType>NINDS Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Form Not Done</AlternateName>
        <AlternateNameType>NINDS Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCIP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Check here if form not completed</AlternateName>
        <AlternateNameType>NINDS Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1041">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2195727</PUBLICID>
    <LONGNAME>Common Toxicity Criteria Adverse Event Orgasm Abnormal Grade</LONGNAME>
    <PREFERREDNAME>CTC_AE_ORGASMABN_GD</PREFERREDNAME>
    <PREFERREDDEFINITION>in CTC category Sexual/Reproductive Function, assessment of the severity of an orgasmic dysfunction adverse event using a graded scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195725</PublicId>
      <PreferredName>CTC_AE_ORGASMABN</PreferredName>
      <PreferredDefinition>information related to the CTC adverse event of orgasmic dysfunction.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Abnormal Orgasm Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2743098</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25401:C73521:C25365</PreferredName>
        <Version>1</Version>
        <LongName>Abnormal Orgasm Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25401</PREFERRED_NAME>
            <LONG_NAME>Abnormal</LONG_NAME>
            <CON_ID>2202623</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73521</PREFERRED_NAME>
            <LONG_NAME>Orgasm</LONG_NAME>
            <CON_ID>2742770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2195726</PublicId>
      <PreferredName>CTC_AE_ORGASMABN_GD</PreferredName>
      <PreferredDefinition>in CTC category Sexual/Reproductive Function, assessment of the severity of an orgasmic dysfunction adverse event using a graded scale.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Orgasm Abnormal Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184299</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Grade</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Transient decrease</VALUEMEANING>
          <MEANINGDESCRIPTION>Transient decrease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Complete inability of orgasmic response; not responding to intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>Complete inability of orgasmic response; not responding to intervention</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Decrease in orgasmic response requiring intervention</VALUEMEANING>
          <MEANINGDESCRIPTION>Decrease in orgasmic response requiring intervention</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTC Adverse Event Orgasmic dy</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CTC Adverse Event Orgasmic dysfunction Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Orgasmic dysfunction Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)</DocumentText>
        <URL>http://ctep.cancer.gov/reporting/ctc.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000132</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1042">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2199908</PUBLICID>
    <LONGNAME>Serious Adverse Event  Indicator</LONGNAME>
    <PREFERREDNAME>AE_SERIOUS_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The response indicating whether a serious adverse event occurred.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Colorectal CDE Disease Committee</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013053</PublicId>
      <PreferredName>AE_SERIOUS</PreferredName>
      <PreferredDefinition>Any expected or unexpected adverse event, related or unrelated to the intervention, occurring at any agent dose, any phase of product or procedure testing, that results in any of the following outcomes: death, a life-threatening adverse event, requires inpatient hospitalization (not required as part of the treatment) or prolongation of existing hospitalization, a persistent or significant disability or incapacity, or cancer, or a congenital anomaly or birth defect. Important medical events that may not result in the listed outcomes may be considered as serious when, based upon appropriate medical judgment, they represent significant hazards or potentially serious harm to the research subject or others and may require medical intervention to prevent one of the outcomes listed in this definition._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Serious Adverse Event Occurrence</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008573</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2717046</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41335</PreferredName>
        <Version>1</Version>
        <LongName>Serious Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41335</PREFERRED_NAME>
            <LONG_NAME>Serious Adverse Event</LONG_NAME>
            <CON_ID>2202356</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181608</PublicId>
      <PreferredName>Y_N_CHAR_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Character Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Serious?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Serious?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serious Adverse Event  Indicator</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serious</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NINDS CDE Project</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>NINDS CDE Project</DocumentText>
        <URL>http://www.commondataelements.ninds.nih.gov/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Optional NCI Standard CRF Question</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>No requirement for inclusion on CRF; use this data element if needed.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is this serious?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this a serious adverse event?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AECC Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this a SAE for this protocol?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>OHSU Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serious AE</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Any of the above events serious?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Any of the above events serious?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Alternate Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serious</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Serious</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serious</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MediData Rave Use</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3308730</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol 10C0052D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3331757</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UC Irvine</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811716</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Albert Einstein Medical Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UPCC 07403</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812574</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DFMO/Sul Colon III UCI 02_06</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCI 0404</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812578</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke 500</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812580</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>P1_CPT_BCNU_RD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Panvec</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812583</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 02452</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812584</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 03058</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812585</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 04251</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Nebraska Med Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812726</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U of Pa Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812727</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Washington</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812731</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FES Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812732</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FMISO Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812733</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AE_104_085</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oregon Health &amp; Sciences University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OHSU_288</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UNMC 284-04</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812981</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859992</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857175</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Adopter CDEs for Reuse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS 3.12B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812490</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2931931</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Iloprost Trial</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Iloprost 12079</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2931952</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3194026</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>KAI Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812550</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3194026</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>KAI Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000679</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5441476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000681</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858960</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Adopted</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAE</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5858965</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Safety Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3135097</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000678</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000680</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_SER</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SPOREs</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCIP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Serious Adverse Event?</AlternateName>
        <AlternateNameType>NINDS Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_SERIOUS_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_SERIOUS_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRDS</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_SERIOUS_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SAE_YN</AlternateName>
        <AlternateNameType>OID, CCR</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1043">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2200284</PUBLICID>
    <LONGNAME>Centers for Disease Control and Prevention Ethnicity Unique Identifier Codes</LONGNAME>
    <PREFERREDNAME>CDC_ETHN_UNQ_ID_CD</PREFERREDNAME>
    <PREFERREDDEFINITION>The unique identifier for reporting information about ethnicity based on the Centers for Disease Control and Prevention (CDC) categories.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDC:Center for Disease Control</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2192213</PublicId>
      <PreferredName>ETHN_GRP_CAT</PreferredName>
      <PreferredDefinition>Classification based on social groupings that are characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease.</PreferredDefinition>
      <LongName>Ethnic Group Category</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2221861</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16564</PreferredName>
        <Version>1</Version>
        <LongName>Ethnic Group</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16564</PREFERRED_NAME>
            <LONG_NAME>Ethnic Group</LONG_NAME>
            <CON_ID>2221860</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177576</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Category</PreferredName>
        <Version>1</Version>
        <LongName>Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200281</PublicId>
      <PreferredName>CDC_ETHN_UNQ_ID_CD</PreferredName>
      <PreferredDefinition>All Centers for Disease Control and Prevention (CDC) unique identifier codes for ethnicity.</PreferredDefinition>
      <LongName>Centers for Disease Control and Prevention Ethnicity Unique Identifier Codes</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>6</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDC:Center for Disease Control</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDC Race &amp; Ethnicity Code Set</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Code set is available as a pdf file or an Excel spreadsheet.</DocumentText>
        <URL>http://www.cdc.gov/nedss/DataModels/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDC Ethnicity Code</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CDC Ethnicity Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NIDA CTN Demographics</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Indicate the group that represents his or her Hispanic origin or ancestry</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NIDA CTN PhenX Ethnicity for SAATier1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Please give the number of the group that represents your Hispanic origin or ancestry</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812358</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ethnicity CDC Code</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2822345</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Demography CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859967</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Demographics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3070841</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Core: Tier 1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3688551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Substance Abuse and Addiction Core Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3689959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mental Health Core Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4550917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Core: Tier 1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4550918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857184</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Potential CDEs for Reuse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PBRN</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812034</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3952293</PublicId>
          <ContextName>NIDA</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDA CTN Usage</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Research</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3952294</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3952293</PublicId>
          <ContextName>NIDA</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDA CTN Usage</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Electronic Health Record</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3952296</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Demography</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5635308</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675695</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDE by Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ethnicity CDC Code</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000313</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIDCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NIDCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIDA</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NIDA</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1044">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2200371</PUBLICID>
    <LONGNAME>Disease Metastasis Stage Number</LONGNAME>
    <PREFERREDNAME>DZ_M_STG_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the stage of disease based on the metastases present (M stage).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2200365</PublicId>
      <PreferredName>DZ_M_STG</PreferredName>
      <PreferredDefinition>Stage of disease based on the metastases present (M stage).</PreferredDefinition>
      <LongName>Disease Metastasis Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2192176</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Diseases and Disorders</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207385</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19151:C16899</PreferredName>
        <Version>1</Version>
        <LongName>Metastasis Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19151</PREFERRED_NAME>
            <LONG_NAME>Metastasis</LONG_NAME>
            <CON_ID>2202751</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016947</PublicId>
      <PreferredName>TNM_DZ_STG_NUM</PreferredName>
      <PreferredDefinition>Numeric value to represent the TNM (tumor, nodes, and metastases) stage of disease.</PreferredDefinition>
      <LongName>TNM Stage of Disease Number</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177868</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Number</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Staging: Metastasis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>M Stage</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>M Stage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Disease M Stage</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Disease M Stage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR 2011 Template</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248617</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Enrollment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248627</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248635</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Albert Einstein Medical Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AE_104_085</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3234177</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Patient Outcomes Data System</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PODS Elements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3234178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1045">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2200455</PUBLICID>
    <LONGNAME>Malignant Neoplasm Chest Bone Metastatic Involvement Ind-3</LONGNAME>
    <PREFERREDNAME>MALN_CH_B_ME_INV_IN3</PREFERREDNAME>
    <PREFERREDDEFINITION>a yes/no indicator to ask if evidence is detected for spread of cancer from a tumor composed of atypical neoplastic cells to bone located in the thoracic region of the body.</PREFERREDDEFINITION>
    <VERSION>1.1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2200454</PublicId>
      <PreferredName>MALNE_CH_BO_MET_INVL</PreferredName>
      <PreferredDefinition>information related to evidence of the spread of cancer from a tumor composed of atypical neoplastic cells to bone located in the thoracic region of the body.</PreferredDefinition>
      <LongName>Malignant Neoplasm Chest Bone Metastatic Involvement</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2660472</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12366:C9305</PreferredName>
        <Version>1</Version>
        <LongName>Bone Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12366</PREFERRED_NAME>
            <LONG_NAME>Bone</LONG_NAME>
            <CON_ID>2202686</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2443797</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25389:C12366:C14174:C25548</PreferredName>
        <Version>1</Version>
        <LongName>Chest Bone Metastatic Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25389</PREFERRED_NAME>
            <LONG_NAME>Chest</LONG_NAME>
            <CON_ID>2202707</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12366</PREFERRED_NAME>
            <LONG_NAME>Bone</LONG_NAME>
            <CON_ID>2202686</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14174</PREFERRED_NAME>
            <LONG_NAME>Metastatic</LONG_NAME>
            <CON_ID>2204914</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Chest</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Chest</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Bone metastasis to the chest</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Chest wall</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MALN_CH_B_ME_INV_IN3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1046">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2217550</PUBLICID>
    <LONGNAME>Blood Specimen Collected Ind-3</LONGNAME>
    <PREFERREDNAME>BLOOD_SPEC_COLL_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether a blood specimen was collected from the patient/participant.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2413073</PublicId>
      <PreferredName>BLOOD_SPEC_COLL</PreferredName>
      <PreferredDefinition>information related to the collection of a blood, is a liquid tissue that transports oxygen and nutrients throughout the body, specimen or sample.</PreferredDefinition>
      <LongName>Blood Specimen Collected</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2413071</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12434:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Blood Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12434</PREFERRED_NAME>
            <LONG_NAME>Blood</LONG_NAME>
            <CON_ID>2202587</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177590</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Collected</PreferredName>
        <Version>1</Version>
        <LongName>Collected</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25452</PREFERRED_NAME>
            <LONG_NAME>Collected</LONG_NAME>
            <CON_ID>2203888</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a hematology sample obtai</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was a hematology sample obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>I agree to have blood samples collected three times during this study</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was sample obtained</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was sample obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a blood specimen collected?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was a blood specimen collected?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AECC Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were blood samples collected</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>OHSU Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Hematology:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was sample collected?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-TEXT-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was research blood collected?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mass General Hospital</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813097</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Myo-Inositol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812876</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>BLOOD_SPEC_COLL_IND3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1047">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2228475</PUBLICID>
    <LONGNAME>Patient Alcohol Consumption Assessment Scale</LONGNAME>
    <PREFERREDNAME>PT_ALCNSMP_ASESS_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>the assessment scale of a patient&#39;s alcohol consumption.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2228474</PublicId>
      <PreferredName>PT_ALCOCNSMPT_ASSESS</PreferredName>
      <PreferredDefinition>information relating to patient alcohol consumption assessment.</PreferredDefinition>
      <LongName>Patient Alcohol Consumption Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2228472</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16273:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Alcohol Consumption Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16273</PREFERRED_NAME>
            <LONG_NAME>Alcohol Consumption</LONG_NAME>
            <CON_ID>2204017</CON_ID>
            <DEFINITION_SOURCE>NCIt</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2194224</PublicId>
      <PreferredName>PT_ASSESS_SCALE</PreferredName>
      <PreferredDefinition>the scale of patient assessment.</PreferredDefinition>
      <LongName>Patient Assessment Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>75</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>Alliance Case Report Form</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately</VALIDVALUE>
          <VALUEMEANING>Moderately</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely</VALIDVALUE>
          <VALUEMEANING>EXTREMELY</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not relevant</VALIDVALUE>
          <VALUEMEANING>Not relevant</VALUEMEANING>
          <MEANINGDESCRIPTION>Not relevant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2825134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A lot</VALIDVALUE>
          <VALUEMEANING>A LOT</VALUEMEANING>
          <MEANINGDESCRIPTION>A LOT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat bothered</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little bit</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all bothered</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2927955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, more than once</VALIDVALUE>
          <VALUEMEANING>Yes, more than once</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, more than once</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-10-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, once</VALIDVALUE>
          <VALUEMEANING>Yes, once</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, once</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-10-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daily</VALIDVALUE>
          <VALUEMEANING>About once a day</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring or done each day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Several times a week</VALIDVALUE>
          <VALUEMEANING>Several times a week</VALUEMEANING>
          <MEANINGDESCRIPTION>Several times a week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>About once a week</VALIDVALUE>
          <VALUEMEANING>ABOUT ONCE A WEEK</VALUEMEANING>
          <MEANINGDESCRIPTION>About once a week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Less than once a week</VALIDVALUE>
          <VALUEMEANING>Less than once a week</VALUEMEANING>
          <MEANINGDESCRIPTION>Less than once a week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3120272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No, not limited at all</VALIDVALUE>
          <VALUEMEANING>No, not limited at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No, not limited at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3442202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, limited a little</VALIDVALUE>
          <VALUEMEANING>Yes, Limited a Little</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, Limited a Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3115762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, limited a lot</VALIDVALUE>
          <VALUEMEANING>Yes, Limited a Lot</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, Limited a Lot</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-04-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3115763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slightly</VALIDVALUE>
          <VALUEMEANING>Slightly</VALUEMEANING>
          <MEANINGDESCRIPTION>Slightly</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-09-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered somewhat</VALIDVALUE>
          <VALUEMEANING>Bothered somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered somewhat</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little</VALIDVALUE>
          <VALUEMEANING>Bothered a little</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered a little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not bothered at all</VALIDVALUE>
          <VALUEMEANING>Not bothered at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not bothered at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not well</VALIDVALUE>
          <VALUEMEANING>Not well</VALUEMEANING>
          <MEANINGDESCRIPTION>Not well</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5290195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very well</VALIDVALUE>
          <VALUEMEANING>Very Well</VALUEMEANING>
          <MEANINGDESCRIPTION>Existing to a great degree.: A cavity or vessel used to contain liquid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70592, C116076</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5290196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Well</VALIDVALUE>
          <VALUEMEANING>Well</VALUEMEANING>
          <MEANINGDESCRIPTION>Well</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4975879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable to me</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5805854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Very Much</VALIDVALUE>
          <VALUEMEANING>Not Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of disagreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5806311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prefer not to answer</VALIDVALUE>
          <VALUEMEANING>Prefer Not to Answer</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual prefers or preferred not to answer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5684650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I drink alcohol</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I drink alcohol</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0920</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_ALCNSMP_ASESS_SCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1048">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2228840</PUBLICID>
    <LONGNAME>Tumor Site Computed Tomography Performed Status</LONGNAME>
    <PREFERREDNAME>TUMSITE_CT_PERF_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>the status of  the CT scan performed on the tumor site.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2228839</PublicId>
      <PreferredName>TUMRSITE_CT_PERFORMD</PreferredName>
      <PreferredDefinition>information relating to tumor site computed tomography performed.</PreferredDefinition>
      <LongName>Tumor Site Computed Tomography Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2228837</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0475445:C17204</PreferredName>
        <Version>1</Version>
        <LongName>Site of neoplasm Computed Tomography</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0475445</PREFERRED_NAME>
            <LONG_NAME>Site of neoplasm</LONG_NAME>
            <CON_ID>2228836</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17204</PREFERRED_NAME>
            <LONG_NAME>Computed Tomography</LONG_NAME>
            <CON_ID>2202436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2184322</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Performed</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2194582</PublicId>
      <PreferredName>SCAN_PERF_STAT</PreferredName>
      <PreferredDefinition>the status of a scan that was performed.</PreferredDefinition>
      <LongName>Scan Performed Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>9</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2184340</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Status</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>NOT DONE</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating from the norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal - Not clinically significant</VALIDVALUE>
          <VALUEMEANING>Abnormal - Not clinically significant</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal - Not clinically significant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2645498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal - Clinically significant</VALIDVALUE>
          <VALUEMEANING>Abnormal - Clinically significant</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal - Clinically significant</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2645499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CT scan of tumor site</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CT scan of tumor site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1049">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2232523</PUBLICID>
    <LONGNAME>Conceptual Domain Administered Item Unresolved Issue java.lang.String</LONGNAME>
    <PREFERREDNAME>2231922v3.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The set of all possible Valid Value meanings of a Data Element Concept expressed without representation. (NCICB)_A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_Any problem that remains unresolved regarding proper documentation of the Administered Item. (ISO 11179)_Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2231922</PublicId>
      <PreferredName>2442937v1:2231608v1</PreferredName>
      <PreferredDefinition>The set of all possible Valid Value meanings of a Data Element Concept expressed without representation. (NCICB)_A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_Any problem that remains unresolved regarding proper documentation of the Administered Item. (ISO 11179)</PreferredDefinition>
      <LongName>Conceptual Domain Administered Item Unresolved Issue</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2442937</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41083:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Domain Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41083</PREFERRED_NAME>
            <LONG_NAME>Conceptual Domain</LONG_NAME>
            <CON_ID>2231553</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231608</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42869</PreferredName>
        <Version>1</Version>
        <LongName>Unresolved Issue</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42869</PREFERRED_NAME>
            <LONG_NAME>Unresolved Issue</LONG_NAME>
            <CON_ID>2231549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Conceptual Domain Administered Item Unresolved Issue java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Conceptual Domain Administered Item Unresolved Issue java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.ConceptualDomain.unresolvedIssue</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ConceptualDomain:unresolvedIssue</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.AdministeredComponent.unresolvedIssue</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AdministeredComponent:unresolvedIssue</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1050">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2236341</PUBLICID>
    <LONGNAME>Endoscopy Assessment Period Text Name</LONGNAME>
    <PREFERREDNAME>ENDO_ASSESSMT_PD_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>Text names to represent the period or timepoint during a protocol in which an endoscopy was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2193931</PublicId>
      <PreferredName>ENDO_ASSESS</PreferredName>
      <PreferredDefinition>Procedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument along either natural body pathways such as the digestive tract, or through keyhole incisions to examine the interior parts of the body. With advances in imaging, endoscope, and miniaturization of endosurgical equipment, surgery can be performed durging endoscopy.  The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Endoscopy Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2486584</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16546</PreferredName>
        <Version>1</Version>
        <LongName>Endoscopy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16546</PREFERRED_NAME>
            <LONG_NAME>Endoscopic Procedure</LONG_NAME>
            <CON_ID>2204779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2178813</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Assessment</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2236339</PublicId>
      <PreferredName>EVAL_PD_TXT_NM</PreferredName>
      <PreferredDefinition>Text terms to designate the period or timepoint within a protocol that an evaluation/procedure is performed.</PreferredDefinition>
      <LongName>Evaluation Period Text Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>9</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Baseline</VALIDVALUE>
          <VALUEMEANING>Baseline</VALUEMEANING>
          <MEANINGDESCRIPTION>A starting point to which things may be compared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-06-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Follow-up</VALIDVALUE>
          <VALUEMEANING>Follow-up</VALUEMEANING>
          <MEANINGDESCRIPTION>Follow-up</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16033</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-06-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Endoscopy Visit Timepoint</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Endoscopy Visit Timepoint</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1051">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2341876</PUBLICID>
    <LONGNAME>Post Hepatic Surgery Treatment Type</LONGNAME>
    <PREFERREDNAME>POST_HEPAT_SX_TX_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of post-surgery treatment plan.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2341874</PublicId>
      <PreferredName>POST_HEPATIC_SX_TX</PreferredName>
      <PreferredDefinition>information relating to post hepatic surgery treatment.</PreferredDefinition>
      <LongName>Post Hepatic Surgery Treatment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2341872</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38008:C13308:C15329</PreferredName>
        <Version>1</Version>
        <LongName>Post Hepatic Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13308</PREFERRED_NAME>
            <LONG_NAME>Hepatic</LONG_NAME>
            <CON_ID>2202660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2324753</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15368</PreferredName>
        <Version>1</Version>
        <LongName>Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2341875</PublicId>
      <PreferredName>POST_HEPAT_SX_TX_TP</PreferredName>
      <PreferredDefinition>the type of post-surgery treatment plan.</PreferredDefinition>
      <LongName>Post Hepatic Surgery Treatment Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</Origin>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Group 1 Patient: Capecitabine + Oxaliplatin</VALIDVALUE>
          <VALUEMEANING>Group 1 Patient: Capecitabine + Oxaliplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>Group 1 Patient: Capecitabine + Oxaliplatin</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Group 1 Patient: Other plan</VALIDVALUE>
          <VALUEMEANING>Group 1 Patient: Other plan</VALUEMEANING>
          <MEANINGDESCRIPTION>Group 1 Patient: Other plan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Group 2 Patient: FUDR + Capecitabine + Oxaliplatin</VALIDVALUE>
          <VALUEMEANING>Group 2 Patient: FUDR + Capecitabine + Oxaliplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>Group 2 Patient: FUDR + Capecitabine + Oxaliplatin</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Group 2 Patient: Only Capecitabine + Oxaliplatin</VALIDVALUE>
          <VALUEMEANING>Group 2 Patient: Only Capecitabine + Oxaliplatin</VALUEMEANING>
          <MEANINGDESCRIPTION>Group 2 Patient: Only Capecitabine + Oxaliplatin</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Group 2 Patient: Other Plan</VALIDVALUE>
          <VALUEMEANING>Group 2 Patient: Other Plan</VALUEMEANING>
          <MEANINGDESCRIPTION>Group 2 Patient: Other Plan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Post-Surgery Treatment Plan</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Post-Surgery Treatment Plan</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1052">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2405741</PUBLICID>
    <LONGNAME>Left Breast Primary Neoplasm Location Mammogram Specify</LONGNAME>
    <PREFERREDNAME>L_BR_PR_NE_LC_MA_SPE</PREFERREDNAME>
    <PREFERREDDEFINITION>the free-text field to specify the abnormal result of a mammogram performed on the left breast.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>IBCSG CRF:International Breast Cancer Study Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2405713</PublicId>
      <PreferredName>L_BRST_PRIM_NEO_LCTN</PreferredName>
      <PreferredDefinition>information related to the location of a primary tumor (abnormal mass of tissue that results from excessive cell division) in the left breast (one of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest).</PreferredDefinition>
      <LongName>Left Breast Primary Neoplasm Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206508</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25229:C12971</PreferredName>
        <Version>1</Version>
        <LongName>Left Breast</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25229</PREFERRED_NAME>
            <LONG_NAME>Left</LONG_NAME>
            <CON_ID>2204810</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12971</PREFERRED_NAME>
            <LONG_NAME>Breast</LONG_NAME>
            <CON_ID>2202571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2405711</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25251:CL053268:C25341</PreferredName>
        <Version>1</Version>
        <LongName>Primary Neoplasm Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL053268</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2204532</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS (Cancer.gov Dictionary). Bethesda (MD): National Cancer Institute, January 2003</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2405740</PublicId>
      <PreferredName>ASSESS_MAM_SPEC</PreferredName>
      <PreferredDefinition>the free-text field to specify information related to a mammogram diagnostic assessment.</PreferredDefinition>
      <LongName>Assessment Mammogram Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2405739</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20178:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Mammogram Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20178</PREFERRED_NAME>
            <LONG_NAME>Mammogram</LONG_NAME>
            <CON_ID>2202867</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Left mammogram results</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Left mammogram results</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1053">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2415069</PUBLICID>
    <LONGNAME>Growth Factor Agent Current Report Period Discontinued Ind-2</LONGNAME>
    <PREFERREDNAME>GF_AG_CU_RE_PD_DX_IN</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether there was a discontinuation of administration of growth factor during the current report period.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2415249</PublicId>
      <PreferredName>GF_AGT_CU_RE_PD_DXD</PreferredName>
      <PreferredDefinition>information related to the discontinuation of growth factor administration, substances made by the body that function to regulate cell division and cell survival, during the current report period.</PreferredDefinition>
      <LongName>Growth Factor Agent Current Report Period Discontinued</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2415066</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20424:C1708</PreferredName>
        <Version>1</Version>
        <LongName>Growth Factor Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20424</PREFERRED_NAME>
            <LONG_NAME>Growth Factor</LONG_NAME>
            <CON_ID>2202650</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2415247</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25471:C25375:C25616:C25484</PreferredName>
        <Version>1</Version>
        <LongName>Current Report Period Discontinued</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25616</PREFERRED_NAME>
            <LONG_NAME>Period</LONG_NAME>
            <CON_ID>2202575</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25484</PREFERRED_NAME>
            <LONG_NAME>Discontinue</LONG_NAME>
            <CON_ID>2203906</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was growth factor permanently</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was growth factor permanently discontined during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>No blood modifiers while enrolled in the study (growth factors such as ESA, G-CSF, platelet or blood transfusions)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1054">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2423140</PUBLICID>
    <LONGNAME>Contact Info Comment java.lang.String</LONGNAME>
    <PREFERREDNAME>2422940v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information regarding the person who submitted the data (caBIO)_A written explanation or criticism or illustration that is added to a book or other textual material._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2422940</PublicId>
      <PreferredName>2224125v1.0:2223274v1.0</PreferredName>
      <PreferredDefinition>Information regarding the person who submitted the data (caBIO)_A written explanation or criticism or illustration that is added to a book or other textual material.</PreferredDefinition>
      <LongName>Contact Info Comment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2224125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41085</PreferredName>
        <Version>1</Version>
        <LongName>Contact Info</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41085</PREFERRED_NAME>
            <LONG_NAME>Person Contact Information</LONG_NAME>
            <CON_ID>2224019</CON_ID>
            <DEFINITION_SOURCE>CABIO</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223274</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25393</PreferredName>
        <Version>1</Version>
        <LongName>Comment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25393</PREFERRED_NAME>
            <LONG_NAME>Comment</LONG_NAME>
            <CON_ID>2202716</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Contact Info Comment java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Contact Info Comment java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ProteomicsLIMS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.fccc.lims.protlims.domain.class.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812037</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.fccc.lims.protlims.domain.class.inventory.ContactDetails.comments</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ContactDetails:comments</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1055">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2424942</PUBLICID>
    <LONGNAME>Patient Androgen Suppression Therapy Received Indicator</LONGNAME>
    <PREFERREDNAME>PT_AND_TX_REC_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether the patient received androgen suppression/deprivation therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2233608</PublicId>
      <PreferredName>PT_ANDRSUP_TX_RECVD</PreferredName>
      <PreferredDefinition>information related to androgen suppression therapy being received by the patient.</PreferredDefinition>
      <LongName>Patient Androgen Suppression Therapy Received</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233606</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15676:C15368:C25639</PreferredName>
        <Version>1</Version>
        <LongName>Androgen Suppression Therapy Received</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15676</PREFERRED_NAME>
            <LONG_NAME>Androgen Suppression</LONG_NAME>
            <CON_ID>2233605</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2424941</PublicId>
      <PreferredName>AND_TX_REC_IND</PreferredName>
      <PreferredDefinition>the yes/no indicator whether androgen suppression therapy was received.</PreferredDefinition>
      <LongName>Androgen Suppression Therapy Received Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>55</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No, previously received surgical castration</VALIDVALUE>
          <VALUEMEANING>No, previously received surgical castration</VALUEMEANING>
          <MEANINGDESCRIPTION>No, previously received surgical castration</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No, other</VALIDVALUE>
          <VALUEMEANING>No, other</VALUEMEANING>
          <MEANINGDESCRIPTION>No, other</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576739</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, androgen deprivation alone</VALIDVALUE>
          <VALUEMEANING>Yes, androgen deprivation alone</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, androgen deprivation alone</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, combined androgen blockade</VALIDVALUE>
          <VALUEMEANING>Yes, combined androgen blockade</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, combined androgen blockade</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the patient receive andro</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the patient receive androgen suppression?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1056">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2431131</PUBLICID>
    <LONGNAME>Deep Vein Thrombosis Prevention Therapy Received Ind-2</LONGNAME>
    <PREFERREDNAME>DVT_PREV_TX_RCV_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator whether the patient received prophylactic treatment for deep vein thrombosis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2431130</PublicId>
      <PreferredName>DVT_PREV_TX_RCVD</PreferredName>
      <PreferredDefinition>information related to the action of having received the administration of therapeutic agents to prevent the formation of blood clots in the deep veins of the extremities.</PreferredDefinition>
      <LongName>Deep Vein Thrombosis Prevention Therapy Received</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2434712</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49343:C15405:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Deep Vein Thrombosis Prevention Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49343</PREFERRED_NAME>
            <LONG_NAME>Deep Vein Thrombosis</LONG_NAME>
            <CON_ID>2434203</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15405</PREFERRED_NAME>
            <LONG_NAME>Prevention</LONG_NAME>
            <CON_ID>2414898</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241679</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25639</PreferredName>
        <Version>1</Version>
        <LongName>Received</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did patient receive DVT proph</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did patient receive DVT prophylaxis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient receive thrombosis prophylaxis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1057">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2433401</PUBLICID>
    <LONGNAME>Gene Version PubMed Version java.lang.String</LONGNAME>
    <PREFERREDNAME>2433368v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).:A form or variant of a type or original._A web application from the National Library of Medicine (NLM).  It provides a single query interface to over 15 million citations for biomedical articles back to the 1950&#39;s. These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.:A form or variant of a type or original._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2433368</PublicId>
      <PreferredName>2433350v1.0:2433340v1.0</PreferredName>
      <PreferredDefinition>A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).:A form or variant of a type or original._A web application from the National Library of Medicine (NLM).  It provides a single query interface to over 15 million citations for biomedical articles back to the 1950&#39;s. These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.:A form or variant of a type or original.</PreferredDefinition>
      <LongName>Gene Version PubMed Version</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2433350</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16612:C25714</PreferredName>
        <Version>1</Version>
        <LongName>Gene Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16612</PREFERRED_NAME>
            <LONG_NAME>Gene</LONG_NAME>
            <CON_ID>2202483</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2433340</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42881:C25714</PreferredName>
        <Version>1</Version>
        <LongName>PubMed Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42881</PREFERRED_NAME>
            <LONG_NAME>PubMed</LONG_NAME>
            <CON_ID>2223993</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Gene Version PubMed Version java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Gene Version PubMed Version java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2661628</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caFE Server</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.fe</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000308</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.fe.GeneVersion.pubmedVersion</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GeneVersion:pubmedVersion</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1058">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2438045</PUBLICID>
    <LONGNAME>Targeted Mutation Blastocyst Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2437842v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A mutation created in a gene at a specific location._An embryo made up of two groups of cells. One group will develop into the fetus and the other will become the placenta.:The words or language units by which a thing is known._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2437842</PublicId>
      <PreferredName>2437780v1.0:2224047v1.0</PreferredName>
      <PreferredDefinition>A mutation created in a gene at a specific location._An embryo made up of two groups of cells. One group will develop into the fetus and the other will become the placenta.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Targeted Mutation Blastocyst Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437780</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48668</PreferredName>
        <Version>1</Version>
        <LongName>Targeted Mutation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48668</PREFERRED_NAME>
            <LONG_NAME>Targeted Mutation</LONG_NAME>
            <CON_ID>2437667</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2224047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13739:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Blastocyst Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13739</PREFERRED_NAME>
            <LONG_NAME>Blastocyst</LONG_NAME>
            <CON_ID>2223982</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Targeted Mutation Blastocyst Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Targeted Mutation Blastocyst Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.TargetedModification.blastocystName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TargetedModification:blastocystName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1059">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2438124</PUBLICID>
    <LONGNAME>Experimental Outcome Bioassay, in vivo Elapse Evaluation Day java.lang.String</LONGNAME>
    <PREFERREDNAME>2437920v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Being studied; investigational; derived by experimentation.:A phenomenon that follows and is caused by some previous phenomenon.:The appraisal of the biological properties or activities of a substance by testing its effect on an organism._To pass by; having passed by.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.:The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours.  This also refers to a specific day._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2437920</PublicId>
      <PreferredName>2437797v1.0:2437755v1.0</PreferredName>
      <PreferredDefinition>Being studied; investigational; derived by experimentation.:A phenomenon that follows and is caused by some previous phenomenon.:The appraisal of the biological properties or activities of a substance by testing its effect on an organism._To pass by; having passed by.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.:The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours.  This also refers to a specific day.</PreferredDefinition>
      <LongName>Experimental Outcome Bioassay, in vivo Elapse Evaluation Day</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437797</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28296:C20200:C18641</PreferredName>
        <Version>1</Version>
        <LongName>Experimental Outcome Bioassay, in vivo</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28296</PREFERRED_NAME>
            <LONG_NAME>Experimental</LONG_NAME>
            <CON_ID>2427519</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18641</PREFERRED_NAME>
            <LONG_NAME>Bioassay, In Vivo</LONG_NAME>
            <CON_ID>2437685</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2437755</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48665:C25214:C25301</PreferredName>
        <Version>1</Version>
        <LongName>Elapse Evaluation Day</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48665</PREFERRED_NAME>
            <LONG_NAME>Elapse</LONG_NAME>
            <CON_ID>2437686</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25301</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2202680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Experimental Outcome Bioassay, in vivo Elapse Evaluation Day java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Experimental Outcome Bioassay, in vivo Elapse Evaluation Day java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.InvivoResult.evaluationDay</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>InvivoResult:evaluationDay</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1060">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2438139</PUBLICID>
    <LONGNAME>Pathology Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2437935v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Value Domain for java language Long datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2437935</PublicId>
      <PreferredName>2437801v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Pathology Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437801</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18189</PreferredName>
        <Version>1</Version>
        <LongName>Pathology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Pathology Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Pathology Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.Histopathology.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Histopathology:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.Histopathology.histopathologyId</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Histopathology:histopathologyId</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1061">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2438146</PUBLICID>
    <LONGNAME>Pathology Microscopic Pathology Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2437942v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination._Too small to be seen except under a microscope.:The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.:A statement or an account describing something._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2437942</PublicId>
      <PreferredName>2437801v1.0:2437764v1.0</PreferredName>
      <PreferredDefinition>The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination._Too small to be seen except under a microscope.:The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.:A statement or an account describing something.</PreferredDefinition>
      <LongName>Pathology Microscopic Pathology Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437801</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18189</PreferredName>
        <Version>1</Version>
        <LongName>Pathology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2437764</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25252:C18189:C25365</PreferredName>
        <Version>1</Version>
        <LongName>Microscopic Pathology Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25252</PREFERRED_NAME>
            <LONG_NAME>Microscopic</LONG_NAME>
            <CON_ID>2204913</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Pathology Microscopic Pathology Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Pathology Microscopic Pathology Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.Histopathology.microscopicDescription</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Histopathology:microscopicDescription</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1062">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2438209</PUBLICID>
    <LONGNAME>Animal Cancer Model Generation Cancer Model java.lang.String</LONGNAME>
    <PREFERREDNAME>2438005v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An animal model which develops cancer or can be used to generate a model that develops cancer._The act of bringing into being.:Any model that can be used to study issues important in cancer such as cancer development or prediction._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2438005</PublicId>
      <PreferredName>2437792v1.0:2437749v1.0</PreferredName>
      <PreferredDefinition>An animal model which develops cancer or can be used to generate a model that develops cancer._The act of bringing into being.:Any model that can be used to study issues important in cancer such as cancer development or prediction.</PreferredDefinition>
      <LongName>Animal Cancer Model Generation Cancer Model</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437792</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41162</PreferredName>
        <Version>1</Version>
        <LongName>Animal Cancer Model</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41162</PREFERRED_NAME>
            <LONG_NAME>Animal Cancer Model</LONG_NAME>
            <CON_ID>2437673</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2437749</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48151:C19691</PreferredName>
        <Version>1</Version>
        <LongName>Generation Cancer Model</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48151</PREFERRED_NAME>
            <LONG_NAME>Generation</LONG_NAME>
            <CON_ID>2437682</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19691</PREFERRED_NAME>
            <LONG_NAME>Cancer Model</LONG_NAME>
            <CON_ID>2224027</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Animal Cancer Model Generation Cancer Model java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Animal Cancer Model Generation Cancer Model java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.AbstractCancerModel.experimentDesign</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AbstractCancerModel:experimentDesign</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.Xenograft.experimentDesign</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Xenograft:experimentDesign</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.AnimalModel.experimentDesign</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AnimalModel:experimentDesign</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1063">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2442709</PUBLICID>
    <LONGNAME>Pregnancy History Indicator</LONGNAME>
    <PREFERREDNAME>PREG_HX_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A Yes/No/Don&#39;t know response to a question that asks whether the participant has ever been pregnant.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2183295</PublicId>
      <PreferredName>PREG_HX</PreferredName>
      <PreferredDefinition>History related to pregnancies.</PreferredDefinition>
      <LongName>Pregnancy History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177222</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Pregnancy</PreferredName>
        <Version>1</Version>
        <LongName>Pregnancy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25742</PREFERRED_NAME>
            <LONG_NAME>Pregnancy</LONG_NAME>
            <CON_ID>2202906</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>History</PreferredName>
        <Version>1</Version>
        <LongName>History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017502</PublicId>
      <PreferredName>YES_NO_DK_IND</PreferredName>
      <PreferredDefinition>Indicator for Yes, No, Don&#39;t Know</PreferredDefinition>
      <LongName>Yes No Don&#39;t Know Indicator</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008514</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>DCP</PreferredName>
        <Version>1</Version>
        <LongName>DCP Conceptual Domain</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2192923</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0021212</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0021212</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2203101</CON_ID>
            <DEFINITION_SOURCE>NCI; National Cancer Institute Thesaurus. September 2003</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>YES</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NO</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DON&#39;T KNOW</VALIDVALUE>
          <VALUEMEANING>Don&#39;t know</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-09-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NOT DONE</VALIDVALUE>
          <VALUEMEANING>NOT DONE</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you ever been pregnant?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you ever been pregnant?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193113</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCEG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CGEMS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812078</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2552643</PublicId>
          <ContextName>Training</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Training Class Examples</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3637837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1064">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2442916</PUBLICID>
    <LONGNAME>Person Tubal Ligation Status Indicator</LONGNAME>
    <PREFERREDNAME>PRSN_TUBLGN_STAT_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no response to a question that asks whether the participant has had a tubal ligation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2442914</PublicId>
      <PreferredName>PRSN_TUBAL_LIGN_STAT</PreferredName>
      <PreferredDefinition>The status a a females tubal ligation.</PreferredDefinition>
      <LongName>Person Tubal Ligation Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2442912</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0695264</PreferredName>
        <Version>1</Version>
        <LongName>Tubal ligation status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0695264</PREFERRED_NAME>
            <LONG_NAME>Tubal ligation status</LONG_NAME>
            <CON_ID>2442911</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017502</PublicId>
      <PreferredName>YES_NO_DK_IND</PreferredName>
      <PreferredDefinition>Indicator for Yes, No, Don&#39;t Know</PreferredDefinition>
      <LongName>Yes No Don&#39;t Know Indicator</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008514</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>DCP</PreferredName>
        <Version>1</Version>
        <LongName>DCP Conceptual Domain</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2192923</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0021212</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0021212</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2203101</CON_ID>
            <DEFINITION_SOURCE>NCI; National Cancer Institute Thesaurus. September 2003</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>YES</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NO</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DON&#39;T KNOW</VALIDVALUE>
          <VALUEMEANING>Don&#39;t know</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-09-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NOT DONE</VALIDVALUE>
          <VALUEMEANING>NOT DONE</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you had a tubal ligation</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you had a tubal ligation, that is, have you ever had your tubes tied?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193113</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCEG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CGEMS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812078</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1065">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2443368</PUBLICID>
    <LONGNAME>Family Member Relationship Text</LONGNAME>
    <PREFERREDNAME>FAM_MEM_REL_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>The free text field used to specify the relationship of relatives to the participant.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2009140</PublicId>
      <PreferredName>FAM_MEMB_RELAT</PreferredName>
      <PreferredDefinition>Family member relationship</PreferredDefinition>
      <LongName>Family member relationship</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008509</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPORES</PreferredName>
        <Version>2.31</Version>
        <LongName>SPOREs</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177165</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Family</PreferredName>
        <Version>1</Version>
        <LongName>Family</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25173</PREFERRED_NAME>
            <LONG_NAME>Family</LONG_NAME>
            <CON_ID>2202639</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177408</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Relative</PreferredName>
        <Version>1</Version>
        <LongName>Relative</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21480</PREFERRED_NAME>
            <LONG_NAME>Relative</LONG_NAME>
            <CON_ID>2202798</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2443071</PublicId>
      <PreferredName>RELAT_TXT</PreferredName>
      <PreferredDefinition>A free text field used to specify the relationship to the participant.</PreferredDefinition>
      <LongName>Relationship Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Who was diagnosed as having c</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Who was diagnosed as having cancer, that is, what is his or her relationship to you?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Document Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Relation to participant</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify family member</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Please specify relationship:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193113</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCEG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CGEMS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812078</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Hormone Receptor-Negative Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5441476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1066">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2452144</PUBLICID>
    <LONGNAME>Or Paralogous Protein Homologous Protein Identical Alignment Percentage java.lang.String</LONGNAME>
    <PREFERREDNAME>2452008v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:A gene related to a similar gene by duplication within a genome.:A protein similar in structure and evolutionary origin to a protein in another species._Exactly alike; incapable of being perceived as different; being the exact same one; coinciding exactly when superimposed; having properties with uniform values along all axes.:The act of adjusting or aligning objects in relation to each other; the result of this activity.:A fraction or ratio with 100 understood as the denominator._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2452008</PublicId>
      <PreferredName>2451978v1.0:2451952v1.0</PreferredName>
      <PreferredDefinition>An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:A gene related to a similar gene by duplication within a genome.:A protein similar in structure and evolutionary origin to a protein in another species._Exactly alike; incapable of being perceived as different; being the exact same one; coinciding exactly when superimposed; having properties with uniform values along all axes.:The act of adjusting or aligning objects in relation to each other; the result of this activity.:A fraction or ratio with 100 understood as the denominator.</PreferredDefinition>
      <LongName>Or Paralogous Protein Homologous Protein Identical Alignment Percentage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2451978</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37998:C49108:C40992</PreferredName>
        <Version>1</Version>
        <LongName>Or Paralogous Protein Homologous Protein</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49108</PREFERRED_NAME>
            <LONG_NAME>Paralogous Gene</LONG_NAME>
            <CON_ID>2451926</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40992</PREFERRED_NAME>
            <LONG_NAME>Homologous Protein</LONG_NAME>
            <CON_ID>2451925</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2451952</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49034:C49033:C25613</PreferredName>
        <Version>1</Version>
        <LongName>Identical Alignment Percentage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49034</PREFERRED_NAME>
            <LONG_NAME>Identical</LONG_NAME>
            <CON_ID>2451928</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49033</PREFERRED_NAME>
            <LONG_NAME>Alignment</LONG_NAME>
            <CON_ID>2451927</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Or Paralogous Protein Homologous Protein Identical Alignment Percentage java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Or Paralogous Protein Homologous Protein Identical Alignment Percentage java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857164</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Cancer Molecular Pages</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Molecular Pages</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812107</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857164</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Cancer Molecular Pages</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CancerMoleculePages</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812108</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CancerMoleculePages.ProteinHomolog.percentIdentical</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProteinHomolog:percentIdentical</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1067">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2463951</PUBLICID>
    <LONGNAME>Person Other Things Thinking Stressful Life Event Response Text Value</LONGNAME>
    <PREFERREDNAME>PRSN_OTX_THK_EVT_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>Text response on a questionnaire that represents a person&#39;s recount that other things cause thinking about stressful life events.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2463550</PublicId>
      <PreferredName>PRSN_OTX_THK_STR_EVT</PreferredName>
      <PreferredDefinition>A person&#39;s recount that other things cause thinking about stressful life events.</PreferredDefinition>
      <LongName>Person Other Things Thinking Stressful Life Event</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2467897</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C17649:C51070:C54226</PreferredName>
        <Version>1</Version>
        <LongName>Person Other Entity Thinking</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54226</PREFERRED_NAME>
            <LONG_NAME>Thinking</LONG_NAME>
            <CON_ID>2463649</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2463007</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C35041:C37987:C25499</PreferredName>
        <Version>1</Version>
        <LongName>Stress Life Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C35041</PREFERRED_NAME>
            <LONG_NAME>Stress</LONG_NAME>
            <CON_ID>2463006</CON_ID>
            <DEFINITION_SOURCE>CSP2003</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37987</PREFERRED_NAME>
            <LONG_NAME>Alive</LONG_NAME>
            <CON_ID>2210813</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2463855</PublicId>
      <PreferredName>QUEST_RESP_TXT_VAL</PreferredName>
      <PreferredDefinition>Text answers to items on a questionnaire.</PreferredDefinition>
      <LongName>Questionnaire Response Text Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2463854</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704:C49100</PreferredName>
        <Version>1</Version>
        <LongName>Text Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49100</PREFERRED_NAME>
            <LONG_NAME>Data Value</LONG_NAME>
            <CON_ID>2463853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at All</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other things kept making me t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other things kept making me think about it.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Standard Tool Reference</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>This CDE represents question #11 on the Impact of Events Scale; author is Dr. Mardi Horowitz.  Dr. Horowitz granted NCICB permission for the creation and maintenance of IES CDEs in the caDSR in March 2006.  </DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1068">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2466880</PUBLICID>
    <LONGNAME>Acute Leukemia Diagnosis Text Code</LONGNAME>
    <PREFERREDNAME>ACUTE_LEUK_DX_TXT_CD</PREFERREDNAME>
    <PREFERREDDEFINITION>Text code term to represent the marrow diagnostic category for a person with acute leukemia.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2466876</PublicId>
      <PreferredName>ACUTE_LEUK_DX</PreferredName>
      <PreferredDefinition>The investigation and recognition of the presence of acute leukemia, in which the involved cell shows little or no differentiation.</PreferredDefinition>
      <LongName>Acute Leukemia Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2466874</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9300</PreferredName>
        <Version>1</Version>
        <LongName>Acute Leukemia</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9300</PREFERRED_NAME>
            <LONG_NAME>Acute Leukemia</LONG_NAME>
            <CON_ID>2466873</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239981</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2466877</PublicId>
      <PreferredName>ACUTE_LEUK_DX_TXT_CD</PreferredName>
      <PreferredDefinition>Text code terms to represent the marrow diagnostic category for a patient with acute leukemia.</PreferredDefinition>
      <LongName>Acute Leukemia Diagnosis Text Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234893</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Text Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>M0</VALIDVALUE>
          <VALUEMEANING>Acute myeloblastic leukemia (AML) without maturation</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myeloblastic leukemia (AML) without maturation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>M1</VALIDVALUE>
          <VALUEMEANING>Acute myeloblastic leukemia (AML)</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myeloblastic leukemia (AML)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>M2</VALIDVALUE>
          <VALUEMEANING>Acute myeloblastic leukemia with differentiation</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute myeloblastic leukemia with differentiation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>M3</VALIDVALUE>
          <VALUEMEANING>Acute promyelocytic leukemia (APL)</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute promyelocytic leukemia (APL)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>M4</VALIDVALUE>
          <VALUEMEANING>Acute myelomonocytic leukemia (AMML)</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute myeloid leukemia (AML) characterized by blasts without evidence of maturation to more mature neutrophils.  The patients present with anemia, neutropenia, and thrombocytopenia.  This type of AML usually follows an aggressive clinical course.  (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3249</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>M5</VALIDVALUE>
          <VALUEMEANING>Acute monocytic leukemia (AMOL)</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute monocytic leukemia (AMOL)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>M6</VALIDVALUE>
          <VALUEMEANING>Acute erythroleukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute erythroleukemia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578417</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>M7</VALIDVALUE>
          <VALUEMEANING>Acute megakaryocytic leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute myeloid leukemia in which at least 50% of the blasts are of megakaryocytic lineage.  The prognosis is usually poor.  (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3170</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Original AML Diagnosis type</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Original AML Diagnosis type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UPCC 07403</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812574</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U of Pa Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812727</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Pa Cancer Center New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812868</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1069">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2475603</PUBLICID>
    <LONGNAME>NCI Thesaurus Concept Semantic_Type_Property java.lang.String</LONGNAME>
    <PREFERREDNAME>2475411v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A concept is the basic unit of information contained in the Thesaurus. They describe sets of individuals in a given domain. A concept has a name, belongs to a Namespace and exists in relation to other concepts. The vertical relationships consist of &quot;isa&quot; statements that form a logical hierarchy (taxonomy or subsumption graph). In general, concepts above a given concept are referred to as superconcepts or parents and those below as subconcepts or children. In addition, there are horizontal named realationships between concepts called Roles, binary relations between concepts that provide a machine-interpretable definition of a concept and the means for discrimination of sibling concepts. A concept may also include Properties, named slots that allow attachment of external information to concepts._The semantic type describes the sort of thing or category to which a concept belongs in the context of the UMLS semantic network._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2475411</PublicId>
      <PreferredName>2475324v1.0:2388854v1.0</PreferredName>
      <PreferredDefinition>A concept is the basic unit of information contained in the Thesaurus. They describe sets of individuals in a given domain. A concept has a name, belongs to a Namespace and exists in relation to other concepts. The vertical relationships consist of &quot;isa&quot; statements that form a logical hierarchy (taxonomy or subsumption graph). In general, concepts above a given concept are referred to as superconcepts or parents and those below as subconcepts or children. In addition, there are horizontal named realationships between concepts called Roles, binary relations between concepts that provide a machine-interpretable definition of a concept and the means for discrimination of sibling concepts. A concept may also include Properties, named slots that allow attachment of external information to concepts._The semantic type describes the sort of thing or category to which a concept belongs in the context of the UMLS semantic network.</PreferredDefinition>
      <LongName>NCI Thesaurus Concept Semantic_Type_Property</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2475324</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43821</PreferredName>
        <Version>1</Version>
        <LongName>NCI Thesaurus Concept</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43821</PREFERRED_NAME>
            <LONG_NAME>NCI Thesaurus Concept</LONG_NAME>
            <CON_ID>2231595</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2388854</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42732</PreferredName>
        <Version>1</Version>
        <LongName>Semantic_Type_Property</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42732</PREFERRED_NAME>
            <LONG_NAME>Semantic_Type</LONG_NAME>
            <CON_ID>2222827</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element NCI Thesaurus Concept Semantic_Type_Property java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element NCI Thesaurus Concept Semantic_Type_Property java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2475251</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTIES 2.0</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.upmc.opi.caBIG.caTIES.database.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812153</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2475251</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTIES 2.0</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caTIES</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812488</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Concept:semanticType</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.upmc.opi.caBIG.caTIES.database.domain.Concept.semanticType</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1070">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2475888</PUBLICID>
    <LONGNAME>Infusion Flow Rate Number</LONGNAME>
    <PREFERREDNAME>INF_FLOW_RT_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent measurement of the continuous movement of an intravenous substance relative to time, expressed as a value in milliliters per minute.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2475880</PublicId>
      <PreferredName>INF_FLOW_RT</PreferredName>
      <PreferredDefinition>Continuous movement of an intravenous infusion at a speed relative to time.</PreferredDefinition>
      <LongName>Infusion Flow Rate</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2475877</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15388</PreferredName>
        <Version>1</Version>
        <LongName>Infusion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15388</PREFERRED_NAME>
            <LONG_NAME>Infusion Procedure</LONG_NAME>
            <CON_ID>2203835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2475878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41141:C25636</PreferredName>
        <Version>1</Version>
        <LongName>Flow Rate</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41141</PREFERRED_NAME>
            <LONG_NAME>Flow</LONG_NAME>
            <CON_ID>2203767</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25636</PREFERRED_NAME>
            <LONG_NAME>Rate</LONG_NAME>
            <CON_ID>2203725</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2475882</PublicId>
      <PreferredName>IV_FLOW_RT_NUM</PreferredName>
      <PreferredDefinition>Numeric value to represent measurement of the continuous movement of an intravenous substance relative to time, expressed as a value in milliliters per minute.</PreferredDefinition>
      <LongName>Intraveous Flow Rate Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>ml/min</UnitOfMeasure>
      <MaximumLength>6</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208014</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25636:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Rate Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25636</PREFERRED_NAME>
            <LONG_NAME>Rate</LONG_NAME>
            <CON_ID>2203725</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Flow Rate</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Flow Rate</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the flow rate of study treatment administration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Flow rate of study treatment administration</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Study Agent Administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3449457</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716207</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ASCO</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Chemotherapy Administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2861473</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Study Agent Administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Study Treatment Administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7590139</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>FAEC_FAORRES_FLRT</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1071">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2479745</PUBLICID>
    <LONGNAME>Therapy Current Course Discontinued Reason</LONGNAME>
    <PREFERREDNAME>TX_CUR_XRSE_DXD_RSN</PREFERREDNAME>
    <PREFERREDDEFINITION>the free-text for the reason the current course or cycle of treatment was discontinued or held.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2479735</PublicId>
      <PreferredName>TX_CUR_CRSE_DXD</PreferredName>
      <PreferredDefinition>information related to the discontinuation, either permanently or temporarily, of the current protocol-prescribed treatment-related activity or  intervention.</PreferredDefinition>
      <LongName>Therapy Current Course Discontinued</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008554</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_OTX_RSNS</PreferredName>
        <Version>1</Version>
        <LongName>Treatment/Off-treatment Reasons</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2416951</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15368</PreferredName>
        <Version>1</Version>
        <LongName>Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2479733</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25471:C25379:C25484</PreferredName>
        <Version>1</Version>
        <LongName>Current Course Discontinued</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25379</PREFERRED_NAME>
            <LONG_NAME>Course</LONG_NAME>
            <CON_ID>2202898</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25484</PREFERRED_NAME>
            <LONG_NAME>Discontinue</LONG_NAME>
            <CON_ID>2203906</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2479744</PublicId>
      <PreferredName>CRSE_DXD_RSN</PreferredName>
      <PreferredDefinition>the reason or explanation a treatment course was discontinued.</PreferredDefinition>
      <LongName>Course Discontinuation Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008554</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_OTX_RSNS</PreferredName>
        <Version>1</Version>
        <LongName>Treatment/Off-treatment Reasons</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2240632</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Primary reason treatment held</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Primary reason treatment held</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1072">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2480207</PUBLICID>
    <LONGNAME>Clinical Data Update System Report Submission Method Type</LONGNAME>
    <PREFERREDNAME>CDUS_REP_SUB_MET_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the method of submission of a Clinical Data Update System (CDUS) report.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CDS:Clinical Data System</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2480149</PublicId>
      <PreferredName>CDUS_REP_SUBM_METH</PreferredName>
      <PreferredDefinition>information related to the method or mode of transmission of the Clinical Data Update system report, a system to standardize and streamline data reporting and reduce administration needs.</PreferredDefinition>
      <LongName>Clinical Data Update System Report Submission Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480146</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19992:C25375</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Data Update System Report</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19992</PREFERRED_NAME>
            <LONG_NAME>Clinical Data Update System</LONG_NAME>
            <CON_ID>2202434</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2480147</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25694:C16847</PreferredName>
        <Version>1</Version>
        <LongName>Submission Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25694</PREFERRED_NAME>
            <LONG_NAME>Submission</LONG_NAME>
            <CON_ID>2202488</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16847</PREFERRED_NAME>
            <LONG_NAME>Technique</LONG_NAME>
            <CON_ID>2203854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2480208</PublicId>
      <PreferredName>CDUS_SUB_METH_TP</PreferredName>
      <PreferredDefinition>the submission method of Clinical Data Update System report.</PreferredDefinition>
      <LongName>Clinical Data Update System Submission Method Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Web</VALIDVALUE>
          <VALUEMEANING>World Wide Web</VALUEMEANING>
          <MEANINGDESCRIPTION>World WIde Web; a computer network consisting of a collection of internet sites that offer text and graphics and sound and animation resources through the hypertext transfer protocol.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FTP</VALIDVALUE>
          <VALUEMEANING>File Transfer Protocol</VALUEMEANING>
          <MEANINGDESCRIPTION>A means of transferring or sharing files across the Internet from one computer system to another.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDUS Submission Mechanism</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CDUS Submission Mechanism</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Data Update System</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812446</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Administrative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812610</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Data Update System</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000130</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1073">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2483041</PUBLICID>
    <LONGNAME>Clinical Coordinator Cellular Telephone Number</LONGNAME>
    <PREFERREDNAME>CLN_CRD_CELL_PH_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>The string of numerals that identifies the connection over distance by a hand-held mobile radiotelephone to the person to whom a clinical investigator delegates the routine administrative requirements of a protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2483039</PublicId>
      <PreferredName>CLIN_CRD_CELL_PH_NUM</PreferredName>
      <PreferredDefinition>The string of numerals that identifies the connection over distance by a hand-held mobile radiotelephone to the person to whom a clinical investigator delegates the routine administrative requirements of a protocol.</PreferredDefinition>
      <LongName>Clinical Coordinator Cellular Telephone Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008544</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TELECOMMUNICATIONS</PreferredName>
        <Version>1</Version>
        <LongName>Telecommunications</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2483138</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C51811:C60787:C40978</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Coordinator Cellular Telephone Telephone Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51811</PREFERRED_NAME>
            <LONG_NAME>Clinical Coordinator</LONG_NAME>
            <CON_ID>2479762</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60787</PREFERRED_NAME>
            <LONG_NAME>Cellular Telephone</LONG_NAME>
            <CON_ID>2482098</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40978</PREFERRED_NAME>
            <LONG_NAME>Telephone Number</LONG_NAME>
            <CON_ID>2223426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2413199</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2481261</PublicId>
      <PreferredName>TELCOM_NUM</PreferredName>
      <PreferredDefinition>A string of numerals that is used for the identification of a unique connection to a device or location to communicate over distance by telephone, computer modem, or similar means.</PreferredDefinition>
      <LongName>Telecommunications Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008544</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TELECOMMUNICATIONS</PreferredName>
        <Version>1</Version>
        <LongName>Telecommunications</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2481260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17188:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Telecommunications Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17188</PREFERRED_NAME>
            <LONG_NAME>Telecommunications</LONG_NAME>
            <CON_ID>2203967</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Clinical Coordinator Cellular</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Clinical Coordinator Cellular Contact Telephone Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1074">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2495419</PUBLICID>
    <LONGNAME>Bottle Identifier Number</LONGNAME>
    <PREFERREDNAME>BOT_ID_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>the numeric identifier for the bottle.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2495417</PublicId>
      <PreferredName>BTTL_ID</PreferredName>
      <PreferredDefinition>information related to the identification of the bottle.</PreferredDefinition>
      <LongName>Bottle Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480215</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43169</PreferredName>
        <Version>1</Version>
        <LongName>Bottle</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43169</PREFERRED_NAME>
            <LONG_NAME>Bottle</LONG_NAME>
            <CON_ID>2480214</CON_ID>
            <DEFINITION_SOURCE>FDA</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2495418</PublicId>
      <PreferredName>BOTT_ID_NUM</PreferredName>
      <PreferredDefinition>the number to identify the bottle.</PreferredDefinition>
      <LongName>Bottle Identifier Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Bottle Number</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Bottle Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Bottle 1 Medication code assigned</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Bottle 2 Medication code assigned</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>MEMs cap number:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Question Text - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Bottle #</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>MEMS® TrackCap unique identifier:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5612586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BOT_ID_NUM</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1075">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2503465</PUBLICID>
    <LONGNAME>Lesion Histology Response Type</LONGNAME>
    <PREFERREDNAME>LES_HIST_RESP_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>The type of nevus lesion histology.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2503461</PublicId>
      <PreferredName>LES_HIST</PreferredName>
      <PreferredDefinition>Information pertaining to an area of abnormal tissue change of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.</PreferredDefinition>
      <LongName>Lesion Histology</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2465192</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3824</PreferredName>
        <Version>1</Version>
        <LongName>Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2186387</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16681</PreferredName>
        <Version>1</Version>
        <LongName>Histology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16681</PREFERRED_NAME>
            <LONG_NAME>Histology</LONG_NAME>
            <CON_ID>2202345</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2503463</PublicId>
      <PreferredName>LES_HIST_RESP_TP</PreferredName>
      <PreferredDefinition>The type of nevus lesion histology.</PreferredDefinition>
      <LongName>Lesion Histology Response Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2503462</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50995:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Response Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50995</PREFERRED_NAME>
            <LONG_NAME>Disease Response</LONG_NAME>
            <CON_ID>2459436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dysplastic nevus</VALIDVALUE>
          <VALUEMEANING>Dysplastic nevus</VALUEMEANING>
          <MEANINGDESCRIPTION>Dysplastic nevus</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580424</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Benign nevus</VALIDVALUE>
          <VALUEMEANING>Benign nevus</VALUEMEANING>
          <MEANINGDESCRIPTION>Benign nevus</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580425</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Obtained</VALIDVALUE>
          <VALUEMEANING>Not Obtained</VALUEMEANING>
          <MEANINGDESCRIPTION>Not Obtained</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lesion Histology</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Lesion Histology</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Safety Study of Resiquimod for Atyical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1076">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2506039</PUBLICID>
    <LONGNAME>Proband Interview Consent Form Received Date</LONGNAME>
    <PREFERREDNAME>INTVW_CONS_RCVD_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>Date of receipt of a consent document for an interview by the first affected individual in a family with a genetic disorder who is manifesting the disease and is diagnosed so.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2506037</PublicId>
      <PreferredName>PRBD_INTVW_CONS_RCVD</PreferredName>
      <PreferredDefinition>Receipt of a consent document for an interview by the first affected individual in a family with a genetic disorder who is manifesting the disease and is diagnosed so.</PreferredDefinition>
      <LongName>Proband Interview Consent Form Received</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2606071</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C64435:C16751:C16468</PreferredName>
        <Version>1</Version>
        <LongName>Proband Interview Consent Form</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64435</PREFERRED_NAME>
            <LONG_NAME>Proband</LONG_NAME>
            <CON_ID>2590809</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16751</PREFERRED_NAME>
            <LONG_NAME>Interview</LONG_NAME>
            <CON_ID>2425737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16468</PREFERRED_NAME>
            <LONG_NAME>Consent Form</LONG_NAME>
            <CON_ID>2202582</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241679</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25639</PreferredName>
        <Version>1</Version>
        <LongName>Received</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017121</PublicId>
      <PreferredName>CTMS_DT</PreferredName>
      <PreferredDefinition>Date as required for Clinical Trials Monitoring Service submissions.  Exchange format is YYYYMMDD.  Display format is DDMMMYYYY, with the month display the first three letters of each month (Jan, Feb, Mar, etc.).</PreferredDefinition>
      <LongName>CTMS Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>DD/MON/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Interview consent date given</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Interview consent date given</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812205</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AZCC 0210</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812575</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1077">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2513897</PUBLICID>
    <LONGNAME>Fluid Specimen Barcode java.lang.String</LONGNAME>
    <PREFERREDNAME>2513631v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A continuous amorphous substance that tends to flow and to conform to the outline of its container (i.e., a liquid or a gas).  Also used as an adjective to describe something with properties like that of a fluid.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A machine-readable representation of information in a visual format on a surface. Originally barcodes stored data in the widths and spacings of printed parallel lines, but today they also come in patterns of dots, concentric circles, and hidden in images (Wikipedia)._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2513631</PublicId>
      <PreferredName>2513376v1.0:2236644v1.0</PreferredName>
      <PreferredDefinition>A continuous amorphous substance that tends to flow and to conform to the outline of its container (i.e., a liquid or a gas).  Also used as an adjective to describe something with properties like that of a fluid.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A machine-readable representation of information in a visual format on a surface. Originally barcodes stored data in the widths and spacings of printed parallel lines, but today they also come in patterns of dots, concentric circles, and hidden in images (Wikipedia).</PreferredDefinition>
      <LongName>Fluid Specimen Barcode</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2513376</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25278:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Fluid Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25278</PREFERRED_NAME>
            <LONG_NAME>Fluid</LONG_NAME>
            <CON_ID>2202644</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2236644</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43361</PreferredName>
        <Version>1</Version>
        <LongName>Barcode</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43361</PREFERRED_NAME>
            <LONG_NAME>Barcode</LONG_NAME>
            <CON_ID>2236527</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Fluid Specimen Barcode java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Fluid Specimen Barcode java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2553133</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812526</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2661745</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_caArray</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000636</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.FluidSpecimen.barcode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FluidSpecimen:barcode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domainobject.FluidSpecimen.barcode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1078">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2519470</PUBLICID>
    <LONGNAME>Laboratory Information Management System File Type Pathname java.lang.String</LONGNAME>
    <PREFERREDNAME>2519381v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Integrated computer systems for capturing and reporting laboratory data.:A set of related records (either written or electronic) kept together._Something distinguishable as an identifiable class based on common qualities.:The specification of a node (file or directory) in a hierarchical file system, usually specified by listing the nodes top-down._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2519381</PublicId>
      <PreferredName>2422777v1.0:2519307v1.0</PreferredName>
      <PreferredDefinition>Integrated computer systems for capturing and reporting laboratory data.:A set of related records (either written or electronic) kept together._Something distinguishable as an identifiable class based on common qualities.:The specification of a node (file or directory) in a hierarchical file system, usually specified by listing the nodes top-down.</PreferredDefinition>
      <LongName>Laboratory Information Management System File Type Pathname</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2422777</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48209:C42883</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Information Management System File</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48209</PREFERRED_NAME>
            <LONG_NAME>Laboratory Information Management System</LONG_NAME>
            <CON_ID>2422638</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42883</PREFERRED_NAME>
            <LONG_NAME>File</LONG_NAME>
            <CON_ID>2422612</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2519307</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284:C47922</PreferredName>
        <Version>1</Version>
        <LongName>Type Pathname</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47922</PREFERRED_NAME>
            <LONG_NAME>Pathname</LONG_NAME>
            <CON_ID>2519294</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Laboratory Information Management System File Type Pathname java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Laboratory Information Management System File Type Pathname java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ProteomicsLIMS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.fccc.lims.protlims.domain.class.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812037</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LimsFile:locationType</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.fccc.lims.protlims.domain.class.inventory.LimsFile.locationType</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1079">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2521288</PUBLICID>
    <LONGNAME>Invasive Breast Carcinoma Anatomic Site Microcalcification java.util.Collection</LONGNAME>
    <PREFERREDNAME>2431346v1.0:2200944v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women. --2003_Named locations of, or within, the body.:Tiny deposits of calcium in the breast that cannot be felt but can be detected on a mammogram. A cluster of these very small specks of calcium may indicate that cancer is present._Generic value domain for a java datatype that is defined as a group of objects.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2431346</PublicId>
      <PreferredName>2431278v1.0:2431219v1.0</PreferredName>
      <PreferredDefinition>A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women. --2003_Named locations of, or within, the body.:Tiny deposits of calcium in the breast that cannot be felt but can be detected on a mammogram. A cluster of these very small specks of calcium may indicate that cancer is present.</PreferredDefinition>
      <LongName>Invasive Breast Carcinoma Anatomic Site Microcalcification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2431278</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9245</PreferredName>
        <Version>1</Version>
        <LongName>Invasive Breast Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9245</PREFERRED_NAME>
            <LONG_NAME>Invasive Breast Carcinoma</LONG_NAME>
            <CON_ID>2431159</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2431219</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717:C8433</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site Microcalcification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C8433</PREFERRED_NAME>
            <LONG_NAME>Microcalcification</LONG_NAME>
            <CON_ID>2203853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200944</PublicId>
      <PreferredName>java.util.Collection</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is defined as a group of objects.</PreferredDefinition>
      <LongName>java.util.Collection</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Collection</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2707862</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45974</PreferredName>
        <Version>1</Version>
        <LongName>Computer Programming Object</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45974</PREFERRED_NAME>
            <LONG_NAME>Computer Programming Object</LONG_NAME>
            <CON_ID>2528432</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Invasive Breast Carcinoma Anatomic Site Microcalcification java.util.Collection does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Invasive Breast Carcinoma Anatomic Site Microcalcification java.util.Collection does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2553954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTRIP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.pitt.cabig.cae.domain.breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812216</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.pitt.cabig.cae.domain.breast.InvasiveBreastCarcinoma.microcalcificationLocation</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>InvasiveBreastCarcinoma:microcalcificationLocation</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.upmc.opi.cabig.caties.cap.domain.breast.InvasiveBreastCarcinoma.microcalcificationLocation</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1080">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2526597</PUBLICID>
    <LONGNAME>Surgical Margin Posterolateral Status</LONGNAME>
    <PREFERREDNAME>SXMARG_PL_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>a state indicating presence or absence of malignant cells at a surgical border of tumor tissue located in a position toward the back/spine and away from the midline.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2526596</PublicId>
      <PreferredName>SXMARG_PL</PreferredName>
      <PreferredDefinition>the edge or border of the tissue removed in cancer surgery located toward the back/spine and away from the middle line.</PreferredDefinition>
      <LongName>Surgical Margin Posterolateral</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008574</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SURG_MARG_MSRMTS</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Margin Measurements</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2427288</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41227</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Margin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41227</PREFERRED_NAME>
            <LONG_NAME>Surgical Margin</LONG_NAME>
            <CON_ID>2202388</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2526594</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0332195</PreferredName>
        <Version>1</Version>
        <LongName>Posterolateral</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0332195</PREFERRED_NAME>
            <LONG_NAME>Posterolateral</LONG_NAME>
            <CON_ID>2226969</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015570</PublicId>
      <PreferredName>SXMARG_STAT</PreferredName>
      <PreferredDefinition>a state indicating presence or absence of malignant cells at the surgical border where tumor tissue was removed from a patient.</PreferredDefinition>
      <LongName>Surgical Margin Status</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTEP CDE Committee</Origin>
      <Representation>
        <PublicId>2184340</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Status</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not examined</VALIDVALUE>
          <VALUEMEANING>NOT EXAMINED</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Having been subjected to inspection or evaluation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25500, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive</VALUEMEANING>
          <MEANINGDESCRIPTION>Involving advantage or good.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Posterolateral Surgical Margin</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Posterolateral Surgical Margin</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1081">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2527085</PUBLICID>
    <LONGNAME>New Cancer Anatomic Site Specify</LONGNAME>
    <PREFERREDNAME>NEW_CAN_ANATLC_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>a text field to identify an organ or tissue site within the body where a new, unique tumor consisting of atypical neoplastic cells is diagnosed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188709</PublicId>
      <PreferredName>NEW_CA_LCTN</PreferredName>
      <PreferredDefinition>information related to the location of a new cancer.</PreferredDefinition>
      <LongName>New Cancer Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206435</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25586:C9305</PreferredName>
        <Version>1</Version>
        <LongName>New Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25586</PREFERRED_NAME>
            <LONG_NAME>New</LONG_NAME>
            <CON_ID>2204982</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177480</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Location</PreferredName>
        <Version>1</Version>
        <LongName>Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2226669</PublicId>
      <PreferredName>ANATSITE_SPEC</PreferredName>
      <PreferredDefinition>the free text field to specify an anatomic site.</PreferredDefinition>
      <LongName>Anatomic Site Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify disease site</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify disease site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1010</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171061</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1005</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171062</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NEW_CAN_ANATLC_SPEC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1082">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2529144</PUBLICID>
    <LONGNAME>Single Nucleotide Polymorphism Assay Design Nucleotide Sequence java.lang.String</LONGNAME>
    <PREFERREDNAME>2528849v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:The determination of the amount of a particular constituent of a mixture or of the biological or pharmacological potency of a drug._The act of working out the form of something (as by making a sketch or outline or plan) or the result of this activity.:The sequence of nucleotide residues along an RNA or DNA chain._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2528849</PublicId>
      <PreferredName>2528730v1.0:2528624v1.0</PreferredName>
      <PreferredDefinition>A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:The determination of the amount of a particular constituent of a mixture or of the biological or pharmacological potency of a drug._The act of working out the form of something (as by making a sketch or outline or plan) or the result of this activity.:The sequence of nucleotide residues along an RNA or DNA chain.</PreferredDefinition>
      <LongName>Single Nucleotide Polymorphism Assay Design Nucleotide Sequence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528730</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18279:C60819</PreferredName>
        <Version>1</Version>
        <LongName>Single Nucleotide Polymorphism Assay</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18279</PREFERRED_NAME>
            <LONG_NAME>Single Nucleotide Polymorphism</LONG_NAME>
            <CON_ID>2433334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60819</PREFERRED_NAME>
            <LONG_NAME>Assay</LONG_NAME>
            <CON_ID>2528534</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528624</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43358:C45374</PreferredName>
        <Version>1</Version>
        <LongName>Design Nucleotide Sequence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43358</PREFERRED_NAME>
            <LONG_NAME>Design</LONG_NAME>
            <CON_ID>2220104</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45374</PREFERRED_NAME>
            <LONG_NAME>Nucleotide Sequence</LONG_NAME>
            <CON_ID>2223191</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Single Nucleotide Polymorphism Assay Design Nucleotide Sequence java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Single Nucleotide Polymorphism Assay Design Nucleotide Sequence java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2528519</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.annotation.snp</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812316</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2707890</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator 2.1</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.annotation.snp</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000401</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SNPAssay:designSequence</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.annotation.snp.SNPAssay.designSequence</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1083">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2529161</PUBLICID>
    <LONGNAME>Single Nucleotide Polymorphism Annotation Single Nucleotide Polymorphism Database Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2528866v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:An explanatory or critical comment that has been added to a text._The Single Nucleotide Polymorphism database (dbSNP) is a database repository and internet resource for a broad collection of simple genetic polymorphisms.  It is hosted by the National Center for Biotechnology Information.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2528866</PublicId>
      <PreferredName>2528732v1.0:2223247v1.0</PreferredName>
      <PreferredDefinition>A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:An explanatory or critical comment that has been added to a text._The Single Nucleotide Polymorphism database (dbSNP) is a database repository and internet resource for a broad collection of simple genetic polymorphisms.  It is hosted by the National Center for Biotechnology Information.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Single Nucleotide Polymorphism Annotation Single Nucleotide Polymorphism Database Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528732</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18279:C44272</PreferredName>
        <Version>1</Version>
        <LongName>Single Nucleotide Polymorphism Annotation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18279</PREFERRED_NAME>
            <LONG_NAME>Single Nucleotide Polymorphism</LONG_NAME>
            <CON_ID>2433334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44272</PREFERRED_NAME>
            <LONG_NAME>Annotation</LONG_NAME>
            <CON_ID>2519066</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223247</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45369:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Single Nucleotide Polymorphism Database Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45369</PREFERRED_NAME>
            <LONG_NAME>Single Nucleotide Polymorphism Database</LONG_NAME>
            <CON_ID>2223182</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Single Nucleotide Polymorphism Annotation Single Nucleotide Polymorphism Database Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Single Nucleotide Polymorphism Annotation Single Nucleotide Polymorphism Database Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2528519</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.annotation.snp</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812316</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2707890</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator 2.1</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.annotation.snp</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000401</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SNPAnnotation:dbsnpId</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.annotation.snp.SNPAnnotation.dbsnpId</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1084">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2529311</PUBLICID>
    <LONGNAME>Surgical Procedure Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2529013v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Used for operative procedures on organs, regions, or tissues in the treatment of diseases, including tissue section by lasers. It excludes transplantation, for which &quot;transplantation&quot; is used._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2529013</PublicId>
      <PreferredName>2322305v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Used for operative procedures on organs, regions, or tissues in the treatment of diseases, including tissue section by lasers. It excludes transplantation, for which &quot;transplantation&quot; is used._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Surgical Procedure Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2322305</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Surgical Procedure Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Surgical Procedure Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2528519</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812313</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.tgen.BCR.Surgery.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.study.Surgery.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Surgery:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1085">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2539754</PUBLICID>
    <LONGNAME>Object Class Relationship Administered Item Source Lowest Multiplicity java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2539562v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A set of ideas, abstractions, or things in the real world that can be identified with explicit boundaries and meaning and whose properties and behavior follow the same rules.:A state of connectedness between people, objects, or events; to be associated or connected with something.:A registry item for which administrative information is recorded in an Administration Record._Where something is available or from where it originates.:In the lowest position, nearest the ground, at the bottom; minimal in magnitude, lowest in rank or importance; an extreme state of adversity.:The number of values for which a given condition holds; an indcation of how many objects may participate in a given relationship; the property of being multiple._Generic value domain for a primitive java dataype that is an Integer (32-bit two&quot;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2539562</PublicId>
      <PreferredName>2539526v1.0:2539484v1.0</PreferredName>
      <PreferredDefinition>A set of ideas, abstractions, or things in the real world that can be identified with explicit boundaries and meaning and whose properties and behavior follow the same rules.:A state of connectedness between people, objects, or events; to be associated or connected with something.:A registry item for which administrative information is recorded in an Administration Record._Where something is available or from where it originates.:In the lowest position, nearest the ground, at the bottom; minimal in magnitude, lowest in rank or importance; an extreme state of adversity.:The number of values for which a given condition holds; an indcation of how many objects may participate in a given relationship; the property of being multiple.</PreferredDefinition>
      <LongName>Object Class Relationship Administered Item Source Lowest Multiplicity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2539526</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41106:C25648:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Object Class Relationship Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41106</PREFERRED_NAME>
            <LONG_NAME>Object Class</LONG_NAME>
            <CON_ID>2223438</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2539484</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25683:C43517:C45676</PreferredName>
        <Version>1</Version>
        <LongName>Source Lowest Multiplicity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25683</PREFERRED_NAME>
            <LONG_NAME>Source</LONG_NAME>
            <CON_ID>2202479</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43517</PREFERRED_NAME>
            <LONG_NAME>Lowest</LONG_NAME>
            <CON_ID>2202385</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45676</PREFERRED_NAME>
            <LONG_NAME>Multiplicity</LONG_NAME>
            <CON_ID>2231594</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Object Class Relationship Administered Item Source Lowest Multiplicity java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Object Class Relationship Administered Item Source Lowest Multiplicity java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.ObjectClassRelationship.sourceLowMultiplicity</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ObjectClassRelationship:sourceLowMultiplicity</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>@sourceLowMultiplicity</AlternateName>
        <AlternateNameType>GME_XMLLocReference</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1086">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2553393</PUBLICID>
    <LONGNAME>Specimen Array Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2553250v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:An orderly arrangement. (from the American Heritage Dictionary)_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2553250</PublicId>
      <PreferredName>2553162v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:An orderly arrangement. (from the American Heritage Dictionary)_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Specimen Array Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2553162</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157:C26358</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Array</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26358</PREFERRED_NAME>
            <LONG_NAME>Array</LONG_NAME>
            <CON_ID>2236563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Specimen Array Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Specimen Array Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2553133</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812526</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2661745</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_caArray</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000636</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2680967</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000633</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000638</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000639</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.SpecimenArray.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SpecimenArray:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1087">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2553406</PUBLICID>
    <LONGNAME>Milliliter Quantity Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2553261v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A metric unit of volume equal to one thousandth of a liter, 10E-6 cubic meter, or approximately to 0.061 023 7 cubic inch. A cubic centimeter is the CGS unit of volume.:How much there is of something that you can measure; the total amount or number._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2553261</PublicId>
      <PreferredName>2553154v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A metric unit of volume equal to one thousandth of a liter, 10E-6 cubic meter, or approximately to 0.061 023 7 cubic inch. A cubic centimeter is the CGS unit of volume.:How much there is of something that you can measure; the total amount or number._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Milliliter Quantity Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2553154</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28254:C25256</PreferredName>
        <Version>1</Version>
        <LongName>Milliliter Quantity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28254</PREFERRED_NAME>
            <LONG_NAME>Milliliter</LONG_NAME>
            <CON_ID>2204829</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Milliliter Quantity Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Milliliter Quantity Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2553133</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812526</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2661745</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_caArray</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000636</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2680967</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000633</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QuantityInMilliliter:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.QuantityInMilliliter.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1088">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2555536</PUBLICID>
    <LONGNAME>Test Clinical Study Schedule Indicator java.lang.Boolean</LONGNAME>
    <PREFERREDNAME>2555463v1.0:2178538v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, mechanism of human diseases, therapy, clinical trials, epidemiology, behavior and health services research.:An ordered list of times at which things are planned to occur.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether or not certain stated circumstances exist or criteria are satisfied._Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2555463</PublicId>
      <PreferredName>2543047v1.0:2555349v1.0</PreferredName>
      <PreferredDefinition>A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, mechanism of human diseases, therapy, clinical trials, epidemiology, behavior and health services research.:An ordered list of times at which things are planned to occur.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether or not certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Test Clinical Study Schedule Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2555349</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15206:C25211:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Study Schedule Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25211</PREFERRED_NAME>
            <LONG_NAME>Schedule</LONG_NAME>
            <CON_ID>2203792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178538</PublicId>
      <PreferredName>java.lang.Boolean</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PreferredDefinition>
      <LongName>java.lang.Boolean</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Boolean</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Test Clinical Study Schedule Indicator java.lang.Boolean does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Test Clinical Study Schedule Indicator java.lang.Boolean does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2555333</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trials Lab Model</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.labhub.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000317</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.labhub.domain.LabTest.studyScheduledIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LabTest:studyScheduledIndicator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.labhub.domain.LaboratoryTest.studyScheduledIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LaboratoryTest:studyScheduledIndicator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1089">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2593047</PUBLICID>
    <LONGNAME>Person Other Premalignant Non-Melanomatous Lesion Specify</LONGNAME>
    <PREFERREDNAME>OTX_NMSC_PRECA_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>Description of nonmelanoma or precancerous lesion(s)not previously identified.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2593039</PublicId>
      <PreferredName>OTX_NMSC_PRECA_LES</PreferredName>
      <PreferredDefinition>Nonmelanoma and precancerous lesions in addition to those already identified.</PreferredDefinition>
      <LongName>Person Other Premalignant Non-Melanomatous Lesion</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2593037</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25624:C36114:C3824</PreferredName>
        <Version>1</Version>
        <LongName>Other Premalignant Non-Melanomatous Lesion Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25624</PREFERRED_NAME>
            <LONG_NAME>Premalignant</LONG_NAME>
            <CON_ID>2202704</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C36114</PREFERRED_NAME>
            <LONG_NAME>Non-Melanomatous Lesion</LONG_NAME>
            <CON_ID>2593036</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2593045</PublicId>
      <PreferredName>OTX_LES_SPEC</PreferredName>
      <PreferredDefinition>Text terms to denote an area of abnormal tissue change that is not otherwise identifed.</PreferredDefinition>
      <LongName>Other Lesion Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2593044</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C3824:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Lesion Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812205</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AZCC 0210</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812575</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Arizona New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1090">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2594843</PUBLICID>
    <LONGNAME>Acute Leukemia Diseases and Disorders Allogeneic Hematopoietic Stem Cell Transplantation Performed Present Specify</LONGNAME>
    <PREFERREDNAME>AL_DZ_HSC_PE_PR_SPE</PREFERREDNAME>
    <PREFERREDDEFINITION>the free-text field to specify the type of acute leukemia, in which the involved cell shows little or no differentiation, usually consisting of blast cells, identified as the primary abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person specified as the reason for a clinical treatment in which HSC capable of reconstituting the immune system and blood production (hematopoiesis) are transferred from one genetically dissimilar individual to another.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Transplant CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2593600</PublicId>
      <PreferredName>AL_DZ_HSCT_PER_PRES</PreferredName>
      <PreferredDefinition>information related to acute leukemia, in which the involved cell shows little or no differentiation, usually consisting of blast cells, as the primary abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person specified as the reason for a clinical treatment in which HSC capable of reconstituting the immune system and blood production (hematopoiesis) are transferred from one genetically dissimilar individual to another.</PreferredDefinition>
      <LongName>Acute Leukemia Diseases and Disorders Allogeneic Hematopoietic Stem Cell Transplantation Performed Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2593598</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9300:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Acute Leukemia Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9300</PREFERRED_NAME>
            <LONG_NAME>Acute Leukemia</LONG_NAME>
            <CON_ID>2466873</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2593589</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C46089:C38000:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Allogeneic Hematopoietic Stem Cell Transplantation Performed Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C46089</PREFERRED_NAME>
            <LONG_NAME>Allogeneic Hematopoietic Stem Cell Transplantation</LONG_NAME>
            <CON_ID>2528308</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018432</PublicId>
      <PreferredName>DX_SPEC</PreferredName>
      <PreferredDefinition>the specified free-text field related to an aspect of patient/participant&#39;s diagnosis</PreferredDefinition>
      <LongName>Diagnosis Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other Acute Leukemia, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other Acute Leukemia, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1091">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2595958</PUBLICID>
    <LONGNAME>Periodontal Scaling and Root Planing Periodontal Treatment Left Maxilla Performed Year Date</LONGNAME>
    <PREFERREDNAME>PSARP_PT_LMA_PER_YD</PREFERREDNAME>
    <PREFERREDDEFINITION>the year date of the treatment to the gums, soft tissues, and bones that support the teeth with instrumentation of the crown and root surfaces of a tooth to remove plaque and calculus from these surfaces in the left upper jaw.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2595922</PublicId>
      <PreferredName>PSARP_PERTX_LMA_PERF</PreferredName>
      <PreferredDefinition>information related to treatment of the gums, soft tissues, and bones that support the teeth with instrumentation of the crown and root surfaces of a tooth to remove plaque and calculus from these surfaces in the left upper jaw.</PreferredDefinition>
      <LongName>Periodontal Scaling and Root Planing Periodontal Treatment Left Maxilla Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2595903</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63714:C63747</PreferredName>
        <Version>1</Version>
        <LongName>Periodontal Scaling and Root Planing Periodontal Treatment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63714</PREFERRED_NAME>
            <LONG_NAME>Periodontal Scaling and Root Planing</LONG_NAME>
            <CON_ID>2547870</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63747</PREFERRED_NAME>
            <LONG_NAME>Periodontal Treatment</LONG_NAME>
            <CON_ID>2547897</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2595920</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25229:C26470:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Left Maxilla Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25229</PREFERRED_NAME>
            <LONG_NAME>Left</LONG_NAME>
            <CON_ID>2204810</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26470</PREFERRED_NAME>
            <LONG_NAME>Maxilla</LONG_NAME>
            <CON_ID>2202586</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2195353</PublicId>
      <PreferredName>YR_DT</PreferredName>
      <PreferredDefinition>the numeric representation of the calendar year. </PreferredDefinition>
      <LongName>Year Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY</DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208026</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29848:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Year Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29848</PREFERRED_NAME>
            <LONG_NAME>Year</LONG_NAME>
            <CON_ID>2203986</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Year</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Year</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnostic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812084</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1092">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2596590</PUBLICID>
    <LONGNAME>Orthodontic Treatment Patient Self-Report Prior Osteonecrosis of Jaw Performed Yes No Unknown Indicator</LONGNAME>
    <PREFERREDNAME>OT_PSR_P_PNJ_P_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no/unknown indicator related to dental treatment to correct malocclusions of the teeth and their surrounding structures prior to self-reported area of necrotic bone in the mandible or maxilla.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2589975</PublicId>
      <PreferredName>O_TX_PSR_P_ONJ_PERF</PreferredName>
      <PreferredDefinition>information related to dental treatment to correct malocclusions of the teeth and their surrounding structures prior to self-reported area of necrotic bone in the mandible or maxilla.</PreferredDefinition>
      <LongName>Orthodontic Treatment Patient Self-Report Prior Osteonecrosis of Jaw Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2589973</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C64248</PreferredName>
        <Version>1</Version>
        <LongName>Orthodontic Treatment
</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64248</PREFERRED_NAME>
            <LONG_NAME>Orthodontic Treatment</LONG_NAME>
            <CON_ID>2558017</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2589929</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21089:C25629:C63924:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Patient Self-Report Prior Osteonecrosis of Jaw Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21089</PREFERRED_NAME>
            <LONG_NAME>Patient Self-Report</LONG_NAME>
            <CON_ID>2234887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63924</PREFERRED_NAME>
            <LONG_NAME>Osteonecrosis of Jaw</LONG_NAME>
            <CON_ID>2549643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Since the year 2000, did you</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Since the year 2000, did you have any of your teeth straightened by orthodontic treatment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Since the year 2000, did you have any of your teeth straightened by orthodontic treatment before the bone became exposed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnostic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812084</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4442461</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDCR CDEs with Retired VDs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDEs for Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4442571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1093">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2596677</PUBLICID>
    <LONGNAME>White Phosphorus Exposure Text</LONGNAME>
    <PREFERREDNAME>W_PHOS_EXPO_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>free text field to specify exposure to the element phosphorus in its allotropic form, a soft, waxy, poisonous solid melting at 44.5 degrees C; soluble in carbon disulfide, insoluble in water and alcohol; self-igniting in air.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2590849</PublicId>
      <PreferredName>W_PHOS_EXPO</PreferredName>
      <PreferredDefinition>information related to exposure to the element phosphorus in its allotropic form, a soft, waxy, poisonous solid melting at 44.5 degrees C; soluble in carbon disulfide, insoluble in water and alcohol; self-igniting in air.</PreferredDefinition>
      <LongName>White Phosphorus Exposure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2590847</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63731</PreferredName>
        <Version>1</Version>
        <LongName>White Phosphorus</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63731</PREFERRED_NAME>
            <LONG_NAME>White Phosphorus</LONG_NAME>
            <CON_ID>2547876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2413363</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17941</PreferredName>
        <Version>1</Version>
        <LongName>Exposure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17941</PREFERRED_NAME>
            <LONG_NAME>Exposure</LONG_NAME>
            <CON_ID>2203924</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018321</PublicId>
      <PreferredName>ASSESS_TXT</PreferredName>
      <PreferredDefinition>a free text field to specify information on the evaluations of the patient and the patient&#39;s disease</PreferredDefinition>
      <LongName>Assessment Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184342</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Text</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Could you please describe how</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Could you please describe how you were exposed to white phosphor</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnostic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812084</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1094">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2608161</PUBLICID>
    <LONGNAME>Observation Relationship Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2607786v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Watching something and taking note of what happens.:A state of connectedness between people, objects, or events; to be associated or connected with something._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2607786</PublicId>
      <PreferredName>2607688v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Watching something and taking note of what happens.:A state of connectedness between people, objects, or events; to be associated or connected with something._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Observation Relationship Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2607688</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25598:C25648</PreferredName>
        <Version>1</Version>
        <LongName>Observation Relationship</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Observation Relationship Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Observation Relationship Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ObservationRelationship:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.ObservationRelationship.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1095">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2608337</PUBLICID>
    <LONGNAME>Organization Street Address java.lang.String</LONGNAME>
    <PREFERREDNAME>2607958v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A formal group of people with one or more shared goals._A component of an address consisting of the house number and street name._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2607958</PublicId>
      <PreferredName>2407006v1.0:2224075v1.0</PreferredName>
      <PreferredDefinition>A formal group of people with one or more shared goals._A component of an address consisting of the house number and street name.</PreferredDefinition>
      <LongName>Organization Street Address</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2407006</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19711</PreferredName>
        <Version>1</Version>
        <LongName>Organization</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19711</PREFERRED_NAME>
            <LONG_NAME>Professional Organization or Group</LONG_NAME>
            <CON_ID>2202773</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2224075</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25690</PreferredName>
        <Version>1</Version>
        <LongName>Street Address</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25690</PREFERRED_NAME>
            <LONG_NAME>Street Address</LONG_NAME>
            <CON_ID>2203802</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Organization Street Address java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Organization Street Address java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.Organization.streetAddress</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Organization:streetAddress</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1096">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2608372</PUBLICID>
    <LONGNAME>Surgical Procedure Begin Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2607990v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Used for operative procedures on organs, regions, or tissues in the treatment of diseases, including tissue section by lasers. It excludes transplantation, for which &quot;transplantation&quot; is used._Have a beginning, in a temporal, spatial, or evaluative sense.:a particular day specified as the time something has, or will, happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2607990</PublicId>
      <PreferredName>2322305v1.0:2207412v1.0</PreferredName>
      <PreferredDefinition>Used for operative procedures on organs, regions, or tissues in the treatment of diseases, including tissue section by lasers. It excludes transplantation, for which &quot;transplantation&quot; is used._Have a beginning, in a temporal, spatial, or evaluative sense.:a particular day specified as the time something has, or will, happen.</PreferredDefinition>
      <LongName>Surgical Procedure Begin Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2322305</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207412</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Begin Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Surgical Procedure Begin Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Surgical Procedure Begin Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.duke.cabig.tumorregistry.domain.Surgery.startDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Surgery:startDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.Surgery.startDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1097">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2608428</PUBLICID>
    <LONGNAME>Histopathology Reporting Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2608043v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.  -- 2004_The act of providing a short account.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2608043</PublicId>
      <PreferredName>2223325v1.0:2607673v1.0</PreferredName>
      <PreferredDefinition>The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.  -- 2004_The act of providing a short account.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Histopathology Reporting Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223325</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18190</PreferredName>
        <Version>1</Version>
        <LongName>Histopathology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18190</PREFERRED_NAME>
            <LONG_NAME>Histopathologic Examination</LONG_NAME>
            <CON_ID>2223204</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607673</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25651:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Reporting Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25651</PREFERRED_NAME>
            <LONG_NAME>Reporting</LONG_NAME>
            <CON_ID>2206359</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Histopathology Reporting Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Histopathology Reporting Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2724612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTODS</PreferredName>
          <Version>0.53</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ctom.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.Histopathology.reportingDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Histopathology:reportingDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1098">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2608429</PUBLICID>
    <LONGNAME>Histopathology Status Code java.lang.String</LONGNAME>
    <PREFERREDNAME>2608044v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.  -- 2004_A condition or state at a particular time.:A system, often of numbered categories, for representation of data._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2608044</PublicId>
      <PreferredName>2223325v1.0:2607549v1.0</PreferredName>
      <PreferredDefinition>The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.  -- 2004_A condition or state at a particular time.:A system, often of numbered categories, for representation of data.</PreferredDefinition>
      <LongName>Histopathology Status Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223325</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18190</PreferredName>
        <Version>1</Version>
        <LongName>Histopathology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18190</PREFERRED_NAME>
            <LONG_NAME>Histopathologic Examination</LONG_NAME>
            <CON_ID>2223204</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607549</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Status Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Histopathology Status Code java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Histopathology Status Code java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2724612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTODS</PreferredName>
          <Version>0.53</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ctom.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Histopathology:statusCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.Histopathology.statusCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1099">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2613350</PUBLICID>
    <LONGNAME>Enzyme Induction Created By java.lang.String</LONGNAME>
    <PREFERREDNAME>2612701v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Enzyme Induction involves initiation of function of a biological molecule (usually protein, RNA, or DNA) that possesses catalytic activity._Indicates the person or authoritative body who brought the item into existence._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2612701</PublicId>
      <PreferredName>2612299v1.0:2231611v1.0</PreferredName>
      <PreferredDefinition>Enzyme Induction involves initiation of function of a biological molecule (usually protein, RNA, or DNA) that possesses catalytic activity._Indicates the person or authoritative body who brought the item into existence.</PreferredDefinition>
      <LongName>Enzyme Induction Created By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2612299</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41564</PreferredName>
        <Version>1</Version>
        <LongName>Enzyme Induction</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41564</PREFERRED_NAME>
            <LONG_NAME>Enzyme Induction</LONG_NAME>
            <CON_ID>2612137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42628</PreferredName>
        <Version>1</Version>
        <LongName>Created By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42628</PREFERRED_NAME>
            <LONG_NAME>Created By</LONG_NAME>
            <CON_ID>2231551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Enzyme Induction Created By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Enzyme Induction Created By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2915522</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caNanoLab</PreferredName>
          <Version>1.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cananolab.domain.characterization.invitro</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2915883</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calab.domain.nano.characterization.invitro.EnzymeInduction.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EnzymeInduction:createdBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.particle.characterization.invitro.EnzymeInduction.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.characterization.invitro.EnzymeInduction.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1100">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2614418</PUBLICID>
    <LONGNAME>Non-Protocol Therapeutic Procedure Biphosphonate Administered Specify</LONGNAME>
    <PREFERREDNAME>NPROT_TX_BI_ADM_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free-text field to specify name or type of biphosphonate, family of drugs used to treat osteoporosis and the bone pain caused by some types of cancer, not specified by the protocol guidelines administered to produce an effect that is intended to alter the course of a pathologic process.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2614417</PublicId>
      <PreferredName>NPROT_TX_BIPHOS_ADM</PreferredName>
      <PreferredDefinition>information related to the administration of biphosphonates, family of drugs used to treat osteoporosis and the bone pain caused by some types of cancer, not specified by the protocol guidelines to produce an effect that is intended to alter the course of a pathologic process.</PreferredDefinition>
      <LongName>Non-Protocol Therapeutic Procedure Biphosphonate Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2614414</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25590:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Non-Protocol Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25590</PREFERRED_NAME>
            <LONG_NAME>Non-Protocol</LONG_NAME>
            <CON_ID>2206325</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2614415</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C443:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Biphosphonate Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C443</PREFERRED_NAME>
            <LONG_NAME>Biphosphonate</LONG_NAME>
            <CON_ID>2202878</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018810</PublicId>
      <PreferredName>TX_SPEC</PreferredName>
      <PreferredDefinition>the free text field related to therapy.</PreferredDefinition>
      <LongName>Therapies Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Non-protocol bisphosphonate therapy, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1101">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2637757</PUBLICID>
    <LONGNAME>Liver Clinical Diagnosis Involvement Reason</LONGNAME>
    <PREFERREDNAME>L_CLINDX_INVL_RSN</PREFERREDNAME>
    <PREFERREDDEFINITION>the reason or cause for the diagnosis of abnormalities or involvement of the liver, a large organ located in the upper abdomen that cleanses the blood and aids in digestion by secreting bile, made from a study of the signs and symptoms of a disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Transplant CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2637754</PublicId>
      <PreferredName>L_CLINDX_INVLT</PreferredName>
      <PreferredDefinition>information related to diagnosis of abnormalities or involvement of the liver, a large organ located in the upper abdomen that cleanses the blood and aids in digestion by secreting bile, made from a study of the signs and symptoms of a disease.</PreferredDefinition>
      <LongName>Liver Clinical Diagnosis Involvement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2637752</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12392</PreferredName>
        <Version>1</Version>
        <LongName>Liver</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12392</PREFERRED_NAME>
            <LONG_NAME>Liver</LONG_NAME>
            <CON_ID>2202332</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2636898</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15607:C25548</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Diagnosis Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15607</PREFERRED_NAME>
            <LONG_NAME>Clinical Diagnosis</LONG_NAME>
            <CON_ID>2513256</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2636868</PublicId>
      <PreferredName>SKIN_INVLT_RSN</PreferredName>
      <PreferredDefinition>the explanation of the cause of involvement of the skin.</PreferredDefinition>
      <LongName>Skin Involvement Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>45</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2240632</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GVHD</VALIDVALUE>
          <VALUEMEANING>Graft Versus Host Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2636869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infection</VALIDVALUE>
          <VALUEMEANING>Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>general term for invasion and growth of microorganisms in bodily tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0021311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Conditioning regimen toxicity</VALIDVALUE>
          <VALUEMEANING>Transplant Conditioning Toxicity</VALUEMEANING>
          <MEANINGDESCRIPTION>Administration of high doses of chemotherapy or radiation therapy, as well as immunosuppressive therapy,
to a transplant.: Toxicity; the degree to which something is poisonous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27990, C64468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2636870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Drug reaction</VALIDVALUE>
          <VALUEMEANING>drug reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>drug reaction</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2633497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Liver abnormalities (clinical</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Liver abnormalities (clinical judgement)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1102">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2641823</PUBLICID>
    <LONGNAME>Object Property Value Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2640445v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A named data value associated with an object.:The information contained in a data field; may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state depending on the nature of the attribute._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2640445</PublicId>
      <PreferredName>2640416v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A named data value associated with an object.:The information contained in a data field; may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state depending on the nature of the attribute._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Object Property Value Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2640416</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62498:C49100</PreferredName>
        <Version>1</Version>
        <LongName>Object Property Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62498</PREFERRED_NAME>
            <LONG_NAME>Computer Programming Object Property</LONG_NAME>
            <CON_ID>2640374</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49100</PREFERRED_NAME>
            <LONG_NAME>Data Value</LONG_NAME>
            <CON_ID>2463853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Object Property Value Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Object Property Value Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2640373</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LabKey CPAS Client API</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.labkey.cpas.client</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.labkey.cpas.client.PropertyValue.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PropertyValue:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1103">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2646327</PUBLICID>
    <LONGNAME>Adjuvant Aromatase Inhibitor Hormone Therapy Change Specify</LONGNAME>
    <PREFERREDNAME>ADJ_AI_HORTX_CHG_SP</PREFERREDNAME>
    <PREFERREDDEFINITION>the free-text field to specify the agent that blocks the function of the enzyme aromatase with antineoplastic activity used to produce therapeutic effects by means of change in hormone levels which are given to augment or stimulate a primary therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2646325</PublicId>
      <PreferredName>ADJ_AI_HORMONTX_CHG</PreferredName>
      <PreferredDefinition>related to the change of the agent that blocks the function of the enzyme aromatase with antineoplastic activity used to produce therapeutic effects by means of change in hormone levels which are given to augment or stimulate a primary therapy.</PreferredDefinition>
      <LongName>Adjuvant Aromatase Inhibitor Hormone Therapy Change</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2646323</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2140:C1740:C15445</PreferredName>
        <Version>1</Version>
        <LongName>Adjuvant Aromatase Inhibitor Hormone Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2140</PREFERRED_NAME>
            <LONG_NAME>Adjuvant</LONG_NAME>
            <CON_ID>2204993</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1740</PREFERRED_NAME>
            <LONG_NAME>Aromatase Inhibitor</LONG_NAME>
            <CON_ID>2221301</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15445</PREFERRED_NAME>
            <LONG_NAME>Hormone Therapy</LONG_NAME>
            <CON_ID>2202373</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446</PreferredName>
        <Version>1</Version>
        <LongName>Change</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018810</PublicId>
      <PreferredName>TX_SPEC</PreferredName>
      <PreferredDefinition>the free text field related to therapy.</PreferredDefinition>
      <LongName>Therapies Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1104">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2664527</PUBLICID>
    <LONGNAME>Second Hand Smoke Cigarette Exposure Daily Number</LONGNAME>
    <PREFERREDNAME>SECHD_CIG_EXPO_D_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of cigarettes exposed to on a daily basis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2010525</PublicId>
      <PreferredName>SECHAND_SMK_EXPO</PreferredName>
      <PreferredDefinition>Exposure to smoke through sources other than self-smoking.</PreferredDefinition>
      <LongName>Second Hand Smoke Exposure</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2190202</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>second hand smoke</PreferredName>
        <Version>1</Version>
        <LongName>second hand smoke</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0872267</PREFERRED_NAME>
            <LONG_NAME>second hand smoke</LONG_NAME>
            <CON_ID>2203183</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177497</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Exposure</PreferredName>
        <Version>1</Version>
        <LongName>Exposure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17941</PREFERRED_NAME>
            <LONG_NAME>Exposure</LONG_NAME>
            <CON_ID>2203924</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2664525</PublicId>
      <PreferredName>CIG_EXPO_D_NUM</PreferredName>
      <PreferredDefinition>The number that represents how many cigarettes a person is exposed to on a daily basis.</PreferredDefinition>
      <LongName>Cigarette Exposure Daily Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2664524</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1802:C17941:C25473:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Cigarette Exposure Daily Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1802</PREFERRED_NAME>
            <LONG_NAME>Cigarette</LONG_NAME>
            <CON_ID>2202497</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17941</PREFERRED_NAME>
            <LONG_NAME>Exposure</LONG_NAME>
            <CON_ID>2203924</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25473</PREFERRED_NAME>
            <LONG_NAME>Daily</LONG_NAME>
            <CON_ID>2204015</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of Cigarettes exposed</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of Cigarettes exposed to per Day</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Myo-Inositol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812876</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Erlotinib - Lesions of Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2813064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Sulindac DFMO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2859628</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1105">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2669674</PUBLICID>
    <LONGNAME>Time Series Image Data Maximum Time java.lang.Double</LONGNAME>
    <PREFERREDNAME>2669519v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The continuum of experience in which events pass from the future through the present to the past; a specific point in this continuum or the interval separating two points.:A group or succession of objects, substances, or events arranged in regular order in space or time, connected by a like relation, or forming a kind of chain.:Any record of an imaging event whether physical or electronic.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._The largest possible quantity or degree.:The continuum of experience in which events pass from the future through the present to the past; a specific point in this continuum or the interval separating two points._Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2669519</PublicId>
      <PreferredName>2669392v1.0:2669369v1.0</PreferredName>
      <PreferredDefinition>The continuum of experience in which events pass from the future through the present to the past; a specific point in this continuum or the interval separating two points.:A group or succession of objects, substances, or events arranged in regular order in space or time, connected by a like relation, or forming a kind of chain.:Any record of an imaging event whether physical or electronic.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._The largest possible quantity or degree.:The continuum of experience in which events pass from the future through the present to the past; a specific point in this continuum or the interval separating two points.</PreferredDefinition>
      <LongName>Time Series Image Data Maximum Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2669392</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25207:C25674:C48179:C25474</PreferredName>
        <Version>1</Version>
        <LongName>Time Series Image Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25674</PREFERRED_NAME>
            <LONG_NAME>Series</LONG_NAME>
            <CON_ID>2202620</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2669369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25564:C25207</PreferredName>
        <Version>1</Version>
        <LongName>Maximum Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25564</PREFERRED_NAME>
            <LONG_NAME>Maximum</LONG_NAME>
            <CON_ID>2202550</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Time Series Image Data Maximum Time java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Time Series Image Data Maximum Time java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614836</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Generic Image</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ivi.genericimage</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ivi.genericimage.TimeSeries.maximumT</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TimeSeries:maximumT</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1106">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2678533</PUBLICID>
    <LONGNAME>Single Nucleotide Polymorphism Microarray Experiment Nucleic Acid Hybridization Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2678290v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.:A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena._Technique in which single stranded nucleic acids are allowed to interact so that complexes, or hybrids, are formed by molecules with sufficiently similar, complementary sequences. By this means the degree of sequence identity can be assessed and specific sequences detected. (From Biology-online):The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2678290</PublicId>
      <PreferredName>2678108v1.0:2678049v1.0</PreferredName>
      <PreferredDefinition>A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.:A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena._Technique in which single stranded nucleic acids are allowed to interact so that complexes, or hybrids, are formed by molecules with sufficiently similar, complementary sequences. By this means the degree of sequence identity can be assessed and specific sequences detected. (From Biology-online):The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Single Nucleotide Polymorphism Microarray Experiment Nucleic Acid Hybridization Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2678108</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18279:C44282:C42790</PreferredName>
        <Version>1</Version>
        <LongName>Single Nucleotide Polymorphism Microarray Experiment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18279</PREFERRED_NAME>
            <LONG_NAME>Single Nucleotide Polymorphism</LONG_NAME>
            <CON_ID>2433334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44282</PREFERRED_NAME>
            <LONG_NAME>Microarray</LONG_NAME>
            <CON_ID>2223237</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42790</PREFERRED_NAME>
            <LONG_NAME>Experiment</LONG_NAME>
            <CON_ID>2223979</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2678049</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16924:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Nucleic Acid Hybridization Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16924</PREFERRED_NAME>
            <LONG_NAME>Nucleic Acid Hybridization</LONG_NAME>
            <CON_ID>2236551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Single Nucleotide Polymorphism Microarray Experiment Nucleic Acid Hybridization Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Single Nucleotide Polymorphism Microarray Experiment Nucleic Acid Hybridization Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2677906</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CoCaNUT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.princeton.cocanut.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.princeton.cocanut.domain.SnpArrayExperiment.hybridizationDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SnpArrayExperiment:hybridizationDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1107">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2678540</PUBLICID>
    <LONGNAME>Family Medical History Amsterdam Criteria I java.lang.String</LONGNAME>
    <PREFERREDNAME>2678297v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A record of a patient&#39;s background regarding health and disease events of blood relatives.  A patients family medical history may be important in diagnosing existing conditions. (NCI)_Research criteria established for defining Hereditary Non-Polyposis Colorectal Cancer (HNPCC) families as established by the International Collaborative Group (ICG) meeting in Amsterdam in 1990: 1. One member diagnosed with colorectal cancer before age 50; 2. Two affected generations; 3. Three affected relatives, 1 of them a first-degree relative of the other 2; 4. Familial adenomatous polyposis should be excluded; 5. Tumors should be verified by pathological examination._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2678297</PublicId>
      <PreferredName>2678109v1.0:2678053v1.0</PreferredName>
      <PreferredDefinition>A record of a patient&#39;s background regarding health and disease events of blood relatives.  A patients family medical history may be important in diagnosing existing conditions. (NCI)_Research criteria established for defining Hereditary Non-Polyposis Colorectal Cancer (HNPCC) families as established by the International Collaborative Group (ICG) meeting in Amsterdam in 1990: 1. One member diagnosed with colorectal cancer before age 50; 2. Two affected generations; 3. Three affected relatives, 1 of them a first-degree relative of the other 2; 4. Familial adenomatous polyposis should be excluded; 5. Tumors should be verified by pathological examination.</PreferredDefinition>
      <LongName>Family Medical History Amsterdam Criteria I</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2678109</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17726</PreferredName>
        <Version>1</Version>
        <LongName>Family Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17726</PREFERRED_NAME>
            <LONG_NAME>Family Medical History</LONG_NAME>
            <CON_ID>2202638</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2678053</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C46069</PreferredName>
        <Version>1</Version>
        <LongName>Amsterdam Criteria I</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C46069</PREFERRED_NAME>
            <LONG_NAME>Amsterdam Criteria</LONG_NAME>
            <CON_ID>2677940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Family Medical History Amsterdam Criteria I java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Family Medical History Amsterdam Criteria I java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2677906</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CoCaNUT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.princeton.cocanut.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.princeton.cocanut.domain.FamilyHistory.hnpccA1</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FamilyHistory:hnpccA1</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1108">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2682366</PUBLICID>
    <LONGNAME>Patient Additional History 10240 Character Text</LONGNAME>
    <PREFERREDNAME>PT_ADD_HIST_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>A character string for one or more paragraphs which may include the Graphic Character set and some Control Characters to describe additional information about the patient&#39;s medical history.  [Standard-based]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DICOM:Digital Imaging and Communications in Medicine</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2682362</PublicId>
      <PreferredName>PT_ADDL_HISTORY</PreferredName>
      <PreferredDefinition>Additional information about the patient&#39;s medical history.</PreferredDefinition>
      <LongName>Patient Additional History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2682360</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25406:C54625</PreferredName>
        <Version>1</Version>
        <LongName>Additional History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25406</PREFERRED_NAME>
            <LONG_NAME>Additional</LONG_NAME>
            <CON_ID>2206153</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54625</PREFERRED_NAME>
            <LONG_NAME>History</LONG_NAME>
            <CON_ID>2519676</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2584118</PublicId>
      <PreferredName>10240_CHAR_TXT</PreferredName>
      <PreferredDefinition>LT: A character string for one or more paragraphs with leading spaces significant; trailing spaces being non-significant.   It may contain the Graphic Character set and some Control Characters.   [Standard-based]</PreferredDefinition>
      <LongName>10240 Character Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>10240</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
      <Representation>
        <PublicId>2637360</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45253:C25704</PreferredName>
        <Version>1</Version>
        <LongName>String Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45253</PREFERRED_NAME>
            <LONG_NAME>String</LONG_NAME>
            <CON_ID>2539471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Additional Patient History</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Additional Patient History</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180933</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>LIDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rider Project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812022</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DICOM Tag CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812790</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614826</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DICOM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review - NCIA DICOM CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812828</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614828</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA Collection</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RIDER</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812771</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>(0010,21B0)</AlternateName>
        <AlternateNameType>DICOM_TAG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Additional Patient History </AlternateName>
        <AlternateNameType>DICOM Attribute Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1109">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2685098</PUBLICID>
    <LONGNAME>Other Acute Leukemia Transplantation Time Status Acute Leukemia Status</LONGNAME>
    <PREFERREDNAME>OTR_ALEUK_TRN_STATUS</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the other acute leukemia disease status at the time of transplantation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2685096</PublicId>
      <PreferredName>OTR_ALEUK_TRN_STAT</PreferredName>
      <PreferredDefinition>Not otherwise specified._A clonal (malignant) hematopoietic disorder affecting the bone marrow and the peripheral blood.  The malignant cells show minimal differentiation and are called blasts, either myeloid blasts (myeloblasts) or lymphoid blasts (lymphoblasts).  According to the type of blasts present, acute leukemias are classified as acute myeloid leukemia (AML) and precursor lymphoblastic or acute lymphoblastic leukemia (ALL)._The grafting of tissues from one individual to another or place to place within a single individual._The continuum of experience in which events pass from the future through the present to the past._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Other Acute Leukemia Transplantation Time Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2674135</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C9300</PreferredName>
        <Version>1</Version>
        <LongName>Other Acute Leukemia</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9300</PREFERRED_NAME>
            <LONG_NAME>Acute Leukemia</LONG_NAME>
            <CON_ID>2466873</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2674595</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15342:C25207:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Transplantation Time Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2685085</PublicId>
      <PreferredName>ALEUK_STAT</PreferredName>
      <PreferredDefinition>A clonal (malignant) hematopoietic disorder affecting the bone marrow and the peripheral blood.  The malignant cells show minimal differentiation and are called blasts, either myeloid blasts (myeloblasts) or lymphoid blasts (lymphoblasts).  According to the type of blasts present, acute leukemias are classified as acute myeloid leukemia (AML) and precursor lymphoblastic or acute lymphoblastic leukemia (ALL)._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Acute Leukemia Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>31</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2685084</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9300:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Acute Leukemia Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9300</PREFERRED_NAME>
            <LONG_NAME>Acute Leukemia</LONG_NAME>
            <CON_ID>2466873</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Relapse</VALIDVALUE>
          <VALUEMEANING>RECURRENT DISEASE</VALUEMEANING>
          <MEANINGDESCRIPTION>Recurrent disease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complete Remission</VALIDVALUE>
          <VALUEMEANING>Complete Remission</VALUEMEANING>
          <MEANINGDESCRIPTION>The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Primary Induction Failure (PIF)</VALIDVALUE>
          <VALUEMEANING>primary induction failure</VALUEMEANING>
          <MEANINGDESCRIPTION>primary induction failure</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-10-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2626147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never treated</VALIDVALUE>
          <VALUEMEANING>Never Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2685077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the status of the ot</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the status of the other acute leukemia at the time of transplantation?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2685098</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedDiagnosis.diseaseStatusCode WHERE PerformedDiagnosis.value(ANY=&gt;CD).originalText = {other acute leukemia} AND PerformedDiagnosis.value(ANY=&gt;CD).nullFlavor = &quot;OTH&quot; AND PerformedDiagnosis &gt; PerformedObservation.dateRange IS LESS THAN OR EQUAL TO PerformedSubstanceAdministration.dateRange AND PerformedSubstanceAdministration &gt; DefinedSubstanceAdministration.nameCode = &quot;Administer Hematopoietic Cell Product{ Transplantation}&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>pre_ted_oal_status_hsct</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedDiagnosis:diseaseStatusCode </AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1110">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2688111</PUBLICID>
    <LONGNAME>Stage Prognostic Factor 1977 Summary Stage Code</LONGNAME>
    <PREFERREDNAME>2688106v1.0:2647784v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Code for summary stage at the initial diagnosis or treatment of the reportable tumor.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2688106</PublicId>
      <PreferredName>2688190v1.0:2688116v1.0</PreferredName>
      <PreferredDefinition>Summary stage at the initial diagnosis or treatment of the reportable tumor.</PreferredDefinition>
      <LongName>Stage Prognostic Factor 1977 Summary Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20047</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic or Prognostic Factor</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2688190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16899:C18959</PreferredName>
        <Version>1</Version>
        <LongName>Stage Prognostic Factor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18959</PREFERRED_NAME>
            <LONG_NAME>Prognostic Factor</LONG_NAME>
            <CON_ID>2512696</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2688116</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45255::1977:C42581:C16899</PreferredName>
        <Version>1</Version>
        <LongName>Integer::1977 Summary Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::1977</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42581</PREFERRED_NAME>
            <LONG_NAME>Summary</LONG_NAME>
            <CON_ID>2203701</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2647784</PublicId>
      <PreferredName>2647784v1.0</PreferredName>
      <PreferredDefinition>A shortened version of a speech or written text, containing only the main points; a summary._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Summary Stage Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
      <Representation>
        <PublicId>2646213</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42581:C16899:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Summary Stage Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42581</PREFERRED_NAME>
            <LONG_NAME>Summary</LONG_NAME>
            <CON_ID>2203701</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>In situ</VALUEMEANING>
          <MEANINGDESCRIPTION>in the natural or normal place, confined to the site of origin without invasion of neighboring tissues. (On-line Medical Dictionary)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Localized</VALUEMEANING>
          <MEANINGDESCRIPTION>Localized</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Distant</VALUEMEANING>
          <MEANINGDESCRIPTION>Situated farthest from a point of attachment or origin, as of a limb or bone; or directed away from the midline of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570251</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Regional, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: Regional; limited to a particular location or area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25643, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2647785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Regional, direct extension only</VALUEMEANING>
          <MEANINGDESCRIPTION>As an immediate result; having nothing intervening; without deviation or interruption.: Extension; an addition to the length of something.: Regional; limited to a particular location or area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25643, C25270, C62254</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2876241</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Regional, direct extension and regional lymph nodes</VALUEMEANING>
          <MEANINGDESCRIPTION>As an immediate result; having nothing intervening; without deviation or interruption.: To increase in length or duration.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Regional; limited to a particular location or area.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.: Regional; limited to a particular location or area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25643, C12745, C25643, C37912, C25270, C62254</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2876242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Regional, regional lymph nodes only</VALUEMEANING>
          <MEANINGDESCRIPTION>A rounded mass of lymphatic tissue that is surrounded by a capsule of connective tissue. Lymph glands filter lymph (lymphatic fluid), and they store lymphocytes (white blood cells). They are located along lymphatic vessels. Also called a lymph node.: Regional; limited to a particular location or area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25643, C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2876243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Unstaged</VALUEMEANING>
          <MEANINGDESCRIPTION>Unstaged</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2646215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination that a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SEER Summary Stage 1977</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>SEER Summary Stage 1977</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR, V 11.1 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.1 Data Standards and Data Dictionary (5/4/06)</DocumentText>
        <URL>http://www.naaccr.org/filesystem/pdf/Volume%20II%20Version%2011.1.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SEER Summary 1977 Description</Name>
        <DocumentType>VALID_VALUE_SOURCE</DocumentType>
        <DocumentText>This has traditionally been used by central registries to monitor time trends. For hospital registries, COC requires its use in the absence of a defined AJCC classification. For site-specific definitions of categories, see the SEER Summary Staging Guide. SEER Summary Stage 1977 is limited to information available within 2 months of the date of diagnosis. NAACCR approved extension of this time period to 4 months for prostate tumors diagnosed beginning January 1, 1995.</DocumentText>
        <URL>http://seer.cancer.gov/manuals/historic/ssm_1977.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.2 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.2 Data Standards and Data Dictionary (5/30/2007)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=PQdlAnykU1U%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.3 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.3 Data Standards and Data Dictionary (4/2008)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=xSH32ZzIzGI%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 12.1, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&amp;tabid=133&amp;mid=473</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 16, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)</DocumentText>
        <URL>https://www.naaccr.org/data-standards-data-dictionary/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 12.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3134707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899833</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>StageProgFactors16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899845</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464305</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>StageProgFactors18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464319</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>760</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>General Summary Stage (SEER/CoC)</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SEER SUMMARY STAGE 1977</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SEER Summary Stage 1977</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1111">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2693184</PUBLICID>
    <LONGNAME>Preoperative Radiation Therapy Administered Begin Date</LONGNAME>
    <PREFERREDNAME>PREOP_RT_ADM_B_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date radiation therapy,  treatment of a disease by means of exposure of the target or the whole body to radiation, administration began during the period immediately before a surgical procedure.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014313</PublicId>
      <PreferredName>PREOP_RT_ADM</PreferredName>
      <PreferredDefinition>information related to radiation therapy,  treatment of a disease by means of exposure of the target or the whole body to radiation, being administered during the period immediately before a surgical procedure.</PreferredDefinition>
      <LongName>Preoperative Radiation Therapy Administered</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2693183</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54732:C15313</PreferredName>
        <Version>1</Version>
        <LongName>Preoperative Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54732</PREFERRED_NAME>
            <LONG_NAME>Preoperative</LONG_NAME>
            <CON_ID>2512567</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188673</PublicId>
      <PreferredName>BEG_DT</PreferredName>
      <PreferredDefinition>The date on which an observation or an event began.</PreferredDefinition>
      <LongName>Begin Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yyyy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Begin Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pre-operative RT begin date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1112">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2693227</PUBLICID>
    <LONGNAME>Treatment First Course Biological Response Modifier Administered Number Code</LONGNAME>
    <PREFERREDNAME>2693225v1.0:2652781v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Records whether immunotherapeutic (biologic response modifiers) agents were administered as first-course treatment at all facilities or the reason they were not given.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2693225</PublicId>
      <PreferredName>2691043v1.0:2693223v1.0</PreferredName>
      <PreferredDefinition>Records whether immunotherapeutic (biologic response modifiers) agents were administered as first-course treatment at all facilities or the reason they were not given.</PreferredDefinition>
      <LongName>Treatment First Course Biological Response Modifier Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435024</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1908</PreferredName>
        <Version>1</Version>
        <LongName>Drug or Chemical</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2691043</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236:C25509:C25379</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure First Course</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25379</PREFERRED_NAME>
            <LONG_NAME>Course</LONG_NAME>
            <CON_ID>2202898</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2693223</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C308:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Biological Response Modifier Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C308</PREFERRED_NAME>
            <LONG_NAME>Immunotherapeutic Agent</LONG_NAME>
            <CON_ID>2426121</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2652781</PublicId>
      <PreferredName>2652781v1.0</PreferredName>
      <PreferredDefinition>Substances or procedures that enhance the host&#39;s ability to inhibit tumorigenesis or tumor progression or that increase the differential between tumor and host susceptibility to therapeutic agents. Thus BRMs can be preventive (vaccines, vitamins) or therapeutic (interferon, monoclonal antibodies, hyperthermia, gene therapy.) Standard, nonspecific therapies such as drugs and radiation are excluded but radiation delivered via antibodies would be included since it exploits a differential susceptibility of tumor and host._The act of having given something (e.g., a medication or test)._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification._A system of numbered categories for representation of data. [Explanatory Comment: Refer to the FORDS and SEER Program Code Manual for additional instructions.]</PreferredDefinition>
      <LongName>Biological Response Modifier Administered Number Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435024</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1908</PreferredName>
        <Version>1</Version>
        <LongName>Drug or Chemical</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
      <Representation>
        <PublicId>2662248</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C308:C25382:C25337:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Biological Response Modifier Administered Number Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C308</PREFERRED_NAME>
            <LONG_NAME>Immunotherapeutic Agent</LONG_NAME>
            <CON_ID>2426121</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>99</VALIDVALUE>
          <VALUEMEANING>It is unknown whether an immunotherapeutic agent(s) was recommended or administered because it is not stated in patient record; death certificate-only cases.</VALUEMEANING>
          <MEANINGDESCRIPTION>It is unknown whether an immunotherapeutic agent(s) was recommended or administered because it is not stated in patient record; death certificate-only cases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2652782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>88</VALIDVALUE>
          <VALUEMEANING>Immunotherapy was recommended, but it is unknown if it was administered.</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunotherapy was recommended, but it is unknown if it was administered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2645267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>86</VALIDVALUE>
          <VALUEMEANING>Immunotherapy was not administered. It was recommended by the patient&#39;s physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunotherapy was not administered. It was recommended by the patient&#39;s physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2652784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>85</VALIDVALUE>
          <VALUEMEANING>Immunotherapy was not administered because the patient died prior to planned or recommended therapy.</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunotherapy was not administered because the patient died prior to planned or recommended therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2645270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>82</VALIDVALUE>
          <VALUEMEANING>Immunotherapy was not recommended/administered because it was contraindicated due to patient risk factors</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunotherapy was not recommended/administered because it was contraindicated due to patient risk factors (i.e., comorbid conditions, advanced age).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2652785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>01</VALIDVALUE>
          <VALUEMEANING>Immunotherapy administered as first course therapy.</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunotherapy administered as first course therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2652786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>00</VALIDVALUE>
          <VALUEMEANING>None, immunotherapy was not part of the planned first course of therapy.</VALUEMEANING>
          <MEANINGDESCRIPTION>None, immunotherapy was not part of the planned first course of therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2652787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>87</VALIDVALUE>
          <VALUEMEANING>Immunotherapy was not administered. It was recommended by the patient&#39;s physician, but this treatment was refused by the patient, the patient&#39;s family member, or the patient&#39;s guardian. The refusal was noted in the patient record.</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunotherapy was not administered. It was recommended by the patient&#39;s physician, but this treatment was refused by the patient, the patient&#39;s family member, or the patient&#39;s guardian. The refusal was noted in the patient record.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3270794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>RX Summary Biological Respons</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>RX Summary Biological Response Modifier</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR, V 11.1 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.1 Data Standards and Data Dictionary (5/4/06)</DocumentText>
        <URL>http://www.naaccr.org/filesystem/pdf/Volume%20II%20Version%2011.1.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>RX Summ--BRM Description</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Immunotherapy consists of biological or chemical agents that alter the immune system or change the host&#39;s response to tumor cells.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Immunotherapy/Biologic Response Modifier (BRM)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Immunotherapy/Biologic Response Modifier (BRM)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 12.1, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&amp;tabid=133&amp;mid=473</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.2 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.2 Data Standards and Data Dictionary (5/30/2007)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=PQdlAnykU1U%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.3 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.3 Data Standards and Data Dictionary (4/2008)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=xSH32ZzIzGI%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 16, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)</DocumentText>
        <URL>https://www.naaccr.org/data-standards-data-dictionary/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 12.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3134707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899833</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment1stCourse16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899849</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464305</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment1stCourse18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464323</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>1410</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Biological Response Modifiers (pre-96 SEER)</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Immunotherapy (SEER/COC)</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RX SUMM--BRM </AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TX_SUMM_BRM_CD</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RX Summ--BRM</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Immunotherapy (SEER/CoC)</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1113">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2695120</PUBLICID>
    <LONGNAME>Audiometric Test Assessment Date</LONGNAME>
    <PREFERREDNAME>AUD_TST_ASSESS_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>Date of the completion of a complete hearing or audiometric test. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2695114</PublicId>
      <PreferredName>AUD_TST_ASSESS</PreferredName>
      <PreferredDefinition>Final results of an Audiometric testing (hearing test), conducted utilizing a manual or microprocessor audiometer. The test is usually carried out in a sound room or sound test chamber.  [Manually-curated]</PreferredDefinition>
      <LongName>Audiometric Test Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2695112</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38036</PreferredName>
        <Version>1</Version>
        <LongName>Audiometric Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38036</PREFERRED_NAME>
            <LONG_NAME>Audiometric Test</LONG_NAME>
            <CON_ID>2660092</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25367</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017121</PublicId>
      <PreferredName>CTMS_DT</PreferredName>
      <PreferredDefinition>Date as required for Clinical Trials Monitoring Service submissions.  Exchange format is YYYYMMDD.  Display format is DDMMMYYYY, with the month display the first three letters of each month (Jan, Feb, Mar, etc.).</PreferredDefinition>
      <LongName>CTMS Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>DD/MON/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date the complete hearing/aud</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date the complete hearing/audimetric test was completed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of pure tone audiometry</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date assessment completed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of evaluation:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of procedure:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of audiometry assessment:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol/Admin.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811961</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1114">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2698108</PUBLICID>
    <LONGNAME>Follow-up Recurrence Death Last Contact Date</LONGNAME>
    <PREFERREDNAME>2698106v1.0:2018550v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Date of last contact with the patient, or date of death.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2698106</PublicId>
      <PreferredName>2698104v1.0:3188117v1.0</PreferredName>
      <PreferredDefinition>Last contact with the patient, or date of death.</PreferredDefinition>
      <LongName>Follow-up Recurrence Death Last Contact</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2698104</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16033:C3352:C28554</PreferredName>
        <Version>1</Version>
        <LongName>Follow-up Recurrence Death</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16033</PREFERRED_NAME>
            <LONG_NAME>Follow-Up</LONG_NAME>
            <CON_ID>2202303</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3352</PREFERRED_NAME>
            <LONG_NAME>Recurrence</LONG_NAME>
            <CON_ID>2202848</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28554</PREFERRED_NAME>
            <LONG_NAME>Dead</LONG_NAME>
            <CON_ID>2202731</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3188117</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25551:C49147</PreferredName>
        <Version>1</Version>
        <LongName>Last Physical Contact</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25551</PREFERRED_NAME>
            <LONG_NAME>Last</LONG_NAME>
            <CON_ID>2206286</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49147</PREFERRED_NAME>
            <LONG_NAME>Physical Contact</LONG_NAME>
            <CON_ID>2607508</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Last Contact</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of Last Contact</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR, V 11.1 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.1 Data Standards and Data Dictionary (5/4/06)</DocumentText>
        <URL>http://www.naaccr.org/filesystem/pdf/Volume%20II%20Version%2011.1.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Last Contact Description</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>See Data Dictionary section of NAACCR Standards Volume II document for description of date format.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.2 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.2 Data Standards and Data Dictionary (5/30/2007)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=PQdlAnykU1U%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.3 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.3 Data Standards and Data Dictionary (4/2008)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=xSH32ZzIzGI%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FollowupRecurrenceDeath11.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103524</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FollowupRecurrenceDeath11.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103540</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FollowupRecurrenceDeath11.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3242102</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Caris Registry</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3060676</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3595692</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Miraca Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Miraca Registry</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3595693</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>1750</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DATE OF LAST CONTACT</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Date of Last Contact or Death  (COC)</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Date of Last Follow-Up or of Death (SEER)</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAST_CONT_DT</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAST_REP_DT</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1115">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2698153</PUBLICID>
    <LONGNAME>Follow-up Recurrence Death Next Follow-up Source Number Code</LONGNAME>
    <PREFERREDNAME>2698151v1.0:2658330v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Identifies the method planned for the next follow-up step.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2698151</PublicId>
      <PreferredName>2698104v1.0:2698149v1.0</PreferredName>
      <PreferredDefinition>The method planned for the next follow-up step.</PreferredDefinition>
      <LongName>Follow-up Recurrence Death Next Follow-up Source</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008576</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DATA_SOURCE</PreferredName>
        <Version>1</Version>
        <LongName>Data Source</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2698104</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16033:C3352:C28554</PreferredName>
        <Version>1</Version>
        <LongName>Follow-up Recurrence Death</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16033</PREFERRED_NAME>
            <LONG_NAME>Follow-Up</LONG_NAME>
            <CON_ID>2202303</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3352</PREFERRED_NAME>
            <LONG_NAME>Recurrence</LONG_NAME>
            <CON_ID>2202848</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28554</PREFERRED_NAME>
            <LONG_NAME>Dead</LONG_NAME>
            <CON_ID>2202731</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2698149</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C53286:C16033:C25683</PreferredName>
        <Version>1</Version>
        <LongName>Next Follow-up Source</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53286</PREFERRED_NAME>
            <LONG_NAME>Next</LONG_NAME>
            <CON_ID>2443959</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16033</PREFERRED_NAME>
            <LONG_NAME>Follow-Up</LONG_NAME>
            <CON_ID>2202303</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25683</PREFERRED_NAME>
            <LONG_NAME>Source</LONG_NAME>
            <CON_ID>2202479</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2658330</PublicId>
      <PreferredName>2658330v1.0</PreferredName>
      <PreferredDefinition>Subsequent; immediately following in time or order._The process by which information about the health status of an individual is obtained after a study has officially closed._Source; where something is available._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Next Follow-up Source Number Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
      <Representation>
        <PublicId>2658329</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C53286:C16033:C25683:C25337:C2</PreferredName>
        <Version>1</Version>
        <LongName>Next Follow-up Source Number Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53286</PREFERRED_NAME>
            <LONG_NAME>Next</LONG_NAME>
            <CON_ID>2443959</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16033</PREFERRED_NAME>
            <LONG_NAME>Follow-Up</LONG_NAME>
            <CON_ID>2202303</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25683</PREFERRED_NAME>
            <LONG_NAME>Source</LONG_NAME>
            <CON_ID>2202479</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Not followed, other cases for which follow-up is not required</VALUEMEANING>
          <MEANINGDESCRIPTION>Not followed, other cases for which follow-up is not required</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2658331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Foreign residents (not followed)</VALUEMEANING>
          <MEANINGDESCRIPTION>Foreign residents (not followed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2658332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Other, NOS</VALUEMEANING>
          <MEANINGDESCRIPTION>Other, NOS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Other hospital contact</VALUEMEANING>
          <MEANINGDESCRIPTION>Other hospital contact</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2658333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Phone Call</VALUEMEANING>
          <MEANINGDESCRIPTION>Phone Call</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Contact letter</VALUEMEANING>
          <MEANINGDESCRIPTION>Contact letter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2658334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Physician letter</VALUEMEANING>
          <MEANINGDESCRIPTION>Physician letter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2658335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Chart requisition</VALUEMEANING>
          <MEANINGDESCRIPTION>Chart requisition</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-06-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2658336</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Next Follow-Up Source</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Next Follow-Up Source</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR, V 11.1 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.1 Data Standards and Data Dictionary (5/4/06)</DocumentText>
        <URL>http://www.naaccr.org/filesystem/pdf/Volume%20II%20Version%2011.1.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.2 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.2 Data Standards and Data Dictionary (5/30/2007)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=PQdlAnykU1U%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.3 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.3 Data Standards and Data Dictionary (4/2008)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=xSH32ZzIzGI%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 12.1, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&amp;tabid=133&amp;mid=473</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 16, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)</DocumentText>
        <URL>https://www.naaccr.org/data-standards-data-dictionary/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 12.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3134707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899833</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FollowupRecurrenceDeath16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464305</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FollowupRecurrenceDeath18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464311</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>1800</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Next Follow-Up Method (pre-96 COC)</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NEXT FOLLOW-UP SOURCE</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Next Follow-Up Source</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1116">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711608</PUBLICID>
    <LONGNAME>List Processing Smoothing Process java.lang.String</LONGNAME>
    <PREFERREDNAME>2710851v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A series of names, words, or other items written, printed, or imagined one after the other.:The act of preparing or putting through a prescribed procedure._The modification of a set of data to make it smooth and nearly continuous and remove or diminish outlying points.:A sequence of events which produces some outcome._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2710851</PublicId>
      <PreferredName>2710712v1.0:2710329v1.0</PreferredName>
      <PreferredDefinition>A series of names, words, or other items written, printed, or imagined one after the other.:The act of preparing or putting through a prescribed procedure._The modification of a set of data to make it smooth and nearly continuous and remove or diminish outlying points.:A sequence of events which produces some outcome.</PreferredDefinition>
      <LongName>List Processing Smoothing Process</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710712</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43432:C48177</PreferredName>
        <Version>1</Version>
        <LongName>List Processing</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43432</PREFERRED_NAME>
            <LONG_NAME>List</LONG_NAME>
            <CON_ID>2236559</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48177</PREFERRED_NAME>
            <LONG_NAME>Processing</LONG_NAME>
            <CON_ID>2422623</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710329</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C64202:C29862</PreferredName>
        <Version>1</Version>
        <LongName>Smoothing Process</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64202</PREFERRED_NAME>
            <LONG_NAME>Smoothing</LONG_NAME>
            <CON_ID>2620108</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29862</PREFERRED_NAME>
            <LONG_NAME>Process</LONG_NAME>
            <CON_ID>2202628</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element List Processing Smoothing Process java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element List Processing Smoothing Process java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.ListProcessing.smoothingProcess</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ListProcessing:smoothingProcess</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1117">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711624</PUBLICID>
    <LONGNAME>Tandem Mass Spectrometry Fraction Target Mass-to-Charge Ratio java.lang.Double</LONGNAME>
    <PREFERREDNAME>2710867v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Mass spectrometers coupled in series.  The targeted compound is selectively ionized, and its characteristic ions are separated from others in the mixture in the first mass spectrometer. The selected primary ions are then decomposed by collision, and from the resulting products the final mass analyzer selects secondary ions characteristic of the targeted compound. Tandem mass spectrometry can achieve specificities and sensitivities equivalent of those of methods such as radioimmunoassay and gas chromatography/mass spectrometry, while performing analyses in much shorter times.:A part, a fragment of a whole._An object fixed as a goal or point of examination; something to point at; a destination.:The abbreviation m/z is used to denote the dimensionless quantity formed by dividing the mass number of an ion by its charge number. It has long been called the mass-to-charge ratio although m is not the ionic mass nor is z a multiple or the elementary (electronic) charge e. (from IUPAC Compendium)_Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2710867</PublicId>
      <PreferredName>2710715v1.0:2710333v1.0</PreferredName>
      <PreferredDefinition>Mass spectrometers coupled in series.  The targeted compound is selectively ionized, and its characteristic ions are separated from others in the mixture in the first mass spectrometer. The selected primary ions are then decomposed by collision, and from the resulting products the final mass analyzer selects secondary ions characteristic of the targeted compound. Tandem mass spectrometry can achieve specificities and sensitivities equivalent of those of methods such as radioimmunoassay and gas chromatography/mass spectrometry, while performing analyses in much shorter times.:A part, a fragment of a whole._An object fixed as a goal or point of examination; something to point at; a destination.:The abbreviation m/z is used to denote the dimensionless quantity formed by dividing the mass number of an ion by its charge number. It has long been called the mass-to-charge ratio although m is not the ionic mass nor is z a multiple or the elementary (electronic) charge e. (from IUPAC Compendium)</PreferredDefinition>
      <LongName>Tandem Mass Spectrometry Fraction Target Mass-to-Charge Ratio</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710715</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18142:C25514</PreferredName>
        <Version>1</Version>
        <LongName>Tandem Mass Spectrometry Fraction</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18142</PREFERRED_NAME>
            <LONG_NAME>Tandem Mass Spectrometry</LONG_NAME>
            <CON_ID>2671518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25514</PREFERRED_NAME>
            <LONG_NAME>Fraction</LONG_NAME>
            <CON_ID>2203814</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710333</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25702:C48049</PreferredName>
        <Version>1</Version>
        <LongName>Target Mass-to-Charge Ratio</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25702</PREFERRED_NAME>
            <LONG_NAME>Target</LONG_NAME>
            <CON_ID>2206261</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48049</PREFERRED_NAME>
            <LONG_NAME>Mass-to-Charge Ratio</LONG_NAME>
            <CON_ID>2632613</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Tandem Mass Spectrometry Fraction Target Mass-to-Charge Ratio java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Tandem Mass Spectrometry Fraction Target Mass-to-Charge Ratio java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.MassSpecMassSpecFraction.targetMToZ</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MassSpecMassSpecFraction:targetMToZ</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1118">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711696</PUBLICID>
    <LONGNAME>Electrophoresis Gel Analysis Record Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2710939v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A gel matrix through which molecules are separated, usually by size or charge, under the influence of an electrical field._Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:Anything (e.g., a document) providing permanent evidence of or information about past events.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2710939</PublicId>
      <PreferredName>2710727v1.0:2710377v1.0</PreferredName>
      <PreferredDefinition>A gel matrix through which molecules are separated, usually by size or charge, under the influence of an electrical field._Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:Anything (e.g., a document) providing permanent evidence of or information about past events.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Electrophoresis Gel Analysis Record Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710727</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45307</PreferredName>
        <Version>1</Version>
        <LongName>Electrophoresis Gel</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45307</PREFERRED_NAME>
            <LONG_NAME>Electrophoresis Gel</LONG_NAME>
            <CON_ID>2240757</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710377</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25391:C25198:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Analysis Record Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25198</PREFERRED_NAME>
            <LONG_NAME>Record</LONG_NAME>
            <CON_ID>2203775</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Electrophoresis Gel Analysis Record Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Electrophoresis Gel Analysis Record Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.Gel.analysisRecordIdentifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Gel:analysisRecordIdentifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1119">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711803</PUBLICID>
    <LONGNAME>Protein Microarray Microplate Reader Specimen Specimen Information java.lang.String</LONGNAME>
    <PREFERREDNAME>2711046v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A molecular biology device consisting of a set of defined proteins, protein fragments, or peptides attached in a specific grid arrangement to a solid support.:An instrument for the automated determination of absorbance data from multiple samples contained in a microplate.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:Knowledge derived from study, experience, or instruction that has been gathered or received by communication._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711046</PublicId>
      <PreferredName>2710736v1.0:2710442v1.0</PreferredName>
      <PreferredDefinition>A molecular biology device consisting of a set of defined proteins, protein fragments, or peptides attached in a specific grid arrangement to a solid support.:An instrument for the automated determination of absorbance data from multiple samples contained in a microplate.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:Knowledge derived from study, experience, or instruction that has been gathered or received by communication.</PreferredDefinition>
      <LongName>Protein Microarray Microplate Reader Specimen Specimen Information</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710736</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25867:C70661:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Protein Microarray Microplate Reader Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25867</PREFERRED_NAME>
            <LONG_NAME>Protein Microarray</LONG_NAME>
            <CON_ID>2710229</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70661</PREFERRED_NAME>
            <LONG_NAME>Microplate Reader</LONG_NAME>
            <CON_ID>2710228</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710442</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157:C48191</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Information</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48191</PREFERRED_NAME>
            <LONG_NAME>Information</LONG_NAME>
            <CON_ID>2422630</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Protein Microarray Microplate Reader Specimen Specimen Information java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Protein Microarray Microplate Reader Specimen Specimen Information java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>A2Sample:sampleInfo</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.A2Sample.sampleInfo</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1120">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711811</PUBLICID>
    <LONGNAME>Differential In-Gel Electrophoresis Electrophoresis Gel Exposure Time java.lang.Double</LONGNAME>
    <PREFERREDNAME>2711054v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A form of gel electrophoresis where up to three different protein samples can be labeled with fluorescent dyes prior to two-dimensional electrophoresis in the same gel. After the gel electrophoresis, the gel is scanned with the excitation wavelength of each dye and the imges are superimposed, allowing detection of changes in protein abundance between samples.:A gel matrix through which molecules are separated, usually by size or charge, under the influence of an electrical field._The act of subjecting someone or something to an influencing experience.:The continuum of experience in which events pass from the future through the present to the past; a specific point in this continuum or the interval separating two points._Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711054</PublicId>
      <PreferredName>2710738v1.0:2553692v1.0</PreferredName>
      <PreferredDefinition>A form of gel electrophoresis where up to three different protein samples can be labeled with fluorescent dyes prior to two-dimensional electrophoresis in the same gel. After the gel electrophoresis, the gel is scanned with the excitation wavelength of each dye and the imges are superimposed, allowing detection of changes in protein abundance between samples.:A gel matrix through which molecules are separated, usually by size or charge, under the influence of an electrical field._The act of subjecting someone or something to an influencing experience.:The continuum of experience in which events pass from the future through the present to the past; a specific point in this continuum or the interval separating two points.</PreferredDefinition>
      <LongName>Differential In-Gel Electrophoresis Electrophoresis Gel Exposure Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710738</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70654:C45307</PreferredName>
        <Version>1</Version>
        <LongName>Differential In-Gel Electrophoresis Electrophoresis Gel</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70654</PREFERRED_NAME>
            <LONG_NAME>Differential In-Gel Electrophoresis</LONG_NAME>
            <CON_ID>2710244</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45307</PREFERRED_NAME>
            <LONG_NAME>Electrophoresis Gel</LONG_NAME>
            <CON_ID>2240757</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2553692</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17941:C25207</PreferredName>
        <Version>1</Version>
        <LongName>Exposure Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17941</PREFERRED_NAME>
            <LONG_NAME>Exposure</LONG_NAME>
            <CON_ID>2203924</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Differential In-Gel Electrophoresis Electrophoresis Gel Exposure Time java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Differential In-Gel Electrophoresis Electrophoresis Gel Exposure Time java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.DigeGel.exposureTime</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DigeGel:exposureTime</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1121">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711955</PUBLICID>
    <LONGNAME>Presentation Threshold Presentation Range List java.lang.String</LONGNAME>
    <PREFERREDNAME>2711200v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>To show or display; the act of presenting something to sight or view: how something looks.:The lowest limit at which something becomes detectable or relevant._To show or display; the act of presenting something to sight or view: how something looks.:The difference between the lowest and highest numerical values.:A series of names, words, or other items written, printed, or imagined one after the other._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711200</PublicId>
      <PreferredName>2710764v1.0:2710527v1.0</PreferredName>
      <PreferredDefinition>To show or display; the act of presenting something to sight or view: how something looks.:The lowest limit at which something becomes detectable or relevant._To show or display; the act of presenting something to sight or view: how something looks.:The difference between the lowest and highest numerical values.:A series of names, words, or other items written, printed, or imagined one after the other.</PreferredDefinition>
      <LongName>Presentation Threshold Presentation Range List</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710764</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61388:C48228</PreferredName>
        <Version>1</Version>
        <LongName>Presentation Threshold</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61388</PREFERRED_NAME>
            <LONG_NAME>Presentation</LONG_NAME>
            <CON_ID>2584121</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48228</PREFERRED_NAME>
            <LONG_NAME>Threshold</LONG_NAME>
            <CON_ID>2423422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710527</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61388:C38013:C43432</PreferredName>
        <Version>1</Version>
        <LongName>Presentation Range List</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61388</PREFERRED_NAME>
            <LONG_NAME>Presentation</LONG_NAME>
            <CON_ID>2584121</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38013</PREFERRED_NAME>
            <LONG_NAME>Range</LONG_NAME>
            <CON_ID>2204649</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43432</PREFERRED_NAME>
            <LONG_NAME>List</LONG_NAME>
            <CON_ID>2236559</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Presentation Threshold Presentation Range List java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Presentation Threshold Presentation Range List java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.PresentationThresholds.rangeClauseList</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PresentationThresholds:rangeClauseList</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1122">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2713467</PUBLICID>
    <LONGNAME>Diagnosis Text Surgical Procedure Diagnostic Procedure Text</LONGNAME>
    <PREFERREDNAME>2713450v1.0:2644975v1.1</PREFERREDNAME>
    <PREFERREDDEFINITION>Text area for manual documentation of all surgical procedures that provide information for staging.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2713450</PublicId>
      <PreferredName>2704295v1.0:2431206v1.0</PreferredName>
      <PreferredDefinition>Manual documentation of all surgical procedures that provide information for staging.</PreferredDefinition>
      <LongName>Diagnosis Text Surgical Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2704295</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2431206</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2644975</PublicId>
      <PreferredName>2644975v1.1</PreferredName>
      <PreferredDefinition>Methods, procedures, and tests performed to diagnose disease, disordered function, or disability._Text; the words of something written.</PreferredDefinition>
      <LongName>Diagnostic Procedure Text</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1000</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3015291</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18020:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic Procedure Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18020</PREFERRED_NAME>
            <LONG_NAME>Diagnostic Procedure</LONG_NAME>
            <CON_ID>2488312</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Text Diagnosis Procedure Oper</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Text Diagnosis Procedure Operative</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 12.1, Data Stds/Dict.</Name>
        <DocumentType>Coding Instructions</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&amp;tabid=133&amp;mid=473</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Version 12 Updated Instructions</Name>
        <DocumentType>Coding Instructions</DocumentType>
        <DocumentText>The rationale and instructional text for NAACCR elements was significantly updated for Version 12.  Please refer to the documentation for new usage information.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Diagnosis/Surgical Procedure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Description</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 16, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)</DocumentText>
        <URL>https://www.naaccr.org/data-standards-data-dictionary/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Question Text - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Diagnosis/surgical procedure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 12.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3134707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899833</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>TextDiagnosis16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899846</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464305</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>TextDiagnosis18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464320</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>2560</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TEXT-DX PROC--OP</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Text--DX Proc--Op</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DIAG_SURG_PROC</AlternateName>
        <AlternateNameType>DCP Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1123">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2716090</PUBLICID>
    <LONGNAME>Diseases and Disorders Patient Self-Report Paget&#39;s Disease Diagnosis Yes No Unknown Indicator</LONGNAME>
    <PREFERREDNAME>DZ_PS_PAGET_DX_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no/unknown indicator for the person self-report of a diagnosis by a physician of Paget&#39;s Disease, a disease of bone that initially results in the excessive resorption of bone (by osteoclasts) followed by the replacement of normal bone marrow with vascular and fibrous tissue, as an abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2716007</PublicId>
      <PreferredName>DAD_PSR_PD_DX</PreferredName>
      <PreferredDefinition>information related to the self-reported diagnosis by a physician of Paget&#39;s Disease, a disease of bone that initially results in the excessive resorption of bone (by osteoclasts) followed by the replacement of normal bone marrow with vascular and fibrous tissue, as an abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person.</PreferredDefinition>
      <LongName>Diseases and Disorders Patient Self-Report Paget&#39;s Disease Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2716005</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21089:C3292:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Patient Self-Report Paget&#39;s Disease Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21089</PREFERRED_NAME>
            <LONG_NAME>Patient Self-Report</LONG_NAME>
            <CON_ID>2234887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3292</PREFERRED_NAME>
            <LONG_NAME>Bone Paget Disease</LONG_NAME>
            <CON_ID>2202768</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you ever been diagnosed</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you ever been diagnosed by your doctor with Paget&#39;s Disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4442461</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDCR CDEs with Retired VDs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDEs for Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4442571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1124">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2716274</PUBLICID>
    <LONGNAME>Exon Microarray Reporter Genomic Orientation GenomicOrientation</LONGNAME>
    <PREFERREDNAME>2716176v1.0:2716257v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.:A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.:A biological material (clone, oligo, etc.) on an array which will report on some biosequence or biosequences. Also refers to any substance that is identifiable by virtue of its radioactive signature, color, or other distinguishing physical property, such as a dye, radioactive isotope, or inert chemical, that is introduced into a biological or mechanical system and can be followed through the course of a process, providing information on the pattern of events in the process or on the redistribution of the parts, elements, or events involved._The orientation of a genomic element on the double stranded molecule._Genomic strand orientation</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2716176</PublicId>
      <PreferredName>2716122v1.0:2423577v1.0</PreferredName>
      <PreferredDefinition>The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.:A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.:A biological material (clone, oligo, etc.) on an array which will report on some biosequence or biosequences. Also refers to any substance that is identifiable by virtue of its radioactive signature, color, or other distinguishing physical property, such as a dye, radioactive isotope, or inert chemical, that is introduced into a biological or mechanical system and can be followed through the course of a process, providing information on the pattern of events in the process or on the redistribution of the parts, elements, or events involved._The orientation of a genomic element on the double stranded molecule.</PreferredDefinition>
      <LongName>Exon Microarray Reporter Genomic Orientation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2716122</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13231:C44282:C44255</PreferredName>
        <Version>1</Version>
        <LongName>Exon Microarray Reporter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13231</PREFERRED_NAME>
            <LONG_NAME>Exon</LONG_NAME>
            <CON_ID>2240634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44282</PREFERRED_NAME>
            <LONG_NAME>Microarray</LONG_NAME>
            <CON_ID>2223237</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44255</PREFERRED_NAME>
            <LONG_NAME>Reporter Substance</LONG_NAME>
            <CON_ID>2236612</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2423577</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48673</PreferredName>
        <Version>1</Version>
        <LongName>Genomic Orientation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48673</PREFERRED_NAME>
            <LONG_NAME>Genomic Orientation</LONG_NAME>
            <CON_ID>2423569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2716257</PublicId>
      <PreferredName>2716257v1.0</PreferredName>
      <PreferredDefinition>Genomic strand orientation</PreferredDefinition>
      <LongName>GenomicOrientation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177848</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0332307</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2203010</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>-</VALIDVALUE>
          <VALUEMEANING>Antisense Orientation</VALUEMEANING>
          <MEANINGDESCRIPTION>Having a DNA sequence complementary to that of a messenger RNA molecule; the non-coding strand in double-stranded DNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2716258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+</VALIDVALUE>
          <VALUEMEANING>Sense Orientation</VALUEMEANING>
          <MEANINGDESCRIPTION>Having a DNA sequence identical to that of a messenger RNA molecule; the coding strand in double-stranded DNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63550</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2716259</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Exon Microarray Reporter Genomic Orientation GenomicOrientation does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Exon Microarray Reporter Genomic Orientation GenomicOrientation does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000537</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000539</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000543</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000536</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000541</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000542</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000544</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ExonArrayReporter:strand</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabio.domain.ExonArrayReporter.strand</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>@strand</AlternateName>
        <AlternateNameType>GME_XMLLocReference</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1125">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2727142</PUBLICID>
    <LONGNAME>Experiment Quality Control Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2726798v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena._A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed):A written or verbal account, representation, statement, or explanation of something._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2726798</PublicId>
      <PreferredName>2619601v1.0:2726686v1.0</PreferredName>
      <PreferredDefinition>A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena._A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed):A written or verbal account, representation, statement, or explanation of something.</PreferredDefinition>
      <LongName>Experiment Quality Control Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2619601</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42790</PreferredName>
        <Version>1</Version>
        <LongName>Experiment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42790</PREFERRED_NAME>
            <LONG_NAME>Experiment</LONG_NAME>
            <CON_ID>2223979</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2726686</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15311:C25365</PreferredName>
        <Version>1</Version>
        <LongName>Quality Control Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15311</PREFERRED_NAME>
            <LONG_NAME>Quality Control</LONG_NAME>
            <CON_ID>2717565</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Experiment Quality Control Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Experiment Quality Control Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812747</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2831137</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caCORRECT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caCORRECT Grid Services 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2832871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2831137</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caCORRECT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000575</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2839153</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>omniBiomarker</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>omniBiomarker Grid Services 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2839155</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2839153</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>omniBiomarker</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000574</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000576</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.project.Experiment.qualityControlDescription</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Experiment:qualityControlDescription</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1126">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2728977</PUBLICID>
    <LONGNAME>Tissue Donor During Or After Hematopoietic Cell Collection Hospitalization Indicator</LONGNAME>
    <PREFERREDNAME>DNR_D_P_CLN_HSP_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the donor was hospitalized during or after the hematopoietic cell product collection.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2728973</PublicId>
      <PreferredName>DNR_D_OR_PT_COL_HSP</PreferredName>
      <PreferredDefinition>Someone who gives blood or tissue or an organ to be used in another person._Within a certain period of time or after a certain point or period in time._Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The act of gathering things together; having been brought together in one place._The condition of being treated as a patient in a hospital.</PreferredDefinition>
      <LongName>Tissue Donor During Or After Hematopoietic Cell Collection Hospitalization</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25168</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Donor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2784456</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49640:C12551:C25453:C25179</PreferredName>
        <Version>1</Version>
        <LongName>During Or After Hematopoietic Stem Cell Collection Hospitalization</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49640</PREFERRED_NAME>
            <LONG_NAME>During or After</LONG_NAME>
            <CON_ID>2480612</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25179</PREFERRED_NAME>
            <LONG_NAME>Hospitalization</LONG_NAME>
            <CON_ID>2202493</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the donor hospitalized (i</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the donor hospitalized (inpatient) during or after the collection?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2006r1: HSCT Infusion</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_demo_dnr_hospital_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Tissue Donor During Or After Hematopoietic Stem Cell Collection Hospitalization Indicator</AlternateName>
        <AlternateNameType>System-Generated</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1127">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2728986</PUBLICID>
    <LONGNAME>Tissue Donor During Or After Hematopoietic Cell Collection Life Threatening or Disabling Adverse Event Indicator</LONGNAME>
    <PREFERREDNAME>DNR_D_P_CLN_AE_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the donor experienced any life-threatening complications during or after the hematopoietic cell product collection.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2728984</PublicId>
      <PreferredName>DNR_D_P_CLN_AE</PreferredName>
      <PreferredDefinition>Someone who gives blood or tissue or an organ to be used in another person._Within a certain period of time or after a certain point or period in time._Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The act of gathering things together; having been brought together in one place._Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.</PreferredDefinition>
      <LongName>Tissue Donor During Or After Hematopoietic Cell Collection Life Threatening or Disabling Adverse Event</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25168</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Donor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2784455</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49640:C12551:C25453:C41337</PreferredName>
        <Version>1</Version>
        <LongName>During Or After Hematopoietic Stem Cell Collection Life Threatening or Disabling Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49640</PREFERRED_NAME>
            <LONG_NAME>During or After</LONG_NAME>
            <CON_ID>2480612</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41337</PREFERRED_NAME>
            <LONG_NAME>Life Threatening or Disabling Adverse Event</LONG_NAME>
            <CON_ID>2472888</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the donor experience any</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the donor experience any life-threatening complications during or after the collection?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_TEXT_1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were there any adverse events that were likely related specifically to GCSF or stem cell collection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2006r1: HSCT Infusion</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase 1/Pilot Consortium</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3303197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_demo_dnr_life_comp_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Tissue Donor During Or After Hematopoietic Stem Cell Collection Life Threatening or Disabling Adverse Event Indicator</AlternateName>
        <AlternateNameType>System-Generated</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1128">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2732792</PUBLICID>
    <LONGNAME>Blackout Date Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2732757v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A suspension of service (especially of radio or tv broadcasting).:The particular day, month and year an event has happened or will happen._A statement or an account describing something._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2732757</PublicId>
      <PreferredName>2732746v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>A suspension of service (especially of radio or tv broadcasting).:The particular day, month and year an event has happened or will happen._A statement or an account describing something.</PreferredDefinition>
      <LongName>Blackout Date Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2732746</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71739:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Blackout Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71739</PREFERRED_NAME>
            <LONG_NAME>Blackout</LONG_NAME>
            <CON_ID>2732737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Blackout Date Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Blackout Date Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2672769</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PSC</PreferredName>
          <Version>2.6</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.bioinformatics.studycalendar.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000049</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.bioinformatics.studycalendar.domain.BlackoutDate.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BlackoutDate:description</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1129">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2734752</PUBLICID>
    <LONGNAME>Past Integer::4 Week Adult Malignant Neoplasm Surgery Therapeutic Procedure Financial Problem Psychometrics Assessment Score</LONGNAME>
    <PREFERREDNAME>PAST_4WK_FIN_PRB_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to reprresent the response to a QLAC question posed to an adult about financial problems over the past four weeks due to the cost of cancer surgery or treatment. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2733831</PublicId>
      <PreferredName>PAST_4WK_ADT_FIN_PRB</PreferredName>
      <PreferredDefinition>Past; before the present time._A number with no fractional part, including the negative and positive numbers as well as zero.::4_Any period of seven consecutive days._A human who has reached reproductive age.__A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.__A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._A difficulty, disorder, or condition needing resolution.</PreferredDefinition>
      <LongName>Past Integer::4 Week Adult Malignant Neoplasm Surgery Therapeutic Procedure Financial Problem</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2732119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25609:C45255::4:C29844:C17600</PreferredName>
        <Version>1</Version>
        <LongName>Past Integer::4 Week Adult</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::4</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29844</PREFERRED_NAME>
            <LONG_NAME>Week</LONG_NAME>
            <CON_ID>2203710</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17600</PREFERRED_NAME>
            <LONG_NAME>Adult</LONG_NAME>
            <CON_ID>2204022</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2733829</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305:C17173:C49236:C28020</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm Surgery Therapeutic Procedure Problem</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17173</PREFERRED_NAME>
            <LONG_NAME>Surgery</LONG_NAME>
            <CON_ID>2203602</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28020</PREFERRED_NAME>
            <LONG_NAME>Problem</LONG_NAME>
            <CON_ID>2203953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>QLAC:Quality of Life in Adult Cancer Survivors Scale</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2734610</PublicId>
      <PreferredName>PSYCH_ASSESS_SC</PreferredName>
      <PreferredDefinition>The science of measuring &quot;psychological&quot; aspects of a person such as knowledge, skills, abilities, or personality. Measurement of these unobservable phenomena is difficult and much of the research and accumulated art of this discipline is designed to reliably define and then quantify._The final result of a determination of the value, significance, or extent of._A number or range of numeric values measuring performance, function, quality, or ability._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Psychometrics Assessment Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2732885</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17034:C25217:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Psychometrics Assessed Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17034</PREFERRED_NAME>
            <LONG_NAME>Psychometrics</LONG_NAME>
            <CON_ID>2520620</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>VERY OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>VERY OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Frequently</VALUEMEANING>
          <MEANINGDESCRIPTION>Frequently</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>About as often as not</VALUEMEANING>
          <MEANINGDESCRIPTION>About as often as not</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2734611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Seldom</VALUEMEANING>
          <MEANINGDESCRIPTION>Seldom</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2734612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>I NEVER had an erection when I wanted one </VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>You had financial problems be</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>You had financial problems becaue of the cost of cancer surgery or treatment.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1130">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2735285</PUBLICID>
    <LONGNAME>Telephone Call Randomization Telephone Number java.lang.String</LONGNAME>
    <PREFERREDNAME>2735149v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Electronic equipment that converts sound into electrical signals that can be transmitted over distances and then converts received signals back into sounds.:Send a message or attempt to reach someone by radio, phone, etc.:The allocation of individuals to groups by chance, especially in order to control the variables in an experiment._A telephone number is a sequence of decimal digits (0-9) that is used for identifying a destination telephone line or other device in a telephone network.  In the US this is a ten digit number resembling &quot;123-456-7890&quot;._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2735149</PublicId>
      <PreferredName>2734858v1.0:2223455v1.0</PreferredName>
      <PreferredDefinition>Electronic equipment that converts sound into electrical signals that can be transmitted over distances and then converts received signals back into sounds.:Send a message or attempt to reach someone by radio, phone, etc.:The allocation of individuals to groups by chance, especially in order to control the variables in an experiment._A telephone number is a sequence of decimal digits (0-9) that is used for identifying a destination telephone line or other device in a telephone network.  In the US this is a ten digit number resembling &quot;123-456-7890&quot;.</PreferredDefinition>
      <LongName>Telephone Call Randomization Telephone Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2734858</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25395:C64924:C25196</PreferredName>
        <Version>1</Version>
        <LongName>Telephone Call Randomization</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25395</PREFERRED_NAME>
            <LONG_NAME>Telephone</LONG_NAME>
            <CON_ID>2202574</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64924</PREFERRED_NAME>
            <LONG_NAME>Call</LONG_NAME>
            <CON_ID>2634973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25196</PREFERRED_NAME>
            <LONG_NAME>Randomization</LONG_NAME>
            <CON_ID>2202624</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223455</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C40978</PreferredName>
        <Version>1</Version>
        <LongName>Telephone Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40978</PREFERRED_NAME>
            <LONG_NAME>Telephone Number</LONG_NAME>
            <CON_ID>2223426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Telephone Call Randomization Telephone Number java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Telephone Call Randomization Telephone Number java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.duke.cabig.c3pr.domain.PhoneCallRandomization.phoneNumber</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PhoneCallRandomization:phoneNumber</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1131">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2738809</PUBLICID>
    <LONGNAME>Invasive Breast Carcinoma Present Diagnosis Ind-3</LONGNAME>
    <PREFERREDNAME>IBC_PRES_DX_IND-3</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no/unknown question related to a patient&#39;s diagnosis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2009018</PublicId>
      <PreferredName>IBC_PRES</PreferredName>
      <PreferredDefinition>information that related to a carcinoma that infiltrates the breast parenchyma, often the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ, being present.</PreferredDefinition>
      <LongName>Invasive Breast Carcinoma Present</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2431278</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9245</PreferredName>
        <Version>1</Version>
        <LongName>Invasive Breast Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9245</PREFERRED_NAME>
            <LONG_NAME>Invasive Breast Carcinoma</LONG_NAME>
            <CON_ID>2431159</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018439</PublicId>
      <PreferredName>DX_IND-3</PreferredName>
      <PreferredDefinition>the yes/no/unknown question related to a patient&#39;s diagnosis.</PreferredDefinition>
      <LongName>Diagnosis Ind-3</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184306</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Ind-3</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is invasive cancer present?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is invasive cancer present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have histologically or cytologically confirmed invasive breast carcinoma?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2597547</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Cancer</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Pathology Answer Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812594</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2597547</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Cancer</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Center for Research and Development</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812600</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1132">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2740582</PUBLICID>
    <LONGNAME>Patient Self-Report Skin Sensitivity Five Point Likert Scale Score</LONGNAME>
    <PREFERREDNAME>PT_SR_SKN_SENS_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Self-reported response to a Skindex-29 question asking if a subject&#39;s skin is sensitive. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Skindex-29 Copyright 1996, M.-M. Chren, MD</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2740315</PublicId>
      <PreferredName>PT_SR_SKN_SENS</PreferredName>
      <PreferredDefinition>Report coming directly from patients or subjects through interviews or self-completed questionnaires or other data capture tools such as diaries about their life, health condition(s) and treatment. NOTE: PROs are used to assess outcomes involving the patients&#39;/subjects&#39; perceptions, symptoms, satisfaction with treatment, adherence to prescribed regimens. PROs include outcomes recorded by interviewers transcribing the views expressed by the patient, but the term does not apply to outcomes recorded by observers who rely on their own judgment. A PRO is usually distinguished from a self-reported objective measurement such as a PEF score or body weight [from PRO Draft Guidance, Gordon Guyatt and Holger Schuneman - personal communication; Patrick, D.L., 2003. After Acquardo C., Berzon C., et al., 2001] See also outcome, subject, patient._1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part.__Sensitivity; the ability to respond to physical stimuli or to register small physical amounts or differences.</PreferredDefinition>
      <LongName>Patient Self-Report Skin Sensitivity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2739630</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21089:C12470</PreferredName>
        <Version>1</Version>
        <LongName>Patient Self-Report Skin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21089</PREFERRED_NAME>
            <LONG_NAME>Patient Self-Report</LONG_NAME>
            <CON_ID>2234887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12470</PREFERRED_NAME>
            <LONG_NAME>Skin</LONG_NAME>
            <CON_ID>2202821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2540472</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25201</PreferredName>
        <Version>1</Version>
        <LongName>Sensitivity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25201</PREFERRED_NAME>
            <LONG_NAME>Sensitivity</LONG_NAME>
            <CON_ID>2203788</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Skindex-29 Copyright 1996, M.-M. Chren, MD</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2740376</PublicId>
      <PreferredName>FIVE_LIK_SCL_SC</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Five Point Likert Scale Score</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>12</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2748286</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Scale Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>All the time</VALIDVALUE>
          <VALUEMEANING>All the time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2732887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>My skin is sensitive.</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>My skin is sensitive.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1133">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2740744</PUBLICID>
    <LONGNAME>Patient Self-Report Skin Pain Five Point Likert Scale Score</LONGNAME>
    <PREFERREDNAME>PT_SR_SKN_PN_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Self-reported response to a Skindex-29 question asking a subject about skin hurting. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Skindex-29 Copyright 1996, M.-M. Chren, MD</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2736778</PublicId>
      <PreferredName>PT_SR_SKN_PN</PreferredName>
      <PreferredDefinition>Report coming directly from patients or subjects through interviews or self-completed questionnaires or other data capture tools such as diaries about their life, health condition(s) and treatment. NOTE: PROs are used to assess outcomes involving the patients&#39;/subjects&#39; perceptions, symptoms, satisfaction with treatment, adherence to prescribed regimens. PROs include outcomes recorded by interviewers transcribing the views expressed by the patient, but the term does not apply to outcomes recorded by observers who rely on their own judgment. A PRO is usually distinguished from a self-reported objective measurement such as a PEF score or body weight [from PRO Draft Guidance, Gordon Guyatt and Holger Schuneman - personal communication; Patrick, D.L., 2003. After Acquardo C., Berzon C., et al., 2001] See also outcome, subject, patient._1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part._The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings._</PreferredDefinition>
      <LongName>Patient Self-Report Skin Pain</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2739630</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21089:C12470</PreferredName>
        <Version>1</Version>
        <LongName>Patient Self-Report Skin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21089</PREFERRED_NAME>
            <LONG_NAME>Patient Self-Report</LONG_NAME>
            <CON_ID>2234887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12470</PREFERRED_NAME>
            <LONG_NAME>Skin</LONG_NAME>
            <CON_ID>2202821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2736776</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3303</PreferredName>
        <Version>1</Version>
        <LongName>Pain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3303</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>2202326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Skindex-29 Copyright 1996, M.-M. Chren, MD</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2740376</PublicId>
      <PreferredName>FIVE_LIK_SCL_SC</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Five Point Likert Scale Score</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>12</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2748286</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Scale Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>All the time</VALIDVALUE>
          <VALUEMEANING>All the time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2732887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>My skin hurts.</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>My skin hurts.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Measure: Item Position</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>This is item #1 in the Skindex-29 measure; there are a total of 30 items that must be assembled in the prescribed order.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Measure: Author Contact Information</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Mary-Margaret Chren, MD, email mmchren(at)itsa.ucsf.edu</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Measure: Number of Items</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>30 items in measure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Measure: Author Name</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Mary-Margaret Chren, MD</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1134">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2741583</PUBLICID>
    <LONGNAME>During Collection Hematopoietic Stem Cell Graft Combined Anticoagulant Agent Administration Indicator</LONGNAME>
    <PREFERREDNAME>D_C_HSC_ANCO_ADM_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not anticoagulants were added to the hematopoietic cell graft during collection.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2741570</PublicId>
      <PreferredName>DR_CO_HSCT_ANCO_ADM</PreferredName>
      <PreferredDefinition>At some point in a given period of time._The act of gathering things together; having been brought together in one place._Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)._Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body._Made or joined or united into one or involving the joint activity of two or more._A drug that helps prevent blood clots from forming. Also called a blood thinner._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.</PreferredDefinition>
      <LongName>During Collection Hematopoietic Stem Cell Graft Combined Anticoagulant Agent Administration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2794370</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25490:C25453:C12551:C12981</PreferredName>
        <Version>1</Version>
        <LongName>During Collection Hematopoietic Stem Cell Graft</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2741566</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25454:C263:C25409</PreferredName>
        <Version>1</Version>
        <LongName>Combined Anticoagulant Agent Administration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25454</PREFERRED_NAME>
            <LONG_NAME>Combined</LONG_NAME>
            <CON_ID>2206179</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C263</PREFERRED_NAME>
            <LONG_NAME>Anticoagulant Agent</LONG_NAME>
            <CON_ID>2202376</CON_ID>
            <DEFINITION_SOURCE>MSH2002_06_01</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were particular anticoagulant</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Were particular anticoagulants added to the product during collection?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2006r1: HSCT Infusion</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2007r1:Cord Blood Unit -SCTOD Data Requirements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3191905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_anticoag_acd_prod_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_anticoag_cpd_prod_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_anticoag_hepn_prod_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_anticoag_othr_prod_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1135">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2743340</PUBLICID>
    <LONGNAME>Sleep Bruxism Patient Self-Report Present Yes No Indicator</LONGNAME>
    <PREFERREDNAME>SLBRUX_PSR_PRES_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator related to sleep involuntary clenching or grinding the teeth as reported coming directly from patients or subjects through interviews or self-completed questionnaires or other data capture tools such as diaries about their life, health condition(s) and treatment.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2743174</PublicId>
      <PreferredName>SL_BRUX_PSR_PRES</PreferredName>
      <PreferredDefinition>information related to sleep involuntary clenching or grinding the teeth as reported coming directly from patients or subjects through interviews or self-completed questionnaires or other data capture tools such as diaries about their life, health condition(s) and treatment.</PreferredDefinition>
      <LongName>Sleep Bruxism Patient Self-Report Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2743172</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C73425:C73511 </PreferredName>
        <Version>1</Version>
        <LongName>Sleep Bruxism </LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73425</PREFERRED_NAME>
            <LONG_NAME>Sleep</LONG_NAME>
            <CON_ID>2736838</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73511</PREFERRED_NAME>
            <LONG_NAME>Bruxism</LONG_NAME>
            <CON_ID>2740972</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2585718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21089:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Patient Self-Report Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21089</PREFERRED_NAME>
            <LONG_NAME>Patient Self-Report</LONG_NAME>
            <CON_ID>2234887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the patient noticed his/h</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the patient noticed his/her sleep bruxism</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Restorative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4442461</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDCR CDEs with Retired VDs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDEs for Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4442571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1136">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2743981</PUBLICID>
    <LONGNAME>Patient Travel Dental Physician Office Distance Duration</LONGNAME>
    <PREFERREDNAME>PT_TR_DEN_PO_DIS_DUR</PREFERREDNAME>
    <PREFERREDDEFINITION>the period of time for patient&#39;s travel to the dental office for the patient.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2742959</PublicId>
      <PreferredName>PT_TRAV_DNTOF_DIST</PreferredName>
      <PreferredDefinition>information related to travel distance to the dental office for the patient._Pertaining to a tooth or teeth, or to odontology._The room or rooms in which the physician and staff provide patient care. The offices include all rooms in the physician&#39;s office suite.</PreferredDefinition>
      <LongName>Patient Travel Dental Physician Office Distance</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2742956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C53462</PreferredName>
        <Version>1</Version>
        <LongName>Patient Travel</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53462</PREFERRED_NAME>
            <LONG_NAME>Travel</LONG_NAME>
            <CON_ID>2741584</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2743960</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C16988:C25167</PreferredName>
        <Version>1</Version>
        <LongName>Dental Physician Office Distance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16988</PREFERRED_NAME>
            <LONG_NAME>Physician Office</LONG_NAME>
            <CON_ID>2743958</CON_ID>
            <DEFINITION_SOURCE>MSH2003_2003_05_12</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25167</PREFERRED_NAME>
            <LONG_NAME>Distance</LONG_NAME>
            <CON_ID>2203902</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2743973</PublicId>
      <PreferredName>PT_TRAVEL_DUR</PreferredName>
      <PreferredDefinition>the period of time for patient&#39;s travel.</PreferredDefinition>
      <LongName>Patient Travel Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <UnitOfMeasure>min</UnitOfMeasure>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
      <Representation>
        <PublicId>2404653</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25330</PreferredName>
        <Version>1</Version>
        <LongName>Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>More than 120 minutes</VALIDVALUE>
          <VALUEMEANING>More than 120 minutes</VALUEMEANING>
          <MEANINGDESCRIPTION>More than 120 minutes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2743974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>91-120 minutes</VALIDVALUE>
          <VALUEMEANING>91-120 minutes</VALUEMEANING>
          <MEANINGDESCRIPTION>91-120 minutes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2743975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>61-90 minutes</VALIDVALUE>
          <VALUEMEANING>61-90 minutes</VALUEMEANING>
          <MEANINGDESCRIPTION>61-90 minutes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2743976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31-60 minutes</VALIDVALUE>
          <VALUEMEANING>31-60 minutes</VALUEMEANING>
          <MEANINGDESCRIPTION>31-60 minutes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2743977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16-30 minutes</VALIDVALUE>
          <VALUEMEANING>16-30 minutes</VALUEMEANING>
          <MEANINGDESCRIPTION>16-30 minutes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2743978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0-15 minutes</VALIDVALUE>
          <VALUEMEANING>0-15 minutes</VALUEMEANING>
          <MEANINGDESCRIPTION>0-15 minutes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2743979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How much time did it take the</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How much time did it take the patient to travel to the dental office today</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Restorative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1137">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2746311</PUBLICID>
    <LONGNAME>Adverse Event Ongoing Event Indicator</LONGNAME>
    <PREFERREDNAME>AE_ONGOING_EVENT_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The flag used to indicate whether the adverse event has resolved or not.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>caBIG:Cancer Biomedical Informatics Grid</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2235998</PublicId>
      <PreferredName>AE_ONGOING_EVENT</PreferredName>
      <PreferredDefinition>information relating to adverse event ongoing event.</PreferredDefinition>
      <LongName>Adverse Event Ongoing Event</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2235992</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2235996</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL259742:C25499</PreferredName>
        <Version>1</Version>
        <LongName>Ongoing episode Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL259742</PREFERRED_NAME>
            <LONG_NAME>Ongoing episode</LONG_NAME>
            <CON_ID>2235994</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181608</PublicId>
      <PreferredName>Y_N_CHAR_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Character Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AE Ongoing?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>AE Ongoing?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Optional NCI Standard CRF Question</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>No requirement for inclusion on CRF; use this data element if needed.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Treatment ongoing</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is AE Ongoing?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF_Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Ongoing?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Alternate Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>AE ongoing</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Adverse Event Ongoing?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859992</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000681</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858960</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Adopted</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caAERS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4861354</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858960</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Adopted</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RAVE Integrations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5858963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858960</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Adopted</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAE</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5858965</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>102960</AlternateName>
        <AlternateNameType>COG GDE #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>OngoingAE</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_ONGOING_EVENT_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>AE_ONGOING_EVENT_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRDS</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCTG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE_ONGOING_EVENT_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1138">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2746423</PUBLICID>
    <LONGNAME>During Hematopoietic Cell Graft Manipulation Anti-CD52 Monoclonal Antibody Administered Indicator</LONGNAME>
    <PREFERREDNAME>MAN_ANT_CD52_ADM_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not anti CD52 monoclonal antibody was used during the hematopoietic cell graft manipulation.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2746421</PublicId>
      <PreferredName>MANI_ANTI_CD52-ADM</PreferredName>
      <PreferredDefinition>At some point in a given period of time._Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body._Move, treat, or operate with the hands or by mechanical means, especially in a skillful manner._Any monoclonal antibody directed against the cell surface glycoprotein CD52, regardless of the antibody type (e.g., rat, mouse, humanized)._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>During Hematopoietic Cell Graft Manipulation Anti-CD52 Monoclonal Antibody Administered</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435033</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16847</PreferredName>
        <Version>1</Version>
        <LongName>Techniques</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2744969</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25490:C12551:C12981:C48310</PreferredName>
        <Version>1</Version>
        <LongName>During Hematopoietic Stem Cell Transplant Manipulation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48310</PREFERRED_NAME>
            <LONG_NAME>Manipulation</LONG_NAME>
            <CON_ID>2437660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2746419</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C72960:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Anti-CD52 Monoclonal Antibody Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C72960</PREFERRED_NAME>
            <LONG_NAME>Anti-CD52 Monoclonal Antibody</LONG_NAME>
            <CON_ID>2735702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was anti CD52 used during pro</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was anti CD52 used during product manipulation?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>anti CD52</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>anti CD52</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was anti CD52 used during graft manipulation?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was anti CD52 used during graft manipulation?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Anti CD52</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Anti CD52</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Anti CD52</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Anti CD52</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping for CDE:2746423</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>[IF EXISTS THEN &quot;true&quot; ELSE &quot;false&quot;] MaterialName.name = &quot;CD52 Antigen&quot; WHERE MaterialName &gt; Product.typeCode = &quot;antibody&quot; AND Product [antibody, used Material] &gt; PerformedMaterialProcessStep AND Biologic [pre-processed HCT product] &gt; Subject &gt; PerformedMaterialProcessStep &gt; Biologic [processed HCT product]</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2100r1: 100 Days Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964902</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2006r1: HSCT Infusion</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2200r1: 6 Month to 2 Year Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964922</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2300r1: Greater Than 2 Years Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_proc_manip_ab_cd52_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>During Hematopoietic Stem Cell Graft Manipulation Anti-CD52 Monoclonal Antibody Administered Indicator</AlternateName>
        <AlternateNameType>System-Generated</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MaterialName:name</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1139">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2748135</PUBLICID>
    <LONGNAME>Meddra Low Level Term MedDRA Code java.lang.String</LONGNAME>
    <PREFERREDNAME>2747871v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Lowest level of the terminology, related to a single PT as a synonym, lexical variant, or quasi-synonym._An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology.:A system, often of numbered categories, used for representation of data._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2747871</PublicId>
      <PreferredName>2747547v1.0:2734836v1.0</PreferredName>
      <PreferredDefinition>Lowest level of the terminology, related to a single PT as a synonym, lexical variant, or quasi-synonym._An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology.:A system, often of numbered categories, used for representation of data.</PreferredDefinition>
      <LongName>Meddra Low Level Term MedDRA Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2747547</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71886</PreferredName>
        <Version>1</Version>
        <LongName>Meddra Low Level Term</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71886</PREFERRED_NAME>
            <LONG_NAME>MedDRA Lowest Level Term</LONG_NAME>
            <CON_ID>2747438</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2734836</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43820:C25162</PreferredName>
        <Version>1</Version>
        <LongName>MedDRA Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43820</PREFERRED_NAME>
            <LONG_NAME>MedDRA</LONG_NAME>
            <CON_ID>2469032</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Meddra Low Level Term MedDRA Code java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Meddra Low Level Term MedDRA Code java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain.meddra</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.meddra.LowLevelTerm.meddraCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LowLevelTerm:meddraCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1140">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752572</PUBLICID>
    <LONGNAME>Special Laboratory Procedure Laboratory Procedure Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2752056v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Surpassing what is common or usual or expected.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752056</PublicId>
      <PreferredName>2751995v1.0:2751738v1.0</PreferredName>
      <PreferredDefinition>Surpassing what is common or usual or expected.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Special Laboratory Procedure Laboratory Procedure Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2751995</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25684:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Special Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25684</PREFERRED_NAME>
            <LONG_NAME>Special</LONG_NAME>
            <CON_ID>2206254</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2751738</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Special Laboratory Procedure Laboratory Procedure Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Special Laboratory Procedure Laboratory Procedure Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.LabSpecial.dateTest</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LabSpecial:dateTest</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1141">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752761</PUBLICID>
    <LONGNAME>Neoplasm Specimen Biopsy Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2752245v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An abnormal tissue growth resulted from uncontrolled cell proliferation.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752245</PublicId>
      <PreferredName>2752001v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>An abnormal tissue growth resulted from uncontrolled cell proliferation.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Neoplasm Specimen Biopsy Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2752001</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3262:C19157:C15189</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm Specimen Biopsy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15189</PREFERRED_NAME>
            <LONG_NAME>Biopsy Procedure</LONG_NAME>
            <CON_ID>2202502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Neoplasm Specimen Biopsy Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Neoplasm Specimen Biopsy Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.TumorSpecimenBiopsy.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TumorSpecimenBiopsy:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1142">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752772</PUBLICID>
    <LONGNAME>On Study Complete Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2752256v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Actively participating in a study._To possess every necessary or normal part or component or step; having come or been brought to a conclusion.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752256</PublicId>
      <PreferredName>2752002v1.0:2475300v1.0</PreferredName>
      <PreferredDefinition>Actively participating in a study._To possess every necessary or normal part or component or step; having come or been brought to a conclusion.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>On Study Complete Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2752002</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C73469</PreferredName>
        <Version>1</Version>
        <LongName>On Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73469</PREFERRED_NAME>
            <LONG_NAME>On Study</LONG_NAME>
            <CON_ID>2751695</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2475300</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25250:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Complete Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25250</PREFERRED_NAME>
            <LONG_NAME>Complete</LONG_NAME>
            <CON_ID>2203885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element On Study Complete Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element On Study Complete Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.OnStudy.dateComplete</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OnStudy:dateComplete</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1143">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2756567</PUBLICID>
    <LONGNAME>Messenger RNA Accession Number java.lang.String</LONGNAME>
    <PREFERREDNAME>2756481v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Messenger RNA.  A class of RNA molecules that contain protein-coding information in their nucleotide sequence and can be translated into the amino acid sequence of a protein. Bacterial mRNAs are generally primary transcripts in that they do not require po_A control number unique to an object, used to identify it among the other objects in a collection._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2756481</PublicId>
      <PreferredName>2322230v1.0:2223255v1.0</PreferredName>
      <PreferredDefinition>Messenger RNA.  A class of RNA molecules that contain protein-coding information in their nucleotide sequence and can be translated into the amino acid sequence of a protein. Bacterial mRNAs are generally primary transcripts in that they do not require po_A control number unique to an object, used to identify it among the other objects in a collection.</PreferredDefinition>
      <LongName>Messenger RNA Accession Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2322230</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C813</PreferredName>
        <Version>1</Version>
        <LongName>Messenger RNA</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C813</PREFERRED_NAME>
            <LONG_NAME>Messenger RNA</LONG_NAME>
            <CON_ID>2322221</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223255</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25402</PreferredName>
        <Version>1</Version>
        <LongName>Accession Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25402</PREFERRED_NAME>
            <LONG_NAME>Accession Number</LONG_NAME>
            <CON_ID>2203569</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Messenger RNA Accession Number java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Messenger RNA Accession Number java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000539</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714661</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000543</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caBIO</PreferredName>
          <Version>4.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabio.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000544</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabio.domain.MessengerRNA.accessionNumber</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MessengerRNA:accessionNumber</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1144">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2761889</PUBLICID>
    <LONGNAME>Hematopoietic Stem Cell Graft Autologous Source Yes No Character Indicator</LONGNAME>
    <PREFERREDNAME>HSCT_AUTO_SRC_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the donor source of the hematopoietic stem cell graft was autologous.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2761838</PublicId>
      <PreferredName>HSCT_AUTO_SRC</PreferredName>
      <PreferredDefinition>Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body._(aw-TAHL-o-gus) Taken from an individual&#39;s own tissues, cells, or DNA._Where something is available or from where it originates.</PreferredDefinition>
      <LongName>Hematopoietic Stem Cell Graft Autologous Source</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2531884</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12551:C12981</PreferredName>
        <Version>1</Version>
        <LongName>Hematopoietic Stem Cell Transplant</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2761836</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28000:C25683</PreferredName>
        <Version>1</Version>
        <LongName>Autologous Source</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28000</PREFERRED_NAME>
            <LONG_NAME>Autologous</LONG_NAME>
            <CON_ID>2205429</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25683</PREFERRED_NAME>
            <LONG_NAME>Source</LONG_NAME>
            <CON_ID>2202479</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181608</PublicId>
      <PreferredName>Y_N_CHAR_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Character Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the donor type of this HS</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the donor type of this HSCT autologous?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Autologous HSCT?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Autologous HSCT?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Donor Type: Autologous</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Donor Type: Autologous</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2761889</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedSubstanceAdministration &gt; SubstanceExtractionAdministrationRelationship.relationCode</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>pre_ted_hsct_auto_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SubstanceExtractionAdministrationRelationship:relationCode</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1145">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2762314</PUBLICID>
    <LONGNAME>Person Ancillary Study Registration Ind-2</LONGNAME>
    <PREFERREDNAME>PER_ANCSTD_AFFIL_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether a person is enrolled on a primary or secondary study at a qualified institution.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2762313</PublicId>
      <PreferredName>PER_ANCSTDY_REG</PreferredName>
      <PreferredDefinition>information related to a person&#39;s enrollment on a secondary study in addition to the primary study.</PreferredDefinition>
      <LongName>Person Ancillary Study Registration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2762311</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16041:C25646</PreferredName>
        <Version>1</Version>
        <LongName>Ancillary Study Registration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16041</PREFERRED_NAME>
            <LONG_NAME>Ancillary Study</LONG_NAME>
            <CON_ID>2762310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25646</PREFERRED_NAME>
            <LONG_NAME>Registration</LONG_NAME>
            <CON_ID>2202799</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the patient registered on</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the patient registered on E3A05 - Ancillary laboratory protocol for collecting diagnostic material on patients considered for studies of plasma cell disorders</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient consent to participate in 70501</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is your site accredited to participate in the imaging component of this study, ACRIN 6695</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the institution pre-qualified by ACRIN for breast MRI acquisition</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the patient registered to a therapeutic ECOG protocol?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol/Admin.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811961</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000175</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PER_ANCSTD_AFFIL_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1146">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2764195</PUBLICID>
    <LONGNAME>Dentist Dental United States Canada Journal Use Specify</LONGNAME>
    <PREFERREDNAME>DENT_D_US_C_JO_US_SP</PREFERREDNAME>
    <PREFERREDDEFINITION>the free-text field related to use United States or Canadian journal by dentist.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2764183</PublicId>
      <PreferredName>DENT_DE_US_C_JOUR_US</PreferredName>
      <PreferredDefinition>information related to use United States or Canadian journal by dentist.</PreferredDefinition>
      <LongName>Dentist Dental United States Canada Journal Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443308</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52654</PreferredName>
        <Version>1</Version>
        <LongName>Dentist</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52654</PREFERRED_NAME>
            <LONG_NAME>Dentist</LONG_NAME>
            <CON_ID>2443130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2764181</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C17234:C16380:C40976:C2</PreferredName>
        <Version>1</Version>
        <LongName>Dental United States Canada Journal Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17234</PREFERRED_NAME>
            <LONG_NAME>United States</LONG_NAME>
            <CON_ID>2480138</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16380</PREFERRED_NAME>
            <LONG_NAME>Canada</LONG_NAME>
            <CON_ID>2202409</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40976</PREFERRED_NAME>
            <LONG_NAME>Journal</LONG_NAME>
            <CON_ID>2223994</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2188481</PublicId>
      <PreferredName>INDS_SPEC</PreferredName>
      <PreferredDefinition>the free-text field to related to a specified attribute of an individual.</PreferredDefinition>
      <LongName>Individual Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other US or Canadian publicat</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other US or Canadian publication</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1147">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2771376</PUBLICID>
    <LONGNAME>Microarray Part Life Sciences Identifier Organizational Unit java.lang.String</LONGNAME>
    <PREFERREDNAME>2771196v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A microarray is a piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues._One of the portions into which something is regarded as divided and which together constitute a whole.:A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:Organizational unit like a laboratory, institute or consortium._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2771196</PublicId>
      <PreferredName>2223346v1.0:2771055v1.0</PreferredName>
      <PreferredDefinition>A microarray is a piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues._One of the portions into which something is regarded as divided and which together constitute a whole.:A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:Organizational unit like a laboratory, institute or consortium.</PreferredDefinition>
      <LongName>Microarray Part Life Sciences Identifier Organizational Unit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223346</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C44282</PreferredName>
        <Version>1</Version>
        <LongName>Microarray</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44282</PREFERRED_NAME>
            <LONG_NAME>Microarray</LONG_NAME>
            <CON_ID>2223237</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2771055</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45313:C47841:C41167</PreferredName>
        <Version>1</Version>
        <LongName>Part Life Sciences Identifier Organizational Unit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45313</PREFERRED_NAME>
            <LONG_NAME>Part</LONG_NAME>
            <CON_ID>2405237</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47841</PREFERRED_NAME>
            <LONG_NAME>Life Sciences Identifier</LONG_NAME>
            <CON_ID>2423426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41167</PREFERRED_NAME>
            <LONG_NAME>Organizational Unit</LONG_NAME>
            <CON_ID>2223214</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Microarray Part Life Sciences Identifier Organizational Unit java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Microarray Part Life Sciences Identifier Organizational Unit java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.array</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812742</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.array.Array.lsidAuthority</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Array:lsidAuthority</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1148">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2783621</PUBLICID>
    <LONGNAME>Generalized Health Diagnosis Diagnosis Age java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2782861v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Widespread; broadly dispersed.:Health refers to a person&#39;s state of physical, mental and social well-being; usually it refers specifically to the state of being in good health, a state of complete physical, mental and social well-being, and does not consist only of the absence of disease or infirmity. In any organism health constitutes a form of homeostasis with inputs and outputs of energy and mass in approximate equilibrium allowing for growth and continued survival. In humans, a subjective feeling of well-being coming from somatic and cognitive perceptions is considered an essential component of health.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:How long something has existed; elapsed time since birth._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2782861</PublicId>
      <PreferredName>2782740v1.0:2554159v1.0</PreferredName>
      <PreferredDefinition>Widespread; broadly dispersed.:Health refers to a person&#39;s state of physical, mental and social well-being; usually it refers specifically to the state of being in good health, a state of complete physical, mental and social well-being, and does not consist only of the absence of disease or infirmity. In any organism health constitutes a form of homeostasis with inputs and outputs of energy and mass in approximate equilibrium allowing for growth and continued survival. In humans, a subjective feeling of well-being coming from somatic and cognitive perceptions is considered an essential component of health.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:How long something has existed; elapsed time since birth.</PreferredDefinition>
      <LongName>Generalized Health Diagnosis Diagnosis Age</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2782740</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63764:C25178:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Generalized Health Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63764</PREFERRED_NAME>
            <LONG_NAME>Generalized</LONG_NAME>
            <CON_ID>2547905</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25178</PREFERRED_NAME>
            <LONG_NAME>Health</LONG_NAME>
            <CON_ID>2202325</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2554159</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220:C25150</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis Age</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25150</PREFERRED_NAME>
            <LONG_NAME>Age</LONG_NAME>
            <CON_ID>2202837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Generalized Health Diagnosis Diagnosis Age java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Generalized Health Diagnosis Diagnosis Age java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.ClinicalAnnotation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000155</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.ClinicalAnnotation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.ClinicalAnnotation.GeneralHealthDiagnosis.ageAtDiagnosis</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GeneralHealthDiagnosis:ageAtDiagnosis</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1149">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2783776</PUBLICID>
    <LONGNAME>Extraprostatic Extension Status ExtraprostaticExtensionStatus</LONGNAME>
    <PREFERREDNAME>2783011v1.0:2783441v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Situated outside of the prostate.:An addition to the length of something; the spreading of something into new regions._A condition or state at a particular time._The status of the extraprostatic extension</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2783011</PublicId>
      <PreferredName>2782790v1.0:2320064v1.0</PreferredName>
      <PreferredDefinition>Situated outside of the prostate.:An addition to the length of something; the spreading of something into new regions._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Extraprostatic Extension Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2782790</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25505:C25270</PreferredName>
        <Version>1</Version>
        <LongName>Extraprostatic Extension</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25505</PREFERRED_NAME>
            <LONG_NAME>Extraprostatic</LONG_NAME>
            <CON_ID>2206212</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25270</PREFERRED_NAME>
            <LONG_NAME>Extend</LONG_NAME>
            <CON_ID>2203922</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2320064</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2783441</PublicId>
      <PreferredName>2783441v1.0</PreferredName>
      <PreferredDefinition>The status of the extraprostatic extension</PreferredDefinition>
      <LongName>ExtraprostaticExtensionStatus</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2513925</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43431</PreferredName>
        <Version>1</Version>
        <LongName>Activity</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>notSpecified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2573360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Extraprostatic Extension Status ExtraprostaticExtensionStatus does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Extraprostatic Extension Status ExtraprostaticExtensionStatus does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_SCG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000322</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_SCG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000323</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ExtraprostaticExtension:status</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.PathAnnotation_SCG.ExtraprostaticExtension.status</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1150">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2783841</PUBLICID>
    <LONGNAME>Melanoma Pathology Ulceration MelanomaUlceration</LONGNAME>
    <PREFERREDNAME>2783076v1.0:2783435v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.:The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination._Ulceration is the formation or development of an ulcer. (NCI)_Development of an ulcer</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2783076</PublicId>
      <PreferredName>2782815v1.0:2431241v1.0</PreferredName>
      <PreferredDefinition>A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.:The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination._Ulceration is the formation or development of an ulcer. (NCI)</PreferredDefinition>
      <LongName>Melanoma Pathology Ulceration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2782815</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3224:C18189</PreferredName>
        <Version>1</Version>
        <LongName>Melanoma Pathology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3224</PREFERRED_NAME>
            <LONG_NAME>Melanoma</LONG_NAME>
            <CON_ID>2202743</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2431241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25757</PreferredName>
        <Version>1</Version>
        <LongName>Ulceration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25757</PREFERRED_NAME>
            <LONG_NAME>Ulceration</LONG_NAME>
            <CON_ID>2203971</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2783435</PublicId>
      <PreferredName>2783435v1.0</PreferredName>
      <PreferredDefinition>Development of an ulcer</PreferredDefinition>
      <LongName>MelanomaUlceration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>notSpecified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2573360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Melanoma Pathology Ulceration MelanomaUlceration does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Melanoma Pathology Ulceration MelanomaUlceration does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_SCG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000322</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_SCG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000323</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.PathAnnotation_SCG.MelanomaPathologyAnnotation.ulceration</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MelanomaPathologyAnnotation:ulceration</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1151">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2783875</PUBLICID>
    <LONGNAME>Specimen Gleason Score Tertiary Gleason Score for Prostate Cancer GleasonTertiaryScore</LONGNAME>
    <PREFERREDNAME>2783110v1.0:2783590v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.:A system of grading prostate cancer cells to determine the best treatment and to predict how well a person is likely to do. A low Gleason score means the cancer cells are very similar to normal prostate cells; a high Gleason score means the cancer cells are very different from normal. _definition pending_Tertiary pattern</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2783110</PublicId>
      <PreferredName>2206585v1.0:2431266v1.0</PreferredName>
      <PreferredDefinition>Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.:A system of grading prostate cancer cells to determine the best treatment and to predict how well a person is likely to do. A low Gleason score means the cancer cells are very similar to normal prostate cells; a high Gleason score means the cancer cells are very different from normal. _definition pending</PreferredDefinition>
      <LongName>Specimen Gleason Score Tertiary Gleason Score for Prostate Cancer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206585</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157:C28084</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Gleason Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28084</PREFERRED_NAME>
            <LONG_NAME>Gleason Score for Prostate Cancer</LONG_NAME>
            <CON_ID>2202653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2431266</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48605</PreferredName>
        <Version>1</Version>
        <LongName>Tertiary Gleason Score for Prostate Cancer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48605</PREFERRED_NAME>
            <LONG_NAME>Tertiary Gleason Pattern</LONG_NAME>
            <CON_ID>2431191</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2783590</PublicId>
      <PreferredName>2783590v1.0</PreferredName>
      <PreferredDefinition>Tertiary pattern</PreferredDefinition>
      <LongName>GleasonTertiaryScore</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2193207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Gleason Pattern 3</VALUEMEANING>
          <MEANINGDESCRIPTION>A pattern of prostate carcinoma characterized by the presence of glands that are infiltrative and vary in size and shape. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2925237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Gleason Pattern 4</VALUEMEANING>
          <MEANINGDESCRIPTION>A pattern of prostate carcinoma characterized by the presence of fused, cribriform, or poorly defined glands. There is partial loss of normal epithelial polarity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28088</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2925238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Gleason Pattern 5</VALUEMEANING>
          <MEANINGDESCRIPTION>A pattern of prostate carcinoma characterized by almost complete loss of epithelial polarity and luminal differentiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2925239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Specimen Gleason Score Tertiary Gleason Score for Prostate Cancer GleasonTertiaryScore does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Specimen Gleason Score Tertiary Gleason Score for Prostate Cancer GleasonTertiaryScore does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_Specimen</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_Specimen</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SpecimenGleasonScore:tertiaryPattern</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.PathAnnotation_Specimen.SpecimenGleasonScore.tertiaryPattern</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.PathAnnotation_Specimen.ProstateSpecimenGleasonScore.tertiaryPattern</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProstateSpecimenGleasonScore:tertiaryPattern</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Tertiary Pattern</AlternateName>
        <AlternateNameType>TCGA_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>tertiary_pattern</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1152">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2783894</PUBLICID>
    <LONGNAME>Quarantine Event Parameter Status QuarantineEventParameterStatus</LONGNAME>
    <PREFERREDNAME>2783129v1.0:2783562v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Place into enforced isolation.:Something that happens at a given place and time.:Any factor that defines a system and determines (or limits) its performance._A condition or state at a particular time._Event associated with the isolation of an errorneous de-identified report because it contains identified data</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2783129</PublicId>
      <PreferredName>2782838v1.0:2320064v1.0</PreferredName>
      <PreferredDefinition>Place into enforced isolation.:Something that happens at a given place and time.:Any factor that defines a system and determines (or limits) its performance._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Quarantine Event Parameter Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2782838</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71902:C25499:C44175</PreferredName>
        <Version>1</Version>
        <LongName>Quarantine Event Parameter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71902</PREFERRED_NAME>
            <LONG_NAME>Quarantine</LONG_NAME>
            <CON_ID>2730266</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44175</PREFERRED_NAME>
            <LONG_NAME>Parameter</LONG_NAME>
            <CON_ID>2236569</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2320064</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2783562</PublicId>
      <PreferredName>2783562v1.0</PreferredName>
      <PreferredDefinition>Event associated with the isolation of an errorneous de-identified report because it contains identified data</PreferredDefinition>
      <LongName>QuarantineEventParameterStatus</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2513925</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43431</PreferredName>
        <Version>1</Version>
        <LongName>Activity</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>notReviewed</VALIDVALUE>
          <VALUEMEANING>Not Reviewed</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Having been appraised, evaluated, or analyzed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45314, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2663090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>replied</VALIDVALUE>
          <VALUEMEANING>Return Communication</VALUEMEANING>
          <MEANINGDESCRIPTION>The exchange of information between objects, people, or groups.:To give something back, or the getting back thereof.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71900, C16452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2783487</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>reviewed</VALIDVALUE>
          <VALUEMEANING>Reviewed</VALUEMEANING>
          <MEANINGDESCRIPTION>Having been appraised, evaluated, or analyzed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2649692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pending</VALIDVALUE>
          <VALUEMEANING>Pending</VALUEMEANING>
          <MEANINGDESCRIPTION>Not yet decided or settled; awaiting conclusion or confirmation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2784518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Quarantine Event Parameter Status QuarantineEventParameterStatus does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Quarantine Event Parameter Status QuarantineEventParameterStatus does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.pathology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000671</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.pathology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000670</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QuarantineEventParameter:status</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.pathology.QuarantineEventParameter.status</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1153">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2783984</PUBLICID>
    <LONGNAME>Local Excision Colorectal Pathology Surgical Procedure SpecimenProcedure</LONGNAME>
    <PREFERREDNAME>2783216v1.0:2783504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Of or belonging to a restricted area or locality.:The act of cutting out; the surgical removal of part or all of a structure or organ.:Relating to the colon and rectum, or to the entire large bowel.:The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination._Surgical Procedure is a diagnostic or treatment medical procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue._The procedure used to obtain a sample fpr pathological studies</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2783216</PublicId>
      <PreferredName>2782788v1.0:2431206v1.0</PreferredName>
      <PreferredDefinition>Of or belonging to a restricted area or locality.:The act of cutting out; the surgical removal of part or all of a structure or organ.:Relating to the colon and rectum, or to the entire large bowel.:The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination._Surgical Procedure is a diagnostic or treatment medical procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue.</PreferredDefinition>
      <LongName>Local Excision Colorectal Pathology Surgical Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2782788</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C67263:C15232:C13363:C18189</PreferredName>
        <Version>1</Version>
        <LongName>Local Excision Colorectal Pathology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67263</PREFERRED_NAME>
            <LONG_NAME>Local</LONG_NAME>
            <CON_ID>2676068</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15232</PREFERRED_NAME>
            <LONG_NAME>Excision</LONG_NAME>
            <CON_ID>2202806</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13363</PREFERRED_NAME>
            <LONG_NAME>Colorectal</LONG_NAME>
            <CON_ID>2202379</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2431206</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2783504</PublicId>
      <PreferredName>2783504v1.0</PreferredName>
      <PreferredDefinition>The procedure used to obtain a sample fpr pathological studies</PreferredDefinition>
      <LongName>SpecimenProcedure Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2658077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25218</PreferredName>
        <Version>1</Version>
        <LongName>Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Incisional Biopsy</VALIDVALUE>
          <VALUEMEANING>Incisional Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>A surgical procedure in which part of a lesion is removed for microscopic examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Excisional Biopsy - polypectomy</VALIDVALUE>
          <VALUEMEANING>Polypectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Polypectomy; surgical removal of a polyp.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2794442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Excision</VALIDVALUE>
          <VALUEMEANING>Resection</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of cutting out; the surgical removal of part or all of a structure or organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biopsy</VALIDVALUE>
          <VALUEMEANING>Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aspirate</VALIDVALUE>
          <VALUEMEANING>Aspiration</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal of fluid or a sample of fluid and cells through a needle. (from medicinenet.com)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15631</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Modified Radical Mastectomy</VALIDVALUE>
          <VALUEMEANING>Modified Radical Mastectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgery for breast cancer in which the breast, most or all of the lymph nodes under the arm, and the lining over the chest muscles are removed. Sometimes the surgeon also removes part of the chest wall muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mastectomy</VALIDVALUE>
          <VALUEMEANING>Mastectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgical removal of the breast.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphadenectomy - sentinel nodes</VALIDVALUE>
          <VALUEMEANING>Sentinel Lymph Node Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgical removal and examination of the sentinel node, the lymph node which is first in receiving the lymphatic drainage of a specified anatomic location and is most likely to be affected by the lymphatic spread of cancer. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Local Excision - Transanal Disk Excision</VALIDVALUE>
          <VALUEMEANING>Transanal Excision</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgery for rectal cancer that spares the anus and leaves the sphincter intact. Surgery is performed through the anus and removes only the rectal tumor and small amounts of surrounding tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lobectomy</VALIDVALUE>
          <VALUEMEANING>Lobectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>(lo-BEK-toe-mee) The removal of a lobe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transurethral Prostatic Resection</VALIDVALUE>
          <VALUEMEANING>Transurethral Prostatic Resection</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgical procedure to remove tissue from the prostate using an instrument inserted through the urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radical Prostatectomy</VALIDVALUE>
          <VALUEMEANING>Radical prostatectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgery to remove the entire prostate. The two types of radical prostatectomy are retropubic prostatectomy and perineal prostatectomy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate Gland Needle Biopsy</VALIDVALUE>
          <VALUEMEANING>Needle Biopsy of Prostate</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal of tissue from the prostate for microscopic examination, using a needle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2794444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pneumonectomy</VALIDVALUE>
          <VALUEMEANING>Pneumonectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>(noo-mo-NEK-toe-mee) An operation to remove an entire lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15305</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Specified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Needle Incisional Biopsy</VALIDVALUE>
          <VALUEMEANING>Needle Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>The removal of tissue or fluid with a needle for examination under a microscope. Also called fine-needle aspiration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2794445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wedge Needle Biopsy</VALIDVALUE>
          <VALUEMEANING>Wedge Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal of a wedge-shaped portion of tissue, for microscopic examinaton.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51916</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wedge Biopsy</VALIDVALUE>
          <VALUEMEANING>Wedge Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal of a wedge-shaped portion of tissue, for microscopic examinaton.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51916</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radical Mastectomy</VALIDVALUE>
          <VALUEMEANING>Radical Mastectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal of the breast, pectoral muscles, axillary lymph nodes, and associated skin and subcutaneous tissue (from MeSH).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2839762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial Nephrectomy</VALIDVALUE>
          <VALUEMEANING>partial nephrectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The surgical removal of a portion of a kidney.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51928</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wedge Resection</VALIDVALUE>
          <VALUEMEANING>Wedge Excision</VALUEMEANING>
          <MEANINGDESCRIPTION>No Value Exists</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51690</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2839764</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radical Nephrectomy</VALIDVALUE>
          <VALUEMEANING>radical nephrectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgical removal of a kidney, the adrenal gland, adjacent lymph nodes, and other surrounding tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51778</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Whipple Resection - Pancreaticoduodenectomy - Total Pancreatectomy</VALIDVALUE>
          <VALUEMEANING>Whipple Resection - Pancreaticoduodenectomy - Total Pancreatectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Whipple Resection - Pancreaticoduodenectomy - Total Pancreatectomy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Whipple Resection - Pancreaticoduodenectomy - Partial Pancreatectomy</VALIDVALUE>
          <VALUEMEANING>Whipple Resection - Pancreaticoduodenectomy - Partial Pancreatectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Whipple Resection - Pancreaticoduodenectomy - Partial Pancreatectomy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trephine Biopsy</VALIDVALUE>
          <VALUEMEANING>Trephine Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Trephine Biopsy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transbronchial Biopsy</VALIDVALUE>
          <VALUEMEANING>Transbronchial Lung Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal of tissue through the bronchial wall, for microscopic examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51749</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Total Resection</VALIDVALUE>
          <VALUEMEANING>Total Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to an entirety or whole, also constituting the full quantity or extent; complete.: A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17173, C25304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Major Airway Resection</VALIDVALUE>
          <VALUEMEANING>Major Airway Resection</VALUEMEANING>
          <MEANINGDESCRIPTION>Major Airway Resection</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinoscopic Biopsy</VALIDVALUE>
          <VALUEMEANING>Mediastinoscopic Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Mediastinoscopic Biopsy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Open Biopsy</VALIDVALUE>
          <VALUEMEANING>Incisional Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>A surgical procedure in which part of a lesion is removed for microscopic examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatic Tail Partial Pancreatectomy</VALIDVALUE>
          <VALUEMEANING>Tail of the Pancreas Partial Pancreatectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The left extremity of the pancreas within the lienorenal ligament.: Surgical removal of part of the pancreas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51666, C12271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatic Body Partial Pancreatectomy</VALIDVALUE>
          <VALUEMEANING>Body of the Pancreas Partial Pancreatectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the pancreas from the point where it crosses the portal vein to the point where it enters the lienorenal ligament.: Surgical removal of part of the pancreas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51666, C12270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925519</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Excision - wide</VALIDVALUE>
          <VALUEMEANING>Broad Excision</VALUEMEANING>
          <MEANINGDESCRIPTION>Very large in expanse or scope; having great extent from one side to the other.: Removal or excision by surgical measures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15232, C61485</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Excision - other</VALIDVALUE>
          <VALUEMEANING>Other Excision</VALUEMEANING>
          <MEANINGDESCRIPTION>Not otherwise specified.: Removal or excision by surgical measures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C15232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Excision - ellipse</VALIDVALUE>
          <VALUEMEANING>Ellipse Excision</VALUEMEANING>
          <MEANINGDESCRIPTION>A closed plane curve resulting from the intersection of a circular cone and a plane cutting completely through it, especially a plane not parallel to the base.: Removal or excision by surgical measures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15232, C64362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Computed Tomography-guided Needle Biopsy</VALIDVALUE>
          <VALUEMEANING>Computed Tomography Image Guided Biopsy Needle Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. : The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis, using imaging technology.: The removal of tissue or fluid with a needle for examination under a microscope. Also called fine-needle aspiration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15190, C15652, C17204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cell Block</VALIDVALUE>
          <VALUEMEANING>Cell Block</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.: Blocks; refers to preserved specimens embedded in support material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25436, C12508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Both Aspirate and Biopsy</VALIDVALUE>
          <VALUEMEANING>Both Aspirate and Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Both Aspirate and Biopsy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood film</VALIDVALUE>
          <VALUEMEANING>Blood film</VALUEMEANING>
          <MEANINGDESCRIPTION>Blood film</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphadenectomy - regopnal nodes</VALIDVALUE>
          <VALUEMEANING>Lymphadenectomy - regopnal nodes</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymphadenectomy - regopnal nodes</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fiberoptic Bronchoscopic Biopsy</VALIDVALUE>
          <VALUEMEANING>Fiberoptic Bronchoscopic Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Fiberoptic Bronchoscopic Biopsy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suprapubic or Retropubic Enucleation</VALIDVALUE>
          <VALUEMEANING>Suprapubic or Retropubic Enucleation</VALUEMEANING>
          <MEANINGDESCRIPTION>Suprapubic or Retropubic Enucleation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Subtotal or Partial Resection</VALIDVALUE>
          <VALUEMEANING>Subtotal or Partial Resection</VALUEMEANING>
          <MEANINGDESCRIPTION>Subtotal or Partial Resection</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stereotactic Needle Core Biopsy</VALIDVALUE>
          <VALUEMEANING>Stereotactic needle core biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>combine the         Surgical procedure in which  tissue is obtained using either computed tomography or magnetic resonance imaging (MRI). The procedure is done in awake (usually sedated) patients or under general anesthesia. For either computed tomography or MRI, the lesion is imaged in reference to a frame attached to the skull, from which stereotactic coordinates are computed for selected target points.  The technique combines the advantages of FNA (no scar, no anesthesia, inexpensive), excisional biopsy (acquisition of solid pieces of tissue rather than smears) and needle localization (precise guidance by x-ray or ultrasound imaging).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Segmentectomy</VALIDVALUE>
          <VALUEMEANING>Segmentectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Resection of a segment of an organ or partial resection of a gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91061</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Segmental Resection</VALIDVALUE>
          <VALUEMEANING>SEGMENTAL RESECTION</VALUEMEANING>
          <MEANINGDESCRIPTION>SEGMENTAL RESECTION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Re-Excision - wide</VALIDVALUE>
          <VALUEMEANING>Broad Repeat Excision</VALUEMEANING>
          <MEANINGDESCRIPTION>Very large in expanse or scope; having great extent from one side to the other.: Make or do or perform again.: Removal or excision by surgical measures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15232, C47886, C61485</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Re-Excision - Other</VALIDVALUE>
          <VALUEMEANING>Other Repeat Excision</VALUEMEANING>
          <MEANINGDESCRIPTION>Not otherwise specified.: Make or do or perform again.: Removal or excision by surgical measures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15232, C47886, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Re-Excision - ellipse</VALIDVALUE>
          <VALUEMEANING>Ellipse Repeat Excision</VALUEMEANING>
          <MEANINGDESCRIPTION>A closed plane curve resulting from the intersection of a circular cone and a plane cutting completely through it, especially a plane not parallel to the base.: Make or do or perform again.: Removal or excision by surgical measures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15232, C47886, C64362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectal Resection</VALIDVALUE>
          <VALUEMEANING>Rectal Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>Rectal; of, or pertaining to, the rectum.: A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17173, C25224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pylorus Sparing - Pancreaticoduodenectomy - Total Pancreatectomy</VALIDVALUE>
          <VALUEMEANING>Pylorus Sparing - Pancreaticoduodenectomy - Total Pancreatectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Pylorus Sparing - Pancreaticoduodenectomy - Total Pancreatectomy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pylorus Sparing - Pancreaticoduodenectomy - Partial Pancreatectomy</VALIDVALUE>
          <VALUEMEANING>Pylorus Sparing - Pancreaticoduodenectomy - Partial Pancreatectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Pylorus Sparing - Pancreaticoduodenectomy - Partial Pancreatectomy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2925511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Local Excision Colorectal Pathology Surgical Procedure SpecimenProcedure does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Local Excision Colorectal Pathology Surgical Procedure SpecimenProcedure does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_SCG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000322</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_SCG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000323</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.PathAnnotation_SCG.LocalExcisionBasedColorectalPathologyAnnotation.specimenProcedure</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LocalExcisionBasedColorectalPathologyAnnotation:specimenProcedure</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1154">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2784572</PUBLICID>
    <LONGNAME>Retreatment Administered Type</LONGNAME>
    <PREFERREDNAME>RETC_ADMIN_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of as related to the repeated act of the dispensing, applying, or tendering of something to another after an initial treatment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2743073</PublicId>
      <PreferredName>RETX_ADMIN</PreferredName>
      <PreferredDefinition>information related the repeated act of the dispensing, applying, or tendering of something to another after an initial treatment.</PreferredDefinition>
      <LongName>Retreatment Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2743071</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54055</PreferredName>
        <Version>1</Version>
        <LongName>Retreatment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54055</PREFERRED_NAME>
            <LONG_NAME>Retreatment</LONG_NAME>
            <CON_ID>2597300</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2743850</PublicId>
      <PreferredName>RETX_TP</PreferredName>
      <PreferredDefinition>the type of retreatment.</PreferredDefinition>
      <LongName>Retreatment Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sealant</VALIDVALUE>
          <VALUEMEANING>Sealant</VALUEMEANING>
          <MEANINGDESCRIPTION>A resinous material designed to be applied to the occlusal surfaces of posterior teeth to prevent occlusal decay by filling in the fissures and/or crevices of the tooth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2743851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RBC</VALIDVALUE>
          <VALUEMEANING>Resin-Based Composite</VALUEMEANING>
          <MEANINGDESCRIPTION>A dental restorative material made up of disparate or separate parts (e.g., resin and quartz particles).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2743852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liner+DBA</VALIDVALUE>
          <VALUEMEANING>Dental Bonding Agent Dental Liner</VALUEMEANING>
          <MEANINGDESCRIPTION>An adhesive used to bond various materials to a tooth.: Material applied to the dental tissue or to the tissue side of a denture to provide biological, chemical and physical protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42795, C62092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DBA alone</VALIDVALUE>
          <VALUEMEANING>Dental Bonding Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>An adhesive used to bond various materials to a tooth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Which rescue treatment did th</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Which rescue treatment did the patient receive</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Which rescue treatment was provided</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1155">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2797494</PUBLICID>
    <LONGNAME>Cryptogenic Organizing Pneumonia Occurrence Indicator</LONGNAME>
    <PREFERREDNAME>CRYP_ORG_PNU_OCR_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not cryptogenic organizing pneumonia occurred.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2796057</PublicId>
      <PreferredName>COP_OCUR</PreferredName>
      <PreferredDefinition>A disease formerly considered a form of interstitial pneumonia. Its etiology is obscure but it may be associated with toxic fumes, infection, and connective tissue disease. Clinical symptoms include cough, dyspnea and influenza-like symptoms with the development of the usual interstitial pneumonia in many cases. Obstructive symptoms are limited to smokers. There are patchy polypoid masses of intra-alveolar granulation tissue in small airway lumina and alveolar ducts. &quot;Organizing&quot; refers to unresolved pneumonia (in which the alveolar exudate persists and eventually undergoes fibrosis) in which fibrous tissue forms in the alveoli._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Cryptogenic Organizing Pneumonia Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2796055</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62586</PreferredName>
        <Version>1</Version>
        <LongName>Cryptogenic Organizing Pneumonia</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62586</PREFERRED_NAME>
            <LONG_NAME>Cryptogenic Organizing Pneumonia</LONG_NAME>
            <CON_ID>2521750</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did cryptogenic organizing pn</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did cryptogenic organizing pneumonia (COP) develop?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the recipient develop cryptogenic organizing pneumonia (COP)?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the recipient develop cryptogenic organizing pneumonia (COP)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the recipient develop cryptogenic organizing pneumonia?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the recipient develop cryptogenic organizing pneumonia?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the recipient develop cryptogenic organizing pneumonia (COP / BOOP)?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Did the recipient develop cryptogenic organizing pneumonia (COP / BOOP)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2552643</PublicId>
          <ContextName>Training</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Training Class Examples</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3637837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2100r1: 100 Days Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964902</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2200r1: 6 Month to 2 Year Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964922</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2300r1: Greater Than 2 Years Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>pulm_cop_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_OF_COP_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1156">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2797722</PUBLICID>
    <LONGNAME>Negation Infectious Disorder Liver Toxicity Other Etiology Specify Text</LONGNAME>
    <PREFERREDNAME>NG_ID_LV_TX_OT_ET_SP</PREFERREDNAME>
    <PREFERREDDEFINITION>The free-text field to describe the other non-infectious liver toxicity etiology.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2797295</PublicId>
      <PreferredName>NG_ID_LV_TX_OT_ET</PreferredName>
      <PreferredDefinition>An operation in which a term denies or inverts the meaning of another term or construction._A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003_A triangular-shaped organ located under the diaphragm in the right hypochondrium.  It is the largest internal organ of the body, weighting up to 2 kg.  Metabolism and bile secretion are its main functions.  It is composed of cells which have the ability to regenerate._The finding of bodily harm due to the poisonous effects of something._Different than the one(s) previously specified or mentioned._The cause of a disease.</PreferredDefinition>
      <LongName>Negation Infectious Disorder Liver Toxicity Other Etiology</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2955541</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C26726:C12392:C27990</PreferredName>
        <Version>1</Version>
        <LongName>Negation Infection Liver Toxicity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26726</PREFERRED_NAME>
            <LONG_NAME>Infectious Disorder</LONG_NAME>
            <CON_ID>2203837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12392</PREFERRED_NAME>
            <LONG_NAME>Liver</LONG_NAME>
            <CON_ID>2202332</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C27990</PREFERRED_NAME>
            <LONG_NAME>Toxicity</LONG_NAME>
            <CON_ID>2202546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2596300</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C16390</PreferredName>
        <Version>1</Version>
        <LongName>Other Etiology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16390</PREFERRED_NAME>
            <LONG_NAME>Etiology</LONG_NAME>
            <CON_ID>2497372</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2799057</PublicId>
      <PreferredName>SPC_TXT</PreferredName>
      <PreferredDefinition>Be specific about something; define clearly._Text; the words of something written.</PreferredDefinition>
      <LongName>Specify Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2799056</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25685:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Specify Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the other non-infecti</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify the other non-infectious liver toxicity:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other etiology</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify other etiology</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping for CDE:2797722</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedDiagnosis [1] &gt; AssessedResultRelationship &gt; PerformedObservation &gt; PerformedDiagnosis.value(ANY+&gt;CD).origianlText [2] WHERE PerformedDiagnosis.value [1] = &quot;non-infectious liver toxicity&quot; AND AssessedResultRelationship.typeCode = &quot;etiology&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other etiology:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify other etiology:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other etiology:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify other etiology:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify other toxicity:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2100r1: 100 Days Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964902</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>liver_tox_othr_spec</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedDiagnosis:value</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_OF_liv_tox_oth_etiol_spec</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1157">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2799251</PUBLICID>
    <LONGNAME>O-6-Methylguanine-DNA Methyltransferase Methylation Status</LONGNAME>
    <PREFERREDNAME>MGMT_METH_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to identify the result of the transfer of methyl groups from O(6) methylguanine and other methylated moities of DNA, to a cysteine residue in itself, thus repairing alkylated DNA in a single step reaction.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>C3D:Central Cancer Clinical Database</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2799202</PublicId>
      <PreferredName>MGMT_METH_STAT</PreferredName>
      <PreferredDefinition>enzyme that transfers methyl groups from O(6) methylguanine and other methylated moities of DNA, to a cysteine residue in itself, thus repairing alkylated DNA in a single step reaction_The attachment of a methyl group to a molecule. Usually refers to DNA methylation. The expression level of a gene is often regulated by its methylation state; expressed genes are usually hypomethylated. C0025723: Methylation_A condition or state at a particular time.</PreferredDefinition>
      <LongName>O-6-Methylguanine-DNA Methyltransferase Methylation Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2799199</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17315</PreferredName>
        <Version>1</Version>
        <LongName>O-6-Methylguanine-DNA Methyltransferase</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17315</PREFERRED_NAME>
            <LONG_NAME>Methylated-DNA-Protein-Cysteine Methyltransferase</LONG_NAME>
            <CON_ID>2799198</CON_ID>
            <DEFINITION_SOURCE>CSP2000</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2799200</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16848:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Methylation Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16848</PREFERRED_NAME>
            <LONG_NAME>Methylation</LONG_NAME>
            <CON_ID>2202913</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2799204</PublicId>
      <PreferredName>METH_STAT</PreferredName>
      <PreferredDefinition>The attachment of a methyl group to a molecule. Usually refers to DNA methylation. The expression level of a gene is often regulated by its methylation state; expressed genes are usually hypomethylated. C0025723: Methylation_A condition or state at a particular time.</PreferredDefinition>
      <LongName>Methylation Status</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2799203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16848:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Methylation Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16848</PREFERRED_NAME>
            <LONG_NAME>Methylation</LONG_NAME>
            <CON_ID>2202913</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypermethylation</VALIDVALUE>
          <VALUEMEANING>Hypermethylation</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypermethylation appears to be a controlled, epigenetic, heritable, and aberrant DNA methylation reaction on gene promoter regions and CpG islands associated with loss of (e.g., tumor-suppressor) gene function in diverse cellular pathways through transcriptional silencing by the formation of transcriptionally repressive chromatin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4266711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Methylated</VALIDVALUE>
          <VALUEMEANING>Methylation</VALUEMEANING>
          <MEANINGDESCRIPTION>The covalent chemical or biochemical addition of a methyl group(s) to a compound. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16848</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-11-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invalid</VALIDVALUE>
          <VALUEMEANING>Invalid Data</VALUEMEANING>
          <MEANINGDESCRIPTION>Not valid data.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50913</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-09-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2929834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-11-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unmethylated</VALIDVALUE>
          <VALUEMEANING>Unmethylated</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: The covalent chemical or biochemical addition of a methyl group(s) to a compound. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16848, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-11-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2799205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not available</VALIDVALUE>
          <VALUEMEANING>Unavailable</VALUEMEANING>
          <MEANINGDESCRIPTION>The desired information is not available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5828000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partially methylated</VALIDVALUE>
          <VALUEMEANING>Partial Methylation</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or affecting only a part of something.: The covalent chemical or biochemical addition of a methyl group(s) to a compound. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16848, C25378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5999759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>MGMT result</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MGMT Status</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>MGMT Status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the result of MGMT analysis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>MGMT Methylation Status:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mass General Hospital</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813097</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MGH New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813098</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1205</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171135</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MGMT_METH_STAT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MGMT_METH_STAT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1158">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2808126</PUBLICID>
    <LONGNAME>Histopathology Grade None Dysplasia Biopsy Number</LONGNAME>
    <PREFERREDNAME>HIST_GD_ND_BX_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of biopsies in the worst grade of no dysplasia.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2808122</PublicId>
      <PreferredName>HIST_GD</PreferredName>
      <PreferredDefinition>Information pertaining to the degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease.</PreferredDefinition>
      <LongName>Histopathology Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223325</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18190</PreferredName>
        <Version>1</Version>
        <LongName>Histopathology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18190</PREFERRED_NAME>
            <LONG_NAME>Histopathologic Examination</LONG_NAME>
            <CON_ID>2223204</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2427327</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18000</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCP:Division of Cancer Prevention</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2808124</PublicId>
      <PreferredName>ND_BX_NUM</PreferredName>
      <PreferredDefinition>The number used to identify the removal of tissue for microscopic examination found in neoplastic transformation of the cell, associated with altered architectural tissue patterns.  The cellular changes include nuclear and cytoplasmic abnormalities.</PreferredDefinition>
      <LongName>None Dysplasia Biopsy Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DCP:Division of Cancer Prevention</Origin>
      <Representation>
        <PublicId>2808123</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41132:C4086:C15189:C25337</PreferredName>
        <Version>1</Version>
        <LongName>None Dysplasia Biopsy Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41132</PREFERRED_NAME>
            <LONG_NAME>None</LONG_NAME>
            <CON_ID>2433421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4086</PREFERRED_NAME>
            <LONG_NAME>Dysplasia</LONG_NAME>
            <CON_ID>2202401</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15189</PREFERRED_NAME>
            <LONG_NAME>Biopsy Procedure</LONG_NAME>
            <CON_ID>2202502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of biopsies in each gr</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of biopsies in each grade (ND)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ursodeoxycholic Acid - Barrett&#39;s Patients</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2813043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1159">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2820746</PUBLICID>
    <LONGNAME>Transplantation Change Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2820726v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The grafting of tissues from one individual to another or place to place within a single individual._An alteration or modification.:A statement or an account describing something. (Bartleby.com)_Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2820726</PublicId>
      <PreferredName>2820715v1.0:2231607v1.0</PreferredName>
      <PreferredDefinition>The grafting of tissues from one individual to another or place to place within a single individual._An alteration or modification.:A statement or an account describing something. (Bartleby.com)</PreferredDefinition>
      <LongName>Transplantation Change Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2820715</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15342</PreferredName>
        <Version>1</Version>
        <LongName>Transplantation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231607</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446:C25365</PreferredName>
        <Version>1</Version>
        <LongName>Change Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Transplantation Change Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Transplantation Change Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.Transplantation.modificationDescription</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Transplantation:modificationDescription</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1160">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2841392</PUBLICID>
    <LONGNAME>Transplantation Graft Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2841391v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The grafting of tissues from one individual to another or place to place within a single individual._Tissue or organ transplanted from a donor to a recipient.:The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2841391</PublicId>
      <PreferredName>2820715v1.0:2778346v1.0</PreferredName>
      <PreferredDefinition>The grafting of tissues from one individual to another or place to place within a single individual._Tissue or organ transplanted from a donor to a recipient.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Transplantation Graft Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2820715</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15342</PreferredName>
        <Version>1</Version>
        <LongName>Transplantation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2778346</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12981:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Graft Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Transplantation Graft Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Transplantation Graft Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.Transplantation.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Transplantation:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1161">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2848578</PUBLICID>
    <LONGNAME>Tissue Sample Platelet Count java.lang.Float</LONGNAME>
    <PREFERREDNAME>2848425v1.0:2178535v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A piece of tissue removed from an organism for examination, analysis, or propagation._The determination of the number of platelets in a blood sample, usually expressed as platelets per cubic millimeter (cmm) of whole blood._Generic value domain for a primitive java datatype that is Single-precision floating point number (32-bit IEEE 754).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2848425</PublicId>
      <PreferredName>2480187v1.00:2848308v1.00</PreferredName>
      <PreferredDefinition>A piece of tissue removed from an organism for examination, analysis, or propagation.:The determination of the number of platelets in a biospecimen.</PreferredDefinition>
      <LongName>Tissue Sample Platelet Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480187</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19697</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Sample</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19697</PREFERRED_NAME>
            <LONG_NAME>Tissue Sample</LONG_NAME>
            <CON_ID>2222017</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2848308</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C51951</PreferredName>
        <Version>1</Version>
        <LongName>Platelet Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51951</PREFERRED_NAME>
            <LONG_NAME>Platelet Count</LONG_NAME>
            <CON_ID>2615509</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178535</PublicId>
      <PreferredName>java.lang.Float</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is Single-precision floating point number (32-bit IEEE 754).</PreferredDefinition>
      <LongName>java.lang.Float</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Float</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Tissue Sample Platelet Count java.lang.Float does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Tissue Sample Platelet Count java.lang.Float does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2611721</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CGWB</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cgwb.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000139</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cgwb.domain.Sample.platelet</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Sample:platelet</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1162">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2848608</PUBLICID>
    <LONGNAME>Conceptual Parent Project Sorting Order java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2848455v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Something from which one or more similar and separate things have developed, or to which they are attached.:Any piece of work that is undertaken or attempted._An operation that segregates items into groups according to a specified criterion.:A logical or comprehensible arrangement of separate elements; a condition of regular or proper arrangement._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2848455</PublicId>
      <PreferredName>2848338v1.0:2848329v1.0</PreferredName>
      <PreferredDefinition>Something from which one or more similar and separate things have developed, or to which they are attached.:Any piece of work that is undertaken or attempted._An operation that segregates items into groups according to a specified criterion.:A logical or comprehensible arrangement of separate elements; a condition of regular or proper arrangement.</PreferredDefinition>
      <LongName>Conceptual Parent Project Sorting Order</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2848338</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C80013:C47885</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Parent Project</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80013</PREFERRED_NAME>
            <LONG_NAME>Conceptual Parent</LONG_NAME>
            <CON_ID>2848249</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47885</PREFERRED_NAME>
            <LONG_NAME>Project</LONG_NAME>
            <CON_ID>2422635</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2848329</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62803:C42680</PreferredName>
        <Version>1</Version>
        <LongName>Sorting Order</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62803</PREFERRED_NAME>
            <LONG_NAME>Sorting</LONG_NAME>
            <CON_ID>2538655</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42680</PREFERRED_NAME>
            <LONG_NAME>Order</LONG_NAME>
            <CON_ID>2231568</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Conceptual Parent Project Sorting Order java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Conceptual Parent Project Sorting Order java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2611721</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CGWB</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cgwb.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000139</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cgwb.domain.SuperProject.sortOrder</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SuperProject:sortOrder</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1163">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2851889</PUBLICID>
    <LONGNAME>Quality of Life Other Evaluation Scale</LONGNAME>
    <PREFERREDNAME>QOL_OTHER_EVAL_SCALE</PREFERREDNAME>
    <PREFERREDDEFINITION>the scale to measure other problems associated with quality of life.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2851887</PublicId>
      <PreferredName>QOL_OTHER_EVAL</PreferredName>
      <PreferredDefinition>information relating to an other (different than the one previously specified or mentioned) evaluation of quality of life (a subjective measurement of an individual&#39;s sense of well-being and ability to enjoy life).</PreferredDefinition>
      <LongName>Quality of Life Other Evaluation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2736450</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17047</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17047</PREFERRED_NAME>
            <LONG_NAME>Quality of Life</LONG_NAME>
            <CON_ID>2202504</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2596642</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25214</PreferredName>
        <Version>1</Version>
        <LongName>Other Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25214</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2202634</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016847</PublicId>
      <PreferredName>FACT_QOL_SCALE</PreferredName>
      <PreferredDefinition>the scale used on FACT Quality of Life questionnaires to assess patient responses.</PreferredDefinition>
      <LongName>FACT Quality of Life Scale</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Always</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all bothered</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little bit</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat bothered</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2927955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately</VALIDVALUE>
          <VALUEMEANING>Moderately</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely</VALIDVALUE>
          <VALUEMEANING>EXTREMELY</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slightly</VALIDVALUE>
          <VALUEMEANING>Slightly</VALUEMEANING>
          <MEANINGDESCRIPTION>Slightly</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not bothered at all</VALIDVALUE>
          <VALUEMEANING>Not bothered at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not bothered at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered somewhat</VALIDVALUE>
          <VALUEMEANING>Bothered somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered somewhat</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little</VALIDVALUE>
          <VALUEMEANING>Bothered a little</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered a little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little difficult</VALIDVALUE>
          <VALUEMEANING>A little difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>A little difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not difficult at all</VALIDVALUE>
          <VALUEMEANING>Not difficult at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not difficult at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted totally</VALIDVALUE>
          <VALUEMEANING>Disrupted totally</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was totally disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted quite a bit</VALIDVALUE>
          <VALUEMEANING>Disrupted quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted somewhat</VALIDVALUE>
          <VALUEMEANING>Disrupted somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted a little</VALIDVALUE>
          <VALUEMEANING>Disrupted a little</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was a little disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not disrupted at all</VALIDVALUE>
          <VALUEMEANING>Not disrupted at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not at all disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to do</VALIDVALUE>
          <VALUEMEANING>UNABLE To Do</VALUEMEANING>
          <MEANINGDESCRIPTION>UNABLE To Do (Health Activity Questionnaire)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very difficult</VALIDVALUE>
          <VALUEMEANING>Very difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Very difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat difficult</VALIDVALUE>
          <VALUEMEANING>Somewhat difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No pain</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had no pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other problems</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other problems</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Char.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1164">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2870042</PUBLICID>
    <LONGNAME>Performed Study Activity Negation Occurrence Reason ISO21090.DSET.SC.v1.0</LONGNAME>
    <PREFERREDNAME>2868365v1.0:2803350v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The text and/or code that describes the rationale behind why an activity is not done.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868365</PublicId>
      <PreferredName>2867719v1.0:2867945v1.0</PreferredName>
      <PreferredDefinition>Executed and carried through to completion.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective; the state of being active._An operation in which a term denies or inverts the meaning of another term or construction.:An instance of something happening, such as an event or incident.:An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Performed Study Activity Negation Occurrence Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867719</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000:C63536:C43431</PreferredName>
        <Version>1</Version>
        <LongName>Performed Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867945</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C25275:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Negation Occurrence Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803350</PublicId>
      <PreferredName>2803350v1.0</PreferredName>
      <PreferredDefinition>A collection containing unordered distinct/discrete values of the type SC.</PreferredDefinition>
      <LongName>ISO21090.DSET.SC.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090DSETv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Performed Study Activity Negation Occurrence Reason ISO21090.DSET.SC.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Performed Study Activity Negation Occurrence Reason ISO21090.DSET.SC.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedActivity.missedReason</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedActivity:missedReason</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1165">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2870255</PUBLICID>
    <LONGNAME>Clinical Trial Eligibility Criteria Observation Performed Study Activity Reason Code ISO21090.DSET.CD.v1.0</LONGNAME>
    <PREFERREDNAME>2868578v1.0:2803321v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>One of a set of conditions that a study subject must meet in order to participate in a study. A coded value specifying the motivation, cause, or rationale of an activity. EXAMPLE(S): routine requirement, drug reaction, infectious disease reporting requirement, on patient request</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868578</PublicId>
      <PreferredName>2867671v1.0:2607667v1.0</PreferredName>
      <PreferredDefinition>Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.:Watching something and taking note of what happens.:Executed and carried through to completion.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective; the state of being active._An explanation of the cause of some phenomenon or action.:A system, often of numbered categories, for representation of data.</PreferredDefinition>
      <LongName>Clinical Trial Eligibility Criteria Observation Performed Study Activity Reason Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867671</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>2867671v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Eligibility Criteria Observation Performed Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607667</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Reason Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803321</PublicId>
      <PreferredName>2803321v1.0</PreferredName>
      <PreferredDefinition>A collection containing unordered distinct/discrete values of the type CD.</PreferredDefinition>
      <LongName>ISO21090.DSET.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090DSETv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Clinical Trial Eligibility Criteria Observation Performed Study Activity Reason Code ISO21090.DSET.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Clinical Trial Eligibility Criteria Observation Performed Study Activity Reason Code ISO21090.DSET.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedEligibilityCriterion.reasonCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedEligibilityCriterion:reasonCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain.PerformedEligibilityCriterion.reasonCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1166">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2870304</PUBLICID>
    <LONGNAME>Product Investigation Performed Observation Outcome Uncertain Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>2868629v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information captured while conducting research on a product. EXAMPLE(S): An electrical problem in a device. A coded value specifying whether and to what degree this evaluation or observation has been asserted to be in doubt in any way. EXAMPLE(S): A patient might have had a cholecystectomy procedure in the past, but isn&#39;t sure what the outcome was.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868629</PublicId>
      <PreferredName>2867645v1.0:2607674v1.0</PreferredName>
      <PreferredDefinition>The end result of a manufacturing process; anything that is produced.:The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts.:Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._Not established beyond doubt; still undecided or unknown.:A system, often of numbered categories, for representation of data.</PreferredDefinition>
      <LongName>Product Investigation Performed Observation Outcome Uncertain Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867645</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>2867645v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Product Investigation Performed Observation Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51980</PREFERRED_NAME>
            <LONG_NAME>Product</LONG_NAME>
            <CON_ID>2527882</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41198</PREFERRED_NAME>
            <LONG_NAME>Investigation</LONG_NAME>
            <CON_ID>2469351</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607674</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47944:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Uncertain Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47944</PREFERRED_NAME>
            <LONG_NAME>Uncertain</LONG_NAME>
            <CON_ID>2342198</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Product Investigation Performed Observation Outcome Uncertain Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Product Investigation Performed Observation Outcome Uncertain Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.AdverseEventSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedProductInvestigationResult.uncertaintyCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedProductInvestigationResult:uncertaintyCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.AdverseEventSubDomain.PerformedProductInvestigationResult.uncertaintyCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1167">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2875768</PUBLICID>
    <LONGNAME>Gastrointestinal Stromal Tumor Oncogene KIT Adjuvant Therapy First Recurrence Date</LONGNAME>
    <PREFERREDNAME>2875758v1.0:2018550v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the date of the first recurrence of a gastrointestinal stromal tumor, a type of tumor that usually begins in cells in the wall of the gastrointestinal tract, following treatment to target the KIT oncogene, KIT proto-oncogene encodes a putative transmembrane receptor tyrosine kinase for stem cell factor and is critical in the development of pluripotent hematopoietic stem cells, migrating embryonic melanoblasts, and primordial germ cells.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2875758</PublicId>
      <PreferredName>2875746v1.0:2875756v1.0</PreferredName>
      <PreferredDefinition>information related to the first recurrence of a gastrointestinal stromal tumor, a type of tumor that usually begins in cells in the wall of the gastrointestinal tract, following treatment to target the KIT oncogene, KIT proto-oncogene encodes a putative transmembrane receptor tyrosine kinase for stem cell factor and is critical in the development of pluripotent hematopoietic stem cells, migrating embryonic melanoblasts, and primordial germ cells.</PreferredDefinition>
      <LongName>Gastrointestinal Stromal Tumor Oncogene KIT Adjuvant Therapy First Recurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2875746</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3868</PreferredName>
        <Version>1</Version>
        <LongName>Gastrointestinal Stromal Tumor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3868</PREFERRED_NAME>
            <LONG_NAME>Gastrointestinal Stromal Tumor</LONG_NAME>
            <CON_ID>2737344</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2875756</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18348:C15675:C25509:C3352</PreferredName>
        <Version>1</Version>
        <LongName>Oncogene KIT Adjuvant Therapy First Recurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18348</PREFERRED_NAME>
            <LONG_NAME>Oncogene KIT</LONG_NAME>
            <CON_ID>2875750</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15675</PREFERRED_NAME>
            <LONG_NAME>Adjuvant Therapy</LONG_NAME>
            <CON_ID>2205339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3352</PREFERRED_NAME>
            <LONG_NAME>Recurrence</LONG_NAME>
            <CON_ID>2202848</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of first recurrence foll</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of first recurrence following adjuvant therapy using agents targeting KIT</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1168">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2876206</PUBLICID>
    <LONGNAME>Colorectal Tumor Histologic Classification American Joint Committee on Cancer Grade</LONGNAME>
    <PREFERREDNAME>2190146v1.0:2876200v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the histologic grade system for colorectal cancer based on American Joint Committee on Cancer 6th Ed., a group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2190146</PublicId>
      <PreferredName>COLO_TUM_HIST_CLASS</PreferredName>
      <PreferredDefinition>information related to histologic classification of a colorectal tumor.</PreferredDefinition>
      <LongName>Colorectal Tumor Histologic Classification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206583</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13363:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Colorectal Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13363</PREFERRED_NAME>
            <LONG_NAME>Colorectal</LONG_NAME>
            <CON_ID>2202379</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207691</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25526:C25161</PreferredName>
        <Version>1</Version>
        <LongName>Histologic Classification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25526</PREFERRED_NAME>
            <LONG_NAME>Histologic</LONG_NAME>
            <CON_ID>2206234</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25161</PREFERRED_NAME>
            <LONG_NAME>Classification</LONG_NAME>
            <CON_ID>2203879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2876200</PublicId>
      <PreferredName>2876200v1.0</PreferredName>
      <PreferredDefinition>the histologic grade system for colorectal cancer based on American Joint Committee on Cancer 6th Ed., a group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.</PreferredDefinition>
      <LongName>Colorectal Carcinoma Histologic American Joint Committee on Cancer Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2876199</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C39315:C48309</PreferredName>
        <Version>1</Version>
        <LongName>American Joint Committee on Cancer Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39315</PREFERRED_NAME>
            <LONG_NAME>American Joint Committee on Cancer</LONG_NAME>
            <CON_ID>2554142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GX</VALIDVALUE>
          <VALUEMEANING>Grade cannot be assessed</VALUEMEANING>
          <MEANINGDESCRIPTION>Grade cannot be assessed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G1</VALIDVALUE>
          <VALUEMEANING>Well Differentiated</VALUEMEANING>
          <MEANINGDESCRIPTION>Definition not available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2876201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G2</VALIDVALUE>
          <VALUEMEANING>Moderately Differentiated</VALUEMEANING>
          <MEANINGDESCRIPTION>Definition not available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14162</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2876202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G3</VALIDVALUE>
          <VALUEMEANING>Poorly Differentiated</VALUEMEANING>
          <MEANINGDESCRIPTION>Definition not available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2876203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G4</VALIDVALUE>
          <VALUEMEANING>Undifferentiated</VALUEMEANING>
          <MEANINGDESCRIPTION>A term used to describe cells or tissues that do not have specialized (&quot;mature&quot;) structures or functions. Undifferentiated cancer cells often grow and spread quickly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14176</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2876204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Grade</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1169">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2898824</PUBLICID>
    <LONGNAME>Measurement Characteristic Life Sciences Identifier Namespace java.lang.String</LONGNAME>
    <PREFERREDNAME>2898658v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Annotation used to indicate that the size or magnitude of something was determined by comparison to a standard.:The distinguishing qualities or prominent aspect of a person, object, action, process, or substance._A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:In general, a namespace is an abstract container, which is or could be filled by names, or technical terms, or words, and these represent or stand for real-world things.  A description logic terminology namespace is a collection of Kind, Role, Property and Concept definitions. As in computer programming, context namespaces are intended to allow multiple knowledge bases to reside in the same physical database. (from Apelon)_Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2898658</PublicId>
      <PreferredName>2726725v1.0:2898545v1.0</PreferredName>
      <PreferredDefinition>Annotation used to indicate that the size or magnitude of something was determined by comparison to a standard.:The distinguishing qualities or prominent aspect of a person, object, action, process, or substance._A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:In general, a namespace is an abstract container, which is or could be filled by names, or technical terms, or words, and these represent or stand for real-world things.  A description logic terminology namespace is a collection of Kind, Role, Property and Concept definitions. As in computer programming, context namespaces are intended to allow multiple knowledge bases to reside in the same physical database. (from Apelon)</PreferredDefinition>
      <LongName>Measurement Characteristic Life Sciences Identifier Namespace</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2726725</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25209:C25447</PreferredName>
        <Version>1</Version>
        <LongName>Measurement Characteristic</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25447</PREFERRED_NAME>
            <LONG_NAME>Characteristic</LONG_NAME>
            <CON_ID>2203874</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2898545</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47841:C42699</PreferredName>
        <Version>1</Version>
        <LongName>Life Sciences Identifier Namespace</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47841</PREFERRED_NAME>
            <LONG_NAME>Life Sciences Identifier</LONG_NAME>
            <CON_ID>2423426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42699</PREFERRED_NAME>
            <LONG_NAME>Namespace</LONG_NAME>
            <CON_ID>2222837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Measurement Characteristic Life Sciences Identifier Namespace java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Measurement Characteristic Life Sciences Identifier Namespace java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000666</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000669</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.sample.MeasurementCharacteristic.lsidNamespace</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MeasurementCharacteristic:lsidNamespace</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1170">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2900013</PUBLICID>
    <LONGNAME>Medical Image Search Outcome Retrieval Array java.lang.Long</LONGNAME>
    <PREFERREDNAME>2899755v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any record of a medical imaging event whether physical or electronic.:The activity of looking thoroughly in order to find something or someone; an operation that determines whether one or more of a set of items has a specified property.:The result of an action._The operation of accessing information or removing an item from storage.:An orderly arrangement._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2899755</PublicId>
      <PreferredName>2899650v1.0:2899691v1.0</PreferredName>
      <PreferredDefinition>Any record of a medical imaging event whether physical or electronic.:The activity of looking thoroughly in order to find something or someone; an operation that determines whether one or more of a set of items has a specified property.:The result of an action._The operation of accessing information or removing an item from storage.:An orderly arrangement.</PreferredDefinition>
      <LongName>Medical Image Search Outcome Retrieval Array</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2899650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19477:C54117:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Medical Image Search Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19477</PREFERRED_NAME>
            <LONG_NAME>Medical Image</LONG_NAME>
            <CON_ID>2202344</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54117</PREFERRED_NAME>
            <LONG_NAME>Search</LONG_NAME>
            <CON_ID>2505702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2899691</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25659:C26358</PreferredName>
        <Version>1</Version>
        <LongName>Retrieval Array</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25659</PREFERRED_NAME>
            <LONG_NAME>Retrieval</LONG_NAME>
            <CON_ID>2203784</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26358</PREFERRED_NAME>
            <LONG_NAME>Array</LONG_NAME>
            <CON_ID>2236563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Medical Image Search Outcome Retrieval Array java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Medical Image Search Outcome Retrieval Array java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2899621</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ImageMiner</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ImageMinerCore</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2899622</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2899621</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ImageMiner</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.imageminer.domain.analysis.imagequery</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2899625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.imageminer.domain.analysis.imagequery.ImageQueryOutput.retrieval</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ImageQueryOutput:retrieval</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1171">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2900074</PUBLICID>
    <LONGNAME>Imaging Technology System Serial Number java.lang.String</LONGNAME>
    <PREFERREDNAME>2899816v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any of a number of technologies that permits the visualization and acquisition of images into a physical or electronic record.:A group of independent but interrelated elements comprising a unified whole._A unique alphanumeric identifier assigned to each of a series of identical manufactured products._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2899816</PublicId>
      <PreferredName>2899667v1.0:2771060v1.0</PreferredName>
      <PreferredDefinition>Any of a number of technologies that permits the visualization and acquisition of images into a physical or electronic record.:A group of independent but interrelated elements comprising a unified whole._A unique alphanumeric identifier assigned to each of a series of identical manufactured products.</PreferredDefinition>
      <LongName>Imaging Technology System Serial Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2899667</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18843:C25700</PreferredName>
        <Version>1</Version>
        <LongName>Imaging Technology System</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18843</PREFERRED_NAME>
            <LONG_NAME>Imaging Technology</LONG_NAME>
            <CON_ID>2615877</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25700</PREFERRED_NAME>
            <LONG_NAME>System</LONG_NAME>
            <CON_ID>2202584</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2771060</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C73518</PreferredName>
        <Version>1</Version>
        <LongName>Serial Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73518</PREFERRED_NAME>
            <LONG_NAME>Serial Number</LONG_NAME>
            <CON_ID>2771050</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Imaging Technology System Serial Number java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Imaging Technology System Serial Number java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2899621</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ImageMiner</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ImageMinerCore</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2899622</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2899621</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ImageMiner</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.imageminer.domain.image</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2899632</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ImagingSystem:serialNumber</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.imageminer.domain.image.ImagingSystem.serialNumber</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1172">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2916069</PUBLICID>
    <LONGNAME>Bioassay, in vivo Characterization Created By java.lang.String</LONGNAME>
    <PREFERREDNAME>2915947v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The appraisal of the biological properties or activities of a substance by testing its effect on an organism.:The act of describing distinctive characteristics or essential features._Indicates the person or authoritative body who brought the item into existence._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2915947</PublicId>
      <PreferredName>2915898v1.0:2231611v1.0</PreferredName>
      <PreferredDefinition>The appraisal of the biological properties or activities of a substance by testing its effect on an organism.:The act of describing distinctive characteristics or essential features._Indicates the person or authoritative body who brought the item into existence.</PreferredDefinition>
      <LongName>Bioassay, in vivo Characterization Created By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2915898</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18641:C62606</PreferredName>
        <Version>1</Version>
        <LongName>Bioassay, in vivo Characterization</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18641</PREFERRED_NAME>
            <LONG_NAME>Bioassay, In Vivo</LONG_NAME>
            <CON_ID>2437685</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62606</PREFERRED_NAME>
            <LONG_NAME>Characterization</LONG_NAME>
            <CON_ID>2554153</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42628</PreferredName>
        <Version>1</Version>
        <LongName>Created By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42628</PREFERRED_NAME>
            <LONG_NAME>Created By</LONG_NAME>
            <CON_ID>2231551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Bioassay, in vivo Characterization Created By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Bioassay, in vivo Characterization Created By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2915522</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caNanoLab</PreferredName>
          <Version>1.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cananolab.domain.characterization.invivo</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2915884</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>InvivoCharacterization:createdBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.characterization.invivo.InvivoCharacterization.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1173">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2925887</PUBLICID>
    <LONGNAME>Medium Biospecimen Present Count</LONGNAME>
    <PREFERREDNAME>MED_SPEC_PRES_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value for a quantity of biospecimens produced that are stored in solution or suspension using a substance to maintain their structure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2925885</PublicId>
      <PreferredName>MED_BIOSPEC_PRES</PreferredName>
      <PreferredDefinition>A substance holding another substance in solution or suspension._Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Medium Biospecimen Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2925883</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48164:C70699</PreferredName>
        <Version>1</Version>
        <LongName>Medium Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48164</PREFERRED_NAME>
            <LONG_NAME>Medium</LONG_NAME>
            <CON_ID>2513277</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018392</PublicId>
      <PreferredName>CT</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of samples in media</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of samples in media</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812605</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1174">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2927734</PUBLICID>
    <LONGNAME>Enumeration Permissible Value java.lang.String</LONGNAME>
    <PREFERREDNAME>2927662v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The act of specifying individually; expressing as a list._The exact names, codes and text that can be stored in a data field in an information management system._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2927662</PublicId>
      <PreferredName>2927601v1.0:2927633v1.0</PreferredName>
      <PreferredDefinition>The act of specifying individually; expressing as a list._The exact names, codes and text that can be stored in a data field in an information management system.</PreferredDefinition>
      <LongName>Enumeration Permissible Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2927601</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45674</PreferredName>
        <Version>1</Version>
        <LongName>Enumeration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45674</PREFERRED_NAME>
            <LONG_NAME>Enumeration</LONG_NAME>
            <CON_ID>2231597</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2927633</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41109</PreferredName>
        <Version>1</Version>
        <LongName>Permissible Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41109</PREFERRED_NAME>
            <LONG_NAME>Permissible Value</LONG_NAME>
            <CON_ID>2231566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Enumeration Permissible Value java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Enumeration Permissible Value java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2927589</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caGrid_Metadata_Models</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caGrid_1.x</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2927590</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2927589</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caGrid_Metadata_Models</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cagrid.metadata.common</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2927592</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Enumeration:permissibleValue</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>@permissibleValue</AlternateName>
        <AlternateNameType>GME_XMLLocReference</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cagrid.metadata.common.Enumeration.permissibleValue</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1175">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2930022</PUBLICID>
    <LONGNAME>Encapsulation Data Data ISO21090.Binary.v1.0</LONGNAME>
    <PREFERREDNAME>2928521v1.0:2862116v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The process or condition of being enclosed.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._A string that is an identifier, and therefore must be either a string representation of an OID, a UUID, or a simple token taken from a lsit of controlled names for the context in which the Uid is used.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2928521</PublicId>
      <PreferredName>2928307v1.0:2423441v1.0</PreferredName>
      <PreferredDefinition>The process or condition of being enclosed.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.</PreferredDefinition>
      <LongName>Encapsulation Data Data</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2928307</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C73476:C25474</PreferredName>
        <Version>1</Version>
        <LongName>Encapsulation Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73476</PREFERRED_NAME>
            <LONG_NAME>Encapsulation</LONG_NAME>
            <CON_ID>2753712</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2423441</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25474</PreferredName>
        <Version>1</Version>
        <LongName>Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2862116</PublicId>
      <PreferredName>2862116v1.0</PreferredName>
      <PreferredDefinition>A string that is an identifier, and therefore must be either a string representation of an OID, a UUID, or a simple token taken from a lsit of controlled names for the context in which the Uid is used.</PreferredDefinition>
      <LongName>ISO21090.Binary.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>UMLBinaryv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Encapsulation Data Data ISO21090.Binary.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Encapsulation Data Data ISO21090.Binary.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2928087</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ISO21090v1_0</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ISO21090v1_0.ISODatatypes</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2928092</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2958963</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COPPA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>coppa_datatypes.iso21090.coppaflavor</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2958966</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ISO21090v1_0.ISODatatypes.ED.data</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ED:data</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>coppa_datatypes.iso21090.coppaflavor.ED.data</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1176">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2943329</PUBLICID>
    <LONGNAME>Computer Job Identifier Value java.lang.String</LONGNAME>
    <PREFERREDNAME>2943292v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A unit of work done by a computer consisting of a single complete task.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._A numerical quantity measured or assigned or computed._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2943292</PublicId>
      <PreferredName>2943267v1.0:2186636v1.0</PreferredName>
      <PreferredDefinition>A unit of work done by a computer consisting of a single complete task.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Computer Job Identifier Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2943267</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C82964:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Computer Job Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82964</PREFERRED_NAME>
            <LONG_NAME>Computer Job</LONG_NAME>
            <CON_ID>2943262</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2186636</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Computer Job Identifier Value java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Computer Job Identifier Value java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2858220</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Taverna-caGrid</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>uk.org.mygrid.cagrid.domain.common</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2858221</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>uk.org.mygrid.cagrid.domain.common.JobId.value</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JobId:value</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1177">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2943338</PUBLICID>
    <LONGNAME>Classification Category java.lang.String</LONGNAME>
    <PREFERREDNAME>2943301v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._This term is used informally to mean a class of things._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2943301</PublicId>
      <PreferredName>2943277v1.0:2236665v1.0</PreferredName>
      <PreferredDefinition>A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._This term is used informally to mean a class of things.</PreferredDefinition>
      <LongName>Classification Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2943277</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25161</PreferredName>
        <Version>1</Version>
        <LongName>Classification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25161</PREFERRED_NAME>
            <LONG_NAME>Classification</LONG_NAME>
            <CON_ID>2203879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2236665</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25372</PreferredName>
        <Version>1</Version>
        <LongName>Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Classification Category java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Classification Category java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2858220</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Taverna-caGrid</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>uk.org.mygrid.cagrid.domain.interproscan</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2858222</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>uk.org.mygrid.cagrid.domain.interproscan.Classification.category</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Classification:category</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1178">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2946401</PUBLICID>
    <LONGNAME>Hepatitis Description Status</LONGNAME>
    <PREFERREDNAME>HB_D_STATUS</PREFERREDNAME>
    <PREFERREDDEFINITION>condition or state at a particular time for description of the inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2946396</PublicId>
      <PreferredName>HEPAT_DESCR</PreferredName>
      <PreferredDefinition>information related to description of the inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.</PreferredDefinition>
      <LongName>Hepatitis Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2946394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3095</PreferredName>
        <Version>1</Version>
        <LongName>Hepatitis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3095</PREFERRED_NAME>
            <LONG_NAME>Hepatitis</LONG_NAME>
            <CON_ID>2205376</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2946397</PublicId>
      <PreferredName>HEP_DESCR_STAT</PreferredName>
      <PreferredDefinition>a condition or state at a particular time for hepatitis.</PreferredDefinition>
      <LongName>Hepatitis Description Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatitis B and C</VALIDVALUE>
          <VALUEMEANING>Hepatitis B and C</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatitis B and C</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-09-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No hepatitis</VALIDVALUE>
          <VALUEMEANING>No hepatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>No hepatitis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-09-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatitis B</VALIDVALUE>
          <VALUEMEANING>Hepatitis B</VALUEMEANING>
          <MEANINGDESCRIPTION>A viral hepatitis caused by the Hepatitis B virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatitis C</VALIDVALUE>
          <VALUEMEANING>Hepatitis C</VALUEMEANING>
          <MEANINGDESCRIPTION>viral disease caused by hepatitis C virus; most common form of post transfusion hepatitis, also is a common acute sporadic hepatitis; may also follow parental drug abuse.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3098</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3423348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatitis B or B and C</VALIDVALUE>
          <VALUEMEANING>Hepatitis B Infection Or Hepatitis B Infection And Hepatitis C Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>A viral infection caused by the hepatitis B virus.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A viral infection caused by the hepatitis B virus.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A viral infection caused by the hepatitis C virus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3098, C37912, C3097, C37998, C3097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-09-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4472684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hepatitis status</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Hepatitis status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hepatobiliary</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3298577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1112</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104993</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HB_D_STATUS</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1179">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2946934</PUBLICID>
    <LONGNAME>Person Past Day Total Diet Intake Number</LONGNAME>
    <PREFERREDNAME>2946931v1.0:2182118v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Person; a human being._Before the present time._The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours. This also refers to a specific day. (NCI)_Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._The things a person eats and drinks._Intake; the substances, or the quantities thereof, taken in and utilized by the body._Number</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ASA24:Automated Self-Administered 24-hour Dietary Recall, NCI</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2946931</PublicId>
      <PreferredName>PER_PAS_D_TO_DI_INT</PreferredName>
      <PreferredDefinition>Person; a human being._Before the present time._The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours. This also refers to a specific day. (NCI)_Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._The things a person eats and drinks._Intake; the substances, or the quantities thereof, taken in and utilized by the body.</PreferredDefinition>
      <LongName>Person Past Day Total Diet Intake</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2946933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>2946933v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Past Day Total Diet Intake</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25301</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2202680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25304</PREFERRED_NAME>
            <LONG_NAME>Total</LONG_NAME>
            <CON_ID>2204938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15222</PREFERRED_NAME>
            <LONG_NAME>Diet</LONG_NAME>
            <CON_ID>2202294</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25538</PREFERRED_NAME>
            <LONG_NAME>Intake</LONG_NAME>
            <CON_ID>2203833</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ASA24:Automated Self-Administered 24-hour Dietary Recall, NCI</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2182118</PublicId>
      <PreferredName>NUMBER</PreferredName>
      <PreferredDefinition>A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>0</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>A measure to assess the foods</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>A measure to assess the foods and beverages consumed throughout the previous day or the prior 24-hours.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Nutrition and Dietary Supplements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3688680</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1180">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2956690</PUBLICID>
    <LONGNAME>Upper GI Tumor Histologic Classification Ind-2</LONGNAME>
    <PREFERREDNAME>2192254v1.0:2404918v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether the upper GI tumor histologic classification was other than the listed values.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2192254</PublicId>
      <PreferredName>UPPER_TUM_HIST_CLASS</PreferredName>
      <PreferredDefinition>information related to upper GI tumor histologic classification or category.</PreferredDefinition>
      <LongName>Upper GI Tumor Histologic Classification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206811</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17639:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Upper GI Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17639</PREFERRED_NAME>
            <LONG_NAME>Upper Gastrointestinal Series</LONG_NAME>
            <CON_ID>2202557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207691</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25526:C25161</PreferredName>
        <Version>1</Version>
        <LongName>Histologic Classification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25526</PREFERRED_NAME>
            <LONG_NAME>Histologic</LONG_NAME>
            <CON_ID>2206234</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25161</PREFERRED_NAME>
            <LONG_NAME>Classification</LONG_NAME>
            <CON_ID>2203879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>2192254v1.0:2404918v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1181">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2960068</PUBLICID>
    <LONGNAME>Observation Study Protocol Document Primary Purpose Other Text ISO21090.ST.v1.0</LONGNAME>
    <PREFERREDNAME>2959331v1.0:2803207v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Watching something and taking note of what happens.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:A rule which guides how an activity should be performed.:An organized collection of records that describe a particular body of data._Occurring first in time or sequence; original; of greatest rank or importance or value.:What something is used for; reason or intention.:Different than the one(s) previously specified or mentioned.:The words of something written._Character string datatype stands for text data.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2959331</PublicId>
      <PreferredName>2867687v1.0:2959171v1.0</PreferredName>
      <PreferredDefinition>Watching something and taking note of what happens.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:A rule which guides how an activity should be performed.:An organized collection of records that describe a particular body of data._Occurring first in time or sequence; original; of greatest rank or importance or value.:What something is used for; reason or intention.:Different than the one(s) previously specified or mentioned.:The words of something written.</PreferredDefinition>
      <LongName>Observation Study Protocol Document Primary Purpose Other Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867687</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25598:C63536:C42651:C19498</PreferredName>
        <Version>1</Version>
        <LongName>Observation Study Protocol Document</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42651</PREFERRED_NAME>
            <LONG_NAME>Protocol</LONG_NAME>
            <CON_ID>2211236</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19498</PREFERRED_NAME>
            <LONG_NAME>Document</LONG_NAME>
            <CON_ID>2223216</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2959171</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25251:C25634:C17649:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Primary Purpose Other Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25634</PREFERRED_NAME>
            <LONG_NAME>Purpose</LONG_NAME>
            <CON_ID>2202870</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803207</PublicId>
      <PreferredName>2803207v1.0</PreferredName>
      <PreferredDefinition>Character string datatype stands for text data.</PreferredDefinition>
      <LongName>ISO21090.ST.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090STv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Observation Study Protocol Document Primary Purpose Other Text ISO21090.ST.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Observation Study Protocol Document Primary Purpose Other Text ISO21090.ST.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2958963</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COPPA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.COPPA.InformationModel</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2958964</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.COPPA.InformationModel.ObservationalStudyProtocol.primaryPurposeOtherText</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ObservationalStudyProtocol:primaryPurposeOtherText</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1182">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2968136</PUBLICID>
    <LONGNAME>Module Form Element Administered Item Origin java.lang.String</LONGNAME>
    <PREFERREDNAME>2967652v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A self-contained component (unit or item) that is used in combination with other components.:A printed or electronic document with spaces to be filled out.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.:A registry item for which administrative information is recorded in an Administration Record._The place where something begins or comes from in either the sense of a physical location or a metaphysical source._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2967652</PublicId>
      <PreferredName>2967420v1.0:2231609v1.0</PreferredName>
      <PreferredDefinition>A self-contained component (unit or item) that is used in combination with other components.:A printed or electronic document with spaces to be filled out.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.:A registry item for which administrative information is recorded in an Administration Record._The place where something begins or comes from in either the sense of a physical location or a metaphysical source.</PreferredDefinition>
      <LongName>Module Form Element Administered Item Origin</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2967420</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42721:C19464:C48792:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Module Form Element Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42721</PREFERRED_NAME>
            <LONG_NAME>Module</LONG_NAME>
            <CON_ID>2231571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19464</PREFERRED_NAME>
            <LONG_NAME>Form</LONG_NAME>
            <CON_ID>2202476</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48792</PREFERRED_NAME>
            <LONG_NAME>Element</LONG_NAME>
            <CON_ID>2513271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231609</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42703</PreferredName>
        <Version>1</Version>
        <LongName>Origin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42703</PREFERRED_NAME>
            <LONG_NAME>Origin</LONG_NAME>
            <CON_ID>2204026</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Module Form Element Administered Item Origin java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Module Form Element Administered Item Origin java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Module:origin</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.Module.origin</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1183">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2968215</PUBLICID>
    <LONGNAME>Conceptual Domain Administered Item Workflow Status Name Administered Component Workflow Status Name</LONGNAME>
    <PREFERREDNAME>2967746v1.0:2463565v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The set of all possible Valid Value meanings of a Data Element Concept expressed without representation. (NCICB):A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_Workflow is the operational aspect of a work procedure: how tasks are structured, who performs them, what their relative order is, how they are synchronized, how information flows to support the tasks and how tasks are being tracked. (from Wikipedia):A condition or state at a particular time.:The words or language units by which a thing is known._A name of a designation of the status in the administrative life-cycle of a Context Owner for handling new administered items.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2967746</PublicId>
      <PreferredName>2442937v1.0:2539494v1.0</PreferredName>
      <PreferredDefinition>The set of all possible Valid Value meanings of a Data Element Concept expressed without representation. (NCICB):A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_Workflow is the operational aspect of a work procedure: how tasks are structured, who performs them, what their relative order is, how they are synchronized, how information flows to support the tasks and how tasks are being tracked. (from Wikipedia):A condition or state at a particular time.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Conceptual Domain Administered Item Workflow Status Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2442937</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41083:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Domain Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41083</PREFERRED_NAME>
            <LONG_NAME>Conceptual Domain</LONG_NAME>
            <CON_ID>2231553</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2539494</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42753:C25688:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Workflow Status Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42753</PREFERRED_NAME>
            <LONG_NAME>Workflow</LONG_NAME>
            <CON_ID>2231547</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2463565</PublicId>
      <PreferredName>2463565v1.0</PreferredName>
      <PreferredDefinition>A name of a designation of the status in the administrative life-cycle of a Context Owner for handling new administered items.</PreferredDefinition>
      <LongName>Administered Component Workflow Status Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2183782</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>NCIP</PreferredName>
        <Version>1</Version>
        <LongName>NCIP</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2422682</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42753:C25688:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Workflow Status Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42753</PREFERRED_NAME>
            <LONG_NAME>Workflow</LONG_NAME>
            <CON_ID>2231547</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>APPRVD FOR TRIAL USE</VALIDVALUE>
          <VALUEMEANING>Approved for trial use</VALUEMEANING>
          <MEANINGDESCRIPTION>Status assigned to Draft New Data Elements included on Common Data Element-compliant forms, as well as their associated Administered Components.  Promotion to this status occurs when the Administered Component has been fully specified and Case Report Forms with which the Data Element is associated are deemed Common Data Element-compliant.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CMTE APPROVED</VALIDVALUE>
          <VALUEMEANING>Committee Approved</VALUEMEANING>
          <MEANINGDESCRIPTION>Admistered component approved by a committee.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576700</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CMTE SUBMTD</VALIDVALUE>
          <VALUEMEANING>Committee Submitted</VALUEMEANING>
          <MEANINGDESCRIPTION>Administered component submitted to a review committee</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CMTE SUBMTD USED</VALIDVALUE>
          <VALUEMEANING>Committee Submitted Used</VALUEMEANING>
          <MEANINGDESCRIPTION>Trial use approved, committee submitted administered component</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DRAFT MOD</VALIDVALUE>
          <VALUEMEANING>Draft Modified</VALUEMEANING>
          <MEANINGDESCRIPTION>New version of an existing administered component</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576703</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DRAFT NEW</VALIDVALUE>
          <VALUEMEANING>Draft New</VALUEMEANING>
          <MEANINGDESCRIPTION>Newly created administered component</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576704</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RELEASED</VALIDVALUE>
          <VALUEMEANING>Released</VALUEMEANING>
          <MEANINGDESCRIPTION>Reviewed and approved administered component</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RELEASED-NON-CMPLNT</VALIDVALUE>
          <VALUEMEANING>Released Non-Compliant</VALUEMEANING>
          <MEANINGDESCRIPTION>Status for short-term use only, to be replaced long term</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RETIRED ARCHIVED</VALIDVALUE>
          <VALUEMEANING>Retired Archived</VALUEMEANING>
          <MEANINGDESCRIPTION>Old version administered component replaced with new version</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576707</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RETIRED DELETED</VALIDVALUE>
          <VALUEMEANING>Retired Deleted</VALUEMEANING>
          <MEANINGDESCRIPTION>Erroneous administered component to be removed from database</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RETIRED PHASED OUT</VALIDVALUE>
          <VALUEMEANING>Retired Phased Out</VALUEMEANING>
          <MEANINGDESCRIPTION>Administered component rejected for general release</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RETIRED WITHDRAWN</VALIDVALUE>
          <VALUEMEANING>Retired Withdrawn</VALUEMEANING>
          <MEANINGDESCRIPTION>Administered component removed from general release</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-05-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Conceptual Domain Administered Item Workflow Status Name Administered Component Workflow Status Name does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Conceptual Domain Administered Item Workflow Status Name Administered Component Workflow Status Name does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.ConceptualDomain.workflowStatusName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ConceptualDomain:workflowStatusName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1184">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2969632</PUBLICID>
    <LONGNAME>Metastatic Neoplasm Lymph Node Confirmed Diagnosis Anatomic Site Name</LONGNAME>
    <PREFERREDNAME>2969624v1.0:2970676v1.1</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the confirmed lymph node metastasis anatomic site.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2969624</PublicId>
      <PreferredName>3061536v1.0:2443856v1.0</PreferredName>
      <PreferredDefinition>A tumor that has spread from its original (primary) site of growth to another site, close to or distant from the primary site.  Metastasis is characteristic of advanced malignancies, but in rare instances can be seen in neoplasms lacking malignant morphology._A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found through out the body. It is composed predominantly of lymphocytes and its main function is immune protection._Confirmed; having been established or verified._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</PreferredDefinition>
      <LongName>Metastatic Neoplasm Lymph Node Confirmed Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3061536</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3261:C12745</PreferredName>
        <Version>1</Version>
        <LongName>Metastatic Neoplasm Lymph Node</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3261</PREFERRED_NAME>
            <LONG_NAME>Metastatic Neoplasm</LONG_NAME>
            <CON_ID>2443854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12745</PREFERRED_NAME>
            <LONG_NAME>Lymph Node</LONG_NAME>
            <CON_ID>2202290</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2443856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25458:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Confirmed Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25458</PREFERRED_NAME>
            <LONG_NAME>Confirmation</LONG_NAME>
            <CON_ID>2203883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2970676</PublicId>
      <PreferredName>2970676v1.0</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The final result of a determination of the value, significance, or extent of._Named locations of or within the body._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Disease or Disorder Assessment Anatomic Site Name</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2986732</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C25217:C13717:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Disease or Disorder Assessment Anatomic Site Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebral hemisphere</VALIDVALUE>
          <VALUEMEANING>Cerebral Hemisphere</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the brain that controls muscle functions and also controls speech, thought, emotions, reading, writing, and learning. The right hemisphere controls the muscles on the left side of the body, and the left hemisphere controls the muscles on the right side of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brainstem</VALIDVALUE>
          <VALUEMEANING>Brain Stem</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the brain that is connected to the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinum</VALIDVALUE>
          <VALUEMEANING>Mediastinum</VALUEMEANING>
          <MEANINGDESCRIPTION>(mee-dee-a-STYE-num) The area between the lungs. The organs in this area include the heart and its large blood vessels, the trachea, the esophagus, the bronchi, and lymph nodes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cranial nerves</VALIDVALUE>
          <VALUEMEANING>Cranial Nerve</VALUEMEANING>
          <MEANINGDESCRIPTION>Cranial; of or relating to the cranium.: Any of the bundles of nerve fibers running to various organs and tissues of the body using chemical and electrical signals to transmit sensory and motor information from one body part to another.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12466, C37936</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebrospinal fluid</VALIDVALUE>
          <VALUEMEANING>Cerebrospinal Fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>The fluid that flows in and around the hollow spaces of the brain and spinal cord, and between two of the meninges (the thin layers of tissue that cover and protect the brain and spinal cord). CSF is made by tissue called the choroid plexus in the ventricles (hollow spaces) in the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebellum</VALIDVALUE>
          <VALUEMEANING>Cerebellum</VALUEMEANING>
          <MEANINGDESCRIPTION>(sair-uh-BELL-um) The portion of the brain in the back of the head between the cerebrum and the brain stem. The cerebellum controls balance for walking and standing, and other complex motor functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone marrow</VALIDVALUE>
          <VALUEMEANING>Bone Marrow (biopsy/aspirate)</VALUEMEANING>
          <MEANINGDESCRIPTION>The soft, sponge-like tissue in the center of bones that produces white blood cells, red blood cells, and platelets.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2873881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone</VALIDVALUE>
          <VALUEMEANING>Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Connective tissue that forms the skeletal components of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenal gland</VALIDVALUE>
          <VALUEMEANING>Adrenal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>Paired glands situated in the retroperitoneal tissues at the superior pole of each kidney.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569663</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central nervous system</VALIDVALUE>
          <VALUEMEANING>Central Nervous System</VALUEMEANING>
          <MEANINGDESCRIPTION>The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin</VALIDVALUE>
          <VALUEMEANING>Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleura</VALIDVALUE>
          <VALUEMEANING>Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>(PLOOR-a) A thin layer of tissue covering the lungs and the wall of the chest cavity to protect and cushion the lungs. A small amount of fluid that acts as a lubricant allows the lungs to move smoothly in the chest cavity during breathing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axillary lymph nodes</VALIDVALUE>
          <VALUEMEANING>Axillary Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymph nodes found in the armpit that drain the lymph channels from the breast.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0229839</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung</VALIDVALUE>
          <VALUEMEANING>Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. SYN pulmo.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2873883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver</VALIDVALUE>
          <VALUEMEANING>Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest wall</VALIDVALUE>
          <VALUEMEANING>Chest Wall</VALUEMEANING>
          <MEANINGDESCRIPTION>The total system of structures outside the lungs that move as a part of breathing; it includes all structures from the skin to the parietal pleura.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Breast</VALIDVALUE>
          <VALUEMEANING>Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone - symptomatic</VALIDVALUE>
          <VALUEMEANING>Bone Symptomatic</VALUEMEANING>
          <MEANINGDESCRIPTION>Bone; a rigid connective tissue that makes up the skeleton of vertebrates.: Having to do with symptoms, which are signs of a condition or disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25269, C12366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone - radiographic</VALIDVALUE>
          <VALUEMEANING>Bone Radiography</VALUEMEANING>
          <MEANINGDESCRIPTION>Bone; a rigid connective tissue that makes up the skeleton of vertebrates.: A radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38101, C12366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor markers</VALIDVALUE>
          <VALUEMEANING>Tumor Marker (p53,CD&#39;s Ki, CEA, Her2/Neu, etc.)</VALUEMEANING>
          <MEANINGDESCRIPTION>A substance sometimes found in an increased amount in the blood, other body fluids, or tissues and which may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (ovarian cancer), CA 15-3 (breast cancer), CEA (ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (prostate cancer). Also called biomarker.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2986712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph nodes, retroperitoneal</VALIDVALUE>
          <VALUEMEANING>Local-Regional Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Local-Regional; affecting only a restricted part or area of the body.: A rounded mass of lymphatic tissue that is surrounded by a capsule of connective tissue. Lymph glands filter lymph (lymphatic fluid), and they store lymphocytes (white blood cells). They are located along lymphatic vessels. Also called a lymph node.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25388, C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2986713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvis</VALIDVALUE>
          <VALUEMEANING>Pelvis (Ilium, Ischium, and Pubis bones)</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Local primary site</VALIDVALUE>
          <VALUEMEANING>Local Primary Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or belonging to a restricted area or locality.: Occurring first in time or sequence; original. (American Heritage Dictionary): Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C25251, C67263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spinal leptomeningeal</VALIDVALUE>
          <VALUEMEANING>Spinal Leptomeningeal Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic or neoplastic pathologic process affecting the leptomeninges of the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3120391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intracranial leptomeningeal</VALIDVALUE>
          <VALUEMEANING>Intracranial Leptomeningeal Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic or neoplastic pathologic process affecting the leptomeninges of the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84358</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3120392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Distant intracranial parenchymal</VALIDVALUE>
          <VALUEMEANING>Distant Intracranial Metastasis</VALUEMEANING>
          <MEANINGDESCRIPTION>The presence of brain metastasis that originates from a cancer growth in a distant anatomic site.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3120393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extraneural</VALIDVALUE>
          <VALUEMEANING>Extraneural</VALUEMEANING>
          <MEANINGDESCRIPTION>Situated or occurring outside the nerve or nerves.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3120394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spinal cord</VALIDVALUE>
          <VALUEMEANING>Spinal Cord</VALUEMEANING>
          <MEANINGDESCRIPTION>The elongated, approximately cylindrical part of the central nervous system of vertebrates that lies in the vertebral canal and from which the spinal nerves emerge.|On-line Medical Dictionary</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph nodes - distant</VALIDVALUE>
          <VALUEMEANING>Distant Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Far apart in space from a point of origin on the body.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25321, C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2963867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right breast</VALIDVALUE>
          <VALUEMEANING>Right Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>Right; being or located on or directed toward the side of the body to the east when facing north.: One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25228, C12971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3061604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left breast</VALIDVALUE>
          <VALUEMEANING>Left Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>Left; being or located on or directed toward the side of the body to the west when facing north.: One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25229, C12971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3061605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s), contralateral internal mammary</VALIDVALUE>
          <VALUEMEANING>Contralateral Internal Mammary Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>On or relating to the opposite side (of the body): Any of the lymph nodes of the breast located under the ribcage, near the sternum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32853, C25307</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2969630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s), mediastinum</VALIDVALUE>
          <VALUEMEANING>Mediastinal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s), subclavicular</VALIDVALUE>
          <VALUEMEANING>Infraclavicular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the area below the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2969629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s), supraclavicular</VALIDVALUE>
          <VALUEMEANING>Supraclavicular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymph nodes located above the clavicle (collarbone).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testes</VALIDVALUE>
          <VALUEMEANING>Testis</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the paired male reproductive glands that produce the male germ cells and the male hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2873868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytogenetic/FISH test results</VALIDVALUE>
          <VALUEMEANING>Cytogenetics And/Or Fluorescence in situ Hybridization Laboratory Test Result</VALUEMEANING>
          <MEANINGDESCRIPTION>Cytogenetics is the study of chromosomes and the related disease states caused by numerical and structural chromosome abnormalities.: Used to indicate that either or both of two items or options: A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.: The outcome of a laboratory test.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36292, C17563, C48928, C16487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3071173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Molecular test results</VALIDVALUE>
          <VALUEMEANING>Molecular Laboratory Test Result</VALUEMEANING>
          <MEANINGDESCRIPTION>Molecular; relating to or produced by or consisting of molecules.: The outcome of a laboratory test.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36292, C25574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3071174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated catecholemines</VALIDVALUE>
          <VALUEMEANING>Elevated Catecholamine</VALUEMEANING>
          <MEANINGDESCRIPTION>Elevated; raised or increased.: A group of sympathetic amines containing a catechol group derived from the amino acid tyrosine.  Catecholamines are neuromodulators and hormones synthesized in the chromaffin cells of the adrenal grands and the postganglionic fibers of the sympathetic nervous system in response to stress.  Examples of catecholamines are epinephrine (adrenaline), norepinephrine (noradrenaline) and dopamine, all of which participate in wide variety of functions throughout the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88516, C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3086002</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lower GI tract</VALIDVALUE>
          <VALUEMEANING>Lower Gastrointestinal Tract</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the gastrointestinal tract that includes the jejunum and ileum of the small intestine and the large intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33010</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3143267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Upper GI tract</VALIDVALUE>
          <VALUEMEANING>Upper Gastrointestinal Tract</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3143268</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arthropathy</VALIDVALUE>
          <VALUEMEANING>Arthropathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Any disease of the joints.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35760</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tongue</VALIDVALUE>
          <VALUEMEANING>Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soft Tissue</VALIDVALUE>
          <VALUEMEANING>Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2990372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brain</VALIDVALUE>
          <VALUEMEANING>Brain</VALUEMEANING>
          <MEANINGDESCRIPTION>That part of the central nervous system contained within the cranium, comprising the prosencephalon, mesencephalon, and rhombencephalon. It is derived from the anterior part of the embryonic neural tube. Functions include muscle control and coordination, sensory reception and integration, speech production, memory storage, and the elaboration of thought and emotions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2986592</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebellar hemisphere / vermis</VALIDVALUE>
          <VALUEMEANING>Cerebellum And/Or Vermis</VALUEMEANING>
          <MEANINGDESCRIPTION>(sair-uh-BELL-um) The portion of the brain in the back of the head between the cerebrum and the brain stem. The cerebellum controls balance for walking and standing, and other complex motor functions.: Used to indicate that either or both of two items or options: A medial narrow structure connecting the two hemispheres of the cerebellum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33866, C48928, C12445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Optic chiasma / hypothalamus / suprasellar area</VALIDVALUE>
          <VALUEMEANING>Hypothalamus And/Or Suprasellar Region</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypothalamus is an important supervisory center in the brain, rich in ganglia, nerve fibers, and synaptic connections. It is composed of several sections called nuclei, each of which controls a specific function. The hypothalamus regulates body temperatur: Used to indicate that either or both of two items or options: The region above or over the sella turcica.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42602, C48928, C12458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other lymph nodes</VALIDVALUE>
          <VALUEMEANING>Other Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A rounded mass of lymphatic tissue that is surrounded by a capsule of connective tissue. Lymph glands filter lymph (lymphatic fluid), and they store lymphocytes (white blood cells). They are located along lymphatic vessels. Also called a lymph node.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thalamus/basal ganglia/corpus callosum</VALIDVALUE>
          <VALUEMEANING>Thalamus And/Or Basal Ganglia And/Or Corpus Callosum</VALUEMEANING>
          <MEANINGDESCRIPTION>(THAL-a-muss) An area of the brain that helps process information from the senses and transmit it to other parts of the brain.: Used to indicate that either or both of two items or options: subcortical masses of gray matter of the cerebrum, namely, the caudate nucleus, putamen, globus pallidus, amygdala, and clastrum; involved in initiating and directing voluntary movements.: Used to indicate that either or both of two items or options: the main neocortical commissure of the cerebral hemispheres; it is subdivided into a genu, a rostrum, a body, and a splenium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12446, C48928, C12447, C48928, C12459</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Both breasts</VALIDVALUE>
          <VALUEMEANING>Bilateral Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>Affecting both sides of the body, or a matched pair of organs.: One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12971, C13332</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3061603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin / subcutaneous tissue</VALIDVALUE>
          <VALUEMEANING>Skin And/Or Subcutaneous</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.: Used to indicate that either or both of two items or options: Beneath the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13353, C48928, C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3264220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node</VALIDVALUE>
          <VALUEMEANING>Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraspinal ganglion</VALIDVALUE>
          <VALUEMEANING>Para-Spinal Ganglion</VALUEMEANING>
          <MEANINGDESCRIPTION>A sympathetic ganglion located adjacent to the spinal column.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97925</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3268517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retro-orbital area</VALIDVALUE>
          <VALUEMEANING>Retro-Orbital Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the body behind the orbit of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3268518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extra-CNS primary site</VALIDVALUE>
          <VALUEMEANING>External Central Nervous System Primary Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>Happening or arising or located outside or beyond some limits, or especially, some surface.: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.: Occurring first in time or sequence; original. (American Heritage Dictionary): Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C25251, C12438, C44280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3285791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney</VALIDVALUE>
          <VALUEMEANING>Kidney</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secret the metabolic products and minerals from the blood, thus maintaining the homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood</VALIDVALUE>
          <VALUEMEANING>Blood</VALUEMEANING>
          <MEANINGDESCRIPTION>Blood circulating throughout the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3111300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spleen</VALIDVALUE>
          <VALUEMEANING>Spleen</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that is part of the lymphatic system. The spleen produces lymphocytes, filters the blood, stores blood cells, and destroys old blood cells. It is located on the left side of the abdomen near the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal tract</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal Tract</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epidural space</VALIDVALUE>
          <VALUEMEANING>Epidural Spinal Canal Space</VALUEMEANING>
          <MEANINGDESCRIPTION>Space between the dura mater and the walls of the vertebral canal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other site</VALIDVALUE>
          <VALUEMEANING>Other Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C13717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2963865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systemic</VALIDVALUE>
          <VALUEMEANING>Systemic Immunosuppressive Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Affecting an entire system._Immunomodulation therapy designed to reduce the body’s immune response.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13310, C15261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4635656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sclerotic bone lesions</VALIDVALUE>
          <VALUEMEANING>Sclerosis Bone Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>A pathological hardening or thickening of tissue, especially that of the interstitial substance.: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43260, C69309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extramedullary plasmacytomas</VALIDVALUE>
          <VALUEMEANING>Extraosseous Plasmacytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A plasma cell neoplasm arising at an extraosseous site. There is no involvement of the bone marrow. It most frequently involves the oropharynx, nasopharynx, sinuses, and larynx. Other sites of involvement include the gastrointestinal tract, central nervous system, breast, skin, lymph nodes, and bladder.  A minority of patients have a monoclonal gammopathy. Treatment includes radiation therapy. Progression to plasma cell myeloma occurs in a minority of patients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2861342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lytic bone lesions</VALIDVALUE>
          <VALUEMEANING>Lytic Bone Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>Destruction of an area of bone due to a disease process, such as cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41040</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6815897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdominal Renal Fossa (prior operative tumor bed)</VALIDVALUE>
          <VALUEMEANING>Prior Operative Tumor Bed Abdominal Renal Fossa</VALUEMEANING>
          <MEANINGDESCRIPTION>Earlier in time or order.: Occurring during or associated with a surgical procedure.: The tissue that envelopes a tumor site, following the surgical removal of the tumor.: Of, or related to, the abdomen.: The usual retroperitoneal location of the kidney in the dorsolumbar region of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142312, C25342, C101558, C54733, C25629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7343391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extra-abdominal Lymph Nodes</VALIDVALUE>
          <VALUEMEANING>Extra-abdominal lymph node(s)</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node outside the abdominal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdominal Lymph Nodes</VALIDVALUE>
          <VALUEMEANING>Intra-Abdominal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Any lymph node within the abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3566777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritoneal Implants</VALIDVALUE>
          <VALUEMEANING>Peritoneal Implant</VALUEMEANING>
          <MEANINGDESCRIPTION>Deposits of borderline, malignant, and rarely benign tumors, usually from the ovary, on the peritoneal surface.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C173164</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7344564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Shoulder</VALIDVALUE>
          <VALUEMEANING>Shoulder Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>A ball-and-socket joint at the upper end of the humerus, located at the junction of humerus and scapula.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Knee</VALIDVALUE>
          <VALUEMEANING>Knee Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint connecting the lower part of the femur with the upper part of the tibia. The lower part of the femur and the upper part of the tibia are attached to each other by ligaments. Other structures of the knee joint include the upper part of the fibula, located below and parallel to the tibia, and the patella which moves as the knee bends.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hip</VALIDVALUE>
          <VALUEMEANING>Hip Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>A ball-and-socket joint between the head of the femur and the acetabulum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3181299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Which sites did the metastasi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Which sites did the metastasis lymph nodes present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2969632</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedDiagnosis &gt; TargetAnatomicSite.code WHERE PerformedDiagnosis.value = &quot;Metastatic Neoplasm&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2020r1: Breast Cancer Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TargetAnatomicSite:code </AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1185">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2974158</PUBLICID>
    <LONGNAME>Paroxysmal Nocturnal Hemoglobinuria Laboratory Procedure Performed Type</LONGNAME>
    <PREFERREDNAME>2974136v1.0:2974148v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the type of laboratory procedure that was performed for the paroxysmal nocturnal hemoglobinuria.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2974136</PublicId>
      <PreferredName>P_N_H_L_P_P</PreferredName>
      <PreferredDefinition>A rare acquired hematologic disorder characterized by hemolytic anemia, dark-colored urine due to the release of hemoglobin in the blood, and thrombosis.  The episodes of hemolysis tend to occur at night.  It is caused by a somatic mutation in the glycosylphosphatidylinositol biosynthesis gene._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Paroxysmal Nocturnal Hemoglobinuria Laboratory Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2974133</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61233:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Paroxysmal Nocturnal Hemoglobinuria Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61233</PREFERRED_NAME>
            <LONG_NAME>Paroxysmal Nocturnal Hemoglobinuria</LONG_NAME>
            <CON_ID>2593266</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2974148</PublicId>
      <PreferredName>P_N_H_L_P_T</PreferredName>
      <PreferredDefinition>A rare acquired hematologic disorder characterized by hemolytic anemia, dark-colored urine due to the release of hemoglobin in the blood, and thrombosis. The episodes of hemolysis tend to occur at night. It is caused by a somatic mutation in the glycosylphosphatidylinositol biosynthesis gene._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Paroxysmal Nocturnal Hemoglobinuria Laboratory Procedure Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2974147</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61233:C25294:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Paroxysmal Nocturnal Hemoglobinuria Laboratory Procedure Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61233</PREFERRED_NAME>
            <LONG_NAME>Paroxysmal Nocturnal Hemoglobinuria</LONG_NAME>
            <CON_ID>2593266</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other test</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sugar water / sucrose lysis test</VALIDVALUE>
          <VALUEMEANING>Sucrose Lysis</VALUEMEANING>
          <MEANINGDESCRIPTION>A disaccharide consisting of glucose and fructose. The linkage is alpha with respect to the glucose and beta with respect to the fructose.: Rupture of cell membranes and loss of cytoplasm. (On-line Medical Dictionary)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37889, C68477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2974149</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hemosiderinuria</VALIDVALUE>
          <VALUEMEANING>Urine Discoloration</VALUEMEANING>
          <MEANINGDESCRIPTION>Change in the color of the urine. Causes include medications, vitamins, urinary tract infection, liver disease, hemolysis, and kidney cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78678</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2943916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ham&#39;s acid hemolysis test</VALIDVALUE>
          <VALUEMEANING>Acid Hemolysis</VALUEMEANING>
          <MEANINGDESCRIPTION>A substance that yields hydrogen ions or protons in aqueous solutions; a substance capable of accepting a pair of electrons for the formation of a coordinate covalent bond; a substance whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water.: Disruption of the integrity of the red cell membrane causing release of hemoglobin. (On-line Medical Dictionary)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37965, C48057</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2974151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flow cytometry for CD55 / CD16 / CD59</VALIDVALUE>
          <VALUEMEANING>Complement Decay-Accelerating Factor Fc-Gamma Receptor III CD59 Glycoprotein Flow Cytometry</VALUEMEANING>
          <MEANINGDESCRIPTION>Complement decay-accelerating factor (381 aa, ~41 kDa) is encoded by the human CD55 gene. This protein plays a role in the negative regulation of the complement cascade.: Fc-Gamma Receptor III is expressed on natural killer cells, granulocytes, and monocytes.  It is included in the zeta natural killer cell receptor complex.  Fc receptor III is encoded by two separate genes: one for the neutrophil receptor (CD16) and another for the receptor on natural killer cells and macrophages.  Some gamma-delta T-cells express CD16.  Mitogenic stimulation of circulating gamma-delta T-cells results in decreased expression of CD16.: CD59 glycoprotein (128 aa, ~14 kDa) is encoded by the human CD59 gene. This protein is involved in the inhibition of the assembly of the membrane attack complex in the complement cascade.: A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16585, C95934, C17487, C95931</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PIGA GPI anchor protein defect</VALIDVALUE>
          <VALUEMEANING>Phosphatidylinositol N-Acetylglucosaminyltransferase Subunit A Protein Defect</VALUEMEANING>
          <MEANINGDESCRIPTION>Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (484 aa, ~54 kDa) is encoded by the human PIGA gene. This protein is involved in the mediation of glycophosphoinositol anchor synthesis.: Any of a group of complex organic macromolecules that contain carbon, hydrogen, oxygen, nitrogen, and usually sulfur and are composed of one or more chains of amino acids. Proteins are fundamental components of all living cells and include many substances, such as enzymes, hormones, and antibodies, that are necessary for the proper functioning of an organism.: A failing or deficiency.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43429, C17021, C95927</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3203135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What paroxysmal nocturnal hem</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What paroxysmal nocturnal hemoglobinuria test was used?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2974158</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedObservationResult &gt; PerformedObservation.methodCode WHERE PerformedObservation &gt; DefinedObservation.nameCode = &quot;Test for Paroxysmal Nocturnal Hemoglobinuria&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedObservation:methodCode</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1186">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2974187</PUBLICID>
    <LONGNAME>Immunotherapy Erythropoietin Prior Administered First Date</LONGNAME>
    <PREFERREDNAME>2771791v1.0:2016734v3.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the first date related to the prior administration of synthetic erythropoietin, a glycoprotein hormone, secreted chiefly by the kidney in the adult and the liver in the fetus, that acts on erythroid stem cells of the bone marrow to stimulate proliferation and differentiation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2771791</PublicId>
      <PreferredName>IT_ERYTH_P_ADM</PreferredName>
      <PreferredDefinition>information related to the prior administration of synthetic erythropoietin, a glycoprotein hormone, secreted chiefly by the kidney in the adult and the liver in the fetus, that acts on erythroid stem cells of the bone marrow to stimulate proliferation and differentiation.</PreferredDefinition>
      <LongName>Immunotherapy Erythropoietin Prior Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2554222</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15262</PreferredName>
        <Version>1</Version>
        <LongName>Immunotherapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15262</PREFERRED_NAME>
            <LONG_NAME>Immunotherapy</LONG_NAME>
            <CON_ID>2202664</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2771789</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20429:C25629:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Erythropoietin Prior Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20429</PREFERRED_NAME>
            <LONG_NAME>Erythropoietin</LONG_NAME>
            <CON_ID>2459801</CON_ID>
            <DEFINITION_SOURCE>MSH2002_06_01</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016734</PublicId>
      <PreferredName>FIRST_DT</PreferredName>
      <PreferredDefinition>the first date of an assessment, test, or treatment.</PreferredDefinition>
      <LongName>First Date</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>mm/dd/yyyy</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C25164</PreferredName>
        <Version>1</Version>
        <LongName>First Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1187">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2974373</PUBLICID>
    <LONGNAME>Disabilities of the Arm Shoulder and Hand Outcome Measure Disability Symptom Total Score</LONGNAME>
    <PREFERREDNAME>DASH_DIS_SX_TTL_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value representing the total score of the Disability/Symptom portion of the Disabilities of the Arm, Shoulder and Hand Outcome measure, a 30-item, self-reported questionnaire designed to measure physical and social function along with symptom impact associated with musculosketetal disorders of the upper limb.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2972020</PublicId>
      <PreferredName>DASH_ASSESS_RSL</PreferredName>
      <PreferredDefinition>A 30-item, self-reported questionnaire designed to measure physical and social function along with symptom impact associated with musculosketetal disorders of the upper limb._Having determined the value, significance, or extent of._Outcome; a phenomenon that follows and is caused by some previous phenomenon.</PreferredDefinition>
      <LongName>Disabilities of the Arm Shoulder and Hand Outcome Measure Assessment Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2972002</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C85391</PreferredName>
        <Version>1</Version>
        <LongName>Disabilities of the Arm Shoulder and Hand Outcome Measure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85391</PREFERRED_NAME>
            <LONG_NAME>Disabilities of the Arm Shoulder and Hand Outcome Measure</LONG_NAME>
            <CON_ID>2971764</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2972008</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25217:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2972032</PublicId>
      <PreferredName>DASH_DIS_SX_TTL_SC</PreferredName>
      <PreferredDefinition>A 30-item, self-reported questionnaire designed to measure physical and social function along with symptom impact associated with musculosketetal disorders of the upper limb._Any physical, mental, or functional impairment that limits a major activity.  It may be partial or complete. (Taber&#39;s)_An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Disabilities of the Arm Shoulder and Hand Outcome Measure Disability Symptom Total Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2972031</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C85391:C21007:C4876:C25304:C25</PreferredName>
        <Version>1</Version>
        <LongName>Disabilities of the Arm Shoulder and Hand Outcome Measure Disability Symptom Total Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85391</PREFERRED_NAME>
            <LONG_NAME>Disabilities of the Arm Shoulder and Hand Outcome Measure</LONG_NAME>
            <CON_ID>2971764</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21007</PREFERRED_NAME>
            <LONG_NAME>Disability</LONG_NAME>
            <CON_ID>2204977</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25304</PREFERRED_NAME>
            <LONG_NAME>Total</LONG_NAME>
            <CON_ID>2204938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DASH Disability/Symptom Total</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>DASH Disability/Symptom Total Score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1188">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2975860</PUBLICID>
    <LONGNAME>Imaging Agent Radioisotope Half Life Float 16 Character Number</LONGNAME>
    <PREFERREDNAME>2975822v1.0:2585012v1.1</PREFERREDNAME>
    <PREFERREDDEFINITION>The radionuclide half life, in seconds, that was used in the correction of this image.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DICOM:Digital Imaging and Communications in Medicine</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2975822</PublicId>
      <PreferredName>2986612v1.0:2986652v1.0</PreferredName>
      <PreferredDefinition>The radionuclide half life that was used in the correction of this image.</PreferredDefinition>
      <LongName>Imaging Agent Radioisotope Half Life</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2986612</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16831:C1708</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16831</PREFERRED_NAME>
            <LONG_NAME>Medical Imaging</LONG_NAME>
            <CON_ID>2224877</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2986652</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C799:C70916</PreferredName>
        <Version>1</Version>
        <LongName>Radioisotope Half Life</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C799</PREFERRED_NAME>
            <LONG_NAME>Radioisotope</LONG_NAME>
            <CON_ID>2202877</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70916</PREFERRED_NAME>
            <LONG_NAME>Half Life</LONG_NAME>
            <CON_ID>2939190</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2585012</PublicId>
      <PreferredName>FLOAT_16_CHAR_NUM</PreferredName>
      <PreferredDefinition>DS: A string of characters representing either a fixed point number or a floating point number. A fixed point number shall contain only the characters 0-9 with an optional leading &quot;+&quot; or &quot;-&quot; and an optional &quot;.&quot; to mark the decimal point. A floating point number shall be conveyed as defined in ANSI X3.9, with an &quot;E&quot; or &quot;e&quot; to indicate the start of the exponent. Decimal Strings may be padded with leading or trailing spaces. Embedded spaces are not allowed.  (valid characters 0-9, +,-, E,e,&quot;.&quot;) [Standard-based]</PreferredDefinition>
      <LongName>Float 16 Character Number</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>16</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DICOM:Digital Imaging and Communications in Medicine</Origin>
      <Representation>
        <PublicId>2585011</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45253:C25337</PreferredName>
        <Version>1</Version>
        <LongName>String Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45253</PREFERRED_NAME>
            <LONG_NAME>String</LONG_NAME>
            <CON_ID>2539471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Imaging Agent Radioisotope Ha</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Imaging Agent Radioisotope Half Life</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>(0018,1075)</AlternateName>
        <AlternateNameType>DICOM_TAG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Radionuclide Half-life</AlternateName>
        <AlternateNameType>DICOM Attribute Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1189">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2987613</PUBLICID>
    <LONGNAME>Cytogenetic Abnormality Trisomy Chromosome 8 Present Indicator</LONGNAME>
    <PREFERREDNAME>2987594v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not an irregularity in the number or structure of chromosomes consisting of the presence of a third copy of chromosome 8 was present.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2987594</PublicId>
      <PreferredName>2459195v1.0:3233679v1.0</PreferredName>
      <PreferredDefinition>An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material._A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number._The designation for each member of the eighth largest human autosomal chromosome pair. Chromosome 8 spans about 145 million base pairs and represents between 4.5 and 5.0% of the total DNA in normal diploid cells._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Cytogenetic Abnormality Trisomy Chromosome 8 Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2459195</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2950</PreferredName>
        <Version>1</Version>
        <LongName>Cytogenetic Abnormality</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2950</PREFERRED_NAME>
            <LONG_NAME>Cytogenetic Abnormality</LONG_NAME>
            <CON_ID>2459194</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3233679</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3421:C13224:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Trisomy Chromosome 8 Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3421</PREFERRED_NAME>
            <LONG_NAME>Trisomy</LONG_NAME>
            <CON_ID>2987552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>RADLEX_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13224</PREFERRED_NAME>
            <LONG_NAME>Human Chromosome 8</LONG_NAME>
            <CON_ID>2958691</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a third copy of chromosom</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was a third copy of chromosome 8 present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>+8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>+8</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>TARGET AML Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>trisomy 8</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>+8</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>+8</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964895</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5650570</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TARGET</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5650572</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>fan_base_karyo_diag_8_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_therapy_multi_tri8_ab_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1190">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2998013</PUBLICID>
    <LONGNAME>Password Creation Policy Password Minimum Length java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2992700v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A secret set of characters, numbers, or symbols used as a form of authentication.:The process by which something is brought into existence; having been brought into existence.:A plan of action adopted by an individual or social group._A secret set of characters, numbers, or symbols used as a form of authentication.:The smallest possible quantity.:The linear extent in space from one end of something to the other end, or the extent of something from beginning to end._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2992700</PublicId>
      <PreferredName>2992547v1.0:2992617v1.0</PreferredName>
      <PreferredDefinition>A secret set of characters, numbers, or symbols used as a form of authentication.:The process by which something is brought into existence; having been brought into existence.:A plan of action adopted by an individual or social group._A secret set of characters, numbers, or symbols used as a form of authentication.:The smallest possible quantity.:The linear extent in space from one end of something to the other end, or the extent of something from beginning to end.</PreferredDefinition>
      <LongName>Password Creation Policy Password Minimum Length</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2992547</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42710:C42620:C17735</PreferredName>
        <Version>1</Version>
        <LongName>Password Creation Policy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42710</PREFERRED_NAME>
            <LONG_NAME>Password</LONG_NAME>
            <CON_ID>2223427</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42620</PREFERRED_NAME>
            <LONG_NAME>Creation</LONG_NAME>
            <CON_ID>2222835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17735</PREFERRED_NAME>
            <LONG_NAME>Policy</LONG_NAME>
            <CON_ID>2790012</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2992617</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42710:C25570:C25334</PreferredName>
        <Version>1</Version>
        <LongName>Password Minimum Length</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42710</PREFERRED_NAME>
            <LONG_NAME>Password</LONG_NAME>
            <CON_ID>2223427</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25570</PREFERRED_NAME>
            <LONG_NAME>Minimum</LONG_NAME>
            <CON_ID>2206306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25334</PREFERRED_NAME>
            <LONG_NAME>Length</LONG_NAME>
            <CON_ID>2203838</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Password Creation Policy Password Minimum Length java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Password Creation Policy Password Minimum Length java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain.security.passwordpolicy</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2992521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.security.passwordpolicy.PasswordCreationPolicy.minPasswordLength</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PasswordCreationPolicy:minPasswordLength</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1191">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2998176</PUBLICID>
    <LONGNAME>Distant Investigator Last Attempt Time java.util.Date</LONGNAME>
    <PREFERREDNAME>2992851v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Far apart in space, time, or relevance from a point of origin.:An individual who conducts scientific research. In a clinical setting this individual actually conducts and/or supervises the clinical investigation and study-related procedures.  The investigator monitors the safety of the trial subjects and investigational staff (under whose immediate direction an agent is administered or dispensed to a subject).  The investigator collects and analyses data and study documents, and provides reports in compliance with applicable requirements._Coming after all others in time or space or degree or being the only one remaining.:An activity intended to do or accomplish something.  Routinely used as in &quot;number of tries to complete a procedure&quot;.:The continuum of experience in which events pass from the future through the present to the past._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2992851</PublicId>
      <PreferredName>2992566v1.0:2992654v1.0</PreferredName>
      <PreferredDefinition>Far apart in space, time, or relevance from a point of origin.:An individual who conducts scientific research. In a clinical setting this individual actually conducts and/or supervises the clinical investigation and study-related procedures.  The investigator monitors the safety of the trial subjects and investigational staff (under whose immediate direction an agent is administered or dispensed to a subject).  The investigator collects and analyses data and study documents, and provides reports in compliance with applicable requirements._Coming after all others in time or space or degree or being the only one remaining.:An activity intended to do or accomplish something.  Routinely used as in &quot;number of tries to complete a procedure&quot;.:The continuum of experience in which events pass from the future through the present to the past.</PreferredDefinition>
      <LongName>Distant Investigator Last Attempt Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2992566</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25321:C25936</PreferredName>
        <Version>1</Version>
        <LongName>Distant Investigator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25321</PREFERRED_NAME>
            <LONG_NAME>Distant</LONG_NAME>
            <CON_ID>2204917</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25936</PREFERRED_NAME>
            <LONG_NAME>Investigator</LONG_NAME>
            <CON_ID>2202869</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2992654</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25551:C39769:C25207</PreferredName>
        <Version>1</Version>
        <LongName>Last Attempt Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25551</PREFERRED_NAME>
            <LONG_NAME>Last</LONG_NAME>
            <CON_ID>2206286</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39769</PREFERRED_NAME>
            <LONG_NAME>Attempt</LONG_NAME>
            <CON_ID>2203722</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Distant Investigator Last Attempt Time java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Distant Investigator Last Attempt Time java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000413</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RemoteInvestigator:lastLoginAttemptTime</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.RemoteInvestigator.lastLoginAttemptTime</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1192">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2998230</PUBLICID>
    <LONGNAME>Distant Research Personnel Staff Identifier java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2992904v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Far apart in space, time, or relevance from a point of origin.:People engaged in research.:The employees of an organization; personnel who assist their superior in carrying out an assigned task._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2992904</PublicId>
      <PreferredName>2992561v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Far apart in space, time, or relevance from a point of origin.:People engaged in research.:The employees of an organization; personnel who assist their superior in carrying out an assigned task._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Distant Research Personnel Staff Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2992561</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25321:C17089:C63612</PreferredName>
        <Version>1</Version>
        <LongName>Distant Research Personnel Staff</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25321</PREFERRED_NAME>
            <LONG_NAME>Distant</LONG_NAME>
            <CON_ID>2204917</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17089</PREFERRED_NAME>
            <LONG_NAME>Research Personnel</LONG_NAME>
            <CON_ID>2202675</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63612</PREFERRED_NAME>
            <LONG_NAME>Staff</LONG_NAME>
            <CON_ID>2667911</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Distant Research Personnel Staff Identifier java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Distant Research Personnel Staff Identifier java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000413</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.RemoteResearchStaff.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RemoteResearchStaff:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1193">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3006893</PUBLICID>
    <LONGNAME>Sample Collection Date</LONGNAME>
    <PREFERREDNAME>2013007v3.0:2532012v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The date when the sample (specimen) was collected.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013007</PublicId>
      <PreferredName>SMPL_COLLCT_DT</PreferredName>
      <PreferredDefinition>Particular, month and year a sample is collected.</PreferredDefinition>
      <LongName>Sample Collection Date</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2241624</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157:C25453</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Collection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2192971</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2532012</PublicId>
      <PreferredName>DATE</PreferredName>
      <PreferredDefinition>The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY-MM-DD</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of test</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of test</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Sample (specimen) collection</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Sample (specimen) collection date.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date tested</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date tested</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify date of bone marrow examination</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify date of bone marrow examination</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Test date</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Test date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of analysis:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of analysis:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of bone marrow examination:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of bone marrow examination:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of most recent test:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of most recent test:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of assessment:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of assessment:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the date molecular testing was performed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the date molecular testing was performed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the date the bone marrow biopsy was performed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the date the bone marrow biopsy was performed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Sample collection date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date sample collected:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Date sample collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date CBC tested</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date CBC tested</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date sample collected:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date assessed</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date assessed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping for CDE:3006893</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedSpecimenCollection.dateRange WHERE PerformedSpecimenCollection &gt; DefinedSpecimenCollection.nameCode = &quot;Collect Sample&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date the disease relapse or progression was established:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date the disease relapse or progression was established:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of karyotyping:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of karyotyping:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of examination:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of examination:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of last assessment:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of last assessment:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of most recent complete blood count:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of most recent complete blood count:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Blood collection date:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Blood collection date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of complete blood count:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of complete blood count:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of blood count:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of blood count:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date cardiac biomarkers were assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date cardiac biomarkers were assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date CBC tested:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date CBC tested:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date CBC drawn:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date CBC drawn:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date sample drawn:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample drawn:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of most recent bone marrow examination:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of most recent bone marrow examination:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date Interleukin-6 collected:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date Interleukin-6 collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date complete blood count (CBC) sample drawn:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date complete blood count (CBC) sample drawn:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date fibrinogen sample collected:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date fibrinogen sample collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date triglyceride sample collected:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date triglyceride sample collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of most recent complete blood count (CBC) sample drawn:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of most recent complete blood count (CBC) sample drawn:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date soluble interleukin-2 receptor alpha collected:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date soluble interleukin-2 receptor alpha collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date C-reactive protein collected:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date C-reactive protein collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date serum ferritin collected:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date serum ferritin collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date lymphocyte analyses performed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date lymphocyte analyses performed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date donor / CBU tested:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date donor / CBU tested:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date soluble interleukin-2 receptor α collected:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date soluble interleukin-2 receptor α collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date recipient tested:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date recipient tested:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date donor tested:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date donor tested:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of most recent CSF testing:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of most recent CSF testing:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of most recent neurocognitive test prior to the preparative regimen:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of most recent neurocognitive test prior to the preparative regimen:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date total serum ferritin collected:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date total serum ferritin collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date serum creatinine collected:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date serum creatinine collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of most recent complete blood count (CBC):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date complete blood count sample drawn (CBC):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date AST (SGOT) collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date ALT (SGPT) collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date total serum bilirubin collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date serum albumin collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date estimated glomerular filtration rate (eGFR) collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date LDH collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date urine albumin collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date serum iron collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date total iron binding capacity collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date interleukin-6 collected:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date interleukin-6 collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of sample collection:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 13</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of serum iron ferritin:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 14</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of hemoglobin:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 15</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of marrow aspirate and / or biopsy:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 16</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date complete blood count (CBC) drawn:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 17</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample for HBsAg collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 18</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample for Anti HBc collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 19</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample for NAAT testing for HBV collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 20</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample for Anti-HCV collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 21</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample NAAT testing for HCV collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 22</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample for HIV-1 p24 antigen collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 23</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample for NAAT testing for HIV-1 collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 24</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample for Anti-HIV 1 and anti-HIV 2 collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 25</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample for Chagas collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 26</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample for Anti-HSV collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 27</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample for EBV collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 28</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample for Anti-VZV collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 29</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample for other infectious disease marker collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 30</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date percentage genetically modified cells sample collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 31</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date viability of cells done:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2000r1: Recipient Baseline Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964872</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2018r1: Lymphoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2025r1: Central Nervous System Tumor Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964893</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2026r1: Neuroblastoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964894</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964895</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2038r1: Mucopolysaccharidosis and Other Storage Diseases Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964898</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2046r1: Fungal Infection Supplemental Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964901</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2100r1: 100 Days Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964902</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2110r1: Acute Myelogenous Leukemia Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964903</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2111r1: All Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2112r1: CML Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2113r1: CLL Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2114r1: MDS Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2118r1: Lymphoma Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2126r1: Neuroblastoma Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2138r1: Mucopolysaccharidosis and Other Storage Diseases Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964919</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2200r1: 6 Month to 2 Year Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964922</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2010r1: Acute Myelogenous Leukemia Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964927</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2011r1: ALL Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964928</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2013r1: CLL Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964930</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2014r1: MDS Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2451:Chimerism Studies</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3160396</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2007r1:Cord Blood Unit -SCTOD Data Requirements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3191905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2131r2: Immune Deficiencies Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3234637</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3279271</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2031r2: Immune Deficiencies Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3638517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sickle Cell Disease Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4809631</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Curative Therapies</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7765018</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2842777</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Labs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>10115208</PublicId>
          <ContextName>TEST</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>10115208v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>QA Test CSI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>10115209</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_DALE_flow_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_DALE_mole_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_LSDX_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_LTHM_mole_samp_collec_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>immune_recon_iga_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>immune_recon_igm_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>chimrsm_mult_dnr_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>chimrsm_sgl_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_base_prep_bm_blst_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>immune_recon_igg_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mds_post_bm_exm_lrpt_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CTI_CPA_te_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CTI_CPA_viab_cel_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mds_base_prep_bm_exam_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>muc_post_enzyme_tst_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_post_tum_mrkr_sf_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_post_tum_mrkr_hva_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_post_tum_mrkr_nse_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_post_tum_mrkr_vma_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_base_mrk_prep_hva_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_base_mrk_prep_nse_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_base_mrk_prep_vma_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>muc_base_csf_test_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>muc_base_enzy_lev_tst_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>current_hematogic_tst_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>prep_ast_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>prep_cbc_test_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>prep_creat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>prep_ldh_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>prep_serum_bili_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_base_prep_bm_exam_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_htlv_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_cmv_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_chagas_ct_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lym_post_rlps_clnc_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lym_post_rlps_fish_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>apl_base_cur_bm_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cns_base_bm_30day_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>muc_post_csf_tst_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cll_post_crnt_hvy_gene_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cll_post_crnt_immunphn_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cll_post_resp_hvy_gene_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cll_post_resp_immunphn_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cll_post_rlps_immunphn_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cll_base_prep_hvy_gene_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cll_base_prep_immunphn_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_lrpt_conv_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_rlps_conv_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_rlps_mole_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_cnv_cyto_eval_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_fish_eval_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_rlps_fish_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_cur_fish_tst_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_curr_cnv_cyt_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_lrpt_clnc_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_rlps_cnv_cyt_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_rlps_hema_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_lrpt_fish_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_lrpt_mole_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_rlps_clnc_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_rlps_fish_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_clinc_eval_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_mole_eval_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_hiv_neut_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_nat_hiv1_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_rlps_clinc_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_rlps_cnv_cyto_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_rlps_mole_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_cur_mole_tst_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_curr_hema_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_rlp_mole_tst_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_rlps_fsh_tst_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_cr_mole_cnfrm_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_cr_conv_cnfrm_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_cr_fish_cnfrm_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>fan_base_bm_exam_diag_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_hbsag_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_hbsag_neut_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_anti_hbc_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_hcv_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_hcv_riba_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_hiv_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_nat_hcv_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_anti_hiv1_hiv2_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_anti_hiv1_wb_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_anti_hiv2_eia_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_htlv_ct_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_sts_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_syph_ct_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_wnv_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_chagas_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_oth1_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lym_post_resp_mole_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_cr_mole_test_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_cr_cyto_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_cr_fish_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>immun_recon_lymph_tst_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lym_base_prep_mole_tst_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_cnvt_cyto_cr_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_fish_conf_cr_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_mole_conf_cr_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_diag_antibody_resp_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_diag_cbc_test_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_diag_iga_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_diag_ige_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_diag_igg_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_diag_igm_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_diag_lymph_funct_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_diag_lymph_tst_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_antibody_resp_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_bcell_egrft_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_lymph_funct_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_lymph_tst_rcnt_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_mrecent_iga_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_mrecent_ige_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_mrecent_igg_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_mrecent_igm_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_mst_recnt_tst_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_myeld_egrft_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_tcell_egrft_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cll_post_rlps_hvy_gene_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PhenX</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PhenX</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lds_base_csf_test_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_hepB_sur_anti_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_hepB_cor_anti_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_hepC_anti_alt_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_hiv1_2_antibody_sam_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_hiv1_nat_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_hiv1_p24_antigen_sam_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_hsv_anti_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_htlv1_2_anti_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_multi_oth_idm_test_sam_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_syphilis_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_toxoplasmo_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_vzv_anti_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_wnv_nat_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_chagas_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_cmv_anti_igg_tot_sam_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_ebv_anti_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_hcv_nat_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_hema_find_prep_cbc_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_organ_func_prep_albumin_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_organ_func_prep_ast_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_organ_func_prep_creat_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_organ_func_prep_ferritin_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_organ_func_prep_ldh_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_organ_func_prep_seru_bili_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_best_resp_stat_mole_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_dis_stat_mole_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_rel_prog_clin_hema_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_rel_progress_conven_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_rel_progress_fish_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_rel_progress_mole_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedSpecimenCollection:dateRange</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_dis_stat_clin_hema_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_dis_stat_conven_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_lab_diag_blast_bld_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_dis_stat_clin_hema_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_dis_stat_conven_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_dis_stat_fish_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_dis_stat_flow_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_dis_stat_mole_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_rel_clin_hematolog_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_rel_flow_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_rel_mole_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_rel_conven_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_rel_fish_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_best_resp_stat_flow_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_best_resp_stat_mole_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_lab_diag_wbc_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_lab_diag_blast_bm_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_lab_diag_cyto_analysis_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_lab_diag_mole_mark_test_sample_collect_dat</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_lab_prep_blasts_bld_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_lab_prep_blasts_bm_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_lab_prep_cyto_analysis_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_lab_prep_flow_cytom_bld_sample_collect_dat</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_lab_prep_mole_mark_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_lab_prep_wbc_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_best_resp_stat_conven_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_best_resp_stat_fish_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_lab_diag_blasts_bld_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_lab_diag_blasts_bm_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_lab_diag_cyto_analysis_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_lab_diag_mole_mark_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_lab_diag_wbc_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_lab_prep_blasts_bld_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_lab_prep_blasts_bm_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_lab_prep_cyto_analysis_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_lab_prep_flow_cytom_bm_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_lab_prep_mole_mark_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_lab_prep_wbc_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_lab_prep_flow_cytomy_bm_sample_collect_dat</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_dis_stat_conven_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_dis_stat_fish_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_best_resp_stat_conven_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_best_resp_stat_fish_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_best_resp_stat_flow_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_best_resp_stat_mole_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_dis_stat_clin_hema_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_lab_prep_flow_cytom_bld_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_dis_stat_flow_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_dis_stat_mole_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_rel_clin_hematolog_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_rel_conven_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_rel_fish_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_rel_flow_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_rel_mole_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_best_resp_stat_conven_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_best_resp_stat_fish_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_lab_recent_bm_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_rel_progress_clin_hema_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_rel_progress_conven_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_rel_progress_fish_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_rel_progress_flow_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_rel_progress_mole_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_best_resp_stat_flow_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_best_resp_stat_mole_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mds_post_rlps_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_best_resp_stat_convent_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_best_resp_stat_fish_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_lab_diag_blasts_bld_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_lab_diag_bm_exam_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_lab_diag_mole_mark_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_lab_diag_mono_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_lab_prep_blasts_bld_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_lab_prep_bm_exam_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_lab_prep_flow_cyto_bld_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_lab_prep_flow_cyto_bm_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_lab_prep_mole_mark_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_lab_prep_mono_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_therapy_multi_cyto_text_sampl_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_dis_stat_convent_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_dis_stat_fish_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_CHF_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_CSM_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_IR_im_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_IR_ly_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpre_dis_stat_prep_ferritin_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpre_dis_stat_prep_fibrogen_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpre_dis_stat_prep_sIL_2R_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpre_dis_stat_prep_triglyce_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_immu_func_cytol_lymph_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_immu_func_cytox_tcell_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_immu_func_nat_killer_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_immu_func_phytohemagg_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_immu_func_plate_aggre_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_immun_func_granu_chem_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_immu_func_dia_cytolyt_degra_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_immu_func_dia_cytotox_tcell_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_immu_func_dia_nkc_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_immu_func_dia_plate_agg_diag_samp_col_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_immu_func_diag_pha_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_immu_func_prep_cytoly_sample_collec_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_immu_func_prep_cytotox_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_immu_func_prep_granu_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_immu_func_prep_nkc_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_immu_func_prep_phytohemagg_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_immu_func_prep_platelet_ag_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_immun_func_granu_chemo_diag_samp_colle_dat</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymph_analy_diag_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_lymph_analy_prep_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpre_lab_prep_bm_exam_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_CSM_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_DABR_clin_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_DABR_fish_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_DABR_flow_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_DABR_kary_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_DABR_mole_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_DABR_rad_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_DALE_clin_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_DALE_fish_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_DALE_flow_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_DALE_kary_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_DALE_mol_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_DALE_rad_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNf_lym_anly_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNf_or_fn_creat_sam_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNf_or_fnc_alb_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNf_or_fnc_alt_samp_col_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNf_or_fnc_ast_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNf_or_fnc_bili_sam_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNf_or_fnc_bm_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNf_or_im_hi_crea_sam_col_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNf_or_im_hi_gfr_sam_col_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNf_or_im_lo_crea_sam_col_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNf_or_im_lo_gfr_sam_col_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNfup_CBC_sampl_collect_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_CS_bil_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_CS_cr_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_LABD_ast_samp_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_LABD_bil_samp_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_LABD_cr_samp_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_LABD_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_MAX_bil_samp_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_MAX_cr_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNb_or_fn_creat_sam_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNb_or_fnc_alb_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNb_or_fnc_alt_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNb_or_fnc_bili_sam_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNba_or_fnc_ast_samp_col_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNba_or_fnc_bm_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNbase_CBC_sampl_collect_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNbase_ly_an_mul_sam_col_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_CRS_c_react_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_CRS_ifn_gam_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_CRS_IL6_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_CRS_sil2_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_CRS_ttl_sf_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_POC_chim_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_POC_flow_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_POC_mole_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSDX_baso_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSDX_bl_bld_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSDX_bl_bm_sampl_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSDX_eos_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSDX_hem_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSDX_plat_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSDX_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSDX_wbc_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSLE_baso_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSLE_bl_bld_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSLE_bl_bm_sampl_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSLE_eos_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSLE_fibr_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LTHM_mole_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_DABR_mole_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_DABR_plate_sampl_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_DABR_wbc_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_PHPI_mole_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_PHPI_plate_sampl_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_PHPI_wbc_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_DABR_mole_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_DSTE_mole_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMSMF_DALR_mut_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLP_LDX_bld_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLP_LLE_wbc_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLP_LLE_bld_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLP_LLE_bm_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DBR_bld_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DBR_bm_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DLR_bld_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DLR_bm_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DTE_bld_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DTE_bm_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DBR_bld_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DBR_bm_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DLR_bld_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DLR_bm_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DTE_bld_sample_collect_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DTE_bm_sample_collect_dat</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLP_LDX_bm_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLP_LLE_bm2_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_PT_therapy_start_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_POC_imm_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_POC_oth_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_ifngam_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_IL6_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_sil2_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_t_sf_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLP_LDX_wbc_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_DALE_fish_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_DALE_flow_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_DALE_kary_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_DALE_m_sample_collect_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLP_LSDX_bld_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLP_LSDX_bm_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLP_LSDX_wbc_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLP_LSLE_blas_bm_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLP_LSLE_bld_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLP_LSLE_bls_bld_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLP_LSLE_bm_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLP_LSLE_wbc_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLP_LLE_bld2_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_CHF_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_dsp_flow_smpl_clct_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_dsp_ngs_smpl_clct_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_dsp_pcr_smpl_clct_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_brs_flow_smpl_clct_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_brs_ngs_smpl_clct_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_brs_pcr_smpl_clct_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CTP_CPA_te_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CTP_CPA_viab_cel_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DLR_mole_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_inf_dm_hbv_sample_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>base_hema_fsample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_comb_fer_sample_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_comb_alb_sample_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MDS_le_smple_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MPN_dx_sample_collect_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MPN_le_sample_collect_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MDS_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_tri_samp_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_ferr_samp_collect_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_creact_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_fib_samp_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_HFPL_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CTP_CPA_gmod_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_HFPL_crea_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_HFPL_ferr_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_HFPL_crp_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DLIN_DLI_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_CBC_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LABM_ADDL_bili_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LABM_ADDL_ast_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LABM_ADDL_alt_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LABM_ADDL_salb_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LABM_ADDL_ualb_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LABM_ADDL_iron_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LABM_ADDL_crea_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LABM_ADDL_egfr_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LABM_ADDL_ldh_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LABM_ADDL_tibc_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LABM_ADDL_ferr_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CBSE_HFPL_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CBSE_HFPL_ferr_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CBSE_HFPL_crp_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CBSE_HFPL_crea_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CFUP_CHF_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CFUP_POC_mole_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CFUP_POC_flow_smpl_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CFUP_POC_imm_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CFUP_POC_oth_sample_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DLIN_DCI_sample_collect_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_DABR_clono_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_com_cys_c_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_comor_crp_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_comor_gfr_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_comor_plt_samp_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1194">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3008875</PUBLICID>
    <LONGNAME>Case Report Form Page Number</LONGNAME>
    <PREFERREDNAME>3008873v1.0:2646319v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The specific page number being referenced in the case report form document.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3008873</PublicId>
      <PreferredName>2542290v1.0:2767639v1.0</PreferredName>
      <PreferredDefinition>A printed, optical, or electronic document designed to record all of the clinical study-required information stipulated in the protocol to be reported to the sponsor on each trial subject._One side of one leaf (of a book or magazine or newspaper or letter etc.) or the written or pictorial matter it contains._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.</PreferredDefinition>
      <LongName>Case Report Form Page Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008555</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MED_RCD_AND_FORMS</PreferredName>
        <Version>1</Version>
        <LongName>Medical Records and Forms</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2542290</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C40988</PreferredName>
        <Version>1</Version>
        <LongName>Case Report Form</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40988</PREFERRED_NAME>
            <LONG_NAME>Case Report Form</LONG_NAME>
            <CON_ID>2202500</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2767639</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42783:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Page Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42783</PREFERRED_NAME>
            <LONG_NAME>Page</LONG_NAME>
            <CON_ID>2223992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2646319</PublicId>
      <PreferredName>PAGE_NUMBER</PreferredName>
      <PreferredDefinition>a numeral or string of numerals expressing value, quantity, or identification related to the page.</PreferredDefinition>
      <LongName>Page Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Page #</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CRF Page #</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Footer CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3008858</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>All Mandatory CRF CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3943912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2012-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3694151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5592146</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5612586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6005698</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635298</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>All Mandatory CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mandatory CRF CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5635299</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Footer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5635315</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Footer - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318335</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1195">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3014441</PUBLICID>
    <LONGNAME>Dementia Cognitive Decline Quartile Category</LONGNAME>
    <PREFERREDNAME>3014439v1.0:3014429v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A set of observations ranked in four equal-sized groups to capture the progressively lowering of cognitive capabilities of the participant.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>eMERGE:Electronic Medical Records and Genomics Network</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3014439</PublicId>
      <PreferredName>3014436v1.0:3014437v1.0</PreferredName>
      <PreferredDefinition>A set of observations ranked in four equal-sized groups to capture the progressively lowering of cognitive capabilities of the participant.</PreferredDefinition>
      <LongName>Dementia Cognitive Decline Quartile</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3014436</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4786</PreferredName>
        <Version>1</Version>
        <LongName>Dementia</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4786</PREFERRED_NAME>
            <LONG_NAME>Dementia</LONG_NAME>
            <CON_ID>2584032</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3014437</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37926:C25475:C87306</PreferredName>
        <Version>1</Version>
        <LongName>Cognitive Declining Quartile</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37926</PREFERRED_NAME>
            <LONG_NAME>Cognitive</LONG_NAME>
            <CON_ID>2470096</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25475</PREFERRED_NAME>
            <LONG_NAME>Declining</LONG_NAME>
            <CON_ID>2206194</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C87306</PREFERRED_NAME>
            <LONG_NAME>Quartile</LONG_NAME>
            <CON_ID>3013015</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>eMERGE:Electronic Medical Records and Genomics Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3014429</PublicId>
      <PreferredName>3014429v1.0</PreferredName>
      <PreferredDefinition>A grouping into quarters of the dementia rate of change of the participant.</PreferredDefinition>
      <LongName>Dementia Quartile Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>eMERGE:Electronic Medical Records and Genomics Network</Origin>
      <Representation>
        <PublicId>2433877</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25372</PreferredName>
        <Version>1</Version>
        <LongName>Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>S</VALIDVALUE>
          <VALUEMEANING>no rate of change</VALUEMEANING>
          <MEANINGDESCRIPTION>single observation so no rate of change available</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D</VALIDVALUE>
          <VALUEMEANING>Dementia at baseline</VALUEMEANING>
          <MEANINGDESCRIPTION>Dementia at baseline</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>fastest rate of change</VALUEMEANING>
          <MEANINGDESCRIPTION>fastest rate of change</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>third slowest change</VALUEMEANING>
          <MEANINGDESCRIPTION>third slowest change</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>second slowest change</VALUEMEANING>
          <MEANINGDESCRIPTION>second slowest change</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014434</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>slowest change</VALUEMEANING>
          <MEANINGDESCRIPTION>slowest change</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-02-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>eMERGE</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Found only for ACT cases from Group Health</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Quartiles of rate of cognitiv</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Quartiles of rate of cognitive decline</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3006612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>eMERGE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>eMERGE Data Variables</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3006613</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Dementia_Coginitive_Decline_Quartile</AlternateName>
        <AlternateNameType>eMERGE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1196">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3022303</PUBLICID>
    <LONGNAME>Other Adverse Event Present Indicator</LONGNAME>
    <PREFERREDNAME>2733215v1.0:2786052v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>an indicator related to presence of other unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCIC CRF:National Cancer Institute of Canada Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2733215</PublicId>
      <PreferredName>O_AE_PRES</PreferredName>
      <PreferredDefinition>information related to presence of other unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.</PreferredDefinition>
      <LongName>Other Adverse Event Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2733213</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C41331</PreferredName>
        <Version>1</Version>
        <LongName>Other Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2786052</PublicId>
      <PreferredName>AE_REP_IND</PreferredName>
      <PreferredDefinition>an event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied for adverse event being reported.</PreferredDefinition>
      <LongName>Adverse Event Report Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>GOG CRF:Gynecologic Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient not evaluated</VALIDVALUE>
          <VALUEMEANING>Patient not evaluated</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient not evaluated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2786053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not assessed</VALIDVALUE>
          <VALUEMEANING>NOT ASSESSED</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that an assessment was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were any additional adverse e</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Were any additional adverse events experienced by the patient</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1197">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3025114</PUBLICID>
    <LONGNAME>Person Education Level Category Code</LONGNAME>
    <PREFERREDNAME>2651173v1.0:3025064v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Coded value representing the highest level of school completed as defined in the Health Information National Trends Survey.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2651173</PublicId>
      <PreferredName>PERSON_EDUC_LVL</PreferredName>
      <PreferredDefinition>A demographic parameter indicating the number of years of schooling or the highest level of achievement at school by a human being.</PreferredDefinition>
      <LongName>Person Education Level</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2653845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17953</PreferredName>
        <Version>1</Version>
        <LongName>Education Level</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17953</PREFERRED_NAME>
            <LONG_NAME>Education Level</LONG_NAME>
            <CON_ID>2202380</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3025064</PublicId>
      <PreferredName>3025064v1.0</PreferredName>
      <PreferredDefinition>Coded value representing a category for a person&#39;s highest level of education.</PreferredDefinition>
      <LongName>Education Level Category Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Bachelor&#39;s Degree Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has received a degree for successful completion of a program of studies that normally requires at least 4-5 years of full-time equivalent college-level work.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Associate Academic Degree Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has received a degree from a 2 year college program.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2733231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Some College Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has attended college but that they did not receive any degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2733233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Vocational Program Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has attended or received a degree from an occupational, technical, or vocational program as their highest level of educational achievement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>High School Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has attended high school and has received a high school diploma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67136</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2733232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Some High School Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has attended high school but that they did not complete high school and did not receive a diploma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C87171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>8th Grade Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 8th grade is the highest level of educational achievement</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2733229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>5th Grade Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that 5th grade is the highest level of educational achievement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67127</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2733226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>Professional Doctorate Degree Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has received a degree allowing them to practice a profession, such as law, medicine, music, or ministry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>Master&#39;s Degree Completion</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has received a degree for completion of at least one year of prescribed study beyond the bachelor&#39;s degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70556</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>No Formal Schooling</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a person has never attended an educational program or formal schooling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2936661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Person Education Level Category Code does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Person Education Level Category Code does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3028392</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HINTS2005</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.dccps.hints2005.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3024953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Person:educationLevel</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PS&amp;CC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.dccps.hints2005.domain.Person.educationLevel</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1198">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3075420</PUBLICID>
    <LONGNAME>Cause of Death Cancer Relationship Code</LONGNAME>
    <PREFERREDNAME>CAUS_DEATH_CA_REL_CD</PREFERREDNAME>
    <PREFERREDDEFINITION>Identifies relationship of death to this cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2192766</PublicId>
      <PreferredName>COD_DESC</PreferredName>
      <PreferredDefinition>information related to the description of cause of death.</PreferredDefinition>
      <LongName>Cause of Death Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2192764</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Cause of Death</PreferredName>
        <Version>1</Version>
        <LongName>Cause of Death</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0007465</PREFERRED_NAME>
            <LONG_NAME>Cause of Death</LONG_NAME>
            <CON_ID>2203003</CON_ID>
            <DEFINITION_SOURCE>MSH2004_2003_12_12</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177536</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Description</PreferredName>
        <Version>1</Version>
        <LongName>Description </LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3075414</PublicId>
      <PreferredName>CA_RLTNSP_CD</PreferredName>
      <PreferredDefinition>A system of numbered categories that represent the relationship of a tumor that invade other tissues.</PreferredDefinition>
      <LongName>Cancer Relationship Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3075413</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305:C25648:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm Relationship Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Directly related to this cancer</VALUEMEANING>
          <MEANINGDESCRIPTION>Directly related to this cancer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3075416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Indirectly related to this cancer</VALUEMEANING>
          <MEANINGDESCRIPTION>Indirectly related to this cancer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3075417</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not related to this cancer</VALUEMEANING>
          <MEANINGDESCRIPTION>Not related to this cancer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3075418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Data not available</VALUEMEANING>
          <MEANINGDESCRIPTION>Data not available</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-04-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3075415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cause of Death</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cause of Death</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Caris Registry</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3060676</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3595692</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Miraca Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Miraca Registry</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3595693</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CS_DTH_CANC_RLT_CD</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1199">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3100901</PUBLICID>
    <LONGNAME>Financial Account Number Display Name java.lang.String</LONGNAME>
    <PREFERREDNAME>3099676v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A formal relationship established to provide for regular banking and business services.:A numeral or string of numerals expressing value, quantity, or identification._Exhibit, present, or demonstrate for viewing.:The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3099676</PublicId>
      <PreferredName>3099519v1.0:2231629v1.0</PreferredName>
      <PreferredDefinition>A formal relationship established to provide for regular banking and business services.:A numeral or string of numerals expressing value, quantity, or identification._Exhibit, present, or demonstrate for viewing.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Financial Account Number Display Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099519</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C88186:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Financial Account Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C88186</PREFERRED_NAME>
            <LONG_NAME>Financial Account</LONG_NAME>
            <CON_ID>3099482</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231629</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25485:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Display Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25485</PREFERRED_NAME>
            <LONG_NAME>Display</LONG_NAME>
            <CON_ID>2203905</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Financial Account Number Display Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Financial Account Number Display Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.administration.customerservice</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099475</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AccountNumber:displayName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.administration.customerservice.AccountNumber.displayName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1200">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101438</PUBLICID>
    <LONGNAME>Transfer Into Event Created By java.lang.String</LONGNAME>
    <PREFERREDNAME>3100195v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Material recorded in a format that requires an electronic device to view or modify the content. [Source: NCI];NCI|The act of moving something from one location to another.:Expressing entrance, or a passing from the outside of a thing to its interior parts.:Something that happens at a given place and time._Indicates the person or authoritative body who brought the item into existence._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100195</PublicId>
      <PreferredName>3099545v1.0:2231611v1.0</PreferredName>
      <PreferredDefinition>Material recorded in a format that requires an electronic device to view or modify the content. [Source: NCI];NCI|The act of moving something from one location to another.:Expressing entrance, or a passing from the outside of a thing to its interior parts.:Something that happens at a given place and time._Indicates the person or authoritative body who brought the item into existence.</PreferredDefinition>
      <LongName>Transfer Into Event Created By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099545</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48167:C25544:C25499</PreferredName>
        <Version>1</Version>
        <LongName>Transfer Into Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48167</PREFERRED_NAME>
            <LONG_NAME>Transfer</LONG_NAME>
            <CON_ID>2422624</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25544</PREFERRED_NAME>
            <LONG_NAME>Into</LONG_NAME>
            <CON_ID>2206279</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42628</PreferredName>
        <Version>1</Version>
        <LongName>Created By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42628</PREFERRED_NAME>
            <LONG_NAME>Created By</LONG_NAME>
            <CON_ID>2231551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Transfer Into Event Created By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Transfer Into Event Created By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory.event</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TransferInEvent:createdBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.event.TransferInEvent.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1201">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101970</PUBLICID>
    <LONGNAME>Visible Light Exposure Description java.lang.String</LONGNAME>
    <PREFERREDNAME>3100730v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Electromagnetic radiation in the portion of the spectrum from about 380 nm (violet) to 800 nm (red).:The act of subjecting someone or something to an influencing experience._A statement or an account describing something._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100730</PublicId>
      <PreferredName>3099601v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>Electromagnetic radiation in the portion of the spectrum from about 380 nm (violet) to 800 nm (red).:The act of subjecting someone or something to an influencing experience._A statement or an account describing something.</PreferredDefinition>
      <LongName>Visible Light Exposure Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099601</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17732:C17941</PreferredName>
        <Version>1</Version>
        <LongName>Visible Light Exposure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17732</PREFERRED_NAME>
            <LONG_NAME>Visible Light</LONG_NAME>
            <CON_ID>3099513</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17941</PREFERRED_NAME>
            <LONG_NAME>Exposure</LONG_NAME>
            <CON_ID>2203924</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Visible Light Exposure Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Visible Light Exposure Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.common.environmentalcondition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LightExposure:description</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.common.environmentalcondition.LightExposure.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1202">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3102089</PUBLICID>
    <LONGNAME>Apgar Score Display Name java.lang.String</LONGNAME>
    <PREFERREDNAME>3100848v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An assessment of the physical condition of an infant at the time birth; involves heart rate, muscle tone, respiratory effort,  color, and reflex responsiveness. _Exhibit, present, or demonstrate for viewing.:The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100848</PublicId>
      <PreferredName>2738495v1.0:2231629v1.0</PreferredName>
      <PreferredDefinition>An assessment of the physical condition of an infant at the time birth; involves heart rate, muscle tone, respiratory effort,  color, and reflex responsiveness. _Exhibit, present, or demonstrate for viewing.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Apgar Score Display Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2738495</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C73437</PreferredName>
        <Version>1</Version>
        <LongName>Apgar Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73437</PREFERRED_NAME>
            <LONG_NAME>Apgar Score</LONG_NAME>
            <CON_ID>2738454</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231629</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25485:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Display Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25485</PREFERRED_NAME>
            <LONG_NAME>Display</LONG_NAME>
            <CON_ID>2203905</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Apgar Score Display Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Apgar Score Display Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>APGARScore:displayName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.APGARScore.displayName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1203">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3102116</PUBLICID>
    <LONGNAME>Coat Color Value java.lang.String</LONGNAME>
    <PREFERREDNAME>3100874v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The covering of hair, wool, or fur on the body of an animal.:The appearance of objects (or light sources) described in terms of a person&#39;s perception of their hue and lightness (or brightness) and saturation._The information contained in a data field._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100874</PublicId>
      <PreferredName>3099577v1.0:2528693v1.0</PreferredName>
      <PreferredDefinition>The covering of hair, wool, or fur on the body of an animal.:The appearance of objects (or light sources) described in terms of a person&#39;s perception of their hue and lightness (or brightness) and saturation._The information contained in a data field.</PreferredDefinition>
      <LongName>Coat Color Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099577</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C88212:C37927</PreferredName>
        <Version>1</Version>
        <LongName>Coat Color</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C88212</PREFERRED_NAME>
            <LONG_NAME>Coat</LONG_NAME>
            <CON_ID>3099501</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37927</PREFERRED_NAME>
            <LONG_NAME>Color</LONG_NAME>
            <CON_ID>2710268</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528693</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49100</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49100</PREFERRED_NAME>
            <LONG_NAME>Data Value</LONG_NAME>
            <CON_ID>2463853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Coat Color Value java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Coat Color Value java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CoatColor:value</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.CoatColor.value</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1204">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3105061</PUBLICID>
    <LONGNAME>Consent Form Patient Responsible Person Signed Name</LONGNAME>
    <PREFERREDNAME>3105045v1.0:2018284v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the name related to signature on a document explaining all relevant study information to assist the study volunteer in understanding the expectations and requirements of participation in a clinical trial by patient and person conducting the form discussion.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCIC CRF:National Cancer Institute of Canada Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3105045</PublicId>
      <PreferredName>2735068v1.0:3105043v1.0</PreferredName>
      <PreferredDefinition>information related to signature on a document explaining all relevant study information to assist the study volunteer in understanding the expectations and requirements of participation in a clinical trial by patient and person conducting the form discussion.</PreferredDefinition>
      <LongName>Consent Form Patient Responsible Person Signed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008530</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PT_CONSENT</PreferredName>
        <Version>1</Version>
        <LongName>Patient Consent</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2735068</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16468</PreferredName>
        <Version>1</Version>
        <LongName>Consent Form</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16468</PREFERRED_NAME>
            <LONG_NAME>Consent Form</LONG_NAME>
            <CON_ID>2202582</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3105043</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C25657:C25679</PreferredName>
        <Version>1</Version>
        <LongName>Patient Responsible Person Signed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25657</PREFERRED_NAME>
            <LONG_NAME>Responsible Person</LONG_NAME>
            <CON_ID>2202516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25679</PREFERRED_NAME>
            <LONG_NAME>Signed</LONG_NAME>
            <CON_ID>2203795</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCIC CRF:National Cancer Institute of Canada Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018284</PublicId>
      <PreferredName>INDS_NAME</PreferredName>
      <PreferredDefinition>The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Individuals Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Name of person conducting the</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Name of person conducting the consent form discussion</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Name of Site Personnel  that Obtained Informed Consent Form</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CONS_FRM_RSPBL_PRSN_DSCN_NAME</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCTG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3105045v1.0:2018284v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPDS_QVAL_ICNAM</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CNSNT_FORM_PT_RESP_SD_NM</AlternateName>
        <AlternateNameType>DCP Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1205">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3107301</PUBLICID>
    <LONGNAME>Neurology Headache Assessment Description Text</LONGNAME>
    <PREFERREDNAME>3107299v1.0:2954078v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the branch of medical science that deals with the study of structure, function, and diseases of the nervous system; for thorough searching also see NEUROSCIENCE, MENTAL DISORDER, NERVOUS SYSTEM DISORDER, NERVOUS SYSTEM DISORDER DIAGNOSIS, MENTAL DISORDER DIAGNOSIS, NERVOUS SYSTEM DISORDER CHEMOTHERAPY, COMMUNICATION DISORDER, NEUROMUSCULAR DISORDER._Pain in various parts of the head, not confined to the area of distribution of any nerve._The final result of a determination of the value, significance, or extent of._The final result of a determination of the value, significance, or extent of._A written or verbal account, representation, statement, or explanation of something._The words of something written.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3107299</PublicId>
      <PreferredName>3076177v1.0:3107297v1.0</PreferredName>
      <PreferredDefinition>the branch of medical science that deals with the study of structure, function, and diseases of the nervous system; for thorough searching also see NEUROSCIENCE, MENTAL DISORDER, NERVOUS SYSTEM DISORDER, NERVOUS SYSTEM DISORDER DIAGNOSIS, MENTAL DISORDER DIAGNOSIS, NERVOUS SYSTEM DISORDER CHEMOTHERAPY, COMMUNICATION DISORDER, NEUROMUSCULAR DISORDER._Pain in various parts of the head, not confined to the area of distribution of any nerve._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Neurology Headache Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3076177</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16908</PreferredName>
        <Version>1</Version>
        <LongName>Neurology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16908</PREFERRED_NAME>
            <LONG_NAME>Neurology</LONG_NAME>
            <CON_ID>2204925</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3107297</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C34661:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Headache Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C34661</PREFERRED_NAME>
            <LONG_NAME>Headache</LONG_NAME>
            <CON_ID>2485871</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2954078</PublicId>
      <PreferredName>ASSE_DESC_TEXT</PreferredName>
      <PreferredDefinition>The final result of a determination of the value, significance, or extent of._A written or verbal account, representation, statement, or explanation of something._The words of something written.</PreferredDefinition>
      <LongName>Assessment Description Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>16040817</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16040817v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Description Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>A questionnaire to assess mig</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>A questionnaire to assess migraines and headaches.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Neurology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3009616</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1206">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3109926</PUBLICID>
    <LONGNAME>Patient Prior Chronic Hepatic Disease or Disorder Eligibility Determination Ind-2</LONGNAME>
    <PREFERREDNAME>3109924v1.0:2018257v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to eligibility of patient for prior chronic hepatic disease (e.g., chronic active hepatitis, cirrhosis).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3109924</PublicId>
      <PreferredName>2233604v1.0:3109922v1.0</PreferredName>
      <PreferredDefinition>information related to eligibility of patient for prior chronic hepatic disease (e.g., chronic active hepatitis, cirrhosis).</PreferredDefinition>
      <LongName>Patient Prior Chronic Hepatic Disease or Disorder Eligibility Determination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3109922</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C14141:C13308:C2991:C25</PreferredName>
        <Version>1</Version>
        <LongName>Prior Chronic Hepatic Disease or Disorder Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14141</PREFERRED_NAME>
            <LONG_NAME>Chronic</LONG_NAME>
            <CON_ID>2206176</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13308</PREFERRED_NAME>
            <LONG_NAME>Hepatic</LONG_NAME>
            <CON_ID>2202660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does the patient have pre-exi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does the patient have pre-existing chronic hepatic disease (e.g., chronic active hepatitis, cirrhosis) that, in the opinion of the investigator and hepatic surgeon, would limit the patient&#39;s ability to undergo hepatic metastasectomy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have severe hepatic disease defined as a diagnosis of Child-Pugh Class B or C hepatic disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have chronic HIV, hepatitis B or hepatitis C infections?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have known chronic or active hepatitis or ongoing or active infection that requires parenteral antibiotics?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CHRONIC_HEP_DIS_ELIG_IND</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3109924v1.0:2018257v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1207">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3116565</PUBLICID>
    <LONGNAME>Dental Pulp Capping Exposure Placement Yes or No Response</LONGNAME>
    <PREFERREDNAME>3116562v1.0:3108967v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Application of a protective agent to an exposed pulp (direct capping) or the remaining thin layer of dentin over a nearly exposed pulp (indirect capping) in order to allow the pulp to recover and maintain its normal vitality and function. Contact with infectious agents (bacteria or viruses) in a manner that promotes transmission and increases the likelihood of disease. Position or arrangement, as of the teeth; the state of being placed or arranged, as the assignment of a person to a appropriate clinical study. A caDSR representation term that is used to indicate a question with permissible values of yes/no</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3116562</PublicId>
      <PreferredName>3115554v1.0:3116560v1.0</PreferredName>
      <PreferredDefinition>Application of a protective agent to an exposed pulp (direct capping) or the remaining thin layer of dentin over a nearly exposed pulp (indirect capping) in order to allow the pulp to recover and maintain its normal vitality and function. Contact with infectious agents (bacteria or viruses) in a manner that promotes transmission and increases the likelihood of disease. Position or arrangement, as of the teeth; the state of being placed or arranged, as the assignment of a person to a appropriate clinical study.</PreferredDefinition>
      <LongName>Dental Pulp Capping Exposure Placement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3115554</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63715</PreferredName>
        <Version>1</Version>
        <LongName>Dental Pulp Capping</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63715</PREFERRED_NAME>
            <LONG_NAME>Dental Pulp Capping</LONG_NAME>
            <CON_ID>2547871</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3116560</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17941:C41148</PreferredName>
        <Version>1</Version>
        <LongName>Exposure Placement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17941</PREFERRED_NAME>
            <LONG_NAME>Exposure</LONG_NAME>
            <CON_ID>2203924</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41148</PREFERRED_NAME>
            <LONG_NAME>Placement</LONG_NAME>
            <CON_ID>2422733</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3108967</PublicId>
      <PreferredName>C49487:C49488:3108967v1.0</PreferredName>
      <PreferredDefinition>A caDSR representation term that is used to indicate a question with permissible values of yes/no</PreferredDefinition>
      <LongName>Yes or No Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No [0]</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes [0]</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pulp cap material placed on a</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pulp cap material placed on area of exposure only</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1208">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3120077</PUBLICID>
    <LONGNAME>Local System Investigator Maiden Name java.lang.String</LONGNAME>
    <PREFERREDNAME>3119963v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Of or belonging to a restricted area or locality.:A group of independent but interrelated elements comprising a unified whole.:An individual who conducts scientific research. In a clinical setting this individual actually conducts and/or supervises the clinical investigation and study-related procedures.  The investigator monitors the safety of the trial subjects and investigational staff (under whose immediate direction an agent is administered or dispensed to a subject).  The investigator collects and analyses data and study documents, and provides reports in compliance with applicable requirements._A woman&#39;s surname before marriage._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3119963</PublicId>
      <PreferredName>3119835v1.0:2590010v1.0</PreferredName>
      <PreferredDefinition>Of or belonging to a restricted area or locality.:A group of independent but interrelated elements comprising a unified whole.:An individual who conducts scientific research. In a clinical setting this individual actually conducts and/or supervises the clinical investigation and study-related procedures.  The investigator monitors the safety of the trial subjects and investigational staff (under whose immediate direction an agent is administered or dispensed to a subject).  The investigator collects and analyses data and study documents, and provides reports in compliance with applicable requirements._A woman&#39;s surname before marriage.</PreferredDefinition>
      <LongName>Local System Investigator Maiden Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3119835</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C67263:C25700:C25936</PreferredName>
        <Version>1</Version>
        <LongName>Local System Investigator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67263</PREFERRED_NAME>
            <LONG_NAME>Local</LONG_NAME>
            <CON_ID>2676068</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25700</PREFERRED_NAME>
            <LONG_NAME>System</LONG_NAME>
            <CON_ID>2202584</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25936</PREFERRED_NAME>
            <LONG_NAME>Investigator</LONG_NAME>
            <CON_ID>2202869</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2590010</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25381</PreferredName>
        <Version>1</Version>
        <LongName>Maiden Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25381</PREFERRED_NAME>
            <LONG_NAME>Maiden Name</LONG_NAME>
            <CON_ID>2202915</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Local System Investigator Maiden Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Local System Investigator Maiden Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.duke.cabig.c3pr.domain.LocalInvestigator.maidenName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LocalInvestigator:maidenName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1209">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3121748</PUBLICID>
    <LONGNAME>Person Surgical Procedure Injury Eligibility Determination Ind-3b</LONGNAME>
    <PREFERREDNAME>2744526v1.0:2958018v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>an indicator that can have a value of yes, no, or not applicable related to the act of determining if a subject is suitable for enrollment in a study by having had a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue or damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>GOG CRF:Gynecologic Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2744526</PublicId>
      <PreferredName>PER_SX_INJ_ELIG</PreferredName>
      <PreferredDefinition>information related to the act of determining if a subject is suitable for enrollment in a study by having had a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue or damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.</PreferredDefinition>
      <LongName>Person Surgical Procedure Injury Eligibility Determination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2744524</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329:C3671:C25171</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure Wound Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3671</PREFERRED_NAME>
            <LONG_NAME>Injury</LONG_NAME>
            <CON_ID>2202560</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506036</PublicId>
      <PreferredName>YES_NO_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.</PreferredDefinition>
      <LongName>Yes No Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694966</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49797</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3b</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49797</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Not Applicable Response</LONG_NAME>
            <CON_ID>2694965</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the patient had a major s</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the patient had a major surgical procedure, open biopsy or significant traumatic injury within 28 days of treatment start date of Bevacizumab therapy (cycle 2)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is a major surgical procedure anticipated during the course of the study?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>GOG_CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient had a major surgical procedure, open biopsy, dental extractions or other dental surgery/procedure that results in an open wound, or significant traumatic injury within 28 days prior to the first date of treatment on this study?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior minor surgical procedure, stereotactic biopsy, fine needle aspiration, or core biopsy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient had a major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to randomization?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient undergone an intermediate surgical procedure as defined in the protocol less than or equal to 2 weeks prior to treatment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0213</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000175</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0213</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000287</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0213</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000288</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GOG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>2744526v1.0:2958018v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>2744526v1.0:2958018v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1210">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3143417</PUBLICID>
    <LONGNAME>Breast Erythema Present Ind-2</LONGNAME>
    <PREFERREDNAME>3143285v1.0:2404918v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator to evaluate the presence of redness of the skin produced by congestion of the capillaries of one of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3143285</PublicId>
      <PreferredName>2411756v1.0:3143283v1.0</PreferredName>
      <PreferredDefinition>information related to the presence of redness of the skin produced by congestion of the capillaries of one of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</PreferredDefinition>
      <LongName>Breast Erythema Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2411756</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12971</PreferredName>
        <Version>1</Version>
        <LongName>Breast</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12971</PREFERRED_NAME>
            <LONG_NAME>Breast</LONG_NAME>
            <CON_ID>2202571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3143283</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C26901:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Erythema Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26901</PREFERRED_NAME>
            <LONG_NAME>Erythema</LONG_NAME>
            <CON_ID>2482163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Erythema present?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Erythema present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1211">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3144327</PUBLICID>
    <LONGNAME>FACT-G Questionnaire Total Score</LONGNAME>
    <PREFERREDNAME>3144286v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value representing the sum of a person&#39;s measurements on the twenty seven Likert scales included in the Functional Assessment of Cancer Therapy General (FACT-G).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3144286</PublicId>
      <PreferredName>3144219v1.0:2714576v1.0</PreferredName>
      <PreferredDefinition>A general quality of life instrument intended for use with a variety of chronic illness conditions. A core instrument in the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System, a system which has multiple disease-, treatment-, and condition-specific subscales to complement the FACT-G.:A number or range of numeric values measuring performance, function, quality, or ability._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete.:A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>FACT-G Questionnaire Score Total Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3144219</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45899:C25338</PreferredName>
        <Version>1</Version>
        <LongName>FACT-G Questionnaire Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45899</PREFERRED_NAME>
            <LONG_NAME>FACT-G Questionnaire</LONG_NAME>
            <CON_ID>2552004</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2714576</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25304:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Total Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25304</PREFERRED_NAME>
            <LONG_NAME>Total</LONG_NAME>
            <CON_ID>2204938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total Score</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Total Score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3144420</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FACT-G</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.dccps.functionalassessmentofcancertherapygeneral_factg</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000173</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4811884</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FACIT System Scales</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Subscale and Total Score CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4836836</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.dccps.functionalassessmentofcancertherapygeneral_factg.FunctionalAssessmentOfCancerTherapyGeneral_Score.totalScore</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PS&amp;CC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FunctionalAssessmentOfCancerTherapyGeneral_Score:totalScore</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1212">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3151872</PUBLICID>
    <LONGNAME>Pathology Specimen Fourth Specimen Collection Date and Time</LONGNAME>
    <PREFERREDNAME>3151621v1.0:3151639v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Records the date and time of the specimen collection for the cancer being reported, not the date read or date the report was typed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3151621</PublicId>
      <PreferredName>2437801v1.0:2453802v1.0</PreferredName>
      <PreferredDefinition>A specialty concerned with the nature and cause of disease as expressed by changes in cellular or tissue structure and function caused by the disease process. (MSH98)_A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.</PreferredDefinition>
      <LongName>Pathology Specimen</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437801</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18189</PreferredName>
        <Version>1</Version>
        <LongName>Pathology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2453802</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3151639</PublicId>
      <PreferredName>3151639v1.0</PreferredName>
      <PreferredDefinition>Following the third position in an ordering or series; coming next after the third and just before the fifth in position._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._The act of gathering something together.__An expression of both date and time that an event has happened or will happened. (NCI)</PreferredDefinition>
      <LongName>Fourth Specimen Collection Date and Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178079</PublicId>
        <ContextName>EDRN</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>DATETIME</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3151638</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54566:C19157:C25453:C37939</PreferredName>
        <Version>1</Version>
        <LongName>Fourth Specimen Collection Date and Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54566</PREFERRED_NAME>
            <LONG_NAME>Fourth</LONG_NAME>
            <CON_ID>2554145</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Rationale</Name>
        <DocumentType>NOTE</DocumentType>
        <DocumentText>Describes the origin of the pathology report contributing to this cancer abstract. The date that the specimen was collected is likely to correspond to the procedure date at the facility where a specimen was obtained.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 12.1, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&amp;tabid=133&amp;mid=473</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Fourth Specimen Collection Da</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Fourth Specimen Collection Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR 16, Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)</DocumentText>
        <URL>https://www.naaccr.org/data-standards-data-dictionary/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 12.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3134707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899833</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology16</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5899841</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464305</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology18</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7464314</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>7323</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OBR-7 Observation Date/Time #00241 (HL7)</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PATH DATE SPEC COLLECT 4</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Path--Date Spec Collection</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Path Date Spec Collect 4</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1213">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3158051</PUBLICID>
    <LONGNAME>Liver Diagnostic Imaging Assessment Date</LONGNAME>
    <PREFERREDNAME>2854176v1.0:2018550v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the date a diagnostic imaging (any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation) of the liver (a large organ located in the upper abdomen that cleanses the blood and aids in digestion by secreting bile) was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2854176</PublicId>
      <PreferredName>LIVER_DXIMAG_ASSESS</PreferredName>
      <PreferredDefinition>information relating to a diagnostic imaging (any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation) of the liver (a large organ located in the upper abdomen that cleanses the blood and aids in digestion by secreting bile) assessment.</PreferredDefinition>
      <LongName>Liver Diagnostic Imaging Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2854172</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12392:C16502</PreferredName>
        <Version>1</Version>
        <LongName>Liver Diagnostic Imaging</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12392</PREFERRED_NAME>
            <LONG_NAME>Liver</LONG_NAME>
            <CON_ID>2202332</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16502</PREFERRED_NAME>
            <LONG_NAME>Diagnostic Imaging Testing</LONG_NAME>
            <CON_ID>2321519</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25367</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Assessment</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of Assessment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date liver imaging performed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1214">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3160867</PUBLICID>
    <LONGNAME>Non-Protocol Therapy Cetuximab Concurrent Radiation Therapy Administered Ind-3</LONGNAME>
    <PREFERREDNAME>3160866v1.0:2018278v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator related to cetuximab treatment not specified in a protocol during radiotherapy being administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3160866</PublicId>
      <PreferredName>2206588v1.0:3160864v1.0</PreferredName>
      <PreferredDefinition>information related to cetuximab treatment not specified in a protocol during radiotherapy being administered.</PreferredDefinition>
      <LongName>Non-Protocol Therapy Cetuximab Concurrent Radiation Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206588</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25590:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Non-Protocol Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25590</PREFERRED_NAME>
            <LONG_NAME>Non-Protocol</LONG_NAME>
            <CON_ID>2206325</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3160864</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1723:C25456:C15313:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Cetuximab Concurrent Radiation Therapy Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1723</PREFERRED_NAME>
            <LONG_NAME>Cetuximab</LONG_NAME>
            <CON_ID>2211857</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25456</PREFERRED_NAME>
            <LONG_NAME>Concurrent</LONG_NAME>
            <CON_ID>2206181</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did patient receive any non-p</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did patient receive any non-protocol cetuximab during radiation therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3160866v1.0:2018278v2.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1215">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3162383</PUBLICID>
    <LONGNAME>PET Blood Glucose Measurement Military Time</LONGNAME>
    <PREFERREDNAME>3162382v1.0:2685220v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The amount of a simple sugar found in the blood at a specific time during a PET imaging event recorded in military time format, e.g. 1:00 pm = 1300 hrs.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACRIN:American College of Radiology Imaging Network</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3162382</PublicId>
      <PreferredName>PET_BLD_GLUCOSE</PreferredName>
      <PreferredDefinition>The amount of a simple sugar found in the blood during a PET imaging event.</PreferredDefinition>
      <LongName>PET Blood Glucose Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2230940</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17007</PreferredName>
        <Version>1</Version>
        <LongName>Positron Emission Tomography</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17007</PREFERRED_NAME>
            <LONG_NAME>Positron Emission Tomography</LONG_NAME>
            <CON_ID>2224887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3162380</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12434:C2831:C25209</PreferredName>
        <Version>1</Version>
        <LongName>Blood Glucose Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12434</PREFERRED_NAME>
            <LONG_NAME>Blood</LONG_NAME>
            <CON_ID>2202587</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2831</PREFERRED_NAME>
            <LONG_NAME>Glucose</LONG_NAME>
            <CON_ID>2206226</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2685220</PublicId>
      <PreferredName>MILITARY_TIME</PreferredName>
      <PreferredDefinition>A specific point in the continuum in which events pass from the future through the present to the past recorded in military time format, e.g. 1:00 pm = 1300 hrs.  [Manually-curated]</PreferredDefinition>
      <LongName>Military Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>TIME</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>TIME (HR(24):MN)</DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
      <Representation>
        <PublicId>2685283</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68638:C25207</PreferredName>
        <Version>1</Version>
        <LongName>Military Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68638</PREFERRED_NAME>
            <LONG_NAME>Military</LONG_NAME>
            <CON_ID>2660071</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PET Blood Glucose</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>PET Blood Glucose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Time blood sample was obtained for glucose measurement</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-ImageAcq-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Serum Glucose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PET Patient Prep CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3162439</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314439</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging Modality</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Positron Emission Tomography (PET)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314449</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506115</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Image Acquisition-Recon</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PET Patient Prep</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000580</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>MCL</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1216">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3163077</PUBLICID>
    <LONGNAME>Scan Series Performed Yes No Indicator</LONGNAME>
    <PREFERREDNAME>3163076v1.0:2015869v3.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A response of Yes or No to indicate if the act of sending data or a collection of images was carried out.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACRIN:American College of Radiology Imaging Network</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3163076</PublicId>
      <PreferredName>SCAN_SERIES_PERF</PreferredName>
      <PreferredDefinition>An indication as to whether the act of sending data or acollection of images was carried out.</PreferredDefinition>
      <LongName>Scan Series Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2436190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17999</PreferredName>
        <Version>1</Version>
        <LongName>Scan</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17999</PREFERRED_NAME>
            <LONG_NAME>Scan</LONG_NAME>
            <CON_ID>2202631</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3163074</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C69225:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Series Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C69225</PREFERRED_NAME>
            <LONG_NAME>Image Series</LONG_NAME>
            <CON_ID>2684083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015869</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>Response of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>IVI:caBIG In Vivo Imaging Workspace</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was this scan series performe</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was this scan series performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PET Emissions Scan CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3163562</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PET Emissions Scan</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3163559</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1217">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3170107</PUBLICID>
    <LONGNAME>Characteristic Image Quantification Method Text</LONGNAME>
    <PREFERREDNAME>IMAG_QUANT_METH_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>The text used to capture the strategy used to select the fields to be analyzed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3134471</PublicId>
      <PreferredName>3134440v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.:The process of measuring attributes of an image, by human sense or machine observations and experiences, and mapping them into members of some set of numbers or coded concepts._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Characteristic Image Quantification Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3134440</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25447:C91062</PreferredName>
        <Version>1</Version>
        <LongName>Characteristic Image Quantification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25447</PREFERRED_NAME>
            <LONG_NAME>Characteristic</LONG_NAME>
            <CON_ID>2203874</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91062</PREFERRED_NAME>
            <LONG_NAME>Image Quantification</LONG_NAME>
            <CON_ID>3124124</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3170098</PublicId>
      <PreferredName>IMAGE_QUANT_METH_TXT</PreferredName>
      <PreferredDefinition>The text used to capture the process of measuring attributes of an image, by human sense or machine observations and experiences, and mapping them into members of some set of numbers or coded concepts.</PreferredDefinition>
      <LongName>Image Quantification Method Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20047</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic or Prognostic Factor</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3170109</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C91062:C71460:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Image Quantification Method Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91062</PREFERRED_NAME>
            <LONG_NAME>Image Quantification</LONG_NAME>
            <CON_ID>3124124</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What strategy was used to sel</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What strategy was used to select the fields to be analyzed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939361</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCTD</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Immunohistochemical Biomarker</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Template Type</ClassificationSchemeItemType>
        <CsiPublicId>3165540</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939361</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCTD</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>In Situ Hybridization Biomarker Template</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Template Type</ClassificationSchemeItemType>
        <CsiPublicId>3232302</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1218">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3171003</PUBLICID>
    <LONGNAME>Colorectal Malignant Neoplasm Recurrent Cancer Progression Assessment Anatomic Site Other Specify</LONGNAME>
    <PREFERREDNAME>3170999v1.0:2201872v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the other specified free-text field related to an anatomic site related to the worsening of a cancer over time or the recurrent disease (tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues) having to do with the colon or the rectum.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3170999</PublicId>
      <PreferredName>2206582v1.0:3170997v1.0</PreferredName>
      <PreferredDefinition>information related to the worsening of a cancer over time or the recurrent disease (tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues) having to do with the colon or the rectum.</PreferredDefinition>
      <LongName>Colorectal Malignant Neoplasm Recurrent Cancer Progression Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206582</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13363:C9305</PreferredName>
        <Version>1</Version>
        <LongName>Colorectal Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13363</PREFERRED_NAME>
            <LONG_NAME>Colorectal</LONG_NAME>
            <CON_ID>2202379</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3170997</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14173:C19987:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Recurrent Cancer Progression Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14173</PREFERRED_NAME>
            <LONG_NAME>Recurrent</LONG_NAME>
            <CON_ID>2204863</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19987</PREFERRED_NAME>
            <LONG_NAME>Cancer Progression</LONG_NAME>
            <CON_ID>2552423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2201872</PublicId>
      <PreferredName>ANAT_SITE_OTHER_SPEC</PreferredName>
      <PreferredDefinition>the other specified free-text field related to an anatomic site.</PreferredDefinition>
      <LongName>Anatomic Site Other Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1219">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176013</PUBLICID>
    <LONGNAME>Schedule Study Activity Status Change Reason Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>3174890v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded value specifying why the status has changed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3174890</PublicId>
      <PreferredName>2867597v1.0:3174581v1.0</PreferredName>
      <PreferredDefinition>An ordered list of times at which things are planned to occur.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective; the state of being active._A condition or state at a particular time.:The act of alteration or modification; changed or altered in form or character.:An explanation of the cause of some phenomenon or action.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Schedule Study Activity Status Change Reason Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867597</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25211:C63536:C43431</PreferredName>
        <Version>1</Version>
        <LongName>Schedule Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25211</PREFERRED_NAME>
            <LONG_NAME>Schedule</LONG_NAME>
            <CON_ID>2203792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3174581</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688:C25446:C25638:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Status Change Reason Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Schedule Study Activity Status Change Reason Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Schedule Study Activity Status Change Reason Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ScheduledActivity.statusChangeReasonCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ScheduledActivity:statusChangeReasonCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain.ScheduledActivity.statusChangeReasonCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ScheduledActivityState.reason</AlternateName>
        <AlternateNameType>Map:PSCv2.6</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1220">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176127</PUBLICID>
    <LONGNAME>Observation Reuse Template Study Activity Subcategory Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>3174976v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity defined at a global library level whose intention is to obtain a result by observing, monitoring, measuring or otherwise qualitatively or quantitatively gathering data or information about one or more aspects of a study subject&#39;s or experimental unit&#39;s physiologic or psychologic state. EXAMPLE(S): blood chemistry panel, body mass index calculation, blood pressure measurement A coded value specifying a subdivision within a larger category of activities. EXAMPLE(S): chemotherapy, radiotherapy, hormonal therapy, alternative therapy. In the case where categoryCode = &quot;anti-cancer treatment&quot;, subcategoryCode may = &quot;radiotherapy&quot;, and nameCode may = &quot;external beam radiotherapy&quot;. If categoryCode = &quot;Intervention&quot;, subcategoryCode may = &quot;Drug&quot; (including placebo), &quot;Device&quot; (including sham), &quot;Biological/Vaccine&quot;, &quot;Procedure/Surgery&quot;, &quot;Radiation&quot;, &quot;Behavioral&quot; (e.g., Psychotherapy, Lifestyle Counseling), &quot;Genetic&quot; (including gene transfer, stem cell and recombinant DNA), Dietary Supplement.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3174976</PublicId>
      <PreferredName>3174191v1.0:2867795v1.0</PreferredName>
      <PreferredDefinition>Watching something and taking note of what happens.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._A subdivision that has common differentiating characteristics within a larger category.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Observation Reuse Template Study Activity Subcategory Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174191</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174191v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Observation Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867795</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25692:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Subcategory Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25692</PREFERRED_NAME>
            <LONG_NAME>Subcategory</LONG_NAME>
            <CON_ID>2203589</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Observation Reuse Template Study Activity Subcategory Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Observation Reuse Template Study Activity Subcategory Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DefinedObservation.subcategoryCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedObservation:subcategoryCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.DefinedObservation.subcategoryCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1221">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176134</PUBLICID>
    <LONGNAME>Observation Reuse Template Study Activity Status Date and Time ISO21090.TS.DATETIME.v1.0</LONGNAME>
    <PREFERREDNAME>3174983v1.0:3148148v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An activity defined at a global library level whose intention is to obtain a result by observing, monitoring, measuring or otherwise qualitatively or quantitatively gathering data or information about one or more aspects of a study subject&#39;s or experimental unit&#39;s physiologic or psychologic state. EXAMPLE(S): blood chemistry panel, body mass index calculation, blood pressure measurement The date (and time) on which the status is assigned to the activity.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3174983</PublicId>
      <PreferredName>3174191v1.0:2867759v1.0</PreferredName>
      <PreferredDefinition>Watching something and taking note of what happens.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._A condition or state at a particular time.:An expression of both date and time that an event has happened or will happen.</PreferredDefinition>
      <LongName>Observation Reuse Template Study Activity Status Date and Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174191</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174191v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Observation Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867759</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688:C37939</PreferredName>
        <Version>1</Version>
        <LongName>Status Date and Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3148148</PublicId>
      <PreferredName>3148148v1.0</PreferredName>
      <PreferredDefinition>Constrains TS so that it&#39;s precision can not be more precise than seconds.</PreferredDefinition>
      <LongName>ISO21090.TS.DATETIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090TSDTTIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Observation Reuse Template Study Activity Status Date and Time ISO21090.TS.DATETIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Observation Reuse Template Study Activity Status Date and Time ISO21090.TS.DATETIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DefinedObservation.statusDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedObservation:statusDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.DefinedObservation.statusDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1222">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176831</PUBLICID>
    <LONGNAME>Study Subject Milestone Administration, Management Performed Study Activity Repetition Number ISO21090.INT.POS.v1.0</LONGNAME>
    <PREFERREDNAME>3175334v1.0:2848082v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The completed activity which marks a study subject-specific, protocol-defined point in the course of a study. EXAMPLE(S): obtain informed consent, verify eligibility criteria, enroll, registration to a study, randomize, assignment to a treatment arm, start of on-study period, complete study visits, end of on-study period, exit trial, break treatment blind, protocol violation, premature withdrawal An integer that identfies the particular occurrence of a repeating activity. The first repetition is defined as &#39;1&#39;. EXAMPLE(S): A PlannedActivity might have a repeatQuantity of 4 which would result in 4 ScheduledActivity and PerformedActivity with repetitionNumbers of 1, 2, 3, and 4 respectively.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175334</PublicId>
      <PreferredName>2867636v1.0:3174579v1.0</PreferredName>
      <PreferredDefinition>A matter or an individual that is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study.:An important event in the progress, development, or history of something or in someone&#39;s life.:Performing or possessing executive duties; acting as a supervisor or manager.:Executed and carried through to completion.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective; the state of being active._An integer that identifies the particular occurrence of a repeating activity or entity.</PreferredDefinition>
      <LongName>Study Subject Milestone Administration, Management Performed Study Activity Repetition Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867636</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>2867636v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Study Subject Milestone Administration, Management Performed Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41189</PREFERRED_NAME>
            <LONG_NAME>Study Subject</LONG_NAME>
            <CON_ID>2202706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70743</PREFERRED_NAME>
            <LONG_NAME>Milestone</LONG_NAME>
            <CON_ID>2691049</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48905</PREFERRED_NAME>
            <LONG_NAME>Administration, Management</LONG_NAME>
            <CON_ID>2528523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3174579</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C93651</PreferredName>
        <Version>1</Version>
        <LongName>Repetition Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C93651</PREFERRED_NAME>
            <LONG_NAME>Repetition Number</LONG_NAME>
            <CON_ID>3162373</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2848082</PublicId>
      <PreferredName>2848082v1.0</PreferredName>
      <PreferredDefinition>Constrains INT to a value of greater than 0.</PreferredDefinition>
      <LongName>ISO21090.INT.POS.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090INTPOSv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2433737</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45255</PreferredName>
        <Version>1</Version>
        <LongName>Integer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Study Subject Milestone Administration, Management Performed Study Activity Repetition Number ISO21090.INT.POS.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Study Subject Milestone Administration, Management Performed Study Activity Repetition Number ISO21090.INT.POS.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedStudySubjectMilestone:repetitionNumber</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedStudySubjectMilestone.repetitionNumber</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain.PerformedStudySubjectMilestone.repetitionNumber</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1223">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3176887</PUBLICID>
    <LONGNAME>Product Investigation Observation Performed Study Activity Method Code ISO21090.DSET.CD.v1.0</LONGNAME>
    <PREFERREDNAME>3175385v1.0:2803321v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The completed process of evaluating a product after it has been returned to the manufacturer or reprocessor. A coded value specifying the technique used to perform the observation. EXAMPLE(S): Arterial puncture, sphygmomanometry (for blood pressure measurement). Global introspection, algorithm, bayesian (for Adverse Event causality). Estrogen Receptor Assay, Progesterone Receptor Assay, p53 Assay (for clinical result assay).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175385</PublicId>
      <PreferredName>3174133v1.0:2839671v1.0</PreferredName>
      <PreferredDefinition>The end result of a manufacturing process; anything that is produced.:The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts.:Watching something and taking note of what happens.:Executed and carried through to completion.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.:A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Product Investigation Observation Performed Study Activity Method Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174133</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174133v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Product Investigation Observation Performed Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51980</PREFERRED_NAME>
            <LONG_NAME>Product</LONG_NAME>
            <CON_ID>2527882</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41198</PREFERRED_NAME>
            <LONG_NAME>Investigation</LONG_NAME>
            <CON_ID>2469351</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2839671</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71460:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Method Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803321</PublicId>
      <PreferredName>2803321v1.0</PreferredName>
      <PreferredDefinition>A collection containing unordered distinct/discrete values of the type CD.</PreferredDefinition>
      <LongName>ISO21090.DSET.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090DSETv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Product Investigation Observation Performed Study Activity Method Code ISO21090.DSET.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Product Investigation Observation Performed Study Activity Method Code ISO21090.DSET.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.PerformedProductInvestigation.methodCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedProductInvestigation:methodCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1224">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3177108</PUBLICID>
    <LONGNAME>Causality Assessment Observation Performed Study Activity Foci Duration ISO21090.PQ.TIME.v1.0</LONGNAME>
    <PREFERREDNAME>3175602v1.0:2848092v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The judgment of relatedness between an adverse event and an activity or observation result. The quantity of time in which the observation result is held to be true. EXAMPLE(S): 2 months is the focalDuration for a question such as &quot;Have you smoked in the last 2 months?&quot;.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175602</PublicId>
      <PreferredName>3174131v1.0:3174558v1.0</PreferredName>
      <PreferredDefinition>The principle that a relationship exists between a primary entity A, or cause, and the occurrence of a secondary entity B, or effect.:The final result of a determination of the value, significance, or extent of.:Watching something and taking note of what happens.:Executed and carried through to completion.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._Area of greatest concentration, attention, or activity; a central point or locus, especially of an infection.:The period of time during which something continues.</PreferredDefinition>
      <LongName>Causality Assessment Observation Performed Study Activity Foci Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174131</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174131v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Causality Assessment Observation Performed Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82552</PREFERRED_NAME>
            <LONG_NAME>Causality</LONG_NAME>
            <CON_ID>3174117</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3174558</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25511:C25330</PreferredName>
        <Version>1</Version>
        <LongName>Foci Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25511</PREFERRED_NAME>
            <LONG_NAME>Focus</LONG_NAME>
            <CON_ID>2203817</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2848092</PublicId>
      <PreferredName>2848092v1.0</PreferredName>
      <PreferredDefinition>Constrains PQ to have units that describe a period of time.</PreferredDefinition>
      <LongName>ISO21090.PQ.TIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090PQTIMEv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Causality Assessment Observation Performed Study Activity Foci Duration ISO21090.PQ.TIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Causality Assessment Observation Performed Study Activity Foci Duration ISO21090.PQ.TIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.AdverseEventSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.CausalAssessment.focalDuration</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CausalAssessment:focalDuration</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.AdverseEventSubDomain.CausalAssessment.focalDuration</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1225">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3177164</PUBLICID>
    <LONGNAME>Subject Activity Group Reuse Template Study Activity Repeat Frequency Ratio ISO21090.RTO.INT,PQ.TIME.v1.0</LONGNAME>
    <PREFERREDNAME>3175660v1.0:3152481v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A collection of activities from a global library that would be performed on a common subject at approximately the same time. EXAMPLE(S): Clinic visit during which a physical exam, a blood test, and a substance administration occur. Telephone contact during which temperature, blood pressure and adverse events are reported. Recording multiple observation results in a diary. A ratio representing the number of occurrences of an activity within a given time period. EXAMPLE(S): Once per 12 hours; 2 times per day</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175660</PublicId>
      <PreferredName>3174187v1.0:3174538v1.0</PreferredName>
      <PreferredDefinition>Some matter, situation, or event that is thought about, written about, or discussed.:An action taken in pursuit of an objective.:Any number of entities (members) considered as a unit.:To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective._Make or do or perform again.:The number of occurrences of something within a given time period.:Quotient of quantities of the same kind for different components within the same system.</PreferredDefinition>
      <LongName>Subject Activity Group Reuse Template Study Activity Repeat Frequency Ratio</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174187</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3174187v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Subject Activity Group Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48910</PREFERRED_NAME>
            <LONG_NAME>Subject</LONG_NAME>
            <CON_ID>2553605</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43359</PREFERRED_NAME>
            <LONG_NAME>Group</LONG_NAME>
            <CON_ID>2236516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3174538</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47886:C25515:C44256</PreferredName>
        <Version>1</Version>
        <LongName>Repeat Frequency Ratio</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47886</PREFERRED_NAME>
            <LONG_NAME>Repeat</LONG_NAME>
            <CON_ID>2415563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44256</PREFERRED_NAME>
            <LONG_NAME>Ratio</LONG_NAME>
            <CON_ID>2230969</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3152481</PublicId>
      <PreferredName>3152481v1.0</PreferredName>
      <PreferredDefinition>Quantity quotient of a numerator of type INT divided by a denominator of type PQ.TIME.</PreferredDefinition>
      <LongName>ISO21090.RTO.INT,PQ.TIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090RTOv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Subject Activity Group Reuse Template Study Activity Repeat Frequency Ratio ISO21090.RTO.INT,PQ.TIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Subject Activity Group Reuse Template Study Activity Repeat Frequency Ratio ISO21090.RTO.INT,PQ.TIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedSubjectActivityGroup:repeatFrequencyRatio</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.DefinedSubjectActivityGroup.repeatFrequencyRatio</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1226">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3182824</PUBLICID>
    <LONGNAME>Direct Pulp Cap Performed Yes No Indicator</LONGNAME>
    <PREFERREDNAME>3182823v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator related to performing the procedure in which the exposed pulp is covered with a dressing that protects the pulp and promotes healing and repair.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3182823</PublicId>
      <PreferredName>3115960v1.0:2184322v1.0</PreferredName>
      <PreferredDefinition>information related to performing the procedure in which the exposed pulp is covered with a dressing that protects the pulp and promotes healing and repair.</PreferredDefinition>
      <LongName>Direct Pulp Cap Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3115960</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52574</PreferredName>
        <Version>1</Version>
        <LongName>Direct Pulp Cap</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52574</PREFERRED_NAME>
            <LONG_NAME>Direct Pulp Cap</LONG_NAME>
            <CON_ID>2443131</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2184322</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Performed</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was direct pulp capping perfo</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was direct pulp capping performed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4442461</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NIDCR CDEs with Retired VDs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDEs for Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4442571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1227">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3188446</PUBLICID>
    <LONGNAME>Diagnosis Enzyme Deficiency Type</LONGNAME>
    <PREFERREDNAME>3188445v1.0:3028408v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the enzyme deficiency.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3188445</PublicId>
      <PreferredName>7533635v1.0:7533636v1.0</PreferredName>
      <PreferredDefinition>The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Molecules that catalyze a chemical reaction. They are usually proteins, although catalytic RNA and DNA molecules have been identified._In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.</PreferredDefinition>
      <LongName>Diagnosis Deficiency Enzyme</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7533635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220:C16554</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis Enzyme</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16554</PREFERRED_NAME>
            <LONG_NAME>Enzyme</LONG_NAME>
            <CON_ID>2596328</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7533636</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C94372</PreferredName>
        <Version>1</Version>
        <LongName>Deficiency</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94372</PREFERRED_NAME>
            <LONG_NAME>Deficiency</LONG_NAME>
            <CON_ID>3188437</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3028408</PublicId>
      <PreferredName>3028408v1.0</PreferredName>
      <PreferredDefinition>Molecules that catalyze a chemical reaction. They are usually proteins, although catalytic RNA and DNA molecules have been identified._In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Enzyme Deficiency Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3188438</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16554:C94372:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Enzyme Deficiency Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16554</PREFERRED_NAME>
            <LONG_NAME>Enzyme</LONG_NAME>
            <CON_ID>2596328</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94372</PREFERRED_NAME>
            <LONG_NAME>Deficiency</LONG_NAME>
            <CON_ID>3188437</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other storage disease</VALIDVALUE>
          <VALUEMEANING>Other Lysosomal Storage Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A group of autosomal recessive or X-linked inherited metabolic disorders caused by defects in the function of the lysosomes.  Signs and symtoms include hepatomegaly, splenomegaly, nervous sytem manifestations, skeletal abnormalities, and mental deterioration.  Representative examples, include Gaucher disease, Neimann-Pick disease, Wolman disease, and Fabry disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61250, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetyl-CoAlpha-glucosaminide acetyltransferase</VALIDVALUE>
          <VALUEMEANING>Mucopolysaccharidosis Type IIIC</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme acetyl-CoA:alpha-glucosaminide acetyltransferase. It is characterized by behavioral changes, sleep disturbances, and mental developmental delays.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005735</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acid lipase deficiency</VALIDVALUE>
          <VALUEMEANING>Wolman Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A very rare, autosomal recessive inherited lysosomal storage disease caused by mutations in the LIPA gene. Signs and symptoms appear in infancy and include developmental delay, vomiting, abdominal distention, hepatosplenomegaly, jaundice, anemia, steatorrhea, and calcification of the adrenal glands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acid sphingomyelinase</VALIDVALUE>
          <VALUEMEANING>Niemann-Pick Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal recessive inherited lysosomal storage disease characterized by deficiency of sphingomyelinase. It results in the accumulation of sphingomyelin in the liver, spleen, brain, lungs, and bone marrow. Signs and symptoms include hepatosplenomegaly, pancytopenia, ataxia, dystonia, and dementia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-fucosidase deficiency</VALIDVALUE>
          <VALUEMEANING>Fucosidosis</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal recessive lysosomal storage disease characterized by a defective alpha-L-fucosidase. It results in accumulation of fucose in the tissues. Signs and symptoms include psychomotor retardation, dysostosis multiplex, and neural disturbances.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61274</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028419</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-L-iduronidase</VALIDVALUE>
          <VALUEMEANING>Hurler Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal recessive inherited disorder of mucopolysaccharide metabolism. It is the most severe form of mucopolysaccharidosis type I. It is characterized by deficiency of the enzyme alpha-L-iduronidase resulting in the accumulation of mucopolysaccharides in the tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-mannosidase B deficiency</VALIDVALUE>
          <VALUEMEANING>Alpha-Mannosidosis</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal recessive lysosomal storage disease characterized by deficient activity of the enzyme alpha-D-mannosidase. There is a wide range of signs and symptoms including hepatomegaly, splenomegaly, hearing loss, respiratory infections, mental retardation, skeletal abnomalities, leveled nasal bridge and protuding forehead.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alpha-N-acetylglucosaminidase</VALIDVALUE>
          <VALUEMEANING>Mucopolysaccharidosis Type IIIB</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme N-acetyl-alpha-D-glucosaminidase. It is characterized by behavioral changes, sleep disturbances, and mental developmental delays.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-galactosidase</VALIDVALUE>
          <VALUEMEANING>Mucopolysaccharidosis Type IVB</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme beta galactosidase. It is characterized by skeletal dysplasia and short stature.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84902</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005742</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Beta-glucuronidase</VALIDVALUE>
          <VALUEMEANING>Sly Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme beta-glucuronidase. It is characterized by hepatosplenomegaly, skeletal deformities, enlarged head, and mental retardation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glucocerebrosidase</VALIDVALUE>
          <VALUEMEANING>Gaucher Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited lysosomal storage disease caused by deficiency of the enzyme glucocerebrosidase. It results in the accumulation of a fatty substance called glucocerebroside in mononuclear cells in the bone marrow, liver, spleen, brain, and kidneys. Signs and symptoms include hepatomegaly, splenomegaly, neurologic disorders, lymphadenopathy, skeletal disorders, anemia and thrombocytopenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heparan N-sulfatase</VALIDVALUE>
          <VALUEMEANING>Mucopolysaccharidosis Type IIIA</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme heparan sulfate sulfatase. It is characterized by behavioral changes, sleep disturbances, mental developmental delays and seizures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84897</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypoxanthine-guanine phosphoribosyltransferase deficiency</VALIDVALUE>
          <VALUEMEANING>Lesch-Nyhan Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An X-linked inherited syndrome caused by mutations in the gene that encodes the enzyme hypoxanthine-guanine phosphoribosyltransferase, resulting in accumulation of uric acid in the body. It affects males and is characterized by neurologic defects, moderate mental retardation, muscle hypotonia, and a tendency for self-mutilation (self-biting of lips, tongue, and fingertips).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61255</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iduronate sulfatase</VALIDVALUE>
          <VALUEMEANING>Hunter Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An X-linked, inherited lysosomal storage disease caused by the deficiency of the enzyme iduronate sulfatase that is responsible for the degradation of mucopolysaccharides.  It nearly always affects males and is characterized by the accumulation of mucopolysaccharides in various organs, resulting in mental dysfunction, enlarged abdomen, hearing loss, obstructive airway disease, heart disease, and hepatosplenomegaly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028417</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-acetylgalactosamine 4-sulfatase</VALIDVALUE>
          <VALUEMEANING>Maroteaux-Lamy Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme N-acetylgalactosamine-4-sulfatase. It is characterized by organomegaly, short stature, joint stiffness, otitis media, and respiratory illnesses.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-acetylgalactosamine 6-sulfatase</VALIDVALUE>
          <VALUEMEANING>Mucopolysaccharidosis Type IVA</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme galactosamine-6-sulfatase. It is characterized by skeletal and central nervous system deficits.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-acetylglucosamine 6-sulfatase</VALIDVALUE>
          <VALUEMEANING>Mucopolysaccharidosis Type IIID</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme N-acetylglucosamine-6-sulfatase. It is characterized by behavioral changes, sleep disturbances and mental developmental delays.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3005734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-aspartyl-Beta-glucosaminidase</VALIDVALUE>
          <VALUEMEANING>Aspartylglycosaminuria</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive lysosomal disorder characterized by deficiency of N-aspartyl-beta-glucosaminidase. It is characterized by developmental delays during childhood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuronal ceroid lipofuscinosis enzyme - NCL 1</VALIDVALUE>
          <VALUEMEANING>Infantile Neuronal Ceroid Lipofuscinosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A very rare form of neuronal ceroid lipofuscinosis inherited in an autosomal recessive pattern.  During the first six to eighteen months of life development is normal.  Subsequently, patients develop developmental abnormalities in speech and motor skills, blindness, epilepsy, and seizures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85861</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3010915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neuronal ceroid lipofuscinosis enzyme - NCL 2: transpeptidase</VALIDVALUE>
          <VALUEMEANING>Late Infantile Neuronal Ceroid Lipofuscinosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Infantile neuronal ceroid lipofuscinosis in which the signs and symptoms appear later in life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85864</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3010914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N-acetylglucosamine-1-phosphotransferase</VALIDVALUE>
          <VALUEMEANING>I-Cell Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited lysosomal storage disease characterized by the presence of dense intracytoplasmic inclusions in mesenchymal cells, especially fibroblasts. Signs and symptoms include developmental delay, psychomotor deterioration, and growth failure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3188499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify enzyme:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify enzyme:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the enzyme deficiency:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify the enzyme deficiency:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the disease subtype:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the disease subtype:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:3188446</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedDiagnosis [first] &gt; AssessedResultRelationship &gt; PerformedObservation &gt; PerformedDiagnosis.value [second] WHERE PerformedDiagnosis.value [first] = &quot;Mucopolysaccharidosis&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2038r1: Mucopolysaccharidosis and Other Storage Diseases Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964898</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>muc_base_spec_batten_sub</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>muc_base_spec_enz_mrqu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>muc_base_spec_enz_snfp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedDiagnosis:value</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1228">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3192283</PUBLICID>
    <LONGNAME>CD3 Complex Present Cell Laboratory Procedure Outcome Integer::1 Decimal Place Value</LONGNAME>
    <PREFERREDNAME>2760298v1.0:2784509v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The 1 decimal place numeric laboratory value measured, assigned or computed related to the assessment of CD3 complex cells in a specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2760298</PublicId>
      <PreferredName>CD3_CEL_LAB_PRO</PreferredName>
      <PreferredDefinition>Consisting of cell surface type I membrane Delta, Epsilon, Gamma, Zeta, and Eta protein subunits with ITAM domains and noncovalently associated with the disulfide bound heterodimeric alpha/beta and gamma/delta TCR, the CD3 complex couples receptor antigen recognition to signal transduction pathways during T-cell activation. During TCR engagement with MHC-associated antigen on host cell surfaces and synapse formation, CD3 activity leads to Tyr-phosphorylated CD3 subunits, Tyr phosphorylation of LAT colocalized in lipid rafts, and MAPK activation. CD3 signal transduction appears to involve LCK, ZAP70, Nck, SLA, SLA2, and DOCK2. CD3 subunits may also associate with the cytoskeleton. CD3 also mediates TCR signal transduction during the developmental transition through positive selection of immature thymocytes to mature CD4+ or CD8+ T cells. (NCI)_Being or existing in a specified place or at the specified time._The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.</PreferredDefinition>
      <LongName>CD3 Complex Present Cell Laboratory Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2760296</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38897:C25626:C12508</PreferredName>
        <Version>1</Version>
        <LongName>CD3 Complex Present Cell</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38897</PREFERRED_NAME>
            <LONG_NAME>CD3 Complex</LONG_NAME>
            <CON_ID>2593496</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12508</PREFERRED_NAME>
            <LONG_NAME>Cell</LONG_NAME>
            <CON_ID>2202900</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2486250</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784509</PublicId>
      <PreferredName>2784509v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Outcome; a phenomenon that follows and is caused by some previous phenomenon._A number with no fractional part, including the negative and positive numbers as well as zero.::1_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Laboratory Procedure Outcome Integer::1 Decimal Place Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784508</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294:C20200:C45255::1:C42646</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Outcome Integer::1 Decimal Place Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total CD3+ cells:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Total CD3+ cells:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the value of CD3+ cel</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the value of CD3+ cells?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Peripheral blood chimerism result (donor CD3+):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2007r1:Cord Blood Unit -SCTOD Data Requirements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3191905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBCHIMERISMRSLT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1229">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3196352</PUBLICID>
    <LONGNAME>Participant Personal Medical History Coronary Artery Disease Indicator</LONGNAME>
    <PREFERREDNAME>MH_CRNRY_ARTRY_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no/unknown response related to the participant&#39;s medical history of coronary artery disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NINDS:National Institute of Neurological Disorders and Stroke Common Data Element Project</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3194075</PublicId>
      <PreferredName>MH_CRNRY_ARTRY</PreferredName>
      <PreferredDefinition>Participant medical history - coronary artery disease: narrowing of the coronary arteries due to fatty deposits inside the arterial walls.</PreferredDefinition>
      <LongName>Participant Personal Medical History Coronary Artery Disease</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2747584</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29867:C18772</PreferredName>
        <Version>1</Version>
        <LongName>Participant Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29867</PREFERRED_NAME>
            <LONG_NAME>Participant</LONG_NAME>
            <CON_ID>2202627</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3193061</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C26732</PreferredName>
        <Version>1</Version>
        <LongName>Coronary Disease</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26732</PREFERRED_NAME>
            <LONG_NAME>Coronary Artery Disease</LONG_NAME>
            <CON_ID>2240677</CON_ID>
            <DEFINITION_SOURCE>MSH2003_2003_05_12</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NINDS:National Institute of Neurological Disorders and Stroke Common Data Element Project</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Coronary artery disease</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Coronary artery disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NINDS CDE Project</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>NINDS CDE Project</DocumentText>
        <URL>http://www.commondataelements.ninds.nih.gov/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General Health History</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3145518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Medical History</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000398</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Participant/Subject History and Family History</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000583</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1230">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3196706</PUBLICID>
    <LONGNAME>Breast Reconstruction Comparison Shoulder Joint Stiffness Assessment Status</LONGNAME>
    <PREFERREDNAME>3196539v1.0:3196695v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>a condition or state related to comparison assessment of shoulder stiffness from the surgical restoration of breast.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3196539</PublicId>
      <PreferredName>3196243v1.0:3196537v1.0</PreferredName>
      <PreferredDefinition>information related to comparison assessment of shoulder stiffness from the surgical restoration of breast.</PreferredDefinition>
      <LongName>Breast Reconstruction Comparison Shoulder Joint Stiffness Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3196243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12971:C25351</PreferredName>
        <Version>1</Version>
        <LongName>Breast Reconstruction</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12971</PREFERRED_NAME>
            <LONG_NAME>Breast</LONG_NAME>
            <CON_ID>2202571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25351</PREFERRED_NAME>
            <LONG_NAME>Reconstructive Surgery</LONG_NAME>
            <CON_ID>2203958</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3196537</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49156:C25203:C79603:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Comparison Shoulder Joint Stiffness Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49156</PREFERRED_NAME>
            <LONG_NAME>Comparison</LONG_NAME>
            <CON_ID>2528577</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25203</PREFERRED_NAME>
            <LONG_NAME>Shoulder</LONG_NAME>
            <CON_ID>2202815</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79603</PREFERRED_NAME>
            <LONG_NAME>Joint Stiffness</LONG_NAME>
            <CON_ID>3196536</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3196695</PublicId>
      <PreferredName>3196695v1.0</PreferredName>
      <PreferredDefinition>a condition or state at a particular time for breast reconstruction comparison assessment between treated and untreated breast and area.</PreferredDefinition>
      <LongName>Breast Reconstruction Comparison Assessment Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slight</VALIDVALUE>
          <VALUEMEANING>Slight</VALUEMEANING>
          <MEANINGDESCRIPTION>A bit</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-03-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2931894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate</VALIDVALUE>
          <VALUEMEANING>Moderately</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2855023</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large</VALIDVALUE>
          <VALUEMEANING>Large</VALUEMEANING>
          <MEANINGDESCRIPTION>Of considerable or relatively great size, extent, or capacity.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to do</VALIDVALUE>
          <VALUEMEANING>UNABLE To Do</VALUEMEANING>
          <MEANINGDESCRIPTION>UNABLE To Do (Health Activity Questionnaire)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very difficult</VALIDVALUE>
          <VALUEMEANING>Very difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Very difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat difficult</VALIDVALUE>
          <VALUEMEANING>Somewhat difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little difficult</VALIDVALUE>
          <VALUEMEANING>A little difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>A little difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not difficult at all</VALIDVALUE>
          <VALUEMEANING>Not difficult at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not difficult at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little</VALIDVALUE>
          <VALUEMEANING>Bothered a little</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered a little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered somewhat</VALIDVALUE>
          <VALUEMEANING>Bothered somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered somewhat</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not bothered at all</VALIDVALUE>
          <VALUEMEANING>Not bothered at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not bothered at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Shoulder stiffness</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Shoulder stiffness</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1005</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171062</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3196539v1.0:3196695v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1231">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3211637</PUBLICID>
    <LONGNAME>Collection Biospecimen Contact Information Email Address Email Address Text</LONGNAME>
    <PREFERREDNAME>3210677v1.0:2484074v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The act of gathering things together; having been brought together in one place.:Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:Information regarding the means of contacting a person or group._An e-mail address identifies a location to which e-mail can be delivered. A modern Internet e-mail address (using SMTP) is a string of the form jsmith@domain.example. (from Wikipedia)_The string of characters that represents an electronic mail address. [Explanatory comment:  The format for this value domain is the SMTP standard local-part@domain]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3210677</PublicId>
      <PreferredName>3210604v1.0:2223457v1.0</PreferredName>
      <PreferredDefinition>The act of gathering things together; having been brought together in one place.:Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:Information regarding the means of contacting a person or group._An e-mail address identifies a location to which e-mail can be delivered. A modern Internet e-mail address (using SMTP) is a string of the form jsmith@domain.example. (from Wikipedia)</PreferredDefinition>
      <LongName>Collection Biospecimen Contact Information Email Address</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3210604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25453:C70699:C60776</PreferredName>
        <Version>1</Version>
        <LongName>Collection Biospecimen Contact Information</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60776</PREFERRED_NAME>
            <LONG_NAME>Contact Information</LONG_NAME>
            <CON_ID>2751571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223457</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42775</PreferredName>
        <Version>1</Version>
        <LongName>Email Address</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42775</PREFERRED_NAME>
            <LONG_NAME>E-mail Address</LONG_NAME>
            <CON_ID>2223429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2484074</PublicId>
      <PreferredName>EMAIL_ADDR_TXT</PreferredName>
      <PreferredDefinition>The string of characters that represents an electronic mail address. [Explanatory comment:  The format for this value domain is the SMTP standard local-part@domain]</PreferredDefinition>
      <LongName>Email Address Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008544</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TELECOMMUNICATIONS</PreferredName>
        <Version>1</Version>
        <LongName>Telecommunications</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>320</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Collection Biospecimen Contact Information Email Address Email Address Text does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Collection Biospecimen Contact Information Email Address Email Address Text does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3204728</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CBM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cbm.domain.LogicalModel</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3204729</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SpecimenCollectionContact:emailAddress</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cbm.domain.LogicalModel.SpecimenCollectionContact.emailAddress</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1232">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3219496</PUBLICID>
    <LONGNAME>IDH1 Gene Mutation Abnormality Status</LONGNAME>
    <PREFERREDNAME>3219357v1.0:3219494v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text that describes the Isocitrate Dehydrogenase 1 gene mutation status.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3219357</PublicId>
      <PreferredName>3219355v1.0:2239981v1.0</PreferredName>
      <PreferredDefinition>This gene plays a role in carbohydrate metabolism._A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</PreferredDefinition>
      <LongName>IDH1 Gene Mutation Abnormality Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3219355</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C77215:C45576</PreferredName>
        <Version>1</Version>
        <LongName>IDH1 Gene Mutation Abnormality</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C77215</PREFERRED_NAME>
            <LONG_NAME>IDH1 Gene</LONG_NAME>
            <CON_ID>3133958</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45576</PREFERRED_NAME>
            <LONG_NAME>Mutation Abnormality</LONG_NAME>
            <CON_ID>2532673</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239981</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3219494</PublicId>
      <PreferredName>3219494v1.0</PreferredName>
      <PreferredDefinition>A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Mutation Abnormality Status</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3219493</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45576:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Mutation Abnormality Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45576</PREFERRED_NAME>
            <LONG_NAME>Mutation Abnormality</LONG_NAME>
            <CON_ID>2532673</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination that a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mutated</VALIDVALUE>
          <VALUEMEANING>Mutation Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3219495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wt</VALIDVALUE>
          <VALUEMEANING>Wild Type</VALUEMEANING>
          <MEANINGDESCRIPTION>The naturally-occurring, normal, non-mutated version of a gene or genome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mutation identified</VALIDVALUE>
          <VALUEMEANING>Mutation Abnormality Identification</VALUEMEANING>
          <MEANINGDESCRIPTION>Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.: The procedure of having an identity established.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45576, C25737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7092322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No mutation detected</VALIDVALUE>
          <VALUEMEANING>Negation Mutation Abnormality Detected Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._Perceived, discerned, or discovered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191719, C45576, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7092323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Results</VALIDVALUE>
          <VALUEMEANING>No Results</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: The result of an action.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20200, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7108382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Available</VALIDVALUE>
          <VALUEMEANING>Unavailable</VALUEMEANING>
          <MEANINGDESCRIPTION>The desired information is not available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-02-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5828000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>IDH1 mutation status</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>IDH1 mutation status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>IDH1 mutation detected?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>IDH1 mutation detected?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>IDH1 mutation detected in any/all specimens?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>IDH1 mutation detected in any/all specimens?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Inactive CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044924</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6705584</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCG_PTCL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HOPE-CARE</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7715738</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idh1</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idh1_het</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1233">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3235798</PUBLICID>
    <LONGNAME>Laboratory Procedure Day 29 Induction Therapy Bone Marrow Blast Result Percentage Value</LONGNAME>
    <PREFERREDNAME>3235788v1.0:2180234v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The number that represents the percent of blasts in bone marrow aspirate at day 29 of induction therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3235788</PublicId>
      <PreferredName>2543047v1.0:3235795v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours._A number with no fractional part.::29_Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains._The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes._Blast cells are in an immature (undifferentiated) stage in cellular development, occurring before the appearance of the definitive characteristics exhibited by fully differentiated cells._Outcome; a phenomenon that follows and is caused by some previous phenomenon.</PreferredDefinition>
      <LongName>Laboratory Procedure Day 29 Induction Therapy Bone Marrow Blast Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3235795</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3235795v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Day Integer::29 Neoadjuvant Therapy Bone Marrow Blast Cell Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25301</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2202680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::29</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15665</PREFERRED_NAME>
            <LONG_NAME>Neoadjuvant Therapy</LONG_NAME>
            <CON_ID>2206319</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12431</PREFERRED_NAME>
            <LONG_NAME>Bone Marrow</LONG_NAME>
            <CON_ID>2202685</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12918</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Blast Cell</LONG_NAME>
            <CON_ID>2202529</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180234</PublicId>
      <PreferredName>LAB_PTG_VAL</PreferredName>
      <PreferredDefinition>the value as a percentage of 100.</PreferredDefinition>
      <LongName>Lab Percentage Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Percent of blasts in bone mar</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Percent of blasts in bone marrow aspirate at day 29 induction therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5650570</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TARGET</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ALL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5650571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1234">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3237581</PUBLICID>
    <LONGNAME>Laboratory Procedure Percent Free Prostate-Specific Antigen Outcome Value</LONGNAME>
    <PREFERREDNAME>LAB_FPSA_OC_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>The result of the free prostate-specific antigen (PSA) procedure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2009195</PublicId>
      <PreferredName>LAB_FPSA_OC</PreferredName>
      <PreferredDefinition>information related to the outcome of the medical procedure that involves testing a sample of blood, urine, or other substance from the body for prostate-specific antigen that circulates freely in the blood, unattached to any protein molecule.</PreferredDefinition>
      <LongName>Laboratory Procedure Percent Free Prostate-Specific Antigen Outcome</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2775188</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20042:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Percent Free Prostate-Specific Antigen Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20042</PREFERRED_NAME>
            <LONG_NAME>Percent Free Prostate-Specific Antigen</LONG_NAME>
            <CON_ID>2775187</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3237580</PublicId>
      <PreferredName>FPSA_VAL</PreferredName>
      <PreferredDefinition>The number that represents the value of the free PSA laboratory test.</PreferredDefinition>
      <LongName>Percent Free Prostate-Specific Antigen Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3237579</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20042:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percent Free Prostate-Specific Antigen Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20042</PREFERRED_NAME>
            <LONG_NAME>Percent Free Prostate-Specific Antigen</LONG_NAME>
            <CON_ID>2775187</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Free PSA Result</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Free PSA Result</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Biospecimen Repository</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3060675</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000011</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1235">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3244006</PUBLICID>
    <LONGNAME>White Spot Lesion Improvement Assessment Scale</LONGNAME>
    <PREFERREDNAME>3244003v1.0:3244004v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A chalky white area that appears on a tooth surface indicating the presence of decalcified enamel and the potential to advance to cavitation._A condition superior to an earlier condition._The final result of a determination of the value, significance, or extent of._an ordered reference standard.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3244003</PublicId>
      <PreferredName>3244000v1.0:3244001v1.0</PreferredName>
      <PreferredDefinition>A chalky white area that appears on a tooth surface indicating the presence of decalcified enamel and the potential to advance to cavitation._A condition superior to an earlier condition._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>White Spot Lesion Improvement Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3244000</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C60714</PreferredName>
        <Version>1</Version>
        <LongName>White Spot Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60714</PREFERRED_NAME>
            <LONG_NAME>White Spot Lesion</LONG_NAME>
            <CON_ID>2481609</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3244001</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C94226:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Improvement Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94226</PREFERRED_NAME>
            <LONG_NAME>Improvement</LONG_NAME>
            <CON_ID>3197285</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3244004</PublicId>
      <PreferredName>3244004v1.0</PreferredName>
      <PreferredDefinition>an ordered reference standard.</PreferredDefinition>
      <LongName>White Spot Lesion Improvement Assessment Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How much improvement do you t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How much improvement do you think your white spot lesions have had over the past 8 weeks?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1236">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3245846</PUBLICID>
    <LONGNAME>Miniscrew Temporary Anchorage Device Therapeutic Procedure Options Satisfaction Yes or No Response</LONGNAME>
    <PREFERREDNAME>3245845v1.0:3108967v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A small screw of between 6-14mm in length placed between the roots of a tooth for purposes of anchoring the tooth during orthodonic treatment._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._Options; alternative choices or actions._The feeling of being pleased and content._A caDSR representation term that is used to indicate a question with permissible values of yes/no</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3245845</PublicId>
      <PreferredName>3244920v1.0:3245843v1.0</PreferredName>
      <PreferredDefinition>A small screw of between 6-14mm in length placed between the roots of a tooth for purposes of anchoring the tooth during orthodonic treatment._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._Options; alternative choices or actions._The feeling of being pleased and content.</PreferredDefinition>
      <LongName>Miniscrew Temporary Anchorage Device Therapeutic Procedure Options Satisfaction</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3244920</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C82082</PreferredName>
        <Version>1</Version>
        <LongName>Miniscrew Temporary Anchorage Device</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82082</PREFERRED_NAME>
            <LONG_NAME>Miniscrew Temporary Anchorage Device</LONG_NAME>
            <CON_ID>2904796</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3247126</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236:C62185</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure Satisfaction</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62185</PREFERRED_NAME>
            <LONG_NAME>Satisfaction</LONG_NAME>
            <CON_ID>2585226</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3108967</PublicId>
      <PreferredName>C49487:C49488:3108967v1.0</PreferredName>
      <PreferredDefinition>A caDSR representation term that is used to indicate a question with permissible values of yes/no</PreferredDefinition>
      <LongName>Yes or No Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No [0]</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes [0]</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Overall, are you satisfied wi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Overall, are you satisfied with the results of treatment using miniscrew TADs?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1237">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3248157</PUBLICID>
    <LONGNAME>Dental Professional Practice Alcohol Illicit Substance Use Counseling Cost Effective Management Specify</LONGNAME>
    <PREFERREDNAME>3248148v1.0:2183516v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to related to feasibility of counseling by the dental professional business directed towards treatment and care of patients for alcohol or illicit drug use.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3248148</PublicId>
      <PreferredName>2443314v1.0:3248146v1.0</PreferredName>
      <PreferredDefinition>information related to feasibility of counseling by the dental professional business directed towards treatment and care of patients for alcohol or illicit drug use.</PreferredDefinition>
      <LongName>Dental Professional Practice Alcohol Illicit Substance Use Counseling Cost Effective Management</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443314</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C52673</PreferredName>
        <Version>1</Version>
        <LongName>Dental Professional Practice</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52673</PREFERRED_NAME>
            <LONG_NAME>Professional Practice</LONG_NAME>
            <CON_ID>2443152</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3248146</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3248146v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Alcohol Illicit Substance Use Counseling Cost Effective Management</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2190</PREFERRED_NAME>
            <LONG_NAME>Alcohol</LONG_NAME>
            <CON_ID>2202315</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79097</PREFERRED_NAME>
            <LONG_NAME>Illicit Substance</LONG_NAME>
            <CON_ID>2820624</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61547</PREFERRED_NAME>
            <LONG_NAME>Counseling</LONG_NAME>
            <CON_ID>2833533</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19248</PREFERRED_NAME>
            <LONG_NAME>Cost Effective Management</LONG_NAME>
            <CON_ID>3248145</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2183516</PublicId>
      <PreferredName>PROT_ADM_SPEC</PreferredName>
      <PreferredDefinition>the free text field to related to protocol administration.</PreferredDefinition>
      <LongName>Protocol Administration Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1238">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3261502</PUBLICID>
    <LONGNAME>Estrogen Receptor Level Minimum Nuclei Positive Percent Number</LONGNAME>
    <PREFERREDNAME>2015006v1.0:3261485v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value that represents the minimum percent Estrogen Receptor positive nuclei using the IHC method to determine a positive finding.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2015006</PublicId>
      <PreferredName>ER_LVL</PreferredName>
      <PreferredDefinition>the level of estrogen receptor.</PreferredDefinition>
      <LongName>ER Level</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177156</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ER</PreferredName>
        <Version>1</Version>
        <LongName>ER</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17069</PREFERRED_NAME>
            <LONG_NAME>Estrogen Receptor Family</LONG_NAME>
            <CON_ID>2202618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177479</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Level</PreferredName>
        <Version>1</Version>
        <LongName>Level</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25554</PREFERRED_NAME>
            <LONG_NAME>Level</LONG_NAME>
            <CON_ID>2202440</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3261485</PublicId>
      <PreferredName>3261485v1.0</PreferredName>
      <PreferredDefinition>The smallest possible quantity._Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton &amp; Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)_An observation confirming something, such as the presence of a disease, condition, or microorganism._Percentage; a fraction or ratio with 100 understood as the denominator._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.</PreferredDefinition>
      <LongName>Minimum Nuclei Positive Percent Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue>100</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>3261484</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3261484v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Minimum Nucleus Positive Finding Percentage Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25570</PREFERRED_NAME>
            <LONG_NAME>Minimum</LONG_NAME>
            <CON_ID>2206306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13197</PREFERRED_NAME>
            <LONG_NAME>Nucleus</LONG_NAME>
            <CON_ID>2205292</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38758</PREFERRED_NAME>
            <LONG_NAME>Positive Finding</LONG_NAME>
            <CON_ID>2516404</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What percent cut-off was used</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What percent cut-off was used by the laboratory to clasify this case as ER positive or negative?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Inactive CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044924</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1239">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3264207</PUBLICID>
    <LONGNAME>Menstrual Cycle End Reason Type</LONGNAME>
    <PREFERREDNAME>2442663v1.0:3263680v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text to describe the reason for cessation of menstrual cycle periods.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2442663</PublicId>
      <PreferredName>MENCYC_END_RSN</PreferredName>
      <PreferredDefinition>The reason the Menstrual Cycle involving regularly recurring hormonal changes and physiologic endometrial changes during the reproductive period in human females, and some primates, and culminates in partial sloughing of the endometrium (menstruation) in the absence of fertilization ends.</PreferredDefinition>
      <LongName>Menstrual Cycle End Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2442660</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16838</PreferredName>
        <Version>1</Version>
        <LongName>Menstrual Cycle</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16838</PREFERRED_NAME>
            <LONG_NAME>Menstrual Cycle</LONG_NAME>
            <CON_ID>2202740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2442661</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25496:C25638</PreferredName>
        <Version>1</Version>
        <LongName>End Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3263680</PublicId>
      <PreferredName>3263680v1.0</PreferredName>
      <PreferredDefinition>Regularly recurring physiologic changes in the endometrium during the reproductive period in human females, and some primates, and culminating in partial sloughing of the endometrium (menstruation) in the absence of fertilization. The hormonal changes that lead up to a woman&#39;s having a period. For most women, one cycle takes 28 days._The point or place at which something terminates in time, space, or extent._An explanation of the cause of some phenomenon or action._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Menstrual Cycle End Reason Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3263679</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16838:C25496:C25638:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Menstrual Cycle End Reason Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16838</PREFERRED_NAME>
            <LONG_NAME>Menstrual Cycle</LONG_NAME>
            <CON_ID>2202740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I had hormone replacement therapy (not including hormone therapy for cancer).</VALIDVALUE>
          <VALUEMEANING>Hormone Replacement Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>RAEB: Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I had chemotherapy, radiation therapy or hormone therapy that stopped my periods.</VALIDVALUE>
          <VALUEMEANING>Chemotherapy Radiation Therapy Endocrine Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04): use PHOTOTHERAPY, LASER THERAPY, or ULTRAVIOLET THERAPY for therapeutic radiation with visible, laser, or ultraviolet light, respectively.: Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy. The concept covers but not limited to: intermittent or permanent hormone suppression or ablation in treatment of hormone-dependent tumors, hormone replacement therapy of any kind, hormonal component of gender reassignment therapy, hormonal contraception, surgical and radiation castration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15445, C15313, C15632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3263681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I had my ovaries removed (but did not have a hysterectomy).</VALIDVALUE>
          <VALUEMEANING>Oophorectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The surgical removal of one or both ovaries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15291</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2832968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I had a hysterectomy but still have my ovaries.</VALIDVALUE>
          <VALUEMEANING>Hysterectomy Without Oophorectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>(hiss-ter-EK-toe-mee) An operation in which the uterus is removed.: Used to indicate the absence or lack of something or someone. (from Merriam-Webster OnLine): The surgical removal of one or both ovaries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15291, C25718, C15256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3263684</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I went through natural menopause.</VALIDVALUE>
          <VALUEMEANING>Natural Menopause</VALUEMEANING>
          <MEANINGDESCRIPTION>A description for something that exists in or is produced by nature, and is not artificial or man-made.: The permanent cessation of menses, usually defined by 6 to 12 months of amenorrhea in a woman over 45 years of age.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3231, C85060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3263685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I am on birth control that stopped my menstrual periods.</VALIDVALUE>
          <VALUEMEANING>Use Birth Control</VALUEMEANING>
          <MEANINGDESCRIPTION>To put into action or service.: The event of being born.: The act of directing or determining; regulation or maintenance of a function or action; a relation of constraint of one entity (thing or person or group) by another.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61299, C25155, C95018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3263686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I am pregnant or nursing.</VALIDVALUE>
          <VALUEMEANING>Gravida Or Breast Feeding</VALUEMEANING>
          <MEANINGDESCRIPTION>To be pregnant. When followed by a numeral, the term indicates how many times a woman has been pregnant, regardless of the outcome of the pregnancy.: Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The nursing of an infant at the mother&#39;s breast.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25596, C37998, C73435</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3263687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I don&#39;t know</VALIDVALUE>
          <VALUEMEANING>Don&#39;t Know/Refused</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I had a hysterectomy and don&#39;t have ovaries.</VALIDVALUE>
          <VALUEMEANING>Hysterectomy With Oophorectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>(hiss-ter-EK-toe-mee) An operation in which the uterus is removed.: Used to indicate the presence of something or someone.: The surgical removal of one or both ovaries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15291, C62355, C15256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3263683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I had a hysterectomy, but I&#39;m not sure if I have ovaries.</VALIDVALUE>
          <VALUEMEANING>Hysterectomy Does Not Know Oophorectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>(hiss-ter-EK-toe-mee) An operation in which the uterus is removed.: The answer is not known by the person answering.: The surgical removal of one or both ovaries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15291, C67142, C15256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3263682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Why do you think you are not</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Why do you think you are not having a period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Health Survey </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259220</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Womens Health</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259225</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1240">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3287213</PUBLICID>
    <LONGNAME>Immediate Family History Bladder Cancer Relative Count Type</LONGNAME>
    <PREFERREDNAME>3286583v1.0:3285523v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text that describes which and how many of the patient&#39;s first degree relatives have been diagnosed with bladder cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3286583</PublicId>
      <PreferredName>3286580v1.0:3286581v1.0</PreferredName>
      <PreferredDefinition>A person related by descent rather than by marriage or law._Chronological record of health and disease events of family members and ancestors. (WEBS84)_A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas._Occurrence; an instance of something happening.</PreferredDefinition>
      <LongName>Immediate Family History Bladder Cancer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3286580</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71384:C17726</PreferredName>
        <Version>1</Version>
        <LongName>Biological Relative Family Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71384</PREFERRED_NAME>
            <LONG_NAME>Biological Relative</LONG_NAME>
            <CON_ID>2714720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17726</PREFERRED_NAME>
            <LONG_NAME>Family Medical History</LONG_NAME>
            <CON_ID>2202638</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3286581</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4912:C25275</PreferredName>
        <Version>1</Version>
        <LongName>Bladder Carcinoma Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4912</PREFERRED_NAME>
            <LONG_NAME>Bladder Carcinoma</LONG_NAME>
            <CON_ID>3130371</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3285523</PublicId>
      <PreferredName>3285523v1.0</PreferredName>
      <PreferredDefinition>Any relative who is one meiosis away from a particular individual in a family; a relative with whom one half of an individual&#39;s genes is shared (i.e., parent, sibling, offspring) (from Genetics Home Reference glossary)_To determine the number or amount of something; the result of this activity._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>First Degree Relative Count Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3285522</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21481:C25463:C25284</PreferredName>
        <Version>1</Version>
        <LongName>First Degree Relative Count Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21481</PREFERRED_NAME>
            <LONG_NAME>First Degree Relative</LONG_NAME>
            <CON_ID>2400271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Don&#39;t know</VALIDVALUE>
          <VALUEMEANING>Don&#39;t Know/Refused</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2 or more brothers and/or sons</VALIDVALUE>
          <VALUEMEANING>Integer::2 Or Greater Than Two Brother Or Son</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::2: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.: Brother; a male sibling.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Son; a male human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25205, C37998, C25289, C66833, C61584, C37998, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3285524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 brother or son</VALIDVALUE>
          <VALUEMEANING>One Brother Or Son</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest natural number and quantity it denotes: a single entity, unit, or object.: Brother; a male sibling.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Son; a male human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25205, C37998, C25289, C66832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3285525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2 or more sisters and/or daughters</VALIDVALUE>
          <VALUEMEANING>Integer::2 Or Greater Than Two Sister Or Daughter</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part.::2: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.: Sister; a female sibling.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Daughter; a female human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61584, C37998, C45255::2, C25165, C37998, C25680, C66833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>4, 5, 6, 0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3285526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 sister or daughter</VALIDVALUE>
          <VALUEMEANING>One Sister Or Daughter</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest natural number and quantity it denotes: a single entity, unit, or object.: Sister; a female sibling.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Daughter; a female human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25165, C37998, C25680, C66832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3285527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Father</VALIDVALUE>
          <VALUEMEANING>Father</VALUEMEANING>
          <MEANINGDESCRIPTION>Father; a male parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mother</VALIDVALUE>
          <VALUEMEANING>Mother</VALUEMEANING>
          <MEANINGDESCRIPTION>Mother; a female parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567344</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has anyone in your immediate</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has anyone in your immediate family (mother, father, full sisters, full brothers, sons, or daughters) ever had any of the following types of cancer?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Health Survey </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259220</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3259219</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>University of Michigan</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Family History of Cancer </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3259227</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1241">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3288283</PUBLICID>
    <LONGNAME>Person T4 Stage Finding Clinical Trial Eligibility Criteria Ind-2</LONGNAME>
    <PREFERREDNAME>3288282v1.0:2018257v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer as an elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3288282</PublicId>
      <PreferredName>2236731v1.0:3288280v1.0</PreferredName>
      <PreferredDefinition>information related to clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer as an elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.</PreferredDefinition>
      <LongName>Person T4 Stage Finding Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3288280</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48732:C16112</PreferredName>
        <Version>1</Version>
        <LongName>T4 Stage Finding Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48732</PREFERRED_NAME>
            <LONG_NAME>T4 TNM Finding</LONG_NAME>
            <CON_ID>2519623</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Clinical T4 tumors</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Clinical T4 tumors</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1242">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3288326</PUBLICID>
    <LONGNAME>Person Bowel Obstruction Clinical Trial Eligibility Criteria Ind-2</LONGNAME>
    <PREFERREDNAME>3288325v1.0:2018257v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to a person having a tumor composed of atypical neoplastic which are relating to the fold of peritoneum, or mesentery, attached to the rectum as an element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3288325</PublicId>
      <PreferredName>2236731v1.0:3288323v1.0</PreferredName>
      <PreferredDefinition>information related to a person having a tumor composed of atypical neoplastic which are relating to the fold of peritoneum, or mesentery, attached to the rectum as an element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.</PreferredDefinition>
      <LongName>Person Bowel Obstruction Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3288323</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9175:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Bowel Obstruction Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9175</PREFERRED_NAME>
            <LONG_NAME>Bowel Obstruction</LONG_NAME>
            <CON_ID>2204024</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tumor is causing symptomatic</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tumor is causing symptomatic bowel obstruction</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1243">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3308192</PUBLICID>
    <LONGNAME>Laboratory Procedure Chemistry Test Repeat Performed Ind-3</LONGNAME>
    <PREFERREDNAME>3308182v1.0:2181324v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator related to a repeated laboratory test designed for the quantification of an organic or inorganic chemical within a biological specimen being performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3308182</PublicId>
      <PreferredName>2543047v1.0:3308180v1.0</PreferredName>
      <PreferredDefinition>information related to a repeated laboratory test designed for the quantification of an organic or inorganic chemical within a biological specimen being performed.</PreferredDefinition>
      <LongName>Laboratory Procedure Chemistry Test Repeat Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3308180</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49237:C47886:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Chemistry Test Repeat Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49237</PREFERRED_NAME>
            <LONG_NAME>Chemistry Test</LONG_NAME>
            <CON_ID>2751688</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47886</PREFERRED_NAME>
            <LONG_NAME>Repeat</LONG_NAME>
            <CON_ID>2415563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was another chemistry panel o</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was another chemistry panel obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1244">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3309040</PUBLICID>
    <LONGNAME>Biomarker Biospecimen Not Submitted Reason</LONGNAME>
    <PREFERREDNAME>BIOM_SPEC_NT_SUB_RSN</PREFERREDNAME>
    <PREFERREDDEFINITION>Text explanation of the reason a biomarker specimen was not submitted.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3309008</PublicId>
      <PreferredName>BIOM_SPEC_NO_SUBM</PreferredName>
      <PreferredDefinition>Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc_Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._An operation in which a term denies or inverts the meaning of another term or construction._Submitted; referred for judgment or consideration.</PreferredDefinition>
      <LongName>Biomarker Biospecimen Not Submitted</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3308959</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16342:C70699</PreferredName>
        <Version>1</Version>
        <LongName>Biomarker Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16342</PREFERRED_NAME>
            <LONG_NAME>Biomarker</LONG_NAME>
            <CON_ID>2202308</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207642</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C25695</PreferredName>
        <Version>1</Version>
        <LongName>Not Submitted</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25695</PREFERRED_NAME>
            <LONG_NAME>Submission</LONG_NAME>
            <CON_ID>2203811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3309018</PublicId>
      <PreferredName>SPEC_NT_SUBM_RSN</PreferredName>
      <PreferredDefinition>A free text field used to describe the reason a sample was not submitted._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Specimen Not Submitted Reason</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3309017</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157:C25594:C25695:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Negation Submission Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25695</PREFERRED_NAME>
            <LONG_NAME>Submission</LONG_NAME>
            <CON_ID>2203811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If not, Reason</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If not, Reason</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812605</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1245">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3350436</PUBLICID>
    <LONGNAME>Participant Personal Medical History Lower Extremity Surgical Procedure Exclusion Criteria Eligibility Ind-2</LONGNAME>
    <PREFERREDNAME>3350432v1.0:2018257v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Someone who takes part in an activity._an account of all medical events and problems a person has experienced._Definition not available._A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Exclusion; the act of restricting entrance or barring from participation._the yes/no indicator related to the patient&#39;s eligibility to participate in the clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3350432</PublicId>
      <PreferredName>2747584v1.0:3350430v1.0</PreferredName>
      <PreferredDefinition>Someone who takes part in an activity._an account of all medical events and problems a person has experienced._Definition not available._A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Exclusion; the act of restricting entrance or barring from participation.</PreferredDefinition>
      <LongName>Participant Personal Medical History Lower Extremity Surgical Procedure Exclusion Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2747584</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29867:C18772</PreferredName>
        <Version>1</Version>
        <LongName>Participant Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29867</PREFERRED_NAME>
            <LONG_NAME>Participant</LONG_NAME>
            <CON_ID>2202627</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3350430</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12742:C15329:C25370</PreferredName>
        <Version>1</Version>
        <LongName>Lower Extremity Surgical Procedure Exclusion Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12742</PREFERRED_NAME>
            <LONG_NAME>Lower Extremity</LONG_NAME>
            <CON_ID>2204814</CON_ID>
            <DEFINITION_SOURCE>NCIt</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25370</PREFERRED_NAME>
            <LONG_NAME>Exclusion Criteria</LONG_NAME>
            <CON_ID>2203927</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the patient had prior low</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the patient had prior lower extremity vascular surgery (arterial or venous) or any inguinal, hip, knee, or ankle surgery, including orthopedic procedures?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>GOG_CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient had prior lower extremity vascular surgery (arterial or venous)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0244</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104884</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0244</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000340</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0244</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000341</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3350432v1.0:2018257v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1246">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3351980</PUBLICID>
    <LONGNAME>Hematopoietic Cell Transplantation Indication Lymphoma And X-Linked Lymphoproliferative Syndrome Disease or Disorder Indicator</LONGNAME>
    <PREFERREDNAME>3351979v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the hematopoietic cell transplantation was for lymphoma and X-linked lymphoproliferative syndrome.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3351979</PublicId>
      <PreferredName>3342357v1.0:3351977v1.0</PreferredName>
      <PreferredDefinition>Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species. _A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication)._A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._An X-linked immunodeficiency syndrome that exclusivesly affects males, although females can be carriers.  The syndrome is characterized by life-threatening episodes of infectious mononucleosis, hypogammaglobulinemia, and subsequent development of lymphomas (usually B-cell lymphomas) and other lymphoproliferative disorders._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</PreferredDefinition>
      <LongName>Hematopoietic Cell Transplantation Indication Lymphoma And X-Linked Lymphoproliferative Syndrome Disease or Disorder</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3342357</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12551:C15342:C41184</PreferredName>
        <Version>1</Version>
        <LongName>Hematopoietic Stem Cell Transplantation Indication</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41184</PREFERRED_NAME>
            <LONG_NAME>Indication</LONG_NAME>
            <CON_ID>2203766</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3351977</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3208:C37912:C61246:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Lymphoma And X-Linked Lymphoproliferative Syndrome Disease or Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3208</PREFERRED_NAME>
            <LONG_NAME>Lymphoma</LONG_NAME>
            <CON_ID>2202736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37912</PREFERRED_NAME>
            <LONG_NAME>And</LONG_NAME>
            <CON_ID>2528554</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61246</PREFERRED_NAME>
            <LONG_NAME>X-Linked Lymphoproliferative Syndrome</LONG_NAME>
            <CON_ID>2593404</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the hematopoietic cell tr</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the hematopoietic cell transplantation for lymphoma and X-linked lymphoproliferative syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the recipient transplanted for lymphoma and XLP?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the recipient transplanted for lymphoma and XLP?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2134r1: X-Linked Lymphoproliferative Syndrome Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3279260</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3279271</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1247">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3361468</PUBLICID>
    <LONGNAME>Human Papilloma Virus Vaccine Quality of Life Condyloma Acuminatum Assessment Type</LONGNAME>
    <PREFERREDNAME>3361444v1.0:3361448v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>a subdivision relating to the subjective measurement of an individual&#39;s sense of well-being and ability to enjoy life as it relates to a sexually transmitted papillary growth caused by the human papillomavirus.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3361444</PublicId>
      <PreferredName>3359930v1.0:3361442v1.0</PreferredName>
      <PreferredDefinition>information relating to the subjective measurement of an individual&#39;s sense of well-being and ability to enjoy life as it relates to a sexually transmitted papillary growth caused by the human papillomavirus.</PreferredDefinition>
      <LongName>Human Papilloma Virus Vaccine Quality of Life Condyloma Acuminatum Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3359930</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1951:C17047</PreferredName>
        <Version>1</Version>
        <LongName>Human Papilloma Virus Vaccine Quality of Life</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1951</PREFERRED_NAME>
            <LONG_NAME>Human Papilloma Virus Vaccine</LONG_NAME>
            <CON_ID>3359929</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17047</PREFERRED_NAME>
            <LONG_NAME>Quality of Life</LONG_NAME>
            <CON_ID>2202504</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3361442</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2960:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Condyloma Acuminatum Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2960</PREFERRED_NAME>
            <LONG_NAME>Condyloma Acuminatum</LONG_NAME>
            <CON_ID>2680337</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AMC CRF:AIDS Malignancy Consortium Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3361448</PublicId>
      <PreferredName>3361448v1.0</PreferredName>
      <PreferredDefinition>a subdivision of a particular kind of thing for quality of life assessment.</PreferredDefinition>
      <LongName>Quality of Life Assessment Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AMC CRF:AIDS Malignancy Consortium Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>False</VALIDVALUE>
          <VALUEMEANING>False</VALUEMEANING>
          <MEANINGDESCRIPTION>Not in accordance with the fact or reality or definitive criteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>True</VALIDVALUE>
          <VALUEMEANING>True</VALUEMEANING>
          <MEANINGDESCRIPTION>Conforming to fact or reality or definitive criteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68850</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Don&#39;t Know</VALIDVALUE>
          <VALUEMEANING>Does Not Know</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Genital warts always go away</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Genital warts always go away permanently if a man gets the right treatment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1248">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3364606</PUBLICID>
    <LONGNAME>Virtual Colonoscopy Outcome Normal/ Abnormal Indicator</LONGNAME>
    <PREFERREDNAME>3363759v1.0:2018775v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An imaging technique of the colon involving helical computed tomography and computer software to generate high-resolution 2-dimensional and 3-dimensional images of the inner surface of the colon. These images are then interpreted by a radiologist to determine the presence of several types of abnormalities of the colon._The result of an action._Text terms to signify if a result or outcome is normal or abnormal.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3363759</PublicId>
      <PreferredName>3364579v1.0:2177339v1.0</PreferredName>
      <PreferredDefinition>An imaging technique of the colon involving helical computed tomography and computer software to generate high-resolution 2-dimensional and 3-dimensional images of the inner surface of the colon. These images are then interpreted by a radiologist to determine the presence of several types of abnormalities of the colon._The result of an action.</PreferredDefinition>
      <LongName>Computed Tomography Colonography Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3364579</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28395</PreferredName>
        <Version>1</Version>
        <LongName>Computed Tomography Colonography</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28395</PREFERRED_NAME>
            <LONG_NAME>Computed Tomography Colonography</LONG_NAME>
            <CON_ID>3364578</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177339</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Result</PreferredName>
        <Version>1</Version>
        <LongName>Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018775</PublicId>
      <PreferredName>NORMAL_ABNORMAL_IND</PreferredName>
      <PreferredDefinition>Text terms to signify if a result or outcome is normal or abnormal.</PreferredDefinition>
      <LongName>Normal/ Abnormal Indicator</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating from the norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline</VALIDVALUE>
          <VALUEMEANING>Borderline</VALUEMEANING>
          <MEANINGDESCRIPTION>Straddling the dividing line between two categories.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not noted</VALIDVALUE>
          <VALUEMEANING>Not noted</VALUEMEANING>
          <MEANINGDESCRIPTION>The finding is not present, but a value of &#39;none&#39; cannot be unequivocally established absence in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48661</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2684793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested</VALIDVALUE>
          <VALUEMEANING>No testing done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a test was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other specify</VALIDVALUE>
          <VALUEMEANING>Other specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Be specific about something; define clearly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal specify</VALIDVALUE>
          <VALUEMEANING>Abnormal specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.: Be specific about something; define clearly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4179872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Undetermined</VALIDVALUE>
          <VALUEMEANING>Undetermined</VALUEMEANING>
          <MEANINGDESCRIPTION>A term referring to the lack of definitive criteria for classification of a finding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5751657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2617835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Results of Virtural Colonosco</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Results of Virtural Colonoscopy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Biospecimen Repository</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3060675</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000190</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1249">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3366912</PUBLICID>
    <LONGNAME>Stem Cell Transplant Day Number</LONGNAME>
    <PREFERREDNAME>2532117v1.0:2896868v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the day of the stem cell transplantation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2532117</PublicId>
      <PreferredName>2531883v1.0:2234856v1.0</PreferredName>
      <PreferredDefinition>Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Hematopoietic Cell Transplantation Occurrence</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2531883</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12551:C15342</PreferredName>
        <Version>1</Version>
        <LongName>Hematopoietic Stem Cell Transplantation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896868</PublicId>
      <PreferredName>EVT_DAY_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._time for Earth to make a complete rotation on its axis._A numeral or string of numerals expressing value, quantity, or identification</PreferredDefinition>
      <LongName>Event Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C0439228:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Day Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0439228</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2204684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>22nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::22: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::22</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>21st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>20th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::20: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>19th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::19: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>18th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::18: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>17th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::17: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>16th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::16: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>15th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::15: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>14th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::14: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>13th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::13: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::10: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::4: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::5: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>31st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::31: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::31</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>30th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::30: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::30</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>29th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::29: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>28th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::28: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>27th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::27: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>26th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::26: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>25th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::25: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>24th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>23rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::23: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day of Stem Cell Transplantat</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Day of Stem Cell Transplantation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLGSP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5655940</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Initial Treatment and Followup Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000268</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1250">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3370377</PUBLICID>
    <LONGNAME>Clinical Study Participant Assignment Begin Date</LONGNAME>
    <PREFERREDNAME>TRT_ARM_ASGN_DATE</PREFERREDNAME>
    <PREFERREDDEFINITION>the assignment of protocol treatment, research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects, for a person where the exchange format is YYYYMMDD, the display format is DDMMMYYYY, with the month display the first three letters of each month (Jan, Feb, Mar, etc.).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRDS</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2672800</PublicId>
      <PreferredName>2672780v1.0:2207412v1.0</PreferredName>
      <PreferredDefinition>Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, mechanism of human diseases, therapy, clinical trials, epidemiology, behavior and health services research.:Someone who takes part in an activity.:An allotting or an appointment to a particular person or use; or for a particular time or object._Have a beginning, in a temporal, spatial, or evaluative sense.:a particular day specified as the time something has, or will, happen.</PreferredDefinition>
      <LongName>Clinical Study Participant Assignment Begin Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2672780</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15206:C29867:C25426</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Study Participant Assignment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29867</PREFERRED_NAME>
            <LONG_NAME>Participant</LONG_NAME>
            <CON_ID>2202627</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25426</PREFERRED_NAME>
            <LONG_NAME>Assignment</LONG_NAME>
            <CON_ID>2204040</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207412</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Begin Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017121</PublicId>
      <PreferredName>CTMS_DT</PreferredName>
      <PreferredDefinition>Date as required for Clinical Trials Monitoring Service submissions.  Exchange format is YYYYMMDD.  Display format is DDMMMYYYY, with the month display the first three letters of each month (Jan, Feb, Mar, etc.).</PreferredDefinition>
      <LongName>CTMS Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>DD/MON/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Intervention/Treatmen</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of Intervention/Treatment Assignment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Question Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of intervention/treatment assignment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDUS Rave Integration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4631915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Data Update System</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000130</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3351909</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>OPEN to Rave Standard Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment Assignment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3351915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5592146</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5612586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6005698</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4631580</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Exceptional Responder CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exceptional Responder CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4631582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858962</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Under Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RAVE Integrations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000092</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858962</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Under Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OPEN</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>TRT_ARM_ASGN_DATE</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TRT_ARM_ASGN_DATE</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRDS</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1251">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3378891</PUBLICID>
    <LONGNAME>Dietary Supplement Multivitamin Use Frequency</LONGNAME>
    <PREFERREDNAME>3378858v1.0:3378861v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of occurrences of a Multivitamin supplement used within a given time period.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>SWOG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3378858</PublicId>
      <PreferredName>3378855v1.0:3378856v1.0</PreferredName>
      <PreferredDefinition>A manner, or usual, or accepted practice of using a dietary supplement containing all or most of the vitamins (multivitamin) that may not be readily available in the diet.</PreferredDefinition>
      <LongName>Dietary Supplement Multivitamin Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SWOG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3378855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1505</PreferredName>
        <Version>1</Version>
        <LongName>Supplements</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1505</PREFERRED_NAME>
            <LONG_NAME>Dietary Supplement</LONG_NAME>
            <CON_ID>2202835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3378856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1654:C25340</PreferredName>
        <Version>1</Version>
        <LongName>Multivitamin Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1654</PREFERRED_NAME>
            <LONG_NAME>Multivitamin</LONG_NAME>
            <CON_ID>2737680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3378861</PublicId>
      <PreferredName>3378861v1.0</PreferredName>
      <PreferredDefinition>The number of occurrences of dietary supplements used within a given time period.</PreferredDefinition>
      <LongName>Dietary Supplement Use Frequency</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SWOG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3378860</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1505:C25340:C25515</PreferredName>
        <Version>1</Version>
        <LongName>Supplements Use Frequency</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1505</PREFERRED_NAME>
            <LONG_NAME>Dietary Supplement</LONG_NAME>
            <CON_ID>2202835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-5 pills per week</VALIDVALUE>
          <VALUEMEANING>2-5 pills per week</VALUEMEANING>
          <MEANINGDESCRIPTION>2-5 pills per week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&lt;= 1 pill per week</VALIDVALUE>
          <VALUEMEANING>&lt;= 1 pill per week</VALUEMEANING>
          <MEANINGDESCRIPTION>&lt;= 1 pill per week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&gt;= 2 pills per day</VALIDVALUE>
          <VALUEMEANING>&gt;= 2 pills per day</VALUEMEANING>
          <MEANINGDESCRIPTION>&gt;= 2 pills per day</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3461153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 pill per day</VALIDVALUE>
          <VALUEMEANING>1 pill per day</VALUEMEANING>
          <MEANINGDESCRIPTION>1 pill per day</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3461154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Estimated frequency of taking</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Estimated frequency of taking each supplement since the previous visit: Multivitamin</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol/Admin.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811961</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1252">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3379640</PUBLICID>
    <LONGNAME>Central Reviewer Submission Timepoint Type</LONGNAME>
    <PREFERREDNAME>Cent_Rev_Subm_Tpoint_TYPE</PREFERREDNAME>
    <PREFERREDDEFINITION>The appraisal, evaluation, or analysis by a single person who critically evaluates and reports on laboratory test results, protocols , or other data at a specific point in the time continuum, including those established relative to an event</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3379633</PublicId>
      <PreferredName>Rpt_Cent_Time_Subm</PreferredName>
      <PreferredDefinition>The appraisal, evaluation, or analysis by a single person who critically evaluates and reports on laboratory test results, protocols , or other data at a specific point in the time continuum, including those established relative to an event.</PreferredDefinition>
      <LongName>Report Central Reviewer Timepoint Submission</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2193110</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Report</PreferredName>
        <Version>1</Version>
        <LongName>Report</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3385924</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C51807:C68568:C25694</PreferredName>
        <Version>1</Version>
        <LongName>Central Reviewer Timepoint Submission</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51807</PREFERRED_NAME>
            <LONG_NAME>Central Reviewer</LONG_NAME>
            <CON_ID>2479758</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68568</PREFERRED_NAME>
            <LONG_NAME>Timepoint</LONG_NAME>
            <CON_ID>2656619</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25694</PREFERRED_NAME>
            <LONG_NAME>Submission</LONG_NAME>
            <CON_ID>2202488</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3379630</PublicId>
      <PreferredName>Eval_Tmpt_Type</PreferredName>
      <PreferredDefinition>A specific point distinguishable as an identifable class in the time continuum, including those established relative to an event.</PreferredDefinition>
      <LongName>Evaluation Timepoint Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>3379629</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C51807:C68568:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Central Reviewer Timepoint Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51807</PREFERRED_NAME>
            <LONG_NAME>Central Reviewer</LONG_NAME>
            <CON_ID>2479758</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68568</PREFERRED_NAME>
            <LONG_NAME>Timepoint</LONG_NAME>
            <CON_ID>2656619</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>After induction cycle 4</VALIDVALUE>
          <VALUEMEANING>After Induction Cycle 4</VALUEMEANING>
          <MEANINGDESCRIPTION>After Induction Cycle 4</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3385925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>After induction cycle 2</VALIDVALUE>
          <VALUEMEANING>After Induction Cycle 2</VALUEMEANING>
          <MEANINGDESCRIPTION>After Induction Cycle 2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3385926</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Baseline</VALIDVALUE>
          <VALUEMEANING>Baseline</VALUEMEANING>
          <MEANINGDESCRIPTION>A starting point to which things may be compared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>After second look surgery</VALIDVALUE>
          <VALUEMEANING>After Second Look Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>After Second Look Surgery</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Completion of induction</VALIDVALUE>
          <VALUEMEANING>completion of induction</VALUEMEANING>
          <MEANINGDESCRIPTION>the completion of the induction phase of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of therapy</VALIDVALUE>
          <VALUEMEANING>End of therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>End of therapy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Relapse</VALIDVALUE>
          <VALUEMEANING>Relapse</VALUEMEANING>
          <MEANINGDESCRIPTION>The return of a disease after a period of remission.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2857244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Second malignant neoplasm</VALIDVALUE>
          <VALUEMEANING>Second Malignant Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Coming next after the first in position in space or time or degree or magnitude.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin&#39;s and non-Hodgkin&#39;s lymphomas, leukemias, melanomas, and sarcomas. -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25666, C9305</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3229262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor progression/recurrence</VALIDVALUE>
          <VALUEMEANING>Tumor progression/recurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>Tumor progression/recurrence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4243571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Week 13</VALIDVALUE>
          <VALUEMEANING>Week 13</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 12 and less than 14 and the quantity that it denotes.: Any period of seven consecutive days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29844, C113427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3630800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Week 10</VALIDVALUE>
          <VALUEMEANING>Week 10</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: Any period of seven consecutive days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29844, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diagnosis</VALIDVALUE>
          <VALUEMEANING>DIAGNOSIS</VALUEMEANING>
          <MEANINGDESCRIPTION>The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Intensification HR Block 3</VALIDVALUE>
          <VALUEMEANING>End of Intensification HR Block 3</VALUEMEANING>
          <MEANINGDESCRIPTION>End of Intensification HR Block 3</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-07-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4411455</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Consolidation</VALIDVALUE>
          <VALUEMEANING>End of Consolidation (prior to start of Post-Consolidation therapy)</VALUEMEANING>
          <MEANINGDESCRIPTION>End of Consolidation (prior to start of Post-Consolidation therapy)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-07-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4411454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Induction</VALIDVALUE>
          <VALUEMEANING>End of Induction</VALUEMEANING>
          <MEANINGDESCRIPTION>End of Induction</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-07-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4411391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Screening</VALIDVALUE>
          <VALUEMEANING>Trial Screening</VALUEMEANING>
          <MEANINGDESCRIPTION>A process of active consideration of potential subjects for enrollment in a trial.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Post-HSCT - Day 100</VALIDVALUE>
          <VALUEMEANING>Post-HSCT - Day 100</VALUEMEANING>
          <MEANINGDESCRIPTION>Post-HSCT - Day 100</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4538496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Post-HSCT - Day 30</VALIDVALUE>
          <VALUEMEANING>Post-HSCT - Day 30</VALUEMEANING>
          <MEANINGDESCRIPTION>Post-HSCT - Day 30</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4538497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pre-HSCT Evaluation</VALIDVALUE>
          <VALUEMEANING>Pre-HSCT Evaluation</VALUEMEANING>
          <MEANINGDESCRIPTION>Pre-HSCT Evaluation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4538498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Evaluation 2</VALIDVALUE>
          <VALUEMEANING>Evaluation 2</VALUEMEANING>
          <MEANINGDESCRIPTION>Evaluation 2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4538499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Evaluation 1</VALIDVALUE>
          <VALUEMEANING>Evaluation 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Evaluation 1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4538500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Definitive surgery</VALIDVALUE>
          <VALUEMEANING>Definitive surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>Definitive surgery</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Interim Maintenance</VALIDVALUE>
          <VALUEMEANING>End of Interim Maintenance</VALUEMEANING>
          <MEANINGDESCRIPTION>End of Interim Maintenance</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5505903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Induction - Day 56</VALIDVALUE>
          <VALUEMEANING>Induction - Day 56</VALUEMEANING>
          <MEANINGDESCRIPTION>Induction - Day 56</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-01-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6059536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Initial diagnosis</VALIDVALUE>
          <VALUEMEANING>Initial Diagnosis</VALUEMEANING>
          <MEANINGDESCRIPTION>occurring at the beginning.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15220, CL052284</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4211287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prior to Maintenance Cycle 5</VALIDVALUE>
          <VALUEMEANING>Prior Cycle Five Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Earlier in time or order.: An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.: A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.: The use of synthetic or naturally-occurring chemicals for the treatment of diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15632, C66836, C25472, C25629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6365860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maintenance Cycle 1</VALIDVALUE>
          <VALUEMEANING>Cycle One Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.: The smallest natural number and quantity it denotes: a single entity, unit, or object.: The use of synthetic or naturally-occurring chemicals for the treatment of diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15632, C66832, C25472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6365196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Progression</VALIDVALUE>
          <VALUEMEANING>Disease Progression</VALUEMEANING>
          <MEANINGDESCRIPTION>The worsening of a disease over time</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Follow-up (10 years)</VALIDVALUE>
          <VALUEMEANING>Ten Year Follow-up</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.: The process by which information about the health status of an individual is obtained after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16033, C29848, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6365847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Follow-up (12 months)</VALIDVALUE>
          <VALUEMEANING>Twelve Month Follow-up</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 11 and less than 13 and the quantity that it denotes.: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The process by which information about the health status of an individual is obtained after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16033, C29846, C113426</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6365242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Follow-up (36 months)</VALIDVALUE>
          <VALUEMEANING>Thirty Six Month Follow-up</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than twenty-nine and less than thirty-one and the quantity that it denotes.: A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The process by which information about the health status of an individual is obtained after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16033, C29846, C66837, C105797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6365848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Follow-up (5 years)</VALIDVALUE>
          <VALUEMEANING>Five Year Follow-up</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.: A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.: The process by which information about the health status of an individual is obtained after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16033, C29848, C66836</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6365849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemoradiotherapy</VALIDVALUE>
          <VALUEMEANING>Chemoradiotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment that combines chemotherapy with radiation therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6349567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Second or later relapse</VALIDVALUE>
          <VALUEMEANING>Subsequent Relapse</VALUEMEANING>
          <MEANINGDESCRIPTION>The reemergence of a disorder as diagnosed by clinical and/or laboratory evidence following two or more documented periods of remission.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6333654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>First relapse</VALIDVALUE>
          <VALUEMEANING>First Relapse</VALUEMEANING>
          <MEANINGDESCRIPTION>The reemergence of a disorder as diagnosed by clinical and/or laboratory evidence following a single documented period of remission.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6333656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prior to Maintenance Cycle 1</VALIDVALUE>
          <VALUEMEANING>Prior Cycle One Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Earlier in time or order.: An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.: The smallest natural number and quantity it denotes: a single entity, unit, or object.: The use of synthetic or naturally-occurring chemicals for the treatment of diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15632, C66832, C25472, C25629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-10-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6475103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Relapse/Progression</VALIDVALUE>
          <VALUEMEANING>Recurrent Disease Progression</VALUEMEANING>
          <MEANINGDESCRIPTION>Either the return of the disease or the progression of the disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-10-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6545345</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Radiotherapy</VALIDVALUE>
          <VALUEMEANING>Post Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Post; occuring after.: use PHOTOTHERAPY, LASER THERAPY, or ULTRAVIOLET THERAPY for therapeutic radiation with visible, laser, or ultraviolet light, respectively.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15313, C38008</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2971678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pre-Operative</VALIDVALUE>
          <VALUEMEANING>Prior To Surgical Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Earlier in time or order.: Used as a function word to indicate direction, purpose, or movement.: A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15329, C65107, C25629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6659704</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Post-Operative</VALIDVALUE>
          <VALUEMEANING>Post Surgical Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Happening at a time subsequent to a reference time; later in time or order.: A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15329, C38008</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2971681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Day 29</VALIDVALUE>
          <VALUEMEANING>Day 29</VALUEMEANING>
          <MEANINGDESCRIPTION>Day 29</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2599706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Day 8</VALIDVALUE>
          <VALUEMEANING>Day 8</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3294261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Consolidation</VALIDVALUE>
          <VALUEMEANING>Consolidation</VALUEMEANING>
          <MEANINGDESCRIPTION>Consolidation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5501075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Induction</VALIDVALUE>
          <VALUEMEANING>Induction</VALUEMEANING>
          <MEANINGDESCRIPTION>Induction</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5544725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Consolidation</VALIDVALUE>
          <VALUEMEANING>End of Consolidation</VALUEMEANING>
          <MEANINGDESCRIPTION>End of Consolidation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6840694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Day 29 of VXLD Reinduction</VALIDVALUE>
          <VALUEMEANING>Day 29 of VXLD Reinduction</VALUEMEANING>
          <MEANINGDESCRIPTION>Day 29 of VXLD Reinduction</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7434503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Day 36 Cycle 2 Immunotherapy</VALIDVALUE>
          <VALUEMEANING>Two Immunotherapy Cycle</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.: Therapy designed to induce changes in a patient&#39;s immune status in order to treat disease.: An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25472, C15262, C66833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7464248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Day 36 Cycle 1 Immunotherapy</VALIDVALUE>
          <VALUEMEANING>One Immunotherapy Cycle</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest natural number and quantity it denotes: a single entity, unit, or object.: Therapy designed to induce changes in a patient&#39;s immune status in order to treat disease.: An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25472, C15262, C66832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7464249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Study Entry</VALIDVALUE>
          <VALUEMEANING>Clinical Study Entry</VALUEMEANING>
          <MEANINGDESCRIPTION>Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.: An item inserted in a written or electronic record.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43381, C15206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-02-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7580749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CNS Necrosis</VALIDVALUE>
          <VALUEMEANING>Necrotic Process Central Nervous System</VALUEMEANING>
          <MEANINGDESCRIPTION>A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.: The part of the nervous system that consists of the brain, spinal cord, and meninges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12438, C16897</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-02-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7580750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Repeat Testing</VALIDVALUE>
          <VALUEMEANING>Repeat Testing</VALUEMEANING>
          <MEANINGDESCRIPTION>Make or do or perform again.: A procedure for critical evaluation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15336, C47886</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7991646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>After repeat Imaging</VALIDVALUE>
          <VALUEMEANING>Post Repeat Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>Happening at a time subsequent to a reference time; later in time or order.: Make or do or perform again.: The data or image obtained by gathering information with a sensing device.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17999, C47886, C38008</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7991667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Primary tumor surgery</VALIDVALUE>
          <VALUEMEANING>Primary Neoplasm Surgical Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>A tumor at the original site of origin._A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15329, C8509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12138322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Relapse/Recurrence</VALIDVALUE>
          <VALUEMEANING>Recurrent Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>The return of a disease after a period of remission.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3828963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autopsy</VALIDVALUE>
          <VALUEMEANING>Autopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Autopsy; an examination and dissection of a dead body to determine cause of death or the changes produced by disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25153</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metastases resection</VALIDVALUE>
          <VALUEMEANING>Metastatic Lesion Resection</VALUEMEANING>
          <MEANINGDESCRIPTION>A tumor arising at a location distant to the primary lesion._The surgical removal of an organ or a part of an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158758, C40557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12138323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metastases</VALIDVALUE>
          <VALUEMEANING>Metastatic Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>A tumor arising at a location distant to the primary lesion.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3860639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Local contral primary</VALIDVALUE>
          <VALUEMEANING>Local contral primary</VALUEMEANING>
          <MEANINGDESCRIPTION>Local contral primary</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12138324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diagnostic</VALIDVALUE>
          <VALUEMEANING>Diagnostic</VALUEMEANING>
          <MEANINGDESCRIPTION>Characteristic or indicative of (e.g., a disease).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25482</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3906453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metastatic site resection</VALIDVALUE>
          <VALUEMEANING>Site of Metastasis Resection</VALUEMEANING>
          <MEANINGDESCRIPTION>The anatomical location where metastasis was detected._The surgical removal of an organ or a part of an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158758, C172233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12138325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regimen A Cycle 1</VALIDVALUE>
          <VALUEMEANING>Regimen A Cycle 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Regimen A Cycle 1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-03-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13168489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regimen A Cycle 2</VALIDVALUE>
          <VALUEMEANING>Regimen A Cycle 2</VALUEMEANING>
          <MEANINGDESCRIPTION>Regimen A Cycle 2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-03-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13168490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regimen A Cycle 3</VALIDVALUE>
          <VALUEMEANING>Regimen A Cycle 3</VALUEMEANING>
          <MEANINGDESCRIPTION>Regimen A Cycle 3</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-03-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13168491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regimen B Cycle 1</VALIDVALUE>
          <VALUEMEANING>Regimen B Cycle 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Regimen B Cycle 1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-03-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13168492</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regimen B Cycle 2</VALIDVALUE>
          <VALUEMEANING>Regimen B Cycle 2</VALUEMEANING>
          <MEANINGDESCRIPTION>Regimen B Cycle 2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-03-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13168493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Refractory disease</VALIDVALUE>
          <VALUEMEANING>Refractory Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A disease that resists treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-03-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4571271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Monotherapy Cycle 2</VALIDVALUE>
          <VALUEMEANING>End of Monotherapy Cycle 2</VALUEMEANING>
          <MEANINGDESCRIPTION>End of Monotherapy Cycle 2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13114849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Monotherapy Cycle 4</VALIDVALUE>
          <VALUEMEANING>End of Monotherapy Cycle 4</VALUEMEANING>
          <MEANINGDESCRIPTION>End of Monotherapy Cycle 4</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13208808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Monotherapy Cycle 8</VALIDVALUE>
          <VALUEMEANING>End of Monotherapy Cycle 8</VALUEMEANING>
          <MEANINGDESCRIPTION>End of Monotherapy Cycle 8</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13208809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Monotherapy Cycle 12</VALIDVALUE>
          <VALUEMEANING>End of Monotherapy Cycle 12</VALUEMEANING>
          <MEANINGDESCRIPTION>End of Monotherapy Cycle 12</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13208810</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Combination Cycle 1</VALIDVALUE>
          <VALUEMEANING>Combination Cycle 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Combination Cycle 1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13230807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Combination Cycle 2</VALIDVALUE>
          <VALUEMEANING>Combination Cycle 2</VALUEMEANING>
          <MEANINGDESCRIPTION>Combination Cycle 2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13230808</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Combination Cycle 3</VALIDVALUE>
          <VALUEMEANING>Combination Cycle 3</VALUEMEANING>
          <MEANINGDESCRIPTION>Combination Cycle 3</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13230809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of VXLD Reinduction</VALIDVALUE>
          <VALUEMEANING>End of VXLD Reinduction</VALUEMEANING>
          <MEANINGDESCRIPTION>End of VXLD Reinduction</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15379702</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monotherapy Cycle 12</VALIDVALUE>
          <VALUEMEANING>Monotherapy Cycle 12</VALUEMEANING>
          <MEANINGDESCRIPTION>Monotherapy Cycle 12</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13230822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monotherapy Cycle 8</VALIDVALUE>
          <VALUEMEANING>Monotherapy Cycle 8</VALUEMEANING>
          <MEANINGDESCRIPTION>Monotherapy Cycle 8</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13230818</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monotherapy Cycle 4</VALIDVALUE>
          <VALUEMEANING>Monotherapy Cycle 4</VALUEMEANING>
          <MEANINGDESCRIPTION>Monotherapy Cycle 4</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13230813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monotherapy Cycle 2</VALIDVALUE>
          <VALUEMEANING>Monotherapy Cycle 2</VALUEMEANING>
          <MEANINGDESCRIPTION>Monotherapy Cycle 2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13230811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Blinatumomab Block 1</VALIDVALUE>
          <VALUEMEANING>End of Blinatumomab Block 1</VALUEMEANING>
          <MEANINGDESCRIPTION>End of Blinatumomab Block 1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16460038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Inotuzumab Ozogamicin Block 1</VALIDVALUE>
          <VALUEMEANING>End of Inotuzumab Ozogamicin Block 1</VALUEMEANING>
          <MEANINGDESCRIPTION>End of Inotuzumab Ozogamicin Block 1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16460037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>End of Consolidation Part 2</VALIDVALUE>
          <VALUEMEANING>End of Consolidation Part 2</VALUEMEANING>
          <MEANINGDESCRIPTION>End of Consolidation Part 2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16460036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Evaluation time point:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Evaluation time point:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Time point:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Review time point:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Time Point:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1253">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3385618</PUBLICID>
    <LONGNAME>Patient Inadequate Renal Function Assessment Ind-2</LONGNAME>
    <PREFERREDNAME>3385608v1.0:2018320v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicates yes / no as to whether a patient has inadequate renal function.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3385608</PublicId>
      <PreferredName>2177068v1.0:3385606v1.0</PreferredName>
      <PreferredDefinition>whether a patient has inadequate renal function</PreferredDefinition>
      <LongName>Patient Inadequate Renal Function Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3385606</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C69177:C25225:C25518:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Inadequate Renal Function Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C69177</PREFERRED_NAME>
            <LONG_NAME>Inadequate</LONG_NAME>
            <CON_ID>2672206</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25225</PREFERRED_NAME>
            <LONG_NAME>Renal</LONG_NAME>
            <CON_ID>2202803</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25518</PREFERRED_NAME>
            <LONG_NAME>Function</LONG_NAME>
            <CON_ID>2202643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has inadequate renal function</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has inadequate renal function or creatinine clearance &lt; 50 ml/min/1.73m2 unless lymphoma related</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1254">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3392470</PUBLICID>
    <LONGNAME>Pharmaceutical Therapy End Less Initial Pathologic Diagnosis Date Calculated Day Value</LONGNAME>
    <PREFERREDNAME>3392455v1.0:3008213v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Time interval from the last day of pharmaceutical treatment to the date of initial pathologic diagnosis, represented as a calculated number of days.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3392455</PublicId>
      <PreferredName>3392453v1.0:2234809v1.0</PreferredName>
      <PreferredDefinition>Treatment of disease through the use of drugs.__The point or place at which something terminates in time, space, or extent._The act of removing a part from the whole._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._the continuum of experience in which events pass from the future through the present to the past._The period of time during which something continues.</PreferredDefinition>
      <LongName>Pharmaceutical Therapy End Subtract Initial Pathologic Diagnosis Time Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3392453</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3392453v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacotherapy End Subtraction Diagnosis Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15986</PREFERRED_NAME>
            <LONG_NAME>Pharmacotherapy</LONG_NAME>
            <CON_ID>2673143</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70590</PREFERRED_NAME>
            <LONG_NAME>Subtraction</LONG_NAME>
            <CON_ID>2710223</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234809</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25330</PreferredName>
        <Version>1</Version>
        <LongName>Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3008213</PublicId>
      <PreferredName>DAY_CALC_VAL</PreferredName>
      <PreferredDefinition>The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours._The procedure or activity of determining something by mathematical or logical methods._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Day Calculation Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>TCGA:The Cancer Genome Atlas</Origin>
      <Representation>
        <PublicId>3008212</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25301:C54125:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Day Calculation Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25301</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2202680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54125</PREFERRED_NAME>
            <LONG_NAME>Calculation</LONG_NAME>
            <CON_ID>2654477</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of Days from Date of I</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of Days from Date of Initial Pathologic Diagnosis to the Date Pharmaceutical Therapy Ended</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <DerivationType>CALCULATED</DerivationType>
      <DerivationTypeDescription>CALCULATED</DerivationTypeDescription>
      <Methods>Date 1 is the concatenation of the component CDE1 to CDE2 to CDE3 to form a date in the format of DDMMYYYY. Date 2 is the concatenation of the component CDE4 to CDE5 to CDE6 to form a date in the format of DDMMYYYY.</Methods>
      <Rule>Calculation is as follows: 1. CDES 1,2,3 are concatenated to create one calendar date for the event referenced (Date1). 2. CDES 4,5,6 are concatenated to create one calendar date for the event referenced (Date2). 3. Values of both dates are converted to milliseconds since the epoch (January 1, 1970) 4. The values of Date2 are subtracted from the value of Date1. 5. The remainder of the subtraction will be divided by the number of milliseconds in a day (86,400,000).</Rule>
      <ConcatenationCharacter/>
      <ComponentDataElementList>
        <ComponentDataElementList_ITEM>
          <PublicId>3103078</PublicId>
          <LongName>Pharmacologic Substance End Occurrence Day Number</LongName>
          <PreferredName>3103076v1.0:2896868v1.0</PreferredName>
          <PreferredDefinition>Numeric value to represent the day that the pharmaceutical therapy ended.</PreferredDefinition>
          <Version>1</Version>
          <WorkflowStatus>RELEASED</WorkflowStatus>
          <ContextName>NCIP</ContextName>
          <DisplayOrder>1</DisplayOrder>
        </ComponentDataElementList_ITEM>
        <ComponentDataElementList_ITEM>
          <PublicId>3103080</PublicId>
          <LongName>Pharmacologic Substance End Occurrence Month Number</LongName>
          <PreferredName>3103076v1.0:2895904v1.0</PreferredName>
          <PreferredDefinition>Numeric value to represent the month that the pharmaceutical therapy ended</PreferredDefinition>
          <Version>1</Version>
          <WorkflowStatus>RELEASED</WorkflowStatus>
          <ContextName>NCIP</ContextName>
          <DisplayOrder>2</DisplayOrder>
        </ComponentDataElementList_ITEM>
        <ComponentDataElementList_ITEM>
          <PublicId>3103082</PublicId>
          <LongName>Pharmacologic Substance End Occurrence Year Number</LongName>
          <PreferredName>3103076v1.0:2896906v1.0</PreferredName>
          <PreferredDefinition>Numeric value to represent the year that the pharmaceutical therapy ended.</PreferredDefinition>
          <Version>1</Version>
          <WorkflowStatus>RELEASED</WorkflowStatus>
          <ContextName>NCIP</ContextName>
          <DisplayOrder>3</DisplayOrder>
        </ComponentDataElementList_ITEM>
        <ComponentDataElementList_ITEM>
          <PublicId>2896958</PublicId>
          <LongName>Day Cancer Initial Diagnosis Number</LongName>
          <PreferredName>DAY_CA_INIT_DX_NUM</PreferredName>
          <PreferredDefinition>Numeric value to represent the day of an individual&#39;s initial pathologic diagnosis of cancer.</PreferredDefinition>
          <Version>1</Version>
          <WorkflowStatus>RELEASED</WorkflowStatus>
          <ContextName>NCIP</ContextName>
          <DisplayOrder>4</DisplayOrder>
        </ComponentDataElementList_ITEM>
        <ComponentDataElementList_ITEM>
          <PublicId>2896956</PublicId>
          <LongName>Month Cancer Initial Diagnosis Number</LongName>
          <PreferredName>MON_CA_INIT_DX_NUM</PreferredName>
          <PreferredDefinition>Numeric value to represent the month of an individual&#39;s initial pathologic diagnosis of cancer.</PreferredDefinition>
          <Version>1</Version>
          <WorkflowStatus>RELEASED</WorkflowStatus>
          <ContextName>NCIP</ContextName>
          <DisplayOrder>5</DisplayOrder>
        </ComponentDataElementList_ITEM>
        <ComponentDataElementList_ITEM>
          <PublicId>2896960</PublicId>
          <LongName>Year Cancer Initial Diagnosis Number</LongName>
          <PreferredName>YR_CA_INIT_DX_NUM</PreferredName>
          <PreferredDefinition>Numeric value to represent the year of an individual&#39;s initial pathologic diagnosis of cancer.</PreferredDefinition>
          <Version>1</Version>
          <WorkflowStatus>RELEASED</WorkflowStatus>
          <ContextName>NCIP</ContextName>
          <DisplayOrder>6</DisplayOrder>
        </ComponentDataElementList_ITEM>
      </ComponentDataElementList>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1255">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3103078</PUBLICID>
    <LONGNAME>Pharmacologic Substance End Occurrence Day Number</LONGNAME>
    <PREFERREDNAME>3103076v1.0:2896868v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the day that the pharmaceutical therapy ended.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3103076</PublicId>
      <PreferredName>2437803v1.0:2598135v1.0</PreferredName>
      <PreferredDefinition>An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b))._information related to the end date or occurrence of chemotherapy.</PreferredDefinition>
      <LongName>Pharmacologic Substance End Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437803</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1909</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacologic Substance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1909</PREFERRED_NAME>
            <LONG_NAME>Pharmacologic Substance</LONG_NAME>
            <CON_ID>2437691</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2598135</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25496:C25275</PreferredName>
        <Version>1</Version>
        <LongName>End Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896868</PublicId>
      <PreferredName>EVT_DAY_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._time for Earth to make a complete rotation on its axis._A numeral or string of numerals expressing value, quantity, or identification</PreferredDefinition>
      <LongName>Event Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C0439228:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Day Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0439228</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2204684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>22nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::22: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::22</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>21st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>20th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::20: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>19th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::19: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>18th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::18: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>17th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::17: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>16th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::16: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>15th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::15: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>14th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::14: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>13th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::13: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::10: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::4: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::5: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>31st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::31: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::31</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>30th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::30: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::30</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>29th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::29: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>28th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::28: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>27th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::27: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>26th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::26: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>25th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::25: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>24th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>23rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::23: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day of Therapy End</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Day of Therapy End</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLGSP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5655940</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Initial Treatment and Followup Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000268</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>day_of_drug_therapy_end</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1256">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3103080</PUBLICID>
    <LONGNAME>Pharmacologic Substance End Occurrence Month Number</LONGNAME>
    <PREFERREDNAME>3103076v1.0:2895904v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the month that the pharmaceutical therapy ended</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3103076</PublicId>
      <PreferredName>2437803v1.0:2598135v1.0</PreferredName>
      <PreferredDefinition>An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b))._information related to the end date or occurrence of chemotherapy.</PreferredDefinition>
      <LongName>Pharmacologic Substance End Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437803</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1909</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacologic Substance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1909</PREFERRED_NAME>
            <LONG_NAME>Pharmacologic Substance</LONG_NAME>
            <CON_ID>2437691</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2598135</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25496:C25275</PreferredName>
        <Version>1</Version>
        <LongName>End Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2895904</PublicId>
      <PreferredName>EVT_MON_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks._A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Event Month Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2895903</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C29846:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Month Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>One of ten equal parts; a quantity corresponding to one tenth of the whole.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C81010</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the fifth position in an ordering or series; coming next after the fifth and just before the seventh in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54568</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the fourth position in an ordering or series; coming next after the fourth and just before the sixth in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54567</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the third position in an ordering or series; coming next after the third and just before the fifth in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the second position in an ordering or series.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Coming next after the first in position in space or time or degree or magnitude.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Preceding all others in time or space or degree.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Month of Therapy End</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Month of Therapy End</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLGSP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5655940</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Initial Treatment and Followup Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000268</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>month_of_drug_therapy_end</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1257">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3103082</PUBLICID>
    <LONGNAME>Pharmacologic Substance End Occurrence Year Number</LONGNAME>
    <PREFERREDNAME>3103076v1.0:2896906v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the year that the pharmaceutical therapy ended.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3103076</PublicId>
      <PreferredName>2437803v1.0:2598135v1.0</PreferredName>
      <PreferredDefinition>An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b))._information related to the end date or occurrence of chemotherapy.</PreferredDefinition>
      <LongName>Pharmacologic Substance End Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437803</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1909</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacologic Substance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1909</PREFERRED_NAME>
            <LONG_NAME>Pharmacologic Substance</LONG_NAME>
            <CON_ID>2437691</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2598135</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25496:C25275</PreferredName>
        <Version>1</Version>
        <LongName>End Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896906</PublicId>
      <PreferredName>EVT_YR_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._The period of time that it takes for Earth to make a complete revolution around the sun; a period of time containing 365 days._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.</PreferredDefinition>
      <LongName>Event Year Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY </DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896905</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C29848:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Year Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29848</PREFERRED_NAME>
            <LONG_NAME>Year</LONG_NAME>
            <CON_ID>2203986</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Year of Therapy end</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Year of Therapy end</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Initial Treatment and Followup Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000268</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655968</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HTMCP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HTMCP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000067</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>year_of_drug_therapy_end</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1258">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2896958</PUBLICID>
    <LONGNAME>Day Cancer Initial Diagnosis Number</LONGNAME>
    <PREFERREDNAME>DAY_CA_INIT_DX_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the day of an individual&#39;s initial pathologic diagnosis of cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189807</PublicId>
      <PreferredName>CA_INIT_DX</PreferredName>
      <PreferredDefinition>information related to first or initial diagnosis of cancer.</PreferredDefinition>
      <LongName>Cancer Initial Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2186369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207337</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C15220</PreferredName>
        <Version>1</Version>
        <LongName>First Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896868</PublicId>
      <PreferredName>EVT_DAY_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._time for Earth to make a complete rotation on its axis._A numeral or string of numerals expressing value, quantity, or identification</PreferredDefinition>
      <LongName>Event Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C0439228:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Day Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0439228</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2204684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>22nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::22: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::22</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>21st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>20th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::20: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>19th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::19: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>18th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::18: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>17th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::17: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>16th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::16: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>15th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::15: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>14th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::14: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>13th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::13: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::10: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::4: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::5: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>31st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::31: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::31</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>30th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::30: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::30</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>29th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::29: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>28th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::28: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>27th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::27: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>26th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::26: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>25th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::25: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>24th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>23rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::23: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day of initial pathologic dia</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Day of initial pathologic diagnosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTSP Question</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Day of Initial Pathologic Diagnosis of Primary Tumor</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLGSP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5655940</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Initial Treatment and Followup Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000268</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Enrollment Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000269</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>day_of_initial_pathologic_diagnosis</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>day_of_initial_pathologic_diagnosis</AlternateName>
        <AlternateNameType>HCMI Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1259">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2896956</PUBLICID>
    <LONGNAME>Month Cancer Initial Diagnosis Number</LONGNAME>
    <PREFERREDNAME>MON_CA_INIT_DX_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the month of an individual&#39;s initial pathologic diagnosis of cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189807</PublicId>
      <PreferredName>CA_INIT_DX</PreferredName>
      <PreferredDefinition>information related to first or initial diagnosis of cancer.</PreferredDefinition>
      <LongName>Cancer Initial Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2186369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207337</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C15220</PreferredName>
        <Version>1</Version>
        <LongName>First Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2895904</PublicId>
      <PreferredName>EVT_MON_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks._A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Event Month Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2895903</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C29846:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Month Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>One of ten equal parts; a quantity corresponding to one tenth of the whole.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C81010</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the fifth position in an ordering or series; coming next after the fifth and just before the seventh in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54568</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the fourth position in an ordering or series; coming next after the fourth and just before the sixth in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54567</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the third position in an ordering or series; coming next after the third and just before the fifth in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the second position in an ordering or series.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Coming next after the first in position in space or time or degree or magnitude.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Preceding all others in time or space or degree.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Month of initial pathologic d</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Month of initial pathologic diagnosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTSP Question</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Month of Initial Pathologic Diagnosis of Primary Tumor</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLGSP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5655940</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Initial Treatment and Followup Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000268</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Enrollment Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000269</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>month_of_initial_pathologic_diagnosis</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>month_of_initial_pathologic_diagnosis</AlternateName>
        <AlternateNameType>HCMI Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1260">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2896960</PUBLICID>
    <LONGNAME>Year Cancer Initial Diagnosis Number</LONGNAME>
    <PREFERREDNAME>YR_CA_INIT_DX_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent the year of an individual&#39;s initial pathologic diagnosis of cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189807</PublicId>
      <PreferredName>CA_INIT_DX</PreferredName>
      <PreferredDefinition>information related to first or initial diagnosis of cancer.</PreferredDefinition>
      <LongName>Cancer Initial Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2186369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9305</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207337</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C15220</PreferredName>
        <Version>1</Version>
        <LongName>First Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896906</PublicId>
      <PreferredName>EVT_YR_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._The period of time that it takes for Earth to make a complete revolution around the sun; a period of time containing 365 days._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.</PreferredDefinition>
      <LongName>Event Year Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY </DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896905</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C29848:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Year Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29848</PREFERRED_NAME>
            <LONG_NAME>Year</LONG_NAME>
            <CON_ID>2203986</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Year of initial pathologic di</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Year of initial pathologic diagnosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>TARGET Alternate Question</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Year of Diagnosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTSP Question</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Year of Initial Pathologic Diagnosis of Primary Tumor</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-Core-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Year of diagnosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-Template Name</Name>
        <DocumentType>Data Collection Template</DocumentType>
        <DocumentText>clinicalcore_v0-1_template-1</DocumentText>
        <URL>https://mcl.nci.nih.gov/resources/standards/mcl-cdes</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-1</Name>
        <DocumentType>Coding Instructions</DocumentType>
        <DocumentText>Refers to current cancer.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3124057</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Sarcoma Database</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma Database CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3124058</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5271073</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MCL Core</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient History</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6357645</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5271073</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MCL Core</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7537143</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5650570</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TARGET</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ALL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5650571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5650570</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TARGET</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5650572</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5650570</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TARGET</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NBL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5650574</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5650570</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TARGET</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5650575</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655939</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BLGSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Enrollment Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000269</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>year_of_initial_pathologic_diagnosis</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>year_of_initial_pathologic_diagnosis</AlternateName>
        <AlternateNameType>HCMI Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>MCL</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>MCL</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>year_of_diagnosis</AlternateName>
        <AlternateNameType>MCL Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1261">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3408544</PUBLICID>
    <LONGNAME>Chemotherapy Quality of Life Clinical Study Treatment Regimen Ind-2</LONGNAME>
    <PREFERREDNAME>Chem_Qual_Clin_Trea_TX_IND-2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to the subjective measurement of an individual&#39;s sense of well-being and ability to enjoy life based upon the use of synthetic or naturally-occurring chemicals for the treatment of diseases for research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3408129</PublicId>
      <PreferredName>Chem_Qual_Clin_Trea</PreferredName>
      <PreferredDefinition>The subjective measurement of an individual&#39;s sense of well-being and ability to enjoy life based upon the use of synthetic or naturally-occurring chemicals for the treatment of diseases for research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects.</PreferredDefinition>
      <LongName>Chemotherapy Quality of Life Clinical Study Treatment Regimen</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3342936</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15632:C17047</PreferredName>
        <Version>1</Version>
        <LongName>Chemotherapy Quality of Life</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15632</PREFERRED_NAME>
            <LONG_NAME>Chemotherapy</LONG_NAME>
            <CON_ID>2202708</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17047</PREFERRED_NAME>
            <LONG_NAME>Quality of Life</LONG_NAME>
            <CON_ID>2202504</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3407734</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15206:C15697</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Study Treatment Regimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15697</PREFERRED_NAME>
            <LONG_NAME>Treatment Regimen</LONG_NAME>
            <CON_ID>2203773</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Are you currently using chemo</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Are you currently using chemotherapy treatment on study?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0275</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104991</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Chem_Qual_Clin_Trea_TX_IND-2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1262">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3419026</PUBLICID>
    <LONGNAME>Tooth Dentin Hypersensitivity Present Code</LONGNAME>
    <PREFERREDNAME>3419003v1.0:2404907v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The identification number of a tooth with dentin hypersensitivity present</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PRECEDENT CRF:Practice-based Research Collaborative in Evidence-Based Dentistry Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3419003</PublicId>
      <PreferredName>2514269v1.0:3419001v1.0</PreferredName>
      <PreferredDefinition>the presence of dentin hypersensitivity on a tooth</PreferredDefinition>
      <LongName>Tooth Dentin Hypersensitivity Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2514269</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12506</PreferredName>
        <Version>1</Version>
        <LongName>Tooth</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12506</PREFERRED_NAME>
            <LONG_NAME>Tooth</LONG_NAME>
            <CON_ID>2202581</CON_ID>
            <DEFINITION_SOURCE>UWDA142</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3419001</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C32453:C3114:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Dentin Hypersensitivity Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C32453</PREFERRED_NAME>
            <LONG_NAME>Dentin</LONG_NAME>
            <CON_ID>2503715</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3114</PREFERRED_NAME>
            <LONG_NAME>Hypersensitivity</LONG_NAME>
            <CON_ID>2203756</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PRECEDENT CRF:Practice-based Research Collaborative in Evidence-Based Dentistry Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2404907</PublicId>
      <PreferredName>NLT_DNTN_CD</PreferredName>
      <PreferredDefinition>The values and value meanings for tooth designation.</PreferredDefinition>
      <LongName>National Dentition Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2407197</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13072:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Dentition Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13072</PREFERRED_NAME>
            <LONG_NAME>Dentition</LONG_NAME>
            <CON_ID>2404901</CON_ID>
            <DEFINITION_SOURCE>MeSH</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>3rd molar (wisdom tooth) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>3rd molar (wisdom tooth) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>1st molar (6-yr. molar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>1st molar (6-yr. molar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd molar (12-yr. molar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd molar (12-yr. molar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>1st molar (6-yr. molar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>1st molar (6-yr. molar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>2nd bicuspid (2nd premolar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd bicuspid (2nd premolar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>1st bicuspid (1st premolar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>1st bicuspid (1st premolar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>cuspid (canine/eye tooth) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>cuspid (canine/eye tooth) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>lateral incisor permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>central incisor permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>central incisor permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>lateral incisor permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>cuspid (canine/eye tooth) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>cuspid (canine/eye tooth) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>1st bicuspid (1st premolar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>1st bicuspid (1st premolar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>2nd bicuspid (2nd premolar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd bicuspid (2nd premolar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>2nd molar (12-yr. molar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd molar (12-yr. molar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>3rd molar (wisdom tooth) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>3rd molar (wisdom tooth) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>3rd molar (wisdom tooth) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>3rd molar (wisdom tooth) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>2nd molar (12-yr. molar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd molar (12-yr. molar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>1st molar (6-yr. molar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>1st molar (6-yr. molar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>2nd bicuspid (2nd premolar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd bicuspid (2nd premolar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>1st bicuspid (1st premolar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>1st bicuspid (1st premolar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>cuspid (canine/eye tooth) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>cuspid (canine/eye tooth) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>lateral incisor permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>central incisor permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>central incisor permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>lateral incisor permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>cuspid (canine/eye tooth) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>cuspid (canine/eye tooth) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>1st bicuspid (1st premolar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>1st bicuspid (1st premolar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>2nd bicuspid (2nd premolar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd bicuspid (2nd premolar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>1st molar (6-yr. molar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>1st molar (6-yr. molar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>2nd molar (12-yr. molar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>2nd molar (12-yr. molar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>32</VALIDVALUE>
          <VALUEMEANING>3rd molar (wisdom tooth) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>3rd molar (wisdom tooth) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>51</VALIDVALUE>
          <VALUEMEANING>supernumerary 3rd molar (wisdom tooth) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 3rd molar (wisdom tooth) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>52</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd molar (12-yr. molar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd molar (12-yr. molar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>53</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st molar (6-yr. molar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st molar (6-yr. molar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>54</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd bicuspid (2nd premolar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd bicuspid (2nd premolar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>55</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st bicuspid (1st premolar) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st bicuspid (1st premolar) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>56</VALIDVALUE>
          <VALUEMEANING>supernumerary cuspid (canine/eye tooth) permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary cuspid (canine/eye tooth) permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>57</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>58</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor permanent arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor permanent arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>59</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>60</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>61</VALIDVALUE>
          <VALUEMEANING>supernumerary cuspid (canine/eye tooth) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary cuspid (canine/eye tooth) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>62</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st bicuspid (1st premolar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st bicuspid (1st premolar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>63</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd bicuspid (2nd premolar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd bicuspid (2nd premolar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>64</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st molar (6-yr. molar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st molar (6-yr. molar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>65</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd molar (12-yr. molar) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd molar (12-yr. molar) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>66</VALIDVALUE>
          <VALUEMEANING>supernumerary 3rd molar (wisdom tooth) permanent arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 3rd molar (wisdom tooth) permanent arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>67</VALIDVALUE>
          <VALUEMEANING>supernumerary 3rd molar (wisdom tooth) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 3rd molar (wisdom tooth) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>68</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd molar (12-yr. molar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd molar (12-yr. molar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>69</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st molar (6-yr. molar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st molar (6-yr. molar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>70</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd bicuspid (2nd premolar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd bicuspid (2nd premolar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>71</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st bicuspid (1st premolar) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st bicuspid (1st premolar) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>72</VALIDVALUE>
          <VALUEMEANING>supernumerary cuspid (canine/eye tooth) permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary cuspid (canine/eye tooth) permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>73</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576217</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>74</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor permanent arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor permanent arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>75</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor permanent arch  lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor permanent arch  lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>76</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>77</VALIDVALUE>
          <VALUEMEANING>supernumerary cuspid (canine/eye tooth) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary cuspid (canine/eye tooth) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>78</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st bicuspid (1st premolar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st bicuspid (1st premolar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>79</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd bicuspid (2nd premolar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd bicuspid (2nd premolar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>80</VALIDVALUE>
          <VALUEMEANING>supernumerary 1st molar (6-yr. molar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 1st molar (6-yr. molar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>81</VALIDVALUE>
          <VALUEMEANING>supernumerary 2nd molar (12-yr. molar) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 2nd molar (12-yr. molar) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>82</VALIDVALUE>
          <VALUEMEANING>supernumerary 3rd molar (wisdom tooth) permanent arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary 3rd molar (wisdom tooth) permanent arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A</VALIDVALUE>
          <VALUEMEANING>second molar primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>second molar primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>B</VALIDVALUE>
          <VALUEMEANING>first molar primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>first molar primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>C</VALIDVALUE>
          <VALUEMEANING>canine(cuspid) primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>canine(cuspid) primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D</VALIDVALUE>
          <VALUEMEANING>lateral incisor primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576230</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>E</VALIDVALUE>
          <VALUEMEANING>central incisor primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>F</VALIDVALUE>
          <VALUEMEANING>central incisor primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>G</VALIDVALUE>
          <VALUEMEANING>lateral incisor primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>H</VALIDVALUE>
          <VALUEMEANING>canine (cuspid) primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>canine (cuspid) primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I</VALIDVALUE>
          <VALUEMEANING>first molar primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>first molar primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576235</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>J</VALIDVALUE>
          <VALUEMEANING>second molar primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>second molar primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>K</VALIDVALUE>
          <VALUEMEANING>second molar primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>second molar primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L</VALIDVALUE>
          <VALUEMEANING>first molar primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>first molar primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>M</VALIDVALUE>
          <VALUEMEANING>canine (cuspid) primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>canine (cuspid) primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>lateral incisor primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>O</VALIDVALUE>
          <VALUEMEANING>central incisor primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576241</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>P</VALIDVALUE>
          <VALUEMEANING>central incisor primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>central incisor primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Q</VALIDVALUE>
          <VALUEMEANING>lateral incisor primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>lateral incisor primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>R</VALIDVALUE>
          <VALUEMEANING>canine (cuspid) primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>canine (cuspid) primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>S</VALIDVALUE>
          <VALUEMEANING>first molar primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>first molar primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T</VALIDVALUE>
          <VALUEMEANING>second molar primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>second molar primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AS</VALIDVALUE>
          <VALUEMEANING>supernumerary second molar primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary second molar primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BS</VALIDVALUE>
          <VALUEMEANING>supernumerary first molar primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary first molar primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CS</VALIDVALUE>
          <VALUEMEANING>supernumerary canine(cuspid) primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary canine(cuspid) primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DS</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ES</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor primary arch upper right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor primary arch upper right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576251</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FS</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GS</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576253</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HS</VALIDVALUE>
          <VALUEMEANING>supernumerary canine (cuspid) primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary canine (cuspid) primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IS</VALIDVALUE>
          <VALUEMEANING>supernumerary first molar primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary first molar primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JS</VALIDVALUE>
          <VALUEMEANING>supernumerary second molar primary arch upper left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary second molar primary arch upper left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KS</VALIDVALUE>
          <VALUEMEANING>supernumerary second molar primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary second molar primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LS</VALIDVALUE>
          <VALUEMEANING>supernumerary first molar primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary first molar primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MS</VALIDVALUE>
          <VALUEMEANING>supernumerary canine (cuspid) primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary canine (cuspid) primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576259</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NS</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OS</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor primary arch lower left</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor primary arch lower left</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PS</VALIDVALUE>
          <VALUEMEANING>supernumerary central incisor primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary central incisor primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>QS</VALIDVALUE>
          <VALUEMEANING>supernumerary lateral incisor primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary lateral incisor primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576263</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RS</VALIDVALUE>
          <VALUEMEANING>supernumerary canine (cuspid) primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary canine (cuspid) primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SS</VALIDVALUE>
          <VALUEMEANING>supernumerary first molar primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary first molar primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TS</VALIDVALUE>
          <VALUEMEANING>supernumerary second molar primary arch lower right</VALUEMEANING>
          <MEANINGDESCRIPTION>supernumerary second molar primary arch lower right</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-09-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Select tooth with presence of</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Select tooth with presence of dentin hypersensitivity:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1263">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3427611</PUBLICID>
    <LONGNAME>New Neoplasm Event Additional Surgical Procedure Indicator</LONGNAME>
    <PREFERREDNAME>3427412v1.0:2182115v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator to signify whether or not an additional surgery was performed for the new tumor event.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3427412</PublicId>
      <PreferredName>3108264v1.0:3427410v1.0</PreferredName>
      <PreferredDefinition>New; having no previous example or precedent or parallel._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Something that happens at a given place and time._Added; extra; further._A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.</PreferredDefinition>
      <LongName>New Neoplasm Event Additional Surgical Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3108264</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25586:C3262</PreferredName>
        <Version>1</Version>
        <LongName>New Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25586</PREFERRED_NAME>
            <LONG_NAME>New</LONG_NAME>
            <CON_ID>2204982</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3427410</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25406:C15329:C25499</PreferredName>
        <Version>1</Version>
        <LongName>Additional Surgical Procedure Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25406</PREFERRED_NAME>
            <LONG_NAME>Additional</LONG_NAME>
            <CON_ID>2206153</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2182115</PublicId>
      <PreferredName>Y_N_U_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes, No, or Unknown to represent a condition.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Additional Surgery for New Tu</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Additional Surgery for New Tumor Event</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>new_tumor_event_additional_surgery_procedure</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1264">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3431404</PUBLICID>
    <LONGNAME>Lymphoma Central Nervous System Other Cancer Progression Specify</LONGNAME>
    <PREFERREDNAME>PDOTHERSP</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify alterations at the molecular level result in a more aggressive cytologic and phenotypic profile and clinical course of a malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes involving the part of the nervous system that consists of the brain, spinal cord, and meninges yet occurring at a site different than the one(s) previously specified or mentioned.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3431332</PublicId>
      <PreferredName>2475110v1.0:3436749v1.0</PreferredName>
      <PreferredDefinition>information related to alterations at the molecular level result in a more aggressive cytologic and phenotypic profile and clinical course of a malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes involving the part of the nervous system that consists of the brain, spinal cord, and meninges yet occurring at a site different than the one(s) previously specified or mentioned.</PreferredDefinition>
      <LongName>Lymphoma Central Nervous System Other Cancer Progression</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2475110</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3208</PreferredName>
        <Version>1</Version>
        <LongName>Lymphoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3208</PREFERRED_NAME>
            <LONG_NAME>Lymphoma</LONG_NAME>
            <CON_ID>2202736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3436749</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12438:C17649:C19987</PreferredName>
        <Version>1</Version>
        <LongName>Central Nervous System Other Cancer Progression</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12438</PREFERRED_NAME>
            <LONG_NAME>Central Nervous System</LONG_NAME>
            <CON_ID>2202492</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19987</PREFERRED_NAME>
            <LONG_NAME>Cancer Progression</LONG_NAME>
            <CON_ID>2552423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2226669</PublicId>
      <PreferredName>ANATSITE_SPEC</PreferredName>
      <PreferredDefinition>the free text field to specify an anatomic site.</PreferredDefinition>
      <LongName>Anatomic Site Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If other, Specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If other, Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1265">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3440218</PUBLICID>
    <LONGNAME>Esophageal Columnar Metaplasia Present Indicator</LONGNAME>
    <PREFERREDNAME>3440142v1.0:2182115v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator to signify whether or not esophageal columnar metaplasia is present.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3440142</PublicId>
      <PreferredName>3440140v1.0:2233878v1.0</PreferredName>
      <PreferredDefinition>Of or relating to the esophagus._A morphologic finding indicating the transformation of non-columnar epithelial cells into columnar cells._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Esophageal Columnar Metaplasia Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3440140</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37950:C35846</PreferredName>
        <Version>1</Version>
        <LongName>Esophageal Columnar Metaplasia</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37950</PREFERRED_NAME>
            <LONG_NAME>Esophageal</LONG_NAME>
            <CON_ID>2202496</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C35846</PREFERRED_NAME>
            <LONG_NAME>Columnar Metaplasia</LONG_NAME>
            <CON_ID>3440139</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2182115</PublicId>
      <PreferredName>Y_N_U_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes, No, or Unknown to represent a condition.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Esophageal Columnar Metaplasi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Esophageal Columnar Metaplasia Present</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>HCMI Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Esophageal columnar metaplasia present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5428034</PublicId>
          <ContextName>GDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000695</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Esophageal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5806865</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>esophageal_columnar_metaplasia_present</AlternateName>
        <AlternateNameType>HCMI Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>GDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GDC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>GDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>esophageal_columnar_metaplasia_present</AlternateName>
        <AlternateNameType>GDC_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1266">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3534600</PUBLICID>
    <LONGNAME>Clinical Trial Participation Treatment Prior To Screening Completion Reason</LONGNAME>
    <PREFERREDNAME>3534583v1.0:3534585v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Explanatory term for the reason a patient who was eligible for a clinical trial started treatment prior to completion of trial screening.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3534583</PublicId>
      <PreferredName>2821304v1.0:3534581v1.0</PreferredName>
      <PreferredDefinition>A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, and preventive care._A doctor; a person who has been educated, trained, and licensed to practice the art and science of medicine; a practitioner of medicine, as contrasted with a surgeon._An operation in which a term denies or inverts the meaning of another term or construction._A period in a clinical study during which subjects receive therapeutic treatment._Earlier in time or order._A systematic examination or assessment._To possess every necessary or normal part or component or step; having come or been brought to a conclusion._A proposal offered for acceptance or rejection.</PreferredDefinition>
      <LongName>Clinical Trial Participation Treatment Prior To Screening Completion</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2821304</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71104:C25608</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Participation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71104</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial</LONG_NAME>
            <CON_ID>2735720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25608</PREFERRED_NAME>
            <LONG_NAME>Participation</LONG_NAME>
            <CON_ID>2206339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3534581</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3534581v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure Prior Screening Complete Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48261</PREFERRED_NAME>
            <LONG_NAME>Screening</LONG_NAME>
            <CON_ID>2437683</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25250</PREFERRED_NAME>
            <LONG_NAME>Complete</LONG_NAME>
            <CON_ID>2203885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3534585</PublicId>
      <PreferredName>3534585v1.0</PreferredName>
      <PreferredDefinition>An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._Earlier in time or order._A systematic examination or assessment._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Therapeutic Procedure Prior To Screening Completion Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3534584</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236:C25629:C48261:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure Prior Screening Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48261</PREFERRED_NAME>
            <LONG_NAME>Screening</LONG_NAME>
            <CON_ID>2437683</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Insufficient medical records at time of screening</VALIDVALUE>
          <VALUEMEANING>Insufficient medical records at time of screening</VALUEMEANING>
          <MEANINGDESCRIPTION>Insufficient medical records at time of screening</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3534593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recurring patient/not new patient</VALIDVALUE>
          <VALUEMEANING>Recurring patient/not new patient</VALUEMEANING>
          <MEANINGDESCRIPTION>Recurring patient/not new patient</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3534594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient not referred to the research team</VALIDVALUE>
          <VALUEMEANING>Patient not referred to the research team</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient not referred to the research team</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3534595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urgency to initiate treatment</VALIDVALUE>
          <VALUEMEANING>Urgency to initiate treatment</VALUEMEANING>
          <MEANINGDESCRIPTION>Urgency to initiate treatment</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3534586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If the patient was not captur</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If the patient was not captured prior to starting treatment, indicate reason why (select only one)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3533741</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCORP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Screening and Accrual Log</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3533742</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1267">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3534761</PUBLICID>
    <LONGNAME>Tumor Location And/Or Extension Inhibit Effective Interstitial Illumination Photodynamic Therapy Indicator</LONGNAME>
    <PREFERREDNAME>3534615v1.0:2181608v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text indicator to signify whether or not the location and extension of the tumor precludes an effective illumination of interstitial photodynamic therapy (I-PDT).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3534615</PublicId>
      <PreferredName>2404687v1.0:3534613v1.0</PreferredName>
      <PreferredDefinition>A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._A position, site, or point in space where something can be found._Used to indicate that either or both of two items or options may be valid._To increase in length or duration._The interference with or prevention of an action or response even though the stimulus for that action or response is present._Existing in fact and ready for service._Photodynamic therapy used to treat deep-seated solid tumors.</PreferredDefinition>
      <LongName>Tumor Location And/Or Extend Inhibit Effective Interstitial Illumination Photodynamic Therapy</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404687</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3262</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3534613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3534613v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Location And/Or Extend Inhibition Effective Interstitial Illumination Photodynamic Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48928</PREFERRED_NAME>
            <LONG_NAME>And/Or</LONG_NAME>
            <CON_ID>2431163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25270</PREFERRED_NAME>
            <LONG_NAME>Extend</LONG_NAME>
            <CON_ID>2203922</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42791</PREFERRED_NAME>
            <LONG_NAME>Inhibition</LONG_NAME>
            <CON_ID>2224031</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49287</PREFERRED_NAME>
            <LONG_NAME>Effective</LONG_NAME>
            <CON_ID>2790040</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102743</PREFERRED_NAME>
            <LONG_NAME>Interstitial Photodynamic Therapy</LONG_NAME>
            <CON_ID>3534580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181608</PublicId>
      <PreferredName>Y_N_CHAR_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Character Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>The location and extension of</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>The location and extension of the tumor precludes an effective I-PDT</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1268">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3536393</PUBLICID>
    <LONGNAME>Anal Squamous Cell Carcinoma (SCC) Histologic Subtype Name</LONGNAME>
    <PREFERREDNAME>3536330v1.0:3536346v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text name for the histologic subtype used to refine a diagnosis of anal squamous cell carcinoma (SCC).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HTMCP:HIV+ Tumor Molecular Characterization Project</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3536330</PublicId>
      <PreferredName>3536328v1.0:2207639v1.0</PreferredName>
      <PreferredDefinition>The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded._A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma._A group forming a type within a larger type.</PreferredDefinition>
      <LongName>Anal Squamous Cell Carcinoma Histologic Subtype</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3536328</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43362:C2929</PreferredName>
        <Version>1</Version>
        <LongName>Anus Squamous Cell Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43362</PREFERRED_NAME>
            <LONG_NAME>Anus</LONG_NAME>
            <CON_ID>2494283</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2929</PREFERRED_NAME>
            <LONG_NAME>Squamous Cell Carcinoma</LONG_NAME>
            <CON_ID>2202404</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207639</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25526:C25696</PreferredName>
        <Version>1</Version>
        <LongName>Histologic Subtype</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25526</PREFERRED_NAME>
            <LONG_NAME>Histologic</LONG_NAME>
            <CON_ID>2206234</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25696</PREFERRED_NAME>
            <LONG_NAME>Subtype</LONG_NAME>
            <CON_ID>2203810</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3536346</PublicId>
      <PreferredName>3536346v1.0</PreferredName>
      <PreferredDefinition>(AY-nus) The opening of the rectum to the outside of the body._A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Anal Squamous Cell Carcinoma Histology Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3536345</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43362:C2929:C16681:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Anus Squamous Cell Carcinoma Histology Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43362</PREFERRED_NAME>
            <LONG_NAME>Anus</LONG_NAME>
            <CON_ID>2494283</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2929</PREFERRED_NAME>
            <LONG_NAME>Squamous Cell Carcinoma</LONG_NAME>
            <CON_ID>2202404</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16681</PREFERRED_NAME>
            <LONG_NAME>Histology</LONG_NAME>
            <CON_ID>2202345</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination that a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large Cell Non-Keratinizing</VALIDVALUE>
          <VALUEMEANING>Non-Keratinizing Malignant Squamous Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant squamous cell that does not produce keratin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36792</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3536348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large Cell Keratinizing</VALIDVALUE>
          <VALUEMEANING>Keratinizing Squamous Cell Carcinoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Squamous cell carcinomas with morphologically prominent production of keratin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4105</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Squamous Cell Carcinoma, Not Otherwise Specified (NOS)</VALIDVALUE>
          <VALUEMEANING>Squamous Cell Carcinoma Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.: Not characterized in any other way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594, C2929</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3293696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Basaloid</VALIDVALUE>
          <VALUEMEANING>Squamous Cell Lung Carcinoma, Basaloid Variant</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic variant of squamous cell lung carcinoma characterized by nuclear palisading. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Histological Subtype (Anal SC</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Histological Subtype (Anal SCC)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5655968</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HTMCP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HTMCP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000067</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1269">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3564086</PUBLICID>
    <LONGNAME>Parent Questionnaire Return Indicator</LONGNAME>
    <PREFERREDNAME>3564085v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator to determine whether or not the parent questionnaire was returned.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3564085</PublicId>
      <PreferredName>3564083v1.0:2871601v1.0</PreferredName>
      <PreferredDefinition>A mother or a father; the immediate progenitor._Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument._To give something back, or the getting back thereof.</PreferredDefinition>
      <LongName>Parent Questionnaire Return</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3564083</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42709:C17048</PreferredName>
        <Version>1</Version>
        <LongName>Parent Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42709</PREFERRED_NAME>
            <LONG_NAME>Parent</LONG_NAME>
            <CON_ID>2222173</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17048</PREFERRED_NAME>
            <LONG_NAME>Questionnaire</LONG_NAME>
            <CON_ID>2202367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2871601</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71900</PreferredName>
        <Version>1</Version>
        <LongName>Return</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71900</PREFERRED_NAME>
            <LONG_NAME>Return</LONG_NAME>
            <CON_ID>2747453</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Parent questionnaires returne</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Parent questionnaires returned either by mail or in person?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did you mail last week&#39;s booklet to your clinic?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1270">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3600198</PUBLICID>
    <LONGNAME>Adjudication Observation Observation Unique Identifier ISO21090.II.v1.0</LONGNAME>
    <PREFERREDNAME>3599689v1.0:2803193v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The final judgment in a legal proceeding.:Watching something and taking note of what happens._Watching something and taking note of what happens.:A set of characters used as a code that is unique in the context or the system for which it is created. It serves as a means of identification and reference (often instead of a name) for an entity, person, thing, function, procedure, activity, variable, or body of data._Identifier that uniquely identifies a thing or object.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3599689</PublicId>
      <PreferredName>3599554v1.0:3599608v1.0</PreferredName>
      <PreferredDefinition>The final judgment in a legal proceeding.:Watching something and taking note of what happens._Watching something and taking note of what happens.:A set of characters used as a code that is unique in the context or the system for which it is created. It serves as a means of identification and reference (often instead of a name) for an entity, person, thing, function, procedure, activity, variable, or body of data.</PreferredDefinition>
      <LongName>Adjudication Observation Observation Unique Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3599554</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C86039:C25598</PreferredName>
        <Version>1</Version>
        <LongName>Adjudication Observation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C86039</PREFERRED_NAME>
            <LONG_NAME>Adjudication</LONG_NAME>
            <CON_ID>3124086</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3599608</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25598:C70663</PreferredName>
        <Version>1</Version>
        <LongName>Observation Unique Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70663</PREFERRED_NAME>
            <LONG_NAME>Unique Identifier</LONG_NAME>
            <CON_ID>2714899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803193</PublicId>
      <PreferredName>2803193v1.0</PreferredName>
      <PreferredDefinition>Identifier that uniquely identifies a thing or object.</PreferredDefinition>
      <LongName>ISO21090.II.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090IIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Adjudication Observation Observation Unique Identifier ISO21090.II.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Adjudication Observation Observation Unique Identifier ISO21090.II.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000057</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3599505</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM FM</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AdjudicationObservation:observationUid</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.AdjudicationObservation.observationUid</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1271">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3624753</PUBLICID>
    <LONGNAME>Central Nervous System Disease or Disorder Inactive Indicator</LONGNAME>
    <PREFERREDNAME>3622806v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not central nervous system disease was inactive.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3622806</PublicId>
      <PreferredName>2962103v1.0:3622801v1.0</PreferredName>
      <PreferredDefinition>The part of the nervous system that consists of the brain, spinal cord, and meninges._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Indicates an absence of a measurable amount of a specific function or role performed by a biological entity in a Biophysical Process, Biochemical Reaction, or Biochemical Process.</PreferredDefinition>
      <LongName>Central Nervous System Disease or Disorder Inactive</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2962103</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12438:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Central Nervous System Disease or Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12438</PREFERRED_NAME>
            <LONG_NAME>Central Nervous System</LONG_NAME>
            <CON_ID>2202492</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3622801</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45422</PreferredName>
        <Version>1</Version>
        <LongName>Inactive</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45422</PREFERRED_NAME>
            <LONG_NAME>Absence of Biochemical Activity</LONG_NAME>
            <CON_ID>2737768</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was central nervous system di</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was central nervous system disease or disorder inactive?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was CNS disease inactive?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was CNS disease inactive?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was CNS disease inactive?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Was CNS disease inactive?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was CNS disease quiescent?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was CNS disease quiescent?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2039r1: Hemophagocytic Lymphohistiocytosis Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3279244</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>felh_base_cns_inactive_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>felh_base_nml_cns_scan_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>felh_base_nml_csf_prtn_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>felh_base_nml_neoptrin_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>felh_base_nml_wbc_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpre_therapy_multi_cns_disease_inact_ynu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1272">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3648748</PUBLICID>
    <LONGNAME>Adrenocortical Carcinoma ENSAT Clinical Distant Metastasis M Stage</LONGNAME>
    <PREFERREDNAME>3648541v1.0:3648554v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Extent of the distant metastasis for the adrenocortical carcinoma based on evidence obtained from clinical assessment parameters determined prior to treatment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3648541</PublicId>
      <PreferredName>3648745v1.0:3648539v1.0</PreferredName>
      <PreferredDefinition>A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing&#39;s syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival._A clinical finding about one or more characteristics of adrenal cancer, following the rules of the ENSAT staging v7 classification system._One criteria of the TMN staging system.  M refers to the presence of metastasis.</PreferredDefinition>
      <LongName>Adrenal Cortex Carcinoma Clinical ENSAT M Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3648745</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9325</PreferredName>
        <Version>1</Version>
        <LongName>Adrenal Cortex Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9325</PREFERRED_NAME>
            <LONG_NAME>Adrenal Cortical Carcinoma</LONG_NAME>
            <CON_ID>3248211</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3648539</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C104026:C25727</PreferredName>
        <Version>1</Version>
        <LongName>Clinical ENSAT Staging Finding v7 M Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104026</PREFERRED_NAME>
            <LONG_NAME>Clinical ENSAT Staging Finding v7</LONG_NAME>
            <CON_ID>3648121</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25727</PREFERRED_NAME>
            <LONG_NAME>M Category</LONG_NAME>
            <CON_ID>2204010</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3648554</PublicId>
      <PreferredName>3648554v1.0</PreferredName>
      <PreferredDefinition>A clinical finding about one or more characteristics of adrenal cancer, following the rules of the ENSAT staging v7 classification system as they pertain to distant metastases._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.</PreferredDefinition>
      <LongName>Clinical Distant Metastasis ENSAT M Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3648553</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C104027:C16899</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Distant Metastasis ENSAT Staging Finding v7 Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104027</PREFERRED_NAME>
            <LONG_NAME>Clinical Distant Metastasis ENSAT Staging Finding v7</LONG_NAME>
            <CON_ID>3648122</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>M0</VALIDVALUE>
          <VALUEMEANING>cM0 ENSAT Staging Finding v7</VALUEMEANING>
          <MEANINGDESCRIPTION>Adrenal cancer with no involvement of distant organs or tissues. (7th Ed, 2009)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104028</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3648562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>M1</VALIDVALUE>
          <VALUEMEANING>cM1 ENSAT Staging Finding v7</VALUEMEANING>
          <MEANINGDESCRIPTION>Adrenal cancer with involvement of distant organs or tissues such as liver, bone or brain. (7th Ed, 2009)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104029</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3648563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Clinical ENSAT Staging: Dista</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Clinical ENSAT Staging: Distant Metastasis (M) (7th Edition, 2009)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Inactive CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044924</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1273">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3653776</PUBLICID>
    <LONGNAME>Laboratory Procedure Serum Glutamic Pyruvic Transaminase Serum Glutamic Oxaloacetic Transferase Eligibility Determination Indicator</LONGNAME>
    <PREFERREDNAME>LAB_SGPT_SGOT_ELIG_Liv_SGPT_SG</PREFERREDNAME>
    <PREFERREDDEFINITION>the indicator related to the medical procedure that involves testing a sample of blood, urine, or other substance for SGOT or SGPT for normal limits based on liver function for determination if a subject is suitable for enrollment in a study according to specific protocol criteria.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2778258</PublicId>
      <PreferredName>LAB_SGPT_SGOT_ELIG</PreferredName>
      <PreferredDefinition>information related to the medical procedure that involves testing a sample of blood, urine, or other substance for Serum Glutamic Pyruvic Transaminase, a test of liver function, human Glutamic-Pyruvate Transaminase (Alanine Aminotransferase Family) is pyridoxal phosphate-dependent enzyme involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis, and Serum Glutamic Oxaloacetic Transferase, test of liver function, 46/47-kDa homodimeric human Aspartate Aminotransferase (Class-I Pyridoxal-Phosphate-Dependent Aminotransferase Family) is pyridoxal phosphate-dependent enzyme involved in amino acid metabolism and in the urea and tricarboxylic acid cycles, as a method of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.</PreferredDefinition>
      <LongName>Laboratory Procedure Serum Glutamic Pyruvic Transaminase Serum Glutamic Oxaloacetic Transferase Eligibility Determination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2778256</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25293:C25202:C25171</PreferredName>
        <Version>1</Version>
        <LongName>SGPT (ALT) SGOT (AST) Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25293</PREFERRED_NAME>
            <LONG_NAME>Alanine Aminotransferase</LONG_NAME>
            <CON_ID>2206251</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25202</PREFERRED_NAME>
            <LONG_NAME>Aspartate Aminotransferase</LONG_NAME>
            <CON_ID>2204991</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3653773</PublicId>
      <PreferredName>Liv_SGPT_SGOT_Ind</PreferredName>
      <PreferredDefinition>the indicator related to the value for the SGOT and SGPT normal limits based on liver function.</PreferredDefinition>
      <LongName>Liver Function SGOT SGPT Upper Limit of Normal Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, AST and ALT less than or equal to 5 X ULN, WITH liver mets</VALIDVALUE>
          <VALUEMEANING>Present Metastatic Malignant Neoplasm to the Liver SGOT (AST) SGPT (ALT) Value Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.: A malignant neoplasm that has spread to the liver from another (primary) anatomic site.  Such malignant neoplasms may be carcinomas (e.g. breast, colon), lymphomas, melanomas, or sarcomas.: Activity measured as a test of liver function, 46/47-kDa homodimeric human Aspartate Aminotransferases (Class-I Pyridoxal-Phosphate-Dependent Aminotransferase Family) are pyridoxal phosphate-dependent enzymes involved in amino acid metabolism and in the urea and tricarboxylic acid cycles. (NCI): Activity measured as a test of liver function, human Glutamic-Pyruvate Transaminases (Alanine Aminotransferase Family) are pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis. Glutamic Pyruvic Transaminases mediate conversion of major intermediate metabolites, catalyzing reversible transamination between alanine and alpha-ketoglutarate to form pyruvate and glutamate. (NCI): A numerical quantity measured or assigned or computed.: The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488, C25712, C25293, C25202, C4758, C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653774</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, AST and ALT less than or equal to 2.5 X ULN, NO liver mets</VALIDVALUE>
          <VALUEMEANING>Absent Metastatic Malignant Neoplasm to the Liver SGOT (AST) SGPT (ALT) Value Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.: A malignant neoplasm that has spread to the liver from another (primary) anatomic site.  Such malignant neoplasms may be carcinomas (e.g. breast, colon), lymphomas, melanomas, or sarcomas.: Activity measured as a test of liver function, 46/47-kDa homodimeric human Aspartate Aminotransferases (Class-I Pyridoxal-Phosphate-Dependent Aminotransferase Family) are pyridoxal phosphate-dependent enzymes involved in amino acid metabolism and in the urea and tricarboxylic acid cycles. (NCI): Activity measured as a test of liver function, human Glutamic-Pyruvate Transaminases (Alanine Aminotransferase Family) are pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis. Glutamic Pyruvic Transaminases mediate conversion of major intermediate metabolites, catalyzing reversible transamination between alanine and alpha-ketoglutarate to form pyruvate and glutamate. (NCI): A numerical quantity measured or assigned or computed.: The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488, C25712, C25293, C25202, C4758, C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Treatment</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment Intent</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Are AST and ALT less than or</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Are AST and ALT less than or equal to 2.5 x ULN? (unless subject has liver metastases in which case both AST and ALT must be less than or equal to 5 x ULN).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have liver involvement with AST and/or ALT less than 5 times the ULN?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have suspected leukemic involvement of the liver?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0254</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104938</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_SGPT_SGOT_ELIG_Liv_SGPT_SG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1274">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3656931</PUBLICID>
    <LONGNAME>MFLIE Leisure Activity 24 Hour Nausea Affect 7 Point Likert Scale</LONGNAME>
    <PREFERREDNAME>MFLIE_LR_NAU_24H_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric response to a question of whether nausea has affected a person&#39;s ability to maintain usual recreation or leisure activities in the past 24 hours.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3656833</PublicId>
      <PreferredName>3656829v1.0:3656251v1.0</PreferredName>
      <PreferredDefinition>The status of one&#39;s ability to perform activities of daily living and participate socially and occupationally._Activities done for the purpose of relaxation or diversion from routine work._Past; before the present time._A number with no fractional part, including the negative and positive numbers as well as zero.::24_In modern usage, an hour is defined as a unit of time 60 minutes, or 3600 seconds in length. It is approximately 1/24 of a median day._A disorder characterized by a queasy sensation and/or the urge to vomit._To be influenced by or change.</PreferredDefinition>
      <LongName>MFLIE Leisure Activity 24 Hour Nausea Affect</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3656829</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C91780:C104103</PreferredName>
        <Version>1</Version>
        <LongName>Functional Well-being Leisure Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91780</PREFERRED_NAME>
            <LONG_NAME>Functional Well-being</LONG_NAME>
            <CON_ID>3133349</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C104103</PREFERRED_NAME>
            <LONG_NAME>Leisure Activity</LONG_NAME>
            <CON_ID>3649926</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3656251</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3656251v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Past Integer::24 Hour Nausea Affected</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::24</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25529</PREFERRED_NAME>
            <LONG_NAME>Hour</LONG_NAME>
            <CON_ID>2203682</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>E10878</PREFERRED_NAME>
            <LONG_NAME>Nausea</LONG_NAME>
            <CON_ID>3123749</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>CTCAE</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64917</PREFERRED_NAME>
            <LONG_NAME>Affected</LONG_NAME>
            <CON_ID>2970209</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3651217</PublicId>
      <PreferredName>MFLIEA_7PT_LIKERT_SC</PreferredName>
      <PreferredDefinition>A number or range of numeric values measuring performance, function, quality, or ability._A number with no fractional part, including the negative and positive numbers as well as zero.::7_The precise location of something; a spatially limited location._A psychometric scale commonly used in questionnaires where a respondent is asked to evaluate an opinion according to subjective or objective criteria, by rating their level of agreement or disagreement with a statement.</PreferredDefinition>
      <LongName>Modified Functional Life Index Affect Integer::7 Point Likert Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3651209</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45255::7:C70656:C85429:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Integer::7 Point Likert Scale Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70656</PREFERRED_NAME>
            <LONG_NAME>Point</LONG_NAME>
            <CON_ID>2710246</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C85429</PREFERRED_NAME>
            <LONG_NAME>Likert Scale</LONG_NAME>
            <CON_ID>2971959</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Score of 2 on a 7 point Likert Scale</VALUEMEANING>
          <MEANINGDESCRIPTION>Score of 2 on a 7 point Likert Scale</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3651216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Score of 3 on a 7 point Likert Scale</VALUEMEANING>
          <MEANINGDESCRIPTION>Score of 3 on a 7 point Likert Scale</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3651215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Score of 4 on a 7 point Likert Scale</VALUEMEANING>
          <MEANINGDESCRIPTION>Score of 4 on a 7 point Likert Scale</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3651214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Score of 5 on a 7 point Likert Scale</VALUEMEANING>
          <MEANINGDESCRIPTION>Score of 5 on a 7 point Likert Scale</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3651213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Score of 6 on a 7 point Likert Scale</VALUEMEANING>
          <MEANINGDESCRIPTION>Score of 6 on a 7 point Likert Scale</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3651212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>A great deal</VALUEMEANING>
          <MEANINGDESCRIPTION>A great deal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3651211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has nausea affected your abil</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has nausea affected your ability to maintain usual recreation or leisure activities in the past 24 hours?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1275">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3685656</PUBLICID>
    <LONGNAME>Medical Device Description Type</LONGNAME>
    <PREFERREDNAME>MEDDEV_DESC_MEDDEV_DESC_Type</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of medical device used.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2192890</PublicId>
      <PreferredName>MEDDEV_DESC</PreferredName>
      <PreferredDefinition>information related to the decription medical device.</PreferredDefinition>
      <LongName>Medical Device Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2541698</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16830</PreferredName>
        <Version>1</Version>
        <LongName>Medical_Device</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16830</PREFERRED_NAME>
            <LONG_NAME>Medical Device</LONG_NAME>
            <CON_ID>2240760</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177536</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Description</PreferredName>
        <Version>1</Version>
        <LongName>Description </LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3685655</PublicId>
      <PreferredName>MEDDEV_DESC_Type</PreferredName>
      <PreferredDefinition>the type of medical device used.</PreferredDefinition>
      <LongName>Medical Device Description Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plastic</VALIDVALUE>
          <VALUEMEANING>Plastic</VALUEMEANING>
          <MEANINGDESCRIPTION>Various high-molecular-weight thermoplastic or thermosetting ploymers that are capable of being molded, extruded, drawn, or otherwise shaped and then hardened into a form. It is solid in its finished state.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86968</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3421428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metal</VALIDVALUE>
          <VALUEMEANING>Metal</VALUEMEANING>
          <MEANINGDESCRIPTION>Electropositive chemical elements characterised by ductility, malleability, luster, and conductance of heat and electricity. They can replace the hydrogen of an acid and form bases with hydroxyl radicals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2632150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Type of Stent Placed</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Type of Stent Placed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>which type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1201</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104994</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MEDDEV_DESC_MEDDEV_DESC_Type</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1276">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3725858</PUBLICID>
    <LONGNAME>Lymphedema and Breast Cancer Questionnaire During Past Year Have Breast Swelling Experience Indicator</LONGNAME>
    <PREFERREDNAME>3722561v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated perception of whether or not during the past year they have or had swelling in their breast, using a yes or no indicator.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>LBCQ: Lymphedema and Breast Cancer Questionnaire, Jane M. Armer</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3722561</PublicId>
      <PreferredName>3718831v1.0:3722559v1.0</PreferredName>
      <PreferredDefinition>A condensed version of a self-administered or structured interview questionnaire designed specifically for evaluating lymphedema symptoms after surgery for breast cancer._At some point in a given period of time._Past; before the present time._The period of time that it takes for Earth to make a complete revolution around the sun; a period of time containing 365 days._A question about whether an individual has or had breast swelling._The accumulation of knowledge or skill that results from direct participation in events or activities.</PreferredDefinition>
      <LongName>Lymphedema and Breast Cancer Questionnaire During Past Year Have Breast Swelling Experience</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3718831</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C105763</PreferredName>
        <Version>1</Version>
        <LongName>Lymphedema and Breast Cancer Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C105763</PREFERRED_NAME>
            <LONG_NAME>Lymphedema and Breast Cancer Questionnaire</LONG_NAME>
            <CON_ID>3715997</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3722559</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3722559v1.0</PreferredName>
        <Version>1</Version>
        <LongName>During Past Year Have Breast Swelling Experience</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29848</PREFERRED_NAME>
            <LONG_NAME>Year</LONG_NAME>
            <CON_ID>2203986</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C105781</PREFERRED_NAME>
            <LONG_NAME>Have Breast Swelling Question</LONG_NAME>
            <CON_ID>3715860</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54627</PREFERRED_NAME>
            <LONG_NAME>Experience</LONG_NAME>
            <CON_ID>2731931</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>LBCQ: Lymphedema and Breast Cancer Questionnaire, Jane M. Armer</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you experienced breast s</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you experienced breast swelling during the past year?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3704455</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LBCQ</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LBCQ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3704456</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1277">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3760746</PUBLICID>
    <LONGNAME>Generalized Statistics Factor Text ISO21090.ED.v1.0</LONGNAME>
    <PREFERREDNAME>3759972v1.0:2803174v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Textual or media-based representation of the general statistical consideration. EXAMPLE(S): (1) Centers within a region with fewer than 3 subjects will be grouped into a pooled center for the region. (2) Visits will be assigned to assessment windows defined by +/- 7 days from the target visit date as defined in the Time and Events Schedule. If multiple visits fall within an assessment window, the visit closest to the target date will be used. In the case of a tie, the earliest visit date will be used.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3759972</PublicId>
      <PreferredName>3757163v1.0:2228365v1.0</PreferredName>
      <PreferredDefinition>Widespread, broadly dispersed, common.:A branch of applied mathematics concerned with the collection and interpretation of quantitative data and the use of probability theory to estimate population parameters.:Anything that contributes causally to a result._The words of something written.</PreferredDefinition>
      <LongName>Generalized Statistics Factor Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3757163</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63764:C17167:C25506</PreferredName>
        <Version>1</Version>
        <LongName>Generalized Statistics Factor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63764</PREFERRED_NAME>
            <LONG_NAME>Generalized</LONG_NAME>
            <CON_ID>2547905</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17167</PREFERRED_NAME>
            <LONG_NAME>Statistics</LONG_NAME>
            <CON_ID>2542369</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25506</PREFERRED_NAME>
            <LONG_NAME>Factor</LONG_NAME>
            <CON_ID>2202640</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2228365</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803174</PublicId>
      <PreferredName>2803174v1.0</PreferredName>
      <PreferredDefinition>Data only for human interpretation or machine processing.</PreferredDefinition>
      <LongName>ISO21090.ED.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090EDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Generalized Statistics Factor Text ISO21090.ED.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Generalized Statistics Factor Text ISO21090.ED.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StatisticalAnalysisSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GeneralStatisticalConsideration:text</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StatisticalAnalysisSubDomain.GeneralStatisticalConsideration.text</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GeneralStatisticalConsideration.text</AlternateName>
        <AlternateNameType>Map:Statistics v1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1278">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3760894</PUBLICID>
    <LONGNAME>Government Funding Research Resource Funding Category Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>3760111v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded value specifying the type of funding provided for a study. EXAMPLE(S): National, Externally Peer-Reviewed, Institutional, Industrial NOTE(S): This is as defined for the NCI Summary 4 Funding requirements.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3760111</PublicId>
      <PreferredName>3174225v1.0:3759942v1.0</PreferredName>
      <PreferredDefinition>The political organization by which a state or nation is ruled.:A sum of money or other resources set aside for a specific purpose.:The funding, research facilities, and materials available for research_A sum of money or other resources set aside for a specific purpose.:This term is used informally to mean a class of things.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Government Funding Research Resource Funding Category Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174225</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C78315:C17769:C15321</PreferredName>
        <Version>1</Version>
        <LongName>Government Funding Research Resource</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78315</PREFERRED_NAME>
            <LONG_NAME>Government</LONG_NAME>
            <CON_ID>2867550</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17769</PREFERRED_NAME>
            <LONG_NAME>Funding</LONG_NAME>
            <CON_ID>2514003</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15321</PREFERRED_NAME>
            <LONG_NAME>Research Resource</LONG_NAME>
            <CON_ID>2867549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3759942</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17769:C25372:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Funding Category Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17769</PREFERRED_NAME>
            <LONG_NAME>Funding</LONG_NAME>
            <CON_ID>2514003</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Government Funding Research Resource Funding Category Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Government Funding Research Resource Funding Category Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.StudyConductSubDomain.GovernmentFunding.fundingCategoryCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GovernmentFunding:fundingCategoryCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudyResourcing.typeCode</AlternateName>
        <AlternateNameType>Map:CTRPv3.8</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>[Summary 4 Funder].Summary 4 Funding Category</AlternateName>
        <AlternateNameType>Map:HSDBv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1279">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3761224</PUBLICID>
    <LONGNAME>Study Protocol Document Version Date and Time ISO21090.TS.DATETIME.v1.0</LONGNAME>
    <PREFERREDNAME>3760431v1.0:3148148v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A representation of a particular edition or snapshot of a document containing a study protocol as it exists at a particular point in time. EXAMPLE(S): Version 3 of a breast cancer protocol. OTHER NAME(S): Amendment NOTE(S): Term &quot;protocol&quot; is somewhat overloaded, must be qualified to provide semantic context, so &quot;study protocol&quot; chosen to disambiguate from other protocols. Notion includes (not limited to) design, statistical considerations, activities to test particular hypothesis/answer particular question that is basis of study, characteristics, specifications, objective(s), background, pre-study/study/post-study portions of plan (including design, methodology, statistical considerations, organization). Study protocol related to other supporting documents, including (not limited to) informed consent documents, case report forms, regulatory/approval documentation, correlative studies, etc. (via inherited association to DocumentVersionRelationship). Complete notion of study protocol represented by StudyProtocol, StudyProtocolVersion, StudyProtocolDocument, StudyProtocolDocumentVersion, StudyExecution and their associations. Term &quot;Amendment&quot; needs to be disambiguated since sometimes refers to amended version of protocol (StudyProtocolDocumentVersion), other times to summary of changes (AmendmentChangeSummaryVersion). The date (and time) on which the document is versioned.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3760431</PublicId>
      <PreferredName>3174205v1.0:2437776v1.0</PreferredName>
      <PreferredDefinition>The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.:An organized collection of records that describe a particular body of work.:A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications._An expression of both date and time that an event has happened or will happened.</PreferredDefinition>
      <LongName>Study Protocol Document Version Date and Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3174205</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70817:C19498:C25714</PreferredName>
        <Version>1</Version>
        <LongName>Study Protocol Document Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70817</PREFERRED_NAME>
            <LONG_NAME>Study Protocol</LONG_NAME>
            <CON_ID>2753699</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19498</PREFERRED_NAME>
            <LONG_NAME>Document</LONG_NAME>
            <CON_ID>2223216</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2437776</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date and Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3148148</PublicId>
      <PreferredName>3148148v1.0</PreferredName>
      <PreferredDefinition>Constrains TS so that it&#39;s precision can not be more precise than seconds.</PreferredDefinition>
      <LongName>ISO21090.TS.DATETIME.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090TSDTTIv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2423394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37939</PreferredName>
        <Version>1</Version>
        <LongName>Date/Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37939</PREFERRED_NAME>
            <LONG_NAME>Date and Time</LONG_NAME>
            <CON_ID>2202495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Study Protocol Document Version Date and Time ISO21090.TS.DATETIME.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Study Protocol Document Version Date and Time ISO21090.TS.DATETIME.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.ProtocolRepresentationSubDomain.StudyProtocolDocumentVersion.date</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudyProtocolDocumentVersion:date</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1280">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3761965</PUBLICID>
    <LONGNAME>Prior Planned Treatment with Radiation Therapy and Concomitant Temozolomide Indicator</LONGNAME>
    <PREFERREDNAME>3761926v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator to signify whether or not the patient received planned treatment with radiation therapy and concomitant temozolomide at least 28 days but no more than 49 days prior to starting treatment on this study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ABTC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3761926</PublicId>
      <PreferredName>3761923v1.0:3761924v1.0</PreferredName>
      <PreferredDefinition>Earlier in time or order._To devise, contrive, or form in design._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._Used to indicate the presence of something or someone._Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Accessory, accompanying especially in a subordinate or incidental way, occurring or existing during the same period of time._A triazene analog of dacarbazine with antineoplastic activity.  As a cytotoxic alkylating agent, temozolomide is converted at physiologic pH to the short-lived active compound, monomethyl triazeno imidazole carboxamide (MTIC). The cytotoxicity of MTIC is due primarily to methylation of DNA at the O6 and N7 positions of guanine, resulting in inhibition of  DNA replication.  Unlike dacarbazine, which is metabolized to MITC only in the liver, temozolomide is metabolized to MITC at all sites. Temozolomide is administered orally and penetrates well into the central nervous system. (NCI04)_The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.</PreferredDefinition>
      <LongName>Prior Planned Treatment with Radiation Therapy and Concomitant Temozolomide Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ABTC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3761923</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C25619:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Prior Plan Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25619</PREFERRED_NAME>
            <LONG_NAME>Plan</LONG_NAME>
            <CON_ID>2203947</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3761924</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3761924v1.0</PreferredName>
        <Version>1</Version>
        <LongName>With Radiation Therapy And Concomitant Temozolomide Administration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62355</PREFERRED_NAME>
            <LONG_NAME>With</LONG_NAME>
            <CON_ID>2532083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37912</PREFERRED_NAME>
            <LONG_NAME>And</LONG_NAME>
            <CON_ID>2528554</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25730</PREFERRED_NAME>
            <LONG_NAME>Concomitant</LONG_NAME>
            <CON_ID>2202429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1244</PREFERRED_NAME>
            <LONG_NAME>Temozolomide</LONG_NAME>
            <CON_ID>2224603</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the patient received plan</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the patient received planned treatment with radiation therapy and concomitant temozolomide at least 28 days but no more than 49 days prior to starting treatment on this study?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ABTC CRF Instruction</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>Patients must have received at least 80% of planned temozolomide and radiation therapy with no grade 3 or grade 4 toxicity attributed to the temozolomide. Arm 2 patients may not have received any other prior chemotherapy, immunotherapy or therapy with biologic agent (including immunotoxins, immunoconjugates, antisense, peptide receptor antagonists, interferons, interleukins, TIL, LAK or gene therapy), or hormonal therapy for their brain tumor. Prior Gliadel Wafers are allowed. Glucocorticoid therapy is allowed.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3335728</PublicId>
          <ContextName>ABTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocols</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ABTC 1202</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3761917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1281">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3767216</PUBLICID>
    <LONGNAME>Hematopoietic Cell Transplantation Most Recent Prior Source Name</LONGNAME>
    <PREFERREDNAME>2527578v2.0:2730897v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the hematopoietic cell source for the last hematopoietic cell transplantation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2527578</PublicId>
      <PreferredName>2531883v1.0:2527576v1.0</PreferredName>
      <PreferredDefinition>Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The grafting of tissues from one individual to another or place to place within a single individual._Nearest to the present time._Earlier in time or order</PreferredDefinition>
      <LongName>Hematopoietic Cell Transplantation Most Recent Prior</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008582</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Techniques</PreferredName>
        <Version>1</Version>
        <LongName>Techniques</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2531883</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12551:C15342</PreferredName>
        <Version>1</Version>
        <LongName>Hematopoietic Stem Cell Transplantation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2527576</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25577:C25629</PreferredName>
        <Version>1</Version>
        <LongName>Most Recent Prior</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25577</PREFERRED_NAME>
            <LONG_NAME>Most Recent</LONG_NAME>
            <CON_ID>2206311</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2730897</PublicId>
      <PreferredName>2730897v2.0</PreferredName>
      <PreferredDefinition>Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Where something is available or from where it originates._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Hematopoietic Cell Source Name</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2730896</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12551:C25683:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Hematopoietic Stem Cell Source Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25683</PREFERRED_NAME>
            <LONG_NAME>Source</LONG_NAME>
            <CON_ID>2202479</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Syngeneic (identical twin)</VALIDVALUE>
          <VALUEMEANING>syngeneic</VALUEMEANING>
          <MEANINGDESCRIPTION>syngeneic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-02-21</PVBEGINDATE>
          <PVENDDATE>2013-10-07</PVENDDATE>
          <VMPUBLICID>2568338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allogeneic, unrelated</VALIDVALUE>
          <VALUEMEANING>Unrelated Allogenic</VALUEMEANING>
          <MEANINGDESCRIPTION>Unrelated; not connected or associated e.g. by kinship.: Taken from different individuals of the same species.  Also called allogeneic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28343, C25328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-06-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2730898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autologous</VALIDVALUE>
          <VALUEMEANING>autologous</VALUEMEANING>
          <MEANINGDESCRIPTION>Taken from an individual&#39;s own tissues, cells, or DNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-06-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allogeneic, related</VALIDVALUE>
          <VALUEMEANING>Related Allogenic</VALUEMEANING>
          <MEANINGDESCRIPTION>Related; connected or associated.: Taken from different individuals of the same species.  Also called allogeneic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28343, C25648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-06-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2730899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Syngeneic</VALIDVALUE>
          <VALUEMEANING>Syngeneic</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting individuals or tissues that are genetically identical.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-10-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3829171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the hematopoietic ce</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the hematopoietic cell transplantation most recent prior source?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify HSC source for the last HCT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify HSC source for the last HCT</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify HSC source for the last HCT</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify HSC source for the last HCT</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2804r4: Unique ID Assignment Form</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3755941</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1282">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3773883</PUBLICID>
    <LONGNAME>Second Chest Tube Thoracic Surgical Procedure Postoperative Required Yes No Indicator</LONGNAME>
    <PREFERREDNAME>SEC_CH_TB_REQ_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to signify whether a patient required a second chest tube be placed as part of recovery from a thoracic surgical procedure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3773882</PublicId>
      <PreferredName>3773879v1.0:3773880v1.0</PreferredName>
      <PreferredDefinition>Coming next after the first in position in space or time or degree or magnitude._Plastic tubes used for drainage of air or fluid from the pleural space. Their surgical insertion is called tube thoracostomy._Surgery performed on the thoracic organs, most commonly the lungs and the heart._After surgery._Required; necessary, not optional.</PreferredDefinition>
      <LongName>Second Chest Tube Thoracic Surgical Procedure Postoperative Required</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3773879</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25666:C0008034</PreferredName>
        <Version>1</Version>
        <LongName>Second Chest Tubes</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25666</PREFERRED_NAME>
            <LONG_NAME>Second</LONG_NAME>
            <CON_ID>2202591</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0008034</PREFERRED_NAME>
            <LONG_NAME>Chest Tubes</LONG_NAME>
            <CON_ID>2203347</CON_ID>
            <DEFINITION_SOURCE>MSH2004_2003_12_12</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3773880</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15655:C28006:C25652</PreferredName>
        <Version>1</Version>
        <LongName>Thoracic Surgical Procedures Postoperative Required</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15655</PREFERRED_NAME>
            <LONG_NAME>Thoracic Surgical Procedure</LONG_NAME>
            <CON_ID>2202293</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28006</PREFERRED_NAME>
            <LONG_NAME>Postoperative</LONG_NAME>
            <CON_ID>2211921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25652</PREFERRED_NAME>
            <LONG_NAME>Requirement</LONG_NAME>
            <CON_ID>2204014</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the patient require a sec</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the patient require a second chest tube as part of postoperative recovery from a thoracic procedure?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was any additional chest tube placed post-surgery?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was any additional chest tube placed post-surgery?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was a chest tube placed at the time of the thoracic surgery?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was a chest tube placed at the time of the thoracic surgery?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886752</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>For Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3891931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1283">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3808797</PUBLICID>
    <LONGNAME>NCCN Guidelines Version 1.2011 Distress Management Problem List Screening Tool Past Week Distress over Physical Problem with Mouth Sores Indicator</LONGNAME>
    <PREFERREDNAME>NCCN_DSTMG_MTHSORE_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how distressed they have been during the past week over physical problems with mouth sores, using a yes or no indicator.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCCN 1.2011 Distress Management Guidelines, 10/12/2010</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3807976</PublicId>
      <PreferredName>3799951v1.0:3807974v1.0</PreferredName>
      <PreferredDefinition>A screening tool developed by the National Comprehensive Cancer Network (NCCN) Distress Management Panel used to identify patient problems in five categories._The most recent week, including today._A question about an individual&#39;s distress related to their physical problems with mouth sores.</PreferredDefinition>
      <LongName>NCCN Guidelines Version 1.2011 Distress Management Problem List Screening Tool Past Week Distress over Physical Problem with Mouth Sores</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3799951</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C107157</PreferredName>
        <Version>1</Version>
        <LongName>NCCN Guidelines Distress Management Problem List Screening Tool Version 1.2011</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107157</PREFERRED_NAME>
            <LONG_NAME>NCCN Guidelines Distress Management Problem List Screening Tool Version 1.2011</LONG_NAME>
            <CON_ID>3794690</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3807974</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C107202</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Distress over Physical Problem with Mouth Sores</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107202</PREFERRED_NAME>
            <LONG_NAME>Distress over Physical Problem with Mouth Sores Question</LONG_NAME>
            <CON_ID>3794761</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCN 1.2011 Distress Management Guidelines, 10/12/2010</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Mouth sores</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Mouth sores</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3793272</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCCN Guidelines</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Distress Management v1.2011</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3793273</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1284">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3824814</PUBLICID>
    <LONGNAME>Edmonton Symptom Assessment System Current Assessment Best Appetite to Worst Possible Appetite Score 11 Point Scale</LONGNAME>
    <PREFERREDNAME>ESAS_APPETITE_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of the severity of their appetite between two extremes (best to worst possible) at the time of the assessment, using an eleven point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ESAS:Edmonton Symptom Assessment System, Bruera E., 2006</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3823152</PublicId>
      <PreferredName>3823131v1.0:3823150v1.0</PreferredName>
      <PreferredDefinition>A self-report assessment tool to screen for the intensity of nine symptoms commonly experienced by cancer patients in palliative care._Occurring in or belonging to the present time._Having determined the value, significance, or extent of._Having the most positive qualities._The natural recurring desire for food._Used as a function word to indicate direction, purpose, or movement._A question about an individual&#39;s appetite at its worst._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Edmonton Symptom Assessment System Current Assessment Best Appetite To Worst Possible Appetite Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3823131</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C107391</PreferredName>
        <Version>1</Version>
        <LongName>Edmonton Symptom Assessment System</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107391</PREFERRED_NAME>
            <LONG_NAME>Edmonton Symptom Assessment System</LONG_NAME>
            <CON_ID>3821162</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3823150</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3823150v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Current Assessment Best Appetite To Worst Possible Appetite Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25432</PREFERRED_NAME>
            <LONG_NAME>Best</LONG_NAME>
            <CON_ID>2206164</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25152</PREFERRED_NAME>
            <LONG_NAME>Appetite</LONG_NAME>
            <CON_ID>2202298</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C65107</PREFERRED_NAME>
            <LONG_NAME>To</LONG_NAME>
            <CON_ID>2672667</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107398</PREFERRED_NAME>
            <LONG_NAME>Worst Possible Appetite Question</LONG_NAME>
            <CON_ID>3821179</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ESAS:Edmonton Symptom Assessment System, Bruera E., 2006</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3822956</PublicId>
      <PreferredName>SYMPT_SEV_RNG_SCL</PreferredName>
      <PreferredDefinition>Subjective evidence of disease perceived by the patient._Used of the degree of something undesirable e.g. pain or weather; also, strictness._The difference between the lowest and highest numerical values; the limits or scale of variation._A number with no fractional part, including the negative and positive numbers as well as zero.::11_The precise location of something; a spatially limited location._an ordered reference standard.</PreferredDefinition>
      <LongName>Symptom Severity Range 11 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>10</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>ESAS:Edmonton Symptom Assessment System, Bruera E., 2006</Origin>
      <Representation>
        <PublicId>3822955</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3822955v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Symptom Severity Range Integer::11 Point Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38013</PREFERRED_NAME>
            <LONG_NAME>Range</LONG_NAME>
            <CON_ID>2204649</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70656</PREFERRED_NAME>
            <LONG_NAME>Point</LONG_NAME>
            <CON_ID>2710246</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Likert Score 1 on an 11 Point Scale from No Symptom to Worst Possible Symptom</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.: Used as a function word to indicate direction, purpose, or movement.: A question about an individual&#39;s experience of a symptom at its worst.: A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: A subjective score of 1 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103506, C38013, C45255::11, C107401, C65107, C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3822958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>Worst Possible Symptom</VALUEMEANING>
          <MEANINGDESCRIPTION>A question about an individual&#39;s experience of a symptom at its worst.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3822959</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Likert Score 2 on an 11 Point Scale from No Symptom to Worst Possible Symptom</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: No person or thing, nobody, not any.: Used as a function word to indicate direction, purpose, or movement.: A question about an individual&#39;s experience of a symptom at its worst.: A subjective score of 2 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91291, C107401, C65107, C41132, C38013, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3822960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Likert Score 3 on an 11 Point Scale from No Symptom to Worst Possible Symptom</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: No person or thing, nobody, not any.: A question about an individual&#39;s experience of a symptom at its worst.: Used as a function word to indicate direction, purpose, or movement.: A subjective score of 3 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38013, C45255::11, C91292, C65107, C107401, C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>4, 5, 0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3822961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Likert Score 4 on an 11 Point Scale from No Symptom to Worst Possible Symptom</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: No person or thing, nobody, not any.: Used as a function word to indicate direction, purpose, or movement.: A question about an individual&#39;s experience of a symptom at its worst.: A subjective score of 4 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91293, C107401, C65107, C41132, C38013, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3822962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Likert Score 5 on an 11 Point Scale from No Symptom to Worst Possible Symptom</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: No person or thing, nobody, not any.: Used as a function word to indicate direction, purpose, or movement.: A question about an individual&#39;s experience of a symptom at its worst.: A subjective score of 5 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91294, C107401, C65107, C41132, C38013, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3822963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Likert Score 6 on an 11 Point Scale from No Symptom to Worst Possible Symptom</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: No person or thing, nobody, not any.: Used as a function word to indicate direction, purpose, or movement.: A question about an individual&#39;s experience of a symptom at its worst.: A subjective score of 6 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103507, C107401, C65107, C41132, C38013, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3822964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Likert Score 7 on an 11 Point Scale from No Symptom to Worst Possible Symptom</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: No person or thing, nobody, not any.: Used as a function word to indicate direction, purpose, or movement.: A question about an individual&#39;s experience of a symptom at its worst.: A subjective score of 7 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103508, C107401, C65107, C41132, C38013, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3822965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Likert Score 8 on an 11 Point Scale from No Symptom to Worst Possible Symptom</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: No person or thing, nobody, not any.: Used as a function word to indicate direction, purpose, or movement.: A question about an individual&#39;s experience of a symptom at its worst.: A subjective score of 8 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103509, C107401, C65107, C41132, C38013, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3822966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Likert Score 9 on an 11 Point Scale from No Symptom to Worst Possible Symptom</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: The difference between the lowest and highest numerical values; the limits or scale of variation.: No person or thing, nobody, not any.: Used as a function word to indicate direction, purpose, or movement.: A question about an individual&#39;s experience of a symptom at its worst.: A subjective score of 9 on a Likert scale.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103510, C107401, C65107, C41132, C38013, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3822967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No Symptom</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.: Subjective evidence of disease perceived by the patient.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4876, C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3822957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Best Appetite to Worst Possib</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Best Appetite to Worst Possible Appetite</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3813677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ESAS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ESAS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3813678</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1285">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3837060</PUBLICID>
    <LONGNAME>Hematopoietic Cell Graft Peripheral Blood Stem Cell Type Indicator</LONGNAME>
    <PREFERREDNAME>3837054v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the hematopoietic cell graft (product) was peripheral blood stem cells.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3837054</PublicId>
      <PreferredName>2531884v1.0:2728548v1.0</PreferredName>
      <PreferredDefinition>Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body._An immature (progenitor) cell circulating in the peripheral blood.  It has the capacity for replication and differentiation to mature blood cells._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Hematopoietic Cell Graft Peripheral Blood Stem Cell Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2531884</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12551:C12981</PreferredName>
        <Version>1</Version>
        <LongName>Hematopoietic Stem Cell Transplant</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2728548</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12946:C25284</PreferredName>
        <Version>1</Version>
        <LongName>PBSC Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12946</PREFERRED_NAME>
            <LONG_NAME>Peripheral Blood Stem Cell</LONG_NAME>
            <CON_ID>2202777</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBSC</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>PBSC</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the graft type peripheral</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the graft type peripheral blood stem cell?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBSC:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>PBSC:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBSC</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>PBSC</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_donor_multi_prod_type_pbsc_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1286">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3856048</PUBLICID>
    <LONGNAME>Expanded Prostate Cancer Index Composite Sexual Medications/Devices Supplement Tried or Currently Use Penile Injection Therapy to Improve Erection Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>EPIC_CAVRJECT_USE_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of whether or not they have tried penile injection therapy or currently use it to improve erections, using a five point Likert Scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3856000</PublicId>
      <PreferredName>3855953v1.0:3855998v1.0</PreferredName>
      <PreferredDefinition>A component of the EPIC designed to assess the use of erectile aids among patients treated for prostate cancer._A question about which medicine or device an individual uses or has used to improve an erection._Self-administered injections of vasodilators into the corpus cavernosa to promote engorgement and tumescence of the glans with sexual stimulation._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Expanded Prostate Cancer Index Composite Sexual Medications/Devices Supplement Medicine or Device Tried or Currently Used to Improve Erection Penile Injection Therapy Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3855953</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C107631</PreferredName>
        <Version>1</Version>
        <LongName>Expanded Prostate Cancer Index Composite, Sexual Medications/Devices Supplement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107631</PREFERRED_NAME>
            <LONG_NAME>Expanded Prostate Cancer Index Composite, Sexual Medications/Devices Supplement</LONG_NAME>
            <CON_ID>3854581</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3855998</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C107634:C107635:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Medicine or Device Tried or Currently Used to Improve Erection Penile Injection Therapy Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107634</PREFERRED_NAME>
            <LONG_NAME>Medicine or Device Tried or Currently Used to Improve Erection Question</LONG_NAME>
            <CON_ID>3854584</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107635</PREFERRED_NAME>
            <LONG_NAME>Penile Injection Therapy</LONG_NAME>
            <CON_ID>3854585</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3856009</PublicId>
      <PreferredName>HELP_SCR_5PT_SCL</PreferredName>
      <PreferredDefinition>The act of contributing to the fulfillment of a need or furtherance of an effort._A number or range of numeric values measuring performance, function, quality, or ability._A number with no fractional part, including the negative and positive numbers as well as zero.::5_The precise location of something; a spatially limited location._an ordered reference standard.</PreferredDefinition>
      <LongName>Help Score 5 Point Likert Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>3856008</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3856008v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Assistance Score Integer::5 Point Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C89271</PREFERRED_NAME>
            <LONG_NAME>Assistance</LONG_NAME>
            <CON_ID>3111305</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70656</PREFERRED_NAME>
            <LONG_NAME>Point</LONG_NAME>
            <CON_ID>2710246</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>It HELPED, and I use it ALWAYS</VALUEMEANING>
          <MEANINGDESCRIPTION>A response that something has helped an individual and it is being used always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3856010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>It HELPED, and I use it SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>A response that something has helped an individual and it is being used sometimes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3856011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>It HELPED, but I am NOT using it NOW</VALUEMEANING>
          <MEANINGDESCRIPTION>A response that something has helped an individual but it is not being used now.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107639</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3856012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Tried it, but was NOT HELPFUL</VALUEMEANING>
          <MEANINGDESCRIPTION>A response that something has been tried by an individual but it has not been found to be helpful.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3856013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Have NOT tried it</VALUEMEANING>
          <MEANINGDESCRIPTION>A response that something has not been tried by an individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3856014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Penile injection therapy (suc</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Penile injection therapy (such as caverject)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3855897</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>EPIC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sexual Medications/Devices Supplement</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3855898</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1287">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3857887</PUBLICID>
    <LONGNAME>Submitted Tumor Tissue Prior Biopsy Or Resection Performed Month Number</LONGNAME>
    <PREFERREDNAME>3857714v1.0:2895904v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value that represents the month that the biopsy or surgical resection prior to the operation that yielded the submitted sample was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3857714</PublicId>
      <PreferredName>3857711v1.0:3857712v1.0</PreferredName>
      <PreferredDefinition>The act of referring for judgment or consideration by others; the act of handing over something._A tissue sample, or entire tumor that is removed for microscopic examination._Earlier in time or order._Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._The act of cutting out; the surgical removal of part or all of a structure or organ._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Submitted Tumor Tissue Prior Biopsy Or Resection Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3857711</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25695:C18009</PreferredName>
        <Version>1</Version>
        <LongName>Submission Tumor Tissue</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25695</PREFERRED_NAME>
            <LONG_NAME>Submission</LONG_NAME>
            <CON_ID>2203811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18009</PREFERRED_NAME>
            <LONG_NAME>Tumor Tissue Sample</LONG_NAME>
            <CON_ID>2431186</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3857712</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3857712v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Prior Biopsy Or Excision Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15189</PREFERRED_NAME>
            <LONG_NAME>Biopsy Procedure</LONG_NAME>
            <CON_ID>2202502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15232</PREFERRED_NAME>
            <LONG_NAME>Excision</LONG_NAME>
            <CON_ID>2202806</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2895904</PublicId>
      <PreferredName>EVT_MON_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks._A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Event Month Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2895903</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C29846:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Month Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>One of ten equal parts; a quantity corresponding to one tenth of the whole.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C81010</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the fifth position in an ordering or series; coming next after the fifth and just before the seventh in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54568</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the fourth position in an ordering or series; coming next after the fourth and just before the sixth in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54567</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the third position in an ordering or series; coming next after the third and just before the fifth in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the second position in an ordering or series.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Coming next after the first in position in space or time or degree or magnitude.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Preceding all others in time or space or degree.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Month of Prior Biopsy or Rese</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Month of Prior Biopsy or Resection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1288">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3861016</PUBLICID>
    <LONGNAME>Serum Creatinine Result mg/dL Float</LONGNAME>
    <PREFERREDNAME>3860962v1.0:3880532v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The laboratory results of serum creatinine.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACRIN:American College of Radiology Imaging Network</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3860962</PublicId>
      <PreferredName>2830511v1.0:2177339v1.0</PreferredName>
      <PreferredDefinition>The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins._The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.(NCI)_The clear liquid part of the blood that remains after blood cells and clotting proteins have been removed._The result of an action.</PreferredDefinition>
      <LongName>Serum Creatinine Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2830511</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13325:C399</PreferredName>
        <Version>1</Version>
        <LongName>Serum Creatinine</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13325</PREFERRED_NAME>
            <LONG_NAME>Serum</LONG_NAME>
            <CON_ID>2203797</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C399</PREFERRED_NAME>
            <LONG_NAME>Creatinine</LONG_NAME>
            <CON_ID>2206188</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177339</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Result</PreferredName>
        <Version>1</Version>
        <LongName>Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3880532</PublicId>
      <PreferredName>3880532v1.0</PreferredName>
      <PreferredDefinition>A float number using the metric measure of milligrams per deciliter (mg/dL).</PreferredDefinition>
      <LongName>mg/dL Float</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>mg/dL</UnitOfMeasure>
      <DisplayFormat>99.99</DisplayFormat>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
      <Representation>
        <PublicId>3880531</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C67015:C48150</PreferredName>
        <Version>1</Version>
        <LongName>Milligram per Deciliter Float</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67015</PREFERRED_NAME>
            <LONG_NAME>Milligram per Deciliter</LONG_NAME>
            <CON_ID>2719051</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48150</PREFERRED_NAME>
            <LONG_NAME>Float</LONG_NAME>
            <CON_ID>2433734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Serum creatinine level</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Serum creatinine level</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314494</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1289">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3865381</PUBLICID>
    <LONGNAME>Tissue Donor And/Or Hematopoietic Cell Graft Test Transplantation Transmission Genetic Disease or Disorder Indicator</LONGNAME>
    <PREFERREDNAME>3865380v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the donor and/or product (graft) was tested for transplantable genetic diseases.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3865380</PublicId>
      <PreferredName>3972471v1.0:3972472v1.0</PreferredName>
      <PreferredDefinition>Someone who gives blood or tissue or an organ to be used in another person._Used to indicate that either or both of two items or options may be valid._Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._The grafting of tissues from one individual to another or place to place within a single individual._A passage or transfer, as of a disease from one individual to another._Having to do with information that is passed from parents to offspring through genes in sperm and egg cells._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. Sometimes the term is used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</PreferredDefinition>
      <LongName>Tissue Donor And/Or Hematopoietic Stem Cell Graft Test Transplantation Transmission Genetic Disease or Disorder</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3972471</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3972471v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Donor And/Or Hematopoietic Stem Cell Graft Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48928</PREFERRED_NAME>
            <LONG_NAME>And/Or</LONG_NAME>
            <CON_ID>2431163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47891</PREFERRED_NAME>
            <LONG_NAME>Test</LONG_NAME>
            <CON_ID>2427511</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3972472</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15342:C17214:C17938:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Transplantation Transmission Genetic Disease or Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17214</PREFERRED_NAME>
            <LONG_NAME>Disease Transmission</LONG_NAME>
            <CON_ID>2542185</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17938</PREFERRED_NAME>
            <LONG_NAME>Genetic</LONG_NAME>
            <CON_ID>2206224</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the donor / product teste</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the donor / product tested for transplantable genetic diseases?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the donor / product tested for potentially transplantable genetic diseases?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Was the donor / product tested for potentially transplantable genetic diseases?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the donor / product tested for potentially transplantable genetic diseases?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the donor / product tested for potentially transplantable genetic diseases?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Sickle cell anemia</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Sickle cell anemia</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Thalassemia</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Thalassemia</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other disease</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were the diseases tested?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were the diseases tested?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>G6PD</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>G6PD</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hemoglobinopathy</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Hemoglobinopathy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_donor_infant_demo_donor_prod_genetic_dis_ynu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Tissue Donor And/Or Hematopoietic Stem Cell Graft Test Transplantation Transmission Genetic Disease or Disorder Indicator</AlternateName>
        <AlternateNameType>System-Generated</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_donor_infant_demo_test_sca_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_donor_infant_demo_test_oth_dis_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_donor_infant_demo_test_thalass_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1290">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3867671</PUBLICID>
    <LONGNAME>Goserelin Agent Administered Day Count</LONGNAME>
    <PREFERREDNAME>3867653v1.0:2018594v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The information related to the number of days the the agent goserelin was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3867653</PublicId>
      <PreferredName>3867651v1.0:2233610v1.0</PreferredName>
      <PreferredDefinition>The information related to the administration of the agent goserelin.</PreferredDefinition>
      <LongName>Goserelin Agent Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3867651</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1374:C1708</PreferredName>
        <Version>1</Version>
        <LongName>Goserelin Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1374</PREFERRED_NAME>
            <LONG_NAME>Goserelin</LONG_NAME>
            <CON_ID>2205042</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018594</PublicId>
      <PreferredName>D_CT</PreferredName>
      <PreferredDefinition>the quantity of days.</PreferredDefinition>
      <LongName>Day Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2207941</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25301:C25463</PreferredName>
        <Version>1</Version>
        <LongName>Day Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25301</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2202680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of days agent was taken</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of days agent was taken</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of days AI was taken during this reporting period</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1291">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3875731</PUBLICID>
    <LONGNAME>Medical Outcomes Study Social Activities Past 4 Weeks How Much Time Physical Health or Emotional Problems Interference with Social Activities Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>MOS_SOC_HLTH_INTF_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated perception of how much time during the past 4 weeks has physical health or emotional problems interfered with their social activities (like visiting with friends, relatives, etc.), using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MOS:Medical Outcomes Study, Sherbourne, C. D., 1991 and Stewart, A. L. and J. E. Ware, Jr., Eds. 1992</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3874634</PublicId>
      <PreferredName>3874631v1.0:3874632v1.0</PreferredName>
      <PreferredDefinition>A survey of multiple dimensions of support, representing the social activities scale._A period of time consisting of the 28 days before the present._The state of a person&#39;s physical and emotional well-being._The act of impeding a person from their normal social activities._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Medical Outcomes Study Social Activities Past 4 Weeks Physical Health or Emotional Problems Interference with Social Activities Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3874631</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C110968</PreferredName>
        <Version>1</Version>
        <LongName>Medical Outcomes Study Social Activities</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110968</PREFERRED_NAME>
            <LONG_NAME>Medical Outcomes Study Social Activities</LONG_NAME>
            <CON_ID>3871095</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3874632</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C110986:C110988:C110989:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past 4 Weeks Physical Health or Emotional Problems Interference with Social Activities Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110986</PREFERRED_NAME>
            <LONG_NAME>Past 4 Weeks</LONG_NAME>
            <CON_ID>3871096</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110988</PREFERRED_NAME>
            <LONG_NAME>Physical Health or Emotional Problems</LONG_NAME>
            <CON_ID>3871098</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110989</PREFERRED_NAME>
            <LONG_NAME>Interference with Social Activities</LONG_NAME>
            <CON_ID>3871099</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MOS:Medical Outcomes Study, Sherbourne, C. D., 1991 and Stewart, A. L. and J. E. Ware, Jr., Eds. 1992</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3875585</PublicId>
      <PreferredName>TIME_5PT_SCL</PreferredName>
      <PreferredDefinition>an ordered reference standard.</PreferredDefinition>
      <LongName>How Much Time 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>MOS:Medical Outcomes Study, Sherbourne, C. D., 1991 and Stewart, A. L. and J. E. Ware, Jr., Eds. 1992</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Most of the time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Some of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened some of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>A Little of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a little of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Question Instruction</Name>
        <DocumentType>NOTE</DocumentType>
        <DocumentText>(Mark one with an X.)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>During the past 4 weeks, how</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>During the past 4 weeks, how much time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance Alt Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>During the past 4 weeks, how much of the time has your physical or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3863415</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MOS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Core Survey Instrument</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3863417</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3863415</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MOS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Social Activity</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3863419</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3863415</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MOS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SF-36v2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4281631</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4280881</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>SF-36v2</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SF-36v2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4281200</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Social Support Survey</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900387</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SF-36v2 Health Survey Past 4 Weeks How Much Time Physical Health or Emotional Problems Interference with Social Activities Score 5 Point Scale</AlternateName>
        <AlternateNameType>Measure Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MOS_SOC_HLTH_INTF_SC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1292">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3906827</PUBLICID>
    <LONGNAME>Nodal Increase Diameter Confirmation Assessment Yes No Indicator</LONGNAME>
    <PREFERREDNAME>NODALINCREASE</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator for information related to the assessment to confirm the presence of increased nodal disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3906826</PublicId>
      <PreferredName>NODALINCREASE</PreferredName>
      <PreferredDefinition>Information related to the assessment to confirm the presence of increased nodal disease.</PreferredDefinition>
      <LongName>Nodal Increase Diameter Confirmation Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3906823</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25323</PreferredName>
        <Version>1</Version>
        <LongName>Nodal</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25323</PREFERRED_NAME>
            <LONG_NAME>Nodal</LONG_NAME>
            <CON_ID>2202852</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3906824</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25533:C25285:C25458:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Increase Diameter Confirmation Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25533</PREFERRED_NAME>
            <LONG_NAME>Increase</LONG_NAME>
            <CON_ID>2203826</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25285</PREFERRED_NAME>
            <LONG_NAME>Diameter</LONG_NAME>
            <CON_ID>2203909</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25458</PREFERRED_NAME>
            <LONG_NAME>Confirmation</LONG_NAME>
            <CON_ID>2203883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Increase of &gt;25% in nodal dis</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Increase of &gt;25% in nodal disease confirmed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NODALINCREASE</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1293">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3910299</PUBLICID>
    <LONGNAME>Flow Cytometry Zeta-Chain Associated Protein Kinase Performed Biospecimen Testing Status</LONGNAME>
    <PREFERREDNAME>ZAP70FLOW</PREFERREDNAME>
    <PREFERREDDEFINITION>The testing status of a protein tyrosine kinase in the syk family of kinases, with signaling functions in the T-cell receptor (TCR) signal transduction pathway.  Associates with the zeta and CD3 chains of the receptor.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3910292</PublicId>
      <PreferredName>ZAP70FLOW</PreferredName>
      <PreferredDefinition>Information related to a protein tyrosine kinase in the syk family of kinases, with signaling functions in the T-cell receptor (TCR) signal transduction pathway.  Associates with the zeta and CD3 chains of the receptor.</PreferredDefinition>
      <LongName>Flow Cytometry Zeta-Chain Associated Protein Kinase Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3910289</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16585</PreferredName>
        <Version>1</Version>
        <LongName>Flow Cytometry</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16585</PREFERRED_NAME>
            <LONG_NAME>Flow Cytometry</LONG_NAME>
            <CON_ID>2202602</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3910290</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17596:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Zeta-Chain Associated Protein Kinase Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17596</PREFERRED_NAME>
            <LONG_NAME>Tyrosine-Protein Kinase ZAP-70</LONG_NAME>
            <CON_ID>3637879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3009113</PublicId>
      <PreferredName>BIOS_TEST_STAT</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._A procedure for critical evaluation._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Biospecimen Testing Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3009112</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699:C15336:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Testing Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15336</PREFERRED_NAME>
            <LONG_NAME>Testing</LONG_NAME>
            <CON_ID>2204718</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>No testing done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a test was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2617835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2931646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ZAP-70 expression status by f</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>ZAP-70 expression status by flow cytometry</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ZAP70FLOW</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1294">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4035076</PUBLICID>
    <LONGNAME>Physician Diagnosed Infection Attribution Oral Antibiotic Therapy Within 12 Months Personal Medical History Yes No Not Applicable Indicator</LONGNAME>
    <PREFERREDNAME>INF_12M_ORAL_HX_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to signify whether a physician has diagnosed any infection in a patient that required oral antibiotics within the last 12 months.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3912559</PublicId>
      <PreferredName>3912557v1.0:3912554v1.0</PreferredName>
      <PreferredDefinition>A doctor; a person who has been educated, trained, and licensed to practice the art and science of medicine; a practitioner of medicine, as contrasted with a surgeon._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact._To assign to a cause or source._The condition of being treated as a patient in a hospital._Oral; of, or relating to, or affecting, or for use in the mouth._Treatment of bacterial infections with antibiotics._On the inside; contained in._A number with no fractional part, including the negative and positive numbers as well as zero.::12_One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks._an account of all medical events and problems a person has experienced_</PreferredDefinition>
      <LongName>Physician Diagnosed Infection Attribution Oral Antibiotic Therapy Within 12 Months Personal Medical History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3912557</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3912557v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Physician Diagnosis Infection Attribution Oral Antibiotic Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25741</PREFERRED_NAME>
            <LONG_NAME>Physician</LONG_NAME>
            <CON_ID>2202785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26726</PREFERRED_NAME>
            <LONG_NAME>Infectious Disorder</LONG_NAME>
            <CON_ID>2203837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25358</PREFERRED_NAME>
            <LONG_NAME>Attribution</LONG_NAME>
            <CON_ID>2202570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25311</PREFERRED_NAME>
            <LONG_NAME>Oral</LONG_NAME>
            <CON_ID>2204975</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15620</PREFERRED_NAME>
            <LONG_NAME>Antibiotic Therapy</LONG_NAME>
            <CON_ID>3528418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3912554</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3912554v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Within Integer::12 Month Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25282</PREFERRED_NAME>
            <LONG_NAME>Within</LONG_NAME>
            <CON_ID>2206273</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::12</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017177</PublicId>
      <PreferredName>YES_NO_NA_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable.</PreferredDefinition>
      <LongName>Yes No Not Applicable Indicator</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2179965</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Indicator</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Infection requiring oral anti</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Infection requiring oral antibiotics within last 12 months</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1295">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4076172</PUBLICID>
    <LONGNAME>Prostate Hot Flashes Problem Past 4 Week Frequency Scale</LONGNAME>
    <PREFERREDNAME>epic_69</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent changes in hot flash symptoms associated with prostate cancer and treatment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2528008</PublicId>
      <PreferredName>PRS_QOL_HOTFLAS_PROB</PreferredName>
      <PreferredDefinition>related to changes in ability to perform routine tasks of daily living due to interference from hot flash symptoms associated with prostate cancer and treatment.</PreferredDefinition>
      <LongName>Prostate Quality of Life Hot Flashes Problem</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2527736</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12410:C17047</PreferredName>
        <Version>1</Version>
        <LongName>Prostate Quality of Life</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12410</PREFERRED_NAME>
            <LONG_NAME>Prostate Gland</LONG_NAME>
            <CON_ID>2202794</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17047</PREFERRED_NAME>
            <LONG_NAME>Quality of Life</LONG_NAME>
            <CON_ID>2202504</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528006</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3109:C28020</PreferredName>
        <Version>1</Version>
        <LongName>Hot Flashes Problem</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3109</PREFERRED_NAME>
            <LONG_NAME>Hot Flashes</LONG_NAME>
            <CON_ID>2526149</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28020</PREFERRED_NAME>
            <LONG_NAME>Problem</LONG_NAME>
            <CON_ID>2203953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4037991</PublicId>
      <PreferredName>PST4WK_FREQ_SCL</PreferredName>
      <PreferredDefinition>Past; before the present time._A number with no fractional part.::4_Any period of seven consecutive days._The number of occurrences of something within a given time period. (NCI)_an ordered reference standard.</PreferredDefinition>
      <LongName>Past 4 Week Frequency Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3210568</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3210568v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Past Integer::4 Week Urine Leakage Frequency Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29844</PREFERRED_NAME>
            <LONG_NAME>Week</LONG_NAME>
            <CON_ID>2203710</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13283</PREFERRED_NAME>
            <LONG_NAME>Urine</LONG_NAME>
            <CON_ID>2202425</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40416</PREFERRED_NAME>
            <LONG_NAME>Leakage</LONG_NAME>
            <CON_ID>2204004</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>More than once a day</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: Occurring or done each day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25473, C61584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>About once a day</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring or done each day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>More than once a week</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: Every week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67069, C61584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>About once a week</VALUEMEANING>
          <MEANINGDESCRIPTION>Every week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2867523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Rarely or never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.: Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543, C37998, C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Over the last 4 weeks, how of</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Over the last 4 weeks, how often have you experienced hot flashes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886752</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>For Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EPIC CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4030518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1296">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4148392</PUBLICID>
    <LONGNAME>Clinical Study Involvement Yes No Indicator</LONGNAME>
    <PREFERREDNAME>4148391v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator related to a patient&#39;s involvement with a clinical study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4148391</PublicId>
      <PreferredName>2176981v1.0:2192548v1.0</PreferredName>
      <PreferredDefinition>Information related to involvement with a clinical study</PreferredDefinition>
      <LongName>Clinical Study Involvement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176981</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Study</PreferredName>
        <Version>1</Version>
        <LongName>Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2192548</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25548</PreferredName>
        <Version>1</Version>
        <LongName>Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the patient have involvem</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the patient have involvement in the planning and/or conduct of the study</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1297">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4187451</PUBLICID>
    <LONGNAME>Urine New Monoclonal Band Or Oligoclonal Bands Present Indicator</LONGNAME>
    <PREFERREDNAME>4187448v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not new monoclonal bands or oligoclonal bands were present in the urine.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4187448</PublicId>
      <PreferredName>4187446v1.0:2233878v1.0</PreferredName>
      <PreferredDefinition>The fluid that is excreted by the kidneys.  It is stored in the bladder and discharged through the urethra._Having no previous example or precedent or parallel; of a kind not seen before._Monoclonal immunoglobulin or monoclonal light chain that is present in the serum and/or urine. It is the result of a clonal B-cell or plasma cell proliferation._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._The presence of more than one immunoglobulin band in the serum, urine, or cerebrospinal fluid. It usually results from infectious or immunologic disorders._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Urine New Monoclonal Band Or Oligoclonal Bands Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4187446</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4187446v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Urine New Monoclonal Band Or Oligoclonal Bands</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13283</PREFERRED_NAME>
            <LONG_NAME>Urine</LONG_NAME>
            <CON_ID>2202425</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25586</PREFERRED_NAME>
            <LONG_NAME>New</LONG_NAME>
            <CON_ID>2204982</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113808</PREFERRED_NAME>
            <LONG_NAME>Monoclonal Band</LONG_NAME>
            <CON_ID>4183208</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113809</PREFERRED_NAME>
            <LONG_NAME>Oligoclonal Bands</LONG_NAME>
            <CON_ID>4183219</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were new monoclonal bands or</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Were new monoclonal bands or oligoclonal bands present in the urine?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>New monoclonal (or oligoclonal) bands</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>New monoclonal (or oligoclonal) bands</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>New monoclonal (or oligoclonal) bands</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>New monoclonal (or oligoclonal) bands</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>New monoclonal bands</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>New monoclonal bands</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mye_post_urin_imm_cur_new</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mye_post_urin_imm_bst_new</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_best_resp_stat_ur_new_monoclonal_band_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpre_lab_prep_urin_new_monoclon_band_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_dis_stat_urine_new_monoclonal_bands_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1298">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4187723</PUBLICID>
    <LONGNAME>Adverse Event Therapeutic Procedure Yes or No Response</LONGNAME>
    <PREFERREDNAME>3735415v1.0:4187713v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator to select if treatment was given and/or procedures were performed for the adverse event.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3735415</PublicId>
      <PreferredName>2235992v1.0:2554155v1.0</PreferredName>
      <PreferredDefinition>Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.</PreferredDefinition>
      <LongName>Adverse Event Therapeutic Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>LCC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2235992</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2554155</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4187713</PublicId>
      <PreferredName>4187713v1.0</PreferredName>
      <PreferredDefinition>A response or indicator that can have a value of either yes or no.</PreferredDefinition>
      <LongName>Yes or No Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, both treatment given and procedure performed</VALIDVALUE>
          <VALUEMEANING>Yes, both treatment given and procedure performed</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, both treatment given and procedure performed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4187714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, procedure performed</VALIDVALUE>
          <VALUEMEANING>Yes, procedure performed</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, procedure performed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4187715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, treatment given</VALIDVALUE>
          <VALUEMEANING>Yes, treatment given</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, treatment given</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4187716</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3216924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was treatment given or proced</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was treatment given or procedure performed for this adverse event</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1299">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4187871</PUBLICID>
    <LONGNAME>Troponin T Laboratory Procedure Performed Upper Limit of Normal 3 Decimal Place Microgram per Liter Value</LONGNAME>
    <PREFERREDNAME>3144001v1.0:4183737v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The 3 decimal place microgram per liter numeric laboratory value representing the upper level of the normal range of values of troponin T in a specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3144001</PublicId>
      <PreferredName>3144141v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>Troponin I, troponin T, and troponin C are the three closely associated subunits of the troponin complex of thin filaments in muscle.  The complex serves as a calcium-sensitive switch that regulates muscle contraction.  Because it is not normally found in blood, cardiac troponin-T in serum is a sensitive indicator of myocardial cell injury._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Troponin T Laboratory Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3144141</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38041:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Troponin T Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38041</PREFERRED_NAME>
            <LONG_NAME>Troponin T</LONG_NAME>
            <CON_ID>2978372</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>RADLEX_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4183737</PublicId>
      <PreferredName>4183737v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter._A number with no fractional part, including the negative and positive numbers as well as zero.::3_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumetric mass) defined as the density of a substance which mass equal to one microgram occupies the volume of one liter._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Laboratory Procedure Upper Limit of Normal 3 Decimal Place Microgram per Liter Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>ug/l</UnitOfMeasure>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>3</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>5671591</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5671591v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Upper Limit of Normal Integer::3 Decimal Place Microgram per Liter Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25706</PREFERRED_NAME>
            <LONG_NAME>Upper Limit of Normal</LONG_NAME>
            <CON_ID>2203609</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67306</PREFERRED_NAME>
            <LONG_NAME>Microgram per Liter</LONG_NAME>
            <CON_ID>2719065</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the upper limit of no</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the upper limit of normal for troponin T?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Upper limit of normal for troponin T:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Upper limit of normal for troponin T:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Upper limit of normal for troponin T:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Upper limit of normal for troponin T:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpre_amy_organ_invol_prep_troponin_T_uln_value</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpre_amy_organ_inv_diag_troponin_T_uln_value</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1300">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4192292</PUBLICID>
    <LONGNAME>Liver Diagnostic Investigation Specify</LONGNAME>
    <PREFERREDNAME>4192273v1.0:2556910v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Specify details of the liver diagnostic investigation</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4192273</PublicId>
      <PreferredName>2177203v1.0:4192271v1.0</PreferredName>
      <PreferredDefinition>Information related to the diagnostic information resulting from the investigation of the liver.</PreferredDefinition>
      <LongName>Liver Diagnostic Investigation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177203</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Liver</PreferredName>
        <Version>1</Version>
        <LongName>Liver</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12392</PREFERRED_NAME>
            <LONG_NAME>Liver</LONG_NAME>
            <CON_ID>2202332</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4192271</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25482:C41198</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic Investigation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25482</PREFERRED_NAME>
            <LONG_NAME>Diagnostic</LONG_NAME>
            <CON_ID>2202397</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41198</PREFERRED_NAME>
            <LONG_NAME>Investigation</LONG_NAME>
            <CON_ID>2469351</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2556910</PublicId>
      <PreferredName>SPEC</PreferredName>
      <PreferredDefinition>Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435024</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1908</PreferredName>
        <Version>1</Version>
        <LongName>Drug or Chemical</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2390957</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25685</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Liver diagnostic investigatio</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Liver diagnostic investigation specification</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1301">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4255292</PUBLICID>
    <LONGNAME>Fibrinogen Antigen Assay Performed Lab Unit of Measure Name</LONGNAME>
    <PREFERREDNAME>4252013v1.0:2017137v3.2</PREFERREDNAME>
    <PREFERREDDEFINITION>The unit of measure that represents a determinate amount or quantity of fibrinogen antigen assays in a laboratory specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4252013</PublicId>
      <PreferredName>4252011v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>A fibrillar protein present in blood plasma; it converts to fibrin during the process of blood clot formation._Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens._A qualitative or quantitative analysis performed to determine the amount of a particular constituent in a sample or the biological or pharmacological potency of a drug._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Fibrinogen Antigen Assay Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4252011</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25736:C268:C60819</PreferredName>
        <Version>1</Version>
        <LongName>Fibrinogen Antigen Assay</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25736</PREFERRED_NAME>
            <LONG_NAME>Fibrinogen</LONG_NAME>
            <CON_ID>2204944</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C268</PREFERRED_NAME>
            <LONG_NAME>Antigen</LONG_NAME>
            <CON_ID>2202300</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60819</PREFERRED_NAME>
            <LONG_NAME>Assay</LONG_NAME>
            <CON_ID>2528534</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017137</PublicId>
      <PreferredName>LAB_UOM_NM</PreferredName>
      <PreferredDefinition>Unit of measure standard values to describe a lab test result.</PreferredDefinition>
      <LongName>Lab Unit of Measure Name</LongName>
      <Version>3.2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L</VALIDVALUE>
          <VALUEMEANING>LITER</VALUEMEANING>
          <MEANINGDESCRIPTION>LITER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol</VALIDVALUE>
          <VALUEMEANING>MILLIMOLE</VALUEMEANING>
          <MEANINGDESCRIPTION>MILLIMOLE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/L</VALIDVALUE>
          <VALUEMEANING>millimole per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>millimole per liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg</VALIDVALUE>
          <VALUEMEANING>milligram per kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a mass fraction expressed as a number of milligrams of substance per kilogram of mixture. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unit</VALIDVALUE>
          <VALUEMEANING>Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>Any division of quantity accepted as a standard of measurement or exchange.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C44278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/mL</VALIDVALUE>
          <VALUEMEANING>Nanograms per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumetric mass) defined as the density of a substance which mass equal to one microgram occupies the volume of one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%</VALIDVALUE>
          <VALUEMEANING>Percent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g</VALIDVALUE>
          <VALUEMEANING>Grams (g)</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass equal to one one thousandth of a kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IUnit/L</VALIDVALUE>
          <VALUEMEANING>International unit per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one liter of the system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq</VALIDVALUE>
          <VALUEMEANING>Milliequivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance equal to one thousandth of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/24hr</VALIDVALUE>
          <VALUEMEANING>Milliequivalents per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance crosses a given surface or is delivered to a given object or space over a period of time equal to twenty four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/dL</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of milliequivalents of solute per deciliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/L</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of milliequivalents of solute per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/dL</VALIDVALUE>
          <VALUEMEANING>Milligram per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67015</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/mL</VALIDVALUE>
          <VALUEMEANING>Milligram per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of mass concentration defined as the concentration of one kilogram of a substance per unit volume of the mixture equal to one cubic meter, or the concentration of one milligram of a substance per unit volume of the mixture equal to one milliliter, or one gram of a substance per one liter of the mixture. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million</VALIDVALUE>
          <VALUEMEANING>Million</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number following 999999 and preceding 100001 and the quantity that it denotes: one thousand thousand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>miu</VALIDVALUE>
          <VALUEMEANING>Milliinternational unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one-thousandth of an international unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>miu/m2</VALIDVALUE>
          <VALUEMEANING>Milliinternational units per meter squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one-thousandth (10E-3) of an arbitrary unit of biological activity (International Unit) of substance per square meter of body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg</VALIDVALUE>
          <VALUEMEANING>Picograms</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass equal to one trillionth of a gram (10E-12 gram).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand</VALIDVALUE>
          <VALUEMEANING>Thousand</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number following 999 and preceding 1001 and the quantity that it denotes: ten times one hundred.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg</VALIDVALUE>
          <VALUEMEANING>Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of weight.  A milligram is approximately 450,000 times smaller than a pound and 28,000 times smaller than an ounce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-05-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>Thousand per microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm2</VALIDVALUE>
          <VALUEMEANING>Thousand per millimeter squared</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter squared</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm3</VALIDVALUE>
          <VALUEMEANING>Thousand per millimeter cubed</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E12 Cells/L</VALIDVALUE>
          <VALUEMEANING>10E12 Cells per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of cell concentration expressed as a number of cells in trillions per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67243</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E3 Cells/microL</VALIDVALUE>
          <VALUEMEANING>10E3 Cells per microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>10E3 Cells per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mill PFU</VALIDVALUE>
          <VALUEMEANING>Million Plaque Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of viable infectious entities expressed in millions in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope or/and to the naked eye as a plaque.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Srce</VALIDVALUE>
          <VALUEMEANING>No Source Data</VALUEMEANING>
          <MEANINGDESCRIPTION>Information regarding the subject is unknown or inaccessible at this time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kU/L</VALIDVALUE>
          <VALUEMEANING>Kilounit per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in thousands of units of biological activity per unit of mass equal to one kilogram. Kilounit per kilogram is also used as a dose calculation unit expressed in thousands of arbitrary units per one kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cubic microns</VALIDVALUE>
          <VALUEMEANING>Cubic microns</VALUEMEANING>
          <MEANINGDESCRIPTION>Cubic microns</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EU</VALIDVALUE>
          <VALUEMEANING>Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The property used in conjunction with a nutrient or food component, typically expressed in gram (g), milligram (mg), microgram (mcg), joule, or kilojoule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EU/dL</VALIDVALUE>
          <VALUEMEANING>Enzyme Units per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Enzyme Units per deciliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EU/mL</VALIDVALUE>
          <VALUEMEANING>Enzyme Units per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Enzyme Units per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fL</VALIDVALUE>
          <VALUEMEANING>Femtoliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-SI unit of volume accepted for use with the SI equal to one quadrillionth of a liter (10E-15 liter).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/24hr</VALIDVALUE>
          <VALUEMEANING>Gram per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>Gram per 24 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/dL</VALIDVALUE>
          <VALUEMEANING>Gram per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Gram per deciliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/L</VALIDVALUE>
          <VALUEMEANING>Gram per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Gram per liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/microL</VALIDVALUE>
          <VALUEMEANING>Gram per microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Gram per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPF</VALIDVALUE>
          <VALUEMEANING>Per High Power Field</VALUEMEANING>
          <MEANINGDESCRIPTION>Per High Power Field</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iunit</VALIDVALUE>
          <VALUEMEANING>INTERNATIONAL UNIT</VALUEMEANING>
          <MEANINGDESCRIPTION>The unitage assigned by the WHO to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization (e.g. hormones, enzymes, and vaccines), to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48579</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IUnit/m2</VALIDVALUE>
          <VALUEMEANING>International unit per meter squared</VALUEMEANING>
          <MEANINGDESCRIPTION>International unit per meter squared</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IUnit/mL</VALIDVALUE>
          <VALUEMEANING>International unit per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IUnit/mL</VALIDVALUE>
          <VALUEMEANING>IU/mL</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE>2019-04-30</PVENDDATE>
          <VMPUBLICID>2573880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LPF</VALIDVALUE>
          <VALUEMEANING>Per Low Power Field</VALUEMEANING>
          <MEANINGDESCRIPTION>Per Low Power Field</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mcg/24hr</VALIDVALUE>
          <VALUEMEANING>Microgram per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>Microgram per 24 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mcg/dL</VALIDVALUE>
          <VALUEMEANING>Microgram per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Microgram per deciliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mcg/L</VALIDVALUE>
          <VALUEMEANING>microgram per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>microgram per liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mcg/mL</VALIDVALUE>
          <VALUEMEANING>Microgram per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Microgram per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567625</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mcg/spec</VALIDVALUE>
          <VALUEMEANING>Microgram per specimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Microgram per specimen</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/kg</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliequivalent per kilogram</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/L</VALIDVALUE>
          <VALUEMEANING>Milligram per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Milligram per liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/mL/min</VALIDVALUE>
          <VALUEMEANING>Milligram per milliliter per minute</VALUEMEANING>
          <MEANINGDESCRIPTION>Milligram per milliliter per minute</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>microIU/mL</VALIDVALUE>
          <VALUEMEANING>Micro International Unit per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Micro International Unit per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>microL</VALIDVALUE>
          <VALUEMEANING>MICROLITER</VALUEMEANING>
          <MEANINGDESCRIPTION>MICROLITER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>micromol/24hr</VALIDVALUE>
          <VALUEMEANING>Micromole per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>Micromole per 24 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>micromol/dL</VALIDVALUE>
          <VALUEMEANING>Micromole per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Micromole per deciliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>micromol/L</VALIDVALUE>
          <VALUEMEANING>Micromole per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Micromole per liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>Million per microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>miu/mL</VALIDVALUE>
          <VALUEMEANING>Milliinternational unit per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliinternational unit per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL</VALIDVALUE>
          <VALUEMEANING>Milliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per minute</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliliter per minute</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/min/1.73/BSA</VALIDVALUE>
          <VALUEMEANING>Milliliter per minute times 1.73 times BSA</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliliter per minute times 1.73 times BSA</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/minute/mmHg</VALIDVALUE>
          <VALUEMEANING>Milliter per minute per millimeters of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliter per minute per millimeters of Mercury</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm/hr</VALIDVALUE>
          <VALUEMEANING>Millimeter per hour</VALUEMEANING>
          <MEANINGDESCRIPTION>Millimeter per hour</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm3</VALIDVALUE>
          <VALUEMEANING>Millimeter cubed</VALUEMEANING>
          <MEANINGDESCRIPTION>Millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg</VALIDVALUE>
          <VALUEMEANING>Millimeter of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth&#39;s surface. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/24hr</VALIDVALUE>
          <VALUEMEANING>Millimole per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>Millimole per 24 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mosmol/kg</VALIDVALUE>
          <VALUEMEANING>Milliosmole per kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliosmole per kilogram</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MU/mL</VALIDVALUE>
          <VALUEMEANING>Million units per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Million units per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not applicable; no UOM required</VALUEMEANING>
          <MEANINGDESCRIPTION>Not applicable; no UOM required</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/mL/hr</VALIDVALUE>
          <VALUEMEANING>Nanogram per milliliter per hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to mass concentration of a substance expressed in nanograms per unit volume of one milliliter per time period of one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/L</VALIDVALUE>
          <VALUEMEANING>Nanomole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nMol/mg protein</VALIDVALUE>
          <VALUEMEANING>Nanomole per milligram of protein</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanomole per milligram of protein</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573910</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/mL</VALIDVALUE>
          <VALUEMEANING>Nanomole per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanomole per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg/dL</VALIDVALUE>
          <VALUEMEANING>Picogram per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Picogram per deciliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pgPGE2/mg protein</VALIDVALUE>
          <VALUEMEANING>pgPGE2/mg protein</VALUEMEANING>
          <MEANINGDESCRIPTION>pgPGE2/mg protein</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/L</VALIDVALUE>
          <VALUEMEANING>Picomole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one trillionth of a mole (10E-12 mole) in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ratio</VALIDVALUE>
          <VALUEMEANING>ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>ratio</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>sec</VALIDVALUE>
          <VALUEMEANING>seconds</VALUEMEANING>
          <MEANINGDESCRIPTION>seconds</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0457385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unit/24hr</VALIDVALUE>
          <VALUEMEANING>Unit per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit per 24 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unit/L</VALIDVALUE>
          <VALUEMEANING>Unit per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit per liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unit/mL</VALIDVALUE>
          <VALUEMEANING>Unit per millilliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit per millilliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unit/mm3</VALIDVALUE>
          <VALUEMEANING>Unit per millimeters cubed</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit per millimeters cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E7 Cells/kg</VALIDVALUE>
          <VALUEMEANING>10E7 Cells per kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>10E7 Cells per kilogram</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/min</VALIDVALUE>
          <VALUEMEANING>Liters per minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one liter of matter crosses a given surface during the period of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/24hr</VALIDVALUE>
          <VALUEMEANING>Milligram per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to twenty four hours. Milligram per twenty four hours is also a dose administration rate unit equal to the rate at which one thousandth of a gram of a product is administered per unit of time equal to twenty four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unit/m2</VALIDVALUE>
          <VALUEMEANING>Unit per meter squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed as a number of arbitrary units of substance per one square meter of a body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%/100 WBC</VALIDVALUE>
          <VALUEMEANING>Percent Per 100 WBC</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for percentage measurement of fraction of any type of white blood cells in the total white blood cell count differential.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/mm3</VALIDVALUE>
          <VALUEMEANING>Per millimeter cubed</VALUEMEANING>
          <MEANINGDESCRIPTION>Per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E6 Cells</VALIDVALUE>
          <VALUEMEANING>10E6 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of cell count expressed in millions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E6 Cells/microL</VALIDVALUE>
          <VALUEMEANING>10E6 Cells per microLiter</VALUEMEANING>
          <MEANINGDESCRIPTION>10E6 Cells per microLiter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E6 Cells/mm3</VALIDVALUE>
          <VALUEMEANING>10E6 Cells per millimeter cubed</VALUEMEANING>
          <MEANINGDESCRIPTION>10E6 Cells per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E8 Cells</VALIDVALUE>
          <VALUEMEANING>10E8 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>10E8 Cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E9 Cells</VALIDVALUE>
          <VALUEMEANING>10E9 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>10E9 Cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E9 Cells/L</VALIDVALUE>
          <VALUEMEANING>10E9 Cells per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>10E9 Cells per Liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cells/microL</VALIDVALUE>
          <VALUEMEANING>Cells per microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Cells per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Copies</VALIDVALUE>
          <VALUEMEANING>Copies</VALUEMEANING>
          <MEANINGDESCRIPTION>Copies</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/dL</VALIDVALUE>
          <VALUEMEANING>nanogram per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>nanogram per deciliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg/mL</VALIDVALUE>
          <VALUEMEANING>Picrogram per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Picrogram per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100 WBC</VALIDVALUE>
          <VALUEMEANING>Per 100 identifiable White blood cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit for measurement of portion of a particular type of blood cells (such as any type of white blood cells or nucleated red blood cells) in the total white blood cell count expressed per count of 100.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAE Unit</VALIDVALUE>
          <VALUEMEANING>Complement activity enzyme unit</VALUEMEANING>
          <MEANINGDESCRIPTION>Complement activity enzyme unit</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Titer</VALIDVALUE>
          <VALUEMEANING>Titer</VALUEMEANING>
          <MEANINGDESCRIPTION>Titer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RNA copies/mL</VALIDVALUE>
          <VALUEMEANING>RNA copies per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>RNA copies per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-04-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574343</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/mm3</VALIDVALUE>
          <VALUEMEANING>Million per millimeter cubed</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cubic microns</VALIDVALUE>
          <VALUEMEANING>CU MIC</VALUEMEANING>
          <MEANINGDESCRIPTION>Cubic Microns</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cubic microns</VALIDVALUE>
          <VALUEMEANING>CU MICR</VALUEMEANING>
          <MEANINGDESCRIPTION>Cubic microns</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cubic microns</VALIDVALUE>
          <VALUEMEANING>CU MICRON</VALUEMEANING>
          <MEANINGDESCRIPTION>Cubic microns</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GPL</VALIDVALUE>
          <VALUEMEANING>IgG anti-cardiolipin antibodies</VALUEMEANING>
          <MEANINGDESCRIPTION>IgG anti-cardiolipin antibodies</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Index value</VALIDVALUE>
          <VALUEMEANING>Index value</VALUEMEANING>
          <MEANINGDESCRIPTION>Index value</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>microU/mL</VALIDVALUE>
          <VALUEMEANING>Microunit per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Microunit per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>M/mcL</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>M/microL</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>M/UI</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>MILL/MCL</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>Mil/UI</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/mm3</VALIDVALUE>
          <VALUEMEANING>M/cmm</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/mm3</VALIDVALUE>
          <VALUEMEANING>MILL/CMM</VALUEMEANING>
          <MEANINGDESCRIPTION>MILL/CMM</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/mm3</VALIDVALUE>
          <VALUEMEANING>M/mm3</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576484</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/minute/mmHg/L</VALIDVALUE>
          <VALUEMEANING>Milliliter per minute per millimeter Hg per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliliter per minute per millimeter Hg per Liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576487</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/min/kPa/L</VALIDVALUE>
          <VALUEMEANING>Millimole per minute per thousand Pascal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Millimole per minute per thousand Pascal per Liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MPL</VALIDVALUE>
          <VALUEMEANING>IgM anti-cardiolipin antibodies</VALUEMEANING>
          <MEANINGDESCRIPTION>IgM anti-cardiolipin antibodies</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>THOU/MCL</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>THOU/UL</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>THOUS/MCL</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576492</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>K/uL</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>K/microL</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm2</VALIDVALUE>
          <VALUEMEANING>K/mm2</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter squared</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm2</VALIDVALUE>
          <VALUEMEANING>1000/mm2</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter squared</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm3</VALIDVALUE>
          <VALUEMEANING>THOU/CMM</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm3</VALIDVALUE>
          <VALUEMEANING>K/mm3</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm3</VALIDVALUE>
          <VALUEMEANING>K/cmm</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm3</VALIDVALUE>
          <VALUEMEANING>1000/mm3</VALUEMEANING>
          <MEANINGDESCRIPTION>1000/mm3</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm3</VALIDVALUE>
          <VALUEMEANING>Thous/CMM</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/sec</VALIDVALUE>
          <VALUEMEANING>Liter per second</VALUEMEANING>
          <MEANINGDESCRIPTION>Liter per second</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>M/uL</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>1000/microL</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Threshold</VALIDVALUE>
          <VALUEMEANING>Threshold</VALUEMEANING>
          <MEANINGDESCRIPTION>The lowest limit at which something becomes detectable or relevant.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E6/L</VALIDVALUE>
          <VALUEMEANING>10E6 per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>10E6 per Liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2755857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ukat/L</VALIDVALUE>
          <VALUEMEANING>Microkatal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of catalytic activity concentration defined as activity equal to one millionth of katal per one liter of the system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/hr/mg protein</VALIDVALUE>
          <VALUEMEANING>Picomole per hour per milligram of protein</VALUEMEANING>
          <MEANINGDESCRIPTION>Picomole per hour per milligram of protein</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3004123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/hr/mg protein</VALIDVALUE>
          <VALUEMEANING>Nanomole per hour per milligram of protein</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanomole per hour per milligram of protein</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3004124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trillion/L</VALIDVALUE>
          <VALUEMEANING>Trillion/Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Trillion per Liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3161477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Billion/L</VALIDVALUE>
          <VALUEMEANING>Billion/Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Billion per Liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3161478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/g</VALIDVALUE>
          <VALUEMEANING>milligram per gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a mass fraction expressed as a number of grams of substance per kilogram of mixture. Gram per kilogram is also used as a dose calculation unit to express a quantity of substance in grams per one kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69104</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-12-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3170018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Minutes</VALIDVALUE>
          <VALUEMEANING>Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/24hr</VALIDVALUE>
          <VALUEMEANING>Milliliter Per Integer::24 Hour Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of volume for a liquid.  A milliliter is approximately 950 times smaller than a quart and 30 times smaller than a fluid ounce.  A milliliter of liquid and a cubic centimeter (cc) of liquid are the same.: For each, generally denoting a ratio.: A number with no fractional part, including the negative and positive numbers as well as zero.::24: In modern usage, an hour is defined as a unit of time 60 minutes, or 3600 seconds in length. It is approximately 1/24 of a median day.: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C25529, C45255::24, C65039, C28254</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3402649</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mU/mL</VALIDVALUE>
          <VALUEMEANING>Milliunit Per Milliliter Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantity equivalent to the one thousandth unit (10E-3 unit).: For each, generally denoting a ratio.: A measure of volume for a liquid.  A milliliter is approximately 950 times smaller than a quart and 30 times smaller than a fluid ounce.  A milliliter of liquid and a cubic centimeter (cc) of liquid are the same.: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C28254, C65039, C67315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3402650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hours</VALIDVALUE>
          <VALUEMEANING>Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>In modern usage, an hour is defined as a unit of time 60 minutes, or 3600 seconds in length. It is approximately 1/24 of a median day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25529</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cells/kg</VALIDVALUE>
          <VALUEMEANING>Cell Per Kilogram Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>Any small compartment.: For each, generally denoting a ratio.: A basic SI unit of mass. It is definied as the mass of an  international prototype in the form of a platinum-iridium cylinder kept at Sevres in france.   A kilogram is equal to 1,000 grams and 2.2046226 pounds.: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C28252, C65039, C48694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3402651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Copies/mL</VALIDVALUE>
          <VALUEMEANING>Copy per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration of RNA copies expressed as a number of copies per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2X10E6 Cells</VALIDVALUE>
          <VALUEMEANING>Integer::2 Multiplication Million Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: An arithmetic operation by which the product of two numbers is computed; the inverse of division.: A natural number following 999999 and preceding 100001 and the quantity that it denotes: one thousand thousand.: The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12508, C67238, C65000, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-05-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3463258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E10</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 10 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::10: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::10, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E2</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 2 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::2: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::2, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E3</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 3 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::3: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45255::3, C95157, C25709, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 2, 0, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E5</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 5 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::5: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::5, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E4</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 4 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::4: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::4, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E7</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 7 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::7: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::7, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E6</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 6 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::6: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::6, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E9</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 9 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::9: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::9, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E8</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 8 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::8: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::8, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E12</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 12 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::12: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::12, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E11</VALIDVALUE>
          <VALUEMEANING>Ten Exponent:11 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::11: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::11, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E14</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 14 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::14: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::14, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E13</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 13 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::13: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::13, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E16</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 16 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::16: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::16, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E15</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 15 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::15: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::15, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E18</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 18 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::18: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::18, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624747</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E17</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 17 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::17: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::17, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E20</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 20 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::20: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::20, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E19</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 19 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::19: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::19, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2X10E8 Cells</VALIDVALUE>
          <VALUEMEANING>Two times 10E8 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Two times 10 exponential value 8 (one hundred million) cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-05-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3463259</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2X10E7 Cells</VALIDVALUE>
          <VALUEMEANING>Two times 10E7 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Two times 10 exponential value 7 (ten million) cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-05-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3463260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/min/kg</VALIDVALUE>
          <VALUEMEANING>Milliliter per Kilogram per Minute </VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per kilogram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73760</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3652827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Log</VALIDVALUE>
          <VALUEMEANING>Logarithm</VALUEMEANING>
          <MEANINGDESCRIPTION>For a specified base b, a function such that its argument results when b is raised to the power given by this function&#39;s value.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94925</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3703164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol CO/min/kPa</VALIDVALUE>
          <VALUEMEANING>Carbon Monoxide Millimoles per Minute per Kilopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>An odorless, tasteless, poisonous gas, CO, that results from the incomplete combustion of carbon. Inhalation causes central nervous system damage and asphyxiation.: A unit of gas diffusion capacity equal to one millimole per minute per kilopascal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116242, C76742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5037092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ml CO/min/mm Hg</VALIDVALUE>
          <VALUEMEANING>Carbon Monoxide Milliliter per Minute per Millimeters of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>An odorless, tasteless, poisonous gas, CO, that results from the incomplete combustion of carbon. Inhalation causes central nervous system damage and asphyxiation.: A unit for measuring a pulmonary diffusing capacity expressed in units of gas flow rate (in milliliters per minute) per a unit of pressure (in torrs).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67417, C76742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5037093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm H2O</VALIDVALUE>
          <VALUEMEANING>Centimeters of water</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure defined by a column of water with a height of one centimeter, frequently used to measure central venous pressure, intracranial pressure, and for pressures during mechanical ventilation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5477037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>copies/L</VALIDVALUE>
          <VALUEMEANING>Copy Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A secondary representation, reproduction, or replica.: A volume unit equal to one liter used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105515, C67336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5637481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Log10 IU/mL</VALIDVALUE>
          <VALUEMEANING>Log10 International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring international units per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5778792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/mL FEU</VALIDVALUE>
          <VALUEMEANING>Microgram per Milliliter Fibrinogen Equivalent Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one cubic meter. The concept also refers to the metric unit of mass density (volumic mass) defined as the density of a substance which mass equal to one gram occupies the volume of one cubic meter.: A unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of fibrinogen contained within that sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96649, C64572</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6479361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/mmol</VALIDVALUE>
          <VALUEMEANING>Gram per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass commonly used to express the molar mass of a substance in gram(s) per mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73721</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E-15L (fL)</VALIDVALUE>
          <VALUEMEANING>Ten Exponential Function 15 Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A function of the form f(x) = ab^x, characterized by the fact that the growth rate of such a function is directly proportional to the value of the function.: A number with no fractional part, including the negative and positive numbers as well as zero.::15: The non-SI unit of volume accepted for use with the SI. One liter is equal to cubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or approximately 61.023 744 cubic inches.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48505, C45255::15, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8057682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Copies per milliliter</VALIDVALUE>
          <VALUEMEANING>Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration expressed as a number of copies per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Log copies per milliliter</VALIDVALUE>
          <VALUEMEANING>Log10 Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arbitrary unit per milliliter</VALIDVALUE>
          <VALUEMEANING>Arbitrary Unit Per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A single undivided thing (unit) based on or subject to individual judgment or preference, and not by necessity, reason, or principle._A volume unit equal to one milliliter used as a denominator to build a derived unit expressed as a ratio. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103452, C75765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10631416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E9 Cells/microL</VALIDVALUE>
          <VALUEMEANING>10E9 Cells per microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>10E9 Cells per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-09-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15128242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/nL</VALIDVALUE>
          <VALUEMEANING>Per Nanoliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A volume unit equal to one nanoliter used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116243</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15424813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/pL</VALIDVALUE>
          <VALUEMEANING>Per Picoliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A volume unit equal to one picoliter used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117964</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15424812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the unit of measure f</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the unit of measure for fibrinogen antigen assay?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpost_assess_fibrinogen_antigen_assay_uom</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpre_clin_feat_lab_diag_fibrino_anti_assay_uom</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpre_clin_feat_lab_prep_fibrino_anti_assay_uom</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpost_lab_eval_fibrinogen_antigen_assay_uom</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpre_dis_stat_prep_fibrinogen_antigen_assay_uom</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1302">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4282940</PUBLICID>
    <LONGNAME>Non-Protocol Therapeutic Procedure Tyrosine Kinase Inhibitor Administered Specify</LONGNAME>
    <PREFERREDNAME>NPTKITYPE</PREFERREDNAME>
    <PREFERREDDEFINITION>The free-text field to specify information related to the administration of a non-protocol tyrosine kinase inhibitor therapy, any substance that inhibits tyrosine kinase, an enzyme involved in the transduction and processing of many extracellular and intracellular signals including cell proliferation. Inhibition of tyrosine kinase may result in inhibition of cell growth and cell proliferation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4282929</PublicId>
      <PreferredName>NPTKI</PreferredName>
      <PreferredDefinition>Information related to the administration of a non-protocol tyrosine kinase inhibitor therapy, any substance that inhibits tyrosine kinase, an enzyme involved in the transduction and processing of many extracellular and intracellular signals including cell proliferation. Inhibition of tyrosine kinase may result in inhibition of cell growth and cell proliferation.</PreferredDefinition>
      <LongName>Non-Protocol Therapeutic Procedure Tyrosine Kinase Inhibitor Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2614414</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25590:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Non-Protocol Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25590</PREFERRED_NAME>
            <LONG_NAME>Non-Protocol</LONG_NAME>
            <CON_ID>2206325</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4282927</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1967:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Tyrosine Kinase Inhibitor Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1967</PREFERRED_NAME>
            <LONG_NAME>Tyrosine Kinase Inhibitor</LONG_NAME>
            <CON_ID>2934693</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2179878</PublicId>
      <PreferredName>TX_ADM_SPEC</PreferredName>
      <PreferredDefinition>the free-text field to specify the therapy administered.</PreferredDefinition>
      <LongName>Therapy Administered Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208052</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Administered Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify type(s) of tyrosine k</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify type(s) of tyrosine kinase inhibitors</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NPTKITYPE</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1303">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4287507</PUBLICID>
    <LONGNAME>Correlative Study Specimen Collection Time</LONGNAME>
    <PREFERREDNAME>COR_ST_SPEC_COLL_TM</PREFERREDNAME>
    <PREFERREDDEFINITION>The time at which the sample for pharmacokinetic or other correlative study was collected.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PBTC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2422060</PublicId>
      <PreferredName>CORR_ST_SPEC_COLL</PreferredName>
      <PreferredDefinition>A type of study that tests for a relationship between a condition and a potential causal factor of the condition._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:The act of gathering things together; having been brought together in one place.</PreferredDefinition>
      <LongName>Correlative Study Specimen Collection</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2422056</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16100:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Correlative Study Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16100</PREFERRED_NAME>
            <LONG_NAME>Correlative Study</LONG_NAME>
            <CON_ID>2206187</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2413010</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25453</PreferredName>
        <Version>1</Version>
        <LongName>Collection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019249</PublicId>
      <PreferredName>TM</PreferredName>
      <PreferredDefinition>the time at which an event was observed or occurred.</PreferredDefinition>
      <LongName>Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>TIME</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>TIME (HR(24):MN)</DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184344</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Time</PreferredName>
        <Version>1</Version>
        <LongName>Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Collection time</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4254096</PublicId>
          <ContextName>PBTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PBTC-042</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4254119</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4254096</PublicId>
          <ContextName>PBTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase I</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>10000103</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1304">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4346933</PUBLICID>
    <LONGNAME>Neoplasm Resection Extent Stratification Type</LONGNAME>
    <PREFERREDNAME>EXTRESECTTYPE</PREFERREDNAME>
    <PREFERREDDEFINITION>The stratification type related to the extent to which an abnormal mass of tissue that results from excessive cell division was surgically removed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014805</PublicId>
      <PreferredName>TUM_RES_EXT</PreferredName>
      <PreferredDefinition>the extent to which an abnormal mass of tissue that results from excessive cell division was surgically removed.</PreferredDefinition>
      <LongName>Neoplasm Resection Extent</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2736813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3262:C15232</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm Excision</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15232</PREFERRED_NAME>
            <LONG_NAME>Excision</LONG_NAME>
            <CON_ID>2202806</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2500212</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25332</PreferredName>
        <Version>1</Version>
        <LongName>Extent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25332</PREFERRED_NAME>
            <LONG_NAME>Extent</LONG_NAME>
            <CON_ID>2203921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4346931</PublicId>
      <PreferredName>EXTRESECTTYPE</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Surgical Resection Stratification Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>Alliance Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Subtotal resection or biopsy</VALIDVALUE>
          <VALUEMEANING>Subtotal resection or biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgical removal of a part of a lesion; some portion of the lesion is detectable on post-operative evaluation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4346932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gross total resection</VALIDVALUE>
          <VALUEMEANING>Gross total resection</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgical removal of an entire visible lesion, with no obvious lesion detected on post-operative evaluation; microscopic residual disease may be present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131672</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Extent of resection</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Extent of resection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EXTRESECTTYPE</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1305">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4364113</PUBLICID>
    <LONGNAME>Patient Ophthalmological Condition Code Indicator</LONGNAME>
    <PREFERREDNAME>PT_EC_1016</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no/not applicable indicator that describes if patient has any known ophthalmological conditions.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4363773</PublicId>
      <PreferredName>2233604v1.0:4363771v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._A surgical specialty concerned with the structure and function of the eye and the medical and surgical treatment of its defects and diseases._A state of being, such as a state of health.</PreferredDefinition>
      <LongName>Patient Ophthalmological Condition</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4363771</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16939:C25457</PreferredName>
        <Version>1</Version>
        <LongName>Ophthalmology Condition</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16939</PREFERRED_NAME>
            <LONG_NAME>Ophthalmology</LONG_NAME>
            <CON_ID>2205431</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25457</PREFERRED_NAME>
            <LONG_NAME>Condition</LONG_NAME>
            <CON_ID>2202899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex Question</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have known ophthalmological conditions as follows: Intra-ocular pressure greater than 21 mmHg, or uncontrolled glaucoma (irrespective of intra-ocular pressure); Current or past history of central serous retinopathy or retinal vein occlusion?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have known ophth</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have known ophthalmological conditions?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a history or current evidence/risk of retinal vein occlusion (RVO)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a history or current evidence/risk of retinal vein occlusion (RVO) or central serous retinopathy (CSR)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_TEXT_1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have known macular degeneration, uncontrolled glaucoma, or cataracts</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have any Retinal Deposits?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have known ophthalmologic conditions such as, current or past history of retinal vein occlusion (RVO) or central serous retinopathy (CSR)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_TEXT_2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have known indicated significant ophthalmologic conditions</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a history or current evidence/risk of retinal vein occlusion (RVO) or retinal pigment epithelial detachment (RPED)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have known risk factors for ocular toxicity, consisting of any of the following: History of serous retinopathy or History of retinal vein occlusion (RVO) or Evidence of ongoing serous retinopathy or RVO at screening?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient  have history of OR evidence of retinal pathology on Ophthalmologic examination that is considered a risk factor for neurosensory retinal detachment, central serous chorioretinopathy, retinal vein occlusion (RVO), or neurovascular macular degeneration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient  have history of or evidence of retinal pathology on Ophthalmologic examination that is considered a risk factor for neurosensory retinal detachment, central serous chorioretinopathy, retinal vein occlusion (RVO), or neurovascular macular degeneration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_TEXT_3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have any of the following ophthalmologic conditions: Current or past history of central serous retinopathy, current or past history of retinal vein occlusion or retinal detachment, or uncontrolled glaucoma</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient has no evidence of retinal pathology on ophthalmologic examination; or neurosensory retinal detachment, RVO, or neovascular macular degeneration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a history of retinal vein occlusion?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have active ocular disorder or abnormality likely to significantly increase the risk of eye toxicity, such as history of or current evidence of central serous retinopathy or retinal vascular occlusion; active wet, age-related macular degeneration; diabetic retinopathy with macular edema; uncontrolled glaucoma (per local standard of care); corneal pathology such as keratitis, keratoconjunctivitis, keratopathy, corneal abrasion, and inflammation or ulceration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex -12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have evidence of retinal pathology on ophthalmologic examination; or neurosensory retinal detachment, RVO, or neovascular macular degeneration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 13</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient currently have central serous retinopathy (CSR) or retinal pigment epithelial detachment of any grade?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have clinically significant corneal disease?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 14</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have active ocular surface disease at baseline (based on ophthalmological evaluation)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 15</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have clinically significant corneal disease, in the opinion of the investigator?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 16</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a history or current evidence of glaucoma or clinically significant abnormalities on the ophthalmological exam, including but not limited to cataract limiting the ability to examine the retina or any optical coherence tomography (OCT) finding that could be a significant risk factor for retinal vein occlusion (RVO), retinopathy, or neovascular macular degeneration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876359</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Exclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical &amp; Concomitant Requirements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000083</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876594</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Theradex</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Theradex - CTMS 3.14</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3876603</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Theradex</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_EC_1016</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1306">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4380973</PUBLICID>
    <LONGNAME>Bone Marrow Specimen Receive Indicator</LONGNAME>
    <PREFERREDNAME>4380694v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no indicator response regarding whether a bone marrow (blood based tumor) tumor specimen was received at a specific location.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4380694</PublicId>
      <PreferredName>2721811v1.0:2241679v1.0</PreferredName>
      <PreferredDefinition>The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._To take, accept, or get something offered</PreferredDefinition>
      <LongName>Bone Marrow Specimen Receive</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2413068</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12431:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Bone Marrow Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12431</PREFERRED_NAME>
            <LONG_NAME>Bone Marrow</LONG_NAME>
            <CON_ID>2202685</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241679</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25639</PreferredName>
        <Version>1</Version>
        <LongName>Received</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Bone marrow (blood based invo</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Bone marrow (blood based involved tumor) tumor specimen received at the BCR:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the specimen received?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4631580</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Exceptional Responder CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exceptional Responder CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4631582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SPEC_REC_IND</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1307">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4385331</PUBLICID>
    <LONGNAME>Medical Device Operator Type</LONGNAME>
    <PREFERREDNAME>4359928v1.0:4385291v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Medical device - any machinery designed to aid diagnostic and medical therapies. Medical device has to be designed with rigorous safety standards. There are several basic types of medical devices: life support equipment used to maintain a patient&#39;s body functions; therapeutic equipment; monitors and detectors to measure the indexes of a patient&#39;s state; imagine machines and laboratory equipment used with diagnostic and status monitoring purposes. In insurance parlance, the term is usually synonymous with assistive device, although it may include medical supplies._Different than the one(s) previously specified or mentioned.:According to the Title 21 Chapter 9 Federal Food, Drug and Cosmetic Act, a medical device is any instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is recognized in the official National Formulary, or the United States Pharmacopeia, or any supplement to them; intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes.:An individual who handles and controls the functioning of medical device._Something distinguishable as an identifiable class based on common qualities.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ONC SDC Project</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4359928</PublicId>
      <PreferredName>2541698v1.0:4359926v1.0</PreferredName>
      <PreferredDefinition>Medical device - any machinery designed to aid diagnostic and medical therapies. Medical device has to be designed with rigorous safety standards. There are several basic types of medical devices: life support equipment used to maintain a patient&#39;s body functions; therapeutic equipment; monitors and detectors to measure the indexes of a patient&#39;s state; imagine machines and laboratory equipment used with diagnostic and status monitoring purposes. In insurance parlance, the term is usually synonymous with assistive device, although it may include medical supplies._Different than the one(s) previously specified or mentioned.:According to the Title 21 Chapter 9 Federal Food, Drug and Cosmetic Act, a medical device is any instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is recognized in the official National Formulary, or the United States Pharmacopeia, or any supplement to them; intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes.:An individual who handles and controls the functioning of medical device.</PreferredDefinition>
      <LongName>Medical Device Operator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19238</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic, Therapeutic, and Research Equipment</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2541698</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16830</PreferredName>
        <Version>1</Version>
        <LongName>Medical_Device</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16830</PREFERRED_NAME>
            <LONG_NAME>Medical Device</LONG_NAME>
            <CON_ID>2240760</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4359926</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C53272</PreferredName>
        <Version>1</Version>
        <LongName>Operator of Medical Device</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53272</PREFERRED_NAME>
            <LONG_NAME>Operator of Medical Device</LONG_NAME>
            <CON_ID>2527473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4385291</PublicId>
      <PreferredName>4385291v1.0</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Device Operator Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435033</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16847</PreferredName>
        <Version>1</Version>
        <LongName>Techniques</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Attorney</VALIDVALUE>
          <VALUEMEANING>Attorney</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who has been qualified and licensed to advise clients on legal matters and to provide legal services, including appearing in court.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Audiologist</VALIDVALUE>
          <VALUEMEANING>Audiologist</VALUEMEANING>
          <MEANINGDESCRIPTION>A trained non-medical health professional who specializes in the identification, testing, habilitation and rehabilitation of hearing loss and other auditory and balance disorders. Particularly, an audiologist may be involved in diagnostic and screening procedures to determine hearing deficits, as well as in assessment of amplification devices and instruction in their care, training in speechreading, and may serve as consultant to government and industry on issues concerning environmental, noise-induced hearing loss. Certification requirements for clinical audiology professional are currently defined at a single level - Certificate of Clinical Competency.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51804</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biomedical Engineer</VALIDVALUE>
          <VALUEMEANING>Biomedical Engineer</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual whose profession is to apply engineering principles to understand, modify, or control biologic systems, as well as design and manufacture products that can monitor physiologic functions and assist in the diagnosis and treatment of patients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dental Assistant</VALIDVALUE>
          <VALUEMEANING>Dental Assistant</VALUEMEANING>
          <MEANINGDESCRIPTION>A person trained and qualified to provide chairside assistance to a dentist, along with performance of other supportive duties such as to receive and prepare patients for dental treatment; to prepare materials and equipment for use by the dentist; to perform reversible intra-oral procedures under the supervision of the dentist; to perform dental radiography work; to maintain dental equipment and treatment area and to keep records of appointments, examinations, treatments and supplies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dental Hygienist</VALIDVALUE>
          <VALUEMEANING>Dental Hygienist</VALUEMEANING>
          <MEANINGDESCRIPTION>A health care professional auxiliary in dentistry trained and licensed to provide preventive, therapeutic and educational services for the control of oral diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2603114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dentist</VALIDVALUE>
          <VALUEMEANING>Dentist</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual licensed for the prevention, diagnosis, and treatment of diseases in the oral cavity, adjacent tissues, and related structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2596207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dietitian</VALIDVALUE>
          <VALUEMEANING>Dietitian</VALUEMEANING>
          <MEANINGDESCRIPTION>A professional trained and qualified to provide nutritional services at individual, institutional and community levels in term of assessing nutritional needs and coordinating them with medical ones, developing and implementing nutrition programs, evaluation and reporting their results, as well as to educate people on healthy eating, and diseases prevention and treatment by means of dietary modifications.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28248</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Emergency Medical Technician</VALIDVALUE>
          <VALUEMEANING>Emergency Medical Technician</VALUEMEANING>
          <MEANINGDESCRIPTION>A person with formal training in basic medical knowledge and skills, certified (requirements vary by state) to respond and to provide a competent prehospital care and transportation to patients in emergency situations including but not limited to medical emergencies, hazardous materials exposure, child birth, abuse, fires, flood, accidents, trauma, and psychiatric crises. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2714432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Home Health Aid</VALIDVALUE>
          <VALUEMEANING>Home Health Aid</VALUEMEANING>
          <MEANINGDESCRIPTION>A person trained to for provide personal patient care and related services for ill or disabled patients, and elderly in home or home-like settings to get patients needs met. The tasks performed by home health aide include personal care, homemaking, communications, working with the patient occupational therapist, physical therapist and other caregivers to assure that the patients are reaching their best physical, mental and social well-being.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hospital Service Technician</VALIDVALUE>
          <VALUEMEANING>Hospital Service Technician</VALUEMEANING>
          <MEANINGDESCRIPTION>A person trained to provide technical advice and assistance concerning the routine maintenance and service of hospital equipment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient</VALIDVALUE>
          <VALUEMEANING>Patient</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2988258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medical Assistant</VALIDVALUE>
          <VALUEMEANING>Medical Assistant</VALUEMEANING>
          <MEANINGDESCRIPTION>A person trained to assist medical professionals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2714430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medical Technologist</VALIDVALUE>
          <VALUEMEANING>Medical Technologist</VALUEMEANING>
          <MEANINGDESCRIPTION>A person with professional knowledge and competence in the field of medical technology that involves performing, advising on, or supervising clinical laboratory testing of human specimens, fluids and tissues, establishing and monitoring quality control systems and measures; developing data which may be used in clinical setting and in support of medical research in such areas as hematology, bacteriology, mycology, virology, parasitology, immunology, serology, immunohematology, clinical chemistry, endocrinology and toxicology, and urinalysis as they relate to clinical laboratory practice. The concept does not refer to professionals primarily involved in technical support work concerned with operating medical machines or instruments as part of the examination or treatment of patients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53418</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nurse</VALIDVALUE>
          <VALUEMEANING>Nurse</VALUEMEANING>
          <MEANINGDESCRIPTION>A health professional trained to care for people who are ill or disabled.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nursing Assistant</VALIDVALUE>
          <VALUEMEANING>Nursing Assistant</VALUEMEANING>
          <MEANINGDESCRIPTION>Person certified as a Nursing Assistant.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occupational Therapist</VALIDVALUE>
          <VALUEMEANING>Occupational Therapist</VALUEMEANING>
          <MEANINGDESCRIPTION>A health professional trained to help people who are ill or disabled learn to manage their daily activities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Other treatment cannot be appropriately assigned to specific data item (i.e. phlebotomy, transfusion, and aspirin or other disease modifying agent). Use for hematopoietic diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3089560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paramedic</VALIDVALUE>
          <VALUEMEANING>Paramedic</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual trained and certified to provide all basic and intermediate life support measures in addition to using invasive medical procedures (including intravenous therapy, cardiac defibrillation, administering medications and solutions, and using ventilation devices) as dictated by state law and performed under medical control in case of medical emergencies, hazardous materials exposure, child birth, abuse, fires, flood, accidents, trauma, and psychiatric crises.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2714431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Physical Therapist</VALIDVALUE>
          <VALUEMEANING>Physical Therapist</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual trained and certified to apply knowledge of the concepts, principles, and practices of physical therapy for the treatment or prevention of physical disability or disease. Physical therapist plans and carries out treatment utilizing therapeutic exercise, massage, and physical agents such as air, water, electricity, sound, and radiant energy; performs tests and measurements involving manual or electrical means; and interpret results. Therapist also devises adaptations of equipment to meet the specific needs of patients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Physician</VALIDVALUE>
          <VALUEMEANING>Physician</VALUEMEANING>
          <MEANINGDESCRIPTION>Physician; a licensed medical practitioner.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Physician Assistant</VALIDVALUE>
          <VALUEMEANING>Physician Assistant</VALUEMEANING>
          <MEANINGDESCRIPTION>A person trained and qualified to provide comprehensive diagnostic, preventive, and therapeutic medical care and services to patients under the guidance of the physician. A scope of physician assistant professional activity does not include the full range of interpretation of medical findings requiring the full professional background of the licensed physician.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2668463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Physicist</VALIDVALUE>
          <VALUEMEANING>Physicist</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual trained and qualified to advise, administer, supervise, or perform research or other professional and scientific work in the investigation and application of the relations between space, time, matter, and energy in the areas of mechanics, sound, optics, heat, electricity, magnetism, radiation, or atomic and nuclear phenomena.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiologic Technologist</VALIDVALUE>
          <VALUEMEANING>Radiologic Technologist</VALUEMEANING>
          <MEANINGDESCRIPTION>A person trained and qualified to perform radiographic procedures by the application of ionizing radiation to produce images on film and on computer assisted equipment displays and perform other related duties including but not limited to the patient instruction on a radiographic procedure, patient positioning, immobilization, protection, and observation during the procedure; radiographs generation and images records maintenance; equipment operation, minor adjustments and evaluation for modification or replacement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Respiratory Therapist</VALIDVALUE>
          <VALUEMEANING>Respiratory Therapist</VALUEMEANING>
          <MEANINGDESCRIPTION>A person trained and qualified to perform technical work concerned with administering therapeutic and diagnostic respiratory care and life support to patients with cardiopulmonary deficiencies and abnormalities. The work involves: operating and monitoring respiratory equipment such as ventilators, medical gas delivery apparatus, environmental control systems, incentive breathing/hyperinflation and aerosol devices; administering medical gases, humidification, and respiratory medications; maintaining clearance of patient natural and artificial airways; obtaining blood samples and interpreting blood gas data; and providing primary assistance in cardiopulmonary resuscitation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Risk Manager</VALIDVALUE>
          <VALUEMEANING>Risk Manager</VALUEMEANING>
          <MEANINGDESCRIPTION>A person trained and licenced to implement and oversight health care risk management programs aimed on assuring greater patient safety in health care facility or institution. The main thrust of the risk manager activity is in identifying incidents occurring in the health care organization, which have an outcome of patient injury and may reflect error in the course of the delivery of health care services, adverse incidents reporting, tracking, trending and elaboration of risk reduction and risk prevention strategies and measures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53448</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Service and Testing Personnel</VALIDVALUE>
          <VALUEMEANING>Service and Testing Personnel</VALUEMEANING>
          <MEANINGDESCRIPTION>Qualified professionals trained and assigned to conduct the device or equipment maintenance and testing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Service Personnel</VALIDVALUE>
          <VALUEMEANING>Service Personnel</VALUEMEANING>
          <MEANINGDESCRIPTION>Qualified persons who have the appropriate technical expertise, training and experience necessary to provide assistance and support in medical device installation, maintenance, operation and repair.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Speech Therapist</VALIDVALUE>
          <VALUEMEANING>Speech Therapist</VALUEMEANING>
          <MEANINGDESCRIPTION>A specialist who evaluates and treats people with communication and swallowing problems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19177</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Phlebotomist</VALIDVALUE>
          <VALUEMEANING>Phlebotomist</VALUEMEANING>
          <MEANINGDESCRIPTION>A person trained to collect blood for transfusion, analysis, or experimental testing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pharmacist</VALIDVALUE>
          <VALUEMEANING>Pharmacist</VALUEMEANING>
          <MEANINGDESCRIPTION>A person trained in pharmacy that prepares and dispenses drugs prescribed by physicians and health practitioners. The responsibilities include instructing patients on the use, hazards, interactions, and side effects of any drug dispensed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51840</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient Family Member Or Friend</VALIDVALUE>
          <VALUEMEANING>Patient Family Member Or Friend</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative of the patient or an individual affiliated with the patient or/and patient family.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other Health Care Professional</VALIDVALUE>
          <VALUEMEANING>Other Health Care Professional</VALUEMEANING>
          <MEANINGDESCRIPTION>Health care professional other than listed in section D5 of FDA MedWatch form 3500A.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other Caregiver</VALIDVALUE>
          <VALUEMEANING>Other Caregiver</VALUEMEANING>
          <MEANINGDESCRIPTION>Different from the previously specified or mentioned type of person who has primary responsibility for the assistance and supervision for an individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nuclear Medicine Technologist</VALIDVALUE>
          <VALUEMEANING>Nuclear Medicine Technologist</VALUEMEANING>
          <MEANINGDESCRIPTION>A professional trained and certified in the field of medicine that utilizes the nuclear properties of radioactive and stable nuclides to make diagnostic evaluations of the anatomic or physiologic conditions of the body and to provide therapy with unsealed radioactive sources. The area of responsibilities of nuclear medicine technologist includes patient care (radiopharmaceuticals preparation and administration, use of radiation detection devices and other laboratory equipment to evaluate the quantity and distribution of radionuclides deposited in the patient or in a patient specimen, in vivo and in vitro diagnostic procedures, use of quality control and safety techniques), technical tasks, and administration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Medical Equipment Company Technician or Representative</VALIDVALUE>
          <VALUEMEANING>Medical Equipment Company Technician or Representative</VALUEMEANING>
          <MEANINGDESCRIPTION>A trained person who is delegated by medical equipment manufacturer to provide technical advice and assistance concerning the routine maintenance and service of equipment produced by the company.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4385330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Operator of Device Code</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Operator of Device Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4272090</PublicId>
          <ContextName>ONC SDC Project</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MedWatch Form FDA 3500A</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Suspect medical device</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4382695</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1308">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4718835</PUBLICID>
    <LONGNAME>Agent CYP2C9 Substrate With Narrow Therapeutic Index Received Indicator</LONGNAME>
    <PREFERREDNAME>4718829v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether or not the patient was taking any CYP2C9 substrates with narrow therapeutic indicies.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ABTC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4718829</PublicId>
      <PreferredName>2223333v1.0:4718827v1.0</PreferredName>
      <PreferredDefinition>An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._Any substance acted upon by cytochrome P450 2C9._Used to indicate the presence of something or someone._A therapeutic index of less than 2-fold difference between the median lethal dose and median effective dose values, or less than 2-fold difference between the minimum toxic concentration and minimum effective concentrations in the blood._To take, accept, or get something offered.</PreferredDefinition>
      <LongName>Agent CYP2C9 Substrate With Narrow Therapeutic Index Received</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ABTC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223333</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1708</PreferredName>
        <Version>1</Version>
        <LongName>Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4718827</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C120266:C62355:C120270:C25639</PreferredName>
        <Version>1</Version>
        <LongName>CYP2C9 Substrate With Narrow Therapeutic Index Receive</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120266</PREFERRED_NAME>
            <LONG_NAME>CYP2C9 Substrate</LONG_NAME>
            <CON_ID>4717717</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62355</PREFERRED_NAME>
            <LONG_NAME>With</LONG_NAME>
            <CON_ID>2532083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120270</PREFERRED_NAME>
            <LONG_NAME>Narrow Therapeutic Index</LONG_NAME>
            <CON_ID>4717719</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is patient receiving CYP2C9 s</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is patient receiving CYP2C9 substrates with narrow therapeutic indices?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3335728</PublicId>
          <ContextName>ABTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocols</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ABTC 1401</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4701487</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1309">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4725108</PUBLICID>
    <LONGNAME>Fluorescence in Situ Hybridization Image Probe Other Specify</LONGNAME>
    <PREFERREDNAME>FISHProbOthSpc</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field related to the other kind of Fluorescence in Situ Hybridization probe used that is captured in the image which will label viral plaques, bacterial colonies or bands on a gel that contain the gene of interest.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4588554</PublicId>
      <PreferredName>4588551v1.0:4588552v1.0</PreferredName>
      <PreferredDefinition>A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping._Any record of an imaging event whether physical or electronic._General term for a piece of DNA or RNA corresponding to a gene or sequence of interest, that has been labelled either radioactively or with some other detectable molecule, such as biotin, digoxygenin or fluorescein. As stretches of DNA or RNA with complementary sequences will hybridize, a probe will label viral plaques, bacterial colonies or bands on a gel that contain the gene of interest.</PreferredDefinition>
      <LongName>Fluorescence in Situ Hybridization Image Probe</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19238</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic, Therapeutic, and Research Equipment</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4588551</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17563:C48179</PreferredName>
        <Version>1</Version>
        <LongName>Fluorescence in Situ Hybridization Image</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17563</PREFERRED_NAME>
            <LONG_NAME>Fluorescence In Situ Hybridization</LONG_NAME>
            <CON_ID>2221360</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4588552</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43523</PreferredName>
        <Version>1</Version>
        <LongName>Probe</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43523</PREFERRED_NAME>
            <LONG_NAME>Probe</LONG_NAME>
            <CON_ID>2433326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2194376</PublicId>
      <PreferredName>ASSESS_OTHER_SPEC</PreferredName>
      <PreferredDefinition>the free text field related to other specified assessment.</PreferredDefinition>
      <LongName>Assessment Other Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Other, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1310">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4732317</PUBLICID>
    <LONGNAME>Parent Main Language With Child Use Type</LONGNAME>
    <PREFERREDNAME>PrtMainLangChTp</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of language which parent mainly uses with child.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4732314</PublicId>
      <PreferredName>PrtMainLangChUse</PreferredName>
      <PreferredDefinition>information related to the main language parent use with child.</PreferredDefinition>
      <LongName>Parent Main Language With Child Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008576</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DATA_SOURCE</PreferredName>
        <Version>1</Version>
        <LongName>Data Source</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3111322</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42709</PreferredName>
        <Version>1</Version>
        <LongName>Parent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42709</PREFERRED_NAME>
            <LONG_NAME>Parent</LONG_NAME>
            <CON_ID>2222173</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4732312</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4732312v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Main Language With Child Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25562</PREFERRED_NAME>
            <LONG_NAME>Main</LONG_NAME>
            <CON_ID>2206300</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16779</PREFERRED_NAME>
            <LONG_NAME>Language</LONG_NAME>
            <CON_ID>2203839</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62355</PREFERRED_NAME>
            <LONG_NAME>With</LONG_NAME>
            <CON_ID>2532083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16423</PREFERRED_NAME>
            <LONG_NAME>Child</LONG_NAME>
            <CON_ID>2205406</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2670708</PublicId>
      <PreferredName>ASSESS_LANGUAGE_TP</PreferredName>
      <PreferredDefinition>the type of language (e.g., English, Spanish) used in an assessment.</PreferredDefinition>
      <LongName>Assessment Language Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>English</VALIDVALUE>
          <VALUEMEANING>ENGLISH</VALUEMEANING>
          <MEANINGDESCRIPTION>A person from England or of that ancestry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spanish</VALIDVALUE>
          <VALUEMEANING>SPANISH</VALUEMEANING>
          <MEANINGDESCRIPTION>SPANISH</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>French</VALIDVALUE>
          <VALUEMEANING>FRENCH</VALUEMEANING>
          <MEANINGDESCRIPTION>FRENCH</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA (The patient is unable to complete a questionnaire in English or Spanish or French.)</VALIDVALUE>
          <VALUEMEANING>NA (The patient is unable to complete a questionnaire in English or Spanish or French.)</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5026035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA (Participant does not speak or read any of the above languages)</VALIDVALUE>
          <VALUEMEANING>Not Applicable (Participant does not speak or read any of the above languages)</VALUEMEANING>
          <MEANINGDESCRIPTION>Not Applicable (Participant does not speak or read any of the above languages)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7181392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Russian</VALIDVALUE>
          <VALUEMEANING>Russian</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes the inhabitants of Russia, a person from there, or their descendants elsewhere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43860</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>German</VALIDVALUE>
          <VALUEMEANING>German</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes the inhabitants of Germany, a person from there, or their descendants elsewhere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4693759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chinese (Simplified)</VALIDVALUE>
          <VALUEMEANING>Chinese (Simplified)</VALUEMEANING>
          <MEANINGDESCRIPTION>Chinese (Simplified)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7181393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA (Patient does not speak or read English or Spanish)</VALIDVALUE>
          <VALUEMEANING>NA (Patient does not speak or read English or Spanish)</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient does not speak or read English or Spanish, so this question is not applicable.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6423353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arabic</VALIDVALUE>
          <VALUEMEANING>Arabic Language</VALUEMEANING>
          <MEANINGDESCRIPTION>A Central Semitic language native to countries of the Arab League, minorities in neighboring countries, and some parts of Asia, Africa, Europe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153339</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6377069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable (Participant does not speak or read any of the above languages or did not consent to PRO study)</VALIDVALUE>
          <VALUEMEANING>Not Applicable (Participant does not speak or read any of the above languages or did not consent to PRO study)</VALUEMEANING>
          <MEANINGDESCRIPTION>Not Applicable (Participant does not speak or read any of the above languages or did not consent to PRO study)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-05-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16127616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Main language you use with yo</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Main language you use with your child:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1311">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4732343</PUBLICID>
    <LONGNAME>Teacher Preference Language School Use Type</LONGNAME>
    <PREFERREDNAME>TchPfrLangTp</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of language which teacher prefers to speak at school.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4732342</PublicId>
      <PreferredName>TchPfrLangUse</PreferredName>
      <PreferredDefinition>information related to the language which teacher prefers to speak at school.</PreferredDefinition>
      <LongName>Teacher Preference Language School Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008576</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DATA_SOURCE</PreferredName>
        <Version>1</Version>
        <LongName>Data Source</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4732339</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102873</PreferredName>
        <Version>1</Version>
        <LongName>Teacher</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102873</PREFERRED_NAME>
            <LONG_NAME>Teacher</LONG_NAME>
            <CON_ID>3574739</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4732340</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41187:C16779:C17118:C25340</PreferredName>
        <Version>1</Version>
        <LongName>Preference Language School Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41187</PREFERRED_NAME>
            <LONG_NAME>Preference</LONG_NAME>
            <CON_ID>2435947</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16779</PREFERRED_NAME>
            <LONG_NAME>Language</LONG_NAME>
            <CON_ID>2203839</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17118</PREFERRED_NAME>
            <LONG_NAME>School</LONG_NAME>
            <CON_ID>2436198</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2670708</PublicId>
      <PreferredName>ASSESS_LANGUAGE_TP</PreferredName>
      <PreferredDefinition>the type of language (e.g., English, Spanish) used in an assessment.</PreferredDefinition>
      <LongName>Assessment Language Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>English</VALIDVALUE>
          <VALUEMEANING>ENGLISH</VALUEMEANING>
          <MEANINGDESCRIPTION>A person from England or of that ancestry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spanish</VALIDVALUE>
          <VALUEMEANING>SPANISH</VALUEMEANING>
          <MEANINGDESCRIPTION>SPANISH</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>French</VALIDVALUE>
          <VALUEMEANING>FRENCH</VALUEMEANING>
          <MEANINGDESCRIPTION>FRENCH</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA (The patient is unable to complete a questionnaire in English or Spanish or French.)</VALIDVALUE>
          <VALUEMEANING>NA (The patient is unable to complete a questionnaire in English or Spanish or French.)</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5026035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA (Participant does not speak or read any of the above languages)</VALIDVALUE>
          <VALUEMEANING>Not Applicable (Participant does not speak or read any of the above languages)</VALUEMEANING>
          <MEANINGDESCRIPTION>Not Applicable (Participant does not speak or read any of the above languages)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7181392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Russian</VALIDVALUE>
          <VALUEMEANING>Russian</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes the inhabitants of Russia, a person from there, or their descendants elsewhere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43860</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6411021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>German</VALIDVALUE>
          <VALUEMEANING>German</VALUEMEANING>
          <MEANINGDESCRIPTION>Denotes the inhabitants of Germany, a person from there, or their descendants elsewhere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4693759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chinese (Simplified)</VALIDVALUE>
          <VALUEMEANING>Chinese (Simplified)</VALUEMEANING>
          <MEANINGDESCRIPTION>Chinese (Simplified)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7181393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA (Patient does not speak or read English or Spanish)</VALIDVALUE>
          <VALUEMEANING>NA (Patient does not speak or read English or Spanish)</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient does not speak or read English or Spanish, so this question is not applicable.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-07-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6423353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arabic</VALIDVALUE>
          <VALUEMEANING>Arabic Language</VALUEMEANING>
          <MEANINGDESCRIPTION>A Central Semitic language native to countries of the Arab League, minorities in neighboring countries, and some parts of Asia, Africa, Europe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153339</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6377069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable (Participant does not speak or read any of the above languages or did not consent to PRO study)</VALIDVALUE>
          <VALUEMEANING>Not Applicable (Participant does not speak or read any of the above languages or did not consent to PRO study)</VALUEMEANING>
          <MEANINGDESCRIPTION>Not Applicable (Participant does not speak or read any of the above languages or did not consent to PRO study)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-05-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16127616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Preferred language spoken by</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Preferred language spoken by child&#39;s teacher in school/day care:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1312">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4735651</PUBLICID>
    <LONGNAME>California Verbal Learning Test - Children&#39;s Version Perseverations Z Score Value</LONGNAME>
    <PREFERREDNAME>CVLTC_PRSEV_ZSCR_VL</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric representation of the Z score for the Perseverations subtest in the California Verbal Learning Test - Children&#39;s Version.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CVLT-C:California Verbal Learning Test-Children&#39;s Version. Delis, D., Kramar, J., Kaplan, E., and Ober, B., Pearson Assessments: San Antonio, TX. 1994</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4735562</PublicId>
      <PreferredName>2527008v1.0:4735560v1.0</PreferredName>
      <PreferredDefinition>Provides a short, individually administered assessment of the strategies and processes involved in learning and recall of verbal material. Assessment is made in the context of an everyday event. It measures both recall and recognition of words over a number of trials and has been found to be sensitive to memory deficits resulting from a variety of neurological conditions. It is designed for ages 5 through 16._Repeats of words that have been previously mentioned on the same trial._Indicates how far and in what direction an item deviates from its distribution&#39;s mean, expressed in units of its distribution&#39;s standard deviation.</PreferredDefinition>
      <LongName>California Verbal Learning Test, Children&#39;s Version Perseverations Z-Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2527008</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62620</PreferredName>
        <Version>1</Version>
        <LongName>California Verbal Learning Test, Children&#39;s Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62620</PREFERRED_NAME>
            <LONG_NAME>California Verbal Learning Test, Children&#39;s Version</LONG_NAME>
            <CON_ID>2522034</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4735560</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C120398:C68741</PreferredName>
        <Version>1</Version>
        <LongName>Perseverations Z-Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120398</PREFERRED_NAME>
            <LONG_NAME>Perseverations</LONG_NAME>
            <CON_ID>4733375</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68741</PREFERRED_NAME>
            <LONG_NAME>Z-Score</LONG_NAME>
            <CON_ID>2671501</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CVLT-C:California Verbal Learning Test-Children&#39;s Version. Delis, D., Kramar, J., Kaplan, E., and Ober, B., Pearson Assessments: San Antonio, TX. 1994</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4735465</PublicId>
      <PreferredName>CVLT_ZSCORE_VAL</PreferredName>
      <PreferredDefinition>A numerical quantity that indicates how far and in what direction an item deviates from its distribution&#39;s mean, expressed in units of standard deviation. Calculation of a z-score requires knowledge about the population&#39;s standard deviation and mean.</PreferredDefinition>
      <LongName>CVLT Z Score Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CVLT-C:California Verbal Learning Test-Children&#39;s Version. Delis, D., Kramar, J., Kaplan, E., and Ober, B., Pearson Assessments: San Antonio, TX. 1994</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>California Verbal Learning Te</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>California Verbal Learning Test - Children&#39;s Version (CVLT-C) - Perseverations Z-score:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1313">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4810533</PUBLICID>
    <LONGNAME>PROMIS 43 Adult Profile v2.0 PFA23 Able to Walk for Fifteen Minutes Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PROMIS43_PFA23_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of the difficulty they have with going for a walk of at least 15 minutes, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4810140</PublicId>
      <PreferredName>4810131v1.0:4810138v1.0</PreferredName>
      <PreferredDefinition>A 43-item multidimensional and universal measure of health intended for use across a variety of conditions. It measures an adult patient&#39;s self-reported health status in seven domains: physical function, anxiety, depression, fatigue, sleep disturbance, pain interference, and participation in social roles._A question about the ability of an individual to go for a walk of at least fifteen minutes._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>PROMIS-43 Adult Profile v2.0 Ability to Walk for Fifteen Minutes Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4810131</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121683</PreferredName>
        <Version>1</Version>
        <LongName>PROMIS-43 Adult Profile v2.0</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121683</PREFERRED_NAME>
            <LONG_NAME>PROMIS-43 Adult Profile v2.0</LONG_NAME>
            <CON_ID>4806811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4810138</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121689:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Ability to Walk for Fifteen Minutes Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121689</PREFERRED_NAME>
            <LONG_NAME>Ability to Walk for Fifteen Minutes Question</LONG_NAME>
            <CON_ID>4806851</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4809918</PublicId>
      <PreferredName>PROMIS_DIFFICULT_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used with the PROMIS items that describes a range of subjective scores from 1: Unable to do, to 5: Without any difficulty.</PreferredDefinition>
      <LongName>PROMIS Ability Difficulty Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Without Any Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something without any difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>With a Little Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something with a little difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809920</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>With Some Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something with some difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121739</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>With Much Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something with much difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Unable to Do</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is unable to do something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring Manual Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText/>
        <URL>http://www.assessmentcenter.net/documents/PROMIS%20Profile%20Scoring%20Manual.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PROMIS 43 Profile v2.0</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Item #3 of 43</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Are you able to go for a walk</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Are you able to go for a walk of at least 15 minutes?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4857911</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PROMIS Item Banks</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult Profiles</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15974421</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult Profiles</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15974422</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1314">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4811128</PUBLICID>
    <LONGNAME>Pittsburgh Sleep Quality Index Q9 Past Month Problem Keeping Up Enough Enthusiasm To Get Things Done Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>PSQI_ENTHUSIASM_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated perception of how often in the past month they had a problem keeping up enough enthusiasm to get things done, using a 4 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PSQI:Pittsburgh Sleep Quality Index, Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. University of Pittsburgh, 1989.</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4806556</PublicId>
      <PreferredName>4806491v1.0:4806554v1.0</PreferredName>
      <PreferredDefinition>A self-rated questionnaire which assesses sleep quality and disturbances over a one month time interval._Before the present time._One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks._A difficulty, disorder, or condition needing resolution._A question about how much of a problem it has been for an individual to keep up enough enthusiasm to get thing done._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Pittsburgh Sleep Quality Index Past Month Problem Enough Enthusiasm to Get Things Done Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4806491</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C103849</PreferredName>
        <Version>1</Version>
        <LongName>Pittsburgh Sleep Quality Index</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C103849</PREFERRED_NAME>
            <LONG_NAME>Pittsburgh Sleep Quality Index</LONG_NAME>
            <CON_ID>4794351</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4806554</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4806554v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Past Month Problem Enough Enthusiasm to Get Things Done Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28020</PREFERRED_NAME>
            <LONG_NAME>Problem</LONG_NAME>
            <CON_ID>2203953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121599</PREFERRED_NAME>
            <LONG_NAME>Enough Enthusiasm to Get Things Done Question</LONG_NAME>
            <CON_ID>4798071</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PSQI:Pittsburgh Sleep Quality Index, Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. University of Pittsburgh, 1989.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4804260</PublicId>
      <PreferredName>PSQI_PROBLEM_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard for the subjective scoring of how much something is a problem that ranges from 0: Not at all to 3: A very big problem.</PreferredDefinition>
      <LongName>PSQI Problem Score 4 Point Likert Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>3</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>PSQI:Pittsburgh Sleep Quality Index, Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. University of Pittsburgh, 1989.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Only Very Slight Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is a minor difficulty requiring resolution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4804261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Somewhat of a Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is a difficulty requiring resolution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4804262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>A Very Big Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is a major difficulty requiring resolution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4804263</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring and Interpretation Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Scoring and Interpretation materials are available on the University of Pittsburg, Sleep Medicine Institute website.</DocumentText>
        <URL>http://www.sleep.pitt.edu/content.asp?id=1484&amp;subid=2316</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>During the past month, how mu</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>During the past month, how much of a problem has it been for you to keep up enough enthusiasm to get things done?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PSQI Question Sequence</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #19 of 26</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measure CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718286</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PSQI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4973673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Symptom Scale</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000343</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Symptom Scale</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551592</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PSQI (Pittsburgh Sleep Quality Index)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4799491</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Symptom Scale</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711249</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1315">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4811591</PUBLICID>
    <LONGNAME>PRO-CTCAE Version 1.0 22a. Past Seven Days Frequency of Arm or Leg Swelling 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PROCTCAE_22A_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how often they experienced arm or leg swelling over the past seven days, using a text term rating of the frequency.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PRO-CTCAE TM:Patient-Reported Outcomes version of the CTCAE, Item Library Version 1.0, 3/24/2016</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4811569</PublicId>
      <PreferredName>3645995v1.0:4811567v1.0</PreferredName>
      <PreferredDefinition>A library of items for patient self-reporting of symptoms and side effects associated with cancer treatment trials._A question about the frequency of an individual&#39;s arm or leg swelling during the past seven days.</PreferredDefinition>
      <LongName>PRO-CTCAE Past Seven Days Frequency of Arm or Leg Swelling</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3645995</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C103843</PreferredName>
        <Version>1</Version>
        <LongName>Patient Reported Outcomes Version of CTCAE</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C103843</PREFERRED_NAME>
            <LONG_NAME>Patient Reported Outcomes Version of CTCAE</LONG_NAME>
            <CON_ID>3640502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4811567</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C121755</PreferredName>
        <Version>1</Version>
        <LongName>Past Seven Days Frequency of Arm or Leg Swelling</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C121755</PREFERRED_NAME>
            <LONG_NAME>Past Seven Days Frequency of Arm or Leg Swelling Question</LONG_NAME>
            <CON_ID>4809871</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PRO-CTCAE TM:Patient-Reported Outcomes version of the CTCAE, Item Library Version 1.0, 3/24/2016</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3826569</PublicId>
      <PreferredName>SYMPT_FREQ_5PT_SCL</PreferredName>
      <PreferredDefinition>Subjective evidence of disease perceived by the patient._The number of occurrences of something within a given time period. (NCI)_A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one._The precise location of something; a spatially limited location._an ordered reference standard.</PreferredDefinition>
      <LongName>Symptom Frequency 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>17</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PRO-CTCAE TM:Patient-Reported Outcomes version of the CTCAE, Item Library Version 1.0, 3/24/2016</Origin>
      <Representation>
        <PublicId>3826568</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3826568v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Symptom Frequency Five Point Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66836</PREFERRED_NAME>
            <LONG_NAME>Five</LONG_NAME>
            <CON_ID>2664639</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70656</PREFERRED_NAME>
            <LONG_NAME>Point</LONG_NAME>
            <CON_ID>2710246</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Almost constantly</VALIDVALUE>
          <VALUEMEANING>Almost constantly</VALUEMEANING>
          <MEANINGDESCRIPTION>Not quite or just short of.: Continually recurring or continuing without interruption.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64638, C107222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3826570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frequently</VALIDVALUE>
          <VALUEMEANING>Frequently</VALUEMEANING>
          <MEANINGDESCRIPTION>Coming at short intervals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3826571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occasionally</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>In the last 7 days, how OFTEN</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>In the last 7 days, how OFTEN did you have ARM OR LEG SWELLING?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PRO-CTCAE Spanish Translation</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>En los últimos 7 días, ¿con qué FRECUENCIA tuvo HINCHAZÓN EN LOS BRAZOS O EN LAS PIERNAS?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Medidata ePRO CDE</Name>
        <DocumentType>ePRO Compliant</DocumentType>
        <DocumentText>This CDE has been validated for use with the Medidata Rave ePRO module.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3638608</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-CTCAE </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-CTCAE Version 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5675450</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574822</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-CTCAE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-CTCAE Item Library Version 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6051090</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-CTCAE Item Library Version 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000711</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6051063</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Electronic PROs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-CTCAE Library Version 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6051064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1316">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4888033</PUBLICID>
    <LONGNAME>Injection Site Dendritic Cell Measurement Percent Value</LONGNAME>
    <PREFERREDNAME>INJ_STE_DEND_PCT_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>Percentage value of dendritic cells at an injection site.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCI CRF:  Duke Cancer Institute Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4887963</PublicId>
      <PreferredName>4887961v1.0:2188090v1.0</PreferredName>
      <PreferredDefinition>The anatomic site at which a medication or a vaccine is injected._Immunocompetent cells of the lymphoid and hemopoietic systems and skin. They function morphologically and phenotypically by presenting or processing antigens, thereby stimulating cellular immunity. They represent the most potent antigen-presenting cells and, therefore, play a critical role in the primary T cell immune response._Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.</PreferredDefinition>
      <LongName>Injection Site Dendritic Cell Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4887961</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C77680:C12583</PreferredName>
        <Version>1</Version>
        <LongName>Injection Site Dendritic Cell</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C77680</PREFERRED_NAME>
            <LONG_NAME>Injection Site</LONG_NAME>
            <CON_ID>3377282</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12583</PREFERRED_NAME>
            <LONG_NAME>Dendritic Cell</LONG_NAME>
            <CON_ID>2615837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2188090</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25209</PreferredName>
        <Version>1</Version>
        <LongName>Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019325</PublicId>
      <PreferredName>PCT_VAL</PreferredName>
      <PreferredDefinition>the numerical quantity measured or assigned or computed as a fraction or ratio with 100 understood as the denominator.</PreferredDefinition>
      <LongName>Percentage Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>%</DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>%DCs at injection site</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>%DCs at injection site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1317">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4888119</PUBLICID>
    <LONGNAME>PROMIS Version 2.0 Adult Physical Health Domain Physical Function PFC45r1 Ability to Sit On and Get Up From the Toilet Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PROMISV2_PFC45r1_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of the difficulty with their ability to sit on and get up from the toilet, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4888107</PublicId>
      <PreferredName>4888071v1.0:4888105v1.0</PreferredName>
      <PreferredDefinition>A Patient Reported Outcomes Measurement Information System (PROMIS) domain that assesses the status of an individual&#39;s physical health._The collection of PROMIS item scales that assess an individual&#39;s ability to carry out activities that require physical actions including more complex activities that require a combination of skills, often within a social context._A question about the ability of an individual to get on and off the toilet._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>PROMIS Adult Physical Health Domain Physical Function Ability to Get On and Off the Toilet Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4888071</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C122346:C122356</PreferredName>
        <Version>1</Version>
        <LongName>PROMIS Adult Physical Health Domain Physical Function Subordinate Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122346</PREFERRED_NAME>
            <LONG_NAME>PROMIS Adult Physical Health Domain</LONG_NAME>
            <CON_ID>4860856</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122356</PREFERRED_NAME>
            <LONG_NAME>Physical Function Subordinate Domain</LONG_NAME>
            <CON_ID>4860871</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4888105</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C122364:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Ability to Get On and Off the Toilet Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122364</PREFERRED_NAME>
            <LONG_NAME>Ability to Get On and Off the Toilet Question</LONG_NAME>
            <CON_ID>4860899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4809918</PublicId>
      <PreferredName>PROMIS_V2_DIFCLT_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used with the PROMIS items that describes a range of subjective scores from 1: Cannot do, to 5: Without any difficulty.</PreferredDefinition>
      <LongName>PROMIS 2.0 Ability Difficulty Score 5 Point Scale</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>PROMIS:Patient Reported Outcomes Measurement Information System, PROMIS Health Organization and PROMIS Cooperative Group, 2008-2012</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Without Any Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something without any difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>With a Little Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something with a little difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809920</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>With Some Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something with some difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121739</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>With Much Difficulty</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is able to do something with much difficulty.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Cannot Do</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual cannot do something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4809953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Are you able to sit on and ge</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Are you able to sit on and get up from the toilet?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring and Interpretation Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Scoring and Interpretation materials are available from the PROMIS Assessment Center.</DocumentText>
        <URL>https://www.assessmentcenter.net/documents/PROMIS%20Physical%20Function%20Scoring%20Manual.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Physical Function - SF 10a</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #10 of 10</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551591</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measure CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718286</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PROMIS Item Bank v1.0 - Physical Function - Short Form 10a</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4887912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PROMIS Item Bank v1.0 - Physical Function - Short Form 10a</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>10000292</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000428</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4857911</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PROMIS Item Banks</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult Physical Health</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4857913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4857911</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PROMIS Item Banks</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical Function</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4857918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Generic Core Domains</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711235</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical Function</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14951259</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1318">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4902234</PUBLICID>
    <LONGNAME>Laboratory Finding Pre-study Corrected QT Interval Greater Than 470 Millisecond Outcome Code Indicator</LONGNAME>
    <PREFERREDNAME>4902233v1.0:3298541v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded response that indicates the pre-study corrected QTc interval is greater than 470 msec.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4902233</PublicId>
      <PreferredName>2471460v1.0:4902231v1.0</PreferredName>
      <PreferredDefinition>The result of a lab test to measure an attribute or to determine the presence, absence or degree of a condition._Occurring before enrollment/treatment on-study._The time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula._A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status._A number with no fractional part, including the negative and positive numbers as well as zero.::470_A unit of time equal to one thousandth of a second (10E-3 second)._The result of an action.</PreferredDefinition>
      <LongName>Laboratory Finding Pre-study Corrected QT Interval Greater Than Integer::470 Millisecond Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2471460</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38470</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38470</PREFERRED_NAME>
            <LONG_NAME>Laboratory Finding</LONG_NAME>
            <CON_ID>2202766</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4902231</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>4902231v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Pre-study Corrected QT Interval Greater Than Integer::470 Millisecond Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38010</PREFERRED_NAME>
            <LONG_NAME>Pre-study</LONG_NAME>
            <CON_ID>2322178</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C100391</PREFERRED_NAME>
            <LONG_NAME>Corrected QT Interval</LONG_NAME>
            <CON_ID>4119291</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61584</PREFERRED_NAME>
            <LONG_NAME>Greater Than</LONG_NAME>
            <CON_ID>2620098</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255::470</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41140</PREFERRED_NAME>
            <LONG_NAME>Millisecond</LONG_NAME>
            <CON_ID>2476188</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is pre-study QTc greater than</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is pre-study QTc greater than 470 msec?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is pre-study mean resting QT interval (QTc using Fredericia&#39;s formula (QTcF) greater than 470 msec?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have mean QT interval corrected for heart rate (QTc) greater than or equal to 470 ms calculated from 3 electrocardiograms (ECGs) using Fridericia&#39;s Correction?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is pre-study mean resting QT interval (QTcF) greater than 470 msec, obtained from 3 electrocardiograms (ECGs), using the screening clinic ECG machine derived QTc value?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a prolonged rate-corrected QT (QTc) interval greater than 480 msec, calculated according to institutional guidelines?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is QTc, on resting ECG, greater than 470 msec or family history of long QT syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a baseline QTc interval greater than 470 msec?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876359</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Exclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory Data (including serologic/viral status)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1319">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4924418</PUBLICID>
    <LONGNAME>Demographics Primary Caregiver Marital Status Assessment Text</LONGNAME>
    <PREFERREDNAME>Demo_Prim_Care_Mari_ASSESS_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>The statistical characterization of human populations or segments of human populations (e.g., characterization by age, sex, race, or income)._Occurring first in time or sequence; original; of greatest rank or importance or value._The primary person in charge of the care of a patient, usually a family member or a designated health care professional._A demographic parameter indicating a person&#39;s conjugal status_a free text field to specify information on the evaluations of the patient and the patient&#39;s disease</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4924417</PublicId>
      <PreferredName>Demo_Prim_Care_Mari</PreferredName>
      <PreferredDefinition>The statistical characterization of human populations or segments of human populations (e.g., characterization by age, sex, race, or income)._Occurring first in time or sequence; original; of greatest rank or importance or value._The primary person in charge of the care of a patient, usually a family member or a designated health care professional._A demographic parameter indicating a person&#39;s conjugal status</PreferredDefinition>
      <LongName>Demographics Primary Caregiver Marital Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2644054</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16495</PreferredName>
        <Version>1</Version>
        <LongName>Demographics</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16495</PREFERRED_NAME>
            <LONG_NAME>Demographics</LONG_NAME>
            <CON_ID>2204033</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4924415</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25251:C17445:C25188</PreferredName>
        <Version>1</Version>
        <LongName>Primary Caregiver Marital Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17445</PREFERRED_NAME>
            <LONG_NAME>Caregiver</LONG_NAME>
            <CON_ID>2797619</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25188</PREFERRED_NAME>
            <LONG_NAME>Marital Status</LONG_NAME>
            <CON_ID>2202371</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018321</PublicId>
      <PreferredName>ASSESS_TXT</PreferredName>
      <PreferredDefinition>a free text field to specify information on the evaluations of the patient and the patient&#39;s disease</PreferredDefinition>
      <LongName>Assessment Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184342</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Text</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Demographics Primary Caregiver Marital Status Assessment Text does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Demographics Primary Caregiver Marital Status Assessment Text does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sickle Cell Disease Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4809631</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sickle Cell Disease Core Tier 2:</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4925612</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1320">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4926371</PUBLICID>
    <LONGNAME>Concomitant Agent Administered Other Specify</LONGNAME>
    <PREFERREDNAME>CON_AGT_ADM_OTH_SPE</PREFERREDNAME>
    <PREFERREDDEFINITION>The response that indicates the name of a concomitant medication that is different from the ones previously selected or reported.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188255</PublicId>
      <PreferredName>CONCOMITANT_AGT_ADM</PreferredName>
      <PreferredDefinition>information related to the concomitant agent administered.</PreferredDefinition>
      <LongName>Concomitant Agent Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206526</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25730:C1708</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25730</PREFERRED_NAME>
            <LONG_NAME>Concomitant</LONG_NAME>
            <CON_ID>2202429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177665</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Administered</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666713</PublicId>
      <PreferredName>OTH_SPEC</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Other Specify</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCI CRF Standards</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other concomitant med</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify other concomitant medication</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Alternate Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify other concomitant medication</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other drug:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify other drug:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other drug:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify other drug:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858960</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Adopted</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAE</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5858965</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Moderately Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRDS</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CTI_COTH_oth_concom_drg_spec</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedSubstanceAdministration:value</AlternateName>
        <AlternateNameType>HCT_BRIDG_5</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CTI_DRTH_oth_concom_drg_spec</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1321">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4987345</PUBLICID>
    <LONGNAME>Adult Hope Scale How True Meet Goals Set for Myself Score 8 Point Scale</LONGNAME>
    <PREFERREDNAME>AHS_MEET_GOALS_SCR</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of how true or false a statement is about meeting the goals they set for themselves, using an 8 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AHS:Adult Hope Scale. Snyder, C. R., Harris, C., Anderson, J. R., Holleran, S. A., Irving, L. M., Sigmon, S. T., et al.(1991).</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4987184</PublicId>
      <PreferredName>4987011v1.0:4987182v1.0</PreferredName>
      <PreferredDefinition>12-item measure of a respondent&#39;s level of hope. Each item is answered using an 8-point Likert-type scale ranging from Definitely False to Definitely True._A question about an individual&#39;s agreement with a statement._A question about whether an individual meets the goals they set for themself._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Adult Hope Scale How True Meet Goals Set for Myself Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4987011</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C123340</PreferredName>
        <Version>1</Version>
        <LongName>Adult Hope Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C123340</PREFERRED_NAME>
            <LONG_NAME>Adult Hope Scale</LONG_NAME>
            <CON_ID>4986832</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4987182</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C91781:C123351:C25338</PreferredName>
        <Version>1</Version>
        <LongName>How True Meet Goals Set for Myself Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91781</PREFERRED_NAME>
            <LONG_NAME>How True Question</LONG_NAME>
            <CON_ID>3133350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C123351</PREFERRED_NAME>
            <LONG_NAME>Meet Goals Set for Myself Question</LONG_NAME>
            <CON_ID>4986843</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AHS:Adult Hope Scale. Snyder, C. R., Harris, C., Anderson, J. R., Holleran, S. A., Irving, L. M., Sigmon, S. T., et al.(1991).</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4986942</PublicId>
      <PreferredName>ADULT_HOPE_SCALE</PreferredName>
      <PreferredDefinition>An ordered reference standard used with the Adult Hope Scale with values ranging from 1:Definitely False to 8:Definitely True.</PreferredDefinition>
      <LongName>Adult Hope Scale Score 8 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>8</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>AHS:Adult Hope Scale. Snyder, C. R., Harris, C., Anderson, J. R., Holleran, S. A., Irving, L. M., Sigmon, S. T., et al.(1991).</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Definitely True</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is definitely true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4987351</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Mostly True</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is mostly true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4987352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Somewhat True</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is somewhat true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123358</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4987353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Slightly True</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is slightly true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123357</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4987354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Slightly False</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is slightly false.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4987355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Somewhat False</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is somewhat false.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4987356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Mostly False</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is mostly false.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4987357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Definitely False</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is definitely false.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-08-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4986943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I meet the goals that I set f</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I meet the goals that I set for myself.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4986872</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AHS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AHS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4986914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult Hope Scale (AHS)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14883066</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1322">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4997455</PUBLICID>
    <LONGNAME>FACT-C Questionnaire Version 4 Q2 Have Ostomy Appliance Indicator</LONGNAME>
    <PREFERREDNAME>FACTC_V4_Q2_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated indication of whether or not they have an ostomy appliance.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FACT-C:Functional Assessment of Cancer Therapy - Colorectal, David Cella, Ph.D., Version 4, Nov. 2007</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4997419</PublicId>
      <PreferredName>4040131v1.0:4997417v1.0</PreferredName>
      <PreferredDefinition>A subscale complement to the FACT-G developed specifically for evaluating the quality of life of colorectal cancer patients._A question about whether an individual has an ostomy appliance.</PreferredDefinition>
      <LongName>FACT-C Questionnaire Have Ostomy Appliance</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4040131</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C113186</PreferredName>
        <Version>1</Version>
        <LongName>FACT-C Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C113186</PREFERRED_NAME>
            <LONG_NAME>FACT-C Questionnaire</LONG_NAME>
            <CON_ID>4035012</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4997417</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C122973</PreferredName>
        <Version>1</Version>
        <LongName>Have Ostomy Appliance</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122973</PREFERRED_NAME>
            <LONG_NAME>Have Ostomy Appliance Question</LONG_NAME>
            <CON_ID>4928113</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>FACT-C:Functional Assessment of Cancer Therapy - Colorectal, David Cella, Ph.D., Version 4, Nov. 2007</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Do you have an ostomy applian</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Do you have an ostomy appliance?  (Mark one box)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents. Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Link to Scoring and Interpretation Materials</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Scoring and Interpretation materials are accessible after registration on the FACIT website.</DocumentText>
        <URL>http://www.facit.org/FACITOrg/Questionnaires</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FACT-C</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Subscale Question #36 of 38</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812358</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measure CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718286</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-C </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4997411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000349</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-C (Functional Assessment of Cancer Therapy - Colorectal)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>4916691</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACIT/FACT</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5918014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FACT-C (Version 4)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6355942</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1323">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5021897</PUBLICID>
    <LONGNAME>Lesion Change From Baseline Percentage Value</LONGNAME>
    <PREFERREDNAME>CHG_BSL_PCT_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value to represent lesion or site of disease percentage change from a baseline measurement</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>C3D:Central Cancer Clinical Database</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5021890</PublicId>
      <PreferredName>2465192v1.0:5021888v1.0</PreferredName>
      <PreferredDefinition>A lesion or site of disease_The act of alteration or modification; changed or altered in form or character._Used to indicate a specified place or time as a starting point; used to indicate a source, cause, agent, or instrument._A starting point to which things may be compared.</PreferredDefinition>
      <LongName>Lesion Change From Baseline</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008548</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TUMOR_MSRMTS</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Measurements</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2465192</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3824</PreferredName>
        <Version>1</Version>
        <LongName>Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5021888</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446:C25516:C25213</PreferredName>
        <Version>1</Version>
        <LongName>Change From Baseline</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25516</PREFERRED_NAME>
            <LONG_NAME>From</LONG_NAME>
            <CON_ID>2206220</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25213</PREFERRED_NAME>
            <LONG_NAME>Baseline</LONG_NAME>
            <CON_ID>2202304</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5021896</PublicId>
      <PreferredName>PCT_VAL</PreferredName>
      <PreferredDefinition>A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Percentage Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <DisplayFormat>999.9</DisplayFormat>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Percent change from baseline</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Percent change from baseline</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1324">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5025029</PUBLICID>
    <LONGNAME>Phosphorylated Epidermal Growth Factor Receptor Staining Positive Assessment Indicator</LONGNAME>
    <PREFERREDNAME>PHOSPHO_EGFR_STN_ASS_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator to ask if the epidermal growth factor receptor protein (EGFR) bearing phosphorylated tyrosine residues within the 194 amino acids of the carboxyl-terminal intracellular domain of the protein was positive.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5025025</PublicId>
      <PreferredName>5025022v1.0:5025023v1.0</PreferredName>
      <PreferredDefinition>Epidermal growth factor receptor protein (EGFR) bearing phosphorylated tyrosine residues within the 194 amino acids of the carboxyl-terminal intracellular domain of the protein. Five ligand-dependent autophosphorylation sites have been identified; overexpression or mutation of EGFR can decouple ligand-binding from autophosphorylation and the subsequent activation of downstream signaling pathways. The presence of phosphorylated EGFR in a malignant tumor is generally correlated with poor prognosis and could be used as a predictive biomarker to identify individuals who may respond to EGFR-tyrosine kinase inhibitor treatment._Discoloration of patient tissue(s) produced by absorption of, or contact with, foreign matter, such as with medical dyes._Involving advantage or good._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Phosphorylated Epidermal Growth Factor Receptor Staining Positive Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5025022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C123765</PreferredName>
        <Version>1</Version>
        <LongName>Phosphorylated Epidermal Growth Factor Receptor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C123765</PREFERRED_NAME>
            <LONG_NAME>Phosphorylated Epidermal Growth Factor Receptor</LONG_NAME>
            <CON_ID>5023047</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5025023</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50753:C25246:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Staining Positive Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50753</PREFERRED_NAME>
            <LONG_NAME>Staining</LONG_NAME>
            <CON_ID>2664657</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25246</PREFERRED_NAME>
            <LONG_NAME>Positive</LONG_NAME>
            <CON_ID>2202905</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCP:Division of Cancer Prevention</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the Phospho-EGFR staining</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the Phospho-EGFR staining positive?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1325">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5040179</PUBLICID>
    <LONGNAME>Acute Graft Versus Host Disease Stage Upper Gastrointestinal Tract Severity Type</LONGNAME>
    <PREFERREDNAME>5040172v1.0:2797643v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of acute graft versus host disease upper gastrointestinal tract severity stage.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5040172</PublicId>
      <PreferredName>2512823v1.0:4843953v1.0</PreferredName>
      <PreferredDefinition>A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation._Any distinct time period in a sequence of events.</PreferredDefinition>
      <LongName>Acute Graft Versus Host Disease Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512823</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4980</PreferredName>
        <Version>1</Version>
        <LongName>Acute Graft Versus Host Disease</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4980</PREFERRED_NAME>
            <LONG_NAME>Acute Graft Versus Host Disease</LONG_NAME>
            <CON_ID>2202363</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4843953</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48308</PreferredName>
        <Version>1</Version>
        <LongName>Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48308</PREFERRED_NAME>
            <LONG_NAME>Stage</LONG_NAME>
            <CON_ID>2676538</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2797643</PublicId>
      <PreferredName>2797643v2.0</PreferredName>
      <PreferredDefinition>A syndrome of immologically mediated tissue damage occurring following allogeneic transplant usually affecting the skin, liver, and gi tract.  Onset is usually within one hundred days of transplantation or immunologic manipulation._The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum._Used of the degree of something undesirable e.g. pain or weather; also, strictness._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Acute Graft Versus Host Disease Upper Gastrointestinal Tract Severity Type</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2955349</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4980:C33837:C25676:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Acute Graft Versus Host Disease Upper Gastrointestinal Tract Severity Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4980</PREFERRED_NAME>
            <LONG_NAME>Acute Graft Versus Host Disease</LONG_NAME>
            <CON_ID>2202363</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C33837</PREFERRED_NAME>
            <LONG_NAME>Upper Gastrointestinal Tract</LONG_NAME>
            <CON_ID>2813542</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage 0</VALIDVALUE>
          <VALUEMEANING>AGVHD Upper GI Stage 0</VALUEMEANING>
          <MEANINGDESCRIPTION>No persistent nausea or vomiting</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5132197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stage 1</VALIDVALUE>
          <VALUEMEANING>AGVHD Upper GI Stage 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Persistent nausea or vomiting</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5132196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the acute graft vers</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the acute graft versus host disease upper gastrointestinal tract severity stage?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Upper intestinal tract</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Upper intestinal tract</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Upper intestinal tract</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Upper intestinal tract</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sickle Cell Disease Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4809631</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Curative Therapies</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7765018</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Moderately Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PhenX</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PhenX</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_AGHD_agvhd_stge_up_intes</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_GVHD_agvhd_stge_up_intes</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_GVHD_agvhd_stge_up_intes</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedClinicalInterpretation:severityCode</AlternateName>
        <AlternateNameType>HCT_BRIDG_5</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_GVHD_dx_agvhd_stge_up_int</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1326">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5044448</PUBLICID>
    <LONGNAME>Peripheral Vascular Disorder Present Specify Text</LONGNAME>
    <PREFERREDNAME>5044444v1.0:2799057v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The free-text field to describe the peripheral vascular disorder.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5044444</PublicId>
      <PreferredName>5044442v1.0:2233878v1.0</PreferredName>
      <PreferredDefinition>Any disorder affecting blood flow through the veins or arteries outside of the heart._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Peripheral Vascular Disorder Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5044442</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C35136</PreferredName>
        <Version>1</Version>
        <LongName>Peripheral Vascular Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C35136</PREFERRED_NAME>
            <LONG_NAME>Peripheral Vascular Disorder</LONG_NAME>
            <CON_ID>3158625</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2799057</PublicId>
      <PreferredName>SPC_TXT</PreferredName>
      <PreferredDefinition>Be specific about something; define clearly._Text; the words of something written.</PreferredDefinition>
      <LongName>Specify Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2799056</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25685:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Specify Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the peripheral vascul</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify the peripheral vascular disorder:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other peripheral vascular disease:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify other peripheral vascular disease:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other peripheral vascular disease:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify other peripheral vascular disease:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Moderately Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_ICT_oth_periph_vas_dx_sp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedDiagnosis:value</AlternateName>
        <AlternateNameType>HCT_BRIDG_5</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1327">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5046712</PUBLICID>
    <LONGNAME>Patient Bulk Neoplasm Definition Clinical Study Protocol Clinical Trial Eligibility Criteria Indicator</LONGNAME>
    <PREFERREDNAME>Bulky_Disease</PREFERREDNAME>
    <PREFERREDDEFINITION>The response which indicates whether or not a person meets the requirements for participation in a clinical trial regarding bulky disease as described in the protocol</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PBTC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5046437</PublicId>
      <PreferredName>2233604v1.0:5046435v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Large size, volume, or amount._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._A concise explanation of the meaning of a word or phrase or symbol._A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the trial, but these could be represented in other protocol referenced documents._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Patient Bulk Neoplasm Definition Clinical Study Protocol Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PBTC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5046435</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5046435v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Bulk Neoplasm Definition Clinical Study Protocol Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C69010</PREFERRED_NAME>
            <LONG_NAME>Bulk</LONG_NAME>
            <CON_ID>3233285</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42777</PREFERRED_NAME>
            <LONG_NAME>Definition</LONG_NAME>
            <CON_ID>2222839</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25320</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Protocol</LONG_NAME>
            <CON_ID>2202702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does the patient have bulky t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does the patient have bulky tumor on imaging as defined in the protocol?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have Bulky tumor on imaging as defined in the protocol based on stratum assignment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1328">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5076569</PUBLICID>
    <LONGNAME>Recipient Or Partner Current Pregnancy Present Indicator</LONGNAME>
    <PREFERREDNAME>5076383v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the recipient or partner was currently pregnant.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5076383</PublicId>
      <PreferredName>5076381v1.0:2233878v1.0</PreferredName>
      <PreferredDefinition>A person who gets something._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A person that is associated with another person in some manner or action._Occurring in or belonging to the present time._The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Recipient Or Partner Current Pregnancy Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5076381</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5076381v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Recipient Or Partner Current Pregnancy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53268</PREFERRED_NAME>
            <LONG_NAME>Recipient</LONG_NAME>
            <CON_ID>2512693</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C100128</PREFERRED_NAME>
            <LONG_NAME>Partner</LONG_NAME>
            <CON_ID>3880600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25742</PREFERRED_NAME>
            <LONG_NAME>Pregnancy</LONG_NAME>
            <CON_ID>2202906</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the recipient or recipient&#39;s partner still pregnant?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the recipient or recipient&#39;s partner still pregnant?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the recipient or recipient&#39;s partner still pregnant?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Was the recipient or recipient&#39;s partner still pregnant?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the recipient or partner</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the recipient or partner currently pregnant?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the recipient or recipient&#39;s partner still pregnant at the date of last contact?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the recipient or recipient&#39;s partner still pregnant at the date of last contact?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was the recipient or recipient&#39;s partner still pregnant at the time of this report?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the recipient or recipient&#39;s partner still pregnant at the time of this report?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Moderately Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_FS_recp_part_cur_preg_ynu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_FS_recp_part_cur_preg_ynu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PREG_FS_rec_part_cur_preg_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedMedicalConditionResult:value</AlternateName>
        <AlternateNameType>HCT_BRIDG_5</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1329">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5077011</PUBLICID>
    <LONGNAME>Patient Diagnosis Eligibility Determination Yes No Unknown Not Applicable Indicator</LONGNAME>
    <PREFERREDNAME>PtDxEligDtnn</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no/unknown/not applicable indicator related to a patient has recognition of the presence and nature of disease to determine eligibility of patients for medical care programs and services.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5076993</PublicId>
      <PreferredName>2233604v1.0:5076991v1.0</PreferredName>
      <PreferredDefinition>Information related to a person who receives medical attention, care, or treatment, with the purpose to receive medical care when necessary.The investigation, analysis and recognition of the presence and nature of disease. Criteria to determine eligibility of patients for medical care programs and services.</PreferredDefinition>
      <LongName>Patient Diagnosis Eligibility Determination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5076991</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220:C25171</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is patient diagnosed with any</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is patient diagnosed with any of the following?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient newly diagnosed and eligible as confirmed by rapid central pathology and molecular screening review on APEC14B1?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have fulminant PTLD?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have any documented donor-derived PTLD?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient newly diagnosed with B-LLy Murphy Stages I or II?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient newly diagnosed with B-LLy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient newly diagnosed with B-LLy Murphy Stages III or IV?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient newly diagnosed non-pontine H3 K27M-mutant HGG without BRAF or IDH1 mutations as confirmed by Rapid Central Pathology and Molecular Screening Reviews performed on APEC14B1?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient newly diagnosed with non-pontine H3 K27M-mutant HGG without BRAF or IDH1 mutations as confirmed by Rapid Central Pathology and Molecular Screening Reviews performed on APEC14B1?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have newly diagnosed B-ALL with definitive evidence of ABL-class fusion?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient been newly diagnosed and declared eligible by rapid central pathology and molecular screening review?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient been newly diagnosed with non-pontine H3 K27M-mutant HGG (without BRAF or IDH1 mutations) as confirmed by Rapid Central Pathology and Molecular Screening Reviews performed on APEC14B1?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 001</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient been newly diagnosed with non-pontine H3 K27M-wild type HGG (without BRAF or IDH1 mutations) as confirmed by Rapid Central Pathology and Molecular Screening Reviews performed on APEC14B1?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 15</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient been newly diagnosed with non-pontine H3 K27M-mutant HGG (without BRAF or IDH1 mutations) as confirmed by Rapid Central Pathology and Molecular Screening Reviews performed on APEC14B1 or through the CCDI Molecular Characterization Initiative?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 17</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient been diagnosed with ALL, AML, or MDS for which an allogeneic hematopoietic stem cell transplant is indicated?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 16</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient been newly diagnosed with non-pontine H3 K27M-wild type HGG (without BRAF or IDH1 mutations) as confirmed by Rapid Central Pathology and Molecular Screening Reviews performed on APEC14B1 or through the CCDI Molecular Characterization Initiative?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 13</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient been newly diagnosed with non-pontine H3 K27M-mutant HGG (without BRAF or IDH1 mutations) as confirmed by Rapid Central Pathology and Molecular Screening Reviews performed on APEC14B1 or through the CCDI Molecular Characterization Initiative (CCDI-MCI)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 14</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient been newly diagnosed with non-pontine H3 K27M-wild type HGG (without BRAF or IDH1 mutations) as confirmed by Rapid Central Pathology and Molecular Screening Reviews performed on APEC14B1 or through the CCDI Molecular Characterization Initiative (CCDI-MCI)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient been diagnosed with AML, B-ALL, T-ALL, or mixed phenotype acute leukemia (MPAL)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have Newly Diagnosed B-ALL, T-ALL, Lymphoblastic Lymphoma, or Mixed-Phenotype Acute Leukemia/Lymphoma?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 18</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have newly diagnosed B-ALL with evidence of ABL-class fusion?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 19</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have newly diagnosed B-ALL with evidence of ABL-class fusion documented by a clinically-validated assay within 15 days of the first dose of vincristine during Induction therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 20</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient CMV sero-positive (i.e., recipient CMV immunoglobulin G positive)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 21</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient been diagnosed with ALL, AML,  MDS or MPAL for which an allogeneic hematopoietic stem cell transplant is indicated?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF 22</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have MDS?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 23</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient newly diagnosed with first cancer exclusive of breast cancer?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 24</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have newly-diagnosed ABL-class Ph-like B-ALL without PDGFRB fusions?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 25</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have newly-diagnosed ABL-class Ph-like B-ALL with PDGFRB fusions?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_DX_ELIG_DETM</AlternateName>
        <AlternateNameType>VM Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PtDxEligDtnn_02</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PtDxFstCanXclBrst</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1330">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5080391</PUBLICID>
    <LONGNAME>Dose-Limiting Protocol Specification Present Yes No Indeterminate Indicator</LONGNAME>
    <PREFERREDNAME>DsLtProtSpec</PREFERREDNAME>
    <PREFERREDDEFINITION>Yes/No/Indeterminate indicator describes side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level of that treatment. A rule which guides how an activity should be performed. A detailed description of criteria for a piece of work. Being or existing in a specified place or at the specified time.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5077094</PublicId>
      <PreferredName>5077091v1.0:5077092v1.0</PreferredName>
      <PreferredDefinition>Information related to describes side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level of that treatment. A rule which guides how an activity should be performed. A detailed description of criteria for a piece of work. Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Dose-Limiting Protocol Specification Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008573</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5077091</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28014</PreferredName>
        <Version>1</Version>
        <LongName>Dose-Limiting</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28014</PREFERRED_NAME>
            <LONG_NAME>Dose-Limiting</LONG_NAME>
            <CON_ID>2422288</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5077092</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42651:C73537:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Specification Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42651</PREFERRED_NAME>
            <LONG_NAME>Protocol</LONG_NAME>
            <CON_ID>2211236</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73537</PREFERRED_NAME>
            <LONG_NAME>Specification</LONG_NAME>
            <CON_ID>2772177</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2846999</PublicId>
      <PreferredName>2846999v1.0</PreferredName>
      <PreferredDefinition>the yes/no/indeterminate indicator.</PreferredDefinition>
      <LongName>Yes No Indeterminate Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No, Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2847000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3216924</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Are all DLTs reported by the</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Are all DLTs reported by the institution in this reporting period, according to protocol specification?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Are there any adverse events that are DLTs according to protocol specification that were not identified as such by the institution?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1331">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5092506</PUBLICID>
    <LONGNAME>Knowledge Understanding and Judgement Scale Four of Five Patients Who Have Radiation Rays Have Erections Firm Enough for Sexual Intercourse Indicator</LONGNAME>
    <PREFERREDNAME>KUJ_RADR_ERCT_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated understanding of the statement, four of five patients who get radiation rays are able to have erections firm enough to have intercourse after radiation, using a true or false indictor.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>KUJ:Knowledge, Understanding and Judgement Scale</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5092462</PublicId>
      <PreferredName>5092397v1.0:5092460v1.0</PreferredName>
      <PreferredDefinition>A questionnaire developed to assess a patient&#39;s knowledge of prostate cancer, understanding of treatment choices, and judgment of survival with and without treatment._A question about whether an individual thinks that four of five patients who get external radiation therapy are able to have erections firm enough to have intercourse after treatment.</PreferredDefinition>
      <LongName>Knowledge, Understanding and Judgment Scale Four of Five Patients Are Able to Have Erections Firm Enough to Have Sexual Intercourse After External Radiation Therapy for Prostate Cancer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5092397</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C124803</PreferredName>
        <Version>1</Version>
        <LongName>Knowledge, Understanding and Judgment Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C124803</PREFERRED_NAME>
            <LONG_NAME>Knowledge, Understanding and Judgment Scale</LONG_NAME>
            <CON_ID>5085191</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5092460</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C124815</PreferredName>
        <Version>1</Version>
        <LongName>Four of Five Patients Are Able to Have Erections Firm Enough to Have Sexual Intercourse After External Radiation Therapy for Prostate Cancer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C124815</PREFERRED_NAME>
            <LONG_NAME>Four of Five Patients Are Able to Have Erections Firm Enough to Have Sexual Intercourse After External Radiation Therapy for Prostate Cancer Question</LONG_NAME>
            <CON_ID>5085293</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>KUJ:Knowledge, Understanding and Judgement Scale</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5092391</PublicId>
      <PreferredName>KUJ_TRUE_FALSE_IND</PreferredName>
      <PreferredDefinition>A response of true or false related to statements associated with the Knowledge, Understanding and Judgement Scale (KUJ).</PreferredDefinition>
      <LongName>KUJ True False Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>KUJ:Knowledge, Understanding and Judgement Scale</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>False</VALIDVALUE>
          <VALUEMEANING>False</VALUEMEANING>
          <MEANINGDESCRIPTION>Not in accordance with the fact or reality or definitive criteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>True</VALIDVALUE>
          <VALUEMEANING>True</VALUEMEANING>
          <MEANINGDESCRIPTION>Conforming to fact or reality or definitive criteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68850</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Four of five patients who get</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Four of five patients who get radiation rays (not seeds) are able to have erections firm enough to have intercourse after radiation.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5090547</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>KUJ</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KUJ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5090548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1332">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5097146</PUBLICID>
    <LONGNAME>Smoking Self-Efficacy Questionnaire 1 Refrain from Smoking when Nervous Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>SEQ12_NERVOUS_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated observation of whether they could refrain from smoking when they feel nervous.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>SEQ-12:Smoking Self-Efficacy Questionnaire</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5097096</PublicId>
      <PreferredName>5097093v1.0:5097094v1.0</PreferredName>
      <PreferredDefinition>A questionnaire measuring the confidence of current and former smokers in their ability to abstain from smoking in high-risk situations. Two six-item subscales measure confidence in ability to refrain from smoking when facing internal and external stimuli._A question about an individual&#39;s certainty that they can avoid smoking when they are feeling nervous._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Smoking Self-Efficacy Questionnaire Refrain from Smoking when Nervous Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5097093</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C124884</PreferredName>
        <Version>1</Version>
        <LongName>Smoking Self-Efficacy Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C124884</PREFERRED_NAME>
            <LONG_NAME>Smoking Self-Efficacy Questionnaire</LONG_NAME>
            <CON_ID>5094871</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5097094</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C124885:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Refrain from Smoking when Nervous Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C124885</PREFERRED_NAME>
            <LONG_NAME>Refrain from Smoking when Nervous Question</LONG_NAME>
            <CON_ID>5094872</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>SEQ-12:Smoking Self-Efficacy Questionnaire</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5096791</PublicId>
      <PreferredName>5096791v1.0</PreferredName>
      <PreferredDefinition>Numeric scores from 1 (Not at all sure) to 5 (Absolutely sure) on a Likert scale used on the Smoking Self-Efficacy Questionnaire.</PreferredDefinition>
      <LongName>Smoking Self-Efficacy Questionnaire Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>SEQ-12:Smoking Self-Efficacy Questionnaire</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Absolutely Sure</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement regarding the certainty of something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Fairly Sure</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of agreement regarding the certainty of something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124905</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>More or Less Sure</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement regarding the certainty of something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Not Very Sure</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement regarding the certainty of something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not At All Sure</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of non-agreement regarding the certainty of something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>When I feel nervous</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>When I feel nervous</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5090653</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>SEQ-12</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SEQ-12</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5090654</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Smoking Self-Efficacy Questionnaire (SEQ-12)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900352</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1333">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5114693</PUBLICID>
    <LONGNAME>Memorial Symptom Assessment Scale D23 Past Week How Much Distress Difficulty Swallowing Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>MSAS_D_SWALLOWING_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated observation in the past week how much distress they had from symptoms of having difficulty swallowing, using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5114619</PublicId>
      <PreferredName>5114473v1.0:5114617v1.0</PreferredName>
      <PreferredDefinition>A patient-rated instrument developed to provide multidimensional information about a diverse group of common symptoms. This 32-question, self-rated questionnaire evaluates the prevalence, characteristics, and distress associated with each of the symptoms._The most recent week, including today._A question about an individual&#39;s distress from their difficulty swallowing._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale Past Week How Much Distress Difficulty Swallowing Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5114473</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C125238</PreferredName>
        <Version>1</Version>
        <LongName>Memorial Symptom Assessment Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125238</PREFERRED_NAME>
            <LONG_NAME>Memorial Symptom Assessment Scale</LONG_NAME>
            <CON_ID>5109052</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5114617</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C125352:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week How Much Distress Difficulty Swallowing Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125352</PREFERRED_NAME>
            <LONG_NAME>How Much Distress Difficulty Swallowing Question</LONG_NAME>
            <CON_ID>5109194</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5114472</PublicId>
      <PreferredName>MSAS_DISTRESS_SCL</PreferredName>
      <PreferredDefinition>Numeric scores from 0 (Not at all) to 4 (Very Much) on a Likert scale used on the Memorial Symptom Assessment Scale questionnaire.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale Distress Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>MSAS-SF:Memorial Symptom Assessment Scale Short Form.Chang VT, et.al., Cancer. 2000 Sep 1;89(5):1162-71.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How much did your difficulty</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How much did your difficulty swallowing DISTRESS or BOTHER you?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure.  The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure. Changes may not be made to these documents.  Where an investigator wants to use single Patient Reported Outcome items that are integrated into a study, DCP review is required prior to inclusion of the item on a case report form.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Difficulty swallowing</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Difficulty swallowing</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4551587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4551585</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS (Memorial Symptom Assessment Scale)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5115651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4718285</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer and/or Treatment Related Symptoms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5711252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840828</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSAS (Memorial Symptom Assessment Scale)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCI Standards</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCI Standards</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1334">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5118535</PUBLICID>
    <LONGNAME>Peritumoral Tissue Sample Preservation Method Type</LONGNAME>
    <PREFERREDNAME>5118518v1.0:2186562v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that represents the kind of preservation method applied to the peritumoral tissue sample.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CTSP/CDDP: Clinical Trial Sequencing and Cancer Driver Discovery Projects</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5118518</PublicId>
      <PreferredName>5085081v1.0:5120671v1.0</PreferredName>
      <PreferredDefinition>Located in tissues surrounding a tumor._A piece of tissue removed from an organism for examination, analysis, or propagation._The activity of protecting something from loss or danger; a process that saves organic substances from decay; to maintain or keep intact._A practiced and regimented skill or series of actions.</PreferredDefinition>
      <LongName>Peritumoral Tissue Sample Preservation Technique</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5085081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C119010:C19697</PreferredName>
        <Version>1</Version>
        <LongName>Peritumoral Tissue Sample</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C119010</PREFERRED_NAME>
            <LONG_NAME>Peritumoral</LONG_NAME>
            <CON_ID>4633481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19697</PREFERRED_NAME>
            <LONG_NAME>Tissue Sample</LONG_NAME>
            <CON_ID>2222017</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5120671</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52243:C16847</PreferredName>
        <Version>1</Version>
        <LongName>Preservation Technique</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52243</PREFERRED_NAME>
            <LONG_NAME>Preservation</LONG_NAME>
            <CON_ID>2443938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16847</PREFERRED_NAME>
            <LONG_NAME>Technique</LONG_NAME>
            <CON_ID>2203854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>TCGA:The Cancer Genome Atlas</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2186562</PublicId>
      <PreferredName>SPEC_PRSVN_METH_TP</PreferredName>
      <PreferredDefinition>Means of preservation of cells, tissues, or organs by freezing.</PreferredDefinition>
      <LongName>Specimen Preservation Method Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2183782</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>NCIP</PreferredName>
        <Version>1</Version>
        <LongName>NCIP</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>-80 Deg C</VALIDVALUE>
          <VALUEMEANING>-80 Degrees Celsius</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantity having a value less than zero.::1: A natural number greater than seventy-nine and less than eighty-one and the quantity that it denotes.::2: A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42559, C105788, C81022</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LN2</VALIDVALUE>
          <VALUEMEANING>Liquid nitrogen</VALUEMEANING>
          <MEANINGDESCRIPTION>A substance in the fluid state of matter having no fixed shape but a fixed volume.: Nitrogen</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61863, C45298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frozen</VALIDVALUE>
          <VALUEMEANING>Frozen Specimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A specimen that has been subjected to and immobilized by severe cold.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3167629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FFPE</VALIDVALUE>
          <VALUEMEANING>Formalin-Fixed Paraffin-Embedded </VALUEMEANING>
          <MEANINGDESCRIPTION>A colorless poisonous gas synthesized by the oxidation of methanol and used as an antiseptic, disinfectant, histologic fixative, and general-purpose chemical reagent for laboratory applications. Formaldehyde is readily soluble in water and is commonly distributed as a 37% solution in water; formalin, a 10% solution of formaldehyde in water, is used as a disinfectant and to preserve biological specimens. Environmentally, formaldehyde may be found in the atmosphere, smoke from fires, automobile exhaust and cigarette smoke. Small amounts are produced during normal metabolic processes in most organisms, including humans.: Tissue which is preserved in a fixative solution, usually formalin.: Tissue that is preserved and embedded in paraffin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19597, C84514, C29744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5118538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Peritumoral Preservation Meth</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Peritumoral Preservation Method</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1335">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5118891</PUBLICID>
    <LONGNAME>Interferon Gamma Measurement Laboratory Procedure Performed Finding Status Indicator</LONGNAME>
    <PREFERREDNAME>5118874v1.0:3436461v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the status of the laboratory results for interferon gamma.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5118874</PublicId>
      <PreferredName>5118872v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>The determination of the amount of interferon gamma present in a sample._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Interferon Gamma Measurement Laboratory Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5118872</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C81996:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Interferon Gamma Measurement Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C81996</PREFERRED_NAME>
            <LONG_NAME>Interferon Gamma Measurement</LONG_NAME>
            <CON_ID>5118871</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3436461</PublicId>
      <PreferredName>3436461v1.0</PreferredName>
      <PreferredDefinition>The result of an examination or inquiry._A condition or state at a particular time._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Finding Status Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3436460</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61036:C25688:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Finding Status Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61036</PREFERRED_NAME>
            <LONG_NAME>Investigation Finding</LONG_NAME>
            <CON_ID>2528540</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not known</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-11</PVBEGINDATE>
          <PVENDDATE>2013-03-12</PVENDDATE>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known</VALIDVALUE>
          <VALUEMEANING>Known</VALUEMEANING>
          <MEANINGDESCRIPTION>Recognized, familiar, or within the scope of knowledge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2934435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3371379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-03-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Interferon gamma IFN-Gamma</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Interferon gamma IFN-Gamma</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the status of the int</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the status of the interferon gamma finding?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Interferon gamma IFN /Gamma/</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Interferon gamma IFN /Gamma/</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Moderately Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_CRS_ifn_gam_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_ifn_gam_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>performedClinicalResult:value</AlternateName>
        <AlternateNameType>HCT_BRIDG_5</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1336">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5151216</PUBLICID>
    <LONGNAME>Lung Neoplasm Expand Into Other Area Pathologic T4 Stage Finding Data Unknown Text</LONGNAME>
    <PREFERREDNAME>LUNGT4EXPANDOTH</PREFERREDNAME>
    <PREFERREDDEFINITION>A checkbox for information related to a determination of pathologic T4 stage finding in lung cancer due to the tumor expanding into any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, or vertebral body.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5151210</PublicId>
      <PreferredName>LUNGT4EXPANDOTH</PreferredName>
      <PreferredDefinition>Information related to a determination of pathologic T4 stage finding in lung cancer due to the tumor expanding into any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, or vertebral body</PreferredDefinition>
      <LongName>Lung Neoplasm Expand Into Other Area Pathologic T4 Stage Finding</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206550</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12468:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Lung Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12468</PREFERRED_NAME>
            <LONG_NAME>Lung</LONG_NAME>
            <CON_ID>2202738</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5151208</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5151208v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Expand Into Other Area Pathologic T4 Stage Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C96889</PREFERRED_NAME>
            <LONG_NAME>Expand</LONG_NAME>
            <CON_ID>4269935</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25544</PREFERRED_NAME>
            <LONG_NAME>Into</LONG_NAME>
            <CON_ID>2206279</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25244</PREFERRED_NAME>
            <LONG_NAME>Area</LONG_NAME>
            <CON_ID>2405233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25610</PREFERRED_NAME>
            <LONG_NAME>Pathologic</LONG_NAME>
            <CON_ID>2204850</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48732</PREFERRED_NAME>
            <LONG_NAME>T4 TNM Finding</LONG_NAME>
            <CON_ID>2519623</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200608</PublicId>
      <PreferredName>DATA_UNKNOWN_TEXT</PreferredName>
      <PreferredDefinition>a single character text field to record data.</PreferredDefinition>
      <LongName>Data Unknown Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tumor has expanded into any o</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tumor has expanded into any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, or vertebral body</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1337">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5189832</PUBLICID>
    <LONGNAME>Human Activity Profile 87 Running or Jogging One Quarter Mile Nonstop 3 Point Scale</LONGNAME>
    <PREFERREDNAME>HAP_Q87_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of their ability to run or jog 1/4 mile (nonstop), using a three point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5189466</PublicId>
      <PreferredName>5188571v1.0:5189464v1.0</PreferredName>
      <PreferredDefinition>A self-administered instrument designed to measure energy expenditure or physical fitness. It was originally developed to measure quality of life achieved by patients in rehabilitation programs for chronic obstructive pulmonary disease, but has also been used as a measure of physical activity in both healthy and impaired populations. The profile consists of 94 common daily activities listed in ascending order according to the energy required to perform them. Activities including self-care tasks, personal/household work, entertainment/social activities, and independent exercise pursuits and respondents are requested to indicate if they are currently able to perform the activity (unassisted), they have stopped performing the activity, or they have never performed the activity._A question about an individual&#39;s ability to run or jog 1/4 mile nonstop.</PreferredDefinition>
      <LongName>Human Activity Profile Running or Jogging 1/4 Mile Nonstop</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5188571</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48948</PreferredName>
        <Version>1</Version>
        <LongName>Human Activity Profile</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48948</PREFERRED_NAME>
            <LONG_NAME>Human Activity Profile</LONG_NAME>
            <CON_ID>5168044</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5189464</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C126223</PreferredName>
        <Version>1</Version>
        <LongName>Running or Jogging 1/4 Mile Nonstop</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126223</PREFERRED_NAME>
            <LONG_NAME>Running or Jogging 1/4 Mile Nonstop Question</LONG_NAME>
            <CON_ID>5168341</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5188567</PublicId>
      <PreferredName>HAP_SCALE</PreferredName>
      <PreferredDefinition>an ordered reference standard.</PreferredDefinition>
      <LongName>HAP Activity 3 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>32</MaximumLength>
      <MinimumLength>23</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>HAP:Human Activity Profile. Daughton, DM and Fix, James, J Rehabil Res Dev. 41(4): 621-630, 1980.</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never Did This Activity</VALIDVALUE>
          <VALUEMEANING>Never Did This Activity</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is never did an activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5188568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Have Stopped Doing This Activity</VALIDVALUE>
          <VALUEMEANING>Have Stopped Doing This Activity</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has stopped doing an activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5188569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Still Doing This Activity</VALIDVALUE>
          <VALUEMEANING>Still Doing This Activity</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is still doing an activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-03-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5188570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Running or jogging 1/4 mile (</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Running or jogging 1/4 mile (nonstop)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Human Activity Profile (HAP)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question 87 of 94</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions. Questions used in this manner do not represent the original measure and should not be referenced by the measure’s name.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>2</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5187973</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HAP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HAP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5187974</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Human Activity Profile (HAP)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900309</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1338">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5235651</PUBLICID>
    <LONGNAME>EGFR vIII Test Percent Unit CD3 Result Percentage Value</LONGNAME>
    <PREFERREDNAME>EGFRVIII_CD3_PCT_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric percentage value to represent the amount of CD3+ present in EGFR vIII test result.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5235357</PublicId>
      <PreferredName>5235318v1.0:5235355v1.0</PreferredName>
      <PreferredDefinition>The protein found on the surface of some cells and to which epidermal growth factor binds, causing the cells to divide. It is found at abnormally high levels on the surface of many types of cancer cells, so these cells may divide excessively in the presence of epidermal growth factor._Genetic alterations found in the neoplastic lesions of the animal model. These alterations are not made intentionally._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred)._Consisting of cell surface type I membrane Delta, Epsilon, Gamma, Zeta, and Eta protein subunits with ITAM domains and noncovalently associated with the disulfide bound heterodimeric alpha/beta and gamma/delta TCR, the CD3 complex couples receptor antigen recognition to signal transduction pathways during T-cell activation._The result of an action.</PreferredDefinition>
      <LongName>EGFR vIII Test Percent Unit CD3 Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435027</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16612</PreferredName>
        <Version>1</Version>
        <LongName>Gene</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5235318</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17068:C16885</PreferredName>
        <Version>1</Version>
        <LongName>Epidermal Growth Factor Receptor Mutation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17068</PREFERRED_NAME>
            <LONG_NAME>Epidermal Growth Factor Receptor</LONG_NAME>
            <CON_ID>2202420</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16885</PREFERRED_NAME>
            <LONG_NAME>Mutation</LONG_NAME>
            <CON_ID>2224010</CON_ID>
            <DEFINITION_SOURCE>CABIO</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5235355</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48570:C38897:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Percent Unit CD3 Complex Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48570</PREFERRED_NAME>
            <LONG_NAME>Percent Unit</LONG_NAME>
            <CON_ID>2475072</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38897</PREFERRED_NAME>
            <LONG_NAME>CD3 Complex</LONG_NAME>
            <CON_ID>2593496</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2434147</PublicId>
      <PreferredName>2434147v1</PreferredName>
      <PreferredDefinition>Percentage; a fraction or ratio with 100 understood as the denominator._A number with no fractional part.</PreferredDefinition>
      <LongName>Percentage Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2183782</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>NCIP</PreferredName>
        <Version>1</Version>
        <LongName>NCIP</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>%</DisplayFormat>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>0</MinimumLength>
      <DecimalPlace/>
      <MaximumValue>100</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>CAP PROTOCOLS:College of American Pathologists Cancer Protocols</Origin>
      <Representation>
        <PublicId>2434146</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C45255</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Integer</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>% of CD3+ that are EGFRvIII</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>% of CD3+ that are EGFRvIII</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1339">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5235909</PUBLICID>
    <LONGNAME>Tissue Donor Past Year Hepatitis C Diagnosed Person Physical Contact Indicator</LONGNAME>
    <PREFERREDNAME>DON_HEPC_CONTACT_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>An indication of whether the donor was living in close physical contact with someone in the last 12 months who has been diagnosed with Hepatitis C as provided by the primary history source.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>BBRB</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5234597</PublicId>
      <PreferredName>2512816v1.0:5234595v1.0</PreferredName>
      <PreferredDefinition>Someone who gives blood or tissue or an organ to be used in another person._A period of time consisting of the 12 months before the present._A viral infection caused by the hepatitis C virus._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A human being._The act of touching physically; the physical coming together of two or more things.</PreferredDefinition>
      <LongName>Tissue Donor Past Year Hepatitis C Diagnosed Person Physical Contact</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>BBRB</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25168</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Donor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5234595</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5234595v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Past Year Hepatitis C Infection Diagnosis Person Physical Contact</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125217</PREFERRED_NAME>
            <LONG_NAME>Past Year</LONG_NAME>
            <CON_ID>5108191</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3098</PREFERRED_NAME>
            <LONG_NAME>Hepatitis C Infection</LONG_NAME>
            <CON_ID>2205375</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49147</PREFERRED_NAME>
            <LONG_NAME>Physical Contact</LONG_NAME>
            <CON_ID>2607508</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Living or close physical cont</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Living or close physical contact with someone in the last 12 months who has been diagnosed with: Hepatitis C</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GTEx - Postmortem Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Donor Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736403</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BBRB</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BBRB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1340">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5242024</PUBLICID>
    <LONGNAME>Specimen Condition Received Shipment Status</LONGNAME>
    <PREFERREDNAME>SPEC_COND_RCV_STATUS</PREFERREDNAME>
    <PREFERREDDEFINITION>The response that indicates whether the shipped specimens were received in good or bad condition.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>BBRB</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2191155</PublicId>
      <PreferredName>SPEC_COND_RCVD</PreferredName>
      <PreferredDefinition>information related to the condition in which a specimen was received.</PreferredDefinition>
      <LongName>Specimen Condition Received</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2241613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2735656</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25457:C25639</PreferredName>
        <Version>1</Version>
        <LongName>Condition Received</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25457</PREFERRED_NAME>
            <LONG_NAME>Condition</LONG_NAME>
            <CON_ID>2202899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5237314</PublicId>
      <PreferredName>5237314v1.0</PreferredName>
      <PreferredDefinition>A condition or state at a particular time.</PreferredDefinition>
      <LongName>Shipment Condition Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>BBRB</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>45</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Shipment received in poor condition</VALIDVALUE>
          <VALUEMEANING>Poor Condition</VALUEMEANING>
          <MEANINGDESCRIPTION>Of low value or worth.: A state of being, such as a state of health.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25457, C77959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-04-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5237315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Shipment received in good condition</VALIDVALUE>
          <VALUEMEANING>Good Condition</VALUEMEANING>
          <MEANINGDESCRIPTION>Valuable or useful or agreeable or pleasing.: A state of being, such as a state of health.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25457, C64975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-04-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5237316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Shipment Condition</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Shipment Condition</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was specimen shipment received in</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>State of Blood Samples/Tissue</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-07-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889176</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2017-09-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GTEx - Postmortem Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Chain of Custody</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736388</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BBRB</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BBRB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1341">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5254723</PUBLICID>
    <LONGNAME>Tissue Donor Prior To Death Ventilator Use Indicator</LONGNAME>
    <PREFERREDNAME>PRIOR_DTH_VENTIL_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indication whether the donor was assisted by a medical device that facilitates breathing immediately prior to death.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>BBRB</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5251773</PublicId>
      <PreferredName>2512816v1.0:5251771v1.0</PreferredName>
      <PreferredDefinition>Someone who gives blood or tissue or an organ to be used in another person._Earlier in time or order._Used as a function word to indicate direction, purpose, or movement._The cessation of life._A medical device that facilitates breathing._A manner, or usual, or accepted practice of using something.</PreferredDefinition>
      <LongName>Tissue Donor Prior To Death Ventilator Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>BBRB</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19238</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic, Therapeutic, and Research Equipment</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25168</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Donor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5251771</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5251771v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Prior To Death Ventilator Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C65107</PREFERRED_NAME>
            <LONG_NAME>To</LONG_NAME>
            <CON_ID>2672667</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28554</PREFERRED_NAME>
            <LONG_NAME>Dead</LONG_NAME>
            <CON_ID>2202731</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38388</PREFERRED_NAME>
            <LONG_NAME>Ventilator</LONG_NAME>
            <CON_ID>2525659</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was donor on a ventilator imm</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was donor on a ventilator immediately prior to death?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GTEx - Postmortem Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Collection Case Report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736402</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BBRB</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BBRB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1342">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5273372</PUBLICID>
    <LONGNAME>CRQ-SAS 2 Last 2 Weeks How Much Shortness of Breath While Taking Care of Basic Needs Score 8 Point Scale</LONGNAME>
    <PREFERREDNAME>CRQSAS_Q2_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation in the last 2 weeks of their shortness of breath while taking care of their basic needs (bathing, showering, eating or dressing), using an 8 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CRQ-SAS:Chronic Respiratory Questionnaire Self-Administered Standardized Format, Peggy Austin, Dr. Holger J. Schünemann, Dr. Gordon H. Guyatt, Department of Clinical Epidemiology and Biostatistics, February 2006.</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5273293</PublicId>
      <PreferredName>5273271v1.0:5273291v1.0</PreferredName>
      <PreferredDefinition>A standardized rating scale developed by Schunemann et al in 2003, which is a self-administered instrument used to measure the health-related quality of life (HRQL) in patients with chronic airflow limitation._A period of time consisting of the 14 days before the present._A question about how much shortness of breath an individual had or has while doing a specific activity._A question about an individual taking care of their basic needs including bathing, showering, eating or dressing._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Chronic Respiratory Questionnaire Self-Administered Standardized Format Past 2 Weeks How Much Shortness of Breath During Activity Take Care of Basic Needs Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5273271</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C126891</PreferredName>
        <Version>1</Version>
        <LongName>Chronic Respiratory Questionnaire Self-Administered Standardized Format</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126891</PREFERRED_NAME>
            <LONG_NAME>Chronic Respiratory Questionnaire Self-Administered Standardized Format</LONG_NAME>
            <CON_ID>5271352</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5273291</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C126890:C126902:C126905:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past 2 Weeks How Much Shortness of Breath During Activity Take Care of Basic Needs Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126890</PREFERRED_NAME>
            <LONG_NAME>Past 2 Weeks</LONG_NAME>
            <CON_ID>5271604</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126902</PREFERRED_NAME>
            <LONG_NAME>How Much Shortness of Breath During Activity Question</LONG_NAME>
            <CON_ID>5271433</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126905</PREFERRED_NAME>
            <LONG_NAME>Take Care of Basic Needs Question</LONG_NAME>
            <CON_ID>5271431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5273191</PublicId>
      <PreferredName>SHORT_BREATH_8PT_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Shortness of Breath Score 8 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>8</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4163021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Not at All Short of Breath</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not at all short of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126932</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>A Little Short of Breath</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was a little short of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126930</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Some Shortness of Breath</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual experiences or experienced some shortness of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126929</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Moderately short of breath</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had moderate shortness of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121896</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4837794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a Bit Short of Breath</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit short of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126928</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Very Short of Breath</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very short of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126927</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Extremely Short of Breath</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was extremely short of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126926</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Taking care of your basic nee</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Taking care of your basic needs (bathing, showering, eating or dressing)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5273171</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRQ-SAS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CRQ-SAS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5273172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1343">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5296938</PUBLICID>
    <LONGNAME>Karyotyping Laboratory Procedure Biospecimen Collection Performed Date</LONGNAME>
    <PREFERREDNAME>5455359v1.0:2532012v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The month, day, and year the karyotyping biospecimen collection was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5455359</PublicId>
      <PreferredName>5455357v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The act or process of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Karyotyping Laboratory Procedure Biospecimen Collection Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5455357</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16768:C25294:C70945</PreferredName>
        <Version>1</Version>
        <LongName>Karyotyping Laboratory Procedure Biospecimen Collection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16768</PREFERRED_NAME>
            <LONG_NAME>Karyotyping</LONG_NAME>
            <CON_ID>2960838</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70945</PREFERRED_NAME>
            <LONG_NAME>Biospecimen Collection</LONG_NAME>
            <CON_ID>2714902</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2532012</PublicId>
      <PreferredName>DATE</PreferredName>
      <PreferredDefinition>The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY-MM-DD</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the date the karyoty</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the date the karyotyping biospecimen collection was performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date sample collected:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date sample collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date sample collected:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Date sample collected:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_LTHM_karyo_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_DABR_karyo_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_DRPI_karyo_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_DSTE_karyo_samp_coll_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_DABR_karyo_sampl_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_DRPI_karyo_sampl_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_PHPI_karyo_sampl_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSDX_karyo_sampl_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LSLE_kary_sample_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LTHM_karyo_sampl_coll_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DLR_bm_perc_dis_detect</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DLR_kary_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_RP_kary_smpl_clct_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DLR_kary_samp_coll_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1344">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5418934</PUBLICID>
    <LONGNAME>Tissue Donor Death Location Other Specify</LONGNAME>
    <PREFERREDNAME>5418933v1.0:2666713v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The location of death that has not previously been specified.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>BBRB</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5418933</PublicId>
      <PreferredName>2512816v1.0:5418931v1.0</PreferredName>
      <PreferredDefinition>Someone who gives blood or tissue or an organ to be used in another person._The cessation of life._A position, site, or point in space where something can be found.</PreferredDefinition>
      <LongName>Tissue Donor Death Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>BBRB</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2230266</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TISSUE BANKING</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Banking</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25168</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Donor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25168</PREFERRED_NAME>
            <LONG_NAME>Tissue Donor</LONG_NAME>
            <CON_ID>2202520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5418931</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28554:C25341</PreferredName>
        <Version>1</Version>
        <LongName>Death Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28554</PREFERRED_NAME>
            <LONG_NAME>Dead</LONG_NAME>
            <CON_ID>2202731</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666713</PublicId>
      <PreferredName>OTH_SPEC</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Other Specify</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NCI CRF Standards</Origin>
      <Representation>
        <PublicId>2208051</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other Death Location</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other Death Location</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GTEx - Postmortem Biospecimen Acquisition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>5405792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5188871</PublicId>
          <ContextName>BBRB</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GTEx - Postmortem Biospecimen </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Collection Case Report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>6736402</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BBRB</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BBRB</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1345">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5427619</PUBLICID>
    <LONGNAME>Tumor Density Type</LONGNAME>
    <PREFERREDNAME>TM_DENSITY_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>A characrerisitic of benign or malignant tissue indicating density.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>MCL</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MCL:Molecular and Cellular Characterization of Screened Lesions</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5427618</PublicId>
      <PreferredName>2404687v1.0:2261962v1.0</PreferredName>
      <PreferredDefinition>A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The amount of something per unit size.</PreferredDefinition>
      <LongName>Tumor Density</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>MCL</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404687</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3262</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2261962</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45781</PreferredName>
        <Version>1</Version>
        <LongName>Density</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45781</PREFERRED_NAME>
            <LONG_NAME>Density</LONG_NAME>
            <CON_ID>2236512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MCL:Molecular and Cellular Characterization of Screened Lesions</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5427612</PublicId>
      <PreferredName>5427612v1.0</PreferredName>
      <PreferredDefinition>The amount of something per unit size._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Density Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>MCL</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>5427611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45781:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Density Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45781</PREFERRED_NAME>
            <LONG_NAME>Density</LONG_NAME>
            <CON_ID>2236512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GGO</VALIDVALUE>
          <VALUEMEANING>Ground Glass Opacity</VALUEMEANING>
          <MEANINGDESCRIPTION>A CT scan finding in the lungs indicating the presence of hazy areas of attenuation in the air spaces.  It is caused by interstitial fibrosis, alveolar collapse, edema, inflammation, or cancer with lepidic spread.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5427613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Part solid</VALIDVALUE>
          <VALUEMEANING>Partial Solid</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or affecting only a part of something.: The state in which a substance has no tendency to flow under moderate stress; resists forces (such as compression) that tend to deform it; and retains a definite size and shape.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45300, C25378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5427614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-solid</VALIDVALUE>
          <VALUEMEANING>Negation Solid</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The state in which a substance has no tendency to flow under moderate stress; resists forces (such as compression) that tend to deform it; and retains a definite size and shape.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45300, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5427615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Solid</VALIDVALUE>
          <VALUEMEANING>Solid</VALUEMEANING>
          <MEANINGDESCRIPTION>The state in which a substance has no tendency to flow under moderate stress; resists forces (such as compression) that tend to deform it; and retains a definite size and shape.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5427616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Density</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Density</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-Lung</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Density (GGO/non-solid/part solid/solid)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506115</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Image Acquisition-Recon</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5840791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>MCL</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>5427618v1.0:5427612v1.0</AlternateName>
        <AlternateNameType>System-Generated</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1346">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5543635</PUBLICID>
    <LONGNAME>RDAS 4 Extent Agreement Disagreement Sex Relations Score 6 Point Scale</LONGNAME>
    <PREFERREDNAME>RDAS_4_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of the extent of agreement or disagreement with their partner regarding sex relations, using a 6 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>RDAS (Revised Dyadic Adjustment Scale)</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5542102</PublicId>
      <PreferredName>5540399v1.0:5542100v1.0</PreferredName>
      <PreferredDefinition>A 14 item self report questionnaire that assess seven dimensions of couple relationship satisfaction. This revised version of the Dyadic Adjustment Scale is shorter and offers improved psychometric properties._A question about the extent of agreement or disagreement between an individual and their partner regarding sex relations._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Revised Dyadic Adjustment Scale Extent of Agreement or Disagreement on Sex Relations Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5540399</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C129539</PreferredName>
        <Version>1</Version>
        <LongName>Revised Dyadic Adjustment Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C129539</PREFERRED_NAME>
            <LONG_NAME>Revised Dyadic Adjustment Scale</LONG_NAME>
            <CON_ID>5527605</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5542100</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C129543:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Extent of Agreement or Disagreement on Sex Relations Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C129543</PREFERRED_NAME>
            <LONG_NAME>Extent of Agreement or Disagreement on Sex Relations Question</LONG_NAME>
            <CON_ID>5527609</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>RDAS (Revised Dyadic Adjustment Scale)</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5543512</PublicId>
      <PreferredName>RDAS_AGRMNT_6_PT_SCL</PreferredName>
      <PreferredDefinition>6 point scale.</PreferredDefinition>
      <LongName>RDAS Agreement Disagreement 6 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>RDAS (Revised Dyadic Adjustment Scale)</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Always Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating disagreement at all times.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5543513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Almost Always Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating disagreement at almost all times.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5543514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Frequently Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating frequent disagreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5543515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Occasionally Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating occasional agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129561</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5543516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Almost Always Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating agreement at almost all times.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5543517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Always Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating agreement at all times.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129559</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5543518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Sex relations</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Sex relations</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>RDAS (Revised Dyadic Adjustment Scale)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #4 of 14.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5529781</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>RDAS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RDAS (Revised Dyadic Adjustment Scale)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5529791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Revised Dyadic Adjustment Scale (RDAS)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900348</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1347">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5596079</PUBLICID>
    <LONGNAME>Activity Card Sort Instrumental Activities Total Score</LONGNAME>
    <PREFERREDNAME>ACS_INST_ACT_TSCR</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric representation of the total score for the Instrumental Activities section of the Activity Card Sort.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACS:Activity Card Sort, 2nd Edition, Carolyn M. Baum, PhD, OTR/L, FAOTA, and Dorothy Edwards, PhD. 2008</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5590804</PublicId>
      <PreferredName>5590801v1.0:5590802v1.0</PreferredName>
      <PreferredDefinition>An assessment tool developed to measure levels of activity engagement in older adults. Participants sort cards depicting people engaged in various activities into categories representing whether the activity is part of the individual&#39;s routine._A domain of the Activity Card Sort (ACS) related to crucial activities that may be part of an individual&#39;s routine such as driving, paying bills, and child care._The sum of a set of numeric values.</PreferredDefinition>
      <LongName>Activity Card Sort Instrumental Activities Domain Total Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5590801</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C129985</PreferredName>
        <Version>1</Version>
        <LongName>Activity Card Sort</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C129985</PREFERRED_NAME>
            <LONG_NAME>Activity Card Sort</LONG_NAME>
            <CON_ID>5586801</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5590802</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C129987:C120457</PreferredName>
        <Version>1</Version>
        <LongName>Instrumental Activities Domain Total Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C129987</PREFERRED_NAME>
            <LONG_NAME>Instrumental Activities Domain</LONG_NAME>
            <CON_ID>5586802</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C120457</PREFERRED_NAME>
            <LONG_NAME>Total Score</LONG_NAME>
            <CON_ID>5505399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACS:Activity Card Sort, 2nd Edition, Carolyn M. Baum, PhD, OTR/L, FAOTA, and Dorothy Edwards, PhD. 2008</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5581594</PublicId>
      <PreferredName>ACS_TTL_SCR</PreferredName>
      <PreferredDefinition>A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Activity Card Sort Total Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue>120.00</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>C3D:Central Cancer Clinical Database</Origin>
      <Representation>
        <PublicId>2193207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total Instrumental Activities</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Total Instrumental Activities</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1348">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5610309</PUBLICID>
    <LONGNAME>Adverse Event Immune-mediated Etiology Component Present Code</LONGNAME>
    <PREFERREDNAME>5610308v1.0:3385536v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded numeric response as to whether an unfavorable or unintended disease, sign, or symptom is caused by the immune system or is part of the result of the activity of the immune system.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5610308</PublicId>
      <PreferredName>2235992v1.0:5610306v1.0</PreferredName>
      <PreferredDefinition>Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._Resulting from the activity of the immune system._The cause of a disease or abnormal condition._An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Adverse Event Immune-mediated Etiology Element Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2235992</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5610306</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C131176:C16390:C48792:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Immune-mediated Etiology Element Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131176</PREFERRED_NAME>
            <LONG_NAME>Immune-mediated</LONG_NAME>
            <CON_ID>5610293</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16390</PREFERRED_NAME>
            <LONG_NAME>Etiology</LONG_NAME>
            <CON_ID>2497372</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48792</PREFERRED_NAME>
            <LONG_NAME>Element</LONG_NAME>
            <CON_ID>2513271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3385536</PublicId>
      <PreferredName>3385536v1.0</PreferredName>
      <PreferredDefinition>A system of numbered categories for representing a yes, no, unknown response.</PreferredDefinition>
      <LongName>Yes No Unknown Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
      <Representation>
        <PublicId>3625150</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>99</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does this event have an immun</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does this event have an immune mediated etiology or an immune mediated component?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000676</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1349">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5627206</PUBLICID>
    <LONGNAME>Rotterdam Symptom Checklist 3 Past Week How Much Bothered by Tiredness 4 Point Scale</LONGNAME>
    <PREFERREDNAME>RSC_SYMPT3_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of how much they have been bothered by tiredness during the past week, using a four-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>RSCL:Rotterdam Symptom Checklist, de Haes, J.C., Olschewski, M., Fayers, P., Visser, M.R.M., Cull, A., Hopwood, P., Sanderman, R., 1982</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5627038</PublicId>
      <PreferredName>5627024v1.0:5627036v1.0</PreferredName>
      <PreferredDefinition>A questionnaire designed to measure both physical and psychological aspects of quality of life as an outcome measure of symptom control._The most recent week, including today._How much there is of something that you can measure; the total amount or number._A question about whether an individual is or was bothered by tiredness.</PreferredDefinition>
      <LongName>Rotterdam Symptom Checklist Past Week Quantity Bothered by Tiredness</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5627024</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C131387</PreferredName>
        <Version>1</Version>
        <LongName>Rotterdam Symptom Checklist</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131387</PREFERRED_NAME>
            <LONG_NAME>Rotterdam Symptom Checklist</LONG_NAME>
            <CON_ID>5622495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5627036</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C25256:C131390</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Quantity Bothered by Tiredness</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131390</PREFERRED_NAME>
            <LONG_NAME>Bothered by Tiredness Question</LONG_NAME>
            <CON_ID>5622498</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>RSCL:Rotterdam Symptom Checklist, de Haes, J.C., Olschewski, M., Fayers, P., Visser, M.R.M., Cull, A., Hopwood, P., Sanderman, R., 1982</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5626980</PublicId>
      <PreferredName>5626980v1.0</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>How Much 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>11</MaximumLength>
      <MinimumLength>8</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>RSCL:Rotterdam Symptom Checklist, de Haes, J.C., Olschewski, M., Fayers, P., Visser, M.R.M., Cull, A., Hopwood, P., Sanderman, R., 1982</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>a little</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you, during the past wee</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you, during the past week, been bothered by tiredness</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5626752</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>RSCL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RSCL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5626753</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rotterdam Symptom Checklist (RSCL)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900350</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1350">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5627226</PUBLICID>
    <LONGNAME>Rotterdam Symptom Checklist 23 Past Week How Much Bothered by Shivering 4 Point Scale</LONGNAME>
    <PREFERREDNAME>RSC_SYMPT23_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Persons&#39; stated observation of how much they have been bothered by shivering during the past week, using a four-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>RSCL:Rotterdam Symptom Checklist, de Haes, J.C., Olschewski, M., Fayers, P., Visser, M.R.M., Cull, A., Hopwood, P., Sanderman, R., 1982</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5627137</PublicId>
      <PreferredName>5627024v1.0:5627135v1.0</PreferredName>
      <PreferredDefinition>A questionnaire designed to measure both physical and psychological aspects of quality of life as an outcome measure of symptom control._The most recent week, including today._How much there is of something that you can measure; the total amount or number._A question about whether an individual is or was bothered by shivering.</PreferredDefinition>
      <LongName>Rotterdam Symptom Checklist Past Week Quantity Bothered by Shivering</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5627024</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C131387</PreferredName>
        <Version>1</Version>
        <LongName>Rotterdam Symptom Checklist</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131387</PREFERRED_NAME>
            <LONG_NAME>Rotterdam Symptom Checklist</LONG_NAME>
            <CON_ID>5622495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5627135</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C25256:C131406</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Quantity Bothered by Shivering</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131406</PREFERRED_NAME>
            <LONG_NAME>Bothered by Shivering Question</LONG_NAME>
            <CON_ID>5622516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>RSCL:Rotterdam Symptom Checklist, de Haes, J.C., Olschewski, M., Fayers, P., Visser, M.R.M., Cull, A., Hopwood, P., Sanderman, R., 1982</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5626980</PublicId>
      <PreferredName>5626980v1.0</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>How Much 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>11</MaximumLength>
      <MinimumLength>8</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>RSCL:Rotterdam Symptom Checklist, de Haes, J.C., Olschewski, M., Fayers, P., Visser, M.R.M., Cull, A., Hopwood, P., Sanderman, R., 1982</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>a little</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you, during the past wee</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you, during the past week, been bothered by shivering</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5626752</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>RSCL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RSCL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5626753</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rotterdam Symptom Checklist (RSCL)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900350</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1351">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5695543</PUBLICID>
    <LONGNAME>Cohort Study One Enrollment Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>CO_SDY_ONE</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded response for questions to determine eligibility for clinical trial participation, as outlined in the study protocol, for patients registered in Cohort Study One.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5695542</PublicId>
      <PreferredName>5695544v1.0:2494487v1.0</PreferredName>
      <PreferredDefinition>Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics._The smallest natural number and quantity it denotes: a single entity, unit, or object._The act of registration, entering in a list, catalog, group, study; also, the number of subjects enrolled._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Cohort Study One Enrollment Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5695544</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15208:C66832:C37948</PreferredName>
        <Version>1</Version>
        <LongName>Cohort Study One Enrollment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15208</PREFERRED_NAME>
            <LONG_NAME>Cohort Study</LONG_NAME>
            <CON_ID>2497523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66832</PREFERRED_NAME>
            <LONG_NAME>One</LONG_NAME>
            <CON_ID>2636736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37948</PREFERRED_NAME>
            <LONG_NAME>Enrollment</LONG_NAME>
            <CON_ID>2203918</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2494487</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16112</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If patient is in cohort 1 (NS</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If patient is in cohort 1 (NSCLC cohort), is the lesion to be irradiated in the bone, lung. Lymph nodes of the neck, adrenal gland or liver?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient is in cohort 1 (NSCLC cohort), is the lesion to be irradiated in the bone, lung, lymph nodes of the neck, adrenal gland or liver?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient is in cohort 1 (NSCLC cohort), is the lesion to be irradiated in the lung, lymph nodes, adrenal gland or liver?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient is in cohort 1 (NSCLC/SCCHN/Bladder Cancer/cSCC cohort), is the lesion to be irradiated in the lung, lymph nodes, adrenal gland or liver?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If patient is enrolled in Phase 2, Cohort 1 is disease PI-non-refractory, i.e., did not progress less than or equal to 60 days after the last PI therapy and had greater than or equal to 25% response while on therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876352</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Inclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Consents &amp; Contraceptive Guidelines</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3876423</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1352">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5702199</PUBLICID>
    <LONGNAME>Best Response First-Line Therapy Day Number</LONGNAME>
    <PREFERREDNAME>5697788v1.0:2896868v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The most clinically favorable response recorded from the start of the study treatment until the end of treatment._The preferred standard treatment for a particular condition._The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day._Event; something that happens at a given place and time._time for Earth to make a complete rotation on its axis._A numeral or string of numerals expressing value, quantity, or identification</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5697788</PublicId>
      <PreferredName>5279911v1.0:5697786v1.0</PreferredName>
      <PreferredDefinition>The most clinically favorable response recorded from the start of the study treatment until the end of treatment._The preferred standard treatment for a particular condition._The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.</PreferredDefinition>
      <LongName>Best Overall Response First-Line Therapy Day</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5279911</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C94536</PreferredName>
        <Version>1</Version>
        <LongName>Best Overall Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C94536</PREFERRED_NAME>
            <LONG_NAME>Best Overall Response</LONG_NAME>
            <CON_ID>3297337</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5697786</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45792:C25301</PreferredName>
        <Version>1</Version>
        <LongName>First-Line Therapy Day</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45792</PREFERRED_NAME>
            <LONG_NAME>First-Line Therapy</LONG_NAME>
            <CON_ID>2229260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25301</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2202680</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2896868</PublicId>
      <PreferredName>EVT_DAY_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._time for Earth to make a complete rotation on its axis._A numeral or string of numerals expressing value, quantity, or identification</PreferredDefinition>
      <LongName>Event Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2896867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C0439228:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Day Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0439228</PREFERRED_NAME>
            <LONG_NAME>Day</LONG_NAME>
            <CON_ID>2204684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>22</VALIDVALUE>
          <VALUEMEANING>22nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::22: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::22</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>21</VALIDVALUE>
          <VALUEMEANING>21st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::21: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::21</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20</VALIDVALUE>
          <VALUEMEANING>20th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::20: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::20</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>19</VALIDVALUE>
          <VALUEMEANING>19th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::19: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::19</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>18</VALIDVALUE>
          <VALUEMEANING>18th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::18: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::18</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>17</VALIDVALUE>
          <VALUEMEANING>17th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::17: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::17</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>16</VALIDVALUE>
          <VALUEMEANING>16th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::16: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::16</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15</VALIDVALUE>
          <VALUEMEANING>15th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::15: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::15</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>14</VALIDVALUE>
          <VALUEMEANING>14th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::14: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::14</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>13</VALIDVALUE>
          <VALUEMEANING>13th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::13: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::13</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::10: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::10</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::4: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::4</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::5: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::5</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::6: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::6</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896889</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>31</VALIDVALUE>
          <VALUEMEANING>31st day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::31: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::31</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896890</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30</VALIDVALUE>
          <VALUEMEANING>30th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::30: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::30</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>29</VALIDVALUE>
          <VALUEMEANING>29th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::29: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::29</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>28</VALIDVALUE>
          <VALUEMEANING>28th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::28: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::28</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>27</VALIDVALUE>
          <VALUEMEANING>27th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::27: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::27</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>26</VALIDVALUE>
          <VALUEMEANING>26th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::26: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::26</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25</VALIDVALUE>
          <VALUEMEANING>25th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::25: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::25</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>24</VALIDVALUE>
          <VALUEMEANING>24th day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::24: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::24</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>23</VALIDVALUE>
          <VALUEMEANING>23rd day of a calendar month</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::23: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.: The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25301, C29846, C19459, C45255::23</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Day of Best Response to First</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Day of Best Response to First Line of Therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1353">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5718116</PUBLICID>
    <LONGNAME>NCCN Distress Thermometer and Problem List for Patients Version 2.2016 Past Week Distress over Family Problem with Family Health Issue Indicator</LONGNAME>
    <PREFERREDNAME>NCCN_DTPL_FMHLTH_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how distressed they have been during the past week over practical problems with family or health issues, using a yes or no indicator.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCCN Distress Management Guidelines, Version 2.2016, 07/25/16.</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5717493</PublicId>
      <PreferredName>5717471v1.0:3807914v1.0</PreferredName>
      <PreferredDefinition>A screening tool developed by the National Comprehensive Cancer Network (NCCN) Distress Management Panel used to identify patient distress coming from any source and patient problems in five categories._The most recent week, including today._A question about an individual&#39;s distress related to their family problems dealing with family health issues.</PreferredDefinition>
      <LongName>NCCN Distress Thermometer and Problem List for Patients Version 2.2016 Past Week Distress over Family Problem with Family Health Issues</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5717471</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C132492</PreferredName>
        <Version>1</Version>
        <LongName>NCCN Distress Thermometer and Problem List for Patients Version 2.2016</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C132492</PREFERRED_NAME>
            <LONG_NAME>NCCN Distress Thermometer and Problem List for Patients Version 2.2016</LONG_NAME>
            <CON_ID>5709921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3807914</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C107178</PreferredName>
        <Version>1</Version>
        <LongName>Past Week Distress over Family Problem with Family Health Issues</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107178</PREFERRED_NAME>
            <LONG_NAME>Distress over Family Problem with Family Health Issues Question</LONG_NAME>
            <CON_ID>3794730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCCN Distress Management Guidelines, Version 2.2016, 07/25/16.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Family health issues</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Family health issues</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Family Problems - Family Health Issues</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3793272</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCCN Guidelines</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Distress Thermometer and Problem List for Patients Version 2.2016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5717470</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1354">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5722208</PUBLICID>
    <LONGNAME>Patient Corrected QT Interval Outcome Or Family Medical History Long QT Syndrome Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>CQT_FAMHX_LQT_SDRM_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded response as to whether a patient meets the criteria for enrolling onto a clinical study for questions related to QTc results of the patient or the patient&#39;s family medical history of a ventricular arrhythmia characterized by a long QT interval as outlined in the study protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5722207</PublicId>
      <PreferredName>5722204v1.0:5722205v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._The time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula._The result of an action._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A record of a patient&#39;s background regarding health and disease events of blood relatives. A patient&#39;s family medical history may be important in diagnosing existing conditions._A ventricular arrhythmia characterized by a long QT interval, and accompanied by syncopal episodes sometimes leading to sudden death due to paroxysmal ventricular arrhythmia. This arrhythmia is associated with a prolongation of repolarization following depolarization of the cardiac ventricles. The prolongation of the Q-T interval combined with torsades de pointes manifests as several different forms; some may be acquired or congenital; some may lead to serious arrhythmia and sudden cardiac death._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Patient Corrected QT Interval Outcome Or Family Medical History Long QT Syndrome Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5722204</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960:C100391</PreferredName>
        <Version>1</Version>
        <LongName>Patient Corrected QT Interval</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C100391</PREFERRED_NAME>
            <LONG_NAME>Corrected QT Interval</LONG_NAME>
            <CON_ID>4119291</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5722205</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5722205v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Outcome Or Family Medical History Long QT Syndrome Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17726</PREFERRED_NAME>
            <LONG_NAME>Family Medical History</LONG_NAME>
            <CON_ID>2202638</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C34786</PREFERRED_NAME>
            <LONG_NAME>Long QT Syndrome</LONG_NAME>
            <CON_ID>3204789</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have a QTc great</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have a QTc greater than 470 msec or family history of long QT syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have Fridericia&#39;s corrected QT interval (QTcF) less than or equal to 450 msec or other factors that increase the risk of QT prolongation or arrhythmic events (e.g., heart failure, hypokalemia, family history of long QT interval syndrome)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a resting ECG with a QTc greater than or equal to 450 msec detected on 2 or more time points within a 2 hour period or family history of long QT syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have Fridericia&#39;s corrected QT interval (QTcF) greater than or equal to 450 msec or other factors that increase the risk of QT prolongation or arrhythmic events (e.g., heart failure, hypokalemia, family history of long QT interval syndrome)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a mean resting correct QTc interval using the Fridericia formula (QTcF) of greater than 470 msec (as calculated per institutional standards) obtained from 3 electrocardiograms (ECGs) 2-5 minutes apart at study entry, or congenital long QT syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a resting EKG with a QTc greater than or equal to  470 msec detected on 2 or more time points within a 2 hour period or family history of long QT syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a QTcF greater than 470 msec (on resting ECG) or family history of long QT syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a resting EKG with a QTc greater than 470 msec on 2 or more time points within a 24 hour period or family history of long QT syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have mean resting correct QT interval (QTc) greater than 470 msec on screening obtained from 3 electrocardiograms (ECGs) or factors that may increase the risk of QTc prolongation such as chronic hypokalaemia not correctable with supplements, congenital or familial long QT syndrome, or family history of unexplained sudden death under 40 years of age?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a resting EKG with a QTc greater than 470 msec or family history of long QT syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have any  factors that may increase the risk of QTc prolongation or risk of arrhythmic event such as heart failure, chronic hypokalaemia not correctable with supplements, congenital or familial long QT syndrome, or family history of unexplained sudden death under 40 years of age or any concomitant medications know to prolong QT interval?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have any  factors that may increase the risk of QTcF prolongation such as chronic hypokalaemia not correctable with supplements, congenital or familial long QT syndrome, or family history of unexplained sudden death under 40 years of age in first degree relatives or any concomitant medications known to prolong QT interval and cause Torsade de Pointes?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have any factors that may increase the risk of QTc prolongation such as chronic hypokalaemia not correctable with supplements, congenital or familial long QT syndrome, or family history of unexplained sudden death under 40 years of age in first degree relatives or any concomitant medications known to prolong QT interval and cause Torsade de Pointes (TdP)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 14</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a prolonged QTc interval greater than 480 milliseconds or a history of congenital long QT syndrome or torsades de pointes?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 13</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have history of additional risk factors for TdP (e.g. heart failure, hypokalemia, family history of long QT Syndrome)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 15</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have clinically significant ECG abnormality, including prolonged corrected QT (QTc) interval greater than 480 msec or history of risk factors for Torsade&#39;s de Pointes (TdP) (i.e. congestive heart failure, hypokalemia, hypomagnesemia, bradyarrhythmias, family history of long QT syndrome)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 16</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have a corrected QT interval (QTc) less than or equal to 470 msec for women and less than or equal to 450 msec for men (based on average screening triplicates)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876359</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Exclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status &amp; Genetics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000703</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876359</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Exclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory Data (including serologic/viral status)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1355">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5727160</PUBLICID>
    <LONGNAME>Clinical Trial Eligibility Criteria Intervention or Procedure Diagnosis Method Code Indicator</LONGNAME>
    <PREFERREDNAME>INTPR_DX_MTHD_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded response to questions which are necessary to allow a subject to participate in a clinical study that address the interventions or procedures performed in order to recognize the presence and nature of disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5727157</PublicId>
      <PreferredName>2767728v1.0:5727155v1.0</PreferredName>
      <PreferredDefinition>Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria._An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.</PreferredDefinition>
      <LongName>Clinical Trial Eligibility Criteria Intervention or Procedure Diagnosis Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2767728</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16112</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5727155</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25218:C15220:C71460</PreferredName>
        <Version>1</Version>
        <LongName>Intervention or Procedure Diagnosis Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71460</PREFERRED_NAME>
            <LONG_NAME>Method</LONG_NAME>
            <CON_ID>2730350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was an incisional or core bio</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was an incisional or core biopsy used for diagnosis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>For patients undergoing mediastinal, laparoscopic, gastrointestinal, or bronchial endoscopic biopsies, will the patient be undergoing a procedure, due to medical necessity, during which tumor will be collected?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If the patient is undergoing mediastinal, laparoscopic, gastrointestinal, or bronchial endoscopic biopsy, is the procedure part of a standard of care procedure?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876352</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Inclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status &amp; Genetics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3876422</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1356">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5796840</PUBLICID>
    <LONGNAME>Radiation Therapy Iobenguane Iodine I-131 Dose Reduced Or Therapy Delayed Or Prolonged Dose Reduction Reason</LONGNAME>
    <PREFERREDNAME>MIBG_131_DS_RDC_OR_TP_DLY_RSN</PREFERREDNAME>
    <PREFERREDDEFINITION>Information regarding reasons for I-131 MIBG therapy dose was reduced or treatment was delay.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5796832</PublicId>
      <PreferredName>2403872v1.00:5796830v1.00</PreferredName>
      <PreferredDefinition>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.:A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells._A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production._An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._An indication that a therapy was either delayed or prolonged._Change, alteration, or adjustment of a dose specified in a treatment plan or/and administered to a patient.</PreferredDefinition>
      <LongName>Radiation Therapy Iobenguane Iodine I-131 Dose Reduced Or Therapy Delayed Or Prolonged Dose Modification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435016</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12218</PreferredName>
        <Version>1</Version>
        <LongName>Chemotherapy Regimen</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2403872</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15313</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5796830</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5796830v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Iobenguane Iodine I-131 Dose Reduced Or Therapy Delayed Or Prolonged Dose Modification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C87757</PREFERRED_NAME>
            <LONG_NAME>Iobenguane</LONG_NAME>
            <CON_ID>3264701</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1639</PREFERRED_NAME>
            <LONG_NAME>Iodine I-131</LONG_NAME>
            <CON_ID>2939365</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49505</PREFERRED_NAME>
            <LONG_NAME>Dose Reduced</LONG_NAME>
            <CON_ID>2452860</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50425</PREFERRED_NAME>
            <LONG_NAME>Therapy Delayed or Prolonged</LONG_NAME>
            <CON_ID>5733033</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54346</PREFERRED_NAME>
            <LONG_NAME>Dose Modification</LONG_NAME>
            <CON_ID>2715003</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5796836</PublicId>
      <PreferredName>5796836v1.0</PreferredName>
      <PreferredDefinition>An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Iobenguane I-131 Dose Reduction Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435016</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12218</PreferredName>
        <Version>1</Version>
        <LongName>Chemotherapy Regimen</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2240632</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient safety</VALIDVALUE>
          <VALUEMEANING>Patient safety</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient safety</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5796837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unforeseen logistical constraint</VALIDVALUE>
          <VALUEMEANING>Unforeseen logistical constraint</VALUEMEANING>
          <MEANINGDESCRIPTION>Unforeseen logistical constraint</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5796838</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lack of agent availability</VALIDVALUE>
          <VALUEMEANING>Lack of agent availability</VALUEMEANING>
          <MEANINGDESCRIPTION>Lack of agent availability</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-04-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5796839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Reason for I-131 MIBG dose re</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Reason for I-131 MIBG dose reductions or treatment delays:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1357">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5836973</PUBLICID>
    <LONGNAME>Postoperative Drainage Device Placement Yes No Unknown Indicator</LONGNAME>
    <PREFERREDNAME>POST_OP_DRAIN_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The Yes/No/Unknown indicator that indicates whether surgical drains were used to drain postoperative dead spaces.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5836972</PublicId>
      <PreferredName>2718844v1.0:5836970v1.0</PreferredName>
      <PreferredDefinition>Relating to or occurring during the period immediately following a surgical operation._The systematic withdrawal of fluids and discharges from a wound, sore or cavity._An object contrived for a specific purpose._The act of putting something into a position or location.</PreferredDefinition>
      <LongName>Postoperative Drainage Device Placement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2718844</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28006</PreferredName>
        <Version>1</Version>
        <LongName>Postoperative</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28006</PREFERRED_NAME>
            <LONG_NAME>Postoperative</LONG_NAME>
            <CON_ID>2211921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5836970</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50434:C62103:C126366</PreferredName>
        <Version>1</Version>
        <LongName>Drainage Device Placement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50434</PREFERRED_NAME>
            <LONG_NAME>Drainage</LONG_NAME>
            <CON_ID>2521941</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62103</PREFERRED_NAME>
            <LONG_NAME>Device</LONG_NAME>
            <CON_ID>2529461</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126366</PREFERRED_NAME>
            <LONG_NAME>Placement</LONG_NAME>
            <CON_ID>5209160</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was postoperative drain placed</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was postoperative drain placed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1358">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5845127</PUBLICID>
    <LONGNAME>PedsQL Cancer Module Version 3 N4 Past One Month How Much Feel Too Nauseated to Eat Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PQL_CM_V3_N4_5P_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how much of a problem it has been in the past one month with feeling too nauseous to eat, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PedsQL: Pediatric Quality of Life, James W. Varni, Ph.D., 1998</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5842443</PublicId>
      <PreferredName>5858488v1.0:5842441v1.0</PreferredName>
      <PreferredDefinition>A complement to the Pediatric Quality of Life generic core scales designed to provide greater measurement sensitivity for patients with cancer. This module has 25 items comprising 8 dimensions for use with children aged 2 to 18 years._A period of time consisting of the 30 days before the present._How much there is of something that you can measure; the total amount or number._A question about whether an individual feels too nauseous to eat._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Pediatric Quality of Life Inventory Cancer Module Past 30 Days Quantity Feel Too Nauseated to Eat Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5858488</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C135089</PreferredName>
        <Version>1</Version>
        <LongName>Pediatric Quality of Life Inventory Cancer Module</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C135089</PREFERRED_NAME>
            <LONG_NAME>Pediatric Quality of Life Inventory Cancer Module</LONG_NAME>
            <CON_ID>5854648</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5842441</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C131330:C25256:C134908:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past 30 Days Quantity Feel Too Nauseated to Eat Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131330</PREFERRED_NAME>
            <LONG_NAME>Past 30 days</LONG_NAME>
            <CON_ID>5615928</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C134908</PREFERRED_NAME>
            <LONG_NAME>Feel Too Nauseated to Eat Question</LONG_NAME>
            <CON_ID>5840034</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PedsQL: Pediatric Quality of Life, James W. Varni, Ph.D., 1998</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5627410</PublicId>
      <PreferredName>PEDSQL_5_POINT_SCALE</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Pediatric Quality of Life Inventory Score 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>PedsQL: Pediatric Quality of Life, James W. Varni, Ph.D., 1998</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Almost All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened almost all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Often</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something occurs frequently.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5628246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Almost Never</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something rarely happens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Scoring Manual Link</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>Document Text  The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure.</DocumentText>
        <URL>http://www.pedsql.org/score.htm</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I feel too sick to my stomach</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I feel too sick to my stomach to eat</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PedsQL Cancer-Specific Module</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #4 of 5 (Nausea)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PedsQL Cancer-Specific Module Parent Report (2-4)(5-7)(8-12) (13-18)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Feeling too nauseous to eat</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PedsQL Cancer-Specific Module (8-12)(13-18)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>I feel too sick to my stomach to eat</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PedsQL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5845418</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Condition Specific Modules</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5845469</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_FELNAUSEAEAT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1359">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5864509</PUBLICID>
    <LONGNAME>Conceptual Parent Specimen Occurrence Tissue Collection Method Type</LONGNAME>
    <PREFERREDNAME>5864508v1.0:2189206v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The collection method used to acquire the parent specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5864508</PublicId>
      <PreferredName>5581163v1.0:2234856v1.0</PreferredName>
      <PreferredDefinition>Something from which one or more similar and separate things have developed, or to which they are attached._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Conceptual Parent Specimen Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178079</PublicId>
        <ContextName>EDRN</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5581163</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C80013:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Parent Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80013</PREFERRED_NAME>
            <LONG_NAME>Conceptual Parent</LONG_NAME>
            <CON_ID>2848249</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCP:Division of Cancer Prevention</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2189206</PublicId>
      <PreferredName>TISS_COLL_METH_TP</PreferredName>
      <PreferredDefinition>the type of tissue collection method.</PreferredDefinition>
      <LongName>Tissue Collection Method Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>55</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biopsy</VALIDVALUE>
          <VALUEMEANING>Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystectomy</VALIDVALUE>
          <VALUEMEANING>Cystectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Cystectomy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-10-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvic lymph node dissection</VALIDVALUE>
          <VALUEMEANING>Pelvic lymph node dissection</VALUEMEANING>
          <MEANINGDESCRIPTION>Pelvic lymph node dissection</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-10-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood</VALIDVALUE>
          <VALUEMEANING>Blood</VALUEMEANING>
          <MEANINGDESCRIPTION>A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urine</VALIDVALUE>
          <VALUEMEANING>Urine</VALUEMEANING>
          <MEANINGDESCRIPTION>The fluid that is excreted by the kidneys.  It is stored in the bladder and discharged through the urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13283</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3111296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectal brushing</VALIDVALUE>
          <VALUEMEANING>Rectal Brush Device Component</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the rectum.: Device consisting of hairs or bristles set into a handle or holder, especially one that conducts current between the rotating and stationary parts of a generator or motor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49851, C25224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5807782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectal Swab</VALIDVALUE>
          <VALUEMEANING>Rectal Swab</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the rectum.: A tuft of material on the end of a stick for applying solutions and suspensions</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17627, C25224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5807783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectal biopsy</VALIDVALUE>
          <VALUEMEANING>Rectal Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal of rectal tissue, for microscopic examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51693</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2833024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EDTA/Purple Top Tube</VALIDVALUE>
          <VALUEMEANING>Purple Top Tube Edetic Acid</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of a group of colors with a hue between that of violet and red.: The uppermost part, side, or surface of something.: A hollow cylinder, especially one for holding or conveying liquids; anything shaped like such a hollow cylinder, e.g. an organic structure having the shape or function of a tube such as channel within a plant or animal body (e.g. fallopian tube).: The acid form of edetate, a chelating agent with anti-hypercalcemic and anticoagulant properties. Edetic acid binds calcium and heavy metal ions, forming soluble stable complexes which are readily excreted by the kidneys. This results in a decrease in serum calcium levels. This agent is also used as an anticoagulant for blood specimens and is applied as a treatment of lead poisoning.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61742, C41277, C62637, C48327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6033200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NaCit/Blue Top Tube</VALIDVALUE>
          <VALUEMEANING>Blue Top Tube Sodium Citrate</VALUEMEANING>
          <MEANINGDESCRIPTION>The hue of that portion of the visible spectrum lying between green and indigo, evoked in the human observer by radiant energy with wavelengths of approximately 420 to 490 nanometers; any of a group of colors that may vary in lightness and saturation, whose hue is that of a clear daytime sky.: The uppermost part, side, or surface of something.: A hollow cylinder, especially one for holding or conveying liquids; anything shaped like such a hollow cylinder, e.g. an organic structure having the shape or function of a tube such as channel within a plant or animal body (e.g. fallopian tube).: The sodium salt of citrate with alkalinizing activity. Upon absorption, sodium citrate dissociates into sodium cations and citrate anions; organic citrate ions are metabolized to bicarbonate ions, resulting in an increase in the plasma bicarbonate concentration, the buffering of excess hydrogen ion, the raising of blood pH, and potentially the reversal of acidosis. In addition, increases in free sodium load due to sodium citrate administration may increase intravascular blood volume, facilitating the excretion of bicarbonate compounds and an anti-urolithic effect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62075, C41277, C62637, C48333</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6033202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Breast tissue</VALIDVALUE>
          <VALUEMEANING>Mammary Gland Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>The glandular tissue of the breast.  In females, it is composed of numerous lobules with alveolar ducts and alveoli.  In males, it is composed of rudimentary glands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5236675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RNA-Later</VALIDVALUE>
          <VALUEMEANING>RNALater</VALUEMEANING>
          <MEANINGDESCRIPTION>Trade name for an aqueous, non-toxic tissue storage reagent that rapidly permeates tissues to stabilize and protect cellular RNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5680788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frozen</VALIDVALUE>
          <VALUEMEANING>Frozen Specimen</VALUEMEANING>
          <MEANINGDESCRIPTION>A specimen that has been subjected to and immobilized by severe cold.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3167629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PK</VALIDVALUE>
          <VALUEMEANING>Pharmacokinetics</VALUEMEANING>
          <MEANINGDESCRIPTION>Pharmacokinetics</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15299</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasma</VALIDVALUE>
          <VALUEMEANING>Plasma</VALUEMEANING>
          <MEANINGDESCRIPTION>Plasma is the fluid (noncellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FFPE</VALIDVALUE>
          <VALUEMEANING>Formalin-Fixed Paraffin-Embedded</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to samples that have been preserved with formalin and then embedded into a paraffin block for sectioning.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C143028</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6050873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Red</VALIDVALUE>
          <VALUEMEANING>Serum Collection Tube</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood collection tube that contains a coagulant, designed for the collection of serum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113675</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5573287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lavender</VALIDVALUE>
          <VALUEMEANING>Complete Blood Count Collection Tube</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood collection tube that contains the anti-coagulant EDTA, designed for complete blood counts and blood films.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113676</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4761272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oral</VALIDVALUE>
          <VALUEMEANING>Oral</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or relating to, or affecting, or for use in the mouth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5711127</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical/Vaginal</VALIDVALUE>
          <VALUEMEANING>Cervical Or Vaginal</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to a neck, or cervix, in any sense.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Of or relating to the vagina.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13309, C37998, C12844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6132675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Green</VALIDVALUE>
          <VALUEMEANING>Green</VALUEMEANING>
          <MEANINGDESCRIPTION>The hue of that portion of the visible spectrum lying between yellow and blue, evoked in the human observer by radiant energy with wavelengths of approximately 490 to 570 nanometers; any of a group of colors that may vary in lightness and saturation and whose hue is that of the emerald or somewhat less yellow than that of growing grass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3124373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Compliance</VALIDVALUE>
          <VALUEMEANING>Compliance</VALUEMEANING>
          <MEANINGDESCRIPTION>The extent to which a patient conforms to medical advice regarding prescribed regimen, lifestyle, dietary changes, follow-up schedule and other recommendations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39490</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-10-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6454117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buffy Coat</VALIDVALUE>
          <VALUEMEANING>Buffy Coat</VALUEMEANING>
          <MEANINGDESCRIPTION>The middle layer of an anticoagulated blood specimen following separation by centrifugation. It contains most of the white blood cells and platelets.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84507</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-10-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5152974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>γ-OHPdG</VALIDVALUE>
          <VALUEMEANING>Gamma-hydroxy-1,N(2)-propanodeoxyguanosine</VALUEMEANING>
          <MEANINGDESCRIPTION>A mutagenic and carcinogenic cyclic 1,N2-propanodeoxy (Pd) DNA adduct derived from the reaction of deoxyguanosine (dG) in DNA with the environmentally widely available or endogenously produced mutagenic and carcinogenic unsaturated aldehyde acrolein (Acr) that can potentially be used as a biomarker for exposure to Acr, the formation of certain forms of cancer and the presence of oxidative stress. The formation of gamma-hydroxy-1,N(2)-propanodeoxyguanosine (g-OH-PdG) damages DNA and stimulates the formation of tumors. Also, as Acr is formed due to oxidation of certain polyunsaturated fatty acids (PUFAs), mostly omega-3-PUFA, the lipid peroxidation-derived DNA adduct g-OH-PdG can potentially be used as a biomarker to assess the presence of oxidized PUFAs, the level of oxidative stress and the extent of oxidative DNA damage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-10-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6450501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocervical swab, Pap smear, and LEEP</VALIDVALUE>
          <VALUEMEANING>Endocervical Swab Pap Smear Loop Electrosurgical Excision</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to the cervix uteri as the intended site of administration.: A tuft of material on the end of a stick for applying solutions and suspensions: A procedure in which cells are scraped from the cervix for examination under a microscope. It is used to detect cancer and changes that may lead to cancer. A Pap smear can also show conditions, such as infection or inflammation, that are not cancer.: Uses a thin, low-voltage electrified wire loop to cut out a thin layer of abnormal tissue; generally used to remove abnormal cells on the surface of the cervix.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51760, C17348, C17627, C149484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6650831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stool Sample</VALIDVALUE>
          <VALUEMEANING>Feces Biospecimen</VALUEMEANING>
          <MEANINGDESCRIPTION>The material discharged from the bowel during defecation.  It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.: Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13234, C70699</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6818509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood for Genomic DNA</VALIDVALUE>
          <VALUEMEANING>Blood for Genomic DNA</VALUEMEANING>
          <MEANINGDESCRIPTION>Blood for Genomic DNA</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-05-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7297658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood for Inflammatory Markers</VALIDVALUE>
          <VALUEMEANING>Blood for Inflammatory Markers</VALUEMEANING>
          <MEANINGDESCRIPTION>Blood for Inflammatory Markers</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-05-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7297659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood for PRO-C3 and PC3X</VALIDVALUE>
          <VALUEMEANING>Blood for PRO-C3 and PC3X</VALUEMEANING>
          <MEANINGDESCRIPTION>Blood for PRO-C3 and PC3X</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-11-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7516158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Parent Specimen Type</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Parent Specimen Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Parent specimen type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-04</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280815</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889179</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889180</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRNT_SPEC_TY</AlternateName>
        <AlternateNameType>DCP Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1360">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5893240</PUBLICID>
    <LONGNAME>Disease or Disorder Present Current Curative Intent Therapeutic Procedure Administration Clinical Trial Eligibility Criteria Ind</LONGNAME>
    <PREFERREDNAME>DZ_PRES_CURTX_INT_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A response to questions which are necessary to allow clinical study participation, as outlined in the study protocol, to address the patient&#39;s existing disease and the current administration of therapy with curative intent.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACRIN:American College of Radiology Imaging Network</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5893235</PublicId>
      <PreferredName>2404658v1.0:5893233v1.0</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Being or existing in a specified place or at the specified time._Occurring in or belonging to the present time._Serving or tending to restore health; a remedy._An anticipated outcome that is the purpose for actions taken, thus guiding the action._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Disease or Disorder Present Current Cure Intent Therapeutic Procedure Administration Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5893233</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>5893233v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Present Current Cure Intent Therapeutic Procedure Administration Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62220</PREFERRED_NAME>
            <LONG_NAME>Cure</LONG_NAME>
            <CON_ID>2503754</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25725</PREFERRED_NAME>
            <LONG_NAME>Intent</LONG_NAME>
            <CON_ID>2203832</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25409</PREFERRED_NAME>
            <LONG_NAME>Administration</LONG_NAME>
            <CON_ID>2202552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does the patient have Stage I</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does the patient have Stage I, II, or III disease at time of enrollment and are being treated with curative-intent?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1361">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5984788</PUBLICID>
    <LONGNAME>Irreversible Electroporation Performed Indicator</LONGNAME>
    <PREFERREDNAME>IRE_PERF_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator for whether or not Irreversible Electroporation was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Princess Margaret Cancer Centre, Toronto, ON</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5984787</PublicId>
      <PreferredName>5984785v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>A non-thermal ablation modality that is used in the treatment of locally advanced soft tissue tumors. This technique uses ultra-short, but strong, electrical fields to create permanent, lethal nanopores in cell membranes, disrupting cellular homeostasis and causing cell death. The technique may be performed intraoperatively, laparoscopically, or percutaneously._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Irreversible Electroporation Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5984785</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C131483</PreferredName>
        <Version>1</Version>
        <LongName>Irreversible Electroporation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131483</PREFERRED_NAME>
            <LONG_NAME>Irreversible Electroporation</LONG_NAME>
            <CON_ID>5625819</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Princess Margaret Cancer Centre, Toronto, ON</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was IRE performed?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was IRE performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>16445930</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PMCC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PMCC Curation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16445931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1362">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>5985732</PUBLICID>
    <LONGNAME>Breast Cancer AJCC Edition 8 Clinical Distant Metastasis M Category</LONGNAME>
    <PREFERREDNAME>BRST_AJC8_CLN_M_CAT</PREFERREDNAME>
    <PREFERREDDEFINITION>Extent of the distant metastasis for breast carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188689</PublicId>
      <PreferredName>BRST_TUMOR_C_M</PreferredName>
      <PreferredDefinition>Information related to clinical M stage for a breast tumor.</PreferredDefinition>
      <LongName>Breast Tumor Clinical M Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206465</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12971:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Breast Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12971</PREFERRED_NAME>
            <LONG_NAME>Breast</LONG_NAME>
            <CON_ID>2202571</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207806</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25398:C25727</PreferredName>
        <Version>1</Version>
        <LongName>Clinical M Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25727</PREFERRED_NAME>
            <LONG_NAME>M Category</LONG_NAME>
            <CON_ID>2204010</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6005691</PublicId>
      <PreferredName>6005691v1.0</PreferredName>
      <PreferredDefinition>A finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to invasive (infiltrating) carcinoma of the breast and ductal carcinoma in situ of the breast. It does not apply to breast sarcoma, phyllodes tumor, and breast lymphoma. (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Breast Carcinoma American Joint Committee on Cancer Edition 8 M Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>3</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
      <Representation>
        <PublicId>6356799</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C139390:C39315:C25727:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Breast Cancer TNM Finding v8 American Joint Committee on Cancer M Category Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C139390</PREFERRED_NAME>
            <LONG_NAME>Breast Cancer TNM Finding v8</LONG_NAME>
            <CON_ID>6005562</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39315</PREFERRED_NAME>
            <LONG_NAME>American Joint Committee on Cancer</LONG_NAME>
            <CON_ID>2554142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25727</PREFERRED_NAME>
            <LONG_NAME>M Category</LONG_NAME>
            <CON_ID>2204010</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cM1</VALIDVALUE>
          <VALUEMEANING>Breast Cancer cM1 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer with distant metastases detected by clinical and radiographic means and/or histologically proven metastases larger than 0.2 mm. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6005693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pM1</VALIDVALUE>
          <VALUEMEANING>Breast Cancer pM1 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer with distant metastases detected by clinical and radiographic means and/or histologically proven metastases larger than 0.2 mm. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6005737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cM0</VALIDVALUE>
          <VALUEMEANING>Breast Cancer cM0 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer without clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the cM0 category. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6005697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cM0(i+)</VALIDVALUE>
          <VALUEMEANING>Breast Cancer cM0(i+) TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Breast cancer in which there is no clinical or radiographic evidence of distant metastases in the presence of tumor cells or deposits no larger than 0.2 mm detected microscopically or by molecular techniques in circulating blood, bone marrow, or other nonregional nodal tissue in a patient without symptoms or signs of metastases. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6005695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Clinical M category</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Clinical M category</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-PCA-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Clinical TNM Class M</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-Template Name</Name>
        <DocumentType>Data Collection Template</DocumentType>
        <DocumentText>breast_v1-2_08sep2020.xlsx</DocumentText>
        <URL>https://mcl.nci.nih.gov/resources/standards/mcl-cdes</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180933</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>LIDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>QIN Breast Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6788757</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506112</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Breast</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast PCA Pilot</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7035094</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AJCC Edition 8</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6005920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000338</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6437797</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Pre-Cancer Atlas (PCA) Pilot</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast PCA Pilot</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7001791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>Clinical M</AlternateName>
        <AlternateNameType>QIN Breast Study</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CIP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>MCL</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>MCL</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>clinical_TNM_class_M_8</AlternateName>
        <AlternateNameType>MCL Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1363">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6001810</PUBLICID>
    <LONGNAME>Adverse Event Current Assessment Yes No Indicator</LONGNAME>
    <PREFERREDNAME>2453724v1.0:3506068v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>information relating to the current assessment of an adverse event._The preferred Value Domain to indicate a question with permissible values of yes/no.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2453724</PublicId>
      <PreferredName>AE_CURRENT_ASSESS</PreferredName>
      <PreferredDefinition>information relating to the current assessment of an adverse event.</PreferredDefinition>
      <LongName>Adverse Event Current Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2235992</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2453722</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25471:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Current Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Were AE&#39;s reviewed at this visit?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1364">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6002280</PUBLICID>
    <LONGNAME>Trypanosoma cruzi Antigen Chagas Disease Laboratory Finding Result</LONGNAME>
    <PREFERREDNAME>6001366v1.0:2676304v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A parasitic infection caused by Trypanosoma cruzi. It is transmitted by insect bites. It is characterized by an acute and chronic phase; in the acute phase patients may have fever, malaise, and swelling at the site of the insect bite. In the chronic phase patients develop hepatosplenomegaly, lymphadenopathy, cardiomyopathy and arrhythmias._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A species of parasitic euglenoid protozoan in the family Trypanosomatidae. T. cruzi is passed between mammalian hosts through the feces of a triatomine insect vector. Infection in humans causes Chagas disease._A parasitic infection caused by Trypanosoma cruzi. It is transmitted by insect bites. It is characterized by an acute and chronic phase; in the acute phase patients may have fever, malaise, and swelling at the site of the insect bite. In the chronic phase patients develop hepatosplenomegaly, lymphadenopathy, cardiomyopathy and arrhythmias._Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens._The outcome of a laboratory test._Outcome; a phenomenon that follows and is caused by some previous phenomenon.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6001366</PublicId>
      <PreferredName>6001364v1.0:2486250v1.0</PreferredName>
      <PreferredDefinition>A parasitic infection caused by Trypanosoma cruzi. It is transmitted by insect bites. It is characterized by an acute and chronic phase; in the acute phase patients may have fever, malaise, and swelling at the site of the insect bite. In the chronic phase patients develop hepatosplenomegaly, lymphadenopathy, cardiomyopathy and arrhythmias._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A species of parasitic euglenoid protozoan in the family Trypanosomatidae. T. cruzi is passed between mammalian hosts through the feces of a triatomine insect vector. Infection in humans causes Chagas disease._A parasitic infection caused by Trypanosoma cruzi. It is transmitted by insect bites. It is characterized by an acute and chronic phase; in the acute phase patients may have fever, malaise, and swelling at the site of the insect bite. In the chronic phase patients develop hepatosplenomegaly, lymphadenopathy, cardiomyopathy and arrhythmias._Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.</PreferredDefinition>
      <LongName>Trypanosoma cruzi Antigen Chagas Disease Laboratory Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6001364</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C125977:C84629:C268</PreferredName>
        <Version>1</Version>
        <LongName>Trypanosoma cruzi Chagas Disease Antigen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125977</PREFERRED_NAME>
            <LONG_NAME>Trypanosoma cruzi</LONG_NAME>
            <CON_ID>5153952</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C84629</PREFERRED_NAME>
            <LONG_NAME>Chagas Disease</LONG_NAME>
            <CON_ID>3188410</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C268</PREFERRED_NAME>
            <LONG_NAME>Antigen</LONG_NAME>
            <CON_ID>2202300</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2486250</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2676304</PublicId>
      <PreferredName>LAB_RSLT</PreferredName>
      <PreferredDefinition>The outcome of a laboratory test._Outcome; a phenomenon that follows and is caused by some previous phenomenon.</PreferredDefinition>
      <LongName>Laboratory Finding Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>41</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2876957</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C36292:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test Result Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C36292</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Result</LONG_NAME>
            <CON_ID>2451822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated</VALIDVALUE>
          <VALUEMEANING>Elevated</VALUEMEANING>
          <MEANINGDESCRIPTION>Elevated; raised or increased.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-05</PVBEGINDATE>
          <PVENDDATE>2013-09-04</PVENDDATE>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes: C49488</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never below</VALIDVALUE>
          <VALUEMEANING>Never Less Than</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).: A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61585, C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2682054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reactive</VALIDVALUE>
          <VALUEMEANING>Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported reactive, not tested</VALIDVALUE>
          <VALUEMEANING>Previous Report Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.: Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637, C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not reported</VALIDVALUE>
          <VALUEMEANING>Not Report</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not performed; HIV NAT testing performed</VALIDVALUE>
          <VALUEMEANING>Human Immunodeficiency Virus Nucleic Acid Amplification Test Performed</VALUEMEANING>
          <MEANINGDESCRIPTION>Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME.: Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.: Performed; carried out.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38000, C20055, C14219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2727600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-reactive</VALIDVALUE>
          <VALUEMEANING>Not Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2617835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known</VALIDVALUE>
          <VALUEMEANING>Laboratory Finding Received</VALUEMEANING>
          <MEANINGDESCRIPTION>The outcome of a laboratory test._To take, accept, or get something offered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25639, C36292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2729916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low</VALIDVALUE>
          <VALUEMEANING>Low</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimum level or position or degree; less than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inconclusive</VALIDVALUE>
          <VALUEMEANING>Uncertain</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2749725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate/equivocal</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-09</PVBEGINDATE>
          <PVENDDATE>2013-12-17</PVENDDATE>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline</VALIDVALUE>
          <VALUEMEANING>Borderline</VALUEMEANING>
          <MEANINGDESCRIPTION>Straddling the dividing line between two categories.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reduced; decreased</VALIDVALUE>
          <VALUEMEANING>Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Made less in size or amount or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-09</PVBEGINDATE>
          <PVENDDATE>2012-06-29</PVENDDATE>
          <VMPUBLICID>3135563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3079341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invalid neutralization</VALIDVALUE>
          <VALUEMEANING>Unacceptable Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>Failing to satisfy an established set of qualifying measures.: The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533, C63354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutralized</VALIDVALUE>
          <VALUEMEANING>Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not neutralizable</VALIDVALUE>
          <VALUEMEANING>Negation Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Increased</VALIDVALUE>
          <VALUEMEANING>Increase</VALUEMEANING>
          <MEANINGDESCRIPTION>Increase; a process of becoming larger or more numerous or more important.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decreased</VALIDVALUE>
          <VALUEMEANING>Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Made less in size or amount or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3135563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Severe</VALIDVALUE>
          <VALUEMEANING>Severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely or extremely bad or unpleasant in degree, quality, or extent; life threatening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2842706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mild</VALIDVALUE>
          <VALUEMEANING>Mild</VALUEMEANING>
          <MEANINGDESCRIPTION>Not severe or strong; far from extreme; not serious enough to endanger life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High</VALIDVALUE>
          <VALUEMEANING>High</VALUEMEANING>
          <MEANINGDESCRIPTION>High; greater than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not evaluable</VALIDVALUE>
          <VALUEMEANING>Not Assessable/Not Evaluable</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to be evaluated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carrier of the trait</VALIDVALUE>
          <VALUEMEANING>Genetic Carrier Trait</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who carries an inheritable genetic mutation without manifestation of the associated condition.: Any genetically determined characteristic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85496, C111031</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3872849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate/equivocal</VALIDVALUE>
          <VALUEMEANING>Indeterminate Or Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071, C37998, C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4012172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resolved</VALIDVALUE>
          <VALUEMEANING>Resolved</VALUEMEANING>
          <MEANINGDESCRIPTION>Return to the normal structure and/or function, e.g. the subsidence of a pathologic process, as the subsidence of an inflammatory lesion or new growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2936016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Improved</VALIDVALUE>
          <VALUEMEANING>Better</VALUEMEANING>
          <MEANINGDESCRIPTION>In an improved condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Worse</VALIDVALUE>
          <VALUEMEANING>Worse</VALUEMEANING>
          <MEANINGDESCRIPTION>In an declined condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unchanged</VALIDVALUE>
          <VALUEMEANING>About the same</VALUEMEANING>
          <MEANINGDESCRIPTION>In an unchanged or similar condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3178174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Involved</VALIDVALUE>
          <VALUEMEANING>Involvement</VALUEMEANING>
          <MEANINGDESCRIPTION>To have a connection by participation or association or use; sharing in an activity or process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4244451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not available</VALIDVALUE>
          <VALUEMEANING>Negation Availability</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Available; obtainable or accessible and ready for use or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25429, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested</VALIDVALUE>
          <VALUEMEANING>Not Tested</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a test was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3918247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-secretory</VALIDVALUE>
          <VALUEMEANING>Non-Secretory Myeloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare type of multiple myeloma in which the plasma cells synthesize but do not secrete immunoglobulins.  As a result, none of the immunoglobulins appear out of the normal range.  The symptoms are generally the same with those of immunoglobulin-secreting myeloma; however, the incidence of renal insufficiency is lower in non-secretory myeloma.  The diagnosis can be missed because of the absence of monoclonal immunoglobulin in the serum or urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4734</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive/Suggestive</VALIDVALUE>
          <VALUEMEANING>Positive Finding And/Or Characteristic</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.: Used to indicate that either or both of two items or options may be valid.: The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25447, C48928, C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5036957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inconclusive / equivocal</VALIDVALUE>
          <VALUEMEANING>Uncertain And/Or Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.: Used to indicate that either or both of two items or options may be valid.: Open to question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071, C48928, C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suggestive</VALIDVALUE>
          <VALUEMEANING>Suggestion</VALUEMEANING>
          <MEANINGDESCRIPTION>A proposal offered for acceptance or rejection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5070731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not assessed</VALIDVALUE>
          <VALUEMEANING>Negation Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The final result of a determination of the value, significance, or extent of.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25594, C25217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4982117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Confirmed positive</VALIDVALUE>
          <VALUEMEANING>Confirmation Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>Having been established or verified.: A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758, C25458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5677531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No growth</VALIDVALUE>
          <VALUEMEANING>Negation Growth</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: A process of becoming larger or longer or more numerous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64379, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5653622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pending</VALIDVALUE>
          <VALUEMEANING>Pending</VALUEMEANING>
          <MEANINGDESCRIPTION>Not yet decided or settled; awaiting conclusion or confirmation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2784518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unsatisfactory</VALIDVALUE>
          <VALUEMEANING>Unsatisfactory</VALUEMEANING>
          <MEANINGDESCRIPTION>Failing to meet the quantitative or qualitative measures for the needs of a situation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5255277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No result</VALIDVALUE>
          <VALUEMEANING>Negation Laboratory Test Result</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The outcome of a laboratory test.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36292, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7096109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Contraindicated</VALIDVALUE>
          <VALUEMEANING>Contraindicated</VALUEMEANING>
          <MEANINGDESCRIPTION>State of a particular method of treatment, regimen, procedure, medication, etc. of being unsuitable and inadvisable, often because of a likely adverse reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14665139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Equivocal</VALIDVALUE>
          <VALUEMEANING>Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>T. cruzi Antigen, Chagas</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>T. cruzi Antigen, Chagas</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3029677</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>UAMS Clinical Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAMS New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812848</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1365">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6006062</PUBLICID>
    <LONGNAME>Surgical Procedure Additional Breast Reconstruction Performed Status</LONGNAME>
    <PREFERREDNAME>6005975v1.0:6005996v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The status of additional breast reconstruction performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6005975</PublicId>
      <PreferredName>2322305v1.0:6005973v1.0</PreferredName>
      <PreferredDefinition>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Added; extra; further._Surgical reconstruction of the breast._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Surgical Procedure Additional Breast Reconstruction Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2322305</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6005973</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25406:C15354:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Additional Mammoplasty Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25406</PREFERRED_NAME>
            <LONG_NAME>Additional</LONG_NAME>
            <CON_ID>2206153</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15354</PREFERRED_NAME>
            <LONG_NAME>Mammoplasty</LONG_NAME>
            <CON_ID>2716449</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6005996</PublicId>
      <PreferredName>6005996v1.0</PreferredName>
      <PreferredDefinition>A condition or state at a particular time.</PreferredDefinition>
      <LongName>Additional Breast Reconstruction Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>75</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>Alliance Case Report Form</Origin>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4th reconstruction surgery</VALIDVALUE>
          <VALUEMEANING>Fourth Reconstructive Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the third position in an ordering or series; coming next after the third and just before the fifth in position.: Surgical restoration of function or form of a part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25351, C54566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6005997</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3rd reconstruction surgery</VALIDVALUE>
          <VALUEMEANING>Third Reconstructive Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the second position in an ordering or series; coming next after the second and just before the fourth in position.: Surgical restoration of function or form of a part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25351, C25260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6005998</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2nd reconstruction surgery</VALIDVALUE>
          <VALUEMEANING>Second Reconstructive Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>Coming next after the first in position in space or time or degree or magnitude.: Surgical restoration of function or form of a part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25351, C25666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6005999</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Additional reconstruction sur</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Additional reconstruction surgery</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1366">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6011116</PUBLICID>
    <LONGNAME>Cytogam Administered Indicator</LONGNAME>
    <PREFERREDNAME>6011114v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not cytogam was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6011114</PublicId>
      <PreferredName>6011112v1.0:2233610v1.0</PreferredName>
      <PreferredDefinition>A sterilized solution containing immunoglobulins (IGs) against cytomegalovirus (CMV) that is derived from human plasma of donors infected with CMV and can be used for passive immunization against CMV. Upon administration, human CMVIG is used to help prevent infection by CMV._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Cytogam Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6011112</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C80826</PreferredName>
        <Version>1</Version>
        <LongName>Human Cytomegalovirus Immune Globulin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80826</PREFERRED_NAME>
            <LONG_NAME>Human Cytomegalovirus Immune Globulin</LONG_NAME>
            <CON_ID>5999816</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was cytogam administered?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was cytogam administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cytogam (CMV hyperimmune gamma globulin)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cytogam (CMV hyperimmune gamma globulin)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cytogam</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Cytogam</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1367">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6032514</PUBLICID>
    <LONGNAME>DART Currently Feel Drowsy Score 11 Point Scale</LONGNAME>
    <PREFERREDNAME>DART_CUR_DROWSY_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of their current feeling of drowsiness, using an 11 point visual analogue scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DART:Distress Assessment and Response Tool, Form D-5668. University Health Network DART Team, Toronto, Canada, 3/2013.</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6032235</PublicId>
      <PreferredName>6032226v1.0:6032233v1.0</PreferredName>
      <PreferredDefinition>A short, self-assessment to measure an individual&#39;s physical symptoms, emotional burden and practical concerns that could interfere with their ability to engage in cancer treatment._Occurring in or belonging to the present time._A question about whether an individual feels or felt drowsy._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Distress Assessment and Response Tool Current Feel Drowsy Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6032226</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C141520</PreferredName>
        <Version>1</Version>
        <LongName>Distress Assessment and Response Tool</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C141520</PREFERRED_NAME>
            <LONG_NAME>Distress Assessment and Response Tool</LONG_NAME>
            <CON_ID>6030970</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6032233</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25471:C107397:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Current Feel Drowsy Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107397</PREFERRED_NAME>
            <LONG_NAME>Feel Drowsy Question</LONG_NAME>
            <CON_ID>3821178</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DART:Distress Assessment and Response Tool, Form D-5668. University Health Network DART Team, Toronto, Canada, 3/2013.</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6032214</PublicId>
      <PreferredName>DART_DROWSINESS_SCL</PreferredName>
      <PreferredDefinition>A short, self-assessment to measure an individual&#39;s physical symptoms, emotional burden and practical concerns that could interfere with their ability to engage in cancer treatment._A scale of drowsiness from 0 to 10 on which the patient marks the current level of drowsiness experienced._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>DART Drowsiness 11 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>10</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>DART:Distress Assessment and Response Tool, Form D-5668. University Health Network DART Team, Toronto, Canada, 3/2013.</Origin>
      <Representation>
        <PublicId>6032213</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C141520:C141545:C25664</PreferredName>
        <Version>1</Version>
        <LongName>Distress Assessment and Response Tool Drowsiness Visual Analogue Scale Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C141520</PREFERRED_NAME>
            <LONG_NAME>Distress Assessment and Response Tool</LONG_NAME>
            <CON_ID>6030970</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C141545</PREFERRED_NAME>
            <LONG_NAME>Drowsiness Visual Analogue Scale</LONG_NAME>
            <CON_ID>6031336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Drowsiness Score 0</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 0 on a drowsiness scale that ranges from 0: No Drowsiness to 10: Worst Possible Drowsiness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6032215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Drowsiness Score 1</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 1 on a drowsiness scale that ranges from 0: No Drowsiness to 10: Worst Possible Drowsiness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6032216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>Drowsiness Score 10</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 10 on a drowsiness scale that ranges from 0: No Drowsiness to 10: Worst Possible Drowsiness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6032217</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Drowsiness Score 2</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 2 on a drowsiness scale that ranges from 0: No Drowsiness to 10: Worst Possible Drowsiness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6032218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Drowsiness Score 3</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 3 on a drowsiness scale that ranges from 0: No Drowsiness to 10: Worst Possible Drowsiness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6032219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Drowsiness Score 4</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 4 on a drowsiness scale that ranges from 0: No Drowsiness to 10: Worst Possible Drowsiness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141550</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6032220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Drowsiness Score 5</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 5 on a drowsiness scale that ranges from 0: No Drowsiness to 10: Worst Possible Drowsiness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141552</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6032221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Drowsiness Score 6</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 6 on a drowsiness scale that ranges from 0: No Drowsiness to 10: Worst Possible Drowsiness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6032222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Drowsiness Score 7</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 7 on a drowsiness scale that ranges from 0: No Drowsiness to 10: Worst Possible Drowsiness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6032223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Drowsiness Score 8</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 8 on a drowsiness scale that ranges from 0: No Drowsiness to 10: Worst Possible Drowsiness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6032224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Drowsiness Score 9</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 9 on a drowsiness scale that ranges from 0: No Drowsiness to 10: Worst Possible Drowsiness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C141556</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6032225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Drowsiness</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Drowsiness</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Please select the number between 0 and 10 that best describes how you have been feeling over the past 24 hours</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Please select the number between 0 and 10 that best describes how you have been feeling over the past 24 hours</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Please select the number between 0 and 10 that best describes how you have been feeling over the past 24 hours</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Please select the number between 0 and 10 that best describes how you have been feeling over the past 24 hours</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions. Questions used in this manner do not represent the original measure and should not be referenced by the measure’s name.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Distress Assessment and Response Tool (DART)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14888278</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6032138</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DART</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DART</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6032148</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1368">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6038250</PUBLICID>
    <LONGNAME>Active Surveillance Pathology Based Contraindication Text</LONGNAME>
    <PREFERREDNAME>AS_PTHBS_CNTRND_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that represents the kind of active surveillance contraindication based on the pathology report.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6037302</PublicId>
      <PreferredName>3090387v1.0:6037232v1.0</PreferredName>
      <PreferredDefinition>Closely watching a patient&#39;s condition but not giving treatment unless there are changes in test results. Active surveillance avoids problems that may be caused by treatments such as radiation or surgery. It is used to find early signs that the condition is getting worse. During active surveillance, patients will be given certain exams and tests done on a regular schedule. It is sometimes used in prostate cancer._The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination._The fundamental assumptions underlying an explanation or a relation that provide the foundation for something._A symptom or medical condition that makes a particular treatment or procedure inadvisable because a person is likely to have a bad reaction.</PreferredDefinition>
      <LongName>Patient Observation Pathology Basis Medical Contraindication</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3090387</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15722</PreferredName>
        <Version>1</Version>
        <LongName>Patient Observation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15722</PREFERRED_NAME>
            <LONG_NAME>Patient Observation</LONG_NAME>
            <CON_ID>2203937</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6037232</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18189:C25430:C50646</PreferredName>
        <Version>1</Version>
        <LongName>Pathology Basis Medical Contraindication</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25430</PREFERRED_NAME>
            <LONG_NAME>Basis</LONG_NAME>
            <CON_ID>2203857</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50646</PREFERRED_NAME>
            <LONG_NAME>Medical Contraindication</LONG_NAME>
            <CON_ID>2683178</CON_ID>
            <DEFINITION_SOURCE>FDA</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2666622</PublicId>
      <PreferredName>2666622v2.0</PreferredName>
      <PreferredDefinition>Text; the words of something written.</PreferredDefinition>
      <LongName>100 Character Text</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008581</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PropertiesOrAttributes</PreferredName>
        <Version>1</Version>
        <LongName>Properties or Attributes</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AS - Contraindication from pa</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>AS - Contraindication from pathology</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1369">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6047245</PUBLICID>
    <LONGNAME>Therapeutic Procedure Initiation Disease or Disorder Development Timespan Interval</LONGNAME>
    <PREFERREDNAME>6047232v1.0:6047234v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A response used to determine the period of time between the act of starting an action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process and the process that involves and promote formation of any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6047232</PublicId>
      <PreferredName>2512834v1.0:6047230v1.0</PreferredName>
      <PreferredDefinition>An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The act of starting something; an act that sets in motion some course of events._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Processes that involve and promote formation of more mature organs, organ systems, or organisms; general development. (NCI)_The period of time between two dates or events or between the beginning and end of something.</PreferredDefinition>
      <LongName>Therapeutic Procedure Initiation Disease or Disorder Development Timespan</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6047230</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47938:C2991:C18732:C68594</PreferredName>
        <Version>1</Version>
        <LongName>Initiation Disease or Disorder Development Timespan</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47938</PREFERRED_NAME>
            <LONG_NAME>Initiation</LONG_NAME>
            <CON_ID>2443907</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18732</PREFERRED_NAME>
            <LONG_NAME>Organism Development</LONG_NAME>
            <CON_ID>4798273</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68594</PREFERRED_NAME>
            <LONG_NAME>Timespan</LONG_NAME>
            <CON_ID>2673257</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6047234</PublicId>
      <PreferredName>6047234v1.0</PreferredName>
      <PreferredDefinition>The period of time between two dates or events or between the beginning and end of something._The period of time or the distance separating two instances, events, or occurrences.</PreferredDefinition>
      <LongName>Timespan Interval</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>6047233</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68594:C25543</PreferredName>
        <Version>1</Version>
        <LongName>Timespan Interval</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68594</PREFERRED_NAME>
            <LONG_NAME>Timespan</LONG_NAME>
            <CON_ID>2673257</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25543</PREFERRED_NAME>
            <LONG_NAME>Interval</LONG_NAME>
            <CON_ID>2202600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Greater than 12 months</VALIDVALUE>
          <VALUEMEANING>Greater Than Twelve Month</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than 11 and less than 13 and the quantity that it denotes.: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C113426, C61584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4857995</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Less than or equal to 12 months</VALIDVALUE>
          <VALUEMEANING>Less Than or Equal To Twelve Month</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.: A natural number greater than 11 and less than 13 and the quantity that it denotes.: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C113426, C61586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4857996</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>The time from initiation of A</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>The time from initiation of ADT (Androgen Deprivation Therapy) to the development of CRPC (Castration Resistant Prostate Cancer).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Baseline Disease Description Form</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Time to CRPC (Castration Resistant Prostate Cancer)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>OPEN Form</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>The time from initiation of ADT (Androgen Deprivation Therapy) for metastatic hormone-sensitive prostate cancer to the development of CRPC (Castration-Resistant Prostate Cancer).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Stratification Factor</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6013685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1370">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6051443</PUBLICID>
    <LONGNAME>Platinum Compound Resistance Process Prior Weekly Therapeutic Procedure Receive Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>PLAT_RES_PRR_WKLY_TX_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded response to determine eligibility for clinical trial participation for questions related to the prior weekly receipt of therapeutic agents in the platinum resistance process.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6051442</PublicId>
      <PreferredName>4939591v1.0:6051440v1.0</PreferredName>
      <PreferredDefinition>A chemotherapy compound that contains a platinum atom. Platinum compounds do not contain alkyl groups but do cause DNA crosslinks and adducts similar to alkylating agents. DNA crosslinks and adducts ultimately lead to the induction of apoptosis._A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent._Earlier in time or order._Every week._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._To take, accept, or get something offered._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Platinum Compound Resistance Process Prior Weekly Therapeutic Procedure Receive Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4939591</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1450</PreferredName>
        <Version>1</Version>
        <LongName>Platinum Compound</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1450</PREFERRED_NAME>
            <LONG_NAME>Platinum Compound</LONG_NAME>
            <CON_ID>2716561</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6051440</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>6051440v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Resistance Process Prior Weekly Therapeutic Procedure Receive Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41546</PREFERRED_NAME>
            <LONG_NAME>Resistance Process</LONG_NAME>
            <CON_ID>3232841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67069</PREFERRED_NAME>
            <LONG_NAME>Weekly</LONG_NAME>
            <CON_ID>2730407</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has patient received prior we</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has patient received prior weekly paclitaxel or bevacizumab in the platinum resistant (disease progression within 6 months of platinum based chemotherapy)/refractory (disease progression during or following the 3 months of the first line platinum based chemotherapy) setting?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876359</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Exclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prior Treatments</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3876424</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1371">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6060060</PUBLICID>
    <LONGNAME>Patient Uncontrolled Seizure Disorder Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>PT_UNCON_SZ_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded response to questions which are necessary to allow a person to participate in a clinical study that are related to uncontrolled seizure as outlined in the protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6060059</PublicId>
      <PreferredName>2233604v1.0:6060057v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Not controlled, regulated, or constrained._A brain disorder characterized by episodes of abnormally increased neuronal discharge resulting in transient episodes of sensory or motor neurological dysfunction, or psychic dysfunction. These episodes may or may not be associated with loss of consciousness or convulsions._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Patient Uncontrolled Seizure Disorder Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6060057</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48932:C3020:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Uncontrolled Seizure Disorder Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48932</PREFERRED_NAME>
            <LONG_NAME>Uncontrolled</LONG_NAME>
            <CON_ID>2437662</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3020</PREFERRED_NAME>
            <LONG_NAME>Seizure Disorder</LONG_NAME>
            <CON_ID>2971316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have uncontrolle</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have uncontrolled seizures?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does patient have an uncontrolled seizure disorder?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876359</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Exclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status &amp; Genetics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000703</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1372">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6119068</PUBLICID>
    <LONGNAME>Metastatic Disease Anatomic Site</LONGNAME>
    <PREFERREDNAME>metastatic_site</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that describes the anatomic site of the metastatic disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HCMI:Human Cancer Models Initiative</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6119044</PublicId>
      <PreferredName>2761292v1.0:2239981v1.0</PreferredName>
      <PreferredDefinition>The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</PreferredDefinition>
      <LongName>Metastasis Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2761292</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19151</PreferredName>
        <Version>1</Version>
        <LongName>Metastasis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19151</PREFERRED_NAME>
            <LONG_NAME>Metastasis</LONG_NAME>
            <CON_ID>2202751</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239981</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HCMI:Human Cancer Models Initiative</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3426799</PublicId>
      <PreferredName>3426799v1.0</PreferredName>
      <PreferredDefinition>A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The place where something begins or comes from in either the sense of a physical location or a metaphysical source._Named locations of, or within, the body.</PreferredDefinition>
      <LongName>Neoplasm Origin Anatomic Site</LongName>
      <Version>2.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3426798</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3262:C42703:C13717</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm Origin Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42703</PREFERRED_NAME>
            <LONG_NAME>Origin</LONG_NAME>
            <CON_ID>2204026</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systemic</VALIDVALUE>
          <VALUEMEANING>Systemic</VALUEMEANING>
          <MEANINGDESCRIPTION>(sis-TEM-ik) Affecting the entire body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3178352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Synovium</VALIDVALUE>
          <VALUEMEANING>Synovial Membrane</VALUEMEANING>
          <MEANINGDESCRIPTION>The inner layer of the connective tissue that seals the joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Subcutaneous tissue</VALIDVALUE>
          <VALUEMEANING>Subcutaneous Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Beneath the skin.: An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12801, C13353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3187285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach, Mucosa only</VALIDVALUE>
          <VALUEMEANING>Stomach Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>The organ located between the esophagus and the small intestine where digestion of food occurs before passing to the small intestine.: The moist tissue that lines some organs and body cavities (such as the nose, mouth, lungs) and makes mucus (a thick, slippery fluid).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13166, C12391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sternum</VALIDVALUE>
          <VALUEMEANING>Sternum</VALUEMEANING>
          <MEANINGDESCRIPTION>The long, flat bone connecting with the cartilages of the first seven ribs and the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12793</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spine/Femur/Radius</VALIDVALUE>
          <VALUEMEANING>Vertebral Column and Femur Radius</VALUEMEANING>
          <MEANINGDESCRIPTION>The spinal or vertebral column.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The longest and largest bone of the skeleton, it is situated between the hip and the knee.: A straight line from the center to the perimeter of a circle or from the center to the surface of a sphere.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63921, C12717, C37912, C12998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spine/Femur</VALIDVALUE>
          <VALUEMEANING>Vertebral Column and Femur</VALUEMEANING>
          <MEANINGDESCRIPTION>The spinal or vertebral column.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The longest and largest bone of the skeleton, it is situated between the hip and the knee.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12717, C37912, C12998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spine</VALIDVALUE>
          <VALUEMEANING>Vertebral Column</VALUEMEANING>
          <MEANINGDESCRIPTION>The spinal or vertebral column.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spinal Cord</VALIDVALUE>
          <VALUEMEANING>Spinal Cord</VALUEMEANING>
          <MEANINGDESCRIPTION>The elongated, approximately cylindrical part of the central nervous system of vertebrates that lies in the vertebral canal and from which the spinal nerves emerge.|On-line Medical Dictionary</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sphenoid bone</VALIDVALUE>
          <VALUEMEANING>Sphenoid Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The butterfly-shaped bone located at the base of the skull that helps to form the orbit of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small Bowel, Mucosa only</VALIDVALUE>
          <VALUEMEANING>Small Bowel Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the digestive tube between the stomach and the cecum or beginning of the large intestine; it consists of three portions: duodenum, jejunum, and ileum. SYN intestinum tenue.: The moist tissue that lines some organs and body cavities (such as the nose, mouth, lungs) and makes mucus (a thick, slippery fluid).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13166, C12386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skull</VALIDVALUE>
          <VALUEMEANING>Skull</VALUEMEANING>
          <MEANINGDESCRIPTION>The skeleton of the head including the bones of the face and the bones enclosing the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibula</VALIDVALUE>
          <VALUEMEANING>Fibula</VALUEMEANING>
          <MEANINGDESCRIPTION>The bone of the lower leg lateral to and smaller than the tibia. In proportion to its length, it is the most slender of the long bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Finger</VALIDVALUE>
          <VALUEMEANING>Fingers (Phalanges)</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the digits of the hand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fibula head</VALIDVALUE>
          <VALUEMEANING>Head of the Fibula</VALUEMEANING>
          <MEANINGDESCRIPTION>The highest portion of the fibula that articulates with the patella.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4199812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Femur</VALIDVALUE>
          <VALUEMEANING>Femur</VALUEMEANING>
          <MEANINGDESCRIPTION>The longest and largest bone of the skeleton, it is situated between the hip and the knee.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fallopian tube</VALIDVALUE>
          <VALUEMEANING>Fallopian tube</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of tubes that extend from the uterus to each of the ovaries. Following ovulation the egg travels down the fallopian tube to the uterus where fertilization may or may not occur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eye</VALIDVALUE>
          <VALUEMEANING>Eye</VALUEMEANING>
          <MEANINGDESCRIPTION>The organ of sight or vision.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ethmoid bone</VALIDVALUE>
          <VALUEMEANING>Ethmoid Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A light and spongy bone that is cubical in shape. This bone is positioned at the anterior part of the cranium, sitting between the two orbits, at the roof of the nose. It consists of four parts: a horizontal or cribriform plate; a perpendicular plate; and two lateral masses or labyrinths.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus, Mucosa only</VALIDVALUE>
          <VALUEMEANING>Esophageal Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the esophagus.: The moist tissue that lines some organs and body cavities (such as the nose, mouth, lungs) and makes mucus (a thick, slippery fluid).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13166, C37950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine gland</VALIDVALUE>
          <VALUEMEANING>Endocrine Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>Ductless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elbow</VALIDVALUE>
          <VALUEMEANING>Elbow Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of hinge joint located between the forearm and upper arm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Effusion</VALIDVALUE>
          <VALUEMEANING>Effusion</VALUEMEANING>
          <MEANINGDESCRIPTION>A collection of fluid in a body cavity.  It may be the result of a non-neoplastic disorder (e.g. heart failure) or a tumor (e.g. carcinoma of the lung). -- 2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3003</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ear, Pinna (External)</VALIDVALUE>
          <VALUEMEANING>External Ear</VALUEMEANING>
          <MEANINGDESCRIPTION>The external part of the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ear canal</VALIDVALUE>
          <VALUEMEANING>Ear Canal</VALUEMEANING>
          <MEANINGDESCRIPTION>The organ of hearing: composed of the external ear, which includes the auricle and the external acoustic, or auditory, meatus; the middle ear, or the tympanic cavity with its ossicles; and the internal ear or inner ear, or labyrinth, which includes the semicircular canals, vestibule, and cochlea. SEE ALSO auricle. SYN auris.: A bodily passage or tube lined with epithelial cells and conveying a secretion or other substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61487, C12394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ear</VALIDVALUE>
          <VALUEMEANING>Ear</VALUEMEANING>
          <MEANINGDESCRIPTION>A sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contains the ossicles (malleus, incus and stapes). The inner ear is made up of the cochlea needed for hearing and the vestibular apparatus required for balance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Duodenum</VALIDVALUE>
          <VALUEMEANING>Duodenum</VALUEMEANING>
          <MEANINGDESCRIPTION>A jointed tube 25-30 cm long that connects the stomach to the jejunum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diaphragm</VALIDVALUE>
          <VALUEMEANING>Diaphragm</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibromuscular tissue that separates the thoracic from the abdominal cavity. It increases the volume of the thoracic cavity through contractions, thus facilitating respiration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bowel</VALIDVALUE>
          <VALUEMEANING>Bowel</VALUEMEANING>
          <MEANINGDESCRIPTION>The long, tube-shaped organ in the abdomen that completes the process of digestion. The intestine has two parts, the small intestine and the large intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4887671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest wall</VALIDVALUE>
          <VALUEMEANING>Chest Wall</VALUEMEANING>
          <MEANINGDESCRIPTION>The total system of structures outside the lungs that move as a part of breathing; it includes all structures from the skin to the parietal pleura.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest</VALIDVALUE>
          <VALUEMEANING>Chest</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervix</VALIDVALUE>
          <VALUEMEANING>Cervix Uteri</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12311</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical/Thoracic/Lumbar spine</VALIDVALUE>
          <VALUEMEANING>Cervical Thoracic Lumbar Spine Vertebral Column</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to a neck, or cervix, in any sense.: Having to do with the chest.: Those vertebrae between the ribs and the pelvis, L1-L5 in man.: A series of bones, muscles, tendons, and other tissues reaching from the base of the skull to the tailbone. The vertebral column forms the axis of the skeleton and encloses as well as protects the spinal cord and the fluid surrounding the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12998, C69314, C13360, C12844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4887891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical vertebra</VALIDVALUE>
          <VALUEMEANING>Cervical Vertebra</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the seven vertebrae that start with C1, connecting the skull to the spine, and ends with C7, which joins the cervical with the thoracic spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12693</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4199814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical spine</VALIDVALUE>
          <VALUEMEANING>Cervical spine</VALUEMEANING>
          <MEANINGDESCRIPTION>Those vertebrae immediately behind (caudal to) the skull, C1-C7 in man.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cranial Nerve</VALIDVALUE>
          <VALUEMEANING>Cranial Nerve</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the 12 paired nerves that originate in the brain stem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12700</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2798874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Connective tissue</VALIDVALUE>
          <VALUEMEANING>Connective Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>The supporting or framework tissue of the animal body, formed of fibrous and ground substance with more or less numerous cells of various kinds; it is derived from the mesenchyme, and this in turn from the mesoderm; the varieties of connective tissue are: areolar or loose; adipose; dense, regular or irregular, white fibrous; elastic; mucous; and lymphoid tissue; cartilage; and bone; the blood and lymph may be regarded as connective tissues the ground substance of which is a liquid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12374</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Common duct</VALIDVALUE>
          <VALUEMEANING>Common Bile Duct</VALUEMEANING>
          <MEANINGDESCRIPTION>Bile ducts are passageways that carry bile. Two major bile ducts come together into a &quot;trunk&quot;-the common bile duct which empties into the upper part of the small intestine (the part next to the stomach).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colon, mucosa only</VALIDVALUE>
          <VALUEMEANING>Colon Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.: The moist tissue that lines some organs and body cavities (such as the nose, mouth, lungs) and makes mucus (a thick, slippery fluid).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13166, C12382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colon and rectum</VALIDVALUE>
          <VALUEMEANING>Colon And Rectum Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12390, C37912, C12382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4887934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Coccyx</VALIDVALUE>
          <VALUEMEANING>Coccyx</VALUEMEANING>
          <MEANINGDESCRIPTION>The last portion of the vertebral column just below the sacrum consisting of 3-5 rudimentary vertebrae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clitoris</VALIDVALUE>
          <VALUEMEANING>Clitoris</VALUEMEANING>
          <MEANINGDESCRIPTION>The erectile tissue in the vulva. It is composed of the corpora cavernosa and the glans clitoris.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clavicle</VALIDVALUE>
          <VALUEMEANING>Clavicle</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone of the upper extremity that articulates with the acromion process of the scapula on one end and the sternum on the other.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12695</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chin</VALIDVALUE>
          <VALUEMEANING>Mentum</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the face below the lower lip and including the protruding part of the lower jaw.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81169</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest/Pelvis</VALIDVALUE>
          <VALUEMEANING>Chest And Pelvis Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12767, C37912, C25389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4887935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest/Abdomen/Pelvis</VALIDVALUE>
          <VALUEMEANING>Chest Abdomen Pelvis Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction.: The portion of the body that lies between the thorax and the pelvis.: The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12767, C12664, C25389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4887936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood vessel</VALIDVALUE>
          <VALUEMEANING>Blood Vessel</VALUEMEANING>
          <MEANINGDESCRIPTION>A tube through which the blood circulates in the body. Blood vessels include a network of arteries, arterioles, capillaries, venules, and veins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12679</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood</VALIDVALUE>
          <VALUEMEANING>Blood</VALUEMEANING>
          <MEANINGDESCRIPTION>A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bile duct</VALIDVALUE>
          <VALUEMEANING>Bile Duct</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the ducts conveying bile between the liver and the intestine, including hepatic, cystic, and common bile duct.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Back</VALIDVALUE>
          <VALUEMEANING>Back</VALUEMEANING>
          <MEANINGDESCRIPTION>The dorsal area between the base of the neck and the sacrum. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13062</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axilla</VALIDVALUE>
          <VALUEMEANING>Axilla</VALUEMEANING>
          <MEANINGDESCRIPTION>Axilla; the hollow under the arm where it is joined to the shoulder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12674</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autonomic nervous system</VALIDVALUE>
          <VALUEMEANING>Autonomic Nervous System</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the nervous system of vertebrates that controls involuntary actions of the smooth muscles and heart and glands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12673</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Auditory canal</VALIDVALUE>
          <VALUEMEANING>Auditory Canal</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the process of hearing.: A bodily passage or tube lined with epithelial cells and conveying a secretion or other substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61487, C37915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ascending Colon Hepatic Flexure</VALIDVALUE>
          <VALUEMEANING>Ascending Colon Hepatic Flexure</VALUEMEANING>
          <MEANINGDESCRIPTION>The first part of the colon (large intestine) that starts in the right lower quadrant of the abdomen and ends at the transverse colon in the right upper quadrant of the abdomen.: The bend of the colon at the juncture of its ascending and transverse portions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12266, C12265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Artery</VALIDVALUE>
          <VALUEMEANING>Artery</VALUEMEANING>
          <MEANINGDESCRIPTION>The vessels carrying blood away from the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12372</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569764</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arm</VALIDVALUE>
          <VALUEMEANING>Arm</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aqueous Fluid</VALIDVALUE>
          <VALUEMEANING>Aqueous Fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>The clear, watery fluid which fills the anterior and posterior chambers of the eye. It has a refractive index lower than the crystalline lens, which it surrounds, and is involved in the metabolism of the cornea and the crystalline lens. (Cline et al., Dictionary of Visual Science, 4th ed, p319)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aortic Body</VALIDVALUE>
          <VALUEMEANING>Aortic Body</VALUEMEANING>
          <MEANINGDESCRIPTION>A small mass that is located in the inferior surface of the aortic arch.  It functions as a peripheral chemoreceptor and is composed of glomus cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97112</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3259520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aorta</VALIDVALUE>
          <VALUEMEANING>Aorta</VALUEMEANING>
          <MEANINGDESCRIPTION>The major arterial trunk that carries oxygenated blood from the left ventricle into the ascending aorta behind the heart, the aortic arch, through the thorax as the descending aorta and through the abdomen as the abdominal aorta; it bifurcates into the left and right common iliac arteries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anus</VALIDVALUE>
          <VALUEMEANING>Anus</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3625363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antecubital fossa</VALIDVALUE>
          <VALUEMEANING>Antecubital Fossa</VALUEMEANING>
          <MEANINGDESCRIPTION>The hinge joint between the forearm and upper arm or the corresponding joint in the forelimb of a quadruped.: A concavity in a surface, especially an anatomical depression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34007, C32497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3393979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anorectum</VALIDVALUE>
          <VALUEMEANING>Anorectum</VALUEMEANING>
          <MEANINGDESCRIPTION>(AY-nus) The opening of the rectum to the outside of the body.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12390, C37912, C43362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3393978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ankle</VALIDVALUE>
          <VALUEMEANING>Ankle</VALUEMEANING>
          <MEANINGDESCRIPTION>A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anal sphincter</VALIDVALUE>
          <VALUEMEANING>Anal Sphincter</VALUEMEANING>
          <MEANINGDESCRIPTION>The area that includes the anus and the perianal skin.: A ring-shaped muscle that relaxes or tightens to open or close a passage or opening in the body. Examples are the anal sphincter (around the opening of the anus) and the pyloric sphincter (at the lower opening of the stomach).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28381, C32069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569665</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leg</VALIDVALUE>
          <VALUEMEANING>Leg</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the two lower extremities in humans used for locomotion and support.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265473</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Laryngopharynx</VALIDVALUE>
          <VALUEMEANING>Hypopharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the pharynx that connects to the esophagus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3595986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large bowel</VALIDVALUE>
          <VALUEMEANING>Large Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>A muscular tube that extends from the end of the small intestine to the anus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lacrimal Gland</VALIDVALUE>
          <VALUEMEANING>Lacrimal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>Paired, almond-shaped exocrine glands situated superior and posterior to each orbit of the eye that produce and secrete the watery serous component of tears.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12346</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lacrimal bone</VALIDVALUE>
          <VALUEMEANING>Lacrimal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A small rectangular thin plate forming part of the medial orbit wall. It is located posterior to the frontal process of the maxilla and articulates with the inferior nasal concha, ethmoid, frontal, and maxillary bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Knee</VALIDVALUE>
          <VALUEMEANING>Knee Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint connecting the lower part of the femur with the upper part of the tibia. The lower part of the femur and the upper part of the tibia are attached to each other by ligaments. Other structures of the knee joint include the upper part of the fibula, located below and parallel to the tibia, and the patella which moves as the knee bends.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Joints</VALIDVALUE>
          <VALUEMEANING>Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>The connection point between two bones or skeletal elements. The joint may be fixed or movable.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13044</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3305580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Jejunum</VALIDVALUE>
          <VALUEMEANING>Jejunum</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the small intestine that extends from the duodenum to the ileum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Jaw</VALIDVALUE>
          <VALUEMEANING>Jaw</VALUEMEANING>
          <MEANINGDESCRIPTION>The bones of the skull that frame the mouth and serve to open it; the bones that hold the teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ischium</VALIDVALUE>
          <VALUEMEANING>Ischium</VALUEMEANING>
          <MEANINGDESCRIPTION>The most posterior and ventral bone making up the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32884</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intestine</VALIDVALUE>
          <VALUEMEANING>Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the gastrointestinal tract between the stomach and the anus. It includes the small intestine and large intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12736</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ilium</VALIDVALUE>
          <VALUEMEANING>Ilium</VALUEMEANING>
          <MEANINGDESCRIPTION>The broad, dorsal, upper, and widest of the three principal bones composing either half of the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ileum</VALIDVALUE>
          <VALUEMEANING>Ileum</VALUEMEANING>
          <MEANINGDESCRIPTION>The final section of the small intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242838</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Humerus</VALIDVALUE>
          <VALUEMEANING>Humerus</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper arm bone between the shoulder and elbow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12731</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hip</VALIDVALUE>
          <VALUEMEANING>Hip</VALUEMEANING>
          <MEANINGDESCRIPTION>The lateral prominence of the pelvis from the waist to the thigh.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hilum</VALIDVALUE>
          <VALUEMEANING>Hilum</VALUEMEANING>
          <MEANINGDESCRIPTION>A depression or fissure where vessels or nerves or ducts enter a bodily organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3243199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatic duct</VALIDVALUE>
          <VALUEMEANING>Hepatic Duct</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the three ducts associated with the liver including the right hepatic duct, left hepatic duct and common hepatic duct.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32730</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613837</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head/Neck/Chest/Abd/Pelvis</VALIDVALUE>
          <VALUEMEANING>Head Neck Chest Abdomen Pelvis Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior and superior part of a human bearing the mouth, the brain and sensory organs.: The region that connects the head to the rest of the body.: The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction.: The portion of the body that lies between the thorax and the pelvis.: The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12767, C12664, C25389, C13063, C12419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4888120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head - face or neck, NOS</VALIDVALUE>
          <VALUEMEANING>Head Face Or Neck Not Otherwise Specified Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior and superior part of a human bearing the mouth, the brain and sensory organs.: The anterior portion of the head extending from the forehead to the chin and ear to ear. The facial structures contain the eyes, nose and mouth, cheeks and jaws.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The region that connects the head to the rest of the body.: Not characterized in any other way.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C19594, C13063, C37998, C13071, C12419</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4888121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hand</VALIDVALUE>
          <VALUEMEANING>Hand</VALUEMEANING>
          <MEANINGDESCRIPTION>The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gum</VALIDVALUE>
          <VALUEMEANING>Gingiva</VALUEMEANING>
          <MEANINGDESCRIPTION>The soft tissue surrounding the neck of individual teeth as well as covering the alveolar bone. The tissue is fibrous and continuous with the periodontal ligament and mucosal covering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32677</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3491749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Groin</VALIDVALUE>
          <VALUEMEANING>Inguinal Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower region of the anterior abdominal wall located laterally to the pubic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Genitourinary</VALIDVALUE>
          <VALUEMEANING>Genitourinary</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or related to the genital and urinary organs or their functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ganglia</VALIDVALUE>
          <VALUEMEANING>Ganglion</VALUEMEANING>
          <MEANINGDESCRIPTION>A cluster of nervous tissue principally composed of neuronal cell bodies external to the central nervous system (CNS).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12719</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frontal lobe</VALIDVALUE>
          <VALUEMEANING>Frontal Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the brain located anterior to the parietal lobes at the front of each cerebral hemisphere. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Frontal bone</VALIDVALUE>
          <VALUEMEANING>Frontal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone of the skull forming the forehead, root of the nose and the roof of both orbits.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foreskin</VALIDVALUE>
          <VALUEMEANING>Male Prepuce</VALUEMEANING>
          <MEANINGDESCRIPTION>A fold of skin covering the tip of the penis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33049</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Forehead</VALIDVALUE>
          <VALUEMEANING>Forehead</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the face between the eyebrows and the normal hairline.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89803</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Forearm</VALIDVALUE>
          <VALUEMEANING>Forearm</VALUEMEANING>
          <MEANINGDESCRIPTION>The structure on the upper limb, between the elbow and the wrist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32628</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foot</VALIDVALUE>
          <VALUEMEANING>Foot</VALUEMEANING>
          <MEANINGDESCRIPTION>The structure found below the ankle joint required for locomotion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluid</VALIDVALUE>
          <VALUEMEANING>Body Fluid or Substance</VALUEMEANING>
          <MEANINGDESCRIPTION>Liquid and semi liquid substances produced by living organisms to fulfill specific functions or excreted as waste; does not include hormones or enzymes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3212369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brow</VALIDVALUE>
          <VALUEMEANING>Eyebrow</VALUEMEANING>
          <MEANINGDESCRIPTION>The arched strip of hair on the bony ridge above each eye socket.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32575</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4889212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Submandibular</VALIDVALUE>
          <VALUEMEANING>Submandibular Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two salivary glands in the neck, located in the space bound by the two bellies of the digastric muscle and the angle of the mandible. It discharges through the submandibular duct. The secretory units are predominantly serous although a few mucous alveoli, some with serous demilunes, occur. (Stedman, 25th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach</VALIDVALUE>
          <VALUEMEANING>Stomach</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Splenic lymph nodes</VALIDVALUE>
          <VALUEMEANING>Splenic Hilar Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the hilar region of the spleen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>splenic hilar</VALIDVALUE>
          <VALUEMEANING>Splenic Hilum</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the spleen through which the vessels and nerves enter or exit the organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33601</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Splenic</VALIDVALUE>
          <VALUEMEANING>Splenic Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest mass of lymphatic tissue in the body. It consists of cells and vessels contained within a capsule lined by mesothelium, from which trabecula enter the splenic parenchyma. The parenchyma is supported by a framework of reticular fibers. The spleen consists of two types of parenchymal tissue, the white and red pulp. The white pulp is composed of elongated cords of compact lymphatic tissue containing nodules. The red pulp is composed of pulp cords and splenic sinusoids.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34086</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spleen</VALIDVALUE>
          <VALUEMEANING>Spleen</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that is part of the lymphatic system. The spleen produces lymphocytes, filters the blood, stores blood cells, and destroys old blood cells. It is located on the left side of the abdomen near the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soft Tissue (muscle, ligaments, subcutaneous)</VALIDVALUE>
          <VALUEMEANING>Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2990372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small Intestine</VALIDVALUE>
          <VALUEMEANING>Small Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>The section of the intestines between the pylorus and cecum. The small intestine is approximately 20 feet long and consists of the duodenum, the jejunum, and the ileum. Its main function is to absorb nutrients from food as the food is transported to the large intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin</VALIDVALUE>
          <VALUEMEANING>Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sinus</VALIDVALUE>
          <VALUEMEANING>Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>A recess, cavity, or channel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33556</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3071180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Salivary Gland</VALIDVALUE>
          <VALUEMEANING>Salivary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>An exocrine gland that secretes saliva.  Salivary glands are mostly located in and around the oral cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12426</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retroperitoneal lymph nodes</VALIDVALUE>
          <VALUEMEANING>Retroperitoneal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the retroperitoneal space.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>retroperitoneal</VALIDVALUE>
          <VALUEMEANING>Retroperitoneal</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring in, or located in the retroperitoneum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3387892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prostate</VALIDVALUE>
          <VALUEMEANING>Prostate Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pre-auricular</VALIDVALUE>
          <VALUEMEANING>Preauricular</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the area in front of the auricle of the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103848</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>porta hepatis</VALIDVALUE>
          <VALUEMEANING>Transverse Fissure</VALUEMEANING>
          <MEANINGDESCRIPTION>A cleft or groove on the visceral surface of the liver located where the portal vein and hepatic artery enter and the hepatic ducts leave the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639606</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>porta caval</VALIDVALUE>
          <VALUEMEANING>Porta caval</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the portal vein and inferior vena cava.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103847</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Popliteal lymph nodes</VALIDVALUE>
          <VALUEMEANING>Popliteal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymph node located within the fat layer of the knee joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>popliteal</VALIDVALUE>
          <VALUEMEANING>Popliteal Fossa</VALUEMEANING>
          <MEANINGDESCRIPTION>A diamond-shaped depression located in the back of the knee joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613838</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleura/Pleural Effusion</VALIDVALUE>
          <VALUEMEANING>Pleura And/Or Pleural Effusion</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissue that lines the wall of the thoracic cavity and the surface of the lungs.: Used to indicate that either or both of two items or options may be valid.: Increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumors, connective tissue disorders, and trauma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3331, C48928, C12469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639608</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleura</VALIDVALUE>
          <VALUEMEANING>Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peripheral Blood</VALIDVALUE>
          <VALUEMEANING>Peripheral Blood</VALUEMEANING>
          <MEANINGDESCRIPTION>On or near an edge or constituting an outer boundary; the outer area.: A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25233, C12434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peri-orbital Soft Tissue</VALIDVALUE>
          <VALUEMEANING>Periorbital Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring in, or located in the area around the orbit of the eye.: Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471, C98190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pericardium</VALIDVALUE>
          <VALUEMEANING>Pericardium</VALUEMEANING>
          <MEANINGDESCRIPTION>A conical membranous sac filled with serous fluid in which the heart as well as the roots of the aorta and other large blood vessels are contained.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13005</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pectoral</VALIDVALUE>
          <VALUEMEANING>Pectoral</VALUEMEANING>
          <MEANINGDESCRIPTION>Pectoral; of or pertaining to the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parotid Gland</VALIDVALUE>
          <VALUEMEANING>Parotid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest of the three paired salivary glands, located in front of the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parotid</VALIDVALUE>
          <VALUEMEANING>Parotid Gland Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located close to, on, or within the parotid gland. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occipital lymph nodes</VALIDVALUE>
          <VALUEMEANING>Occipital Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the back of the head adjacent to the trapezius muscle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>occipital</VALIDVALUE>
          <VALUEMEANING>Occipital Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the four regions of cortex in each cerebral hemisphere. It is located posterior to the temporal lobe and inferior to the parietal lobe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Known Nodal Involvement</VALIDVALUE>
          <VALUEMEANING>No Known Nodal Involvement</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Recognized, familiar, or within the scope of knowledge.: Nodal; of or pertaining to a node, any bulge or swelling of an anatomical structure or part.: To have a connection by participation or association or use; sharing in an activity or process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25548, CL110875, C80137, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3636157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Known Extranodal Involvement</VALIDVALUE>
          <VALUEMEANING>No Known Extranodal Involvement</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Recognized, familiar, or within the scope of knowledge.: Situated outside of a node.: To have a connection by participation or association or use; sharing in an activity or process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25548, C25504, C80137, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3636173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasopharynx</VALIDVALUE>
          <VALUEMEANING>Nasopharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the pharynx in the back of the throat, at and above the soft palate. The nasopharynx is continuous with the nasal passages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal Soft Tissue</VALIDVALUE>
          <VALUEMEANING>Nasal Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>By or having to do with the nose.: Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471, C27958</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesenteric lymph nodes</VALIDVALUE>
          <VALUEMEANING>Mesenteric Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the mesentery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mesenteric</VALIDVALUE>
          <VALUEMEANING>Mesenteric</VALUEMEANING>
          <MEANINGDESCRIPTION>Mesenteric; of, or relating to, or located in a mesentery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25226</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinal Soft Tissue</VALIDVALUE>
          <VALUEMEANING>Mediastinal Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Mediastinal; related to the mediastinum.: Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471, C25310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinal lymph nodes</VALIDVALUE>
          <VALUEMEANING>Mediastinal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinal / Intra-thoracic</VALIDVALUE>
          <VALUEMEANING>Mediastinal Lymph Node And/Or Intrathoracic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent.: Used to indicate that either or both of two items or options may be valid.: Any lymph node within the thoracic cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12359, C48928, C33073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mediastinal</VALIDVALUE>
          <VALUEMEANING>Mediastinal</VALUEMEANING>
          <MEANINGDESCRIPTION>Mediastinal; related to the mediastinum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25310</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maxilla</VALIDVALUE>
          <VALUEMEANING>Maxilla</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper jawbone in vertebrates: it is fused to the cranium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568923</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mandible</VALIDVALUE>
          <VALUEMEANING>Mandible</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower jaw bone holding the lower teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>lower para-aortic</VALIDVALUE>
          <VALUEMEANING>Lower Paraaortic Region</VALUEMEANING>
          <MEANINGDESCRIPTION>Lower; the bottom one of two.: Regions near to the aorta.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25316, C25309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Leptomeninges</VALIDVALUE>
          <VALUEMEANING>Leptomeninges</VALUEMEANING>
          <MEANINGDESCRIPTION>The two innermost layers of tissue that cover the brain and spinal cord, the arachnoid mater and the pia mater.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32979</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578457</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Large Intestine</VALIDVALUE>
          <VALUEMEANING>Large Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>A muscular tube that extends from the end of the small intestine to the anus. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12379</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2873884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Kidney</VALIDVALUE>
          <VALUEMEANING>Kidney</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secret the metabolic products and minerals from the blood, thus maintaining the homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12415</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraocular</VALIDVALUE>
          <VALUEMEANING>Intraocular</VALUEMEANING>
          <MEANINGDESCRIPTION>Within the eyeball.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282263</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>inguinal/femoral/iliac</VALIDVALUE>
          <VALUEMEANING>Inguinal Region And/Or Femur And/Or Ilium</VALUEMEANING>
          <MEANINGDESCRIPTION>The external junctural region between the lower part of the abdomen and the thigh.: Used to indicate that either or both of two items or options may be valid.: The longest and largest bone of the skeleton, it is situated between the hip and the knee.: Used to indicate that either or both of two items or options may be valid.: The broad, dorsal, upper, and widest of the three principal bones composing either half of the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32765, C48928, C12717, C48928, C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>inguinal/femoral</VALIDVALUE>
          <VALUEMEANING>Inguinal Region And/Or Femur</VALUEMEANING>
          <MEANINGDESCRIPTION>The external junctural region between the lower part of the abdomen and the thigh.: Used to indicate that either or both of two items or options may be valid.: The longest and largest bone of the skeleton, it is situated between the hip and the knee.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12717, C48928, C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inguinal</VALIDVALUE>
          <VALUEMEANING>Inguinal Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower region of the anterior abdominal wall located laterally to the pubic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>infraclavicular/axillary/pectoral</VALIDVALUE>
          <VALUEMEANING>Infraclavicular Region And/Or Axillary And/Or Pectoral</VALUEMEANING>
          <MEANINGDESCRIPTION>The region below the clavicle.: Used to indicate that either or both of two items or options may be valid.: (AK-sil-air-ee) Pertaining to the armpit area, including the lymph nodes that are located there.: Used to indicate that either or both of two items or options may be valid.: Pectoral; of or pertaining to the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25611, C48928, C13351, C48928, C25268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thorax</VALIDVALUE>
          <VALUEMEANING>Thorax</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper part of the trunk between the neck and the abdomen. It contains the chief organs of the circulatory and respiratory systems. (From Stedman, 25th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12799</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thoracic/Lumbar spine</VALIDVALUE>
          <VALUEMEANING>Thoracic And Lumbar Spine</VALUEMEANING>
          <MEANINGDESCRIPTION>(thor-ASS-ik) Having to do with the chest.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Those vertebrae between the ribs and the pelvis, L1-L5 in man.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69314, C37912, C13360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thoracic vertebra</VALIDVALUE>
          <VALUEMEANING>Thoracic Vertebra</VALUEMEANING>
          <MEANINGDESCRIPTION>One of 12 vertebrae in the human vertebral column. The thoracic vertebrae are situated between the seventh cervical vertebra down to the first lumbar vertebra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thoracic spine</VALIDVALUE>
          <VALUEMEANING>Thoracic spine</VALUEMEANING>
          <MEANINGDESCRIPTION>Those vertebrae of the thoracic region, T1-T12 in man.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thigh</VALIDVALUE>
          <VALUEMEANING>Thigh</VALUEMEANING>
          <MEANINGDESCRIPTION>A part of the lower limb, located between hip and knee.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testicle</VALIDVALUE>
          <VALUEMEANING>Testicle</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the paired male reproductive glands that produce the male germ cells and the male hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tendon</VALIDVALUE>
          <VALUEMEANING>Tendon</VALUEMEANING>
          <MEANINGDESCRIPTION>A band of fibrous connective tissue that joins bone to muscle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Temporal bone</VALIDVALUE>
          <VALUEMEANING>Temporal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A large irregular bone situated at the base and side of the skull, connected with the mandible via the temporomandibular joint. The temporal bone consists of the squamous, tympanic and petrous parts. The petrous portion of the temporal bone contains the vestibulocochlear organ of the inner ear. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tarsus</VALIDVALUE>
          <VALUEMEANING>Tarsal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the seven bones forming the instep of the foot. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Zygomatic bone</VALIDVALUE>
          <VALUEMEANING>Zygomatic Buttress</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the maxillary jaw bone and other facial bones that form the most lateral mid face skeletal structure known as the cheekbone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94592</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wrist</VALIDVALUE>
          <VALUEMEANING>Wrist</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint between the distal end of the radius and the proximal row of carpal bones. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Whole body</VALIDVALUE>
          <VALUEMEANING>Body</VALUEMEANING>
          <MEANINGDESCRIPTION>The entire physical structure of an organism.  It is composed of anatomic systems, regions, cavities, and spaces.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13041</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566770</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vulva</VALIDVALUE>
          <VALUEMEANING>Vulva</VALUEMEANING>
          <MEANINGDESCRIPTION>The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vertebral column</VALIDVALUE>
          <VALUEMEANING>Vertebral Column</VALUEMEANING>
          <MEANINGDESCRIPTION>A series of bones, muscles, tendons, and other tissues reaching from the base of the skull to the tailbone. The vertebral column forms the axis of the skeleton and encloses as well as protects the spinal cord and the fluid surrounding the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vertebra</VALIDVALUE>
          <VALUEMEANING>Vertebra</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the ring-shaped bony structures that constitute the spinal column and surround the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vena Cava, Inferior/Superior</VALIDVALUE>
          <VALUEMEANING>Vena Cava</VALUEMEANING>
          <MEANINGDESCRIPTION>A large vein which returns blood from the head, neck and extremities to the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12817</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>infraclavicular</VALIDVALUE>
          <VALUEMEANING>Infraclavicular Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The region below the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iliac-external</VALIDVALUE>
          <VALUEMEANING>External Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located along the external iliac artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iliac-common</VALIDVALUE>
          <VALUEMEANING>Internal Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located along the internal iliac artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iliac</VALIDVALUE>
          <VALUEMEANING>Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the three lymph nodes of the pelvis: the superior gluteal, interior gluteal or sacral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hilar lymph nodes</VALIDVALUE>
          <VALUEMEANING>Hilar Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the hilum of the lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hilar</VALIDVALUE>
          <VALUEMEANING>Hilar</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to the area where nerves and blood vessels attach to an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25724</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heart</VALIDVALUE>
          <VALUEMEANING>Heart</VALUEMEANING>
          <MEANINGDESCRIPTION>A hollow muscular organ which receives the blood from the veins and propels it into the arteries. It is divided by a musculomembranous septum into two halves -- right or venous and left or arterial -- each of which consists of a receiving chamber (atrium) and an ejecting chamber (ventricle). SYN cor, coeur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastrointestinal / Abdominal</VALIDVALUE>
          <VALUEMEANING>Gastrointestinal And/Or Abdominal</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the stomach and intestines. : Used to indicate that either or both of two items or options may be valid.: Of, or related to, the abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25342, C48928, C13359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Femoral lymph nodes</VALIDVALUE>
          <VALUEMEANING>Femoral Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the upper inner portion of the thigh.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Femoral</VALIDVALUE>
          <VALUEMEANING>Femur</VALUEMEANING>
          <MEANINGDESCRIPTION>The longest and largest bone of the skeleton, it is situated between the hip and the knee.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremities</VALIDVALUE>
          <VALUEMEANING>Limb</VALUEMEANING>
          <MEANINGDESCRIPTION>A body region referring to an upper or lower extremity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2677356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>external/internal iliac</VALIDVALUE>
          <VALUEMEANING>External Iliac Lymph Node And/Or Internal Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located along the external iliac artery.: Used to indicate that either or both of two items or options may be valid.: A lymph node located along the internal iliac artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88142, C48928, C88143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus</VALIDVALUE>
          <VALUEMEANING>Esophagus</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>epitrochlear/brachial</VALIDVALUE>
          <VALUEMEANING>Epitrochlear Lymph Node And/Or Brachial Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located above and adjacent to the elbow.: Used to indicate that either or both of two items or options may be valid.: An axillary lymph node along the brachial vein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92221, C48928, C98182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epitrochlear lymph nodes</VALIDVALUE>
          <VALUEMEANING>Epitrochlear Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located above and adjacent to the elbow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epidural</VALIDVALUE>
          <VALUEMEANING>Epidural Spinal Canal Space</VALUEMEANING>
          <MEANINGDESCRIPTION>Space between the dura mater and the walls of the vertebral canal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41449</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2954131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epididymis</VALIDVALUE>
          <VALUEMEANING>Epididymis</VALUEMEANING>
          <MEANINGDESCRIPTION>A crescent-like structure located in the upper and posterior surfaces of the testis. It consists of the efferent ductules and the duct of the epididymis. It facilitates the maturation of sperm that is produced in the testis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gallbladder</VALIDVALUE>
          <VALUEMEANING>Gallbladder</VALUEMEANING>
          <MEANINGDESCRIPTION>A pear-shaped organ just below the liver that stores the bile secreted by the liver, delivering the bile through the bile ducts into the intestines to help with digestion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trachea</VALIDVALUE>
          <VALUEMEANING>Trachea</VALUEMEANING>
          <MEANINGDESCRIPTION>The fibrocartilaginous, mucous-lined tube passing from the larynx to the bronchi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577701</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Distant Metastasis</VALIDVALUE>
          <VALUEMEANING>Distant Metastasis</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to cancer that has spread from the original (primary) tumor to distant organs or distant lymph nodes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568046</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regional Cutaneous or Subcutaneous Tissue (includes satellite &amp; in-transit metastasis)</VALIDVALUE>
          <VALUEMEANING>Regional Cutaneous Or Subcutaneous Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Regional; limited to a particular location or area.: Having to do with the skin.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Beneath the skin.: An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12801, C13353, C37998, C13316, C25643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3426803</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Regional Lymph Node</VALIDVALUE>
          <VALUEMEANING>Regional Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node that drains lymph from a region of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3422988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Primary Tumor</VALIDVALUE>
          <VALUEMEANING>Primary Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>The original tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2971662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trunk</VALIDVALUE>
          <VALUEMEANING>Trunk</VALUEMEANING>
          <MEANINGDESCRIPTION>The body excluding the head and neck and limbs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, Specify</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3423348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brain</VALIDVALUE>
          <VALUEMEANING>Brain</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver</VALIDVALUE>
          <VALUEMEANING>Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone</VALIDVALUE>
          <VALUEMEANING>Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Connective tissue that forms the skeletal components of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lung</VALIDVALUE>
          <VALUEMEANING>Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head &amp; Neck</VALIDVALUE>
          <VALUEMEANING>Head and Neck</VALUEMEANING>
          <MEANINGDESCRIPTION>For oncology, area of the body generally construed to comprise base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12418</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2912041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremities</VALIDVALUE>
          <VALUEMEANING>Extremities</VALUEMEANING>
          <MEANINGDESCRIPTION>A body region referring to an upper or lower extremity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectosigmoid Junction</VALIDVALUE>
          <VALUEMEANING>Rectosigmoid Junction</VALUEMEANING>
          <MEANINGDESCRIPTION>An area of the body consisting of the rectum and the sigmoid colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3522962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transverse Colon</VALIDVALUE>
          <VALUEMEANING>Transverse Colon</VALUEMEANING>
          <MEANINGDESCRIPTION>The third division of the colon (large intestine). It communicates with the ascending colon in the upper right-hand quadrant of the abdomen and the descending colon in the upper left-hand quadrant.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tail of Pancreas</VALIDVALUE>
          <VALUEMEANING>Tail of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>The left extremity of the pancreas within the lienorenal ligament.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sigmoid Colon</VALIDVALUE>
          <VALUEMEANING>Sigmoid Colon</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the colon that connects to the descending colon above and the rectum below.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Splenic Flexure</VALIDVALUE>
          <VALUEMEANING>Splenic Flexure</VALUEMEANING>
          <MEANINGDESCRIPTION>The bend at the junction of the transverse and descending colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3088304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectum</VALIDVALUE>
          <VALUEMEANING>Rectum</VALUEMEANING>
          <MEANINGDESCRIPTION>The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oropharynx</VALIDVALUE>
          <VALUEMEANING>Oropharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>(or-o-FAIR-inks) The middle part of the throat that includes the soft palate, the base of the tongue, and the tonsils.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12762</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oral Tongue</VALIDVALUE>
          <VALUEMEANING>Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oral Cavity</VALIDVALUE>
          <VALUEMEANING>Oral Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The cavity lying at the upper end of the alimentary canal, bounded on the outside by the lips and inside by the oropharynx and containing in humans the tongue, gums, and teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lip</VALIDVALUE>
          <VALUEMEANING>Lip</VALUEMEANING>
          <MEANINGDESCRIPTION>Fleshy fold which surrounds the opening of the mouth. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3522963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Larynx</VALIDVALUE>
          <VALUEMEANING>Larynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The cartilaginous structure of the respiratory tract between the pharynx and the trachea. It contains elastic vocal cords required for sound production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypopharynx</VALIDVALUE>
          <VALUEMEANING>Hypopharynx (Laryngopharynx)</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the pharynx between the inferior portion of the oropharynx and the larynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatic Flexure</VALIDVALUE>
          <VALUEMEANING>Hepatic Flexure</VALUEMEANING>
          <MEANINGDESCRIPTION>The bend of the colon at the juncture of its ascending and transverse portions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12266</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head of Pancreas</VALIDVALUE>
          <VALUEMEANING>Head of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>That portion of the pancreas lying in the concavity of the duodenum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hard Palate</VALIDVALUE>
          <VALUEMEANING>Hard Palate</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony anterior part of the roof of the mouth separating the nose from the mouth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12230</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3522964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gastroesophageal Junction</VALIDVALUE>
          <VALUEMEANING>Gastroesophageal Junction</VALUEMEANING>
          <MEANINGDESCRIPTION>The anatomical location where the esophagus joins to the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131339</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fundus/Body</VALIDVALUE>
          <VALUEMEANING>Fundus, Body</VALUEMEANING>
          <MEANINGDESCRIPTION>The entire physical structure of an organism.  It is composed of anatomic systems, regions, cavities, and spaces.: The bottom portion or the portion that is furthest from the opening of a hollow organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13378, C13041</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3522965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Floor of Mouth</VALIDVALUE>
          <VALUEMEANING>Floor of Mouth</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the mouth under the ventral surface of the tongue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sacrum</VALIDVALUE>
          <VALUEMEANING>Sacrum</VALUEMEANING>
          <MEANINGDESCRIPTION>The wedge-shaped bone consisting of five fused vertebrae, S1-S5 in man, forming the posterior part of the pelvis; its base connects with the lowest lumbar vertebra and its tip with the coccyx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Round ligament</VALIDVALUE>
          <VALUEMEANING>Round Ligament</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the round ligaments including the round ligament of the liver and the round ligament of the uterus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12319</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ribs</VALIDVALUE>
          <VALUEMEANING>Ribs</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the paired bones, 12 on either side, extending from the thoracic vertebrae toward the median line on the ventral aspect of the trunk. The long curved bones which form the rib cage. Generally, ribs 1 to 7 are connected to the sternum&#39; by their costal cartilages and are called true ribs, whereas ribs 8 to 12 are termed false ribs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12782</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568925</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retro-orbital Area</VALIDVALUE>
          <VALUEMEANING>Retro-Orbital Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the body behind the orbit of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3268518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retina</VALIDVALUE>
          <VALUEMEANING>Retina</VALUEMEANING>
          <MEANINGDESCRIPTION>A light-sensitive membrane that lines the back wall of the eyeball. The retina is continuous with the optic nerve and this way transmits optical images to the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radius</VALIDVALUE>
          <VALUEMEANING>Radius Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The long bone of the forearm that extends from the lateral aspect of the elbow to the thumb-side of the wrist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pulmonary system</VALIDVALUE>
          <VALUEMEANING>Respiratory System</VALUEMEANING>
          <MEANINGDESCRIPTION>(RES-pih-ra-tor-ee) The organs that are involved in breathing. These include the nose, throat, larynx, trachea, bronchi, and lungs.Also known as the respiratory tract.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3192589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pubis</VALIDVALUE>
          <VALUEMEANING>Pubic Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two bones (left and right) that form the front of the pelvis.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Popliteal fossa</VALIDVALUE>
          <VALUEMEANING>Popliteal Fossa</VALUEMEANING>
          <MEANINGDESCRIPTION>A diamond-shaped depression located in the back of the knee joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613838</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Placenta</VALIDVALUE>
          <VALUEMEANING>Placenta</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother&#39;s immune system by excretion of neurokinin B.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3192159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pituitary gland</VALIDVALUE>
          <VALUEMEANING>Pituitary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A small, unpaired gland situated in the sella turcica tissue. It is connected to the hypothalamus by a short stalk.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pineal Gland</VALIDVALUE>
          <VALUEMEANING>Pineal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A small endocrine gland in the brain, situated beneath the back part of the corpus callosum, that secretes melatonin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pharynx</VALIDVALUE>
          <VALUEMEANING>Pharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>(FAIR-inks) The hollow tube about 5 inches long that starts behind the nose and ends at the top of the trachea (windpipe) and esophagus (the tube that goes to the stomach).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritoneum</VALIDVALUE>
          <VALUEMEANING>Peritoneum</VALUEMEANING>
          <MEANINGDESCRIPTION>(PAIR-ih-toe-NEE-um) The tissue that lines the abdominal wall and covers most of the organs in the abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritoneal cavity</VALIDVALUE>
          <VALUEMEANING>Peritoneal Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the abdomen that contains the intestines (the last part of the digestive tract), the stomach, and the liver. It is bound by thin membranes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12769</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Perianus</VALIDVALUE>
          <VALUEMEANING>Anal Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The area that includes the anus and the perianal skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Penis</VALIDVALUE>
          <VALUEMEANING>Penis</VALUEMEANING>
          <MEANINGDESCRIPTION>The male organ of urination and copulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patella</VALIDVALUE>
          <VALUEMEANING>Patella</VALUEMEANING>
          <MEANINGDESCRIPTION>A small flat triangular bone in front of the knee that articulates with the femur and protects the knee joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571145</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parietal bone</VALIDVALUE>
          <VALUEMEANING>Parietal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two cranial bones that by their union form the sides and roof of the skull.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12766</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parathyroid</VALIDVALUE>
          <VALUEMEANING>Parathyroid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two small paired endocrine glands, superior and inferior, usually found embedded in the connective tissue capsule on the posterior surface of the thyroid gland; these glands secrete parathyroid hormone that regulates the metabolism of calcium and phosphorus. The parenchyma is composed of chief and oxyphilic cells arranged in anastomosing cords.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraspinal Ganglion</VALIDVALUE>
          <VALUEMEANING>Spinal Ganglion</VALUEMEANING>
          <MEANINGDESCRIPTION>Spinal; of or relating to the spine or spinal cord.: A cluster of nervous tissue principally composed of neuronal cell bodies external to the central nervous system (CNS).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12719, C38026</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palate</VALIDVALUE>
          <VALUEMEANING>Palate</VALUEMEANING>
          <MEANINGDESCRIPTION>(PAL-et) The roof of the mouth. The front portion is bony (hard palate), and the back portion is muscular (soft palate).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PA/Lat</VALIDVALUE>
          <VALUEMEANING>Posterior Anterior Lateral Chest</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting the back surface of the body; at or near the hind end in quadrupeds or toward the spine in primates.: Denoting the front surface of the body; often used to indicate the position of one structure relative to another.: Lateral; situated at or extending to the side.: The part of the human body between the neck and the diaphragm or the corresponding part in other vertebrates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25389, C25230, C25231, C25622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3395964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Descending Colon</VALIDVALUE>
          <VALUEMEANING>Descending Colon</VALUEMEANING>
          <MEANINGDESCRIPTION>The fourth portion of the large intestine (colon) that communicates with the transverse colon in the left-upper quadrant of the abdomen and the rectum below.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cecum</VALIDVALUE>
          <VALUEMEANING>Cecum</VALUEMEANING>
          <MEANINGDESCRIPTION>A blind pouch-like commencement of the colon in the right lower quadrant of the abdomen at the end of the small intestine and the start of the large intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cardia/Proximal</VALIDVALUE>
          <VALUEMEANING>Gastric Cardia, Proximal </VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal; situated nearest to a point of attachment or origin.: The area around the esophagogastric mucosal junction where the esophageal mucosa transitions into the gastric mucosa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12256, C25236</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3212020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buccal Mucosa</VALIDVALUE>
          <VALUEMEANING>Buccal Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>The mucosal membranes located on the inside of the cheek, in the buccal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3522966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchus</VALIDVALUE>
          <VALUEMEANING>Bronchus</VALUEMEANING>
          <MEANINGDESCRIPTION>Tubular structure in continuation with the trachea, serving as air passage. It terminates in the lung (terminal bronchiole).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558344</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchial</VALIDVALUE>
          <VALUEMEANING>Bronchial</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or pertaining to, the bronchus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2966741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Body of Pancreas</VALIDVALUE>
          <VALUEMEANING>Body of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the pancreas from the point where it crosses the portal vein to the point where it enters the lienorenal ligament.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Base of tongue</VALIDVALUE>
          <VALUEMEANING>Base of the Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>The posterior one third of the tongue behind the terminal sulcus that forms the anterior aspect of the oro-pharynx responsible for swallowing and modification of the voice in speech.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ascending Colon</VALIDVALUE>
          <VALUEMEANING>Ascending Colon</VALUEMEANING>
          <MEANINGDESCRIPTION>The first part of the colon (large intestine) that starts in the right lower quadrant of the abdomen and ends at the transverse colon in the right upper quadrant of the abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12265</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antrum/Distal</VALIDVALUE>
          <VALUEMEANING>Antrum, Distal</VALUEMEANING>
          <MEANINGDESCRIPTION>Situated farthest from a point of attachment or origin, as of a limb or bone; or directed away from the midline of the body. : A chamber formation in an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97102, C25237</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3522967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alveolar Ridge</VALIDVALUE>
          <VALUEMEANING>Alveolar Ridge</VALUEMEANING>
          <MEANINGDESCRIPTION>The thickened bony structures in the mandible and maxilla that contain the sockets of the teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89749</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3491658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Conjunctiva</VALIDVALUE>
          <VALUEMEANING>Conjunctiva</VALUEMEANING>
          <MEANINGDESCRIPTION>A thin, transparent mucous membrane that covers the posterior surface of lids (palpebral conjunctiva) and the outer surface of the sclera (bulbar conjunctiva).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12341</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>common pelvic</VALIDVALUE>
          <VALUEMEANING>Common Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>Widely known or encountered; standard; of no special distinction or quality.: The structure of the vertebrate skeleton supporting the lower limbs in humans and the hind limbs or corresponding parts in other vertebrates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12767, C43461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colon</VALIDVALUE>
          <VALUEMEANING>Colon</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical lymph nodes</VALIDVALUE>
          <VALUEMEANING>Cervical Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the lymph nodes located in the neck.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cervical</VALIDVALUE>
          <VALUEMEANING>Cervical</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to a neck, or cervix, in any sense.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2966750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>celiac axis/retrocrural/upper para-aortic</VALIDVALUE>
          <VALUEMEANING>celiac axis/retrocrural/upper para-aortic</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node at the base of the celiac artery.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A lymph node located within the most inferior portion of the posterior mediastinum. (NCI): An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Higher in place or position; the topmost one of two.: A lymph node located adjacent to the lumbar region of the spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77643, C25355, C37998, C103439, C37998, C65166</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>celiac axis/retrocrural</VALIDVALUE>
          <VALUEMEANING>celiac axis/retrocrural space</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the most inferior portion of the posterior mediastinum.: A major abdominal artery that arises from the abdominal aorta below the diaphragm.  It supplies blood to the digestive organs. It has three major branches, left gastric artery, common hepatic artery, and splenic artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52846, C103846</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Breast</VALIDVALUE>
          <VALUEMEANING>Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Marrow</VALIDVALUE>
          <VALUEMEANING>Bone Marrow</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>axillary/brachial</VALIDVALUE>
          <VALUEMEANING>Axillary And/Or Brachial Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>(AK-sil-air-ee) Pertaining to the armpit area, including the lymph nodes that are located there.: Used to indicate that either or both of two items or options may be valid.: An axillary lymph node along the brachial vein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92221, C48928, C13351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axillary lymph nodes</VALIDVALUE>
          <VALUEMEANING>Axillary Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axillary</VALIDVALUE>
          <VALUEMEANING>Axillary</VALUEMEANING>
          <MEANINGDESCRIPTION>(AK-sil-air-ee) Pertaining to the armpit area, including the lymph nodes that are located there.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ascites/Peritoneum</VALIDVALUE>
          <VALUEMEANING>Ascites And/Or Peritoneum</VALUEMEANING>
          <MEANINGDESCRIPTION>Accumulation of fluid in the peritoneal cavity.  The fluid may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum. -- 2004: Used to indicate that either or both of two items or options may be valid.: The tissue that lines the wall of the abdominal cavity, intestine, and mesentery. It consists of the parietal peritoneum that covers the inside of the abdominal wall and the visceral peritoneum that covers the surface of the intestine and mesentery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12770, C48928, C2885</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenal</VALIDVALUE>
          <VALUEMEANING>Adrenal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Appendix</VALIDVALUE>
          <VALUEMEANING>Appendix</VALUEMEANING>
          <MEANINGDESCRIPTION>A small, fingerlike pouch that sticks out from the cecum (the first part of the large intestine near the end of the small intestine).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3123667</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Distant Lymph Node</VALIDVALUE>
          <VALUEMEANING>Distant Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located distant to the anatomic site of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4206839</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central Nervous System</VALIDVALUE>
          <VALUEMEANING>Central Nervous System</VALUEMEANING>
          <MEANINGDESCRIPTION>The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thoracic</VALIDVALUE>
          <VALUEMEANING>Thoracic</VALUEMEANING>
          <MEANINGDESCRIPTION>(thor-ASS-ik) Having to do with the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2966753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvis</VALIDVALUE>
          <VALUEMEANING>Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination that a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3091616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdomen</VALIDVALUE>
          <VALUEMEANING>Abdominal Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the body that lies between the thorax and the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12664</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689447</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thymus</VALIDVALUE>
          <VALUEMEANING>Thymus Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that is part of the lymphatic system, in which T lymphocytes grow and multiply. The thymus is in the chest behind the breastbone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bladder</VALIDVALUE>
          <VALUEMEANING>Bladder</VALUEMEANING>
          <MEANINGDESCRIPTION>The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12414</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior Mediastinum</VALIDVALUE>
          <VALUEMEANING>Anterior Mediastinum</VALUEMEANING>
          <MEANINGDESCRIPTION>The area between the lungs; it contains the thymus, some lymph nodes, and vessels and branches of the internal thoracic artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32098</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4575892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdomen/Pelvis</VALIDVALUE>
          <VALUEMEANING>Abdomen and Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the body that lies between the thorax and the pelvis.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The structure of the vertebrate skeleton supporting the lower limbs in humans and the hind limbs or corresponding parts in other vertebrates.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12767, C37912, C12664</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3393975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anal canal</VALIDVALUE>
          <VALUEMEANING>Anal Canal</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ampulla of Vater</VALIDVALUE>
          <VALUEMEANING>Ampulla of Vater</VALUEMEANING>
          <MEANINGDESCRIPTION>The junction of the common bile and main pancreatic ducts, which protrudes into the medial aspect of the descending duodenum at the major duodenal papilla. The flow of bile and pancreatic juices into the duodenum through the Ampulla of Vater is controlled by the sphincter of Oddi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amniotic Fluid</VALIDVALUE>
          <VALUEMEANING>Amniotic Fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>The fluid within the amniotic cavity which surrounds and protects the developing embryo.  It is initially produced by the amnion and then later by the lungs and kidneys.  The amount at term normally varies from 500 to 2000 ml.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adipose</VALIDVALUE>
          <VALUEMEANING>Adipose Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Connective tissue composed of fat cells lodged in the meshes of areolar tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574799</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adenoid</VALIDVALUE>
          <VALUEMEANING>Tonsillar Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>A fold of lymphatic tissue covered by ciliated epithelium at the very back of the nose, in the roof of the nasopharynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2761349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Acetabulum</VALIDVALUE>
          <VALUEMEANING>Acetabulum</VALUEMEANING>
          <MEANINGDESCRIPTION>Two cup shaped areas, one each on the lateral side of the lower pelvis that house the head of the femur to form the ball and socket joint of the hip.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdominal wall</VALIDVALUE>
          <VALUEMEANING>Abdominal wall</VALUEMEANING>
          <MEANINGDESCRIPTION>The tissues that surround the organs that are present within the abdominal cavity. The abdominal wall tissue is composed of layers of fat, parietal peritoneum, fascia, and muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Femoral</VALIDVALUE>
          <VALUEMEANING>Femoral Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the upper inner portion of the thigh.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284848</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Hilar</VALIDVALUE>
          <VALUEMEANING>Pulmonary Hilar Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the hilum of the lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4618073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Epitrochlear</VALIDVALUE>
          <VALUEMEANING>Epitrochlear Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located above and adjacent to the elbow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Omentum</VALIDVALUE>
          <VALUEMEANING>Omentum</VALUEMEANING>
          <MEANINGDESCRIPTION>A fold of peritoneum originating at the stomach and supporting the viscera. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oral Cavity, Mucosa only</VALIDVALUE>
          <VALUEMEANING>Oral Cavity Mucosa</VALUEMEANING>
          <MEANINGDESCRIPTION>The cavity lying at the upper end of the alimentary canal, bounded on the outside by the lips and inside by the oropharynx and containing in humans the tongue, gums, and teeth.: The moist tissue that lines some organs and body cavities (such as the nose, mouth, lungs) and makes mucus (a thick, slippery fluid).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13166, C12421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ocular Orbits</VALIDVALUE>
          <VALUEMEANING>Orbit</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa.  Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occipital bone</VALIDVALUE>
          <VALUEMEANING>Occipital Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The trapezoidal-shaped bone that forms the back and part of the base of the skull.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nerve(s) Cranial</VALIDVALUE>
          <VALUEMEANING>Cranial Nerve</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the 12 paired nerves that originate in the brain stem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12700</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2798874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nerve</VALIDVALUE>
          <VALUEMEANING>nerve</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the bundles of nerve fibers running to various organs and tissues of the body using chemical and electrical signals to transmit sensory and motor information from one body part to another.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neck/Chest/Abdomen/Pelvis</VALIDVALUE>
          <VALUEMEANING>Neck and Chest and Abdomen and Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>The region that connects the head to the rest of the body.: The part of the human body between the neck and the diaphragm or the corresponding part in other vertebrates.: The portion of the body that lies between the thorax and the pelvis.: The structure of the vertebrate skeleton supporting the lower limbs in humans and the hind limbs or corresponding parts in other vertebrates.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12767, C12664, C25389, C13063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3395963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neck/Chest</VALIDVALUE>
          <VALUEMEANING>Neck and Chest</VALUEMEANING>
          <MEANINGDESCRIPTION>The region that connects the head to the rest of the body.: The part of the human body between the neck and the diaphragm or the corresponding part in other vertebrates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25389, C13063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757726</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neck</VALIDVALUE>
          <VALUEMEANING>Neck</VALUEMEANING>
          <MEANINGDESCRIPTION>The region that connects the head to the rest of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal Cavity</VALIDVALUE>
          <VALUEMEANING>Nasal Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The proximal portion of the respiratory passages on either side of the nasal septum lying between the floor of the cranium and the roof of the mouth and extending from the face to the pharynx. The nasal cavity is lined with ciliated mucosa, extending from the nares to the pharynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3613635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal bone</VALIDVALUE>
          <VALUEMEANING>Nasal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two small oblong bones placed side by side at the middle and upper part of the face.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4204332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nails</VALIDVALUE>
          <VALUEMEANING>Nail</VALUEMEANING>
          <MEANINGDESCRIPTION>The cutaneous plate on the dorsal surface of the distal end of a finger or toe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33156</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211554</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Muscle</VALIDVALUE>
          <VALUEMEANING>Muscle</VALUEMEANING>
          <MEANINGDESCRIPTION>Muscle; one of the contractile organs of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13056</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mouth</VALIDVALUE>
          <VALUEMEANING>Oral Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The cavity lying at the upper end of the alimentary canal, bounded on the outside by the lips and inside by the oropharynx and containing in humans the tongue, gums, and teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mini Mantle</VALIDVALUE>
          <VALUEMEANING>Minimantle Radiation Field</VALUEMEANING>
          <MEANINGDESCRIPTION>A radiation field that includes the bilateral cervical, supraclavicular, and axillary lymph nodes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metatarsus</VALIDVALUE>
          <VALUEMEANING>Metatarsal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone belonging to the middle part of the foot located between toes and ankle. There are 5 metatarsal bones and they are numbered from the medial side.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metacarpus</VALIDVALUE>
          <VALUEMEANING>Metacarpal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the five bones between the wrist and the fingers that form the skeleton of the palm.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesothelium</VALIDVALUE>
          <VALUEMEANING>Mesothelium</VALUEMEANING>
          <MEANINGDESCRIPTION>A simple layer of cells, derived from the mesoderm that lines the coelom or body cavity of the embryo. In the adult, it covers all true serous membranes (peritoneum, pericardium, pleura).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33105</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mesentery</VALIDVALUE>
          <VALUEMEANING>Mesentery</VALUEMEANING>
          <MEANINGDESCRIPTION>A double layer of peritoneum that attaches to the back wall of the abdominal cavity and supports the small intestines.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinum</VALIDVALUE>
          <VALUEMEANING>Mediastinum</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of organs surrounded by loose connective tissue, separating the two pleural sacs, between the sternum anteriorly and the vertebral column posteriorly as well as from the thoracic inlet superiorly to the diaphragm inferiorly. The mediastinum contains the heart and pericardium, the bases of the great vessels, the trachea and bronchi, esophagus, thymus, lymph nodes, thoracic duct, phrenic and vagus nerves, and other structures and tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mammary Gland</VALIDVALUE>
          <VALUEMEANING>Mammary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the breast.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoma</VALIDVALUE>
          <VALUEMEANING>Lymphoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Supraclav</VALIDVALUE>
          <VALUEMEANING>Supraclavicular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node which is located above the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Submandibular</VALIDVALUE>
          <VALUEMEANING>Submandibular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located beneath the floor of the oral cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Subclavicular</VALIDVALUE>
          <VALUEMEANING>Infraclavicular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the area below the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2969629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Splenic</VALIDVALUE>
          <VALUEMEANING>Splenic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the hilar region of the spleen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s) Scalene</VALIDVALUE>
          <VALUEMEANING>Scalene Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in proximity to any of the scalene muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3395734</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Retroperitoneal</VALIDVALUE>
          <VALUEMEANING>Retroperitoneal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the retroperitoneal space.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s) Distant</VALIDVALUE>
          <VALUEMEANING>Distant Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Far apart in space from a point of origin on the body.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25321, C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2963867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Cervical</VALIDVALUE>
          <VALUEMEANING>Cervical Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the lymph nodes located in the neck.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Axilla</VALIDVALUE>
          <VALUEMEANING>Axillary Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12904</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s)</VALIDVALUE>
          <VALUEMEANING>Lymph node</VALUEMEANING>
          <MEANINGDESCRIPTION>A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lumbar vertebra</VALIDVALUE>
          <VALUEMEANING>Lumbar Vertebra</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the five bones situated between the thoracic vertebrae and the sacrum in the lower part of the spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lumbar spine</VALIDVALUE>
          <VALUEMEANING>Lumbar spine</VALUEMEANING>
          <MEANINGDESCRIPTION>Those vertebrae between the ribs and the pelvis, L1-L5 in man.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver/Spleen</VALIDVALUE>
          <VALUEMEANING>Liver And Spleen Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>A triangular-shaped organ located under the diaphragm in the right hypochondrium.  It is the largest internal organ of the body, weighting up to 2 kg.  Metabolism and bile secretion are its main functions.  It is composed of cells which have the ability to regenerate.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: An organ that is part of the lymphatic system. The spleen produces lymphocytes, filters the blood, stores blood cells, and destroys old blood cells. It is located on the left side of the abdomen near the stomach.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37912, C12392, C13717, C12432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>2, 3, 0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4888353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver and intrahepatic duct</VALIDVALUE>
          <VALUEMEANING>Liver Hepatic Duct Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>A triangular-shaped organ located under the diaphragm in the right hypochondrium.  It is the largest internal organ of the body, weighting up to 2 kg.  Metabolism and bile secretion are its main functions.  It is composed of cells which have the ability to regenerate.: Refers to the liver.: A tube that carries various secretions from one part of the body to another.: Named locations of or within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12948, C13308, C12392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4888354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ligament</VALIDVALUE>
          <VALUEMEANING>Ligament</VALUEMEANING>
          <MEANINGDESCRIPTION>Band of fibrous tissue connecting bone to bone or cartilage to bone thereby supporting or strengthening a joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skeletal Muscle</VALIDVALUE>
          <VALUEMEANING>Skeletal Muscle Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Striated muscles that are under voluntary control of the organism. They are connected at either or both ends to a bone and are utilized for locomotion and other movements. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13050</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sinus(es), Maxillary</VALIDVALUE>
          <VALUEMEANING>Maxillary Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>A pyramidal-shaped, thin-walled, air-filled cavity located in the maxilla. It is lined by mucus membrane and periosteum (mucoperiosteum) which contains cilia. It is adjacent to the nasal cavity and communicates with the middle meatus of the nose. It is the largest paranasal sinus and is composed of three recesses: alveolar, zygomatic, and infraorbital.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Shoulder</VALIDVALUE>
          <VALUEMEANING>Shoulder Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>The region of the body between the neck and the upper arm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Seminal Vesicle</VALIDVALUE>
          <VALUEMEANING>Seminal Vesicle</VALUEMEANING>
          <MEANINGDESCRIPTION>(SEM-in-al VES-ih-kulz) Glands that help produce semen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12787</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2932862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scrotum</VALIDVALUE>
          <VALUEMEANING>Scrotum</VALUEMEANING>
          <MEANINGDESCRIPTION>The musculocutaneous pouch that encloses the testicles. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scapula</VALIDVALUE>
          <VALUEMEANING>Scapula</VALUEMEANING>
          <MEANINGDESCRIPTION>The flat triangle-shaped bone that connects the humerus with the clavicle in the back of the shoulder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Scalp</VALIDVALUE>
          <VALUEMEANING>Scalp</VALUEMEANING>
          <MEANINGDESCRIPTION>The skin which covers the top of the head and which is usually covered by hair.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89807</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569920</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s) Regional</VALIDVALUE>
          <VALUEMEANING>Regional Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or belonging to a broader area or region of the body.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25643, C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2963866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Popliteal</VALIDVALUE>
          <VALUEMEANING>Popliteal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Lymph node located within the fat layer of the knee joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Periportal</VALIDVALUE>
          <VALUEMEANING>Periportal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Extending on all sides of simultaneously; encircling.: Of or pertaining to a porta, especially the porta of the liver; as, the portal vein, which enters the liver at the porta, and divides into capillaries after the manner of an artery. Portal is applied to other veins which break up into capillaries; as, the renal portal veins in the frog. (On-line Medical Dictionary): A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C38007, C52247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3526806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Pelvic</VALIDVALUE>
          <VALUEMEANING>Pelvic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Any lymph node within the pelvic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Parotid</VALIDVALUE>
          <VALUEMEANING>Parotid Gland Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located close to, on, or within the parotid gland. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Paracaval</VALIDVALUE>
          <VALUEMEANING>Paracaval Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Extending on all sides of simultaneously; encircling.: A large vein which returns blood from the head, neck and extremeties to the heart.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C12817, C52247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3526807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s) Para aortic</VALIDVALUE>
          <VALUEMEANING>Paraaortic Region Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Regions near to the aorta.: A rounded mass of lymphatic tissue that is surrounded by a capsule of connective tissue. Lymph glands filter lymph (lymphatic fluid), and they store lymphocytes (white blood cells). They are located along lymphatic vessels. Also called a lymph node.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25316, C12745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2965209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Occipital</VALIDVALUE>
          <VALUEMEANING>Occipital Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the back of the head adjacent to the trapezius muscle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Mesenteric</VALIDVALUE>
          <VALUEMEANING>Mesenteric Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the mesentery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77641</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3778534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Mediastinal</VALIDVALUE>
          <VALUEMEANING>Mediastinal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Mammary</VALIDVALUE>
          <VALUEMEANING>Mammary Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the breast.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C43595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3395732</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Int Mammary</VALIDVALUE>
          <VALUEMEANING>Internal Mammary Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the lymph nodes of the breast located under the ribcage, near the sternum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32853</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3395731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Inguinal</VALIDVALUE>
          <VALUEMEANING>Inguinal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A superficial or deep lymph node located in the inguinal area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Iliac-external</VALIDVALUE>
          <VALUEMEANING>External Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located along the external iliac artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Iliac-common</VALIDVALUE>
          <VALUEMEANING>Common Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Widely known or encountered.: One of the three lymph nodes of the pelvis: the superior gluteal, interior gluteal or sacral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32761, C43461</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3354957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph Node(s) Iliac</VALIDVALUE>
          <VALUEMEANING>Iliac Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the three lymph nodes of the pelvis: the superior gluteal, interior gluteal or sacral.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32761</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Capillary</VALIDVALUE>
          <VALUEMEANING>Capillary</VALUEMEANING>
          <MEANINGDESCRIPTION>Tiny blood vessels that connect the arterioles with the venules.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calf</VALIDVALUE>
          <VALUEMEANING>Calf</VALUEMEANING>
          <MEANINGDESCRIPTION>The posterior aspect of the lower extremity that extends from the knee to the foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Calcaneus</VALIDVALUE>
          <VALUEMEANING>Calcaneum</VALUEMEANING>
          <MEANINGDESCRIPTION>The irregular and largest tarsal bone that forms the heel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4199816</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buttock</VALIDVALUE>
          <VALUEMEANING>Buttock</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the fleshy mounds in the rear pelvic area of the human body formed by the gluteal muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Buccal cavity</VALIDVALUE>
          <VALUEMEANING>Buccal Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchus and Lung</VALIDVALUE>
          <VALUEMEANING>Bronchus And Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>Tubular structure in continuation with the trachea, serving as air passage. It terminates in the lung (terminal bronchiole).: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13717, C12468, C37912, C12683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchiole</VALIDVALUE>
          <VALUEMEANING>Bronchiole</VALUEMEANING>
          <MEANINGDESCRIPTION>(BRON-kee-olz) The tiny branches of air tubes in the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571106</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Broad ligament</VALIDVALUE>
          <VALUEMEANING>Broad Ligament</VALUEMEANING>
          <MEANINGDESCRIPTION>A broad fold of peritoneum that extends from the side of the uterus to the wall of the pelvis. (MeSH)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brain stem</VALIDVALUE>
          <VALUEMEANING>Brain Stem</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the brain that is connected to the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Throat</VALIDVALUE>
          <VALUEMEANING>Throat</VALUEMEANING>
          <MEANINGDESCRIPTION>The narrow passage from the mouth to the cavity at the back of the mouth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pylorus</VALIDVALUE>
          <VALUEMEANING>Pylorus</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the stomach that connects to the duodenum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebrum</VALIDVALUE>
          <VALUEMEANING>Cerebral Hemisphere</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the brain that controls muscle functions and also controls speech, thought, emotions, reading, writing, and learning. The right hemisphere controls the muscles on the left side of the body, and the left hemisphere controls the muscles on the right side of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebrospinal fluid</VALIDVALUE>
          <VALUEMEANING>Cerebrospinal fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567374</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebral cortex</VALIDVALUE>
          <VALUEMEANING>Cerebral Cortex</VALUEMEANING>
          <MEANINGDESCRIPTION>The outer layer of the cerebrum composed of neurons and unmyelinated nerve fibers.  It is responsible for memory, attention, consciousness and other high mental functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12443</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3134756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cerebellum</VALIDVALUE>
          <VALUEMEANING>Cerebellum</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the brain located at the base of the skull that is responsible for balance, equilibrium and movement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566001</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central Line Catheter</VALIDVALUE>
          <VALUEMEANING>Central Venous Access Catheter</VALUEMEANING>
          <MEANINGDESCRIPTION>A venous catheter positioned with the tip in the proximal third of the superior vena cava, the right atrium, or the inferior vena cava.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17612</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394019</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cartilage</VALIDVALUE>
          <VALUEMEANING>Cartilage</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of connective tissue composed of chondrocytes and an extracellular matrix, composed of collagen, elastin, and ground substance. There are three types of cartilage; namely elastic, hyaline, and fibrocartilage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12373</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carpus</VALIDVALUE>
          <VALUEMEANING>Carpal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>The eight bones of the wrist: capitate bone, hamate bone, lunate bone (SEMILUNAR BONE), pisiform bone, SCAPHOID BONE, trapezium bone, trapezoid bone and triquetral bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4199815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carotid body</VALIDVALUE>
          <VALUEMEANING>Carotid Body</VALUEMEANING>
          <MEANINGDESCRIPTION>A cluster of cells that function as chemo-receptors, located at the bifurcation of the carotid artery. Its main purpose is to detect changes in the composition of arterial blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carotid artery</VALIDVALUE>
          <VALUEMEANING>Carotid Artery</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carina</VALIDVALUE>
          <VALUEMEANING>Carina</VALUEMEANING>
          <MEANINGDESCRIPTION>A ridge or ridge-like structure.  In humans it usually refers to the trachea.  The carina of trachea is part of the lowest tracheal cartilage which is placed between the orifices of the two bronchi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3394021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>paratracheal</VALIDVALUE>
          <VALUEMEANING>Paratracheal</VALUEMEANING>
          <MEANINGDESCRIPTION>Regions near to the trachea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25317</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extra-adrenal Site</VALIDVALUE>
          <VALUEMEANING>Extra-Adrenal</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to tissues outside the adrenal gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4132071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paraaortic lymph nodes</VALIDVALUE>
          <VALUEMEANING>Paraaortic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located adjacent to the lumbar region of the spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>para-aortic</VALIDVALUE>
          <VALUEMEANING>Paraaortic</VALUEMEANING>
          <MEANINGDESCRIPTION>Regions near to the aorta.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreas</VALIDVALUE>
          <VALUEMEANING>Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-encapsulated elongated and lobulated organ, extending from the concavity of the duodenum to the spleen; it consists of a head, an elongated body, and a tail. It contains two functional components: an exocrine component that secretes juices into the intestine and an endocrine component that secretes hormones (insulin and glucagon).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ovary</VALIDVALUE>
          <VALUEMEANING>Ovary</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the paired female reproductive glands containing the ova or germ cells; the ovary&#39;s stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova; surrounding this stroma is a more condensed layer of stroma called the tunica albuginea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574083</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other Nodal</VALIDVALUE>
          <VALUEMEANING>Other Nodal</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Nodal; of or pertaining to a node, any bulge or swelling of an anatomical structure or part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25323, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other Extranodal Site</VALIDVALUE>
          <VALUEMEANING>Other Extranodal Anatomic Site</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Situated outside of a node.: Named locations of, or within, the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25504, C13717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>2, 1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3282256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>orbital</VALIDVALUE>
          <VALUEMEANING>Orbital Ridge</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony elevation located beneath the eyebrow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82953</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Orbit</VALIDVALUE>
          <VALUEMEANING>Orbit</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa.  Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>waldeyer&#39;s ring</VALIDVALUE>
          <VALUEMEANING>Waldeyer&#39;s Tonsillar Ring</VALUEMEANING>
          <MEANINGDESCRIPTION>The ring of lymphoid tissue located in the pharynx, consisting of the pharyngeal, tubal, palatine, and lingual tonsils.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73468</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uterus</VALIDVALUE>
          <VALUEMEANING>Uterus</VALUEMEANING>
          <MEANINGDESCRIPTION>A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>upper para-aortic</VALIDVALUE>
          <VALUEMEANING>Upper Paraaortic Region</VALUEMEANING>
          <MEANINGDESCRIPTION>Higher in place or position; the topmost one of two.: Regions near to the aorta.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25316, C25355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3639598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroid</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testes</VALIDVALUE>
          <VALUEMEANING>Testis</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the paired male reproductive glands that produce the male germ cells and the male hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567251</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Supraclavicular lymph nodes</VALIDVALUE>
          <VALUEMEANING>Supraclavicular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node which is located above the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3284855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>supraclavicular</VALIDVALUE>
          <VALUEMEANING>Supraclavicular</VALUEMEANING>
          <MEANINGDESCRIPTION>Supraclavicular; positioned above the clavicle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Submandibular lymph nodes</VALIDVALUE>
          <VALUEMEANING>Submandibular Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located beneath the floor of the oral cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3280100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vein</VALIDVALUE>
          <VALUEMEANING>Vein</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood vessel that carries blood toward the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2757727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vas Deferens</VALIDVALUE>
          <VALUEMEANING>Vas Deferens</VALUEMEANING>
          <MEANINGDESCRIPTION>Duct carrying spermatozoa.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vagina</VALIDVALUE>
          <VALUEMEANING>Vagina</VALUEMEANING>
          <MEANINGDESCRIPTION>The female genital canal, extending from the uterus to the vulva.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uvula</VALIDVALUE>
          <VALUEMEANING>Uvula</VALUEMEANING>
          <MEANINGDESCRIPTION>The fleshy lobe that hangs at the back of the soft palate.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary tract</VALIDVALUE>
          <VALUEMEANING>Urinary System</VALUEMEANING>
          <MEANINGDESCRIPTION>The organs of the body that produce and discharge urine. These include the kidneys, ureters, bladder, and urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urethra</VALIDVALUE>
          <VALUEMEANING>Urethra</VALUEMEANING>
          <MEANINGDESCRIPTION>(yoo-REE-thra) The tube through which urine leaves the body. It empties urine from the bladder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3181637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ureter</VALIDVALUE>
          <VALUEMEANING>Ureter</VALUEMEANING>
          <MEANINGDESCRIPTION>The thick-walled tube that carries urine from each kidney to the bladder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Upper extremity</VALIDVALUE>
          <VALUEMEANING>Upper Extremity</VALUEMEANING>
          <MEANINGDESCRIPTION>The region of the body that includes the arm, the forearm, and hand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12671</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Umbilical Cord</VALIDVALUE>
          <VALUEMEANING>Umbilical Cord</VALUEMEANING>
          <MEANINGDESCRIPTION>Extraembryonic structure that connects the fetus to the placenta. It contains two arteries and one vein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34320</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ulna</VALIDVALUE>
          <VALUEMEANING>Ulna</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the bones that comprise the forearm. The largest aspect articulates with the humerus at the elbow joint and the smallest portion of the ulna articulates with the carpal bones in the wrist.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trunk, Superficial</VALIDVALUE>
          <VALUEMEANING>Superficial Trunk</VALUEMEANING>
          <MEANINGDESCRIPTION>Of little substance or significance; involving only a surface.: The body excluding the head and neck and limbs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33816, C25239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trachea/Major Bronchi</VALIDVALUE>
          <VALUEMEANING>Trachea and Main Bronchus</VALUEMEANING>
          <MEANINGDESCRIPTION>The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi.: The left and right main bronchi considered as a group.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12284, C12428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tonsil, Pharyngeal</VALIDVALUE>
          <VALUEMEANING>Tonsillar Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>A fold of lymphatic tissue covered by ciliated epithelium at the very back of the nose, in the roof of the nasopharynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2761349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tonsil</VALIDVALUE>
          <VALUEMEANING>Tonsil</VALUEMEANING>
          <MEANINGDESCRIPTION>The two organs situated in the throat on either side of the narrow passage from the mouth to the pharynx. They are composed of lymphoid tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12802</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tongue, Base of tongue</VALIDVALUE>
          <VALUEMEANING>Base of the Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>The posterior one third of the tongue behind the terminal sulcus that forms the anterior aspect of the oro-pharynx responsible for swallowing and modification of the voice in speech.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tongue</VALIDVALUE>
          <VALUEMEANING>Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Toe</VALIDVALUE>
          <VALUEMEANING>Toes (Phalanges)</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the terminal digits of the foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33788</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4207651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tibia</VALIDVALUE>
          <VALUEMEANING>Tibia</VALUEMEANING>
          <MEANINGDESCRIPTION>The second longest bone of the skeleton. It is located on the medial side of the lower leg, articulating with the FIBULA laterally, the TALUS distally, and the FEMUR proximally.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thyroid gland</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>(THIGH-royd) A gland located beneath the voice box (larynx) that produces thyroid hormone. The thyroid helps regulate growth and metabolism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenal gland</VALIDVALUE>
          <VALUEMEANING>Adrenal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3638642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oropharyngeal Soft Tissue</VALIDVALUE>
          <VALUEMEANING>Oropharyngeal Tissue Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Tissue that occupies the area between the soft palate and upper portion of the epiglottis.: Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471, C92600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5727044</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s) non-regional</VALIDVALUE>
          <VALUEMEANING>Lymph node(s), non-regional</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Of or belonging to a broader area or region of the body.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C25643, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6065880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node (not mediastinum)</VALIDVALUE>
          <VALUEMEANING>Not Mediastinum Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: A group of organs surrounded by loose connective tissue, separating the two pleural sacs, between the sternum anteriorly and the vertebral column posteriorly as well as from the thoracic inlet superiorly to the diaphragm inferiorly. The mediastinum contains the heart and pericardium, the bases of the great vessels, the trachea and bronchi, esophagus, thymus, lymph nodes, thoracic duct, phrenic and vagus nerves, and other structures and tissues.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C12748, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5981833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Renal pelvis</VALIDVALUE>
          <VALUEMEANING>Renal Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>The area at the center of the kidney. Urine collects here and is funneled into the ureter, the tube that connects the kidney to the bladder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3138163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peripheral nerves and autonomic nervous system of trunk</VALIDVALUE>
          <VALUEMEANING>Peripheral Nerve And Autonomic Nervous System Trunk</VALUEMEANING>
          <MEANINGDESCRIPTION>Any nerve outside the brain or spinal cord that connects with peripheral receptors or effectors. (NCI): An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The part of the nervous system of vertebrates that controls involuntary actions of the smooth muscles and heart and glands.: The body excluding the head and neck and limbs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33816, C12673, C37912, C12768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6127499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other ill-defined sites</VALIDVALUE>
          <VALUEMEANING>Other Ill-defined Site</VALUEMEANING>
          <MEANINGDESCRIPTION>An anatomic site that is not specified or defined well enough to associate with a specific site.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C147919</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6127500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Meninges</VALIDVALUE>
          <VALUEMEANING>Meninges</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of three membranes that surround the brain and spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Male genital organs</VALIDVALUE>
          <VALUEMEANING>Male Genitalia</VALUEMEANING>
          <MEANINGDESCRIPTION>The external male sexual organs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6127501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Accessory sinus</VALIDVALUE>
          <VALUEMEANING>Paranasal Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the air-filled spaces within the ethmoid, frontal, maxillary, or sphenoid bones, which communicate with the nasal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ascites</VALIDVALUE>
          <VALUEMEANING>Ascites</VALUEMEANING>
          <MEANINGDESCRIPTION>The accumulation of fluid in the peritoneal cavity, which may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2885</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5446318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extrahepatic Bile Duct</VALIDVALUE>
          <VALUEMEANING>Extrahepatic Bile Duct</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the biliary tract outside the liver; the common hepatic duct joins the cystic duct to form the common bile duct.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleural nodules</VALIDVALUE>
          <VALUEMEANING>Pleural Nodule</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the pleura.: A small lump, swelling or collection of tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3280, C25223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6161750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pleural effusion</VALIDVALUE>
          <VALUEMEANING>Pleural Effusion</VALUEMEANING>
          <MEANINGDESCRIPTION>Increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumors, connective tissue disorders, and trauma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3331</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4264940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritoneal nodes</VALIDVALUE>
          <VALUEMEANING>Peritoneal Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located in the peritoneum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6659691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intrahepatic Bile Duct</VALIDVALUE>
          <VALUEMEANING>Intrahepatic Bile Duct</VALUEMEANING>
          <MEANINGDESCRIPTION>The bile ducts that pass through and drain bile from the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12677</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-03-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3691244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left tubo-ovarian</VALIDVALUE>
          <VALUEMEANING>Left Tubo-Ovarian</VALUEMEANING>
          <MEANINGDESCRIPTION>A term that implies the left fallopian tube and left ovary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right tubo-ovarian</VALIDVALUE>
          <VALUEMEANING>Right Tubo-Ovarian</VALUEMEANING>
          <MEANINGDESCRIPTION>A term that implies the right fallopian tube and right ovary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left fallopian tube</VALIDVALUE>
          <VALUEMEANING>Left Fallopian Tube</VALUEMEANING>
          <MEANINGDESCRIPTION>The fallopian tube that extends from the uterus to the ovary in the left side of the pelvic cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6692814</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right fallopian tube</VALIDVALUE>
          <VALUEMEANING>Right Fallopian Tube</VALUEMEANING>
          <MEANINGDESCRIPTION>The fallopian tube that extends from the uterus to the ovary in the right side of the pelvic cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left ovary</VALIDVALUE>
          <VALUEMEANING>Left Ovary</VALUEMEANING>
          <MEANINGDESCRIPTION>The ovary that is located in the left side of the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right ovary</VALIDVALUE>
          <VALUEMEANING>Right Ovary</VALUEMEANING>
          <MEANINGDESCRIPTION>The ovary that is located in the right side of the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin/subcutaneous</VALIDVALUE>
          <VALUEMEANING>Subcutaneous Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>Beneath the skin.: An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13353, C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429927</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Head and neck (non-PM)</VALIDVALUE>
          <VALUEMEANING>Negation Parameningeal Head and Neck</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Of, or related to, the structures proximal to meninges.: For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12418, C93030, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5983505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left lower lobe lung</VALIDVALUE>
          <VALUEMEANING>Lower Lobe of the Left Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>The larger lobe of the left lung, situated below and behind the oblique fissure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33020</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139462</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left upper lobe lung</VALIDVALUE>
          <VALUEMEANING>Upper Lobe of the Left Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>The smaller lobe of the left lung, situated above and in front the oblique fissure, which includes the apex.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33021</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right lower lobe lung</VALIDVALUE>
          <VALUEMEANING>Lower Lobe of the Right Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>The lobe of the right lung situated below the oblique fissure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33022</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right middle lobe lung</VALIDVALUE>
          <VALUEMEANING>Middle Lobe of the Right Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest lobe of the right lung, situated above the oblique fissure and below the horizontal fissure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right upper lobe lung</VALIDVALUE>
          <VALUEMEANING>Upper Lobe of the Right Lung</VALUEMEANING>
          <MEANINGDESCRIPTION>The lobe of the right lung, situated above the horizontal fissure, which includes the apex.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33023</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left breast</VALIDVALUE>
          <VALUEMEANING>Left Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>The hemispheric projection, including the mammary gland, located on the anterior portion of the chest, lateral to the midline, on the side of the body to the west when facing north.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2969601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right breast</VALIDVALUE>
          <VALUEMEANING>Right Breast</VALUEMEANING>
          <MEANINGDESCRIPTION>The hemispheric projection, including the mammary gland, located on the anterior portion of the chest, lateral to the midline, on the side of the body to the east when facing north.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47856</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ileocecal valve</VALIDVALUE>
          <VALUEMEANING>Ileocecal Valve</VALUEMEANING>
          <MEANINGDESCRIPTION>The valve between the ileum of the small intestine and the cecum of the large intestine.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13066</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242757</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soft tissue</VALIDVALUE>
          <VALUEMEANING>Soft Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2990372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CNS</VALIDVALUE>
          <VALUEMEANING>Central Nervous System</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the nervous system that consists of the brain, spinal cord, and meninges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5343369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Testis</VALIDVALUE>
          <VALUEMEANING>Testis</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the paired male reproductive glands that produce the male germ cells and the male hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2873868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retroperitoneum</VALIDVALUE>
          <VALUEMEANING>Retroperitoneum</VALUEMEANING>
          <MEANINGDESCRIPTION>The back of the abdomen where the kidneys lie and the great blood vessels run.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parameningeal</VALIDVALUE>
          <VALUEMEANING>Parameningeal</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or related to, the structures proximal to the meninges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3155931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Limb</VALIDVALUE>
          <VALUEMEANING>Limb</VALUEMEANING>
          <MEANINGDESCRIPTION>A body region referring to an upper or lower extremity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2677356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biliary tract/liver</VALIDVALUE>
          <VALUEMEANING>Biliary Tract Or Liver</VALUEMEANING>
          <MEANINGDESCRIPTION>The system that transports bile from the hepatocytes in the liver to the small intestine. It is comprised of the intrahepatic bile ducts, hepatic ducts, common bile duct, cystic duct, and the gallbladder.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392, C37998, C12678</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5983504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatic tail</VALIDVALUE>
          <VALUEMEANING>Tail of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>The left extremity of the pancreas within the lienorenal ligament.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4742916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatic body</VALIDVALUE>
          <VALUEMEANING>Body of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the pancreas from the point where it crosses the portal vein to the point where it enters the lienorenal ligament.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4742914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pancreatic head</VALIDVALUE>
          <VALUEMEANING>Head of the Pancreas</VALUEMEANING>
          <MEANINGDESCRIPTION>That portion of the pancreas lying in the concavity of the duodenum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4742915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus - distal third</VALIDVALUE>
          <VALUEMEANING>Lower Third of the Esophagus</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower one third of the esophagus in which the muscle layer is composed of muscle cells predominantly of the smooth type.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12255</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4419327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus - middle third</VALIDVALUE>
          <VALUEMEANING>Middle Third of the Esophagus</VALUEMEANING>
          <MEANINGDESCRIPTION>The middle one third of the esophagus in which the muscle layer is composed of muscle cells of the striated and smooth types.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12254</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Esophagus - proximal third</VALIDVALUE>
          <VALUEMEANING>Upper Third of the Esophagus</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper one third of esophagus in which the muscle layer is composed of muscle cells of the striated type.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peritoneal surfaces</VALIDVALUE>
          <VALUEMEANING>Peritoneal surface</VALUEMEANING>
          <MEANINGDESCRIPTION>The outer layer of the serous membrane that lines the abdominal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-regional/distant lymph nodes</VALIDVALUE>
          <VALUEMEANING>Negation Regional Or Distant Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Of or belonging to a broader area or region of the body.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A lymph node located distant to the anatomic site of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106042, C37998, C25643, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6816254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stomach (NOS)</VALIDVALUE>
          <VALUEMEANING>Stomach, Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: An organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12391, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3684610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fundus</VALIDVALUE>
          <VALUEMEANING>Fundus</VALUEMEANING>
          <MEANINGDESCRIPTION>The bottom portion or the portion that is furthest from the opening of a hollow organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Body</VALIDVALUE>
          <VALUEMEANING>Body</VALUEMEANING>
          <MEANINGDESCRIPTION>The entire physical structure of an organism.  It is composed of anatomic systems, regions, cavities, and spaces.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13041</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566770</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antrum</VALIDVALUE>
          <VALUEMEANING>Antrum</VALUEMEANING>
          <MEANINGDESCRIPTION>A chamber formation in an organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parotid gland, superficial lobe</VALIDVALUE>
          <VALUEMEANING>Parotid Gland Superficial Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the parotid gland that is superficial to the facial vein and facial nerve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal vestibule</VALIDVALUE>
          <VALUEMEANING>Nasal Vestibule</VALUEMEANING>
          <MEANINGDESCRIPTION>The most anterior part of the nasal cavity, lined by squamous epithelium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160989</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal lateral wall</VALIDVALUE>
          <VALUEMEANING>Lateral Wall of the Nose</VALUEMEANING>
          <MEANINGDESCRIPTION>The outside wall of the nasal passages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160988</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glottis, with subglottic extension</VALIDVALUE>
          <VALUEMEANING>Glottic Laryngeal Tumor with Subgolttic Extension</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of glottic involvement from a laryngeal tumor with extension of the tumor into the subglottis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161004</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arytenoid(s)</VALIDVALUE>
          <VALUEMEANING>Arytenoid Cartilage</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of a pair of small pyramidal laryngeal cartilages that articulate with the lamina of the cricoid cartilage and give attachment to the posterior part of the corresponding vocal ligament and to several muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32148</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aryepiglottic folds</VALIDVALUE>
          <VALUEMEANING>Aryepiglottic Fold</VALUEMEANING>
          <MEANINGDESCRIPTION>A membranous fold extending between the arytenoid cartilage and the epiglottis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32147</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epiglottis, laryngeal aspect</VALIDVALUE>
          <VALUEMEANING>Laryngeal Surface of the Epiglottis</VALUEMEANING>
          <MEANINGDESCRIPTION>The surface of the epiglottis that is oriented toward the larynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160979</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alveolar process, mandibular</VALIDVALUE>
          <VALUEMEANING>Mandibular Alveolar Process</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the mandible that contains the sockets of the teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alveolar process, maxillary</VALIDVALUE>
          <VALUEMEANING>Maxillary Alveolar Process</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the maxilla that contains the sockets of the teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160973</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vestibule of mouth, mandibular</VALIDVALUE>
          <VALUEMEANING>Mandibular Vestibule of the Mouth</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the mouth between the cheeks and the teeth of the mandible.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vestibule of mouth, maxillary</VALIDVALUE>
          <VALUEMEANING>Maxillary Vestibule of the Mouth</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the mouth between the cheeks and the teeth of the maxilla.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lateral border of tongue</VALIDVALUE>
          <VALUEMEANING>Lateral Surface of the Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>The side of the tongue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C160983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6785170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenal gland, ipsilateral</VALIDVALUE>
          <VALUEMEANING>Ipsilateral Adrenal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the same side of the body.: A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12666, C25308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6789069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adrenal gland, contralateral</VALIDVALUE>
          <VALUEMEANING>Contralateral Adrenal Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>On or relating to the opposite side of the body.: A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12666, C25307</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6789070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Minor gland(s)</VALIDVALUE>
          <VALUEMEANING>Minor Salivary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A small salivary gland located in the oral cavity.  It produces saliva.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sublingual gland</VALIDVALUE>
          <VALUEMEANING>Sublingual Salivary Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>A salivary gland located under the tongue in the floor of the oral cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Submandibular gland</VALIDVALUE>
          <VALUEMEANING>Submandibular Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two salivary glands in the neck, located in the space bound by the two bellies of the digastric muscle and the angle of the mandible. It discharges through the submandibular duct. The secretory units are predominantly serous although a few mucous alveoli, some with serous demilunes, occur. (Stedman, 25th ed)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parotid gland, total</VALIDVALUE>
          <VALUEMEANING>Parotid Gland</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest of the three paired salivary glands, located in front of the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parotid gland, deep lobe</VALIDVALUE>
          <VALUEMEANING>Parotid Gland Deep Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the parotid gland parenchyma lying deep to the facial nerve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96176</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paranasal sinus(es), sphenoid</VALIDVALUE>
          <VALUEMEANING>Sphenoid Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the paired paranasal sinuses, located in the anterior part of the body of the sphenoid bone and communicating with the superior meatus of the nasal cavity on the same side.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3698219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paranasal sinus(es), maxillary</VALIDVALUE>
          <VALUEMEANING>Maxillary Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>A pyramidal-shaped, thin-walled, air-filled cavity located in the maxilla. It is lined by mucus membrane and periosteum (mucoperiosteum) which contains cilia. It is adjacent to the nasal cavity and communicates with the middle meatus of the nose. It is the largest paranasal sinus and is composed of three recesses: alveolar, zygomatic, and infraorbital.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12275</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3396652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paranasal sinus(es), frontal</VALIDVALUE>
          <VALUEMEANING>Frontal Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>The paired, mucosal lined air spaces located above the orbit and communicating with the nasal passages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paranasal sinus(es), ethmoid</VALIDVALUE>
          <VALUEMEANING>Ethmoid Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>A sinus of the meatuses of the nasal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12276</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal cavity, NOS</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified Nasal Cavity</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.: The proximal portion of the respiratory passages on either side of the nasal septum lying between the floor of the cranium and the roof of the mouth and extending from the face to the pharynx. The nasal cavity is lined with ciliated mucosa, extending from the nares to the pharynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12424, C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal floor</VALIDVALUE>
          <VALUEMEANING>Nasal Cavity Floor</VALUEMEANING>
          <MEANINGDESCRIPTION>The proximal portion of the respiratory passages on either side of the nasal septum lying between the floor of the cranium and the roof of the mouth and extending from the face to the pharynx. The nasal cavity is lined with ciliated mucosa, extending from the nares to the pharynx.: The lower inner surface of an open space or hollow organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66795, C12424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasal septum</VALIDVALUE>
          <VALUEMEANING>Nasal Septum</VALUEMEANING>
          <MEANINGDESCRIPTION>The thin wall between the two nasal cavities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6403391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other (specify)</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Subglottis</VALIDVALUE>
          <VALUEMEANING>Subglottis</VALUEMEANING>
          <MEANINGDESCRIPTION>The area of the larynx below the vocal cords down to the trachea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3698216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Posterior commissure</VALIDVALUE>
          <VALUEMEANING>Posterior Commissure</VALUEMEANING>
          <MEANINGDESCRIPTION>A small fasciculus that decussates in the inferior pineal lamina in the midbrain, and is the junctional landmark between the diencephalon and the mesencephalon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior commissure</VALIDVALUE>
          <VALUEMEANING>Anterior Commissure</VALUEMEANING>
          <MEANINGDESCRIPTION>A rounded band or bundle of nerve fibers that connects the two hemispheres of the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32086</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>True vocal cord</VALIDVALUE>
          <VALUEMEANING>True Vocal Cord</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower pair of vocal folds located below the glottis, which are the primary source of phonation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33815</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Larynx ventricle</VALIDVALUE>
          <VALUEMEANING>Laryngeal Ventricle</VALUEMEANING>
          <MEANINGDESCRIPTION>A fusiform fossa on the lateral sides of the larynx between the inferior and superior vocal cords.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32935</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>False vocal cord</VALIDVALUE>
          <VALUEMEANING>False Vocal Cord</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two folds of a mucous membrane spanning the larynx. The two folds aid in breathing and preventing regurgitation to a greater extent than producing sounds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5566348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Epiglottis, lingual aspect</VALIDVALUE>
          <VALUEMEANING>Anterior Surface of the Epiglottis</VALUEMEANING>
          <MEANINGDESCRIPTION>The lingual or upper surface of the epiglottis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pharyngeal wall (posterior and/or lateral)</VALIDVALUE>
          <VALUEMEANING>Posterior Wall of the Pharynx And/Or Lateral Wall of the Pharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The dorsal portion of the fibromuscular tube that extends from the skull base to the lower border of the cricoid cartilage, and acts as a conduit for both the digestive and respiratory systems.: Used to indicate that either or both of two items or options may be valid.: The walls on either side of the swallowing passage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C129817, C48928, C54222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Postcricoid</VALIDVALUE>
          <VALUEMEANING>Postcricoid region</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the hypopharynx that is located posteriorly to the larynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3698171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Piriform sinus</VALIDVALUE>
          <VALUEMEANING>Pyriform Sinus</VALUEMEANING>
          <MEANINGDESCRIPTION>A pear-shaped fossa in the wall of the laryngeal pharynx lateral to the arytenoid cartilage and medial to the lamina of the thyroid cartilage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nasopharyngeal tonsils (adenoids)</VALIDVALUE>
          <VALUEMEANING>Tonsillar Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>A fold of lymphatic tissue covered by ciliated epithelium at the very back of the nose, in the roof of the nasopharynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2761349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pharyngeal wall (posterior)</VALIDVALUE>
          <VALUEMEANING>Posterior Wall of the Pharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>The dorsal portion of the fibromuscular tube that extends from the skull base to the lower border of the cricoid cartilage, and acts as a conduit for both the digestive and respiratory systems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Soft palate</VALIDVALUE>
          <VALUEMEANING>Soft Palate</VALUEMEANING>
          <MEANINGDESCRIPTION>A movable fold suspended from the posterior border of the hard palate. (MeSH)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3400913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Base of tongue, including lingual tonsil</VALIDVALUE>
          <VALUEMEANING>Base of the Tongue Include Lingual Tonsil</VALUEMEANING>
          <MEANINGDESCRIPTION>The posterior one third of the tongue behind the terminal sulcus that forms the anterior aspect of the oro-pharynx responsible for swallowing and modification of the voice in speech.: Add as part of something else; put in as part of a set, group, or category.: The lymphoid follicles on the dorsal surface in the posterior region of the tongue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32988, C74521, C12228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palatine tonsil</VALIDVALUE>
          <VALUEMEANING>Palatine Tonsil</VALUEMEANING>
          <MEANINGDESCRIPTION>Two masses of lymphatic tissue located one on either side of the oropharynx in the oropharyngeal isthmus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s), regional</VALIDVALUE>
          <VALUEMEANING>Regional Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node that drains lymph from a region of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3422988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymph node(s), non-regional</VALIDVALUE>
          <VALUEMEANING>Negation Local-Regional Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Of or belonging to both a local and regional area of the body.: A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12745, C25388, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776235</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Retromolar area</VALIDVALUE>
          <VALUEMEANING>Retromolar Trigone</VALUEMEANING>
          <MEANINGDESCRIPTION>The small area behind the wisdom teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3698194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior floor of mouth</VALIDVALUE>
          <VALUEMEANING>Anterior Floor of Mouth</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting the front surface of the body; often used to indicate the position of one structure relative to another.: The area of the mouth under the ventral surface of the tongue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54187, C25231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>External upper lip</VALIDVALUE>
          <VALUEMEANING>External Upper Lip</VALUEMEANING>
          <MEANINGDESCRIPTION>The external surface of the upper lip.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lower gingiva</VALIDVALUE>
          <VALUEMEANING>Lower Gingiva</VALUEMEANING>
          <MEANINGDESCRIPTION>The gingiva covering the mandibular alveolar bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Upper gingiva</VALIDVALUE>
          <VALUEMEANING>Upper Gingiva</VALUEMEANING>
          <MEANINGDESCRIPTION>The gingiva covering the maxillary alveolar bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior two-thirds of tongue</VALIDVALUE>
          <VALUEMEANING>Anterior 67 Percent Unit Tongue</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting the front surface of the body; often used to indicate the position of one structure relative to another.: A number with no fractional part, including the negative and positive numbers as well as zero.::67: A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).: The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12422, C48570, C45255::67, C25231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dorsal surface of tongue</VALIDVALUE>
          <VALUEMEANING>Dorsal Tongue Surface</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the back or upper surface of the body; opposite of ventral.: The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech.: The extended two-dimensional outer boundary of a three-dimensional object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25245, C12422, C45874</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ventral surface of tongue</VALIDVALUE>
          <VALUEMEANING>Ventral Tongue Surface</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the underside or lower surface of the body; opposite of dorsal.: The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech.: The extended two-dimensional outer boundary of a three-dimensional object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25245, C12422, C45875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Commissure of lip</VALIDVALUE>
          <VALUEMEANING>Commissure of the Lip</VALUEMEANING>
          <MEANINGDESCRIPTION>The junction of the upper and lower lips at the corner of the mouth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucosa of lower lip</VALIDVALUE>
          <VALUEMEANING>Mucosa of the Lower Lip</VALUEMEANING>
          <MEANINGDESCRIPTION>The lining of the inferior fleshy fold bordering the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mucosa of upper lip</VALIDVALUE>
          <VALUEMEANING>Mucosa of the Upper Lip</VALUEMEANING>
          <MEANINGDESCRIPTION>The lining of the superior fleshy fold bordering the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6776232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>External lower lip</VALIDVALUE>
          <VALUEMEANING>External Lower Lip</VALUEMEANING>
          <MEANINGDESCRIPTION>The external surface of the lower lip.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6402403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lower uterine segment</VALIDVALUE>
          <VALUEMEANING>Endometrium Isthmus Uteri</VALUEMEANING>
          <MEANINGDESCRIPTION>The mucous membrane comprising the inner layer of the uterine wall; it consists of a simple columnar epithelium and a lamina propria that contains simple tubular uterine glands. The structure, thickness, and state of the endometrium undergo marked change with the menstrual cycle.: An elongated constriction of the lower part of the uterus, located at the junction of the body of the uterus and the cervix, that is composed principally of smooth muscle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12312, C12313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Para-aortic lymph node(s)</VALIDVALUE>
          <VALUEMEANING>Paraaortic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node located adjacent to the lumbar region of the spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77643</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3137527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvic lymph node(s)</VALIDVALUE>
          <VALUEMEANING>Pelvic Lymph Node</VALUEMEANING>
          <MEANINGDESCRIPTION>Any lymph node within the abdominal pelvic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12363</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5216171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extra-abdominal lymph node(s)</VALIDVALUE>
          <VALUEMEANING>Extra-abdominal lymph node(s)</VALUEMEANING>
          <MEANINGDESCRIPTION>A lymph node outside the abdominal cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C165584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvic recurrence</VALIDVALUE>
          <VALUEMEANING>Pelvis Recurrence</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.: To come back or to return.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3352, C12767</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7009950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endometrium</VALIDVALUE>
          <VALUEMEANING>Endometrium</VALUEMEANING>
          <MEANINGDESCRIPTION>The mucous membrane comprising the inner layer of the uterine wall; it consists of a simple columnar epithelium and a lamina propria that contains simple tubular uterine glands. The structure, thickness, and state of the endometrium undergo marked change with the menstrual cycle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3242713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Posterior commissure of glottis</VALIDVALUE>
          <VALUEMEANING>Posterior commissure of glottis</VALUEMEANING>
          <MEANINGDESCRIPTION>The posterior surface of the glottic opening at the level of the vocal cords.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C164282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6943245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior commissure of glottis</VALIDVALUE>
          <VALUEMEANING>Anterior commissure of glottis</VALUEMEANING>
          <MEANINGDESCRIPTION>The anterior-most portion of the vocal cord, located within the larynx, that constitutes the junction of the conus elasticus and the thyroepiglottic, vestibular, and vocal ligaments.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128630</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6943246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not specified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5697867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Contralateral pleura</VALIDVALUE>
          <VALUEMEANING>Contralateral Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>On or relating to the opposite side (of the body): The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469, C25307</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3813651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Visceral pleura</VALIDVALUE>
          <VALUEMEANING>Visceral Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>Visceral; of, or relating to, or affecting the internal organs.: (PLOOR-a) A thin layer of tissue covering the lungs and the wall of the chest cavity to protect and cushion the lungs. A small amount of fluid that acts as a lubricant allows the lungs to move smoothly in the chest cavity during breathing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469, C25315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parietal pleura</VALIDVALUE>
          <VALUEMEANING>Parietal Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>The outermost of the two pleural membranes. It consists of a thin basal layer of fibrous tissue upon which sits a continuous layer of mesothelial cells. The cells function to secrete the lubricant lining the pleural cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33273</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7590003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bilateral pleura</VALIDVALUE>
          <VALUEMEANING>Bilateral Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>Affecting both sides of the body or a matched pair of organs.: The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469, C13332</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7590004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left pleura</VALIDVALUE>
          <VALUEMEANING>Left Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the west when facing north.: The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469, C25229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7590005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right pleura</VALIDVALUE>
          <VALUEMEANING>Right Pleura</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or located on or directed toward the side of the body to the east when facing north.: The tissue that lines the wall of the thoracic cavity and the surface of the lungs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12469, C25228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7590006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdominal/non-adrenal</VALIDVALUE>
          <VALUEMEANING>Abdominal/non-adrenal</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex)._Of, or related to, the abdomen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25342, C12666, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10360279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Posterior mediastinum</VALIDVALUE>
          <VALUEMEANING>Posterior Mediastinum</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the lower portion of the mediastinum that is located behind the pericardium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33368</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5983746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Metastatic site</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Metastatic site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1373">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6132724</PUBLICID>
    <LONGNAME>Adult Temperament Questionnaire Assessment Scale</LONGNAME>
    <PREFERREDNAME>Adul_Temp_Ques_ASSESS_SCALE</PREFERREDNAME>
    <PREFERREDDEFINITION>A human who has reached reproductive age._An individual&#39;s habitual frame of mind or natural emotional disposition._Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument._the scale to determine the patient&#39;s assessment of general health.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6132723</PublicId>
      <PreferredName>Adul_Temp_Ques</PreferredName>
      <PreferredDefinition>A human who has reached reproductive age._An individual&#39;s habitual frame of mind or natural emotional disposition._Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.</PreferredDefinition>
      <LongName>Adult Temperament Questionnaire</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2944354</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17600</PreferredName>
        <Version>1</Version>
        <LongName>Adult</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17600</PREFERRED_NAME>
            <LONG_NAME>Adult</LONG_NAME>
            <CON_ID>2204022</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6132721</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C93212:C17048</PreferredName>
        <Version>1</Version>
        <LongName>Temperament Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C93212</PREFERRED_NAME>
            <LONG_NAME>Temperament</LONG_NAME>
            <CON_ID>3162367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17048</PREFERRED_NAME>
            <LONG_NAME>Questionnaire</LONG_NAME>
            <CON_ID>2202367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016428</PublicId>
      <PreferredName>ASSESS_SCALE</PreferredName>
      <PreferredDefinition>the scale to determine the patient&#39;s assessment of general health.</PreferredDefinition>
      <LongName>Assessment Scale</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>All of the time</VALIDVALUE>
          <VALUEMEANING>All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Most of the time</VALIDVALUE>
          <VALUEMEANING>Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A good bit of the time</VALIDVALUE>
          <VALUEMEANING>A Good Bit of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a good bit of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some of the time</VALIDVALUE>
          <VALUEMEANING>Some of the time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened some of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little of the time</VALIDVALUE>
          <VALUEMEANING>A Little of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a little of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None of the time</VALIDVALUE>
          <VALUEMEANING>None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat bothered</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little bit</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all bothered</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted totally</VALIDVALUE>
          <VALUEMEANING>Disrupted totally</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was totally disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted quite a bit</VALIDVALUE>
          <VALUEMEANING>Disrupted quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted somewhat</VALIDVALUE>
          <VALUEMEANING>Disrupted somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted a little</VALIDVALUE>
          <VALUEMEANING>Disrupted a little</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was a little disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not disrupted at all</VALIDVALUE>
          <VALUEMEANING>Not disrupted at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not at all disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable/have not received instructions about taking 6MP</VALIDVALUE>
          <VALUEMEANING>Not Applicable Have Negation Receive Instruction Approximate Take Six Mercaptopurine</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.: Used to describe the possession, relationships, or the state of something or someone.: An operation in which a term denies or inverts the meaning of another term or construction.: To take, accept, or get something offered.: A message describing how something is to be done.: Not quite exact or correct; almost exact or correct.: As pertains to a medication: ingest, inhale, instill, or inject.: A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.: A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities.  Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5&#39;-phosphate (6-thioGMP) and 6-thioinosine monophosphate (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis.  This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C195, C66837, C65105, C45828, C42688, C25639, C25594, C101282, C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5, 6, 7, 8</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5782771</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>About half of the time</VALIDVALUE>
          <VALUEMEANING>Approximate Half Time</VALUEMEANING>
          <MEANINGDESCRIPTION>Not quite exact or correct; almost exact or correct.: One of two equal parts; a quantity corresponding to one half of the whole.: The continuum of experience in which events pass from the future through the present to the past.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25207, C81009, C45828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5782772</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>All or almost all the time</VALIDVALUE>
          <VALUEMEANING>All of the Time Or Almost All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened all of the time.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A response indicating that something happens or happened almost all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119986, C37998, C110990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6630428</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None or almost none of the time</VALIDVALUE>
          <VALUEMEANING>None of the Time Or Nearly None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened none of the time.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Not quite or just short of.: A response indicating that something happens or happened none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110994, C107222, C37998, C110994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-02-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6630427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Adult Temperament Questionnaire Assessment Scale does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Adult Temperament Questionnaire Assessment Scale does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Psychosocial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3009619</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1374">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6142506</PUBLICID>
    <LONGNAME>Molecular Analysis Locus Location Text</LONGNAME>
    <PREFERREDNAME>locus</PREFERREDNAME>
    <PREFERREDDEFINITION>Alphanumeric value used to describe the locus of a specific genetic variant.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT MOD</WORKFLOWSTATUS>
    <CONTEXTNAME>GDC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>GDC:NCI Genomic Data Commons</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6140906</PublicId>
      <PreferredName>2626369v1.0:6140904v1.0</PreferredName>
      <PreferredDefinition>A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level._The position of a gene or a chromosomal marker on a chromosome; also, a stretch of DNA at a particular place on a particular chromosome. The use of locus is sometimes restricted to mean regions of DNA that are expressed._A position, site, or point in space where something can be found.</PreferredDefinition>
      <LongName>Molecular Analysis Locus Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT MOD</WorkflowStatus>
      <ContextName>GDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2626369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19770</PreferredName>
        <Version>1</Version>
        <LongName>Molecular Analysis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19770</PREFERRED_NAME>
            <LONG_NAME>Molecular Analysis</LONG_NAME>
            <CON_ID>2528322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6140904</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45822:C25341</PreferredName>
        <Version>1</Version>
        <LongName>Locus Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45822</PREFERRED_NAME>
            <LONG_NAME>Locus</LONG_NAME>
            <CON_ID>3107130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>RADLEX_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>GDC:NCI Genomic Data Commons</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181231</PublicId>
      <PreferredName>DESCR_TXT</PreferredName>
      <PreferredDefinition>The text that provides a description of a topic.</PreferredDefinition>
      <LongName>Descriptive Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Locus</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Locus</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Format and Example</Name>
        <DocumentType>EXAMPLE</DocumentType>
        <DocumentText>Format: [chromosome][chromosome arm].[band+sub-bands]. Example: 17p13.1.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5428034</PublicId>
          <ContextName>GDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Molecular Test</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6142391</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>10429357</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GDC (Genomic Data Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Candidate New GDC CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14506028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594093</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Molecular Test</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594226</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>locus</AlternateName>
        <AlternateNameType>CCDI Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>molecular_test</AlternateName>
        <AlternateNameType>CCDI Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>GDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>locus</AlternateName>
        <AlternateNameType>GDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1375">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6142528</PUBLICID>
    <LONGNAME>Molecular Analysis Cell Count</LONGNAME>
    <PREFERREDNAME>cell_count</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value used to describe the number of cells used for molecular testing.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT MOD</WORKFLOWSTATUS>
    <CONTEXTNAME>GDC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>GDC:NCI Genomic Data Commons</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6141075</PublicId>
      <PreferredName>2626369v1.0:6141073v1.0</PreferredName>
      <PreferredDefinition>A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level._A procedure to determine the number of cells in a sample. Also used to mean the result of such a procedure.</PreferredDefinition>
      <LongName>Molecular Analysis Cell Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT MOD</WorkflowStatus>
      <ContextName>GDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2626369</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19770</PreferredName>
        <Version>1</Version>
        <LongName>Molecular Analysis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19770</PREFERRED_NAME>
            <LONG_NAME>Molecular Analysis</LONG_NAME>
            <CON_ID>2528322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6141073</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48938</PreferredName>
        <Version>1</Version>
        <LongName>Cell Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48938</PREFERRED_NAME>
            <LONG_NAME>Cell Count</LONG_NAME>
            <CON_ID>2488847</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>GDC:NCI Genomic Data Commons</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2531904</PublicId>
      <PreferredName>CELL_CT</PreferredName>
      <PreferredDefinition>the cell count.</PreferredDefinition>
      <LongName>Cell Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cell count</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cell count</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5428034</PublicId>
          <ContextName>GDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Molecular Test</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6142391</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>10429357</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GDC (Genomic Data Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Candidate New GDC CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14506028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594093</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sequencing</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594094</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sequencing File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594223</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Single Cell Sequencing File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594225</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Molecular Test</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594226</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cell_count</AlternateName>
        <AlternateNameType>CCDI Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Total_Number_of_Input_Cells</AlternateName>
        <AlternateNameType>CCDI Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>molecular_test</AlternateName>
        <AlternateNameType>CCDI Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>sequencing_file</AlternateName>
        <AlternateNameType>CCDI Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>GDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cell_count</AlternateName>
        <AlternateNameType>GDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1376">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6148351</PUBLICID>
    <LONGNAME>Imaging Technique Investigation Performed Imaging Type</LONGNAME>
    <PREFERREDNAME>IMG_INV_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the type of imaging technique performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCTG: Canadian Cancer Trials Group</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6148341</PublicId>
      <PreferredName>3061537v1.0:6148339v1.0</PreferredName>
      <PreferredDefinition>Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy._The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Imaging Technique Investigation Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3061537</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17369</PreferredName>
        <Version>1</Version>
        <LongName>Imaging Technique</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17369</PREFERRED_NAME>
            <LONG_NAME>Imaging Procedure</LONG_NAME>
            <CON_ID>2713347</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6148339</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41198:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Investigation Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41198</PREFERRED_NAME>
            <LONG_NAME>Investigation</LONG_NAME>
            <CON_ID>2469351</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCTG: Canadian Cancer Trials Group</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6147420</PublicId>
      <PreferredName>6147420v1.0</PreferredName>
      <PreferredDefinition>Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Imaging Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCTG: Canadian Cancer Trials Group</Origin>
      <Representation>
        <PublicId>4136307</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17369:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Imaging Technique Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17369</PREFERRED_NAME>
            <LONG_NAME>Imaging Procedure</LONG_NAME>
            <CON_ID>2713347</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET-CT</VALIDVALUE>
          <VALUEMEANING>Positron Emission Tomography and Computed Tomography Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5627465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Xray</VALIDVALUE>
          <VALUEMEANING>Radiography</VALUEMEANING>
          <MEANINGDESCRIPTION>A radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mammogram</VALIDVALUE>
          <VALUEMEANING>Mammogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A low voltage X-ray photograph of the breast generally done to detect breast cancer. This method is also valuable in diagnosis of benign abnormal conditions of the breast such as fibroadenoma, mastitis, abscess, and cysts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20178</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561001</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skeletal survey</VALIDVALUE>
          <VALUEMEANING>Skeletal Survey X-Ray</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure used to detect fractures, tumors, or degenerative conditions of the bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2969552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone scan</VALIDVALUE>
          <VALUEMEANING>Bone Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A nuclear imaging method used to evaluate pathological bone metabolism. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ultrasound</VALIDVALUE>
          <VALUEMEANING>Ultrasound</VALUEMEANING>
          <MEANINGDESCRIPTION>High frequency sound, generally with a frequency greater than 20,000 Hz.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3109382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CT</VALIDVALUE>
          <VALUEMEANING>Computed Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI</VALIDVALUE>
          <VALUEMEANING>Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET scan</VALIDVALUE>
          <VALUEMEANING>Positron Emission Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2919109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET-MRI</VALIDVALUE>
          <VALUEMEANING>Positron Emission Tomography Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16809, C17007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-02-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8037942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clinical Evaluation</VALIDVALUE>
          <VALUEMEANING>Clinical Evaluation</VALUEMEANING>
          <MEANINGDESCRIPTION>An assessment of an individual&#39;s physical, mental, or emotional condition; information can be gathered from multiple sources, including physical exam, personal interview and observation, medical history, laboratory and imaging tests.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-02-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6427461</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PSMA PET scan</VALIDVALUE>
          <VALUEMEANING>PSMA PET Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A positron emission tomography imaging technique that uses the PET-sensitive drug, 68Ga-PSMA-11, to bind to cancer cells and locate cancer lesions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C179333</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14620027</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PSMA PET-CT</VALIDVALUE>
          <VALUEMEANING>PSMA PET-CT Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging technique that combines positron emission tomography with computed tomography to detect 68Ga-PSMA-11 bound to cancer cells and locate cancer lesions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C179332</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14620028</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Radiology investigations</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Radiology investigations</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Investigation type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Type of Imaging (Suspected)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Type of Imaging (Definite)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_04</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of Assessment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_05</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Type of Imaging:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_06</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of assessment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>IMG_INV_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD_NECK</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD_OTHERRAD</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD_IMAGING_SUS</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD_IMAGING_DEF</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BE_BESCAT_IMAGETYP</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD_BONESCAN</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD_OLIGO_RECIST</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD_OLIGO_PERCIST</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD_PERCIST</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1377">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6356740</PUBLICID>
    <LONGNAME>MET Amplification Detected Finding Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>MET AMP_DET_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded response to questions which are necessary to allow a person to participate in a clinical study that are related to identifying the abnormality indicating the presence of multiple copies of the MET gene as outlined in the protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6356643</PublicId>
      <PreferredName>6356640v1.00:16216793v1.00</PreferredName>
      <PreferredDefinition>A molecular genetic abnormality indicating the presence of multiple copies of the MET gene.:Perceived, discerned, or discovered._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>c-MET Gene Amplification Detected Finding Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6356640</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43532</PreferredName>
        <Version>1</Version>
        <LongName>c-MET Gene Amplification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43532</PREFERRED_NAME>
            <LONG_NAME>c-MET Gene Amplification</LONG_NAME>
            <CON_ID>4794134</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16216793</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C191719:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Detected Finding Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C191719</PREFERRED_NAME>
            <LONG_NAME>Detected Finding</LONG_NAME>
            <CON_ID>12573666</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has MET amplification been de</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has MET amplification been detected by the Guardant360 cfDNA screening assay?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has MET amplification been detected by the Guardant360 cfDNA screening assay (MET copy number greater than or equal to 2.2)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the activation of MET pathway previously identified using local CLIA test been confirmed by subsequent FDA approved test?  (Please wait until FDA approved test results are available to answer this question.)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876352</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Inclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status &amp; Genetics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3876422</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1378">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6360511</PUBLICID>
    <LONGNAME>Osteoporosis Study of Osteoporotic Fractures Frailty Index Assessment Score</LONGNAME>
    <PREFERREDNAME>Oste_Stud_ASSES_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>A disorder characterized by reduced bone mass, with a decrease in cortical thickness and in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence._A frailty index consisting of 3 components: weight loss, the subjects inability to rise from a chair 5 times without using their arms, and reduced energy level._A number or range of numeric values measuring performance, function, quality, or ability.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6360510</PublicId>
      <PreferredName>Oste_Stud</PreferredName>
      <PreferredDefinition>A disorder characterized by reduced bone mass, with a decrease in cortical thickness and in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence._A frailty index consisting of 3 components: weight loss, the subject s inability to rise from a chair 5 times without using their arms, and reduced energy level.</PreferredDefinition>
      <LongName>Osteoporosis Study of Osteoporotic Fractures Frailty Index</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6360507</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>E12508</PreferredName>
        <Version>1</Version>
        <LongName>Osteoporosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>E12508</PREFERRED_NAME>
            <LONG_NAME>Osteoporosis</LONG_NAME>
            <CON_ID>3123757</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>CTCAE</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6406090</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C153302</PreferredName>
        <Version>1</Version>
        <LongName>Study of Osteoporotic Fractures Frailty Index</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C153302</PREFERRED_NAME>
            <LONG_NAME>Study of Osteoporotic Fractures Frailty Index</LONG_NAME>
            <CON_ID>6360987</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3076086</PublicId>
      <PreferredName>ASSES_SC</PreferredName>
      <PreferredDefinition>A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Assessment Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2193207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Osteoporosis Study of Osteoporotic Fractures Frailty Index Assessment Score does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Osteoporosis Study of Osteoporotic Fractures Frailty Index Assessment Score does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Geriatrics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5622164</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1379">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6379546</PUBLICID>
    <LONGNAME>Clinical Performed Observation Outcome Data PCORnet CDM General Observation Qualitative Result</LONGNAME>
    <PREFERREDNAME>OBSGEN_RESULT_QUAL</PREFERREDNAME>
    <PREFERREDDEFINITION>Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._Standardized result for qualitative results.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175329</PublicId>
      <PreferredName>2867629v1.0:2423441v1.0</PreferredName>
      <PreferredDefinition>Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.</PreferredDefinition>
      <LongName>Clinical Performed Observation Outcome Data</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867629</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25398:C38000:C25598:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Performed Observation Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2423441</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25474</PreferredName>
        <Version>1</Version>
        <LongName>Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6379411</PublicId>
      <PreferredName>6379411v1.0</PreferredName>
      <PreferredDefinition>Standardized result for qualitative results.</PreferredDefinition>
      <LongName>PCORnet CDM General Observation Qualitative Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</Origin>
      <Representation>
        <PublicId>2476191</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20200</PreferredName>
        <Version>1</Version>
        <LongName>Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ABNORMAL</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BORDERLINE</VALIDVALUE>
          <VALUEMEANING>Borderline</VALUEMEANING>
          <MEANINGDESCRIPTION>Straddling the dividing line between two categories.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ELEVATED</VALIDVALUE>
          <VALUEMEANING>Elevated</VALUEMEANING>
          <MEANINGDESCRIPTION>Elevated; raised or increased.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HIGH</VALIDVALUE>
          <VALUEMEANING>High</VALUEMEANING>
          <MEANINGDESCRIPTION>An elevated level or position or degree; greater than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4382322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LOW</VALIDVALUE>
          <VALUEMEANING>Low</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimum level or position or degree; less than normal in degree, intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5434474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NEGATIVE</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2840098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NI</VALIDVALUE>
          <VALUEMEANING>No Information Available</VALUEMEANING>
          <MEANINGDESCRIPTION>Information regarding the subject is unknown or inaccessible at this time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NORMAL</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OT</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5697874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>POSITIVE</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5042698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UN</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UNDETERMINED</VALIDVALUE>
          <VALUEMEANING>Undetermined</VALUEMEANING>
          <MEANINGDESCRIPTION>A term referring to the lack of definitive criteria for classification of a finding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5751657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>General Observation Quantitat</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>General Observation Quantitative Result</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6093453</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PCORnet CDM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Observations General</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>8003789</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OBSGEN_RESULT_QUAL</AlternateName>
        <AlternateNameType>PCORNet Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OBSERVATIONS_GENERAL_(OBS_GEN)</AlternateName>
        <AlternateNameType>PCORnet Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1380">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6379548</PUBLICID>
    <LONGNAME>Reuse Template Study Activity Name Code PCORnet CDM General Observation Terminology Type</LONGNAME>
    <PREFERREDNAME>OBSGEN_TYPE</PREFERREDNAME>
    <PREFERREDDEFINITION>To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective; the state of being active._The words or language units by which a thing is known.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation._Terminology / vocabulary used to describe the clinical observation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2869529</PublicId>
      <PreferredName>2867579v1.0:2867793v1.0</PreferredName>
      <PreferredDefinition>To use again.:Something that establishes or serves as a pattern for reference; a form, mold, or pattern used as a guide to making something.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective; the state of being active._The words or language units by which a thing is known.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Reuse Template Study Activity Name Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867579</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C79891:C45677:C63536:C43431</PreferredName>
        <Version>1</Version>
        <LongName>Reuse Template Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79891</PREFERRED_NAME>
            <LONG_NAME>Reuse</LONG_NAME>
            <CON_ID>2839821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45677</PREFERRED_NAME>
            <LONG_NAME>Template</LONG_NAME>
            <CON_ID>2231570</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867793</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Name Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6379419</PublicId>
      <PreferredName>6379419v1.0</PreferredName>
      <PreferredDefinition>Terminology / vocabulary used to describe the clinical observation.</PreferredDefinition>
      <LongName>PCORnet CDM General Observation Terminology Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PC_*</VALIDVALUE>
          <VALUEMEANING>PCORnet reserved</VALUEMEANING>
          <MEANINGDESCRIPTION>A code used for PCORNet network-wide activities related to general observation data.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C155814</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6379420</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UD_*</VALIDVALUE>
          <VALUEMEANING>User Definition</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who uses a computer, program, network, or related service for work or entertainment.: A concise explanation of the meaning of a word or phrase or symbol.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42777, C42745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6379421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CVX</VALIDVALUE>
          <VALUEMEANING>Administered Vaccine</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of having given something (e.g., a medication or test).: Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C923, C25382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6379422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GM</VALIDVALUE>
          <VALUEMEANING>Global Medical Device Nomenclature</VALUEMEANING>
          <MEANINGDESCRIPTION>A system of internationally agreed generic descriptors used to identify all medical device products.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6379423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RX</VALIDVALUE>
          <VALUEMEANING>RxNorm</VALUEMEANING>
          <MEANINGDESCRIPTION>A system that provides normalized names for generic and branded drugs and that functions as a tool to support interoperability between terminologies. RxNorm is produced by the National Library of Medicine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127112</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6379409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HG</VALIDVALUE>
          <VALUEMEANING>Human Genome Organization</VALUEMEANING>
          <MEANINGDESCRIPTION>An international organization of scientists involved in human genetics. Established in 1989 by a collection of the world&#39;s leading human geneticists, the primary ethos of the Human Genome Organisation is to promote and sustain international collaboration in the field of human genetics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48690</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6379424</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HP</VALIDVALUE>
          <VALUEMEANING>Human Phenotype Ontology</VALUEMEANING>
          <MEANINGDESCRIPTION>A standardized vocabulary of phenotypic abnormalities encountered in human disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154414</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6345399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SM</VALIDVALUE>
          <VALUEMEANING>Systematized Nomenclature of Medicine</VALUEMEANING>
          <MEANINGDESCRIPTION>A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ON</VALIDVALUE>
          <VALUEMEANING>International Classification of Diseases for Oncology</VALUEMEANING>
          <MEANINGDESCRIPTION>The International Classification of Diseases for Oncology has been used for nearly 25 years as a tool for coding diagnoses of neoplasms in tumor and cancer registrars and in pathology laboratories. ICD-O is a dual classification with coding systems for both topography and morphology. The topography code describes the site of origin of the neoplasm. The morphology code describes the characteristics of the tumor itself, including its cell type and biologic activity. (from Amazon.com)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37978</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6379425</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>ICD-11-CM/PCS</VALUEMEANING>
          <MEANINGDESCRIPTION>The International Classification of Diseases, Eleventh Revision, Clinical Modification/Procedure Coding System is the U.S. health system&#39;s adaptation of international ICD11 standard list of six-character alphanumeric codes used in hospital inpatient settings for inpatient procedure coding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6345400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>ICD-10-CM/PCS</VALUEMEANING>
          <MEANINGDESCRIPTION>The International Classification of Diseases, Tenth Revision, Clinical Modification/Procedure Coding System is the U.S. health system&#39;s adaptation of international ICD-10 standard list of six-character alphanumeric codes used in hospital inpatient settings for inpatient procedure coding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6345401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>09</VALIDVALUE>
          <VALUEMEANING>ICD-9-CM</VALUEMEANING>
          <MEANINGDESCRIPTION>An extension of the ICD-9 created by the U.S. National Center for Health Statistics so that the system could be used to capture more morbidity data. This extension included a section of procedure codes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71891</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6356783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CH</VALIDVALUE>
          <VALUEMEANING>CPT or HCPCS</VALUEMEANING>
          <MEANINGDESCRIPTION>A proprietary medical nomenclature of the American Medical Association widely used to report medical procedures and services under public and private health insurance programs.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A standardized coding system used by Medicare and other health insurance programs to ensure that claims are processed in an orderly and consistent manner. The coding system comprises the procedure codes of the American Medical Association Current Procedural Terminology (CPT) and an additional standardized coding set that is used primarily to identify products, supplies, and services not included in the CPT codes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132306, C37998, C87308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6369655</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LC</VALIDVALUE>
          <VALUEMEANING>Logical Observation Identifiers Names and Codes</VALUEMEANING>
          <MEANINGDESCRIPTION>Published by the The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ND</VALIDVALUE>
          <VALUEMEANING>FDA National Drug Code</VALUEMEANING>
          <MEANINGDESCRIPTION>A unique numeric code assigned by the U.S. Food and Drug Administration to prescription drugs and insulin products manufactured, prepared, processed, or propagated by registered establishments for commercial distribution. U.S. prescription drugs must use an NDC; most non-prescription drugs are also primarily referenced by NDC. NDC codes change often as companies merge, new products are introduced, and drugs are retired.  Each code is a unique 10-digit, 3-segment number in one of the following configurations: 4-4-2, 5-3-2, or 5-4-1. The first, labeler code segment is assigned by the FDA to identify the establishment. The second, product code segment identifies a specific strength, dosage form, and formulation for a particular firm. The third, package code segment identifies package sizes and types. Both the product and package codes are assigned by the establishment. An asterisk may appear as a placeholder in the second or third segments.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5123196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NI</VALIDVALUE>
          <VALUEMEANING>No Information Available</VALUEMEANING>
          <MEANINGDESCRIPTION>Information regarding the subject is unknown or inaccessible at this time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578438</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OT</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UN</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-07-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>General Observation Terminolo</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>General Observation Terminology Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6093453</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PCORnet CDM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Observations General</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>8003789</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OBSGEN_TYPE</AlternateName>
        <AlternateNameType>PCORNet Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OBSERVATIONS_GENERAL_(OBS_GEN)</AlternateName>
        <AlternateNameType>PCORnet Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1381">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6385392</PUBLICID>
    <LONGNAME>Performed Observation Outcome Data Sentinel CDM Cause of Death Code Type</LONGNAME>
    <PREFERREDNAME>CodeType</PREFERREDNAME>
    <PREFERREDDEFINITION>Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._Cause of death code type.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Sentinel CDM:The Sentinel Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3174905</PublicId>
      <PreferredName>2867619v1.0:2423441v1.0</PreferredName>
      <PreferredDefinition>Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.</PreferredDefinition>
      <LongName>Performed Observation Outcome Data</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867619</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000:C25598:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Performed Observation Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2423441</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25474</PreferredName>
        <Version>1</Version>
        <LongName>Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6384224</PublicId>
      <PreferredName>6384224v1.0</PreferredName>
      <PreferredDefinition>Cause of death code type.</PreferredDefinition>
      <LongName>Sentinel CDM Cause of Death Code Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>Sentinel CDM:The Sentinel Common Data Model</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>International Classification of Disease, Tenth Revision</VALUEMEANING>
          <MEANINGDESCRIPTION>The tenth version of the International Classification of Diseases (ICD), published by the World Health Organization in 1992.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71892</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3178382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>09</VALIDVALUE>
          <VALUEMEANING>International Classification of Diseases, Ninth Revision</VALUEMEANING>
          <MEANINGDESCRIPTION>The ninth version of the International Classification of Diseases (ICD), published by the World Health Organization in 1977.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71890</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6345596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cause of Death Code Type</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cause of Death Code Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6093485</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Sentinel CDM 6.02</PreferredName>
          <Version>6.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cause of Death</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6093487</CsiPublicId>
        <CsiVersion>6.02</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CodeType</AlternateName>
        <AlternateNameType>Sentinel Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CAUSE_OF_DEATH</AlternateName>
        <AlternateNameType>Sentinel Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1382">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6407954</PUBLICID>
    <LONGNAME>ECG Method</LONGNAME>
    <PREFERREDNAME>EGMETHOD</PREFERREDNAME>
    <PREFERREDDEFINITION>Method of the test or examination.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6407938</PublicId>
      <PreferredName>6407934v1.0:6407936v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to electrocardiogram._The mechanism by which the electrocardiogram assessment is carried out.</PreferredDefinition>
      <LongName>Electrocardiogram Domain Electrocardiogram Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407934</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49626</PreferredName>
        <Version>1</Version>
        <LongName>Electrocardiogram Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49626</PREFERRED_NAME>
            <LONG_NAME>Electrocardiogram Domain</LONG_NAME>
            <CON_ID>2469059</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6407936</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83089</PreferredName>
        <Version>1</Version>
        <LongName>Electrocardiogram Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83089</PREFERRED_NAME>
            <LONG_NAME>Electrocardiogram Method</LONG_NAME>
            <CON_ID>6407935</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6406927</PublicId>
      <PreferredName>EGMETHOD</PreferredName>
      <PreferredDefinition>Terminology codelist used with ECG Test Methods within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>CDISC SDTM ECG Test Method Terminology Type</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6406926</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71151:C25284</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM ECG Test Method Terminology Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71151</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM ECG Test Method Terminology</LONG_NAME>
            <CON_ID>6406925</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HOLTER CONTINUOUS ECG RECORDING</VALIDVALUE>
          <VALUEMEANING>Holter Monitoring</VALUEMEANING>
          <MEANINGDESCRIPTION>An ambulatory electrocardiography technique that records a continuous electrocardiographic rhythm pattern for 24 hours or more to detect heart arrhythmias.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12-LEAD EXTENDED RIGHT</VALIDVALUE>
          <VALUEMEANING>12-LEAD EXTENDED RIGHT</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby the rightward oriented V leads progress from V1R, placed instead of the standard V2, to V6R. The V3 lead in the standard placement is replaced by V4R.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STANDARD 12-LEAD EXTENDED LEFT</VALIDVALUE>
          <VALUEMEANING>12 Lead Placement Standard Extended Left</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby the standard lead placement is modified by having leads V7, V8 and V9.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PSEUDO-ORTHOGONAL XYZ LEAD SYSTEM</VALIDVALUE>
          <VALUEMEANING>Lead Placement Pseudo Orthogonal XYZ</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement that allows monitoring and recording of cardiac electrical activity. A V1-type lead is used whose positive electrode is localized in the 4th intercostal space, 2.5cm from the sternum. Its negative electrode is placed below the left clavicle. An addition of lead V5 and aVF can be made to facilitate interpretation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 LEAD 1 LEAD MISSING</VALIDVALUE>
          <VALUEMEANING>12 Lead Placement 1 Lead Missing</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but one standard lead position is missing therefore requiring a Mortara source consistency filter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71125</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 LEAD EASI DOWER TRANSFORMATION</VALIDVALUE>
          <VALUEMEANING>Lead Placement EASI Dower Transformation</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby 4 chest electrodes and 1 reference electrode are used to allow for continuous monitoring at the clinical level. This placement creates a 12 lead ECG that allows the acquisition of simultaneous events in the frontal, horizontral and sagittal heart planes with the linear transformation of vectors. This system provides a three-dimensional portrayal of the heart and uses mathematical and fixed coefficients for each lead.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71123</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BIPOLAR UNCORRECTED XYZ LEAD SYSTEM</VALIDVALUE>
          <VALUEMEANING>Lead Placement Bipolar Uncorrected XYZ</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby the X+ lead is placed at the right mid-axillary line at the 4th intercostal space, X- at the left mid-axillary line at the 4th intercostal space, Y+ at the proximal left leg, Y- at the superior aspect of the manubrium, Z+ at the direct posterior to Z- and Z- at the 4th intercostal space at the left sternal margin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71121</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STANDARD 12-LEAD AND CC5-CM5-ML</VALIDVALUE>
          <VALUEMEANING>12 Lead Placement Standard And CC5-CM5-ML</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the negative reference is at CM5 and the active electrode is at the left leg position.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71128</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STANDARD 12-LEAD AND CM5-CC5-CH5</VALIDVALUE>
          <VALUEMEANING>12 Lead Placement Standard And CC5-CM5-CH5</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the bipolar lead groups place the negative of the reference electrode over the manubrium (CM5), the right scapula (CB5), V5R (CC5) or on the forehead (CH5) and the active electrode at V5.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71126</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CUBE LEAD SYSTEM</VALIDVALUE>
          <VALUEMEANING>Lead Placement Cube</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement that is a type of uncorrected vectorcardiograph. This lead system is based on a rectangular body axis. It uses an extra number of electrodes to make it three-dimensional.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71120</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406947</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 LEAD NON-STANDARD</VALIDVALUE>
          <VALUEMEANING>12 Lead Placement Non-Standard</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby the limb leads are placed on the torso for easier and faster application in emergency situations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71114</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406949</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 LEAD SINGLE PAD</VALIDVALUE>
          <VALUEMEANING>12 Lead Placement Chest</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that all leads on the chest are part of a single electrode pad.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71112</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 LEAD UNSPECIFIED</VALIDVALUE>
          <VALUEMEANING>12 Lead Placement Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the position of the leads is unspecified.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 LEAD STANDARD</VALIDVALUE>
          <VALUEMEANING>12 Lead Placement Standard</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby 12 leads are recorded, with each lead representing an electrical &quot;view&quot; of the heart. The six leads recorded in the frontal plane are derived from the placement of 3 electrodes (RA or Right Arm, LA, or Left Arm, and LL or Left Leg). These bipolar frontal leads form the basis of Einthoven&#39;s triangle, and are represented by leads I, II, and III.  Three other derived (or augmented) bipolar frontal vectors are also recorded on a standard 12-lead EKG, aVR, aVF, and aVL. 6 unipolar leads, corresponding to V1 - V6 measure the electrical activity in the horizontal plane. The placement for the &quot;V&quot; leads is as follows: V1: right 4th intercostal space,V2: left 4th intercostal space, V3: halfway between V2 and V4, V4: left 5th intercostal space, mid-clavicular line, V5: horizontal to V4, anterior axillary line, V6: horizontal to V5, mid-axillary line.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MCFEE-PARUNGAO LEAD SYSTEM</VALIDVALUE>
          <VALUEMEANING>Lead Placement McFee-Parungao</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (back to front), Y (right to left) and Z (foot to head) of the heart. This system places the electrodes closer to the heart to achieve better orthogonality and a homogeneous lead field.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71119</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 LEAD MASON LIKAR</VALIDVALUE>
          <VALUEMEANING>12 Lead Placement Mason Likar</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified for ECG recording during exercise. Exercise stress testing requires moving the limb electrodes to more central positions on the thorax. The electrodes are placed in bony prominences close to the bases of the respective limbs in order to avoid skeletal muscle artifact, provide stability for recording electrodes and to record waveforms similar to the standard limb sites.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FRANK LEAD SYSTEM</VALIDVALUE>
          <VALUEMEANING>Lead Placement Frank</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (right to left direction), Y (foot to head direction) and Z (back to front direction) of the heart. For this method a minimum of 4 electrodes are needed that represent the right arm, left arm, left leg and back. However, ususally 7 electrodes are used to avoid dependence on the dipole location and facilitate interpretation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71118</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406959</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STANDARD LEADS ONE INTERCOSTAL SPACE HIGHER</VALIDVALUE>
          <VALUEMEANING>Lead Placement Standard Intercostal Space Higher</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiographic lead placement schema in which the &quot;V&quot; leads are placed one intercostal space cephalad to the position they would have in the standard lead placement schema.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71117</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 LEAD MODIFIED MASON LIKAR</VALIDVALUE>
          <VALUEMEANING>12 Lead Placement Mason Likar Modified</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the Mason Likar lead positions have been modified so that V1 to V6 on the chest are part of a single electrode pad. In addition, lead CM5 is substituted for lead aVR.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71110</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 LEAD CABRERA</VALIDVALUE>
          <VALUEMEANING>12 Lead Placement Cabrera</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby the display of the 12 standard ECG leads is in an &#39;orderly&#39; sequence in a single horizontal display of: aVL, I, -aVR, II, aVF, III, V1 to V6. In the Cabrera display the limb lead aVR is inverted (-aVR) to obtain the same positive leftward orientation as the other 5 limbs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VECTORCARDIOGRAPH CORRECTED</VALIDVALUE>
          <VALUEMEANING>Vectorcardiograph Corrected</VALUEMEANING>
          <MEANINGDESCRIPTION>This is a measurement of electric heart vectors whereby this type of measurement aims to create an orthonormal measurement of the electric cardiac vector.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VECTORCARDIOGRAPH UNCORRECTED</VALIDVALUE>
          <VALUEMEANING>Vectorcardiograph Uncorrected</VALUEMEANING>
          <MEANINGDESCRIPTION>A measurement of electric heart vectors whereby this type of measurement does not consider the distortions caused by the boundary and internal inhomogeneities of the body. These lead systems assure the direction of the spatial line connecting an electrode pair and yields the orientation of the corresponding lead vectors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71093</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 LEAD RIGHT-SIDED PRECORDIAL LEADS</VALIDVALUE>
          <VALUEMEANING>12 Lead Placement Right-sided Precordial Leads</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby the precordial leads are intentionally placed on the right side of the chest. (CDISC)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116139</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406970</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6 LEAD STANDARD</VALIDVALUE>
          <VALUEMEANING>6 Lead Standard</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram lead placement on the patient using a six electrode lead set with three standard leads and three augmented derived leads to elicit an electrical view of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10 LEAD STANDARD</VALIDVALUE>
          <VALUEMEANING>10 Lead Standard</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram lead placement on the patient using a ten electrode lead set to synthesize standard 12 lead electrocardiograph data to elicit an electrical view of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90349</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STANDARD LEADS FOR BICYCLE EXERCISE</VALIDVALUE>
          <VALUEMEANING>Lead Placement Bicycle</VALUEMEANING>
          <MEANINGDESCRIPTION>Limb leads on the back (shoulder and on the hips).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71115</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTINUOUS AMBULATORY ECG</VALIDVALUE>
          <VALUEMEANING>Continuous Ambulatory ECG</VALUEMEANING>
          <MEANINGDESCRIPTION>A continuous electrocardiographic (ECG) recording that utilizes one or more leads that both records and stores data directly to a device worn by the subject, such that the subject need not be restricted to a medical facility, and may be able to participate in their customary activities of daily living.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 LEAD ECG EXTRACTED FROM 12 LEAD CONTINUOUS ECG RECORDING</VALIDVALUE>
          <VALUEMEANING>12 Lead ECG Extracted From 12 Lead Continuous ECG Recording</VALUEMEANING>
          <MEANINGDESCRIPTION>Any electrocardiogram (ECG) reading excerpted from a continuous, 12 Lead ECG.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12 LEAD CONTINUOUS ECG</VALIDVALUE>
          <VALUEMEANING>12 Lead Continuous ECG</VALUEMEANING>
          <MEANINGDESCRIPTION>A continuous electrocardiographic (ECG) recording that utilizes twelve leads, though the lead placement may vary from the standard 12 Lead ECG placement. Examples include, but are not limited to, 12 lead Holter with modified Mason-Likar lead placements, 12 lead exercise ECGs, and 12 lead telemetry systems.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6 LEAD NEHB-SPORI</VALIDVALUE>
          <VALUEMEANING>6 Lead NEHB-SPORI</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead configuration that is primarily used to record ECGs in non-human animals, and which uses six (6) electrodes to generate eight (8) ECG leads (ECG wave forms). The six electrode configuration includes the following: four (4) limb electrodes, which are placed analogous to an Einthoven configuration in humans, and two (2) chest electrodes. The eight (8) ECG leads recorded comprise three standard limb leads (leads I, II, and III), three augmented leads (Leads aVr, aVF, and aVL), and two chest leads, which are generated using two unipolar chest leads, typically CV5RL [rV2] and CV6LL [V2] for canines, or MV1 and MV2 for primates. (CDISC)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132355</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8 LEAD STANDARD</VALIDVALUE>
          <VALUEMEANING>8 Lead Standard</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) recorded using 6 electrodes to generate 8 ECG leads (ECG wave forms). The 6 electrode configuration includes 4 limb electrodes in an Einthoven configuration and two chest electrodes. The 8 ECG leads recorded comprise three standard limb leads (leads I, II, and III), three augmented leads (leads aVR, aVF, and aVL), and two chest leads, which are generated using two unipolar chest leads, typically CV5RL [rV2] and CV6LL [V2] for canines, or MV1 and MV2 for non-human primates. This lead configuration is typically used to record ECGs in non-human animals. (CDISC)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132356</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7 LEAD STANDARD, NON-HUMAN</VALIDVALUE>
          <VALUEMEANING>7 Lead Placement Standard for Non-Human Subjects</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram lead placement for non-human species using a five-electrode lead set to monitor and/or record 7 ECG leads, analogous to the standard and augmented human limb leads and one chest lead. (CDISC)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6774521</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15 LEAD INCLUDING V3R-V5R</VALIDVALUE>
          <VALUEMEANING>15 Lead Placement Including V3R-V5R</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby 15 lead points are recorded using the standard 12 lead ECG positions and 3 additional leads placed on the right side of the chest. The positions of these right-sided leads V3R to V5R are opposite to the positions of V3-V5 on the right side of the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204620</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15 LEAD INCLUDING V7-V9</VALIDVALUE>
          <VALUEMEANING>15 Lead Placement Including V7-V9</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiogram (ECG) lead placement whereby 15 lead points are recorded using the standard 12 lead ECG positions and 3 additional leads placed on the back of the chest. The positions of these posterior leads V7 to V9 are at the same vertical level as V6 and at the horizontal positions of the left posterior axillary line (V7), left scapular line (V8), and left paravertebral line (V9).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C204619</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14920959</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTINUOUS SURFACE ECG RECORDING FOR NON-HUMAN SPECIES</VALIDVALUE>
          <VALUEMEANING>Continuous Surface ECG Recording for Non-human Species</VALUEMEANING>
          <MEANINGDESCRIPTION>A continuous electrocardiographic (ECG) recording utilizing one or more surface leads in a non-human species. (CDISC)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14921035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CONTINUOUS ECG RECORDING FOR NON-HUMAN SPECIES USING IMPLANTED LEADS</VALIDVALUE>
          <VALUEMEANING>Continuous ECG Recording for Non-human Species Using Implanted Leads</VALUEMEANING>
          <MEANINGDESCRIPTION>A continuous electrocardiographic (ECG) recording utilizing one or more implanted leads in a non-human species. (CDISC)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14921034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the method used for the ECG?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC SDTM ECG Test Method Terminology</Name>
        <DocumentType>VALID_VALUE_SOURCE</DocumentType>
        <DocumentText>Terminology codelist used with ECG Test Methods within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model.</DocumentText>
        <URL>https://ncit.nci.nih.gov/ncitbrowser/ajax?action=create_src_vs_tree&amp;amp;vsd_uri=http%3A//evs.nci.nih.gov/valueset/CDISC/C71151</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form  Completion Instructions</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the method used to measure ECG.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>EGMETHOD</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>Results may be affected by whether conditions for ECG as specified in the protocol were properly met. One possible condition is the method used to collect or calculate the ECG data. If the protocol requires this type of information, then this question may be included to confirm that the method used matches the protocol. The following are examples of when it is not necessary to collect these data on the CRF: Method of ECG is provided as part of the electronic data, or Method of ECG is not pertinent to the protocol, or The protocol specifies only one possible method for collecting ECG measurements and the sponsor does not feel there is significant risk of the sites performing the ECG using the incorrect method.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the method used for the ECG?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ECG Test Results (EG) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329796</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Semantically Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685479</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC ECG Test Results (EG) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943381</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EG.EGMETHOD</AlternateName>
        <AlternateNameType>Map:CDASHv1.1</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>EG_EGMETHOD</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1383">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6409584</PUBLICID>
    <LONGNAME>Deviation Start Date</LONGNAME>
    <PREFERREDNAME>DVSTDAT</PREFERREDNAME>
    <PREFERREDDEFINITION>The start date of deviation represented in an unambiguous date format (e.g., DD-MON-YYYY).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6409225</PublicId>
      <PreferredName>6408404v1.0:6409223v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to protocol deviations._The date on which the protocol deviation begins.</PreferredDefinition>
      <LongName>Protocol Deviations Domain Protocol Deviation Start Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6408404</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49585</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Deviations Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49585</PREFERRED_NAME>
            <LONG_NAME>Protocol Deviations Domain</LONG_NAME>
            <CON_ID>2469058</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6409223</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83126</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Deviation Start Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83126</PREFERRED_NAME>
            <LONG_NAME>Protocol Deviation Start Date</LONG_NAME>
            <CON_ID>6409222</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338240</PublicId>
      <PreferredName>CDISCDAT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>11</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396655</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25164</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the protocol deviati</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the protocol deviation start date?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Start Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form  Completion Instructions</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the start date that the protocol deviation using this format (DD-MON-YYYY). This should be the start or occurrence of the protocol deviation and not the date it was discovered or reported.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DVSTDTC</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>This does not map directly to an SDTMIG variable. For the SDTM submission dataset, concatenate all collected CDASH START DATE and TIME components and populate the SDTMIG variable DVSTDTC in ISO 8601 format.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>This may be derived if not collected on a CRF.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 2434998 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Template Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Protocol Deviation Occurrence Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of interruption or delay</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRDS Alternate Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Deviation start date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Protocol deviation date</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Protocol deviation date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the protocol deviation date?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the protocol deviation date?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date deviation occurred</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the protocol deviation start date?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858962</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Under Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol Deviations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>6941892</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5858962</PublicId>
          <ContextName>NRDS</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Under Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>10000389</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol Deviations (DV) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329794</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol Deviations - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318363</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Protocol Deviations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7590137</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13140248</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>13140248v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTSU CDISC Protocol Deviation v2.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15018483</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Protocol Deviations (DV) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943379</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DV_DVSTDAT</AlternateName>
        <AlternateNameType>OID, NRDS Standard</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRDS</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRDS</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DV.DVSTDAT</AlternateName>
        <AlternateNameType>Map:CDASHv1.1</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Theradex</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Theradex</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DV_DVSTDAT</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1384">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6413061</PUBLICID>
    <LONGNAME>Subcategory for Physical Examination</LONGNAME>
    <PREFERREDNAME>PESCAT</PREFERREDNAME>
    <PREFERREDDEFINITION>A sub-division of the PECAT values based on user defined characteristics.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6412919</PublicId>
      <PreferredName>6407676v1.0:6412917v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to physical exam._A subdivision of physical examination data.</PreferredDefinition>
      <LongName>Physical Exam Domain Physical Examination Subcategory</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407676</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49608</PreferredName>
        <Version>1</Version>
        <LongName>Physical Exam Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49608</PREFERRED_NAME>
            <LONG_NAME>Physical Exam Domain</LONG_NAME>
            <CON_ID>2469072</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6412917</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83355</PreferredName>
        <Version>1</Version>
        <LongName>Physical Examination Subcategory</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83355</PREFERRED_NAME>
            <LONG_NAME>Physical Examination Subcategory</LONG_NAME>
            <CON_ID>6412916</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[PE Subcategory]; NULL</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was subcategory of the p</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was subcategory of the physical examination?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the physical examination subcategory, if not pre-printed on the CRF.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PESCAT</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>Sponsor-defined Controlled Terminology. The CRF can capture the different subtypes of Physical Exams categories using PESCAT. This may be pre-printed on the CRF. If PESCAT is not collected (e.g. it is self-evident from the protocol design), it could be populated during the SDTM-based dataset creation process. PESCAT can only be used if there is a PECAT and it must be a subcategorization of PECAT.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>[PE Subcategory]; NULL</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Physical Examination (PE) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329807</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Semantically Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685479</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Physical Examination (PE) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943399</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PE_PESCAT</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1385">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6421490</PUBLICID>
    <LONGNAME>Clinical Performed Observation Outcome Data PCORnet CDM Lab Result Value</LONGNAME>
    <PREFERREDNAME>RESULT_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._Standardized/converted result for quantitative results.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3175329</PublicId>
      <PreferredName>2867629v1.0:2423441v1.0</PreferredName>
      <PreferredDefinition>Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.</PreferredDefinition>
      <LongName>Clinical Performed Observation Outcome Data</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867629</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25398:C38000:C25598:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Performed Observation Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2423441</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25474</PreferredName>
        <Version>1</Version>
        <LongName>Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6380322</PublicId>
      <PreferredName>6380322v1.0</PreferredName>
      <PreferredDefinition>Standardized/converted result for quantitative results.</PreferredDefinition>
      <LongName>PCORnet CDM Lab Result Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</Origin>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Laboratory Result Number</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Laboratory Result Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6093453</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PCORnet CDM 4.0</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lab Result</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>8003786</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RESULT_NUM</AlternateName>
        <AlternateNameType>PCORNet Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_RESULT</AlternateName>
        <AlternateNameType>PCORnet Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1386">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6421528</PUBLICID>
    <LONGNAME>Procedure Reason Not Done</LONGNAME>
    <PREFERREDNAME>PRREASND</PREFERREDNAME>
    <PREFERREDDEFINITION>An explanation of why the data are not available.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6421227</PublicId>
      <PreferredName>6407261v1.0:6421225v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._The explanation given as to why an action was not completed.</PreferredDefinition>
      <LongName>Procedure Domain Not-Done Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102700</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102700</PREFERRED_NAME>
            <LONG_NAME>Procedure Domain</LONG_NAME>
            <CON_ID>6407260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6421225</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C82556</PreferredName>
        <Version>1</Version>
        <LongName>Not-Done Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82556</PREFERRED_NAME>
            <LONG_NAME>Not-Done Reason</LONG_NAME>
            <CON_ID>6421224</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Provide the reason why the procedure was not done.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PRREASND</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>The reason the data are not available may be chosen from a sponsor defined list (or example, broken equipment, subject refused, etc.) or entered as free text. When PRREASND is used, the SDTMIG variable PRSTAT should also be populated in the SDTM-based dataset. The value &quot;NOT DONE&quot; here indicates that the subject was not questioned/data was not collected. It does not mean that the subject did not have the procedure.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason not done</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the reason not done?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the reason not done?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If evaluation was not done specify reason</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If &quot;Other&quot;, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If bone marrow biopsy was not performed, please specify why it was not done:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If bone marrow aspirate was not performed, please specify why it was not done:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If MIBG scan was not performed, please specify why not done:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If bone marrow evaluation was not done, please specify why it was not done:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other Specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Other, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the reason not done?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Procedures (PR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329808</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-Up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000342</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Event</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000436</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Procedures (PR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943401</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR_PRREASND_MUGA</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR_PRREASND_ECHO</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR_PRREASND_OCULAR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OTHSP_PRREASND</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR_PRREASND_BM</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR_PRREASND_BMASP</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR_PRREASND_BMBX</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR_PRREASND_MIBG</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TR_TRDAT_ENDO_OTH</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TR_TRDAT_DRE_OTH</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TR_TRDAT_MRIT2WI_OTH</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TR_TRDAT_MRIDW_CRO</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TR_TRREASND_ENDO_OTH</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TR_TRREASND_DRE_OTH</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TR_TRREASND_MRIT2WI_OTH</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TR_TRREASND_MRIDW_OTH</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR_PRREASND_SURG_OTHS</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR_PRREASND_MRI</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PR_PRREASND</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1387">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6421544</PUBLICID>
    <LONGNAME>Education Level</LONGNAME>
    <PREFERREDNAME>EDLEVEL_SCORRES</PREFERREDNAME>
    <PREFERREDDEFINITION>Result of the [SCTEST] as originally received or collected.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6421275</PublicId>
      <PreferredName>6408455v1.0:6421273v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject characteristics._An indication of the years of schooling completed in graded public, private, or parochial schools, and in colleges, universities, or professional schools._The earliest outcome of the subject characteristics assessment.</PreferredDefinition>
      <LongName>Subject Characteristics Domain Education Level Subject Characteristics Original Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6408455</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49610</PreferredName>
        <Version>1</Version>
        <LongName>Subject Characteristics Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49610</PREFERRED_NAME>
            <LONG_NAME>Subject Characteristics Domain</LONG_NAME>
            <CON_ID>2469075</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6421273</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17953:C83107</PreferredName>
        <Version>1</Version>
        <LongName>Education Level Subject Characteristics Original Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17953</PREFERRED_NAME>
            <LONG_NAME>Education Level</LONG_NAME>
            <CON_ID>2202380</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83107</PREFERRED_NAME>
            <LONG_NAME>Subject Characteristics Original Result</LONG_NAME>
            <CON_ID>6421266</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Education Level</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the subject&#39;s educati</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the subject&#39;s education level?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the result.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SCORRES;SCTEST;SCTESTCD</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable. In addition to the SDTMIG variable SCORRES, create the SDTMIG variable SCTESTCD from the CDASH variable name and determine the value of SCTEST from SCTESTCD. The CDASH prompt may also contain the SCTEST. Use appropriate CDISC Controlled Terminology for the test and test code.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>Each test may be collected using the CDASH variable [TESTCD] (e.g., EDLEVEL) or [TESTCD]_SCORRES where TESTCD is the appropriate CT for the SC test code e.g., EDLEVEL_SCORRES.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Highest Education Level</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the level of education attained?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the level of education attained?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Level of education attained</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Level of education attained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the subject&#39;s education level?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2552643</PublicId>
          <ContextName>Training</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Training Class Examples</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3637837</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Optional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329805</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Subject Characteristics (SC) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329811</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Demography</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7473997</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Moonshot Biobank</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13484615</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTDC CDISC CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14645981</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Subject Characteristics (SC) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943406</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Theradex</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Theradex</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SC_SCORRES_EDULEV</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HIGHEST_EDUCATION_LEVEL</AlternateName>
        <AlternateNameType>CMB Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SC_SCORRES_EDLEVEL</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1388">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6421550</PUBLICID>
    <LONGNAME>Flare Size</LONGNAME>
    <PREFERREDNAME>FLARESZ_SRORRES</PREFERREDNAME>
    <PREFERREDDEFINITION>The size of the area of redness that forms around the site of an antigenic challenge to the skin.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6421312</PublicId>
      <PreferredName>6407705v1.0:6421310v1.0</PreferredName>
      <PreferredDefinition>A findings domain for assessments that determine whether a therapy induced an immune response._The size of the area of redness that forms around the site of an antigenic challenge to the skin._The outcome of the skin response assessment as originally received or collected.</PreferredDefinition>
      <LongName>Skin Response Domain Flare Size Skin Response Original Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407705</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C112420</PreferredName>
        <Version>1</Version>
        <LongName>Skin Response Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C112420</PREFERRED_NAME>
            <LONG_NAME>Skin Response Domain</LONG_NAME>
            <CON_ID>6407704</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6421310</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C112283:C117679</PreferredName>
        <Version>1</Version>
        <LongName>Flare Size Skin Response Original Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C112283</PREFERRED_NAME>
            <LONG_NAME>Antigenic Skin Flare Size Measurement</LONG_NAME>
            <CON_ID>6409758</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117679</PREFERRED_NAME>
            <LONG_NAME>Skin Response Original Result</LONG_NAME>
            <CON_ID>6421309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the test result.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SRORRES;SRTEST;SRTESTCD</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable. In addition to the SDTMIG variable SRORRES, create the SDTMIG variable SRTESTCD from the CDASH variable name and determine the value of SRTEST from SRTESTCD. The CDASH prompt may also contain the SRTEST. Use appropriate CDISC Controlled Terminology for the test and test code.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>Each test may be collected using the CDASH variable [TESTCD] (e.g., FLARESZ) or [TESTCD]_SRORRES where TESTCD is the appropriate CT for the SR test code e.g., FLARESZ_SRORRES.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Flare Size</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the result of the fl</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the result of the flare size measurement?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the result of the flare size measurement?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Recommended/Conditional Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329810</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Skin Response (SR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Skin Response (SR) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943407</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SR_SRORRES_FLARESZ</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1389">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6421597</PUBLICID>
    <LONGNAME>Death Details Result</LONGNAME>
    <PREFERREDNAME>DDTESTCD_DDORRES</PREFERREDNAME>
    <PREFERREDDEFINITION>Result of the death detail assessment, as originally received or collected.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6421589</PublicId>
      <PreferredName>6408103v1.0:6421587v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to death diagnosis._A character or string that represents the short code name of the death diagnosis assessment._The outcome of the death diagnosis assessment as originally received or collected.</PreferredDefinition>
      <LongName>Death Diagnosis Domain Death Diagnosis Assessment Test Code Death Diagnosis Original Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6408103</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95087</PreferredName>
        <Version>1</Version>
        <LongName>Death Diagnosis Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95087</PREFERRED_NAME>
            <LONG_NAME>Death Diagnosis Domain</LONG_NAME>
            <CON_ID>6408102</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6421587</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117544:C117546</PreferredName>
        <Version>1</Version>
        <LongName>Death Diagnosis Assessment Test Code Death Diagnosis Original Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117544</PREFERRED_NAME>
            <LONG_NAME>Death Diagnosis Assessment Test Code</LONG_NAME>
            <CON_ID>6413081</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117546</PREFERRED_NAME>
            <LONG_NAME>Death Diagnosis Original Result</LONG_NAME>
            <CON_ID>6421572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6400810</PublicId>
      <PreferredName>CDISCRES</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The result of an action.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6400811</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C20200</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH PROMPT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Result</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the death detail ass</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the death detail assessment result?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Case Report Form  Completion Instructions</Name>
        <DocumentType>CDISC CRF Instruction</DocumentType>
        <DocumentText>Record the death detail response.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DDORRES; DDTEST; DDTESTCD;</Name>
        <DocumentType>CDASH to SDTM Mapping</DocumentType>
        <DocumentText>Maps directly to the SDTMIG variable. In addition to the SDTMIG variable DDORRES, create DDTESTCD from the CDASH variable name and determine the value of DDTEST from DDTESTCD. The CDASH prompt may also contain the DDTEST. Use appropriate CDISC Controlled Terminology for the test and test code.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDASH Implementation Notes</Name>
        <DocumentType>CDASH Implementation Note</DocumentType>
        <DocumentText>Each test may be collected using the CDASH variable [TESTCD] (e.g., PRCDTH) or [TESTCD]_DDORRES where TESTCD is the appropriate CT for the DD test code e.g., PRCDTH_DDORRES. This CDASH variable name is an example of what &quot;variable name&quot; can be used in a denormalized data structure.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the death detail assessment result?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDASH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6338163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Death (DD) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329791</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Highly Recommended Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329800</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Death (DD) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000714</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Death (DD) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943376</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DD_DDORRES_DDTESTCD</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DD</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DDTESTCD_DDORRES</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1390">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6436434</PUBLICID>
    <LONGNAME>Cancer Survivorship Research Document Submission Type</LONGNAME>
    <PREFERREDNAME>CAN_SUR_RES_DOC_SUB_TYPE</PREFERREDNAME>
    <PREFERREDDEFINITION>The method used to submit the survivorship care plan.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6435312</PublicId>
      <PreferredName>6435309v1.0:6435310v1.0</PreferredName>
      <PreferredDefinition>Research on cancer survivors, covers the full spectrum of biomedical and psycho-social issues that arise at the point of discontinuation of cancer-specific therapy to the point of terminal diagnosis (6 months or less to live)._A physical object, or electronic counterpart, that is characterized by containing writing which is meant to be human-readable._The act of referring for judgment or consideration by others; the act of handing over something.</PreferredDefinition>
      <LongName>Cancer Survivorship Research Document Submission</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6435309</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18674</PreferredName>
        <Version>1</Version>
        <LongName>Cancer Survivorship Research</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18674</PREFERRED_NAME>
            <LONG_NAME>Cancer Survivorship Research</LONG_NAME>
            <CON_ID>3521342</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6435310</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19498:C25695</PreferredName>
        <Version>1</Version>
        <LongName>Document Submission</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19498</PREFERRED_NAME>
            <LONG_NAME>Document</LONG_NAME>
            <CON_ID>2223216</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25695</PREFERRED_NAME>
            <LONG_NAME>Submission</LONG_NAME>
            <CON_ID>2203811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6436432</PublicId>
      <PreferredName>6436432v1.0</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Cancer Survivorship Research Document Submission Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mail</VALIDVALUE>
          <VALUEMEANING>Mail</VALUEMEANING>
          <MEANINGDESCRIPTION>Mail</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-09-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not sent</VALIDVALUE>
          <VALUEMEANING>Not sent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not sent</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2018-09-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6436433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Electronic</VALIDVALUE>
          <VALUEMEANING>Electronic</VALUEMEANING>
          <MEANINGDESCRIPTION>A questionnaire or measure that is administered on an electronic device, such as a computer, tablet, or smartphone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C154486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6379823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fax</VALIDVALUE>
          <VALUEMEANING>Fax</VALUEMEANING>
          <MEANINGDESCRIPTION>Fax is short for facsimile, a telecommunications technology used to transfer copies of documents using devices operating over the telephone network.  It is used to refer both to the activity and the resulting document.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2990717</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Method used to send SCP to PC</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Method used to send SCP to PCP/Cardiologist</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1391">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6459257</PUBLICID>
    <LONGNAME>Psychiatric Diagnostic and Statistical Manual of Mental Disorders, 4th Edition Post-Traumatic Stress Disorder Reaction Index Assessment Text</LONGNAME>
    <PREFERREDNAME>Psyc_Diag_Post_Reac_Inde_ASSES</PREFERREDNAME>
    <PREFERREDDEFINITION>Symptoms, physical examination results, and/or laboratory test results related to mental health.:Published by the American Psychiatric Association, the DSM is a listing of currently recognized mental health disorders and their diagnostic criteria, for children and adults. It includes statistical information on etiology, incidence, prevalence, age of onset and prognosis. The 4th edition was published in 1994. As new information becomes available subsequent editions are published._An anxiety disorder precipitated by an experience of intense fear or horror while exposed to a traumatic (especially life-threatening) event. The disorder is characterized by intrusive recurring thoughts or images of the traumatic event; avoidance of anything associated with the event; a state of hyperarousal and diminished emotional responsiveness. These symptoms are present for at least one month and the disorder is usually long-term._A response generated by a stimulus._A numerical scale used to compare variables with one another or with some reference number; a number used to select an element of a list, vector, array or other sequence._a free text field to specify information on the evaluations of the patient and the patient&#39;s disease</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6459252</PublicId>
      <PreferredName>14148235v1.00:6133131v1.00</PreferredName>
      <PreferredDefinition>Symptoms, physical examination results, and/or laboratory test results related to mental health.:Published by the American Psychiatric Association, the DSM is a listing of currently recognized mental health disorders and their diagnostic criteria, for children and adults. It includes statistical information on etiology, incidence, prevalence, age of onset and prognosis. The 4th edition was published in 1994. As new information becomes available subsequent editions are published._An anxiety disorder precipitated by an experience of intense fear or horror while exposed to a traumatic (especially life-threatening) event. The disorder is characterized by intrusive recurring thoughts or images of the traumatic event; avoidance of anything associated with the event; a state of hyperarousal and diminished emotional responsiveness. These symptoms are present for at least one month and the disorder is usually long-term._A response generated by a stimulus._A numerical scale used to compare variables with one another or with some reference number; a number used to select an element of a list, vector, array or other sequence.</PreferredDefinition>
      <LongName>Psychiatric Diagnostic and Statistical Manual of Mental Disorders, 4th Edition Post-Traumatic Stress Disorder Reaction Index</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14148235</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C168404</PreferredName>
        <Version>1</Version>
        <LongName>Psychiatric Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C168404</PREFERRED_NAME>
            <LONG_NAME>Psychiatric Finding</LONG_NAME>
            <CON_ID>10042562</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6133131</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C86966:C3389:C25637:C25390</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic and Statistical Manual of Mental Disorders, 4th Edition Post-Traumatic Stress Disorder Reaction Index</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C86966</PREFERRED_NAME>
            <LONG_NAME>Diagnostic and Statistical Manual of Mental Disorders, 4th Edition</LONG_NAME>
            <CON_ID>3013012</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3389</PREFERRED_NAME>
            <LONG_NAME>Post-Traumatic Stress Disorder</LONG_NAME>
            <CON_ID>3075480</CON_ID>
            <DEFINITION_SOURCE>MSH2003_2003_05_12</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>RADLEX_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25637</PREFERRED_NAME>
            <LONG_NAME>Reaction</LONG_NAME>
            <CON_ID>2203961</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25390</PREFERRED_NAME>
            <LONG_NAME>Index</LONG_NAME>
            <CON_ID>2203825</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018321</PublicId>
      <PreferredName>ASSESS_TXT</PreferredName>
      <PreferredDefinition>a free text field to specify information on the evaluations of the patient and the patient&#39;s disease</PreferredDefinition>
      <LongName>Assessment Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184342</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Text</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Psychiatric Diagnostic and Statistical Manual of Mental Disorders, 4th Edition Post-Traumatic Stress Disorder Reaction Index Assessment Text does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Psychiatric Diagnostic and Statistical Manual of Mental Disorders, 4th Edition Post-Traumatic Stress Disorder Reaction Index Assessment Text does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Psychiatric</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3009618</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1392">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6576596</PUBLICID>
    <LONGNAME>Trochlear Nerve Assessment Status</LONGNAME>
    <PREFERREDNAME>TROCR_NRV_ASSES_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>A response used to indicate the condition or state of the trochlear nerve.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Princess Margaret Cancer Centre, Toronto, ON</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6576593</PublicId>
      <PreferredName>6576591v1.0:2465182v1.0</PreferredName>
      <PreferredDefinition>The cranial nerve that controls the superior oblique muscle of the eye._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Trochlear Nerve Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6576591</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12808</PreferredName>
        <Version>1</Version>
        <LongName>Trochlear Nerve</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12808</PREFERRED_NAME>
            <LONG_NAME>Trochlear Nerve</LONG_NAME>
            <CON_ID>5043306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2465182</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25217</PreferredName>
        <Version>1</Version>
        <LongName>Assessed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Princess Margaret Cancer Centre, Toronto, ON</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6576579</PublicId>
      <PreferredName>6576579v1.0</PreferredName>
      <PreferredDefinition>Part of the peripheral nervous system composed of bundles of nerve fibers running to various organs and tissues of the body using chemical and electrical signals to transmit sensory and motor information from one body part to another._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Nerve Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>Princess Margaret Cancer Centre, Toronto, ON</Origin>
      <Representation>
        <PublicId>6576578</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12466:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Nerve Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12466</PREFERRED_NAME>
            <LONG_NAME>Nerve</LONG_NAME>
            <CON_ID>2202756</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Intact</VALIDVALUE>
          <VALUEMEANING>Negation Intact</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Undamaged in any way; whole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62399, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6576580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intact</VALIDVALUE>
          <VALUEMEANING>Intact</VALUEMEANING>
          <MEANINGDESCRIPTION>Undamaged in any way; whole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568753</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Trochlear Nerve</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Trochlear Nerve</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>16445930</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PMCC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PMCC Curation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16445931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1393">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6576602</PUBLICID>
    <LONGNAME>Gastric Cancer AJCC Edition 8 Postneodjuvant Therapy Group Stage</LONGNAME>
    <PREFERREDNAME>GAST_AJC8_PTX_STG</PREFERREDNAME>
    <PREFERREDDEFINITION>Postneodjuvant treatment stage group based on the combination of T, N, and M categories and relevant prognostic factors for gastric carcinoma, using AJCC Ed. 8 criteria.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6576380</PublicId>
      <PreferredName>3443882v1.0:6576378v1.0</PreferredName>
      <PreferredDefinition>Relating to the stomach._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Happening at a time subsequent to a reference time; later in time or order._The administration of therapeutic agents prior to the primary treatment for the purpose of making the primary treatment more effective._An assessment based on the combined evaluation of the patient&#39;s T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.</PreferredDefinition>
      <LongName>Gastric Neoplasm Post Neoadjuvant Therapy Stage Grouping</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3443882</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13307:C3262</PreferredName>
        <Version>1</Version>
        <LongName>Gastric Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13307</PREFERRED_NAME>
            <LONG_NAME>Gastric</LONG_NAME>
            <CON_ID>2204923</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6576378</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38008:C15665:C38027</PreferredName>
        <Version>1</Version>
        <LongName>Post Neoadjuvant Therapy Stage Grouping</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15665</PREFERRED_NAME>
            <LONG_NAME>Neoadjuvant Therapy</LONG_NAME>
            <CON_ID>2206319</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38027</PREFERRED_NAME>
            <LONG_NAME>Stage Grouping</LONG_NAME>
            <CON_ID>2230142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6576558</PublicId>
      <PreferredName>6576558v1.0</PreferredName>
      <PreferredDefinition>A term that refers to the postneoadjuvant therapy staging of gastric cancer according to the American Joint Committee on Cancer, 8th edition._An assessment based on the combined evaluation of the patient&#39;s T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.</PreferredDefinition>
      <LongName>Gastric Carcinoma American Joint Committee on Cancer Edition 8 Postneoadjuvant Therapy Group Stage</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
      <Representation>
        <PublicId>6576557</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C133641:C38027:C16899</PreferredName>
        <Version>1</Version>
        <LongName>Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage Stage Grouping Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C133641</PREFERRED_NAME>
            <LONG_NAME>Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage</LONG_NAME>
            <CON_ID>6576556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38027</PREFERRED_NAME>
            <LONG_NAME>Stage Grouping</LONG_NAME>
            <CON_ID>2230142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IV</VALIDVALUE>
          <VALUEMEANING>Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133673</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6576560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>III</VALIDVALUE>
          <VALUEMEANING>Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Stage III includes: (T4a, N1, M0); (T3, N2, M0); (T2, N3, M0); (T4b, N0, M0); (T4b, N1, M0); (T4a, N2, M0); (T3, N3, M0); (T4b, N2, M0); (T4b, N3, M0); (T4a, N3, M0). T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133672</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6576562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>II</VALIDVALUE>
          <VALUEMEANING>Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Stage II includes: (T3, N0, M0); (T2, N1, M0); (T1, N2, M0); (T4a, N0, M0); (T3, N1, M0); (T2, N2, M0); (T1, N3, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133671</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6576564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>I</VALIDVALUE>
          <VALUEMEANING>Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Stage I includes: (T1, N0, M0); (T2, N0, M0); (T1, N1, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6576566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Postneodjuvant therapy diseas</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Postneodjuvant therapy disease stage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AJCC Edition 8</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6005920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Stomach</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000182</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1394">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6584270</PUBLICID>
    <LONGNAME>International Classification of Diseases for Oncology, Third Edition Histology Code Specify</LONGNAME>
    <PREFERREDNAME>ICD-O-3_histology_other</PREFERREDNAME>
    <PREFERREDDEFINITION>text to specify other ICD-O-3 histology code</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>OCG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HCMI:Human Cancer Models Initiative</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3226274</PublicId>
      <PreferredName>3226272v1.0:2222855v1.0</PreferredName>
      <PreferredDefinition>The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>International Classification of Diseases for Oncology, Third Edition Histology Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3226272</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C87061:C16681</PreferredName>
        <Version>1</Version>
        <LongName>International Classification of Diseases for Oncology, Third Edition Histology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C87061</PREFERRED_NAME>
            <LONG_NAME>International Classification of Diseases for Oncology, Third Edition</LONG_NAME>
            <CON_ID>3007232</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16681</PREFERRED_NAME>
            <LONG_NAME>Histology</LONG_NAME>
            <CON_ID>2202345</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6584269</PublicId>
      <PreferredName>C0332437:6584269v1.0</PreferredName>
      <PreferredDefinition>Five-digit codes representing the histology  (morphology) of neoplasms from the International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3). The first four digits indicate the specific histological term. The fifth digit after the slash or solidus (/) is a behaviour code which indicates whether a tumour is malignant, benign, in situ, or uncertain whether benign or malignant. [Explanatory Comment: A URL to a downloadable Excel file containing the permissible values for this Value Domain is provided in Reference Documents.]</PreferredDefinition>
      <LongName>Specify ICD-O-3 Morphology Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008562</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ICD-O-3</PreferredName>
        <Version>1</Version>
        <LongName>ICD-O-3</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify morphology</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify morphology</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rare Cancers</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7589449</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1395">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6586584</PUBLICID>
    <LONGNAME>Iris Uveal Melanoma AJCC Edition 8 Clinical Distant Metastasis M Category</LONGNAME>
    <PREFERREDNAME>IRIS_AJC8_CLN_M_CAT</PREFERREDNAME>
    <PREFERREDDEFINITION>Extent of the distant metastasis for iris melanoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6584938</PublicId>
      <PreferredName>6584932v1.0:2207806v1.0</PreferredName>
      <PreferredDefinition>The colored disc of the eye composed of connective tissue, epithelium, and endothelium. It separates the anterior chamber from the posterior chamber._A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. M refers to the presence of metastasis.</PreferredDefinition>
      <LongName>Iris Uveal Melanoma Clinical M Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6584932</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12737:C7712</PreferredName>
        <Version>1</Version>
        <LongName>Iris Uveal Melanoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12737</PREFERRED_NAME>
            <LONG_NAME>Iris</LONG_NAME>
            <CON_ID>4134130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C7712</PREFERRED_NAME>
            <LONG_NAME>Uveal Melanoma</LONG_NAME>
            <CON_ID>3251351</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207806</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25398:C25727</PreferredName>
        <Version>1</Version>
        <LongName>Clinical M Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25727</PREFERRED_NAME>
            <LONG_NAME>M Category</LONG_NAME>
            <CON_ID>2204010</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6586487</PublicId>
      <PreferredName>6586487v1.0</PreferredName>
      <PreferredDefinition>A clinical finding about one or more characteristics of uveal melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Uveal Melanoma American Joint Committee on Cancer Edition 8 Clinical M Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>3</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
      <Representation>
        <PublicId>6586502</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C140605:C39315:C25727:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Uveal Melanoma Clinical Distant Metastasis TNM Finding v8 American Joint Committee on Cancer M Category Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C140605</PREFERRED_NAME>
            <LONG_NAME>Uveal Melanoma Clinical Distant Metastasis TNM Finding v8</LONG_NAME>
            <CON_ID>6586501</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39315</PREFERRED_NAME>
            <LONG_NAME>American Joint Committee on Cancer</LONG_NAME>
            <CON_ID>2554142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25727</PREFERRED_NAME>
            <LONG_NAME>M Category</LONG_NAME>
            <CON_ID>2204010</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pM1</VALIDVALUE>
          <VALUEMEANING>Uveal Melanoma pM1 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Uveal melanoma with distant metastasis. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140613</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6586489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cM1c</VALIDVALUE>
          <VALUEMEANING>Uveal Melanoma cM1c TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Uveal melanoma with largest diameter of the largest metastasis 8.1 cm or more. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6586491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cM1b</VALIDVALUE>
          <VALUEMEANING>Uveal Melanoma cM1b TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Uveal melanoma with largest diameter of the largest metastasis 3.1-8.0 cm. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6586493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cM1a</VALIDVALUE>
          <VALUEMEANING>Uveal Melanoma cM1a TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Uveal melanoma with largest diameter of the largest metastasis 3.0 cm or less. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6586495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cM1</VALIDVALUE>
          <VALUEMEANING>Uveal Melanoma cM1 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Uveal melanoma with distant metastasis. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140607</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6586497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cM0</VALIDVALUE>
          <VALUEMEANING>Uveal Melanoma cM0 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Uveal melanoma with no distant metastasis by clinical classification. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C140606</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6586499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Clinical M category</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Clinical M category</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AJCC Edition 8</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6005920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Uveal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6581919</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1396">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6617457</PUBLICID>
    <LONGNAME>Iron Chelation Therapeutic Procedure Negation Fulfill Criterion Reason Specify</LONGNAME>
    <PREFERREDNAME>6617445v1.0:6609353v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The free-text field to describe the reason why the iron chelation therapeutic procedure criteria was not fulfilled.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6617445</PublicId>
      <PreferredName>6617400v1.0:6617443v1.0</PreferredName>
      <PreferredDefinition>Iron Chelation involves non-covalent coordination bonding between iron and an organic chemical, often as part of an enzyme or protein complex, as in the iron-binding porphyrin group of hemoglobin._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._An operation in which a term denies or inverts the meaning of another term or construction._Satisfy the requirements or expectations of._That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.</PreferredDefinition>
      <LongName>Iron Chelation Therapeutic Procedure Negation Fulfill Criterion</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435033</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16847</PreferredName>
        <Version>1</Version>
        <LongName>Techniques</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6617400</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C40516:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Iron Chelation Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40516</PREFERRED_NAME>
            <LONG_NAME>Iron Chelation</LONG_NAME>
            <CON_ID>2873820</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6617443</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C87531:C25466</PreferredName>
        <Version>1</Version>
        <LongName>Negation Fulfill Criterion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C87531</PREFERRED_NAME>
            <LONG_NAME>Fulfill</LONG_NAME>
            <CON_ID>3017448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25466</PREFERRED_NAME>
            <LONG_NAME>Criterion</LONG_NAME>
            <CON_ID>2203889</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6609353</PublicId>
      <PreferredName>6609353v1.0</PreferredName>
      <PreferredDefinition>An explanation of the cause of some phenomenon or action._Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Reason Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>6609352</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638:C25685</PreferredName>
        <Version>1</Version>
        <LongName>Reason Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify why the iron chelatio</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify why the iron chelation therapeutic procedure criteria was not fulfilled:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other reason criteria not met:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify other reason criteria not met:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other reason criteria not met:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify other reason criteria not met:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_IAED_i_ch_cr_nt_mt_rsn_sp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_HMGL_i_ch_cr_nt_mt_rsn_sp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1397">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6622278</PUBLICID>
    <LONGNAME>HHIA-S 3 Difficulty Hearing or Understanding Co-workers, Clients, or Customers Due to Hearing Problem Score 3 Point Scale</LONGNAME>
    <PREFERREDNAME>HHIA_S_3_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation indicating whether they have difficulty hearing / understanding co-workers, clients or customers, using a three-point scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6622261</PublicId>
      <PreferredName>6622235v1.0:6622259v1.0</PreferredName>
      <PreferredDefinition>A 10-item questionnaire, derived from the Hearing Handicap Inventory for the Elderly, developed to assess how adult individuals under 65 perceive the social and emotional effects of hearing loss._A question about whether an individual has or had difficulty hearing or understanding co-workers, clients or customers._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Hearing Handicap Inventory Screening Questionnaire for Adults Difficulty Hearing or Understanding Co-workers, Clients, or Customers Due to Hearing Problem Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6622235</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C157368</PreferredName>
        <Version>1</Version>
        <LongName>Hearing Handicap Inventory Screening Questionnaire for Adults</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C157368</PREFERRED_NAME>
            <LONG_NAME>Hearing Handicap Inventory Screening Questionnaire for Adults</LONG_NAME>
            <CON_ID>6618500</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6622259</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C157326:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Difficulty Hearing or Understanding Co-workers, Clients, or Customers Due to Hearing Problem Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C157326</PREFERRED_NAME>
            <LONG_NAME>Difficulty Hearing or Understanding Co-workers, Clients, or Customers Due to Hearing Problem Question</LONG_NAME>
            <CON_ID>6617484</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4134550</PublicId>
      <PreferredName>IND_3PT_SCL</PreferredName>
      <PreferredDefinition>an ordered reference standard.</PreferredDefinition>
      <LongName>Indicator 3 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>HHIE-S:Hearing Handicap Inventory for the Elderly Screening Version, Ventry &amp; Weinstein, 1983</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3945562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Do you have difficulty hearin</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Do you have difficulty hearing / understanding co-workers, clients or customers?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6615075</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HHIE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HHIA-S</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Form Type</ClassificationSchemeItemType>
        <CsiPublicId>6629769</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1398">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6634067</PUBLICID>
    <LONGNAME>Sequence Number</LONGNAME>
    <PREFERREDNAME>AESEQ</PREFERREDNAME>
    <PREFERREDDEFINITION>An identifier that describes the relative position of adverse event data within a series.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6633799</PublicId>
      <PreferredName>2514626v1.0:6633797v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to an adverse event._An identifier that describes the relative position of adverse event data within a series.</PreferredDefinition>
      <LongName>Adverse Event Domain Adverse Event Sequence Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2514626</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49562</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Submission Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49562</PREFERRED_NAME>
            <LONG_NAME>Adverse Event Domain</LONG_NAME>
            <CON_ID>2469047</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6633797</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83213</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Sequence Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83213</PREFERRED_NAME>
            <LONG_NAME>Adverse Event Sequence Number</LONG_NAME>
            <CON_ID>6633796</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6623992</PublicId>
      <PreferredName>CDISCNUM</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6623991</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25337</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Sequence Number</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Sequence Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Required</Name>
        <DocumentType>SDTM Core</DocumentType>
        <DocumentText>Required</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDTM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7218795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events (AE) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7329786</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AESEQ</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AE</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1399">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6648433</PUBLICID>
    <LONGNAME>Treatment Cohort Study 10246 Code</LONGNAME>
    <PREFERREDNAME>TX_COHT_SDY_10246_CD</PREFERREDNAME>
    <PREFERREDDEFINITION>The code that represents the information pertaining to protocol 10246 in which subsets of a defined population are identified.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2497526</PublicId>
      <PreferredName>TX_COHORT_STDY</PreferredName>
      <PreferredDefinition>Medical care intended to treat or cure a condition or lessen its symptoms. This includes the administration of drugs, surgical procedures, physical or psychotherapy, or the use of therapeutic devices.:A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).</PreferredDefinition>
      <LongName>Therapeutic Procedure Cohort Study</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2497524</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15208</PreferredName>
        <Version>1</Version>
        <LongName>Cohort Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15208</PREFERRED_NAME>
            <LONG_NAME>Cohort Study</LONG_NAME>
            <CON_ID>2497523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6648020</PublicId>
      <PreferredName>6648020v1.0</PreferredName>
      <PreferredDefinition>A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.</PreferredDefinition>
      <LongName>10246 Cohort Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
      <Representation>
        <PublicId>4386398</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61512:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Cohort Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61512</PREFERRED_NAME>
            <LONG_NAME>Cohort</LONG_NAME>
            <CON_ID>2555083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SG2</VALIDVALUE>
          <VALUEMEANING>PARTB Dose Expansion</VALUEMEANING>
          <MEANINGDESCRIPTION>PARTB Dose Expansion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6648021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SG1</VALIDVALUE>
          <VALUEMEANING>PARTA Dose Escalation</VALUEMEANING>
          <MEANINGDESCRIPTION>PARTA Dose Escalation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6648022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Subgroup</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Subgroup</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1400">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6681206</PUBLICID>
    <LONGNAME>Other Transfer Genetic Or Clonality Abnormality Disease or Disorder Present Specify Text</LONGNAME>
    <PREFERREDNAME>6681204v1.0:2799057v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The free-text field that describes another transferable genetic or clonal abnormality disease or disorder that was present.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6681204</PublicId>
      <PreferredName>6681202v1.0:2233878v1.0</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._The act of conveying or transporting from one place to another._Having to do with information that is passed from parents to offspring through genes in sperm and egg cells._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Related by descent from a single progenitor cell._A condition that differs from the usual physical or mental state._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Other Transfer Genetic Or Clonality Abnormality Disease or Disorder Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6681202</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>6681202v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Other Transfer Genetic Or Clonality Abnormality Disease or Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48167</PREFERRED_NAME>
            <LONG_NAME>Transfer</LONG_NAME>
            <CON_ID>2422624</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17938</PREFERRED_NAME>
            <LONG_NAME>Genetic</LONG_NAME>
            <CON_ID>2206224</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18304</PREFERRED_NAME>
            <LONG_NAME>Clonality</LONG_NAME>
            <CON_ID>2615826</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9440</PREFERRED_NAME>
            <LONG_NAME>Abnormality</LONG_NAME>
            <CON_ID>2203567</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25626</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2799057</PublicId>
      <PreferredName>SPC_TXT</PreferredName>
      <PreferredDefinition>Be specific about something; define clearly._Text; the words of something written.</PreferredDefinition>
      <LongName>Specify Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2799056</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25685:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Specify Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the other transferab</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the other transferable genetic or clonal abnormality disease or disorder that was present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other transferable genetic or clonal abnormality:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify other transferable genetic or clonal abnormality:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify other transferable genetic or clonal abnormality:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify other transferable genetic or clonal abnormality:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_demo_oth_tr_gen_clo_ab_sp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1401">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6689893</PUBLICID>
    <LONGNAME>Adapted WLQ Past 4 Weeks How Much of the Time Did Caregiving Responsibilities Make it Difficult to Think Clearly When Working Difficulty 6 Point Scale</LONGNAME>
    <PREFERREDNAME>THINK_CLEAR_6PT_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how much of the time their caregiving responsibilities made it difficult for them to think clearly when working, using a 6 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6689694</PublicId>
      <PreferredName>6689338v1.0:6689692v1.0</PreferredName>
      <PreferredDefinition>The act of alteration or modification; changed or altered in form or character._A standardized rating scale originally developed by Lerner et al in 1998. This instrument is used to measure the degree to which health problems interfere with specific aspects of job performance and health-related productivity loss in employed individuals._A period of time consisting of the 28 days before the present._A question about how much of the time something is occurring or has occurred._A question about if an individual&#39;s caregiving responsibilities made it difficult to think clearly when working.</PreferredDefinition>
      <LongName>Change WLQ Past 4 Weeks How Much of the Time Did Caregiving Responsibilities Make it Difficult to Think Clearly When Working</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6689338</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446:C119096</PreferredName>
        <Version>1</Version>
        <LongName>Change Work Limitations Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C119096</PREFERRED_NAME>
            <LONG_NAME>Work Limitations Questionnaire</LONG_NAME>
            <CON_ID>6643422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6689692</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C110986:C111702:C159145</PreferredName>
        <Version>1</Version>
        <LongName>Past 4 Weeks How Much of the Time Did Caregiving Responsibilities Make it Difficult to Think Clearly When Working</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110986</PREFERRED_NAME>
            <LONG_NAME>Past 4 Weeks</LONG_NAME>
            <CON_ID>3871096</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C111702</PREFERRED_NAME>
            <LONG_NAME>How Much of the Time Question</LONG_NAME>
            <CON_ID>3930498</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159145</PREFERRED_NAME>
            <LONG_NAME>Did Caregiving Responsibilities Make it Difficult to Think Clearly When Working Question</LONG_NAME>
            <CON_ID>6689434</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6689792</PublicId>
      <PreferredName>6689792v1.0</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Difficulty 6 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>45</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Does not apply to my job</VALIDVALUE>
          <VALUEMEANING>Does Not Apply to My Job</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something does not apply to an individual&#39;s job.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Difficult none of the time (0%)</VALIDVALUE>
          <VALUEMEANING>Difficult None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something is or was difficult none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Difficult a slight bit of the time</VALIDVALUE>
          <VALUEMEANING>Difficult a Slight Bit of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something is or was difficult a slight bit of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159186</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Difficult some of the time</VALIDVALUE>
          <VALUEMEANING>Difficult Some of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something is or was difficult some of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Difficult most of the time</VALIDVALUE>
          <VALUEMEANING>Difficult Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something is or was difficult most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159184</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Difficult all of the time</VALIDVALUE>
          <VALUEMEANING>Difficult All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something is or was difficult all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How much of the time did your</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How much of the time did your caregiving responsibilities make it difficult for you to think clearly when working?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1402">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6690017</PUBLICID>
    <LONGNAME>Adapted WLQ Past 4 Weeks How Much of the Time Did Caregiving Responsibilities Make it Difficult to Work Fast Enough Difficulty 6 Point Scale</LONGNAME>
    <PREFERREDNAME>WORK_FAST_6PT_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of how much of the time their caregiving responsibilities made it difficult for them to work fast enough, using a 6 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6689733</PublicId>
      <PreferredName>6689338v1.0:6689731v1.0</PreferredName>
      <PreferredDefinition>The act of alteration or modification; changed or altered in form or character._A standardized rating scale originally developed by Lerner et al in 1998. This instrument is used to measure the degree to which health problems interfere with specific aspects of job performance and health-related productivity loss in employed individuals._A period of time consisting of the 28 days before the present._A question about how much of the time something is occurring or has occurred._A question about if an individual&#39;s caregiving responsibilities made it difficult for them to work fast enough.</PreferredDefinition>
      <LongName>Change WLQ Past 4 Weeks How Much of the Time Did Caregiving Responsibilities Make it Difficult to Work Fast Enough</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6689338</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446:C119096</PreferredName>
        <Version>1</Version>
        <LongName>Change Work Limitations Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C119096</PREFERRED_NAME>
            <LONG_NAME>Work Limitations Questionnaire</LONG_NAME>
            <CON_ID>6643422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6689731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C110986:C111702:C159163</PreferredName>
        <Version>1</Version>
        <LongName>Past 4 Weeks How Much of the Time Did Caregiving Responsibilities Make it Difficult to Work Fast Enough</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110986</PREFERRED_NAME>
            <LONG_NAME>Past 4 Weeks</LONG_NAME>
            <CON_ID>3871096</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C111702</PREFERRED_NAME>
            <LONG_NAME>How Much of the Time Question</LONG_NAME>
            <CON_ID>3930498</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159163</PREFERRED_NAME>
            <LONG_NAME>Did Caregiving Responsibilities Make it Difficult to Work Fast Enough Question</LONG_NAME>
            <CON_ID>6689446</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6689792</PublicId>
      <PreferredName>6689792v1.0</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Difficulty 6 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>45</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Does not apply to my job</VALIDVALUE>
          <VALUEMEANING>Does Not Apply to My Job</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something does not apply to an individual&#39;s job.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Difficult none of the time (0%)</VALIDVALUE>
          <VALUEMEANING>Difficult None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something is or was difficult none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Difficult a slight bit of the time</VALIDVALUE>
          <VALUEMEANING>Difficult a Slight Bit of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something is or was difficult a slight bit of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159186</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Difficult some of the time</VALIDVALUE>
          <VALUEMEANING>Difficult Some of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something is or was difficult some of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689796</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Difficult most of the time</VALIDVALUE>
          <VALUEMEANING>Difficult Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something is or was difficult most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159184</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Difficult all of the time</VALIDVALUE>
          <VALUEMEANING>Difficult All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something is or was difficult all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6689798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How much of the time did your</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How much of the time did your caregiving responsibilities make it difficult for you to work fast enough?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1403">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6692738</PUBLICID>
    <LONGNAME>Lung Segmental Bronchus Location Anatomic Site</LONGNAME>
    <PREFERREDNAME>LUNG_SEG_BROC_ANAT_ST</PREFERREDNAME>
    <PREFERREDDEFINITION>The lung position on one of the divisions of the lung lobar bronchus that supplies a bronchopulmonary segment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>MCL</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MCL:Molecular and Cellular Characterization of Screened Lesions</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6690445</PublicId>
      <PreferredName>2399007v1.0:6690443v1.0</PreferredName>
      <PreferredDefinition>One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border._One of the divisions of the lobar bronchus that supplies a bronchopulmonary segment._A position, site, or point in space where something can be found.</PreferredDefinition>
      <LongName>Lung Segmental Bronchus Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>MCL</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2399007</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12468</PreferredName>
        <Version>1</Version>
        <LongName>Lung</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12468</PREFERRED_NAME>
            <LONG_NAME>Lung</LONG_NAME>
            <CON_ID>2202738</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6690443</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C33526:C25341</PreferredName>
        <Version>1</Version>
        <LongName>Segmental Bronchus Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C33526</PREFERRED_NAME>
            <LONG_NAME>Segmental Bronchus</LONG_NAME>
            <CON_ID>6690442</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MCL:Molecular and Cellular Characterization of Screened Lesions</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6690600</PublicId>
      <PreferredName>6690600v1.0</PreferredName>
      <PreferredDefinition>One of the divisions of the lobar bronchus that supplies a bronchopulmonary segment._Named locations of or within the body.</PreferredDefinition>
      <LongName>Segmental Bronchus Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>MCL</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435021</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20047</PreferredName>
        <Version>1</Version>
        <LongName>Diagnostic or Prognostic Factor</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>MCL:Molecular and Cellular Characterization of Screened Lesions</Origin>
      <Representation>
        <PublicId>6690599</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C33526:C13717</PreferredName>
        <Version>1</Version>
        <LongName>Segmental Bronchus Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C33526</PREFERRED_NAME>
            <LONG_NAME>Segmental Bronchus</LONG_NAME>
            <CON_ID>6690442</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Segmental Bronchus One</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the divisions of the lobar bronchus that supplies a bronchopulmonary segment.: The smallest natural number and quantity it denotes: a single entity, unit, or object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66832, C33526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6936205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Segmental Bronchus Six</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the divisions of the lobar bronchus that supplies a bronchopulmonary segment.: A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66837, C33526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6936207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Segmental Bronchus Five</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the divisions of the lobar bronchus that supplies a bronchopulmonary segment.: A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66836, C33526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6936208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Segmental Bronchus Nine</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the divisions of the lobar bronchus that supplies a bronchopulmonary segment.: A natural number greater than 8 and less than 10 and the quantity that it denotes: the sum of nine and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66840, C33526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6936209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Segmental Bronchus Eight</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the divisions of the lobar bronchus that supplies a bronchopulmonary segment.: A natural number greater than 7 and less than 9 and the quantity that it denotes: the sum of seven and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66839, C33526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6936210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Segmental Bronchus Seven</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the divisions of the lobar bronchus that supplies a bronchopulmonary segment.: A natural number greater than 6 and less than 8 and the quantity that it denotes: the sum of six and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66838, C33526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6936211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Segmental Bronchus Four</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the divisions of the lobar bronchus that supplies a bronchopulmonary segment.: A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66835, C33526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6936212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Segmental Bronchus Three</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the divisions of the lobar bronchus that supplies a bronchopulmonary segment.: A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66834, C33526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6936213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Segmental Bronchus Two</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the divisions of the lobar bronchus that supplies a bronchopulmonary segment.: A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66833, C33526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6936214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>Segmental Bronchus Ten</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the divisions of the lobar bronchus that supplies a bronchopulmonary segment.: A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69122, C33526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6936215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not reported</VALIDVALUE>
          <VALUEMEANING>Not Reported</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Segment</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Segment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-PCA-Lung-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lung segment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-Template Name</Name>
        <DocumentType>Data Collection Template</DocumentType>
        <DocumentText>lung_v0_2021_08_25-metrics.xlsx</DocumentText>
        <URL>https://mcl.nci.nih.gov/resources/standards/mcl-cdes</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506111</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Lung</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung Core</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5858017</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506111</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Lung</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung PCA Pilot</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7781146</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6437797</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Pre-Cancer Atlas (PCA) Pilot</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung PCA Pilot</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7001792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>MCL</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>segment</AlternateName>
        <AlternateNameType>MCL Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1404">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6701309</PUBLICID>
    <LONGNAME>Barthel Index Total Score</LONGNAME>
    <PREFERREDNAME>BARTHEL100_TOTAL_SCR</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric representation of the sum of scores for ten items from the Barthel Index.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Barthel Index:Barthel Index of Activities of Daily Living. Collin et al., 1988</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5654282</PublicId>
      <PreferredName>5654250v1.0:2714576v1.0</PreferredName>
      <PreferredDefinition>A clinical assessment tool designed to measure functional independence and need for assistance in mobility, self-care, and activities of daily living._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Barthel Index of Activities of Daily Living Total Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5654250</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C131914</PreferredName>
        <Version>1</Version>
        <LongName>Barthel Index of Activities of Daily Living</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131914</PREFERRED_NAME>
            <LONG_NAME>Barthel Index of Activities of Daily Living</LONG_NAME>
            <CON_ID>5653125</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2714576</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25304:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Total Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25304</PREFERRED_NAME>
            <LONG_NAME>Total</LONG_NAME>
            <CON_ID>2204938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Barthel Index:Barthel Index of Activities of Daily Living. Collin et al., 1988</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6690811</PublicId>
      <PreferredName>BI100_TTL_SCR</PreferredName>
      <PreferredDefinition>A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Barthel Index 100 Total Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>100</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>Barthel Index:Barthel Index of Activities of Daily Living. Collin et al., 1988</Origin>
      <Representation>
        <PublicId>2193207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total Score</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Total Score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5653600</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Barthel Index</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barthel Index 100 Scale</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6701298</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1405">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6730433</PUBLICID>
    <LONGNAME>Memorial Symptom Assessment Scale (MSAS) 7-12 Yesterday or Today How Long Not Feeling Like Eating Lasted Score Scale</LONGNAME>
    <PREFERREDNAME>MSAS7_12_A_EAT_SC_2</PREFERREDNAME>
    <PREFERREDDEFINITION>A patient-rated questionnaire designed to evaluate the prevalence, characteristics, and distress to young children with cancer aged 7-12. This is to evaluate a person&#39;s stated observation of how long not feeling like eating lasted yesterday or today, using a three-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MSAS 7-10: Memorial Symptom Assessment Scale (7-10). J. Collins, et al. Journal of Pain and Symptom Management. 2002 Jan; 23(1): 10-16</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5873820</PublicId>
      <PreferredName>5873754v1.0:5873818v1.0</PreferredName>
      <PreferredDefinition>A patient-rated questionnaire designed to evaluate the prevalence, characteristics, and distress to young children with cancer aged 7-12. This 8-question instrument was adapted from a previously-validated adult version._The time period consisting of the current day and the preceding day._A question about how long not feeling like eating lasted._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Memorial Symptom Assessment Scale (MSAS) 7-12 Yesterday or Today How Long Not Feeling Like Eating Lasted Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5873754</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C136319</PreferredName>
        <Version>1</Version>
        <LongName>Memorial Symptom Assessment Scale (MSAS) 7-12</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C136319</PREFERRED_NAME>
            <LONG_NAME>Memorial Symptom Assessment Scale (MSAS) 7-12</LONG_NAME>
            <CON_ID>5872235</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5873818</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C136321:C136366:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Yesterday or Today How Long Not Feeling Like Eating Lasted Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C136321</PREFERRED_NAME>
            <LONG_NAME>Yesterday or Today</LONG_NAME>
            <CON_ID>5872236</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C136366</PREFERRED_NAME>
            <LONG_NAME>How Long Not Feeling Like Eating Lasted Question</LONG_NAME>
            <CON_ID>5872269</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MSAS 7-10: Memorial Symptom Assessment Scale (7-10). J. Collins, et al. Journal of Pain and Symptom Management. 2002 Jan; 23(1): 10-16</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6730429</PublicId>
      <PreferredName>6730429v1.0</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>3</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>MSAS 7-10: Memorial Symptom Assessment Scale (7-10). J. Collins, et al. Journal of Pain and Symptom Management. 2002 Jan; 23(1): 10-16</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Almost all the time</VALIDVALUE>
          <VALUEMEANING>Almost all the time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something  happened almost all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6730430</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A medium amount</VALIDVALUE>
          <VALUEMEANING>A medium amount of time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response that indicates something happened for a very short time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6730431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A very short amount</VALIDVALUE>
          <VALUEMEANING>A very short amount of time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened for a very short time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6730432</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How long did this last?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How long did this last?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_LONGLST_EAT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1406">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6740226</PUBLICID>
    <LONGNAME>Survey Administer Location Description Text</LONGNAME>
    <PREFERREDNAME>SURV_ADMIN_LOC_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>Text that describes location where survey was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6740225</PublicId>
      <PreferredName>3024964v1.0:6740223v1.0</PreferredName>
      <PreferredDefinition>A document used in a method of data collection that involves interviewing (or giving questionnaires to) a representative and often large group of people._To dispense, apply, or tender something to another, such as administering a medicine._A position, site, or point in space where something can be found.</PreferredDefinition>
      <LongName>Survey Administer Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3024964</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17176</PreferredName>
        <Version>1</Version>
        <LongName>Survey</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17176</PREFERRED_NAME>
            <LONG_NAME>Survey</LONG_NAME>
            <CON_ID>2614081</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6740223</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C64912:C25341</PreferredName>
        <Version>1</Version>
        <LongName>Administer Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64912</PREFERRED_NAME>
            <LONG_NAME>Administer</LONG_NAME>
            <CON_ID>3251412</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5811381</PublicId>
      <PreferredName>5811381v1.0</PreferredName>
      <PreferredDefinition>A written or verbal account, representation, statement, or explanation of something._The words of something written.</PreferredDefinition>
      <LongName>Description Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PBTC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>250</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208096</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Description  Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Site at which survey was admi</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Site at which survey was administered:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1407">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6751788</PUBLICID>
    <LONGNAME>Adverse Event Clinical Study Procedure Relationship Type</LONGNAME>
    <PREFERREDNAME>6751774v1.0:6751777v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the clinical study procedure related to the adverse event.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6751774</PublicId>
      <PreferredName>2235992v1.0:6751772v1.0</PreferredName>
      <PreferredDefinition>Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research._Any stepwise set of actions._A state of connectedness between people, objects, or events; to be associated or connected with something.</PreferredDefinition>
      <LongName>Adverse Event Clinical Study Procedure Relationship</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2235992</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6751772</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15206:C79751:C25648</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Study Procedure Relationship</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79751</PREFERRED_NAME>
            <LONG_NAME>Procedure</LONG_NAME>
            <CON_ID>2833027</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6751777</PublicId>
      <PreferredName>6751777v1.0</PreferredName>
      <PreferredDefinition>Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research._Any stepwise set of actions._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Clinical Study Procedure Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>6751776</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15206:C79751:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Study Procedure Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C79751</PREFERRED_NAME>
            <LONG_NAME>Procedure</LONG_NAME>
            <CON_ID>2833027</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Optional research blood sample collection</VALIDVALUE>
          <VALUEMEANING>Optional Research Blood Sample Collection</VALUEMEANING>
          <MEANINGDESCRIPTION>Possible but not necessary; left to personal choice._Systematic investigation into a subject in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered._A small volume of blood removed for testing or storage._The act of gathering things together; having been brought together in one place.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25453, C17610, C15429, C25603</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6751785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Completing QOL surveys</VALIDVALUE>
          <VALUEMEANING>Quality of Life Survey Complete</VALUEMEANING>
          <MEANINGDESCRIPTION>The subjective measurement of an individual&#39;s sense of well-being and ability to enjoy life. The concept holds varying meanings for different people and may evolve over time. For some individuals it implies autonomy, empowerment, capability, and choice; for others, security, social integration, or freedom from stress or illness.: A document used in a method of data collection that involves interviewing (or giving questionnaires to) a representative and often large group of people.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25250, C17176, C17047</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6751786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Study consent process</VALIDVALUE>
          <VALUEMEANING>Clinical Study Consent Process</VALUEMEANING>
          <MEANINGDESCRIPTION>Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.: Permission to do something.: A sequence of events which produces some outcome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29862, C25460, C15206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6751787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the clinical study p</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the clinical study procedure related to the adverse event?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify which study procedure the adverse event is related to</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify which study procedure the adverse event is related to</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify which study procedure the adverse event is related to</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify which study procedure the adverse event is related to</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1408">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6753591</PUBLICID>
    <LONGNAME>Lymphedema Symptom Intensity and Distress Survey-Arm V 2.0 During Past Week Have Pain in Your Arm Indicator</LONGNAME>
    <PREFERREDNAME>LSIDSA_5_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation of whether or not they had pain in their arm during the past week, using a yes or no response.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>LSIDS-A:Lymphedema Symptom and Intensity Survey-Arm; SH Ridner et al., Support Care Cancer (2015)</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6751607</PublicId>
      <PreferredName>6752947v1.0:6753593v1.0</PreferredName>
      <PreferredDefinition>A self-report tool designed to evaluate arm lymphedema and associated symptoms in breast cancer survivors._At some point in a given period of time._The most recent week. May include the present day._A question about whether an individual experiences or experienced pain in their arm.</PreferredDefinition>
      <LongName>Lymphedema Symptom Intensity and Distress Survey-Arm During Past Week Have Pain in Your Arm</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6752947</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C159908</PreferredName>
        <Version>1</Version>
        <LongName>Lymphedema Symptom Intensity and Distress Survey-Arm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159908</PREFERRED_NAME>
            <LONG_NAME>Lymphedema Symptom Intensity and Distress Survey - Arm</LONG_NAME>
            <CON_ID>6751805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6753593</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25490:C95402:C159913</PreferredName>
        <Version>1</Version>
        <LongName>During Past Week Have Pain in Your Arm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159913</PREFERRED_NAME>
            <LONG_NAME>Have Pain in Your Arm Question</LONG_NAME>
            <CON_ID>6751808</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>LSIDS-A:Lymphedema Symptom and Intensity Survey-Arm; SH Ridner et al., Support Care Cancer (2015)</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lymphedema Symptom Intensity and Distress Survey-Arm Version 2.0</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #13 of 90</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pain in your arm</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pain in your arm</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphedema Symptom Intensity and Distress Survey-Arm (LSIDS-A)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900320</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6736342</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LSIDS-A</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LSIDS-A</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6736343</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1409">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6754317</PUBLICID>
    <LONGNAME>Lymphedema Symptom Intensity and Distress Survey-Arm V 2.0 During Past Week Have Loss of Confidence in Body Distress Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>LSIDSA_22.2_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation about the distress level of having loss of confidence in body during the past week, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>LSIDS-A:Lymphedema Symptom and Intensity Survey-Arm; SH Ridner et al., Support Care Cancer (2015)</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6753459</PublicId>
      <PreferredName>6752947v1.0:6753457v1.0</PreferredName>
      <PreferredDefinition>A self-report tool designed to evaluate arm lymphedema and associated symptoms in breast cancer survivors._At some point in a given period of time._The most recent week. May include the present day._A question about whether an individual feels or felt a loss of confidence in their body._A state of physiological or psychological stress that cannot be compensated for by normal adaptive measures._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Lymphedema Symptom Intensity and Distress Survey-Arm During Past Week Have Loss of Confidence in Body Distress Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6752947</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C159908</PreferredName>
        <Version>1</Version>
        <LongName>Lymphedema Symptom Intensity and Distress Survey-Arm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159908</PREFERRED_NAME>
            <LONG_NAME>Lymphedema Symptom Intensity and Distress Survey - Arm</LONG_NAME>
            <CON_ID>6751805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6753457</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>6753457v1.0</PreferredName>
        <Version>1</Version>
        <LongName>During Past Week Have Loss of Confidence in Body Distress Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25490</PREFERRED_NAME>
            <LONG_NAME>During</LONG_NAME>
            <CON_ID>2206200</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159929</PREFERRED_NAME>
            <LONG_NAME>Have Loss of Confidence in Body Question</LONG_NAME>
            <CON_ID>6751827</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37942</PREFERRED_NAME>
            <LONG_NAME>Distress</LONG_NAME>
            <CON_ID>2667531</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>LSIDS-A:Lymphedema Symptom and Intensity Survey-Arm; SH Ridner et al., Support Care Cancer (2015)</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6753779</PublicId>
      <PreferredName>6753779v1.0</PreferredName>
      <PreferredDefinition>A scale for the subjective scoring of a symptom&#39;s intensity and distress that ranges from 1: Slight to 5: Severe._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Symptoms Intensity and Distress 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>LSIDS-A:Lymphedema Symptom and Intensity Survey-Arm; SH Ridner et al., Support Care Cancer (2015)</Origin>
      <Representation>
        <PublicId>6753778</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C159934:C25664</PreferredName>
        <Version>1</Version>
        <LongName>Symptoms Intensity and Distress Likert Scale Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159934</PREFERRED_NAME>
            <LONG_NAME>Symptoms Intensity and Distress Likert Scale</LONG_NAME>
            <CON_ID>6751835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5 Severe</VALIDVALUE>
          <VALUEMEANING>Intensity and Distress 5</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 5 on a symptom&#39;s intensity and distress scale that ranges from 1: Slight to 5: Severe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159939</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6753780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Intensity and Distress 4</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 4 on a symptom&#39;s intensity and distress scale that ranges from 1: Slight to 5: Severe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159938</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6753781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Intensity and Distress 3</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 3 on a symptom&#39;s intensity and distress scale that ranges from 1: Slight to 5: Severe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159937</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6753782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Intensity and Distress 2</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 2 on a symptom&#39;s intensity and distress scale that ranges from 1: Slight to 5: Severe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159936</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6753783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 Slight</VALIDVALUE>
          <VALUEMEANING>Intensity and Distress 1</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 1 on a symptom&#39;s intensity and distress scale that ranges from 1: Slight to 5: Severe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159935</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6753785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Distress</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Distress</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lymphedema Symptom Intensity and Distress Survey-Arm Version 2.0</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #66 of 90</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphedema Symptom Intensity and Distress Survey-Arm (LSIDS-A)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900320</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6736342</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LSIDS-A</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LSIDS-A</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6736343</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1410">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6770086</PUBLICID>
    <LONGNAME>Laboratory Procedure Prolactin Measurement Outcome Finding Status Indicator</LONGNAME>
    <PREFERREDNAME>6770085v1.0:3436461v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information related to the status of the laboratory results for the prolactin measurement.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6770085</PublicId>
      <PreferredName>2543047v1.0:6770083v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The determination of the amount of prolactin hormone present in a sample._The result of an action.</PreferredDefinition>
      <LongName>Laboratory Procedure Prolactin Measurement Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6770083</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C74870:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Prolactin Measurement Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C74870</PREFERRED_NAME>
            <LONG_NAME>Prolactin Measurement</LONG_NAME>
            <CON_ID>6413472</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3436461</PublicId>
      <PreferredName>3436461v1.0</PreferredName>
      <PreferredDefinition>The result of an examination or inquiry._A condition or state at a particular time._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Finding Status Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3436460</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61036:C25688:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Finding Status Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61036</PREFERRED_NAME>
            <LONG_NAME>Investigation Finding</LONG_NAME>
            <CON_ID>2528540</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not known</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-11</PVBEGINDATE>
          <PVENDDATE>2013-03-12</PVENDDATE>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known</VALIDVALUE>
          <VALUEMEANING>Known</VALUEMEANING>
          <MEANINGDESCRIPTION>Recognized, familiar, or within the scope of knowledge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2934435</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3371379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-03-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the status of the pro</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the status of the prolactin measurement finding?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Prolactin level</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prolactin level</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Prolactin level</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Prolactin level</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1411">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6770668</PUBLICID>
    <LONGNAME>Lesion Biopsy Performed Indicator</LONGNAME>
    <PREFERREDNAME>LES_BX_PERF_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator response as to whether a biopsy on the lesion(s) was executed and carried through to completion.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>MCL</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MCL:Molecular and Cellular Characterization of Screened Lesions</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6770661</PublicId>
      <PreferredName>2465192v1.0:2718333v1.0</PreferredName>
      <PreferredDefinition>A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Lesion Biopsy Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>MCL</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2465192</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3824</PreferredName>
        <Version>1</Version>
        <LongName>Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2718333</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15189:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Biopsy Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15189</PREFERRED_NAME>
            <LONG_NAME>Biopsy Procedure</LONG_NAME>
            <CON_ID>2202502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>MCL:Molecular and Cellular Characterization of Screened Lesions</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6682528</PublicId>
      <PreferredName>YES_NO_UNK_DATA_NA_IND</PreferredName>
      <PreferredDefinition>A response or indicator that can have a value of yes, no, unknown, not applicable, or that the data is not present in the original source.</PreferredDefinition>
      <LongName>Yes No Unknown Data Not Available Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>MCL</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>18</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>MCL:Molecular and Cellular Characterization of Screened Lesions</Origin>
      <Representation>
        <PublicId>6763099</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148:C67329:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Yes, No, or Unknown Response Source Data Not Available Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67329</PREFERRED_NAME>
            <LONG_NAME>Source Data Not Available</LONG_NAME>
            <CON_ID>2724563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Data not available</VALIDVALUE>
          <VALUEMEANING>Source Data Not Available</VALUEMEANING>
          <MEANINGDESCRIPTION>Data from an original source is not present, accessible or ready for use or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4842575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-05-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not reported</VALIDVALUE>
          <VALUEMEANING>Not Reported</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-01-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lesion Biopsied?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Lesion Biopsied?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-Breast-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Each Lesion biopsied?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506112</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Breast</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Initial Diagnosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6643181</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1412">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6773743</PUBLICID>
    <LONGNAME>Speech Word Decoding Test of Word Reading Efficiency, Second Edition Assessment Score</LONGNAME>
    <PREFERREDNAME>6773742v1.0:3076086v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The exchange of spoken words._A test that assesses a respondent&#39;s ability to pronounce words accurately. It tests a respondent&#39;s word reading accuracy and fluency._A measure designed to provide professionals in schools and clinics with a reliable and valid measure of fluency and accuracy of print-based word-reading skills. It is a nationally normed measure of word reading accuracy and speed, comprised of two subtests: the Sight Word Efficiency (SWE) subtest, a measure of an individual&#39;s ability to pronounce printed words, and the Phonemic Decoding Efficiency (PDE) subtest, a measure of an individual&#39;s ability to pronounce phonemically regular nonwords._A number or range of numeric values measuring performance, function, quality, or ability.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6773742</PublicId>
      <PreferredName>3139278v1.0:6773740v1.0</PreferredName>
      <PreferredDefinition>The exchange of spoken words._A test that assesses a respondent&#39;s ability to pronounce words accurately. It tests a respondent&#39;s word reading accuracy and fluency._A measure designed to provide professionals in schools and clinics with a reliable and valid measure of fluency and accuracy of print-based word-reading skills. It is a nationally normed measure of word reading accuracy and speed, comprised of two subtests: the Sight Word Efficiency (SWE) subtest, a measure of an individual&#39;s ability to pronounce printed words, and the Phonemic Decoding Efficiency (PDE) subtest, a measure of an individual&#39;s ability to pronounce phonemically regular nonwords.</PreferredDefinition>
      <LongName>Speech Word Decoding Test of Word Reading Efficiency, Second Edition</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3139278</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38025</PreferredName>
        <Version>1</Version>
        <LongName>Speech</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38025</PREFERRED_NAME>
            <LONG_NAME>Speech</LONG_NAME>
            <CON_ID>2202857</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6773740</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C92464:C160858</PreferredName>
        <Version>1</Version>
        <LongName>Word Decoding Test of Word Reading Efficiency, Second Edition</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C92464</PREFERRED_NAME>
            <LONG_NAME>Word Decoding</LONG_NAME>
            <CON_ID>3143356</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C160858</PREFERRED_NAME>
            <LONG_NAME>Test of Word Reading Efficiency, Second Edition</LONG_NAME>
            <CON_ID>6770860</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3076086</PublicId>
      <PreferredName>ASSES_SC</PreferredName>
      <PreferredDefinition>A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Assessment Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2193207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>The Test of Word Reading Efficiency Second Edition (TOWRE-2) is a nationally normed measure of word reading accuracy and speed. The test contains two subtests: the Sight Word Efficiency (SWE) subtest, and the Phonemic Decoding Efficiency (PDE) subtest. The SWE subtest involves presenting the respondent with a list of real printed words. The respondent must accurately read and pronounce as many words as possible in 45 seconds. This subtest evaluates the respondents&#39; ability to identify sight words. The PDE subtest involves presenting a list of printed nonwords. The respondent must accurately decode and pronounce as many words as possible in 45 seconds. This subtest evaluates the respondents&#39; ability to decode (&#39;sound out&#39;) nonwords. The examiner scores each item as it is being pronounced.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Speech and Hearing</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3009622</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1413">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6782287</PUBLICID>
    <LONGNAME>Amyloid Subtype Performed Indicator</LONGNAME>
    <PREFERREDNAME>6782286v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not amyloid subtyping was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6782286</PublicId>
      <PreferredName>6782288v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>An insoluble, fibrous aggregate of misfolded proteins or protein fragments. These fibrillar structures usually exhibit a cross-beta-sheet conformation. Deposition of amyloid aggregates is associated with a number of pathologies including amyloidosis and several neurodegenerative disorders._A group forming a type within a larger type._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Amyloid Subtype Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6782288</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117187:C25696</PreferredName>
        <Version>1</Version>
        <LongName>Amyloid Subtype</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117187</PREFERRED_NAME>
            <LONG_NAME>Amyloid</LONG_NAME>
            <CON_ID>4456232</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25696</PREFERRED_NAME>
            <LONG_NAME>Subtype</LONG_NAME>
            <CON_ID>2203810</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was amyloid subtyping perform</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was amyloid subtyping performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was amyloid subtyping performed?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Was amyloid subtyping performed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1414">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6789985</PUBLICID>
    <LONGNAME>Normal Range Lower Limit-Original Units</LONGNAME>
    <PREFERREDNAME>OEORNRLO</PREFERREDNAME>
    <PREFERREDDEFINITION>The lower end of normal range or reference range for continuous results stored in OEORRES.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6789668</PublicId>
      <PreferredName>6789652v1.0:6420450v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to ophthalmic examinations._The lowest number in a previously accepted range of values as originally received or collected.</PreferredDefinition>
      <LongName>Ophthalmic Examinations Domain Normal Range Lower Limit Original Unit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6789652</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C147180</PreferredName>
        <Version>1</Version>
        <LongName>Ophthalmic Examinations Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C147180</PREFERRED_NAME>
            <LONG_NAME>Ophthalmic Examinations Domain</LONG_NAME>
            <CON_ID>6789651</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6420450</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C82580</PreferredName>
        <Version>1</Version>
        <LongName>Normal Range Lower Limit Original Unit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82580</PREFERRED_NAME>
            <LONG_NAME>Normal Range Lower Limit Original Unit</LONG_NAME>
            <CON_ID>6420449</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Normal Range Lower Limit-Orig</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Normal Range Lower Limit-Original Units</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Normal Range Lower Limit</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SDTM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7218795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6338162</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ophthalmic Examinations (OE) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7330204</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14943368</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>14943368v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Ophthalmic Examinations (OE) Domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943397</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OE</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OEORNRLO</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>OE_OEORNRLO</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1415">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6790111</PUBLICID>
    <LONGNAME>Patient Hypersensitivity Eligibility Determination Yes No Indicator</LONGNAME>
    <PREFERREDNAME>PT_HYSEN_DG_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The yes/no response to whether the patient is hypersensitive to any drugs on their treatment arm.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6790105</PublicId>
      <PreferredName>2404694v1.0:6790103v1.0</PreferredName>
      <PreferredDefinition>An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen._The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures._A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.</PreferredDefinition>
      <LongName>Patient Hypersensitivity Eligibility Determination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6790103</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3114:C25171</PreferredName>
        <Version>1</Version>
        <LongName>Hypersensitivity Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3114</PREFERRED_NAME>
            <LONG_NAME>Hypersensitivity</LONG_NAME>
            <CON_ID>2203756</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have hypersensit</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have hypersensitivity to any drugs on their expected treatment arm?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient experience grade 2+ hypersensitivity reaction (i.e., allergic reaction, anaphylaxis or infusion related reaction)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1416">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6815865</PUBLICID>
    <LONGNAME>Total Participant Started Study Intervention Number</LONGNAME>
    <PREFERREDNAME>TTL_PT_START_S_INTRVN_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>The number associated with the participants beginning a detailed examination, analysis, or critical inspection that produces an effect or that is intended to alter the course of a pathologic process.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6815864</PublicId>
      <PreferredName>6815861v1.0:6815862v1.0</PreferredName>
      <PreferredDefinition>Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._Someone who takes part in an activity._Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins._A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it._An action or ministration that produces an effect or that is intended to alter the course of a pathologic process.</PreferredDefinition>
      <LongName>Total Participant Started Study Intervention</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6815861</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25304:C29867</PreferredName>
        <Version>1</Version>
        <LongName>Total Participant</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25304</PREFERRED_NAME>
            <LONG_NAME>Total</LONG_NAME>
            <CON_ID>2204938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29867</PREFERRED_NAME>
            <LONG_NAME>Participant</LONG_NAME>
            <CON_ID>2202627</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6815862</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C63536:C16197</PreferredName>
        <Version>1</Version>
        <LongName>Begin Study Interventions</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16197</PREFERRED_NAME>
            <LONG_NAME>Interventions</LONG_NAME>
            <CON_ID>2203830</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCP:Division of Cancer Prevention</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2182118</PublicId>
      <PreferredName>NUMBER</PreferredName>
      <PreferredDefinition>A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>0</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total Number of Participants</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Total Number of Participants Started Study Intervention</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1417">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6825750</PUBLICID>
    <LONGNAME>Laboratory Procedure Serum IgE Outcome 2 Decimal Place International Unit per Milliliter Value</LONGNAME>
    <PREFERREDNAME>2195800v1.0:6825749v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The 2 decimal place international unit per milliliter numeric laboratory value measured, assigned or computed related to the assessment of serum IgE in a specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195800</PublicId>
      <PreferredName>LAB_SRM_IGE_OC</PreferredName>
      <PreferredDefinition>information related to the results of the medical procedure that involves testing a sample of blood serum, the clear liquid part of the blood that remains after blood cells and clotting proteins have been removed, for IgE, an immunoglobulin isotype (subclass) that has the unique ability to bind with high affinity to IgE receptors (FceRI) on mast cells and basophils and induce degranulation and cytokine production by these cells when they are crosslinked by antigen.</PreferredDefinition>
      <LongName>Laboratory Procedure Serum IgE Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2780161</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13325:C567:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Serum IgE Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13325</PREFERRED_NAME>
            <LONG_NAME>Serum</LONG_NAME>
            <CON_ID>2203797</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C567</PREFERRED_NAME>
            <LONG_NAME>IgE</LONG_NAME>
            <CON_ID>2615876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6825749</PublicId>
      <PreferredName>6825749v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A number with no fractional part, including the negative and positive numbers as well as zero.::2_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Laboratory Procedure 2 Decimal Place International Unit per Milliliter Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>IU/mL</UnitOfMeasure>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>6825748</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>6825748v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Integer::2 Decimal Place International Unit per Milliliter Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67377</PREFERRED_NAME>
            <LONG_NAME>International Unit per Milliliter</LONG_NAME>
            <CON_ID>2718865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the value for serum I</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the value for serum IgE?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>IgE:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>IgE:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1418">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6831607</PUBLICID>
    <LONGNAME>Derived Flag Amyloidosis Hematologic Response Assessment Performed Date</LONGNAME>
    <PREFERREDNAME>6831564v1.0:2532012v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The day, month and year of the amyloidosis hematologic response assessment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6831564</PublicId>
      <PreferredName>6825758v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>An indication that a data element has been derived from one or more data elements._A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands._An evaluation of the hematologic response of the disease to the therapy._The final result of a determination of the value, significance, or extent of._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Derived Flag Amyloidosis Hematologic Response Assessment Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6825758</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C81197:C2868:C123622:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Derived Flag Amyloidosis Hematologic Response Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C81197</PREFERRED_NAME>
            <LONG_NAME>Derived Flag</LONG_NAME>
            <CON_ID>6141841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2868</PREFERRED_NAME>
            <LONG_NAME>Amyloidosis</LONG_NAME>
            <CON_ID>2443944</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C123622</PREFERRED_NAME>
            <LONG_NAME>Hematologic Response</LONG_NAME>
            <CON_ID>5508134</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2532012</PublicId>
      <PreferredName>DATE</PreferredName>
      <PreferredDefinition>The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY-MM-DD</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the date of the amyl</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the date of the amyloidosis hematologic response assessment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date assessed:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Date assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date current hematologic status assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date current hematologic status assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <DerivationType>COMPOUND</DerivationType>
      <DerivationTypeDescription>COMPOUND</DerivationTypeDescription>
      <Methods/>
      <Rule>The date of hematologic response when the response to CDE 4251895 (Plasma Cell Disorder Classification Diagnosis Type) is &amp;quot;Amyloidosis&amp;quot; and the date is known to CDE 2936618 (Disease or Disorder Status Date), and the response to CDE 2309 (Assessment Method Type) is &amp;quot;Hematologic&amp;quot;.</Rule>
      <ConcatenationCharacter/>
      <ComponentDataElementList>
        <ComponentDataElementList_ITEM>
          <PublicId>4251895</PublicId>
          <LongName>Plasma Cell Disorder Classification Diagnosis Type</LongName>
          <PreferredName>2688899v1.0:4251892v1.0</PreferredName>
          <PreferredDefinition>A description of the plasma cell disorder classification.</PreferredDefinition>
          <Version>1</Version>
          <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
          <ContextName>NHLBI</ContextName>
          <DisplayOrder>1</DisplayOrder>
        </ComponentDataElementList_ITEM>
        <ComponentDataElementList_ITEM>
          <PublicId>2936618</PublicId>
          <LongName>Disease or Disorder Status Date</LongName>
          <PreferredName>2512861v1.0:2532012v2.0</PreferredName>
          <PreferredDefinition>The month, day, and year of the disease or disorder status.</PreferredDefinition>
          <Version>1</Version>
          <WorkflowStatus>RELEASED</WorkflowStatus>
          <ContextName>NHLBI</ContextName>
          <DisplayOrder>2</DisplayOrder>
        </ComponentDataElementList_ITEM>
        <ComponentDataElementList_ITEM>
          <PublicId>2309</PublicId>
          <LongName>Assessment Method Type</LongName>
          <PreferredName>ASSESS_METH_TP</PreferredName>
          <PreferredDefinition>the type or description of a method of assessment.</PreferredDefinition>
          <Version>5</Version>
          <WorkflowStatus>RELEASED</WorkflowStatus>
          <ContextName>CTEP</ContextName>
          <DisplayOrder>3</DisplayOrder>
        </ComponentDataElementList_ITEM>
      </ComponentDataElementList>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1419">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>4251895</PUBLICID>
    <LONGNAME>Plasma Cell Disorder Classification Diagnosis Type</LONGNAME>
    <PREFERREDNAME>2688899v1.0:4251892v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the plasma cell disorder classification.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Retired</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2688899</PublicId>
      <PreferredName>PLSM_CL_DZ_CLS</PreferredName>
      <PreferredDefinition>Specialized forms of antibody-producing B-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. (Rosen et al., Dictionary of Immunology, 1989, p169 &amp; Abbas et al., Cellular and Molecular Immunology, 2d ed, p20)_Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. Sometimes the term is used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.</PreferredDefinition>
      <LongName>Plasma Cell Disorder Classification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2685344</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12486:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Plasma Cell Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12486</PREFERRED_NAME>
            <LONG_NAME>Plasma Cell</LONG_NAME>
            <CON_ID>2202530</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2321361</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25161</PreferredName>
        <Version>1</Version>
        <LongName>Classification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25161</PREFERRED_NAME>
            <LONG_NAME>Classification</LONG_NAME>
            <CON_ID>2203879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4251892</PublicId>
      <PreferredName>4251892v1.0</PreferredName>
      <PreferredDefinition>Specialized forms of antibody-producing B-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. (Rosen et al., Dictionary of Immunology, 1989, p169 &amp; Abbas et al., Cellular and Molecular Immunology, 2d ed, p20)_Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Plasma Cell Disease or Disorder Diagnosis Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RETIRED ARCHIVED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>4251891</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12486:C2991:C15220:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Plasma Cell Disease or Disorder Diagnosis Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12486</PREFERRED_NAME>
            <LONG_NAME>Plasma Cell</LONG_NAME>
            <CON_ID>2202530</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Osteosclerotic myeloma / POEMS syndrome</VALIDVALUE>
          <VALUEMEANING>Osteosclerotic Myeloma Or POEMS Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A plasma cell neoplasm associated with osteosclerotic and fibrotic changes in the bone trabeculae.  Often, the lymph nodes show changes resembling the plasma cell variant of Castleman disease.  It is often part of POEMS syndrome which is characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes.  It is often associated with osteosclerotic myeloma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80303, C37998, C7765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4251911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other plasma cell disorder (PCD)</VALIDVALUE>
          <VALUEMEANING>Other Plasma Cell Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Specialized forms of antibody-producing B-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. (Rosen et al., Dictionary of Immunology, 1989, p169 &amp; Abbas et al., Cellular and Molecular Immunology, 2d ed, p20): Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C12486, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4251893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plasma cell leukemia (PCL)</VALIDVALUE>
          <VALUEMEANING>Plasma Cell Leukemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An aggressive plasma cell neoplasm with usually short survival. It is characterized by the presence of neoplastic plasma cells in the peripheral blood. The peripheral blood plasma cells comprise more than 20% of the peripheral blood white cells. It may be the initial presentation of a plasma cell neoplasm or manifest as a terminal complication of plasma cell myeloma. Lymphadenopathy and organomegaly are frequent clinical signs, whereas bone pain and osteolytic lesions are less frequently present.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3180</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Light chain deposition disease</VALIDVALUE>
          <VALUEMEANING>Light Chain Deposition Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which plasma cells secrete immunoglobulin light chains of only one type, kappa or lambda. Light chain deposition disease is often associated with multiple myeloma or lymphoproliferative disease, but as many as 50% of patients have no evidence of neoplastic plasma cell proliferation. Light chains excreted in the urine are known as Bence Jones protein. Amyloidosis and severe renal failure occur more frequently than in multiple myeloma. Also known as Bence Jones myeloma. L-chain disease, L-chain myeloma, and LCDD. --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3928712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amyloidosis</VALIDVALUE>
          <VALUEMEANING>Amyloidosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2868</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoclonal gammopathy of unknown significance</VALIDVALUE>
          <VALUEMEANING>Monoclonal Gammopathy of Undetermined Significance</VALUEMEANING>
          <MEANINGDESCRIPTION>A plasma cell disorder in which an abnormal amount of a single immunoglobulin is present in the serum. Up to 25% of cases of monoclonal gammopathy of undetermined significance (MGUS) progress to a B-cell malignancy or myeloma. MGUS may occur in conjunction with various carcinomas, chronic inflammatory and infectious conditions, and other diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3996</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2838621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multiple myeloma</VALIDVALUE>
          <VALUEMEANING>Plasma Cell Myeloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Solitary plasmacytoma</VALIDVALUE>
          <VALUEMEANING>Solitary Plasmacytoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A single focus of clonal (malignant) plasma cells either in the bone or in another anatomic site without peripheral blood involvement. --2003</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6932</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2951236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Smoldering myeloma</VALIDVALUE>
          <VALUEMEANING>Smoldering Myeloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A plasma cell myeloma lacking clinical manifestations and organ impairment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7149</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multiple myeloma-non-secretory</VALIDVALUE>
          <VALUEMEANING>Non-Secretory Myeloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare type of multiple myeloma in which the plasma cells synthesize but do not secrete immunoglobulins.  As a result, none of the immunoglobulins appear out of the normal range.  The symptoms are generally the same with those of immunoglobulin-secreting myeloma; however, the incidence of renal insufficiency is lower in non-secretory myeloma.  The diagnosis can be missed because of the absence of monoclonal immunoglobulin in the serum or urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4734</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multiple myeloma-light chain only</VALIDVALUE>
          <VALUEMEANING>Multiple Myeloma-Light Chain Only</VALUEMEANING>
          <MEANINGDESCRIPTION>Only the light chain (kappa or lambda) of the immunoglobulin is defective.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70605</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monoclonal gammopathy of renal significance (MGRS)</VALIDVALUE>
          <VALUEMEANING>Monoclonal Gammopathy of Renal Significance</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition caused by a B-cell or plasma cell clone resulting in the deposition of the secreted monoclonal immunoglobulin, without evidence for overt lymphoma or myeloma. This category includes a wide spectrum of renal pathology and include such lesions as immunoglobulin-associated amyloidosis, the monoclonal immunoglobulin deposition diseases (MIDDs; light chain deposition disease, heavy chain deposition disease, and light and heavy chain deposition disease), proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID), C3 glomerulopathy with monoclonal gammopathy, light chain proximal tubulopathy (Fanconi syndrome), and several others.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157343</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6682421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the plasma cell disor</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the plasma cell disorder diagnosis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the diagnosis?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the diagnosis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the diagnosis?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>What is the diagnosis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the disease diagnosis</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the disease diagnosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the multiple myeloma/plasma cell disorder (PCD) classification</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the multiple myeloma/plasma cell disorder (PCD) classification</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpre_assess_diag_mye_dis_name</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_PCD_mye_pcd_class_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1420">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2936618</PUBLICID>
    <LONGNAME>Disease or Disorder Status Date</LONGNAME>
    <PREFERREDNAME>2512861v1.0:2532012v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The month, day, and year of the disease or disorder status.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2512861</PublicId>
      <PreferredName>2404658v1.0:2320064v1.0</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Disease or Disorder Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2320064</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2532012</PublicId>
      <PreferredName>DATE</PreferredName>
      <PreferredDefinition>The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY-MM-DD</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date the disease status was e</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date the disease status was established:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Disease status date:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Disease status date:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date disease response established:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date disease response established:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of response:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of response:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of assessment for the disease evaluation:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of assessment for the disease evaluation:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of assessment for disease status:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of assessment for disease status:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of disease status measurement:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of disease status measurement:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the date the disease status was determined:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the date the disease status was determined:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the date of assessment for disease status:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the date of assessment for disease status:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the date of assessment:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the date of assessment:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date response evaluated:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date response evaluated:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date disease status was documented:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date disease status was documented:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2936618</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedObservation.dateRange WHERE PerformedObservation &gt; PerformedDiagnosis.value = {specified diagnosis}</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date assessed:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Date assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping for CDE:2936618</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedObservation.dateRange WHERE  PerformedObservation &gt; PerformedDiagnosis.value = &quot;Testicular / Germ Cell Cancer&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of most recent disease assessment:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of most recent disease assessment:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date current peripheral nervous system response assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date current peripheral nervous system response assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date current renal response assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date current renal response assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date current hepatic response assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date current hepatic response assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of assessment of current disease status:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of assessment of current disease status:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date GI involvement assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date GI involvement assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date current status of this system assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date current status of this system assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date current cardiac response assessed:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date current cardiac response assessed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date response established:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date response established:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2016r1: Myeloma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964888</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2018r1: Lymphoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2020r1: Breast Cancer Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2025r1: Central Nervous System Tumor Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964893</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2026r1: Neuroblastoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964894</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2022r1: Testicular / Germ Cell Cancer Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964899</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2100r1: 100 Days Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964902</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2110r1: Acute Myelogenous Leukemia Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964903</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2111r1: All Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2112r1: CML Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2113r1: CLL Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2114r1: MDS Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2116r1: Myeloma Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2117r1: Amyloidosis Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2118r1: Lymphoma Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2120r1: Breast Cancer Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2122r1: Testicular / Germ Cell Cancer Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2125r1: Central Nervous System Tumor Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2126r1: Neuroblastoma Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2010r1: Acute Myelogenous Leukemia Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964927</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2011r1: ALL Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964928</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2012r1: CML Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964929</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2013r1: CLL Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964930</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2014r1: MDS Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2132r1: Chediak-Higashi Syndrome Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3279259</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Status</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3279271</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2019r1: Waldenström&#39;s Macroglobulinemia Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3279308</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mye_post_curr_dx_sts_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cns_post_dx_part_rspn_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_base_prep_st_eval_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_curr_dx_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>bc_post_dx_part_rspn_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>bc_post_curr_dx_sts_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>amy_post_crnt_card_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>amy_post_crnt_dx_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>amy_post_crnt_gi_rspn_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>amy_post_crnt_hemat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>amy_post_crnt_hpt_rsp_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>amy_post_crnt_neur_rs_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>amy_post_crnt_othr_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>amy_post_crnt_pneuro_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>amy_post_crnt_renal_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>dci_disease_status_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_post_current_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_base_prep_st_eval_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lym_post_current_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mds_post_current_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>tc_base_tx_best_resp_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cll_post_crnt_dx_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cll_base_prep_dx_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_trt_response_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_current_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_crnt_dx_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_base_status_prep_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cns_post_cur_dx_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mds_base_prep_st_eval_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>oc_base_cur_dx_status_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>oc_post_cur_dx_status_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>sar_base_cur_dx_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>sar_post_cur_dx_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>scl_base_dx_stat_eval_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>scl_post_curr_dx_sts_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cns_base_cur_dx_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lym_base_prep_sts_dt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mye_base_curr_dx_sts_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>tc_base_curr_dx_sts_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>tc_post_cur_dx_status_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mac_base_curr_dx_sts_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>tc_post_dx_part_rspns_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_base_curr_dx_sts_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>chs_post_cur_status_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedObservation:dateRange </AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_pri_dis_hct_mds_pt_tran_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_prime_dis_hct_all_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_prime_dis_hct_aml_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_prime_dis_hct_cml_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_prime_dis_hct_hodg_lym_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_prime_dis_hct_mye_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_prime_dis_hct_nhl_lym_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_prime_dis_hct_oth_acute_lk_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_prime_dis_hct_oth_lk_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_dis_assess_prep_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpre_prep_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpre_dis_stat_prep_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_dis_assess_prep_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpost_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpre_dis_stat_prep_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_plasma_cell_mye_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_amy_hema_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_amy_autonomic_neuro_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_amy_card_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_amy_gi_tract_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_amy_hepatic_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_amy_neuropathy_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_amy_oth_organ_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpost_amy_renal_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpost_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpre_dis_stat_prep_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpost_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MACpre_prep_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_CDS_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_dis_stat_prep_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_DALE_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLP_DSLE_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_DSTE_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_ALMN_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_ALL_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_AML_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_CML_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_HL_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MDS_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_NHL_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_OL_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_PCD_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_DSLE_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_DSTE_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DTE_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DTE_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_DSTE_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_LYM_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_DS_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_DS_rad_dis_stat_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_PCD_dis_stat_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MPN_eval_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DLIN_DLI_dis_best_resp_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DLIN_DCI_dis_best_resp_date</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1421">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2309</PUBLICID>
    <LONGNAME>Assessment Method Type</LONGNAME>
    <PREFERREDNAME>ASSESS_METH_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the type or description of a method of assessment.</PREFERREDDEFINITION>
    <VERSION>5</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013937</PublicId>
      <PreferredName>ASSESS_METH</PreferredName>
      <PreferredDefinition>information related to the method of assessment.</PreferredDefinition>
      <LongName>Assessment Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176954</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Assessment</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177492</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Method</PreferredName>
        <Version>1</Version>
        <LongName>Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16847</PREFERRED_NAME>
            <LONG_NAME>Technique</LONG_NAME>
            <CON_ID>2203854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015230</PublicId>
      <PreferredName>ASSESS_METH_TP</PreferredName>
      <PreferredDefinition>the enumerated list of methods of conducting diagnostic evaluation.</PreferredDefinition>
      <LongName>Assessment Method Type</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone scan</VALIDVALUE>
          <VALUEMEANING>Bone Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A nuclear imaging method used to evaluate pathological bone metabolism. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17646</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CT scan</VALIDVALUE>
          <VALUEMEANING>CT Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest x-ray</VALIDVALUE>
          <VALUEMEANING>Chest X-Ray</VALUEMEANING>
          <MEANINGDESCRIPTION>Chest X-Ray</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clinical examination</VALIDVALUE>
          <VALUEMEANING>CLINICAL EXAMINATION (PE)</VALUEMEANING>
          <MEANINGDESCRIPTION>CLINICAL EXAMINATION (PE)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytology</VALIDVALUE>
          <VALUEMEANING>Cytology</VALUEMEANING>
          <MEANINGDESCRIPTION>Cytology; the branch of biology that studies the structure and function of cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16491</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fine needle aspiration biopsy</VALIDVALUE>
          <VALUEMEANING>FINE NEEDLE ASPIRATION BIOPSY</VALUEMEANING>
          <MEANINGDESCRIPTION>Biopsy by a fine needle aspiration technique</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE>2005-04-13</PVENDDATE>
          <VMPUBLICID>2574518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fine needle aspiration biopsy, with wire localization</VALIDVALUE>
          <VALUEMEANING>FINE NEEDLE ASPIRATION BIOPSY WITH WIRE LOCALIZATION</VALUEMEANING>
          <MEANINGDESCRIPTION>Biopsy by a fine needle aspiration technique using wire localization</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE>2005-04-13</PVENDDATE>
          <VMPUBLICID>2574519</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Histology</VALIDVALUE>
          <VALUEMEANING>HISTOLOGY</VALUEMEANING>
          <MEANINGDESCRIPTION>HISTOLOGY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Incisional biopsy</VALIDVALUE>
          <VALUEMEANING>INCISIONAL BIOPSY</VALUEMEANING>
          <MEANINGDESCRIPTION>A surgical procedure in which part of a lesion is removed for microscopic examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Incisional biopsy, with wire localization</VALIDVALUE>
          <VALUEMEANING>INCISIONAL BIOPSY, WITH WIRE LOCALIZATION</VALUEMEANING>
          <MEANINGDESCRIPTION>INCISIONAL BIOPSY, WITH WIRE LOCALIZATION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI (NMR)</VALIDVALUE>
          <VALUEMEANING>MRI</VALUEMEANING>
          <MEANINGDESCRIPTION>Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE>2015-10-29</PVENDDATE>
          <VMPUBLICID>2559279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mastectomy</VALIDVALUE>
          <VALUEMEANING>Mastectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgical removal of the breast.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15277</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Needle biopsy (tru-cut or core)</VALIDVALUE>
          <VALUEMEANING>NEEDLE BIOPSY (TRU-CUT OR CORE)</VALUEMEANING>
          <MEANINGDESCRIPTION>NEEDLE BIOPSY (TRU-CUT OR CORE)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Needle biopsy (tru-cut or core), with wire localization)</VALIDVALUE>
          <VALUEMEANING>NEEDLE BIOPSY (TRU-CUT OR CORE), WITH WIRE LOCALIZATION</VALUEMEANING>
          <MEANINGDESCRIPTION>NEEDLE BIOPSY (TRU-CUT OR CORE), WITH WIRE LOCALIZATION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not evaluated</VALIDVALUE>
          <VALUEMEANING>Not Evaluated</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25214, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resection/re-excision of lumpectomy margins</VALIDVALUE>
          <VALUEMEANING>RESECTION/RE-EXCISION OF LUMPECTOMY MARGINS</VALUEMEANING>
          <MEANINGDESCRIPTION>RESECTION/RE-EXCISION OF LUMPECTOMY MARGINS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spiral CT scan</VALIDVALUE>
          <VALUEMEANING>SPIRAL CT SCAN</VALUEMEANING>
          <MEANINGDESCRIPTION>SPIRAL CT SCAN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor markers</VALIDVALUE>
          <VALUEMEANING>Tumor Markers</VALUEMEANING>
          <MEANINGDESCRIPTION>Tumor Markers</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ultrasound</VALIDVALUE>
          <VALUEMEANING>Ultrasound</VALUEMEANING>
          <MEANINGDESCRIPTION>Very high frequency sound. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570770</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Autopsy</VALIDVALUE>
          <VALUEMEANING>Autopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Autopsy; an examination and dissection of a dead body to determine cause of death or the changes produced by disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25153</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axillary dissection</VALIDVALUE>
          <VALUEMEANING>AXILLARY DISSECTION</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the armpit area, including the lymph nodes that are located there.: The process of cutting apart or separating tissue as, for example, in the study of anatomy or in the course of a surgical procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15227, C13351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ductal lavage</VALIDVALUE>
          <VALUEMEANING>DUCTAL LAVAGE</VALUEMEANING>
          <MEANINGDESCRIPTION>DUCTAL LAVAGE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>CL054589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ductoscopic biopsy</VALIDVALUE>
          <VALUEMEANING>DUCTOSCOPIC BIOPSY</VALUEMEANING>
          <MEANINGDESCRIPTION>DUCTOSCOPIC BIOPSY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Excisional biopsy or lumpectomy</VALIDVALUE>
          <VALUEMEANING>EXCISIONAL BIOPSY OR LUMPECTOMY</VALUEMEANING>
          <MEANINGDESCRIPTION>EXCISIONAL BIOPSY OR LUMPECTOMY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Excisional biopsy or lumpectomy, with wire localization</VALIDVALUE>
          <VALUEMEANING>LUMPECTOMY, WITH WIRE LOCALIZATION</VALUEMEANING>
          <MEANINGDESCRIPTION>LUMPECTOMY, WITH WIRE LOCALIZATION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluid cytology, ascites</VALIDVALUE>
          <VALUEMEANING>FLUID CYTOLOGY, ASCITES</VALUEMEANING>
          <MEANINGDESCRIPTION>FLUID CYTOLOGY, ASCITES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluid cytology, cerebrospinal fluid</VALIDVALUE>
          <VALUEMEANING>FLUID CYTOLOGY, CEREBROSPINAL FLUID</VALUEMEANING>
          <MEANINGDESCRIPTION>FLUID CYTOLOGY, CEREBROSPINAL FLUID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluid cytology, pleural</VALIDVALUE>
          <VALUEMEANING>FLUID CYTOLOGY, PLEURAL</VALUEMEANING>
          <MEANINGDESCRIPTION>FLUID CYTOLOGY, PLEURAL</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558794</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nipple fluid</VALIDVALUE>
          <VALUEMEANING>NIPPLE FLUID</VALUEMEANING>
          <MEANINGDESCRIPTION>NIPPLE FLUID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other, specify</VALIDVALUE>
          <VALUEMEANING>Other specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prophalactic mastectomy</VALIDVALUE>
          <VALUEMEANING>Prophylactic Mastectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgery to reduce the risk of developing breast cancer by removing one or both breasts before disease develops.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sentinel node biopsy</VALIDVALUE>
          <VALUEMEANING>SENTINEL NODE BIOPSY</VALUEMEANING>
          <MEANINGDESCRIPTION>SENTINEL NODE BIOPSY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560027</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Laparotomy</VALIDVALUE>
          <VALUEMEANING>LAPAROTOMY</VALUEMEANING>
          <MEANINGDESCRIPTION>LAPAROTOMY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15266</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559025</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Laparoscopy</VALIDVALUE>
          <VALUEMEANING>Laparoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>(lap-a-RAHS-ko-pee) The insertion of a thin, lighted tube (called a laparoscope) through the abdominal wall to inspect the inside of the abdomen and remove tissue samples.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biopsy other</VALIDVALUE>
          <VALUEMEANING>Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-12-19</PVBEGINDATE>
          <PVENDDATE>2012-07-10</PVENDDATE>
          <VMPUBLICID>2574093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Preoperative CT scan</VALIDVALUE>
          <VALUEMEANING>CT Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-12-19</PVBEGINDATE>
          <PVENDDATE>2018-06-06</PVENDDATE>
          <VMPUBLICID>2570151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EKG</VALIDVALUE>
          <VALUEMEANING>EKG</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure to assess heart function using an electrocardiogram (EKG) device</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-08-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biopsy</VALIDVALUE>
          <VALUEMEANING>Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pathologic</VALIDVALUE>
          <VALUEMEANING>Pathologic</VALUEMEANING>
          <MEANINGDESCRIPTION>Caused by or altered by or manifesting disease or pathology.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559724</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Physical exam</VALIDVALUE>
          <VALUEMEANING>PHYSICAL EXAM</VALUEMEANING>
          <MEANINGDESCRIPTION>PHYSICAL EXAM</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559805</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiograph</VALIDVALUE>
          <VALUEMEANING>RADIOGRAPH</VALUEMEANING>
          <MEANINGDESCRIPTION>RADIOGRAPH</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bilateral mammogram</VALIDVALUE>
          <VALUEMEANING>Bilateral mammogram</VALUEMEANING>
          <MEANINGDESCRIPTION>Affecting both sides of the body or a matched pair of organs.: A low voltage X-ray photograph of the breast generally done to detect breast cancer. This method is also valuable in diagnosis of benign abnormal conditions of the breast such as fibroadenoma, mastitis, abscess, and cysts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13332, C20178</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-11-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bimanual examination</VALIDVALUE>
          <VALUEMEANING>BIMANUAL EXAMINATION</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to, or performed by, both hands.: A formal or careful inspection of an object or subject.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131902, C25433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Direct inspection</VALIDVALUE>
          <VALUEMEANING>DIRECT INSPECTION</VALUEMEANING>
          <MEANINGDESCRIPTION>DIRECT INSPECTION</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intraoperative ultrasound</VALIDVALUE>
          <VALUEMEANING>INTRAOPERATIVE ULTRASOUND</VALUEMEANING>
          <MEANINGDESCRIPTION>INTRAOPERATIVE ULTRASOUND</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surgery</VALIDVALUE>
          <VALUEMEANING>Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Primary surgery</VALIDVALUE>
          <VALUEMEANING>PRIMARY SURGERY</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgery of curative intent to remove tumor or malignant tissue</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-10-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X-ray</VALIDVALUE>
          <VALUEMEANING>X-RAY </VALUEMEANING>
          <MEANINGDESCRIPTION>X-RAY </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-12-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET scan</VALIDVALUE>
          <VALUEMEANING>PET Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>Positron Emission Tomography</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gallium scan</VALIDVALUE>
          <VALUEMEANING>Gallium Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>Gallium Scan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38087</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>NOT DONE</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Differential</VALIDVALUE>
          <VALUEMEANING>DIFFERENTIAL</VALUEMEANING>
          <MEANINGDESCRIPTION>evaluation by differential</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Visual assessment</VALIDVALUE>
          <VALUEMEANING>VISUAL ASSESSMENT</VALUEMEANING>
          <MEANINGDESCRIPTION>evaluation by visual assessment</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clinical</VALIDVALUE>
          <VALUEMEANING>Clinical</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the examination and treatment of patients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytologic confirmation</VALIDVALUE>
          <VALUEMEANING>Cytologic confirmation</VALUEMEANING>
          <MEANINGDESCRIPTION>Cytologic confirmation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytoscopy</VALIDVALUE>
          <VALUEMEANING>Cytoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Examination of the bladder and urethra using a cystoscope, inserted into the urethra. A cystoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a tool to remove tissue to be checked under a microscope for signs of disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cystoscopy</VALIDVALUE>
          <VALUEMEANING>Cystoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Endoscopic examination of the urinary bladder or urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16482</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palpation</VALIDVALUE>
          <VALUEMEANING>Palpation</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of feeling with the hands during a physical examination. The health care provider touches and feels the patient&#39;s body to examine the size, consistency, texture, location and tenderness of an organ or body part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569463</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Visualization</VALIDVALUE>
          <VALUEMEANING>Visualization</VALUEMEANING>
          <MEANINGDESCRIPTION>Visualization</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colposcopy</VALIDVALUE>
          <VALUEMEANING>Colposcopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Colposcopy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endoscopy</VALIDVALUE>
          <VALUEMEANING>Endoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>(en-DAHS-ko-pee) The use of a thin, lighted tube (called an endoscope) to examine the inside of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI scan</VALIDVALUE>
          <VALUEMEANING>MRI scan</VALUEMEANING>
          <MEANINGDESCRIPTION>MRI scan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plain film/X-ray without contrast</VALIDVALUE>
          <VALUEMEANING>Plain film/X-ray without contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>Plain film/X-ray without contrast</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plain film/X-ray with contrast</VALIDVALUE>
          <VALUEMEANING>Plain film/X-ray with contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>Plain film/X-ray with contrast</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radioisotope scan</VALIDVALUE>
          <VALUEMEANING>Radioisotope scan</VALUEMEANING>
          <MEANINGDESCRIPTION>Radioisotope scan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569467</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Histologic confirmation</VALIDVALUE>
          <VALUEMEANING>Histologic confirmation</VALUEMEANING>
          <MEANINGDESCRIPTION>Histologic confirmation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-05-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Histologic</VALIDVALUE>
          <VALUEMEANING>histologic</VALUEMEANING>
          <MEANINGDESCRIPTION>histologic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-10-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiographic</VALIDVALUE>
          <VALUEMEANING>Radiographic</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of Radiographic methodology</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tumor Marker</VALIDVALUE>
          <VALUEMEANING>Tumor Marker</VALUEMEANING>
          <MEANINGDESCRIPTION>Tumor Marker</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-11-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mammogram</VALIDVALUE>
          <VALUEMEANING>Mammogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A low voltage X-ray photograph of the breast generally done to detect breast cancer. This method is also valuable in diagnosis of benign abnormal conditions of the breast such as fibroadenoma, mastitis, abscess, and cysts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20178</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561001</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Echocardiogram</VALIDVALUE>
          <VALUEMEANING>Echocardiogram</VALUEMEANING>
          <MEANINGDESCRIPTION>An image of the heart produced by ultrasonography.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37945</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566540</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MUGA scan</VALIDVALUE>
          <VALUEMEANING>MUGA Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A multi-gated acquisition (MUGA) scan and a form of radionuclide imaging that provides a comprehensive look at blood flow and the function of the lower chambers of the heart ventricles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-10-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571740</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Contrast enhanced CT scan/CT perfusion exam</VALIDVALUE>
          <VALUEMEANING>CONTRAST ENHANCED CT SCAN</VALUEMEANING>
          <MEANINGDESCRIPTION>Contrast enhanced computed tomography scan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575809</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MSK Nomogram</VALIDVALUE>
          <VALUEMEANING>Nomograms</VALUEMEANING>
          <MEANINGDESCRIPTION>A graphical calculating device or a two-dimensional diagram designed to allow the approximate graphical computation of a function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-03-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET/CT scan</VALIDVALUE>
          <VALUEMEANING>Positron Emission Tomography and Computed Tomography Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PSA Assessment</VALIDVALUE>
          <VALUEMEANING>Prostate-Specific Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>Alternate isoforms of the single-chain 261-aa 30-kD Kallikrein 3 (Prostate Specific Antigen) glycoprotein precursor are encoded by human KLK3 Gene (Kallikrein Family). Frameshifted isoform 2 has a shorter distinct C-terminus. A serine protease in seminal plasma, PSA may function in liquefaction of seminal coagulum by (preferential Tyr-X) cleavage of seminal vesicle protein. Kallikrein proteases have diverse functions. Mounting evidence implicates kallikreins in carcinogenesis; some have potential as cancer biomarkers. The serum level of PSA is useful in diagnosis and monitoring of prostatic carcinoma. (from LocusLink, Swiss-Prot, OMIM, and NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580427</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Digital rectal exam</VALIDVALUE>
          <VALUEMEANING>Digital Rectal Examination</VALUEMEANING>
          <MEANINGDESCRIPTION>Digital rectal examination.  An examination in which a doctor inserts a lubricated, gloved finger into the rectum to feel for abnormalities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17631</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ipsilateral Axilla Ultrasound</VALIDVALUE>
          <VALUEMEANING>Ipsilateral Axilla Ultrasound</VALUEMEANING>
          <MEANINGDESCRIPTION>Ipsilateral Axilla Ultrasound</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-10-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CT/MRI scan</VALIDVALUE>
          <VALUEMEANING>CT/MRI scan</VALUEMEANING>
          <MEANINGDESCRIPTION>Computed tomographic and magnetic image resonance scan</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-03-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2604641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endoscopy with biopsy</VALIDVALUE>
          <VALUEMEANING>Endoscopy with biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Endoscopy with biopsy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-03-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2604642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiological</VALIDVALUE>
          <VALUEMEANING>Radiologic</VALUEMEANING>
          <MEANINGDESCRIPTION>Any imaging procedure that uses radiation to create an image for the purpose of assisting with the execution of an intervention.: The use of radiation (such as x-rays) or other imaging technologies (such as ultrasound and magnetic resonance imaging) to diagnose or treat disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17059, C118849</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2640362</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchoscopy</VALIDVALUE>
          <VALUEMEANING>Bronchoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure in which a thin, lighted tube is inserted through the nose or mouth. NCI Concept Code C16366</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16366</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-05-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Upper endoscopy</VALIDVALUE>
          <VALUEMEANING>Upper Endoscopy Esophagogastroduodenoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Upper Endoscopy Esophagogastroduodenoscopy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-05-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colonoscopy</VALIDVALUE>
          <VALUEMEANING>Colonoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Endoscopic examination of the luminal surface of the colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16450</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-05-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sigmoidoscopy</VALIDVALUE>
          <VALUEMEANING>Sigmoidoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Sigmoidoscopy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-05-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Proctoscopy/sigmoidoscopy</VALIDVALUE>
          <VALUEMEANING>Proctoscopy/sigmoidoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Examination of the anus or sigmoid colon using a flexible tube enclosing a light and camera.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2672935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdominal MRI</VALIDVALUE>
          <VALUEMEANING>Abdominal MRI</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or related to, the abdomen.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16809, C25342</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2673036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transrectal ultrasound</VALIDVALUE>
          <VALUEMEANING>Transrectal Ultrasound</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure that uses sound waves to create a video image of the prostate gland. A small, lubricated probe placed into the rectum releases sound waves, which create echoes as they enter the prostate. Prostate tumors sometimes create echoes that are different from normal prostate tissue. The echoes that bounce back are sent to a computer that translates the pattern of echoes into a picture of the prostate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chest CT</VALIDVALUE>
          <VALUEMEANING>Chest Radiography</VALUEMEANING>
          <MEANINGDESCRIPTION>An x-ray examination of the chest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdominal CT</VALIDVALUE>
          <VALUEMEANING>Abdominal CT-scan</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or related to, the abdomen.: A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25342, C17204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2667062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvic CT</VALIDVALUE>
          <VALUEMEANING>Pelvic CT</VALUEMEANING>
          <MEANINGDESCRIPTION>Pelvic computed tomography</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2671035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Evaluated but no disease found</VALIDVALUE>
          <VALUEMEANING>Evaluated but no disease found</VALUEMEANING>
          <MEANINGDESCRIPTION>Evaluated but no disease found</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Core biopsy</VALIDVALUE>
          <VALUEMEANING>Core Needle Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>The removal of a tissue sample using a needle with a relatively large diameter, for microscopic examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Excisional biopsy with frozen section</VALIDVALUE>
          <VALUEMEANING>Excisional biopsy with frozen section</VALUEMEANING>
          <MEANINGDESCRIPTION>Excisional biopsy with frozen section</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2722512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Skin biopsy</VALIDVALUE>
          <VALUEMEANING>Skin biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>the removal of a piece of skin to diagnose or rule out an illness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2722511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Contralateral mammogram</VALIDVALUE>
          <VALUEMEANING>Contralateral mammogram</VALUEMEANING>
          <MEANINGDESCRIPTION>An x-ray picture of the breast not involved with the primary tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2697040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ipsilateral mammogram</VALIDVALUE>
          <VALUEMEANING>Ipsilateral mammogram</VALUEMEANING>
          <MEANINGDESCRIPTION>An x-ray picture of the breast with the primary tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2697041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CEA</VALIDVALUE>
          <VALUEMEANING>Carcinoembryonic Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>Carcinoembryonic antigen. A substance that is sometimes found in an increased amount in the blood of people with certain cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2633456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pelvic MRI</VALIDVALUE>
          <VALUEMEANING>Pelvic Magnetic Resonance imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure in which a magnet linked to a computer is used to create detailed pictures of areas inside the pelivs. Also called nuclear magnetic resonance </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Colonscopy/proctoscopy</VALIDVALUE>
          <VALUEMEANING>Colonscopy/proctoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>An examination of the rectum using a thin, lighted tube called a proctoscope or An examination of the inside of the colon using a thin, lighted tube (called a colonoscope).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-01-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717947</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CT of Abdomen/Pelvis</VALIDVALUE>
          <VALUEMEANING>CT of Abdomen/Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>CT of Abdomen/Pelvis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2765399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI of Abdomen/Pelvis</VALIDVALUE>
          <VALUEMEANING>MRI of Abdomen/Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>MRI of Abdomen/Pelvis</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-07-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2765400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Diagnostic Imaging</VALIDVALUE>
          <VALUEMEANING>Diagnostic Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation..</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16502</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flow cytometry, cerebrospinal fluid</VALIDVALUE>
          <VALUEMEANING>Flow cytometry, cerebrospinal fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>Flow cytometry, cerebrospinal fluid</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-01-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2824966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IVP</VALIDVALUE>
          <VALUEMEANING>Intravenous Pyelogram</VALUEMEANING>
          <MEANINGDESCRIPTION>Intravenous Pyelogram</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphangiogram</VALIDVALUE>
          <VALUEMEANING>Lymphangiogram</VALUEMEANING>
          <MEANINGDESCRIPTION>An x-ray image of the lymphatic system using a radiopaque imaging agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16805</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-01-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiologic</VALIDVALUE>
          <VALUEMEANING>Radiologic</VALUEMEANING>
          <MEANINGDESCRIPTION>Any imaging procedure that uses radiation to create an image for the purpose of assisting with the execution of an intervention.: The use of radiation (such as x-rays) or other imaging technologies (such as ultrasound and magnetic resonance imaging) to diagnose or treat disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17059, C118849</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-07</PVBEGINDATE>
          <PVENDDATE>2016-01-05</PVENDDATE>
          <VMPUBLICID>2640362</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-D Echocardiogram</VALIDVALUE>
          <VALUEMEANING>2-D Echocardiogram</VALUEMEANING>
          <MEANINGDESCRIPTION>The property of being measured and described using two orthogonal directions.: An image of the heart produced by ultrasonography.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37945, C48282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2847201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serological</VALIDVALUE>
          <VALUEMEANING>Serology</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the in vitro reactions and properties of immune sera, particularly, the concept refers to the use of such reactions to measure serum titers of antibody against infectious and non-infectious agents (serologic tests), to the clinical correlations of the antibody titer, and to the use of serologic reactions to detect antigens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41264</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CT w/contrast</VALIDVALUE>
          <VALUEMEANING>CT w/contrast</VALUEMEANING>
          <MEANINGDESCRIPTION>Computed tomography that uses a contrast agent to visualize anatomic structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C137805</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2876591</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ECHO</VALIDVALUE>
          <VALUEMEANING>ECHO</VALUEMEANING>
          <MEANINGDESCRIPTION>Echocardiogram</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-10-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2951058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FDG-PET</VALIDVALUE>
          <VALUEMEANING>Positron Emission Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2919109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Marrow Biopsy</VALIDVALUE>
          <VALUEMEANING>BONE MARROW BIOPSY</VALUEMEANING>
          <MEANINGDESCRIPTION>BONE MARROW BIOPSY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Marrow Aspirate</VALIDVALUE>
          <VALUEMEANING>Aspirate, Bone Marrow</VALUEMEANING>
          <MEANINGDESCRIPTION>(as-per-AY-shun) The removal of a small sample of bone marrow (usually from the hip) through a needle for examination under a microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15644</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peripheral Blood Counts</VALIDVALUE>
          <VALUEMEANING>Peripheral Blood Counts</VALUEMEANING>
          <MEANINGDESCRIPTION>Peripheral Blood Counts</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2978652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spiral CT</VALIDVALUE>
          <VALUEMEANING>Spiral CT</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of computed tomography (CT) that uses continuous rotation of the X-ray tube and continuous transport of the patient through the scanning aperture that allows the rapid acquisition of a volume of CT data.  Advantages over conventional CT include: rapid acquisition of a large volume of data within a single breath-hold, thus minimizing respiration artifact and misregistration between slices; the ability to reconstruct images retrospectively at any level within the scanned volume; optimization of intravenous contrast enhancement due to the short scan times; improved multi-planar and 3-D reconstruction; and the potential for radiation dose reduction.  Same as helical computed tomography. (British Journal of Radiology 1994 May;67(797):436-44)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970362</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Plain X-Ray</VALIDVALUE>
          <VALUEMEANING>X-Ray</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of high-energy radiation.  In low doses, x-rays are used to diagnose diseases by making pictures of the inside of the body.  In high doses, x-rays are used to treat cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970340</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunophenotyping (4 Color flow cytometry)</VALIDVALUE>
          <VALUEMEANING>Four Color Flow Cytometry Immunophenotype</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.: The appearance of objects (or light sources) described in terms of a person&#39;s perception of their hue and lightness (or brightness) and saturation.: A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.: Immunophenotype is the characterization of a set of cells according to the antigens expressed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20072, C16585, C37927, C66835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3027791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Heavy chain gene rearrangement</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin Heavy Chain Gene Rearrangement</VALUEMEANING>
          <MEANINGDESCRIPTION>A protein complex that consists of two heavy chains (gamma, alpha, delta, epsilon or mu). The larger of the two immunoglobulin chain types determines the immunoglobulin class (G, A, D, E or M, respectively). The heavy chain molecules exhibit the same structure and composition, which consists of constant, variable, and hypervariable regions._Any DNA sequence rearrangement that results in the creation of a novel protein-coding capacity. Within certain genes, gene rearrangement is a normal part of development, facilitating the affinity maturation of B and T lymphocytes as well as class switching of immunoglobulins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16611, C16717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3027713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytogenetic analysis by FISH</VALIDVALUE>
          <VALUEMEANING>Cytogenetic Analysis Fluorescence in situ Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.: A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17563, C18280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clinical and/or hematologic analysis</VALIDVALUE>
          <VALUEMEANING>Clinical And/Or Hematologic Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the examination and treatment of patients.: Used to indicate that either or both of two items or options: Pertaining to or related to the blood and blood-forming organs.: Analysis; examination and interpretation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25391, C62780, C48928, C25398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytogenetic Analysis</VALIDVALUE>
          <VALUEMEANING>Cytogenetic Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2861225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Molecular Analysis</VALIDVALUE>
          <VALUEMEANING>Molecular Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2861224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DEXA scan</VALIDVALUE>
          <VALUEMEANING>Scan, Dual-Energy X-ray Absorpitometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for scanning bone and measuring bone mineral density (BMD). A DXA scanner produces 2 X-ray beams, each with different energy levels. One beam is high energy while the other is low energy. The amount of x-rays that pass through the bone is measured for each beam. This will vary depending on the thickness of the bone. Based on the difference between the 2 beams, the bone density can be measured.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Caliper measurement by clinical exam</VALIDVALUE>
          <VALUEMEANING>Vernier Caliper Measurement Physical Examination</VALUEMEANING>
          <MEANINGDESCRIPTION>A medical device that is a combination of ruler and caliper that can measure the distance between two points. The configuration of this device permits the measurement of internal dimensions.: Measurement; the size or magnitude of something.: A physical examination is a systemic evaluation of the body and its functions using visual inspection, palpation, percussion, and auscultation, aimed to determine the presence or absence of physical signs of disease or abnormality for individual&#39;s health assessment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20989, C25209, C81184</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Culture</VALIDVALUE>
          <VALUEMEANING>Culture Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>Any laboratory procedure for growing microorganisms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25300</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aspergillus galactomannan assay</VALIDVALUE>
          <VALUEMEANING>ELISA</VALUEMEANING>
          <MEANINGDESCRIPTION>A highly sensitive technique for detecting and measuring antigens or antibodies in a solution; the solution is run over a surface to which immobilized antibodies specific to the substance have been attatched, and if the substance is present, it will bind to the antibody layer, and its presence is verified and visualized with an application of antibodies that have been tagged in some way. (BioTech Life Science Dictionary)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3173905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KOH / calcofluor stain</VALIDVALUE>
          <VALUEMEANING>Calcofluor White Stain</VALUEMEANING>
          <MEANINGDESCRIPTION>A fluorescent stain that binds to the cell wall.  It is used for the detection of fungi, parasites, and yeasts, using fluorescent microscopy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85880</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3181377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET/Conventional CT</VALIDVALUE>
          <VALUEMEANING>Computed Tomography Positron Emission Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. : A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17007, C17204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3237468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET/Spiral CT</VALIDVALUE>
          <VALUEMEANING>Spiral CT Positron Emission Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of computed tomography (CT) that uses continuous rotation of the X-ray tube and continuous transport of the patient through the scanning aperture that allows the rapid acquisition of a volume of CT data.  Advantages over conventional CT include: rapid acquisition of a large volume of data within a single breath-hold, thus minimizing respiration artifact and misregistration between slices; the ability to reconstruct images retrospectively at any level within the scanned volume; optimization of intravenous contrast enhancement due to the short scan times; improved multi-planar and 3-D reconstruction; and the potential for radiation dose reduction.  Same as helical computed tomography. (British Journal of Radiology 1994 May;67(797):436-44): A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17007, C20645</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-05-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3237469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI of Spine</VALIDVALUE>
          <VALUEMEANING>MRI of Spine</VALUEMEANING>
          <MEANINGDESCRIPTION>MRI of Spine</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3392215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI of Brain</VALIDVALUE>
          <VALUEMEANING>MRI of Brain</VALUEMEANING>
          <MEANINGDESCRIPTION>MRI of Brain</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3392216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urine catecholamines</VALIDVALUE>
          <VALUEMEANING>Urine catecholamines</VALUEMEANING>
          <MEANINGDESCRIPTION>Urine catecholamines</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3566835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone marrow morphology</VALIDVALUE>
          <VALUEMEANING>Bone marrow morphology</VALUEMEANING>
          <MEANINGDESCRIPTION>Bone marrow morphology</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MIBG scintiscan</VALIDVALUE>
          <VALUEMEANING>MIBG scintiscan</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging test that uses a radioisotope (MIBG, iodine-131-meta-iodobenzylguanidine) tracer and a special scanner to find or confirm the presence of pheochromocytoma and neuroblastoma, which are tumors of specific types of nervous tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-05-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3458598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CA-125 assay</VALIDVALUE>
          <VALUEMEANING>CA-125 assay</VALUEMEANING>
          <MEANINGDESCRIPTION>CA-125 assay</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-06-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3485237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiographic Imaging</VALIDVALUE>
          <VALUEMEANING>Radiograph Imaging Technique</VALUEMEANING>
          <MEANINGDESCRIPTION>An image produced on a radiosensitive surface by x-ray radiation that has penetrated and passed through a structure.: Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17369, C60727</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3626193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polymerase Chain Reaction</VALIDVALUE>
          <VALUEMEANING>Polymerase Chain Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17003</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-10-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3234683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>in situ hybridization</VALIDVALUE>
          <VALUEMEANING>in situ Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-10-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939763</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flow Cytometry</VALIDVALUE>
          <VALUEMEANING>Flow Cytometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2974014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Physical examination with imaging</VALIDVALUE>
          <VALUEMEANING>Imaging With Physical Examination</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.: Used to indicate the presence of something or someone.: A physical examination is a systemic evaluation of the body and its functions using visual inspection, palpation, percussion, and auscultation, aimed to determine the presence or absence of physical signs of disease or abnormality for individual&#39;s health assessment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20989, C62355, CL024911</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3906854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Microscopic evaluation</VALIDVALUE>
          <VALUEMEANING>Microscopic evaluation</VALUEMEANING>
          <MEANINGDESCRIPTION>Microscopic evaluation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4120631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Macroscopic evaluation</VALIDVALUE>
          <VALUEMEANING>Macroscopic evaluation</VALUEMEANING>
          <MEANINGDESCRIPTION>Macroscopic evaluation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4120632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antigen</VALIDVALUE>
          <VALUEMEANING>Antigen</VALUEMEANING>
          <MEANINGDESCRIPTION>Any substance that appears foreign or potentially adverse to the body and elicits immune response.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3167779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI + DWI</VALIDVALUE>
          <VALUEMEANING>MRI DWI</VALUEMEANING>
          <MEANINGDESCRIPTION>Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.: A diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111116, C16809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4253231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Shell Vial Culture</VALIDVALUE>
          <VALUEMEANING>Shell Vial Culture</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for virus culture and detection in which a virus sample is mixed with a susceptible cell type and then centrifuged into a single layer of cells. Following a short incubation, viral growth is determined using immunological detection techniques.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114597</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-04-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4262871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI T2</VALIDVALUE>
          <VALUEMEANING>MRI T2</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of magnetic resonance imaging (MRI) that creates contrast between tissues based on differences in the transverse relaxation of a tissue&#39;s net magnetization vector; it measures the time taken for spinning protons to lose phase coherence among the nuclei spinning perpendicular to the main field. This MRI sequence is produced by using a longer time to echo (TE) and repetition time (TR) than a T1-weighted sequence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C180729</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4231311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI T1gad</VALIDVALUE>
          <VALUEMEANING>MRI T1gad</VALUEMEANING>
          <MEANINGDESCRIPTION>Magnetic resonance imaging (MRI) of the T1gad signal intensity ratio (SIR)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4231312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI T1gad and MRI T2</VALIDVALUE>
          <VALUEMEANING>MRI T1gad and MRI T2</VALUEMEANING>
          <MEANINGDESCRIPTION>MRI T1gad and MRI T2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-07-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4377743</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CT of Neck</VALIDVALUE>
          <VALUEMEANING>CT of Neck</VALUEMEANING>
          <MEANINGDESCRIPTION>CT of Neck</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-10-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4512871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Combination of these methods</VALIDVALUE>
          <VALUEMEANING>Combination of these methods</VALUEMEANING>
          <MEANINGDESCRIPTION>Combination of these methods</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-01-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4669452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Direct inspection / endoscopy under anesthesia</VALIDVALUE>
          <VALUEMEANING>Direct inspection / endoscopy under anesthesia</VALUEMEANING>
          <MEANINGDESCRIPTION>Direct inspection / endoscopy under anesthesia</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-01-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4669453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Direct inspection / in office endoscopy</VALIDVALUE>
          <VALUEMEANING>Direct inspection / in office endoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Direct inspection / in office endoscopy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-01-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4669454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fiberoptic nasopharyngolaryngoscopy</VALIDVALUE>
          <VALUEMEANING>Fiberoptic nasopharyngolaryngoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Fiberoptic nasopharyngolaryngoscopy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4726691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Laryngoscopy</VALIDVALUE>
          <VALUEMEANING>Laryngoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Endoscopic examination of the larynx.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16781</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2832055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>WBC differential</VALIDVALUE>
          <VALUEMEANING>WBC differential</VALUEMEANING>
          <MEANINGDESCRIPTION>A hematologic procedure for the evaluation of the qualitative and quantitative characteristics of the white cells in peripheral blood smears and bone marrow aspirates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4845352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Peripheral smear</VALIDVALUE>
          <VALUEMEANING>Peripheral smear</VALUEMEANING>
          <MEANINGDESCRIPTION>A sample of blood applied in a thin film to a microscope slide for study under a microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4845353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Myelin-Associated Glycoprotein</VALIDVALUE>
          <VALUEMEANING>Myelin-Associated Glycoprotein</VALUEMEANING>
          <MEANINGDESCRIPTION>An autoantibody directed against myelin-associated glycoprotein (MAG). It is associated with active demyelination in peripheral neuropathy and is detected in about 50% of patients with IgM&amp;#8200;paraproteinemia and may occur in some patients with multiple sclerosis, Guillain-Barre syndrome, chronic polyneuropathy, or myasthenia gravis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121771</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4811579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MIBG</VALIDVALUE>
          <VALUEMEANING>MIBG</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C87757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRV</VALIDVALUE>
          <VALUEMEANING>MRV</VALUEMEANING>
          <MEANINGDESCRIPTION>Magnetic resonance venography</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4723853</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRA</VALIDVALUE>
          <VALUEMEANING>MRI-Based Angiogram</VALUEMEANING>
          <MEANINGDESCRIPTION>An image of blood vessels constructed using magnetic resonance imaging.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114867</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4723855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None of the above</VALIDVALUE>
          <VALUEMEANING>None of the above</VALUEMEANING>
          <MEANINGDESCRIPTION>None of the choices above are suitable.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133298</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577583</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary cytology with mass visualized during upper tract endoscopy</VALIDVALUE>
          <VALUEMEANING>Urinary cytology with mass visualized during upper tract endoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Urinary cytology with mass visualized during upper tract endoscopy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-02-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4719232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Urinary cytology with 3-D upper urinary tract mass on Cross-Sectional Imaging</VALIDVALUE>
          <VALUEMEANING>Urinary cytology with 3-D upper urinary tract mass on Cross-Sectional Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>Urinary cytology with 3-D upper urinary tract mass on Cross-Sectional Imaging</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-02-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4719233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Image-guided Biopsy</VALIDVALUE>
          <VALUEMEANING>Image-guided Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis, using imaging technology.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15652</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4719251</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Electromyography</VALIDVALUE>
          <VALUEMEANING>Electromyography</VALUEMEANING>
          <MEANINGDESCRIPTION>An assessment of skeletal muscle function and nerve control, obtained by recording and studying the intrinsic electrical properties of the muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38056</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4821875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SQUID</VALIDVALUE>
          <VALUEMEANING>Superconducting Quantum Interference Device</VALUEMEANING>
          <MEANINGDESCRIPTION>A device designed to measure extremely weak magnetic fields. It is comprised of a Josephson junction with two superconducting loops separated by an insulating layer thin enough to allow electrons to pass through.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124066</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5039992</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver Biopsy</VALIDVALUE>
          <VALUEMEANING>Liver Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal of tissue from the liver for microscopic examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51677</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2831213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI</VALIDVALUE>
          <VALUEMEANING>Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5039993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease specific molecular marker</VALIDVALUE>
          <VALUEMEANING>Disease specific molecular marker</VALUEMEANING>
          <MEANINGDESCRIPTION>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.::2: Clearly and explicitly stated.::2: A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16342, C38024, C2991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5084231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chimerism testing</VALIDVALUE>
          <VALUEMEANING>Chimerism testing</VALUEMEANING>
          <MEANINGDESCRIPTION>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.: The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with mosaicism in which the different cell populations are derived from a single individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62582, C25294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-11-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FDG-PET + MRI</VALIDVALUE>
          <VALUEMEANING>FDG-PET + MRI</VALUEMEANING>
          <MEANINGDESCRIPTION>FDG-PET + MRI</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-03-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5170915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FDG-PET + CT</VALIDVALUE>
          <VALUEMEANING>FDG-PET + CT</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging procedure that combines FDG PET with a CT scan to overlay activity data onto detailed anatomic images.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C137817</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-03-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5170916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clinical Palpation</VALIDVALUE>
          <VALUEMEANING>Clinical Palpation</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.: A method of feeling with the hands during a physical examination. The health care provider touches and feels the patient&#39;s body to examine the size, consistency, texture, location and tenderness of an organ or body part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16950, C25398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5283971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Imaging</VALIDVALUE>
          <VALUEMEANING>Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5283972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sokal</VALIDVALUE>
          <VALUEMEANING>Sokal Score</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for assessing prognosis for patients with chronic myeloid leukemia. The numerical value is calculated at diagnosis from the percentage of blast cells in peripheral blood, the platelet count, the spleen size, and the age of the patient.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5485916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hasford</VALIDVALUE>
          <VALUEMEANING>Hasford Score</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high, medium, or low risk on the basis of age, spleen size, and eosinophil, basophil, and platelet counts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127873</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5485917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EUTOS</VALIDVALUE>
          <VALUEMEANING>European Treatment Outcome Study Score</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high or low risk on the basis of the percentage of basophils in the peripheral blood and spleen size at diagnosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127872</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5485918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IgH/TCR PCR</VALIDVALUE>
          <VALUEMEANING>Immunoglobulin Heavy Locus T-Cell Receptor Polymerase Chain Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>This region represents the germline organization of the immunoglobulin heavy chain locus. The locus includes V (variable), J (joining), diversity (D), and C (constant) segments. During B cell development, a recombination event at the DNA level joins a D segment with a J segment; a V segment is then joined to the D-J gene. The C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several D and J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase, and by somatic hypermutation, which occurs during B cell maturation in the spleen and lymph nodes. (from LocusLink): Heterodimeric antigen receptors present on the surface of T-cells.  Two T-cell antigen receptors have been identified, consisting of heterodimeric 40-55 kD Ig-like alpha/beta or gamma/delta integral membrane glycoproteins.  Genes for TCR alpha, beta, gamma, and delta subunits are assembled during T-cell development by somatic rearrangement of germline gene segments, resembling B-cell Ig genes in their mechanisms of diversity generation and activation of expression.  Alpha/beta heterodimers are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented by MHC gene products.  T-cells expressing gamma/delta heterodimers directly recognize proteins and non-proteinacious phospho-ligands.  T-cell receptors are non-covalently associated with CD3, forming the TCR-CD3 complex.  TCRs activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70.  (from OMIM and NCI): A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly s</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17003, C17065, C26422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5664683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BCR-ABL1/FISH</VALIDVALUE>
          <VALUEMEANING>BCR Protein Fluorescence in Situ Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>The 160 kD BCR phosphoprotein exhibits a unique serine/threonine kinase activity, at least two SH2 binding sites, and a C-terminal GTPase activating domain for p21(rac).  The Philadelphia translocation produces a BCR-ABL1 chimeric product required for induction and maintenance of leukemia.  (from OMIM 151410 and NCI): A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17563, C17477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5664705</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Morphology</VALIDVALUE>
          <VALUEMEANING>Morphology</VALUEMEANING>
          <MEANINGDESCRIPTION>The science of the form and structure of organisms (plants, animals, and other forms of life), or of their parts, and the study or science of the same.  In pathology, the specific appearance of cells and tissues (normal and abnormal) under the light or electron microscope.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17943</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4661331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunohistochemistry</VALIDVALUE>
          <VALUEMEANING>Immunohistochemistry Staining Method</VALUEMEANING>
          <MEANINGDESCRIPTION>Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C23020</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiographic confirmation only</VALIDVALUE>
          <VALUEMEANING>Radiographic Examination Confirmation Only</VALUEMEANING>
          <MEANINGDESCRIPTION>A radiographic procedure using the emission of penetrating energy waves to form an image of the structure penetrated by the radiation._Having been established or verified._Not accompanied by another or others; exclusive of anyone or anything else.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48440, C25458, C128940</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5977653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pathologic confirmation</VALIDVALUE>
          <VALUEMEANING>Pathologic Confirmation</VALUEMEANING>
          <MEANINGDESCRIPTION>Caused by or altered by or manifesting disease or pathology.: Having been established or verified.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25458, C25610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5633738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gene expression profile</VALIDVALUE>
          <VALUEMEANING>Microarray Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>Analysis using microarray technology (e.g., cDNA arrays to see gene expression or protein microarrays to profile the pattern of proteins).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18477</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3600806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CT of Brain</VALIDVALUE>
          <VALUEMEANING>Computed Tomography Brain</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.: An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12439, C17204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6058859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FLAIR</VALIDVALUE>
          <VALUEMEANING>Fluid Attenuated Inversion Recovery</VALUEMEANING>
          <MEANINGDESCRIPTION>A magnetic resonance imaging (MRI) pulse sequence that uses an inversion recovery technique to null fluids present in the imaging area, improving clarity of the object of interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6147291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Both</VALIDVALUE>
          <VALUEMEANING>Both</VALUEMEANING>
          <MEANINGDESCRIPTION>One and the other; relating to or being two in conjunction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Axumin PET Scan</VALIDVALUE>
          <VALUEMEANING>Fluciclovine F18 Positron Emission Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A radiotracer containing a synthetic amino acid analogue of L-leucine radiolabeled with fluorine F 18 with potential diagnostic imaging use. Similar to most amino acids, fluciclovine F18 appears to enter cells through the energy-independent L-type amino acid transporter (LAT) system. As an amino acid analogue, this agent is preferentially accumulated by tumor cells due to their increased metabolic needs; however, unlike naturally occurring amino acids, this non-natural amino acid-analogue radiotracer is not metabolized. Accordingly, fluciclovine F18 accumulates in tumor cells and can potentially be used to image tumors using positron emission tomography (PET).: A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17007, C74002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6399698</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PSMA PET Scan</VALIDVALUE>
          <VALUEMEANING>Glutamate Carboxypeptidase 2 Positron Emission Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>Glutamate carboxypeptidase 2 (750 aa, ~84 kDa) is encoded by the human FOLH1 gene. This protein plays a role in the mediation of folate metabolism.: A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17007, C17796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6399696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Preoperative CT Scan</VALIDVALUE>
          <VALUEMEANING>Preoperative Computed Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to or occurring during the period immediately before a surgical operation.: A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17204, C54732</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6332631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Next generation sequencing (NGS)</VALIDVALUE>
          <VALUEMEANING>Next Generation Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>Technologies that facilitate the rapid determination of the DNA sequence of large numbers of strands or segments of DNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4448577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Liver MRI</VALIDVALUE>
          <VALUEMEANING>Liver Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12392, C16809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7147344</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Capillary electrophoresis</VALIDVALUE>
          <VALUEMEANING>Capillary Electrophoresis</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrophoresis procedure, in which a sample is introduced into a capillary tube and the components are separated by the application of high voltage. Due to the large surface to volume ratio, cooling is more efficient, allowing use of higher voltages.  As a result, separation occurs more quickly and sensitivity is increased. The technique allows for separation of proteins, nucleic acids, and carbohydrates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-10-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2915741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SQUID MRI</VALIDVALUE>
          <VALUEMEANING>Superconducting Quantum Interference Device Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>A device designed to measure extremely weak magnetic fields. It is comprised of a Josephson junction with two superconducting loops separated by an insulating layer thin enough to allow electrons to pass through.: Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16809, C124066</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6576956</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>T2 MRI</VALIDVALUE>
          <VALUEMEANING>T2 (Observed)-Weighted Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>MRI imaging based on the observed T2 relaxation time of tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156447</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6576930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FerriScan</VALIDVALUE>
          <VALUEMEANING>FerriScan</VALUEMEANING>
          <MEANINGDESCRIPTION>A proprietary method to determine liver iron concentration through an MRI-based imaging technology that uses R2-MRI relaxometry.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153820 </MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-12-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6576931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polymerase Chain Reaction (PCR)</VALIDVALUE>
          <VALUEMEANING>Polymerase Chain Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17003</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-12</PVBEGINDATE>
          <PVENDDATE>2019-07-15</PVENDDATE>
          <VMPUBLICID>3234683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FISH</VALIDVALUE>
          <VALUEMEANING>Fluorescence in Situ Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5622317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Karyotype</VALIDVALUE>
          <VALUEMEANING>Karyotype</VALUEMEANING>
          <MEANINGDESCRIPTION>The assessment of the chromosomal morphology and number in somatic cells of an individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5255756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MRI of the Brain with orbital cuts</VALIDVALUE>
          <VALUEMEANING>MRI of the Brain with orbital cuts</VALUEMEANING>
          <MEANINGDESCRIPTION>MRI of the Brain with orbital cuts</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2019-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6649483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunofluorescence</VALIDVALUE>
          <VALUEMEANING>Fluorescent Antibody Technique</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunological technique in which the antibodies are coupled with molecules which fluoresce under ultra violet (UV) light. This makes them particularly suitable for detection of specific antigens in tissues or on cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17370</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2978232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mass spectrometry</VALIDVALUE>
          <VALUEMEANING>Mass Spectrometry</VALUEMEANING>
          <MEANINGDESCRIPTION>An analytical technique wherein ions are separate according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17156</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3339145</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ICE</VALIDVALUE>
          <VALUEMEANING>Immune Effector Encephalopathy - ICE Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>A grading system for Immune Effector Cell Associated Neurotoxicity Syndrome that includes: orientation to year, month, city, hospital; ability to name objects; ability to follow simple commands; ability to write a standard sentence; and ability to count backwards from 100 by 10. Grading ranges from 10: no impairment to 0: patient unarousable and unable to perform ICE assessment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C162916</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6927187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CARTOX</VALIDVALUE>
          <VALUEMEANING>CARTOX 10 Point Neurological Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>A test to monitor for neurotoxicity related to CAR T therapy: orientation to year, month, city, hospital, and President; ability to name 3 specified objects; ability to write a standard sentence; ability to count backwards from 100 by 10.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C155295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6927188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Serum ferritin</VALIDVALUE>
          <VALUEMEANING>Serum Ferritin Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The clear liquid part of the blood that remains after blood cells and clotting proteins have been removed.: The determination of the amount of ferritin present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74737, C13325</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7147345</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multicolor flow cytometry</VALIDVALUE>
          <VALUEMEANING>Multiple Color Flow Cytometry</VALUEMEANING>
          <MEANINGDESCRIPTION>Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.: The appearance of objects (or light sources) described in terms of a person&#39;s perception of their hue and lightness (or brightness) and saturation.: A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16585, C37927, C17648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7246031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Molecular assay</VALIDVALUE>
          <VALUEMEANING>Molecular Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to or produced by or consisting of molecules.: A qualitative or quantitative analysis performed to determine the amount of a particular constituent in a sample or the biological or pharmacological properties of a drug.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60819, C25574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7246030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right Heart Catheterization</VALIDVALUE>
          <VALUEMEANING>Right Heart Catheterization</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic procedure in which a catheter is guided into the right heart, where pressures may be measured and radiocontrast material may be injected to visualize blood flow in and around the right heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7244953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clinical exam</VALIDVALUE>
          <VALUEMEANING>Clinical exam</VALUEMEANING>
          <MEANINGDESCRIPTION>Clinical exam</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2020-06-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7340571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complete red blood cell count</VALIDVALUE>
          <VALUEMEANING>Complete Erythrocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: The determination of the number of erythrocytes in a blood sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51946, C25250</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7320617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pitted Erythrocyte Count</VALIDVALUE>
          <VALUEMEANING>Pitted Erythrocyte Count</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of pitted erythrocytes in a blood sample, expressed as a percentage. It is used as an indicator of splenic function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7320618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Next generation sequencing (NGS) by Guardant360</VALIDVALUE>
          <VALUEMEANING>Guardant360 Genomic Profiling</VALUEMEANING>
          <MEANINGDESCRIPTION>A proprietary epigenomic and genomic profiling system for the identification of disease and treatment response biomarkers in cell-free circulating tumor DNA (ctDNA) found in liquid biopsy (blood) samples. This system uses next-generation digital sequencing technology to assist in the diagnosis of multiple solid tumor types, facilitate the selection of diagnosis-specific targeted therapeutics based on markers for treatment sensitivity or resistance and identification of new markers of disease progression, minimal residual disease and recurrence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153090</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7334407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Next generation sequencing (NGS) by FoundationOne</VALIDVALUE>
          <VALUEMEANING>FoundationOne Genomic Profiling</VALUEMEANING>
          <MEANINGDESCRIPTION>A set of proprietary genomic profiling techniques that utilize next generation sequencing. FoundationOne CDX is optimized for PPFE samples from solid tumors; FoundationOne Liquid is optimized for peripheral whole blood, targeting solid tumors; FoundationOne Heme is optimized for leukemias, lymphomas, sarcomas, and solid tumors using RNA sequencing on samples obtained from FFPE, peripheral whole blood, or bone marrow aspirate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172873</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7334408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Splenic Scan</VALIDVALUE>
          <VALUEMEANING>Splenic Scan</VALUEMEANING>
          <MEANINGDESCRIPTION>A radionuclide imaging technique that is used to evaluate the size and shape of the spleen, and to detect and evaluate lesions, rupture, and hematomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7331906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Research Flexible Sigmoidoscopy</VALIDVALUE>
          <VALUEMEANING>Research Activity Flexible Sigmoidoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Systematic investigation into a subject in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered.: Able to be adjusted readily to different conditions.: Endoscopic examination of the luminal surface of the sigmoid colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17131, C80495, C15429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7536999</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flexible Sigmoidoscopy</VALIDVALUE>
          <VALUEMEANING>Flexible Sigmoidoscopy</VALUEMEANING>
          <MEANINGDESCRIPTION>Able to be adjusted readily to different conditions.: Endoscopic examination of the luminal surface of the sigmoid colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17131, C80495</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7537000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Open / thorascopic (VATS) lung biopsy</VALIDVALUE>
          <VALUEMEANING>Open Lung Biopsy Or Video-assisted Thoracic Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal of tissue from the lung, for microscopic examination, obtained during an open surgical procedure.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Thoracic surgery that is aided by the use of a video camera.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63704, C37998, C51923</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7715759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bronchoalveolar Lavage</VALIDVALUE>
          <VALUEMEANING>Bronchoalveolar Lavage</VALUEMEANING>
          <MEANINGDESCRIPTION>Washing out the bronchi and alveoli by flushing with a fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51913</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transbronchial Biopsy</VALIDVALUE>
          <VALUEMEANING>Transbronchial Lung Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal of tissue through the bronchial wall, for microscopic examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51749</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2795720</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multiplex ligation-dependent probe amplification (MLPA)</VALIDVALUE>
          <VALUEMEANING>Multiplex Ligation-dependent Probe Amplification</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of high-throughput, multiplex PCR method used to determine abnormal DNA copy number changes of up to 50 genomic DNA or RNA sequences with a single pair of PCR primers. It is frequently used in the detection of genetic aberrations in tumors, and can distinguish sequences differing in only a single nucleotide.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6413914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Loss of heterozygosity (LOH)</VALIDVALUE>
          <VALUEMEANING>Loss of Heterozygosity</VALUEMEANING>
          <MEANINGDESCRIPTION>genetic phenomenon due to deletion or mutation in one allele of a polymorphic gene, as detected by expression after cell fusion; used as a test for tumor-promoting mutations; do not confuse with &quot;loss of heterogeneity&quot; which applies to diverse cell populations within a tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18016</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3082343</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RT-PCR amplification (e.g., MethyLight)</VALIDVALUE>
          <VALUEMEANING>RT-PCR</VALUEMEANING>
          <MEANINGDESCRIPTION>RT-PCR is short for reverse transcriptase-polymerase chain reaction. It is a technique in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase. (from Wikipedia)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18136</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3121570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sequencing (e.g., bisulfite sequencing)</VALIDVALUE>
          <VALUEMEANING>Bisulfite Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A DNA sequencing technique that can differentiate cytosine from 5-methylcytosine in a DNA sample. First, a denatured DNA sample is treated with bisulfite which converts non-methylated cytosine to uracil. Next, the sample is amplified using a PCR method that does not discriminate between non-methylated and methylated sequences. The amplified DNA is subjected to nucleotide sequencing. The resulting sequence is compared to an identical control sample of DNA that was not treated with bisulfite. Unmethylated cytosines will be displayed as cytosines in the control sample and as thymines in the bisulfite-treated sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106054</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7736012</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quantitative CT</VALIDVALUE>
          <VALUEMEANING>Quantitative Computed Tomography</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of computed tomography in which a calibration standard correlates radiodensity values to quantitative tissue density values.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C161405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6859111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CSF examination</VALIDVALUE>
          <VALUEMEANING>Cerebrospinal Fluid Examination</VALUEMEANING>
          <MEANINGDESCRIPTION>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord.: A formal or careful inspection of an object or subject.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131902, C12692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8078596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not assessed</VALIDVALUE>
          <VALUEMEANING>Not Assessed</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that an assessment was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5189423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Karyotyping</VALIDVALUE>
          <VALUEMEANING>Karyotyping</VALUEMEANING>
          <MEANINGDESCRIPTION>The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16768</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5095203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clonality Analysis</VALIDVALUE>
          <VALUEMEANING>Clonality Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10382636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mutation Abnormality</VALIDVALUE>
          <VALUEMEANING>Mutation Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3219495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surgical biopsy</VALIDVALUE>
          <VALUEMEANING>Excisional Biopsy</VALUEMEANING>
          <MEANINGDESCRIPTION>A surgical procedure in which an entire lesion is removed for microscopic examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-07-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Molecular testing / NextGen sequencing</VALIDVALUE>
          <VALUEMEANING>Molecular Analysis And/Or Next Generation Sequencing Method</VALUEMEANING>
          <MEANINGDESCRIPTION>A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level._Used to indicate that either or both of two items or options may be valid._Technologies that facilitate the rapid determination of the nucleotide sequence of large numbers of strands or segments of DNA or RNA._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71460, C101293, C48928, C19770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12134398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allelic editing frequency</VALIDVALUE>
          <VALUEMEANING>Allelic Editing Frequency Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the frequency of allele editing detected after a subject is exposed to gene editing agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12137221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clonal expansion</VALIDVALUE>
          <VALUEMEANING>Clonal Expansion</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiplication or reproduction by cell division of a population of identical cells descended from a single progenitor. In immunology, may refer to the clonal proliferation of cells responsive to a specific antigen as part of an immune response. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20613</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12137222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Homology directed DNA repair (HDR) frequency</VALIDVALUE>
          <VALUEMEANING>Homology-Directed DNA Repair Frequency Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the frequency of directed gene modification or DNA repair occurring after a subject is exposed to homology-directed DNA repair promoting agents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191744</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12137224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indel mutations frequency</VALIDVALUE>
          <VALUEMEANING>Indel Mutation Frequency Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the frequency of indel mutations in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191745</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12137225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transgene expression</VALIDVALUE>
          <VALUEMEANING>Transgene Expression Level Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the level of expression of a transgene in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191746</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12137226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vector copy number</VALIDVALUE>
          <VALUEMEANING>Vector Copy Number</VALUEMEANING>
          <MEANINGDESCRIPTION>The number of vector molecules present in a cell or sub-cellular location, sometimes stated as copies per diploid genome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C180599</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12137227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gene therapy globin expression</VALIDVALUE>
          <VALUEMEANING>Therapeutic Globin Gene Level Expression Analysis</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the level of expression of a therapeutic globin gene in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191743</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12137223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ddPCR</VALIDVALUE>
          <VALUEMEANING>Droplet Digital PCR</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of digital polymerase chain reaction technique in which the sample is fractionated into thousands of tiny droplets using a water-oil emulsion droplet technology, within which individual PCR reactions occur in each droplet.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C166064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7167105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MicroRNA Sequencing</VALIDVALUE>
          <VALUEMEANING>MicroRNA Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>A next-generation or massively parallel high-throughput DNA sequencing-based procedure that can identify and quantify the microRNA sequences present in a biological sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C156057</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13331403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>qPCR</VALIDVALUE>
          <VALUEMEANING>Real Time PCR</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified polymerase chain reaction (PCR) technique in which DNA amplification is detected and quantified as the PCR reaction progresses, through the use of fluorescent DNA probes in the reaction mixture.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51962</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3727155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Reported</VALIDVALUE>
          <VALUEMEANING>Not Reported</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ClonoSEQ</VALIDVALUE>
          <VALUEMEANING>clonoSEQ Assay</VALUEMEANING>
          <MEANINGDESCRIPTION>A next generation sequencing-based proprietary immunogenetic assay that identifies and quantitates the expression of the B-cell receptor (BCR) and T-cell receptor (TCR) variable, diversity and joining segments in a peripheral blood sample from subject. This assay can establish a genetic barcode for clonal lymphoid malignancies, including multiple myeloma, chronic lymphocytic leukemia (CLL), and B-cell acute lymphoblastic leukemia (B-ALL), and can be leveraged to monitor clonal recurrence and/or measurable residual disease during and after treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>11509111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PET/MRI Scan</VALIDVALUE>
          <VALUEMEANING>Positron Emission Tomography and Magnetic Resonance Imaging</VALUEMEANING>
          <MEANINGDESCRIPTION>An imaging technique that utilizes positron emission tomography and magnetic resonance imaging in a single machine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-01-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4136341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Assessment Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Method of Evaluation</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Method of Evaluation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Outcome Measures CRF Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of Disease Status Evaluation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Outcome Measures CRF Question</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of Evaluation for Current Response</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Outcome Measures CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of Evaluation for Recurrence</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Outcome Measure CRF Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of Evaluation for Progressive Disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Evaluation Method</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Evaluation Method</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What method of evaluation is used to obtain tumor measurements?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG_CRF_TEXT_1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How was the new disease detected during this reporting period</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Method of Evaluation</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of Evaluation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of evaluation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of Assessment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Modality:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of evaluation:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cardiac Evaluation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of imaging:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Procedure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>How was this diagnosed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify method of assessment</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify method of assessment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify method of assessment</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify method of assessment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>MRI sequence used to measure the lesion:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Methodology</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>methodology</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>response criteria based on</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of Evaluation:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text13</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of assessment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Method of evaluation</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of evaluation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of evaluation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the method of detection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF TEXT 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Criteria used to diagnose:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method of identification</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Molecular test performed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Upper GI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Lung Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812017</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811951</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Char.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tumor Markers</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811964</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer DataMart</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Esophageal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811789</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Gastric</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811790</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Esophageal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811810</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Cervical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Endometrial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Ovarian</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811819</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811821</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Extensive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811822</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Limited</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Unresect Pancreatic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811827</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Resect Pancreatic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811829</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811884</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811886</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811889</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Localized Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811919</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Non-local Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Local-Reg Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811927</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Stage I-III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811932</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Gyn</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811934</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Recurrent Gyn</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811938</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812013</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain Recurr</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metastatic Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812015</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hepatobiliary</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3298577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Advanced</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000001</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000027</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma Recur</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Met/Urothelial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000311</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Superficial Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000312</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Curative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000369</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Gastric</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000446</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Muscle Invasive Blad</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000462</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Palliative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000614</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180933</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>LIDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>QIN Breast Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6788757</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ALA PDT - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812194</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Lung Pre-Surgical NSCLC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3152820</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer Data Mart</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812624</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RECIST</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2831187</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase 1/Pilot Consortium</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3303197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2964591</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Eligibility Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Structured Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2965104</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2964591</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Eligibility Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3070842</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Caris Registry</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3060676</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3234177</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Patient Outcomes Data System</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PODS Elements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3234178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3461586</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BOLD </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preoperative Elements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3461587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3461586</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BOLD </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General Elements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3461588</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3461586</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BOLD </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging Elements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3461589</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886753</PublicId>
          <ContextName>BOLD</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>General Elements</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3902138</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886754</PublicId>
          <ContextName>BOLD</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging Elements</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3902139</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886755</PublicId>
          <ContextName>BOLD</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Preoperative Elements</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preoperative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3902140</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0278</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4058120</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0219</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104879</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0240</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104883</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0263</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0265</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104886</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229L</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229N</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229O</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104892</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0250</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104897</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0258</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104898</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0261</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104899</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0277</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104900</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0286B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104901</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0212</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0213</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0252</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104930</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104941</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1112</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104993</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1010</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171061</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1005</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171062</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0534</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171063</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0815</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0924</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171065</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000079</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0218</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000080</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000175</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000275</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0283</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000276</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0213</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000287</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0213</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000288</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0252</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000589</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0252</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000590</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0212</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000593</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0212</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000594</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0281</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000705</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7312662</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000686</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIDCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NIDCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>ASSESS_METH_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ASSESS_METH_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ASSESS_METH_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SWOG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>S0ASSCD</AlternateName>
        <AlternateNameType>OID, SWOG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BOLD</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BOLD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>N0ASSCD</AlternateName>
        <AlternateNameType>OID, SWOG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ASSESS_METH_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ASSESS_METH_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ASSESS_METH_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ASSESS_METH_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLP_LSLE_flow_morph_meth</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>Method of determination</AlternateName>
        <AlternateNameType>QIN Breast Study</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CIP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QSMETHOD_QSLOC1</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QSMETHOD_QSLOC2</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QSMETHOD_QSLOC3</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>METHEVAL</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DXMTHD</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD_BMB</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TU_TUMETHOD_ SIGCOL</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MI_MIMETHOD_MOLTEST</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1422">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6848671</PUBLICID>
    <LONGNAME>Montreal Cognitive Assessment Version 8.3 Orientation Test Score</LONGNAME>
    <PREFERREDNAME>MOCA_ORIENT_V8.3_SCR</PREFERREDNAME>
    <PREFERREDDEFINITION>The score of the Orientation test.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>MoCA:Montreal Cognitive Assessment; Z.S.Nasreddine et al., J AM Geriatric Society (2005)</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6848606</PublicId>
      <PreferredName>6848575v1.0:6848604v1.0</PreferredName>
      <PreferredDefinition>A standardized rating scale developed by Ziad Nasreddine in 1996 to screen for mild cognitive dysfunction and impairment. This instrument assesses the following cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation._The individual is asked to to state the date, month, year, day, place, and city.</PreferredDefinition>
      <LongName>Montreal Cognitive Assessment Functional Test Montreal Cognitive Assessment Orientation Test</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6848575</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C123667</PreferredName>
        <Version>1</Version>
        <LongName>Montreal Cognitive Assessment Functional Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C123667</PREFERRED_NAME>
            <LONG_NAME>Montreal Cognitive Assessment Functional Test</LONG_NAME>
            <CON_ID>6681573</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6848604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C162718</PreferredName>
        <Version>1</Version>
        <LongName>Montreal Cognitive Assessment Orientation Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C162718</PREFERRED_NAME>
            <LONG_NAME>Montreal Cognitive Assessment Orientation Test</LONG_NAME>
            <CON_ID>6841894</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3297238</PublicId>
      <PreferredName>QUEST_TTL_SC</PreferredName>
      <PreferredDefinition>Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Questionnaire Total Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>30</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>3297237</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17048:C25304:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Total Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17048</PREFERRED_NAME>
            <LONG_NAME>Questionnaire</LONG_NAME>
            <CON_ID>2202367</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25304</PREFERRED_NAME>
            <LONG_NAME>Total</LONG_NAME>
            <CON_ID>2204938</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Orientation</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Orientation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Montreal Cognitive Assessment (MoCA)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900327</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6841710</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MoCA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MoCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6841711</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1423">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6866999</PUBLICID>
    <LONGNAME>Colorectal Neuroendocrine Tumor AJCC Edition 8 Pathologic Distant Metastasis M Category</LONGNAME>
    <PREFERREDNAME>CRNET_AJC8_PTH_M_CAT</PREFERREDNAME>
    <PREFERREDDEFINITION>Extent of the distant metastasis for colon and rectal neuroendocrine tumor based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6866956</PublicId>
      <PreferredName>6866944v1.0:2207807v1.0</PreferredName>
      <PreferredDefinition>A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the colon or rectum._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. M refers to the presence of metastasis.</PreferredDefinition>
      <LongName>Colorectal Neuroendocrine Tumor Pathologic M Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6866944</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C96159</PreferredName>
        <Version>1</Version>
        <LongName>Colorectal Neuroendocrine Tumor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C96159</PREFERRED_NAME>
            <LONG_NAME>Colorectal Neuroendocrine Tumor</LONG_NAME>
            <CON_ID>6866943</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207807</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25610:C25727</PreferredName>
        <Version>1</Version>
        <LongName>Pathologic M Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25610</PREFERRED_NAME>
            <LONG_NAME>Pathologic</LONG_NAME>
            <CON_ID>2204850</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25727</PREFERRED_NAME>
            <LONG_NAME>M Category</LONG_NAME>
            <CON_ID>2204010</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6866916</PublicId>
      <PreferredName>6866916v1.0</PreferredName>
      <PreferredDefinition>A pathologic finding about one or more characteristics of a colorectal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Colorectal Neuroendocrine Tumor American Joint Committee on Cancer Edition 8 Pathologic M Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>3</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
      <Representation>
        <PublicId>6866915</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C135170:C39315:C25727:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Colorectal Neuroendocrine Tumor Pathologic Distant Metastasis TNM Finding v8 American Joint Committee on Cancer M Category Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C135170</PREFERRED_NAME>
            <LONG_NAME>Colorectal Neuroendocrine Tumor Pathologic Distant Metastasis TNM Finding v8</LONG_NAME>
            <CON_ID>6866914</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39315</PREFERRED_NAME>
            <LONG_NAME>American Joint Committee on Cancer</LONG_NAME>
            <CON_ID>2554142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25727</PREFERRED_NAME>
            <LONG_NAME>M Category</LONG_NAME>
            <CON_ID>2204010</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pM1c</VALIDVALUE>
          <VALUEMEANING>Colorectal Neuroendocrine Tumor pM1c TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Colorectal neuroendocrine tumor with both hepatic and extrahepatic metastases. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135175</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6866918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pM1b</VALIDVALUE>
          <VALUEMEANING>Colorectal Neuroendocrine Tumor pM1b TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Colorectal neuroendocrine tumor with metastasis in at least one extrahepatic site (e.g., lung, ovary, nonregional lymph node, peritoneum, bone). (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6866920</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pM1a</VALIDVALUE>
          <VALUEMEANING>Colorectal Neuroendocrine Tumor pM1a TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Colorectal neuroendocrine tumor with metastasis confined to liver. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6866922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cM0</VALIDVALUE>
          <VALUEMEANING>Colorectal Neuroendocrine Tumor cM0 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Colorectal neuroendocrine tumor without evidence of distant metastasis. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135164</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6866913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cM1</VALIDVALUE>
          <VALUEMEANING>Colorectal Neuroendocrine Tumor cM1 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Colorectal neuroendocrine tumor with distant metastasis. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6866911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pM1</VALIDVALUE>
          <VALUEMEANING>Colorectal Neuroendocrine Tumor pM1 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Colorectal neuroendocrine tumor with distant metastasis. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C135171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6866903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pathologic M category</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pathologic M category</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AJCC Edition 8</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6005920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574838</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Staging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000194</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1424">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6931159</PUBLICID>
    <LONGNAME>Tumor Sample Adequacy Assessment Month Number</LONGNAME>
    <PREFERREDNAME>6930805v1.0:2895904v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Numeric value that represents the month the tumor sample adequacy was assessed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCG:Center for Cancer Genomics</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6930805</PublicId>
      <PreferredName>6930803v1.0:4380778v1.0</PreferredName>
      <PreferredDefinition>A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._Meeting a quantitative or qualitative measure necessary for a requirement; enough to meet the needs of a situation._The final result of a determination of the value, significance, or extent of._The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Neoplasm Biospecimen Sufficient Assessment Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6930803</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3262:C70699</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6930806</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63351:C25217:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Sufficient Assessment Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63351</PREFERRED_NAME>
            <LONG_NAME>Sufficient</LONG_NAME>
            <CON_ID>2538604</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCG:Center for Cancer Genomics</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2895904</PublicId>
      <PreferredName>EVT_MON_NUM</PreferredName>
      <PreferredDefinition>Event; something that happens at a given place and time._One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks._A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Event Month Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2895903</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499:C29846:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Event Month Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>One of ten equal parts; a quantity corresponding to one tenth of the whole.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C81010</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12</VALIDVALUE>
          <VALUEMEANING>12th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::12: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::12</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>11</VALIDVALUE>
          <VALUEMEANING>11th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::11: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::11</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::9: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::9</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896396</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::8: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::8</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896397</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::7: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C45255::7</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896398</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the fifth position in an ordering or series; coming next after the fifth and just before the seventh in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54568</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the fourth position in an ordering or series; coming next after the fourth and just before the sixth in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54567</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4th month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the third position in an ordering or series; coming next after the third and just before the fifth in position.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C54566</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3rd month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Following the second position in an ordering or series.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2nd month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Coming next after the first in position in space or time or degree or magnitude.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2896403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>1st month of a calendar year</VALUEMEANING>
          <MEANINGDESCRIPTION>Preceding all others in time or space or degree.: A list or register of events; a tabular array of the days.: One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon&#39;s phases, about 30 days or 4 weeks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29846, C19459, C25509</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2896404</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tumor sample adequacy assessm</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tumor sample adequacy assessment month</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1425">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6931407</PUBLICID>
    <LONGNAME>Prior Maintenance Therapy Or BCG Regimen Induction Administered Agent Dose Number</LONGNAME>
    <PREFERREDNAME>6931406v1.0:2183362v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of doses related to prior administered maintenance therapy or BCG regimen induction.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Alliance Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6931406</PublicId>
      <PreferredName>6930855v1.0:6931404v1.0</PreferredName>
      <PreferredDefinition>Earlier in time or order._Continuation of treatment for an extended period of time to prevent relapse._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._An immunotherapy regimen consisting of Bacillus Calmette-Guerin (BCG) that may be used in the treatment of bladder cancer._The act of bringing about something._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Prior Maintenance Therapy Or BCG Regimen Induction Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6951304</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C15688</PreferredName>
        <Version>1</Version>
        <LongName>Prior Maintenance Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15688</PREFERRED_NAME>
            <LONG_NAME>Maintenance Therapy</LONG_NAME>
            <CON_ID>2737352</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6951306</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37998:C159996:C61367:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Or BCG Regimen Induction Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C159996</PREFERRED_NAME>
            <LONG_NAME>BCG Regimen</LONG_NAME>
            <CON_ID>6859311</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61367</PREFERRED_NAME>
            <LONG_NAME>Induction</LONG_NAME>
            <CON_ID>2612143</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Alliance Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2183362</PublicId>
      <PreferredName>AGT_DOSE_NUM</PreferredName>
      <PreferredDefinition>the number of doses of an agent given to a patient.</PreferredDefinition>
      <LongName>Agent Dose Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184315</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Number</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of maintenance therapy</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of maintenance therapy or second induction BCG doses</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Yes, Number of maintenance therapy or second induction BCG doses</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1426">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6950266</PUBLICID>
    <LONGNAME>Coverage</LONGNAME>
    <PREFERREDNAME>PFORRES_COV</PREFERREDNAME>
    <PREFERREDDEFINITION>The total number of sequencing reads at this position.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6950247</PublicId>
      <PreferredName>6944198v1.0:6950261v1.0</PreferredName>
      <PreferredDefinition>A findings domain for gene expression and genetic variation assessments._The outcome of the test or finding as originally received or collected._The number of times that a pharmacogenomics region of interest was fully sequenced.</PreferredDefinition>
      <LongName>Pharmacogenomics Findings Domain Original Result or Finding Pharmacogenomics Read Depth</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6944198</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C111289</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacogenomics Findings Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C111289</PREFERRED_NAME>
            <LONG_NAME>Pharmacogenomics Findings Domain</LONG_NAME>
            <CON_ID>6944197</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6950261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117221:C164669</PreferredName>
        <Version>1</Version>
        <LongName>Original Result or Finding Pharmacogenomics Read Depth</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117221</PREFERRED_NAME>
            <LONG_NAME>Original Result or Finding</LONG_NAME>
            <CON_ID>6789425</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C164669</PREFERRED_NAME>
            <LONG_NAME>Pharmacogenomics Read Depth</LONG_NAME>
            <CON_ID>6950231</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6001805</PublicId>
      <PreferredName>2666622v2.0</PreferredName>
      <PreferredDefinition>Text; the words of something written.</PreferredDefinition>
      <LongName>200 Character Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008581</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PropertiesOrAttributes</PreferredName>
        <Version>1</Version>
        <LongName>Properties or Attributes</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength>0</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Coverage</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Coverage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1427">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>6962626</PUBLICID>
    <LONGNAME>Enrollment Treatment Study Assignment Code</LONGNAME>
    <PREFERREDNAME>ENROLL_TX_ASSIGNT_CD</PREFERREDNAME>
    <PREFERREDDEFINITION>Code delivered at the time of patient enrollment onto a clinical trial to denote the treatment assignment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4987262</PublicId>
      <PreferredName>2512834v1.0:2454524v1.0</PreferredName>
      <PreferredDefinition>An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._An allotting or an appointment to a particular person or use, or for a particular time or object.</PreferredDefinition>
      <LongName>Therapeutic Procedure Assignment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2454524</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25426</PreferredName>
        <Version>1</Version>
        <LongName>Assignment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25426</PREFERRED_NAME>
            <LONG_NAME>Assignment</LONG_NAME>
            <CON_ID>2204040</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6962458</PublicId>
      <PreferredName>6962458v1.0</PreferredName>
      <PreferredDefinition>Codes to represent subject Treatment Assignment Code (TAC) at the time of enrollment to a clinical trial.</PreferredDefinition>
      <LongName>Enrollment Treatment Study Assignment Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>275</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
      <Representation>
        <PublicId>2544496</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37948:C49656:C25426:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Enrollment Treatment Study Assignment Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37948</PREFERRED_NAME>
            <LONG_NAME>Enrollment</LONG_NAME>
            <CON_ID>2203918</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49656</PREFERRED_NAME>
            <LONG_NAME>Treatment Study</LONG_NAME>
            <CON_ID>2480684</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25426</PREFERRED_NAME>
            <LONG_NAME>Assignment</LONG_NAME>
            <CON_ID>2204040</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Treatment Assignment Code for next round of therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Current Treatment Assignment Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Treatment Assignment Code</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Treatment Assignment Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Existing Treatment Assignment Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1428">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7050072</PUBLICID>
    <LONGNAME>Survival Status</LONGNAME>
    <PREFERREDNAME>SSORRES_SURVSTAT</PREFERREDNAME>
    <PREFERREDDEFINITION>The outcome of the subject&#39;s survival status assessment as originally received or collected.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7050061</PublicId>
      <PreferredName>6608783v1.0:7050059v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject status._The outcome of the subject status assessment as originally received or collected._The state or condition of being living or deceased; also includes the case where the vital status is unknown.</PreferredDefinition>
      <LongName>Subject Status Domain Subject Status Original Result Survival Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008552</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PHYS_DESC_OF_INDS</PreferredName>
        <Version>1</Version>
        <LongName>Physical Description of Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6608783</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117655</PreferredName>
        <Version>1</Version>
        <LongName>Subject Status Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117655</PREFERRED_NAME>
            <LONG_NAME>Subject Status Domain</LONG_NAME>
            <CON_ID>6608782</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7050059</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117663:C25717</PreferredName>
        <Version>1</Version>
        <LongName>Subject Status Original Result Vital Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117663</PREFERRED_NAME>
            <LONG_NAME>Subject Status Original Result</LONG_NAME>
            <CON_ID>6641868</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25717</PREFERRED_NAME>
            <LONG_NAME>Vital Status</LONG_NAME>
            <CON_ID>2203980</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7050071</PublicId>
      <PreferredName>SSTATRS</PreferredName>
      <PreferredDefinition>Terminology associated with the subject status response codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM)._A condition or state at a particular time.</PreferredDefinition>
      <LongName>CDISC SDTM Subject Status Response Terminology Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6622121</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C124304:C25688</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Subject Status Response Terminology Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C124304</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Subject Status Response Terminology</LONG_NAME>
            <CON_ID>6622120</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ALIVE</VALIDVALUE>
          <VALUEMEANING>Alive</VALUEMEANING>
          <MEANINGDESCRIPTION>Showing characteristics of life; displaying signs of life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580948</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DEAD</VALIDVALUE>
          <VALUEMEANING>Death</VALUEMEANING>
          <MEANINGDESCRIPTION>The cessation of life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3141242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UNKNOWN</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Survival Status</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Survival Status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Vital status:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 100</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Survival Status:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Survival status</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Survival status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the survival status?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the survival status?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCR Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Mother alive or dead</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCR Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Father alive or dead</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCR Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Sibling alive or dead</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCR Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is your half sibling alive or dead</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCR Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Child alive or dead</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCR Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is your maternal grandmother alive or dead</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCR Text 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is your maternal grandfather alive or dead</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCR Text 8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Are they alive or dead</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCR Text 9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is your paternal grandfather alive or dead</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCR Text 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is your paternal grandmother alive or dead</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Follow Up/Survival</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7475678</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cancer Moonshot Biobank</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13484615</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTDC CDISC CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14645981</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SS_SSORRES_SURVSTAT</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Theradex</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Theradex</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SS_SSORRES_SURVSTAT</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>survival_status</AlternateName>
        <AlternateNameType>CMB Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>survival_status</AlternateName>
        <AlternateNameType>CTDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1429">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7050433</PUBLICID>
    <LONGNAME>Lesion Response</LONGNAME>
    <PREFERREDNAME>LSRESP</PREFERREDNAME>
    <PREFERREDDEFINITION>The reaction of a lesion to some foregoing stimulus or agent.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7050428</PublicId>
      <PreferredName>2465192v1.0:2193203v1.0</PreferredName>
      <PreferredDefinition>A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.</PreferredDefinition>
      <LongName>Lesion Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2465192</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3824</PreferredName>
        <Version>1</Version>
        <LongName>Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2193203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25755</PreferredName>
        <Version>1</Version>
        <LongName>Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25755</PREFERRED_NAME>
            <LONG_NAME>Response</LONG_NAME>
            <CON_ID>2202805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7050409</PublicId>
      <PreferredName>7050409v1.0</PreferredName>
      <PreferredDefinition>A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Lesion Response Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>7050408</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3824:C25755:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Lesion Response Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25755</PREFERRED_NAME>
            <LONG_NAME>Response</LONG_NAME>
            <CON_ID>2202805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NOT EXAMINED</VALIDVALUE>
          <VALUEMEANING>NOT ASSESSED</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that an assessment was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C139527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-11-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>STABLE</VALIDVALUE>
          <VALUEMEANING>Stable</VALUEMEANING>
          <MEANINGDESCRIPTION>Stable; subject to little fluctuation; showing little if any change.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C30103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-11-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RESOLVED</VALIDVALUE>
          <VALUEMEANING>Resolution</VALUEMEANING>
          <MEANINGDESCRIPTION>A means of finding a solution to a problem, or a means of finding agreement or harmony.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-11-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6063614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NEW</VALIDVALUE>
          <VALUEMEANING>New</VALUEMEANING>
          <MEANINGDESCRIPTION>Having no previous example or precedent or parallel; of a kind not seen before.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-11-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3588517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>DECREASING</VALIDVALUE>
          <VALUEMEANING>Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Made less in size or amount or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-11-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3135563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INCREASING</VALIDVALUE>
          <VALUEMEANING>Increase</VALUEMEANING>
          <MEANINGDESCRIPTION>A process of becoming larger, more numerous, more important, or more likely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-11-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4592292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BASELINE</VALIDVALUE>
          <VALUEMEANING>Baseline</VALUEMEANING>
          <MEANINGDESCRIPTION>A starting point to which things may be compared.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-11-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lesion Response</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Lesion Response</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1430">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7072174</PUBLICID>
    <LONGNAME>Imaging Acquisition Scan Start Time Minute Value</LONGNAME>
    <PREFERREDNAME>PRSTTIMM</PREFERREDNAME>
    <PREFERREDDEFINITION>The minute the imaging acquisition started represented as a numerical value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCI CRF Standards</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7071917</PublicId>
      <PreferredName>6407261v1.0:7071915v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._The process by which an image is acquired or obtained._The data or image obtained by gathering information with a sensing device._The time at which something is to start or did start._A unit measure of time equal to 60 seconds.</PreferredDefinition>
      <LongName>Procedure Domain Image Acquisition Scan Start Time Minute</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102700</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102700</PREFERRED_NAME>
            <LONG_NAME>Procedure Domain</LONG_NAME>
            <CON_ID>6407260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7071915</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43385:C17999:C78441:C48154</PreferredName>
        <Version>1</Version>
        <LongName>Image Acquisition Scan Start Time Minute</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43385</PREFERRED_NAME>
            <LONG_NAME>Image Acquisition</LONG_NAME>
            <CON_ID>2236552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17999</PREFERRED_NAME>
            <LONG_NAME>Scan</LONG_NAME>
            <CON_ID>2202631</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C78441</PREFERRED_NAME>
            <LONG_NAME>Start Time</LONG_NAME>
            <CON_ID>2975813</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>RADLEX_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48154</PREFERRED_NAME>
            <LONG_NAME>Minute</LONG_NAME>
            <CON_ID>2513263</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCI CRF Standards</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6412664</PublicId>
      <PreferredName>CDISCVL</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6412663</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25712</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Time scan initiated: minutes</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Time scan initiated: minutes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 2614000 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the procedure start minutes?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the procedure start minutes?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Start minutes</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Start minutes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Image - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318337</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Image Administration -- CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318338</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Imaging Administration</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7590128</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>PR_PRSTMM</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1431">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7092901</PUBLICID>
    <LONGNAME>ClinicalTrials.gov Clinical Study Identifier</LONGNAME>
    <PREFERREDNAME>5055916v1.0:6944203v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A unique identifier assigned to a ClinicalTrials.gov clinical study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5055916</PublicId>
      <PreferredName>5055914v1.0:3951411v1.0</PreferredName>
      <PreferredDefinition>A Web-based resource that provides patients, their family members, health care professionals, researchers, and the public with access to information on publicly and privately supported clinical studies. A service of the National Institutes of Health (NIH), ClinicalTrials.gov is both a registry and a results database._Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.</PreferredDefinition>
      <LongName>ClinicalTrials.gov Clinical Study</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5055914</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C124233</PreferredName>
        <Version>1</Version>
        <LongName>ClinicalTrials.gov</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C124233</PREFERRED_NAME>
            <LONG_NAME>ClinicalTrials.gov</LONG_NAME>
            <CON_ID>5055891</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3951411</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15206</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6944203</PublicId>
      <PreferredName>6944203v1.0</PreferredName>
      <PreferredDefinition>One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the ClinicalTrials.go</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the ClinicalTrials.gov clinical study identifier?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the ClinicalTrials.gov identification number:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the ClinicalTrials.gov identification number:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the ClinicalTrials.gov identification number:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify the ClinicalTrials.gov identification number:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_RDM_cl_tr_gov_st_id</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_rec_dat_cl_tr_gov_st_id</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1432">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7097667</PUBLICID>
    <LONGNAME>Prior Therapy Administered Text</LONGNAME>
    <PREFERREDNAME>PRPRITRX</PREFERREDNAME>
    <PREFERREDDEFINITION>The therapeutic procedure administered before protocol therapy not previously listed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCI CRF Standards</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7097652</PublicId>
      <PreferredName>6407261v1.0:4768791v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._Prior action or administration of therapeutic agents that produced an effect that is intended to alter or stop a pathologic process._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Procedure Domain Prior Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102700</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102700</PREFERRED_NAME>
            <LONG_NAME>Procedure Domain</LONG_NAME>
            <CON_ID>6407260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4768791</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16124:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Prior Therapy Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16124</PREFERRED_NAME>
            <LONG_NAME>Prior Therapy</LONG_NAME>
            <CON_ID>2202433</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCI CRF Standards</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 2542520 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Prior Therapy Other Administr</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Prior Therapy Other Administration</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Description of other prior therapy:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If other prior agent, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Other, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prior/Post therapies - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318355</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR_PRPRITRX_OTHS</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PR_PRYN_PRIOR_OTHS</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1433">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7097701</PUBLICID>
    <LONGNAME>Post Clinical Trial Therapeutic Procedure Type</LONGNAME>
    <PREFERREDNAME>PRPSTTRT</PREFERREDNAME>
    <PREFERREDDEFINITION>The subsequent medication/treatment/therapy received after protocol therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCI CRF Standards</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7097331</PublicId>
      <PreferredName>6407261v1.0:7097329v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to procedure._Happening at a time subsequent to a reference time; later in time or order._A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</PreferredDefinition>
      <LongName>Procedure Domain Post Clinical Trial Therapeutic Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6407261</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C102700</PreferredName>
        <Version>1</Version>
        <LongName>Procedure Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C102700</PREFERRED_NAME>
            <LONG_NAME>Procedure Domain</LONG_NAME>
            <CON_ID>6407260</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7097329</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38008:C71104:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Post Clinical Trial Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71104</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial</LONG_NAME>
            <CON_ID>2735720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCI CRF Standards</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3021568</PublicId>
      <PreferredName>POST_PROT_TX_TP</PreferredName>
      <PreferredDefinition>Post; occuring after._A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, and preventive care._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Post Clinical Trial Treatment Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3021567</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38008:C71104:C15368:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Post Clinical Trial Therapy Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71104</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial</LONG_NAME>
            <CON_ID>2735720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemotherapy</VALIDVALUE>
          <VALUEMEANING>Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunotherapy</VALIDVALUE>
          <VALUEMEANING>Immunotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>(IM-yoo-no-THER-a-pee) Treatment to stimulate or restore the ability of the immune system to fight infections and other diseases. Also used to lessen side effects that may be caused by some cancer treatments.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hormonal Therapy</VALIDVALUE>
          <VALUEMEANING>Endocrine Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy. The concept covers but not limited to: intermittent or permanent hormone suppression or ablation in treatment of hormone-dependent tumors, hormone replacement therapy of any kind, hormonal component of gender reassignment therapy, hormonal contraception, surgical and radiation castration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiation Therapy</VALIDVALUE>
          <VALUEMEANING>Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BMT</VALIDVALUE>
          <VALUEMEANING>Bone Marrow Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure to replace diseased bone marrow with transplanted healthy bone marrow cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surgery</VALIDVALUE>
          <VALUEMEANING>Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other specify</VALIDVALUE>
          <VALUEMEANING>Other Specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Be specific about something; define clearly.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4188777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiosurgery</VALIDVALUE>
          <VALUEMEANING>Radiosurgery</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. It is used to treat brain tumors and other brain disorders that cannot be treated by regular surgery. It is also being studied in the treatment of other types of cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15696</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4287124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brachytherapy</VALIDVALUE>
          <VALUEMEANING>Internal Radiation Therapy/Brachytherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of radiation therapy in which radioactive material sealed in needles, seeds, wires, or catheters is placed directly into or near a tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4287125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Biologic/targeted therapy</VALIDVALUE>
          <VALUEMEANING>Targeted Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of treatment that uses drugs or other substances, such as monoclonal antibodies, to identify and attack specific cancer cells. Targeted therapy may have fewer side effects than other types of cancer treatments.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3623150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palliative care</VALIDVALUE>
          <VALUEMEANING>Palliative Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Palliative care is the patient-and family-centered active holistic care of patients with advanced, progressive disease. Traditional models reflect abandonment of proactive treatment and a simultaneous increase in symptom control and comfort-related services, as a disease progressed in linear fashion through its course. Essential components of palliative care are: pain and symptom control, communication regarding treatment and alternatives, prognosis, and available services, rehabilitation services, care that addresses treatment and palliative concerns, intellectual, emotional, social, and spiritual needs, terminal care, support in bereavement. The goal of palliative care is an achievement of the best quality of life for patients and their families.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-04-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SBRT</VALIDVALUE>
          <VALUEMEANING>Stereotactic Body Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Stereotactic radiation therapy in which one or several maximum dose radiation treatments are delivered targeting cancers of the body, excluding the brain or spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3193538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surgical Ablation</VALIDVALUE>
          <VALUEMEANING>Surgical Ablation</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Removal, separation, detachment, extirpation, or eradication of a body part, pathway, or function by surgery, chemical destruction, morbid process, or noxious substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20985, C15329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5907956</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiation, salvage</VALIDVALUE>
          <VALUEMEANING>Salvage Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment that is given after the cancer has not responded to other treatments.: Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15313, C15359</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7330134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiation, adjuvant</VALIDVALUE>
          <VALUEMEANING>Adjuvant Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Radiation therapy that is administered subsequent to the main treatment plan to minimize or prevent disease recurrence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4885460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HIFU</VALIDVALUE>
          <VALUEMEANING>High-Intensity Focused Ultrasound Ablation</VALUEMEANING>
          <MEANINGDESCRIPTION>A procedure in which high-energy sound waves are aimed directly at an area of abnormal cells or tissue in the body. The waves create heat that kills the cells. HIFU is being studied in the treatment of prostate cancer and some other types of cancer and other diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7330136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Focal laser ablation</VALIDVALUE>
          <VALUEMEANING>Laser Interstitial Thermal Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A thermal ablation therapy in which neoplasms are heated with prolonged and moderate temperature elevations.  It results in coagulative necrosis in the heated tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5630043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Active surveillance</VALIDVALUE>
          <VALUEMEANING>Active Surveillance</VALUEMEANING>
          <MEANINGDESCRIPTION>Closely watching a patient&#39;s condition but not giving treatment unless there are changes in test results. Active surveillance avoids problems that may be caused by treatments such as radiation or surgery. It is used to find early signs that the condition is getting worse. During active surveillance, patients will be given certain exams and tests done on a regular schedule. It is sometimes used in prostate cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6034921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Subsequent Therapy Type</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Subsequent Therapy Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 3021572 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1434">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7101988</PUBLICID>
    <LONGNAME>Lung Cancer AJCC Edition 8 Pathologic Distant Metastasis M Category</LONGNAME>
    <PREFERREDNAME>AJLG203P</PREFERREDNAME>
    <PREFERREDDEFINITION>Extent of the distant metastasis for lung cancer based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCI CRF Standards</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7101145</PublicId>
      <PreferredName>6607890v1.0:7101143v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire._One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. M refers to the presence of metastasis.</PreferredDefinition>
      <LongName>Questionnaire Domain Lung Neoplasm Pathologic M Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6607890</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49609</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49609</PREFERRED_NAME>
            <LONG_NAME>Questionnaire Domain</LONG_NAME>
            <CON_ID>2469074</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7101143</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12468:C3262:C25610:C25727</PreferredName>
        <Version>1</Version>
        <LongName>Lung Neoplasm Pathologic M Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12468</PREFERRED_NAME>
            <LONG_NAME>Lung</LONG_NAME>
            <CON_ID>2202738</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25610</PREFERRED_NAME>
            <LONG_NAME>Pathologic</LONG_NAME>
            <CON_ID>2204850</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25727</PREFERRED_NAME>
            <LONG_NAME>M Category</LONG_NAME>
            <CON_ID>2204010</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCI CRF Standards</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6006323</PublicId>
      <PreferredName>6006323v1.0</PreferredName>
      <PreferredDefinition>A pathologic finding about one or more characteristics of lung cancer, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system.  M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Lung Carcinoma American Joint Committee on Cancer Edition 8 Pathologic M Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>3</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System</Origin>
      <Representation>
        <PublicId>6686899</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C136439:C39315:C25727:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Lung Cancer Pathologic Distant Metastasis TNM Finding v8 American Joint Committee on Cancer M Category Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C136439</PREFERRED_NAME>
            <LONG_NAME>Lung Cancer Pathologic Distant Metastasis TNM Finding v8</LONG_NAME>
            <CON_ID>6006321</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39315</PREFERRED_NAME>
            <LONG_NAME>American Joint Committee on Cancer</LONG_NAME>
            <CON_ID>2554142</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25727</PREFERRED_NAME>
            <LONG_NAME>M Category</LONG_NAME>
            <CON_ID>2204010</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cM1</VALIDVALUE>
          <VALUEMEANING>Lung Cancer cM1 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Lung cancer with distant metastasis. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6005990</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cM0</VALIDVALUE>
          <VALUEMEANING>Lung Cancer cM0 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Lung cancer without distant metastasis. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136433</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6005993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pM1</VALIDVALUE>
          <VALUEMEANING>Lung Cancer pM1 TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Lung cancer with distant metastasis. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6006533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pM1a</VALIDVALUE>
          <VALUEMEANING>Lung Cancer pM1a TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural or pericardial nodules or malignant pleural or pericardial effusion. Most pleural (pericardial) effusions with lung cancer are a result of the tumor. In a few patients, however, multiple microscopic examinations of pleural (pericardial) fluid are negative for tumor, and the fluid is nonbloody and not an exudate. If these elements and clinical judgment dictate that the effusion is not related to the tumor, the effusion should be excluded as a staging descriptor. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6006531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pM1b</VALIDVALUE>
          <VALUEMEANING>Lung Cancer pM1b TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Lung cancer with single extrathoracic metastasis in a single organ (including involvement of a single nonregional node). (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136442</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6006529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pM1c</VALIDVALUE>
          <VALUEMEANING>Lung Cancer pM1c TNM Finding v8</VALUEMEANING>
          <MEANINGDESCRIPTION>Lung cancer with multiple extrathoracic metastases in a single organ or in multiple organs. (from AJCC 8th Ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C136443</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6030968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 5989983 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pathologic M category</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pathologic M category</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pathologic M category</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Pathologic M category</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the AJCC1-distant metastasis (M) category?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTEP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>AJCC1-distant metastasis (M) category</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Staging/Extent of Disease - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318368</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AJCC ED.8, Lung - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318385</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7434158</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CTEP CDISC Harmonization</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTEP CDISC Staging AJCC Edition 8 Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7554868</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>RS_RSORRES_AJCC106</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>RS_RSORRES_AJCC103_P</AlternateName>
        <AlternateNameType>CTEP CDISC CDE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1435">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7164512</PUBLICID>
    <LONGNAME>Symptom Checklist Past 4 Weeks How Much Does Swelling of Hands or Feet Bother You Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>CHKLST_SWLLHNDFT_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation to the extent, in the past 4 weeks, that they were bothered by swelling of hands or feet, using a 5 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7161862</PublicId>
      <PreferredName>7158642v1.0:7161860v1.0</PreferredName>
      <PreferredDefinition>Subjective evidence of disease perceived by the patient._A list of items required or things to be done or considered._A period of time consisting of the 28 days before the present._A question about how much something bothers an individual._A question about the extent to which an individual is bothered by swelling of hands or feet._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Symptom Checklist Past 4 Weeks How Much Does It Bother You Bothered by Swelling of Hands or Feet Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7158642</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4876:C49073</PreferredName>
        <Version>1</Version>
        <LongName>Symptom Checklist</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4876</PREFERRED_NAME>
            <LONG_NAME>Symptom</LONG_NAME>
            <CON_ID>2202622</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49073</PREFERRED_NAME>
            <LONG_NAME>Checklist</LONG_NAME>
            <CON_ID>2551430</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7161860</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C110986:C105747:C168706:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past 4 Weeks How Much Does It Bother You Bothered by Swelling of Hands or Feet Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C110986</PREFERRED_NAME>
            <LONG_NAME>Past 4 Weeks</LONG_NAME>
            <CON_ID>3871096</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C105747</PREFERRED_NAME>
            <LONG_NAME>How Much Does It Bother You Question</LONG_NAME>
            <CON_ID>3714556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C168706</PREFERRED_NAME>
            <LONG_NAME>Bothered by Swelling of Hands or Feet Question</LONG_NAME>
            <CON_ID>7158694</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7163987</PublicId>
      <PreferredName>7163987v1.0</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes from 0 - Not at all bothered, to 4 - Very bothered.</PreferredDefinition>
      <LongName>Extent of Symptoms 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Symptoms Extent Score 2</VALUEMEANING>
          <MEANINGDESCRIPTION>A subject score of 2 on a symptoms extent scale that ranges from 0: Not at All to 4: Very Bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168711</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7163990</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Symptoms Extent Score 1</VALUEMEANING>
          <MEANINGDESCRIPTION>A subject score of 1 on a symptoms extent scale that ranges from 0: Not at All to 4: Very Bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168710</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7163991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Symptoms Extent Score 4</VALUEMEANING>
          <MEANINGDESCRIPTION>A subject score of 4 on a symptoms extent scale that ranges from 0: Not at All to 4: Very Bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7163988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Symptoms Extent Score 3</VALUEMEANING>
          <MEANINGDESCRIPTION>A subject score of 3 on a symptoms extent scale that ranges from 0: Not at All to 4: Very Bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7163989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Symptoms Extent Score 0</VALUEMEANING>
          <MEANINGDESCRIPTION>A subject score of 0 on a symptoms extent scale that ranges from 0: Not at All to 4: Very Bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168709</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7163992</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Swelling of hands or feet</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Swelling of hands or feet</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1436">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7204051</PUBLICID>
    <LONGNAME>EPIC-26 - Best Describes Urinary Control Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>EPIC102</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated observation in the past 4 weeks of their urinary control, using a 4 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NCI CRF Standards</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7203977</PublicId>
      <PreferredName>6607890v1.0:7203975v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire._The Expanded Prostate Cancer Index Composite Short Form (EPIC-26) Which of the following best describes your urinary control during the last 4 weeks?_A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Questionnaire Domain EPIC-26 - Best Describes Urinary Control Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6607890</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49609</PreferredName>
        <Version>1</Version>
        <LongName>Questionnaire Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49609</PREFERRED_NAME>
            <LONG_NAME>Questionnaire Domain</LONG_NAME>
            <CON_ID>2469074</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7203975</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C127374:C25338</PreferredName>
        <Version>1</Version>
        <LongName>EPIC-26 - Best Describes Urinary Control Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C127374</PREFERRED_NAME>
            <LONG_NAME>EPIC-26 - Best Describes Urinary Control</LONG_NAME>
            <CON_ID>7203974</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCI CRF Standards</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5094772</PublicId>
      <PreferredName>EPIC_URIN_CTRL_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard related to urinary control associated with the EPIC measure.</PreferredDefinition>
      <LongName>EPIC Urinary Control 4 Point Scale</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>EPIC:Expanded Prostate Cancer Index Composite</Origin>
      <Representation>
        <PublicId>2184332</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Scale</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>No urinary control whatsoever</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that an individual has or had no urinary control.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C138090</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4076052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Frequent dribbling</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that an individual frequently dribbles urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C138092</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Occasional dribbling</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that an individual occasionally dribbles urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C138094</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Total control</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that an individual has or had total urinary control.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C138095</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210584</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDISC Aligned NCI Standard Equivalent CDE</Name>
        <DocumentType>CDISC Note</DocumentType>
        <DocumentText>This data element is to be used for CDISC aligned data collection in place of CDE 5105634 from the original NCI Standard CRF Template.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Which of the following best d</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Which of the following best describes your urinary control during the last 4 weeks?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRO-HRQoL Measures - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318356</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6921971</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC Aligned Collection CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EPIC-26 - CDISC Aligned</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>7318358</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_EPIC26_02</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1437">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7252669</PUBLICID>
    <LONGNAME>Patient Receive Therapeutic Procedure COVID-19 Clinical Trial Eligibility Criteria Code Indicator</LONGNAME>
    <PREFERREDNAME>PT_REC_TX_COVID_CD_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The coded indicator to determine clinical trial participation for questions that address a patient receiving of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process relating to COVID-19 as outlined in the study protocol.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>THERADEX:Theradex Systems Inc</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7252668</PublicId>
      <PreferredName>2233604v1.0:7261289v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._To take, accept, or get something offered._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Patient Receive Therapeutic Procedure SARS Coronavirus 2 Infection Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7261289</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25639:C49236:C171133:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Receive Therapeutic Procedure SARS Coronavirus 2 Infection Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C171133</PREFERRED_NAME>
            <LONG_NAME>COVID-19 Infection</LONG_NAME>
            <CON_ID>7252794</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3298541</PublicId>
      <PreferredName>YES_NO_NA_CD_IND</PreferredName>
      <PreferredDefinition>Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Yes No Not Applicable Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTMS:Clinical Trials Monitoring Service</Origin>
      <Representation>
        <PublicId>3298540</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3298540v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Not Applicable Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If patient has received prior</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If patient has received prior IL6 specific targeting strategies for treatment of COVID-19, including siltuximab, tocilizumab and sarilumab, there was no benefit after maximum dosing (patients who have received only 1 prior dose and there was evidence of potential benefit may be eligible)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3876359</PublicId>
          <ContextName>Theradex</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Exclusion Criteria</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prior Treatments</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3876424</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1438">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7263249</PUBLICID>
    <LONGNAME>Study Protocol Cohort Assignment Category</LONGNAME>
    <PREFERREDNAME>7263209v1.0:7263204v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis._A group of individuals, identified by a common characteristic._An allotting or an appointment to a particular person or use, or for a particular time or object._A grouping of items based on some commonality or by user defined characteristics.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>ECOG-ACRIN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7263209</PublicId>
      <PreferredName>7263207v1.0:2454524v1.0</PreferredName>
      <PreferredDefinition>The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis._A group of individuals, identified by a common characteristic._An allotting or an appointment to a particular person or use, or for a particular time or object.</PreferredDefinition>
      <LongName>Study Protocol Cohort Assignment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7263207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70817:C61512</PreferredName>
        <Version>1</Version>
        <LongName>Study Protocol Cohort</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70817</PREFERRED_NAME>
            <LONG_NAME>Study Protocol</LONG_NAME>
            <CON_ID>2753699</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61512</PREFERRED_NAME>
            <LONG_NAME>Cohort</LONG_NAME>
            <CON_ID>2555083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2454524</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25426</PreferredName>
        <Version>1</Version>
        <LongName>Assignment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25426</PREFERRED_NAME>
            <LONG_NAME>Assignment</LONG_NAME>
            <CON_ID>2204040</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7263204</PublicId>
      <PreferredName>7263204v1.0</PreferredName>
      <PreferredDefinition>A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Cohort Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2433877</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25372</PreferredName>
        <Version>1</Version>
        <LongName>Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Randomized cohort: Patients without molecular alterations</VALIDVALUE>
          <VALUEMEANING>Randomization Cohort Patient Without Eligible Molecular Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.: A group of individuals, identified by a common characteristic.: A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.: Used to indicate the absence or lack of something or someone.: Satisfying the appropriate conditions for inclusion.: A molecular or cytogenic abnormality which occurs in either human disease states or disease models.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3910, C126586, C25718, C16960, C61512, C25196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7263205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Targeted cohort: Patients with eligible molecular alterations</VALIDVALUE>
          <VALUEMEANING>Target Cohort Patient With Eligible Molecular Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>An object fixed as a goal or point of examination; something to point at; a destination.: A group of individuals, identified by a common characteristic.: A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.: Used to indicate the presence of something or someone.: Satisfying the appropriate conditions for inclusion.: A molecular or cytogenic abnormality which occurs in either human disease states or disease models.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3910, C126586, C62355, C16960, C61512, C25702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-04-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7263206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>One</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest natural number and quantity it denotes: a single entity, unit, or object. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Two</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612444</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin eligible</VALIDVALUE>
          <VALUEMEANING>Cisplatin Eligible</VALUEMEANING>
          <MEANINGDESCRIPTION>An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.: Satisfying the appropriate conditions for inclusion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126586, C376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7576034</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cisplatin ineligible</VALIDVALUE>
          <VALUEMEANING>Cisplatin Ineligibility</VALUEMEANING>
          <MEANINGDESCRIPTION>An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.: The state or quality of being disqualified by law, rule, or provision.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C40412, C376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6712212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No prior targeted therapy</VALIDVALUE>
          <VALUEMEANING>No prior targeted therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question._Earlier in time or order._A type of cancer treatment that uses testing and medication to more precisely identify and treat cancer. These treatments target and disable genes or proteins necessary to the proliferation of cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93352, C25629, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13571184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prior targeted therapy</VALIDVALUE>
          <VALUEMEANING>Prior Targeted Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Earlier in time or order._A type of cancer treatment that uses testing and medication to more precisely identify and treat cancer. These treatments target and disable genes or proteins necessary to the proliferation of cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93352, C25629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13571185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HGBCL-DH-BCL2</VALIDVALUE>
          <VALUEMEANING>HGBCL-DH-BCL2</VALUEMEANING>
          <MEANINGDESCRIPTION>HGBCL-DH-BCL2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-04-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14905504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CD10-negative DLBCL</VALIDVALUE>
          <VALUEMEANING>CD10-negative DLBCL</VALUEMEANING>
          <MEANINGDESCRIPTION>CD10-negative DLBCL</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-04-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14905503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cohort</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cohort</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>OPEN Checklist</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Select the cohort status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG-ACRIN - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cohort Assignment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1439">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7315312</PUBLICID>
    <LONGNAME>Weight Change Occurrence Indicator</LONGNAME>
    <PREFERREDNAME>7315304v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not a change in weight occurred.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7315304</PublicId>
      <PreferredName>7315302v1.0:2234856v1.0</PreferredName>
      <PreferredDefinition>An increase or decrease in the weight of an individual._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Weight Change Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7315302</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9232</PreferredName>
        <Version>1</Version>
        <LongName>Weight Change</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9232</PREFERRED_NAME>
            <LONG_NAME>Weight Change</LONG_NAME>
            <CON_ID>7315301</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did a change in weight occur?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did a change in weight occur?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you lost or gained weight?</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Have you lost or gained weight?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>To the best of your knowledge, have you lost or gained weight?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>To the best of your knowledge, have you lost or gained weight?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1440">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7344439</PUBLICID>
    <LONGNAME>Sentinel Lymph Node Mapping Frozen Section Performed Indicator</LONGNAME>
    <PREFERREDNAME>SLNM_FRZN__PERF_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator if frozen section of the lymph node using sentinel lymph node mapping technique was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Princess Margaret Cancer Centre, Toronto, ON</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7344436</PublicId>
      <PreferredName>3061555v1.0:7344434v1.0</PreferredName>
      <PreferredDefinition>A technique that uses dyes and/or radioactive agents to map the lymphatic drainage of an area in which a tumor is located, thereby identifying the sentinel node. A thin slice of tissue cut from a frozen specimen, often used for rapid microscopic diagnosis._Executed and carried through to completion._</PreferredDefinition>
      <LongName>Sentinel Lymph Node Mapping Frozen Section Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3061555</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20206</PreferredName>
        <Version>1</Version>
        <LongName>Sentinel Lymph Node Mapping</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20206</PREFERRED_NAME>
            <LONG_NAME>Sentinel Lymph Node Mapping</LONG_NAME>
            <CON_ID>2978472</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>RADLEX_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7344434</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C67462:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Frozen Section Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67462</PREFERRED_NAME>
            <LONG_NAME>Frozen Section</LONG_NAME>
            <CON_ID>2645107</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>Princess Margaret Cancer Centre, Toronto, ON</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>frozen section SLNM</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>frozen section SLNM</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>16445930</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PMCC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PMCC Curation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16445931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1441">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7350333</PUBLICID>
    <LONGNAME>Hemophilia Disease or Disorder Indicator</LONGNAME>
    <PREFERREDNAME>HEMPHLC_EROCCUR</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether or not the participant is a hemophiliac.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7350332</PublicId>
      <PreferredName>2412140v1.0:2239878v1.0</PreferredName>
      <PreferredDefinition>Group of hereditary disorders in which affected individuals fail to make enough of certain proteins needed to form blood clots._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</PreferredDefinition>
      <LongName>Hemophilia Disease or Disorder</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>AMC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2412140</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3093</PreferredName>
        <Version>1</Version>
        <LongName>Hemophilia</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3093</PREFERRED_NAME>
            <LONG_NAME>Hemophilia</LONG_NAME>
            <CON_ID>2412139</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239878</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AMC CRF:AIDS Malignancy Consortium Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6343337</PublicId>
      <PreferredName>NY</PreferredName>
      <PreferredDefinition>Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6343336</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66742:C25180</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66742</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</LONG_NAME>
            <CON_ID>4852475</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5676138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hemophiliac</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Hemophiliac</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Baseline Evaluations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7283433</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HHSHEMO</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HEMOPHELIA_IND</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1442">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7373703</PUBLICID>
    <LONGNAME>Visceral Kaposi Sarcoma Lesion Anatomic Location Specify</LONGNAME>
    <PREFERREDNAME>QSLOC1</PREFERREDNAME>
    <PREFERREDDEFINITION>Text description of the visceral Kaposi sarcoma lesion anatomic location.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7373701</PublicId>
      <PreferredName>7373694v1.0:2442487v1.0</PreferredName>
      <PreferredDefinition>Of, or relating to, or affecting the internal organs._A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS)._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Relating to anatomy._A position, site, or point in space where something can be found.</PreferredDefinition>
      <LongName>Visceral Kaposi Sarcoma Lesion Anatomic Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>AMC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7373694</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25315:C9087:C3824</PreferredName>
        <Version>1</Version>
        <LongName>Visceral Kaposi Sarcoma Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25315</PREFERRED_NAME>
            <LONG_NAME>Visceral</LONG_NAME>
            <CON_ID>2202888</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9087</PREFERRED_NAME>
            <LONG_NAME>Kaposi Sarcoma</LONG_NAME>
            <CON_ID>2637488</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2442487</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25421:C25341</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25421</PREFERRED_NAME>
            <LONG_NAME>Anatomic</LONG_NAME>
            <CON_ID>2202601</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25341</PREFERRED_NAME>
            <LONG_NAME>Location</LONG_NAME>
            <CON_ID>2202456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>AMC CRF:AIDS Malignancy Consortium Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2226669</PublicId>
      <PreferredName>ANATSITE_SPEC</PreferredName>
      <PreferredDefinition>the free text field to specify an anatomic site.</PreferredDefinition>
      <LongName>Anatomic Site Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Site of KS lesion</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Site of KS lesion</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7312662</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QSLOC3</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QSLOC2</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1443">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7409918</PUBLICID>
    <LONGNAME>Laboratory Test Performed Type</LONGNAME>
    <PREFERREDNAME>LAB_TT_PRFM_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>The name of the lab test performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2471462</PublicId>
      <PreferredName>LAB_FNG_NM</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Laboratory Finding Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>C3D:Central Cancer Clinical Database</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7409912</PublicId>
      <PreferredName>7409912v1.0</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Laboratory Procedure Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2207978</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Test Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AMH</VALIDVALUE>
          <VALUEMEANING>Anti-Mullerian Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the anti-Mullerian hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6412840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Free T4 Level</VALIDVALUE>
          <VALUEMEANING>Free T4 Level </VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free thyroxine present in a sample.: A position on a scale measuring intensity, quality, or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25554, C74786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7412786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FSH</VALIDVALUE>
          <VALUEMEANING>Follicle Stimulating Hormone</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of follicle stimulating hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3293687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LH</VALIDVALUE>
          <VALUEMEANING>Luteinizing Hormone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of luteinizing hormone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74790</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3293685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Total Testosterone</VALIDVALUE>
          <VALUEMEANING>Total Testosterone Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>The determination of the amount of free and bound testosterone present in a sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74793</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404149</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TSH</VALIDVALUE>
          <VALUEMEANING>Thyroid Stimulating Hormone</VALUEMEANING>
          <MEANINGDESCRIPTION>A hormone produced by the pituitary gland. TSH stimulates the release of thyroid hormone from thyroglobulin. It also stimulates the growth of thyroid follicular cells. An abnormal TSH level may mean that the thyroid hormonal regulation system is out of control, usually as a result of a benign condition (hyperthyroidism or hypothyroidism).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3308482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6149013</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prolactin</VALIDVALUE>
          <VALUEMEANING>Prolactin</VALUEMEANING>
          <MEANINGDESCRIPTION>Human prolactin (227 aa, 26 kDa precursor) is encoded by the human prolactin (PIT1) gene. This secreted lactogenic glycoprotein is expressed in both anterior pituitary lactotropes and the decidual endometrium. It acts primarily on the mammary gland and, in synergy with estrogen, induces progesterone release by corpus luteum cells to render the uterine mucosa suitable for implantation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C778</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3564200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Estradiol</VALIDVALUE>
          <VALUEMEANING>Estradiol</VALUEMEANING>
          <MEANINGDESCRIPTION>Estradiol (E2). beta-estradiol; 17 beta-estradiol; 1,3,5(10)-estratriene-3,17 beta-diol; the most potent naturally occurring estrogen in mammals, formed by the ovary, placenta, testis, and possibly the adrenal cortex; therapeutic indications for estradiol are those typical of an estrogen. alpha-Estradiol, (17 alpha-estradiol), exhibits considerably less biologic activity. Estradiol is used in the treatment of menstrual disorders, menopause problems, etc. SYN estrogenic hormone, oestradiol.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2295</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-08-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Test performed:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Test performed:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1444">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7412806</PUBLICID>
    <LONGNAME>Laboratory Data Domain Confirmatory Testing Type</LONGNAME>
    <PREFERREDNAME>LB_LBTEST_BM</PREFERREDNAME>
    <PREFERREDDEFINITION>An indication of the type of confirmatory testing performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6422504</PublicId>
      <PreferredName>6401816v1.0:6422502v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to laboratory data._A character or string that represents the full name of the laboratory assessment.</PreferredDefinition>
      <LongName>Laboratory Data Domain Laboratory Test</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6401816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49592</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Data Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49592</PREFERRED_NAME>
            <LONG_NAME>Laboratory Data Domain</LONG_NAME>
            <CON_ID>2469066</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6422502</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C117142</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C117142</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Name</LONG_NAME>
            <CON_ID>5581796</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7412805</PublicId>
      <PreferredName>7412805v1.0</PreferredName>
      <PreferredDefinition>Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Confirmatory Testing Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Flow Cytometry</VALIDVALUE>
          <VALUEMEANING>Flow Cytometry</VALUEMEANING>
          <MEANINGDESCRIPTION>A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2974014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Karyotype</VALIDVALUE>
          <VALUEMEANING>Karyotype</VALUEMEANING>
          <MEANINGDESCRIPTION>The assessment of the chromosomal morphology and number in somatic cells of an individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5255756</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3126125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FISH</VALIDVALUE>
          <VALUEMEANING>Fluorescence in Situ Hybridization</VALUEMEANING>
          <MEANINGDESCRIPTION>A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5622317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Next Generation Sequencing (NGS)</VALIDVALUE>
          <VALUEMEANING>Next Generation Sequencing</VALUEMEANING>
          <MEANINGDESCRIPTION>Technologies that facilitate the rapid determination of the DNA sequence of large numbers of strands or segments of DNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4448577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Polymerase Chain Reaction (PCR)</VALIDVALUE>
          <VALUEMEANING>Polymerase Chain Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17003</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3234683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HTS MRD Tracking</VALIDVALUE>
          <VALUEMEANING>HTS MRD Tracking</VALUEMEANING>
          <MEANINGDESCRIPTION>HTS MRD Tracking</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14862781</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HTS Clonality ID</VALIDVALUE>
          <VALUEMEANING>HTS Clonality ID</VALUEMEANING>
          <MEANINGDESCRIPTION>HTS Clonality ID</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14862780</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the name of the conf</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the name of the confirmatory test?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_BM_KYTYP</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_BM_FISH</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_BM_FLOW</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_BM_NGS</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_BM_OTH</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_BM_PCR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_NA</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_CNS2_FISH</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_CNS2_FLOW</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_CNS2_OTH</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB_LBTEST_HTSMRD</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1445">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7412875</PUBLICID>
    <LONGNAME>Patient HER2 Mutation Clinical Trial Eligibility Criteria Yes No Indicator</LONGNAME>
    <PREFERREDNAME>HER2_PT_HX_ELIG_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no indicator to determine if a patient has the HER2 positive mutation to determine eligibility criteria to enroll in a clinical trial.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>4890993</PublicId>
      <PreferredName>2177068v1.0:4890991v1.0</PreferredName>
      <PreferredDefinition>information related to HER2 Activating Mutation as an element of the personal medical history which is necessary to allow an individual to participate in a specific clinical trial.</PreferredDefinition>
      <LongName>Patient HER2 Mutation Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4890991</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C112312:C0026882:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Human Epidermal Growth Factor Receptor 2 Measurement Mutation Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C112312</PREFERRED_NAME>
            <LONG_NAME>Human Epidermal Growth Factor Receptor 2 Measurement</LONG_NAME>
            <CON_ID>4577519</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0026882</PREFERRED_NAME>
            <LONG_NAME>Mutation</LONG_NAME>
            <CON_ID>3448538</CON_ID>
            <DEFINITION_SOURCE>MSH</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient&#39;s HER2 expression result, based on tumor tissue testing, meet the inclusion criteria?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does the patient have osteosa</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does the patient have osteosarcoma with positive HER2 expression based on tumor tissue testing?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRFT Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the HER2 evaluation based on local site immunohistochemistry (IHC), fluorescent in-situ hybridization (FISH), or local/commercial next generation sequencing (NGS)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1446">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7474146</PUBLICID>
    <LONGNAME>Transplantation Healthcare Facility Data Manager Signature Individuals Name</LONGNAME>
    <PREFERREDNAME>7474140v1.0:2018286v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The signature of the transplantation healthcare facility data manager.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7474140</PublicId>
      <PreferredName>7474138v1.0:2436718v1.0</PreferredName>
      <PreferredDefinition>Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species._The buildings and organizations where healthcare services are provided._A person primarily responsible for database creation, data collection, validation, integration, coding, review, quality evaluation, and archiving, as well as for preparation of reports and data displays._Individual&#39;s name or personal mark, used to sign documents and employed to signify that the writing which precedes accords with one&#39;s wishes and intentions; having a handwritten signature.</PreferredDefinition>
      <LongName>Transplantation Healthcare Facility Data Manager Signature</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7474138</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15342:C21541:C51820</PreferredName>
        <Version>1</Version>
        <LongName>Transplantation Healthcare Facility Data Manager</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21541</PREFERRED_NAME>
            <LONG_NAME>Healthcare Facility</LONG_NAME>
            <CON_ID>2202668</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51820</PREFERRED_NAME>
            <LONG_NAME>Data Manager</LONG_NAME>
            <CON_ID>2479775</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2436718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25678</PreferredName>
        <Version>1</Version>
        <LongName>Signature</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25678</PREFERRED_NAME>
            <LONG_NAME>Signature</LONG_NAME>
            <CON_ID>2202359</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018286</PublicId>
      <PreferredName>INDS_SIG_NAME</PreferredName>
      <PreferredDefinition>the signature of an individual.</PreferredDefinition>
      <LongName>Individuals Signature Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2217568</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>C25678:C25191</PreferredName>
        <Version>1</Version>
        <LongName>Signature Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25678</PREFERRED_NAME>
            <LONG_NAME>Signature</LONG_NAME>
            <CON_ID>2202359</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25191</PREFERRED_NAME>
            <LONG_NAME>Person Name</LONG_NAME>
            <CON_ID>2203721</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Signature of the transplantat</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Signature of the transplantation healthcare facility data manager:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Signature of transplant center data manager:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Signature of transplant center data manager:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Signature of transplant center data manager:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Signature of transplant center data manager:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TNFR_RRT_trf_from_data_mgr_sig</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TNFR_RRT_trf_to_data_mgr_sig</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1447">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7516269</PUBLICID>
    <LONGNAME>IWQOL-Lite 15 Past Week How True Because of My Weight Do Not Like Myself Score How True 5 Point Scale</LONGNAME>
    <PREFERREDNAME>IWQOL_15_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation in the past week about how true it is that they don&#39;t like themselves because of their weight, using a 5 point Likert scale.  </PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7515826</PublicId>
      <PreferredName>7515781v1.0:7515824v1.0</PreferredName>
      <PreferredDefinition>A 31-item, self-report questionnaire that utilizes a five-point rating scale to measure obesity-specific quality of life in adults. The assessment consists of a total score, as well as individual scores for each of five specific domains, including physical function, self-esteem, sexual life, public distress, and work._The most recent week. May include the present day._A question about an individual&#39;s agreement with a statement._A question about the effects of an individual&#39;s weight._A question about whether an individual does not like themself._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Impact of Weight on Quality of Life-Lite Past Week How True Because of My Weight Do Not Like Myself Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7515781</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C175905</PreferredName>
        <Version>1</Version>
        <LongName>Impact of Weight on Quality of Life-Lite</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C175905</PREFERRED_NAME>
            <LONG_NAME>Impact of Weight on Quality of Life-Lite</LONG_NAME>
            <CON_ID>7505060</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7515824</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>7515824v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Past Week How True Because of My Weight Do Not Like Myself Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C91781</PREFERRED_NAME>
            <LONG_NAME>How True Question</LONG_NAME>
            <CON_ID>3133350</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C175906</PREFERRED_NAME>
            <LONG_NAME>Because of My Weight Question</LONG_NAME>
            <CON_ID>7505061</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C126444</PREFERRED_NAME>
            <LONG_NAME>Do Not Like Myself Question</LONG_NAME>
            <CON_ID>5211747</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7515876</PublicId>
      <PreferredName>7515876v1.0</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes ranging from 1 - Never True to 5 - Always True.</PreferredDefinition>
      <LongName>How True 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>5</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Rarely True</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is rarely true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6740164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Sometimes True</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is sometime true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C159758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6740065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Usually True</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is usually true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176031</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7516166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Always True</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is always true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7516167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Never True</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is never true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176032</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-11-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7516168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Because of my weight I don&#39;t</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Because of my weight I don&#39;t like myself.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Impact of Weight on Quality of Life (IWQOL-Lite)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #15 of 31</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Impact of Weight on Quality of Life-Lite (IWQOL-Lite)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900316</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7516456</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>IWQOL-Lite</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>IWQOL-Lite</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7516457</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1448">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7533480</PUBLICID>
    <LONGNAME>Primary Immune Regulatory Disorder Description Name</LONGNAME>
    <PREFERREDNAME>PIRD_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to describe the primary immune regulatory disorder.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7533465</PublicId>
      <PreferredName>7533463v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>A group of immune diseases characterized predominantly by immune dysregulation leading to organ-specific autoimmunity, excessive inflammation, and non-malignant lymphoproliferation. Unlike classical primary immunodeficiencies, susceptibility to infections is typically less prominent in these disorders._A written or verbal account, representation, statement, or explanation of something.</PreferredDefinition>
      <LongName>Primary Immune Regulatory Disorder Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7533463</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C176600</PreferredName>
        <Version>1</Version>
        <LongName>Primary Immune Regulatory Disorder</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C176600</PREFERRED_NAME>
            <LONG_NAME>Primary Immune Regulatory Disorder</LONG_NAME>
            <CON_ID>7533426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7533467</PublicId>
      <PreferredName>PIRD_NAME</PreferredName>
      <PreferredDefinition>A group of immune diseases characterized predominantly by immune dysregulation leading to organ-specific autoimmunity, excessive inflammation, and non-malignant lymphoproliferation. Unlike classical primary immunodeficiencies, susceptibility to infections is typically less prominent in these disorders._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Primary Immune Regulatory Disorder Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>7533466</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C176600:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Primary Immune Regulatory Disorder Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C176600</PREFERRED_NAME>
            <LONG_NAME>Primary Immune Regulatory Disorder</LONG_NAME>
            <CON_ID>7533426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HLH</VALIDVALUE>
          <VALUEMEANING>Hemophagocytic Lymphohistiocytosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare but potentially life-threatening disorder characterized by the proliferation of histiocytes and macrophages and phagocytosis of red blood cells, white blood cells, and platelets. It may be inherited or secondary, due to infections, autoimmune disorders, or underlying malignancies. Signs and symptoms include fever, lymphadenopathy, hepatomegaly, splenomegaly, and pancytopenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34792</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytokine/Regulatory Proteins</VALIDVALUE>
          <VALUEMEANING>Cytokine Immunoprotein</VALUEMEANING>
          <MEANINGDESCRIPTION>A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.: A protein whose activities affect or play a role in immune system functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16725, C20464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7533468</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transcriptional Regulators</VALIDVALUE>
          <VALUEMEANING>Transcription Regulatory Protein</VALUEMEANING>
          <MEANINGDESCRIPTION>A protein that is involved in the regulation of transcription.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26199</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7533469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>JAK/STAT</VALIDVALUE>
          <VALUEMEANING>Jak-STAT Signaling Pathway</VALUEMEANING>
          <MEANINGDESCRIPTION>The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is one of a handful of pleiotropic cascades used to transduce a multitude of signals for development and homeostasis in animals, from humans to flies.  In mammals, the JAK/STAT pathway is the principal signaling mechanism for a wide array of cytokines and growth factors. Following the binding of cytokines to their cognate receptor, STATs are activated by members of the JAK family of tyrosine kinases. Once activated, they dimerize and translocate to the nucleus and modulate the expression of target genes. In addition to the activation of STATs, JAKs mediate the recruitment of other molecules such as the MAP kinases, PI3 kinase etc. These molecules process downstream signals via the Ras-Raf-MAP kinase and PI3 kinase pathways which results in the activation of additional transcription factors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7533470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PI3 Kinase</VALIDVALUE>
          <VALUEMEANING>Phosphatidylinositol 3 Kinase</VALUEMEANING>
          <MEANINGDESCRIPTION>An enzyme that catalyzes the conversion of phosphatidylinositol to phosphatidylinositol 3-phosphate. This is the first committed step in the biosynthesis of phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. This pathway is thought to play a critical role in DNA repair, V(D)J recombination and cell cycle checkpoints. (from LocusLink)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3412291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EBV Susceptibility</VALIDVALUE>
          <VALUEMEANING>EBV Susceptibility</VALUEMEANING>
          <MEANINGDESCRIPTION>An immune system finding indicating that an individual has a likelihood for developing Epstein Barr virus infections.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C176692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7533471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NFkB signaling</VALIDVALUE>
          <VALUEMEANING>NFkB signaling</VALUEMEANING>
          <MEANINGDESCRIPTION>Nuclear factor kB (NF-kB) is a nuclear transcription factor that regulates expression of a large number of genes that are critical for the regulation of apoptosis, viral replication, tumorigenesis, inflammation, and various autoimmune diseases. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39163</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7533597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lymphoproliferative disorder</VALIDVALUE>
          <VALUEMEANING>Lymphoproliferative Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis). --2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9308</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3235573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Eczema</VALIDVALUE>
          <VALUEMEANING>Eczema</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of dermatitis characterized by red, itchy, scaly, or crusty patches that can be chronic or intermittent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3001</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Asthma</VALIDVALUE>
          <VALUEMEANING>Asthma</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2975594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Allergic rhinitis</VALIDVALUE>
          <VALUEMEANING>Allergic Rhinitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the nasal mucous membranes caused by an IgE-mediated response to external allergens. The inflammation may also involve the mucous membranes of the sinuses, eyes, middle ear, and pharynx. Symptoms include sneezing, nasal congestion, rhinorrhea, and itching. It may lead to fatigue, drowsiness, and malaise thus causing impairment of the quality of life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79532</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Granuloma</VALIDVALUE>
          <VALUEMEANING>Granuloma</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory reaction usually caused by infectious organisms, foreign bodies, or cholesterol deposits. It is characterized by the presence of epithelioid histiocytes and chronic inflammation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-02-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5021905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PIRD</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>PIRD</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Immune Dysregulation Disorders</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Immune Dysregulation Disorders</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1449">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7571422</PUBLICID>
    <LONGNAME>Supportive Care When I Hear the Term Palliative Care, I Feel Depression Agreement 5 Point Likert Scale</LONGNAME>
    <PREFERREDNAME>7571421v1.0:3682709v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s agreement with a statement related to feeling depressed when hearing the term palliative care using a five-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7571421</PublicId>
      <PreferredName>7559951v1.0:7571419v1.0</PreferredName>
      <PreferredDefinition>Supportive care is that which helps the patient and their family to cope with cancer and treatment of it from pre-diagnosis, through the process of diagnosis and treatment, to cure, continuing illness or death and into bereavement. It helps the patient to maximize the benefits of treatment and to live as well as possible with the effects of the disease. Supportive therapy may provide a patient with friendship, encouragement, practical advice such as access to community resources or how to develop a more active social life, vocational counseling, suggestions for minimizing friction with family members, and, above all, hope that the life of the patient may be improved. In all situations, supportive therapy involves the teaching of such life skills as managing medication, learning to socialize, handling finances, and getting a job._A question about how strongly an individual agrees that they would feel a specified emotion when they hear the term &quot;palliative care&quot;._A melancholy feeling of sadness and despair._The act of agreeing to a plan, protocol, or arrangement. Also used to describe a harmony of opinion._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Supportive Care When I Hear the Term Palliative Care, I Feel Depression Agreement Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7559951</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15747</PreferredName>
        <Version>1</Version>
        <LongName>Supportive Care</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15747</PREFERRED_NAME>
            <LONG_NAME>Supportive Care</LONG_NAME>
            <CON_ID>2205256</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7571419</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C177230:C2982:C25369:C25664</PreferredName>
        <Version>1</Version>
        <LongName>What I Feel When I Hear Palliative Care Depression Agreement Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C177230</PREFERRED_NAME>
            <LONG_NAME>What I Feel When I Hear Palliative Care Question</LONG_NAME>
            <CON_ID>7569328</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2982</PREFERRED_NAME>
            <LONG_NAME>Depression</LONG_NAME>
            <CON_ID>2205037</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25369</PREFERRED_NAME>
            <LONG_NAME>Agreement</LONG_NAME>
            <CON_ID>2204037</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3682709</PublicId>
      <PreferredName>AGMT_5PT_SCL</PreferredName>
      <PreferredDefinition>A number with no fractional part, including the negative and positive numbers as well as zero.::5_The precise location of something; a spatially limited location._an ordered reference standard.</PreferredDefinition>
      <LongName>Agreement 5 Point Likert Scale</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>MDADI:M.D.Anderson Dysphagia Inventory, Amy Y.Chen, 2000</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strongly Disagree</VALIDVALUE>
          <VALUEMEANING>Strongly Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely at odds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disagree</VALIDVALUE>
          <VALUEMEANING>Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>To be at odds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104479</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Opinion</VALIDVALUE>
          <VALUEMEANING>No Opinion</VALUEMEANING>
          <MEANINGDESCRIPTION>Without concurrence or opposition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103804</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Agree</VALIDVALUE>
          <VALUEMEANING>Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>To concur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strongly Agree</VALIDVALUE>
          <VALUEMEANING>Strongly agree</VALUEMEANING>
          <MEANINGDESCRIPTION>Intense concurrence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I feel depressed when hearing</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I feel depressed when hearing the term palliative care.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>When I hear the term palliative care, I feel depressed</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>When I hear the term palliative care, I feel depressed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>When I hear the term palliative care, I feel depressed</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>When I hear the term palliative care, I feel depressed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>When I hear the term palliative care, I feel depressed.</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>When I hear the term palliative care, I feel depressed.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1450">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7575423</PUBLICID>
    <LONGNAME>COVID-19 Vaccine Initial Immunization Administered Date</LONGNAME>
    <PREFERREDNAME>7554833v1.0:2532012v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The month, day, and year the initial COVID-19 vaccine was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7554833</PublicId>
      <PreferredName>7554830v1.0:7554831v1.0</PreferredName>
      <PreferredDefinition>Any vaccine that may prevent coronavirus disease-2019 (COVID-19) that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)._Preceding all others in time or space or degree._A technique used to cause an immune response that results in resistance to a specific disease, especially an infectious disease._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>COVID-19 Vaccine Initial Immunization Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2831222</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15347</PreferredName>
        <Version>1</Version>
        <LongName>Vaccine Therapy</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7554830</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C173023</PreferredName>
        <Version>1</Version>
        <LongName>COVID-19 Vaccine</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C173023</PREFERRED_NAME>
            <LONG_NAME>COVID-19 Vaccine</LONG_NAME>
            <CON_ID>7554829</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7554831</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C15258:C25382</PreferredName>
        <Version>1</Version>
        <LongName>First Immunization Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15258</PREFERRED_NAME>
            <LONG_NAME>Immunization</LONG_NAME>
            <CON_ID>3151210</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2532012</PublicId>
      <PreferredName>DATE</PreferredName>
      <PreferredDefinition>The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY-MM-DD</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of first dose:</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Date of first dose:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of first dose:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of first dose:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>When was the initial COVID-19</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>When was the initial COVID-19 vaccine administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of first dose received:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of first dose received:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_INF_COVID19_vac_dse1_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_INF_COVID19_vac_dse1_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_INF_COVID19_vac_dse1_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_CC_COVID19_vac_dse1_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1451">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7584604</PUBLICID>
    <LONGNAME>TAS 10 Know That Will do Better if Work Hard to Learn About Technology Score 6 Point Scale</LONGNAME>
    <PREFERREDNAME>TAS_10_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated level of agreement that they know if they work hard to learn about technology, they will do better, using a 6 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7584579</PublicId>
      <PreferredName>7584549v1.0:7584577v1.0</PreferredName>
      <PreferredDefinition>A 15-item questionnaire that utilizes a six-point rating scale to assess an individual&#39;s attitude toward the use of technology, including their confidence in using technology, the value of using technology, and their perceptions of technology and its usefulness in specific settings._A question about how strongly an individual agrees that if they work hard to learn about technology they will do better._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Technology Attitude Scale Know That Will do Better if Work Hard to Learn About Technology Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7584549</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C177742</PreferredName>
        <Version>1</Version>
        <LongName>Technology Attitude Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C177742</PREFERRED_NAME>
            <LONG_NAME>Technology Attitude Scale</LONG_NAME>
            <CON_ID>7584436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7584577</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C177754:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Know That Will do Better if Work Hard to Learn About Technology Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C177754</PREFERRED_NAME>
            <LONG_NAME>Know That Will do Better if Work Hard to Learn About Technology Question</LONG_NAME>
            <CON_ID>7584447</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6396790</PublicId>
      <PreferredName>PPOS_AGREEMENT_SCL</PreferredName>
      <PreferredDefinition>6 point Likert scale ranging from 1: Strongly Disagree to 6: Strongly Agree</PreferredDefinition>
      <LongName>Agreement 6 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>6</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>PAR-Q+: Physical Activity Readiness Questionnaire for Everyone</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Strongly agree</VALUEMEANING>
          <MEANINGDESCRIPTION>Intense concurrence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Moderately Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating moderate agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6396817</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Slightly Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in slight agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5119337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Slightly Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in slight disagreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5119338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Moderately Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating moderate disagreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C153546</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6396818</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Strongly Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely at odds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-08-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I know if I work hard to lear</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I know if I work hard to learn about technology, I will do better.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Technology Attitude Scale (TAS)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900356</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7584653</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TAS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>TAS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7584654</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1452">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7588561</PUBLICID>
    <LONGNAME>Laboratory Procedure Nucleated Cell Count Outcome Absolute Neutrophil Count Lab Unspecified Value</LONGNAME>
    <PREFERREDNAME>LAB_TNC_RSLT</PREFERREDNAME>
    <PREFERREDDEFINITION>The determination of the total amount of nucleated cells present in a sample.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7588560</PublicId>
      <PreferredName>LAB_TNC_RSLT</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The determination of the amount of nucleated cells present in a sample._The result of an action.</PreferredDefinition>
      <LongName>Laboratory Procedure Nucleated Cell Count Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7588558</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C150841:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Nucleated Cell Count Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C150841</PREFERRED_NAME>
            <LONG_NAME>Nucleated Cell Count</LONG_NAME>
            <CON_ID>6403967</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2597280</PublicId>
      <PreferredName>ANC_LAB_UNS_VAL</PreferredName>
      <PreferredDefinition>the numerical quantity measured for absolute neutrophils (units not specified).</PreferredDefinition>
      <LongName>Absolute Neutrophil Count Lab Unspecified Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>9</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2586710</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38046:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Unspecified Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38046</PREFERRED_NAME>
            <LONG_NAME>Unspecified</LONG_NAME>
            <CON_ID>2230154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total nucleated cell count (T</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Total nucleated cell count (TNC):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1453">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7604749</PUBLICID>
    <LONGNAME>Radiation Clinical Target Volume One Fractionation Number</LONGNAME>
    <PREFERREDNAME>RAD_CTV1_FRAC_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>The number that represents the radiation dose fractions for clinical target volume 1 (CTV1).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7604732</PublicId>
      <PreferredName>2403872v1.0:7605955v1.0</PreferredName>
      <PreferredDefinition>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._The tissue volume that contains a demonstrable gross target volume and/or sub-clinical microscopic malignant disease, which has to be eliminated. This volume must be treated adequately in order to achieve the aim of therapy, cure or palliation._The smallest natural number and quantity it denotes: a single entity, unit, or object._Dividing the total dose of radiation therapy into several smaller, equal doses delivered over a period of several days.</PreferredDefinition>
      <LongName>Radiation Therapy Clinical Target Volume One Fractionation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2403872</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15313</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7605955</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C112912:C66832:C15654</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Target Volume One Fractionation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C112912</PREFERRED_NAME>
            <LONG_NAME>Clinical Target Volume</LONG_NAME>
            <CON_ID>3991803</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66832</PREFERRED_NAME>
            <LONG_NAME>One</LONG_NAME>
            <CON_ID>2636736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15654</PREFERRED_NAME>
            <LONG_NAME>Fractionated Radiotherapy</LONG_NAME>
            <CON_ID>2203815</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6013152</PublicId>
      <PreferredName>6013152v1.0</PreferredName>
      <PreferredDefinition>A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>19</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>4</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DCP:Division of Cancer Prevention</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Radiation # of Fractions for</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Radiation # of Fractions for CTV1</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1454">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7615230</PUBLICID>
    <LONGNAME>Patient Abnormal Bone Metabolic Process Disease or Disorder Study Eligiblity Criterion Type Indicator</LONGNAME>
    <PREFERREDNAME>PT_AB_BONE_MTBL_DIS_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A y/n/na/unk indicator of whether a patient has a disease and/or disorder associated with abnormal bone metabolism.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7615229</PublicId>
      <PreferredName>2233604v1.0:7615227v1.0</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm._Connective tissue that forms the skeletal components of the body._The sum of all chemical changes that take place in a cell through which energy and basic components are provided for essential processes, including the synthesis of new molecules and the breakdown and removal of others._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._An indication as to whether the criteria applied to a subject or case established that the subject should be included in or excluded from a study, trial or arm.</PreferredDefinition>
      <LongName>Patient Abnormal Bone Metabolic Process Disease or Disorder Study Eligiblity Criterion Type Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7615227</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>7615227v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Abnormal Bone Metabolic Process Disease or Disorder Study Eligiblity Criterion Type Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25401</PREFERRED_NAME>
            <LONG_NAME>Abnormal</LONG_NAME>
            <CON_ID>2202623</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12366</PREFERRED_NAME>
            <LONG_NAME>Bone</LONG_NAME>
            <CON_ID>2202686</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19536</PREFERRED_NAME>
            <LONG_NAME>Metabolic Process</LONG_NAME>
            <CON_ID>3190585</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C173950</PREFERRED_NAME>
            <LONG_NAME>Study Eligiblity Criterion Type Indicator</LONG_NAME>
            <CON_ID>7615057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Does patient have a disorder</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Does patient have a disorder associated with abnormal bone metabolism?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1455">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7625615</PUBLICID>
    <LONGNAME>CDISC Domain Clinical Report Specify Text</LONGNAME>
    <PREFERREDNAME>QVAL_RPTTYP_OTHS</PREFERREDNAME>
    <PREFERREDDEFINITION>Description of the type of clincal report.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7351241</PublicId>
      <PreferredName>6409461v1.0:7385432v1.0</PreferredName>
      <PreferredDefinition>A collection of data variables or metadata for use with a Clinical Data Interchange Standards Consortium (CDISC) data submission. Representative examples include Laboratory (LB), Subject Characteristics (SC), and Trial Summary (TS)._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._A short textual account; having provided a short account.</PreferredDefinition>
      <LongName>CDISC Domain Clinical Report</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008555</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MED_RCD_AND_FORMS</PreferredName>
        <Version>1</Version>
        <LongName>Medical Records and Forms</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6409461</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C103182</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C103182</PREFERRED_NAME>
            <LONG_NAME>CDISC Domain</LONG_NAME>
            <CON_ID>6409460</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7385432</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25398:C25375</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Report</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6338238</PublicId>
      <PreferredName>CDISCTXT</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The words of something written.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6396647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C25704</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Describe the type of report:</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Describe the type of report:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Other, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1456">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7637928</PUBLICID>
    <LONGNAME>FIQOL 26 Due to Accidental Bowel Leakage Avoid Traveling by Plane or Train Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>FIQOL_26_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation about their level of agreement that they avoid traveling by plane or train due to accidental bowel leakage, using a 4 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7637854</PublicId>
      <PreferredName>7637362v1.0:7637867v1.0</PreferredName>
      <PreferredDefinition>A 29-question quality of life scale developed to address issues related specifically to fecal incontinence._A question about how often or how strongly an individual agrees that they had certain feelings, thoughts, or experiences due to an accidental bowel leakage._A question about how strongly an individual agrees that they avoid traveling by plane or train._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Fecal Incontinence Quality of Life Scale Due to Accidental Bowel Leakage Avoid Traveling by Plane or Train Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7637362</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C178808</PreferredName>
        <Version>1</Version>
        <LongName>Fecal Incontinence Quality of Life Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C178808</PREFERRED_NAME>
            <LONG_NAME>Fecal Incontinence Quality of Life Scale</LONG_NAME>
            <CON_ID>7634451</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7637867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C178810:C178815:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Due to Accidental Bowel Leakage Avoid Traveling by Plane or Train Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C178810</PREFERRED_NAME>
            <LONG_NAME>Due to Accidental Bowel Leakage Question</LONG_NAME>
            <CON_ID>7634452</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C178815</PREFERRED_NAME>
            <LONG_NAME>Avoid Traveling by Plane or Train Question</LONG_NAME>
            <CON_ID>7634478</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7637914</PublicId>
      <PreferredName>7637914v1.0</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes from Most of the Time to None of the Time.</PreferredDefinition>
      <LongName>Agreement 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat Disagree</VALIDVALUE>
          <VALUEMEANING>Slightly Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in slight disagreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5119338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat Agree</VALIDVALUE>
          <VALUEMEANING>Slightly Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in slight agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5119337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strongly Agree</VALIDVALUE>
          <VALUEMEANING>Strongly agree</VALUEMEANING>
          <MEANINGDESCRIPTION>Intense concurrence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strongly Disagree</VALIDVALUE>
          <VALUEMEANING>Strongly Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely at odds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>I avoid traveling by plane or train</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I avoid traveling by plane or</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I avoid traveling by plane or train.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Fecal Incontinence Quality of Life Scale (FIQOL)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question 26 of 29</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7638005</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Measures</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FIQOL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7637948</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FIQL0126_QSORRES</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_FIQL3l</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1457">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7637940</PUBLICID>
    <LONGNAME>FIQOL 7 Due to Accidental Bowel Leakage Stay Near Restroom as Much as Possible When Away from Home Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>FIQOL_7_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation about their level of agreement that whenever they are away from home, they try to stay near a restroom as much as possible due to accidental bowel leakage, using a 4 point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7637771</PublicId>
      <PreferredName>7637362v1.0:7637897v1.0</PreferredName>
      <PreferredDefinition>A 29-question quality of life scale developed to address issues related specifically to fecal incontinence._A question about how often or how strongly an individual agrees that they had certain feelings, thoughts, or experiences due to an accidental bowel leakage._A question about how often an individual, whenever away from home, tries to stay near a restroom as much as possible._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Fecal Incontinence Quality of Life Scale Due to Accidental Bowel Leakage Stay Near Restroom as Much as Possible When Away from Home Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7637362</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C178808</PreferredName>
        <Version>1</Version>
        <LongName>Fecal Incontinence Quality of Life Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C178808</PREFERRED_NAME>
            <LONG_NAME>Fecal Incontinence Quality of Life Scale</LONG_NAME>
            <CON_ID>7634451</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7637897</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C178810:C178820:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Due to Accidental Bowel Leakage Stay Near Restroom as Much as Possible When Away from Home Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C178810</PREFERRED_NAME>
            <LONG_NAME>Due to Accidental Bowel Leakage Question</LONG_NAME>
            <CON_ID>7634452</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C178820</PREFERRED_NAME>
            <LONG_NAME>Stay Near Restroom as Much as Possible When Away from Home Question</LONG_NAME>
            <CON_ID>7634460</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5576825</PublicId>
      <PreferredName>FIQOL_4_PT_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes from Most of the Time to None of the Time</PreferredDefinition>
      <LongName>FIQOL 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None of the Time </VALIDVALUE>
          <VALUEMEANING>None of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened none of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A Little of the Time </VALIDVALUE>
          <VALUEMEANING>A Little of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened a little of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some of the Time </VALIDVALUE>
          <VALUEMEANING>Some of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened some of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3875588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Most of the Time </VALIDVALUE>
          <VALUEMEANING>Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Whenever I am away from home, I try to stay near a restroom as much as possible</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Whenever I am away from home,</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Whenever I am away from home, I try to stay near a restroom as much as possible.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Fecal Incontinence Quality of Life Scale (FIQOL)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question 7 of 29</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7638005</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Measures</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FIQOL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7637948</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FIQL0107_QSORRES</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_FIQL2f</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1458">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7717181</PUBLICID>
    <LONGNAME>Definitive Diagnosis Basis Type</LONGNAME>
    <PREFERREDNAME>dx_basis</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to descript the basis of definitive diagnosis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCG:Center for Cancer Genomics</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7717166</PublicId>
      <PreferredName>7717164v1.0:6033042v1.0</PreferredName>
      <PreferredDefinition>Supplying or being a final or conclusive settlement or result._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._The fundamental assumptions underlying an explanation or a relation that provide the foundation for something.</PreferredDefinition>
      <LongName>Definitive Diagnosis Basis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7717164</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62607:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Definitive Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62607</PREFERRED_NAME>
            <LONG_NAME>Definitive</LONG_NAME>
            <CON_ID>2554152</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6033042</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25430</PreferredName>
        <Version>1</Version>
        <LongName>Basis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25430</PREFERRED_NAME>
            <LONG_NAME>Basis</LONG_NAME>
            <CON_ID>2203857</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCG:Center for Cancer Genomics</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7717179</PublicId>
      <PreferredName>Defi_Diag_Type</PreferredName>
      <PreferredDefinition>Supplying or being a final or conclusive settlement or result._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Definitive Diagnosis Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCG:Center for Cancer Genomics</Origin>
      <Representation>
        <PublicId>7717178</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62607:C15220:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Definitive Diagnosis Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62607</PREFERRED_NAME>
            <LONG_NAME>Definitive</LONG_NAME>
            <CON_ID>2554152</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other criteria</VALIDVALUE>
          <VALUEMEANING>Other Criterion</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C25466</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7717180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Based on molecular profile</VALIDVALUE>
          <VALUEMEANING>Molecular Fingerprint of Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>All cell types, depending on their functions, have unique, identifiable &quot;signatures&quot; - special characteristics such as which genes are active and what proteins or other cellular products are manufactured by the cell.  During transformation of a normal cell to a cancer cell, the signature changes, and that change becomes a signal of the presence of cancer.  (Bypass Budget)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5021533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Based on histopathology</VALIDVALUE>
          <VALUEMEANING>Histopathology</VALUEMEANING>
          <MEANINGDESCRIPTION>The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.  -- 2004</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574778</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Based on imaging (radiology)</VALIDVALUE>
          <VALUEMEANING>Radiology</VALUEMEANING>
          <MEANINGDESCRIPTION>The branch of medical science dealing with the medical use of X-rays or other penetrating radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17059</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6035460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Basis of definitive diagnosis?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Basis of definitive diagnosis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6705584</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCG_PTCL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HOPE-CARE</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7715738</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1459">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7717187</PUBLICID>
    <LONGNAME>Surgical Procedure Primary Glioma Performed Indicator</LONGNAME>
    <PREFERREDNAME>prim_surgery_yn</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to signify whether primary surgery for glioma performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCG:Center for Cancer Genomics</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7717186</PublicId>
      <PreferredName>2322305v1.0:7717184v1.0</PreferredName>
      <PreferredDefinition>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._Occurring first in time or sequence; original; of greatest rank or importance or value._A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Surgical Procedure Primary Glioma Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2322305</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7717184</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25251:C3059:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Primary Glioma Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3059</PREFERRED_NAME>
            <LONG_NAME>Glioma</LONG_NAME>
            <CON_ID>2786103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCG:Center for Cancer Genomics</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is this surgery for the prima</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is this surgery for the primary glioma diagnosis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6705584</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCG_PTCL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HOPE-CARE</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7715738</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1460">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7717466</PUBLICID>
    <LONGNAME>Primary Beyond Surgical Intervention or Procedure Therapy Specified Type</LONGNAME>
    <PREFERREDNAME>prim_intervention</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to describe the type of primary intervention which is beyond surgery.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCG:Center for Cancer Genomics</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7717464</PublicId>
      <PreferredName>7717461v1.0:7717462v1.0</PreferredName>
      <PreferredDefinition>Occurring first in time or sequence; original; of greatest rank or importance or value._Past a place or outside an area._A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery._An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.</PreferredDefinition>
      <LongName>Primary Beyond Surgical Intervention or Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7717461</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25251</PreferredName>
        <Version>1</Version>
        <LongName>Primary</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25251</PREFERRED_NAME>
            <LONG_NAME>Primary</LONG_NAME>
            <CON_ID>2203705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7717462</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C151408:C15329:C25218</PreferredName>
        <Version>1</Version>
        <LongName>Beyond Surgical Procedure Intervention or Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C151408</PREFERRED_NAME>
            <LONG_NAME>Beyond</LONG_NAME>
            <CON_ID>6789994</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCG:Center for Cancer Genomics</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015449</PublicId>
      <PreferredName>TX_SPEC_TP</PreferredName>
      <PreferredDefinition>the type of therapy administered to a patient.</PreferredDefinition>
      <LongName>Therapy Specified Type</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength>5</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemotherapy</VALIDVALUE>
          <VALUEMEANING>Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term is used to describe any therapy involving the use of chemical-based agents, it is particularly used to refer to the use of chemical-based agents to treat cancer. Antineoplastic chemotherapy works by arresting or killing the growth and spread of cancer cells. Chemotherapy may also include agents that enhance immune function or alter hormonal activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558484</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hormonal therapy</VALIDVALUE>
          <VALUEMEANING>Hormonal Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Immunotherapy</VALIDVALUE>
          <VALUEMEANING>Immunotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>(IM-yoo-no-THER-a-pee) Treatment to stimulate or restore the ability of the immune system to fight infections and other diseases. Also used to lessen side effects that may be caused by some cancer treatments.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558928</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiation therapy</VALIDVALUE>
          <VALUEMEANING>Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>use PHOTOTHERAPY, LASER THERAPY, or ULTRAVIOLET THERAPY for therapeutic radiation with visible, laser, or ultraviolet light, respectively.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surgery</VALIDVALUE>
          <VALUEMEANING>Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antibiotic</VALIDVALUE>
          <VALUEMEANING>Antibiotic</VALUEMEANING>
          <MEANINGDESCRIPTION>(an-tih-by-AH-tik) A drug used to treat infections caused by bacteria and other microorganisms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C258</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bone Marrow Transplantation</VALIDVALUE>
          <VALUEMEANING>Bone Marrow Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>(trans-plan-TAY-shun) A procedure to replace bone marrow destroyed by treatment with high doses of anticancer drugs or radiation. Transplantation may be autologous (an individual&#39;s own marrow saved before treatment), allogeneic (marrow donated by someone else), or syngeneic (marrow donated by an identical twin).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antiretroviral</VALIDVALUE>
          <VALUEMEANING>Antiretroviral Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment of retroviral infections with medications that target the virus directly, limiting the ability of infected cells to produce new virus particles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94631</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antifungal</VALIDVALUE>
          <VALUEMEANING>Antifungal Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>Drugs that treat infections caused by fungi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-04-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blood and Blood Products</VALIDVALUE>
          <VALUEMEANING>Blood and Blood Products</VALUEMEANING>
          <MEANINGDESCRIPTION>Whole blood or any of the components into which it can be separated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19448</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2869443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antiemetic</VALIDVALUE>
          <VALUEMEANING>Antiemetic Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>Drugs that prevent or reduce nausea and vomiting.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2869448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Antidiarrheal</VALIDVALUE>
          <VALUEMEANING>Antidiarrheal Agent</VALUEMEANING>
          <MEANINGDESCRIPTION>Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition. (MeSH)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C266</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2869456</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stem Cell Transplant</VALIDVALUE>
          <VALUEMEANING>Stem Cell Transplantation</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of replacing the immature blood-forming cells lost due to high-dose chemotherapy, and possibly radiation therapy, used to destroy leukemia cells.  The stem cells are given to the patient after treatment to help the bone marrow recover and continue producing healthy blood cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15431</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Endocrine therapy</VALIDVALUE>
          <VALUEMEANING>Endocrine Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy. The concept covers but not limited to: intermittent or permanent hormone suppression or ablation in treatment of hormone-dependent tumors, hormone replacement therapy of any kind, hormonal component of gender reassignment therapy, hormonal contraception, surgical and radiation castration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A type of chemotherapy</VALIDVALUE>
          <VALUEMEANING>Type Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Something distinguishable as an identifiable class based on common qualities.: The use of synthetic or naturally-occurring chemicals for the treatment of diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15632, C25284</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5778745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Vitamin</VALIDVALUE>
          <VALUEMEANING>Vitamin</VALUEMEANING>
          <MEANINGDESCRIPTION>A nutrient that the body needs in small amounts to function and stay healthy. Sources of vitamins are plant and animal food products and dietary supplements. Some vitamins are made in the human body from food products. Vitamins are either fat-soluble (can dissolve in fats and oils) or water-soluble (can dissolve in water). Excess fat-soluble vitamins are stored in the body&#39;s fatty tissue, but excess water-soluble vitamins are removed in the urine. Examples are vitamin A, vitamin C, and vitamin E.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5778746</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiopharmaceutical Therapy</VALIDVALUE>
          <VALUEMEANING>Radiopharmaceutical Compound Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>An agent that contains a radioactive isotope and is used for diagnostic or therapeutic purposes._Medical care intended to treat or cure a condition or lessen its symptoms. This includes the administration of drugs, surgical procedures, physical or psychotherapy, or the use of therapeutic devices.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C1446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5920653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Targeted Therapy </VALIDVALUE>
          <VALUEMEANING>Targeted Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of treatment that uses drugs or other substances, such as monoclonal antibodies, to identify and attack specific cancer cells. Targeted therapy may have fewer side effects than other types of cancer treatments.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C93352</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3623150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systemic therapy</VALIDVALUE>
          <VALUEMEANING>Systemic Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5028391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemotherapy/Radiation</VALIDVALUE>
          <VALUEMEANING>Chemoradiotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment that combines chemotherapy with radiation therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-10-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6349567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytokine Therapy</VALIDVALUE>
          <VALUEMEANING>Cytokine Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of cytokines in the treatment of any disease or disorder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6943864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cell Therapy</VALIDVALUE>
          <VALUEMEANING>Cellular Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70601</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-09-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4666954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-12-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4001711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Refused Treatment</VALIDVALUE>
          <VALUEMEANING>Declined therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>To decline to do, accept, give, or allow something.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C49161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4163032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clinical Trial</VALIDVALUE>
          <VALUEMEANING>Clinical Trial</VALUEMEANING>
          <MEANINGDESCRIPTION>A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71104</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5215037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Palliation</VALIDVALUE>
          <VALUEMEANING>Palliative</VALUEMEANING>
          <MEANINGDESCRIPTION>Palliative care is the patient-and family-centered active holistic care of patients with advanced, progressive disease. Traditional models reflect abandonment of proactive treatment and a simultaneous increase in symptom control and comfort-related services, as a disease progressed in linear fashion through its course. Essential components of palliative care are: pain and symptom control, communication regarding treatment and alternatives, prognosis, and available services, rehabilitation services, care that addresses treatment and palliative concerns, intellectual, emotional, social, and spiritual needs, terminal care, support in bereavement. The goal of palliative care is an achievement of the best quality of life for patients and their families.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-07-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2971623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systemic viral therapy</VALIDVALUE>
          <VALUEMEANING>Viral Systemic Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with a virus.: Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15698, C27985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8083026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adjuvant</VALIDVALUE>
          <VALUEMEANING>Adjuvant</VALUEMEANING>
          <MEANINGDESCRIPTION>An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neoadjuvant</VALIDVALUE>
          <VALUEMEANING>Neoadjuvant</VALUEMEANING>
          <MEANINGDESCRIPTION>Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10245711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Primary Intervention beyond s</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Primary Intervention beyond surgery:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6705584</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCG_PTCL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HOPE-CARE</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7715738</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1461">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7799611</PUBLICID>
    <LONGNAME>Vaccination Status</LONGNAME>
    <PREFERREDNAME>CMVXSTAT</PREFERREDNAME>
    <PREFERREDDEFINITION>The response indicating the status of an individual&#39;s vaccinations.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7799220</PublicId>
      <PreferredName>4550855v1.0:7799218v1.0</PreferredName>
      <PreferredDefinition>A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration._Administration of vaccines to stimulate the host&#39;s immune response. This includes any preparation intended for active immunological prophylaxis or treatment.</PreferredDefinition>
      <LongName>Concomitant Medication Domain Vaccination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2831222</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15347</PreferredName>
        <Version>1</Version>
        <LongName>Vaccine Therapy</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>4550855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49568</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Medication Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49568</PREFERRED_NAME>
            <LONG_NAME>Concomitant Medication Domain</LONG_NAME>
            <CON_ID>2469052</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7799218</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15346</PreferredName>
        <Version>1</Version>
        <LongName>Vaccination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15346</PREFERRED_NAME>
            <LONG_NAME>Vaccination</LONG_NAME>
            <CON_ID>2203972</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7799607</PublicId>
      <PreferredName>VXSTAT</PreferredName>
      <PreferredDefinition>Administration of vaccines to stimulate the host&#39;s immune response. This includes any preparation intended for active immunological prophylaxis or treatment._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Vaccination Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2831222</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15347</PreferredName>
        <Version>1</Version>
        <LongName>Vaccine Therapy</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>7799606</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15346:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Vaccination Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15346</PREFERRED_NAME>
            <LONG_NAME>Vaccination</LONG_NAME>
            <CON_ID>2203972</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UNKNOWN</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NOT VACCINATED</VALIDVALUE>
          <VALUEMEANING>Not Vaccinated</VALUEMEANING>
          <MEANINGDESCRIPTION>A status indicating that an individual has not received any of the required vaccinations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C183125</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7799608</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PARTIALLY VACCINATED</VALIDVALUE>
          <VALUEMEANING>Partially Vaccinated</VALUEMEANING>
          <MEANINGDESCRIPTION>A status indicating that an individual has received some of the required vaccinations.

</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C183124</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7799609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FULLY VACCINATED</VALIDVALUE>
          <VALUEMEANING>Fully Vaccinated</VALUEMEANING>
          <MEANINGDESCRIPTION>A status indicating that an individual has received all the required vaccinations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C183123</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7799610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the patient&#39;s vaccine</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the patient&#39;s vaccine status?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Theradex - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>At the time of the patient&#39;s first positive SARS-CoV-2 test, what was the patient&#39;s vaccine status?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1462">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>7802691</PUBLICID>
    <LONGNAME>HEAR-QL-26 7 Hard to Hear in Classroom Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>HEARQL26_7_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated response of whether it is hard to hear in their classroom, using a 5-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HEAR-QL:Hearing Environments And Reflection on Quality of Life Measurement for Children aged from Preschool through Adolescense;A. Umansky et al., J Am Acad Audiology</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7802690</PublicId>
      <PreferredName>7802646v1.0:7805085v1.0</PreferredName>
      <PreferredDefinition>A questionnaire designed to assess how a child is affected by their hearing loss, and to aid a clinician in determining where intervention is warranted to improve the child&#39;s overall wellbeing._A question about whether an individual has or had a hard time hearing in their classroom._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Hearing Environments and Reflection on Quality of Life for Children Hard to Hear in Classroom Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>7802646</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C183180</PreferredName>
        <Version>1</Version>
        <LongName>Hearing Environments and Reflection on Quality of Life for Children</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C183180</PREFERRED_NAME>
            <LONG_NAME>Hearing Environments and Reflection on Quality of Life for Children</LONG_NAME>
            <CON_ID>7801478</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7805085</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C183223:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Hard to Hear in Classroom Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C183223</PREFERRED_NAME>
            <LONG_NAME>Hard to Hear in Classroom Question</LONG_NAME>
            <CON_ID>7801780</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HEAR-QL:Hearing Environments And Reflection on Quality of Life Measurement for Children aged from Preschool through Adolescense;A. Umansky et al., J Am Acad Audiology</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7801521</PublicId>
      <PreferredName>HEAR_SCL</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes from 0 (Almost Always) to 4 (Never) on a 5-point Likert scale.</PreferredDefinition>
      <LongName>Hearing Environments And Reflection on Quality of Life 5 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>HEAR-QL:Hearing Environments And Reflection on Quality of Life Measurement for Children aged from Preschool through Adolescense;A. Umansky et al., J Am Acad Audiology</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Almost All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened almost all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5273232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Almost Never</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something rarely happens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232436</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2889147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Often</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer that something occurs frequently.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120595</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5628246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Hearing Environments and Reflection on Quality of Life for Children</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question #7 of 26</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is it hard to hear in your cl</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is it hard to hear in your classroom?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HEAR-QL-26</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14900312</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7801527</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HEAR-QL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HEAR-QL-26</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7801529</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1463">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>8012050</PUBLICID>
    <LONGNAME>Specimen Submission Correlative Study Clinical Trial Eligibility Criteria Yes No Indicator</LONGNAME>
    <PREFERREDNAME>IE_IEORRES_SPECSUB</PREFERREDNAME>
    <PREFERREDDEFINITION>The response that indicates the patient meets the eligibility requirements for participation in a clinical trial with regards to correlative study specimen submissions.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>6077821</PublicId>
      <PreferredName>2241613v1.0:6077819v1.0</PreferredName>
      <PreferredDefinition>A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._The act of referring for judgment or consideration by others; the act of handing over something._A type of study that tests for a relationship between a condition and a potential causal factor of the condition._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.</PreferredDefinition>
      <LongName>Specimen Submission Correlative Study Clinical Trial Eligibility Criteria</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2241613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6077819</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25695:C16100:C16112</PreferredName>
        <Version>1</Version>
        <LongName>Submission Correlative Study Clinical Trial Eligibility Criteria</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25695</PREFERRED_NAME>
            <LONG_NAME>Submission</LONG_NAME>
            <CON_ID>2203811</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16100</PREFERRED_NAME>
            <LONG_NAME>Correlative Study</LONG_NAME>
            <CON_ID>2206187</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16112</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Eligibility Criteria</LONG_NAME>
            <CON_ID>2202439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Patient has agreed to have sp</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Patient has agreed to have specimens submitted for translational medicine (MRD) and has been offered the opportunity to submit biosamples for banking per myeloMATCH Master Screening and Reassessment Protocol (MSRP).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Participant has agreed to have specimens submitted for translational medicine (MRD) and has been offered to opportunity to submit biosamples for banking per MYELOMATCH Master Screening and Reassessment Protocol (MSRP).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1464">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>8058286</PUBLICID>
    <LONGNAME>Microscope Device Immersion Medium Type</LONGNAME>
    <PREFERREDNAME>7788933v1.0:7794849v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text specifying the kind of fluid used to fill the space between a microscope&#39;s objective lens and the coverslip.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>HTAN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HTAN:Human Tumor Atlas Network</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>7788933</PublicId>
      <PreferredName>5981624v1.0:7788931v1.0</PreferredName>
      <PreferredDefinition>An optical instrument that uses a combination of lenses to produce magnified images of very small objects_A fluid used to fill the space between a microscopes objective lens and the coverslip. It is used to increase the effective numerical aperture of the lens.</PreferredDefinition>
      <LongName>Microscope Device Immersion Medium</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>HTAN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5981624</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50069</PreferredName>
        <Version>1</Version>
        <LongName>Microscope Device Component</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50069</PREFERRED_NAME>
            <LONG_NAME>Microscope Device</LONG_NAME>
            <CON_ID>5981623</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>7788931</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C182013</PreferredName>
        <Version>1</Version>
        <LongName>Immersion Medium</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C182013</PREFERRED_NAME>
            <LONG_NAME>Immersion Medium</LONG_NAME>
            <CON_ID>7788583</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HTAN:Human Tumor Atlas Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7794849</PublicId>
      <PreferredName>7794849v1.0</PreferredName>
      <PreferredDefinition>A fluid used to fill the space between a microscopes objective lens and the coverslip. It is used to increase the effective numerical aperture of the lens._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Immersion Medium Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>HTAN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>HTAN:Human Tumor Atlas Network</Origin>
      <Representation>
        <PublicId>7794848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C182013:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Immersion Medium Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C182013</PREFERRED_NAME>
            <LONG_NAME>Immersion Medium</LONG_NAME>
            <CON_ID>7788583</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multi</VALIDVALUE>
          <VALUEMEANING>Multiple</VALUEMEANING>
          <MEANINGDESCRIPTION>Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Glycerol</VALIDVALUE>
          <VALUEMEANING>Glycerin</VALUEMEANING>
          <MEANINGDESCRIPTION>A trihydroxyalcohol with localized osmotic diuretic and laxative effects. Glycerin elevates the blood plasma osmolality thereby extracting water from tissues into interstitial fluid and plasma. This agent also prevents water reabsorption in the proximal tubule in the kidney leading to an increase in water and sodium excretion and a reduction in blood volume. Administered rectally, glycerin exerts a hyperosmotic laxative effect by attracting water into the rectum, thereby relieving constipation. In addition, glycerin is used as a solvent, humectant and vehicle in various pharmaceutical preparations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29077</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3192058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Air</VALIDVALUE>
          <VALUEMEANING>Air</VALUEMEANING>
          <MEANINGDESCRIPTION>A mixture of gases making up the earth&#39;s atmosphere, consisting mainly of nitrogen, oxygen, argon, and carbon dioxide.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7794850</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Water</VALIDVALUE>
          <VALUEMEANING>Water</VALUEMEANING>
          <MEANINGDESCRIPTION>H2O, a clear, colorless, odorless, tasteless liquid that freezes into ice below 0 degrees centigrade and boils above 100 degrees centigrade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C65147</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2754192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Oil</VALIDVALUE>
          <VALUEMEANING>Oil</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of numerous unctuous combustible substances that are liquid or can be liquefied easily on warming, are soluble in ether but not in water, and leave a greasy stain on paper or cloth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2021-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2620900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Immersion Medium</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Immersion Medium</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7788578</PublicId>
          <ContextName>HTAN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging Data Tier 2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7788582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>8064110</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GC (General Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14470388</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>immersion</AlternateName>
        <AlternateNameType>GC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1465">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10118311</PUBLICID>
    <LONGNAME>Inoculation Administered Date</LONGNAME>
    <PREFERREDNAME>INO_ADMN_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>The date inoculation was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>10118310</PublicId>
      <PreferredName>5097033v1.00:2177665v1.00</PreferredName>
      <PreferredDefinition>To implant microbes or infective materials, introduce immune serum, vaccines of various kinds, and other antigenic materials for preventive, curative, or experimental purposes.:The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Inoculation Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435024</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1908</PreferredName>
        <Version>1</Version>
        <LongName>Drug or Chemical</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5097033</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C68774</PreferredName>
        <Version>1</Version>
        <LongName>Inoculation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68774</PREFERRED_NAME>
            <LONG_NAME>Inoculation</LONG_NAME>
            <CON_ID>2673211</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177665</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Administered</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Inoculation</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of Inoculation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1466">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10404422</PUBLICID>
    <LONGNAME>Hematopoietic Cell Transplantation Disease or Disorder Indication Acute Lymphoblastic Leukemia Reason</LONGNAME>
    <PREFERREDNAME>HCT_IND_ALL_REA</PREFERREDNAME>
    <PREFERREDDEFINITION>The specific indication for the hematopoietic cell transplantation for acute lymphoblastic leukemia.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>10404358</PublicId>
      <PreferredName>2659877v1.00:10404357v1.00</PreferredName>
      <PreferredDefinition>A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).</PreferredDefinition>
      <LongName>Hematopoietic Cell Transplantation Disease or Disorder Indication</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2659877</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15431</PreferredName>
        <Version>1</Version>
        <LongName>Stem Cell Transplantation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15431</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Cell Transplantation</LONG_NAME>
            <CON_ID>2512694</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>10404357</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C41184</PreferredName>
        <Version>1</Version>
        <LongName>Disease or Disorder Indication</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41184</PREFERRED_NAME>
            <LONG_NAME>Indication</LONG_NAME>
            <CON_ID>2203766</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>10404371</PublicId>
      <PreferredName>10404371v1.00</PreferredName>
      <PreferredDefinition>Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia._A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication)._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Acute Lymphoblastic Leukemia Hematopoietic Cell Transplantation Indication Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>10404370</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>10404370v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Acute Lymphoblastic Leukemia Hematopoietic Cell Transplantation Indication Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3167</PREFERRED_NAME>
            <LONG_NAME>Acute Lymphoblastic Leukemia</LONG_NAME>
            <CON_ID>2202314</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15431</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Cell Transplantation</LONG_NAME>
            <CON_ID>2512694</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41184</PREFERRED_NAME>
            <LONG_NAME>Indication</LONG_NAME>
            <CON_ID>2203766</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR1 induction failure</VALIDVALUE>
          <VALUEMEANING>CR1 induction failure</VALUEMEANING>
          <MEANINGDESCRIPTION>CR1 induction failure</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR1 with persistent or recurrent cytogenetic or molecular evidence of disease during therapy requiring additional therapy after induction to achieve remission</VALIDVALUE>
          <VALUEMEANING>CR1 with persistent or recurrent cytogenetic or molecular evidence of disease during therapy requiring additional therapy after induction to achieve remission</VALUEMEANING>
          <MEANINGDESCRIPTION>CR1 with persistent or recurrent cytogenetic or molecular evidence of disease during therapy requiring additional therapy after induction to achieve remission</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Treated with CART cells for whom transplant is indicated transplant for consolidation</VALIDVALUE>
          <VALUEMEANING>Treated with CART cells for whom transplant is indicated transplant for consolidation</VALUEMEANING>
          <MEANINGDESCRIPTION>Treated with CART cells for whom transplant is indicated transplant for consolidation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR1 treatment failure as per MRD by flow cytometry &gt;0.01% after consolidation</VALIDVALUE>
          <VALUEMEANING>CR1 treatment failure as per MRD by flow cytometry &gt;0.01% after consolidation</VALUEMEANING>
          <MEANINGDESCRIPTION>CR1 treatment failure as per MRD by flow cytometry &gt;0.01% after consolidation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404410</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Loss of CART persistence and/or B cell aplasia &lt; 6 months from infusion</VALIDVALUE>
          <VALUEMEANING>Loss of CART persistence and/or B cell aplasia &lt; 6 months from infusion</VALUEMEANING>
          <MEANINGDESCRIPTION>Loss of CART persistence and/or B cell aplasia &lt; 6 months from infusion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR1 T cell ALL with persistent MRD &gt; 0.01% after consolidation</VALIDVALUE>
          <VALUEMEANING>CR1 T cell ALL with persistent MRD &gt; 0.01% after consolidation</VALUEMEANING>
          <MEANINGDESCRIPTION>CR1 T cell ALL with persistent MRD &gt; 0.01% after consolidation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404412</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR3 or greater</VALIDVALUE>
          <VALUEMEANING>CR3 or greater</VALUEMEANING>
          <MEANINGDESCRIPTION>CR3 or greater</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Treated with CART and now has other evidence (e.g., MRD+) that transplant is indicated to prevent relapse</VALIDVALUE>
          <VALUEMEANING>Treated with CART and now has other evidence (e.g., MRD+) that transplant is indicated to prevent relapse</VALUEMEANING>
          <MEANINGDESCRIPTION>Treated with CART and now has other evidence (e.g., MRD+) that transplant is indicated to prevent relapse</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10466844</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR2 T-cell or Ph+ BM relapse at any time</VALIDVALUE>
          <VALUEMEANING>CR2 T-cell or Ph+ BM relapse at any time</VALUEMEANING>
          <MEANINGDESCRIPTION>CR2 T-cell or Ph+ BM relapse at any time</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404415</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR2 T or B cell end-Block 1 MRD ≥ 0.1%</VALIDVALUE>
          <VALUEMEANING>CR2 T or B cell end-Block 1 MRD ≥ 0.1%</VALUEMEANING>
          <MEANINGDESCRIPTION>CR2 T or B cell end-Block 1 MRD ≥ 0.1%</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR2 T or B-cell early (&lt;18 months) IEM (isolated early extramedullary relapse)</VALIDVALUE>
          <VALUEMEANING>CR2 T or B-cell early (&lt;18 months) IEM (isolated early extramedullary relapse)</VALUEMEANING>
          <MEANINGDESCRIPTION>CR2 T or B-cell early (&lt;18 months) IEM (isolated early extramedullary relapse)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404417</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR2 B cell late BM relapse (≥ 36 months) with MRD &gt; 0.1% by flow cytometry after first re-induction therapy</VALIDVALUE>
          <VALUEMEANING>CR2 B cell late BM relapse (≥ 36 months) with MRD &gt; 0.1% by flow cytometry after first re-induction therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>CR2 B cell late BM relapse (≥ 36 months) with MRD &gt; 0.1% by flow cytometry after first re-induction therapy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR2 B cell early (&lt;36 months from initiation of therapy) BM relapse</VALIDVALUE>
          <VALUEMEANING>CR2 B cell early (&lt;36 months from initiation of therapy) BM relapse</VALUEMEANING>
          <MEANINGDESCRIPTION>CR2 B cell early (&lt;36 months from initiation of therapy) BM relapse</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404419</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR 2 T or B cell late (≥ 18 months) IEM</VALIDVALUE>
          <VALUEMEANING>CR 2 T or B cell late (≥ 18 months) IEM</VALUEMEANING>
          <MEANINGDESCRIPTION>CR 2 T or B cell late (≥ 18 months) IEM</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR1 hypodiploidy (&lt;44 chromosomes) with MRD greater than 0.01% after induction</VALIDVALUE>
          <VALUEMEANING>CR1 hypodiploidy (&lt;44 chromosomes) with MRD greater than 0.01% after induction</VALUEMEANING>
          <MEANINGDESCRIPTION>CR1 hypodiploidy (&lt;44 chromosomes) with MRD great than 0.01% after induction</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404423</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the indication for the hematopoietic cell transplantation for acute lymphoblastic leukemia?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the indication for the hematopoietic cell transplantation for acute lymphoblastic leukemia?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Select the specific indication for HCT:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1467">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10543035</PUBLICID>
    <LONGNAME>DSQ Past 30 Days How Often Eat Chocolate or Other Candy Score Frequency</LONGNAME>
    <PREFERREDNAME>DSQ_CHOC_SWT_FRQ</PREFERREDNAME>
    <PREFERREDDEFINITION>A participant&#39;s response about how often they ate chocolate or any other types of candy during the past month.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Alliance</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>10540266</PublicId>
      <PreferredName>10540215v1.00:10540265v1.00</PreferredName>
      <PreferredDefinition>_A 26-item questionnaire, developed by the Risk Factor Assessment Branch of the National Cancer Institute&#39;s Epidemiology and Genomics Research Program, that assesses the frequency of consumption in the past month of fruits and vegetables, added sugar, dairy, whole grains, calcium, fiber, red meat, and processed meat:A period of time consisting of the 30 days before the present._A question about how often an individual eats or ate chocolate or other candy._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Dietary Screener Questionnaire Past 30 Days How Often Eat Chocolate or Other Candy Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>10540215</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C188186</PreferredName>
        <Version>1</Version>
        <LongName>Dietary Screener Questionnaire</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C188186</PREFERRED_NAME>
            <LONG_NAME>Dietary Screener Questionnaire</LONG_NAME>
            <CON_ID>10538158</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>10540265</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C131330:C188106:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past 30 Days How Often Eat Chocolate or Other Candy Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C131330</PREFERRED_NAME>
            <LONG_NAME>Past 30 days</LONG_NAME>
            <CON_ID>5615928</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C188106</PREFERRED_NAME>
            <LONG_NAME>How Often Eat Chocolate or Other Candy Question</LONG_NAME>
            <CON_ID>10471898</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>10542248</PublicId>
      <PreferredName>10542248v1.00</PreferredName>
      <PreferredDefinition>The number of occurrences of something within a given time period (month, week day)</PreferredDefinition>
      <LongName>Temporal Frequency</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Alliance</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2443080</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25515</PreferredName>
        <Version>1</Version>
        <LongName>Temporal Frequency</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 time last month</VALIDVALUE>
          <VALUEMEANING>1 time last month</VALUEMEANING>
          <MEANINGDESCRIPTION>1 time last month</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7639571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2­-3 times last month</VALIDVALUE>
          <VALUEMEANING>2­-3 times last month</VALUEMEANING>
          <MEANINGDESCRIPTION>2­-3 times last month</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10542499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 time per week</VALIDVALUE>
          <VALUEMEANING>1 time per week</VALUEMEANING>
          <MEANINGDESCRIPTION>1 time per week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10542500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2 times per week</VALIDVALUE>
          <VALUEMEANING>2 times per week</VALUEMEANING>
          <MEANINGDESCRIPTION>2 times per week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7639569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5­-6 times per week</VALIDVALUE>
          <VALUEMEANING>5-­6 times per week</VALUEMEANING>
          <MEANINGDESCRIPTION>5-­6 times per week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10542502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 time per day</VALIDVALUE>
          <VALUEMEANING>Once a day</VALUEMEANING>
          <MEANINGDESCRIPTION>Scheduled or occurring at a frequency of once per day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125004</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5543631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2-­3 times per day</VALIDVALUE>
          <VALUEMEANING>2-­3 times per day</VALUEMEANING>
          <MEANINGDESCRIPTION>2-­3 times per day</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10542503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4-­5 times per day</VALIDVALUE>
          <VALUEMEANING>4­-5 times per day</VALUEMEANING>
          <MEANINGDESCRIPTION>4­-5 times per day</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10542504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6 or more times per day</VALIDVALUE>
          <VALUEMEANING>6 or more times per day</VALUEMEANING>
          <MEANINGDESCRIPTION>6 or more times per day</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7639566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3­-4 times per week</VALIDVALUE>
          <VALUEMEANING>3­-4 times per week</VALUEMEANING>
          <MEANINGDESCRIPTION>3­-4 times per week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10542501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2 or more times per day</VALIDVALUE>
          <VALUEMEANING>2 or more times per day</VALUEMEANING>
          <MEANINGDESCRIPTION>2 or more times per day</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10544800</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>During the past month, how oft</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>During the past month, how often did you eat chocolate or any other types of candy? Do
not include sugar-­free candy.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1468">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10803661</PUBLICID>
    <LONGNAME>Dose Limiting Toxicity Indicator</LONGNAME>
    <PREFERREDNAME>DOSE_LIMT_TOX_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether adverse event was a dose-limiting toxicity.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2012911</PublicId>
      <PreferredName>DOSE_LIMT_TOX</PreferredName>
      <PreferredDefinition>Toxicity type that makes it impossible to escalate the dosage of a therapy agent/measure.</PreferredDefinition>
      <LongName>Dose Limiting Toxicity</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008573</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206422</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488:CL110648</PreferredName>
        <Version>1</Version>
        <LongName>Dose Limited</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL110648</PREFERRED_NAME>
            <LONG_NAME>Limited</LONG_NAME>
            <CON_ID>2203515</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177313</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Toxicity</PreferredName>
        <Version>1</Version>
        <LongName>Toxicity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C27990</PREFERRED_NAME>
            <LONG_NAME>Toxicity</LONG_NAME>
            <CON_ID>2202546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6343337</PublicId>
      <PreferredName>NY</PreferredName>
      <PreferredDefinition>Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6343336</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66742:C25180</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66742</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</LONG_NAME>
            <CON_ID>4852475</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5676138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was this a Dose-Limiting Toxicity?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DOSE_LIMT_TOX_IND</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1469">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>10907134</PUBLICID>
    <LONGNAME>EORTC QLQ-CR29 Version 2.1 47 Past Week Been Dissatisfied With Your Body Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>EORTC_QLQCR29_47_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Person&#39;s stated response during the past week of being dissatisfied with their body, using a 4-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>10882757</PublicId>
      <PreferredName>10882720v1.00:10882756v1.00</PreferredName>
      <PreferredDefinition>_A question associated with the EORTC QLQ-CR29 Version 2.1 questionnaire:The most recent week. May include the present day._European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Module Version 2.1 (EORTC QLQ-CR29 Version 2.1) During the past week: Have you been dissatisfied with your body?_A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>EORTC QLQ-CR29 Version 2.1 Questionnaire Question Past Week EORTC QLQ-CR29 Version 2.1 - Been Dissatisfied With Your Body Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>10882720</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C170531</PreferredName>
        <Version>1</Version>
        <LongName>EORTC QLQ-CR29 Version 2.1 Questionnaire Question</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C170531</PREFERRED_NAME>
            <LONG_NAME>EORTC QLQ-CR29 Version 2.1 Questionnaire Question</LONG_NAME>
            <CON_ID>10043266</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>10882756</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C170673:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week EORTC QLQ-CR29 Version 2.1 - Been Dissatisfied With Your Body Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C170673</PREFERRED_NAME>
            <LONG_NAME>EORTC QLQ-CR29 Version 2.1 - Been Dissatisfied With Your Body</LONG_NAME>
            <CON_ID>10041316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4728552</PublicId>
      <PreferredName>EORTC_4PT_SCL</PreferredName>
      <PreferredDefinition>Numeric scores from 1 (Not at All) to 4 (Very Much) on a Likert scale used on EORTC questionnaires.</PreferredDefinition>
      <LongName>EORTC Score 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue>4</MaximumValue>
      <MinimumValue>1</MinimumValue>
      <Origin>EORTC QLQ-C30:European Organization for Research and Treatment of Cancer Quality of Life Group, Questionnaire C30, Version 3. 1995</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A Little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4733151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement or ability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very Much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a great amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you been dissatisfied with your body?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Rectal Cancer Female Sexuality Score</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question 17 of 35</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>2</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions. Questions used in this manner do not represent the original measure and should not be referenced by the measure’s name.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>3</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EORTC QLQ-CR29</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15869800</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_QSORRES_QLQCR29_47</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1470">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>11060768</PUBLICID>
    <LONGNAME>Leukapheresis Delay Indicator</LONGNAME>
    <PREFERREDNAME>DELAY_LEUKAP_FAORRES</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether leukapheresis was delayed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>11055669</PublicId>
      <PreferredName>11055666v1.00:2718948v1.00</PreferredName>
      <PreferredDefinition>_A procedure that collects white blood cells from the peripheral blood while returning the rest to the donor:Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.</PreferredDefinition>
      <LongName>Leukapheresis Delay</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>AMC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>11055666</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15269</PreferredName>
        <Version>1</Version>
        <LongName>Leukapheresis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15269</PREFERRED_NAME>
            <LONG_NAME>Leukapheresis</LONG_NAME>
            <CON_ID>2482154</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2718948</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25476</PreferredName>
        <Version>1</Version>
        <LongName>Delay</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25476</PREFERRED_NAME>
            <LONG_NAME>Delay</LONG_NAME>
            <CON_ID>2203898</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6343337</PublicId>
      <PreferredName>NY</PreferredName>
      <PreferredDefinition>Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6343336</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66742:C25180</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66742</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</LONG_NAME>
            <CON_ID>4852475</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5676138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was leukapheresis delayed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1471">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>11262143</PUBLICID>
    <LONGNAME>Colonoscopy Withdrawal Time</LONGNAME>
    <PREFERREDNAME>COLO_WITH_TIME</PREFERREDNAME>
    <PREFERREDDEFINITION>The time indicating when Colonoscopy was withdrawn.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>11262142</PublicId>
      <PreferredName>2716436v1.00:4271451v1.00</PreferredName>
      <PreferredDefinition>Endoscopic examination of the luminal surface of the colon.:A social or emotional detachment, pathological retreat from objective reality, interpersonal contact and social involvement, as in some forms of schizophrenia, depression, or schizoid, avoidant, or schizotypal personality disorders.</PreferredDefinition>
      <LongName>Colonoscopy Withdrawal</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2716436</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16450</PreferredName>
        <Version>1</Version>
        <LongName>Colonoscopy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16450</PREFERRED_NAME>
            <LONG_NAME>Colonoscopy</LONG_NAME>
            <CON_ID>2528526</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>4271451</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41341</PreferredName>
        <Version>1</Version>
        <LongName>Withdrawal</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41341</PREFERRED_NAME>
            <LONG_NAME>Withdrawal</LONG_NAME>
            <CON_ID>2660094</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019249</PublicId>
      <PreferredName>TM</PreferredName>
      <PreferredDefinition>the time at which an event was observed or occurred.</PreferredDefinition>
      <LongName>Time</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>TIME</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>TIME (HR(24):MN)</DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184344</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Time</PreferredName>
        <Version>1</Version>
        <LongName>Time</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25207</PREFERRED_NAME>
            <LONG_NAME>Time</LONG_NAME>
            <CON_ID>2202306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Withdrawal Time</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Withdrawal Time (MM:SS)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Withdrawal Time (HH:MM:SS)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1472">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>11280338</PUBLICID>
    <LONGNAME>Data File Description Text</LONGNAME>
    <PREFERREDNAME>11280314v2.00:6847557v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>A free text field that can be used to document the content and other details about a data file that may not be captured elsewhere.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CRDC:Cancer Research Data Commons</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>11280314</PublicId>
      <PreferredName>11280312v1.00:11280313v1.00</PreferredName>
      <PreferredDefinition>A data file stored as an electronic record.:A free text field that can be used to document details about an electronic file that may not be captured elsewhere.</PreferredDefinition>
      <LongName>Data File Description</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CRDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>11280312</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C189945</PreferredName>
        <Version>1</Version>
        <LongName>Electronic File</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C189945</PREFERRED_NAME>
            <LONG_NAME>Electronic File</LONG_NAME>
            <CON_ID>11280309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>11280317</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C171190</PreferredName>
        <Version>1</Version>
        <LongName>Electronic File Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C171190</PREFERRED_NAME>
            <LONG_NAME>Electronic File Description</LONG_NAME>
            <CON_ID>10043929</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CRDC:Cancer Research Data Commons</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6847557</PublicId>
      <PreferredName>6847557v1.0</PreferredName>
      <PreferredDefinition>The words of something written.</PreferredDefinition>
      <LongName>4000 Character Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>4000</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>File Description</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>8064110</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GC (General Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>12177496</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>8064110</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GC (General Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14470388</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>10466051</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>All CRDC Standard CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14193211</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MATCHBox</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13484613</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTDC Model</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14413707</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Data File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14413714</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594093</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sequencing</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594094</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sequencing File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594223</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Methylation Array File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594224</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Single Cell Sequencing File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13594225</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Measure File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13596237</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Radiology File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>13596238</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14470394</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13574489</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCDI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cytogenomic File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14596129</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14733231</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>14733231v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14733741</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15020003</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PopSci Data Commons</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Data File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15020130</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15020048</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ICDC (Integrated Canine DC)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Data File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15020059</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15103644</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>15103644v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>File</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15105436</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Data File Description</AlternateName>
        <AlternateNameType>CRDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>data_file_description</AlternateName>
        <AlternateNameType>PSDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>data_file</AlternateName>
        <AlternateNameType>CTDC Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>file_description</AlternateName>
        <AlternateNameType>ICDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>File description</AlternateName>
        <AlternateNameType>CCDI-Fed Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>clinical_measure_file</AlternateName>
        <AlternateNameType>CCDI Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cytogenomic_file</AlternateName>
        <AlternateNameType>CCDI Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>methylation_array_file</AlternateName>
        <AlternateNameType>CCDI Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>pathology_file</AlternateName>
        <AlternateNameType>CCDI Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>radiology_file</AlternateName>
        <AlternateNameType>CCDI Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>sequencing_file</AlternateName>
        <AlternateNameType>CCDI Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>file_description</AlternateName>
        <AlternateNameType>GC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>data_file_description</AlternateName>
        <AlternateNameType>CTDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>file_description</AlternateName>
        <AlternateNameType>CCDI Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>file_description</AlternateName>
        <AlternateNameType>MATCH Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>file_description</AlternateName>
        <AlternateNameType>MATCHBox Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1473">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>12253708</PUBLICID>
    <LONGNAME>Clinical Assessment Performed Indicator</LONGNAME>
    <PREFERREDNAME>CHSINIDX_CLNC</PREFERREDNAME>
    <PREFERREDDEFINITION>Response indicating whether clinical assessment was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>AMC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5608407</PublicId>
      <PreferredName>5608408v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The final result of a determination of the value, significance, or extent of._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Clinical Disease or Disorder Assessment Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>ECOG-ACRIN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5608408</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25398:C2991:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Disease or Disorder Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6343337</PublicId>
      <PreferredName>NY</PreferredName>
      <PreferredDefinition>Terminology codelist used with Yes No Unknown or Not Applicable Response within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6343336</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C66742:C25180</PreferredName>
        <Version>1</Version>
        <LongName>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66742</PREFERRED_NAME>
            <LONG_NAME>CDISC SDTM Yes No Unknown or Not Applicable Response Terminology</LONG_NAME>
            <CON_ID>4852475</CON_ID>
            <DEFINITION_SOURCE>CDISC</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5676138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5043360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>U</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Clinical Only</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CHSRCNTDX_CLNC</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1474">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>12285181</PUBLICID>
    <LONGNAME>Estrogen Receptor or Progesterone Receptor Positive per ASCO/CAP Guideline Indicator</LONGNAME>
    <PREFERREDNAME>ER_PGR_POSITIVE_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Response indicating whether tumor is Estrogen Receptor (ER) and/or Progesterone Receptor (PgR) positive per American Society of Clinical Oncology (ASCO) or College of American Pathologists (CAP) guideline.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>12285179</PublicId>
      <PreferredName>12285177v1.00:12285178v1.00</PreferredName>
      <PreferredDefinition>An indication that estrogen receptor alpha expression has been detected in a sample._An indication that progesterone receptor (PRG; PR) expression has been detected in a sample.:The world&#39;s leading professional organization representing physicians of all oncology disciplines and subspecialties. ASCO sets the standard for cancer care, supports funding for clinical and translational research, fosters the exchange of information related to cancer, including cancer biology, diagnosis, staging, treatment and psychosocial impact.  ASCO provides training in clinical research and patient care and publishes the Journal of Clinical Oncology._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A member-based physician that serves patients, pathologists, and the public by fostering and advocating best practices in pathology and laboratory medicine._A systematic statement of policy rules or principles. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by convening expert panels.</PreferredDefinition>
      <LongName>Estrogen Receptor Positive Progesterone Receptor Positive American Society of Clinical Oncology Or College of American Pathologists Guideline</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>12285180</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15492:C15496</PreferredName>
        <Version>1</Version>
        <LongName>Estrogen Receptor Positive Progesterone Receptor Positive</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15492</PREFERRED_NAME>
            <LONG_NAME>Estrogen Receptor Positive</LONG_NAME>
            <CON_ID>4264819</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15496</PREFERRED_NAME>
            <LONG_NAME>Progesterone Receptor Positive</LONG_NAME>
            <CON_ID>4411284</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>12285184</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C39319:C37998:C157719:C17564</PreferredName>
        <Version>1</Version>
        <LongName>American Society of Clinical Oncology Or College of American Pathologists Guideline</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C39319</PREFERRED_NAME>
            <LONG_NAME>American Society of Clinical Oncology</LONG_NAME>
            <CON_ID>2913898</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37998</PREFERRED_NAME>
            <LONG_NAME>Or</LONG_NAME>
            <CON_ID>2233137</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C157719</PREFERRED_NAME>
            <LONG_NAME>College of American Pathologists</LONG_NAME>
            <CON_ID>6658453</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17564</PREFERRED_NAME>
            <LONG_NAME>Guideline</LONG_NAME>
            <CON_ID>2443697</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the tumor determined to be ER and/or PgR positive assessed by current ASCO/CAP Guideline Recommendations for hormone receptor testing?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the tumor ER and/or PgR-positive by current ASCO/CAP guidelines based on local testing results?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1475">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>12390772</PUBLICID>
    <LONGNAME>Ped-PRO-CTCAE Past 7 Days How Often Shortness of Breath Score 4 Point Scale</LONGNAME>
    <PREFERREDNAME>PPROCTCAE_SHBRTH_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated response in the past 7 days about how often they had problems breathing (shortness of breath), using a 4-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Ped-PRO-CTCAE Item Library Version 1.0 - January 28, 2022; Ped-PRO-CTCAE© was developed with funding from the National Cancer Institute</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>12384489</PublicId>
      <PreferredName>12368867v1.00:5114512v1.00</PreferredName>
      <PreferredDefinition>A measurement system that characterized the frequency, severity, interference,and presence/absence of symptomatic toxicities that include pain, fatigue, nausea, and cutaneous side effects such as rash and hand-foot syndrome, all toxicities that can be meaningfully reported from the patient prespective. The pediatric module permits self-reporting by children and adolescents ages 7-17 years.:The most recent week. May include the present day._A question about how often an individual has or had shortness or breath._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Ped-PRO-CTCAE Past Week How Often Shortness of Breath Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>12368867</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C186439</PreferredName>
        <Version>1</Version>
        <LongName>Ped-PRO-CTCAE</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C186439</PREFERRED_NAME>
            <LONG_NAME>Ped-PRO-CTCAE</LONG_NAME>
            <CON_ID>10055951</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>5114512</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C95402:C125279:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Past Week How Often Shortness of Breath Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C95402</PREFERRED_NAME>
            <LONG_NAME>Past Week</LONG_NAME>
            <CON_ID>3185130</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125279</PREFERRED_NAME>
            <LONG_NAME>How Often Shortness of Breath Question</LONG_NAME>
            <CON_ID>5109065</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>12387693</PublicId>
      <PreferredName>12387693v1.00</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>PRO 4 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>13</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>Ped-PRO-CTCAE Item Library Version 1.0 - January 28, 2022; Ped-PRO-CTCAE© was developed with funding from the National Cancer Institute</Origin>
      <Representation>
        <PublicId>2184332</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Scale</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Most of the Time</VALIDVALUE>
          <VALUEMEANING>Most of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened most of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C110991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes </VALIDVALUE>
          <VALUEMEANING>Sometimes</VALUEMEANING>
          <MEANINGDESCRIPTION>From time to time, but not continually or always.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C90025</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3232437</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Almost all the time</VALIDVALUE>
          <VALUEMEANING>Almost All of the Time</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something happens or happened almost all of the time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>12387694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Never</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3025032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>In the past 7 days, how often did you have problems breathing (shortness of breath)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5574822</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO-CTCAE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped-PRO-CTCAE ITEMS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14617987</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped-PRO-CTCAE ITEMS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15018436</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1476">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>13252384</PUBLICID>
    <LONGNAME>Patient Discontinue Induction Therapy Yes No Indicator</LONGNAME>
    <PREFERREDNAME>DISCON_INDCTN_TX_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Yes/No Indicator of whether patient discontinued induction therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NRG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>13249591</PublicId>
      <PreferredName>2411801v1.00:2718948v1.00</PreferredName>
      <PreferredDefinition>A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.:To stop or end, permanently or temporarily._The first choice of treatment for a particular type of cancer.</PreferredDefinition>
      <LongName>Patient Discontinue Induction Therapy</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NRG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>13252383</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25484:C158876</PreferredName>
        <Version>1</Version>
        <LongName>Discontinue Induction Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25484</PREFERRED_NAME>
            <LONG_NAME>Discontinue</LONG_NAME>
            <CON_ID>2203906</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C158876</PREFERRED_NAME>
            <LONG_NAME>Induction Therapy</LONG_NAME>
            <CON_ID>6859324</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015869</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>Response of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>IVI:caBIG In Vivo Imaging Workspace</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did patient discontinue induction therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If the patient did not complete 6 cycles of induction treatment was it due to  significant dose delays as a result of treatment related toxicities or intercurrent illness that rendered the patient unable to continue induction treatment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1477">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>13382770</PUBLICID>
    <LONGNAME>Disease Staging System Name</LONGNAME>
    <PREFERREDNAME>13381591v1.00:13362445v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The words by which the systematic method for clinicopathologic evaluation of tumors is known.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>Pediatric Cancer</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCDC:Pediatric Cancer Data Commons</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>13381591</PublicId>
      <PreferredName>2404658v1.00:2607511v1.00</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:A systematic method for clinicopathologic evaluation of tumors.</PreferredDefinition>
      <LongName>Disease Staging System</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>Pediatric Cancer</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607511</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18004</PreferredName>
        <Version>1</Version>
        <LongName>Staging System</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18004</PREFERRED_NAME>
            <LONG_NAME>Staging System</LONG_NAME>
            <CON_ID>2607494</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PCDC:Pediatric Cancer Data Commons</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>13362445</PublicId>
      <PreferredName>13362445v1.00</PreferredName>
      <PreferredDefinition>A systematic method for clinicopathologic evaluation of tumors._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Staging System Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>Pediatric Cancer</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PCDC:Pediatric Cancer Data Commons</Origin>
      <Representation>
        <PublicId>13362444</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>13362444v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Staging System Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18004</PREFERRED_NAME>
            <LONG_NAME>Staging System</LONG_NAME>
            <CON_ID>2607494</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>COG</VALIDVALUE>
          <VALUEMEANING>Children&#39;s Oncology Group</VALUEMEANING>
          <MEANINGDESCRIPTION>An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children&#39;s Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FIGO</VALIDVALUE>
          <VALUEMEANING>Federation of Gynecology and Obstetrics</VALUEMEANING>
          <MEANINGDESCRIPTION>An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89808</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13367962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>AJCC</VALIDVALUE>
          <VALUEMEANING>American Joint Committee on Cancer</VALUEMEANING>
          <MEANINGDESCRIPTION>A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2647206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ann Arbor</VALIDVALUE>
          <VALUEMEANING>Ann Arbor</VALUEMEANING>
          <MEANINGDESCRIPTION>The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation &quot;B&quot; and have a worse prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54179</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2876478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INSS</VALIDVALUE>
          <VALUEMEANING>International Neuroblastoma Staging System</VALUEMEANING>
          <MEANINGDESCRIPTION>A surgicopathological staging system for neuroblastoma, based on the Evans staging system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85416</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13367963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INRGSS</VALIDVALUE>
          <VALUEMEANING>International Neuroblastoma Risk Group Staging System</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical staging system for neuroblastoma based on preoperative imaging and determined prior to any treatment, including surgery. It includes two stages of localized disease (L1 and L2) and two stages of metastatic disease (M and MS).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13367964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EVANS</VALIDVALUE>
          <VALUEMEANING>Evans et al Tumor Regression Grade (1992)</VALUEMEANING>
          <MEANINGDESCRIPTION>A grading system developed by Evans et al (1992) to assess a decrease in tumor size or extent in the body. (Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. (1992) 127:1335-9.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C181469</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Reported</VALIDVALUE>
          <VALUEMEANING>Not Reported</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-04-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chang Staging</VALIDVALUE>
          <VALUEMEANING>Modified Chang Staging System for Medulloblastoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A classification system for the staging of medulloblastomas based on tumor size and location of metastasis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C198826</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-05-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13570016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Stage System</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Ped Core Tier</Name>
        <DocumentType>Tier</DocumentType>
        <DocumentText>Conditional</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>11518160</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16075984</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>12173174</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>12173174v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Attributes</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>12173178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>12173174</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>12173174v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Staging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>12173198</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>13954630</PublicId>
          <ContextName>Pediatric Cancer</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>All Pediatric Core CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Observation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14599256</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>STAGE_SYSTEM</AlternateName>
        <AlternateNameType>PCDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Pediatric Cancer</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Stage System</AlternateName>
        <AlternateNameType>Ped Cancer Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>disease_staging_system</AlternateName>
        <AlternateNameType>CIDC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1478">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>13628802</PUBLICID>
    <LONGNAME>Transplant Healthcare Facility Identifier Institution::National Marrow Donor Program Facility Number</LONGNAME>
    <PREFERREDNAME>13628798v1.00:12113516v1.10</PREFERREDNAME>
    <PREFERREDDEFINITION>A unique numeric National Marrow Donor Program identifier assigned to a transplant healthcare facility.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>13628798</PublicId>
      <PreferredName>13628797v1.00:2222848v1.00</PreferredName>
      <PreferredDefinition>Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species._The buildings and organizations where healthcare services are provided.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Transplantation Healthcare Facility Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>13628797</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15342:C21541</PreferredName>
        <Version>1</Version>
        <LongName>Transplantation Healthcare Facility</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21541</PREFERRED_NAME>
            <LONG_NAME>Healthcare Facility</LONG_NAME>
            <CON_ID>2202668</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>12113516</PublicId>
      <PreferredName>12113516v1.10</PreferredName>
      <PreferredDefinition>An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research; also used to refer to a building or buildings occupied or used by such organization.::National Marrow Donor Program_Services and space and equipment provided for a particular purpose; a building or place that provides a particular service or is used for a particular industry._A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Institution::National Marrow Donor Program Facility Number</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008529</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RSCH_PROT</PreferredName>
        <Version>1</Version>
        <LongName>Research Protocols</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2728530</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41206:C62574:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Institution Facility Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41206</PREFERRED_NAME>
            <LONG_NAME>Institution</LONG_NAME>
            <CON_ID>2228359</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62574</PREFERRED_NAME>
            <LONG_NAME>Facility</LONG_NAME>
            <CON_ID>2542035</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the National Marrow Donor Program identifier assigned to a transplant healthcare facility?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>TC Code:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1479">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14216940</PUBLICID>
    <LONGNAME>Tumor/Lesion Identification Supplemental Qualifiers Dataset Low Grade Glioma Visual Pathway Glioma Yes No Unknown Not Applicable Indicator</LONGNAME>
    <PREFERREDNAME>SUPPTU_QVAL_TULGG_OPTCGLI</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator to specify if the target low grade glioma an optic pathway glioma.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14216939</PublicId>
      <PreferredName>10379801v1.00:14216938v1.00</PreferredName>
      <PreferredDefinition>A dataset containing supplemental information, specifically non-standard variables, to parent records in the tumor/lesion identification domain.:A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma._A glioma that arises from the visual pathway. This condition can be seen in association with neurofibromatosis 1. It is most commonly seen in the pediatric age group.</PreferredDefinition>
      <LongName>Tumor/Lesion Identification Supplemental Qualifiers Dataset Low Grade Glioma Visual Pathway Glioma</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>10379801</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C147264</PreferredName>
        <Version>1</Version>
        <LongName>Tumor/Lesion Identification Supplemental Qualifiers Dataset</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C147264</PREFERRED_NAME>
            <LONG_NAME>Tumor/Lesion Identification Supplemental Qualifiers Dataset</LONG_NAME>
            <CON_ID>10029717</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14216938</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C132067:C8567</PreferredName>
        <Version>1</Version>
        <LongName>Low Grade Glioma Visual Pathway Glioma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C132067</PREFERRED_NAME>
            <LONG_NAME>Low Grade Glioma</LONG_NAME>
            <CON_ID>6641388</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C8567</PREFERRED_NAME>
            <LONG_NAME>Visual Pathway Glioma</LONG_NAME>
            <CON_ID>6641763</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the target low grade glioma (LGG) an optic pathway glioma (OPG)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1480">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14263646</PUBLICID>
    <LONGNAME>Chronic Renal Failure Requirement Dialysis Occurrence Indicator</LONGNAME>
    <PREFERREDNAME>14263645v1.00:2784450v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not chronic renal failure requiring dialysis occurred.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14263645</PublicId>
      <PreferredName>14263644v1.00:2234856v1.00</PreferredName>
      <PreferredDefinition>Impairment of the renal function due to chronic kidney damage._Something that is a necessary condition; something that is obligatory._A procedure to remove toxic substances from the blood that is used in patients with end-stage chronic kidney disease or acute kidney failure. This includes hemodialysis and peritoneal dialysis.:An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Chronic Renal Failure Requirement Dialysis Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14263644</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9438:C25652:C15221</PreferredName>
        <Version>1</Version>
        <LongName>Chronic Renal Failure Requirement Dialysis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9438</PREFERRED_NAME>
            <LONG_NAME>Chronic Renal Failure</LONG_NAME>
            <CON_ID>3204820</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25652</PREFERRED_NAME>
            <LONG_NAME>Requirement</LONG_NAME>
            <CON_ID>2204014</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15221</PREFERRED_NAME>
            <LONG_NAME>Dialysis</LONG_NAME>
            <CON_ID>2465277</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did chronic renal failure requiring dialysis occur?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the recipient experience chronic renal failure requiring dialysis?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 2</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Did chronic renal failure requiring dialysis occur?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_REN_chron_ren_req_dia_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1481">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14468327</PUBLICID>
    <LONGNAME>Patient Myelodysplastic Syndrome Diagnosis Genetic Abnormality Type</LONGNAME>
    <PREFERREDNAME>MDS_GEN_AB_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the genetic abnormalities present for myelodysplastic syndrome.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>COG CRF:Children&#39;s Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3544337</PublicId>
      <PreferredName>PT_MDS_DX</PreferredName>
      <PreferredDefinition>information related to a person who has a scientific determination of clonal hematopoietic disorder, accompanied by an increase in myeloblasts as a result of exposure to alkylating agents and/or radiotherapy.</PreferredDefinition>
      <LongName>Patient Myelodysplastic Syndrome Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2497374</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3247:C15220</PreferredName>
        <Version>1</Version>
        <LongName>MDS Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3247</PREFERRED_NAME>
            <LONG_NAME>Myelodysplastic Syndrome</LONG_NAME>
            <CON_ID>2202745</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>10401859</PublicId>
      <PreferredName>10401859v1.00</PreferredName>
      <PreferredDefinition>A molecular or cytogenic abnormality which occurs in either human disease states or disease models._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Molecular Abnormality Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>5946071</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3910:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Molecular Abnormality Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3910</PREFERRED_NAME>
            <LONG_NAME>Molecular Abnormality</LONG_NAME>
            <CON_ID>2582540</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BCR-ABL1 t(9;22)(q34;q11.2)</VALIDVALUE>
          <VALUEMEANING>BCR-ABL1 t(9;22)(q34;q11.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>BCR-ABL1 t(9;22)(q34;q11.2)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BCR-ABL1-like (Ph-like) ALL</VALIDVALUE>
          <VALUEMEANING>BCR-ABL1-like (Ph-like) ALL</VALUEMEANING>
          <MEANINGDESCRIPTION>BCR-ABL1-like (Ph-like) ALL</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KMT2A (MLL)</VALIDVALUE>
          <VALUEMEANING>KMT2A (MLL)</VALUEMEANING>
          <MEANINGDESCRIPTION>A molecular abnormality indicating rearrangement of the KMT2A (MLL) gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10404268</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>TCF3-HLF</VALIDVALUE>
          <VALUEMEANING>TCF3-HLF</VALUEMEANING>
          <MEANINGDESCRIPTION>TCF3-HLF</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10383309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CRLF2/JAK pathway abnormalities</VALIDVALUE>
          <VALUEMEANING>CRLF2/JAK pathway abnormalities</VALUEMEANING>
          <MEANINGDESCRIPTION>CRLF2/JAK pathway abnormalities</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10383310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>tp53</VALIDVALUE>
          <VALUEMEANING>tp53</VALUEMEANING>
          <MEANINGDESCRIPTION>A change in the nucleotide sequence of the TP53 gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118396</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10382635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3030997</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-06-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6424136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BCR::ABL1</VALIDVALUE>
          <VALUEMEANING>BCR/ABL1 Fusion Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5&#39; part of the BCR gene to the 5&#39; side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3935833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KMT2A</VALIDVALUE>
          <VALUEMEANING>KMT2A Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>This gene is involved in transcriptional regulation and alterations in the gene are associated with acute lymphoblastic leukemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3370205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ZNF384</VALIDVALUE>
          <VALUEMEANING>ZNF384 Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>This gene is involved in both transcriptional regulation and DNA binding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97882</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6143054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BCL11B</VALIDVALUE>
          <VALUEMEANING>BCL11B Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>This gene may play a role in tumor suppression, signaling and T cell development.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7546304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monosomy 7 or del(7q)</VALIDVALUE>
          <VALUEMEANING>Loss of Chromosome 7</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenic abnormality that refers to loss of all or part of chromosome 7.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36524</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6845818</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Del(5q)</VALIDVALUE>
          <VALUEMEANING>Loss of Chromosome 5q</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenic abnormality that refers to loss of all or part of the long arm of chromosome 5 (5q). It is associated with the development of myelodysplastic syndrome with isolated deletion (5q), acute myeloid leukemia with multilineage dysplasia, and acute myeloid leukemia with myelodysplasia-related changes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5606929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PTPN11</VALIDVALUE>
          <VALUEMEANING>PTPN11 Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>This gene plays a role in the regulation of cell signaling. It is involved in cell migration, metabolic control, mitogenic activation and gene transcription.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26337</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6142267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KRAS</VALIDVALUE>
          <VALUEMEANING>KRAS Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>This gene is involved in signal transduction and apoptosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4233115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NRAS</VALIDVALUE>
          <VALUEMEANING>NRAS Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>This gene plays a role in signal transduction and cell cycle regulation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4233114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NF1</VALIDVALUE>
          <VALUEMEANING>NF1 Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>This gene plays a role in signal transduction and cytoskeletal remodeling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17424</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3425296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CBL</VALIDVALUE>
          <VALUEMEANING>CBL Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>This gene plays a role in signal transduction and the regulation of protein degradation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18364</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4233116</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SETBP1</VALIDVALUE>
          <VALUEMEANING>SETBP1 Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>This gene may be involved in the modulation of protein SET activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106635</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4566851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RRAS2</VALIDVALUE>
          <VALUEMEANING>RRAS2 Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>This gene is involved in signal transduction and intracellular protein transport.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C24755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14900363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the genetic abnormalities present for myelodysplastic syndrome?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Myelodysplastic syndrome with known defining genetic abnormality:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Myelodysplastic syndrome genetic abnormality:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1482">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14479404</PUBLICID>
    <LONGNAME>KSHV Inflammatory Cytokine Syndrome Disease Response Category</LONGNAME>
    <PREFERREDNAME>KSHV_KICS_DS_RSP_CAT</PREFERREDNAME>
    <PREFERREDDEFINITION>Code assigned to describe the KSHV inflammatory cytokine syndrome patient&#39;s disease response or outcome to treatment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14479381</PublicId>
      <PreferredName>14479380v1.00:2459437v1.00</PreferredName>
      <PreferredDefinition>A syndrome caused by Kaposi sarcoma-associated herpesvirus (KSHV) infection. It manifests with fever, weight loss, and fluid retention in the legs or abdomen. Patients are at risk of developing KSHV-related cancers including Kaposi sarcoma and lymphoma.:The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.</PreferredDefinition>
      <LongName>KSHV Inflammatory Cytokine Syndrome Disease Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14479380</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C125711</PreferredName>
        <Version>1</Version>
        <LongName>KSHV Inflammatory Cytokine Syndrome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125711</PREFERRED_NAME>
            <LONG_NAME>KSHV Inflammatory Cytokine Syndrome</LONG_NAME>
            <CON_ID>7607409</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2459437</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50995</PreferredName>
        <Version>1</Version>
        <LongName>Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50995</PREFERRED_NAME>
            <LONG_NAME>Disease Response</LONG_NAME>
            <CON_ID>2459436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2721678</PublicId>
      <PreferredName>DZ_RESP_CAT</PreferredName>
      <PreferredDefinition>In medicine, an improvement related to treatment._Category; used informally to mean a class of things.</PreferredDefinition>
      <LongName>Disease Response Category</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2721677</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C50995:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Response Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50995</PREFERRED_NAME>
            <LONG_NAME>Disease Response</LONG_NAME>
            <CON_ID>2459436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ND</VALIDVALUE>
          <VALUEMEANING>No Response</VALUEMEANING>
          <MEANINGDESCRIPTION>No apparent change or worsening in lesion staging classification.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PD</VALIDVALUE>
          <VALUEMEANING>Progressive Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Cancer that is increasing in scope or severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PR</VALIDVALUE>
          <VALUEMEANING>Partial Response</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial Response</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-01-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR</VALIDVALUE>
          <VALUEMEANING>Complete Response</VALUEMEANING>
          <MEANINGDESCRIPTION>The disappearance of all signs of cancer in response to treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NE</VALIDVALUE>
          <VALUEMEANING>Not evaluable</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to be evaluated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3589199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SD</VALIDVALUE>
          <VALUEMEANING>Stable Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Cancer that is neither decreasing nor increasing in extent or severity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C18213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NU</VALIDVALUE>
          <VALUEMEANING>No sites of uptake</VALUEMEANING>
          <MEANINGDESCRIPTION>No sites of uptake on FDG-PET scan at study entry and scan remains negative</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3589197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>KSHV-associated inflammatory Cytokine Syndrome (KICS) Response Assessment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MediData Rave Use</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3308730</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1483">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14600036</PUBLICID>
    <LONGNAME>Pediatric EAT-10 8 Food Sticks in Child&#39;s Throat and Causes Choking While Eating Score 5 Point Scale</LONGNAME>
    <PREFERREDNAME>PED_EAT10_8_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>Parent&#39;s stated response about the problem severity of food sticking to their child&#39;s throat and child choking while eating, using a 5-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14599748</PublicId>
      <PreferredName>14599711v1.00:14599747v1.00</PreferredName>
      <PreferredDefinition>A pediatric version of the Eating Assessment Tool-10, designed to allow a parent to report their child&#39;s swallowing difficulties.:A question about whether food sticks in individual&#39;s child&#39;s throat, causing choking while eating._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Pediatric Eating Assessment Tool-10 Food Sticks in Child&#39;s Throat and Causes Choking While Eating Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14599711</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C202103</PreferredName>
        <Version>1</Version>
        <LongName>Pediatric Eating Assessment Tool-10</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C202103</PREFERRED_NAME>
            <LONG_NAME>Pediatric Eating Assessment Tool-10</LONG_NAME>
            <CON_ID>14599667</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14599747</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C202111:C25338</PreferredName>
        <Version>1</Version>
        <LongName>Food Sticks in Child&#39;s Throat and Causes Choking While Eating Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C202111</PREFERRED_NAME>
            <LONG_NAME>Food Sticks in Child&#39;s Throat and Causes Choking While Eating Question</LONG_NAME>
            <CON_ID>14599675</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14599774</PublicId>
      <PreferredName>14599774v1.00</PreferredName>
      <PreferredDefinition>A ten question measure designed to assess swallowing difficulties._An ordered reference standard used to measure incremental changes.</PreferredDefinition>
      <LongName>Problem Severity Scale Eating Assessment Tool-10</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>Integer</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>14672710</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>14672710v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Eating Assessment Tool-10 Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C202084</PREFERRED_NAME>
            <LONG_NAME>Eating Assessment Tool-10</LONG_NAME>
            <CON_ID>14599720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 0 on a problem severity scale that ranges from 0: No problem to 4: Severe problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14599775</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Mild Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 1 on a problem severity scale that ranges from 0: No problem to 4: Severe problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202097</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14599776</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Mild to Moderate Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 2 on a problem severity scale that ranges from 0: No problem to 4: Severe problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202098</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14599777</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Moderate Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 3 on a problem severity scale that ranges from 0: No problem to 4: Severe problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14599778</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Severe Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective score of 4 on a problem severity scale that ranges from 0: No problem to 4: Severe problem.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C202100</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-11-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14599779</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Food sticks to my child&#39;s throat and my child chokes while eating.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Pediatric Eating Assessment Tool (PEDI-EAT-10)</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question 8 of 10</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QS_CHKET</AlternateName>
        <AlternateNameType>OID, COG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1484">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14604164</PUBLICID>
    <LONGNAME>Defect Closure Occurrence Indicator</LONGNAME>
    <PREFERREDNAME>DEF_CL_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of whether or not there was a defect closure occurrence.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCTG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCTG: Canadian Cancer Trials Group</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14604163</PublicId>
      <PreferredName>14604162v1.00:2234856v1.00</PreferredName>
      <PreferredDefinition>The repair of a congenital, traumatic or surgical wound.:An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Defect Closure Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCTG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14604162</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C202126</PreferredName>
        <Version>1</Version>
        <LongName>Defect Closure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C202126</PREFERRED_NAME>
            <LONG_NAME>Defect Closure</LONG_NAME>
            <CON_ID>14604161</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCTG: Canadian Cancer Trials Group</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506035</PublicId>
      <PreferredName>YES_NO_UNKNOWN_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown/not applicable.</PreferredDefinition>
      <LongName>Yes No Unknown Not Applicable Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2694968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49486</PreferredName>
        <Version>1</Version>
        <LongName>Ind-4</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49486</PREFERRED_NAME>
            <LONG_NAME>Yes, No, Unknown, or Not Applicable Response</LONG_NAME>
            <CON_ID>2475171</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3261243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did a defect closure occur?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Defect Closure:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TR_TRORRES_DEFECT</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1485">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14652267</PUBLICID>
    <LONGNAME>Person Age Range Category Code</LONGNAME>
    <PREFERREDNAME>2634443v1.00:14652058v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded response that answers questions in regards to a participant&#39;s age.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>SWOG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2634443</PublicId>
      <PreferredName>2236731v1.0:2239916v1.0</PreferredName>
      <PreferredDefinition>The length of time a person has been living since birth.</PreferredDefinition>
      <LongName>Person Age</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239916</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25150</PreferredName>
        <Version>1</Version>
        <LongName>Age</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25150</PREFERRED_NAME>
            <LONG_NAME>Age</LONG_NAME>
            <CON_ID>2202837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NHLBI FBPP:Family Blood Pressure Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14652058</PublicId>
      <PreferredName>14652058v1.00</PreferredName>
      <PreferredDefinition>A human being._How long something has existed; elapsed time since birth._The difference between the lowest and highest numerical values; the limits or scale of variation._A grouping of items based on some commonality or by user defined characteristics._A symbol or combination of symbols which is assigned to the members of a collection.</PreferredDefinition>
      <LongName>Person Age Range Category Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SWOG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>SWOG CRF:Southwest Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>14652057</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>14652057v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Person Age Range Category Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25150</PREFERRED_NAME>
            <LONG_NAME>Age</LONG_NAME>
            <CON_ID>2202837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38013</PREFERRED_NAME>
            <LONG_NAME>Range</LONG_NAME>
            <CON_ID>2204649</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>18-21</VALUEMEANING>
          <MEANINGDESCRIPTION>18-21</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14652167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>22-30</VALUEMEANING>
          <MEANINGDESCRIPTION>22-30</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14652168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>31-39</VALUEMEANING>
          <MEANINGDESCRIPTION>31-39</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14652169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>40-60</VALUEMEANING>
          <MEANINGDESCRIPTION>40-60</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-12-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14667055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Person Age Range Category</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SWOG - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Which is the participant&#39;s age?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>SWOG - 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the participant&#39;s age?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1486">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14665974</PUBLICID>
    <LONGNAME>Completely Satisfied With Medication Taken Agreement 5 Point Likert Scale</LONGNAME>
    <PREFERREDNAME>COMPLT_SATSFY_MEDCN_TKN</PREFERREDNAME>
    <PREFERREDDEFINITION>The scale that indicates the satisfaction rating of the participant with the medication taken.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14665973</PublicId>
      <PreferredName>14665971v1.00:14665972v1.00</PreferredName>
      <PreferredDefinition>To possess every necessary or normal part or component or step; having come or been brought to a conclusion._A subjective response indicating that an individual is pleased and content.:Used to indicate the presence of something or someone._A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product._Having been accepted for some purpose; ingested as a medication.</PreferredDefinition>
      <LongName>Completely Satisfied With Medication Taken</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14665971</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25250:C125072</PreferredName>
        <Version>1</Version>
        <LongName>Complete Satisfied</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25250</PREFERRED_NAME>
            <LONG_NAME>Complete</LONG_NAME>
            <CON_ID>2203885</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125072</PREFERRED_NAME>
            <LONG_NAME>Satisfied</LONG_NAME>
            <CON_ID>5100491</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14665972</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62355:C459:C25701</PreferredName>
        <Version>1</Version>
        <LongName>With Medication Taken</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62355</PREFERRED_NAME>
            <LONG_NAME>With</LONG_NAME>
            <CON_ID>2532083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25701</PREFERRED_NAME>
            <LONG_NAME>Taken</LONG_NAME>
            <CON_ID>2203968</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3682709</PublicId>
      <PreferredName>AGMT_5PT_SCL</PreferredName>
      <PreferredDefinition>A number with no fractional part, including the negative and positive numbers as well as zero.::5_The precise location of something; a spatially limited location._an ordered reference standard.</PreferredDefinition>
      <LongName>Agreement 5 Point Likert Scale</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>MDADI:M.D.Anderson Dysphagia Inventory, Amy Y.Chen, 2000</Origin>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strongly Disagree</VALIDVALUE>
          <VALUEMEANING>Strongly Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely at odds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disagree</VALIDVALUE>
          <VALUEMEANING>Disagree</VALUEMEANING>
          <MEANINGDESCRIPTION>To be at odds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104479</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682711</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Opinion</VALIDVALUE>
          <VALUEMEANING>No Opinion</VALUEMEANING>
          <MEANINGDESCRIPTION>Without concurrence or opposition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103804</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Agree</VALIDVALUE>
          <VALUEMEANING>Agree</VALUEMEANING>
          <MEANINGDESCRIPTION>To concur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682713</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Strongly Agree</VALIDVALUE>
          <VALUEMEANING>Strongly agree</VALUEMEANING>
          <MEANINGDESCRIPTION>Intense concurrence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C104475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3682714</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I am completely satisfied with the medication I am taking.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1487">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14667249</PUBLICID>
    <LONGNAME>Address Second Line Text</LONGNAME>
    <PREFERREDNAME>14667099v1.00:14596815v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>A standardized representation of the location of a person, business, building, or organization.:A unit of time, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). The second is the duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the caesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour._Text consisting of a row of words written across a page or computer screen.:The words of something written.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>OMOP CDM:The Observational Medical Outcomes Partnership (OMOP) Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14667099</PublicId>
      <PreferredName>2341906v1.00:14667098v1.00</PreferredName>
      <PreferredDefinition>A standardized representation of the location of a person, business, building, or organization.:A unit of time, one of the seven base units of the International System of Units (Systeme International d&#39;Unites, SI). The second is the duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the caesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour._Text consisting of a row of words written across a page or computer screen.</PreferredDefinition>
      <LongName>Address Second Line</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2861581</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ADDRESS</PreferredName>
        <Version>1</Version>
        <LongName>Address</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2341906</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25407</PreferredName>
        <Version>1</Version>
        <LongName>Address</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25407</PREFERRED_NAME>
            <LONG_NAME>Address</LONG_NAME>
            <CON_ID>2202289</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14667098</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42535:C49259</PreferredName>
        <Version>1</Version>
        <LongName>Second Text Line</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42535</PREFERRED_NAME>
            <LONG_NAME>Second</LONG_NAME>
            <CON_ID>2534958</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49259</PREFERRED_NAME>
            <LONG_NAME>Text Line</LONG_NAME>
            <CON_ID>2516224</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14596815</PublicId>
      <PreferredName>14596815v1.00</PreferredName>
      <PreferredDefinition>The words of something written.</PreferredDefinition>
      <LongName>Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>varchar</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>OMOP CDM:The Observational Medical Outcomes Partnership (OMOP) Common Data Model</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Address 2</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>userGuidance</Name>
        <DocumentType>OMOP CDM User Guidance</DocumentType>
        <DocumentText>This is the second line of the address</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14522466</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>OMOP 5.4</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Location</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>14522487</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>address_2</AlternateName>
        <AlternateNameType>OMOP Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LOCATION</AlternateName>
        <AlternateNameType>OMOP Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1488">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14673472</PUBLICID>
    <LONGNAME>Immunization Incomplete Reason PCORnet Common Data Model Code</LONGNAME>
    <PREFERREDNAME>14673366v1.00:14673372v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Inoculating an individual with either killed or live agents to prevent contraction of a disease.:The act of the dispensing, applying, or tendering a medical product or other agent._Not whole; lacking some necessary part or detail; unfinished._A condition or state at a particular time._A coded value specifying the rationale for an activity or entity.:Inoculating an individual with either killed or live agents to prevent contraction of a disease._The act of the dispensing, applying, or tendering a medical product or other agent._Not whole; lacking some necessary part or detail; unfinished._A condition or state at a particular time._A coded value specifying the rationale for an activity or entity._A symbol or combination of symbols which is assigned to the members of a collection.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14673366</PublicId>
      <PreferredName>14673288v1.00:14741443v1.00</PreferredName>
      <PreferredDefinition>Inoculating an individual with either killed or live agents to prevent contraction of a disease.:Not whole; lacking some necessary part or detail; unfinished._A condition or state at a particular time._An explanation of the cause of some phenomenon or action.</PreferredDefinition>
      <LongName>Immunization Incomplete Status Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14673288</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15258</PreferredName>
        <Version>1</Version>
        <LongName>Immunization</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15258</PREFERRED_NAME>
            <LONG_NAME>Immunization</LONG_NAME>
            <CON_ID>3151210</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14741443</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49160:C25688:C25638</PreferredName>
        <Version>1</Version>
        <LongName>Incomplete Status Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49160</PREFERRED_NAME>
            <LONG_NAME>Incomplete</LONG_NAME>
            <CON_ID>2427335</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14673372</PublicId>
      <PreferredName>14673372v1.00</PreferredName>
      <PreferredDefinition>Not whole; lacking some necessary part or detail; unfinished._An explanation of the cause of some phenomenon or action._A data model designed to standardize PCORnet data._A symbol or combination of symbols which is assigned to the members of a collection.</PreferredDefinition>
      <LongName>Incomplete Reason PCORnet Common Data Model Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>SAS Char</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>15018711</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15018711v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Incomplete Reason PCORnet Common Data Model Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49160</PREFERRED_NAME>
            <LONG_NAME>Incomplete</LONG_NAME>
            <CON_ID>2427335</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C203939</PREFERRED_NAME>
            <LONG_NAME>PCORnet Common Data Model</LONG_NAME>
            <CON_ID>14741507</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IM</VALIDVALUE>
          <VALUEMEANING>Immunity</VALUEMEANING>
          <MEANINGDESCRIPTION>The protection against infectious disease conferred by the immune response. It encompasses the capacity to distinguish foreign material from self, and to neutralize, eliminate, or metabolize that which is foreign.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16710</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14893099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MP</VALIDVALUE>
          <VALUEMEANING>Disease Transmission Precaution</VALUEMEANING>
          <MEANINGDESCRIPTION>A passage or transfer, as of a disease from one individual to another._A measure taken beforehand to prevent harm or secure good.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60827, C17214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14893100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NI</VALIDVALUE>
          <VALUEMEANING>No Information Available</VALUEMEANING>
          <MEANINGDESCRIPTION>Information regarding the subject is unknown or inaccessible at this time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3151989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OS</VALIDVALUE>
          <VALUEMEANING>Negation Availability Stock</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._The quality of being obtainable or accessible and ready for use or service._The merchandise that a shop has on hand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48288, C25429, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14893101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>OT</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6431768</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PO</VALIDVALUE>
          <VALUEMEANING>Deny</VALUEMEANING>
          <MEANINGDESCRIPTION>Refuse to accept, recognize or acknowledge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14893102</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UN</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-04-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Immunization Status Reason</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Immunization Status Reason</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14522553</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PCORnet CDM 6.1</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Immunization</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>14522577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VX_STATUS_REASON</AlternateName>
        <AlternateNameType>PCORNet Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>IMMUNIZATION</AlternateName>
        <AlternateNameType>PCORnet Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1489">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14673487</PUBLICID>
    <LONGNAME>Immunization Data Source Data Value Anatomic Site</LONGNAME>
    <PREFERREDNAME>14673432v1.00:14961553v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Inoculating an individual with either killed or live agents to prevent contraction of a disease.:Named locations of or within the body._The person or authoritative body who provided the information._The information contained in a data field. It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute.:Named locations of or within the body.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PCORNet CDM:The Patient-Centered Outcomes Research Network Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14673432</PublicId>
      <PreferredName>14673288v1.00:15022042v1.00</PreferredName>
      <PreferredDefinition>Inoculating an individual with either killed or live agents to prevent contraction of a disease.:The entire physical structure of an organism. It is composed of anatomic systems, regions, cavities, and spaces._A position in relation to its surroundings._The person or authoritative body who provided the information._The information contained in a data field. It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute.</PreferredDefinition>
      <LongName>Immunization Body Site Data Source Data Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14673288</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15258</PreferredName>
        <Version>1</Version>
        <LongName>Immunization</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15258</PREFERRED_NAME>
            <LONG_NAME>Immunization</LONG_NAME>
            <CON_ID>3151210</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15022042</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13041:C37901:C16493:C49100</PreferredName>
        <Version>1</Version>
        <LongName>Body Site Data Source Data Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13041</PREFERRED_NAME>
            <LONG_NAME>Body</LONG_NAME>
            <CON_ID>2202687</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37901</PREFERRED_NAME>
            <LONG_NAME>Site</LONG_NAME>
            <CON_ID>2202394</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16493</PREFERRED_NAME>
            <LONG_NAME>Data Source</LONG_NAME>
            <CON_ID>2223421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49100</PREFERRED_NAME>
            <LONG_NAME>Data Value</LONG_NAME>
            <CON_ID>2463853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14961553</PublicId>
      <PreferredName>14961553v1.00</PreferredName>
      <PreferredDefinition>Named locations of or within the body.</PreferredDefinition>
      <LongName>Anatomic Site</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>SAS Char</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2519596</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Raw Immunization Body Site</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14522553</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PCORnet CDM 6.1</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Immunization</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>14522577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RAW_VX_BODY_SITE</AlternateName>
        <AlternateNameType>PCORNet Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>IMMUNIZATION</AlternateName>
        <AlternateNameType>PCORnet Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1490">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14735830</PUBLICID>
    <LONGNAME>Blood Gene Mouse Code</LONGNAME>
    <PREFERREDNAME>2860144v1.00:14735829v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Test CDE with Value Domain containing special characters for Values.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>TEST</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2860144</PublicId>
      <PreferredName>FireFox Test Blood Gene Mouse</PreferredName>
      <PreferredDefinition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide. It supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection._A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of an enzyme or other protein. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule)._Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae. Test Edit Definition.</PreferredDefinition>
      <LongName>Blood Gene Mouse</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>TEST</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2513925</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43431</PreferredName>
        <Version>1</Version>
        <LongName>Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2860141</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12434:C16612</PreferredName>
        <Version>1</Version>
        <LongName>Blood Gene</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12434</PREFERRED_NAME>
            <LONG_NAME>Blood</LONG_NAME>
            <CON_ID>2202587</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16612</PREFERRED_NAME>
            <LONG_NAME>Gene</LONG_NAME>
            <CON_ID>2202483</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2860142</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14238</PreferredName>
        <Version>1</Version>
        <LongName>Mouse</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14238</PREFERRED_NAME>
            <LONG_NAME>Mouse</LONG_NAME>
            <CON_ID>2437670</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14735829</PublicId>
      <PreferredName>14735829v1.00</PreferredName>
      <PreferredDefinition>A system of numbered categories for representation of data.</PreferredDefinition>
      <LongName>Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>TEST</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2211945</PublicId>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ADVERSE EVENT</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <DisplayFormat>999.99</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue>300</MaximumValue>
      <MinimumValue>22</MinimumValue>
      <Origin>2003 National Children&#39;s Food Survey</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>double dagger</VALIDVALUE>
          <VALUEMEANING>Double Dagger</VALUEMEANING>
          <MEANINGDESCRIPTION>Double Dagger</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3694074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>^</VALIDVALUE>
          <VALUEMEANING>Exponent or Caret</VALUEMEANING>
          <MEANINGDESCRIPTION>Exponent or Caret</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3952131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&lt;</VALIDVALUE>
          <VALUEMEANING>Less Than</VALUEMEANING>
          <MEANINGDESCRIPTION>Less Than</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>&gt;</VALIDVALUE>
          <VALUEMEANING>Greater Than</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3134509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>≥</VALIDVALUE>
          <VALUEMEANING>&gt;=45</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways._The natural number greater than forty-four and less than forty-six and the quantity that it denotes._The length of a person&#39;s life, stated in years since birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37908, C175677, C61583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2960758</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>≤</VALIDVALUE>
          <VALUEMEANING>Less Than or Equal To</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3134510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X</VALIDVALUE>
          <VALUEMEANING>Superscript</VALUEMEANING>
          <MEANINGDESCRIPTION>Superscript  </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3694071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>X₂</VALIDVALUE>
          <VALUEMEANING>Subscript</VALUEMEANING>
          <MEANINGDESCRIPTION>Subscript  </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3694072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>°</VALIDVALUE>
          <VALUEMEANING>Degree</VALUEMEANING>
          <MEANINGDESCRIPTION>Degree °</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3694073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>β</VALIDVALUE>
          <VALUEMEANING>BETA</VALUEMEANING>
          <MEANINGDESCRIPTION>BETA</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>λ</VALIDVALUE>
          <VALUEMEANING>Lambda</VALUEMEANING>
          <MEANINGDESCRIPTION>A mixing parameter typically giving a degree of smoothing used, or a relaxation parameter defining a rate of convergence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48926</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3218940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>±</VALIDVALUE>
          <VALUEMEANING>Plus-minus</VALUEMEANING>
          <MEANINGDESCRIPTION>Plus-minus ±</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3694075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>α</VALIDVALUE>
          <VALUEMEANING>Alpha</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates the probability of rejecting the statistical hypothesis tested when in fact, that hypothesis is true.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C72484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2829745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>γ</VALIDVALUE>
          <VALUEMEANING>Gamma</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of magnetic flux density equal to 10(E-9) tesla (one nanotesla) or 10(E-5) oersted, traditionally used in geophysics for measurement of changes in the Earth&#39;s magnetic field.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68914</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3694076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>δ</VALIDVALUE>
          <VALUEMEANING>Delta</VALUEMEANING>
          <MEANINGDESCRIPTION>Delta</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54126</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>Unevaluable No</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to be evaluated.: The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487, C62222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3625612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>test special character &lt; 7*minutes  ß Superscript: (x2) x²  Subscript: (x2)  x₂&lt;, &gt;,Greater than or equal to: (&gt;=),Less than or equal to: (&lt;=), Micro: (µ), Degree: (°), Kappa: (Κ),Lambda : (λ),Plus-minus: (±), Alpha: (α), Gamma: (γ), Delta: (δ) test</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1491">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14745980</PUBLICID>
    <LONGNAME>Disease Response Domain Induction Therapy Response Type</LONGNAME>
    <PREFERREDNAME>RS_RSORRES_RESPGOODPOOR</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term that describes the type of response for induction therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14745975</PublicId>
      <PreferredName>6608777v1.00:14767185v1.00</PreferredName>
      <PreferredDefinition>A domain for disease response evaluations.:The first choice of treatment for a particular type of cancer._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.</PreferredDefinition>
      <LongName>Disease Response Domain Induction Therapy Response</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>6608777</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C107097</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response Domain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C107097</PREFERRED_NAME>
            <LONG_NAME>Disease Response Domain</LONG_NAME>
            <CON_ID>6608776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14767185</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C158876:C25755</PreferredName>
        <Version>1</Version>
        <LongName>Induction Therapy Response</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C158876</PREFERRED_NAME>
            <LONG_NAME>Induction Therapy</LONG_NAME>
            <CON_ID>6859324</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25755</PREFERRED_NAME>
            <LONG_NAME>Response</LONG_NAME>
            <CON_ID>2202805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>COG CRF:Children&#39;s Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14745977</PublicId>
      <PreferredName>14745977v1.00</PreferredName>
      <PreferredDefinition>The first choice of treatment for a particular type of cancer._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Induction Therapy Response Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>14745976</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>14745976v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Induction Therapy Response Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C158876</PREFERRED_NAME>
            <LONG_NAME>Induction Therapy</LONG_NAME>
            <CON_ID>6859324</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25755</PREFERRED_NAME>
            <LONG_NAME>Response</LONG_NAME>
            <CON_ID>2202805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PEIR</VALIDVALUE>
          <VALUEMEANING>Poor End Induction Therapy Response</VALUEMEANING>
          <MEANINGDESCRIPTION>Of low value or worth._The point or place at which something terminates in time, space, or extent._The first choice of treatment for a particular type of cancer._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25755, C158876, C25496, C77959</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14745978</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GEIR</VALIDVALUE>
          <VALUEMEANING>Good End Induction Therapy Response</VALUEMEANING>
          <MEANINGDESCRIPTION>Valuable or useful or agreeable or pleasing._The point or place at which something terminates in time, space, or extent._The first choice of treatment for a particular type of cancer._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25755, C158876, C25496, C64975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14745979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cannot be determined</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done (ND)</VALIDVALUE>
          <VALUEMEANING>Not done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5501320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7590024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Induction therapy response</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>ANBL2131 Central Review of GEIR/PEIR:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the patient&#39;s response per GEIR/PEIR criteria?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RS_RSORRES_EOI_RESP_GOOD_POOR</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1492">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14753604</PUBLICID>
    <LONGNAME>Pharmacogenomics/Genetics Findings Supplemental Qualifiers Dataset Cytogenetic Abnormality Present Other Specify Text</LONGNAME>
    <PREFERREDNAME>SUPPGF_QVAL_SCA_OTH</PREFERREDNAME>
    <PREFERREDDEFINITION>Text description of other cytogenetic abnormality present not previously specified from the list of values.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>COG</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14672142</PublicId>
      <PreferredName>14670408v1.00:14672141v1.00</PreferredName>
      <PreferredDefinition>A dataset containing supplemental information, specifically non-standard variables, to parent records in the pharmacogenomics/genetics findings domain.:An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Pharmacogenomics/Genetics Findings Supplemental Qualifiers Dataset Cytogenetic Abnormality Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>COG</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14670408</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C147235</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacogenomics/Genetics Findings Supplemental Qualifiers Dataset</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C147235</PREFERRED_NAME>
            <LONG_NAME>Pharmacogenomics/Genetics Findings Supplemental Qualifiers Dataset</LONG_NAME>
            <CON_ID>10029427</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14672141</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2950:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Cytogenetic Abnormality Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2950</PREFERRED_NAME>
            <LONG_NAME>Cytogenetic Abnormality</LONG_NAME>
            <CON_ID>2459194</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4975733</PublicId>
      <PreferredName>OTH_SPEC_TXT</PreferredName>
      <PreferredDefinition>The free text field that describes another response when other is chosen from a list of values.</PreferredDefinition>
      <LongName>Other Specify Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>500</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CTEP:Cancer Therapy Evaluation Program</Origin>
      <Representation>
        <PublicId>2857047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25685:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Other Specify Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Segmental chromosomal alterations Present, other specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify (in the form 2q-, 3q+, etc):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1493">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14765193</PUBLICID>
    <LONGNAME>Multiplex Imaging Emission Bandwidth Number</LONGNAME>
    <PREFERREDNAME>14765192v1.00:7425863v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>A numerical quantity which captures the nominal width of an emission spectrum used in multiplex imaging.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CRDC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDS:Cancer Data Service</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14765192</PublicId>
      <PreferredName>14765202v1.00:14765191v1.00</PreferredName>
      <PreferredDefinition>Methods for analyzing the architecture of cell structure using combinations of a variety of optical and mass-spectrometry based methods, including imaging with fluorescent antibodies, aptamers, peptides, dyes, and similar detection reagents.:The nominal width of an emission spectrum.</PreferredDefinition>
      <LongName>Multiplex Imaging Emission Bandwidth</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CRDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14765202</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C203942</PreferredName>
        <Version>1</Version>
        <LongName>Multiplexed Tissue Imaging</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C203942</PREFERRED_NAME>
            <LONG_NAME>Multiplexed Tissue Imaging</LONG_NAME>
            <CON_ID>14742307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14765191</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C204097</PreferredName>
        <Version>1</Version>
        <LongName>Emission Bandwidth</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C204097</PREFERRED_NAME>
            <LONG_NAME>Emission Bandwidth</LONG_NAME>
            <CON_ID>14764296</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CDS:Cancer Data Service</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>7425863</PublicId>
      <PreferredName>7425863v1.0</PreferredName>
      <PreferredDefinition>A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>OCCPR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CPTAC: Clinical Proteomic Tumor Analysis Consortium</Origin>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>A mathematical element that when added to another number yields the same number; the cardinal number meaning one less than one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-10-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2683226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>Ten</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2861010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>Nine</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 8 and less than 10 and the quantity that it denotes: the sum of nine and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66840</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>Eight</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 7 and less than 9 and the quantity that it denotes: the sum of seven and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66839</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225984</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>Seven</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 6 and less than 8 and the quantity that it denotes: the sum of six and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66838</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225985</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>Six</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66836</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2783515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Three</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3218929</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>One</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest natural number and quantity it denotes: a single entity, unit, or object. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66832</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-09-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Emission Bandwidth</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDS Example</Name>
        <DocumentType>EXAMPLE</DocumentType>
        <DocumentText>30</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>8064110</PublicId>
          <ContextName>CRDC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GC (General Commons)</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14470388</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CRDC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>emission_bandwidth</AlternateName>
        <AlternateNameType>GC Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1494">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14845118</PUBLICID>
    <LONGNAME>Medical Device Quantity Value</LONGNAME>
    <PREFERREDNAME>14842080v1.00:14793612v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Any physical object that is useful for prevention, diagnosis, monitoring, or treatment of disease or other conditions.:How much there is of something that you can measure; the total amount or number.:A numerical quantity measured or assigned or computed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>OMOP CDM:The Observational Medical Outcomes Partnership (OMOP) Common Data Model</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14842080</PublicId>
      <PreferredName>2541698v1.00:2440114v1.00</PreferredName>
      <PreferredDefinition>Any physical object that is useful for prevention, diagnosis, monitoring, or treatment of disease or other conditions.:How much there is of something that you can measure; the total amount or number.</PreferredDefinition>
      <LongName>Medical Device Quantity</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2541698</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16830</PreferredName>
        <Version>1</Version>
        <LongName>Medical_Device</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16830</PREFERRED_NAME>
            <LONG_NAME>Medical Device</LONG_NAME>
            <CON_ID>2240760</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2440114</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25256</PreferredName>
        <Version>1</Version>
        <LongName>Quantity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>14793612</PublicId>
      <PreferredName>14793612v1.00</PreferredName>
      <PreferredDefinition>A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Quantity</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>14522466</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>OMOP 5.4</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Device Exposure</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Table</ClassificationSchemeItemType>
        <CsiPublicId>14522477</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>quantity</AlternateName>
        <AlternateNameType>OMOP Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DEVICE_EXPOSURE</AlternateName>
        <AlternateNameType>OMOP Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1495">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14947016</PUBLICID>
    <LONGNAME>Event Randomization To Therapeutic Procedure Start Date Day Number</LONGNAME>
    <PREFERREDNAME>randomization_to_tx_start_days</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of days from the randomization to the start date of therapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCG:Center for Cancer Genomics</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14943636</PublicId>
      <PreferredName>2423306v1.00:14943635v1.00</PreferredName>
      <PreferredDefinition>Something that happens at a given place and time.:The allocation of individuals to groups by chance, especially in order to control the variables in an experiment._Used as a function word to indicate direction, purpose, or movement._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The calendar date on which something is to start or did start.</PreferredDefinition>
      <LongName>Event Randomization To Therapeutic Procedure Start Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2423306</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25499</PreferredName>
        <Version>1</Version>
        <LongName>Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14943635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25196:C65107:C49236:C68616</PreferredName>
        <Version>1</Version>
        <LongName>Randomization To Therapeutic Procedure Start Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25196</PREFERRED_NAME>
            <LONG_NAME>Randomization</LONG_NAME>
            <CON_ID>2202624</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C65107</PREFERRED_NAME>
            <LONG_NAME>To</LONG_NAME>
            <CON_ID>2672667</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C68616</PREFERRED_NAME>
            <LONG_NAME>Start Date</LONG_NAME>
            <CON_ID>2712678</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCG:Center for Cancer Genomics</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2184729</PublicId>
      <PreferredName>DAY_NUM</PreferredName>
      <PreferredDefinition>information related to the day number.</PreferredDefinition>
      <LongName>Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184315</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Number</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How many days from randomization to the therapy start date?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How many days from randomization to the therapy start date?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NCIP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of days from date of randomization to treatment start date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1496">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>14959189</PUBLICID>
    <LONGNAME>Specimen Proliferation Assessment Score</LONGNAME>
    <PREFERREDNAME>14959188v1.00:5046311v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The numeric response that identifies the proliferation assessment score of the specimen involved in the investigation or research study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CIP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>TCIA:TheCancerImagingArchive</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14959188</PublicId>
      <PreferredName>2859635v1.00:14959187v1.00</PreferredName>
      <PreferredDefinition>Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:Multiplying or increasing in number._The final result of a determination of the value, significance, or extent of.</PreferredDefinition>
      <LongName>Specimen Proliferation Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2859635</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70699</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70699</PREFERRED_NAME>
            <LONG_NAME>Biospecimen</LONG_NAME>
            <CON_ID>2726660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14959187</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28378:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Proliferation Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28378</PREFERRED_NAME>
            <LONG_NAME>Proliferation</LONG_NAME>
            <CON_ID>2532676</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>TCIA:TheCancerImagingArchive</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>5046311</PublicId>
      <PreferredName>SCORE</PreferredName>
      <PreferredDefinition>A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CITN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>999.9</DisplayFormat>
      <MaximumLength>4</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue>400</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin>CITN CRF: Cancer Immunotherapy Trials Network Case Report Form</Origin>
      <Representation>
        <PublicId>2193207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specimen Proliferation Score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6305258</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TCIA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AURORA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>14943540</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>Proliferation Score</AlternateName>
        <AlternateNameType>TCIA Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1497">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15008294</PUBLICID>
    <LONGNAME>Participant Suggested Escalate To Next Dose Level Yes No Indicator</LONGNAME>
    <PREFERREDNAME>PT_SUGGST_ESC_NXT_DL</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that specifies whether or not the participant was suggested to escalate to next level.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15008293</PublicId>
      <PreferredName>15008291v1.00:15008292v1.00</PreferredName>
      <PreferredDefinition>Someone who takes part in an activity._A proposal offered for acceptance or rejection.:An increase in extent or intensity; to become more serious._Used as a function word to indicate direction, purpose, or movement._Subsequent; immediately following in time or order._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.</PreferredDefinition>
      <LongName>Participant Suggested Escalate To Next Dose Level</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>15008291</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29867:C48313</PreferredName>
        <Version>1</Version>
        <LongName>Participant Suggestion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29867</PREFERRED_NAME>
            <LONG_NAME>Participant</LONG_NAME>
            <CON_ID>2202627</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48313</PREFERRED_NAME>
            <LONG_NAME>Suggestion</LONG_NAME>
            <CON_ID>2772174</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15008292</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C125176:C65107:C53286:C25488</PreferredName>
        <Version>1</Version>
        <LongName>Escalation To Next Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C125176</PREFERRED_NAME>
            <LONG_NAME>Escalation</LONG_NAME>
            <CON_ID>5103600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C65107</PREFERRED_NAME>
            <LONG_NAME>To</LONG_NAME>
            <CON_ID>2672667</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C53286</PREFERRED_NAME>
            <LONG_NAME>Next</LONG_NAME>
            <CON_ID>2443959</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCP:Division of Cancer Prevention</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was the participant advised to escalate to the next dose level?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1498">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15114136</PUBLICID>
    <LONGNAME>Health Status Assessment FAQLQ-PF10 6 Food Allergy Impact Child Feels Worried in Social Situations with Unfamiliar People Who Might Not Understand Food Allergy Score 7 Point Scale</LONGNAME>
    <PREFERREDNAME>FAQLQ_PF10_6_SCL</PREFERREDNAME>
    <PREFERREDDEFINITION>A person&#39;s stated observation, due to the impact of their child&#39;s food allergy, whether their child feels worried in social situations with unfamiliar adults/children who might not understand food allergy, using a 7-point Likert scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCI Standards</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FAQLQ-PF10: Food Allergy Quality of Life Questionnaire, Parent Form 10, Moynihan D., Morrissey E., et al.,  Clinical and Translational Allergy, 2015</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15114114</PublicId>
      <PreferredName>14936166v1.00:15114146v1.00</PreferredName>
      <PreferredDefinition>Assessments of health-related matters of interest, importance, or worry to a patient, patient&#39;s family, or patient&#39;s healthcare provider that could identify a need, problem, or condition.:A 10-item, shortened version of the Food Allergy Quality of Life Questionnaire - Parent Form, which is designed to be completed by a parent to assess how much of an impact food allergies have on their child&#39;s quality of life._An allergic reaction triggered by exposure to allergens found in food; exposure can occur through the skin, respiratory tract or digestive tract._The effect or consequence of an event or condition._A question about whether an individual&#39;s child feels or has felt worried in social situations with unfamiliar adults or children who might not understand food allergy._A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Health Status Assessment Food Allergy Quality of Life Questionnaire - Parent Form 10 Food Allergy Impact Child Feels Worried in Social Situations with Unfamiliar People Who Might Not Understand Food Allergy Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14936166</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C205784</PreferredName>
        <Version>1</Version>
        <LongName>Health Status Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C205784</PREFERRED_NAME>
            <LONG_NAME>Health Status Assessment</LONG_NAME>
            <CON_ID>14920961</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15114146</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15114146v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Food Allergy Quality of Life Questionnaire - Parent Form 10 Food Allergy Impact Child Feels Worried in Social Situations with Unfamiliar People Who Might Not Understand Food Allergy Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C210473</PREFERRED_NAME>
            <LONG_NAME>Food Allergy Quality of Life Questionnaire - Parent Form 10</LONG_NAME>
            <CON_ID>15114002</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C172304</PREFERRED_NAME>
            <LONG_NAME>Food Allergy</LONG_NAME>
            <CON_ID>7465895</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C122929</PREFERRED_NAME>
            <LONG_NAME>Impact</LONG_NAME>
            <CON_ID>4930073</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C210479</PREFERRED_NAME>
            <LONG_NAME>Child Feels Worried in Social Situations with Unfamiliar People Who Might Not Understand Food Allergy Question</LONG_NAME>
            <CON_ID>15114008</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>FAQLQ-PF10: Food Allergy Quality of Life Questionnaire, Parent Form 10, Moynihan D., Morrissey E., et al.,  Clinical and Translational Allergy, 2015</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15114068</PublicId>
      <PreferredName>15114068v1.00</PreferredName>
      <PreferredDefinition>An ordered reference standard used to measure incremental changes with values 0=Not at all, 1=Hardly at all, 2=A little bit, 3=Moderate Response, 4=Quite a bit, 5=Very much, 6=Extremely.</PreferredDefinition>
      <LongName>Patient Reported Outcome Measures 7 Point Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2524082</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>MEASURE/INSTRUMENT TESTING</PreferredName>
        <Version>1</Version>
        <LongName>Person Measure/Instrument Testing</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>15382018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15382018v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Patient Reported Outcome Measures Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C177377</PREFERRED_NAME>
            <LONG_NAME>Patient Reported Outcome Measures</LONG_NAME>
            <CON_ID>10049650</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>EXTREMELY</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3144291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Moderate Response</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of a degree of agreement that is approximately halfway between the highest and lowest degrees of agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125256</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5576773</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3014718</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Hardly at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that something occurs rarely or with very little intensity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4267061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Because of food allergy, my child feels worried in social situations with unfamiliar adults/children who might not understand food allergy</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Because of food allergy, my child feels worried in social situations with unfamiliar adults/children who might not understand food allergy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Feels worried in social situations with unfamiliar adults/children who might not understand food allergy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>FAQLQ-Parent Form 10</Name>
        <DocumentType>Measure Sequence Number</DocumentType>
        <DocumentText>Question 6 of 10</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Using PRO/HRQoL Measures</Name>
        <DocumentType>Outcome Measure Implementation</DocumentType>
        <DocumentText>This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions. Questions used in this manner do not represent the original measure and should not be referenced by the measure’s name.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>2</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Copyrighted/Trademarked/Licensed PRO/HRQoL Measures</Name>
        <DocumentType>Proprietary Measure Permission</DocumentType>
        <DocumentText>This data element is part of a set of items that comprise a proprietary PRO/HRQoL measure. Permission from the owning organization/entity must be acquired prior to use.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>3</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5675693</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRO HRQoL</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Parent Forms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15175023</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15099037</PublicId>
          <ContextName>NIAID</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>15099037v1.00</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Parent Forms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15100801</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1499">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15264388</PUBLICID>
    <LONGNAME>Treatment Cohort Study 10667 Code</LONGNAME>
    <PREFERREDNAME>TX_COH_SDY_10667_CD</PREFERREDNAME>
    <PREFERREDDEFINITION>The code that represents the information pertaining to protocol 10667 in which subsets of a defined population are identified</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>Theradex</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2497526</PublicId>
      <PreferredName>TX_COHORT_STDY</PreferredName>
      <PreferredDefinition>Medical care intended to treat or cure a condition or lessen its symptoms. This includes the administration of drugs, surgical procedures, physical or psychotherapy, or the use of therapeutic devices.:A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).</PreferredDefinition>
      <LongName>Therapeutic Procedure Cohort Study</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2497524</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15208</PreferredName>
        <Version>1</Version>
        <LongName>Cohort Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15208</PREFERRED_NAME>
            <LONG_NAME>Cohort Study</LONG_NAME>
            <CON_ID>2497523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15264385</PublicId>
      <PreferredName>15264385v1.00</PreferredName>
      <PreferredDefinition>A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.</PreferredDefinition>
      <LongName>10667 Cohort Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>Theradex</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>THERADEX:Theradex Systems Inc</Origin>
      <Representation>
        <PublicId>4386398</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C61512:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Cohort Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61512</PREFERRED_NAME>
            <LONG_NAME>Cohort</LONG_NAME>
            <CON_ID>2555083</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SG2</VALIDVALUE>
          <VALUEMEANING>SG2: non-HRD cohort</VALUEMEANING>
          <MEANINGDESCRIPTION>SG2: non-HRD cohort</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15264387</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>SG1</VALIDVALUE>
          <VALUEMEANING>SG1: HRD cohort</VALUEMEANING>
          <MEANINGDESCRIPTION>SG1: HRD cohort</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15264386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Patient Subgroup</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1500">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15732409</PUBLICID>
    <LONGNAME>Intervention or Procedure Complication HL7 FHIR Terminology Code</LONGNAME>
    <PREFERREDNAME>15725588v1.00:15732404v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Any complications that occurred during the procedure, or in the immediate post-performance period. These are generally tracked separately from the notes, which will typically describe the procedure itself rather than any &#39;post procedure&#39; issues. This element holds the &quot;code&quot; part of the value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15725588</PublicId>
      <PreferredName>2233215v1.00:2430116v1.00</PreferredName>
      <PreferredDefinition>An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.:Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.</PreferredDefinition>
      <LongName>Intervention or Procedure Complication</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233215</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25218</PreferredName>
        <Version>1</Version>
        <LongName>Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2430116</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2959</PreferredName>
        <Version>1</Version>
        <LongName>Complication</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2959</PREFERRED_NAME>
            <LONG_NAME>Complication</LONG_NAME>
            <CON_ID>2203884</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15732404</PublicId>
      <PreferredName>15732404v1.00</PreferredName>
      <PreferredDefinition>An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects._Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure._A set of healthcare-associated terms, codes, and related resources that comprise the Health Level Seven (HL7) Fast Healthcare Interoperability Resources standard for data exchange._A symbol or combination of symbols which is assigned to the members of a collection.</PreferredDefinition>
      <LongName>Intervention or Procedure Complication HL7 FHIR Terminology Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1048576</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>16084505</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16084505v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Intervention or Procedure Complication HL7 FHIR Terminology Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2959</PREFERRED_NAME>
            <LONG_NAME>Complication</LONG_NAME>
            <CON_ID>2203884</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C213710</PREFERRED_NAME>
            <LONG_NAME>HL7 FHIR Terminology</LONG_NAME>
            <CON_ID>15750010</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>888003</VALIDVALUE>
          <VALUEMEANING>Fetal or Neonatal Effect of Maternal Blood Loss</VALUEMEANING>
          <MEANINGDESCRIPTION>The sequelae observed in a fetus or neonate as a consequence of maternal hemorrhage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2470005</VALIDVALUE>
          <VALUEMEANING>Brain Injury</VALUEMEANING>
          <MEANINGDESCRIPTION>Trauma to the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1682008</VALIDVALUE>
          <VALUEMEANING>Temporary Amino Acid Metabolism Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Not permanent; not lasting; lacking continuity or regularity._An inherited disorder that affects the metabolism of the amino acids. Representative examples include alkaptonuria, homocystinuria, tyrosinemia, and phenylketonuria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97090, C53288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>109006</VALIDVALUE>
          <VALUEMEANING>Childhood Or Adolescence Anxiety Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A time period that begins at the beginning of the human embryonic stage and continues until the end of adolescence._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A human life stage that begins at twelve years of age and continues until twenty-one complete years of age, generally marked by the beginning of puberty and lasting to the beginning of adulthood._A category of psychiatric disorders which are characterized by anxious feelings or fear often accompanied by physical symptoms associated with anxiety.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2878, C39298, C37998, C89345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3254001</VALIDVALUE>
          <VALUEMEANING>Strongyloidiasis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection that is caused by nematodes of the genus Strongyloides, most commonly Strongyloides stercoralis, which is a soil-transmitted helminth, and which is characterized by a variety of gastrointestinal, dermatologic, and, occasionally, pulmonary manifestations. The worm&#39;s autoinfective life cycle can lead to hyper-infection and life-threatening dissemination in immunocompromised hosts decades after initial infection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2471009</VALIDVALUE>
          <VALUEMEANING>Intra-abdominal Abscess Post-Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>An abscess within the abdomen._The time period after a diagnostic or therapeutic procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100059, C128326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1685005</VALIDVALUE>
          <VALUEMEANING>Rat-Bite Fever</VALUEMEANING>
          <MEANINGDESCRIPTION>An infectious disease that is caused transmitted by the bite of a rat. Two species of bacteria can cause the infection: Streptobacillus moniliformis and Spirillum minus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>890002</VALIDVALUE>
          <VALUEMEANING>Deep Third-Degree Burn Elbow Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>Extending relatively far inward._An injury that includes all skin layers into the subcutaneous tissue due to chemical, friction, radiation or thermal exposure. The affected area appears dry and thickened; damage to nerve endings usually renders the wound painless._A type of hinge joint located between the forearm and upper arm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C32497, C76132, C25240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222519</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3282008</VALIDVALUE>
          <VALUEMEANING>Photokeratitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Injury to the cornea secondary to ultraviolet light.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2472002</VALIDVALUE>
          <VALUEMEANING>Anuria</VALUEMEANING>
          <MEANINGDESCRIPTION>Absence of urine output.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114699</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3283003</VALIDVALUE>
          <VALUEMEANING>Foreign Body Sensation</VALUEMEANING>
          <MEANINGDESCRIPTION>Feeling of grittiness or having something in the eye; frequently caused by a foreign body. Other possible causes include corneal abrasion, corneal ulcer, inturned eye lash or acute conjunctivitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50572</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4394859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>899001</VALIDVALUE>
          <VALUEMEANING>Axis I Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A diagnosis category, as classified by the Diagnostic and Statistical Manual of Mental Disorders (DSM) version IV, that included mental health and substance use disorder of a clinical nature. Personality Disorders were classified as Axis II. DSM-V eliminated the multi-axial classification system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217550</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1686006</VALIDVALUE>
          <VALUEMEANING>Sedative and Hypnotic And/Or Antianxiety Agent Induction Anxiety Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Any agent that depresses the central nervous system (CNS) and is used to induce calm and sleep._Used to indicate that either or both of two items or options may be valid._Any agent used to treat anxiety._The act of bringing about something._A category of psychiatric disorders which are characterized by anxious feelings or fear often accompanied by physical symptoms associated with anxiety.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2878, C61367, C28197, C48928, C29756</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>127009</VALIDVALUE>
          <VALUEMEANING>Spontaneous Abortion With Cervix Uteri Laceration</VALUEMEANING>
          <MEANINGDESCRIPTION>Fetal loss at less than 20 weeks of gestation._Used to indicate the presence of something or someone._The lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions._A cut or tear in any tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50446, C12311, C62355, C34336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2477008</VALIDVALUE>
          <VALUEMEANING>Superficial Phlebitis, CTCAE</VALUEMEANING>
          <MEANINGDESCRIPTION>Of little substance or significance; involving only a surface._A disorder characterized by inflammation of the wall of a vein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C143761, C25239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>CTCAE, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>928000</VALIDVALUE>
          <VALUEMEANING>Musculoskeletal Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic or neoplastic disorder that affects muscles and bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C107377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16225369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3286006</VALIDVALUE>
          <VALUEMEANING>Patient Status Determine Greater Very Much Improved</VALUEMEANING>
          <MEANINGDESCRIPTION>An indicator that provides information on the current health status of a patient._The establishment of a state or result._Notable in size, number, measure, magnitude, degree, or effectiveness._A subjective response indicating that something is or was very much improved.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C164139, C61421, C136827, C166244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2492009</VALIDVALUE>
          <VALUEMEANING>Nutritional Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Any condition related to a disturbance between proper intake and utilization of nourishment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26836</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6660965</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>134006</VALIDVALUE>
          <VALUEMEANING>Decreased Hair Growth</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is or has decreased._The filamentous outgrowth of the epidermis._A process of becoming larger or longer or more numerous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64379, C32705, C164132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1698001</VALIDVALUE>
          <VALUEMEANING>Bile Duct Ulcer</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the ducts conveying bile between the liver and the intestine, including hepatic, cystic, and common bile duct._A circumscribed inflammatory and often suppurating lesion on the skin or an internal mucous surface resulting in necrosis of tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3426, C12376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>931004</VALIDVALUE>
          <VALUEMEANING>Gestation Nine Week</VALUEMEANING>
          <MEANINGDESCRIPTION>The period of fetal development in the uterus from the start of conception until its birth._A natural number greater than 8 and less than 10 and the quantity that it denotes: the sum of nine and one._Any period of seven consecutive days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29844, C66840, C92804</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222520</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2523007</VALIDVALUE>
          <VALUEMEANING>Salmonella Pneumonia</VALUEMEANING>
          <MEANINGDESCRIPTION>A genus of motile, rod-shaped Gram-negative enterobacteria in the phylum Proteobacteria._An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3333, C76380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222566</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3291007</VALIDVALUE>
          <VALUEMEANING>Two Rib Closed Fracture of Rib</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one._Any one of the paired bones, 12 on either side, extending from the thoracic vertebrae toward the median line on the ventral aspect of the trunk. The long curved bones which form the rib cage. Generally, ribs 1 to 7 are connected to the sternum by their costal cartilages and are called true ribs, whereas ribs 8 to 12 are termed false ribs._A traumatic break in one of the bones in the rib cage that does not involve a break in the adjacent skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35350, C12782, C66833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222609</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>140004</VALIDVALUE>
          <VALUEMEANING>Chronic Pharyngitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Usually used to describe a condition that is persistent and long standing._Inflammation of the throat most often caused by viral and bacterial infections. Other causes include allergens, chemical substances, and trauma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26851, C14141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1703007</VALIDVALUE>
          <VALUEMEANING>Increase Leg Circumference</VALUEMEANING>
          <MEANINGDESCRIPTION>A process of becoming larger, more numerous, more important, or more likely._The portion of the lower extremity between the knee and the ankle. For clinical purposes this term is also used to refer to the whole inferior limb._The length of the closed curve of a circle; the size of something as given by the distance around it.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64265, C32974, C25533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>932006</VALIDVALUE>
          <VALUEMEANING>Flat Affect</VALUEMEANING>
          <MEANINGDESCRIPTION>The absence of emotional expressiveness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797425</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2526004</VALIDVALUE>
          <VALUEMEANING>Non-Inflammatory Female Reproductive System Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-inflammatory disorder that affects the female reproductive system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C174191</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3298001</VALIDVALUE>
          <VALUEMEANING>Amnesia Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Systematic and extensive loss of memory caused by organic or psychological factors. The loss may be temporary or permanent, and may involve old or recent memories._A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28193, C2867</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>943003</VALIDVALUE>
          <VALUEMEANING>Congenital Retinal Aneurysm</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting something that is present at birth._Of, relating to, or involving the retina._Bulging or ballooning in an area of an artery secondary to arterial wall weakening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26693, C87176, C99210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1705000</VALIDVALUE>
          <VALUEMEANING>Closed Fracture of Femoral Neck</VALUEMEANING>
          <MEANINGDESCRIPTION>A fracture of the femoral neck that does not break the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>144008</VALIDVALUE>
          <VALUEMEANING>Normal Peripheral Sight</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm._On or near an edge or constituting an outer boundary; the outer area._The faculty of vision, the perception of objects by the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38533, C25233, C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212987</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2528003</VALIDVALUE>
          <VALUEMEANING>Viremia</VALUEMEANING>
          <MEANINGDESCRIPTION>A laboratory test result indicating the presence of a virus in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35125</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1714005</VALIDVALUE>
          <VALUEMEANING>Photokeratitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Injury to the cornea secondary to ultraviolet light.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2532009</VALIDVALUE>
          <VALUEMEANING>Choroid Rupture</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood vessel-containing membrane of the eye that lies between the retina and the sclera._Forcible tearing or disruption of tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9445, C12344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>961007</VALIDVALUE>
          <VALUEMEANING>Acute Erythema Nodosum</VALUEMEANING>
          <MEANINGDESCRIPTION>A septal panniculitis characterized by the sudden onset of painful, firm, erythematous nodules or plaques that most commonly erupt on the pretibial extensor surfaces. Though generally idiopathic and self-limited, this disorder may be a sign of a co-morbid systemic disease or the sequela of the use of certain medications.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3303004</VALIDVALUE>
          <VALUEMEANING>Disease or Disorder Due To Arenavirus</VALUEMEANING>
          <MEANINGDESCRIPTION>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Caused by or resulting from._A genus of negative-sense, single-stranded, RNA viruses of the family Arenaviridae that are spherical in shape and enveloped in a lipid membrane. The mechanism of replication is unknown, however new virions containing host ribosomes bud off of the surface of host cells. These zoonotic viruses are found mostly in rodent reservoirs, although the Tacaribe virus was isolated from a bat.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14306, C89272, C2991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222610</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>150003</VALIDVALUE>
          <VALUEMEANING>Abnormal Bladder Continence Question</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm._A question about an individual&#39;s ability to control their bladder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131917, C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1723008</VALIDVALUE>
          <VALUEMEANING>Schistosomiasis Urethral Stricture</VALUEMEANING>
          <MEANINGDESCRIPTION>A parasitic infection caused by flukes of the genus Schistosoma. Signs and symptoms include fever, abdominal pain, eosinophilia and hepatosplenomegaly. If left untreated it may eventually cause liver damage leading to cirrhosis, bladder cancer and kidney failure._Narrowing of the lumen of the urethra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79821, C35000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2534005</VALIDVALUE>
          <VALUEMEANING>Congenital Vena Cava Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormality of the superior or inferior vena cava that is present at birth. Representative examples include persistent left superior vena cava, absence of infrarenal inferior vena cava, or absence of the entire inferior vena cava.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98886</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>962000</VALIDVALUE>
          <VALUEMEANING>Disability Evaluation</VALUEMEANING>
          <MEANINGDESCRIPTION>Any physical or mental impairment that interferes with an individual&#39;s ability to perform desired activities._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25214, C21007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222521</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>151004</VALIDVALUE>
          <VALUEMEANING>Gonococcal Infection Meningitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection that is caused by Gonococcus._A disorder characterized by acute inflammation of the meninges of the brain and/or spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26828, C35730</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212996</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3304005</VALIDVALUE>
          <VALUEMEANING>Bronchial Compression</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or pertaining to, the bronchus._The act, process, or result of pressing together, flattening, or condensing, particularly, increasing an external physical pressure on a body structure. Also refers to the reduction in the volume of a body or substance and augmentation of its density due to pressure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41208, C25222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218966</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2541004</VALIDVALUE>
          <VALUEMEANING>Compulsion Purchase</VALUEMEANING>
          <MEANINGDESCRIPTION>A series of actions or ritualistic behavior that is difficult to suppress and is performed to relieve or prevent anxiety._The action of obtaining something by payment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122672, C94241</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1734006</VALIDVALUE>
          <VALUEMEANING>Spinal Cord Injury Vertebral Fracture</VALUEMEANING>
          <MEANINGDESCRIPTION>Traumatic damage of the spinal cord._Traumatic or pathological injury to the spine in which the continuity of a vertebral bone is broken. Symptoms include back pain and difficulty bending and twisting.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80516, C50750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>964004</VALIDVALUE>
          <VALUEMEANING>Open Injury Pharynx Without Complication</VALUEMEANING>
          <MEANINGDESCRIPTION>Affording unobstructed entrance and exit; affording free passage or access; accessible to all._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity._A hollow tube that starts posterior to the mouth and nasal cavity and ends superior to the trachea and esophagus._Used to indicate the absence or lack of something or someone._Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2959, C25718, C12425, C3671, C49069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222522</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3305006</VALIDVALUE>
          <VALUEMEANING>Lymphatic Vessel Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A tubule that carries lymph throughout the body._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C33038</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1735007</VALIDVALUE>
          <VALUEMEANING>Precordial Palpation Finding of Thrill</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical finding in which humming vibration; accompanying a loud, harsh or rumbling murmur felt during palpation of the precordium or over the blood vessels. (ACC/AHA)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212988</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2556008</VALIDVALUE>
          <VALUEMEANING>Periodontal Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process of the gingival tissues and/or periodontal membrane of the teeth, resulting in an abnormally deep gingival sulcus, possibly producing periodontal pockets and loss of alveolar bone support.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C63743</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>172001</VALIDVALUE>
          <VALUEMEANING>Endometritis Post Molar Pregnancy Indicator And/Or Ectopic Pregnancy</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute or chronic, usually bacterial infectious process affecting the endometrium. It may extend to the myometrium and parametrial tissues. Symptoms include lower abdominal pain, vaginal discharge, and vaginal bleeding._Happening at a time subsequent to a reference time; later in time or order._An indication as to whether a molar pregnancy (hydatidiform mole) has occurred._Used to indicate that either or both of two items or options may be valid._An abnormal pregnancy in which the conception is implanted outside the endometrial cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34945, C48928, C209678, C38008, C26764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3308008</VALIDVALUE>
          <VALUEMEANING>Atrophy Hyperplasia Gastritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Any weakening or degeneration, especially through lack of use._An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement._Inflammation of the stomach.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26780, C3113, C79748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>975000</VALIDVALUE>
          <VALUEMEANING>Anorectal Agenesis</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to the anus and rectum._A congenital abnormality resulting in the absence of an anatomical structure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120864, C129464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1739001</VALIDVALUE>
          <VALUEMEANING>Occipital Fracture</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or related to, or in the direction of the occiput, or back of the head._A traumatic injury to the bone in which the continuity of the bone is broken.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3046, C161326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2582004</VALIDVALUE>
          <VALUEMEANING>Lower Extremity Multiple Anatomic Sites Deep Third-Degree Burn</VALUEMEANING>
          <MEANINGDESCRIPTION>The limb that is composed of the hip, thigh, leg and foot._Present at many sites of the body._Extending relatively far inward._An injury that includes all skin layers into the subcutaneous tissue due to chemical, friction, radiation or thermal exposure. The affected area appears dry and thickened; damage to nerve endings usually renders the wound painless.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C76132, C25240, C13420, C12742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222567</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>175004</VALIDVALUE>
          <VALUEMEANING>Supraorbital Neuralgia</VALUEMEANING>
          <MEANINGDESCRIPTION>Located above the eye socket._Intense painful sensation along a nerve or group of nerves. It is caused by irritation or trauma to a nerve or inflammation of a nerve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79695, C95444</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1742007</VALIDVALUE>
          <VALUEMEANING>Female Hypersexualism</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who belongs to the sex that normally produces ova._Excessive sexual behavior.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118189, C16576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212995</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>978003</VALIDVALUE>
          <VALUEMEANING>Chronic Infancy Eczema</VALUEMEANING>
          <MEANINGDESCRIPTION>Usually used to describe a condition that is persistent and long standing._A human life stage that begins at birth and continues until twelve complete months of age._A form of dermatitis characterized by red, itchy, scaly, or crusty patches that can be chronic or intermittent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3001, C89889, C14141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218945</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3310005</VALIDVALUE>
          <VALUEMEANING>Skin Foreign Body Granuloma</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages._An inflammatory lesion comprised of epithelioid histiocytes and chronic inflammation that is caused by the presence of extraneous material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3066, C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>179005</VALIDVALUE>
          <VALUEMEANING>Dressing Apraxia</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of putting on clothes._A neurological disorder characterized by the inability to execute skilled movements, despite having the willingness, physical ability and understanding of how to perform them.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C180557, C95544</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2585002</VALIDVALUE>
          <VALUEMEANING>Streptococcus pneumoniae Pleuritis</VALUEMEANING>
          <MEANINGDESCRIPTION>A Gram-positive, alpha-hemolytic diplococcus aerotolerant anaerobe Streptococcus species._Inflammation of the pleura. It is usually caused by infections. Chest pain while breathing or coughing is the presenting symptom.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26860, C76384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1748006</VALIDVALUE>
          <VALUEMEANING>Deep Femoral Vein Thrombophlebitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A vein located in the upper thigh that connects, through tributaries, to the popliteal and inferior gluteal veins, and joins the superficial femoral vein at the groin to form the common femoral vein._Inflammation of the veins associated with the presence of a thrombus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3410, C154776</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222535</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3321001</VALIDVALUE>
          <VALUEMEANING>Renal Abscess</VALUEMEANING>
          <MEANINGDESCRIPTION>An abscess that is located within the renal parenchyma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123017</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>981008</VALIDVALUE>
          <VALUEMEANING>Hemorrhage Proctitis</VALUEMEANING>
          <MEANINGDESCRIPTION>The flow of blood from a ruptured blood vessel._An inflammatory process affecting the anus. It is usually caused by sexually transmitted infectious agents and/or inflammatory bowel disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38011, C26791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>181007</VALIDVALUE>
          <VALUEMEANING>Hemorrhage Bronchopneumonia</VALUEMEANING>
          <MEANINGDESCRIPTION>The flow of blood from a ruptured blood vessel._Acute inflammation of the walls of the terminal bronchioles that spreads into the peribronchial alveoli and alveolar ducts.  It results in the creation of foci of consolidation, which are surrounded by normal parenchyma. It affects one or more lobes, and is frequently bilateral and basal.  It is usually caused by bacteria (e.g., Staphylococcus, Streptococcus, Haemophilus influenzae).  Signs and symptoms include fever, cough with production of brown-red sputum, dyspnea, and chest pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26710, C26791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2589008</VALIDVALUE>
          <VALUEMEANING>Acute Dacryoadenitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Having a severe and rapid onset of symptoms with short duration._Inflammation and enlargement of the lacrimal gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26971, C14140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3323003</VALIDVALUE>
          <VALUEMEANING>Penile Leukoplakia</VALUEMEANING>
          <MEANINGDESCRIPTION>A precancerous condition characterized by the presence of abnormal whitish areas on the glans or prepuce of the penis. Risk factors include chronic irritation, inflammation, and infection of the penis, and poor genital hygiene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3151</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212999</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1761006</VALIDVALUE>
          <VALUEMEANING>Biliary Cirrhosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Cirrhosis of the liver caused either by destruction of the intrahepatic bile ducts (primary biliary cirrhosis) or blockage of the extrahepatic bile ducts (secondary biliary cirrhosis).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>987007</VALIDVALUE>
          <VALUEMEANING>Temple Region Cellulitis</VALUEMEANING>
          <MEANINGDESCRIPTION>The flat area on either side of the head that is located posterior to the eye and forehead, anterior to the ear, and superior to the cheek bone._An area or portion of something with more or less definite boundaries designed or specified according to some established biological, administrative, economic, demographic, etc. criteria._Inflammation of the dermis and subcutaneous tissues caused by a bacterial infection. Symptoms include erythema, edema, and pain to the affected area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26715, C41129, C142369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3331008</VALIDVALUE>
          <VALUEMEANING>Open Fracture of Neck of Metacarpal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A traumatic break in the area of the metacarpal bone located between the diaphysis and the distal metaphysis that involves a break in the adjacent skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35358</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>183005</VALIDVALUE>
          <VALUEMEANING>Autoimmune Pancytopenia</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to autoimmunity._A finding of low numbers of red and white blood cells and platelets in the peripheral blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34889, C37916</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1767005</VALIDVALUE>
          <VALUEMEANING>Miller Fisher Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An autoimmune process characterized by the clinical triad of ophthalmoplegia, ataxia, and areflexia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116958</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2591000</VALIDVALUE>
          <VALUEMEANING>Shoulder Crush Injury</VALUEMEANING>
          <MEANINGDESCRIPTION>The region of the body between the neck and the upper arm._Traumatic compression of the body or a part of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35375, C25203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222570</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3344003</VALIDVALUE>
          <VALUEMEANING>Toxin Labyrinthitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chemical, physical, or biological agent that causes disease or some alteration of the normal structure and function of an organism. Usually refers to poisonous substance produced during the metabolism and growth of certain microorganisms and some higher plant and animal species, or any poisonous isomer, homolog, or derivative of such a substance. It causes either permanent or reversible injury to the health of a living thing on contact or absorption, typically by interacting with biological macromolecules such as enzymes and receptors. Onset of effects may be immediate or delayed, and impairments may be slight or severe. (NCI)_Inflammation of the anatomical structures of the inner ear secondary to an infectious process. Symptoms include severe vertigo, nausea, vomiting, anxiety, and pain. Viral etiology is most common, and recent history of an upper respiratory infection is common.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128369, C894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1776003</VALIDVALUE>
          <VALUEMEANING>Renal Tubular Acidosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Failure of the renal tubules of the kidney to excrete urine of normal acidity resulting in metabolic acidosis. It may lead to hypercalcinuria, nephrolithiasis, and renal failure. Causes include autoimmune disorders (e.g., Sjogren syndrome, systemic lupus erythematosus, and rheumatoid arthritis), medications (e.g., non steroidal anti-inflammatory drugs, diuretics, and blood pressure medications), Fanconi syndrome, or it may be familiar.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2593002</VALIDVALUE>
          <VALUEMEANING>Dubowitz Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, autosomal recessive inherited syndrome characterized by microcephaly, growth retardation, and a small, round, triangular shaped face with a pointed, receding chin, a broad, wide-tipped nose, and wide-set eyes with drooping eyelids.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125591</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>998008</VALIDVALUE>
          <VALUEMEANING>Chagas Disease With Heart Involvement</VALUEMEANING>
          <MEANINGDESCRIPTION>A parasitic infection caused by Trypanosoma cruzi. It is transmitted by insect bites. It is characterized by an acute and chronic phase; in the acute phase patients may have fever, malaise, and swelling at the site of the insect bite. In the chronic phase patients develop hepatosplenomegaly, lymphadenopathy, cardiomyopathy and arrhythmias._Used to indicate the presence of something or someone._A hollow organ located slightly to the left of the middle portion of the chest. It is composed of muscle and it is divided by a septum into two sides: the right side which receives de-oxygenated blood from the body and the left side which sends newly oxygenated blood to the body. Each side is composed of two chambers: the atrium (receiving blood) and ventricle (ejecting blood)._To have a connection by participation or association or use; sharing in an activity or process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25548, C12727, C62355, C84629</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213009</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>188001</VALIDVALUE>
          <VALUEMEANING>Intercostal Artery Injury</VALUEMEANING>
          <MEANINGDESCRIPTION>The nine paired arteries arising from the aorta that supply the intercostal spaces (area between the ribs)._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3671, C32821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213025</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3345002</VALIDVALUE>
          <VALUEMEANING>Idiopathic Osteoporosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Arising from an unknown or unidentified cause._A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3298, C28242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2602008</VALIDVALUE>
          <VALUEMEANING>Shoulder Hemarthrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>The region of the body between the neck and the upper arm._Bleeding into a joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C206552, C25203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222571</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1778002</VALIDVALUE>
          <VALUEMEANING>Abnormal Swallowing Malocclusion</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm._The act of passing something through the mouth and throat into the stomach._An inherited or acquired dental abnormality characterized by improper alignment of the teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85055, C38028, C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>192008</VALIDVALUE>
          <VALUEMEANING>Congenital Syphilis Hepatomegaly</VALUEMEANING>
          <MEANINGDESCRIPTION>A life-threatening bacterial infection of the newborn caused by Treponema pallidum. It is transmitted to the infant from a mother with syphilis through the placenta during pregnancy. Signs and symptoms include irritability, fever, failure to thrive, saddle nose, cutaneous rash, and pneumonia._Abnormal enlargement of the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3100, C84649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218930</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1003002</VALIDVALUE>
          <VALUEMEANING>Religious Beliefs Discrimination</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual&#39;s belief in a system of philosophy, history and myth that relates humanity to divinity or spirituality, and from which, ethical and moral values may be derived._The unfair treatment of a person or group based on class or category bias.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92450, C189174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213017</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3368006</VALIDVALUE>
          <VALUEMEANING>Dull Chest Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>The sensation of chest pain described as a mild or blunted discomfort.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2606006</VALIDVALUE>
          <VALUEMEANING>Perineum Furuncle</VALUEMEANING>
          <MEANINGDESCRIPTION>The area located between the anus and vulva in females, and anus and scrotum in males._Bacterial infection of the hair follicle and the surrounding skin. It is caused by Staphylococcus aureus. It presents as a painful, erythematous and swollen skin lesion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99087, C33301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218963</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1794009</VALIDVALUE>
          <VALUEMEANING>Idiopathic Corneal Edema</VALUEMEANING>
          <MEANINGDESCRIPTION>Arising from an unknown or unidentified cause._Hazy, swollen cornea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50508, C28242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3391005</VALIDVALUE>
          <VALUEMEANING>Negative for Neoplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A microscopic finding indicating the absence of neoplastic cells in a tissue sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>198007</VALIDVALUE>
          <VALUEMEANING>Disease or Disorder Due To Filoviridae</VALUEMEANING>
          <MEANINGDESCRIPTION>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Caused by or resulting from._A family of filamentous viruses with helical capsids and glycoprotein projections on their surface. The virus may have a branched morphology of varying length. The genome is composed of a linear single-strand of negative sense RNA. Filoviridae infect primates, pigs and bats in nature and are a causitive agent of viral hemorrhagic fevers in humans and primates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112031, C89272, C2991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218931</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1020003</VALIDVALUE>
          <VALUEMEANING>Disease or Disorder Due To Nairovirus</VALUEMEANING>
          <MEANINGDESCRIPTION>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Caused by or resulting from._A genus of enveloped, spherical viruses in the family Bunyaviridae. The genome is composed of a circular single-strand of negative sense RNA. Nairoviruses are tick-borne with human and animal hosts and cause hemorrhagic fevers and gastroenteritis in humans.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112358, C89272, C2991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2615004</VALIDVALUE>
          <VALUEMEANING>Graafian Follicle Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the fluid-filled vesicles in the mammalian ovary containing a maturing ovum._A sac-like closed membranous structure that may be empty or contain fluid or amorphous material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2978, C32692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3398004</VALIDVALUE>
          <VALUEMEANING>Cadmium Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>An element with atomic symbol Cd, atomic number 48, and atomic weight 112.4._Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C44348</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213023</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>199004</VALIDVALUE>
          <VALUEMEANING>Decreased Lactating</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective response indicating that something is or has decreased._An indication that the subject is currently producing milk.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82463, C164132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1822007</VALIDVALUE>
          <VALUEMEANING>Impairment Glucose Intolerance Pancreatic Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Loss or abnormality of psychological, physiological, or anatomic structure or function._The inability to regulate blood glucose levels resulting in hyperglycemia._Of or pertaining to the pancreas._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C25726, C34646, C21055</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1023001</VALIDVALUE>
          <VALUEMEANING>Apnea</VALUEMEANING>
          <MEANINGDESCRIPTION>Transient cessation of respiration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2618002</VALIDVALUE>
          <VALUEMEANING>Chronic Major Depressive Disorder, Recurrent, Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Usually used to describe a condition that is persistent and long standing._Evidence of major depressive disorder, recurrent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C195908, C14141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>208008</VALIDVALUE>
          <VALUEMEANING>Neurocutaneous Melanosis Sequence</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital condition characterized by the presence of giant and/or multiple satellite congenital melanocytic nevi in the skin and benign melanocytic pigmentation of the leptomeninges._A serial arrangement in which things follow in logical order or a recurrent pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25673, C175215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213038</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1027000</VALIDVALUE>
          <VALUEMEANING>Biliary Esophagitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A term that refers to the biliary tract structures._An acute or chronic inflammatory process affecting the esophageal wall.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9224, C28011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213027</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1824008</VALIDVALUE>
          <VALUEMEANING>Eosinophilic Gastritis</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunoinflammatory disorder of the stomach characterized by eosinophilic infiltration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27052</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16225413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3419005</VALIDVALUE>
          <VALUEMEANING>Faucial Diphtheria</VALUEMEANING>
          <MEANINGDESCRIPTION>Infection of the fauces by Corynebacterium diphtheriae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213029</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2622007</VALIDVALUE>
          <VALUEMEANING>Skin Ulcer Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>A circumscribed and often suppurating skin crater which usually includes loss of skin integrity of the superficial skin or the mucous membranes._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320, C54247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1826005</VALIDVALUE>
          <VALUEMEANING>Granuloma Granuloma</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory reaction usually caused by infectious organisms, foreign bodies, or cholesterol deposits. It is characterized by the presence of epithelioid histiocytes and chronic inflammation._An inflammatory reaction usually caused by infectious organisms, foreign bodies, or cholesterol deposits. It is characterized by the presence of epithelioid histiocytes and chronic inflammation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3064, C3064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222539</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>222008</VALIDVALUE>
          <VALUEMEANING>Acute Epiglottitis With Obstruction</VALUEMEANING>
          <MEANINGDESCRIPTION>Having a severe and rapid onset of symptoms with short duration._Inflammation of the epiglottis._Used to indicate the presence of something or someone._Blockage of the normal flow of the contents of an anatomical passageway.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3284, C62355, C116007, C14140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2624008</VALIDVALUE>
          <VALUEMEANING>Prepuberty Periodontitis</VALUEMEANING>
          <MEANINGDESCRIPTION>The period of development immediately prior to the onset of puberty when changes occur that lead to sexual maturity._An acute or chronic inflammatory process that affects the tissues that surround and support the teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34918, C87136</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1031006</VALIDVALUE>
          <VALUEMEANING>Open Injury Trachea Without Complication</VALUEMEANING>
          <MEANINGDESCRIPTION>Affording unobstructed entrance and exit; affording free passage or access; accessible to all._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity._The fibrocartilaginous, mucous-lined tube passing from the larynx to the bronchi._Used to indicate the absence or lack of something or someone._Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2959, C25718, C12428, C3671, C49069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213032</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3424008</VALIDVALUE>
          <VALUEMEANING>Rapidly Heart Rate</VALUEMEANING>
          <MEANINGDESCRIPTION>Acting or occurring in a brief period of time._The number of heartbeats per unit of time, usually expressed as beats per minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49677, C65069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>241006</VALIDVALUE>
          <VALUEMEANING>Simple Partial Motor Status Epilepticus</VALUEMEANING>
          <MEANINGDESCRIPTION>Status epilepticus that is characterized by focal motor seizures of which the individual is aware.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213047</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2634004</VALIDVALUE>
          <VALUEMEANING>Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2869</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4291759</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3426005</VALIDVALUE>
          <VALUEMEANING>Retain Magnet Device Intraocular Foreign Body</VALUEMEANING>
          <MEANINGDESCRIPTION>To maintain possession of something._A device that attracts iron and produces a magnetic field._External material inside the eyeball.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118742, C50040, C99569</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1835003</VALIDVALUE>
          <VALUEMEANING>Pancreatic Necrotic Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>A necrotic process affecting the pancreas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1033009</VALIDVALUE>
          <VALUEMEANING>Thoracic Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the chest._An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2883, C13360</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213036</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2638001</VALIDVALUE>
          <VALUEMEANING>Hypercalcemia Due To Pharmacologic Substance</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormally high concentration of calcium in the peripheral blood._Caused by or resulting from._Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1909, C89272, C3112</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1845001</VALIDVALUE>
          <VALUEMEANING>Paraparesis</VALUEMEANING>
          <MEANINGDESCRIPTION>A slight paralysis or weakness of both legs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7797416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>257006</VALIDVALUE>
          <VALUEMEANING>Rosacea Erythema Telangiectasia Type</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic erythematous skin disorder that affects the face. It is characterized by the development of redness in the cheeks, nose, and/or forehead and telangiectasia. Sometimes, the erythematous changes may involve the eyelids._Red discoloration of the skin caused by infectious agents, inflammation, drug hypersensitivity, or underlying disease._Local dilatation of small vessels resulting in red discoloration of the skin or mucous membranes._Something distinguishable as an identifiable class based on common qualities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25284, C28194, C26901, C97136</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222492</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3434004</VALIDVALUE>
          <VALUEMEANING>Myotonia Fluctuans</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant inherited potassium aggravated myotonia caused by mutations of the SCN4A gene. It is characterized by mild muscle stiffness that develops during rest approximately an hour after exercise and lasts for about an hour.  It worsens by ingestion of potassium-rich food.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213039</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1034003</VALIDVALUE>
          <VALUEMEANING>Superior Mesenteric Artery Portal Vein Fistula</VALUEMEANING>
          <MEANINGDESCRIPTION>An artery arising from the abdominal aorta with numerous branches that supply the intestines from the duodenum to the transverse colon and the pancreas._A short thick trunk vein that transports blood containing the absorbed products of digestion from the intestine directly to the liver._Abnormal epithelial-lined communication between two anatomical structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3045, C33343, C33685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213040</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1847009</VALIDVALUE>
          <VALUEMEANING>Endophthalmitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infectious process affecting the internal structures of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3441005</VALIDVALUE>
          <VALUEMEANING>Sebaceous Gland Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Small glands located within the epidermis, and associated with the hair follicle, that produce and secrete an oily substance that lubricates the skin and hair._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C33519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2640006</VALIDVALUE>
          <VALUEMEANING>Clinical Stage IV</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._Cancer that has spread to distant anatomic sites beyond its original site of growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27971, C25398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213048</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>264008</VALIDVALUE>
          <VALUEMEANING>Blindness due to Hypertensive Retinopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Blindness caused by prolonged high blood pressure in the retina.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1848004</VALIDVALUE>
          <VALUEMEANING>Gas Anesthetic Agent Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>A fluid in the gaseous state having neither independent shape nor volume and being able to expand indefinitely._A pharmacological agent that acts in a reversible fashion and can be applied either locally or systemically to cause a partial or total loss of sensation and pain or to induce unconsciousness._Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C245, C45299</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213046</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3449007</VALIDVALUE>
          <VALUEMEANING>Finger Agnosia</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the digits of the hand._A rare disorder characterized by the lack of ability to recognize individuals, objects, shapes, sounds, or smells. There is no loss of memory. It is caused by neurological damage in the brain, specifically in the occipital or parietal lobes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84542, C32608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222616</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1051005</VALIDVALUE>
          <VALUEMEANING>Alpha Cell Hyperplasia With Gastrin Excessive</VALUEMEANING>
          <MEANINGDESCRIPTION>A cell in the periphery of the pancreatic islets that secretes glucagon._An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement._Used to indicate the presence of something or someone._Gastrin (101 aa, ~11 kDa) is encoded by the human GAST gene. This protein plays a role in the modulation of gastric acid and pancreatic digestive enzyme secretion._Beyond normal limits; unrestrained.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73992, C94668, C62355, C3113, C32052</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>279001</VALIDVALUE>
          <VALUEMEANING>Elderly Myocarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>An age group comprised of individuals 65 years of age and older._Inflammation of the muscle tissue of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34831, C16268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2651006</VALIDVALUE>
          <VALUEMEANING>Elbow Joint Injury Closed Dislocation</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of hinge joint located between the forearm and upper arm._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity._A dislocation not complicated by an external wound</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35705, C3671, C32497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1855002</VALIDVALUE>
          <VALUEMEANING>Developmental Finding Learning Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Symptoms, physical examination results, and/or laboratory test results related to physical, emotional, behavioral, or social development._A group of disorders that affect a person&#39;s ability to learn or process specific types of information which is in contrast to his/her apparent level of intellect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C89334, C168182</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>290006</VALIDVALUE>
          <VALUEMEANING>Melnick-Fraser Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant inherited syndrome caused by mutations in the EYA1, SIX1, and SIX5 genes. It is characterized by the abnormal development of the second branchial arch, resulting in the formation of branchial cleft cysts and fistulae, hearing loss and ear malformations, and renal abnormalities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2663001</VALIDVALUE>
          <VALUEMEANING>Palpation Range</VALUEMEANING>
          <MEANINGDESCRIPTION>A method of feeling with the hands during a physical examination. The health care provider touches and feels the patient&#39;s body to examine the size, consistency, texture, location and tenderness of an organ or body part._The difference between the lowest and highest numerical values; the limits or scale of variation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38013, C16950</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3456001</VALIDVALUE>
          <VALUEMEANING>Chronic Progressive Negation Inherited Chorea</VALUEMEANING>
          <MEANINGDESCRIPTION>Usually used to describe a condition that is persistent and long standing._Advancing in extent or severity._An operation in which a term denies or inverts the meaning of another term or construction._Transmitted through genes from parents to offspring. (genome.gov)_A neurological condition affecting the involuntary movements. It is characterized by brief, non-repetitive irregular muscle contractions. It is seen in patients with Huntington&#39;s disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84633, C28018, C25594, C25254, C14141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1070000</VALIDVALUE>
          <VALUEMEANING>Facial Myokymia</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or related to, or in the direction of the face._A disorder characterized by involuntary and irregular muscle contractions not associated with muscle weakness or atrophy. It most often affects facial muscles. It may be localized or generalized.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84911, C161327</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213050</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1857005</VALIDVALUE>
          <VALUEMEANING>Congenital Rubella</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition, whose clinical manifestations include intrauterine growth restriction, petechial rash, jaundice, generalized lymphadenopathy, hepatosplenomegaly, peripheral pulmonary stenosis, cataracts, and sensorineural deafness, that is caused by fetal exposure to the rubella virus during the first trimester of pregnancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>292003</VALIDVALUE>
          <VALUEMEANING>Electroencephalography Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>The neurophysiologic exploration of the electrical activity of the brain by the application of electrodes to the scalp. The resulting traces are known as an electroencephalogram (EEG). This test is used to assess brain damage, epilepsy and other problems._Clinical, laboratory or molecular evidence, or absence of evidence of disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3367, C38054</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218932</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2665008</VALIDVALUE>
          <VALUEMEANING>Coordination Seizure</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of bringing into common action, movement, or condition._Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2962, C25462</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1073003</VALIDVALUE>
          <VALUEMEANING>Xeroderma Pigmentosum, Complementation Group B</VALUEMEANING>
          <MEANINGDESCRIPTION>Xeroderma pigmentosum caused by bi-allelic mutations in ERCC3 gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1869002</VALIDVALUE>
          <VALUEMEANING>Iris Sphincter Rupture</VALUEMEANING>
          <MEANINGDESCRIPTION>The colored disc of the eye composed of connective tissue, epithelium, and endothelium. It separates the anterior chamber from the posterior chamber._A circular band of muscle that functions to regulate the size of an orifice in the body._Forcible tearing or disruption of tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9445, C28381, C12737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>310008</VALIDVALUE>
          <VALUEMEANING>Penis Furuncle</VALUEMEANING>
          <MEANINGDESCRIPTION>The male organ of urination and copulation._Bacterial infection of the hair follicle and the surrounding skin. It is caused by Staphylococcus aureus. It presents as a painful, erythematous and swollen skin lesion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99087, C12409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2694001</VALIDVALUE>
          <VALUEMEANING>Myelophthisis</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition resulting from the destruction of bone marrow precursor cells and their stroma. Bone marrow is displaced by fibrosis, tumors, or granulomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C197938</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1074009</VALIDVALUE>
          <VALUEMEANING>Familial Hyperaldosteronism Type 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Familial hyperaldosteronism caused by a chimeric gene containing regions of CYP11B1 and CYP11B2. This condition is responsive to exogenous glucocorticoids.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3458000</VALIDVALUE>
          <VALUEMEANING>Myositis Ossificans Associated With Dermatomyositis And/Or Polymyositis</VALUEMEANING>
          <MEANINGDESCRIPTION>A self-limited benign neoplasm characterized by a zonal architecture. It is composed of spindle cells oriented randomly or in short intersecting fascicles. Peripherally, the spindle cells merge with osteoblasts that rim and populate ill-defined trabeculae and sheets of unmineralized woven bone, which is surrounded by well-formed trabecular and cortical-type bone that remodels into lamellar bone. Treatment is usually simple excision. Prognosis is excellent; recurrence is uncommon. (WHO 2020)_Joined in some kind of relationship._Used to indicate the presence of something or someone._Inflammation of the skin and muscle._Used to indicate that either or both of two items or options may be valid._An idiopathic inflammatory disorder affecting the muscles. It presents with symmetrical proximal muscle weakness and elevated skeletal muscle enzymes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26925, C48928, C26744, C62355, C25281, C3253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2704003</VALIDVALUE>
          <VALUEMEANING>Acute Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A disease that is characterized by a sudden onset and short duration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C209926</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>317006</VALIDVALUE>
          <VALUEMEANING>Reactive Hypoglycemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Showing a response to a stimulus._Abnormally low level of glucose in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3126, C206329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1881003</VALIDVALUE>
          <VALUEMEANING>Increase Nutritional Requirements Research</VALUEMEANING>
          <MEANINGDESCRIPTION>A process of becoming larger, more numerous, more important, or more likely._Studies on the components within food, including proteins, carbohydrates, fats, vitamins, minerals, and other factors, required to maintain a healthy body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15287, C25533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1077002</VALIDVALUE>
          <VALUEMEANING>Septal Myocardial Infarction by ECG Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiographic finding suggesting an infarction in the anatomic location of the cardiac septum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35519</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6659174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>320003</VALIDVALUE>
          <VALUEMEANING>Cervical Dilation</VALUEMEANING>
          <MEANINGDESCRIPTION>A stretching and opening of the cervical os during childbirth in preparation for delivery of the baby; the diameter is measured in centimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1079004</VALIDVALUE>
          <VALUEMEANING>Cystoid Macular Edema</VALUEMEANING>
          <MEANINGDESCRIPTION>An accumulation of fluid in the outer plexiform layer, secondary to an increase in permeability of perifoveal retinal capillaries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34794</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1896004</VALIDVALUE>
          <VALUEMEANING>Ectopic Tissue Mammary Gland Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>A tissue that forms in a location of the body at or in which it is not normally associated._The glandular tissue of the breast.  In females, it is composed of numerous lobules with alveolar ducts and alveoli.  In males, it is composed of rudimentary glands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12370, C132486</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222540</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3461004</VALIDVALUE>
          <VALUEMEANING>Deep Third-Degree Burn Hand Digit 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Extending relatively far inward._An injury that includes all skin layers into the subcutaneous tissue due to chemical, friction, radiation or thermal exposure. The affected area appears dry and thickened; damage to nerve endings usually renders the wound painless._The thick and short hand digit which is next to the index finger in humans.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52834, C76132, C25240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222618</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>324007</VALIDVALUE>
          <VALUEMEANING>Plaster Ulcer</VALUEMEANING>
          <MEANINGDESCRIPTION>An ulcer that is formed on the skin due to constant pressure or rubbing from a plaster cast.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213079</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1085006</VALIDVALUE>
          <VALUEMEANING>Vulva Candidiasis</VALUEMEANING>
          <MEANINGDESCRIPTION>The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia._Infection with the organism Candida.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26711, C12408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2725003</VALIDVALUE>
          <VALUEMEANING>Previous Abnormality Glucose Tolerance</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else._A condition that differs from the usual physical or mental state._A simple sugar monosaccharide having two isoforms, alpha and beta, with a chemical structure of C6H12O6 that acts as an energy source for both plants and animals by reacting with oxygen, generating carbon dioxide and water, and releasing energy._The allowable deviation from a standard; a permissible difference.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43414, C2831, C9440, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222578</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>330007</VALIDVALUE>
          <VALUEMEANING>Occipital Headache</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or related to, or in the direction of the occiput, or back of the head._Pain in various parts of the head, not confined to the area of distribution of any nerve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34661, C161326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3468005</VALIDVALUE>
          <VALUEMEANING>Newborn Infection Mastitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An age group comprised of infants during the first month after birth._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce._Inflammation of breast tissue during lactation or postpartum due to an obstructed duct or infection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53662, C128320, C16731</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222619</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1089000</VALIDVALUE>
          <VALUEMEANING>Congenital Septicemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting something that is present at birth._The presence of pathogenic microorganisms in the blood stream causing a rapidly progressing systemic reaction that may lead to shock. Symptoms include fever, chills, tachycardia, and increased respiratory rate. It is a medical emergency that requires urgent medical attention.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3364, C99210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218946</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1939005</VALIDVALUE>
          <VALUEMEANING>Abnormal Vascular Blood Circulation</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm._Relating to or containing blood vessels._The movement of blood to and from the heart and to the rest of the body&#39;s organs, tissues, and cells through the network of arteries, veins, and capillaries. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16353, C13311, C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2733002</VALIDVALUE>
          <VALUEMEANING>Heel of the Foot Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>The rounded back part of the foot below the ankle and behind the arch._The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3303, C161381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222579</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>349006</VALIDVALUE>
          <VALUEMEANING>Areflexia</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding indicating the complete absence of neurological reflexes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C115420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4320530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3469002</VALIDVALUE>
          <VALUEMEANING>Hand Digit 1 Second-Degree Burn</VALUEMEANING>
          <MEANINGDESCRIPTION>The thick and short hand digit which is next to the index finger in humans._An injury that includes the entire epidermis and upper layers of the dermis due to a chemical, friction, radiation or thermal exposure. The affected area appears as moist red or white skin that does not blanch. Often it is painful with the presence of blisters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C76131, C52834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1111005</VALIDVALUE>
          <VALUEMEANING>Normal Sebaceous Gland Activity</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm._Small glands located within the epidermis, and associated with the hair follicle, that produce and secrete an oily substance that lubricates the skin and hair._An active process; excludes processes and mechanisms which fulfill biological functions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43431, C33519, C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>355001</VALIDVALUE>
          <VALUEMEANING>Hemorrhagic Shock</VALUEMEANING>
          <MEANINGDESCRIPTION>Hypoperfusion of body tissues due to acute blood loss, resulting in cellular injury and vital organ dysfunction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35017</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2740001</VALIDVALUE>
          <VALUEMEANING>Gout Proteinuria</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals._The presence of abnormal amounts of protein in the urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38012, C34650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222580</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3474005</VALIDVALUE>
          <VALUEMEANING>Soybean Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>No value exists._Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C72010</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218969</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>357009</VALIDVALUE>
          <VALUEMEANING>Closed Fracture Trapezoid Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A traumatic break to the bone in which the continuity of the bone has not broken through the skin._A carpal bone located between the trapezium and capitate bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12859, C34623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1961000</VALIDVALUE>
          <VALUEMEANING>Polyarticular Arthritis Juvenile Rheumatoid Arthritis</VALUEMEANING>
          <MEANINGDESCRIPTION>An arthritis affecting five or more separate joints._An older, deprecated term that encompassed three major types of autoimmune or autoinflammatory arthritis in children: systemic-onset, pauciarticular, or polyarticular arthritis. The juvenile rheumatoid arthritis classification system has been replaced by the International League of Associations for Rheumatology (ILAR) juvenile idiopathic arthritis classification system.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27179, C26996</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2749000</VALIDVALUE>
          <VALUEMEANING>Congenital Deformity of Hip</VALUEMEANING>
          <MEANINGDESCRIPTION>Any anatomic abnormality of the hip that is present at the time of birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34881</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1112003</VALIDVALUE>
          <VALUEMEANING>Degenerative Disorder Eyelid</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by the progressive loss of function and/or structure of the affected tissues._A thin membrane of skin with the purpose of covering and protecting an eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12713, C27090</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3480002</VALIDVALUE>
          <VALUEMEANING>Wrist Joint Burn</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint between the distal end of the radius and the proximal row of carpal bones._A traumatic injury involving interruption of tissue cohesiveness that results from exposure to caustic chemicals, extreme heat, extreme cold or excessive radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34441, C33894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1963002</VALIDVALUE>
          <VALUEMEANING>Paroxysmal Nocturnal Hemoglobinuria</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare acquired hematologic disorder characterized by hemolytic anemia, dark-colored urine due to the release of hemoglobin in the blood, and thrombosis. The episodes of hemolysis tend to occur at night. It is caused by a somatic mutation in the glycosylphosphatidylinositol biosynthesis gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2764000</VALIDVALUE>
          <VALUEMEANING>Joint Crepitus</VALUEMEANING>
          <MEANINGDESCRIPTION>The connection point between two bones or skeletal elements. The joint may be fixed or movable._Air trapped in the subcutaneous space. It can be palpated or heard as a crackling or grating sensation under the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121573, C13044</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222581</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>358004</VALIDVALUE>
          <VALUEMEANING>MVA-BN Smallpox Vaccine Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>A vaccine consisting of modified vaccinia Ankara-Bavarian Nordic (MVA-BN), a live, attenuated, non-replicating, proprietary version of the MVA virus, used for the prevention of smallpox and monkeypox, with potential antineoplastic activity. Upon intratumoral administration, MVA-BN smallpox vaccine may induce both cellular and humoral immune responses, which may lead to tumor cell lysis._Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C173552</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1116000</VALIDVALUE>
          <VALUEMEANING>Chronic Hepatitis B</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatitis B infection persisting longer than six months.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C212171</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3482005</VALIDVALUE>
          <VALUEMEANING>Postoperative Esophagitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to or occurring during the period immediately following a surgical operation._An acute or chronic inflammatory process affecting the esophageal wall.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9224, C28006</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222620</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>359007</VALIDVALUE>
          <VALUEMEANING>Kernicterus Related to Isoimmunization</VALUEMEANING>
          <MEANINGDESCRIPTION>Encephalopathy in infants due to high levels of unconjugated bilirubin that are a result of Rh incompatibility between the mother and the fetus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101270</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2772003</VALIDVALUE>
          <VALUEMEANING>Epidermolysis Bullosa Acquisita</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic autoimmune inflammatory disorder characterized by the formation of subepidermal blisters in the skin and the mucous membranes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84690</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211048</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1965009</VALIDVALUE>
          <VALUEMEANING>Normal Skin pH</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm._An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages._Quantity of dimension one used to express on a scale from 0 to 14 the amount-of-substance concentration of hydrogen ion of dilute aqueous solution, calculated as the logarithm of the reciprocal of hydrogen-ion concentration in gram atoms per liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45997, C12470, C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1124005</VALIDVALUE>
          <VALUEMEANING>Postpartum</VALUEMEANING>
          <MEANINGDESCRIPTION>The period of time immediately after labor and delivery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213088</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3483000</VALIDVALUE>
          <VALUEMEANING>Chronic or Unspecified Peptic Ulcer, Site Unspecified, with Perforation</VALUEMEANING>
          <MEANINGDESCRIPTION>Evidence of chronic or unspecified peptic ulcer, site unspecified, with perforation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C196819</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213089</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>360002</VALIDVALUE>
          <VALUEMEANING>Acute Radiation Toxicity</VALUEMEANING>
          <MEANINGDESCRIPTION>Toxicities that present across multiple organ systems that are noted within days to weeks of exposure to ionizing radiation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213106</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2776000</VALIDVALUE>
          <VALUEMEANING>Organic Brain Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A mental disorder caused by intrinsic disease which is characterized by acute or chronic impairment of intellectual functioning, behavior, mood or judgment. It is attributable to a medical etiology and excludes a primary psychiatric cause. A chronic course usually correlates to a poorer prognosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34868</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1977004</VALIDVALUE>
          <VALUEMEANING>Oxymetholone Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally active synthetic anabolic steroid and a 17alpha-methylated derivative of dihydrotestosterone, with androgenic activity. Although oxymetholone has low affinity for binding the androgen receptor (AR), it strongly activates AR-mediated signaling, which stimulates both protein synthesis and erythropoietin production. This agent may stimulate muscle growth, induce hemoglobin production and red blood cell formation, and promote increased bone density._Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C723</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1125006</VALIDVALUE>
          <VALUEMEANING>Septicemia During Birthing Labor</VALUEMEANING>
          <MEANINGDESCRIPTION>The presence of pathogenic microorganisms in the blood stream causing a rapidly progressing systemic reaction that may lead to shock. Symptoms include fever, chills, tachycardia, and increased respiratory rate. It is a medical emergency that requires urgent medical attention._At some point in a given period of time._Uterine contractions resulting in cervical change (dilation and/or effacement). (reVITALize)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92743, C25490, C3364</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3487004</VALIDVALUE>
          <VALUEMEANING>Pulmonary Candidiasis</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract._Infection with the organism Candida.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26711, C13304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222621</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>368009</VALIDVALUE>
          <VALUEMEANING>Valvular Heart Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Any heart disorder characterized by a defect in valve structure or function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45525</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210765</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2782002</VALIDVALUE>
          <VALUEMEANING>Jaw Joint Dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>The joint between the head of the lower mandible and the temporal bone._A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns. The cellular changes include nuclear and cytoplasmic abnormalities. Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4086, C32888</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222582</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1979001</VALIDVALUE>
          <VALUEMEANING>Focal Posterior Uveitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Limited to a specific area._An inflammatory process that affects the choroid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35111, C28224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3502005</VALIDVALUE>
          <VALUEMEANING>Cervical Lymphadenitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the cervical lymph nodes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26937</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>369001</VALIDVALUE>
          <VALUEMEANING>Normal Jugular Venous Pressure</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm._The estimated height of the mean jugular venous waveform above the right atrium, as measured by observation of the bifid pulsation while the patient is supine and their neck is inclined at a 45 degree angle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C191459, C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2783007</VALIDVALUE>
          <VALUEMEANING>Gastrojejunal Ulcer, Unspecified as Acute or Chronic, without Hemorrhage or Perforation</VALUEMEANING>
          <MEANINGDESCRIPTION>Evidence of gastrojejunal ulcer, unspecified as acute or chronic, without hemorrhage or perforation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C196831</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1980003</VALIDVALUE>
          <VALUEMEANING>Secretory Otitis Media</VALUEMEANING>
          <MEANINGDESCRIPTION>Otitis media associated with accumulation of fluid in the middle ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34886</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>378007</VALIDVALUE>
          <VALUEMEANING>Morquio Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal recessive lysosomal storage disease characterized by abnormal skeletal developments, dwarfism, heart disorders, and central nervous system deficits.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593471</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1131009</VALIDVALUE>
          <VALUEMEANING>Congenital Valvular Insufficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting something that is present at birth._Dysfunction of one of the cardiac valves characterized by incomplete valve closure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50796, C99210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218947</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3505007</VALIDVALUE>
          <VALUEMEANING>Arm Negation Biomedicine Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb._An operation in which a term denies or inverts the meaning of another term or construction._The branch of medical science that applies biological and physiological principles to clinical practice._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3824, C61479, C25594, C32141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213102</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2786004</VALIDVALUE>
          <VALUEMEANING>Ovarian Epithelial Tumor FIGO Stage III</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, borderline, or malignant tumor that originates from the surface epithelium of the ovary.  It is composed of epithelial cells and stroma.  Representative examples of benign tumors include serous cystadenoma, mucinous cystadenoma, and benign Brenner tumor.  Representative examples of borderline tumors include serous surface papillary tumor, mucinous adenofibroma, and borderline Brenner tumor.  Representative examples of malignant tumors include serous adenocarcinoma, mucinous adenocarcinoma, endometrioid adenocarcinoma, and malignant Brenner tumor._A FIGO stage term that applies to gynecologic cancers.  For cervical cancer, it refers to cancer that extends to the pelvic wall, and/or involves the lower third of vagina, and/or causes hydronephrosis or non-functioning kidney; for endometrial cancer, FIGO stage III is subdivided into stages IIIA and IIIB; in FIGO stage IIIA, there is involvement of the serosa and/or the adnexa; for FIGO stage IIIB, there is vaginal or parametrial involvement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96255, C4381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1989002</VALIDVALUE>
          <VALUEMEANING>Vagina And/Or Uterus Burning Sensation</VALUEMEANING>
          <MEANINGDESCRIPTION>The female genital canal, extending from the uterus to the vulva._Used to indicate that either or both of two items or options may be valid._A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy._A sensation of stinging or heat, not necessarily accompanied by redness or physical signs of irritation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50476, C12405, C48928, C12407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222543</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1134001</VALIDVALUE>
          <VALUEMEANING>Muehrcke Lines</VALUEMEANING>
          <MEANINGDESCRIPTION>Multiple transverse white lines that occur parallel to the lunula. They are commonly seen in association with hypoalbuminemia or in those individuals undergoing chemotherapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>383004</VALIDVALUE>
          <VALUEMEANING>Hip Joint Passive Range of Motion Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A ball-and-socket joint between the head of the femur and the acetabulum._A measure of how far a joint can move when it is being manipulated by someone other than the patient._Clinical, laboratory or molecular evidence, or absence of evidence of disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3367, C63512, C32742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2805007</VALIDVALUE>
          <VALUEMEANING>Phosmet Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic trialkyl phosphate compound and organophosphate acetylcholinesterase inhibitor that is used as a pesticide. It is characterized as an off-white crystalline solid with an offensive odor, and exposure occurs by inhalation, ingestion, or contact._Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C76877</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3506008</VALIDVALUE>
          <VALUEMEANING>Retinal Artery Stenosis</VALUEMEANING>
          <MEANINGDESCRIPTION>An artery arising from the ophthalmic artery that supplies the retina._Narrowing or stricture of a vessel, duct or canal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50754, C52997</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1151008</VALIDVALUE>
          <VALUEMEANING>Narrow Visual Field</VALUEMEANING>
          <MEANINGDESCRIPTION>Having a width, or side to side dimension, that is less than is normally expected._Relating to or using sight; able to be seen._The region in which a particular type of force can be observed, often viewed as a space which was modified by the sources of the force which the field represents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70773, C38059, C124564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2012002</VALIDVALUE>
          <VALUEMEANING>Fracture Lunate Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A traumatic injury to the bone in which the continuity of the bone is broken._The bone in the proximal row of carpal bones that lies between the scaphoid and triquetral bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12786, C3046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222544</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2807004</VALIDVALUE>
          <VALUEMEANING>Chronic or Unspecified Gastrojejunal Ulcer with Perforation</VALUEMEANING>
          <MEANINGDESCRIPTION>Evidence of chronic or unspecified gastrojejunal ulcer with perforation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C196828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>385006</VALIDVALUE>
          <VALUEMEANING>Secondary Peripheral Neuropathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value._A disorder affecting the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119734, C25667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213127</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3507004</VALIDVALUE>
          <VALUEMEANING>Thigh Abscess</VALUEMEANING>
          <MEANINGDESCRIPTION>A part of the lower limb, located between hip and knee._An inflammatory process characterized by the accumulation of pus within a newly formed tissue cavity which is the result of a bacterial, fungal, or parasitic infection or the presence of a foreign body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26686, C33763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1152001</VALIDVALUE>
          <VALUEMEANING>Negative Skin Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding that indicates the absence of an immune response to an antigen that is introduced to the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2815001</VALIDVALUE>
          <VALUEMEANING>Sexual Arousal Pyromania</VALUEMEANING>
          <MEANINGDESCRIPTION>Heightened urges of sexual desires in preparation for sexual behavior._A disorder characterized by a fascination with fire and recurrent episodes of fire setting during which the individual experiences a rising subjective sense of tension before the fire setting and a sense of gratification or relief when setting the fire. There is no ulterior motive (such as monetary gain or the expression of political ideology) to the fire setting.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94334, C73522</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>407000</VALIDVALUE>
          <VALUEMEANING>Congenital Hepatomegaly</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting something that is present at birth._Abnormal enlargement of the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3100, C99210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2024009</VALIDVALUE>
          <VALUEMEANING>Dilated Cardiomyopathy Secondary To Animal Myocarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive heart failure._Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value._Used as a function word to indicate direction, purpose, or movement._A living organism that has membranous cell walls, requires oxygen and organic foods, and is capable of voluntary movement, as distinguished from a plant or mineral._Inflammation of the muscle tissue of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34831, C14182, C65107, C25667, C84673</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3511005</VALIDVALUE>
          <VALUEMEANING>Infectious Disorder Thyroiditis</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact._Inflammation of the thyroid gland. This category includes Hashimoto thyroiditis, Riedel thyroiditis, acute thyroiditis, subacute thyroiditis, and radiation-induced thyroiditis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26894, C26726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213116</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1155004</VALIDVALUE>
          <VALUEMEANING>Determine Electrocardiogram Myocardial Hypertrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>The establishment of a state or result._A record of the electrical activity of the heart._Thickening of the myocardium often due to chronic pressure overload.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C172011, C168186, C136827</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2816000</VALIDVALUE>
          <VALUEMEANING>Secondary Myotonic Dystrophy Dilated Cardiomyopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value._An inherited progressive disorder affecting the muscles. It is characterized by muscle wasting and hypotonia, cataracts, heart conduction defects and endocrinopathies._Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive heart failure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84673, C84914, C25667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3519007</VALIDVALUE>
          <VALUEMEANING>Synovitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of a synovial membrane.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50766</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2032001</VALIDVALUE>
          <VALUEMEANING>Cerebral Edema</VALUEMEANING>
          <MEANINGDESCRIPTION>Swelling due to an excessive accumulation of fluid in the brain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4909</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>426008</VALIDVALUE>
          <VALUEMEANING>Superficial Ankle Injury Without Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>Of little substance or significance; involving only a surface._Trauma to the ankle joint._Used to indicate the absence or lack of something or someone._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320, C25718, C35137, C25239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1184008</VALIDVALUE>
          <VALUEMEANING>Glasgow Coma Scale-NINDS Version 1.0 Clinical Classification Ten</VALUEMEANING>
          <MEANINGDESCRIPTION>A standardized rating scale developed by Teasdale and Jennett in 1974, which is a classification system used to assess the level of consciousness. The NINDS version measures eye opening, motor and verbal responses._A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69122, C124710</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2819007</VALIDVALUE>
          <VALUEMEANING>Magnesium Sulfate Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>A magnesium salt of sulfuric acid, that can be used to normalize magnesium levels in the body, and to prevent seizures in eclampsia and preeclampsia. Magnesium is a divalent cation essential for a number of biochemical processes involved in nerve signaling, bone mineralization and muscle contractions. About 350 enzymes involved in glycolysis and the Krebs cycle, formation of cyclic-AMP and ATP, cellular signal transduction and protein and nucleic acid synthesis are dependent on magnesium. Magnesium blocks neuromuscular transmission and decreases the amount of acetylcholine liberated at the end plate by the motor nerve impulse, thereby preventing convulsions and seizures._Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2036003</VALIDVALUE>
          <VALUEMEANING>Acquired Factor VII Deficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>An acquired coagulation disorder characterized by the partial or complete absence of factor VII activity in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131625</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3528008</VALIDVALUE>
          <VALUEMEANING>Restriction Carbohydrate Dietary Lipid Control Diet</VALUEMEANING>
          <MEANINGDESCRIPTION>Anything that limits; a limitation._A class of hydrocarbons with an empirical formula of Cm(H20)n (where m and n may be equal) and includes monomers, polymers and derivatives of aldoses, ketoses, saccharides, and alditols._A class of food constituents, also known as fats and oils, that serve as a source of energy and essential fatty acids in animals. The major components of lipids are fatty acids, triglycerides, phospholipids, glycolipids, sphingolipids, steroids (cholesterol), and lipoproteins._The act of directing or determining; regulation or maintenance of a function or action; a relation of constraint of one entity (thing or person or group) by another._The customary allowance of food and drink taken by a person or an animal from day to day, particularly one especially planned to meet specific requirements of the individual, including or excluding certain items of food; a prescribed course of eating and drinking in which the amount and kind of food, as well as the times at which it is to be taken, are regulated for therapeutic purposes or selected with reference to a particular state of health.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15222, C61299, C2317, C344, C53452</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>431005</VALIDVALUE>
          <VALUEMEANING>Hypertrophy Scrotum</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormal enlargement of a body part or organ._The musculocutaneous pouch that encloses the testicles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12785, C3124</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1192004</VALIDVALUE>
          <VALUEMEANING>Familial Amyloid Polyneuropathy Type IV</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant inherited form of familial amyloid neuropathy caused by mutation(s) in the GSN gene, encoding gelsolin. It is characterized by lattice corneal dystrophy, cranial neuropathy, bulbar signs, and skin changes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2043009</VALIDVALUE>
          <VALUEMEANING>Alcoholic Gastritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the stomach resulting from alcohol ingestion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26977</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2831009</VALIDVALUE>
          <VALUEMEANING>Pylorus Gastric Antral Vascular Ectasia</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower part of the stomach that connects to the duodenum._Dilatation of the vessels in the antrum of the stomach. It is associated with portal hypertension, scleroderma, and chronic renal failure. It may cause gastric bleeding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84724, C12260</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222583</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>442001</VALIDVALUE>
          <VALUEMEANING>Secondary Hypopituitarism, CTCAE</VALUEMEANING>
          <MEANINGDESCRIPTION>Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value._A disorder characterized by a decrease in production of hormones from the pituitary gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C143194, C25667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>CTCAE, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2061000</VALIDVALUE>
          <VALUEMEANING>Conductive Hearing Loss of Combined Sites</VALUEMEANING>
          <MEANINGDESCRIPTION>Conductive hear loss presenting across multiple sites in the ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3529000</VALIDVALUE>
          <VALUEMEANING>Aerococcus sanguinicola Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>A species of gram-positive, catalase-negative, vancomycin-susceptible coccoid bacteria belonging to the genus Aerococcus that is commonly found as a human pathogen, particularly in urinary tract infections, sepsis, and endocarditis._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320, C119314</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1194003</VALIDVALUE>
          <VALUEMEANING>Disease or Disorder Condition Determine Well Disease Controlled</VALUEMEANING>
          <MEANINGDESCRIPTION>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A state of being, such as a state of health._The establishment of a state or result._A subjective response of good agreement or ability._An indication or description that a particular disorder is being managed successfully.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82500, C182125, C136827, C25457, C2991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2835000</VALIDVALUE>
          <VALUEMEANING>Cardiac Injury Due To Hemolytic Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with the heart._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity._Caused by or resulting from._Anemia resulting from the premature destruction of the peripheral blood red cells. It may be congenital or it may be caused by infections, medications, or malignancies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34376, C89272, C3671, C13306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222584</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2065009</VALIDVALUE>
          <VALUEMEANING>Autosomal Dominant Optic Atrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant hereditary condition characterized by optic atrophy and progressive visual loss.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84577</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>447007</VALIDVALUE>
          <VALUEMEANING>Sports Injury Coach</VALUEMEANING>
          <MEANINGDESCRIPTION>An injury sustained while practicing or competing in a sport._Someone who teaches a special skill (e.g., how to implement a treatment or intervention).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157483, C34405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3544004</VALIDVALUE>
          <VALUEMEANING>Hair Split</VALUEMEANING>
          <MEANINGDESCRIPTION>The filamentous outgrowth of the epidermis._To separate or divide into distinct parts or portions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54572, C32705</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222624</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2070002</VALIDVALUE>
          <VALUEMEANING>Eye Burning Sensation</VALUEMEANING>
          <MEANINGDESCRIPTION>The organ of sight or vision._A sensation of stinging or heat, not necessarily accompanied by redness or physical signs of irritation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50476, C12401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222546</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2853006</VALIDVALUE>
          <VALUEMEANING>Macula Keratitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A yellowish, highly pigmented, oval shaped area slightly lateral to the center of the retina of the eye which contains the fovea centralis and is mostly comprised of retinal cones, for high-acuity vision, and which if damaged will result in the partial/complete loss of central vision._Inflammation of the cornea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26805, C26464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222585</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>450005</VALIDVALUE>
          <VALUEMEANING>Ulcerative Stomatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the mouth mucosa associated with the presence of ulcers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35039</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1196001</VALIDVALUE>
          <VALUEMEANING>Chronic Bipolar II Disorder Most Recent Episode Single Episode of Major Depressive Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Usually used to describe a condition that is persistent and long standing._A bipolar disorder in which at least one episode of major depression alternates with at least one episode of hypomania. In contrast to bipolar I disorder, affected individuals do not experience any manic episodes._The latest occurrence of an episode._An episode of depression lasting two or more weeks without an intervening episode of mania.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34796, C191305, C197849, C14141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3545003</VALIDVALUE>
          <VALUEMEANING>Diastolic Dysfunction</VALUEMEANING>
          <MEANINGDESCRIPTION>Impairment in the filling of the ventricles during diastole. Causes include hypertrophic and restrictive cardiomyopathies, coronary artery disease, chronic high blood pressure, aortic stenosis, and aging.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79547</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2073000</VALIDVALUE>
          <VALUEMEANING>Delusion</VALUEMEANING>
          <MEANINGDESCRIPTION>False personal beliefs held contrary to reality, despite contradictory evidence and common sense.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944343</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2856003</VALIDVALUE>
          <VALUEMEANING>Retinol Response Dermatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>The fat soluble vitamin retinol. Vitamin A binds to and activates retinoid receptors (RARs), thereby inducing cell differentiation and apoptosis of some cancer cell types and inhibiting carcinogenesis. Vitamin A plays an essential role in many physiologic processes, including proper functioning of the retina, growth and differentiation of target tissues, proper functioning of the reproductive organs, and modulation of immune function._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._A disorder involving lesions or eruptions of the skin, usually without inflammation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27554, C25755, C68302</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2087000</VALIDVALUE>
          <VALUEMEANING>Pulmonary Nocardiosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract._A bacterial infection caused by members of the gram-positive bacilli genus Nocardia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C171147, C13304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3548001</VALIDVALUE>
          <VALUEMEANING>Brachial Plexus Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A nerve network originating from C5 to T1 that supplies cutaneous and muscular innervation to the arm and hand._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C12682</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>452002</VALIDVALUE>
          <VALUEMEANING>Inguinal Region Blister Without Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower region of the anterior abdominal wall located laterally to the pubic region._An intraepidermal/subepidermal cavity filled with clear, serosanguineous or cloudy fluid._Used to indicate the absence or lack of something or someone._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320, C25718, C75564, C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1197005</VALIDVALUE>
          <VALUEMEANING>Heel of the Foot Furuncle</VALUEMEANING>
          <MEANINGDESCRIPTION>The rounded back part of the foot below the ankle and behind the arch._Bacterial infection of the hair follicle and the surrounding skin. It is caused by Staphylococcus aureus. It presents as a painful, erythematous and swollen skin lesion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99087, C161381</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218948</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2858002</VALIDVALUE>
          <VALUEMEANING>Postpartum Septicemia</VALUEMEANING>
          <MEANINGDESCRIPTION>The period of time immediately after labor and delivery._The presence of pathogenic microorganisms in the blood stream causing a rapidly progressing systemic reaction that may lead to shock. Symptoms include fever, chills, tachycardia, and increased respiratory rate. It is a medical emergency that requires urgent medical attention.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3364, C92851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3549009</VALIDVALUE>
          <VALUEMEANING>Pancreatic Acinar Cell Atrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the pancreas._A secreting cell that lines an acinus (i.e. a small sac or sac-like structure).  A representative example is the acinar cell located in the pancreas that produces pancreatic enzymes and juices._Any weakening or degeneration, especially through lack of use.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79748, C13077, C25726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218970</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1201005</VALIDVALUE>
          <VALUEMEANING>Benign Essential Hypertension</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition of mild to moderate high blood pressure that has no identifiable cause.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3656</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>467003</VALIDVALUE>
          <VALUEMEANING>Old Laceration Pelvic Floor Muscle</VALUEMEANING>
          <MEANINGDESCRIPTION>Not new, of an earlier time._A cut or tear in any tissue._The muscles, composed of the levator ani and the coccygeus muscles, that create a division between the pelvic cavity and the perineal region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C33290, C50446, C65010</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2091005</VALIDVALUE>
          <VALUEMEANING>Pharyngoesophageal Diverticulum</VALUEMEANING>
          <MEANINGDESCRIPTION>A diverticulum of the posterior pharyngeal wall opening, which is located just posterior the cricoid cartilage, between the inferior pharyngeal constrictor and the cricopharyngeus muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35138</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2884008</VALIDVALUE>
          <VALUEMEANING>Weill-Marchesani Syndrome 1</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal recessive subtype of Weill-Marchesani Syndrome caused by mutations in the ADAMTS10 gene, encoding a disintegrin and metalloproteinase with thrombospondin motifs 10.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1207009</VALIDVALUE>
          <VALUEMEANING>Glaucoma Optic Atrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor._A disorder characterized by loss of optic nerve fibers. It may be inherited or acquired. Acquired causes include ischemia, optic nerve neuropathy, glaucoma, trauma, radiation, brain tumors, and multiple sclerosis. It leads to vision disturbances.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34863, C26782</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3558002</VALIDVALUE>
          <VALUEMEANING>Mesenteric Vein Infarction</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two veins (inferior or superior) that returns deoxygenated blood from the intestines._A localized pathological necrosis of tissue resulting from obstruction of the blood supply usually by a thrombus, an embolus, or vascular torsion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25738, C53055</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222625</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2897005</VALIDVALUE>
          <VALUEMEANING>Primary Immune Thrombocytopenia</VALUEMEANING>
          <MEANINGDESCRIPTION>Acquired thrombocytopenia of unknown cause, characterized by immune-mediated destruction of normal platelets. It affects both children and adults. It manifests with petechiae, purpura, and overt bleeding. Based upon the duration of the disease, it is classified as newly diagnosed (from diagnosis until 3 months), persistent (3-12 months), and chronic (lasting for more than 12 months).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3446</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2102007</VALIDVALUE>
          <VALUEMEANING>Deep Cornea Neovascularization</VALUEMEANING>
          <MEANINGDESCRIPTION>Extending relatively far inward._A dome-shaped, transparent, avascular tissue covering the front of the eye. It is composed of five layers: squamous epithelium, Bowman&#39;s membrane, stroma, Descemet&#39;s membrane, and endothelium. Refraction of light contributing to eye&#39;s focusing ability is its characteristic function. It contains unmyelinated nerve endings which are responsible for the high sensitivity of the tissue._The formation of new or recent blood vessels. The vasculature network is critical to the development of neoplasms. As the tumor burden grows, vascular endothelial cells are recruited to form new blood vessels as an increased demand for blood and nourishment is required.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16900, C12342, C25240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>488007</VALIDVALUE>
          <VALUEMEANING>Cardiac Fibroma Myocarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare benign heart neoplasm usually occurring in young children. It is characterized by the presence of bland spindle cells and collagenous stroma formation. Clinical presentation may include cardiac arrhythmia, cyanosis, heart failure or sudden death._Inflammation of the muscle tissue of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34831, C6947</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1212005</VALIDVALUE>
          <VALUEMEANING>Childhood Dermatomyositis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory myopathy of childhood resulting in muscle weakness, and associated with a characteristic skin rash.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3560000</VALIDVALUE>
          <VALUEMEANING>Recurrent Bilateral Inguinal Hernia</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring again._Affecting both sides of the body or a matched pair of organs._The protrusion of a sac-like structure containing fibroadipose tissue through an abnormal opening in the inguinal region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34690, C13332, C14173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222626</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2900003</VALIDVALUE>
          <VALUEMEANING>Renal Artery Fibromuscular Dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of two arteries (right or left) that arise from the aorta to supply the kidneys._A disorder characterized by fibrous thickening of the arterial wall resulting in narrowing of the arterial lumen. It most often affects the renal artery and less often the carotid artery and abdominal arteries. It can cause hypertension and aneurysm formation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84714, C12778</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>490008</VALIDVALUE>
          <VALUEMEANING>Upper Respiratory System Hypersensitivity</VALUEMEANING>
          <MEANINGDESCRIPTION>The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea._An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3114, C33839</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1214006</VALIDVALUE>
          <VALUEMEANING>Strongyloidiasis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection that is caused by nematodes of the genus Strongyloides, most commonly Strongyloides stercoralis, which is a soil-transmitted helminth, and which is characterized by a variety of gastrointestinal, dermatologic, and, occasionally, pulmonary manifestations. The worm&#39;s autoinfective life cycle can lead to hyper-infection and life-threatening dissemination in immunocompromised hosts decades after initial infection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2103002</VALIDVALUE>
          <VALUEMEANING>Complex Regional Pain Syndrome I Upper Extremity</VALUEMEANING>
          <MEANINGDESCRIPTION>A neurologic condition characterized by burning pain, tenderness, swelling, and changes in the skin color and temperature of a body part or extremity that has no identifiable nerve injury; most pediatric patients present with this form._The region of the body that includes the arm, the forearm, and hand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12671, C85042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222548</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2902006</VALIDVALUE>
          <VALUEMEANING>Lymphocytes with Decreased Life Span</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of lymphocytes in the serum that have reduced longevity as compared to the standard life span of lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1232006</VALIDVALUE>
          <VALUEMEANING>Arthrogryposis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, non-progressive congenital disorder characterized by multiple joint contractures which are present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84572</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3570003</VALIDVALUE>
          <VALUEMEANING>Polycythemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormally high mass or concentration of red blood cells in the blood, either due to an increase in erythropoiesis or a decrease in plasma volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26863</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2107001</VALIDVALUE>
          <VALUEMEANING>Unequal Limb Length</VALUEMEANING>
          <MEANINGDESCRIPTION>Discrepancy between the lengths of the lower or upper extremities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78657</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>517007</VALIDVALUE>
          <VALUEMEANING>Foreign Body Hypopharynx</VALUEMEANING>
          <MEANINGDESCRIPTION>Extraneous material within the body._The lower part of the pharynx that connects to the esophagus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12246, C34620</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1240000</VALIDVALUE>
          <VALUEMEANING>Prone Position</VALUEMEANING>
          <MEANINGDESCRIPTION>An anterior recumbent body position whereby the person lies on its stomach and faces downward.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2904007</VALIDVALUE>
          <VALUEMEANING>Male Infertility</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who belongs to the sex that normally produces sperm._Inability to conceive for at least one year after trying and having unprotected sex. Causes of female infertility include endometriosis, fallopian tubes obstruction, and polycystic ovary syndrome. Causes of male infertility include abnormal sperm production or function, blockage of the epididymis, blockage of the ejaculatory ducts, hypospadias, exposure to pesticides, and health related issues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3836, C20197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222587</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3571004</VALIDVALUE>
          <VALUEMEANING>Megaloblastic Anemia Due To Pancreatic Insufficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>Anemia characterized by the presence of unusually large erythroblasts in the bone marrow called megaloblasts. It is usually caused by vitamin B12 or folic acid deficiency. Other causes include toxins and drugs._Caused by or resulting from._Inability of the exocrine pancreas to produce and secrete an adequate amount of digestive enzymes into the small intestine.  Patients present with symptoms of malabsorption syndrome, abdominal discomfort, and bloating.  Causes include chronic pancreatitis, cystic fibrosis, and autoimmune disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84316, C89272, C34382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2109003</VALIDVALUE>
          <VALUEMEANING>Isolation Somatotropin Deficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>A state of separation; the act of isolating something; setting something apart from others; marked by separation of or from usually contiguous elements._Abnormally low levels of circulating somatotropin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C102986, C25549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>518002</VALIDVALUE>
          <VALUEMEANING>Multiple Aggregation</VALUEMEANING>
          <MEANINGDESCRIPTION>Having, relating to, or consisting of more than one individual, element, part, or other component; manifold._A process by which particles collect to form a cohesive mass or cluster. The resulting structure is called an aggregate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62344, C17648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1261007</VALIDVALUE>
          <VALUEMEANING>Rib Multiple Fractures</VALUEMEANING>
          <MEANINGDESCRIPTION>Any one of the paired bones, 12 on either side, extending from the thoracic vertebrae toward the median line on the ventral aspect of the trunk. The long curved bones which form the rib cage. Generally, ribs 1 to 7 are connected to the sternum by their costal cartilages and are called true ribs, whereas ribs 8 to 12 are termed false ribs._Two or more simultaneous traumatic breaks in one or more bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26778, C12782</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2910007</VALIDVALUE>
          <VALUEMEANING>Penis Discharge Body Fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>The male organ of urination and copulation._Normal or abnormal secretions expelled from a body location.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C142366, C12409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2114004</VALIDVALUE>
          <VALUEMEANING>Cysticercosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A parasitic infection caused by the larval form of Taenia solium. It is a disseminated infection affecting the central nervous system, subcutaneous tissues, lungs, heart and liver. The most serious complications result from infection of the brain parenchyma. Patients may develop seizures, hydrocephalus, encephalopathy and meningoencephalitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3586005</VALIDVALUE>
          <VALUEMEANING>Dissociative Fugue</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by sudden, unexpected travel away from one&#39;s home or place of work accompanied by an inability to recall one&#39;s past; the individual is confused about his or her personal identity and may assume a new identity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>520004</VALIDVALUE>
          <VALUEMEANING>Congenital Septal Deviation</VALUEMEANING>
          <MEANINGDESCRIPTION>Septal deviation that is present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1286003</VALIDVALUE>
          <VALUEMEANING>Vitamin K Deficiency Coagulation Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Deficiency of vitamin K. It may lead to bleeding, manifested with ecchymoses, petechiae, and hematomas. In infants it may cause hemorrhagic disease of newborn with intracranial and retroperitoneal bleeding._A condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2902, C99108</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218949</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2128005</VALIDVALUE>
          <VALUEMEANING>Pharyngeal Tonsil Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A fold of lymphatic tissue covered by ciliated epithelium at the very back of the nose, in the roof of the nasopharynx._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C33318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2917005</VALIDVALUE>
          <VALUEMEANING>Temporary Hypothyroidism</VALUEMEANING>
          <MEANINGDESCRIPTION>Not permanent; not lasting; lacking continuity or regularity._Abnormally low levels of thyroid hormone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26800, C53288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222589</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3589003</VALIDVALUE>
          <VALUEMEANING>Syphilis Pericarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>A contagious bacterial infection caused by the spirochete Treponema pallidum. It is a sexually transmitted disorder, although it can also be transmitted from the mother to the fetus in utero. Typically, it is initially manifested with a single sore which heals without treatment. If the infection is left untreated, the initial stage is followed by skin rash and mucous membrane lesions. A late stage follows, which is characterized by damage of the internal organs, including the nervous system._An inflammatory process affecting the pericardium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34915, C35055</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>548004</VALIDVALUE>
          <VALUEMEANING>Partial Trisomy 13 Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or affecting only a part of something._A chromosomal abnormality characterized by the presence of three copies of genetic material for chromosome 13, instead of the normal two. It leads to a variety of abnormalities that include mental retardation, microcephaly, low-set ears, eye structural defects, polydactyly, and limb abnormalities._A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28193, C36529, C25378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2129002</VALIDVALUE>
          <VALUEMEANING>Pharynx Edema</VALUEMEANING>
          <MEANINGDESCRIPTION>A hollow tube that starts posterior to the mouth and nasal cavity and ends superior to the trachea and esophagus._Accumulation of an excessive amount of fluid in cells or intercellular tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3002, C12425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218956</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1308001</VALIDVALUE>
          <VALUEMEANING>Reimplantation Complication</VALUEMEANING>
          <MEANINGDESCRIPTION>A surgical procedure that places something in the body that was previously lost or removed._Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2959, C101242</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2918000</VALIDVALUE>
          <VALUEMEANING>Bacteroides Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>A genus of bacteria within the phylum Bacteroidetes consisting of gram-negative bacilli or cocco-bacilli that comprise a major portion of the human normal flora, predominating in the intestinal tract._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320, C76204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222590</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3633001</VALIDVALUE>
          <VALUEMEANING>Hand Abscess</VALUEMEANING>
          <MEANINGDESCRIPTION>The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits._An inflammatory process characterized by the accumulation of pus within a newly formed tissue cavity which is the result of a bacterial, fungal, or parasitic infection or the presence of a foreign body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26686, C32712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>554003</VALIDVALUE>
          <VALUEMEANING>Partial Trisomy 2 Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or affecting only a part of something._A chromosomal abnormality consisting of the presence of a third copy of chromosome 2 in somatic cells._A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28193, C36495, C25378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1318006</VALIDVALUE>
          <VALUEMEANING>Post-Translational Modification</VALUEMEANING>
          <MEANINGDESCRIPTION>The enzymatic processing of a polypeptide chain after translation from messenger RNA and after peptide bond formation has occurred. Examples include glycosylation, acylation, limited proteolysis, phosphorylation, isoprenylation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17019</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2134003</VALIDVALUE>
          <VALUEMEANING>Diffuse Pain</VALUEMEANING>
          <MEANINGDESCRIPTION>Widely spread; not localized or confined._The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3303, C14175</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2919008</VALIDVALUE>
          <VALUEMEANING>Nausea Vomiting Diarrhea</VALUEMEANING>
          <MEANINGDESCRIPTION>Upper abdominal discomfort associated with an urge to vomit._Forceful ejection of the contents of the stomach through the mouth._Watery bowel movements.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2987, C3442, C3258</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3634007</VALIDVALUE>
          <VALUEMEANING>Legally Induced Abortion Complication Due To Metabolic Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Lawfully induced expulsion of all products of conception._Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure._Caused by or resulting from._A congenital (due to inherited enzyme abnormality) or acquired (due to failure of a metabolic important organ) disorder resulting from an abnormal metabolic process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3235, C89272, C2959, C34339</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1323006</VALIDVALUE>
          <VALUEMEANING>Kanamycin Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>An aminoglycoside antibiotic with antimicrobial property. Amikacin irreversibly binds to the bacterial 30S ribosomal subunit, specifically in contact with 16S rRNA and S12 protein within the 30S subunit. This leads to interference with translational initiation complex and, misreading of mRNA, thereby hampering protein synthesis and resulting in bactericidal effect. This agent is usually used for treatment of E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species._Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C65997</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>563001</VALIDVALUE>
          <VALUEMEANING>Nystagmus</VALUEMEANING>
          <MEANINGDESCRIPTION>Involuntary movements of the eyeballs. The presence or absence of nystagmus is often used in the diagnosis of a variety of neurological and visual disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3282</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2145000</VALIDVALUE>
          <VALUEMEANING>Anus Sex Behavior</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded._Behaviors involved with sexual arousal and/or intercourse.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17127, C43362</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2929001</VALIDVALUE>
          <VALUEMEANING>Arterial Occlusion</VALUEMEANING>
          <MEANINGDESCRIPTION>Complete closure of the normally patent lumen of the blood vessels which carry blood away from the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35318</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1335005</VALIDVALUE>
          <VALUEMEANING>Penile Fibromatosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Fibromatosis arising from the soft tissues of the penis. It is characterized by the presence of spindle-shaped fibroblasts, and an infiltrative growth pattern.  It causes the penis to bend when it becomes erect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>568005</VALIDVALUE>
          <VALUEMEANING>Habit Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A pattern of repeat behavior requiring little conscious thought._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C94571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2177002</VALIDVALUE>
          <VALUEMEANING>Post-Herpetic Neuralgia</VALUEMEANING>
          <MEANINGDESCRIPTION>Pain that occurs after the disappearance of herpes zoster infection lesions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117084</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2935001</VALIDVALUE>
          <VALUEMEANING>Anti-asthmatic Agent Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Classified as bronchodilators (beta-adrenoreceptor agonists, xanthines, muscarinic-receptor antagonists) and anti-inflammatory agents (glucocorticoids, cromolyn), natural or synthetic Anti-asthmatic Agents relieve asthma (a recurrent airway obstruction) in multiple ways and at various sites, by reducing bronchial spasm, dyspnea, allergic reaction, local inflammation, and pain. Other agents, such as anti-histamine and antibiotics, may also be used in asthma. (NCI04)_Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C29712</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3640000</VALIDVALUE>
          <VALUEMEANING>Injury Amputation Late Effect</VALUEMEANING>
          <MEANINGDESCRIPTION>Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity._The surgical removal of all or part of a limb or other appendage._Being or occurring at an advanced period of time or after a usual or expected time._A phenomenon that follows and is caused by some previous phenomenon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25492, C64998, C15179, C3671</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1351002</VALIDVALUE>
          <VALUEMEANING>Iliac Artery Injury</VALUEMEANING>
          <MEANINGDESCRIPTION>A branch of the abdominal aorta that supplies blood to the lower trunk and the legs._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3671, C12733</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2198002</VALIDVALUE>
          <VALUEMEANING>Visceral Seizure Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Of, or relating to, or affecting the internal organs._A brain disorder characterized by episodes of abnormally increased neuronal discharge resulting in transient episodes of sensory or motor neurological dysfunction, or psychic dysfunction. These episodes may or may not be associated with loss of consciousness or convulsions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3020, C25315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>590005</VALIDVALUE>
          <VALUEMEANING>Congenital Anterior Communicating Artery Aneurysm</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting something that is present at birth._An artery that joins the two anterior cerebral arteries._Bulging or ballooning in an area of an artery secondary to arterial wall weakening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26693, C32087, C99210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2955000</VALIDVALUE>
          <VALUEMEANING>Chronic Ulcer Pulpitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Usually used to describe a condition that is persistent and long standing._A circumscribed inflammatory and often suppurating lesion on the skin or an internal mucous surface resulting in necrosis of tissue._Inflammation of the dental pulp.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52595, C3426, C14141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3644009</VALIDVALUE>
          <VALUEMEANING>Skin Maceration</VALUEMEANING>
          <MEANINGDESCRIPTION>Softening and whitening of the skin due to excessive moisture.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C83472</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2213002</VALIDVALUE>
          <VALUEMEANING>Congenital Vena Cava Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormality of the superior or inferior vena cava that is present at birth. Representative examples include persistent left superior vena cava, absence of infrarenal inferior vena cava, or absence of the entire inferior vena cava.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98886</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212986</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1356007</VALIDVALUE>
          <VALUEMEANING>Common Bile Duct Stone With Obstruction</VALUEMEANING>
          <MEANINGDESCRIPTION>The presence of one or more stones in the common bile duct. They are composed either of cholesterol or, less commonly, calcium salts and bilirubin._Used to indicate the presence of something or someone._Blockage of the normal flow of the contents of an anatomical passageway.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3284, C62355, C34499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>596004</VALIDVALUE>
          <VALUEMEANING>Premenstrual Dysphoric Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A more severe form of premenstrual syndrome (PMS) with more extreme mood and physical symptoms. As with PMS, symptoms begin prior to an individual&#39;s menstrual cycle and typically taper off as menstruation begins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C197949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2216005</VALIDVALUE>
          <VALUEMEANING>Wet Dream</VALUEMEANING>
          <MEANINGDESCRIPTION>An involuntary ejaculation of semen accompanying an erotic dream.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86938</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2972007</VALIDVALUE>
          <VALUEMEANING>Anterior Spinal Artery Occlusion</VALUEMEANING>
          <MEANINGDESCRIPTION>The artery that delivers blood to the anterior portion of the spinal cord._Obstruction or a closure of hollow organ, passageway or vessel; also the transient approximation of the edges of a natural opening; imperforation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50678, C12833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222591</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3649004</VALIDVALUE>
          <VALUEMEANING>Trunk Multiple Site Contusion</VALUEMEANING>
          <MEANINGDESCRIPTION>The body excluding the head and neck and limbs._Having, relating to, or consisting of more than one individual, element, part, or other component; manifold._A position in relation to its surroundings._A bruise due to trauma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50441, C37901, C17648, C33816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>599006</VALIDVALUE>
          <VALUEMEANING>Persistent Pneumothorax, CTCAE</VALUEMEANING>
          <MEANINGDESCRIPTION>Retained; never-ceasing._A disorder characterized by abnormal presence of air in the pleural cavity resulting in the collapse of the lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C58201, C43623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>CTCAE, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1367008</VALIDVALUE>
          <VALUEMEANING>Superior Mesenteric Artery Injury</VALUEMEANING>
          <MEANINGDESCRIPTION>An artery arising from the abdominal aorta with numerous branches that supply the intestines from the duodenum to the transverse colon and the pancreas._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3671, C33685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2219003</VALIDVALUE>
          <VALUEMEANING>Disability Evaluation Disability One Hundred Percent</VALUEMEANING>
          <MEANINGDESCRIPTION>Any physical or mental impairment that interferes with an individual&#39;s ability to perform desired activities._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria._Any physical or mental impairment that interferes with an individual&#39;s ability to perform desired activities._All, one hundred percent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C158695, C21007, C25214, C21007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2978006</VALIDVALUE>
          <VALUEMEANING>Conjunctiva Aneurysm</VALUEMEANING>
          <MEANINGDESCRIPTION>A thin, transparent tissue divided into the palpebral conjunctiva (covering the inner side of the eye lid) and the bulbar conjunctiva (covering the eyeball)._Bulging or ballooning in an area of an artery secondary to arterial wall weakening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26693, C12341</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>600009</VALIDVALUE>
          <VALUEMEANING>Pyromania</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by a fascination with fire and recurrent episodes of fire setting during which the individual experiences a rising subjective sense of tension before the fire setting and a sense of gratification or relief when setting the fire. There is no ulterior motive (such as monetary gain or the expression of political ideology) to the fire setting.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94334</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1370007</VALIDVALUE>
          <VALUEMEANING>Open Fracture of Metacarpal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>A traumatic break in one or more of the metacarpal bones that involves a break in the adjacent skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3650004</VALIDVALUE>
          <VALUEMEANING>Total Hepatic Agenesis</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._Pertaining to, affecting, or associated with the liver._A congenital abnormality resulting in the absence of an anatomical structure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120864, C13308, C25304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218971</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>602001</VALIDVALUE>
          <VALUEMEANING>Ross River Virus Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>A species of enveloped, spherical viruses with a capsid with T=4 icosahedral symmetry in the Togaviridae family and Alphavirus genus. The genome is composed of monopartite, single-stranded, positive-sense RNA. Ross river viruses are found in both vertebrates and invertebrates, and cause Ross River Fever in humans. Ross river viruses are transmitted via the bite of infected mosquitoes._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320, C112411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222505</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2224000</VALIDVALUE>
          <VALUEMEANING>Selenium Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>A nonmetallic chemical element found in trace amounts in human body. Selenium primarily occurs in vivo as selenocompounds, mostly selenoproteins such as glutathione peroxidase and thioredoxin reductase (enzymes responsible for detoxification). Alone or in combination with Vitamin E, selenocompounds act as antioxidants. These agents scavenge free radicals; prevent blood clots by inhibiting platelet aggregation; strengthen the immune system; and have been shown, in some instances, to inhibit chromosomal damage and mutations. Exhibiting chemopreventive activity, selenocompounds also inhibit the induction of protein kinase C._Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C825</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1376001</VALIDVALUE>
          <VALUEMEANING>Obsessive-Compulsive Personality Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by an enduring pattern of inflexibility, extreme orderliness, and perfectionism which interfere with efficiency and which may manifest in many different contexts, including work and leisure activities, financial matters, and issues of morality or ethics.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92638</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3652007</VALIDVALUE>
          <VALUEMEANING>Growth Hormone Excess</VALUEMEANING>
          <MEANINGDESCRIPTION>Overproduction of growth hormone, a protein-based peptide that stimulates growth, cell reproduction, and cell regeneration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2989004</VALIDVALUE>
          <VALUEMEANING>Post Hydatidiform Mole And/Or Ectopic Pregnancy Complication</VALUEMEANING>
          <MEANINGDESCRIPTION>Happening at a time subsequent to a reference time; later in time or order._A gestational trophoblastic disorder characterized by marked enlargement of the chorionic villi, hyperplasia of the villous trophoblastic cells and hydropic changes._Used to indicate that either or both of two items or options may be valid._An abnormal pregnancy in which the conception is implanted outside the endometrial cavity._Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2959, C34945, C48928, C3110, C38008</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222592</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>613003</VALIDVALUE>
          <VALUEMEANING>Fragile X Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A genetic syndrome caused by mutations in the FMR1 gene which is responsible for the expression of the fragile X mental retardation 1 protein. This protein participates in neural development. This syndrome is manifested with mental, emotional, behavioral, physical, and learning disabilities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211085</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2229005</VALIDVALUE>
          <VALUEMEANING>Chimera</VALUEMEANING>
          <MEANINGDESCRIPTION>An organism with tissues derived from two or more genotypes; composed of parts that are of different origin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1383008</VALIDVALUE>
          <VALUEMEANING>Hallucinogen Induction Mood Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Any naturally-derived or synthetic substance that can induce hallucinations._The act of bringing about something._A category of psychiatric disorders which have as their most predominant feature a disturbance in mood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92200, C61367, C105554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3662000</VALIDVALUE>
          <VALUEMEANING>Paraesophageal Hiatal Hernia</VALUEMEANING>
          <MEANINGDESCRIPTION>Body regions near to the esophagus._Herniation of the upper part of the stomach through the diaphragm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98945, C25344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>615005</VALIDVALUE>
          <VALUEMEANING>Foreign Body Obstruction</VALUEMEANING>
          <MEANINGDESCRIPTION>Extraneous material within the body._Blockage of the normal flow of the contents of an anatomical passageway.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3284, C34620</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218937</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2990008</VALIDVALUE>
          <VALUEMEANING>Lymphocytic Leukemoid Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to lymphocytes._A hematology test result that indicates the presence of an increased white blood cell count and increased neutrophil precursors resembling leukemia, in a peripheral blood smear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3185, C13350</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222593</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2231001</VALIDVALUE>
          <VALUEMEANING>Nerve Plexus Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A network of intersecting nerve fibers that link peripheral nerves with specific areas of the body._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C12929</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1384002</VALIDVALUE>
          <VALUEMEANING>Middle Ear Cholesteatoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic lesion characterized by the proliferation of keratinizing squamous epithelium in the middle ear that results in the accumulation of keratin and cells.  It is usually caused by repeated infections.  If left untreated, it may increase in size and destroy the adjacent delicate bones of the middle ear.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3677008</VALIDVALUE>
          <VALUEMEANING>Academia Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>College, University or institute with scholastic life or environment._A difficulty, disorder, or condition needing resolution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28020, C18240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2992000</VALIDVALUE>
          <VALUEMEANING>Brain Iron Accumulation Type I Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare neuroaxonal dystrophy, histologically characterized by axonal spheroids, iron deposition, lewy body (LB)-like intraneuronal inclusions and neurofibrillary tangles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C8967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210919</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>631002</VALIDVALUE>
          <VALUEMEANING>Incompatible Blood Transfusion Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>Receiving incorrect or incompatible whole blood or a blood component._A response generated by a stimulus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637, C172090</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222506</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2237002</VALIDVALUE>
          <VALUEMEANING>Painful Respiration</VALUEMEANING>
          <MEANINGDESCRIPTION>Causing physical or psychological misery, pain or distress._Distinct from cell or tissue respiration, Respiration is the act of breathing with the lungs and consists of inspiration, or taking ambient air into the lungs, and expiration, or expelling modified air that contains more carbon dioxide than the air taken in. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17091, C25271</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222552</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1386000</VALIDVALUE>
          <VALUEMEANING>Intracranial Hemorrhage</VALUEMEANING>
          <MEANINGDESCRIPTION>Bleeding within the cranium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2768998</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3681008</VALIDVALUE>
          <VALUEMEANING>Torcular Herophili Thrombophlebitis</VALUEMEANING>
          <MEANINGDESCRIPTION>The site of confluence of the superior sagittal sinus, the left and right transverse sinuses, and the straight sinus, which is located near the internal occipital protuberance._Inflammation of the veins associated with the presence of a thrombus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3410, C33795</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>643001</VALIDVALUE>
          <VALUEMEANING>Lip Hypertrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>Fleshy fold which surrounds the opening of the mouth._Abnormal enlargement of a body part or organ.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3124, C12220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222507</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2999009</VALIDVALUE>
          <VALUEMEANING>Ear Region Injury</VALUEMEANING>
          <MEANINGDESCRIPTION>A sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contains the ossicles (malleus, incus and stapes). The inner ear is made up of the cochlea needed for hearing and the vestibular apparatus required for balance._An area or portion of something with more or less definite boundaries designed or specified according to some established biological, administrative, economic, demographic, etc. criteria._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3671, C41129, C12394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1388004</VALIDVALUE>
          <VALUEMEANING>Metabolic Alkalosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormally increased pH levels in the blood due to excessive loss of acid and/or accumulation of base.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114478</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2239004</VALIDVALUE>
          <VALUEMEANING>Six Number of Previous Pregnancies</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one._A measurement of the total number of pregnancy events experienced by the female subject prior to the current pregnancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120836, C66837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222553</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3705009</VALIDVALUE>
          <VALUEMEANING>Congenital Abnormality Anterior Chamber of the Eye</VALUEMEANING>
          <MEANINGDESCRIPTION>Any abnormality, anatomical or biochemical, evident at birth or during the neonatal period._The space in the eye, filled with aqueous humor, bounded anteriorly by the cornea and a small portion of the sclera and posteriorly by a small portion of the ciliary body, the iris, and that part of the crystalline lens which presents through the pupil. (Cline et al., Dictionary of Visual Science, 4th ed, p109)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12667, C2849</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1395008</VALIDVALUE>
          <VALUEMEANING>Therapeutic Ultrasound Complication</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of treatment that uses very high frequency sound waves for the purpose of treating an injury or illness._Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2959, C28003</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>646009</VALIDVALUE>
          <VALUEMEANING>Anterior Chamber of the Eye Iris Idiopathic Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>The space in the eye, filled with aqueous humor, bounded anteriorly by the cornea and a small portion of the sclera and posteriorly by a small portion of the ciliary body, the iris, and that part of the crystalline lens which presents through the pupil. (Cline et al., Dictionary of Visual Science, 4th ed, p109)_A cyst of unknown cause that arises from the iris.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3983, C12667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3002002</VALIDVALUE>
          <VALUEMEANING>Thyroid Gland Hemorrhage</VALUEMEANING>
          <MEANINGDESCRIPTION>An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control._The flow of blood from a ruptured blood vessel.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26791, C12400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218964</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2243000</VALIDVALUE>
          <VALUEMEANING>Hypercalcemia Due To Hyperthyroidism</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormally high concentration of calcium in the peripheral blood._Caused by or resulting from._Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves&#39; disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3123, C89272, C3112</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3716002</VALIDVALUE>
          <VALUEMEANING>Goiter</VALUEMEANING>
          <MEANINGDESCRIPTION>Enlargement of the thyroid gland usually caused by lack of iodine in the diet, hyperthyroidism, or thyroid nodules. Symptoms include difficulty in breathing and swallowing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210815</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>649002</VALIDVALUE>
          <VALUEMEANING>Ulna Open Fracture</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the bones that comprise the forearm. The largest aspect articulates with the humerus at the elbow joint and the smallest portion of the ulna articulates with the carpal bones in the wrist._A traumatic break to the bone in which the continuity of the bone has broken through the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34624, C12809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222508</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3004001</VALIDVALUE>
          <VALUEMEANING>Congenital Esophageal Dilation</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting something that is present at birth._Of or relating to the esophagus._The condition of being dilated or stretched.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C113136, C37950, C99210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222594</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2245007</VALIDVALUE>
          <VALUEMEANING>Nasopharynx Foreign Body</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the pharynx in the back of the throat, at and above the soft palate. The nasopharynx is continuous with the nasal passages._Extraneous material within the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34620, C12423</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218960</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3720003</VALIDVALUE>
          <VALUEMEANING>Hemoglobin Abnormal Present</VALUEMEANING>
          <MEANINGDESCRIPTION>The red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the oxygen is readily released and HbO2 becomes Hb._Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm._Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626, C25401, C16676</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222631</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1418007</VALIDVALUE>
          <VALUEMEANING>Hypochondroplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant disorder that is often caused by a defect in fibroblast growth factor receptor 3, and characterized by short stature, micromelia, and a comparatively large head. The features are milder than those seen in achondroplasia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118697</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>652005</VALIDVALUE>
          <VALUEMEANING>Gangrene Tonsillitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Death of tissue, usually in considerable mass and generally associated with loss of vascular (nutritive) supply and followed by bacterial invasion and putrefaction._Inflammation of the tonsillar tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116006, C50573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222509</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1427008</VALIDVALUE>
          <VALUEMEANING>Intraspinal Abscess</VALUEMEANING>
          <MEANINGDESCRIPTION>Within the spine._An inflammatory process characterized by the accumulation of pus within a newly formed tissue cavity which is the result of a bacterial, fungal, or parasitic infection or the presence of a foreign body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26686, C96908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213230</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2256007</VALIDVALUE>
          <VALUEMEANING>Identical Twin</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two offspring resulting from a shared ovum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3723001</VALIDVALUE>
          <VALUEMEANING>Joint Inflammation</VALUEMEANING>
          <MEANINGDESCRIPTION>The connection point between two bones or skeletal elements. The joint may be fixed or movable._A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3137, C13044</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222632</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2284002</VALIDVALUE>
          <VALUEMEANING>Pulse Exophthalmos</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of a series of intermittent occurrences characterized by a brief, sudden change in a quantity._The anterior displacement of the eye within the orbit, giving a bulging appearance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118763, C64713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3021005</VALIDVALUE>
          <VALUEMEANING>Normal Gastric Acid pH Measurement</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm._No value exists._The measure of acidity or alkalinity of an aqueous solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C205029, C94192, C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3738000</VALIDVALUE>
          <VALUEMEANING>Viral Hepatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute or chronic inflammation of the liver parenchyma caused by viruses. Representative examples include hepatitis A, B, and C, cytomegalovirus hepatitis, and herpes simplex hepatitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35124</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946504</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1469007</VALIDVALUE>
          <VALUEMEANING>Spontaneous Abortion With Urinary Tract Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>Fetal loss at less than 20 weeks of gestation._Used to indicate the presence of something or someone._A bacterial infectious process affecting any part of the urinary tract, most commonly the bladder and the urethra. Symptoms include urinary urgency and frequency, burning sensation during urination, lower abdominal discomfort, and cloudy urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50791, C62355, C34336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3744001</VALIDVALUE>
          <VALUEMEANING>Hyperlipoproteinemia</VALUEMEANING>
          <MEANINGDESCRIPTION>An elevated concentration of lipoproteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34709</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222633</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2296009</VALIDVALUE>
          <VALUEMEANING>Iron Dextran Toxicity</VALUEMEANING>
          <MEANINGDESCRIPTION>A colloidal solution containing ferric oxyhydroxide complexed with polymerized dextran, used as a form of parenteral iron-replacement therapy. Upon administration and absorption, the iron dextran complex is removed from plasma by the reticuloendothelial system which cleaves it into the components iron and dextran; ferric iron subsequently binds to transferrin or is stored as hemosiderin or ferritin. Transferrin-bound iron is transported in the plasma to the liver, spleen and bone marrow, where is it is incorporated into hemoglobin (Hgb) and to muscle where it is incorporated into myoglobin (Mb). Use of this agent circumvents the gastrointestinal adverse effects commonly encountered with the use of orally administered iron salt preparations. Because of cross-reactivity with antibodies targeted against polysaccharides similar to dextran, anaphylactic reactions may occur with this type of iron formulation._The finding of bodily harm due to the poisonous effects of something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27990, C76837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222554</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>663008</VALIDVALUE>
          <VALUEMEANING>Pulmonary Embolism Post Molar Pregnancy Indicator And/Or Ectopic Pregnancy</VALUEMEANING>
          <MEANINGDESCRIPTION>The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung._Happening at a time subsequent to a reference time; later in time or order._An indication as to whether a molar pregnancy (hydatidiform mole) has occurred._Used to indicate that either or both of two items or options may be valid._An abnormal pregnancy in which the conception is implanted outside the endometrial cavity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34945, C48928, C209678, C38008, C50713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1475003</VALIDVALUE>
          <VALUEMEANING>Cold Sore</VALUEMEANING>
          <MEANINGDESCRIPTION>A lesion caused by type 1 or type 2 herpes simplex virus, involving the oralfacial region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34695</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213235</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3038009</VALIDVALUE>
          <VALUEMEANING>Acute Umbilicus Lymphangitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Having a severe and rapid onset of symptoms with short duration._The depression or scar on the abdomen that marks the former site of attachment of the umbilical cord._Inflammation of the lymphatic vessels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34790, C77533, C14140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3751005</VALIDVALUE>
          <VALUEMEANING>Labial Contusion</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring in, or located in the lips or vagina._A bruise due to trauma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50441, C96267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222634</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2303007</VALIDVALUE>
          <VALUEMEANING>Gangrene Inguinal Hernia</VALUEMEANING>
          <MEANINGDESCRIPTION>Death of tissue, usually in considerable mass and generally associated with loss of vascular (nutritive) supply and followed by bacterial invasion and putrefaction._The protrusion of a sac-like structure containing fibroadipose tissue through an abnormal opening in the inguinal region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34690, C50573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1482004</VALIDVALUE>
          <VALUEMEANING>Chalazion</VALUEMEANING>
          <MEANINGDESCRIPTION>A slowly growing eyelid lump caused by the blockage and swelling of a meibomian gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>664002</VALIDVALUE>
          <VALUEMEANING>Delay Ovulation</VALUEMEANING>
          <MEANINGDESCRIPTION>Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later._The discharge of a secondary oocyte from a vesicular follicle of the ovary.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66849, C25476</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3044008</VALIDVALUE>
          <VALUEMEANING>Vitreous Chamber Prolapse</VALUEMEANING>
          <MEANINGDESCRIPTION>The largest space within the eye which is bounded by the lens and the retina and filled with the gelatinous vitreous humor._A condition in which an organ or body tissue drops or bulges out of place.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36173, C33885</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3752003</VALIDVALUE>
          <VALUEMEANING>Trichuriasis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection that is caused by the nematode Trichuris trichiura, a soil-transmitted helminth, which is transmitted via food and/or water contaminated with the eggs of the worm. Symptoms are usually mild and include abdominal pain, diarrhea, fatigue, and possibly anemia secondary to blood loss in diarrhea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1486001</VALIDVALUE>
          <VALUEMEANING>Orbit Congestive</VALUEMEANING>
          <MEANINGDESCRIPTION>The bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa. Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine bones._Relating to or affected by an abnormal collection of blood or other fluid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25459, C12347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2304001</VALIDVALUE>
          <VALUEMEANING>Intervertebral Disc Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>Spongy discs located between the vertebrae of the spinal column; composed of the outer annulus fibrosus and inner nucleus pulposus._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320, C49571</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222556</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>675003</VALIDVALUE>
          <VALUEMEANING>Intestinal Volvulus</VALUEMEANING>
          <MEANINGDESCRIPTION>Twisting of a loop of bowel that results in intestinal obstruction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98963</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3053001</VALIDVALUE>
          <VALUEMEANING>Nitroglycerin Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>An organic nitrate with vasodilator activity. Nitroglycerin is converted into nitric oxide (NO) in smooth muscle and activates guanylyl cyclase, thereby increasing cGMP concentration, and resulting in smooth muscle relaxation. Dilatation of the veins results in decreased venous return to the heart, thereby decreasing left ventricular volume (reduced preload) and decreasing myocardial oxygen requirements. Arteriolar relaxation reduces arteriolar resistance (reduced afterload), thereby decreasing myocardial oxygen demands. In addition, nitroglycerine causes coronary artery dilatation, thereby improving myocardial blood distribution._Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C29294</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3754002</VALIDVALUE>
          <VALUEMEANING>Vaginal Dysplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to the vagina._A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns. The cellular changes include nuclear and cytoplasmic abnormalities. Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4086, C13309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1488000</VALIDVALUE>
          <VALUEMEANING>Postoperative Nausea and Vomiting</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to or occurring during the period immediately following a surgical operation._Expelling the contents of the stomach and the sensations associated with it. They are symptoms of an underlying disease or condition and not a specific illness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28006, C3259</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2307008</VALIDVALUE>
          <VALUEMEANING>Surrounding Pancreatic Fat Necrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Extending on all sides of simultaneously; encircling._Of or pertaining to the pancreas._Destruction of adipose tissue caused by the activity of lipase on damaged fat cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26772, C25726, C52247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213253</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3755001</VALIDVALUE>
          <VALUEMEANING>Pityriasis Rubra Pilaris</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare cutaneous disorder of unknown etiology characterized by the presence of reddish-orange scaly plaques, palmoplantar keratoderma, keratotic follicular papules, and confluent erythematous areas with areas of normal skin between the lesions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85014</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3059002</VALIDVALUE>
          <VALUEMEANING>Thigh Acute Lymphangitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A part of the lower limb, located between hip and knee._Having a severe and rapid onset of symptoms with short duration._Inflammation of the lymphatic vessels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34790, C14140, C33763</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>685002</VALIDVALUE>
          <VALUEMEANING>Acquired Telangiectasia Small Intestine And/Or Large Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or relating to a medical condition or characteristic that is not present at birth but develops subsequently._Local dilatation of small vessels resulting in red discoloration of the skin or mucous membranes._The section of the intestines between the pylorus and cecum. The small intestine is approximately 20 feet long and consists of the duodenum, the jejunum, and the ileum. Its main function is to absorb nutrients from food as the food is transported to the large intestine._Used to indicate that either or both of two items or options may be valid._A muscular tube that extends from the end of the small intestine to the anus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12379, C48928, C12386, C28194, C85869</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1489008</VALIDVALUE>
          <VALUEMEANING>External Stye</VALUEMEANING>
          <MEANINGDESCRIPTION>Happening or arising or located outside or beyond some limits, or especially, some surface._An infection of one or more of the glands surrounding the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118722, C44280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2308003</VALIDVALUE>
          <VALUEMEANING>Absence of Signs or Symptoms Allele</VALUEMEANING>
          <MEANINGDESCRIPTION>Absence of detectable signs or symptoms._Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16277, C106101</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222557</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3071008</VALIDVALUE>
          <VALUEMEANING>Widow</VALUEMEANING>
          <MEANINGDESCRIPTION>A woman who has lost her spouse by death and has not remarried.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C150722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6228067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3798002</VALIDVALUE>
          <VALUEMEANING>Too Early Birth Identical Twin Both Stillbirth</VALUEMEANING>
          <MEANINGDESCRIPTION>At a point before the usual, expected, or specified time._The event of being born._Either of the two offspring resulting from a shared ovum._One and the other; relating to or being two in conjunction._A fetus of at least 20 weeks gestation, or of a birth weight of at least 350 grams if the gestational age is unknown, that is born without signs of life at the time of delivery, and with an Apgar score of zero at both one and five minutes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49151, C49636, C73429, C25155, C133441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1493002</VALIDVALUE>
          <VALUEMEANING>Acute Endophthalmitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Having a severe and rapid onset of symptoms with short duration._An infectious process affecting the internal structures of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34586, C14140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3073006</VALIDVALUE>
          <VALUEMEANING>Bannayan-Riley-Ruvalcaba Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A genetic syndrome caused by mutations in the PTEN gene. It is characterized by macrocephaly and the presence of hamartomas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3939</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213268</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>701003</VALIDVALUE>
          <VALUEMEANING>Adult Spinal Osteochondritis</VALUEMEANING>
          <MEANINGDESCRIPTION>An age group comprised of humans who have reached reproductive age._Of or relating to the spine or spinal cord._Inflammation of the bone and cartilage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34877, C38026, C17600</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2312009</VALIDVALUE>
          <VALUEMEANING>Inhibition Type Reactive Attachment Disorder of Infancy or Early Childhood</VALUEMEANING>
          <MEANINGDESCRIPTION>The interference with or prevention of an action or response even though the stimulus for that action or response is present._Something distinguishable as an identifiable class based on common qualities._A condition in which the failure to establish healthy bonds with caregivers in early childhood leads to lifelong impairment of social interactions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118190, C25284, C42791</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3820005</VALIDVALUE>
          <VALUEMEANING>Inner Ear Conductive Hearing Loss</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the ear located within the temporal bone that is involved in both hearing and balance and includes the semicircular canals, vestibule, and cochlea. (from American Heritage Dictionary online)_Hearing loss caused by impaired transmission of signals from the external auditory canal or middle ear to the cochlea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27645, C12499</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1512006</VALIDVALUE>
          <VALUEMEANING>Bile Duct Congenital Stenosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the ducts conveying bile between the liver and the intestine, including hepatic, cystic, and common bile duct._Denoting something that is present at birth._Narrowing or stricture of a vessel, duct or canal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50754, C99210, C12376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222526</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>703000</VALIDVALUE>
          <VALUEMEANING>Ankyloglossia</VALUEMEANING>
          <MEANINGDESCRIPTION>A developmental abnormality in which the bottom of the tongue is attached to the floor of the mouth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124538</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3094009</VALIDVALUE>
          <VALUEMEANING>Infant And/Or Child Vomiting</VALUEMEANING>
          <MEANINGDESCRIPTION>An age group comprised of individuals between one month and two years of age._Used to indicate that either or both of two items or options may be valid._An age group comprised of individuals who are not yet an adult. The specific cut-off age will vary by purpose._Forceful ejection of the contents of the stomach through the mouth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3442, C16423, C48928, C27956</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2314005</VALIDVALUE>
          <VALUEMEANING>Unprotected Sexual Intercourse</VALUEMEANING>
          <MEANINGDESCRIPTION>Sexual intercourse without the use of precautions to prevent conception or the transmission of sexually transmitted diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C88146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3827008</VALIDVALUE>
          <VALUEMEANING>Neck Artery Aneurysm</VALUEMEANING>
          <MEANINGDESCRIPTION>The region that connects the head to the rest of the body._A blood vessel that carries blood away from the heart._Bulging or ballooning in an area of an artery secondary to arterial wall weakening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26693, C12372, C13063</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>715001</VALIDVALUE>
          <VALUEMEANING>Negation Injury Urethral Rupture</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity._Relating to the urethra (the urogenital canal, connecting the bladder to the outside of the body) as the intended site of administration._Forcible tearing or disruption of tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9445, C200224, C3671, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222512</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3095005</VALIDVALUE>
          <VALUEMEANING>Induction Malaria</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of bringing about something._A protozoan infection caused by the genus Plasmodium. There are four species of Plasmodium that can infect humans: Plasmodium falciparum, vivax, ovale, and malariae. It is transmitted to humans by infected mosquitoes. Signs and symptoms include paroxysmal high fever, sweating, chills, and anemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34797, C61367</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1521007</VALIDVALUE>
          <VALUEMEANING>Buttock Blister Without Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the fleshy mounds in the rear pelvic area of the human body formed by the gluteal muscles._An intraepidermal/subepidermal cavity filled with clear, serosanguineous or cloudy fluid._Used to indicate the absence or lack of something or someone._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320, C25718, C75564, C89806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2339001</VALIDVALUE>
          <VALUEMEANING>Hypersexualism</VALUEMEANING>
          <MEANINGDESCRIPTION>Excessive sexual behavior.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3830001</VALIDVALUE>
          <VALUEMEANING>Subcutaneous Emphysema</VALUEMEANING>
          <MEANINGDESCRIPTION>The presence of air or gas in subcutaneous tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C127819</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5296392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2341000</VALIDVALUE>
          <VALUEMEANING>Rat-Bite Fever</VALUEMEANING>
          <MEANINGDESCRIPTION>An infectious disease that is caused transmitted by the bite of a rat. Two species of bacteria can cause the infection: Streptobacillus moniliformis and Spirillum minus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>718004</VALIDVALUE>
          <VALUEMEANING>Acute Bronchiolitis With Obstruction</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute inflammation of the bronchioles usually caused by the respiratory syncytial virus._Used to indicate the presence of something or someone._Blockage of the normal flow of the contents of an anatomical passageway.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3284, C62355, C39659</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3097002</VALIDVALUE>
          <VALUEMEANING>Superficial Injury Lip With Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>Of little substance or significance; involving only a surface._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity._Fleshy fold which surrounds the opening of the mouth._Used to indicate the presence of something or someone._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320, C62355, C12220, C3671, C25239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222598</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1523005</VALIDVALUE>
          <VALUEMEANING>Clinical Stage IVB</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVB depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVB is defined as follows: (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N1: Regional lymph node metastasis. M1b: Metastasis to other distant sites; for vaginal cancer, stage IVB is defined as follows: Any T, Any N, M1. M1: Distant metastasis. (partially adapted from AJCC 7th ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27980, C25398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3841004</VALIDVALUE>
          <VALUEMEANING>Cheek Blister With Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>The fleshy part of the face bounded by the eyes, nose, ear, and jaw line._An intraepidermal/subepidermal cavity filled with clear, serosanguineous or cloudy fluid._Used to indicate the presence of something or someone._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320, C62355, C75564, C13070</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2351004</VALIDVALUE>
          <VALUEMEANING>DNA Transduction</VALUEMEANING>
          <MEANINGDESCRIPTION>The introduction of DNA into a cell by a virus or viral vector.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C180568</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222558</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>736004</VALIDVALUE>
          <VALUEMEANING>Hip Abscess</VALUEMEANING>
          <MEANINGDESCRIPTION>The lateral prominence of the pelvis from the waist to the thigh._An inflammatory process characterized by the accumulation of pus within a newly formed tissue cavity which is the result of a bacterial, fungal, or parasitic infection or the presence of a foreign body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26686, C64193</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3098007</VALIDVALUE>
          <VALUEMEANING>Interventricular Septum Rupture</VALUEMEANING>
          <MEANINGDESCRIPTION>The wall that separates the left and right ventricles of the heart._Forcible tearing or disruption of tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9445, C32874</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2365002</VALIDVALUE>
          <VALUEMEANING>Simple Chronic Pharyngitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Easy, not involved or complicated, not elaborate, having few parts._Usually used to describe a condition that is persistent and long standing._Inflammation of the throat most often caused by viral and bacterial infections. Other causes include allergens, chemical substances, and trauma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26851, C14141, C47880</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222559</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1525003</VALIDVALUE>
          <VALUEMEANING>Foot Blister Without Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>The structure found below the ankle joint._An intraepidermal/subepidermal cavity filled with clear, serosanguineous or cloudy fluid._Used to indicate the absence or lack of something or someone._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320, C25718, C75564, C32622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3845008</VALIDVALUE>
          <VALUEMEANING>Intestinal Duplication</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare congenital abnormality characterized by the presence of a duplicated segment of the intestine. The duplicated segment is cystic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218973</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>750009</VALIDVALUE>
          <VALUEMEANING>Schistosoma Mansoni Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection that is caused by Schistosoma mansoni.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222513</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3105002</VALIDVALUE>
          <VALUEMEANING>Intron</VALUEMEANING>
          <MEANINGDESCRIPTION>Non-coding, intervening sequences of DNA that are transcribed, but are removed from within the primary gene transcript and rapidly degraded during maturation of messenger RNA.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13249</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2848475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3855007</VALIDVALUE>
          <VALUEMEANING>Pancreatic Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A non-neoplastic or neoplastic disorder that affects the pancreas.  Representative examples of non-neoplastic disorders include pancreatitis and pancreatic insufficiency.  Representative examples of neoplastic disorders include cystadenomas, carcinomas, lymphomas, and neuroendocrine neoplasms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26842</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2366001</VALIDVALUE>
          <VALUEMEANING>Late Effect Dislocation</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or occurring at an advanced period of time or after a usual or expected time._A phenomenon that follows and is caused by some previous phenomenon._A displacement of a part (especially a bone) from its normal position.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35724, C25492, C64998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1532007</VALIDVALUE>
          <VALUEMEANING>Viral Pharyngitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Having to do with a virus._Inflammation of the throat most often caused by viral and bacterial infections. Other causes include allergens, chemical substances, and trauma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26851, C27985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>758002</VALIDVALUE>
          <VALUEMEANING>Uterus Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy._A sac-like closed membranous structure that may be empty or contain fluid or amorphous material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2978, C12405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222514</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3129009</VALIDVALUE>
          <VALUEMEANING>Ovary Infarction</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the paired female reproductive glands containing the ova or germ cells; the ovary&#39;s stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova._A localized pathological necrosis of tissue resulting from obstruction of the blood supply usually by a thrombus, an embolus, or vascular torsion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25738, C12404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222599</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3885002</VALIDVALUE>
          <VALUEMEANING>Pregnancy ABO Hemolytic Disease of the Newborn</VALUEMEANING>
          <MEANINGDESCRIPTION>The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth._A condition of the newborn characterized by the destruction of red blood cells initiated by the transmission of anti-A or anti-B antibodies from a mother to the child via the placenta against A or B antigens of the newborn&#39;s blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C106273, C25742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1539003</VALIDVALUE>
          <VALUEMEANING>Trigger Finger Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A painful hand deformity affecting the fingers. It is due to damage of the finger flexor tendons, causing the finger to remain in a locked position.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85203</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>776009</VALIDVALUE>
          <VALUEMEANING>Partial Retinal Arterial Occlusion</VALUEMEANING>
          <MEANINGDESCRIPTION>A partial occlusion of the retinal artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35192</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2367005</VALIDVALUE>
          <VALUEMEANING>Acute Hemorrhagic Gastritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Having a severe and rapid onset of symptoms with short duration._Inflammation of the stomach resulting in bleeding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26928, C14140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222560</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3135009</VALIDVALUE>
          <VALUEMEANING>Otitis Externa</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the anatomical structures of the outer ear and ear canal, which is most often caused by an infectious process. Symptoms include erythema, edema, and pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79601</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222601</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3899003</VALIDVALUE>
          <VALUEMEANING>Neutropenia Typhlitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A decrease in the number of neutrophils in the peripheral blood._Inflammation of the cecum, usually accompanied by neutropenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38043, C80520</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1542009</VALIDVALUE>
          <VALUEMEANING>Omphalocele With Obstruction</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital defect in the muscles of the abdominal wall that results in the intestines and other abdominal organs developing outside the abdominal wall covered in a sac._Used to indicate the presence of something or someone._Blockage of the normal flow of the contents of an anatomical passageway.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3284, C62355, C98997</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>786005</VALIDVALUE>
          <VALUEMEANING>Clinical Stage IB</VALUEMEANING>
          <MEANINGDESCRIPTION>Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._Invasive cancer confined to the original anatomic site of growth without lymph node involvement.  The definition of stage IB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IB is defined as follows: (T0, N1mi, M0); (T1, N1mi, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N1mi: Nodal micrometastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IB is defined as follows: (T2, N0, M0, G1, G2, GX); (T3, N0, M0, G1, G2, GX). T2: Tumor more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (partially adapted from AJCC 7th ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27976, C25398</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2385003</VALIDVALUE>
          <VALUEMEANING>Pectoral Region Cellulitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or pertaining to the chest._An area or portion of something with more or less definite boundaries designed or specified according to some established biological, administrative, economic, demographic, etc. criteria._Inflammation of the dermis and subcutaneous tissues caused by a bacterial infection. Symptoms include erythema, edema, and pain to the affected area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26715, C41129, C25611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3140001</VALIDVALUE>
          <VALUEMEANING>Subacute Type Citrullinemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A disease characteristic falling between acute and chronic, but predominantly acute._Something distinguishable as an identifiable class based on common qualities._A rare autosomal recessive inherited disorder caused by mutations in the ASS1 and SLC25A13 genes. It is characterized by a defective urea cycle, resulting in the accumulation of ammonia and other toxic substances in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84639, C25284, C120855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222602</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3914008</VALIDVALUE>
          <VALUEMEANING>Childhood Psychiatric Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A time period that begins at the beginning of the human embryonic stage and continues until the end of adolescence._A disorder characterized by behavioral and/or psychological abnormalities, often accompanied by physical symptoms. The symptoms may cause clinically significant distress or impairment in social and occupational areas of functioning. Representative examples include anxiety disorders, cognitive disorders, mood disorders and schizophrenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2893, C89345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1551001</VALIDVALUE>
          <VALUEMEANING>Femur Osteomyelitis</VALUEMEANING>
          <MEANINGDESCRIPTION>The upper leg bone positioned between the pelvis and the knee._An acute or chronic inflammation of the bone and its structures due to infection with pyogenic bacteria.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27577, C12717</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>787001</VALIDVALUE>
          <VALUEMEANING>Rheumatic Mitral Stenosis With Mitral Valve Regurgitation</VALUEMEANING>
          <MEANINGDESCRIPTION>Mitral valve stenosis secondary to rheumatic fever._Used to indicate the presence of something or someone._The backward flow of blood from the left ventricle into the left atrium, owing to insufficiency of the mitral valve; it may be acute or chronic, usually due to mitral valve prolapse, rheumatic heart disease or a complication of cardiac dilatation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50852, C62355, C197956</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2390000</VALIDVALUE>
          <VALUEMEANING>Acute Gonococcal Infection Vulvovaginitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Having a severe and rapid onset of symptoms with short duration._An infection that is caused by Gonococcus._An inflammatory pathologic process that affects the vulva and the vagina.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35131, C35730, C14140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222561</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3144005</VALIDVALUE>
          <VALUEMEANING>Staphylococcus Pleuritis</VALUEMEANING>
          <MEANINGDESCRIPTION>A genus of nonmotile, nonspore-forming, aerobic to facultatively anaerobic bacteria containing Gram-positive, spherical cells, 0.5-1.5 microns in diameter, which divide in more than one plane to form irregular clusters. Coagulase-positive strains produce a variety of toxins and are therefore potentially pathogenic and may cause food poisoning. They are found on the skin, in skin glands, on the nasal and other mucous membranes of warm-blooded animals, and in various food products. The type species is Staphylococcus aureus._Inflammation of the pleura. It is usually caused by infections. Chest pain while breathing or coughing is the presenting symptom.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26860, C62583</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3928002</VALIDVALUE>
          <VALUEMEANING>Zika Virus Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A species of positive sense ssRNA viruses in the family Flaviviridae that is carried and spread by Aedes mosquitoes. This virus causes zika fever and infection in pregnant women can pass to the fetus and is associated with microcephaly and other birth defects. Zika virus infection can also trigger Guillain-Barre paralysis._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C128553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>788006</VALIDVALUE>
          <VALUEMEANING>Disease or Disorder Relationship Diet</VALUEMEANING>
          <MEANINGDESCRIPTION>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A state of connectedness between people, objects, or events; to be associated or connected with something._The customary allowance of food and drink taken by a person or an animal from day to day, particularly one especially planned to meet specific requirements of the individual, including or excluding certain items of food; a prescribed course of eating and drinking in which the amount and kind of food, as well as the times at which it is to be taken, are regulated for therapeutic purposes or selected with reference to a particular state of health.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15222, C25648, C2991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2391001</VALIDVALUE>
          <VALUEMEANING>Achondrogenesis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare group of disorders characterized by defective development of bones and cartilage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84527</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3944006</VALIDVALUE>
          <VALUEMEANING>X-Linked Ichthyosis</VALUEMEANING>
          <MEANINGDESCRIPTION>The second most common form of ichthyosis. It is an X-linked inherited disorder with mild skin manifestations. The skin changes appear at birth and include keratinization and scaling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211537</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3168002</VALIDVALUE>
          <VALUEMEANING>Intracranial Venous Sinus Thrombophlebitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Situated or occurring within the cranium; affecting or involving intracranial structures._A large vein or channel for the circulation of venous blood, such as one of the sinuses of the dura mater._Inflammation of the veins associated with the presence of a thrombus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3410, C12877, C84351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1563006</VALIDVALUE>
          <VALUEMEANING>Protein S Deficiency Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare thrombophilia disorder characterized by deficiency of protein S. It results in venous thromboembolism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C99026</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218951</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3950001</VALIDVALUE>
          <VALUEMEANING>Birth</VALUEMEANING>
          <MEANINGDESCRIPTION>The event of being born.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2398007</VALIDVALUE>
          <VALUEMEANING>Electrocardiogram Detected Finding Quinidine Toxicity</VALUEMEANING>
          <MEANINGDESCRIPTION>A record of the electrical activity of the heart._Perceived, discerned, or discovered._An alkaloid extracted from the bark of the Cinchona tree with class 1A antiarrhythmic and antimalarial effects. Quinidine stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels, thereby inhibiting the sodium influx required for the initiation and conduction of impulses resulting in an increase of the threshold for excitation and decreased depolarization during phase 0 of the action potential. In addition, the effective refractory period (ERP), action potential duration (APD), and ERP/APD ratios are increased, resulting in decreased conduction velocity of nerve impulses. Quinidine exerts its antimalarial activity by acting primarily as an intra-erythrocytic schizonticide through association with the heme polymer (hemazoin) in the acidic food vacuole of the parasite thereby preventing further polymerization by heme polymerase enzyme. This results in accumulation of toxic heme and death of the parasite._The finding of bodily harm due to the poisonous effects of something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27990, C793, C191719, C168186</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222562</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1567007</VALIDVALUE>
          <VALUEMEANING>Chronic Gastric Ulcer without Hemorrhage or Perforation Without Obstruction</VALUEMEANING>
          <MEANINGDESCRIPTION>Evidence of chronic gastric ulcer without hemorrhage or perforation._Used to indicate the absence or lack of something or someone._Blockage of the normal flow of the contents of an anatomical passageway.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3284, C25718, C196803</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222528</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3199001</VALIDVALUE>
          <VALUEMEANING>Shoulder Joint Sprain</VALUEMEANING>
          <MEANINGDESCRIPTION>A ball-and-socket joint at the upper end of the humerus, located at the junction of humerus and scapula._A stretching or tearing of a ligament.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35035, C33548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>799008</VALIDVALUE>
          <VALUEMEANING>Colonic Ulcer</VALUEMEANING>
          <MEANINGDESCRIPTION>A circumscribed inflammatory and necrotic erosive lesion in the mucosa surface of the colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78244</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3214003</VALIDVALUE>
          <VALUEMEANING>Invasive Pulmonary Aspergillosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of aspergillosis characterized by the presence of septate, acute, branching hyphae invading lung tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C162141</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1588003</VALIDVALUE>
          <VALUEMEANING>Contrasexual Sexual Development</VALUEMEANING>
          <MEANINGDESCRIPTION>The development of secondary sexual characteristics contrary to pre-pubertal phenotype (feminization in boys; virilization in girls).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218952</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2415007</VALIDVALUE>
          <VALUEMEANING>Lumbosacral Region Nerve Root Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the spine in the lower back that consists of the lumbar region and the sacrum._The initial segment of a nerve after it has branched off from the central nervous system._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3824, C54024, C48824</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3972004</VALIDVALUE>
          <VALUEMEANING>Primary Insomnia</VALUEMEANING>
          <MEANINGDESCRIPTION>A sleep disorder characterized by difficulty initiating or maintaining sleep; this difficulty does not occur in the context of another sleep disorder and is not etiologically linked to a mental disorder, substance use, or a general medical condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34949</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>815008</VALIDVALUE>
          <VALUEMEANING>Bulbar Conjunctivitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the thin layer of tissue lining the sclera of the eye characterized by redness in the white portion of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3218000</VALIDVALUE>
          <VALUEMEANING>Fungal Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection caused by a fungus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3245</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573407</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1593000</VALIDVALUE>
          <VALUEMEANING>Infant Hemiplegia</VALUEMEANING>
          <MEANINGDESCRIPTION>An age group comprised of individuals between one month and two years of age._Paralysis of one side of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64329, C27956</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3975002</VALIDVALUE>
          <VALUEMEANING>Lower Extremity Deep Third-Degree Burn</VALUEMEANING>
          <MEANINGDESCRIPTION>The limb that is composed of the hip, thigh, leg and foot._Extending relatively far inward._An injury that includes all skin layers into the subcutaneous tissue due to chemical, friction, radiation or thermal exposure. The affected area appears dry and thickened; damage to nerve endings usually renders the wound painless.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C76132, C25240, C12742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222640</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2420007</VALIDVALUE>
          <VALUEMEANING>Multiple Anatomic Sites Upper Extremity Third-Degree Burn</VALUEMEANING>
          <MEANINGDESCRIPTION>Present at many sites of the body._The region of the body that includes the arm, the forearm, and hand._An injury that includes all skin layers into the subcutaneous tissue due to chemical, friction, radiation or thermal exposure. The affected area appears dry and thickened; damage to nerve endings usually renders the wound painless.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C76132, C12671, C13420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222564</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>818005</VALIDVALUE>
          <VALUEMEANING>Multiple Anatomic Sites Lower Extremity Third-Degree Burn</VALUEMEANING>
          <MEANINGDESCRIPTION>Present at many sites of the body._The limb that is composed of the hip, thigh, leg and foot._An injury that includes all skin layers into the subcutaneous tissue due to chemical, friction, radiation or thermal exposure. The affected area appears dry and thickened; damage to nerve endings usually renders the wound painless.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C76132, C12742, C13420</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222516</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1647007</VALIDVALUE>
          <VALUEMEANING>Primaquine Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic, 8-aminoquinoline derivative with antimalarial properties.  Although its mechanism of action is unclear, primaquine bind to and alter the properties of protozoal DNA.  This agent eliminates tissue (exo-erythrocytic) malarial infection, preventing the development of the erythrocytic forms of the parasite which are responsible for relapses in Plasmodium vivax and ovale malaria.  Primaquine is active against late hepatic stages (hypnozoites, schizonts). (NCI04)_Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C62071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222529</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3219008</VALIDVALUE>
          <VALUEMEANING>Disease or Disorder Disease or Disorder And/Or Category Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Used to indicate that either or both of two items or options may be valid._A grouping of items based on some commonality or by user defined characteristics._Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998, C25372, C48928, C2991, C2991</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3978000</VALIDVALUE>
          <VALUEMEANING>Warm Antibody Autoimmune Hemolytic Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>The most common form of autoimmune hemolytic anemia, in which the autoantibodies react with red blood cells at temperatures greater than or equal to 37 degrees Celsius.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C162611</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2432006</VALIDVALUE>
          <VALUEMEANING>Cerebrospinal Fluid Circulatory Process Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord._A Circulatory Process consists of functions of cellular, cell, or tissue components of the heart and vessels by which blood and lymph is circulated through the body._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C41510, C12692</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1648002</VALIDVALUE>
          <VALUEMEANING>Lung Inflammatory Myofibroblastic Tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>An intermediate fibroblastic neoplasm arising from the lung.  It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39740</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>13614972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>825003</VALIDVALUE>
          <VALUEMEANING>Superficial Injury Axilla With Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>Of little substance or significance; involving only a surface._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity._The underside concavity where the arm and the shoulder are joined._Used to indicate the presence of something or someone._The invasion of an organism&#39;s body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128320, C62355, C12674, C3671, C25239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222517</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3987009</VALIDVALUE>
          <VALUEMEANING>Tracheal Agenesis</VALUEMEANING>
          <MEANINGDESCRIPTION>Congenital absence of the trachea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3228009</VALIDVALUE>
          <VALUEMEANING>Radius Shaft Closed Fracture</VALUEMEANING>
          <MEANINGDESCRIPTION>The slightly curved, prismoid, elongated bony body of a radius compressing of the anterior, posterior and external surfaces separated by the anterior, posterior and interosseous borders._A traumatic break to the bone in which the continuity of the bone has not broken through the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34623, C120674</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222606</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2437000</VALIDVALUE>
          <VALUEMEANING>Circumvallate Placenta</VALUEMEANING>
          <MEANINGDESCRIPTION>A placenta characterized by fetal membranes that are folded along all or part of the disc perimeter. The amnion may or may not be included in the folded tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117347</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1654001</VALIDVALUE>
          <VALUEMEANING>Steroid Compound Induction Glaucoma</VALUEMEANING>
          <MEANINGDESCRIPTION>Compounds possessing the skeleton of cyclopenta[a]phenanthrene or a skeleton derived therefrom by one or more bond scissions or ring expansions or contractions. Methyl groups are normally present at C-10 and C-13. An alkyl side chain may also be present at C-17.  They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons._The act of bringing about something._Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26782, C61367, C843</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4003003</VALIDVALUE>
          <VALUEMEANING>Alphavirus Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A genus of enveloped, spherical, or pleomorphic viruses with T=4 icosahedral symmetry, in the family Togaviridae. The genome is composed of a linear, single-strand of positive sense RNA. Alphaviruses are spread by insect vector, able to infect vertebrates and invertebrates, and cause arthritis, encephalitis, rashes and fever in humans._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C112030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3229001</VALIDVALUE>
          <VALUEMEANING>Trachea Ulcer</VALUEMEANING>
          <MEANINGDESCRIPTION>The fibrocartilaginous, mucous-lined tube passing from the larynx to the bronchi._A circumscribed inflammatory and often suppurating lesion on the skin or an internal mucous surface resulting in necrosis of tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3426, C12428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2438005</VALIDVALUE>
          <VALUEMEANING>Iniencephaly</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare neural tube defect characterized by extreme retroflexion of the head and severe defects of the spine. It is usually associated with other congenital anomalies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>841002</VALIDVALUE>
          <VALUEMEANING>Acrania</VALUEMEANING>
          <MEANINGDESCRIPTION>Absence of skull bone(s) at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1658003</VALIDVALUE>
          <VALUEMEANING>Lateral End Clavicle Closed Fracture</VALUEMEANING>
          <MEANINGDESCRIPTION>Situated at or extending to the side._The point or place at which something terminates in time, space, or extent._One of a pair of bones linking the scapula and the sternum. The clavicle is part of the pectoral girdle._A traumatic break to the bone in which the continuity of the bone has not broken through the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34623, C12695, C25496, C25230</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4009004</VALIDVALUE>
          <VALUEMEANING>Lower Urinary Tract Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>The bottom one of two._A bacterial infectious process affecting any part of the urinary tract, most commonly the bladder and the urethra. Symptoms include urinary urgency and frequency, burning sensation during urination, lower abdominal discomfort, and cloudy urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50791, C25309</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>842009</VALIDVALUE>
          <VALUEMEANING>Consanguineous Offspring</VALUEMEANING>
          <MEANINGDESCRIPTION>The offspring of a relationship between biologically-related individuals.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C189764</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213336</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2443003</VALIDVALUE>
          <VALUEMEANING>Hydrogen Sulfide Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>A highly flammable conjugate acid of a cyanide that occurs naturally in crude petroleum, natural gas, and hot springs, and can be produced by bacterial breakdown of organic material and waste. It is used as a chemical weapon agent and is characterized as a colorless gas with a strong rotten egg odor that causes irritation of the eyes and respiratory tract, as well as toxic systemic effects._Injury to the body or interference of normal body functions by a substance that is swallowed, inhaled, injected, or absorbed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34933, C163666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3230006</VALIDVALUE>
          <VALUEMEANING>Illegal Abortion With Afibrinogenemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Unlawfully induced expulsion of all products of conception._Used to indicate the presence of something or someone._A blood coagulation disorder characterized by the complete absence of fibrinogen in the blood, resulting in bleeding.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98130, C62355, C34337</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222607</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4016003</VALIDVALUE>
          <VALUEMEANING>Mastoid Process Empyema</VALUEMEANING>
          <MEANINGDESCRIPTION>A honeycombed section of bone located near the base of the skull, protruding behind the outer ear. It is connected to the middle ear._An accumulation of pus in the pleural space.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34572, C12503</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>844005</VALIDVALUE>
          <VALUEMEANING>Behavior Relationship Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>The actions or reactions of an object or organism, usually in relation to the environment or surrounding world of stimuli._A state of connectedness between people, objects, or events; to be associated or connected with something._Clinical, laboratory or molecular evidence, or absence of evidence of disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3367, C25648, C16326</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213339</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3238004</VALIDVALUE>
          <VALUEMEANING>Pericarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process affecting the pericardium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1663004</VALIDVALUE>
          <VALUEMEANING>Grade 2 Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic qualifier indicating that a cancerous lesion is moderately differentiated._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3262, C28078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4039009</VALIDVALUE>
          <VALUEMEANING>Multiple Vitamin Deficiency Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Having, relating to, or consisting of more than one individual, element, part, or other component; manifold._A disorder that is caused by the deficiency of a vitamin. The deficiency may result from either suboptimal vitamin intake or conditions that prevent the vitamin&#39;s use or absorption in the body. Representative examples include beriberi caused by thiamine deficiency, scurvy caused by vitamin C deficiency, and rickets caused by vitamin D deficiency.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35772, C17648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3239007</VALIDVALUE>
          <VALUEMEANING>Lymphocyte Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>White blood cells formed in the body&#39;s lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each); those with characteristics of neither major class are called null cells._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C12535</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>845006</VALIDVALUE>
          <VALUEMEANING>Inferior Mesenteric Artery Injury</VALUEMEANING>
          <MEANINGDESCRIPTION>A blood vessel arising from the aorta that supplies blood to the descending and sigmoid colon as well as the rectum._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3671, C32780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1667003</VALIDVALUE>
          <VALUEMEANING>Craniosynostosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital disorder characterized by earlier than normal closure of some or all sutures of the infant skull.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210992</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3253007</VALIDVALUE>
          <VALUEMEANING>Abnormal Pigmentation</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormality in the formation or distribution of pigment in the skin, hair or nails.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34930</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222608</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4041005</VALIDVALUE>
          <VALUEMEANING>Macula Congenital Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>A yellowish, highly pigmented, oval shaped area slightly lateral to the center of the retina of the eye which contains the fovea centralis and is mostly comprised of retinal cones, for high-acuity vision, and which if damaged will result in the partial/complete loss of central vision._Any abnormality, anatomical or biochemical, evident at birth or during the neonatal period.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2849, C26464</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1670004</VALIDVALUE>
          <VALUEMEANING>Cerebral Hemisphere Hemiparesis</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the brain that controls muscle functions and also controls speech, thought, emotions, reading, writing, and learning. The right hemisphere controls the muscles on the left side of the body, and the left hemisphere controls the muscles on the right side of the body._Weakness or incomplete paralysis of either the left or right side of the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122583, C12351</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>849000</VALIDVALUE>
          <VALUEMEANING>Total Cataract</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._Partial or complete opacity of the crystalline lens of one or both eyes that decreases visual acuity and eventually results in blindness. Some cataracts appear in infancy or in childhood, but most develop in older individuals. (Sternberg Diagnostic Surgical Pathology, 3rd ed.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26713, C25304</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4046000</VALIDVALUE>
          <VALUEMEANING>Degeneration Spondylolisthesis</VALUEMEANING>
          <MEANINGDESCRIPTION>The process of declining from a higher to a lower level of effective power or vitality or essential quality._A condition in which there is forward displacement of a vertebral bone over the on below it.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35033, C61557</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1674008</VALIDVALUE>
          <VALUEMEANING>Meesmann Corneal Dystrophy</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal dominant inherited corneal disorder caused by mutations in the KRT3 and KRT12 genes. It is characterized by the formation of multiple tiny cysts in the epithelial layer of the cornea. The cysts may rupture, causing pain, redness and light sensitivity. Vision usually is not affected.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84795</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4062006</VALIDVALUE>
          <VALUEMEANING>Lumbosacral Plexus Lesion</VALUEMEANING>
          <MEANINGDESCRIPTION>A network of nerves composed of the lumbar plexus (T12-L4) and the sacral plexus (L4-S4), which innervates the pelvic girdle and the lower limb._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3824, C52805</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>865004</VALIDVALUE>
          <VALUEMEANING>Ileus Total Parenteral Nutrition</VALUEMEANING>
          <MEANINGDESCRIPTION>Decrease in peristalsis in the absence of a mechanical bowel obstruction._Total parenteral nutrition formulated for intravenous administration in patients who cannot eat or cannot get enough nutrients from the foods they eat.  It is a liquid mixture of proteins, carbohydrates, fats, vitamins, minerals and other nutrients.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C29484, C37979</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1679003</VALIDVALUE>
          <VALUEMEANING>Arthritis Associated With Other Disease or Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain._Joined in some kind of relationship._Used to indicate the presence of something or someone._Different than the one(s) previously specified or mentioned._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2991, C17649, C62355, C25281, C2883</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213340</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4082005</VALIDVALUE>
          <VALUEMEANING>Syphilis Myocarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>A contagious bacterial infection caused by the spirochete Treponema pallidum. It is a sexually transmitted disorder, although it can also be transmitted from the mother to the fetus in utero. Typically, it is initially manifested with a single sore which heals without treatment. If the infection is left untreated, the initial stage is followed by skin rash and mucous membrane lesions. A late stage follows, which is characterized by damage of the internal organs, including the nervous system._Inflammation of the muscle tissue of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34831, C35055</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>874002</VALIDVALUE>
          <VALUEMEANING>Diuretic Therapeutic Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>A class of agents that increases the production of urine by the kidney. Via various mechanism of actions, diuretics retain water in urine, thus provides a means of forced diuresis._Medical care intended to treat or cure a condition or lessen its symptoms. This includes the administration of drugs, surgical procedures, physical or psychotherapy, or the use of therapeutic devices.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49236, C448</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4088009</VALIDVALUE>
          <VALUEMEANING>Acquired Hydrocephalus</VALUEMEANING>
          <MEANINGDESCRIPTION>Hydrocephalus that results from head trauma, brain tumors, intracranial hemorrhage, or meningitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98803</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4106009</VALIDVALUE>
          <VALUEMEANING>Rotator Cuff Rupture</VALUEMEANING>
          <MEANINGDESCRIPTION>A supporting structure of the shoulder consisting of the muscles and tendons that attach the arm to the shoulder joint and enable the arm to move._Forcible tearing or disruption of tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9445, C33497</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213351</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4120002</VALIDVALUE>
          <VALUEMEANING>Bronchiolitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the bronchioles characterized by swelling of the bronchioles and mucus accumulation. It is usually caused by the respiratory syncytial virus and affects children. Signs and symptoms include coughing, wheezing, and shortness of breath.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C39658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7976150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4127004</VALIDVALUE>
          <VALUEMEANING>Prostatic Obstruction</VALUEMEANING>
          <MEANINGDESCRIPTION>Squeezing of the urethra secondary to enlargement of the prostate gland, resulting in voiding symptoms (straining to void, slow urine stream, and incomplete emptying of the bladder).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4136000</VALIDVALUE>
          <VALUEMEANING>Toe Macrodactyly</VALUEMEANING>
          <MEANINGDESCRIPTION>One of the terminal digits of the foot._A condition in which a finger or toe is larger than normal size secondary to excessive growth of the anatomical structures or abnormal accumulation of substances.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48900, C33788</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4160001</VALIDVALUE>
          <VALUEMEANING>Upper Respiratory System Congenital Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea._Any abnormality, anatomical or biochemical, evident at birth or during the neonatal period.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2849, C33839</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4175009</VALIDVALUE>
          <VALUEMEANING>Myiasis</VALUEMEANING>
          <MEANINGDESCRIPTION>The infection of a fly larva (maggot) in human tissue, which most commonly occurs in tropical climates. Affected tissues most commonly include skin, especially if open wounds are present, nasal passages, ears, and eyes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4181001</VALIDVALUE>
          <VALUEMEANING>Normal Peak Expiratory Flow</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm._The maximum rate of gas flow, beginning at the point of peak inspiratory capacity, that can be sustained during forced exhalation for a defined period of time. This test is most often used in combination with other studies of lung function to diagnose and monitor obstructive and restrictive lung disease(s).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41372, C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4183003</VALIDVALUE>
          <VALUEMEANING>Charcot-Marie-Tooth Disease Type 1C</VALUEMEANING>
          <MEANINGDESCRIPTION>Charcot-Marie-Tooth disease caused by autosomal dominant mutation(s) in the LITAF gene, encoding lipopolysaccharide-induced tumor necrosis factor-alpha factor. It is characterized by distal muscle weakness, atrophy, and depressed deep tendon reflexes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217417</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4199009</VALIDVALUE>
          <VALUEMEANING>18p Partial Trisomy Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 18_Being or affecting only a part of something._A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number._A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28193, C3421, C25378, C13544</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4208000</VALIDVALUE>
          <VALUEMEANING>Both Lower Extremity Closed Multiple Fractures</VALUEMEANING>
          <MEANINGDESCRIPTION>One and the other; relating to or being two in conjunction._The limb that is composed of the hip, thigh, leg and foot._Not affording passage or access; blocked against entry._Two or more simultaneous traumatic breaks in one or more bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26778, C49070, C12742, C49636</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4210003</VALIDVALUE>
          <VALUEMEANING>Ocular Hypertension</VALUEMEANING>
          <MEANINGDESCRIPTION>Abnormally high intraocular pressure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3285</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4223005</VALIDVALUE>
          <VALUEMEANING>Parkinsonism Due To Pharmacologic Substance</VALUEMEANING>
          <MEANINGDESCRIPTION>One or more of the following symptoms including bradykinesia associated with rigidity, resting tremor, gait disturbance, which may be due to multiple etiologies._Caused by or resulting from._Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1909, C89272, C116922</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4224004</VALIDVALUE>
          <VALUEMEANING>Infusion Procedure Complication</VALUEMEANING>
          <MEANINGDESCRIPTION>Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord._Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2959, C15388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4225003</VALIDVALUE>
          <VALUEMEANING>Nasal Tuberculosis</VALUEMEANING>
          <MEANINGDESCRIPTION>In reference to the nose._A chronic, recurrent infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis (TB) may affect almost any tissue or organ of the body with the lungs being the most common site of infection. The clinical stages of TB are primary or initial infection, latent or dormant infection, and recrudescent or adult-type TB. Ninety to 95% of primary TB infections may go unrecognized. Histopathologically, tissue lesions consist of granulomas which usually undergo central caseation necrosis. Local symptoms of TB vary according to the part affected; acute symptoms include hectic fever, sweats, and emaciation; serious complications include granulomatous erosion of pulmonary bronchi associated with hemoptysis. If untreated, progressive TB may be associated with a high degree of mortality. This infection is frequently observed in immunocompromised individuals with AIDS or a history of illicit IV drug use.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3423, C27958</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213362</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4237001</VALIDVALUE>
          <VALUEMEANING>Suppuration Pulpitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A pathologic process consisting of the formation and discharge of pus._Inflammation of the dental pulp.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52595, C63710</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222649</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4240001</VALIDVALUE>
          <VALUEMEANING>Aorta Rupture</VALUEMEANING>
          <MEANINGDESCRIPTION>The major arterial trunk that carries oxygenated blood from the left ventricle into the ascending aorta behind the heart, the aortic arch, through the thorax as the descending aorta and through the abdomen as the abdominal aorta; it bifurcates into the left and right common iliac arteries._Forcible tearing or disruption of tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C9445, C12669</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4241002</VALIDVALUE>
          <VALUEMEANING>Listeriosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A bacterial infection caused by Listeria monocytogenes. It occurs in newborns, elderly, and immunocompromised patients. The bacteria are transmitted through ingestion of contaminated food. Clinical manifestations include fever, muscle pain, respiratory distress, nausea, diarrhea, neck stiffness, irritability, seizures, and lethargy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82994</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4242009</VALIDVALUE>
          <VALUEMEANING>Distal 18q Deletion Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A contiguous gene deletion syndrome involving deletion of the distal portion of the long arm of chromosome 18. The clinically heterogenous condition is characterized by some or all of the following: growth hormone deficiency with resulting short stature; hand, foot, skull, facial, and genital anomalies; hypotonia; and developmental delay.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C130986</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4244005</VALIDVALUE>
          <VALUEMEANING>Erythema Toxicum Neonatorum</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign, self-limited eruption of vesicles, pustules, papules and macules seen in newborns. An eosinophilic infiltrate can be isolated suggesting an immune-mediated reaction in the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4249000</VALIDVALUE>
          <VALUEMEANING>Peripheral Artery Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder of the arteries supplying the upper and lower extremity and the visceral organs. This includes the mesenteric arteries, the renal arteries and the aorta and excludes cerebrovascular arterial disease. Patients experience cramping and pain usually in the calves and thighs while walking. The symptoms subside with rest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84496</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4251001</VALIDVALUE>
          <VALUEMEANING>Stye</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection of one or more of the glands surrounding the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14476342</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4260009</VALIDVALUE>
          <VALUEMEANING>Sacral Spinal Cord Injury Without Bone Injury</VALUEMEANING>
          <MEANINGDESCRIPTION>The portion of the spinal cord located in the sacral region._Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity._Used to indicate the absence or lack of something or someone._Trauma to bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35487, C25718, C3671, C12896</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4262001</VALIDVALUE>
          <VALUEMEANING>Superior Sagittal Sinus Phlebitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An intracranial venous sinus that lies in a superior and midline location above the interhemispheric fissure along the superior border of the falx cerebri of the brain. The sinus receives blood from the cerebral veins and drains posteriorly into the lateral sinuses of the brain, which in turn drain into the internal jugular veins._Inflammation of a vein.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38003, C12515</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4264000</VALIDVALUE>
          <VALUEMEANING>Chronic Pericoronitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Long-term inflammation of the gingiva surrounding the crown of a tooth, usually of an incompletely erupted tooth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94558</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4269005</VALIDVALUE>
          <VALUEMEANING>Chronic Gastrojejunal Ulcer without Hemorrhage or Perforation</VALUEMEANING>
          <MEANINGDESCRIPTION>Evidence of chronic gastrojejunal ulcer without hemorrhage or perforation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C196830</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4287008</VALIDVALUE>
          <VALUEMEANING>Penile Chordee</VALUEMEANING>
          <MEANINGDESCRIPTION>Congenital curvature of the penis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4300009</VALIDVALUE>
          <VALUEMEANING>Forearm Deep Third-Degree Burn</VALUEMEANING>
          <MEANINGDESCRIPTION>The structure on the upper limb, between the elbow and the wrist._Extending relatively far inward._An injury that includes all skin layers into the subcutaneous tissue due to chemical, friction, radiation or thermal exposure. The affected area appears dry and thickened; damage to nerve endings usually renders the wound painless.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C76132, C25240, C32628</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4310000</VALIDVALUE>
          <VALUEMEANING>Wrist Joint And/Or Hand Third-Degree Burn</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint between the distal end of the radius and the proximal row of carpal bones._Used to indicate that either or both of two items or options may be valid._The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits._An injury that includes all skin layers into the subcutaneous tissue due to chemical, friction, radiation or thermal exposure. The affected area appears dry and thickened; damage to nerve endings usually renders the wound painless.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C76132, C32712, C48928, C33894</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213374</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4320005</VALIDVALUE>
          <VALUEMEANING>Factor V Deficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>A coagulation disorder characterized by the partial or complete absence of factor V activity in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131738</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4324001</VALIDVALUE>
          <VALUEMEANING>Subacute Cystitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A disease characteristic falling between acute and chronic, but predominantly acute._Inflammation of the urinary bladder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26738, C120855</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222655</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4349002</VALIDVALUE>
          <VALUEMEANING>Multiple Site Open Fracture of Metacarpal Bone</VALUEMEANING>
          <MEANINGDESCRIPTION>Having, relating to, or consisting of more than one individual, element, part, or other component; manifold._A position in relation to its surroundings._A traumatic break in one or more of the metacarpal bones that involves a break in the adjacent skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35233, C37901, C17648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4354006</VALIDVALUE>
          <VALUEMEANING>Open Dislocation Scapula</VALUEMEANING>
          <MEANINGDESCRIPTION>Affording unobstructed entrance and exit; affording free passage or access; accessible to all._A displacement of a part (especially a bone) from its normal position._The flat triangle-shaped bone that connects the humerus with the clavicle in the back of the shoulder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12783, C35724, C49069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4356008</VALIDVALUE>
          <VALUEMEANING>Gingival Recession</VALUEMEANING>
          <MEANINGDESCRIPTION>A loss of gum tissue resulting in an exposure of the roots of the teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C82068</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3419355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4359001</VALIDVALUE>
          <VALUEMEANING>Early Congenital Syphilis</VALUEMEANING>
          <MEANINGDESCRIPTION>At or near the beginning of a period of time or course of events._A life-threatening bacterial infection of the newborn caused by Treponema pallidum. It is transmitted to the infant from a mother with syphilis through the placenta during pregnancy. Signs and symptoms include irritability, fever, failure to thrive, saddle nose, cutaneous rash, and pneumonia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84649, C61589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4373005</VALIDVALUE>
          <VALUEMEANING>Digital Clubbing</VALUEMEANING>
          <MEANINGDESCRIPTION>An enlargement of the tips of the fingers or toes and a change in the angle where the nails emerge. It occurs when the amount of soft tissue beneath the nail beds increases. It may be idiopathic, hereditary, or associated with a wide range of diseases, including cardiopulmonary disorders and malignant neoplasms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85489</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4374004</VALIDVALUE>
          <VALUEMEANING>Congenital Malformation of Tricuspid Valve</VALUEMEANING>
          <MEANINGDESCRIPTION>A defect of the tricuspid valve present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C197880</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4386001</VALIDVALUE>
          <VALUEMEANING>Bronchospasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Sudden contraction of the smooth muscles of the bronchial wall.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34439</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4397001</VALIDVALUE>
          <VALUEMEANING>Partial Congenital Duodenal Obstruction</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or affecting only a part of something._Denoting something that is present at birth._Blockage of the normal flow of stomach contents through the duodenum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79548, C99210, C25378</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218976</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4406004</VALIDVALUE>
          <VALUEMEANING>Male Reproductive System Congenital Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>The sex organs of the male._Any abnormality, anatomical or biochemical, evident at birth or during the neonatal period.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2849, C12722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4412009</VALIDVALUE>
          <VALUEMEANING>Finger Nerve Damage</VALUEMEANING>
          <MEANINGDESCRIPTION>Any of the digits of the hand._Injury to nervous tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50669, C32608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4426000</VALIDVALUE>
          <VALUEMEANING>Ten Previous Induced Abortion Procedure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one._Occurring prior to something else._A surgical or medical procedure that terminates a pregnancy by removing the products of conception.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92954, C25627, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4434006</VALIDVALUE>
          <VALUEMEANING>Bloom Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Bloom syndrome is an autosomal recessive disorder associated with mutations in BLM gene encoding protein that belongs to the family of DNA helicases. It is characterized by predisposition to cancer, immunodeficiency, high sensitivity to UV and genomic instability of somatic cells. (Oncogene 2001 Dec 13;20(57):8276-80)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2730287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4439001</VALIDVALUE>
          <VALUEMEANING>Rieger Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital condition associated with mutation(s) in the PITX2 and/or FOXC1 genes, encoding pituitary homeobox 2 and forkhead box protein C1, respectively. The condition is characterized by anterior segment dysgenesis of the eye(s), iris and corneal anomalies, glaucoma, craniofacial anomalies, hypodontia, and pituitary hypoplasia with hypopituitarism, and hypospadius.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131001</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4448006</VALIDVALUE>
          <VALUEMEANING>Allergic Headache</VALUEMEANING>
          <MEANINGDESCRIPTION>Pertaining to, caused by, affected with or of the nature of allergy._Pain in various parts of the head, not confined to the area of distribution of any nerve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34661, C37910</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4463009</VALIDVALUE>
          <VALUEMEANING>Familial Amyloid Polyneuropathy Type II</VALUEMEANING>
          <MEANINGDESCRIPTION>A subtype of hereditary transthyretin amyloidosis with polyneuropathy characterized by a course of disease with polyneuropathy beginning at the hands and frequent carpal tunnel syndrome operations. Originally thought to be the result of the same genetic mutation, it was determined that substitution of histidine for leucine at position 58 of the TTR gene (L58H) results in the Maryland/German variant, whereas substitution of serine for isoleucine at position 84 of transthyretin (I84S) results in the Indiana/Swiss variant. The Maryland/German variant is further distinguished from the Indiana/Swiss variant by a lack of vitreous opacities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217418</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213387</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4470009</VALIDVALUE>
          <VALUEMEANING>Skin Blanching</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages._Transient pallor of the skin caused by reduced blood flow to the affected region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C112176, C12470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4473006</VALIDVALUE>
          <VALUEMEANING>Migraine With Aura</VALUEMEANING>
          <MEANINGDESCRIPTION>A migraine disorder characterized by episodes that are preceded by focal neurological symptoms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117005</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16222663</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4477007</VALIDVALUE>
          <VALUEMEANING>Childhood Myopathy And Lactic Acidosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A time period that begins at the beginning of the human embryonic stage and continues until the end of adolescence._A non-neoplastic disorder that affects the muscles. Representative examples include muscular dystrophy, metabolic myopathies, muscular atrophies, and dermatomyositis._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Metabolic acidosis characterized by the accumulation of lactate in the body. It is caused by tissue hypoxia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98969, C37912, C101216, C89345</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16218977</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4478002</VALIDVALUE>
          <VALUEMEANING>Upper Extremity And Lower Extremity Multiple Fractures</VALUEMEANING>
          <MEANINGDESCRIPTION>The region of the body that includes the arm, the forearm, and hand._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._The limb that is composed of the hip, thigh, leg and foot._Two or more simultaneous traumatic breaks in one or more bones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26778, C12742, C37912, C12671</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4481007</VALIDVALUE>
          <VALUEMEANING>Abnormal Gastric Secretion Regulatory Process</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm._The digestive secretions of the gastric glands in the stomach, consisting mainly of pepsin, hydrochloric acid, rennin, and mucin._A process that acts to control the rate or manner in which another process progresses or a product is formed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48805, C32661, C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16225414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>160245001</VALIDVALUE>
          <VALUEMEANING>Negation Current Problem Or Disability</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._Occurring in or belonging to the present time._A difficulty, disorder, or condition needing resolution._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Any physical or mental impairment that interferes with an individual&#39;s ability to perform desired activities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C21007, C37998, C28020, C25471, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15181765</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>122003</VALIDVALUE>
          <VALUEMEANING>Choroidal Hemorrhage</VALUEMEANING>
          <MEANINGDESCRIPTION>Blood extravasation in the choroid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C187280</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16212970</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3415004</VALIDVALUE>
          <VALUEMEANING>Cyanosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A bluish or purplish discoloration of the skin and mucous membranes resulting from a reduced amount of oxygenated hemoglobin in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26737</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395738</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1829003</VALIDVALUE>
          <VALUEMEANING>Microcephaly</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital or acquired developmental disorder in which the circumference of the head is smaller than normal for the person&#39;s age and sex.  It is the result of brain developmental delay.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85874</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3004991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2707005</VALIDVALUE>
          <VALUEMEANING>Necrotizing Enterocolitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A serious, life-threatening disorder characterized by necrotic changes affecting portions of the small and large intestine. It is usually seen in neonates, particularly premature infants. Signs and symptoms include abdominal distention and tenderness, intestinal bleeding and ileus. It may lead to cardiovascular collapse and shock.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1926006</VALIDVALUE>
          <VALUEMEANING>Osteopetrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Excessive formation of dense trabecular bone leading to pathological fractures, OSTEITIS, SPLENOMEGALY with infarct, ANEMIA, and extramedullary hemopoiesis (HEMATOPOIESIS, EXTRAMEDULLARY).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26840</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1953005</VALIDVALUE>
          <VALUEMEANING>Skin Hypopigmentation</VALUEMEANING>
          <MEANINGDESCRIPTION>Loss of skin pigment. Vitiligo, albinism, and leukoderma are among the disorders that are associated with skin hypopigmentation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78610</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1126007</VALIDVALUE>
          <VALUEMEANING>Knee Joint Locking</VALUEMEANING>
          <MEANINGDESCRIPTION>A joint connecting the lower part of the femur with the upper part of the tibia. The lower part of the femur and the upper part of the tibia are attached to each other by ligaments. Other structures of the knee joint include the upper part of the fibula, located below and parallel to the tibia, and the patella which moves as the knee bends._Joint is unable to move freely.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C206537, C32898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16213098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2089002</VALIDVALUE>
          <VALUEMEANING>Bone Paget Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Paget&#39;s Disease is a disease of bone that initially results in the excessive resorption of bone (by osteoclasts) followed by the replacement of normal bone marrow with vascular and fibrous tissue. (On-line Medical Dictionary)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1415005</VALIDVALUE>
          <VALUEMEANING>Lymphadenitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An acute or chronic infectious process affecting the lymph nodes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2945697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3006004</VALIDVALUE>
          <VALUEMEANING>Impaired Level of Consciousness</VALUEMEANING>
          <MEANINGDESCRIPTION>A level of awareness and arousal other than normal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C121627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5026555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>655007</VALIDVALUE>
          <VALUEMEANING>Fetal Distress</VALUEMEANING>
          <MEANINGDESCRIPTION>Results from fetal surveillance indicating potential fetal acidosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C50563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4395661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2326000</VALIDVALUE>
          <VALUEMEANING>Annulled</VALUEMEANING>
          <MEANINGDESCRIPTION>Marriage contract has been declared null and to not have existed. (HL7)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C76240</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6226680</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1556006</VALIDVALUE>
          <VALUEMEANING>reticular dermis</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating that the cutaneous melanoma has invaded the reticular dermis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94815</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571760</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>792004</VALIDVALUE>
          <VALUEMEANING>Creutzfeldt-Jacob Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare transmittable degenerative disorder of the brain caused by prions. Morphologically it is characterized by spongiform degeneration of the cerebral and cerebellar cortex. Signs and symptoms include sleep disturbances, personality changes, aphasia, ataxia, muscle atrophy and weakness, visual loss, and myoclonus. It usually leads to death within a year from the onset of the disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26802</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210993</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3951002</VALIDVALUE>
          <VALUEMEANING>Proctitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Proctitis; inflammation of the rectum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38011</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946079</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>805002</VALIDVALUE>
          <VALUEMEANING>SILICOSIS</VALUEMEANING>
          <MEANINGDESCRIPTION>SILICOSIS</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3369</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560051</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>857002</VALIDVALUE>
          <VALUEMEANING>Erythema Multiforme</VALUEMEANING>
          <MEANINGDESCRIPTION>A hypersensitivity reaction characterized by the sudden appearance of symmetrical cutaneous and mucocutaneous macular or popular lesions which evolve into lesions with bright red borders (target lesions). The lesions usually appear in the hands, feet, extremities, and face. Symptoms include fever, malaise, sore throat, cough, vomiting, diarrhea, arthalgia, and myalgia. Causes include infections (most commonly herpes simplex virus), drugs (e.g., sulfonamides, anticonvulsants, and antibiotics), malignancies, and collagen vascular disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3024</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944715</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4103001</VALIDVALUE>
          <VALUEMEANING>Complex Partial Seizure</VALUEMEANING>
          <MEANINGDESCRIPTION>A seizure that originates in a single area of the brain that affects consciousness.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C155290</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4135001</VALIDVALUE>
          <VALUEMEANING>WAGR Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A very rare congenital condition involving the complex of Wilms&#39; tumor, aniridia, genitourinary abnormalities, and mental retardation. Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation (WAGR) syndrome involves deletions of several adjacent genes in chromosome region 11p13. Two or more of the four conditions must be present for an individual to be diagnosed with WAGR Syndrome. The clinical picture varies, depending upon the combination of abnormalities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3718</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3078439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4325000</VALIDVALUE>
          <VALUEMEANING>Jacobsen Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A very rare genetic syndrome caused by deletion of the terminal band of chromosome 11.  It is characterized by the presence of growth and psychomotor retardation, broad nasal bridge, low set ears, strabismus, trigonocephaly, and thrombocytopenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C75457</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4468000</VALIDVALUE>
          <VALUEMEANING>Oppenheim Gait</VALUEMEANING>
          <MEANINGDESCRIPTION>Walking with an irregular oscillation of the head, limbs and body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220067</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482052</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1837006</VALIDVALUE>
          <VALUEMEANING>Orciprenaline Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Deleterious effects due to excessive amounts of the bronchodilator metaproterenol in an individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220068</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2946003</VALIDVALUE>
          <VALUEMEANING>Osmotic Diarrhea</VALUEMEANING>
          <MEANINGDESCRIPTION>Watery diarrhea in which the stool electrolytes and the measured osmolality are at odds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3783004</VALIDVALUE>
          <VALUEMEANING>Enamel Pearls</VALUEMEANING>
          <MEANINGDESCRIPTION>Concretions of enamel that form on the root of a tooth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219919</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482055</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1479009</VALIDVALUE>
          <VALUEMEANING>Distal Duplication 20q Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A syndrome characterized by the partial trisomy of the long arm of chromosome 20, leading to a variety of abnormalities that include neurodevelopmental delay, cardiac malformations, and facial dysmorphism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219908</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482056</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3657001</VALIDVALUE>
          <VALUEMEANING>Osteospermum Species Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Poisoning by inhalation, ingestion or dermal contact with members of the Osteospermum species.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220072</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482057</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1959009</VALIDVALUE>
          <VALUEMEANING>Encephalartos Species Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Poisoning due to exposure to the species of the plant genus, Encephalartos.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219920</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2496007</VALIDVALUE>
          <VALUEMEANING>Acalculia</VALUEMEANING>
          <MEANINGDESCRIPTION>An acquired impairment in the ability to perform simple mathematical tasks.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219773</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482059</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2657005</VALIDVALUE>
          <VALUEMEANING>Overflow Proteinuria</VALUEMEANING>
          <MEANINGDESCRIPTION>A pathologic condition that occurs when the plasma concentration of low-molecular weight proteins exceeds the tubular capacity to reabsorb the filtered proteins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220073</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3590007</VALIDVALUE>
          <VALUEMEANING>Enteroenteric Fistula</VALUEMEANING>
          <MEANINGDESCRIPTION>A pathologic tract that connects two non-contiguous areas of the small intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219923</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482061</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4313003</VALIDVALUE>
          <VALUEMEANING>Acardiacus Anceps</VALUEMEANING>
          <MEANINGDESCRIPTION>A subtype of cardiac twin in which there is a partially developed head, brain, thorax, abdomen, and upper extremities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219774</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>276008</VALIDVALUE>
          <VALUEMEANING>Oxytocin Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Excessive amounts of oxytocin in the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220074</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482063</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3539006</VALIDVALUE>
          <VALUEMEANING>Enteromenia</VALUEMEANING>
          <MEANINGDESCRIPTION>Cyclical bleeding triggered by intestinal tissue responsive to the effects of estrogen or progesterone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219924</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482064</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1694004</VALIDVALUE>
          <VALUEMEANING>Supernumerary Lung Lobe</VALUEMEANING>
          <MEANINGDESCRIPTION>Lung tissue that is separated by an accessory fissure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4070001</VALIDVALUE>
          <VALUEMEANING>Palinphrasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Involuntary repetition of words or phrases when talking.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220076</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482066</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2028007</VALIDVALUE>
          <VALUEMEANING>Erythema Induratum</VALUEMEANING>
          <MEANINGDESCRIPTION>A lobular panniculitis associated with necrosis and a mixed granulomatous infiltrate with vasculitis. It is characterized clinically by erythematous, tender, ulcerated subcutaneous nodules, typically presenting on the posterior lower legs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219928</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1856001</VALIDVALUE>
          <VALUEMEANING>Polyrrhinia</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare congenital nasal anomaly characterized by duplication of the fully developed nose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220100</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1534008</VALIDVALUE>
          <VALUEMEANING>Conjugate Gaze Palsy</VALUEMEANING>
          <MEANINGDESCRIPTION>A neurological disorder in which the eyes cannot move simultaneously in one direction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219882</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>299007</VALIDVALUE>
          <VALUEMEANING>Paraffinoma of Skin</VALUEMEANING>
          <MEANINGDESCRIPTION>A granuloma caused by paraffin injections into the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220078</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>165002</VALIDVALUE>
          <VALUEMEANING>Accident Prone</VALUEMEANING>
          <MEANINGDESCRIPTION>A higher than average susceptibility of accidents due to personality traits or behaviors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219776</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>308006</VALIDVALUE>
          <VALUEMEANING>Pearly Penile Papules</VALUEMEANING>
          <MEANINGDESCRIPTION>Small, skin-colored bumps that form on the head of the penis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2121004</VALIDVALUE>
          <VALUEMEANING>Profenamine Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Poisoning due to overexposure to profenamine, a medication used to treat Parkinson disease and the extrapyramidal signs associated with certain antipsychotic medications.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220106</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4063001</VALIDVALUE>
          <VALUEMEANING>Achillodynia</VALUEMEANING>
          <MEANINGDESCRIPTION>Pain caused by inflammation of the Achilles tendon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219778</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4075006</VALIDVALUE>
          <VALUEMEANING>Peganum harmala Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Poisoning by the seeds of the Peganum harmala plant, which is a traditional medicine used as to treat menstrual flow or aid in abortion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220083</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2041006</VALIDVALUE>
          <VALUEMEANING>Eunuchoid Gigantism</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare form of gigantism associated with the delayed onset of puberty and a eunuchoid habitus, characterized by a tall, slim build with long extremities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219929</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2204004</VALIDVALUE>
          <VALUEMEANING>Acquired Pinna Deformity</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormality in the structure or shape of the outer ear that develops or occurs after birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219781</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3514002</VALIDVALUE>
          <VALUEMEANING>Peribronchial Fibrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Scarring and thickening of the tissue surrounding the bronchi.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220086</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4403007</VALIDVALUE>
          <VALUEMEANING>Exclamation Point Hair</VALUEMEANING>
          <MEANINGDESCRIPTION>A weakened or broken hair strand with a thick distal portion and a tapered, thinner proximal portion. This is a result of anagen phase arrest leading to the disruption of hair shaft formation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219932</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482079</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2463005</VALIDVALUE>
          <VALUEMEANING>Acquired Heterochromia</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which an individual develops differently colored irises or different colors within the same iris after birth due to injury, surgery, medical conditions, or medications.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219779</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3760002</VALIDVALUE>
          <VALUEMEANING>Hereditary Combined Coagulation Factors VIII, IX and XI Deficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare inherited combined deficiency of coagulation factors VIII, IX, and XI.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3797007</VALIDVALUE>
          <VALUEMEANING>Periodontal Cyst</VALUEMEANING>
          <MEANINGDESCRIPTION>A cyst in the structures supporting the teeth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220088</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4152002</VALIDVALUE>
          <VALUEMEANING>Acquired Factor II Deficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>An acquired coagulation disorder characterized by the partial or complete absence of prothrombin (factor II) activity in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482083</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1108009</VALIDVALUE>
          <VALUEMEANING>Female Pattern Alopecia</VALUEMEANING>
          <MEANINGDESCRIPTION>Androgenetic alopecia in females that is characterized by thinning hair at the top of the scalp that progresses by widening from the midline.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219942</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>984000</VALIDVALUE>
          <VALUEMEANING>Perirectal Cellulitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection in the skin tissue around the rectum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220090</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482085</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3327002</VALIDVALUE>
          <VALUEMEANING>Acquired Jerk Nystagmus</VALUEMEANING>
          <MEANINGDESCRIPTION>Nystagmus that develops after birth and is characterized by a slow drift of the eyeballs in one direction followed by a fast corrective movement to the original position.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2452007</VALIDVALUE>
          <VALUEMEANING>Fetal Rotation</VALUEMEANING>
          <MEANINGDESCRIPTION>The process by which the head of a fetus rotates as it descends into the birth canal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219943</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4340003</VALIDVALUE>
          <VALUEMEANING>Acrodermatitis Chronica Atrophicans</VALUEMEANING>
          <MEANINGDESCRIPTION>A late and chronic manifestation of Lyme borreliosis that is characterized by chronic cutaneous atrophy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219782</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482088</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2751001</VALIDVALUE>
          <VALUEMEANING>Fibrocalculous Pancreatic Diabetes</VALUEMEANING>
          <MEANINGDESCRIPTION>An uncommon form of diabetes mellitus that is ketosis-resistant and associated with pancreatic abnormalities that include large intraductal calculi and fibrosis progressing to exocrine and endocrine pancreatic failure. Patients are commonly young, normal weight, and originate from tropical countries.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219945</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482089</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1833005</VALIDVALUE>
          <VALUEMEANING>Phacoanaphylactic Endophthalmitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A chronic endophthalmitis with a sonal granulomatous inflammatory area surrounding a ruptured lens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220094</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482090</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3163006</VALIDVALUE>
          <VALUEMEANING>Acute Adenoviral Follicular Conjunctivitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute follicular conjunctivitis caused by adenovirus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219783</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>811004</VALIDVALUE>
          <VALUEMEANING>Flail Chest</VALUEMEANING>
          <MEANINGDESCRIPTION>A physical examination finding of paradoxical movement of the chest inward with inhalation and outward with exhalation due to the fracture of multiple ribs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219946</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4229009</VALIDVALUE>
          <VALUEMEANING>Phthisical Eye</VALUEMEANING>
          <MEANINGDESCRIPTION>An eye that has become damaged and has shrunk and stopped working.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220096</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4399003</VALIDVALUE>
          <VALUEMEANING>Acute Hemorrhagic Pancreatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Acute pancreatitis characterized by bleeding in or around the pancreas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219784</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3274008</VALIDVALUE>
          <VALUEMEANING>Flat Chest</VALUEMEANING>
          <MEANINGDESCRIPTION>A physical examination finding of a chest with an anteroposterior diameter which is less than half its transverse diameter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219947</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1955003</VALIDVALUE>
          <VALUEMEANING>Ear Dimple</VALUEMEANING>
          <MEANINGDESCRIPTION>A pit or dimple in front of the ear of a newborn is a common finding; rarely, such a dimple may get infected, which will be manifested with redness and swelling and will require medical attention.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C87071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482096</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>364006</VALIDVALUE>
          <VALUEMEANING>Acute Left Heart Failure</VALUEMEANING>
          <MEANINGDESCRIPTION>Sudden, severe failure of adequate output by the left cardiac ventricle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219785</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>409002</VALIDVALUE>
          <VALUEMEANING>Allergen Elimination Diet</VALUEMEANING>
          <MEANINGDESCRIPTION>A dietary plan where one omits specific foods from their diet to identify and/or manage food allergies or intolerances.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219792</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>297009</VALIDVALUE>
          <VALUEMEANING>Acute Myringitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the tympanic membrane that is characterized by sudden onset of severe pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219786</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2251002</VALIDVALUE>
          <VALUEMEANING>Ocular Hypotony</VALUEMEANING>
          <MEANINGDESCRIPTION>Lower than normal intraocular pressure, which ranges from 12 to 22 mm Hg, or an IOP low enough to cause visual impairment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220062</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1402001</VALIDVALUE>
          <VALUEMEANING>Fear</VALUEMEANING>
          <MEANINGDESCRIPTION>A feeling of apprehension that one may be in danger.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C77960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3533007</VALIDVALUE>
          <VALUEMEANING>Acute Palmoplantar Pustular Psoriasis</VALUEMEANING>
          <MEANINGDESCRIPTION>A sudden outbreak of psoriasis characterized by pus-filled blisters that affects the palms of the hands and the soles of the feet .</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219787</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482102</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>258001</VALIDVALUE>
          <VALUEMEANING>Pseudoknuckle Pad</VALUEMEANING>
          <MEANINGDESCRIPTION>A callus that forms over a knuckle from repeated trauma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220109</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3696007</VALIDVALUE>
          <VALUEMEANING>Functional Dyspepsia</VALUEMEANING>
          <MEANINGDESCRIPTION>Dyspepsia without an identifiable cause.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219957</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482104</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2554006</VALIDVALUE>
          <VALUEMEANING>Acute Purulent Pericarditis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, life-threatening bacterial or fungal infection that is characterized by a severe and sudden onset and an accumulation of pus in the pericardial sac.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219788</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482105</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3376008</VALIDVALUE>
          <VALUEMEANING>Pseudoptyalism</VALUEMEANING>
          <MEANINGDESCRIPTION>The inability of an individual to swallow normal amounts of saliva due to a disease process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220110</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482106</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>486006</VALIDVALUE>
          <VALUEMEANING>Acute Vascular Insufficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which there is a sudden reduction in vascular blood flow.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219789</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2170000</VALIDVALUE>
          <VALUEMEANING>Summation Gallop</VALUEMEANING>
          <MEANINGDESCRIPTION>An auscultated finding in which S3 and S4 fuse, during tachycardia or a prolonged PR interval or both. (ACC/AHA)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C168027</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482108</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>335002</VALIDVALUE>
          <VALUEMEANING>Pylorospasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Involuntary spasms of the pylorus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220113</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4418008</VALIDVALUE>
          <VALUEMEANING>Gangrenous Ergotism</VALUEMEANING>
          <MEANINGDESCRIPTION>The initial ischemic phase of ergotism, the intoxication caused by consumption of food contaminated with alkaloids produced by the fungal species, Claviceps purpurea. Ischemia of the extremities (dry gangrene)progresses to nausea and vomiting, and then eventually seizures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219960</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2055003</VALIDVALUE>
          <VALUEMEANING>Recurrent Corneal Erosion Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic relapsing disease where the outer layer of the cornea separates from underlying layers. It is often accompanied by pain, photophobia, redness and watery eyes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220117</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1168007</VALIDVALUE>
          <VALUEMEANING>Allotype</VALUEMEANING>
          <MEANINGDESCRIPTION>An immunologically detectable variation in an immunoglobulin constant region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219793</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4410001</VALIDVALUE>
          <VALUEMEANING>Retroperitoneal Hernia with Obstruction</VALUEMEANING>
          <MEANINGDESCRIPTION>The protrusion of contents of the abdominal cavity through a mesenteric defect into the retroperitoneal space, resulting in obstruction of peristalsis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482113</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2066005</VALIDVALUE>
          <VALUEMEANING>Perforated Hemorrhagic Gastric Ulcer without Obstruction</VALUEMEANING>
          <MEANINGDESCRIPTION>A gastric ulcer that presents with hemorrhaging and perforation, but without obstruction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220085</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>504009</VALIDVALUE>
          <VALUEMEANING>Androgen-dependent Hirsutism</VALUEMEANING>
          <MEANINGDESCRIPTION>Hirsutism that arises from an excess of male hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219797</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1208004</VALIDVALUE>
          <VALUEMEANING>Gastroptosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Displacement of the stomach inferiorly such that the greater curvature is located in the pelvis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219965</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482116</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4464003</VALIDVALUE>
          <VALUEMEANING>Rocio Virus Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>A viral disorder caused by Rocio virus. Symptoms include fever, malaise, severe headache, lower-extremity weakness, and severe neurologic disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220128</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>862001</VALIDVALUE>
          <VALUEMEANING>Anemia Due to Chlorate Exposure</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of hemolytic anemia that results from exposure to chlorate.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>816009</VALIDVALUE>
          <VALUEMEANING>DNA Recombination Process</VALUEMEANING>
          <MEANINGDESCRIPTION>Any type of DNA sequence rearrangement involving possible exchange and frequent loss of segments of DNA by either homologous recombination or non-homologous end-joining of broken DNA strands. Recombination is involved in assorting genes during reproduction, in repairing broken DNA, and in maintaining cell viability at the expense of long-term genomic stability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482119</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>651003</VALIDVALUE>
          <VALUEMEANING>Root Canal</VALUEMEANING>
          <MEANINGDESCRIPTION>A dental surgical procedure that removes the dental pulp to treat infection or tooth damage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220131</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>813001</VALIDVALUE>
          <VALUEMEANING>Ankle Instability</VALUEMEANING>
          <MEANINGDESCRIPTION>An inability to bear weight on the ankle due to injury to the lateral ankle ligaments.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219800</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482121</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>536002</VALIDVALUE>
          <VALUEMEANING>Glisson Capsule Cirrhosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Cirrhosis affecting the Glisson capsule, the layer of connective tissue that covers the liver and contains the hepatic portal triad.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482122</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4308002</VALIDVALUE>
          <VALUEMEANING>Repetitive Strain Injury</VALUEMEANING>
          <MEANINGDESCRIPTION>Damage and pain caused by repeating the same motion over and over.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220120</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2893009</VALIDVALUE>
          <VALUEMEANING>Chromosome 10 Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>An irregularity in the structure of chromosome 10.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219858</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3639002</VALIDVALUE>
          <VALUEMEANING>Glossoptosis</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal posterior placement of the tongue involving downward displacement or retraction, which may cause airway disruption.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219968</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482125</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2355008</VALIDVALUE>
          <VALUEMEANING>Rud Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare hereditary disorder characterized by congenital ichthyosis, epilepsy, dwarfism, sexual infantilism, polyneuritis, and macrocytic anemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482126</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1412008</VALIDVALUE>
          <VALUEMEANING>Anterior Subcapsular Polar Cataract</VALUEMEANING>
          <MEANINGDESCRIPTION>A cataract that develops beneath the lens capsule at the anterior pole of the lens.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219804</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482127</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1515008</VALIDVALUE>
          <VALUEMEANING>Gorham-Stout Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare bone disorder characterized by progressive bone loss due to abnormal lymphatic vessel proliferation resorption of bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219969</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482128</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3200003</VALIDVALUE>
          <VALUEMEANING>Sacrocoxalgia</VALUEMEANING>
          <MEANINGDESCRIPTION>Discomfort or pain in the sacrococcygeal region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220133</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3355003</VALIDVALUE>
          <VALUEMEANING>Common Cold Medication Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Toxicity resulting from overconsumption or abuse of common cold medication.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219869</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>479003</VALIDVALUE>
          <VALUEMEANING>Graves Disease with Pretibial Myxedema and Thyrotoxic Crisis</VALUEMEANING>
          <MEANINGDESCRIPTION>Graves disease associated with thyrotoxic crisis and cutaneous non-pitting edema and plaque formation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219971</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482131</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>634005</VALIDVALUE>
          <VALUEMEANING>Saddle Boil</VALUEMEANING>
          <MEANINGDESCRIPTION>A boil on the buttocks or perineal area, particularly those in cyclists or horse riders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220134</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3110003</VALIDVALUE>
          <VALUEMEANING>Infectious Otitis Media</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the anatomical structures of the middle ear secondary to an infectious process. Bacterial etiology is most common, but both viral and fungal pathogens are also possible. Symptoms include erythema and edema of the tympanic membrane, pain, and possibly fever. In severe infections, inflammation and edema of the structures of the middle ear can lead to perforation of the tympanic membrane secondary to the buildup of pressure in the narrow space.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1671000</VALIDVALUE>
          <VALUEMEANING>Sago Spleen</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition of the spleen where it becomes affected by amyloid deposits that are primarily concentrated within the Malpighian corpuscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220135</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482134</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1717003</VALIDVALUE>
          <VALUEMEANING>Guttate Hypomelanosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign skin condition characterized by white or whitish spots or patches on sun-exposed areas of the skin due to decreased melanin production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482135</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4191007</VALIDVALUE>
          <VALUEMEANING>Scaphocephaly</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal skull shape caused by premature fusion of the sagittal suture, forming an osseous ridge.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220137</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482136</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>303002</VALIDVALUE>
          <VALUEMEANING>Fulminant Necrotizing Pancreatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A severe form of acute pancreatitis that rapidly progresses to pancreatic tissue necrosis and multiple organ failure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219956</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482137</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2176006</VALIDVALUE>
          <VALUEMEANING>Halogenoderma</VALUEMEANING>
          <MEANINGDESCRIPTION>Cutaneous eruptions resembling acne caused by exposure to and accumulation of halogen-containing compounds, including medications containing bromine, bromide, iodine and iodide.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219975</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4129001</VALIDVALUE>
          <VALUEMEANING>Argyll Robertson Pupils</VALUEMEANING>
          <MEANINGDESCRIPTION>Bilateral small pupils that constrict during near vision tasks but not in response to bright light.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219811</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1259003</VALIDVALUE>
          <VALUEMEANING>Slate Pneumoconiosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Pneumoconiosis caused by exposure to slate dust.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482140</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1345007</VALIDVALUE>
          <VALUEMEANING>Hangnail</VALUEMEANING>
          <MEANINGDESCRIPTION>A torn piece of skin that forms next to a fingernail or toenail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219977</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482141</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4338008</VALIDVALUE>
          <VALUEMEANING>Ear-Cough Reflex</VALUEMEANING>
          <MEANINGDESCRIPTION>Cough reflex triggered by activation of the auricular branch of the vagus nerve through mechanical stimulation of the external auditory meatus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219912</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2228002</VALIDVALUE>
          <VALUEMEANING>Scintillating Scotoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A visual aura with a distinct flickering effect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220138</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482143</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4040006</VALIDVALUE>
          <VALUEMEANING>Peripheral Corneal Guttata</VALUEMEANING>
          <MEANINGDESCRIPTION>Age-related small transparent growths on the posterior surface of Descemet&#39;s membrane of the cornea.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220089</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482144</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4113009</VALIDVALUE>
          <VALUEMEANING>Arrested Hydrocephalus</VALUEMEANING>
          <MEANINGDESCRIPTION>Hydrocephalus that is stable and asymptomatic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219812</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482145</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3109008</VALIDVALUE>
          <VALUEMEANING>Early Onset Secondary Dysthymia</VALUEMEANING>
          <MEANINGDESCRIPTION>Dysthymia that develops after a person experiences another mental health condition and is diagnosed before age 21.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219914</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482146</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1755008</VALIDVALUE>
          <VALUEMEANING>Healed Coronary Artery</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding indicating that a previously ruptured or eroded atherosclerotic coronary artery plaque has undergone a healing process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219978</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482147</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3750006</VALIDVALUE>
          <VALUEMEANING>Arteriospasm</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal spasm of an artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219813</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482148</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>616006</VALIDVALUE>
          <VALUEMEANING>Eyelid Sensorimotor Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>Conditions characterized by abnormal coordination between the sensory and motor functions of the eyelids. These disorders can lead to involuntary movements, spasms, or paralysis of the eyelid muscles, resulting in difficulties with eyelid closure, blinking, or vision.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219940</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482149</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4416007</VALIDVALUE>
          <VALUEMEANING>Uveoparotid Fever</VALUEMEANING>
          <MEANINGDESCRIPTION>Sarcoidosis characterized by facial nerve palsy, parotid gland swelling, fever, and uveitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482150</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2625009</VALIDVALUE>
          <VALUEMEANING>Senter Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A cutaneous condition associated with glycogen storage dysfunction that is characterized by vascular keratitis, congenital ichthyosis, neurosensorial deafness, hepatomegaly, hepatic cirrhosis, growth failure and intellectual disability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220143</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482151</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3947004</VALIDVALUE>
          <VALUEMEANING>High Oxygen Affinity Hemoglobin Polycythemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Polycythemia due to rare gene mutations that result in the expression of hemoglobin with increased affinity for oxygen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219983</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482152</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2562003</VALIDVALUE>
          <VALUEMEANING>Athanasia trifurcata Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Toxicity resulting exposure to the Athanasia trifurcata plant.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219815</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4441000</VALIDVALUE>
          <VALUEMEANING>Severe Bipolar Disorder with Psychotic Features</VALUEMEANING>
          <MEANINGDESCRIPTION>Bipolar disorder that includes hallucinations, delusions, disordered thinking, and a lack of awareness of reality.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220145</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3259006</VALIDVALUE>
          <VALUEMEANING>Moraea Species Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Poisoning due to ingestion of the toxic cardiac glycosides found in plants belonging to species of the Moraea (formerly Homeria) genus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220045</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482155</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2951009</VALIDVALUE>
          <VALUEMEANING>Atopic Cataract</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of cataract that is associated with atopic dermatitis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219816</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482156</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3387000</VALIDVALUE>
          <VALUEMEANING>Auditory Discrimination Aphasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Aphasia that is characterized by an inability to distinguish between similar sounding spoken sounds in words.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219818</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>129007</VALIDVALUE>
          <VALUEMEANING>Homeothermic</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that an organism is able to maintain a stable internal body temperature regardless of external influences.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219984</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482158</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>162004</VALIDVALUE>
          <VALUEMEANING>Severe Bipolar I Disorder without Psychotic Features</VALUEMEANING>
          <MEANINGDESCRIPTION>Bipolar disorder characterized by at least one manic episode lasting for at least one week, but without psychotic features. It may also include periods of depression.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220146</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482159</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2724004</VALIDVALUE>
          <VALUEMEANING>Auditory Recruitment</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition in which an individual with hearing loss perceives sounds as getting disproportionately louder with increasing sound intensity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219819</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2736005</VALIDVALUE>
          <VALUEMEANING>Atrophoderma Vermiculatum</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare skin disorder with a reticular pattern of atrophy, particularly appearing on the face and in childhood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219817</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482161</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3014005</VALIDVALUE>
          <VALUEMEANING>Autoeczematization</VALUEMEANING>
          <MEANINGDESCRIPTION>Eczema that arises secondary to an inflammatory skin disease that is localized to a different site.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219821</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482162</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3745000</VALIDVALUE>
          <VALUEMEANING>Circadian Rhythm Sleep Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A sleep disorder characterized by persistent sleep disruption (excessive sleepiness and/or insomnia) that is due to a conflict between the individual&#39;s internal sleep-wake system and the demands of his or her environment regarding the timing and duration of sleep.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482163</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2359002</VALIDVALUE>
          <VALUEMEANING>Hyperbetaalaninemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare acquired or congenital disorder that is characterized by the presence of excess levels of beta amino acids (including, beta-alanine, beta-amino-isobutyric acid and taurine) in the blood and/or urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4301008</VALIDVALUE>
          <VALUEMEANING>Autoimmune Status</VALUEMEANING>
          <MEANINGDESCRIPTION>Autoimmune Status; the state of a person&#39;s health in regard to autoimmune disease or antibody presence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26053</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1387009</VALIDVALUE>
          <VALUEMEANING>Solanum nigrum Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Poisoning resulting from consuming Solanum nigrum, black nightshade.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220151</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3939004</VALIDVALUE>
          <VALUEMEANING>Transparent Bacterial Colony Density</VALUEMEANING>
          <MEANINGDESCRIPTION>The density of a transparent bacterial colony.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220201</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>626004</VALIDVALUE>
          <VALUEMEANING>Ectopic Cushing Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A form of Cushing syndrome in which a tumor outside the pituitary gland produces adrenocorticotropic hormone (ACTH), which leads to excess cortisol production by the adrenal gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219915</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1135000</VALIDVALUE>
          <VALUEMEANING>Solar Retinopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Damage to the retina caused by bright light, commonly sunlight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220152</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3275009</VALIDVALUE>
          <VALUEMEANING>Vascular Behcet Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Behcet syndrome that manifests with vascular abnormalities including superficial thrombophlebitis, deep vein thrombosis, and aortic aneurysm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220614</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>547009</VALIDVALUE>
          <VALUEMEANING>Calcitonin Hypersecretion</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding indicating that calcitonin is being secreted at abnormally high levels.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219840</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>610000</VALIDVALUE>
          <VALUEMEANING>Abductor Spasmodic Dysphonia</VALUEMEANING>
          <MEANINGDESCRIPTION>Aphonia resulting from spasms of the vocal cords.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219771</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1310004</VALIDVALUE>
          <VALUEMEANING>Genetic Syndrome-Associated Glucose Intolerance</VALUEMEANING>
          <MEANINGDESCRIPTION>The inability to regulate blood glucose levels caused by genetic variations or chromosome alterations.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219966</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4465002</VALIDVALUE>
          <VALUEMEANING>Spherophakia</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital disorder of the eye where the lens is abnormally small and spherical.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220153</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2058001</VALIDVALUE>
          <VALUEMEANING>Bilateral Vestibular Weakness</VALUEMEANING>
          <MEANINGDESCRIPTION>A reduction or absence of vestibular function occurring in both inner ears.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219826</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482175</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1865008</VALIDVALUE>
          <VALUEMEANING>Protein Malabsorption</VALUEMEANING>
          <MEANINGDESCRIPTION>Inadequate absorption of proteins by the small intestine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220107</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482176</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1518005</VALIDVALUE>
          <VALUEMEANING>Splenitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the spleen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3585009</VALIDVALUE>
          <VALUEMEANING>Blinking</VALUEMEANING>
          <MEANINGDESCRIPTION>Voluntary or involuntary rapid closure and opening of the eyelids.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2806008</VALIDVALUE>
          <VALUEMEANING>Developmental Coordination Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by an impairment in the development of an individual&#39;s motor coordination skills; this impairment in motor development is not due to a medical condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C92561</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3472009</VALIDVALUE>
          <VALUEMEANING>Grade 4 Spondylolisthesis</VALUEMEANING>
          <MEANINGDESCRIPTION>Anterior displacement of a vertebra by greater than 75% of its normal position.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219970</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2836004</VALIDVALUE>
          <VALUEMEANING>Butane Toxicity</VALUEMEANING>
          <MEANINGDESCRIPTION>Toxicity resulting from exposure to butane.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219839</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1608005</VALIDVALUE>
          <VALUEMEANING>Increased Capillary Permeability</VALUEMEANING>
          <MEANINGDESCRIPTION>A cardiovascular finding indicating the presence of abnormally porous walls of capillaries, which causes leakage of excess fluids and proteins into interstitial spaces.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219992</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>527001</VALIDVALUE>
          <VALUEMEANING>Roederer Spontaneous Fetal Evolution</VALUEMEANING>
          <MEANINGDESCRIPTION>A situation during childbirth where the fetus spontaneously changes its presentation or position, often from a transverse to a cephalic presentation, in which the head and thorax are jammed tightly into each other and are born together.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2094002</VALIDVALUE>
          <VALUEMEANING>Carbon Disulfide Toxicity</VALUEMEANING>
          <MEANINGDESCRIPTION>Toxicity resulting from exposure to carbon disulfide.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1297003</VALIDVALUE>
          <VALUEMEANING>Cladosporium carrionii Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>A fungal infection involving Cladosporium carrionii. C. carrionii is the causative agent for chromoblastomycosis, a skin disease typically contracted by humans through a puncture from a thorn or splinter contaminated with the fungus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219861</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>460001</VALIDVALUE>
          <VALUEMEANING>Prostatic Squamous Metaplasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A morphologic finding indicating that the prostate glandular epithelium is replaced with squamous epithelium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C7758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1156003</VALIDVALUE>
          <VALUEMEANING>Cavitary Prostatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic inflammation of the prostate gland with formation of cavities within the prostate tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219848</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3641001</VALIDVALUE>
          <VALUEMEANING>Taenia serialis Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>A parasitic infection involving the cestode Taenia serialis. In humans T. serialis does not mature to the tapeworm stage but, after accidental ingestion of cestode eggs, the metacestode larval form (coenurus or bladder worms) can invade and form cysts in the muscles, brain, eye or subcutaneous tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220177</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1892002</VALIDVALUE>
          <VALUEMEANING>Macula Star</VALUEMEANING>
          <MEANINGDESCRIPTION>A descriptive term for swelling of the optic disk with peripapillary and macular exudates that may occur in a star pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220026</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482189</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>875001</VALIDVALUE>
          <VALUEMEANING>Chalcosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Copper deposits in the eye due to intraocular foreign bodies containing copper.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219852</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482190</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2158004</VALIDVALUE>
          <VALUEMEANING>Contracaecum Infection</VALUEMEANING>
          <MEANINGDESCRIPTION>A parasitic infection involving nematodes of the Contracaecum genus (usually C. osculatum complex). Contracaecum can cause anisakiasis, a disease affecting the gastric and intestinal mucosa contracted by humans through ingestion of larvae in raw or undercooked fish or squid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3756000</VALIDVALUE>
          <VALUEMEANING>Static Ataxia</VALUEMEANING>
          <MEANINGDESCRIPTION>Ataxia marked by a swaying of the body when standing still.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220160</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1821000</VALIDVALUE>
          <VALUEMEANING>Chemoreceptor Apnea</VALUEMEANING>
          <MEANINGDESCRIPTION>Apnea that is attributed to activation of chemoreflexes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219854</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1055001</VALIDVALUE>
          <VALUEMEANING>Precerebral Artery Stenosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A narrowing of an extracerebral arteries supplying the brain, including the carotid artery, vertebral artery, and basilar artery.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220103</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4107000</VALIDVALUE>
          <VALUEMEANING>Male Infertility</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition where a man is unable to conceive a child due to genetic disorders, structural problems, hormonal imbalances, or lifestyle choices that negatively affect sperm production and/or transport.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220028</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>903008</VALIDVALUE>
          <VALUEMEANING>Chorioretinal Infarction</VALUEMEANING>
          <MEANINGDESCRIPTION>Thrombotic or non-thrombotic ischemia of the retinal and choriodal vasculature of the eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219856</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482196</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3160009</VALIDVALUE>
          <VALUEMEANING>Infertility of Cervical Origin</VALUEMEANING>
          <MEANINGDESCRIPTION>Female infertility where a woman&#39;s cervix is the primary cause of her inability to conceive. This condition may be due to cervical stenosis, issues with cervical mucus or other cervical abnormalities that interfere with fertilization.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219995</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482197</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3272007</VALIDVALUE>
          <VALUEMEANING>Stomatocytosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition where red blood cells have a central slit-like appearance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220162</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4390004</VALIDVALUE>
          <VALUEMEANING>Lithium - Induced Nephropathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Kidney damage resulting from lithium which may include distal or collecting tubular cysts, proteinuria, interstitial nephritis and nephrogenic diabetes insipidus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C123130</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>640003</VALIDVALUE>
          <VALUEMEANING>Vagus Nerve Injury</VALUEMEANING>
          <MEANINGDESCRIPTION>Injury to the vagus nerve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1763009</VALIDVALUE>
          <VALUEMEANING>Stromal Keratitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A corneal inflammation affecting the stromal layer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220167</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1141007</VALIDVALUE>
          <VALUEMEANING>Circumoral Paresthesia</VALUEMEANING>
          <MEANINGDESCRIPTION>Burning, numbness or tingling around the mouth and lips.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219860</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1771008</VALIDVALUE>
          <VALUEMEANING>Defective Insulin Biosynthesis</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that there are abnormalities affecting the production of insulin by pancreatic beta cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219901</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1378000</VALIDVALUE>
          <VALUEMEANING>Supination-eversion Injury of Ankle</VALUEMEANING>
          <MEANINGDESCRIPTION>An ankle injury resulting from both supination (inversion and adduction) and external rotation (eversion) of the foot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220169</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482204</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2581006</VALIDVALUE>
          <VALUEMEANING>Clasp Knife Rigidity</VALUEMEANING>
          <MEANINGDESCRIPTION>Increased resistance of a limb to passive stretching or bending followed by sudden relaxation of the muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482205</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2473007</VALIDVALUE>
          <VALUEMEANING>Intermittent Vertical Strabismus</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition where at times the eyes are aligned but occasionally one eye drifts upward (hypertropia) or downward (hypotropia) relative to the other eye.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219997</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482206</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>253005</VALIDVALUE>
          <VALUEMEANING>Sycosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of hair follicles of the chin or beard region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4306003</VALIDVALUE>
          <VALUEMEANING>DSM-V Cluster B Personality Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A grouping of personality disorders, as classified in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V), that are characterized by dramatic, emotional, or erratic behaviors. This grouping includes antisocial, borderline, histrionic, and narcissistic personal disorders.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219911</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4026005</VALIDVALUE>
          <VALUEMEANING>Postpartum Interstitial Mastitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Mastitis of the breast tissue, but not the milk ducts, following childbirth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4483005</VALIDVALUE>
          <VALUEMEANING>Syphilitic Punched Out Ulcer</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of ulcer associated with syphilis with a sharply defined, crater-like appearance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220176</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482210</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3909009</VALIDVALUE>
          <VALUEMEANING>Coeur en Sabot</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding on a plain radiograph that shows an upturned cardiac apex due to right ventricular hypertrophy and a concave pulmonary arterial segment due to reduced pulmonary artery outflow from subpulmonic stenosis. The cardiac remodeling takes the appearance of a boot. It may be a characteristic finding in tetralogy of Fallot.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219864</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482211</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2775001</VALIDVALUE>
          <VALUEMEANING>Loose Skeletal Fragments in Synovial Joint</VALUEMEANING>
          <MEANINGDESCRIPTION>Presence of fibrous, bony, cartilaginous or osseocartilaginous fragments in a synovial joint.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217053</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4445009</VALIDVALUE>
          <VALUEMEANING>Urogenital Tuberculosis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection in the urogenital system due to Mycobacterium tuberculosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1045000</VALIDVALUE>
          <VALUEMEANING>Colonospasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Sudden, involuntary contraction of the smooth muscles of the colon.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219865</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>934007</VALIDVALUE>
          <VALUEMEANING>Thalassemia Intermedia</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical designation for syndromes in which the alpha/beta chain imbalance and symptoms fall between those observed in thalassemia minor and thalassemia major, but without the need for regular transfusion therapy to maintain the hemoglobin level.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220180</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482215</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4409006</VALIDVALUE>
          <VALUEMEANING>Combined Methylmalonic Aciduria and Homocystinuria</VALUEMEANING>
          <MEANINGDESCRIPTION>A genetically heterogeneous disorder of cobalamin (cbl; vitamin B12) metabolism due to loss of function mutations in the enzymes that synthesize the coenzymes adenosylcobalamin (AdoCbl) and methylcobalamin (MeCbl). This is a subtype of methylmalonic acidemia that includes complementation groups cblC, cblD, cblF, cblJ, cblL and cblX.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219868</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482216</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1140008</VALIDVALUE>
          <VALUEMEANING>Thermal Hypoesthesia</VALUEMEANING>
          <MEANINGDESCRIPTION>A reduced or diminished sensitivity to temperature stimuli.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220181</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482217</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2186007</VALIDVALUE>
          <VALUEMEANING>Compensated Metabolic Acidosis</VALUEMEANING>
          <MEANINGDESCRIPTION>The presence of metabolic acidosis despite a nearly normal pH due to a physiologic respiratory compensatory response that lowers the partial pressure of carbon dioxide (PaCO2) by inducing hyperventilation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482218</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2116002</VALIDVALUE>
          <VALUEMEANING>Intramembranous Ossification</VALUEMEANING>
          <MEANINGDESCRIPTION>A process by which bones are formed from mesenchymal tissue, rather than via replacement of a cartilage template.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220000</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482219</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2169001</VALIDVALUE>
          <VALUEMEANING>Thoracic Radiculitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of a nerve root in the thoracic area of the spine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220183</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482220</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2655002</VALIDVALUE>
          <VALUEMEANING>Invalidism</VALUEMEANING>
          <MEANINGDESCRIPTION>The incapacity to work or function normally due to prolonged disability.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220002</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482221</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2560006</VALIDVALUE>
          <VALUEMEANING>Complex Syndactyly of Fingers</VALUEMEANING>
          <MEANINGDESCRIPTION>Syndactyly of the fingers in which the fused tissue includes skin, bone and soft tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219871</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482222</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1769008</VALIDVALUE>
          <VALUEMEANING>Thoracodidymus</VALUEMEANING>
          <MEANINGDESCRIPTION>Conjoined twins united at the thorax.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220185</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482223</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3703002</VALIDVALUE>
          <VALUEMEANING>Gangrenous Sciatic Hernia</VALUEMEANING>
          <MEANINGDESCRIPTION>A protrusion of necrotic abdominal tissue through either the greater or lesser sciatic foramen in the pelvic ischial bone.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219961</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482224</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1139006</VALIDVALUE>
          <VALUEMEANING>Confrontation Visual Field Test</VALUEMEANING>
          <MEANINGDESCRIPTION>A test for gross visual field defects that involves the patient focusing on a point on the examiner&#39;s face while the examiner presents fingers or objects starting at the extremes of the periphery of every quadrant of the patient&#39;s field of vision to determine when and whether they can discern them.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219872</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482225</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2899008</VALIDVALUE>
          <VALUEMEANING>Thought Blocking</VALUEMEANING>
          <MEANINGDESCRIPTION>A sudden and involuntary cessation of thought or speech.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220186</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482226</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1280009</VALIDVALUE>
          <VALUEMEANING>Isologous Chimera</VALUEMEANING>
          <MEANINGDESCRIPTION>A chimeric organism made up of cells or tissues derived from two different organisms that have the same genotype.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220004</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482227</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4168008</VALIDVALUE>
          <VALUEMEANING>Tibial Plateau Chondromalacia</VALUEMEANING>
          <MEANINGDESCRIPTION>The softening and degradation of the hyaline cartilage on the superior surface of the tibia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220187</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482228</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1967001</VALIDVALUE>
          <VALUEMEANING>Congenital Absence of Forearm</VALUEMEANING>
          <MEANINGDESCRIPTION>Absence of the radius and ulna that is present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219873</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482229</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2513003</VALIDVALUE>
          <VALUEMEANING>Trichophyton Tinea Capitis</VALUEMEANING>
          <MEANINGDESCRIPTION>A fungal infection of the scalp caused by a species of Trichophyton fungus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482230</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2538008</VALIDVALUE>
          <VALUEMEANING>Ketosis</VALUEMEANING>
          <MEANINGDESCRIPTION>An organismal metabolic process where the body burns fat for energy instead of carbohydrates, resulting in a buildup of ketones. This process occurs when glucose availability is limited by normal dietary practices, such as following a low-carb diet or fasting or pathologic factors such as starvation, genetic predisposition or diabetes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220009</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1922008</VALIDVALUE>
          <VALUEMEANING>Urethral Atresia</VALUEMEANING>
          <MEANINGDESCRIPTION>Absence of the urethra that is present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3276005</VALIDVALUE>
          <VALUEMEANING>Toad Toxin Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Human poisoning due to exposure to toad toxins.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1271009</VALIDVALUE>
          <VALUEMEANING>Bart-Pumphrey Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal dominant condition caused by mutation(s) in the GJB2 gene, encoding gap junction beta-2 protein (connexin-26). This condition is characterized by sensorineural hearing loss, hyperkeratotic plaques on finger joints (knuckle pads), and white discoloration of nails (leukonychia) and may also be associated with palmoplantar keratoderma.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219823</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1492007</VALIDVALUE>
          <VALUEMEANING>Congenital Abnormality of the Large Intestine</VALUEMEANING>
          <MEANINGDESCRIPTION>A malformation in any part of the large intestine that is present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C98881</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482235</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>408005</VALIDVALUE>
          <VALUEMEANING>Teeth Chattering</VALUEMEANING>
          <MEANINGDESCRIPTION>A shivering of the jaw muscles causing the upper and lower teeth to collide together. It can be a response to cold or fear, but can be a symptom of an underlying medical condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220178</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1282001</VALIDVALUE>
          <VALUEMEANING>Laryngeal Perichondritis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare acute inflammatory disorder affecting the perichondrium and cartilage of the larynx. This can be triggered by underlying medical conditions, injury, the presence of foreign objects or microbial infection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220010</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1239002</VALIDVALUE>
          <VALUEMEANING>Congenital Femoral Anteversion</VALUEMEANING>
          <MEANINGDESCRIPTION>A rotation of the femur toward the midline such that the foot points inwards that is present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219878</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>965003</VALIDVALUE>
          <VALUEMEANING>Toxic Amblyopia</VALUEMEANING>
          <MEANINGDESCRIPTION>Amblyopia due to exposure to a toxin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220194</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>827006</VALIDVALUE>
          <VALUEMEANING>Late Latent Congenital Syphilis</VALUEMEANING>
          <MEANINGDESCRIPTION>The occurrence of syphilis symptoms in individuals who were infected before or during birth and have not exhibited signs of the disease for over a year.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220012</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2495006</VALIDVALUE>
          <VALUEMEANING>Congenital Cerebral Arteriovenous Aneurysm</VALUEMEANING>
          <MEANINGDESCRIPTION>An aneurysm formed from a cerebrovascular arteriovenous malformation that is present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219874</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482241</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1657008</VALIDVALUE>
          <VALUEMEANING>Phosdrin Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Toxic effects of phosdrin exposure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220095</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3577000</VALIDVALUE>
          <VALUEMEANING>Lattice Retinal Degeneration</VALUEMEANING>
          <MEANINGDESCRIPTION>Degeneration of the peripheral retina characterized by thinning accompanied by the appearance of pigment clumps or sclerotic vessels in a crosshatching pattern.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220015</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3733009</VALIDVALUE>
          <VALUEMEANING>Congenital Diaphragmatic Crural Eventration</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal elevation of the diaphragm due to compromise of the right crus tendon that is present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219875</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2576002</VALIDVALUE>
          <VALUEMEANING>Trachoma</VALUEMEANING>
          <MEANINGDESCRIPTION>A bacterial infection of the eye caused by Chlamydia trachomatis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4030008</VALIDVALUE>
          <VALUEMEANING>Le Dantec Virus Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection caused by a rhabdovirus in the Ledantevirus genus that is primarily transmitted through the bite of an infected mosquito. This viral infection is characterized by symptoms such as fever, headache, and muscle pain and can progress to more severe conditions, including hepatosplenomegaly, encephalitis and hemorrhagic fever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220016</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3886001</VALIDVALUE>
          <VALUEMEANING>Congenital Fecaliths</VALUEMEANING>
          <MEANINGDESCRIPTION>The presence of fecal concretions within the intestinal tract that are present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219877</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3699000</VALIDVALUE>
          <VALUEMEANING>Transverse Arm Deficiency</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital truncation of the arm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220202</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482248</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1943009</VALIDVALUE>
          <VALUEMEANING>Left-Right Confusion</VALUEMEANING>
          <MEANINGDESCRIPTION>An inability to accurately differentiate between left and right directions or directional commands.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220019</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4184009</VALIDVALUE>
          <VALUEMEANING>Congenital Endocrine Gland Malformation</VALUEMEANING>
          <MEANINGDESCRIPTION>A malformation of an endocrine gland that is present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219876</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482250</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1852004</VALIDVALUE>
          <VALUEMEANING>Abducens Nerve Injury</VALUEMEANING>
          <MEANINGDESCRIPTION>Damage to the sixth cranial (abducens) nerve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219770</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482251</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1393001</VALIDVALUE>
          <VALUEMEANING>Lenz-Majewski Hyperostotic Dwarfism</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare autosomal dominant condition caused by mutation(s) in the PTDSS1 gene, encoding phosphatidylserine synthase 1. This condition is characterized by intellectual disability, sclerosing bone dysplasia, distinct craniofacial and dental anomalies, loose skin, distal limb anomalies, including brachydactyly and symphalangism, and progressive generalized hyperostosis that leads to severe growth retardation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220020</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482252</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1150009</VALIDVALUE>
          <VALUEMEANING>Congenital Microcheilia</VALUEMEANING>
          <MEANINGDESCRIPTION>Smaller than average sized lips that are present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219879</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482253</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4174008</VALIDVALUE>
          <VALUEMEANING>Tripartite Placenta</VALUEMEANING>
          <MEANINGDESCRIPTION>A variant form of the placenta where it is divided into three lobes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482254</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3660008</VALIDVALUE>
          <VALUEMEANING>Canine Lethal Glossopharyngeal Defect</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal recessive condition in canine species where a malformed tongue prevents the animal from nursing, which results in death within a few days of birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219842</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482255</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1519002</VALIDVALUE>
          <VALUEMEANING>Congenital Phlebectasia</VALUEMEANING>
          <MEANINGDESCRIPTION>Widening of a vein that is present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219881</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>223003</VALIDVALUE>
          <VALUEMEANING>Uterine Corpus Neoplasm During Pregnancy</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign or malignant neoplasm of the uterus corpus occurring during pregnancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1361009</VALIDVALUE>
          <VALUEMEANING>Leukocoria</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormal eye finding involving the appearance of a bright white reflection upon shining light through the pupil.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220021</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2818004</VALIDVALUE>
          <VALUEMEANING>Congenital Ocular Vascular Malformation</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormality of the blood vessels that perfuse the eye that is present at birth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219880</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482259</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>168000</VALIDVALUE>
          <VALUEMEANING>Typhlolithiasis</VALUEMEANING>
          <MEANINGDESCRIPTION>The formation of a stone in the cecum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4275001</VALIDVALUE>
          <VALUEMEANING>Conjugate Gaze Spasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Sudden, involuntary movement of both eyes in the same direction caused by spasm of the extraocular muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219883</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3358001</VALIDVALUE>
          <VALUEMEANING>Keratosis Lichenoides Chronica</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare skin disorder with brownish-purple, thick scaly papules or small nodules arranged in a linear or reticulate pattern on the trunk and limbs. Many cases are associated with seborrheic dermatitis- or rosacea-like lesions on the face. It is distinguished from lichen planus by the absence of pruritus, a lack of response to a topical or systemic corticosteroid and the presence of focal parakeratosis in histological samples.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220008</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2829000</VALIDVALUE>
          <VALUEMEANING>Uhl Disease</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital heart condition characterized by the absence or near absence of the myocardium in the right ventricle of the heart.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482263</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1332008</VALIDVALUE>
          <VALUEMEANING>Conjugated Visual Deviation</VALUEMEANING>
          <MEANINGDESCRIPTION>A sustained shift in the gaze of both eyes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219884</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2138000</VALIDVALUE>
          <VALUEMEANING>Left Sacral Posterior Presentation</VALUEMEANING>
          <MEANINGDESCRIPTION>A breech fetal presentation in which the fetus is positioned with its sacrum towards the left side of the mother and its back is facing the mother&#39;s back.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1372004</VALIDVALUE>
          <VALUEMEANING>Unicornuate Uterus</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital abnormality where the uterus develops with only one Fallopian tube.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>539009</VALIDVALUE>
          <VALUEMEANING>Conjunctival Argyrosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A grayish discoloration of the conjunctiva associated with chronic exposure to silver compounds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219885</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482267</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>228007</VALIDVALUE>
          <VALUEMEANING>Lucio Phenomenon</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare complication of advanced, untreated diffuse non-nodular lepromatous leprosy that is characterized by necrotizing vasculitis, skin ulcers and potentially life-threatening skin necrosis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220024</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482268</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1046004</VALIDVALUE>
          <VALUEMEANING>Ureteritis Glandularis</VALUEMEANING>
          <MEANINGDESCRIPTION>A benign inflammatory lesion of the ureter characterized by glandular metaplasia of the urethral lining. It is a further proliferative progression of cystitis glandularis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1744008</VALIDVALUE>
          <VALUEMEANING>Connated Teeth</VALUEMEANING>
          <MEANINGDESCRIPTION>The development of a single tooth from the fusion of two adjacent tooth germs or the interrupted splitting of a single tooth germ which forms a larger than expected tooth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219886</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2396006</VALIDVALUE>
          <VALUEMEANING>Malignant Pyoderma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare skin disease characterized by destructive and necrotizing ulcers located on the face, neck and upper trunk.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220029</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4381006</VALIDVALUE>
          <VALUEMEANING>Verbal Paraphasia</VALUEMEANING>
          <MEANINGDESCRIPTION>A speech error where a person substitutes one word for another during speaking. This substitution can be related to the intended word (semantic paraphasia) or unrelated (remote paraphasia). It can be a sign of a neurological disorder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>586008</VALIDVALUE>
          <VALUEMEANING>Primula Dermatitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Allergic contact dermatitis secondary to exposure to organic compounds found in Primula (primrose) species.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220105</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3263004</VALIDVALUE>
          <VALUEMEANING>Verumontanitis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the verumontanum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220226</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>387003</VALIDVALUE>
          <VALUEMEANING>Melanuria</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication of dark brown or black urine discoloration due to the presence of melanin or its precursors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220030</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>871005</VALIDVALUE>
          <VALUEMEANING>Contracted Pelvis</VALUEMEANING>
          <MEANINGDESCRIPTION>A pelvis with one or more reduced diameters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219888</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>470004</VALIDVALUE>
          <VALUEMEANING>Vitreous Touch Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A complication of eye surgery or trauma where vitreous humor prolapses through a wound and contacts the corneal endothelium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220229</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4089001</VALIDVALUE>
          <VALUEMEANING>Meningococcemia</VALUEMEANING>
          <MEANINGDESCRIPTION>Septicemia due to the presence of the bacterium Neisseria meningitidis in the bloodstream.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220031</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3815005</VALIDVALUE>
          <VALUEMEANING>Crohn Disease of Rectum</VALUEMEANING>
          <MEANINGDESCRIPTION>Crohn disease affecting the rectum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219892</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4022007</VALIDVALUE>
          <VALUEMEANING>Plasma Cell Vulvitis</VALUEMEANING>
          <MEANINGDESCRIPTION>An inflammatory condition of the vulva characterized by well-defined, glistening, erythematous patches or plaques on the vulva comprised of dense dermal infiltrates of plasma cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220099</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482280</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3591006</VALIDVALUE>
          <VALUEMEANING>Hyperchloremic Acidosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Metabolic acidosis with a normal serum ratio of anions to cations and replacement of bicarbonate with chloride.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219988</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2518007</VALIDVALUE>
          <VALUEMEANING>Idiopathic Precocious Puberty</VALUEMEANING>
          <MEANINGDESCRIPTION>Precocious puberty for which no underlying cause can be identified.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C120165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482282</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3067005</VALIDVALUE>
          <VALUEMEANING>Weak Rhesus C Phenotype</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition where the Rhesus (Rh) C antigen on red blood cells is present at a reduced level.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3261002</VALIDVALUE>
          <VALUEMEANING>Regional Migratory Osteoporosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare arthralgia affecting the weight-bearing joints of the lower limb that is characterized by bone marrow edema with subchondral sparing without subchondral fracture.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220118</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>443006</VALIDVALUE>
          <VALUEMEANING>Cystocele Affecting Pregnancy</VALUEMEANING>
          <MEANINGDESCRIPTION>A prolapse of the bladder into the vagina that complicates pregnancy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219896</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4283007</VALIDVALUE>
          <VALUEMEANING>Mirizzi Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare complication of chronic gallstone disease characterized by biliary obstruction due to gallstone impaction causing external compression of the bile and/or hepatic ducts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220036</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2120003</VALIDVALUE>
          <VALUEMEANING>Weak Cry of Newborn</VALUEMEANING>
          <MEANINGDESCRIPTION>A weak cry in a newborn can be a sign of minor or serious conditions. It can be associated with hypotonia or neurological conditions, but can also be related to temporary factors like fluid in the airways.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220230</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2149006</VALIDVALUE>
          <VALUEMEANING>Decreased Hormone Production</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding indicating lower than normal hormone production.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219898</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2781009</VALIDVALUE>
          <VALUEMEANING>Miscarriage-Related Hemorrhage</VALUEMEANING>
          <MEANINGDESCRIPTION>A complication characterized by excessive bleeding during or after a miscarriage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220037</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>607007</VALIDVALUE>
          <VALUEMEANING>Decreased Vital Capacity</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding indicating that the measured vital capacity is less than a previous or predicted value.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219899</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>991002</VALIDVALUE>
          <VALUEMEANING>Wide QRS by ECG Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>An electrocardiographic finding of QRS complexes of 120 milliseconds or longer in duration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220232</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3900008</VALIDVALUE>
          <VALUEMEANING>Mixed Sensory-Motor Polyneuropathy</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital or acquired condition where multiple peripheral nerves are damaged causing individuals to experience both sensory disturbances and motor difficulties.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220039</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>313005</VALIDVALUE>
          <VALUEMEANING>Deja Vu</VALUEMEANING>
          <MEANINGDESCRIPTION>A transitory belief that one has experienced something before despite never having undergone that experience. It may be a consequence of certain neuropsychiatric conditions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219902</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>184004</VALIDVALUE>
          <VALUEMEANING>Withdrawal Arrhythmia</VALUEMEANING>
          <MEANINGDESCRIPTION>A cardiac arrhythmia associated with withdrawal from alcohol or drugs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220233</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>832007</VALIDVALUE>
          <VALUEMEANING>Moderate Major Depression</VALUEMEANING>
          <MEANINGDESCRIPTION>A depressive disorder characterized by persistent feelings of sadness, loss of interest in activities and other depression symptoms that may interfere with normal functioning.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220040</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>216004</VALIDVALUE>
          <VALUEMEANING>Persecutory Type Delusional Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A subtype of delusional disorder characterized by the central delusional theme that the individual is being malevolently treated (for example, maligned, harassed, conspired against, poisoned or drugged) by another person or group.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2241003</VALIDVALUE>
          <VALUEMEANING>X-Linked Absence of Thyroxine-Binding Globulin</VALUEMEANING>
          <MEANINGDESCRIPTION>An abnormality of thyroid hormone transport caused by mutations in the SERPINA7 gene and lack of thyroxine-binding globulin in the blood.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3680009</VALIDVALUE>
          <VALUEMEANING>Monocephalus Tripus Dibrachius</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare form of conjoined twinning characterized by the development of one head, two arms, and three feet.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220042</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3611003</VALIDVALUE>
          <VALUEMEANING>Demeton Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Poisoning due to exposure to the organophosphate insecticide, demeton.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2374000</VALIDVALUE>
          <VALUEMEANING>Monofascicular Block</VALUEMEANING>
          <MEANINGDESCRIPTION>A cardiac condition in which one fascicule is damaged, but conduction between the atria and the ventricles of the heart remains intact.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220043</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2403008</VALIDVALUE>
          <VALUEMEANING>Dependence</VALUEMEANING>
          <MEANINGDESCRIPTION>The psychological or physiological need to take a substance in order to experience its effects or to avoid the effects of its absence.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C35458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482301</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3185000</VALIDVALUE>
          <VALUEMEANING>Mood-Congruent Delusion</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of delusion where the content is consistent with the predominant mood of the individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220044</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>555002</VALIDVALUE>
          <VALUEMEANING>Dicentra Species Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Poisoning due to exposure to the species of the plant genus, Dicentra.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219906</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4142001</VALIDVALUE>
          <VALUEMEANING>Muscular Asthenopia</VALUEMEANING>
          <MEANINGDESCRIPTION>Non-specific symptoms such as visual disturbances, fatigue, and pain in or around the eyes that are caused by disorders of the extraocular muscles.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220047</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3704008</VALIDVALUE>
          <VALUEMEANING>Diffuse Endocapillary Glomerulonephritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Glomerulonephritis characterized by endocapillary proliferation and the presence of inflammatory cells affecting 50% or more of all glomeruli.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C122806</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4316006</VALIDVALUE>
          <VALUEMEANING>Myometritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Inflammation of the myometrium.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220048</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1954004</VALIDVALUE>
          <VALUEMEANING>Toxic Dilated Cardiomyopathy</VALUEMEANING>
          <MEANINGDESCRIPTION>Dilated cardiomyopathy secondary to exposure to a toxin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220195</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1426004</VALIDVALUE>
          <VALUEMEANING>Necrotizing Glomerulonephritis</VALUEMEANING>
          <MEANINGDESCRIPTION>Necrosis of glomeruli that results from small vessel vasculitis in the kidney.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C217743</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1038000</VALIDVALUE>
          <VALUEMEANING>Disacchariduria</VALUEMEANING>
          <MEANINGDESCRIPTION>A laboratory test result which indicates the presence of disaccharides in the urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219907</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2689001</VALIDVALUE>
          <VALUEMEANING>Epidermolysis Bullosa with Congenital Localized Absence of Skin and Deformity of Nails</VALUEMEANING>
          <MEANINGDESCRIPTION>A clinical variant of autosomal dominant epidermolysis bullosa dystrophica caused by mutation(s) in the COL7A1 gene, encoding collagen alpha-1(VII) chain. A heterozygous 6007G-to-A transition in exon 73 results in a glycine-to-arginine substitution at position 2003 (G2003R) within the triple helical domain. This variant is characterized by the congenital absence of skin on the lower extremities, blistering of skin and mucous membranes, and the congenital absence or deformity of nails.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219925</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2965006</VALIDVALUE>
          <VALUEMEANING>Nevoid Congenital Alopecia</VALUEMEANING>
          <MEANINGDESCRIPTION>Alopecia that is present at birth in a localized, circumscribed area with highly pigmented, nevus-like areas.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220054</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1145003</VALIDVALUE>
          <VALUEMEANING>Developmental Speech Disorder</VALUEMEANING>
          <MEANINGDESCRIPTION>A grouping of disorders ranging from mild delays in articulation and language development to severe comprehension difficulties and lack of speech development.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219905</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1531000</VALIDVALUE>
          <VALUEMEANING>Nitrofuran Derivative Poisoning</VALUEMEANING>
          <MEANINGDESCRIPTION>Poisoning by a derivative of nitrofuran.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220055</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1343000</VALIDVALUE>
          <VALUEMEANING>Deep Transverse Arrest</VALUEMEANING>
          <MEANINGDESCRIPTION>Hindrance of delivery due to malposition of the fetal head in a transverse orientation deep within the maternal pelvis which limits anterior rotation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2967003</VALIDVALUE>
          <VALUEMEANING>Noncomitant Strabismus</VALUEMEANING>
          <MEANINGDESCRIPTION>Strabismus in which the degree of deviation is dependent on the direction in which the eyes are turned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220056</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3427001</VALIDVALUE>
          <VALUEMEANING>Nonglucosuric Melituria</VALUEMEANING>
          <MEANINGDESCRIPTION>The presence of nonglucose sugar in the urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220057</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4195003</VALIDVALUE>
          <VALUEMEANING>Anal Canal Duplication</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare, congenital anomaly in which a second anal canal is formed with the orifice located in the perineum posterior to the normal anus. The extra opening of the anal canal does not typically communicate with the true anorectum.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219796</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2388001</VALIDVALUE>
          <VALUEMEANING>Normal Nuchal Translucency</VALUEMEANING>
          <MEANINGDESCRIPTION>Nuchal translucency is within normal limits.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220058</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1107004</VALIDVALUE>
          <VALUEMEANING>Early Latent Syphilis</VALUEMEANING>
          <MEANINGDESCRIPTION>Latent syphilis when infection was acquired less than twelve months previously.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2004005</VALIDVALUE>
          <VALUEMEANING>Normotensive</VALUEMEANING>
          <MEANINGDESCRIPTION>Blood pressure is within normal limits.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220059</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2506003</VALIDVALUE>
          <VALUEMEANING>Early Onset Dysthymia</VALUEMEANING>
          <MEANINGDESCRIPTION>Dysthymic disorder diagnosed before the age of 21.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219913</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482321</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2261009</VALIDVALUE>
          <VALUEMEANING>Obstetrical Pulmonary Fat Embolism</VALUEMEANING>
          <MEANINGDESCRIPTION>A fat embolism to the lungs during pregnancy or the post partum period.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3747008</VALIDVALUE>
          <VALUEMEANING>Ejection Click</VALUEMEANING>
          <MEANINGDESCRIPTION>An auscultated finding describing a high pitched sound that occurs after the first heart sound (S1) and corresponds to the moment of maximal opening of the aortic or pulmonary valves. It may signify the presence of a dilated aorta or pulmonary artery or the presence of a bicuspid or flexible stenotic aortic or pulmonary valve.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219917</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1779005</VALIDVALUE>
          <VALUEMEANING>Orofacial Digital Syndrome 2</VALUEMEANING>
          <MEANINGDESCRIPTION>An autosomal recessive inherited disease associated with compound heterozygous mutations in the NEK1 gene and characterized by absence of medial incisors, median cleft lip, poly lobed tongue and polydactyly of hands and feet.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220070</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4170004</VALIDVALUE>
          <VALUEMEANING>Arthrochalasia Ehlers-Danlos Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>Variants of Ehlers-Danlos syndrome type VII caused by mutations in either the COL1A1 gene or COL1A2 gene that result in disruptions of the procollagen collagenase cleavage site.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C219916</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2469009</VALIDVALUE>
          <VALUEMEANING>Onchomalacia</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder in which the nails become soft.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220064</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1059007</VALIDVALUE>
          <VALUEMEANING>Opisthorchiasis</VALUEMEANING>
          <MEANINGDESCRIPTION>A parasitic disease caused by species of the genus Opisthorchis. This infection with liver flukes is transmitted by eating raw or undercooked fish.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220065</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>734001</VALIDVALUE>
          <VALUEMEANING>Opocephalus</VALUEMEANING>
          <MEANINGDESCRIPTION>A malformed fetus with ears fused to the head, one orbit, no mouth or nose.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220066</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16482328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>440009</VALIDVALUE>
          <VALUEMEANING>Phenylketonuria</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder characterized by the body&#39;s inability to break down and utilize the essential amino acid phenylalanine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>219006</VALIDVALUE>
          <VALUEMEANING>Drinker</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who drinks at least once per week with regularity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16181672</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2435008</VALIDVALUE>
          <VALUEMEANING>Ascariasis</VALUEMEANING>
          <MEANINGDESCRIPTION>An infection that is caused by the roundworm Ascaris lumbricoides, many cases of which remain asymptomatic. During the transient larval migratory phase, shortness of breath, fever, and eosinophilia can occur. Depending on the intestinal worm burden, a spectrum of gastrointestinal tract symptoms can occur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128392</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6840938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3439009</VALIDVALUE>
          <VALUEMEANING>Severe Combined Immunodeficiency with Absence of T, Normal B Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>An inherited, severe immunodeficiency disorder characterized by abnormalities in the development and function of T cell immunity. The peripheral T lymphocytes are absent or in very low counts. The B lymphocyte counts are normal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2593381</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>193003</VALIDVALUE>
          <VALUEMEANING>Arterionephrosclerosis</VALUEMEANING>
          <MEANINGDESCRIPTION>Scarring and atrophy of the renal cortex that occurs in hypertensive patients and in old age.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97144</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3252180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1102005</VALIDVALUE>
          <VALUEMEANING>Babesiosis</VALUEMEANING>
          <MEANINGDESCRIPTION>A parasitic infection caused by Babesia. It is transmitted by ticks and infects the red blood cells. Signs and symptoms include fever, fatigue and hemolytic anemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C84581</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210896</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1287007</VALIDVALUE>
          <VALUEMEANING>Biliary Atresia</VALUEMEANING>
          <MEANINGDESCRIPTION>A congenital disorder characterized by blockage or absence of an extrahepatic bile duct.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C34421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3210776</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4294006</VALIDVALUE>
          <VALUEMEANING>Precocious Puberty</VALUEMEANING>
          <MEANINGDESCRIPTION>Unusually early sexual maturity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C79704</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2040007</VALIDVALUE>
          <VALUEMEANING>Thoracic Outlet Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A syndrome resulting from the compression of the blood vessels or nerves in the space between the clavicle and first rib (thoracic outlet). It is caused by car accident injuries or repetitive job or sport-related injuries. Signs and symptoms include pain in the shoulders and neck, numbness in the fingers, and weakening grip.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85188</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-09-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3211480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Complication Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Procedure Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15744772</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Procedure</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>complication[].coding[].code@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1501">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15743233</PUBLICID>
    <LONGNAME>Subject Pharmacotherapy Type</LONGNAME>
    <PREFERREDNAME>15743189v1.00:15743201v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The kind of drug therapy used to treat a disease, condition, or symptom.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>HTAN</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>HTAN:Human Tumor Atlas Network</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15743189</PublicId>
      <PreferredName>2523466v1.00:3869982v1.00</PreferredName>
      <PreferredDefinition>A matter or an individual that is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study.:Treatment of disease through the use of drugs.</PreferredDefinition>
      <LongName>Subject Pharmacotherapy</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>HTAN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2523466</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41189</PreferredName>
        <Version>1</Version>
        <LongName>Study Subject</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41189</PREFERRED_NAME>
            <LONG_NAME>Study Subject</LONG_NAME>
            <CON_ID>2202706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3869982</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15986</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacotherapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15986</PREFERRED_NAME>
            <LONG_NAME>Pharmacotherapy</LONG_NAME>
            <CON_ID>2673143</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>HTAN:Human Tumor Atlas Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15743201</PublicId>
      <PreferredName>15743201v1.00</PreferredName>
      <PreferredDefinition>Treatment of disease through the use of drugs._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Pharmacotherapy Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>HTAN</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>HTAN:Human Tumor Atlas Network</Origin>
      <Representation>
        <PublicId>15743200</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>15743200v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Pharmacotherapy Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15986</PREFERRED_NAME>
            <LONG_NAME>Pharmacotherapy</LONG_NAME>
            <CON_ID>2673143</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Reported</VALIDVALUE>
          <VALUEMEANING>Not Reported</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Combination Drug Therapy</VALIDVALUE>
          <VALUEMEANING>Combination Drug Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Drug therapy with two or more drugs given separately or together for a combined effect.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16144</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5084133</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Single Drug Therapy</VALIDVALUE>
          <VALUEMEANING>Single Agent Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Pharmacotherapy consisting of a single agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C157514</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7217266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Pharmacotherapy Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15872542</PublicId>
          <ContextName>HTAN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HTAN 2025 Model CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Model v1 CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15872543</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>HTAN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Pharmacotherapy Type</AlternateName>
        <AlternateNameType>HTAN Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1502">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>15879004</PUBLICID>
    <LONGNAME>Diagnosis Grade Four Lower GI Acute Graft Versus Host Disease Occurrence Date</LONGNAME>
    <PREFERREDNAME>GR_4_ LOWGI_AGVHD_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>The date on which grade four acute graft versus host disease of the lower gastrointestinal tract occurred.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>15878991</PublicId>
      <PreferredName>2442484v1.00:15878990v1.00</PreferredName>
      <PreferredDefinition>The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:A position on a scale of intensity or amount or quality._A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one._The lower part of the gastrointestinal tract that includes the jejunum and ileum of the small intestine and the large intestine._A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.</PreferredDefinition>
      <LongName>Diagnosis Grade Four Lower Gastrointestinal Tract Acute Graft Versus Host Disease</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2442484</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>15878990</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48309:C66835:C33010:C4980</PreferredName>
        <Version>1</Version>
        <LongName>Grade Four Lower Gastrointestinal Tract Acute Graft Versus Host Disease</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C66835</PREFERRED_NAME>
            <LONG_NAME>Four</LONG_NAME>
            <CON_ID>2673235</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C33010</PREFERRED_NAME>
            <LONG_NAME>Lower Gastrointestinal Tract</LONG_NAME>
            <CON_ID>2813540</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4980</PREFERRED_NAME>
            <LONG_NAME>Acute Graft Versus Host Disease</LONG_NAME>
            <CON_ID>2202363</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of aGVHD Lower GI Stage 4</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1503">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16022235</PUBLICID>
    <LONGNAME>Disease or Disorder Assessment Performed CMML Response Type</LONGNAME>
    <PREFERREDNAME>DS_CMML_RESP_TYPE</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the CMML response type.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CCR:Center for Cancer Research</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>5094995</PublicId>
      <PreferredName>2861247v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The final result of a determination of the value, significance, or extent of._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Disease or Disorder Assessment Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2861247</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C25217</PreferredName>
        <Version>1</Version>
        <LongName>Disease or Disorder Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25217</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2202457</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>16022108</PublicId>
      <PreferredName>CMML_DS_RSP_TY</PreferredName>
      <PreferredDefinition>A myelodysplastic/myeloproliferative neoplasm which is characterized by persistent monocytosis, absence of a Philadelphia chromosome and BCR/ABL fusion gene, fewer than 20 percent blasts in the bone marrow and blood, myelodysplasia, and absence of PDGFRA or PDGFRB rearrangement._The molecular/pathological and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Chronic Myelomonocytic Leukemia Disease Response Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>75</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>16022107</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16022107v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Chronic Myelomonocytic Leukemia Disease Response Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3178</PREFERRED_NAME>
            <LONG_NAME>Chronic Myelomonocytic Leukemia</LONG_NAME>
            <CON_ID>2204758</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C50995</PREFERRED_NAME>
            <LONG_NAME>Disease Response</LONG_NAME>
            <CON_ID>2459436</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease Progression</VALIDVALUE>
          <VALUEMEANING>Disease Progression</VALUEMEANING>
          <MEANINGDESCRIPTION>Disease Progression</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16022171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Clinical benefit</VALIDVALUE>
          <VALUEMEANING>Clinical benefit</VALUEMEANING>
          <MEANINGDESCRIPTION>Clinical benefit</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16022170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial marrow response</VALIDVALUE>
          <VALUEMEANING>Partial marrow response</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial marrow response</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16022169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Optimal marrow response</VALIDVALUE>
          <VALUEMEANING>Optimal marrow response</VALUEMEANING>
          <MEANINGDESCRIPTION>Optimal marrow response</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16022168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial remission</VALIDVALUE>
          <VALUEMEANING>Partial remission</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial remission</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16022167</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complete cytogenetic remission</VALIDVALUE>
          <VALUEMEANING>Complete cytogenetic remission</VALUEMEANING>
          <MEANINGDESCRIPTION>Complete cytogenetic remission</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16022166</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CR</VALIDVALUE>
          <VALUEMEANING>Complete Response</VALUEMEANING>
          <MEANINGDESCRIPTION>Complete Response</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2025-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16022138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CMML Response</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1504">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16040867</PUBLICID>
    <LONGNAME>Subject Parous Indicator</LONGNAME>
    <PREFERREDNAME>16040844v1.00:6059598v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>A response to indicate whether or not an individual has given birth to one or more offspring.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CRDC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PSDC: Population Science Data Commons</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16040844</PublicId>
      <PreferredName>2523466v1.00:16040843v1.00</PreferredName>
      <PreferredDefinition>A matter or an individual that is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study.:Having given birth to one or more offspring.</PreferredDefinition>
      <LongName>Subject Parous</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CRDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2523466</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41189</PreferredName>
        <Version>1</Version>
        <LongName>Study Subject</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41189</PREFERRED_NAME>
            <LONG_NAME>Study Subject</LONG_NAME>
            <CON_ID>2202706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16040843</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C215213</PreferredName>
        <Version>1</Version>
        <LongName>Parous</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C215213</PREFERRED_NAME>
            <LONG_NAME>Parous</LONG_NAME>
            <CON_ID>16040818</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PSDC: Population Science Data Commons</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6059598</PublicId>
      <PreferredName>Y_N_UNK_NRPT_IND</PreferredName>
      <PreferredDefinition>An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Yes No Unknown Not Reported Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>GDC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>GDC:NCI Genomic Data Commons</Origin>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Reported</VALIDVALUE>
          <VALUEMEANING>Not Reported</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5697865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5697866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-02-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5682953</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Parous</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1505">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16078555</PUBLICID>
    <LONGNAME>Laboratory Procedure Test Original Result CDISC Variable Terminology Outcome</LONGNAME>
    <PREFERREDNAME>14900731v1.00:6400810v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Result of the measurement or finding as originally received or collected.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CDISC:Clinical Data Interchange Standards Consortium</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14900731</PublicId>
      <PreferredName>2543047v1.00:6421010v1.00</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:The outcome of the laboratory test assessment.</PreferredDefinition>
      <LongName>Laboratory Procedure Laboratory Test Original Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008558</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>UOM</PreferredName>
        <Version>1</Version>
        <LongName>Units of Measure</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>6421010</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83165</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test Original Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83165</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Original Result</LONG_NAME>
            <CON_ID>6421009</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>6400810</PublicId>
      <PreferredName>CDISCRES</PreferredName>
      <PreferredDefinition>The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._The result of an action.</PreferredDefinition>
      <LongName>CDISC Variable Terminology Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CDISC:Clinical Data Interchange Standards Consortium</Origin>
      <Representation>
        <PublicId>6400811</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C83187:C20200</PreferredName>
        <Version>1</Version>
        <LongName>CDISC Variable Terminology Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C83187</PREFERRED_NAME>
            <LONG_NAME>CDISC Variable Terminology</LONG_NAME>
            <CON_ID>6396645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Result or Finding in Original Units</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063880</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDISC - SDTM</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Laboratory Test Results (LB)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15969143</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LB</AlternateName>
        <AlternateNameType>CDISC SDTM Domain</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LBORRES</AlternateName>
        <AlternateNameType>CDISC SDTM Variable</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1506">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16081790</PUBLICID>
    <LONGNAME>Health Status Assessment Pregnancy Status Type LOINC Code</LONGNAME>
    <PREFERREDNAME>16081764v1.00:16081778v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>Describes what was observed. Sometimes this is called the observation &quot;name&quot;. This element holds the &quot;code&quot; part of the value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16081764</PublicId>
      <PreferredName>14936166v1.00:16456920v1.00</PreferredName>
      <PreferredDefinition>Assessments of health-related matters of interest, importance, or worry to a patient, patient&#39;s family, or patient&#39;s healthcare provider that could identify a need, problem, or condition.:The pregnancy status of an individual._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Health Status Assessment Pregnancy Status Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14936166</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C205784</PreferredName>
        <Version>1</Version>
        <LongName>Health Status Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C205784</PREFERRED_NAME>
            <LONG_NAME>Health Status Assessment</LONG_NAME>
            <CON_ID>14920961</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16456920</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C69218:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Pregnancy Status Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C69218</PREFERRED_NAME>
            <LONG_NAME>Pregnancy Status</LONG_NAME>
            <CON_ID>2684128</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>16081778</PublicId>
      <PreferredName>16081778v1.00</PreferredName>
      <PreferredDefinition>The pregnancy status of an individual._A sequence of characters that identifies laboratory and clinical tests within the Logical Observation Identifiers Names and Codes (LOINC) database._A symbol or combination of symbols which is assigned to the members of a collection.</PreferredDefinition>
      <LongName>Pregnancy Status LOINC Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1048576</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>16456933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16456933v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Pregnancy Status LOINC Code Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C69218</PREFERRED_NAME>
            <LONG_NAME>Pregnancy Status</LONG_NAME>
            <CON_ID>2684128</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C82502</PREFERRED_NAME>
            <LONG_NAME>LOINC Code</LONG_NAME>
            <CON_ID>10097362</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>82810-3</VALIDVALUE>
          <VALUEMEANING>Pregnancy Status</VALUEMEANING>
          <MEANINGDESCRIPTION>The pregnancy status of an individual.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-04-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16081811</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Code Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Observation Pregnancy Status Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16075304</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ObservationPregnancyStatus</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>code.coding[].code@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1507">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16304887</PUBLICID>
    <LONGNAME>Health Status Assessment Pregnancy Status Category Text</LONGNAME>
    <PREFERREDNAME>16081762v1.00:15102792v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>A code that classifies the general type of observation being made. This element holds the &quot;text&quot; part of the value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16081762</PublicId>
      <PreferredName>14936166v1.00:16456928v1.00</PreferredName>
      <PreferredDefinition>Assessments of health-related matters of interest, importance, or worry to a patient, patient&#39;s family, or patient&#39;s healthcare provider that could identify a need, problem, or condition.:The pregnancy status of an individual._A grouping of items based on some commonality or by user defined characteristics.</PreferredDefinition>
      <LongName>Health Status Assessment Pregnancy Status Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>14936166</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C205784</PreferredName>
        <Version>1</Version>
        <LongName>Health Status Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C205784</PREFERRED_NAME>
            <LONG_NAME>Health Status Assessment</LONG_NAME>
            <CON_ID>14920961</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16456928</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C69218:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Pregnancy Status Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C69218</PREFERRED_NAME>
            <LONG_NAME>Pregnancy Status</LONG_NAME>
            <CON_ID>2684128</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15102792</PublicId>
      <PreferredName>15102792v1.00</PreferredName>
      <PreferredDefinition>The words of something written.</PreferredDefinition>
      <LongName>Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1048576</MaximumLength>
      <MinimumLength>0</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Category Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Observation Pregnancy Status Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16075304</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ObservationPregnancyStatus</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>category[].text@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1508">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16317913</PUBLICID>
    <LONGNAME>Medication Dispensing Route of Administration Text</LONGNAME>
    <PREFERREDNAME>14808175v1.00:15102792v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>How drug should enter body. This element holds the &quot;text&quot; part of the value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>CDMH</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>FHIR US Core Profiles:Fast Healthcare Interoperability Resources US Core Profiles</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>14808175</PublicId>
      <PreferredName>2411879v1.00:14808174v1.00</PreferredName>
      <PreferredDefinition>A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.:Prescriptions filled through a community, mail-order or hospital pharmacy. Outpatient dispensing may not be directly captured within healthcare systems._Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.</PreferredDefinition>
      <LongName>Medication Dispensing Route of Administration</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2411879</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C459</PreferredName>
        <Version>1</Version>
        <LongName>Medication</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>14808174</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C154629:C38114</PreferredName>
        <Version>1</Version>
        <LongName>Dispensing Route of Administration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C154629</PREFERRED_NAME>
            <LONG_NAME>Dispensing</LONG_NAME>
            <CON_ID>6424596</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38114</PREFERRED_NAME>
            <LONG_NAME>Route of Administration</LONG_NAME>
            <CON_ID>2437663</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>15102792</PublicId>
      <PreferredName>15102792v1.00</PreferredName>
      <PreferredDefinition>The words of something written.</PreferredDefinition>
      <LongName>Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>CDMH</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <Datatype>string</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>1048576</MaximumLength>
      <MinimumLength>0</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Dosage Instruction Route Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15063879</PublicId>
          <ContextName>CDMH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>FHIR - US CORE</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>US Core Medication Dispense Profile</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>16075307</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MedicationDispense</AlternateName>
        <AlternateNameType>FHIR US CORE Table</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CDMH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>dosageInstruction[].route.text@value</AlternateName>
        <AlternateNameType>FHIR US CORE Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1509">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>16396303</PUBLICID>
    <LONGNAME>Disease or Disorder Hemorrhagic Cystitis And/Or Hematuria Requirement Medical Intervention Present Disorder Indicator</LONGNAME>
    <PREFERREDNAME>16396292v1.00:16392819v1.00</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes the hemorrhagic cystitis and/or hematuria requiring medical intervention that was present.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>DRAFT NEW</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>16396292</PublicId>
      <PreferredName>2404658v1.00:16396291v1.00</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Inflammation of the bladder resulting in bloody urine._Used to indicate that either or both of two items or options may be valid._Blood in the urine._Something that is a necessary condition; something that is obligatory._Relating to the study or practice of medicine._An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects._Being or existing in a specified place or at the specified time.</PreferredDefinition>
      <LongName>Disease or Disorder Hemorrhagic Cystitis And/Or Hematuria Requirement Medical Clinical Intervention or Procedure Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008548</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TUMOR_MSRMTS</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Measurements</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>16396291</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>16396291v1.00</PreferredName>
        <Version>1</Version>
        <LongName>Hemorrhagic Cystitis And/Or Hematuria Requirement Medical Clinical Intervention or Procedure Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C114666</PREFERRED_NAME>
            <LONG_NAME>Hemorrhagic Cystitis</LONG_NAME>
            <CON_ID>5073079</CON_ID>
            <DEFINITION_SOURCE>NICHD</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>6</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48928</PREFERRED_NAME>
            <LONG_NAME>And/Or</LONG_NAME>
            <CON_ID>2431163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3090</PREFERRED_NAME>
            <LONG_NAME>Hematuria</LONG_NAME>
            <CON_ID>2206233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25652</PREFERRED_NAME>
            <LONG_NAME>Requirement</LONG_NAME>
            <CON_ID>2204014</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25261</PREFERRED_NAME>
            <LONG_NAME>Medical</LONG_NAME>
            <CON_ID>2202452</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25218</PREFERRED_NAME>
            <LONG_NAME>Clinical Intervention or Procedure</LONG_NAME>
            <CON_ID>2202893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>16392819</PublicId>
      <PreferredName>16392819v1.00</PreferredName>
      <PreferredDefinition>Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Disease or Disorder Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>DRAFT NEW</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>120</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2684204</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not present</VALIDVALUE>
          <VALUEMEANING>Negation Present</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction._Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-08-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16392821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Persisted</VALIDVALUE>
          <VALUEMEANING>Persistent</VALUEMEANING>
          <MEANINGDESCRIPTION>Retained; never-ceasing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43623</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-08-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567846</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Developed</VALIDVALUE>
          <VALUEMEANING>Develop</VALUEMEANING>
          <MEANINGDESCRIPTION>To occur, create, or be acquired over time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C220631</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2025-08-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>16392820</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PQT</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was hemorrhagic cystitis and/or hematuria requiring medical intervention present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Was hemorrhagic cystitis / hematuria requiring medical intervention present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1510">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>316</PUBLICID>
    <LONGNAME>Person Address Postal Code</LONGNAME>
    <PREFERREDNAME>2014826v1.0:2018437v5.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the address or postal information for a person, the address number indicating a postal district (in the USA this is a 5 or 9 digit number (10 including the hyphen)).</PREFERREDDEFINITION>
    <VERSION>5</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CDUS:Clinical Data Update System</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014826</PublicId>
      <PreferredName>PERSON_ADDR</PreferredName>
      <PreferredDefinition>the address or postal information for a person.</PreferredDefinition>
      <LongName>Person Address</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008543</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>GEO_LCTNS</PreferredName>
        <Version>1</Version>
        <LongName>Geographic Locations</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177663</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Address</PreferredName>
        <Version>1</Version>
        <LongName>Address</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25407</PREFERRED_NAME>
            <LONG_NAME>Address</LONG_NAME>
            <CON_ID>2202289</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018437</PublicId>
      <PreferredName>POSTAL_CD</PreferredName>
      <PreferredDefinition>the address number indicating a postal district (in the USA this is a 5 or 9 digit number (10 including the hyphen)).</PreferredDefinition>
      <LongName>Postal Code</LongName>
      <Version>5</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008543</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>GEO_LCTNS</PreferredName>
        <Version>1</Version>
        <LongName>Geographic Locations</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Patient Zip Code</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Patient Zip Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Patient Postal Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>Data element and all values comply with Clinical Data Update System (CDUS) v3.0 Release 2; for CDUS reporting, the last four
digits of the complete nine-digit Zip code should not be submitted to assure patient
confidentiality</DocumentText>
        <URL>http://ctep.cancer.gov/reporting/cdus.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>-COMMENT</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>(USA)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Zip code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Zip or postal code for place of recipient&#39;s residence</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Zip or postal code for place of recipient&#39;s residence</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Zip or postal code for place of recipient&#39;s residence (USA recipients only):</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Zip or postal code for place of recipient&#39;s residence (USA recipients only):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping for CDE:316</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>Subject &gt; Person.postalAddress</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Zip or postal code for place of recipient&#39;s residence:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Zip or postal code for place of recipient&#39;s residence:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Zip code:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Zip code:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Zip +4 Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the zip code of your primary residence?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the zip code of your primary residence?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Postal Code</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Postal Code</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Upper GI</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Lung Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812017</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Demographics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811960</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol/Admin.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811961</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Data Update System</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812446</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>APL Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811786</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Esophageal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811789</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Gastric</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811790</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Esophageal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CLL Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811795</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CML Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811797</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HCL Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811802</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDS Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811806</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811810</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Cervical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Endometrial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Ovarian</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811819</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811821</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Extensive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811822</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Limited</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Unresect Pancreatic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811827</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Resect Pancreatic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811829</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811884</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811886</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811889</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Localized Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811919</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Non-local Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ALL Relapse/Refract</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811921</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AML Relapse/Refract</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811922</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>APL Relapse/Refract</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CLL Relapse/Refract</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811924</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CML Relapse/Refract</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811925</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HCL Relapse/Refract</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811926</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Local-Reg Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811927</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDS Relapse/Refract</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811928</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Stage I-III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Recurrent Gyn</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811938</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812013</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain Recurr</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metastatic Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812015</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Advanced</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000001</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000027</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma Recur</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Met/Urothelial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000311</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Superficial Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000312</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AML Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000362</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Curative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000369</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Gastric</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000446</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ALL Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000449</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Muscle Invasive Blad</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000462</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Palliative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000614</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SPOREs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811689</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2190530</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Demonstration Applications</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rembrandt</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2812349</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Demographic Items</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812623</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Data Update System</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000130</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2000r1: Recipient Baseline Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964872</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Restorative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857184</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Potential CDEs for Reuse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PBRN</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812034</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0278</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4058120</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0240</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104883</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0261</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104899</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0277</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104900</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0255</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0268</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104940</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0279</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104996</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000175</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0255</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000591</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0255</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000592</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7244861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COVID-19</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>8038915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7244861</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COVID-19</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Project 5 CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>8038916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7977821</PublicId>
          <ContextName>NIH</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Project 5 COVID</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tier 1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7977823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0002122</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0058371</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0061364</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0062869</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0064912</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0065461</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0001047</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0001277</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NHLBI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>zip</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>2014826v1.0:2018437v5.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_RD_zip</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_recip_data_usa_postal_code</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Person:postalAddress</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>2014826v1.0:2018437v5.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNcntct_patient_zip</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNcntct_prnt_grd_zip</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNcntct_alt_multi_zip</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NIH</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPRE_RD_usa_postal_code</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_recip_data_zip</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Address Postal Code</AlternateName>
        <AlternateNameType>NIH COVID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIH</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>The address or postal information for a person, the address number indicating a postal district (in the USA this is a 5 or 9 digit number (10 including the hyphen)).</AlternateName>
        <AlternateNameType>Manually-curated</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1511">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>1791</PUBLICID>
    <LONGNAME>Non-protocol Hormonal Therapy Administered Ind-3</LONGNAME>
    <PREFERREDNAME>NPR_HORMONAL_ADM_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator to ask if, since submission of last follow-up form and prior to protocol treatment failure or second primary, a patient received hormonal therapy for cancer not indicated by protocol.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188816</PublicId>
      <PreferredName>NPROT_HORMONAL_ADM</PreferredName>
      <PreferredDefinition>information related to a non-protocol hormonal therapy administered.</PreferredDefinition>
      <LongName>Non-protocol Hormonal Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206406</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25590:C15445</PreferredName>
        <Version>1</Version>
        <LongName>Non-Protocol Hormone Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25590</PREFERRED_NAME>
            <LONG_NAME>Non-Protocol</LONG_NAME>
            <CON_ID>2206325</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15445</PREFERRED_NAME>
            <LONG_NAME>Hormone Therapy</LONG_NAME>
            <CON_ID>2202373</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177665</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Administered</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COMMENT_119</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>(includes medical and surgical)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Non-Protocol Hormonal Therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Non-Protocol Hormonal Therapy?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Non-Protocol Hormonal Therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811810</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Cervical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Endometrial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Ovarian</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811819</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811821</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Extensive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811822</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Limited</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811884</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811886</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811889</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Localized Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Non-local Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Stage I-III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Recurrent Gyn</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811938</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812013</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain Recurr</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metastatic Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812015</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Advanced</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000001</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000027</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma Recur</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0002361</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0002550</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0002630</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0058427</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0061342</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0062847</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0064891</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>2182676</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1512">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>58308</PUBLICID>
    <LONGNAME>Laboratory Procedure Promyelocyte Result Percentage Value</LONGNAME>
    <PREFERREDNAME>LAB_PRO_RS_PTG_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>peripheral blood promyelocytes percentage.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189882</PublicId>
      <PreferredName>LAB_PROMYL_RSLT</PreferredName>
      <PreferredDefinition>information related to the result of a medical procedure that involves testing a sample of blood for promyelocytes, a cell of the bone marrow that is derived from myeloblasts and will give rise to myelocytes, precursors of myeloid cells and neutrophil granulocytes.</PreferredDefinition>
      <LongName>Laboratory Procedure Promyelocyte Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2739332</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13114:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Promyelocyte Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13114</PREFERRED_NAME>
            <LONG_NAME>Promyelocyte</LONG_NAME>
            <CON_ID>2615936</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019101</PublicId>
      <PreferredName>HMT_LAB_PTG_VAL</PreferredName>
      <PreferredDefinition>a percentage for a hematologic laboratory value.</PreferredDefinition>
      <LongName>Blood Specimen Lab Percentage Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Peripheral Promyelocytes (%)</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Peripheral Promyelocytes (%)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lab, Hematology, Promyelocytes, Cell Percentage </DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>APL Relapse/Refract</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AML Prev Untreated</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000362</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1513">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>62642</PUBLICID>
    <LONGNAME>Specimen ICF Signed Date</LONGNAME>
    <PREFERREDNAME>SPEC_ICF_SIG_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date the patient signed the consent for specimen use in studies with optional specimen banking.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2190099</PublicId>
      <PreferredName>SPEC_ICF_SIG</PreferredName>
      <PreferredDefinition>information related to specimen informed consent formed signed.</PreferredDefinition>
      <LongName>Specimen ICF Signed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206704</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157:C16468</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Consent Form</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16468</PREFERRED_NAME>
            <LONG_NAME>Consent Form</LONG_NAME>
            <CON_ID>2202582</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177360</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Signed</PreferredName>
        <Version>1</Version>
        <LongName>Signed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25679</PREFERRED_NAME>
            <LONG_NAME>Signed</LONG_NAME>
            <CON_ID>2203795</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Informed Consent Date Signed, Specimen Use</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Consent for Specimen</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of Consent for Specimen Use</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date biological material consent signed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of Biopsy Consent</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Lung Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812017</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol/Admin.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811961</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811810</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC 2nd Line</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811821</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Extensive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811822</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SCLC Limited</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811823</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811884</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811886</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811889</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Stage I-III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812013</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain Recurr</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metastatic Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812015</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NSCLC Advanced</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000001</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000027</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma Recur</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Curative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000369</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Palliative Head/Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000614</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-08-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889185</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0064846</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1514">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>62706</PUBLICID>
    <LONGNAME>Distant Metastasis Progression Ind-3</LONGNAME>
    <PREFERREDNAME>DIS_MET_PROG_IND-3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator to identify progressive disease diagnosed in non-nodal distant anatomic structures from the primary tumor site.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2190124</PublicId>
      <PreferredName>DIS_MET_PROG</PreferredName>
      <PreferredDefinition>information related to distant metastasis progression.</PreferredDefinition>
      <LongName>Distant Metastasis Progression</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206715</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25321:C19151</PreferredName>
        <Version>1</Version>
        <LongName>Distant Metastasis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25321</PREFERRED_NAME>
            <LONG_NAME>Distant</LONG_NAME>
            <CON_ID>2204917</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19151</PREFERRED_NAME>
            <LONG_NAME>Metastasis</LONG_NAME>
            <CON_ID>2202751</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177380</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Progression</PreferredName>
        <Version>1</Version>
        <LongName>Progression</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25331</PREFERRED_NAME>
            <LONG_NAME>Progression</LONG_NAME>
            <CON_ID>2202788</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Progression Ind, Distant Metastatic</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the patient been diagnose</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the patient been diagnosed with a distant metastatic progression that has not been previously reported</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did disease recur or progress at a new site of disease (metastatic recurrence)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Metastatic</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811955</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer DataMart</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Met/Urothelial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000311</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Superficial Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000312</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Muscle Invasive Blad</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000462</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer Data Mart</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812624</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DIS_MET_PROG_IND-3</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1515">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>64171</PUBLICID>
    <LONGNAME>Tumor Lymphatic/Small Vessel Invasion Ind</LONGNAME>
    <PREFERREDNAME>TUM_LYM/SMVS_INV_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>a yes/no indicator to ask if malignant cells are present in small or thin-walled vessels suggesting lymphatic involvement.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2009610</PublicId>
      <PreferredName>TUMO_LYMPT/SMVES_INV</PreferredName>
      <PreferredDefinition>presence of malignant cell growth (tumor) in small or thin-walled vessels surrounding a neoplasm (suggesting presence of disease in the lymphatic system).</PreferredDefinition>
      <LongName>Tumor Lymphatic/Small Vessel Invasion</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176931</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Tumor</PreferredName>
        <Version>1</Version>
        <LongName>Tumor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2226721</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>C1317503</PreferredName>
        <Version>1</Version>
        <LongName>LYMPHATIC.SMALL VESSEL.INVASION</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1317503</PREFERRED_NAME>
            <LONG_NAME>LYMPHATIC.SMALL VESSEL.INVASION</LONG_NAME>
            <CON_ID>2226720</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018823</PublicId>
      <PreferredName>INV_EXT_DZ_IND</PreferredName>
      <PreferredDefinition>the indicator for the involvement or extent of the disease.</PreferredDefinition>
      <LongName>Involvement Extent Disease Ind</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>23</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>YES</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NO</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>UNKNOWN</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INDETERMINATE</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No source documentation</VALIDVALUE>
          <VALUEMEANING>No source documentation</VALUEMEANING>
          <MEANINGDESCRIPTION>Data from an original source is not present, accessible or ready for use or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67329</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2590731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A</VALIDVALUE>
          <VALUEMEANING>Not Available</VALUEMEANING>
          <MEANINGDESCRIPTION>Information regarding the subject is unknown or inaccessible at this time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ND</VALIDVALUE>
          <VALUEMEANING>Not Determined</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2876209</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not sampled/dissected</VALIDVALUE>
          <VALUEMEANING>Not sampled/dissected</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: The process of cutting apart or separating tissue as, for example, in the study of anatomy or in the course of a surgical procedure.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15227, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3192095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present - extensive</VALIDVALUE>
          <VALUEMEANING>Present - extensive</VALUEMEANING>
          <MEANINGDESCRIPTION>Large in quantity, range, or spatial extent.: Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626, C47863</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4730371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present - minimal</VALIDVALUE>
          <VALUEMEANING>Present - Minimal</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status._The smallest natural number and quantity it denotes: a single entity, unit, or object._A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch._To increase in length or duration._The dense connective tissue that surrounds a lymph node._The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19151, C33028, C25270, C28251, C66832, C61585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3729231</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unspecified</VALIDVALUE>
          <VALUEMEANING>Unspecified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not stated explicitly or in detail.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38046</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Small thin-walled vessel inva</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Small thin-walled vessel invasion (probably lymphatic)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lymphatic/Small vessel Invasion</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Lymphatic Invasion Present</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lymphatic Invasion Present</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>HCMI Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Lymphatic invasion present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811933</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AVC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7589445</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5806857</PublicId>
          <ContextName>OCG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HCMI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000192</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Lymphatic Invasion</AlternateName>
        <AlternateNameType>TCGA_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lymphatic_invasion</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OCG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OCG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>tumor_lymphatic_invasion</AlternateName>
        <AlternateNameType>HCMI Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1516">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>64510</PUBLICID>
    <LONGNAME>Laboratory Procedure Viable Cell Specimen Outcome Percentage Value</LONGNAME>
    <PREFERREDNAME>LAB_VI_CE_SP_PTG_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>the percentage of viable cells, cells capable of life or normal growth and development, from a bit of tissue or blood or urine that is taken or used for research purposes.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2763998</PublicId>
      <PreferredName>LAB_VIA_CEL_SPEC_OC</PreferredName>
      <PreferredDefinition>information related to the medical procedure that involves testing a sample of blood, urine, or other substance from the body to determine the viability, capable of life or normal growth and development, of the cells, the smallest units of living structure capable of independent existence, from a bit of tissue or blood or urine that is taken or used for research purposes.</PreferredDefinition>
      <LongName>Laboratory Procedure Viable Cell Specimen Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2763996</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25324:C12508:C19157:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Viable Cell Specimen Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25324</PREFERRED_NAME>
            <LONG_NAME>Viable</LONG_NAME>
            <CON_ID>2206271</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12508</PREFERRED_NAME>
            <LONG_NAME>Cell</LONG_NAME>
            <CON_ID>2202900</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019202</PublicId>
      <PreferredName>SPEC_LAB_PTG_VAL</PreferredName>
      <PreferredDefinition>the percentage value for a specimen laboratory finding.</PreferredDefinition>
      <LongName>Specimen Lab Percentage Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208119</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25613:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Percentage Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25613</PREFERRED_NAME>
            <LONG_NAME>Percentage</LONG_NAME>
            <CON_ID>2203724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Percent Cells Viable</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Percent Cells Viable</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cells, Viable Percentage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Percent viable small cell tumor (%):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Percent viable tumor?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Immunophenotype</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811956</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811935</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1517">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>64730</PUBLICID>
    <LONGNAME>Tumor Marker Assessment Specify</LONGNAME>
    <PREFERREDNAME>TMMKR_ASSESS_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>a text field to identify a tumor marker being tested for presence in a sample which is not listed.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2010873</PublicId>
      <PreferredName>TMMKR_ASSESS</PreferredName>
      <PreferredDefinition>information related to examination of a biological sample to detect the (increased) amount of a biomarker in blood, body fluid, or tissue which can indicate presence of a specific type of cancer.</PreferredDefinition>
      <LongName>Tumor Marker Assessment</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443094</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17220</PreferredName>
        <Version>1</Version>
        <LongName>Tumor Marker</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17220</PREFERRED_NAME>
            <LONG_NAME>Tumor Marker</LONG_NAME>
            <CON_ID>2202551</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2261670</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20989</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018806</PublicId>
      <PreferredName>ASSESS_SPEC</PreferredName>
      <PreferredDefinition>The free text field to specify the assessment performed.</PreferredDefinition>
      <LongName>Assessment Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Marker Name Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Assay Type Other Specify</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Assay Type Other Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tumor Markers</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811964</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer DataMart</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811932</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939361</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCTD</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Assay Development</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2939362</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1518">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>64770</PUBLICID>
    <LONGNAME>Pathology Tissue Specimen Stain Cell Classification Specify</LONGNAME>
    <PREFERREDNAME>PA_TI_SP_ST_CE_CL_SP</PREFERREDNAME>
    <PREFERREDDEFINITION>a text field to provide the group or category for a sample of cells with similar characteristics dyed for microscopic assessment of disease by a specialist in tissue and cell function and changes.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2010646</PublicId>
      <PreferredName>PA_TI_SPE_STN_CE_CLA</PreferredName>
      <PreferredDefinition>related to the grouping by category for a sample of cells with similar specialized characteristics dyed for microscopic assessment of disease by a specialist in tissue and cell function and changes.</PreferredDefinition>
      <LongName>Pathology Tissue Specimen Stain Cell Classification</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2488643</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18189:C12801:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Pathology Tissue Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12801</PREFERRED_NAME>
            <LONG_NAME>Tissue</LONG_NAME>
            <CON_ID>2202489</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2488845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C841:C12508:C25161</PreferredName>
        <Version>1</Version>
        <LongName>Stain Cell Classification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C841</PREFERRED_NAME>
            <LONG_NAME>Stain</LONG_NAME>
            <CON_ID>2202830</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12508</PREFERRED_NAME>
            <LONG_NAME>Cell</LONG_NAME>
            <CON_ID>2202900</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25161</PREFERRED_NAME>
            <LONG_NAME>Classification</LONG_NAME>
            <CON_ID>2203879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180669</PublicId>
      <PreferredName>SPEC_CHAR_SPEC</PreferredName>
      <PreferredDefinition>information related to specified characteristics of a specimen.</PreferredDefinition>
      <LongName>Specimen Characteristics Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Stained Cell Type Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tumor Markers</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811964</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811932</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1519">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>64947</PUBLICID>
    <LONGNAME>Prior Limb Perfusion Peformed Specify</LONGNAME>
    <PREFERREDNAME>PRI_LIMBPER_PER_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>a text field to provide details about an isolation limb perfusion procedure completed in the past.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CTEP CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2010164</PublicId>
      <PreferredName>PRIOR_LIMB_PERF_PERF</PreferredName>
      <PreferredDefinition>information related to prior isolation limb perfusion being performed.</PreferredDefinition>
      <LongName>Prior Limb Perfusion Performed</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206801</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C15393</PreferredName>
        <Version>1</Version>
        <LongName>Prior Limb Perfusion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15393</PREFERRED_NAME>
            <LONG_NAME>Isolated Chemotherapeutic Limb Perfusion</LONG_NAME>
            <CON_ID>2202357</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177693</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Performed</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018810</PublicId>
      <PreferredName>TX_SPEC</PreferredName>
      <PreferredDefinition>the free text field related to therapy.</PreferredDefinition>
      <LongName>Therapies Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Yes specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Yes specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior ILP specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811835</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Char.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811919</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Local-Reg Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811927</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1520">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>65102</PUBLICID>
    <LONGNAME>Tumor Relative Position Type</LONGNAME>
    <PREFERREDNAME>TUMOR_RELTV_POS_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the relative position of a tumor as anterior or posterior within an organ (paired or unpaired) or its relative position for any tissue or tumor specimen sampled for analysis.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2192241</PublicId>
      <PreferredName>TUMOR_RELTV_POS</PreferredName>
      <PreferredDefinition>information related to relative tumor position.</PreferredDefinition>
      <LongName>Tumor Relative Position</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176931</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Tumor</PreferredName>
        <Version>1</Version>
        <LongName>Tumor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207783</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21480:C25339</PreferredName>
        <Version>1</Version>
        <LongName>Relative Position</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21480</PREFERRED_NAME>
            <LONG_NAME>Relative</LONG_NAME>
            <CON_ID>2202798</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25339</PREFERRED_NAME>
            <LONG_NAME>Position</LONG_NAME>
            <CON_ID>2203955</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015574</PublicId>
      <PreferredName>TUMOR_RELTV_POS_TP</PreferredName>
      <PreferredDefinition>the relative position of a tumor as anterior or posterior within an organ (paired or unpaired) or its relative position for any tissue or tumor specimen sampled for analysis.</PreferredDefinition>
      <LongName>Tumor Relative Position Type</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior</VALIDVALUE>
          <VALUEMEANING>Anterior</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting the front surface of the body; often used to indicate the position of one structure relative to another.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25231</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Posterior</VALIDVALUE>
          <VALUEMEANING>Posterior</VALUEMEANING>
          <MEANINGDESCRIPTION>Denoting the back surface of the body; at or near the hind end in quadrupeds or toward the spine in primates.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559840</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Anterior or Posterior</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Anterior or Posterior</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Tumor Location Relative Position</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811937</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1521">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2004106</PUBLICID>
    <LONGNAME>Dose Limiting Toxicity Ind</LONGNAME>
    <PREFERREDNAME>DOSE_LIMT_TOX_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Indication (Y or N) of an Adverse event considered to be a dose-limiting toxicity</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2012911</PublicId>
      <PreferredName>DOSE_LIMT_TOX</PreferredName>
      <PreferredDefinition>Toxicity type that makes it impossible to escalate the dosage of a therapy agent/measure.</PreferredDefinition>
      <LongName>Dose Limiting Toxicity</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008573</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206422</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488:CL110648</PreferredName>
        <Version>1</Version>
        <LongName>Dose Limited</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL110648</PREFERRED_NAME>
            <LONG_NAME>Limited</LONG_NAME>
            <CON_ID>2203515</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177313</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Toxicity</PreferredName>
        <Version>1</Version>
        <LongName>Toxicity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C27990</PREFERRED_NAME>
            <LONG_NAME>Toxicity</LONG_NAME>
            <CON_ID>2202546</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017337</PublicId>
      <PreferredName>Y_N_TXT_CD_IND</PreferredName>
      <PreferredDefinition>Response of Y (Yes) or N (No) to a question.</PreferredDefinition>
      <LongName>Yes No Text Code Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234868</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704:C25162:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Text Code Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Y</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Dose-Limiting Toxicity?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Dose-Limiting Toxicity?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Dose Limiting Toxicity Ind</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Optional NCI Standard CRF Question</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>No requirement for inclusion on CRF; use this data element if needed.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Dose Limiting Toxicity (Y/N)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Dose Limiting Toxicity (Y/N)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was the event a dose limiting toxicity (DLT)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did patient experience any dose limiting toxicities during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If yes, Was it due to treatment related toxicity?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If yes,  Was it due to treatment related toxicity?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMSv3.02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811686</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR 2011 Template</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248617</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000677</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UC Irvine</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811716</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Albert Einstein Medical Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UPCC 07403</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812574</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DFMO/Sul Colon III UCI 02_06</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCI 0404</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812578</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke 500</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812580</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DC_0205</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812581</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>P1_CPT_BCNU_RD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Panvec</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812583</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 02452</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812584</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 03058</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812585</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 04251</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Nebraska Med Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812726</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U of Pa Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812727</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>U Washington</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812731</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FES Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812732</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>FMISO Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812733</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AE_104_085</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UNMC 284-04</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812981</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859992</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857175</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Adopter CDEs for Reuse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS 3.12B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812490</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2931931</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Iloprost Trial</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Iloprost 12079</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2931952</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase 1/Pilot Consortium</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3303197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5635300</PublicId>
          <ContextName>NCI Standards</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Case Report Form (CRF) Modules</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000681</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DOSE_LIMT_TOX_IND</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DOSE_LIMT_TOX_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>102007</AlternateName>
        <AlternateNameType>COG GDE #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DsLimitTxyTrp</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AECC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AECC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DOSE_LIMT_TOX_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OHSU Knight</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DOSE_LIMT_TOX_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DOSE_LIMT_TOX_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1522">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2004152</PUBLICID>
    <LONGNAME>Death Date</LONGNAME>
    <PREFERREDNAME>DEATH_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>The actual date of a patient&#39;s/participant&#39;s death.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013084</PublicId>
      <PreferredName>DEATH_DT</PreferredName>
      <PreferredDefinition>A particular day specified as the date of death.</PreferredDefinition>
      <LongName>Death Date</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177148</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Death</PreferredName>
        <Version>1</Version>
        <LongName>Death</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28554</PREFERRED_NAME>
            <LONG_NAME>Dead</LONG_NAME>
            <CON_ID>2202731</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177607</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Date</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017121</PublicId>
      <PreferredName>CTMS_DT</PreferredName>
      <PreferredDefinition>Date as required for Clinical Trials Monitoring Service submissions.  Exchange format is YYYYMMDD.  Display format is DDMMMYYYY, with the month display the first three letters of each month (Jan, Feb, Mar, etc.).</PreferredDefinition>
      <LongName>CTMS Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>DD/MON/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>4</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CCR:Center for Cancer Research</Origin>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Death</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of Death</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Death Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Year of Death</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of Last Contact or Death</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of Last Contact or Death</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NINDS CDE Project</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>NINDS CDE Project</DocumentText>
        <URL>http://www.commondataelements.ninds.nih.gov/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date Format</Name>
        <DocumentType>NOTE</DocumentType>
        <DocumentText>MM/DD/YYYY</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If dead, date of death</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If dead, date of death</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ACRIN 6702</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of death</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If deceased, provide date of death</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of death:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text- 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date of Death</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-Lung-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Death date (MM/DD/YYYY)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What was the subject&#39;s date of death?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMSv3.02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811686</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR 2011 Template</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248617</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Survival</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248648</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms Version 3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2957372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180933</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>LIDC</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>QIN Breast Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6788757</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MediData Rave Use</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3308730</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Protocol 10C0052D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3331757</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UC Irvine</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811716</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Albert Einstein Medical Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DFMO/Sul Colon III UCI 02_06</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812577</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke 500</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812580</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>P1_CPT_BCNU_RD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Panvec</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812583</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 02452</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812584</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi 04251</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AE_104_085</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oregon Health &amp; Sciences University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OHSU_288</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812832</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>St. Joseph Hospital</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813054</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SJO_ERCC1_07035</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813090</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Candidate Reuse</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2992453</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2190530</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Demonstration Applications</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rembrandt</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2812349</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Survival CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3828994</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAMe - Hepatitis C cirrhosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812148</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pancreatic Mucinous Neoplasms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812149</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate - Lycopene</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus - ASA-Esomeprazole</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma Pathobiology - Lovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812157</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Hormone Receptor-Negative Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Safety Study of Resiquimod for Atyical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Effect of Finasteride - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812182</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Atrovastatin in Women at High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812183</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Spectral Markers in ASA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812184</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Se-Methyl-Seleno-L-Cystein (MSC) in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812188</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Pre-prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812189</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Acolbifene - High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812190</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ALA PDT - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812194</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Drug and Carcinogen Enzymes - Resveratrol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812258</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Aminolevulinic Acid - Barrett&#39;s Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Subclinical Neoplastic Lesions</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Bladder Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812539</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>9cUAB30</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EGF Receptor Signaling in ACF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>3, 3-Diindolylmethane Cervical Intraepithelial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812735</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Transdermal 4-OHT vs oral TAM DCIS of the Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812736</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PK and Safety - Novel Retinoid (9cUAB30)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812768</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imiquimod for Atypical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812836</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyethylene Glycol - Colon Carcinogenesis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812843</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Myo-Inositol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812876</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exp. PK Formulations of SR13668</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812998</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac - Increased Risk of Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813002</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ursodeoxycholic Acid - Barrett&#39;s Patients</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2813043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Erlotinib - Lesions of Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2813064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Letrozole - Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2842768</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Sulindac DFMO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2859628</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E in Women w/ Modulation of Arachidonic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2936518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2979172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin Colorectal Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018781</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Resveratrol in Postmenopausal Women</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018782</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSC and L SeMet in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3110219</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cholecalciferol and Genistein</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3114163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Lung Pre-Surgical NSCLC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3152820</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vitamin D - Bioactivity in the Skin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182878</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin - Pre-Prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182879</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barrett&#39;s Esophagus Chemoprevention Metformin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3211792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAB30 in NMSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3293737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pomegranate - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3303133</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2487057</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DESK</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>E-Progress Report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Inactive CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044924</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857175</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Adopter CDEs for Reuse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS 3.12B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812490</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2931931</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Iloprost Trial</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Iloprost 12079</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2931952</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase 1/Pilot Consortium</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3303197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3021954</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Caris Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Caris Registry</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3060676</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3234177</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Patient Outcomes Data System</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PODS Elements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3234178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>End of Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314492</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3314482</PublicId>
          <ContextName>ECOG-ACRIN</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Follow-up</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3314493</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3595692</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Miraca Life Sciences</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Miraca Registry</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3595693</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3835419</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Pharmacovigilance</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>End of Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3835424</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896537</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896538</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4111771</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4188651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261112</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2013-01-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528054</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528056</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-04-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280811</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280812</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280813</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280814</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-04</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280815</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5416571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5441476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5592146</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5598962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5612586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-07-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889176</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2017-09-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889179</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889180</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-08-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889185</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889187</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2017-09-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5981652</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6005698</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6046252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229L</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4272090</PublicId>
          <ContextName>ONC SDC Project</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MedWatch Form FDA 3500A</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Event or Product Problem</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4382694</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4382692</PublicId>
          <ContextName>ONC SDC Project</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MedWatch Form FDA 3500</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Event, Produce Problem or Error</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4394091</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4382692</PublicId>
          <ContextName>ONC SDC Project</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MedWatch Form FDA 3500</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>All Sections</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4940571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4631580</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Exceptional Responder CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exceptional Responder CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4631582</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506111</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Lung</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung-Vanderbilt</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5506169</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506111</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Lung</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5506172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506115</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Imaging</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vanderbilt Image Archive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5983666</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Outcomes and End Points</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3139155</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>End Points</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3139157</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Death Report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3139160</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DEATH_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DEATH_DT</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DEATH_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NCIP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Date of Death</AlternateName>
        <AlternateNameType>NINDS Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CTEP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>10278</AlternateName>
        <AlternateNameType>COG GDE #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DeathDATE</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>DEATH_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SWOG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DEATHDT</AlternateName>
        <AlternateNameType>OID, SWOG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DEATH_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ONC SDC Project</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SDC Pilot Project</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DEATH_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DEATH_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DEATH_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DEATH_DT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>MCL</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>Date of death</AlternateName>
        <AlternateNameType>QIN Breast Study</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>CIP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DTHDAT</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1523">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2005396</PUBLICID>
    <LONGNAME>Metastatic Internal Mammary Sentinel Node Examined Count</LONGNAME>
    <PREFERREDNAME>M_I_MAM_SN_EXM_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>the numeric count of metastatic internal mammary nodes examined.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013853</PublicId>
      <PreferredName>METC_INT_MAM_SN_EXM</PreferredName>
      <PreferredDefinition>information relating to metastatic internal mammary sentinel nodes examined.</PreferredDefinition>
      <LongName>Metastatic Internal Mammary Sentinel Node Examined</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2413366</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14174:C25234:C43595:C12947</PreferredName>
        <Version>1</Version>
        <LongName>Metastatic Internal Mammary Sentinel Node</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14174</PREFERRED_NAME>
            <LONG_NAME>Metastatic</LONG_NAME>
            <CON_ID>2204914</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25234</PREFERRED_NAME>
            <LONG_NAME>Internal</LONG_NAME>
            <CON_ID>2206277</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43595</PREFERRED_NAME>
            <LONG_NAME>Mammary</LONG_NAME>
            <CON_ID>2413347</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12947</PREFERRED_NAME>
            <LONG_NAME>Sentinel Lymph Node</LONG_NAME>
            <CON_ID>2202807</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2330418</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25500</PreferredName>
        <Version>1</Version>
        <LongName>Examined</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25500</PREFERRED_NAME>
            <LONG_NAME>Examined</LONG_NAME>
            <CON_ID>2203928</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018392</PublicId>
      <PreferredName>CT</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of metastatic internal mammary sentinel nodes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1524">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2006422</PUBLICID>
    <LONGNAME>Dose modification start date</LONGNAME>
    <PREFERREDNAME>DOSE_MOD_START_DATE</PREFERREDNAME>
    <PREFERREDDEFINITION>The start date when any dose modifications of an agent were made.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>SPOREs</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014544</PublicId>
      <PreferredName>DOSE_MODIFICATION</PreferredName>
      <PreferredDefinition>Dose Modification</PreferredDefinition>
      <LongName>Dose modification</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008509</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPORES</PreferredName>
        <Version>2.31</Version>
        <LongName>SPOREs</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177152</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Dose</PreferredName>
        <Version>1</Version>
        <LongName>Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177416</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Modification</PreferredName>
        <Version>1</Version>
        <LongName>Modification</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25572</PREFERRED_NAME>
            <LONG_NAME>Modification</LONG_NAME>
            <CON_ID>2203850</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015863</PublicId>
      <PreferredName>DATE</PreferredName>
      <PreferredDefinition>A particular day specified as the time something has, or will, happen.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYYMMDD</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Dose Modification Start Date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Dose Modification Start Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180156</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>NEW CDEs PER STUDY</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Iloprost 01279</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811713</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1525">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2006694</PUBLICID>
    <LONGNAME>Cigarette use freqency</LONGNAME>
    <PREFERREDNAME>CIG_FREQ</PREFERREDNAME>
    <PREFERREDDEFINITION>How regular does the individual smoke cigarettes?</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>SPOREs</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014295</PublicId>
      <PreferredName>CIGARETTE_USE</PreferredName>
      <PreferredDefinition>Cigarette Use</PreferredDefinition>
      <LongName>Cigarette Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177134</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Cigarettes</PreferredName>
        <Version>1</Version>
        <LongName>Cigarettes</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1802</PREFERRED_NAME>
            <LONG_NAME>Cigarette</LONG_NAME>
            <CON_ID>2202497</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177321</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Use</PreferredName>
        <Version>1</Version>
        <LongName>Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018680</PublicId>
      <PreferredName>FREQUENCY</PreferredName>
      <PreferredDefinition>The number of regular recurrences in a given time.</PreferredDefinition>
      <LongName>Frequency Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2480861</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25515:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Frequency Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25515</PREFERRED_NAME>
            <LONG_NAME>Temporal Frequency</LONG_NAME>
            <CON_ID>2202418</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some days</VALIDVALUE>
          <VALUEMEANING>SOME OF THE TIME (1-2 DAYS)</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual experiences or experienced something on some days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C131735</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-03-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561165</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Refused</VALIDVALUE>
          <VALUEMEANING>Refused to answer the question</VALUEMEANING>
          <MEANINGDESCRIPTION>To decline to do, accept, give, or allow something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565806</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daily</VALIDVALUE>
          <VALUEMEANING>Every day</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring or done each day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Weekly</VALIDVALUE>
          <VALUEMEANING>Weekly</VALUEMEANING>
          <MEANINGDESCRIPTION>Every week.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67069</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565647</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monthly</VALIDVALUE>
          <VALUEMEANING>Monthly</VALUEMEANING>
          <MEANINGDESCRIPTION>Every month.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64498</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565648</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yearly</VALIDVALUE>
          <VALUEMEANING>Yearly</VALUEMEANING>
          <MEANINGDESCRIPTION>A frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74924</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565649</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>I NEVER had an erection when I wanted one </VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561555</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How regular does the individu</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How regular does the individual smoke cigarettes?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Do you NOW smoke cigarettes every day, some days or not at all?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2180156</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>NEW CDEs PER STUDY</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Iloprost 01279</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811713</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2931931</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Iloprost Trial</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Iloprost 12079</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2931952</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1526">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2179582</PUBLICID>
    <LONGNAME>Dose Route Text</LONGNAME>
    <PREFERREDNAME>DOSE_ROUTE_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>The text that describe the dosage route.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2012668</PublicId>
      <PreferredName>ACCESS_RTE</PreferredName>
      <PreferredDefinition>An established means of access (for administration of agents, taking vital signs, etc.).</PreferredDefinition>
      <LongName>Access Route</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2635254</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25396</PreferredName>
        <Version>1</Version>
        <LongName>Access</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25396</PREFERRED_NAME>
            <LONG_NAME>Access</LONG_NAME>
            <CON_ID>2203568</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2452898</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25169</PreferredName>
        <Version>1</Version>
        <LongName>Route</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25169</PREFERRED_NAME>
            <LONG_NAME>Route</LONG_NAME>
            <CON_ID>2203782</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2179411</PublicId>
      <PreferredName>DOSE_ROUTE_TXT</PreferredName>
      <PreferredDefinition>All text that describe the dosage route.</PreferredDefinition>
      <LongName>Dose Route Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength>5</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rectal</VALIDVALUE>
          <VALUEMEANING>Rectal</VALUEMEANING>
          <MEANINGDESCRIPTION>Related to the rectum</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565646</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Topical</VALIDVALUE>
          <VALUEMEANING>Topical</VALUEMEANING>
          <MEANINGDESCRIPTION>Topical</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13344</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567782</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intradermal</VALIDVALUE>
          <VALUEMEANING>Intradermal</VALUEMEANING>
          <MEANINGDESCRIPTION>Intradermal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567783</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transdermal</VALIDVALUE>
          <VALUEMEANING>Transdermal</VALUEMEANING>
          <MEANINGDESCRIPTION>Through the skin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28017</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567784</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Orally</VALIDVALUE>
          <VALUEMEANING>Orally</VALUEMEANING>
          <MEANINGDESCRIPTION>Orally</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567785</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Infusion</VALIDVALUE>
          <VALUEMEANING>Infusion</VALUEMEANING>
          <MEANINGDESCRIPTION>Infusion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inhaled</VALIDVALUE>
          <VALUEMEANING>Inhaled</VALUEMEANING>
          <MEANINGDESCRIPTION>Inhaled</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intramuscular</VALIDVALUE>
          <VALUEMEANING>Intramuscular</VALUEMEANING>
          <MEANINGDESCRIPTION>Intramuscular</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C27974</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567788</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Subcutaneous</VALIDVALUE>
          <VALUEMEANING>Subcutaneous</VALUEMEANING>
          <MEANINGDESCRIPTION>Subcutaneous</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13353</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Route</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Route</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SeriousAdverseEvents</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812325</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CSAERS Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812969</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4382692</PublicId>
          <ContextName>ONC SDC Project</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>MedWatch Form FDA 3500</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>All Sections</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>4940571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1527">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2179649</PUBLICID>
    <LONGNAME>Laboratory Test High Range Text</LONGNAME>
    <PREFERREDNAME>LAB_HIGH_RANGE_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>The text that represents the normal high range for a laboratory value.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014832</PublicId>
      <PreferredName>TST_RESULT</PreferredName>
      <PreferredDefinition>the result of a test.</PreferredDefinition>
      <LongName>Test Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176920</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Test</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177339</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Result</PreferredName>
        <Version>1</Version>
        <LongName>Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2179489</PublicId>
      <PreferredName>LAB_HIGH_RANGE_TXT</PreferredName>
      <PreferredDefinition>All text that represents the normal high range for a laboratory value.</PreferredDefinition>
      <LongName>Laboratory Test High Range Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>10,3</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength>3</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Normal Range High</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Normal Range High</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Laboratory Test High Range Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CSAERS Review Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811695</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CSAERS Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812969</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2190530</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Demonstration Applications</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CIAF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812341</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_HIGH_RANGE_TXT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1528">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2179937</PUBLICID>
    <LONGNAME>Patient Relative Family Medical History Type</LONGNAME>
    <PREFERREDNAME>PT_RELTV_FAMMEDHX_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the description of the relationship between a patient and their relative for family medical history.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195354</PublicId>
      <PreferredName>PT_RELTV_FAMMEDHX</PreferredName>
      <PreferredDefinition>information related to the family medical history of a patient&#39;s relative.</PreferredDefinition>
      <LongName>Patient Relative Family Medical History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177068</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Patient</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207266</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21480:C17726</PreferredName>
        <Version>1</Version>
        <LongName>Relative Family History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21480</PREFERRED_NAME>
            <LONG_NAME>Relative</LONG_NAME>
            <CON_ID>2202798</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17726</PREFERRED_NAME>
            <LONG_NAME>Family Medical History</LONG_NAME>
            <CON_ID>2202638</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2179936</PublicId>
      <PreferredName>PT_RELTV_FAM_TP</PreferredName>
      <PreferredDefinition>the description of the relationship between a patient and their relative for family medical history.</PreferredDefinition>
      <LongName>Patient Relative Family Medical History Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mother</VALIDVALUE>
          <VALUEMEANING>Mother</VALUEMEANING>
          <MEANINGDESCRIPTION>Mother; a female parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567344</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>father</VALIDVALUE>
          <VALUEMEANING>Father</VALUEMEANING>
          <MEANINGDESCRIPTION>Father; a male parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>sister</VALIDVALUE>
          <VALUEMEANING>Sister</VALUEMEANING>
          <MEANINGDESCRIPTION>Sister; a female sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>brother</VALIDVALUE>
          <VALUEMEANING>Brother</VALUEMEANING>
          <MEANINGDESCRIPTION>Brother; a male sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>daughter</VALIDVALUE>
          <VALUEMEANING>Daughter</VALUEMEANING>
          <MEANINGDESCRIPTION>Daughter; a female human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>son</VALIDVALUE>
          <VALUEMEANING>Son</VALUEMEANING>
          <MEANINGDESCRIPTION>Son; a male human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567345</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>half-sister (same mother)</VALIDVALUE>
          <VALUEMEANING>half-sister (same mother)</VALUEMEANING>
          <MEANINGDESCRIPTION>half-sister (same mother)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567997</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>half-sister (same father)</VALIDVALUE>
          <VALUEMEANING>half-sister (same father)</VALUEMEANING>
          <MEANINGDESCRIPTION>half-sister (same father)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567998</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>half-brother (same mother)</VALIDVALUE>
          <VALUEMEANING>half-brother (same mother)</VALUEMEANING>
          <MEANINGDESCRIPTION>half-brother (same mother)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567999</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>half-brother (same father)</VALIDVALUE>
          <VALUEMEANING>half-brother (same father)</VALUEMEANING>
          <MEANINGDESCRIPTION>half-brother (same father)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568000</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mother&#39;s mother</VALIDVALUE>
          <VALUEMEANING>mother&#39;s mother</VALUEMEANING>
          <MEANINGDESCRIPTION>mother&#39;s mother</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568001</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mother&#39;s father</VALIDVALUE>
          <VALUEMEANING>mother&#39;s father</VALUEMEANING>
          <MEANINGDESCRIPTION>mother&#39;s father</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568002</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>father&#39;s mother</VALIDVALUE>
          <VALUEMEANING>father&#39;s mother</VALUEMEANING>
          <MEANINGDESCRIPTION>father&#39;s mother</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>father&#39;s father</VALIDVALUE>
          <VALUEMEANING>father&#39;s father</VALUEMEANING>
          <MEANINGDESCRIPTION>father&#39;s father</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568004</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mother&#39;s sister</VALIDVALUE>
          <VALUEMEANING>mother&#39;s sister</VALUEMEANING>
          <MEANINGDESCRIPTION>mother&#39;s sister</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568005</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mother&#39;s brother</VALIDVALUE>
          <VALUEMEANING>mother&#39;s brother</VALUEMEANING>
          <MEANINGDESCRIPTION>mother&#39;s brother</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>father&#39;s sister</VALIDVALUE>
          <VALUEMEANING>father&#39;s sister</VALUEMEANING>
          <MEANINGDESCRIPTION>father&#39;s sister</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568007</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>father&#39;s brother</VALIDVALUE>
          <VALUEMEANING>father&#39;s brother</VALUEMEANING>
          <MEANINGDESCRIPTION>father&#39;s brother</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568008</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>niece</VALIDVALUE>
          <VALUEMEANING>niece</VALUEMEANING>
          <MEANINGDESCRIPTION>niece</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568009</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nephew</VALIDVALUE>
          <VALUEMEANING>nephew</VALUEMEANING>
          <MEANINGDESCRIPTION>nephew</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568010</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cousin</VALIDVALUE>
          <VALUEMEANING>cousin</VALUEMEANING>
          <MEANINGDESCRIPTION>A child of your aunt or uncle or their descendents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568011</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grandchild-female</VALIDVALUE>
          <VALUEMEANING>Grandchild-female</VALUEMEANING>
          <MEANINGDESCRIPTION>Grandchild-female</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046819</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grandchild-male</VALIDVALUE>
          <VALUEMEANING>Grandchild-male</VALUEMEANING>
          <MEANINGDESCRIPTION>Grandchild-male</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046820</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cousin-maternal female</VALIDVALUE>
          <VALUEMEANING>Cousin-maternal female</VALUEMEANING>
          <MEANINGDESCRIPTION>Cousin-maternal female</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046821</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cousin-paternal female</VALIDVALUE>
          <VALUEMEANING>Cousin-paternal female</VALUEMEANING>
          <MEANINGDESCRIPTION>Cousin-paternal female</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046822</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cousin-maternal male</VALIDVALUE>
          <VALUEMEANING>Cousin-maternal male</VALUEMEANING>
          <MEANINGDESCRIPTION>Cousin-maternal male</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046823</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cousin-paternal male</VALIDVALUE>
          <VALUEMEANING>Cousin-paternal male</VALUEMEANING>
          <MEANINGDESCRIPTION>Cousin-paternal male</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046824</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uncle-maternal</VALIDVALUE>
          <VALUEMEANING>Uncle-maternal</VALUEMEANING>
          <MEANINGDESCRIPTION>Uncle-maternal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uncle-paternal</VALIDVALUE>
          <VALUEMEANING>Uncle-paternal</VALUEMEANING>
          <MEANINGDESCRIPTION>Uncle-paternal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aunt-maternal</VALIDVALUE>
          <VALUEMEANING>Aunt-maternal</VALUEMEANING>
          <MEANINGDESCRIPTION>Aunt-maternal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aunt-paternal</VALIDVALUE>
          <VALUEMEANING>Aunt-paternal</VALUEMEANING>
          <MEANINGDESCRIPTION>Aunt-paternal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046828</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grandfather-maternal</VALIDVALUE>
          <VALUEMEANING>Grandfather-maternal</VALUEMEANING>
          <MEANINGDESCRIPTION>Grandfather-maternal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046829</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grandfather-paternal</VALIDVALUE>
          <VALUEMEANING>Grandfather-paternal</VALUEMEANING>
          <MEANINGDESCRIPTION>Grandfather-paternal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046830</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grandmother-maternal</VALIDVALUE>
          <VALUEMEANING>Grandmother-maternal</VALUEMEANING>
          <MEANINGDESCRIPTION>Grandmother-maternal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grandmother-paternal</VALIDVALUE>
          <VALUEMEANING>Grandmother-paternal</VALUEMEANING>
          <MEANINGDESCRIPTION>Grandmother-paternal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046832</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>child-female</VALIDVALUE>
          <VALUEMEANING>child-female</VALUEMEANING>
          <MEANINGDESCRIPTION>child-female</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046833</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Child-male</VALIDVALUE>
          <VALUEMEANING>Child-male</VALUEMEANING>
          <MEANINGDESCRIPTION>Child-male</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5046834</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unrelated</VALIDVALUE>
          <VALUEMEANING>Unrelated</VALUEMEANING>
          <MEANINGDESCRIPTION>Not connected or associated e.g. by kinship.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25328</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5284031</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Relationship to you</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Relationship to you</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF_Text_2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Relative type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811912</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Char.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3194026</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>KAI Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812550</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3194026</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>KAI Research</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Family History</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000379</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1529">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2180266</PUBLICID>
    <LONGNAME>Uncertain Complete Response Non-Hodgkin Lymphoma Observed Date</LONGNAME>
    <PREFERREDNAME>UNC_CR_NHL_OBS_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date on which all criteria for complete response uncertain for non-Hodgkin&#39;s lymphoma were first reported in a patient&#39;s medical records.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195511</PublicId>
      <PreferredName>UNCERT_CR_NHL_OBS</PreferredName>
      <PreferredDefinition>information related to the observed uncertain complete response of a Non-Hodgkin&#39;s lymphoma.</PreferredDefinition>
      <LongName>Uncertain Complete Response Non-Hodgkin&#39;s Lymphoma Observed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2660583</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47944:C0677874</PreferredName>
        <Version>1</Version>
        <LongName>Uncertain Complete Remission</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47944</PREFERRED_NAME>
            <LONG_NAME>Uncertain</LONG_NAME>
            <CON_ID>2342198</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0677874</PREFERRED_NAME>
            <LONG_NAME>Complete Remission</LONG_NAME>
            <CON_ID>2203247</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660817</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3211:C25599</PreferredName>
        <Version>1</Version>
        <LongName>Non-Hodgkin&#39;s Lymphoma Observed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3211</PREFERRED_NAME>
            <LONG_NAME>Non-Hodgkin Lymphoma</LONG_NAME>
            <CON_ID>2205428</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25599</PREFERRED_NAME>
            <LONG_NAME>Observed</LONG_NAME>
            <CON_ID>2203942</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Complete Response uncertain (CRu) First Observed Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Response</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1530">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2180321</PUBLICID>
    <LONGNAME>Transplant Neutrophil Lab Declining Ind-3</LONGNAME>
    <PREFERREDNAME>TSPL_NEU_LAB_DEC_IN3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator to ask if a patient in a transplant study experienced a reduction in number of neutrophils in their blood after transplant based on a laboratory result of less than 500 cells.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195596</PublicId>
      <PreferredName>TSPL_NEUTROPHIL_LAB</PreferredName>
      <PreferredDefinition>information related to the neutrophil lab following transplant.</PreferredDefinition>
      <LongName>Transplant Neutrophil Lab</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176929</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Transplant</PreferredName>
        <Version>1</Version>
        <LongName>Transplant</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207416</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12533:C37984</PreferredName>
        <Version>1</Version>
        <LongName>Neutrophil Laboratory</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12533</PREFERRED_NAME>
            <LONG_NAME>Neutrophil</LONG_NAME>
            <CON_ID>2206322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37984</PREFERRED_NAME>
            <LONG_NAME>Laboratory</LONG_NAME>
            <CON_ID>2202883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did absolute neutrophil count</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did absolute neutrophil count (ANC) fall below 500 following therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text_1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient have any periods of neutropenia (ANC&lt; 500) during the Study period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text_02</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient&#39;s absolute neutrophil count (ANC) fall below 500/µL post infusion?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Amyloidosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Waldenstrom Macrogl</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Hodgkin&#39;s Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811943</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NonHodgkins Lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811944</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPRS_QVAL_ANCBEL500</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1531">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2181940</PUBLICID>
    <LONGNAME>Malignant Disease Other Present Specify</LONGNAME>
    <PREFERREDNAME>MAL_DZ_O_PRES_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to list specific other malignancies that the patient may report.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>Brain CDE Disease Committee</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2192224</PublicId>
      <PreferredName>MAL_DZ_OTHER_PRES</PreferredName>
      <PreferredDefinition>information related to other malignant disease being present.</PreferredDefinition>
      <LongName>Malignant Disease Other Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206619</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14143:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Malignant Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14143</PREFERRED_NAME>
            <LONG_NAME>Malignant</LONG_NAME>
            <CON_ID>2203843</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207556</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Other Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018432</PublicId>
      <PreferredName>DX_SPEC</PreferredName>
      <PreferredDefinition>the specified free-text field related to an aspect of patient/participant&#39;s diagnosis</PreferredDefinition>
      <LongName>Diagnosis Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other malignancies specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other malignancies specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811886</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811889</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812013</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain Recurr</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metastatic Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812015</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1532">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2182813</PUBLICID>
    <LONGNAME>Modified Dose Amount</LONGNAME>
    <PREFERREDNAME>AGT_MOD_DOSE</PREFERREDNAME>
    <PREFERREDDEFINITION>The text that describes the new dose of the agent.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2179317</PublicId>
      <PreferredName>MOD_DOSE_AMT</PreferredName>
      <PreferredDefinition>Modified Dose Amount.</PreferredDefinition>
      <LongName>Modified Dose Amount</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2931562</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446:C25488</PreferredName>
        <Version>1</Version>
        <LongName>Change Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2182816</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Amount</PreferredName>
        <Version>1</Version>
        <LongName>Amount</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25417</PREFERRED_NAME>
            <LONG_NAME>Amount</LONG_NAME>
            <CON_ID>2202462</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2182726</PublicId>
      <PreferredName>AGT_DOSE</PreferredName>
      <PreferredDefinition>The amount of agent taken at one time.</PreferredDefinition>
      <LongName>Agent Dose</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008514</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>DCP</PreferredName>
        <Version>1</Version>
        <LongName>DCP Conceptual Domain</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>10</MaximumLength>
      <MinimumLength>3</MinimumLength>
      <DecimalPlace>4</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2432127</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488</PreferredName>
        <Version>1</Version>
        <LongName>Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify new regimen dose</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify new regimen dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>New Regimen Dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>New dose</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2811734</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms Version 3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2957372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Budesonide Lung Nodules</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812102</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAMe - Hepatitis C cirrhosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812148</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pancreatic Mucinous Neoplasms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812149</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate - Lycopene</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus - ASA-Esomeprazole</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Sulindac</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sporadic Colorectal Neoplasia - Atrovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812155</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma Pathobiology - Lovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812157</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Hormone Receptor-Negative Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Effect of Finasteride - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812182</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Atrovastatin in Women at High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812183</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Spectral Markers in ASA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812184</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Se-Methyl-Seleno-L-Cystein (MSC) in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812188</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DIM - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812202</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812364</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812377</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E for Cervical Ca</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812399</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812415</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Unconjugated Isoflavones in Women at High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Subclinical Neoplastic Lesions</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Bladder Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812539</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>9cUAB30</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EGF Receptor Signaling in ACF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyethylene Glycol - Colon Carcinogenesis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812843</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Myo-Inositol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812876</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812998</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ursodeoxycholic Acid - Barrett&#39;s Patients</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2813043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Letrozole - Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2842768</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E in Women w/ Modulation of Arachidonic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2936518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2979172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin Colorectal Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018781</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSC and L SeMet in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3110219</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cholecalciferol and Genistein</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3114163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vitamin D - Bioactivity in the Skin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182878</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin - Pre-Prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182879</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barrett&#39;s Esophagus Chemoprevention Metformin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3211792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAB30 in NMSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3293737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pomegranate - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3303133</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896537</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896538</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4111771</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528056</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889187</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1533">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2183254</PUBLICID>
    <LONGNAME>Alpha DVG Lab Result</LONGNAME>
    <PREFERREDNAME>ALPHA_DVG_LAB_RSLT</PREFERREDNAME>
    <PREFERREDDEFINITION>Oracle&#39;s Discrete Value Group (DVG) for not obtained lab results.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2181673</PublicId>
      <PreferredName>ALPHA_DVG_NOT_OBTAINED_IND</PreferredName>
      <PreferredDefinition>The DEC of the Alpha DVG Not Obtained Indicator.</PreferredDefinition>
      <LongName>Alpha DVG Not Obtained Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008583</PublicId>
        <ContextName>EDRN</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>RESPONSE</PreferredName>
        <Version>1</Version>
        <LongName>Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236773</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25209</PreferredName>
        <Version>1</Version>
        <LongName>Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2415348</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2183252</PublicId>
      <PreferredName>ALPHA_DVG_LAB_RSLT</PreferredName>
      <PreferredDefinition>Oracle&#39;s Discrete Value Group (DVG) for not obtained lab results.</PreferredDefinition>
      <LongName>Alpha DVG Lab Result</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008514</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>DCP</PreferredName>
        <Version>1</Version>
        <LongName>DCP Conceptual Domain</LongName>
      </ConceptualDomain>
      <Datatype>Numeric Alpha DVG</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>12</MaximumLength>
      <MinimumLength>12</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2476191</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20200</PreferredName>
        <Version>1</Version>
        <LongName>Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Obtained</VALIDVALUE>
          <VALUEMEANING>Not Obtained</VALUEMEANING>
          <MEANINGDESCRIPTION>Not Obtained</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alpha DVG Lab Result Value</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Alpha DVG Lab Result Value</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2811734</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms Version 3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2957372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Budesonide Lung Nodules</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812102</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAMe - Hepatitis C cirrhosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812148</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pancreatic Mucinous Neoplasms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812149</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate - Lycopene</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus - ASA-Esomeprazole</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Sulindac</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sporadic Colorectal Neoplasia - Atrovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812155</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma Pathobiology - Lovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812157</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Hormone Receptor-Negative Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Safety Study of Resiquimod for Atyical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Atrovastatin in Women at High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812183</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Se-Methyl-Seleno-L-Cystein (MSC) in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812188</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Pre-prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812189</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Acolbifene - High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812190</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ALA PDT - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812194</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Resiquimod - Atypical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DIM - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812202</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Drug and Carcinogen Enzymes - Resveratrol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812258</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Aminolevulinic Acid - Barrett&#39;s Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812364</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812377</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812388</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E for Cervical Ca</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812399</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812415</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Subclinical Neoplastic Lesions</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Bladder Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812539</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>9cUAB30</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EGF Receptor Signaling in ACF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>3, 3-Diindolylmethane Cervical Intraepithelial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812735</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Transdermal 4-OHT vs oral TAM DCIS of the Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812736</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PK and Safety - Novel Retinoid (9cUAB30)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812768</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imiquimod for Atypical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812836</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyethylene Glycol - Colon Carcinogenesis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812843</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Myo-Inositol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812876</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exp. PK Formulations of SR13668</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812998</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac - Increased Risk of Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813002</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ursodeoxycholic Acid - Barrett&#39;s Patients</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2813043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Erlotinib - Lesions of Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2813064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Letrozole - Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2842768</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Sulindac DFMO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2859628</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E in Women w/ Modulation of Arachidonic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2936518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin Colorectal Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018781</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Resveratrol in Postmenopausal Women</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018782</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSC and L SeMet in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3110219</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cholecalciferol and Genistein</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3114163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Lung Pre-Surgical NSCLC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3152820</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vitamin D - Bioactivity in the Skin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182878</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin - Pre-Prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182879</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barrett&#39;s Esophagus Chemoprevention Metformin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3211792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAB30 in NMSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3293737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pomegranate - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3303133</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <DerivationType>COMPOUND</DerivationType>
      <DerivationTypeDescription>COMPOUND</DerivationTypeDescription>
      <Methods/>
      <Rule>Combines Alpha DVG Lab Result 2183254 with Not Obtained Indicator 2182879 that could be used for Oracle Clinical.</Rule>
      <ConcatenationCharacter/>
      <ComponentDataElementList>
        <ComponentDataElementList_ITEM>
          <PublicId>2183254</PublicId>
          <LongName>Alpha DVG Lab Result</LongName>
          <PreferredName>ALPHA_DVG_LAB_RSLT</PreferredName>
          <PreferredDefinition>Oracle&#39;s Discrete Value Group (DVG) for not obtained lab results.</PreferredDefinition>
          <Version>2</Version>
          <WorkflowStatus>RELEASED</WorkflowStatus>
          <ContextName>DCP</ContextName>
          <DisplayOrder>1</DisplayOrder>
        </ComponentDataElementList_ITEM>
        <ComponentDataElementList_ITEM>
          <PublicId>2182879</PublicId>
          <LongName>Not Obtained Indicator</LongName>
          <PreferredName>NOT_OBTAINED_IND</PreferredName>
          <PreferredDefinition>The indicator that represents that a specific test, exam, or specimen was not obtained, not examined, not applicable, unknown or not required, etc.</PreferredDefinition>
          <Version>1</Version>
          <WorkflowStatus>RELEASED</WorkflowStatus>
          <ContextName>DCP</ContextName>
          <DisplayOrder>2</DisplayOrder>
        </ComponentDataElementList_ITEM>
      </ComponentDataElementList>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1534">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2183254</PUBLICID>
    <LONGNAME>Alpha DVG Lab Result</LONGNAME>
    <PREFERREDNAME>ALPHA_DVG_LAB_RSLT</PREFERREDNAME>
    <PREFERREDDEFINITION>Oracle&#39;s Discrete Value Group (DVG) for not obtained lab results.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2181673</PublicId>
      <PreferredName>ALPHA_DVG_NOT_OBTAINED_IND</PreferredName>
      <PreferredDefinition>The DEC of the Alpha DVG Not Obtained Indicator.</PreferredDefinition>
      <LongName>Alpha DVG Not Obtained Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008583</PublicId>
        <ContextName>EDRN</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>RESPONSE</PreferredName>
        <Version>1</Version>
        <LongName>Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236773</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25209</PreferredName>
        <Version>1</Version>
        <LongName>Measurement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2415348</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2183252</PublicId>
      <PreferredName>ALPHA_DVG_LAB_RSLT</PreferredName>
      <PreferredDefinition>Oracle&#39;s Discrete Value Group (DVG) for not obtained lab results.</PreferredDefinition>
      <LongName>Alpha DVG Lab Result</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008514</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>DCP</PreferredName>
        <Version>1</Version>
        <LongName>DCP Conceptual Domain</LongName>
      </ConceptualDomain>
      <Datatype>Numeric Alpha DVG</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>12</MaximumLength>
      <MinimumLength>12</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2476191</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20200</PreferredName>
        <Version>1</Version>
        <LongName>Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Obtained</VALIDVALUE>
          <VALUEMEANING>Not Obtained</VALUEMEANING>
          <MEANINGDESCRIPTION>Not Obtained</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alpha DVG Lab Result Value</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Alpha DVG Lab Result Value</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2811734</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms Version 3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2957372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Budesonide Lung Nodules</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812102</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAMe - Hepatitis C cirrhosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812148</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pancreatic Mucinous Neoplasms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812149</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate - Lycopene</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus - ASA-Esomeprazole</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Sulindac</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sporadic Colorectal Neoplasia - Atrovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812155</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma Pathobiology - Lovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812157</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Hormone Receptor-Negative Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Safety Study of Resiquimod for Atyical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Atrovastatin in Women at High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812183</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Se-Methyl-Seleno-L-Cystein (MSC) in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812188</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Pre-prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812189</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Acolbifene - High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812190</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ALA PDT - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812194</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Resiquimod - Atypical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DIM - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812202</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Drug and Carcinogen Enzymes - Resveratrol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812258</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Aminolevulinic Acid - Barrett&#39;s Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812364</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812377</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812388</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E for Cervical Ca</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812399</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812415</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Subclinical Neoplastic Lesions</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Bladder Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812539</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>9cUAB30</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EGF Receptor Signaling in ACF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>3, 3-Diindolylmethane Cervical Intraepithelial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812735</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Transdermal 4-OHT vs oral TAM DCIS of the Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812736</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PK and Safety - Novel Retinoid (9cUAB30)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812768</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imiquimod for Atypical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812836</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyethylene Glycol - Colon Carcinogenesis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812843</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Myo-Inositol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812876</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exp. PK Formulations of SR13668</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812998</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac - Increased Risk of Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813002</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ursodeoxycholic Acid - Barrett&#39;s Patients</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2813043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Erlotinib - Lesions of Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2813064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Letrozole - Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2842768</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Sulindac DFMO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2859628</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E in Women w/ Modulation of Arachidonic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2936518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin Colorectal Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018781</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Resveratrol in Postmenopausal Women</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018782</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSC and L SeMet in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3110219</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cholecalciferol and Genistein</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3114163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Lung Pre-Surgical NSCLC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3152820</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vitamin D - Bioactivity in the Skin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182878</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin - Pre-Prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182879</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barrett&#39;s Esophagus Chemoprevention Metformin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3211792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAB30 in NMSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3293737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pomegranate - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3303133</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <DerivationType>COMPOUND</DerivationType>
      <DerivationTypeDescription>COMPOUND</DerivationTypeDescription>
      <Methods/>
      <Rule>Combines Alpha DVG Lab Result 2183254 with Not Obtained Indicator 2182879 that could be used for Oracle Clinical.</Rule>
      <ConcatenationCharacter/>
      <ComponentDataElementList>
        <ComponentDataElementList_ITEM>
          <PublicId>2183254</PublicId>
          <LongName>Alpha DVG Lab Result</LongName>
          <PreferredName>ALPHA_DVG_LAB_RSLT</PreferredName>
          <PreferredDefinition>Oracle&#39;s Discrete Value Group (DVG) for not obtained lab results.</PreferredDefinition>
          <Version>2</Version>
          <WorkflowStatus>RELEASED</WorkflowStatus>
          <ContextName>DCP</ContextName>
          <DisplayOrder>1</DisplayOrder>
        </ComponentDataElementList_ITEM>
        <ComponentDataElementList_ITEM>
          <PublicId>2182879</PublicId>
          <LongName>Not Obtained Indicator</LongName>
          <PreferredName>NOT_OBTAINED_IND</PreferredName>
          <PreferredDefinition>The indicator that represents that a specific test, exam, or specimen was not obtained, not examined, not applicable, unknown or not required, etc.</PreferredDefinition>
          <Version>1</Version>
          <WorkflowStatus>RELEASED</WorkflowStatus>
          <ContextName>DCP</ContextName>
          <DisplayOrder>2</DisplayOrder>
        </ComponentDataElementList_ITEM>
      </ComponentDataElementList>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1535">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2182879</PUBLICID>
    <LONGNAME>Not Obtained Indicator</LONGNAME>
    <PREFERREDNAME>NOT_OBTAINED_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that represents that a specific test, exam, or specimen was not obtained, not examined, not applicable, unknown or not required, etc.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2192291</PublicId>
      <PreferredName>NOT_OBTAINED_IND</PreferredName>
      <PreferredDefinition>Indicator for Not Obtained.</PreferredDefinition>
      <LongName>Not Obtained Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008583</PublicId>
        <ContextName>EDRN</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>RESPONSE</PreferredName>
        <Version>1</Version>
        <LongName>Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2660637</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL310460:CL052458</PreferredName>
        <Version>1</Version>
        <LongName>Obtained Not</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL310460</PREFERRED_NAME>
            <LONG_NAME>Obtained</LONG_NAME>
            <CON_ID>2204520</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL052458</PREFERRED_NAME>
            <LONG_NAME>Not</LONG_NAME>
            <CON_ID>2203520</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2415348</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2182877</PublicId>
      <PreferredName>NOT_OBTND_EXAM_APP_U</PreferredName>
      <PreferredDefinition>The indicator that represents that a specific laboratory test, physical exam, or specimen was not obtained.</PreferredDefinition>
      <LongName>Not Obtained, Examined, Applicable or Unknown Indicator</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008573</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>14</MaximumLength>
      <MinimumLength>7</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2192923</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0021212</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0021212</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2203101</CON_ID>
            <DEFINITION_SOURCE>NCI; National Cancer Institute Thesaurus. September 2003</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Obtained</VALIDVALUE>
          <VALUEMEANING>Not Obtained</VALUEMEANING>
          <MEANINGDESCRIPTION>Not Obtained</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569006</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Examined</VALIDVALUE>
          <VALUEMEANING>Not Examined</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Examined; having been subjected to an examination.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25500, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569132</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unk</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-05-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Required</VALIDVALUE>
          <VALUEMEANING>Not Required</VALUEMEANING>
          <MEANINGDESCRIPTION>Not Required</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-09-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>NOT DONE</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Don&#39;t Know</VALIDVALUE>
          <VALUEMEANING>Don&#39;t know</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-06-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>not present</VALIDVALUE>
          <VALUEMEANING>Not Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Value is not present in a message. This is only defined in messages, never in application data! All values not present in the message must be replaced by the applicable default, or no-information (NI) as the default of all defaults.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1549059</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-10-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581130</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Available</VALIDVALUE>
          <VALUEMEANING>Not Available</VALUEMEANING>
          <MEANINGDESCRIPTION>Information regarding the subject is unknown or inaccessible at this time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562605</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Detected</VALIDVALUE>
          <VALUEMEANING>Not Detected</VALUEMEANING>
          <MEANINGDESCRIPTION>Not Detected</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2880402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Reported</VALIDVALUE>
          <VALUEMEANING>Not Stated</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2964573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Not Obtained</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Unknown</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Unknown</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Reason information not provided</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason information not provided</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Not Applicable</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Agent End Date Not Applicable</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date on Follow-up Not Applicable</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Date Off Follow-up Not Applicable</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>PR Status % Not Applicable</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was lab specimen collected?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-11</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Age at First Live Birth</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Not Obtained Indicator</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-13</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Examination not done</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-14</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Time Assessed not obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-15</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Height not obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Systolic Blood Pressure Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-8</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Diastolic Blood Pressure Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-19</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Temp Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-12</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Check here if NO body systems were examined</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-18</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Respiration Rate Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-20</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Temperature not obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-21</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Pulse not obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-22</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Unknown/Not specified</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-9</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior Annual Mammogram</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-10</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Age at Menarche</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-16</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Weight not obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-17</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Pulse Rate Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-24</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Unknown amount of agent taken this period (tabs)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-23</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Unknown number of interruptions</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-32</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Age at Menopause</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-33</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Age at First Live Birth</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-34</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Quadrant Biopsy Collection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-26</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>On Follow-up</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-28</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Second Recurrent Disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-30</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>No body systems were examined</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-31</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Check here if NO Body systems were examined</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-27</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Off Follow-up</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-29</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>HER2 (IHC)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-25</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Randomization</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-39</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Pulse Rate Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-40</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Karnofsky Performance Status Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-36</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Biopsy Consent (N/A)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-38</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>BMI not obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-35</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Telephone Consent (N/A)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-41</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Not Done</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-37</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>NO body systems were examined</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-46</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Enrollment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-44</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Agent Modification</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-45</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Agent Interruption</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-43</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Registration</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-47</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Location matched pre-enrollment and prostatectomy tumor(s)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-42</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Blood Pressure Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-49</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Contact Time</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-51</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Screen 1</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-52</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Screen 2</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-50</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Not on Study Intervention</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-48</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Time Assessed not obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-53</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Check here if no results were obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-54</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Not Reported</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-58</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Second Recurrent Disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-55</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Check here if Specimen was Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-61</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Weight Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-57</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Check here if not obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-62</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Check here if Width is unknown</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-60</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of Positive Lymph Nodes Not Applicable</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-59</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of Lymph Nodes Removed Not Applicable</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-56</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Check here if Contact Time is Unknown</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-63</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>NO Body Systems Were Examined</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-65</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>ECOG Performance Status Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-64</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Temperature Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP CRF TEXT 66</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Performance Status Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-67</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Body Mass Index (BMI) Not Obtained</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-68</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Check Here if Time Specimen Collected is Unknown</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CSAERS Review Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811695</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2811734</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SeriousAdverseEvents</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812325</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms Version 3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2957372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Budesonide Lung Nodules</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812102</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SAMe - Hepatitis C cirrhosis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812148</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pancreatic Mucinous Neoplasms</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812149</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate - Lycopene</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812151</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus - ASA-Esomeprazole</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Sulindac</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sporadic Colorectal Neoplasia - Atrovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812155</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Melanoma Pathobiology - Lovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812157</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Hormone Receptor-Negative Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Safety Study of Resiquimod for Atyical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Effect of Finasteride - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812182</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Atrovastatin in Women at High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812183</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Spectral Markers in ASA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812184</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Se-Methyl-Seleno-L-Cystein (MSC) in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812188</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Pre-prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812189</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Acolbifene - High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812190</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ALA PDT - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812194</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Resiquimod - Atypical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812197</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DIM - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812202</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Drug and Carcinogen Enzymes - Resveratrol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812258</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Aminolevulinic Acid - Barrett&#39;s Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812277</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812364</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812377</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812388</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E for Cervical Ca</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812399</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812415</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Unconjugated Isoflavones in Women at High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Subclinical Neoplastic Lesions</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Bladder Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812539</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>9cUAB30</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>EGF Receptor Signaling in ACF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>3, 3-Diindolylmethane Cervical Intraepithelial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812735</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Transdermal 4-OHT vs oral TAM DCIS of the Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812736</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PK and Safety - Novel Retinoid (9cUAB30)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812768</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imiquimod for Atypical Nevi</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812836</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyethylene Glycol - Colon Carcinogenesis</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812843</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Myo-Inositol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812876</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exp. PK Formulations of SR13668</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812998</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac - Increased Risk of Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813002</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ursodeoxycholic Acid - Barrett&#39;s Patients</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2813043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Erlotinib - Lesions of Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2813064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Letrozole - Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2842768</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Sulindac DFMO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2859628</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E in Women w/ Modulation of Arachidonic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2936518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2979172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin Colorectal Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018781</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Resveratrol in Postmenopausal Women</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018782</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MSC and L SeMet in Adult Men</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3110219</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cholecalciferol and Genistein</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3114163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Lung Pre-Surgical NSCLC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3152820</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Vitamin D - Bioactivity in the Skin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182878</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Metformin - Pre-Prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3182879</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barrett&#39;s Esophagus Chemoprevention Metformin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3211792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAB30 in NMSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3293737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pomegranate - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3303133</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939361</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCTD</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Immunohistochemical Biomarker</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Template Type</ClassificationSchemeItemType>
        <CsiPublicId>3165540</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896537</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896538</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-00-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4111771</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4188651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261112</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261411</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528056</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280816</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280817</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5416571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5441476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5592146</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5598962</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5612586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-07-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889176</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889177</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2017-09-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889178</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2016-08-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889185</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5889187</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2017-09-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5981652</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2017-09-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6005698</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2016-08-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6046252</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NOT_OBTAINED_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1536">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2183402</PUBLICID>
    <LONGNAME>Abdominal Tumor Perforation Ind-2</LONGNAME>
    <PREFERREDNAME>ABD_TUM_PERFORA_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether or not the tumor shows evidence of perforation in the patient&#39;s abdomen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014559</PublicId>
      <PreferredName>TUMOR_PERF</PreferredName>
      <PreferredDefinition>the perforation of the tumor.</PreferredDefinition>
      <LongName>Tumor Perforation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176931</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Tumor</PreferredName>
        <Version>1</Version>
        <LongName>Tumor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177445</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Perforation</PreferredName>
        <Version>1</Version>
        <LongName>Perforation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4080</PREFERRED_NAME>
            <LONG_NAME>Perforation</LONG_NAME>
            <CON_ID>2203944</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the tumor demonstrate &quot;fr</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did the tumor demonstrate &quot;free&quot; perforation as manifested by free air or free fluid in the abdomen?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Perforation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1537">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2183494</PUBLICID>
    <LONGNAME>Transplant Received Day Number</LONGNAME>
    <PREFERREDNAME>TSPL_RECD_DAY_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Number of days lapsed since receipt of transplant (marrow or cells) infusion.  </PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014635</PublicId>
      <PreferredName>TSPL_RECD</PreferredName>
      <PreferredDefinition>information related to receiving a healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body.</PreferredDefinition>
      <LongName>Transplant Received</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512833</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12981</PreferredName>
        <Version>1</Version>
        <LongName>Graft</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12981</PREFERRED_NAME>
            <LONG_NAME>Graft</LONG_NAME>
            <CON_ID>2202844</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241679</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25639</PreferredName>
        <Version>1</Version>
        <LongName>Received</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178476</PublicId>
      <PreferredName>CRSE_DAY_NUM</PreferredName>
      <PreferredDefinition>The day within a particular course (cycle) of intervention/therapy that a particular event occurred.</PreferredDefinition>
      <LongName>Course Day Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2177868</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Number</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Days Post Transplant</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Days Post Transplant</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF TEXT1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Transplant Received Day Number</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR 2011 Template</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248617</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Chimerism</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3248621</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857175</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Adopter CDEs for Reuse</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS 3.12B</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812490</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TSPL_RECD_DAY_NUM</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1538">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2188251</PUBLICID>
    <LONGNAME>Dose Modification Reason Specify</LONGNAME>
    <PREFERREDNAME>DOSE_MOD_RSN_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify a reason related to dose modification.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2184763</PublicId>
      <PreferredName>2411801v1.00:2239855v1.00</PreferredName>
      <PreferredDefinition>A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.:The act of alteration or modification; changed or altered in form or character.</PreferredDefinition>
      <LongName>Dose Change</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2411801</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488</PreferredName>
        <Version>1</Version>
        <LongName>Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239855</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446</PreferredName>
        <Version>1</Version>
        <LongName>Change</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2019106</PublicId>
      <PreferredName>TX_OTX_RSN_SPEC</PreferredName>
      <PreferredDefinition>the free text field to specify a reason or event that caused a patient to be removed from a clinical protocol.</PreferredDefinition>
      <LongName>Treatment Off-Treatment Reason Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008554</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_OTX_RSNS</PreferredName>
        <Version>1</Version>
        <LongName>Treatment/Off-treatment Reasons</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If dose modification reason =</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If dose modification reason = 99, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRFText2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If Other, specify:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If other, please specify the reason for dose modification:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Muscle Invasive Blad</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000462</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1308</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104933</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1216</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104934</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1221</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104935</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1306</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104937</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0848</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171060</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DOSE_MOD_RSN_SPEC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DOSE_MOD_RSN_SPEC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1539">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2194486</PUBLICID>
    <LONGNAME>No Smoking History Ind-2</LONGNAME>
    <PREFERREDNAME>NO_SMK_HX_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether a patient/participant has no history of smoking.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2194483</PublicId>
      <PreferredName>NO_SMK_HX</PreferredName>
      <PreferredDefinition>information related to no smoking history.</PreferredDefinition>
      <LongName>No Smoking History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2660531</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49487:C17934</PreferredName>
        <Version>1</Version>
        <LongName>No Smoking</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17934</PREFERRED_NAME>
            <LONG_NAME>Tobacco Smoking</LONG_NAME>
            <CON_ID>2202827</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>History</PreferredName>
        <Version>1</Version>
        <LongName>History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Are you a never smoker</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Are you a never smoker</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF_Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have any history of smoking?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0920</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NO_SMK_HX_IND2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1540">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2195094</PUBLICID>
    <LONGNAME>Common Toxicity Criteria Adverse Event Exostosis Grade</LONGNAME>
    <PREFERREDNAME>CTC_AE_EXOSTOSIS_GD</PREFERREDNAME>
    <PREFERREDDEFINITION>in CTC category Musculoskeletal/Soft Tissue, assessment of the severity of an exostosis adverse event using a graded scale.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195092</PublicId>
      <PreferredName>CTC_AE_EXOSTOSIS</PreferredName>
      <PreferredDefinition>information related to the CTC adverse event of exostosis.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Exostosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2480706</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49704</PreferredName>
        <Version>1</Version>
        <LongName>Common Terminology Criteria for Adverse Events</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49704</PREFERRED_NAME>
            <LONG_NAME>Common Terminology Criteria for Adverse Events</LONG_NAME>
            <CON_ID>2480705</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2195090</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Exostosis</PreferredName>
        <Version>1</Version>
        <LongName>Exostosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3029</PREFERRED_NAME>
            <LONG_NAME>Exostosis</LONG_NAME>
            <CON_ID>2203633</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2195093</PublicId>
      <PreferredName>CTC_AE_EXOSTOSIS_GD</PreferredName>
      <PreferredDefinition>in CTC category Musculoskeletal/Soft Tissue, assessment of the severity of an exostosis adverse event using a graded scale.</PreferredDefinition>
      <LongName>Common Toxicity Criteria Adverse Event Exostosis Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>1</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184299</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Grade</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Asymptomatic</VALUEMEANING>
          <MEANINGDESCRIPTION>Without clinical signs or indications that raise the possibility of a particular disorder or dysfunction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-08-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>Involving multiple sites; pain or interfering with function</VALUEMEANING>
          <MEANINGDESCRIPTION>Involving multiple sites; pain or interfering with function</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572708</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Excision indicated</VALUEMEANING>
          <MEANINGDESCRIPTION>Excision indicated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572709</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Progression to malignancy (i.e., chondrosarcoma)</VALUEMEANING>
          <MEANINGDESCRIPTION>Progression to malignancy (i.e., chondrosarcoma)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572710</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>Death</VALUEMEANING>
          <MEANINGDESCRIPTION>The cessation of life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Exostosis Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Source</Name>
        <DocumentType>DATA_ELEMENT_SOURCE</DocumentType>
        <DocumentText>Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)</DocumentText>
        <URL>http://ctep.cancer.gov/reporting/ctc.html</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CTC Adverse Event Exostosis G</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CTC Adverse Event Exostosis Grade</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812032</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2604617</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Submission and Reporting</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Common Terminology Criteria for Adverse Events v3.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000132</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1541">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2195205</PUBLICID>
    <LONGNAME>Deep Vein Thrombosis Clinical Evaluation Assessment</LONGNAME>
    <PREFERREDNAME>DVT_C_EVAL_ASSESS_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Evaluation to assess if the patient/participant has experienced deep vein thrombosis (DVT) since the previous evaluation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2195195</PublicId>
      <PreferredName>DVT_C_EVAL</PreferredName>
      <PreferredDefinition>Evaluation of the participant&#39;s deep vein thrombosis (DVT).</PreferredDefinition>
      <LongName>Deep Vein Thrombosis Clinical Evaluation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2195193</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0149871</PreferredName>
        <Version>1</Version>
        <LongName>Deep vein thrombosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0149871</PREFERRED_NAME>
            <LONG_NAME>Deep vein thrombosis</LONG_NAME>
            <CON_ID>2203242</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207902</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25398:CL107454</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Evaluation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL107454</PREFERRED_NAME>
            <LONG_NAME>Evaluation</LONG_NAME>
            <CON_ID>2204523</CON_ID>
            <DEFINITION_SOURCE>NCI04</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2195203</PublicId>
      <PreferredName>DVT_C_EVAL_ASSESS_TP</PreferredName>
      <PreferredDefinition>Evaluation to assess if the patient/participant has or had experienced deep vein thrombosis (DVT).</PreferredDefinition>
      <LongName>Deep Vein Thrombosis Clinical Evaluation Assessment Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ongoing</VALIDVALUE>
          <VALUEMEANING>Ongoing</VALUEMEANING>
          <MEANINGDESCRIPTION>Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53279</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572735</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>New Onset</VALIDVALUE>
          <VALUEMEANING>New Onset</VALUEMEANING>
          <MEANINGDESCRIPTION>Having no previous example or precedent or parallel; of a kind not seen before.: The start, beginning, or early stages.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25279, C25586</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572736</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present at Baseline</VALIDVALUE>
          <VALUEMEANING>Present at Baseline</VALUEMEANING>
          <MEANINGDESCRIPTION>Present at Baseline</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-01-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Deep Vein Thrombosis</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Deep Vein Thrombosis</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2190530</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Demonstration Applications</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Rembrandt</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2812349</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1542">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2195441</PUBLICID>
    <LONGNAME>Chronic Disease Other Diagnosis Ind-2</LONGNAME>
    <PREFERREDNAME>CHR_DZ_O_DX_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to other diagnosis of disease or condition that persists or progresses over a long period of time.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2672662</PublicId>
      <PreferredName>CHRON_DZ_O_DX</PreferredName>
      <PreferredDefinition>information related to other diagnosis of disease or condition that persists or progresses over a long period of time.</PreferredDefinition>
      <LongName>Chronic Disease Other Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206569</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14141:C2991</PreferredName>
        <Version>1</Version>
        <LongName>Chronic Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14141</PREFERRED_NAME>
            <LONG_NAME>Chronic</LONG_NAME>
            <CON_ID>2206176</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2425591</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C15220</PreferredName>
        <Version>1</Version>
        <LongName>Other Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1543">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2197652</PUBLICID>
    <LONGNAME>Signature Present Indicator</LONGNAME>
    <PREFERREDNAME>SIG_PRES_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no response to indicate whether a signature is present on a form.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2197649</PublicId>
      <PreferredName>SIG_PRES</PreferredName>
      <PreferredDefinition>Indicates whether a signature is present on a form.</PreferredDefinition>
      <LongName>Signature Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2197646</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Signature</PreferredName>
        <Version>1</Version>
        <LongName>Signature</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25678</PREFERRED_NAME>
            <LONG_NAME>Signature</LONG_NAME>
            <CON_ID>2202359</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2197647</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Present</PreferredName>
        <Version>1</Version>
        <LongName>Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015873</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>A choice of Yes and No answer.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008509</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPORES</PreferredName>
        <Version>2.31</Version>
        <LongName>SPOREs</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>YES</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NO</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Signature Present</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Signature Present</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Signature</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Signature</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>2</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is GEP70 signature present?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SeriousAdverseEvents</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812325</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Oral Leukoplakia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812388</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1544">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2199542</PUBLICID>
    <LONGNAME>Adverse Event Therapeutic Procedure Specify</LONGNAME>
    <PREFERREDNAME>AE_TX_SURGPROC_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify the treatment for an adverse event.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2179888</PublicId>
      <PreferredName>AE_TX</PreferredName>
      <PreferredDefinition>the adverse event related to a particular treatment modality or to the patient&#39;s disease._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</PreferredDefinition>
      <LongName>Adverse Event Therapeutic Procedure</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2184272</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Adverse Event</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2554155</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018370</PublicId>
      <PreferredName>AE_SPEC</PreferredName>
      <PreferredDefinition>the free text field to specify an adverse event.</PreferredDefinition>
      <LongName>Adverse Event Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Surgery, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Surgery, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bladder</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811907</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adverse Events</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811951</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1545">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2200447</PUBLICID>
    <LONGNAME>Abdominal Lymph Node Metastasis Present Ind-3</LONGNAME>
    <PREFERREDNAME>ABD_LN_MET_PRES_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator whether metastatic disease is present in the abdominal lymph nodes.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2200446</PublicId>
      <PreferredName>ABD_LN_MET_PRES</PreferredName>
      <PreferredDefinition>information related to the presence of metastasis to abdominal lymph nodes.</PreferredDefinition>
      <LongName>Abdominal Lymph Node Metastasis Present</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2207019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25342:C12745</PreferredName>
        <Version>1</Version>
        <LongName>Abdominal Lymph Node</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25342</PREFERRED_NAME>
            <LONG_NAME>Abdominal</LONG_NAME>
            <CON_ID>2204983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12745</PREFERRED_NAME>
            <LONG_NAME>Lymph Node</LONG_NAME>
            <CON_ID>2202290</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207563</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19151:C25626</PreferredName>
        <Version>1</Version>
        <LongName>Metastasis Present</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19151</PREFERRED_NAME>
            <LONG_NAME>Metastasis</LONG_NAME>
            <CON_ID>2202751</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25626</PREFERRED_NAME>
            <LONG_NAME>Present</LONG_NAME>
            <CON_ID>2203654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Abdominal nodes</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Abdominal nodes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Abdominal/Retroperitoneal</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Colorectal</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811871</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1546">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2200933</PUBLICID>
    <LONGNAME>Urinary Symptoms Patient Limitation Assessment Quality of Life Scale</LONGNAME>
    <PREFERREDNAME>UR_PT_LI_ASS_QOL_SCA</PREFERREDNAME>
    <PREFERREDDEFINITION>the patient&#39;s assessment of the limitation on activities by urinary symptoms based on the FACT questionnaire.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2200932</PublicId>
      <PreferredName>URNSM_PT_LIM_ASSESS</PreferredName>
      <PreferredDefinition>information related to the patient&#39;s assessment of limitation due to urinary symptoms.</PreferredDefinition>
      <LongName>Urinary Symptoms Patient Limitation Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2660507</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0426359:C16960</PreferredName>
        <Version>1</Version>
        <LongName>Urinary symptoms Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0426359</PREFERRED_NAME>
            <LONG_NAME>Urinary symptoms</LONG_NAME>
            <CON_ID>2615981</CON_ID>
            <DEFINITION_SOURCE>SNOMEDCT_2004_01_31</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2660956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0449295:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Limitation Physical Examination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0449295</PREFERRED_NAME>
            <LONG_NAME>Limitation</LONG_NAME>
            <CON_ID>2615891</CON_ID>
            <DEFINITION_SOURCE>SNOMEDCT_2004_01_31</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2016847</PublicId>
      <PreferredName>FACT_QOL_SCALE</PreferredName>
      <PreferredDefinition>the scale used on FACT Quality of Life questionnaires to assess patient responses.</PreferredDefinition>
      <LongName>FACT Quality of Life Scale</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little bit</VALIDVALUE>
          <VALUEMEANING>A little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat</VALIDVALUE>
          <VALUEMEANING>Somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of partial agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quite a bit</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very much</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A Little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-07-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561586</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Zero</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2740377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rarely</VALIDVALUE>
          <VALUEMEANING>Rarely</VALUEMEANING>
          <MEANINGDESCRIPTION>Not often.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73116</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sometimes</VALIDVALUE>
          <VALUEMEANING>SOMETIMES</VALUEMEANING>
          <MEANINGDESCRIPTION>SOMETIMES</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561568</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Often</VALIDVALUE>
          <VALUEMEANING>OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Always</VALIDVALUE>
          <VALUEMEANING>Always</VALUEMEANING>
          <MEANINGDESCRIPTION>At all times; on every occasion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all bothered</VALIDVALUE>
          <VALUEMEANING>Not at all bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not bothered at all.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111755</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851443</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little bit</VALIDVALUE>
          <VALUEMEANING>Bothered a little bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was bothered just a little.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111754</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851442</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat bothered</VALIDVALUE>
          <VALUEMEANING>Somewhat bothered</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125683</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered quite a bit</VALIDVALUE>
          <VALUEMEANING>Bothered quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111752</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851440</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered very much</VALIDVALUE>
          <VALUEMEANING>Bothered very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was very bothered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111751</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2851439</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>Very much</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of strong agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>Quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer describing a fairly large amount or extent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>A little</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of weak agreement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2927955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderately</VALIDVALUE>
          <VALUEMEANING>Moderately</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extremely</VALIDVALUE>
          <VALUEMEANING>EXTREMELY</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is in extreme agreement with something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125681</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Slightly</VALIDVALUE>
          <VALUEMEANING>Slightly</VALUEMEANING>
          <MEANINGDESCRIPTION>Slightly</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-02-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not bothered at all</VALIDVALUE>
          <VALUEMEANING>Not bothered at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not bothered at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered somewhat</VALIDVALUE>
          <VALUEMEANING>Bothered somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered somewhat</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bothered a little</VALIDVALUE>
          <VALUEMEANING>Bothered a little</VALUEMEANING>
          <MEANINGDESCRIPTION>Bothered a little</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>A little difficult</VALIDVALUE>
          <VALUEMEANING>A little difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>A little difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not difficult at all</VALIDVALUE>
          <VALUEMEANING>Not difficult at all</VALUEMEANING>
          <MEANINGDESCRIPTION>Not difficult at all</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653181</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted totally</VALIDVALUE>
          <VALUEMEANING>Disrupted totally</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was totally disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted quite a bit</VALIDVALUE>
          <VALUEMEANING>Disrupted quite a bit</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was quite a bit disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted somewhat</VALIDVALUE>
          <VALUEMEANING>Disrupted somewhat</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was somewhat disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disrupted a little</VALIDVALUE>
          <VALUEMEANING>Disrupted a little</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was a little disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125684</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not disrupted at all</VALIDVALUE>
          <VALUEMEANING>Not disrupted at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual is or was not at all disrupted.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C125688</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3653288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to do</VALIDVALUE>
          <VALUEMEANING>UNABLE To Do</VALUEMEANING>
          <MEANINGDESCRIPTION>UNABLE To Do (Health Activity Questionnaire)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very difficult</VALIDVALUE>
          <VALUEMEANING>Very difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Very difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Somewhat difficult</VALIDVALUE>
          <VALUEMEANING>Somewhat difficult</VALUEMEANING>
          <MEANINGDESCRIPTION>Somewhat difficult</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-01-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578160</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>No pain</VALUEMEANING>
          <MEANINGDESCRIPTION>A response indicating that an individual has or had no pain.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119987</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>My problems with urinating li</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>My problems with urinating limit my activities</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1547">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2201325</PUBLICID>
    <LONGNAME>Adverse Event Reporter Telephone Number</LONGNAME>
    <PREFERREDNAME>AE_REPR_PH_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>Name of the individual submitting an Adverse Event report.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CIP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2183628</PublicId>
      <PreferredName>AE_REPR</PreferredName>
      <PreferredDefinition>Name of the individual responsible for the submission of an Adverse Event report to the Institution Review Board (IRB).</PreferredDefinition>
      <LongName>Adverse Event Reporter</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2183601</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Adverse event NOS</PreferredName>
        <Version>1</Version>
        <LongName>Adverse event NOS</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0877248</PREFERRED_NAME>
            <LONG_NAME>Adverse event NOS</LONG_NAME>
            <CON_ID>2203158</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2183626</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>reporter</PreferredName>
        <Version>1</Version>
        <LongName>reporter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0335038</PREFERRED_NAME>
            <LONG_NAME>reporter</LONG_NAME>
            <CON_ID>2203383</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015979</PublicId>
      <PreferredName>TELEPHONE_NUM</PreferredName>
      <PreferredDefinition>the telephone number for a person or organization.</PreferredDefinition>
      <LongName>Telephone Number</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008544</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TELECOMMUNICATIONS</PreferredName>
        <Version>1</Version>
        <LongName>Telecommunications</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength>7</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208005</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25395:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Telephone Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25395</PREFERRED_NAME>
            <LONG_NAME>Telephone</LONG_NAME>
            <CON_ID>2202574</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Caller Phone #</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Caller Phone #</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2201295</PublicId>
          <ContextName>CIP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Adverse Events</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>AE/SAE CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812387</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>ENGLISH</AlternateName>
        <AlternateNameType>CONTEXT NAME</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1548">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2228652</PUBLICID>
    <LONGNAME>Head and Neck Right Lymph Node Neoplasm Involvement Status</LONGNAME>
    <PREFERREDNAME>HN_RT_LN_TU_INV_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>information related to tumor involvement of a head and neck lymph node on the right side of the body.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>RTOG CRF:Radiation Therapy Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2239900</PublicId>
      <PreferredName>HN_RT_LN_TUM_INVLT</PreferredName>
      <PreferredDefinition>information related to tumor involvement of a head and neck lymph node on the right side of the body.</PreferredDefinition>
      <LongName>Head and Neck Right Lymph Node Neoplasm Involvement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2239898</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12418:C25228:C12745</PreferredName>
        <Version>1</Version>
        <LongName>Head and Neck Right Lymph Node</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12418</PREFERRED_NAME>
            <LONG_NAME>Head and Neck</LONG_NAME>
            <CON_ID>2203706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25228</PREFERRED_NAME>
            <LONG_NAME>Right</LONG_NAME>
            <CON_ID>2204868</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12745</PREFERRED_NAME>
            <LONG_NAME>Lymph Node</LONG_NAME>
            <CON_ID>2202290</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2228631</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3262:C25548</PreferredName>
        <Version>1</Version>
        <LongName>Neoplasm Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3262</PREFERRED_NAME>
            <LONG_NAME>Neoplasm</LONG_NAME>
            <CON_ID>2202518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2228638</PublicId>
      <PreferredName>LN_INVLT_STAT</PreferredName>
      <PreferredDefinition>the status of lymph node involvement.</PreferredDefinition>
      <LongName>Lymph Node Involvement Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength>7</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184340</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Status</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complete resection of all gross disease</VALIDVALUE>
          <VALUEMEANING>complete resection of all gross tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>complete resection of all gross tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567980</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Incomplete/partial resection of gross tumor</VALIDVALUE>
          <VALUEMEANING>incomplete/partial resection of gross tumor</VALUEMEANING>
          <MEANINGDESCRIPTION>incomplete/partial resection of gross tumor</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-06-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not operated</VALIDVALUE>
          <VALUEMEANING>Not operated</VALUEMEANING>
          <MEANINGDESCRIPTION>Not operated</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574766</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Extracapsular nodal extension</VALIDVALUE>
          <VALUEMEANING>Extracapsular nodal extension</VALUEMEANING>
          <MEANINGDESCRIPTION>Extracapsular nodal extension</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574789</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Perineural invasion</VALIDVALUE>
          <VALUEMEANING>Perineural invasion</VALUEMEANING>
          <MEANINGDESCRIPTION>Perineural invasion</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Angio-lympatic spread</VALIDVALUE>
          <VALUEMEANING>Angio-lympatic spread</VALUEMEANING>
          <MEANINGDESCRIPTION>Angio-lympatic spread</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-05-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574791</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Neck nodal site right</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Neck nodal site right</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1221</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104935</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1016</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HN_RT_LN_TU_INV_STAT</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1549">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2230160</PUBLICID>
    <LONGNAME>Analyte Test Name</LONGNAME>
    <PREFERREDNAME>ANALYTE_TST_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>The name of the analyte.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013245</PublicId>
      <PreferredName>TEST_NM</PreferredName>
      <PreferredDefinition>Name of a test or procedure for critical evaluation.</PreferredDefinition>
      <LongName>Test Name</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512817</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47891</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47891</PREFERRED_NAME>
            <LONG_NAME>Test</LONG_NAME>
            <CON_ID>2427511</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2230158</PublicId>
      <PreferredName>ANALYTE_TST_NM</PreferredName>
      <PreferredDefinition>The name of the analyte.</PreferredDefinition>
      <LongName>Analyte Test Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>200</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sulindac</VALIDVALUE>
          <VALUEMEANING>Sulindac</VALUEMEANING>
          <MEANINGDESCRIPTION>Sulindac</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sulindac Sulfide</VALIDVALUE>
          <VALUEMEANING>Sulindac Sulfide</VALUEMEANING>
          <MEANINGDESCRIPTION>Sulindac Sulfide</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sulindac Sulfone</VALIDVALUE>
          <VALUEMEANING>Sulindac Sulfone</VALUEMEANING>
          <MEANINGDESCRIPTION>Sulindac Sulfone</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IGF-1</VALIDVALUE>
          <VALUEMEANING>IGF-1</VALUEMEANING>
          <MEANINGDESCRIPTION>Insulin-like Growth Factor-1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579544</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IGFBP-3</VALIDVALUE>
          <VALUEMEANING>IGFBP-3</VALUEMEANING>
          <MEANINGDESCRIPTION>Insulin-Like Growth Factor Binding Protein-3</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-07-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579545</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resveratrol</VALIDVALUE>
          <VALUEMEANING>Resveratrol</VALUEMEANING>
          <MEANINGDESCRIPTION>Resveratrol</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2597472</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GST-pi</VALIDVALUE>
          <VALUEMEANING>GST-pi</VALUEMEANING>
          <MEANINGDESCRIPTION>GST-pi</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2597549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GST Activity</VALIDVALUE>
          <VALUEMEANING>GST Activity</VALUEMEANING>
          <MEANINGDESCRIPTION>GST Activity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-02-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2597550</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>VEGF expression</VALIDVALUE>
          <VALUEMEANING>VEGF expression</VALUEMEANING>
          <MEANINGDESCRIPTION>VEGF expression</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-10-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2793110</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Apoptotic cells</VALIDVALUE>
          <VALUEMEANING>Apoptotic cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Apoptotic cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-10-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2793111</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resveratrol 3-sulfate</VALIDVALUE>
          <VALUEMEANING>Resveratrol 3-sulfate</VALUEMEANING>
          <MEANINGDESCRIPTION>Resveratrol 3-sulfate</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3162097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resveratrol di-sulfate</VALIDVALUE>
          <VALUEMEANING>Resveratrol di-sulfate</VALUEMEANING>
          <MEANINGDESCRIPTION>Resveratrol di-sulfate</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3162098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resveratrol monoglucuronide 2</VALIDVALUE>
          <VALUEMEANING>Resveratrol monoglucuronide 2</VALUEMEANING>
          <MEANINGDESCRIPTION>Resveratrol monoglucuronide 2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3162099</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resveratrol monoglucuronide 1</VALIDVALUE>
          <VALUEMEANING>Resveratrol monoglucuronide 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Resveratrol monoglucuronide 1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3162100</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resveratrol sulfate-glucuronide</VALIDVALUE>
          <VALUEMEANING>Resveratrol sulfate-glucuronide</VALUEMEANING>
          <MEANINGDESCRIPTION>Resveratrol sulfate-glucuronide</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3162101</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Test Name</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Test Name</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Document Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Analyte</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Pre-prostatectomy Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812189</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Drug and Carcinogen Enzymes - Resveratrol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812258</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812415</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sulindac - Increased Risk of Melanoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2813002</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Resveratrol in Postmenopausal Women</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3018782</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1550">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2230950</PUBLICID>
    <LONGNAME>Cigarette Smoking Status Text Type</LONGNAME>
    <PREFERREDNAME>CIG_SMK_STAT_TXT_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Text representation of a person&quot;s status relative to smoking tobacco in the form of cigarettes, based on questions about current and former use of cigarettes.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2230947</PublicId>
      <PreferredName>CIG_SMK_STAT</PreferredName>
      <PreferredDefinition>Status of a peson relative to smoking tobacco in the form of cigarettes, based on questions about current and former use of cigarettes.</PreferredDefinition>
      <LongName>Smoking Status Cigarette</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2230945</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1802:C0037369</PreferredName>
        <Version>1</Version>
        <LongName>Cigarette Smoking</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1802</PREFERRED_NAME>
            <LONG_NAME>Cigarette</LONG_NAME>
            <CON_ID>2202497</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0037369</PREFERRED_NAME>
            <LONG_NAME>Smoking</LONG_NAME>
            <CON_ID>2202991</CON_ID>
            <DEFINITION_SOURCE>MSH2003_2003_05_12</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2181646</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Status</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0449438</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2203372</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2230948</PublicId>
      <PreferredName>SMK_STAT_TXT_TP</PreferredName>
      <PreferredDefinition>Text descriptors of a person&#39;s smoking status.</PreferredDefinition>
      <LongName>Smoking Status Text Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2207966</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Text Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Current</VALIDVALUE>
          <VALUEMEANING>Current Smoker</VALUEMEANING>
          <MEANINGDESCRIPTION>An adult who has smoked 100 cigarettes in his or her lifetime and who currently smokes cigarettes. Includes daily smokers and non-daily smokers (also known as occasional smokers).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67147</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Former</VALIDVALUE>
          <VALUEMEANING>Former Smoker</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who was not smoking at the time of the interview but has smoked at least 100 cigarettes in their life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67148</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572541</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never</VALIDVALUE>
          <VALUEMEANING>Never smoked</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).: A person who inhales or has inhaled combustible products of organic material during their lifetime.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68751, C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Smoking Status Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Smoking Status Unknown</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Smoking Status</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Smoking Status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cigarette history</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Smoking history</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Smoking history</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>AMC Question Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Smoking status/usage</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Candidate Reuse</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2992453</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Budesonide Lung Nodules</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812102</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exp. PK Formulations of SR13668</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2201036</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Head and Neck SPOREs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Head and Neck/HIV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2943034</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2201036</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Head and Neck SPOREs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Past Medical and Social History </ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2958714</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2931931</PublicId>
          <ContextName>SPOREs</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Iloprost Trial</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Iloprost 12079</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2931952</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2013-02-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAZ2015-05-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4915511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-07-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5612586</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MAY2016-08-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>6025104</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>7283431</PublicId>
          <ContextName>AMC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CRF CDEs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Baseline Evaluations</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>7283433</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CIG_SMK_STAT_TXT_TP</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>SPOREs</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SWOG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CIGHIST1</AlternateName>
        <AlternateNameType>OID, SWOG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>AMC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CIGARETTES_SUNCF</AlternateName>
        <AlternateNameType>OID, AMC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1551">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2232329</PUBLICID>
    <LONGNAME>Classification Scheme Item Modified By java.lang.String</LONGNAME>
    <PREFERREDNAME>2231728v3.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A component of content in a Classification Scheme. This may be a node in a taxonomy or ontology or a term in a thesaurus, etc. (NCICB)_Indicates the person or authoritative body who changed an item._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2231728</PublicId>
      <PreferredName>2231654v1.0:2231612v1.0</PreferredName>
      <PreferredDefinition>A component of content in a Classification Scheme. This may be a node in a taxonomy or ontology or a term in a thesaurus, etc. (NCICB)_Indicates the person or authoritative body who changed an item.</PreferredDefinition>
      <LongName>Classification Scheme Item Modified By</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2231654</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41080</PreferredName>
        <Version>1</Version>
        <LongName>Classification Scheme Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41080</PREFERRED_NAME>
            <LONG_NAME>Classification Scheme Item</LONG_NAME>
            <CON_ID>2231565</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231612</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42629</PreferredName>
        <Version>1</Version>
        <LongName>Modified By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42629</PREFERRED_NAME>
            <LONG_NAME>Modified By</LONG_NAME>
            <CON_ID>2231552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Classification Scheme Item Modified By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Classification Scheme Item Modified By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ClassificationSchemeItem:modifiedBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.ClassificationSchemeItem.modifiedBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1552">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2232520</PUBLICID>
    <LONGNAME>Conceptual Domain Administered Item End Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2231919v3.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The set of all possible Valid Value meanings of a Data Element Concept expressed without representation. (NCICB)_The point or place at which something terminates in time, space, or extent.:The particular day, month and year an event will happen or has happened._Java Date Type</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2231919</PublicId>
      <PreferredName>2442937v1:2231605v1</PreferredName>
      <PreferredDefinition>The set of all possible Valid Value meanings of a Data Element Concept expressed without representation. (NCICB)_A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_The point or place at which something terminates in time, space, or extent.:The particular day, month and year an event will happen or has happened.</PreferredDefinition>
      <LongName>Conceptual Domain Administered Item End Date</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2442937</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41083:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Domain Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41083</PREFERRED_NAME>
            <LONG_NAME>Conceptual Domain</LONG_NAME>
            <CON_ID>2231553</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231605</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25496:C25164</PreferredName>
        <Version>1</Version>
        <LongName>End Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Conceptual Domain Administered Item End Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Conceptual Domain Administered Item End Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.ConceptualDomain.endDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ConceptualDomain:endDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.AdministeredComponent.endDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AdministeredComponent:endDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1553">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2232738</PUBLICID>
    <LONGNAME>Question Text Modified By java.lang.String</LONGNAME>
    <PREFERREDNAME>2232137v3.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The actual text of the data element as specified on a Case Report Form of a Protocol. (NCICB)_Indicates the person or authoritative body who changed an item._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2232137</PublicId>
      <PreferredName>2231663v1.0:2231612v1.0</PreferredName>
      <PreferredDefinition>The actual text of the data element as specified on a Case Report Form of a Protocol. (NCICB)_Indicates the person or authoritative body who changed an item.</PreferredDefinition>
      <LongName>Question Text Modified By</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2231663</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41116</PreferredName>
        <Version>1</Version>
        <LongName>Question Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41116</PREFERRED_NAME>
            <LONG_NAME>Question</LONG_NAME>
            <CON_ID>2231575</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231612</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42629</PreferredName>
        <Version>1</Version>
        <LongName>Modified By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42629</PREFERRED_NAME>
            <LONG_NAME>Modified By</LONG_NAME>
            <CON_ID>2231552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Question Text Modified By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Question Text Modified By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.report</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813052</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.Question.modifiedBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Question:modifiedBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.AdministeredComponent.modifiedBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AdministeredComponent:modifiedBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.report.Query.modifiedBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Query:modifiedBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1554">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2234831</PUBLICID>
    <LONGNAME>Patient Cancer and Leukemia Group B Study Enrollment Ind-3</LONGNAME>
    <PREFERREDNAME>PT_CALGB_ST_ENR_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether a patient is enrolled on CALGB 9594.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2234830</PublicId>
      <PreferredName>PT_CALGB_STUD_ENROLL</PreferredName>
      <PreferredDefinition>information related to the patient enrollment in a CALGB study.</PreferredDefinition>
      <LongName>Patient Cancer and Leukemia Group B Study Enrollment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234828</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25442:C15206:C37948</PreferredName>
        <Version>1</Version>
        <LongName>Cancer and Leukemia Group B Study Enrollment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25442</PREFERRED_NAME>
            <LONG_NAME>Cancer and Leukemia Group B</LONG_NAME>
            <CON_ID>2205049</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37948</PREFERRED_NAME>
            <LONG_NAME>Enrollment</LONG_NAME>
            <CON_ID>2203918</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is patient enrolling in CALGB</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is patient enrolling in CALGB 9594</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1555">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2236221</PUBLICID>
    <LONGNAME>Vertebral Bone XRay Fracture Assessment Current Ind-2</LONGNAME>
    <PREFERREDNAME>VE_BON_DX_ASS_C_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to a current vertebral bone diagnostic radiology assessment for a fracture.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2236218</PublicId>
      <PreferredName>VERT_BONE_X_FX_ASS</PreferredName>
      <PreferredDefinition>information related to the x-ray assessment of vertebral bone for a fracture.</PreferredDefinition>
      <LongName>Vertebral Bone X-Ray Fracture Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236215</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25715:C12366</PreferredName>
        <Version>1</Version>
        <LongName>Vertebral Bone</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25715</PREFERRED_NAME>
            <LONG_NAME>Vertebral</LONG_NAME>
            <CON_ID>2206269</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12366</PREFERRED_NAME>
            <LONG_NAME>Bone</LONG_NAME>
            <CON_ID>2202686</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2236222</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17261:C3046:C20989</PreferredName>
        <Version>1</Version>
        <LongName>X-Ray Fracture Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17261</PREFERRED_NAME>
            <LONG_NAME>X-Ray</LONG_NAME>
            <CON_ID>2202559</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3046</PREFERRED_NAME>
            <LONG_NAME>Fracture</LONG_NAME>
            <CON_ID>2203813</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is there evidence of any vert</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is there evidence of any vertebral body fracture in current films relative to previous ones?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1556">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2238032</PUBLICID>
    <LONGNAME>Computer Application Released Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2237881v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A program that gives a computer instructions that provide the user with tools to accomplish a task._Having been made available.:The particular day, month and year an event will happen or has happened._Java Date Type</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2237881</PublicId>
      <PreferredName>2223473v1.0:2224083v1.0</PreferredName>
      <PreferredDefinition>A program that gives a computer instructions that provide the user with tools to accomplish a task._Having been made available.:The particular day, month and year an event will happen or has happened.</PreferredDefinition>
      <LongName>Computer Application Released Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223473</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42608</PreferredName>
        <Version>1</Version>
        <LongName>Computer Application</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42608</PREFERRED_NAME>
            <LONG_NAME>Computer Application</LONG_NAME>
            <CON_ID>2223419</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2224083</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42882:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Released Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42882</PREFERRED_NAME>
            <LONG_NAME>Release</LONG_NAME>
            <CON_ID>2224024</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Computer Application Released Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Computer Application Released Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.mageom.domain.Protocol.SoftwareApplication.releaseDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SoftwareApplication:releaseDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1557">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2238047</PUBLICID>
    <LONGNAME>Ontology Entry Object Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2237896v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A single entry from an ontology or a controlled vocabulary.  For instance, category could be &#39;species name&#39;, value could be &#39;homo sapiens&#39; and ontology would be taxonomy database, NCBI._A statement or an account describing something._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2237896</PublicId>
      <PreferredName>2236772v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>A single entry from an ontology or a controlled vocabulary.  For instance, category could be &#39;species name&#39;, value could be &#39;homo sapiens&#39; and ontology would be taxonomy database, NCBI._A statement or an account describing something.</PreferredDefinition>
      <LongName>Ontology Entry Object Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236772</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C44174</PreferredName>
        <Version>1</Version>
        <LongName>Ontology Entry Object</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44174</PREFERRED_NAME>
            <LONG_NAME>Ontology Entry</LONG_NAME>
            <CON_ID>2236578</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Ontology Entry Object Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Ontology Entry Object Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.mageom.domain.Description.OntologyEntry.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OntologyEntry:description</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.OntologyEntry.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1558">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2240668</PUBLICID>
    <LONGNAME>Tumor Size Mammogram Assessment Ind-2</LONGNAME>
    <PREFERREDNAME>TUMSZ_MMG_ASESS_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator that asks whether the tumor size was measured by mammogram.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2240667</PublicId>
      <PreferredName>TUMORSIZE_MMG_ASSESS</PreferredName>
      <PreferredDefinition>information relating to tumor size mammogram assessment.</PreferredDefinition>
      <LongName>Tumor Size Mammogram Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2240664</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL228347</PreferredName>
        <Version>1</Version>
        <LongName>Tumor size</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL228347</PREFERRED_NAME>
            <LONG_NAME>Tumor size</LONG_NAME>
            <CON_ID>2240663</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2240665</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20178:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Mammogram Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20178</PREFERRED_NAME>
            <LONG_NAME>Mammogram</LONG_NAME>
            <CON_ID>2202867</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tumor size measured by mammog</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tumor size measured by mammogram</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1559">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2320041</PUBLICID>
    <LONGNAME>Vascular Retina Choroid Examination Text</LONGNAME>
    <PREFERREDNAME>VASC_RETN_CHOR_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>Text field to capture results of an examination of the vascular aspects of the retina and choroid of the eye(s).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2320038</PublicId>
      <PreferredName>VASC_RETN_CHOR_EXAM</PreferredName>
      <PreferredDefinition>Examination of the vascular aspects of the retina and choroid of the eye(s).</PreferredDefinition>
      <LongName>Vascular Retina Choroid Examination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2320039</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13311:CL037326</PreferredName>
        <Version>1</Version>
        <LongName>Vascular Retina, choroid and vitreous hemorrhages and vascular disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13311</PREFERRED_NAME>
            <LONG_NAME>Vascular</LONG_NAME>
            <CON_ID>2202503</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL037326</PREFERRED_NAME>
            <LONG_NAME>Retina, choroid and vitreous hemorrhages and vascular disorders</LONG_NAME>
            <CON_ID>2320034</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2320036</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25305</PreferredName>
        <Version>1</Version>
        <LongName>Exam</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25305</PREFERRED_NAME>
            <LONG_NAME>Medical Examination Assessment</LONG_NAME>
            <CON_ID>2202633</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2201296</PublicId>
      <PreferredName>AE_ASSESS_SHORT_TXT</PreferredName>
      <PreferredDefinition>Abbreviated text field of information related to an adverse event assessment.</PreferredDefinition>
      <LongName>Adverse Event Assessment Short Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CIP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208098</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25249:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Short Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25249</PREFERRED_NAME>
            <LONG_NAME>Short</LONG_NAME>
            <CON_ID>2206252</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Vascular Retina and Choroid E</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Vascular Retina and Choroid Exam</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1560">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2342555</PUBLICID>
    <LONGNAME>Negation Terminal Amino Acid End java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2342378v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Negation is an operation in which a term denies or inverts the meaning of another term or construction.:Being or situated at an end; occurring at or forming an end.:Organic compounds containing amino (-NH2) and carboxyl (-COOH) groups.  In biochemistry, used to refer to the twenty-plus L-alpha-amino acids found in proteins._The point or place at which something terminates in time or space._Value Domain for java language Integer datatype</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2342378</PublicId>
      <PreferredName>2342243v1.0:2236677v1.0</PreferredName>
      <PreferredDefinition>Negation is an operation in which a term denies or inverts the meaning of another term or construction.:Being or situated at an end; occurring at or forming an end.:Organic compounds containing amino (-NH2) and carboxyl (-COOH) groups.  In biochemistry, used to refer to the twenty-plus L-alpha-amino acids found in proteins._The point or place at which something terminates in time or space.</PreferredDefinition>
      <LongName>Negation Terminal Amino Acid End</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2342243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C47940:C231</PreferredName>
        <Version>1</Version>
        <LongName>Negation Terminal Amino Acid</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47940</PREFERRED_NAME>
            <LONG_NAME>Terminal</LONG_NAME>
            <CON_ID>2342186</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C231</PREFERRED_NAME>
            <LONG_NAME>Amino Acid</LONG_NAME>
            <CON_ID>2342175</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2236677</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25496</PreferredName>
        <Version>1</Version>
        <LongName>End</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25496</PREFERRED_NAME>
            <LONG_NAME>End</LONG_NAME>
            <CON_ID>2223233</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Negation Terminal Amino Acid End java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Negation Terminal Amino Acid End java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2496586</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PIR 1.1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.georgetown.pir.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812496</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716603</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PIR 1.2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.georgetown.pir.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000532</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.georgetown.pir.domain.NonTerminalResidue.end</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NonTerminalResidue:end</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.georgetown.pir.domain.ProteinFeature.end</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProteinFeature:end</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1561">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2342594</PUBLICID>
    <LONGNAME>Alternate Splicing Variation Begin java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2342417v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Alternate Splicing is a process in which multiple protein isoforms or products are generated from a single gene as a result of splicing together different nonconsecutive exons during the processing of initially identical nascent transcripts of a gene into mature mRNA transcripts. An exon may be connected to any one of several alternative exons to form the mRNA and generate related proteins, often in a tissue or developmental stage specific manner.:An alteration or difference from a norm or standard._Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins._Value Domain for java language Integer datatype</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2342417</PublicId>
      <PreferredName>2342253v1.0:2236678v1.0</PreferredName>
      <PreferredDefinition>Alternate Splicing is a process in which multiple protein isoforms or products are generated from a single gene as a result of splicing together different nonconsecutive exons during the processing of initially identical nascent transcripts of a gene into mature mRNA transcripts. An exon may be connected to any one of several alternative exons to form the mRNA and generate related proteins, often in a tissue or developmental stage specific manner.:An alteration or difference from a norm or standard._Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins.</PreferredDefinition>
      <LongName>Alternate Splicing Variation Begin</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2342253</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16280:C25713</PreferredName>
        <Version>1</Version>
        <LongName>Alternate Splicing Variation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16280</PREFERRED_NAME>
            <LONG_NAME>Alternate Splicing</LONG_NAME>
            <CON_ID>2342193</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25713</PREFERRED_NAME>
            <LONG_NAME>Variation</LONG_NAME>
            <CON_ID>2203982</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2236678</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431</PreferredName>
        <Version>1</Version>
        <LongName>Begin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Alternate Splicing Variation Begin java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Alternate Splicing Variation Begin java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2496586</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PIR 1.1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.georgetown.pir.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812496</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716603</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PIR 1.2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.georgetown.pir.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000532</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.georgetown.pir.domain.SpliceVariant.begin</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SpliceVariant:begin</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.georgetown.pir.domain.ProteinFeature.begin</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProteinFeature:begin</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1562">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2390913</PUBLICID>
    <LONGNAME>National Surgical Adjuvant Breast and Bowel Project Treatment Not Administered Reason</LONGNAME>
    <PREFERREDNAME>NSABP_TX_N_ADMIN_RSN</PREFERREDNAME>
    <PREFERREDDEFINITION>information relating to a clinical trial in the National Surgical Adjuvant Breast and Bowel Project (NSABP) and treatment not administered._the trial-specific reason why treatment ended prematurely or did not begin.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2390911</PublicId>
      <PreferredName>NSABP_TX_NOT_ADMIN</PreferredName>
      <PreferredDefinition>information relating to a clinical trial in the National Surgical Adjuvant Breast and Bowel Project (NSABP) and treatment not administered.</PreferredDefinition>
      <LongName>National Surgical Adjuvant Breast and Bowel Project Treatment Not Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008554</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_OTX_RSNS</PreferredName>
        <Version>1</Version>
        <LongName>Treatment/Off-treatment Reasons</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2390909</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15818:C15368</PreferredName>
        <Version>1</Version>
        <LongName>National Surgical Adjuvant Breast and Bowel Project Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15818</PREFERRED_NAME>
            <LONG_NAME>National Surgical Adjuvant Breast and Bowel Project</LONG_NAME>
            <CON_ID>2205058</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207837</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Not Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2390912</PublicId>
      <PreferredName>NSABP_TX_N_ADMIN_RSN</PreferredName>
      <PreferredDefinition>the trial-specific reason why treatment ended prematurely or did not begin.</PreferredDefinition>
      <LongName>National Surgical Adjuvant Breast and Bowel Project Treatment Not Administered Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008554</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_OTX_RSNS</PreferredName>
        <Version>1</Version>
        <LongName>Treatment/Off-treatment Reasons</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>130</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</Origin>
      <Representation>
        <PublicId>2240632</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unable to implant catheter/pump, or catheter/pump malfunction</VALIDVALUE>
          <VALUEMEANING>Unable to implant catheter/pump, or catheter/pump malfunction</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to implant catheter/pump, or catheter/pump malfunction</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Treatment completed per protocol criteria</VALIDVALUE>
          <VALUEMEANING>Treatment completed per protocol criteria</VALUEMEANING>
          <MEANINGDESCRIPTION>The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.: Indicates that the patient was fully compliant with the full course of treatment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105740, C70817</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570762</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adverse event/side effects/complications</VALIDVALUE>
          <VALUEMEANING>Adverse event/side effects/complications</VALUEMEANING>
          <MEANINGDESCRIPTION>Adverse event/side effects/complications</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient withdrawal or refusal</VALIDVALUE>
          <VALUEMEANING>Patient withdrawal or refusal</VALUEMEANING>
          <MEANINGDESCRIPTION>An indication that a study participant has removed itself from the study.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: To decline to do, accept, give, or allow something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49161, C37998, C49634</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Alternative therapy</VALIDVALUE>
          <VALUEMEANING>Alternative Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Forms of treatment that are used in addition to (complementary) or instead of (alternative) standard treatments. These practices generally are not considered standard medical approaches. Standard treatments go through a long and careful research process to prove they are safe and effective, but less is known about most types of CAM. CAM may include dietary supplements, megadose vitamins, herbal preparations, special teas, acupuncture, massage therapy, magnet therapy, spiritual healing, and meditation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15178</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Death, recurrence, or second primary cancer</VALIDVALUE>
          <VALUEMEANING>Death, recurrence, or second primary cancer</VALUEMEANING>
          <MEANINGDESCRIPTION>Death, recurrence, or second primary cancer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-08-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569460</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>New lesion (including second primary cancer) or other sign of progression</VALIDVALUE>
          <VALUEMEANING>New lesion (including second primary cancer) or other sign of progression</VALUEMEANING>
          <MEANINGDESCRIPTION>New lesion (including second primary cancer) or other sign of progression</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Treatment Completed per Registration Program</VALIDVALUE>
          <VALUEMEANING>Treatment Completed per Registration Program</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment Completed per Registration Program</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580256</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other Adverse Event/Side Effects/Complications</VALIDVALUE>
          <VALUEMEANING>Other Adverse Event/Side Effects/Complications</VALUEMEANING>
          <MEANINGDESCRIPTION>Other Adverse Event/Side Effects/Complications</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571544</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Declining Bone Density/Osteoporotic Bone Fracture</VALIDVALUE>
          <VALUEMEANING>Declining Bone Density/Osteoporotic Bone Fracture</VALUEMEANING>
          <MEANINGDESCRIPTION>Declining Bone Density/Osteoporotic Bone Fracture</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580257</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease progression or relapse</VALIDVALUE>
          <VALUEMEANING>Disease progression or relapse</VALUEMEANING>
          <MEANINGDESCRIPTION>Disease progression or relapse</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Death</VALIDVALUE>
          <VALUEMEANING>Death</VALUEMEANING>
          <MEANINGDESCRIPTION>The cessation of life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28554</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient off-treatment for other complicating disease</VALIDVALUE>
          <VALUEMEANING>Patient off-treatment for other complicating disease</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient off-treatment for other complicating disease</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-07-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559741</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient withdrawal or refusal for reason other than toxicity</VALIDVALUE>
          <VALUEMEANING>PATIENT WITHDRAWAL OR REFUSAL FOR REASON OTHER THAN TOXICITY</VALUEMEANING>
          <MEANINGDESCRIPTION>PATIENT WITHDRAWAL OR REFUSAL FOR REASON OTHER THAN TOXICITY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease progression, relapse during active treatment</VALIDVALUE>
          <VALUEMEANING>Disease progression, relapse during active treatment</VALUEMEANING>
          <MEANINGDESCRIPTION>Disease progression, relapse during active treatment</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Death on study</VALIDVALUE>
          <VALUEMEANING>Death on Study</VALUEMEANING>
          <MEANINGDESCRIPTION>Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.: The cessation of life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28554, C15206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558597</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient withdrawal/refusal for reason other than toxicity</VALIDVALUE>
          <VALUEMEANING>PATIENT WITHDRAWAL OR REFUSAL FOR REASON OTHER THAN TOXICITY</VALUEMEANING>
          <MEANINGDESCRIPTION>PATIENT WITHDRAWAL OR REFUSAL FOR REASON OTHER THAN TOXICITY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559752</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Patient withdrawal/refusal after beginning therapy</VALIDVALUE>
          <VALUEMEANING>Patient withdrawal/refusal after beginning therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient withdrawal/refusal after beginning therapy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-09-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2944961</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease progression, recurrence or second primary cancer</VALIDVALUE>
          <VALUEMEANING>Disease progression, recurrence or second primary cancer</VALUEMEANING>
          <MEANINGDESCRIPTION>Disease progression, recurrence or second primary cancer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3107694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Physician withdrawal</VALIDVALUE>
          <VALUEMEANING>Physician withdrawal</VALUEMEANING>
          <MEANINGDESCRIPTION>Physician withdrawal</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569458</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surgical complications</VALIDVALUE>
          <VALUEMEANING>Surgical complications</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgical complications</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Toxicity/adverse event during therapy</VALIDVALUE>
          <VALUEMEANING>Toxicity/adverse event during therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Toxicity/adverse event during therapy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3107695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Recurrence or second primary cancer</VALIDVALUE>
          <VALUEMEANING>Recurrence or second primary cancer</VALUEMEANING>
          <MEANINGDESCRIPTION>The reemergence of a neoplasm after a period of remission: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A primary malignant neoplasm in a patient who has been already diagnosed with a primary malignant neoplasm in another anatomic site.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95606, C37998, C4798</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-12-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3166035</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-protocol-specified toxicity/adverse event</VALIDVALUE>
          <VALUEMEANING>Non-protocol-specified toxicity/adverse event</VALUEMEANING>
          <MEANINGDESCRIPTION>Non-protocol-specified toxicity/adverse event</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3163874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Protocol-specified toxicity/adverse event</VALIDVALUE>
          <VALUEMEANING>Protocol-specified toxicity/adverse event</VALUEMEANING>
          <MEANINGDESCRIPTION>Protocol-specified toxicity/adverse event</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3163875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Toxicity/adverse event</VALIDVALUE>
          <VALUEMEANING>Toxicity/adverse event</VALUEMEANING>
          <MEANINGDESCRIPTION>The finding of bodily harm due to the poisonous effects of something.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41331, C37998, C27990</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3423459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lost to follow-up</VALIDVALUE>
          <VALUEMEANING>Lost to Follow-up</VALUEMEANING>
          <MEANINGDESCRIPTION>The loss or lack of continuation of subject participation after a study has officially closed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-01-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561825</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-compliance with protocol requirements</VALIDVALUE>
          <VALUEMEANING>Noncompliance with Protocol</VALUEMEANING>
          <MEANINGDESCRIPTION>Noncompliance with Protocol</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-01-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2572459</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease Progression</VALIDVALUE>
          <VALUEMEANING>Disease Progression</VALUEMEANING>
          <MEANINGDESCRIPTION>The worsening of a disease over time</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17747</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2816916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cytogenetic Resistance</VALIDVALUE>
          <VALUEMEANING>Cytogenetic resistance</VALUEMEANING>
          <MEANINGDESCRIPTION>The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.: A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41546, C16487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Symptomatic deterioriation</VALIDVALUE>
          <VALUEMEANING>Symptomatic deterioriation</VALUEMEANING>
          <MEANINGDESCRIPTION>Symptomatic deterioriation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5978786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Disease progression before active treatment</VALIDVALUE>
          <VALUEMEANING>Disease progression before active treatment</VALUEMEANING>
          <MEANINGDESCRIPTION>Disease progression before active treatment</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2017-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Why did treatment end or not</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Why did treatment end or not begin</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason Treatment Ended</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason RT Treatment Ended</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason Treatment did not begin</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Primary reason agent was stopped or never started</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason protocol treatment ended</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Primary reason HER2 therapy was stopped or never started</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Off treatment reason</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0278</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4058120</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0240</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104883</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0263</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229L</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229N</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0229O</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104892</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0249</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0250</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104897</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0258</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104898</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0261</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104899</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0277</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104900</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0225</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104913</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0252</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0275</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104991</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0269</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104995</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0279</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104996</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0241</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000172</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0262</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000175</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0225</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000421</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0225</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000422</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0252</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000589</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0252</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000590</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NSABP_TX_N_ADMIN_RSN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NSABP_TX_N_ADMIN_RSN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1563">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2404820</PUBLICID>
    <LONGNAME>Disease Suspicious Clinical Finding Ind-2</LONGNAME>
    <PREFERREDNAME>DZ_SUSP_C_FIND_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>a yes/no indicator to ask if signs and symptoms are present indicating possible detection of a pathologic process based on clinical manifestations observed by a physician or patient.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2404661</PublicId>
      <PreferredName>DZ_SUSP_CLIN_FINDING</PreferredName>
      <PreferredDefinition>related to signs and symptoms indicating the possible detection of a pathologic process based on clinical manifestations observed by a physician or patient.</PreferredDefinition>
      <LongName>Disease Suspicious Clinical Finding</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404658</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2404659</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0750493:C25398:C0037088</PreferredName>
        <Version>1</Version>
        <LongName>SUSPICIOUS Clinical Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0750493</PREFERRED_NAME>
            <LONG_NAME>SUSPICIOUS</LONG_NAME>
            <CON_ID>2205535</CON_ID>
            <DEFINITION_SOURCE>N/A</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25398</PREFERRED_NAME>
            <LONG_NAME>Clinical</LONG_NAME>
            <CON_ID>2203600</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0037088</PREFERRED_NAME>
            <LONG_NAME>Finding</LONG_NAME>
            <CON_ID>2203020</CON_ID>
            <DEFINITION_SOURCE>MSH2003_2003_05_12</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were there suspicious finding</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Were there suspicious findings?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Were there suspicious findings on bone scan or PET scan</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MCL-Lung-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Suspicious (yes/no)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506111</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Lung</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lung-Vanderbilt</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5506169</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5506111</PublicId>
          <ContextName>MCL</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Lung</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Imaging</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5506173</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>MCL</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MCL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1564">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2405488</PUBLICID>
    <LONGNAME>Specimen Transport Frozen Laboratory Specify</LONGNAME>
    <PREFERREDNAME>SPC_TRN_FRZ_LAB_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify the other reason a sample was shipped using dry ice.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2405483</PublicId>
      <PreferredName>SPEC_TRNSPRT_FRZ_LAB</PreferredName>
      <PreferredDefinition>information relating to frozen specimen transport to a lab.</PreferredDefinition>
      <LongName>Specimen Transport Frozen Laboratory</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2241613</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2405481</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL314684:CL267638:C37984</PreferredName>
        <Version>1</Version>
        <LongName>Transport Frozen Laboratory</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL314684</PREFERRED_NAME>
            <LONG_NAME>Transport</LONG_NAME>
            <CON_ID>2248171</CON_ID>
            <DEFINITION_SOURCE/>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL267638</PREFERRED_NAME>
            <LONG_NAME>Frozen</LONG_NAME>
            <CON_ID>2204514</CON_ID>
            <DEFINITION_SOURCE>No value exists.</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37984</PREFERRED_NAME>
            <LONG_NAME>Laboratory</LONG_NAME>
            <CON_ID>2202883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180669</PublicId>
      <PreferredName>SPEC_CHAR_SPEC</PreferredName>
      <PreferredDefinition>information related to specified characteristics of a specimen.</PreferredDefinition>
      <LongName>Specimen Characteristics Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Reason</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1565">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2423092</PUBLICID>
    <LONGNAME>Project Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2422892v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any piece of work that is undertaken or attempted._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Value Domain for java language Long datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2422892</PublicId>
      <PreferredName>2422768v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Any piece of work that is undertaken or attempted._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Project Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2422768</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47885</PreferredName>
        <Version>1</Version>
        <LongName>Project</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47885</PREFERRED_NAME>
            <LONG_NAME>Project</LONG_NAME>
            <CON_ID>2422635</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Project Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Project Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2611721</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CGWB</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cgwb.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000139</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2629622</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TrAPSS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>TrAPSS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812813</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2629622</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TrAPSS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.uiowa.clcg.trapss.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812814</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812747</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.workflow</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099477</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857183</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ProteomicsLIMS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.fccc.lims.protlims.domain.class.labproject</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812036</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000576</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.uiowa.clcg.trapss.domain.Project.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calab.domain.Project.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cgwb.domain.Project.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Project:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.fccc.lims.protlims.domain.class.labproject.Project.projectId</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Project:projectId</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.project.Project.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.workflow.Project.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1566">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2423688</PUBLICID>
    <LONGNAME>Specimen Collected IBCSG Specify</LONGNAME>
    <PREFERREDNAME>SPEC_COLL_IBCSG_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free text field to specify the status of a pathology specimen that was collected.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>IBCSG CRF:International Breast Cancer Study Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014993</PublicId>
      <PreferredName>SPEC_COLL</PreferredName>
      <PreferredDefinition>the sample collected from the patient for analysis or examination.</PreferredDefinition>
      <LongName>Specimen Collected</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177026</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specimen</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177590</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Collected</PreferredName>
        <Version>1</Version>
        <LongName>Collected</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25452</PREFERRED_NAME>
            <LONG_NAME>Collected</LONG_NAME>
            <CON_ID>2203888</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2421123</PublicId>
      <PreferredName>IBCSG_SPEC</PreferredName>
      <PreferredDefinition>the free text field to specify information for an IBCSG trial.</PreferredDefinition>
      <LongName>IBCSG Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>IBCSG CRF:International Breast Cancer Study Group Case Report Form</Origin>
      <Representation>
        <PublicId>2390957</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25685</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>give reason</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>give reason</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1567">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2429536</PUBLICID>
    <LONGNAME>Renal Sinus Invasion Status</LONGNAME>
    <PREFERREDNAME>RENL_SIN_INVASN_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>the status of a renal sinus invasion.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2429419</PublicId>
      <PreferredName>RENAL_SINUS_INVASION</PreferredName>
      <PreferredDefinition>information relating to invasion of the renal sinus.</PreferredDefinition>
      <LongName>Renal Sinus Invasion</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2429417</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25225:C33556</PreferredName>
        <Version>1</Version>
        <LongName>Renal Sinus</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25225</PREFERRED_NAME>
            <LONG_NAME>Renal</LONG_NAME>
            <CON_ID>2202803</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C33556</PREFERRED_NAME>
            <LONG_NAME>Sinus</LONG_NAME>
            <CON_ID>2429416</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2404647</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20625</PreferredName>
        <Version>1</Version>
        <LongName>Invasion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20625</PREFERRED_NAME>
            <LONG_NAME>Tumor Cell Invasion</LONG_NAME>
            <CON_ID>2203828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2429525</PublicId>
      <PreferredName>TUMOR_STATUS</PreferredName>
      <PreferredDefinition>the status of a tumor or a tumor-related feature.</PreferredDefinition>
      <LongName>Tumor Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cannot be assessed</VALIDVALUE>
          <VALUEMEANING>Cannot be assessed</VALUEMEANING>
          <MEANINGDESCRIPTION>Aspects of the context prevent the evaluation needed to determine a value.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48657</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No extrarenal tissues sampled</VALIDVALUE>
          <VALUEMEANING>No extrarenal tissues sampled</VALUEMEANING>
          <MEANINGDESCRIPTION>No extrarenal tissues sampled</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576974</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568053</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not sampled</VALIDVALUE>
          <VALUEMEANING>Not sampled</VALUEMEANING>
          <MEANINGDESCRIPTION>Not sampled</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-11-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576975</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Renal Sinus Invasion</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Renal Sinus Invasion</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1568">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2431903</PUBLICID>
    <LONGNAME>Transurethral Prostatic Resection Prostate Gland Surgical Pathology Specimen Missing Value Reason Surgical Procedure java.lang.String</LONGNAME>
    <PREFERREDNAME>2431506v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Surgical procedure to remove tissue from the prostate using an instrument inserted through the urethra.:The walnut shaped accessory sex gland of the male reproductive system.  It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra.  The prostate gland secretes a fluid which is part of the semen.:A field of anatomical pathology in which living tissue is surgically removed for the purpose of diagnosis and treatment.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A specific reason explaining why a meaningful value is not available.  A meaningful value answers the question posed by a Data Element Concept.  In contrast, a Missing Value Reason answers the implicit question &quot;Why is there no &#39;meaningful&#39; value?&quot;, when there is none.:Surgical Procedure is a diagnostic or treatment medical procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>CAP PROTOCOLS:College of American Pathologists Cancer Protocols</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2431506</PublicId>
      <PreferredName>2431311v1.0:2431207v1.0</PreferredName>
      <PreferredDefinition>Surgical procedure to remove tissue from the prostate using an instrument inserted through the urethra.:The walnut shaped accessory sex gland of the male reproductive system.  It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra.  The prostate gland secretes a fluid which is part of the semen.:A field of anatomical pathology in which living tissue is surgically removed for the purpose of diagnosis and treatment.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A specific reason explaining why a meaningful value is not available.  A meaningful value answers the question posed by a Data Element Concept.  In contrast, a Missing Value Reason answers the implicit question &quot;Why is there no &#39;meaningful&#39; value?&quot;, when there is none.:Surgical Procedure is a diagnostic or treatment medical procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue.</PreferredDefinition>
      <LongName>Transurethral Prostatic Resection Prostate Gland Surgical Pathology Specimen Missing Value Reason Surgical Procedure</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2431311</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15343:C12410:C16958:C19157</PreferredName>
        <Version>1</Version>
        <LongName>Transurethral Prostatic Resection Prostate Gland Surgical Pathology Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15343</PREFERRED_NAME>
            <LONG_NAME>Transurethral Prostatic Resection</LONG_NAME>
            <CON_ID>2431192</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12410</PREFERRED_NAME>
            <LONG_NAME>Prostate Gland</LONG_NAME>
            <CON_ID>2202794</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16958</PREFERRED_NAME>
            <LONG_NAME>Surgical Pathology</LONG_NAME>
            <CON_ID>2431154</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2431207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48655:C15329</PreferredName>
        <Version>1</Version>
        <LongName>Missing Value Reason Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48655</PREFERRED_NAME>
            <LONG_NAME>Missing Value Reason</LONG_NAME>
            <CON_ID>2431146</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CAP PROTOCOLS:College of American Pathologists Cancer Protocols</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Transurethral Prostatic Resection Prostate Gland Surgical Pathology Specimen Missing Value Reason Surgical Procedure java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Transurethral Prostatic Resection Prostate Gland Surgical Pathology Specimen Missing Value Reason Surgical Procedure java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857187</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CAP Cancer Checklists</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.upmc.opi.cabig.caties.cap.domain.prostate.transurethral_resection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812069</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.upmc.opi.cabig.caties.cap.domain.prostate.transurethral_resection.TransurethralResectionProstateSurgicalPathologySpecimen.surgicalProcedureMVR</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TransurethralResectionProstateSurgicalPathologySpecimen:surgicalProcedureMVR</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1569">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2433397</PUBLICID>
    <LONGNAME>Gene Version UniSTS Version java.lang.String</LONGNAME>
    <PREFERREDNAME>2433364v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).:A form or variant of a type or original._A comprehensive database of sequence tagged sites (STSs) derived from STS-based maps and other experiments providing a unified, non-redundant view of sequence tagged sites. UniSTS integrates marker and mapping data from a variety of public resources.:A form or variant of a type or original._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2433364</PublicId>
      <PreferredName>2433350v1.0:2433337v1.0</PreferredName>
      <PreferredDefinition>A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).:A form or variant of a type or original._A comprehensive database of sequence tagged sites (STSs) derived from STS-based maps and other experiments providing a unified, non-redundant view of sequence tagged sites. UniSTS integrates marker and mapping data from a variety of public resources.:A form or variant of a type or original.</PreferredDefinition>
      <LongName>Gene Version UniSTS Version</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2433350</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16612:C25714</PreferredName>
        <Version>1</Version>
        <LongName>Gene Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16612</PREFERRED_NAME>
            <LONG_NAME>Gene</LONG_NAME>
            <CON_ID>2202483</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2433337</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48815:C25714</PreferredName>
        <Version>1</Version>
        <LongName>UniSTS Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48815</PREFERRED_NAME>
            <LONG_NAME>UniSTS</LONG_NAME>
            <CON_ID>2433327</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Gene Version UniSTS Version java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Gene Version UniSTS Version java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2661628</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caFE Server</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.fe</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000308</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.fe.GeneVersion.uniSTSVersion</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GeneVersion:uniSTSVersion</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1570">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2436875</PUBLICID>
    <LONGNAME>Cancer Risk Genetic Testing Indicator</LONGNAME>
    <PREFERREDNAME>CA_RSK_GNTST_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>Text indicator to represent a record or history of an individual&#39;s analysis of DNA to look for a genetic alteration that may indicate an increased risk for developing cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2436865</PublicId>
      <PreferredName>CA_RSK_GNTST</PreferredName>
      <PreferredDefinition>Evaluation of an individual&#39;s DNA to look for a genetic alteration that may indicate an increased risk for developing cancer.</PreferredDefinition>
      <LongName>Cancer Risk Genetic Testing</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2183055</PublicId>
        <ContextName>TEST</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>DIAGNOSIS</PreferredName>
        <Version>3</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2436876</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18077</PreferredName>
        <Version>1</Version>
        <LongName>Cancer Risk</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18077</PREFERRED_NAME>
            <LONG_NAME>Cancer Risk</LONG_NAME>
            <CON_ID>2436861</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2436877</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15709</PreferredName>
        <Version>1</Version>
        <LongName>Genetic Testing</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15709</PREFERRED_NAME>
            <LONG_NAME>Genetic Testing</LONG_NAME>
            <CON_ID>2436862</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2181608</PublicId>
      <PreferredName>Y_N_CHAR_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes or No to a question.</PreferredDefinition>
      <LongName>Yes No Character Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Have you ever been tested for</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Have you ever been tested for genetic risks for cancer?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was participant previously tested:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was participant previously tested:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1571">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2438165</PUBLICID>
    <LONGNAME>Spontaneous Mutation Comment java.lang.String</LONGNAME>
    <PREFERREDNAME>2437961v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Happening or arising without apparent external cause.:A permanent change in the genetic material._A written explanation or criticism or illustration that is added to a book or other textual material._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2437961</PublicId>
      <PreferredName>2437806v1.0:2223274v1.0</PreferredName>
      <PreferredDefinition>Happening or arising without apparent external cause.:A permanent change in the genetic material._A written explanation or criticism or illustration that is added to a book or other textual material.</PreferredDefinition>
      <LongName>Spontaneous Mutation Comment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2437806</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48307:C16885</PreferredName>
        <Version>1</Version>
        <LongName>Spontaneous Mutation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48307</PREFERRED_NAME>
            <LONG_NAME>Spontaneous</LONG_NAME>
            <CON_ID>2437694</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16885</PREFERRED_NAME>
            <LONG_NAME>Mutation</LONG_NAME>
            <CON_ID>2224010</CON_ID>
            <DEFINITION_SOURCE>CABIO</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223274</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25393</PreferredName>
        <Version>1</Version>
        <LongName>Comment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25393</PREFERRED_NAME>
            <LONG_NAME>Comment</LONG_NAME>
            <CON_ID>2202716</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Spontaneous Mutation Comment java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Spontaneous Mutation Comment java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.SpontaneousMutation.comments</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SpontaneousMutation:comments</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1572">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2438186</PUBLICID>
    <LONGNAME>Contact Info Institution java.lang.String</LONGNAME>
    <PREFERREDNAME>2437982v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Information regarding the person who submitted the data (caBIO)_An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research as, a literary institution; also, a building or the buildings occupied or used by such organization._Value Domain for java language String datatype.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2437982</PublicId>
      <PreferredName>2224125v1.0:2230198v1.0</PreferredName>
      <PreferredDefinition>Information regarding the person who submitted the data (caBIO)_An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research as, a literary institution; also, a building or the buildings occupied or used by such organization.</PreferredDefinition>
      <LongName>Contact Info Institution</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2224125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41085</PreferredName>
        <Version>1</Version>
        <LongName>Contact Info</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41085</PREFERRED_NAME>
            <LONG_NAME>Person Contact Information</LONG_NAME>
            <CON_ID>2224019</CON_ID>
            <DEFINITION_SOURCE>CABIO</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2230198</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41206</PreferredName>
        <Version>1</Version>
        <LongName>Institution</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41206</PREFERRED_NAME>
            <LONG_NAME>Institution</LONG_NAME>
            <CON_ID>2228359</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Contact Info Institution java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Contact Info Institution java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2534690</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMOD_2.5</PreferredName>
          <Version>2.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.camod.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000547</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.camod.domain.ContactInfo.institute</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ContactInfo:institute</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1573">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2439994</PUBLICID>
    <LONGNAME>Lung Resection Type</LONGNAME>
    <PREFERREDNAME>LUNG_RESEC_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of lung resection.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2439992</PublicId>
      <PreferredName>LUNG_RESECTION</PreferredName>
      <PreferredDefinition>information relating to lung resection.</PreferredDefinition>
      <LongName>Lung Resection</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2399007</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12468</PreferredName>
        <Version>1</Version>
        <LongName>Lung</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12468</PREFERRED_NAME>
            <LONG_NAME>Lung</LONG_NAME>
            <CON_ID>2202738</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2439990</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15232</PreferredName>
        <Version>1</Version>
        <LongName>Resection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15232</PREFERRED_NAME>
            <LONG_NAME>Excision</LONG_NAME>
            <CON_ID>2202806</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2439993</PublicId>
      <PreferredName>LUNG_RESEC_TP</PreferredName>
      <PreferredDefinition>the type of lung resection.</PreferredDefinition>
      <LongName>Lung Resection Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intrapericardial pneumonectomy</VALIDVALUE>
          <VALUEMEANING>Intrapericardial pneumonectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Intrapericardial pneumonectomy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pneumonectomy</VALIDVALUE>
          <VALUEMEANING>Pneumonectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>(noo-mo-NEK-toe-mee) An operation to remove an entire lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15305</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lobectomy</VALIDVALUE>
          <VALUEMEANING>Lobectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>(lo-BEK-toe-mee) The removal of a lobe.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15272</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bilobectomy</VALIDVALUE>
          <VALUEMEANING>Bilobectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>A therapeutic surgical procedure involving the removal of two lobes of the right lung.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sleeve lobectomy</VALIDVALUE>
          <VALUEMEANING>Sleeve lobectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Sleeve lobectomy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lobectomy and chest wall resection</VALIDVALUE>
          <VALUEMEANING>Lobectomy and chest wall resection</VALUEMEANING>
          <MEANINGDESCRIPTION>Lobectomy and chest wall resection</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-12-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Segmentectomy</VALIDVALUE>
          <VALUEMEANING>Segmentectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Resection of a segment of an organ or partial resection of a gland.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91061</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3124185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wedge Resection</VALIDVALUE>
          <VALUEMEANING>Wedge Excision</VALUEMEANING>
          <MEANINGDESCRIPTION>Surgical removal of a triangular wedge shaped section of tissue.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51690</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-06-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3121807</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Minimally invasive</VALIDVALUE>
          <VALUEMEANING>Minimum Invasive</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest possible quantity.: Marked by a tendency to spread especially into healthy tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14159, C25570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104249</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invasive</VALIDVALUE>
          <VALUEMEANING>Invasive</VALUEMEANING>
          <MEANINGDESCRIPTION>Marked by a tendency to spread especially into healthy tissue.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14159</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-05-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575198</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Resection Type</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Resection Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Type of resection planned</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1574">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2442630</PUBLICID>
    <LONGNAME>Laboratory Procedure Oncotype DX Breast Cancer Assay Result Score</LONGNAME>
    <PREFERREDNAME>LAB_ONCODX_RSL_SC</PREFERREDNAME>
    <PREFERREDDEFINITION>the source of an Oncotype DX breast cancer assay, a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2442628</PublicId>
      <PreferredName>LAB_ONCOTPDX_RSLT</PreferredName>
      <PreferredDefinition>information related the result of the medical procedure that involves testing a tissue sample by Oncotype DX breast cancer assay, a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100).</PreferredDefinition>
      <LongName>Laboratory Procedure Oncotype DX Breast Cancer Assay Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738969</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52159:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Oncotype DX Breast Cancer Assay Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52159</PREFERRED_NAME>
            <LONG_NAME>Oncotype DX Breast Cancer Assay</LONG_NAME>
            <CON_ID>2442615</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2442629</PublicId>
      <PreferredName>ONCOTPDX_SC</PreferredName>
      <PreferredDefinition>The Oncotype DX score.</PreferredDefinition>
      <LongName>Oncotype DX Breast Cancer Assay Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue>100</MaximumValue>
      <MinimumValue>0</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2193207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Oncotype DX Recurrence Score</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Oncotype DX Recurrence Score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Recurrence Score Result</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>MA39</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Oncotype Dx Recurrence Score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Oncotype Dx Score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716207</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ASCO</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer Adjuvant Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812713</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2015-06-04</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5280815</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCTG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_ONCODX_RSL_SC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1575">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2442944</PUBLICID>
    <LONGNAME>Uterus Removed Age Category</LONGNAME>
    <PREFERREDNAME>UTERUS_RMVD_AGE_CAT</PREFERREDNAME>
    <PREFERREDDEFINITION>The age the participant had her uterus or womb removed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2011501</PublicId>
      <PreferredName>HYSTERECT_PERF</PreferredName>
      <PreferredDefinition>information related to a hysterectomy being performed.</PreferredDefinition>
      <LongName>Hysterectomy Performed</LongName>
      <Version>3</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2211764</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>C15256</PreferredName>
        <Version>1</Version>
        <LongName>Hysterectomy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15256</PREFERRED_NAME>
            <LONG_NAME>Hysterectomy</LONG_NAME>
            <CON_ID>2211763</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2184322</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Performed</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2442942</PublicId>
      <PreferredName>UTERUS_RMVD_AGE_CAT</PreferredName>
      <PreferredDefinition>The age the participant had her uterus or womb removed.</PreferredDefinition>
      <LongName>Uterus Removed Age Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008542</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>REPRODUCTION</PreferredName>
        <Version>1</Version>
        <LongName>Reproduction</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2433877</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25372</PreferredName>
        <Version>1</Version>
        <LongName>Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Less than 40</VALIDVALUE>
          <VALUEMEANING>Less than 40</VALUEMEANING>
          <MEANINGDESCRIPTION>Less than 40</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>40-44</VALIDVALUE>
          <VALUEMEANING>40-44</VALUEMEANING>
          <MEANINGDESCRIPTION>40-44</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>45-49</VALIDVALUE>
          <VALUEMEANING>45-49</VALUEMEANING>
          <MEANINGDESCRIPTION>45-49</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>50-54</VALIDVALUE>
          <VALUEMEANING>50-54</VALUEMEANING>
          <MEANINGDESCRIPTION>50-54</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>55 or older</VALIDVALUE>
          <VALUEMEANING>55 or older</VALUEMEANING>
          <MEANINGDESCRIPTION>55 or older</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the age when you had</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the age when you had your uterus or womb removed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193113</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCEG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CGEMS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812078</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1576">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2442973</PUBLICID>
    <LONGNAME>Pelvic Examination Response Text Type</LONGNAME>
    <PREFERREDNAME>PLVCEXAM_RESP_TXT_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>The response to a question that asks whether the participant has had a pelvic examination within the last three years.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2442971</PublicId>
      <PreferredName>PELVIC_EXAM_ASSESS</PreferredName>
      <PreferredDefinition>Information related to a pelvic examination assessment.</PreferredDefinition>
      <LongName>Pelvic Examination Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2442969</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25399:C25305</PreferredName>
        <Version>1</Version>
        <LongName>Pelvic Exam</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25399</PREFERRED_NAME>
            <LONG_NAME>Pelvic</LONG_NAME>
            <CON_ID>2204851</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25305</PREFERRED_NAME>
            <LONG_NAME>Medical Examination Assessment</LONG_NAME>
            <CON_ID>2202633</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233077</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25367</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2442958</PublicId>
      <PreferredName>PROC_TST_RESP_TXT_TP</PreferredName>
      <PreferredDefinition>The response to a question that asks if the participant has had a procedure or test.</PreferredDefinition>
      <LongName>Procedure/Test Response Text Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2208031</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704:C0332307</PreferredName>
        <Version>1</Version>
        <LongName>Text Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0332307</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2203010</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, once</VALIDVALUE>
          <VALUEMEANING>Yes, once</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, once</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, more than once</VALIDVALUE>
          <VALUEMEANING>Yes, more than once</VALUEMEANING>
          <MEANINGDESCRIPTION>Yes, more than once</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Don&#39;t know</VALIDVALUE>
          <VALUEMEANING>Don&#39;t know</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573786</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>During the past three years,</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>During the past three years, have you had a pelvic examination?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193113</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCEG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CGEMS</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812078</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1577">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2448317</PUBLICID>
    <LONGNAME>Practitioners Engaged in Applied Research and Learning Network Information Received Type</LONGNAME>
    <PREFERREDNAME>PEARLN_INFO_RCVD_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of information about the PEARL network, an infrastructure to conduct office-based research that will answer the questions facing general dental practitioners in the routine care of their patients, having been received.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2443653</PublicId>
      <PreferredName>PEARL_INFO_RCVD</PreferredName>
      <PreferredDefinition>information related to information about the PEARL network, an infrastructure to conduct office-based research that will answer the questions facing general dental practitioners in the routine care of their patients, having been received.</PreferredDefinition>
      <LongName>Practitioners Engaged in Applied Research and Learning Network Information Received</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52664</PreferredName>
        <Version>1</Version>
        <LongName>Practitioners Engaged in Applied Research and Learning Network</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52664</PREFERRED_NAME>
            <LONG_NAME>Practitioners Engaged in Applied Research and Learning Network</LONG_NAME>
            <CON_ID>2443148</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2443651</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48191:C25639</PreferredName>
        <Version>1</Version>
        <LongName>Information Received</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48191</PREFERRED_NAME>
            <LONG_NAME>Information</LONG_NAME>
            <CON_ID>2422630</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2445977</PublicId>
      <PreferredName>PEARLN_REC_TP</PreferredName>
      <PreferredDefinition>the type received of an infrastructure to conduct office-based research that will answer the questions facing general dental practitioners in the routine care of their patients.</PreferredDefinition>
      <LongName>Practitioners Engaged in Applied Research and Learning Network Received Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Letter from NYU</VALIDVALUE>
          <VALUEMEANING>Letter from NYU</VALUEMEANING>
          <MEANINGDESCRIPTION>Letter from NYU (New York University)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577636</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Email from NYU</VALIDVALUE>
          <VALUEMEANING>Email from NYU</VALUEMEANING>
          <MEANINGDESCRIPTION>Email from NYU (New York University)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577637</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NYU Part-time Newsletter</VALIDVALUE>
          <VALUEMEANING>NYU Part-time Newsletter</VALUEMEANING>
          <MEANINGDESCRIPTION>NYU Part-time Newsletter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577638</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Letter/email from AGD</VALIDVALUE>
          <VALUEMEANING>Letter/email from AGD</VALUEMEANING>
          <MEANINGDESCRIPTION>Letter/email from AGD</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Letter/email from Levin Group</VALIDVALUE>
          <VALUEMEANING>Letter/email from Levin Group</VALUEMEANING>
          <MEANINGDESCRIPTION>Letter/email from Levin Group</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577641</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Letter from MetLife</VALIDVALUE>
          <VALUEMEANING>Letter from MetLife</VALUEMEANING>
          <MEANINGDESCRIPTION>Letter from MetLife</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577642</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Personal Contact</VALIDVALUE>
          <VALUEMEANING>Personal Contact</VALUEMEANING>
          <MEANINGDESCRIPTION>Personal Contact</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577643</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other source</VALIDVALUE>
          <VALUEMEANING>Other source</VALUEMEANING>
          <MEANINGDESCRIPTION>Other source</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-02-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577644</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How did you hear about the PE</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How did you hear about the PEARL Network</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1578">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2466064</PUBLICID>
    <LONGNAME>Serum Protein Electrophoresis Assessment Date</LONGNAME>
    <PREFERREDNAME>SRMPRT_ELEC_ASESS_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date of a serum protein electrophoresis assessment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2466063</PublicId>
      <PreferredName>SRMPRT_ELECPHR_ASESS</PreferredName>
      <PreferredDefinition>information relating to a serum protein electrophoresis assessment.</PreferredDefinition>
      <LongName>Serum Protein Electrophoresis Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2466061</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13325:C17021:C16539</PreferredName>
        <Version>1</Version>
        <LongName>Serum Protein Polyacrylamide Gel Electrophoresis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13325</PREFERRED_NAME>
            <LONG_NAME>Serum</LONG_NAME>
            <CON_ID>2203797</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17021</PREFERRED_NAME>
            <LONG_NAME>Protein</LONG_NAME>
            <CON_ID>2202792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16539</PREFERRED_NAME>
            <LONG_NAME>Polyacrylamide Gel Electrophoresis</LONG_NAME>
            <CON_ID>2466060</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2261670</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20989</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1579">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2468768</PUBLICID>
    <LONGNAME>Stereotactic Radiosurgery Therapy First Metastatic Malignant Neoplasm to the Brain Administered Date</LONGNAME>
    <PREFERREDNAME>SRS_TX_F_MET_ADM_DT</PREFERREDNAME>
    <PREFERREDDEFINITION>the date that stereotactic radiosurgery was administered to the first brain lesion.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2468764</PublicId>
      <PreferredName>SRS_TX_F_MET_ADM</PreferredName>
      <PreferredDefinition>information related to stereotactic radiosurgery, high-dose radiation is administered through openings in the head frame to the tumor while decreasing the amount of radiation given to normal brain tissue, administered as therapy to the first neoplasm from a primary site to the brain.</PreferredDefinition>
      <LongName>Stereotactic Radiosurgery Therapy First Metastatic Malignant Neoplasm to the Brain Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2468761</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15358:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Stereotactic Radiosurgery Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15358</PREFERRED_NAME>
            <LONG_NAME>Stereotactic Radiosurgery</LONG_NAME>
            <CON_ID>2468760</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2468762</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C3813:C25382</PreferredName>
        <Version>1</Version>
        <LongName>First Metastatic Malignant Neoplasm to the Brain Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3813</PREFERRED_NAME>
            <LONG_NAME>Metastatic Malignant Neoplasm in the Brain</LONG_NAME>
            <CON_ID>2464448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date first lesion(s) treated</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date first lesion(s) treated</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1580">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2475548</PUBLICID>
    <LONGNAME>Report Section Document Fragment java.lang.String</LONGNAME>
    <PREFERREDNAME>2475357v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A short textual account.:One of several parts or pieces that fit with others to constitute a whole object; a self-contained part of a larger composition (written or musical)._A writing that contains information; used here to represent any thing that is categorized by writing..:A part of a larger entity._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2475357</PublicId>
      <PreferredName>2475319v1.0:2388848v1.0</PreferredName>
      <PreferredDefinition>A short textual account.:One of several parts or pieces that fit with others to constitute a whole object; a self-contained part of a larger composition (written or musical)._A writing that contains information; used here to represent any thing that is categorized by writing..:A part of a larger entity.</PreferredDefinition>
      <LongName>Report Section Document Fragment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2475319</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25375:C54091</PreferredName>
        <Version>1</Version>
        <LongName>Report Section</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25375</PREFERRED_NAME>
            <LONG_NAME>Report</LONG_NAME>
            <CON_ID>2202481</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54091</PREFERRED_NAME>
            <LONG_NAME>Section</LONG_NAME>
            <CON_ID>2475257</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2388848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19498:C48295</PreferredName>
        <Version>1</Version>
        <LongName>Document Fragment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19498</PREFERRED_NAME>
            <LONG_NAME>Document</LONG_NAME>
            <CON_ID>2223216</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48295</PREFERRED_NAME>
            <LONG_NAME>Fragment</LONG_NAME>
            <CON_ID>2388822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Report Section Document Fragment java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Report Section Document Fragment java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2475251</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTIES 2.0</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.upmc.opi.caBIG.caTIES.database.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812153</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2475251</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTIES 2.0</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caTIES</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812488</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.upmc.opi.caBIG.caTIES.database.domain.ReportSection.documentFragment</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ReportSection:documentFragment</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1581">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2475598</PUBLICID>
    <LONGNAME>NCI Thesaurus Concept Version java.lang.Long</LONGNAME>
    <PREFERREDNAME>2475406v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A concept is the basic unit of information contained in the Thesaurus. They describe sets of individuals in a given domain. A concept has a name, belongs to a Namespace and exists in relation to other concepts. The vertical relationships consist of &quot;isa&quot; statements that form a logical hierarchy (taxonomy or subsumption graph). In general, concepts above a given concept are referred to as superconcepts or parents and those below as subconcepts or children. In addition, there are horizontal named realationships between concepts called Roles, binary relations between concepts that provide a machine-interpretable definition of a concept and the means for discrimination of sibling concepts. A concept may also include Properties, named slots that allow attachment of external information to concepts._A form or variant of a type or original._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2475406</PublicId>
      <PreferredName>2475324v1.0:2231602v1.0</PreferredName>
      <PreferredDefinition>A concept is the basic unit of information contained in the Thesaurus. They describe sets of individuals in a given domain. A concept has a name, belongs to a Namespace and exists in relation to other concepts. The vertical relationships consist of &quot;isa&quot; statements that form a logical hierarchy (taxonomy or subsumption graph). In general, concepts above a given concept are referred to as superconcepts or parents and those below as subconcepts or children. In addition, there are horizontal named realationships between concepts called Roles, binary relations between concepts that provide a machine-interpretable definition of a concept and the means for discrimination of sibling concepts. A concept may also include Properties, named slots that allow attachment of external information to concepts._A form or variant of a type or original.</PreferredDefinition>
      <LongName>NCI Thesaurus Concept Version</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2475324</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43821</PreferredName>
        <Version>1</Version>
        <LongName>NCI Thesaurus Concept</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43821</PREFERRED_NAME>
            <LONG_NAME>NCI Thesaurus Concept</LONG_NAME>
            <CON_ID>2231595</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231602</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25714</PreferredName>
        <Version>1</Version>
        <LongName>Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element NCI Thesaurus Concept Version java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element NCI Thesaurus Concept Version java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2475251</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTIES 2.0</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.upmc.opi.caBIG.caTIES.database.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812153</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2475251</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTIES 2.0</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caTIES</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812488</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Concept:version</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.upmc.opi.caBIG.caTIES.database.domain.Concept.version</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1582">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2480039</PUBLICID>
    <LONGNAME>Protocol Screen Indicator</LONGNAME>
    <PREFERREDNAME>PROT_SCRN_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>A yes/no question that asks whether the participant was a screen failure.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2184689</PublicId>
      <PreferredName>PROT_SCRN</PreferredName>
      <PreferredDefinition>A human being._A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.:A systematic examination or assessment.</PreferredDefinition>
      <LongName>Person Protocol Screen</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>5633268</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C71104</PreferredName>
        <Version>1</Version>
        <LongName>Person Clinical Trial</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71104</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial</LONG_NAME>
            <CON_ID>2735720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2680362</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48261</PreferredName>
        <Version>1</Version>
        <LongName>Screening</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48261</PREFERRED_NAME>
            <LONG_NAME>Screening</LONG_NAME>
            <CON_ID>2437683</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>CCR:Center for Cancer Research</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2015873</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>A choice of Yes and No answer.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008509</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPORES</PreferredName>
        <Version>2.31</Version>
        <LongName>SPOREs</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>YES</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question or activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-03-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2560453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NO</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559515</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is the participant a screen f</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the participant a screen failure?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP v2 Template Question</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this participant a screen failure?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms Version 3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2957372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Lombardi Cancer Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barretts Esophagus - ASA-Esomeprazole</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Sulindac</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812154</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sporadic Colorectal Neoplasia - Atrovastatin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812155</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>9cUAB30</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812551</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Transdermal 4-OHT vs oral TAM DCIS of the Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812736</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Myo-Inositol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812876</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Erlotinib - Lesions of Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2813064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Sulindac DFMO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2859628</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E in Women w/ Modulation of Arachidonic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2936518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Cholecalciferol and Genistein</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3114163</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Lung Pre-Surgical NSCLC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3152820</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barrett&#39;s Esophagus Chemoprevention Metformin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3211792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UAB30 in NMSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3293737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pomegranate - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3303133</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2014-03-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528053</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>OHSU Knight</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PROT_SCRN_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1583">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2486626</PUBLICID>
    <LONGNAME>Prior Therapy Administered Type</LONGNAME>
    <PREFERREDNAME>PRIOR_TX_ADM_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>The type of treatment previously given to a participant for cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2197794</PublicId>
      <PreferredName>PRIOR_TX_ADM</PreferredName>
      <PreferredDefinition>information related to the prior therapy administered.</PreferredDefinition>
      <LongName>Prior Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3693401</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25629:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Prior Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177665</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Administered</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2486620</PublicId>
      <PreferredName>PRIOR_TX_ADM_TP</PreferredName>
      <PreferredDefinition>A type of treatment previously given to a participant for cancer.</PreferredDefinition>
      <LongName>Prior Therapy Administered Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemotherapy (NOS)</VALIDVALUE>
          <VALUEMEANING>Non-systemic chemotherapy treatment or chemotherapy not described by Chemotherapy Single Agent Systemic or Multi-Agent Systemic</VALUEMEANING>
          <MEANINGDESCRIPTION>Non-systemic chemotherapy treatment or chemotherapy not described by Chemotherapy Single Agent Systemic or Multi-Agent Systemic</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2003-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567118</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Radiation therapy</VALIDVALUE>
          <VALUEMEANING>Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567129</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Surgery</VALIDVALUE>
          <VALUEMEANING>Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2912042</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hormonal Therapy</VALIDVALUE>
          <VALUEMEANING>Endocrine Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy. The concept covers but not limited to: intermittent or permanent hormone suppression or ablation in treatment of hormone-dependent tumors, hormone replacement therapy of any kind, hormonal component of gender reassignment therapy, hormonal contraception, surgical and radiation castration.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021569</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neo-Adjuvant</VALIDVALUE>
          <VALUEMEANING>Neoadjuvant Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15665</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580142</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adjuvant</VALIDVALUE>
          <VALUEMEANING>Adjuvant</VALUEMEANING>
          <MEANINGDESCRIPTION>An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2140</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3646981</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-11-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chemotherapy</VALIDVALUE>
          <VALUEMEANING>Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15632</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-11-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anti-androgen therapy</VALIDVALUE>
          <VALUEMEANING>Antiandrogen Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment with drugs used to block production or interfere with the action of male sex hormones.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15481</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-11-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5053421</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Breast Surgery</VALIDVALUE>
          <VALUEMEANING>Breast Surgery</VALUEMEANING>
          <MEANINGDESCRIPTION>One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.: The branch of medical science that treats disease or injury by operative procedures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12971, C17173</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-06-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5036372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Targeted biological therapy</VALIDVALUE>
          <VALUEMEANING>Targeted Biological Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>The process of directing an agent to a specific anatomic location.: A form of treatment that implies the administration of substances which produce a biological reaction in the organism thus enhancing or restoring the host immune response, modifying the behavior of cancer cells, blocking the pathways of cell neoplastic transformation and tumor ability to metastasize, or facilitating the repair of cells damaged by aggressive forms of cancer treatment.  It includes the use of sera, antitoxins, vaccines, genes, cells, tissues, and organs.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15187, C64542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5622073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Percutaneous ablation</VALIDVALUE>
          <VALUEMEANING>Percutaneous Ablation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Administration through the skin.: Removal, separation, detachment, extirpation, or eradication of a body part, pathway, or function by surgery, chemical destruction, morbid process, or noxious substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20985, C38676</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5622070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Transarterial chemoembolization</VALIDVALUE>
          <VALUEMEANING>Transarterial Chemoembolization</VALUEMEANING>
          <MEANINGDESCRIPTION>A hepatic artery embolization technique involving the injection of a blocking agent and a chemotherapy agent to treat liver cancers.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101513</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5622072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ablation therapy</VALIDVALUE>
          <VALUEMEANING>Ablation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Removal, separation, detachment, extirpation, or eradication of a body part, pathway, or function by surgery, chemical destruction, morbid process, or noxious substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C20985</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5633958</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>No Prior Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>No prior treatment for the study disorder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6060343</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systemic therapy</VALIDVALUE>
          <VALUEMEANING>Systemic Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-09-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5028391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously treated with systemic therapy</VALIDVALUE>
          <VALUEMEANING>Systemic Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15698</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5028391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Treatment naive</VALIDVALUE>
          <VALUEMEANING>No Prior Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>No prior treatment for the study disorder.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C118903</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6060343</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Therapy Type</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Therapy Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior treatment regimen type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CITN</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Line of Therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Prior Treatment</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior Treatment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Polyphenon E - Hormone Receptor-Negative Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812174</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Erlotinib - Lesions of Lung</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2813064</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2014-04-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5441476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRIOR_TX_ADM_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1584">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2494828</PUBLICID>
    <LONGNAME>Prior Aromatase Inhibitor Received Month Duration</LONGNAME>
    <PREFERREDNAME>P_AI_RCVD_M_DUR</PREFERREDNAME>
    <PREFERREDDEFINITION>the number of months that patient previously was administered aromatase inhibitor.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2011991</PublicId>
      <PreferredName>PRI_AROMINHIB_RECVD</PreferredName>
      <PreferredDefinition>information related to prior aromatase inhibitor received.</PreferredDefinition>
      <LongName>Prior Aromatase Inhibitor Received</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2221302</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>C25629:C1740</PreferredName>
        <Version>1</Version>
        <LongName>Prior Aromatase Inhibitor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25629</PREFERRED_NAME>
            <LONG_NAME>Prior</LONG_NAME>
            <CON_ID>2204016</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1740</PREFERRED_NAME>
            <LONG_NAME>Aromatase Inhibitor</LONG_NAME>
            <CON_ID>2221301</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2184327</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Received</PreferredName>
        <Version>1</Version>
        <LongName>Received</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2494827</PublicId>
      <PreferredName>M_DUR</PreferredName>
      <PreferredDefinition>the number of months during which an event occurred.</PreferredDefinition>
      <LongName>Month Duration</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue>1</MinimumValue>
      <Origin/>
      <Representation>
        <PublicId>2480485</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C29846:C25330</PreferredName>
        <Version>1</Version>
        <LongName>Month Duration</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29846</PREFERRED_NAME>
            <LONG_NAME>Month</LONG_NAME>
            <CON_ID>2202580</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25330</PREFERRED_NAME>
            <LONG_NAME>Duration</LONG_NAME>
            <CON_ID>2202512</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cumulative Duration of AIs</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cumulative Duration of AIs</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1585">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2497529</PUBLICID>
    <LONGNAME>Treatment Cohort Indicator</LONGNAME>
    <PREFERREDNAME>TX_COHORT_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator used to represent a treatment assignment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2497526</PublicId>
      <PreferredName>TX_COHORT_STDY</PreferredName>
      <PreferredDefinition>Medical care intended to treat or cure a condition or lessen its symptoms. This includes the administration of drugs, surgical procedures, physical or psychotherapy, or the use of therapeutic devices.:A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).</PreferredDefinition>
      <LongName>Therapeutic Procedure Cohort Study</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2512834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2497524</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15208</PreferredName>
        <Version>1</Version>
        <LongName>Cohort Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15208</PREFERRED_NAME>
            <LONG_NAME>Cohort Study</LONG_NAME>
            <CON_ID>2497523</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2497527</PublicId>
      <PreferredName>TX_COHORT_IND</PreferredName>
      <PreferredDefinition>The indicator used to represent a treatment assignment.</PreferredDefinition>
      <LongName>Treatment Cohort Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Treatment</VALIDVALUE>
          <VALUEMEANING>Treatment</VALUEMEANING>
          <MEANINGDESCRIPTION>Treatment Intent</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-07-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Treatment</VALIDVALUE>
          <VALUEMEANING>No Treatment</VALUEMEANING>
          <MEANINGDESCRIPTION>No Treatment for Adverse Event</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-07-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571551</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Treatment Cohort</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Treatment Cohort</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Atrovastatin in Women at High Risk for Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812183</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1586">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2509360</PUBLICID>
    <LONGNAME>Tooth Sensitivity Other Assessment Scale</LONGNAME>
    <PREFERREDNAME>PT_O_SNS_T_ASS_SCA</PREFERREDNAME>
    <PREFERREDDEFINITION>the patient&#39;s assessment of his/her tooth&#39;s sensitivity or ability to respond to other unexpected stimuli.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2500510</PublicId>
      <PreferredName>PT_O_SNS_T_ASSESS</PreferredName>
      <PreferredDefinition>information related to the assessment of other sensitivity (the ability to respond to physical stimuli or to register small physical amounts or differences) in patient&#39;s hard bonelike structures in the jaws of vertebrates.</PreferredDefinition>
      <LongName>Tooth Sensitivity Other Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3201262</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12506:C25201</PreferredName>
        <Version>1</Version>
        <LongName>Tooth Sensitivity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12506</PREFERRED_NAME>
            <LONG_NAME>Tooth</LONG_NAME>
            <CON_ID>2202581</CON_ID>
            <DEFINITION_SOURCE>UWDA142</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25201</PREFERRED_NAME>
            <LONG_NAME>Sensitivity</LONG_NAME>
            <CON_ID>2203788</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2795795</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C25367</PreferredName>
        <Version>1</Version>
        <LongName>Other Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25367</PREFERRED_NAME>
            <LONG_NAME>Assessment</LONG_NAME>
            <CON_ID>2203593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2504090</PublicId>
      <PreferredName>OHIP_SCALE</PreferredName>
      <PreferredDefinition>a scaled index of the social impact of oral disorders which draws on a theoretical heirarchy of  oral health outcomes (Oral Health Impact Profile).</PreferredDefinition>
      <LongName>Oral Health Impact Profile Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2452834</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25664</PreferredName>
        <Version>1</Version>
        <LongName>Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not at all</VALIDVALUE>
          <VALUEMEANING>Not at all</VALUEMEANING>
          <MEANINGDESCRIPTION>A subjective answer of no agreement, ability, or occurrence whatsoever.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-05-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561180</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hardly ever</VALIDVALUE>
          <VALUEMEANING>Hardly ever</VALUEMEANING>
          <MEANINGDESCRIPTION>Hardly ever</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580453</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Occasionally</VALIDVALUE>
          <VALUEMEANING>OCCASIONALLY</VALUEMEANING>
          <MEANINGDESCRIPTION>OCCASIONALLY</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fairly often</VALIDVALUE>
          <VALUEMEANING>Fairly often</VALUEMEANING>
          <MEANINGDESCRIPTION>Fairly often</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2580454</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very often</VALIDVALUE>
          <VALUEMEANING>VERY OFTEN</VALUEMEANING>
          <MEANINGDESCRIPTION>VERY OFTEN</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>I experience unexpected pain</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>I experience unexpected pain in this tooth</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>I experience pain or discomfort in the teeth other than the implant</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnostic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812084</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PEARL</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812039</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3232580</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRL0602</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3232568</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3232580</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PRL0602</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.nidcr.prl0602</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3232569</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIDCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.nidcr.prl0602.ToothSensitivity.other_Sensitivity_Tooth_A</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NIDCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ToothSensitivity:other_Sensitivity_Tooth_A</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1587">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2513799</PUBLICID>
    <LONGNAME>Cancer Research Group Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2513533v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A collection of scientist and/or clinician users with a common research objective related to diagnosis and treatment of cancer._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2513533</PublicId>
      <PreferredName>2513389v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A collection of scientist and/or clinician users with a common research objective related to diagnosis and treatment of cancer._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Cancer Research Group Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2513389</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48168</PreferredName>
        <Version>1</Version>
        <LongName>Cancer Research Group</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48168</PREFERRED_NAME>
            <LONG_NAME>Cancer Research Group</LONG_NAME>
            <CON_ID>2513280</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Cancer Research Group Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Cancer Research Group Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2553133</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812526</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2661745</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_caArray</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000636</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2680967</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000633</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000638</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000639</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.CancerResearchGroup.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CancerResearchGroup:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domainobject.CancerResearchGroup.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1588">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2520443</PUBLICID>
    <LONGNAME>Caries Radiography Assessment Depth Measurement</LONGNAME>
    <PREFERREDNAME>CAR_RAD_ASS_DPT_MEAS</PREFERREDNAME>
    <PREFERREDDEFINITION>the depth measurement from the evaluation of decay of a tooth, in which it becomes softened, discolored, and/or porous by radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2503700</PublicId>
      <PreferredName>CAR_RAD_ASSESS</PreferredName>
      <PreferredDefinition>information related to the evaluation of decay of a tooth, in which it becomes softened, discolored, and/or porous by radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation.</PreferredDefinition>
      <LongName>Caries Radiography Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443776</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C52593</PreferredName>
        <Version>1</Version>
        <LongName>Caries</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52593</PREFERRED_NAME>
            <LONG_NAME>Caries</LONG_NAME>
            <CON_ID>2443118</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2503698</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38101:C20989</PreferredName>
        <Version>1</Version>
        <LongName>Radiography Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38101</PREFERRED_NAME>
            <LONG_NAME>X-Ray Imaging</LONG_NAME>
            <CON_ID>2429874</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2520189</PublicId>
      <PreferredName>CARIES_DEPTH_MSRMT</PreferredName>
      <PreferredDefinition>information related to the deepness measurement of the decay of a tooth, in which it becomes softened, discolored, and/or porous.</PreferredDefinition>
      <LongName>Caries Depth Measurement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <UnitOfMeasure>mm</UnitOfMeasure>
      <DisplayFormat>9999999</DisplayFormat>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2520188</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25333:C25209</PreferredName>
        <Version>1</Version>
        <LongName>Depth Measure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25333</PREFERRED_NAME>
            <LONG_NAME>Depth</LONG_NAME>
            <CON_ID>2203893</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Radiographic depth of lesion</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Radiographic depth of lesion</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1589">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2528197</PUBLICID>
    <LONGNAME>Prostate Quality of Life Urinary Frequency Problem Type</LONGNAME>
    <PREFERREDNAME>PRS_QOL_UR_FRQ_PR_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>a scaled set of values rating changes in routines for daily living due to increase in urgency or occasions to excrete urine from the bladder due to interference from symptoms of prostate cancer.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2528107</PublicId>
      <PreferredName>PRS_QOL_URN_FRQ_PROB</PreferredName>
      <PreferredDefinition>related to changes in routines for daily living due to increase in urgency or occasions to excrete urine from the bladder due to interference from symptoms of prostate cancer.</PreferredDefinition>
      <LongName>Prostate Quality of Life Urinary Frequency Problem</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2527736</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12410:C17047</PreferredName>
        <Version>1</Version>
        <LongName>Prostate Quality of Life</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12410</PREFERRED_NAME>
            <LONG_NAME>Prostate Gland</LONG_NAME>
            <CON_ID>2202794</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17047</PREFERRED_NAME>
            <LONG_NAME>Quality of Life</LONG_NAME>
            <CON_ID>2202504</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528105</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C26906:C28020</PreferredName>
        <Version>1</Version>
        <LongName>Urinary Frequency Problem</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26906</PREFERRED_NAME>
            <LONG_NAME>Urinary Frequency</LONG_NAME>
            <CON_ID>2203691</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28020</PREFERRED_NAME>
            <LONG_NAME>Problem</LONG_NAME>
            <CON_ID>2203953</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2527724</PublicId>
      <PreferredName>PRS_QOL_PROB_TP</PreferredName>
      <PreferredDefinition>a scaled set of values rating interference of prostate cancer symptoms with activities of daily living.</PreferredDefinition>
      <LongName>Prostate Quality of Life Problem Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
      <Representation>
        <PublicId>2177853</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No problem</VALIDVALUE>
          <VALUEMEANING>No Problem</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.: A difficulty, disorder, or condition needing resolution. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28020, C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Very small problem</VALIDVALUE>
          <VALUEMEANING>MILD PROBLEM</VALUEMEANING>
          <MEANINGDESCRIPTION>MILD PROBLEM</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Small problem</VALIDVALUE>
          <VALUEMEANING>MILD TO MODERATE PROBLEM</VALUEMEANING>
          <MEANINGDESCRIPTION>MILD TO MODERATE PROBLEM</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate problem</VALIDVALUE>
          <VALUEMEANING>MODERATE PROBLEM</VALUEMEANING>
          <MEANINGDESCRIPTION>MODERATE PROBLEM</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561602</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Big problem</VALIDVALUE>
          <VALUEMEANING>SEVERE PROBLEM</VALUEMEANING>
          <MEANINGDESCRIPTION>SEVERE PROBLEM</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-10-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561608</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Need to urinate frequently du</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Need to urinate frequently during the day</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-0924</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4171065</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>epic_33</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PRS_QOL_UR_FRQ_PR_TP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1590">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2529184</PUBLICID>
    <LONGNAME>Gene Expression Fold Change Finding Normal Intensity java.lang.Double</LONGNAME>
    <PREFERREDNAME>2528889v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:An indication of the magnitude difference between two values specified as the number of multiples of the first value to the second value (e.g., from 10 to 20 is a 2-fold increase, from 10 to 50 is a five-fold increase).:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom)._Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.:The degree or magnitude of strength, energy, or feeling._Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2528889</PublicId>
      <PreferredName>2528738v1.0:2718286v1.0</PreferredName>
      <PreferredDefinition>Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:An indication of the magnitude difference between two values specified as the number of multiples of the first value to the second value (e.g., from 10 to 20 is a 2-fold increase, from 10 to 50 is a five-fold increase).:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom)._Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.:The degree or magnitude of strength, energy, or feeling.</PreferredDefinition>
      <LongName>Gene Expression Fold Change Finding Normal Intensity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528738</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16608:C60693:C3367</PreferredName>
        <Version>1</Version>
        <LongName>Gene Expression Fold Change Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16608</PREFERRED_NAME>
            <LONG_NAME>Gene Expression</LONG_NAME>
            <CON_ID>2203923</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60693</PREFERRED_NAME>
            <LONG_NAME>Fold Change</LONG_NAME>
            <CON_ID>2528541</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3367</PREFERRED_NAME>
            <LONG_NAME>Finding</LONG_NAME>
            <CON_ID>2202448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2718286</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14165:C25539</PreferredName>
        <Version>1</Version>
        <LongName>Normal Intensity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14165</PREFERRED_NAME>
            <LONG_NAME>Normal</LONG_NAME>
            <CON_ID>2204843</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25539</PREFERRED_NAME>
            <LONG_NAME>Intensity</LONG_NAME>
            <CON_ID>2202454</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Gene Expression Fold Change Finding Normal Intensity java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Gene Expression Fold Change Finding Normal Intensity java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2528519</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.finding.geneExpression.differentialFoldChangeFinding</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812321</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2707890</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator 2.1</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.finding.geneExpression.differentialFoldChangeFinding</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000642</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DiffFoldChangeFinding:normalIntensity</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.finding.geneExpression.differentialFoldChangeFinding.DiffFoldChangeFinding.normalIntensity</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1591">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2532917</PUBLICID>
    <LONGNAME>HER2/neu Level Summary Result</LONGNAME>
    <PREFERREDNAME>HER2NEU_SUMM_RSL</PREFERREDNAME>
    <PREFERREDDEFINITION>Intensity, quality, or amount of the ERBB2 Gene at 17q21.1 encodes ERRB2 Receptor Protein Tyrosine Kinase, a 185 kD type I membrane glycoprotein that controls cell growth with features similar to EGFR.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2532915</PublicId>
      <PreferredName>HER2NEU_LVL</PreferredName>
      <PreferredDefinition>Intensity, quality, or amount of the ERBB2 Gene at 17q21.1 encodes ERRB2 Receptor Protein Tyrosine Kinase, a 185 kD type I membrane glycoprotein that controls cell growth with features similar to EGFR. Ligand binding increases phosphorylation of tyrosine residues. A potential heterodimer with ERBB3 and ERBB4 receptors, p185ERBB2 is an essential component of the heregulin/neuregulin receptor complex. ERBB2 homodimers do not bind heregulin but ERBB2/ERBB3 heterodimers do. Neuregulins do not interact with ERBB2 alone. The IL6 cytokine induces tyrosine phosphorylation of ERBB2 and ERBB3, but not EGFR. ERBB2 forms an IL6-dependent complex with the IL6R gp130 subunit resulting in MAPK activation. Expressed in fetal kidney and liver, herstatin is a 68 kD secreted product of an alternative ERBB2 transcript that retains intron 8. Herstatin binds p185ERBB2 as an inhibitor by disrupting ERBB2 dimers and reducing p185 tyrosine phosphorylation.  (from SWISS-PROT, OMIM and NCI)</PreferredDefinition>
      <LongName>HER2/neu Level</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2532913</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17756</PreferredName>
        <Version>1</Version>
        <LongName>HER2/neu</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17756</PREFERRED_NAME>
            <LONG_NAME>ERBB2 Gene</LONG_NAME>
            <CON_ID>2202658</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2238473</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25554</PreferredName>
        <Version>1</Version>
        <LongName>Level</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25554</PREFERRED_NAME>
            <LONG_NAME>Level</LONG_NAME>
            <CON_ID>2202440</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178360</PublicId>
      <PreferredName>RSL_TXT_NM</PreferredName>
      <PreferredDefinition>Text names to represent result of an assessment or test.</PreferredDefinition>
      <LongName>Result Text Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>15</MaximumLength>
      <MinimumLength>7</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>POSITIVE</VALIDVALUE>
          <VALUEMEANING>Positive</VALUEMEANING>
          <MEANINGDESCRIPTION>Involving advantage or good.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559831</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NEGATIVE</VALIDVALUE>
          <VALUEMEANING>Negative</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-08-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NOT DONE</VALIDVALUE>
          <VALUEMEANING>NOT DONE</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-09-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559596</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>INDETERMINATE</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-09-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline</VALIDVALUE>
          <VALUEMEANING>Borderline</VALUEMEANING>
          <MEANINGDESCRIPTION>Straddling the dividing line between two categories.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-10-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unevaluable</VALIDVALUE>
          <VALUEMEANING>Unevaluable</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to be evaluated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3855538</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0</VALIDVALUE>
          <VALUEMEANING>0</VALUEMEANING>
          <MEANINGDESCRIPTION>A mathematical element that when added to another number yields the same number; the cardinal number meaning one less than one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1+</VALIDVALUE>
          <VALUEMEANING>1+</VALUEMEANING>
          <MEANINGDESCRIPTION>1+</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2+</VALIDVALUE>
          <VALUEMEANING>2+</VALUEMEANING>
          <MEANINGDESCRIPTION>2+</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3+</VALIDVALUE>
          <VALUEMEANING>3+</VALUEMEANING>
          <MEANINGDESCRIPTION>3+</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2022-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558083</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Amplified</VALIDVALUE>
          <VALUEMEANING>Amplified</VALUEMEANING>
          <MEANINGDESCRIPTION>An observation confirming something, such as the presence of a disease, condition, or microorganism.: Any DNA sequence rearrangement that results in the gain of one or more copies of a DNA segment that contains at least one gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16605, C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3079272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not amplified</VALIDVALUE>
          <VALUEMEANING>Not Amplified</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.: Any DNA sequence rearrangement that results in the gain of one or more copies of a DNA segment that contains at least one gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16605, C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-05-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3079273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>0 - No erythema</VALIDVALUE>
          <VALUEMEANING>Negative Erythema</VALUEMEANING>
          <MEANINGDESCRIPTION>Involving disadvantage or harm._Red discoloration of the skin caused by infectious agents, inflammation, drug hypersensitivity, or underlying disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26901, C25247</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14230933</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>1 - Mild erythema</VALIDVALUE>
          <VALUEMEANING>Mild Erythema</VALUEMEANING>
          <MEANINGDESCRIPTION>Gentle or temperate in nature or degree.: Red discoloration of the skin caused by infectious agents, inflammation, drug hypersensitivity, or underlying disease.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C26901, C70666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8035918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2 - Severe erythema with minimal scaling</VALIDVALUE>
          <VALUEMEANING>Severe Erythema MINIMAL Scaling</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely bad or unpleasant in degree, quality or extent._Red discoloration of the skin caused by infectious agents, inflammation, drug hypersensitivity, or underlying disease._Definition not available._The act of altering the size of an object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67036, C0547039, C26901, C70667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14230934</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3 - Severe erythema with significant scaling</VALIDVALUE>
          <VALUEMEANING>Severe Erythema Significant Scaling</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely bad or unpleasant in degree, quality or extent._Red discoloration of the skin caused by infectious agents, inflammation, drug hypersensitivity, or underlying disease._A term applied to differences, correlations, cause-and-effect relationships, etc., to indicate that they are noticeable, probably too closely correlated to be attributed to chance and therefore indicating a systematic relation: substantial, fairly large; also having consequence or import, important in effect or meaning. In statistics significant ordinarily indicates a probability of not less than 95 percent, while highly significant indicates a probability of not less than 99 percent._The act of altering the size of an object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67036, C41130, C26901, C70667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-07-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14230935</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4 - Severe erythema with ulceration, scaling, crusting, itching and burning</VALIDVALUE>
          <VALUEMEANING>4 - Severe erythema with ulceration, scaling, crusting, itching and burning</VALUEMEANING>
          <MEANINGDESCRIPTION>4 - Severe erythema with ulceration, scaling, crusting, itching and burning</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2023-07-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14230936</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>N/A - Screening</VALIDVALUE>
          <VALUEMEANING>Not Applicable Screening</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context._A systematic examination or assessment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48261, C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-09-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14484236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Her2/Neu</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Her2/Neu</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Results</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ThermoDox Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812723</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2716207</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ASCO</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer Adjuvant Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812713</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886752</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>For Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3891931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1592">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2539915</PUBLICID>
    <LONGNAME>Project Database Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2539717v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any piece of work that is undertaken or attempted._A database is an information set with a regular structure. Although it can be applied to any set of information the term was invented to refer to computerised data, and is used almost exclusively in computing. (from Wikipedia):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2539717</PublicId>
      <PreferredName>2422768v1.0:2231598v1.0</PreferredName>
      <PreferredDefinition>Any piece of work that is undertaken or attempted._A database is an information set with a regular structure. Although it can be applied to any set of information the term was invented to refer to computerised data, and is used almost exclusively in computing. (from Wikipedia):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Project Database Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2422768</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47885</PreferredName>
        <Version>1</Version>
        <LongName>Project</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47885</PREFERRED_NAME>
            <LONG_NAME>Project</LONG_NAME>
            <CON_ID>2422635</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231598</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15426:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Database Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15426</PREFERRED_NAME>
            <LONG_NAME>Database</LONG_NAME>
            <CON_ID>2228339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Project Database Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Project Database Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.umlproject.domain.Project.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Project:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1593">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2547440</PUBLICID>
    <LONGNAME>Infusion Diluent Name</LONGNAME>
    <PREFERREDNAME>INF_DILNT_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>Text term to identify the solution used to dissolve and deliver an intravenous infusion to a subject.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2547436</PublicId>
      <PreferredName>INF_DILNT</PreferredName>
      <PreferredDefinition>Reference to a  liquid used to lessen the strength of a solution or mixture of another ingredient in order to deliver an intravenous infusion.</PreferredDefinition>
      <LongName>Infusion Diluent</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2475877</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15388</PreferredName>
        <Version>1</Version>
        <LongName>Infusion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15388</PREFERRED_NAME>
            <LONG_NAME>Infusion Procedure</LONG_NAME>
            <CON_ID>2203835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2547434</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C60823</PreferredName>
        <Version>1</Version>
        <LongName>Diluent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60823</PREFERRED_NAME>
            <LONG_NAME>Diluent</LONG_NAME>
            <CON_ID>2547433</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2547438</PublicId>
      <PreferredName>2547438v1.0</PreferredName>
      <PreferredDefinition>Text terms to identify solutions used to dissolve and deliver materials, including medications, into the bloodstream.</PreferredDefinition>
      <LongName>Infusion Diluent Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008560</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_DOSES</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Doses</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2547437</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15388:C60823:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Infusion Diluent Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15388</PREFERRED_NAME>
            <LONG_NAME>Infusion Procedure</LONG_NAME>
            <CON_ID>2203835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60823</PREFERRED_NAME>
            <LONG_NAME>Diluent</LONG_NAME>
            <CON_ID>2547433</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D5 1/2 Normal Saline</VALIDVALUE>
          <VALUEMEANING>Dextrose 5% in 1/2 Normal Saline</VALUEMEANING>
          <MEANINGDESCRIPTION>Dextrose 5% in 1/2 Normal Saline</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582182</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D5 1/4 Normal Saline</VALIDVALUE>
          <VALUEMEANING>Dextrose 5% in 1/4 Normal Saline</VALUEMEANING>
          <MEANINGDESCRIPTION>Dextrose 5% in 1/4 Normal Saline</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D5 Normal Saline</VALIDVALUE>
          <VALUEMEANING>Dextrose 5% in Normal Saline</VALUEMEANING>
          <MEANINGDESCRIPTION>Dextrose 5% in Normal Saline</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D50 Water</VALIDVALUE>
          <VALUEMEANING>Dextrose 50% in Water</VALUEMEANING>
          <MEANINGDESCRIPTION>Dextrose 50% in Water</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>D5 Water</VALIDVALUE>
          <VALUEMEANING>Dextrose 5% in Water</VALUEMEANING>
          <MEANINGDESCRIPTION>Dextrose 5% in Water</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal Saline</VALIDVALUE>
          <VALUEMEANING>Normal Saline</VALUEMEANING>
          <MEANINGDESCRIPTION>Normal Saline</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582187</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ringers Lactate</VALIDVALUE>
          <VALUEMEANING>Lactated Ringers Solution</VALUEMEANING>
          <MEANINGDESCRIPTION>Lactated Ringers Solution</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-11-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582188</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Solution</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Solution</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1594">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2548504</PUBLICID>
    <LONGNAME>Highest Gleason Score Combined Pattern Value</LONGNAME>
    <PREFERREDNAME>HST_GLSNS_C_PATT_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>The Gleason Score from the focus with the highest Gleason Score in the specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2548502</PublicId>
      <PreferredName>2548500v1.0:2207771v1.0</PreferredName>
      <PreferredDefinition>Information related to the highest Gleason score combined pattern.</PreferredDefinition>
      <LongName>Highest Gleason Score Combined Pattern</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2548500</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25525:C28084</PreferredName>
        <Version>1</Version>
        <LongName>Highest Gleason Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25525</PREFERRED_NAME>
            <LONG_NAME>Highest</LONG_NAME>
            <CON_ID>2202386</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28084</PREFERRED_NAME>
            <LONG_NAME>Gleason Score for Prostate Cancer</LONG_NAME>
            <CON_ID>2202653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207771</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25454:C25336</PreferredName>
        <Version>1</Version>
        <LongName>Combined Pattern</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25454</PREFERRED_NAME>
            <LONG_NAME>Combined</LONG_NAME>
            <CON_ID>2206179</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25336</PREFERRED_NAME>
            <LONG_NAME>Pattern</LONG_NAME>
            <CON_ID>2203946</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2634971</PublicId>
      <PreferredName>GLEASO_COMB_PATT_VAL</PreferredName>
      <PreferredDefinition>A numeric value for the overall pattern or pathologic grade for a groups of specimens as interpreted by a pathologist using a combined Gleason Score if primary and secondary patterns are unavailable.</PreferredDefinition>
      <LongName>Gleason Score Combined Pattern Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2414933</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25712</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10</VALIDVALUE>
          <VALUEMEANING>10</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2</VALIDVALUE>
          <VALUEMEANING>2</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66833</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>3</VALIDVALUE>
          <VALUEMEANING>3</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66834</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558081</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>4</VALIDVALUE>
          <VALUEMEANING>4</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66835</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558084</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5</VALIDVALUE>
          <VALUEMEANING>5</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66836</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558086</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>6</VALIDVALUE>
          <VALUEMEANING>6</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>7</VALIDVALUE>
          <VALUEMEANING>7</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 6 and less than 8 and the quantity that it denotes: the sum of six and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66838</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558098</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>8</VALIDVALUE>
          <VALUEMEANING>8</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 7 and less than 9 and the quantity that it denotes: the sum of seven and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66839</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558102</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9</VALIDVALUE>
          <VALUEMEANING>9</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 8 and less than 10 and the quantity that it denotes: the sum of nine and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66840</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558107</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specimen Gleason score</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specimen Gleason score</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Standard CRFs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnosis Gross Tumor CRF</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3914492</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Tissue Effect of Finasteride - Prostate Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812182</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1595">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2548540</PUBLICID>
    <LONGNAME>Patient Periodontal Probing Past Year Personal Medical History Yes No Unknown Indicator</LONGNAME>
    <PREFERREDNAME>2548530v1.0:2182115v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Indicator of Yes, No, or Unknown to represent a condition of the act of inserting a periodontal probe between the gingival tissues and the tooth in a person who requires medical care occurring before the period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period in a record of a patient&quot;s background regarding health and the occurrence of disease events of the individual.  In addition, personal medical history may be a variable in epidemiologic studies.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2548530</PublicId>
      <PreferredName>2233604v1.0:2548528v1.0</PreferredName>
      <PreferredDefinition>The act of inserting a periodontal probe between the gingival tissues and the tooth in a person who requires medical care occurring before the period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period in a record of a patient&#39;s background regarding health and the occurrence of disease events of the individual.  In addition, personal medical history may be a variable in epidemiologic studies.</PreferredDefinition>
      <LongName>Patient Periodontal Probing Past Year Personal Medical History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2548528</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25609:C29848:C62544:C18772</PreferredName>
        <Version>1</Version>
        <LongName>Past Year Periodontal Probing Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25609</PREFERRED_NAME>
            <LONG_NAME>Past</LONG_NAME>
            <CON_ID>2203983</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C29848</PREFERRED_NAME>
            <LONG_NAME>Year</LONG_NAME>
            <CON_ID>2203986</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62544</PREFERRED_NAME>
            <LONG_NAME>Periodontal Probing</LONG_NAME>
            <CON_ID>2518907</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2182115</PublicId>
      <PreferredName>Y_N_U_IND</PreferredName>
      <PreferredDefinition>Indicator of Yes, No, or Unknown to represent a condition.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-03-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Has the patient had a full mo</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Has the patient had a full mouth periodontal probing recorded in the last 12 months?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnostic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812084</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1596">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2550905</PUBLICID>
    <LONGNAME>Specimen Slice Plane Type</LONGNAME>
    <PREFERREDNAME>SPEC_SLICE_PLN_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>Name of the axis or plane used for slicing a specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2550812</PublicId>
      <PreferredName>SPEC_SLICE_PLN</PreferredName>
      <PreferredDefinition>Axis upon which a slice of specimen tissue is cut.</PreferredDefinition>
      <LongName>Specimen Slice Plane</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2550809</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C19157:C25682</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Slice</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25682</PREFERRED_NAME>
            <LONG_NAME>Slice</LONG_NAME>
            <CON_ID>2202619</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2550810</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63534</PreferredName>
        <Version>1</Version>
        <LongName>Plane</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63534</PREFERRED_NAME>
            <LONG_NAME>Plane</LONG_NAME>
            <CON_ID>2538641</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2550814</PublicId>
      <PreferredName>SLICE_PLN_TP</PreferredName>
      <PreferredDefinition>Text terms to identify the axis used to cut 2-dimensional slices from a specimen.  </PreferredDefinition>
      <LongName>Slice Plane Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2550813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25682:C63534:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Slice Plane Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25682</PREFERRED_NAME>
            <LONG_NAME>Slice</LONG_NAME>
            <CON_ID>2202619</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63534</PREFERRED_NAME>
            <LONG_NAME>Plane</LONG_NAME>
            <CON_ID>2538641</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Superior/inferior</VALIDVALUE>
          <VALUEMEANING>Superior/Inferior</VALUEMEANING>
          <MEANINGDESCRIPTION>Superior/Inferior</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Anterior/posterior</VALIDVALUE>
          <VALUEMEANING>Anterior/Posterior</VALUEMEANING>
          <MEANINGDESCRIPTION>Anterior/Posterior</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Which plane was used for slic</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Which plane was used for slicing?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2548333</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>I-SPY</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C911/C1000</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812254</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1597">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2551877</PUBLICID>
    <LONGNAME>Invasive Breast Carcinoma Histologically Confirmed Cellularity Value Category</LONGNAME>
    <PREFERREDNAME>BRSTCA_CELL_VAL_CAT</PREFERREDNAME>
    <PREFERREDDEFINITION>Text category to capture the cellularity (in %) of invasive disease present in a pathology sample.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2009267</PublicId>
      <PreferredName>INV_BCAR_HIST_CONF</PreferredName>
      <PreferredDefinition>information related to verified involvement through use of histology or histological techniques of tendency to spread of a carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.</PreferredDefinition>
      <LongName>Invasive Breast Carcinoma Histologically Confirmed</LongName>
      <Version>2.31</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2508844</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14159:C4872</PreferredName>
        <Version>1</Version>
        <LongName>Invasive Breast Carcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14159</PREFERRED_NAME>
            <LONG_NAME>Invasive</LONG_NAME>
            <CON_ID>2203841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4872</PREFERRED_NAME>
            <LONG_NAME>Breast Carcinoma</LONG_NAME>
            <CON_ID>2475940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2450502</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25527:C25458</PreferredName>
        <Version>1</Version>
        <LongName>Histologically Confirmed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25527</PREFERRED_NAME>
            <LONG_NAME>Histologically</LONG_NAME>
            <CON_ID>2206235</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25458</PREFERRED_NAME>
            <LONG_NAME>Confirmation</LONG_NAME>
            <CON_ID>2203883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2551874</PublicId>
      <PreferredName>DZ_CELL_VAL_CAT</PreferredName>
      <PreferredDefinition>Numeric value category to represent the extent or cellularity of a histologic type present in breast tissue.</PreferredDefinition>
      <LongName>Disease Cellularity Value Category</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <UnitOfMeasure>%</UnitOfMeasure>
      <MaximumLength>4</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2551873</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C37923:C25712:C25372</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders Cellularity Value Category</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37923</PREFERRED_NAME>
            <LONG_NAME>Cellularity</LONG_NAME>
            <CON_ID>2204939</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25372</PREFERRED_NAME>
            <LONG_NAME>Category</LONG_NAME>
            <CON_ID>2203876</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>5%</VALIDVALUE>
          <VALUEMEANING>5% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>5% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10%</VALIDVALUE>
          <VALUEMEANING>10% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>10% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15%</VALIDVALUE>
          <VALUEMEANING>15% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>15% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582358</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>20%</VALIDVALUE>
          <VALUEMEANING>20% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>20% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>25%</VALIDVALUE>
          <VALUEMEANING>25% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>25% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582360</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>30%</VALIDVALUE>
          <VALUEMEANING>30% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>30% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>35%</VALIDVALUE>
          <VALUEMEANING>35% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>35% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582362</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>40%</VALIDVALUE>
          <VALUEMEANING>40% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>40% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>45%</VALIDVALUE>
          <VALUEMEANING>45% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>45% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>50%</VALIDVALUE>
          <VALUEMEANING>50% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>50% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>55%</VALIDVALUE>
          <VALUEMEANING>55% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>55% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>60%</VALIDVALUE>
          <VALUEMEANING>60% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>60% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>65%</VALIDVALUE>
          <VALUEMEANING>65% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>65% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>70%</VALIDVALUE>
          <VALUEMEANING>70% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>70% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>75%</VALIDVALUE>
          <VALUEMEANING>75% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>75% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>80%</VALIDVALUE>
          <VALUEMEANING>80% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>80% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>85%</VALIDVALUE>
          <VALUEMEANING>85% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>85% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>90%</VALIDVALUE>
          <VALUEMEANING>90% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>90% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>95%</VALIDVALUE>
          <VALUEMEANING>95% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>95% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582374</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>100%</VALIDVALUE>
          <VALUEMEANING>100% Cellularity</VALUEMEANING>
          <MEANINGDESCRIPTION>100% Cellularity</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2006-12-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582375</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cellularity (of invasive dise</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Cellularity (of invasive disease, if present)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2548333</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>I-SPY</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C911/C1000</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812254</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1598">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2552734</PUBLICID>
    <LONGNAME>Clinical Trial Protocol Administered Item Long Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2552541v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will recei:A registry item for which administrative information is recorded in an Administration Record._Of relatively great or greater than average spatial extension or temporal duration.:The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>caCORE</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2552541</PublicId>
      <PreferredName>2539530v1.0:2231601v1.0</PreferredName>
      <PreferredDefinition>An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will recei:A registry item for which administrative information is recorded in an Administration Record._Of relatively great or greater than average spatial extension or temporal duration.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Clinical Trial Protocol Administered Item Long Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2539530</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25320:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Protocol Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25320</PREFERRED_NAME>
            <LONG_NAME>Clinical Study Protocol</LONG_NAME>
            <CON_ID>2202702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231601</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25248:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Long Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25248</PREFERRED_NAME>
            <LONG_NAME>Long</LONG_NAME>
            <CON_ID>2206292</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Clinical Trial Protocol Administered Item Long Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Clinical Trial Protocol Administered Item Long Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.Protocol.longName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Protocol:longName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1599">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2553405</PUBLICID>
    <LONGNAME>Embed Event Parameter Object Timestamp java.util.Date</LONGNAME>
    <PREFERREDNAME>2553260v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>To surround a pathological or histological specimen with a firm and sometimes hard medium such as paraffin, wax, celloidin, or a resin, in order to make possible the cutting of thin sections for microscopic examination. (On-line Medical Dictionary):Something that happens at a given place and time.:Any factor that defines a system and determines (or limits) its performance._A variation of the Date datatype that&#39;s useful for storing very precise datetime values, down to small fractions of seconds. The Timestamp datatype stores all the information that the Date datatype stores, but also includes fractional seconds._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2553260</PublicId>
      <PreferredName>2513382v1.0:2553105v1.0</PreferredName>
      <PreferredDefinition>To surround a pathological or histological specimen with a firm and sometimes hard medium such as paraffin, wax, celloidin, or a resin, in order to make possible the cutting of thin sections for microscopic examination. (On-line Medical Dictionary):Something that happens at a given place and time.:Any factor that defines a system and determines (or limits) its performance._A variation of the Date datatype that&#39;s useful for storing very precise datetime values, down to small fractions of seconds. The Timestamp datatype stores all the information that the Date datatype stores, but also includes fractional seconds.</PreferredDefinition>
      <LongName>Embed Event Parameter Object Timestamp</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2513382</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48163:C25499:C44175</PreferredName>
        <Version>1</Version>
        <LongName>Embed Event Parameter Object</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48163</PREFERRED_NAME>
            <LONG_NAME>Embedding</LONG_NAME>
            <CON_ID>2513276</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44175</PREFERRED_NAME>
            <LONG_NAME>Parameter</LONG_NAME>
            <CON_ID>2236569</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2553105</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54086</PreferredName>
        <Version>1</Version>
        <LongName>Timestamp</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54086</PREFERRED_NAME>
            <LONG_NAME>Timestamp Data Type</LONG_NAME>
            <CON_ID>2553062</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Embed Event Parameter Object Timestamp java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Embed Event Parameter Object Timestamp java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2553133</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812526</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2661745</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_caArray</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000636</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2680967</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Core_1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000633</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.EmbeddedEventParameters.timestamp</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EmbeddedEventParameters:timestamp</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1600">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2596443</PUBLICID>
    <LONGNAME>Laboratory Procedure Leukocyte Result Upper Limit of Normal Value</LONGNAME>
    <PREFERREDNAME>LAB_WBC_RSL_ULN_VAL</PREFERREDNAME>
    <PREFERREDDEFINITION>information related to the upper limit of normal, the top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for a white blood cell laboratory result or other quantitative parameter.</PREFERREDDEFINITION>
    <VERSION>4</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>Transplant CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188763</PublicId>
      <PreferredName>LAB_WBC_RSLT</PreferredName>
      <PreferredDefinition>information related to the result of a medical procedure that involves testing a sample of blood for white blood cells, a blood cell that does not contain hemoglobin and includes monocytes, basophils, lymphocytes, neutrophils, eosinophils, macrophages, and mast cells.</PreferredDefinition>
      <LongName>Laboratory Procedure Leukocyte Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738870</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12529:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Leukocyte Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12529</PREFERRED_NAME>
            <LONG_NAME>Leukocyte</LONG_NAME>
            <CON_ID>2203728</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2596442</PublicId>
      <PreferredName>WBC_ULN_VAL</PreferredName>
      <PreferredDefinition>the upper limit of normal, the top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for a white blood cell laboratory result or other quantitative parameter.</PreferredDefinition>
      <LongName>White Blood Cell Upper Limit of Normal Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>5</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>1</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2500946</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25706:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Upper Limit of Normal Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25706</PREFERRED_NAME>
            <LONG_NAME>Upper Limit of Normal</LONG_NAME>
            <CON_ID>2203609</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Peripheral WBC count, LLN</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Peripheral WBC count, ULN</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>WBC ULN</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multiple Myeloma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811950</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>RTOG-1112</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104993</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_WBC_RSL_ULN_VAL</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1601">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2603117</PUBLICID>
    <LONGNAME>Dental Responsible Person Occupation Type</LONGNAME>
    <PREFERREDNAME>D_RES_P_OCC_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>the type of individual&#39;s occupation for responsible dental-related person.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2190356</PublicId>
      <PreferredName>RSPB_PER_OCC</PreferredName>
      <PreferredDefinition>information related to occupation of responsible person.</PreferredDefinition>
      <LongName>Responsible Person Occupation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206597</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25657:C25190</PreferredName>
        <Version>1</Version>
        <LongName>Responsible Person Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25657</PREFERRED_NAME>
            <LONG_NAME>Responsible Person</LONG_NAME>
            <CON_ID>2202516</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177431</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Occupation</PreferredName>
        <Version>1</Version>
        <LongName>Occupation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25193</PREFERRED_NAME>
            <LONG_NAME>Occupation</LONG_NAME>
            <CON_ID>2202912</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2603111</PublicId>
      <PreferredName>DNTAL_RES_PER_O_TP</PreferredName>
      <PreferredDefinition>the type of individual&#39;s occupation for responsible dental-related person.</PreferredDefinition>
      <LongName>Dental Responsible Person Occupation Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dentist</VALIDVALUE>
          <VALUEMEANING>Dentist</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual licensed for the prevention, diagnosis, and treatment of diseases in the oral cavity, adjacent tissues, and related structures.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2596207</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Office Manager</VALIDVALUE>
          <VALUEMEANING>Office Manager</VALUEMEANING>
          <MEANINGDESCRIPTION>An employee charged with the general administrative responsibilities of any given office of a corporation or business, responsible for all paperwork, including its filing and retention over time, and the supervision of office staff.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52663</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2603112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dental Hygienist</VALIDVALUE>
          <VALUEMEANING>Dental Hygienist</VALUEMEANING>
          <MEANINGDESCRIPTION>A health care professional auxiliary in dentistry trained and licensed to provide preventive, therapeutic and educational services for the control of oral diseases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53293</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2603114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>PBRN Staff</VALIDVALUE>
          <VALUEMEANING>Practice-based Research Network</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of practicing clinicians who link their expertise and resources in collaborative efforts to address important research questions of shared interest.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52671</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2603115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No one is responsible for counseling tobacco users</VALIDVALUE>
          <VALUEMEANING>No one is responsible for counseling tobacco users</VALUEMEANING>
          <MEANINGDESCRIPTION>No one is responsible for counseling tobacco users</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dental Assistant</VALIDVALUE>
          <VALUEMEANING>Dental Assistant</VALUEMEANING>
          <MEANINGDESCRIPTION>A person trained and qualified to provide chairside assistance to a dentist, along with performance of other supportive duties such as to receive and prepare patients for dental treatment; to prepare materials and equipment for use by the dentist; to perform reversible intra-oral procedures under the supervision of the dentist; to perform dental radiography work; to maintain dental equipment and treatment area and to keep records of appointments, examinations, treatments and supplies.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3247380</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Designation of the person</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Designation of the person</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Diagnostic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812084</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857180</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Type of Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preventive</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812085</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1602">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2613201</PUBLICID>
    <LONGNAME>Antigen Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2612553v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens._A statement or an account describing something._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2612553</PublicId>
      <PreferredName>2612313v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens._A statement or an account describing something.</PreferredDefinition>
      <LongName>Antigen Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2612313</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C268</PreferredName>
        <Version>1</Version>
        <LongName>Antigen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C268</PREFERRED_NAME>
            <LONG_NAME>Antigen</LONG_NAME>
            <CON_ID>2202300</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Antigen Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Antigen Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2915522</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caNanoLab</PreferredName>
          <Version>1.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cananolab.domain.function</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2915887</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Antigen:description</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calab.domain.nano.function.Antigen.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.particle.samplecomposition.Antigen.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.Antigen.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.function.Antigen.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1603">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2636915</PUBLICID>
    <LONGNAME>Skin Clinical Diagnosis Involvement Specify</LONGNAME>
    <PREFERREDNAME>SKIN_CLINDX_INVL_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free-text field to specify the reason or cause of skin involvement based on a diagnosis made from a study of the signs and symptoms of a disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>Transplant CDE Committee</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2636900</PublicId>
      <PreferredName>SKIN_CLINDX_INVLT</PreferredName>
      <PreferredDefinition>information related to diagnosis of skin invlovement made from a study of the signs and symptoms of a disease.</PreferredDefinition>
      <LongName>Skin Clinical Diagnosis Involvement</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2442989</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12470</PreferredName>
        <Version>1</Version>
        <LongName>Skin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12470</PREFERRED_NAME>
            <LONG_NAME>Skin</LONG_NAME>
            <CON_ID>2202821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2636898</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15607:C25548</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Diagnosis Involvement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15607</PREFERRED_NAME>
            <LONG_NAME>Clinical Diagnosis</LONG_NAME>
            <CON_ID>2513256</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25548</PREFERRED_NAME>
            <LONG_NAME>Involvement</LONG_NAME>
            <CON_ID>2203737</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018432</PublicId>
      <PreferredName>DX_SPEC</PreferredName>
      <PreferredDefinition>the specified free-text field related to an aspect of patient/participant&#39;s diagnosis</PreferredDefinition>
      <LongName>Diagnosis Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1604">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2646312</PUBLICID>
    <LONGNAME>Kaposi Sarcoma Malignant Neoplasm Flat Count</LONGNAME>
    <PREFERREDNAME>KS_MALIGNEO_FLAT_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>the total number of flat malignant neoplasms (lesions) identified in Kaposi Sarcoma.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>AMC CRF:AIDS Malignancy Consortium Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2640020</PublicId>
      <PreferredName>KS_MLIGNEO_FLT_QTY</PreferredName>
      <PreferredDefinition>information relating to the quantity or number of flat malignant neoplasms (lesions) in Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells).</PreferredDefinition>
      <LongName>Kaposi Sarcoma Malignant Neoplasm Flat Quantity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008549</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INV_AND_EXT_OF_DZ</PreferredName>
        <Version>1</Version>
        <LongName>Involvement and Extent of Disease</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2640017</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C9087:C9305</PreferredName>
        <Version>1</Version>
        <LongName>Kaposi Sarcoma Malignant Neoplasm</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9087</PREFERRED_NAME>
            <LONG_NAME>Kaposi Sarcoma</LONG_NAME>
            <CON_ID>2637488</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C9305</PREFERRED_NAME>
            <LONG_NAME>Malignant Neoplasm</LONG_NAME>
            <CON_ID>2202593</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2640018</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C0205324:C25256</PreferredName>
        <Version>1</Version>
        <LongName>Flat Quantity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0205324</PREFERRED_NAME>
            <LONG_NAME>Flat</LONG_NAME>
            <CON_ID>2615856</CON_ID>
            <DEFINITION_SOURCE>SNOMEDCT_2004_01_31</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25256</PREFERRED_NAME>
            <LONG_NAME>Quantity</LONG_NAME>
            <CON_ID>2202797</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018392</PublicId>
      <PreferredName>CT</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Total Number Flat Lesions</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Total Number Flat Lesions</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CITN - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Flat</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CITN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1605">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2651623</PUBLICID>
    <LONGNAME>Concomitant Therapeutic Procedure Performed Text</LONGNAME>
    <PREFERREDNAME>CONCOMIT_PROC_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>the free-text field related to having accessory action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2651626</PublicId>
      <PreferredName>CONCOM_TXPR_PERF</PreferredName>
      <PreferredDefinition>information related to having accessory action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.</PreferredDefinition>
      <LongName>Concomitant Therapeutic Procedure Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2651624</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25730:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25730</PREFERRED_NAME>
            <LONG_NAME>Concomitant</LONG_NAME>
            <CON_ID>2202429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2180739</PublicId>
      <PreferredName>TX_TXT</PreferredName>
      <PreferredDefinition>the free-text field related to treatment or therapy.</PreferredDefinition>
      <LongName>Therapy Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Name of treatment</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Name of treatment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1606">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2652972</PUBLICID>
    <LONGNAME>Therapy Required Ind-2</LONGNAME>
    <PREFERREDNAME>TX_REQ_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to necessary action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2652970</PublicId>
      <PreferredName>TX_REQU</PreferredName>
      <PreferredDefinition>information related to necessary action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.</PreferredDefinition>
      <LongName>Therapy Required</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2416951</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15368</PreferredName>
        <Version>1</Version>
        <LongName>Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2652968</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25652</PreferredName>
        <Version>1</Version>
        <LongName>Required</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25652</PREFERRED_NAME>
            <LONG_NAME>Requirement</LONG_NAME>
            <CON_ID>2204014</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Do you get treatment for it</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Treatment Required</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Treatment Required</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was treatment required?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the patient receive treatment for the new malignancy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF_TEXT1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Will the patient receive pelvic treatment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Will the patient receive pelvic lymph node treatment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0275</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104991</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TX_REQ_IND2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1607">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2669568</PUBLICID>
    <LONGNAME>Image Data Entity Maximum Channel java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2669413v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any record of an imaging event whether physical or electronic.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.:An independently existing thing (living or nonliving)._The largest possible quantity or degree.:An independent acquisition scheme, i.e., a route or conduit through which flows data consisting of one particular measurement using one particular parameter._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2669413</PublicId>
      <PreferredName>2669395v1.0:2669366v1.0</PreferredName>
      <PreferredDefinition>Any record of an imaging event whether physical or electronic.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.:An independently existing thing (living or nonliving)._The largest possible quantity or degree.:An independent acquisition scheme, i.e., a route or conduit through which flows data consisting of one particular measurement using one particular parameter.</PreferredDefinition>
      <LongName>Image Data Entity Maximum Channel</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2669395</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48179:C25474:C51070</PreferredName>
        <Version>1</Version>
        <LongName>Image Data Entity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2669366</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25564:C44170</PreferredName>
        <Version>1</Version>
        <LongName>Maximum Channel</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25564</PREFERRED_NAME>
            <LONG_NAME>Maximum</LONG_NAME>
            <CON_ID>2202550</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44170</PREFERRED_NAME>
            <LONG_NAME>Channel</LONG_NAME>
            <CON_ID>2236547</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Image Data Entity Maximum Channel java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Image Data Entity Maximum Channel java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614836</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Generic Image</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ivi.genericimage</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ivi.genericimage.ImageDataItem.maximumChannel</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ImageDataItem:maximumChannel</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1608">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2669639</PUBLICID>
    <LONGNAME>Channel Data Child Minimum Index java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2669484v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An independent acquisition scheme, i.e., a route or conduit through which flows data consisting of one particular measurement using one particular parameter.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._A human offspring (son or daughter) of any age; an immediate progeny.:The smallest possible quantity.:A numerical scale used to compare variables with one another or with some reference number; a number used to select an element of a list, vector, array or other sequence._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2669484</PublicId>
      <PreferredName>2669390v1.0:2669374v1.0</PreferredName>
      <PreferredDefinition>An independent acquisition scheme, i.e., a route or conduit through which flows data consisting of one particular measurement using one particular parameter.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._A human offspring (son or daughter) of any age; an immediate progeny.:The smallest possible quantity.:A numerical scale used to compare variables with one another or with some reference number; a number used to select an element of a list, vector, array or other sequence.</PreferredDefinition>
      <LongName>Channel Data Child Minimum Index</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2669390</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C44170:C25474</PreferredName>
        <Version>1</Version>
        <LongName>Channel Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44170</PREFERRED_NAME>
            <LONG_NAME>Channel</LONG_NAME>
            <CON_ID>2236547</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2669374</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42708:C25570:C25390</PreferredName>
        <Version>1</Version>
        <LongName>Child Minimum Index</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42708</PREFERRED_NAME>
            <LONG_NAME>Offspring</LONG_NAME>
            <CON_ID>2483744</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25570</PREFERRED_NAME>
            <LONG_NAME>Minimum</LONG_NAME>
            <CON_ID>2206306</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25390</PREFERRED_NAME>
            <LONG_NAME>Index</LONG_NAME>
            <CON_ID>2203825</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Channel Data Child Minimum Index java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Channel Data Child Minimum Index java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614836</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Generic Image</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ivi.genericimage</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ivi.genericimage.Channel.minimumChildIndex</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Channel:minimumChildIndex</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1609">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2669690</PUBLICID>
    <LONGNAME>Region Child Maximum Index java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2669535v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An area or portion of something with more or less definite boundaries designed or specified according to some established biological, administrative, economic, demographic, etc. criteria._A human offspring (son or daughter) of any age; an immediate progeny.:The largest possible quantity or degree.:A numerical scale used to compare variables with one another or with some reference number; a number used to select an element of a list, vector, array or other sequence._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2669535</PublicId>
      <PreferredName>2669394v1.0:2669367v1.0</PreferredName>
      <PreferredDefinition>An area or portion of something with more or less definite boundaries designed or specified according to some established biological, administrative, economic, demographic, etc. criteria._A human offspring (son or daughter) of any age; an immediate progeny.:The largest possible quantity or degree.:A numerical scale used to compare variables with one another or with some reference number; a number used to select an element of a list, vector, array or other sequence.</PreferredDefinition>
      <LongName>Region Child Maximum Index</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2669394</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41129</PreferredName>
        <Version>1</Version>
        <LongName>Region</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41129</PREFERRED_NAME>
            <LONG_NAME>Region</LONG_NAME>
            <CON_ID>2422333</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2669367</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42708:C25564:C25390</PreferredName>
        <Version>1</Version>
        <LongName>Child Maximum Index</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42708</PREFERRED_NAME>
            <LONG_NAME>Offspring</LONG_NAME>
            <CON_ID>2483744</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25564</PREFERRED_NAME>
            <LONG_NAME>Maximum</LONG_NAME>
            <CON_ID>2202550</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25390</PREFERRED_NAME>
            <LONG_NAME>Index</LONG_NAME>
            <CON_ID>2203825</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Region Child Maximum Index java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Region Child Maximum Index java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614836</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Generic Image</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ivi.genericimage</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812918</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Tile:maximumChildIndex</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ivi.genericimage.Tile.maximumChildIndex</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1610">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2678506</PUBLICID>
    <LONGNAME>Patient Follow-up Status java.lang.String</LONGNAME>
    <PREFERREDNAME>2678265v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A person who requires medical care._The process by which information about the health status of an individual is obtained after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done.:A condition or state at a particular time._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2678265</PublicId>
      <PreferredName>2233604v1.0:2678036v1.0</PreferredName>
      <PreferredDefinition>A person who requires medical care._The process by which information about the health status of an individual is obtained after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done.:A condition or state at a particular time.</PreferredDefinition>
      <LongName>Patient Follow-up Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2678036</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16033:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Follow-up Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16033</PREFERRED_NAME>
            <LONG_NAME>Follow-Up</LONG_NAME>
            <CON_ID>2202303</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Patient Follow-up Status java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Patient Follow-up Status java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2677906</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CoCaNUT</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.princeton.cocanut.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812737</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.princeton.cocanut.domain.Patient.followupStatus</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Patient:followupStatus</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1611">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2678810</PUBLICID>
    <LONGNAME>Ductal Breast Carcinoma in Situ Size Documented ind-2</LONGNAME>
    <PREFERREDNAME>DCIS_SZ_DOC_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether the size of a Ductal Breast Carcinoma in Situ, a carcinoma entirely confined to the mammary ducts, was documented or recorded.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>SWOG CRF:Southwest Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2678785</PublicId>
      <PreferredName>DCIS_SZ_DOC</PreferredName>
      <PreferredDefinition>information related to the size of a Ductal Breast Carcinoma in Situ, a carcinoma entirely confined to the mammary ducts, being documented or recorded.</PreferredDefinition>
      <LongName>Ductal Breast Carcinoma in Situ Size Documented</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2413053</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2924</PreferredName>
        <Version>1</Version>
        <LongName>DCIS</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2924</PREFERRED_NAME>
            <LONG_NAME>Breast Ductal Carcinoma In Situ</LONG_NAME>
            <CON_ID>2202722</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2678783</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25681:C25356</PreferredName>
        <Version>1</Version>
        <LongName>Size Documented</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25681</PREFERRED_NAME>
            <LONG_NAME>Size</LONG_NAME>
            <CON_ID>2203799</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25356</PREFERRED_NAME>
            <LONG_NAME>Documented</LONG_NAME>
            <CON_ID>2203901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is DCIS size documented</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is DCIS size documented</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1612">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2681528</PUBLICID>
    <LONGNAME>Demographics Address 2000 Census Tract  Number Text</LONGNAME>
    <PREFERREDNAME>DM_ADDR_CN_TR_NM_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>The number that represents the Census Tract for a location as defined by boundaries identified in the year 2000.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2681523</PublicId>
      <PreferredName>DM_CN_TRCT</PreferredName>
      <PreferredDefinition>The Census Tract for a location as defined by boundaries identified in the year 2000.</PreferredDefinition>
      <LongName>Demographics 2000 Census Tract</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435032</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20189</PreferredName>
        <Version>1</Version>
        <LongName>Property or Attribute</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2644054</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16495</PreferredName>
        <Version>1</Version>
        <LongName>Demographics</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16495</PREFERRED_NAME>
            <LONG_NAME>Demographics</LONG_NAME>
            <CON_ID>2204033</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2681521</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C67490</PreferredName>
        <Version>1</Version>
        <LongName>Census Tract</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67490</PREFERRED_NAME>
            <LONG_NAME>Census Tract</LONG_NAME>
            <CON_ID>2645118</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2681525</PublicId>
      <PreferredName>ADDR_CN_TRCT_NUM_TXT</PreferredName>
      <PreferredDefinition>The number between 000100 and 999998 that represents the Census Tract for a location as defined by boundaries identified in 2000.</PreferredDefinition>
      <LongName>Address Census Tract Number Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>6</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2682011</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25407:C67490:C25337:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Address Census Tract Number Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25407</PREFERRED_NAME>
            <LONG_NAME>Address</LONG_NAME>
            <CON_ID>2202289</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67490</PREFERRED_NAME>
            <LONG_NAME>Census Tract</LONG_NAME>
            <CON_ID>2645118</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>2000 Census Tract  Codes</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>2000 Census Tract  Codes</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Sulindac DFMO</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2859628</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2718902</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ONS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Multisite Research Study</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812728</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1613">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2683262</PUBLICID>
    <LONGNAME>Breast Conservation Treatment Post Neoadjuvant Therapy Failed Performed Reason</LONGNAME>
    <PREFERREDNAME>BCT_P_NEO_FA_PER_RSN</PREFERREDNAME>
    <PREFERREDDEFINITION>the reason for a failed or unsuccessful breast conservation treatment, surgical excision limited to the primary tumor and adjacent breast tissue followed by radiation therapy, following neoadjuvant therapy, treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>CALGB CRF:Cancer and Leukemia Group B Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2683259</PublicId>
      <PreferredName>BCT_P_NEO_FAIL_PERF</PreferredName>
      <PreferredDefinition>information related to a failed or unsuccessful breast conservation treatment, surgical excision limited to the primary tumor and adjacent breast tissue followed by radiation therapy, following neoadjuvant therapy, treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents.</PreferredDefinition>
      <LongName>Breast Conservation Treatment Post Neoadjuvant Therapy Failed Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2683151</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15280</PreferredName>
        <Version>1</Version>
        <LongName>Breast Conservation Treatment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15280</PREFERRED_NAME>
            <LONG_NAME>Breast Conservation Treatment</LONG_NAME>
            <CON_ID>2683150</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2683257</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38008:C15665:C44281:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Post Neoadjuvant Therapy Failed Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15665</PREFERRED_NAME>
            <LONG_NAME>Neoadjuvant Therapy</LONG_NAME>
            <CON_ID>2206319</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44281</PREFERRED_NAME>
            <LONG_NAME>Failed</LONG_NAME>
            <CON_ID>2236611</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2683260</PublicId>
      <PreferredName>BCT_FAIL_RSN</PreferredName>
      <PreferredDefinition>An explanation of why Breast Conservation Treatment failed or was unsuccessful.</PreferredDefinition>
      <LongName>Breast Conservation Treatment Failed Reason</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2240632</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25638</PreferredName>
        <Version>1</Version>
        <LongName>Reason</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive Margins</VALIDVALUE>
          <VALUEMEANING>Positive Surgical Margin</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates the presence of tumor cells at the edge of a surgically excised specimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48620</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2683261</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Reason BCT unsuccessful?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Reason BCT unsuccessful?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1614">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2685991</PUBLICID>
    <LONGNAME>Hospital Specific First Contact Date</LONGNAME>
    <PREFERREDNAME>2685989v1.0:2018550v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Date of first patient contact, as inpatient or outpatient, with the reporting facility for the diagnosis and/or treatment of the tumor.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PS-CC</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NAACCR:North American Association of Central Cancer Registries</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2685989</PublicId>
      <PreferredName>2685312v1.0:3187940v1.0</PreferredName>
      <PreferredDefinition>First patient contact, as inpatient or outpatient, with the reporting facility for the diagnosis and/or treatment of the tumor.</PreferredDefinition>
      <LongName>Hospital Specific First Patient Physical Contact</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2685312</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16696:C38024</PreferredName>
        <Version>1</Version>
        <LongName>Hospital Specified</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16696</PREFERRED_NAME>
            <LONG_NAME>Hospital</LONG_NAME>
            <CON_ID>2202656</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38024</PREFERRED_NAME>
            <LONG_NAME>Specified</LONG_NAME>
            <CON_ID>2211671</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3187940</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25509:C16960:C49147</PreferredName>
        <Version>1</Version>
        <LongName>First Patient Physical Contact</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25509</PREFERRED_NAME>
            <LONG_NAME>First</LONG_NAME>
            <CON_ID>2206214</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49147</PREFERRED_NAME>
            <LONG_NAME>Physical Contact</LONG_NAME>
            <CON_ID>2607508</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NAACCR:North American Association of Central Cancer Registries</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of 1st Contact</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Date of 1st Contact</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR, V 11.1 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.1 Data Standards and Data Dictionary (5/4/06)</DocumentText>
        <URL>http://www.naaccr.org/filesystem/pdf/Volume%20II%20Version%2011.1.pdf</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Date of 1st Contact Description</Name>
        <DocumentType>COMMENT</DocumentType>
        <DocumentText>The date may represent the date of an outpatient visit for a biopsy, x-ray, scan, or laboratory test. See page 87 for date format. When Pathology Specimen Only (Class of Case 7, Type of Reporting Source 3) tumors are collected, the Path--Date of Specimen Collection [7320] from the pathology report should be used for the Date of 1st Contact. If a pathology-specimen-only case is followed by a patient contact with the facility for the diagnosis and/or treatment of the respective tumor, the Date of 1st Contact is not changed. The date of the initial pathology laboratory specimen collection remains the Date of 1st Contact. When Death Certificate Only (Class of Case 8, Type of Reporting Source 7) tumors are collected, the date of death should be used as the Date of 1st Contact. When Autopsy Only (Class of Case 5, Type of Reporting Source 6) tumors are collected, the date of death should be used as the Date of 1st Contact.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.2 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.2 Data Standards and Data Dictionary (5/30/2007)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=PQdlAnykU1U%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NAACCR V11.3 Data Stds/Dict.</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.3 Data Standards and Data Dictionary (4/2008)</DocumentText>
        <URL>http://www.naaccr.org/LinkClick.aspx?fileticket=xSH32ZzIzGI%3d</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NAACCR 11.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HospitalSpecific11.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103526</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HospitalSpecific11.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3103542</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2193114</PublicId>
          <ContextName>PS-CC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCCPS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HospitalSpecific11.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3242104</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>580</AlternateName>
        <AlternateNameType>NAACCR Item #</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DATE OF 1ST CONTACT</AlternateName>
        <AlternateNameType>NAACCR Item Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PS-CC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Date of Adm/1st Contact</AlternateName>
        <AlternateNameType>NAACCR Alt Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HOSP_SPC_FRS_CONT_DT</AlternateName>
        <AlternateNameType>C3D Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Date of First Contact</AlternateName>
        <AlternateNameType>TW Cancer Dataset</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1615">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2691581</PUBLICID>
    <LONGNAME>Clinical Study Document Central Institutional Review Board Approval Date</LONGNAME>
    <PREFERREDNAME>C_S_DOC_CIRB_APPR_DY</PREFERREDNAME>
    <PREFERREDDEFINITION>The date the Central Institutional Review Board (CIRB) approved the document.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2691579</PublicId>
      <PreferredName>C_STDY_DOC_CIRB_APPR</PreferredName>
      <PreferredDefinition>Information pertaining to a writing that contains information about a type of research study that tests how well new medical treatments or other interventions work in people and the acceptance by the Central Institutional Review Board.</PreferredDefinition>
      <LongName>Clinical Study Document Central Institutional Review Board Approval</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2689665</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15206:C19498</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Study Document Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19498</PREFERRED_NAME>
            <LONG_NAME>Document</LONG_NAME>
            <CON_ID>2223216</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2691577</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70907:C42782</PreferredName>
        <Version>1</Version>
        <LongName>Central Institutional Review Board Approval</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70907</PREFERRED_NAME>
            <LONG_NAME>Central Institutional Review Board</LONG_NAME>
            <CON_ID>2691462</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42782</PREFERRED_NAME>
            <LONG_NAME>Approval</LONG_NAME>
            <CON_ID>2224036</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCP:Division of Cancer Prevention</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018550</PublicId>
      <PreferredName>DT</PreferredName>
      <PreferredDefinition>The date on which an observation was made or an event occurred.</PreferredDefinition>
      <LongName>Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>MM/DD/YYYY</DisplayFormat>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CIRB Approval Date</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>CIRB Approval Date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>DCP-Text-1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Consent form IRB approval start date</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2487057</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DESK</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DESK Database</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812256</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NWU2013-01-03</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4528054</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1616">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2693142</PUBLICID>
    <LONGNAME>Curation Data User Identifier java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2693125v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>To organize and oversee.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._An individual who uses a computer, program, network, or related service for work or entertainment. (from http://www.computeruser.com/resources/dictionary/index.html):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>IVI:caBIG In Vivo Imaging Workspace</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2693125</PublicId>
      <PreferredName>2553705v1.0:2475308v1.0</PreferredName>
      <PreferredDefinition>To organize and oversee.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._An individual who uses a computer, program, network, or related service for work or entertainment. (from http://www.computeruser.com/resources/dictionary/index.html):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Curation Data User Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2553705</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48292:C25474</PreferredName>
        <Version>1</Version>
        <LongName>Curation Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48292</PREFERRED_NAME>
            <LONG_NAME>Curation</LONG_NAME>
            <CON_ID>2553612</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2475308</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42745:C25364</PreferredName>
        <Version>1</Version>
        <LongName>User Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42745</PREFERRED_NAME>
            <LONG_NAME>System User</LONG_NAME>
            <CON_ID>2203603</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>IVI:caBIG In Vivo Imaging Workspace</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Curation Data User Identifier java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Curation Data User Identifier java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2693115</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA_Model</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ncia.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000239</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CurationData:userId</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ncia.domain.CurationData.userId</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1617">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2693145</PUBLICID>
    <LONGNAME>Image Series Synchronization Frame of Reference Unique Identifier</LONGNAME>
    <PREFERREDNAME>IMG_SER_SYCH_FRM_UID</PREFERREDNAME>
    <PREFERREDDEFINITION>A set of equipment may share a common acquisition synchronization environment, which is identified by a Synchronization Frame of Reference UID. All SOP Instances that share the same Synchronization Frame of Reference UID shall be temporally related to each other. If a Synchronization Frame of Reference UID is present, all SOP Instances in the Series must share the same Frame of Reference.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DICOM:Digital Imaging and Communications in Medicine</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2693128</PublicId>
      <PreferredName>Imag_Seri_Sync_Fram_Uniq_Iden</PreferredName>
      <PreferredDefinition>A set of equipment may share a common acquisition synchronization environment, which is identified by a Synchronization Frame of Reference UID. All SOP Instances that share the same Synchronization Frame of Reference UID shall be temporally related to each other. If a Synchronization Frame of Reference UID is present, all SOP Instances in the Series must share the same Frame of Reference.</PreferredDefinition>
      <LongName>Image Series Synchronization Frame of Reference Identity Unique Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2436196</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48179:C25674</PreferredName>
        <Version>1</Version>
        <LongName>Image Series</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25674</PREFERRED_NAME>
            <LONG_NAME>Series</LONG_NAME>
            <CON_ID>2202620</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2693118</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48444:C69296:C45282:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Synchronization Frame of Reference Identity Unique Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48444</PREFERRED_NAME>
            <LONG_NAME>Synchronous</LONG_NAME>
            <CON_ID>2553607</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C69296</PREFERRED_NAME>
            <LONG_NAME>Frame of Reference Identity</LONG_NAME>
            <CON_ID>2684099</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45282</PREFERRED_NAME>
            <LONG_NAME>Unique</LONG_NAME>
            <CON_ID>2231550</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2191273</PublicId>
      <PreferredName>UID</PreferredName>
      <PreferredDefinition>Unique identifier for an object or person.</PreferredDefinition>
      <LongName>Unique Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>64</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2405190</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Synchronization Frame of Refe</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Synchronization Frame of Reference UID</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2693115</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA_Model</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Silver Review Modified CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2838921</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2693115</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NCIA_Model</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ncia.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000239</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2944977</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NBIA</PreferredName>
          <Version>5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ncia.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000240</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ncia.domain.Series.synchronizationFrameOfReferenceUID</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Series:synchronizationFrameOfReferenceUID</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ImageSeries:synchronizationFrameOfReferenceUID</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ncia.domain.ImageSeries.synchronizationFrameOfReferenceUID</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1618">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2695088</PUBLICID>
    <LONGNAME>Serological Laboratory Procedure Syphilis Laboratory Finding Result</LONGNAME>
    <PREFERREDNAME>SRLGC_LAB_SYPH_RSLT</PREFERREDNAME>
    <PREFERREDDEFINITION>The outcome of the laboratory procedure related to the assessment of the serologic testing for syphilis.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2693366</PublicId>
      <PreferredName>SRLGC_LAB_SYPH</PreferredName>
      <PreferredDefinition>Pertaining to the in vitro reactions and properties of immune sera, particularly, the concept refers to the use of such reactions to measure serum titers of antibody against infectious and non-infectious agents (serologic tests), to the clinical correlations of the antibody titer, and to the use of serologic reactions to detect antigens._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.</PreferredDefinition>
      <LongName>Serological Laboratory Procedure Syphilis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2727622</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41264:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Serological Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41264</PREFERRED_NAME>
            <LONG_NAME>Serological</LONG_NAME>
            <CON_ID>2634498</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2727623</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C35055</PreferredName>
        <Version>1</Version>
        <LongName>Syphilis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C35055</PREFERRED_NAME>
            <LONG_NAME>Syphilis</LONG_NAME>
            <CON_ID>2443251</CON_ID>
            <DEFINITION_SOURCE>MSH2003_2003_05_12</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2676304</PublicId>
      <PreferredName>LAB_RSLT</PreferredName>
      <PreferredDefinition>The outcome of a laboratory test._Outcome; a phenomenon that follows and is caused by some previous phenomenon.</PreferredDefinition>
      <LongName>Laboratory Finding Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>41</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2876957</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C36292:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test Result Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C36292</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Result</LONG_NAME>
            <CON_ID>2451822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elevated</VALIDVALUE>
          <VALUEMEANING>Elevated</VALUEMEANING>
          <MEANINGDESCRIPTION>Elevated; raised or increased.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25493</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-08-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-09-05</PVBEGINDATE>
          <PVENDDATE>2013-09-04</PVENDDATE>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes: C49488</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported</VALIDVALUE>
          <VALUEMEANING>Previous Report</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2676338</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Never below</VALIDVALUE>
          <VALUEMEANING>Never Less Than</VALUEMEANING>
          <MEANINGDESCRIPTION>Not ever; at no time in the past (or future).: A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61585, C70543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2682054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reactive</VALIDVALUE>
          <VALUEMEANING>Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707888</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Previously reported reactive, not tested</VALIDVALUE>
          <VALUEMEANING>Previous Report Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring prior to something else.: Report; a short account.: Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637, C25375, C25627</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707887</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not reported</VALIDVALUE>
          <VALUEMEANING>Not Report</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Report; a short account.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25375, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not performed; HIV NAT testing performed</VALIDVALUE>
          <VALUEMEANING>Human Immunodeficiency Virus Nucleic Acid Amplification Test Performed</VALUEMEANING>
          <MEANINGDESCRIPTION>Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME.: Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.: Performed; carried out.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38000, C20055, C14219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2727600</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-reactive</VALIDVALUE>
          <VALUEMEANING>Not Reaction</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25637, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2707884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2617835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Known</VALIDVALUE>
          <VALUEMEANING>Laboratory Finding Received</VALUEMEANING>
          <MEANINGDESCRIPTION>The outcome of a laboratory test._To take, accept, or get something offered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25639, C36292</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2729916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low</VALIDVALUE>
          <VALUEMEANING>Low</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimum level or position or degree; less than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-22</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inconclusive</VALIDVALUE>
          <VALUEMEANING>Uncertain</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2749725</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate/equivocal</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-10-09</PVBEGINDATE>
          <PVENDDATE>2013-12-17</PVENDDATE>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Absent</VALIDVALUE>
          <VALUEMEANING>Absent</VALUEMEANING>
          <MEANINGDESCRIPTION>Not existing in a specified place at a specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48190</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2566329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Borderline</VALIDVALUE>
          <VALUEMEANING>Borderline</VALUEMEANING>
          <MEANINGDESCRIPTION>Straddling the dividing line between two categories.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14157</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Reduced; decreased</VALIDVALUE>
          <VALUEMEANING>Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Made less in size or amount or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-09-09</PVBEGINDATE>
          <PVENDDATE>2012-06-29</PVENDDATE>
          <VMPUBLICID>3135563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Present</VALIDVALUE>
          <VALUEMEANING>Present</VALUEMEANING>
          <MEANINGDESCRIPTION>Being or existing in a specified place or at the specified time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25626</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3079341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Invalid neutralization</VALIDVALUE>
          <VALUEMEANING>Unacceptable Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>Failing to satisfy an established set of qualifying measures.: The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533, C63354</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Neutralized</VALIDVALUE>
          <VALUEMEANING>Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not neutralizable</VALIDVALUE>
          <VALUEMEANING>Negation Neutralization</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The act of rendering something ineffective or inactive.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95533, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3204286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Increased</VALIDVALUE>
          <VALUEMEANING>Increase</VALUEMEANING>
          <MEANINGDESCRIPTION>Increase; a process of becoming larger or more numerous or more important.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3031157</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decreased</VALIDVALUE>
          <VALUEMEANING>Reduced</VALUEMEANING>
          <MEANINGDESCRIPTION>Made less in size or amount or degree.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3135563</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Severe</VALIDVALUE>
          <VALUEMEANING>Severe</VALUEMEANING>
          <MEANINGDESCRIPTION>Intensely or extremely bad or unpleasant in degree, quality, or extent; life threatening.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70667</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2842706</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Moderate</VALIDVALUE>
          <VALUEMEANING>Moderate</VALUEMEANING>
          <MEANINGDESCRIPTION>The quality of being within reasonable or average limits; not excessive or extreme.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3225979</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mild</VALIDVALUE>
          <VALUEMEANING>Mild</VALUEMEANING>
          <MEANINGDESCRIPTION>Not severe or strong; far from extreme; not serious enough to endanger life.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70666</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-07-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563414</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High</VALIDVALUE>
          <VALUEMEANING>High</VALUEMEANING>
          <MEANINGDESCRIPTION>High; greater than normal in degree or intensity or amount.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25227</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not evaluable</VALIDVALUE>
          <VALUEMEANING>Not Assessable/Not Evaluable</VALUEMEANING>
          <MEANINGDESCRIPTION>Unable to be evaluated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3361719</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carrier of the trait</VALIDVALUE>
          <VALUEMEANING>Genetic Carrier Trait</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who carries an inheritable genetic mutation without manifestation of the associated condition.: Any genetically determined characteristic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85496, C111031</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3872849</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-09-04</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate</VALIDVALUE>
          <VALUEMEANING>Indeterminate</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Indeterminate/equivocal</VALIDVALUE>
          <VALUEMEANING>Indeterminate Or Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Cannot distinguish between two or more possible values in the current context.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071, C37998, C48658</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-12-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4012172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resolved</VALIDVALUE>
          <VALUEMEANING>Resolved</VALUEMEANING>
          <MEANINGDESCRIPTION>Return to the normal structure and/or function, e.g. the subsidence of a pathologic process, as the subsidence of an inflammatory lesion or new growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2936016</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Improved</VALIDVALUE>
          <VALUEMEANING>Better</VALUEMEANING>
          <MEANINGDESCRIPTION>In an improved condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71685</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3139193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Worse</VALIDVALUE>
          <VALUEMEANING>Worse</VALUEMEANING>
          <MEANINGDESCRIPTION>In an declined condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71686</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unchanged</VALIDVALUE>
          <VALUEMEANING>About the same</VALUEMEANING>
          <MEANINGDESCRIPTION>In an unchanged or similar condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3178174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Involved</VALIDVALUE>
          <VALUEMEANING>Involvement</VALUEMEANING>
          <MEANINGDESCRIPTION>To have a connection by participation or association or use; sharing in an activity or process.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25548</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4244451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abnormal</VALIDVALUE>
          <VALUEMEANING>Abnormal</VALUEMEANING>
          <MEANINGDESCRIPTION>Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-04-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4265117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not available</VALIDVALUE>
          <VALUEMEANING>Negation Availability</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Available; obtainable or accessible and ready for use or service.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25429, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3186683</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested</VALIDVALUE>
          <VALUEMEANING>Not Tested</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a test was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-05-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3918247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-secretory</VALIDVALUE>
          <VALUEMEANING>Non-Secretory Myeloma</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare type of multiple myeloma in which the plasma cells synthesize but do not secrete immunoglobulins.  As a result, none of the immunoglobulins appear out of the normal range.  The symptoms are generally the same with those of immunoglobulin-secreting myeloma; however, the incidence of renal insufficiency is lower in non-secretory myeloma.  The diagnosis can be missed because of the absence of monoclonal immunoglobulin in the serum or urine.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C4734</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2688913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive/Suggestive</VALIDVALUE>
          <VALUEMEANING>Positive Finding And/Or Characteristic</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.: Used to indicate that either or both of two items or options may be valid.: The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25447, C48928, C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5036957</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inconclusive / equivocal</VALIDVALUE>
          <VALUEMEANING>Uncertain And/Or Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Not established beyond doubt; still undecided or unknown.: Used to indicate that either or both of two items or options may be valid.: Open to question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071, C48928, C47944</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-01-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Suggestive</VALIDVALUE>
          <VALUEMEANING>Suggestion</VALUEMEANING>
          <MEANINGDESCRIPTION>A proposal offered for acceptance or rejection.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5070731</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not assessed</VALIDVALUE>
          <VALUEMEANING>Negation Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The final result of a determination of the value, significance, or extent of.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25594, C25217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4982117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Confirmed positive</VALIDVALUE>
          <VALUEMEANING>Confirmation Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>Having been established or verified.: A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758, C25458</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5677531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No growth</VALIDVALUE>
          <VALUEMEANING>Negation Growth</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: A process of becoming larger or longer or more numerous.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64379, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-02-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5653622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pending</VALIDVALUE>
          <VALUEMEANING>Pending</VALUEMEANING>
          <MEANINGDESCRIPTION>Not yet decided or settled; awaiting conclusion or confirmation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53470</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-04-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2784518</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unsatisfactory</VALIDVALUE>
          <VALUEMEANING>Unsatisfactory</VALUEMEANING>
          <MEANINGDESCRIPTION>Failing to meet the quantitative or qualitative measures for the needs of a situation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126862</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5255277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No result</VALIDVALUE>
          <VALUEMEANING>Negation Laboratory Test Result</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: The outcome of a laboratory test.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36292, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7096109</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Contraindicated</VALIDVALUE>
          <VALUEMEANING>Contraindicated</VALUEMEANING>
          <MEANINGDESCRIPTION>State of a particular method of treatment, regimen, procedure, medication, etc. of being unsuitable and inadvisable, often because of a likely adverse reaction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37933</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2023-12-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>14665139</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Equivocal</VALIDVALUE>
          <VALUEMEANING>Equivocal</VALUEMEANING>
          <MEANINGDESCRIPTION>Open to question; uncertain as a sign or indication; open to two or more interpretations; of uncertain nature or significance. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C86071</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-09-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558729</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Test results of infectious di</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Test results of infectious disease marker for syphilis using serologic testing for syphilis(STS)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>STS:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>STS:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>STS: (serologic screening test)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>STS: (serologic screening test)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2695088</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedClinicalResult.value WHERE PerformedClinicalResult &gt; PerformedObservation &gt; DefinedObservation.nameCode = &quot;test for Infectious Disease Marker for Syphilis&quot; AND DefinedObservation.methodCode = &quot;Serologic&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>STS</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>STS</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>STS</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>STS</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Syphilis (screening test)</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Syphilis (screening test)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2004r1: Infectious Disease Markers</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964896</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2007r1:Cord Blood Unit -SCTOD Data Requirements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3191905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Infectious Diseases and Immunity</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3009615</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2842777</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Labs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Infectious Disease Markers (IDMs)</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859933</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_sts_tst</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedClinicalResult:value </AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>idm_infect_dis_mark_syphilis_result</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1619">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2695328</PUBLICID>
    <LONGNAME>HLA-DQ Antigen  Serological Antigen Count</LONGNAME>
    <PREFERREDNAME>HLA_DQ_SRLG_ANTGN_CT</PREFERREDNAME>
    <PREFERREDDEFINITION>The numeric value related to the HLA-DQ serological antigen count.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2695326</PublicId>
      <PreferredName>HLA_DQ_SRLG</PreferredName>
      <PreferredDefinition>HLA-DQ antigen is a class of glycoproteins that consist of dimers of alpha and beta subunits, which are encoded by the polymorphic human genes HLA-DQA1 and HLA-DQB1, respectively. This protein complex is expressed primarily in lymphoid cells and function to present antigens for CD4+ T lymphocytes. Certain HLA-DQ protein variants are associated with susceptibility to insulin-dependent diabetes mellitus and several autoimmune diseases._Pertaining to the in vitro reactions and properties of immune sera, particularly, the concept refers to the use of such reactions to measure serum titers of antibody against infectious and non-infectious agents (serologic tests), to the clinical correlations of the antibody titer, and to the use of serologic reactions to detect antigens.</PreferredDefinition>
      <LongName>HLA-DQ Antigen  Serological</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2695324</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62792</PreferredName>
        <Version>1</Version>
        <LongName>HLA-DQ Antigen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62792</PREFERRED_NAME>
            <LONG_NAME>HLA-DQ Antigen</LONG_NAME>
            <CON_ID>2528500</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2684923</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41264</PreferredName>
        <Version>1</Version>
        <LongName>Serological</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41264</PREFERRED_NAME>
            <LONG_NAME>Serological</LONG_NAME>
            <CON_ID>2634498</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2693337</PublicId>
      <PreferredName>ANTGN_CT</PreferredName>
      <PreferredDefinition>Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens._To determine the number or amount of something; the result of this activity.</PreferredDefinition>
      <LongName>Antigen Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2713387</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C268:C25463</PreferredName>
        <Version>1</Version>
        <LongName>Antigen Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C268</PREFERRED_NAME>
            <LONG_NAME>Antigen</LONG_NAME>
            <CON_ID>2202300</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>One</VALIDVALUE>
          <VALUEMEANING>integer::1</VALUEMEANING>
          <MEANINGDESCRIPTION>integer::1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2693329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Two</VALIDVALUE>
          <VALUEMEANING>integer::2</VALUEMEANING>
          <MEANINGDESCRIPTION>integer::2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2007-11-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2693328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of DQ antigens provide</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of DQ antigens provided:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2695328</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedClinicalResult.value(ANY=&gt;INT) WHERE PerformedClinicalResult &gt; PerformedObservation &gt; DefinedObservation.nameCode = &quot;test for HLA-DQ Serological Antigen&quot; AND PerformedClinicalResult.targetBiomarkerCode = &#39;HLA-DQ Antigen&#39;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2005r1: Confirmation of HLA Typing</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2842777</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Labs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HLA Typing</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2859958</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>hla_srlgy_num_dq_atgn_prv</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedClinicalResult:value</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1620">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2708021</PUBLICID>
    <LONGNAME>Gene Expression Fold Change Finding Array Identifier BioAssayArrayType</LONGNAME>
    <PREFERREDNAME>2707953v1.0:2707988v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:An indication of the magnitude difference between two values specified as the number of multiples of the first value to the second value (e.g., from 10 to 20 is a 2-fold increase, from 10 to 50 is a five-fold increase).:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom)._An orderly arrangement. (from the American Heritage Dictionary):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._array design identifier, given by the manufactures of the array: eg: U133plus2.0 by Affy manufactures</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2707953</PublicId>
      <PreferredName>2528738v1.0:2528703v1.0</PreferredName>
      <PreferredDefinition>Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:An indication of the magnitude difference between two values specified as the number of multiples of the first value to the second value (e.g., from 10 to 20 is a 2-fold increase, from 10 to 50 is a five-fold increase).:Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom)._An orderly arrangement. (from the American Heritage Dictionary):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Gene Expression Fold Change Finding Array Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2528738</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16608:C60693:C3367</PreferredName>
        <Version>1</Version>
        <LongName>Gene Expression Fold Change Finding</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16608</PREFERRED_NAME>
            <LONG_NAME>Gene Expression</LONG_NAME>
            <CON_ID>2203923</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60693</PREFERRED_NAME>
            <LONG_NAME>Fold Change</LONG_NAME>
            <CON_ID>2528541</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3367</PREFERRED_NAME>
            <LONG_NAME>Finding</LONG_NAME>
            <CON_ID>2202448</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528703</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C26358:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Array Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26358</PREFERRED_NAME>
            <LONG_NAME>Array</LONG_NAME>
            <CON_ID>2236563</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2707988</PublicId>
      <PreferredName>2707988v1.0</PreferredName>
      <PreferredDefinition>array design identifier, given by the manufactures of the array: eg: U133plus2.0 by Affy manufactures</PreferredDefinition>
      <LongName>BioAssayArrayType</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435022</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C7057</PreferredName>
        <Version>1</Version>
        <LongName>Disease, Disorder or Finding</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cdnaarray</VALIDVALUE>
          <VALUEMEANING>CDNA Array</VALUEMEANING>
          <MEANINGDESCRIPTION>A molecular biology device that utilizes a set of defined cDNA clones attached in a specific grid arrangement to a solid support for nucleic acid hybridization assays in gene mapping studies or in determining gene sequences, sequence variations, or gene expression patterns.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19819</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2707989</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hgu133p2</VALIDVALUE>
          <VALUEMEANING>hgu133p2</VALUEMEANING>
          <MEANINGDESCRIPTION>Affymetrics Human Genome U133 Plus 2.0 Array</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2707990</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>hm100ksnparray</VALIDVALUE>
          <VALUEMEANING>hm100ksnparray</VALUEMEANING>
          <MEANINGDESCRIPTION>Affymetic&#39;s Gene Chip Human Mapping 100K </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE/>
          <PVENDDATE/>
          <VMPUBLICID>2707991</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Gene Expression Fold Change Finding Array Identifier BioAssayArrayType does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Gene Expression Fold Change Finding Array Identifier BioAssayArrayType does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2707890</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caIntegrator 2.1</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caintegrator.domain.finding.geneExpression.differentialFoldChangeFinding</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000642</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caintegrator.domain.finding.geneExpression.differentialFoldChangeFinding.DiffFoldChangeFinding.arrayType</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DiffFoldChangeFinding:arrayType</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1621">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711622</PUBLICID>
    <LONGNAME>Tandem Mass Spectrometry Fraction Peak List Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2710865v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Mass spectrometers coupled in series.  The targeted compound is selectively ionized, and its characteristic ions are separated from others in the mixture in the first mass spectrometer. The selected primary ions are then decomposed by collision, and from the resulting products the final mass analyzer selects secondary ions characteristic of the targeted compound. Tandem mass spectrometry can achieve specificities and sensitivities equivalent of those of methods such as radioimmunoassay and gas chromatography/mass spectrometry, while performing analyses in much shorter times.:A part, a fragment of a whole._The most extreme possible amount or value; the highest point.:A series of names, words, or other items written, printed, or imagined one after the other.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2710865</PublicId>
      <PreferredName>2710715v1.0:2710328v1.0</PreferredName>
      <PreferredDefinition>Mass spectrometers coupled in series.  The targeted compound is selectively ionized, and its characteristic ions are separated from others in the mixture in the first mass spectrometer. The selected primary ions are then decomposed by collision, and from the resulting products the final mass analyzer selects secondary ions characteristic of the targeted compound. Tandem mass spectrometry can achieve specificities and sensitivities equivalent of those of methods such as radioimmunoassay and gas chromatography/mass spectrometry, while performing analyses in much shorter times.:A part, a fragment of a whole._The most extreme possible amount or value; the highest point.:A series of names, words, or other items written, printed, or imagined one after the other.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Tandem Mass Spectrometry Fraction Peak List Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710715</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18142:C25514</PreferredName>
        <Version>1</Version>
        <LongName>Tandem Mass Spectrometry Fraction</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18142</PREFERRED_NAME>
            <LONG_NAME>Tandem Mass Spectrometry</LONG_NAME>
            <CON_ID>2671518</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25514</PREFERRED_NAME>
            <LONG_NAME>Fraction</LONG_NAME>
            <CON_ID>2203814</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710328</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48054:C43432:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Peak List Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48054</PREFERRED_NAME>
            <LONG_NAME>Peak</LONG_NAME>
            <CON_ID>2483456</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43432</PREFERRED_NAME>
            <LONG_NAME>List</LONG_NAME>
            <CON_ID>2236559</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Tandem Mass Spectrometry Fraction Peak List Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Tandem Mass Spectrometry Fraction Peak List Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.MassSpecMassSpecFraction.peakLisIdentifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MassSpecMassSpecFraction:peakLisIdentifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1622">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711820</PUBLICID>
    <LONGNAME>Other Mass Spectrometry Analysis Ontology Entry Ontology Entry Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2711064v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Different than the one(s) previously specified or mentioned.:An analytical technique wherein ions are separate according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:A single entry from an ontology or a controlled vocabulary.  For instance, category could be &#39;species name&#39;, value could be &#39;homo sapiens&#39; and ontology would be taxonomy database, NCBI. (caMAGE)_A single entry from an ontology or a controlled vocabulary.  For instance, category could be &#39;species name&#39;, value could be &#39;homo sapiens&#39; and ontology would be taxonomy database, NCBI. (caMAGE):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711064</PublicId>
      <PreferredName>2710741v1.0:2710447v1.0</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned.:An analytical technique wherein ions are separate according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:A single entry from an ontology or a controlled vocabulary.  For instance, category could be &#39;species name&#39;, value could be &#39;homo sapiens&#39; and ontology would be taxonomy database, NCBI. (caMAGE)_A single entry from an ontology or a controlled vocabulary.  For instance, category could be &#39;species name&#39;, value could be &#39;homo sapiens&#39; and ontology would be taxonomy database, NCBI. (caMAGE):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Other Mass Spectrometry Analysis Ontology Entry Ontology Entry Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710741</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C17156:C25391:C44174</PreferredName>
        <Version>1</Version>
        <LongName>Other Mass Spectrometry Analysis Ontology Entry</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17156</PREFERRED_NAME>
            <LONG_NAME>Mass Spectrometry</LONG_NAME>
            <CON_ID>2710222</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44174</PREFERRED_NAME>
            <LONG_NAME>Ontology Entry</LONG_NAME>
            <CON_ID>2236578</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710447</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C44174:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Ontology Entry Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44174</PREFERRED_NAME>
            <LONG_NAME>Ontology Entry</LONG_NAME>
            <CON_ID>2236578</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Other Mass Spectrometry Analysis Ontology Entry Ontology Entry Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Other Mass Spectrometry Analysis Ontology Entry Ontology Entry Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.OtherMZAnalysisOntologyEntry.ontologyEntryIdentifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OtherMZAnalysisOntologyEntry:ontologyEntryIdentifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1623">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711855</PUBLICID>
    <LONGNAME>Mass Spectrometry Analysis Mass Spectrometry Analysis Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2711100v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An analytical technique wherein ions are separate according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it._An analytical technique wherein ions are separate according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711100</PublicId>
      <PreferredName>2710748v1.0:2710375v1.0</PreferredName>
      <PreferredDefinition>An analytical technique wherein ions are separate according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it._An analytical technique wherein ions are separate according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Mass Spectrometry Analysis Mass Spectrometry Analysis Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710748</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17156:C25391</PreferredName>
        <Version>1</Version>
        <LongName>Mass Spectrometry Analysis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17156</PREFERRED_NAME>
            <LONG_NAME>Mass Spectrometry</LONG_NAME>
            <CON_ID>2710222</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710375</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17156:C25391:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Mass Spectrometry Analysis Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17156</PREFERRED_NAME>
            <LONG_NAME>Mass Spectrometry</LONG_NAME>
            <CON_ID>2710222</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Mass Spectrometry Analysis Mass Spectrometry Analysis Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Mass Spectrometry Analysis Mass Spectrometry Analysis Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.MZAnalysis.mZAnalysisIdentifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MZAnalysis:mZAnalysisIdentifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1624">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2711912</PUBLICID>
    <LONGNAME>Experiment Database Search Experiment Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2711157v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena.:An information set with a regular structure.  Although it can be applied to any set of information the term was invented to refer to computerized data, and is used almost exclusively in computing.:The activity of looking thoroughly in order to find something or someone; an operation that determines whether one or more of a set of items has a specified property._In the scientific method, an experiment is a set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena. The experiment is a cornerstone of the empirical approach to knowledge. (from Wikipedia):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711157</PublicId>
      <PreferredName>2710760v1.0:2224061v1.0</PreferredName>
      <PreferredDefinition>A set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena.:An information set with a regular structure.  Although it can be applied to any set of information the term was invented to refer to computerized data, and is used almost exclusively in computing.:The activity of looking thoroughly in order to find something or someone; an operation that determines whether one or more of a set of items has a specified property._In the scientific method, an experiment is a set of actions and observations, performed to verify or falsify a hypothesis or research a causal relationship between phenomena. The experiment is a cornerstone of the empirical approach to knowledge. (from Wikipedia):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Experiment Database Search Experiment Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710760</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42790:C15426:C54117</PreferredName>
        <Version>1</Version>
        <LongName>Experiment Database Search</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42790</PREFERRED_NAME>
            <LONG_NAME>Experiment</LONG_NAME>
            <CON_ID>2223979</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15426</PREFERRED_NAME>
            <LONG_NAME>Database</LONG_NAME>
            <CON_ID>2228339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54117</PREFERRED_NAME>
            <LONG_NAME>Search</LONG_NAME>
            <CON_ID>2505702</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2224061</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42790:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Experiment Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42790</PREFERRED_NAME>
            <LONG_NAME>Experiment</LONG_NAME>
            <CON_ID>2223979</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Experiment Database Search Experiment Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Experiment Database Search Experiment Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.ExperimentToDatabaseSearch.experimentIdentifier</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ExperimentToDatabaseSearch:experimentIdentifier</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1625">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2712063</PUBLICID>
    <LONGNAME>Average Spot Information Background Error java.lang.Double</LONGNAME>
    <PREFERREDNAME>2711308v1.0:2200948v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A statistical calculation describing the central tendency of a set of numbers; used to interpret quantitative data.:A mark on a substance or body made by foreign matter; a blot; a place discolored.:Knowledge derived from study, experience, or instruction that has been gathered or received by communication._Existing conditions, especially those that would be confused with the phenomenon to be observed or measured.:A discrepancy between a computed, observed, or measured value or condition and the true, specified, or theoretically correct value or condition._Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711308</PublicId>
      <PreferredName>2710780v1.0:2710582v1.0</PreferredName>
      <PreferredDefinition>A statistical calculation describing the central tendency of a set of numbers; used to interpret quantitative data.:A mark on a substance or body made by foreign matter; a blot; a place discolored.:Knowledge derived from study, experience, or instruction that has been gathered or received by communication._Existing conditions, especially those that would be confused with the phenomenon to be observed or measured.:A discrepancy between a computed, observed, or measured value or condition and the true, specified, or theoretically correct value or condition.</PreferredDefinition>
      <LongName>Average Spot Information Background Error</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710780</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37917:C48039:C48191</PreferredName>
        <Version>1</Version>
        <LongName>Average Spot Information</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37917</PREFERRED_NAME>
            <LONG_NAME>Average</LONG_NAME>
            <CON_ID>2204654</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48039</PREFERRED_NAME>
            <LONG_NAME>Spot</LONG_NAME>
            <CON_ID>2422621</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48191</PREFERRED_NAME>
            <LONG_NAME>Information</LONG_NAME>
            <CON_ID>2422630</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710582</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45782:C43369</PreferredName>
        <Version>1</Version>
        <LongName>Background Error</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45782</PREFERRED_NAME>
            <LONG_NAME>Background</LONG_NAME>
            <CON_ID>2236603</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43369</PREFERRED_NAME>
            <LONG_NAME>Error</LONG_NAME>
            <CON_ID>2236607</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2200948</PublicId>
      <PreferredName>java.lang.Double</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Double-precision floating point number (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>java.lang.Double</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Average Spot Information Background Error java.lang.Double does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Average Spot Information Background Error java.lang.Double does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.AveragedSpotInformation.backgroundError</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AveragedSpotInformation:backgroundError</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1626">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2712093</PUBLICID>
    <LONGNAME>Collision Cell Gas Type java.lang.String</LONGNAME>
    <PREFERREDNAME>2711338v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An accident resulting from violent impact of a moving object; an brief event in which two or more bodies come together.:Any small compartment._A fluid in the gaseous state having neither independent shape nor volume and being able to expand indefinitely.:Something distinguishable as an identifiable class based on common qualities._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711338</PublicId>
      <PreferredName>2710783v1.0:2710606v1.0</PreferredName>
      <PreferredDefinition>An accident resulting from violent impact of a moving object; an brief event in which two or more bodies come together.:Any small compartment._A fluid in the gaseous state having neither independent shape nor volume and being able to expand indefinitely.:Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Collision Cell Gas Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710783</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48052:C48694</PreferredName>
        <Version>1</Version>
        <LongName>Collision Cell</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48052</PREFERRED_NAME>
            <LONG_NAME>Collision</LONG_NAME>
            <CON_ID>2710288</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48694</PREFERRED_NAME>
            <LONG_NAME>Cell</LONG_NAME>
            <CON_ID>2519063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710606</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45299:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Gas Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45299</PREFERRED_NAME>
            <LONG_NAME>Gas</LONG_NAME>
            <CON_ID>2710289</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Collision Cell Gas Type java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Collision Cell Gas Type java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.CollisionCell.gasType</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CollisionCell:gasType</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1627">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2713331</PUBLICID>
    <LONGNAME>Differential In-Gel Electrophoresis Electrophoresis Gel TIFF Image java.lang.Object</LONGNAME>
    <PREFERREDNAME>2711057v1.0:2483682v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A form of gel electrophoresis where up to three different protein samples can be labeled with fluorescent dyes prior to two-dimensional electrophoresis in the same gel. After the gel electrophoresis, the gel is scanned with the excitation wavelength of each dye and the imges are superimposed, allowing detection of changes in protein abundance between samples.:A gel matrix through which molecules are separated, usually by size or charge, under the influence of an electrical field._A bitmap graphics file format utilizing tagged fields.:Any record of an imaging event whether physical or electronic._Generic value domain for a java datatype that is the root of the class hierarchy used as a superclass for all classes.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2711057</PublicId>
      <PreferredName>2710738v1.0:2710445v1.0</PreferredName>
      <PreferredDefinition>A form of gel electrophoresis where up to three different protein samples can be labeled with fluorescent dyes prior to two-dimensional electrophoresis in the same gel. After the gel electrophoresis, the gel is scanned with the excitation wavelength of each dye and the imges are superimposed, allowing detection of changes in protein abundance between samples.:A gel matrix through which molecules are separated, usually by size or charge, under the influence of an electrical field._A bitmap graphics file format utilizing tagged fields.:Any record of an imaging event whether physical or electronic.</PreferredDefinition>
      <LongName>Differential In-Gel Electrophoresis Electrophoresis Gel TIFF Image</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2710738</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70654:C45307</PreferredName>
        <Version>1</Version>
        <LongName>Differential In-Gel Electrophoresis Electrophoresis Gel</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70654</PREFERRED_NAME>
            <LONG_NAME>Differential In-Gel Electrophoresis</LONG_NAME>
            <CON_ID>2710244</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45307</PREFERRED_NAME>
            <LONG_NAME>Electrophoresis Gel</LONG_NAME>
            <CON_ID>2240757</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2710445</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70631:C48179</PreferredName>
        <Version>1</Version>
        <LongName>TIFF Image</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70631</PREFERRED_NAME>
            <LONG_NAME>TIFF</LONG_NAME>
            <CON_ID>2710242</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48179</PREFERRED_NAME>
            <LONG_NAME>Image</LONG_NAME>
            <CON_ID>2422618</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2483682</PublicId>
      <PreferredName>java.lang.Object</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is the root of the class hierarchy used as a superclass for all classes.</PreferredDefinition>
      <LongName>java.lang.Object</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Object</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2707862</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45974</PreferredName>
        <Version>1</Version>
        <LongName>Computer Programming Object</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45974</PREFERRED_NAME>
            <LONG_NAME>Computer Programming Object</LONG_NAME>
            <CON_ID>2528432</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Differential In-Gel Electrophoresis Electrophoresis Gel TIFF Image java.lang.Object does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Differential In-Gel Electrophoresis Electrophoresis Gel TIFF Image java.lang.Object does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>ProteinDB</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2812696</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2710221</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NHLBI</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.jhu.icm.proteindb</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812697</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DigeGel:tiffImage</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.jhu.icm.proteindb.DigeGel.tiffImage</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1628">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2722734</PUBLICID>
    <LONGNAME>Specimen Therapeutic Effect</LONGNAME>
    <PREFERREDNAME>SPEC_TE_SPEC</PREFERREDNAME>
    <PREFERREDDEFINITION>the free-text field to specify the pathologic change in the  specimen tissues that show evidence of treatment with cancer therapy prior to collection of the specimen.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2014223</PublicId>
      <PreferredName>SPEC_TE</PreferredName>
      <PreferredDefinition>evidence of cancer treatment in the tissue specimen.</PreferredDefinition>
      <LongName>Specimen Therapeutic Effect</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2177026</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specimen</PreferredName>
        <Version>1</Version>
        <LongName>Specimen</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2184343</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Therapeutic Effect</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Effect</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38032</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Effect</LONG_NAME>
            <CON_ID>2203965</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2233400</PublicId>
      <PreferredName>TX_RSLT_SPEC</PreferredName>
      <PreferredDefinition>the free text field to specify result of a therapeutic intervention.</PreferredDefinition>
      <LongName>Therapy Result Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008563</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Therapy Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>CALGB CRF:Cancer and Leukemia Group B Case Report Form</Origin>
      <Representation>
        <PublicId>2184338</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Specify</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811910</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Brain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II Breast Cancer</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812245</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Sarcoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000607</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Disease Description</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811953</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Patient Char.</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast Cancer DataMart</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811884</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adult STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811885</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811886</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ped STS Recurrent</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811889</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Adjuvant Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Advanced Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811932</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pathology Prostate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2811937</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Primary Brain Recurr</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma New</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000027</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008594</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>TTU</PreferredName>
          <Version>2.31</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bone Sarcoma Recur</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>10000028</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase II</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811891</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3461586</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BOLD </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preoperative Elements</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3461587</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886755</PublicId>
          <ContextName>BOLD</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Preoperative Elements</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Preoperative</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3902140</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <AlternateName>0065097</AlternateName>
        <AlternateNameType>HISTORICAL_CDE_ID</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>caBIG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>BOLD</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BOLD</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1629">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2724796</PUBLICID>
    <LONGNAME>Biospecimen Collection Anatomic Site Condition Code java.lang.String</LONGNAME>
    <PREFERREDNAME>2724676v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The act or process of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes._Named locations of or within the body.:A state of being, such as a state of health or physical being.:A system, often of numbered categories, for representation of data._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2724676</PublicId>
      <PreferredName>2715159v1.0:2607569v1.0</PreferredName>
      <PreferredDefinition>The act or process of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes._Named locations of or within the body.:A state of being, such as a state of health or physical being.:A system, often of numbered categories, for representation of data.</PreferredDefinition>
      <LongName>Biospecimen Collection Anatomic Site Condition Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2715159</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70945</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Collection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70945</PREFERRED_NAME>
            <LONG_NAME>Biospecimen Collection</LONG_NAME>
            <CON_ID>2714902</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607569</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717:C25457:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site Condition Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25457</PREFERRED_NAME>
            <LONG_NAME>Condition</LONG_NAME>
            <CON_ID>2202899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Biospecimen Collection Anatomic Site Condition Code java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Biospecimen Collection Anatomic Site Condition Code java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2724612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTODS</PreferredName>
          <Version>0.53</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ctom.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.SpecimenAcquisition.siteConditionCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SpecimenAcquisition:siteConditionCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1630">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2724806</PUBLICID>
    <LONGNAME>Human Study Subject Protocol Agent Dose Level java.lang.Long</LONGNAME>
    <PREFERREDNAME>2724686v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A living individual about whom an investigator (whether professional or student) conducting research obtains data through intervention or interaction with the individual, or identifiable private information. Intervention includes both physical procedures by which data are gathered (for example, venipuncture) and manipulations of the subject or the subject&#39;s environment that are performed for research purposes. Interaction includes communication or interpersonal contact between investigator and subject. Private information includes information about behavior that occurs in a context in which an individual can reasonably expect that no observation or recording is taking place, and information which has been provided for specific purposes by an individual and which the individual can reasonably expect will not be made public (for example, a medical record). Private information must be individually identifiable (i.e., the identity of the subject is or may readily be ascertained by the investigator or associated with the information) in order for obtaining the information to constitute research involving human subjects. (Code of Federal Regulations, TITLE 45, PART 46, PROTECTION OF HUMAN SUBJECTS)._A therapeutic agent (drug, intervention therapy) used in a clinical trial protocol.:The total quantity or strength of a substance administered at one time.:A position on a scale measuring intensity, quality, or amount._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2724686</PublicId>
      <PreferredName>2715167v1.0:2607649v1.0</PreferredName>
      <PreferredDefinition>A living individual about whom an investigator (whether professional or student) conducting research obtains data through intervention or interaction with the individual, or identifiable private information. Intervention includes both physical procedures by which data are gathered (for example, venipuncture) and manipulations of the subject or the subject&#39;s environment that are performed for research purposes. Interaction includes communication or interpersonal contact between investigator and subject. Private information includes information about behavior that occurs in a context in which an individual can reasonably expect that no observation or recording is taking place, and information which has been provided for specific purposes by an individual and which the individual can reasonably expect will not be made public (for example, a medical record). Private information must be individually identifiable (i.e., the identity of the subject is or may readily be ascertained by the investigator or associated with the information) in order for obtaining the information to constitute research involving human subjects. (Code of Federal Regulations, TITLE 45, PART 46, PROTECTION OF HUMAN SUBJECTS)._A therapeutic agent (drug, intervention therapy) used in a clinical trial protocol.:The total quantity or strength of a substance administered at one time.:A position on a scale measuring intensity, quality, or amount.</PreferredDefinition>
      <LongName>Human Study Subject Protocol Agent Dose Level</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2715167</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70665</PreferredName>
        <Version>1</Version>
        <LongName>Human Study Subject</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70665</PREFERRED_NAME>
            <LONG_NAME>Human Study Subject</LONG_NAME>
            <CON_ID>2714925</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607649</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41161:C25488:C25554</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Agent Dose Level</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41161</PREFERRED_NAME>
            <LONG_NAME>Protocol Agent</LONG_NAME>
            <CON_ID>2390873</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25554</PREFERRED_NAME>
            <LONG_NAME>Level</LONG_NAME>
            <CON_ID>2202440</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Human Study Subject Protocol Agent Dose Level java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Human Study Subject Protocol Agent Dose Level java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2724612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTODS</PreferredName>
          <Version>0.53</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ctom.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>StudyParticipantAssignment:studyAgentDoseLevel</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.StudyParticipantAssignment.studyAgentDoseLevel</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1631">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2724844</PUBLICID>
    <LONGNAME>Biospecimen Collection Anatomic Site Code System java.lang.String</LONGNAME>
    <PREFERREDNAME>2724738v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The act or process of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes._Named locations of or within the body.:A system, often of numbered categories, for representation of data.:A group of independent but interrelated elements comprising a unified whole._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2724738</PublicId>
      <PreferredName>2715159v1.0:2607552v1.0</PreferredName>
      <PreferredDefinition>The act or process of gathering biospecimens for testing, diagnostic, propagation, treatment or research purposes._Named locations of or within the body.:A system, often of numbered categories, for representation of data.:A group of independent but interrelated elements comprising a unified whole.</PreferredDefinition>
      <LongName>Biospecimen Collection Anatomic Site Code System</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2715159</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70945</PreferredName>
        <Version>1</Version>
        <LongName>Biospecimen Collection</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70945</PREFERRED_NAME>
            <LONG_NAME>Biospecimen Collection</LONG_NAME>
            <CON_ID>2714902</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2607552</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13717:C25162:C25700</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Site Code System</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25700</PREFERRED_NAME>
            <LONG_NAME>System</LONG_NAME>
            <CON_ID>2202584</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Biospecimen Collection Anatomic Site Code System java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Biospecimen Collection Anatomic Site Code System java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2724612</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CTODS</PreferredName>
          <Version>0.53</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.ctom.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000404</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SpecimenAcquisition:anatomicSiteCodeSystem</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.ctom.domain.SpecimenAcquisition.anatomicSiteCodeSystem</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1632">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2727101</PUBLICID>
    <LONGNAME>Single Nucleotide Polymorphism Probe Annotation Genomic Feature Physical Location java.lang.Long</LONGNAME>
    <PREFERREDNAME>2726757v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:General term for a piece of DNA or RNA corresponding to a gene or sequence of interest, that has been labelled either radioactively or with some other detectable molecule, such as biotin, digoxygenin or fluorescein. As stretches of DNA or RNA with complementary sequences will (hybridize), a probe will label viral plaques, bacterial colonies or bands on a gel that contain the gene of interest.:An explanatory or critical comment that has been added to a text._The physical location on a specified chromosome of a feature or area of interest expressed as a base pair position._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2726757</PublicId>
      <PreferredName>2726700v1.0:2632627v1.0</PreferredName>
      <PreferredDefinition>A variation of a single nucleotide at a specific location of the genome due to base substitution, present at an appreciable frequency between individuals of a single interbreeding population.:General term for a piece of DNA or RNA corresponding to a gene or sequence of interest, that has been labelled either radioactively or with some other detectable molecule, such as biotin, digoxygenin or fluorescein. As stretches of DNA or RNA with complementary sequences will (hybridize), a probe will label viral plaques, bacterial colonies or bands on a gel that contain the gene of interest.:An explanatory or critical comment that has been added to a text._The physical location on a specified chromosome of a feature or area of interest expressed as a base pair position.</PreferredDefinition>
      <LongName>Single Nucleotide Polymorphism Probe Annotation Genomic Feature Physical Location</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2726700</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18279:C43523:C44272</PreferredName>
        <Version>1</Version>
        <LongName>Single Nucleotide Polymorphism Probe Annotation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18279</PREFERRED_NAME>
            <LONG_NAME>Single Nucleotide Polymorphism</LONG_NAME>
            <CON_ID>2433334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43523</PREFERRED_NAME>
            <LONG_NAME>Probe</LONG_NAME>
            <CON_ID>2433326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44272</PREFERRED_NAME>
            <LONG_NAME>Annotation</LONG_NAME>
            <CON_ID>2519066</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2632627</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C64389</PreferredName>
        <Version>1</Version>
        <LongName>Genomic Feature Physical Location</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64389</PREFERRED_NAME>
            <LONG_NAME>Genomic Feature Physical Location</LONG_NAME>
            <CON_ID>2632612</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Single Nucleotide Polymorphism Probe Annotation Genomic Feature Physical Location java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Single Nucleotide Polymorphism Probe Annotation Genomic Feature Physical Location java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.array</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812742</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.array</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000649</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.array</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000652</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.array.SNPProbeAnnotation.physicalPosition</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SNPProbeAnnotation:physicalPosition</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1633">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2727138</PUBLICID>
    <LONGNAME>Variable Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2726794v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any characteristic or attribute that can be measured. (CDC)_The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2726794</PublicId>
      <PreferredName>2236761v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>Any characteristic or attribute that can be measured. (CDC)_The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Variable Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236761</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43371</PreferredName>
        <Version>1</Version>
        <LongName>Variable</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43371</PREFERRED_NAME>
            <LONG_NAME>Variable Characteristic</LONG_NAME>
            <CON_ID>2236568</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Variable Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Variable Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812747</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000573</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.project</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000576</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2953481</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Service</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Service 1.0</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2953482</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2953481</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Service</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.external.v1_0.factor</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2953487</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.project.Factor.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Factor:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.external.v1_0.factor.Factor.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1634">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2727310</PUBLICID>
    <LONGNAME>Measurement Characteristic Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2726961v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Annotation used to indicate that the size or magnitude of something was determined by comparison to a standard.:The distinguishing qualities or prominent aspect of a person, object, action, process, or substance._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2726961</PublicId>
      <PreferredName>2726725v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Annotation used to indicate that the size or magnitude of something was determined by comparison to a standard.:The distinguishing qualities or prominent aspect of a person, object, action, process, or substance._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Measurement Characteristic Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2726725</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25209:C25447</PreferredName>
        <Version>1</Version>
        <LongName>Measurement Characteristic</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25209</PREFERRED_NAME>
            <LONG_NAME>Measurement</LONG_NAME>
            <CON_ID>2203848</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25447</PREFERRED_NAME>
            <LONG_NAME>Characteristic</LONG_NAME>
            <CON_ID>2203874</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Measurement Characteristic Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Measurement Characteristic Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812750</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000666</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.sample</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000669</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.sample.MeasurementCharacteristic.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MeasurementCharacteristic:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1635">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2728739</PUBLICID>
    <LONGNAME>Mother Age Unknown Indicator</LONGNAME>
    <PREFERREDNAME>MOTHER_AGE_UKN_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not the mother&#39;s age was known.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2595731</PublicId>
      <PreferredName>Mother_Age</PreferredName>
      <PreferredDefinition>Mother; a female parent._A period or stage in life, usually stated in years since birth.</PreferredDefinition>
      <LongName>Mother Age</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008532</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>INDS</PreferredName>
        <Version>1</Version>
        <LongName>Individuals</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2595944</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25189</PreferredName>
        <Version>1</Version>
        <LongName>Mother</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25189</PREFERRED_NAME>
            <LONG_NAME>Mother</LONG_NAME>
            <CON_ID>2202747</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239916</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25150</PreferredName>
        <Version>1</Version>
        <LongName>Age</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25150</PREFERRED_NAME>
            <LONG_NAME>Age</LONG_NAME>
            <CON_ID>2202837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2615087</PublicId>
      <PreferredName>UKN_IND</PreferredName>
      <PreferredDefinition>Not known, not observed, not recorded, or refused. (NCI)_An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether or not certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2615086</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17998:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Unknown Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did you know mother&#39;s age?</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Did you know mother&#39;s age?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Age unknown</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Age unknown</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2006r1: HSCT Infusion</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964920</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1636">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2731945</PUBLICID>
    <LONGNAME>Concomitant Agent Adverse Event Visit Type</LONGNAME>
    <PREFERREDNAME>CONC_MED_AE_VST_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>The name of the visit at which data reported on the Concomitant Medication and Adverse Event forms were collected.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2182696</PublicId>
      <PreferredName>VST_REP_MON_TP</PreferredName>
      <PreferredDefinition>The number of months from the time of study entry until the date of a clinic visit being reported.
</PreferredDefinition>
      <LongName>Visit Report Month Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008583</PublicId>
        <ContextName>EDRN</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>RESPONSE</PreferredName>
        <Version>1</Version>
        <LongName>Response</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2181693</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Visit</PreferredName>
        <Version>1</Version>
        <LongName>Visit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25716</PREFERRED_NAME>
            <LONG_NAME>Visit</LONG_NAME>
            <CON_ID>2202626</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2182694</PublicId>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>Type</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2731937</PublicId>
      <PreferredName>CONC_MED_AE_VST_TP</PreferredName>
      <PreferredDefinition>The name that represents the period of the visit on the Concomitant Medications and Adverse Events forms.</PreferredDefinition>
      <LongName>Concomitant Agent Adverse Event Visit Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008528</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>PROT_ADM</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Administration</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DCP:Division of Cancer Prevention</Origin>
      <Representation>
        <PublicId>2731936</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70902:C41331:C25716:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Agent Adverse Event Visit Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70902</PREFERRED_NAME>
            <LONG_NAME>Concomitant Agent</LONG_NAME>
            <CON_ID>2715024</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25716</PREFERRED_NAME>
            <LONG_NAME>Visit</LONG_NAME>
            <CON_ID>2202626</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Follow up</VALIDVALUE>
          <VALUEMEANING>Follow up</VALUEMEANING>
          <MEANINGDESCRIPTION>Follow up</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 6</VALIDVALUE>
          <VALUEMEANING>Month 6</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 6</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574450</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 5 Telephone Interview</VALIDVALUE>
          <VALUEMEANING>Month 5 Telephone Interview</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 5 Telephone Interview</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2731938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 4 Telephone Interview</VALIDVALUE>
          <VALUEMEANING>Month 4 Telephone Interview</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 4 Telephone Interview</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2731939</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 3</VALIDVALUE>
          <VALUEMEANING>Month 3</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 3</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 2 Telephone Interview</VALIDVALUE>
          <VALUEMEANING>Month 2 Telephone Interview</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 2 Telephone Interview</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2731940</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 1</VALIDVALUE>
          <VALUEMEANING>Month 1</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 1</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574448</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Week 2 Telephone Interview</VALIDVALUE>
          <VALUEMEANING>Week 2 Telephone Interview</VALUEMEANING>
          <MEANINGDESCRIPTION>Week 2 Telephone Interview</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2731941</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Prior to Reg/Rand</VALIDVALUE>
          <VALUEMEANING>Prior to Registration/Randomization</VALUEMEANING>
          <MEANINGDESCRIPTION>Prior to Registration/Randomization</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2731942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 5</VALIDVALUE>
          <VALUEMEANING>Month 5</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 5</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2727656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 4</VALIDVALUE>
          <VALUEMEANING>Month 4</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 4</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574798</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 2</VALIDVALUE>
          <VALUEMEANING>Month 2</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 2</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574797</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Week 2</VALIDVALUE>
          <VALUEMEANING>WEEK 2</VALUEMEANING>
          <MEANINGDESCRIPTION>the second week</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-05-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Telephone Follow-up 30 days</VALIDVALUE>
          <VALUEMEANING>Telephone Follow-up 30 days</VALUEMEANING>
          <MEANINGDESCRIPTION>Telephone Follow-up 30 days</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2784489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Telephone Follow-up 7-10 days</VALIDVALUE>
          <VALUEMEANING>Telephone Follow-up 7-10 days</VALUEMEANING>
          <MEANINGDESCRIPTION>Telephone Follow-up 7-10 days</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2784490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Agent Administration</VALIDVALUE>
          <VALUEMEANING>Agent Administration</VALUEMEANING>
          <MEANINGDESCRIPTION>Agent Administration</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2784491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Registration/Randomization</VALIDVALUE>
          <VALUEMEANING>Registration/Randomization</VALUEMEANING>
          <MEANINGDESCRIPTION>Registration/Randomization</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575818</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Follow-up 30 days</VALIDVALUE>
          <VALUEMEANING>Follow-up 30 days</VALUEMEANING>
          <MEANINGDESCRIPTION>Follow-up 30 days</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-11-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2958962</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Final AE Assessment</VALIDVALUE>
          <VALUEMEANING>Final Adverse Event Assessment</VALUEMEANING>
          <MEANINGDESCRIPTION>Conclusive in a process or progression.: Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.: Having determined the value, significance, or extent of.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25217, C41331, C25508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3260750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Post-Intervention Evaluation</VALIDVALUE>
          <VALUEMEANING>Post-Intervention Evaluation</VALUEMEANING>
          <MEANINGDESCRIPTION>Post-Intervention Evaluation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3153627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Safety Evaluation Second Contact</VALIDVALUE>
          <VALUEMEANING>Safety Evaluation Second Contact</VALUEMEANING>
          <MEANINGDESCRIPTION>Safety Evaluation Second Contact</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3153628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Safety Evaluation First Contact</VALIDVALUE>
          <VALUEMEANING>Safety Evaluation First Contact</VALUEMEANING>
          <MEANINGDESCRIPTION>Safety Evaluation First Contact</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3153629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Baseline Evaluation</VALIDVALUE>
          <VALUEMEANING>Baseline Evaluation</VALUEMEANING>
          <MEANINGDESCRIPTION>Baseline Evaluation</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-10-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3153630</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Week 6</VALIDVALUE>
          <VALUEMEANING>Week 6</VALUEMEANING>
          <MEANINGDESCRIPTION>Week 6</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3078422</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Day 1</VALIDVALUE>
          <VALUEMEANING>Day 1</VALUEMEANING>
          <MEANINGDESCRIPTION>The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day._The smallest natural number and quantity it denotes: a single entity, unit, or object.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66832, C25301</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570938</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Week 8</VALIDVALUE>
          <VALUEMEANING>Week Integer</VALUEMEANING>
          <MEANINGDESCRIPTION>Any period of seven consecutive days.: A number with no fractional part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45255, C29844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3226212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Week 4</VALIDVALUE>
          <VALUEMEANING>Week Integer</VALUEMEANING>
          <MEANINGDESCRIPTION>Any period of seven consecutive days.: A number with no fractional part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45255, C29844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3226213</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Week 1</VALIDVALUE>
          <VALUEMEANING>Week Integer</VALUEMEANING>
          <MEANINGDESCRIPTION>Any period of seven consecutive days.: A number with no fractional part.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45255, C29844</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3226214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pre-Registration</VALIDVALUE>
          <VALUEMEANING>Provisional Registration</VALUEMEANING>
          <MEANINGDESCRIPTION>The act of enrolling, contingent upon satisfactory results obtained from additional screening</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60537</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-04-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2667617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Post-Intervention (Week 12)</VALIDVALUE>
          <VALUEMEANING>Post-Intervention (Week 12)</VALUEMEANING>
          <MEANINGDESCRIPTION>Post-Intervention (Week 12)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2011-04-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3228179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Visit 3</VALIDVALUE>
          <VALUEMEANING>Integer::3 Visit</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::3: the act of going to see some person or place or thing for a short time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25716, C45255::3</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3626183</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Visit 2</VALIDVALUE>
          <VALUEMEANING>Integer::2 Visit</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: the act of going to see some person or place or thing for a short time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25716, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3626184</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Visit 1</VALIDVALUE>
          <VALUEMEANING>Integer::1 Visit</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::1: the act of going to see some person or place or thing for a short time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25716, C45255::1</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3626185</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Screening/Eligibility</VALIDVALUE>
          <VALUEMEANING>Screening Eligibility Determination</VALUEMEANING>
          <MEANINGDESCRIPTION>A systematic examination or assessment.: Criteria to determine eligibility of patients for medical care programs and services.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25171, C48261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3626186</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Post-surgery Phone Contact</VALIDVALUE>
          <VALUEMEANING>Post-surgery Phone Contact</VALUEMEANING>
          <MEANINGDESCRIPTION>Post-surgery Phone Contact</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3896292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pre-surgery Visit</VALIDVALUE>
          <VALUEMEANING>Pre-surgery Visit</VALUEMEANING>
          <MEANINGDESCRIPTION>Pre-surgery Visit</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3896293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pre-surgery Phone Contact</VALIDVALUE>
          <VALUEMEANING>Pre-surgery Phone Contact</VALUEMEANING>
          <MEANINGDESCRIPTION>Pre-surgery Phone Contact</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3896294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Day 8 Visit</VALIDVALUE>
          <VALUEMEANING>Day 8 Visit</VALUEMEANING>
          <MEANINGDESCRIPTION>Day 8 Visit</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3896295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Screening/Baseline</VALIDVALUE>
          <VALUEMEANING>Screening/Baseline</VALUEMEANING>
          <MEANINGDESCRIPTION>Screening/Baseline</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3896296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other contact, Specify</VALIDVALUE>
          <VALUEMEANING>Other contact, Specify</VALUEMEANING>
          <MEANINGDESCRIPTION>Other contact, Specify</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2013-09-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3896291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 13 (Follow-Up)</VALIDVALUE>
          <VALUEMEANING>Month 13 (Follow-Up)</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 13 (Follow-Up)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4119391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 12</VALIDVALUE>
          <VALUEMEANING>Month 12</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 12</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574451</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 9</VALIDVALUE>
          <VALUEMEANING>Month 9</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 9</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Randomization</VALIDVALUE>
          <VALUEMEANING>Randomization</VALUEMEANING>
          <MEANINGDESCRIPTION>The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2659950</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Baseline/Registration</VALIDVALUE>
          <VALUEMEANING>Baseline/Registration</VALUEMEANING>
          <MEANINGDESCRIPTION>Baseline/Registration</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-01-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4119392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Visit 6</VALIDVALUE>
          <VALUEMEANING>Visit 6</VALUEMEANING>
          <MEANINGDESCRIPTION>A visit by a patient or study participant to a medical professional.: A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66837, C39564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2955721</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Visit 7 (Follow up)</VALIDVALUE>
          <VALUEMEANING>Visit 7 (Follow up)</VALUEMEANING>
          <MEANINGDESCRIPTION>A visit by a patient or study participant to a medical professional.: A natural number greater than 6 and less than 8 and the quantity that it denotes: the sum of six and one.  This visit could be described as the Follow up visit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4116088</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Visit 5</VALIDVALUE>
          <VALUEMEANING>Visit 5</VALUEMEANING>
          <MEANINGDESCRIPTION>A visit by a patient or study participant to a medical professional.: A natural number greater than 4 and less than 6 and the quantity that it denotes: the sum of four and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66836, C39564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2955722</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Visit 4</VALIDVALUE>
          <VALUEMEANING>Visit 4</VALUEMEANING>
          <MEANINGDESCRIPTION>A visit by a patient or study participant to a medical professional.: A natural number greater than 3 and less than 5 and the quantity that it denotes: the sum of three and one.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66835, C39564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2955723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Screening/Eligibility/Randomization</VALIDVALUE>
          <VALUEMEANING>Screening/Eligibility/Randomization</VALUEMEANING>
          <MEANINGDESCRIPTION>Screening/Eligibility/Randomization</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2014-01-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4116089</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 18</VALIDVALUE>
          <VALUEMEANING>Month 18</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 18</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574452</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Month 15</VALIDVALUE>
          <VALUEMEANING>Month 15</VALUEMEANING>
          <MEANINGDESCRIPTION>Month 15</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2016-06-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575967</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Visit Type</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Visit Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2179692</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Category</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Case Report Forms Version 3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2957372</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Bronchial Dysplasia - Myo-Inositol</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812876</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Exp. PK Formulations of SR13668</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2812949</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Pioglitazone - Lung Pre-Surgical NSCLC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3152820</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Barrett&#39;s Esophagus Chemoprevention Metformin</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3211792</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Docosahexaenoic Acid</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3528035</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UWI2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>3896537</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4188651</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-01-01</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>4261412</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3896529</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Consortia 2012 Studies</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>MDA2013-02-02</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>5416571</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1637">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2738487</PUBLICID>
    <LONGNAME>Post Hematopoietic Cell Transplantation Therapeutic Procedure Type</LONGNAME>
    <PREFERREDNAME>PST_HCT_TX_TYP</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of additional post hematopoietic cell transplantation therapy.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2738479</PublicId>
      <PreferredName>PST_HCT_TX_TYP</PreferredName>
      <PreferredDefinition>Happening at a time subsequent to a reference time; later in time or order._Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The grafting of tissues from one individual to another or place to place within a single individual._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Post Hematopoietic Cell Transplantation Therapeutic Procedure Type</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2738477</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38008:C12551:C15342:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Post Hematopoietic Stem Cell Transplantation Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2738481</PublicId>
      <PreferredName>PST_HCT_TX_TYP</PreferredName>
      <PreferredDefinition>Happening at a time subsequent to a reference time; later in time or order._Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The grafting of tissues from one individual to another or place to place within a single individual._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Post Hematopoietic Cell Transplantation Therapeutic Procedure Type</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2738480</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38008:C12551:C15342:C49236:C2</PreferredName>
        <Version>1</Version>
        <LongName>Post Hematopoietic Stem Cell Transplantation Therapeutic Procedure Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38008</PREFERRED_NAME>
            <LONG_NAME>Post</LONG_NAME>
            <CON_ID>2204992</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12551</PREFERRED_NAME>
            <LONG_NAME>Hematopoietic Stem Cell</LONG_NAME>
            <CON_ID>2486421</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15342</PREFERRED_NAME>
            <LONG_NAME>Transplantation</LONG_NAME>
            <CON_ID>2205403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tyrosine kinase inhibitor</VALIDVALUE>
          <VALUEMEANING>Tyrosine Kinase Inhibitor</VALUEMEANING>
          <MEANINGDESCRIPTION>Substances that inhibit tyrosine kinase enzymes, involved with the transduction and processing of many extracellular and intracellular signals including cell proliferation. They have numerous applications in the prevention and treatment of cancer. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1967</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3837891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dexamethasone</VALIDVALUE>
          <VALUEMEANING>Dexamethasone</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04) [Source: NCI]</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C422</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028376</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Subsequent HSCT</VALIDVALUE>
          <VALUEMEANING>Transplantation Next Hematopoietic Stem Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>The grafting of tissues from one individual to another or place to place within a single individual.: Subsequent; immediately following in time or order.: Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12551, C53286, C15342</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2866921</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central nervous system irradiation</VALIDVALUE>
          <VALUEMEANING>Radiation Therapy Central Nervous System</VALUEMEANING>
          <MEANINGDESCRIPTION>use PHOTOTHERAPY, LASER THERAPY, or ULTRAVIOLET THERAPY for therapeutic radiation with visible, laser, or ultraviolet light, respectively.: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12438, C15313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2866900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Systemic / intrathecal therapy</VALIDVALUE>
          <VALUEMEANING>And/Or Intrathecal Route of Administration Systemic Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Used to indicate that either or both of two items or options: Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.: (sis-TEM-ik THER-a-pee) Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15698, C38267, C48928</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2866901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Donor leukocyte infusions</VALIDVALUE>
          <VALUEMEANING>Donor Leukocyte Infusion</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of therapy in which lymphocytes from the blood of a donor are given to a patient who has already received a stem cell transplant from the same donor. The donor lymphocytes may kill remaining cancer cells. Donor lymphocyte infusion is used to treat chronic myelogenous leukemia (CML) that has come back and myeloma. It is being studied in the treatment of other types of cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C16145</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-05-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2866902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Withdrawal of immunosuppression</VALIDVALUE>
          <VALUEMEANING>Immunosuppressive Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>deliberate suppression of immune system function for experimental or therapeutic purposes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15261</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-08-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2935384</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thalidomide (Thalomid)</VALIDVALUE>
          <VALUEMEANING>Thalidomide</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic derivative of glutamic acid (alpha-phthalimido-glutarimide) with teratogenic, immunomodulatory, anti-inflammatory and anti-angiogenic properties.  Thalidomide acts primarily by inhibiting both the production of tumor necrosis factor alpha (TNF-alpha) in stimulated peripheral monocytes and the activities of interleukins and interferons.  This agent also inhibits polymorphonuclear chemotaxis and monocyte phagocytosis.  In addition, thalidomide inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), thereby inhibiting angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C870</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568117</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Rituximab (Rituxan, Mabthera)</VALIDVALUE>
          <VALUEMEANING>Rituximab</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of monoclonal antibody used in cancer detection or therapy. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1702</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Local radiotherapy</VALIDVALUE>
          <VALUEMEANING>Local Radiation Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Of or belonging to a restricted area or locality.: use PHOTOTHERAPY, LASER THERAPY, or ULTRAVIOLET THERAPY for therapeutic radiation with visible, laser, or ultraviolet light, respectively.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15313, C67263</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lenalidomide (Revlimid)</VALIDVALUE>
          <VALUEMEANING>CC 5013 (Lenalidomide)</VALUEMEANING>
          <MEANINGDESCRIPTION>A thalidomide analog with potential antineoplastic activity.  Lenalidomide inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis.  This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2668</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2662266</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Intrathecal chemotherapy</VALIDVALUE>
          <VALUEMEANING>Intrathecal Chemotherapy</VALUEMEANING>
          <MEANINGDESCRIPTION>(in-tra-THEE-kal KEE-mo-THER-a-pee) Anticancer drugs that are injected into the fluid-filled space between the thin layers of tissue that cover the brain and spinal cord.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15750</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Imanitib mesylate (Gleevec, Glivec)</VALIDVALUE>
          <VALUEMEANING>Imatinib Mesylate</VALUEMEANING>
          <MEANINGDESCRIPTION>The mesylate salt of an antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain the Philadelphia chromosome.  Imatinib also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and stem cell factor (SCF)/c-kit; the SCF/c-kit receptor tyrosine kinase is activated in gastrointestinal stromal tumor (GIST).  This agent inhibits proliferation and induces apoptosis in cells that overexpress these oncoproteins. It is also known as Gleevec.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1687</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737465</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cellular therapy (e.g. DCI, DLI)</VALIDVALUE>
          <VALUEMEANING>Cellular Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>Utilization of specific cells modified or not for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70601</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738484</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bortezomib (Velcade)</VALIDVALUE>
          <VALUEMEANING>Bortezomib</VALUEMEANING>
          <MEANINGDESCRIPTION>A modified dipeptidyl boronic acid with antineoplastic activity. Via boronic acid moiety, bortezomib reversibly binds to the 26S proteasome, where degradation of ubiquinated proteins occurs. By blocking the targeted proteolysis normally performed by the proteasome, bortezomib disrupts various cell signaling pathways, leading to cell cycle arrest, apoptosis, and inhibition of angiogenesis.  Specifically, the agent inhibits nuclear factor (NF)-kappaB, a protein that is constitutively activated in some cancers, thereby interfering with NF-kappaB-mediated cell survival, tumor growth, and angiogenesis. In vivo, bortezomib delays tumor growth and enhances the cytotoxic effects of radiation and chemotherapy.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1851</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2738485</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>FGF (velafermin)</VALIDVALUE>
          <VALUEMEANING>Velafermin</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant human fibroblast growth factor-20 (rhFGF-20) protein with pro-proliferative activity.  Velafermin stimulates DNA synthesis and cell proliferation, specifically promoting epithelial and mesenchymal cell proliferation, and may prevent radiation or chemotherapy-induced oral mucositis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48425</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2769628</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>KGF (palifermin, kepivance)</VALIDVALUE>
          <VALUEMEANING>Palifermin</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant form of the endogenous human keratinocyte growth factor with cell growth promoting activity. Palifermin acts in the manner similar to the endogenous keratinocyte growth factor that binds to keratinocyte growth factor receptors on the epithelial cell surface in the lining of mouth and gastrointestinal tract. This results in stimulation of epithelial cell proliferation, differentiation and upregulation of cytoprotective mechanisms.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2455</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-07-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2769629</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dasatinib</VALIDVALUE>
          <VALUEMEANING>Dasatinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases.  Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38713</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737464</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, observed, recorded; or reported as unknown by the data contributor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104212</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sunitinib</VALIDVALUE>
          <VALUEMEANING>Sunitinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An indolinone derivative and tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation.  This agent also inhibits the phosphorylation of Fms-related tyrosine kinase 3 (FLT3), another receptor tyrosine kinase expressed by some leukemic cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71622</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3107588</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sorafenib</VALIDVALUE>
          <VALUEMEANING>Sorafenib</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C61948</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3380164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Quizartinib</VALIDVALUE>
          <VALUEMEANING>Quizartinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available small molecule with potential antineoplastic activity. Quizartinib selectively inhibits class III receptor tyrosine kinases, including FMS-related tyrosine kinase 3 (FLT3/STK1), colony-stimulating factor 1 receptor (CSF1R/FMS), stem cell factor receptor (SCFR/KIT), and platelet derived growth factor receptors (PDGFRs), resulting in inhibition of ligand-independent leukemic cell proliferation and apoptosis. Mutations in FLT3, resulting in constitutive activation, are the most frequent genetic alterations in acute myeloid leukemia (AML) and occur in approximately one-third of AML cases.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68936</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429348</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ponatinib</VALIDVALUE>
          <VALUEMEANING>Ponatinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities. Ponatinib inhibits unmutated and all mutated forms of Bcr-Abl, including T315I, the highly drug therapy-resistant missense mutation of Bcr-Abl. This agent also inhibits other tyrosine kinases including those associated with vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs); in addition, it inhibits the tyrosine kinase receptor TIE2 and FMS-related tyrosine kinase receptor-3 (Flt3). RTK inhibition by ponatinib may result in the inhibition of cellular proliferation and angiogenesis and may induce cell death. Bcr-Abl is a fusion tyrosine kinase encoded by the Philadelphia chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C95777</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3776076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Pacritinib</VALIDVALUE>
          <VALUEMEANING>Pacritinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Oral JAK2 inhibitor SB1518 competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders; the JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The JAK-STAT signaling pathway is a major mediator of cytokine activity.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C78837</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429530</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Obinutuzumab</VALIDVALUE>
          <VALUEMEANING>Obinutuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A glycoengineered, humanized IgG1 monoclonal antibody with potential antineoplastic activity. Afutuzumab, a third generation type II anti-CD20 antibody, selectivity binds to the extracellular domain of the human CD20 antigen on malignant human B cells. The Fc region carbohydrates of the antibody, enriched in bisected non-fucosylated glycosylation variants, contribute to its higher binding affinity for human FcgammaRIII receptors compared to non-glycoengineered antibodies, resulting in enhanced antibody-dependent cellular cytotoxicity (ADCC) and caspase-independent apoptosis. In addition, modification of elbow hinge sequences within the antibody variable framework regions may account for the strong apoptosis-inducing activity of R7159 upon binding to CD20 on target cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70741</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5096860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nilotinib</VALIDVALUE>
          <VALUEMEANING>Nilotinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable aminopyrimidine-derivative Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. Designed to overcome imatinib resistance, nilotinib binds to and stabilizes the inactive conformation of the kinase domain of the Abl protein of the Bcr-Abl fusion protein, resulting in the inhibition of the Bcr-Abl-mediated proliferation of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) cells. This agent also inhibits the receptor tyrosine kinases platelet-derived growth factor receptor (PDGF-R) and c-kit, a receptor tyrosine kinase mutated and constitutively activated in most gastrointestinal stromal tumors (GISTs). With a binding mode that is energetically more favorable than that of imatinib, nilotinib has been shown to have an approximately 20-fold increased potency in kinase and proliferation assays compared to imatinib.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48375</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5805905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Midostaurin</VALIDVALUE>
          <VALUEMEANING>Midostaurin</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic indolocarbazole multikinase inhibitor with potential antiangiogenic and antineoplastic activities. Midostaurin inhibits protein kinase C alpha (PKCalpha), vascular endothelial growth factor receptor 2 (VEGFR2), c-kit, platelet-derived growth factor receptor (PDGFR) and FMS-like tyrosine kinase 3 (FLT3) tyrosine kinases, which may result in disruption of the cell cycle, inhibition of proliferation, apoptosis, and inhibition of angiogenesis in susceptible tumors.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C1872</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5805895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Lestaurtinib</VALIDVALUE>
          <VALUEMEANING>Lestaurtinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable indolocarbazole derivative with antineoplastic properties. Lestaurtinib inhibits autophosphorylation of FMS-like tyrosine kinase 3 (FLT3), resulting in inhibition of FLT3 activity and induction of apoptosis in tumor cells that overexpress FLT3. (NCI05)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ixazomib</VALIDVALUE>
          <VALUEMEANING>Ixazomib</VALUEMEANING>
          <MEANINGDESCRIPTION>An active metabolite of MLN9708, a second generation, boron containing peptide proteasome inhibitor (PI) with potential antineoplastic activity. Ixazomib binds to and inhibits the 20S catalytic core of the proteasome, thereby blocking the targeted proteolysis normally performed by the proteasome, which results in an accumulation of unwanted or misfolded proteins; disruption of various cell signaling pathways may follow, resulting in the induction of apoptosis. Compared to first generation PIs, second generation PIs may have an improved pharmacokinetic profile with increased potency and less toxicity. Proteasomes are large protease complexes that degrade unneeded or damaged proteins that have been ubiquinated.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C97940</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5944043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ivosidenib</VALIDVALUE>
          <VALUEMEANING>Ivosidenib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1), with potential antineoplastic activity. Upon administration, AG-120 specifically inhibits a mutated form of IDH1 in the cytoplasm, which inhibits the formation of the oncometabolite, 2-hydroxyglutarate (2HG). This may lead to both an induction of cellular differentiation and an inhibition of cellular proliferation in IDH1-expressing tumor cells. IDH1, an enzyme in the citric acid cycle, is mutated in a variety of cancers; it initiates and drives cancer growth by both blocking cell differentiation and catalyzing the formation of 2HG.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ibrutinib</VALIDVALUE>
          <VALUEMEANING>Ibrutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, small-molecule inhibitor of Bruton&#39;s tyrosine kinase (BTK) with potential antineoplastic activity. Upon oral administration, ibrutinib binds to and irreversibly inhibits BTK activity, thereby preventing both B-cell activation and B-cell-mediated signaling. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is required for B cell receptor signaling, plays a key role in B-cell maturation, and is overexpressed in a number of B-cell malignancies. The expression of BTK in tumor cells is also associated with increased proliferation and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C81934</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5588944</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gilteritinib</VALIDVALUE>
          <VALUEMEANING>Gilteritinib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable inhibitor of the receptor tyrosine kinases (RTKs) FMS-related tyrosine kinase 3 (FLT3, STK1, or FLK2), AXL (UFO or JTK11) and anaplastic lymphoma kinase (ALK or CD246), with potential antineoplastic activity. Gilteritinib binds to and inhibits both the wild-type and mutated forms of FLT3, AXL and ALK. This may result in an inhibition of FLT3, AXL, and ALK-mediated signal transduction pathways and reduces tumor cell proliferation in cancer cell types that overexpress these RTKs. FLT3, AXL and ALK, overexpressed or mutated in a variety of cancer cell types, play a key role in tumor cell growth and survival.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116722</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429350</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Enasidenib</VALIDVALUE>
          <VALUEMEANING>Enasidenib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally available inhibitor of specific mutant forms of the mitochondrial enzyme isocitrate dehydrogenase type 2 (IDH2), with potential antineoplastic activity. Upon administration, enasidenib specifically inhibits various mutant forms of IDH2, including the IDH2 variants R140Q, R172S, and R172K, which inhibits the formation of 2-hydroxyglutarate (2HG). This may lead to both an induction of cellular differentiation and an inhibition of cellular proliferation in IDH2-expressing tumor cells. IDH2, an enzyme in the citric acid cycle, is mutated in a variety of cancers; it initiates and drives cancer growth by blocking differentiation and the production of the oncometabolite 2HG.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C111573</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6429528</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Elotuzumab</VALIDVALUE>
          <VALUEMEANING>Elotuzumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A humanized monoclonal antibody directed against the human CS1 (CD2 subset 1, CRACC, SLAMF7) antigen with potential antineoplastic activity. Elotuzumab binds to the CS1 antigen, which may trigger antibody-dependent cellular cytotoxicity (ADCC) in cells expressing CS1. CS1 is a cell surface glycoprotein belonging to the CD2 subset of the immunoglobulin superfamily (IgSF) and is highly expressed by multiple myeloma cells, but minimally expressed by normal cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C66982</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621728</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Decitabine</VALIDVALUE>
          <VALUEMEANING>Decitabine</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytidine antimetabolite analogue with potential antineoplastic activity. Decitabine incorporates into DNA and inhibits DNA methyltransferase, resulting in hypomethylation of DNA and intra-S-phase arrest of DNA replication. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C981</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daratumumab</VALIDVALUE>
          <VALUEMEANING>Daratumumab</VALUEMEANING>
          <MEANINGDESCRIPTION>A fully human monoclonal antibody directed against the cell surface glycoprotein CD-38 with potential antineoplastic activity. The binding of anti-CD38 monoclonal antibody to natural killer (NK) cells mimics the normal CD38-CD31 interaction on the NK cell surface. CD38 is also present on multiple myeloma (MM) cells and plasma leukemia cells; this agent may preferentially bind these cells, triggering antitumoral antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). CD38, a cell surface glycoprotein, is present on various immune cells and has been shown to regulate the cytotoxic response of activated NK cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C74007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5621727</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Crenolanib</VALIDVALUE>
          <VALUEMEANING>Crenolanib</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable small molecule, targeting the platelet-derived growth factor receptor (PDGFR), with potential antineoplastic activity. Crenolanib binds to and inhibits PDGFR, which may result in the inhibition of PDGFR-related signal transduction pathways, and, so, the inhibition of tumor angiogenesis and tumor cell proliferation. PDGFR, up-regulated in many tumor cell types, is a receptor tyrosine kinase essential to cell migration and the development of the microvasculature.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64639</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3422120</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Carfilzomib</VALIDVALUE>
          <VALUEMEANING>Carfilzomib</VALUEMEANING>
          <MEANINGDESCRIPTION>An epoxomicin derivate with potential antineoplastic activity. Carfilzomib irreversibly binds to and inhibits the chymotrypsin-like activity of the 20S catalytic core subunit of the proteasome, a protease complex responsible for degrading a large variety of cellular proteins. Inhibition of proteasome-mediated proteolysis results in an accumulation of polyubiquinated proteins, which may lead to cell cycle arrest, induction of apoptosis, and inhibition of tumor growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C52196</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3378843</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brentuximab</VALIDVALUE>
          <VALUEMEANING>Monoclonal Antibody SGN-30</VALUEMEANING>
          <MEANINGDESCRIPTION>A monoclonal antibody that binds to cells that have the CD30 antigen on their surface, including Hodgkin disease cells and cells from anaplastic large cell lymphoma, and cutaneous T-cell lymphoma. SGN-30 is being studied in the treatment of cancer. It is a type of monoclonal antibody.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2007</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3438595</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Bosutinib</VALIDVALUE>
          <VALUEMEANING>Bosutinib</VALUEMEANING>
          <MEANINGDESCRIPTION>A synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity. Unlike imatinib, bosutinib inhibits the autophosphorylation of both Abl and Src kinases, resulting in inhibition of cell growth and apoptosis. Because of the dual mechanism of action, this agent may have activity in resistant CML disease, other myeloid malignancies and solid tumors. Abl kinase is upregulated in the presence of the abnormal Bcr-abl fusion protein which is commonly associated with chronic myeloid leukemia (CML). Overexpression of specific Src kinases is also associated with the imatinib-resistant CML phenotype.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C60809</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3379565</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Blinatumomab</VALIDVALUE>
          <VALUEMEANING>Blinatumomab</VALUEMEANING>
          <MEANINGDESCRIPTION>A recombinant, single-chain, anti-CD19/anti-CD3 bispecific monoclonal antibody with potential immunostimulating and antineoplastic activities. Blinatumomab possesses two antigen-recognition sites, one for the CD3 complex, a group of T cell surface glycoproteins that complex with the T cell receptor (TCR), and one for CD19, a tumor-associated antigen (TAA) overexpressed on the surface of B cells. This bispecific monoclonal antibody brings CD19-expressing tumor B-cells and cytotoxic T lymphocytes (CTLs) and helper T lymphocytes (HTLs) together, which may result in the CTL- and HTL-mediated cell death of CD19-expressing B-lymphocytes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3690103</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Azacitidine</VALIDVALUE>
          <VALUEMEANING>Azacitidine</VALUEMEANING>
          <MEANINGDESCRIPTION>A pyrimidine nucleoside analogue of cytidine with antineoplastic activity. Azacitidine is incorporated into DNA, where it reversibly inhibits DNA methyltransferase, thereby blocking DNA methylation.  Hypomethylation of DNA by azacitidine may activate tumor suppressor genes silenced by hypermethylation, resulting in an antitumor effect. This agent is also incorporated into RNA, thereby disrupting normal RNA function and impairing tRNA cytosine-5-methyltransferase activity. (NCI04)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C288</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-09-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3013054</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Venetoclax</VALIDVALUE>
          <VALUEMEANING>Venetoclax</VALUEMEANING>
          <MEANINGDESCRIPTION>An orally bioavailable, selective small molecule inhibitor of the anti-apoptotic protein Bcl-2, with potential antineoplastic activity. Venetoclax mimics BH3-only proteins, the native ligands of Bcl-2 and apoptosis activators, by binding to the hydrophobic groove of Bcl-2 proteins thereby repressing Bcl-2 activity and restoring apoptotic processes in tumor cells. Bcl-2 protein is overexpressed in some cancers and plays an important role in the regulation of apoptosis; its expression is associated with increased drug resistance and tumor cell survival. Compared to the Bcl-2 inhibitor navitoclax, this agent does not inhibit bcl-XL and does not cause bcl-XL-mediated thrombocytopenia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103147</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5944045</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAR-T</VALIDVALUE>
          <VALUEMEANING>Chimeric Antigen Receptor T-Cell Therapy</VALUEMEANING>
          <MEANINGDESCRIPTION>A type of treatment in which a patient&#39;s T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient&#39;s blood. Then the gene for a special receptor that binds to a certain protein on the patient&#39;s cancer cells is added in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. Chimeric antigen receptor T-cell therapy is being studied in the treatment of some types of cancer.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C126102</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7331413</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify treatment(s) given:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify treatment(s) given:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the type of post-hem</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the type of post-hematopoietic cell transplantation therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Post - HSCT Therapy</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Post - HSCT Therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2738487</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>&quot;PerformedProcedure [post-HCT therapy] &gt; DefinedProcedure.nameCode(CD).code OR DefinedProcedure.nameCode(CD).originalText WHERE DeffinedProcedure.nameCode = {administer specified therapy} AND DefinedProcedure [post-HCT therapy] &gt; DefinedCompositeRelationship [1] &gt; DefinedActivity.nameCode = &quot;&quot;Perform Overall Hematopoietic Stem Cell Transplantation&quot;&quot; [overall HCT process] &gt; DefinedCompositeRelationship [2] &gt; DefinedSubstanceAdministration.nameCode = &quot;&quot;Administer Hematopoietic Stem CellProduct { Transplantation}&quot;&quot; AND DefinedCompositeRelationship.sequenceNumber [1] IS GREATER THAN DefinedCompositionRelationship.sequenceNumber [2] AND PerformedProcedure.negationIndicator(BL).value = &quot;&quot;false&quot;&quot; [Yes] OR &quot;&quot;true&quot;&quot; [No] OR PerformedProcedure.negationIndicator(BL).nullFlavor = &quot;&quot;MSK&quot;&quot; [Masked] OR &quot;&quot;UNK&quot;&quot; [Unknown]&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What additional post-HCT therapy is planned?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What additional post-HCT therapy is planned?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2400r1: Pre-TED</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964924</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2450r1: Post-TED</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964925</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedProcedure:nameCode</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Post Hematopoietic Stem Cell Transplantation Therapeutic Procedure Type Post Hematopoietic Stem Cell Transplantation Therapeutic Procedure Type</AlternateName>
        <AlternateNameType>System-Generated</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1638">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2747877</PUBLICID>
    <LONGNAME>MedDRA Vocabulary Container Object Hoechst Adverse Reaction Terminology System Code java.lang.String</LONGNAME>
    <PREFERREDNAME>2747622v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The MedDRA Maintenance and Support Services Organization holds a contract with the International Federation of Pharmaceutical Manufacturers Associations to maintain and support the implementation of the terminology.:A listing of the words used in some enterprise.:An object that holds the values or locations of other objects._A terminology for coding of adverse reactions, developed by Hoechst in 1991.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2747622</PublicId>
      <PreferredName>2747546v1.0:2747455v1.0</PreferredName>
      <PreferredDefinition>An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The MedDRA Maintenance and Support Services Organization holds a contract with the International Federation of Pharmaceutical Manufacturers Associations to maintain and support the implementation of the terminology.:A listing of the words used in some enterprise.:An object that holds the values or locations of other objects._A terminology for coding of adverse reactions, developed by Hoechst in 1991.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>MedDRA Vocabulary Container Object Hoechst Adverse Reaction Terminology System Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2747546</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43820:C43528:C43446</PreferredName>
        <Version>1</Version>
        <LongName>MedDRA Vocabulary Container Object</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43820</PREFERRED_NAME>
            <LONG_NAME>MedDRA</LONG_NAME>
            <CON_ID>2469032</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43528</PREFERRED_NAME>
            <LONG_NAME>Enterprise Vocabulary</LONG_NAME>
            <CON_ID>2223176</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43446</PREFERRED_NAME>
            <LONG_NAME>Container Object</LONG_NAME>
            <CON_ID>2236557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2747455</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71884:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Hoechst Adverse Reaction Terminology System Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71884</PREFERRED_NAME>
            <LONG_NAME>Hoechst Adverse Reaction Terminology System</LONG_NAME>
            <CON_ID>2747432</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element MedDRA Vocabulary Container Object Hoechst Adverse Reaction Terminology System Code java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element MedDRA Vocabulary Container Object Hoechst Adverse Reaction Terminology System Code java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain.meddra</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.meddra.AbstractMeddraDomain.hartsCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AbstractMeddraDomain:hartsCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1639">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2748078</PUBLICID>
    <LONGNAME>Preferred Term Hoechst Adverse Reaction Terminology System Code java.lang.String</LONGNAME>
    <PREFERREDNAME>2747814v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A descriptive word or phrase selected as an authorized descriptor to represent a discrete concept._A terminology for coding of adverse reactions, developed by Hoechst in 1991.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2747814</PublicId>
      <PreferredName>2747550v1.0:2747455v1.0</PreferredName>
      <PreferredDefinition>A descriptive word or phrase selected as an authorized descriptor to represent a discrete concept._A terminology for coding of adverse reactions, developed by Hoechst in 1991.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Preferred Term Hoechst Adverse Reaction Terminology System Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2747550</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71887</PreferredName>
        <Version>1</Version>
        <LongName>Preferred Term</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71887</PREFERRED_NAME>
            <LONG_NAME>Preferred Term</LONG_NAME>
            <CON_ID>2747439</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2747455</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71884:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Hoechst Adverse Reaction Terminology System Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71884</PREFERRED_NAME>
            <LONG_NAME>Hoechst Adverse Reaction Terminology System</LONG_NAME>
            <CON_ID>2747432</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Preferred Term Hoechst Adverse Reaction Terminology System Code java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Preferred Term Hoechst Adverse Reaction Terminology System Code java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain.meddra</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.meddra.PreferredTerm.hartsCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreferredTerm:hartsCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1640">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2748104</PUBLICID>
    <LONGNAME>Meddra High Level Term International Classification of Disease, Tenth Revision Code java.lang.String</LONGNAME>
    <PREFERREDNAME>2747840v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A superordinate descriptor for one or more preferred terms (PTs). It is subordinate to high level group term (HLGT)._The tenth version of the International Classification of Disease (ICD), published by the World Health Organization in 1992.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2747840</PublicId>
      <PreferredName>2747545v1.0:2747456v1.0</PreferredName>
      <PreferredDefinition>A superordinate descriptor for one or more preferred terms (PTs). It is subordinate to high level group term (HLGT)._The tenth version of the International Classification of Disease (ICD), published by the World Health Organization in 1992.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Meddra High Level Term International Classification of Disease, Tenth Revision Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2747545</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71880</PreferredName>
        <Version>1</Version>
        <LongName>Meddra High Level Term</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71880</PREFERRED_NAME>
            <LONG_NAME>MedDRA High Level Term</LONG_NAME>
            <CON_ID>2747430</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2747456</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71892:C25162</PreferredName>
        <Version>1</Version>
        <LongName>International Classification of Disease, Tenth Revision Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71892</PREFERRED_NAME>
            <LONG_NAME>International Classification of Diseases, Tenth Revision</LONG_NAME>
            <CON_ID>2747433</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Meddra High Level Term International Classification of Disease, Tenth Revision Code java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Meddra High Level Term International Classification of Disease, Tenth Revision Code java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain.meddra</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000156</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.meddra.HighLevelTerm.icd10Code</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HighLevelTerm:icd10Code</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1641">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2750408</PUBLICID>
    <LONGNAME>Calculation Mathematical Markup Language java.lang.String</LONGNAME>
    <PREFERREDNAME>2750267v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The procedure or activity of determining something by mathematical or logical methods._An application of XML for describing mathematical notations and capturing both its structure and content. It aims at integrating mathematical formulae into World Wide Web documents._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2750267</PublicId>
      <PreferredName>2750194v1.0:2750168v1.0</PreferredName>
      <PreferredDefinition>The procedure or activity of determining something by mathematical or logical methods._An application of XML for describing mathematical notations and capturing both its structure and content. It aims at integrating mathematical formulae into World Wide Web documents.</PreferredDefinition>
      <LongName>Calculation Mathematical Markup Language</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2750194</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54125</PreferredName>
        <Version>1</Version>
        <LongName>Calculation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54125</PREFERRED_NAME>
            <LONG_NAME>Calculation</LONG_NAME>
            <CON_ID>2654477</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2750168</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71609</PreferredName>
        <Version>1</Version>
        <LongName>Mathematical Markup Language</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71609</PREFERRED_NAME>
            <LONG_NAME>Mathematical Markup Language</LONG_NAME>
            <CON_ID>2750139</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Calculation Mathematical Markup Language java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Calculation Mathematical Markup Language java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 3.0</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000056</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.Calculation.mathML</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Calculation:mathML</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1642">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752591</PUBLICID>
    <LONGNAME>Longterm Follow-up Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2752075v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The follow-up activities that take place following the end of the active intervention period._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752075</PublicId>
      <PreferredName>2751996v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>The follow-up activities that take place following the end of the active intervention period._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Longterm Follow-up Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2751996</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16032</PreferredName>
        <Version>1</Version>
        <LongName>Longterm Follow-up</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16032</PREFERRED_NAME>
            <LONG_NAME>Long-term Follow-up</LONG_NAME>
            <CON_ID>2751672</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Longterm Follow-up Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Longterm Follow-up Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.LongTermFU.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LongTermFU:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1643">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752702</PUBLICID>
    <LONGNAME>Generalized Laboratory Procedure Hemoglobin Measurement Value java.lang.Float</LONGNAME>
    <PREFERREDNAME>2752186v1.0:2178535v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Widespread, broadly dispersed, common.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A quantitative measurement of the amount of hemoglobin present in a sample.:A numerical quantity measured or assigned or computed._Generic value domain for a primitive java datatype that is Single-precision floating point number (32-bit IEEE 754).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752186</PublicId>
      <PreferredName>2751998v1.0:2751827v1.0</PreferredName>
      <PreferredDefinition>Widespread, broadly dispersed, common.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A quantitative measurement of the amount of hemoglobin present in a sample.:A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Generalized Laboratory Procedure Hemoglobin Measurement Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2751998</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63764:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Generalized Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63764</PREFERRED_NAME>
            <LONG_NAME>Generalized</LONG_NAME>
            <CON_ID>2547905</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2751827</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C64848:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Hemoglobin Measurement Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C64848</PREFERRED_NAME>
            <LONG_NAME>Hemoglobin Measurement</LONG_NAME>
            <CON_ID>2751691</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178535</PublicId>
      <PreferredName>java.lang.Float</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is Single-precision floating point number (32-bit IEEE 754).</PreferredDefinition>
      <LongName>java.lang.Float</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Float</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Generalized Laboratory Procedure Hemoglobin Measurement Value java.lang.Float does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Generalized Laboratory Procedure Hemoglobin Measurement Value java.lang.Float does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.LabGeneral.hemoglobinValue</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LabGeneral:hemoglobinValue</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1644">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752721</PUBLICID>
    <LONGNAME>Generalized Laboratory Procedure Leukocyte Count Grade java.lang.Character</LONGNAME>
    <PREFERREDNAME>2752205v1.0:2467195v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Widespread, broadly dispersed, common.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A test to determine the number of leukocytes in a sample of blood.:A position on a scale of intensity or amount or quality._Generic value domain for a primitive java dataype that is a single character (16-bit Unicode character).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752205</PublicId>
      <PreferredName>2751998v1.0:2751844v1.0</PreferredName>
      <PreferredDefinition>Widespread, broadly dispersed, common.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A test to determine the number of leukocytes in a sample of blood.:A position on a scale of intensity or amount or quality.</PreferredDefinition>
      <LongName>Generalized Laboratory Procedure Leukocyte Count Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2751998</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63764:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Generalized Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63764</PREFERRED_NAME>
            <LONG_NAME>Generalized</LONG_NAME>
            <CON_ID>2547905</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2751844</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C51948:C48309</PreferredName>
        <Version>1</Version>
        <LongName>Leukocyte Count Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51948</PREFERRED_NAME>
            <LONG_NAME>Leukocyte Count</LONG_NAME>
            <CON_ID>2751694</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2467195</PublicId>
      <PreferredName>java.lang.Character</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a single character (16-bit Unicode character).</PreferredDefinition>
      <LongName>java.lang.Character</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Character</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Generalized Laboratory Procedure Leukocyte Count Grade java.lang.Character does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Generalized Laboratory Procedure Leukocyte Count Grade java.lang.Character does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.LabGeneral.WBCGrade</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LabGeneral:WBCGrade</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1645">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752773</PUBLICID>
    <LONGNAME>On Study Informed Consent Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2752257v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Actively participating in a study._Consent by a patient to a surgical or medical procedure or participation in a clinical study after achieving an understanding of the relevant medical facts and the risks involved.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752257</PublicId>
      <PreferredName>2752002v1.0:2751861v1.0</PreferredName>
      <PreferredDefinition>Actively participating in a study._Consent by a patient to a surgical or medical procedure or participation in a clinical study after achieving an understanding of the relevant medical facts and the risks involved.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>On Study Informed Consent Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2752002</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C73469</PreferredName>
        <Version>1</Version>
        <LongName>On Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C73469</PREFERRED_NAME>
            <LONG_NAME>On Study</LONG_NAME>
            <CON_ID>2751695</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2751861</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16735:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Informed Consent Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16735</PREFERRED_NAME>
            <LONG_NAME>Informed Consent</LONG_NAME>
            <CON_ID>2202451</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element On Study Informed Consent Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element On Study Informed Consent Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.OnStudy.dateConsent</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>OnStudy:dateConsent</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1646">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752819</PUBLICID>
    <LONGNAME>Baseline Stage Clinical Study Identifier java.lang.String</LONGNAME>
    <PREFERREDNAME>2752303v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A starting point to which things may be compared.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body._Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, mechanism of human diseases, therapy, clinical trials, epidemiology, behavior and health services research.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752303</PublicId>
      <PreferredName>2752005v1.0:2555361v1.0</PreferredName>
      <PreferredDefinition>A starting point to which things may be compared.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body._Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, mechanism of human diseases, therapy, clinical trials, epidemiology, behavior and health services research.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Baseline Stage Clinical Study Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2752005</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25213:C16899</PreferredName>
        <Version>1</Version>
        <LongName>Baseline Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25213</PREFERRED_NAME>
            <LONG_NAME>Baseline</LONG_NAME>
            <CON_ID>2202304</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2555361</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15206:C25364</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Study Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Baseline Stage Clinical Study Identifier java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Baseline Stage Clinical Study Identifier java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.BaselineStage.studyID</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BaselineStage:studyID</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1647">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2752957</PUBLICID>
    <LONGNAME>Concomitant Medication Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2752440v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Concomitant; following as a consequence.:biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2752440</PublicId>
      <PreferredName>2206481v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Concomitant; following as a consequence.:biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Concomitant Medication Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206481</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25730:C459</PreferredName>
        <Version>1</Version>
        <LongName>Concomitant Medication</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25730</PREFERRED_NAME>
            <LONG_NAME>Concomitant</LONG_NAME>
            <CON_ID>2202429</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Concomitant Medication Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Concomitant Medication Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2751669</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LEADS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.emory.wci.lymphoma</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813014</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.emory.wci.lymphoma.ConcomitantMedication.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ConcomitantMedication:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1648">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2756039</PUBLICID>
    <LONGNAME>Target Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2753929v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An object fixed as a goal or point of examination; something to point at; a destination._The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2753929</PublicId>
      <PreferredName>2753804v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>An object fixed as a goal or point of examination; something to point at; a destination._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Target Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2753804</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25702</PreferredName>
        <Version>1</Version>
        <LongName>Target</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25702</PREFERRED_NAME>
            <LONG_NAME>Target</LONG_NAME>
            <CON_ID>2206261</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Target Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Target Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2915522</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caNanoLab</PreferredName>
          <Version>1.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cananolab.domain.function</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2915887</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.particle.samplecomposition.Target.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Target:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.function.Target.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1649">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2756220</PUBLICID>
    <LONGNAME>Emulsion Created Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2754110v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A suspension of liqid within another liquid or a dispersion consisting of two or more liquid phases._Brought into existence.:The particular day, month and year an event will happen or has happened._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2754110</PublicId>
      <PreferredName>2753789v1.0:2222853v1.0</PreferredName>
      <PreferredDefinition>A suspension of liqid within another liquid or a dispersion consisting of two or more liquid phases._Brought into existence.:The particular day, month and year an event will happen or has happened.</PreferredDefinition>
      <LongName>Emulsion Created Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2753789</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63807</PreferredName>
        <Version>1</Version>
        <LongName>Emulsion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63807</PREFERRED_NAME>
            <LONG_NAME>Emulsion</LONG_NAME>
            <CON_ID>2612132</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222853</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42620:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Created Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42620</PREFERRED_NAME>
            <LONG_NAME>Creation</LONG_NAME>
            <CON_ID>2222835</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Emulsion Created Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Emulsion Created Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2915522</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caNanoLab</PreferredName>
          <Version>1.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cananolab.domain.nanomaterial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2915889</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.particle.samplecomposition.base.Emulsion.createdDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Emulsion:createdDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.nanomaterial.Emulsion.createdDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1650">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2759185</PUBLICID>
    <LONGNAME>Adjuvant Hormone Therapy  Agent Name</LONGNAME>
    <PREFERREDNAME>ADJ_HORM_TX_AGT_NM</PREFERREDNAME>
    <PREFERREDDEFINITION>Name of the adjuvant hormonal prior therapy agent administered to an individual. [Manually-curated]</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2759183</PublicId>
      <PreferredName>ADJ__HORM_AGT</PreferredName>
      <PreferredDefinition>information related to the prior occurrence of platinum-based treatment._Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment._Earlier in time or order._Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects._An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)_Agents given to augment or stimulate a primary therapy or alleviate adverse effects caused by the primary therapy._Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.</PreferredDefinition>
      <LongName>Adjuvant Hormone Therapy  Agent</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2759181</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2140:C2315:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Adjuvant Hormone Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2140</PREFERRED_NAME>
            <LONG_NAME>Adjuvant</LONG_NAME>
            <CON_ID>2204993</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2315</PREFERRED_NAME>
            <LONG_NAME>Hormone</LONG_NAME>
            <CON_ID>2231216</CON_ID>
            <DEFINITION_SOURCE>MSH2002_06_01</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2514627</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1708</PreferredName>
        <Version>1</Version>
        <LongName>Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018334</PublicId>
      <PreferredName>AGT_NAME</PreferredName>
      <PreferredDefinition>the name of the agent or drug that has been administered to the patient.</PreferredDefinition>
      <LongName>Agent Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2738661</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1708:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Agent Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Drug(s) used</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Drug(s) used</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Inactive CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044924</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1651">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2760451</PUBLICID>
    <LONGNAME>Cytogenetic Abnormality Diagnosis Type</LONGNAME>
    <PREFERREDNAME>2760446v1.0:2760448v1.1</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the cytogenetic abnormality.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2760446</PublicId>
      <PreferredName>2459195v1.0:2239981v1.0</PreferredName>
      <PreferredDefinition>An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.</PreferredDefinition>
      <LongName>Cytogenetic Abnormality Diagnosis</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008537</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DX</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2459195</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2950</PreferredName>
        <Version>1</Version>
        <LongName>Cytogenetic Abnormality</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2950</PREFERRED_NAME>
            <LONG_NAME>Cytogenetic Abnormality</LONG_NAME>
            <CON_ID>2459194</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2239981</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15220</PreferredName>
        <Version>1</Version>
        <LongName>Diagnosis</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15220</PREFERRED_NAME>
            <LONG_NAME>Diagnosis Assessment</LONG_NAME>
            <CON_ID>2202734</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2760448</PublicId>
      <PreferredName>CYT_ABN_TYP</PreferredName>
      <PreferredDefinition>An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Cytogenetic Abnormality Type</LongName>
      <Version>1.1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3021182</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2950:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Cytogenetic Abnormality Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2950</PREFERRED_NAME>
            <LONG_NAME>Cytogenetic Abnormality</LONG_NAME>
            <CON_ID>2459194</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>-Y</VALIDVALUE>
          <VALUEMEANING>Chromosome Y Monosomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The male sex chromosome, being the differential sex chromosome carried by half the male gametes and none of the female gametes in man and in some other male-heterogametic species in which the homologue of the X chromosome has been retained.: The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3239, C13286</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(16;16)</VALIDVALUE>
          <VALUEMEANING>Chromosome 16 Chromosome 16 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the sixteenth largest human autosomal chromosome pair. Chromosome 16 spans about 90 million base pairs and represents just under 3% of the total DNA in normal diploid cells.: The designation for each member of the sixteenth largest human autosomal chromosome pair. Chromosome 16 spans about 90 million base pairs and represents just under 3% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13211, C13211</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021323</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(3;3)</VALIDVALUE>
          <VALUEMEANING>Chromosome 3 Chromosome 3 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the third largest human autosomal chromosome pair. Chromosome 3 spans almost 200 million base pairs and represents about 6.5% of the total DNA in normal diploid cells.: The designation for each member of the third largest human autosomal chromosome pair. Chromosome 3 spans almost 200 million base pairs and represents about 6.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13219, C13219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021320</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(6;9)</VALIDVALUE>
          <VALUEMEANING>t(6;9)</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenetic abnormality that involves a translocation between chromosomes 6 and 9.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128650</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021328</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(8;21)</VALIDVALUE>
          <VALUEMEANING>Chromosome 8 Chromosome 21 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenetic abnormality that involves a translocation between chromosomes 8 and 21.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119608</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021333</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(9;11)</VALIDVALUE>
          <VALUEMEANING>Chromosome 9 Chromosome 11 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the ninth largest human autosomal chromosome pair. Chromosome 9 spans about 145 million base pairs of nucleic acids and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the eleventh largest human autosomal chromosome pair. Chromosome 11 spans about 134.5 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13206, C13225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3133341</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+11</VALIDVALUE>
          <VALUEMEANING>Chromosome 11 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the eleventh largest human autosomal chromosome pair. Chromosome 11 spans about 134.5 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021292</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+13</VALIDVALUE>
          <VALUEMEANING>Chromosome 13 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the thirteenth largest human autosomal chromosome pair. Chromosome 13 spans about 113 million base pairs and represents between 3.5 and 4% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+14</VALIDVALUE>
          <VALUEMEANING>Chromosome 14 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the fourteenth largest human autosomal chromosome pair. Chromosome 14 spans about 105 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+21</VALIDVALUE>
          <VALUEMEANING>Chromosome 21 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the second smallest human autosomal chromosome pair. Chromosome 21 spans around 47 million nucleotides and represents about 1.5% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021286</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+22</VALIDVALUE>
          <VALUEMEANING>Chromosome 22 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the smallest human autosomal chromosome pair. Chromosome 22 spans about 49 million base pairs and represents between 1.5 and 2% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13218</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021285</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+4</VALIDVALUE>
          <VALUEMEANING>Chromosome 4 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the fourth largest human autosomal chromosome pair. Chromosome 4 spans more than 186 million base pairs and represents between 6 and 6.5% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13220, C3421</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021200</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+8</VALIDVALUE>
          <VALUEMEANING>Chromosome 8 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the eighth largest human autosomal chromosome pair. Chromosome 8 spans about 145 million base pairs and represents between 4.5 and 5.0% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021201</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>add(17q)</VALIDVALUE>
          <VALUEMEANING>17q Add</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 17: The act of joining or combining or uniting with others; increasing the quality, quantity, size or scope of.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64911, C13543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>add(14q)</VALIDVALUE>
          <VALUEMEANING>14q Add</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 14: The act of joining or combining or uniting with others; increasing the quality, quantity, size or scope of.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64911, C13538</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(6q) / 6q-</VALIDVALUE>
          <VALUEMEANING>6q Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 6: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13560</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021308</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(9p) / 9p-</VALIDVALUE>
          <VALUEMEANING>9p Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 9: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-11-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2936671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hyperdiploid (&gt; 50)</VALIDVALUE>
          <VALUEMEANING>Greater Than Integer::50 Hyperdiploidy</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A number with no fractional part.::50: A chromosomal abnormality in which the chromosomal number is greater than the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80336, C45255::50, C61584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3029115</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hypodiploid (&lt; 46)</VALIDVALUE>
          <VALUEMEANING>Less Than Integer::46 Hypodiploidy</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: A number with no fractional part.::46: A chromosomal abnormality in which the chromosomal number is less than the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80337, C45255::46, C61585</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3029114</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(11;14)</VALIDVALUE>
          <VALUEMEANING>Chromosome 11 Chromosome 14 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the eleventh largest human autosomal chromosome pair. Chromosome 11 spans about 134.5 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the fourteenth largest human autosomal chromosome pair. Chromosome 14 spans about 105 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13209, C13206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021312</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(2;8)</VALIDVALUE>
          <VALUEMEANING>Chromosome 2 Chromosome 8 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the second largest human autosomal chromosome pair. Chromosome 2 spans more than 237 million base pairs and represents almost 8% of the total DNA in normal diploid cells.: The designation for each member of the eighth largest human autosomal chromosome pair. Chromosome 8 spans about 145 million base pairs and represents between 4.5 and 5.0% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13224, C13215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3321386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(8;22)</VALIDVALUE>
          <VALUEMEANING>Chromosome 8 Chromosome 22 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the eighth largest human autosomal chromosome pair. Chromosome 8 spans about 145 million base pairs and represents between 4.5 and 5.0% of the total DNA in normal diploid cells.: The designation for each member of the smallest human autosomal chromosome pair. Chromosome 22 spans about 49 million base pairs and represents between 1.5 and 2% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13218, C13224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-12-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3321385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(8;14)</VALIDVALUE>
          <VALUEMEANING>Chromosome 8 Chromosome 14 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenetic abnormality that involves a translocation between chromosomes 8 and 14.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021235</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+17</VALIDVALUE>
          <VALUEMEANING>Chromosome 17 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021199</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(13q) / 13q-</VALIDVALUE>
          <VALUEMEANING>13q Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 13: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13534</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>-13</VALIDVALUE>
          <VALUEMEANING>Chromosome 13 Monosomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the thirteenth largest human autosomal chromosome pair. Chromosome 13 spans about 113 million base pairs and represents between 3.5 and 4% of the total DNA in normal diploid cells.: The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3239, C13208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021243</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>-20</VALIDVALUE>
          <VALUEMEANING>Chromosome 20 Monosomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the third smallest human autosomal chromosome pair. Chromosome 20 spans around 63 million base pairs and represents between 2 and 2.5% of the total DNA in normal diploid cells.: The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3239, C13216</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(2;11)</VALIDVALUE>
          <VALUEMEANING>Chromosome 2 Chromosome 11 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the second largest human autosomal chromosome pair. Chromosome 2 spans more than 237 million base pairs and represents almost 8% of the total DNA in normal diploid cells.: The designation for each member of the eleventh largest human autosomal chromosome pair. Chromosome 11 spans about 134.5 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13206, C13215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3855613</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(11;16)</VALIDVALUE>
          <VALUEMEANING>Chromosome 11 Chromosome 16 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the eleventh largest human autosomal chromosome pair. Chromosome 11 spans about 134.5 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the sixteenth largest human autosomal chromosome pair. Chromosome 16 spans about 90 million base pairs and represents just under 3% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13211, C13206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3855611</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(1;3)</VALIDVALUE>
          <VALUEMEANING>Chromosome 1 Chromosome 3 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the largest human autosomal chromosome pair. Chromosome 1 spans about 247 million nucleotide base pairs and represents about 8% of the total DNA in normal diploid cells.: The designation for each member of the third largest human autosomal chromosome pair. Chromosome 3 spans almost 200 million base pairs and represents about 6.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13219, C13204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3855614</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(3;21)</VALIDVALUE>
          <VALUEMEANING>Chromosome 3 Chromosome 21 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the third largest human autosomal chromosome pair. Chromosome 3 spans almost 200 million base pairs and represents about 6.5% of the total DNA in normal diploid cells.: The designation for each member of the second smallest human autosomal chromosome pair. Chromosome 21 spans around 47 million nucleotides and represents about 1.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13217, C13219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3855612</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+19</VALIDVALUE>
          <VALUEMEANING>Chromosome 19 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the nineteenth largest human autosomal chromosome pair. Chromosome 19 spans more than 63 million base pairs and represents between 2 and 2.5% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13214</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(12p) / 12p-</VALIDVALUE>
          <VALUEMEANING>12p Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 12: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13532</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2762283</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(14q) / 14q-</VALIDVALUE>
          <VALUEMEANING>14q Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 14: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13538</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(17p) / 17p-</VALIDVALUE>
          <VALUEMEANING>17p Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 17: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021299</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(1p) / 1p-</VALIDVALUE>
          <VALUEMEANING>1p Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 1: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ins(19p)</VALIDVALUE>
          <VALUEMEANING>19p Insertion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 19: Mutations that result in the insertion of one or more nucleotides into a wild type DNA sequence.  Can result in a frame shift in the coding sequence of a gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19295, C13545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3103065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(12;14)</VALIDVALUE>
          <VALUEMEANING>Chromosome 12 Chromosome 14 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the twelfth largest human autosomal chromosome pair. Chromosome 12 spans about 143 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the fourteenth largest human autosomal chromosome pair. Chromosome 14 spans about 105 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13209, C13207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(12;15)</VALIDVALUE>
          <VALUEMEANING>t(12;15)</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the twelfth largest human autosomal chromosome pair. Chromosome 12 spans about 143 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the fifteenth largest human autosomal chromosome pair. Chromosome 15 spans about 106 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13210, C13207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021321</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(12;16)</VALIDVALUE>
          <VALUEMEANING>Chromosome 12 Chromosome 16 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the twelfth largest human autosomal chromosome pair. Chromosome 12 spans about 143 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the sixteenth largest human autosomal chromosome pair. Chromosome 16 spans about 90 million base pairs and represents just under 3% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13211, C13207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021319</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(12;19)</VALIDVALUE>
          <VALUEMEANING>Chromosome 12 Chromosome 19 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the twelfth largest human autosomal chromosome pair. Chromosome 12 spans about 143 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the nineteenth largest human autosomal chromosome pair. Chromosome 19 spans more than 63 million base pairs and represents between 2 and 2.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13214, C13207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021318</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(12;22)</VALIDVALUE>
          <VALUEMEANING>t(12;22)</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the twelfth largest human autosomal chromosome pair. Chromosome 12 spans about 143 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the smallest human autosomal chromosome pair. Chromosome 22 spans about 49 million base pairs and represents between 1.5 and 2% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13218, C13207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021316</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(13;22)</VALIDVALUE>
          <VALUEMEANING>Chromosome 13 Chromosome 22 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the thirteenth largest human autosomal chromosome pair. Chromosome 13 spans about 113 million base pairs and represents between 3.5 and 4% of the total DNA in normal diploid cells.: The designation for each member of the smallest human autosomal chromosome pair. Chromosome 22 spans about 49 million base pairs and represents between 1.5 and 2% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13218, C13208</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021329</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(14;16)</VALIDVALUE>
          <VALUEMEANING>Chromosome 14 Chromosome 16 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the fourteenth largest human autosomal chromosome pair. Chromosome 14 spans about 105 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: The designation for each member of the sixteenth largest human autosomal chromosome pair. Chromosome 16 spans about 90 million base pairs and represents just under 3% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13211, C13209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021327</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(14;20)</VALIDVALUE>
          <VALUEMEANING>Chromosome 14 Chromosome 20 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the fourteenth largest human autosomal chromosome pair. Chromosome 14 spans about 105 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: The designation for each member of the third smallest human autosomal chromosome pair. Chromosome 20 spans around 63 million base pairs and represents between 2 and 2.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13216, C13209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-15</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3855615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(17;22)</VALIDVALUE>
          <VALUEMEANING>Chromosome 17 Chromosome 22 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.: The designation for each member of the smallest human autosomal chromosome pair. Chromosome 22 spans about 49 million base pairs and represents between 1.5 and 2% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13218, C13212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021336</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(1;13)</VALIDVALUE>
          <VALUEMEANING>Chromosome 1 Chromosome 13 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenetic abnormality that involves a translocation between chromosomes 1 and 13.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128655</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021315</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(1;16)</VALIDVALUE>
          <VALUEMEANING>Chromosome 1 Chromosome 16 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the largest human autosomal chromosome pair. Chromosome 1 spans about 247 million nucleotide base pairs and represents about 8% of the total DNA in normal diploid cells.: The designation for each member of the sixteenth largest human autosomal chromosome pair. Chromosome 16 spans about 90 million base pairs and represents just under 3% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13211, C13204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021313</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(1;7)</VALIDVALUE>
          <VALUEMEANING>Chromosome 1 Chromosome 7 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the largest human autosomal chromosome pair. Chromosome 1 spans about 247 million nucleotide base pairs and represents about 8% of the total DNA in normal diploid cells.: The designation for each member of the seventh largest human autosomal chromosome pair. Chromosome 7 spans more than 158 million base pairs and represents between 5 and 5.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13223, C13204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021314</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(21;22)</VALIDVALUE>
          <VALUEMEANING>Chromosome 21 Chromosome 22 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the second smallest human autosomal chromosome pair. Chromosome 21 spans around 47 million nucleotides and represents about 1.5% of the total DNA in normal diploid cells.: The designation for each member of the smallest human autosomal chromosome pair. Chromosome 22 spans about 49 million base pairs and represents between 1.5 and 2% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13218, C13217</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021335</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(2;13)</VALIDVALUE>
          <VALUEMEANING>Chromosome 2 Chromosome 13 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenetic abnormality that involves a translocation between chromosomes 2 and 13.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128653</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021322</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(4;14)</VALIDVALUE>
          <VALUEMEANING>Chromosome 4 Chromosome 14 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the fourth largest human autosomal chromosome pair. Chromosome 4 spans more than 186 million base pairs and represents between 6 and 6.5% of the total DNA in normal diploid cells.: The designation for each member of the fourteenth largest human autosomal chromosome pair. Chromosome 14 spans about 105 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13209, C13220</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021317</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(5;7)</VALIDVALUE>
          <VALUEMEANING>Chromosome 5 Chromosome 7 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the fifth largest human autosomal chromosome pair. Chromosome 5 spans about 181 million base pairs and represents almost 6% of the total DNA in normal diploid cells.: The designation for each member of the seventh largest human autosomal chromosome pair. Chromosome 7 spans more than 158 million base pairs and represents between 5 and 5.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13223, C13221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021330</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(6;14)</VALIDVALUE>
          <VALUEMEANING>Chromosome 6 Chromosome 14 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the sixth largest human autosomal chromosome pair. Chromosome 6 spans more than 170 million base pairs and represents between 5.5 and 6% of the total DNA in normal diploid cells.: The designation for each member of the fourteenth largest human autosomal chromosome pair. Chromosome 14 spans about 105 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13209, C13222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021326</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(7;16)</VALIDVALUE>
          <VALUEMEANING>Chromosome 7 Chromosome 16 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the seventh largest human autosomal chromosome pair. Chromosome 7 spans more than 158 million base pairs and represents between 5 and 5.5% of the total DNA in normal diploid cells.: The designation for each member of the sixteenth largest human autosomal chromosome pair. Chromosome 16 spans about 90 million base pairs and represents just under 3% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13211, C13223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021324</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(7;22)</VALIDVALUE>
          <VALUEMEANING>Chromosome 7 Chromosome 22 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the seventh largest human autosomal chromosome pair. Chromosome 7 spans more than 158 million base pairs and represents between 5 and 5.5% of the total DNA in normal diploid cells.: The designation for each member of the smallest human autosomal chromosome pair. Chromosome 22 spans about 49 million base pairs and represents between 1.5 and 2% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13218, C13223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021337</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(8;16)</VALIDVALUE>
          <VALUEMEANING>Chromosome 8 Chromosome 16 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the eighth largest human autosomal chromosome pair. Chromosome 8 spans about 145 million base pairs and represents between 4.5 and 5.0% of the total DNA in normal diploid cells.: The designation for each member of the sixteenth largest human autosomal chromosome pair. Chromosome 16 spans about 90 million base pairs and represents just under 3% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13211, C13224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021334</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(X;17)</VALIDVALUE>
          <VALUEMEANING>Chromosome X Chromosome 17 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in man and other male-heterogametic species.: The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13212, C13285</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(X;18)</VALIDVALUE>
          <VALUEMEANING>Chromosome X Chromosome 18 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in man and other male-heterogametic species.: The designation for each member of the eighteenth largest human autosomal chromosome pair. Chromosome 18 spans about 76 million base pairs and represents about 2.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13213, C13285</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+12</VALIDVALUE>
          <VALUEMEANING>Chromosome 12 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the twelfth largest human autosomal chromosome pair. Chromosome 12 spans about 143 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13207</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021291</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+15</VALIDVALUE>
          <VALUEMEANING>Chromosome 15 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the fifteenth largest human autosomal chromosome pair. Chromosome 15 spans about 106 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13210</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+3</VALIDVALUE>
          <VALUEMEANING>Chromosome 3 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the third largest human autosomal chromosome pair. Chromosome 3 spans almost 200 million base pairs and represents about 6.5% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+5</VALIDVALUE>
          <VALUEMEANING>Chromosome 5 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the fifth largest human autosomal chromosome pair. Chromosome 5 spans about 181 million base pairs and represents almost 6% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021263</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+7</VALIDVALUE>
          <VALUEMEANING>Chromosome 7 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the seventh largest human autosomal chromosome pair. Chromosome 7 spans more than 158 million base pairs and represents between 5 and 5.5% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13223</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021262</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+9</VALIDVALUE>
          <VALUEMEANING>Chromosome 9 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the ninth largest human autosomal chromosome pair. Chromosome 9 spans about 145 million base pairs of nucleic acids and represents between 4 and 4.5% of the total DNA in normal diploid cells.: A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021293</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>12p any abnormality</VALIDVALUE>
          <VALUEMEANING>12p Cytogenetic Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 12: An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2950, C13532</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>9p any abnormality</VALIDVALUE>
          <VALUEMEANING>9p Cytogenetic Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 9: An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2950, C13563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3685575</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Any abnormality at 1p</VALIDVALUE>
          <VALUEMEANING>1p Cytogenetic Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 1: An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2950, C13526</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689265</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(15;17) and variants</VALIDVALUE>
          <VALUEMEANING>Chromosome 15 Chromosome 17 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenetic abnormality that involves a translocation between chromosomes 15 and 17.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128656</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021325</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Any abnormality at 1q</VALIDVALUE>
          <VALUEMEANING>1q Cytogenetic Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 1: An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2950, C13528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3689264</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Masked near-haploidy</VALIDVALUE>
          <VALUEMEANING>Masked Near-Haploidy</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromosomal abnormality in which a near-haploid cell line is masked by a co-existing hyperdiploid line.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114475</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4255851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Near-haploidy (&lt;30 chr)</VALIDVALUE>
          <VALUEMEANING>Near-Haploidy</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromosomal abnormality in which there are less than thirty chromosomes in a cell.  </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C114474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4255852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(11q) / 11q-</VALIDVALUE>
          <VALUEMEANING>11q Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 11: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(16q) / 16q-</VALIDVALUE>
          <VALUEMEANING>16q Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 16: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13542</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(17q) / 17q-</VALIDVALUE>
          <VALUEMEANING>17q Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 17: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021300</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(20q) / 20q-</VALIDVALUE>
          <VALUEMEANING>20q Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 20: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13549</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021298</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(5q) / 5q-</VALIDVALUE>
          <VALUEMEANING>5q Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 5: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13380</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(7q) / 7q-</VALIDVALUE>
          <VALUEMEANING>7q Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 7: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021307</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(9q) / 9q-</VALIDVALUE>
          <VALUEMEANING>9q Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 9: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13564</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021306</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>inv(16)</VALIDVALUE>
          <VALUEMEANING>Chromosome 16 Chromosomal Inversion</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromosomal inversion that involves chromosome 16.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C119609</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021284</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>inv(3)</VALIDVALUE>
          <VALUEMEANING>Chromosome 3 Chromosomal Inversion</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the third largest human autosomal chromosome pair. Chromosome 3 spans almost 200 million base pairs and represents about 6.5% of the total DNA in normal diploid cells.: A type of chromosome rearrangement in which a segment has been turned through 180 degrees (inverted), and inserted back into its original location on the chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6827, C13219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>-17</VALIDVALUE>
          <VALUEMEANING>Chromosome 17 Monosomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.: The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3239, C13212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021245</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>-18</VALIDVALUE>
          <VALUEMEANING>Chromosome 18 Monosomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the eighteenth largest human autosomal chromosome pair. Chromosome 18 spans about 76 million base pairs and represents about 2.5% of the total DNA in normal diploid cells.: The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3239, C13213</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>-5</VALIDVALUE>
          <VALUEMEANING>Chromosome 5 Monosomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the fifth largest human autosomal chromosome pair. Chromosome 5 spans about 181 million base pairs and represents almost 6% of the total DNA in normal diploid cells.: The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3239, C13221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021246</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>-7</VALIDVALUE>
          <VALUEMEANING>Monosomy 7</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromosomal abnormality consisting of the absence of one of the copies of chromosome 7 in somatic cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2762295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>-X</VALIDVALUE>
          <VALUEMEANING>Chromosome X Monosomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in man and other male-heterogametic species.: The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3239, C13285</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021241</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(4;11)</VALIDVALUE>
          <VALUEMEANING>Chromosome 4 Chromosome 11 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenetic abnormality that involves a translocation between chromosomes 4 and 11.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128652</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021233</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(10;14)</VALIDVALUE>
          <VALUEMEANING>Chromosome 10 Chromosome 14 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the tenth largest human autosomal chromosome pair. Chromosome 10 spans about 135 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the fourteenth largest human autosomal chromosome pair. Chromosome 14 spans about 105 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13209, C13205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(1;19)</VALIDVALUE>
          <VALUEMEANING>Chromosome 1 Chromosome 19 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenetic abnormality that involves a translocation between chromosomes 1 and 19.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128654</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021232</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(5;17)</VALIDVALUE>
          <VALUEMEANING>Chromosome 5 Chromosome 17 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the fifth largest human autosomal chromosome pair. Chromosome 5 spans about 181 million base pairs and represents almost 6% of the total DNA in normal diploid cells.: The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13212, C13221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021234</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(9;22)</VALIDVALUE>
          <VALUEMEANING>Chromosome 9 Chromosome 22 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the ninth largest human autosomal chromosome pair. Chromosome 9 spans about 145 million base pairs of nucleic acids and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the smallest human autosomal chromosome pair. Chromosome 22 spans about 49 million base pairs and represents between 1.5 and 2% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13218, C13225</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021236</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(v;11q23)</VALIDVALUE>
          <VALUEMEANING>t(V;11)(v;q23) Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromosomal abnormality consisting of the translocation of genetic material from any one of several chromosomes to the 11q23.3 region, resulting in an MLL gene rearrangement._A genetic exchange where a piece of one chromosome is transferred to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C36517</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021237</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Increased breaks</VALIDVALUE>
          <VALUEMEANING>Increase Chromosome Breakage</VALUEMEANING>
          <MEANINGDESCRIPTION>Increase; a process of becoming larger or more numerous or more important.: A structural chromosomal abnormality caused by the spontaneous or induced breakage of a chromosome. It may result in DNA sequence deletions, chromosomal translocations, or chromosomal inversions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C85870, C25533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3029116</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>translocation 9p</VALIDVALUE>
          <VALUEMEANING>9p Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 9: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13563</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021239</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(12;21)</VALIDVALUE>
          <VALUEMEANING>Chromosome 12 Chromosome 21 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenetic abnormality that involves a translocation between chromosomes 12 and 21.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C128657</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021203</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>translocation 12p</VALIDVALUE>
          <VALUEMEANING>12p Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 12: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13532</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021238</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Any translocation of 14</VALIDVALUE>
          <VALUEMEANING>Any Chromosomal Translocation Chromosome 14</VALUEMEANING>
          <MEANINGDESCRIPTION>One, some, every, or all without specification.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.: The designation for each member of the fourteenth largest human autosomal chromosome pair. Chromosome 14 spans about 105 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C13209, C3420, C81168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-08-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3131202</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not done</VALIDVALUE>
          <VALUEMEANING>Not Done</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or not been completed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3104692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Normal</VALIDVALUE>
          <VALUEMEANING>Normal</VALUEMEANING>
          <MEANINGDESCRIPTION>Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C14165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567281</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>i(7q)(q10)</VALIDVALUE>
          <VALUEMEANING>7q Isochromosome</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 7: Metacentric chromosomes produced during MEIOSIS or MITOSIS when the CENTROMERE splits transversely instead of longitudinally. The chromosomes produced by this abnormal division are one chromosome having the two long arms of the original chromosome, but no short arms, and the other chromosome consisting of the two short arms and no long arms. Each of these isochromosomes constitutes a simultaneous duplication and deletion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3897, C13384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3690240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>i17q</VALIDVALUE>
          <VALUEMEANING>17q Isochromosome</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 17: Metacentric chromosomes produced during MEIOSIS or MITOSIS when the CENTROMERE splits transversely instead of longitudinally. The chromosomes produced by this abnormal division are one chromosome having the two long arms of the original chromosome, but no short arms, and the other chromosome consisting of the two short arms and no long arms. Each of these isochromosomes constitutes a simultaneous duplication and deletion.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3897, C13543</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3685345</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(3q) / 3q-</VALIDVALUE>
          <VALUEMEANING>3q Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 3: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13555</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3685347</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>abnormal (11q23)</VALIDVALUE>
          <VALUEMEANING>11q23 Cytogenetic Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromosome band present on 11q: An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2950, C13390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3685441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(5;14)</VALIDVALUE>
          <VALUEMEANING>Chromosome 5 Chromosome 14 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the fifth largest human autosomal chromosome pair. Chromosome 5 spans about 181 million base pairs and represents almost 6% of the total DNA in normal diploid cells.: The designation for each member of the fourteenth largest human autosomal chromosome pair. Chromosome 14 spans about 105 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13209, C13221</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-13</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3685574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(21q) / 21q-</VALIDVALUE>
          <VALUEMEANING>21q Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 21: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13552</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3685349</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(10;11)(p13;q14)</VALIDVALUE>
          <VALUEMEANING>Chromosome 10 Chromosome 11 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the tenth largest human autosomal chromosome pair. Chromosome 10 spans about 135 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the eleventh largest human autosomal chromosome pair. Chromosome 11 spans about 134.5 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13206, C13205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4178091</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complex karyotype (≥ 5 abn) without translocation</VALIDVALUE>
          <VALUEMEANING>Complex Karyotype Greater Than or Equal To Integer::5 Cytogenetic Abnormality Without Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>Karyotype with at least three chromosomal aberrations.: A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.: A number with no fractional part, including the negative and positive numbers as well as zero.::5: An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.: Used to indicate the absence or lack of something or someone.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C25718, C2950, C45255::5, C61583, C97138</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4178112</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other 11q23/MLL translocations</VALIDVALUE>
          <VALUEMEANING>Other 11q23 MLL Gene Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A chromosome band present on 11q: This gene is involved in transcriptional regulation and alterations in the gene are associated with acute lymphoblastic leukemia.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C18585, C13390, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4178094</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(14;18)</VALIDVALUE>
          <VALUEMEANING>Chromosome 14 Chromosome 18 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the fourteenth largest human autosomal chromosome pair. Chromosome 14 spans about 105 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: The designation for each member of the eighteenth largest human autosomal chromosome pair. Chromosome 18 spans about 76 million base pairs and represents about 2.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13213, C13209</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4170531</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(11;18)</VALIDVALUE>
          <VALUEMEANING>Chromosome 11 Chromosome 18 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the eleventh largest human autosomal chromosome pair. Chromosome 11 spans about 134.5 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the eighteenth largest human autosomal chromosome pair. Chromosome 18 spans about 76 million base pairs and represents about 2.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13213, C13206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4170532</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(2;5)</VALIDVALUE>
          <VALUEMEANING>Chromosome 2 Chromosome 5 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the second largest human autosomal chromosome pair. Chromosome 2 spans more than 237 million base pairs and represents almost 8% of the total DNA in normal diploid cells.: The designation for each member of the fifth largest human autosomal chromosome pair. Chromosome 5 spans about 181 million base pairs and represents almost 6% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13221, C13215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4170533</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(1;14)</VALIDVALUE>
          <VALUEMEANING>Chromosome 1 Chromosome 14 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the largest human autosomal chromosome pair. Chromosome 1 spans about 247 million nucleotide base pairs and represents about 8% of the total DNA in normal diploid cells.: The designation for each member of the fourteenth largest human autosomal chromosome pair. Chromosome 14 spans about 105 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13209, C13204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4170534</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Combined low hypodiploidy (30-39 chr)/near triploidy (60-78 chr)</VALIDVALUE>
          <VALUEMEANING>Low Hypodiploidy Integer::30-39 Chromosome Near Triploidy Integer::30-39 Chromosome Combined</VALUEMEANING>
          <MEANINGDESCRIPTION>A minimum level or position or degree; less than normal in degree, intensity or amount.: A chromosomal abnormality in which the chromosomal number is less than the normal diploid number.: A number with no fractional part, including the negative and positive numbers as well as zero.::30-39: One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.: Not far distant in time or space or degree or circumstances.: A numerical chromosomal abnormality characterized by the presence of three complete sets of chromosomes.: A number with no fractional part, including the negative and positive numbers as well as zero.::30-39: One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.: Made or joined or united into one or involving the joint activity of two or more.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C54722, C25454, C13202, C45255::30-39, C8324, C48927, C13202, C45255::30-39, C80337</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>8, 0, 1, 2, 3, 4, 5, 6, 7</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4183603</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tetraploidy (&gt; 80 chr) with no structural changes</VALIDVALUE>
          <VALUEMEANING>Greater Than Integer::80 Chromosome Without Chromosomal Rearrangement Tetraploidy</VALUEMEANING>
          <MEANINGDESCRIPTION>A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A number with no fractional part, including the negative and positive numbers as well as zero.::80: One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.: Used to indicate the absence or lack of something or someone.: Any change in the structure of one or more chromosomes.: A numerical chromosomal abnormality characterized by the presence of four complete sets of chromosomes.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28450, C36541, C25718, C13202, C45255::80, C61584</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4183604</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other TCR translocations</VALIDVALUE>
          <VALUEMEANING>Other T-Cell Receptor Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: Heterodimeric antigen receptors present on the surface of T-cells.  Two T-cell antigen receptors have been identified, consisting of heterodimeric 40-55 kD Ig-like alpha/beta or gamma/delta integral membrane glycoproteins.  Genes for TCR alpha, beta, gamma, and delta subunits are assembled during T-cell development by somatic rearrangement of germline gene segments, resembling B-cell Ig genes in their mechanisms of diversity generation and activation of expression.  Alpha/beta heterodimers are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented by MHC gene products.  T-cells expressing gamma/delta heterodimers directly recognize proteins and non-proteinacious phospho-ligands.  T-cell receptors are non-covalently associated with CD3, forming the TCR-CD3 complex.  TCRs activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70.  (from OMIM and NCI): A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C17065, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4173572</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>abn of 11q (not MLL)</VALIDVALUE>
          <VALUEMEANING>11q Cytogenetic Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 11: An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2950, C13389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4173573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(17;19)</VALIDVALUE>
          <VALUEMEANING>Chromosome 17 Chromosome 19 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.: The designation for each member of the nineteenth largest human autosomal chromosome pair. Chromosome 19 spans more than 63 million base pairs and represents between 2 and 2.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13214, C13212</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4173574</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(7p)</VALIDVALUE>
          <VALUEMEANING>7p Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 7: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13561</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4173576</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Low hyperdiploidy (47-50 chr)</VALIDVALUE>
          <VALUEMEANING>Integer::47-50 Chromosome Low Hyperdiploidy</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::47-50: One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.: A minimum level or position or degree; less than normal in degree, intensity or amount.: A chromosomal abnormality in which the chromosomal number is greater than the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80336, C54722, C13202, C45255::47-50</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4179331</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>High hyperdiploidy (51-65 chr) with no structural changes</VALIDVALUE>
          <VALUEMEANING>Integer::51-65 Chromosome Without Chromosomal Rearrangement High Hyperdiploidy</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::51-65: One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.: Used to indicate the absence or lack of something or someone.: Any change in the structure of one or more chromosomes.: An elevated level or position or degree; greater than normal in degree or intensity or amount.: A chromosomal abnormality in which the chromosomal number is greater than the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C80336, C25227, C36541, C25718, C13202, C45255::51-65</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4, 5</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4179332</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>(11q23) any abnormality</VALIDVALUE>
          <VALUEMEANING>11q23 Any Cytogenetic Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromosome band present on 11q: One, some, every, or all without specification.: An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2950, C81168, C13390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-11-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3943192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chromosome 8q gain</VALIDVALUE>
          <VALUEMEANING>8q Chromosomal Duplication</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 8: An irregularity in the number of chromosomes, usually in the form of a gain of genetic material. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6829, C13562</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3871652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chromosome 3 loss</VALIDVALUE>
          <VALUEMEANING>Chromosome 3 Chromosomal Loss</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the third largest human autosomal chromosome pair. Chromosome 3 spans almost 200 million base pairs and represents about 6.5% of the total DNA in normal diploid cells.: Loss of an entire chromosome or chromosome arm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36315, C13219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3871654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chromosome 6p gain</VALIDVALUE>
          <VALUEMEANING>6p Chromosomal Duplication</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 6: An irregularity in the number of chromosomes, usually in the form of a gain of genetic material. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6829, C13559</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3871658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Chromosome 1 loss</VALIDVALUE>
          <VALUEMEANING>Chromosome 1 Chromosomal Loss</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the largest human autosomal chromosome pair. Chromosome 1 spans about 247 million nucleotide base pairs and represents about 8% of the total DNA in normal diploid cells.: Loss of an entire chromosome or chromosome arm.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36315, C13204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-08-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3871659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(6p) / 6p-</VALIDVALUE>
          <VALUEMEANING>6p Deletion Mutation</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 6: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19296, C13559</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2936673</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Down syndrome</VALIDVALUE>
          <VALUEMEANING>Down Syndrome</VALUEMEANING>
          <MEANINGDESCRIPTION>A disorder caused by the presence of an extra chromosome 21 and characterized by mental retardation and distinguishing physical features.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2993</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2730288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fanconi anemia</VALIDVALUE>
          <VALUEMEANING>Fanconi Anemia</VALUEMEANING>
          <MEANINGDESCRIPTION>A rare and often fatal inherited disease in which the bone marrow fails to produce red blood cells, white blood cells, platelets, or a combination of these cells. The disease may transform into myelodysplastic syndrome or leukemia.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62505</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2760449</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-06-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Monosomy</VALIDVALUE>
          <VALUEMEANING>Monosomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3239</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2647302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Balanced abnormal (11q23)</VALIDVALUE>
          <VALUEMEANING>11q23 Balanced Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromosome band present on 11q: Interchanges of genetic material among different chromosomes following the breaking off of pieces of chromosomes such that the total chromosome composition may still contain all of the genetic material.Balanced Chromosomal Rearrangement.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6822, C13390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>abnormal 8</VALIDVALUE>
          <VALUEMEANING>Chromosome 8 Cytogenetic Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the eighth largest human autosomal chromosome pair. Chromosome 8 spans about 145 million base pairs and represents between 4.5 and 5.0% of the total DNA in normal diploid cells.: An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2950, C13224</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>abnormal 6</VALIDVALUE>
          <VALUEMEANING>Chromosome 6 Cytogenetic Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the sixth largest human autosomal chromosome pair. Chromosome 6 spans more than 170 million base pairs and represents between 5.5 and 6% of the total DNA in normal diploid cells.: An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2950, C13222</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other abnormality</VALIDVALUE>
          <VALUEMEANING>Other Cytogenetic Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C2950, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3021310</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Any translocation involving 14q32 (IGH)</VALIDVALUE>
          <VALUEMEANING>14q32 Any Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromosome band present on 14q: One, some, every, or all without specification.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C81168, C13941</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-02-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4178093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Complex - &gt;= 3 distinct abnormalities</VALIDVALUE>
          <VALUEMEANING>Abnormality Greater Than or Equal To Integer::3 Complex</VALUEMEANING>
          <MEANINGDESCRIPTION>A condition that differs from the usual physical or mental state.: A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.: A number with no fractional part.::3: Hard, involved or complicated, elaborate, having many parts.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47881, C45255::3, C61583, C9440</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3017722</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MLL</VALIDVALUE>
          <VALUEMEANING>KMT2A wt Allele</VALUEMEANING>
          <MEANINGDESCRIPTION>Human KMT2A wild-type allele is located in the vicinity of 11q23 and is approximately 89 kb in length. This allele, which encodes histone-lysine N-methyltransferase 2A protein, is involved in the modulation of transcription by RNA Polymerase II. Several acute leukemias are associated with translocations of the gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53066</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2014-12-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4634972</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>amp 1q</VALIDVALUE>
          <VALUEMEANING>1q Gene Amplification Abnormality</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 1: An increase in the copy number of a particular gene. This type of abnormality can be either inherited or somatic.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45581, C13528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-03-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5727014</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested</VALIDVALUE>
          <VALUEMEANING>Not Tested</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates that a test was not performed.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C101887</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-03-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3918247</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>iAMP21</VALIDVALUE>
          <VALUEMEANING>Intrachromosomal Amplification of Chromosome 21</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenetic abnormality that refers to the allelic gain of an internal part of chromosome 21. It is a rare high-risk chromosomal abnormality that occurs in approximately 2-5% of pediatric patients with B-cell precursor Acute Lymphoblastic Leukemia. This abnormality has been associated with a poor outcome in patients treated by standard protocols.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C124874</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-05-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5094536</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>P53 deletion</VALIDVALUE>
          <VALUEMEANING>TP53 Gene Deletion</VALUEMEANING>
          <MEANINGDESCRIPTION>A molecular abnormality referring to the loss of at least one copy of the TP53 gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C133694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-11-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5782787</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(11q23)</VALIDVALUE>
          <VALUEMEANING>del(11q23)</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenetic abnormality that refers to the deletion of the chromosomal band 11q23.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36533</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6010547</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unmutated IgVH</VALIDVALUE>
          <VALUEMEANING>Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene</VALUEMEANING>
          <MEANINGDESCRIPTION>Chronic lymphocytic leukemia characterized by the absence of somatic hypermutation within the immunoglobulin heavy chain gene variable region of neoplastic clones. Patients have a significantly worse prognosis as compared to those with mutated immunoglobulin heavy chain gene variable region rearrangements.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-10-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6005466</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MYC rearrangement</VALIDVALUE>
          <VALUEMEANING>MYC Gene Rearrangement</VALUEMEANING>
          <MEANINGDESCRIPTION>A molecular abnormality indicating rearrangement of the MYC gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132018</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-06-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5782793</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>dup(1)</VALIDVALUE>
          <VALUEMEANING>Chromosome 1 Chromosomal Duplication</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the largest human autosomal chromosome pair. Chromosome 1 spans about 247 million nucleotide base pairs and represents about 8% of the total DNA in normal diploid cells.: An irregularity in the number of chromosomes, usually in the form of a gain of genetic material. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6829, C13204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7166168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(11q23;any)</VALIDVALUE>
          <VALUEMEANING>Any 11q23 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>One, some, every, or all without specification.: A chromosome band present on 11q: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13390, C81168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7166169</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(12p11.2;any)</VALIDVALUE>
          <VALUEMEANING>Any 12p11.2 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>One, some, every, or all without specification.: A chromosome band present on 12p: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C24926, C81168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7166171</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(3q21;any)</VALIDVALUE>
          <VALUEMEANING>Any 3q21 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>One, some, every, or all without specification.: A chromosome band present on 3q: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13764, C81168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7166173</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(1;any)</VALIDVALUE>
          <VALUEMEANING>Any Chromosome 1 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>One, some, every, or all without specification.: The designation for each member of the largest human autosomal chromosome pair. Chromosome 1 spans about 247 million nucleotide base pairs and represents about 8% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13204, C81168</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2020-02-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>7166174</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CyclinD1</VALIDVALUE>
          <VALUEMEANING>CCND1 Gene Rearrangement</VALUEMEANING>
          <MEANINGDESCRIPTION>A molecular abnormality indicating rearrangement of the CCND1 gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C173881</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15020043</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BCL6 rearrangement</VALIDVALUE>
          <VALUEMEANING>BCL6 Gene Rearrangement</VALUEMEANING>
          <MEANINGDESCRIPTION>A molecular abnormality indicating rearrangement of the BCL6 gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132020</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5782795</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>BCL2 rearrangement</VALIDVALUE>
          <VALUEMEANING>BCL2 Gene Rearrangement</VALUEMEANING>
          <MEANINGDESCRIPTION>A molecular abnormality indicating rearrangement of the BCL2 gene.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C132019</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5782276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(11;22)</VALIDVALUE>
          <VALUEMEANING>Chromosome 11 Chromosome 22 Chromosomal Translocation</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the eleventh largest human autosomal chromosome pair. Chromosome 11 spans about 134.5 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells._The designation for each member of the smallest human autosomal chromosome pair. Chromosome 22 spans about 49 million base pairs and represents between 1.5 and 2% of the total DNA in normal diploid cells._A genetic exchange where a piece of one chromosome is transferred to another chromosome.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3420, C13218, C13206</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-07</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15177639</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ins(19p) / 19p+</VALIDVALUE>
          <VALUEMEANING>19p Insertion Mutation 19p Chromosomal Gain</VALUEMEANING>
          <MEANINGDESCRIPTION>Proximal (short) arm of chromosome 19_Any rearrangement to the genomic content that adds one or more extra nucleotides into the DNA. Insertions may be reversible, particulary if caused by transposable elements. They may alter the reading frame of a gene, or may cause large scale additions of genomic DNA._Proximal (short) arm of chromosome 19_A cytogenetic abnormality that refers to gain of an entire chromosome, a chromosome arm or a chromosomal band.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C36438, C13545, C19295, C13545</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15220922</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Duplication of 1q</VALIDVALUE>
          <VALUEMEANING>1q Chromosomal Duplication</VALUEMEANING>
          <MEANINGDESCRIPTION>Distal (long) arm of chromosome 1_An irregularity in the number of chromosomes, usually in the form of a gain of genetic material. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C6829, C13528</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15232363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other IGH rearrangement</VALIDVALUE>
          <VALUEMEANING>Other IGH Gene Rearrangement</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned._A molecular abnormality indicating rearrangement of the immunoglobulin heavy (IGH) gene locus.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C188129</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-10-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15232364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>15q14</VALIDVALUE>
          <VALUEMEANING>15q14</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromosome band present on 15q</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C24955</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15334511</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>+10</VALIDVALUE>
          <VALUEMEANING>Chromosome 10 Trisomy</VALUEMEANING>
          <MEANINGDESCRIPTION>The designation for each member of the tenth largest human autosomal chromosome pair. Chromosome 10 spans about 135 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells._A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C3421, C13205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-11-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15334510</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>del(7p12.2)</VALIDVALUE>
          <VALUEMEANING>del(7p12.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>A chromosomal deletion involving the p12.2 band on the short arm of chromosome 7.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C212083</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15354911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>t(3q26.2;v)</VALIDVALUE>
          <VALUEMEANING>t(v;3q26.2)</VALUEMEANING>
          <MEANINGDESCRIPTION>A cytogenetic abnormality that refers to a translocation where one of the breakpoints is located in the q26.2 band on the long arm of chromosome 3.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C212082</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15354910</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify if any of the following cytogenetic abnormalities were identified</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify if any of the following cytogenetic abnormalities were identified</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the chromosome abnorm</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the chromosome abnormality diagnosis type?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify diagnosis:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify diagnosis:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify abnormality:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify abnormality:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Cytogenetic Analysis Abnormality Type</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Cytogenetic Analysis Abnormality Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of Days from Initial Diagnosis to Date of Tissue Procurement</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Number of Days from Initial Diagnosis to Date of Tissue Procurement</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>1</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify abnormalities identified:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify abnormalities identified:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2760451</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedDiagnosis [first] &gt; AssessedResultRelationship &gt; PerformedObservation &gt; PerformedDiagnosis.value [second] WHERE PerformedDiagnosis.value [first] = &quot;Cytogenetic Abnormality&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Abnormalities</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Chromosomal Alterations</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Chromosomal Alterations</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Abnormality</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify cytogenetic abnormalities identified</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify cytogenetic abnormalities identified</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify abnormalities</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify abnormalities</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify abnormalities</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify abnormalities</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify abnormality</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify abnormality</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify cytogenetic abnormalities</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Chromosomal aberrations:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>C3D</ClassificationSchemeItemType>
        <CsiPublicId>2811685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2000r1: Recipient Baseline Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964872</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2026r1: Neuroblastoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964894</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2010r1: Acute Myelogenous Leukemia Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964927</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2011r1: ALL Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964928</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2013r1: CLL Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964930</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SWOG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>SWOG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COMPKARY</AlternateName>
        <AlternateNameType>OID, SWOG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CCR</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_ALL_FISHB_all_cy_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_ALL_FISHD_all_cy_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_ALL_FISHL_all_cy_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_ALL_KARYB_all_cy_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_ALL_KARYD_all_cy_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_ALL_KARYL_all_cy_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_AML_FISHB_aml_cy_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_AML_FISHD_aml_cy_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_AML_FISHL_aml_cy_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_AML_KARYB_aml_cy_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_AML_KARYD_aml_cy_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_AML_KARYL_aml_cy_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DBR_fsh_all_cyto_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DBR_kar_all_cyto_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DLR_fsh_all_cyto_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DLR_kar_all_cyto_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DTE_fsh_all_cyto_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_DTE_kar_all_cyto_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_best_resp_stat_all_cyto_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DBR_fish_aml_cyto_abn_tp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DBR_kary_aml_cyto_abn_tp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DLR_fish_aml_cyto_abn_tp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DLR_kary_aml_cyto_abn_tp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DTE_fish_aml_cyto_abn_typ</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_DTE_kary_aml_cyto_abn_tp</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_ASDG_lym_cyto_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_astrn_lym_cyto_abn_ty</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_dsp_lym_cyto_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MDS_mds_mpn_cyto_abn_typ</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MDS_mds_mpn_cyto_abn_ty</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_PCD_MM_PCD_cyto_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_PCD_MM_PCD_cyto_abn_type2</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MDS_mds_cyt_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MDS_mds_cyto_abn_ty</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MDS_mds_cyto_abn_typ</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MDS_mds_cyto_abn_type</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MPN_FISHD_mpn_cyto_ab_typ</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MPN_FISHL_mpn_cyto_ab_typ</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MPN_KARYD_mpn_cyto_ab_typ</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_MPN_KARYL_mpn_cyto_ab_typ</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>GF_GFORRES_CHROM</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1652">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2764469</PUBLICID>
    <LONGNAME>Dental Professional Practice State Local Meeting Use Status</LONGNAME>
    <PREFERREDNAME>DENT_PP_S_L_M_U_STA</PREFERREDNAME>
    <PREFERREDDEFINITION>the state of use as related to state or local meeting being used in business directed towards treatment and care of patients pertaining to a tooth or teeth, or to odontology.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2764381</PublicId>
      <PreferredName>DEN_PRP_ST_L_MTG_USE</PreferredName>
      <PreferredDefinition>information related to State or local meeting being used in business directed towards treatment and care of patients pertaining to a tooth or teeth, or to odontology.</PreferredDefinition>
      <LongName>Dental Professional Practice State Local Meeting Use</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2443314</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C52673</PreferredName>
        <Version>1</Version>
        <LongName>Dental Professional Practice</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52673</PREFERRED_NAME>
            <LONG_NAME>Professional Practice</LONG_NAME>
            <CON_ID>2443152</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2764379</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C30010:C67263:C52661:C25340</PreferredName>
        <Version>1</Version>
        <LongName>State Local Meeting Use</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C30010</PREFERRED_NAME>
            <LONG_NAME>US State</LONG_NAME>
            <CON_ID>2204013</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C67263</PREFERRED_NAME>
            <LONG_NAME>Local</LONG_NAME>
            <CON_ID>2676068</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C52661</PREFERRED_NAME>
            <LONG_NAME>Meeting</LONG_NAME>
            <CON_ID>2443140</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25340</PREFERRED_NAME>
            <LONG_NAME>Use</LONG_NAME>
            <CON_ID>2203973</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2764389</PublicId>
      <PreferredName>DEN_PP_USE_TP</PreferredName>
      <PreferredDefinition>the state of use by dental professional practice.</PreferredDefinition>
      <LongName>Dental Professional Practice Use Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008527</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>RES_ORGS</PreferredName>
        <Version>1</Version>
        <LongName>Research Organizations</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form</Origin>
      <Representation>
        <PublicId>2404650</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25688</PreferredName>
        <Version>1</Version>
        <LongName>Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Most Influence</VALIDVALUE>
          <VALUEMEANING>Most Influence</VALUEMEANING>
          <MEANINGDESCRIPTION>Most Influence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2764390</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Some Influence</VALIDVALUE>
          <VALUEMEANING>Some Influence</VALUEMEANING>
          <MEANINGDESCRIPTION>Some Influence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2764391</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Little Influence</VALIDVALUE>
          <VALUEMEANING>Little Influence</VALUEMEANING>
          <MEANINGDESCRIPTION>Little Influence</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-07-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2764392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>State or local dental meetings</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>State or local dental meetings</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2857182</PublicId>
          <ContextName>NIDCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Forms</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>NIDCR</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812041</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1653">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2770312</PUBLICID>
    <LONGNAME>Video-assisted Thoracic Surgery Open Lung Biopsy Diagnostic Procedure Occurrence Indicator</LONGNAME>
    <PREFERREDNAME>VD_OP_LG_DX_OC_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not a open lung biopsy video-assisted thoracic surgery diagnostic procedure was performed.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2770287</PublicId>
      <PreferredName>VA_OLB_DP_OC</PreferredName>
      <PreferredDefinition>Endoscopic surgery of the pleural cavity performed with visualization via video transmission._Removal of tissue from the lung, for microscopic examination, obtained during an open surgical procedure._Methods, procedures, and tests performed to diagnose disease, disordered function, or disability._An instance of something happening, such as an event or incident.</PreferredDefinition>
      <LongName>Video-assisted Thoracic Surgery Open Lung Biopsy Diagnostic Procedure Occurrence</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2182370</PublicId>
        <ContextName>CCR</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>PROCEDURES</PreferredName>
        <Version>1</Version>
        <LongName>Procedures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2770285</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63704:C51923:C18020</PreferredName>
        <Version>1</Version>
        <LongName>Video-assisted Thoracic Surgery Open Lung Biopsy Diagnostic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63704</PREFERRED_NAME>
            <LONG_NAME>Video-Assisted Thoracic Surgery</LONG_NAME>
            <CON_ID>2547484</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51923</PREFERRED_NAME>
            <LONG_NAME>Open Lung Biopsy</LONG_NAME>
            <CON_ID>2770284</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18020</PREFERRED_NAME>
            <LONG_NAME>Diagnostic Procedure</LONG_NAME>
            <CON_ID>2488312</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2234856</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25275</PreferredName>
        <Version>1</Version>
        <LongName>Occurrence</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was diagnosis evaluated by op</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was diagnosis evaluated by open / thorascopic (VATS) lung biopsy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Open / thorascopic (VATS) lung biopsy</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Open / thorascopic (VATS) lung biopsy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Open / thorascopic lung biopsy</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Open / thorascopic lung biopsy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping for CDE:2770312</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>[IF EXISTS THEN &quot;true&quot; ELSE &quot;false&quot;] PerformedObservation.methodCode WHERE PerformedObservation.methodCode = &quot;VATS&quot; and PerformedObservation &gt; DefinedObservation.nameCode = &quot;biopsy&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Open / thorascopic (VATS) lung biopsy</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Open / thorascopic (VATS) lung biopsy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2100r1: 100 Days Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964902</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2200r1: 6 Month to 2 Year Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964922</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>pulm_cop_open_bx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>pulm_dvlp_bo_open_bx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>pulm_hemrhage_open_bx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>pulm_ip_ards_open_bx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedObservation:methodCode</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_OF_a_vats_open_lung_bx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_OF_b_vats_open_lung_bx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_OF_c_vats_open_lung_bx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_OF_i_vats_open_lung_bx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1654">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2771327</PUBLICID>
    <LONGNAME>CaArray File Part Life Sciences Identifier Namespace java.lang.String</LONGNAME>
    <PREFERREDNAME>2771144v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>An NCICB informatics project consisting of a microarray database and microarray data analysis and visualization tools.:A set of related records (either written or electronic) kept together._One of the portions into which something is regarded as divided and which together constitute a whole.:A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:In general, a namespace is an abstract container, which is or could be filled by names, or technical terms, or words, and these represent or stand for real-world things.  A description logic terminology namespace is a collection of Kind, Role, Property and Concept definitions. As in computer programming, context namespaces are intended to allow multiple knowledge bases to reside in the same physical database. (from Apelon)_Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2771144</PublicId>
      <PreferredName>2726721v1.0:2771056v1.0</PreferredName>
      <PreferredDefinition>An NCICB informatics project consisting of a microarray database and microarray data analysis and visualization tools.:A set of related records (either written or electronic) kept together._One of the portions into which something is regarded as divided and which together constitute a whole.:A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:In general, a namespace is an abstract container, which is or could be filled by names, or technical terms, or words, and these represent or stand for real-world things.  A description logic terminology namespace is a collection of Kind, Role, Property and Concept definitions. As in computer programming, context namespaces are intended to allow multiple knowledge bases to reside in the same physical database. (from Apelon)</PreferredDefinition>
      <LongName>CaArray File Part Life Sciences Identifier Namespace</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2726721</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71459:C42883</PreferredName>
        <Version>1</Version>
        <LongName>CaArray File</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71459</PREFERRED_NAME>
            <LONG_NAME>caArray</LONG_NAME>
            <CON_ID>2726655</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42883</PREFERRED_NAME>
            <LONG_NAME>File</LONG_NAME>
            <CON_ID>2422612</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2771056</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45313:C47841:C42699</PreferredName>
        <Version>1</Version>
        <LongName>Part Life Sciences Identifier Namespace</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45313</PREFERRED_NAME>
            <LONG_NAME>Part</LONG_NAME>
            <CON_ID>2405237</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47841</PREFERRED_NAME>
            <LONG_NAME>Life Sciences Identifier</LONG_NAME>
            <CON_ID>2423426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42699</PREFERRED_NAME>
            <LONG_NAME>Namespace</LONG_NAME>
            <CON_ID>2222837</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element CaArray File Part Life Sciences Identifier Namespace java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element CaArray File Part Life Sciences Identifier Namespace java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.file</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2812745</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2726654</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray</PreferredName>
          <Version>2.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray 2.1</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2813048</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.file.CaArrayFile.lsidNamespace</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CaArrayFile:lsidNamespace</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1655">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2773374</PUBLICID>
    <LONGNAME>Biological Characteristic Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2772720v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Pertaining to biology or to life and living things.:The distinguishing qualities or prominent aspect of a person, object, action, process, or substance._A statement or an account describing something._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2772720</PublicId>
      <PreferredName>2772255v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>Pertaining to biology or to life and living things.:The distinguishing qualities or prominent aspect of a person, object, action, process, or substance._A statement or an account describing something.</PreferredDefinition>
      <LongName>Biological Characteristic Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2772255</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28226:C25447</PreferredName>
        <Version>1</Version>
        <LongName>Biological Characteristic</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28226</PREFERRED_NAME>
            <LONG_NAME>Biological</LONG_NAME>
            <CON_ID>2206378</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25447</PREFERRED_NAME>
            <LONG_NAME>Characteristic</LONG_NAME>
            <CON_ID>2203874</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Biological Characteristic Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Biological Characteristic Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>BioCharacteristics:description</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.BioCharacteristics.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1656">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2775876</PUBLICID>
    <LONGNAME>Laboratory Procedure Leukocyte Result Missing Value Reason Indicator</LONGNAME>
    <PREFERREDNAME>2188763v1.0:2756825v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>information related to the result of a medical procedure that involves testing a sample of blood for white blood cells, a blood cell that does not contain hemoglobin and includes monocytes, basophils, lymphocytes, neutrophils, eosinophils, macrophages, and mast cells._A specific reason explaining why a meaningful value is not available.  A meaningful value answers the question posed by a Data Element Concept.  In contrast, a Missing Value Reason answers the implicit question &quot;Why is there no &#39;meaningful&#39; value?&quot;, when there is none._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2188763</PublicId>
      <PreferredName>LAB_WBC_RSLT</PreferredName>
      <PreferredDefinition>information related to the result of a medical procedure that involves testing a sample of blood for white blood cells, a blood cell that does not contain hemoglobin and includes monocytes, basophils, lymphocytes, neutrophils, eosinophils, macrophages, and mast cells.</PreferredDefinition>
      <LongName>Laboratory Procedure Leukocyte Result</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2738870</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12529:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Leukocyte Result</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12529</PREFERRED_NAME>
            <LONG_NAME>Leukocyte</LONG_NAME>
            <CON_ID>2203728</CON_ID>
            <DEFINITION_SOURCE>MSH2001</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2756825</PublicId>
      <PreferredName>MISS_IND</PreferredName>
      <PreferredDefinition>A specific reason explaining why a meaningful value is not available.  A meaningful value answers the question posed by a Data Element Concept.  In contrast, a Missing Value Reason answers the implicit question &quot;Why is there no &#39;meaningful&#39; value?&quot;, when there is none._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.</PreferredDefinition>
      <LongName>Missing Value Reason Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2756824</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48655:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Missing Value Reason Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48655</PREFERRED_NAME>
            <LONG_NAME>Missing Value Reason</LONG_NAME>
            <CON_ID>2431146</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Non-quantitative</VALIDVALUE>
          <VALUEMEANING>Negation Quantitative</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: Capable of being estimated or expressed with numeric values.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C70766, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-08-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2777712</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested</VALIDVALUE>
          <VALUEMEANING>Negation Test</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C47891, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2756826</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown/not applicable</VALIDVALUE>
          <VALUEMEANING>Unknown Not Applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.: Determination that a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660, C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-06-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2756827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not tested / unknown</VALIDVALUE>
          <VALUEMEANING>Negation Test Or Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>An operation in which a term denies or inverts the meaning of another term or construction.: A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.: Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998, C37998, C47891, C25594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3262968</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not measurable</VALIDVALUE>
          <VALUEMEANING>Non-Measurable</VALUEMEANING>
          <MEANINGDESCRIPTION>Non-Measurable; not possible to be measured.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25589</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2678954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-03-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the reason for the WB</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the reason for the WBC missing value?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Not tested</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Not tested</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify if the WBCs were not tested:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify if the WBCs were not tested:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2775876</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedClinicalResult.valueNullFlavorReason WHERE PerformedClinicalResult &gt; PerformedObservation &gt; DefinedObservation.nameCode = &quot;Count Leukocytes(WBC)&quot; AND PerformedObservation.negationIndicator = &quot;true&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2000r1: Recipient Baseline Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964872</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2100r1: 100 Days Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964902</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2200r1: 6 Month to 2 Year Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964922</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2131r2: Immune Deficiencies Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3234637</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2031r2: Immune Deficiencies Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3638517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>current_wbc_nt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>prep_wbc_nt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_diag_wbc_nt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_mrecent_wbc_nt</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedClinicalResult:valueNullFlavorReason</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1657">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2778693</PUBLICID>
    <LONGNAME>Laboratory Procedure International Normalized Ratio Eligibility Determination Ind-2</LONGNAME>
    <PREFERREDNAME>LAB_INR_ELIG_IND</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether a medical procedure was performed that involves testing a sample of blood for the International Normalized Ratio, established by the World Health Organization (WHO) and the International Committee on Thrombosis and Hemostasis for reporting the results of blood coagulation (clotting) tests, as a method of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.</PREFERREDDEFINITION>
    <VERSION>3</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2778695</PublicId>
      <PreferredName>LAB_INR_ELIG</PreferredName>
      <PreferredDefinition>information related to the medical procedure that involves testing a sample of blood for the International Normalized Ratio, established by the World Health Organization (WHO) and the International Committee on Thrombosis and Hemostasis for reporting the results of blood coagulation (clotting) tests, as a method of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.</PreferredDefinition>
      <LongName>Laboratory Procedure International Normalized Ratio Eligibility Determination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2778692</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25352:C25171</PreferredName>
        <Version>1</Version>
        <LongName>International Normalized Ratio Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25352</PREFERRED_NAME>
            <LONG_NAME>International Normalized Ratio</LONG_NAME>
            <CON_ID>2203754</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>International Normalization R</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>International Normalization Ratio (INR) &lt;= 1.5 X ULN</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>An international normalized ratio (INR) &lt;= 1.5 (patients who are therapeutically anti-coagulated for unrelated medical conditions such as atrial fibrillation and whose anti-thrombotic treatment can be withheld for operation will be eligible)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>International Normalized Ration (INR) &lt;=1.5 x institutional normal (ULN)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>INR within institutional limits</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>INR &lt;= 1.5 x institutional ULN unless patient is therapeutically anticoagulated in which case the INR must be within appropriate anticoagulation limits for the clinical indication</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>International Normalized Ratio (INR) &lt;= 1.5 x institutional ULN unless patient is receiving anticoagulant therapy in which case the INR must be within the therapeutic range of intended use for the anticoagulant</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>International Normalized Ratio (INR) &lt;=1.5 x institutional ULN unless patient is receiving anticoagulant therapy, in which case the INR or PT must be within the therapeutic range of intended use for the anticoagulant</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is this patient&#39;s International Normalized Ratio (INR) less than or equal to 1.5 x institutional ULN?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF_Text_2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is international normalized ratio (INR) less than or equal to 1.5 X ULN (or an in-range INR, usually between 2 and 3, if a patient is on a stable dose of therapeutic warfarin) within 14 days of registration?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CITN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LAB_INR_ELIG_IND</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1658">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2779014</PUBLICID>
    <LONGNAME>Clinical Trial Protocol Agent Availability Checklist Ind-2</LONGNAME>
    <PREFERREDNAME>CT_PROTAGT_AV_CH_IN</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator whether there was availability a medical product, practice, or application that is tested in a clinical trial, a type of research study that tests how well new medical treatments or other interventions work in people, as past of the list of items required.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCCTG CRF:North Central Cancer Treatment Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2778993</PublicId>
      <PreferredName>CT_PROTAGT_AVAIL_CHK</PreferredName>
      <PreferredDefinition>A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.:A medical product, practice, or application that is tested in a clinical trial._The quality of being obtainable or accessible and ready for use or service._A list of items required or things to be done or considered.</PreferredDefinition>
      <LongName>Clinical Trial Protocol Agent Availability Checklist</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2813546</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71104</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71104</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial</LONG_NAME>
            <CON_ID>2735720</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2778991</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41161:C25429:C49073</PreferredName>
        <Version>1</Version>
        <LongName>Protocol Agent Availability Checklist</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41161</PREFERRED_NAME>
            <LONG_NAME>Protocol Agent</LONG_NAME>
            <CON_ID>2390873</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25429</PREFERRED_NAME>
            <LONG_NAME>Availability</LONG_NAME>
            <CON_ID>2204038</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49073</PREFERRED_NAME>
            <LONG_NAME>Checklist</LONG_NAME>
            <CON_ID>2551430</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Study drug availability check</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Study drug availability checked</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Study drug availability confirmed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Breast</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811831</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Eligibility Criteria</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811954</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1659">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2783849</PUBLICID>
    <LONGNAME>Carcinoma In Situ Status Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2783084v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.:A condition or state at a particular time._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2783084</PublicId>
      <PreferredName>2782818v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.:A condition or state at a particular time._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Carcinoma In Situ Status Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2782818</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2917:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Carcinoma In Situ Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2917</PREFERRED_NAME>
            <LONG_NAME>Carcinoma In Situ</LONG_NAME>
            <CON_ID>2202714</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Carcinoma In Situ Status Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Carcinoma In Situ Status Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_SCG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000322</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.PathAnnotation_SCG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000323</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CarcinomaInSituStatus:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.PathAnnotation_SCG.CarcinomaInSituStatus.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1660">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2784174</PUBLICID>
    <LONGNAME>Quarantine Event Parameter Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2783405v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Place into enforced isolation.:Something that happens at a given place and time.:Any factor that defines a system and determines (or limits) its performance._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2783405</PublicId>
      <PreferredName>2782838v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>Place into enforced isolation.:Something that happens at a given place and time.:Any factor that defines a system and determines (or limits) its performance._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Quarantine Event Parameter Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2782838</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71902:C25499:C44175</PreferredName>
        <Version>1</Version>
        <LongName>Quarantine Event Parameter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71902</PREFERRED_NAME>
            <LONG_NAME>Quarantine</LONG_NAME>
            <CON_ID>2730266</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44175</PREFERRED_NAME>
            <LONG_NAME>Parameter</LONG_NAME>
            <CON_ID>2236569</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Quarantine Event Parameter Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Quarantine Event Parameter Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.pathology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000671</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain.pathology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000670</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>QuarantineEventParameter:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.pathology.QuarantineEventParameter.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1661">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2793029</PUBLICID>
    <LONGNAME>Other Therapeutic Procedure Administered Indicator</LONGNAME>
    <PREFERREDNAME>2791145v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not other therapy was administered.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2791145</PublicId>
      <PreferredName>OTHR_THER_PROC_ADM</PreferredName>
      <PreferredDefinition>Different than the one(s) previously specified or mentioned._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The act of having given something (e.g., a medication or test).</PreferredDefinition>
      <LongName>Other Therapeutic Procedure Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2554232</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17649:C49236</PreferredName>
        <Version>1</Version>
        <LongName>Other Therapeutic Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was another therapy administe</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was another therapy administered?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other treatment</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other treatment</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was other treatment given?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was other treatment given?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other therapy:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other therapy:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the recipient receive any other significant treatment(s)?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the recipient receive any other significant treatment(s)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other therapy</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Other therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other therapy</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other drug</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other drug</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other drug used to treat this infection</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Other drug used to treat this infection</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2018r1: Lymphoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2026r1: Neuroblastoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964894</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2110r1: Acute Myelogenous Leukemia Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964903</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2111r1: All Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964904</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2112r1: CML Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964905</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2113r1: CLL Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964906</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2118r1: Lymphoma Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964911</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2126r1: Neuroblastoma Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2014r1: MDS Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2131r2: Immune Deficiencies Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3234637</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2031r2: Immune Deficiencies Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>3638517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Testing Set – Moderately Different</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mds_base_tx_othr_oth_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_OF_pr_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_post_plan_other_tx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cll_post_plan_othr_trt_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_base_tx_oth_trt_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_rlps_oth_trt_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_plan_other_tx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>aml_post_plan_oth_trt_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_plnd_oth_trt_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>amy_post_othr_tx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lym_base_tx_other_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>lym_post_plan_othr_trt_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_base_tx_oth_drug_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>rcc_base_tx_oth_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_post_othr_sig_trt_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cml_post_trt_other_trt_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>all_post_rlps_other_tx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>id_prep_othr_sig_tx_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PreTed_prime_dis_hct_cml_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>inf_pre_collect_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLpost_rel_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_rel_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLpost_therapy_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MDSpre_therapy_multi_other_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpost_therapy_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HLHpre_therapy_multi_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>XLPpre_assess_diag_prep_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_ES_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_PHCT_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_RP_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_OF_ir_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>HPST_OF_tm_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>JMMLpre_therapy_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpost_therapy_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PDDpre_therapy_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TPST_LTP_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_THPY_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_CRS_oth_therapy_ynu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>VOD_CS_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_CRS_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNbase_thr_m_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RITNfup_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_DRPI_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CLLF_PHPI_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TDIS_CML_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLP_LTHM_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_PHPI_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CMLF_PLTH_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_IGM_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ALLF_PT_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CPST_TOX_oth_therapy_ynu</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_IGM_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AMLF_PT_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SNFM_PCTH_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_OT_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpost_THM_oth_therapy_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedDiagnosis:value</AlternateName>
        <AlternateNameType>HCT_BRIDG_5</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1662">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2793170</PUBLICID>
    <LONGNAME>Household Member Relationship Type</LONGNAME>
    <PREFERREDNAME>HOUS_MEMB_REL_TP</PREFERREDNAME>
    <PREFERREDDEFINITION>The subgroup that describes the state of connectedness between members of a social unit comprised of one or more individuals living together (all of whom need not be related) in the same dwelling, who aggregate and share their incomes. [Manually Curated]  </PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACS:American Community Survey 2008 Questionnaire</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2793166</PublicId>
      <PreferredName>HOUS_MEMB_REL</PreferredName>
      <PreferredDefinition>The subgroup that describes the state of connectedness between members of a social unit comprised of one or more individuals living together (all of whom need not be related) in the same dwelling, who aggregate and share their incomes.</PreferredDefinition>
      <LongName>Household Member Relationship</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2793164</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41194:C25368</PreferredName>
        <Version>1</Version>
        <LongName>Household Member</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41194</PREFERRED_NAME>
            <LONG_NAME>Household</LONG_NAME>
            <CON_ID>2493178</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25368</PREFERRED_NAME>
            <LONG_NAME>Member</LONG_NAME>
            <CON_ID>2202742</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2185695</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25648</PreferredName>
        <Version>1</Version>
        <LongName>Related</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2793168</PublicId>
      <PreferredName>HOUS_MEM_REL_TP</PreferredName>
      <PreferredDefinition>The subgroup that describes the state of connectedness between members of the unit of society organized around kinship ties._A social unit comprised of one or more individuals living together (all of whom need not be related) in the same dwelling, who aggregate and share their incomes. Household is a common unit for classifying population data._A state of connectedness between people, objects, or events; to be associated or connected with something._One of the persons who compose a social group, especially an individual who has joined and participates in a group organization._A state of connectedness between people, objects, or events; to be associated or connected with something.</PreferredDefinition>
      <LongName>Household Member Relationship Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435019</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20181</PreferredName>
        <Version>1</Version>
        <LongName>Conceptual Entity</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>40</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2793167</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41194:C25368:C25648:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Household Member Relationship Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41194</PREFERRED_NAME>
            <LONG_NAME>Household</LONG_NAME>
            <CON_ID>2493178</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25368</PREFERRED_NAME>
            <LONG_NAME>Member</LONG_NAME>
            <CON_ID>2202742</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25648</PREFERRED_NAME>
            <LONG_NAME>Relationship</LONG_NAME>
            <CON_ID>2203770</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal Half Brother</VALIDVALUE>
          <VALUEMEANING>Maternal Relative Half Brother</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: A male sibling with whom you only share a single parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71402, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717373</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal Half Sibling</VALIDVALUE>
          <VALUEMEANING>Maternal Relative Half Sibling</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: A sibling with whom you share a single parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71391, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737029</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal Half Sister</VALIDVALUE>
          <VALUEMEANING>Maternal Relative Half Sister</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: A female sibling with whom you only share a single parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71403, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717372</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal Uncle</VALIDVALUE>
          <VALUEMEANING>Maternal Relative Uncle</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: The brother of your father or mother; the husband of your aunt.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71404, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717289</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mother</VALIDVALUE>
          <VALUEMEANING>Mother</VALUEMEANING>
          <MEANINGDESCRIPTION>Mother; a female parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25189</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567344</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mother-in-law</VALIDVALUE>
          <VALUEMEANING>Mother-in-law</VALUEMEANING>
          <MEANINGDESCRIPTION>The mother of your spouse.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68639</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2658749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Brother</VALIDVALUE>
          <VALUEMEANING>Biological Relative Brother</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: Brother; a male sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25289, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Child</VALIDVALUE>
          <VALUEMEANING>Biological Relative Child</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: A human offspring (son or daughter) of any age; an immediate progeny.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42708, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717658</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Daughter</VALIDVALUE>
          <VALUEMEANING>Biological Relative Daughter</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: Daughter; a female human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25165, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717311</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Father</VALIDVALUE>
          <VALUEMEANING>Biological Relative Father</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: Father; a male parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25174, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717657</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Grandchild</VALIDVALUE>
          <VALUEMEANING>Biological Relative Grandchild</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: A child of your son or daughter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71397, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717656</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Grandfather</VALIDVALUE>
          <VALUEMEANING>Biological Relative Grandfather</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: The father of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71387, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717655</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Grandmother</VALIDVALUE>
          <VALUEMEANING>Biological Relative Grandmother</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: The mother of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71386, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Grandparent</VALIDVALUE>
          <VALUEMEANING>Biological Relative Grandparent</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: A parent of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71385, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717653</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Mother</VALIDVALUE>
          <VALUEMEANING>Biological Relative Mother</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: Mother; a female parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25189, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717663</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Parent</VALIDVALUE>
          <VALUEMEANING>Biological Relative Parent</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: A mother or a father; the immediate progenitor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42709, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717662</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Sibling</VALIDVALUE>
          <VALUEMEANING>Biological Relative Sibling</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: Sibling; a person&#39;s brother or sister.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25204, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717661</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Sister</VALIDVALUE>
          <VALUEMEANING>Biological Relative Sister</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: Sister; a female sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25680, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Natural Son</VALIDVALUE>
          <VALUEMEANING>Biological Relative Son</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by descent rather than by marriage or law.: Son; a male human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25205, C71384</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717244</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Nephew</VALIDVALUE>
          <VALUEMEANING>Nephew</VALUEMEANING>
          <MEANINGDESCRIPTION>A son of your brother or sister.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2716528</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Niece</VALIDVALUE>
          <VALUEMEANING>Niece</VALUEMEANING>
          <MEANINGDESCRIPTION>A daughter of your brother or sister.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71408</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717072</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>None</VALIDVALUE>
          <VALUEMEANING>None at all</VALUEMEANING>
          <MEANINGDESCRIPTION>No person or thing, nobody, not any.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C41132</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574138</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adopted Daughter</VALIDVALUE>
          <VALUEMEANING>Adoptive Relative Daughter</VALUEMEANING>
          <MEANINGDESCRIPTION>Family relation established by a legal proceeding that creates a parent-child relation between persons not related by blood.: Daughter; a female human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25165, C71394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717357</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adopted Son</VALIDVALUE>
          <VALUEMEANING>Adoptive Relative Son</VALUEMEANING>
          <MEANINGDESCRIPTION>Family relation established by a legal proceeding that creates a parent-child relation between persons not related by blood.: Son; a male human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25205, C71394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717356</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adoptive Brother</VALIDVALUE>
          <VALUEMEANING>Adoptive Relative Brother</VALUEMEANING>
          <MEANINGDESCRIPTION>Family relation established by a legal proceeding that creates a parent-child relation between persons not related by blood.: Brother; a male sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25289, C71394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717355</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adoptive Father</VALIDVALUE>
          <VALUEMEANING>Adoptive Relative Father</VALUEMEANING>
          <MEANINGDESCRIPTION>Family relation established by a legal proceeding that creates a parent-child relation between persons not related by blood.: Father; a male parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25174, C71394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717353</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adoptive Mother</VALIDVALUE>
          <VALUEMEANING>Adoptive Relative Mother</VALUEMEANING>
          <MEANINGDESCRIPTION>Family relation established by a legal proceeding that creates a parent-child relation between persons not related by blood.: Mother; a female parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25189, C71394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717354</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Adoptive Sister</VALIDVALUE>
          <VALUEMEANING>Adoptive Relative Sister</VALUEMEANING>
          <MEANINGDESCRIPTION>Family relation established by a legal proceeding that creates a parent-child relation between persons not related by blood.: Sister; a female sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25680, C71394</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717352</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Aunt</VALIDVALUE>
          <VALUEMEANING>Aunt</VALUEMEANING>
          <MEANINGDESCRIPTION>The sister of your father or mother; the wife of your uncle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71405</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brother</VALIDVALUE>
          <VALUEMEANING>Brother</VALUEMEANING>
          <MEANINGDESCRIPTION>Brother; a male sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25289</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565681</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Brother-in-law</VALIDVALUE>
          <VALUEMEANING>Brother-in-law</VALUEMEANING>
          <MEANINGDESCRIPTION>A brother by marriage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71406</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717274</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Child</VALIDVALUE>
          <VALUEMEANING>Child</VALUEMEANING>
          <MEANINGDESCRIPTION>A human offspring (son or daughter) of any age; an immediate progeny.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42708</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2716525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cousin</VALIDVALUE>
          <VALUEMEANING>Cousin</VALUEMEANING>
          <MEANINGDESCRIPTION>A child of your aunt or uncle or their descendents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71410</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717277</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daughter</VALIDVALUE>
          <VALUEMEANING>Daughter</VALUEMEANING>
          <MEANINGDESCRIPTION>Daughter; a female human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25165</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567346</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Daughter-in-law</VALIDVALUE>
          <VALUEMEANING>Daughter-in-law</VALUEMEANING>
          <MEANINGDESCRIPTION>The wife of your son.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717275</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Domestic Partner</VALIDVALUE>
          <VALUEMEANING>Domestic Partnership</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who is a member of an unmarried couple, including same sex couples, living together in long standing relationships that are registered or un-registered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Don&#39;t Know</VALIDVALUE>
          <VALUEMEANING>Don&#39;t Know/Refused</VALUEMEANING>
          <MEANINGDESCRIPTION>The answer is not known by the person answering.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67142</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2654058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Father</VALIDVALUE>
          <VALUEMEANING>Father</VALUEMEANING>
          <MEANINGDESCRIPTION>Father; a male parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25174</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Father-in-law</VALIDVALUE>
          <VALUEMEANING>Father-in-law</VALUEMEANING>
          <MEANINGDESCRIPTION>The father of your spouse.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68640</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2658748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Female Cousin</VALIDVALUE>
          <VALUEMEANING>Female Cousin</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who belongs to the sex that normally produces ova._A child of your aunt or uncle or their descendents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71410, C16576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717370</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>First Cousin</VALIDVALUE>
          <VALUEMEANING>First Cousin</VALUEMEANING>
          <MEANINGDESCRIPTION>A child of your aunt or uncle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71411</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>First Cousin Once Removed</VALIDVALUE>
          <VALUEMEANING>First Cousin Once Removed</VALUEMEANING>
          <MEANINGDESCRIPTION>A child of your first cousin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71412</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717279</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foster Brother</VALIDVALUE>
          <VALUEMEANING>Foster Relative Brother</VALUEMEANING>
          <MEANINGDESCRIPTION>Unrelated persons who are part of the same foster family.: Brother; a male sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25289, C71393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717369</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foster Daughter</VALIDVALUE>
          <VALUEMEANING>Foster Relative Daughter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unrelated persons who are part of the same foster family.: Daughter; a female human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25165, C71393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717368</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foster Father</VALIDVALUE>
          <VALUEMEANING>Foster Relative Father</VALUEMEANING>
          <MEANINGDESCRIPTION>Unrelated persons who are part of the same foster family.: Father; a male parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25174, C71393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717367</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foster Mother</VALIDVALUE>
          <VALUEMEANING>Foster Relative Mother</VALUEMEANING>
          <MEANINGDESCRIPTION>Unrelated persons who are part of the same foster family.: Mother; a female parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25189, C71393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717366</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foster Sister</VALIDVALUE>
          <VALUEMEANING>Foster Relative Sister</VALUEMEANING>
          <MEANINGDESCRIPTION>Unrelated persons who are part of the same foster family.: Sister; a female sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25680, C71393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Foster Son</VALIDVALUE>
          <VALUEMEANING>Foster Relative Son</VALUEMEANING>
          <MEANINGDESCRIPTION>Unrelated persons who are part of the same foster family.: Son; a male human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25205, C71393</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717364</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fraternal Twin Brother</VALIDVALUE>
          <VALUEMEANING>Fraternal Twin Brother</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two offspring from separately fertilized ova during the same pregnancy.: Brother; a male sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25289, C73428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737025</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fraternal Twin Sibling</VALIDVALUE>
          <VALUEMEANING>Fraternal Twin Sibling</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two offspring from separately fertilized ova during the same pregnancy.: Sibling; a person&#39;s brother or sister.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25204, C73428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737023</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fraternal Twin Sister</VALIDVALUE>
          <VALUEMEANING>Fraternal Twin Sister</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two offspring from separately fertilized ova during the same pregnancy.: Sister; a female sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25680, C73428</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Full Brother</VALIDVALUE>
          <VALUEMEANING>Full Sibling Brother</VALUEMEANING>
          <MEANINGDESCRIPTION>A sibling with whom you share both parents.: Brother; a male sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25289, C71390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717363</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Full Sister</VALIDVALUE>
          <VALUEMEANING>Full Sibling Sister</VALUEMEANING>
          <MEANINGDESCRIPTION>A sibling with whom you share both parents.: Sister; a female sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25680, C71390</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717362</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grand Nephew</VALIDVALUE>
          <VALUEMEANING>Grand Relative Nephew</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative separated by two generations.: A son of your brother or sister.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71409, C71388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717067</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grand Niece</VALIDVALUE>
          <VALUEMEANING>Grand Relative Niece</VALUEMEANING>
          <MEANINGDESCRIPTION>A relative separated by two generations.: A daughter of your brother or sister.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71408, C71388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717309</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grandchild</VALIDVALUE>
          <VALUEMEANING>Grandchild</VALUEMEANING>
          <MEANINGDESCRIPTION>A child of your son or daughter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717271</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grandfather</VALIDVALUE>
          <VALUEMEANING>Grandfather</VALUEMEANING>
          <MEANINGDESCRIPTION>The father of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71387</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717270</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grandmother</VALIDVALUE>
          <VALUEMEANING>Grandmother</VALUEMEANING>
          <MEANINGDESCRIPTION>The mother of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71386</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717383</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Grandparent</VALIDVALUE>
          <VALUEMEANING>Grandparent</VALUEMEANING>
          <MEANINGDESCRIPTION>A parent of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2716523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Great Grandchild</VALIDVALUE>
          <VALUEMEANING>Great Relative Grandchild</VALUEMEANING>
          <MEANINGDESCRIPTION>When combined with another relation &quot;great&quot; indicates an additional generation of separation between relatives.: A child of your son or daughter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71397, C71389</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717382</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Half Brother</VALIDVALUE>
          <VALUEMEANING>Half Brother</VALUEMEANING>
          <MEANINGDESCRIPTION>A male sibling with whom you only share a single parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71402</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2590724</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Half Sibling</VALIDVALUE>
          <VALUEMEANING>Half Sibling</VALUEMEANING>
          <MEANINGDESCRIPTION>A sibling with whom you share a single parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71391</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717269</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Half Sister</VALIDVALUE>
          <VALUEMEANING>Half Sister</VALUEMEANING>
          <MEANINGDESCRIPTION>A female sibling with whom you only share a single parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71403</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2590723</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Husband</VALIDVALUE>
          <VALUEMEANING>Husband</VALUEMEANING>
          <MEANINGDESCRIPTION>A male partner in marriage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71588</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719659</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Identical Twin Brother</VALIDVALUE>
          <VALUEMEANING>Identical Twin Brother</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two offspring resulting from a shared ovum.: Brother; a male sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25289, C73429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737021</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Identical Twin Sibling</VALIDVALUE>
          <VALUEMEANING>Identical Twin Sibling</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two offspring resulting from a shared ovum.: Sibling; a person&#39;s brother or sister.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25204, C73429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737022</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Identical Twin Sister</VALIDVALUE>
          <VALUEMEANING>Identical Twin Sister</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of the two offspring resulting from a shared ovum.: Sister; a female sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25680, C73429</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737020</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Legal Guardian</VALIDVALUE>
          <VALUEMEANING>Guardian</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who is authorized under applicable State or local law to consent on behalf of a child or incapable person to general medical care including participation in clinical research.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C51828</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578770</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Male Cousin</VALIDVALUE>
          <VALUEMEANING>Male Cousin</VALUEMEANING>
          <MEANINGDESCRIPTION>An individual who belongs to the sex that normally produces sperm._A child of your aunt or uncle or their descendents.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71410, C20197</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717381</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal Aunt</VALIDVALUE>
          <VALUEMEANING>Maternal Relative Aunt</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: The sister of your father or mother; the wife of your uncle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71405, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717290</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal First Cousin</VALIDVALUE>
          <VALUEMEANING>Maternal Relative First Cousin</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: A child of your aunt or uncle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71411, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717379</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal First Cousin Once Removed</VALIDVALUE>
          <VALUEMEANING>Maternal Relative First Cousin Once Removed</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: A child of your first cousin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71412, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal Grandfather</VALIDVALUE>
          <VALUEMEANING>Maternal Relative Grandfather</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: The father of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71387, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal Grandmother</VALIDVALUE>
          <VALUEMEANING>Maternal Relative Grandmother</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: The mother of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71386, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal Grandparent</VALIDVALUE>
          <VALUEMEANING>Maternal Relative Grandparent</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: A parent of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71385, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717069</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal Great Aunt</VALIDVALUE>
          <VALUEMEANING>Maternal Relative Great Relative Aunt</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: When combined with another relation &quot;great&quot; indicates an additional generation of separation between relatives.: The sister of your father or mother; the wife of your uncle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71405, C71389, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717377</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal Great Grandparent</VALIDVALUE>
          <VALUEMEANING>Maternal Relative Great Relative Grandparent</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: When combined with another relation &quot;great&quot; indicates an additional generation of separation between relatives.: A parent of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71385, C71389, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717287</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Maternal Great Uncle</VALIDVALUE>
          <VALUEMEANING>Maternal Relative Great Relative Uncle</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the mother&#39;s side of the family.: When combined with another relation &quot;great&quot; indicates an additional generation of separation between relatives.: The brother of your father or mother; the husband of your aunt.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71404, C71389, C71383</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717374</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567790</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Parent</VALIDVALUE>
          <VALUEMEANING>Parent</VALUEMEANING>
          <MEANINGDESCRIPTION>A mother or a father; the immediate progenitor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42709</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2716524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal Aunt</VALIDVALUE>
          <VALUEMEANING>Paternal Relative Aunt</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: The sister of your father or mother; the wife of your uncle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71405, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717288</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal First Cousin</VALIDVALUE>
          <VALUEMEANING>Paternal Relative First Cousin</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: A child of your aunt or uncle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71411, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal First Cousin Once Removed</VALIDVALUE>
          <VALUEMEANING>Paternal Relative First Cousin Once Removed</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: A child of your first cousin.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71412, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717665</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal Grandfather</VALIDVALUE>
          <VALUEMEANING>Paternal Relative Grandfather</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: The father of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71387, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717305</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal Grandmother</VALIDVALUE>
          <VALUEMEANING>Paternal Relative Grandmother</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: The mother of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71386, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal Grandparent</VALIDVALUE>
          <VALUEMEANING>Paternal Relative Grandparent</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: A parent of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71385, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717070</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal Great Aunt</VALIDVALUE>
          <VALUEMEANING>Paternal Relative Great Relative Aunt</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: When combined with another relation &quot;great&quot; indicates an additional generation of separation between relatives.: The sister of your father or mother; the wife of your uncle.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71405, C71389, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717668</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal Great Grandparent</VALIDVALUE>
          <VALUEMEANING>Paternal Relative Great Relative Grandparent</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: When combined with another relation &quot;great&quot; indicates an additional generation of separation between relatives.: A parent of your father or mother.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71385, C71389, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717087</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal Great Uncle</VALIDVALUE>
          <VALUEMEANING>Paternal Relative Great Relative Uncle</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: When combined with another relation &quot;great&quot; indicates an additional generation of separation between relatives.: The brother of your father or mother; the husband of your aunt.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71404, C71389, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717671</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal Half Brother</VALIDVALUE>
          <VALUEMEANING>Paternal Relative Half Brother</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: A male sibling with whom you only share a single parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71402, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717669</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal Half Sibling</VALIDVALUE>
          <VALUEMEANING>Paternal Relative Half Sibling</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: A sibling with whom you share a single parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71391, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737030</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal Half Sister</VALIDVALUE>
          <VALUEMEANING>Paternal Relative Half Sister</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: A female sibling with whom you only share a single parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71403, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717670</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Paternal Uncle</VALIDVALUE>
          <VALUEMEANING>Paternal Relative Uncle</VALUEMEANING>
          <MEANINGDESCRIPTION>A person related by lineage through the father&#39;s side of the family.: The brother of your father or mother; the husband of your aunt.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71404, C71382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717068</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Refused</VALIDVALUE>
          <VALUEMEANING>Refused</VALUEMEANING>
          <MEANINGDESCRIPTION>To decline to do, accept, give, or allow something.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49161</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579385</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sibling</VALIDVALUE>
          <VALUEMEANING>Sibling</VALUEMEANING>
          <MEANINGDESCRIPTION>Sibling; a person&#39;s brother or sister.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25204</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717664</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sister</VALIDVALUE>
          <VALUEMEANING>Sister</VALUEMEANING>
          <MEANINGDESCRIPTION>Sister; a female sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25680</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-10-17</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sister-in-law</VALIDVALUE>
          <VALUEMEANING>Sister-in-law</VALUEMEANING>
          <MEANINGDESCRIPTION>A sister by marriage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71407</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717276</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Son</VALIDVALUE>
          <VALUEMEANING>Son</VALUEMEANING>
          <MEANINGDESCRIPTION>Son; a male human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25205</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567345</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Son-in-law</VALIDVALUE>
          <VALUEMEANING>Son-in-law</VALUEMEANING>
          <MEANINGDESCRIPTION>The husband of your daughter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71400</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717273</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Spouse</VALIDVALUE>
          <VALUEMEANING>Spouse</VALUEMEANING>
          <MEANINGDESCRIPTION>A person&#39;s partner in marriage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C62649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717272</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Step Child</VALIDVALUE>
          <VALUEMEANING>Step Relative Child</VALUEMEANING>
          <MEANINGDESCRIPTION>A family relation established through a subsequent marriage of your parent.: A human offspring (son or daughter) of any age; an immediate progeny.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42708, C71395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737027</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Step Sibling</VALIDVALUE>
          <VALUEMEANING>Step Relative Sibling</VALUEMEANING>
          <MEANINGDESCRIPTION>A family relation established through a subsequent marriage of your parent.: Sibling; a person&#39;s brother or sister.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25204, C71395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737028</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stepbrother</VALIDVALUE>
          <VALUEMEANING>Step Brother</VALUEMEANING>
          <MEANINGDESCRIPTION>A family relation established through a subsequent marriage of your parent.: Brother; a male sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25289, C71395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717679</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stepdaughter</VALIDVALUE>
          <VALUEMEANING>Step Relative Daughter</VALUEMEANING>
          <MEANINGDESCRIPTION>A family relation established through a subsequent marriage of your parent.: Daughter; a female human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25165, C71395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717678</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stepfather</VALIDVALUE>
          <VALUEMEANING>Step Relative Father</VALUEMEANING>
          <MEANINGDESCRIPTION>A family relation established through a subsequent marriage of your parent.: Father; a male parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25174, C71395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717677</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stepmother</VALIDVALUE>
          <VALUEMEANING>Step Relative Mother</VALUEMEANING>
          <MEANINGDESCRIPTION>A family relation established through a subsequent marriage of your parent.: Mother; a female parent.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25189, C71395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717676</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stepsister</VALIDVALUE>
          <VALUEMEANING>Step Sister</VALUEMEANING>
          <MEANINGDESCRIPTION>A family relation established through a subsequent marriage of your parent.: Sister; a female sibling.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25680, C71395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717675</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Stepson</VALIDVALUE>
          <VALUEMEANING>Step Relative Son</VALUEMEANING>
          <MEANINGDESCRIPTION>A family relation established through a subsequent marriage of your parent.: Son; a male human offspring.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25205, C71395</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717674</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Twin Sibling</VALIDVALUE>
          <VALUEMEANING>Twin Sibling</VALUEMEANING>
          <MEANINGDESCRIPTION>Either of two offspring born from the same pregnancy.: Sibling; a person&#39;s brother or sister.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25204, C73427</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2737026</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Uncle</VALIDVALUE>
          <VALUEMEANING>Uncle</VALUEMEANING>
          <MEANINGDESCRIPTION>The brother of your father or mother; the husband of your aunt.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71404</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-20</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2716527</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ward</VALIDVALUE>
          <VALUEMEANING>Ward</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who is under the protection or in the custody of another.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71413</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-12-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2717073</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Wife</VALIDVALUE>
          <VALUEMEANING>Wife</VALUEMEANING>
          <MEANINGDESCRIPTION>A female partner in marriage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C71587</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-01-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2719660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unmarried Partner</VALIDVALUE>
          <VALUEMEANING>Domestic Partnership</VALUEMEANING>
          <MEANINGDESCRIPTION>A person who is a member of an unmarried couple, including same sex couples, living together in long standing relationships that are registered or un-registered.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other Relative</VALIDVALUE>
          <VALUEMEANING>Other Relative</VALUEMEANING>
          <MEANINGDESCRIPTION>Not otherwise specified.: Relative; a person related by blood or marriage.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C21480, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-10-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570523</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How is this person related to</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How is this person related to Person 1?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is your relationship to the patient?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Demographics</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3070841</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Core: Tier 2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3688552</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Substance Abuse and Addiction Core Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3689959</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>15689233</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>HHS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Completed</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>15910169</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPQS_QVAL_RELPT</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1663">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2808130</PUBLICID>
    <LONGNAME>Histopathology Low Grade Dysplasia Biopsy Number</LONGNAME>
    <PREFERREDNAME>HIST_LGD_BX_NUM</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of biopsies in low grade dysplasia.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>DCP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>DCP:Division of Cancer Prevention</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2808122</PublicId>
      <PreferredName>HIST_GD</PreferredName>
      <PreferredDefinition>Information pertaining to the degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease.</PreferredDefinition>
      <LongName>Histopathology Grade</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2223325</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18190</PreferredName>
        <Version>1</Version>
        <LongName>Histopathology</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18190</PREFERRED_NAME>
            <LONG_NAME>Histopathologic Examination</LONG_NAME>
            <CON_ID>2223204</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2427327</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18000</PreferredName>
        <Version>1</Version>
        <LongName>Grade</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18000</PREFERRED_NAME>
            <LONG_NAME>Histologic Grade</LONG_NAME>
            <CON_ID>2203821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>DCP:Division of Cancer Prevention</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2808128</PublicId>
      <PreferredName>LGD_BX_NUM</PreferredName>
      <PreferredDefinition>The number used to identify the minimum degree of tissue removal for microscopic examination found in neoplastic transformation of the cell, associated with altered architectural tissue patterns. The cellular changes include nuclear and cytoplasmic abnormalities.</PreferredDefinition>
      <LongName>Low Grade Dysplasia Biopsy Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>DCP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>DCP:Division of Cancer Prevention</Origin>
      <Representation>
        <PublicId>2808127</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54722:C48309:C4086:C15189:C25</PreferredName>
        <Version>1</Version>
        <LongName>Low Grade Dysplasia Biopsy Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54722</PREFERRED_NAME>
            <LONG_NAME>Low</LONG_NAME>
            <CON_ID>2509528</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48309</PREFERRED_NAME>
            <LONG_NAME>Grade</LONG_NAME>
            <CON_ID>2434105</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4086</PREFERRED_NAME>
            <LONG_NAME>Dysplasia</LONG_NAME>
            <CON_ID>2202401</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15189</PREFERRED_NAME>
            <LONG_NAME>Biopsy Procedure</LONG_NAME>
            <CON_ID>2202502</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Number of biopsies in each gr</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Number of biopsies in each grade (LGD)</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2194255</PublicId>
          <ContextName>DCP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Condition</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Ursodeoxycholic Acid - Barrett&#39;s Patients</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>TRIAL_TYPE_USAGE</ClassificationSchemeItemType>
        <CsiPublicId>2813043</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1664">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2819879</PUBLICID>
    <LONGNAME>Copy Number Analysis Programming Parameter Hidden Markov Model Copy Number State Value double Collection</LONGNAME>
    <PREFERREDNAME>2819831v1.0:2789833v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The number of molecules of a particular type on or in a cell or part of a cell. Usually applied to specific genes or to plasmids within a bacterium.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:A value that is passed to a routine._A statistical model in which the system being modeled has unknown parameters, but the hidden parameters can be determined from the observable parameters. While the state is not directly visible, the variables influenced by the state are visible. Each state has a probability distribution over the possible output tokens. Therefore the sequence of tokens generated by a Hidden Markov Model (HMM) gives some information about the sequence of states.:The number of molecules of a particular type on or in a cell or part of a cell. Usually applied to specific genes or to plasmids within a bacterium.:The way something is with respect to its main attributes.:A numerical quantity measured or assigned or computed._Generic value domain for a collection of double-precision floating point numbers (64-bit IEEE 7540).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2819831</PublicId>
      <PreferredName>2819800v1.0:2819785v1.0</PreferredName>
      <PreferredDefinition>The number of molecules of a particular type on or in a cell or part of a cell. Usually applied to specific genes or to plasmids within a bacterium.:Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.:A value that is passed to a routine._A statistical model in which the system being modeled has unknown parameters, but the hidden parameters can be determined from the observable parameters. While the state is not directly visible, the variables influenced by the state are visible. Each state has a probability distribution over the possible output tokens. Therefore the sequence of tokens generated by a Hidden Markov Model (HMM) gives some information about the sequence of states.:The number of molecules of a particular type on or in a cell or part of a cell. Usually applied to specific genes or to plasmids within a bacterium.:The way something is with respect to its main attributes.:A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Copy Number Analysis Programming Parameter Hidden Markov Model Copy Number State Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2819800</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49142:C25391:C48913</PreferredName>
        <Version>1</Version>
        <LongName>Copy Number Analysis Programming Parameter</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49142</PREFERRED_NAME>
            <LONG_NAME>Copy Number</LONG_NAME>
            <CON_ID>2528506</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25391</PREFERRED_NAME>
            <LONG_NAME>Analysis</LONG_NAME>
            <CON_ID>2202310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48913</PREFERRED_NAME>
            <LONG_NAME>Programming Parameter</LONG_NAME>
            <CON_ID>2451932</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2819785</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C75940:C49142:C25687:C25712</PreferredName>
        <Version>1</Version>
        <LongName>Hidden Markov Model Copy Number State Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C75940</PREFERRED_NAME>
            <LONG_NAME>Hidden Markov Model</LONG_NAME>
            <CON_ID>2819754</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49142</PREFERRED_NAME>
            <LONG_NAME>Copy Number</LONG_NAME>
            <CON_ID>2528506</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25687</PREFERRED_NAME>
            <LONG_NAME>State</LONG_NAME>
            <CON_ID>2203805</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2789833</PublicId>
      <PreferredName>2789833v1.0</PreferredName>
      <PreferredDefinition>Generic value domain for a collection of double-precision floating point numbers (64-bit IEEE 7540).</PreferredDefinition>
      <LongName>double Collection</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2183782</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>NCIP</PreferredName>
        <Version>1</Version>
        <LongName>NCIP</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Double</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2789861</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43446</PreferredName>
        <Version>1</Version>
        <LongName>Container Object</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43446</PREFERRED_NAME>
            <LONG_NAME>Container Object</LONG_NAME>
            <CON_ID>2236557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Copy Number Analysis Programming Parameter Hidden Markov Model Copy Number State Value double Collection does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Copy Number Analysis Programming Parameter Hidden Markov Model Copy Number State Value double Collection does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2819751</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Copy Number Analysis Tool</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.icr.asrv1.cnat</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2819753</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.icr.asrv1.cnat.CnatParameters.hmmParameterState</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CnatParameters:hmmParameterState</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1665">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2828465</PUBLICID>
    <LONGNAME>Chromosome Segment Chromosome Number java.lang.String</LONGNAME>
    <PREFERREDNAME>2828414v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.:One of the parts into which something naturally divides._One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.:A numeral or string of numerals expressing value, quantity, or identification._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2828414</PublicId>
      <PreferredName>2828382v1.0:2771061v1.0</PreferredName>
      <PreferredDefinition>One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.:One of the parts into which something naturally divides._One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.:A numeral or string of numerals expressing value, quantity, or identification.</PreferredDefinition>
      <LongName>Chromosome Segment Chromosome Number</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2828382</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13202:C45312</PreferredName>
        <Version>1</Version>
        <LongName>Chromosome Segment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13202</PREFERRED_NAME>
            <LONG_NAME>Chromosome</LONG_NAME>
            <CON_ID>2203872</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45312</PREFERRED_NAME>
            <LONG_NAME>Segment</LONG_NAME>
            <CON_ID>2480800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2771061</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13202:C25337</PreferredName>
        <Version>1</Version>
        <LongName>Chromosome Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13202</PREFERRED_NAME>
            <LONG_NAME>Chromosome</LONG_NAME>
            <CON_ID>2203872</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Chromosome Segment Chromosome Number java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Chromosome Segment Chromosome Number java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2620091</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GenePattern</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GISTIC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2828339</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2620091</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>GenePattern</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.icr.asrv1.segment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2828341</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2828532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DNA Copy Analytical Service</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.icr.asrv1.segment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000375</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2839207</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CS OverlapFinderAcrossSamples</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.icr.asrv1.segment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000376</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2856819</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CS OverlapFinderAcrossSources</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.icr.asrv1.segment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000377</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ChromosomalSegment:chromosomeNumber</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.icr.asrv1.segment.ChromosomalSegment.chromosomeNumber</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1666">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2830293</PUBLICID>
    <LONGNAME>Pathology Observation Change Date java.util.Date</LONGNAME>
    <PREFERREDNAME>2830182v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.:Watching something and taking note of what happens._The act of alteration or modification; changed or altered in form or character.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2830182</PublicId>
      <PreferredName>2830099v1.0:2539482v1.0</PreferredName>
      <PreferredDefinition>The medical science, and specialty practice, concerned with all aspects of disease, but with special reference to the essential nature, causes, and development of abnormal conditions, as well as the structural and functional changes that result from the disease processes. Informally used to mean the result of such an examination.:Watching something and taking note of what happens._The act of alteration or modification; changed or altered in form or character.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Pathology Observation Change Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2830099</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18189:C25598</PreferredName>
        <Version>1</Version>
        <LongName>Pathology Observation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18189</PREFERRED_NAME>
            <LONG_NAME>Pathology</LONG_NAME>
            <CON_ID>2202779</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2539482</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Change Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Pathology Observation Change Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Pathology Observation Change Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2619399</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caElmir</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.ucdavis.caelmir.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2830086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.ucdavis.caelmir.domain.PathologyObservation.modifiedDate</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PathologyObservation:modifiedDate</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1667">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2839845</PUBLICID>
    <LONGNAME>Tobacco Type Descriptive Short Text</LONGNAME>
    <PREFERREDNAME>OTX_TOBA_TP_DESC_TXT</PREFERREDNAME>
    <PREFERREDDEFINITION>Text to describe an individual&#39;s use of other noncigarette tobacco products.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2193965</PublicId>
      <PreferredName>Toba_Type</PreferredName>
      <PreferredDefinition>Indicates if an individual smokes or has ever smoked any other tobacco or tobacco related product and what type.</PreferredDefinition>
      <LongName>Tobacco Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PS-CC</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008566</PublicId>
        <ContextName>SPOREs</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>BEHAVIOR</PreferredName>
        <Version>1</Version>
        <LongName>Behavior</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2662193</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C891</PreferredName>
        <Version>1</Version>
        <LongName>Tobacco</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C891</PREFERRED_NAME>
            <LONG_NAME>Tobacco</LONG_NAME>
            <CON_ID>2202548</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223243</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2390787</PublicId>
      <PreferredName>DESC_SHORT_TXT</PreferredName>
      <PreferredDefinition>Abbreviated or shortened text field to describe an activity, topic, or item.</PreferredDefinition>
      <LongName>Descriptive Short Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2525585</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365:C25249:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Description  Short Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25249</PREFERRED_NAME>
            <LONG_NAME>Short</LONG_NAME>
            <CON_ID>2206252</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Other, specify</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Other, specify</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify Type</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008601</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>C3D Domain</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caBIG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812367</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2182125</PublicId>
          <ContextName>CCR</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CCR Implementation</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>C3D</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811673</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke University</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811715</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CTMS C3D Adopter Sites</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812625</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2183535</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Clinical Trial Mgmt Systems</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Duke U New CDEs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2812724</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3886752</PublicId>
          <ContextName>DCI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>For Review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>For Review</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3891931</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCI</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1668">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2840190</PUBLICID>
    <LONGNAME>Surgical Procedure Abscess Antibiotic Administered Ind-2</LONGNAME>
    <PREFERREDNAME>SX_ABSC_ANT_COM_IND2</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to the accumulation of purulent material in tissues, organs, or circumscribed spaces as a complication for a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue that requires drug used to treat infections caused by bacteria and other microorganisms.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>GOG CRF:Gynecologic Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2840186</PublicId>
      <PreferredName>SX_ABSC_ANT_COM</PreferredName>
      <PreferredDefinition>information related to the accumulation of purulent material in tissues, organs, or circumscribed spaces as a complication for a diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue that requires drug used to treat infections caused by bacteria and other microorganisms.</PreferredDefinition>
      <LongName>Surgical Procedure Abscess Antibiotic Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008517</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>AE</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Events</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2322305</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15329</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15329</PREFERRED_NAME>
            <LONG_NAME>Surgical Procedure</LONG_NAME>
            <CON_ID>2202399</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2840184</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C26686:C258:C25382</PreferredName>
        <Version>1</Version>
        <LongName>Abscess Antibiotic Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C26686</PREFERRED_NAME>
            <LONG_NAME>Abscess</LONG_NAME>
            <CON_ID>2203612</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C258</PREFERRED_NAME>
            <LONG_NAME>Antibiotic</LONG_NAME>
            <CON_ID>2202302</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>GOG CRF:Gynecologic Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Were antibiotics given</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Were antibiotics given</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>were antibiotics prescribed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Gynecologic</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811908</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811963</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008608</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase III</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>2811890</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0252</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0252</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000589</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0252</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000590</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SX_ABSC_ANT_COM_IND2</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1669">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2869749</PUBLICID>
    <LONGNAME>Study Activity Comment ISO21090.ST.v1.0</LONGNAME>
    <PREFERREDNAME>2868076v1.0:2803207v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Additional description of the activity.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868076</PublicId>
      <PreferredName>2867622v1.0:2223274v1.0</PreferredName>
      <PreferredDefinition>A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:An action taken in pursuit of an objective; the state of being active._A written explanation or criticism or illustration that is added to a book or other textual material.</PreferredDefinition>
      <LongName>Study Activity Comment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867622</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63536:C43431</PreferredName>
        <Version>1</Version>
        <LongName>Study Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2223274</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25393</PreferredName>
        <Version>1</Version>
        <LongName>Comment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25393</PREFERRED_NAME>
            <LONG_NAME>Comment</LONG_NAME>
            <CON_ID>2202716</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803207</PublicId>
      <PreferredName>2803207v1.0</PreferredName>
      <PreferredDefinition>Character string datatype stands for text data.</PreferredDefinition>
      <LongName>ISO21090.ST.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090STv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Study Activity Comment ISO21090.ST.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Study Activity Comment ISO21090.ST.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.CommonSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757153</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Activity:comment</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.Activity.comment</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.CommonSubDomain.Activity.comment</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SubstanceAdministration.comment</AlternateName>
        <AlternateNameType>Map:CTRPv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Specimen.commentsFromLaboratory</AlternateName>
        <AlternateNameType>Map:Lab</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Specimen.commentsFromInvestigator</AlternateName>
        <AlternateNameType>Map:Lab</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Activity.comment</AlternateName>
        <AlternateNameType>Map:CTRv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedCompositionRelationship.comment</AlternateName>
        <AlternateNameType>Map:LSDAMv2.2.3Plus</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Activity.comment</AlternateName>
        <AlternateNameType>Map:CDMHv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Base Test.Test Level Comments</AlternateName>
        <AlternateNameType>Map:CDISCLabv1.0.1</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Activity.comment</AlternateName>
        <AlternateNameType>Map:LSDAMv2.2.3Plus</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Patient Study Module - Service Episode Description (0038,0062)</AlternateName>
        <AlternateNameType>Map:DICOM</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CourseAgent.comments</AlternateName>
        <AlternateNameType>Map:caAERSv2.2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TreatmentAssignment.comments</AlternateName>
        <AlternateNameType>Map:caAERSv2.2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PlannedEligibilityCriterion.comment</AlternateName>
        <AlternateNameType>Map:CTRPv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LabTest.comments</AlternateName>
        <AlternateNameType>Map:Lab</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CausalityAssessment.text (in IndividualCaseSafetyReport)</AlternateName>
        <AlternateNameType>Map:ICSRr2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Activity.comment</AlternateName>
        <AlternateNameType>Map:CTRPv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ScheduledActivity.notes</AlternateName>
        <AlternateNameType>Map:PSCv2.6</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedObservationResult.commentText</AlternateName>
        <AlternateNameType>Map:CTRv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Specimen.commentFromLaboratory</AlternateName>
        <AlternateNameType>Map:LabViewer2.2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ReportReviewComment</AlternateName>
        <AlternateNameType>Map:caAERSv2.2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LaboratoryTest.comment</AlternateName>
        <AlternateNameType>Map:LabViewer2.2</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PlannedActivity.comment</AlternateName>
        <AlternateNameType>Map:CTRPv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ScheduledEvent.notes</AlternateName>
        <AlternateNameType>Map:PSC</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PlannedObservation.comment</AlternateName>
        <AlternateNameType>Map:CTRPv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1670">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2869812</PUBLICID>
    <LONGNAME>Person Biological Entity Marital Status Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>2868139v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded value specifying the domestic partnership status of a person. EXAMPLE(S): Married, Widowed, Single, Separated</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868139</PublicId>
      <PreferredName>2867644v1.0:2493201v1.0</PreferredName>
      <PreferredDefinition>A single human being.:Pertaining to biology or to life and living things.:An independently existing thing (living or nonliving)._A demographic parameter indicating a person&#39;s conjugal status.:A system, often of numbered categories, for representation of data.</PreferredDefinition>
      <LongName>Person Biological Entity Marital Status Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867644</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190:C28226:C51070</PreferredName>
        <Version>1</Version>
        <LongName>Person Biological Entity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28226</PREFERRED_NAME>
            <LONG_NAME>Biological</LONG_NAME>
            <CON_ID>2206378</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2493201</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25188:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Marital Status Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25188</PREFERRED_NAME>
            <LONG_NAME>Marital Status</LONG_NAME>
            <CON_ID>2202371</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Person Biological Entity Marital Status Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Person Biological Entity Marital Status Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.CommonSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757153</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.Person.maritalStatusCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Person:maritalStatusCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.CommonSubDomain.Person.maritalStatusCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1671">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2870051</PUBLICID>
    <LONGNAME>Adverse Event Performed Observation Outcome Severity Code ISO21090.CD.v1.0</LONGNAME>
    <PREFERREDNAME>2868374v1.0:2803170v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A coded value specifying the intensity of the event. EXAMPLE(S): Moderate could be used to describe acne.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868374</PublicId>
      <PreferredName>2867728v1.0:2867827v1.0</PreferredName>
      <PreferredDefinition>Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s).:Executed and carried through to completion.:Watching something and taking note of what happens.:The result of an action._Used of the degree of something undesirable e.g. pain or weather; also, strictness.:A symbol or combination of symbols which is given an arbitrary meaning within a systematized collection of concepts used for data representation.</PreferredDefinition>
      <LongName>Adverse Event Performed Observation Outcome Severity Code</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867728</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41331:C38000:C25598:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Adverse Event Performed Observation Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41331</PREFERRED_NAME>
            <LONG_NAME>Adverse Event</LONG_NAME>
            <CON_ID>2202353</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867827</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25676:C25162</PreferredName>
        <Version>1</Version>
        <LongName>Severity Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25676</PREFERRED_NAME>
            <LONG_NAME>Severity</LONG_NAME>
            <CON_ID>2202697</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803170</PublicId>
      <PreferredName>2803170v1.0</PreferredName>
      <PreferredDefinition>Reference concept defined by a referenced code system.</PreferredDefinition>
      <LongName>ISO21090.CD.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090CDv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2261841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162</PreferredName>
        <Version>1</Version>
        <LongName>Code</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Adverse Event Performed Observation Outcome Severity Code ISO21090.CD.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Adverse Event Performed Observation Outcome Severity Code ISO21090.CD.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2714898</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.0.2</PreferredName>
          <Version>3.02</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2867548</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3757111</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG 3.2</PreferredName>
          <Version>3.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.BRIDG.domain.AdverseEventSubDomain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3757152</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AdverseEvent:severityCode</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.AdverseEvent.severityCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.AdverseEventSubDomain.AdverseEvent.severityCode</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AdverseEvent.severityCode</AlternateName>
        <AlternateNameType>Map:CTRv1.0</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AdverseEvent.gradeOrSeverity</AlternateName>
        <AlternateNameType>Map:AE</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AdverseEvent.description</AlternateName>
        <AlternateNameType>Map:PSCv2.6</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1672">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2870503</PUBLICID>
    <LONGNAME>Intervention Trial Study Protocol Document Publisher Author Reference Text ISO21090.ST.v1.0</LONGNAME>
    <PREFERREDNAME>2868828v1.0:2803207v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A pre-clinical or clinical study in human beings in which individuals are assigned by an investigator based on a protocol to receive specific interventions. The individuals are then followed and biomedical and/or health outcomes are assessed.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:A rule which guides how an activity should be performed.:An organized collection of records that describe a particular body of data._A person or firm engaged in publishing periodicals or books or music.:The writer of a book, article, or other text.:A note acknowledging a source of information or quoting a passage.:The words of something written._Character string datatype stands for text data.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2868828</PublicId>
      <PreferredName>2867669v1.0:2867938v1.0</PreferredName>
      <PreferredDefinition>A pre-clinical or clinical study in human beings in which individuals are assigned by an investigator based on a protocol to receive specific interventions. The individuals are then followed and biomedical and/or health outcomes are assessed.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:A rule which guides how an activity should be performed.:An organized collection of records that describe a particular body of data._A person or firm engaged in publishing periodicals or books or music.:The writer of a book, article, or other text.:A note acknowledging a source of information or quoting a passage.:The words of something written.</PreferredDefinition>
      <LongName>Intervention Trial Study Protocol Document Publisher Author Reference Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2867669</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16140:C63536:C42651:C19498</PreferredName>
        <Version>1</Version>
        <LongName>Intervention Trial Study Protocol Document</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16140</PREFERRED_NAME>
            <LONG_NAME>Intervention Trial</LONG_NAME>
            <CON_ID>2867568</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42651</PREFERRED_NAME>
            <LONG_NAME>Protocol</LONG_NAME>
            <CON_ID>2211236</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19498</PREFERRED_NAME>
            <LONG_NAME>Document</LONG_NAME>
            <CON_ID>2223216</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2867938</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43416:C42781:C25641:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Publisher Author Reference Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43416</PREFERRED_NAME>
            <LONG_NAME>Publisher</LONG_NAME>
            <CON_ID>2236595</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42781</PREFERRED_NAME>
            <LONG_NAME>Author</LONG_NAME>
            <CON_ID>2223995</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25641</PREFERRED_NAME>
            <LONG_NAME>Reference</LONG_NAME>
            <CON_ID>2206357</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2803207</PublicId>
      <PreferredName>2803207v1.0</PreferredName>
      <PreferredDefinition>Character string datatype stands for text data.</PreferredDefinition>
      <LongName>ISO21090.ST.v1.0</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2846956</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>ISO21090 DATA TYPES</PreferredName>
        <Version>1</Version>
        <LongName>ISO21090 Data Types</LongName>
      </ConceptualDomain>
      <Datatype>ISO21090STv1.0</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ISO:International Organization for Standardization</Origin>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Intervention Trial Study Protocol Document Publisher Author Reference Text ISO21090.ST.v1.0 does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Intervention Trial Study Protocol Document Publisher Author Reference Text ISO21090.ST.v1.0 does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2958963</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COPPA</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.COPPA.InformationModel</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2958964</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.BRIDG.domain.InterventionalStudyProtocol.bibliographicDesignation</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>InterventionalStudyProtocol:bibliographicDesignation</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.COPPA.InformationModel.InterventionalStudyProtocol.bibliographicDesignation</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1673">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2898772</PUBLICID>
    <LONGNAME>Person Life Sciences Identifier Organizational Unit java.lang.String</LONGNAME>
    <PREFERREDNAME>2898606v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A human being._A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:Organizational unit like a laboratory, institute or consortium._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2898606</PublicId>
      <PreferredName>2236731v1.0:2898544v1.0</PreferredName>
      <PreferredDefinition>A human being._A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:Organizational unit like a laboratory, institute or consortium.</PreferredDefinition>
      <LongName>Person Life Sciences Identifier Organizational Unit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2898544</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47841:C41167</PreferredName>
        <Version>1</Version>
        <LongName>Life Sciences Identifier Organizational Unit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47841</PREFERRED_NAME>
            <LONG_NAME>Life Sciences Identifier</LONG_NAME>
            <CON_ID>2423426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41167</PREFERRED_NAME>
            <LONG_NAME>Organizational Unit</LONG_NAME>
            <CON_ID>2223214</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Person Life Sciences Identifier Organizational Unit java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Person Life Sciences Identifier Organizational Unit java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.contact</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000253</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.contact</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000254</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.contact.Person.lsidAuthority</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Person:lsidAuthority</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1674">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2898786</PUBLICID>
    <LONGNAME>Derived Microarray Data Life Sciences Identifier Organizational Unit java.lang.String</LONGNAME>
    <PREFERREDNAME>2898620v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>To take, obtain, or receive from a source; having been determined by mathematical computation.:A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:Organizational unit like a laboratory, institute or consortium._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2898620</PublicId>
      <PreferredName>2726716v1.0:2898544v1.0</PreferredName>
      <PreferredDefinition>To take, obtain, or receive from a source; having been determined by mathematical computation.:A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.:A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn._A unique identifier meant to be a common way to identify and access biologically significant data, whether that data is stored in files, relational databases, in applications, or in internal or public data sources. Every LSID consists of up to five parts: the Network Identifier (NID); the root DNS name of the issuing authority; the namespace chosen by the issuing authority; the object id unique in that namespace; and an optional revision id for storing versioning information. Each part is separated by a colon.:Organizational unit like a laboratory, institute or consortium.</PreferredDefinition>
      <LongName>Derived Microarray Data Life Sciences Identifier Organizational Unit</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2726716</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42885:C44282:C25474</PreferredName>
        <Version>1</Version>
        <LongName>Derived Microarray Data</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42885</PREFERRED_NAME>
            <LONG_NAME>Derivation</LONG_NAME>
            <CON_ID>2231196</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44282</PREFERRED_NAME>
            <LONG_NAME>Microarray</LONG_NAME>
            <CON_ID>2223237</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25474</PREFERRED_NAME>
            <LONG_NAME>Data</LONG_NAME>
            <CON_ID>2202724</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2898544</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C47841:C41167</PreferredName>
        <Version>1</Version>
        <LongName>Life Sciences Identifier Organizational Unit</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C47841</PREFERRED_NAME>
            <LONG_NAME>Life Sciences Identifier</LONG_NAME>
            <CON_ID>2423426</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41167</PREFERRED_NAME>
            <LONG_NAME>Organizational Unit</LONG_NAME>
            <CON_ID>2223214</CON_ID>
            <DEFINITION_SOURCE>NCICB</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Derived Microarray Data Life Sciences Identifier Organizational Unit java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Derived Microarray Data Life Sciences Identifier Organizational Unit java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.3</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2898533</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000406</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caArray Internal 2.4</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>3120357</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2898532</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caArray Internal</PreferredName>
          <Version>2.4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.caarray.domain.data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000410</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DerivedArrayData:lsidAuthority</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.caarray.domain.data.DerivedArrayData.lsidAuthority</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1675">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2900196</PUBLICID>
    <LONGNAME>Tissue Slide Unique Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>2899938v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>is an organ part that consists of similarly specialized cells and intercellular matrix, aggregated according to specific spatial relationships; together with other tissues, it constitutes an organ component. Example(s): epithelium, muscle(tissue), connective tissue, neural tissue, lymphoid tissue.:A flat rectangular piece of glass on which specimens can be mounted for microscopic study._A set of characters used as a code that is unique in the context or the system for which it is created. It serves as a means of identification and reference (often instead of a name) for an entity, person, thing, function, procedure, activity, variable, or a body of data._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2899938</PublicId>
      <PreferredName>2230078v1.0:2715029v1.0</PreferredName>
      <PreferredDefinition>is an organ part that consists of similarly specialized cells and intercellular matrix, aggregated according to specific spatial relationships; together with other tissues, it constitutes an organ component. Example(s): epithelium, muscle(tissue), connective tissue, neural tissue, lymphoid tissue.:A flat rectangular piece of glass on which specimens can be mounted for microscopic study._A set of characters used as a code that is unique in the context or the system for which it is created. It serves as a means of identification and reference (often instead of a name) for an entity, person, thing, function, procedure, activity, variable, or a body of data.</PreferredDefinition>
      <LongName>Tissue Slide Unique Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2230078</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12801:C25325</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Slide</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12801</PREFERRED_NAME>
            <LONG_NAME>Tissue</LONG_NAME>
            <CON_ID>2202489</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25325</PREFERRED_NAME>
            <LONG_NAME>Slide</LONG_NAME>
            <CON_ID>2202820</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2715029</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70663</PreferredName>
        <Version>1</Version>
        <LongName>Unique Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70663</PREFERRED_NAME>
            <LONG_NAME>Unique Identifier</LONG_NAME>
            <CON_ID>2714899</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Tissue Slide Unique Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Tissue Slide Unique Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2899621</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ImageMiner</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>org.imageminer.domain.pathology</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2899633</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>org.imageminer.domain.pathology.TissueSlide.uid</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TissueSlide:uid</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1676">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2915827</PUBLICID>
    <LONGNAME>Nanomaterial Entity Created By java.lang.String</LONGNAME>
    <PREFERREDNAME>2915638v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A bulk material composed of discrete nano-substructures that are engineered, synthesized and characterized for a myriad of applications.:An independently existing thing (living or nonliving)._Indicates the person or authoritative body who brought the item into existence._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2915638</PublicId>
      <PreferredName>2915583v1.0:2231611v1.0</PreferredName>
      <PreferredDefinition>A bulk material composed of discrete nano-substructures that are engineered, synthesized and characterized for a myriad of applications.:An independently existing thing (living or nonliving)._Indicates the person or authoritative body who brought the item into existence.</PreferredDefinition>
      <LongName>Nanomaterial Entity Created By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2915583</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62371:C51070</PreferredName>
        <Version>1</Version>
        <LongName>Nanomaterial Entity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62371</PREFERRED_NAME>
            <LONG_NAME>Nanomaterial</LONG_NAME>
            <CON_ID>2915525</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C51070</PREFERRED_NAME>
            <LONG_NAME>Entity</LONG_NAME>
            <CON_ID>2452881</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42628</PreferredName>
        <Version>1</Version>
        <LongName>Created By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42628</PREFERRED_NAME>
            <LONG_NAME>Created By</LONG_NAME>
            <CON_ID>2231551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Nanomaterial Entity Created By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Nanomaterial Entity Created By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2915522</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caNanoLab</PreferredName>
          <Version>1.5</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cananolab.domain.particle</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000482</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cananolab.domain.particle.NanomaterialEntity.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NanomaterialEntity:createdBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1677">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2919633</PUBLICID>
    <LONGNAME>Cell Specimen Requirement Class Specimen Class Text Type</LONGNAME>
    <PREFERREDNAME>2919485v1.0:2615469v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid. Cells are highly variable and specialized in both structure and function, though all must at some stage replicate proteins and nucleic acids, utilize energy, and reproduce themselves.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:Something that is necessary; condition, something that is obligatory._Class; a collection of things sharing a common attribute._Specimen; a bit of tissue or blood or urine that is taken or used for research purposes._Class; a collection of things sharing a common attribute._Text; the words of something written._Type; a subdivision of a particular kind of thing.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2919485</PublicId>
      <PreferredName>2513391v1.0:2430993v1.0</PreferredName>
      <PreferredDefinition>The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid. Cells are highly variable and specialized in both structure and function, though all must at some stage replicate proteins and nucleic acids, utilize energy, and reproduce themselves.:A sample or part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:Something that is necessary; condition, something that is obligatory._Class; a collection of things sharing a common attribute.</PreferredDefinition>
      <LongName>Cell Specimen Requirement Class</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2513391</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12508:C19157:C38015</PreferredName>
        <Version>1</Version>
        <LongName>Cell Specimen Requirement</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12508</PREFERRED_NAME>
            <LONG_NAME>Cell</LONG_NAME>
            <CON_ID>2202900</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C19157</PREFERRED_NAME>
            <LONG_NAME>Specimen</LONG_NAME>
            <CON_ID>2202566</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38015</PREFERRED_NAME>
            <LONG_NAME>Requirement</LONG_NAME>
            <CON_ID>2203776</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2430993</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25346</PreferredName>
        <Version>1</Version>
        <LongName>Class</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25346</PREFERRED_NAME>
            <LONG_NAME>Class</LONG_NAME>
            <CON_ID>2203880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2615469</PublicId>
      <PreferredName>2615469v1.0</PreferredName>
      <PreferredDefinition>Specimen; a bit of tissue or blood or urine that is taken or used for research purposes._Class; a collection of things sharing a common attribute._Text; the words of something written._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Specimen Class Text Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435030</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C28389</PreferredName>
        <Version>1</Version>
        <LongName>NCI Administrative Concept</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2207966</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Text Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Fluid</VALIDVALUE>
          <VALUEMEANING>Fluid</VALUEMEANING>
          <MEANINGDESCRIPTION>Fluid</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568058</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Molecular</VALIDVALUE>
          <VALUEMEANING>Molecular</VALUEMEANING>
          <MEANINGDESCRIPTION>relating to or produced by or consisting of molecules.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25574</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2568065</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Tissue</VALIDVALUE>
          <VALUEMEANING>Tissue</VALUEMEANING>
          <MEANINGDESCRIPTION>An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12801</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567371</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cell</VALIDVALUE>
          <VALUEMEANING>Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid. Cells are highly variable and specialized in both structure and function, though all must at some stage replicate proteins and nucleic acids, utilize energy, and reproduce themselves.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12508</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-03-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2615470</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Cell Specimen Requirement Class Specimen Class Text Type does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Cell Specimen Requirement Class Specimen Class Text Type does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_1</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000638</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2919341</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caTissue_Suite1_2</PreferredName>
          <Version>1.2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.wustl.catissuecore.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000639</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.wustl.catissuecore.domain.CellSpecimenRequirement.specimenClass</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>CellSpecimenRequirement:specimenClass</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1678">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2927784</PUBLICID>
    <LONGNAME>Software Service Unified Modeling Language Class Package Name java.lang.String</LONGNAME>
    <PREFERREDNAME>2927712v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A software system providing a public need.:A non-proprietary, third generation modelling language. The Unified Modeling Language is an open method used to specify, visualise, construct and document the artifacts of an object-oriented software-intensive system under development. The UML represents a compilation of &quot;best engineering practices&quot; which have proven successful in modelling large, complex systems.:A grouping of things based on shared common attributes._Written programs or procedures or rules and associated documentation pertaining to the operation of a computer system and that are stored in read/write memory.:The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2927712</PublicId>
      <PreferredName>2927609v1.0:2927634v1.0</PreferredName>
      <PreferredDefinition>A software system providing a public need.:A non-proprietary, third generation modelling language. The Unified Modeling Language is an open method used to specify, visualise, construct and document the artifacts of an object-oriented software-intensive system under development. The UML represents a compilation of &quot;best engineering practices&quot; which have proven successful in modelling large, complex systems.:A grouping of things based on shared common attributes._Written programs or procedures or rules and associated documentation pertaining to the operation of a computer system and that are stored in read/write memory.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Software Service Unified Modeling Language Class Package Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2927609</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C80736:C54193:C25346</PreferredName>
        <Version>1</Version>
        <LongName>Software Service Unified Modeling Language Class</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C80736</PREFERRED_NAME>
            <LONG_NAME>Software Service</LONG_NAME>
            <CON_ID>2927597</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54193</PREFERRED_NAME>
            <LONG_NAME>Unified Modeling Language</LONG_NAME>
            <CON_ID>2539475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25346</PREFERRED_NAME>
            <LONG_NAME>Class</LONG_NAME>
            <CON_ID>2203880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2927634</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54192:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Package Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54192</PREFERRED_NAME>
            <LONG_NAME>Package</LONG_NAME>
            <CON_ID>2539480</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Software Service Unified Modeling Language Class Package Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Software Service Unified Modeling Language Class Package Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2927589</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caGrid_Metadata_Models</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>caGrid_1.x</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_ALIAS</ClassificationSchemeItemType>
        <CsiPublicId>2927590</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2927589</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caGrid_Metadata_Models</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cagrid.metadata.data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2927593</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cagrid.metadata.data.UMLClass.packageName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>UMLClass:packageName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1679">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2939404</PUBLICID>
    <LONGNAME>Tissue Collection Method Status</LONGNAME>
    <PREFERREDNAME>TISS_COLL_METH_STAT</PREFERREDNAME>
    <PREFERREDDEFINITION>The values used to describe a condition or state at a particular time for collection of tissue.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2189204</PublicId>
      <PreferredName>TISS_COLL_METH</PreferredName>
      <PreferredDefinition>information related to tissue collection method.</PreferredDefinition>
      <LongName>Tissue Collection Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2176924</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Tissue</PreferredName>
        <Version>1</Version>
        <LongName>Tissue</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12801</PREFERRED_NAME>
            <LONG_NAME>Tissue</LONG_NAME>
            <CON_ID>2202489</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207680</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25453:C16847</PreferredName>
        <Version>1</Version>
        <LongName>Collection Method</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16847</PREFERRED_NAME>
            <LONG_NAME>Technique</LONG_NAME>
            <CON_ID>2203854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2939400</PublicId>
      <PreferredName>TISS_COLL_STAT</PreferredName>
      <PreferredDefinition>The values used to describe a condition or state at a particular time for the anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.</PreferredDefinition>
      <LongName>Tissue Collection Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435013</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17828 </PreferredName>
        <Version>1</Version>
        <LongName>Biological Process</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2939399</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C12801:C25453:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Tissue Collection Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12801</PREFERRED_NAME>
            <LONG_NAME>Tissue</LONG_NAME>
            <CON_ID>2202489</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25453</PREFERRED_NAME>
            <LONG_NAME>Collection</LONG_NAME>
            <CON_ID>2203887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Specified</VALIDVALUE>
          <VALUEMEANING>Not Otherwise Specified</VALUEMEANING>
          <MEANINGDESCRIPTION>Not characterized in any other way.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C19594</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2853071</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Voluntary</VALIDVALUE>
          <VALUEMEANING>Voluntary</VALUEMEANING>
          <MEANINGDESCRIPTION>Patient may choose to provide tissue or participate in study but does not need to do so.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mandatory on Consent</VALIDVALUE>
          <VALUEMEANING>Mandatory on Consent</VALUEMEANING>
          <MEANINGDESCRIPTION>Must be performed or collected if patient consents to provide tissue or participate in study.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939402</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mandatory</VALIDVALUE>
          <VALUEMEANING>Mandatory</VALUEMEANING>
          <MEANINGDESCRIPTION>Must be performed on trial or study.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2009-09-10</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2939403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Tissue Collection Method</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Tissue Collection Method</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939361</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCTD</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Clinical Assay Development</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>USAGE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2939362</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939361</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCTD</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>In Situ Hybridization Biomarker Template</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Template Type</ClassificationSchemeItemType>
        <CsiPublicId>3232302</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939361</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCTD</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Biomarker Abstraction</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3263369</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2939361</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>DCTD</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>DNA-based Mutation Assays</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Template Type</ClassificationSchemeItemType>
        <CsiPublicId>3322359</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1680">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2943353</PUBLICID>
    <LONGNAME>Protein Sequence Database Description java.lang.String</LONGNAME>
    <PREFERREDNAME>2943316v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The sequence of amino acids along a polypeptide chain.:An information set with a regular structure.  Although it can be applied to any set of information the term was invented to refer to computerized data, and is used almost exclusively in computing._A statement or an account describing something._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2943316</PublicId>
      <PreferredName>2943266v1.0:2222846v1.0</PreferredName>
      <PreferredDefinition>The sequence of amino acids along a polypeptide chain.:An information set with a regular structure.  Although it can be applied to any set of information the term was invented to refer to computerized data, and is used almost exclusively in computing._A statement or an account describing something.</PreferredDefinition>
      <LongName>Protein Sequence Database Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2943266</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13187:C15426</PreferredName>
        <Version>1</Version>
        <LongName>Protein Sequence Database</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13187</PREFERRED_NAME>
            <LONG_NAME>Amino Acid Sequence</LONG_NAME>
            <CON_ID>2223225</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15426</PREFERRED_NAME>
            <LONG_NAME>Database</LONG_NAME>
            <CON_ID>2228339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222846</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25365</PreferredName>
        <Version>1</Version>
        <LongName>Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Protein Sequence Database Description java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Protein Sequence Database Description java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2858220</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Taverna-caGrid</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>uk.org.mygrid.cagrid.domain.common</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2858221</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>uk.org.mygrid.cagrid.domain.common.ProteinSequenceDatabase.description</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ProteinSequenceDatabase:description</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1681">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2953097</PUBLICID>
    <LONGNAME>Laboratory Procedure Serum Calcium Outcome Lab Unit of Measure Name</LONGNAME>
    <PREFERREDNAME>2194503v1.0:2017137v3.2</PREFERREDNAME>
    <PREFERREDDEFINITION>The unit of measure that represents a determinate amount or quantity of serum calcium in a laboratory specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2194503</PublicId>
      <PreferredName>LAB_SRM_CA_OC</PreferredName>
      <PreferredDefinition>information related to the result of the medical procedure that involves testing a sample of blood for serum calcium, the amount of calcium found in clear liquid part of the blood that remains after blood cells and clotting proteins have been removed.</PreferredDefinition>
      <LongName>Laboratory Procedure Serum Calcium Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2543047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294</PreferredName>
        <Version>1</Version>
        <LongName>Test</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2780768</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13325:C331:C20200</PreferredName>
        <Version>1</Version>
        <LongName>Serum Calcium Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13325</PREFERRED_NAME>
            <LONG_NAME>Serum</LONG_NAME>
            <CON_ID>2203797</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C331</PREFERRED_NAME>
            <LONG_NAME>Calcium</LONG_NAME>
            <CON_ID>2204986</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2017137</PublicId>
      <PreferredName>LAB_UOM_NM</PreferredName>
      <PreferredDefinition>Unit of measure standard values to describe a lab test result.</PreferredDefinition>
      <LongName>Lab Unit of Measure Name</LongName>
      <Version>3.2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2229718</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L</VALIDVALUE>
          <VALUEMEANING>LITER</VALUEMEANING>
          <MEANINGDESCRIPTION>LITER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559062</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575365</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol</VALIDVALUE>
          <VALUEMEANING>MILLIMOLE</VALUEMEANING>
          <MEANINGDESCRIPTION>MILLIMOLE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559240</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/L</VALIDVALUE>
          <VALUEMEANING>millimole per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>millimole per liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2002-02-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/kg</VALIDVALUE>
          <VALUEMEANING>milligram per kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a mass fraction expressed as a number of milligrams of substance per kilogram of mixture. The unit is also used as a dose calculation unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67401</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567577</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unit</VALIDVALUE>
          <VALUEMEANING>Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>Any division of quantity accepted as a standard of measurement or exchange.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C44278</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567622</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/mL</VALIDVALUE>
          <VALUEMEANING>Nanograms per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one liter. The concept also refers to the unit of mass density (volumetric mass) defined as the density of a substance which mass equal to one microgram occupies the volume of one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67306</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2003-12-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567617</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%</VALIDVALUE>
          <VALUEMEANING>Percent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48570</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-01-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567635</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g</VALIDVALUE>
          <VALUEMEANING>Grams (g)</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass equal to one one thousandth of a kilogram.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48155</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567359</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IUnit/L</VALIDVALUE>
          <VALUEMEANING>International unit per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one liter of the system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67376</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569386</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq</VALIDVALUE>
          <VALUEMEANING>Milliequivalent</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of a substance equal to one thousandth of an equivalent weight.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48512</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569399</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/24hr</VALIDVALUE>
          <VALUEMEANING>Milliequivalents per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance crosses a given surface or is delivered to a given object or space over a period of time equal to twenty four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67471</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567654</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/dL</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of milliequivalents of solute per deciliter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67473</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569400</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/L</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A concentration unit measured as a number of milliequivalents of solute per liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67474</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569401</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/dL</VALIDVALUE>
          <VALUEMEANING>Milligram per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67015</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/mL</VALIDVALUE>
          <VALUEMEANING>Milligram per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A SI derived unit of mass concentration defined as the concentration of one kilogram of a substance per unit volume of the mixture equal to one cubic meter, or the concentration of one milligram of a substance per unit volume of the mixture equal to one milliliter, or one gram of a substance per one liter of the mixture. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C42576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569406</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million</VALIDVALUE>
          <VALUEMEANING>Million</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number following 999999 and preceding 100001 and the quantity that it denotes: one thousand thousand.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569409</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>miu</VALIDVALUE>
          <VALUEMEANING>Milliinternational unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit equal to one-thousandth of an international unit.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67316</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569411</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>miu/m2</VALIDVALUE>
          <VALUEMEANING>Milliinternational units per meter squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to one-thousandth (10E-3) of an arbitrary unit of biological activity (International Unit) of substance per square meter of body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67409</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569418</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg</VALIDVALUE>
          <VALUEMEANING>Picograms</VALUEMEANING>
          <MEANINGDESCRIPTION>The metric unit of mass equal to one trillionth of a gram (10E-12 gram).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64551</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569433</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand</VALIDVALUE>
          <VALUEMEANING>Thousand</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number following 999 and preceding 1001 and the quantity that it denotes: ten times one hundred.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569441</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg</VALIDVALUE>
          <VALUEMEANING>Milligram</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of weight.  A milligram is approximately 450,000 times smaller than a pound and 28,000 times smaller than an ounce.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C28253</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-05-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>Thousand per microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571191</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm2</VALIDVALUE>
          <VALUEMEANING>Thousand per millimeter squared</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter squared</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571192</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm3</VALIDVALUE>
          <VALUEMEANING>Thousand per millimeter cubed</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571193</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E12 Cells/L</VALIDVALUE>
          <VALUEMEANING>10E12 Cells per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of cell concentration expressed as a number of cells in trillions per unit volume equal to one liter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67243</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571194</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E3 Cells/microL</VALIDVALUE>
          <VALUEMEANING>10E3 Cells per microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>10E3 Cells per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2004-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2571195</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mill PFU</VALIDVALUE>
          <VALUEMEANING>Million Plaque Forming Units</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of viable infectious entities expressed in millions in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope or/and to the naked eye as a plaque.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67268</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569408</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No Srce</VALIDVALUE>
          <VALUEMEANING>No Source Data</VALUEMEANING>
          <MEANINGDESCRIPTION>Information regarding the subject is unknown or inaccessible at this time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C53269</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-07-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567095</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>kU/L</VALIDVALUE>
          <VALUEMEANING>Kilounit per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>An arbitrary unit of substance content expressed in thousands of units of biological activity per unit of mass equal to one kilogram. Kilounit per kilogram is also used as a dose calculation unit expressed in thousands of arbitrary units per one kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67382</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2004-04-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2569392</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cubic microns</VALIDVALUE>
          <VALUEMEANING>Cubic microns</VALUEMEANING>
          <MEANINGDESCRIPTION>Cubic microns</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573867</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EU</VALIDVALUE>
          <VALUEMEANING>Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>The property used in conjunction with a nutrient or food component, typically expressed in gram (g), milligram (mg), microgram (mcg), joule, or kilojoule.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C68553</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573870</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EU/dL</VALIDVALUE>
          <VALUEMEANING>Enzyme Units per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Enzyme Units per deciliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573871</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>EU/mL</VALIDVALUE>
          <VALUEMEANING>Enzyme Units per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Enzyme Units per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573872</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>fL</VALIDVALUE>
          <VALUEMEANING>Femtoliter</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-SI unit of volume accepted for use with the SI equal to one quadrillionth of a liter (10E-15 liter).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64780</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567645</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/24hr</VALIDVALUE>
          <VALUEMEANING>Gram per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>Gram per 24 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573873</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/dL</VALIDVALUE>
          <VALUEMEANING>Gram per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Gram per deciliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573874</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/L</VALIDVALUE>
          <VALUEMEANING>Gram per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Gram per liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573875</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>g/microL</VALIDVALUE>
          <VALUEMEANING>Gram per microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Gram per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573876</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>HPF</VALIDVALUE>
          <VALUEMEANING>Per High Power Field</VALUEMEANING>
          <MEANINGDESCRIPTION>Per High Power Field</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Iunit</VALIDVALUE>
          <VALUEMEANING>INTERNATIONAL UNIT</VALUEMEANING>
          <MEANINGDESCRIPTION>The unitage assigned by the WHO to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization (e.g. hormones, enzymes, and vaccines), to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48579</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558982</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IUnit/m2</VALIDVALUE>
          <VALUEMEANING>International unit per meter squared</VALUEMEANING>
          <MEANINGDESCRIPTION>International unit per meter squared</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573878</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IUnit/mL</VALIDVALUE>
          <VALUEMEANING>International unit per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573879</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>IUnit/mL</VALIDVALUE>
          <VALUEMEANING>IU/mL</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one milliliter of system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67377</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE>2019-04-30</PVENDDATE>
          <VMPUBLICID>2573880</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>LPF</VALIDVALUE>
          <VALUEMEANING>Per Low Power Field</VALUEMEANING>
          <MEANINGDESCRIPTION>Per Low Power Field</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573881</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mcg/24hr</VALIDVALUE>
          <VALUEMEANING>Microgram per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>Microgram per 24 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573882</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mcg/dL</VALIDVALUE>
          <VALUEMEANING>Microgram per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Microgram per deciliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573883</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mcg/L</VALIDVALUE>
          <VALUEMEANING>microgram per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>microgram per liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563854</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mcg/mL</VALIDVALUE>
          <VALUEMEANING>Microgram per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Microgram per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567625</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mcg/spec</VALIDVALUE>
          <VALUEMEANING>Microgram per specimen</VALUEMEANING>
          <MEANINGDESCRIPTION>Microgram per specimen</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573884</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mEq/kg</VALIDVALUE>
          <VALUEMEANING>Milliequivalent per kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliequivalent per kilogram</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573885</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/L</VALIDVALUE>
          <VALUEMEANING>Milligram per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Milligram per liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573886</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/mL/min</VALIDVALUE>
          <VALUEMEANING>Milligram per milliliter per minute</VALUEMEANING>
          <MEANINGDESCRIPTION>Milligram per milliliter per minute</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573891</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>microIU/mL</VALIDVALUE>
          <VALUEMEANING>Micro International Unit per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Micro International Unit per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>microL</VALIDVALUE>
          <VALUEMEANING>MICROLITER</VALUEMEANING>
          <MEANINGDESCRIPTION>MICROLITER</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2559214</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>micromol/24hr</VALIDVALUE>
          <VALUEMEANING>Micromole per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>Micromole per 24 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573893</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>micromol/dL</VALIDVALUE>
          <VALUEMEANING>Micromole per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Micromole per deciliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573894</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>micromol/L</VALIDVALUE>
          <VALUEMEANING>Micromole per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Micromole per liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567627</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>Million per microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573895</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>miu/mL</VALIDVALUE>
          <VALUEMEANING>Milliinternational unit per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliinternational unit per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573897</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL</VALIDVALUE>
          <VALUEMEANING>Milliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573898</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/min</VALIDVALUE>
          <VALUEMEANING>Milliliter per minute</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliliter per minute</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573899</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/min/1.73/BSA</VALIDVALUE>
          <VALUEMEANING>Milliliter per minute times 1.73 times BSA</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliliter per minute times 1.73 times BSA</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573900</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/minute/mmHg</VALIDVALUE>
          <VALUEMEANING>Milliter per minute per millimeters of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliter per minute per millimeters of Mercury</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573901</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm/hr</VALIDVALUE>
          <VALUEMEANING>Millimeter per hour</VALUEMEANING>
          <MEANINGDESCRIPTION>Millimeter per hour</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573902</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mm3</VALIDVALUE>
          <VALUEMEANING>Millimeter cubed</VALUEMEANING>
          <MEANINGDESCRIPTION>Millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573903</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmHg</VALIDVALUE>
          <VALUEMEANING>Millimeter of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth&#39;s surface. </MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49670</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573904</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/24hr</VALIDVALUE>
          <VALUEMEANING>Millimole per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>Millimole per 24 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mosmol/kg</VALIDVALUE>
          <VALUEMEANING>Milliosmole per kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliosmole per kilogram</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567615</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MU/mL</VALIDVALUE>
          <VALUEMEANING>Million units per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Million units per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573906</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>NA</VALIDVALUE>
          <VALUEMEANING>Not applicable; no UOM required</VALUEMEANING>
          <MEANINGDESCRIPTION>Not applicable; no UOM required</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573907</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/mL/hr</VALIDVALUE>
          <VALUEMEANING>Nanogram per milliliter per hour</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit equal to mass concentration of a substance expressed in nanograms per unit volume of one milliliter per time period of one hour.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67430</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573908</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/L</VALIDVALUE>
          <VALUEMEANING>Nanomole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573909</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nMol/mg protein</VALIDVALUE>
          <VALUEMEANING>Nanomole per milligram of protein</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanomole per milligram of protein</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573910</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/mL</VALIDVALUE>
          <VALUEMEANING>Nanomole per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanomole per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573911</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg/dL</VALIDVALUE>
          <VALUEMEANING>Picogram per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Picogram per deciliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573912</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pgPGE2/mg protein</VALIDVALUE>
          <VALUEMEANING>pgPGE2/mg protein</VALUEMEANING>
          <MEANINGDESCRIPTION>pgPGE2/mg protein</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573914</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/L</VALIDVALUE>
          <VALUEMEANING>Picomole per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration (molarity unit) equal to one trillionth of a mole (10E-12 mole) in one liter of solution.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67434</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573915</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Ratio</VALIDVALUE>
          <VALUEMEANING>ratio</VALUEMEANING>
          <MEANINGDESCRIPTION>ratio</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2562393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>sec</VALIDVALUE>
          <VALUEMEANING>seconds</VALUEMEANING>
          <MEANINGDESCRIPTION>seconds</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C0457385</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN></MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unit/24hr</VALIDVALUE>
          <VALUEMEANING>Unit per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit per 24 hours</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573916</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unit/L</VALIDVALUE>
          <VALUEMEANING>Unit per liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit per liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567623</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unit/mL</VALIDVALUE>
          <VALUEMEANING>Unit per millilliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit per millilliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573917</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unit/mm3</VALIDVALUE>
          <VALUEMEANING>Unit per millimeters cubed</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit per millimeters cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573918</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E7 Cells/kg</VALIDVALUE>
          <VALUEMEANING>10E7 Cells per kilogram</VALUEMEANING>
          <MEANINGDESCRIPTION>10E7 Cells per kilogram</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573847</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/min</VALIDVALUE>
          <VALUEMEANING>Liters per minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of volumetric flow rate defined as the rate at which one liter of matter crosses a given surface during the period of time equal to one minute.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67388</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573851</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/24hr</VALIDVALUE>
          <VALUEMEANING>Milligram per 24 hours</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter crosses a given surface or is delivered to a given object or space over a period of time equal to twenty four hours. Milligram per twenty four hours is also a dose administration rate unit equal to the rate at which one thousandth of a gram of a product is administered per unit of time equal to twenty four hours.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67399</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573852</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unit/m2</VALIDVALUE>
          <VALUEMEANING>Unit per meter squared</VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed as a number of arbitrary units of substance per one square meter of a body surface area.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67467</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>%/100 WBC</VALIDVALUE>
          <VALUEMEANING>Percent Per 100 WBC</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit for percentage measurement of fraction of any type of white blood cells in the total white blood cell count differential.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67215</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573856</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/mm3</VALIDVALUE>
          <VALUEMEANING>Per millimeter cubed</VALUEMEANING>
          <MEANINGDESCRIPTION>Per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E6 Cells</VALIDVALUE>
          <VALUEMEANING>10E6 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of cell count expressed in millions.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67246</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573858</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E6 Cells/microL</VALIDVALUE>
          <VALUEMEANING>10E6 Cells per microLiter</VALUEMEANING>
          <MEANINGDESCRIPTION>10E6 Cells per microLiter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573859</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E6 Cells/mm3</VALIDVALUE>
          <VALUEMEANING>10E6 Cells per millimeter cubed</VALUEMEANING>
          <MEANINGDESCRIPTION>10E6 Cells per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573860</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E8 Cells</VALIDVALUE>
          <VALUEMEANING>10E8 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>10E8 Cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573861</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E9 Cells</VALIDVALUE>
          <VALUEMEANING>10E9 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>10E9 Cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573862</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E9 Cells/L</VALIDVALUE>
          <VALUEMEANING>10E9 Cells per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>10E9 Cells per Liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573863</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cells/microL</VALIDVALUE>
          <VALUEMEANING>Cells per microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Cells per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573864</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Copies</VALIDVALUE>
          <VALUEMEANING>Copies</VALUEMEANING>
          <MEANINGDESCRIPTION>Copies</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-28</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573865</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ng/dL</VALIDVALUE>
          <VALUEMEANING>nanogram per deciliter</VALUEMEANING>
          <MEANINGDESCRIPTION>nanogram per deciliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2563855</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pg/mL</VALIDVALUE>
          <VALUEMEANING>Picrogram per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Picrogram per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573913</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/100 WBC</VALIDVALUE>
          <VALUEMEANING>Per 100 identifiable White blood cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Natural number unit for measurement of portion of a particular type of blood cells (such as any type of white blood cells or nucleated red blood cells) in the total white blood cell count expressed per count of 100.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67219</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2005-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574302</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>CAE Unit</VALIDVALUE>
          <VALUEMEANING>Complement activity enzyme unit</VALUEMEANING>
          <MEANINGDESCRIPTION>Complement activity enzyme unit</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Titer</VALIDVALUE>
          <VALUEMEANING>Titer</VALUEMEANING>
          <MEANINGDESCRIPTION>Titer</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-04-01</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574304</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>RNA copies/mL</VALIDVALUE>
          <VALUEMEANING>RNA copies per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>RNA copies per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-04-06</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2574343</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/mm3</VALIDVALUE>
          <VALUEMEANING>Million per millimeter cubed</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-06-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575469</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cubic microns</VALIDVALUE>
          <VALUEMEANING>CU MIC</VALUEMEANING>
          <MEANINGDESCRIPTION>Cubic Microns</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573866</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cubic microns</VALIDVALUE>
          <VALUEMEANING>CU MICR</VALUEMEANING>
          <MEANINGDESCRIPTION>Cubic microns</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573869</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cubic microns</VALIDVALUE>
          <VALUEMEANING>CU MICRON</VALUEMEANING>
          <MEANINGDESCRIPTION>Cubic microns</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2573868</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>GPL</VALIDVALUE>
          <VALUEMEANING>IgG anti-cardiolipin antibodies</VALUEMEANING>
          <MEANINGDESCRIPTION>IgG anti-cardiolipin antibodies</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576474</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Index value</VALIDVALUE>
          <VALUEMEANING>Index value</VALUEMEANING>
          <MEANINGDESCRIPTION>Index value</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576475</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>microU/mL</VALIDVALUE>
          <VALUEMEANING>Microunit per milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>Microunit per milliliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>M/mcL</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>M/microL</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>M/UI</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576479</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>MILL/MCL</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576480</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>Mil/UI</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/mm3</VALIDVALUE>
          <VALUEMEANING>M/cmm</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576482</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/mm3</VALIDVALUE>
          <VALUEMEANING>MILL/CMM</VALUEMEANING>
          <MEANINGDESCRIPTION>MILL/CMM</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576483</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/mm3</VALIDVALUE>
          <VALUEMEANING>M/mm3</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576484</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/minute/mmHg/L</VALIDVALUE>
          <VALUEMEANING>Milliliter per minute per millimeter Hg per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Milliliter per minute per millimeter Hg per Liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576487</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol/min/kPa/L</VALIDVALUE>
          <VALUEMEANING>Millimole per minute per thousand Pascal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Millimole per minute per thousand Pascal per Liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576488</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>MPL</VALIDVALUE>
          <VALUEMEANING>IgM anti-cardiolipin antibodies</VALUEMEANING>
          <MEANINGDESCRIPTION>IgM anti-cardiolipin antibodies</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576489</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>THOU/MCL</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576490</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>THOU/UL</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576491</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>THOUS/MCL</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576492</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>K/uL</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576493</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>K/microL</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576494</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm2</VALIDVALUE>
          <VALUEMEANING>K/mm2</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter squared</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576495</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm2</VALIDVALUE>
          <VALUEMEANING>1000/mm2</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter squared</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576496</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm3</VALIDVALUE>
          <VALUEMEANING>THOU/CMM</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576497</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm3</VALIDVALUE>
          <VALUEMEANING>K/mm3</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576498</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm3</VALIDVALUE>
          <VALUEMEANING>K/cmm</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576499</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm3</VALIDVALUE>
          <VALUEMEANING>1000/mm3</VALUEMEANING>
          <MEANINGDESCRIPTION>1000/mm3</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2570024</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/mm3</VALIDVALUE>
          <VALUEMEANING>Thous/CMM</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per millimeter cubed</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576500</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>L/sec</VALIDVALUE>
          <VALUEMEANING>Liter per second</VALUEMEANING>
          <MEANINGDESCRIPTION>Liter per second</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576501</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Million/microL</VALIDVALUE>
          <VALUEMEANING>M/uL</VALUEMEANING>
          <MEANINGDESCRIPTION>Million per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576502</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Thousand/microL</VALIDVALUE>
          <VALUEMEANING>1000/microL</VALUEMEANING>
          <MEANINGDESCRIPTION>Thousand per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-10-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2576503</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Threshold</VALIDVALUE>
          <VALUEMEANING>Threshold</VALUEMEANING>
          <MEANINGDESCRIPTION>The lowest limit at which something becomes detectable or relevant.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48228</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2006-04-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2578737</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E6/L</VALIDVALUE>
          <VALUEMEANING>10E6 per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>10E6 per Liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2008-06-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2755857</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ukat/L</VALIDVALUE>
          <VALUEMEANING>Microkatal per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Unit of catalytic activity concentration defined as activity equal to one millionth of katal per one liter of the system volume.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67397</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-03-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2970208</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>pmol/hr/mg protein</VALIDVALUE>
          <VALUEMEANING>Picomole per hour per milligram of protein</VALUEMEANING>
          <MEANINGDESCRIPTION>Picomole per hour per milligram of protein</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3004123</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>nmol/hr/mg protein</VALIDVALUE>
          <VALUEMEANING>Nanomole per hour per milligram of protein</VALUEMEANING>
          <MEANINGDESCRIPTION>Nanomole per hour per milligram of protein</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-01-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3004124</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Trillion/L</VALIDVALUE>
          <VALUEMEANING>Trillion/Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Trillion per Liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3161477</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Billion/L</VALIDVALUE>
          <VALUEMEANING>Billion/Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>Billion per Liter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3161478</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/g</VALIDVALUE>
          <VALUEMEANING>milligram per gram</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of a mass fraction expressed as a number of grams of substance per kilogram of mixture. Gram per kilogram is also used as a dose calculation unit to express a quantity of substance in grams per one kilogram of body mass.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69104</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-12-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3170018</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Minutes</VALIDVALUE>
          <VALUEMEANING>Minute</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit measure of time equal to 60 seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48154</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567660</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/24hr</VALIDVALUE>
          <VALUEMEANING>Milliliter Per Integer::24 Hour Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A measure of volume for a liquid.  A milliliter is approximately 950 times smaller than a quart and 30 times smaller than a fluid ounce.  A milliliter of liquid and a cubic centimeter (cc) of liquid are the same.: For each, generally denoting a ratio.: A number with no fractional part, including the negative and positive numbers as well as zero.::24: In modern usage, an hour is defined as a unit of time 60 minutes, or 3600 seconds in length. It is approximately 1/24 of a median day.: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C25529, C45255::24, C65039, C28254</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3, 4</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3402649</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mU/mL</VALIDVALUE>
          <VALUEMEANING>Milliunit Per Milliliter Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A quantity equivalent to the one thousandth unit (10E-3 unit).: For each, generally denoting a ratio.: A measure of volume for a liquid.  A milliliter is approximately 950 times smaller than a quart and 30 times smaller than a fluid ounce.  A milliliter of liquid and a cubic centimeter (cc) of liquid are the same.: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C28254, C65039, C67315</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3402650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hours</VALIDVALUE>
          <VALUEMEANING>Hour</VALUEMEANING>
          <MEANINGDESCRIPTION>In modern usage, an hour is defined as a unit of time 60 minutes, or 3600 seconds in length. It is approximately 1/24 of a median day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25529</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567650</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cells/kg</VALIDVALUE>
          <VALUEMEANING>Cell Per Kilogram Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>Any small compartment.: For each, generally denoting a ratio.: A basic SI unit of mass. It is definied as the mass of an  international prototype in the form of a platinum-iridium cylinder kept at Sevres in france.   A kilogram is equal to 1,000 grams and 2.2046226 pounds.: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C28252, C65039, C48694</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-03-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3402651</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Copies/mL</VALIDVALUE>
          <VALUEMEANING>Copy per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration of RNA copies expressed as a number of copies per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67441</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-02-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2725041</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2X10E6 Cells</VALIDVALUE>
          <VALUEMEANING>Integer::2 Multiplication Million Cell</VALUEMEANING>
          <MEANINGDESCRIPTION>A number with no fractional part, including the negative and positive numbers as well as zero.::2: An arithmetic operation by which the product of two numbers is computed; the inverse of division.: A natural number following 999999 and preceding 100001 and the quantity that it denotes: one thousand thousand.: The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12508, C67238, C65000, C45255::2</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-05-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3463258</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E10</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 10 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::10: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::10, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624685</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E2</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 2 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::2: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::2, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624686</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E3</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 3 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::3: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C45255::3, C95157, C25709, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 2, 0, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624687</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E5</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 5 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::5: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::5, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624688</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E4</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 4 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::4: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::4, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624689</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E7</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 7 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::7: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::7, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624690</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E6</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 6 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::6: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::6, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624691</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E9</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 9 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::9: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::9, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624692</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E8</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 8 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::8: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::8, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624693</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E12</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 12 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::12: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::12, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624694</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E11</VALIDVALUE>
          <VALUEMEANING>Ten Exponent:11 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::11: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::11, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E14</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 14 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::14: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::14, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624696</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E13</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 13 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::13: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::13, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624697</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E16</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 16 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::16: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::16, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624744</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E15</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 15 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::15: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::15, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624745</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E18</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 18 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::18: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::18, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624747</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E17</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 17 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::17: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::17, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624748</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E20</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 20 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::20: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::20, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624749</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E19</VALIDVALUE>
          <VALUEMEANING>Ten Exponent 19 Unit of Measure</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A mathematical expression that results when e(=2.71828) is raised to it argument&#39;s power.: A number with no fractional part, including the negative and positive numbers as well as zero.::19: A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25709, C45255::19, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-11-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3624750</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2X10E8 Cells</VALIDVALUE>
          <VALUEMEANING>Two times 10E8 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Two times 10 exponential value 8 (one hundred million) cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-05-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3463259</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>2X10E7 Cells</VALIDVALUE>
          <VALUEMEANING>Two times 10E7 Cells</VALUEMEANING>
          <MEANINGDESCRIPTION>Two times 10 exponential value 7 (ten million) cells</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2012-05-29</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3463260</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mL/min/kg</VALIDVALUE>
          <VALUEMEANING>Milliliter per Kilogram per Minute </VALUEMEANING>
          <MEANINGDESCRIPTION>A dose calculation unit expressed in milliliter(s) per kilogram per period of time equal to sixty seconds.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73760</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-01-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3652827</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Log</VALIDVALUE>
          <VALUEMEANING>Logarithm</VALUEMEANING>
          <MEANINGDESCRIPTION>For a specified base b, a function such that its argument results when b is raised to the power given by this function&#39;s value.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C94925</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2013-03-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3703164</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mmol CO/min/kPa</VALIDVALUE>
          <VALUEMEANING>Carbon Monoxide Millimoles per Minute per Kilopascal</VALUEMEANING>
          <MEANINGDESCRIPTION>An odorless, tasteless, poisonous gas, CO, that results from the incomplete combustion of carbon. Inhalation causes central nervous system damage and asphyxiation.: A unit of gas diffusion capacity equal to one millimole per minute per kilopascal.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116242, C76742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5037092</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ml CO/min/mm Hg</VALIDVALUE>
          <VALUEMEANING>Carbon Monoxide Milliliter per Minute per Millimeters of Mercury</VALUEMEANING>
          <MEANINGDESCRIPTION>An odorless, tasteless, poisonous gas, CO, that results from the incomplete combustion of carbon. Inhalation causes central nervous system damage and asphyxiation.: A unit for measuring a pulmonary diffusing capacity expressed in units of gas flow rate (in milliliters per minute) per a unit of pressure (in torrs).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C67417, C76742</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-10-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5037093</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>cm H2O</VALIDVALUE>
          <VALUEMEANING>Centimeters of water</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of pressure defined by a column of water with a height of one centimeter, frequently used to measure central venous pressure, intracranial pressure, and for pressures during mechanical ventilation.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C91060</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-09-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5477037</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>copies/L</VALIDVALUE>
          <VALUEMEANING>Copy Per Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A secondary representation, reproduction, or replica.: A volume unit equal to one liter used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C105515, C67336</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-01-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5637481</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Log10 IU/mL</VALIDVALUE>
          <VALUEMEANING>Log10 International Units per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring international units per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116238</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-04-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5778792</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>ug/mL FEU</VALIDVALUE>
          <VALUEMEANING>Microgram per Milliliter Fibrinogen Equivalent Unit</VALUEMEANING>
          <MEANINGDESCRIPTION>A metric unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one cubic meter. The concept also refers to the metric unit of mass density (volumic mass) defined as the density of a substance which mass equal to one gram occupies the volume of one cubic meter.: A unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of fibrinogen contained within that sample.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C96649, C64572</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2018-10-12</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6479361</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>mg/mmol</VALIDVALUE>
          <VALUEMEANING>Gram per Mole</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of mass commonly used to express the molar mass of a substance in gram(s) per mole.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C73721</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2019-07-31</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6406905</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E-15L (fL)</VALIDVALUE>
          <VALUEMEANING>Ten Exponential Function 15 Liter</VALUEMEANING>
          <MEANINGDESCRIPTION>A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A function of the form f(x) = ab^x, characterized by the fact that the growth rate of such a function is directly proportional to the value of the function.: A number with no fractional part, including the negative and positive numbers as well as zero.::15: The non-SI unit of volume accepted for use with the SI. One liter is equal to cubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or approximately 61.023 744 cubic inches.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48505, C45255::15, C95157, C69122</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2, 3</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-02-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>8057682</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Copies per milliliter</VALIDVALUE>
          <VALUEMEANING>Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A unit of concentration expressed as a number of copies per unit volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100900</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6404378</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Log copies per milliliter</VALIDVALUE>
          <VALUEMEANING>Log10 Copies per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A logarithmic-scale (base 10) unit for measuring copies per unit of volume equal to one milliliter.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117972</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>6405652</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Arbitrary unit per milliliter</VALIDVALUE>
          <VALUEMEANING>Arbitrary Unit Per Milliliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A single undivided thing (unit) based on or subject to individual judgment or preference, and not by necessity, reason, or principle._A volume unit equal to one milliliter used as a denominator to build a derived unit expressed as a ratio. (NCI)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103452, C75765</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2022-07-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>10631416</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>10E9 Cells/microL</VALIDVALUE>
          <VALUEMEANING>10E9 Cells per microliter</VALUEMEANING>
          <MEANINGDESCRIPTION>10E9 Cells per microliter</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2024-09-19</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15128242</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/nL</VALIDVALUE>
          <VALUEMEANING>Per Nanoliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A volume unit equal to one nanoliter used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C116243</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15424813</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>/pL</VALIDVALUE>
          <VALUEMEANING>Per Picoliter</VALUEMEANING>
          <MEANINGDESCRIPTION>A volume unit equal to one picoliter used as a denominator to build a derived unit expressed as a ratio.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C117964</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-12-30</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>15424812</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the unit of measure f</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the unit of measure for serum calcium?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2953097</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedClinicalResult.value (ANY=&gt;PQ.UOM) WHERE PerformedClinicalResult &gt; PerformedObservation &gt; DefinedObservation.nameCode = &quot;Measure Serum Calcium &quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2016r1: Myeloma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964888</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2842777</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Labs</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>General</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000685</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mye_base_srm_ca_diag_uom</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedClinicalResult:value</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpre_lab_diag_serum_calcium_uom</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PCDpre_lab_prep_serum_calcium_uom</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1682">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2954716</PUBLICID>
    <LONGNAME>Plasma Cell Myeloma Chemosensitivity Type</LONGNAME>
    <PREFERREDNAME>2954714v1.0:4771392v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the sensitivity of myeloma to chemotherapy.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2954714</PublicId>
      <PreferredName>PCM_CHMOSTY</PreferredName>
      <PreferredDefinition>A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)_Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better.</PreferredDefinition>
      <LongName>Plasma Cell Myeloma Chemosensitivity</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2842596</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C18919 </PreferredName>
        <Version>1</Version>
        <LongName>Outcome of Therapy</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2647790</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3242</PreferredName>
        <Version>1</Version>
        <LongName>Myeloma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3242</PREFERRED_NAME>
            <LONG_NAME>Multiple Myeloma</LONG_NAME>
            <CON_ID>2202758</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2954712</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71488</PreferredName>
        <Version>1</Version>
        <LongName>Chemosensitivity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71488</PREFERRED_NAME>
            <LONG_NAME>Chemosensitivity</LONG_NAME>
            <CON_ID>2719537</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>4771392</PublicId>
      <PreferredName>4771392v1.0</PreferredName>
      <PreferredDefinition>A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)_Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Plasma Cell Myeloma Chemosensitivity Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008550</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>DZ_RESP</PreferredName>
        <Version>1</Version>
        <LongName>Disease Response</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>4771391</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3242:C71488:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Plasma Cell Myeloma Chemosensitivity Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3242</PREFERRED_NAME>
            <LONG_NAME>Multiple Myeloma</LONG_NAME>
            <CON_ID>2202758</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71488</PREFERRED_NAME>
            <LONG_NAME>Chemosensitivity</LONG_NAME>
            <CON_ID>2719537</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2015-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>no chemotherapy, or chemotherapy ended more than 6 months prior to the preparative regimen.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4771393</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Resistant</VALIDVALUE>
          <VALUEMEANING>Resistant</VALUEMEANING>
          <MEANINGDESCRIPTION>less than 50 percent reduction of Ig level, or less than 90 percent reduction in urinary light chains in light chain only disease, or less than 50 percent reduction of plasma cells in bone marrow for nonsecretory myeloma (includes disease status of SD and PD).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4771394</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sensitive</VALIDVALUE>
          <VALUEMEANING>Sensitive</VALUEMEANING>
          <MEANINGDESCRIPTION>greater than or equal to 50 percent reduction in Ig level, or greater than or equal to 90 percent reduction in urinary light chains in light chain only disease, or greater than or equal to 50 percent reduction of plasma cells in bone marrow for nonsecretory myeloma (includes disease status of sCR, CR, VGPR and PR).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2015-04-03</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>4771395</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the sensitivity of my</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Specify the sensitivity of myeloma to chemotherapy:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2016r1: Myeloma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964888</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>mye_base_chem_sen_prep_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1683">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2957282</PUBLICID>
    <LONGNAME>Radiation Therapy Administered Anatomic Site</LONGNAME>
    <PREFERREDNAME>2013998v1.0:2635301v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A description of the location on or within the human body where radiation was administered.</PREFERREDDEFINITION>
    <VERSION>2</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2013998</PublicId>
      <PreferredName>RT_ADM</PreferredName>
      <PreferredDefinition>information related to radiation therapy administered to a patient.</PreferredDefinition>
      <LongName>Radiation Therapy Administered</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2403872</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15313</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2233610</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25382</PreferredName>
        <Version>1</Version>
        <LongName>Administered</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25382</PREFERRED_NAME>
            <LONG_NAME>Administered</LONG_NAME>
            <CON_ID>2204029</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2635301</PublicId>
      <PreferredName>2635301v2.0</PreferredName>
      <PreferredDefinition>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.: Named locations of, or within, the body</PreferredDefinition>
      <LongName>Radiation Therapy Anatomic Site</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008526</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ANAT_SITES</PreferredName>
        <Version>1</Version>
        <LongName>Anatomic Sites</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>22</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>3108497</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15313:C13717</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Therapy Anatomic Site</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13717</PREFERRED_NAME>
            <LONG_NAME>Anatomic Site</LONG_NAME>
            <CON_ID>2202400</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central Nervous System</VALIDVALUE>
          <VALUEMEANING>Central Nervous System</VALUEMEANING>
          <MEANINGDESCRIPTION>The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12438</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2558476</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Splenic</VALIDVALUE>
          <VALUEMEANING>Spleen</VALUEMEANING>
          <MEANINGDESCRIPTION>An organ that produces lymphocytes, filters the blood, stores blood cells, and destroys those that are aging. It is located on the left side of the abdomen near the stomach. (OCC)</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12432</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567549</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Gonadal</VALIDVALUE>
          <VALUEMEANING>Gonad</VALUEMEANING>
          <MEANINGDESCRIPTION>The part of the reproductive system that produces and releases eggs (ovaries) or sperm (testicles/testes).</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12725</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2007-05-02</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2635303</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other</VALIDVALUE>
          <VALUEMEANING>Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2946060</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Site of residual tumor</VALIDVALUE>
          <VALUEMEANING>Residual Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Remaining or left behind.: (NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C37895, C3262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2957278</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Primary tumor</VALIDVALUE>
          <VALUEMEANING>Primary Neoplasm</VALUEMEANING>
          <MEANINGDESCRIPTION>Occurring first in time or sequence; original. (American Heritage Dictionary): A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25251, C3262</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>1, 0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2011-08-09</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3260877</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinum / chest</VALIDVALUE>
          <VALUEMEANING>Mediastinum And/Or Chest</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of organs surrounded by loose connective tissue, separating the two pleural sacs, between the sternum anteriorly and the vertebral column posteriorly as well as from the thoracic inlet superiorly to the diaphragm inferiorly. The mediastinum contains the heart and pericardium, the bases of the great vessels, the trachea and bronchi, esophagus, thymus, lymph nodes, thoracic duct, phrenic and vagus nerves, and other structures and tissues.: Used to indicate that either or both of two items or options may be valid.: The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25389, C48928, C12748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5935524</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Inguinal</VALIDVALUE>
          <VALUEMEANING>Inguinal Region</VALUEMEANING>
          <MEANINGDESCRIPTION>The lower region of the anterior abdominal wall located laterally to the pubic region.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12726</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2577666</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Cervical spine</VALIDVALUE>
          <VALUEMEANING>Cervical Spine</VALUEMEANING>
          <MEANINGDESCRIPTION>Those vertebrae immediately behind (caudal to) the skull, C1-C7 in man.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C69313</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241892</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Abdominopelvic</VALIDVALUE>
          <VALUEMEANING>Abdomen And Pelvic</VALUEMEANING>
          <MEANINGDESCRIPTION>The cavity located between the lungs and pelvis. It contains the lower esophagus, stomach, pancreas, intestines, liver, gallbladder and spleen._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12767, C37912, C12664</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1, 2</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2017-08-16</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5935525</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Mediastinum</VALIDVALUE>
          <VALUEMEANING>Mediastinum</VALUEMEANING>
          <MEANINGDESCRIPTION>A group of organs surrounded by loose connective tissue, separating the two pleural sacs, between the sternum anteriorly and the vertebral column posteriorly as well as from the thoracic inlet superiorly to the diaphragm inferiorly. The mediastinum contains the heart and pericardium, the bases of the great vessels, the trachea and bronchi, esophagus, thymus, lymph nodes, thoracic duct, phrenic and vagus nerves, and other structures and tissues.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C12748</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2024-07-26</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>5612431</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the site of radiation</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the site of radiation therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify radiation field:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify radiation field:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2957282</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedSubstanceAdministration.targetAnatomicSiteCode WHERE PerformedSubstanceAdministration &gt; DefinedSubstanceAdministration.nameCode = &quot;Administer Radiation Therapy&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify radiation field</Name>
        <DocumentType>Application Standard Question Text</DocumentType>
        <DocumentText>Specify radiation field</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify site of radiation</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify site of radiation</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NMDP Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify site(s) of radiation therapy</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2000r1: Recipient Baseline Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964872</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2026r1: Neuroblastoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964894</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2126r1: Neuroblastoma Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964916</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedSubstanceAdministration:targetAnatomicSiteCode</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>prep_add_rad_cns_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LYMpre_thrpym_rad_thrpy_site</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1684">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2957826</PUBLICID>
    <LONGNAME>Person Valvular Heart Disorder Personal Medical History Ind-3</LONGNAME>
    <PREFERREDNAME>PER_VHD_PMH_IND3</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no/unknown indicator that asks whether there was a history of heart valve disease.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ECOG CRF:Eastern Cooperative Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2957820</PublicId>
      <PreferredName>PER_VHD_PMH</PreferredName>
      <PreferredDefinition>information relating to a valvular heart disorder (any heart disorder characterized by a defect in valve structure or function) and the personal medical history of a person.</PreferredDefinition>
      <LongName>Person Valvular Heart Disorder Personal Medical History</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008571</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CHR_O_ASS_DZ_AND_EXP</PreferredName>
        <Version>1</Version>
        <LongName>Chronic or Associated Diseases and Exposures</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2236731</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25190</PreferredName>
        <Version>1</Version>
        <LongName>Person</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25190</PREFERRED_NAME>
            <LONG_NAME>Person</LONG_NAME>
            <CON_ID>2202486</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2957818</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45525:C18772</PreferredName>
        <Version>1</Version>
        <LongName>Valvular Heart Disorder Personal Medical History</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45525</PREFERRED_NAME>
            <LONG_NAME>Valvular Heart Disorder</LONG_NAME>
            <CON_ID>2689424</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C18772</PREFERRED_NAME>
            <LONG_NAME>Personal Medical History</LONG_NAME>
            <CON_ID>2202879</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506034</PublicId>
      <PreferredName>YES_NO_UNKNOWN_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.</PreferredDefinition>
      <LongName>Yes No Unknown Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>7</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2548260</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38148</PreferredName>
        <Version>1</Version>
        <LongName>Ind-3</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38148</PREFERRED_NAME>
            <LONG_NAME>Yes, No, or Unknown Response</LONG_NAME>
            <CON_ID>2204653</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3241403</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Heart valve disease</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Heart valve disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>LCC Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Valvular abnormalities (regurgitation or stenosis more than mild):</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ECOG Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Pre-existing Valvular Heart Disease</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF_Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Valvulopathy that is severe, moderate, or deemed clinically significant</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF_Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient have valvulopathy that is severe, moderate, or deemed clinically significant?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008587</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>DISEASE</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Leukemia</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811909</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>ECOG-ACRIN</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ECOG-ACRIN</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PER_VHD_PMH_IND3</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>LCC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LCC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1685">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2958544</PUBLICID>
    <LONGNAME>Assessment Head Circumference java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2958438v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Examination of the body by auscultation, palpation, percussion, inspection, and olfaction.  (Taber&quot;s)_A circumferential measurement of the head at the widest point, which is traditionally above the eyebrows._Generic value domain for a primitive java dataype that is an Integer (32-bit two&quot;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NICHD</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2958438</PublicId>
      <PreferredName>2411342v1.0:2958359v1.0</PreferredName>
      <PreferredDefinition>Examination of the body by auscultation, palpation, percussion, inspection, and olfaction.  (Taber&#39;s)_A circumferential measurement of the head at the widest point, which is traditionally above the eyebrows.</PreferredDefinition>
      <LongName>Assessment Head Circumference</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2411342</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20989</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2958359</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C81255</PreferredName>
        <Version>1</Version>
        <LongName>Head Circumference</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C81255</PREFERRED_NAME>
            <LONG_NAME>Head Circumference</LONG_NAME>
            <CON_ID>2958283</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Assessment Head Circumference java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Assessment Head Circumference java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PhysicalExam:headCircumference</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NewbornExamClasses.PhysicalExam.headCircumference</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1686">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2964601</PUBLICID>
    <LONGNAME>Laboratory Test Result Unit of Measure Code System Version java.lang.String</LONGNAME>
    <PREFERREDNAME>2964544v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The outcome of a laboratory test.:A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds._A systematized collection of concepts that define corresponding codes.:A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2964544</PublicId>
      <PreferredName>2964513v1.0:2715140v1.0</PreferredName>
      <PreferredDefinition>The outcome of a laboratory test.:A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds._A systematized collection of concepts that define corresponding codes.:A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications.</PreferredDefinition>
      <LongName>Laboratory Test Result Unit of Measure Code System Version</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2964513</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C36292:C25709</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Test Result Unit of Measure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C36292</PREFERRED_NAME>
            <LONG_NAME>Laboratory Test Result</LONG_NAME>
            <CON_ID>2451822</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25709</PREFERRED_NAME>
            <LONG_NAME>Unit of Measure</LONG_NAME>
            <CON_ID>2203864</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2715140</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C70895:C25714</PreferredName>
        <Version>1</Version>
        <LongName>Code System Version</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70895</PREFERRED_NAME>
            <LONG_NAME>Code System</LONG_NAME>
            <CON_ID>2715008</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Laboratory Test Result Unit of Measure Code System Version java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Laboratory Test Result Unit of Measure Code System Version java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2964508</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>LabViewer</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.labhub.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000318</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.labhub.domain.LabResultUnitOfMeasure.codeSystemVersion</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LabResultUnitOfMeasure:codeSystemVersion</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1687">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2965486</PUBLICID>
    <LONGNAME>Radiation Therapy Fractionation Therapeutic Procedure Schedule Type</LONGNAME>
    <PREFERREDNAME>2953089v1.0:2965293v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._Dividing the total dose of radiation therapy into several smaller, equal doses delivered over a period of several days._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._An ordered list of times at which things are planned to occur._Something distinguishable as an identifiable class based on common qualities.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2953089</PublicId>
      <PreferredName>RADTHER_FRAC</PreferredName>
      <PreferredDefinition>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._Dividing the total dose of radiation therapy into several smaller, equal doses delivered over a period of several days.</PreferredDefinition>
      <LongName>Radiation Therapy Fractionation</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2403872</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15313</PreferredName>
        <Version>1</Version>
        <LongName>Radiation Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15313</PREFERRED_NAME>
            <LONG_NAME>Radiation Therapy</LONG_NAME>
            <CON_ID>2202467</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2953087</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15654</PreferredName>
        <Version>1</Version>
        <LongName>Fractionation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15654</PREFERRED_NAME>
            <LONG_NAME>Fractionated Radiotherapy</LONG_NAME>
            <CON_ID>2203815</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2965293</PublicId>
      <PreferredName>THERP_PR_SCHED_TP</PreferredName>
      <PreferredDefinition>An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._An ordered list of times at which things are planned to occur._Something distinguishable as an identifiable class based on common qualities.</PreferredDefinition>
      <LongName>Therapeutic Procedure Schedule Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>60</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2965292</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49236:C25211:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Therapeutic Procedure Schedule Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49236</PREFERRED_NAME>
            <LONG_NAME>Therapeutic Procedure</LONG_NAME>
            <CON_ID>2467309</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25211</PREFERRED_NAME>
            <LONG_NAME>Schedule</LONG_NAME>
            <CON_ID>2203792</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Single</VALIDVALUE>
          <VALUEMEANING>Once</VALUEMEANING>
          <MEANINGDESCRIPTION>One time.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C64576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2965297</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Single Daily</VALIDVALUE>
          <VALUEMEANING>Once Daily</VALUEMEANING>
          <MEANINGDESCRIPTION>One time.: Occurring or done each day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25473, C64576</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2965296</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Multiple daily</VALIDVALUE>
          <VALUEMEANING>Multiple Daily</VALUEMEANING>
          <MEANINGDESCRIPTION>many copies of or many forms: Occurring or done each day.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25473, C17648</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2965295</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other schedule</VALIDVALUE>
          <VALUEMEANING>Other Schedule</VALUEMEANING>
          <MEANINGDESCRIPTION>Different than the one(s) previously specified or mentioned.: A schedule is an ordered list of times at which things are planned to occur.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C25211, C17649</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2009-12-08</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2965294</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the fractional sched</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the fractional schedule of radiation therapy?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Fractionation schedule</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Fractionation schedule</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify fractionation schedule:</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify fractionation schedule:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2965486</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>PerformedProcedure &gt; DefinedSubstanceAdministration.doseFrequecyCode WHERE DefinedActivity.nameCode = &quot;Perform Fractionation&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2025r1: Central Nervous System Tumor Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964893</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2022r1: Testicular / Germ Cell Cancer Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964899</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2125r1: Central Nervous System Tumor Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964915</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2842912</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Therapy</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Radiation</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2842914</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cns_base_tx_rad_frac_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cns_post_tx_rad_frac_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>cns_post_tx_rlps_frac_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>tc_base_tx_rad_frac_kn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DefinedSubstanceAdministration:doseFrequencyCode</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1688">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2968218</PUBLICID>
    <LONGNAME>Classification Scheme Administered Item Current Version Indicator java.lang.String</LONGNAME>
    <PREFERREDNAME>2552482v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The descriptive information for an arrangement or division of objects into groups based on characteristics that the objects have in common.  (ISO 11179):A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_Occurring in or belonging to the present time.:Version; something a little different from others of the same type; one of a sequence of copies of a program, each incorporating new modifications.:An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)_Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2552482</PublicId>
      <PreferredName>2231652v1.0:2400225v1.0</PreferredName>
      <PreferredDefinition>The descriptive information for an arrangement or division of objects into groups based on characteristics that the objects have in common.  (ISO 11179):A registry item for which administrative information is recorded in an Administration Record. (ISO 11179)_Occurring in or belonging to the present time.:Version; something a little different from others of the same type; one of a sequence of copies of a program, each incorporating new modifications.:An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)</PreferredDefinition>
      <LongName>Classification Scheme Administered Item Current Version Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2231652</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41079:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Classification Scheme Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41079</PREFERRED_NAME>
            <LONG_NAME>Classification Scheme</LONG_NAME>
            <CON_ID>2231557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2400225</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25471:C25714:C25180</PreferredName>
        <Version>1</Version>
        <LongName>Current Version Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25471</PREFERRED_NAME>
            <LONG_NAME>Current</LONG_NAME>
            <CON_ID>2202334</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25714</PREFERRED_NAME>
            <LONG_NAME>Version</LONG_NAME>
            <CON_ID>2203981</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Classification Scheme Administered Item Current Version Indicator java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Classification Scheme Administered Item Current Version Indicator java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.ClassificationScheme.latestVersionIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ClassificationScheme:latestVersionIndicator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1689">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2968238</PUBLICID>
    <LONGNAME>Classification Scheme Item Administered Item Modified By java.lang.String</LONGNAME>
    <PREFERREDNAME>2967763v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A component of content in a Classification Scheme. This may be a node in a taxonomy or ontology or a term in a thesaurus, etc.:A registry item for which administrative information is recorded in an Administration Record._Indicates the person or authoritative body who changed an item._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2967763</PublicId>
      <PreferredName>2967431v1.0:2231612v1.0</PreferredName>
      <PreferredDefinition>A component of content in a Classification Scheme. This may be a node in a taxonomy or ontology or a term in a thesaurus, etc.:A registry item for which administrative information is recorded in an Administration Record._Indicates the person or authoritative body who changed an item.</PreferredDefinition>
      <LongName>Classification Scheme Item Administered Item Modified By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2967431</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41080:C42613</PreferredName>
        <Version>1</Version>
        <LongName>Classification Scheme Item Administered Item</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41080</PREFERRED_NAME>
            <LONG_NAME>Classification Scheme Item</LONG_NAME>
            <CON_ID>2231565</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42613</PREFERRED_NAME>
            <LONG_NAME>Administered Item</LONG_NAME>
            <CON_ID>2231545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231612</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42629</PreferredName>
        <Version>1</Version>
        <LongName>Modified By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42629</PREFERRED_NAME>
            <LONG_NAME>Modified By</LONG_NAME>
            <CON_ID>2231552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Classification Scheme Item Administered Item Modified By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Classification Scheme Item Administered Item Modified By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2967376</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caDSR</PreferredName>
          <Version>4</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cadsr.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000553</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cadsr.domain.ClassificationSchemeItem.modifiedBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ClassificationSchemeItem:modifiedBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1690">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2969347</PUBLICID>
    <LONGNAME>Calculation Code Value java.lang.String</LONGNAME>
    <PREFERREDNAME>2969267v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The procedure or activity of determining something by mathematical or logical methods._A system, often of numbered categories, used for representation of data.:The information contained in a data field.  It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2969267</PublicId>
      <PreferredName>2750194v1.0:2750148v1.0</PreferredName>
      <PreferredDefinition>The procedure or activity of determining something by mathematical or logical methods._A system, often of numbered categories, used for representation of data.:The information contained in a data field.  It may represent a numeric quantity, a textual characterization, a date or time measurement, or some other state, depending on the nature of the attribute.</PreferredDefinition>
      <LongName>Calculation Code Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2750194</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C54125</PreferredName>
        <Version>1</Version>
        <LongName>Calculation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C54125</PREFERRED_NAME>
            <LONG_NAME>Calculation</LONG_NAME>
            <CON_ID>2654477</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2750148</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25162:C49100</PreferredName>
        <Version>1</Version>
        <LongName>Code Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25162</PREFERRED_NAME>
            <LONG_NAME>Code</LONG_NAME>
            <CON_ID>2203865</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49100</PREFERRED_NAME>
            <LONG_NAME>Data Value</LONG_NAME>
            <CON_ID>2463853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Calculation Code Value java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Calculation Code Value java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2614824</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>AIM 3.0</PreferredName>
          <Version>3</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.radiology.AIM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000056</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Calculation:codeValue</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.radiology.AIM.Calculation.codeValue</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1691">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2979195</PUBLICID>
    <LONGNAME>Chemotherapy Last Cycle Begin Date</LONGNAME>
    <PREFERREDNAME>2979193v1.0:2557783v2.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The month, day, and year the last chemotherapy cycle began.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2979193</PublicId>
      <PreferredName>2404910v1.0:2207209v1.0</PreferredName>
      <PreferredDefinition>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term is used to describe any therapy involving the use of chemical-based agents, it is particularly used to refer to the use of chemical-based agents to treat cancer. Antineoplastic chemotherapy works by arresting or killing the growth and spread of cancer cells. Chemotherapy may also include agents that enhance immune function or alter hormonal activity._Coming after all others in time or space or degree or being the only one remaining._An event or sequence of events that constitute a round or succession of observable phenomena, recurring usually at regular or approximately regular time intervals and in the same sequence.</PreferredDefinition>
      <LongName>Chemotherapy Last Cycle</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2404910</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15632</PreferredName>
        <Version>1</Version>
        <LongName>Chemotherapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15632</PREFERRED_NAME>
            <LONG_NAME>Chemotherapy</LONG_NAME>
            <CON_ID>2202708</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207209</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25551:C25472</PreferredName>
        <Version>1</Version>
        <LongName>Last Cycle</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25551</PREFERRED_NAME>
            <LONG_NAME>Last</LONG_NAME>
            <CON_ID>2206286</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25472</PREFERRED_NAME>
            <LONG_NAME>Cycle</LONG_NAME>
            <CON_ID>2202487</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2557783</PublicId>
      <PreferredName>BEG_DT</PreferredName>
      <PreferredDefinition>Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins._The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Begin Date</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008561</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>OCURS</PreferredName>
        <Version>1</Version>
        <LongName>Occurrences</LongName>
      </ConceptualDomain>
      <Datatype>DATE</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <DisplayFormat>YYYY-MM-DD</DisplayFormat>
      <MaximumLength>10</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2208020</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25431:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Begin Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25431</PREFERRED_NAME>
            <LONG_NAME>Begin</LONG_NAME>
            <CON_ID>2206163</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Specify the date the last chemotherapy cycle began</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Specify the date the last chemotherapy cycle began</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What was the date of the last</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What was the date of the last chemotherapy cycle?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>BRIDG mapping path for CDE:2979195</Name>
        <DocumentType>BRIDG Mapping Path</DocumentType>
        <DocumentText>MAXIMUM PerformedProcedure.dateRange WHERE PerformedProcedure &gt; DefinedSubstanceAdministration.categoryCode = &quot;Administer Chemotherapy&quot;</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2026r1: Neuroblastoma Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964894</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3553940</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Version 3.2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4133055</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6685474</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>ANNA for BRIDG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Training Set</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6685476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>neu_base_chm_lcyc_str_dte</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PerformedProcedure:dateRange</AlternateName>
        <AlternateNameType>HCT_BRIDG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1692">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2985994</PUBLICID>
    <LONGNAME>Microarray Observation Activity Status java.lang.String</LONGNAME>
    <PREFERREDNAME>2985951v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.:Watching something and taking note of what happens._The state of being active; any specific activity.:A condition or state at a particular time._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2985951</PublicId>
      <PreferredName>2830093v1.0:2513283v1.0</PreferredName>
      <PreferredDefinition>A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.:Watching something and taking note of what happens._The state of being active; any specific activity.:A condition or state at a particular time.</PreferredDefinition>
      <LongName>Microarray Observation Activity Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2830093</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C44282:C25598</PreferredName>
        <Version>1</Version>
        <LongName>Microarray Observation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C44282</PREFERRED_NAME>
            <LONG_NAME>Microarray</LONG_NAME>
            <CON_ID>2223237</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25598</PREFERRED_NAME>
            <LONG_NAME>Observation Activity</LONG_NAME>
            <CON_ID>2224011</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2513283</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43431:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Activity Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Microarray Observation Activity Status java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Microarray Observation Activity Status java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2619399</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caElmir</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.ucdavis.caelmir.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2830086</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.ucdavis.caelmir.domain.MicroarrayObservation.activityStatus</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>MicroarrayObservation:activityStatus</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1693">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2990801</PUBLICID>
    <LONGNAME>Clinical Trial Epoch Randomization Flag java.lang.Boolean</LONGNAME>
    <PREFERREDNAME>2990590v1.0:2178538v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A portion of the study containing one or more study segments with a consistent objective such as screening subjects or treating disease._The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.:An indicator that can be set or unset in order to signal whether a particular condition is true._Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2990590</PublicId>
      <PreferredName>2732749v1.0:2990529v1.0</PreferredName>
      <PreferredDefinition>A portion of the study containing one or more study segments with a consistent objective such as screening subjects or treating disease._The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.:An indicator that can be set or unset in order to signal whether a particular condition is true.</PreferredDefinition>
      <LongName>Clinical Trial Epoch Randomization Flag</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2732749</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C71738</PreferredName>
        <Version>1</Version>
        <LongName>Clinical Trial Epoch</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C71738</PREFERRED_NAME>
            <LONG_NAME>Clinical Trial Epoch</LONG_NAME>
            <CON_ID>2732738</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2990529</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25196:C43578</PreferredName>
        <Version>1</Version>
        <LongName>Randomization Flag</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25196</PREFERRED_NAME>
            <LONG_NAME>Randomization</LONG_NAME>
            <CON_ID>2202624</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43578</PREFERRED_NAME>
            <LONG_NAME>Flag</LONG_NAME>
            <CON_ID>2223213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178538</PublicId>
      <PreferredName>java.lang.Boolean</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PreferredDefinition>
      <LongName>java.lang.Boolean</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Boolean</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Clinical Trial Epoch Randomization Flag java.lang.Boolean does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Clinical Trial Epoch Randomization Flag java.lang.Boolean does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.duke.cabig.c3pr.domain.Epoch.randomizedIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Epoch:randomizedIndicator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1694">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>2998272</PUBLICID>
    <LONGNAME>Funding Sponsor Identifier java.lang.Integer</LONGNAME>
    <PREFERREDNAME>2992946v1.0:2178537v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A sum of money or other resources set aside for a specific purpose.:A person or organization that supports or champions something._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2992946</PublicId>
      <PreferredName>2992585v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>A sum of money or other resources set aside for a specific purpose.:A person or organization that supports or champions something._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Funding Sponsor Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2992585</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17769:C48355</PreferredName>
        <Version>1</Version>
        <LongName>Funding Sponsor</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17769</PREFERRED_NAME>
            <LONG_NAME>Funding</LONG_NAME>
            <CON_ID>2514003</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48355</PREFERRED_NAME>
            <LONG_NAME>Sponsor</LONG_NAME>
            <CON_ID>2448403</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178537</PublicId>
      <PreferredName>java.lang.Integer</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is an Integer (32-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Integer</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Integer</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Funding Sponsor Identifier java.lang.Integer does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Funding Sponsor Identifier java.lang.Integer does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2747429</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caAERS</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.cabig.caaers.domain</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000413</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.cabig.caaers.domain.FundingSponsor.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>FundingSponsor:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1695">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3007035</PUBLICID>
    <LONGNAME>Clinical or Research Activity Performed Activity Occurrence Date java.util.Date</LONGNAME>
    <PREFERREDNAME>3007021v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Any specific activity undertaken during the course of a clinical study or research protocol.:Executed and carried through to completion._An action taken in pursuit of an objective; the state of being active.:An instance of something happening, such as an event or incident.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3007021</PublicId>
      <PreferredName>3006997v1.0:2964953v1.0</PreferredName>
      <PreferredDefinition>Any specific activity undertaken during the course of a clinical study or research protocol.:Executed and carried through to completion._An action taken in pursuit of an objective; the state of being active.:An instance of something happening, such as an event or incident.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Clinical or Research Activity Performed Activity Occurrence Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3006997</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16203:C38000</PreferredName>
        <Version>1</Version>
        <LongName>Clinical or Research Activity Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16203</PREFERRED_NAME>
            <LONG_NAME>Clinical or Research Activity</LONG_NAME>
            <CON_ID>2222474</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2964953</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43431:C25275:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Activity Occurrence Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43431</PREFERRED_NAME>
            <LONG_NAME>Activity</LONG_NAME>
            <CON_ID>2222740</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25275</PREFERRED_NAME>
            <LONG_NAME>Occurrence</LONG_NAME>
            <CON_ID>2203940</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Clinical or Research Activity Performed Activity Occurrence Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Clinical or Research Activity Performed Activity Occurrence Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2672769</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PSC</PreferredName>
          <Version>2.6</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>edu.northwestern.bioinformatics.studycalendar.domain.scheduledactivitystate</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>10000051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.northwestern.bioinformatics.studycalendar.domain.scheduledactivitystate.Occurred.date</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Occurred:date</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1696">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3014244</PUBLICID>
    <LONGNAME>Moderate Exercise Physical Activity Assessment Scale</LONGNAME>
    <PREFERREDNAME>2202081v1.0:3014236v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Response to an inquiry about a person&#39;s level of activity on a typical day and health limits in the performance of moderate activities.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2202081</PublicId>
      <PreferredName>MODEX_PHYSACT_ASSESS</PreferredName>
      <PreferredDefinition>information relating to a physical activity assessment involving moderate exercise.</PreferredDefinition>
      <LongName>Moderate Exercise Physical Activity Assessment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2211696</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>CL323823:C0221187</PreferredName>
        <Version>1</Version>
        <LongName>Moderate Exercise Physical Activity</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL323823</PREFERRED_NAME>
            <LONG_NAME>Moderate Exercise</LONG_NAME>
            <CON_ID>2211695</CON_ID>
            <DEFINITION_SOURCE>NCI04</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C0221187</PREFERRED_NAME>
            <LONG_NAME>Physical Activity</LONG_NAME>
            <CON_ID>2203293</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>UMLS_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2177637</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>Assessment</PreferredName>
        <Version>1</Version>
        <LongName>Assessment</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20989</PREFERRED_NAME>
            <LONG_NAME>Physical Examination</LONG_NAME>
            <CON_ID>2202921</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3014236</PublicId>
      <PreferredName>3014236v1.0</PreferredName>
      <PreferredDefinition>the scale to determine the patient&#39;s physical activity._Any form of exercise or movement. Physical activity may include planned activity such as walking, running, basketball, or other sports. Physical activity may also include other daily activities such as household chores, yard work, walking the dog, etc.</PreferredDefinition>
      <LongName>Physical Activity Scale</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008553</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>QOL</PreferredName>
        <Version>1</Version>
        <LongName>Quality of Life</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>30</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3014235</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17708:C25664</PreferredName>
        <Version>1</Version>
        <LongName>Physical Activity Scale</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17708</PREFERRED_NAME>
            <LONG_NAME>Physical Activity</LONG_NAME>
            <CON_ID>2202366</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25664</PREFERRED_NAME>
            <LONG_NAME>Scale</LONG_NAME>
            <CON_ID>2203964</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not reported</VALIDVALUE>
          <VALUEMEANING>Not Stated</VALUEMEANING>
          <MEANINGDESCRIPTION>Not provided or available.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C43234</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-02-21</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2964573</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No, not limited at all</VALIDVALUE>
          <VALUEMEANING>NO, NOT LIMITED AT ALL</VALUEMEANING>
          <MEANINGDESCRIPTION>NO, NOT LIMITED AT ALL</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561179</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, limited a little</VALIDVALUE>
          <VALUEMEANING>YES, LIMITED A LITTLE</VALUEMEANING>
          <MEANINGDESCRIPTION>YES, LIMITED A LITTLE</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561178</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes, limited a lot</VALIDVALUE>
          <VALUEMEANING>YES, LIMITED A LOT</VALUEMEANING>
          <MEANINGDESCRIPTION>YES, LIMITED A LOT</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2005-03-25</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2561177</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Moderate activities, such as</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling or golf</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2760132</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMatch</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HOW Trial</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2988352</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2760132</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caMatch</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>My Health as of Today</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3009818</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1697">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3021135</PUBLICID>
    <LONGNAME>Eye Examination Under Anesthesia Performed Indicator</LONGNAME>
    <PREFERREDNAME>3021064v1.0:2784450v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The indicator that describes whether or not an eye exam was performed under anesthesia.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3021064</PublicId>
      <PreferredName>3020990v1.0:2241241v1.0</PreferredName>
      <PreferredDefinition>A test performed by an ophthalmologist or optometrist assessing vision and ability to focus on and discern objects, as well as other tests and examinations pertaining to the eyes._A medical inspection, qualified according to the methods employed, as physical examination, radiologic examination, diagnostic imaging examination, etc., performed under conditions of patient&#39;s complete or partial local or general insensibility to pain with or without the loss of consciousness, induced by an anesthetic agent or by non-pharmacological anesthesia technique._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Eye Examination Under Anesthesia Performed</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3020990</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38060:C40971</PreferredName>
        <Version>1</Version>
        <LongName>Eye Examination Examination Under Anesthesia</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38060</PREFERRED_NAME>
            <LONG_NAME>Eye Examination</LONG_NAME>
            <CON_ID>2831577</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C40971</PREFERRED_NAME>
            <LONG_NAME>Examination Under Anesthesia</LONG_NAME>
            <CON_ID>2831411</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784450</PublicId>
      <PreferredName>Y_N_U_ND_NA_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.</PreferredDefinition>
      <LongName>Yes No Unk ND NA Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>25</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784449</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49488:C49487:C17998:C49484:C4</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Unknown Not Done Not Applicable Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49488</PREFERRED_NAME>
            <LONG_NAME>Yes</LONG_NAME>
            <CON_ID>2451557</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>5</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49487</PREFERRED_NAME>
            <LONG_NAME>No</LONG_NAME>
            <CON_ID>2451556</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17998</PREFERRED_NAME>
            <LONG_NAME>Unknown</LONG_NAME>
            <CON_ID>2202475</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49484</PREFERRED_NAME>
            <LONG_NAME>Not Done</LONG_NAME>
            <CON_ID>2480549</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48660</PREFERRED_NAME>
            <LONG_NAME>Not Applicable</LONG_NAME>
            <CON_ID>2428103</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567168</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2567170</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Applicable</VALIDVALUE>
          <VALUEMEANING>Not applicable</VALUEMEANING>
          <MEANINGDESCRIPTION>Determination of a value is not relevant in the current context.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C48660</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2581003</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Not Done</VALIDVALUE>
          <VALUEMEANING>Not Done: C49484</VALUEMEANING>
          <MEANINGDESCRIPTION>Indicates a task, process or examination that has either not been initiated or completed.
</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49484</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2008-09-11</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2579172</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Did the recipient undergo an opthalmologic exam under anesthesia?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Did the recipient undergo an opthalmologic exam under anesthesia?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Was an ophthalmologic exam pe</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Was an ophthalmologic exam performed under anesthesia?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was diagnostic EUA performed within 14 days prior to study entry?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>COG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Was Exam Under Anesthesia (EUA) done?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2038r1: Mucopolysaccharidosis and Other Storage Diseases Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964898</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2138r1: Mucopolysaccharidosis and Other Storage Diseases Post-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964919</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2961451</PublicId>
          <ContextName>COG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>COG</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Statistics and Data Center</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2961452</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>muc_base_opth_ex_anest_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>muc_post_opth_ex_anest_yn</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>COG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DxEUAPfm</AlternateName>
        <AlternateNameType>COG GDE Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>COG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>EUA_DONE_IND</AlternateName>
        <AlternateNameType>COG Form Element</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1698">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3021900</PUBLICID>
    <LONGNAME>Pills Negation Taken Count</LONGNAME>
    <PREFERREDNAME>3021898v1.0:2018392v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the quantity related to missed pills.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCIC CRF:National Cancer Institute of Canada Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3021898</PublicId>
      <PreferredName>2458719v1.0:2207787v1.0</PreferredName>
      <PreferredDefinition>information related to missed medication.</PreferredDefinition>
      <LongName>Pills Negation Taken</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2458719</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25394</PreferredName>
        <Version>1</Version>
        <LongName>Pills</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25394</PREFERRED_NAME>
            <LONG_NAME>Pill Dosage Form</LONG_NAME>
            <CON_ID>2202784</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2207787</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25594:C25701</PreferredName>
        <Version>1</Version>
        <LongName>Not Taken</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25594</PREFERRED_NAME>
            <LONG_NAME>Negation</LONG_NAME>
            <CON_ID>2204956</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25701</PREFERRED_NAME>
            <LONG_NAME>Taken</LONG_NAME>
            <CON_ID>2203968</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCIC CRF:National Cancer Institute of Canada Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2018392</PublicId>
      <PreferredName>CT</PreferredName>
      <PreferredDefinition>The quantity of the specified item.</PreferredDefinition>
      <LongName>Count</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008541</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>NUMS</PreferredName>
        <Version>1</Version>
        <LongName>Numbers</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>2</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace>0</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2261845</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25463</PreferredName>
        <Version>1</Version>
        <LongName>Count</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25463</PREFERRED_NAME>
            <LONG_NAME>Count</LONG_NAME>
            <CON_ID>2202368</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>How many pills does the subje</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>How many pills does the subject report having missed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText># Tabs missed</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CCTG_01</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If no, how many pills does the participant report having missed during this reporting period?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>CCTG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>SUPPEC_QVAL_TXMISSED</AlternateName>
        <AlternateNameType>OID, CCTG</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1699">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3056164</PUBLICID>
    <LONGNAME>Serum Beta-2-Microglobulin Protein Laboratory Procedure Performed Outcome Integer::2 Decimal Place Value</LONGNAME>
    <PREFERREDNAME>2861049v1.0:2784513v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The 2 decimal place numeric laboratory value measured, assigned or computed related to the assessment of serum beta 2 microglobulin in a specimen.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NHLBI</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NMDP:National Marrow Donor Program</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2861049</PublicId>
      <PreferredName>2861047v1.0:2828214v1.0</PreferredName>
      <PreferredDefinition>The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins._Beta-2-microglobulin protein (119 aa, ~14 kDa) is encoded by the human B2M gene. This protein plays a role in immune responses and is a key component of major histocompatibility complex class I molecules. The protein is localized to the surface of cells and is utilized as a prognostic marker in persons with cancers that involve white blood cells. The polypeptide is also used as a marker in kidney damage diagnosis and in the detection of viral infection._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.</PreferredDefinition>
      <LongName>Serum Beta-2-Microglobulin Protein Laboratory Procedure Performed</LongName>
      <Version>2</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2861047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13325:C62657:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Serum Beta-2-Microglobulin Protein Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13325</PREFERRED_NAME>
            <LONG_NAME>Serum</LONG_NAME>
            <CON_ID>2203797</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62657</PREFERRED_NAME>
            <LONG_NAME>Beta-2-Microglobulin</LONG_NAME>
            <CON_ID>2525592</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2241241</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38000</PreferredName>
        <Version>1</Version>
        <LongName>Performed</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38000</PREFERRED_NAME>
            <LONG_NAME>Performed</LONG_NAME>
            <CON_ID>2203950</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NMDP:National Marrow Donor Program</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2784513</PublicId>
      <PreferredName>LAB_PROC_OUT_2DP_VAL</PreferredName>
      <PreferredDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Outcome; a phenomenon that follows and is caused by some previous phenomenon._A number with no fractional part, including the negative and positive numbers as well as zero.::2_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.</PreferredDefinition>
      <LongName>Laboratory Procedure Outcome Integer::2 Decimal Place Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008557</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>LAB_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Lab Results</LongName>
      </ConceptualDomain>
      <Datatype>NUMBER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace>2</DecimalPlace>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2784512</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25294:C20200:C45255::2:C42646</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Procedure Outcome Integer::2 Decimal Place Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45255</PREFERRED_NAME>
            <LONG_NAME>Integer</LONG_NAME>
            <CON_ID>2433736</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42646</PREFERRED_NAME>
            <LONG_NAME>Decimal Place</LONG_NAME>
            <CON_ID>2555336</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25712</PREFERRED_NAME>
            <LONG_NAME>Value</LONG_NAME>
            <CON_ID>2203990</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the value for serum b</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>What is the value for serum beta 2 microglobulin?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>What is the value for serum ß2 microglobulin?</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>What is the value for serum ß2 microglobulin?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2695319</PublicId>
          <ContextName>NHLBI</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NMDP: CDEs to review</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>2017r1: Amyloidosis Pre-HSCT Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Case Report Form</ClassificationSchemeItemType>
        <CsiPublicId>2964889</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NHLBI</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>amy_base_serumb2_diag_rst</AlternateName>
        <AlternateNameType>NMDP_FN</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1700">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3098957</PUBLICID>
    <LONGNAME>Colon Adenocarcinoma Peritoneal Surface Disseminate Type</LONGNAME>
    <PREFERREDNAME>3091418v1.0:3098953v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the type as related to the mode of presentation of peritoneal surface of an adenocarcinoma arising from the colon.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3091418</PublicId>
      <PreferredName>3091415v1.0:3091416v1.0</PreferredName>
      <PreferredDefinition>information related to the mode of presentation of peritoneal surface of an adenocarcinoma arising from the colon.</PreferredDefinition>
      <LongName>Colon Adenocarcinoma Peritoneal Surface Disseminate</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3091415</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C4349</PreferredName>
        <Version>1</Version>
        <LongName>Colon Adenocarcinoma</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C4349</PREFERRED_NAME>
            <LONG_NAME>Colon Adenocarcinoma</LONG_NAME>
            <CON_ID>2923205</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3091416</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25313:C25245:C28222</PreferredName>
        <Version>1</Version>
        <LongName>Peritoneal Surface Disseminate</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25313</PREFERRED_NAME>
            <LONG_NAME>Peritoneal</LONG_NAME>
            <CON_ID>2204854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25245</PREFERRED_NAME>
            <LONG_NAME>Surface</LONG_NAME>
            <CON_ID>2203807</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C28222</PREFERRED_NAME>
            <LONG_NAME>Disseminate</LONG_NAME>
            <CON_ID>2873896</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3098953</PublicId>
      <PreferredName>3098953v1.0</PreferredName>
      <PreferredDefinition>the type as related to mode of presentation of peritoneal surface dissemination of colon adenocarcinoma</PreferredDefinition>
      <LongName>Colon Adenocarcinoma Peritoneal Surface Disseminate Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>35</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Metachronous</VALIDVALUE>
          <VALUEMEANING>Metachronous</VALUEMEANING>
          <MEANINGDESCRIPTION>Metachronous</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3098954</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Synchronous</VALIDVALUE>
          <VALUEMEANING>Synchronous</VALUEMEANING>
          <MEANINGDESCRIPTION>Synchronous</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-05-24</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3098955</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Mode of presentation of perit</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Mode of presentation of peritoneal surface dissemination of colon adenocarcinoma</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1701">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101060</PUBLICID>
    <LONGNAME>Chemical Compound Created By java.lang.String</LONGNAME>
    <PREFERREDNAME>3099831v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties.:A substance formed by chemical union of two or more elements or ingredients in definite proportion by weight._Indicates the person or authoritative body who brought the item into existence._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3099831</PublicId>
      <PreferredName>3099563v1.0:2231611v1.0</PreferredName>
      <PreferredDefinition>A substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties.:A substance formed by chemical union of two or more elements or ingredients in definite proportion by weight._Indicates the person or authoritative body who brought the item into existence.</PreferredDefinition>
      <LongName>Chemical Compound Created By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099563</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C48807:C43366</PreferredName>
        <Version>1</Version>
        <LongName>Chemical Compound</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C48807</PREFERRED_NAME>
            <LONG_NAME>Chemical</LONG_NAME>
            <CON_ID>2523382</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43366</PREFERRED_NAME>
            <LONG_NAME>Compound</LONG_NAME>
            <CON_ID>2236539</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42628</PreferredName>
        <Version>1</Version>
        <LongName>Created By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42628</PREFERRED_NAME>
            <LONG_NAME>Created By</LONG_NAME>
            <CON_ID>2231551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Chemical Compound Created By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Chemical Compound Created By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.ChemicalCompound.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ChemicalCompound:createdBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1702">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101095</PUBLICID>
    <LONGNAME>Laboratory Supplies Display Name java.lang.String</LONGNAME>
    <PREFERREDNAME>3099861v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.:Goods for the support and maintenance of some endeavor._Exhibit, present, or demonstrate for viewing.:The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3099861</PublicId>
      <PreferredName>3099572v1.0:2231629v1.0</PreferredName>
      <PreferredDefinition>A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.:Goods for the support and maintenance of some endeavor._Exhibit, present, or demonstrate for viewing.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Laboratory Supplies Display Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099572</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37984:C60759</PreferredName>
        <Version>1</Version>
        <LongName>Laboratory Supplies</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37984</PREFERRED_NAME>
            <LONG_NAME>Laboratory</LONG_NAME>
            <CON_ID>2202883</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C60759</PREFERRED_NAME>
            <LONG_NAME>Supplies</LONG_NAME>
            <CON_ID>2922995</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231629</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25485:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Display Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25485</PREFERRED_NAME>
            <LONG_NAME>Display</LONG_NAME>
            <CON_ID>2203905</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Laboratory Supplies Display Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Laboratory Supplies Display Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>LabSupply:displayName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.LabSupply.displayName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1703">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101487</PUBLICID>
    <LONGNAME>Carbohydrate Identifier java.lang.Long</LONGNAME>
    <PREFERREDNAME>3100244v1.0:2178534v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The largest class of organic compounds, including starches, glycogens, cellulose, gums, and simple sugars. Carbohydrates are composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. (MeSH)_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100244</PublicId>
      <PreferredName>3099582v1.0:2222848v1.0</PreferredName>
      <PreferredDefinition>The largest class of organic compounds, including starches, glycogens, cellulose, gums, and simple sugars. Carbohydrates are composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. (MeSH)_One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.</PreferredDefinition>
      <LongName>Carbohydrate Identifier</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099582</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C344</PreferredName>
        <Version>1</Version>
        <LongName>Carbohydrate</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C344</PREFERRED_NAME>
            <LONG_NAME>Carbohydrate</LONG_NAME>
            <CON_ID>3099505</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222848</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25364</PreferredName>
        <Version>1</Version>
        <LongName>Identifier</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25364</PREFERRED_NAME>
            <LONG_NAME>Identifier</LONG_NAME>
            <CON_ID>2202473</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178534</PublicId>
      <PreferredName>java.lang.Long</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java dataype that is a long integer (64-bit two&#39;s complement).</PreferredDefinition>
      <LongName>java.lang.Long</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Long</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233101</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25337</PreferredName>
        <Version>1</Version>
        <LongName>Number</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25337</PREFERRED_NAME>
            <LONG_NAME>Number</LONG_NAME>
            <CON_ID>2202701</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Carbohydrate Identifier java.lang.Long does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Carbohydrate Identifier java.lang.Long does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.Carbohydrate.id</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Carbohydrate:id</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1704">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101518</PUBLICID>
    <LONGNAME>Animal Birth Weight Value java.lang.String</LONGNAME>
    <PREFERREDNAME>3100275v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A living organism that has membranous cell walls, requires oxygen and organic foods, and is capable of voluntary movement, as distinguished from a plant or mineral.:The event of being born.:The vertical force exerted by a mass as a result of gravity._The information contained in a data field._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100275</PublicId>
      <PreferredName>3099568v1.0:2528693v1.0</PreferredName>
      <PreferredDefinition>A living organism that has membranous cell walls, requires oxygen and organic foods, and is capable of voluntary movement, as distinguished from a plant or mineral.:The event of being born.:The vertical force exerted by a mass as a result of gravity._The information contained in a data field.</PreferredDefinition>
      <LongName>Animal Birth Weight Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099568</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C14182:C25155:C25208</PreferredName>
        <Version>1</Version>
        <LongName>Animal Birth Weight</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C14182</PREFERRED_NAME>
            <LONG_NAME>Animal</LONG_NAME>
            <CON_ID>2210812</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25155</PREFERRED_NAME>
            <LONG_NAME>Birth</LONG_NAME>
            <CON_ID>2202896</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25208</PREFERRED_NAME>
            <LONG_NAME>Weight</LONG_NAME>
            <CON_ID>2202868</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528693</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49100</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49100</PREFERRED_NAME>
            <LONG_NAME>Data Value</LONG_NAME>
            <CON_ID>2463853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Animal Birth Weight Value java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Animal Birth Weight Value java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.AnimalBirthWeight.value</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>AnimalBirthWeight:value</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1705">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101636</PUBLICID>
    <LONGNAME>Receive Event Modified By java.lang.String</LONGNAME>
    <PREFERREDNAME>3100396v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>To take, accept, or get something offered.:Something that happens at a given place and time._Indicates the person or authoritative body who changed an item._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100396</PublicId>
      <PreferredName>3099539v1.0:2231612v1.0</PreferredName>
      <PreferredDefinition>To take, accept, or get something offered.:Something that happens at a given place and time._Indicates the person or authoritative body who changed an item.</PreferredDefinition>
      <LongName>Receive Event Modified By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099539</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25639:C25499</PreferredName>
        <Version>1</Version>
        <LongName>Receive Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25639</PREFERRED_NAME>
            <LONG_NAME>Receive</LONG_NAME>
            <CON_ID>2203960</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231612</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42629</PreferredName>
        <Version>1</Version>
        <LongName>Modified By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42629</PREFERRED_NAME>
            <LONG_NAME>Modified By</LONG_NAME>
            <CON_ID>2231552</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Receive Event Modified By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Receive Event Modified By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory.event</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.event.ReceiveEvent.modifiedBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>ReceiveEvent:modifiedBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1706">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101649</PUBLICID>
    <LONGNAME>Ventilation Change Date java.util.Date</LONGNAME>
    <PREFERREDNAME>3100409v1.0:2222504v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The act of moving air into and out of a space._The act of alteration or modification; changed or altered in form or character.:The particular day, month and year an event has happened or will happen._Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100409</PublicId>
      <PreferredName>3099604v1.0:2539482v1.0</PreferredName>
      <PreferredDefinition>The act of moving air into and out of a space._The act of alteration or modification; changed or altered in form or character.:The particular day, month and year an event has happened or will happen.</PreferredDefinition>
      <LongName>Ventilation Change Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C88203</PreferredName>
        <Version>1</Version>
        <LongName>Ventilation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C88203</PREFERRED_NAME>
            <LONG_NAME>Ventilation</LONG_NAME>
            <CON_ID>3099515</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2539482</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25446:C25164</PreferredName>
        <Version>1</Version>
        <LongName>Change Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25446</PREFERRED_NAME>
            <LONG_NAME>Change</LONG_NAME>
            <CON_ID>2202307</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2222504</PublicId>
      <PreferredName>java.util.Date</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that represents a specific instant in time, with millisecond precision.</PreferredDefinition>
      <LongName>java.util.Date</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.util.Date</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2233081</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25164</PreferredName>
        <Version>1</Version>
        <LongName>Date</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25164</PREFERRED_NAME>
            <LONG_NAME>Date</LONG_NAME>
            <CON_ID>2202880</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Ventilation Change Date java.util.Date does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Ventilation Change Date java.util.Date does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.common.environmentalcondition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.common.environmentalcondition.Ventilation.dateModified</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Ventilation:dateModified</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1707">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101796</PUBLICID>
    <LONGNAME>Withdraw Event Display Name java.lang.String</LONGNAME>
    <PREFERREDNAME>3100556v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>To cease active participation in; remove from active use.:Something that happens at a given place and time._Exhibit, present, or demonstrate for viewing.:The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100556</PublicId>
      <PreferredName>3099547v1.0:2231629v1.0</PreferredName>
      <PreferredDefinition>To cease active participation in; remove from active use.:Something that happens at a given place and time._Exhibit, present, or demonstrate for viewing.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Withdraw Event Display Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099547</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38061:C25499</PreferredName>
        <Version>1</Version>
        <LongName>Withdraw Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38061</PREFERRED_NAME>
            <LONG_NAME>Withdraw</LONG_NAME>
            <CON_ID>2434706</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231629</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25485:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Display Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25485</PREFERRED_NAME>
            <LONG_NAME>Display</LONG_NAME>
            <CON_ID>2203905</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Withdraw Event Display Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Withdraw Event Display Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory.event</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099476</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.event.RetireEvent.displayName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>RetireEvent:displayName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1708">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101804</PUBLICID>
    <LONGNAME>Whole Organism Created By java.lang.String</LONGNAME>
    <PREFERREDNAME>3100564v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Considering the organism as a whole_Indicates the person or authoritative body who brought the item into existence._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100564</PublicId>
      <PreferredName>3099558v1.0:2231611v1.0</PreferredName>
      <PreferredDefinition>Considering the organism as a whole_Indicates the person or authoritative body who brought the item into existence.</PreferredDefinition>
      <LongName>Whole Organism Created By</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099558</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13413</PreferredName>
        <Version>1</Version>
        <LongName>Whole Organism</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13413</PREFERRED_NAME>
            <LONG_NAME>Whole Organism</LONG_NAME>
            <CON_ID>3099495</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231611</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42628</PreferredName>
        <Version>1</Version>
        <LongName>Created By</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42628</PREFERRED_NAME>
            <LONG_NAME>Created By</LONG_NAME>
            <CON_ID>2231551</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Whole Organism Created By java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Whole Organism Created By java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.WholeOrganism.createdBy</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>WholeOrganism:createdBy</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1709">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101878</PUBLICID>
    <LONGNAME>Nutritional Required Display Name java.lang.String</LONGNAME>
    <PREFERREDNAME>3100638v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Of or relating to or providing nutrition.:Necessary, not optional._Exhibit, present, or demonstrate for viewing.:The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100638</PublicId>
      <PreferredName>3099561v1.0:2231629v1.0</PreferredName>
      <PreferredDefinition>Of or relating to or providing nutrition.:Necessary, not optional._Exhibit, present, or demonstrate for viewing.:The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>Nutritional Required Display Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099561</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25597:C25652</PreferredName>
        <Version>1</Version>
        <LongName>Nutritional Required</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25597</PREFERRED_NAME>
            <LONG_NAME>Nutritional</LONG_NAME>
            <CON_ID>2206329</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25652</PREFERRED_NAME>
            <LONG_NAME>Requirement</LONG_NAME>
            <CON_ID>2204014</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2231629</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25485:C42614</PreferredName>
        <Version>1</Version>
        <LongName>Display Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25485</PREFERRED_NAME>
            <LONG_NAME>Display</LONG_NAME>
            <CON_ID>2203905</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Nutritional Required Display Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Nutritional Required Display Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.NutritionalRequirement.displayName</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NutritionalRequirement:displayName</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1710">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101904</PUBLICID>
    <LONGNAME>Stage Flag Quantitative java.lang.Boolean</LONGNAME>
    <PREFERREDNAME>3100664v1.0:2178538v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body._An indicator that can be set or unset in order to signal whether a particular condition is true.:Capable of being estimated or expressed with numeric values._Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100664</PublicId>
      <PreferredName>3099583v1.0:3099631v1.0</PreferredName>
      <PreferredDefinition>The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body._An indicator that can be set or unset in order to signal whether a particular condition is true.:Capable of being estimated or expressed with numeric values.</PreferredDefinition>
      <LongName>Stage Flag Quantitative</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099583</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16899</PreferredName>
        <Version>1</Version>
        <LongName>Stage</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16899</PREFERRED_NAME>
            <LONG_NAME>Neoplasm Stage</LONG_NAME>
            <CON_ID>2202831</CON_ID>
            <DEFINITION_SOURCE>NCI-GLOSS</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3099631</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43578:C70766</PreferredName>
        <Version>1</Version>
        <LongName>Flag Quantitative</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43578</PREFERRED_NAME>
            <LONG_NAME>Flag</LONG_NAME>
            <CON_ID>2223213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C70766</PREFERRED_NAME>
            <LONG_NAME>Quantitative Concept</LONG_NAME>
            <CON_ID>2772180</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178538</PublicId>
      <PreferredName>java.lang.Boolean</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PreferredDefinition>
      <LongName>java.lang.Boolean</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Boolean</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Stage Flag Quantitative java.lang.Boolean does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Stage Flag Quantitative java.lang.Boolean does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>TumorStage:isQuantitative</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.TumorStage.isQuantitative</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1711">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101946</PUBLICID>
    <LONGNAME>Generation Value java.lang.String</LONGNAME>
    <PREFERREDNAME>3100706v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A single step in the line of descent from a common ancestor._The information contained in a data field._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100706</PublicId>
      <PreferredName>3099559v1.0:2528693v1.0</PreferredName>
      <PreferredDefinition>A single step in the line of descent from a common ancestor._The information contained in a data field.</PreferredDefinition>
      <LongName>Generation Value</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099559</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C88214</PreferredName>
        <Version>1</Version>
        <LongName>Generation</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C88214</PREFERRED_NAME>
            <LONG_NAME>Generation</LONG_NAME>
            <CON_ID>3099496</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2528693</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C49100</PreferredName>
        <Version>1</Version>
        <LongName>Value</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C49100</PREFERRED_NAME>
            <LONG_NAME>Data Value</LONG_NAME>
            <CON_ID>2463853</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Generation Value java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Generation Value java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.inventory</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>2813051</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.inventory.Generation.value</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Generation:value</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1712">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3101965</PUBLICID>
    <LONGNAME>PH Name java.lang.String</LONGNAME>
    <PREFERREDNAME>3100725v1.0:2178533v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Quantity of dimension one used to express on a scale from 0 to 14 the amount-of-substance concentration of hydrogen ion of dilute aqueous solution, calculated as the logarithm of the reciprocal of hydrogen-ion concentration in gram atoms per liter._The words or language units by which a thing is known._Generic value domain for a java datatype that is a class that represents character strings.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3100725</PublicId>
      <PreferredName>3099606v1.0:2222841v1.0</PreferredName>
      <PreferredDefinition>Quantity of dimension one used to express on a scale from 0 to 14 the amount-of-substance concentration of hydrogen ion of dilute aqueous solution, calculated as the logarithm of the reciprocal of hydrogen-ion concentration in gram atoms per liter._The words or language units by which a thing is known.</PreferredDefinition>
      <LongName>PH Name</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3099606</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C45997</PreferredName>
        <Version>1</Version>
        <LongName>PH</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C45997</PREFERRED_NAME>
            <LONG_NAME>pH</LONG_NAME>
            <CON_ID>2422616</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2222841</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42614</PreferredName>
        <Version>1</Version>
        <LongName>Name</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42614</PREFERRED_NAME>
            <LONG_NAME>Name</LONG_NAME>
            <CON_ID>2222821</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178533</PublicId>
      <PreferredName>java.lang.String</PreferredName>
      <PreferredDefinition>Generic value domain for a java datatype that is a class that represents character strings.</PreferredDefinition>
      <LongName>java.lang.String</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.String</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2234203</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25704</PreferredName>
        <Version>1</Version>
        <LongName>Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element PH Name java.lang.String does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element PH Name java.lang.String does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2772168</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>caLIMS2</PreferredName>
          <Version>1.1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>gov.nih.nci.calims2.domain.common.environmentalcondition</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>UML_PACKAGE_NAME</ClassificationSchemeItemType>
        <CsiPublicId>3099478</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>pH:name</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>gov.nih.nci.calims2.domain.common.environmentalcondition.pH.name</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1713">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3105276</PUBLICID>
    <LONGNAME>Abnormal Other Laboratory Procedure Outcome Ind-2</LONGNAME>
    <PREFERREDNAME>3105274v1.0:2018320v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to result that deviates from the norm in the laboratory results different than the one(s) previously specified or mentioned.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NCIC CRF:National Cancer Institute of Canada Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3105274</PublicId>
      <PreferredName>3105272v1.0:2224045v1.0</PreferredName>
      <PreferredDefinition>information related to result that deviates from the norm in the laboratory results different than the one(s) previously specified or mentioned.</PreferredDefinition>
      <LongName>Abnormal Other Laboratory Procedure Outcome</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3105272</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25401:C17649:C25294</PreferredName>
        <Version>1</Version>
        <LongName>Abnormal Other Laboratory Procedure</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25401</PREFERRED_NAME>
            <LONG_NAME>Abnormal</LONG_NAME>
            <CON_ID>2202623</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17649</PREFERRED_NAME>
            <LONG_NAME>Other</LONG_NAME>
            <CON_ID>2202691</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25294</PREFERRED_NAME>
            <LONG_NAME>Laboratory Procedure</LONG_NAME>
            <CON_ID>2202340</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2224045</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C20200</PreferredName>
        <Version>1</Version>
        <LongName>Outcome</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C20200</PREFERRED_NAME>
            <LONG_NAME>Outcome</LONG_NAME>
            <CON_ID>2203785</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NCIC CRF:National Cancer Institute of Canada Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Are there any other relevant</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Are there any other relevant investigations to report</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2008589</PublicId>
          <ContextName>CTEP</ContextName>
          <ContextVersion>2.31</ContextVersion>
          <PreferredName>CATEGORY</PreferredName>
          <Version>2</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Labs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>2811957</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1714">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3109084</PUBLICID>
    <LONGNAME>Hepatic Lesion Surgical Resection Treatment Type</LONGNAME>
    <PREFERREDNAME>2322448v1.0:3109073v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>a subdivision relating to hepatic lesion surgical resection treatment.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2322448</PublicId>
      <PreferredName>HEPAT_LES_SX_RES_TX</PreferredName>
      <PreferredDefinition>information relating to hepatic lesion surgical resection treatment.</PreferredDefinition>
      <LongName>Hepatic Lesion Surgical Resection Treatment</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2321288</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C13308:C3824</PreferredName>
        <Version>1</Version>
        <LongName>Hepatic Lesion</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C13308</PREFERRED_NAME>
            <LONG_NAME>Hepatic</LONG_NAME>
            <CON_ID>2202660</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3824</PREFERRED_NAME>
            <LONG_NAME>Lesion</LONG_NAME>
            <CON_ID>2202339</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2322446</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>CL052737:C15232:C15368</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Resection Therapy</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>CL052737</PREFERRED_NAME>
            <LONG_NAME>Surgical</LONG_NAME>
            <CON_ID>2322444</CON_ID>
            <DEFINITION_SOURCE>NCI04</DEFINITION_SOURCE>
            <ORIGIN/>
            <EVS_SOURCE>NCI_META_CUI</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15232</PREFERRED_NAME>
            <LONG_NAME>Excision</LONG_NAME>
            <CON_ID>2202806</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15368</PREFERRED_NAME>
            <LONG_NAME>Therapy</LONG_NAME>
            <CON_ID>2202841</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3109073</PublicId>
      <PreferredName>3109073v1.0</PreferredName>
      <PreferredDefinition>a subdivision of a particular kind of thing for liver resection.</PreferredDefinition>
      <LongName>Hepatic Lesion Surgical Resection Treatment Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008538</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>TX</PreferredName>
        <Version>1</Version>
        <LongName>Therapies</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form</Origin>
      <Representation>
        <PublicId>2234813</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25284</PreferredName>
        <Version>1</Version>
        <LongName>Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Caudate resection</VALIDVALUE>
          <VALUEMEANING>Caudate resection</VALUEMEANING>
          <MEANINGDESCRIPTION>Caudate resection</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3109074</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial hepatectomy, multiple</VALIDVALUE>
          <VALUEMEANING>Partial hepatectomy, multiple</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial hepatectomy, multiple</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3109075</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Partial hepatectomy, single</VALIDVALUE>
          <VALUEMEANING>Partial hepatectomy, single</VALUEMEANING>
          <MEANINGDESCRIPTION>Partial hepatectomy, single</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3109076</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Hepatic segmentectomy, other</VALIDVALUE>
          <VALUEMEANING>Hepatic segmentectomy, other</VALUEMEANING>
          <MEANINGDESCRIPTION>Hepatic segmentectomy, other</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3109077</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right anterior sectionectomy</VALIDVALUE>
          <VALUEMEANING>Right anterior sectionectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Right anterior sectionectomy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3109078</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right posterior sectionectomy</VALIDVALUE>
          <VALUEMEANING>Right posterior sectionectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Right posterior sectionectomy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3109079</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left lateral sectionectomy</VALIDVALUE>
          <VALUEMEANING>Left lateral sectionectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Left lateral sectionectomy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3109080</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Central hepatectomy</VALIDVALUE>
          <VALUEMEANING>Center Hepatectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>A point or area that is approximately central within some larger region or structure.: Surgery to remove all or part of the liver.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C15249, C25445</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3109082</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Left hepatectomy</VALIDVALUE>
          <VALUEMEANING>Left Hepatectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Left Hepatectomy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3028999</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Right hepatectomy</VALIDVALUE>
          <VALUEMEANING>Right Hepatectomy</VALUEMEANING>
          <MEANINGDESCRIPTION>Right Hepatectomy</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3029001</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Other/Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown Other</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.: Different than the one(s) previously specified or mentioned.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17649, C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus, NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0, 1</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-14</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3108769</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Liver procedure</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Liver procedure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1715">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3114007</PUBLICID>
    <LONGNAME>Disease Surgical Margin Status</LONGNAME>
    <PREFERREDNAME>2238456v1.0:3114002v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text descriptor of the conclusive results following examination of tissue margin(s) for the presence of disease..</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>TCGA:The Cancer Genome Atlas</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>2238456</PublicId>
      <PreferredName>FINAL_MARG_DZ_STAT</PreferredName>
      <PreferredDefinition>Conclusive results following examination of tissue margin(s) for the presence of disease.</PreferredDefinition>
      <LongName>Final Margin Disease Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>SPOREs</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2206402</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25508:C25563</PreferredName>
        <Version>1</Version>
        <LongName>Final Margin</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25508</PREFERRED_NAME>
            <LONG_NAME>Final</LONG_NAME>
            <CON_ID>2206213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25563</PREFERRED_NAME>
            <LONG_NAME>Margin</LONG_NAME>
            <CON_ID>2202676</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2238454</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C2991:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Diseases and Disorders Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C2991</PREFERRED_NAME>
            <LONG_NAME>Disease or Disorder</LONG_NAME>
            <CON_ID>2202471</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3114002</PublicId>
      <PreferredName>3114002v1.0</PreferredName>
      <PreferredDefinition>The edge or border of the tissue removed in cancer surgery.  The margin is described as negative or clean when the pathologist finds no cancer cells at the edge of the tissue, suggesting that all of the cancer has been removed.  The margin is described as positive or involved when the pathologist finds cancer cells at the edge of the tissue, suggesting that all of the cancer has not been removed._A condition or state at a particular time.</PreferredDefinition>
      <LongName>Surgical Margin Status</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008547</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>SPEC_CHAR</PreferredName>
        <Version>1</Version>
        <LongName>Specimen Characteristics</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>8</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3114001</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41227:C25688</PreferredName>
        <Version>1</Version>
        <LongName>Surgical Margin Status</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41227</PREFERRED_NAME>
            <LONG_NAME>Surgical Margin</LONG_NAME>
            <CON_ID>2202388</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25688</PREFERRED_NAME>
            <LONG_NAME>Status</LONG_NAME>
            <CON_ID>2202322</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Negative</VALIDVALUE>
          <VALUEMEANING>Negative Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38757</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2617835</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Close</VALIDVALUE>
          <VALUEMEANING>Close</VALUEMEANING>
          <MEANINGDESCRIPTION>A surgical margin which is in close proximity to the excised tumor.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C103267</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2575542</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Positive</VALIDVALUE>
          <VALUEMEANING>Positive Finding</VALUEMEANING>
          <MEANINGDESCRIPTION>An observation confirming something, such as the presence of a disease, condition, or microorganism.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C38758</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-06-23</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2840097</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Unknown</VALIDVALUE>
          <VALUEMEANING>Unknown</VALUEMEANING>
          <MEANINGDESCRIPTION>Not known, not observed, not recorded, or refused.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C17998</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2016-10-05</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2565695</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Margin Status</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Margin Status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CDDP/CTSP Clinical Data Form</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Margin Status after first surgical proceure</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Surgical margin status</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2756809</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>The Cancer Genome Atlas</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Active CDEs as of March 2017</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>6044923</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BLCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787499</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>BRCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787500</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CESC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787502</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>COAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787503</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GBM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787504</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>HNSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787505</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KICH</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787506</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787507</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>KIRP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787508</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LAML</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787509</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LGG</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787510</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LIHC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787511</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787512</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>LUSC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787513</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>OV</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787514</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PAAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787515</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PRAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787516</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>READ</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787517</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SARC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787518</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>SKCM</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787519</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>STAD</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787520</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>THCA</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787521</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>3787498</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>TCGA 2.6 by Disease</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>UCEC</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>DISEASE_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3787522</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>5589063</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>CDDP/CTSP</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>CDDP/CTSP</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>5589068</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>margin_status</AlternateName>
        <AlternateNameType>TCGA_XML_Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>2238456v1.0:3114002v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1716">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3120013</PUBLICID>
    <LONGNAME>Study Ancillary Study Flag java.lang.Boolean</LONGNAME>
    <PREFERREDNAME>3119902v1.0:2178538v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical trial._Studies which are secondary to another study.:An indicator that can be set or unset in order to signal whether a particular condition is true._Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RETIRED ARCHIVED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Superceded</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3119902</PublicId>
      <PreferredName>2430995v1.0:2990543v1.0</PreferredName>
      <PreferredDefinition>A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical trial._Studies which are secondary to another study.:An indicator that can be set or unset in order to signal whether a particular condition is true.</PreferredDefinition>
      <LongName>Study Ancillary Study Flag</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2222502</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>UML DEFAULT CD</PreferredName>
        <Version>1</Version>
        <LongName>UML DEFAULT CD</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2430995</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C15206</PreferredName>
        <Version>1</Version>
        <LongName>Study</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C15206</PREFERRED_NAME>
            <LONG_NAME>Clinical Study</LONG_NAME>
            <CON_ID>2202828</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2990543</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16041:C43578</PreferredName>
        <Version>1</Version>
        <LongName>Ancillary Study Flag</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16041</PREFERRED_NAME>
            <LONG_NAME>Ancillary Study</LONG_NAME>
            <CON_ID>2762310</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43578</PREFERRED_NAME>
            <LONG_NAME>Flag</LONG_NAME>
            <CON_ID>2223213</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2178538</PublicId>
      <PreferredName>java.lang.Boolean</PreferredName>
      <PreferredDefinition>Generic value domain for a primitive java datatype that is a Boolean value (true or false).</PreferredDefinition>
      <LongName>java.lang.Boolean</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>caCORE</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2178532</PublicId>
        <ContextName>caCORE</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>BIOINFORMATICS</PreferredName>
        <Version>1</Version>
        <LongName>Bioinformatics</LongName>
      </ConceptualDomain>
      <Datatype>java.lang.Boolean</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2320047</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25180</PreferredName>
        <Version>1</Version>
        <LongName>Indicator</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25180</PREFERRED_NAME>
            <LONG_NAME>Indicator</LONG_NAME>
            <CON_ID>2202683</CON_ID>
            <DEFINITION_SOURCE>Source =&gt; Name: NCI, </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Data Element Study Ancillary Study Flag java.lang.Boolean does not have Preferred Question Text</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Data Element Study Ancillary Study Flag java.lang.Boolean does not have Preferred Question Text</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder>0</DisplayOrder>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>edu.duke.cabig.c3pr.domain.Study.companionIndicator</AlternateName>
        <AlternateNameType>UML Qualified Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Study:companionIndicator</AlternateName>
        <AlternateNameType>UML Class:UML Attr</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1717">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3126917</PUBLICID>
    <LONGNAME>Dental Tooth Fracture Description Specify</LONGNAME>
    <PREFERREDNAME>3126916v1.0:2556910v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Pertaining to a tooth or teeth, or to odontology. An organ, the organ parts of which primarily consist of dentine and dental enamel; together with other teeth it constitutes a subdivision of the facial skeleton. Example(s): incisor, molar. A finding of traumatic injury to the bone in which the continuity of the bone is broken. Description; a statement that represents something in words. Be specific about something; define clearly.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3126916</PublicId>
      <PreferredName>2240058v1.0:3126914v1.0</PreferredName>
      <PreferredDefinition>Pertaining to a tooth or teeth, or to odontology. An organ, the organ parts of which primarily consist of dentine and dental enamel; together with other teeth it constitutes a subdivision of the facial skeleton. Example(s): incisor, molar. A finding of traumatic injury to the bone in which the continuity of the bone is broken. Description; a statement that represents something in words.</PreferredDefinition>
      <LongName>Dental Tooth Fracture Description</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2240058</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C41136:C12506</PreferredName>
        <Version>1</Version>
        <LongName>Dental Tooth</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C41136</PREFERRED_NAME>
            <LONG_NAME>Dental</LONG_NAME>
            <CON_ID>2240057</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12506</PREFERRED_NAME>
            <LONG_NAME>Tooth</LONG_NAME>
            <CON_ID>2202581</CON_ID>
            <DEFINITION_SOURCE>UWDA142</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3126914</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>E11703:C25365</PreferredName>
        <Version>1</Version>
        <LongName>Fracture Description</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>E11703</PREFERRED_NAME>
            <LONG_NAME>Fracture</LONG_NAME>
            <CON_ID>3123444</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>CTCAE</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25365</PREFERRED_NAME>
            <LONG_NAME>Description</LONG_NAME>
            <CON_ID>2202730</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2556910</PublicId>
      <PreferredName>SPEC</PreferredName>
      <PreferredDefinition>Be specific about something; define clearly.</PreferredDefinition>
      <LongName>Specify</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NHLBI</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435024</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1908</PreferredName>
        <Version>1</Version>
        <LongName>Drug or Chemical</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength>1</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NMDP:National Marrow Donor Program</Origin>
      <Representation>
        <PublicId>2390957</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25685</PreferredName>
        <Version>1</Version>
        <LongName>Specify</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25685</PREFERRED_NAME>
            <LONG_NAME>Specify</LONG_NAME>
            <CON_ID>2203800</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>If yes, describe</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>If yes, describe</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1718">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3139329</PUBLICID>
    <LONGNAME>Child Life Event Assessment Score</LONGNAME>
    <PREFERREDNAME>3139328v1.0:3076086v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>A human offspring (son or daughter) of any age; an immediate progeny._Life; the organic phenomenon that distinguishes living organisms from nonliving ones._Event; something that happens at a given place and time._The final result of a determination of the value, significance, or extent of._A number or range of numeric values measuring performance, function, quality, or ability.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>PhenX</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3139328</PublicId>
      <PreferredName>3007557v1.0:3139323v1.0</PreferredName>
      <PreferredDefinition>A human offspring (son or daughter) of any age; an immediate progeny._Life; the organic phenomenon that distinguishes living organisms from nonliving ones._Event; something that happens at a given place and time.</PreferredDefinition>
      <LongName>Child Life Event</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3007557</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C42708</PreferredName>
        <Version>1</Version>
        <LongName>Child</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C42708</PREFERRED_NAME>
            <LONG_NAME>Offspring</LONG_NAME>
            <CON_ID>2483744</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3139323</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C37987:C25499</PreferredName>
        <Version>1</Version>
        <LongName>Life Event</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C37987</PREFERRED_NAME>
            <LONG_NAME>Alive</LONG_NAME>
            <CON_ID>2210813</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25499</PREFERRED_NAME>
            <LONG_NAME>Event</LONG_NAME>
            <CON_ID>2202572</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3076086</PublicId>
      <PreferredName>ASSES_SC</PreferredName>
      <PreferredDefinition>A number or range of numeric values measuring performance, function, quality, or ability.</PreferredDefinition>
      <LongName>Assessment Score</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>PhenX</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>100</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2193207</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25338</PreferredName>
        <Version>1</Version>
        <LongName>Score</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25338</PREFERRED_NAME>
            <LONG_NAME>Score</LONG_NAME>
            <CON_ID>2204643</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>This measure is a questionnai</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>This measure is a questionnaire to assess the respondent&#39;s exposure to a broad range of life events.</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Mental Health Core Collection</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4550917</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2793652</PublicId>
          <ContextName>PhenX</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>PhenX </PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Core: Tier 2</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4550971</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>DCP</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>DCP</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1719">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3153626</PUBLICID>
    <LONGNAME>Patient Strong Cytochrome P450 3A4 Induction Medication Eligibility Determination Ind-2</LONGNAME>
    <PREFERREDNAME>3153625v1.0:2018257v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>the yes/no indicator related to criteria to determine eligibility of patients for medical care programs and services based on strongly human CYP3A4 Gene inducing medication.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>CTEP</CONTEXTNAME>
    <CONTEXTVERSION>2.31</CONTEXTVERSION>
    <ORIGIN>GOG CRF:Gynecologic Oncology Group Case Report Form</ORIGIN>
    <REGISTRATIONSTATUS>Qualified</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3153625</PublicId>
      <PreferredName>2233604v1.0:3153623v1.0</PreferredName>
      <PreferredDefinition>information related to criteria to determine eligibility of patients for medical care programs and services based on strongly human CYP3A4 Gene inducing medication.</PreferredDefinition>
      <LongName>Patient Strong Cytochrome P450 3A4 Induction Medication Eligibility Determination</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>CTEP</ContextName>
      <ContextVersion>2.31</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008525</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ELIG</PreferredName>
        <Version>1</Version>
        <LongName>Eligibility</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2233604</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C16960</PreferredName>
        <Version>1</Version>
        <LongName>Patient</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16960</PREFERRED_NAME>
            <LONG_NAME>Patient</LONG_NAME>
            <CON_ID>2202778</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3153623</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>3153623v1.0</PreferredName>
        <Version>1</Version>
        <LongName>Strong Cytochrome P450 3A4 Induction Medication Eligibility Determination</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62223</PREFERRED_NAME>
            <LONG_NAME>Strong</LONG_NAME>
            <CON_ID>2528545</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>4</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17573</PREFERRED_NAME>
            <LONG_NAME>Cytochrome P450 3A4</LONG_NAME>
            <CON_ID>2944364</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C61367</PREFERRED_NAME>
            <LONG_NAME>Induction</LONG_NAME>
            <CON_ID>2612143</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C459</PREFERRED_NAME>
            <LONG_NAME>Medication</LONG_NAME>
            <CON_ID>2202423</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25171</PREFERRED_NAME>
            <LONG_NAME>Eligibility Determination</LONG_NAME>
            <CON_ID>2202422</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>GOG CRF:Gynecologic Oncology Group Case Report Form</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3506068</PublicId>
      <PreferredName>YES_NO_IND</PreferredName>
      <PreferredDefinition>The preferred Value Domain to indicate a question with permissible values of yes/no.</PreferredDefinition>
      <LongName>Yes No Indicator</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCI Standards</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>3502157</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>YES_NO_IND_VD</PreferredName>
        <Version>1</Version>
        <LongName>Yes No Indicator Value Domains</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength>3</MaximumLength>
      <MinimumLength>2</MinimumLength>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>2421125</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C38147</PreferredName>
        <Version>1</Version>
        <LongName>Ind-2</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C38147</PREFERRED_NAME>
            <LONG_NAME>Yes or No Response</LONG_NAME>
            <CON_ID>2204645</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>No</VALIDVALUE>
          <VALUEMEANING>No</VALUEMEANING>
          <MEANINGDESCRIPTION>The non-affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49487</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197154</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Yes</VALIDVALUE>
          <VALUEMEANING>Yes</VALUEMEANING>
          <MEANINGDESCRIPTION>The affirmative response to a question.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C49488</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2012-06-27</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3197153</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is the patient receiving any</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the patient receiving any Strong CYP3A4 inhibitors?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient require the use of calcium channel blockers that are CYP3A4 inhibitors?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient taking medications that are strong inhibitors or inducers of CYP3A4/5 (e.g., itroconzole, ketoconaole, clarithromycin, ritonavir, phenytoin, phenobarbital, and rifampicin) these medications cannot be changed?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient receiving drugs that are strong inducers or inhibitors of CYP3A4?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient take any sensitive substrates of CYP3A4, CYP1A2, and CY2E1, and/or strong inhibitors and inducers of CYP2C9, CYP2D6, CYP2C19, and CYP3A4?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient received drugs known to be moderate and strong inhibitors or inducers of isoenzyme CYP3A within 7 days prior to enrollment? (Please note that co-treatment with weak inhibitors of CYP3A is allowed).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient received drugs known to be moderate and strong inhibitors or inducers of isoenzyme CYP3A within 7 days prior to registration? (Please note that co-treatment with weak inhibitors of CYP3A is allowed).</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has the patient recieved chronic concomitant treatment with strong CYP3A4 inhibitor(s)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Use of drugs metabolized by CYP2D6</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient within the last 7 days received or cannot discontinue drugs that are strong or moderate inducers or inhibitors of CYP3A4/5 including enzyme inducing anti-convulsant drugs (EIACDs)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient on any drugs that are strong inducers or inhibitors of CYP3A4, CYP1A2, CYP2C19, UGT1A9, P-gp, and BCRP?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PBTC_Text5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is patient receiving strong inducers of CYP3A4, strong inhibitors of CYP3A4 or CYP1A2, or CYP3A4 substrates with a narrow therapeutic index within 2 weeks of the first dose of savolitinib (3 weeks for St John&#39;s Wort)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 5</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient using any strong cytochrome (CYP) 3A inhibitors (e.g., itraconazole, telithromycin, clarithromycin, protease inhibitors boosted with ritonavir or cobicistat, indinavir, saquinavir, nelfinavir, boceprevir, telaprevir)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Chronic concomitant treatment with strong inhibitors of CYP3A4?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Chronic concomitant treatment with a strong CYP3A4 inhibitor?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance - 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior concomitant use of strong CYP3A4 inducers?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>CRF Text 7</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Prior strong CYP3A4 inducer treatment?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Alliance text 6</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Has patient taken (or received) any known sensitive CYP3A4 substrates with narrow therapeutic window (such as alfentanil, astemizole, cisapride, dihydroergotamine, pimozide, quinidine, sirolimus, or terfenadine)  within the 14 days prior to receiving the first dose of AMG 232?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF_Text_3</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient using known strong CYP3A inhibitors (e.g., itraconazole, telithromycin, clarithromycin, protease inhibitors boosted with ritonavir or cobicistat, indinavir, saquinavir, nelfinavir, boceprevir, telaprevir) or known moderate CYP3A inhibitors (e.g., ciprofloxacin, erythromycin, diltiazem, Fluconazole, verapamil)?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF Text 1</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient taking any drugs that are strong inhibitors of CYP3A4 or CYP1A2?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG_CRF_Text_4</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Is the patient currently taking and unwilling/unable to discontinue the use of major substrates of CYP3A with a narrow therapeutic window?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NRG CRF Text 2</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Does the patient require concomitant strong CYP3A4 inhibitors or inducers?</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0227G</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104881</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4057943</PublicId>
          <ContextName>NRG</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Disease Site</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>GOG-0268</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>CATEGORY_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4104940</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4254096</PublicId>
          <ContextName>PBTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>PBTC-042</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>4254119</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>4254096</PublicId>
          <ContextName>PBTC</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Protocol Phase</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Phase I</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>Phase Type</ClassificationSchemeItemType>
        <CsiPublicId>10000103</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <ALTERNATENAMELIST>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>PBTC</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PBTC</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>NRG</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>3153625v1.0:2018257v1.0</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>Alliance</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>Alliance</AlternateName>
        <AlternateNameType>USED_BY</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
      <ALTERNATENAMELIST_ITEM>
        <ContextName>NRG</ContextName>
        <ContextVersion>1</ContextVersion>
        <AlternateName>PT_STR_CYTOCHR_P450</AlternateName>
        <AlternateNameType>Context Short Name</AlternateNameType>
        <Language>ENGLISH</Language>
      </ALTERNATENAMELIST_ITEM>
    </ALTERNATENAMELIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1720">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3161972</PUBLICID>
    <LONGNAME>Patient Self-Report Tooth Cold PainType</LONGNAME>
    <PREFERREDNAME>3161960v1.0:3161941v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Subjective reports made by the patient_is an organ, the organ parts of which primarily consist of dentine and dental enamel; together with other teeth it constitutes a subdivision of the facial skeleton. Example(s): incisor, molar._Having less heat energy than the object against which it is compared; the absence of heat._The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings._The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings._Type; a subdivision of a particular kind of thing.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NIDCR</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN/>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3161960</PublicId>
      <PreferredName>3161938v1.0:3161958v1.0</PreferredName>
      <PreferredDefinition>Subjective reports made by the patient_is an organ, the organ parts of which primarily consist of dentine and dental enamel; together with other teeth it constitutes a subdivision of the facial skeleton. Example(s): incisor, molar._Having less heat energy than the object against which it is compared; the absence of heat._The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.</PreferredDefinition>
      <LongName>Patient Self-Report Tooth Cold Pain</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008551</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS</PreferredName>
        <Version>1</Version>
        <LongName>Assessments</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3161938</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C21089:C12506</PreferredName>
        <Version>1</Version>
        <LongName>Patient Self-Report Tooth</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C21089</PREFERRED_NAME>
            <LONG_NAME>Patient Self-Report</LONG_NAME>
            <CON_ID>2234887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C12506</PREFERRED_NAME>
            <LONG_NAME>Tooth</LONG_NAME>
            <CON_ID>2202581</CON_ID>
            <DEFINITION_SOURCE>UWDA142</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>3161958</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C62180:C3303</PreferredName>
        <Version>1</Version>
        <LongName>Cold Pain</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C62180</PREFERRED_NAME>
            <LONG_NAME>Cold</LONG_NAME>
            <CON_ID>2503466</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3303</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>2202326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin/>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3161941</PublicId>
      <PreferredName>3161941v1.0</PreferredName>
      <PreferredDefinition>The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings._Type; a subdivision of a particular kind of thing.</PreferredDefinition>
      <LongName>Tooth Pain Type</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NIDCR</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>ALPHANUMERIC</Datatype>
      <ValueDomainType>Enumerated</ValueDomainType>
      <MaximumLength/>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin/>
      <Representation>
        <PublicId>3134649</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C3303:C25284</PreferredName>
        <Version>1</Version>
        <LongName>Pain Type</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C3303</PREFERRED_NAME>
            <LONG_NAME>Pain</LONG_NAME>
            <CON_ID>2202326</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25284</PREFERRED_NAME>
            <LONG_NAME>Type</LONG_NAME>
            <CON_ID>2202431</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
      <PermissibleValues>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Throbbing</VALIDVALUE>
          <VALUEMEANING>Throbbing</VALUEMEANING>
          <MEANINGDESCRIPTION>Brief Pain Inventory (BPI) Check Yes or No if the adjective applies to your pain; throbbing.</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS>C100317</MEANINGCONCEPTS>
          <MEANINGCONCEPTORIGIN>NCI Thesaurus</MEANINGCONCEPTORIGIN>
          <MEANINGCONCEPTDISPLAYORDER>0</MEANINGCONCEPTDISPLAYORDER>
          <PVBEGINDATE>2010-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>2582445</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Sharp</VALIDVALUE>
          <VALUEMEANING>Sharp</VALUEMEANING>
          <MEANINGDESCRIPTION>Sharp</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3161942</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
        <PermissibleValues_ITEM>
          <VALIDVALUE>Dull</VALIDVALUE>
          <VALUEMEANING>Dull</VALUEMEANING>
          <MEANINGDESCRIPTION>Dull</MEANINGDESCRIPTION>
          <MEANINGCONCEPTS/>
          <MEANINGCONCEPTORIGIN/>
          <MEANINGCONCEPTDISPLAYORDER/>
          <PVBEGINDATE>2010-11-18</PVBEGINDATE>
          <PVENDDATE/>
          <VMPUBLICID>3161943</VMPUBLICID>
          <VMVERSION>1</VMVERSION>
        </PermissibleValues_ITEM>
      </PermissibleValues>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Is the study tooth painful to</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Is the study tooth painful to cold. If yes, Quality of pain:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1721">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3164208</PUBLICID>
    <LONGNAME>Study Agent Dose Formation Text</LONGNAME>
    <PREFERREDNAME>STDY_DRG_FORM</PREFERREDNAME>
    <PREFERREDDEFINITION>Formation of the medicine for a study.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>NINDS:National Institute of Neurological Disorders and Stroke Common Data Element Project</ORIGIN>
    <REGISTRATIONSTATUS>Application</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3162523</PublicId>
      <PreferredName>STDY_DRG_DOSE</PreferredName>
      <PreferredDefinition>The amount of medicine taken, or radiation given, at one time.</PreferredDefinition>
      <LongName>Study Agent Dose</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435024</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1908</PreferredName>
        <Version>1</Version>
        <LongName>Drug or Chemical</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>2839674</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C63536:C1708</PreferredName>
        <Version>1</Version>
        <LongName>Study Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C63536</PREFERRED_NAME>
            <LONG_NAME>Study</LONG_NAME>
            <CON_ID>2553063</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2193052</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25488</PreferredName>
        <Version>1</Version>
        <LongName>Dose</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>NINDS:National Institute of Neurological Disorders and Stroke Common Data Element Project</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>3163968</PublicId>
      <PreferredName>DRG_FORM_TXT</PreferredName>
      <PreferredDefinition>Formationn of the medicine taken.</PreferredDefinition>
      <LongName>Agent Dose Formation Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2435024</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1908</PreferredName>
        <Version>1</Version>
        <LongName>Drug or Chemical</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>20</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>NINDS:National Institute of Neurological Disorders and Stroke Common Data Element Project</Origin>
      <Representation>
        <PublicId>3163967</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C1708:C25488:C25513:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Agent Dose Formation Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1708</PREFERRED_NAME>
            <LONG_NAME>Agent</LONG_NAME>
            <CON_ID>2202316</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>3</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25488</PREFERRED_NAME>
            <LONG_NAME>Dose</LONG_NAME>
            <CON_ID>2202287</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25513</PREFERRED_NAME>
            <LONG_NAME>Formation</LONG_NAME>
            <CON_ID>2203816</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Dose Form</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Dose Form</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>NINDS CDE Project</Name>
        <DocumentType>REFERENCE</DocumentType>
        <DocumentText>NINDS CDE Project</DocumentText>
        <URL>http://www.commondataelements.ninds.nih.gov/</URL>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Treatment/Intervention Data</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3151264</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Study Drug Compliance</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>3151268</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>6272292</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>NINDS</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <ClassificationSchemeItemName>Drugs</ClassificationSchemeItemName>
        <ClassificationSchemeItemType>GROUP_TYPE</ClassificationSchemeItemType>
        <CsiPublicId>10000418</CsiPublicId>
        <CsiVersion>1</CsiVersion>
      </CLASSIFICATIONSLIST_ITEM>
    </CLASSIFICATIONSLIST>
    <DATAELEMENTDERIVATION>
      <Methods/>
      <Rule/>
      <ConcatenationCharacter/>
    </DATAELEMENTDERIVATION>
  </DataElement>
  <DataElement num="1722">
    <RAI>2.16.840.1.113883.3.26.2</RAI>
    <PUBLICID>3165839</PUBLICID>
    <LONGNAME>PET Imaging Agent Manufactured Method Text</LONGNAME>
    <PREFERREDNAME>3165838v1.0:2598113v1.0</PREFERREDNAME>
    <PREFERREDDEFINITION>Text describing the series of actions used to synthesize a radioactive material used in Positron Emission Tomography (PET) imaging.</PREFERREDDEFINITION>
    <VERSION>1</VERSION>
    <WORKFLOWSTATUS>RELEASED</WORKFLOWSTATUS>
    <CONTEXTNAME>NCIP</CONTEXTNAME>
    <CONTEXTVERSION>1</CONTEXTVERSION>
    <ORIGIN>ACRIN:American College of Radiology Imaging Network</ORIGIN>
    <REGISTRATIONSTATUS>Standard</REGISTRATIONSTATUS>
    <DATAELEMENTCONCEPT>
      <PublicId>3165838</PublicId>
      <PreferredName>3165818v1.0:2717700v1.0</PreferredName>
      <PreferredDefinition>A series of actions used to synthesize a radioactive form of glucose from raw materials used in positron emission tomography (PET).</PreferredDefinition>
      <LongName>PET Imaging Agent Manufactured Method</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2233241</PublicId>
        <ContextName>CIP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>MEDICAL IMAGING</PreferredName>
        <Version>1</Version>
        <LongName>Medical Imaging</LongName>
      </ConceptualDomain>
      <ObjectClass>
        <PublicId>3165818</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C17007:C1966</PreferredName>
        <Version>1</Version>
        <LongName>Positron Emission Tomography Imaging Agent</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C17007</PREFERRED_NAME>
            <LONG_NAME>Positron Emission Tomography</LONG_NAME>
            <CON_ID>2224887</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C1966</PREFERRED_NAME>
            <LONG_NAME>Imaging Agent</LONG_NAME>
            <CON_ID>3162377</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>CTCAE_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </ObjectClass>
      <Property>
        <PublicId>2717700</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C43360:C16847</PreferredName>
        <Version>1</Version>
        <LongName>Manufacture Technique</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C43360</PREFERRED_NAME>
            <LONG_NAME>Manufacture</LONG_NAME>
            <CON_ID>2236530</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C16847</PREFERRED_NAME>
            <LONG_NAME>Technique</LONG_NAME>
            <CON_ID>2203854</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Property>
      <Origin>ACRIN:American College of Radiology Imaging Network</Origin>
    </DATAELEMENTCONCEPT>
    <VALUEDOMAIN>
      <PublicId>2598113</PublicId>
      <PreferredName>SHORT_RSN_TXT</PreferredName>
      <PreferredDefinition>Text describing a short reason up to 40 characters as to why the exam was not performed.</PreferredDefinition>
      <LongName>Short Reason Text</LongName>
      <Version>1</Version>
      <WorkflowStatus>RELEASED</WorkflowStatus>
      <ContextName>NCIP</ContextName>
      <ContextVersion>1</ContextVersion>
      <ConceptualDomain>
        <PublicId>2008556</PublicId>
        <ContextName>CTEP</ContextName>
        <ContextVersion>2.31</ContextVersion>
        <PreferredName>ASSESS_RESULTS</PreferredName>
        <Version>1</Version>
        <LongName>Assessment Results</LongName>
      </ConceptualDomain>
      <Datatype>CHARACTER</Datatype>
      <ValueDomainType>Non-enumerated</ValueDomainType>
      <MaximumLength>50</MaximumLength>
      <MinimumLength/>
      <DecimalPlace/>
      <MaximumValue/>
      <MinimumValue/>
      <Origin>IVI:caBIG In Vivo Imaging Workspace</Origin>
      <Representation>
        <PublicId>2598112</PublicId>
        <ContextName>NCIP</ContextName>
        <ContextVersion>1</ContextVersion>
        <PreferredName>C25249:C25638:C25704</PreferredName>
        <Version>1</Version>
        <LongName>Short Reason Text</LongName>
        <ConceptDetails>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25249</PREFERRED_NAME>
            <LONG_NAME>Short</LONG_NAME>
            <CON_ID>2206252</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>2</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25638</PREFERRED_NAME>
            <LONG_NAME>Reason</LONG_NAME>
            <CON_ID>2202901</CON_ID>
            <DEFINITION_SOURCE>NCI</DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>No</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>1</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
          <ConceptDetails_ITEM>
            <PREFERRED_NAME>C25704</PREFERRED_NAME>
            <LONG_NAME>Text</LONG_NAME>
            <CON_ID>2203863</CON_ID>
            <DEFINITION_SOURCE>NCI </DEFINITION_SOURCE>
            <ORIGIN>NCI Thesaurus</ORIGIN>
            <EVS_SOURCE>NCI_CONCEPT_CODE</EVS_SOURCE>
            <PRIMARY_FLAG_IND>Yes</PRIMARY_FLAG_IND>
            <DISPLAY_ORDER>0</DISPLAY_ORDER>
          </ConceptDetails_ITEM>
        </ConceptDetails>
      </Representation>
    </VALUEDOMAIN>
    <REFERENCEDOCUMENTSLIST>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>Method [of synthesis]</Name>
        <DocumentType>Preferred Question Text</DocumentType>
        <DocumentText>Method [of synthesis]</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>PET Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>If PET Imaging Agent is synthesized, provide the method by which it is synthesized:</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
      <REFERENCEDOCUMENTSLIST_ITEM>
        <Name>ACRIN Text</Name>
        <DocumentType>Alternate Question Text</DocumentType>
        <DocumentText>Method used to prepare agent in-house</DocumentText>
        <URL/>
        <Language>ENGLISH</Language>
        <DisplayOrder/>
      </REFERENCEDOCUMENTSLIST_ITEM>
    </REFERENCEDOCUMENTSLIST>
    <CLASSIFICATIONSLIST>
      <CLASSIFICATIONSLIST_ITEM>
        <ClassificationScheme>
          <PublicId>2192345</PublicId>
          <ContextName>NCIP</ContextName>
          <ContextVersion>1</ContextVersion>
          <PreferredName>Data Standards</PreferredName>
          <Version>1</Version>
        </ClassificationScheme>
        <Classifica